PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Modi, DA; Tagare, RD; Karthikeyan, S; Russo, A; Dean, M; Davis, DA; Lantvit, DD; Burdette, JE				Modi, D. A.; Tagare, R. D.; Karthikeyan, S.; Russo, A.; Dean, M.; Davis, D. A.; Lantvit, D. D.; Burdette, J. E.			PAX2 function, regulation and targeting in fallopiantube-derived high-grade serous ovarian cancer	ONCOGENE			English	Article							TUBE EPITHELIAL-CELLS; GENE-EXPRESSION; BRCT-DOMAIN; DNA-DAMAGE; STATHMIN 1; TRANSFORMATION; MODEL; PTIP; P53; CARCINOGENESIS	The fallopian tube epithelium (FTE) is one of the progenitor populations for high-grade serous ovarian cancer (HGSC). Loss of PAX2 is the earliest known molecular aberration in the FTE occurring in serous carcinogenesis followed by a mutation in p53. Pathological studies report consistent loss of PAX2 in benign lesions as well as serous tumors. In the current study, the combined loss of PAX2 and expression of the R273H p53 mutant protein in murine oviductal epithelial (MOE) cells enhanced proliferation and growth in soft agar in vitro but was insufficient to drive tumorigenesis in vivo. A serially passaged model was generated to investigate the role of aging, but was also insufficient to drive tumorigenesis. These models recapitulate early benign lesions and suggest that a latency period exists between loss of PAX2, p53 mutation and tumor formation. Stathmin and fut8 were identified as downstream targets regulated by loss of PAX2 and mutation of p53 in MOE cells. Re-expression of PAX2 in PAX2-null human HGSC cells reduced cell survival via apoptosis. Phosphatase and tensin homolog (PTEN)(shRNA) negatively regulated PAX2 expression and stable re-expression of PAX2 in MOE: PTENshRNA cells significantly reduced proliferation and peritoneal tumor formation in athymic nude mice. PAX2 was determined to be a direct transcriptional target that was activated by wild-type p53, whereas mutant p53 inhibited PAX2 transcription in MOE cells. A small molecule screen using the proximal PAX2 promoter driving luciferase identified four small molecules that were able to enhance PAX2 mRNA expression in MOE cells. PAX2 re-expression in HGSC cells and PTEN-deficient oviductal tumors may have the potential to induce apoptosis. In summary, mutant p53 and PTEN loss negatively regulated PAX2 and PAX2 re-expression in HGSC cells induced cell death.	[Modi, D. A.; Tagare, R. D.; Karthikeyan, S.; Russo, A.; Dean, M.; Davis, D. A.; Lantvit, D. D.; Burdette, J. E.] Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Ctr Biomol Sci, M-C 870,Mol Biol Res Bldg,900 S Ashland Ave, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Burdette, JE (corresponding author), Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Ctr Biomol Sci, M-C 870,Mol Biol Res Bldg,900 S Ashland Ave, Chicago, IL 60607 USA.	joannab@uic.edu		Karthikeyan, Subbulakshmi/0000-0003-0815-164X; Dean, Matthew/0000-0001-5014-9311	American Cancer Society (ACS) [RSG-12-230-01]; NIH [R21 CA208610-01]; Office of the Director, National Institutes of Health (OD); National Center for Complementary & Integrative Health (NCCIH) [T32AT007533]; Tell Every Amazing Lady About Ovarian Cancer; NATIONAL CANCER INSTITUTE [R21CA208610] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [T32AT007533] Funding Source: NIH RePORTER	American Cancer Society (ACS)(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Director, National Institutes of Health (OD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health (NCCIH); Tell Every Amazing Lady About Ovarian Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by American Cancer Society (ACS) grant RSG-12-230-01 (J.E.B.), NIH R21 CA208610-01 (J.E.B.), the Office of the Director, National Institutes of Health (OD) & National Center for Complementary & Integrative Health (NCCIH; T32AT007533; M.D.) and Tell Every Amazing Lady About Ovarian Cancer, T.E.A.L. (J.E.B). We thank Dr Barbara Vanderhyden (University of Ottawa) for kindly providing MOE and MOSE cells, Dr Kwong Wong (University of Texas, M.D. Anderson Cancer Center) for the NEO and PAX2 plasmids, Dr Gregory Dressler (University of Michigan) for the PAX2-Luc plasmid, Dr Kiira Ratia (University of Illinois at Chicago, High Throughput Screen Core) for providing compounds for screening.	Al-Hujaily EM, 2015, CANCER PREV RES, V8, P1163, DOI 10.1158/1940-6207.CAPR-15-0121-T; Alli E, 2002, CANCER RES, V62, P6864; Auersperg N, 2011, INT J GYNECOL PATHOL, V30, P12, DOI 10.1097/PGP.0b013e3181f45f3e; Baldassarre G, 2005, CANCER CELL, V7, P51, DOI 10.1016/j.ccr.2004.11.025; Cai Y, 2002, J BIOL CHEM, V277, P1217, DOI 10.1074/jbc.M109663200; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Chen EY, 2010, J PATHOL, V222, P110, DOI 10.1002/path.2739; Chen WL, 2016, BMC CANCER, V16, DOI 10.1186/s12885-015-1988-0; Dressler GR, 1999, INT J DEV BIOL, V43, P463; DRESSLER GR, 1990, DEVELOPMENT, V109, P787; Eddie SL, 2015, ONCOTARGET, V6, P20500, DOI 10.18632/oncotarget.3985; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Endsley MP, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00154; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hilliard TS, 2013, INT J MOL SCI, V14, P4762, DOI 10.3390/ijms14034762; Jazaeri AA, 2011, NEOPLASIA, V13, P899, DOI 10.1593/neo.11138; Karst AM, 2011, GYNECOL ONCOL, V123, P5, DOI 10.1016/j.ygyno.2011.05.021; Karst AM, 2011, P NATL ACAD SCI USA, V108, P7547, DOI 10.1073/pnas.1017300108; Kim J, 2012, P NATL ACAD SCI USA, V109, P3921, DOI 10.1073/pnas.1117135109; Kim JS, 2005, IMMUNOLOGY, V115, P375, DOI 10.1111/j.1365-2567.2005.02156.x; Kindelberger DW, 2007, AM J SURG PATHOL, V31, P161, DOI 10.1097/01.pas.0000213335.40358.47; King SM, 2013, CARCINOGENESIS, V34, P1125, DOI 10.1093/carcin/bgt003; King SM, 2011, ENDOCR-RELAT CANCER, V18, P627, DOI 10.1530/ERC-11-0107; Lechner MS, 2000, NUCLEIC ACIDS RES, V28, P2741, DOI 10.1093/nar/28.14.2741; Levanon K, 2010, ONCOGENE, V29, P1103, DOI 10.1038/onc.2009.402; Lin Y, 2008, CURR CANCER DRUG TAR, V8, P634, DOI 10.2174/156800908786241050; Medeiros F, 2006, AM J SURG PATHOL, V30, P230, DOI 10.1097/01.pas.0000180854.28831.77; Mehra Karishma, 2011, Front Biosci (Elite Ed), V3, P625, DOI 10.2741/e275; Mitra AK, 2015, GYNECOL ONCOL, V138, P372, DOI 10.1016/j.ygyno.2015.05.040; Monte NM, 2010, CANCER RES, V70, P6225, DOI 10.1158/0008-5472.CAN-10-0149; Ning G, 2014, J PATHOL, V234, P478, DOI 10.1002/path.4417; Novak M, 2015, GYNECOL ONCOL, V139, P104, DOI 10.1016/j.ygyno.2015.07.100; Patel SR, 2007, DEV CELL, V13, P580, DOI 10.1016/j.devcel.2007.09.004; Patel SR, 2004, DEV BIOL, V267, P505, DOI 10.1016/j.ydbio.2003.11.002; Perets R, 2013, CANCER CELL, V24, P751, DOI 10.1016/j.ccr.2013.10.013; Piek JMJ, 2001, J PATHOL, V195, P451, DOI 10.1002/path.1000; Quartuccio SM, 2015, INT J CANCER, V137, P1528, DOI 10.1002/ijc.29528; Quick CM, 2012, MODERN PATHOL, V25, P449, DOI 10.1038/modpathol.2011.175; Rana S, 2008, EXPERT REV ANTICANC, V8, P1461, DOI 10.1586/14737140.8.9.1461; Rodgers LH, 2016, ONCOTARGET, V7, P32785, DOI 10.18632/oncotarget.9051; Roh MH, 2010, MODERN PATHOL, V23, P1316, DOI 10.1038/modpathol.2010.119; Saifudeen Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044869; Shaw PA, 2009, MODERN PATHOL, V22, P1133, DOI 10.1038/modpathol.2009.89; Sherman-Baust CA, 2014, J PATHOL, V233, P228, DOI 10.1002/path.4353; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Song HJ, 2013, INT J MOL SCI, V14, P6090, DOI 10.3390/ijms14036090; Stayner CK, 1998, J BIOL CHEM, V273, P25472, DOI 10.1074/jbc.273.39.25472; Sukerkar PA, 2011, BIOCONJUGATE CHEM, V22, P2304, DOI 10.1021/bc2003555; Vasudevan D, 2015, CANCER RES, V75, P5299, DOI 10.1158/0008-5472.CAN-15-1582; Wu JX, 2009, J BIOL CHEM, V284, P18078, DOI 10.1074/jbc.M109.002527; Yamamoto Y, 2016, J PATHOL, V238, P519, DOI 10.1002/path.4649; Zhang SL, 2015, CANCER RES, V75, P3842, DOI 10.1158/0008-5472.CAN-13-1079	52	11	11	0	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 25	2017	36	21					3015	3024		10.1038/onc.2016.455	http://dx.doi.org/10.1038/onc.2016.455			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EV7ZP	27991925	Green Accepted			2022-12-26	WOS:000402000400009
J	Bigarella, CL; Li, JF; Rimmele, P; Liang, R; Sobol, RW; Ghaffari, S				Bigarella, Carolina L.; Li, Jianfeng; Rimmele, Pauline; Liang, Raymond; Sobol, Robert W.; Ghaffari, Saghi			FOXO3 Transcription Factor Is Essential for Protecting Hematopoietic Stem and Progenitor Cells from Oxidative DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; INDUCED APOPTOSIS; STRESS; XRCC1; MAINTENANCE; PATHWAY; PHOSPHORYLATION; DIFFERENTIATION; HOMEOSTASIS; INHIBITION	Accumulation of damaged DNA in hematopoietic stem cells (HSC) is associated with chromosomal abnormalities, genomic instability, and HSC aging and might promote hematological malignancies with age. Despite this, the regulatory pathways implicated in the HSC DNA damage response have not been fully elucidated. One of the sources of DNA damage is reactive oxygen species (ROS) generated by both exogenous and endogenous insults. Balancing ROS levels in HSC requires FOXO3, which is an essential transcription factor for HSC maintenance implicated in HSC aging. Elevated ROS levels result in defective Foxo3(-/-) HSC cycling, among many other deficiencies. Here, we show that loss of FOXO3 leads to the accumulation of DNA damage in primitive hematopoietic stem and progenitor cells (HSPC), associated specifically with reduced expression of genes implicated in the repair of oxidative DNA damage. We provide further evidence that Foxo3(-/-) HSPC are defective in DNAdamage repair. Specifically, we show that the base excision repair pathway, the main pathway utilized for the repair of oxidative DNA damage, is compromised in Foxo3(-/-) primitive hematopoietic cells. Treating mice in vivo withN-acetylcysteine reduces ROS levels, rescues HSC cycling defects, and partially mitigates HSPC DNA damage. These results indicate that DNA damage accrued as a result of elevated ROS in Foxo3(-/-) mutant HSPC is at least partially reversible. Collectively, our findings suggest that FOXO3 serves as a protector of HSC genomic stability and health.	[Bigarella, Carolina L.; Rimmele, Pauline; Liang, Raymond; Ghaffari, Saghi] Icahn Sch Med Mt Sinai, Dept Cell Dev & Regenerat Biol, New York, NY 10029 USA; [Li, Jianfeng; Sobol, Robert W.] Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, Mobile, AL 36604 USA; [Liang, Raymond; Ghaffari, Saghi] Icahn Sch Med Mt Sinai, Dev & Stem Cell Biol Multidisciplinary Training A, New York, NY 10029 USA; [Ghaffari, Saghi] Icahn Sch Med Mt Sinai, Dept Med, Div Hematol & Oncol, New York, NY 10029 USA; [Ghaffari, Saghi] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA; [Ghaffari, Saghi] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; University of South Alabama; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Ghaffari, S (corresponding author), Icahn Sch Med Mt Sinai, Dept Cell Dev & Regenerat Biol, New York, NY 10029 USA.	saghi.ghaffari@mssm.edu	Sobol, Robert W./E-4125-2013	Sobol, Robert W./0000-0001-7385-3563	National Institutes of Health [CA148629, ES025138, CA205975, HL116365, T32 GM08553-13]; Myeloproliferative Neoplasm Foundation; Tisch Cancer Institute; American Society of Hematology; Roche Translational and Clinical Research Center; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA148629, R01CA205975] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R43ES025138] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Myeloproliferative Neoplasm Foundation; Tisch Cancer Institute; American Society of Hematology; Roche Translational and Clinical Research Center; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by National Institutes of Health Grants CA148629 and ES025138 (to R.W.S.) and CA205975 and HL116365, Myeloproliferative Neoplasm Foundation, Tisch Cancer Institute, and American Society of Hematology (to S.G.). R.W.S. is a scientific consultant for Trevigen, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by a Roche Translational and Clinical Research Center-Young Investigator award.; Supported by National Institutes of Health Grant T32 GM08553-13 and an American Heart Association fellowship.	Ahn JS, 2016, ONCOGENE, V35, P2235, DOI 10.1038/onc.2015.285; Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016; Bigarella C., 2013, BLOOD, V122, P4199; Bigarella CL, 2014, DEVELOPMENT, V141, P4206, DOI 10.1242/dev.107086; Brenkman AB, 2010, FASEB J, V24, P4271, DOI 10.1096/fj.10-158717; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; Campalans A, 2015, MOL CELL BIOL, V35, P1648, DOI 10.1128/MCB.00134-15; Chapuis N, 2010, BLOOD, V116, P4240, DOI 10.1182/blood-2009-12-260711; COMMONER B, 1954, NATURE, V174, P689, DOI 10.1038/174689a0; Eijkelenboom A, 2013, CELL REP, V5, P1664, DOI 10.1016/j.celrep.2013.11.031; Fang QM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6513; Ghaffari S, 2003, P NATL ACAD SCI USA, V100, P6523, DOI 10.1073/pnas.0731871100; Ghosh S, 2015, NEUROBIOL AGING, V36, P2319, DOI 10.1016/j.neurobiolaging.2015.04.004; Greer EL, 2008, ACTA PHYSIOL, V192, P19, DOI 10.1111/j.1748-1716.2007.01780.x; Gu TL, 2004, BLOOD, V103, P4622, DOI 10.1182/blood-2003-03-0820; Hillion J, 1997, BLOOD, V90, P3714, DOI 10.1182/blood.V90.9.3714; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Janik J, 2011, MUTAT RES-FUND MOL M, V709-10, P21, DOI 10.1016/j.mrfmmm.2011.02.009; Kuo LJ, 2008, IN VIVO, V22, P305; Lagadinou ED, 2013, CELL STEM CELL, V12, P329, DOI 10.1016/j.stem.2012.12.013; Lee JY, 2010, CELL STEM CELL, V7, P593, DOI 10.1016/j.stem.2010.09.015; Li J, 2010, BLOOD, V115, P1545, DOI 10.1182/blood-2009-07-234385; Li XL, 2015, J BIOL CHEM, V290, P2715, DOI 10.1074/jbc.M114.619536; Liang R, 2016, CELL CYCLE, V15, P861, DOI 10.1080/15384101.2015.1123355; Liang R, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005526; Liang R, 2014, ANTIOXID REDOX SIGN, V20, P1902, DOI 10.1089/ars.2013.5300; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Marty C, 2013, LEUKEMIA, V27, P2187, DOI 10.1038/leu.2013.102; Mehta A, 2015, IMMUNITY, V42, P1021, DOI 10.1016/j.immuni.2015.05.017; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Miyamoto K, 2008, BLOOD, V112, P4485, DOI 10.1182/blood-2008-05-159848; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Muslimovic A, 2008, NAT PROTOC, V3, P1187, DOI 10.1038/nprot.2008.93; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; OLIVE PL, 1990, RADIAT RES, V122, P86, DOI 10.2307/3577587; Pellicano F, 2014, STEM CELLS, V32, P2324, DOI 10.1002/stem.1748; Rimmele P, 2014, STEM CELL R IN PRESS, V3, P1, DOI DOI 10.1016/J.STEMCR.2014.04.015; Rimmele P, 2015, EMBO REP, V16, P1164, DOI 10.15252/embr.201439704; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Santamaria CM, 2009, LEUKEMIA RES, V33, P1706, DOI 10.1016/j.leukres.2009.04.024; Santo EE, 2016, CELL CYCLE, V15, P879, DOI 10.1080/15384101.2016.1151721; Santos MA, 2014, NATURE, V514, P107, DOI 10.1038/nature13483; Scheijen B, 2004, ONCOGENE, V23, P3338, DOI 10.1038/sj.onc.1207456; Svilar D, 2012, JOVE-J VIS EXP, DOI 10.3791/4168; Svilar D, 2011, ANTIOXID REDOX SIGN, V14, P2491, DOI 10.1089/ars.2010.3466; Sykes SM, 2011, CELL, V146, P697, DOI 10.1016/j.cell.2011.07.032; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Vandenberg CJ, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.396; Walter D, 2015, NATURE, V520, P549, DOI 10.1038/nature14131; Yahata T, 2011, BLOOD, V118, P2941, DOI 10.1182/blood-2011-01-330050; Yalcin S, 2008, J BIOL CHEM, V283, P25692, DOI 10.1074/jbc.M800517200; Yalcin S, 2010, EMBO J, V29, P4118, DOI 10.1038/emboj.2010.292; Zhang X, 2014, AM J HEMATOL, V89, P954, DOI 10.1002/ajh.23786; Zhang X, 2011, NAT CELL BIOL, V13, P1092, DOI 10.1038/ncb2293; Zhang X, 2011, CURR DRUG TARGETS, V12, P1267, DOI 10.2174/138945011796150325	55	36	39	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					3005	3015		10.1074/jbc.M116.769455	http://dx.doi.org/10.1074/jbc.M116.769455			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	27994057	hybrid, Green Published			2022-12-26	WOS:000395535100039
J	Li, YN; Schang, G; Boehm, U; Deng, CX; Graff, J; Bernard, DJ				Li, Yining; Schang, Gauthier; Boehm, Ulrich; Deng, Chu-Xia; Graff, Jonathan; Bernard, Daniel J.			SMAD3 Regulates Follicle-stimulating Hormone Synthesis by Pituitary Gonadotrope Cells in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SUBUNIT TRANSCRIPTION; AMINO-ACID-SEQUENCE; TARGETED DISRUPTION; LUTEINIZING-HORMONE; GENE-EXPRESSION; GNRH RECEPTOR; DNA-BINDING; ACTIVATOR PROTEIN-1; NORMAL PUBERTY; FSH SYNTHESIS	Pituitary follicle-stimulating hormone (FSH) is an essential regulator of fertility in females and of quantitatively normal spermatogenesis in males. Pituitary-derived activins are thought to act as major stimulators of FSH synthesis by gonadotrope cells. In vitro, activins signal via SMAD3, SMAD4, and forkhead box L2 (FOXL2) to regulate transcription of the FSH beta subunit gene (Fshb). Consistent with this model, gonadotrope-specific Smad4 or Foxl2 knock-out mice have greatly reduced FSH and are subfertile. The role of SMAD3 in vivo is unresolved; however, residual FSH production in Smad4 conditional knockout mice may derive from partial compensation by SMAD3 and its ability to bind DNA in the absence of SMAD4. To test this hypothesis and determine the role of SMAD3 in FSH biosynthesis, we generated mice lacking both the SMAD3 DNA binding domain and SMAD4 specifically in gonadotropes. Conditional knock-out females were hypogonadal, acyclic, and sterile and had thread-like uteri; their ovaries lacked antral follicles and corpora lutea. Knock-out males were fertile but had reduced testis weights and epididymal sperm counts. These phenotypes were consistent with those of Fshb knock-out mice. Indeed, pituitary Fshb mRNA levels were nearly undetectable in both male and female knock-outs. In contrast, gonadotropin-releasing hormone receptor mRNA levels were significantly elevated in knock-outs in both sexes. Interestingly, luteinizing hormone production was altered in a sex-specific fashion. Overall, our analyses demonstrate that SMAD3 is required for FSH synthesis in vivo.	[Li, Yining; Schang, Gauthier; Bernard, Daniel J.] McGill Univ, Dept Pharmacol & Therapeut, Ctr Res Reprod & Dev, Montreal, PQ H3G 1Y6, Canada; [Boehm, Ulrich] Univ Saarland, Dept Pharmacol & Toxicol, Sch Med, D-66421 Homburg, Germany; [Deng, Chu-Xia] Univ Macau, Fac Hlth Sci, Macau Sar 999078, Peoples R China; [Graff, Jonathan] Univ Texas Southwestern, Dept Dev Biol, Dallas, TX 75390 USA	McGill University; Saarland University; University of Macau; University of Texas System; University of Texas Southwestern Medical Center Dallas	Bernard, DJ (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, 3655 Promenade Sir William Osler,Rm 1315, Montreal, PQ H3G 1Y6, Canada.	daniel.bernard@mcgill.ca		Bernard, Daniel/0000-0001-5365-5586	Canadian Institutes of Health Research Operating Grant [MOP-133394]; Natural Sciences and Engineering Research Council of Canada Discovery Grant [2015-05178]; Samuel Solomon Fellowship in Endocrinology from McGill University; Eunice Kennedy Shriver NICHD/National Institutes of Health (National Centers for Translational Research in Reproduction and Infertility) [P50-HD28934]; Canadian Foundation for Innovation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD028934] Funding Source: NIH RePORTER	Canadian Institutes of Health Research Operating Grant(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Samuel Solomon Fellowship in Endocrinology from McGill University; Eunice Kennedy Shriver NICHD/National Institutes of Health (National Centers for Translational Research in Reproduction and Infertility); Canadian Foundation for Innovation(Canada Foundation for Innovation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by Canadian Institutes of Health Research Operating Grant MOP-133394 (to D.J.B.), Natural Sciences and Engineering Research Council of Canada Discovery Grant 2015-05178 (to D.J.B.), and a Samuel Solomon Fellowship in Endocrinology from McGill University (to Y.L.). The University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core is supported by Eunice Kennedy Shriver NICHD/National Institutes of Health (National Centers for Translational Research in Reproduction and Infertility) Grant P50-HD28934. The Cell Vision Core Facility for Flow Cytometry and Single Cell Analysis at the McGill Life Science Complex was supported by funding from the Canadian Foundation for Innovation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abel MH, 2000, ENDOCRINOLOGY, V141, P1795, DOI 10.1210/en.141.5.1795; Bernard DJ, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-52; Bernard DJ, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.107797; Bernard DJ, 2010, FERTIL STERIL, V93, P2465, DOI 10.1016/j.fertnstert.2010.03.034; Bernard DJ, 2004, MOL ENDOCRINOL, V18, P606, DOI 10.1210/me.2003-0264; BIELINSKA M, 1994, MOL ENDOCRINOL, V8, P919, DOI 10.1210/me.8.7.919; Blount AL, 2009, J BIOL CHEM, V284, P7631, DOI 10.1074/jbc.M806676200; Bull P, 2000, MOL HUM REPROD, V6, P582, DOI 10.1093/molehr/6.7.582; Caligioni CS, 2009, CURR PROTOC NEUROSCI, V4, p4I, DOI DOI 10.1002/0471142301.NSA04IS48; Calonge MJ, 1999, J BIOL CHEM, V274, P33637, DOI 10.1074/jbc.274.47.33637; CARROLL RS, 1989, MOL ENDOCRINOL, V3, P1969, DOI 10.1210/mend-3-12-1969; Chacko BM, 2004, MOL CELL, V15, P813, DOI 10.1016/j.molcel.2004.07.016; Clark AD, 2003, FERTIL STERIL, V79, P379, DOI 10.1016/S0015-0282(02)04660-5; Corpuz PS, 2010, MOL ENDOCRINOL, V24, P1037, DOI 10.1210/me.2009-0425; Coss D, 2005, MOL ENDOCRINOL, V19, P2610, DOI 10.1210/me.2005-0047; Dalkin AC, 2001, ENDOCRINOLOGY, V142, P139, DOI 10.1210/en.142.1.139; Dalkin AC, 1999, ENDOCRINOLOGY, V140, P903, DOI 10.1210/en.140.2.903; Datto MB, 1999, MOL CELL BIOL, V19, P2495; Dennler S, 1999, ONCOGENE, V18, P1643, DOI 10.1038/sj.onc.1202729; Dierich A, 1998, P NATL ACAD SCI USA, V95, P13612, DOI 10.1073/pnas.95.23.13612; Ellsworth BS, 2003, MOL CELL ENDOCRINOL, V206, P93, DOI 10.1016/S0303-7207(03)00235-1; FIDDES J C, 1981, Journal of Molecular and Applied Genetics, V1, P3; Fortin J, 2014, FASEB J, V28, P3396, DOI 10.1096/fj.14-249532; Fortin J, 2014, FASEB J, V28, P1474, DOI 10.1096/fj.13-237818; Fortin J, 2010, CELL SIGNAL, V22, P936, DOI 10.1016/j.cellsig.2010.01.019; Ghochani Y, 2012, ENDOCRINOLOGY, V153, P2023, DOI 10.1210/en.2011-1763; GOYETTE MC, 1992, MOL CELL BIOL, V12, P1387, DOI 10.1128/MCB.12.3.1387; Han SO, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-66; Ho CC, 2011, MOL CELL ENDOCRINOL, V332, P242, DOI 10.1016/j.mce.2010.10.019; Huang HJ, 2001, ENDOCRINOLOGY, V142, P2267, DOI 10.1210/en.142.6.2267; Huhtaniemi IT, 2005, ENDOCRINE, V26, P207, DOI 10.1385/ENDO:26:3:207; Kaiser UB, 1997, ENDOCRINOLOGY, V138, P1224, DOI 10.1210/en.138.3.1224; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; Lamba P, 2006, J MOL ENDOCRINOL, V36, P201, DOI 10.1677/jme.1.01961; Lamba P, 2010, ENDOCRINOLOGY, V151, P5456, DOI 10.1210/en.2010-0605; Lamba P, 2009, MOL ENDOCRINOL, V23, P1001, DOI 10.1210/me.2008-0324; Layman LC, 2002, J CLIN ENDOCR METAB, V87, P3702, DOI 10.1210/jc.87.8.3702; Li QL, 2008, MOL CELL BIOL, V28, P7001, DOI 10.1128/MCB.00732-08; Lindstedt G, 1998, CLIN CHEM LAB MED, V36, P663, DOI 10.1515/CCLM.1998.118; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; MATTHEWS CH, 1993, NAT GENET, V5, P83, DOI 10.1038/ng0993-83; McGillivray SM, 2007, ENDOCRINOLOGY, V148, P762, DOI 10.1210/en.2006-0952; Oakes CC, 2007, J PHARMACOL EXP THER, V322, P1171, DOI 10.1124/jpet.107.121699; Pangas SA, 2000, TRENDS ENDOCRIN MET, V11, P309, DOI 10.1016/S1043-2760(00)00294-0; RATHNAM P, 1975, J BIOL CHEM, V250, P6735; Rejon CA, 2013, CELL SIGNAL, V25, P1403, DOI 10.1016/j.cellsig.2013.03.002; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Simoni M, 1997, ENDOCR REV, V18, P739, DOI 10.1210/er.18.6.739; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Steyn FJ, 2013, ENDOCRINOLOGY, V154, P4939, DOI 10.1210/en.2013-1502; Suszko MI, 2005, MOL ENDOCRINOL, V19, P1849, DOI 10.1210/me.2004-0475; Themmen APN, 2005, REPRODUCTION, V130, P263, DOI 10.1530/rep.1.00663; Tomic D, 2004, MOL ENDOCRINOL, V18, P2224, DOI 10.1210/me.2003-0414; Tran S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076642; Tran S, 2013, MOL ENDOCRINOL, V27, P407, DOI 10.1210/me.2012-1286; Tran S, 2011, MOL ENDOCRINOL, V25, P1170, DOI 10.1210/me.2010-0480; Trarbach EB, 2007, PITUITARY, V10, P381, DOI 10.1007/s11102-007-0061-7; Wang A, 2007, AM J PHYSIOL-RENAL, V293, pF1657, DOI 10.1152/ajprenal.00274.2007; Wang Y, 2012, NANO, V7, DOI 10.1142/S1793292012500427; Wang Y, 2008, ENDOCRINOLOGY, V149, P5577, DOI 10.1210/en.2008-0220; Wen S, 2008, ENDOCRINOLOGY, V149, P2701, DOI 10.1210/en.2007-1502; West BE, 2004, ENDOCRINOLOGY, V145, P4866, DOI 10.1210/en.2004-0598; Wreford NG, 2001, ENDOCRINOLOGY, V142, P2916, DOI 10.1210/en.142.7.2916; Yagi K, 1999, J BIOL CHEM, V274, P703, DOI 10.1074/jbc.274.2.703; Yang X, 2002, GENESIS, V32, P80, DOI 10.1002/gene.10029; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4	68	37	39	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2301	2314		10.1074/jbc.M116.759167	http://dx.doi.org/10.1074/jbc.M116.759167			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	27994055	Green Published, hybrid			2022-12-26	WOS:000395530300022
J	Jacobsen, FW; Stevenson, R; Li, C; Salimi-Moosavi, H; Liu, L; Wen, J; Luo, QZ; Daris, K; Buck, L; Miller, S; Ho, SY; Wang, W; Chen, Q; Walker, K; Wypych, J; Narhi, L; Gunasekaran, K				Jacobsen, Frederick W.; Stevenson, Riki; Li, Cynthia; Salimi-Moosavi, Hossein; Liu, Ling; Wen, Jie; Luo, Quanzhou; Daris, Kristine; Buck, Lynette; Miller, Sterling; Ho, Shu-Yin; Wang, Wei; Chen, Qing; Walker, Kenneth; Wypych, Jette; Narhi, Linda; Gunasekaran, Kannan			Engineering an IgG Scaffold Lacking Effector Function with Optimized Developability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody engineering; drug development; Fc receptor; immunoglobulin G (IgG); protein stability; aglycosylated IgG; antibody developability; antibody-dependent cellular cytotoxicity; complement-dependent cytotoxicity; disulfide engineering	FC-GAMMA-RIII; ANTIBODY THERAPEUTICS; BINDING-SITE; IN-VIVO; STABILITY; GLYCOSYLATION; ISOFORMS; SUBCLASS	IgG isotypes can differentially bind to Fc receptors and complement, making the selection of which isotype to pursue for development of a particular therapeutic antibody important in determining the safety and efficacy of the drug. IgG2 and IgG4 isotypes have significantly lower binding affinity to Fc receptors. Recent evidence suggests that the IgG2 isotype is not completely devoid of effector function, whereas the IgG4 isotype can undergo in vivo Fab arm exchange leading to bispecific antibody and off-target effects. Here an attempt was made to engineer an IgG1-based scaffold lacking effector function but with stability equivalent to that of the parent IgG1. Care was taken to ensure that both stability and lack of effector function was achieved with a minimum number of mutations. Among the Asn(297) mutants that result in lack of glycosylation and thus loss of effector function, we demonstrate that the N297G variant has better stability and developability compared with the N297Q or N297A variants. To further improve the stability of N297G, we introduced a novel engineered disulfide bond at a solvent inaccessible location in the CH2 domain. The resulting scaffold has stability greater than or equivalent to that of the parental IgG1 scaffold. Extensive biophysical analyses and pharmacokinetic (PK) studies in mouse, rat, and monkey further confirmed the developability of this unique scaffold, and suggest that it could be used for all Fc containing therapeutics (e.g. antibodies, bispecific antibodies, and Fc fusions) requiring lack of effector function or elimination of binding to Fc gamma receptors.	[Jacobsen, Frederick W.; Stevenson, Riki; Li, Cynthia; Salimi-Moosavi, Hossein; Liu, Ling; Wen, Jie; Luo, Quanzhou; Daris, Kristine; Buck, Lynette; Miller, Sterling; Ho, Shu-Yin; Wang, Wei; Chen, Qing; Walker, Kenneth; Wypych, Jette; Narhi, Linda; Gunasekaran, Kannan] Amgen Inc, Clin Immunol & Proc Dev, Biol Optimizat Therapeut Discovery, Thousand Oaks, CA 91320 USA	Amgen	Jacobsen, FW (corresponding author), One Amgen Ctr Dr,MS 29-2-A, Thousand Oaks, CA 91320 USA.; Gunasekaran, K (corresponding author), Affinita Biotech, 329 Oyster Point Blvd,3rd Floor, San Francisco, CA 94080 USA.	rjacobse@amgen.com; guna.kannan@yahoo.com			Amgen	Amgen(Amgen)	This work was supported by Amgen. All authors work or have worked at Amgen	Aalberse RC, 2002, IMMUNOLOGY, V105, P9, DOI 10.1046/j.0019-2805.2001.01341.x; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Aronson R, 2014, DIABETES CARE, V37, P2746, DOI 10.2337/dc13-0327; BERNSTEIN FC, 1978, ARCH BIOCHEM BIOPHYS, V185, P584, DOI 10.1016/0003-9861(78)90204-7; Chapman AP, 1999, NAT BIOTECHNOL, V17, P780, DOI 10.1038/11717; Clarke SJ, 2009, J CLIN ONCOL, V27; Demarest SJ, 2008, CURR OPIN DRUG DISC, V11, P675; Dillon TM, 2008, J BIOL CHEM, V283, P16206, DOI 10.1074/jbc.M709988200; Everds NE, 2013, TOXICOL PATHOL, V41, P280, DOI 10.1177/0192623312467400; Gong R, 2009, J BIOL CHEM, V284, P14203, DOI 10.1074/jbc.M900769200; GUDDAT LW, 1993, P NATL ACAD SCI USA, V90, P4271, DOI 10.1073/pnas.90.9.4271; Gunasekaran K, 1996, J MOL BIOL, V264, P191, DOI 10.1006/jmbi.1996.0633; Hari SB, 2010, BIOCHEMISTRY-US, V49, P9328, DOI 10.1021/bi100841u; Hristodorov D, 2013, MOL BIOTECHNOL, V54, P1056, DOI 10.1007/s12033-012-9612-x; Idusogie EE, 2000, J IMMUNOL, V164, P4178, DOI 10.4049/jimmunol.164.8.4178; Ishihara T, 2010, J CHROMATOGR B, V878, P2141, DOI 10.1016/j.jchromb.2010.06.003; Ito T, 2013, PROTEIN SCI, V22, P1542, DOI 10.1002/pro.2340; Jacobsen FW, 2011, J IMMUNOL, V186, P341, DOI 10.4049/jimmunol.1001685; Jefferis R, 2009, TRENDS PHARMACOL SCI, V30, P356, DOI 10.1016/j.tips.2009.04.007; Jung ST, 2011, CURR OPIN BIOTECH, V22, P858, DOI 10.1016/j.copbio.2011.03.002; Keymeulen B, 2010, DIABETOLOGIA, V53, P614, DOI 10.1007/s00125-009-1644-9; Leabman MK, 2013, MABS-AUSTIN, V5, P896, DOI 10.4161/mabs.26436; Liu HF, 2010, MABS-AUSTIN, V2, P480, DOI 10.4161/mabs.2.5.12645; Liu L, 2017, J BIOL CHEM, V292, P1876, DOI 10.1074/jbc.M116.748707; Mimura Y, 2000, MOL IMMUNOL, V37, P697, DOI 10.1016/S0161-5890(00)00105-X; Naso MF, 2010, MABS-AUSTIN, V2, P519, DOI 10.4161/mabs.2.5.13078; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Nimmerjahn F, 2007, J EXP MED, V204, P11, DOI 10.1084/jem.20061788; Nimmerjahn F, 2011, CURR TOP MICROBIOL, V350, P105, DOI 10.1007/82_2010_86; Reusch D, 2015, GLYCOBIOLOGY, V25, P1325, DOI 10.1093/glycob/cwv065; Schneider-Merck T, 2010, J IMMUNOL, V184, P512, DOI 10.4049/jimmunol.0900847; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; SOWDHAMINI R, 1989, PROTEIN ENG, V3, P95, DOI 10.1093/protein/3.2.95; Strohl WR, 2009, CURR OPIN BIOTECH, V20, P685, DOI 10.1016/j.copbio.2009.10.011; TAO MH, 1989, J IMMUNOL, V143, P2595; Warncke M, 2012, J IMMUNOL, V188, P4405, DOI 10.4049/jimmunol.1200090; Wypych J, 2008, J BIOL CHEM, V283, P16194, DOI 10.1074/jbc.M709987200; Zhang QC, 2013, J BIOL CHEM, V288, P16371, DOI 10.1074/jbc.M113.468397	39	46	56	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1865	1875		10.1074/jbc.M116.748525	http://dx.doi.org/10.1074/jbc.M116.748525			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27994062	Green Published, hybrid			2022-12-26	WOS:000395515600026
J	Akhoundan, M; Shadman, Z; Jandaghi, P; Aboeerad, M; Larijani, B; Jamshidi, Z; Ardalani, H; Nikoo, MK				Akhoundan, Mahdieh; Shadman, Zhaleh; Jandaghi, Parisa; Aboeerad, Maryam; Larijani, Bagher; Jamshidi, Zahra; Ardalani, Hamidreza; Nikoo, Mohsen Khoshniat			The Association of Bread and Rice with Metabolic Factors in Type 2 Diabetic Patients	PLoS One			English	Article							CORONARY-HEART-DISEASE; WHOLE-GRAIN INTAKE; GLYCEMIC INDEX; RISK-FACTORS; WHITE RICE; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; DIETARY FIBER; LOAD; MELLITUS	Purpose Carbohydrates are shown to have an important role in blood glucose control, type 2 diabetes and cardiovascular diseases risk. This is even more challenging when considering populations consuming refined grains diets. Bread and rice are staple foods which supply main proportion of Iranian calorie intake. This study was designed to investigate the effect of bread and rice intake on blood glucose control, lipid profile and anthropometric measurements in Iranian type 2 diabetic patients. Methods 426 patients with type 2 diabetes were included in this study. Anthropometric measurements were done using standard methods. Dietary information was assessed by a valid and reliable food frequency questionnaire (FFQ). Fasting blood glucose (FBG), glycated hemoglobin (HbA1c), serum triglycride (TG), total cholesterol (TC), low density lipoprotein (LDL) and high density lipoprotein (HDL) cholesterol were examined after 12-hour fasting. Results The results represented that people in the highest tertile compared to the lowest tertile of calorie adjusted total bread intake have higher FBG. FBG in the highest tertile of calorie adjusted total bread-rice intake was also significantly higher than the lowest. The association remained significant after adjusting for potential confounders. Rice intake showed no association with cardio-metabolic risk factors. Conclusion We founded that higher total bread intake and total bread-rice intake were associated with FBG in type 2 diabetic patients whereas rice intake was not associated with glucose and lipid profile. This result should be confirmed in prospective studies, considering varieties, glycemic index (GI), glycemic load (GL) and cooking method of bread and rice.	[Akhoundan, Mahdieh; Shadman, Zhaleh; Jandaghi, Parisa] Univ Tehran Med Sci, Diabet Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran; [Akhoundan, Mahdieh; Shadman, Zhaleh; Jandaghi, Parisa; Larijani, Bagher; Jamshidi, Zahra] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr EMRC, Endocrinol & Metab Res Inst, Tehran, Iran; [Aboeerad, Maryam; Nikoo, Mohsen Khoshniat] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran; [Ardalani, Hamidreza] Islamic Azad Univ, Dept Hort Sci, Sci & Res Branch, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Islamic Azad University	Nikoo, MK (corresponding author), Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran.	M.khoshniatnikoo@yahoo.com	Ardalani, Hamidreza/AAB-5211-2020; larijani, Bagher/ABE-3315-2020	Ardalani, Hamidreza/0000-0002-3245-7991; larijani, Bagher/0000-0001-5386-7597				Adeghate E, 2006, ANN NY ACAD SCI, V1084, P1, DOI 10.1196/annals.1372.029; ANDERSON JW, 1991, DIABETES CARE, V14, P1126, DOI 10.2337/diacare.14.12.1126; Azizi F, 2003, East Mediterr Health J, V9, P1122; Chen YJ, 2010, WORLD J GASTROENTERO, V16, P1512, DOI 10.3748/wjg.v16.i12.1512; Eshak ES, 2011, J NUTR, V141, P595, DOI 10.3945/jn.110.132167; Esmaillzadeh A, 2005, EUR J CLIN NUTR, V59, P353, DOI 10.1038/sj.ejcn.1602080; Ezenwaka CE, 2005, INDIAN J MED RES, V121, P23; Fasanmade O A, 2008, Afr J Med Med Sci, V37, P99; Foster-Powell K, 2002, AM J CLIN NUTR, V76, P5, DOI 10.1093/ajcn/76.1.5; Frei M, 2003, FOOD CHEM, V83, P395, DOI 10.1016/S0308-8146(03)00101-8; Gadsby R, 2002, ADV DRUG DELIVER REV, V54, P1165, DOI 10.1016/S0169-409X(02)00094-7; Ghaffarpour M, 1999, TEHRAN NASHRE OLUME, V7, P213; Kalantari N., 2005, NATL COMPREHENSIVE S; Kaseb F., 2010, IRAN J DIAB OBES, V2, P33; Kelishadi R, 2001, SHAHREKORD U MED SCI; Kelishadi R, 2012, INT J PREVENTIVE MED, V3, P394; Khosravi-Boroujeni H, 2013, J HEALTH POPUL NUTR, V31, P252; Kimiagar S. M., 1998, Eastern Mediterranean Health Journal, V4, P539; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Liu SM, 2001, CURR OPIN LIPIDOL, V12, P395, DOI 10.1097/00041433-200108000-00005; Liu SM, 2000, AM J PUBLIC HEALTH, V90, P1409, DOI 10.2105/AJPH.90.9.1409; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Manson J, 1993, AM J PREV MED, V10, P172; MCGEE DL, 1984, AM J EPIDEMIOL, V119, P667, DOI 10.1093/oxfordjournals.aje.a113788; McKeown NM, 2004, DIABETES CARE, V27, P538, DOI 10.2337/diacare.27.2.538; McKeown NM, 2002, AM J CLIN NUTR, V76, P390, DOI 10.1093/ajcn/76.2.390; Meyer KA, 2000, AM J CLIN NUTR, V71, P921; MILLER JB, 1992, AM J CLIN NUTR, V56, P1034, DOI 10.1093/ajcn/56.6.1034; Mirmiran P, 2010, PUBLIC HEALTH NUTR, V13, P654, DOI 10.1017/S1368980009991698; Mizoue T, 2006, J NUTR, V136, P1352, DOI 10.1093/jn/136.5.1352; Murakami K, 2006, AM J CLIN NUTR, V83, P1161, DOI 10.1093/ajcn/83.5.1161; Paolisso G, 1997, AM J HYPERTENS, V10, P346, DOI 10.1016/S0895-7061(96)00342-1; Radhika G, 2009, METABOLISM, V58, P675, DOI 10.1016/j.metabol.2009.01.008; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Sahyoun NR, 2006, AM J CLIN NUTR, V83, P124; Shadman Z, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-71; Slavin J, 2003, P NUTR SOC, V62, P129, DOI 10.1079/PNS2002221; Sugiyama M, 2003, EUR J CLIN NUTR, V57, P743, DOI 10.1038/sj.ejcn.1601606; Sun Q, 2010, ARCH INTERN MED, V170, P961, DOI 10.1001/archinternmed.2010.109; Villegas R, 2007, ARCH INTERN MED, V167, P2310, DOI 10.1001/archinte.167.21.2310; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yu DX, 2013, AM J EPIDEMIOL, V178, P1542, DOI 10.1093/aje/kwt178; Zarrati M, 2008, INT J ENDOCRINOL MET, V6, P200	43	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0167921	10.1371/journal.pone.0167921	http://dx.doi.org/10.1371/journal.pone.0167921			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005914	Green Published, Green Submitted, gold			2022-12-26	WOS:000392843200024
J	Starosolski, R				Starosolski, Roman			Skipping Selected Steps of DWT Computation in Lossless JPEG 2000 for Improved Bitrates	PLoS One			English	Article							IMAGE COMPRESSION; WAVELET TRANSFORMS; LIFTING STEPS	In order to improve bitrates of lossless JPEG 2000, we propose to modify the discrete wavelet transform (DWT) by skipping selected steps of its computation. We employ a heuristic to construct the skipped steps DWT (SS-DWT) in an image-adaptive way and define fixed SS-DWT variants. For a large and diverse set of images, we find that SS-DWT significantly improves bitrates of non-photographic images. From a practical standpoint, the most interesting results are obtained by applying entropy estimation of coding effects for selecting among the fixed SS-DWT variants. This way we get the compression scheme that, as opposed to the general SS-DWT case, is compliant with the JPEG 2000 part 2 standard. It provides average bitrate improvement of roughly 5% for the entire test-set, whereas the overall compression time becomes only 3% greater than that of the unmodified JPEG 2000. Bitrates of photographic and non-photographic images are improved by roughly 0.5% and 14%, respectively. At a significantly increased cost of exploiting a heuristic, selecting the steps to be skipped based on the actual bitrate instead of an estimated one, and by applying reversible denoising and lifting steps to SS-DWT, we have attained greater bitrate improvements of up to about 17.5% for non-photographic images.	[Starosolski, Roman] Silesian Tech Univ, Inst Informat, Fac Automat Control Elect & Comp Sci, Gliwice, Poland	Silesian University of Technology	Starosolski, R (corresponding author), Silesian Tech Univ, Inst Informat, Fac Automat Control Elect & Comp Sci, Gliwice, Poland.	rstarosolski@polsl.pl	Starosolski, Roman/AAF-6974-2019	Starosolski, Roman/0000-0003-1322-3345	Institute of Informatics, Silesian University of Technology [BK-219/RAU2/2016]; Silesian University of Technology [02/020/RGH15/0060]	Institute of Informatics, Silesian University of Technology; Silesian University of Technology	This work was supported by the BK-219/RAU2/2016 grant from the Institute of Informatics, Silesian University of Technology and by the 02/020/RGH15/0060 grant from the Silesian University of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, 230082 ISOIEC, P701; [Anonymous], 2004, 154442 ISOIEC; Boulgouris NV, 2001, IEEE T IMAGE PROCESS, V10, P1, DOI 10.1109/83.892438; Bruylants T, 2015, SIGNAL PROCESS-IMAGE, V31, P112, DOI 10.1016/j.image.2014.12.007; Claypoole RL, 2003, IEEE T IMAGE PROCESS, V12, P1449, DOI 10.1109/TIP.2003.817237; Daubechies I, 1998, J FOURIER ANAL APPL, V4, P247, DOI 10.1007/BF02476026; Dufaux F, 2009, IEEE SIGNAL PROC MAG, V26, P195, DOI 10.1109/MSP.2009.934187; International Telecommunications Union, 2012, T832 ITUT; ISO/ IEC, 2004, 154441 ISOIEC; ISO/IEC and ITU-T, 2006, 144951 ISOIEC; ISO/IEC and ITU-T, 2011, 1544410 ISOIEC; MALLAT SG, 1989, IEEE T PATTERN ANAL, V11, P674, DOI 10.1109/34.192463; MARTUCCI SA, 1990, 1990 IEEE INTERNATIONAL SYMP ON CIRCUITS AND SYSTEMS, VOLS 1-4, P1310, DOI 10.1109/ISCAS.1990.112371; Starosolski R, 2016, PREPRINT; Starosolski R, 2016, J ELECTRON IMAGING, V25, DOI 10.1117/1.JEI.25.4.043025; Starosolski R, 2015, SIGNAL PROCESS-IMAGE, V39, P249, DOI 10.1016/j.image.2015.09.013; Strutz T, 2015, IEEE SIGNAL PROC LET, V22, P1269, DOI 10.1109/LSP.2015.2397034; Strutz T, 2013, IEEE T CIRC SYST VID, V23, P1249, DOI 10.1109/TCSVT.2013.2242612; Sullivan GJ, 2012, IEEE T CIRC SYST VID, V22, P1649, DOI 10.1109/TCSVT.2012.2221191; Taubman DS, 2004, JPEG2000 IMAGE COMPR; Weinberger MJ, 2000, IEEE T IMAGE PROCESS, V9, P1309, DOI 10.1109/83.855427	21	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168704	10.1371/journal.pone.0168704	http://dx.doi.org/10.1371/journal.pone.0168704			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006015	Green Published, Green Submitted, gold			2022-12-26	WOS:000392843200085
J	Takada, H; Shimada, T; Dey, D; Quyyum, MZ; Nakano, M; Ishiguro, A; Yoshida, H; Yamamoto, K; Sen, R; Ishihama, A				Takada, Hiraku; Shimada, Tomohiro; Dey, Debashish; Quyyum, M. Zuhaib; Nakano, Masahiro; Ishiguro, Akira; Yoshida, Hideji; Yamamoto, Kaneyoshi; Sen, Ranjan; Ishihama, Akira			Differential Regulation of rRNA and tRNA Transcription from the rRNA-tRNA Composite Operon in Escherichia coli	PLOS ONE			English	Article							PROKARYOTIC GENOME REGULATION; PROTEIN H-NS; INTERNAL PROMOTER; TRYPTOPHAN OPERON; IN-VIVO; POLYMERASE-BINDING; ILVGMEDA OPERON; E ESSENTIALITY; DNA-SEQUENCES; CELL-DIVISION	Escherichia coli contains seven rRNA operons, each consisting of the genes for three rRNAs (16S, 23S and 5S rRNA in this order) and one or two tRNA genes in the spacer between 16S and 23S rRNA genes and one or two tRNA genes in the 3' proximal region. All of these rRNA and tRNA genes are transcribed from two promoters, P1 and P2, into single large precursors that are afterward processed to individual rRNAs and tRNAs by a set of RNases. In the course of Genomic SELEX screening of promoters recognized by RNA polymerase (RNAP) holoenzyme containing RpoD sigma, a strong binding site was identified within 16S rRNA gene in each of all seven rRNA operons. The binding in vitro of RNAP RpoD holoenzyme to an internal promoter, referred to the promoter of riRNA (an internal RNA of the rRNA operon), within each 16S rRNA gene was confirmed by gel shift assay and AFM observation. Using this riRNA promoter within the rrnD operon as a representative, transcription in vitro was detected with use of the purified RpoD holoenzyme, confirming the presence of a constitutive promoter in this region. LacZ reporter assay indicated that this riRNA promoter is functional in vivo. The location of riRNA promoter in vivo as identified using a set of reporter plasmids agrees well with that identified in vitro. Based on transcription profile in vitro and Northern blot analysis in vivo, the majority of transcript initiated from this riRNA promoter was estimated to terminate near the beginning of 23S rRNA gene, indicating that riRNA leads to produce the spacer -coded tRNA. Under starved conditions, transcription of the rRNA operon is markedly repressed to reduce the intracellular level of ribosomes, but the levels of both riRNA and its processed tRNAGIu stayed unaffected, implying that riRNA plays a role in the continued steady-state synthesis of tRNAs from the spacers of rRNA operons. We then propose that the tRNA genes organized within the spacers of rRNA-tRNA composite operons are expressed independent of rRNA synthesis under specific conditions where further synthesis of ribosomes is not needed.	[Takada, Hiraku; Shimada, Tomohiro; Ishiguro, Akira; Yamamoto, Kaneyoshi; Ishihama, Akira] Hosei Univ, Res Ctr Micronano Technol, Koganei, Tokyo, Japan; [Shimada, Tomohiro] Tokyo Inst Technol, Lab Chem & Life Sci, Yokohama, Kanagawa, Japan; [Dey, Debashish; Quyyum, M. Zuhaib; Sen, Ranjan] Ctr DNA Fingerprinting & Diagnost, Hyderabad, Andhra Pradesh, India; [Nakano, Masahiro] Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto, Japan; [Yoshida, Hideji] Osaka Med Coll, Dept Phys, Takatsuki, Osaka, Japan; [Yamamoto, Kaneyoshi; Ishihama, Akira] Hosei Univ, Dept Frontier Biosci, Koganei, Tokyo, Japan; [Takada, Hiraku] Rikkyo Univ, Dept Life Sci, Toshima Ku, Tokyo, Japan	Hosei University; Tokyo Institute of Technology; Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Kyoto University; Osaka Medical College; Hosei University; Rikkyo University	Ishihama, A (corresponding author), Hosei Univ, Res Ctr Micronano Technol, Koganei, Tokyo, Japan.; Ishihama, A (corresponding author), Hosei Univ, Dept Frontier Biosci, Koganei, Tokyo, Japan.	aishiham@hosei.ac.jp	Shimada, Tomohiro/E-7660-2014; Qayyum, Mohammad Zuhaib/AAD-8672-2022; Yoshida, Hideji/P-1403-2018	Shimada, Tomohiro/0000-0002-8361-0730; Qayyum, Mohammad Zuhaib/0000-0003-2442-4812; Yoshida, Hideji/0000-0001-7213-4735; Ishihama, Akira/0000-0002-6339-9042; Ishiguro, Akira/0000-0003-1867-3134; Takada, Hiraku/0000-0003-2034-5666	MEXT [21241047, 18310133, 25430173, 24710214, 208-2012 (S0801037)]; Research Fund from IFO (Institute for Fermentation, Osaka); MEXT Cooperative Research Program of Network Joint Research Center for Materials and Devices	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Fund from IFO (Institute for Fermentation, Osaka); MEXT Cooperative Research Program of Network Joint Research Center for Materials and Devices	MEXT Grants-in-Aid for Scientific Research (A) (21241047), (B) (18310133) and (C) (25430173) to A lshihama, MEXT Grant-in-Aid for Young Scientists (B) (24710214) to TS, Research Fund from IFO (Institute for Fermentation, Osaka) to TS, a support from the MEXT Cooperative Research Program of Network Joint Research Center for Materials and Devices to TS and A lshihama, and the MEXT-Supported Program for the Strategic Research Foundation at Private Universities 208-2012 (S0801037) to Hosei University.	ADAMS CW, 1985, J BIOL CHEM, V260, P8538; Afflerbach H, 1998, MOL MICROBIOL, V28, P641, DOI 10.1046/j.1365-2958.1998.00829.x; AMEMIYA K, 1986, J MOL BIOL, V187, P1, DOI 10.1016/0022-2836(86)90401-8; APIRION D, 1993, BIOESSAYS, V15, P113, DOI 10.1002/bies.950150207; Appleman JA, 1998, J BACTERIOL, V180, P1525, DOI 10.1128/JB.180.6.1525-1532.1998; Asai T, 1999, J BACTERIOL, V181, P3803, DOI 10.1128/JB.181.12.3803-3809.1999; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barker MM, 2001, J BACTERIOL, V183, P6315, DOI 10.1128/JB.183.21.6315-6323.2001; BERG KL, 1987, J BACTERIOL, V169, P1691, DOI 10.1128/jb.169.4.1691-1701.1987; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BROSIUS J, 1981, J MOL BIOL, V148, P107, DOI 10.1016/0022-2836(81)90508-8; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; CHANG SC, 1992, BIOCHIM BIOPHYS ACTA, V1129, P219, DOI 10.1016/0167-4781(92)90491-H; CHASHEL M, 1969, NATURE, V221, P838, DOI 10.1038/221838a0; CONDON C, 1995, J BACTERIOL, V177, P4152, DOI 10.1128/jb.177.14.4152-4156.1995; CONDON C, 1993, EMBO J, V12, P4305, DOI 10.1002/j.1460-2075.1993.tb06115.x; Conway T, 2014, MBIO, V5, DOI 10.1128/mBio.01442-14; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davies BW, 2010, MOL MICROBIOL, V78, P506, DOI 10.1111/j.1365-2958.2010.07351.x; DEBOER HA, 1979, CELL, V17, P201, DOI 10.1016/0092-8674(79)90308-8; Dennis PP, 2004, MICROBIOL MOL BIOL R, V68, P639, DOI 10.1128/MMBR.68.4.639-668.2004; EMILSSON V, 1990, EMBO J, V9, P4359, DOI 10.1002/j.1460-2075.1990.tb07885.x; EMILSSON V, 1993, J MOL BIOL, V230, P483, DOI 10.1006/jmbi.1993.1165; Fujita N, 1996, METHOD ENZYMOL, V273, P121; Gourse RL, 1996, ANNU REV MICROBIOL, V50, P645, DOI 10.1146/annurev.micro.50.1.645; Gralla JD, 2005, MOL MICROBIOL, V55, P973, DOI 10.1111/j.1365-2958.2004.04455.x; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Gyorfy Z, 2015, NUCLEIC ACIDS RES, V43, P1783, DOI 10.1093/nar/gkv040; Hara H, 1997, J BACTERIOL, V179, P5802, DOI 10.1128/jb.179.18.5802-5811.1997; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; HILL CW, 1981, P NATL ACAD SCI-BIOL, V78, P7069, DOI 10.1073/pnas.78.11.7069; Hirvonen CA, 2001, J BACTERIOL, V183, P6305, DOI 10.1128/JB.183.21.6305-6314.2001; HOROWITZ H, 1982, J MOL BIOL, V156, P257, DOI 10.1016/0022-2836(82)90327-8; IKEMURA T, 1982, COLD SPRING HARB SYM, V47, P1087, DOI 10.1101/SQB.1983.047.01.123; Ishihama A, 1990, Adv Biophys, V26, P19, DOI 10.1016/0065-227X(90)90005-E; Ishihama A, 1999, GENES CELLS, V4, P135, DOI 10.1046/j.1365-2443.1999.00247.x; Ishihama A, 1981, Adv Biophys, V14, P1; Ishihama A, 2016, NUCLEIC ACIDS RES, V44, P2058, DOI 10.1093/nar/gkw051; Ishihama A, 2012, P JPN ACAD B-PHYS, V88, P485, DOI 10.2183/pjab.88.485; Ishihama A, 2010, FEMS MICROBIOL REV, V34, P628, DOI 10.1111/j.1574-6976.2010.00227.x; JACKSON EN, 1972, J MOL BIOL, V69, P307, DOI 10.1016/0022-2836(72)90232-X; Jishage M, 1997, J BACTERIOL, V179, P959, DOI 10.1128/jb.179.3.959-963.1997; KAJITANI M, 1984, J BIOL CHEM, V259, P1951; KJELDGAARD NO, 1958, J GEN MICROBIOL, V19, P607, DOI 10.1099/00221287-19-3-607; KOLTER R, 1992, ANNU REV MICROBIOL, V46, P141, DOI 10.1146/annurev.mi.46.100192.001041; KURLAND CG, 1993, BIOCHEM SOC T, V21, P841, DOI 10.1042/bst0210841; Li ZW, 1999, RNA, V5, P139, DOI 10.1017/S1355838299981669; Li ZW, 1999, EMBO J, V18, P2878, DOI 10.1093/emboj/18.10.2878; LOPES JM, 1989, GENE, V76, P255, DOI 10.1016/0378-1119(89)90166-2; MAALOE O, 1996, CONTROL MACROMOLECUL; Maeda M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144697; MANKIN AS, 1987, FEBS LETT, V219, P269, DOI 10.1016/0014-5793(87)80233-8; Millar JH, 1972, EXPT MOL GENETICS; Mishra S, 2015, NUCLEIC ACIDS RES, V43, P5744, DOI 10.1093/nar/gkv479; MISRA TK, 1979, J BIOL CHEM, V254, P1154; MORSE DE, 1968, J MOL BIOL, V38, P447, DOI 10.1016/0022-2836(68)90401-4; Nakano M, 2014, FEMS MICROBIOL LETT, V355, P93, DOI 10.1111/1574-6968.12466; NILSSON L, 1994, J BIOL CHEM, V269, P9460; NOMURA M, 1977, ANNU REV GENET, V11, P297, DOI 10.1146/annurev.ge.11.120177.001501; Ogasawara H, 2007, J BACTERIOL, V189, P4791, DOI 10.1128/JB.00319-07; ORTUNO MJ, 1987, NUCLEIC ACIDS RES, V15, P1521, DOI 10.1093/nar/15.4.1521; Paul BJ, 2004, ANNU REV GENET, V38, P749, DOI 10.1146/annurev.genet.38.072902.091347; ROSS W, 1990, EMBO J, V9, P3733, DOI 10.1002/j.1460-2075.1990.tb07586.x; Schneider DA, 2003, CURR OPIN MICROBIOL, V6, P151, DOI 10.1016/S1369-5274(03)00038-9; Shimada K, 2013, MICROBIOL-SGM, V159, P2501, DOI 10.1099/mic.0.067538-0; Shimada T, 2005, GENES CELLS, V10, P907, DOI 10.1111/j.1365-2443.2005.00888.x; Shimada T, 2007, MOL MICROBIOL, V66, P744, DOI 10.1111/j.1365-2958.2007.05954.x; Shimada T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090447; Shimada T, 2011, MOL MICROBIOL, V82, P378, DOI 10.1111/j.1365-2958.2011.07818.x; SRIVASTAVA AK, 1990, ANNU REV MICROBIOL, V44, P105, DOI 10.1146/annurev.mi.44.100190.000541; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Tamura M, 2013, J BACTERIOL, V195, P1133, DOI 10.1128/JB.01558-12; Tamura M, 2012, J BACTERIOL, V194, P1919, DOI 10.1128/JB.06652-11; TAYLOR WE, 1979, GENE, V6, P331, DOI 10.1016/0378-1119(79)90073-8; Tenson T, 1995, BIOCHEM CELL BIOL, V73, P1061, DOI 10.1139/o95-114; Tenson T, 1996, P NATL ACAD SCI USA, V93, P5641, DOI 10.1073/pnas.93.11.5641; TIPPNER D, 1994, MOL MICROBIOL, V11, P589, DOI 10.1111/j.1365-2958.1994.tb00339.x; Umitsuki G, 2001, GENES CELLS, V6, P403, DOI 10.1046/j.1365-2443.2001.00430.x; Vicente M, 1998, CELL MOL LIFE SCI, V54, P317, DOI 10.1007/s000180050158; Wada A, 1998, GENES CELLS, V3, P203, DOI 10.1046/j.1365-2443.1998.00187.x; WEK RC, 1986, NUCLEIC ACIDS RES, V14, P2763, DOI 10.1093/nar/14.6.2763; YAMAO F, 1991, NUCLEIC ACIDS RES, V19, P6119, DOI 10.1093/nar/19.22.6119; YOUNG RA, 1979, CELL, V17, P225, DOI 10.1016/0092-8674(79)90310-6; ZACHARIAS M, 1989, MOL MICROBIOL, V3, P405, DOI 10.1111/j.1365-2958.1989.tb00185.x	84	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0163057	10.1371/journal.pone.0163057	http://dx.doi.org/10.1371/journal.pone.0163057			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005933	Green Submitted, Green Published, gold			2022-12-26	WOS:000392843200001
J	Burgute, BD; Peche, VS; Muller, R; Matthias, J; Gassen, B; Eichinger, L; Glockner, G; Noegel, AA				Burgute, Bhagyashri D.; Peche, Vivek S.; Mueller, Rolf; Matthias, Jan; Gassen, Berthold; Eichinger, Ludwig; Gloeckner, Gernot; Noegel, Angelika A.			The C-Terminal SynMuv/DdDUF926 Domain Regulates the Function of the N-Terminal Domain of DdNKAP	PLOS ONE			English	Article							DICTYOSTELIUM; PROTEIN; GENE; CHROMATIN; GENOME; DIFFERENTIATION; IDENTIFICATION; COMPLEX; NKAP	NKAP (NF-kappa B activating protein) is a highly conserved SR (serine/arginine-rich) protein involved in transcriptional control and splicing in mammals. We identified DdNKAP, the Dictyostelium discoideum ortholog of mammalian NKAP, as interacting partner of the nuclear envelope protein SUN-1. DdNKAP harbors a number of basic RDR/RDRS repeats in its N-terminal domain and the SynMuv/DUF926 domain at its C-terminus. We describe a novel and direct interaction between DdNKAP and Prp19 (Pre mRNA processing factor 19) which might be relevant for the observed DdNKAP ubiquitination. Genome wide analysis using cross-linking immunoprecipitation-high-throughput sequencing (CLIP-seq) revealed DdNKAP association with intergenic regions, exons, introns and non-coding RNAs. Ectopic expression of DdNKAP and its domains affects several developmental aspects like stream formation, aggregation, and chemotaxis. We conclude that DdNKAP is a multifunctional protein, which might influence Dictyostelium development through its interaction with RNA and RNA binding proteins. Mutants overexpressing full length DdNKAP and the N-terminal domain alone (DdN-NKAP) showed opposite phenotypes in development and opposite expression profiles of several genes and rRNAs. The observed interaction between DdNNKAP and the DdDUF926 domain indicates that the DdDUF926 domain acts as negative regulator of the N-terminus.	[Burgute, Bhagyashri D.; Peche, Vivek S.; Mueller, Rolf; Matthias, Jan; Gassen, Berthold; Eichinger, Ludwig; Gloeckner, Gernot; Noegel, Angelika A.] Univ Cologne, CMMC, Fac Med,Inst Biochem 1, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Gloeckner, Gernot] IGB, Leibniz Inst Freshwater Ecol & Inland Fisheries, Berlin, Germany	University of Cologne; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	Noegel, AA (corresponding author), Univ Cologne, CMMC, Fac Med,Inst Biochem 1, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany.	noegel@uni-koeln.de	Peche, Vivek/GWZ-4668-2022; Glöckner, Gernot/A-7800-2010; Eichinger, Ludwig/AAJ-8895-2021	Glöckner, Gernot/0000-0002-9061-1061; Eichinger, Ludwig/0000-0003-1594-6117	International Graduate School in Development, Health and Disease (IGSDHD); Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) [C05]; Maria Pesch Foundation	International Graduate School in Development, Health and Disease (IGSDHD); Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD); Maria Pesch Foundation	B.D.B was supported by the International Graduate School in Development, Health and Disease (IGSDHD). This work was supported by the Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), grant C05. The funding through the Maria Pesch Foundation to B.D.B. is acknowledged.	Aguilera V, 2015, PLANT CELL, V1; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Burgute BD, 2013, NUCLEIC ACIDS RES, P1; Catalano A, 2012, HISTOCHEM CELL BIOL, V138, P515, DOI 10.1007/s00418-012-0973-9; Chanarat S, 2013, BBA-MOL CELL RES, V1833, P2126, DOI 10.1016/j.bbamcr.2013.05.023; Chanarat S, 2011, GENE DEV, V25, P1147, DOI 10.1101/gad.623411; Chang W, 2015, J CELL BIOL, V208, P11, DOI 10.1083/jcb.201409047; Chen DY, 2003, BIOCHEM BIOPH RES CO, V310, P720, DOI 10.1016/j.bbrc.2003.09.074; de Almeida SF, 2012, TRENDS BIOCHEM SCI, V37, P248, DOI 10.1016/j.tibs.2012.02.002; DiAntonio A, 2004, ANNU REV NEUROSCI, V27, P223, DOI 10.1146/annurev.neuro.27.070203.144317; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Faix J, 2001, EMBO J, V20, P3705, DOI 10.1093/emboj/20.14.3705; Farbrother P, 2006, CELL MICROBIOL, V8, P438, DOI 10.1111/j.1462-5822.2005.00633.x; Fisher PR, 1997, CURR BIOL, V7, P889, DOI 10.1016/S0960-9822(06)00379-4; GERISCH G, 1981, J CELL SCI, V52, P1; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Hegele A, 2012, MOL CELL, V45, P567, DOI 10.1016/j.molcel.2011.12.034; Hinas A, 2006, EUKARYOT CELL, V5, P924, DOI 10.1128/EC.00065-06; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ji HT, 2015, PLANT J, V81, P399, DOI 10.1111/tpj.12733; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; Konig J, 2011, JOVE-J VIS EXP, DOI 10.3791/2638; Kruse J, 2016, RNA BIOL, V13, P1000, DOI 10.1080/15476286.2016.1212153; Kwong PN, 2015, J BIOL CHEM, V290, P30119, DOI 10.1074/jbc.M115.681171; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li P, 2015, NUCLEIC ACIDS RES, V43; Meier D, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006057; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Muller-Taubenberger A, 2013, EUR J CELL BIOL, V92, P45, DOI 10.1016/j.ejcb.2012.10.003; MULLERTAUBENBERGER A, 1988, J CELL SCI, V90, P51; Muramoto T, 2008, DEVELOPMENT, V135, P1647, DOI 10.1242/dev.020115; Noegel AA, 2004, MOL BIOL CELL, V15, P934, DOI 10.1091/mbc.E03-05-0269; O'Day DH, 2014, BIOL REV; Pajerowski AG, 2010, BLOOD, V116, P2684, DOI 10.1182/blood-2010-02-268391; Pajerowski AG, 2009, IMMUNITY, V30, P696, DOI 10.1016/j.immuni.2009.02.011; Pandit S, 2008, CURR OPIN CELL BIOL, V20, P260, DOI 10.1016/j.ceb.2008.03.001; Poulin G, 2005, EMBO J, V24, P2613, DOI 10.1038/sj.emboj.7600726; Sasaki K, 2008, DIFFERENTIATION, V76, P1093, DOI 10.1111/j.1432-0436.2008.00298.x; SCHLEICHER M, 1984, EMBO J, V3, P2095, DOI 10.1002/j.1460-2075.1984.tb02096.x; Shepard PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-242; Sucgang R, 2003, NUCLEIC ACIDS RES, V31, P2361, DOI 10.1093/nar/gkg348; Sutherland BW, 2001, EMBO REP, V2, P1024, DOI 10.1093/embo-reports/kve222; Taniura H, 2006, J BIOL CHEM, V281, P12336, DOI 10.1074/jbc.M512723200; TARN WY, 1993, P NATL ACAD SCI USA, V90, P10821, DOI 10.1073/pnas.90.22.10821; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Urushihara H, 2004, NUCLEIC ACIDS RES, V32, P1647, DOI 10.1093/nar/gkh262; Westphal M, 1997, CURR BIOL, V7, P176, DOI 10.1016/S0960-9822(97)70088-5; Xiong HJ, 2008, TRAFFIC, V9, P708, DOI 10.1111/j.1600-0854.2008.00721.x; Yu B, 2011, PROTEIN CELL, V2, P395, DOI 10.1007/s13238-011-1052-z	51	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168617	10.1371/journal.pone.0168617	http://dx.doi.org/10.1371/journal.pone.0168617			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997579	Green Submitted, gold, Green Published			2022-12-26	WOS:000392842900063
J	Sibille, E; Berdeaux, O; Martine, L; Bron, AM; Creuzot-Garcher, CP; He, ZG; Thuret, G; Bretillon, L; Masson, EAY				Sibille, Estelle; Berdeaux, Olivier; Martine, Lucy; Bron, Alain M.; Creuzot-Garcher, Catherine P.; He, Zhiguo; Thuret, Gilles; Bretillon, Lionel; Masson, Elodie A. Y.			Ganglioside Profiling of the Human Retina: Comparison with Other Ocular Structures, Brain and Plasma Reveals Tissue Specificities	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; CERAMIDE COMPOSITION; SIGNAL-TRANSDUCTION; MAJOR GANGLIOSIDES; FUNCTIONAL-ROLE; RAT RETINA; GLYCOSPHINGOLIPIDS; GM1; BOVINE; RAFTS	Gangliosides make a wide family of glycosphingolipids, highly heterogeneous in both the ceramide moiety and the oligosaccharide chain. While ubiquitously expressed in mammalian tissues, they are particularly abundant in the brain and the peripheral nervous system. Gangliosides are known to play a crucial role in the development, maintenance and functional integrity of the nervous system. However, the expression and roles of gangliosides in the retina, although often considered as a window on the brain, has been far less studied. We performed an in-depth analysis of gangliosides of the human retina, especially using powerful LC/MS methods. We compared the pattern of ganglioside classes and ceramide molecular species of this tissue with other ocular structures and with brain and plasma in elderly human individuals. About a hundred of ganglioside molecular species among 15 distinct classes were detected illustrating the huge structural diversity of these compounds. The retina exhibited a very diverse ganglioside profile and shared several common features with the brain (prominence of tetraosylgangliosides, abundance of d20:1 long chain base and 18:0 fatty acid...). However, the retina stood out with the specific expression of GD3, GT3 and AcGT3, which further presented a peculiar molecular species distribution. The unique ganglioside pattern we observed in the human retina suggests that these ganglioside species play a specific role in the structure and function of this tissue. This lipidomic study, by highlighting retina specific ganglioside species, opens up novel research directions for a better understanding of the biological role of gangliosides in the retina.	[Sibille, Estelle; Berdeaux, Olivier; Martine, Lucy; Bron, Alain M.; Creuzot-Garcher, Catherine P.; Bretillon, Lionel; Masson, Elodie A. Y.] Univ Bourgogne Franche Comte, CNRS, Ctr Sci Gout & Alimentat, INRA, Dijon, France; [Bron, Alain M.; Creuzot-Garcher, Catherine P.] Univ Hosp, Dept Ophthalmol, Dijon, France; [He, Zhiguo; Thuret, Gilles] Univ Jean Monnet, Lab Biol Imaging & Engn Corneal Grafts, EA2521, Fac Med, St Etienne, France; [Thuret, Gilles] Inst Univ France, Paris, France	INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; CHU Dijon Bourgogne; Institut Universitaire de France	Masson, EAY (corresponding author), Univ Bourgogne Franche Comte, CNRS, Ctr Sci Gout & Alimentat, INRA, Dijon, France.	elodie.masson@inra.fr	Bron, Alain/AAP-8010-2020	Bron, Alain/0000-0002-7265-931X; MASSON, Elodie/0000-0001-6312-0913; Bretillon, Lionel/0000-0002-6957-100X	Regional Council of Burgundy; French National Institute for Research on Agronomy (INRA); European Regional Development Fund (FEDER)	Regional Council of Burgundy(Region Bourgogne-Franche-Comte); French National Institute for Research on Agronomy (INRA); European Regional Development Fund (FEDER)(European Commission)	This work was supported by the Regional Council of Burgundy, the European Regional Development Fund (FEDER) and the French National Institute for Research on Agronomy (INRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi JS, 2003, INVEST OPHTH VIS SCI, V44, P1747, DOI 10.1167/iovs.01-0886; DANIOTTI JL, 1991, J NEUROCHEM, V57, P2054, DOI 10.1111/j.1471-4159.1991.tb06421.x; DANIOTTI JL, 1994, J NEUROCHEM, V62, P1131; Degroote S, 2004, SEMIN CELL DEV BIOL, V15, P375, DOI 10.1016/j.semcdb.2004.03.007; Denny CA, 2007, J NEUROCHEM, V101, P1294, DOI 10.1111/j.1471-4159.2007.04525.x; Dreyfus H, 1976, Adv Exp Med Biol, V71, P163; Dreyfus H, 1996, INVEST OPHTH VIS SCI, V37, P574; DUBOIS C, 1986, J BIOL CHEM, V261, P3826; Fontaine V, 1998, GLYCOBIOLOGY, V8, P183, DOI 10.1093/glycob/8.2.183; Furukawa K, 2011, NEUROCHEM RES, V36, P1578, DOI 10.1007/s11064-011-0494-2; Garcia AD, 2014, J CHROMATOGR B, V947, P1, DOI 10.1016/j.jchromb.2013.11.025; HAKOMORI S, 1995, J BIOCHEM, V118, P1091, DOI 10.1093/oxfordjournals.jbchem.a124992; HOLM M, 1974, FEBS LETT, V45, P159, DOI 10.1016/0014-5793(74)80835-5; HOLM M, 1974, FEBS LETT, V38, P261, DOI 10.1016/0014-5793(74)80067-0; Ikeda K, 2008, J LIPID RES, V49, P2678, DOI 10.1194/jlr.D800038-JLR200; Ikeda K, 2010, RAPID COMMUN MASS SP, V24, P2957, DOI 10.1002/rcm.4716; KADOWAKI H, 1984, J LIPID RES, V25, P1132; Kolter T, 2006, BBA-BIOMEMBRANES, V1758, P2057, DOI 10.1016/j.bbamem.2006.05.027; LANDA CA, 1985, DEV BRAIN RES, V21, P193, DOI 10.1016/0165-3806(85)90208-1; Lauritzen L, 2001, PROG LIPID RES, V40, P1, DOI 10.1016/S0163-7827(00)00017-5; Li YT, 2002, J LIPID RES, V43, P1019, DOI 10.1194/jlr.M200010-JLR200; Masson EAY, 2015, J LIPID RES, V56, P1821, DOI 10.1194/jlr.D060764; MohandSaid S, 1997, STROKE, V28, P617, DOI 10.1161/01.STR.28.3.617; Ngamukote S, 2007, J NEUROCHEM, V103, P2327, DOI 10.1111/j.1471-4159.2007.04910.x; PALESTINI P, 1993, J NEUROCHEM, V61, P955, DOI 10.1111/j.1471-4159.1993.tb03608.x; PALESTINI P, 1990, J NEUROCHEM, V54, P230, DOI 10.1111/j.1471-4159.1990.tb13305.x; PALESTINI P, 1995, BBA-BIOMEMBRANES, V1235, P221, DOI 10.1016/0005-2736(95)80008-4; Proia RL, 2003, PHILOS T R SOC B, V358, P879, DOI 10.1098/rstb.2003.1268; Sango K, 2005, INVEST OPHTH VIS SCI, V46, P3420, DOI 10.1167/iovs.05-0038; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Simpson MA, 2004, NAT GENET, V36, P1225, DOI 10.1038/ng1460; Sonnino S, 2000, BBA-REV BIOMEMBRANES, V1469, P63, DOI 10.1016/S0005-2736(00)00210-8; Sonnino S, 2007, GLYCOBIOLOGY, V17, p1R, DOI 10.1093/glycob/cwl052; Sonnino S, 2006, CHEM REV, V106, P2111, DOI 10.1021/cr0100446; Svennerholm L, 1980, Adv Exp Med Biol, V125, P11; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; Tsui ZC, 2005, ANAL BIOCHEM, V341, P251, DOI 10.1016/j.ab.2005.03.036; Urban P F, 1980, Adv Exp Med Biol, V125, P149; Vukelic Z, 2007, GLYCOBIOLOGY, V17, P504, DOI 10.1093/glycob/cwm012; Yu R. K., 2007, COMPREHENSIVE GLYCOS, P73, DOI 10.1016/B978-044451967-2/00003-9; YU RK, 1972, J LIPID RES, V13, P680; Yu RK, 2007, J NEUROCHEM, V103, P39, DOI 10.1111/j.1471-4159.2007.04710.x; Yu RK, 2012, NEUROCHEM RES, V37, P1230, DOI 10.1007/s11064-012-0744-y; Zamfir A, 2004, J AM SOC MASS SPECTR, V15, P1649, DOI 10.1016/j.jasms.2004.08.002; Zamfir A, 2002, ELECTROPHORESIS, V23, P2894, DOI 10.1002/1522-2683(200209)23:17<2894::AID-ELPS2894>3.0.CO;2-Q; Zamfir AD, 2013, ANAL BIOANAL CHEM, V405, P7321, DOI 10.1007/s00216-013-7173-x	48	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168794	10.1371/journal.pone.0168794	http://dx.doi.org/10.1371/journal.pone.0168794			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997589	gold, Green Submitted, Green Published			2022-12-26	WOS:000392842900076
J	Ren, C; Chen, HB; Yang, BT; Liu, F; Ouyang, ZY; Bo, XC; Shu, WJ				Ren, Chao; Chen, Hebing; Yang, Bite; Liu, Feng; Ouyang, Zhangyi; Bo, Xiaochen; Shu, Wenjie			iFORM: Incorporating Find Occurrence of Regulatory Motifs	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; HOT REGIONS; BINDING; DNA; DISCOVERY; DATABASE; TOOLS	Accurately identifying the binding sites of transcription factors (TFs) is crucial to understanding the mechanisms of transcriptional regulation and human disease. We present incorporating Find Occurrence of Regulatory Motifs (iFORM), an easy-to-use and efficient tool for scanning DNA sequences with TF motifs described as position weight matrices (PWMs). Both performance assessment with a receiver operating characteristic (ROC) curve and a correlation-based approach demonstrated that iFORM achieves higher accuracy and sensitivity by integrating five classical motif discovery programs using Fisher's combined probability test. We have used iFORM to provide accurate results on a variety of data in the ENCODE Project and the NIH Roadmap Epigenomics Project, and the tool has demonstrated its utility in further elucidating individual roles of functional elements. Both the source and binary codes for iFORM can be freely accessed at https://github.com/wenjiegroup/iFORM. The identified TF binding sites across human cell and tissue types using iFORM have been deposited in the Gene Expression Omnibus under the accession ID GSE53962.	[Ren, Chao; Chen, Hebing; Yang, Bite; Liu, Feng; Ouyang, Zhangyi; Bo, Xiaochen; Shu, Wenjie] Beijing Inst Radiat Med, Dept Biotechnol, Beijing, Peoples R China; [Liu, Feng] 188th Hosp Chaozhou, Dept Informat, Chaozhou, Peoples R China	Academy of Military Medical Sciences - China	Bo, XC; Shu, WJ (corresponding author), Beijing Inst Radiat Med, Dept Biotechnol, Beijing, Peoples R China.	boxc@bmi.ac.cn; shuwj@bmi.ac.cn		Shu, Wenjie/0000-0001-9044-2352; Chen, Hebing/0000-0003-4102-356X; Bo, Xiao-chen/0000-0003-1911-7922	Major Research plan of the National Natural Science Foundation of China [U1435222]; Program of International ST Cooperation [2014DFB30020]; National High Technology Research and Development Program of China [2015AA020108]	Major Research plan of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of International ST Cooperation; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by grants from the Major Research plan of the National Natural Science Foundation of China (No. U1435222), the Program of International S&T Cooperation (No. 2014DFB30020) and the National High Technology Research and Development Program of China (No. 2015AA020108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bradley RK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000343; Chen HB, 2015, SCI REP-UK, V5, DOI 10.1038/srep08465; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gretton A., 2007, ADV NEURAL INF PROCE, V20, P585; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Haverty PM, 2004, BIOINFORMATICS, V20, P1815, DOI 10.1093/bioinformatics/bth162; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Li H, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3077-4; Li H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11633; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; MacIsaac KD, 2006, PLOS COMPUT BIOL, V2, P201, DOI 10.1371/journal.pcbi.0020036; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Robasky K, 2011, NUCLEIC ACIDS RES, V39, pD124, DOI 10.1093/nar/gkq992; Scholkopf Bernhard, 2016, KERNEL BASED TESTS J, P67; Schones DE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-19; Speir ML, 2016, NUCLEIC ACIDS RES, V44, pD717, DOI 10.1093/nar/gkv1275; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; STORMO GD, 1989, P NATL ACAD SCI USA, V86, P1183, DOI 10.1073/pnas.86.4.1183; Thomas-Chollier M, 2011, NUCLEIC ACIDS RES, V39, pW86, DOI 10.1093/nar/gkr377; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053	26	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168607	10.1371/journal.pone.0168607	http://dx.doi.org/10.1371/journal.pone.0168607			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992540	Green Submitted, Green Published, gold			2022-12-26	WOS:000392842600078
J	Hong, JW; Noh, JH; Kim, DJ				Hong, Jae Won; Noh, Jung Hyun; Kim, Dong-Jun			The Association of Resting Heart Rate with the Presence of Diabetes in Korean Adults: The 2010-2013 Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							METABOLIC SYNDROME; INSULIN-RESISTANCE; NERVOUS-SYSTEM; BLOOD-PRESSURE; LIFE-STYLE; RISK; POPULATION; OBESITY; DETERMINANTS; HYPERTENSION	Background Previous epidemiologic studies have shown that elevated resting heart rate (HR) is associated with higher cardiovascular disease (CVD) morbidity and mortality. Although the relationship between elevated HR and CVD is well established, the association between resting HR and diabetes has been relatively understudied, particularly in non-Western populations. Objectives We confirmed the association between the presence of type 2 diabetes and resting HR in the Korean adult population using data from the 2010-2013 Korea National Health and Nutrition Examination Survey (KNHANES). Methods Among 25,712 adults (>= 19 years of age) who participated in the 2010-2013 KNHANES, a total of 22,512 subjects completed laboratory examinations and were included in this analysis. The fasting plasma glucose (FPG) level was categorized into the following five groups: normal fasting glucose (NFG) 1 (<90 mg/dL), NFG 2 (90-99 mg/dL), impaired fasting glucose (IFG) 1 (100-110 mg/dL), IFG 2 (111-125 mg/dL), and diabetes (>= 126 mg/dL). Results The unadjusted weighted resting HRs were 69.6, 69.4, 69.8, 70.1, and 72.0 beats per minute (bpm) in the NFG 1, NFG 2, IFG 1, IFG 2, and diabetes groups, respectively (P<0.001). We assessed the adjusted weighted resting HR according to the FPG level after adjusting for age, sex, smoking history, high risk alcohol drinking, daily energy intake, waist circumference, serum total cholesterol level, serum triglyceride (TG) level, serum white blood cell (WBC) count, serum hemoglobin (Hb), and the presence of hypertension. The adjusted weighted resting HR significantly increased across the FPG groups (P<0.001). The weighted prevalence rates of diabetes were 6.8% (6.2-7.5%), 7.6% (6.7-8.5%), 8.0% (7.0-9.1%), and 11.8% (10.8-12.7%) in subjects with HR <= 64, 65-69, 70-75, and >= 76 bpm, respectively (P<0.001), after adjusting for the confounding factors mentioned above. Using resting HR <= 64 bpm as the control, resting HR >= 76 bpm was correlated with the presence of diabetes (adjusted OR 1.83, 95% CI 1.55-2.16, P<0.001). Each 10 bpm increment of HR increased the risk of the presence of diabetes by 35% (P<0.001). This association of high resting HR with the presence of diabetes was not influenced by the status of blood pressure (BP) medication. Conclusion We demonstrated that higher HR was associated with diabetes in a representative sample of Korean adults. These positive associations were independent of age, sex, current smoking, high risk alcohol drinking, daily energy intake, waist circumference, and the presence of hypertension and other potential confounders. This study suggests that individuals with higher resting HR are at risk of diabetes and that HR might provide an easy and simple surrogate marker for the risk of diabetes.	[Hong, Jae Won; Noh, Jung Hyun; Kim, Dong-Jun] Inje Univ, Dept Internal Med, Ilsan Paik Hosp, Coll Med, Koyang, Gyeonggi Do, South Korea	Inje University	Kim, DJ (corresponding author), Inje Univ, Dept Internal Med, Ilsan Paik Hosp, Coll Med, Koyang, Gyeonggi Do, South Korea.	djkim@paik.ac.kr	Noh, Junghyun/AAU-8113-2020					Aune D, 2015, NUTR METAB CARDIOVAS, V25, P526, DOI 10.1016/j.numecd.2015.02.008; Babor T.F., 2001, ALCOHOL USE DISORDER; Balcioglu AS, 2015, WORLD J DIABETES, V6, P80, DOI 10.4239/wjd.v6.i1.80; Bohm M, 2015, AM J MED, V128, P219, DOI 10.1016/j.amjmed.2014.09.016; Carnethon MR, 2008, DIABETES CARE, V31, P335, DOI 10.2337/dc07-0874; Carnethon MR, 2003, CIRCULATION, V107, P2190, DOI 10.1161/01.CIR.0000066324.74807.95; Christou DD, 2008, J APPL PHYSIOL, V105, P24, DOI 10.1152/japplphysiol.90401.2008; CRYER PE, 1976, NEW ENGL J MED, V295, P573, DOI 10.1056/NEJM197609092951101; DYER AR, 1980, AM J EPIDEMIOL, V112, P736, DOI 10.1093/oxfordjournals.aje.a113046; Esser N, 2014, DIABETES RES CLIN PR, V105, P141, DOI 10.1016/j.diabres.2014.04.006; Flanagan DE, 1999, J CLIN ENDOCR METAB, V84, P1263, DOI 10.1210/jc.84.4.1263; GILLUM RF, 1991, AM HEART J, V121, P172, DOI 10.1016/0002-8703(91)90970-S; Grantham NM, 2013, DIABETIC MED, V30, P421, DOI 10.1111/dme.12045; Hartaigh BO, 2013, ACTA DIABETOL, V50, P325, DOI 10.1007/s00592-012-0396-z; Hong JW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000611; JAMERSON KA, 1993, HYPERTENSION, V21, P618, DOI 10.1161/01.HYP.21.5.618; Julius S, 1992, Blood Press, V1, P9, DOI 10.3109/08037059209065119; Julius S, 2000, HYPERTENSION, V35, P807, DOI 10.1161/01.HYP.35.3.807; KANNEL WB, 1987, AM HEART J, V113, P1489, DOI 10.1016/0002-8703(87)90666-1; Li YQ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1052; Low PA, 2004, DIABETES CARE, V27, P2942, DOI 10.2337/diacare.27.12.2942; Mancia G, 2007, J HYPERTENS, V25, P909, DOI 10.1097/HJH.0b013e328048d004; Ministry of Health and Welfare, 1998, KOR HLTH IND DEV I D; Nagaya T, 2010, INT J EPIDEMIOL, V39, P215, DOI 10.1093/ije/dyp229; Nilsson PM, 2004, DIABETES CARE, V27, P2464, DOI 10.2337/diacare.27.10.2464; Oda E, 2014, ACTA DIABETOL, V51, P85, DOI 10.1007/s00592-013-0503-9; Pop-Busui R, 2010, DIABETES CARE, V33, P434, DOI 10.2337/dc09-1294; Rogowski O, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-55; Shibao C, 2007, HYPERTENSION, V49, P27, DOI 10.1161/01.HYP.0000251679.87348.05; Shigetoh Y, 2009, AM J HYPERTENS, V22, P151, DOI 10.1038/ajh.2008.331; Stolarz K, 2003, J HYPERTENS, V21, P525, DOI 10.1097/00004872-200303000-00018; Straznicky NE, 2005, J CLIN ENDOCR METAB, V90, P5998, DOI 10.1210/jc.2005-0961; The Korean Centers for Disease Control and Prevention, KOR HLTH IND DEV I G; Valentini M, 2004, J HYPERTENS, V22, P1999, DOI 10.1097/00004872-200410000-00024; Valentini M, 2009, PROG CARDIOVASC DIS, V52, P11, DOI 10.1016/j.pcad.2009.05.004; Vinik Aaron I, 2012, Front Endocrinol (Lausanne), V3, P71, DOI 10.3389/fendo.2012.00071; Wang L, 2015, INT J EPIDEMIOL, V44, P689, DOI 10.1093/ije/dyv079; Whelton SP, 2014, AM J CARDIOL, V113, P644, DOI 10.1016/j.amjcard.2013.11.009; Yang HI, 2016, CLIN CHIM ACTA, V455, P195, DOI 10.1016/j.cca.2016.01.006; Zhang J, 1999, EUR HEART J, V20, P103, DOI 10.1053/euhj.1999.1230; Zhang XL, 2010, INT J EPIDEMIOL, V39, P900, DOI 10.1093/ije/dyq068	41	6	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168527	10.1371/journal.pone.0168527	http://dx.doi.org/10.1371/journal.pone.0168527			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992613	Green Published, Green Submitted, gold			2022-12-26	WOS:000392758000057
J	Obidzinski, A; Medrzycki, P; Kolaczkowska, E; Ciurzycki, W; Marciszewska, K				Obidzinski, Artur; Medrzycki, Piotr; Kolaczkowska, Ewa; Ciurzycki, Wojciech; Marciszewska, Katarzyna			Do David and Goliath Play the Same Game? Explanation of the Abundance of Rare and Frequent Invasive Alien Plants in Urban Woodlands in Warsaw, Poland	PLOS ONE			English	Article							SPECIES-RICHNESS; SAMPLE-SIZE; TEMPERATE; FRAMEWORK; PERFORMANCE; COEXISTENCE; ECOLOGY; SUCCESS; FORESTS; MODELS	Invasive Alien Plants occur in numbers differing by orders of magnitude at subsequent invasion stages. Effective sampling and quantifying niches of rare invasive plants are quite problematic. The aim of this paper is an estimation of the influence of invasive plants frequency on the explanation of their local abundance. We attempted to achieve it through: (1) assessment of occurrence of self-regenerating invasive plants in urban woodlands, (2) comparison of Random Forest modelling results for frequent and rare species. We hypothesized that the abundance of frequent species would be explained better than that of rare ones and that both rare and frequent species share a common hierarchy of the most important determinants. We found 15 taxa in almost two thirds of 1040 plots with a total number of 1068 occurrences. There were recorded 6 taxa of high frequency-Prunus serotina, Quercus rubra, Acer negundo, Robinia pseudoacacia, Impatiens parviflora and Solidago spp.-and 9 taxa of low frequency: Acer saccharinum, Amelanchier spicata, Cornus spp., Fraxinus spp., Parthenocissus spp., Syringa vulgaris, Echinocystis lobata, Helianthus tuberosus, Reynoutria spp. Random Forest's models' quality grows with the number of occurrences of frequent taxa but not of the rare ones. Both frequent and rare taxa share a similar hierarchy of predictors' importance: Land use > Tree stand > Seed source and, for frequent taxa, Forest properties as well. We conclude that there is an 'explanation jump' at higher species frequencies, but rare species are surprisingly similar to frequent ones in their determinant's hierarchy, with differences conforming with their respective stages of invasion.	[Obidzinski, Artur; Ciurzycki, Wojciech; Marciszewska, Katarzyna] Warsaw Univ Life Sci, Fac Forestry, Dept Forest Bot, Warsaw, Poland; [Medrzycki, Piotr] Univ Ecol & Management, Fac Ecol, Lab Appl Plant Ecol, Warsaw, Poland; [Kolaczkowska, Ewa] Polish Acad Sci, Inst Geog & Spatial Org, Dept Geoecol & Climatol, Warsaw, Poland	Warsaw University of Life Sciences; Polish Academy of Sciences	Obidzinski, A (corresponding author), Warsaw Univ Life Sci, Fac Forestry, Dept Forest Bot, Warsaw, Poland.	artur.obidzinski@wl.sggw.pl		MARCISZEWSKA, KATARZYNA/0000-0002-8550-7390; Kolaczkowska, Ewa/0000-0001-9553-7350	Warsaw Municipal Forests Company [506-01-0325-00-02]	Warsaw Municipal Forests Company	The research was financed exclusively with a research grant No 506-01-0325-00-02 awarded by Warsaw Municipal Forests Company (http://lasymiejskie.waw.pl) to the Faculty of Forestry, Warsaw University of Life Sciences. AO, PM, WC & KM received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk A. B., 2011, Prace i Studia Geograficzne, V47, P355; Adamowski W, 2002, PHYTOCOENOSIS S, V14, P1; Adamowski W, 1998, PHYTOCOENOSIS S, V10, P211; Bartelink HH, 1998, ECOL MODEL, V105, P213, DOI 10.1016/S0304-3800(97)00165-8; Bertaud A, 2004, C WINDS SOC CH UNPUB; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2006, RANDOMFOREST BREIMAN; CANHAM CD, 1990, CAN J FOREST RES, V20, P620, DOI 10.1139/x90-084; Cape JN, 2004, ENVIRON POLLUT, V132, P469, DOI 10.1016/j.envpol.2004.05.009; Carboni M, 2011, J VEG SCI, V22, P751, DOI 10.1111/j.1654-1103.2011.01303.x; Castri F. di, 1990, Biological invasions in Europe and the Mediterranean Basin., P3; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chojnacki J, 1991, ZRO ZNICOWANIE PRZES; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Duguay S, 2007, LANDSCAPE ECOL, V22, P589, DOI 10.1007/s10980-006-9050-x; Essl F, 2012, BIOL INVASIONS, V14, P1331, DOI 10.1007/s10530-011-0156-y; Essl F, 2011, BASIC APPL ECOL, V12, P1, DOI 10.1016/j.baae.2010.10.003; Evans JS, 2011, PREDICTIVE SPECIES AND HABITAT MODELING IN LANDSCAPE ECOLOOGY: CONCEPTS AND APPLICATIONS, P139, DOI 10.1007/978-1-4419-7390-0_8; Foxcroft LC, 2008, ENVIRON MANAGE, V41, P32, DOI 10.1007/s00267-007-9027-9; Franklin J, 2009, MAPPING SPECIES DIST; Gavier-Pizarro GI, 2010, ECOL APPL, V20, P1913, DOI 10.1890/09-2168.1; Georges D, 2013, EXAMPLE SPECIES DIST; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; Hammer O, 2012, REFERENCE MANUAL; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HOBBS RJ, 1995, CONSERV BIOL, V9, P761, DOI 10.1046/j.1523-1739.1995.09040761.x; Hubbell Stephen P., 2001, V32, pi; Kalisz P, 2009, THESIS; Knight KS, 2008, DIVERS DISTRIB, V14, P666, DOI 10.1111/j.1472-4642.2008.00468.x; Kowarik I, 2005, CROP FERALITY AND VOLUNTEERISM, P97; Kowarik I, 1992, VERH BOT VER BERLIN, V3; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Kursa MB, 2010, FUND INFORM, V101, P271, DOI 10.3233/FI-2010-288; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; Landenberger Rick E., 2009, Urban Ecosystems, V12, P437, DOI 10.1007/s11252-009-0087-x; Lee PK, 2005, CHEMOSPHERE, V60, P672, DOI 10.1016/j.chemosphere.2005.01.048; Liendo D, 2015, PLANT BIOSYST, V149, P289, DOI 10.1080/11263504.2013.822434; MacArthur R.H., 1967, THEORY ISLAND BIOGEO; Malinowski K, 2012, THESIS; Matuszkiewicz W, 2005, PRZEWODNIK OZNACZANI; Menuz DR, 2013, BIOL INVASIONS, V15, P1601, DOI 10.1007/s10530-012-0395-6; Menuz DR, 2014, ECOGRAPHY, V37, P1; Milbau A, 2009, BIOL INVASIONS, V11, P941, DOI 10.1007/s10530-008-9306-2; Miller ME, 2006, PLANT SOIL, V288, P1, DOI 10.1007/s11104-006-0058-4; Morawski W, 1980, OBJASNIENIA SZCZEGOL; Niinemets U, 2006, ECOL MONOGR, V76, P521, DOI 10.1890/0012-9615(2006)076[0521:TTSDAW]2.0.CO;2; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pedrotti F, 2013, GEOBOTANY STUDIES; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Pickett STA, 2008, BIOSCIENCE, V58, P139, DOI 10.1641/B580208; Pino J, 2005, BIOL CONSERV, V122, P339, DOI 10.1016/j.biocon.2004.08.006; Pysek P, 2010, P NATL ACAD SCI USA, V107, P12157, DOI 10.1073/pnas.1002314107; QGIS Development Team, 2009, QGIS GEOGR INF SYST; Questad EJ, 2008, ECOL LETT, V11, P717, DOI 10.1111/j.1461-0248.2008.01186.x; R Core Team, 2021, R LANGUAGE ENV STAT; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Romaniak O, 2009, THESIS; Sarnacka Z, 1980, OBJASNIENIA SZCZEGOL; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Snyder RE, 2003, ECOL LETT, V6, P301, DOI 10.1046/j.1461-0248.2003.00434.x; Stanczak J, 2013, POPULATION; Stockwell DRB, 2002, ECOL MODEL, V148, P1, DOI 10.1016/S0304-3800(01)00388-X; Sudnik-Wojcikowska B, 2011, PLANTS AND HABITATS OF EUROPEAN CITIES, P499; Sung CY, 2011, LANDSCAPE URBAN PLAN, V100, P278, DOI 10.1016/j.landurbplan.2010.12.014; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; THUILLER W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI DOI 10.1111/J.1365-2486.2005.01018.X; Tokarska-Guzik B, 2012, GEN DYR OCHR SROD WA; VanDerWal J, 2011, SDM TOOLS SPECIES DI; Vidra RL, 2008, RESTOR ECOL, V16, P217, DOI 10.1111/j.1526-100X.2008.00387.x; Von Holle B, 2007, BIOL CONSERV, V136, P33, DOI 10.1016/j.biocon.2006.10.044; Weng QH, 2004, REMOTE SENS ENVIRON, V89, P467, DOI 10.1016/j.rse.2003.11.005; Wierzbicka M, 1998, ENVIRON POLLUT, V101, P415, DOI 10.1016/S0269-7491(98)00012-8; Williams JN, 2009, DIVERS DISTRIB, V15, P565, DOI 10.1111/j.1472-4642.2009.00567.x; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Yang RY, 2007, BOT STUD, V48, P453	79	5	5	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168365	10.1371/journal.pone.0168365	http://dx.doi.org/10.1371/journal.pone.0168365			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992516	Green Submitted, Green Published, gold			2022-12-26	WOS:000392758000041
J	Cella, K; Carmona, L; Ekimova, I; Chichvarkhin, A; Schepetov, D; Gosliner, TM				Cella, Kristen; Carmona, Leila; Ekimova, Irina; Chichvarkhin, Anton; Schepetov, Dimitry; Gosliner, Terrence M.			A Radical Solution: The Phylogeny of the Nudibranch Family Fionidae	PLOS ONE			English	Article							GASTROPODA NUDIBRANCHIA; TERGIPEDIDAE GASTROPODA; SPECIES DELIMITATION; MOLLUSCA; OPISTHOBRANCHIA; CEPHALASPIDEA; SYSTEMATICS; DIVERSITY; SEA; AEOLIDINA	Tergipedidae represents a diverse and successful group of aeolid nudibranchs, with approximately 200 species distributed throughout most marine ecosystems and spanning all biogeographical regions of the oceans. However, the systematics of this family remains poorly understood since no modern phylogenetic study has been undertaken to support any of the proposed classifications. The present study is the first molecular phylogeny of Tergipedidae based on partial sequences of two mitochondrial (COI and 16S) genes and one nuclear gene (H3). Maximum likelihood, maximum parsimony and Bayesian analysis were conducted in order to elucidate the systematics of this family. Our results do not recover the traditional Tergipedidae as monophyletic, since it belongs to a larger clade that includes the families Eubranchidae, Fionidae and Calmidae. This newly recovered clade is here referred to as Fionidae, the oldest name for this taxon. In addition, the present molecular phylogeny does not recover the traditional systematic relationships at a generic level, and therefore, systematic changes are required. We recognize the following clades within Fionidae: Calma, Cuthona, Cuthonella, Eubranchus, Fiona, Murmania, Tenellia, Tergipes, Tergiposacca gen. nov., Rubramoena gen. nov. and Abronica gen. nov. The type species of Tergiposacca, T. longicerata nov. sp. is described. The other two new genera have a previously described species as their type species. Most of these taxa, with the exceptions of Eubranchus, Tergipes and Fiona are composed of radically different constituent species from their traditional membership, but appear to be supported by morphological synapomorphies as well as molecular data. Aenigmastyletus, Catriona, Phestilla, Tenellia and Trinchesia are nested within other clades and, thus are here considered as synonyms of the larger clades. The phylogenetic position and validity of Myja, Guyvalvoria, Leostyletus and Subcuthona still need to be tested in future studies when material becomes available.	[Cella, Kristen; Gosliner, Terrence M.] Calif Acad Sci, Dept Invertebrate Zool, San Francisco, CA 94118 USA; [Carmona, Leila] Univ Gothenburg, Dept Marine Sci, Gothenburg, Sweden; [Ekimova, Irina; Chichvarkhin, Anton] Far Eastern Fed Univ, Vladivostok, Russia; [Ekimova, Irina] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia; [Chichvarkhin, Anton] Russian Acad Sci, AV Zhirmunsky Inst Marine Biol, Vladivostok, Russia; [Schepetov, Dimitry] Natl Res Univ, Higher Sch Econ, Moscow, Russia	California Academy of Sciences; University of Gothenburg; Far Eastern Federal University; Lomonosov Moscow State University; Russian Academy of Sciences; National Scientific Center of Marine Biology, Far East Branch of the Russian Academy of Sciences; HSE University (National Research University Higher School of Economics)	Carmona, L (corresponding author), Univ Gothenburg, Dept Marine Sci, Gothenburg, Sweden.	leilacarmonabarnosi@gmail.com	Chichvarkhin, Anton/J-1253-2014; Schepetov, Dimitry M/S-5444-2018; Ekimova, Irina/AAT-4377-2020; Carmona, Leila/L-8021-2014; Ekimova, Irina/L-3958-2015	Chichvarkhin, Anton/0000-0001-8017-6783; Schepetov, Dimitry M/0000-0002-1195-0461; Ekimova, Irina/0000-0002-1846-0780; Carmona, Leila/0000-0002-2070-4684; Ekimova, Irina/0000-0002-1846-0780	Conchologists of America Grant [CGL2010-17187]; Lerner-Grey Grant for Marine Research the Arthur Nelson Graduate Scholarship; California Academy of Sciences Graduate Assistantship Program in Research and Education; Far East Program [15-I-6-014o]; Russian Science Foundation [14-50-00034, 15-29-02456]; Swedish Taxonomy Initiative [2015-7 4.3]; National Science Foundation [DEB 12576304, REU 1358680]; Basic Research Program of the National Research University Higher School of Economics; Direct For Biological Sciences [1257630] Funding Source: National Science Foundation	Conchologists of America Grant; Lerner-Grey Grant for Marine Research the Arthur Nelson Graduate Scholarship; California Academy of Sciences Graduate Assistantship Program in Research and Education; Far East Program; Russian Science Foundation(Russian Science Foundation (RSF)); Swedish Taxonomy Initiative; National Science Foundation(National Science Foundation (NSF)); Basic Research Program of the National Research University Higher School of Economics; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the research grants (CGL2010-17187), Conchologists of America Grant, the Lerner-Grey Grant for Marine Research the Arthur Nelson Graduate Scholarship and the California Academy of Sciences Graduate Assistantship Program in Research and Education. This contribution was partially funded by Far East Program grant #15-I-6-014o to AC, and Russian Science Foundation grant 14-50-00034 to IE. Sequencing of Russian specimens was funded by Russian Science Foundation grant 14-50-00034 to IE and Russian Foundation for Basic Research grant 15-29-02456 to AC. Sequencing of Swedish, Irish and Scottish specimens was funded by the Swedish Taxonomy Initiative grant dha 2015-7 4.3. This research was also supported by two grants from National Science Foundation: DEB 12576304 grant to Terrence Gosliner, Richard Mooi, Luis Rocha and Gary Williams to inventory the biodiversity of the Verde Island Passage and REU 1358680 to Richard Mooi, which supported Elise Ongs participation in this project. Support from the Basic Research Program of the National Research University Higher School of Economics is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder J., 1854, ANN MAG NAT HIST, V2, P102, DOI DOI 10.1080/037454809494312; ALDER J., 1843, ANN MAGAZINE NATURAL, V12, P233, DOI DOI 10.1080/03745484309442517; Alfaro ME, 2003, MOL BIOL EVOL, V20, P255, DOI 10.1093/molbev/msg028; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 1855, MONOGRAPH BRIT NUDIB; Baba K., 1961, Publications of the Seto Marine Biological Laboratory, V9, P367; Behrens DW, 2008, INDOPACIFIC NUDIBRAN; Bergh L. S. R., 1884, ZOOLOGY, V10, P1; BERGH L. S. R., 1896, REV SUISSE ZOOL, V4, P385; Bergh R., 1890, Zoologischer Jahresbericht, Vv, P1; Betti F., 2011, REGNO NUDIBRANCHI GU; Bouchet P, 2005, MALACOLOGIA, V47, P1; Bouchet P., 2015, TERGIPEDIDAE BERGH 1; Bouchet P, 2015, PHESTILLA SIBOGAE BE; Bouchet P, 2016, TERGIPES; Bouchet P, 2015, CUTHONA; Bragt PH, 2002, CUTHONA RUBESCENS CO; BROWN GH, 1980, ZOOL J LINN SOC-LOND, V69, P225, DOI 10.1111/j.1096-3642.1980.tb01124.x; BURN R, 1973, Proceedings of the Royal Society of Victoria, V86, P39; Caballer M, 2013, EUBRANCHIDAE ODHNER; Calado G, 2002, J MOLLUS STUD, V68, P311, DOI 10.1093/mollus/68.4.311; Camacho-Garcia Y., 2005, FIELD GUIDE SEA SLUG; Camacho-Garcia YE, 2014, MOL PHYLOGENET EVOL, V71, P113, DOI 10.1016/j.ympev.2013.11.010; Camara S, 2014, J MOLLUS STUD, V80, P642, DOI 10.1093/mollus/eyu015; Carmona L, 2014, ZOOL J LINN SOC-LOND, V171, P108, DOI 10.1111/zoj12129; Carmona L, 2014, HELGOLAND MAR RES, V68, P37, DOI 10.1007/s10152-013-0367-y; Carmona L, 2014, ZOOL J LINN SOC-LOND, V170, P132, DOI 10.1111/zoj12098; Carmona L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063000; Cervera J. L., 2004, Boletin Instituto Espanol de Oceanografia, V20, P5; Churchill CKC, 2014, INVERTEBR SYST, V28, P174, DOI 10.1071/IS13038; Churchill CKC, 2014, MAR BIOL, V161, P899, DOI 10.1007/s00227-014-2389-7; Churchill CKC, 2013, P R SOC B, V280, P1471; Debelius H, 2007, NUDIBRANCHS WORLD; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edmunds M, 2016, J CONCHOL, V42, P23; Eliot CA, 1910, MONOGRAPH BRIT NUDIB; Evans TJ, 1922, Q J MICROSC SCI, V66, P439; Evertsen Jussi, 2013, Fauna Norvegica, V32, P45, DOI 10.5324/fn.v31i0.1576; Goddard J., 2003, RE WHICH IS EUBRANCH; Gofas S, 2015, CUTHONELLA BERGH; Gosliner T.M., 1992, P 7 INT COR REEF S G, P702; Gosliner Terrence M., 2004, Proceedings of the California Academy of Sciences, V55, P125; GOSLINER TM, 1979, PAC SCI, V33, P37; Gosliner TM, 1981, ANN S AFR MUS, V82, P102; Gosliner TM., 2015, NUDIBRANCH SEA SLUG; Gosliner TM., 1987, NUDIBRANCHS SO AFRIC; Hamatani I, 1993, JPN J MALACOL, V52, P127; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Huelsenbeck JP, 1996, TRENDS ECOL EVOL, V11, P152, DOI 10.1016/0169-5347(96)10006-9; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; ICZN, 1999, INT CODE ZOOLOGICAL; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kienberger K, 2016, ZOOL J LINN SOC-LOND, V177, P481, DOI 10.1111/zoj.12379; Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531; Lindsay T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154265; LUNDIN K., 2015, SVENSKA NAKENSNACKOR; MacFarland F. M., 1966, Memoirs of the California Academy of Sciences, V6, P1; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Malaquias MAE, 2008, ACTA ZOOL-STOCKHOLM, V89, P205, DOI 10.1111/j.1463-6395.2007.00308.x; Marcus, 1961, Veliger Suppl, V3, P1; Martynov A.V., 2006, Ruthenica, V16, P73; Martynov A.V., 2000, Ruthenica, V10, P5; Martynov AV, 1998, ZOOL ZH, V77, P763; MARTYNOV AV, 1992, ZOOL ZH, V71, P18; Martynov AV, 2006, MARINE BRACKISH WATE, P268; Martynov AV, 2011, OPISTHOBRANCH MOLLUS; Martynov AV, 2005, CATALOGUE MOLLUSCS R, P177; Martynov AV, 2015, P 15 INT SCI C PETR, P55; MILLEN SV, 1986, CAN J ZOOL, V64, P1356, DOI 10.1139/z86-202; MILLER MC, 1977, ZOOL J LINN SOC-LOND, V60, P197, DOI 10.1111/j.1096-3642.1977.tb01027.x; Miller MC, 2004, J NAT HIST, V38, P1183, DOI 10.1080/0022293031000077699; Miller MC, 2006, VITA MARINA, V3, P69; Moller H. P. C., 1842, INDEX MOLLUSCORUM GR; Montagu G, 1808, T LINN SOC LOND, V9, P81, DOI DOI 10.1111/J.1096-3642.1804.TB00282.X; Nylander JAA, 2004, PROGRAM DISTRIBUTED; Oskars TR, 2015, MOL PHYLOGENET EVOL, V89, P130, DOI 10.1016/j.ympev.2015.04.011; Padula V, 2014, J MOLLUS STUD, V80, P575, DOI 10.1093/mollus/eyu052; Picton B.E., 1994, FIELD GUIDE NUDIBRAN; PICTON BE, 1978, J CONCHOL, V29, P345; Pittman C, 2014, CUTHONA SP 13; Platts E., 1985, N ATLANTIC NUDIBRANC, V2, P150; Pola M, 2006, ANN ZOOL FENN, V43, P52; Pola M, 2010, MOL PHYLOGENET EVOL, V56, P931, DOI 10.1016/j.ympev.2010.05.003; Prkic J, 2014, MEDITERR MAR SCI, V15, P423, DOI 10.12681/mms.709; Pruvot-Fol A, 1951, ARCH ZOOLOGIE EXPT G, V88, P1; Pruvot-Fol A., 1954, MOLLUSQUES OPISTHOBR, V58; Pruvot-Fol A, 1948, B MUS NATL HIST NAT, V20, P273; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; RUDMAN WB, 1981, ZOOL J LINN SOC-LOND, V71, P373, DOI 10.1111/j.1096-3642.1981.tb01136.x; Rudman WB, 2005, CUTHONA PUSTULATA AL; Shine J., 2012, NUDIBRANCHS NE; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thiele J., 1931, HDB SYSTEMATICSCHEN; Thompson TE., 1984, BIOL OPISTHOBRANCH M, V2; Volodchenko N. I., 1941, Investigations of the Far East Seas of USSR, V1, P53; Willan R.C., 1979, Tane, V25, P141; WILLIAMS GC, 1979, ZOOL J LINN SOC-LOND, V67, P203, DOI 10.1111/j.1096-3642.1979.tb01112.x; Wilson NG, 2015, ZOOL J LINN SOC-LOND, V175, P119, DOI 10.1111/zoj.12266; Yorifuji M, 2012, ZOOL SCI, V29, P359, DOI 10.2108/zsj.29.359; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	104	31	38	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0167800	10.1371/journal.pone.0167800	http://dx.doi.org/10.1371/journal.pone.0167800			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977703	Green Published, gold, Green Submitted			2022-12-26	WOS:000391217400032
J	Dupont, C; Maduro, C; Den Braanker, H; Boers, R; Kurek, D; Gribnau, J				Dupont, Catherine; Maduro, Cheryl; Den Braanker, Hannah; Boers, Ruben; Kurek, Dorota; Gribnau, Joost			Characterization of Histone Modifications Associated with Inactive X-Chromosome in Trophoblast Stem Cells, eXtra-Embryonic Endoderm Cells and in In Vitro Derived Undifferentiated and Differentiated Epiblast Like Stem Cells	PLOS ONE			English	Article							XIST RNA; MOUSE EMBRYOS; GIANT-CELLS; METHYLATION; CHROMATIN; PROTEINS; DNA; METHYLTRANSFERASE; GENES; H3	In mouse, X-chromosome inactivation (XCI) can either be imprinted or random. Imprinted XCI (iXCI) is considered unstable and depending on continuous Xist expression, whereas random XCI (rXCI) is stably maintained even in the absence of Xist. Here we have systematically examined epigenetic modifications associated with the inactive X-chromosome (Xi) in Trophoblast Stem cells, eXtra-Embryonic Endoderm Cells, undifferentiated and differentiated Epiblast Like Stem Cells in order to understand intrinsic differences in epigenetic mechanisms involved in silencing of the inactive X-chromosome in lineages presenting iXCI and rXCI. Whereas euchromatic histone modifications are predominantly lost from the Xi territory in all cell types, the accumulation of heterochromatic modifications diverges in between the analysed cell lineages. Particularly, only the Xi of multipotent Trophoblast (iXCI) and Epiblast stem cells (rXCI) display a visible accumulation of Polycomb Repressive Complexes (PRCs), in contrast to the Xi in differentiated Epiblast Like Stem Cells and eXtra-embryonic Endoderm cells. Despite this, the histone modifications catalysed by PRCs, ubH2AK119 and H3K27me3, remain the best heterochromatic markers for the Xi in all assessed lineages. Heterochromatic chromatin modifications associated with the Xi are a reflection of the epigenetic landscape of the entire genome of the assessed cell regardless whether XCI is imprinted or random.	[Dupont, Catherine; Maduro, Cheryl; Den Braanker, Hannah; Boers, Ruben; Kurek, Dorota; Gribnau, Joost] Erasmus MC, Dept Dev Biol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Dupont, C; Gribnau, J (corresponding author), Erasmus MC, Dept Dev Biol, Rotterdam, Netherlands.	c.dupont@erasmusmc.nl; j.gribnau@erasmusmc.nl	Boers, Ruben/AAF-8181-2020	Boers, Ruben/0000-0002-3377-2897; Dupont, Catherine/0000-0002-6228-1202; Kurek, Dorota/0000-0002-7168-8944				BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; Chaumeil J, 2002, CYTOGENET GENOME RES, V99, P75, DOI 10.1159/000071577; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025; Corbel C, 2013, DEVELOPMENT, V140, P861, DOI 10.1242/dev.087429; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Fang J, 2004, J BIOL CHEM, V279, P52812, DOI 10.1074/jbc.C400493200; Gayen S, 2015, CELL REP, V11, P1251, DOI 10.1016/j.celrep.2015.04.039; Hadjantonakis AK, 2001, GENESIS, V29, P133, DOI 10.1002/gene.1016; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Kalantry S, 2006, NAT CELL BIOL, V8, P195, DOI 10.1038/ncb1351; Keohane AM, 1996, DEV BIOL, V180, P618, DOI 10.1006/dbio.1996.0333; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; KRATZER PG, 1983, CELL, V33, P37, DOI 10.1016/0092-8674(83)90332-X; KRUMLAUF R, 1986, NATURE, V319, P224, DOI 10.1038/319224a0; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Mak W, 2002, CURR BIOL, V12, P1016, DOI 10.1016/S0960-9822(02)00892-8; McHugh CA, 2015, NATURE, V521, P232, DOI 10.1038/nature14443; Mermoud JE, 2002, CURR BIOL, V12, P247, DOI 10.1016/S0960-9822(02)00660-7; Merzouk S, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-11; Minajigi A, 2015, SCIENCE, V349, DOI [10.1126/science.aab2276, 10.1126/science.aab2276 aab2276]; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Moindrot B, 2015, CELL REP, V12, P562, DOI 10.1016/j.celrep.2015.06.053; Monfort A, 2015, CELL REP, V12, P554, DOI 10.1016/j.celrep.2015.06.067; Monkhorst K, 2008, CELL, V132, P410, DOI 10.1016/j.cell.2007.12.036; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Ohhata T, 2008, DEVELOPMENT, V135, P227, DOI 10.1242/dev.008490; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Okamoto I, 2009, CHROMOSOME RES, V17, P659, DOI 10.1007/s10577-009-9057-7; Patrat C, 2009, P NATL ACAD SCI USA, V106, P5198, DOI 10.1073/pnas.0810683106; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; RASTAN S, 1982, J EMBRYOL EXP MORPH, V71, P11; Sado T, 2000, DEV BIOL, V225, P294, DOI 10.1006/dbio.2000.9823; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Senner CE, 2012, STEM CELLS, V30, P2732, DOI 10.1002/stem.1249; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314	42	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0167154	10.1371/journal.pone.0167154	http://dx.doi.org/10.1371/journal.pone.0167154			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977710	Green Published, gold, Green Submitted			2022-12-26	WOS:000391217400012
J	Marotta, A; Tinazzi, M; Cavedini, C; Zampini, M; Fiorio, M				Marotta, Angela; Tinazzi, Michele; Cavedini, Clelia; Zampini, Massimiliano; Fiorio, Mirta			Individual Differences in the Rubber Hand Illusion Are Related to Sensory Suggestibility	PLOS ONE			English	Article							BODY-OWNERSHIP; BRAIN; EXPERIENCES; THATS; LIMB	In the rubber hand illusion (RHI), watching a rubber hand being stroked in synchrony with one's own hidden hand may induce a sense of ownership over the rubber hand. The illusion relies on bottom-up multisensory integration of visual, tactile, and proprioceptive information, and on top-down processes through which the rubber hand is incorporated into pre-existing representations of the body. Although the degree of illusory experience varies largely across individuals, the factors influencing individual differences are unknown. We investigated whether sensory suggestibility might modulate susceptibility to the RHI. Sensory suggestibility is a personality trait related to how individuals react to sensory information. Because of its sensory nature, this trait could be relevant for studies using the RHI paradigm. Seventy healthy volunteers were classified by Sensory Suggestibility Scale (SSS) scores as having high or low suggestibility and assigned to either a high-(High-SSS) or a low-suggestibility (Low-SSS) group. Two components of the RHI were evaluated in synchronous and asynchronous stroking conditions: subjective experience of sense of ownership over the rubber hand via a 9-statement questionnaire, and proprioceptive drift as measured with a ruler. The High-SSS group was generally more susceptible to the subjective component; in the synchronous condition, they rated the statement assessing the sense of ownership higher than the Low-SSS group. The scores for this statement significantly correlated with the total SSS score, indicating that the higher the sensory suggestibility, the stronger the sense of ownership. No effect of sensory suggestibility on proprioceptive drift was observed, suggesting that the effect is specific for the subjective feeling of ownership. This study demonstrates that sensory suggestibility may contribute to participants' experience of the illusion and should be considered when using the RHI paradigm.	[Marotta, Angela; Tinazzi, Michele; Cavedini, Clelia; Fiorio, Mirta] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy; [Zampini, Massimiliano] Univ Trento, Dept Psychol & Cognit Sci, Rovereto, Italy; [Zampini, Massimiliano] Univ Trento, Ctr Mind Brain Sci, Trento, Italy	University of Verona; University of Trento; University of Trento	Marotta, A; Fiorio, M (corresponding author), Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy.	angela.marotta@univr.it; mirta.fiorio@univr.it	Marotta, Angela/K-4562-2016; Marotta, Angela/AAB-4418-2021; Zampini, Massimiliano/AAR-1311-2020; TINAZZI, Michele/J-7134-2018	Marotta, Angela/0000-0002-0738-0240; Zampini, Massimiliano/0000-0001-5950-7365; TINAZZI, Michele/0000-0002-2370-7063; Fiorio, Mirta/0000-0002-6356-0211; Marotta, Angela/0000-0002-2083-3005				Abdulkarim Z, 2016, ATTEN PERCEPT PSYCHO, V78, P707, DOI 10.3758/s13414-015-1016-0; Asai T, 2011, CONSCIOUS COGN, V20, P1744, DOI 10.1016/j.concog.2011.02.005; Bekrater-Bodmann R, 2012, BRAIN RES, V1452, P130, DOI 10.1016/j.brainres.2012.03.001; Bertamini M, 2014, CONSCIOUS COGN, V27, P89, DOI 10.1016/j.concog.2014.04.010; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Costantini M, 2007, CONSCIOUS COGN, V16, P229, DOI 10.1016/j.concog.2007.01.001; De Pascalis V, 2002, PAIN, V96, P393, DOI 10.1016/S0304-3959(01)00485-7; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Fiorio M, 2011, BRAIN, V134, P1428, DOI 10.1093/brain/awr026; Germine L, 2013, PSYCHIAT RES, V207, P45, DOI 10.1016/j.psychres.2012.11.022; Gheorghiu V.A., 2000, SUGGESTION SUGGESTIB, P1; Gheorghiu V. A., 2008, CONT HYPNOSIS, V25, P78, DOI DOI 10.1002/CH.357; Gheorghiu VA, 1995, HYPNOSIS CONNECTING, P14; Gheorghiu VA, 1976, REV ROUMAINE SCI SOC, V20, P29; Gheorghiu VA, 2001, CONT HYPNOSIS, V18, P21, DOI DOI 10.1002/ch.213; Haans A, 2012, ACTA PSYCHOL, V141, P169, DOI 10.1016/j.actpsy.2012.07.016; Holle H, 2011, COGN NEUROSCI-UK, V2, P171, DOI 10.1080/17588928.2011.603828; Ionta S, 2013, COGN AFFECT BEHAV NE, V13, P197, DOI 10.3758/s13415-012-0120-z; Kallai J, 2015, PSYCHIAT RES, V229, P410, DOI 10.1016/j.psychres.2015.05.109; Kilteni K, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00141; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Lund K, 2015, J PSYCHOSOM RES, V79, P663, DOI 10.1016/j.jpsychores.2015.05.002; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; Netter P., 1989, SUGGESTION SUGGESTIB, P123; Newport R, 2010, EXP BRAIN RES, V204, P385, DOI 10.1007/s00221-009-2104-y; Ocklenburg S, 2011, LATERALITY, V16, P174, DOI 10.1080/13576500903483515; Pavani F, 2007, PERCEPTION, V36, P1547, DOI 10.1068/p5853; Perez-Marcos D, 2009, NEUROREPORT, V20, P589, DOI 10.1097/WNR.0b013e32832a0a2a; Polczyk R, 2006, INT J CLIN EXP HYP, V54, P392, DOI 10.1080/00207140600856764; Rohde M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021659; Slater M, 2009, FRONT NEUROSCI-SWITZ, V3, P214, DOI 10.3389/neuro.01.029.2009; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P2740, DOI 10.1016/j.neuropsychologia.2010.05.021; Tsakiris M, 2010, EXP BRAIN RES, V204, P343, DOI 10.1007/s00221-009-2039-3; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; Walsh E, 2015, PERCEPTION, V44, P709, DOI 10.1177/0301006615594266	37	58	59	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168489	10.1371/journal.pone.0168489	http://dx.doi.org/10.1371/journal.pone.0168489			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7HN	27977783	Green Published, gold, Green Submitted			2022-12-26	WOS:000391217400112
J	Mattos, RT; Medeiros, NI; Menezes, CA; Fares, RCG; Franco, EP; Dutra, WO; Rios-Santos, F; Correa-Oliveira, R; Gomes, JAS				Mattos, Rafael T.; Medeiros, Nayara I.; Menezes, Carlos A.; Fares, Rafaelle C. G.; Franco, Eliza P.; Dutra, Walderez O.; Rios-Santos, Fabricio; Correa-Oliveira, Rodrigo; Gomes, Juliana A. S.			Chronic Low-Grade Inflammation in Childhood Obesity Is Associated with Decreased IL-10 Expression by Monocyte Subsets	PLOS ONE			English	Article							INNATE IMMUNITY; ADIPOSE-TISSUE; CD36; DIFFERENTIATION; ANGIOGENESIS; MACROPHAGES; ACTIVATION; TLR4	Chronic low-grade inflammation is related to the development of comorbidities and poor prognosis in obesity. Monocytes are main sources of cytokines and play a pivotal role in inflammation. We evaluated monocyte frequency, phenotype and cytokine profile of monocyte subsets, to determine their association with the pathogenesis of childhood obesity. Children with obesity were evaluated for biochemical and anthropometric parameters. Monocyte subsets were characterized by flow cytometry, considering cytokine production and activation/ recognition molecules. Correlation analysis between clinical parameters and immunological data delineated the monocytes contribution for low-grade inflammation. We observed a higher frequency of non-classical monocytes in the childhood obesity group ( CO) than normal-weight group ( NW). All subsets displayed higher TLR4 expression in CO, but their recognition and antigen presentation functions seem to be diminished due to lower expression of CD40, CD80/86 and HLA-DR. All subsets showed a lower expression of IL-10 in CO and correlation analyses showed changes in IL-10 expression profile. The lower expression of IL-10 may be decisive for the maintenance of the low-grade inflammation status in CO, especially for alterations in non-classical monocytes profile. These cells may contribute to supporting inflammation and loss of regulation in the immune response of children with obesity.	[Mattos, Rafael T.; Medeiros, Nayara I.; Franco, Eliza P.; Dutra, Walderez O.; Gomes, Juliana A. S.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, Lab Biol Interacoes Celulares, Belo Horizonte, MG, Brazil; [Medeiros, Nayara I.; Fares, Rafaelle C. G.; Correa-Oliveira, Rodrigo] Fiocruz MS, Ctr Pesquisa Rene Rachou, Lab Imunol Celular & Mol, Belo Horizonte, MG, Brazil; [Menezes, Carlos A.] Univ Estadual Santa Cruz, Dept Genet, Ilheus, BA, Brazil; [Menezes, Carlos A.] Unimed, Serv Med Prevent, Aracaju, SE, Brazil; [Dutra, Walderez O.; Correa-Oliveira, Rodrigo] Univ Fed Mato Grasso, INCT DT, Cuiaba, MT, Brazil; [Rios-Santos, Fabricio] Univ Fed Mato Grasso, Fac Med, Dept Ciencias Basicas Saude, Cuiaba, MT, Brazil; [Fares, Rafaelle C. G.] US FDA, Ctr Biol Evaluat & Res Silver Spring, Rockville, MD 20857 USA	Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; Universidade Estadual de Santa Cruz; US Food & Drug Administration (FDA)	Gomes, JAS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, Lab Biol Interacoes Celulares, Belo Horizonte, MG, Brazil.	juliana@icb.ufmg.br	Dutra, Walderez Ornelas/CAH-1502-2022; Medeiros, Nayara I/F-3273-2018; Gomes, Juliana A. S./M-4083-2017; Duarte, Graziela Biude Silva/Q-7728-2016	Dutra, Walderez Ornelas/0000-0002-7586-9996; Medeiros, Nayara I/0000-0002-5791-4802; Gomes, Juliana A. S./0000-0002-8332-2907; Fares Gusmao, Rafaelle/0000-0002-2186-4145; Correa-Oliveira, Rodrigo/0000-0001-6419-9459	FAPEMIG; FAPEMIG/PROBIC; CNPq PQ Fellowship program	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FAPEMIG/PROBIC(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq PQ Fellowship program	RTM and NIM are received financial support from FAPEMIG. EPF received fellowship from FAPEMIG/PROBIC. WOD, RCO and JASG received financial support from CNPq PQ Fellowship program.	Al-Sharea A, 2016, THROMB HAEMOSTASIS, V115, P762, DOI 10.1160/TH15-07-0571; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Ayina CNA, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0264-x; Bleau C, 2015, DIABETES-METAB RES, V31, P545, DOI 10.1002/dmrr.2617; BRAY GA, 1992, AM J CLIN NUTR, V55, P488, DOI 10.1093/ajcn/55.2.488s; BROOKE OG, 1985, HUM NUTR-APPL NUTR, V39A, P304; Cao DY, 2016, SCI REP-UK, V6, DOI 10.1038/srep23132; Carolan E, 2014, J CLIN ENDOCR METAB, V99, pE474, DOI 10.1210/jc.2013-3529; Cheng SB, 2015, AM J REPROD IMMUNOL, V73, P487, DOI 10.1111/aji.12329; Chow DC, 2016, HIV CLIN TRIALS, V17, P114, DOI 10.1080/15284336.2016.1162386; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Gaur P, 2016, CLIN EXP IMMUNOL; Groen B, 2015, SCI REP-UK, V5, DOI 10.1038/srep13618; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Ingersoll MA, 2011, TRENDS IMMUNOL, V32, P470, DOI 10.1016/j.it.2011.05.001; Ip B, 2016, OBESITY, V24, P102, DOI 10.1002/oby.21243; Jakubzick C, 2008, J IMMUNOL, V180, P3019, DOI 10.4049/jimmunol.180.5.3019; Janabi M, 2000, ARTERIOSCL THROM VAS, V20, P1953, DOI 10.1161/01.ATV.20.8.1953; Karlsson EA, 2010, EXP BIOL MED, V235, P1412, DOI 10.1258/ebm.2010.010227; Koleva Daniela Iv, 2013, Folia Med (Plovdiv), V55, P25; Kopp A, 2009, OBESITY, V17, P648, DOI 10.1038/oby.2008.607; Kuczmarski RJ, 2000, VITAL HLTH STAT, V11, P1; MALEFYT RD, 1991, J EXP MED, V174, P1209; Milner JJ, 2015, J IMMUNOL, V194, P4846, DOI 10.4049/jimmunol.1402295; Milner JJ, 2012, P NUTR SOC, V71, P298, DOI 10.1017/S0029665112000158; Poitou C, 2011, ARTERIOSCL THROM VAS, V31, P2322, DOI 10.1161/ATVBAHA.111.230979; Schaeffler A, 2009, IMMUNOLOGY, V126, P233, DOI 10.1111/j.1365-2567.2008.02892.x; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Sun SY, 2012, ANNU REV NUTR, V32, P261, DOI 10.1146/annurev-nutr-071811-150623; Thomas G, 2015, ARTERIOSCL THROM VAS, V35, P1306, DOI 10.1161/ATVBAHA.114.304650; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; van Greevenbroek MMJ, 2013, NETH J MED, V71, P174; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Williams DW, 2015, J LEUKOCYTE BIOL, V97, P401, DOI 10.1189/jlb.5A0714-347R; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Zawada AM, 2011, BLOOD, V118, pE50, DOI 10.1182/blood-2011-01-326827; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	39	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168610	10.1371/journal.pone.0168610	http://dx.doi.org/10.1371/journal.pone.0168610			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977792	gold, Green Published, Green Submitted			2022-12-26	WOS:000391217400122
J	Oh, SY; Fong, JJ; Park, MS; Lim, YW				Oh, Seung-Yoon; Fong, Jonathan J.; Park, Myung Soo; Lim, Young Woon			Distinctive Feature of Microbial Communities and Bacterial Functional Profiles in Tricholoma matsutake Dominant Soil	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; HELPER PSEUDOMONAS-FLUORESCENS; III SECRETION; ECTOMYCORRHIZAL SYMBIOSIS; LACCARIA-BICOLOR; PINUS-SYLVESTRIS; GENE-EXPRESSION; FAIRY RING; S-ITO; FOREST	Tricholoma matsutake, the pine mushroom, is a valuable forest product with high economic value in Asia, and plays an important ecological role as an ectomycorrhizal fungus. Around the host tree, T. matsutake hyphae generate a distinctive soil aggregating environment called a fairy ring, where fruiting bodies form. Because T. matsutake hyphae dominate the soil near the fairy ring, this species has the potential to influence the microbial community. To explore the influence of T. matsutake on the microbial communities, we compared the microbial community and predicted bacterial function between two different soil types D T. matsutake dominant and T. matsutake minor. DNA sequence analyses showed that fungal and bacterial diversity were lower in the T. matsutake dominant soil compared to T. matsutake minor soil. Some microbial taxa were significantly more common in the T. matsutake dominant soil across geographic locations, many of which were previously identified as mycophillic or mycorrhiza helper bacteria. Between the two soil types, the predicted bacterial functional profiles (using PICRUSt) had significantly distinct KEGG modules. Modules for amino acid uptake, carbohydrate metabolism, and the type III secretion system were higher in the T. matsutake dominant soil than in the T. matsutake minor soil. Overall, similar microbial diversity, community structure, and bacterial functional profiles of the T. matsutake dominant soil across geographic locations suggest that T. matsutake may generate a dominance effect.	[Oh, Seung-Yoon; Park, Myung Soo; Lim, Young Woon] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; [Fong, Jonathan J.] Lingnan Univ, Sci Unit, Tuen Mun, Hong Kong, Peoples R China	Seoul National University (SNU); Lingnan University	Lim, YW (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea.	ywlim@snu.ac.kr	Oh, Seung-Yoon/H-4958-2018	Oh, Seung-Yoon/0000-0002-9745-1849; FONG, Jonathan/0000-0002-3648-6730	National Institute of Forest Science [FP 0801-2009-01]	National Institute of Forest Science(National Institute of Forest Science (NIFOS), Republic of South Korea)	This study was supported by the National Institute of Forest Science (FP 0801-2009-01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreote FD, 2009, WORLD J MICROB BIOT, V25, P1065, DOI 10.1007/s11274-009-9990-9; Antony-Babu S, 2014, ENVIRON MICROBIOL, V16, P2831, DOI 10.1111/1462-2920.12294; Bakker MG, 2013, FEMS MICROBIOL ECOL, V83, P596, DOI 10.1111/1574-6941.12017; Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119; Bending GD, 2002, FEMS MICROBIOL ECOL, V39, P219, DOI 10.1111/j.1574-6941.2002.tb00924.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boersma FGH, 2010, SOIL BIOL BIOCHEM, V42, P2137, DOI 10.1016/j.soilbio.2010.08.009; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carvalhais LC, 2013, METHOD ENZYMOL, V531, P251, DOI 10.1016/B978-0-12-407863-5.00013-7; Chen L-x, 2014, ISME J, pe245; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; Corrigan A, 2015, APPL ENVIRON MICROB, V81, P3460, DOI 10.1128/AEM.04194-14; CROMACK K, 1988, AGR ECOSYST ENVIRON, V24, P161, DOI 10.1016/0167-8809(88)90063-1; Cusano AM, 2011, ENV MICROBIOL REP, V3, P203, DOI 10.1111/j.1758-2229.2010.00209.x; de Voogd NJ, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv019; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Deveau A, 2007, NEW PHYTOL, V175, P743, DOI 10.1111/j.1469-8137.2007.02148.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Frey-Klett P, 2007, NEW PHYTOL, V176, P22, DOI 10.1111/j.1469-8137.2007.02191.x; Frey-Klett P, 2005, NEW PHYTOL, V165, P317, DOI 10.1111/j.1469-8137.2004.01212.x; FreyKlett P, 1997, APPL ENVIRON MICROB, V63, P139, DOI 10.1128/AEM.63.1.139-144.1997; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; GRIFFITHS RP, 1991, PLANT SOIL, V134, P255, DOI 10.1007/BF00012043; GRIFFITHS RP, 1994, SOIL BIOL BIOCHEM, V26, P331, DOI 10.1016/0038-0717(94)90282-8; Guerin-Laguette Alexis, 2003, Mycological Progress, V2, P37, DOI 10.1007/s11557-006-0042-7; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hall IR, 2003, TRENDS BIOTECHNOL, V21, P433, DOI 10.1016/S0167-7799(03)00204-X; Halsey JA, 2016, ANTON LEEUW INT J G, V109, P1353, DOI 10.1007/s10482-016-0734-1; Hrynkiewicz K, 2009, BIOL FERT SOILS, V45, P385, DOI 10.1007/s00374-008-0346-7; Izumi H, 2011, ENVIRON MICROBIOL, V13, P819, DOI 10.1111/j.1462-2920.2010.02393.x; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; KANG A-S, 1989, Korean Journal of Mycology, V17, P51; Kataoka R, 2012, J MICROBIOL, V50, P199, DOI 10.1007/s12275-012-1371-7; Kim M, 2014, J APPL MICROBIOL, V117, P699, DOI 10.1111/jam.12572; Kim M, 2013, J MICROBIOL BIOTECHN, V23, P1347, DOI 10.4014/jmb.1306.06068; Kirst ME, 2015, APPL ENVIRON MICROB, V81, P783, DOI 10.1128/AEM.02712-14; Kluber LA, 2011, SOIL BIOL BIOCHEM, V43, P1042, DOI 10.1016/j.soilbio.2011.01.022; Kluber LA, 2010, SOIL BIOL BIOCHEM, V42, P1607, DOI 10.1016/j.soilbio.2010.06.001; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Koo Chang Duck, 2003, [Journal of Korean Society of Forest Science, 한국산림과학회지], V92, P632; KOPE HH, 1990, CAN J BOT, V68, P1254, DOI 10.1139/b90-159; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lee C-Y, 1997, KOREAN J MYCOL, V25, P226; Leveau JHJ, 2008, NEW PHYTOL, V177, P859, DOI 10.1111/j.1469-8137.2007.02325.x; LI CY, 1992, PLANT SOIL, V140, P35, DOI 10.1007/BF00012804; Lian CL, 2006, NEW PHYTOL, V171, P825, DOI 10.1111/j.1469-8137.2006.01801.x; Ma B, 2015, J APPL MICROBIOL, V118, P890, DOI 10.1111/jam.12756; Matsushita Norihisa, 2005, Mycoscience, V46, P90, DOI 10.1007/s10267-004-0220-x; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; 김인엽, 2005, [The Korean Journal of Mycology, 한국균학회지], V33, P22; Muyzer G., 1996, MOL MICROBIAL ECOLOG, P1; Nazir R, 2010, SOIL BIOL BIOCHEM, V42, P2146, DOI 10.1016/j.soilbio.2010.08.019; Nazir R, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00598; Nazir R, 2010, FEMS MICROBIOL ECOL, V71, P169, DOI 10.1111/j.1574-6941.2009.00807.x; Nguyen NH, 2015, MICROB ECOL, V69, P914, DOI 10.1007/s00248-015-0574-y; OGAWA M, 1976, T MYCOL SOC JPN, V17, P492; OHARA H, 1967, NATURE, V213, P528, DOI 10.1038/213528a0; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Preston GM, 2007, CELL HOST MICROBE, V2, P291, DOI 10.1016/j.chom.2007.10.004; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; R Core Team, 2014, R A LANGUAGE AND ENV; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Requena N, 1997, NEW PHYTOL, V136, P667, DOI 10.1046/j.1469-8137.1997.00786.x; 유영현, 2011, [The Korean Journal of Mycology, 한국균학회지], V39, P223; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sabella E, 2015, MYCOL PROG, V14, DOI 10.1007/s11557-015-1083-6; SASEK V, 1967, FOLIA MICROBIOL, V12, P515, DOI 10.1007/BF02875713; Sharpton TJ, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00209; Simon A, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv116; Smith S.E., 2010, MYCORRHIZAL SYMBIOSI, V3rd, DOI DOI 10.1097/00010694-198403000-00011; SONG H-S, 1991, Korean Journal of Mycology, V19, P109; Summerbell RC, 2005, STUD MYCOL, P191, DOI 10.3114/sim.53.1.191; Takakura Y, 2015, CAN J MICROBIOL, V61, P447, DOI 10.1139/cjm-2014-0843; Timonen S, 2006, CAN J MICROBIOL, V52, P769, DOI 10.1139/W06-016; Tominaga Y., 1963, Bulletin of the Hiroshima Agricultural College, Hiroshima, V2, P105; Trappe M. J., 2012, Diversity, V4, P196, DOI 10.3390/d4020196; Uroz S, 2012, APPL ENVIRON MICROB, V78, P3020, DOI 10.1128/AEM.06742-11; Vaario LM, 2011, APPL ENVIRON MICROB, V77, P8523, DOI 10.1128/AEM.05839-11; Vik U, 2013, SCI REP-UK, V3, DOI 10.1038/srep03471; Viollet A, 2011, FEMS MICROBIOL ECOL, V75, P457, DOI 10.1111/j.1574-6941.2010.01021.x; Voronina EY, 2011, MICROBIOLOGY+, V80, P584, DOI 10.1134/S0026261711040217; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Yun, 1997, Economic Botany, V51, P311, DOI 10.1007/BF02862101; Warmink JA, 2009, ENVIRON MICROBIOL, V11, P300, DOI 10.1111/j.1462-2920.2008.01767.x; Warmink JA, 2008, ISME J, V2, P887, DOI 10.1038/ismej.2008.41; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Yang XF, 2012, FUNGAL DIVERS, V56, P189, DOI 10.1007/s13225-012-0163-z; Zhang MZ, 2014, FEMS MICROBIOL ECOL, V89, P516, DOI 10.1111/1574-6941.12350	93	32	34	5	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168573	10.1371/journal.pone.0168573	http://dx.doi.org/10.1371/journal.pone.0168573			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977803	gold, Green Submitted, Green Published			2022-12-26	WOS:000391217400118
J	Priyadarsini, S; Sarker-Nag, A; Rowsey, TG; Ma, JX; Karamichos, D				Priyadarsini, Shrestha; Sarker-Nag, Akhee; Rowsey, Tyler G.; Ma, Jian-Xing; Karamichos, Dimitrios			Establishment of a 3D In Vitro Model to Accelerate the Development of Human Therapies against Corneal Diabetes	PLOS ONE			English	Article							EPITHELIAL BARRIER FUNCTION; BASEMENT-MEMBRANE; OXIDATIVE STRESS; SKELETAL-MUSCLE; MATRIX; CELLS; MITOCHONDRIA; METABOLISM; EXPRESSION; THICKNESS	Purpose To establish an in vitro model that would mirror the in vivo corneal stromal environment in diabetes (DM) patients. Methods Human corneal fibroblasts from Healthy (HCFs), Type 1DM (T1DM) and Type 2DM (T2DM) donors were isolated and cultured for 4 weeks with Vitamin C stimulation in order to allow for extracellular matrix (ECM) secretion and assembly. Results Our data indicated altered cellular morphology, increased cellular migration, increased ECM assembly, and severe mitochondrial damage in both T1DM and T2DMs when compared to HCFs. Furthermore, we found significant downregulation of Collagen I and Collagen V expression in both T1DM and T2DMs. Furthermore, a significant up regulation of fibrotic markers was seen, including a-smooth muscle actin in T2DM and Collagen III in both T1DM and T2DMs. Metabolic analysis suggested impaired Glycolysis and Tricarboxylic acid cycle (TCA) pathway. Conclusion DM has significant effects on physiological and clinical aspects of the human cornea. The benefits in developing and fully characterizing our 3D in vitro model are enormous and might provide clues for the development of novel therapeutics.	[Priyadarsini, Shrestha; Sarker-Nag, Akhee; Karamichos, Dimitrios] Univ Oklahoma, Hlth Sci Ctr, Dean McGee Eye Inst, Dept Ophthalmol, Oklahoma City, OK 73104 USA; [Rowsey, Tyler G.] East Cent Univ, Dept Biol & Chem, Ada, OK 74820 USA; [Ma, Jian-Xing] Univ Oklahoma, Hlth Sci Ctr, Harold Hamm Diabet Ctr, Dept Physiol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Karamichos, D (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dean McGee Eye Inst, Dept Ophthalmol, Oklahoma City, OK 73104 USA.	dimitrios-karamichos@ouhsc.edu		karamichos, dimitrios/0000-0002-8761-3824	National Eye Institute [EY020886, P30EY021725]	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute, EY020886 (DK), https://nei.nih.gov/; National Eye Institute, P30EY021725 (Dr. Gene Anderson), https://nei.nih.gov/.	Alper M G, 1975, Trans Am Ophthalmol Soc, V73, P323; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; ARAKI K, 1994, CURR EYE RES, V13, P203, DOI 10.3109/02713689408995778; BAKER KS, 1993, INVEST OPHTH VIS SCI, V34, P137; Bardsley Joan K, 2004, Crit Care Nurs Q, V27, P106; BIRK DE, 1988, J CELL BIOL, V106, P999, DOI 10.1083/jcb.106.3.999; Bravard A, 2011, AM J PHYSIOL-ENDOC M, V300, pE581, DOI 10.1152/ajpendo.00455.2010; Burkart AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep22788; BUSTED N, 1981, BRIT J OPHTHALMOL, V65, P687, DOI 10.1136/bjo.65.10.687; Crescenzo R, 2015, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00512; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Fillmore N, 2014, BRIT J PHARMACOL, V171, P2080, DOI 10.1111/bph.12475; Forouhi Nita Gandhi, 2014, Medicine (Abingdon), V42, P698; FOULKS GN, 1979, ARCH OPHTHALMOL-CHIC, V97, P1076; Gallagher EJ, 2011, ANN NY ACAD SCI, V1243, P54, DOI 10.1111/j.1749-6632.2011.06285.x; Garrett Q, 2014, AUSTIN J CLIN OPHTHA, V1; Gekka M, 2004, CORNEA, V23, P35, DOI 10.1097/00003226-200401000-00006; Gibran NS, 2002, J SURG RES, V108, P122, DOI 10.1006/jsre.2002.6525; GOBBELS M, 1989, GRAEF ARCH CLIN EXP, V227, P142, DOI 10.1007/BF02169787; Guo XQ, 2007, INVEST OPHTH VIS SCI, V48, P4050, DOI 10.1167/iovs.06-1216; HERSE PR, 1988, AM J OPTOM PHYS OPT, V65, P224; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; Karamichos D, 2014, EXP EYE RES, V124, P31, DOI 10.1016/j.exer.2014.04.020; Karamichos D, 2014, SCI REP-UK, V4, DOI 10.1038/srep04608; Karamichos D, 2011, J TISSUE ENG REGEN M, V5, pE228, DOI 10.1002/term.429; Karamichos D, 2012, J FUNCT BIOMATER, V3, P760, DOI 10.3390/jfb3040760; Karamichos D, 2011, J FUNCT BIOMATER, V2, P213, DOI 10.3390/jfb2030213; Karamichos D, 2007, INVEST OPHTH VIS SCI, V48, P5030, DOI 10.1167/iovs.07-0443; Karamichos D, 2010, INVEST OPHTH VIS SCI, V51, P1382, DOI 10.1167/iovs.09-3860; Karamichos D, 2009, CELL MOTIL CYTOSKEL, V66, P1, DOI 10.1002/cm.20326; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; Koussounadis A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10775; Lambert P., 2002, MEDICINE, V30, P1, DOI [DOI 10.1383/MEDC.30.1.1.28264, 10.1383/medc.30.1.1.28264.edit]; Lee JS, 2006, EYE, V20, P315, DOI 10.1038/sj.eye.6701868; Leppin K, 2014, INVEST OPHTH VIS SCI, V55, P3603, DOI 10.1167/iovs.14-14307; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu H, 2015, INT J CLIN EXP PATHO, V8, P7644; Ljubimov AV, 1998, J HISTOCHEM CYTOCHEM, V46, P1033, DOI 10.1177/002215549804600907; Ljubimov AV, 2001, J HISTOCHEM CYTOCHEM, V49, P1341, DOI 10.1177/002215540104901102; McKay TB, 2015, CELL BIOCHEM FUNCT, V33, P341, DOI 10.1002/cbf.3122; Mishima S., 1957, JPN J OPHTHALMOL, V1, P65; NERUP J, 1994, DIABETOLOGIA, V37, pS82, DOI 10.1007/BF00400830; Owen CG, 2005, OPHTHALMOLOGY, V112, P1801, DOI 10.1016/j.ophtha.2005.04.030; Pascal LE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-246; Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027; Priyadarsini S, 2015, MOL VIS, V21, P577; Priyadarsini S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113310; Putti R, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00109; Rehany U, 2000, CORNEA, V19, P534, DOI 10.1097/00003226-200007000-00026; Ren R, 2008, DEV DYNAM, V237, P2705, DOI 10.1002/dvdy.21606; Rizvi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018137; Robert L, 2001, PATHOL BIOL, V49, P353, DOI 10.1016/S0369-8114(01)00144-4; Rother KI, 2007, NEW ENGL J MED, V356, P1499, DOI 10.1056/NEJMp078030; SAINI JS, 1995, CAN J OPHTHALMOL, V30, P142; Saini JS, 1996, ARCH OPHTHALMOL-CHIC, V114, P649, DOI 10.1001/archopht.1996.01100130641001; Schultz R O, 1981, Trans Am Ophthalmol Soc, V79, P180; SCHULTZ RO, 1983, AM J OPHTHALMOL, V96, P368, DOI 10.1016/S0002-9394(14)77829-8; SCHWARTZ DE, 1974, ARCH OPHTHALMOL-CHIC, V91, P174; Sherer TB, 2002, NEUROSCIENTIST, V8, P192, DOI 10.1177/1073858402008003004; Skarbez K, 2010, EXPERT REV OPHTHALMO, V5, P557, DOI 10.1586/EOP.10.44; Su DHW, 2008, OPHTHALMOLOGY, V115, P964, DOI 10.1016/j.ophtha.2007.08.021; Torricelli AAM, 2014, EXP EYE RES, V129, P151, DOI 10.1016/j.exer.2014.09.013; Trepat X, 2012, COMPR PHYSIOL, V2, P2369, DOI 10.1002/cphy.c110012; Webhofer C, 2013, J PSYCHIATR RES, V47, P289, DOI 10.1016/j.jpsychires.2012.11.003; Welf ES, 2011, WIRES SYST BIOL MED, V3, P231, DOI 10.1002/wsbm.110; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Yang Y, 2006, CLIN SCI, V110, P627, DOI 10.1042/CS20050330; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; ZIESKE JD, 1994, EXP CELL RES, V214, P621, DOI 10.1006/excr.1994.1300	71	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168845	10.1371/journal.pone.0168845	http://dx.doi.org/10.1371/journal.pone.0168845			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005998	Green Published, Green Submitted, gold			2022-12-26	WOS:000392843200103
J	Tota, JE; Jiang, MZ; Ramanakumar, AV; Walter, SD; Kaufman, JS; Coutlee, F; Richardson, H; Burchell, AN; Koushik, A; Mayrand, MH; Villa, LL; Franco, EL				Tota, Joseph E.; Jiang, Mengzhu; Ramanakumar, Agnihotram V.; Walter, Stephen D.; Kaufman, Jay S.; Coutlee, Francois; Richardson, Harriet; Burchell, Ann N.; Koushik, Anita; Mayrand, Marie Helene; Villa, Luisa L.; Franco, Eduardo L.			Epidemiologic Evaluation of Human Papillomavirus Type Competition and the Potential for Type Replacement Post-Vaccination	PLOS ONE			English	Article							CERVICAL-CANCER; HPV TYPES; CLUSTERING PATTERNS; PARTICLE VACCINE; INFECTION; WOMEN; RISK; DNA; COINFECTION; ACQUISITION	Background Millions of women have been vaccinated with one of two first-generation human papillomavirus (HPV) vaccines. Both vaccines remain in use and target two oncogenic types (HPVs 16 and 18); however, if these types naturally compete with others that are not targeted, type replacement may occur following reductions in the circulating prevalence of targeted types. To explore the potential for type replacement, we evaluated natural HPV type competition in unvaccinated females. Methods Valid HPV DNA typing information was available from five epidemiological studies conducted in Canada and Brazil (n = 14,685; enrollment across studies took place between1993 and 2010), which used similar consensus-primer PCR assays, capable of detecting up to 40 HPV types. A total of 38,088 cervicovaginal specimens were available for inclusion in our analyses evaluating HPV type-type interactions involving vaccine-targeted types (6, 11, 16, and 18), and infection with each of the other HPV types. Results Across the studies, the average age of participants ranged from 21.0 to 43.7 years. HPV16 was the most common type (prevalence range: 1.0% to 13.8%), and in general HPV types were more likely to be detected as part of a multiple infection than as single infections. In our analyses focusing on each of the vaccine-targeted HPV types separately, many significant positive associations were observed (particularly involving HPV16); however, we did not observe any statistically significant negative associations. Conclusions Our findings suggest that natural HPV type competition does not exist, and that type replacement is unlikely to occur in vaccinated populations.	[Tota, Joseph E.; Jiang, Mengzhu; Ramanakumar, Agnihotram V.; Franco, Eduardo L.] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Tota, Joseph E.; Kaufman, Jay S.; Franco, Eduardo L.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Tota, Joseph E.] NCI, Div Canc Epidemiol & Genet, Infect & Immunoepidemiol Branch, Rockville, MD 20892 USA; [Walter, Stephen D.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Coutlee, Francois] Univ Montreal, Dept Microbiol & Infectiol, Montreal, PQ, Canada; [Coutlee, Francois; Koushik, Anita; Mayrand, Marie Helene] Univ Montreal, Hosp Res Ctr, Montreal, PQ, Canada; [Richardson, Harriet] Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada; [Burchell, Ann N.] St Michaels Hosp, Dept Family & Community Med, Toronto, ON, Canada; [Burchell, Ann N.] Li Ka Shing Knowledge Inst, Ctr Res Inner City Hlth, Toronto, ON, Canada; [Koushik, Anita] Univ Montreal, Dept Med Sociale & Prevent, Montreal, PQ, Canada; [Mayrand, Marie Helene] Univ Montreal, Dept Obstet Gynecol & Med Sociale & Prevent, Montreal, PQ, Canada; [Villa, Luisa L.] Univ Sao Paulo, Sch Med, Dept Radiol & Oncol, Sao Paulo, Brazil	McGill University; McGill University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); McMaster University; Universite de Montreal; Universite de Montreal; Queens University - Canada; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; Universite de Montreal; Universite de Montreal; Universidade de Sao Paulo	Tota, JE (corresponding author), McGill Univ, Dept Oncol, Montreal, PQ, Canada.; Tota, JE (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.; Tota, JE (corresponding author), NCI, Div Canc Epidemiol & Genet, Infect & Immunoepidemiol Branch, Rockville, MD 20892 USA.	joseph.tota@nih.gov	VILLA, LUISA/AAH-4761-2019; Walter, Stephen/AAB-5548-2022; Mayrand, Marie-Hélène/ABB-7029-2020; Franco, Eduardo/C-6445-2014	VILLA, LUISA/0000-0003-4074-2335; Walter, Stephen/0000-0003-4157-8928; Franco, Eduardo/0000-0002-4409-8084; Kaufman, Jay/0000-0003-1606-401X	Canadian Institutes of Health Research [MOP-53111, MOP-49396, MOP-68893, MOP-42532, MCT-54063, MOP-67155, CRN-83320]; Canadian Cancer Society [12030]; US National Institutes of Health [CA70269, AI073889]; Society of Gynecologic Oncology of Canada; Roseau FRSQ SIDA maladies infectieuses; CIHR New Investigator awards; Canada Research Chairs program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Society of Gynecologic Oncology of Canada; Roseau FRSQ SIDA maladies infectieuses; CIHR New Investigator awards(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs program(Canada Research Chairs)	Funding for this study and for the parent investigations was provided by the Canadian Institutes of Health Research (grants MOP-53111, MOP-49396, MOP-68893, MOP-42532, MCT-54063, MOP-67155, CRN-83320), Canadian Cancer Society (grant 12030), the US National Institutes of Health (grants CA70269, AI073889), the Society of Gynecologic Oncology of Canada, and by the Roseau FRSQ SIDA maladies infectieuses. A.N.B. and A.K. are supported by CIHR New Investigator awards. J.S.K. was supported by the Canada Research Chairs program.	Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; Burchell AN, 2010, EPIDEMIOLOGY, V21, P31, DOI 10.1097/EDE.0b013e3181c1e70b; Chaturvedi AK, 2005, CANCER EPIDEM BIOMAR, V14, P2439, DOI 10.1158/1055-9965.EPI-05-0465; Chaturvedi AK, 2011, J INFECT DIS, V203, P910, DOI 10.1093/infdis/jiq139; Cole SR, 2010, INT J EPIDEMIOL, V39, P417, DOI 10.1093/ije/dyp334; Coutlee F, 1997, CLIN DIAGN VIROL, V8, P123, DOI 10.1016/S0928-0197(97)00021-4; Coutlee F, 2002, J CLIN MICROBIOL, V40, P902, DOI 10.1128/JCM.40.3.902-907.2002; Coutlee Francois, 2005, Can J Infect Dis Med Microbiol, V16, P83; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Dillner J, 2011, CLIN EXP IMMUNOL, V163, P17, DOI 10.1111/j.1365-2249.2010.04268.x; Franco E, 1999, Rev Panam Salud Publica, V6, P223, DOI 10.1590/S1020-49891999000900001; Gheit T, 2011, METHODS MOL BIOL, V665, P195, DOI 10.1007/978-1-60761-817-1_12; Giovannelli L, 2004, J CLIN MICROBIOL, V42, P3861, DOI 10.1128/JCM.42.8.3861-3864.2004; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Greenland S, 2000, INT J EPIDEMIOL, V29, P158, DOI 10.1093/ije/29.1.158; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Hubbard RA, 2003, ARCH PATHOL LAB MED, V127, P940; Joura EA, 2015, NEW ENGL J MED, V372, P711, DOI 10.1056/NEJMoa1405044; Kahn JA, 2012, PEDIATRICS, V130, pE249, DOI 10.1542/peds.2011-3587; Koushik A, 2005, CANCER DETECT PREV, V29, P307, DOI 10.1016/j.cdp.2005.06.007; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Liaw KL, 2001, J INFECT DIS, V183, P8, DOI 10.1086/317638; Martcheva M, 2008, J R SOC INTERFACE, V5, P3, DOI 10.1098/rsif.2007.0236; Mayrand MH, 2006, INT J CANCER, V119, P615, DOI 10.1002/ijc.21897; Mejlhede N, 2010, APMIS, V118, P346, DOI 10.1111/j.1600-0463.2010.02602.x; Mendez F, 2005, J INFECT DIS, V192, P1158, DOI 10.1086/444391; Mollers M, 2014, AM J EPIDEMIOL; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Plummer M, 2007, J INFECT DIS, V195, P1582, DOI 10.1086/516784; Richardson H, 2003, CANCER EPIDEM BIOMAR, V12, P485; Rositch AF, 2011, J INFECT DIS; Rousseau MC, 2003, SEX TRANSM DIS, V30, P581, DOI 10.1097/00007435-200307000-00010; Rousseau MC, 2001, J INFECT DIS, V184, P1508, DOI 10.1086/324579; Schiffman Mark, 2009, Infect Agent Cancer, V4, P8, DOI 10.1186/1750-9378-4-8; Thomas KK, 2000, J INFECT DIS, V182, P1097, DOI 10.1086/315805; Tota JE, 2016, J INFECT DIS; Tota JE, 2015, CANCER EPIDEM BIOMAR, V24, P286, DOI 10.1158/1055-9965.EPI-14-0566; Tota JE, 2013, AM J EPIDEMIOL, V178, P625, DOI 10.1093/aje/kwt018; Tota JE, 2011, PREV MED, V53, pS12, DOI 10.1016/j.ypmed.2011.08.017; Vaccarella S, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-50; Vaccarella S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071617; Vaccarella S, 2011, J INFECT DIS, V204, P385, DOI 10.1093/infdis/jir286; Vaccarella S, 2010, CANCER EPIDEM BIOMAR, V19, P503, DOI 10.1158/1055-9965.EPI-09-0983; VILLA LL, 1989, J NATL CANCER I, V81, P332, DOI 10.1093/jnci/81.5.332; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Yang ZH, 2014, AM J EPIDEMIOL, V180, P1066, DOI 10.1093/aje/kwu267	48	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0166329	10.1371/journal.pone.0166329	http://dx.doi.org/10.1371/journal.pone.0166329			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005904	Green Published, Green Submitted, gold			2022-12-26	WOS:000392843200005
J	van der Heide, I; Gehring, U; Koppelman, GH; Wijga, AH				van der Heide, Iris; Gehring, Ulrike; Koppelman, Gerard H.; Wijga, Alet H.			Health-Related Factors Associated with Discrepancies between Children's Potential and Attained Secondary School Level: A Longitudinal Study	PLOS ONE			English	Article							MENTAL-HEALTH; PERFORMANCE; ADOLESCENCE; PATHWAYS; OUTCOMES; COHORT	Objectives This longitudinal study examines children's health-related characteristics in relation to discrepancies between their educational potential assessed by a cognitive test in primary school at age 11 and their attained secondary school level at age 14. Methods Data were used from 1510 participants of the Dutch PIAMA (Prevention and Incidence of Asthma and Mite Allergy) birth cohort. Multiple multinomial logistic regression analyses were used to estimate the associations between indicators of physical health, psychosocial health, lifestyle, sleeping patterns and stressful life events and attending a higher or lower level of secondary education than indicated by the cognitive test. Results We found no evidence that physical health contributes to discrepancies between the potential and attained level of secondary education, but attention disorders and stressful life events (nasty experiences and parents' divorce) were associated with educational attainment below children's potential level. Furthermore, substance use (alcohol, drugs and smoking) were strongly associated with attending a lower level of secondary education than expected (odds ratios from 2.2 (CI: 1.5-3.3) to 5.0 (CI: 2.8-8.7)). Conclusion In this general population study, attention disorders, stressful life events and especially substance use seemed to be more important than physical health for the discrepancy between expected and attained level of secondary education. The longitudinal design of the present study and the broad range of health-related factors that were studied, adds insights to the process of health-selection.	[van der Heide, Iris; Wijga, Alet H.] Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands; [Gehring, Ulrike] Univ Utrecht, Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, GRIAC Res Inst,Dept Pediat Pulmonol & Pediat Alle, Groningen, Netherlands	Netherlands National Institute for Public Health & the Environment; Utrecht University	van der Heide, I (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands.	irisvanderheide@gmail.com	Koppelman, Gerard/AAG-9187-2020	Gehring, Ulrike/0000-0003-3612-5780; Koppelman, Gerard/0000-0001-8567-3252	The Netherlands Organisation for Health Research and Development; Netherlands Asthma Foundation; the Netherlands Ministry of Planning, Housing and the Environment; the Netherlands Ministry of Health, Welfare and Sport; Institute for Public Health and the Environment	The Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Asthma Foundation; the Netherlands Ministry of Planning, Housing and the Environment; the Netherlands Ministry of Health, Welfare and Sport; Institute for Public Health and the Environment	The Prevention and Incidence of Asthma and Mite Allergy Study was funded by grants from The Netherlands Organisation for Health Research and Development; the Netherlands Asthma Foundation; the Netherlands Ministry of Planning, Housing and the Environment; the Netherlands Ministry of Health, Welfare and Sport; and the Institute for Public Health and the Environment. The study sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Alper J, 2014, EXPLORING OPPORTUNIT; Basch CE, 2011, J SCHOOL HEALTH, V81, P593, DOI 10.1111/j.1746-1561.2011.00632.x; BERWICK DM, 1991, MED CARE, V29, P169, DOI 10.1097/00005650-199102000-00008; Bevans KB, 2010, QUAL LIFE RES, V19, P1195, DOI 10.1007/s11136-010-9687-4; Bosker RJ, 1985, GENERATIE GESELECT 1; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Brunekreef B, 2002, PEDIAT ALLERG IMM-UK, V13, P55, DOI 10.1034/j.1399-3038.13.s.15.1.x; Chevalier A, 2005, DISCUSSION PAPER SER, V1496; Cito, 2014, BET STAND CIT; Forrest CB, 2013, J ADOLESCENT HEALTH, V52, P186, DOI 10.1016/j.jadohealth.2012.06.019; Glew GM, 2005, ARCH PEDIAT ADOL MED, V159, P1026, DOI 10.1001/archpedi.159.11.1026; Glew GM, 2008, J PEDIATR-US, V152, P123, DOI 10.1016/j.jpeds.2007.05.045; Goodman A, 2010, J EPIDEMIOL COMMUN H, V64, pA11, DOI 10.1136/jech.2010.120956.27; Hoeymans N, 2010, HLTH DETERMINANTS SE; Koivusilta L, 2003, SOC SCI MED, V57, P577, DOI 10.1016/S0277-9536(02)00405-7; Koivusilta LK, 2001, HEALTH EDUC RES, V16, P201, DOI 10.1093/her/16.2.201; Onderwijsconsument, 2008, UITSL CIT 2008; Rosenbaum JE, 1999, SOCIOL EDUC, V72, P179, DOI 10.2307/2673228; Ruijsbroek A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134780; Rumpf HJ, 2001, PSYCHIAT RES, V105, P243, DOI 10.1016/S0165-1781(01)00329-8; Sharif I, 2006, PEDIATRICS, V118, pE1061, DOI 10.1542/peds.2005-2854; Stenberga S-A, 2014, BRIT J SOCIOLOGY ED; Stroucken L, 2008, SOCIAALECONOMISCHE T, P7; Suhrcke M, 2011, IMPACT HLTH HLTH BEH; Timmermans A. C., 2013, SCHOOLADVIEZEN ONDER; Traag T, 2008, ROLE STUDENT FAMILY; Uiters E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1104; Van de Mheen D., 1999, INEQUALITIES HLTH BE; Wolfson AR, 2003, SLEEP MED REV, V7, P491, DOI 10.1016/S1087-0792(03)90003-7	29	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168110	10.1371/journal.pone.0168110	http://dx.doi.org/10.1371/journal.pone.0168110			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QH	28005962	Green Published, gold, Green Submitted			2022-12-26	WOS:000392843200029
J	Hinton, JW; Proctor, C; Kelly, MJ; van Manen, FT; Vaughan, MR; Chamberlain, MJ				Hinton, Joseph W.; Proctor, Christine; Kelly, Marcella J.; van Manen, Frank T.; Vaughan, Michael R.; Chamberlain, Michael J.			Space Use and Habitat Selection by Resident and Transient Red Wolves (Canis rufus)	PLOS ONE			English	Article							EASTERN NORTH-CAROLINA; SCENT-MARKING; LARGE CARNIVORE; GRAY WOLVES; BODY-SIZE; WOLF; RANGE; HYBRIDIZATION; DISPERSAL; DYNAMICS	Recovery of large carnivores remains a challenge because complex spatial dynamics that facilitate population persistence are poorly understood. In particular, recovery of the critically endangered red wolf (Canis rufus) has been challenging because of its vulnerability to extinction via human-caused mortality and hybridization with coyotes (Canis latrans). Therefore, understanding red wolf space use and habitat selection is important to assist recovery because key aspects of wolf ecology such as interspecific competition, foraging, and habitat selection are well-known to influence population dynamics and persistence. During 2009-2011, we used global positioning system (GPS) radio-telemetry to quantify space use and 3rd-order habitat selection for resident and transient red wolves on the Albemarle Peninsula of eastern North Carolina. The Albemarle Peninsula was a predominantly agricultural landscape in which red wolves maintained spatially stable home ranges that varied between 25 km(2) and 190 km(2). Conversely, transient red wolves did not maintain home ranges and traversed areas between 122 km(2) and 681 km(2). Space use by transient red wolves was not spatially stable and exhibited shifting patterns until residency was achieved by individual wolves. Habitat selection was similar between resident and transient red wolves in which agricultural habitats were selected over forested habitats. However, transients showed stronger selection for edges and roads than resident red wolves. Behaviors of transient wolves are rarely reported in studies of space use and habitat selection because of technological limitations to observed extensive space use and because they do not contribute reproductively to populations. Transients in our study comprised displaced red wolves and younger dispersers that competed for limited space and mating opportunities. Therefore, our results suggest that transiency is likely an important life-history strategy for red wolves that facilitates metapopulation dynamics through short- and long-distance movements and eventual replacement of breeding residents lost to mortality.	[Hinton, Joseph W.; Chamberlain, Michael J.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Proctor, Christine; Kelly, Marcella J.; Vaughan, Michael R.] Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA USA; [van Manen, Frank T.] US Geol Survey, Northern Rocky Mt Sci Ctr, Interagency Grizzly Bear Study Team, Bozeman, MT USA	University System of Georgia; University of Georgia; Virginia Polytechnic Institute & State University; United States Department of the Interior; United States Geological Survey	Hinton, JW (corresponding author), Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA.	jhinton@uga.edu	Kelly, Marcella/B-4891-2011	Kelly, Marcella/0000-0001-9044-3873; T. van Manen, Frank/0000-0001-5340-8489	North Carolina Department of Transportation VT - NCDOT [09-0776-10]; Warnell of School of Forestry and Natural Resources	North Carolina Department of Transportation VT - NCDOT; Warnell of School of Forestry and Natural Resources	This work was supported by the North Carolina Department of Transportation VT - NCDOT Contract No. 09-0776-10. Publication fees were covered by the Warnell of School of Forestry and Natural Resources.	Abbott KC, 2011, ECOL LETT, V14, P1158, DOI 10.1111/j.1461-0248.2011.01670.x; Adams LG, 2008, WILDLIFE MONOGR, P1, DOI 10.2193/2008-012; BEKOFF M, 1981, OECOLOGIA, V50, P386, DOI 10.1007/BF00344981; Benson JF, 2015, OIKOS; Benson JF, 2014, ECOLOGY, V95, P254, DOI 10.1890/13-0698.1; Benson JF, 2013, METHODS ECOL EVOL, V4, P244, DOI 10.1111/2041-210x.12006; Berger KM, 2007, J ANIM ECOL, V76, P1075, DOI 10.1111/j.1365-2656.2007.01287.x; Bohling JH, 2016, EVOL APPL, V9, P791, DOI 10.1111/eva.12388; Bohling JH, 2015, BIOL CONSERV, V184, P108, DOI 10.1016/j.biocon.2015.01.013; Borg BL, 2015, J ANIM ECOL, V84, P177, DOI 10.1111/1365-2656.12256; Brainerd SM, 2008, J WILDLIFE MANAGE, V72, P89, DOI 10.2193/2006-305; Breitenmoser U, 1991, CARNIVORE CONSERVATI, P241; Brzeski KE, 2014, MOL ECOL, V23, P4241, DOI 10.1111/mec.12871; Byrne ME, 2014, J ANIM ECOL; Cassidy KA, 2015, BEHAV ECOL, V26, P1352, DOI 10.1093/beheco/arv081; Chadwick J, 2010, SOUTHEAST NAT, V9, P303, DOI 10.1656/058.009.0207; Dellinger JA, 2013, BIOL CONSERV, V157, P324, DOI 10.1016/j.biocon.2012.09.004; Dickie M, 2016, J APPL ECOL; Frair JL, 2010, PHILOS T R SOC B, V365, P2187, DOI 10.1098/rstb.2010.0084; FULLER TK, 1989, WILDLIFE MONOGR, P1; Fuller Todd K., 2003, P161; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Gese EM, 1997, ANIM BEHAV, V54, P1155, DOI 10.1006/anbe.1997.0561; Gese EM, 2015, BIOL CONSERV, V192, P11, DOI 10.1016/j.biocon.2015.09.003; Gese EM, 2015, CURR ZOOL, V61, P191, DOI 10.1093/czoolo/61.1.191; Gier HT., 1968, KAN STATE COLL AG EX, V939, P1; Gipson PS, 2000, J WILDLIFE MANAGE, V64, P752, DOI 10.2307/3802745; Gittleman J.L., 1989, P183; GITTLEMAN JL, 1982, BEHAV ECOL SOCIOBIOL, V10, P57, DOI 10.1007/BF00296396; GOMPPER ME, 1991, OECOLOGIA, V87, P343, DOI 10.1007/BF00634589; Gurarie E, 2009, ECOL LETT, V12, P395, DOI 10.1111/j.1461-0248.2009.01293.x; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; HANSKI I, 1991, BIOL J LINN SOC, V42, P3, DOI 10.1111/j.1095-8312.1991.tb00548.x; Hayward MW, 2007, ORYX, V41, P205, DOI 10.1017/S0030605307001767; Henry V. G., 1998, FED REGISTER, V63, P54152; Hinton J. W., 2014, THESIS; Hinton JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132203; Hinton JW, 2014, J MAMMAL, V95, P855, DOI 10.1644/13-MAMM-A-202; Hinton Joseph W., 2013, Animals, V3, P722, DOI 10.3390/ani3030722; Hinton JW, 2012, AM MIDL NAT, V168, P281; Hinton JW, 2010, J WILDLIFE MANAGE, V74, P55, DOI 10.2193/2008-583; Hinton JW, 2015, CANID BIOL CONSERV, V18, P22; Hinton JW, 2017, J WILDLIFE IN PRESS; Hinton JW, 2015, ORYX; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Kamler JF, 2000, CAN J ZOOL, V78, P2106, DOI 10.1139/cjz-78-12-2106; Karlin M, 2012, J ZOOL, V286, P266, DOI 10.1111/j.1469-7998.2011.00876.x; Karlin M, 2016, MAMM STUDY, V41, P87; Kellert SR, 1996, CONSERV BIOL, V10, P977, DOI 10.1046/j.1523-1739.1996.10040977.x; Kelly B. T., 1999, POP HAB VIAB ASS WOR; Kleiman DG, 2011, BEHAV GENET, V41, P803, DOI 10.1007/s10519-011-9459-0; Kranstauber B, 2012, J ANIM ECOL, V81, P738, DOI 10.1111/j.1365-2656.2012.01955.x; Kyle CJ, 2006, CONSERV GENET, V7, P273, DOI 10.1007/s10592-006-9130-0; Lucash C, 1999, ECOSYSTEM MANAGEMENT, P225; Manly B.F.J., 2002, RESOURCE SELECTION A; Mauney HF, 2005, THESIS; McKerrow AJ, 2006, CAROLINA GAP ANAL PR; MCNAB BK, 1963, AM NAT, V97, P133, DOI 10.1086/282264; Mech L. David, 2003, P1; Miller CR, 2003, MOL ECOL, V12, P3287, DOI 10.1046/j.1365-294X.2003.02003.x; Moveud Collier B., 2013, MOVEUD CREATES DYNAM; Murray DL, 2015, CONSERV LETT, V8, P338, DOI 10.1111/conl.12157; PETERS RP, 1975, AM SCI, V63, P628; R Core Team, 2021, R LANGUAGE ENV STAT; Rabon D.R., 2013, RED WOLF ADAPTIVE MA; Reading Richard P., 1996, P296; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Rutledge LY, 2012, BIOL CONSERV, V155, P186, DOI 10.1016/j.biocon.2012.05.017; Rutledge LY, 2012, ECOL EVOL, V2, P19, DOI 10.1002/ece3.61; Rutledge LY, 2010, BIOL CONSERV, V143, P332, DOI 10.1016/j.biocon.2009.10.017; Sawyer H, 2011, J ANIM ECOL, V80, P1078, DOI 10.1111/j.1365-2656.2011.01845.x; Sillero-Zubiri C, 1998, J ZOOL, V245, P351, DOI 10.1111/j.1469-7998.1998.tb00110.x; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stoskopf MK, 2005, WILDLIFE SOC B, V33, P1145, DOI 10.2193/0091-7648(2005)33[1145:FTFIRO]2.0.CO;2; TAYLOR AD, 1990, ECOLOGY, V71, P429, DOI 10.2307/1940297; THURBER JM, 1991, J MAMMAL, V72, P750, DOI 10.2307/1381838; Treves A, 2015, BIOL REV; U.S. Fish and Wildlife Service, 2016, CAUS MORT WILD RED W; U.S. Fish and Wildlife Service, 1989, RED WOLF REC SPEC SU; Whittington J, 2005, ECOL APPL, V15, P543, DOI 10.1890/03-5317; Wyatt TD, 2014, PHEROMONES AND ANIMAL BEHAVIOR: CHEMICAL SIGNALS AND SIGNATURES, 2ND EDITION, P1	82	31	31	6	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167603	10.1371/journal.pone.0167603	http://dx.doi.org/10.1371/journal.pone.0167603			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002495	Green Published, gold, Green Submitted			2022-12-26	WOS:000392853100015
J	Hemmatzadeh, F; Boardman, W; Alinejad, A; Hematzade, A; Moghadam, MK				Hemmatzadeh, Farhid; Boardman, Wayne; Alinejad, Arezo; Hematzade, Azar; Moghadam, Majid Kharazian			Molecular and Serological Survey of Selected Viruses in Free-Ranging Wild Ruminants in Iran	PLOS ONE			English	Article							MALIGNANT CATARRHAL FEVER; DES PETITS RUMINANTS; MOUTH-DISEASE VIRUS; POLYMERASE-CHAIN-REACTION; VIRAL DIARRHEA VIRUS; SHEEP OVIS-ORIENTALIS; BLUETONGUE VIRUS; BOVINE HERPESVIRUS-1; INFECTIOUS-DISEASES; ANTIBODIES	A molecular and serological survey of selected viruses in free-ranging wild ruminants was conducted in 13 different districts in Iran. Samples were collected from 64 small wild ruminants belonging to four different species including 25 Mouflon (Ovis orientalis), 22 wild goat (Capra aegagrus), nine Indian gazelle (Gazella bennettii) and eight Goitered gazelle (Gazella subgutturosa) during the national survey for wildlife diseases in Iran. Serum samples were evaluated using serologic antibody tests for Peste de petits ruminants virus (PPRV), Pestiviruses [Border Disease virus (BVD) and Bovine Viral Diarrhoea virus (BVDV)], Bluetongue virus (BTV), Bovine herpesvirus type 1 (BHV-1), and Parainfluenza type 3 (P13). Sera were also ELISA tested for Pestivirus antigen. Tissue samples including spleen, liver, lung, tonsils, mesenteric and mediastinal lymph nodes and white blood cells (WBCs) were tested using polymerase chain reaction (PCR) for PPRV, Foot and Mouth Disease virus (FMDV), Pestivirus, BTV, Ovine herpesvirus type 2 (OvHV-2) and BHV-1. Serologic tests were positive for antibodies against PPRV (17%), Pestiviruses (2%) and BTV (2%). No antibodies were detected for BHV-1 or P13, and no Pestivirus antigen was detected. PCR results were positive for PPRV (7.8%), FMDV (11%), BTV (3%), OvHV-2 (31%) and BHV-1 (1.5%). None of the samples were positive for Pestiviruses.	[Hemmatzadeh, Farhid; Boardman, Wayne] Univ Adelaide, Sch Anim & Vet Sci, Adelaide, SA, Australia; [Boardman, Wayne] Univ South Australia, Sch Pharm & Med Sci, Adelaide, SA, Australia; [Alinejad, Arezo] Univ Tehran, Fac Vet Med, Tehran, Iran; [Hematzade, Azar] Islamic Azad Univ, Shahrekord Branch, Fac Agr, Shahrekord, Iran; [Moghadam, Majid Kharazian] Iran Dept Environm, Tehran, Iran	University of Adelaide; University of South Australia; University of Tehran; Islamic Azad University	Hemmatzadeh, F (corresponding author), Univ Adelaide, Sch Anim & Vet Sci, Adelaide, SA, Australia.	Farhid.hemmatzadeh@adelaide.edu.au	Boardman, Wayne S.J/J-6479-2013; Boardman, Wayne/ABE-7528-2020	Boardman, Wayne/0000-0002-1746-0682; Hemmatzadeh, Farhid/0000-0002-4572-8869	Iran DoE fund [01-1384]	Iran DoE fund	This work was supported by Iran DoE fund (project number 01-1384). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahpour G., 2006, Journal of Veterinary Medicine. Series B, V53, P14, DOI 10.1111/j.1439-0450.2006.01013.x; AFSHAR A, 1994, COMP IMMUNOL MICROB, V17, P221, DOI 10.1016/0147-9571(94)90045-0; AFSHAR A, 1974, VET REC, V94, P233, DOI 10.1136/vr.94.11.233; Akens MK, 1997, VET IMMUNOL IMMUNOP, V58, P231, DOI 10.1016/S0165-2427(97)00044-5; AKITA GY, 1992, J VET DIAGN INVEST, V4, P400, DOI 10.1177/104063879200400405; Alexandersen S, 2003, J COMP PATHOL, V129, P1, DOI 10.1016/S0021-9975(03)00041-0; Alexandersen S, 2002, MICROBES INFECT, V4, P1099, DOI 10.1016/S1286-4579(02)01634-9; Alexandrov T, 2013, VET MICROBIOL, V166, P84, DOI 10.1016/j.vetmic.2013.05.016; ANDERSON J, 1994, EPIDEMIOL INFECT, V112, P225, DOI 10.1017/S0950268800057599; [Anonymous], 2006, REFERENCE REV, V20, P40; Banyard AC, 2010, J GEN VIROL, V91, P2885, DOI 10.1099/vir.0.025841-0; Bashari H, 2013, J NAT CONSERV, V21, P319, DOI 10.1016/j.jnc.2013.03.005; Bazargani TT, 2008, IRAN J VET RES, V9, P271; Bazarghani T. T., 2006, Journal of Veterinary Medicine. Series B, V53, P17, DOI 10.1111/j.1439-0450.2006.01014.x; Benetka V, 2009, J WILDLIFE DIS, V45, P508, DOI 10.7589/0090-3558-45.2.508; Bengis RH, 2004, REV SCI TECH OIE, V23, P497; Bolortsetseg S, 2012, J WILDLIFE DIS, V48, P33, DOI 10.7589/0090-3558-48.1.33; Bouwknegt C, 2010, EXP APPL ACAROL, V52, P183, DOI 10.1007/s10493-010-9359-7; Brito BP, 2015, TRANSBOUND EMERG DIS; Casaubon J, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-204; Chauhan HC, 2014, REV SCI TECH OIE, V33, P803, DOI 10.20506/rst.33.3.2319; Coetzee P, 2014, VIRUS RES, V182, P21, DOI 10.1016/j.virusres.2013.12.044; Cunha CW, 2012, VET MICROBIOL, V159, P307, DOI 10.1016/j.vetmic.2012.04.021; Daniels PW, 2007, CURR TOP MICROBIOL, V315, P113; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Department of Environment Islamic Tepublic of Iran, 2015, INCR MORT DUE SMALL; Drolet BS, 2015, VECTOR-BORNE ZOONOT, V15, P339, DOI 10.1089/vbz.2014.1701; Ellis JA, 2010, VET CLIN N AM-FOOD A, V26, P575, DOI 10.1016/j.cvfa.2010.08.002; ESLAMI A, 1980, VET PARASITOL, V7, P75, DOI 10.1016/0304-4017(80)90012-6; Forsyth MA, 1995, VIRUS RES, V39, P151, DOI 10.1016/0168-1702(95)00076-3; Garcia-Lastra R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034421; GHRAM A, 1989, CAN J VET RES, V53, P62; Griebel P, 2014, ANIM HEALTH RES REV, V15, P161, DOI 10.1017/S1466252314000280; Hoffmann B, 2012, TRANSBOUND EMERG DIS, V59, P173, DOI 10.1111/j.1865-1682.2011.01270.x; Jafarzadeh SR, 2014, PREV VET MED, V115, P101, DOI 10.1016/j.prevetmed.2014.03.018; Kalman D, 2005, J WILDLIFE DIS, V41, P482, DOI 10.7589/0090-3558-41.3.482; Karamii M, 2008, KOMENTOVANY SOUPIS S, V39, P63; Keyvanfar H, 1999, J FACULTY VET MED U, V54, P6; Khezri M, 2013, VET WORLD, V6, P122, DOI [10.5455/vetworld.2013.122-125, 10.14202/vetworld.2013.974-977, 10.14202/vetworld.2013.964-977]; Kim SH, 2014, J WILDLIFE DIS, V50, P478, DOI 10.7589/2013-06-137; Knowles NJ, 2003, VIRUS RES, V91, P65, DOI 10.1016/S0168-1702(02)00260-5; Kojouri G. A., 2011, Comparative Clinical Pathology, V20, P201, DOI 10.1007/s00580-010-0958-9; Kruse H, 2004, EMERG INFECT DIS, V10, P2067, DOI 10.3201/eid1012.040707; Kumar N, 2014, VIRUSES-BASEL, V6, P2287, DOI 10.3390/v6062287; Lemaire M, 2000, J CLIN MICROBIOL, V38, P1885, DOI 10.1128/JCM.38.5.1885-1894.2000; Leylabadlo HE, 2016, PESTE PETITS RUMINAN, V4, P2; Li H, 2014, ANNU REV ANIM BIOSCI, V2, P209, DOI 10.1146/annurev-animal-022513-114156; Mahravani H., 2010, Journal of Veterinary Research, V65, P123; Mallon DP, 2009, J APPL ECOL, V46, P516, DOI 10.1111/j.1365-2664.2009.01654.x; Matzat T, 2015, BERL MUNCH TIERARZTL, V128, P218, DOI 10.2376/0005-9366-128-218; Mkama Mathias, 2014, Onderstepoort J Vet Res, V81, pE1, DOI 10.4102/ojvr.v81i2.718; Momatz H, 2009, RES J BIOL SCI, V4, P558; Morrison W.I, 2010, MERCK VET MANUAL, V10, P33; Mouchantat S, 2014, VET MICROBIOL, V172, P329, DOI 10.1016/j.vetmic.2014.05.021; Mozaffari Ali Asghar, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, pS275, DOI 10.12980/APJTB.4.2014B599; Munir M, 2014, TRANSBOUND EMERG DIS, V61, P411, DOI 10.1111/tbed.12052; Muylkens B, 2007, VET RES, V38, P181, DOI 10.1051/vetres:2006059; NADLER CF, 1971, CYTOGENETICS, V10, P137, DOI 10.1159/000130135; Noaman V, 2013, VET ITAL, V49, P141, DOI 10.12834/VetIt.2013.492.141.144; Palmer MV, 2013, J COMP PATHOL, V149, P162, DOI 10.1016/j.jcpa.2013.01.005; Passler Thomas, 2010, Animal Health Research Reviews, V11, P191, DOI 10.1017/S1466252309990065; Pedersen AB, 2007, CONSERV BIOL, V21, P1269, DOI 10.1111/j.1523-1739.2007.00776.x; RAMYAR H, 1972, VET REC, V91, P630, DOI 10.1136/vr.91.25.630; Raoofi A, 2010, TROP ANIM HEALTH PRO, V42, P411, DOI 10.1007/s11250-009-9435-3; Ridpath JF, 1998, MOL CELL PROBE, V12, P101, DOI 10.1006/mcpr.1998.0158; Roeder P, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0139; Ruiz-Fons F, 2014, VIRUS RES, V182, P50, DOI 10.1016/j.virusres.2013.12.031; Russell GC, 2009, VET J, V179, P324, DOI 10.1016/j.tvjl.2007.11.007; Siembieda J. L., 2011, Animal Health Research Reviews, V12, P95, DOI 10.1017/S1466252311000041; Smith MJ, 2009, P NATL ACAD SCI USA, V106, P7905, DOI 10.1073/pnas.0809145106; Temmam S, 2014, INT J MOL SCI, V15, P10377, DOI 10.3390/ijms150610377; Ullah A, 2016, TRANSBOUND EMERG DIS; VALDEZ R, 1976, J MAMMAL, V57, P762, DOI 10.2307/1379451; Vangrysperre W, 1996, ARCH VIROL, V141, P331, DOI 10.1007/BF01718403; Vilcek S, 2006, VET MICROBIOL, V116, P1, DOI 10.1016/j.vetmic.2006.06.003; VILCEK S, 1993, J VIROL METHODS, V41, P245, DOI 10.1016/0166-0934(93)90132-B; Weaver GV, 2013, J WILDLIFE DIS, V49, P759, DOI 10.7589/2012-11-276; Weinberg A N, 1991, Infect Dis Clin North Am, V5, P1; Zakian A, 2016, TROP ANIM HLTH PROD; Zibaei S., 2010, Journal of Veterinary Research, V65, P199	80	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168756	10.1371/journal.pone.0168756	http://dx.doi.org/10.1371/journal.pone.0168756			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997620	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000392842900073
J	Ismael, FO; Barrett, TJ; Sheipouri, D; Brown, BE; Davies, MJ; Hawkins, CL				Ismael, Fahd O.; Barrett, Tessa J.; Sheipouri, Diba; Brown, Bronwyn E.; Davies, Michael J.; Hawkins, Clare L.			Role of Myeloperoxidase Oxidants in the Modulation of Cellular Lysosomal Enzyme Function: A Contributing Factor to Macrophage Dysfunction in Atherosclerosis?	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; HYPOCHLOROUS ACID; OXIDIZED LDL; HYPOTHIOCYANOUS ACID; CHOLESTEROL HOMEOSTASIS; OXIDATIVE MODIFICATIONS; CARDIOVASCULAR-DISEASE; APOLIPOPROTEIN-B; YOUNG-PEOPLE; CATHEPSIN-B	Low-density lipoprotein (LDL) is the major source of lipid within atherosclerotic lesions. Myeloperoxidase (MPO) is present in lesions and forms the reactive oxidants hypochlorous acid (HOCl) and hypothiocyanous acid (HOSCN). These oxidants modify LDL and have been strongly linked with the development of atherosclerosis. In this study, we examined the effect of HOCl, HOSCN and LDL pre-treated with these oxidants on the function of lysosomal enzymes responsible for protein catabolism and lipid hydrolysis in murine macrophage -like J774A.1 cells. In each case, the cells were exposed to HOCI or HOSCN or LDL pre-treated with these oxidants. Lysosomal cathepsin (B, L and D) and acid lipase activities were quantified, with cathepsin and LAMP-1 protein levels determined by Western blotting. Exposure of J774A.1 cells to HOCI or HOSCN resulted in a significant decrease in the activity of the Cys-dependent cathepsins B and L, but not the Asp-dependent cathepsin D. Cathepsins B and L were also inhibited in macrophages exposed to HOSCN-modified, and to a lesser extent, HOCI-modified LDL. No change was seen in cathepsin D activity or the expression of the cathepsin proteins or lysosomal marker protein LAMP-1. The activity of lysosomal acid lipase was also decreased on treatment of macrophages with each modified LDL. Taken together, these results suggest that HOCI, HOSCN and LDL modified by these oxidants could contribute to lysosomal dysfunction and thus perturb the cellular processing of LDL, which could be important during the development of atherosclerosis.	[Ismael, Fahd O.; Barrett, Tessa J.; Sheipouri, Diba; Brown, Bronwyn E.; Davies, Michael J.; Hawkins, Clare L.] Heart Res Inst, Sydney, NSW, Australia; [Ismael, Fahd O.; Barrett, Tessa J.; Brown, Bronwyn E.; Davies, Michael J.; Hawkins, Clare L.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Davies, Michael J.] Univ Copenhagen, Panum Inst, Dept Biomed Sci, Copenhagen, Denmark	University of Sydney; Heart Research Institute; University of Sydney; University of Copenhagen	Hawkins, CL (corresponding author), Heart Res Inst, Sydney, NSW, Australia.; Hawkins, CL (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia.	clare.hawkins@hri.org.au	Davies, Michael J/H-4939-2011; Hawkins, Clare/AAV-7424-2021; Davies, Michael/GWV-2527-2022; Hawkins, Clare L/F-6696-2014; Davies, Michael/AGX-9184-2022	Davies, Michael J/0000-0002-5196-6919; Hawkins, Clare/0000-0003-2738-5089; Hawkins, Clare L/0000-0003-2738-5089; Davies, Michael/0000-0002-5196-6919; Barrett, Tessa/0000-0003-0751-1578	National Health and Medical Research Council (AU) Project Grant [570829]; Australian Research Council (AU) Centre's of Excellence Scheme [CE0561607]; Australian Research Council (AU) Future Fellowship Scheme [FT120100682]; Australian Postgraduate Award, University of Sydney	National Health and Medical Research Council (AU) Project Grant; Australian Research Council (AU) Centre's of Excellence Scheme(Australian Research Council); Australian Research Council (AU) Future Fellowship Scheme(Australian Research Council); Australian Postgraduate Award, University of Sydney	This work was supported National Health and Medical Research Council (AU) Project Grant, Grant #570829; (http://www.nhmrc.gov.au/) to CH, MD; Australian Research Council (AU) Centre's of Excellence Scheme, Grant # CE0561607 (http://www.arc.gov.au/) to MD; Australian Research Council (AU) Future Fellowship Scheme, Grant # FT120100682(http://www.arc.gov.au/) to CH and Australian Postgraduate Award, University of Sydney to TB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RA, 1991, J BIOL CHEM, V266, P22479; Barrett TJ, 2012, FREE RADICAL BIO MED, V52, P1075, DOI 10.1016/j.freeradbiomed.2011.12.024; Bobryshev YV, 2013, J CELL MOL MED, V17, P626, DOI 10.1111/jcmm.12042; Botti TP, 1996, ATHEROSCLEROSIS, V124, P191, DOI 10.1016/0021-9150(96)05825-X; Brown BE, 2005, DIABETOLOGIA, V48, P361, DOI 10.1007/s00125-004-1648-4; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Calay D, 2010, ANTIOXID REDOX SIGN, V13, P1491, DOI 10.1089/ars.2009.2971; Carr AC, 2001, REDOX REP, V6, P343, DOI 10.1179/135100001101536526; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Chevallier J, 2008, J BIOL CHEM, V283, P27871, DOI 10.1074/jbc.M801463200; Cox BE, 2007, J LIPID RES, V48, P1012, DOI 10.1194/jlr.M600390-JLR200; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; Delporte C, 2014, J LIPID RES, V55, P747, DOI 10.1194/jlr.M047449; Dubland JA, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00003; Emanuel R, 2014, ARTERIOSCL THROM VAS, V34, P1942, DOI 10.1161/ATVBAHA.114.303342; Exner M, 2004, FREE RADICAL BIO MED, V37, P146, DOI 10.1016/j.freeradbiomed.2004.04.039; Eyer P, 2003, ANAL BIOCHEM, V312, P224, DOI 10.1016/S0003-2697(02)00506-7; Hawkins CL, 2009, FREE RADICAL BIO MED, V46, P965, DOI 10.1016/j.freeradbiomed.2009.01.007; Hawkins CL, 2008, BIOCHEM J, V416, P441, DOI 10.1042/BJ20070941; Hazell LJ, 1996, J CLIN INVEST, V97, P1535, DOI 10.1172/JCI118576; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; Headlam HA, 2006, FREE RADICAL BIO MED, V40, P1539, DOI 10.1016/j.freeradbiomed.2005.12.036; HOPPE G, 1994, J CLIN INVEST, V94, P1506, DOI 10.1172/JCI117490; Ismael FO, 2015, ARCH BIOCHEM BIOPHYS, V573, P40, DOI 10.1016/j.abb.2015.03.008; Itabe H, 2000, BBA-MOL CELL BIOL L, V1487, P233, DOI 10.1016/S1388-1981(00)00098-6; JESSUP W, 1992, BIOCHIM BIOPHYS ACTA, V1126, P167, DOI 10.1016/0005-2760(92)90287-6; Levitan I, 2010, ANTIOXID REDOX SIGN, V13, P39, DOI 10.1089/ars.2009.2733; Li W, 1998, ARTERIOSCL THROM VAS, V18, P177, DOI 10.1161/01.ATV.18.2.177; Lloyd MM, 2008, BIOCHEM J, V414, P271, DOI 10.1042/BJ20080468; Lougheed M, 1999, ARTERIOSCL THROM VAS, V19, P1881, DOI 10.1161/01.ATV.19.8.1881; Lutgens SPM, 2007, FASEB J, V21, P3029, DOI 10.1096/fj.06-7924com; MAEHIRA F, 1994, BIOCHEM MOL BIOL INT, V32, P221; Malle E, 2006, BBA-MOL CELL BIOL L, V1761, P392, DOI 10.1016/j.bbalip.2006.03.024; Moheimani F, 2012, ATHEROSCLEROSIS, V223, P144, DOI 10.1016/j.atherosclerosis.2012.04.026; Morgan PE, 2015, FREE RADICAL RES, V49, P743, DOI 10.3109/10715762.2015.1019347; ONeil J, 1997, FREE RADICAL BIO MED, V23, P215, DOI 10.1016/S0891-5849(96)00612-0; Pattison DI, 2012, FREE RADICAL RES, V46, P975, DOI 10.3109/10715762.2012.667566; Pattison DI, 2003, CHEM RES TOXICOL, V16, P439, DOI 10.1021/tx025670s; Peskin AV, 2006, FREE RADICAL BIO MED, V40, P45, DOI 10.1016/j.freeradbiomed.2005.08.019; Scanlon CEO, 1996, ATHEROSCLEROSIS, V121, P23, DOI 10.1016/0021-9150(95)05672-6; Schindhelm RK, 2009, CLIN CHEM, V55, P1462, DOI 10.1373/clinchem.2009.126029; Sokolov AV, 2014, CHEM PHYS LIPIDS, V180, P72, DOI 10.1016/j.chemphyslip.2014.02.006; Stadler N, 2004, ARTERIOSCL THROM VAS, V24, P949, DOI 10.1161/01.ATV.0000124892.90999.cb; Stark G R, 1972, Methods Enzymol, V25, P579, DOI 10.1016/S0076-6879(72)25057-1; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Summers FA, 2012, BIOCHEM BIOPH RES CO, V425, P157, DOI 10.1016/j.bbrc.2012.07.057; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; WOLMAN M, 1995, CLIN PEDIATR, V34, P207, DOI 10.1177/000992289503400406; Yan C, 2006, AM J PATHOL, V169, P916, DOI 10.2353/ajpath.2006.051327; Zschenker O, 2006, J BIOCHEM, V140, P23, DOI 10.1093/jb/mvj137	53	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168844	10.1371/journal.pone.0168844	http://dx.doi.org/10.1371/journal.pone.0168844			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997605	Green Published, gold, Green Submitted			2022-12-26	WOS:000392842900079
J	Sayegh, RSR; Batista, IDC; de Melo, RL; Riske, KA; Daffre, S; Montich, G; da Silva, PI				Rosa Sayegh, Raphael Santa; Correia Batista, Isabel de Fatima; de Melo, Robson Lopes; Riske, Karin A.; Daffre, Sirlei; Montich, Guillermo; da Silva Junior, Pedro Ismael			Longipin: An Amyloid Antimicrobial Peptide from the Harvestman Acutisoma longipes (Arachnida: Opiliones) with Preferential Affinity for Anionic Vesicles	PLOS ONE			English	Article							TICK BOOPHILUS-MICROPLUS; SPIDER ACANTHOSCURRIA-GOMESIANA; HOST-DEFENSE PEPTIDES; CATTLE TICK; INNATE IMMUNITY; MASS-SPECTROMETRY; HORSESHOE-CRAB; THIOFLAVIN-T; BETA-SHEET; HEMOCYTES	In contrast to vertebrate immune systems, invertebrates lack an adaptive response and rely solely on innate immunity in which antimicrobial peptides (AMPs) play an essential role. Most of them are membrane active molecules that are typically unstructured in solution and adopt secondary/tertiary structures upon binding to phospholipid bilayers. This work presents the first characterization of a constitutive AMP from the hemolymph of an Opiliones order animal: the harvestman Acutisoma longipes. This peptide was named longipin. It presents 18 aminoacid residues (SGYLPGKEYVYKYKGKVF) and a positive net charge at neutral pH. No similarity with other AMPs was observed. However, high sequence similarity with heme-lipoproteins from ticks suggested that longipin might be a protein fragment. The synthetic peptide showed enhanced antifungal activity against Candida guilliermondii and C. tropicalis yeasts (MIC: 3.8-7.5 mu M) and did not interfered with VERO cells line viability at all concentrations tested (200-0.1 mu M). This selectivity against microbial cells is related to the highest affinity of longipin for anionic charged vesicles (POPG:POPC) compared to zwitterionic ones (POPC), once microbial plasma membrane are generally more negatively charged compared to mammalian cells membrane. Dye leakage from carboxyfluorescein-loaded POPG:POPC vesicles suggested that longipin is a membrane active antimicrobial peptide and FT-IR spectroscopy showed that the peptide chain is mainly unstructured in solution or in the presence of POPC vesicles. However, upon binding to POPG:POPC vesicles, the FT-IR spectrum showed bands related to beta-sheet and amyloid-like fibril conformations in agreement with thioflavin-T binding assays, indicating that longipin is an amyloid antimicrobial peptide.	[Rosa Sayegh, Raphael Santa; da Silva Junior, Pedro Ismael] Univ Sao Paulo, Inst Ciencias Biomed, Programa Interunidades Biotecnol, Sao Paulo, Brazil; [Rosa Sayegh, Raphael Santa; de Melo, Robson Lopes; da Silva Junior, Pedro Ismael] Inst Butantan, Lab Especial Toxinol Aplicada, Sao Paulo, Brazil; [Correia Batista, Isabel de Fatima] Inst Butantan, Unidade Sequenciamento Prot & Peptideos, Sao Paulo, Brazil; [Correia Batista, Isabel de Fatima] Inst Butantan, Lab Bioquim & Biofis, Sao Paulo, Brazil; [Riske, Karin A.] Univ Fed Sao Paulo, Dept Biofis, Sao Paulo, Brazil; [Daffre, Sirlei] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, Sao Paulo, Brazil; [Montich, Guillermo] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, Ctr Invest Quim Biol Cordoba CIQUIBIC,CONICET, Cordoba, Argentina	Universidade de Sao Paulo; Instituto Butantan; Instituto Butantan; Instituto Butantan; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Sayegh, RSR; da Silva, PI (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Programa Interunidades Biotecnol, Sao Paulo, Brazil.; Sayegh, RSR; da Silva, PI (corresponding author), Inst Butantan, Lab Especial Toxinol Aplicada, Sao Paulo, Brazil.	raphael.sayegh@usp.br; pedro.junior@butantan.gov.br	Batista, Isabel FC/B-9535-2015; Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015; Riske, Karin A/F-2314-2014; Daffre, Sirlei/M-4233-2013	Batista, Isabel FC/0000-0001-7398-4184; Daffre, Sirlei/0000-0002-9966-0433; da Silva Junior, Pedro Ismael/0000-0001-6619-6489	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, State of Sao Paulo Foundation) [2013/07467-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [472744/2012-7]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Red de Universidades de America Latina y el Caribe	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, State of Sao Paulo Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Red de Universidades de America Latina y el Caribe	This work was support by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, State of Sao Paulo Foundation, grant 2013/07467-1, CeTICS-CEPID) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, grant 472744/2012-7). RSRS acknowledges the scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and from Red de Universidades de America Latina y el Caribe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was support by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, State of Sao Paulo Foundation, grant 2013/07467-1, CeTICS-CEPID) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, grant 472744/2012-7). RSRS acknowledges the scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and from Red de Universidades de America Latina y el Caribe. The authors also would like to thank Daniel M. Lorenzini (in memoriam) for his support with the mass spectrometry analysis, Prof. Antonio de Miranda for his suggestions on ThT assays, Mauricio P. M. Pavani for collection of animals and Dr. Ronaldo Zucatelli Mendonca and Juliana Cuoco Badari for their help with the MTT assay.	Amblard M, 2006, MOL BIOTECHNOL, V33, P239, DOI 10.1385/MB:33:3:239; Arrondo JLR, 1999, PROG BIOPHYS MOL BIO, V72, P367, DOI 10.1016/S0079-6107(99)00007-3; Baumann T, 2010, CELL MOL LIFE SCI, V67, P2643, DOI 10.1007/s00018-010-0354-2; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Braz GRC, 1999, CURR BIOL, V9, P703, DOI 10.1016/S0960-9822(99)80312-1; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Bulet P, 2005, PROTEIN PEPTIDE LETT, V12, P3, DOI 10.2174/0929866053406011; BULET P, 1993, J BIOL CHEM, V268, P14893; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Caillon L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075528; Charlet M, 1996, J BIOL CHEM, V271, P21808, DOI 10.1074/jbc.271.36.21808; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Costa JP, 2015, APPL MICROBIOL BIOT, V99, P2023, DOI [10.1007/s00253-015-6375-x, DOI 10.1007/S00253-015-6375-X]; DaSilva MB, 2009, INVERTEBR SYST, V23, P530, DOI 10.1071/IS09022; Destoumieux-Garzon D, 2001, J BIOL CHEM, V276, P47070, DOI 10.1074/jbc.M103817200; EhretSabatier L, 1996, J BIOL CHEM, V271, P29537, DOI 10.1074/jbc.271.47.29537; FALICK AM, 1993, J AM SOC MASS SPECTR, V4, P882, DOI 10.1016/1044-0305(93)87006-X; Fogaca AC, 2006, PEPTIDES, V27, P667, DOI 10.1016/j.peptides.2005.07.013; Fogaca AC, 1999, J BIOL CHEM, V274, P25330, DOI 10.1074/jbc.274.36.25330; Fogaca AC, 2004, DEV COMP IMMUNOL, V28, P191, DOI 10.1016/j.dci.2003.08.001; Garvey M, 2013, BBA-PROTEINS PROTEOM, V1834, P1615, DOI 10.1016/j.bbapap.2013.04.030; Hancock REW, 2006, IMMUNOBIOLOGY, V211, P315, DOI 10.1016/j.imbio.2005.10.017; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; IWANAGA S, 1993, CURR OPIN IMMUNOL, V5, P74, DOI 10.1016/0952-7915(93)90084-6; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Iwanaga S, 2002, CURR OPIN IMMUNOL, V14, P87, DOI 10.1016/S0952-7915(01)00302-8; Jang H, 2011, BIOPHYS J, V100, P1775, DOI 10.1016/j.bpj.2011.01.072; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kagan BL, 2012, MOL PHARMACEUT, V9, P708, DOI 10.1021/mp200419b; KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6; Lee MT, 2008, P NATL ACAD SCI USA, V105, P5087, DOI 10.1073/pnas.0710625105; Lorenzini DM, 2003, INSECT BIOCHEM MOLEC, V33, P1011, DOI 10.1016/S0965-1748(03)00115-2; Lorenzini DM, 2003, DEV COMP IMMUNOL, V27, P781, DOI 10.1016/S0145-305X(03)00058-2; Luders T, 2005, ANTIMICROB AGENTS CH, V49, P2399, DOI 10.1128/AAC.49.6.2399-2406.2005; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; Matsuzaki K, 2009, BBA-BIOMEMBRANES, V1788, P1687, DOI 10.1016/j.bbamem.2008.09.013; Maya-Monteiro CM, 2000, J BIOL CHEM, V275, P36584, DOI 10.1074/jbc.M007344200; Mouls L, 2007, J PROTEOME RES, V6, P1378, DOI 10.1021/pr060574o; Nolan V, 2003, BBA-BIOMEMBRANES, V1611, P98, DOI 10.1016/S0005-2736(03)00030-0; Petersen B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015079; Riciluca K C T, 2012, Results Immunol, V2, P66, DOI 10.1016/j.rinim.2012.03.001; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Rossi LM, 2008, J PHARM SCI-US, V97, P1060, DOI 10.1002/jps.21053; Samgina TY, 2010, J AM SOC MASS SPECTR, V21, P104, DOI 10.1016/j.jasms.2009.09.008; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Silva PI, 2000, J BIOL CHEM, V275, P33464, DOI 10.1074/jbc.M001491200; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; Tzeng YL, 2015, BBA BIOMEMBRANES; Vaisar T, 1996, J MASS SPECTROM, V31, P1185, DOI 10.1002/(SICI)1096-9888(199610)31:10<1185::AID-JMS396>3.0.CO;2-Q; Wu C, 2009, J MOL BIOL, V394, P627, DOI 10.1016/j.jmb.2009.09.056; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang KL, 2004, PROTEOMICS, V4, P1, DOI 10.1002/pmic.200300503; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5; Zhao H, 2006, BBA-BIOMEMBRANES, V1758, P1461, DOI 10.1016/j.bbamem.2006.03.037; BIOPOLYMERS	58	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0167953	10.1371/journal.pone.0167953	http://dx.doi.org/10.1371/journal.pone.0167953			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997568	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842900020
J	Qin, H; Wang, YY; Wang, J; Liu, H; Zhao, H; Deng, ZA; Zhang, ZL; Huang, RF; Zhang, ZJ				Qin, Hua; Wang, Yayun; Wang, Juan; Liu, Hai; Zhao, Hui; Deng, Zaian; Zhang, Zhili; Huang, Rongfeng; Zhang, Zhijin			Knocking Down the Expression of GMPase Gene OsVTC1-1 Decreases Salt Tolerance of Rice at Seedling and Reproductive Stages	PLoS One			English	Article							GDP-MANNOSE PYROPHOSPHORYLASE; DEFICIENT ARABIDOPSIS MUTANT; ASCORBIC-ACID SYNTHESIS; ROOT-GROWTH INHIBITION; VITAMIN-C; L-GALACTONO-1,4-LACTONE DEHYDROGENASE; DISEASE RESISTANCE; SALICYLIC-ACID; HIGHER-PLANTS; FLORAL DIP	Salinity is a severe environmental stress that greatly impairs production of crops worldwide. Previous studies have shown that GMPase plays an important role in tolerance of plants to salt stress at vegetative stage. However, the function of GMPase in plant responses to salt stress at reproductive stage remains unclear. Studies have shown that heterologous expression of rice GMPase OsVTC1-1 enhanced salt tolerance of tobacco seedlings, but the native role of OsVTC1-1 in salt stress tolerance of rice is unknown. To illustrate the native function of GMPase in response of rice to salt stress, OsVTC1-1 expression was suppressed using RNAi-mediated gene silencing. Suppressing OsVTC1-1 expression obviously decreased salt tolerance of rice varieties at vegetative stage. Intriguingly, grain yield of OsVTC1-1 RNAi rice was also significantly reduced under salt stress, indicating that OsVTC1-1 plays an important role in salt tolerance of rice at both seedling and reproductive stages. OsVTC1-1 RNAi rice accumulated more ROS under salt stress, and supplying exogenous ascorbic acid restored salt tolerance of OsVTC1-1 RNAi lines, suggesting that OsVTC1-1 is involved in salt tolerance of rice through the biosynthesis regulation of ascorbic acid. Altogether, results of present study showed that rice GMPase gene OsVTC1-1 plays a critical role in salt tolerance of rice at both vegetative and reproductive stages through AsA scavenging of excess ROS.	[Qin, Hua; Wang, Yayun; Wang, Juan; Zhao, Hui; Deng, Zaian; Huang, Rongfeng; Zhang, Zhijin] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China; [Wang, Juan; Huang, Rongfeng; Zhang, Zhijin] Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China; [Liu, Hai] Univ Virginia, Dept Biol, Charlottesville, VA USA; [Deng, Zaian; Zhang, Zhili] Hainan Acad Agr Sci, Haikou, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; University of Virginia	Huang, RF; Zhang, ZJ (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China.; Huang, RF; Zhang, ZJ (corresponding author), Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China.	rfhuang@caas.cn; zhangzhijin@caas.cn	Zhao, Hui/GXH-9348-2022; Liu, Hai/AAE-6577-2020	Liu, Hai/0000-0002-1846-9718	National Basic Research Program of China [2013CB127003]; National Science Foundation of China [31070270]; National Transgenic Major Program [2015ZX08001-002, 2014ZX08009-15B]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Transgenic Major Program	This work was supported by the National Basic Research Program of China (Grant No: 2013CB127003), the National Science Foundation of China (Grant No: 31070270) and National Transgenic Major Program (Grant No: 2015ZX08001-002 and Grant No: 2014ZX08009-15B).	Agius F, 2003, NAT BIOTECHNOL, V21, P177, DOI 10.1038/nbt777; Alhagdow M, 2007, PLANT PHYSIOL, V145, P1408, DOI 10.1104/pp.107.106500; AONO M, 1993, PLANT CELL PHYSIOL, V34, P129; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Barth C, 2004, PLANT PHYSIOL, V134, P1784, DOI 10.1104/pp.103.032185; Barth C, 2010, J EXP BOT, V61, P379, DOI 10.1093/jxb/erp310; Bent A, 2006, METH MOL B, V343, P87; Bose J, 2014, J EXP BOT, V65, P1241, DOI 10.1093/jxb/ert430; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Conklin PL, 2006, J BIOL CHEM, V281, P15662, DOI 10.1074/jbc.M601409200; Conklin PL, 2004, PLANT CELL ENVIRON, V27, P959, DOI 10.1111/j.1365-3040.2004.01203.x; Conklin PL, 1996, P NATL ACAD SCI USA, V93, P9970, DOI 10.1073/pnas.93.18.9970; Conklin PL, 1997, PLANT PHYSIOL, V115, P1277, DOI 10.1104/pp.115.3.1277; Conklin PL, 1999, P NATL ACAD SCI USA, V96, P4198, DOI 10.1073/pnas.96.7.4198; Dowdle J, 2007, PLANT J, V52, P673, DOI 10.1111/j.1365-313X.2007.03266.x; Flowers TJ, 2015, ANN BOT-LONDON, V115, P419, DOI 10.1093/aob/mcu217; Frei M, 2012, PLANT PHYSIOL BIOCH, V59, P63, DOI 10.1016/j.plaphy.2012.02.015; Freshour G, 2003, PLANT PHYSIOL, V131, P1602, DOI 10.1104/pp.102.016444; Gatzek S, 2002, PLANT J, V30, P541, DOI 10.1046/j.1365-313X.2002.01315.x; Hu TX, 2016, PLANT J, V85, P16, DOI 10.1111/tpj.13085; Huang CH, 2005, J EXP BOT, V56, P3041, DOI 10.1093/jxb/eri301; Keller R, 1999, PLANT J, V19, P131, DOI 10.1046/j.1365-313X.1999.00507.x; Kotchoni SO, 2009, PLANT PHYSIOL, V149, P803, DOI 10.1104/pp.108.132324; Kumar R, 2012, PLANT MOL BIOL, V79, P555, DOI 10.1007/s11103-012-9928-8; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lee MH, 2013, PLANT PHYSIOL BIOCH, V70, P325, DOI 10.1016/j.plaphy.2013.05.047; Li Q, 2010, PLANT CELL ENVIRON, V33, P1529, DOI 10.1111/j.1365-3040.2010.02162.x; Linster CL, 2008, TRENDS PLANT SCI, V13, P567, DOI 10.1016/j.tplants.2008.08.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorence A, 2004, PLANT PHYSIOL, V134, P1200, DOI 10.1104/pp.103.033936; Lukowitz W, 2001, P NATL ACAD SCI USA, V98, P2262, DOI 10.1073/pnas.051625798; Lutts S, 1995, J EXP BOT, V46, P1843, DOI 10.1093/jxb/46.12.1843; Maeda Y, 2008, BBA-GEN SUBJECTS, V1780, P861, DOI 10.1016/j.bbagen.2008.03.005; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Moradi F, 2007, ANN BOT-LONDON, V99, P1161, DOI 10.1093/aob/mcm052; Mortimer JC, 2013, PLANT CELL, V25, P1881, DOI 10.1105/tpc.113.111500; Mukherjee M, 2010, MOL PLANT MICROBE IN, V23, P340, DOI 10.1094/MPMI-23-3-0340; Nickle TC, 1998, PLANT J, V15, P321, DOI 10.1046/j.1365-313X.1998.00212.x; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Pastori GM, 2003, PLANT CELL, V15, P939, DOI 10.1105/tpc.010538; Pavet V, 2005, PLANT PHYSIOL, V139, P1291, DOI 10.1104/pp.105.067686; Pospisil P, 2009, BBA-BIOENERGETICS, V1787, P1151, DOI 10.1016/j.bbabio.2009.05.005; Qin C, 2008, P NATL ACAD SCI USA, V105, P18308, DOI 10.1073/pnas.0806168105; Qin H, 2016, PLANT MOL BIOL, V90, P317, DOI 10.1007/s11103-015-0420-0; Rao PS, 2008, PLANT BREEDING, V127, P256, DOI 10.1111/j.1439-0523.2007.01455.x; Shalata A, 2001, J EXP BOT, V52, P2207, DOI 10.1093/jexbot/52.364.2207; Smirnoff N, 2000, CRIT REV BIOCHEM MOL, V35, P291, DOI 10.1080/10409230008984166; SMOOT JW, 1985, EUR J BIOCHEM, V148, P83, DOI 10.1111/j.1432-1033.1985.tb08810.x; Tabata K, 2001, PLANT J, V27, P139, DOI 10.1046/j.1365-313x.2001.01074.x; Tajdoost S, 2007, Pak J Biol Sci, V10, P2086, DOI 10.3923/pjbs.2007.2086.2090; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Uchendu EE, 2010, PLANT CELL REP, V29, P25, DOI 10.1007/s00299-009-0795-y; Veljovic-Jovanovic SD, 2001, PLANT PHYSIOL, V127, P426, DOI 10.1104/pp.010141; Walia H, 2007, PLANT MOL BIOL, V63, P609, DOI 10.1007/s11103-006-9112-0; Wang HS, 2012, MOL BIOL REP, V39, P10413, DOI 10.1007/s11033-012-1920-5; Wang HS, 2011, PLANT CELL REP, V30, P1029, DOI 10.1007/s00299-011-1009-y; Wang J, 2013, PLANT CELL, V25, P625, DOI 10.1105/tpc.112.106880; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Wolucka BA, 2003, J BIOL CHEM, V278, P47483, DOI 10.1074/jbc.M309135200; Yadav S, 2011, J ENVIRON BIOL, V32, P667; Zeng LH, 2000, CROP SCI, V40, P996, DOI 10.2135/cropsci2000.404996x; Zhang CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061987; Zhang CJ, 2011, PLANT CELL REP, V30, P389, DOI 10.1007/s00299-010-0939-0; Zhang GY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125870; Zhang ZJ, 2012, PLANT J, V71, P273, DOI 10.1111/j.1365-313X.2012.04996.x	65	21	21	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168650	10.1371/journal.pone.0168650	http://dx.doi.org/10.1371/journal.pone.0168650			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992560	gold, Green Published, Green Submitted			2022-12-26	WOS:000392842600086
J	Walker, S; Bellhouse, C; Fairley, CK; Bilardi, JE; Chow, EPF				Walker, Sandra; Bellhouse, Clare; Fairley, Christopher K.; Bilardi, Jade E.; Chow, Eric P. F.			Pharyngeal Gonorrhoea: The Willingness of Australian Men Who Have Sex with Men to Change Current Sexual Practices to Reduce Their Risk of Transmission-A Qualitative Study	PLOS ONE			English	Article							NEISSERIA-GONORRHOEAE; CHLAMYDIA-TRACHOMATIS; TRANSMITTED-DISEASES; SAN-FRANCISCO; PREVALENCE; INFECTIONS; CALIFORNIA; BEHAVIORS; INCREASES; SAMPLE	Background The pharynx is a common site of gonorrhoea among men who have sex with men (MSM) and may serve as a reservoir for infection, with saliva implicated in transmission possibly through oral sex, kissing, and rimming. Reducing sexual activities involving saliva may reduce pharyngeal gonorrhoea. This study aimed to explore MSM's views and knowledge of pharyngeal gonorrhoea and their willingness to change saliva transmitting sexual practices. MSM were also asked their views on using alcohol-containing mouthwash to potentially reduce transmission. Methods Using a qualitative descriptive approach, 30 MSM who were part of a larger study (GONE) conducted at the Melbourne Sexual Health Centre agreed to take part in semi-structured interviews between 14th May and 8th September 2015. The 10 interviews conducted face to face and 20 by telephone, lasted between 20-45 minutes. Data were analysed using qualitative content analysis. Results Most men considered pharyngeal gonorrhoea to be a non-serious sexually transmitted infection and attributed transmission primarily to oral sex. Almost all men reported they would not stop kissing, oral sex, or consider using condoms for oral sex to reduce their risk of pharyngeal gonorrhoea. Kissing and oral sex were commonly practised and considered enjoyable low risk sexual activities. Men were more likely to consider stopping sexual activities they did not enjoy or practice often, in particular insertive rimming. If proven effective, the majority of men reported they would use alcohol-containing mouthwash to reduce or prevent their risk of pharyngeal gonorrhoea. Conclusion Findings from this study suggest MSM are unlikely to stop saliva transmitting sexual practices they enjoy and consider low risk. Men would, however, consider using alcohol-containing mouthwash if found to be effective, highlighting the importance of exploring innovative strategies to reduce pharyngeal gonorrhoea.	[Walker, Sandra; Fairley, Christopher K.; Bilardi, Jade E.; Chow, Eric P. F.] Monash Univ, Cent Clin Sch, Fac Med Nursing & Hlth Sci, Melbourne, Vic, Australia; [Walker, Sandra; Bellhouse, Clare; Fairley, Christopher K.; Bilardi, Jade E.; Chow, Eric P. F.] Melbourne Sexual Hlth Ctr, Alfred Hlth, Melbourne, Vic, Australia; [Bilardi, Jade E.] Univ Melbourne, Dept Practice, Melbourne, Vic, Australia	Monash University; University of Melbourne	Walker, S (corresponding author), Monash Univ, Cent Clin Sch, Fac Med Nursing & Hlth Sci, Melbourne, Vic, Australia.; Walker, S (corresponding author), Melbourne Sexual Hlth Ctr, Alfred Hlth, Melbourne, Vic, Australia.	swalker@mshc.org.au	Chow, Eric P.F./W-6684-2019	Chow, Eric P.F./0000-0003-1766-0657; Christopher, Fairley/0000-0001-9081-1664; Bilardi, Jade/0000-0003-0461-2605	National Health and Medical Research Council (NHMRC) [568971]; Australian NHMRC [1013135, 1091226]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	Funding for this project was, in part, supplied by a National Health and Medical Research Council (NHMRC) programme grant (number 568971). JB and EPFC are supported by the Early Career Fellowships from the Australian NHMRC (JB: 1013135; EPFC: 1091226).	Arrington-Sanders R, 2016, J HOMOSEXUAL, V63, P968, DOI 10.1080/00918369.2015.1113836; Benn PD, 2007, SEX TRANSM INFECT, V83, P106, DOI 10.1136/sti.2006.021329; Bernstein KT, 2009, CLIN INFECT DIS, V49, P1793, DOI 10.1086/648427; Bissessor M, 2011, J CLIN MICROBIOL, V49, P4304, DOI 10.1128/JCM.05341-11; Blomquist PB, 2014, FUTURE MICROBIOL, V9, P189, DOI 10.2217/fmb.13.155; Booth A., COREQ CONSOLIDATED C; Butler LM, 2009, JAIDS-J ACQ IMM DEF, V50, P162, DOI 10.1097/QAI.0b013e31819388a9; CDC, 2013, ANTIBIOTIC RESISTANC; Cheung KT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156160; Chow EP, 2015, SEX TRANSM INFECT; Chow EP, 2016, SEX TRANSM INFECT, V92; Chow EP, 2016, SEX TRANSM INFECT; Chow EPF, 2015, SEX TRANSM DIS, V42, P81, DOI 10.1097/OLQ.0000000000000232; Cornelisse VJ, 2016, SEXUAL HLTH; Deguchi T, 2012, ANTIMICROB AGENTS CH, V56, P4039, DOI 10.1128/AAC.00505-12; Dilley JW, 2003, SEX TRANSM DIS, V30, P874, DOI 10.1097/01.OLQ.0000091137.49974.79; Feier IO, 2010, MED EVOLUTION, P79; HALLQVIST L, 1975, BRIT J VENER DIS, V51, P395; Hui BB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133202; Katz DA, 2016, SEX TRANSM DIS, V43, P249, DOI 10.1097/OLQ.0000000000000423; Kent CK, 2005, CLIN INFECT DIS, V41, P67, DOI 10.1086/430704; Kinghorn G, 2010, SEX TRANSM INFECT, V86, P413, DOI 10.1136/sti.2010.043349; Lafferty WE, 1997, SEX TRANSM DIS, V24, P272, DOI 10.1097/00007435-199705000-00007; Lahra MM, 2013, SEX TRANSM INFECT, V89, P19, DOI 10.1136/sextrans-2012-050906; Lister NA, 2003, SEX TRANSM DIS, V30, P886, DOI 10.1097/01.OLQ.0000099160.26205.22; Marcus JL, 2011, SEX TRANSM DIS, V38, P922, DOI 10.1097/OLQ.0b013e31822a2b2e; Marcus U, 2006, SEX TRANSM DIS, V33, P11, DOI 10.1097/01.olq.0000187224.10428.31; Mayring P., 2000, FORUM QUALITATIVE SO, V1, P1, DOI [10.17169/fqs-1.2.1089, DOI 10.17169/FQS-22.2.3826]; Morris SR, 2006, CLIN INFECT DIS, V43, P1284, DOI 10.1086/508460; Neergaard MA, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-52; Ohnishi M, 2011, ANTIMICROB AGENTS CH, V55, P3538, DOI 10.1128/AAC.00325-11; Papp JR, 2007, DIAGN MICR INFEC DIS, V59, P259, DOI 10.1016/j.diagmicrobio.2007.05.010; Phipps W, 2005, AIDS PATIENT CARE ST, V19, P495, DOI 10.1089/apc.2005.19.495; Prestage G, 2009, PLEASURE HLTH PASH S; QSR International, 1999, NVIVO QUAL DAT AN SO; Richters J, 2003, CULT HEALTH SEX, V5, P37, DOI 10.1080/713804637; Rosenberger JG, 2011, J SEX MED, V8, P3040, DOI 10.1111/j.1743-6109.2011.02438.x; Sandelowski M., 2000, RES NURS HLTH, V23; Teddlie C, 2007, J MIXED METHODS RES, V1; Templeton DJ, 2010, SEX TRANSM INFECT, V86, P90, DOI 10.1136/sti.2009.036814; The Kirby Institute, 2013, HIV VIR HEP SEX TRAN; WILLMOTT FE, 1974, BRIT J VENER DIS, V50, P317; World Health Organisation, 2012, GLOB ACT PLAN CONTR	43	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0164033	10.1371/journal.pone.0164033	http://dx.doi.org/10.1371/journal.pone.0164033			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QC	27992427	Green Published, gold			2022-12-26	WOS:000392842600001
J	Zhang, JS; Liu, X; Wang, JD; Xiong, Y; Li, J; Li, XX; Zhao, J; You, QS; Huang, Y; Tsai, F; Baum, L; Jhanji, V; Wan, XH				Zhang, Jing Shang; Liu, Xue; Wang, Jin Da; Xiong, Ying; Li, Jing; Li, Xiao Xia; Zhao, Jing; You, Qi Sheng; Huang, Yao; Tsai, Frank; Baum, Larry; Jhanji, Vishal; Wan, Xiu Hua			Outcomes of Phacoemulsification Using Different Size of Clear Corneal Incision in Eyes with Previous Radial Keratotomy	PLoS One			English	Article							OCULAR INTEGRITY; CATARACT-SURGERY; DEHISCENCE	Objective To evaluate visual outcomes and complications after phacoemulsification in eyes with cataract and previous radial keratotomy (RK) cuts using different sizes of clear corneal incisions. Methods The study was a retrospective study. Thirty eyes with cataract and previous RK underwent phacoemulsification and intraocular lens (IOL) implantation. Among them 7 eyes had 8 RK cuts, 13 eyes had 12 RK cuts, and 10 eyes had 16 RK cuts. Phacoemulsification and IOL implantation were performed through a 2.0-3.2 mm clear corneal incision by a single surgeon. In the 8 RK cuts group, 3.2 mm clear corneal incisions were used in 4 eyes, and 3.0 mm clear corneal incisions were used in 3 eyes. In the 12 RK cuts group, 3.2 mm clear corneal incisions were used in 6 eyes, and 2.2 mm clear corneal incisions were used in 7 eyes. In the 16 RK cuts group, 3.2 mm clear corneal incisions were used in 5 eyes, and 2.0 mm clear corneal incisions were used in 5 eyes. Patients were followed up 1 day, 1 week, 1 month, 3 months, 6 months, 1 year, 2 years, and 3 years postoperatively and were examined for the dehiscence of RK cuts during or after the surgery, post-operative best-corrected visual acuity (BCVA), corneal astigmatism, corneal endothelial cell density and complications. Results Successful phacoemulsification with IOL implantation was performed in all eyes. No wound dehiscence was noted in any eyes with 8 or 12 RK cuts. Wound dehiscence was noted in 2 eyes with 16 RK cuts. The dehiscence of RK cuts was closed successfully by injecting an air bubble with or without viscoelastic agent into the anterior chamber at the end of surgery. During the follow-up, the cuts were well apposed in all eyes, and no new dehiscence of RK cuts was noted. At the last follow-up, mean BCVA (0.2 +/- 0.18 logMAR) was better than pre-operative BCVA(0.45 +/- 0.19 logMAR) (P < 0.001). There was no significant difference between the long-term preoperative and postoperative mean corneal astigmatism (P = 0.3). However, there was a significant reduction in postoperative corneal endothelial cell density (1866.5 +/- 773.9 / mm(2) vs 2421.7 +/- 655.7/mm(2)) (P < 0.001). Conclusions Phacoemulsification and IOL implantation with clear corneal incisions in eyes with previous RK were associated with good surgical outcomes. Wound dehiscence was not specificaly related to the size of clear corneal incision during phacoemulsification in these eyes.	[Zhang, Jing Shang; Liu, Xue; Wang, Jin Da; Li, Xiao Xia; Zhao, Jing; You, Qi Sheng; Wan, Xiu Hua] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Key Lab Ophthalmol & Visual Sci,Beijing I, Beijing, Peoples R China; [Xiong, Ying; Li, Jing; Huang, Yao] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Key Lab Ophthalmol & Visual Sci, Beijing, Peoples R China; [You, Qi Sheng; Tsai, Frank] Univ Calif San Diego, Jacobs Retina Ctr, Shiley Eye Inst, San Diego, CA 92103 USA; [Baum, Larry] Univ Hong Kong, Ctr Genom Sci, Hong Kong, Hong Kong, Peoples R China; [Jhanji, Vishal] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Hong Kong, Peoples R China	Capital Medical University; Capital Medical University; University of California System; University of California San Diego; University of Hong Kong; Chinese University of Hong Kong	Wan, XH (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Key Lab Ophthalmol & Visual Sci,Beijing I, Beijing, Peoples R China.	xiuhuawan@163.com	Baum, Lawrence/B-1005-2013; You, Qisheng/AAG-7153-2020	Baum, Lawrence/0000-0002-5345-9355; You, Qisheng/0000-0003-0743-7320; Li, Jing/0000-0001-9392-6600	Beijing New Star of Science and Technology [H020821380190, Z131102000413025]; Fund of Work Committee for Women and Children of China State Department [2014108]; National Natural Science Fund Projects of China [30471861]	Beijing New Star of Science and Technology; Fund of Work Committee for Women and Children of China State Department; National Natural Science Fund Projects of China(National Natural Science Foundation of China (NSFC))	This work was supported by Beijing New Star of Science and Technology (H020821380190, Z131102000413025), Fund of Work Committee for Women and Children of China State Department (2014108), and the National Natural Science Fund Projects of China (30471861). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behl S, 2001, J CATARACT REFR SURG, V27, P1132, DOI 10.1016/S0886-3350(01)00763-5; BINDER PS, 1987, AM J OPHTHALMOL, V103, P432, DOI 10.1016/S0002-9394(14)77767-0; Budak K, 1998, J CATARACT REFR SURG, V24, P278, DOI 10.1016/S0886-3350(98)80211-3; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Day A, 2007, EYE, V21, P886, DOI 10.1038/sj.eye.6702762; Freeman M, 2004, EYE, V18, P101, DOI 10.1038/sj.eye.6700526; FYODOROV SN, 1979, ANN OPHTHALMOL, V11, P1885; LARSON BC, 1983, OPHTHALMOLOGY, V90, P660; [刘雪 Liu Xue], 2015, [眼科, Ophthalmology in China], V24, P373; LUTTRULL JK, 1982, ARCH OPHTHALMOL-CHIC, V100, P319; McCarthy M, 2011, OPHTHALMOLOGY, V118, P940, DOI 10.1016/j.ophtha.2010.08.048; Peacock LW, 1997, OPHTHALMOLOGY, V104, P1079, DOI 10.1016/S0161-6420(97)30182-1; Wang L, 2015, OPHTHALMOLOGY, V122, P2443, DOI 10.1016/j.ophtha.2015.08.037; WARING GO, 1985, AM J OPHTHALMOL, V100, P218, DOI 10.1016/S0002-9394(14)75010-X; Wilczynski Michal, 2011, Klin Oczna, V113, P314; 章伟利, 2015, [中华眼视光学与视觉科学杂志, Chinese Journal of Optometry Ophthalmology and Visual Science], V17, P60; 宋慧, 2009, [中华眼科杂志, Chinese Journal of Ophthalmology], V45, P848	17	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0165474	10.1371/journal.pone.0165474	http://dx.doi.org/10.1371/journal.pone.0165474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992428	Green Published, gold			2022-12-26	WOS:000392842600005
J	Ducarme, G; Hamel, JF; Brun, S; Madar, H; Merlot, B; Sentilhes, L				Ducarme, Guillaume; Hamel, Jean-Francois; Brun, Stephanie; Madar, Hugo; Merlot, Benjamin; Sentilhes, Loic			Pelvic Floor Disorders 6 Months after Attempted Operative Vaginal Delivery According to the Fetal Head Station: A Prospective Cohort Study	PLOS ONE			English	Article							STRESS URINARY-INCONTINENCE; TRACT SYMPTOMS QUESTIONNAIRE; ANAL INCONTINENCE; FECAL INCONTINENCE; INSTRUMENTAL DELIVERY; NEONATAL MORBIDITY; CESAREAN DELIVERY; 1ST DELIVERY; MODE; POSTPARTUM	Objective To evaluate the effect of the fetal head station at attempted operative vaginal delivery (aOVD), and specifically midpelvic or low aOVD, on urinary incontinence (UI), anal incontinence (AI), and perineal pain at 6 months. Design Prospective cohort study. Setting 1941 women with singleton term fetuses in vertex presentation with midpelvic or low aOVD between 2008 and 2013 in a tertiary care university hospital. Methods Symptoms of urinary incontinence (UI) using the Bristol Female Lower Urinary Tract Symptoms questionnaire, and symptoms of anal incontinence (AI) severity using Fecal Incontinence Severity Index (FISI) were assessed 6 months after aOVD. We measured the association between midpelvic or low aOVD and symptoms of UI, AI, and perineal pain at 6 months using multiple regression and adjusting for demographics, and risk factors of UI and AI, with adjusted odds ratios (aORs) and 95% confidence intervals (95% CI). Results The study included 907 women (46.7%) who responded to the questionnaire; 18.4% (167/ 907) had midpelvic aOVD, and 81.6% (740/907) low; and none of women with symptoms of UI (26.6%, and 22.4%, respectively; p = 0.31), AI (15.9%, and 21.8%; p = 0.09), the FISI score, and perineal pain (17.2%, and 12.7%; p = 0.14) differed significantly between groups. The same was true for stress, urge, and mixed-type UI, severe UI and difficulty voiding. Compared with low pelvic aOVD, the aORs for symptoms of UI in midpelvic aOVD were 0.70 (0.46-1.05) and AI 1.42 (0.85-2.39). Third-and fourth-degree tears were a major risk factor of symptoms of UI (aOR 3.08, 95% CI 1.35-7.00) and AI (aOR 3.47, 95% CI 1.43-8.39). Conclusion Neither symptoms of urinary nor anal incontinence differed at 6 months among women who had midpelvic and low pelvic aOVD. These findings are reassuring and need further studies at long-term to confirm these short-term data.	[Ducarme, Guillaume] Ctr Hosp Dept, Dept Obstet & Gynecol, La Roche Sur Yon, France; [Hamel, Jean-Francois] Angers Univ Hosp, Clin Res Ctr, Angers, France; [Brun, Stephanie; Madar, Hugo; Merlot, Benjamin; Sentilhes, Loic] Bordeaux Univ Hosp, Dept Obstet & Gynecol, Bordeaux, France	CHD Vendee; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Bordeaux	Ducarme, G (corresponding author), Ctr Hosp Dept, Dept Obstet & Gynecol, La Roche Sur Yon, France.	g.ducarme@gmail.com	, DUCARME/I-1248-2019	, DUCARME/0000-0002-2549-353X	Angers University Hospital	Angers University Hospital	The Angers University Hospital provided the funding for the study. The funding source had no role in the design or conduct of the study, collection, analysis, or interpretation of the date, or writing the article or decision to submit for publication.	[Anonymous], 2013, J GYNECOL OBST BIO R, V42, P1018, DOI 10.1016/j.jgyn.2013.09.023; Bahl R, 2005, AM J OBSTET GYNECOL, V192, P789, DOI 10.1016/j.ajog.2004.10.601; Borello-France D, 2006, OBSTET GYNECOL, V108, P863, DOI 10.1097/01.AOG.0000232504.32589.3b; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Brookes ST, 2004, AM J OBSTET GYNECOL, V191, P73, DOI 10.1016/j.ajog.2003.12.027; Brown S, 1998, BRIT J OBSTET GYNAEC, V105, P156, DOI 10.1111/j.1471-0528.1998.tb10045.x; Buhling KJ, 2006, EUR J OBSTET GYN R B, V124, P42, DOI 10.1016/j.ejogrb.2005.04.008; Burgio KL, 2003, OBSTET GYNECOL, V102, P1291, DOI 10.1016/j.obstetgynecol.2003.09.013; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Ducarme G, 2015, OBSTET GYNECOL, V126, P521, DOI 10.1097/AOG.0000000000001000; Eason E, 2002, CAN MED ASSOC J, V166, P326; Farrell SA, 2001, OBSTET GYNECOL, V97, P350, DOI 10.1016/S0029-7844(00)01164-9; Fritel X, 2008, BJOG-INT J OBSTET GY, V115, P247, DOI 10.1111/j.1471-0528.2007.01540.x; Fritel X, 2005, BJOG-INT J OBSTET GY, V112, P1646, DOI 10.1111/j.1471-0528.2005.00763.x; Fritel X, 2004, ACTA OBSTET GYN SCAN, V83, P941, DOI 10.1111/j.0001-6349.2004.00457.x; HADLOCK FP, 1985, AM J OBSTET GYNECOL, V151, P333, DOI 10.1016/0002-9378(85)90298-4; Handa VL, 2015, NEUROUROL URODYNAM, V34, P356, DOI 10.1002/nau.22583; Handa VL, 2012, OBSTET GYNECOL, V119, P233, DOI 10.1097/AOG.0b013e318240df4f; Hannah ME, 2004, AM J OBSTET GYNECOL, V191, P917, DOI 10.1016/j.ajog.2004.08.004; Herbruck LF, 2008, UROL NURS, V28, P185; Herbruck Lianne F, 2008, Urol Nurs, V28, P173; Hijaz A, 2012, INT UROGYNECOL J, V23, P395, DOI 10.1007/s00192-011-1562-5; Huebner M, 2013, INT J GYNECOL OBSTET, V121, P74, DOI 10.1016/j.ijgo.2012.10.023; Jackson S, 1996, BRIT J UROL, V77, P805, DOI 10.1046/j.1464-410X.1996.00186.x; Johannessen HH, 2014, BJOG-INT J OBSTET GY, V121, P269, DOI 10.1111/1471-0528.12438; Johannessen HH, 2015, ACTA OBSTET GYN SCAN, V94, P1005, DOI 10.1111/aogs.12689; Johanson RB, 1999, BRIT J OBSTET GYNAEC, V106, P544, DOI 10.1111/j.1471-0528.1999.tb08322.x; Lal M, 2003, OBSTET GYNECOL, V101, P305, DOI 10.1016/S0029-7844(02)02716-3; Liebling RE, 2004, AM J OBSTET GYNECOL, V191, P4, DOI 10.1016/j.ajog.2004.01.013; MacArthur C, 2005, BJOG-INT J OBSTET GY, V112, P1075, DOI 10.1111/j.1471-0528.2005.00721.x; MacArthur C, 2001, BRIT J OBSTET GYNAEC, V108, P678, DOI 10.1111/j.1471-0528.2001.00183.x; Murphy DJ, 2001, LANCET, V358, P1203, DOI 10.1016/S0140-6736(01)06341-3; Peaceman AM, 2015, OBSTET GYNECOL, V126, pE56, DOI 10.1097/AOG.0000000000001147; Pretlove SJ, 2008, BJOG-INT J OBSTET GY, V115, P421, DOI 10.1111/j.1471-0528.2007.01553.x; Quiboeuf E, 2016, BJOG-INT J OBSTET GY, V123, P1222, DOI 10.1111/1471-0528.13545; Rockwood TH, 2004, GASTROENTEROLOGY, V126, pS106, DOI 10.1053/j.gastro.2003.10.057; Rockwood TH, 1999, DIS COLON RECTUM, V42, P1525, DOI 10.1007/BF02236199; Rortveit G, 2003, AM J OBSTET GYNECOL, V189, P1268, DOI 10.1067/S0002-9378(03)00588-X; Rortveit G, 2003, NEW ENGL J MED, V348, P900, DOI 10.1056/NEJMoa021788; Solans-Domenech M, 2010, OBSTET GYNECOL, V115, P618, DOI 10.1097/AOG.0b013e3181d04dff; SULTAN AH, 1994, BRIT MED J, V308, P887, DOI 10.1136/bmj.308.6933.887; Tahtinen RM, 2016, EUR UROL, V70, P148, DOI 10.1016/j.eururo.2016.01.037; Zetterstrom JP, 1999, BRIT J OBSTET GYNAEC, V106, P324, DOI 10.1111/j.1471-0528.1999.tb08269.x	43	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168591	10.1371/journal.pone.0168591	http://dx.doi.org/10.1371/journal.pone.0168591			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992558	gold, Green Submitted, Green Published			2022-12-26	WOS:000392758000063
J	Wang, HZ; Zheng, YS; Lai, JZ; Luo, QP; Ke, HC; Chen, Q				Wang, Hanze; Zheng, Yansong; Lai, Junzhong; Luo, Qianping; Ke, Huican; Chen, Qi			Methylation-Sensitive Melt Curve Analysis of the Reprimo Gene Methylation in Gastric Cancer	PLOS ONE			English	Article							CIRCULATING TUMOR DNA; NUCLEIC-ACIDS	Reprimo (RPRM) is a p53-induced tumor suppressor gene. Its aberrant DNA methylation is correlated with carcinogenesis and may be used as a surrogate marker for the early detection of gastric cancer. However, the detail information regarding its DNA methylation has not been revealed. Here, we investigated the RPRM gene methylation in gastric cancer tumor and plasma samples by methylation-sensitive melt curve analysis (MS-MCA) and bisulfite sequencing in depth. We developed a semi-quantitative method based on MS-MCA for detecting DNA methylation and unraveled the RPRM gene methylation pattern in gastric cancer. This study provides a solid foundation for the future application of detecting RPRM gene methylation in human plasma or serum samples to help diagnose gastric cancer or for prognosis evaluation.	[Wang, Hanze; Lai, Junzhong; Luo, Qianping; Ke, Huican; Chen, Qi] Fujian Normal Univ, Coll Life Sci, Biomed Res Ctr South China, Fujian Key Lab Innate Immune Biol, Qishan Campus, Fuzhou, Fujian, Peoples R China; [Zheng, Yansong] Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Fujian, Peoples R China	Fujian Normal University; Fujian Medical University	Chen, Q (corresponding author), Fujian Normal Univ, Coll Life Sci, Biomed Res Ctr South China, Fujian Key Lab Innate Immune Biol, Qishan Campus, Fuzhou, Fujian, Peoples R China.	nfsw@fjnu.edu.cn	yang, zheng/HGC-7753-2022		Fujian Provincial Health and Education Alliance Funds [WKJ-FJ-28]; Fujian Key Laboratories Funds; Fujian Provincial Lingjun Scholarship	Fujian Provincial Health and Education Alliance Funds; Fujian Key Laboratories Funds; Fujian Provincial Lingjun Scholarship	This work was supported by Fujian Provincial Health and Education Alliance Funds (WKJ-FJ-28), Fujian Key Laboratories Funds, and a Fujian Provincial Lingjun Scholarship to QC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker P, 1999, CANCER METAST REV, V18, P65, DOI 10.1023/A:1006260319913; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bernal C, 2008, CLIN CANCER RES, V14, P6264, DOI 10.1158/1078-0432.CCR-07-4522; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Gilbert N, 2007, J CELL BIOL, V177, P401, DOI 10.1083/jcb.200607133; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; KLEIN E, 1976, ANN NY ACAD SCI, V276, P207, DOI 10.1111/j.1749-6632.1976.tb41647.x; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Ohki R, 2000, J BIOL CHEM, V275, P22627, DOI 10.1074/jbc.C000235200; Ooki A, 2013, MOL CANCER RES, V11, P1362, DOI 10.1158/1541-7786.MCR-13-0091; Otsuka T, 1996, GENE CHROMOSOME CANC, V16, P113, DOI 10.1002/(SICI)1098-2264(199606)16:2<113::AID-GCC5>3.0.CO;2-2; Parkin DM, 2004, ONCOGENE, V23, P6329, DOI 10.1038/sj.onc.1207726; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Takahashi T, 2005, INT J CANCER, V115, P503, DOI 10.1002/ijc.20910; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Tong YK, 2006, CLIN CHIM ACTA, V363, P187, DOI 10.1016/j.cccn.2005.05.048; Wong TS, 2005, INT J CANCER, V117, P697, DOI 10.1002/ijc.21208; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; ZWEIG MH, 1993, CLIN CHEM, V39, P561	20	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168635	10.1371/journal.pone.0168635	http://dx.doi.org/10.1371/journal.pone.0168635			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992600	Green Published, Green Submitted, gold			2022-12-26	WOS:000392758000069
J	Duran, J; Oyarce, C; Pavez, M; Valladares, D; Basualto-Alarcon, C; Lagos, D; Barrientos, G; Troncoso, MF; Ibarra, C; Estrada, M				Duran, Javier; Oyarce, Cesar; Pavez, Mario; Valladares, Denisse; Basualto-Alarcon, Carla; Lagos, Daniel; Barrientos, Genaro; Francisca Troncoso, Mayarling; Ibarra, Cristian; Estrada, Manuel			GSK-3 beta/NFAT Signaling Is Involved in Testosterone-Induced Cardiac Myocyte Hypertrophy	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; ANDROGEN-RECEPTOR; BETA-CATENIN; CARDIOMYOCYTE HYPERTROPHY; CARDIOVASCULAR-DISEASE; MUSCLE DEVELOPMENT; KINASE 3; IN-VIVO; PATHWAY; CALCINEURIN	Testosterone induces cardiac hypertrophy through a mechanism that involves a concerted crosstalk between cytosolic and nuclear signaling pathways. Nuclear factor of activated T-cells (NFAT) is associated with the promotion of cardiac hypertrophy, glycogen synthase kinase-3 beta (GSK-3 beta) is considered to function as a negative regulator, mainly by modulating NFAT activity. However, the role played by calcineurin-NFAT and GSK-3 beta signaling in testosterone-induced cardiac hypertrophy has remained unknown. Here, we determined that testosterone stimulates cardiac myocyte hypertrophy through NFAT activation and GSK-3 beta inhibition. Testosterone increased the activity of NFAT-luciferase (NFAT-Luc) in a time-and dose-dependent manner, with the activity peaking after 24 h of stimulation with 100 nM testosterone. NFAT-Luc activity induced by testosterone was blocked by the calcineurin inhibitors FK506 and cyclosporine A and by 11R-VIVIT, a specific peptide inhibitor of NFAT. Conversely, testosterone inhibited GSK-3 beta activity as determined by increased GSK-3 beta phosphorylation at Ser9 and beta-catenin protein accumulation, and also by reduction in beta-catenin phosphorylation at residues Ser33, Ser37, and Thr41. GSK-3 beta inhibition with 1-azakenpaullone or a GSK-3 beta-targeting siRNA increased NFAT-Luc activity, whereas overexpression of a constitutively active GSK-3 beta mutant (GSK-3 beta S9A) inhibited NFAT-Luc activation mediated by testosterone. Testosterone-induced cardiac myocyte hypertrophy was established by increased cardiac myocyte size and [H-3]-leucine incorporation (as a measurement of cellular protein synthesis). Calcineurin-NFAT inhibition abolished and GSK-3 beta inhibition promoted the hypertrophy stimulated by testosterone. GSK-3 beta activation by GSK-3 beta S9A blocked the increase of hypertrophic markers induced by testosterone. Moreover, inhibition of intracellular androgen receptor prevented testosterone-induced NFAT-Luc activation. Collectively, these results suggest that cardiac myocyte hypertrophy induced by testosterone involves a cooperative mechanism that links androgen signaling with the recruitment of NFAT through calcineurin activation and GSK-3 beta inhibition.	[Duran, Javier; Oyarce, Cesar; Pavez, Mario; Valladares, Denisse; Lagos, Daniel; Barrientos, Genaro; Francisca Troncoso, Mayarling; Estrada, Manuel] Univ Chile, Fac Med, Inst Ciencias Biomed, Lab Endocrinol Celular,Programa Fisiol & Biofis, Santiago, Chile; [Basualto-Alarcon, Carla] Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Anat & Biol Desarrollo, Santiago, Chile; [Ibarra, Cristian] AstraZeneca R&D, Heart Failure Bioscience Dept, Cardiovasc & Metab Dis CVMD, Innovat Med & Early Dev iMED Biotech Unit, Molndal, Sweden	Universidad de Chile; Universidad de Chile; AstraZeneca	Estrada, M (corresponding author), Univ Chile, Fac Med, Inst Ciencias Biomed, Lab Endocrinol Celular,Programa Fisiol & Biofis, Santiago, Chile.	iestrada@med.uchile.cl	Valladares-Ide, Denisse/AAE-6675-2019; Pavez-Giani, Mario/AAD-5347-2022; Estrada, Manuel/AAS-5605-2020; Estrada, Manuel/C-1269-2014; Pavez-Giani, Mario/AAV-3110-2021	Pavez-Giani, Mario/0000-0002-3330-9384; Estrada, Manuel/0000-0001-7877-8160; Estrada, Manuel/0000-0001-7877-8160; Valladares-Ide, Denisse/0000-0001-7625-7978	Fondo Nacional de Cienciay Tecnologia (FONDECYT) [1151118]; CONICYT	Fondo Nacional de Cienciay Tecnologia (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by Fondo Nacional de Cienciay Tecnologia (FONDECYT grant 1151118 to ME). JD, CO, and MP thank CONICYT for their PhD fellowships. I also confirm that AstraZeneca did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamirano F, 2009, J ENDOCRINOL, V202, P299, DOI 10.1677/JOE-09-0044; Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Campbell S E, 1993, Blood Press, V2, P213, DOI 10.3109/08037059309077553; Chen X, 2006, MOL CELL BIOL, V26, P4462, DOI 10.1128/MCB.02157-05; CHIEN KR, 1991, FASEB J, V5, P3037, DOI 10.1096/fasebj.5.15.1835945; Church DR, 2005, PROSTATE, V63, P155, DOI 10.1002/pros.20172; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Dorn GW, 2007, HYPERTENSION, V49, P962, DOI 10.1161/HYPERTENSIONAHA.106.079426; Estrada M, 2006, J CELL SCI, V119, P733, DOI 10.1242/jcs.02775; Estrada M, 2003, ENDOCRINOLOGY, V144, P3586, DOI 10.1210/en.2002-0164; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Gu SC, 2014, CELL PHYSIOL BIOCHEM, V34, P1402, DOI 10.1159/000366346; Haq S, 2003, P NATL ACAD SCI USA, V100, P4610, DOI 10.1073/pnas.0835895100; Haq S, 2000, J CELL BIOL, V151, P117, DOI 10.1083/jcb.151.1.117; Hardt SE, 2002, CIRC RES, V90, P1055, DOI 10.1161/01.RES.0000018952.70505.F1; Hardt SE, 2004, CARDIOVASC RES, V63, P500, DOI 10.1016/j.cardiores.2004.03.015; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Ibarra C, 2013, CIRC RES, V112, P236, DOI 10.1161/CIRCRESAHA.112.273839; Ikeda Y, 2012, J ENDOCRINOL, V214, P1, DOI 10.1530/JOE-12-0126; Kenessey A, 2006, J BIOL CHEM, V281, P20666, DOI 10.1074/jbc.M512671200; Kerkela R, 2008, J CLIN INVEST, V118, P3609, DOI 10.1172/JCI36245; Kloner RA, 2016, J CARDIOVASC PHARM T; Kloner RA, 2016, J AM COLL CARDIOL, V67, P545, DOI 10.1016/j.jacc.2015.12.005; Li HJ, 2007, CARDIOVASC RES, V73, P130, DOI 10.1016/j.cardiores.2006.10.014; Liao WQ, 2005, FEBS J, V272, P1845, DOI 10.1111/j.1742-4658.2005.04614.x; Liu PY, 2003, ENDOCR REV, V24, P313, DOI 10.1210/er.2003-0005; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Markou T, 2008, CELL SIGNAL, V20, P206, DOI 10.1016/j.cellsig.2007.10.004; Marsh JD, 1998, CIRCULATION, V98, P256, DOI 10.1161/01.CIR.98.3.256; McKinsey TA, 2007, NAT REV DRUG DISCOV, V6, P617, DOI 10.1038/nrd2193; Michels G, 2008, FRONT NEUROENDOCRIN, V29, P182, DOI 10.1016/j.yfrne.2007.08.004; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Morisco C, 2000, J BIOL CHEM, V275, P14466, DOI 10.1074/jbc.275.19.14466; Neal JW, 2001, J BIOL CHEM, V276, P3666, DOI 10.1074/jbc.M004888200; Nelson CC, 1999, MOL ENDOCRINOL, V13, P2090, DOI 10.1210/me.13.12.2090; Papasozomenos SC, 2002, P NATL ACAD SCI USA, V99, P1140, DOI 10.1073/pnas.032646799; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; Periyasamy S, 2007, ENDOCRINOLOGY, V148, P4716, DOI 10.1210/en.2007-0145; Qin WP, 2015, MOL CELL ENDOCRINOL, V399, P336, DOI 10.1016/j.mce.2014.09.025; Satomi-Kobayashi S, 2004, CIRC J, V68, P247, DOI 10.1253/circj.68.247; Schulz RA, 2004, DEV BIOL, V266, P1, DOI 10.1016/j.ydbio.2003.10.008; Shaw M, 1999, FEBS LETT, V461, P120, DOI 10.1016/S0014-5793(99)01434-9; Singh R, 2009, ENDOCRINOLOGY, V150, P1259, DOI 10.1210/en.2008-0858; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Sugden PH, 2008, BRIT J PHARMACOL, V153, pS137, DOI 10.1038/sj.bjp.0707659; van de Wijngaart DJ, 2012, MOL CELL ENDOCRINOL, V352, P57, DOI 10.1016/j.mce.2011.08.007; Vicencio JM, 2006, ENDOCRINOLOGY, V147, P1386, DOI 10.1210/en.2005-1139; Welsh GI, 1998, FEBS LETT, V421, P125, DOI 10.1016/S0014-5793(97)01548-2; Wyce A, 2010, MOL ENDOCRINOL, V24, P1665, DOI 10.1210/me.2010-0138; Yang FJ, 2002, J BIOL CHEM, V277, P11336, DOI 10.1074/jbc.M111962200; Yao YY, 2008, CARDIOVASC RES, V80, P354, DOI 10.1093/cvr/cvn223; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zhang CG, 2009, BIOCHEM BIOPH RES CO, V390, P258, DOI 10.1016/j.bbrc.2009.09.101; Zhua YM, 2013, BRAIN RES, V1494, P1, DOI 10.1016/j.brainres.2012.11.047	59	23	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168255	10.1371/journal.pone.0168255	http://dx.doi.org/10.1371/journal.pone.0168255			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977752	Green Published, gold, Green Submitted			2022-12-26	WOS:000391217400082
J	Kai, M; Niinuma, T; Kitajima, H; Yamamoto, E; Harada, T; Aoki, H; Maruyama, R; Toyota, M; Sasaki, Y; Sugai, T; Tokino, T; Nakase, H; Suzuki, H				Kai, Masahiro; Niinuma, Takeshi; Kitajima, Hiroshi; Yamamoto, Eiichiro; Harada, Taku; Aoki, Hironori; Maruyama, Reo; Toyota, Mutsumi; Sasaki, Yasushi; Sugai, Tamotsu; Tokino, Takashi; Nakase, Hiroshi; Suzuki, Hiromu			TET1 Depletion Induces Aberrant CpG Methylation in Colorectal Cancer Cells	PLOS ONE			English	Article							ADAPTER PROTEIN GRB10; EPIGENETIC INACTIVATION; DNA METHYLATION; PROMOTER METHYLATION; ISLAND METHYLATION; FAMILY PROTEINS; POOR-PROGNOSIS; 5-HYDROXYMETHYLCYTOSINE; EXPRESSION; METASTASIS	Aberrant DNA methylation is commonly observed in colorectal cancer (CRC), but the underlying mechanism is not fully understood. 5-hydroxymethylcytosine levels and TET1 expression are both reduced in CRC, while epigenetic silencing of TET1 is reportedly associated with the CpG island methylator phenotype. In the present study, we aimed to clarify the relationship between loss of TET1 and aberrant DNA methylation in CRC. Stable TET1 knockdown clones were established using Colo320DM cells, which express high levels of TET1, and HCT116 cells, which express TET1 at a level similar to that in normal colonic tissue. Infinium HumanMethylation450 BeadChip assays revealed increased levels of 5-methylcytosine at more than 10,000 CpG sites in TET1-depleted Colo320DM cells. Changes in DNA methylation were observed at various positions within the genome, including promoters, gene bodies and intergenic regions, and the altered methylation affected expression of a subset of genes. By contrast, TET1 knockdown did not significantly affect DNA methylation in HCT116 cells. However, TET1 depletion was associated with attenuated effects of 5-aza-2'-deoxycytidine on gene expression profiles in both cell lines. These results suggest that loss of TET1 may induce aberrant DNA methylation and may attenuate the effect of 5-aza-2'-deoxycytidine in CRC cells.	[Kai, Masahiro; Niinuma, Takeshi; Kitajima, Hiroshi; Yamamoto, Eiichiro; Harada, Taku; Aoki, Hironori; Maruyama, Reo; Toyota, Mutsumi; Suzuki, Hiromu] Sapporo Med Univ, Sch Med, Dept Mol Biol, Sapporo, Hokkaido, Japan; [Yamamoto, Eiichiro; Nakase, Hiroshi] Sapporo Med Univ, Sch Med, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan; [Sasaki, Yasushi; Tokino, Takashi] Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Med Genome Sci, Sapporo, Hokkaido, Japan; [Sugai, Tamotsu] Iwate Med Univ, Dept Mol Diagnost Pathol, Morioka, Iwate, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Iwate Medical University	Suzuki, H (corresponding author), Sapporo Med Univ, Sch Med, Dept Mol Biol, Sapporo, Hokkaido, Japan.	hsuzuki@sapmed.ac.jp	Sasaki, Yasushi/AAA-3079-2019; Tokino, Takashi/AAI-9887-2021; Nakase, Hiroshi/AAZ-4425-2020	Sasaki, Yasushi/0000-0002-3500-8059; 	Japan Society for the Promotion of Science [JSPS KAKENHI15H04299, JSPS KAKENHI 15K18431, JSPS KAKENHI 15K19339]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html) (JSPS KAKENHI15H04299, H.Suzuki) and Grants-in-Aid for Young Investigators (B) from Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html) (JSPS KAKENHI 15K18431, T. Harada; JSPS KAKENHI 15K19339, H. Aoki).	Arnaud P, 2003, HUM MOL GENET, V12, P1005, DOI 10.1093/hmg/ddg110; Bai RY, 1998, ONCOGENE, V17, P941, DOI 10.1038/sj.onc.1202024; Bernert B, 2011, J BIOL CHEM, V286, P42349, DOI 10.1074/jbc.M111.278598; Bharadwaj AG, 2009, AM J PATHOL, V174, P1027, DOI 10.2353/ajpath.2009.080501; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Bu FF, 2015, ONCOTARGET, V6, P2120, DOI 10.18632/oncotarget.2940; Chapman CG, 2015, SCI REP-UK, V5, DOI 10.1038/srep17568; Chen XB, 2010, DIGEST DIS SCI, V55, P2219, DOI 10.1007/s10620-009-0992-0; Cimmino L, 2011, CELL STEM CELL, V9, P193, DOI 10.1016/j.stem.2011.08.007; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Dong WJ, 2014, BIOCHEM BIOPH RES CO, V453, P772, DOI 10.1016/j.bbrc.2014.10.016; Dong XY, 2015, EXP MOL PATHOL, V98, P192, DOI 10.1016/j.yexmp.2015.01.013; Estecio MRH, 2007, GENOME RES, V17, P1529, DOI 10.1101/gr.6417007; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Haugen AC, 2008, CANCER RES, V68, P8465, DOI 10.1158/0008-5472.CAN-08-0002; Ichimura N, 2015, CANCER PREV RES, V8, P702, DOI 10.1158/1940-6207.CAPR-14-0306; Igarashi S, 2010, CLIN CANCER RES, V16, P5114, DOI 10.1158/1078-0432.CCR-10-0581; Kazi JU, 2013, MOL ONCOL, V7, P402, DOI 10.1016/j.molonc.2012.11.003; Kebache S, 2007, J BIOL CHEM, V282, P21873, DOI 10.1074/jbc.M611066200; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Kohi S, 2016, CLIN EXP METASTAS, V33, P225, DOI 10.1007/s10585-015-9771-9; Kudo Y, 2012, CANCER SCI, V103, P670, DOI 10.1111/j.1349-7006.2012.02213.x; Kulis M, 2012, NAT GENET, V44, P1236, DOI 10.1038/ng.2443; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Liu Chunhua, 2013, P 2013 IEEE INT S IN, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0062828; Lu B, 2008, CLIN CANCER RES, V14, P7405, DOI 10.1158/1078-0432.CCR-08-0409; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Mirmohammadsadegh A, 2004, CELLS TISSUES ORGANS, V177, P119, DOI 10.1159/000079985; Murata A, 2015, ONCOTARGET, V6, P23372, DOI 10.18632/oncotarget.4281; Nakajima T, 2009, INT J CANCER, V124, P905, DOI 10.1002/ijc.24018; Neri F, 2015, ONCOGENE, V34, P4168, DOI 10.1038/onc.2014.356; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Okino K, 2005, ONCOL REP, V13, P1069; Okuda H, 2012, CANCER RES, V72, P537, DOI 10.1158/0008-5472.CAN-11-1678; OOI J, 1995, ONCOGENE, V10, P1621; Park J, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500661; Rawluszko-Wieczorek AA, 2015, J CANCER RES CLIN, V141, P1379, DOI 10.1007/s00432-014-1901-2; Sajadian SO, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0133-x; Sato H, 2007, CARCINOGENESIS, V28, P2459, DOI 10.1093/carcin/bgm178; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Shen LL, 2007, CANCER RES, V67, P11335, DOI 10.1158/0008-5472.CAN-07-1502; Shtivelman E, 1997, ONCOGENE, V14, P2167, DOI 10.1038/sj.onc.1201059; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Suzuki H, 2014, BIOCHEM BIOPH RES CO, V455, P35, DOI 10.1016/j.bbrc.2014.07.007; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Udabage L, 2005, EXP CELL RES, V310, P205, DOI 10.1016/j.yexcr.2005.07.026; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; Wu BK, 2014, CELL REP, V9, P1827, DOI 10.1016/j.celrep.2014.10.063; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang W, 2008, CANCER RES, V68, P2764, DOI 10.1158/0008-5472.CAN-07-6349	54	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168281	10.1371/journal.pone.0168281	http://dx.doi.org/10.1371/journal.pone.0168281			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977763	gold, Green Submitted, Green Published			2022-12-26	WOS:000391217400087
J	Okagawa, Y; Takada, K; Arihara, Y; Kikuchi, S; Osuga, T; Nakamura, H; Kamihara, Y; Hayasaka, N; Usami, M; Murase, K; Miyanishi, K; Kobune, M; Kato, J				Okagawa, Yutaka; Takada, Kohichi; Arihara, Yohei; Kikuchi, Shohei; Osuga, Takahiro; Nakamura, Hajime; Kamihara, Yusuke; Hayasaka, Naotaka; Usami, Makoto; Murase, Kazuyuki; Miyanishi, Koji; Kobune, Masayoshi; Kato, Junji			Activated p53 with Histone Deacetylase Inhibitor Enhances L-Fucose-Mediated Drug Delivery through Induction of Fucosyltransferase 8 Expression in Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							REACTIVE ALPHA-FETOPROTEIN; ENDOTHELIAL GROWTH-FACTOR; CANCER; SORAFENIB	Background The prognosis of advanced hepatocellular carcinoma (HCC) is dismal, underscoring the need for novel effective treatments. The alpha 1,6-fucosyltransferase (fucosyltransferase 8, FUT8) has been reported to accelerate malignant potential in HCC. Our study aimed to investigate the regulation of FUT8 expression by p53 and develop a novel therapeutic strategy for targeting HCC cells using L-fucose-mediated drug delivery. Methods Binding sites for p53 were searched for within the FUT8 promoter region. FUT8 expression was assessed by immunoblotting. Chromatin immunoprecipitation (ChIP) assays were performed to analyze p53 binding to the FUT8 promoter. The delivery of Cy5.5-encapsulated L-fucose-liposomes (Fuc-Lip-Cy5.5) to a Lens Culinaris agglutinin-reactive fraction of a-fetoprotein (AFP-L3)-expressing HCC cells was analyzed by flow cytometry. The induction of FUT8 by histone deacetylase inhibitor (HDACi) -inducing acetylated -p53 was evaluated by immunoblotting. Flow cytometric analysis was performed to assess whether the activation of p53 by HDACi affected the uptake of Fuc-Lip-Cy5.5 by HCC cells. The cytotoxicity of an L-fucose-bound liposome carrying sorafenib (Fuc-Lip-sorafenib) with HDACi was assessed in vivo and in vitro. Results The knock down of p53 with siRNA led to decreased FUT8 expression. ChIP assays revealed p53 binds to the FUT8 promoter region. Flow cytometric analyses demonstrated the specific uptake of Fuc-Lip-Cy5.5 into AFP-L3-expressing HCC cells in a p53- and FUT8- dependent manner. HDACi upregulated the uptake of Fuc-Lip-Cy5.5 by HCC cells by increasing FUT8 via acetylated -p53. The addition of a HDACi increased apoptosis induced by Fuc-Lip-sorafenib in HCC cells. Conclusions Our findings reveal that FUT8 is a p53 target gene and suggest that p53 activated by HDACi induces Fuc-Lip-sorafenib uptake by HCC cells, highlighting this pathway as a promising therapeutic intervention for HCC.	[Okagawa, Yutaka; Takada, Kohichi; Arihara, Yohei; Kikuchi, Shohei; Osuga, Takahiro; Nakamura, Hajime; Kamihara, Yusuke; Hayasaka, Naotaka; Usami, Makoto; Murase, Kazuyuki; Miyanishi, Koji; Kobune, Masayoshi; Kato, Junji] Sapporo Med Univ, Dept Med Oncol & Hematol, Sch Med, Sapporo, Hokkaido, Japan	Sapporo Medical University	Kato, J (corresponding author), Sapporo Med Univ, Dept Med Oncol & Hematol, Sch Med, Sapporo, Hokkaido, Japan.	jkato@sapmed.ac.jp	Kikuchi, Shohei/AAF-6775-2020	Kikuchi, Shohei/0000-0002-0961-6253; Miyanishi, Koji/0000-0002-6466-3458				Abou-Alfa GK, 2006, J CLIN ONCOL, V24, P4293, DOI 10.1200/JCO.2005.01.3441; Ahmed KM, 2013, CANCER RES, V73, P3737, DOI 10.1158/0008-5472.CAN-12-3537; Bouchard MJ, 2011, CANCER LETT, V305, P123, DOI 10.1016/j.canlet.2010.11.014; Chan LH, 2015, MOL CELLS, V38, P202, DOI 10.14348/molcells.2015.2356; Chen CY, 2013, P NATL ACAD SCI USA, V110, P630, DOI 10.1073/pnas.1220425110; Cheng JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087011; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gong WD, 2005, CLIN CANCER RES, V11, P1386, DOI 10.1158/1078-0432.CCR-04-0487; HUTCHINSON WL, 1991, HEPATOLOGY, V13, P683, DOI 10.1002/hep.1840130412; Lathia C, 2006, CANCER CHEMOTH PHARM, V57, P685, DOI 10.1007/s00280-005-0068-6; Moriwaki H, 1997, CLIN CANCER RES, V3, P727; Muinelo-Romay L, 2008, INT J CANCER, V123, P641, DOI 10.1002/ijc.23521; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Nakagawa T, 2008, J PROTEOME RES, V7, P2222, DOI 10.1021/pr700841q; Noda K, 2003, CANCER RES, V63, P6282; Oka H, 2001, J GASTROEN HEPATOL, V16, P1378, DOI 10.1046/j.1440-1746.2001.02643.x; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Osuga T., 2016, J NATL CANC I, V108; Siu LL, 2006, CLIN CANCER RES, V12, P144, DOI 10.1158/1078-0432.CCR-05-1571; Strumberg D, 2005, J CLIN ONCOL, V23, P965, DOI 10.1200/JCO.2005.06.124; Tada T, 2005, LIVER INT, V25, P848, DOI 10.1111/j.1478-3231.2005.01111.x; TAKETA K, 1990, GASTROENTEROLOGY, V99, P508, DOI 10.1016/0016-5085(90)91034-4; TAKETA K, 1990, HEPATOLOGY, V12, P1420, DOI 10.1002/hep.1840120625; Takimoto R, 2005, CANCER BIOL THER, V4, P421; Terui T, 2003, CANCER RES, V63, P8948; Uozumi N, 1996, J BIOL CHEM, V271, P27810, DOI 10.1074/jbc.271.44.27810; Wang MY, 2014, SCI REP-UK, V4, DOI 10.1038/srep06145; Wang X, 2015, CANC RES; YAMAZAKI N, 1994, METHOD ENZYMOL, V242, P56; Yoshida M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039545; Zhang MF, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-110; Zhao XY, 2015, J NANOMATER, V2015, DOI 10.1155/2015/104193; Zoller H, 2016, METABOLISM, V65, P1151, DOI 10.1016/j.metabol.2016.01.010	33	6	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168355	10.1371/journal.pone.0168355	http://dx.doi.org/10.1371/journal.pone.0168355			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977808	Green Published, Green Submitted, gold			2022-12-26	WOS:000391217400100
J	Wu, ZY; Wang, C; Zhang, Z; Liu, WL; Xu, HS; Wang, HQ; Wang, Y; Zhang, W; Wang, SL				Wu, Ziyu; Wang, Chao; Zhang, Zhan; Liu, Wenlou; Xu, Hengsen; Wang, Huanqiang; Wang, Yun; Zhang, Wei; Wang, Shou-Lin			High Expression of Derlin-1 Is Associated with the Malignancy of Bladder Cancer in a Chinese Han Population	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; CELL-SURFACE; PROMOTES; DISLOCATION; APOPTOSIS; PROTEINS; HYPOXIA	Derlin-1 is overexpressed in various types of solid tumors and has an important function in cancer progression. However, its expression pattern in and association with the clinicopathological characteristics of human bladder cancer remain unclear. In the present study, 3 pairs of fresh samples of bladder cancer tissue and paracancerous tissue were first detected by liquid chromatography tandem mass spectrometry (UPLC-MS/MS) to screen for differentially expressed proteins. Following bioinformatics analysis and assessments by qRT-PCR and western blotting, Derlin-1 was selected as a candidate protein and was then validated in samples from patients with bladder cancer by immunohistochemistry and western blotting. The results showed that the bladder cancer tissues exhibited higher levels of Derlin-1 expression than the paracancerous tissues (P < 0.05). Positive expression of Derlin-1 was significantly correlated with tumor stage, histological grade, and lymph node metastasis (P < 0.001) but was not correlated with other clinicopathological parameters including patient age (P = 0.758) and gender (P = 0.831). Besides, Derlin-1 was highly expressed in BC cell lines (um-uc-3 and T24), and the interference of Derlin-1 could reverse EMT progression, inhibit the tumor migration and invasion in T24 cells. Further, patients with positive Derlin-1 expression had shorter overall survival than those with negative expression (P < 0.001). Taken together, our results demonstrated that Derlin-1 was overexpressed in bladder cancer and was associated with the malignancy of bladder cancer.	[Wu, Ziyu; Wang, Chao; Zhang, Zhan; Xu, Hengsen; Wang, Huanqiang; Wang, Yun; Wang, Shou-Lin] Nanjing Med Univ, Sch Publ Hlth, 101 Longmian Ave, Nanjing, Jiangsu, Peoples R China; [Wu, Ziyu] Xuzhou Med Univ, Dept Urol, Huaian Hosp, Huaian, Peoples R China; [Liu, Wenlou] Wuhan Univ, Dept Oncol, Zhongnan Hosp, Wuhan, Peoples R China; [Zhang, Wei] Nanjing Med Univ, Dept Urol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Xuzhou Medical University; Wuhan University; Nanjing Medical University	Wang, SL (corresponding author), Nanjing Med Univ, Sch Publ Hlth, 101 Longmian Ave, Nanjing, Jiangsu, Peoples R China.; Zhang, W (corresponding author), Nanjing Med Univ, Dept Urol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	wangshl@njmu.edu.cn; zhang_wei5919@126.com	Zhang, Zhan/AAR-6278-2020	Zhang, Zhan/0000-0002-9685-5753	Huai'an Technology R&D program on Social Development [HAS2013025]; National Natural Science Foundation of China [81372956, 81573194]; Natural Science Foundation of Jiangsu province [BK20151555]; Natural Science Foundation of Jiangsu Universities [14KJA330002]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), China	Huai'an Technology R&D program on Social Development; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province); Natural Science Foundation of Jiangsu Universities; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), China	This work was supported by Huai'an Technology R&D program on Social Development (HAS2013025), National Natural Science Foundation of China (81372956, 81573194), Natural Science Foundation of Jiangsu province (BK20151555), Natural Science Foundation of Jiangsu Universities (14KJA330002), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), China.	Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Bohnenberger H, 2015, JOVE-J VIS EXP, DOI 10.3791/52435; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Cho SM, 2013, NANOSCALE RES LETT, V8, P1, DOI 10.1186/1556-276X-8-491; Cho S, 2013, BIOCHEM BIOPH RES CO, V430, P787, DOI 10.1016/j.bbrc.2012.11.068; Dinney CPN, 2004, CANCER CELL, V6, P111, DOI 10.1016/j.ccr.2004.08.002; Dong QZ, 2013, AM J PATHOL, V182, P954, DOI 10.1016/j.ajpath.2012.11.019; Eble JN, 2004, PATHOLOGY GENETICS T; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fels DR, 2006, CANCER BIOL THER, V5, P723, DOI 10.4161/cbt.5.7.2967; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Geiger T, 2010, NAT METHODS, V7, P383, DOI 10.1038/nmeth.1446; Hockel M, 2001, SEMIN ONCOL, V28, P36, DOI 10.1016/S0093-7754(01)90211-8; Koong AC, 2006, CANCER BIOL THER, V5, P756, DOI 10.4161/cbt.5.7.2973; Le QT, 2004, CANCER METAST REV, V23, P293, DOI 10.1023/B:CANC.0000031768.89246.d7; Lei CY, 2015, UROLOGIC ONCOLOGY; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Parkin DM, 2008, SCAND J UROL NEPHROL, V42, P12, DOI 10.1080/03008880802285032; Ran YL, 2008, CLIN CANCER RES, V14, P6538, DOI 10.1158/1078-0432.CCR-08-0476; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shan YJ, 2013, J NUTR BIOCHEM, V24, P1062, DOI 10.1016/j.jnutbio.2012.08.004; Sun C, 2012, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2012-46; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Tan XM, 2015, MOL CELL BIOCHEM, V408, P205, DOI 10.1007/s11010-015-2496-x; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Wang J, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1849; Wu CL, 2016, ONCOTARGET, V7, P26593, DOI 10.18632/oncotarget.8557; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	29	10	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168351	10.1371/journal.pone.0168351	http://dx.doi.org/10.1371/journal.pone.0168351			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977784	Green Submitted, Green Published, gold			2022-12-26	WOS:000391217400099
J	Cheng, ZK; Zhu, Q; Dee, R; Opheim, Z; Mack, CP; Cyr, DM; Taylor, JM				Cheng, Zhaokang; Zhu, Qiang; Dee, Rachel; Opheim, Zachary; Mack, Christopher P.; Cyr, Douglas M.; Taylor, Joan M.			Focal Adhesion Kinase-mediated Phosphorylation of Beclin1 Protein Suppresses Cardiomyocyte Autophagy and Initiates Hypertrophic Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPRAVALVULAR AORTIC CONSTRICTION; CARDIAC-HYPERTROPHY; INHIBITS AUTOPHAGY; CELLULAR AUTOPHAGY; HEART; DELETION; DOMAIN; RATS; FAK	Autophagy is an evolutionarily conserved intracellular degradation/recycling system that is essential for cellular homeostasis but is dysregulated in a number of diseases, including myocardial hypertrophy. Although it is clear that limiting or accelerating autophagic flux can result in pathological cardiac remodeling, the physiological signaling pathways that fine-tune cardiac autophagy are poorly understood. Herein, we demonstrated that stimulation of cardiomyocytes with phenylephrine (PE), a well known hypertrophic agonist, suppresses autophagy and that activation of focal adhesion kinase (FAK) is necessary for PE-stimulated autophagy suppression and subsequent initiation of hypertrophic growth. Mechanistically, we showed that FAK phosphorylates Beclin1, a core autophagy protein, on Tyr233 and that this post-translational modification limits Beclin1 association with Atg14L and reduces Beclin1-dependent autophagosome formation. Remarkably, although ectopic expression of wild-type Beclin1 promoted cardiomyocyte atrophy, expression of a Y233E phosphomimetic variant of Beclin1 failed to affect cardiomyocyte size. Moreover, genetic depletion of Beclin1 attenuated PE-mediated/FAK-dependent initiation of myocyte hypertrophy in vivo. Collectively, these findings identify FAK as a novel negative regulator of Beclin1-mediated autophagy and indicate that this pathway can facilitate the promotion of compensatory hypertrophic growth. This novel mechanism to limit Beclin1 activity has important implications for treating a variety of pathologies associated with altered autophagic flux.	[Cheng, Zhaokang; Zhu, Qiang; Dee, Rachel; Opheim, Zachary; Mack, Christopher P.; Taylor, Joan M.] Univ N Carolina, Dept Pathol, Chapel Hill, NC 27599 USA; [Mack, Christopher P.; Taylor, Joan M.] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC 27599 USA; [Cyr, Douglas M.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Taylor, JM (corresponding author), Univ N Carolina, Dept Pathol & Lab Med, 501 Brinkhous Bullitt Bldg,CB 7525, Chapel Hill, NC 27599 USA.	jmt3x@med.unc.edu		Cheng, Zhaokang/0000-0002-9646-4824; Taylor, Joan/0000-0002-8794-5167; Dee, Rachel/0000-0002-6982-8952; Cyr, Douglas/0000-0002-4928-3414	National Institutes of Health from NHLBI [HL-081844, HL-130367, K99/R00, K99HL119605]; American Heart Association [0355776U, 11POST7600008]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069768, R01HL130367, R00HL119605, R01HL081844, R01HL109607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056981] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants HL-081844 and HL-130367 from NHLBI and American Heart Association Grant 0355776U (to J. M. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by American Heart Association Postdoctoral Fellowship 11POST7600008 and National Institutes of Health K99/R00 Pathway to Independence Award K99HL119605 from NHLBI.	Ceylan-Isik AF, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0335-3; Cheng ZK, 2012, ARTERIOSCL THROM VAS, V32, P924, DOI 10.1161/ATVBAHA.112.245134; Cheng Z, 2014, J APPL MATH, DOI 10.1155/2014/369350; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Clemente CFMZ, 2007, CIRC RES, V101, P1339, DOI 10.1161/CIRCRESAHA.107.160978; DAMMRICH J, 1983, VIRCHOWS ARCH B, V43, P265, DOI 10.1007/BF02932961; DAMMRICH J, 1983, VIRCHOWS ARCH B, V43, P287, DOI 10.1007/BF02932962; DiMichele LA, 2006, CIRC RES, V99, P636, DOI 10.1161/01.RES.0000240498.44752.d6; DiMichele LA, 2009, CIRC RES, V104, P1201, DOI 10.1161/CIRCRESAHA.109.195941; Farre JC, 2011, CELL, V144, P172, DOI 10.1016/j.cell.2011.01.005; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Gabarra-Niecko V, 2002, BIOCHEM J, V365, P591, DOI 10.1042/BJ20020065; Gurkar AU, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3189; Gustafsson AB, 2009, CIRC RES, V104, P150, DOI 10.1161/CIRCRESAHA.108.187427; Hamacher-Brady A, 2006, J BIOL CHEM, V281, P29776, DOI 10.1074/jbc.M603783200; Hariharan N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051632; Hariharan N, 2011, ANTIOXID REDOX SIGN, V14, P2179, DOI 10.1089/ars.2010.3488; Hathaway CK, 2015, P NATL ACAD SCI USA, V112, P5141, DOI 10.1073/pnas.1504557112; Huang S, 2015, J CELL MOL MED, V19, P608, DOI 10.1111/jcmm.12445; Hurley JH, 2014, CELL, V157, P300, DOI 10.1016/j.cell.2014.01.070; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Kanamori H, 2011, CARDIOVASC RES, V91, P330, DOI 10.1093/cvr/cvr073; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kim Hye Joo, 2012, Evid Based Complement Alternat Med, V2012, P639469, DOI 10.1155/2012/639469; Li DL, 2016, CIRCULATION, V133, P1668, DOI 10.1161/CIRCULATIONAHA.115.017443; Li XH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1648; Lock R, 2008, CURR OPIN CELL BIOL, V20, P583, DOI 10.1016/j.ceb.2008.05.002; Long WW, 2010, MOL CELL, V37, P321, DOI 10.1016/j.molcel.2010.01.004; Maejima Y, 2016, J MOL CELL CARDIOL, V95, P19, DOI 10.1016/j.yjmcc.2015.10.032; Maejima Y, 2013, NAT MED, V19, P1478, DOI 10.1038/nm.3322; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Nakaoka M, 2015, BIOCHEM BIOPH RES CO, V456, P250, DOI 10.1016/j.bbrc.2014.11.067; Nishida K, 2009, CELL DEATH DIFFER, V16, P31, DOI 10.1038/cdd.2008.163; Nishida K, 2016, J MOL CELL CARDIOL, V95, P11, DOI 10.1016/j.yjmcc.2015.12.003; Oyabu J, 2013, BIOCHEM BIOPH RES CO, V441, P787, DOI 10.1016/j.bbrc.2013.10.135; PFEIFER U, 1987, J MOL CELL CARDIOL, V19, P1179, DOI 10.1016/S0022-2828(87)80528-X; Pham CG, 2000, AM J PHYSIOL-HEART C, V279, pH2916, DOI 10.1152/ajpheart.2000.279.6.H2916; Platta HW, 2012, BIOCHEM J, V441, P399, DOI 10.1042/BJ20111424; Rothermel BA, 2008, CIRC RES, V103, P1363, DOI 10.1161/CIRCRESAHA.108.186551; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Sandilands E, 2015, CELL SIGNAL, V27, P1816, DOI 10.1016/j.cellsig.2015.05.017; Shi CS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000751; Taylor JM, 2000, J BIOL CHEM, V275, P19250, DOI 10.1074/jbc.M909099199; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Wauson EM, 2014, TRENDS ENDOCRIN MET, V25, P274, DOI 10.1016/j.tem.2014.03.006; Wei YJ, 2015, ELIFE, V4, DOI 10.7554/eLife.05289; Wei YJ, 2013, CELL, V154, P1269, DOI 10.1016/j.cell.2013.08.015; Wesselborg S, 2015, CELL MOL LIFE SCI, V72, P4721, DOI 10.1007/s00018-015-2034-8; Xia PY, 2013, EMBO J, V32, P2685, DOI 10.1038/emboj.2013.189; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Zalckvar E, 2009, EMBO REP, V10, P285, DOI 10.1038/embor.2008.246; Zhang T, 2015, ELIFE, V4, DOI 10.7554/eLife.06734; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	55	30	33	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2065	2079		10.1074/jbc.M116.758268	http://dx.doi.org/10.1074/jbc.M116.758268			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	27994061	Green Published, hybrid			2022-12-26	WOS:000395530300002
J	Liu, L; Jacobsen, FW; Everds, N; Zhuang, Y; Yu, YB; Li, NY; Clark, D; Nguyen, MP; Fort, M; Narayanan, P; Kim, K; Stevenson, R; Narhi, L; Gunasekaran, K; Bussiere, JL				Liu, Ling; Jacobsen, Frederick W.; Everds, Nancy; Zhuang, Yao; Yu, Yan Bin; Li, Nianyu; Clark, Darcey; Mai Phuong Nguyen; Fort, Madeline; Narayanan, Padma; Kim, Kei; Stevenson, Riki; Narhi, Linda; Gunasekaran, Kannan; Bussiere, Jeanine L.			Biological Characterization of a Stable Effector Functionless (SEFL) Monoclonal Antibody Scaffold in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody engineering; Fc receptor; immunoglobulin G (IgG); phagocytosis; platelet; platelet depletion; antibody-dependent cellular cytotoxicity; complement-dependent cytotoxicity; cynomolgus macaque	DEPENDENT CELLULAR CYTOTOXICITY; LENGTH IGG ANTIBODIES; THERMAL-STABILITY; GLYCOSYLATION; EXPRESSION; FC; THERAPEUTICS; AGGREGATION; THERAPY	The stable effector functionLess (SEFL) antibody was designed as an IgG1 antibody with a constant region that lacks the ability to interact with Fc receptors. The engineering and stability and pharmacokinetic assessments of the SEFL scaffold is described in the accompanying article (Jacobsen, F. W., Stevenson, R., Li, C., Salimi-Moosavi, H., Liu, L., Wen, J., Luo, Q., Daris, K., Buck, L., Miller, S., Ho, S-Y., Wang, W., Chen, Q., Walker, K., Wypych, J., Narhi, L., and Gunasekaran, K. (2017) J. Biol. Chem. 292). The biological properties of these SEFL antibodies were assessed in a variety of human and cynomolgus monkey in vitro assays. Binding of parent molecules and their SEFL variants to human and cynomolgus monkey FcRs were evaluated using flow cytometry-based binding assays. The SEFL variants tested showed decreased binding affinity to human and cynomolgus FcRs compared with the wild-type IgG1 antibody. In addition, SEFL variants demonstrated no antibody-dependent cell-mediated cytotoxicity in vitro against Daudi cells with cynomolgus monkey peripheral blood mononuclear cells, and had minimal complement-dependent cytotoxicity activity similar to that of the negative control IgG2 in a CD20(+) human Raji lymphoma cell line. SEFL mutations eliminated off-target antibody-dependent monocyte phagocytosis of cynomolgus monkey platelets, and cynomolgus platelet activation in vitro. These experiments demonstrate that the SEFL modifications successfully eliminated Fc-associated effector binding and functions.	[Liu, Ling; Jacobsen, Frederick W.; Gunasekaran, Kannan] Amgen Inc, Dept Biol Optimizat, Thousand Oaks, CA 91320 USA; [Everds, Nancy; Li, Nianyu; Clark, Darcey; Mai Phuong Nguyen; Fort, Madeline; Narayanan, Padma; Kim, Kei; Bussiere, Jeanine L.] Amgen Inc, Dept Comparat Biol & Safety Sci, Thousand Oaks, CA 91320 USA; [Zhuang, Yao; Yu, Yan Bin] Amgen Inc, Dept Clin Immunol, Thousand Oaks, CA 91320 USA; [Stevenson, Riki; Narhi, Linda] Amgen Inc, Dept Proc Dev, Thousand Oaks, CA 91320 USA	Amgen; Amgen; Amgen; Amgen	Liu, L (corresponding author), One Amgen Ctr Dr,MS 14-2-A, Thousand Oaks, CA 91320 USA.	ling.liu@amgen.com	Ozkan, Hayri/T-6335-2017	Ozkan, Hayri/0000-0001-8443-8074	Amgen	Amgen(Amgen)	This work was supported by Amgen. All authors work or have worked at Amgen.	Fernandez LA, 2011, CURR OPIN BIOTECH, V22, P839, DOI 10.1016/j.copbio.2011.08.001; Awan FT, 2010, BLOOD, V115, P1204, DOI 10.1182/blood-2009-06-229039; Ejima D, 2007, PROTEINS, V66, P954, DOI 10.1002/prot.21243; Everds N, 2013, TOXICOL PATHOL, V41, P951, DOI 10.1177/0192623312474727; Everds NE, 2013, TOXICOL PATHOL, V41, P280, DOI 10.1177/0192623312467400; Ferrara C, 2006, BIOTECHNOL BIOENG, V93, P851, DOI 10.1002/bit.20777; Franey H, 2010, PROTEIN SCI, V19, P1601, DOI 10.1002/pro.434; Ha S, 2011, GLYCOBIOLOGY, V21, P1087, DOI 10.1093/glycob/cwr047; Ishiguro T, 2010, CANCER SCI, V101, P2227, DOI 10.1111/j.1349-7006.2010.01663.x; Ishihara T, 2010, J CHROMATOGR B, V878, P2141, DOI 10.1016/j.jchromb.2010.06.003; Jacobsen F., 2017, J BIOL CHEM, V292; Jacobsen FW, 2011, J IMMUNOL, V186, P341, DOI 10.4049/jimmunol.1001685; Jefferis R, 2009, TRENDS PHARMACOL SCI, V30, P356, DOI 10.1016/j.tips.2009.04.007; Ju MS, 2014, CURR OPIN BIOTECH, V30, P128, DOI 10.1016/j.copbio.2014.06.013; Jung ST, 2011, CURR OPIN BIOTECH, V22, P858, DOI 10.1016/j.copbio.2011.03.002; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; Koren E., 2002, Current Pharmaceutical Biotechnology, V3, P349, DOI 10.2174/1389201023378175; Leabman MK, 2013, MABS-AUSTIN, V5, P896, DOI 10.4161/mabs.26436; Li CH, 2012, BIOCHEMISTRY-US, V51, P10056, DOI 10.1021/bi300702e; Liu HC, 2006, IMMUNOL LETT, V106, P144, DOI 10.1016/j.imlet.2006.05.011; Mimura Y, 2000, MOL IMMUNOL, V37, P697, DOI 10.1016/S0161-5890(00)00105-X; Musolino A, 2008, J CLIN ONCOL, V26, P1789, DOI 10.1200/JCO.2007.14.8957; Natsume A, 2009, CANCER SCI, V100, P2411, DOI 10.1111/j.1349-7006.2009.01327.x; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Patel Dipa, 2010, Human Antibodies, V19, P89, DOI 10.3233/HAB-2010-0232; Raju TS, 2008, CURR OPIN IMMUNOL, V20, P471, DOI 10.1016/j.coi.2008.06.007; Santostefano MJ, 2012, TOXICOL PATHOL, V40, P899, DOI 10.1177/0192623312444029; Schneider-Merck T, 2010, J IMMUNOL, V184, P512, DOI 10.4049/jimmunol.0900847; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; van Meerten T, 2006, CLIN CANCER RES, V12, P4027, DOI 10.1158/1078-0432.CCR-06-0066; Walsh G, 2003, NAT BIOTECHNOL, V21, P865, DOI 10.1038/nbt0803-865; Warncke M, 2012, J IMMUNOL, V188, P4405, DOI 10.4049/jimmunol.1200090	32	11	13	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1876	1883		10.1074/jbc.M116.748707	http://dx.doi.org/10.1074/jbc.M116.748707			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27994063	Green Published, hybrid			2022-12-26	WOS:000395515600027
J	Kemp, MG; Spandau, DF; Simman, R; Travers, JB				Kemp, Michael G.; Spandau, Dan F.; Simman, Richard; Travers, Jeffrey B.			Insulin-like Growth Factor 1 Receptor Signaling Is Required for Optimal ATR-CHK1 Kinase Signaling in Ultraviolet B (UVB)-irradiated Human Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; INDUCED DNA-DAMAGE; REPLICATION PROTEIN-A; SINGLE-STRANDED-DNA; FACTOR-I RECEPTOR; SKIN-CANCER; CHECKPOINT ACTIVATION; HUMAN-CELLS; ATR KINASE; S PHASE	UVB wavelengths of light induce the formation of photoproducts in DNA that are potentially mutagenic if not properly removed by the nucleotide excision repair machinery. As an additional mechanism to minimize the risk of mutagenesis, UVB-irradiated cells also activate a checkpoint signaling cascade mediated by the ATM and Rad3-related (ATR) and checkpoint kinase 1 (CHK1) kinases to transiently suppress DNA synthesis and cell cycle progression. Given that keratinocytes in geriatric skin display reduced activation of the insulin-like growth factor 1 receptor (IGF-1R) and alterations in DNA repair rate, apoptosis, and senescence following UVB exposure, here we used cultured human keratinocytes in vitro and skin explants ex vivo to examine how IGF-1R activation status affects ATR-CHK1 kinase signaling and the inhibition of DNA replication following UVB irradiation. We find that disruption of IGF-1R signaling with small-molecule inhibitors or IGF-1 withdrawal partially abrogates both the phosphorylation and activation of CHK1 by ATR and the accompanying inhibition of chromosomal DNA synthesis in UVB-irradiated keratinocytes. A critical protein factor that mediates both ATR-CHK1 signaling and nucleotide excision repair is replication protein A, and we find that its accumulation on UVB-damaged chromatin is partially attenuated in cells with an inactive IGF-1R. These results indicate that mutagenesis and skin carcinogenesis in IGF-1-deficient geriatric skin may be caused by defects in multiple cellular responses to UVB-induced DNA damage, including through a failure to properly suppress DNA synthesis on UVB-damaged DNA templates.	[Kemp, Michael G.; Simman, Richard; Travers, Jeffrey B.] Wright State Univ, Dept Pharmacol & Toxicol, Boonshoft Sch Med, Dayton, OH 45435 USA; [Spandau, Dan F.] Indiana Univ Sch Med, Dept Dermatol, Indianapolis, IN 46202 USA; [Spandau, Dan F.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Travers, Jeffrey B.] Dayton Vet Affairs Med Ctr, Dayton, OH 45428 USA	University System of Ohio; Wright State University Dayton; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Kemp, MG (corresponding author), Wright State Univ, Dept Pharmacol & Toxicol, Boonshoft Sch Med, Dayton, OH 45435 USA.	mike.kemp@wright.edu	Kemp, Michael G./AAT-1545-2021	Kemp, Michael G./0000-0001-8203-0745; Travers, Jeffrey/0000-0001-7232-1039	NIEHS, National Institutes of Health [ES020866]; NIA, National Institutes of Health Grant [AG048946]; Veterans Administration Grant [1101CX000809]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG048946] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000809] Funding Source: NIH RePORTER	NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIA, National Institutes of Health Grant; Veterans Administration Grant; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by NIEHS, National Institutes of Health Grant ES020866 (to D. F. S. and J. B. T.), NIA, National Institutes of Health Grant AG048946 (to D. F. S. and J. B. T.), and by Veterans Administration Grant 1101CX000809 (to J. B. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acevedo J, 2016, J BIOL CHEM, V291, P13124, DOI 10.1074/jbc.M116.729194; Auclair Y, 2008, P NATL ACAD SCI USA, V105, P17896, DOI 10.1073/pnas.0801585105; BARRECA A, 1992, J CELL PHYSIOL, V151, P262, DOI 10.1002/jcp.1041510207; Belanger F, 2016, J BIOL CHEM, V291, P522, DOI 10.1074/jbc.M115.685883; Brown EJ, 2000, GENE DEV, V14, P397; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Choi JH, 2010, P NATL ACAD SCI USA, V107, P13660, DOI 10.1073/pnas.1007856107; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Fang Y, 2004, EMBO J, V23, P3164, DOI 10.1038/sj.emboj.7600315; Fernandez TL, 2015, EXP DERMATOL, V24, P235, DOI 10.1111/exd.12637; Giannattasio M, 2010, MOL CELL, V40, P50, DOI 10.1016/j.molcel.2010.09.004; Guven M, 2015, J INVEST DERMATOL, V135, P2834, DOI 10.1038/jid.2015.255; Heffernan TP, 2002, MOL CELL BIOL, V22, P8552, DOI 10.1128/MCB.22.24.8552-8561.2002; Jarrett SG, 2016, NUCLEIC ACIDS RES, V44, P10711, DOI 10.1093/nar/gkw871; Jarrett SG, 2014, MOL CELL, V54, P999, DOI 10.1016/j.molcel.2014.05.030; Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612; Kaufmann WK, 2010, CARCINOGENESIS, V31, P751, DOI 10.1093/carcin/bgp230; Kemp MG, 2016, J BIOL CHEM, V291, P9330, DOI 10.1074/jbc.M116.719740; Kemp MG, 2014, J BIOL CHEM, V289, P26574, DOI 10.1074/jbc.M114.597088; Kemp MG, 2010, J BIOL CHEM, V285, P16562, DOI 10.1074/jbc.M110.110304; Kohler C, 2016, CELL CYCLE, V15, P974, DOI 10.1080/15384101.2016.1152424; Kraemer KH, 1997, P NATL ACAD SCI USA, V94, P11, DOI 10.1073/pnas.94.1.11; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuhn C, 1999, INT J CANCER, V80, P431, DOI 10.1002/(SICI)1097-0215(19990129)80:3<431::AID-IJC16>3.3.CO;2-X; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Lam MH, 2004, CANCER CELL, V6, P45, DOI 10.1016/j.ccr.2004.06.015; Lee TH, 2014, ONCOGENE, V33, P19, DOI 10.1038/onc.2012.539; Lewis DA, 2010, ONCOGENE, V29, P1475, DOI 10.1038/onc.2009.440; Lewis DA, 2008, MOL BIOL CELL, V19, P1346, DOI 10.1091/mbc.E07-10-1041; Lewis DA, 2011, AGING-US, V3, P407, DOI 10.18632/aging.100318; Lewis DA, 2009, J INVEST DERMATOL, V129, P787, DOI 10.1038/jid.2008.293; Lindsey-Boltz LA, 2014, J BIOL CHEM, V289, P5074, DOI 10.1074/jbc.M113.542787; Liu QH, 2000, GENE DEV, V14, P1448; Loesch MM, 2016, MOL ONCOL, V10, P1245, DOI 10.1016/j.molonc.2016.06.002; Marechal A, 2015, CELL RES, V25, P9, DOI 10.1038/cr.2014.147; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200; Nam EA, 2011, BIOCHEM J, V436, P527, DOI 10.1042/BJ20102162; Overmeer RM, 2011, J CELL BIOL, V192, P401, DOI 10.1083/jcb.201006011; Reardon JT, 2005, PROG NUCLEIC ACID RE, V79, P183, DOI 10.1016/S0079-6603(04)79004-2; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Scharer OD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012609; Sertic S, 2011, P NATL ACAD SCI USA, V108, P13647, DOI 10.1073/pnas.1108547108; Shell SM, 2009, J BIOL CHEM, V284, P24213, DOI 10.1074/jbc.M109.000745; Smits VAJ, 2015, FEBS J, V282, P3681, DOI 10.1111/febs.13387; Spandau DF, 2012, J INVEST DERMATOL, V132, P1591, DOI 10.1038/jid.2012.29; TAVAKKOL A, 1992, J INVEST DERMATOL, V99, P343, DOI 10.1111/1523-1747.ep12616668; Tho LM, 2012, ONCOGENE, V31, P1366, DOI 10.1038/onc.2011.326; Toledo LI, 2008, GENE DEV, V22, P297, DOI 10.1101/gad.452308; Toledo LI, 2013, CELL, V155, P1088, DOI 10.1016/j.cell.2013.10.043; Travers JB, 2013, DERMATOL SURG, V39, P967, DOI 10.1111/dsu.12138; Tsaalbi-Shtylik A, 2014, NUCLEIC ACIDS RES, V42, P4406, DOI 10.1093/nar/gkt1412; Wolf C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11752; Xu X, 2008, MOL CELL BIOL, V28, P7345, DOI 10.1128/MCB.01079-08; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622	62	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1231	1239		10.1074/jbc.M116.765883	http://dx.doi.org/10.1074/jbc.M116.765883			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27979966	hybrid, Green Published			2022-12-26	WOS:000393339800008
J	Nishi, A; Matamales, M; Musante, V; Valjent, E; Kuroiwa, M; Kitahara, Y; Rebholz, H; Greengard, P; Girault, JA; Nairn, AC				Nishi, Akinori; Matamales, Miriam; Musante, Veronica; Valjent, Emmanuel; Kuroiwa, Mahomi; Kitahara, Yosuke; Rebholz, Heike; Greengard, Paul; Girault, Jean-Antoine; Nairn, Angus C.			Glutamate Counteracts Dopamine/PKA Signaling via Dephosphorylation of DARPP-32 Ser-97 and Alteration of Its Cytonuclear Distribution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASEIN KINASE-II; CAMP-REGULATED PHOSPHOPROTEIN; DEPENDENT PROTEIN-KINASE; NEOSTRIATAL NEURONS; STRIATAL NEURONS; PHOSPHATASE CASCADE; IN-VITRO; PHOSPHORYLATION; RECEPTOR; ACTIVATION	The interaction of glutamate and dopamine in the striatum is heavily dependent on signaling pathways that converge on the regulatory protein DARPP-32. The efficacy of dopamine/D1 receptor/PKA signaling is regulated by DARPP-32 phosphorylated at Thr-34 (the PKA site), a process that inhibits protein phosphatase 1 (PP1) and potentiates PKA action. Activation of dopamine/D1receptor/PKA signaling also leads to dephosphorylation of DARPP-32 at Ser-97 (the CK2 site), leading to localization of phospho-Thr-34 DARPP-32 in the nucleus where it also inhibits PP1. In this study the role of glutamate in the regulation of DARPP-32 phosphorylation at four major sites was further investigated. Experiments using striatal slices revealed that glutamate decreased the phosphorylation states of DARPP-32 at Ser-97 as well as Thr-34, Thr-75, and Ser-130 by activating NMDA or AMPA receptors in both direct and indirect pathway striatal neurons. The effect of glutamate in decreasing Ser-97 phosphorylation was mediated by activation of PP2A. In vitro phosphatase assays indicated that the PP2A/PR72 heterotrimer complex was likely responsible for glutamate/Ca2+-regulated dephosphorylation of DARPP-32 at Ser-97. As a consequence of Ser-97 dephosphorylation, glutamate induced the nuclear localization in cultured striatal neurons of dephospho-Thr-34/dephospho-Ser-97 DARPP-32. It also reduced PKA-dependent DARPP-32 signaling in slices and in vivo. Taken together, the results suggest that by inducing dephosphorylation of DARPP-32 at Ser-97 and altering its cytonuclear distribution, glutamate may counteract dopamine/D1 receptor/PKA signaling at multiple cellular levels.	[Nishi, Akinori; Kuroiwa, Mahomi; Kitahara, Yosuke] Kurume Univ, Sch Med, Dept Pharmacol, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan; [Matamales, Miriam; Girault, Jean-Antoine] UPMC UMR S839, INSERM, Inst Fer Moulin, F-75005 Paris, France; [Musante, Veronica; Nairn, Angus C.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA; [Valjent, Emmanuel] Univ Montpellier, UMR CNRS 5203, Inserm U1191, Inst Genom Fonct, F-34094 Montpellier, France; [Rebholz, Heike; Greengard, Paul] Rockefeller Univ, Lab Mol & Cellular Neurosci, New York, NY 10065 USA; [Matamales, Miriam] Univ Queensland, Queensland Brain Inst, Clem Jones Ctr Ageing Dementia Res, Brisbane, Qld 4072, Australia; [Rebholz, Heike] CUNY City Coll, CUNY Sch Med, Dept Physiol Pharmacol & Neurosci, New York, NY 10031 USA	Kurume University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Yale University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Rockefeller University; University of Queensland; City University of New York (CUNY) System; City College of New York (CUNY)	Nishi, A (corresponding author), Kurume Univ, Sch Med, Dept Pharmacol, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	nishia@med.kurume-u.ac.jp	Matamales, Miriam/J-5189-2014; Girault, Jean-Antoine/F-7518-2013	Matamales, Miriam/0000-0001-9978-0091; Girault, Jean-Antoine/0000-0002-7900-1705; Greengard, Paul/0000-0002-4437-0893; Rebholz, Heike/0000-0002-0400-7547; Valjent, Emmanuel/0000-0002-1034-606X; Nairn, Angus/0000-0002-7075-0195	National Institutes of Health [DA10044, MH090963]; Japan Society for the Promotion of Science [18300128, 16H05135, 26860951]; JPB Foundation; Leon Black Family Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH090963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG047270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [16K10198] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JPB Foundation; Leon Black Family Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants DA10044 (NIDA) and MH090963 (NIMH) (both to P. G. and A. C. N.). This work was also supported by Grants-in-aid for Scientific Research from the Japan Society for the Promotion of Science (18300128 and 16H05135 (to A. N.) and 26860951 (to M. K.)) and by The JPB Foundation (to P. G.) and the Leon Black Family Foundation (to P. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn JH, 2007, P NATL ACAD SCI USA, V104, P9876, DOI 10.1073/pnas.0703589104; Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Bateup HS, 2008, NAT NEUROSCI, V11, P932, DOI 10.1038/nn.2153; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; Brami-Cherrier K, 2002, J NEUROSCI, V22, P8911; DESDOUITS F, 1995, P NATL ACAD SCI USA, V92, P2682, DOI 10.1073/pnas.92.7.2682; Desdouits F, 1998, BIOCHEM J, V330, P211, DOI 10.1042/bj3300211; DESDOUITS F, 1995, J BIOL CHEM, V270, P8772, DOI 10.1074/jbc.270.15.8772; Engmann O, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10099; Fino E, 2011, NEUROPHARMACOLOGY, V60, P780, DOI 10.1016/j.neuropharm.2011.01.023; GIRAULT JA, 1989, J BIOL CHEM, V264, P21748; GIRAULT JA, 1990, J NEUROCHEM, V55, P1772, DOI 10.1111/j.1471-4159.1990.tb04968.x; Girault JA, 2007, CURR OPIN PHARMACOL, V7, P77, DOI 10.1016/j.coph.2006.08.012; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; HALPAIN S, 1990, NATURE, V343, P369, DOI 10.1038/343369a0; Hamada M, 2005, J PHARMACOL EXP THER, V315, P872, DOI 10.1124/jpet.105.090852; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; KUENZEL EA, 1985, P NATL ACAD SCI USA, V82, P737, DOI 10.1073/pnas.82.3.737; KUENZEL EA, 1987, J BIOL CHEM, V262, P9136; Kuroiwa M, 2008, J NEUROCHEM, V107, P1014, DOI 10.1111/j.1471-4159.2008.05702.x; Li L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7319; Liu F, 2001, P NATL ACAD SCI USA, V98, P11062, DOI 10.1073/pnas.191353898; MEINKOTH JL, 1990, P NATL ACAD SCI USA, V87, P9595, DOI 10.1073/pnas.87.24.9595; NIGG EA, 1985, EMBO J, V4, P2801, DOI 10.1002/j.1460-2075.1985.tb04006.x; Nishi A, 2000, P NATL ACAD SCI USA, V97, P12840, DOI 10.1073/pnas.220410397; Nishi A, 2005, P NATL ACAD SCI USA, V102, P1199, DOI 10.1073/pnas.0409138102; Nishi A, 1999, J NEUROCHEM, V72, P2015, DOI 10.1046/j.1471-4159.1999.0722015.x; Nishi A, 2003, P NATL ACAD SCI USA, V100, P1322, DOI 10.1073/pnas.0237126100; Nishi A, 1997, J NEUROSCI, V17, P8147; Nishi A, 2002, J NEUROCHEM, V81, P832, DOI 10.1046/j.1471-4159.2002.00876.x; Snyder GL, 2000, J NEUROSCI, V20, P4480, DOI 10.1523/JNEUROSCI.20-12-04480.2000; SOMMERCORN J, 1987, J BIOL CHEM, V262, P3839; Stipanovich A, 2008, NATURE, V453, P879, DOI 10.1038/nature06994; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Svenningsson P, 2003, SCIENCE, V302, P1412, DOI 10.1126/science.1089681; Tanda K, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-19; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Valjent E, 2006, P NATL ACAD SCI USA, V103, P2932, DOI 10.1073/pnas.0511030103; Walaas SI, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00050; Yagishita S, 2014, SCIENCE, V345, P1616, DOI 10.1126/science.1255514; Yger M, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00056	42	17	17	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1462	1476		10.1074/jbc.M116.752402	http://dx.doi.org/10.1074/jbc.M116.752402			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27998980	Green Published, hybrid			2022-12-26	WOS:000393339800027
J	Short, SM; Morse, TM; McTavish, TS; Shepherd, GM; Verhagen, JV				Short, Shaina M.; Morse, Thomas M.; McTavish, Thomas S.; Shepherd, Gordon M.; Verhagen, Justus V.			Respiration Gates Sensory Input Responses in the Mitral Cell Layer of the Olfactory Bulb	PLOS ONE			English	Article							EXTERNAL TUFTED CELLS; RECEPTOR NEURON INPUT; DEPENDENT MODULATION; ODOR DISCRIMINATION; EVOKED ACTIVITY; INHIBITION; INFORMATION; AWAKE; SNIFF; ORGANIZATION	Respiration plays an essential role in odor processing. Even in the absence of odors, oscillating excitatory and inhibitory activity in the olfactory bulb synchronizes with respiration, commonly resulting in a burst of action potentials in mammalian mitral/tufted cells (MTCs) during the transition from inhalation to exhalation. This excitation is followed by inhibition that quiets MTC activity in both the glomerular and granule cell layers. Odor processing is hypothesized to be modulated by and may even rely on respiration-mediated activity, yet exactly how respiration influences sensory processing by MTCs is still not well understood. By using optogenetics to stimulate discrete sensory inputs in vivo, it was possible to temporally vary the stimulus to occur at unique phases of each respiration. Single unit recordings obtained from the mitral cell layer were used to map spatiotemporal patterns of glomerular evoked responses that were unique to stimulations occurring during periods of inhalation or exhalation. Sensory evoked activity in MTCs was gated to periods outside phasic respiratory mediated firing, causing net shifts in MTC activity across the cycle. In contrast, odor evoked inhibitory responses appear to be permitted throughout the respiratory cycle. Computational models were used to further explore mechanisms of inhibition that can be activated by respiratory activity and influence MTC responses. In silico results indicate that both periglomerular and granule cell inhibition can be activated by respiration to internally gate sensory responses in the olfactory bulb. Both the respiration rate and strength of lateral connectivity influenced inhibitory mechanisms that gate sensory evoked responses.	[Short, Shaina M.; Morse, Thomas M.; McTavish, Thomas S.; Shepherd, Gordon M.; Verhagen, Justus V.] Yale Sch Med, Dept Neurosci, New Haven, CT 06510 USA; [Short, Shaina M.; Verhagen, Justus V.] John B Pierce Lab, New Haven, CT 06519 USA; [Short, Shaina M.] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA	Yale University; Yale University; The John B Pierce Laboratory, Inc; Utah System of Higher Education; University of Utah	Short, SM (corresponding author), Yale Sch Med, Dept Neurosci, New Haven, CT 06510 USA.; Short, SM (corresponding author), John B Pierce Lab, New Haven, CT 06519 USA.; Short, SM (corresponding author), Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA.	shainashort@gmail.com			NIH [R01DC011286, R01DC009994, R01DC014723, R01DC009977, T15LM007056, T32NS007224, RR19895, RR029676-01]; Yale's HPC facilities; National Science Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC014723, R01DC009977] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale's HPC facilities; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by NIH grants: R01DC011286, R01DC009994 and R01DC014723 to Dr. Justus V. Verhagen, R01DC009977 to Dr. Gordon M. Shepherd, and departmental training awards T15LM007056 to Dr. Thomas S. McTavish and T32NS007224 to Dr. Shaina M. Short. This work was also supported by Yale's HPC facilities operated by the Yale Center for Research Computing and Yale's W.M. Keck Biotechnology Laboratory, funded by NIH grants: RR19895 and RR029676-01. We are grateful for the Neuroscience Gateway (NSG) Portal supported by the National Science Foundation.	Abraham NM, 2010, NEURON, V65, P399, DOI 10.1016/j.neuron.2010.01.009; ADRIAN ED, 1950, ELECTROEN CLIN NEURO, V2, P377, DOI 10.1016/0013-4694(50)90075-7; Balu R, 2004, J NEUROPHYSIOL, V92, P743, DOI 10.1152/jn.00016.2004; Banerjee A, 2015, NEURON, V87, P193, DOI 10.1016/j.neuron.2015.06.019; Bazhenov M, 2001, NEURON, V30, P569, DOI 10.1016/S0896-6273(01)00286-0; Bhalla US, 1997, J COMPUT NEUROSCI, V4, P221, DOI 10.1023/A:1008819818970; Briffaud V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043964; Brunert D, 2016, J NEUROSCI, V36, P6820, DOI 10.1523/JNEUROSCI.3667-15.2016; Burton SD, 2014, J PHYSIOL-LONDON, V592, P2097, DOI 10.1113/jphysiol.2013.269886; Carey RM, 2009, J NEUROPHYSIOL, V101, P1073, DOI 10.1152/jn.90902.2008; Cazakoff BN, 2014, NAT NEUROSCI, V17, P569, DOI 10.1038/nn.3669; CHAPUT MA, 1986, PHYSIOL BEHAV, V36, P319, DOI 10.1016/0031-9384(86)90023-5; Connelly T, 2013, J NEUROPHYSIOL, V110, P55, DOI 10.1152/jn.00910.2012; Cury KM, 2010, NEURON, V68, P570, DOI 10.1016/j.neuron.2010.09.040; David F, 2008, J COMPUT NEUROSCI, V25, P25, DOI 10.1007/s10827-007-0063-5; Dhawale AK, 2010, NAT NEUROSCI, V13, P1404, DOI 10.1038/nn.2673; Fukunaga I, 2014, NAT NEUROSCI, V17, P1208, DOI 10.1038/nn.3760; Fukunaga I, 2012, NEURON, V75, P320, DOI 10.1016/j.neuron.2012.05.017; GETCHELL TV, 1975, J PHYSIOL-LONDON, V251, P523, DOI 10.1113/jphysiol.1975.sp011106; Gire DH, 2012, J NEUROSCI, V32, P2964, DOI 10.1523/JNEUROSCI.5580-11.2012; Grosmaitre X, 2007, NAT NEUROSCI, V10, P348, DOI 10.1038/nn1856; Haddad R, 2013, NAT NEUROSCI, V16, P949, DOI 10.1038/nn.3407; Hayar A, 2004, J NEUROSCI, V24, P6676, DOI 10.1523/JNEUROSCI.1367-04.2004; Hayar A, 2004, J NEUROSCI, V24, P1190, DOI 10.1523/JNEUROSCI.4714-03.2004; Hines ML, 2004, J COMPUT NEUROSCI, V17, P7, DOI 10.1023/B:JCNS.0000023869.22017.2e; Hines ML, 2001, NEUROSCIENTIST, V7, P123, DOI 10.1177/107385840100700207; Homma R, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00023; Igarashi KM, 2012, J NEUROSCI, V32, P7970, DOI 10.1523/JNEUROSCI.0154-12.2012; Kato HK, 2013, NEURON, V80, P1218, DOI 10.1016/j.neuron.2013.08.036; Kato HK, 2012, NEURON, V76, P962, DOI 10.1016/j.neuron.2012.09.037; Kay LM, 2006, SEMIN CELL DEV BIOL, V17, P433, DOI 10.1016/j.semcdb.2006.04.012; Kay LM, 2009, TRENDS NEUROSCI, V32, P207, DOI 10.1016/j.tins.2008.11.008; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; Kosaka T, 2016, ANAT SCI INT, V91, P115, DOI 10.1007/s12565-015-0309-7; Labarrera C, 2013, J PHYSIOL-LONDON, V591, P1841, DOI 10.1113/jphysiol.2012.241851; Lehmann A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00015; Li A, 2014, J NEUROSCI, V34, P16058, DOI 10.1523/JNEUROSCI.3382-14.2014; Li GS, 2013, J NEUROSCI, V33, P3037, DOI 10.1523/JNEUROSCI.2831-12.2013; Liu SL, 2016, J NEUROSCI, V36, P9604, DOI 10.1523/JNEUROSCI.1763-16.2016; Liu SL, 2012, J NEUROPHYSIOL, V107, P473, DOI 10.1152/jn.00741.2011; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; McTavish TS, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00003; Nagayama S, 2004, J NEUROPHYSIOL, V91, P2532, DOI 10.1152/jn.01266.2003; ONODA N, 1980, J NEUROPHYSIOL, V44, P29, DOI 10.1152/jn.1980.44.1.29; PAGER J, 1985, BEHAV BRAIN RES, V16, P81, DOI 10.1016/0166-4328(85)90084-1; Phillips ME, 2012, J NEUROSCI, V32, P85, DOI 10.1523/JNEUROSCI.4278-11.2012; PINCHING AJ, 1971, J CELL SCI, V9, P347; Rebello MR, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002021; ROSPARS JP, 1994, BRAIN RES, V662, P31, DOI 10.1016/0006-8993(94)90793-5; Schaefer AT, 2006, PLOS BIOL, V4, P1010, DOI 10.1371/journal.pbio.0040163; Schoppa NE, 2006, J NEUROSCI, V26, P12996, DOI 10.1523/JNEUROSCI.3503-06.2006; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, DOI [DOI 10.1093/ACPROF:OSO/9780195159561.001.1, 10.1093/acprof:oso/9780195159561.001.1]; SHEPHERD GM, 1972, PHYSIOL REV, V52, P864, DOI 10.1152/physrev.1972.52.4.864; Shusterman R, 2011, NAT NEUROSCI, V14, P1039, DOI 10.1038/nn.2877; Sivagnanam S, 2013, CEUR WORKSHOP P, V993; Smear M, 2011, NATURE, V479, P397, DOI 10.1038/nature10521; Spors H, 2006, J NEUROSCI, V26, P1247, DOI 10.1523/JNEUROSCI.3100-05.2006; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Verhagen JV, 2007, NAT NEUROSCI, V10, P631, DOI 10.1038/nn1892; Wachowiak M, 2006, SEMIN CELL DEV BIOL, V17, P411, DOI 10.1016/j.semcdb.2006.04.007; Wachowiak M, 2011, NEURON, V71, P962, DOI 10.1016/j.neuron.2011.08.030; Wesson DW, 2008, PLOS BIOL, V6, P717, DOI 10.1371/journal.pbio.0060082; Wienisch M, 2016, SCI REPORTS, P6; Willhite DC, 2006, P NATL ACAD SCI USA, V103, P12592, DOI 10.1073/pnas.0602032103; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Young TA, 1999, NEUROSCI LETT, V276, P65, DOI 10.1016/S0304-3940(99)00781-8; Youngstrom IA, 2015, J NEUROSCI, V35, P8758, DOI 10.1523/JNEUROSCI.0311-15.2015; Yu YG, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003014	69	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168356	10.1371/journal.pone.0168356	http://dx.doi.org/10.1371/journal.pone.0168356			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005923	Green Published, Green Submitted, gold			2022-12-26	WOS:000392843200045
J	Alam, MF; Laskar, AA; Maryam, L; Younus, H				Alam, Md. Fazle; Laskar, Amaj Ahmed; Maryam, Lubna; Younus, Hina			Activation of Human Salivary Aldehyde Dehydrogenase by Sulforaphane: Mechanism and Significance	PLOS ONE			English	Article							SERUM-ALBUMIN; GENETIC POLYMORPHISMS; HEALTH-BENEFITS; CANCER-RISK; ALCOHOL; DRINKING; ETHANOL; BINDING; ENZYME; LOMEFLOXACIN	Cruciferous vegetables contain the bio-active compound sulforaphane (SF) which has been reported to protect individuals against various diseases by a number of mechanisms, including activation of the phase Ildetoxification enzymes. In this study, we show that the extracts of five cruciferous vegetables that we commonly consume and SF activate human salivary aldehyde dehydrogenase (hsALDH), which is a very important detoxifying enzyme in the mouth. Maximum activation was observed at 1 lag/m1 of cabbage extract with 2.6 fold increase in the activity. There was a-1.9 fold increase in the activity of hsALDH at SF concentration of > 100 nM. The concentration of SF at half the maximum response (EC50 value) was determined to be 52 2 nM. There was an increase in the Vmaxand a decrease in the Km of the enzyme in the presence of SF. Hence, SF interacts with the enzyme and increases its affinity for the substrate. UV absorbance, fluorescence and CD studies revealed that SF binds to hsALDH and does not disrupt its native structure. SF binds with the enzyme with a binding constant of 1.23 x 107M(-1). There is one binding site on hsALDH for SF, and the thermodynamic parameters indicate the formation of a spontaneous strong complex between the two. Molecular docking analysis depicted that SF fits into the active site of ALDH3A1, and facilitates the catalytic mechanism of the enzyme. SF being an antioxidant, is very likely to protect the catalytic Cys 243 residue from oxidation, which leads to the increase in the catalytic efficiency and hence the activation of the enzyme. Further, hsALDH which is virtually inactive towards acetaldehyde exhibited significant activity towards it in the presence of SF. It is therefore very likely that consumption of large quantities of cruciferous vegetables or SF supplements, through their activating effect on hsALDH can protect individuals who are alcohol intolerant against acetaldehyde toxicity and also lower the risk of oral cancer development.	[Alam, Md. Fazle; Laskar, Amaj Ahmed; Maryam, Lubna; Younus, Hina] Aligarh Muslim Univ, Enzymol Lab, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India	Aligarh Muslim University	Younus, H (corresponding author), Aligarh Muslim Univ, Enzymol Lab, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India.	hyounus.cb@amu.ac.in	Younus, Hina/AAF-3337-2019; Alam, Mohammad Fazle/N-9959-2019	ALAM, MOHAMMAD/0000-0002-3684-2475; Younus, Hina/0000-0003-3066-1312; Laskar, Amaj/0000-0002-5730-7906				Ajmal M, 2015, J HYDRO-ENVIRON RES, V9, P592, DOI 10.1016/j.jher.2014.11.003; Alam MF, 2016, CELL BIOCHEM BIOPHYS, V74, P307, DOI 10.1007/s12013-016-0742-9; Anwar S, 2014, INT J BIOL MACROMOL, V69, P476, DOI 10.1016/j.ijbiomac.2014.06.003; Baan R, 2007, LANCET ONCOL, V8, P292, DOI 10.1016/S1470-2045(07)70099-2; Baig U, 2016, INT J POLYM MAT POLY; Baig U, 2016, J PHOTOCH PHOTOBIO B, V164, P244, DOI 10.1016/j.jphotobiol.2016.09.034; Balbo S, 2012, MUTAGENESIS, V27, P485, DOI 10.1093/mutage/ges008; Boddupalli Sekhar, 2012, Frontiers in Genetics, V3, P7, DOI 10.3389/fgene.2012.00007; Brooks PJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000050; Chamani J, 2010, J LUMIN, V130, P1160, DOI 10.1016/j.jlumin.2010.02.014; Chamani J, 2011, J PHARMACEUT BIOMED, V55, P114, DOI 10.1016/j.jpba.2010.12.029; Chaturvedi SK, 2015, MOL BIOSYST, V11, P307, DOI 10.1039/c4mb00548a; Chen CH, 2015, P NATL ACAD SCI USA, V112, P3074, DOI 10.1073/pnas.1414657112; Chen CH, 2014, PHYSIOL REV, V94, P1, DOI 10.1152/physrev.00017.2013; Crabb DW, 2004, P NUTR SOC, V63, P49, DOI 10.1079/PNS2003327; Druesne-Pecollo N, 2009, LANCET ONCOL, V10, P173, DOI 10.1016/S1470-2045(09)70019-1; Elbarbry F, 2011, J MED PLANTS RES, V5, P473; Eng MY, 2007, ALCOHOL RES HEALTH, V30, P22; Fahey JW, 2012, CANCER PREV RES, V5, P179, DOI 10.1158/1940-6207.CAPR-11-0572; Giebultowicz J, 2009, MOLECULES, V14, P2363, DOI 10.3390/molecules14072363; Giebuttowicz J, 2010, ACTA BIOCHIM POL, V57, P361; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Helminen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074418; Hempel J, 2001, EUR J BIOCHEM, V268, P722, DOI 10.1046/j.1432-1327.2001.01926.x; Herr I, 2013, WIEN MED WOCHENSCHR, V163, P80, DOI 10.1007/s10354-012-0163-3; IMPRAIM C, 1982, AM J HUM GENET, V34, P837; Kabiri M, 2012, MOLECULES, V17, P3114, DOI 10.3390/molecules17033114; LAKOWICZ JR, 1973, BIOCHEMISTRY-US, V12, P4171, DOI 10.1021/bi00745a021; Laskar AA, 2016, BIOCHIMIE, V127, P205, DOI 10.1016/j.biochi.2016.05.020; Li DW, 2012, HUM GENET, V131, P725, DOI 10.1007/s00439-011-1116-4; Manchali S, 2012, J FUNCT FOODS, V4, P94, DOI 10.1016/j.jff.2011.08.004; Moazzez R, 2011, EUR J ORAL SCI, V119, P441, DOI 10.1111/j.1600-0722.2011.00886.x; Moosavi-Movahedi AA, 2003, J PROTEIN CHEM, V22, P23, DOI 10.1023/A:1023011609931; Moosavi-Movahedi AA, 2003, BIOORGAN MED CHEM, V11, P4303, DOI 10.1016/S0968-0896(03)00524-8; Nienhaus Karin, 2005, V305, P215; Oze I, 2011, JPN J CLIN ONCOL, V41, P677, DOI 10.1093/jjco/hyr026; Pelucchi C, 2008, EUR J CANCER PREV, V17, P340, DOI 10.1097/CEJ.0b013e3282f75e91; Perez-Miller S, 2010, NAT STRUCT MOL BIOL, V17, P159, DOI 10.1038/nsmb.1737; Riedl MA, 2009, CLIN IMMUNOL, V130, P244, DOI 10.1016/j.clim.2008.10.007; Sasaki K, 2012, J CHROMATOGR B, V903, P171, DOI 10.1016/j.jchromb.2012.07.017; Shakir M, 2016, J PHOTOCH PHOTOBIO B, V165, P96, DOI 10.1016/j.jphotobiol.2016.10.006; Sladek NE, 2003, J BIOCHEM MOL TOXIC, V17, P7, DOI 10.1002/jbt.10057; Sreerama L, 1995, CLIN CANCER RES, V1, P1153; Talalay P, 1995, TOXICOL LETT, V82-3, P173, DOI 10.1016/0378-4274(95)03553-2; Tang B, 2016, FOOD CHEM, V212, P434, DOI 10.1016/j.foodchem.2016.06.007; Ushida Y, 2013, ALCOHOL ALCOHOLISM, V48, P526, DOI 10.1093/alcalc/agt063; Vahedian-Movahed H, 2011, J BIOMOL STRUCT DYN, V28, P483, DOI 10.1080/07391102.2011.10508590; Vasiliou V, 2000, PHARMACOLOGY, V61, P192, DOI 10.1159/000028400; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wierzchowski J, 1997, ANAL BIOCHEM, V245, P69, DOI 10.1006/abio.1996.9921; Yokoyama A, 1998, CARCINOGENESIS, V19, P1383, DOI 10.1093/carcin/19.8.1383; Yokoyama A, 2002, CARCINOGENESIS, V23, P1851, DOI 10.1093/carcin/23.11.1851; Yoshida A, 1998, EUR J BIOCHEM, V251, P549, DOI 10.1046/j.1432-1327.1998.2510549.x; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; Ziyarat FP, 2014, J BIOMOL STRUCT DYN, V32, P613, DOI 10.1080/07391102.2013.785919	55	20	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168463	10.1371/journal.pone.0168463	http://dx.doi.org/10.1371/journal.pone.0168463			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997560	Green Submitted, gold, Green Published			2022-12-26	WOS:000392842900048
J	Antonissen, G; Haesendonck, R; Devreese, M; Broekaert, N; Verbrugghe, E; De Saeger, S; Audenaert, K; Haesebrouck, F; Pasmans, F; Ducatelle, R; Croubels, S; Martel, A				Antonissen, Gunther; Haesendonck, Roel; Devreese, Mathias; Broekaert, Nathan; Verbrugghe, Elin; De Saeger, Sarah; Audenaert, Kris; Haesebrouck, Freddy; Pasmans, Frank; Ducatelle, Richard; Croubels, Siska; Martel, An			The Impact of Deoxynivalenol on Pigeon Health: Occurrence in Feed, Toxicokinetics and Interaction with Salmonellosis	PLOS ONE			English	Article							T-2 TOXIN; ORAL BIOAVAILABILITY; MYCOTOXINS; TYPHIMURIUM; TOXICITY; FOOD; FUMONISINS; RESISTANCE; TOXICOLOGY; INFECTION	Seed-based pigeon diets could be expected to result in exposure of pigeons to mycotoxins such as deoxynivalenol (DON). Ingestion of low to moderate contamination levels of DON may impair intestinal health, immune function and/or pathogen fitness, resulting in altered host-pathogen interactions and thus different outcome of infections. Here we demonstrate that DON was one of the most frequently detected mycotoxins in seed-based racing pigeons feed, contaminating 5 out of 10 samples (range 177-1,466 mu g/kg). Subsequently, a toxicokinetic analysis revealed a low absolute oral bioavailability (F) of DON in pigeons (30.4%), which is comparable to other avian species. Furthermore, semi-quantitative analysis using high-resolution mass spectrometry revealed that DON-3 alpha-sulphate is the major metabolite of DON in pigeons after intravenous as well as oral administration. Following ingestion of DON contaminated feed, the intestinal epithelial cells are exposed to significant DON concentrations which eventually may affect intestinal translocation and colonization of bacteria. Feeding pigeons a DON contaminated diet resulted in an increased percentage of pigeons shedding Salmonella compared to birds fed control diet, 87 +/- 17% versus 74 +/- 13%, respectively. However, no impact of DON was observed on the Salmonella induced disease signs, organ lesions, faecal and organ Salmonella counts. The presented risk assessment indicates that pigeons are frequently exposed to mycotoxins such as DON, which can affect the outcome of a Salmonella infection. The increasing number of pigeons shedding Salmonella suggests that DON can promote the spread of the bacterium within pigeon populations.	[Antonissen, Gunther; Devreese, Mathias; Broekaert, Nathan; Croubels, Siska] Univ Ghent, Fac Vet Med, Dept Pharmacol Toxicol & Biochem, Merelbeke, Belgium; [Antonissen, Gunther; Haesendonck, Roel; Verbrugghe, Elin; Haesebrouck, Freddy; Pasmans, Frank; Ducatelle, Richard; Martel, An] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium; [De Saeger, Sarah] Univ Ghent, Fac Pharmaceut Sci, Dept Bioanal, Ghent, Belgium; [Audenaert, Kris] Univ Ghent, Fac Biosci Engn, Dept Appl Biosci, Ghent, Belgium	Ghent University; Ghent University; Ghent University; Ghent University	Antonissen, G (corresponding author), Univ Ghent, Fac Vet Med, Dept Pharmacol Toxicol & Biochem, Merelbeke, Belgium.; Antonissen, G (corresponding author), Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium.	Gunther.Antonissen@UGent.be	Haesebrouck, Freddy/M-3857-2014; Pasmans, Frank/D-3667-2014	Haesebrouck, Freddy/0000-0002-1709-933X; Croubels, Siska/0000-0001-6357-3517; Antonissen, Gunther/0000-0001-8832-1498	Biomin GmbH (Herzogenburg, Austria); Special Research Fund of Ghent University, Belgium (BOF) [01D20312]	Biomin GmbH (Herzogenburg, Austria); Special Research Fund of Ghent University, Belgium (BOF)	G. Antonissen is supported by a postdoctoral fellowship from Biomin GmbH (Herzogenburg, Austria). R. Haesendonck is supported by the Special Research Fund of Ghent University, Belgium (BOF Grant 01D20312). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alassane-Kpembi I, 2013, TOXICOL APPL PHARM, V272, P191, DOI 10.1016/j.taap.2013.05.023; Alexander J, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2407; Antonissen G, 2015, J AGR FOOD CHEM, V63, P10846, DOI 10.1021/acs.jafc.5b04119; Antonissen G, 2015, VET RES, V46, DOI 10.1186/s13567-015-0234-8; Antonissen G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108775; Antonissen G, 2014, TOXINS, V6, P430, DOI 10.3390/toxins6020430; Bottalico A., 1998, Journal of Plant Pathology, V80, P85; Bouhet S, 2005, VET IMMUNOL IMMUNOP, V108, P199, DOI 10.1016/j.vetimm.2005.08.010; Broekaert N, 2014, J CHROMATOGR B, V971, P43, DOI 10.1016/j.jchromb.2014.09.012; Broekaert N, 2015, J AGR FOOD CHEM, V63, P8734, DOI 10.1021/acs.jafc.5b03270; Burel C, 2013, TOXINS, V5, P841, DOI 10.3390/toxins5040841; Clarke R, 2014, TOXICON, V90, P70, DOI 10.1016/j.toxicon.2014.07.019; CUNDLIFFE E, 1974, P NATL ACAD SCI USA, V71, P30, DOI 10.1073/pnas.71.1.30; Devreese M, 2015, WORLD MYCOTOXIN J, V8, P533, DOI 10.3920/WMJ2014.1843; FADDOUL GP, 1965, AVIAN DIS, V9, P377, DOI 10.2307/1588367; Maresca M, 2013, TOXINS, V5, P784, DOI 10.3390/toxins5040784; Monbaliu S, 2010, J AGR FOOD CHEM, V58, P66, DOI 10.1021/jf903859z; Osselaere A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069014; Osselaere A, 2013, FOOD CHEM TOXICOL, V51, P350, DOI 10.1016/j.fct.2012.10.006; Ostry V, 2008, WORLD MYCOTOXIN J, V1, P175, DOI 10.3920/WMJ2008.x013; Oswald IP, 2005, FOOD ADDIT CONTAM A, V22, P354, DOI 10.1080/02652030500058320; Pasmans F, 2003, INFECT IMMUN, V71, P6068, DOI 10.1128/IAI.71.10.6068-6074.2003; Pasmans F, 2008, ANTIMICROB AGENTS CH, V52, P954, DOI 10.1128/AAC.00575-07; Pestka JJ, 2007, ANIM FEED SCI TECH, V137, P283, DOI 10.1016/j.anifeedsci.2007.06.006; Pestka JJ, 2005, J TOXICOL ENV HEAL B, V8, P39, DOI 10.1080/10937400590889458; Rotter BA, 1996, J TOXICOL ENV HEALTH, V48, P1, DOI 10.1080/009841096161447; Schatzmayr G, 2013, WORLD MYCOTOXIN J, V6, P213, DOI 10.3920/WMJ2013.1572; Streit E, 2013, J SCI FOOD AGR, V93, P2892, DOI 10.1002/jsfa.6225; Streit E, 2012, TOXINS, V4, P788, DOI 10.3390/toxins4100788; TAI JH, 1990, MYCOPATHOLOGIA, V109, P149, DOI 10.1007/BF00436803; TAI JH, 1988, FOOD CHEM TOXICOL, V26, P691, DOI 10.1016/0278-6915(88)90068-3; THOMPSON WL, 1986, TOXICON, V24, P985, DOI 10.1016/0041-0101(86)90004-8; Vandenbroucke V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023871; Vandenbroucke V, 2009, VET RES, V40, DOI 10.1051/vetres/2009045; Verbrugghe E, 2012, VET RES, V43, P1; VIDAL D, 1989, INFECT IMMUN, V57, P2260, DOI 10.1128/IAI.57.7.2260-2264.1989; Wan D, 2014, J AGR FOOD CHEM, V62, P288, DOI 10.1021/jf4047946; Widestrand J, 2001, FOOD ADDIT CONTAM, V18, P987, DOI 10.1080/02652030110050168; Wu F, 2014, ANNU REV FOOD SCI T, V5, P351, DOI 10.1146/annurev-food-030713-092431; ZIPRIN RL, 1990, AM J VET RES, V51, P1869	40	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168205	10.1371/journal.pone.0168205	http://dx.doi.org/10.1371/journal.pone.0168205			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997572	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842900026
J	Boer, S; Unal, S; van Wouwe, JP; van Dommelen, P				Boer, Suzanne; Unal, Sevim; van Wouwe, Jacobus P.; van Dommelen, Paula			Evidence Based Weighing Policy during the First Week to Prevent Neonatal Hypernatremic Dehydration while Breastfeeding	PLOS ONE			English	Article							FED INFANTS	Background Neonatal hypernatremic dehydration is prevented by daily neonatal weight monitoring. We aim to provide evidence-based support of this universally promoted weighing policy and to establish the most crucial days of weighing. Methods Weight measurements of 2,359 healthy newborns and of 271 newborns with clinical hypernatremic dehydration were used within the first seven days of life to simulate various weighting policies to prevent hypernatremic dehydration; its sensitivity, specificity and positive predictive value (PPV) of these policies were calculated. Various referral criteria were also evaluated. Results A policy of daily weighing with a cut-off value of -2.5 Standard Deviation Score (SDS) on the growth chart for weight loss, had a 97.6% sensitivity, 97.6% specificity and a PPV of 2.80%. Weighing at birth and only at days two, four and seven with the same -2.5 SDS cut-off, resulted in 97.3% sensitivity, 98.5% specificity and a PPV of 4.43%. Conclusion A weighing policy with measurements restricted to birth and day two, four and seven applying the -2.5 SDS cut-off seems an optimal policy to detect hypernatremic dehydration. Therefore we recommend to preferably weigh newborns at least on day two (i.e. -48h), four and seven, and refer them to clinical pediatric care if their weight loss increases below -2.5 SDS. We also suggest lactation support for the mother, full clinical assessment of the infant and weighing again the following day in all newborns reaching a weight loss below -2.0 SDS.	[Boer, Suzanne; van Dommelen, Paula] Netherlands Org Appl Sci Res TNO, Dept Life Style, Leiden, Netherlands; [Unal, Sevim] Ankara Childrens Hematol & Oncol Res Hosp, Neonatal Intens Care Unit, Ankara, Turkey; [van Wouwe, Jacobus P.] Netherlands Org Appl Sci Res TNO, Dept Child Hlth, Leiden, Netherlands	Netherlands Organization Applied Science Research; Ankara Children's Hematology Oncology Training & Research Hospital; Netherlands Organization Applied Science Research	van Wouwe, JP (corresponding author), Netherlands Org Appl Sci Res TNO, Dept Child Hlth, Leiden, Netherlands.	ko.vanwouwe@tno.nl	unal, sevim/G-4468-2014; Van Wouwe, Jacobus P/D-5549-2018	unal, sevim/0000-0002-7863-1924; Van Wouwe, Jacobus P/0000-0001-9273-6258				[Anonymous], 2016, LANCET, V387, P404, DOI DOI 10.1016/50140-6736(16)00210-5; Boskabadi H, 2010, ASIA PAC J CLIN NUTR, V19, P301; Breuning-Boers J M, 2006, Ned Tijdschr Geneeskd, V150, P904; Britton C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001141.pub3; Chantry CJ, 2011, PEDIATRICS, V127, pE171, DOI 10.1542/peds.2009-2663; Cole TJ, 1998, STAT MED, V17, P2697, DOI 10.1002/(SICI)1097-0258(19981215)17:23<2697::AID-SIM36>3.3.CO;2-F; Iyer NP, 2008, ARCH DIS CHILD, V93, P297, DOI 10.1136/adc.2006.108415; Konetzny G, 2009, EUR J PEDIATR, V168, P815, DOI 10.1007/s00431-008-0841-8; Livingstone V, 1995, World Rev Nutr Diet, V78, P28; Livingstone VH, 2000, CAN MED ASSOC J, V162, P647; Manganaro R, 2001, J PEDIATR-US, V139, P673, DOI 10.1067/mpd.2001.118880; Oddie S, 2001, ARCH DIS CHILD, V85, P318, DOI 10.1136/adc.85.4.318; Pelleboer RAA, 2009, ACTA PAEDIATR, V98, P807, DOI 10.1111/j.1651-2227.2009.01230.x; Rollins NC, 2016, LANCET, V387, P491, DOI 10.1016/S0140-6736(15)01044-2; Unal S, 2008, PEDIATR INT, V50, P29, DOI 10.1111/j.1442-200X.2007.02507.x; van Dommelen P, 2014, STAT METHODS MED RES, V23, P369, DOI 10.1177/0962280212473301; van Dommelen P, 2014, BIRTH-ISS PERINAT C, V41, P153, DOI 10.1111/birt.12105; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7	18	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0167313	10.1371/journal.pone.0167313	http://dx.doi.org/10.1371/journal.pone.0167313			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997557	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842900006
J	Sachindra, DA; Perera, BJC				Sachindra, D. A.; Perera, B. J. C.			Statistical Downscaling of General Circulation Model Outputs to Precipitation Accounting for Non-Stationarities in Predictor-Predictand Relationships	PLOS ONE			English	Article							CLIMATE-CHANGE; SUPPORT VECTOR; NONSTATIONARY; TEMPERATURE; EVAPORATION; REGRESSION; SCENARIOS; IMPACT	This paper presents a novel approach to incorporate the non-stationarities characterised in the GCM outputs, into the Predictor-Predictand Relationships (PPRs) in statistical down scaling models. In this approach, a series of 42 PPRs based on multi-linear regression (MLR) technique were determined for each calendar month using a 20-year moving window moved at a 1-year time step on the predictor data obtained from the NCEP/NCAR reanalysis data archive and observations of precipitation at 3 stations located in Victoria, Australia, for the period 1950-2010. Then the relationships between the constants and coefficients in the PPRs and the statistics of reanalysis data of predictors were determined for the period 1950-2010, for each calendar month. Thereafter, using these relationships with the statistics of the past data of HadCM3 GCM pertaining to the predictors, new PPRs were derived for the periods 1950-69,1970-89 and 1990-99 for each station. This process yielded a non-stationary downscaling model consisting of a PPR per calendar month for each of the above three periods for each station. The non-stationarities in the climate are characterised by the long-term changes in the statistics of the climate variables and above process enabled relating the non-stationarities in the climate to the PPRs. These new PPRs were then used with the past data of HadCM3, to reproduce the observed precipitation. It was found that the non-stationary MLR based downscaling model was able to produce more accurate simulations of observed precipitation more often than conventional stationary downscaling models developed with MLR and Genetic Programming (GP).	[Sachindra, D. A.; Perera, B. J. C.] Victoria Univ, Coll Engn & Sci, Inst Sustainabil & Innovat, Melbourne, Vic, Australia	Victoria University	Sachindra, DA (corresponding author), Victoria Univ, Coll Engn & Sci, Inst Sustainabil & Innovat, Melbourne, Vic, Australia.	sachindra.dhanapalaarachchige@vu.edu.au	Arachchige, Sachindra Dhanapala/AAB-1926-2019; Perera, Chris/J-7130-2019	Dhanapala Arachchige, Sachindra/0000-0002-4022-0636	Victoria University, Australia	Victoria University, Australia	The authors wish to acknowledge the financial assistance provided by the Victoria University, Australia (https://www.vu.edu.au/) for this project.	Anandhi A, 2008, INT J CLIMATOL, V28, P401, DOI 10.1002/joc.1529; Benestad RE, 2008, EMPIRICAL STAT DOWNS, DOI 10.1142/6908; Beuchat X, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016449; Duan J., 2012, BRIT HYDR SOC 11 NAT; Fowler HJ, 2007, INT J CLIMATOL, V27, P1547, DOI 10.1002/joc.1556; Hertig E, 2013, J GEOPHYS RES-ATMOS, V118, P520, DOI 10.1002/jgrd.50112; Iizumi T, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD014513; Jeffrey SJ, 2001, ENVIRON MODELL SOFTW, V16, P309, DOI 10.1016/S1364-8152(01)00008-1; Johnson F, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR010464; Koza JR, 1992, GENETIC PROGRAMMING; Maurer EP, 2008, HYDROL EARTH SYST SC, V12, P551; Prudhomme C, 2010, J HYDROL, V390, P198, DOI 10.1016/j.jhydrol.2010.06.043; Raje D, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008425; Rashid MM, 2016, THEOR APPL CLIMATOL, V124, P919, DOI 10.1007/s00704-015-1465-3; Rummukainen M, 2010, WIRES CLIM CHANGE, V1, P82, DOI 10.1002/wcc.8; Russo R., 2003, STAT BEHAV SCI INTRO; Sachindra DA, 2015, J WATER CLIM CHANGE, V6, P241, DOI 10.2166/wcc.2014.145; Sachindra DA, 2014, J WATER CLIM CHANGE, V5, P496, DOI 10.2166/wcc.2014.056; Sachindra DA, 2014, INT J CLIMATOL, V34, P3264, DOI 10.1002/joc.3914; Sachindra DA, 2014, INT J CLIMATOL, V34, P3282, DOI 10.1002/joc.3915; Sachindra DA, 2014, Q J ROY METEOR SOC, V140, P1161, DOI 10.1002/qj.2205; Sachindra DA, 2013, INT J CLIMATOL, V33, P1087, DOI 10.1002/joc.3493; Schmith T, 2008, J CLIMATE, V21, P4529, DOI 10.1175/2008JCLI1910.1; Smith I, 2010, CLIMATIC CHANGE, V102, P377, DOI 10.1007/s10584-009-9757-1; Tisseuil C, 2010, J HYDROL, V385, P279, DOI 10.1016/j.jhydrol.2010.02.030; Tofiq FA, 2014, J HYDROL, V517, P1145, DOI 10.1016/j.jhydrol.2014.06.028; Vrac M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030295; Wilby RL, 1997, INT J CLIMATOL, V17, P439, DOI 10.1002/(SICI)1097-0088(19970330)17:4<439::AID-JOC145>3.0.CO;2-U; Yang T, 2012, HYDROL PROCESS, V26, P3510, DOI 10.1002/hyp.8427; Zhang XC, 2013, INT J CLIMATOL, V33, P326, DOI 10.1002/joc.3425	30	19	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168701	10.1371/journal.pone.0168701	http://dx.doi.org/10.1371/journal.pone.0168701			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997609	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000392842900070
J	Wu, X; Li, YX; Fu, JJ; Li, X; Li, CH; Zhang, DF; Shi, YS; Song, YC; Li, Y; Wang, TY				Wu, Xun; Li, Yongxiang; Fu, Junjie; Li, Xin; Li, Chunhui; Zhang, Dengfeng; Shi, Yunsu; Song, Yanchun; Li, Yu; Wang, Tianyu			Exploring Identity-By-Descent Segments and Putative Functions Using Different Foundation Parents in Maize	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; POPULATION-STRUCTURE; INBRED LINES; GENETIC-CHARACTERIZATION; LINKAGE DISEQUILIBRIUM; ASSOCIATION; DIVERSITY; ADAPTATION; POLYMORPHISMS; ENVIRONMENT	Maize foundation parents (FPs) play no-alternative roles in hybrid breeding because they were widely used in the development of new lines and hybrids. The combination of different identity-by-descent (IBD) segments and genes could account for the formation patterns of different FPs, and knowledge of these IBD regions would provide an extensive foundation for the development of new candidate FP lines in future maize breeding. In this paper, a panel of 304 elite lines derived from FPs, i.e., B73, 207, Mo17, and Huangzaosi (HZS), was collected and analyzed using 43,252 single nucleotide polymorphism (SNP) markers. Most IBD segments specific to particular FP groups were identified, including 116 IBD segments in B73, 105 in Mo17, 111 in 207, and 190 in HZS. In these regions, 423 quantitative trait nucleotides (QTNs) associated with 15 agronomic traits and 804 candidate genes were identified. Some known adaptation-related genes, e.g., dwarf8 and vgtl in HZS, zcn8 and epc in Mo17, and ZmCCT in 207, were validated as being tightly linked to particular IBD segments. In addition, numerous new candidate genes were also identified. For example, GRMZM2G154278 in HZS, which belongs to the cell cycle control family, was closely linked to a QTN of the ear height/plant height (EH/PH) trait; GRMZM2G051943 in 207, which encodes an endochitinase precursor (EP) chitinase, was closely linked to a QTN for kernel density; and GRMZM2G170586 in Mo17 was closely linked to a QTN for ear diameter. Complex correlations among these genes were also found. Many IBD segments and genes were included in the formation of FP lines, and complex regulatory networks exist among them. These results provide new insights on the genetic basis of complex traits and provide new candidate IBD regions or genes for the improvement of special traits in maize production.	[Wu, Xun; Li, Yongxiang; Fu, Junjie; Li, Xin; Li, Chunhui; Zhang, Dengfeng; Shi, Yunsu; Song, Yanchun; Li, Yu; Wang, Tianyu] Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China; [Wu, Xun] Guizhou Inst Upland Food Crops, Guiyang, Guizhou, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Li, Y; Wang, TY (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China.	yuli@mail.caas.net.cn; wangtianyu@caas.cn	li, yong/HDN-3885-2022; li, yongxiang/GPW-6930-2022	Fu, Junjie/0000-0002-4702-2392	Ministry of Science and Technology of China [2016YFD0100303, 2016YFD0100103, 2014CB138200, 2013BAD01B02]; National Natural Science Foundation [91335206]; CAAS Innovation Program; China Postdoctoral Sciences Foundation [2014M550901]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); CAAS Innovation Program; China Postdoctoral Sciences Foundation(China Postdoctoral Science Foundation)	This research was supported by the Ministry of Science and Technology of China (2016YFD0100303, 2016YFD0100103, 2014CB138200, 2013BAD01B02), the National Natural Science Foundation (91335206), the CAAS Innovation Program, and the China Postdoctoral Sciences Foundation (2014M550901).	Beyene Y, 2015, CROP SCI, V55, P154, DOI 10.2135/cropsci2014.07.0460; Bouchet S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071377; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brown PJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002383; Browning SR, 2012, GENETICS, V190, P1521, DOI 10.1534/genetics.111.136937; Browning SR, 2010, AM J HUM GENET, V86, P526, DOI 10.1016/j.ajhg.2010.02.021; Ducrocq S, 2008, GENETICS, V178, P2433, DOI 10.1534/genetics.107.084830; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Hung HY, 2012, P NATL ACAD SCI USA, V109, pE1913, DOI 10.1073/pnas.1203189109; Jiao YP, 2012, NAT GENET, V44, P812, DOI 10.1038/ng.2312; Kim EJ, 2012, GENES GENOM, V34, P529, DOI 10.1007/s13258-012-0074-0; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Legesse BW, 2007, HEREDITAS, V144, P10, DOI 10.1111/j.2006.0018-0661.01921.x; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; [黎裕 Li Yu], 2010, [玉米科学, Maize Science], V18, P1; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Liu CL, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0344-z; Liu HJ, 2015, MOL PLANT, V8, P871, DOI 10.1016/j.molp.2015.01.016; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Lu YL, 2009, THEOR APPL GENET, V120, P93, DOI 10.1007/s00122-009-1162-7; Mikel MA, 2006, CROP SCI, V46, P1193, DOI 10.2135/cropsci2005.10-0371; Passarinho PA, 2001, PLANTA, V212, P556, DOI 10.1007/s004250000464; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Peng B, 2011, THEOR APPL GENET, V122, P1305, DOI 10.1007/s00122-011-1532-9; Pritchard JK, 2000, GENETICS, V155, P945; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Schaefer CM, 2013, CROP SCI, V53, P1529, DOI 10.2135/cropsci2012.11.0632; Schnable JC, 2012, GENOME BIOL EVOL, V4, P265, DOI 10.1093/gbe/evs009; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith JSC, 2004, CROP SCI, V44, P1935, DOI 10.2135/cropsci2004.1935; Smith S, 2007, CROP SCI, V47, P1914, DOI 10.2135/cropsci2006.12.0763; Stevens EL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002287; Teng F, 2013, PLANT J, V73, P405, DOI 10.1111/tpj.12038; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Troyer AF, 2007, CROP SCI, V47, P905, DOI 10.2135/cropsci2006.10.0651; van Heerwaarden J, 2012, P NATL ACAD SCI USA, V109, P12420, DOI 10.1073/pnas.1209275109; Vega SH, 2002, PLANT CELL, V14, P133, DOI 10.1105/tpc.010406; Wang RH, 2008, THEOR APPL GENET, V117, P1141, DOI 10.1007/s00122-008-0852-x; Wang TY, 2011, CROP SCI, V51, P512, DOI 10.2135/cropsci2010.06.0383; Westerlind H, 2015, EUR J HUM GENET, V23, P688, DOI 10.1038/ejhg.2014.155; Wu X, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0646-7; Wu X, 2014, THEOR APPL GENET, V127, P621, DOI 10.1007/s00122-013-2246-y; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; Yang N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004573; Yang XH, 2011, MOL BREEDING, V28, P511, DOI 10.1007/s11032-010-9500-7; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Yu YT, 2014, GENET MOL RES, V13, P3069, DOI 10.4238/2014.April.17.3; Zambrano JL, 2014, MOL BREEDING, V34, P989, DOI 10.1007/s11032-014-0091-6	50	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168374	10.1371/journal.pone.0168374	http://dx.doi.org/10.1371/journal.pone.0168374			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997600	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842900038
J	Embaby, AM; Melika, RR; Hussein, A; El-Kamel, AH; Marey, HS				Embaby, Amira M.; Melika, Ramy R.; Hussein, Ahmed; El-Kamel, Amal H.; Marey, Heba S.			A Novel Non-Cumbersome Approach Towards Biosynthesis of Pectic-Oligosaccharides by Non-Aflatoxigenic Aspergillus sp Section Flavi Strain EGY1 DSM 101520 through Citrus Pectin Fermentation	PLOS ONE			English	Article							PREBIOTIC PROPERTIES; POLYGALACTURONASE; ENZYME; HEALTH	Pectic-Oligosaccharides (POS) have a growing potential in food and feed industries. To satisfy the demand of worldwide markets from POS and avoid the shortcomings of currently applied methodologies encountered in their preparation, the present study highlights a novel robust approach for POS biosynthesis. In the current approach, Aspergillus sp.section Flavi strain EGY1 DSM 101520 was grown on citrus pectin-based medium as a core POS production medium. POS' levels accumulated in the fungal fermentation broth were optimized through a three step sequential statistical mathematical methodology; Plackett-Burman design (PBD), Box-Behnken design (BBD) and canonical analysis. Three key determinants namely citrus pectin, peptone and NaH2PO4 were pointed out by PBD to impose significant consequences (P<0.05) on the process outcome (POS' levels). Optimal levels of these key determinants along with maximal of POS' levels were set by BBD and canonical analysis to be 2.28% (w/v) citrus pectin, 0.026% (w/v) peptone and 0.28% (w/v) NaH2PO4 to achieve a net amount of 1.3 g POS /2.28 g citrus pectin. Through this approach, a yield of 57% (w/w) POS of the total citrus pectin was obtained after 24 h of fungal growth on optimized citrus pectin based medium. A fold enhancement of 13 times in POS' levels released in the fermentation fungal broth was realized by the end of the optimization strategy. This novel robust approach is considered a new insight towards POS biosynthesis via efficient, rapid and non-cumbersome procedure. To the best of authors' knowledge, the present work is the first article underlining detailed POS production from the fermentation broth of a fungus growing on citrus pectin-based medium.	[Embaby, Amira M.; Melika, Ramy R.; Hussein, Ahmed] Univ Alexandria, Inst Grad Studies & Res, Dept Biotechnol, Alexandria, Egypt; [Hussein, Ahmed] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX USA; [El-Kamel, Amal H.] Univ Alexandria, Fac Pharm, Dept Pharmaceut, Alexandria, Egypt; [Marey, Heba S.] Univ Alexandria, Inst Grad Studies & Res, Dept Environm Studies, Alexandria, Egypt; [Marey, Heba S.] Univ Alberta, Dept Civil & Environm Engn, Edmonton, AB, Canada	Egyptian Knowledge Bank (EKB); Alexandria University; Texas Tech University System; Texas Tech University; Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Alexandria University; University of Alberta	Embaby, AM (corresponding author), Univ Alexandria, Inst Grad Studies & Res, Dept Biotechnol, Alexandria, Egypt.	Amira.Embaby@alexu.edu.eg	Embaby, Amira M./AAD-5080-2021	Elkamel, Amal/0000-0001-8773-5365; Hussein, Ahmed/0000-0002-6887-2927; Embaby, Amira/0000-0001-8068-4200				[Anonymous], 2001, COMPENDIUM METHODS M; Babbar N, 2016, CRIT REV BIOTECHNOL, V36, P594, DOI 10.3109/07388551.2014.996732; Box G. E., 1960, TECHNOMETRICS, V2, P455, DOI [10.2307/1266454, DOI 10.2307/1266454, 10.1080/00401706.1960.10489912, DOI 10.1080/00401706.1960.10489912]; Chen J, 2013, CARBOHYD POLYM, V91, P175, DOI 10.1016/j.carbpol.2012.08.021; Combo AMM, 2013, INT J BIOL MACROMOL, V52, P148, DOI 10.1016/j.ijbiomac.2012.09.006; Dagnino EO, 2009, 2 JORN INV ING NEA P; Demir H, 2016, J SCI FOOD AGR, V96, P3575, DOI 10.1002/jsfa.7543; Dung VK, 2015, TAP CHI SINH HOC, V37; Embaby AM, 2015, J BIOPROCESS BIOTECH, V5, P231, DOI DOI 10.4172/2155-9821.1000231; Embaby Amira M, 2014, ScientificWorldJournal, V2014, P396304, DOI 10.1155/2014/396304; Embaby AM, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-327; Gomez B, 2014, J CHEM TECHNOL BIOTE; Gomez B, 2014, J AGR FOOD CHEM, V62, P9769, DOI 10.1021/jf503475b; Gullon B, 2013, TRENDS FOOD SCI TECH, V30, P153, DOI 10.1016/j.tifs.2013.01.006; Hadj-Taieb N, 2011, APPL BIOCHEM BIOTECH, V165, P1652, DOI 10.1007/s12010-011-9384-y; Holck J, 2011, PROCESS BIOCHEM, V46, P1039, DOI 10.1016/j.procbio.2011.01.013; Irshad M, 2014, NAT PROD COMMUN, V9, P1649; Kuhnel S, 2010, BIORESOURCE TECHNOL, V101, P8300, DOI 10.1016/j.biortech.2010.05.070; Lama-Munoz A, 2012, FOOD HYDROCOLLOID, V28, P92, DOI 10.1016/j.foodhyd.2011.11.008; Leijdekkers AGM, 2013, BIORESOURCE TECHNOL, V128, P518, DOI 10.1016/j.biortech.2012.10.126; Maller Alexandre, 2011, Enzyme Res, V2011, P289206, DOI 10.4061/2011/289206; Manderson K, 2005, APPL ENVIRON MICROB, V71, P8383, DOI 10.1128/AEM.71.12.8383-8389.2005; Martin N, 2010, Mikrobiologiia, V79, P321; Martinez M, 2010, IND ENG CHEM RES, V49, P8470, DOI 10.1021/ie101066m; Martinez M, 2009, IND ENG CHEM RES, V48, P4681, DOI 10.1021/ie8017753; Mata-Gomez MA, 2015, J SCI FOOD AGR, V95, P1554, DOI 10.1002/jsfa.6864; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mohamed SA, 2013, J MICROBIOL, V51, P605, DOI 10.1007/s12275-013-3016-x; Monteiro AC., 2009, OPEN BIOTECHNOL J, V3, P9, DOI [10.2174/1874070700903010009, DOI 10.2174/1874070700903010009]; Myers R.H., 1976, RESPONSE SURFACE MET; Olano-Martin E, 2003, ANTICANCER RES, V23, P341; Olano-Martin E, 2001, J FOOD SCI, V66, P966, DOI 10.1111/j.1365-2621.2001.tb08220.x; Pedrolli D.B., 2014, ENZYME RES, V2014, P1, DOI DOI 10.1155/2014/353915; PLACKETT RL, 1946, BIOMETRIKA 4, V33, P305, DOI DOI 10.1093/BIOMET/33.4.305; Rastall RA, 2005, FEMS MICROBIOL ECOL, V52, P145, DOI 10.1016/j.femsec.2005.01.003; Reda A. B., 2008, Journal of Applied Sciences Research, P1708; Rehman HU, 2012, CARBOHYD POLYM, V90, P387, DOI 10.1016/j.carbpol.2012.05.055; Sohail M, 2016, JUNDISHAPUR J MICROB, V9, DOI 10.5812/jjm.28594; Tamburini E, 2003, ENVIRON MICROBIOL, V5, P730, DOI 10.1046/j.1462-2920.2003.00462.x; Tepe O, 2014, ENVIRON SCI POLLUT R, V21, P9911, DOI 10.1007/s11356-014-2833-8; Xu SX, 2015, LETT APPL MICROBIOL, V60, P181, DOI 10.1111/lam.12357; Zhu L., 2005, THESIS	42	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0167981	10.1371/journal.pone.0167981	http://dx.doi.org/10.1371/journal.pone.0167981			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992459	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842600027
J	Fargier, R; Laganaro, M				Fargier, Raphael; Laganaro, Marina			Neurophysiological Modulations of Non Verbal and Verbal Dual-Tasks Interference during Word Planning	PLOS ONE			English	Article							TIME-COURSE; CHRONOMETRIC EVIDENCE; VISUAL COMPLEXITY; IMAGE VARIABILITY; NAMING OBJECTS; LEXICAL ACCESS; NAME AGREEMENT; FRENCH; FAMILIARITY; ACTIVATION	Running a concurrent task while speaking clearly interferes with speech planning, but whether verbal vs. non-verbal tasks interfere with the same processes is virtually unknown. We investigated the neural dynamics of dual-task interference on word production using event-related potentials (ERPs) with either tones or syllables as concurrent stimuli. Participants produced words from pictures in three conditions: without distractors, while passively listening to distractors and during a distractor detection task. Production latencies increased for tasks with higher attentional demand and were longer for syllables relative to tones. ERP analyses revealed common modulations by dual-task for verbal and non-verbal stimuli around 240 ms, likely corresponding to lexical selection. Modulations starting around 350 ms prior to vocal onset were only observed when verbal stimuli were involved. These later modulations, likely reflecting interference with phonological-phonetic encoding, were observed only when overlap between tasks was maximal and the same underlying neural circuits were engaged (cross-talk).	[Fargier, Raphael; Laganaro, Marina] Univ Geneva, Fac Psychol & Educ Sci, Geneva, Switzerland	University of Geneva	Fargier, R (corresponding author), Univ Geneva, Fac Psychol & Educ Sci, Geneva, Switzerland.	raphael.fargier@unige.ch	Fargier, Raphaël/P-7125-2019	Fargier, Raphaël/0000-0002-0165-0238; Laganaro, Marina/0000-0002-4054-0939	Swiss National Science Foundation [105319_146113]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation grant no 105319_146113. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alario FX, 1999, BEHAV RES METH INS C, V31, P531, DOI 10.3758/BF03200732; Aristei S, 2011, J COGNITIVE NEUROSCI, V23, P1567, DOI 10.1162/jocn.2010.21474; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Bergen B, 2013, J EXP PSYCHOL GEN, V142, P119, DOI 10.1037/a0028428; Bonin P, 2003, BEHAV RES METH INS C, V35, P158, DOI 10.3758/BF03195507; Brunet D, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/813870; Burki A, 2015, BRAIN LANG, V150, P90, DOI 10.1016/j.bandl.2015.08.006; Christoffels IK, 2007, BRAIN RES, V1147, P192, DOI 10.1016/j.brainres.2007.01.137; Cook AE, 2008, J EXP PSYCHOL LEARN, V34, P886, DOI 10.1037/0278-7393.34.4.886; Costa A, 2009, P NATL ACAD SCI USA, V106, P21442, DOI 10.1073/pnas.0908921106; Daliri A, 2015, BRAIN LANG, V143, P59, DOI 10.1016/j.bandl.2015.03.002; DELL GS, 1986, PSYCHOL REV, V93, P283, DOI 10.1037/0033-295X.93.3.283; Fargier R, 2015, BRAIN LANG, V150, P129, DOI 10.1016/j.bandl.2015.09.004; Ferreira VS, 2002, J EXP PSYCHOL LEARN, V28, P1187, DOI 10.1037//0278-7393.28.6.1187; Garrod S, 2006, AUTOMATICITY LANGUAG, P1; GOLDSTEIN H, 1987, BIOMETRIKA, V74, P430, DOI 10.1093/biomet/74.2.430; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; Hazeltine E, 2006, COGNITIVE PSYCHOL, V52, P291, DOI 10.1016/j.cogpsych.2005.11.001; Hommel B, 1998, J EXP PSYCHOL HUMAN, V24, P1368, DOI 10.1037/0096-1523.24.5.1368; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Indefrey P, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00255; Johnston JC, 1995, PSYCHOL SCI, V6, P365, DOI 10.1111/j.1467-9280.1995.tb00527.x; Jongman SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137557; Joos K, 2014, NEUROSCI BIOBEHAV R, V42, P148, DOI 10.1016/j.neubiorev.2014.02.009; Kahneman D., 1973, ATTENTION EFFORT; Kinsbourne M., 1978, ATTENTION PERFORM, VVII, P345; Kleinman D, 2013, J EXP PSYCHOL LEARN, V39, P1860, DOI 10.1037/a0033095; Koenig T, 2014, BRAIN TOPOGR, V27, P72, DOI 10.1007/s10548-013-0310-1; Koenig T, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/938925; Korvorst M, 2007, EXP PSYCHOL, V54, P187, DOI 10.1027/1618-3169.54.3.187; Kuznetsova A, 2013, LEMERTEST TESTS RAND, P2; Laganaro M, 2015, NEUROIMAGE, V111, P204, DOI 10.1016/j.neuroimage.2015.02.027; Laganaro M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00493; Laganaro M, 2012, NEUROIMAGE, V59, P3881, DOI 10.1016/j.neuroimage.2011.10.082; Laganaro M, 2011, BRAIN TOPOGR, V24, P19, DOI 10.1007/s10548-010-0162-x; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Levelt W., 1989, SPEAKING INTENTION A; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Lien MC, 2002, PSYCHON B REV, V9, P212, DOI 10.3758/BF03196277; Lin SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098260; Marti S, 2015, NEURON, V88, P1297, DOI 10.1016/j.neuron.2015.10.040; Max L, 2008, P 8 INT SEM SPEECH P, P41; Meyer AS, 2000, PSYCHON B REV, V7, P314, DOI 10.3758/BF03212987; Meyer AS, 1998, COGNITION, V66, pB25, DOI 10.1016/S0010-0277(98)00009-2; Meyer AS, 2003, J MEM LANG, V48, P131, DOI 10.1016/S0749-596X(02)00509-0; Michel C.M., 2009, ELECT NEUROIMAGING; Michel CM, 2001, BRAIN RES REV, V36, P108, DOI 10.1016/S0165-0173(01)00086-8; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Navon D, 2002, COGNITIVE PSYCHOL, V44, P193, DOI 10.1006/cogp.2001.0767; New B, 2004, BEHAV RES METH INS C, V36, P516, DOI 10.3758/BF03195598; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; PASHLER H, 1989, Q J EXP PSYCHOL-A, V41, P19, DOI 10.1080/14640748908402351; Perret C, 2014, BRAIN LANG, V135, P20, DOI 10.1016/j.bandl.2014.04.006; Protopapas A, 2007, BEHAV RES METHODS, V39, P859, DOI 10.3758/BF03192979; Roelofs A, 2004, MEM COGNITION, V32, P212, DOI 10.3758/BF03196853; Roelofs A, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00307; Roelofs A, 2008, J EXP PSYCHOL HUMAN, V34, P1580, DOI 10.1037/a0012476; Schubert T, 2008, J EXP PSYCHOL HUMAN, V34, P376, DOI 10.1037/0096-1523.34.2.376; Strijkers K, 2010, CEREB CORTEX, V20, P912, DOI 10.1093/cercor/bhp153; Tombu M, 2003, J EXP PSYCHOL HUMAN, V29, P3, DOI 10.1037/0096-1523.29.1.3; Valente A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00390; WELFORD AT, 1952, AM J PSYCHOL, V65, P91, DOI 10.2307/1418834	65	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168358	10.1371/journal.pone.0168358	http://dx.doi.org/10.1371/journal.pone.0168358			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QC	27992586	gold, Green Submitted, Green Published			2022-12-26	WOS:000392842600051
J	Ferrari, S; Horri, K; Allal, F; Vergnet, A; Benhaim, D; Vandeputte, M; Chatain, B; Begout, ML				Ferrari, Sebastien; Horri, Khaled; Allal, Francois; Vergnet, Alain; Benhaim, David; Vandeputte, Marc; Chatain, Beatrice; Begout, Marie-Laure			Heritability of Boldness and Hypoxia Avoidance in European Seabass, Dicentrarchus labrax	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; STRESS-COPING STYLES; SALMON SALMO-SALAR; RAINBOW-TROUT; INDIVIDUAL-DIFFERENCES; ATLANTIC SALMON; RISK-TAKING; BEHAVIORAL PLASTICITY; CONFINEMENT STRESS; REARING CONDITIONS	To understand the genetic basis of coping style in European seabass, fish from a full factorial mating (10 females x 50 males) were reared in common garden and individually tagged. Individuals coping style was characterized through behavior tests at four different ages, categorizing fish into proactive or reactive: a hypoxia avoidance test (at 255 days post hatching, dph) and 3 risk-taking tests (at 276, 286 and 304 dph). We observed significant heritability of the coping style, higher for the average of risk-taking scores (h(2) = 0.45 +/- 0.14) than for the hypoxia avoidance test (h(2) = 0.19 +/- 0.10). The genetic correlations between the three risk-taking scores were very high (r(A) = 0.96-0.99) showing that although their repeatability was moderately high (r(P) = 0.64-0.72), successive risk-taking tests evaluated the same genetic variation. A mild genetic correlation between the results of the hypoxia avoidance test and the average of risk-taking scores (0.45 +/- 0.27) suggested that hypoxia avoidance and risk-taking tests do not address exactly the same behavioral and physiological responses. Genetic correlations between weight and risk taking traits showed negative values whatever the test used in our population i.e. reactive individual weights were larger. The results of this quantitative genetic analysis suggest a potential for the development of selection programs based on coping styles that could increase seabass welfare without altering growth performances. Overall, it also contributes to a better understanding of the origin and the significance of individual behavioral differences.	[Ferrari, Sebastien; Begout, Marie-Laure] IFREMER, Pl Gaby Coll, Fisheries Lab, Lhoumeau, France; [Horri, Khaled; Allal, Francois; Vergnet, Alain; Chatain, Beatrice] IFREMER, MARBEC UMR9190, Chemin Maguelone, Palavas Les Flots, France; [Benhaim, David] Normandie Univ, UNICAEN, LUSAC, Cherbourg, France; [Benhaim, David] Conservatoire Natl Arts & Metiers Intechmer, Cherbourg, France; [Vandeputte, Marc] Univ Paris Saclay, AgroParisTech, INRA, GABI, Jouy En Josas, France; [Vandeputte, Marc] IFREMER, L3AS, Chemin Maguelone, Palavas Les Flots, France	Ifremer; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; heSam Universite; Conservatoire National Arts & Metiers (CNAM); Universite de Caen Normandie; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ifremer	Ferrari, S; Begout, ML (corresponding author), IFREMER, Pl Gaby Coll, Fisheries Lab, Lhoumeau, France.	sebferrari@hotmail.fr; Marie.Laure.Begout@ifremer.fr	Begout, Marie-Laure/L-7730-2019; Allal, F./Q-8075-2018; Benhaim, David/A-9991-2019; Vandeputte, Marc/I-7218-2019; Vandeputte, Marc/A-4734-2011	Begout, Marie-Laure/0000-0003-1416-3479; Allal, F./0000-0002-8232-904X; Vandeputte, Marc/0000-0001-9929-4587; Vandeputte, Marc/0000-0001-9929-4587; Horri, Khaled/0000-0002-8408-7531	European Commission under the 7th Framework Program [265957 COPEWELL, FP7-KBBE-2010-4]; Conseil General de la Charente-Maritime	European Commission under the 7th Framework Program(European Commission); Conseil General de la Charente-Maritime(Region Nouvelle-Aquitaine)	This research project was supported by the European Commission under the 7th Framework Program FP7-KBBE-2010-4 Contract No. 265957 COPEWELL. The PhD work of Sebastien Ferrari was supported by the Conseil General de la Charente-Maritime.	Adriaenssens B, 2011, BEHAV ECOL, V22, P135, DOI 10.1093/beheco/arq185; [Anonymous], 1994, ESTIMATION AMELIORAT; [Anonymous], 1997, GENETICS ANAL QUANTI; Ariyomo TO, 2013, BEHAV GENET, V43, P161, DOI 10.1007/s10519-013-9585-y; Bolhuis JE, 2004, BEHAV BRAIN RES, V152, P351, DOI 10.1016/j.bbr.2003.10.024; Brelin D, 2005, ANN NY ACAD SCI, V1040, P239, DOI 10.1196/annals.1327.033; Brown C, 2007, J FISH BIOL, V71, P1590, DOI 10.1111/j.1095-8649.2007.01627.x; Brown C, 2007, BEHAV ECOL SOCIOBIOL, V62, P237, DOI 10.1007/s00265-007-0458-3; Careau V, 2012, PHYSIOL BIOCHEM ZOOL, V85, P543, DOI 10.1086/666970; Castanheira MF, 2017, REV AQUACULT, V9, P23, DOI 10.1111/raq.12100; Castanheira MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062037; Chapuis H, 2010, P 9 WORLD C GEN APPL; Chervet N, 2011, INT J EVOLUTIONARY B, V2011, P15; Coleman K, 1998, ANIM BEHAV, V56, P927, DOI 10.1006/anbe.1998.0852; Daule S, 2014, AQUACULTURE, V420, pS42, DOI 10.1016/j.aquaculture.2013.05.036; Ruiz-Gomez MD, 2011, PHYSIOL BEHAV, V102, P317, DOI 10.1016/j.physbeh.2010.11.023; DEBOER SF, 1990, PHYSIOL BEHAV, V47, P691, DOI 10.1016/0031-9384(90)90079-J; Dingemanse NJ, 2012, J EVOLUTION BIOL, V25, P485, DOI 10.1111/j.1420-9101.2011.02439.x; Dupont-Nivet M, 2002, AQUACULTURE, V204, P361, DOI 10.1016/S0044-8486(01)00839-0; Dupont-Nivet M, 2008, AQUACULTURE, V275, P81, DOI 10.1016/j.aquaculture.2007.12.032; Falconer D. S., 1996, INTRO QUANTITATIVE G; Ferrari S., 2014, THESIS; Ferrari S, 2015, APPL ANIM BEHAV SCI, V167, P74, DOI 10.1016/j.applanim.2015.03.006; FEVOLDEN SE, 1993, AQUACULTURE, V118, P205, DOI 10.1016/0044-8486(93)90457-A; FEVOLDEN SE, 1993, AQUACULTURE, V109, P215, DOI 10.1016/0044-8486(93)90164-T; FEVOLDEN SE, 1991, AQUACULTURE, V95, P53, DOI 10.1016/0044-8486(91)90072-F; Fevolden SE, 2002, AQUACULTURE, V205, P61, DOI 10.1016/S0044-8486(01)00660-3; Fevolden Svein Erik, 1993, Aquaculture, V111, P293, DOI 10.1016/0044-8486(93)90050-9; Fox J., 2019, R COMPANION APPL REG, V.; Gilmour A. R., 2015, ASREML USER GUIDE RE; Grima L, 2010, AQUACULTURE, V302, P169, DOI 10.1016/j.aquaculture.2010.02.016; Herrera M, 2014, APPL ANIM BEHAV SCI, V155, P101, DOI 10.1016/j.applanim.2014.03.001; Huntingford FA, 2010, J FISH BIOL, V76, P1576, DOI 10.1111/j.1095-8649.2010.02582.x; Huntingford FA, 2004, J FISH BIOL, V65, P122, DOI 10.1111/j.0022-1112.2004.00562.x; Huntingford FA, 2005, BEHAVIOUR, P1; Killen SS, 2012, FUNCT ECOL, V26, P134, DOI 10.1111/j.1365-2435.2011.01920.x; Koolhaas JM, 2008, BRAIN BEHAV IMMUN, V22, P662, DOI 10.1016/j.bbi.2007.11.006; Koolhaas JM, 2007, BRAIN BEHAV EVOLUT, V70, P218, DOI 10.1159/000105485; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Kortet R, 2014, BEHAV ECOL SOCIOBIOL, V68, P927, DOI 10.1007/s00265-014-1705-z; Laursen DC, 2011, APPL ANIM BEHAV SCI, V132, P211, DOI 10.1016/j.applanim.2011.03.011; MacKenzie S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005314; Martins CIM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028084; Martins CIM, 2005, AQUAC RES, V36, P1509, DOI 10.1111/j.1365-2109.2005.01372.x; Mazue GPF, 2015, BEHAV ECOL, V26, P900, DOI 10.1093/beheco/arv030; McKenzie DJ, 2015, J EXP BIOL, V218, P3762, DOI 10.1242/jeb.122903; Menu B, 2005, AQUAC RES, V36, P41, DOI 10.1111/j.1365-2109.2004.01181.x; Millot S, 2009, J FISH BIOL, V75, P1733, DOI 10.1111/j.1095-8649.2009.02425.x; Millot S., 2008, THESIS; Millot S, 2014, BEHAV GENET, P1; Silva PIM, 2010, APPL ANIM BEHAV SCI, V124, P75, DOI 10.1016/j.applanim.2010.01.008; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Overli O, 2006, PHYSIOL BEHAV, V87, P506, DOI 10.1016/j.physbeh.2005.11.012; Overli O, 2005, INTEGR COMP BIOL, V45, P463, DOI 10.1093/icb/45.3.463; Overli O, 2004, HORM BEHAV, V45, P324, DOI 10.1016/j.yhbeh.2004.01.001; Overli O, 2004, HORM BEHAV, V45, P235, DOI 10.1016/j.yhbeh.2003.12.002; Overli O, 2002, J EXP BIOL, V205, P391; Overli O, 2007, NEUROSCI BIOBEHAV R, V31, P396, DOI 10.1016/j.neubiorev.2006.10.006; Overli O, 2006, AQUACULTURE, V261, P776, DOI 10.1016/j.aquaculture.2006.08.049; Pottinger T. G., 1997, Fish stress and health in aquaculture., P171; Pottinger TG, 1999, GEN COMP ENDOCR, V116, P122, DOI 10.1006/gcen.1999.7355; Pottinger TG, 2001, HORM BEHAV, V40, P419, DOI 10.1006/hbeh.2001.1707; Pottinger TG, 2003, CEFAS, V36, P14; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Reale D, 2010, PHILOS T R SOC B, V365, P4051, DOI 10.1098/rstb.2010.0208; Rexroad CE, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-97; Ruiz-Gomez MD, 2008, HORM BEHAV, V54, P534, DOI 10.1016/j.yhbeh.2008.05.005; Saillant E, 2006, AQUACULTURE, V254, P139, DOI 10.1016/j.aquaculture.2005.10.018; Saillant E, 2003, AQUACULTURE, V221, P183, DOI 10.1016/S0044-8486(02)00539-2; Schjolden J, 2006, J FISH BIOL, V68, P920, DOI 10.1111/1095-8649.2006.00935.x; Sih A, 2012, ECOL LETT, V15, P278, DOI 10.1111/j.1461-0248.2011.01731.x; Sundstrom LF, 2004, BEHAV ECOL, V15, P192, DOI 10.1093/beheco/arg089; van Oers K, 2005, BEHAVIOUR, V142, P1185, DOI 10.1163/156853905774539364; Vandeputte M, 2007, AQUACULTURE, V272, pS315, DOI 10.1016/j.aquaculture.2007.07.195; Vandeputte M, 2006, MOL ECOL NOTES, V6, P265, DOI 10.1111/j.1471-8286.2005.01167.x; Vandeputte M, 2016, AQUACULTURE, V455, P1, DOI 10.1016/j.aquaculture.2016.01.003; Vandeputte M, 2001, AQUACULTURE, V202, P329, DOI 10.1016/S0044-8486(01)00782-7; Vandeputte M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00432; Vandeputte M, 2014, AQUACULTURE, V424, P239, DOI 10.1016/j.aquaculture.2014.01.005; Vandeputte M, 2011, AQUACULTURE, V314, P80, DOI 10.1016/j.aquaculture.2011.01.043; Vandeputte M, 2009, AQUACULTURE, V286, P20, DOI 10.1016/j.aquaculture.2008.09.008; vanRaaij MTM, 1996, HORM BEHAV, V30, P85, DOI 10.1006/hbeh.1996.0012; Volckaert FAM, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-15; White JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068900; Wilson ADM, 2010, BEHAV ECOL SOCIOBIOL, V64, P703, DOI 10.1007/s00265-009-0888-1; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1; Wright D, 2006, BEHAV GENET, V36, P271, DOI 10.1007/s10519-005-9029-4	87	17	17	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168506	10.1371/journal.pone.0168506	http://dx.doi.org/10.1371/journal.pone.0168506			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992517	Green Published, gold			2022-12-26	WOS:000392842600071
J	Ji, P; Xu, F; Huang, BY; Li, YX; Li, L; Zhang, GF				Ji, Peng; Xu, Fei; Huang, Baoyu; Li, Yingxiang; Li, Li; Zhang, Guofan			Molecular Characterization and Functional Analysis of a Putative Octopamine/Tyramine Receptor during the Developmental Stages of the Pacific Oyster, Crassostrea gigas	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; GATED CHLORIDE CHANNEL; LARVAL NERVOUS-SYSTEM; TYRAMINE-RECEPTOR; PHARMACOLOGICAL CHARACTERIZATION; DROSOPHILA-MELANOGASTER; SIGNAL-TRANSDUCTION; ILYANASSA-OBSOLETA; CHLAMYS-FARRERI; GENE-EXPRESSION	Octopamine (OA) and its precursor, tyramine (TA), participate in invertebrate development such as growth, maturation, and reproduction by activating their corresponding G protein-coupled receptors (GPCRs). Although OA was first discovered in mollusks (octopus), subsequent studies on OA, TA and related receptors have primarily been conducted in Ecdysozoa, especially in insects. Accordingly, only limited reports on OA/TA receptors in mollusks are available and their physiological roles remain unclear. Here, a full-length cDNA encoding a putative 524 amino acid OA/TA receptor (CgGPR1) was isolated from the Pacific oyster Crassostrea gigas. CgGPR1 was most closely related to the Lymnaea stagnalis OA receptor OAR2 in sequence. Phylogenetic analysis showed that CgGPR1 belongs to a poorly studied subfamily of invertebrate OA/TA receptors. The spatio-temporal expression of CgGPR1 in C. gigas larvae was examined by quantitative real-time PCR and Western blot analysis. CgGPR1 was expressed during all developmental stages of C. gigas with higher levels at mid-developmental stages, indicating its potential role in embryogenesis and tissue differentiation. Immunoreactive fluorescence of CgGPR1 was mainly observed in the velum, foot, gill and mantle of C. gigas larvae. CgGPR1 transcripts were detected in all the tested organs of adult C. gigas, with highest level in the mantle. Pharmacological analysis showed that cAMP and Ca2+ concentrations remained unchanged in HEK293 cells expressing CgGPR1 upon addition of OA, TA or related amines, suggesting that CgGPR1 modulates other unknown molecules rather than cAMP and Ca2+. Our study sheds light on CgGPR1 function in oysters.	[Ji, Peng; Xu, Fei; Huang, Baoyu; Li, Yingxiang; Li, Li; Zhang, Guofan] Chinese Acad Sci, Key Lab Expt Marine Biol, Inst Oceanol, Qingdao, Shandong, Peoples R China; [Ji, Peng] Univ Chinese Acad Sci, Beijing, Peoples R China; [Ji, Peng; Xu, Fei; Huang, Baoyu; Li, Yingxiang; Li, Li; Zhang, Guofan] Chinese Acad Sci, Natl & Local Joint Engn Lab Ecol Mariculture, Inst Oceanol, Qingdao, Shandong, Peoples R China; [Xu, Fei; Zhang, Guofan] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Shandong, Peoples R China; [Li, Li] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries & Aquaculture, Qingdao, Shandong, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Oceanology, CAS; Qingdao National Laboratory for Marine Science & Technology; Qingdao National Laboratory for Marine Science & Technology	Xu, F; Zhang, GF (corresponding author), Chinese Acad Sci, Key Lab Expt Marine Biol, Inst Oceanol, Qingdao, Shandong, Peoples R China.; Xu, F; Zhang, GF (corresponding author), Chinese Acad Sci, Natl & Local Joint Engn Lab Ecol Mariculture, Inst Oceanol, Qingdao, Shandong, Peoples R China.; Xu, F; Zhang, GF (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Shandong, Peoples R China.	xufei@qdio.ac.cn; gfzhang@qdio.ac.cn	li, li/GPX-3938-2022; Xu, Fei/A-1736-2012; Li, Li/AEM-3636-2022; li, li/HII-4157-2022; LI, LI/GVS-5344-2022	Xu, Fei/0000-0002-0981-8429; Li, Yingxiang/0000-0001-6671-2965	National Natural Science Foundation of China [31402285, 31530079]; National Basic Research Program of China (973 Program) [2010CB126401]; Earmarked Fund for Modern Agro-industry Technology Research System [CARS-48]; Scientific and Technological Innovation Project - Qingdao National Laboratory for Marine Science and Technology [2015ASKJ02-03]; Taishan Scholars Climbing Program of Shandong	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Earmarked Fund for Modern Agro-industry Technology Research System; Scientific and Technological Innovation Project - Qingdao National Laboratory for Marine Science and Technology; Taishan Scholars Climbing Program of Shandong	This research was supported by the National Natural Science Foundation of China (31402285, 31530079), the National Basic Research Program of China (973 Program, 2010CB126401), the Earmarked Fund for Modern Agro-industry Technology Research System (CARS-48), the Scientific and Technological Innovation Project Financially Supported by Qingdao National Laboratory for Marine Science and Technology (2015ASKJ02-03), and Taishan Scholars Climbing Program of Shandong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; Amador-Cano G, 2006, BIOL BULL-US, V210, P121, DOI 10.2307/4134601; BARAK LS, 1994, J BIOL CHEM, V269, P2790; Bayne BL, 1971, SOME MORPHOLOGICAL C; Blais V, 2010, GEN COMP ENDOCR, V167, P215, DOI 10.1016/j.ygcen.2010.03.008; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Braubach OR, 2006, J EXP BIOL, V209, P4676, DOI 10.1242/jeb.02556; Chambon JP, 2007, DEVELOPMENT, V134, P1203, DOI 10.1242/dev.002220; CLARE AS, 1995, J EXP BIOL, V198, P655; Crocker A, 2008, J NEUROSCI, V28, P9377, DOI 10.1523/JNEUROSCI.3072-08a.2008; Croll RP, 2004, INVERTEBR REPROD DEV, V46, P173, DOI 10.1080/07924259.2004.9652620; Dickinson AJG, 2003, J COMP NEUROL, V466, P197, DOI 10.1002/cne.10863; Du YS, 2013, FISH SHELLFISH IMMUN, V34, P939, DOI 10.1016/j.fsi.2012.12.007; Duportets L, 2010, INSECT MOL BIOL, V19, P489, DOI 10.1111/j.1365-2583.2010.01009.x; Evans Peter D., 2005, Invertebrate Neuroscience, V5, P111, DOI 10.1007/s10158-005-0001-z; FRETTER VERA, 1967, PROC MALACOL SOC LONDON, V37, P357; Gerhardt CC, 1997, J BIOL CHEM, V272, P6201, DOI 10.1074/jbc.272.10.6201; Gerhardt CC, 1997, MOL PHARMACOL, V51, P293, DOI 10.1124/mol.51.2.293; Gerhart J, 1999, TERATOLOGY, V60, P226; Grohmann L, 2003, J NEUROCHEM, V86, P725, DOI 10.1046/j.1471-4159.2003.01876.x; Harper EM, 1997, PALAEONTOLOGY, V40, P71; Haszprunar G, 2012, CURR BIOL, V22, pR510, DOI 10.1016/j.cub.2012.05.039; Holm ER, 1998, BIOL BULL, V195, P21, DOI 10.2307/1542772; Hoyer SC, 2008, CURR BIOL, V18, P159, DOI 10.1016/j.cub.2007.12.052; Huang W, 2015, GENE, V567, P164, DOI 10.1016/j.gene.2015.04.082; Kurten RC, 2003, ADV DRUG DELIVER REV, V55, P1405, DOI 10.1016/j.addr.2003.07.003; Kutsukake M, 2000, GENE, V245, P31, DOI 10.1016/S0378-1119(99)00569-7; LANE DJW, 1975, J MAR BIOL ASSOC UK, V55, P477, DOI 10.1017/S0025315400016076; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACKIE GO, 1976, BIOL BULL-US, V151, P182, DOI 10.2307/1540713; Monastirioti M, 2003, DEV BIOL, V264, P38, DOI 10.1016/j.ydbio.2003.07.019; Mustard JA, 2005, J COMP NEUROL, V483, P66, DOI 10.1002/cne.20420; Ohhara Y, 2015, P NATL ACAD SCI USA, V112, P1452, DOI 10.1073/pnas.1414966112; PAWLIK JR, 1990, B MAR SCI, V46, P512; Pirri JK, 2009, NEURON, V62, P526, DOI 10.1016/j.neuron.2009.04.013; Pryce Kerri, 2015, In Vivo (Brooklyn), V37, P16; Rao VTS, 2010, MOL BIOCHEM PARASIT, V173, P64, DOI 10.1016/j.molbiopara.2010.05.005; Rex E, 2005, J NEUROCHEM, V94, P181, DOI 10.1111/j.1471-4159.2005.03180.x; Selcho M, 2012, J COMP NEUROL, V520, P3764, DOI 10.1002/cne.23152; Smith KA, 2007, MOL BIOCHEM PARASIT, V154, P52, DOI 10.1016/j.molbiopara.2007.04.004; STRADER CD, 1995, FASEB J, V9, P745, DOI 10.1096/fasebj.9.9.7601339; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; VonNickischRosenegk E, 1996, INSECT BIOCHEM MOLEC, V26, P817, DOI 10.1016/S0965-1748(96)00031-8; Wu SF, 2013, PEST MANAG SCI, V69, P126, DOI 10.1002/ps.3378; Wu TT, 2012, FISH SHELLFISH IMMUN, V33, P286, DOI 10.1016/j.fsi.2012.05.011; YAMAMOTO H, 1995, ZOOL SCI, V12, P391, DOI 10.2108/zsj.12.391; Yang BY, 2015, MOL BIOL REP, V42, P963, DOI 10.1007/s11033-014-3833-y; Yang BY, 2013, COMP BIOCHEM PHYS B, V164, P168, DOI 10.1016/j.cbpb.2012.12.006; Yang BY, 2012, AQUACULTURE, V366, P54, DOI 10.1016/j.aquaculture.2012.08.040; Yue F, 2013, FISH SHELLFISH IMMUN, V34, P855, DOI 10.1016/j.fsi.2012.12.023; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	51	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168574	10.1371/journal.pone.0168574	http://dx.doi.org/10.1371/journal.pone.0168574			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992549	Green Published, gold, Green Submitted			2022-12-26	WOS:000392758000059
J	Appaduray, MA; Masedunskas, A; Bryce, NS; Lucas, CA; Warren, SC; Timpson, P; Stear, JH; Gunning, PW; Hardeman, EC				Appaduray, Mark A.; Masedunskas, Andrius; Bryce, Nicole S.; Lucas, Christine A.; Warren, Sean C.; Timpson, Paul; Stear, Jeffrey H.; Gunning, Peter W.; Hardeman, Edna C.			Recruitment Kinetics of Tropomyosin Tpm3.1 to Actin Filament Bundles in the Cytoskeleton Is Independent of Actin Filament Kinetics	PLOS ONE			English	Article							MUSCLE ALPHA-TROPOMYOSIN; AMINO-TERMINUS; IN-VITRO; F-ACTIN; JASPLAKINOLIDE; DYNAMICS; TROPONIN; ISOFORMS; REVEALS; POLYMERIZATION	The actin cytoskeleton is a dynamic network of filaments that is involved in virtually every cellular process. Most actin filaments in metazoa exist as a co-polymer of actin and tropomyosin (Tpm) and the function of an actin filament is primarily defined by the specific Tpm isoform associated with it. However, there is little information on the interdependence of these co-polymers during filament assembly and disassembly. We addressed this by investigating the recovery kinetics of fluorescently tagged isoform Tpm3.1 into actin filament bundles using FRAP analysis in cell culture and in vivo in rats using intracellular intravital microscopy, in the presence or absence of the actin-targeting drug jasplakinolide. The mobile fraction of Tpm3.1 is between 50% and 70% depending on whether the tag is at the C-or N-terminus and whether the analysis is in vivo or in cultured cells. We find that the continuous dynamic exchange of Tpm3.1 is not significantly impacted by jasplakinolide, unlike tagged actin. We conclude that tagged Tpm3.1 may be able to undergo exchange in actin filament bundles largely independent of the assembly and turnover of actin.	[Appaduray, Mark A.; Masedunskas, Andrius; Bryce, Nicole S.; Lucas, Christine A.; Stear, Jeffrey H.; Gunning, Peter W.; Hardeman, Edna C.] UNSW Australia, Sch Med Sci, Cellular & Genet Med Unit, Sydney, NSW, Australia; [Warren, Sean C.; Timpson, Paul] Garvan Inst Med Res, Kinghorn Canc Ctr, Sydney, NSW, Australia	University of New South Wales Sydney; Garvan Institute of Medical Research	Hardeman, EC (corresponding author), UNSW Australia, Sch Med Sci, Cellular & Genet Med Unit, Sydney, NSW, Australia.	e.hardeman@unsw.edu.au	Gunning, Peter W/E-9058-2010; Warren, Sean C./A-9392-2016; Timpson, Paul/A-9429-2016	Warren, Sean C./0000-0002-5253-7147; Hardeman, Edna/0000-0003-1649-7712; Timpson, Paul/0000-0002-5514-7080; Bryce, Nicole/0000-0001-9799-7393; Stear, Jeffrey/0000-0002-2255-8297; Gunning, Peter/0000-0003-0833-3128	Australian National and Medical Research Council (NHMRC) [APP1026616, APP1079866]; Australian Research Council (ARC) Linkage, Infrastructure, Equipment and Facilities (LIEF) [LE140100166]; Kids' Cancer Project	Australian National and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC) Linkage, Infrastructure, Equipment and Facilities (LIEF)(Australian Research Council); Kids' Cancer Project	This work was supported by Australian National and Medical Research Council (NHMRC) Project Grants APP1026616 (PWG, ECH) and APP1079866 (ECH, AM, PWG), Australian Research Council (ARC) Linkage, Infrastructure, Equipment and Facilities (LIEF) grant LE140100166 (PWG, ECH), and funding from the The Kids' Cancer Project (AM, NSB, PWG, ECH).	Bach CTT, 2009, MOL CELL BIOL, V29, P1506, DOI 10.1128/MCB.00857-08; Barua B, 2012, P NATL ACAD SCI USA, V109, P18425, DOI 10.1073/pnas.1212754109; Brooker HR, 2016, FEBS LETT, V590, P3111, DOI 10.1002/1873-3468.12346; Bryce NS, 2003, MOL BIOL CELL, V14, P1002, DOI 10.1091/mbc.E02-04-0244; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; CHO YJ, 1990, J BIOL CHEM, V265, P538; Coscoy S, 2002, P NATL ACAD SCI USA, V99, P12813, DOI 10.1073/pnas.192084599; Erami Z, 2016, CELL REP, V14, P152, DOI 10.1016/j.celrep.2015.12.020; Fritzsche M, 2013, MOL BIOL CELL, V24, P757, DOI 10.1091/mbc.E12-06-0485; Greenfield NJ, 2003, BIOCHEMISTRY-US, V42, P614, DOI 10.1021/bi026989e; Gunning P, 2008, PHYSIOL REV, V88, P1, DOI 10.1152/physrev.00001.2007; Gunning PW, 2015, J CELL SCI, V128, P2965, DOI 10.1242/jcs.172502; Gunning PW, 2005, TRENDS CELL BIOL, V15, P333, DOI 10.1016/j.tcb.2005.04.007; HEALD RW, 1988, J BIOL CHEM, V263, P5254; HELFMAN DM, 1984, J BIOL CHEM, V259, P4136; Holzinger A, 2009, METHODS MOL BIOL, V586, P71, DOI 10.1007/978-1-60761-376-3_4; Johnson M, 2014, CURR BIOL, V24, P1525, DOI 10.1016/j.cub.2014.05.034; Lehrer SS, 2014, J MUSCLE RES CELL M, V35, P153, DOI 10.1007/s10974-014-9383-z; Li Y, 2002, P NATL ACAD SCI USA, V99, P7378, DOI 10.1073/pnas.102179999; Martin C, 2010, J STRUCT BIOL, V170, P286, DOI 10.1016/j.jsb.2009.12.016; Masedunskas Andrius, 2013, Methods Mol Biol, V931, P153, DOI 10.1007/978-1-62703-056-4_9; Maytum R, 2000, BIOCHEMISTRY-US, V39, P11913, DOI 10.1021/bi000977g; Murakoshi H, 2008, BRAIN CELL BIOL, V36, P31, DOI 10.1007/s11068-008-9024-9; NOVY RE, 1993, CELL MOTIL CYTOSKEL, V26, P248, DOI 10.1002/cm.970260308; Palm T, 2003, BIOPHYS J, V84, P3181, DOI 10.1016/S0006-3495(03)70042-3; PITTENGER MF, 1992, J CELL BIOL, V118, P841, DOI 10.1083/jcb.118.4.841; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; SANDERS C, 1985, J BIOL CHEM, V260, P7264; Schevzov G, 2005, J HISTOCHEM CYTOCHEM, V53, P557, DOI 10.1369/jhc.4A6505.2005; Schevzov Galina, 2011, Bioarchitecture, V1, P135; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/NMETH.2413, 10.1038/nmeth.2413]; Stehn JR, 2013, CANCER RES, V73, P5169, DOI 10.1158/0008-5472.CAN-12-4501; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Tojkander S, 2011, CURR BIOL, V21, P539, DOI 10.1016/j.cub.2011.03.007; Vlahovich N, 2009, MOL BIOL CELL, V20, P400, DOI 10.1091/mbc.E08-06-0616; von der Ecken J, 2015, NATURE, V519, P114, DOI 10.1038/nature14033; Wang JS, 2014, CYTOSKELETON, V71, P513, DOI 10.1002/cm.21189; WEGNER A, 1979, J MOL BIOL, V131, P839, DOI 10.1016/0022-2836(79)90204-3	38	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168203	10.1371/journal.pone.0168203	http://dx.doi.org/10.1371/journal.pone.0168203			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977753	Green Submitted, gold, Green Published			2022-12-26	WOS:000391217400076
J	Jiang, C; Zhu, Y; Zhou, Z; Gumin, J; Bengtsson, L; Wu, W; Songyang, Z; Lang, FF; Lin, X				Jiang, C.; Zhu, Y.; Zhou, Z.; Gumin, J.; Bengtsson, L.; Wu, W.; Songyang, Z.; Lang, F. F.; Lin, X.			TMEM43/LUMA is a key signaling component mediating EGFR-induced NF-kappa B activation and tumor progression	ONCOGENE			English	Article							GROWTH-FACTOR-RECEPTOR; NECROSIS-FACTOR-ALPHA; PATHWAYS; FAMILY; CELLS; PROTEINS; COMPLEX; CARMA3	Epidermal growth factor receptor (EGFR) family members play pivotal roles in cell proliferation, differentiation and survival. Overexpression and mutations of EGFRs, or aberrant EGFR signaling are commonly associated with the development of various cancers, where constitutive NF-kappa B activation is often found to promote the expression of various proteins involved in the proliferation, survival, migration and epithelial-to-mesenchymal transition of cancer cells. However, the mechanism of EGFR-induced NF-kappa B activation is not fully defined. Here, we used a Bimolecular Fluorescence Complementation-based functional genomics method to perform a high throughput screening and identified TMEM43/LUMA as a critical component in EGFR signaling network, mediating EGFR-induced NF-kappa B activation. Our data show that EGFR recruits TMEM43 following EGF stimulation. TMEM43 interacts with the scaffold protein CARMA3 and its associating complex to induce downstream NF-kappa B activation, and plays a critical role in controlling cell survival. TMEM43 deficiency significantly affects colony formation, survival of anoikis-induced cell death, migration and invasion of cancer cells in vitro, as well as tumor progression in vivo. Importantly, higher expression of TMEM43 closely correlates with brain tumor malignancy, and suppression of TMEM43 expression in brain tumor cells inhibited their growth both in vitro and in vivo. Altogether, our studies reveal a crucial link of EGF receptor to NF-kappa B activation and tumor progression.	[Jiang, C.; Zhu, Y.; Zhou, Z.; Wu, W.; Lin, X.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd,Unit 108, Houston, TX 77030 USA; [Gumin, J.; Lang, F. F.] Univ Texas MD Anderson Canc Ctr, Div Surg, Dept Neurosurg, Houston, TX 77030 USA; [Bengtsson, L.] Max Delbrueck Ctr Mol Med, Berlin, Germany; [Songyang, Z.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Lin, X.] Tsinghua Univ, Sch Med, Dept Basic Med Sci, Inst Immunol, Beijing, Peoples R China; [Zhu, Y.] Sun Yet San Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Wu, W.] Nankai Univ, Dept Microbiol, Coll Life Sci, Tianjin, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Baylor College of Medicine; Tsinghua University; Sun Yat Sen University; Nankai University	Jiang, C; Lin, X (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd,Unit 108, Houston, TX 77030 USA.	cjiang@mdanderson.org; linxin307@tsinghua.edu.cn	Jiang, Changying/AAL-3711-2020	Jiang, Changying/0000-0003-3778-4438; Bengtsson, Luiza/0000-0001-6048-3743	National Natural Science Foundation of China [81570211]; Cancer Prevention Research Institute of Texas [RP120316]; National Institutes of Health [R01 AI116722]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Cancer Prevention Research Institute of Texas; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was partially supported by grants from the National Natural Science Foundation of China (81570211), Cancer Prevention Research Institute of Texas (RP120316) and National Institutes of Health (R01 AI116722) to X Lin.	Ando K, 2005, CLIN CANCER RES, V11, P8872, DOI 10.1158/1078-0432.CCR-05-0811; Bancroft CC, 2002, INT J CANCER, V99, P538, DOI 10.1002/ijc.10398; Bengtsson L, 2008, J CELL SCI, V121, P536, DOI 10.1242/jcs.019281; Bhat-Nakshatri P, 2002, ONCOGENE, V21, P2066, DOI 10.1038/sj.onc.1205243; Biswas DK, 2006, J CELL PHYSIOL, V209, P645, DOI 10.1002/jcp.20785; Biswas Debajit K, 2005, Sci STKE, V2005, ppe27, DOI 10.1126/stke.2882005pe27; Biswas DK, 2000, P NATL ACAD SCI USA, V97, P8542, DOI 10.1073/pnas.97.15.8542; Biswas DK, 2003, CANCER RES, V63, P290; Blonska M, 2005, J BIOL CHEM, V280, P43056, DOI 10.1074/jbc.M507807200; Blonska M, 2011, CELL RES, V21, P55, DOI 10.1038/cr.2010.182; Dreger M, 2001, P NATL ACAD SCI USA, V98, P11943, DOI 10.1073/pnas.211201898; Driskell OJ, 2007, NAT CELL BIOL, V9, P113, DOI 10.1038/ncb1525; Grabiner BC, 2007, GENE DEV, V21, P984, DOI 10.1101/gad.1502507; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Haywood AFM, 2013, EUR HEART J, V34, P1002, DOI 10.1093/eurheartj/ehs383; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Jiang T, 2011, CANCER RES, V71, P2183, DOI 10.1158/0008-5472.CAN-10-3626; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kerppola TK, 2009, CHEM SOC REV, V38, P2876, DOI 10.1039/b909638h; Lal S, 2000, J NEUROSURG, V92, P326, DOI 10.3171/jns.2000.92.2.0326; Le Page C, 2005, PROSTATE, V65, P130, DOI 10.1002/pros.20234; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Marciniak DJ, 2004, MOL CANCER THER, V3, P1615; Merner ND, 2008, AM J HUM GENET, V82, P809, DOI 10.1016/j.ajhg.2008.01.010; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Pan D, 2016, ONCOGENE, V35, P919, DOI 10.1038/onc.2015.146; Pan D, 2016, MOL CANCER RES, V14, P93, DOI 10.1158/1541-7786.MCR-15-0229-T; Pianetti S, 2001, ONCOGENE, V20, P1287, DOI 10.1038/sj.onc.1204257; Shimizu M, 2005, CLIN CANCER RES, V11, P2735, DOI 10.1158/1078-0432.CCR-04-2014; Sun JY, 2008, P NATL ACAD SCI USA, V105, P17085, DOI 10.1073/pnas.0802701105; Thornburg NJ, 2003, CANCER RES, V63, P8293; Vanderschuren KLA, 2013, GENET RES INT, V2013, DOI 10.1155/2013/460805; Wang HM, 2004, LAB INVEST, V84, P941, DOI 10.1038/labinvest.3700123; Wang ZW, 2006, CANCER RES, V66, P7653, DOI 10.1158/0008-5472.CAN-06-1019	36	24	25	3	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 18	2017	36	20					2813	2823		10.1038/onc.2016.430	http://dx.doi.org/10.1038/onc.2016.430			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EV3ZM	27991920				2022-12-26	WOS:000401697800004
J	Hinojosa, R; Hinojosa, MS				Hinojosa, Ramon; Hinojosa, Melanie Sberna			Activity-Limiting Musculoskeletal Conditions in US Veterans Compared to Non-Veterans: Results from the 2013 National Health Interview Survey	PLOS ONE			English	Article							PERSIAN-GULF-WAR; LOW-BACK-PAIN; MILITARY SERVICE; UNITED-STATES; MORTALITY; AFGHANISTAN; BURDEN; PREVALENCE; TRANSITION; DEPLOYMENT	Past military service is associated with health outcomes, both positive and negative. In this study we use the 2013 National Health Interview Survey to examine the constellation of conditions referred to as musculoskeletal disorders (MSDs) for Veterans and non-veterans with health conditions that limit their daily activities. Multivariate logistic regression analysis reveal that Veterans are more likely to report MSDs like neck and back problems, fracture bone and joint problems as an activity limiting problem compared to non-veterans. The relationship between age and reports of activity limiting MSDs is moderated by Veteran status. Veterans in this sample report more activity limiting MSDs at younger ages compared to non-veterans and fewer MSDs at older ages. This research contributes to our understanding of potentially limiting health conditions at earlier ages for Veterans.	[Hinojosa, Ramon; Hinojosa, Melanie Sberna] Univ Cent Florida, Dept Sociol, 4297 Andromeda Loop North,Howard Phillips Hall 40, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Hinojosa, MS (corresponding author), Univ Cent Florida, Dept Sociol, 4297 Andromeda Loop North,Howard Phillips Hall 40, Orlando, FL 32816 USA.	melanie.hinojosa@ucf.edu	Hinojosa, Melanie Sberna/AAA-9467-2019	Hinojosa, Melanie/0000-0001-5188-3315				Agha Z, 2000, ARCH INTERN MED, V160, P3252, DOI 10.1001/archinte.160.21.3252; [Anonymous], 1958, VETERANS BENEFITS; Barber J, 2011, MIL MED, V176, P151, DOI 10.7205/MILMED-D-09-00275; Bollinger MJ, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0040-6; Cameron KL, 2011, ARTHRITIS RHEUM-US, V63, P2974, DOI 10.1002/art.30498; Center D.M.D., 2015, PROF CURR DEPL PERS; Clever M, 2013, FUTURE CHILD, V23, P13, DOI 10.1353/foc.2013.0018; Department of Veterans Affairs, 1976, SCHED RAT DIS 4; Department of Veterans Affairs, 2010, NAT SURV VET ACT DUT; DOD, 2016, DODIG2016088; DOD U. S. D. o. D., 2015, PROF MIL COMM; Dominick KL, 2006, J RHEUMATOL, V33, P348; Fasoli DR, 2010, MED CARE, V48, P288, DOI 10.1097/MLR.0b013e3181cafbe3; Fejer R, 2012, CHIROPR MAN THER, V20, DOI 10.1186/2045-709X-20-31; GAO, 2015, GAO15266; Haskell SG, 2011, WOMEN HEALTH ISS, V21, P92, DOI 10.1016/j.whi.2010.08.001; Hinojosa R., 2010, J MENS STUDIES, V18, P179, DOI DOI 10.3149/JMS.1802.179; Hoerster KD, 2012, AM J PREV MED, V43, P483, DOI 10.1016/j.amepre.2012.07.029; Kaaria S, 2006, PAIN, V120, P131, DOI 10.1016/j.pain.2005.10.020; Kang HK, 1996, NEW ENGL J MED, V335, P1498, DOI 10.1056/NEJM199611143352006; Kang HK, 2002, OCCUP ENVIRON MED, V59, P794, DOI 10.1136/oem.59.12.794; Kelty R, 2010, FUTURE CHILD, V20, P181; Kessler RC, 2001, J OCCUP ENVIRON MED, V43, P218, DOI 10.1097/00043764-200103000-00009; Knox J, 2011, SPINE, V36, P1492, DOI 10.1097/BRS.0b013e3181f40ddd; LP S., 2014, STATA DAT AN STAT SO; McLaughlin R, 2008, ANN EPIDEMIOL, V18, P928, DOI 10.1016/j.annepidem.2008.09.002; Murphy LB, 2014, MMWR-MORBID MORTAL W, V63, P999; National Center for Health Statistics. National Health Interview Survey, 2013, PUBL US DAT FIL DOC; NCVAS National Center for Veterans Analysis and Statistics, 2014, PROF VET FY 2012 DAT; NCVAS National Center for Veterans Analysis and Statistics, 2014, UN VET US REP FY 201; Nelson KM, 2006, J GEN INTERN MED, V21, P915, DOI 10.1007/BF02743137; Pizarro J, 2006, ARCH GEN PSYCHIAT, V63, P193, DOI 10.1001/archpsyc.63.2.193; Roy TC, 2013, SPINE, V38, P1310, DOI 10.1097/BRS.0b013e31829265c4; Roy TC, 2012, AVIAT SPACE ENVIR MD, V83, P1060, DOI 10.3357/ASEM.3341.2012; Roy TC, 2012, MIL MED, V177, P716, DOI 10.7205/MILMED-D-11-00402; SELTZER CC, 1974, AM J EPIDEMIOL, V100, P367, DOI 10.1093/oxfordjournals.aje.a112047; Thompson JM, 2015, DISABIL REHABIL, V37, P884, DOI 10.3109/09638288.2014.947441; VanDenKerkhof E. G., 2014, JBI DATABASE SYSTEMA, V12; VanDenKerkhof EG, 2015, PAIN RES MANAG, V20, P89, DOI 10.1155/2015/763768; Waller M, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-7; Watch H. R., 2016, BOOTED LACK RECOURSE; Wilmoth J. M., 2011, HDB SOCIOLOGY AGING; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646	43	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0167143	10.1371/journal.pone.0167143	http://dx.doi.org/10.1371/journal.pone.0167143			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QH	28005905	Green Published, gold, Green Submitted			2022-12-26	WOS:000392843200009
J	Huhndorf, M; Moussavi, A; Kramann, N; Will, O; Hattermann, K; Stadelmann, C; Jansen, O; Boretius, S				Huhndorf, Monika; Moussavi, Amir; Kramann, Nadine; Will, Olga; Hattermann, Kirsten; Stadelmann, Christine; Jansen, Olav; Boretius, Susann			Alterations of the Blood-Brain Barrier and Regional Perfusion in Tumor Development: MRI Insights from a Rat C6 Glioma Model	PLoS One			English	Article							CONTRAST-ENHANCED MRI; SIGNAL INTENSITY RECOVERY; HIGH-GRADE GLIOMAS; GLIOBLASTOMA-MULTIFORME; GAMMA-VARIATE; DIFFERENTIATION; PERCENTAGE; SYSTEM; GROWTH; VOLUME	Objectives Angiogenesis and anti-angiogenetic medications play an important role in progression and therapy of glioblastoma. In this context, in vivo characterization of the blood-brain-barrier and tumor vascularization may be important for individual prognosis and therapy optimization. Methods We analyzed perfusion and capillary permeability of C6-gliomas in rats at different stages of tumor-growth by contrast enhanced MRI and dynamic susceptibility contrast (DSC) MRI at 7 Tesla. The analyses included maps of relative cerebral blood volume (CBV) and signal recovery derived from DSC data over a time period of up to 35 days after tumor cell injections. Results In all rats tumor progression was accompanied by temporal and spatial changes in CBV and capillary permeability. A leakage of the blood-brain barrier (slow contrast enhancement) was observed as soon as the tumor became detectable on T2-weighted images. Interestingly, areas of strong capillary permeability (fast signal enhancement) were predominantly localized in the center of the tumor. In contrast, the tumor rim was dominated by an increased CBV and showed the highest vessel density compared to the tumor center and the contralateral hemisphere as confirmed by histology. Conclusion Substantial regional differences in the tumor highlight the importance of parameter maps in contrast or in addition to region-of-interest analyses. The data vividly illustrate how MRI including contrast-enhanced and DSC-MRI may contribute to a better understanding of tumor development.	[Huhndorf, Monika; Moussavi, Amir; Will, Olga; Jansen, Olav; Boretius, Susann] Univ Kiel, Univ Med Ctr, Clin Radiol & Neuroradiol, Schleswig Holstein, Kiel, Germany; [Moussavi, Amir; Will, Olga; Boretius, Susann] Univ Kiel, Mol Imaging North Competence Ctr, Kiel, Germany; [Moussavi, Amir; Boretius, Susann] Leibniz Inst Primate Res, German Primate Ctr, Gottingen, Germany; [Kramann, Nadine; Stadelmann, Christine] Univ Med Ctr Gottingen, Inst Neuropathol, Gottingen, Germany; [Hattermann, Kirsten] Univ Kiel, Inst Anat, Kiel, Germany; [Boretius, Susann] Univ Gottingen, Fac Biol & Psychol, Gottingen, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Deutsches Primatenzentrum (DPZ); University of Gottingen; University of Kiel; University of Gottingen	Boretius, S (corresponding author), Univ Kiel, Univ Med Ctr, Clin Radiol & Neuroradiol, Schleswig Holstein, Kiel, Germany.; Boretius, S (corresponding author), Univ Kiel, Mol Imaging North Competence Ctr, Kiel, Germany.; Boretius, S (corresponding author), Leibniz Inst Primate Res, German Primate Ctr, Gottingen, Germany.; Boretius, S (corresponding author), Univ Gottingen, Fac Biol & Psychol, Gottingen, Germany.	sboretius@dpz.eu	Hattermann, Kirsten/E-8043-2010; Boretius, Susann/ABF-4993-2021; Jansen, Olav/CAF-4179-2022	Boretius, Susann/0000-0003-2792-7423; Stadelmann, Christine/0000-0003-1766-5458	European Regional Development Fund (ERDF) [CCI: 2007DE052P0011]	European Regional Development Fund (ERDF)(European Commission)	This study has received funding by the European Regional Development Fund (ERDF), CCI: 2007DE052P0011 (http://ec.europa.eu/regional_policy/en/funding/erdf/).	Aprile I, 2015, RADIOL MED, V120, P967, DOI 10.1007/s11547-015-0511-7; Artzi M, 2015, J NEURO-ONCOL, V121, P349, DOI 10.1007/s11060-014-1639-3; Barth RF, 2009, J NEURO-ONCOL, V94, P299, DOI 10.1007/s11060-009-9875-7; BELLIVEAU JW, 1990, MAGNET RESON MED, V14, P538, DOI 10.1002/mrm.1910140311; Benner T, 1997, MAGN RESON IMAGING, V15, P307, DOI 10.1016/S0730-725X(96)00392-X; Blasel S, 2013, J NEURO-ONCOL, V114, P127, DOI 10.1007/s11060-013-1161-z; Boretius S, 2012, NEUROIMAGE, V59, P2678, DOI 10.1016/j.neuroimage.2011.08.051; Boxerman JL, 2006, AM J NEURORADIOL, V27, P859; Cha S, 2007, AM J NEURORADIOL, V28, P1078, DOI 10.3174/ajnr.A0484; Cha S, 2003, MAGNET RESON MED, V49, P848, DOI 10.1002/mrm.10446; Chakravorty A, 2015, NEURORADIOL J, V28, P574, DOI 10.1177/1971400915611916; Chinot OL, 2011, ADV THER, V28, P334, DOI 10.1007/s12325-011-0007-3; da Silva AC, 2012, EINSTEIN-SAO PAULO, V10, P11, DOI 10.1590/S1679-45082012000100004; EDELMAN RR, 1990, RADIOLOGY, V176, P211, DOI 10.1148/radiology.176.1.2353094; Fan GG, 2005, ACAD RADIOL, V12, P640, DOI 10.1016/j.acra.2005.01.024; Garcia-Palmero I, 2013, NMR BIOMED, V26, P1059, DOI 10.1002/nbm.2918; Grobben B, 2002, CELL TISSUE RES, V310, P257, DOI 10.1007/s00441-002-0651-7; Hartmann M, 2003, NEUROSCI LETT, V338, P119, DOI 10.1016/S0304-3940(02)01367-8; Heye AK, 2014, NEUROIMAGE-CLIN, V6, P262, DOI 10.1016/j.nicl.2014.09.002; Jensen-Kondering U, 2012, NEUROL RES, V34, P984, DOI 10.1179/1743132812Y.0000000105; Kim WY, 2009, FEBS J, V276, P4653, DOI 10.1111/j.1742-4658.2009.07177.x; Law M, 2003, AM J NEURORADIOL, V24, P1989; Law M, 2002, RADIOLOGY, V222, P715, DOI 10.1148/radiol.2223010558; Liao WH, 2009, ACTA RADIOL, V50, P217, DOI 10.1080/02841850802616752; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Mangla R, 2011, AM J NEURORADIOL, V32, P1004, DOI 10.3174/ajnr.A2441; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; ROSEN BR, 1990, MAGNET RESON MED, V14, P249, DOI 10.1002/mrm.1910140211; Server A, 2011, NEURORADIOLOGY, V53, P435, DOI 10.1007/s00234-010-0770-x; Shin JH, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.3.1790783; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Sourbron SP, 2013, NMR BIOMED, V26, P1004, DOI 10.1002/nbm.2940; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Thomas AA, 2014, CURR TREAT OPTION ON, V15, P551, DOI 10.1007/s11864-014-0308-2; THOMPSON HK, 1964, CIRC RES, V14, P502, DOI 10.1161/01.RES.14.6.502; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Young RJ, 2013, CLIN IMAG, V37, P41, DOI 10.1016/j.clinimag.2012.02.016	37	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168174	10.1371/journal.pone.0168174	http://dx.doi.org/10.1371/journal.pone.0168174			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005983	Green Published, gold			2022-12-26	WOS:000392843200034
J	Josefson, AB				Josefson, Alf B.			Species Sorting of Benthic Invertebrates in a Salinity Gradient - Importance of Dispersal Limitation	PLOS ONE			English	Article							METACOMMUNITY STRUCTURE; BETA-DIVERSITY; DEVELOPMENTAL MODE; DISTANCE DECAY; BALTIC SEA; RICHNESS; COLONIZATION; NESTEDNESS; TURNOVER; PATTERNS	The relative importance of environment and dispersal related processes for community assembly has attracted great interest over recent decades, but few empirical studies from the marine/estuarine realm have examined the possible effects of these two types of factors in the same system. Importance of these processes was investigated in a hypothetical metacommunity of benthic invertebrates in 16 micro-tidal estuaries connected to the same open sea area. The estuaries differed in size and connectivity to the open sea and represented a salinity gradient across the estuaries. The Elements of Metacommunity Structure (EMS) approach on estuary scale was complemented with a mechanistic variance partitioning approach on sample scale to disentangle effects of factors affecting assembly of three trait groups of species with different dispersivity. A quasi-Clementsian pattern was observed for all three traits, a likely response to some latent gradient. The primary axis in the pattern was most strongly related to gradients in estuary salinity and estuary entrance width and correlation with richness indicated nestedness only in the matrix of the most dispersive trait group. In the variance partitioning approach measures of turnover and nestedness between paired samples each from different estuaries were related to environmental distance in different gradients. Distance between estuaries was unimportant suggesting importance of factors characterizing the estuaries. While the high dispersive species mainly were sorted in the salinity gradient, apparently according to their tolerance ranges towards salinity, the two less dispersive traits were additionally affected by estuary entrance width and possibly also area. The results exemplify a mechanism of community assembly in the marine realm where the niche factor salinity in conjunction with differential dispersal structure invertebrates in a metacommunity of connected estuaries, and support the idea that dispersive species are more controlled by the environment than less dispersive species.	[Josefson, Alf B.] Aarhus Univ, Dept Biosci, Roskilde, Denmark	Aarhus University	Josefson, AB (corresponding author), Aarhus Univ, Dept Biosci, Roskilde, Denmark.	aj@bios.au.dk	Josefson, Alf B/J-8174-2013		Danish Nature Agency; DEVOTES project in the European Union's Seventh Program for research, technological development and demonstration [308392]; Cocoa project under the EU-Bonus programme The Danish Nature Agency; EU [S12657705, MARE/2012/10 - Lot 5]	Danish Nature Agency; DEVOTES project in the European Union's Seventh Program for research, technological development and demonstration; Cocoa project under the EU-Bonus programme The Danish Nature Agency; EU(European Commission)	The author received funding for this work from The Danish Nature Agency, The DEVOTES project in the European Union's Seventh Program for research, technological development and demonstration under grant agreement No "308392", The Cocoa project under the EU-Bonus programme The Danish Nature Agency collected the primary data. This work was also supported by EU EMODnet contr. No. S12657705 under contract no. MARE/2012/10 - Lot 5 Biology.	Algarte VM, 2014, HYDROBIOLOGIA, V722, P279, DOI 10.1007/s10750-013-1711-6; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Astorga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P365, DOI 10.1111/j.1466-8238.2011.00681.x; Baselga A, 2015, METHODS ECOL EVOL; Baselga A, 2007, ECOGRAPHY, V30, P838, DOI 10.1111/j.2007.0906-7590.05191.x; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Beauchamp VB, 2011, ECOL APPL, V21, P465, DOI 10.1890/09-1638.1; Bleich S, 2011, MAR ECOL PROG SER, V436, P101, DOI 10.3354/meps09219; Bloch CP, 2007, OIKOS, V116, P395, DOI 10.1111/j.0030-1299.2007.15391.x; Bonsdorff E, 1999, AUST J ECOL, V24, P312, DOI 10.1046/j.1442-9993.1999.00986.x; Brault S, 2013, GLOBAL ECOL BIOGEOGR, V22, P433, DOI 10.1111/geb.12005; BUHLJENSEN L, 1986, SARSIA, V71, P193, DOI 10.1080/00364827.1986.10419690; BUHLMORTENSEN L, 1993, MAR ECOL PROG SER, V97, P209, DOI 10.3354/meps097209; Cadotte MW, 2006, ECOLOGY, V87, P1008, DOI 10.1890/0012-9658(2006)87[1008:MIOCRA]2.0.CO;2; Carvalho JC, 2012, GLOBAL ECOL BIOGEOGR, V21, P760, DOI 10.1111/j.1466-8238.2011.00694.x; Chase J.M., 2009, ECOLOGICAL NICHES; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Chase JM, 2011, PHILOS T R SOC B, V366, P2351, DOI 10.1098/rstb.2011.0063; Chesson P, 2000, THEOR POPUL BIOL, V58, P211, DOI 10.1006/tpbi.2000.1486; Conley DJ, 2000, ESTUARIES, V23, P820, DOI 10.2307/1353000; COOK RR, 1995, OECOLOGIA, V102, P413, DOI 10.1007/BF00341353; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Dahl E., 1956, Oikos, V7, P1, DOI 10.2307/3564981; Dallas T, 2014, ECOGRAPHY, V37, P402, DOI 10.1111/j.1600-0587.2013.00695.x; De Bie T, 2012, ECOL LETT, V15, P740, DOI 10.1111/j.1461-0248.2012.01794.x; Foggo A, 2007, J ANIM ECOL, V76, P695, DOI 10.1111/j.1365-2656.2007.01245.x; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Gronroos M, 2013, ECOL EVOL, V3, P4473, DOI 10.1002/ece3.834; GUNTER G, 1961, LIMNOL OCEANOGR, V6, P182, DOI 10.4319/lo.1961.6.2.0182; Heino J, 2015, FRESHWATER BIOL, V60, P845, DOI 10.1111/fwb.12533; Heino J, 2013, OECOLOGIA, V171, P971, DOI 10.1007/s00442-012-2451-4; HELCOM, 1988, BALTIC SEA ENV P, V27D, P1; Hendrickx F, 2009, GLOBAL ECOL BIOGEOGR, V18, P607, DOI 10.1111/j.1466-8238.2009.00473.x; Josefson AB, 2004, GLOBAL ECOL BIOGEOGR, V13, P273, DOI 10.1111/j.1466-822X.2004.00091.x; Josefson AB, 2013, J BIOGEOGR, V40, P1000, DOI 10.1111/jbi.12047; Josefson AB, 2009, MAR ECOL PROG SER, V396, P283, DOI 10.3354/meps08375; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Leibold MA, 2002, OIKOS, V97, P237, DOI 10.1034/j.1600-0706.2002.970210.x; Lindo Z, 2008, OIKOS, V117, P1856, DOI 10.1111/j.1600-0706.2008.16920.x; Loo SE, 2002, OECOLOGIA, V132, P118, DOI 10.1007/s00442-002-0933-5; May F, 2012, OIKOS, V121, P942, DOI 10.1111/j.1600-0706.2011.20078.x; Mercier A, 2013, GLOBAL ECOL BIOGEOGR, V22, P517, DOI 10.1111/geb.12018; Meynard CN, 2013, J BIOGEOGR, V40, P1560, DOI 10.1111/jbi.12116; Moritz C, 2013, OIKOS, V122, P1401, DOI 10.1111/j.1600-0706.2013.00377.x; Mouquet N, 2003, AM NAT, V162, P544, DOI 10.1086/378857; PATTERSON BD., 2000, BONN ZOOL MONOGR, V46, P9; Pilditch CA, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0795; Presley SJ, 2010, OIKOS, V119, P908, DOI 10.1111/j.1600-0706.2010.18544.x; Presley SJ, 2010, GLOBAL ECOL BIOGEOGR, V19, P185, DOI 10.1111/j.1466-8238.2009.00505.x; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; Qian H, 2009, GLOBAL ECOL BIOGEOGR, V18, P327, DOI 10.1111/j.1466-8238.2009.00450.x; Rasmussen B, 2002, ESTUAR COAST SHELF S, V54, P65, DOI 10.1006/ecss.2001.0836; Remane A., 1934, ZOOL ANZ, V7, P34; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Sommer B, 2014, ECOLOGY, V95, P1000, DOI 10.1890/13-1445.1; Thompson R, 2006, J ANIM ECOL, V75, P476, DOI 10.1111/j.1365-2656.2006.01068.x; THORSON G, 1946, REPROD LARVAL DEV DA; TILMAN D, 1982, ANNU REV ECOL SYST, V13, P349, DOI 10.1146/annurev.es.13.110182.002025; Ulrich W, 2009, OIKOS, V118, P3, DOI 10.1111/j.1600-0706.2008.17053.x; Valanko S, 2015, ECOL EVOL, V5, P5203, DOI 10.1002/ece3.1767; Wlodarska-Kowalczuk M, 2012, MAR ECOL PROG SER, V463, P73, DOI 10.3354/meps09858	61	18	19	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168908	10.1371/journal.pone.0168908	http://dx.doi.org/10.1371/journal.pone.0168908			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006014	gold, Green Submitted, Green Published			2022-12-26	WOS:000392843200109
J	La, J; Reed, E; Chan, L; Smolyaninova, LV; Akomova, OA; Mutlu, GM; Orlov, SN; Dulin, NO				La, Jennifer; Reed, Eleanor; Chan, Lan; Smolyaninova, Larisa V.; Akomova, Olga A.; Mutlu, Gokhan M.; Orlov, Sergei N.; Dulin, Nickolai O.			Downregulation of TGF-beta Receptor-2 Expression and Signaling through Inhibition of Na/K-ATPase	PLoS One			English	Article							GROWTH-FACTOR-BETA; PULMONARY MYOFIBROBLAST DIFFERENTIATION; EPITHELIAL-CELL PROLIFERATION; SMOOTH-MUSCLE-CELLS; CARDIAC-GLYCOSIDES; NA+/K+-ATPASE; BREAST-CANCER; FIBROBLASTS; FIBROSIS; DIGITALIS	Transforming growth factor-beta (TGF-beta) is a multi-functional cytokine implicated in the control of cell growth and differentiation. TGF-beta signals through a complex of TGF-beta receptors 1 and 2 (TGF beta R1 and TGF beta R2) that phosphorylate and activate Smad2/3 transcription factors driving transcription of the Smad-target genes. The Na+/K+-ATPase is an integral plasma membrane protein critical for maintaining the electro-chemical gradient of Na+ and K+ in the cell. We found that inhibition of the Na+/K+ ATPase by ouabain results in a dramatic decrease in the expression of TGF beta R2 in human lung fibrobalsts (HLF) at the mRNA and protein levels. This was accompanied by inhibition of TGF-beta-induced Smad phosphorylation and the expression of TGF-beta target genes, such as fibronectin and smooth muscle alpha-actin. Inhibition of Na+/K+ ATPase by an alternative approach (removal of extracellular potassium) had a similar effect in HLF. Finally, treatment of lung alveolar epithelial cells (A549) with ouabain also resulted in the downregulation of TGF beta R2, the inhibition of TGF-beta-induced Smad phosphorylation and of the expression of mesenchymal markers, vimentin and fibronectin. Together, these data demonstrate a critical role of Na+/K+-ATPase in the control of TGF beta R2 expression, TGF-beta signaling and cell responses to TGF-beta.	[La, Jennifer; Reed, Eleanor; Chan, Lan; Mutlu, Gokhan M.; Dulin, Nickolai O.] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Smolyaninova, Larisa V.; Akomova, Olga A.; Orlov, Sergei N.] Lomonosov Moscow State Univ, Fac Biol, Dept Biophys, Lab Biomembranes, Moscow, Russia; [Orlov, Sergei N.; Dulin, Nickolai O.] Siberian Med State Univ, Tomsk, Russia	University of Chicago; Lomonosov Moscow State University; Siberian State Medical University	Dulin, NO (corresponding author), Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.; Orlov, SN (corresponding author), Lomonosov Moscow State Univ, Fac Biol, Dept Biophys, Lab Biomembranes, Moscow, Russia.; Orlov, SN; Dulin, NO (corresponding author), Siberian Med State Univ, Tomsk, Russia.	sergeinorlov@ya.ru; ndulin@medicine.bsd.uchicago.edu	Smolyaninova, Larisa/H-4093-2014; Orlov, Sergey N./T-3729-2018; Mutlu, Gokhan/HIR-2545-2022		National Institutes of Health Award [1R56HL127395]; National Center For Advancing Translational Sciences of the National Institutes of Health [UL1TR000430]; American Heart Association Predoctoral Fellowship [14PRE18360017]; Russian Foundation for Fundamental Research [14-04-31705, 15-04-385 00101]; Russian Scientific Foundation [14-15-0006]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL127395] Funding Source: NIH RePORTER	National Institutes of Health Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center For Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); American Heart Association Predoctoral Fellowship(American Heart Association); Russian Foundation for Fundamental Research(Russian Foundation for Basic Research (RFBR)); Russian Scientific Foundation(Russian Science Foundation (RSF)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research reported in this publication was supported by the National Institutes of Health Award 1R56HL127395 (N.O.D.) and National Center For Advancing Translational Sciences of the National Institutes of Health under Award UL1TR000430 (N.O.D.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This study was also supported by American Heart Association Predoctoral Fellowship Award 14PRE18360017 (J.L.), the Russian Foundation for Fundamental Research (14-04-31705 and 15-04-385 00101) and the Russian Scientific Foundation #14-15-0006. (O.A.A., S.N.O.).	Abramowitz J, 2003, CIRCULATION, V108, P3048, DOI 10.1161/01.CIR.0000101919.00548.86; ACKERMANN U, 1990, FEBS LETT, V269, P105, DOI 10.1016/0014-5793(90)81130-G; Bai Y, 2016, PHYSL GENOMICS; BARNARD JA, 1989, P NATL ACAD SCI USA, V86, P1578, DOI 10.1073/pnas.86.5.1578; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; BOYD FT, 1989, J BIOL CHEM, V264, P2272; Bridoux F, 1997, J EXP MED, V185, P1769, DOI 10.1084/jem.185.10.1769; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Chen YG, 2009, CELL RES, V19, P58, DOI 10.1038/cr.2008.315; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Fan D, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-15; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Frese S, 2006, CANCER RES, V66, P5867, DOI 10.1158/0008-5472.CAN-05-3544; Geering K, 2001, J BIOENERG BIOMEMBR, V33, P425, DOI 10.1023/A:1010623724749; GEERING K, 1989, AM J PHYSIOL, V257, pC851, DOI 10.1152/ajpcell.1989.257.5.C851; Geering K, 1996, J CELL BIOL, V133, P1193, DOI 10.1083/jcb.133.6.1193; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Kach J, 2014, J BIOL CHEM, V289, P7505, DOI 10.1074/jbc.M113.546812; Kach J, 2013, AM J PHYSIOL-LUNG C, V304, pL757, DOI 10.1152/ajplung.00262.2012; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kometiani P, 2005, MOL PHARMACOL, V67, P929, DOI 10.1124/mol.104.007302; Lee SJ, 2014, WORLD J HEPATOL, V6, P207, DOI 10.4254/wjh.v6.i4.207; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li ZC, 2009, J BIOL CHEM, V284, P21066, DOI 10.1074/jbc.M109.013821; Liang M, 2007, J BIOL CHEM, V282, P10585, DOI 10.1074/jbc.M609181200; Lin SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123305; Lingrel JB, 2010, ANNU REV PHYSIOL, V72, P395, DOI 10.1146/annurev-physiol-021909-135725; Liu LJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1489, DOI 10.1152/ajpcell.00158.2007; Liu LJ, 2004, AM J PHYSIOL-HEART C, V287, pH2173, DOI 10.1152/ajpheart.00352.2004; Liu LJ, 2003, AM J PHYSIOL-CELL PH, V284, pC1550, DOI 10.1152/ajpcell.00555.2002; Mack CP, 2011, ARTERIOSCL THROM VAS, V31, P1495, DOI 10.1161/ATVBAHA.110.221135; Menger L, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23082; Meran S, 2011, INT J EXP PATHOL, V92, P158, DOI 10.1111/j.1365-2613.2011.00764.x; MONTESANO R, 1988, P NATL ACAD SCI USA, V85, P4894, DOI 10.1073/pnas.85.13.4894; MOSES HL, 1992, MOL REPROD DEV, V32, P179, DOI 10.1002/mrd.1080320215; MUSTOE TA, 1987, SCIENCE, V237, P1333, DOI 10.1126/science.2442813; OROSZ F, 1986, ANAL BIOCHEM, V156, P171, DOI 10.1016/0003-2697(86)90169-7; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Penheiter SG, 2002, MOL CELL BIOL, V22, P4750, DOI 10.1128/MCB.22.13.4750-4759.2002; Phan SH, 2002, CHEST, V122, p286S, DOI 10.1378/chest.122.6_suppl.286S; Pickup M, 2013, NAT REV CANCER, V13, P788, DOI 10.1038/nrc3603; Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004; Quintas LEM, 2010, J MOL CELL CARDIOL, V49, P525, DOI 10.1016/j.yjmcc.2010.04.015; Rahimtoola SH, 1996, CURR PROB CARDIOLOGY, V21, P787; Sandbo N, 2011, AM J PHYSIOL-LUNG C, V301, pL656, DOI 10.1152/ajplung.00166.2011; Sandbo N, 2009, AM J RESP CELL MOL, V41, P332, DOI 10.1165/rcmb.2008-0288OC; Schoner W, 2007, AM J PHYSIOL-CELL PH, V293, pC509, DOI 10.1152/ajpcell.00098.2007; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Slingerland M, 2013, INVEST NEW DRUG, V31, P1087, DOI 10.1007/s10637-013-9984-1; SOLOMON AK, 1956, J GEN PHYSIOL, V40, P327, DOI 10.1085/jgp.40.2.327; Stenkvist B, 1999, ONCOL REP, V6, P493; STENKVIST B, 1979, LANCET, V1, P563; STENKVIST B, 1982, NEW ENGL J MED, V306, P484; Strutz F, 2006, J AM SOC NEPHROL, V17, P2992, DOI 10.1681/ASN.2006050420; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; Wu J, 2013, BIOCHEMISTRY-US, V52, P9059, DOI 10.1021/bi4011804; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Ye QQ, 2011, J BIOL CHEM, V286, P6225, DOI 10.1074/jbc.M110.202051	65	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168363	10.1371/journal.pone.0168363	http://dx.doi.org/10.1371/journal.pone.0168363			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006004	Green Submitted, Green Published, gold			2022-12-26	WOS:000392843200046
J	Liao, YL; Wang, LF; Li, YM; Li, Y; Jiang, QQ				Liao, Yulei; Wang, Leifeng; Li, Yiming; Li, Ye; Jiang, Quanquan			The Intelligent Control System and Experiments for an Unmanned Wave Glider (Publication with Expression of Concern. See vol. 17, 2022)	PLOS ONE			English	Article; Publication with Expression of Concern								The control system designing of Unmanned Wave Glider (UWG) is challenging since the control system is weak maneuvering, large time-lag and large disturbance, which is difficult to establish accurate mathematical model. Meanwhile, to complete marine environment monitoring in long time scale and large spatial scale autonomously, UWG asks high requirements of intelligence and reliability. This paper focuses on the "Ocean Rambler" UWG. First, the intelligent control system architecture is designed based on the cerebrum basic function combination zone theory and hierarchic control method. The hardware and software designing of the embedded motion control system are mainly discussed. A motion control system based on rational behavior model of four layers is proposed. Then, combining with the line-of sight method(LOS), a self-adapting PID guidance law is proposed to compensate the steady state error in path following of UWG caused by marine environment disturbance especially current. Based on S-surface control method, an improved S-surface heading controller is proposed to solve the heading control problem of the weak maneuvering carrier under large disturbance. Finally, the simulation experiments were carried out and the UWG completed autonomous path following and marine environment monitoring in sea trials. The simulation experiments and sea trial results prove that the proposed intelligent control system, guidance law, controller have favorable control performance, and the feasibility and reliability of the designed intelligent control system of UWG are verified.	[Liao, Yulei; Wang, Leifeng; Li, Yiming; Li, Ye; Jiang, Quanquan] Harbin Engn Univ, Sci & Technol Underwater Vehicle Lab, Harbin, Heilongjiang, Peoples R China	Harbin Engineering University	Liao, YL (corresponding author), Harbin Engn Univ, Sci & Technol Underwater Vehicle Lab, Harbin, Heilongjiang, Peoples R China.	liaoyulei@hrbeu.edu.cn	li, ye/GWN-2672-2022		National Natural Science Foundation of China [51409061, 51409054, 51579053, 51579022]; Natural Science Foundation of Heilongjiang Province of China [QC2016062]; China Postdoctoral Science Foundation [2013M540271]; Heilongjiang Postdoctoral Financial Assistance [LBH-Z13055]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Heilongjiang Postdoctoral Financial Assistance	This work is supported by the National Natural Science Foundation of China (Grant: 51409061 to Y. Liao), the Natural Science Foundation of Heilongjiang Province of China (Grant: QC2016062 to Y. Liao), the China Postdoctoral Science Foundation (Grant: 2013M540271 to Y. Liao), the Heilongjiang Postdoctoral Financial Assistance (Grant: LBH-Z13055 to Y. Liao), and the National Natural Science Foundation of China (Grants: 51409054, 51579053, and 51579022 to Y. Liao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SH, 2016, IEEE T VEH TECHNOL, V65, P3954, DOI 10.1109/TVT.2016.2558650; Bertaska IR, 2015, OCEAN ENG, V106, P496, DOI 10.1016/j.oceaneng.2015.07.002; Bibuli M, 2008, 2008 IEEE/RSJ INTERNATIONAL CONFERENCE ON ROBOTS AND INTELLIGENT SYSTEMS, VOLS 1-3, CONFERENCE PROCEEDINGS, P3641, DOI 10.1109/IROS.2008.4650890; Breivik M, 2008, UNDERWATER VEHICLES, P51; Cordeschi N, 2015, VEH COMMUN, V2, P1, DOI 10.1016/j.vehcom.2014.08.004; Crimmins DA, 2006, OCEANS-IEEE, P1690; Du QH, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0506-5; Fossen TI, 2002, MARINE CONTROL SYSTE, P1; Galgani Francois, 2013, Rapport du Congress de la CIESM, V40, P306; [甘永 Gan Yong], 2004, [机器人, Robot], V26, P246; Goebel NL, 2014, METHODS OCEANOGRAPHY, V10, P90; Hermsdorfer K, 2015, 19 C AIR SEA INT; Kraus ND, 2012, WAVE GLIDER DYNAMIC, P27; Kraus ND, 2011, OCEANS, P1; [廖煜雷 Liao Yulei], 2012, [高技术通讯, Chinese High Technology Letters], V22, P416; Liao YL, 2010, 2ND IEEE INTERNATIONAL CONFERENCE ON ADVANCED COMPUTER CONTROL (ICACC 2010), VOL. 4, P70, DOI 10.1109/ICACC.2010.5486937; Liu HB, 2005, NEUROPSYCHOLOGICAL M, P18; Liu X.M., 2001, OCEAN ENG, V19, P81; Lu X., 2015, RES GEN TECHNOLOGY W, P23; Manley J, 2011, IEEE INSTRUMENTATION, V13, P8; Manley JE., 2008, P OC 2008 MTS IEEE Q; Meyer-Gutbrod E, 2012, IEEE MTS OCEANS 2012, V11, P1; Moreira L, 2007, OCEAN ENG, V34, P2074, DOI 10.1016/j.oceaneng.2007.02.005; Ngo P, 2013, P AUSTR C ROB AUT AU, P1; Ngo P, 2014, IEEE INT C INT ROBOT, P2250, DOI 10.1109/IROS.2014.6942866; O'Reilly TC, 2015, COMMICATIONS RELAY A; Oh SR, 2009, OCEAN ENG, V36, P1; [史健 Shi Jian], 2014, [传感器与微系统, Transducer and Microsystem Technology], V33, P23; Shojafar Mohammad, 2013, Journal of Computing Science and Engineering, V7, P44, DOI 10.5626/JCSE.2013.7.1.44; Smith RN, 2011, OCEANS 11 MTS IEEE K, P1; Van LV, 2015, PLOS ONE, V10, P1; Wang XM, 2012, RENEW SUST ENERG REV, V16, P1958, DOI 10.1016/j.rser.2011.12.016; Xu C. Y., 2014, J OCEAN TECHNOL, V33, P111; [张顺 Zhang Shun], 2014, [振动与冲击, Journal of Vibration and Shock], V33, P119; 王迅, 2008, [海洋科学, Marine Sciences], V32, P84	35	19	23	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168792	10.1371/journal.pone.0168792	http://dx.doi.org/10.1371/journal.pone.0168792			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005956	Green Submitted, Green Published, gold			2022-12-26	WOS:000392843200094
J	Ma, LN; Wang, LY; Chu, YF; Li, XR; Cui, YJ; Chen, SL; Zhou, JH; Li, CL; Lu, ZX; Liu, JX; Liu, YS				Ma, Lina; Wang, Liyan; Chu, Yuefeng; Li, Xuerui; Cui, Yujun; Chen, Shengli; Zhou, Jianhua; Li, Chunling; Lu, Zhongxin; Liu, Jixing; Liu, Yongsheng			Characterization of Chinese Haemophilus parasuis Isolates by Traditional Serotyping and Molecular Serotyping Methods	PLoS One			English	Article							SEROLOGICAL CHARACTERIZATION; INDIRECT HEMAGGLUTINATION; RESPIRATORY-TRACT; PIGS; PREVALENCE; SEROVARS; STRAINS; SWINE; PCR; PASTEURELLACEAE	Haemophilus parasuis is classified mainly through serotyping, but traditional serotyping always yields non-typable (NT) strains and unreliable results via cross-reactions. Here, we surveyed the serotype prevalence of Chinese H. parasuis isolates using traditional serotyping (gel immuno-diffusion test, GID) and molecular serotyping (multiplex PCR, mPCR). We also investigated why discrepant results between these methods were obtained, and investigated mPCR failure through whole-genome sequencing. Of the 100 isolate tested, 73 (73%) and 93 (93%) were serotyped by the GID test and mPCR, respectively, with a concordance rate of 66% (66/100). Additionally, mPCR reduced the number of NT isolates from 27 (27%) for the GID testing, to seven (7%). Eleven isolates were sequenced, including nine serotype-discrepant isolates from mPCR and GID typing (excluding strains that were NT by GID only) and two NT isolates from both methods, and their in silico serotypes were obtained from genome sequencing based on their capsule loci. The mPCR results were supported by the in silico serotyping of the seven serotype-discrepant isolates. The discrepant results and NT isolates determined by mPCR were attributed to deletions and unknown sequences in the serotype-specific region of each capsule locus. Compared with previous investigations, this study found a similar predominant serotype profile, but a different prevalence frequency for H. parasuis, and the five most prevalent serotypes or strain groups were serotypes 5, 4, NT, 7 and 13 for mPCR, and serotypes 5, NT, 4, 7 and 13/10/14 for GID. Additionally, serotype 7 was recognized as a principal serotype in this work.	[Ma, Lina; Wang, Liyan; Chu, Yuefeng; Li, Xuerui; Chen, Shengli; Zhou, Jianhua; Lu, Zhongxin; Liu, Jixing; Liu, Yongsheng] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China; [Cui, Yujun] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Li, Chunling] Guangdong Acad Agr Sci, Inst Anim Hlth, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Beijing Institute of Microbiology & Epidemiology; Guangdong Academy of Agricultural Sciences	Liu, YS (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China.	liuyongsheng@caas.cn	Chu, Yuefeng/K-9892-2019		National Nature Science Foundation of China [31172335]; Special Fund for Agro-scientific Research in the Public Interest [201303034-2]; State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, CAAS [SKLVEB2012KFKT010]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, CAAS	This work was supported by National Nature Science Foundation of China (No.31172335) for YL, the Special Fund for Agro-scientific Research in the Public Interest (Grant No. 201303034-2) for ZI and State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, CAAS (No. SKLVEB2012KFKT010) for YC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angen O, 2004, VET MICROBIOL, V103, P255, DOI 10.1016/j.vetmic.2004.07.013; Angen O, 2007, VET MICROBIOL, V119, P266, DOI 10.1016/j.vetmic.2006.10.008; Aragon V, 2010, VET MICROBIOL, V142, P387, DOI 10.1016/j.vetmic.2009.10.025; BIBERSTEIN EL, 1969, J MED MICROBIOL, V2, P75, DOI 10.1099/00222615-2-1-75; Blackall PJ, 1996, AUST VET J, V73, P93, DOI 10.1111/j.1751-0813.1996.tb09984.x; Brockmeier SL, 2002, POLYMICROBIAL DISEASES, P231; Cai XW, 2005, VET MICROBIOL, V111, P231, DOI 10.1016/j.vetmic.2005.07.007; Castilla KS, 2012, RES VET SCI, V92, P366, DOI 10.1016/j.rvsc.2011.04.006; Del Rio ML, 2003, J CLIN MICROBIOL, V41, P880, DOI 10.1128/JCM.41.2.880-882.2003; Dijkman R, 2012, RES VET SCI, V93, P589, DOI 10.1016/j.rvsc.2011.10.013; Gentle A, 2016, J CLIN MICROBIOL, V54, P1456, DOI 10.1128/JCM.03386-15; Howell KJ, 2015, J CLIN MICROBIOL, V53, P3812, DOI 10.1128/JCM.01991-15; Howell KJ, 2013, J BACTERIOL, V195, P4264, DOI 10.1128/JB.00471-13; KIELSTEIN P, 1992, J CLIN MICROBIOL, V30, P862, DOI 10.1128/JCM.30.4.862-865.1992; KIELSTEIN P, 1991, J VET MED B, V38, P315, DOI 10.1111/j.1439-0450.1991.tb00877.x; Kim J, 2002, J VET MED SCI, V64, P57, DOI 10.1292/jvms.64.57; Maskell D.J, 2014, BMC GENOMICS, V15, P1179, DOI 10.1186/1471-2164-15-1179; MOLLER K, 1993, VET MICROBIOL, V36, P261, DOI 10.1016/0378-1135(93)90093-M; MOLLER K, 1990, J CLIN MICROBIOL, V28, P2711; MOROZUMI T, 1986, J CLIN MICROBIOL, V23, P1022, DOI 10.1128/JCM.23.6.1022-1025.1986; MOROZUMI T, 1986, J CLIN MICROBIOL, V23, P138, DOI 10.1128/JCM.23.1.138-142.1986; Oliveira S, 2004, VET MICROBIOL, V99, P1, DOI 10.1016/j.vetmic.2003.12.001; Oliveira S, 2003, AM J VET RES, V64, P435, DOI 10.2460/ajvr.2003.64.435; Palzer A, 2015, CAN VET J, V56, P285; Rafiee M, 2000, AUST VET J, V78, P172, DOI 10.1111/j.1751-0813.2000.tb10586.x; RAPPGABRIELSON VJ, 1992, AM J VET RES, V53, P659; Rubies X, 1999, VET MICROBIOL, V66, P245, DOI 10.1016/S0378-1135(99)00007-3; SMART NL, 1989, CAN VET J, V30, P339; Tadjine A, 2004, J CLIN MICROBIOL, V42, P839, DOI 10.1128/JCM.42.2.839-840.2004; Turni C, 2005, VET MICROBIOL, V106, P145, DOI 10.1016/j.vetmic.2004.12.019; Turni C, 2010, AUST VET J, V88, P255, DOI 10.1111/j.1751-0813.2010.00592.x; Yu J, 2012, VET MICROBIOL, V158, P316, DOI 10.1016/j.vetmic.2012.03.001; Yue M, 2009, J BACTERIOL, V191, P1359, DOI 10.1128/JB.01682-08; Zhang J, 2011, LETT APPL MICROBIOL, V52, P589, DOI 10.1111/j.1472-765X.2011.03048.x	34	25	32	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168903	10.1371/journal.pone.0168903	http://dx.doi.org/10.1371/journal.pone.0168903			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005999	Green Published, Green Submitted, gold			2022-12-26	WOS:000392843200108
J	Persson, N; Jansson, B; Stuhr-Hansen, N; Kovacs, A; Welinder, C; Danielsson, L; Blixt, O				Persson, Nina; Jansson, Bo; Stuhr-Hansen, Nicolai; Kovacs, Andras; Welinder, Charlotte; Danielsson, Lena; Blixt, Ola			A Combinatory Antibody-Antigen Microarray Assay for High-Content Screening of Single-Chain Fragment Variable Clones from Recombinant Libraries	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; TN-ANTIGEN; CONSTRUCTION; EXPRESSION; GENERATION	We have developed a combinatory antibody-antigen microarray for direct screening of multiple single-chain fragment variable (scFv) clones with no need for pre-purification or enrichment before screening. The straightforward workflow allows for early selection of binders to predefined peptide and glycopeptide targets. A capture antibody is contact printed on microarray slides, side by side with the antigens of interest. A large number of scFv clones, in supernatants, are printed on top of the capture antibody and the antigen in a "spot-on-spot" print. The printed scFv clones, which bind to the capture antibody, are detected using biotinylated antigen, while the binding of scFv clones to the printed antigen is detected through a mouse anti-tag antibody. Two different analyses are thus performed on the same slide, generating two kinds of information: one on the ability of an individual scFv clone to bind to the soluble form of the antigen, which may favour selection for higher affinity rather than avidity, while the other allows the identification of large numbers of clones, simultaneously, due to the binding of scFv clones to densely presented antigens, thus providing an overall increased hit rate. The functionality of the new screening approach was illustrated through the generation of antibodies against peptides from the chaperone complex Ku70/Ku80 and the GalNAc alpha-serine/threonine epitope on the IgA1 alpha chain hinge region. In total, 659 scFv clones were screened with a hit rate of approximately 20%. This approach allowed the identification of functional antibodies in both cases, illustrating the usefulness and capacity of this combinatory microarray screening technique for efficient analysis and validation of antibodies at an early stage of antibody generation.	[Persson, Nina; Stuhr-Hansen, Nicolai; Kovacs, Andras; Blixt, Ola] Univ Copenhagen, Dept Chem, Chem Glycobiol Lab, Copenhagen, Denmark; [Jansson, Bo; Welinder, Charlotte] Lund Univ, Div Oncol & Pathol, Dept Clin Sci Lund, Lund, Sweden; [Kovacs, Andras; Danielsson, Lena] Lund Univ, Div Clin Chem & Pharmacol, Dept Lab Med, Lund, Sweden; [Welinder, Charlotte] Lund Univ, Ctr Excellence Biol & Med Mass Spectrometry CEBMM, Biomed Ctr D13, Lund, Sweden	University of Copenhagen; Lund University; Lund University; Lund University	Blixt, O (corresponding author), Univ Copenhagen, Dept Chem, Chem Glycobiol Lab, Copenhagen, Denmark.	olablixt@chem.ku.dk	Welinder, Charlotte/G-1144-2014	Welinder, Charlotte/0000-0001-9626-0576; Stuhr-Hansen, Nicolai/0000-0001-7497-8915; Blixt, Ola/0000-0003-4143-6276	European Union, Seventh Framework Programme, GastricGlycoExplorer (GGE) initial training network [316929]; Danish Research Council [DFF-4005-00285]; Innovationsfonden; Mrs. Berta Kamprad's Foundation	European Union, Seventh Framework Programme, GastricGlycoExplorer (GGE) initial training network; Danish Research Council(Det Frie Forskningsrad (DFF)); Innovationsfonden; Mrs. Berta Kamprad's Foundation	This work was supported by European Union, Seventh Framework Programme, GastricGlycoExplorer (GGE) initial training network: grant number 316929, OB; The Danish Research Council: DFF-4005-00285, OB, BJ, LD, CW; Innovationsfonden in the framework of the EU-ERASynBio project SynGlycTis, OB; and Mrs. Berta Kamprad's Foundation, CW and BJ.	Abdiche YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092451; Ando H, 2008, BIOL PHARM BULL, V31, P1739, DOI 10.1248/bpb.31.1739; Angenendt P, 2004, ANAL CHEM, V76, P2916, DOI 10.1021/ac035357a; Ayriss J, 2007, J PROTEOME RES, V6, P1072, DOI 10.1021/pr0604108; Babel I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-61; Blixt O, 2013, METHODS MOL BIOL, V1047, P201, DOI 10.1007/978-1-62703-544-6_14; Blixt O, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2841; Blixt O, 2010, J PROTEOME RES, V9, P5250, DOI 10.1021/pr1005229; Cai H, 2015, CHEMBIOCHEM, V16, P959, DOI 10.1002/cbic.201402689; Ecker DM, 2015, MABS-AUSTIN, V7, P9, DOI 10.4161/19420862.2015.989042; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Ju TZ, 2014, CANCER BIOMARK, V14, P63, DOI 10.3233/CBM-130375; Kibat J, NEW BIOTECHNOLOGY; Kibat J, 2016, NEW BIOTECHNOL, V33, P574, DOI 10.1016/j.nbt.2015.12.003; Krebber A, 1997, J IMMUNOL METHODS, V201, P35, DOI 10.1016/S0022-1759(96)00208-6; Li J, 2010, ACTA PHARMACOL SIN, V31, P1198, DOI 10.1038/aps.2010.120; Lindner Peter, 2001, P637; Loureiro LR, 2015, BIOMOLECULES, V5, P1783, DOI 10.3390/biom5031783; Muller C, 2005, CELL CYCLE, V4, P438, DOI 10.4161/cc.4.3.1565; NAKADA H, 1991, BIOCHEM BIOPH RES CO, V179, P762, DOI 10.1016/0006-291X(91)91882-D; Schaefer JV, 2010, ANTIBODY ENGINEERING, VOL 1, SECOND EDITION, P21, DOI 10.1007/978-3-642-01144-3_3; Schwenk JM, 2007, MOL CELL PROTEOMICS, V6, P125, DOI 10.1074/mcp.T600035-MCP200; Seurynck-Servoss SL, 2008, PROTEOMICS, V8, P2199, DOI 10.1002/pmic.200701036; Shahsavarian MA, 2014, J IMMUNOL METHODS, V407, P26, DOI 10.1016/j.jim.2014.03.015; Turunen L, 2009, J BIOMOL SCREEN, V14, P282, DOI 10.1177/1087057108330113; Welinder C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061749; Welinder C, 2011, GLYCOBIOLOGY, V21, P1097, DOI 10.1093/glycob/cwr048; Yuasa N, 2012, J BIOCHEM, V151, P371, DOI 10.1093/jb/mvs007; ZEGERS N, 1990, J IMMUNOL METHODS, V130, P195, DOI 10.1016/0022-1759(90)90048-Z	29	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168761	10.1371/journal.pone.0168761	http://dx.doi.org/10.1371/journal.pone.0168761			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002485	Green Published, gold, Green Submitted			2022-12-26	WOS:000392853100065
J	Xue, B; Lipps, D; Devineni, S				Xue, Bin; Lipps, David; Devineni, Sree			Integrated Strategy Improves the Prediction Accuracy of miRNA in Large Dataset	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; MICRORNA PRECURSORS; HUMAN GENOME; CONSENSUS PREDICTION; IDENTIFICATION; SEQUENCE; REAL; CLASSIFICATION; MAP	MiRNAs are short non-coding RNAs of about 22 nucleotides, which play critical roles in gene expression regulation. The biogenesis of miRNAs is largely determined by the sequence and structural features of their parental RNA molecules. Based on these features, multiple computational tools have been developed to predict if RNA transcripts contain miRNAs or not. Although being very successful, these predictors started to face multiple challenges in recent years. Many predictors were optimized using datasets of hundreds of miRNA samples. The sizes of these datasets are much smaller than the number of known miRNAs. Consequently, the prediction accuracy of these predictors in large dataset becomes unknown and needs to be re-tested. In addition, many predictors were optimized for either high sensitivity or high specificity. These optimization strategies may bring in serious limitations in applications. Moreover, to meet continuously raised expectations on these computational tools, improving the prediction accuracy becomes extremely important. In this study, a meta-predictor mirMeta was developed by integrating a set of non-linear transformations with meta-strategy. More specifically, the outputs of five individual predictors were first preprocessed using non-linear transformations, and then fed into an artificial neural network to make the meta-prediction. The prediction accuracy of meta-predictor was validated using both multi-fold cross-validation and independent dataset. The final accuracy of meta-predictor in newly-designed large dataset is improved by 7% to 93%. The meta-predictor is also proved to be less dependent on datasets, as well as has refined balance between sensitivity and specificity. This study has two folds of importance: First, it shows that the combination of non-linear transformations and artificial neural networks improves the prediction accuracy of individual predictors. Second, a new miRNA predictor with significantly improved prediction accuracy is developed for the community for identifying novel miRNAs and the complete set of miRNAs.	[Xue, Bin; Lipps, David; Devineni, Sree] Univ S Florida, Coll Arts & Sci, Dept Cell Biol Microbiol & Mol Biol, Sch Nat Sci & Math, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Xue, B (corresponding author), Univ S Florida, Coll Arts & Sci, Dept Cell Biol Microbiol & Mol Biol, Sch Nat Sci & Math, Tampa, FL 33620 USA.	binxue@usf.edu	D, Sree Phani Kishore/U-5335-2018	D, Sree Phani Kishore/0000-0001-7287-5162	Department of Cell Biology, Microbiology and Molecular Biology and College of Arts and Sciences at the University of South Florida	Department of Cell Biology, Microbiology and Molecular Biology and College of Arts and Sciences at the University of South Florida	This work was supported by startup funding from the Department of Cell Biology, Microbiology and Molecular Biology and College of Arts and Sciences at the University of South Florida to BX. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brameier M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-478; Chatterjee P, 2011, J MOL MODEL, V17, P2191, DOI 10.1007/s00894-011-1102-8; Chorley BN, 2008, MUTAT RES-REV MUTAT, V659, P147, DOI 10.1016/j.mrrev.2008.05.001; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; den Dunnen JT, 2000, HUM MUTAT, V15, P7; DENMAN RB, 1993, BIOTECHNIQUES, V15, P1090; Dezulian T, 2006, BIOINFORMATICS, V22, P359, DOI 10.1093/bioinformatics/bti802; Dole NS, 2016, BONE, V84, P57, DOI 10.1016/j.bone.2015.12.016; Ennis S, 2001, Brief Bioinform, V2, P375, DOI 10.1093/bib/2.4.375; Eyers CE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003384; Fischer D, 2003, PROTEINS, V51, P434, DOI 10.1002/prot.10357; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gan YL, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-49; Gaspari Z, 2012, BBA-PROTEINS PROTEOM, V1824, P637, DOI 10.1016/j.bbapap.2012.01.012; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Haraksingh RR, 2013, J MOL BIOL, V425, P3970, DOI 10.1016/j.jmb.2013.07.015; Hertel J, 2006, BIOINFORMATICS, V22, pE197, DOI 10.1093/bioinformatics/btl257; Hooper CM, 2014, BIOINFORMATICS, V30, P3356, DOI 10.1093/bioinformatics/btu550; Huang QY, 2015, J GENET GENOMICS, V42, P87, DOI 10.1016/j.jgg.2015.02.001; Huang TH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-341; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Legendre M, 2005, BIOINFORMATICS, V21, P841, DOI 10.1093/bioinformatics/bti073; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Liu J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm562; Mathelier A, 2010, BIOINFORMATICS, V26, P2226, DOI 10.1093/bioinformatics/btq329; Mishra PJ, 2008, CELL CYCLE, V7, P853, DOI 10.4161/cc.7.7.5666; Morozova N, 2012, RNA, V18, P1635, DOI 10.1261/rna.032284.112; Nam JW, 2006, NUCLEIC ACIDS RES, V34, pW455, DOI 10.1093/nar/gkl321; Nawrocki EP, 2015, NUCLEIC ACIDS RES, V43, pD130, DOI 10.1093/nar/gku1063; Ohue Masahito, 2013, BMC Proc, V7, pS6, DOI 10.1186/1753-6561-7-S7-S6; Riley J H, 2000, Pharmacogenomics, V1, P39, DOI 10.1517/14622416.1.1.39; Ritchie W, 2008, BIOINFORMATICS, V24, P1394, DOI 10.1093/bioinformatics/btn137; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Schlessinger A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004433; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Sewer A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-267; Singh H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105667; Stefl S, 2013, J MOL BIOL, V425, P3919, DOI 10.1016/j.jmb.2013.07.014; Wan J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm848; Wang JW, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-374; Wang Xuting, 2005, Toxicol Appl Pharmacol, V207, P84, DOI 10.1016/j.taap.2004.09.024; Wang XW, 2005, BIOINFORMATICS, V21, P3610, DOI 10.1093/bioinformatics/bti562; Wu YG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-107; Xia JF, 2010, AMINO ACIDS, V39, P1595, DOI 10.1007/s00726-010-0588-1; Xue B, 2008, PROTEINS, V72, P427, DOI 10.1002/prot.21940; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Xue B, 2009, FEBS LETT, V583, P1469, DOI 10.1016/j.febslet.2009.03.070; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Yates CM, 2013, J MOL BIOL, V425, P3949, DOI 10.1016/j.jmb.2013.07.012; Yousef M, 2006, BIOINFORMATICS, V22, P1325, DOI 10.1093/bioinformatics/btl094	58	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168392	10.1371/journal.pone.0168392	http://dx.doi.org/10.1371/journal.pone.0168392			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002428	Green Submitted, gold, Green Published			2022-12-26	WOS:000392853100042
J	Chang, L; He, SY; Mao, DQ; Liu, YH; Xiong, ZJ; Fu, DK; Li, B; Wei, SG; Xu, X; Li, SB; Yuan, H				Chang, Liao; He, Shiyang; Mao, Danqing; Liu, Yuanhong; Xiong, Zijun; Fu, Dongke; Li, Bo; Wei, Shuguang; Xu, Xun; Li, Shengbin; Yuan, Hui			Signatures of Crested Ibis MHC Revealed by Recombination Screening and Short-Reads Assembly Strategy	PLOS ONE			English	Article							C-TYPE LECTIN; CHICKEN MHC; GENES; COMPLEX; CONSTRUCTION; COEVOLUTION; DIVERSITY; EVOLUTION; SEQUENCE; CHOICE	Whole-genome shotgun (WGS) sequencing has become a routine method in genome research over the past decade. However, the assembly of highly polymorphic regions in WGS projects remains a challenge, especially for large genomes. Employing BAC library constructing, PCR screening and Sanger sequencing, traditional strategy is laborious and expensive, which hampers research on polymorphic genomic regions. As one of the most highly polymorphic regions, the major histocompatibility complex (MHC) plays a central role in the adaptive immunity of all jawed vertebrates. In this study, we introduced an efficient procedure based on recombination screening and short-reads assembly. With this procedure, we constructed a high quality 488-kb region of crested ibis MHC that consists of 3 superscaffolds and contains 50 genes. Our sequence showed comparable quality (97.29% identity) to traditional Sanger assembly, while the workload was reduced almost 7 times. Comparative study revealed distinctive features of crested ibis by exhibiting the COL11A2-BLA-BLB-BRD2 cluster and presenting both ADPRH and odorant receptor (OR) gene in the MHC region. Furthermore, the conservation of the BF-TAP1-TAP2 structure in crested ibis and other vertebrate lineages is interesting in light of the hypothesis that coevolution of functionally related genes in the primordial MHC is responsible for the appearance of the antigen presentation pathways at the birth of the adaptive immune system.	[Chang, Liao; Xiong, Zijun; Fu, Dongke; Wei, Shuguang; Li, Shengbin] Xi An Jiao Tong Univ, Coll Med & Forens, Xian, Shaanxi, Peoples R China; [Chang, Liao; He, Shiyang; Mao, Danqing; Liu, Yuanhong; Xiong, Zijun; Li, Bo; Xu, Xun; Li, Shengbin; Yuan, Hui] BGI Shenzhen, Shenzhen, Guangdong, Peoples R China; [Yuan, Hui] Northeast Agr Univ, Coll Anim Sci & Technol, Harbin, Heilongjiang, Peoples R China	Xi'an Jiaotong University; Beijing Genomics Institute (BGI); Northeast Agricultural University - China	Li, SB (corresponding author), Xi An Jiao Tong Univ, Coll Med & Forens, Xian, Shaanxi, Peoples R China.; Li, SB; Yuan, H (corresponding author), BGI Shenzhen, Shenzhen, Guangdong, Peoples R China.; Yuan, H (corresponding author), Northeast Agr Univ, Coll Anim Sci & Technol, Harbin, Heilongjiang, Peoples R China.	shbinlee@mail.xjtu.edu.cn; huiyuanChina@163.com	He, Shiyang/CAH-6600-2022; Xu, Xun/AAI-6763-2020; Chang, Liao/AAG-1643-2020	He, Shiyang/0000-0002-1849-2635; Xu, Xun/0000-0002-5338-5173; Xiong, Zijun/0000-0003-3923-0703; Yuan, Hui/0000-0001-9739-3645				Alexeyenko A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-439; Asakawa S, 1997, GENE, V191, P69, DOI 10.1016/S0378-1119(97)00044-9; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Balakrishnan CN, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-29; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Chaves LD, 2009, J IMMUNOL, V183, P6530, DOI 10.4049/jimmunol.0901310; Chen LC, 2015, SCI REP-UK, V5, DOI 10.1038/srep07963; Dirscherl H, 2014, DEV COMP IMMUNOL, V46, P11, DOI 10.1016/j.dci.2014.02.018; Ekblom R, 2011, IMMUNOGENETICS, V63, P523, DOI [10.1007/s00251-011-0525-9, 10.1007/s00251-011-0528-6]; Farrar K, 2007, NAT PROTOC, V2, P1661, DOI 10.1038/nprot.2007.204; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Hedrick PW, 2000, EVOLUTION, V54, P2145; Huddleston J, 2014, GENOME RES, V24, P688, DOI 10.1101/gr.168450.113; Hughes CR, 2008, IMMUNOGENETICS, V60, P219, DOI 10.1007/s00251-008-0287-1; Hughes JF, 2012, NATURE, V483, P82, DOI 10.1038/nature10843; Hurt P, 2004, GENOME RES, V14, P631, DOI 10.1101/gr.1987704; Jaratlerdsiri W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114631; Kaufman J, 1999, NATURE, V401, P923, DOI 10.1038/44856; Laloi D, 2011, BEHAV PROCESS, V88, P149, DOI 10.1016/j.beproc.2011.08.011; Li SB, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0557-1; LI SX, 2014, J INEQUAL APPL 1119, P6312, DOI DOI 10.1186/S13059-014-0557-1; LIN YZ, 1981, ACTA ZOOL SINICA, V27, P273; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Magor KE, 2013, DEV COMP IMMUNOL, V41, P377, DOI 10.1016/j.dci.2013.04.010; McPeek MA, 2006, EVOLUTION, V60, P1967, DOI 10.1111/j.0014-3820.2006.tb01835.x; Miller MM, 2014, J HERED, V105, P203, DOI 10.1093/jhered/est091; Miller MM, 2004, IMMUNOGENETICS, V56, P261, DOI 10.1007/s00251-004-0682-1; Nedelkova M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr668; Ohta Y, 2015, IMMUNOL REV, V267, P6, DOI 10.1111/imr.12324; Ren LM, 2011, IMMUNOGENETICS, V63, P667, DOI 10.1007/s00251-011-0545-5; Richardson DS, 2003, MOL ECOL, V12, P3523, DOI 10.1046/j.1365-294X.2003.02005.x; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Roberts SC, 2003, NAT GENET, V35, P103, DOI 10.1038/ng1231; Rogers SL, 2005, J IMMUNOL, V174, P3475, DOI 10.4049/jimmunol.174.6.3475; Ruby T, 2005, IMMUNOGENETICS, V57, P116, DOI 10.1007/s00251-005-0770-x; Salomonsen J, 2003, IMMUNOGENETICS, V55, P605, DOI 10.1007/s00251-003-0620-7; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; She R, 2009, GENOME RES, V19, P143, DOI 10.1101/gr.082081.108; Shiina T, 2006, ANIM SCI J, V77, P151, DOI 10.1111/j.1740-0929.2006.00333.x; Shiina T, 2004, J IMMUNOL, V172, P6751, DOI 10.4049/jimmunol.172.11.6751; Shiina T, 2007, J IMMUNOL, V178, P7162, DOI 10.4049/jimmunol.178.11.7162; Solinhac R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-616; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Taniguchi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108506; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Walker BA, 2011, P NATL ACAD SCI USA, V108, P8396, DOI 10.1073/pnas.1019496108; Walter L, 2000, IMMUNOGENETICS, V51, P829, DOI 10.1007/s002510000219; Wang B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-553; Wilming LG, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat011; Ye Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032154; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	53	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168744	10.1371/journal.pone.0168744	http://dx.doi.org/10.1371/journal.pone.0168744			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997612	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842900072
J	Levchenko, M; Lorenzi, I; Dudek, J				Levchenko, Mariia; Lorenzi, Isotta; Dudek, Jan			The Degradation Pathway of the Mitophagy Receptor Atg32 Is Re-Routed by a Posttranslational Modification	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; AUTOPHAGOSOME FORMATION; MITOCHONDRIAL PROTEIN; VACUOLAR HYDROLASES; SELECTIVE AUTOPHAGY; MEDIATES MITOPHAGY; CONJUGATION SYSTEM; IN-VIVO; YEAST; FISSION	The outer mitochondrial membrane protein Atg32 is the central receptor for mitophagy, the mitochondria-specific form of autophagy. Atg32 is an unstable protein, and is rapidly degraded under conditions in which mitophagy is not induced. Here we show that Atg32 undergoes a posttranslational modification upon induction of mitophagy. The modification is dependent on the core autophagic machinery, including Atg8, and on the mitophagy-specific adaptor protein Atg11. The modified Atg32 is targeted to the vacuole where it becomes stabilized when vacuolar proteases are deficient. Interestingly, we find that this degradation pathway differs from the degradation pathway of non-modified Atg32, which neither involves vacuolar proteases, nor the proteasome. These analyses reveal that a posttranslational modification discriminates a form of Atg32 targeting mitochondria for mitophagy from that, which escapes mitophagy by rapid degradation.	[Levchenko, Mariia; Lorenzi, Isotta; Dudek, Jan] Georg August Univ, Dept Cellular Biochem, Gottingen, Germany	University of Gottingen	Dudek, J (corresponding author), Georg August Univ, Dept Cellular Biochem, Gottingen, Germany.	Jan.Dudek@med.uni-goettingen.de		Levchenko, Maria/0000-0003-0706-515X	Boehringer Ingelheim Fonds; Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences; Deutsche Forschungsgemeinschaft (DFG)	Boehringer Ingelheim Fonds(Boehringer Ingelheim); Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by the "Boehringer Ingelheim Fonds" (ML) and the "Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences".; This study was supported by the "Boehringer Ingelheim Fonds" (ML) and the "Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences". We also thank the Deutsche Forschungsgemeinschaft (DFG) for funding, Dr. Blanche Schwappach for the Pgk1 antibody, Dr. Michael Thumm and Dr. Peter Rehling for discussion.	Aoki Y, 2011, MOL BIOL CELL, V22, P3206, DOI 10.1091/mbc.E11-02-0145; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Bhatia-Kissova I, 2010, FEMS YEAST RES, V10, P1023, DOI 10.1111/j.1567-1364.2010.00659.x; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Farre JC, 2013, EMBO REP, V14, P441, DOI 10.1038/embor.2013.40; Frazier AE, 2006, J CELL BIOL, V172, P553, DOI 10.1083/jcb.200505060; Geng JF, 2008, EMBO REP, V9, P859, DOI 10.1038/embor.2008.163; Germain D, 2008, MOL MICROBIOL, V70, P1334, DOI 10.1111/j.1365-2958.2008.06502.x; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Harding TM, 1996, J BIOL CHEM, V271, P17621, DOI 10.1074/jbc.271.30.17621; HEINEMEYER W, 1991, EMBO J, V10, P555, DOI 10.1002/j.1460-2075.1991.tb07982.x; HILT W, 1993, J BIOL CHEM, V268, P3479; HOCHSTRASSER M, 1991, P NATL ACAD SCI USA, V88, P4606, DOI 10.1073/pnas.88.11.4606; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Janke C, 2004, VERSATILE TOOLBOX PC, P1; Jin MY, 2014, FEBS LETT, V588, P2457, DOI 10.1016/j.febslet.2014.06.015; Jin MY, 2013, CELL, V152, P368, DOI 10.1016/j.cell.2013.01.004; JONES EW, 1982, GENETICS, V102, P665; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kanki T, 2013, EMBO REP, V14, P788, DOI 10.1038/embor.2013.114; Kanki T, 2011, ANTIOXID REDOX SIGN, V14, P1989, DOI 10.1089/ars.2010.3762; Kanki T, 2009, AUTOPHAGY, V5, P1201, DOI 10.4161/auto.5.8.9747; Kanki T, 2009, AUTOPHAGY, V5, P1186, DOI 10.4161/auto.5.8.9854; Kanki T, 2009, MOL BIOL CELL, V20, P4730, DOI 10.1091/mbc.E09-03-0225; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kissova I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kraft C, 2012, CURR OPIN CELL BIOL, V24, P496, DOI 10.1016/j.ceb.2012.05.001; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Kurihara Y, 2012, J BIOL CHEM, V287, P3265, DOI 10.1074/jbc.M111.280156; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Livnat-Levanon N, 2011, BBA-GENE REGUL MECH, V1809, P80, DOI 10.1016/j.bbagrm.2010.07.005; Malagelada C, 2010, J NEUROSCI, V30, P1166, DOI 10.1523/JNEUROSCI.3944-09.2010; Mao K, 2013, DEV CELL, V26, P9, DOI 10.1016/j.devcel.2013.05.024; Mao K, 2011, J CELL BIOL, V193, P755, DOI 10.1083/jcb.201102092; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; Mendl N, 2011, J CELL SCI, V124, P1339, DOI 10.1242/jcs.076406; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Muller M, 2015, CELL REP, V10, P1215, DOI 10.1016/j.celrep.2015.01.044; Murakawa T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8527; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Neutzner A, 2008, ANN NY ACAD SCI, V1147, P242, DOI 10.1196/annals.1427.012; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Otsu K, 2015, AUTOPHAGY, V11, P1932, DOI 10.1080/15548627.2015.1084459; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Rehling P, 2003, SCIENCE, V299, P1747, DOI 10.1126/science.1080945; Schrepfer E, 2016, MOL CELL, V61, P683, DOI 10.1016/j.molcel.2016.02.022; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Takeda K, 2010, AUTOPHAGY, V6, P564, DOI 10.4161/auto.6.4.11948; Teter SA, 2001, J BIOL CHEM, V276, P2083, DOI 10.1074/jbc.C000739200; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wang K.X., 2013, J COMPUT INF SYST, V9, P1; Welter E, 2013, FEBS J, V280, P4970, DOI 10.1111/febs.12468; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; ZUBENKO GS, 1983, P NATL ACAD SCI-BIOL, V80, P510, DOI 10.1073/pnas.80.2.510	66	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168518	10.1371/journal.pone.0168518	http://dx.doi.org/10.1371/journal.pone.0168518			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992522	Green Published, Green Submitted, gold			2022-12-26	WOS:000392758000056
J	Sakamoto, S; Ikeda, H; Tsuyuguchi, N; Uda, T; Okumura, E; Asakawa, T; Haruta, Y; Nishiyama, H; Okada, T; Kamada, H; Ohata, K; Miki, Y				Sakamoto, Shinichi; Ikeda, Hidetoshi; Tsuyuguchi, Naohiro; Uda, Takehiro; Okumura, Eiichi; Asakawa, Takashi; Haruta, Yasuhiro; Nishiyama, Hideki; Okada, Toyoji; Kamada, Hajime; Ohata, Kenji; Miki, Yukio			MEG Frequency Analysis Depicts the Impaired Neurophysiological Condition of Ischemic Brain	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CEREBRAL-ARTERY OCCLUSION; ACUTE HEMISPHERIC STROKE; BLOOD-FLOW; COMPUTED-TOMOGRAPHY; SOURCE LOCALIZATION; OXYGEN-METABOLISM; QUANTITATIVE EEG; MISERY-PERFUSION; MAGNETIC-FIELD	Purpose Quantitative imaging of neuromagnetic fields based on automated region of interest (ROI) setting was analyzed to determine the characteristics of cerebral neural activity in ischemic areas. Methods Magnetoencephalography (MEG) was used to evaluate spontaneous neuromagnetic fields in the ischemic areas of 37 patients with unilateral internal carotid artery (ICA) occlusive disease. Voxel-based time-averaged intensity of slow waves was obtained in two frequency bands (0.3-4 Hz and 4-8 Hz) using standardized low-resolution brain electromagnetic tomography (sLORETA) modified for a quantifiable method (sLORETA-qm). ROIs were automatically applied to the anterior cerebral artery (ACA), anterior middle cerebral artery (MCAa), posterior middle cerebral artery (MCAp), and posterior cerebral artery (PCA) using statistical parametric mapping (SPM). Positron emission tomography with O-15-gas inhalation (O-15-PET) was also performed to evaluate cerebral blood flow (CBF) and oxygen extraction fraction (OEF). Statistical analyses were performed using laterality index of MEG and O-15-PET in each ROI with respect to distribution and intensity. Results MEG revealed statistically significant laterality in affected MCA regions, including 4-8 Hz waves in MCAa, and 0.3-4 Hz and 4-8 Hz waves in MCAp (95% confidence interval: 0.020-0.190, 0.030-0.207, and 0.034-0.213), respectively. We found that 0.3-4 Hz waves in MCAp were highly correlated with CBF in MCAa and MCAp (r = 0.74, r = 0.68, respectively), whereas 4-8 Hz waves were moderately correlated with CBF in both the MCAa and MCAp (r = 0.60, r = 0.63, respectively). We also found that 4-8 Hz waves in MCAp were statistically significant for misery perfusion identified on 15 O-PET (p<0.05). Conclusions Quantitatively imaged spontaneous neuromagnetic fields using the automated ROI setting enabled clear depiction of cerebral ischemic areas. Frequency analysis may reveal unique neural activity that is distributed in the impaired vascular metabolic territory, in which the cerebral infarction has not yet been completed.	[Sakamoto, Shinichi; Miki, Yukio] Osaka City Univ, Grad Sch Med, Dept Diagnost & Intervent Radiol, Osaka, Japan; [Ikeda, Hidetoshi; Tsuyuguchi, Naohiro; Uda, Takehiro; Ohata, Kenji] Osaka City Univ, Grad Sch Med, Dept Neurosurg, Osaka, Japan; [Okumura, Eiichi; Asakawa, Takashi] Ricoh Co Ltd, Med Imaging Business Dept, Kanazawa, Ishikawa, Japan; [Haruta, Yasuhiro] Kanazawa Inst Technol, Appl Elect Lab, Kanazawa, Ishikawa, Japan; [Nishiyama, Hideki] Nihon Medi Phys Corp, Tokyo, Japan; [Okada, Toyoji] Hokuto Hosp, Dept Clin Lab, Obihiro, Hokkaido, Japan; [Kamada, Hajime] Hokuto Hosp, Dept Neurosurg, Obihiro, Hokkaido, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Ricoh Company, Ltd.; Kanazawa Institute of Technology	Sakamoto, S (corresponding author), Osaka City Univ, Grad Sch Med, Dept Diagnost & Intervent Radiol, Osaka, Japan.	s-sakamoto@med.osaka-cu.ac.jp	Uda, Takehiro/ABD-7340-2021; Miki, Yukio/AAY-2146-2020	Miki, Yukio/0000-0003-0621-0044; Uda, Takehiro/0000-0001-6422-4140	JSPS (Japan Society for the Promotion of Science) KAKENHI [22591349]	JSPS (Japan Society for the Promotion of Science) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS (Japan Society for the Promotion of Science) KAKENHI Grant Number 22591349, Grant-in-Aid for Scientific Research (C) (URLs:http://www.jsps.go.jp/index.html) This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Two authors, EO and TA, are employed by commercial company: "Ricoh Company, Ltd "and one author, HN, is employed by commercial company:" Nihon Medi-Physics Corporation". These funders provided support in the form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; BARON JC, 1981, STROKE, V12, P454, DOI 10.1161/01.STR.12.4.454; Bundo M, 2002, STROKE, V33, P61, DOI 10.1161/hs0102.101816; Burghaus L, 2007, CLIN NEUROL NEUROSUR, V109, P45, DOI 10.1016/j.clineuro.2006.06.003; Butz M, 2004, NEUROSCI LETT, V355, P93, DOI 10.1016/j.neulet.2003.10.065; Didelot A, 2010, J NUCL MED, V51, P1732, DOI 10.2967/jnumed.109.070938; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; FAUGHT E, 1993, STROKE, V24, P609, DOI 10.1161/01.STR.24.4.609; FAUGHT E, 1988, Neurological Research, V10, P184; Fernandez-Bouzas A, 2000, CLIN ELECTROENCEPHAL, V31, P165, DOI 10.1177/155005940003100403; Finnigan S, 2013, CLIN NEUROPHYSIOL, V124, P10, DOI 10.1016/j.clinph.2012.07.003; FRACKOWIAK RSJ, 1980, J COMPUT ASSIST TOMO, V4, P727, DOI 10.1097/00004728-198012000-00001; Furlan M, 1996, ANN NEUROL, V40, P216, DOI 10.1002/ana.410400213; Goto T, 2002, J NEUROSURG, V96, P62, DOI 10.3171/spi.2002.96.1.0062; Grubb RL, 1998, JAMA-J AM MED ASSOC, V280, P1055, DOI 10.1001/jama.280.12.1055; Heiss WD, 2000, J CEREBR BLOOD F MET, V20, P1276, DOI 10.1097/00004647-200009000-00002; Higuchi M, 1997, APPL SUPERCOND, V5, P441, DOI 10.1016/S0964-1807(98)00071-4; Huang MX, 1999, PHYS MED BIOL, V44, P423, DOI 10.1088/0031-9155/44/2/010; Ito H, 2004, EUR J NUCL MED MOL I, V31, P635, DOI 10.1007/s00259-003-1430-8; Jovin TG, 2003, STROKE, V34, P2426, DOI 10.1161/01.STR.0000091232.81947.C9; Kamada K, 1997, ANN NEUROL, V42, P554, DOI 10.1002/ana.410420405; KAPPELLE LJ, 1990, J NEUROL NEUROSUR PS, V53, P63, DOI 10.1136/jnnp.53.1.63; KURODA S, 1993, NEUROSURGERY, V32, P912, DOI 10.1227/00006123-199306000-00005; LAMMERTSMA AA, 1983, J CEREBR BLOOD F MET, V3, P416, DOI 10.1038/jcbfm.1983.67; LEBLANC R, 1989, CAN J NEUROL SCI, V16, P51, DOI 10.1017/S031716710002850X; MACDONELL RAL, 1988, ARCH NEUROL-CHICAGO, V45, P520, DOI 10.1001/archneur.1988.00520290048013; Machado C, 2004, CLIN EEG NEUROSCI, V35, P116, DOI 10.1177/155005940403500303; MARTIN WRW, 1987, J CEREBR BLOOD F MET, V7, P421, DOI 10.1038/jcbfm.1987.85; Muller C, 2002, EUR NEUROL, V48, P164, DOI 10.1159/000065509; Murphy BD, 2006, STROKE, V37, P1771, DOI 10.1161/01.STR.0000227243.96808.53; NAGATA K, 1989, Brain Topography, V2, P119, DOI 10.1007/BF01128849; NAGATA K, 1989, ELECTROEN CLIN NEURO, V72, P16, DOI 10.1016/0013-4694(89)90027-8; NUWER MR, 1987, NEUROLOGY, V37, P1153, DOI 10.1212/WNL.37.7.1153; Ogasawara K, 2002, STROKE, V33, P1857, DOI 10.1161/01.STR.0000019511.81583.A8; Ogura T, 2009, ANN NUCL MED, V23, P33, DOI 10.1007/s12149-008-0203-7; Ohtomo S, 2009, CLIN NEUROPHYSIOL, V120, P1227, DOI 10.1016/j.clinph.2009.05.015; Oppenheim C, 2000, STROKE, V31, P2175, DOI 10.1161/01.STR.31.9.2175; OTOMO E, 1966, ELECTROEN CLIN NEURO, V20, P77, DOI 10.1016/0013-4694(66)90143-X; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Phan TG, 2012, CEREBROVASC DIS, V33, P405, DOI 10.1159/000336332; POWERS WJ, 1987, ANN INTERN MED, V106, P27, DOI 10.7326/0003-4819-106-1-27; Prosser J, 2005, STROKE, V36, P1700, DOI 10.1161/01.STR.0000173407.40773.17; Rohl L, 2001, STROKE, V32, P1140, DOI 10.1161/01.STR.32.5.1140; Sakamoto S, 2003, EPILEPSIA, V44, P1196, DOI 10.1046/j.1528-1157.2003.08603.x; Sakamoto S, 2010, NEUROIMAGE, V49, P488, DOI 10.1016/j.neuroimage.2009.07.039; Sakamoto S, 2008, ACTA NEUROCHIR, V150, P1285, DOI 10.1007/s00701-008-0156-6; Seki S, 2005, NEUROIMAGE, V25, P502, DOI 10.1016/j.neuroimage.2004.11.025; SILVERMAN AJ, 1955, ELECTROEN CLIN NEURO, V7, P67, DOI 10.1016/0013-4694(55)90060-2; Srinivasan A, 2006, RADIOGRAPHICS, V26, pS75, DOI 10.1148/rg.26si065501; Stippich C, 2000, NEUROREPORT, V11, P3309, DOI 10.1097/00001756-200010200-00010; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Tecchio F, 2005, NEUROIMAGE, V28, P72, DOI 10.1016/j.neuroimage.2005.05.051; Terakawa Y, 2008, CLIN NEUROPHYSIOL, V119, P1917, DOI 10.1016/j.clinph.2008.04.008; TOLONEN U, 1981, ELECTROEN CLIN NEURO, V51, P177, DOI 10.1016/0013-4694(81)90007-9; TORRES F, 1983, ELECTROEN CLIN NEURO, V56, P391, DOI 10.1016/0013-4694(83)90220-1; Tsutada T, 1999, CLIN NEUROPHYSIOL, V110, P2127, DOI 10.1016/S1388-2457(99)00188-1; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Vieth J B, 1990, Adv Neurol, V54, P261; Wintermark M, 2006, STROKE, V37, P979, DOI 10.1161/01.STR.0000209238.61459.39; Yamauchi H, 1996, J NEUROL NEUROSUR PS, V61, P18, DOI 10.1136/jnnp.61.1.18; YAMAUCHI H, 1990, STROKE, V21, P1400, DOI 10.1161/01.STR.21.10.1400; Zumsteg D, 2006, CLIN NEUROPHYSIOL, V117, P2257, DOI 10.1016/j.clinph.2006.07.137	62	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168588	10.1371/journal.pone.0168588	http://dx.doi.org/10.1371/journal.pone.0168588			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992543	Green Submitted, Green Published, gold			2022-12-26	WOS:000392758000062
J	Swidnicka-Siergiejko, AK; Gomez-Chou, SB; Cruz-Monserrate, Z; Deng, D; Liu, Y; Huang, H; Ji, B; Azizian, N; Daniluk, J; Lu, W; Wang, H; Maitra, A; Logsdon, CD				Swidnicka-Siergiejko, A. K.; Gomez-Chou, S. B.; Cruz-Monserrate, Z.; Deng, D.; Liu, Y.; Huang, H.; Ji, B.; Azizian, N.; Daniluk, J.; Lu, W.; Wang, H.; Maitra, A.; Logsdon, C. D.			Chronic inflammation initiates multiple forms of K-Ras-independent mouse pancreatic cancer in the absence of TP53	ONCOGENE			English	Article							FACTOR-KAPPA-B; ACINAR DIFFERENTIATION; DUCTAL ADENOCARCINOMAS; MICE; OVEREXPRESSION; CELLS; ACTIVATION; EXPRESSION; INDUCTION; NEOPLASMS	Chronic inflammation (CI) is a risk factor for pancreatic cancer (PC) including the most common type, ductal adenocarcinoma (PDAC), but its role and the mechanisms involved are unclear. To investigate the role of CI in PC, we generated genetic mouse models with pancreatic specific CI in the presence or absence of TP53. Mice were engineered to express either cyclooxygenase-2 (COX-2) or I kappa B kinase-2 (IKK2), and TP53(+/+) or TP53(f/f) specifically in adult pancreatic acinar cells by using a full-length pancreatic elastase promoter-driven Cre. Animals were followed for > 80 weeks and pancreatic lesions were evaluated histologically and immunohistochemically. The presence of K-ras mutations was assessed by direct sequencing, locked nuclei acid (LNA)-based PCR, and immunohistochemistry. We observed that sustained COX-2/IKK2 expression caused histological abnormalities of pancreas, including increased immune cell infiltration, proliferation rate and DNA damage. A minority of animals with CI developed pre-neoplastic lesions, but cancer was not observed in any TP53(+/+) animals within 84 weeks. In contrast, all animals with CI-lacking TP53 developed various subtypes of PC, including acinar cell carcinoma, ductal adenocarcinoma, sarcomatoid carcinoma and neuroendocrine tumors, and all died within 65 weeks. No evidence of K-ras mutations was observed. Variations in the activity of the Hippo, pERK and c-Myc pathways were found in the diverse cancer subtypes. In summary, chronic inflammation is extremely inefficient at inducing PC in the presence of TP53. However, in the absence of TP53, CI leads to the development of several rare K-ras-independent forms of PC, with infrequent PDAC. This may help explain the rarity of PDAC in persons with chronic inflammatory conditions.	[Swidnicka-Siergiejko, A. K.; Gomez-Chou, S. B.; Deng, D.; Liu, Y.; Huang, H.; Ji, B.; Azizian, N.; Daniluk, J.; Logsdon, C. D.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Unit 1906,1515 Holcombe Blvd, Houston, TX 77030 USA; [Swidnicka-Siergiejko, A. K.; Daniluk, J.] Univ Bialystok, Dept Gastroenterol & Internal Med, Bialystok, Poland; [Cruz-Monserrate, Z.] Ohio State Univ, Dept Internal Med, Div Gastroenterol Hepatol & Nutr, Wexner Med Ctr, Columbus, OH 43210 USA; [Huang, H.] Second Mil Med Univ, Shanghai Hosp, Dept Gastroenterol, Shanghai, Peoples R China; [Ji, B.] Mayo Clin, Dept Biochem & Mol Biol, Jacksonville, FL 32224 USA; [Lu, W.; Logsdon, C. D.] Univ Texas MD Anderson Canc Ctr, Dept GI Med Oncol, Houston, TX 77030 USA; [Wang, H.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Maitra, A.] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Bialystok; University System of Ohio; Ohio State University; Naval Medical University; Mayo Clinic; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Logsdon, CD (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Unit 1906,1515 Holcombe Blvd, Houston, TX 77030 USA.	clogsdon@mdanderson.org	Daniluk, Jaroslaw/T-3437-2018	Daniluk, Jaroslaw/0000-0002-0787-1461; Cruz-Monserrate, Zobeida/0000-0003-0849-655X; , Agnieszka/0000-0001-6577-5796; azizian, nancy/0000-0002-1158-0608	Lockton Endowment;  [NIH-DK05206];  [AA020822]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020822] Funding Source: NIH RePORTER	Lockton Endowment; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank Dr Bogdan Czerniak, Dr Tadeusz Majewski and Jolanta Bondaruk from Department of Pathology and Todd Moore from Department of Surgery, University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA for technical support. Grant support: NIH-DK05206, AA020822 and The Lockton Endowment (to CDL).	Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Cho CH, 2012, ADV DIAGNOSIS THERAP; Colby JK, 2008, NEOPLASIA, V10, P782, DOI 10.1593/neo.08330; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Daniluk J, 2012, J CLIN INVEST, V122, P1519, DOI 10.1172/JCI59743; Feldmann G, 2011, CANCER BIOL THER, V11, P959, DOI 10.4161/cbt.11.11.15534; Grippo PJ, 2012, INT J CANCER, V131, P1243, DOI 10.1002/ijc.27322; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Hill R, 2010, CANCER RES, V70, P7114, DOI 10.1158/0008-5472.CAN-10-1649; Holmes C, 2007, STEM CELLS, V25, P1339, DOI 10.1634/stemcells.2006-0644; Hu Y, 2009, MUTAT RES-GEN TOX EN, V677, P27, DOI 10.1016/j.mrgentox.2009.05.003; Huang H, 2014, ONCOGENE, V33, P532, DOI 10.1038/onc.2012.619; Huang HJ, 2013, GASTROENTEROLOGY, V144, P202, DOI 10.1053/j.gastro.2012.09.059; Ji BA, 2008, GENESIS, V46, P390, DOI 10.1002/dvg.20411; Jiao YC, 2014, J PATHOL, V232, P428, DOI 10.1002/path.4310; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kamei K, 2006, GENESIS, V44, P177, DOI 10.1002/dvg.20199; Kwon MJ, 2015, PANCREAS, V44, P484, DOI 10.1097/MPA.0000000000000280; La Rosa S, 2016, VIRCHOWS ARCH, V468, P289, DOI 10.1007/s00428-015-1882-9; La Rosa S, 2015, FRONT MED, V2, DOI 10.3389/fmed.2015.00041; Ling SB, 2014, ONCOL LETT, V7, P1747, DOI 10.3892/ol.2014.2003; Liu B, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0260-7; Marrache F, 2008, GASTROENTEROLOGY, V135, P1277, DOI 10.1053/j.gastro.2008.06.078; Morton JP, 2008, AM J PATHOL, V172, P1081, DOI 10.2353/ajpath.2008.070778; Morvaridi S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16759; Murata M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/623019; Myant K, 2015, CELL REP, V12, P1019, DOI 10.1016/j.celrep.2015.07.003; Phesse TJ, 2014, CELL DEATH DIFFER, V21, P956, DOI 10.1038/cdd.2014.15; Philip B, 2013, GASTROENTEROLOGY, V145, P1449, DOI 10.1053/j.gastro.2013.08.018; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Rowley M, 2011, GASTROENTEROLOGY, V140, P1303, DOI 10.1053/j.gastro.2010.12.039; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; SANDGREN EP, 1990, CELL, V61, P1121, DOI 10.1016/0092-8674(90)90075-P; URBAN T, 1993, J NATL CANCER I, V85, P2008, DOI 10.1093/jnci/85.24.2008; Wang WX, 1999, CLIN CANCER RES, V5, P119; Wood LD, 2014, SEMIN DIAGN PATHOL, V31, P491, DOI 10.1053/j.semdp.2014.08.003	38	30	31	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 1	2017	36	22					3149	3158		10.1038/onc.2016.461	http://dx.doi.org/10.1038/onc.2016.461			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EW6KA	27991926	hybrid, Green Published			2022-12-26	WOS:000402617900007
J	Ding, YH; Gong, Z; Dong, X; Liu, K; Liu, Z; Liu, C; He, SM; Dong, MQ; Tang, C				Ding, Yue-He; Gong, Zhou; Dong, Xu; Liu, Kan; Liu, Zhu; Liu, Chao; He, Si-Min; Dong, Meng-Qiu; Tang, Chun			Modeling Protein Excited-state Structures from "Over-length" Chemical Cross-links	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMINE-BINDING-PROTEIN; SUGAR PHOSPHOTRANSFERASE SYSTEM; MASS-SPECTROMETRY; ENZYME-I; CONFORMATIONAL ENSEMBLES; MOLECULAR ARCHITECTURE; DISTANCE RESTRAINTS; ANGSTROM RESOLUTION; DYNAMIC EQUILIBRIUM; INITIATION COMPLEX	Chemical cross-linking coupled with mass spectroscopy (CXMS) provides proximity information for the cross-linked residues and is used increasingly for modeling protein structures. However, experimentally identified cross-links are sometimes incompatible with the known structure of a protein, as the distance calculated between the cross-linked residues far exceeds the maximum length of the cross-linker. The discrepancies may persist even after eliminating potentially false cross-links and excluding intermolecular ones. Thus the "overlength" cross-links may arise from alternative excited-state conformation of the protein. Here we present a method and associated software DynaXL for visualizing the ensemble structures of multidomain proteins based on intramolecular cross-links identified by mass spectrometry with high confidence. Representing the cross-linkers and cross-linking reactions explicitly, we show that the protein excited-state structure can be modeled with as few as two over-length cross-links. We demonstrate the generality of our method with three systems: calmodulin, enzyme I, and glutamine-binding protein, and we show that these proteins alternate between different conformations for interacting with other proteins and ligands. Taken together, the over-length chemical cross-links contain valuable information about protein dynamics, and our findings here illustrate the relationship between dynamic domain movement and protein function.	[Gong, Zhou; Dong, Xu; Liu, Kan; Tang, Chun] Chinese Acad Sci, State Key Lab Magnet Resonance & Atom Mol Phys, Natl Ctr Magnet Resonance Wuhan, Wuhan Inst Phys & Math,CAS Key Lab Magnet Resonan, Wuhan 430071, Hubei Province, Peoples R China; [Ding, Yue-He; Dong, Meng-Qiu] Natl Inst Biol Sci, 7 Sci Pk Rd,ZGC Life Sci Pk, Beijing 102206, Peoples R China; [Liu, Zhu; Tang, Chun] Zhejiang Univ, Sch Med, Dept Pharmacol, Hangzhou 310058, Zhejiang, Peoples R China; [Liu, Chao; He, Si-Min] Chinese Acad Sci, Inst Comp Technol, Key Lab Intelligent Informat Proc, Beijing 100190, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS; National Institute of Biological Sciences, Beijing; Zhejiang University; Chinese Academy of Sciences; Institute of Computing Technology, CAS	Dong, MQ (corresponding author), Natl Inst Biol Sci, 7 Sci Pk Rd,ZGC Life Sci Pk, Beijing 102206, Peoples R China.; Tang, C (corresponding author), Chinese Acad Sci, Wuhan Inst Phys & Math, 30 W Xiao Hong Shan, Wuhan 43001, Peoples R China.	dongmengqiu@nibs.ac.cn; tanglab@wipm.ac.cn	Tang, Chun/P-4060-2019; ding, yuehe/AAZ-6994-2021; liu, chao/GQZ-6687-2022	liu, zhu/0000-0003-4073-7237; Dong, Meng-Qiu/0000-0002-6094-1182; Liu, Kan/0000-0002-5484-5039; Tang, Chun/0000-0001-6477-6500	Chinese Ministry of Science and Technology [2013CB910200, 2016YFA0501200, 2014CB849800, 2012CB910602]; National Natural Science Foundation of China [31225007, 21375010, 31400735, 31400644]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Chinese Ministry of Science and Technology (2013CB910200, 2016YFA0501200 (to C. T.), 2014CB849800 (to M.-Q. D.), and 2012CB910602 (to C. L.)) and the National Natural Science Foundation of China (31225007 to (to C. T.), 21375010 (to M.-Q. D.), 31400735 (to Z. G.), and 31400644 (to X. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Anthis NJ, 2011, J AM CHEM SOC, V133, P18966, DOI 10.1021/ja2082813; Belsom A, 2016, MOL CELL PROTEOMICS, V15, P1105, DOI 10.1074/mcp.M115.048504; Bermejo GA, 2012, PROTEIN SCI, V21, P1824, DOI 10.1002/pro.2163; Bertini I, 2004, P NATL ACAD SCI USA, V101, P6841, DOI 10.1073/pnas.0308641101; Bertini I, 2009, J AM CHEM SOC, V131, P5134, DOI 10.1021/ja8080764; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bouvignies G, 2011, NATURE, V477, P111, DOI 10.1038/nature10349; Case DA, 2014, AMBER 14; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Erzberger JP, 2014, CELL, V158, P1123, DOI 10.1016/j.cell.2014.07.044; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Ferber M, 2016, NAT METHODS, V13, P515, DOI [10.1038/NMETH.3838, 10.1038/nmeth.3838]; Fernandez-Leiro R, 2016, NATURE, V537, P339, DOI 10.1038/nature19948; Fraser JS, 2011, P NATL ACAD SCI USA, V108, P16247, DOI 10.1073/pnas.1111325108; Garrett DS, 1999, NAT STRUCT BIOL, V6, P166; Gong Zhou, 2015, Biophys Rep, V1, P127, DOI 10.1007/s41048-015-0015-y; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Herzog F, 2012, SCIENCE, V337, P1348, DOI 10.1126/science.1221483; Hsiao CD, 1996, J MOL BIOL, V262, P225, DOI 10.1006/jmbi.1996.0509; Iwahara J, 2007, J MAGN RESON, V184, P185, DOI 10.1016/j.jmr.2006.10.003; Jennebach S, 2012, NUCLEIC ACIDS RES, V40, P5591, DOI 10.1093/nar/gks220; Jenner M, 2011, ANGEW CHEM INT EDIT, V50, P8291, DOI 10.1002/anie.201101077; Kahraman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073411; Kahraman A, 2011, BIOINFORMATICS, V27, P2163, DOI 10.1093/bioinformatics/btr348; Kalisman N, 2012, P NATL ACAD SCI USA, V109, P2884, DOI 10.1073/pnas.1119472109; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lanman J, 2004, NAT STRUCT MOL BIOL, V11, P676, DOI 10.1038/nsmb790; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Lee YJ, 2009, J AM SOC MASS SPECTR, V20, P1896, DOI 10.1016/j.jasms.2009.06.020; Liao DI, 1996, STRUCTURE, V4, P861, DOI 10.1016/S0969-2126(96)00092-5; Liu C, 2014, ANAL CHEM, V86, P5286, DOI 10.1021/ac404246w; Liu Z, 2014, BIOCHEMISTRY-US, V53, P1403, DOI 10.1021/bi4015715; Lossl P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112886; Lopez A, 2016, J MASS SPECTROM, V51, P504, DOI 10.1002/jms.3777; Merkley ED, 2014, PROTEIN SCI, V23, P747, DOI 10.1002/pro.2458; Petrotchenko EV, 2014, J PROTEOMICS, V109, P104, DOI 10.1016/j.jprot.2014.06.014; Plaschka C, 2015, NATURE, V518, P376, DOI 10.1038/nature14229; Politis A, 2014, NAT METHODS, V11, P403, DOI [10.1038/NMETH.2841, 10.1038/nmeth.2841]; Rappsilber J, 2011, J STRUCT BIOL, V173, P530, DOI 10.1016/j.jsb.2010.10.014; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Sekhar A, 2013, P NATL ACAD SCI USA, V110, P12867, DOI 10.1073/pnas.1305688110; Shi Y, 2014, MOL CELL PROTEOMICS, V13, P2927, DOI 10.1074/mcp.M114.041673; Sun YJ, 1998, J MOL BIOL, V278, P219, DOI 10.1006/jmbi.1998.1675; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201; Taverner T, 2002, J BIOL CHEM, V277, P46487, DOI 10.1074/jbc.M207370200; Teplyakov A, 2006, P NATL ACAD SCI USA, V103, P16218, DOI 10.1073/pnas.0607587103; Venditti V, 2015, P NATL ACAD SCI USA, V112, P11565, DOI 10.1073/pnas.1515366112; Walzthoeni T, 2012, NAT METHODS, V9, P901, DOI 10.1038/nmeth.2103; Xu T, 2015, J PROTEOMICS, V129, P16, DOI 10.1016/j.jprot.2015.07.001; Xue ZD, 2013, BIOINFORMATICS, V29, P247, DOI 10.1093/bioinformatics/btt209; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Zhou YB, 2007, J BIOL CHEM, V282, P35005, DOI 10.1074/jbc.M707728200	54	28	29	4	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1187	1196		10.1074/jbc.M116.761841	http://dx.doi.org/10.1074/jbc.M116.761841			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27994050	Green Published, hybrid			2022-12-26	WOS:000393339800004
J	Thweatt, JL; Ferlez, BH; Golbeck, JH; Bryant, DA				Thweatt, Jennifer L.; Ferlez, Bryan H.; Golbeck, John H.; Bryant, Donald A.			BciD Is a Radical S-Adenosyl-L-methionine (SAM) Enzyme That Completes Bacteriochlorophyllide e Biosynthesis by Oxidizing a Methyl Group into a Formyl Group at C-7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN SULFUR BACTERIA; CHLOROBIUM-TEPIDUM CHLOROSOMES; C-20 METHYLTRANSFERASE; C BIOSYNTHESIS; PHOTOSYSTEM-I; CHLOROPHYLL-A; LIGHT; GENE; MUTANT; BCHU	Green bacteria are chlorophotorophs that synthesize bacteriochlorophyll (BChl) c, d, or e, which assemble into supramolecular, nanotubular structures in large light-harvesting structures called chlorosomes. The biosynthetic pathways of these chlorophylls are known except for one reaction. Null mutants of bciD, which encodes a putative radical S-adenosyl-L-methionine (SAM) protein, are unable to synthesize BChl e but accumulate BChl c; however, it is unknown whether BciD is sufficient to convert BChl c (or its precursor, bacteriochlorophyllide (BChlide) c) into BChl e (or BChlide e). To determine the function of BciD, we expressed the bciD gene of Chlorobaculum limnaeum strain DSMZ 1677(T) in Escherichia coli and purified the enzyme under anoxic conditions. Electron paramagnetic resonance spectroscopy of BciD indicated that it contains a single [4Fe-4S] cluster. In assays containing SAM, BChlide c or d, and sodium dithionite, BciD catalyzed the conversion of SAM into 5'-deoxyadenosine and BChlide c or d into BChlide e or f, respectively. Our analyses also identified intermediates that are proposed to be 7(1)-OH-BChlide c and d. Thus, BciD is a radical SAM enzyme that converts the methyl group of BChlide c or d into the formyl group of BChlide e or f. This probably occurs by a mechanism involving consecutive hydroxylation reactions of the C-7 methyl group to form a geminal diol intermediate, which spontaneously dehydrates to produce the final products, BChlide e or BChlide f. The demonstration that BciD is sufficient to catalyze the conversion of BChlide c into BChlide e completes the biosynthetic pathways for all "Chlorobium chlorophylls."	[Thweatt, Jennifer L.; Ferlez, Bryan H.; Golbeck, John H.; Bryant, Donald A.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Golbeck, John H.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Bryant, Donald A.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Montana State University System; Montana State University Bozeman	Bryant, DA (corresponding author), Dept Biochem & Mol Biol, Althouse Lab 403C, University Pk, PA 16802 USA.	dab14@psu.edu		Ferlez, Bryan/0000-0003-0505-2099	Photosynthetic Systems Program, Division of Chemical Sciences, Geosciences, and Biosciences (CSGB), Office of Basic Energy Sciences of the United States Department of Energy [DE-FG02-94ER20137, DE-FG02-98ER20314]	Photosynthetic Systems Program, Division of Chemical Sciences, Geosciences, and Biosciences (CSGB), Office of Basic Energy Sciences of the United States Department of Energy	This work was supported by Grants DE-FG02-94ER20137 (to D. A. B.) and DE-FG02-98ER20314 (to J. H. G) from the Photosynthetic Systems Program, Division of Chemical Sciences, Geosciences, and Biosciences (CSGB), Office of Basic Energy Sciences of the United States Department of Energy. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PG, 2013, BBA-BIOENERGETICS, V1827, P1235, DOI 10.1016/j.bbabio.2013.07.004; Akiva E, 2014, NUCLEIC ACIDS RES, V42, pD521, DOI 10.1093/nar/gkt1130; BOBE FW, 1990, BIOCHEMISTRY-US, V29, P4340, DOI 10.1021/bi00470a012; Borrego CM, 1999, PHOTOSYNTH RES, V59, P159, DOI 10.1023/A:1006161302838; BORREGO CM, 1994, PHOTOSYNTH RES, V41, P157, DOI 10.1007/BF02184156; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROCHDUE M, 1978, FEMS MICROBIOL LETT, V3, P305, DOI 10.1111/j.1574-6968.1978.tb01953.x; Bryant DA, 2002, BIOCHEMISTRY-US, V41, P14403, DOI 10.1021/bi026599s; Bryant DA, 2007, SCIENCE, V317, P523, DOI 10.1126/science.1143236; Bryant DA, 2006, TRENDS MICROBIOL, V14, P488, DOI 10.1016/j.tim.2006.09.001; Bryant DA, 2013, ADV BOT RES, V66, P99, DOI 10.1016/B978-0-12-397923-0.00004-7; Bryant DA, 2012, ADV PHOTOSYNTH RESP, V33, P47, DOI 10.1007/978-94-007-1533-2_3; Chen GE, 2016, J BACTERIOL, V198, P2056, DOI 10.1128/JB.00121-16; Chew A. Gomez Maqueo, 2005, PHOTOSYNTHESIS FUNDA, P875; Chew AGM, 2007, J BACTERIOL, V189, P6176, DOI 10.1128/JB.00519-07; Delli-Bovi TA, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-73; Eisen JA, 2002, P NATL ACAD SCI USA, V99, P9509, DOI 10.1073/pnas.132181499; Frigaard N-U., 2006, COMPLEX INTRACELLULA, V2, P79, DOI [10.1007/7171_021, DOI 10.1007/7171_021]; Frigaard NU, 1997, ARCH MICROBIOL, V167, P343, DOI 10.1007/s002030050453; Frigaard NU, 2002, J BACTERIOL, V184, P3368, DOI 10.1128/JB.184.12.3368-3376.2002; Frigaard NU, 2001, APPL ENVIRON MICROB, V67, P2538, DOI 10.1128/AEM.67.6.2538-2544.2001; Harada J, 2005, FEBS LETT, V579, P1983, DOI 10.1016/j.febslet.2005.01.087; Harada J., 2005, PHOTOSYNTHESIS FUNDA, P119; Harada J, 2015, MOL MICROBIOL, V98, P1184, DOI 10.1111/mmi.13208; Harada J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060026; Harada J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00671; Ho Ming-Yang, 2017, Photosynth Res, V131, P187, DOI 10.1007/s11120-016-0303-5; Imhoff JF, 2003, INT J SYST EVOL MICR, V53, P941, DOI 10.1099/ijs.0.02403-0; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lanz ND, 2012, METHOD ENZYMOL, V516, P125, DOI 10.1016/B978-0-12-394291-3.00030-7; Liu ZF, 2012, ISME J, V6, P1869, DOI 10.1038/ismej.2012.24; Liu ZF, 2011, J BIOL CHEM, V286, P22393, DOI 10.1074/jbc.M111.249433; Llorens-Mares T, 2017, ISME J, V11, P201, DOI 10.1038/ismej.2016.93; LOVENBERG W, 1963, J BIOL CHEM, V238, P3899; Mallorqui N, 2005, J PALEOLIMNOL, V34, P271, DOI 10.1007/s10933-005-3731-3; Manske AK, 2005, APPL ENVIRON MICROB, V71, P8049, DOI 10.1128/AEM.71.12.8049-8060.2005; Maqueo Chew AG, 2007, ANNU REV MICROBIOL, V61, P113, DOI 10.1146/annurev.micro.61.080706.093242; Maresca J. A., 2007, THESIS; Maresca JA, 2004, J BACTERIOL, V186, P2558, DOI 10.1128/JB.186.9.2558-2566.2004; Maresca JA, 2008, J BACTERIOL, V190, P6384, DOI 10.1128/JB.00758-08; Marschall E, 2010, ENVIRON MICROBIOL, V12, P1348, DOI 10.1111/j.1462-2920.2010.02178.x; Montano GA, 2003, BIOPHYS J, V85, P2560, DOI 10.1016/S0006-3495(03)74678-5; MONTESINOS E, 1983, APPL ENVIRON MICROB, V46, P1007, DOI 10.1128/AEM.46.5.1007-1016.1983; Niedzwiedzki DM, 2014, J PHYS CHEM B, V118, P2295, DOI 10.1021/jp409495m; Oostergetel GT, 2010, PHOTOSYNTH RES, V104, P245, DOI 10.1007/s11120-010-9533-0; Orf GS, 2013, PHOTOSYNTH RES, V116, P315, DOI 10.1007/s11120-013-9869-3; Orf GS, 2013, BBA-BIOENERGETICS, V1827, P493, DOI 10.1016/j.bbabio.2013.01.006; Oster U, 1997, J BIOL CHEM, V272, P9671; Ouchane S, 2004, J BIOL CHEM, V279, P6385, DOI 10.1074/jbc.M309851200; Saga Y, 2004, J PHOTOCH PHOTOBIO B, V75, P89, DOI 10.1016/j.jphotobiol.2004.05.012; Saga Y, 2015, BIOCHEMISTRY-US, V54, P4998, DOI 10.1021/acs.biochem.5b00311; Scheer Hugo, 2006, V25, P1; Seo D, 2001, BBA-BIOENERGETICS, V1503, P377, DOI 10.1016/S0005-2728(00)00245-0; SHEN GZ, 1995, PHOTOSYNTH RES, V44, P41, DOI 10.1007/BF00018295; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Suzuki JY, 1997, ANNU REV GENET, V31, P61, DOI 10.1146/annurev.genet.31.1.61; Tanaka A, 1998, P NATL ACAD SCI USA, V95, P12719, DOI 10.1073/pnas.95.21.12719; Tank M., 2016, MODERN TOPICS PHOTOT; Teramura M, 2016, PHOTOSYNTH RES, V130, P33, DOI 10.1007/s11120-016-0220-7; Teramura M, 2016, PLANT CELL PHYSIOL, V57, P1048, DOI 10.1093/pcp/pcw045; Tomitani A, 1999, NATURE, V400, P159, DOI 10.1038/22101; Tsukatani Y, 2013, PHOTOCH PHOTOBIO SCI, V12, P2195, DOI 10.1039/c3pp50253h; Van Gemerden H, 1995, ANOXYGENIC PHOTOSYNT, P49; Vila X, 2001, HYDROBIOLOGIA, V452, P15, DOI 10.1023/A:1011909330390; Vogl K, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00298; Wada K, 2006, J MOL BIOL, V360, P839, DOI 10.1016/j.jmb.2006.05.057; Wang JR, 2014, ACS CHEM BIOL, V9, P1929, DOI 10.1021/cb5004674; Yang J, 2011, MOL CELL, V44, P997, DOI 10.1016/j.molcel.2011.10.020; Yoon KS, 2001, J BIOL CHEM, V276, P44027, DOI 10.1074/jbc.M107852200; ZHAO JD, 1990, FEBS LETT, V276, P175, DOI 10.1016/0014-5793(90)80536-R; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	72	19	21	0	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1361	1373		10.1074/jbc.M116.767665	http://dx.doi.org/10.1074/jbc.M116.767665			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27994052	Green Published, hybrid			2022-12-26	WOS:000393339800018
J	Zhang, BY; Wang, G; Xu, XW; Yang, SS; Zhuang, TH; Wang, GP; Ren, H; Cheng, SY; Jiang, Q; Zhang, CM				Zhang, Boyan; Wang, Gang; Xu, Xiaowei; Yang, Sisi; Zhuang, Tenghan; Wang, Guopeng; Ren, He; Cheng, Steven Y.; Jiang, Qing; Zhang, Chuanmao			DAZ-interacting Protein 1 (Dzip1) Phosphorylation by Polo-like Kinase 1 (Plk1) Regulates the Centriolar Satellite Localization of the BBSome Protein during the Cell Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEDGEHOG SIGNAL-TRANSDUCTION; ZINC-FINGER PROTEIN; MITOTIC ENTRY; PRIMARY CILIA; GLI TURNOVER; ZEBRAFISH; ENCODES; COMPLEX; CILIOGENESIS; IGUANA/DZIP1	The function of the primary cilia, which is assembled in most vertebrate cells, is achieved by transport in and out of kinds of signaling receptors. The BBSome protein complex could recognize and target membrane proteins to the cilia, but how the BBSome itself is transported into the cilia is poorly understood. Here we demonstrate that the centrosome protein Dzip1 mediates the assembly of the BBSome-Dzip1-PCM1 complex in the centriolar satellites (CS) at the G(0) phase for ciliary translocation of the BBSome. Phosphorylation of Dzip1 at Ser-210 by Plk1 (polo-like kinase 1) during the G(2) phase promotes disassembly of this complex, resulting in removal of Dzip1 and the BBSome from the CS. Inhibiting the kinase activity of Plk1 maintains the CS localization of the BBSome and Dzip1 at the G(2) phase. Collectively, our findings reveal the cell cycle-dependent regulation of BBSome transport to the CS and highlight a potential mechanism that the BBSome-mediated signaling pathways are accordingly regulated during the cell cycle.	[Zhang, Boyan; Wang, Gang; Xu, Xiaowei; Yang, Sisi; Zhuang, Tenghan; Wang, Guopeng; Ren, He; Jiang, Qing; Zhang, Chuanmao] Peking Univ, Minist Educ, Key Lab Cell Proliferat & Differentiat, Beijing 100871, Peoples R China; [Zhang, Boyan; Wang, Gang; Xu, Xiaowei; Yang, Sisi; Zhuang, Tenghan; Wang, Guopeng; Ren, He; Jiang, Qing; Zhang, Chuanmao] Peking Univ, Coll Life Sci, State Key Lab Membrane Biol, Beijing 100871, Peoples R China; [Cheng, Steven Y.] Nanjing Med Univ, Sch Basic Med Sci, Dept Dev Genet, Nanjing 210029, Jiangsu, Peoples R China	Peking University; Peking University; Nanjing Medical University	Zhang, CM (corresponding author), Peking Univ, Minist Educ, Key Lab Cell Proliferat & Differentiat, Beijing 100871, Peoples R China.; Zhang, CM (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Membrane Biol, Beijing 100871, Peoples R China.	zhangcm@pku.edu.cn	Wang, Gang/Q-7267-2019	Xu, Xiaowei/0000-0001-6050-9536; Ren, He/0000-0003-0660-3657; Zhang, Boyan/0000-0001-7112-9870; Wang, Gang/0000-0002-0297-6467	National Natural Science Foundation of China (NSFC) [31520103906, 31571386, 31371365, 31430051]; Ministry of Science and Technology of China [2016YFA0100501, 2016YFA0500201]; Postdoctoral Fellowship of the Peking-Tsinghua Center for Life Sciences at Peking University	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Postdoctoral Fellowship of the Peking-Tsinghua Center for Life Sciences at Peking University	This work was supported by the National Natural Science Foundation of China (NSFC) (31520103906, 31571386, 31371365, and 31430051) and the Ministry of Science and Technology of China (2016YFA0100501 and 2016YFA0500201). The authors declare that they have no conflicts of interest with the contents of this article.r Supported in part by a Postdoctoral Fellowship of the Peking-Tsinghua Center for Life Sciences at Peking University.	Barbelanne M, 2015, HUM MOL GENET, V24, P2185, DOI 10.1093/hmg/ddu738; Brand M, 1996, DEVELOPMENT, V123, P129; Chamling X, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004083; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a; Glazer AM, 2010, DEV BIOL, V337, P148, DOI 10.1016/j.ydbio.2009.10.025; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Jin ZG, 2011, J BIOL CHEM, V286, P36171, DOI 10.1074/jbc.M111.274761; Karlstrom RO, 1996, DEVELOPMENT, V123, P427; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Kim HR, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-65; Lee K, 2011, J CELL BIOL, V195, P1093, DOI 10.1083/jcb.201106093; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Moore FL, 2004, GENOMICS, V83, P834, DOI 10.1016/j.ygeno.2003.11.005; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Schwend T, 2013, J BIOL CHEM, V288, P32809, DOI 10.1074/jbc.M113.512962; Sekimizu K, 2004, DEVELOPMENT, V131, P2521, DOI 10.1242/dev.01059; Seo S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002358; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; Stowe TR, 2012, MOL BIOL CELL, V23, P3322, DOI 10.1091/mbc.E12-02-0134; Tay SY, 2010, DEV DYNAM, V239, P527, DOI 10.1002/dvdy.22199; Wang CB, 2013, J BIOL CHEM, V288, P29518, DOI 10.1074/jbc.M113.492066; Wang G, 2013, J CELL SCI, V126, P1355, DOI 10.1242/jcs.114918; Wolff C, 2004, GENE DEV, V18, P1565, DOI 10.1101/gad.296004; Zhang BY, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002129; Zhang QH, 2013, J CELL SCI, V126, P2372, DOI 10.1242/jcs.111740; Zhang QH, 2012, J BIOL CHEM, V287, P20625, DOI 10.1074/jbc.M112.341487; Zhang QH, 2012, HUM MOL GENET, V21, P1945, DOI 10.1093/hmg/dds004	30	20	21	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1351	1360		10.1074/jbc.M116.765438	http://dx.doi.org/10.1074/jbc.M116.765438			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27979967	hybrid, Green Published			2022-12-26	WOS:000393339800017
J	Han, RT; Back, SK; Lee, H; Lee, J; Kim, HY; Kim, HJ; Na, HS				Han, Rafael Taeho; Back, Seung Keun; Lee, Hyunkyoung; Lee, JaeHee; Kim, Hye Young; Kim, Hee Jin; Na, Heung Sik			Formaldehyde-Induced Aggravation of Pruritus and Dermatitis Is Associated with the Elevated Expression of Thl Cytokines in a Rat Model of Atopic Dermatitis	PLoS One			English	Article							HUMAN SERUM-ALBUMIN; MATERNAL SEPARATION; MEDICAL-STUDENTS; LESIONAL SKIN; PATCH TEST; EXPOSURE; MICE; INFLAMMATION; DISEASE; ECZEMA	Atopic dermatitis is a complex disease of heterogeneous pathogenesis, in particular, genetic predisposition, environmental triggers, and their interactions. Indoor air pollution, increasing with urbanization, plays a role as environmental risk factor in the development of AD. However, we still lack a detailed picture of the role of air pollution in the development of the disease. Here, we examined the effect of formaldehyde (FA) exposure on the manifestation of atopic dermatitis and the underlying molecular mechanism in naive rats and in a rat model of atopic dermatitis (AD) produced by neonatal capsaicin treatment. The AD and naive rats were exposed to 0.8 ppm FA, 1.2 ppm FA, or fresh air (Air) for 6 weeks (2 hours/day and 5 days/week). So, six groups, namely the 1.2 FA-AD, 0.8 FA-AD, Air-AD, 1.2 FA-naive, 0.8 FA-naive and Air-naive groups, were established. Pruritus and dermatitis, two major symptoms of atopic dermatitis, were evaluated every week for 6 weeks. After that, samples of the blood, the skin and the thymus were collected from the 1.2 FA-AD, the Air-AD, the 1.2 FA naive and the Air-naive groups. Serum IgE levels were quantified with ELISA, and mRNA expression levels of inflammatory cytokines from extracts of the skin and the thymus were calculated with qRT-PCR. The dermatitis and pruritus significantly worsened in 1.2 FA-AD group, but not in 0.8 FA-AD, compared to the Air-AD animals, whereas FA didn't induce any symptoms in naive rats. Consistently, the levels of serum IgE were significantly higher in 1.2 FA-AD than in air-AD, however, there was no significant difference following FA exposure in naive animals. In the skin, mRNA expression levels of Th1 cytokines such as INF-a and IL 113 were significantly higher in the 1.2 FA-AD rats compared to the air-AD rats, whereas mRNA expression levels of Th2 cytokines (IL-4, IL-5, IL-13), IL-17A and TSLP were significantly higher in 1.2 FA-naive group than in the Air-naive group. These results suggested that 1.2 ppm of FA penetrated the injured skin barrier, and exacerbated Th1 responses and serum IgE level in the AD rats so that dermatitis and pruritus were aggravated, while the elevated expression of Th2 cytokines by 1.2 ppm of FA in naive rats was probably insufficient for clinical manifestation. In conclusion, in a rat model of atopic dermatitis, exposure to 1.2 ppm of FA aggravated pruritus and skin inflammation, which was associated with the elevated expression of Th1 cytokines.	[Han, Rafael Taeho; Lee, Hyunkyoung; Lee, JaeHee; Kim, Hye Young; Na, Heung Sik] Korea Univ, Coll Med, Neurosci Res Inst, Seoul, South Korea; [Han, Rafael Taeho; Lee, Hyunkyoung; Lee, JaeHee; Kim, Hye Young; Na, Heung Sik] Korea Univ, Coll Med, Dept Physiol, Seoul, South Korea; [Back, Seung Keun] Konyang Univ, Coll Med Engn, Dept Pharmaceut & Biotechnol, Chungnam, South Korea; [Kim, Hee Jin] Yonsei Univ, Coll Sci & Technol, Div Biol Sci & Technol, Wonju Campus, Wonju, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Konyang University; Yonsei University	Na, HS (corresponding author), Korea Univ, Coll Med, Neurosci Res Inst, Seoul, South Korea.; Na, HS (corresponding author), Korea Univ, Coll Med, Dept Physiol, Seoul, South Korea.	hsna@korea.ac.kr	Kim, Heejin/HII-8568-2022	Han, Rafael/0000-0002-0123-877X; Han, Rafael Taeho/0000-0002-0127-2396	National Research Foundation of Korea [NRF-2015M3C8A5060108]; Chung Yang, Cha Young Sun, M.D. and Jang Hi Joo Yeu Sa Memorial Fund	National Research Foundation of Korea(National Research Foundation of Korea); Chung Yang, Cha Young Sun, M.D. and Jang Hi Joo Yeu Sa Memorial Fund	This work was supported by National Research Foundation of Korea, Recipient: Heung Sik Na, www.nrf.re.kr, NRF-2015M3C8A5060108; and The Chung Yang, Cha Young Sun, M.D. and Jang Hi Joo Yeu Sa Memorial Fund, Recipient: Heung Sik Na, No URL, No grant numbers.	Adgate JL, 2014, ENVIRON SCI TECHNOL, V48, P8307, DOI 10.1021/es404621d; Ahmed Ijaz, 2007, J Pak Med Assoc, V57, P431; Ahn K, 2014, J ALLERGY CLIN IMMUN, V134, P993, DOI 10.1016/j.jaci.2014.09.023; Back SK, 2012, J DERMATOL SCI, V67, P111, DOI 10.1016/j.jdermsci.2012.05.006; Barnes KC, 2010, J ALLERGY CLIN IMMUN, V125, P16, DOI 10.1016/j.jaci.2009.11.008; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Brandt E.B., 2011, J CLIN CELLULAR IMMU, V2; Darsow U, 2004, ALLERGY, V59, P1318, DOI 10.1111/j.1398-9995.2004.00556.x; DaVeiga SP, 2012, ALLERGY ASTHMA PROC, V33, P227, DOI 10.2500/aap.2012.33.3569; Dearman RJ, 1999, CLIN EXP ALLERGY, V29, P124; DYKEWICZ MS, 1991, J ALLERGY CLIN IMMUN, V87, P48, DOI 10.1016/0091-6749(91)90212-7; Eichenfield LF, 2014, J AM ACAD DERMATOL, V70, P338, DOI 10.1016/j.jaad.2013.10.010; Eyerich K, 2013, ALLERGY, V68, P974, DOI 10.1111/all.12184; Eyerich K, 2008, INT ARCH ALLERGY IMM, V145, P213, DOI 10.1159/000109290; Fujimaki H, 2004, TOXICOLOGY, V197, P1, DOI 10.1016/j.tox.2003.11.015; GREWE M, 1995, J INVEST DERMATOL, V105, P407, DOI 10.1111/1523-1747.ep12321078; Hisamitsu Minako, 2011, Allergology International, V60, P373, DOI 10.2332/allergolint.10-OA-0210; Jeong CW, 2003, CLIN EXP ALLERGY, V33, P1717, DOI 10.1111/j.1365-2222.2003.01782.x; Jeong KY, 2015, ALLERGY ASTHMA IMMUN, V7, P69, DOI 10.4168/aair.2015.7.1.69; Jung WW, 2007, ENVIRON TOXICOL PHAR, V24, P174, DOI 10.1016/j.etap.2007.05.001; Kim H, 1999, ARCH ENVIRON HEALTH, V54, P115, DOI 10.1080/00039899909602245; Kim J, 2013, J ALLERGY CLIN IMMUN, V132, P495, DOI 10.1016/j.jaci.2013.04.019; Koga C, 2008, J INVEST DERMATOL, V128, P2625, DOI 10.1038/jid.2008.111; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Laske N, 2004, PEDIAT ALLERG IMM-UK, V15, P86, DOI 10.1046/j.0905-6157.2003.00106.x; Leung DYM, 2004, J CLIN INVEST, V113, P651, DOI 10.1172/JCI200421060; Lippmann M, 2007, EUR J NEUROSCI, V25, P3091, DOI 10.1111/j.1460-9568.2007.05522.x; Liu YJ, 2006, J EXP MED, V203, P269, DOI 10.1084/jem.20051745; McAleer MA, 2013, J ALLERGY CLIN IMMUN, V131, P280, DOI 10.1016/j.jaci.2012.12.668; Mihara K, 2004, BRIT J DERMATOL, V151, P335, DOI 10.1111/j.1365-2133.2004.06036.x; OSOBA D, 1966, CAN MED ASSOC J, V94, P488; Aguggia JP, 2013, BEHAV BRAIN RES, V248, P25, DOI 10.1016/j.bbr.2013.03.040; Saito A, 2011, ENVIRON TOXICOL, V26, P224, DOI 10.1002/tox.20547; Salthammer T, 2010, CHEM REV, V110, P2536, DOI 10.1021/cr800399g; Song S, 2011, ENVIRON RES, V111, P394, DOI 10.1016/j.envres.2010.10.010; TARKOWSKI M, 1995, INT ARCH ALLERGY IMM, V106, P422, DOI 10.1159/000236876; Tazawa T, 2004, ARCH DERMATOL RES, V295, P459, DOI 10.1007/s00403-004-0455-6; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tupker RA, 1996, J ALLERGY CLIN IMMUN, V97, P1064, DOI 10.1016/S0091-6749(96)70259-2; Xu BH, 2002, IMMUNOL LETT, V84, P49, DOI 10.1016/S0165-2478(02)00126-8	40	17	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168466	10.1371/journal.pone.0168466	http://dx.doi.org/10.1371/journal.pone.0168466			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005965	Green Published, gold, Green Submitted			2022-12-26	WOS:000392843200057
J	Othman, EM; Naseem, M; Awad, E; Dandekar, T; Stopper, H				Othman, Eman M.; Naseem, Muhammed; Awad, Eman; Dandekar, Thomas; Stopper, Helga			The Plant Hormone Cytokinin Confers Protection against Oxidative Stress in Mammalian Cells	PLoS One			English	Article							ANTIOXIDANT ACTIVITY; FAMILIAL DYSAUTONOMIA; KINETIN-RIBOSIDE; FREE-RADICALS; HUMAN-DISEASE; D-GALACTOSE; FIBROBLASTS; PATIENT; CANCER; OXYGEN	Modulating key dynamics of plant growth and development, the effects of the plant hormone cytokinin on animal cells gained much attention recently. Most previous studies on cytokinin effects on mammalian cells have been conducted with elevated cytokinin concentration (in the mu M range). However, to examine physiologically relevant dose effects of cytokinins on animal cells, we systematically analyzed the impact of kinetin in cultured cells at low and high concentrations (1nM-10 mu M) and examined cytotoxic and genotoxic conditions. We furthermore measured the intrinsic antioxidant activity of kinetin in a cell-free system using the Ferric Reducing Antioxidant Power assay and in cells using the dihydroethidium staining method. Monitoring viability, we looked at kinetin effects in mammalian cells such as HL60 cells, HaCaT human keratinocyte cells, NRK rat epithelial kidney cells and human peripheral lymphocytes. Kinetin manifests no antioxidant activity in the cell free system and high doses of kinetin (500 nM and higher) reduce cell viability and mediate DNA damage in vitro. In contrast, low doses (concentrations up to 100 nM) of kinetin confer protection in cells against oxidative stress. Moreover, our results show that pretreatment of the cells with kinetin significantly reduces 4-nitroquinoline 1-oxide mediated reactive oxygen species production. Also, pretreatment with kinetin retains cellular GSH levels when they are also treated with the GSH-depleting agent patulin. Our results explicitly show that low kinetin doses reduce apoptosis and protect cells from oxidative stress mediated cell death. Future studies on the interaction between cytokinins and human cellular pathway targets will be intriguing.	[Othman, Eman M.; Awad, Eman; Stopper, Helga] Univ Wurzburg, Inst Pharmacol & Toxicol, Wurzburg, Germany; [Othman, Eman M.] Univ El Minia, Fac Pharm, Dept Analyt Chem, Al Minya, Egypt; [Naseem, Muhammed; Dandekar, Thomas] Univ Wurzburg, Bioctr, Dept Bioinformat, Wurzburg, Germany; [Naseem, Muhammed] Bogazici Univ, Dept Mol Biol & Genet, Kuzey Pk, Istanbul, Turkey	University of Wurzburg; Egyptian Knowledge Bank (EKB); Minia University; University of Wurzburg; Bogazici University	Othman, EM (corresponding author), Univ Wurzburg, Inst Pharmacol & Toxicol, Wurzburg, Germany.; Othman, EM (corresponding author), Univ El Minia, Fac Pharm, Dept Analyt Chem, Al Minya, Egypt.; Dandekar, T (corresponding author), Univ Wurzburg, Bioctr, Dept Bioinformat, Wurzburg, Germany.	eman@toxi.uni-wuerzburg.de; dandekar@biozentrum.uni-wuerzburg.de	; Dandekar, Thomas/A-4431-2017	Naseem, Muhammad/0000-0001-8712-8936; Dandekar, Thomas/0000-0003-1886-7625	Deutsche Forschungsgemeinschaft [TR124/B1]; University of Wurzburg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Wurzburg	We thank Deutsche Forschungsgemeinschaft (TR124/B1) for support. This publication was supported by the open access publication fund of the University of Wurzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen UR, 2012, MAR DRUGS, V10, P2208, DOI 10.3390/md10102208; Alfardan J, 2010, MOL GENET METAB, V100, P333, DOI 10.1016/j.ymgme.2010.04.014; Axelrod FB, 2011, PEDIATR RES, V70, P480, DOI 10.1203/PDR.0b013e31822e1825; Bartsch I, 2004, IN VITRO CELL DEV-AN, V40, P278; Benzie IFF, 1999, METHOD ENZYMOL, V299, P15; Boone N, 2012, HUM MUTAT, V33, P530, DOI 10.1002/humu.22010; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Cabello CM, 2009, BIOCHEM PHARMACOL, V77, P1125, DOI 10.1016/j.bcp.2008.12.002; Chiu Pin-Chi, 2007, J Cosmet Dermatol, V6, P243; Cronin H, 2010, J COSMET DERMATOL-US, V9, P218, DOI 10.1111/j.1473-2165.2010.00516.x; CROSS CE, 1987, ANN INTERN MED, V107, P526, DOI 10.7326/0003-4819-107-4-526; GALLAGHER R, 1979, BLOOD, V54, P713; Griffaut B, 2004, INT J BIOL MACROMOL, V34, P271, DOI 10.1016/j.ijbiomac.2004.06.004; HALLIWELL B, 1992, J LAB CLIN MED, V119, P598; Hims MM, 2007, J MOL MED, V85, P149, DOI 10.1007/s00109-006-0137-2; Huda-Faujan N, 2009, AFR J BIOTECHNOL, V8, P484; Hwang I, 2012, ANNU REV PLANT BIOL, V63, P353, DOI 10.1146/annurev-arplant-042811-105503; Jablonska-Trypuc A, 2016, MOL CELL BIOCHEM, V413, P97, DOI 10.1007/s11010-015-2642-5; KEHRER JP, 1993, CRIT REV TOXICOL, V23, P21, DOI 10.3109/10408449309104073; Lappas CM, 2015, CELL MOL IMMUNOL, V12, DOI 10.1038/cmi.2014.33; Lee YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038865; Li MY, 2014, J VET SCI, V15, P353, DOI 10.4142/jvs.2014.15.3.353; Mehrzad J, 2011, AFR J BIOTECHNOL, V10, P6304; Moyer RA, 2002, J AGR FOOD CHEM, V50, P519, DOI 10.1021/jf011062r; Naseem M, 2015, TRENDS PLANT SCI, V20, P781, DOI 10.1016/j.tplants.2015.10.017; Naseem M, 2014, TRENDS PLANT SCI, V19, P481, DOI 10.1016/j.tplants.2014.04.001; Olsen A, 1999, BIOCHEM BIOPH RES CO, V265, P499, DOI 10.1006/bbrc.1999.1669; RATTAN SIS, 1994, BIOCHEM BIOPH RES CO, V201, P665, DOI 10.1006/bbrc.1994.1752; Robischon M, 2015, BIOESSAYS, V37, P356, DOI 10.1002/bies.201400099; Samanovic MI, 2015, MOL CELL, V57, P984, DOI 10.1016/j.molcel.2015.01.024; Saurav K, 2012, SAUDI J BIOL SCI, V19, P81, DOI 10.1016/j.sjbs.2011.07.003; Schmitt E, 2002, TOXICOL LETT, V136, P133, DOI 10.1016/S0378-4274(02)00290-4; Sun Jiang-Hong, 2013, Shengli Xuebao, V65, P389; Verbeke P, 2000, BIOCHEM BIOPH RES CO, V276, P1265, DOI 10.1006/bbrc.2000.3616; Villanueva C, 2012, INT J MOL SCI, V13, P2091, DOI 10.3390/ijms13022091; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; Wu JJ, 2007, CLIN EXP DERMATOL, V32, P693, DOI 10.1111/j.1365-2230.2007.02513.x	37	28	30	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168386	10.1371/journal.pone.0168386	http://dx.doi.org/10.1371/journal.pone.0168386			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005918	Green Published, Green Submitted, gold			2022-12-26	WOS:000392843200048
J	Lim, K; Jackson, KL; Burke, SL; Head, GA				Lim, Kyungjoon; Jackson, Kristy L.; Burke, Sandra L.; Head, Geoffrey A.			The Effects of Rilmenidine and Perindopril on Arousal Blood Pressure during 24 Hour Recordings in SHR	PLoS One			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; SYMPATHETIC-NERVOUS-SYSTEM; MORNING SURGE; CARDIOVASCULAR ACTIONS; CARDIAC BAROREFLEX; CONSCIOUS RABBITS; STROKE; CLONIDINE; RHYTHMICITY; VARIABILITY	The surge in arterial pressure during arousal in the waking period is thought to be largely due to activation of the sympathetic nervous system. In this study we compared in SHR the effects of chronic administration of the centrally acting sympatholytic agent rilmenidine with an angiotensin converting enzyme inhibitor perindopril on the rate of rise and power of the surge in mean arterial pressure (MAP) that occurs with arousal associated with the onset of night. Recordings were made using radiotelemetry in 17 adult SHR before and after treatment with rilmenidine (2mg/kg/day), perindopril (1 mg/kg/day) or vehicle in the drinking water for 2 weeks. Rilmenidine reduced MAP by 7.2 +/- 1.7mmHg while perindopril reduced MAP by 19 +/- 3mmHg. Double logistic curve fit analysis showed that the rate and power of increase in systolic pressure during the transition from light to dark was reduced by 50% and 65%, respectively, but had no effect on diastolic pressure. Rilmenidine also reduced blood pressure variability in the autonomic frequency in the active period as assessed by spectral analysis which is consistent with reduction in sympathetic nervous system activity. Perindopril had no effect on the rate or power of the arousal surge in either systolic or diastolic pressure. These results suggest that the arousal induced surge in blood pressure can largely be reduced by an antihypertensive agent that inhibits the sympathetic nervous system and that angiotensin converting enzyme inhibition, while effective in reducing blood pressure, does not alter the rate or power of the surge associated with arousal.	[Lim, Kyungjoon; Jackson, Kristy L.; Burke, Sandra L.; Head, Geoffrey A.] Baker IDI Heart & Diabet Inst, Neuropharmacol Lab, Melbourne, Vic, Australia; [Head, Geoffrey A.] Monash Univ, Dept Pharmacol, Clayton, Vic, Australia	Baker Heart and Diabetes Institute; Monash University	Lim, K (corresponding author), Baker IDI Heart & Diabet Inst, Neuropharmacol Lab, Melbourne, Vic, Australia.	joon.lim@bakeridi.edu.au	Head, Geoffrey A./B-2177-2010; Lim, Joon/AAX-7788-2020	Head, Geoffrey A./0000-0002-7623-137X; Jackson, Kristy/0000-0002-4707-4096				Adams DJ, 2006, J BIOL CHEM, V281, P31753, DOI 10.1074/jbc.M605720200; BROCKWAY BP, 1991, CLIN EXP HYPERTENS A, V13, P885, DOI 10.3109/10641969109042094; Burke SL, 2016, AM J PHYSIOL-HEART C, V310, pH1222, DOI 10.1152/ajpheart.00866.2015; Burke SL, 1998, J AUTONOM NERV SYST, V72, P177, DOI 10.1016/S0165-1838(98)00103-9; Chan CKS, 1996, J PHARMACOL EXP THER, V276, P411; Davern PJ, 2009, HYPERTENSION, V54, P852, DOI 10.1161/HYPERTENSIONAHA.109.136069; Elliott WJ, 1998, STROKE, V29, P992, DOI 10.1161/01.STR.29.5.992; Fennessy PA, 1996, PHARMACOL RES, V34, P135, DOI 10.1006/phrs.1996.0078; Finta E, 2006, J HYPERTENS, V24, P1619, DOI 10.1097/01.hjh.0000239298.63377.db; Gallerani M, 1996, STROKE, V27, P1793, DOI 10.1161/01.STR.27.10.1793; Gaudet E, 1996, AM J PHYSIOL-REG I, V270, pR1265, DOI 10.1152/ajpregu.1996.270.6.R1265; Hashimoto J, 2003, J HYPERTENS, V21, P805, DOI 10.1097/00004872-200304000-00025; Head G A, 1995, Ann N Y Acad Sci, V763, P531, DOI 10.1111/j.1749-6632.1995.tb32447.x; Head GA, 1998, J HYPERTENS, V16, pS7; Head GA, 2004, J HYPERTENS, V22, P2075, DOI 10.1097/00004872-200411000-00008; Head GA, 2001, IEEE ENG MED BIOL, V20, P43, DOI 10.1109/51.917723; Head GA, 2006, AM J HYPERTENS, V19, P1010, DOI 10.1016/j.amjhyper.2006.03.014; Head GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093186; Head GA, 2010, AM J HYPERTENS, V23, P1074, DOI 10.1038/ajh.2010.126; Hermida RC, 2008, AM J HYPERTENS, V21, P948, DOI 10.1038/ajh.2008.216; Hermida RC, 2004, CHRONOBIOL INT, V21, P277, DOI 10.1081/CBI-120037772; Jackson KL, 2014, J HYPERTENS, V32, P575, DOI 10.1097/HJH.0000000000000036; JANSSEN BJA, 1993, CHRONOBIOL INT, V10, P420, DOI 10.3109/07420529309059718; Janssen BJA, 2002, AM J PHYSIOL-RENAL, V282, pF113, DOI 10.1152/ajprenal.0153.2001; JULIEN C, 1990, AM J PHYSIOL, V259, pH1337, DOI 10.1152/ajpheart.1990.259.5.H1337; Kario K, 2005, HYPERTENSION, V45, P485, DOI 10.1161/01.HYP.0000158313.57142.3f; Kario K, 2003, CIRCULATION, V107, P1401, DOI 10.1161/01.CIR.0000056521.67546.AA; Kario K, 2006, HYPERTENS RES, V29, P581, DOI 10.1291/hypres.29.581; Lambert EA, 2014, AM J HYPERTENS, V27, P783, DOI 10.1093/ajh/hpt273; Lim K, 2015, EXP PHYSIOL, V100, P1132, DOI 10.1113/EP085312; Luo Y, 2013, CHINESE MED J-PEKING, V126, P510, DOI 10.3760/cma.j.issn.0366-6999.20122110; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Martin CA, 2013, J HUM HYPERTENS, V27, P315, DOI 10.1038/jhh.2012.44; Mayorov DN, 2001, J CARDIOVASC PHARM, V37, P252, DOI 10.1097/00005344-200103000-00003; MIDDLEKAUFF HR, 1995, CIRCULATION, V91, P2549, DOI 10.1161/01.CIR.91.10.2549; MINAMI N, 1993, J HYPERTENS, V11, P523, DOI 10.1097/00004872-199305000-00008; MINAMI N, 1992, COLLOQ INSE, V218, P69; Monassier L, 2004, J CARDIOVASC PHARM, V43, P394, DOI 10.1097/00005344-200403000-00010; Navakatikyan MA, 2002, IEEE T BIO-MED ENG, V49, P662, DOI 10.1109/TBME.2002.1010849; Nowak L, 2005, AM J HYPERTENS, V18, P1470, DOI 10.1016/j.amjhyper.2005.05.026; Ricketts JH, 1999, AM J PHYSIOL-REG I, V277, pR441, DOI 10.1152/ajpregu.1999.277.2.R441; SANNAJUST F, 1989, CLIN EXP PHARMACOL P, V16, P837, DOI 10.1111/j.1440-1681.1989.tb01523.x; SASSARD J, 1989, B ACAD NAT MED PARIS, V173, P1219; WILLICH SN, 1989, CIRCULATION, V80, P853, DOI 10.1161/01.CIR.80.4.853	44	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168425	10.1371/journal.pone.0168425	http://dx.doi.org/10.1371/journal.pone.0168425			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002478	Green Submitted, Green Published, gold			2022-12-26	WOS:000392853100045
J	Mogollon, CM; van Pul, FJA; Imai, T; Ramesar, J; Chevalley-Maurel, S; de Roo, GM; Veld, SAJ; Kroeze, H; Franke-Fayard, BMD; Janse, CJ; Khan, SM				Mogollon, Catherin Marin; van Pul, Fiona J. A.; Imai, Takashi; Ramesar, Jai; Chevalley-Maurel, Severine; de Roo, Guido M.; Veld, Sabrina A. J.; Kroeze, Hans; Franke-Fayard, Blandine M. D.; Janse, Chris J.; Khan, Shahid M.			Rapid Generation of Marker-Free P. falciparum Fluorescent Reporter Lines Using Modified CRISPR/Cas9 Constructs and Selection Protocol	PLOS ONE			English	Article							TARGETED GENE DELETION; PLASMODIUM-FALCIPARUM; MALARIA PARASITE; NEGATIVE SELECTION; EXPRESSES GFP; BLOOD STAGES; LIVER-STAGE; LUCIFERASE; TRANSFECTION; GAMETOCYTES	The CRISPR/Cas9 system is a powerful genome editing technique employed in a wide variety of organisms including recently the human malaria parasite, P. falciparum. Here we report on further improvements to the CRISPR/Cas9 transfection constructs and selection protocol to more rapidly modify the P. falciparum genome and to introduce transgenes into the parasite genome without the inclusion of drug-selectable marker genes. This method was used to stably integrate the gene encoding GFP into the P. falciparum genome under the control of promoters of three different Plasmodium genes (calmodulin, gapdh and hsp70). These genes were selected as they are highly transcribed in blood stages. We show that the three reporter parasite lines generated in this study (GFP@ cam, GFP@gapdh and GFP@ hsp70) have in vitro blood stage growth kinetics and drug-sensitivity profiles comparable to the parental P. falciparum (NF54) wild-type line. Both asexual and sexual blood stages of the three reporter lines expressed GFP-fluorescence with GFP@ hsp70 having the highest fluorescent intensity in schizont stages as shown by flow cytometry analysis of GFP-fluorescence intensity. The improved CRISPR/Cas9 constructs/protocol will aid in the rapid generation of transgenic and modified P. falciparum parasites, including those expressing different reporters proteins under different (stage specific) promoters.	[Mogollon, Catherin Marin; van Pul, Fiona J. A.; Imai, Takashi; Ramesar, Jai; Chevalley-Maurel, Severine; Kroeze, Hans; Franke-Fayard, Blandine M. D.; Janse, Chris J.; Khan, Shahid M.] Leiden Univ, Med Ctr, Dept Parasitol, Leiden Malaria Res Grp, Leiden, Netherlands; [de Roo, Guido M.; Veld, Sabrina A. J.] Leiden Univ, Med Ctr, Dept Hematol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Khan, SM (corresponding author), Leiden Univ, Med Ctr, Dept Parasitol, Leiden Malaria Res Grp, Leiden, Netherlands.	S.M.Khan@lumc.nl		Imai, Takashi/0000-0001-9049-8102; , Blandine/0000-0001-6041-4182; Khan, Shahid/0000-0002-0533-4670; Janse, Chris J/0000-0002-6410-6205	Colciencias Ph.D. fellowship; Uehara Memorial Foundation	Colciencias Ph.D. fellowship; Uehara Memorial Foundation(Uehara Memorial Foundation)	C. M. Mogollon was supported by Colciencias Ph.D. fellowship (Call 568 from 2012 Resolution 01218 Bogota, Colombia). Takashi Imai was, in part, supported by Uehara Memorial Foundation grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjalley SH, 2010, METHODS MOL BIOL, V634, P87, DOI 10.1007/978-1-60761-652-8_6; Amino R, 2005, CURR OPIN MICROBIOL, V8, P407, DOI 10.1016/j.mib.2005.06.019; Annoura T, 2012, VACCINE, V30, P2662, DOI 10.1016/j.vaccine.2012.02.010; Braks JAM, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj033; Coombes JL, 2010, NAT REV IMMUNOL, V10, P353, DOI 10.1038/nri2746; Cui L, 2008, EXP PARASITOL, V120, P80, DOI 10.1016/j.exppara.2008.05.003; de Koning-Ward TF, 2015, NAT REV MICROBIOL, V13, P373, DOI 10.1038/nrmicro3450; Dube A, 2009, TRENDS PARASITOL, V25, P432, DOI 10.1016/j.pt.2009.06.006; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; Erbs P, 2000, CANCER RES, V60, P3813; Franke-Fayard B, 2008, INT J PARASITOL, V38, P1651, DOI 10.1016/j.ijpara.2008.05.012; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Heussler V, 2006, TRENDS PARASITOL, V22, P192, DOI 10.1016/j.pt.2006.03.001; Hill DA, 2007, P NATL ACAD SCI USA, V104, P1063, DOI 10.1073/pnas.0610353104; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Janse CJ, 2011, TRENDS PARASITOL, V27, P31, DOI 10.1016/j.pt.2010.06.016; JANSE CJ, 1994, METHOD CELL BIOL, V42, P295; Khan SM, 2012, CURRENT OPINION BIOT; LaMonte G, 2016, MBIO, V7, DOI 10.1128/mBio.00696-16; Lee MCS, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0063-9; Lin Jing-Wen, 2013, Methods Mol Biol, V923, P507; Lin JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029289; Longley RJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11820; Lu JN, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1487-4; Maier AG, 2006, MOL BIOCHEM PARASIT, V150, P118, DOI 10.1016/j.molbiopara.2006.06.014; Maier Alexander G, 2013, Methods Mol Biol, V923, P3; Manzoni G, 2014, SCI REP-UK, V4, DOI 10.1038/srep04760; Meister S, 2011, SCIENCE, V334, P1372, DOI 10.1126/science.1211936; Militello KT, 2003, PARASITOL RES, V89, P154, DOI 10.1007/s00436-002-0721-5; Mojica FJ, 2016, TRENDS MICROBIOL; Ng CL, 2016, MOL MICROBIOL, V101, P381, DOI 10.1111/mmi.13397; O'Neill MT, 2011, INT J PARASITOL, V41, P117, DOI 10.1016/j.ijpara.2010.08.001; Ploemen IHJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007881; PONNUDURAI T, 1981, TROP GEOGR MED, V33, P50; PONNUDURAI T, 1986, PARASITOLOGY, V93, P263, DOI 10.1017/S003118200005143X; Rankin KE, 2010, CELL MICROBIOL, V12, P569, DOI 10.1111/j.1462-5822.2010.01454.x; Rijpma SR, 2016, CELL MICROBIOL, V18, P369, DOI 10.1111/cmi.12517; Rug M, 2013, METHOD MOL BIOL, V923, P75, DOI [DOI 10.1007/978-1-62703-026-7_6, 10.1007/978-1-62703-026-7_6]; Silvie O, 2008, CURR OPIN MICROBIOL, V11, P352, DOI 10.1016/j.mib.2008.06.005; Talman AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009156; van Dijk MR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000853; van Niekerk DD, 2016, FEBS J, V283, P634, DOI 10.1111/febs.13615; van Schaijk BCL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015121; Vaughan AM, 2012, MOL BIOCHEM PARASIT, V186, P143, DOI 10.1016/j.molbiopara.2012.10.004; Wagner JC, 2014, NAT METHODS, V11, P915, DOI [10.1038/NMETH.3063, 10.1038/nmeth.3063]; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035	47	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168362	10.1371/journal.pone.0168362	http://dx.doi.org/10.1371/journal.pone.0168362			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997583	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842900037
J	Mukherjee, A; Nayak, MK; Dutta, S; Panda, S; Satpathi, BR; Chawla-Sarkar, M				Mukherjee, Anupam; Nayak, Mukti Kant; Dutta, Shanta; Panda, Samiran; Satpathi, Biswa Ranjan; Chawla-Sarkar, Mamta			Genetic Characterization of Circulating 2015 A(H1N1)pdm09 Influenza Viruses from Eastern India	PLOS ONE			English	Article							A H1N1 VIRUS; NEURAMINIDASE INHIBITORS; EVOLUTIONARY DYNAMICS; HEMAGGLUTININ; H1N1PDM09; HUMANS	In 2015, the swine derived A(H1N1)pdm09 pandemic strain outbreak became widespread throughout the different states of India. The reported cases and deaths in 2015 surpassed the previous years with more than 39000 laboratory confirmed cases and a death toll of more than 2500 people. There are relatively limited complete genetic sequences available for this virus from Asian countries. In this study, we describe the full genome analysis of influenza 2015 A(H1N1)pdm09 viruses isolated from West Bengal between January through December 2015. The phylogenetic analysis of the haemagglutinin sequence revealed clustering with globally circulating strains of genogroup 6B. This was further confirmed by the constructed concatenated tree using all eight complete gene segments of Kolkata A(H1N1)pdm09 isolates with the other strains from different timeline and lineages. A study from Massachusetts Institute of Technology (MIT) in 2015 reported novel mutations T200A and D225N in haemagglutinin gene of a 2014 Indian strain (A/India/6427/2014). However, in all the pandemic strains of 2014-2015 reported from India, so far including A(H1N1)pdm09 strains from Kolkata, D225N mutation was not observed, though the T200A mutation was found to be conserved. Neuraminidase gene of the analyzed strains did not show any oseltamivir resistant mutation H275Y suggesting continuation of Tamiflu as drug of choice. The amino acid sequences of the all gene segments from 2015 A(H1N1)pdm09 isolates identified several new mutations compared to the 2009 A(H1N1)pdm09 strains, which may have contributed towards enhanced virulence, compared to 2009 A(H1N1)pdm09 strains.	[Mukherjee, Anupam; Nayak, Mukti Kant; Chawla-Sarkar, Mamta] Natl Inst Cholera & Enter Dis, Div Mol Virol, Kolkata, India; [Dutta, Shanta] Natl Inst Cholera & Enter Dis, Div Bacteriol, Kolkata, India; [Panda, Samiran] Natl Inst Cholera & Enter Dis, Div Epidemiol, Kolkata, India; [Satpathi, Biswa Ranjan] Govt West Bengal, Dept Hlth & Family Welf, Kolkata, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Chawla-Sarkar, M (corresponding author), Natl Inst Cholera & Enter Dis, Div Mol Virol, Kolkata, India.	chawlam70@gmail.com	Mukherjee, Anupam/ABB-9438-2020	Mukherjee, Anupam/0000-0002-0612-2258	Department of Health and Family Welfare, Government of West Bengal [10-2/2015-SD]	Department of Health and Family Welfare, Government of West Bengal	Genetic characterization of 2015 H1N1pdm09 strains was financially supported by the Department of Health and Family Welfare, Government of West Bengal funded research grant - D.O.No.10-2/2015-SD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anupam Mukherjee, 2010, Journal of Public Health and Epidemiology, V2, P171; Baillie GJ, 2012, J VIROL, V86, P11, DOI 10.1128/JVI.05347-11; Baranovich T, 2015, ANTIVIR RES, V117, P10, DOI 10.1016/j.antiviral.2015.02.004; Barrero PR, 2011, J VIROL, V85, P1058, DOI 10.1128/JVI.00936-10; Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Broor S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029129; COUSINS S, 2015, BMJ-BRIT MED J, V351, DOI DOI 10.1136/BMJ.H4966; DuBois RM, 2011, J VIROL, V85, P865, DOI 10.1128/JVI.01412-10; European Centre for Disease Prevention and Control (ECDC), 2013, INFL VIR CHAR SUMM E; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gatherer D, 2009, J CLIN VIROL, V45, P174, DOI 10.1016/j.jcv.2009.06.004; Goka EA, 2014, ARCH VIROL, V159, P3167, DOI 10.1007/s00705-014-2179-z; Gubareva LV, 2010, ANTIVIR THER, V15, P1151, DOI 10.3851/IMP1678; Hanson RM, 2013, ISR J CHEM, V53, P207, DOI 10.1002/ijch.201300024; Horm SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110713; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Igarashi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008553; Ilyushina NA, 2010, MBIO, V1, DOI 10.1128/mBio.00249-10; Jimenez-Jorge S, 2014, EUROSURVEILLANCE, V19, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20727; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LeGoff J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037095; Li XY, 2013, VIRUS GENES, V47, P199, DOI 10.1007/s11262-013-0931-1; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; McKimm-Breschkin JL, 2013, INFLUENZA OTHER RESP, V7, P25, DOI 10.1111/irv.12047; Mir MA, 2012, J MED VIROL, V84, P386, DOI 10.1002/jmv.23205; Mishra AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010540; Morens DM, 2010, MBIO, V1, DOI 10.1128/mBio.00211-10; Mullick J, 2011, INFECT GENET EVOL, V11, P997, DOI 10.1016/j.meegid.2011.03.015; Nelson Martha, 2009, PLoS Curr, V1, pRRN1126; Nelson MI, 2011, J VIROL, V85, P828, DOI 10.1128/JVI.01762-10; Parida M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.5.30124; Rogers MB, 2015, MBIO, V6, DOI 10.1128/mBio.02464-14; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tate MD, 2014, VIRUSES-BASEL, V6, P1294, DOI 10.3390/v6031294; Taubenberger JK, 2010, PUBLIC HEALTH REP, V125, P16, DOI 10.1177/00333549101250S305; Tharakaraman K, 2015, CELL HOST MICROBE, V17, P279, DOI 10.1016/j.chom.2015.02.019; Treanor J, 2004, NEW ENGL J MED, V350, P218, DOI 10.1056/NEJMp038238; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Viboud C, 2005, J INFECT DIS, V192, P233, DOI 10.1086/431150; Wang B, 2010, ANTIVIR RES, V87, P16, DOI 10.1016/j.antiviral.2010.04.002; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; WHO, 2009, SEQ PRIM PROT; World Health Organization, 2009, CDC PROT REAL TIM RT	43	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168464	10.1371/journal.pone.0168464	http://dx.doi.org/10.1371/journal.pone.0168464			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997573	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842900049
J	Chiu, TF; Chuang, YW; Lin, CL; Yu, TM; Chung, MC; Li, CY; Chung, CJ; Ho, WC				Chiu, Ting-Fang; Chuang, Ya-Wen; Lin, Cheng-Li; Yu, Tung-Min; Chung, Mu-Chi; Li, Chi-Yuan; Chung, Chi-Jung; Ho, Wen-Chao			Long-Term Outcomes of Systemic Lupus Erythematous Patients after Pregnancy: A Nationwide Population-Based Cohort Study	PLOS ONE			English	Article							RENAL-DISEASE; NEPHRITIS	Background Data on long-term maternal outcomes in patients with systemic lupus erythematosus (SLE) are lacking. The study aimed to explore the relationships among SLE, pregnancy, outcomes of end-stage renal disease (ESRD), and overall mortality. Methods We established a retrospective cohort study consisting of four cohorts: pregnant (case cohort) and nonpregnant SLE patients, as well as pregnant and nonpregnant non-SLE patients. One case cohort and three comparison cohorts were matched by age at first pregnancy and index date of pregnancy by using the Taiwan National Health Insurance Research Dataset. All study subjects were selected based on the index date to the occurrence of ESRD or overall death. Cox proportional hazard regression models and Kaplan-Meier curves were used in the analysis. Results SLE pregnant patients exhibited significantly increased risk of ESRD after adjusting for other important confounders, including immunosuppressant and parity (HR = 3.19, 95% CI: 1.35-7.52 for pregnant non-SLE; and HR = 2.77, 95% CI: 1.24-6.15 for nonpregnant non-SLE patients). No significant differences in ESRD incidence were observed in pregnant and nonpregnant SLE patients. Pregnant SLE patients exhibited better clinical condition at the baseline and a significantly lower risk of overall mortality than nonpregnant SLE patients. Conclusions Our data support current recommendations for SLE patients to avoid pregnancy until disease activity is quiescent. Multicenter recruitment and clinical information can be used to further examine the association of SLE and ESRD (or mortality) after pregnancy.	[Chiu, Ting-Fang] Taipei City Hosp, Dept Pediat, Zhongxiao Branch, Taipei, Taiwan; [Chuang, Ya-Wen; Yu, Tung-Min; Chung, Mu-Chi] Taichung Vet Gen Hosp, Div Nephrol, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ & Hosp, Coll Med, Dept Med, Taichung, Taiwan; [Li, Chi-Yuan] China Med Univ Hosp, Dept Anesthesiol, Taichung, Taiwan; [Chung, Chi-Jung] China Med Univ, Coll Publ Hlth, Dept Hlth Risk Management, Taichung, Taiwan; [Chung, Chi-Jung] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Ho, Wen-Chao] China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan	Taipei City Hospital; Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Ho, WC (corresponding author), China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan.	wcho@mail.cmu.edu.tw			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002]; China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project [BM104010092]; NRPB (The National Radiological Protection Board) Stroke Clinical Trial Consortium [MOST 103-2325-B-039-006]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project; NRPB (The National Radiological Protection Board) Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW104-TDU-B-212-113002), China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project (BM104010092), NRPB (The National Radiological Protection Board) Stroke Clinical Trial Consortium (MOST 103-2325-B-039-006), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal Surabhi, 2009, Curr Rheumatol Rep, V11, P241; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Brenner BM, 1996, KIDNEY INT, V49, P1774, DOI 10.1038/ki.1996.265; Cavallasca JA, 2008, CLIN RHEUMATOL, V27, P41, DOI 10.1007/s10067-007-0649-3; Chakravarty EF, 2005, AM J OBSTET GYNECOL, V192, P1897, DOI 10.1016/j.ajog.2005.02.063; Chapman AB, 1998, KIDNEY INT, V54, P2056, DOI 10.1046/j.1523-1755.1998.00217.x; Clowse MEB, 2007, RHEUM DIS CLIN N AM, V33, P237, DOI 10.1016/j.rdc.2007.01.002; Clowse MEB, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.03.012; DERKSEN RHWM, 1994, LUPUS, V3, P149, DOI 10.1177/096120339400300304; Helal I, 2012, NAT REV NEPHROL, V8, P293, DOI 10.1038/nrneph.2012.19; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; HOSTETTER TH, 1981, AM J PHYSIOL, V241, pF85, DOI 10.1681/ASN.V1261315; Hou S, 1999, AM J KIDNEY DIS, V33, P235, DOI 10.1016/S0272-6386(99)70296-9; Moroni G, 2002, AM J KIDNEY DIS, V40, P713, DOI 10.1053/ajkd.2002.35678; Ramin SM, 2006, OBSTET GYNECOL, V108, P1531, DOI 10.1097/01.AOG.0000246790.84218.44; Ritchie J, 2012, LUPUS, V21, P534, DOI 10.1177/0961203311434939; Ruiz-Irastorza G, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2764; Schrier RW, 2010, J AM SOC NEPHROL, V21, P570, DOI 10.1681/ASN.2009060653; Smyth A, 2010, CLIN J AM SOC NEPHRO, V5, P2060, DOI 10.2215/CJN.00240110; Stanhope TJ, 2012, CLIN J AM SOC NEPHRO, V7, P2089, DOI 10.2215/CJN.12441211; Wang IK, 2013, CAN MED ASSOC J, V185, P207, DOI 10.1503/cmaj.120230; Wong Chiong-Hee, 2006, Taiwan J Obstet Gynecol, V45, P120	22	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0167946	10.1371/journal.pone.0167946	http://dx.doi.org/10.1371/journal.pone.0167946			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992461	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842600026
J	Jois, T; Howard, V; Youngs, K; Cowley, MA; Sleeman, MW				Jois, Tara; Howard, Victor; Youngs, Kristina; Cowley, Michael A.; Sleeman, Mark W.			Dietary Macronutrient Composition Directs ChREBP Isoform Expression and Glucose Metabolism in Mice	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; DE-NOVO LIPOGENESIS; HEPATIC INSULIN-RESISTANCE; URBAN-RURAL EPIDEMIOLOGY; CORONARY-ARTERY-DISEASE; ADIPOSE-TISSUE; TRANSCRIPTION FACTOR; GENE-EXPRESSION; GLYCEMIC LOAD; OB/OB MICE	Carbohydrate response element binding protein (ChREBP) is a lipogenic transcription factor that is thought to be involved in the development of hepatic steatosis and insulin resistance. Increased ChREBP expression in liver results in increased hepatic steatosis, and the isoform ChREBP6 in adipose tissue can predict insulin sensitivity in obese humans. As ChREBP is activated by glucose, it was postulated that the composition of diet would regulate ChREBP isoform expression in metabolically relevant tissues. We compared the effects of diets with high complex carbohydrate, high fat, or a normal chow on ChREBP expression and metabolic parameters in C57BL/6 mice. We found that diets high in fat decrease ChREBP expression in adipose tissue, but isocaloric diets high in carbohydrate have no effect. Interestingly, this decrease in adipose ChREBP was associated with increased inflammatory markers. In the same animals a high carbohydrate diet induced a robust increase in hepatic ChREBP6 expression (approximate to 2-fold; p = 0.0002), but little detectable change in the more abundant ChREBP alpha transcript. This change was accompanied by increased expression of target genes liver pyruvate kinase (p<0.0001), acetyl-CoA carboxylase (p = 0.0191) and stearoyl-CoA desaturase-1 (p = 0.0045). This increase in ChREBP expression was associated with increased hepatic steatosis, despite no changes in body weight or body fat when compared to chow-fed mice. Unexpectedly, mice fed a high carbohydrate diet displayed enhanced sensitivity to exogenous insulin, despite having mild glucose intolerance and increased liver steatosis. In summary, we have shown the composition of diet can selectively regulate ChREBP isoform expression in a tissue specific manner. Furthermore, we have shown a high complex carbohydrate diet selectively increases hepatic ChREBP6 expression, which associates with hepatic steatosis but not insulin resistance. In contrast, a high fat diet reduces adipose ChREBP, which associates with inflammation and insulin resistance.	[Jois, Tara; Howard, Victor; Youngs, Kristina; Cowley, Michael A.; Sleeman, Mark W.] Monash Univ, Dept Physiol, Clayton, Vic, Australia; [Cowley, Michael A.; Sleeman, Mark W.] Monash Univ, Biomed Discovery Inst, Clayton, Vic, Australia; [Sleeman, Mark W.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia	Monash University; Monash University; Monash University	Sleeman, MW (corresponding author), Monash Univ, Dept Physiol, Clayton, Vic, Australia.; Sleeman, MW (corresponding author), Monash Univ, Biomed Discovery Inst, Clayton, Vic, Australia.; Sleeman, MW (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	mark.sleeman@monash.edu	Cowley, Michael A/B-9428-2008	Cowley, Michael A/0000-0001-7811-134X				Agius L, 2013, BIOCHEM PHARMACOL, V85, P306, DOI 10.1016/j.bcp.2012.09.019; Arden C, 2012, BIOCHEM J, V443, P111, DOI 10.1042/BJ20111280; Barclay AW, 2008, AM J CLIN NUTR, V87, P627, DOI 10.1093/ajcn/87.3.627; Benhamed F, 2012, J CLIN INVEST, V122, P2176, DOI 10.1172/JCI41636; Bricambert J, 2010, J CLIN INVEST, V120, P4316, DOI 10.1172/JCI41624; Buettner R, 2004, AM J PHYSIOL-ENDOC M, V286, pE828, DOI 10.1152/ajpendo.00453.2003; Cairo S, 2001, HUM MOL GENET, V10, P617, DOI 10.1093/hmg/10.6.617; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Dentin R, 2005, J CLIN INVEST, V115, P2843, DOI 10.1172/JCI25256; Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Diaz-Moralli S, 2012, AM J PHYSIOL-ENDOC M, V303, pE234, DOI 10.1152/ajpendo.00675.2011; Eissing L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2537; FOLCH J, 1957, J BIOL CHEM, V226, P497; Galgani J, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-22; Guo SR, 2011, CLIN CHIM ACTA, V412, P1854, DOI 10.1016/j.cca.2011.06.024; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; del Pozo CH, 2011, BBA-MOL CELL BIOL L, V1811, P1194, DOI 10.1016/j.bbalip.2011.07.016; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Iizuka K, 2006, AM J PHYSIOL-ENDOC M, V291, pE358, DOI 10.1152/ajpendo.00027.2006; Iizuka K, 2013, ENDOCR J, V60, P473; Janevski M, 2012, FOOD FUNCT, V3, P141, DOI 10.1039/c1fo10111k; Jeong YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022544; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; Kursawe R, 2013, DIABETES, V62, P837, DOI 10.2337/db12-0889; Letexier D, 2005, DIABETES METAB, V31, P558, DOI 10.1016/S1262-3636(07)70231-8; Li MV, 2010, BIOCHEM BIOPH RES CO, V395, P395, DOI 10.1016/j.bbrc.2010.04.028; Liu J, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/585897; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Mohan V, 2009, BRIT J NUTR, V102, P1498, DOI 10.1017/S0007114509990468; Nakagawa T, 2013, J BIOL CHEM, V288, P28358, DOI 10.1074/jbc.M113.498550; Nuotio-Antar AM, 2015, ENDOCRINOLOGY, V156, P4020, DOI 10.1210/en.2015-1210; Oliveira MC, 2013, OBESITY, V21, pE396, DOI [10.1002/oby.20230, 10.1038/oby.20230]; Oslowski CM, 2012, CELL METAB, V16, P265, DOI 10.1016/j.cmet.2012.07.005; Park MJ, 2014, J BIOL CHEM, V289, P13519, DOI 10.1074/jbc.M113.530139; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; Radhika G, 2009, EUR J CLIN NUTR, V63, P413, DOI 10.1038/sj.ejcn.1602951; Radhika G, 2011, PUBLIC HEALTH NUTR, V14, P591, DOI 10.1017/S136898001000203X; Radhika G, 2009, METABOLISM, V58, P675, DOI 10.1016/j.metabol.2009.01.008; RASTOGI GK, 1970, DIABETOLOGIA, V6, P445, DOI 10.1007/BF01212080; Sarrazy V, 2015, CELL REP, V13, P132, DOI 10.1016/j.celrep.2015.08.068; Schwarz JM, 1995, J CLIN INVEST, V96, P2735, DOI 10.1172/JCI118342; Shao JH, 2005, DIABETES, V54, P976, DOI 10.2337/diabetes.54.4.976; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Tang YF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11365; Wang HY, 2002, J BIOL CHEM, V277, P32746, DOI 10.1074/jbc.M201635200; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Wutthisathapornchai A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102730; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Yore MM, 2014, CELL, V159, P318, DOI 10.1016/j.cell.2014.09.035	50	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168797	10.1371/journal.pone.0168797	http://dx.doi.org/10.1371/journal.pone.0168797			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992582	Green Submitted, gold, Green Published			2022-12-26	WOS:000392842600099
J	Merida-Vieyra, J; De Colsa, A; Castaneda, YC; Barbosa, PA; Andrade, AA				Merida-Vieyra, Jocelin; De Colsa, Agustin; Calderon Castaneda, Yair; Arzate Barbosa, Patricia; Aquino Andrade, Alejandra			First Report of Group CTX-M-9 Extended Spectrum Beta-Lactamases in Escherichia coli Isolates from Pediatric Patients in Mexico	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; URINARY-TRACT-INFECTIONS; CTX-M; ANTIMICROBIAL SUSCEPTIBILITY; HEALTHY HUMANS; ENTEROBACTERIACEAE; EPIDEMIOLOGY; ESBL; EMERGENCE; GENES	The aim of this study was to identify the presence of group CTX-M-9 extended spectrum beta-lactamases (ESBL) in clinical Escherichia coli isolates from pediatric patients. A total of 404 non-repeated positive ESBL E. coli isolates were collected from documented clinical infections in pediatric patients over a 2-year period. The identification and susceptibility profiles were determined using an automated system. Isolates that suggested ESBL production based on their resistance profiles to third and fourth generation cephalosporin and monobactam were selected. ESBL production was phenotypically confirmed using a diffusion method with cefotaxime and ceftazidime discs alone and in combination with clavulanic acid. bla(ESBL) gene identification was performed through PCR amplification and sequencing. Pulsed Field Gel Electrophoresis (PFGE) and Multilocus Sequence Typing (MLST) were performed to establish the clonal relationships of the E. coli isolates. CTX-M-9-type ESBLs were detected in 2.5% of the isolates. The subtypes corresponded to bla(CTX-M-14) (n = 4) and bla(CTX-M-27) (n = 6). Additionally, coexistence with other beta-lactamases was observed. A clonal relationship was established in three isolates; the rest were classified as non-related. We found seven different sequence type (ST) in CTX-M-9-producing E. coli isolates. ST38 was the most frequent. This study is the first report in Mexico to document the presence of group CTX-M-9 ESBLs in E. coli isolates from pediatric patients.	[Merida-Vieyra, Jocelin; De Colsa, Agustin; Aquino Andrade, Alejandra] INP, Mol Microbiol Lab, Mexico City, DF, Mexico; [Merida-Vieyra, Jocelin] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Microbiol, Mexico City, DF, Mexico; [De Colsa, Agustin] INP, Pediat Infect Dis Dept, Mexico City, DF, Mexico; [Calderon Castaneda, Yair; Arzate Barbosa, Patricia] INP, Clin Bacteriol Lab, Mexico City, DF, Mexico	Instituto Politecnico Nacional - Mexico	Andrade, AA (corresponding author), INP, Mol Microbiol Lab, Mexico City, DF, Mexico.	alejandra.aquino@infecto.mx			National Council of Science and Technology (CONACyT) [FOSISS 2012-1-181041]	National Council of Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the National Council of Science and Technology (CONACyT) FOSISS 2012-1-181041. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktar F, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7240864; Alcantar-Curiel D, 2004, CLIN INFECT DIS, V38, P1067, DOI 10.1086/382354; Allocati N, 2013, INT J ENV RES PUB HE, V10, P6235, DOI 10.3390/ijerph10126235; Bajaj P, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00417; Bartoloni A, 2013, CLIN MICROBIOL INFEC, V19, P356, DOI 10.1111/j.1469-0691.2012.03807.x; Blanco VM, 2016, ENFERM INFEC MICR CL, V34, P559, DOI 10.1016/j.eimc.2015.11.017; Bonnet R, 2003, J ANTIMICROB CHEMOTH, V52, P29, DOI 10.1093/jac/dkg256; Brolund A, 2014, CLIN MICROBIOL INFEC, V20, pO344, DOI 10.1111/1469-0691.12413; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Bush K, 2013, ANN NY ACAD SCI, V1277, P84, DOI 10.1111/nyas.12023; Cai JC, 2014, ANTIMICROB AGENTS CH, V58, P1146, DOI 10.1128/AAC.00912-13; Delgado DYC, 2016, BRAZ J INFECT DIS, V20, P627, DOI 10.1016/j.bjid.2016.07.001; Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110; Castanheira M, 2016, ANTIMICROB AGENTS CH, V60, P4770, DOI 10.1128/AAC.00540-16; Cheng MF, 2015, PEDIATR INFECT DIS J, V34, P469, DOI 10.1097/INF.0000000000000623; Clinical Laboratory Standards Institute, 2015, M100S25 CLSI S, V35; Cornejo-Juarez P, 2016, SUPPORT CARE CANCER, V24, P253, DOI 10.1007/s00520-015-2772-z; D'Andrea MM, 2013, INT J MED MICROBIOL, V303, P305, DOI 10.1016/j.ijmm.2013.02.008; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; Dhanji H, 2012, ANTIMICROB AGENTS CH, V56, P3376, DOI 10.1128/AAC.00313-12; Fair RJ, 2014, PERSPECT MED CHEM, V6, P25, DOI 10.4137/PMC.S14459; Garrido A, 2014, MICROB DRUG RESIST, V20, P301, DOI 10.1089/mdr.2013.0109; Garza-Gonzalez E, 2011, J MED MICROBIOL, V60, P84, DOI 10.1099/jmm.0.022970-0; Guenther S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053039; Guo SY, 2015, MICROBES INFECT, V17, P266, DOI 10.1016/j.micinf.2014.12.016; Hayakawa K, 2013, ANTIMICROB AGENTS CH, V57, P4010, DOI 10.1128/AAC.02516-12; Ho PL, 2012, DIAGN MICR INFEC DIS, V73, P182, DOI 10.1016/j.diagmicrobio.2012.03.009; Hu YY, 2013, APPL ENVIRON MICROB, V79, P5988, DOI 10.1128/AEM.01740-13; Jeong SH, 2015, DIAGN MICR INFEC DIS, V82, P70, DOI 10.1016/j.diagmicrobio.2015.02.001; Jones RN, 2013, BRAZ J INFECT DIS, V17, P672, DOI 10.1016/j.bjid.2013.07.002; Kim S, 2016, J MICROBIOL BIOTECHN, V26, P1643, DOI 10.4014/jmb.1603.03063; Liu HH, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00335; Liu X, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01057; Lukac PJ, 2015, CLIN INFECT DIS, V60, P1389, DOI 10.1093/cid/civ020; McGrath EJ, 2011, INDIAN J PEDIATR, V78, P176, DOI 10.1007/s12098-010-0253-4; Minarini LAR, 2009, DIAGN MICR INFEC DIS, V65, P202, DOI 10.1016/j.diagmicrobio.2009.05.021; Miranda-Romero AL, 2016, DIAGN MICROBIOL INFE; Mora A, 2011, INT J ANTIMICROB AG, V37, P16, DOI 10.1016/j.ijantimicag.2010.09.012; Morfin-Otero R, 2013, MICROB DRUG RESIST, V19, P378, DOI 10.1089/mdr.2012.0263; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Muller A, 2016, SCI TOTAL ENVIRON, V541, P667, DOI 10.1016/j.scitotenv.2015.09.135; Murray TS, 2015, CURR OPIN PEDIATR, V27, P124, DOI 10.1097/MOP.0000000000000182; Navarro F, 2007, FEMS MICROBIOL LETT, V273, P120, DOI 10.1111/j.1574-6968.2007.00791.x; Oteo J, 2012, ANTIMICROB AGENTS CH, V56, P54, DOI 10.1128/AAC.05103-11; Oteo J, 2009, INT J ANTIMICROB AG, V34, P173, DOI 10.1016/j.ijantimicag.2009.03.006; Pitout JDD, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00009; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Rodrigues C, 2016, J ANTIMICROB CHEMOTH, V71, P1120, DOI 10.1093/jac/dkv443; Rodriguez I, 2014, INT J ANTIMICROB AG, V43, P553, DOI 10.1016/j.ijantimicag.2014.02.019; Rodriguez-Bano J, 2010, J CLIN MICROBIOL, V48, P1726, DOI 10.1128/JCM.02353-09; Sader HS, 2016, INT J ANTIMICROB AG, V48, P144, DOI 10.1016/j.ijantimicag.2016.04.021; Sader HS, 2014, DIAGN MICR INFEC DIS, V78, P443, DOI 10.1016/j.diagmicrobio.2013.11.025; Salles MJC, 2013, EPIDEMIOL INFECT, V141, P2459, DOI 10.1017/S095026881300191X; Schaufler K, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00336; Sennati S, 2012, ANTIMICROB AGENTS CH, V56, P6003, DOI 10.1128/AAC.00745-12; Shaikh S, 2015, SAUDI J BIOL SCI, V22, P90, DOI 10.1016/j.sjbs.2014.08.002; Shibasaki M, 2016, J INFECT CHEMOTHER, V22, P395, DOI 10.1016/j.jiac.2016.03.001; Silva-Sanchez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077968; Song W, 2009, J MED MICROBIOL, V58, P261, DOI 10.1099/jmm.0.004507-0; Stoesser N, 2016, MBIO, V7, DOI 10.1128/mBio.02162-15; Suzuki S, 2009, J ANTIMICROB CHEMOTH, V63, P72, DOI 10.1093/jac/dkn463; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Yamamoto T, 2011, J INFECT CHEMOTHER, V17, P435, DOI 10.1007/s10156-011-0232-3; Zhang J, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0659-0; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhao WH, 2013, CRIT REV MICROBIOL, V39, P79, DOI 10.3109/1040841X.2012.691460; Zurfluh K, 2015, APPL ENVIRON MICROB, V81, P3115, DOI 10.1128/AEM.00258-15	68	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168608	10.1371/journal.pone.0168608	http://dx.doi.org/10.1371/journal.pone.0168608			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992527	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842600079
J	Liu, JJ; Sniezko, R; Murray, M; Wang, N; Chen, H; Zamany, A; Sturrock, RN; Savin, D; Kegley, A				Liu, Jun-Jun; Sniezko, Richard; Murray, Michael; Wang, Ning; Chen, Hao; Zamany, Arezoo; Sturrock, Rona N.; Savin, Douglas; Kegley, Angelia			Genetic Diversity and Population Structure of Whitebark Pine (Pinus albicaulis Engelm.) in Western North America	PLOS ONE			English	Article							BLISTER RUST; POSTGLACIAL COLONIZATION; ROCKY-MOUNTAINS; HOST-RESISTANCE; MONTICOLA; SEED; DNA; ASSOCIATION; GENERATION; CHALLENGES	Whitebark pine (WBP, Pinus albicaulis Engelm.) is an endangered conifer species due to heavy mortality from white pine blister rust (WPBR, caused by Cronartium ribicola) and mountain pine beetle (Dendroctonus ponderosae). Information about genetic diversity and population structure is of fundamental importance for its conservation and restoration. However, current knowledge on the genetic constitution and genomic variation is still limited for WBP. In this study, an integrated genomics approach was applied to characterize seed collections from WBP breeding programs in western North America. RNA-seq analysis was used for de novo assembly of the WBP needle transcriptome, which contains 97,447 protein-coding transcripts. Within the transcriptome, single nucleotide polymorphisms (SNPs) were discovered, and more than 22,000 of them were non-synonymous SNPs (ns-SNPs). Following the annotation of genes with ns-SNPs, 216 ns-SNPs within candidate genes with putative functions in disease resistance and plant defense were selected to design SNP arrays for high-throughput genotyping. Among these SNP loci, 71 were highly polymorphic, with sufficient variation to identify a unique genotype for each of the 371 individuals originating from British Columbia (Canada), Oregon and Washington (USA). A clear genetic differentiation was evident among seed families. Analyses of genetic spatial patterns revealed varying degrees of diversity and the existence of several genetic subgroups in the WBP breeding populations. Genetic components were associated with geographic variables and phenotypic rating of WPBR disease severity across landscapes, which may facilitate further identification of WBP genotypes and gene alleles contributing to local adaptation and quantitative resistance to WPBR. The WBP genomic resources developed here provide an invaluable tool for further studies and for exploitation and utilization of the genetic diversity preserved within this endangered conifer and other five-needle pines.	[Liu, Jun-Jun; Wang, Ning; Chen, Hao; Zamany, Arezoo; Sturrock, Rona N.] Nat Resources Canada, Canadian Forest Serv, Pacific Forestry Ctr, 506 West Burnside Rd, Victoria, BC, Canada; [Sniezko, Richard; Savin, Douglas; Kegley, Angelia] US Forest Serv, USDA, Dorena Genet Resource Ctr, 34963 Shoreview Rd, Cottage Grove, OR USA; [Murray, Michael] Minist Forests Lands & Nat Resource Operat, Nelson, BC, Canada; [Wang, Ning] Qinghai Univ, Acad Agr & Forestry Sci, 253 Ningda Rd, Xining, Qinghai, Peoples R China	Natural Resources Canada; Canadian Forest Service; United States Department of Agriculture (USDA); United States Forest Service; Qinghai University	Liu, JJ (corresponding author), Nat Resources Canada, Canadian Forest Serv, Pacific Forestry Ctr, 506 West Burnside Rd, Victoria, BC, Canada.	Jun-Jun.Liu@Canada.Ca	Chen, Hao/GLQ-8407-2022; Liu, Jun-Jun/T-4300-2019	Liu, Jun-Jun/0000-0002-9745-8258	Genomics Research & Development Initiative of the Canadian Forest Service (CFS-GRDI); CFS A-based fund; CFS-PFC DG's fund; US-FS; Ministry of Forests, Lands, and Natural Resource Operations; China Scholarship Council	Genomics Research & Development Initiative of the Canadian Forest Service (CFS-GRDI)(Natural Resources CanadaCanadian Forest Service); CFS A-based fund(Natural Resources CanadaCanadian Forest Service); CFS-PFC DG's fund(Natural Resources CanadaCanadian Forest Service); US-FS; Ministry of Forests, Lands, and Natural Resource Operations; China Scholarship Council(China Scholarship Council)	JJL received funding from the Genomics Research & Development Initiative of the Canadian Forest Service (CFS-GRDI), CFS A-based fund, and CFS-PFC DG's fund for this work. RAS received the base funding from US-FS that allowed continuous collaboration between CFS and US-FS. MM received both base and project research funding from the Ministry of Forests, Lands, and Natural Resource Operations. NW was supported partly by the China Scholarship Council.	AUBRY C.A., 2008, WHITEBARK PINE RESTO; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bower AD, 2008, AM J BOT, V95, P66, DOI 10.3732/ajb.95.1.66; Bruederle LP, 1998, CAN J BOT, V76, P83, DOI 10.1139/cjb-76-1-83; Callaway RM, 1998, OIKOS, V82, P561, DOI 10.2307/3546376; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Eckert AJ, 2013, MOL ECOL, V22, P5635, DOI 10.1111/mec.12514; Eckert AJ, 2009, GENETICS, V183, P289, DOI 10.1534/genetics.109.103895; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FARNES PE, 1990, USDA INTERM, V270, P302; Friedline CJ, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0866-x; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hamlin J, 2011, US FOR SERV RMRS-P, V63, P133; Hansen A, 2016, FORESTS, V7, DOI 10.3390/f7030054; Holliday JA, 2010, NEW PHYTOL, V188, P501, DOI 10.1111/j.1469-8137.2010.03380.x; Jorgensen SM, 1997, CAN J FOREST RES, V27, P1574, DOI 10.1139/cjfr-27-10-1574; Krakowski J, 2003, CONSERV GENET, V4, P581, DOI 10.1023/A:1025667700479; Ledig FT, 1997, EVOLUTION, V51, P1815, DOI [10.2307/2411004, 10.1111/j.1558-5646.1997.tb05105.x]; Liu J-J, 2016, BMC GENOMIC IN PRESS; Liu JJ, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0380-6; Liu JJ, 2014, CONSERV GENET RESOUR, V6, P647, DOI 10.1007/s12686-014-0168-x; Liu JJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-884; Liu JJ, 2013, PLANTA, V237, P43, DOI 10.1007/s00425-012-1747-2; Mahalovich MF, 2011, US FOR SERV RMRS-P, V63, P118; Mitton JB, 2006, MANAG FOR ECOSYST, V9, P147; Murray MP, 2014, P 61 ANN W INT FOR D, P35; Nadeau S, 2015, AM J BOT, V102, P1342, DOI 10.3732/ajb.1500160; Neale DB, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r59; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perrier X., 2003, GENETIC DIVERSITY CU, P43; Pritchard JK, 2000, GENETICS, V155, P945; Rajora OP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158691; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Resler LM, 2008, ARCT ANTARCT ALP RES, V40, P161, DOI 10.1657/1523-0430(06-116)[RESLER]2.0.CO;2; Richardson BA, 2002, CAN J FOREST RES, V32, P1103, DOI [10.1139/x02-037, 10.1139/X02-037]; Richardson BA, 2002, MOL ECOL, V11, P215, DOI 10.1046/j.1365-294X.2002.01435.x; Rogers DL, 1999, EVOLUTION, V53, P74, DOI 10.2307/2640921; Schoettle AW, 2007, J FOREST RES-JPN, V12, P327, DOI 10.1007/s10310-007-0024-x; Shi WT, 2010, MOL BIOL EVOL, V27, P385, DOI 10.1093/molbev/msp243; Smith CM, 2013, CAN J FOREST RES, V43, P90, DOI 10.1139/cjfr-2012-0127; Sniezko RA, 2011, US FOR SERV RMRS-P, V63, P246; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Syring JV, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00484; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Tomback DF, 2010, FOREST PATHOL, V40, P186, DOI 10.1111/j.1439-0329.2010.00655.x; Tomback D.F., 2001, WHITEBARK PINE COMMU; USFWS, 2011, FED REGISTER, V76, P42631; ZAVARIN E, 1991, BIOCHEM SYST ECOL, V19, P147, DOI 10.1016/0305-1978(91)90038-2	51	15	16	4	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0167986	10.1371/journal.pone.0167986	http://dx.doi.org/10.1371/journal.pone.0167986			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992468	gold, Green Published, Green Submitted			2022-12-26	WOS:000392758000020
J	Nippert, F; Schreckenberg, R; Hess, A; Weber, M; Schluter, KD				Nippert, Franziska; Schreckenberg, Rolf; Hess, Antonia; Weber, Martin; Schlueter, Klaus-Dieter			The Effects of Swiprosin-1 on the Formation of Pseudopodia-Like Structures and beta-Adrenoceptor Coupling in Cultured Adult Rat Ventricular Cardiomyocytes	PLOS ONE			English	Article							LONG-TERM CULTURES; CARDIAC MYOCYTES; MYOCARDIAL-INFARCTION; CELL-CULTURE; REGENERATION; CALCINEURIN; MECHANISMS; DEDIFFERENTIATION; STIMULATION; HYPERTROPHY	Background Recent findings suggest that adult terminally differentiated cardiomyocytes adapt to stress by cellular de-and redifferentiation. In the present study we tested the hypothesis that swiprosin-1 is a key player in this process. Furthermore, the relationship between swiprosin-1 and beta-adrenoceptor coupling was analyzed. Methods In order to study the function of swiprosin-1 in adult rat ventricular cardiomyocytes (ARVC) they were isolated and cultured in a medium containing 20% fetal calf serum (FCS). Changes in cell morphology of ARVC during cultivation were quantified by light and confocal laser scan microscopy. Small interfering RNA (siRNA) was used to reduce the expression of swiprosin-1. The impact of calcium on swiprosin-1 dependent processes was investigated with Bapta-AM. Immunoblot techniques and qRT-PCR were performed to measure mRNA and protein expression. Results In culture, ARVC first lost their contractile elements, which was followed by a formation of pseudopodia-like structures (spreading). Swiprosin-1 was detected in ARVC at all time points. However, swiprosin-1 expression was increased when ARVC started to spread. Reduction of swiprosin-1 expression with siRNA delayed ARVC spreading. Similarly, Bapta-AM attenuated swiprosin-1 expression and spreading of ARVC. Furthermore, swiprosin-1 expression correlated with the expression of G protein-coupled receptor kinase 2 (GRK2). Moreover, silencing of swiprosin-1 was associated with a down regulation of GRK2 and caused a sensitization of beta-adrenergic receptors. Conclusion Swiprosin-1 is required for ARVC to adapt to culture conditions. Additionally, it seems to be involved in the desensitization of beta-adrenergic receptors. Assuming that ARVC adapt to cardiac stress in a similar way, swiprosin-1 may play a key role in cardiac remodeling.	[Nippert, Franziska; Schreckenberg, Rolf; Hess, Antonia; Weber, Martin; Schlueter, Klaus-Dieter] Justus Liebig Univ, Inst Physiol, Giessen, Germany	Justus Liebig University Giessen	Nippert, F (corresponding author), Justus Liebig Univ, Inst Physiol, Giessen, Germany.	Franziska.Nippert@physiologie.med.uni-giessen.de		Petersen, Antonia/0000-0002-0957-6474	Deutsche Forschungsgemeinschaft [Schl 324/7-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported by the Deutsche Forschungsgemeinschaft (grant Schl 324/7-1; Klaus-Dieter Schluter). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar A, 2008, PFLUG ARCH EUR J PHY, V457, P485, DOI 10.1007/s00424-008-0520-7; BUGAISKY LB, 1989, CIRC RES, V64, P493, DOI 10.1161/01.RES.64.3.493; DECKER ML, 1991, CIRC RES, V69, P86, DOI 10.1161/01.RES.69.1.86; Dutting S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-2; EPPENBERGER ME, 1988, DEV BIOL, V130, P1, DOI 10.1016/0012-1606(88)90408-3; EPPENBERGEREBERHARDT M, 1990, DEV BIOL, V139, P269, DOI 10.1016/0012-1606(90)90296-U; Fiedler B, 2005, EXPERT OPIN THER TAR, V9, P963, DOI 10.1517/14728222.9.5.963; Fiedler B, 2004, CARDIOVASC RES, V63, P450, DOI 10.1016/j.cardiores.2004.04.002; Fontana M, 2007, BRIT J PHARMACOL, V151, P779, DOI 10.1038/sj.bjp.0707300; Heineke J, 2005, P NATL ACAD SCI USA, V102, P1655, DOI 10.1073/pnas.0405488102; HILENSKI LL, 1991, CELL TISSUE RES, V264, P577, DOI 10.1007/BF00319047; Howard PA, 2000, AM FAM PHYSICIAN, V62, P1853; Huh YH, 2013, CELL MOL LIFE SCI, V70, P4841, DOI 10.1007/s00018-013-1447-5; Joshi-Mukherjee R, 2013, J MOL CELL CARDIOL, V65, P76, DOI 10.1016/j.yjmcc.2013.09.009; Kezerashvili A, 2012, CURR CARDIOL REV, V8, P77, DOI 10.2174/157340312801215764; Kubin T, 2011, CELL STEM CELL, V9, P420, DOI 10.1016/j.stem.2011.08.013; Kwon MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071626; LANGE R, 1983, AM J CARDIOL, V51, P1759, DOI 10.1016/0002-9149(83)90224-2; Leri A, 2011, TRENDS CARDIOVAS MED, V21, P52, DOI 10.1016/j.tcm.2012.02.006; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Lim HW, 1999, NAT MED, V5, P246, DOI 10.1038/6430; Mason RP, 2009, J CARDIOVASC PHARM, V54, P123, DOI 10.1097/FJC.0b013e3181ad207b; Najafi A, 2016, EUR J CLIN INVEST, V46, P362, DOI 10.1111/eci.12598; Poling J, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-013-0396-3; Poling J, 2012, CELL CYCLE, V11, P439, DOI 10.4161/cc.11.3.19024; Schluter K.-D, 2016, CARDIOMYOCYTES ACTIV, DOI [10.1007/978-3-319-31251-4, DOI 10.1007/978-3-319-31251-4]; Schluter KD, 2000, CIRC RES, V86, P946, DOI 10.1161/01.RES.86.9.946; Schluter KD, 1995, AM J PHYSIOL, V269, P6; Schluter KD, 2005, PROTEIN TYROSINE KIN, P305; Schreckenberg R, 2015, PFLUG ARCH EUR J PHY, V467, P379, DOI 10.1007/s00424-014-1498-y; SCHWARZFELD TA, 1981, J MOL CELL CARDIOL, V13, P563, DOI 10.1016/0022-2828(81)90327-8; Szibor M, 2014, CELL MOL LIFE SCI, V71, P1907, DOI 10.1007/s00018-013-1535-6; TSIEN RY, 1981, NATURE, V290, P527, DOI 10.1038/290527a0; Zhou XJ, 1996, MOL CELL BIOCHEM, V164, P211, DOI 10.1007/BF00408660	34	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0167655	10.1371/journal.pone.0167655	http://dx.doi.org/10.1371/journal.pone.0167655			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992454	Green Submitted, Green Published, gold			2022-12-26	WOS:000392758000014
J	Infantes, E; Crouzy, C; Moksnes, PO				Infantes, Eduardo; Crouzy, Caroline; Moksnes, Per-Olav			Seed Predation by the Shore Crab Carcinus maenas: A Positive Feedback Preventing Eelgrass Recovery?	PLOS ONE			English	Article							ZOSTERA-MARINA; SEAGRASS ECOSYSTEMS; NUTRIENT ENRICHMENT; COASTAL ECOSYSTEMS; RESTORATION; ABUNDANCE; BAY; VEGETATION; SELECTION; SUCCESS	There is an increasing interest to restore the ecosystem services that eelgrass provides, after their continuous worldwide decline. Most attempts to restore eelgrass using seeds are challenged by very high seed losses and the reasons for these losses are not all clear. We assess the impact of predation on seed loss and eelgrass establishment, and explore methods to decrease seed loss during restoration in the Swedish northwest coast. In a laboratory study we identified three previously undescribed seed predators, the shore crab Carcinus maenas, the hermit crab Pagurus bernhardus and the sea urchin Strongylocentrotus droebachiensis, of which shore crabs consumed 2-7 times more seeds than the other two species. The importance of shore crabs as seed predators was supported in field cage experiments where one enclosed crab caused 73% loss of seeds over a 1-week period on average (similar to 21 seeds per day). Seedling establishment was significantly higher (14%) in cages that excluded predators over an 8-month period than in uncaged plots and cages that allowed predators but prevented seed-transport (0.5%), suggesting that seed predation constitutes a major source of seed loss in the study area. Burying the seeds 2 cm below the sediment surface prevented seed predation in the laboratory and decreased predation in the field, constituting a way to decrease seed loss during restoration. Shore crabs may act as a key feedback mechanism that prevent the return of eelgrass both by direct consumption of eelgrass seeds and as a predator of algal mesograzers, allowing algal mats to overgrow eelgrass beds. This shore crab feedback mechanism could become self-generating by promoting the growth of its own nursery habitat (algal mats) and by decreasing the nursery habitat (seagrass meadow) of its dominant predator (cod). This double feedback-loop is supported by a strong increase of shore crab abundance in the last decades and may partly explain the regime shift in vegetation observed along the Swedish west coast.	[Infantes, Eduardo; Crouzy, Caroline; Moksnes, Per-Olav] Univ Gothenburg, Dept Marine Sci, Gothenburg, Sweden; [Infantes, Eduardo; Crouzy, Caroline] Kristineberg 566, SE-45178 Fiskebackskil, Sweden; [Moksnes, Per-Olav] Box 461, SE-40530 Gothenburg, Sweden	University of Gothenburg	Infantes, E (corresponding author), Univ Gothenburg, Dept Marine Sci, Gothenburg, Sweden.; Infantes, E (corresponding author), Kristineberg 566, SE-45178 Fiskebackskil, Sweden.	eduardo.infantes@marine.gu.se	Infantes, Eduardo/D-6105-2019	Infantes, Eduardo/0000-0002-9724-9237	FORMAS [212-2011-758, 231-2014-735]	FORMAS(Swedish Research Council Formas)	FORMAS grant Dnr. 212-2011-758 and FORMAS grant Dnr. 231-2014-735.	ADAMS SM, 1976, T AM FISH SOC, V105, P514, DOI 10.1577/1548-8659(1976)105<514:FEOEFC>2.0.CO;2; Baden S, 2003, AMBIO, V32, P374, DOI 10.1639/0044-7447(2003)032[0374:VSZMLI]2.0.CO;2; Baden S, 2012, MAR ECOL PROG SER, V451, P61, DOI 10.3354/meps09585; Baden S, 2010, LIMNOL OCEANOGR, V55, P1435, DOI 10.4319/lo.2010.55.3.1435; Carstensen J, 2011, ENVIRON SCI TECHNOL, V45, P9122, DOI 10.1021/es202351y; Cole SG, 2016, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00121; Davis RC, 1998, RESTOR ECOL, V6, P297, DOI 10.1046/j.1526-100X.1998.00634.x; Delefosse M, 2012, J SEA RES, V71, P41, DOI 10.1016/j.seares.2012.04.006; Duarte CM, 2009, ESTUAR COAST, V32, P29, DOI 10.1007/s12237-008-9111-2; DUARTE CM, 1995, OPHELIA, V41, P87, DOI 10.1080/00785236.1995.10422039; Duffy JE, 2014, MARINE COMMUNITY ECOLOGY AND CONSERVATION, P271; Eriander L, 2016, J EXP MAR BIOL ECOL, V479, P76, DOI 10.1016/j.jembe.2016.03.005; Eriksson BK, 2011, AMBIO, V40, P786, DOI 10.1007/s13280-011-0158-0; Eriksson BK, 2011, MAR BIOL, V158, P747, DOI 10.1007/s00227-010-1602-6; Fishman JR, 1996, J EXP MAR BIOL ECOL, V198, P11, DOI 10.1016/0022-0981(95)00176-X; Frederiksen M, 2004, AQUAT BOT, V78, P147, DOI 10.1016/j.aquabot.2003.10.003; Gallopin G, 2005, ECOSYSTEMS HUMAN WEL; Garbary DJ, 2014, MAR BIOL, V161, P3, DOI 10.1007/s00227-013-2323-4; Govers LL, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0812; Granger SL., 2000, BIOL MAR MEDITERR, V7, P55; Green E.P., 2003, WORLD ATLAS SEAGRASS; Heck KL, 2000, LIMNOL OCEANOGR, V45, P1041, DOI 10.4319/lo.2000.45.5.1041; Holbrook SJ, 2000, MAR BIOL, V136, P739, DOI 10.1007/s002270050733; Hughes AR, 2009, FRONT ECOL ENVIRON, V7, P242, DOI 10.1890/080041; Infantes E, 2016, MAR ECOL PROG SER, V546, P31, DOI 10.3354/meps11615; Kallstrom B, 2008, AQUAT BOT, V88, P148, DOI 10.1016/j.aquabot.2007.09.005; Krause-Jensen D, 2008, ECOL INDIC, V8, P515, DOI 10.1016/j.ecolind.2007.06.004; Malyshev A, 2011, ICES J MAR SCI, V68, P1852, DOI 10.1093/icesjms/fsr126; Marion SR, 2012, MAR ECOL PROG SER, V448, P197, DOI 10.3354/meps09612; Marion SR, 2010, RESTOR ECOL, V18, P514, DOI 10.1111/j.1526-100X.2010.00692.x; Moksnes P-O, 1999, THESIS; Moksnes PO, 2008, OIKOS, V117, P763, DOI 10.1111/j.0030-1299.2008.16521.x; Moksnes PO, 1998, MAR ECOL PROG SER, V166, P211, DOI 10.3354/meps166211; Moksnes PO, 2004, ECOLOGY, V85, P1343, DOI 10.1890/02-0750; MOORE KA, 1993, AQUAT BOT, V45, P79, DOI 10.1016/0304-3770(93)90054-Z; Munkes B, 2005, AQUAT SCI, V67, P372, DOI 10.1007/s00027-005-0761-x; Nakaoka M, 2002, AQUAT BOT, V72, P99, DOI 10.1016/S0304-3770(01)00213-3; Neckles HA, 2015, NORTHEAST NAT, V22, P478, DOI 10.1656/045.022.0305; Nyqvist A, 2009, AMBIO, V38, P85, DOI 10.1579/0044-7447-38.2.85; Nystrom M, 2012, ECOSYSTEMS, V15, P695, DOI 10.1007/s10021-012-9530-6; Ostman O, 2015, J APPL ECOL, V53, P1138; Ostman O, 2016, J APPL ECOL; Pihl L, 1999, J SEA RES, V41, P281, DOI 10.1016/S1385-1101(99)00004-0; PIHL L, 1985, MAR ECOL PROG SER, V22, P169, DOI 10.3354/meps022169; PIHL L, 1982, J EXP MAR BIOL ECOL, V57, P273, DOI 10.1016/0022-0981(82)90197-6; Pihl L., 1995, Netherlands Journal of Aquatic Ecology, V29, P349, DOI 10.1007/BF02084234; Ropes J. W., 1968, FISHERY B FISH WILDL, V67, P183; Short FT, 2000, ECOL ENG, V15, P239, DOI 10.1016/S0925-8574(00)00079-3; Short FT, 2002, MAR ECOL PROG SER, V227, P253, DOI 10.3354/meps227253; Sokal R.R., 1995, BIOL RES; Sumoski SE, 2012, MAR ECOL PROG SER, V471, P1, DOI 10.3354/meps10145; SwAM, 2012, GOD HAVSM 2020 INL B; Traber MS, 2003, ECOLOGICAL RESTORATI, V21, P213; Tulipani DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103346; Tulp I, 2012, MAR ECOL PROG SER, V458, P141, DOI 10.3354/meps09743; Uchida M, 2014, J BIOSCI BIOENG, V118, P646, DOI 10.1016/j.jbiosc.2014.05.017; Valdemarsen T, 2011, J EXP MAR BIOL ECOL, V410, P45, DOI 10.1016/j.jembe.2011.10.006; Valiela I, 1997, LIMNOL OCEANOGR, V42, P1105, DOI 10.4319/lo.1997.42.5_part_2.1105; van der Heide T, 2007, ECOSYSTEMS, V10, P1311, DOI 10.1007/s10021-007-9099-7; van der Heide T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016504; van Katwijk MM, 2016, J APPL ECOL, V53, P567, DOI 10.1111/1365-2664.12562; WASSENBERG TJ, 1990, AUST J MAR FRESH RES, V41, P301; WASSENBERG TJ, 1987, AUST J MAR FRESH RES, V38, P169, DOI 10.1071/MF9870169; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; WIGAND C, 1988, ESTUARIES, V11, P180, DOI 10.2307/1351970; Williams SL, 2001, ECOL APPL, V11, P1472, DOI 10.1890/1051-0761(2001)011[1472:RGDIET]2.0.CO;2	66	21	22	6	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168128	10.1371/journal.pone.0168128	http://dx.doi.org/10.1371/journal.pone.0168128			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977802	Green Submitted, Green Published, gold			2022-12-26	WOS:000391217400064
J	Jung, NH; Gleich, B; Gattinger, N; Hoess, C; Haug, C; Siebner, HR; Mall, V				Jung, Nikolai H.; Gleich, Bernhard; Gattinger, Norbert; Hoess, Catrina; Haug, Carolin; Siebner, Hartwig R.; Mall, Volker			Quadri-Pulse Theta Burst Stimulation using Ultra-High Frequency Bursts - A New Protocol to Induce Changes in Cortico-Spinal Excitability in Human Motor Cortex	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; DEPENDENT SYNAPTIC PLASTICITY; HOMEOSTATIC PLASTICITY; TERM DEPRESSION; HALF-SINE; METAPLASTICITY; DIRECTION; NETWORKS; CIRCUITS; MEMORY	Patterned transcranial magnetic stimulation (TMS) such as theta burst stimulation (TBS) or quadri-pulse stimulation (QPS) can induce changes in cortico-spinal excitability, commonly referred to as long-term potentiation (LTP)-like and long-term depression (LTD)-like effects in human motor cortex (M1). Here, we aimed to test the plasticity-inducing capabilities of a novel protocol that merged TBS and QPS. 360 bursts of quadri-pulse TBS (qTBS) were continuously given to M1 at 90% of active motor threshold (1440 full-sine pulses). In a first experiment, stimulation frequency of each burst was set to 666 Hz to mimic the rhythmicity of the descending cortico-spinal volleys that are elicited by TMS (i.e., I-wave periodicity). In a second experiment, burst frequency was set to 200 Hz to maximize postsynaptic Ca2+ influx using a temporal pattern unrelated to I-wave periodicity. The second phase of sinusoidal TMS pulses elicited either a posterior-anterior (PA) or anterior-posterior (AP) directed current in M1. Motor evoked potentials (MEPs) were recorded before and after qTBS to probe changes in cortico-spinal excitability. PA-qTBS at 666 Hz caused a decrease in PAMEP amplitudes, whereas AP-qTBS at 666 Hz induced an increase in mean AP-MEP amplitudes. At a burst frequency of 200 Hz, PA-qTBS and AP-qTBS produced an increase in cortico- spinal excitability outlasting for at least 60 minutes in PA- and AP-MEP amplitudes, respectively. Continuous qTBS at 666 Hz or 200 Hz can induce lasting changes in corticospinal excitability. Induced current direction in the brain appears to be relevant when qTBS targets I-wave periodicity, corroborating that high-fidelity spike timing mechanisms are critical for inducing bi-directional plasticity in human M1.	[Jung, Nikolai H.; Hoess, Catrina; Haug, Carolin; Mall, Volker] Tech Univ Munich, Dept Pediat, Heiglhofstr 63, Munich, Germany; [Gleich, Bernhard; Gattinger, Norbert] Tech Univ Munich IMETUM, Zentralinst Med Tech, Boltzmannstr 11, Garching, Germany; [Siebner, Hartwig R.] Copenhagen Univ Hosp Hvidovre, Danish Res Ctr Magnet Resonance, Kettegaard Alle 30, Hvidovre, Denmark; [Siebner, Hartwig R.] Copenhagen Univ Hosp Bispebjerg, Dept Neurol, Copenhagen, Denmark	Technical University of Munich; Technical University of Munich; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital	Mall, V (corresponding author), Tech Univ Munich, Dept Pediat, Heiglhofstr 63, Munich, Germany.	volker.mall@tum.de	Gleich, Bernhard/D-4803-2009	Gleich, Bernhard/0000-0002-0574-7678	Lundbeck Foundation [R59-A5399]; Novo Nordisk Foundation Interdisciplinary Synergy Program "Biophysically adjusted state-informed cortex stimulation (BASICS) [NNF14OC0011413]; Novo Nordisk Fonden [NNF14OC0011413] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation Interdisciplinary Synergy Program "Biophysically adjusted state-informed cortex stimulation (BASICS); Novo Nordisk Fonden(Novo Nordisk Foundation)	Hartwig R. Siebner received financial support from the Lundbeck Foundation [Grant of Excellence "Mapping, Modulation and Modeling the Control of Actions"; grant number R59-A5399] and the Novo Nordisk Foundation Interdisciplinary Synergy Program 2014 ["Biophysically adjusted state-informed cortex stimulation (BASICS); grant number NNF14OC0011413]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; Awiszus F, 2003, SUPPL CLIN NEUROPHYS, V56, P13; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Buschler A, 2012, HIPPOCAMPUS, V22, P2238, DOI 10.1002/hipo.22041; Caroni P, 2012, NAT REV NEUROSCI, V13, P478, DOI 10.1038/nrn3258; Cash RFH, 2013, J NEUROPHYSIOL, V109, P106, DOI 10.1152/jn.00584.2011; Cash RFH, 2009, EXP BRAIN RES, V193, P1, DOI 10.1007/s00221-008-1590-7; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Delvendahl I, 2014, BRAIN STIMUL, V7, P49, DOI 10.1016/j.brs.2013.08.002; Delvendahl I, 2010, CLIN NEUROPHYSIOL, V121, P594, DOI 10.1016/j.clinph.2009.09.034; Di Lazzaro V, 2008, J PHYSIOL-LONDON, V586, P3871, DOI 10.1113/jphysiol.2008.152736; Di Lazzaro V, 2005, J PHYSIOL-LONDON, V565, P945, DOI 10.1113/jphysiol.2005.087288; Di Lazzaro V, 2012, BRAIN STIMUL, V5, P512, DOI 10.1016/j.brs.2011.07.008; Di Lazzaro V, 2001, J PHYSIOL-LONDON, V537, P1047, DOI 10.1113/jphysiol.2001.012572; Grover LM, 2009, LEARN MEMORY, V16, P69, DOI 10.1101/lm.1179109; Hamada M, 2008, J PHYSIOL-LONDON, V586, P3927, DOI 10.1113/jphysiol.2008.152793; Hamada M, 2014, J NEUROSCI, V34, P12837, DOI 10.1523/JNEUROSCI.1960-14.2014; Hamada M, 2013, CEREB CORTEX, V23, P1593, DOI 10.1093/cercor/bhs147; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Jung NH, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-139; Karabanov A, 2015, BRAIN STIMUL, V8, P442, DOI 10.1016/j.brs.2015.01.404; Kenney J, 2013, NEUROPHARMACOLOGY, V74, P108, DOI 10.1016/j.neuropharm.2013.02.017; Lang N, 2004, BIOL PSYCHIAT, V56, P634, DOI 10.1016/j.biopsych.2004.07.017; Naie K, 2004, CEREB CORTEX, V14, P189, DOI 10.1093/cercor/bhg118; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Siebner HR, 2004, J NEUROSCI, V24, P3379, DOI 10.1523/JNEUROSCI.5316-03.2004; Simeoni S, 2016, BRAIN STIMUL, V9, P148, DOI 10.1016/j.brs.2015.10.007; Sommer M, 2006, CLIN NEUROPHYSIOL, V117, P838, DOI 10.1016/j.clinph.2005.10.029; Sommer M, 2013, BRAIN STIMUL, V6, P363, DOI 10.1016/j.brs.2012.07.003; Thickbroom GW, 2011, BRAIN STIMUL, V4, P77, DOI 10.1016/j.brs.2010.04.002; Wankerl K, 2010, J NEUROSCI, V30, P6197, DOI 10.1523/JNEUROSCI.4673-09.2010; Ziemann U, 2001, BRAIN, V124, P1171, DOI 10.1093/brain/124.6.1171; Ziemann U, 2008, BRAIN STIMUL, V1, P164, DOI 10.1016/j.brs.2008.06.006	34	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168410	10.1371/journal.pone.0168410	http://dx.doi.org/10.1371/journal.pone.0168410			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977758	Green Submitted, gold, Green Published			2022-12-26	WOS:000391217400106
J	Merino, P; Diaz, A; Jeanneret, V; Wu, F; Torre, E; Cheng, LH; Yepes, M				Merino, Paola; Diaz, Ariel; Jeanneret, Valerie; Wu, Fang; Torre, Enrique; Cheng, Lihong; Yepes, Manuel			Urokinase-type Plasminogen Activator (uPA) Binding to the uPA Receptor (uPAR) Promotes Axonal Regeneration in the Central Nervous System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-2-MACROGLOBULIN RECEPTOR; GROWTH; PROTEIN; STROKE; INJURY; BRAIN; COMPLEXES; RECOVERY; SURVIVAL; MOTILITY	Axonal injury is a common cause of neurological dysfunction. Unfortunately, in contrast to axons from the peripheral nervous system, the limited capacity of regeneration of central nervous system (CNS) axons is a major obstacle for functional recovery in patients suffering neurological diseases that involve the subcortical white matter. Urokinase-type plasminogen activator (uPA) is a serine proteinase that upon binding to the urokinasetype plasminogen activator receptor (uPAR) catalyzes the conversion of plasminogen into plasmin on the cell surface. uPAR expression increases after an injury, and signaling through uPAR promotes tissue remodeling. However, it is yet unknown whether uPA binding to uPAR has an effect on axonal recovery in the CNS. Here, we used in vitro and in vivo models of CNS axonal injury to test the hypothesis that uPA binding to uPAR promotes axonal regeneration in the CNS. We found that newly formed growth cones from axons re-emerging from an axonal injury express uPAR and that binding of uPA to this uPAR promotes axonal recovery by a mechanism that does not require the generation of plasmin. Our data indicate that the binding of recombinant uPA or endogenous uPA to uPAR induces membrane recruitment and activation of beta 1 integrin via the low density lipoprotein receptor-related protein-1 ( LRP1), which leads to activation of the Rho family small GTPase Rac1 and Rac1induced axonal regeneration. Our results show that the uPA/ uPAR/LRP1 system is a potential target for the development of therapeutic strategies to promote axonal recovery following a CNS injury.	[Merino, Paola; Diaz, Ariel; Jeanneret, Valerie; Wu, Fang; Torre, Enrique; Cheng, Lihong; Yepes, Manuel] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Merino, Paola; Diaz, Ariel; Jeanneret, Valerie; Wu, Fang; Torre, Enrique; Cheng, Lihong; Yepes, Manuel] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Merino, Paola; Diaz, Ariel; Jeanneret, Valerie; Wu, Fang; Torre, Enrique; Cheng, Lihong; Yepes, Manuel] Yerkes Natl Primate Res Ctr, Div Neurosci, Atlanta, GA 30329 USA; [Yepes, Manuel] Vet Affairs Med Ctr, Dept Neurol, Atlanta, GA 30033 USA	Emory University; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Yepes, M (corresponding author), Emory Univ, Dept Neurol, Whitehead Biomed Res Bldg,615 Michael St,Ste 505J, Atlanta, GA 30322 USA.; Yepes, M (corresponding author), Emory Univ, Ctr Neurodegenerat Dis, Whitehead Biomed Res Bldg,615 Michael St,Ste 505J, Atlanta, GA 30322 USA.	myepes@emory.edu	Díaz, Ariel/ABF-7295-2020; Jeanneret, Valerie/AAY-6356-2020	Díaz, Ariel/0000-0001-5677-5751; Merino, Paola/0000-0002-5203-4507	National Institutes of Health Grants [NS-079331, NS-091201]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091201, R01NS079331] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003441] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by National Institutes of Health Grants NS-079331 (to M. Y.) and NS-091201 (to M. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alfano D, 2005, THROMB HAEMOSTASIS, V93, P205, DOI 10.1160/TH04-09-0592; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Campana WM, 2006, J NEUROSCI, V26, P11197, DOI 10.1523/JNEUROSCI.2709-06.2006; Collen D, 1999, THROMB HAEMOSTASIS, V82, P259; Connolly BM, 2010, BLOOD, V116, P1593, DOI 10.1182/blood-2010-03-276642; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Echeverry R, 2010, J CLIN INVEST, V120, P2194, DOI 10.1172/JCI41722; FRIES W, 1993, BRAIN, V116, P369, DOI 10.1093/brain/116.2.369; Gaultier A, 2008, J CLIN INVEST, V118, P161, DOI 10.1172/JCI32371; GOLDBERG DJ, 1986, J CELL BIOL, V103, P1921, DOI 10.1083/jcb.103.5.1921; He ZG, 2016, NEURON, V90, P437, DOI 10.1016/j.neuron.2016.04.022; Herz J, 2001, NEURON, V29, P571, DOI 10.1016/S0896-6273(01)00234-3; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hinman JD, 2014, CURR OPIN NEUROL, V27, P615, DOI 10.1097/WCO.0000000000000149; Hua ZL, 2015, NEURAL DEV, V10, DOI 10.1186/s13064-015-0049-3; Hur EM, 2012, TRENDS NEUROSCI, V35, P164, DOI 10.1016/j.tins.2011.11.002; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kjoller L, 2001, J CELL BIOL, V152, P1145, DOI 10.1083/jcb.152.6.1145; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; Kukley M, 2007, NAT NEUROSCI, V10, P311, DOI 10.1038/nn1850; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Ma Z, 2002, J CELL BIOL, V159, P1061, DOI 10.1083/jcb.200207070; Myers JP, 2011, DEV NEUROBIOL, V71, P901, DOI 10.1002/dneu.20931; Nykjaer A, 1997, EMBO J, V16, P2610, DOI 10.1093/emboj/16.10.2610; NYKJAER A, 1992, J BIOL CHEM, V267, P14543; Orr AW, 2003, J CELL BIOL, V161, P1179, DOI 10.1083/jcb.200302069; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Rasband MN, 2010, NAT REV NEUROSCI, V11, P552, DOI 10.1038/nrn2852; SKENE JHP, 1989, ANNU REV NEUROSCI, V12, P127, DOI 10.1146/annurev.ne.12.030189.001015; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; Sturge J, 2003, J CELL BIOL, V162, P789, DOI 10.1083/jcb.200302124; Stys PK, 2011, TRENDS NEUROSCI, V34, P393, DOI 10.1016/j.tins.2011.06.004; Torre ER, 2010, MOL CELL NEUROSCI, V44, P135, DOI 10.1016/j.mcn.2010.03.003; Wei Y, 2001, MOL BIOL CELL, V12, P2975, DOI 10.1091/mbc.12.10.2975; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551; Wu F, 2014, J NEUROSCI, V34, P14219, DOI 10.1523/JNEUROSCI.5309-13.2014; Wu F, 2012, J NEUROSCI, V32, P9848, DOI 10.1523/JNEUROSCI.1241-12.2012; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212; Yoon C, 2013, J BIOL CHEM, V288, P26557, DOI 10.1074/jbc.M113.478552	41	45	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2741	2753		10.1074/jbc.M116.761650	http://dx.doi.org/10.1074/jbc.M116.761650			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	27986809	Green Published, hybrid			2022-12-26	WOS:000395535100016
J	Yamada, S; Hashizume, A; Hijikata, Y; Inagaki, T; Suzuki, K; Kondo, N; Kawai, K; Noda, S; Nakanishi, H; Banno, H; Hirakawa, A; Koike, H; Halievski, K; Jordan, CL; Katsuno, M; Sobue, G				Yamada, Shinichiro; Hashizume, Atsushi; Hijikata, Yasuhiro; Inagaki, Tomonori; Suzuki, Keisuke; Kondo, Naohide; Kawai, Kaori; Noda, Seiya; Nakanishi, Hirotaka; Banno, Haruhiko; Hirakawa, Akihiro; Koike, Haruki; Halievski, Katherine; Jordan, Cynthia L.; Katsuno, Masahisa; Sobue, Gen			Decreased Peak Expiratory Flow Associated with Muscle Fiber-Type Switching in Spinal and Bulbar Muscular Atrophy	PLoS One			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ACTIVATED PROTEIN-KINASE; ANDROGEN RECEPTOR GENE; SKELETAL-MUSCLE; CAG REPEAT; IIB FIBERS; FEATURES; SBMA; LARYNGOSPASM; CONTRACTILE	The aim of this study was to characterize the respiratory function profile of subjects with spinal and bulbar muscular atrophy (SBMA), and to explore the underlying pathological mechanism by comparing the clinical and biochemical indices of this disease with those of amyotrophic lateral sclerosis (ALS). We enrolled male subjects with SBMA (n = 40) and ALS (n = 25) along with 15 healthy control subjects, and assessed their respiratory function, motor function, and muscle strength. Predicted values of peak expiratory flow (%PEF) and forced vital capacity were decreased in subjects with SBMA compared with controls. In SBMA, both values were strongly correlated with the trunk subscores of the motor function tests and showed deterioration relative to disease duration. Compared with activities of daily living (ADL)-matched ALS subjects, %PEF, tongue pressure, and grip power were substantially decreased in subjects with SBMA. Both immunofluorescence and RT-PCR demonstrated a selective decrease in the expression levels of the genes encoding the myosin heavy chains specific to fast-twitch fibers in SBMA subjects. The mRNA levels of peroxisome proliferator-activated receptor gamma coactivator 1-alpha and peroxisome proliferator-activated receptor delta were up-regulated in SBMA compared with ALS and controls. In conclusion, %PEF is a disease-specific respiratory marker for the severity and progression of SBMA. Explosive muscle strength, including %PEF, was selectively affected in subjects with SBMA and was associated with activation of the mitochondrial biogenesis-related molecular pathway in skeletal muscles.	[Yamada, Shinichiro; Hashizume, Atsushi; Hijikata, Yasuhiro; Inagaki, Tomonori; Kondo, Naohide; Kawai, Kaori; Noda, Seiya; Nakanishi, Hirotaka; Banno, Haruhiko; Koike, Haruki; Katsuno, Masahisa; Sobue, Gen] Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi, Japan; [Suzuki, Keisuke] Natl Ctr Geriatr & Gerontol, Innovat Ctr Clin Res, Obu, Japan; [Banno, Haruhiko] Nagoya Univ, Inst Adv Res, Nagoya, Aichi, Japan; [Hirakawa, Akihiro] Nagoya Univ, Grad Sch Med, Ctr Adv Med & Clin Res, Biostat Sect, Nagoya, Aichi, Japan; [Halievski, Katherine; Jordan, Cynthia L.] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA; [Sobue, Gen] Nagoya Univ, Grad Sch Med, Res Div Dementia & Neurodegenerat Dis, Nagoya, Aichi, Japan	Nagoya University; National Center for Geriatrics & Gerontology; Nagoya University; Nagoya University; Michigan State University; Nagoya University	Katsuno, M; Sobue, G (corresponding author), Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi, Japan.; Sobue, G (corresponding author), Nagoya Univ, Grad Sch Med, Res Div Dementia & Neurodegenerat Dis, Nagoya, Aichi, Japan.	ka2no@med.nagoya-u.ac.jp; sobueg@med.nagoya-u.ac.jp	Hirakawa, Akihiro/AAE-5936-2019; Banno, Haruhiko/AAN-4305-2021; Banno, Haruhiko/Q-1029-2015; Halievski, Katherine/AAA-1563-2022	Banno, Haruhiko/0000-0002-0404-3839; Banno, Haruhiko/0000-0002-0404-3839; Halievski, Katherine/0000-0003-0365-5953	KAKENHI grants from Japan Society for the Promotion of Science [26293206, 26670440, 15K15337, 16K15480]; Japan Agency for Medical Research and Development [15ek0109025, 15ek0109048]; KAKENHI grant from Japan Society for the Promotion of Science [26293206]; Japan Science and Technology Agency; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045195] Funding Source: NIH RePORTER	KAKENHI grants from Japan Society for the Promotion of Science; Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); KAKENHI grant from Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Dr. Katsuno received KAKENHI grants from Japan Society for the Promotion of Science (https://www.jsps.go.jp/) (Nos. 26293206, 26670440, 15K15337, and 16K15480) and grants from the Japan Agency for Medical Research and Development (http://www.amed.go.jp/) (Nos. 15ek0109025, 15ek0109048). Dr. Sobue received a KAKENHI grant from Japan Society for the Promotion of Science (https://www.jsps.go.jp/) (No. 26293206), grants from the Japan Agency for Medical Research and Development (http://www.amed.go.jp/) (Nos. 15ek0109025, 15ek0109048), and grants from the Japan Science and Technology Agency (https://www.jst.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsuta N, 2006, BRAIN, V129, P1446, DOI 10.1093/brain/awl096; BALDWIN ED, 1948, MEDICINE, V27, P243; BERGLUND E, 1963, ACTA MED SCAND, V173, P185; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Dejager S, 2002, J CLIN ENDOCR METAB, V87, P3893, DOI 10.1210/jc.87.8.3893; DOYU M, 1992, ANN NEUROL, V32, P707, DOI 10.1002/ana.410320517; Fernandez-Rhodes LE, 2011, LANCET NEUROL, V10, P140, DOI 10.1016/S1474-4422(10)70321-5; Fratta P, 2014, NEUROLOGY, V82, P2077, DOI 10.1212/WNL.0000000000000507; Hashizume A, 2015, NEUROMUSCULAR DISORD, V25, P554, DOI 10.1016/j.nmd.2015.03.008; Hashizume A, 2012, BRAIN, V135, P2838, DOI 10.1093/brain/aws170; Katsuno M, 2012, PROG NEUROBIOL, V99, P246, DOI 10.1016/j.pneurobio.2012.05.007; Katsuno M, 2010, LANCET NEUROL, V9, P875, DOI 10.1016/S1474-4422(10)70182-4; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lo Coco D, 2006, NEUROLOGY, V67, P761, DOI 10.1212/01.wnl.0000227785.73714.64; Maeshima S, 2015, J NEUROL, V262, P1035, DOI 10.1007/s00415-015-7680-0; Mantilla CB, 2013, J APPL PHYSIOL, V114, P380, DOI 10.1152/japplphysiol.01122.2012; Mayer OH, 2015, PEDIATR PULM, V50, P487, DOI 10.1002/ppul.23172; Miller RG, 2009, NEUROLOGY, V73, P1218, DOI 10.1212/WNL.0b013e3181bc0141; Oki K, 2015, J APPL PHYSIOL, V118, P941, DOI 10.1152/japplphysiol.00886.2014; Oki K, 2013, MUSCLE NERVE, V47, P823, DOI 10.1002/mus.23813; Pedersen O F, 1997, Eur Respir J Suppl, V24, p9S; Ranganathan S, 2009, HUM MOL GENET, V18, P27, DOI 10.1093/hmg/ddn310; Rocchi A, 2016, ACTA NEUROPATHOL, V132, P127, DOI 10.1007/s00401-016-1550-4; Rockl KSC, 2007, DIABETES, V56, P2062, DOI 10.2337/db07-0255; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Shen M, 2014, J CELL PHYSIOL, V229, P688, DOI 10.1002/jcp.24494; Sieck GC, 2013, COMPR PHYSIOL, V3, P1533, DOI 10.1002/cphy.c130003; SMERDU V, 1994, AM J PHYSIOL-CELL PH, V267, pC1723, DOI 10.1152/ajpcell.1994.267.6.C1723; Smith M, 2013, INT J EPIDEMIOL, V42, P803, DOI 10.1093/ije/dyt079; Soraru G, 2008, J NEUROL SCI, V264, P100, DOI 10.1016/j.jns.2007.08.012; Sperfeld AD, 2005, NEUROLOGY, V64, P753, DOI 10.1212/01.WNL.0000151978.74467.E7; Stevens L, 2008, NEUROPATH APPL NEURO, V34, P659, DOI 10.1111/j.1365-2990.2008.00950.x; Tanaka S, 2014, J NEUROL SCI, V337, P193, DOI 10.1016/j.jns.2013.12.010; Tzani P, 2014, EUR J PHYS REHAB MED, V50, P427; Wang AY, 1997, SPINAL CORD, V35, P299, DOI 10.1038/sj.sc.3100370; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294	39	20	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168846	10.1371/journal.pone.0168846	http://dx.doi.org/10.1371/journal.pone.0168846			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005993	Green Submitted, gold, Green Published			2022-12-26	WOS:000392843200104
J	Dovel, K; Yeatman, S; van Oosterhout, JJ; Chan, A; Mantengeni, A; Landes, M; Bedell, R; Kawalazira, G; Sodhi, S				Dovel, Kathryn; Yeatman, Sara; van Oosterhout, Joep J.; Chan, Adrienne; Mantengeni, Alfred; Landes, Megan; Bedell, Richard; Kawalazira, Gift; Sodhi, Sumeet			Trends in ART Initiation among Men and Non-Pregnant/Non-Breastfeeding Women before and after Option B plus in Southern Malawi	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; ANTIRETROVIRAL THERAPY; HIV; CARE; PREVENTION; RETENTION; COMMUNITY; DISTRICT; AFRICA; RISK	Background Option B+ is promoted as a key component to eliminating vertical transmission of HIV; however, little is known about the policy's impact on non-targeted populations, such as men and non-pregnant/non-breastfeeding women. We compare ART uptake among non-targeted populations during pre/post Option B+ periods in Zomba District, Malawi. Methods Individual-level ART registry data from 27 health facilities were digitized and new-ART initiates were disaggregated by sex and type of initiate (Option B+ or not). Data were analyzed over the pre-(January 2009-June 2011) and post-(July 2011-December 2013) Option B+ periods. Results After the implementation of Option B+, the total number of new female initiates increased significantly (quarterly median: 547 vs. 816; P = 0.001) and their median age decreased from 34 to 31 years (P = <0.001). Both changes were the result of the rapid and sustained uptake of ART among Option B+ clients. Post-policy, Option B+ clients represented 48% of all new female initiates while the number of females who initiated through CD4 or WHO staging criteria significantly decreased (quarterly median: 547 vs. 419; P = 0.005). The number and age of male initiates remained stable; however, the proportion of men among new initiates decreased (36% vs. 31%; P = <0.001). Conclusions Option B+ shifted the profile of first-time initiates towards younger and fertile women. Declines among non-Option B+ women most likely reflect earlier initiation during pregnancies before deteriorations in health. The decreased proportion of men among first-time initiates represents a growing gender disparity in HIV services that deserves immediate attention.	[Dovel, Kathryn] Univ Calif Los Angeles, David Geffen Sch Med, Ctr World Hlth, Div Infect Dis, Los Angeles, CA 90095 USA; [Yeatman, Sara] Univ Colorado, Dept Hlth & Behav Sci, Denver, CO 80202 USA; [van Oosterhout, Joep J.] Univ Malawi, Dept Med, Coll Med, Blantyre, Malawi; [van Oosterhout, Joep J.; Chan, Adrienne; Mantengeni, Alfred; Landes, Megan; Bedell, Richard; Sodhi, Sumeet] Dignitas Int, Zomba, Malawi; [Chan, Adrienne; Landes, Megan; Sodhi, Sumeet] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Chan, Adrienne] Univ Toronto, Div Infect Dis, Dept Med, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Kawalazira, Gift] Minist Hlth, Dist Hlth Off, Zomba, Malawi; [Sodhi, Sumeet] Toronto Western Hosp, Univ Hlth Network, Dept Family & Community Med, Toronto, ON, Canada	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Colorado System; University of Colorado Denver; University of Malawi; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Dovel, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Ctr World Hlth, Div Infect Dis, Los Angeles, CA 90095 USA.	kdovel@mednet.ucla.edu	Bedell, Richard/AAC-2595-2020	Bedell, Richard/0000-0002-5687-8053; Yeatman, Sara/0000-0002-5991-6473	Canadian Institutes for Health Research under Grant HIV/AIDS Operating Grant; United States Agency for International Development [674-A-00-010-00034-00]; National Institute of Child Health and Human Development [R01-HD077873]; National Institute of Mental Health [F31-MH103078]	Canadian Institutes for Health Research under Grant HIV/AIDS Operating Grant(Canadian Institutes of Health Research (CIHR)); United States Agency for International Development(United States Agency for International Development (USAID)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was partially funded by the Canadian Institutes for Health Research under Grant HIV/AIDS Operating Grant 2010 and 2012, and the United States Agency for International Development under Grant 674-A-00-010-00034-00. Authors' time was supported by the National Institute of Child Health and Human Development under Grant R01-HD077873, and the National Institute of Mental Health under Grant F31-MH103078. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2013, PUBLIC HEALTH ACTION, V3, P175, DOI 10.5588/pha.12.0096; Bemelmans M, 2014, TROP MED INT HEALTH, V19, P968, DOI 10.1111/tmi.12332; Bor J, 2016, COMMUNICATION; Bor J, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001905; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; CDC, 2011, MMWR-MORBID MORTAL W, V62, P148; Chan AK, 2010, TROP MED INT HEALTH, V15, P90, DOI 10.1111/j.1365-3156.2010.02503.x; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cornell M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001304; Coutsoudis A, 2013, LANCET, V381, P269, DOI 10.1016/S0140-6736(12)61807-8; Dieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828; Doherty M, 2016, UPTAKE IMPLEMENTATIO; Dovel K, 2015, AIDS, V29, P1123, DOI 10.1097/QAD.0000000000000655; Estem KS, 2016, CURR HIV-AIDS REP, V13, P107, DOI 10.1007/s11904-016-0307-y; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Haas AD, 2016, LANCET HIV, V3, pE175, DOI 10.1016/S2352-3018(16)00008-4; Hawkins C, 2011, AIDS, V25, P1189, DOI 10.1097/QAD.0b013e3283471deb; Hensen B, 2014, AIDS, V28, P2133, DOI 10.1097/QAD.0000000000000395; Kennedy CE, 2013, AIDS BEHAV, V17, P1571, DOI 10.1007/s10461-012-0241-y; Khanna AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134271; Kim MH, 2015, JAIDS-J ACQ IMM DEF, V70, P99, DOI 10.1097/QAI.0000000000000692; Lahuerta M, 2014, CLIN INFECT DIS, V58, P432, DOI 10.1093/cid/cit724; Lowrance D, 2007, TROP MED INT HEALTH, V12, P377, DOI 10.1111/j.1365-3156.2006.01800.x; Matheson R, 2015, J INT AIDS SOC, V18, P50, DOI 10.7448/IAS.18.6.20286; Ministry of Health Government of Malawi, 2008, TREATM AIDS GUID US; Ministry of Health Government of Malawi, 2011, CLIN MAN HIV CHILDR; Ministry of Health [Malawi], 2014, INT HIV PROGR REP JA; Ministry of Health [Malawi], 2011, INT HIV PROGR REP AP; Ministry of Health [Malawi], 2012, 2012 GLOB AIDS RESP; NSO & ORC Macro, 2011, MAL DEM HLTH SURV 20; Schouten EJ, 2011, LANCET, V378, P282, DOI 10.1016/S0140-6736(10)62303-3; Shaffer N, 2014, AIDS, V28, P599, DOI 10.1097/QAD.0000000000000144; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; Siedner MJ, 2015, CLIN INFECT DIS, V60, P1120, DOI 10.1093/cid/ciu1137; Staveteig S, 2013, DHS COMP REPORTS; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; The Interagency Task Team on the Prevention and Treatment of HIV Infection in Pregnant Women Mothers and Children (IATT), 2015, OPT B COUNTR PMTCT R; Van de Perre P, 2012, BMJ-BRIT MED J, V346, pf3767; van Lettow M, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18994; Venkatesh KK, 2011, JAIDS-J ACQ IMM DEF, V56, P151, DOI 10.1097/QAI.0b013e318202c82c; World Health Organization, 2015, GUID START ANT THER; Zachariah R, 2011, TROP MED INT HEALTH, V16, P37, DOI 10.1111/j.1365-3156.2010.02669.x	43	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0165025	10.1371/journal.pone.0165025	http://dx.doi.org/10.1371/journal.pone.0165025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002413	Green Submitted, gold, Green Published			2022-12-26	WOS:000392853100002
J	Tan, XM; Xu, XP; Gao, Y; Yang, QM; Zhu, YS; Wang, JQ; Wan, FH; Zhou, HX				Tan, Xiumei; Xu, Xiuping; Gao, Yong; Yang, Qinmin; Zhu, Yunsheng; Wang, Jiqing; Wan, Fanghao; Zhou, Hongxu			Levels of Salivary Enzymes of Apolygus Lucorum (Hemiptera: Miridae), From 1st Instar Nymph to Adult, and Their Potential Relation to Bug Feeding	PLOS ONE			English	Article							INDUCED PLANT-RESPONSES; DIGESTIVE ENZYMES; STYLET MORPHOLOGY; LYGUS-HESPERUS; ALPHA-AMYLASE; BT COTTON; SUNN PEST; ADAPTATIONS; PROTEINS; APHIDS	In recent years, Apolygus lucorum has caused increasing damage to cotton and fruit trees in China. The salivary enzymes secreted by A. lucorum when sucking on host plants induce a series of biochemical reactions in plants, and the pre-oral digestion benefits the bug feeding. In this study, the food intake of A. lucorum from 1 st instar nymphs to adults was measured, and the corresponding salivary activity of pectinase, amylase, cellulase, protease, polyphenol oxidase and peroxidase was determined. Daily food intake varied with developmental stage, peaking in 3rd and 4 th instar nymphs. Pectinase, amylase, cellulase and protease were detected in both nymphal and adult saliva of A. lucorum, while neither polyphenol oxidase nor peroxidase was detected. Protease activity varied with food intake peaking at the 3rd-4th instar, and then slightly decreasing at the 5th instar. Levels of pectinase, amylase and cellulase increased significantly with the daily feeding level until the 3 rd instar, corresponding with increasing damage to host plants. The activity of both cellulase and protease had a significant linear relationship with the average daily food intake. The increasing activity of enzymes in saliva explain stage-specific impacts of A. lucorum on the host plants, and suggest that optimal management of A. lucorum would be confined to its control threshold prior to the peak of daily feeding in the 3rd instar.	[Tan, Xiumei; Xu, Xiuping; Gao, Yong; Zhu, Yunsheng; Wan, Fanghao; Zhou, Hongxu] Qingdao Agr Univ, Coll Agron & Plant Protect, Key Lab Integrated Crop Pest Management Shandong, Qingdao, Peoples R China; [Yang, Qinmin] Gen Stn Plant Protect Shandong Prov, Jinan, Peoples R China; [Wang, Jiqing] Qingdao Acad Agr Sci, Inst Plant Protect, Qingdao, Peoples R China; [Wan, Fanghao] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China	Qingdao Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Zhou, HX (corresponding author), Qingdao Agr Univ, Coll Agron & Plant Protect, Key Lab Integrated Crop Pest Management Shandong, Qingdao, Peoples R China.	hxzhou@qau.edu.cn			National Key Research and Development Plan [2016YFC1201200]; Special Fund for Agro-scientific Research in the Public Interest [201103012]; Natural Science Foundation of Shandong Province [ZR2012CM018]; Taishan Mountain Scholar Constructive Engineering Foundation of Shandong Province	National Key Research and Development Plan; Special Fund for Agro-scientific Research in the Public Interest; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Taishan Mountain Scholar Constructive Engineering Foundation of Shandong Province	This research was supported by the National Key Research and Development Plan (2016YFC1201200), the Special Fund for Agro-scientific Research in the Public Interest (201103012), the Natural Science Foundation of Shandong Province (ZR2012CM018) and the Taishan Mountain Scholar Constructive Engineering Foundation of Shandong Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JB, 1963, CAN J ZOOLOG, V41, P1263, DOI 10.1139/z63-108; Adams JB, 1963, CAN J ZOOL, V41, P489; Agrawal AA, 2005, ENTOMOL EXP APPL, V115, P97, DOI 10.1111/j.1570-7458.2005.00294.x; Agusti N, 2000, J ENTOMOL SCI, V35, P176, DOI 10.18474/0749-8004-35.2.176; Bai LiXin, 2004, Jiangsu Journal of Agricultural Sciences, V20, P233; Boyd DW, 2003, ANN ENTOMOL SOC AM, V96, P667, DOI 10.1603/0013-8746(2003)096[0667:DEASMO]2.0.CO;2; Boyd DW, 2002, ANN ENTOMOL SOC AM, V95, P395, DOI 10.1603/0013-8746(2002)095[0395:DEASMO]2.0.CO;2; Chen Julian, 2000, Scientia Agricultura Sinica, V33, P54; Chen MS, 2004, INSECT MOL BIOL, V13, P101, DOI 10.1111/j.1365-2583.2004.00465.x; Chen Y.-n., 1988, Entomological Knowledge, V25, P235; Chen Z.-h., 1987, Entomological Knowledge, V24, P299; Cipollini D, 2003, BASIC APPL ECOL, V4, P79, DOI 10.1078/1439-1791-00134; Cohen AC, 1998, AM ENTOMOLOGIST  SUM, P103; Cohen Allen C., 1996, P1; Dicke M, 1999, HERBIVORES: BETWEEN PLANTS AND PREDATORS, P483; Fan GuangHua, 2009, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V17, P728; Geng Hui-Hui, 2012, Chinese Journal of Applied Entomology, V49, P601; Jiang X, 2010, SCI TECHNOLOGY FOOD, V5, P65; JIANG Y, 1993, PHYTOCHEMISTRY, V33, P29; Karban R, 1997, INDUCED RESPONSE HER; Kazzazi M., 2005, Communications in Agricultural and Applied Biological Sciences, V70, P863; Kazzazi M, 2005, ENTOMOL SCI, V8, P371, DOI 10.1111/j.1479-8298.2005.00137.x; Lian Mei-Xia, 2011, Chinese Journal of Applied Entomology, V48, P982; Lu YH, 2008, CROP PROT, V27, P465, DOI 10.1016/j.cropro.2007.07.017; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Lu Yanhui, 2008, Acta Phytophylacica Sinica, V35, P215; [罗礼智 Luo Lizhi], 2008, [植物保护, Plant Protection], V34, P32; Madhusudhan VV, 1994, THESIS, P81; Madhusudhan VV, 2008, ENTOMOL EXPERIMEN AP, V86, P25; MCALLAN JW, 1961, CAN J ZOOLOG, V39, P305, DOI 10.1139/z61-034; Mehrabadi M, 2014, CR BIOL, V337, P373, DOI 10.1016/j.crvi.2014.04.003; MILES P. W., 1965, J INSECT PHYSIOL, V11, P1261, DOI 10.1016/0022-1910(65)90119-8; Miles P.W., 1987, World Crop Pests, V2A, P321; MILES PW, 1991, ENTOMOL EXP APPL, V59, P123, DOI 10.1007/BF00351957; Peng Lu, 2010, Chinese Bulletin of Entomology, V47, P1017; Powell G, 2006, ANNU REV ENTOMOL, V51, P309, DOI 10.1146/annurev.ento.51.110104.151107; Rodriguez-Saona C, 2002, J CHEM ECOL, V28, P1733, DOI 10.1023/A:1020552932566; Shackel KA, 2005, ARCH INSECT BIOCHEM, V58, P69, DOI 10.1002/arch.20033; STRONG FE, 1968, J INSECT PHYSIOL, V14, P1113, DOI 10.1016/0022-1910(68)90050-4; TJALLINGII WF, 1993, PHYSIOL ENTOMOL, V18, P317, DOI 10.1111/j.1365-3032.1993.tb00604.x; Urbanska A, 1998, ENTOMOL EXP APPL, V86, P197, DOI 10.1023/A:1003119900578; Wang TL, 2008, FOOD MACHINERY, V3; Wang XM, 2007, SCI TECHNOLOGY FOOD, V5, P227; Yang YP, 2006, FOOD RES DEV, V3, P116; Yin Hai-Di, 2006, Acta Entomologica Sinica, V49, P843; Zangerl AR, 2003, BASIC APPL ECOL, V4, P91, DOI 10.1078/1439-1791-00135; Zeng F, 2000, COMP BIOCHEM PHYS A, V126, P101, DOI 10.1016/S1095-6433(00)00193-8; [张飞 Zhang Fei], 2004, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V13, P134; Zhang Guifen, 2008, Shengwu Duoyangxing, V16, P313, DOI 10.3724/SP.J.1003.2008.08050	49	7	7	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168848	10.1371/journal.pone.0168848	http://dx.doi.org/10.1371/journal.pone.0168848			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002486	Green Submitted, Green Published, gold			2022-12-26	WOS:000392853100070
J	Volgenant, CMC; Hoogenkamp, MA; Krom, BP; Janus, MM; ten Cate, JM; de Soet, JJ; Crielaard, W; van der Veen, MH				Volgenant, Catherine M. C.; Hoogenkamp, Michel A.; Krom, Bastiaan P.; Janus, Marleen M.; ten Cate, Jacob M.; de Soet, Johannes J.; Crielaard, Wim; van der Veen, Monique H.			Red and Green Fluorescence from Oral Biofilms	PLOS ONE			English	Article							LIGHT-INDUCED FLUORESCENCE; DENTAL MICROCOSM BIOFILM; STREPTOCOCCUS-MUTANS; CHAIN-LENGTH; AUTOFLUORESCENCE; GROWTH; QLF; LESIONS; PLAQUE	Red and green autofluorescence have been observed from dental plaque after excitation by blue light. It has been suggested that this red fluorescence is related to caries and the cariogenic potential of dental plaque. Recently, it was suggested that red fluorescence may be related to gingivitis. Little is known about green fluorescence from biofilms. Therefore, we assessed the dynamics of red and green fluorescence in real-time during biofilm formation. In addition, the fluorescence patterns of biofilm formed from saliva of eight different donors are described under simulated gingivitis and caries conditions. Biofilm formation was analysed for 12 hours under flow conditions in a microfluidic BioFlux flow system with high performance microscopy using a camera to allow live cell imaging. For fluorescence images dedicated excitation and emission filters were used. Both green and red fluorescence were linearly related with the total biomass of the biofilms. All biofilms displayed to some extent green and red fluorescence, with higher red and green fluorescence intensities from biofilms grown in the presence of serum (gingivitis simulation) as compared to the sucrose grown biofilms (cariogenic simulation). Remarkably, cocci with long chain lengths, presumably streptococci, were observed in the biofilms. Green and red fluorescence were not found homogeneously distributed within the biofilms: highly fluorescent spots (both green and red) were visible throughout the biomass. An increase in red fluorescence from the in vitro biofilms appeared to be related to the clinical inflammatory response of the respective saliva donors, which was previously assessed during an in vivo period of performing no-oral hygiene. The BioFlux model proved to be a reliable model to assess biofilm fluorescence. With this model, a prediction can be made whether a patient will be prone to the development of gingivitis or caries.	[Volgenant, Catherine M. C.; Hoogenkamp, Michel A.; Krom, Bastiaan P.; Janus, Marleen M.; ten Cate, Jacob M.; de Soet, Johannes J.; Crielaard, Wim; van der Veen, Monique H.] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Prevent Dent, Amsterdam, Netherlands; [Volgenant, Catherine M. C.; Hoogenkamp, Michel A.; Krom, Bastiaan P.; Janus, Marleen M.; ten Cate, Jacob M.; de Soet, Johannes J.; Crielaard, Wim; van der Veen, Monique H.] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Krom, Bastiaan P.; Janus, Marleen M.; Crielaard, Wim] Top Inst Food & Nutr, Wageningen, Netherlands	Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Top Institute Food & Nutrition	Volgenant, CMC (corresponding author), Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Prevent Dent, Amsterdam, Netherlands.; Volgenant, CMC (corresponding author), Vrije Univ Amsterdam, Amsterdam, Netherlands.	c.volgenant@acta.nl	Volgenant, Catherine/AAT-7868-2020; van der Veen, Monique H/B-3719-2014; Krom, Bastiaan/ABC-7026-2020	Volgenant, Catherine/0000-0002-4049-2914; Krom, Bastiaan/0000-0002-1497-1161	Dutch Technology Foundation STW [10948]; Inspektor Research Systems BV, the Netherlands; Top Institute Food and Nutrition (TIFN); NWO Earth and Life Sciences (ALW) [834.13.006]	Dutch Technology Foundation STW(Technologiestichting STW); Inspektor Research Systems BV, the Netherlands(Netherlands Government); Top Institute Food and Nutrition (TIFN); NWO Earth and Life Sciences (ALW)	This research was supported by the Dutch Technology Foundation STW (http://www.stw.nl/en/, project number 10948) and Inspektor Research Systems BV, the Netherlands (http://www.inspektor.nl/). The used saliva samples were obtained as part of a clinical trial [16], which was supported by the Top Institute Food and Nutrition (TIFN; http://www.tifn.nl/). TIFN is a public-private partnership on precompetitive research in food and nutrition. Purchase of the BioFlux Z1000 setup was (partially) funded by NWO Earth and Life Sciences (ALW; http://www.nwo.nl/en), project 834.13.006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khateeb S, 1998, AM J ORTHOD DENTOFAC, V113, P595; Ammann TW, 2012, BMC MICROBIOL, V12, P1; Belda-Ferre P, 2012, ISME J, V6, P46, DOI 10.1038/ismej.2011.85; Benedict H C, 1928, Science, V67, P442, DOI 10.1126/science.67.1739.442; Benoit MR, 2010, APPL ENVIRON MICROB, V76, P4136, DOI 10.1128/AEM.03065-09; Billinton N, 2001, ANAL BIOCHEM, V291, P175, DOI 10.1006/abio.2000.5006; Bittar DG, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.6.065004; Buchalla W, 2004, J PERIODONTAL RES, V39, P327, DOI 10.1111/j.1600-0765.2004.00747.x; DaCosta RS, 2003, PHOTOCHEM PHOTOBIOL, V78, P384, DOI 10.1562/0031-8655(2003)078<0384:MFEMRT>2.0.CO;2; de Veld DCG, 2003, LASER SURG MED, V32, P367, DOI 10.1002/lsm.10185; Deng DM, 2004, CARIES RES, V38, P54, DOI 10.1159/000073921; EKSTEDT RD, 1960, J EXP MED, V112, P671, DOI 10.1084/jem.112.4.671; Exterkate RAM, 2010, CARIES RES, V44, P372, DOI 10.1159/000316541; FELLNER MJ, 1976, ARCH DERMATOL, V112, P667, DOI 10.1001/archderm.112.5.667; Hajishengallis G, 2014, TRENDS IMMUNOL, V35, P3, DOI 10.1016/j.it.2013.09.001; Heinrich-Weltzien R, 2003, QUINTESSENCE INT, V34, P181; IACONO VJ, 1985, J DENT RES, V64, P48, DOI 10.1177/00220345850640010901; Janus MM, 2015, BIOFOULING, V31, P503, DOI 10.1080/08927014.2015.1067887; Kim YS, 2014, J DENT, V42, P691, DOI 10.1016/j.jdent.2014.03.006; Koenig K., 1994, P SOC PHOTO-OPT INS, V2135, P129; Koenig K., 1993, PROC SPIE, V2080, P170; Lee ES, 2013, J DENT, V41, P1264, DOI 10.1016/j.jdent.2013.08.021; Lennon AM, 2006, CARIES RES, V40, P2, DOI 10.1159/000088898; LOE H, 1965, J PERIODONTOL, V36, P177, DOI 10.1902/jop.1965.36.3.177; Marsh P D, 1994, Adv Dent Res, V8, P263; Mukherjee S, 1985, J Periodontol, V56, P22, DOI 10.1902/jop.1985.56.11s.22; MURCHISON H, 1982, INFECT IMMUN, V38, P282, DOI 10.1128/IAI.38.1.282-291.1982; Peterson SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058487; Schneckenburger H., 1994, PROC SPIE, V2128, P403; Shigetani Y, 2008, ODONTOLOGY, V96, P21, DOI 10.1007/s10266-007-0077-5; SHIZUKUISHI S, 1995, FEMS MICROBIOL LETT, V131, P313; Simon-Soro A, 2015, TRENDS MICROBIOL, V23, P76, DOI 10.1016/j.tim.2014.10.010; Stubel, 1911, FLUORESZENZ TIERISCH, P1; Van der Veen MH, 2006, CARIES RES, V40, P542, DOI 10.1159/000095655; van der Veen MH, 2000, MONOGR ORAL SCI, V17, P144; van der Veen MH, 2016, J DENT, V48, P71, DOI 10.1016/j.jdent.2016.02.010; VANDERWEIJDEN GA, 1994, J CLIN PERIODONTOL, V21, P589; vanRaamsdonk M, 1997, CARIES RES, V31, P35, DOI 10.1159/000262371; Volgenant CMC, 2016, J ORAL MICROBIOL, V8, DOI 10.3402/jom.v8.30346; Volgenant CMC, 2013, EUR J ORAL SCI, V121, P156, DOI 10.1111/eos.12045; Volgenant CMC, 2016, CLIN ORAL INVEST, P1, DOI [10.1007/s00784-015-1547-8, DOI 10.1007/S00784-015-1547-8]; WIBAWAN IWT, 1993, J VET MED B, V40, P430, DOI 10.1111/j.1439-0450.1993.tb00160.x	42	12	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168428	10.1371/journal.pone.0168428	http://dx.doi.org/10.1371/journal.pone.0168428			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997567	Green Submitted, Green Published, gold			2022-12-26	WOS:000392842900043
J	Alsnes, IV; Janszky, I; Asvold, BO; Okland, I; Forman, MR; Vatten, LJ				Alsnes, Ingvild V.; Janszky, Imre; Asvold, Bjorn O.; Okland, Inger; Forman, Michele R.; Vatten, Lars J.			Maternal Preeclampsia and Androgens in the Offspring around Puberty: A Follow-Up Study	PLOS ONE			English	Article							12-YEAR-OLD CHILDREN BORN; BREAST-CANCER; RISK-FACTORS; GESTATIONAL HYPERTENSION; PREMATURE ADRENARCHE; BLOOD-PRESSURE; HORMONE-LEVELS; BODY-SIZE; PREGNANCY; WOMEN	Background Children born after preeclampsia may have a dominant androgen profile in puberty compared with other children. Circulating androgen concentrations at 11-12 years of age were compared between offspring born after preeclampsia, and children whose mothers did not have preeclampsia. Methods A total of 611 mother-offspring pairs were followed up 11 (daughters) or 12 (sons) years after birth:218 pairs in the preeclampsia group, and 383 pairs without preeclampsia. Circulating total testosterone, androstenedione, dehydroepiandrosterone sulfate (DHEAS), and insulin-like growth factor I (IGF-I) were measured in the children. In boys, testicular volume was also measured. Results Among girls born after preeclampsia, DHEAS concentrations were higher than in unexposed girls (p<0.001), however, girls born after preeclampsia with severe features had the lowest DHEAS levels. In contrast, testosterone concentrations were highest in girls born after preeclampsia with severe features, both compared to other girls in the preeclampsia group, and compared to unexposed girls (p<0.001). For boys, testosterone concentrations were higher in the preeclampsia group compared with unexposed boys (p< 0.001), and boys born after preeclampsia with severe features had the lowest concentrations of DHEAS. Compared with unexposed boys, testicular volume (p = 0.015) and IGF-I (p = 0.004) were higher for boys in the preeclampsia group, except for boys in the clinically severe preeclampsia group. Conclusions In utero exposure to preeclampsia is associated with androgen hormonal patterns in early puberty that depend on clinical severity of preeclampsia and sex of the offspring. The hormonal differences may reflect different timing of pubertal development, and may have consequences for future health of the offspring.	[Alsnes, Ingvild V.; Okland, Inger] Stavanger Univ Hosp, Dept Obstet & Gynecol, Stavanger, Norway; [Alsnes, Ingvild V.; Janszky, Imre; Asvold, Bjorn O.; Vatten, Lars J.] NTNU Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth, Trondheim, Norway; [Asvold, Bjorn O.] Univ Trondheim Hosp, St Olavs Hosp, Dept Endocrinol, Trondheim, Norway; [Forman, Michele R.] Univ Texas Austin, Dept Nutr Sci, Austin, TX 78712 USA	Stavanger University Hospital; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Texas System; University of Texas Austin	Alsnes, IV (corresponding author), Stavanger Univ Hosp, Dept Obstet & Gynecol, Stavanger, Norway.; Alsnes, IV (corresponding author), NTNU Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth, Trondheim, Norway.	ingvild.vatten@gmail.com	Vatten, Lars/AAF-9380-2022; Vatten, Lars/AFK-2073-2022	Alsnes, Ingvild Vatten/0000-0002-2136-6664	Stavanger University Hospital; Norwegian University of Science and Technology; Norwegian Research Council	Stavanger University Hospital; Norwegian University of Science and Technology; Norwegian Research Council(Research Council of NorwayEuropean Commission)	This study was supported by grants from Stavanger University Hospital, the Norwegian University of Science and Technology, and the Norwegian Research Council (IVA). These institutions had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsnes IV, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.06.026; Ananth CV, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6564; Auchus RJ, 2004, CLIN ENDOCRINOL, V60, P288, DOI 10.1046/j.1365-2265.2003.01858.x; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; BEROYZ G, 1994, LANCET, V343, P619; Biro FM, 2003, J PEDIATR-US, V142, P643, DOI 10.1067/mpd.2003.244; Davis EF, 2012, PEDIATRICS, V129, pE1552, DOI 10.1542/peds.2011-3093; Ferreira I, 2009, J HYPERTENS, V27, P1955, DOI 10.1097/HJH.0b013e328331b8c6; Forman MR, 2005, CANCER INVEST, V23, P609, DOI 10.1080/07357900500283093; Giles GG, 2003, INT J CANCER, V103, P241, DOI 10.1002/ijc.10810; Goede J, 2011, HORM RES PAEDIAT, V76, P56, DOI 10.1159/000326057; Holl K, 2009, INT J CANCER, V124, P2923, DOI 10.1002/ijc.24312; Ibanez L, 2000, ENDOCR REV, V21, P671, DOI 10.1210/er.21.6.671; Idkowiak J, 2011, EUR J ENDOCRINOL, V165, P189, DOI 10.1530/EJE-11-0223; Juul A, 2011, ARCH DIS CHILD, V96, P703, DOI 10.1136/adc.2010.202028; Kajantie E, 2008, HORM-INT J ENDOCRINO, V7, P101, DOI 10.1007/BF03401501; Kim JS, 2013, ACTA ONCOL, V52, P1643, DOI 10.3109/0284186X.2012.750033; Laivuori H, 1998, J CLIN ENDOCR METAB, V83, P344, DOI 10.1210/jc.83.2.344; Lisonkova S, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.019; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Mouritsen A, 2015, CLIN CHIM ACTA, V450, P370, DOI 10.1016/j.cca.2015.09.020; Mouritsen A, 2013, EUR J ENDOCRINOL, V168, P129, DOI 10.1530/EJE-12-0191; Nechuta S, 2010, CANCER CAUSE CONTROL, V21, P967, DOI 10.1007/s10552-010-9524-7; Odegard RA, 2000, OBSTET GYNECOL, V96, P950, DOI 10.1016/S0029-7844(00)01040-1; Odegard RA, 2000, BRIT J OBSTET GYNAEC, V107, P1410, DOI 10.1111/j.1471-0528.2000.tb11657.x; Ogland B, 2009, ARCH DIS CHILD, V94, P855, DOI 10.1136/adc.2008.150870; Ogland B, 2011, ARCH DIS CHILD, V96, P740, DOI 10.1136/adc.2009.178434; Ogland B, 2010, HORM RES PAEDIAT, V74, P92, DOI 10.1159/000313376; Opdahl S, 2008, BRIT J CANCER, V99, P201, DOI 10.1038/sj.bjc.6604449; Opdahl S, 2012, BRIT J CANCER, V107, P176, DOI 10.1038/bjc.2012.195; Pettersson A, 2008, CANCER RES, V68, P8832, DOI 10.1158/0008-5472.CAN-08-2309; Rich-Edwards JW, 2014, EPIDEMIOL REV, V36, P57, DOI 10.1093/epirev/mxt006; Roberts CL, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000101; Ruder EH, 2010, CANCER CAUSE CONTROL, V21, P1379, DOI 10.1007/s10552-010-9565-y; Sharifzadeh F, 2012, GYNECOL ENDOCRINOL, V28, P834, DOI 10.3109/09513590.2012.683061; Tenhola S, 2003, J CLIN ENDOCR METAB, V88, P1217, DOI 10.1210/jc.2002-020903; Tenhola S, 2002, J PEDIATR-US, V141, P477, DOI 10.1067/mpd.2002.126923; Troisi R, 2003, INT J EPIDEMIOL, V32, P455, DOI 10.1093/ije/dyg094; Troisi R, 2007, CANCER EPIDEM BIOMAR, V16, P1700, DOI 10.1158/1055-9965.EPI-07-0073; Valensise H, 2008, HYPERTENSION, V52, P873, DOI 10.1161/HYPERTENSIONAHA.108.117358; van der Merwe JL, 2010, HYPERTENS PREGNANCY, V29, P457, DOI 10.3109/10641950903572282; Villar J, 2006, AM J OBSTET GYNECOL, V194, P921, DOI 10.1016/j.ajog.2005.10.813; Xue F, 2007, LANCET ONCOL, V8, P1088, DOI 10.1016/S1470-2045(07)70377-7	44	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0167714	10.1371/journal.pone.0167714	http://dx.doi.org/10.1371/journal.pone.0167714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992610	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842600020
J	Hansen, S; Schafer, J; Fechner, K; Czerny, CP; Abd El Wahed, A				Hansen, Soeren; Schaefer, Jenny; Fechner, Kim; Czerny, Claus-Peter; Abd El Wahed, Ahmed			Development of a Recombinase Polymerase Amplification Assay for Rapid Detection of the Mycobacterium avium subsp paratuberculosis	PLoS One			English	Article							CROHNS-DISEASE; DNA; PREVALENCE; SAMPLES; IS900; SHEEP	Background The detection of Mycobacterium avium subsp. paratuberculosis (MAP) infections in ruminants is crucial to control spread among animals and to humans. Cultivation of MAP is seen as the gold standard for detection, although it is very time consuming and labour intensive. In addition, several PCR assays have been developed to detect MAP in around 90 minutes, but these assays required highly sophisticated equipment as well as lengthy and complicated procedure. Methodology/Principal Findings In this study, we have developed a rapid assay for the detection of MAP based on the recombinase polymerase amplification (RPA) assay targeting a MAP specific region, the IS900 gene. The detection limit was 16 DNA molecules in 15 minutes as determined by the probit analysis on eight runs of the plasmid standard. Cross reactivity with other mycobacterial and environmentally associated bacterial strains was not observed. The clinical performance of the MAP RPA assay was tested using 48 MAP-positive and 20 MAP-negative blood, sperm, faecal and tissue samples. All results were compared with reads of a highly sensitive real-time PCR assay. The specificity of the MAP RPA assay was 100%, while the sensitivity was 89.5%. Conclusions/Significance The RPA assay is quicker and much easier to handle than real-time PCR. All RPA reagents were cold-chain independent. Moreover, combining RPA assay with a simple extraction protocol will maximize its use at point of need for rapid detection of MAP.	[Hansen, Soeren; Schaefer, Jenny; Fechner, Kim; Czerny, Claus-Peter; Abd El Wahed, Ahmed] Georg August Univ, Div Microbiol & Anim Hyg, Inst Vet Med, Dept Anim Sci,Fac Agr Sci, Gottingen, Germany	University of Gottingen	Abd El Wahed, A (corresponding author), Georg August Univ, Div Microbiol & Anim Hyg, Inst Vet Med, Dept Anim Sci,Fac Agr Sci, Gottingen, Germany.	abdelwahed@gwdg.de						Angelidou E, 2016, PREV VET MED, V124, P102, DOI 10.1016/j.prevetmed.2015.12.011; Benedictus A, 2008, PREV VET MED, V83, P215, DOI 10.1016/j.prevetmed.2007.07.008; Boyle DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103091; Cheng J, 2005, WORLD J MICROB BIOT, V21, P1175, DOI 10.1007/s11274-005-0809-z; Chi J, 2002, PREV VET MED, V55, P137, DOI 10.1016/S0167-5877(02)00094-6; Daher R., 2015, RECOMBINASE POLYMERA; Daher RK, 2014, CLIN CHEM, V60, P660, DOI 10.1373/clinchem.2013.213504; Dalziel TK., 1913, BRIT MED J, V2; Enosawa M, 2003, J CLIN MICROBIOL, V41, P4359, DOI 10.1128/JCM.41.9.4359-4365.2003; Fechner K, 2015, TRANSBOUNDARY EMERGI; Knosel T, 2009, PATHOL RES PRACT, V205, P223, DOI 10.1016/j.prp.2008.04.018; Lutz S, 2010, LAB CHIP, V10, P887, DOI 10.1039/b921140c; Manning EJB, 2001, REV SCI TECH OIE, V20, P133, DOI 10.20506/rst.20.1.1275; Mendoza JL, 2010, WORLD J GASTROENTERO, V16, P4558, DOI 10.3748/wjg.v16.i36.4558; Mobius P, 2008, VET MICROBIOL, V126, P324, DOI 10.1016/j.vetmic.2007.07.016; Munster P, 2011, VET MICROBIOL, V154, P197, DOI 10.1016/j.vetmic.2011.06.033; Patil KN, 2011, BIOCHEMISTRY-US, V50, P300, DOI 10.1021/bi1018013; Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204; Plain KM, 2014, J CLIN MICROBIOL, V52, P745, DOI 10.1128/JCM.03233-13; Ren H, 2016, MOL CELL PROBE, V30, P122, DOI 10.1016/j.mcp.2016.02.007; Rohrman B, 2015, ANAL CHEM, V87, P1963, DOI 10.1021/ac504365v; Vansnick E, 2004, VET MICROBIOL, V100, P197, DOI 10.1016/j.vetmic.2004.02.006; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Zhong CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016025	24	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168733	10.1371/journal.pone.0168733	http://dx.doi.org/10.1371/journal.pone.0168733			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992571	gold, Green Submitted, Green Published			2022-12-26	WOS:000392842600095
J	Kazmierczak, PM; Todica, A; Gildehaus, FJ; Hirner-Eppeneder, H; Brendel, M; Eschbach, RS; Hellmann, M; Nikolaou, K; Reiser, MF; Wester, HJ; Kropf, S; Rominger, A; Cyran, CC				Kazmierczak, Philipp M.; Todica, Andrei; Gildehaus, Franz-Josef; Hirner-Eppeneder, Heidrun; Brendel, Matthias; Eschbach, Ralf S.; Hellmann, Magdalena; Nikolaou, Konstantin; Reiser, Maximilian F.; Wester, Hans-Juergen; Kropf, Saskia; Rominger, Axel; Cyran, Clemens C.			Ga-68-TRAP-(RGD)(3) Hybrid Imaging for the In Vivo Monitoring of alpha(v)beta(3)-Integrin Expression as Biomarker of Anti-Angiogenic Therapy Effects in Experimental Breast Cancer	PLoS One			English	Article							HUMAN TUMOR XENOGRAFTS; F-18-FDG PET/CT; VEGF; GROWTH; RADIOPHARMACEUTICALS; ANTIBODIES; EFFICACY; MODEL	Objectives To investigate Ga-68-TRAP-(RGD)3 hybrid imaging for the in vivo monitoring of alpha(v)beta(3)-integrin expression as biomarker of anti-angiogenic therapy effects in experimental breast cancer. Materials and Methods Human breast cancer (MDA-MB-231) xenografts were implanted orthotopically into the mammary fat pads of n = 25 SCID mice. Transmission/emission scans (53 min to 90 min after i.v. injection of 20 MBq Ga-68-TRAP-(RGD)3) were performed on a dedicated small animal PET before (day 0, baseline) and after (day 7, follow-up) a 1-week therapy with the VEGF antibody bevacizumab or placebo (imaging cohort n = 13; therapy n = 7, control n = 6). The target-to-background ratio (TBR, VOlmaxtumor/VOlmeanmuscie) served as semiquantitative measure of tumor radiotracer uptake. Unenhanced CT data sets were subsequently acquired for anatomic coregistration and morphology-based tumor response assessments (CT volumetry). The imaging results were validated by multiparametric ex vivo immunohistochemistry (alpha(v)beta(3)-integrin, microvascular density CD31, proliferation Ki-67, apoptosis TUNEL) conducted in a dedicated immunohistochemistry cohort (n = 12). Results Ga-68-TRAP-(RGD)(3) binding was significantly reduced under VEGF inhibition and decreased in all bevacizumab-treated animals (ATBRfollow-up/baseline: therapy-1.07 0.83, control +0.32 1.01, p = 0.022). No intergroup difference in tumor volume development between day 0 and day 7 was observed (Delta TBRvolumetherapy 134 77 pL, AvoluMecontrol 132 56 pL, p = 1.000).Immunohistochemistry revealed a significant reduction of a,133-integrin expression (308 135 vs. 635 325, p = 0.03), microvascular density (CD31, 168 108 vs. 432 70, p = 0.002), proliferation (Ki-67, 5,195 1,002 vs. 7,574 418, p = 0.004) and significantly higher apoptosis (TUNEL, 14,432 1,974 vs. 3,776 1,378, p = 0.002) in the therapy compared to the control group. Conclusions Ga-68-TRAP-(RGD)3 hybrid imaging allows for the in vivo assessment of a,133-integrin expression as biomarker of anti-angiogenic therapy effects in experimental breast cancer.	[Kazmierczak, Philipp M.; Hirner-Eppeneder, Heidrun; Eschbach, Ralf S.; Hellmann, Magdalena; Reiser, Maximilian F.; Cyran, Clemens C.] Ludwig Maximilians Univ Munchen, Hosp Munich, Inst Clin Radiol, Expt Radiol Lab, Munich, Germany; [Todica, Andrei; Gildehaus, Franz-Josef; Brendel, Matthias; Rominger, Axel] Ludwig Maximilians Univ Munchen, Hosp Munich, Dept Nucl Med, Munich, Germany; [Nikolaou, Konstantin] Univ Hosp Tubingen, Dept Diagnost & Intervent Radiol, Tubingen, Germany; [Wester, Hans-Juergen] Tech Univ Munich, Lehrstuhl Pharmazeut Radiochem, D-80290 Munich, Germany; [Kropf, Saskia] SCINTOMICS GmbH, Furstenfeldbruck, Germany	University of Munich; University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Technical University of Munich	Kazmierczak, PM (corresponding author), Ludwig Maximilians Univ Munchen, Hosp Munich, Inst Clin Radiol, Expt Radiol Lab, Munich, Germany.	philipp.kazmierczak@med.lmu.de	Rominger, Axel/K-5891-2019	Rominger, Axel/0000-0002-1954-736X	German Federal Ministry of Education and Research (BMBF) [01EX1021X]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was funded by the German Federal Ministry of Education and Research (BMBF, www.bmbf.de) Excellence Cluster M4 (01EX1021X) (received by CCC and KN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study received no funding from Scintomics GmbH.	Arjaans M., 2016, ONCOTARGET; Bagri A, 2010, CLIN CANCER RES, V16, P3887, DOI 10.1158/1078-0432.CCR-09-3100; Beer AJ, 2014, JACC-CARDIOVASC IMAG, V7, P178, DOI 10.1016/j.jcmg.2013.12.003; Byzova TV, 2000, MOL CELL, V6, P851, DOI 10.1016/S1097-2765(05)00076-6; Camacho X, 2013, ONCOLOGY-BASEL, V84, P200, DOI 10.1159/000338961; Chen HJ, 2016, THERANOSTICS, V6, P78, DOI 10.7150/thno.13242; Gaertner FC, 2010, Q J NUCL MED MOL IMA; Gerber HP, 2007, P NATL ACAD SCI USA, V104, P3478, DOI 10.1073/pnas.0611492104; Gulyas B, 2012, Q J NUCL MED MOL IM, V56, P173; Heijmen L, 2014, CONTRAST MEDIA MOL I, V9, P237, DOI 10.1002/cmmi.1564; Hollanders K, 2015, CURR EYE RES, V40, P611, DOI 10.3109/02713683.2014.943910; Kazmierczak PM, 2014, RADIOLOGE, V54, P117, DOI 10.1007/s00117-013-2547-9; Kazmierczak PM, 2016, INVEST RADIOL; Kenny LM, 2008, J NUCL MED, V49, P879, DOI 10.2967/jnumed.107.049452; Laitinen I, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-38; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Lopez-Rodriguez V, 2016, J NUCL MED, V57, P404, DOI 10.2967/jnumed.115.161653; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Morgan RA, 2012, MOL THER, V20, P882, DOI 10.1038/mt.2012.73; Notni J, 2013, NUCL MED BIOL, V40, P33, DOI 10.1016/j.nucmedbio.2012.08.006; Notni J, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-28; Notni J, 2011, CHEM-EUR J, V17, P14718, DOI 10.1002/chem.201103503; Rahbar K, 2016, J NUCL MED, V57, P563, DOI 10.2967/jnumed.115.169243; Roland CL, 2009, MOL CANCER THER, V8, P1761, DOI 10.1158/1535-7163.MCT-09-0280; Rylova SN, 2014, J NUCL MED, V55, P1878, DOI 10.2967/jnumed.114.137570; Santhanam P, 2015, EUR J NUCL MED MOL I, V42, P1144, DOI 10.1007/s00259-015-3027-4; Seguin L, 2015, TRENDS CELL BIOL, V25, P234, DOI 10.1016/j.tcb.2014.12.006; Shi JY, 2014, MOL PHARMACEUT, V11, P3915, DOI 10.1021/mp5003202; Spicks C, 2016, J NUCL MED, V57, P420, DOI 10.2967/jnumed.115.158808; Taherian A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-293; Wang H, 2016, RADIOLOGY; Withofs N, 2015, J NUCL MED, V56, P361, DOI 10.2967/jnumed.114.149021; Yoon HJ, 2014, EUR J NUCL MED MOL I, V41, P1534, DOI 10.1007/s00259-014-2744-4; Zhang Wei, 2002, Angiogenesis, V5, P35, DOI 10.1023/A:1021540120521	34	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168248	10.1371/journal.pone.0168248	http://dx.doi.org/10.1371/journal.pone.0168248			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992512	Green Submitted, Green Published, gold			2022-12-26	WOS:000392842600043
J	Kirschmer, N; Bandleon, S; von Ehrlich-Treuenstatt, V; Hartmann, S; Schaaf, A; Lamprecht, AK; Miranda-Laferte, E; Langsenlehner, T; Ritter, O; Eder, P				Kirschmer, Nadine; Bandleon, Sandra; von Ehrlich-Treuenstaett, Viktor; Hartmann, Sonja; Schaaf, Alice; Lamprecht, Anna-Karina; Miranda-Laferte, Erick; Langsenlehner, Tanja; Ritter, Oliver; Eder, Petra			TRPC4 alpha and TRPC4 beta Similarly Affect Neonatal Cardiomyocyte Survival during Chronic GPCR Stimulation	PLoS One			English	Article							PATHOLOGICAL CARDIAC-HYPERTROPHY; RAT VENTRICULAR MYOCYTES; CA2+ CHANNELS; TRPC CHANNELS; SARCOPLASMIC-RETICULUM; HEART-FAILURE; HEK293 CELLS; ACTIVATION; EXPRESSION; LOCALIZATION	The Transient Receptor Potential Channel Subunit 4 (TRPC4) has been considered as a crucial Ca2+ component in cardiomyocytes promoting structural and functional remodeling in the course of pathological cardiac hypertrophy. TRPC4 assembles as homo or hetero-tetramer in the plasma membrane, allowing a non-selective Na+ and Ca2+ influx. Gaq protein coupled receptor (GPCR) stimulation is known to increase TRPC4 channel activity and a TRPC4-mediated Ca2+ influx which has been regarded as ideal Ca2+ source for calcineurin and subsequent nuclear factor of activated T-cells (NFAT) activation. Functional properties of TRPC4 are also based on the expression of the TRPC4 splice variants TRPC4 alpha and TRPC4 beta. Aim of the present study was to analyze cytosolic Ca2+ signals, signaling, hypertrophy and vitality of cardiomyocytes in dependence on the expression level of either TRPC4 alpha or TRPC4 beta. The analysis of Ca2+ transients in neonatal rat cardiomyocytes (NRCs) showed that TRPC4 alpha and TRPC4 beta affected Ca2+ cycling in beating cardiomyocytes with both splice variants inducing an elevation of the Ca2+ transient amplitude at baseline and TRPC4 beta increasing the Ca2+ peak during angiotensin II (Ang II) stimulation. NRCs infected with TRPC4 beta (Ad-CV) also responded with a sustained Ca2+ influx when treated with Ang II under non-pacing conditions. Consistent with the Ca2+ data, NRCs infected with TRPC4 alpha (Ad-C4 beta) showed an elevated calcineurin/NFAT activity and a baseline hypertrophic phenotype but did not further develop hypertrophy during chronic Ang II/phenylephrine stimulation. Down-regulation of endogenous TRPC4 alpha reversed these effects, resulting in less hypertrophy of NRCs at baseline but a markedly increased hypertrophic enlargement after chronic agonist stimulation. Ad-CV NRCs did not exhibit baseline calcineurin/NFAT activity or hypertrophy but responded with an increased calcineurin/NFAT activity after GPCR stimulation. However, this effect was not translated into an increased propensity towards hypertrophy but rather less hypertrophy during GPCR stimulation. Further analyses revealed that, although hypertrophy was preserved in Ad-C4 alpha NRCs and even attenuated in Ad-C4 beta NRCs, cardiomyocytes had an increased apoptosis rate and thus were less viable after chronic GPCR stimulation. These findings suggest that TRPC4 alpha and TRPC4 beta differentially affect Ca2+ signals, calcineurin/NFAT signaling and hypertrophy but similarly impair cardiomyocyte viability during GPCR stimulation.	[Kirschmer, Nadine; Bandleon, Sandra; von Ehrlich-Treuenstaett, Viktor; Schaaf, Alice; Lamprecht, Anna-Karina; Eder, Petra] Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany; [Kirschmer, Nadine; Bandleon, Sandra; von Ehrlich-Treuenstaett, Viktor; Schaaf, Alice; Lamprecht, Anna-Karina; Eder, Petra] Univ Hosp Wurzburg, Comprehens Heart Failure Ctr Wurzburg, Wurzburg, Germany; [Hartmann, Sonja] Univ Florida, Dept Pharmaceut, Ctr Pharmacometr & Syst Pharmacol, Coll Pharm, Orlando, FL USA; [Miranda-Laferte, Erick] Univ Wurzburg, Inst Physiol, Wurzburg, Germany; [Langsenlehner, Tanja] Med Univ Graz, Dept Therapeut Radiol & Oncol, Graz, Austria; [Ritter, Oliver] Univ Hosp Brandenburg, Brandenburg Med Sch, Dept Cardiol & Pulmol, Brandenburg, Germany	University of Wurzburg; University of Wurzburg; State University System of Florida; University of Florida; University of Wurzburg; Medical University of Graz	Eder, P (corresponding author), Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany.; Eder, P (corresponding author), Univ Hosp Wurzburg, Comprehens Heart Failure Ctr Wurzburg, Wurzburg, Germany.	Eder_P@ukw.de			Bundesministerium fur Bildung and Forschung, Germany [01E01004, 01E01504]; Deutsche Forschungsgemeinschaft [ED 266/1-1]	Bundesministerium fur Bildung and Forschung, Germany(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Support was provided by the Bundesministerium fur Bildung and Forschung, Germany: 01E01004 (NK, SB, AS, PE) and 01E01504 (SB, AS, PE) and the Deutsche Forschungsgemeinschaft: ED 266/1-1 (PE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140; BASSANI RA, 1995, BIOPHYS J, V68, P2015, DOI 10.1016/S0006-3495(95)80378-4; Brenner JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000802; Bush EW, 2006, J BIOL CHEM, V281, P33487, DOI 10.1074/jbc.M605536200; Camors E, 2012, J MOL CELL CARDIOL, V52, P1240, DOI 10.1016/j.yjmcc.2012.02.010; Cooley N, 2014, MOL PHARMACOL, V86, P399, DOI 10.1124/mol.114.093690; Correll RN, 2014, CIRC RES, V114, P249, DOI 10.1161/CIRCRESAHA.114.302293; De Windt LJ, 2000, CIRC RES, V86, P255, DOI 10.1161/01.RES.86.3.255; Dietrich A, 2003, J BIOL CHEM, V278, P47842, DOI 10.1074/jbc.M302983200; Eder P, 2007, CARDIOVASC RES, V73, P111, DOI 10.1016/j.cardiores.2006.10.016; Eder P, 2011, CIRC RES, V108, P265, DOI 10.1161/CIRCRESAHA.110.225888; Freichel M, 2014, HANDB EXP PHARMACOL, V222, P85, DOI 10.1007/978-3-642-54215-2_5; Gao H, 2012, J MOL CELL CARDIOL, V53, P657, DOI 10.1016/j.yjmcc.2012.08.005; Gorbe A, 2010, BASIC RES CARDIOL, V105, P643, DOI 10.1007/s00395-010-0097-0; He LP, 2005, J BIOL CHEM, V280, P10997, DOI 10.1074/jbc.M411797200; Jiang Y, 2014, CELL TISSUE RES, V355, P201, DOI 10.1007/s00441-013-1733-4; Kuwahara K, 2006, J CLIN INVEST, V116, P3114, DOI 10.1172/JCI27702; Li HL, 2010, J BIOL CHEM, V285, P39171, DOI 10.1074/jbc.M110.149690; Liu QH, 2006, MOL CELL BIOL, V26, P3785, DOI 10.1128/MCB.26.10.3785-3797.2006; Liu QH, 2012, CIRC RES, V110, P1077, DOI 10.1161/CIRCRESAHA.111.260729; Londono JEC, 2015, EUR HEART J, V36, P2257, DOI 10.1093/eurheartj/ehv250; Makarewich CA, 2014, CIRC RES, V115, P567, DOI 10.1161/CIRCRESAHA.115.303831; McKay RR, 2000, BIOCHEM J, V351, P735, DOI 10.1042/0264-6021:3510735; Mery L, 2002, J CELL SCI, V115, P3497; Nakayama H, 2006, FASEB J, V20, P1660, DOI 10.1096/fj.05-5560com; Obukhov AG, 2004, J CELL PHYSIOL, V201, P227, DOI 10.1002/jcp.20057; Otsuguro KI, 2008, J BIOL CHEM, V283, P10026, DOI 10.1074/jbc.M707306200; Sabourin J, 2016, J BIOL CHEM, V291, P13394, DOI 10.1074/jbc.M115.693911; Saito S, 2000, J BIOL CHEM, V275, P34528, DOI 10.1074/jbc.M002844200; Satoh S, 2007, MOL CELL BIOCHEM, V294, P205, DOI 10.1007/s11010-006-9261-0; Schaefer M, 2002, J BIOL CHEM, V277, P3752, DOI 10.1074/jbc.M109850200; Seth M, 2009, CIRC RES, V105, P1023, DOI 10.1161/CIRCRESAHA.109.206581; Wu X, 2010, P NATL ACAD SCI USA, V107, P7000, DOI 10.1073/pnas.1001825107; Yamada H, 2000, NEUROSCI LETT, V285, P111, DOI 10.1016/S0304-3940(00)01033-8; Zitt C, 2004, J BIOL CHEM, V279, P12427, DOI 10.1074/jbc.M309297200	35	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168446	10.1371/journal.pone.0168446	http://dx.doi.org/10.1371/journal.pone.0168446			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992507	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842600058
J	Kotov, AA; Karabanov, DP; Bekker, EI; Neretina, TV; Taylor, DJ				Kotov, Alexey A.; Karabanov, Dmitry P.; Bekker, Eugeniya I.; Neretina, Tatiana V.; Taylor, Derek J.			Phylogeography of the Chydorus sphaericus Group (Cladocera: Chydoridae) in the Northern Palearctic	PLOS ONE			English	Article							POPULATION-GROWTH; SPECIES CLADOCERA; DAPHNIA-MAGNA; N-SP; CRUSTACEA; ANOMOPODA; BRANCHIOPODA; ORIGIN; GENUS; DIVERSIFICATION	The biodiversity and the biogeography are still poorly understood for freshwater invertebrates. The crustacean Chydorus sphaericus-brevilabris complex (Cladocera: Chydoridae) is composed of species that are important components of Holarctic freshwater food webs. Recent morphological and genetic study of the complex has indicated a substantial species diversity in the northern hemisphere. However, we know little of the geographic boundaries of these novel lineages. Moreover, a large section of the Palearctic remains unexamined at the genetic level. Here we attempt to address the biodiversity knowledge gap for the Chydorus sphaericus group in the central Palearctic and assess its diversity and biogeographic boundaries. We sequenced nuclear (ITS-2) and mitochondrial (COI) gene regions of Chydorus specimens across the Palearctic and compared them with already available Holarctic sequences. We detected six main clades in the C. sphaericus group in the Palearctic, of which two of the groups are novel. Three of the more divergent clades are geographically widespread. The central portion of Eurasia (the Yenisey River basin) appears to be a narrow zone of secondary contact for phylogroups that expanded from European and Beringian refugia. As such, the previously unsampled central Palearctic represents an important region for understanding the evolutionary consequences of Pleistocene climatic oscillations on the Chydorus sphaericus group.	[Kotov, Alexey A.; Karabanov, Dmitry P.; Bekker, Eugeniya I.] Russian Acad Sci, Lab Aquat Ecol & Invas, AN Severtsov Inst Ecol & Evolut, Moscow, Russia; [Karabanov, Dmitry P.] Russian Acad Sci, Yaroslavl Area, Lab Fish Ecol, ID Papanin Inst Biol Inland Waters, Borok, Russia; [Neretina, Tatiana V.] Moscow MV Lomonosov State Univ, Fac Biol, White Sea Biol Stn, Moscow, Russia; [Taylor, Derek J.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY USA	Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Severtsov Institute of Ecology & Evolution; Papanin Institute for Biology of Inland Waters; Russian Academy of Sciences; Lomonosov Moscow State University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Kotov, AA (corresponding author), Russian Acad Sci, Lab Aquat Ecol & Invas, AN Severtsov Inst Ecol & Evolut, Moscow, Russia.	alexey-a-kotov@yandex.ru	Kotov, Alexey A./B-1549-2010; Karabanov, Dmitry/F-3779-2011; Bekker, Eugeniya/M-6955-2016; Neretina, Tatiana Vladimirovna/O-3724-2016	Kotov, Alexey A./0000-0002-8863-6438; Karabanov, Dmitry/0000-0001-6008-7441; Bekker, Eugeniya/0000-0001-6425-7727; 	Russian Science Foundation [14-14-0078]; Directorate For Geosciences [1023334] Funding Source: National Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The work of AAK, DPK and EIB was supported by the Russian Science Foundation grant 14-14-0078. TVN and DJT received no specific funding for their work.	Adamowicz SJ, 2009, MOL PHYLOGENET EVOL, V50, P423, DOI 10.1016/j.ympev.2008.11.026; ALONSO M, 1990, J CRUSTACEAN BIOL, V10, P148, DOI 10.2307/1548678; Alonso M., 1996, CRUSTACEA BRANCHIOPO, V7; Andreicheva LN, 2007, STRATIGR GEO CORREL+, V15, P421, DOI 10.1134/S0869593807040065; Astakhov V.I., 2006, BOREAS, V35, P607, DOI DOI 10.1111/J.1502-3885.2006.TB01167.X; Astakhov VI, 2013, BOREAS, V42, P1, DOI 10.1111/j.1502-3885.2012.00269.x; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bekker EI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161737; Bekker EI, 2012, ZOOTAXA, P1; Bekker EI, 2014, ZOOTAXA, V3895, P297, DOI 10.11646/zootaxa.3895.2.11; Belyaeva M, 2009, MOL PHYLOGENET EVOL, V50, P534, DOI 10.1016/j.ympev.2008.11.007; BENZIE JAH, 1987, HYDROBIOLOGIA, V145, P51, DOI 10.1007/BF02530265; Birge E. A., 1893, T WISC ACAD SCI, V9, P275; Bolotov IN, 2016, HYDROBIOLOGIA; Chen Shouzhong, 1984, Acta Hydrobiologica Sinica, V8, P341; CHENGALATH R, 1981, T AM MICROSC SOC, V100, P229, DOI 10.2307/3225548; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; Crease TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046620; Daday E, 1898, TERMTUD FUZ, V21, P1, DOI DOI 10.5962/BHL.TITLE.114901; Daday EV., 1905, ZOOLOGICA STUTTGART, V44, P1; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; deWaard JR, 2006, MOL PHYLOGENET EVOL, V39, P491, DOI 10.1016/j.ympev.2005.11.003; Dlouha S, 2010, HYDROBIOLOGIA, V643, P107, DOI 10.1007/s10750-010-0128-8; Ehlers J, 2008, EPISODES, V31, P211, DOI 10.18814/epiiugs/2008/v31i2/004; Elias-Gutierrez M, 2008, ZOOTAXA, P1; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Flossner D., 1972, Tierwelt Deutschlands, V60, P1; Flossner D, 2000, HAPLOPODA CLADOCERA; Forro L, 2008, HYDROBIOLOGIA, V595, P177, DOI 10.1007/s10750-007-9013-5; Frey D.G., 1986, Crustacean Issues, V4, P237; FREY DG, 1980, HYDROBIOLOGIA, V69, P83, DOI 10.1007/BF00016540; FREY DG, 1982, HYDROBIOLOGIA, V93, P255, DOI 10.1007/BF00012335; FREY DG, 1982, ECOLOGY, V63, P223; FREY DG, 1987, HYDROBIOLOGIA, V145, P5, DOI 10.1007/BF02530260; FREY DG, 1982, ARCH HYDROBIOL, V93, P484; FREY DG, 1982, CAN J ZOOL, V60, P1892, DOI 10.1139/z82-246; FREY DG, 1985, INT REV GES HYDROBIO, V70, P3; FREY DG, 1987, PHILOS T ROY SOC B, V315, P353, DOI 10.1098/rstb.1987.0012; FREY DG, 1982, HYDROBIOLOGIA, V86, P231, DOI 10.1007/BF00006141; FRYER G, 1972, ZOOL J LINN SOC-LOND, V51, P79, DOI 10.1111/j.1096-3642.1972.tb00774.x; FRYER G, 1995, HYDROBIOLOGIA, V307, P57, DOI 10.1007/BF00031997; Fu YX, 1997, GENETICS, V147, P915; Galimov Y, 2011, J EVOLUTION BIOL, V24, P1572, DOI 10.1111/j.1420-9101.2011.02288.x; Hebert PDN, 2007, LIMNOL OCEANOGR, V52, P2507, DOI 10.4319/lo.2007.52.6.2507; Henry M, 1919, J P ROYAL SOC NEW S, V52, P463; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt Godfrey M., 2004, Frontiers in Zoology, V1, P1, DOI 10.1186/1742-9994-1-4; Ho SYW, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0194; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Hudec I., 2010, FAUNA SLOVENSKA, V3; Incagnone G, 2015, HYDROBIOLOGIA, V750, P103, DOI 10.1007/s10750-014-2110-3; Ishida S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-52; Ishida S, 2007, MOL ECOL, V16, P569, DOI 10.1111/j.1365-294X.2006.03160.x; Ishida S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-209; Jeffery Nicholas W., 2011, PLoS ONE, V6, P1; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; King R.L., 1853, P ROYAL SOC VAN DIEM, V2, P253; Klimovsky AI, 2015, ZOOL ZH, V94, P1367, DOI 10.7868/S0044513415120077; Klimovsky AI, 2015, ZOOL ZH, V94, P1257, DOI 10.7868/S0044513415110057; Korosi JB, 2012, J PALEOLIMNOL, V48, P587, DOI 10.1007/s10933-012-9636-z; Korovchinsky, 2004, CLADOCERANS ORDER CT; Korovchinsky NM, 2006, ZOOL J LINN SOC-LOND, V147, P109, DOI 10.1111/j.1096-3642.2006.00217.x; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Kotov AA, 2016, ZOOL ZH, V95, P748, DOI 10.7868/S0044513416070059; Kotov AA, 2007, J NAT HIST, V41, P13, DOI 10.1080/00222930601164445; Kotov AA, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-129; Kotov AA, 2009, ZOOL J LINN SOC-LOND, V156, P1, DOI 10.1111/j.1096-3642.2008.00475.x; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Leach WE, 1816, ENCY BRITANNICA 2, P401; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Litvinchuk LF, 2016, ARCH BIOL SCI, V68, P67, DOI 10.2298/ABS150505010L; Mangerud J, 2001, J QUATERNARY SCI, V16, P773, DOI 10.1002/jqs.661; Millette KL, 2011, LIMNOL OCEANOGR, V56, P1725, DOI 10.4319/lo.2011.56.5.1725; Molak M, 2015, PEERJ, V3, DOI 10.7717/peerj.821; Muller O.F., 1776, ZOOLOGIE DANICAE PRO; Novichkova AA, 2016, J NAT HIST, V50, P1357, DOI 10.1080/00222933.2015.1113319; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Omilian AR, 2001, MOL BIOL EVOL, V18, P2201, DOI 10.1093/oxfordjournals.molbev.a003767; Ortells R, 2014, HYDROBIOLOGIA, V723, P167, DOI 10.1007/s10750-013-1593-7; PAGGI J C, 1972, Physis (Buenos Aires), V31, P223; Petrusek A, 2004, HYDROBIOLOGIA, V526, P73, DOI 10.1023/B:HYDR.0000041612.08425.f0; Petrusek A, 2012, LIMNOL OCEANOGR, V57, P1838, DOI 10.4319/lo.2012.57.6.1838; Poggenpol M, 1874, IZVESTIYA IMPERATORS, V10, P69; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Prosser S, 2013, MOL ECOL RESOUR, V13, P1151, DOI 10.1111/1755-0998.12132; RAJAPAKSA R, 1986, CAN J ZOOL, V64, P818, DOI 10.1139/z86-123; REMINGTON C L, 1968, Evolutionary Biology (New York), P321; ROEN U, 1987, HYDROBIOLOGIA, V145, P125, DOI 10.1007/BF02530272; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sacherova V, 2003, BIOL J LINN SOC, V79, P629, DOI 10.1046/j.1095-8312.2003.00216.x; Sars G.O., 1890, FORHANDLINGER VIDENS, V1, P1; Sars G.O., 1901, ARCH MATH NATURVIDEN, VXXIII, P1; Schodler J.E., 1862, JAHRESBERICHT DOROTH, V1862, P1; SCHWENK K, 1993, MOL BIOL EVOL, V10, P1289; Sharma P, 2015, J LIMNOL, V74, P225, DOI 10.4081/jlimnol.2014.1037; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smirnov NN, 2010, ZOOL ZH, V89, P635; Smirnov N.N., 1971, FAUNA SSSR R, V1, P1; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Stingelin T, 1905, ZOOL JB SYST OKOL GE, V21, P327; Svendsen JI, 2004, QUATERNARY SCI REV, V23, P1229, DOI 10.1016/j.quascirev.2003.12.008; Swofford D., 2003, PHYLOGENETIC ANAL US; Szeroczynska K., 2007, ATLAS SUBFOSSIL CLAD; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Taylor DJ, 2002, LIMNOL OCEANOGR, V47, P1486, DOI 10.4319/lo.2002.47.5.1486; Tsvetkov A.A., 1990, INT GEOL REV, V32, P1202; Van Damme K, 2010, BRAZ J BIOL, V70, P755, DOI 10.1590/S1519-69842010000400008; Wooller MJ, 2015, QUATERNARY SCI REV, V120, P118, DOI 10.1016/j.quascirev.2015.04.027; Xu S, 2009, MOL ECOL, V18, P5161, DOI 10.1111/j.1365-294X.2009.04422.x; Xu S, 2013, MOL ECOL, V22, P4549, DOI 10.1111/mec.12407; Zuykova EI, 2016, RUSS J GENET+, V52, P585, DOI 10.1134/S102279541604013X; Zuykova EI, 2013, HYDROBIOLOGIA, V715, P135, DOI 10.1007/s10750-012-1423-3; [No title captured]	119	55	61	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168711	10.1371/journal.pone.0168711	http://dx.doi.org/10.1371/journal.pone.0168711			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992559	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842600092
J	Marco-Mendez, C; Wessel, C; Scheffel, W; Ferrero-Vicente, L; Fernandez-Torquemada, Y; Cebrian, J; Heck, KL; Sanchez-Lizaso, JL				Marco-Mendez, Candela; Wessel, Caitlin; Scheffel, Whitney; Ferrero-Vicente, Luis; Fernandez-Torquemada, Yolanda; Cebrian, Just; Heck, Kenneth L.; Luis Sanchez-Lizaso, Jose			Lack of Impact of Posidonia oceanica Leaf Nutrient Enrichment on Sarpa salpa Herbivory: Additional Evidence for the Generalist Consumer Behavior of This Cornerstone Mediterranean Herbivore	PLOS ONE			English	Article							TURTLEGRASS THALASSIA-TESTUDINUM; FISH HERBIVORY; TROPHIC ROLE; SEA-URCHINS; PATCH SIZE; SEAGRASS; RESPONSES; MEADOW; CONSUMPTION; PATTERNS	The fish Sarpa salpa (L.) is one of the main macroherbivores in the western Mediterranean. Through direct and indirect mechanisms, this herbivore can exert significant control on the structure and functional dynamics of seagrass beds and macroalgae. Past research has suggested nutritional quality of their diet influences S. salpa herbivory, with the fish feeding more intensively and exerting greater top down control on macrophytes with higher internal nutrient contents. However recent findings have questioned this notion and shown that herbivores do not preferentially feed on macrophytes with higher nutrient contents, but rather feed on a wide variety of them with no apparent selectivity. To contribute to this debate, we conducted a field fertilization experiment where we enriched leaves of the seagrass Posidonia oceanica, a staple diet for S. salpa, and examined the response by the herbivore. These responses included quantification of leaf consumption in fertilized and non-fertilized/control plots within the bed, and food choice assays where fertilized and non-fertilized/control leaves were simultaneously offered to the herbivore. Despite the duration of leaf exposure to herbivores (30 days) and abundant schools of S. salpa observed around the plots, leaf consumption was generally low in the plots examined. Consumption was not higher on fertilized than on non-fertilized leaves. Food choice experiments did not show strong evidence for selectivity of enriched leaves. These results add to a recent body of work reporting a broad generalist feeding behavior by S. salpa with no clear selectivity for seagrass with higher nutrient content. In concert, this and other studies suggest S. salpa is often generalist consumers not only dictated by diet nutrient content but by complex interactions between other traits of nutritional quality, habitat heterogeneity within their ample foraging area, and responses to predation risk.	[Marco-Mendez, Candela; Ferrero-Vicente, Luis; Fernandez-Torquemada, Yolanda; Luis Sanchez-Lizaso, Jose] Univ Alicante, Dept Marine Sci & Appl Biol, Alicante, Spain; [Marco-Mendez, Candela; Ferrero-Vicente, Luis] Marine Res Ctr Santa Pola CIMAR, Alicante, Spain; [Wessel, Caitlin; Scheffel, Whitney; Cebrian, Just; Heck, Kenneth L.] Dauphin Isl Sea Lab, Dauphin Isl, AL USA; [Wessel, Caitlin; Scheffel, Whitney; Cebrian, Just; Heck, Kenneth L.] Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA	Universitat d'Alacant; Dauphin Island Sea Lab; University of South Alabama	Marco-Mendez, C (corresponding author), Univ Alicante, Dept Marine Sci & Appl Biol, Alicante, Spain.; Marco-Mendez, C (corresponding author), Marine Res Ctr Santa Pola CIMAR, Alicante, Spain.	candela.marco@ua.es	Lizaso, José Luis L Sánchez/J-4939-2017; Fernández-Torquemada, Yolanda/C-4289-2015; MARCO-MENDEZ, CANDELA/AGZ-0310-2022	Lizaso, José Luis L Sánchez/0000-0002-3927-5699; Fernández-Torquemada, Yolanda/0000-0003-0533-4109; Marco-Mendez, Candela/0000-0003-4278-5363	Department of Marine Science and Applied Biology (University of Alicante); University of South Alabama (Alabama, USA)	Department of Marine Science and Applied Biology (University of Alicante); University of South Alabama (Alabama, USA)	This research was co-funded by the Department of Marine Science and Applied Biology (University of Alicante) and the University of South Alabama (Alabama, USA) in a collaborative agreement.	Alcoverro T, 2004, ECOGRAPHY, V27, P361, DOI 10.1111/j.0906-7590.2004.03736.x; Alcoverro T, 1997, AQUAT BOT, V56, P93, DOI 10.1016/S0304-3770(96)01098-4; Alcoverro T, 2000, MAR ECOL PROG SER, V194, P13, DOI 10.3354/meps194013; Boudouresque CF, 1982, DECOUVERTE HERBIER P, P79; Bowman J, 2002, CONSERV ECOL, V6; Bukovinszky T, 2005, OIKOS, V109, P435, DOI 10.1111/j.0030-1299.2005.13707.x; CAMP DK, 1973, BIOSCIENCE, V23, P37, DOI 10.2307/1296366; Cebrian J, 1996, MAR ECOL PROG SER, V130, P147, DOI 10.3354/meps130147; Cebrian J, 2004, AQUAT ECOL SER, V2, P153; Cebrian J, 1998, AQUAT BOT, V60, P67, DOI 10.1016/S0304-3770(97)00070-3; Cohen J.E., 1988, STAT POWER ANAL BEHA; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Cornell HV, 2003, AM NAT, V161, P507, DOI 10.1086/368346; Delgado O, 1997, OCEANOL ACTA, V20, P557; Den Hartog C., 1970, VERH KON NED AKAD WE, V59; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FRITZ RS, 1992, PLANT RESISTANCE HER; Goecker ME, 2005, MAR ECOL PROG SER, V286, P239, DOI 10.3354/meps286239; Goldenberg SU, 2014, J FISH BIOL, V84, P1474, DOI 10.1111/jfb.12371; Havelange S, 1997, MAR ECOL-P S Z N I, V18, P289, DOI 10.1111/j.1439-0485.1997.tb00443.x; Hemminga M.A., 2000, SEAGRASS ECOLOGY, DOI 10.1017/CBO9780511525551; Hughes R.N., 1980, Oceanography and Marine Biology an Annual Review, V18, P423; Jadot C, 2006, ICES J MAR SCI, V63, P128, DOI 10.1016/j.icesjms.2005.06.010; Jadot C, 2002, AQUAT LIVING RESOUR, V15, P343, DOI 10.1016/S0990-7440(02)01193-2; Kirsch KD, 2002, MAR ECOL PROG SER, V227, P71, DOI 10.3354/meps227071; KLUMPP DW, 1993, AQUAT BOT, V45, P205, DOI 10.1016/0304-3770(93)90022-O; KLUMPP DW, 1983, MAR ECOL PROG SER, V12, P207, DOI 10.3354/meps012207; Leoni V, 2006, J EXP MAR BIOL ECOL, V339, P1, DOI 10.1016/j.jembe.2006.05.017; Lizaso JLS, 2000, ENVIRON CONSERV, V27, P144, DOI 10.1017/S0376892900000187; Marco-Mendez C, 2016, ESTUAR COAST SHELF S; Marco-Mendez C, 2015, ESTUAR COAST SHELF S, V154, P94, DOI 10.1016/j.ecss.2014.12.043; Marco-Mendez C, 2012, MAR ECOL PROG SER, V460, P91, DOI 10.3354/meps09781; Mariani S, 1999, MAR ECOL PROG SER, V189, P295, DOI 10.3354/meps189295; MCCLANAHAN TR, 1994, J EXP MAR BIOL ECOL, V184, P237, DOI 10.1016/0022-0981(94)90007-8; MORAN N, 1980, J THEOR BIOL, V86, P247, DOI 10.1016/0022-5193(80)90004-1; PAUL VJ, 1990, MAR ECOL PROG SER, V60, P23, DOI 10.3354/meps060023; Perez M, 2008, MAR POLLUT BULL, V56, P869, DOI 10.1016/j.marpolbul.2008.02.001; Prado P, 2008, MAR ECOL PROG SER, V371, P11, DOI 10.3354/meps07662; Prado P, 2008, MAR ECOL PROG SER, V359, P89, DOI 10.3354/meps07438; Prado P, 2007, MAR ECOL PROG SER, V340, P63, DOI 10.3354/meps340063; Prado P, 2011, MAR BIOL, V158, P1473, DOI 10.1007/s00227-011-1664-0; Prado P, 2010, MAR ECOL PROG SER, V409, P229, DOI 10.3354/meps08585; Romero J., 1989, INT WORKSHOP POSIDON, V2, P85; Ruiz JM, 2010, MAR ENVIRON RES, V69, P118, DOI 10.1016/j.marenvres.2009.09.002; Ruiz JM, 2001, MAR POLLUT BULL, V42, P749, DOI 10.1016/S0025-326X(00)00215-0; Ruiz JM, 2009, BOT MAR; Sparks EL, 2015, ESTUAR COAST, V38, P988, DOI 10.1007/s12237-014-9858-6; Steele L, 2014, ANIM BIODIV CONSERV, V37, P49; Stergiou KI, 2001, REV FISH BIOL FISHER, V11, P217, DOI 10.1023/A:1020556722822; Taylor RB, 2002, OECOLOGIA, V132, P68, DOI 10.1007/s00442-002-0944-2; THAYER GW, 1984, ESTUARIES, V7, P351, DOI 10.2307/1351619; Tomas F, 2005, MAR ECOL PROG SER, V301, P95, DOI 10.3354/meps301095; Tomas F, 2005, MAR ECOL PROG SER, V287, P115, DOI 10.3354/meps287115; Tomas F, 2011, ESTUAR COAST SHELF S, V92, P27, DOI 10.1016/j.ecss.2010.12.004; Tuya F, 2013, MAR ECOL PROG SER, V490, P23, DOI 10.3354/meps10448; Underwood A.J, 1997, EXPT ECOLOGY THEIR L; Verges A, 2007, MAR ECOL PROG SER, V343, P107, DOI 10.3354/meps06885; Verges A, 2011, OECOLOGIA, V166, P381, DOI 10.1007/s00442-010-1830-y; VERLAQUE M, 1990, OCEANOL ACTA, V13, P373; VERMAAT JE, 1995, MAR ECOL PROG SER, V124, P215, DOI 10.3354/meps124215; ZIEMAN JC, 1974, AQUACULTURE, V4, P139, DOI 10.1016/0044-8486(74)90029-5	61	5	5	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168398	10.1371/journal.pone.0168398	http://dx.doi.org/10.1371/journal.pone.0168398			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992498	gold, Green Published			2022-12-26	WOS:000392842600055
J	Liu, QF; Wang, R; Li, RJ; Hu, YX; Guo, SL				Liu, Qingfang; Wang, Rui; Li, Rujian; Hu, Yaxian; Guo, Shengli			Temperature Sensitivity of Soil Respiration to Nitrogen Fertilization: Varying Effects between Growing and Non-Growing Seasons	PLOS ONE			English	Article							LOESS PLATEAU; MICROBIAL ACTIVITY; WATER-CONTENT; RESPONSES; COMMUNITY; QUALITY; BIOMASS; MAIZE	Nitrogen (N) fertilization has a considerable effect on food production and carbon cycling in agro-ecosystems. However, the impacts of N fertilization rates on the temperature sensitivity of soil respiration (Q(10)) were controversial. Five N rates (N0, N45, N90, N135, and N180) were applied to a continuous winter wheat (Triticum aestivum L.) cropon the semi-arid Loess Plateau, and the in situ soil respiration was monitored during five consecutive years from 2008 to 2013. During the growing season, the mean soil respiration rates increased with increasing N fertilization rates, peaking at 1.53 mu mol m(-2) s(-1) in the N135 treatment. A similar dynamic pattern was observed during the non-growing season, yet on average with 7.3% greater soil respiration rates than the growing season. In general for all the N fertilization treatments, the mean Q(10) value during the non-growing season was significantly greater than that during the growing season. As N fertilization rates increased, the Q(10) values did not change significantly in the growing season but significantly decreased in the non-growing season. Overall, N fertilization markedly influenced soil respirations and Q(10) values, in particular posing distinct effects on the Q(10) values between the growing and non-growing seasons.	[Liu, Qingfang; Wang, Rui; Guo, Shengli] Northwest A&F Univ, Coll Resources & Environm, Yangling, Peoples R China; [Li, Rujian; Hu, Yaxian; Guo, Shengli] Northwest A&F Univ, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China; [Hu, Yaxian; Guo, Shengli] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling, Peoples R China; [Hu, Yaxian; Guo, Shengli] Minist Water Resource, Yangling, Peoples R China	Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS	Guo, SL (corresponding author), Northwest A&F Univ, Coll Resources & Environm, Yangling, Peoples R China.; Guo, SL (corresponding author), Northwest A&F Univ, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China.; Guo, SL (corresponding author), Chinese Acad Sci, Inst Soil & Water Conservat, Yangling, Peoples R China.; Guo, SL (corresponding author), Minist Water Resource, Yangling, Peoples R China.	slguo@ms.iswc.ac.cn			Natural Science Foundation of China [41371279]; "Strategic Priority Research Program-Climate Change: Carbon Budget and Related Issues" of the Chinese Academy of Sciences [XDA05050504]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Strategic Priority Research Program-Climate Change: Carbon Budget and Related Issues" of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the Natural Science Foundation of China (No. 41371279) and the "Strategic Priority Research Program-Climate Change: Carbon Budget and Related Issues" of the Chinese Academy of Sciences (Grant No. XDA05050504). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren GI, 2007, SOIL BIOL BIOCHEM, V39, P1794, DOI 10.1016/j.soilbio.2007.02.007; Allison SD, 2008, GLOBAL CHANGE BIOL, V14, P1156, DOI 10.1111/j.1365-2486.2008.01549.x; [Anonymous], 2011, PEOPLES REPUBLIC CHI; Ball BA, 2014, POLAR BIOL, V37, P573, DOI 10.1007/s00300-014-1459-0; Blagodatskaya E, 2010, GLOBAL CHANGE BIOL, V16, P836, DOI 10.1111/j.1365-2486.2009.02006.x; Bosatta E, 1999, SOIL BIOL BIOCHEM, V31, P1889, DOI 10.1016/S0038-0717(99)00105-4; Bowden RD, 2004, FOREST ECOL MANAG, V196, P43, DOI 10.1016/j.foreco.2004.03.011; Chen ST, 2010, AGR FOREST METEOROL, V150, P590, DOI 10.1016/j.agrformet.2010.02.004; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Dietzel R, 2015, CROP SCI, V55, P910, DOI 10.2135/cropsci2014.08.0572; Drenovsky RE, 2004, MICROB ECOL, V48, P424, DOI 10.1007/s00248-003-1063-2; Fan J, 2000, SOIL ENV SCI, V9, P23; Gao HY, 2009, CARBON SEQUESTRATION; Guo SL, 2012, PLANT SOIL, V353, P321, DOI 10.1007/s11104-011-1034-1; Guo ShengLi, 2009, Plant Nutrition and Fertilizer Science, V15, P808; Huang MB, 2003, SOIL TILL RES, V72, P95, DOI 10.1016/S0167-1987(03)00065-5; Huang MB, 2003, AGR WATER MANAGE, V58, P267, DOI 10.1016/S0378-3774(02)00086-0; Huntingford C, 2000, ECOL MODEL, V134, P41, DOI 10.1016/S0304-3800(00)00330-6; Jia XX, 2013, PLANT SOIL, V373, P125, DOI 10.1007/s11104-013-1771-4; Kuzyakov Y, 2010, GLOBAL CHANGE BIOL, V16, P3386, DOI 10.1111/j.1365-2486.2010.02179.x; Li Z, 2010, SCI CHINA EARTH SCI, V53, P710, DOI 10.1007/s11430-009-0186-9; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Lu SJ, 1998, SOIL BIOL BIOCHEM, V30, P331, DOI 10.1016/S0038-0717(97)00134-X; McCulley RL, 2007, SOIL SCI SOC AM J, V71, P820, DOI 10.2136/sssaj2006.0303; Morell FJ, 2010, AGR ECOSYST ENVIRON, V139, P167, DOI 10.1016/j.agee.2010.07.015; Ni K, 2012, J SOIL SEDIMENT, V12, P1007, DOI 10.1007/s11368-012-0529-6; Madelene OA, 2006, LAND USE POLICY, V23, P361, DOI 10.1016/j.landusepol.2005.04.004; Ruan J, 2010, PLANT BIOLOGY, V12, P724, DOI 10.1111/j.1438-8677.2009.00288.x; Tian W, 2015, AGR ECOSYST ENVIRON, V213, P219, DOI 10.1016/j.agee.2015.08.009; van Grinsven HJM, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/2/025002; Wan L, 2014, HYDROL PROCESS, V28, P4971, DOI 10.1002/hyp.9951; Wang XK, 2015, AGR WATER MANAGE, V161, P53, DOI 10.1016/j.agwat.2015.07.019; Xu M, 2001, GLOBAL BIOGEOCHEM CY, V15, P687, DOI 10.1029/2000GB001365; Xu X, 2012, SOIL BIOL BIOCHEM, V50, P142, DOI 10.1016/j.soilbio.2012.03.007; Zhou LY, 2014, GLOBAL CHANGE BIOL, V20, P2332, DOI 10.1111/gcb.12490; Zhou XH, 2009, ECOSYSTEMS, V12, P1369, DOI 10.1007/s10021-009-9296-7	37	8	8	10	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168599	10.1371/journal.pone.0168599	http://dx.doi.org/10.1371/journal.pone.0168599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992576	Green Submitted, Green Published, gold			2022-12-26	WOS:000392758000064
J	Monecke, S; Gavier-Widen, D; Hotzel, H; Peters, M; Guenther, S; Lazaris, A; Loncaric, I; Muller, E; Reissig, A; Ruppelt-Lorz, A; Shore, AC; Walter, B; Coleman, DC; Ehricht, R				Monecke, Stefan; Gavier-Widen, Dolores; Hotzel, Helmut; Peters, Martin; Guenther, Sebastian; Lazaris, Alexandros; Loncaric, Igor; Mueller, Elke; Reissig, Annett; Ruppelt-Lorz, Antje; Shore, Anna C.; Walter, Birgit; Coleman, David C.; Ehricht, Ralf			Diversity of Staphylococcus aureus Isolates in European Wildlife	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; VIRULENCE-ASSOCIATED GENES; METHICILLIN-RESISTANT; MOLECULAR CHARACTERIZATION; MECA HOMOLOG; CLONAL COMPLEXES; ANTIMICROBIAL SUSCEPTIBILITY; ANTIBIOTIC-RESISTANCE; RAPID DETECTION; SLAUGHTER PIGS	Staphylococcus aureus is a well-known colonizer and cause of infection among animals and it has been described from numerous domestic and wild animal species. The aim of the present study was to investigate the molecular epidemiology of S. aureus in a convenience sample of European wildlife and to review what previously has been observed in the subject field. 124 S. aureus isolates were collected from wildlife in Germany, Austria and Sweden; they were characterized by DNA microarray hybridization and, for isolates with novel hybridization patterns, by multilocus sequence typing (MLST). The isolates were assigned to 29 clonal complexes and singleton sequence types (CC1, CC5, CC6, CC7, CC8, CC9, CC12, CC15, CC22, CC25, CC30, CC49, CC59, CC88, CC97, CC130, CC133, CC398, ST425, CC599, CC692, CC707, ST890, CC1956, ST2425, CC2671, ST2691, CC2767 and ST2963), some of which (ST2425, ST2691, ST2963) were not described previously. Resistance rates in wildlife strains were rather low and mecA-MRSA isolates were rare (n = 6). mecC-MRSA (n = 8) were identified from a fox, a fallow deer, hares and hedgehogs. The common cattle-associated lineages CC479 and CC705 were not detected in wildlife in the present study while, in contrast, a third common cattle lineage, CC97, was found to be common among cervids. No Staphylococcus argenteus or Staphylococcus schweitzeri-like isolates were found. Systematic studies are required to monitor the possible transmission of human-and livestock-associated S. aureus/MRSA to wildlife and vice versa as well as the possible transmission, by unprotected contact to animals. The prevalence of S. aureus/MRSA in wildlife as well as its population structures in different wildlife host species warrants further investigation.	[Monecke, Stefan; Ruppelt-Lorz, Antje] Tech Univ Dresden, IMMH, Dresden, Germany; [Monecke, Stefan; Mueller, Elke; Reissig, Annett; Ehricht, Ralf] Alere Technol GmbH, Jena, Germany; [Monecke, Stefan; Mueller, Elke; Reissig, Annett; Ehricht, Ralf] InfectoGnostics Res Campus, Jena, Germany; [Gavier-Widen, Dolores] Natl Vet Inst SVA, Dept Pathol & Wildlife Dis, Uppsala, Sweden; [Gavier-Widen, Dolores] Swedish Univ Agr Sci SLU, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden; [Hotzel, Helmut] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Bacterial Infect & Zoonoses, Jena, Germany; [Peters, Martin] Chem & Veterina Runtersuchungsamt Westfalen, Standort Arnsberg, Arnsberg, Germany; [Guenther, Sebastian; Walter, Birgit] Free Univ Berlin, Fac Vet, Inst Microbiol & Epizoot, Berlin, Germany; [Lazaris, Alexandros; Shore, Anna C.; Coleman, David C.] Univ Dublin, Dublin Dent Univ Hosp, Trinity Coll Dublin, Microbiol Res Unit, Dublin, Ireland; [Loncaric, Igor] Univ Vet Med, Inst Microbiol, Vienna, Austria	Technische Universitat Dresden; Alere; National Veterinary Institute SVA; Swedish University of Agricultural Sciences; Friedrich Loeffler Institute; Free University of Berlin; Trinity College Dublin; University of Veterinary Medicine Vienna	Monecke, S (corresponding author), Tech Univ Dresden, IMMH, Dresden, Germany.; Monecke, S (corresponding author), Alere Technol GmbH, Jena, Germany.; Monecke, S (corresponding author), InfectoGnostics Res Campus, Jena, Germany.	monecke@rocketmail.com	Coleman, David C./C-2008-2009; Guenther, Sebastian/O-5005-2014	Coleman, David C./0000-0003-1797-2888; Hotzel, Helmut/0000-0002-2413-296X; Guenther, Sebastian/0000-0003-0173-7314; Walther, Birgit/0000-0003-3112-5722	EU [222633]; Network "Rodent associated pathogens" (NaUPa-Net) [01KI1018]; German Research Foundation [GU 1283/3-1]; InfectoGnostics Research Campus Jena	EU(European Commission); Network "Rodent associated pathogens" (NaUPa-Net); German Research Foundation(German Research Foundation (DFG)); InfectoGnostics Research Campus Jena	A part of the work (by D. Gavier-Widen and partially by R. Ehricht) was founded by the EU (Wildtech project; EU 7th Framework Program for Research and Technological Development, grant agreement no. 222633), another (by B. Walter and S. Guenther) by the Network "Rodent associated pathogens" (NaUPa-Net Grant 01KI1018). S. Guenther was funded by a Grant of the German Research Foundation (Grant GU 1283/3-1). For the other authors, there was no external funding, and their institutions covered the costs of experiments performed in the respective units and granted the time needed to perform this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the InfectoGnostics Research Campus Jena and Prof. E. Jacobs (IMMH Dresden) for support.	Abbott Y, 2010, VET REC, V166, P451, DOI 10.1136/vr.b4814; Abdel-moein KA, 2012, TRANSBOUND EMERG DIS, V59, P331, DOI 10.1111/j.1865-1682.2011.01273.x; Abdel-Moein KA, 2011, VECTOR-BORNE ZOONOT, V11, P627, DOI 10.1089/vbz.2010.0272; Abdulgader SM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00348; Aklilu E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043329; Akobi B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-279; Alba P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137143; Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Bar-Gal GK, 2015, VET MICROBIOL, V176, P143, DOI 10.1016/j.vetmic.2015.01.007; Basset P, 2013, J HOSP INFECT, V83, P257, DOI 10.1016/j.jhin.2012.12.004; Bath GF, 2011, J S AFR VET ASSOC, V82, P227; Battisti A, 2010, VET MICROBIOL, V142, P361, DOI 10.1016/j.vetmic.2009.10.008; Bengtsson B, 2011, SVARM 2011 SWEDISH V; Blomfeldt A, 2013, J CLIN MICROBIOL, V51, P345, DOI 10.1128/JCM.02571-12; Boost M, 2013, ZOONOSES PUBLIC HLTH, V60, P572, DOI 10.1111/zph.12034; Briscoe JA, 2008, J AVIAN MED SURG, V22, P336, DOI 10.1647/2008-014.1; Budd KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134592; CAMPBELL GA, 1981, J WILDLIFE DIS, V17, P177, DOI 10.7589/0090-3558-17.2.177; Chen CJ, 2007, DIAGN MICR INFEC DIS, V59, P287, DOI 10.1016/j.diagmicrobio.2007.05.015; Chen MMS, 2016, ONE HLTH; CLAUSEN B, 1980, J WILDLIFE DIS, V16, P475, DOI 10.7589/0090-3558-16.4.475; CLSI, 2019, PERFORMANCE STANDARD, V28th edn; COLEMAN D, 1991, MOL MICROBIOL, V5, P933, DOI 10.1111/j.1365-2958.1991.tb00768.x; COLEMAN DC, 1989, J GEN MICROBIOL, V135, P1679; COLGROVE G S, 1976, Journal of Wildlife Diseases, V12, P271; Conceicao T, 2016, MICROB DRUG RESIST, V22, P22, DOI 10.1089/mdr.2015.0236; Porrero MC, 2014, ENV MICROBIOL REP, V6, P705, DOI 10.1111/1758-2229.12191; Porrero MC, 2014, APPL ENVIRON MICROB, V80, P4865, DOI 10.1128/AEM.00647-14; Coombs GW, 2010, ANTIMICROB AGENTS CH, V54, P1914, DOI 10.1128/AAC.01287-09; Coombs GW, 2006, EMERG INFECT DIS, V12, P241; Couto I, 1996, MICROB DRUG RESIST, V2, P377, DOI 10.1089/mdr.1996.2.377; Cui SH, 2009, J ANTIMICROB CHEMOTH, V64, P680, DOI 10.1093/jac/dkp275; Cuny C, 2006, Euro Surveill, V11, P44; Cuny C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024360; Cuny C, 2010, INT J MED MICROBIOL, V300, P109, DOI 10.1016/j.ijmm.2009.11.002; Davis R, 2013, GENOME ANNOUNC, V1; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; de Sousa MA, 2003, J CLIN MICROBIOL, V41, P159, DOI [10.1128/JCM.41.1.159-163.2002, 10.1128/JCM.41.1.159-163.2003]; Drougka E, 2015, OPEN VET J, V5, P148; Ebner R, 2013, J FOOD PROTECT, V76, P1471, DOI 10.4315/0362-028X.JFP-13-009; Egyir B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089716; El-Ashker M, 2015, J DAIRY SCI, V98, P7450, DOI 10.3168/jds.2015-9432; Elbir H, 2010, J INFECT DEV COUNTR, V4, P235, DOI 10.3855/jidc.632; Elstrom P, 2011, NORM VET N; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Eriksson J, 2013, VET MICROBIOL, V163, P110, DOI 10.1016/j.vetmic.2012.12.006; Espinosa-Gongora C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101988; Faires MC, 2009, EMERG INFECT DIS; Fall C, 2012, FOODBORNE PATHOG DIS, V9, P962, DOI 10.1089/fpd.2012.1197; Fessler AT, 2011, APPL ENV MICROBIOL; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Gharsa H, 2015, VECTOR-BORNE ZOONOT, V15, P109, DOI 10.1089/vbz.2014.1655; Gharsa H, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-203; Gharsa H, 2012, VET MICROBIOL, V156, P367, DOI 10.1016/j.vetmic.2011.11.009; Gomez P, 2016, J ANTIMICROB CHEMOTH, V71, P53, DOI 10.1093/jac/dkv314; Gomez P, 2014, J ANTIMICROB CHEMOTH, V69, P2061, DOI 10.1093/jac/dku100; Gomez-Sanz E, 2010, FOODBORNE PATHOG DIS, V7, P1269, DOI 10.1089/fpd.2010.0610; Gonzalez-Candela M, 2006, J WILDLIFE DIS, V42, P325, DOI 10.7589/0090-3558-42.2.325; Guardabassi L, 2009, EMERG INFECT DIS, V15, P1998, DOI 10.3201/eid1512.090378; Guenther S, 2013, ANTIMICROB AGENTS CH, V57, P2424, DOI 10.1128/AAC.02321-12; HAJEK V, 1988, RES VET SCI, V44, P242, DOI 10.1016/S0034-5288(18)30848-8; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Harrison EM, 2013, ANTIMICROB AGENTS CH, V57, P1524, DOI 10.1128/AAC.01882-12; Holtfreter S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071142; Hower S, 2013, MICROB ECOL, V65, P1024, DOI 10.1007/s00248-013-0178-3; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; Hukkanen RR, 2003, COMPARATIVE MED, V53, P548; Ito T, 2012, ANTIMICROB AGENTS CH, V56, P4997, DOI 10.1128/AAC.01199-12; Janssen D., 2009, Morbidity and Mortality Weekly Report, V58, P194; Kaneko J, 1997, BIOSCI BIOTECH BIOCH, V61, P541, DOI 10.1271/bbb.61.541; Kinnevey PM, 2014, ANTIMICROB AGENTS CH, V58, P1907, DOI 10.1128/AAC.02653-13; Kodikara D. S., 1999, Veterinary Ophthalmology, V2, P191; Lahuerta-Marin A, 2016, VET MICROBIOL, V182, P131, DOI 10.1016/j.vetmic.2015.11.019; LAUKOVA A, 1995, VET MED-CZECH, V40, P317; Laurent F, 2012, EMERG INFECT DIS, V18, P1465, DOI 10.3201/eid1809.111920; Li GH, 2015, FOODBORNE PATHOG DIS, V12, P203, DOI 10.1089/fpd.2014.1850; Linares JA, 2001, AVIAN DIS, V45, P1068, DOI 10.2307/1592891; Loncaric I, 2014, VET DERMATOL, V25, P147, DOI 10.1111/vde.12116; Loncaric I, 2014, VET MICROBIOL, V168, P381, DOI 10.1016/j.vetmic.2013.11.022; Loncaric I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084048; Loncaric I, 2013, J ANTIMICROB CHEMOTH, V68, P2222, DOI 10.1093/jac/dkt186; Losito P, 2005, POULTRY SCI, V84, P1802, DOI 10.1093/ps/84.11.1802; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Luedicke C, 2010, EUR J CLIN MICROBIOL, V29, P457, DOI 10.1007/s10096-010-0884-4; Luzzago C, 2014, VET MICROBIOL, V170, P157, DOI 10.1016/j.vetmic.2014.01.016; MARSHALL MM, 1983, J WILDLIFE DIS, V19, P98, DOI 10.7589/0090-3558-19.2.98; McBurney S, 2000, J WILDLIFE DIS, V36, P788, DOI 10.7589/0090-3558-36.4.788; Meemken D, 2013, APPL ENVIRON MICROB, V79, P1739, DOI 10.1128/AEM.03189-12; Monecke S, 2009, EUR J CLIN MICROBIOL, V28, P1159, DOI 10.1007/s10096-009-0752-2; Monecke S, 2014, PLOS ONE; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Monecke S, 2007, VET MICROBIOL, V125, P128, DOI 10.1016/j.vetmic.2007.05.016; Monecke S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162654; Monecke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066166; Monecke S, 2013, J CLIN MICROBIOL, V51, P487, DOI 10.1128/JCM.02285-12; Monecke S, 2013, VET MICROBIOL, V162, P806, DOI 10.1016/j.vetmic.2012.10.018; Monecke S, 2012, ANTIMICROB AGENTS CH, V56, P5547, DOI 10.1128/AAC.00574-12; Monecke S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-146; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Monecke S, 2011, VET MICROBIOL, V150, P309, DOI 10.1016/j.vetmic.2011.02.001; Montgomery JM, 2002, J WILDLIFE DIS, V38, P545, DOI 10.7589/0090-3558-38.3.545; Moon DC, 2015, FOODBORNE PATHOG DIS, V12, P327, DOI 10.1089/fpd.2014.1868; Moremi N, 2012, J INFECT DEV COUNTR, V6, P620, DOI 10.3855/jidc.2093; Neela V, 2009, J CLIN MICROBIOL, V47, P4138, DOI 10.1128/JCM.01363-09; Nowakiewicz A, 2016, COMP IMMUNOL MICROB, V44, P21, DOI 10.1016/j.cimid.2015.11.003; Overesch G, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-30; Paterson GK, 2012, J ANTIMICROB CHEMOTH, V67, P2809, DOI 10.1093/jac/dks329; Petersen A, 2013, CLIN MICROBIOL INFEC, V19, pE16, DOI 10.1111/1469-0691.12036; PLOMMET MG, 1969, J COMP PATHOL, V79, P425, DOI 10.1016/0021-9975(69)90062-0; Porrero MC, 2013, VET J, V198, P127, DOI 10.1016/j.tvjl.2013.06.004; Power E, 2002, VET REC, V150, P819; PRATTIS SM, 1990, LAB ANIM SCI, V40, P402; Pyzik E, 2012, POL J VET SCI, V15, P767, DOI 10.2478/v10181-012-0116-1; Rainard P, 2003, CLIN DIAGN LAB IMMUN, V10, P272, DOI 10.1128/CDLI.10.2.272-277.2003; Robb A, 2013, VET MICROBIOL, V162, P300, DOI 10.1016/j.vetmic.2012.09.003; Robinson DA, 2004, J BACTERIOL, V186, P1060, DOI 10.1128/JB.186.4.1060-1064.2004; Robinson DA, 2005, LANCET, V365, P1256, DOI 10.1016/S0140-6736(05)74814-5; ROUNDTREE P. M., 1958, MED JOUR AUSTRALIA II, V45, P789; RYAN MJ, 1979, J WILDLIFE DIS, V15, P533, DOI 10.7589/0090-3558-15.4.533; Sabat AJ, 2012, J CLIN MICROBIOL, V50, P3374, DOI 10.1128/JCM.01121-12; Sasaki T, 2012, J CLIN MICROBIOL, V50, P2152, DOI 10.1128/JCM.06739-11; Scerri J, 2013, J EPIDEMIOL GLOB HEA, V3, P165, DOI 10.1016/j.jegh.2013.05.003; Schaumburg F, 2012, ENV MICROBIOL REP, V4, P141, DOI 10.1111/j.1758-2229.2011.00316.x; Schaumburg F, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.12.001; Schaumburg F, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0286-3; Schlotter K, 2014, J DAIRY SCI, V97, P2782, DOI 10.3168/jds.2013-7378; Schlotter K, 2013, BERL MUNCH TIERARZTL, V126, P37, DOI 10.2376/0005-9366-126-37; Schlotter K, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-42; Senok A., 2016, New Microbes and New Infections, V14, P13, DOI 10.1016/j.nmni.2016.07.009; Senok A, 2016, INT J INFECT DIS, V51, P31, DOI 10.1016/j.ijid.2016.08.016; Shore AC, 2011, ANTIMICROB AGENTS CH, V55, P3765, DOI 10.1128/AAC.00187-11; Shuiep ES, 2009, RES VET SCI, V86, P211, DOI 10.1016/j.rvsc.2008.07.011; Siebert U, 2002, VET REC, V150, P273, DOI 10.1136/vr.150.9.273; Silvanose CD, 1999, AVIAN PATHOL, V28, P94, DOI 10.1080/03079459995109; Silvanose CD, 2001, AVIAN DIS, V45, P447, DOI 10.2307/1592986; Simpson VR, 2013, VET MICROBIOL, V162, P987, DOI 10.1016/j.vetmic.2012.10.025; Simpson VR, 2010, VET REC, V167, P59, DOI 10.1136/vr.b4887; Sing A, 2008, NEW ENGL J MED, V358, P1200, DOI 10.1056/NEJMc0706805; Siqueira DB, 2010, J ZOO WILDLIFE MED, V41, P526, DOI 10.1638/2009-0079.1; Smith EM, 2014, INFECT GENET EVOL, V22, P208, DOI 10.1016/j.meegid.2013.09.008; SMITH JMB, 1965, J HYG-CAMB, V63, P285, DOI 10.1017/S0022172400045162; Smyth DS, 2009, J MED MICROBIOL, V58, P1343, DOI 10.1099/jmm.0.009837-0; Sousa M, 2014, VET MICROBIOL, V171, P436, DOI 10.1016/j.vetmic.2014.02.034; Stegger M, 2012, CLIN MICROBIOL INFEC, V18, P395, DOI 10.1111/j.1469-0691.2011.03715.x; Strommenger B, 2006, J ANTIMICROB CHEMOTH, V57, P461, DOI 10.1093/jac/dki471; Thornton SM, 1998, J ZOO WILDLIFE MED, V29, P171; Ulrich RG, 2008, PARASITOL RES, V103, pS121, DOI 10.1007/s00436-008-1054-9; Unnerstad HE, 2012, MRSA PAVISAD HOS SVE, P35; Unnerstad HE, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-6; van Duijkeren E, 2008, VET MICROBIOL, V126, P383, DOI 10.1016/j.vetmic.2007.07.021; van Elk CE, 2012, VET MICROBIOL, V156, P343, DOI 10.1016/j.vetmic.2011.10.034; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; Vancraeynest D, 2006, J VET MED B, V53, P418, DOI 10.1111/j.1439-0450.2006.00977.x; Vandendriessche S, 2013, J ANTIMICROB CHEMOTH, V68, P1510, DOI 10.1093/jac/dkt047; Vincze S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085656; Wagenaar JA, 2009, VET MICROBIOL, V139, P405, DOI 10.1016/j.vetmic.2009.06.014; Walther B, 2008, VET MICROBIOL, V127, P171, DOI 10.1016/j.vetmic.2007.07.018; Walther B, 2012, EMERG INFECT DIS, V18, P2017, DOI 10.3201/eid1812.120238; Walther B, 2009, J CLIN MICROBIOL, V47, P704, DOI 10.1128/JCM.01626-08; Wang X, 2014, FOODBORNE PATHOG DIS, V11, P281, DOI 10.1089/fpd.2013.1643; Weese JS, 2006, VET MICROBIOL, V115, P148, DOI 10.1016/j.vetmic.2006.01.004; Weese JS, 2005, EMERG INFECT DIS, V11, P430, DOI 10.3201/eid1103.040481; WOBESER G, 1992, J WILDLIFE DIS, V28, P215, DOI 10.7589/0090-3558-28.2.215; Wulf M, 2006, EMERG INFECT DIS, V12, P1939; Yamada T, 2005, VET MICROBIOL, V110, P97, DOI 10.1016/j.vetmic.2005.07.006; Ye XH, 2015, AM J INFECT CONTROL, V43, P676, DOI 10.1016/j.ajic.2015.03.026; Zou D, 2000, BIOSCI BIOTECH BIOCH, V64, P2631, DOI 10.1271/bbb.64.2631	167	65	66	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168433	10.1371/journal.pone.0168433	http://dx.doi.org/10.1371/journal.pone.0168433			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992523	gold, Green Published, Green Submitted			2022-12-26	WOS:000392758000050
J	Chang, WT; Chen, JS; Tsai, MH; Tsai, WC; Juang, JN; Liu, PY				Chang, Wei-Ting; Chen, Jung-San; Tsai, Meng-Hang; Tsai, Wei-Chuan; Juang, Jer-Nan; Liu, Ping-Yen			Interplay of Aging and Hypertension in Cardiac Remodeling: A Mathematical Geometric Model	PLOS ONE			English	Article							HEART-FAILURE; ELASTIC-MODULUS; MAGNETIC-RESONANCE; AORTIC-WALL; STRESS; RATS; ATHEROSCLEROSIS; DISTENSIBILITY; DEFORMATION; INDIVIDUALS	Hypertensive disorder can cause cardiac deformities. Elastic characteristic parameters, like Young's modulus of elasticity (E) derived from a traditional cylindrical model, increase significantly with aging. However, the geometric and component changes of aging hearts because of chronic hypertension remain unknown. To better describe the effects, we propose an elliptical elastic and mathematical model to evaluate myocardial stiffness. Ninetysix hypertensive patients (HTNPos) (men: 59.3%; age >= 65 years: 20.8%) were enrolled and compared with normotensive controls (HTNNeg) (n = 47, 48.9%). HTNPos patients had a thicker interventricular septum in diastole (IVSd) (HTNPos : 0.96 +/- 0.21 cm vs. HTNNeg : 0.77 +/- 0.15; p = 0.005) and higher intracardiac pressure (e/e': 9.06 +/- 4.85 cm vs. 7.76 +/- 3.41; p = 0.01), especially the elderly (>65 years) (IVSd: 1.03 +/- 0.19 cm, e/e': 11.39 +/- 1.99; p = 0.006 and 0.01, respectively). Nevertheless, the internal dimension decreased more significantly in the HTNPos rather than in the HTNNeg elderly (5.23 +/- 0.46 vs. 4.74 +/- 0.69 cm; p = 0.02). We found different directions of cardiac remodeling with normotensive and hypertensive loads. Different from the longitudinal and circumferential strain, E and Poisson's ratio (.) are values that directly present the rigidity of myocardium. E was significantly higher in the elderly (8011.92 +/- 2431.85 vs. 6052.43 +/- 3121.50; p = 0.02), whereas. was significantly higher in all HTNPos patients (0.73 +/- 0.12 vs. 0.61 +/- 0.07; p < 0.001). Because E and. reflected the material changes of myocardium in the HTNPos elderly, the proposed elliptical mathematical heart model better describes the geometric deformity induced by aging and hypertension.	[Chang, Wei-Ting] Chi Mei Med Ctr, Div Cardiol, Internal Med, Tainan, Taiwan; [Chang, Wei-Ting; Chen, Jung-San; Tsai, Meng-Hang; Juang, Jer-Nan] Natl Cheng Kung Univ, Dept Engn Sci, Tainan, Taiwan; [Chang, Wei-Ting] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Tsai, Wei-Chuan; Liu, Ping-Yen] Natl Cheng Kung Univ Hosp, Div Cardiol, Internal Med, Tainan, Taiwan; [Liu, Ping-Yen] Natl Cheng Kung Univ, Inst Clin Med, Tainan, Taiwan; [Liu, Ping-Yen] China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan	Chi Mei Hospital; National Cheng Kung University; Southern Taiwan University of Science & Technology; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; China Medical University Taiwan	Juang, JN (corresponding author), Natl Cheng Kung Univ, Dept Engn Sci, Tainan, Taiwan.; Liu, PY (corresponding author), Natl Cheng Kung Univ Hosp, Div Cardiol, Internal Med, Tainan, Taiwan.; Liu, PY (corresponding author), Natl Cheng Kung Univ, Inst Clin Med, Tainan, Taiwan.; Liu, PY (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan.	jjuang@mail.ncku.edu.tw; larry@mail.ncku.edu.tw		Liu, Ping-Yen/0000-0002-3643-5204	Headquarters of University Advancement at the National Cheng Kung University; Health Promotion Program: Blood Pressure Control from Health Promotion Administration, Ministry of Health and Welfare, Taiwan, ROC; Ministry of Science and Technology, Taiwan [MOST 103-2628-B-006-002-MY4, 105-2314-B-006-057-MY3, 103-2221-E-006-032]; National Cheng Kung University Hospital	Headquarters of University Advancement at the National Cheng Kung University; Health Promotion Program: Blood Pressure Control from Health Promotion Administration, Ministry of Health and Welfare, Taiwan, ROC; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Cheng Kung University Hospital	This research was supported in part by the Headquarters of University Advancement at the National Cheng Kung University; Health Promotion Program: Blood Pressure Control from Health Promotion Administration, Ministry of Health and Welfare, Taiwan, ROC; grants from Ministry of Science and Technology, Taiwan (MOST 103-2628-B-006-002-MY4, 105-2314-B-006-057-MY3, 103-2221-E-006-032) and a grant from National Cheng Kung University Hospital (2012-2015, P.Y.L.). The investigator (P.Y.L.) was granted by A Landmark Project to Promote Innovation & Competitiveness of Clinical Trials by the Excellent Clinical Trial and Research Center in National Cheng Kung University Hospital, Ministry of Health and Welfare, Taiwan.	Alter P, 2008, PFLUG ARCH EUR J PHY, V455, P627, DOI 10.1007/s00424-007-0323-2; ANVERSA P, 1986, J AM COLL CARDIOL, V8, P1441, DOI 10.1016/S0735-1097(86)80321-7; Arnett DK, 2000, AM J HYPERTENS, V13, P317, DOI 10.1016/S0895-7061(99)00281-2; Bayoumi AM, 2009, AL KHWARIZMI ENG J, V5, P66; Bezie Y, 1998, ARTERIOSCL THROM VAS, V18, P1027, DOI 10.1161/01.ATV.18.7.1027; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Celic V, 2014, AM J CARDIOL, V113, P832, DOI 10.1016/j.amjcard.2013.11.031; Chang WT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097455; Cheng S, 2010, CIRCULATION, V122, P570, DOI 10.1161/CIRCULATIONAHA.110.937821; DART A, 1993, EUR HEART J, V14, P1465, DOI 10.1093/eurheartj/14.11.1465; Elgeti T, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-44; Gill P.E., 1981, PRACTICAL OPTIMIZATI; HOOD WP, 1969, CIRC RES, V24, P575; ISNARD RN, 1989, J AM COLL CARDIOL, V13, P399, DOI 10.1016/0735-1097(89)90518-4; Jaarsma T, 1999, EUR J HEART FAIL, V1, P151, DOI 10.1016/S1388-9842(99)00007-0; KIM HC, 1985, IEEE T BIO-MED ENG, V32, P503, DOI 10.1109/TBME.1985.325567; Kouzu H, 2011, J AM SOC ECHOCARDIOG, V24, P192, DOI 10.1016/j.echo.2010.10.020; LAURENT S, 1994, HYPERTENSION, V23, P878, DOI 10.1161/01.HYP.23.6.878; LAURENT S, 1994, ARTERIOSCLER THROMB, V14, P1223, DOI 10.1161/01.ATV.14.7.1223; Lieber SC, 2004, AM J PHYSIOL-HEART C, V287, pH645, DOI 10.1152/ajpheart.00564.2003; Lin J, 2008, EXP GERONTOL, V43, P296, DOI 10.1016/j.exger.2007.12.005; Marque V, 1999, HYPERTENSION, V34, P415, DOI 10.1161/01.HYP.34.3.415; Mor-Avi V, 2011, J AM SOC ECHOCARDIOG, V24, P277, DOI 10.1016/j.echo.2011.01.015; Nikitin NP, 2006, INT J CARDIOL, V108, P76, DOI 10.1016/j.ijcard.2005.04.009; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Roman MJ, 1996, J AM COLL CARDIOL, V28, P751, DOI 10.1016/0735-1097(96)00225-2; ROMAN MJ, 1992, CIRCULATION, V86, P1909, DOI 10.1161/01.CIR.86.6.1909; TRESCH DD, 1995, J AM GERIATR SOC, V43, P1035, DOI 10.1111/j.1532-5415.1995.tb05570.x; WARSHAW DM, 1979, CIRC RES, V45, P250, DOI 10.1161/01.RES.45.2.250; WONG AYK, 1968, AM HEART J, V75, P649, DOI 10.1016/0002-8703(68)90325-6; Yoneyama K, 2012, CIRCULATION, V126, P2481, DOI 10.1161/CIRCULATIONAHA.112.093146	31	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168071	10.1371/journal.pone.0168071	http://dx.doi.org/10.1371/journal.pone.0168071			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977729	Green Published, gold, Green Submitted			2022-12-26	WOS:000391217400053
J	Gilder, AS; Wang, L; Natali, L; Karimi-Mostowfi, N; Brifault, C; Gonias, SL				Gilder, Andrew S.; Wang, Lei; Natali, Letizia; Karimi-Mostowfi, Nicki; Brifault, Coralie; Gonias, Steven L.			Pertussis Toxin Is a Robust and Selective Inhibitor of High Grade Glioma Cell Migration and Invasion	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CANCER STEM-CELLS; PLASMINOGEN-ACTIVATOR RECEPTOR; UROKINASE RECEPTOR; EGF RECEPTOR; MUTANT EGFR; UPAR; RESISTANCE; TUMOR; MICE	In high grade glioma (HGG), extensive tumor cell infiltration of normal brain typically precludes identifying effective margins for surgical resection or irradiation. Pertussis toxin (PT) is a multimeric complex that inactivates diverse G(i/o) G-protein coupled receptors (GPCRs). Despite the broad continuum of regulatory events controlled by GPCRs, PT may be applicable as a therapeutic. We have shown that the urokinase receptor (uPAR) is a major driver of HGG cell migration. uPAR-initiated cell-signaling requires a G(i/o) GPCR, N-formyl Peptide Receptor 2 (FPR2), as an essential co-receptor and is thus, PT-sensitive. Herein, we show that PT robustly inhibits migration of three separate HGG-like cell lines that express a mutated form of the EGF Receptor (EGFR), EGFRvIII, which is constitutively active. PT also almost completely blocked the ability of HGG cells to invade Matrigel. In the equivalent concentration range (0.01-1.0 mu g/mL), PT had no effect on cell survival and only affected proliferation of one cell line. Neutralization of EGFRvIII expression in HGG cells, which is known to activate uPAR-initiated cell-signaling, promoted HGG cell migration. The increase in HGG cell migration, induced by EGFRvIII neutralization, was entirely blocked by silencing FPR2 gene expression or by treating the cells with PT. When U87MG HGG cells were cultured as suspended neurospheres in serum-free, growth factor-supplemented medium, uPAR expression was increased. HGG cells isolated from neurospheres migrated through Transwell membranes without loss of cell contacts; this process was inhibited by PT by >90%. PT also inhibited expression of vimentin by HGG cells; vimentin is associated with epithelial-mesenchymal transition and worsened prognosis. We conclude that PT may function as a selective inhibitor of HGG cell migration and invasion.	[Gilder, Andrew S.; Wang, Lei; Natali, Letizia; Karimi-Mostowfi, Nicki; Brifault, Coralie; Gonias, Steven L.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Wang, Lei] Xuzhou Med Univ, Dept Histol & Embryol, Xuzhou, Jiangsu, Peoples R China; [Natali, Letizia] Univ Pisa, Dept Pharm, Pisa, Italy	University of California System; University of California San Diego; Xuzhou Medical University; University of Pisa	Gonias, SL (corresponding author), Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA.	sgonias@ucsd.edu		brifault, coralie/0000-0002-9831-4491	NIH [R01 CA169096]; NATIONAL CANCER INSTITUTE [R01CA169096] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grant R01 CA169096 to SLG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; BOKOCH GM, 1983, J BIOL CHEM, V258, P2072; Chaichana K, 2006, STEM CELLS, V24, P2851, DOI 10.1634/stemcells.2006-0399; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; D'Alessio S, 2009, FRONT BIOSCI-LANDMRK, V14, P4575, DOI 10.2741/3550; Gonias SL, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00154; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; Heimberger AB, 2005, CLIN CANCER RES, V11, P1462, DOI 10.1158/1078-0432.CCR-04-1737; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Hu J, 2015, ONCOGENE, V34, P4078, DOI 10.1038/onc.2014.336; Hu JJ, 2011, P NATL ACAD SCI USA, V108, P15984, DOI 10.1073/pnas.1113416108; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Jo MJ, 2005, J BIOL CHEM, V280, P17449, DOI 10.1074/jbc.M413141200; KASLOW HR, 1992, FASEB J, V6, P2684, DOI 10.1096/fasebj.6.9.1612292; Kost CK, 1999, CLIN EXP PHARMACOL P, V26, P449; Ksiazkiewicz M, 2010, IMMUNOBIOLOGY, V215, P737, DOI 10.1016/j.imbio.2010.05.019; LINTHICUM DS, 1982, CELL IMMUNOL, V73, P299, DOI 10.1016/0008-8749(82)90457-9; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Locht C, 2011, FEBS J, V278, P4668, DOI 10.1111/j.1742-4658.2011.08237.x; Magana-Maldonado R, 2014, J CANCER RES CLIN, V140, P291, DOI 10.1007/s00432-013-1565-3; Manning TJ, 2000, CELL MOTIL CYTOSKEL, V45, P185, DOI 10.1002/(SICI)1097-0169(200003)45:3<185::AID-CM2>3.0.CO;2-G; Mazar AP, 2011, CURR PHARM DESIGN, V17, P1970; Mukasa A, 2010, P NATL ACAD SCI USA, V107, P2616, DOI 10.1073/pnas.0914356107; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Oppermann M, 2004, CELL SIGNAL, V16, P1201, DOI 10.1016/j.cellsig.2004.04.007; Orozco-Morales M, 2012, J CANCER RES CLIN, V138, P23, DOI 10.1007/s00432-011-1069-y; Otto T, 1999, UROLOGY, V54, P458, DOI 10.1016/S0090-4295(99)00154-5; Pala Andrej, 2012, Cancers (Basel), V4, P523, DOI 10.3390/cancers4020523; Persson M, 2014, MOL PHARMACEUT, V11, P2796, DOI 10.1021/mp500177c; Resnati M, 2002, P NATL ACAD SCI USA, V99, P1359, DOI 10.1073/pnas.022652999; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489; Schildge Sebastian, 2013, J Vis Exp, DOI 10.3791/50079; Seidel S, 2010, BRAIN, V133, P983, DOI 10.1093/brain/awq042; Silbergeld DL, 1997, J NEUROSURG, V86, P525, DOI 10.3171/jns.1997.86.3.0525; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Stahle M, 2003, J CELL SCI, V116, P3835, DOI 10.1242/jcs.00679; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; SUGAWA N, 1990, P NATL ACAD SCI USA, V87, P8602, DOI 10.1073/pnas.87.21.8602; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Webb DJ, 2000, J CELL SCI, V113, P123; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Wykosky J, 2015, CANCER RES, V75, P394, DOI 10.1158/0008-5472.CAN-14-2004; YONG T, 1993, J NEUROIMMUNOL, V45, P47, DOI 10.1016/0165-5728(93)90162-R; Yu SC, 2008, CANCER LETT, V265, P124, DOI 10.1016/j.canlet.2008.02.010; Zhao J, 2016, APPL IMMUNOHISTOCHEM	49	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168418	10.1371/journal.pone.0168418	http://dx.doi.org/10.1371/journal.pone.0168418			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977780	gold, Green Published, Green Submitted			2022-12-26	WOS:000391217400107
J	Guillemaud, T; Lombaert, E; Bourguet, D				Guillemaud, Thomas; Lombaert, Eric; Bourguet, Denis			Conflicts of Interest in GM Bt Crop Efficacy and Durability Studies	PLOS ONE			English	Article							BIOMEDICAL-RESEARCH	Public confidence in genetically modified (GM) crop studies is tenuous at best in many countries, including those of the European Union in particular. A lack of information about the effects of ties between academic research and industry might stretch this confidence to the breaking point. We therefore performed an analysis on a large set of research articles (n = 672) focusing on the efficacy or durability of GM Bt crops and ties between the researchers carrying out these studies and the GM crop industry. We found that ties between researchers and the GM crop industry were common, with 40% of the articles considered displaying conflicts of interest (COI). In particular, we found that, compared to the absence of COI, the presence of a COI was associated with a 50% higher frequency of outcomes favorable to the interests of the GM crop company. Using our large dataset, we were able to propose possible direct and indirect mechanisms behind this statistical association. They might notably include changes of authorship or funding statements after the results of a study have been obtained and a choice in the topics studied driven by industrial priorities.	[Guillemaud, Thomas; Lombaert, Eric] Univ Nice Sophia Antipolis, INRA, CNRS, UMR 1355 7254,Inst Sophia Agrobiotech, Sophia Antipolis, France; [Bourguet, Denis] Montpellier SupAgro, Ctr Biol Gest Populat, UMR 1062, INRA,IRD,CIRAD,CS, 755 Ave Campus Agropolis, Montferrier Sur Lez, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD)	Guillemaud, T (corresponding author), Univ Nice Sophia Antipolis, INRA, CNRS, UMR 1355 7254,Inst Sophia Agrobiotech, Sophia Antipolis, France.	guillem@sophia.inra.fr	; guillemaud, thomas/B-4899-2012	Bourguet, Denis/0000-0002-2109-5323; guillemaud, thomas/0000-0003-0451-1644				Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Angell M., 2005, TRUTH DRUG CO THEY D; Auguie B, 2017, GRIDEXTRA MISCELLANE; Barbour V, 2008, PLOS MED, V5, P1299, DOI 10.1371/journal.pmed.0050199; BARNES DE, 1995, JAMA-J AM MED ASSOC, V274, P248, DOI 10.1001/jama.274.3.248; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Bes-Rastrollo M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001578; Bouzidi R, 2011, ORTHOPEDICS, V34, P932, DOI 10.3928/01477447-20111021-01; Campbell EG, 2006, NEW ENGL J MED, V355, P2321, DOI 10.1056/NEJMsa061457; Diels J, 2011, FOOD POLICY, V36, P197, DOI 10.1016/j.foodpol.2010.11.016; Field MJ., 2009, CONFLICT INTEREST ME; Krimsky S., 2004, SCI PRIVATE INTEREST; Krimsky S, 2013, SCI TECHNOL HUM VAL, V38, P566, DOI 10.1177/0162243912456271; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Loewenstein G, 2012, JAMA-J AM MED ASSOC, V307, P669, DOI 10.1001/jama.2012.154; Sanchez MA, 2015, NAT BIOTECHNOL, V33, P135, DOI 10.1038/nbt.3133; Shrader-Frechette K, 2011, SCI ENG ETHICS, V17, P75, DOI 10.1007/s11948-009-9181-y	17	8	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0167777	10.1371/journal.pone.0167777	http://dx.doi.org/10.1371/journal.pone.0167777			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977705	Green Published, Green Submitted, gold			2022-12-26	WOS:000391217400031
J	Sun, XY; Bernabe, E; Liu, XN; Gallagher, JE; Zheng, SG				Sun, Xiangyu; Bernabe, Eduardo; Liu, Xuenan; Gallagher, Jennifer Elizabeth; Zheng, Shuguo			Determinants of Catastrophic Dental Health Expenditure in China	PLOS ONE			English	Article							OUT-OF-POCKET; HOUSEHOLD SURVEYS; ORAL-HEALTH; CARE; PERFORMANCE; INEQUALITY; SYSTEM; INDIA	This study explored catastrophic health expenditure in China, due to out-of-pocket payments for dental care, and its associated individual-and contextual-level factors. We pooled data from 31,566 adults who participated in the third National Oral Health Survey with province-level data from different sources. We defined catastrophic dental health expenditure (CDHE) as payments for dental services and/or medication for dental problems during the last year that exceeded the 10% and 20% of the household income. The association of individual and contextual factors with catastrophic dental health expenditure was evaluated using two-level logistic regression models with individuals nested within provinces. Socioeconomic position (education and household income), household size and dental status (pain in teeth or mouth and number of teeth) were the individual-level factors associated with CDHE among the full sample of participants; and, also, among those who used dental services in the past year. Greater gross domestic product per capita was the only contextual factor associated with CDHE, and only at the lower income threshold. This study shows that out-of-pocket expenses for dental services may put a considerable, and unnecessary, burden on households' finances. Our findings also help characterise those households more likely to face catastrophic expenditure on health if they have to pay for dental services.	[Sun, Xiangyu; Liu, Xuenan; Zheng, Shuguo] Peking Univ, Natl Engn Lab Digital & Mat Technol Stomatol, Beijing Key Lab Digital Stomatol, Dept Prevent Dent,Sch & Hosp Stomatol, Beijing, Peoples R China; [Sun, Xiangyu; Bernabe, Eduardo; Gallagher, Jennifer Elizabeth] Guys Hosp, Kings Coll London, Inst Dent, Populat & Patient Hlth Div, London, England; [Sun, Xiangyu; Bernabe, Eduardo; Gallagher, Jennifer Elizabeth] Kings Coll Hosp London, Kings Coll London, Inst Dent, Populat & Patient Hlth Div, London, England; [Sun, Xiangyu; Bernabe, Eduardo; Gallagher, Jennifer Elizabeth] St Thomas Hosp, Kings Coll London, Inst Dent, Populat & Patient Hlth Div, London, England	Peking University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Zheng, SG (corresponding author), Peking Univ, Natl Engn Lab Digital & Mat Technol Stomatol, Beijing Key Lab Digital Stomatol, Dept Prevent Dent,Sch & Hosp Stomatol, Beijing, Peoples R China.; Gallagher, JE (corresponding author), Guys Hosp, Kings Coll London, Inst Dent, Populat & Patient Hlth Div, London, England.; Gallagher, JE (corresponding author), Kings Coll Hosp London, Kings Coll London, Inst Dent, Populat & Patient Hlth Div, London, England.; Gallagher, JE (corresponding author), St Thomas Hosp, Kings Coll London, Inst Dent, Populat & Patient Hlth Div, London, England.	jenny.gallagher@kcl.ac.uk; zhengsg86@gmail.com	Sun, Xiangyu/T-8264-2019; Bernabe, Eduardo/R-3441-2017; Zheng, Shuguo/AAO-7612-2020	Bernabe, Eduardo/0000-0002-1858-3713; Gallagher, Jennifer Elizabeth/0000-0001-5068-8008				[Anonymous], 2008, ANAL HLTH EQUITY USI; Arsenijevic J, 2013, SOC SCI MED, V78, P17, DOI 10.1016/j.socscimed.2012.11.014; Bank WW, 2014, MON PROGR UN HLTH CO; Brinda EM, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/1472-698X-14-5; BUHMANN B, 1988, REV INCOME WEALTH, P115; Cai TJ, 2013, SOCIOL METHODOL, V43, P178, DOI 10.1177/0081175012460221; Carle AC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-49; Fang PQ, 2010, HEALTH POLICY, V94, P14, DOI 10.1016/j.healthpol.2009.08.002; Goryakin Y, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0107-1; Hsiao W, 2014, UNIVERSAL HLTH COVER; Hu DY, 2011, INT J ORAL SCI, V3, P7, DOI 10.4248/IJOS11006; Kavosi Z, 2012, HEALTH POLICY PLANN, V27, P613, DOI 10.1093/heapol/czs001; Kim Y, 2011, HEALTH POLICY, V100, P239, DOI 10.1016/j.healthpol.2010.08.008; Lavado RF, 2013, B WORLD HEALTH ORGAN, V91, P519, DOI 10.2471/BLT.12.115535; Liang L., 2013, LONG MARCH UNIVERSAL; LIBERATOS P, 1988, EPIDEMIOL REV, V10, P87, DOI 10.1093/oxfordjournals.epirev.a036030; Limwattananon S, 2007, B WORLD HEALTH ORGAN, V85, P600, DOI 10.2471/BLT.06.033720; Lin HC, 2001, COMMUNITY DENT ORAL, V29, P319, DOI 10.1034/j.1600-0528.2001.290501.x; Liu YL, 2008, LANCET, V372, P1914, DOI 10.1016/S0140-6736(08)61362-8; Lu CL, 2009, B WORLD HEALTH ORGAN, V87, P238, DOI 10.2471/BLT.08.054379; Knaul FM, 2011, SALUD PUBLICA MEXICO, V53, pS85; Masood M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123075; Meng QY, 2015, LANCET, V386, P1484, DOI 10.1016/S0140-6736(15)00342-6; National Bureau of Statistics of China, 2006, NAT STAT YB 2005; Raban MZ, 2013, B WORLD HEALTH ORGAN, V91, P726, DOI 10.2471/BLT.12.113100; Rabe-Hesketh S, 2006, J R STAT SOC A STAT, V169, P805, DOI 10.1111/j.1467-985X.2006.00426.x; Sahin I, 2014, EUR J HLTH EC; Wagstaff A, 2008, POLICY RES WORKING P, V4554; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2016, WORLD HLTH STAT 2016; World Health Organization, 2015, TRACK UN HLTH COV 1; World Health Organization, 2013, ORAL HLTH SURVEYS BA, V5th edn, p., P19; Xie Y, 2014, P NATL ACAD SCI USA, V111, P6928, DOI 10.1073/pnas.1403158111; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972; Xu LXC, 2000, CHINA ECON REV, V11, P149, DOI 10.1016/S1043-951X(00)00015-8; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Yip W, 2008, HEALTH AFFAIR, V27, P921, DOI 10.1377/hlthaff.27.4.921; Yu H, 2015, HEALTH POLICY, V119, P1145, DOI 10.1016/j.healthpol.2015.07.008; Zhu L, 2005, INT DENT J, V55, P231, DOI 10.1111/j.1875-595X.2005.tb00321.x	40	12	13	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168341	10.1371/journal.pone.0168341	http://dx.doi.org/10.1371/journal.pone.0168341			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7HN	27977756	Green Published, gold, Green Submitted			2022-12-26	WOS:000391217400097
J	Wilbiks, JMP; Dyson, BJ				Wilbiks, Jonathan M. P.; Dyson, Benjamin J.			The Dynamics and Neural Correlates of Audio-Visual Integration Capacity as Determined by Temporal Unpredictability, Proactive Interference, and SOA	PLOS ONE			English	Article							SHORT-TERM-MEMORY; WORKING-MEMORY; ATTENTION; PERCEPTION; COMPONENT; LIMITS; INDEX; ERP	Over 5 experiments, we challenge the idea that the capacity of audio-visual integration need be fixed at 1 item. We observe that the conditions under which audio-visual integration is most likely to exceed 1 occur when stimulus change operates at a slow rather than fast rate of presentation and when the task is of intermediate difficulty such as when low levels of proactive interference (3 rather than 8 interfering visual presentations) are combined with the temporal unpredictability of the critical frame (Experiment 2), or, high levels of proactive interference are combined with the temporal predictability of the critical frame (Experiment 4). Neural data suggest that capacity might also be determined by the quality of perceptual information entering working memory. Experiment 5 supported the proposition that audiovisual integration was at play during the previous experiments. The data are consistent with the dynamic nature usually associated with cross-modal binding, and while audio-visual integration capacity likely cannot exceed uni-modal capacity estimates, performance may be better than being able to associate only one visual stimulus with one auditory stimulus.	[Wilbiks, Jonathan M. P.; Dyson, Benjamin J.] Ryerson Univ, Dept Psychol, Toronto, ON, Canada; [Wilbiks, Jonathan M. P.] Mt Allison Univ, Dept Psychol, Sackville, NB, Canada; [Dyson, Benjamin J.] Univ Sussex, Sch Psychol, Falmer, England	Toronto Metropolitan University; Mount Allison University; University of Sussex	Wilbiks, JMP (corresponding author), Ryerson Univ, Dept Psychol, Toronto, ON, Canada.; Wilbiks, JMP (corresponding author), Mt Allison Univ, Dept Psychol, Sackville, NB, Canada.	jwilbiks@mta.ca		Wilbiks, Jonathan/0000-0002-6882-5215	Ontario Graduate Scholarship; Ontario Ministry of Research and Innovation	Ontario Graduate Scholarship(Ontario Graduate Scholarship); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	JMPW was funded by an Ontario Graduate Scholarship. BJD was supported by an Early Researcher Award granted by Ontario Ministry of Research and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler RF., 2014, INTERACT COMPUT; ANDERSON KJ, 1990, PSYCHOL BULL, V107, P96, DOI 10.1037/0033-2909.107.1.96; Andrade GN, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.63; BERG P, 1994, ELECTROEN CLIN NEURO, V90, P229, DOI 10.1016/0013-4694(94)90094-9; Calvert GA, 2004, J PHYSIOL-PARIS, V98, P191, DOI 10.1016/j.jphysparis.2004.03.018; Chan YM, 2014, FRONT AGING NEUROSCI, V6, P1; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Crowder R.G., 1976, PRINCIPLES LEARNING; Drew T, 2013, COGNITION, V126, P213, DOI 10.1016/j.cognition.2012.10.003; Dyson BJ, 2004, J ACOUST SOC AM, V115, P280, DOI 10.1121/1.1631945; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Holcombe AO, 2013, J VISION, V13, DOI 10.1167/13.1.12; Kane MJ, 2000, J EXP PSYCHOL LEARN, V26, P336, DOI 10.1037//0278-7393.26.2.336; Kawachi Y, 2014, J VISION, V14, DOI 10.1167/14.8.16; Koelewijn T, 2010, ACTA PSYCHOL, V134, P372, DOI 10.1016/j.actpsy.2010.03.010; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; LUCK SJ, 1990, ELECTROEN CLIN NEURO, V75, P528, DOI 10.1016/0013-4694(90)90139-B; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Marois R, 2005, TRENDS COGN SCI, V9, P296, DOI 10.1016/j.tics.2005.04.010; Mazza V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017453; NORMAN DA, 1975, COGNITIVE PSYCHOL, V7, P44, DOI 10.1016/0010-0285(75)90004-3; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Van der Burg E, 2008, J EXP PSYCHOL HUMAN, V34, P1053, DOI 10.1037/0096-1523.34.5.1053; Van der Burg E, 2013, PSYCHOL SCI, V24, P345, DOI 10.1177/0956797612452865; Van der Burg E, 2011, NEUROIMAGE, V55, P1208, DOI 10.1016/j.neuroimage.2010.12.068; van Wassenhove V, 2007, NEUROPSYCHOLOGIA, V45, P598, DOI 10.1016/j.neuropsychologia.2006.01.001; Verleger R, 2005, J PSYCHOPHYSIOL, V19, P165, DOI 10.1027/0269-8803.19.3.165; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Vogel EK, 2000, PSYCHOPHYSIOLOGY, V37, P190, DOI 10.1111/1469-8986.3720190; Vroomen J, 2010, ATTEN PERCEPT PSYCHO, V72, P871, DOI 10.3758/APP.72.4.871; WASSERMAN EA, 1983, LEARN MOTIV, V14, P406, DOI 10.1016/0023-9690(83)90025-5; Wilbiks JMP, 2013, MULTISENS RES, V26, P561, DOI 10.1163/22134808-00002432; WOLDORFF MG, 1993, PSYCHOPHYSIOLOGY, V30, P98, DOI 10.1111/j.1469-8986.1993.tb03209.x; YANTIS S, 1992, COGNITIVE PSYCHOL, V24, P295, DOI 10.1016/0010-0285(92)90010-Y	37	6	6	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168304	10.1371/journal.pone.0168304	http://dx.doi.org/10.1371/journal.pone.0168304			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7HN	27977790	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000391217400091
J	Zhang, AD; Liu, DD; Hua, CM; Yan, A; Liu, BH; Wu, MJ; Liu, YH; Huang, LL; Ali, I; Gan, YB				Zhang, Aidong; Liu, Dongdong; Hua, Changmei; Yan, An; Liu, Bohan; Wu, Minjie; Liu, Yihua; Huang, Linli; Ali, Imran; Gan, Yinbo			The Arabidopsis Gene zinc finger protein 3(ZFP3) Is Involved in Salt Stress and Osmotic Stress Response	PLOS ONE			English	Article							REGULATES TRICHOME INITIATION; WRKY TRANSCRIPTION FACTORS; HIGH-SALINITY STRESS; PROLINE ACCUMULATION; DROUGHT TOLERANCE; ABIOTIC STRESSES; ABSCISIC-ACID; WATER-STRESS; PLANTS; EXPRESSION	Plants are continuously challenged by various abiotic and biotic stresses. To tide over these adversities, plants evolved intricate regulatory networks to adapt these unfavorable environments. So far, many researchers have clarified the molecular and genetic pathways involved in regulation of stress responses. However, the mechanism through which these regulatory networks operate is largely unknown. In this study, we cloned a C2H2-type zinc finger protein gene ZFP3 from Arabidopsis thaliana and investigated its function in salt and osmotic stress response. Our results showed that the expression level of ZFP3 was highly suppressed by NaCl, mannitol and sucrose. Constitutive expression of ZFP3 enhanced tolerance of plants to salt and osmotic stress while the zfp3 mutant plants displays reduced tolerance in Arabidopsis. Gain-and Loss-of-function studies of ZFP3 showed that ZFP3 significantly changes proline accumulation and chlorophyll content. Furthermore, over-expression of ZFP3 induced the expressions of stress-related gene KIN1, RD22, RD29B and AtP5CS1. These results suggest that ZFP3 is involved in salt and osmotic stress response.	[Zhang, Aidong; Liu, Dongdong; Hua, Changmei; Yan, An; Liu, Bohan; Wu, Minjie; Liu, Yihua; Huang, Linli; Ali, Imran; Gan, Yinbo] Zhejiang Univ, Zhejiang Key Lab Crop Germplasm, Dept Agron, Coll Agr & Biotechnol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Gan, YB (corresponding author), Zhejiang Univ, Zhejiang Key Lab Crop Germplasm, Dept Agron, Coll Agr & Biotechnol, Hangzhou, Zhejiang, Peoples R China.	ygan@zju.edu.cn	Liu, Bohan/D-4731-2015; Liu, Bohan/G-4704-2017; Gan, Yinbo/N-1480-2015	Liu, Bohan/0000-0002-8318-9667; Liu, Bohan/0000-0002-8318-9667; 	Seven Agricultural Crop Breeding Program [2016YFD0100700]; Major State Basic Research Development Program (973 Program) [2015CB150200]; Zhejiang Provincial Natural Science Foundation of China [LZ15C020001]; National Natural Science Foundation of China [31570183, 31529001]	Seven Agricultural Crop Breeding Program; Major State Basic Research Development Program (973 Program)(National Basic Research Program of China); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was funded by Seven Agricultural Crop Breeding Program (2016YFD0100700); Major State Basic Research Development Program (973 Program, grant no. 2015CB150200); Zhejiang Provincial Natural Science Foundation of China (Grant No. LZ15C020001) and National Natural Science Foundation of China (Grant No. 31570183; 31529001).	An LJ, 2012, PLANT J, V72, P474, DOI 10.1111/j.1365-313X.2012.05094.x; Bao SJ, 2011, BOTANY, V89, P647, DOI [10.1139/B11-053, 10.1139/b11-053]; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Borsani O, 2001, PLANT PHYSIOL, V126, P1024, DOI 10.1104/pp.126.3.1024; Cai SQ, 2008, PLANT PHYSIOL, V146, P1305, DOI 10.1104/pp.107.110908; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Chrispeels HE, 2000, PLANT MOL BIOL, V42, P279, DOI 10.1023/A:1006352809700; Ciftci-Yilmaz S, 2008, CELL MOL LIFE SCI, V65, P1150, DOI 10.1007/s00018-007-7473-4; Ciftci-Yilmaz S, 2007, J BIOL CHEM, V282, P9260, DOI 10.1074/jbc.M611093200; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; Deuschle K, 2004, PLANT CELL, V16, P3413, DOI 10.1105/tpc.104.023622; Dobra J, 2010, J PLANT PHYSIOL, V167, P1360, DOI 10.1016/j.jplph.2010.05.013; Fabro G, 2004, MOL PLANT MICROBE IN, V17, P343, DOI 10.1094/MPMI.2004.17.4.343; Gan YB, 2007, DEVELOPMENT, V134, P2073, DOI 10.1242/dev.005017; Gan YB, 2006, PLANT CELL, V18, P1383, DOI 10.1105/tpc.106.041533; Han GL, 2014, PLANT MOL BIOL, V86, P237, DOI 10.1007/s11103-014-0226-5; Hong ZL, 2000, PLANT PHYSIOL, V122, P1129, DOI 10.1104/pp.122.4.1129; Hua XJ, 1997, PLANT PHYSIOL, V114, P1215, DOI 10.1104/pp.114.4.1215; Joseph MP, 2014, PLANT PHYSIOL, V165, P1203, DOI 10.1104/pp.113.234294; Jung YJ, 2013, PLANT BIOLOGY, V15, P274, DOI 10.1111/j.1438-8677.2012.00631.x; Kodaira KS, 2011, PLANT PHYSIOL, V157, P742, DOI 10.1104/pp.111.182683; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Li MY, 2016, SCI REP-UK, V6, DOI 10.1038/srep23101; Lv WT, 2011, PLANT PHYSIOL, V156, P1921, DOI 10.1104/pp.111.175810; Meng D, 2016, PLANT PHYSIOL BIOCH, V103, P71, DOI 10.1016/j.plaphy.2016.02.006; Mittler R, 2006, FEBS LETT, V580, P6537, DOI 10.1016/j.febslet.2006.11.002; Moon SJ, 2015, PLANT MOL BIOL, V89, P421, DOI 10.1007/s11103-015-0378-y; Mukhopadhyay A, 2004, P NATL ACAD SCI USA, V101, P6309, DOI 10.1073/pnas.0401572101; Nakashima K, 2009, PLANT PHYSIOL, V149, P88, DOI 10.1104/pp.108.129791; Milla MA, 2006, PLANT MOL BIOL, V61, P13, DOI 10.1007/s11103-005-5798-7; Sakamoto H, 2000, GENE, V248, P23, DOI 10.1016/S0378-1119(00)00133-5; Sakamoto H, 2004, PLANT PHYSIOL, V136, P2734, DOI 10.1104/pp.104.046599; Signorelli S, 2013, PLANT PHYSIOL BIOCH, V70, P195, DOI 10.1016/j.plaphy.2013.05.028; Sun LL, 2013, J ZHEJIANG UNIV-SC B, V14, P563, DOI 10.1631/jzus.B1200349; Sun LL, 2015, NEW PHYTOL, V206, P220, DOI 10.1111/nph.13218; Tang LL, 2013, PLANT PHYSIOL BIOCH, V71, P22, DOI 10.1016/j.plaphy.2013.06.024; Tian B, 2010, IEEE INT C ULTR ICUW, V1, P1, DOI DOI 10.1111/J.1438-8677.2009.00276.X; Tian MM, 2015, PLANT J, V82, P81, DOI 10.1111/tpj.12797; Xu SM, 2007, PLANT CELL REP, V26, P497, DOI 10.1007/s00299-006-0248-9; Yamaji N, 2009, PLANT CELL, V21, P3339, DOI 10.1105/tpc.109.070771; Yan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085208; Zang DD, 2015, PLANT SCI, V235, P111, DOI 10.1016/j.plantsci.2015.02.016; Zhang LN, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01174; Zhou ZJ, 2013, NEW PHYTOL, V198, P699, DOI 10.1111/nph.12211; Zhou ZJ, 2012, PLANT SIGNAL BEHAV, V7, P28, DOI 10.4161/psb.7.1.18404; Zhou ZJ, 2011, PLANT PHYSIOL, V157, P673, DOI 10.1104/pp.111.180281; Zhu J., TRENDS PLANT SCI, V6, P66	49	32	36	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168367	10.1371/journal.pone.0168367	http://dx.doi.org/10.1371/journal.pone.0168367			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977750	Green Submitted, gold, Green Published			2022-12-26	WOS:000391217400101
J	Chand, KK; Lee, KM; Lavidis, NA; Noakes, PG				Chand, Kirat K.; Lee, Kah Meng; Lavidis, Nickolas A.; Noakes, Peter G.			Loss of laminin-alpha 4 results in pre-and postsynaptic modifications at the neuromuscular junction	FASEB JOURNAL			English	Article						basal lamina; neuromuscular synapses; neurotransmission; skeletal muscle	READILY RELEASABLE POOL; MOTOR-NERVE TERMINALS; SYNAPTIC VESICLE POOLS; END-PLATE POTENTIALS; ACTIVE ZONES; TRANSMITTER RELEASE; CALCIUM-CHANNELS; NEUROTRANSMITTER RELEASE; FUNCTIONAL-ANALYSIS; AXON WITHDRAWAL	Synaptic basal lamina such as laminin-421 (alpha 4 beta 2 gamma 1) mediate differentiation of the neuromuscular junction (NMJ). Laminins interact with their pre-or postsynaptic receptors to provide stability and alignment of the pre-to postsynaptic specializations. Knockout of the laminin-alpha 4 gene (lama(4)) does not alter gross NMJ morphogenesis. However, mice deficient in laminin-a4 (lama4-/- mice) display disruptions in the alignment of the active zones and postsynaptic folds at the NMJ, although the physiological consequences of this loss have not been examined. The present study investigated the differences in neurotransmission during the early development and maturation of the NMJ in lama4-/-and wild-typemice. Lama4-/- NMJs demonstrated a decrease inminiature end-plate potential (EPP) frequency and increased amplitude of miniature EPPs and evoked EPPs. Binomial parameters analysis of neurotransmitter release revealed a decrease in quantal release, the result of a decrease in the number of active release sites, but not in the probability of transmitter release. Lama4-/- NMJs displayed higher levels of synaptic depression under high-frequency stimulation and altered facilitation, suggesting compromised delivery of synaptic vesicles. This idea is supported by ourmolecular investigations of lama4-/- NMJs, where we see altered distribution of Bassoon, amolecular component of active zones, presumably resulting from perturbed neurotransmission.-Chand, K. K., Lee, K. M., Lavidis, N. A., Noakes, P. G. Loss of laminin-alpha 4 results in pre-and postsynaptic modifications at the neuromuscular junction.	[Chand, Kirat K.; Lee, Kah Meng; Lavidis, Nickolas A.; Noakes, Peter G.] Univ Queensland, Sch Biomed Sci, Res Rd, St Lucia, Qld 4072, Australia; [Noakes, Peter G.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia	University of Queensland; University of Queensland	Noakes, PG (corresponding author), Univ Queensland, Sch Biomed Sci, Res Rd, St Lucia, Qld 4072, Australia.	p.noakes@uq.edu.au	Noakes, Peter/X-9825-2019	Noakes, Peter/0000-0001-9821-8478; Chand, Kirat/0000-0001-7739-2098; Lee, Kah Meng/0000-0002-1659-0178	Australian National Health and Medical Research Council [569680]; Motor Neuron Disease Research Institute Australia [GIA1429, GIA1547]; University of Queensland	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Motor Neuron Disease Research Institute Australia; University of Queensland(University of Queensland)	This work was supported, in part, by Australian National Health and Medical Research Council Grant 569680 (to P.G.N.), Motor Neuron Disease Research Institute Australia Grants GIA1429 and GIA1547 (both to P.G.N.), and internal funds from The University of Queensland. The authors thank B. Patton (Oregon Health and Science University School of Medicine, Portland, OR, USA) for providing the knockout mouse line used in this study, S. Meriney (Center for Neuroscience, University of Pittsburgh, Pittsburgh, PA, USA) for technical assistance in optimization of Bassoon staining, and S. Ngo (School of Biomedical Sciences, The University of Queensland) for the modified fiber staining protocol. The authors also thank M. White and M. Shayegh (School of Biomedical Sciences, The University of Queensland) for technical assistance with genotyping. K.K.C. and K.M.L are co-first authors, and N.A.L. and P.G.N. are co-senior authors.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ALDERDICE MT, 1979, BRAIN RES, V178, P596, DOI 10.1016/0006-8993(79)90721-2; BALICEGORDON RJ, 1993, NEURON, V11, P801, DOI 10.1016/0896-6273(93)90110-D; BaliceGordon RJ, 1997, MUSCLE NERVE, pS83; BALICEGORDON RJ, 1993, J NEUROSCI, V13, P834; Bennett MR, 2001, NEUROREPORT, V12, pA15, DOI 10.1097/00001756-200103050-00003; BENNETT MR, 1974, J PHYSIOL-LONDON, V238, P93, DOI 10.1113/jphysiol.1974.sp010512; Bloom O, 2003, J CELL BIOL, V161, P737, DOI 10.1083/jcb.200212140; Caillol G, 2012, EUR J NEUROSCI, V36, P2400, DOI 10.1111/j.1460-9568.2012.08164.x; Cano R, 2013, MOL NEUROBIOL, V47, P209, DOI 10.1007/s12035-012-8347-9; Carlson SS, 2010, J NEUROCHEM, V115, P654, DOI 10.1111/j.1471-4159.2010.06965.x; Chai RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028090; Chand KK, 2016, SCI REP-UK, V6, DOI 10.1038/srep29446; Chand KK, 2015, J PHYSIOL-LONDON, V593, P245, DOI 10.1113/jphysiol.2014.284133; Chen J, 2011, J NEUROSCI, V31, P512, DOI 10.1523/JNEUROSCI.3771-10.2011; Chi P, 2001, NAT NEUROSCI, V4, P1187, DOI 10.1038/nn756; Cho SI, 1998, J NEUROBIOL, V37, P339, DOI 10.1002/(SICI)1097-4695(19981115)37:3<339::AID-NEU1>3.3.CO;2-0; Cohen MW, 2000, J NEUROSCI, V20, P4912; Coleman WL, 2007, NEUROSCIENCE, V148, P1, DOI 10.1016/j.neuroscience.2007.06.011; Coleman WL, 2009, SYNAPSE, V63, P531, DOI 10.1002/syn.20635; Cousin MA, 2003, J BIOL CHEM, V278, P29065, DOI 10.1074/jbc.M302386200; Culican SM, 1998, J NEUROSCI, V18, P4953; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Dyar KA, 2014, MOL METAB, V3, P29, DOI 10.1016/j.molmet.2013.10.005; ELMQVIST D, 1965, J PHYSIOL-LONDON, V178, P505, DOI 10.1113/jphysiol.1965.sp007639; ERXLEBEN C, 1988, J PHYSIOL-LONDON, V400, P645, DOI 10.1113/jphysiol.1988.sp017141; Farchi N, 2003, J PHYSIOL-LONDON, V546, P165, DOI 10.1113/jphysiol.2002.030841; Fogarty MJ, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00153; Fourcaudot E, 2008, P NATL ACAD SCI USA, V105, P15130, DOI 10.1073/pnas.0806938105; Fujiwara H, 2001, J BIOL CHEM, V276, P17550, DOI 10.1074/jbc.M010155200; GERTLER RA, 1978, BRAIN RES, V142, P160, DOI 10.1016/0006-8993(78)90186-5; Gitler D, 2004, J NEUROSCI, V24, P11368, DOI 10.1523/JNEUROSCI.3795-04.2004; Hosaka M, 1999, NEURON, V24, P377, DOI 10.1016/S0896-6273(00)80851-X; Knight D, 2003, J PHYSIOL-LONDON, V546, P789, DOI 10.1113/jphysiol.2002.030924; LI C, 1994, NEURON, V13, P885, DOI 10.1016/0896-6273(94)90254-2; Liu JX, 2011, INVEST OPHTH VIS SCI, V52, P4842, DOI 10.1167/iovs.10-7132; Mantilla CB, 2007, NEUROSCIENCE, V146, P178, DOI 10.1016/j.neuroscience.2007.01.048; Mantilla CB, 2009, RESP PHYSIOL NEUROBI, V169, P133, DOI 10.1016/j.resp.2009.09.002; Marques MJ, 2000, J NEUROSCI, V20, P3663, DOI 10.1523/JNEUROSCI.20-10-03663.2000; Massoulie J, 2009, CURR OPIN PHARMACOL, V9, P316, DOI 10.1016/j.coph.2009.04.004; MCLACHLAN EM, 1981, J PHYSIOL-LONDON, V311, P307, DOI 10.1113/jphysiol.1981.sp013586; MILEDI R, 1960, J PHYSIOL-LONDON, V154, P190, DOI 10.1113/jphysiol.1960.sp006573; Nishimune H, 2004, NATURE, V432, P580, DOI 10.1038/nature03112; Nishimune H, 2008, J CELL BIOL, V182, P1201, DOI 10.1083/jcb.200805095; Nishimune H, 2016, SCI REP-UK, V6, DOI 10.1038/srep27935; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; Patton BL, 2000, MICROSC RES TECHNIQ, V51, P247, DOI 10.1002/1097-0029(20001101)51:3<247::AID-JEMT5>3.0.CO;2-Z; Patton BL, 2001, NAT NEUROSCI, V4, P597, DOI 10.1038/88414; Patton BL, 1998, NATURE, V393, P698, DOI 10.1038/31502; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; Poort JE, 2016, HUM MOL GENET, V25, P3768, DOI 10.1093/hmg/ddw222; Prakash YS, 1999, MUSCLE NERVE, V22, P307, DOI 10.1002/(SICI)1097-4598(199903)22:3<307::AID-MUS3>3.3.CO;2-D; Rasi K, 2010, J NEUROSCI, V30, P14490, DOI 10.1523/JNEUROSCI.2644-10.2010; Reid B, 1999, J NEUROSCI, V19, P2511; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rizzoli SO, 2004, SCIENCE, V303, P2037, DOI 10.1126/science.1094682; Rocha MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073846; Rosato-Siri MD, 2002, EUR J NEUROSCI, V15, P1874, DOI 10.1046/j.1460-9568.2002.02015.x; Ruiz R, 2014, NEUROPHARMACOLOGY, V76, P106, DOI 10.1016/j.neuropharm.2013.08.032; Ruiz R, 2011, J NEUROSCI, V31, P2000, DOI 10.1523/JNEUROSCI.4663-10.2011; Samuel MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046663; Sellin LC, 1996, PFLUG ARCH EUR J PHY, V431, P325, DOI 10.1007/BF02207269; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sudhof TC, 1997, NEURON, V18, P519, DOI 10.1016/S0896-6273(00)80292-5; Sugita S, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0105-7; Suzuki N, 2005, CONNECT TISSUE RES, V46, P142, DOI 10.1080/03008200591008527; Talts JF, 2000, J BIOL CHEM, V275, P35192, DOI 10.1074/jbc.M003261200; Valdez G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034640; Valdez G, 2010, P NATL ACAD SCI USA, V107, P14863, DOI 10.1073/pnas.1002220107; Wallquist W, 2005, J NEUROSCI, V25, P3692, DOI 10.1523/JNEUROSCI.5225-04.2005; WEINSTEIN SP, 1980, J PHYSIOL-LONDON, V307, P453, DOI 10.1113/jphysiol.1980.sp013446; Yamagata T, 1997, Nihon Jibiinkoka Gakkai Kaiho, V100, P244	73	9	9	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1323	1336		10.1096/fj.201600899R	http://dx.doi.org/10.1096/fj.201600899R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	27998908				2022-12-26	WOS:000398504300007
J	Kajzer-Bonk, J; Skorka, P; Nowicki, P; Bonk, M; Krol, W; Szpilyk, D; Woyciechowski, M				Kajzer-Bonk, Joanna; Skorka, Piotr; Nowicki, Piotr; Bonk, Maciej; Krol, Wieslaw; Szpilyk, Damian; Woyciechowski, Michal			Relative Contribution of Matrix Structure, Patch Resources and Management to the Local Densities of Two Large Blue Butterfly Species	PLOS ONE			English	Article							DIFFERENT SPATIAL SCALES; MACULINEA BUTTERFLIES; FRAGMENTED LANDSCAPES; AGRICULTURAL LANDSCAPES; HABITAT FRAGMENTATION; POPULATION-SIZE; LEPIDOPTERA LYCAENIDAE; METAPOPULATION THEORY; TELEIUS LEPIDOPTERA; ROAD VERGES	The type of matrix, the landscape surrounding habitat patches, may determine the distribution and function of local populations. However, the matrix is often heterogeneous, and its various components may differentially contribute to metapopulation processes at different spatial scales, a phenomenon that has rarely been investigated. The aim of this study was to estimate the relative importance of matrix composition and spatial scale, habitat quality, and management intensity on the occurrence and density of local populations of two endangered large blue butterflies: Phengaris teleius and P. nausithous. Presence and abundance data were assessed over two years, 2011-12, in 100 local patches within two heterogeneous regions (near Krakow and Tarnow, southern Poland). The matrix composition was analyzed at eight spatial scales. We observed high occupancy rates in both species, regions and years. With the exception of area and isolation, almost all of the matrix components contributed to Phengaris sp. densities. The different matrix components acted at different spatial scales (grassland cover within 4 and 3 km, field cover within 0.4 and 0.3 km and water cover within 4 km radii for P. teleius and P. nausithous, respectively) and provided the highest independent contribution to the butterfly densities. Additionally, the effects of a 0.4 km radius of forest cover and a food plant cover on P. teleius, and a 1 km radius of settlement cover and management intensity on P. nausithous densities were observed. Contrary to former studies we conclude that the matrix heterogeneity and spatial scale rather than general matrix type are of relevance for densities of butterflies. Conservation strategies for these umbrella species should concentrate on maintaining habitat quality and managing matrix composition at the most appropriate spatial scales.	[Kajzer-Bonk, Joanna; Nowicki, Piotr; Szpilyk, Damian; Woyciechowski, Michal] Jagiellonian Univ, Inst Environm Sci, Krakow, Poland; [Skorka, Piotr; Bonk, Maciej; Krol, Wieslaw] Polish Acad Sci, Inst Nat Conservat, Krakow, Poland; [Bonk, Maciej] Jagiellonian Univ, Inst Zool, Krakow, Poland	Jagiellonian University; Polish Academy of Sciences; Jagiellonian University	Kajzer-Bonk, J (corresponding author), Jagiellonian Univ, Inst Environm Sci, Krakow, Poland.	joanna.kajzer.bonk@gmail.com	Skórka, Piotr/B-7218-2009; Kajzer-Bonk, Joanna/ABE-1587-2020; Nowicki, Piotr/AFP-2530-2022	Skórka, Piotr/0000-0002-3221-296X; Kajzer-Bonk, Joanna/0000-0003-4063-2785; Skorka, Piotr/0000-0002-7486-2928; Krol, Wieslaw/0000-0002-1217-1654; Nowicki, Piotr/0000-0002-9797-886X	EU FP7 SCALES 410 program [22685]; Polish National Science Centre [N N304 064139, DEC-2013/11/B/NZ8/00912]; Matopolska Foundation; Jagiellonian University [DS/WBiNoZ/INoS/761/10-12]	EU FP7 SCALES 410 program; Polish National Science Centre; Matopolska Foundation; Jagiellonian University	The study was funded by the EU FP7 SCALES 410 program ("Securing the Conservation of biodiversity across Administrative Levels and spatial, temporal and Ecological Scales"; project #22685), the Polish National Science Centre through grants N N304 064139 and DEC-2013/11/B/NZ8/00912, the Matopolska Foundation for PhD Students "Doctus" and the Jagiellonian University through grant DS/WBiNoZ/INoS/761/10-12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Anton C, 2007, MOL ECOL, V16, P3828, DOI 10.1111/j.1365-294X.2007.03441.x; Baguette M, 2004, BASIC APPL ECOL, V5, P213, DOI 10.1016/j.baae.2004.03.001; Banski J, 2010, LANDSCAPE URBAN PLAN, V94, P116, DOI 10.1016/j.landurbplan.2009.08.005; Barton K., MUMIN MULTIMODEL INF; Batary P, 2007, EUR J ENTOMOL, V104, P731, DOI 10.14411/eje.2007.093; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Bender DJ, 2005, ECOLOGY, V86, P1023, DOI 10.1890/03-0769; Bergman KO, 2004, ECOGRAPHY, V27, P619, DOI 10.1111/j.0906-7590.2004.03906.x; Bignal EM, 1996, J APPL ECOL, V33, P413, DOI 10.2307/2404973; Billeter R, 2008, J APPL ECOL, V45, P141, DOI 10.1111/j.1365-2664.2007.01393.x; Bommarco R, 2014, DIVERS DISTRIB, V20, P1; Bonelli S, 2013, POPUL ECOL, V55, P469, DOI 10.1007/s10144-013-0377-2; Botham MS, 2015, J INSECT CONSERV, V19, P403, DOI 10.1007/s10841-015-9760-y; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cattin MF, 2003, BIOL CONSERV, V113, P179, DOI 10.1016/S0006-3207(02)00297-5; Clough Y, 2014, ECOL LETT, V17, P1168, DOI 10.1111/ele.12325; Collins S, 2010, VS2010037 BUTT CONS; Cooch E, 2012, PROGRAM MARK GENTLE; Cozzi G, 2008, LANDSCAPE ECOL, V23, P269, DOI 10.1007/s10980-007-9178-3; Cremene C, 2005, CONSERV BIOL, V19, P1606, DOI 10.1111/j.1523-1739.2005.00084.x; Davis JD, 2007, LANDSCAPE ECOL, V22, P1341, DOI 10.1007/s10980-007-9111-9; Dennis R.L.H., 2010, BUTTERFLIES BRIT LAN; Dennis RLH, 2003, OIKOS, V102, P417, DOI 10.1034/j.1600-0706.2003.12387.x; Didham RK, 2012, OIKOS, V121, P161, DOI 10.1111/j.1600-0706.2011.20273.x; Dierks A, 2009, BIODIVERS CONSERV, V18, P3663, DOI 10.1007/s10531-009-9670-y; Driscoll DA, 2013, TRENDS ECOL EVOL, V28, P605, DOI 10.1016/j.tree.2013.06.010; Ekroos J, 2010, J APPL ECOL, V47, P459, DOI 10.1111/j.1365-2664.2009.01767.x; Elmes GW, 1998, J INSECT CONSERV, V2, P67, DOI 10.1023/A:1009696823965; ELMES GW, 1992, BIODIVERS CONSERV, V1, P155, DOI 10.1007/BF00695913; Eycott AE, 2012, LANDSCAPE ECOL, V27, P1263, DOI 10.1007/s10980-012-9781-9; Fahrig L, 2001, BIOL CONSERV, V100, P65, DOI 10.1016/S0006-3207(00)00208-1; Franklin JF, 2009, P NATL ACAD SCI USA, V106, P349, DOI 10.1073/pnas.0812016105; Gagne SA, 2011, ECOL APPL, V21, P2297, DOI 10.1890/09-1905.1; Grill A, 2008, J INSECT CONSERV, V12, P617, DOI 10.1007/s10841-007-9098-1; Habel JC, 2013, BIODIVERS CONSERV, V22, P2131, DOI 10.1007/s10531-013-0537-x; Hamback PA, 2005, ECOL LETT, V8, P1057, DOI 10.1111/j.1461-0248.2005.00811.x; HANSKI I, 1994, ECOLOGY, V75, P747, DOI 10.2307/1941732; Hanski I, 1996, AM NAT, V147, P527, DOI 10.1086/285864; HANSKI I, 1997, METAPOPULATION BIOL; Hanski Ilkka, 1997, P69, DOI 10.1016/B978-012323445-2/50007-9; Harper KA, 2005, CONSERV BIOL, V19, P768, DOI 10.1111/j.1523-1739.2005.00045.x; Hovestadt T, 2011, J ANIM ECOL, V80, P1070, DOI 10.1111/j.1365-2656.2011.01848.x; Humbert JY, 2012, ENVIRON EVID, V1, DOI 10.1186/2047-2382-1-9; Humbert JY, 2012, BIOL CONSERV, V152, P96, DOI 10.1016/j.biocon.2012.03.015; Johst K, 2006, J APPL ECOL, V43, P333, DOI 10.1111/j.1365-2664.2006.01125.x; Joyce CB, 2014, ECOL ENG, V66, P91, DOI 10.1016/j.ecoleng.2013.05.008; Kacki Z., 2009, OCHRONA ZAGROZONYCH, p[12, 29]; Kajzer-Bonk J, 2016, J INSECT CONSERV, V20, P99, DOI 10.1007/s10841-016-9843-4; Kajzer-Bonk J, 2013, J INSECT CONSERV, V17, P1105, DOI 10.1007/s10841-013-9591-7; Kalarus K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138557; Kleijn D, 2006, BASIC APPL ECOL, V7, P201, DOI 10.1016/j.baae.2005.07.011; Kormann U, 2015, DIVERS DISTRIB, V21, P1204, DOI 10.1111/ddi.12324; Korosi A, 2014, AGR ECOSYST ENVIRON, V196, P24, DOI 10.1016/j.agee.2014.06.019; Krauss J, 2003, J BIOGEOGR, V30, P889, DOI 10.1046/j.1365-2699.2003.00878.x; Kumar S, 2009, BIODIVERS CONSERV, V18, P739, DOI 10.1007/s10531-008-9536-8; Kunes P, 2015, QUATERNARY SCI REV, V116, P15, DOI 10.1016/j.quascirev.2015.03.014; Leidner AK, 2010, CONSERV GENET, V11, P2311, DOI 10.1007/s10592-010-0117-5; Lenda M, 2012, BIOL CONSERV, V148, P180, DOI 10.1016/j.biocon.2012.01.014; Levins R., 1970, SOME MATH PROBLEMS B, P75; Lindenmayer D, 2008, ECOL LETT, V11, P78, DOI 10.1111/j.1461-0248.2007.01114.x; LORITZ H, 2005, STUDIES ECOLOGY CONS, V2, P221; MAC ARTHUR ROBERT H., 1967; Mac Nally R, 2002, BIODIVERS CONSERV, V11, P1397, DOI 10.1023/A:1016250716679; Magura T, 2007, AGR ECOSYST ENVIRON, V119, P396, DOI 10.1016/j.agee.2006.08.014; Marini L, 2014, ECOGRAPHY, V37, P544, DOI 10.1111/j.1600-0587.2013.00369.x; Marini L, 2009, INSECT CONSERV DIVER, V2, P213, DOI 10.1111/j.1752-4598.2009.00053.x; MARTIN J., 1999, NATURE ENV, V97; Martins IS, 2014, ACTA OECOL, V61, P41, DOI 10.1016/j.actao.2014.10.005; Marzluff John M., 2001, P19; Mendenhall CD, 2014, NATURE, V509, P213, DOI 10.1038/nature13139; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nowicki P, 2005, POPUL ECOL, V47, P203, DOI 10.1007/s10144-005-0223-2; Nowicki P, 2007, BIOL CONSERV, V140, P119, DOI 10.1016/j.biocon.2007.08.001; Nowicki P, 2014, LANDSCAPE ECOL, V29, P401, DOI 10.1007/s10980-013-9971-0; Nowicki P, 2011, OECOLOGIA, V167, P657, DOI 10.1007/s00442-011-2025-x; Nowicki Piotr, 2005, P144; Nowicki P, 2009, OECOLOGIA, V161, P227, DOI 10.1007/s00442-009-1373-2; Ockinger E, 2012, ECOGRAPHY, V35, P259, DOI [10.1111/ j. 1600- 0587.2011.06870, DOI 10.1111/J.1600-0587.2011.06870]; Ovaskainen O, 2002, J THEOR BIOL, V215, P95, DOI 10.1006/jtbi.2001.2502; Pereira HM, 2006, ECOLOGY, V87, P1877, DOI 10.1890/0012-9658(2006)87[1877:MBDICL]2.0.CO;2; Poyry J, 2009, OECOLOGIA, V160, P577, DOI 10.1007/s00442-009-1328-7; Prevedello JA, 2010, BIODIVERS CONSERV, V19, P1205, DOI 10.1007/s10531-009-9750-z; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; Pykala J, 2000, CONSERV BIOL, V14, P705, DOI 10.1046/j.1523-1739.2000.99119.x; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Ries L, 2001, J ANIM ECOL, V70, P840, DOI 10.1046/j.0021-8790.2001.00546.x; Pedro ARS, 2015, LANDSCAPE ECOL, V30, P1561, DOI 10.1007/s10980-015-0213-5; Roland J, 2000, ECOLOGY, V81, P1642, DOI 10.1890/0012-9658(2000)081[1642:APBDEO]2.0.CO;2; Rosin ZM, 2011, EUR J ENTOMOL, V108, P99, DOI 10.14411/eje.2011.013; Saunders SC, 2005, ECOL COMPLEX, V2, P87, DOI 10.1016/j.ecocom.2004.11.002; Schippers P, 2002, AGR ECOSYST ENVIRON, V93, P351, DOI 10.1016/S0167-8809(01)00339-5; Skorka P, 2007, AGR ECOSYST ENVIRON, V121, P319, DOI 10.1016/j.agee.2006.11.001; Skorka P, 2016, LANDSCAPE ECOL, V31, P2063, DOI 10.1007/s10980-016-0382-x; Skorka P, 2013, LANDSCAPE ECOL, V28, P533, DOI 10.1007/s10980-013-9855-3; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Sweaney N, 2014, J INSECT CONSERV, V18, P283, DOI 10.1007/s10841-014-9641-9; Thomas J, 1980, ORYX, V15, P243; Thomas J. A., 2005, STUDIES ECOLOGY CONS, V2, P28; Thomas JA, 2004, NATURE, V432, P283, DOI 10.1038/432283a; THOMAS JA, 1989, OECOLOGIA, V79, P452, DOI 10.1007/BF00378660; Thomas JA, 1998, INSECT POPULATIONS IN THEORY AND IN PRACTICE, P261; Trzcinski MK, 1999, ECOL APPL, V9, P586, DOI 10.1890/1051-0761(1999)009[0586:IEOFCA]2.0.CO;2; Tyler GA, 1998, BIRD STUDY, V45, P35, DOI 10.1080/00063659809461076; Valtonen A., 2006, Animal Biodiversity and Conservation, V29, P133; Van Dyck H, 2005, BASIC APPL ECOL, V6, P535, DOI 10.1016/j.baae.2005.03.005; Villemey A, 2015, BIOL CONSERV, V191, P206, DOI 10.1016/j.biocon.2015.06.030; Walasz K., 2015, OCHRONA KRAJOBRAZU Z; WallisDeVries MF, 2004, CONSERV BIOL, V18, P489; Walsh C., 2005, HIER PART PACKAGE VE; Weibull AC, 2000, ECOGRAPHY, V23, P743, DOI 10.1034/j.1600-0587.2000.230611.x; Westphal MI, 2003, LANDSCAPE ECOL, V18, P413, DOI 10.1023/A:1026115807529; Wettstein W, 1999, J APPL ECOL, V36, P363, DOI 10.1046/j.1365-2664.1999.00404.x; WIKUM DA, 1978, ENVIRON MANAGE, V2, P323, DOI 10.1007/BF01866672; Winter M, 2006, J WILDLIFE MANAGE, V70, P158, DOI 10.2193/0022-541X(2006)70[158:PSALEO]2.0.CO;2; Witek M, 2006, OECOLOGIA, V148, P729, DOI 10.1007/s00442-006-0404-5; Wu JG, 2004, LANDSCAPE ECOL, V19, P125, DOI 10.1023/B:LAND.0000021711.40074.ae; Wynhoff I, 2011, J INSECT CONSERV, V15, P189, DOI 10.1007/s10841-010-9337-8; Wysocki C., 2002, FITOSOCJOLOGIA STOSO; Yan H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102124; [No title captured]	121	7	7	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168679	10.1371/journal.pone.0168679	http://dx.doi.org/10.1371/journal.pone.0168679			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005942	Green Published, gold			2022-12-26	WOS:000392843200079
J	Laker, RC; Taddeo, EP; Akhtar, YN; Zhang, M; Hoehn, KL; Yan, Z				Laker, Rhianna C.; Taddeo, Evan P.; Akhtar, Yasir N.; Zhang, Mei; Hoehn, Kyle L.; Yan, Zhen			The Mitochondrial Permeability Transition Pore Regulator Cyclophilin D Exhibits Tissue-Specific Control of Metabolic Homeostasis	PLOS ONE			English	Article							MEMBRANE; TRANSLOCATOR; TARGET	The mitochondrial permeability transition pore (mPTP) is a key regulator of mitochondrial function that has been implicated in the pathogenesis of metabolic disease. Cyclophilin D (CypD) is a critical regulator that directly binds to mPTP constituents to facilitate the pore opening. We previously found that global CypD knockout mice (KO) are protected from diet-induced glucose intolerance; however, the tissue-specific function of CypD and mPTP, particularly in the control of glucose homeostasis, has not been ascertained. To this end, we performed calcium retention capacity (CRC) assay to compare the importance of CypD in the liver versus skeletal muscle. We found that liver mitochondria are more dependent on CypD for mPTP opening than skeletal muscle mitochondria. To ascertain the tissue-specific role of CypD in metabolic homeostasis, we generated liver-specific and muscle-specific CypD knockout mice (LKO and MKO, respectively) and fed them either a chow diet or 45% high-fat diet (HFD) for 14 weeks. MKO mice displayed similar body weight gain and glucose intolerance compared with wild type littermates (WT), whereas LKO mice developed greater visceral obesity, glucose intolerance and pyruvate intolerance compared with WT mice. These findings demonstrate that loss of muscle CypD is not sufficient to alter whole body glucose metabolism, while the loss of liver CypD exacerbates obesity and whole-body metabolic dysfunction in mice fed HFD.	[Laker, Rhianna C.; Akhtar, Yasir N.; Zhang, Mei; Yan, Zhen] Univ Virginia, Sch Med, Dept Med, Charlottesville, VA 22908 USA; [Laker, Rhianna C.; Akhtar, Yasir N.; Zhang, Mei; Hoehn, Kyle L.; Yan, Zhen] Univ Virginia, Sch Med, Ctr Skeletal Muscle Res Robert M Berne Cardiovasc, Charlottesville, VA 22908 USA; [Taddeo, Evan P.; Hoehn, Kyle L.; Yan, Zhen] Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA; [Yan, Zhen] Univ Virginia, Sch Med, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Yan, Z (corresponding author), Univ Virginia, Sch Med, Dept Med, Charlottesville, VA 22908 USA.; Yan, Z (corresponding author), Univ Virginia, Sch Med, Ctr Skeletal Muscle Res Robert M Berne Cardiovasc, Charlottesville, VA 22908 USA.; Yan, Z (corresponding author), Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA.; Yan, Z (corresponding author), Univ Virginia, Sch Med, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA.	zhen.yan@virginia.edu		Yan, Zhen/0000-0002-4826-9813; Hoehn, Kyle/0000-0002-0214-3238	American Heart Association Postdoctoral Fellowship [14POST20450061]; American Diabetes Association Junior Faculty Award [1-11-JF-17]; American Diabetes Association Basic Research Award [1-11-BS-181]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101803] Funding Source: NIH RePORTER	American Heart Association Postdoctoral Fellowship(American Heart Association); American Diabetes Association Junior Faculty Award(American Diabetes Association); American Diabetes Association Basic Research Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the American Heart Association Postdoctoral Fellowship to RCL (14POST20450061), American Diabetes Association Junior Faculty Award to KLH (1-11-JF-17) and an American Diabetes Association Basic Research Award to ZY (1-11-BS-181). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS V, 1989, BIOCHIM BIOPHYS ACTA, V981, P213, DOI 10.1016/0005-2736(89)90031-X; Akimoto T, 2004, AM J PHYSIOL-CELL PH, V287, pC1311, DOI 10.1152/ajpcell.00248.2004; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; BUCHELER K, 1991, BIOCHIM BIOPHYS ACTA, V1056, P233, DOI 10.1016/S0005-2728(05)80054-4; Csukly K, 2006, J PHYSIOL-LONDON, V574, P319, DOI 10.1113/jphysiol.2006.109702; Deutsch MJ, 2014, ANAL BIOCHEM, V445, P87, DOI 10.1016/j.ab.2013.10.001; Devalaraja-Narashimha K, 2011, FEBS LETT, V585, P677, DOI 10.1016/j.febslet.2011.01.031; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Elrod JW, 2013, CIRC J, V77, P1111, DOI 10.1253/circj.CJ-13-0321; Endlicher Rene, 2009, Acta Medica (Hradec Kralove), V52, P69; Fontaine E, 1998, J BIOL CHEM, V273, P12662, DOI 10.1074/jbc.273.20.12662; Giorgi C, 2012, MITOCHONDRION, V12, P77, DOI 10.1016/j.mito.2011.07.004; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Giorgio V, 2009, J BIOL CHEM, V284, P33982, DOI 10.1074/jbc.M109.020115; Halestrap AP, 1997, J BIOL CHEM, V272, P3346, DOI 10.1074/jbc.272.6.3346; Halestrap AP, 1998, BBA-BIOENERGETICS, V1366, P79, DOI 10.1016/S0005-2728(98)00122-4; Hansson MJ, 2011, J NEUROTRAUM, V28, P143, DOI 10.1089/neu.2010.1613; Hausenloy DJ, 2010, CARDIOVASC RES, V88, P67, DOI 10.1093/cvr/cvq113; He LH, 2002, FEBS LETT, V512, P1, DOI 10.1016/S0014-5793(01)03314-2; Huser J, 1999, BIOCHEM J, V343, P311, DOI 10.1042/0264-6021:3430311; Javadov S, 2009, J PHARMACOL EXP THER, V330, P670, DOI 10.1124/jpet.109.153213; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Krauskopf A, 2006, BBA-BIOENERGETICS, V1757, P590, DOI 10.1016/j.bbabio.2006.02.007; Luvisetto S, 2008, NEUROSCIENCE, V155, P585, DOI 10.1016/j.neuroscience.2008.06.030; Nguyen TT, 2011, J BIOL CHEM, V286, P40184, DOI 10.1074/jbc.M111.243469; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Rodriguez-Enriquez S, 2004, INT J BIOCHEM CELL B, V36, P2463, DOI 10.1016/j.biocel.2004.04.009; Rodriguez-Enriquez S, 2009, AUTOPHAGY, V5, P1099, DOI 10.4161/auto.5.8.9825; Shang W, 2016, J MOL CELL CARDIOL, V91, P63, DOI 10.1016/j.yjmcc.2015.10.036; Taddeo EP, 2014, MOL METAB, V3, P124, DOI 10.1016/j.molmet.2013.11.003; Tavecchio M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15981; Tubbs E, 2014, DIABETES, V63, P3279, DOI 10.2337/db13-1751; Vyssokikh MY, 2001, BIOCHEM J, V358, P349, DOI 10.1042/0264-6021:3580349; Zorov DB, 2009, CARDIOVASC RES, V83, P213, DOI 10.1093/cvr/cvp151	35	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0167910	10.1371/journal.pone.0167910	http://dx.doi.org/10.1371/journal.pone.0167910			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005946	Green Published, Green Submitted, gold			2022-12-26	WOS:000392843200023
J	Langkilde, A; Olsen, LC; Saetrom, P; Drablos, F; Besenbacher, S; Raaby, L; Johansen, C; Iversen, L				Langkilde, Ane; Olsen, Lene C.; Saetrom, Pal; Drablos, Finn; Besenbacher, Soren; Raaby, Line; Johansen, Claus; Iversen, Lars			Pathway Analysis of Skin from Psoriasis Patients after Adalimumab Treatment Reveals New Early Events in the Anti-Inflammatory Mechanism of Anti-TNF-alpha	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; NECROSIS-FACTOR-ALPHA; LARGE GENE LISTS; RHEUMATOID-ARTHRITIS; CLINICAL-TRIAL; THERAPY; INHIBITION; CELLS; INFLIXIMAB; AXIS	Psoriasis is a chronic cutaneous inflammatory disease. The immunopathogenesis is a complex interplay between T cells, dendritic cells and the epidermis in which T cells and dendritic cells maintain skin inflammation. Anti-tumour necrosis factor (anti-INF)-a agents have been approved for therapeutic use across a range of inflammatory disorders including psoriasis, but the anti-inflammatory mechanisms of anti-INF-a in lesional psoriatic skin are not fully understood. We investigated early events in skin from psoriasis patients after treatment with anti-INF-a antibodies by use of bioinformatics tools. We used the Human Gene 1.0 ST Array to analyse gene expression in punch biopsies taken from psoriatic patients before and also 4 and 14 days after initiation of treatment with the anti-INF-a agent adalimumab. The gene expression was analysed by gene set enrichment analysis using the Functional Annotation Tool from DAVID Bioinformatics Resources. The most enriched pathway was visualised by the Pathview Package on Kyoto Encyclopedia of Genes and Genomes (KEGG) graphs. The analysis revealed new very early events in psoriasis after adalimumab treatment. Some of these events have been described after longer periods of anti-INF-a treatment when clinical and histological changes appear, suggesting that effects of anti-INF-a treatment on gene expression appear very early before clinical and histological changes. Combining microarray data on biopsies from psoriasis patients with pathway analysis allowed us to integrate in vitro findings into the identification of mechanisms that may be important in vivo. Furthermore, these results may reflect primary effect of anti-INF-a treatment in contrast to studies of gene expression changes following clinical and histological changes, which may reflect secondary changes correlated to the healing of the skin.	[Langkilde, Ane; Raaby, Line; Johansen, Claus; Iversen, Lars] Aarhus Univ Hosp, Dept Dermatol, Aarhus C, Denmark; [Olsen, Lene C.; Saetrom, Pal; Drablos, Finn] Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Fac Med, Trondheim, Norway; [Saetrom, Pal] Norwegian Univ Sci & Technol NTNU, Fac Informat Technol Math & Elect Engn, Dept Comp & Informat Sci, Trondheim, Norway; [Besenbacher, Soren] Aarhus Univ, Bioinformat Res Ctr, Aarhus C, Denmark	Aarhus University; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Aarhus University	Iversen, L (corresponding author), Aarhus Univ Hosp, Dept Dermatol, Aarhus C, Denmark.	lars.iversen@clin.au.dk	Sætrom, Pål/AAH-1216-2019; Drablos, Finn/L-4970-2019	Sætrom, Pål/0000-0001-8142-7441; Drablos, Finn/0000-0001-5794-828X; Johansen, Claus/0000-0002-5665-5212; Johansen, Claus/0000-0003-0240-5127; Olsen, Lene Christin/0000-0002-5869-4952; Iversen, Lars/0000-0003-1816-4508; Besenbacher, Soren/0000-0003-1455-1738; Raaby, Line/0000-0002-3327-9613	Aase og Einar Danielsens Fond; A.P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til almene Formaal-Fonden til Laegevidenskabens Fremme; Kongelig Hofbuntmager Aage Bangs Fond	Aase og Einar Danielsens Fond; A.P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til almene Formaal-Fonden til Laegevidenskabens Fremme; Kongelig Hofbuntmager Aage Bangs Fond	This work was supported by Aase og Einar Danielsens Fond, http://www.danielsensfond.dk/Default.aspx (AL); A.P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til almene Formaal-Fonden til Laegevidenskabens Fremme, http://www.apmollerfonde.dk/ansoegning/laegefonden.aspx (AL) and Kongelig Hofbuntmager Aage Bangs Fond (AL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banno T, 2004, J BIOL CHEM, V279, P32633, DOI 10.1074/jbc.M400642200; Bose F, 2013, AM J PATHOL, V183, P413, DOI 10.1016/j.ajpath.2013.04.021; Bose F, 2011, CLIN IMMUNOL, V139, P164, DOI 10.1016/j.clim.2011.01.015; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Campanati A, 2014, ARCH DERMATOL RES, V306, P915, DOI 10.1007/s00403-014-1493-3; Chen L, 2013, J INVEST DERMATOL, V133, P418, DOI 10.1038/jid.2012.333; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Dominical VM, 2011, J IMMUNOL, V73, P309, DOI [10.1111/j.1365-3083.2011.02503.x, DOI 10.1111/J.1365-3083.2011.02503.X]; El Malki K, 2013, J INVEST DERMATOL, V133, P441, DOI 10.1038/jid.2012.318; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; Fitch Erin, 2007, Curr Rheumatol Rep, V9, P461, DOI 10.1007/s11926-007-0075-1; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Goldminz AM, 2015, JAMA DERMATOL, V151, P837, DOI 10.1001/jamadermatol.2015.0452; Gottlieb AB, 2005, J IMMUNOL, V175, P2721, DOI 10.4049/jimmunol.175.4.2721; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jani M, 2014, RHEUMATOLOGY, V53, P213, DOI 10.1093/rheumatology/ket260; Johansen C, 2010, BRIT J DERMATOL, V163, P1194, DOI 10.1111/j.1365-2133.2010.10036.x; Kalden JR, 2008, CLIN EXP RHEUMATOL, V26, P834; Katou F, 2003, J PATHOL, V199, P98, DOI 10.1002/path.1255; Keermann M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1508-2; Kemp DM, 2007, BIOINFORMATICS, V23, P1356, DOI 10.1093/bioinformatics/btm116; Klimiuk PA, 2006, CLIN EXP RHEUMATOL, V24, P529; Kyle S, 2005, RHEUMATOLOGY, V44, P390, DOI 10.1093/rheumatology/keh514; LARSEN CG, 1989, SCIENCE, V243, P1464, DOI 10.1126/science.2648569; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Lun SWM, 2007, INT IMMUNOPHARMACOL, V7, P1668, DOI 10.1016/j.intimp.2007.08.021; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Marina Mihaela Elena, 2015, Clujul Med, V88, P247, DOI 10.15386/cjmed-494; Miele E, 2004, J PEDIATR GASTR NUTR, V38, P502, DOI 10.1097/00005176-200405000-00008; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Otkjaer K, 2005, BRIT J DERMATOL, V153, P911, DOI 10.1111/j.1365-2133.2005.06800.x; Paleolog EM, 1998, ARTHRITIS RHEUM, V41, P1258, DOI 10.1002/1529-0131(199807)41:7<1258::AID-ART17>3.0.CO;2-1; Piaserico S, 2014, DRUG DEVELOP RES, V75, pS73, DOI 10.1002/ddr.21202; Pickens SR, 2011, ARTHRITIS RHEUM-US, V63, P914, DOI 10.1002/art.30232; Plasencia C, 2012, ANN RHEUM DIS, V71, P1955, DOI 10.1136/annrheumdis-2011-200828; Raychaudhuri SP, 2001, J EUR ACAD DERMATOL, V15, P16, DOI 10.1046/j.1468-3083.2001.00192.x; Reich K, 2015, EXP DERMATOL, V24, P529, DOI 10.1111/exd.12710; Ritchie M.E., 2018, LIMMA POWERS DIFFERE, V43, DOI [10.1093/nar/gkv007, DOI 10.1093/NAR/GKV007]; Saxena V, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl766; SLOMINSKI A, 2013, J STEROID BIOCHEM, V137, P107, DOI [10.1016/.jsbmb.2013.02.006, DOI 10.1016/J.JSBMB.2013.02.006]; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Slominski Andrzej T, 2012, Adv Anat Embryol Cell Biol, V212, P1; Soegaard-Madsen L, 2010, BRIT J DERMATOL, V162, P1216, DOI 10.1111/j.1365-2133.2010.09706.x; Takekoshi T, 2013, J INVEST DERMATOL, V133, P2530, DOI 10.1038/jid.2013.151; Witte E, 2015, J MOL MED BERL; Wolfle U, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/630128; Wongpiyabovorn J, 2003, J DERMATOL SCI, V33, P31, DOI 10.1016/S0923-1811(03)00148-8; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Zaba LC, 2007, J EXP MED, V204, P3183, DOI 10.1084/jem.20071094; Zaba LC, 2009, J ALLERGY CLIN IMMUN, V124, P1022, DOI 10.1016/j.jaci.2009.08.046; Zhou A, 2003, ONCOGENE, V22, P2054, DOI 10.1038/sj.onc.1206262; Zhou XH, 2003, PHYSIOL GENOMICS, V13, P69, DOI 10.1152/physiolgenomics.00157.2002	53	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0167437	10.1371/journal.pone.0167437	http://dx.doi.org/10.1371/journal.pone.0167437			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005985	Green Published, gold			2022-12-26	WOS:000392843200018
J	Sbiera, S; Tryfonidou, MA; Weigand, I; Grinwis, GCM; Broeckx, B; Herterich, S; Allolio, B; Deutschbein, T; Fassnacht, M; Meij, BP				Sbiera, Silviu; Tryfonidou, Marianna A.; Weigand, Isabel; Grinwis, Guy C. M.; Broeckx, Bart; Herterich, Sabine; Allolio, Bruno; Deutschbein, Timo; Fassnacht, Martin; Meij, Bjorn P.			Lack of Ubiquitin Specific Protease 8 (USP8) Mutations in Canine Corticotroph Pituitary Adenomas	PLoS One			English	Article							CUSHINGS-DISEASE; DEPENDENT HYPERADRENOCORTICISM; TRANSSPHENOIDAL HYPOPHYSECTOMY; MEDICAL-MANAGEMENT; DOGS; TUMORS; CELLS	Purpose Cushing's disease (CD), also known as pituitary-dependent hyperadrenocorticism, is caused by adrenocorticotropic hormone (ACTH)-secreting pituitary tumours. Affected humans and dogs have similar clinical manifestations, however, the incidence of the canine disease is thousand-fold higher. This makes the dog an obvious model for studying the pathogenesis of pituitary-dependent hyperadrenocorticism. Despite certain similarities identified at the molecular level, the question still remains whether the two species have a shared oncogenetic background. Recently, hotspot recurrent mutations in the gene encoding for ubiquitin specific protease 8 (USP8) have been identified as the main driver behind the formation of ACTH-secreting pituitary adenomas in humans. In this study, we aimed to verify whether USP8 mutations also play a role in the development of such tumours in dogs. Methods Presence of USP8 mutations was analysed by Sanger and PCR-cloning sequencing in 38 canine ACTH-secreting adenomas. Furthermore, the role of USP8 and EGFR protein expression was assessed by immunohistochemistry in a subset of 25 adenomas. Results None of the analysed canine ACTH-secreting adenomas presented mutations in the USP8 gene. In a subset of these adenomas, however, we observed an increased nuclear expression of USP8, a phenotype characteristic for the USP8 mutated human tumours, that correlated with smaller tumour size but elevated ACTH production in those tumours. Conclusions Canine ACTH-secreting pituitary adenomas lack mutations in the USP8 gene suggesting a different genetic background of pituitary tumourigenesis in dogs. However, elevated nuclear USP8 protein expression in a subset of tumours was associated with a similar phenotype as in their human counterparts, indicating a possible end-point convergence of the different genetic backgrounds in the two species. In order to establish the dog as a useful animal model for the study of CD, further comprehensive studies are needed.	[Sbiera, Silviu; Weigand, Isabel; Allolio, Bruno; Fassnacht, Martin] Univ Wurzburg, Univ Hosp Wurzburg, Div Endocrinol & Diabet, Dept Internal Med 1, Wurzburg, Germany; [Tryfonidou, Marianna A.; Meij, Bjorn P.] Univ Utrecht, Dept Clin Sci Compan Anim, Fac Vet Med, Utrecht, Netherlands; [Grinwis, Guy C. M.] Univ Utrecht, Dept Pathobiol, Vet Pathol Diagnost Ctr, Fac Vet Med, Utrecht, Netherlands; [Broeckx, Bart; Fassnacht, Martin] Univ Ghent, Fac Pharmaceut Sci, Lab Pharmaceut Biotechnol, Ghent, Belgium; [Herterich, Sabine; Deutschbein, Timo] Univ Wurzburg, Univ Hosp Wurzburg, Clin Chem & Lab Med, Wurzburg, Germany; [Fassnacht, Martin] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany	University of Wurzburg; Utrecht University; Utrecht University; Ghent University; University of Wurzburg; University of Wurzburg	Sbiera, S (corresponding author), Univ Wurzburg, Univ Hosp Wurzburg, Div Endocrinol & Diabet, Dept Internal Med 1, Wurzburg, Germany.	Sbiera_S@ukw.de	Broeckx, Bart/AAH-3940-2021; Sbiera, Silviu/E-8128-2019; Deutschbein, Timo/AAI-4662-2020; Fassnacht, Martin/N-9614-2019; Tryfonidou, Marianna/O-3114-2017	Broeckx, Bart/0000-0001-6742-3911; Sbiera, Silviu/0000-0002-6271-5533; Fassnacht, Martin/0000-0001-6170-6398; Grinwis, Guy/0000-0002-1583-9648; Tryfonidou, Marianna/0000-0002-2333-7162	Deutsche Forschungsgemeinschaft [SB 52/1-1, FA 466/5-1, DE 2657/1-1]; IZKF Wurzburg [Z-2/57, B-281]; ERA-NET "E-Rare" [01GM1407B]; Novartis-Stiftung fur theraputische Forschung; Deutsche Forschungsgemeinschaft (DFG); University of Wuerzburg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IZKF Wurzburg; ERA-NET "E-Rare"; Novartis-Stiftung fur theraputische Forschung; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This study was funded by Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/) (grant SB 52/1-1 to SS, grant FA 466/5-1 to ME and grant DE 2657/1-1 to TD), IZKF Wurzburg (http://www.izkf.ukw.de/) (grant Z-2/57 to TD and grant B-281 to ME), the ERA-NET "E-Rare" (http://www.erare.eu/) (grant 01GM1407B to ME) and a fellowship from the Novartis-Stiftung fur theraputische Forschung to SS. In addition, publication costs are covered partially by the Deutsche Forschungsgemeinschaft (DFG) and the University of Wuerzburg through the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assie G, 2014, NAT GENET, V46, P607, DOI 10.1038/ng.2953; Biller BMK, 2008, J CLIN ENDOCR METAB, V93, P2454, DOI 10.1210/jc.2007-2734; Broeckx BJG, 2015, SCI REP-UK, V5, DOI 10.1038/srep12810; de Bruin C, 2009, HORM RES, V71, P140, DOI 10.1159/000178058; Dorton A M, 2000, Neonatal Netw, V19, P9; ETXABE J, 1994, CLIN ENDOCRINOL, V40, P479, DOI 10.1111/j.1365-2265.1994.tb02486.x; Feelders RA, 2013, J CLIN ENDOCR METAB, V98, P425, DOI 10.1210/jc.2012-3126; Fukuoka H, 2011, J CLIN INVEST, V121, P4712, DOI 10.1172/JCI60417; Galac S, 1997, VET QUART, V19, P17, DOI 10.1080/01652176.1997.9694731; HALMI NS, 1981, SCIENCE, V211, P72, DOI 10.1126/science.6255564; Hamrahian AH, 2014, ENDOCR PRACT, V20, P746, DOI 10.4158/EP14147.RA; Hanson JM, 2007, J NEUROSURG, V107, P830, DOI 10.3171/JNS-07/10/0830; Hanson JM, 2005, J VET INTERN MED, V19, P687, DOI 10.1892/0891-6640(2005)19[687:EOTHIT]2.0.CO;2; Hayashi K, 2016, EUR J ENDOCRINOL, V174, P213, DOI 10.1530/EJE-15-0689; KEMPPAINEN RJ, 1989, ENDOCRINOLOGY, V124, P2208, DOI 10.1210/endo-124-5-2208; Kooistra HS, 1997, J ENDOCRINOL, V152, P387, DOI 10.1677/joe.0.1520387; Lindholm J, 2001, J CLIN ENDOCR METAB, V86, P117, DOI 10.1210/jc.86.1.117; Ma ZY, 2015, CELL RES, V25, P306, DOI 10.1038/cr.2015.20; Mayer MN, 2007, CAN VET J, V48, P316; Meij BP, 1998, VET SURG, V27, P246, DOI 10.1111/j.1532-950X.1998.tb00123.x; Meij BP, 1997, VET SURG, V26, P295, DOI 10.1111/j.1532-950X.1997.tb01502.x; Meij BP, 2001, VET CLIN N AM-SMALL, V31, P1015, DOI 10.1016/S0195-5616(01)50011-X; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Perez-Rivas LG, 2015, J CLIN ENDOCR METAB, V100, pE997, DOI 10.1210/jc.2015-1453; Reincke M, 2015, NAT GENET, V47, P31, DOI 10.1038/ng.3166; Reine NJ, 2007, CLIN TECH SMALL AN P, V22, P18, DOI 10.1053/j.ctsap.2007.02.003; Rowell JL, 2011, TRENDS MOL MED, V17, P380, DOI 10.1016/j.molmed.2011.02.004; Sbiera S, 2013, HORM METAB RES, V45, P137, DOI 10.1055/s-0032-1327750; Sbiera S, 2015, TRENDS ENDOCRIN MET, V26, P573, DOI 10.1016/j.tem.2015.08.003; Thuroczy J, 1998, ACTA VET HUNG, V46, P157; van Rijn SJ, 2010, DOMEST ANIM ENDOCRIN, V38, P244, DOI 10.1016/j.domaniend.2009.11.003	31	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0169009	10.1371/journal.pone.0169009	http://dx.doi.org/10.1371/journal.pone.0169009			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005997	Green Submitted, Green Published, gold			2022-12-26	WOS:000392843200122
J	Poulet, B; Liu, K; Plumb, D; Vo, P; Shah, M; Staines, K; Sampson, A; Nakamura, H; Nagase, H; Carriero, A; Shefelbine, S; Pitsillides, AA; Bou-Gharios, G				Poulet, Blandine; Liu, Ke; Plumb, Darren; Vo, Phoung; Shah, Mittal; Staines, Katherine; Sampson, Alexandra; Nakamura, Hiroyuki; Nagase, Hideaki; Carriero, Alessandra; Shefelbine, Sandra; Pitsillides, Andrew A.; Bou-Gharios, George			Overexpression of TIMP-3 in Chondrocytes Produces Transient Reduction in Growth Plate Length but Permanently Reduces Adult Bone Quality and Quantity	PLoS One			English	Article							TISSUE INHIBITOR; MATRIX METALLOPROTEINASES; GENE-EXPRESSION; TRANSGENIC MICE; OSTEOBLASTS; DIFFERENTIATION; COLLAGEN; CARTILAGE; CELLS; OSTEOCYTES	Bone development and length relies on the growth plate formation, which is dependent on degradative enzymes such as MMPs. Indeed, deletion of specific members of this enzyme family in mice results in important joint and bone abnormalities, suggesting a role in skeletal development. As such, the control of MMP activity is vital in the complex process of bone formation and growth. We generated a transgenic mouse line to overexpress TIMP3 in mouse chondrocytes using the Col2a1-chondrocyte promoter. This overexpression in cartilage resulted in a transient shortening of growth plate in homozygote mice but bone length was restored at eight weeks of age. However, tibial bone structure and mechanical properties remained compromised. Despite no transgene expression in adult osteoblasts from transgenic mice in vitro, their differentiation capacity was decreased. Neonates, however, did show transgene expression in a subset of bone cells. Our data demonstrate for the first time that transgene function persists in the chondro-osseous lineage continuum and exert influence upon bone quantity and quality.	[Poulet, Blandine; Liu, Ke; Plumb, Darren; Bou-Gharios, George] Univ Liverpool, Inst Ageing & Chron Dis, Dept Musculoskeletal Biol, Apex Bldg, Liverpool, Merseyside, England; [Vo, Phoung; Nakamura, Hiroyuki; Nagase, Hideaki] Kennedy Inst Rheumatol, Oxford, England; [Shah, Mittal; Staines, Katherine; Sampson, Alexandra; Pitsillides, Andrew A.] Royal Vet Coll, Comparat Biomed Sci, London, England; [Carriero, Alessandra] Florida Inst Technol, Dept Biomed Engn, Melbourne, FL 32901 USA; [Shefelbine, Sandra] Northeastern Univ, Coll Engn, Boston, MA 02115 USA	University of Liverpool; University of Oxford; University of London; University of London Royal Veterinary College; Florida Institute of Technology; Northeastern University	Bou-Gharios, G (corresponding author), Univ Liverpool, Inst Ageing & Chron Dis, Dept Musculoskeletal Biol, Apex Bldg, Liverpool, Merseyside, England.	ggharios@liverpool.ac.uk	Staines, Katherine/AAF-6823-2020; nakamura, hiroyuki/A-2953-2013; Carriero, Alessandra/D-7893-2013	nakamura, hiroyuki/0000-0002-2524-3063; Nagase, Hideaki/0000-0002-8563-2263; Poulet, Blandine/0000-0002-9224-5253; Staines, Katherine/0000-0002-8492-9778; Bou-Gharios, George/0000-0002-9563-9418; Carriero, Alessandra/0000-0001-8103-4795	Arthritis Research UK [20039, 18768]; BBSRC [BB/1014608/1]; Orthopaedic Research UK [471]; BBSRC [BB/I014608/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I014608/1] Funding Source: researchfish; Versus Arthritis [20581, 20859, 20039] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Orthopaedic Research UK; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Versus Arthritis(Versus Arthritis)	This study was funded by Arthritis Research UK (20039, 18768), BBSRC (grant BB/1014608/1) and Orthopaedic Research UK (project 471). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APTE SS, 1994, DEV DYNAM, V200, P177, DOI 10.1002/aja.1002000302; Barthelemi S, 2012, J CELL BIOCHEM, V113, P760, DOI 10.1002/jcb.23401; Basu R, 2013, CARDIOVASC RES, V98, P360, DOI 10.1093/cvr/cvt067; Carriero A, 2014, J BIOMECH, V47, P2490, DOI 10.1016/j.jbiomech.2014.03.035; Carriero A, 2014, J BONE MINER RES, V29, P1392, DOI 10.1002/jbmr.2172; de la Pena S, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/285906; Fan D, 2014, CARDIOVASC RES, V103, P268, DOI 10.1093/cvr/cvu072; Gendron C, 2003, FEBS LETT, V555, P431, DOI 10.1016/S0014-5793(03)01295-X; Govoni KE, 2007, PHYSIOL GENOMICS, V30, P354, DOI 10.1152/physiolgenomics.00022.2007; Guevremont M, 2003, J BONE MINER RES, V18, P1073, DOI 10.1359/jbmr.2003.18.6.1073; Haeusler G, 2005, CALCIFIED TISSUE INT, V76, P326, DOI 10.1007/s00223-004-0161-6; Hatori K, 2004, ANAT REC PART A, V277A, P262, DOI 10.1002/ar.a.20007; Hayami T, 2008, MATRIX BIOL, V27, P682, DOI 10.1016/j.matbio.2008.07.005; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Jiang J, 2005, BIOCHEM BIOPH RES CO, V338, P762, DOI 10.1016/j.bbrc.2005.10.025; Karsdal MA, 2004, DNA CELL BIOL, V23, P155, DOI 10.1089/104454904322964751; Kulkarni RN, 2012, BIOCHEM BIOPH RES CO, V417, P824, DOI 10.1016/j.bbrc.2011.12.045; Leco KJ, 2001, J CLIN INVEST, V108, P817, DOI 10.1172/JCI12067; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeda Y, 2007, P NATL ACAD SCI USA, V104, P6382, DOI 10.1073/pnas.0608449104; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Manduca P, 2009, BONE, V44, P251, DOI 10.1016/j.bone.2008.10.046; Murphy G, 2008, NAT CLIN PRACT RHEUM, V4, P128, DOI 10.1038/ncprheum0727; Nieminen J, 2008, CALCIFIED TISSUE INT, V82, P229, DOI 10.1007/s00223-008-9110-0; Ono N, 2014, NAT CELL BIOL, V16, P1157, DOI 10.1038/ncb3067; Prideaux M, 2015, GENE EXPR PATTERNS, V18, P29, DOI 10.1016/j.gep.2015.04.004; Rosewell KL, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.112.106989; Sahebjam S, 2007, ARTHRITIS RHEUM, V56, P905, DOI 10.1002/art.22427; Saxon LK, 2011, BONE, V49, P184, DOI 10.1016/j.bone.2011.03.683; Shah M, 2010, BONE, V47, P309, DOI 10.1016/j.bone.2010.04.596; Shen Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013086; Shi J, 2008, DEV BIOL, V313, P196, DOI 10.1016/j.ydbio.2007.10.017; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Tang SY, 2012, J BONE MINER RES, V27, P1936, DOI 10.1002/jbmr.1646; Tesson L, 2002, TRANSGENIC RES, V11, P43, DOI 10.1023/A:1013928600442; Wang WG, 2012, DEVELOPMENT, V139, P601, DOI 10.1242/dev.069575; Zaman G, 1997, J BONE MINER RES, V12, P769, DOI 10.1359/jbmr.1997.12.5.769; ZHOU G, 1995, J CELL SCI, V108, P3677; Zhou X, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004820; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	41	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167971	10.1371/journal.pone.0167971	http://dx.doi.org/10.1371/journal.pone.0167971			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002442	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000392853100029
J	Eom, YS; Gwon, AR; Kwak, KM; Kim, JY; Yu, SH; Lee, S; Kim, YS; Park, IB; Kim, KW; Lee, K; Kim, BJ				Eom, Young Sil; Gwon, A-Ryeong; Kwak, Kyung Min; Kim, Ju-Young; Yu, Seung Hee; Lee, Sihoon; Kim, Yeun Sun; Park, Ie Byung; Kim, Kwang-Won; Lee, Kiyoung; Kim, Byung-Joon			Protective Effects of Vildagliptin against Pioglitazone-Induced Bone Loss in Type 2 Diabetic Rats	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; BETA-CELL FUNCTION; MINERAL DENSITY; POSTMENOPAUSAL WOMEN; COMBINATION THERAPY; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; FRACTURE RISK; THIAZOLIDINEDIONES; SCLEROSTIN	Long-term use of thiazolidinediones (TZDs) is associated with bone loss and an increased risk of fracture in patients with type 2 diabetes (T2DM). Incretin-based drugs (glucagon-like peptide-1 (GLP-1) agonists and dipeptidylpeptidase-4 (DPP-4) inhibitors) have several benefits in many systems in addition to glycemic control. In a previous study, we reported that exendin-4 might increase bone mineral density (BMD) by decreasing the expression of SOST/sclerostin in osteocytes in a T2DM animal model. In this study, we investigated the effects of a DPP-4 inhibitor on TZD-induced bone loss in a T2DM animal model. We randomly divided 12-week-old male Zucker Diabetic Fatty (ZDF) rats into four groups; control, vildagliptin, pioglitazone, and vildagliptin and pioglitazone combination. Animals in each group received the respective treatments for 5 weeks. We performed an intraperitoneal glucose tolerance test (IPGTT) before and after treatment. BMD and the trabecular micro-architecture were measured by DEXA and micro CT, respectively, at the end of the treatment. The circulating levels of active GLP-1, bone turnover markers, and sclerostin were assayed. Vildagliptin treatment significantly increased BMD and trabecular bone volume. The combination therapy restored BMD, trabecular bone volume, and trabecular bone thickness that were decreased by pioglitazone. The levels of the bone formation marker, osteocalcin, decreased and that of the bone resorption marker, tartrate-resistant acid phosphatase (TRAP) 5b increased in the pioglitazone group. These biomarkers were ameliorated and the pioglitazone-induced increase in sclerostin level was lowered to control values by the addition of vildagliptin. In conclusion, our results indicate that orally administered vildagliptin demonstrated a protective effect on pioglitazone-induced bone loss in a type 2 diabetic rat model.	[Eom, Young Sil; Lee, Sihoon; Park, Ie Byung; Kim, Byung-Joon] Gachon Univ, Sch Med, Dept Internal Med, Incheon, South Korea; [Gwon, A-Ryeong; Kwak, Kyung Min; Yu, Seung Hee; Kim, Yeun Sun; Kim, Kwang-Won; Lee, Kiyoung] Gachon Univ, Gil Med Ctr, Dept Internal Med, Incheon, South Korea; [Kim, Ju-Young] Wonkang Univ, Imaging Sci Based Lung & Bone Dis Res Ctr, Iksan, Jeonbuk, South Korea	Gachon University; Gachon University; Wonkwang University	Kim, BJ (corresponding author), Gachon Univ, Sch Med, Dept Internal Med, Incheon, South Korea.; Lee, K (corresponding author), Gachon Univ, Gil Med Ctr, Dept Internal Med, Incheon, South Korea.	kylee@gilhospital.com; kbjoon4u@naver.com		EOM, YOUNG SIL/0000-0002-9281-7290	National Research Foundation of Korea(NRF) - Korea government (Ministry of Education) [2013R1A1A2011278]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Korea government (Ministry of Health Fare) [HI13C-1602-010015]; Handok pharmaceutical company, Republic of Korea	National Research Foundation of Korea(NRF) - Korea government (Ministry of Education); Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Korea government (Ministry of Health Fare); Handok pharmaceutical company, Republic of Korea	This study was supported by the National Research Foundation of Korea(NRF) grant, funded by the Korea government (Ministry of Education) (No. 2013R1A1A2011278), the Grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by Korea government (Ministry of Health & Fare) (No. HI13C-1602-010015) and the Grant of Handok pharmaceutical company, Republic of Korea. The funders had no role in study design, data collecion and analysis, decision to publish, or preparation of the manuscript.	Ali AA, 2005, ENDOCRINOLOGY, V146, P1226, DOI 10.1210/en.2004-0735; Bilezikian JP, 2013, J CLIN ENDOCR METAB, V98, P1519, DOI 10.1210/jc.2012-4018; Bone HG, 2013, J CLIN ENDOCR METAB, V98, P4691, DOI 10.1210/jc.2012-4096; Compton JT, 2014, J BONE JOINT SURG AM, V96A, P1659, DOI 10.2106/JBJS.M.01096; Gaudin-Audrain C, 2013, BONE, V53, P221, DOI 10.1016/j.bone.2012.11.039; Glorie L, 2014, AM J PHYSIOL-ENDOC M, V307, pE447, DOI 10.1152/ajpendo.00217.2014; GOODMAN WG, 1984, DIABETES, V33, P825, DOI 10.2337/diabetes.33.9.825; Gruntmanis U, 2010, CALCIFIED TISSUE INT, V86, P343, DOI 10.1007/s00223-010-9352-5; Higashijima Y, 2015, AM J PHYSIOL-RENAL, V308, pF878, DOI 10.1152/ajprenal.00590.2014; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Kahn SE, 2008, DIABETES CARE, V31, P845, DOI 10.2337/dc07-2270; Kim JY, 2013, LIFE SCI, V92, P533, DOI 10.1016/j.lfs.2013.01.001; Sbaraglini ML, 2014, EUR J PHARMACOL, V727, P8, DOI 10.1016/j.ejphar.2014.01.028; Lazarenko OP, 2007, ENDOCRINOLOGY, V148, P2669, DOI 10.1210/en.2006-1587; Loke YK, 2009, CAN MED ASSOC J, V180, P32, DOI 10.1503/cmaj.080486; Mabilleau G, 2010, DIABETIC MED, V27, P925, DOI 10.1111/j.1464-5491.2010.03048.x; McDonough AK, 2008, NAT CLIN PRACT ENDOC, V4, P507, DOI 10.1038/ncpendmet0920; Mieczkowska A, 2013, BONE, V56, P337, DOI 10.1016/j.bone.2013.07.003; Moraes RM, 2015, J PERIODONTOL, V86, P1287, DOI 10.1902/jop.2015.150278; Nishida H, 2014, J BONE MINER RES, V29, P2439, DOI 10.1002/jbmr.2277; NOLAN JJ, 1994, NEW ENGL J MED, V331, P1188, DOI 10.1056/NEJM199411033311803; Nuche-Berenguer B, 2010, REGUL PEPTIDES, V159, P61, DOI 10.1016/j.regpep.2009.06.010; Palermo A, 2015, OSTEOPOROSIS INT, V26, P2073, DOI 10.1007/s00198-015-3123-0; Rathmann W, 2004, DIABETES CARE, V27, P2568, DOI 10.2337/diacare.27.10.2568; Rosenstock J, 2007, DIABETES OBES METAB, V9, P175, DOI 10.1111/j.1463-1326.2006.00698.x; Russell-Jones D, 2012, CLIN ENDOCRINOL, V77, P489, DOI 10.1111/j.1365-2265.2012.04483.x; Saltiel AR, 1996, DIABETES, V45, P1661, DOI 10.2337/diabetes.45.12.1661; Sanz C, 2010, AM J PHYSIOL-ENDOC M, V298, pE634, DOI 10.1152/ajpendo.00460.2009; Sapir-Koren R, 2014, OSTEOPOROSIS INT, V25, P2685, DOI 10.1007/s00198-014-2808-0; Schwartz AV, 2015, J CLIN ENDOCR METAB, V100, P4059, DOI 10.1210/jc.2015-1215; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; van Raalte DH, 2014, EUR J ENDOCRINOL, V170, P565, DOI 10.1530/EJE-13-0639; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; Yamada C, 2008, ENDOCRINOLOGY, V149, P574, DOI 10.1210/en.2007-1292; Zander M, 2002, LANCET, V359, P824, DOI 10.1016/S0140-6736(02)07952-7	35	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168569	10.1371/journal.pone.0168569	http://dx.doi.org/10.1371/journal.pone.0168569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997588	Green Submitted, Green Published, gold			2022-12-26	WOS:000392842900060
J	Gable, TD; Windels, SK; Bruggink, JG; Homkes, AT				Gable, Thomas D.; Windels, Steve K.; Bruggink, John G.; Homkes, Austin T.			Where and How Wolves (Canis lupus) Kill Beavers (Castor canadensis)	PLoS One			English	Article							GRAY WOLVES; CENTRAL ONTARIO; WOLF DIET; SYSTEM; PREDATION; QUEBEC; LANDSCAPE; CANADA; RATES; DEER	Beavers (Castor canadensis) can be a significant prey item for wolves (Canis lupus) in boreal ecosystems due to their abundance and vulnerability on land. How wolves hunt beavers in these systems is largely unknown, however, because observing predation is challenging. We inferred how wolves hunt beavers by identifying kill sites using clusters of locations from GPS-collared wolves in Voyageurs National Park, Minnesota. We identified 22 sites where wolves from 4 different packs killed beavers. We classified these kill sites into 8 categories based on the beaver-habitat type near which each kill occurred. Seasonal variation existed in types of kill sites as 7 of 12 (58%) kills in the spring occurred at sites below dams and on shorelines, and 8 of 10 (80%) kills in the fall occurred near feeding trails and canals. From these kill sites we deduced that the typical hunting strategy has 3 components: 1) waiting near areas of high beaver use (e.g., feeding trails) until a beaver comes near shore or ashore, 2) using vegetation, the dam, or other habitat features for concealment, and 3) immediately attacking the beaver, or ambushing the beaver by cutting off access to water. By identifying kill sites and inferring hunting behavior we have provided the most complete description available of how and where wolves hunt and kill beavers.	[Gable, Thomas D.; Bruggink, John G.; Homkes, Austin T.] Northern Michigan Univ, Dept Biol, Marquette, MI 49855 USA; [Windels, Steve K.] Voyageurs Natl Pk, Int Falls, MN USA	Northern Michigan University	Gable, TD (corresponding author), Northern Michigan Univ, Dept Biol, Marquette, MI 49855 USA.	thomasd.gable@gmail.com			Northern Michigan University; Voyageurs National Park; National Park Service Great Lakes Research and Education Center; Wolf Park; Rainy Lake Conservancy	Northern Michigan University; Voyageurs National Park; National Park Service Great Lakes Research and Education Center; Wolf Park; Rainy Lake Conservancy	Northern Michigan University (nmu.edu, JGB) provided financial support by supporting TDG as a graduate assistant. Voyageurs National Park (nps.gov/voya, SKW) provided both financial and logistical support for this project. National Park Service Great Lakes Research and Education Center (nps.gov/rlc/greatlakes, SKW), Wolf Park (wolfpark.org, TDG), and the Rainy Lake Conservancy (rainylakeconservancy.org, SKW) all provided financial support for this project. Financial support also came from the contribution of 58 individual donors via a crowd-funding campaign (crowd-funding site: experiment.com, TDG).	ALEKSIUK M, 1969, CAN J ZOOLOG, V47, P471, DOI 10.1139/z69-086; Bailey RG, 1980, MISCELLANEOUS PUBLIC, V1391; Baker BW, 2014, WILD MAMMALS N AM BI, P288; Barber-Meyer S.M, 2015, CAN WILDL BIOL MANAG, V4, P163; Basey JM, 1995, CAN J ZOOL, V73, P2197, DOI 10.1139/z95-260; Buech RR, 1995, CAN J ZOOL, V73, P2133, DOI 10.1139/z95-250; Darimont CT, 2002, CAN J ZOOL, V80, P1638, DOI 10.1139/Z02-149; Demma DJ, 2007, J WILDLIFE MANAGE, V71, P2767, DOI 10.2193/2006-382; ESRI, 2015, ARCMAP GIS VER 10 2; Forbes GJ, 1996, CAN J ZOOL, V74, P1511, DOI 10.1139/z96-165; Franke A, 2006, ECOL MODEL, V197, P237, DOI 10.1016/j.ecolmodel.2006.02.043; Fuller T. K., 1989, WILDLIFE MONOGR, V105, P3; Haber GC., 1977, THESIS; Hall A.M., 1971, THESIS; Hop K, 2001, FINAL REPORT USGS NP; Huggard D. J., 1991, THESIS; JOHNSTON CA, 1990, LANDSCAPE ECOL, V4, P5, DOI 10.1007/BF02573947; Johnston CA, 2015, J WILDLIFE MANAGE, V79, P1072, DOI 10.1002/jwmg.927; Kallemeyn L. W., 2003, 20030001 US GEOL SUR; Latham ADM, 2013, ECOGRAPHY, V36, P1276, DOI 10.1111/j.1600-0587.2013.00035.x; Latham ADM, 2009, THESIS; Mech L.D., 1966, FAUNA NATL PARKS US, V7, P1; Mech L.D., 2015, WOLVES HUNT BEHAV WO; Mech LD, 2007, ARCTIC, V60, P145; Mech L. David, 2003, P131; Mech LD., 1970, WOLF ECOLOGY BEHAV E; Messier F, 1985, OECOLOGIA, V65, P503, DOI 10.1007/BF00379664; Morehouse AT, 2011, FRONT ECOL ENVIRON, V9, P440, DOI 10.1890/100172; Nichols Theodore C., 2015, Canadian Field-Naturalist, V129, P290; Palacios V, 2011, EUR J WILDLIFE RES, V57, P149, DOI 10.1007/s10344-010-0408-7; Peterson R. O., 1977, NAT PARK SERV SCI MO, V11, P1; PETERSON RO, 1988, J MAMMAL, V69, P89, DOI 10.2307/1381751; Peterson Rolf O., 2003, P104; POTVIN F, 1992, CAN J ZOOL, V70, P180, DOI 10.1139/z92-026; Romanski M.C, 2010, THESIS MICHIGAN TECH; Sand H, 2005, WILDLIFE SOC B, V33, P914, DOI 10.2193/0091-7648(2005)33[914:UGTAGC]2.0.CO;2; Sand H, 2008, OECOLOGIA, V156, P53, DOI 10.1007/s00442-008-0969-2; Shelton P.C, 1966, THESIS; Sikes RS, 2016, J MAMMAL, V92, P235, DOI DOI 10.1644/10-MAMM-F-355.1; SLOUGH BG, 1978, J WILDLIFE MANAGE, V42, P644, DOI 10.2307/3800833; Smith DW, 1988, EFFECTS REGULATED LA; THURBER JM, 1993, J MAMMAL, V74, P879, DOI 10.2307/1382426; Tremblay JP, 2001, ALCES-N AM MOOSE CON, V37, P1; VOIGT DR, 1976, J WILDLIFE MANAGE, V40, P663, DOI 10.2307/3800561; Webb NF, 2008, J WILDLIFE MANAGE, V72, P798, DOI 10.2193/2006-566; Wiebe N, 2009, ARCTIC, V62, P399; Windels SK, 2015, 2015 VOYAGEURS NATL, V2015/971; Zimmermann B, 2007, J WILDLIFE MANAGE, V71, P1177, DOI 10.2193/2006-306	48	32	32	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0165537	10.1371/journal.pone.0165537	http://dx.doi.org/10.1371/journal.pone.0165537			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992441	Green Submitted, gold, Green Published			2022-12-26	WOS:000392842600006
J	Girouard, MP; Pool, M; Alchini, R; Rambaldi, I; Fournier, AE				Girouard, Marie-Pier; Pool, Madeline; Alchini, Ricardo; Rambaldi, Isabel; Fournier, Alyson E.			RhoA Proteolysis Regulates the Actin Cytoskeleton in Response to Oxidative Stress	PLoS One			English	Article							HYDROGEN-PEROXIDE; INDUCED APOPTOSIS; ROD FORMATION; IN-VIVO; PROTEIN; GTPASES; CELLS; DEGRADATION; PHOSPHORYLATION; REORGANIZATION	The small GTPase RhoA regulates the actin cytoskeleton to affect multiple cellular processes including endocytosis, migration and adhesion. RhoA activity is tightly regulated through several mechanisms including GDP/GTP cycling, phosphorylation, glycosylation and prenylation. Previous reports have also reported that cleavage of the carboxy-terminus inactivates RhoA. Here, we describe a novel mechanism of RhoA proteolysis that generates a stable amino-terminal RhoA fragment (RhoA-NTF). RhoA-NTF is detectable in healthy cells and tissues and is upregulated following cell stress. Overexpression of either Rho-ANTF or the carboxy-terminal RhoA cleavage fragment (RhoA-CTF) induces the formation of disorganized actin stress fibres. RhoA-CTF also promotes the formation of disorganized actin stress fibres and nuclear actin rods. Both fragments disrupt the organization of actin stress fibres formed by endogenous RhoA. Together, our findings describe a novel RhoA regulatory mechanism.	[Girouard, Marie-Pier; Pool, Madeline; Alchini, Ricardo; Rambaldi, Isabel; Fournier, Alyson E.] Rue Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada	McGill University	Fournier, AE (corresponding author), Rue Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada.	alyson.fournier@mcgill.ca		Fournier, Alyson/0000-0002-1859-7015	Canadian Institute of Health Research [CIHR] [MOP 136794]; Canadian Institutes of Health Research CIHR; McGill Training Program in Neuroengineering; Vanier Canada Graduate Scholarship	Canadian Institute of Health Research [CIHR](Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research CIHR(Canadian Institutes of Health Research (CIHR)); McGill Training Program in Neuroengineering; Vanier Canada Graduate Scholarship	This work was supported by grants from the Canadian Institute of Health Research [CIHR MOP 136794 (AEF); Canadian Institutes of Health Research CIHR; http://www.cihr-irsc.gc.ca/e.193.html] and the McGill Training Program in Neuroengineering. RA was supported by a Vanier Canada Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON P, 1992, J CELL BIOL, V119, P617, DOI 10.1083/jcb.119.3.617; Aghajanian A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008045; Belaid A, 2013, CANCER RES, V73, P4311, DOI 10.1158/0008-5472.CAN-12-4142; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Chen YZ, 2009, MOL CELL, V35, P841, DOI 10.1016/j.molcel.2009.09.004; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Domazetovska A, 2007, BRAIN, V130, P3275, DOI 10.1093/brain/awm247; Ellerbroek SM, 2003, J BIOL CHEM, V278, P19023, DOI 10.1074/jbc.M213066200; Forget MA, 2002, BIOCHEM J, V361, P243, DOI 10.1042/0264-6021:3610243; Fujisawa K, 1998, J BIOL CHEM, V273, P18943, DOI 10.1074/jbc.273.30.18943; Gray CW, 2000, EUR J BIOCHEM, V267, P5699, DOI 10.1046/j.1432-1327.2000.01589.x; Greenberg DL, 2003, BIOCHEMISTRY-US, V42, P702, DOI 10.1021/bi027100x; Grigoriev I, 2006, CELL MOTIL CYTOSKEL, V63, P29, DOI 10.1002/cm.20107; Gunther MI, 2015, J NEUROSCI METH, V251, P143, DOI 10.1016/j.jneumeth.2015.05.021; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HORI Y, 1991, ONCOGENE, V6, P515; Huot J, 1997, CIRC RES, V80, P383, DOI 10.1161/01.RES.80.3.383; Hutchinson DO, 2006, NEUROMUSCULAR DISORD, V16, P113, DOI 10.1016/j.nmd.2005.11.004; Ihara K, 1998, J BIOL CHEM, V273, P9656, DOI 10.1074/jbc.273.16.9656; Jank T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8807; Kulkarni S, 2002, J BIOL CHEM, V277, P24435, DOI 10.1074/jbc.M203457200; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Li G, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.519; Miller AL, 2009, NAT CELL BIOL, V11, P71, DOI 10.1038/ncb1814; Munsie L, 2011, HUM MOL GENET, V20, P1937, DOI 10.1093/hmg/ddr075; Munsie LN, 2012, J CELL SCI, V125, P3977, DOI 10.1242/jcs.097667; ONO S, 1993, J MUSCLE RES CELL M, V14, P195, DOI 10.1007/BF00115454; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Pampalakis G, 2014, ONCOTARGET, V5, P2390, DOI 10.18632/oncotarget.1235; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Saito Y, 2006, FREE RADICAL RES, V40, P619, DOI 10.1080/10715760600632552; Sawada N, 2001, BIOCHEM BIOPH RES CO, V280, P798, DOI 10.1006/bbrc.2000.4194; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schoenwaelder SM, 1999, J BIOL CHEM, V274, P14359, DOI 10.1074/jbc.274.20.14359; Shao F, 2003, P NATL ACAD SCI USA, V100, P904, DOI 10.1073/pnas.252770599; Solski PA, 2002, CELL GROWTH DIFFER, V13, P363; Sorg I, 2001, INFECT IMMUN, V69, P7535, DOI 10.1128/IAI.69.12.7535-7543.2001; Stultiens Audrey, 2012, Commun Integr Biol, V5, P99; Subauste MC, 2000, J BIOL CHEM, V275, P9725, DOI 10.1074/jbc.275.13.9725; Teramoto S, 1999, JPN J PHARMACOL, V79, P33, DOI 10.1254/jjp.79.33; Tu S, 2001, J BIOL CHEM, V276, P19656, DOI 10.1074/jbc.M009838200; Vega FM, 2011, J CELL BIOL, V193, P655, DOI 10.1083/jcb.201011038; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Wei JX, 2013, BBA-MOL CELL RES, V1833, P2757, DOI 10.1016/j.bbamcr.2013.07.005; Zhu Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.103	48	15	15	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168641	10.1371/journal.pone.0168641	http://dx.doi.org/10.1371/journal.pone.0168641			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992599	Green Submitted, gold, Green Published			2022-12-26	WOS:000392842600085
J	Ling, J; Lopez-Dee, ZP; Cottell, C; Wolfe, L; Nye, D				Ling, Jun; Lopez-Dee, Zenaida P.; Cottell, Colby; Wolfe, Laura; Nye, Derek			Regulation of mRNA Translation Is a Novel Mechanism for Phthalate Toxicity	PLOS ONE			English	Article							N-BUTYL PHTHALATE; CARNITINE PALMITOYLTRANSFERASE; INITIATION; DI(2-ETHYLHEXYL)PHTHALATE; INHIBITION; EXPOSURE; RIBOSOME; BINDING; LIVER; RATS	Phthalates are a group of plasticizers that are widely used in many consumer products and medical devices, thus generating a huge burden to human health. Phthalates have been known to cause a number of developmental and reproductive disorders functioning as endocrine modulators. They are also involved in carcinogenesis with mechanisms less understood. To further understand the molecular mechanisms of phthalate toxicity, in this study we reported a new effect of phthalates on mRNA translation/protein synthesis, a key regulatory step of gene expression. Butyl benzyl phthalate (BBP) was found to directly inhibit mRNA translation in vitro but showed a complicated pattern of affecting mRNA translation in cells. In human kidney embryonic cell (HEK-293T), BBP increased cap-dependent mRNA translation at lower concentrations but showed inhibitory effect at higher concentrations. Cap-independent translation was not affected. On the other hand, mono (2-ethylhexyl) phthalate (MEHP) as a major metabolite of another important phthalate di (2-ethylhexyl) phthalate (DEHP) inhibited both can-dependent and -independent mRNA translation in vivo. In contrast, BBP and MEHP exhibited an overall promoting effect on mRNA translation in cancer cells. Mechanistic studies identified that the level and phosphorylation of eIF4E-BP (eIF4E binding protein) and the amount of eIF4GI in eIF4F complex were altered in accordance with the effect of BBP on translation. BBP was also identified to directly bind to eIF4E, providing a further mechanism underlying the regulation of mRNA by phthalate. At the cellular level BBP inhibited normal cell growth but slightly promoted cancer cells (HT29) growth. Overall, this study provides the first evidence that phthalates can directly regulate mRNA translation as a novel mechanism to mediate their biological toxicities.	[Ling, Jun; Lopez-Dee, Zenaida P.; Cottell, Colby; Wolfe, Laura; Nye, Derek] Commonwealth Med Coll, Dept Basic Sci, Scranton, PA 18509 USA; [Cottell, Colby; Wolfe, Laura] Marywood Univ, Dept Sci, Scranton, PA USA; [Nye, Derek] Wilkes Univ, Dept Biol, Wilkes Barre, PA USA; [Nye, Derek] Penn State Hershey Coll Med, Univ Dr, Hershey, PA USA	Geisinger Commonwealth School of Medicine; Wilkes University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Ling, J (corresponding author), Commonwealth Med Coll, Dept Basic Sci, Scranton, PA 18509 USA.	jling@tcmc.edu		Nye, Derek/0000-0003-0539-075X	Commonwealth Medical College	Commonwealth Medical College	This research is supported by the startup funds of The Commonwealth Medical College to JL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker MG, 2009, J MOL BIOL, V385, P491, DOI 10.1016/j.jmb.2008.10.029; Andaya A, 2014, INT J MOL SCI, V15, P11523, DOI 10.3390/ijms150711523; BRADY PS, 1987, BIOCHEM J, V246, P641, DOI 10.1042/bj2460641; Byrd MP, 2005, J BIOL CHEM, V280, P18610, DOI 10.1074/jbc.M414014200; Caldwell JC, 2012, MUTAT RES-REV MUTAT, V751, P82, DOI 10.1016/j.mrrev.2012.03.001; CHAPIN RE, 1988, TOXICOL APPL PHARM, V92, P467, DOI 10.1016/0041-008X(88)90186-X; Clemens MJ, 2000, CELL DEATH DIFFER, V7, P603, DOI 10.1038/sj.cdd.4400695; Department of Health and Human Services & Centers for Disease Control and Prevention, 2005, 3 NAT REP HUM EXP EN, P253; Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.200600243; GANNING AE, 1989, TOXICOL LETT, V48, P185, DOI 10.1016/0378-4274(89)90173-2; GARBERG P, 1991, CARCINOGENESIS, V12, P7, DOI 10.1093/carcin/12.1.7; Guyton KZ, 2009, ENVIRON HEALTH PERSP, V117, P1664, DOI 10.1289/ehp.0900758; Hauser R, 2005, OCCUP ENVIRON MED, V62, DOI 10.1136/oem.2004.017590; Herrero O, 2016, CHEMOSPHERE, V144, P1874, DOI 10.1016/j.chemosphere.2015.10.051; Herreros MA, 2013, ENVIRON TOXICOL PHAR, V36, P1141, DOI 10.1016/j.etap.2013.09.020; Huang PC, 2014, ENVIRON SCI POLLUT R, V21, P13964, DOI 10.1007/s11356-014-3260-6; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kamrin MA, 2009, J TOXICOL ENV HEAL B, V12, P157, DOI 10.1080/10937400902729226; LeFebvre AK, 2006, J BIOL CHEM, V281, P22917, DOI 10.1074/jbc.M605418200; Ling J, 2005, EMBO J, V24, P4094, DOI 10.1038/sj.emboj.7600868; Ling J, 2008, J BIOL CHEM, V283, P30585, DOI 10.1074/jbc.M803548200; Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139, DOI 10.1289/ehp.5658; Lu HC, 2016, TOXICOL LETT, V241, P95, DOI 10.1016/j.toxlet.2015.11.009; MATHEWS MB, 2007, COLD SPRING HARB MON, V48, P1; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Merrick WC, 2004, GENE, V332, P1, DOI 10.1016/j.gene.2004.02.051; Moral R, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-5; National Toxicology Program, 1997, Natl Toxicol Program Tech Rep Ser, V458, P1; OZASA H, 1983, J BIOCHEM-TOKYO, V94, P543, DOI 10.1093/oxfordjournals.jbchem.a134385; Pichon X, 2012, CURR PROTEIN PEPT SC, V13, P294, DOI 10.2174/138920312801619475; Poehlsgaard J, 2005, NAT REV MICROBIOL, V3, P870, DOI 10.1038/nrmicro1265; Ren HZ, 2010, TOXICOL SCI, V113, P45, DOI 10.1093/toxsci/kfp251; Rusyn I, 2006, CRIT REV TOXICOL, V36, P459, DOI 10.1080/10408440600779065; Shu L, 2016, J SEP SCI, V39, P3163, DOI 10.1002/jssc.201600364; Singh S, 2011, GENOMICS, V97, P148, DOI 10.1016/j.ygeno.2010.11.008; Spade DJ, 2014, TOXICOL SCI, V138, P148, DOI 10.1093/toxsci/kft266; Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007; Wang SW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.420; Wang Y, 2016, TOXICOL IN VITRO, V32, P86, DOI 10.1016/j.tiv.2015.12.012; Wang YY, 2016, ZOOKEYS, P1, DOI 10.3897/zookeys.603.9125; Welsh M, 2008, J CLIN INVEST, V118, P1479, DOI 10.1172/JCI34241; Wilson VS, 2008, INT J ANDROL, V31, P178, DOI 10.1111/j.1365-2605.2007.00861.x; Xiao-Feng Z, 2009, INT J TOXICOL, V28, P448, DOI 10.1177/1091581809342596	43	7	9	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0167914	10.1371/journal.pone.0167914	http://dx.doi.org/10.1371/journal.pone.0167914			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992464	gold, Green Submitted, Green Published			2022-12-26	WOS:000392842600025
J	Marin-Webb, V; Jessen, H; Kopp, U; Jessen, AB; Hahn, K				Marin-Webb, Victor; Jessen, Heiko; Kopp, Ute; Jessen, Arne B.; Hahn, Katrin			Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; COGNITIVE IMPAIRMENT; INFECTED PATIENTS; PREVALENCE; HIV/AIDS; COHORT; VALIDITY; CHINA; RISK	Background HIV-associated neurocognitive disorders (HAND) are widely present among people living with HIV. Especially its milder forms, asymptomatic neurocognitive impairment (ANI) and mild neurocognitive disorder (MND), remain highly prevalent worldwide. Diagnosing these conditions is subject to a time and resource consuming neuropsychological assessment. Selecting patients at a higher risk of cognitive impairment by using a simple but effective screening tool helps to organise access to further neuropsychological diagnosis. The International HIV Dementia Scale (IHDS) has until now been a well-established screening tool in African and American countries, however these populations' demographics defer significantly from ours, so using the same parameters could be ineffective. Objectives To calculate the prevalence of this condition among people attending an HIV outpatient clinic in Berlin and to validate the use of the IHDS as a screening tool for HAND in a Germanspeaking population. Methods We screened 480 HIV-infected patients using the IHDS, 89% of them were on a stable antiretroviral treatment. Ninety of them completed a standardised neuropsychological battery of tests and a specific cognitive complaints questionnaire. The same procedure was applied to a control group of 30 HIV-negative participants. HAND diagnosis was established according to the Frascati criteria. Results The overall prevalence of HAND in our cohort was 43% (20% ANI, 17% MND and 6% HIV associated dementia). The optimal cut-off on the IHDS for detecting HAND cases was set at 11 and achieved both a sensitivity and a specificity of 80%. When specifically screening for the more severe form of HAND, HIV -associated dementia, a cut-off value of 10 offered an increase in both sensitivity (94%) and specificity (86%). The Youden Index for diagnostic accuracy was 0.6 and 0.8, respectively. Conclusions The prevalence of HAND was comparable to the reported by recent studies performed in countries with a similar economic development. The study confirms the IHDS to be a useful HAND screening tool in primary care settings and establishes new recommendations for its use in German-speaking countries.	[Marin-Webb, Victor; Jessen, Heiko; Jessen, Arne B.] Praxis Jessen 2 Kollegen, Berlin, Germany; [Marin-Webb, Victor; Kopp, Ute; Hahn, Katrin] Charite, Dept Neurol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hahn, K (corresponding author), Charite, Dept Neurol, Berlin, Germany.	katrin.hahn@charite.de	Jessen, Heiko/P-2192-2019	Hahn, Katrin/0000-0002-6013-0072	"la Caixa" Banking Foundation; German Academic Exchange Service (DAAD)	"la Caixa" Banking Foundation(La Caixa Foundation); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by "la Caixa" Banking Foundation and the German Academic Exchange Service (DAAD) thanks to their joint post-graduate fellowship programme and is part of VMW's doctoral studies at Charite Medical School; www.obrasociallacaixa.org/en/educacion-becas; www.daad.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Antinori A, 2013, CLIN INFECT DIS, V56, P1004, DOI 10.1093/cid/cis975; Aschenbrenner A, 2000, RWT REGENSBURGER WOR; Bonnet F, 2013, AIDS, V27, P391, DOI 10.1097/QAD.0b013e32835b1019; Brickenkamp R, 2009, TEST D2 REVISION D2; Brouillette MJ, 2015, AIDS, V29, P895, DOI 10.1097/QAD.0000000000000152; Canestri A, 2010, CLIN INFECT DIS, V50, P773, DOI 10.1086/650538; Cicchetti D. V., 2004, METHODOLOGICAL BIOST; Cysique LA, 2010, HIV MED, V11, P642, DOI 10.1111/j.1468-1293.2010.00834.x; Cysique LA, 2004, J NEUROVIROL, V10, P350, DOI 10.1080/13550280490521078; Cysique LA, 2014, J NEUROVIROL, V20, P258, DOI 10.1007/s13365-014-0242-x; Dang C, 2015, INT J INFECT DIS, V33, P56, DOI 10.1016/j.ijid.2014.12.042; Fogel GB, 2015, J NEUROVIROL, V21, P56, DOI 10.1007/s13365-014-0296-9; Gisslen M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-356; Grant I, 2014, NEUROLOGY, V82, P2055, DOI 10.1212/WNL.0000000000000492; H?rting, 2000, WECHSLER GEDACHTNIST; Haddow LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061826; Heaton K, 2009, NEUROPSYCHOLOGICAL A; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton R.K., 2004, REVISED COMPREHENSIV; Heaton RK, 2008, J NEUROVIROL, V14, P536, DOI 10.1080/13550280802378880; Helmstaedter C, 2001, VMLT VERBALER LERN U; Joska JA, 2011, AIDS PATIENT CARE ST, V25, P95, DOI 10.1089/apc.2010.0292; Kwasa J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032898; Lawler K, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-15; Letendre Scott L, 2010, Top HIV Med, V18, P45; McDonnell J, 2014, JAIDS-J ACQ IMM DEF, V67, P120, DOI 10.1097/QAI.0000000000000273; Moore DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047310; Morgan EE, 2008, J CLIN EXP NEUROPSYC, V30, P83, DOI 10.1080/13803390701233865; Munoz-Moreno JA, 2008, AIDS RES HUM RETROV, V24, P1301, DOI 10.1089/aid.2007.0310; Munnoz-Moreno JA, 2013, JAIDS-J ACQ IMM DEF, V63, P585, DOI 10.1097/QAI.0b013e31829e1408; Neubauer A, 2006, ZAHLEN SYMBOL TEST K, P77; Overton ET, 2011, AIDS BEHAV, V15, P1902, DOI 10.1007/s10461-011-0033-9; POWER C, 1995, J ACQ IMMUN DEF SYND, V8, P273, DOI 10.1097/00042560-199503010-00008; Robbins RN, 2011, AIDS PATIENT CARE ST, V25, P587, DOI 10.1089/apc.2011.0154; Robertson KR, 2007, AIDS, V21, P1915, DOI 10.1097/QAD.0b013e32828e4e27; Sacktor NC, 2005, AIDS, V19, P1367; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; Singh D, 2008, Afr J Psychiatry (Johannesbg), V11, P282; Skinner S, 2009, HIV MED, V10, P246, DOI 10.1111/j.1468-1293.2008.00679.x; Spreen O., 1991, PROFILE TEST RESULTS; Strauss E, 2006, COMPENDIUM NEUROPSYC; Tozzi V, 2005, J NEUROVIROL, V11, P265, DOI 10.1080/13550280590952790; Trites R., 2002, GROOVED PEGBOARD TES; UNAIDS, 2013, GLOBAL REPORT UNAIDS; University of Munich, 2008, AKT KONS TESTN NEUR; Valcour V, 2004, NEUROLOGY, V63, P822, DOI 10.1212/01.WNL.0000134665.58343.8D; Valcour V, 2011, CLIN INFECT DIS, V53, P836, DOI 10.1093/cid/cir524; Villaverde ML, 1993, ESTUDIO COMUNITARIO; Wolfram H, 1989, FARBE WORT INTERTERE, P205; Wolfram H, 1989, NICHTVERBALER INTELL, P63; Zipursky AR, 2013, AIDS, V27, P2385, DOI 10.1097/QAD.0b013e328363bf56	52	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168225	10.1371/journal.pone.0168225	http://dx.doi.org/10.1371/journal.pone.0168225			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QC	27992497	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842600042
J	Studnicki, M; Wozniak, G; Stepkowski, D				Studnicki, Marcin; Wozniak, Grazyna; Stepkowski, Dariusz			The Calculator of Anti-Alzheimer's Diet. Macronutrients	PLOS ONE			English	Article							CALORIC-INTAKE; MEDITERRANEAN DIET; RISK; DISEASE; BRAIN; ALCOHOL; HEALTH; WINE; MULTICENTER; IMPACTS	The opinions about optimal proportions of macronutrients in a healthy diet have changed significantly over the last century. At the same time nutritional sciences failed to provide strong evidence backing up any of the variety of views on macronutrient proportions. Herein we present an idea how these proportions can be calculated to find an optimal balance of macronutrients with respect to prevention of Alzheimer's Disease (AD) and dementia. These calculations are based on our published observation that per capita personal income (PCPI) in the USA correlates with age-adjusted death rates for AD (AADR). We have previously reported that PCPI through the period 1925-2005 correlated with AADR in 2005 in a remarkable, statistically significant oscillatory manner, as shown by changes in the correlation coefficient R (R-original) A question thus arises what caused the oscillatory behavior of R-original? What historical events in the life of 2005 AD victims had shaped their future with AD? Looking for the answers we found that, considering changes in the per capita availability of macronutrients in the USA in the period 1929-2005, we can mathematically explain the variability of R-original for each quarter of a human life. On the basis of multiple regression of R-original with regard to the availability of three macronutrients: carbohydrates, total fat, and protein, with or without alcohol, we propose seven equations (referred to as "the calculator" throughout the text) which allow calculating optimal changes in the proportions of macronutrients to reduce the risk of AD for each age group: youth, early middle age, late middle age and late age. The results obtained with the use of "the calculator" are grouped in a table (Table 4) of macronutrient proportions optimal for reducing the risk of AD in each age group through minimizing Rpredicted-i.e., minimizing the strength of correlation between PCPI and future AADR.	[Studnicki, Marcin] Warsaw Univ Life Sci SGGW, Dept Expt Design & Bioinformat, Warsaw, Poland; [Wozniak, Grazyna; Stepkowski, Dariusz] Nencki Inst Expt Biol, Lab Mol Basis Cell Motil, Warsaw, Poland	Warsaw University of Life Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Stepkowski, D (corresponding author), Nencki Inst Expt Biol, Lab Mol Basis Cell Motil, Warsaw, Poland.	d.stepkowski@nencki.gov.pl	Stępkowski, Dariusz/R-4134-2016; Studnicki, Marcin/J-4927-2019	Stępkowski, Dariusz/0000-0002-9926-3542; Studnicki, Marcin/0000-0001-9773-7313				Basu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057873; Cunnane SC, 2016, ANN NY ACAD SCI, V1367, P12, DOI 10.1111/nyas.12999; Dietary Guidelines Advisory Committee, 2015, SCI REP 2015 DIET GU; FARQUHARSON J, 1995, ARCH DIS CHILD, V72, P198, DOI 10.1136/adc.72.3.198; Feart C, 2015, CURR OPIN CLIN NUTR, V18, P51, DOI 10.1097/MCO.0000000000000131; Granger C. W. J., 1969, INVESTIGATING CAUSAL, V37, P424; Gu YA, 2010, ARCH NEUROL-CHICAGO, V67, P699, DOI 10.1001/archneurol.2010.84; Henderson ST, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-31; Holmes O, 2012, BIOCHEMISTRY-US, V51, P3565, DOI 10.1021/bi300303g; Janssen CIF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155307; Kadish I., 2016, EXP GERONTOL; Kerr WC, 2005, ALCOHOL CLIN EXP RES, V29, P2015, DOI 10.1097/01.alc.0000187596.92804.bd; Kromhout D, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4034; Laitinen MH, 2006, DEMENT GERIATR COGN, V22, P99, DOI 10.1159/000093478; Leonard WR, 2010, EVOLUTIONARY PERSPEC; Luchsinger JA, 2002, ARCH NEUROL-CHICAGO, V59, P1258, DOI 10.1001/archneur.59.8.1258; Mosconi Lisa, 2005, Eur J Nucl Med Mol Imaging, V32, P486, DOI 10.1007/s00259-005-1762-7; OBRIEN JS, 1965, J LIPID RES, V6, P537; Orlov M.L., 1996, MULTIPLE LINEAR REGR; Panza F, 2012, INT J GERIATR PSYCH, V27, P1218, DOI 10.1002/gps.3772; Raider K, 2016, NEUROCHEM INT, V97, P172, DOI 10.1016/j.neuint.2016.04.008; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Rimm EB, 1996, BRIT MED J, V312, P731, DOI 10.1136/bmj.312.7033.731; Roberts RO, 2012, J ALZHEIMERS DIS, V32, P329, DOI 10.3233/JAD-2012-120862; Robin A, 2011, 92 PHS NIH US DEP HL; Scarmeas N, 2006, ANN NEUROL, V59, P912, DOI 10.1002/ana.20854; Shakersain B, 2016, ALZHEIMERS DEMENT, V12, P100, DOI 10.1016/j.jalz.2015.08.002; Simpson SJ, 2015, CELL, V161, P18, DOI 10.1016/j.cell.2015.02.033; Solfrizzi V, 2006, NEUROBIOL AGING, V27, P1694, DOI 10.1016/j.neurobiolaging.2005.09.026; Solfrizzi V, 2010, AGEING RES REV, V9, P184, DOI 10.1016/j.arr.2009.07.005; Solon-Biet SM, 2015, J ENDOCRINOL, V226, pR17, DOI 10.1530/JOE-15-0173; Solon-Biet SM, 2015, P NATL ACAD SCI USA, V112, P3481, DOI 10.1073/pnas.1422041112; Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009; Stafstrom CE, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00059; Stepkowski D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126139; Vining EPG, 1998, ARCH NEUROL-CHICAGO, V55, P1433, DOI 10.1001/archneur.55.11.1433; Walker JM, 2015, NUTRIENTS, V7, P7332, DOI 10.3390/nu7095341; Wang DD, 2016, JAMA INTERN MED, V176, P1134, DOI 10.1001/jamainternmed.2016.2417	38	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168385	10.1371/journal.pone.0168385	http://dx.doi.org/10.1371/journal.pone.0168385			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992612	gold, Green Submitted, Green Published			2022-12-26	WOS:000392842600053
J	Witte, AK; Mester, P; Fister, S; Witte, M; Schoder, D; Rossmanith, P				Witte, Anna Kristina; Mester, Patrick; Fister, Susanne; Witte, Matthias; Schoder, Dagmar; Rossmanith, Peter			A Systematic Investigation of Parameters Influencing Droplet Rain in the Listeria monocytogenes prfA Assay - Reduction of Ambiguous Results in ddPCR	PLoS One			English	Article							POLYMERASE-CHAIN-REACTION; TIME QUANTITATIVE PCR; DNA COPY NUMBER; DIGITAL PCR; QUANTIFICATION	The droplet digital polymerase chain reaction (ddPCR) determines DNA amounts based upon the pattern of positive and negative droplets, according to Poisson distribution, without the use of external standards. However, division into positive and negative droplets is often not clear because a part of the droplets has intermediate fluorescence values, appearing as "rain" in the plot. Despite the droplet rain, absolute quantification with ddPCR is possible, as shown previously for the prfA assay in quantifying Listeria monocytogenes. Nevertheless, reducing the rain, and thus ambiguous results, promotes the accuracy and credibility of ddPCR. In this study, we extensively investigated chemical and physical parameters for optimizing the prfA assay for ddPCR. While differences in the concentration of all chemicals and the dye, quencher and supplier of the probe did not alter the droplet pattern, changes in the PCR cycling program, such as prolonged times and increased cycle numbers, improved the assay.	[Witte, Anna Kristina; Mester, Patrick; Fister, Susanne; Schoder, Dagmar; Rossmanith, Peter] Univ Vet Med, Inst Milk Hyg, Dept Farm Anim & Vet Publ Hlth, Christian Doppler Lab Monitoring Microbial Contam, Vienna, Austria; [Witte, Matthias] Graz Univ, Dept Psychol, Graz, Austria; [Schoder, Dagmar; Rossmanith, Peter] Univ Vet Med, Inst Milk Hyg, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria	University of Veterinary Medicine Vienna; University of Graz; University of Veterinary Medicine Vienna	Rossmanith, P (corresponding author), Univ Vet Med, Inst Milk Hyg, Dept Farm Anim & Vet Publ Hlth, Christian Doppler Lab Monitoring Microbial Contam, Vienna, Austria.; Rossmanith, P (corresponding author), Univ Vet Med, Inst Milk Hyg, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria.	peter.rossmanith@vetmeduni.ac.at	Mester, Patrick-Julian/ABC-1614-2020	Mester, Patrick-Julian/0000-0002-3193-4987; Witte, Anna Kristina/0000-0001-6471-0763	Austrian Federal Ministry of Science, Research and Economy	Austrian Federal Ministry of Science, Research and Economy	The financial support by the Austrian Federal Ministry of Science, Research and Economy is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	D'Agostino M, 2004, J FOOD PROTECT, V67, P1646, DOI 10.4315/0362-028X-67.8.1646; Dingle TC, 2013, CLIN CHEM, V59, P1670, DOI 10.1373/clinchem.2013.211045; Dong LH, 2014, ANAL BIOANAL CHEM, V406, P1701, DOI 10.1007/s00216-013-7546-1; Dreo T, 2014, ANAL BIOANAL CHEM, V406, P6513, DOI 10.1007/s00216-014-8084-1; Duewer DL, 2015, ANAL BIOANAL CHEM, V407, P9061, DOI 10.1007/s00216-015-9073-8; Fu W, 2015, SCI REP-UK, V5, DOI 10.1038/srep12715; Gerdes Lars, 2016, Biomol Detect Quantif, V7, P9, DOI 10.1016/j.bdq.2015.12.003; Hilscher C, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni181; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Jones M, 2014, J VIROL METHODS, V202, P46, DOI 10.1016/j.jviromet.2014.02.020; Karlin-Neumann G, 2013, DRUG DISCOV WORLD, V15; Kim YH, 2008, BIOTECHNIQUES, V44, P495, DOI 10.2144/000112705; Kiselinova M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085999; Koppel R, 2015, EUR FOOD RES TECHNOL, V241, P427, DOI 10.1007/s00217-015-2475-1; Kramer MF, 2001, CURR PROTOC TOXICOL; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; Laurie MT, 2013, BIOTECHNIQUES, V55, P61, DOI 10.2144/000114063; Markoulatos P, 2002, J CLIN LAB ANAL, V16, P47, DOI 10.1002/jcla.2058; MORISSET D, 2013, PLOS ONE, V8; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Rossmanith P, 2006, RES MICROBIOL, V157, P763, DOI 10.1016/j.resmic.2006.03.003; Rothrock M. J., 2013, ADV MICROBIOL-IRVINE, V3, P403, DOI [10.4236/aim.2013.35055, DOI 10.4236/AIM.2013.35055]; Strain MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055943; Trypsteen W, 2015, ANAL BIOANAL CHEM, V407, P5827, DOI 10.1007/s00216-015-8773-4; Witte AK, ANAL BIOANA IN PRESS; Witwer KW, 2013, RNA BIOL, V10, P1080, DOI 10.4161/rna.25246	26	32	32	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168179	10.1371/journal.pone.0168179	http://dx.doi.org/10.1371/journal.pone.0168179			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992475	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842600040
J	Fan, BL; Zhang, AP; Yang, Y; Ma, QL; Li, XM; Zhao, CM				Fan, Baoli; Zhang, Aiping; Yang, Yi; Ma, Quanlin; Li, Xuemin; Zhao, Changming			Long-Term Effects of Xerophytic Shrub Haloxylon ammodendron Plantations on Soil Properties and Vegetation Dynamics in Northwest China	PLOS ONE			English	Article							HORQIN SANDY LAND; NORTHERN CHINA; TENGGER DESERT; INNER-MONGOLIA; SHORTGRASS STEPPE; RESTORATION; DESERTIFICATION; REGION; DUNES; NITROGEN	The xerophytic desert shrub Haloxylon ammodendron (C. A. Mey.) Bunge. is distributed naturally in Asian and African deserts, and is widely used for vegetation restoration in the desert regions of Northern China. However, there are limited long-term chrono-sequence studies on the impact of changed soil properties and vegetation dynamics following establishment of this shrub on mobile sand dunes. In Minqin County, Gansu Province, we investigated soil properties and herbaceous vegetation development of 10, 20, 30, 40, 50-yearold H. ammodendron plantations on mobile sand dunes. Soil sampling at two depths (0-5 and 5-20 cm) under the shrubs determined SOC, nutrition and soil physical characteristics. The results showed that: establishment of H. ammodendron had improved soil physio-chemical properties, increased thickness of soil crusts and coverage of biological soil crusts (BSCs), and promoted development of topsoil over an extended period of 5 decades. Soil texture and soil nutrition improved along the chrono-sequence according to three distinct phases: i) an initial fast development from 0 to 10 years, ii) a stabilizing phase from 10 to 30 years followed by iii) a relatively marked restoration development in 40 and 50-year-old plantations. Meanwhile, herbaceous community coverage also markedly increased in 30-year-old plantations. However, both soil and vegetation restoration were very slow due to low annual precipitation in Minqin county compared to other Northern China sand afforestation sites. Canonical Correspondence Analysis results demonstrated that herbaceous plant development was closely associated with changes in soil texture (increased clay and silt percentage) and availability of soil nutrients. Thus our results indicated that selection of the long-lived shrub H. ammodendron is an essential and effective tool in arid desert re-vegetation.	[Fan, Baoli; Zhang, Aiping; Yang, Yi; Zhao, Changming] Lanzhou Univ, Sch Life Sci, State Key Lab Grassland Agroecosyst, Lanzhou, Gansu, Peoples R China; [Fan, Baoli; Ma, Quanlin; Li, Xuemin] Gansu Desert Control Res Inst, State Key Lab Desertificat & Aeolian Sand Disaste, Lanzhou, Gansu, Peoples R China	Lanzhou University	Zhao, CM (corresponding author), Lanzhou Univ, Sch Life Sci, State Key Lab Grassland Agroecosyst, Lanzhou, Gansu, Peoples R China.	zhaochm@lzu.edu.cn			National Natural Science Foundation of China [31360098, 31522013, 31270754]; Fundament Research and Innovation Group Program of Gansu Province [145RJIA335]; Fundament Research Funds for the Central Universities [Izujbky-2016-ct10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundament Research and Innovation Group Program of Gansu Province; Fundament Research Funds for the Central Universities	This study was supported by the National Natural Science Foundation of China (No. 31360098, 31522013, 31270754), the Fundament Research and Innovation Group Program of Gansu Province (145RJIA335) and the Fundament Research Funds for the Central Universities (Izujbky-2016-ct10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brotherson J.D., 1983, W N AM NAT, V43, P73; Burke A, 2014, J ARID ENVIRON, V100, P18, DOI 10.1016/j.jaridenv.2013.10.002; Cao SX, 2008, ENVIRON SCI TECHNOL, V42, P1826, DOI 10.1021/es0870597; Cao SX, 2010, NATURE, V465, P31, DOI 10.1038/465031d; DANIN A, 1989, Ecologia Mediterranea, V15, P55; Delgado-Baquerizo M, 2013, NATURE, V502, P672, DOI 10.1038/nature12670; Dodd MB, 1997, PLANT ECOL, V133, P13, DOI 10.1023/A:1009759421640; Dodd MB, 2002, PLANT ECOL, V158, P127, DOI 10.1023/A:1015525303754; Dong ZB, 2010, GEOMORPHOLOGY, V116, P58, DOI 10.1016/j.geomorph.2009.10.008; Donohue RJ, 2007, HYDROL EARTH SYST SC, V11, P983, DOI 10.5194/hess-11-983-2007; Du JH, 2010, INT J BIOMETEOROL, V54, P583, DOI 10.1007/s00484-010-0315-3; Duan ZH, 2004, GEOMORPHOLOGY, V59, P237, DOI 10.1016/j.geomorph.2003.07.019; ELDEMERDASH MA, 1995, J ARID ENVIRON, V30, P161, DOI 10.1016/S0140-1963(05)80067-9; Gao GL, 2014, ECOL INDIC, V43, P236, DOI 10.1016/j.ecolind.2014.03.001; Gregory SO, 2001, J ARID ENVIRON, V47, P123; Guo YR, 2008, ENVIRON GEOL, V54, P653, DOI 10.1007/s00254-007-1130-y; Institute of Soil Science Chinese Academy of Sciences (ISSCAS), 1978, PHYS CHEM AN METH SO, P7; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; Lee KE, 1977, IMPACT HERBIVORES AR, P173; Li XR, 2007, GEOMORPHOLOGY, V88, P254, DOI 10.1016/j.geomorph.2006.11.009; Li XR, 2007, PLANT SOIL, V300, P221, DOI 10.1007/s11104-007-9407-1; Li XR, 2010, HYDROL PROCESS, V24, P3621, DOI 10.1002/hyp.7791; Li XR, 2006, ECOL ENG, V28, P149, DOI 10.1016/j.ecoleng.2006.05.020; Li XR, 2004, J ARID ENVIRON, V57, P1, DOI 10.1016/S0140-1963(03)00089-2; Li YL, 2009, ECOL ENG, V35, P118, DOI 10.1016/j.ecoleng.2008.09.013; [马全林 MA QuanLin], 2007, [生态学报, Acta Ecologica Sinica], V27, P5057, DOI 10.1016/S1872-2032(08)60014-1; Miao RH, 2015, ECOL ENG, V74, P164, DOI 10.1016/j.ecoleng.2014.10.004; Miki T, 2002, ECOL LETT, V5, P624, DOI 10.1046/j.1461-0248.2002.00347.x; Mitchell DJ, 1998, J ARID ENVIRON, V39, P239, DOI 10.1006/jare.1998.0396; Moberly C, 2004, SER INT C EC REST VI, P24; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; OSU SCAS, 2004, OSU RES HELP CHIN RE; PARKINSON JA, 1975, COMMUN SOIL SCI PLAN, V6, P1, DOI 10.1080/00103627509366539; PATRICIA M, 2000, RESTORATION ECOLOGY, V9, P71; Potthoff M, 2005, RESTOR ECOL, V13, P61, DOI 10.1111/j.1526-100X.2005.00008.x; Pyankov VI, 1999, PLANT CELL PHYSIOL, V40, P125, DOI 10.1093/oxfordjournals.pcp.a029519; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; Shirato Y, 2004, SOIL SCI PLANT NUTR, V50, P537, DOI 10.1080/00380768.2004.10408510; Su YZ, 2007, ECOL ENG, V29, P117, DOI 10.1016/j.ecoleng.2005.10.015; Su YZ, 2003, ECOL ENG, V20, P223, DOI 10.1016/S0925-8574(03)00042-9; Sun DF, 2006, J ENVIRON MANAGE, V79, P348, DOI 10.1016/j.jenvman.2005.08.004; Tavili A, 2009, INT J ENVIRON RES, V3, P239; Tobe K, 2000, AUST J BOT, V48, P455, DOI 10.1071/BT99013; Tornquist CG, 1999, AGR ECOSYST ENVIRON, V73, P19, DOI 10.1016/S0167-8809(99)00004-3; URQUIAGA S, 1992, SOIL SCI SOC AM J, V56, P105, DOI 10.2136/sssaj1992.03615995005600010017x; Wang WJ, 2011, GLOBAL CHANGE BIOL, V17, P2657, DOI 10.1111/j.1365-2486.2011.02447.x; Wang XP, 2006, ECOL RES, V21, P415, DOI 10.1007/s11284-005-0135-9; Wortley L, 2013, RESTOR ECOL, V21, P537, DOI 10.1111/rec.12028; Wu B, 2002, J ARID ENVIRON, V50, P429, DOI 10.1006/jare.2001.0847; Zhang ZS, 2008, J ARID ENVIRON, V72, P964, DOI 10.1016/j.jaridenv.2007.11.010; Zhao HL, 2007, ECOL ENG, V31, P1, DOI 10.1016/j.ecoleng.2007.04.010; Zhao HL, 2011, GEODERMA, V160, P367, DOI 10.1016/j.geoderma.2010.10.005; Zhu S., 2012, J GEOGR GEOL, V4, P69, DOI [10.5539/jgg.v4n3p69, DOI 10.5539/JGG.V4N3P69]; Zuo XA, 2008, SOIL TILL RES, V99, P202, DOI 10.1016/j.still.2008.02.008; Zuo XA, 2009, PLANT SOIL, V318, P153, DOI 10.1007/s11104-008-9826-7	55	15	24	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168000	10.1371/journal.pone.0168000	http://dx.doi.org/10.1371/journal.pone.0168000			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992458	Green Submitted, Green Published, gold			2022-12-26	WOS:000392758000022
J	Wein, A; Bauhus, J; Bilodeau-Gauthier, S; Scherer-Lorenzen, M; Nock, C; Staab, M				Wein, Annika; Bauhus, Juergen; Bilodeau-Gauthier, Simon; Scherer-Lorenzen, Michael; Nock, Charles; Staab, Michael			Tree Species Richness Promotes Invertebrate Herbivory on Congeneric Native and Exotic Tree Saplings in a Young Diversity Experiment	PLOS ONE			English	Article							ENEMY RELEASE HYPOTHESIS; ACER-PLATANOIDES L.; INSECT HERBIVORY; ASSOCIATIONAL RESISTANCE; FOREST DIVERSITY; NATURAL ENEMIES; BIODIVERSITY; PLANTS; GROWTH; COMPLEMENTARITY	Tree diversity in forests is an important driver of ecological processes including herbivory. Empirical evidence suggests both negative and positive effects of tree diversity on herbivory, which can be, respectively, attributed to associational resistance or associational susceptibility. Tree diversity experiments allow testing for associational effects, but evidence regarding which pattern predominates is mixed. Furthermore, it is unknown if herbivory on tree species of native vs. exotic origin is influenced by changing tree diversity in a similar way, or if exotic tree species escape natural enemies, resulting in lower damage that is unrelated to tree diversity. To address these questions, we established a young tree diversity experiment in temperate southwestern Germany that uses high planting density (49 trees per plot; plot size 13 m(2)). The species pool consists of six congeneric species pairs of European and North American origin (12 species in total) planted in monocultures and mixtures (1, 2, 4, 6 species). We assessed leaf damage by leaf-chewing insects on more than 5,000 saplings of six broadleaved tree species. Plot-level tree species richness increased leaf damage, which more than doubled from monocultures to six-species mixtures, strongly supporting associational susceptibility. However, leaf damage among congeneric native and exotic species pairs was similar. There were marked differences in patterns of leaf damage across tree genera, and only the genera likely having a predominately generalist herbivore community showed associational susceptibility, irrespective of the geographical origin of a tree species. In conclusion, an increase in tree species richness in young temperate forests may result in associational susceptibility to feeding by generalist herbivores.	[Wein, Annika; Staab, Michael] Univ Freiburg, Fac Environm & Nat Resources, Dept Nat Conservat & Landscape Ecol, Freiburg, Germany; [Bauhus, Juergen; Nock, Charles] Univ Freiburg, Fac Environm & Nat Resources, Dept Silviculture, Freiburg, Germany; [Bilodeau-Gauthier, Simon] Univ Quebec Montreal, Ctr Forest Res, Centre Ville Stn, Montreal, PQ H3C 3P8, Canada; [Scherer-Lorenzen, Michael; Nock, Charles] Univ Freiburg, Fac Biol, Dept Geobot, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Quebec; University of Quebec Montreal; University of Freiburg	Staab, M (corresponding author), Univ Freiburg, Fac Environm & Nat Resources, Dept Nat Conservat & Landscape Ecol, Freiburg, Germany.	michael.staab@nature.uni-freiburg.de	Bauhus, Jürgen/G-4449-2013; Scherer-Lorenzen, Michael/AGB-4140-2022; Staab, Michael/I-6544-2019	Bauhus, Jürgen/0000-0002-9673-4986; Scherer-Lorenzen, Michael/0000-0001-9566-590X; Staab, Michael/0000-0003-0894-7576	Albert-Ludwigs-University Freiburg; Innovationsfonds Forschung; German Research Foundation (DFG)	Albert-Ludwigs-University Freiburg; Innovationsfonds Forschung; German Research Foundation (DFG)(German Research Foundation (DFG))	The Freiburg field site of IDENT is administratively and financially supported by the Albert-Ludwigs-University Freiburg (www.unifreiburg.de), including a grant to MSL from the "Innovationsfonds Forschung" for the project "Mechanisms of tree diversity effects on ecosystem functioning". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The article processing charge was funded by the German Research Foundation (DFG; www.dfg.de) and the Albert-Ludwigs-University Freiburg in the funding program Open Access Publishing.	Abdala-Roberts L, 2015, OIKOS, V124, P1527, DOI 10.1111/oik.02033; Adams JM, 2009, BIOL INVASIONS, V11, P1005, DOI 10.1007/s10530-008-9312-4; Agrawal AA, 2003, ECOL LETT, V6, P712, DOI 10.1046/j.1461-0248.2003.00498.x; Agrawal AA, 2006, Q REV BIOL, V81, P349, DOI 10.1086/511529; Alalouni U, 2014, BASIC APPL ECOL, V15, P685, DOI 10.1016/j.baae.2014.08.013; Barbehenn R, 2005, J CHEM ECOL, V31, P969, DOI 10.1007/s10886-005-4242-4; Barbosa P, 2009, ANNU REV ECOL EVOL S, V40, P1, DOI 10.1146/annurev.ecolsys.110308.120242; Barton K, 2015, MUMIN MULTIMODEL INT, V1, P4, DOI DOI 10.1111/J.2041-210X.2012.00261.X; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BERNAYS EA, 1994, ECOLOGY, V75, P1997, DOI 10.2307/1941604; Branco M, 2015, J APPL ECOL, V52, P69, DOI 10.1111/1365-2664.12362; BROWN BJ, 1987, ECOLOGY, V68, P108, DOI 10.2307/1938810; Bruelheide H, 2014, METHODS ECOL EVOL, V5, P74, DOI 10.1111/2041-210X.12126; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Castagneyrol B, 2014, J APPL ECOL, V51, P134, DOI 10.1111/1365-2664.12175; Castagneyrol B, 2013, J ECOL, V101, P418, DOI 10.1111/1365-2745.12055; Chapman SK, 2003, ECOLOGY, V84, P2867, DOI 10.1890/02-0046; Cincotta CL, 2009, BIOL INVASIONS, V11, P379, DOI 10.1007/s10530-008-9255-9; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; COLEY PD, 1988, OECOLOGIA, V74, P531, DOI 10.1007/BF00380050; Comita LS, 2009, ECOLOGY, V90, P328, DOI 10.1890/08-0451.1; FAO, 2020, GLOBAL FOREST RESOUR; Forister ML, 2015, P NATL ACAD SCI USA, V112, P442, DOI 10.1073/pnas.1423042112; Gossner MM, 2009, AM NAT, V173, P599, DOI 10.1086/597603; Haase J, 2015, OIKOS, V124, P1674, DOI 10.1111/oik.02090; Hagele BF, 1999, OECOLOGIA, V119, P521, DOI 10.1007/s004420050815; Hajek P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00415; Halekoh U, 2014, J STAT SOFTW, V59, P1; Hamback PA, 2014, ECOLOGY, V95, P1370, DOI 10.1890/13-0793.1; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Hynynen J, 2010, FORESTRY, V83, P103, DOI 10.1093/forestry/cpp035; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Jactel H, 2007, ECOL LETT, V10, P835, DOI 10.1111/j.1461-0248.2007.01073.x; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Kirichenko N, 2013, BIOL INVASIONS, V15, P2105, DOI 10.1007/s10530-013-0436-9; KLIMETZEK D, 1993, MITT DGAAE, V8, P505; Langellotto GA, 2004, OECOLOGIA, V139, P1, DOI 10.1007/s00442-004-1497-3; Liu H, 2006, BIOL INVASIONS, V8, P1535, DOI 10.1007/s10530-005-5845-y; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Metcalfe DB, 2014, ECOL LETT, V17, P324, DOI 10.1111/ele.12233; Nadrowski K, 2010, CURR OPIN ENV SUST, V2, P75, DOI 10.1016/j.cosust.2010.02.003; Nagel R.-V., 2015, POTENZIALE RISIKEN E, P219; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Ness JH, 2011, OIKOS, V120, P1327, DOI 10.1111/j.1600-0706.2011.19119.x; Plath M, 2012, OECOLOGIA, V169, P477, DOI 10.1007/s00442-011-2215-6; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Scherer-Lorenzen M., 2014, FORESTS GLOBAL CHANG, P195, DOI DOI 10.1017/CBO9781107323506.011; Scherer-Lorenzen M, 2007, PERSPECT PLANT ECOL, V9, P53, DOI 10.1016/j.ppees.2007.08.002; Schuldt A, 2015, J ECOL, V103, P563, DOI 10.1111/1365-2745.12396; Schuldt A, 2012, ECOL LETT, V15, P732, DOI 10.1111/j.1461-0248.2012.01792.x; Schuldt A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022905; Schuldt A, 2010, J ECOL, V98, P917, DOI 10.1111/j.1365-2745.2010.01659.x; Schultheis EH, 2015, ECOLOGY, V96, P2446, DOI 10.1890/14-2158.1; SCHULTZ JC, 1982, AM J BOT, V69, P753, DOI 10.2307/2442965; Shaw DC, 2006, WEST N AM NATURALIST, V66, P473, DOI 10.3398/1527-0904(2006)66[473:SHIAOC]2.0.CO;2; Singer MS, 2002, ANIM BEHAV, V64, P629, DOI 10.1006/anbe.2002.3082; Sobek S, 2009, OECOLOGIA, V160, P279, DOI 10.1007/s00442-009-1304-2; Sprick Peter, 2008, P261; Staab M, 2015, OIKOS, V124, P827, DOI 10.1111/oik.01723; Staab M, 2014, ECOL ENTOMOL, V39, P637, DOI 10.1111/een.12143; TAHVANAINEN JO, 1972, OECOLOGIA, V10, P321, DOI 10.1007/BF00345736; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tobner CM, 2014, OECOLOGIA, V174, P609, DOI 10.1007/s00442-013-2815-4; Unsicker SB, 2008, OECOLOGIA, V156, P313, DOI 10.1007/s00442-008-0973-6; van Wilgen NJ, 2011, DIVERS DISTRIB, V17, P172, DOI 10.1111/j.1472-4642.2010.00717.x; Vehvilainen H, 2007, OECOLOGIA, V152, P287, DOI 10.1007/s00442-007-0673-7; Verheyen K, 2016, AMBIO, V45, P29, DOI 10.1007/s13280-015-0685-1; Woziwoda B, 2014, ACTA SOC BOT POL, V83, P39, DOI 10.5586/asbp.2013.035; Zuur Alain F., 2009, P1; Zvereva EL, 2012, OIKOS, V121, P2036, DOI 10.1111/j.1600-0706.2012.20688.x	74	12	12	6	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168751	10.1371/journal.pone.0168751	http://dx.doi.org/10.1371/journal.pone.0168751			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992554	Green Published, Green Submitted, gold			2022-12-26	WOS:000392758000076
J	Wrozyna, C; Neubauer, TA; Meyer, J; Piller, WE				Wrozyna, Claudia; Neubauer, Thomas A.; Meyer, Juliane; Piller, Werner E.			Shape Variation in Neotropical Cytheridella (Ostracoda) Using Semilandmarks-Based Geometric Morphometrics: A Methodological Approach and Possible Biogeographical Implications	PLOS ONE			English	Article							LATE MIOCENE; SOLIMOES FORMATION; CRUSTACEA; INVERTEBRATES; POPULATIONS; CYPRIDEIS; EVOLUTION	Geometric morphometrics offer effective methods to obtain information about shape and shape variability. In ostracodology, landmark-based methods are, however, not well established. To test the applicability of geometric morphometric analyses for ostracods, we investigated shape variation among recent and fossil populations of the genus Cytheridella using a combination of landmarks and semilandmarks. The study focuses on the species' intraspecific morphological variability on a supra-regional scale, comparing living populations from Florida, Yucata A n, Colombia and Brazil. We performed Generalized least-squares Procrustes Analysis on 508 adult and juvenile specimens (valves) including stages A-1 to A-4. The analyses show that the primary pattern in shape variation is ontogenetic allometry, supporting a clear separation of adults and juveniles. Shape changes are relatively small during ontogeny from A-4 to A-1. Greatest modification of valve shape occurs during the last molt phase. Insufficient differentiation of sexes is caused by females with less developed brood pouches. Disentangling size-and non-size-dependent shape changes reveals regional differences between populations of the species C. ilosvayi and supports its taxonomic distinction from a fossil relative (C. danielopoli). The distribution of regional morphotypes of C. ilosvayi in Florida, Mexico, and Brazil are congruent with fly ways of water birds.	[Wrozyna, Claudia; Meyer, Juliane; Piller, Werner E.] Graz Univ, Inst Earth Sci, NAWI Graz Geoctr, Graz, Austria; [Neubauer, Thomas A.] Nat Hist Museum Vienna, Geol Paleontol Dept, Vienna, Austria; [Neubauer, Thomas A.] Justus Liebig Univ, Dept Anim Ecol & Systemat, Giessen, Germany	University of Graz; Justus Liebig University Giessen	Wrozyna, C (corresponding author), Graz Univ, Inst Earth Sci, NAWI Graz Geoctr, Graz, Austria.	claudia.wrozyna@uni-graz.at	Neubauer, Thomas A./I-1889-2019	Neubauer, Thomas A./0000-0002-1398-9941; Wrozyna, Claudia/0000-0003-1416-7058	Austrian Science Fund (FWF) [P26554]; Austrian Science Fund (FWF) [P 26554] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work is financed through the Austrian Science Fund (http://www.fwf.ac.at/; FWF-project P26554). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello G, 2007, ACTA PALAEONTOL POL, V52, P563; Baltanas A, 2002, BIOL J LINN SOC, V75, P9, DOI 10.1046/j.1095-8312.2002.00001.x; Baltanas A, 2000, HYDROBIOLOGIA, V419, P65, DOI 10.1023/A:1003994209369; Baltanas Angel, 2011, Joannea Geologie und Palaeontologie, V11, P235; BaltanuYs A., 2003, PALEONTOLOGICAL SOC, V9, P101, DOI DOI 10.1017/S1089332600002175; Boere CG, 2006, WATERBIRDS WORLD, P40; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Bookstein FL, 1996, B MATH BIOL, V58, P313, DOI 10.1016/0092-8240(95)00329-0; Bookstein FL, 1991, MORPHOMETRIC TOOLS L; Brochet AL, 2010, HYDROBIOLOGIA, V637, P255, DOI 10.1007/s10750-009-9975-6; CRAMPTON JS, 1995, LETHAIA, V28, P179, DOI 10.1111/j.1502-3931.1995.tb01611.x; Danielopol Dan L., 2011, Joannea Geologie und Palaeontologie, V11, P273; Danielopol Dan L., 2008, Senckenbergiana Lethaea, V88, P183; Danielopol DL, 2014, GEOECOMARINA, V20, P5; Elewa AMT, 2004, MORPHOMETRICS: APPLICATIONS IN BIOLOGY AND PALEONTOLOGY, P7; Elewa AMT, 2003, PALAEONT ELEC, V6, P11; Frisch D, 2007, AQUAT SCI, V69, P568, DOI 10.1007/s00027-007-0915-0; Gitter F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0109360; Green AJ, 2013, LIMNETICA, V32, P39; Gross M, 2013, J S AM EARTH SCI, V42, P216, DOI 10.1016/j.jsames.2012.10.002; Gross M, 2011, J S AM EARTH SCI, V32, P169, DOI 10.1016/j.jsames.2011.05.004; Gross Martin, 2008, Senckenbergiana Lethaea, V88, P161; Gueziec A, 1996, NATO ADV SCI INST SE, V284, P253; Gunz P, 2005, STAT GEOMETRIC RECON; Gunz P, 2013, HYSTRIX, V24, P1; Gunz P, 2007, J HUM EVOL, V52, P262, DOI 10.1016/j.jhevol.2006.08.010; Haines AJ, 2000, PALAEONTOLOGY, V43, P765, DOI 10.1111/1475-4983.00148; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Horne DJ, 1998, ERGEB LIMNOL, V52, P549; Kaesler R.L., 1988, Developments in Palaeontology and Stratigraphy, V11, P207; Karanovic I., 2012, CRUSTACEA OSTRACODA; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; Ligios Silvia, 2012, Revue de Micropaleontologie, V55, P171, DOI 10.1016/j.revmic.2012.09.002; LOHMANN GP, 1983, J INT ASS MATH GEOL, V15, P659, DOI 10.1007/BF01033230; MacLeod N, 1999, PALEOBIOLOGY, V25, P107; Maddocks R.F., 1988, Developments in Palaeontology and Stratigraphy, V11, P219; MANESS T R, 1987, University of Kansas Paleontological Contributions Paper, P1; Mesquita-Joanes F., 2012, DEV QUATERNARY SCI, V17, P5, DOI DOI 10.1016/B978-0-444-53636-5.00002-0; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; Munoz J, 2013, PEERJ, V1, DOI 10.7717/peerj.200; Namiotko T, 2012, INT REV HYDROBIOL, V97, P356, DOI 10.1002/iroh.201211496; Neubauer TA, 2014, PALAEOGEOGR PALAEOCL, V414, P116, DOI 10.1016/j.palaeo.2014.08.015; Neubauer TA, 2013, BIOL J LINN SOC, V110, P320, DOI 10.1111/bij.12120; Neubauer TA, 2013, PALAEOGEOGR PALAEOCL, V370, P117, DOI 10.1016/j.palaeo.2012.11.025; PURPER I, 1974, AN ACAD BRAS CIENC, V46, P635; Reyment RA, 1997, B MATH BIOL, V59, P63; Reyment Richard A., 1993, Revista Espanola de Paleontologia, V8, P125; Rohlf F. J., 2013, TPSDIG DIGITIZE LAND; Rohlf F. J., 2015, TPSRELW RELATIVE WAR; Rohlf F. J., 2015, TPSUTIL FILE UTILITY; ROHLF FJ, 1990, ANNU REV ECOL SYST, V21, P299, DOI 10.1146/annurev.es.21.110190.001503; SCHWEITZER PN, 1986, PALEOBIOLOGY, V12, P290, DOI 10.1017/S0094837300013798; Sheets H. David, 2006, Frontiers in Zoology, V3, pUnpaginated, DOI 10.1186/1742-9994-3-15; Tanaka G, 2009, BIOL J LINN SOC, V97, P810, DOI 10.1111/j.1095-8312.2009.01222.x; Webster M, 2010, PALEONTOLOGICAL SOC, V,, P163, DOI DOI 10.1017/S1089332600001868; Wrozyna C, 2014, CRUSTACEANA, V87, P1043, DOI 10.1163/15685403-00003342	56	21	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168438	10.1371/journal.pone.0168438	http://dx.doi.org/10.1371/journal.pone.0168438			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977765	Green Published, Green Submitted, gold			2022-12-26	WOS:000391217400108
J	Shahriari, K; Shen, F; Worrede-Mahdi, A; Liu, Q; Gong, Y; Garcia, FU; Fatatis, A				Shahriari, K.; Shen, F.; Worrede-Mahdi, A.; Liu, Q.; Gong, Y.; Garcia, F. U.; Fatatis, A.			Cooperation among heterogeneous prostate cancer cells in the bone metastatic niche	ONCOGENE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; NEUROENDOCRINE DIFFERENTIATION; BREAST-CANCER; TUMOR-GROWTH; PROGRESSION; FIBROBLASTS; EXPRESSION; MICE; ADENOCARCINOMA; IDENTIFICATION	The growth of disseminated tumor cells into metastatic lesions depends on the establishment of a favorable microenvironment in the stroma of the target organs. Here we show that mice treated with anakinra, an antagonist of the interleukin (IL)-1 beta receptor (IL-1R), or harboring a targeted deletion of IL-1R are significantly less prone to develop bone tumors when inoculated in the arterial circulation with human prostate cancer (PCa) cells expressing IL-1 beta. Interestingly, human mesenchymal stem cells exposed in vitro to medium conditioned by IL-1 beta-expressing cancer cells responded by upregulating S100A4, a marker of cancer-associated fibroblasts (CAFs), and this effect was blocked by anakinra. Analogously, the stroma adjacent to skeletal metastases generated in mice by IL-1 beta-expressing cancer cells showed a dramatic increase in S100A4, COX-2 and the alteration of 30 tumor-related genes as measured by Nanostring analysis. These effects were not observed in the stroma associated with the rare and much smaller metastases generated by the same cells in IL-1R knockout animals, confirming that tumor-secreted IL-1 beta generates skeletal CAFs and conditions the surrounding bone microenvironment. In skeletal lesions from patients with metastatic PCa, histological and molecular analyses revealed that IL-1 beta is highly expressed in cancer cells in which the androgen receptor (AR) is not detected (AR-), whereas this cytokine is uniformly absent in the AR-positive (AR+) metastatic cells. The stroma conditioned by IL-1 beta-expressing cancer cells served as a supportive niche also for coexisting IL-1 beta-lacking cancer cells, which are otherwise unable to generate tumors after independently seeding the skeleton of mice. This niche is established very early following tumor seeding and hints to a role of IL-1 beta in promoting early colonization of PCa at the skeletal level.	[Shahriari, K.; Shen, F.; Worrede-Mahdi, A.; Liu, Q.; Fatatis, A.] Drexel Univ, Coll Med, Dept Pharmacol & Physiol, 245N 15th St,NCB 8211, Philadelphia, PA 19102 USA; [Gong, Y.; Garcia, F. U.; Fatatis, A.] Drexel Univ, Coll Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Garcia, F. U.] Eastern Reg Med Ctr, Canc Treatment Ctr Amer, Philadelphia, PA USA; [Fatatis, A.] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Program Prostate Canc, Philadelphia, PA 19107 USA; [Liu, Q.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA	Drexel University; Drexel University; Jefferson University; University of Texas System; UTMD Anderson Cancer Center	Fatatis, A (corresponding author), Drexel Univ, Coll Med, Dept Pharmacol & Physiol, 245N 15th St,NCB 8211, Philadelphia, PA 19102 USA.	afatatis@drexelmed.edu		Worrede, Asurayya/0000-0003-2013-0112	NIH [F30CA192896-01]; Department of Defense [PC080987]; NATIONAL CANCER INSTITUTE [F30CA192896] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Olimpia Meucci (Department of Pharmacology and Physiology at Drexel University College of Medicine) for invaluable advice, Dr Kevin Kelly (Medical Oncology) and all the other members of the Greater Philadelphia Prostate Cancer Working Group at the Sidney Kimmel Cancer Center, Thomas Jefferson University for insightful discussions, Dr Ruth Birbe (Pathology) at Thomas Jefferson University for providing the human specimens of skeletal metastases and Danielle Jernigan (Fatatis laboratory) for critical reading of the manuscript. This work was supported by NIH F30CA192896-01 grant to KS and in part by Department of Defense PC080987 Idea Award to AF.	Bedard PL, 2013, NATURE, V501, P355, DOI 10.1038/nature12627; Beltran H, 2011, CANCER DISCOV, V1, P487, DOI 10.1158/2159-8290.CD-11-0130; Bersani F, 2014, CANCER RES, V74, P7229, DOI 10.1158/0008-5472.CAN-14-1809; Boye K, 2010, AM J PATHOL, V176, P528, DOI 10.2353/ajpath.2010.090526; Childs RW, 2015, NAT REV DRUG DISCOV, V14, P487, DOI 10.1038/nrd4506; Cindolo L, 2007, EUR UROL, V52, P1365, DOI 10.1016/j.eururo.2006.11.030; Cohen SB, 2004, RHEUM DIS CLIN N AM, V30, P365, DOI 10.1016/j.rdc.2004.01.005; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Dinarello CA, 2010, CANCER METAST REV, V29, P317, DOI 10.1007/s10555-010-9229-0; Drake JM, 2005, CLIN EXP METASTAS, V22, P674, DOI 10.1007/s10585-006-9011-4; Drake JM, 2010, CANCER BIOL THER, V9, P607, DOI 10.4161/cbt.9.8.11112; Eckhardt BL, 2012, NAT REV DRUG DISCOV, V11, P479, DOI 10.1038/nrd2372; FENTON MJ, 1992, INT J IMMUNOPHARMACO, V14, P401, DOI 10.1016/0192-0561(92)90170-P; Garrett SC, 2006, J BIOL CHEM, V281, P677, DOI 10.1074/jbc.R500017200; Giannoni E, 2010, CANCER RES, V70, P6945, DOI 10.1158/0008-5472.CAN-10-0785; Goel HL, 2008, ENDOCR-RELAT CANCER, V15, P657, DOI 10.1677/ERC-08-0019; Hemingway F, 2011, BONE, V48, P938, DOI 10.1016/j.bone.2010.12.023; Jamieson-Gladney WL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3016; Jiborn T, 1998, UROLOGY, V51, P585, DOI 10.1016/S0090-4295(97)00684-5; Kalos M, 2004, PROSTATE, V60, P246, DOI 10.1002/pros.20043; Karagiannis GS, 2012, MOL CANCER RES, V10, P1403, DOI 10.1158/1541-7786.MCR-12-0307; Kim S, 2000, P NATL ACAD SCI USA, V97, P2731, DOI 10.1073/pnas.050588297; Klein CA, 2013, NATURE, V501, P365, DOI 10.1038/nature12628; Komiya A, 2009, INT J UROL, V16, P37, DOI 10.1111/j.1442-2042.2008.02175.x; Lewis AM, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-48; Li HJ, 2012, CANCER DISCOV, V2, P840, DOI 10.1158/2159-8290.CD-12-0101; Liu QX, 2013, CANCER RES, V73, P3297, DOI 10.1158/0008-5472.CAN-12-3970; Madar S, 2013, TRENDS MOL MED, V19, P447, DOI 10.1016/j.molmed.2013.05.004; MICKEY DD, 1977, CANCER RES, V37, P4049; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pio R, 2014, ADV EXP MED BIOL, V772, P229, DOI 10.1007/978-1-4614-5915-6_11; Russell MR, 2009, ONCOGENE, V28, P412, DOI 10.1038/onc.2008.390; Shariff AH, 2006, UROLOGY, V68, P2, DOI 10.1016/j.urology.2006.02.002; Sharma A, 2010, J CLIN INVEST, V120, P4478, DOI 10.1172/JCI44239; Shen F, 2016, MOL CANCER RES, V14, P518, DOI 10.1158/1541-7786.MCR-16-0013; Sheridan T, 2007, AM J SURG PATHOL, V31, P1351, DOI 10.1097/PAS.0b013e3180536678; Sun Y, 2009, AM J TRANSL RES, V1, P148; Tabassum DP, 2015, NAT REV CANCER, V15, P473, DOI 10.1038/nrc3971; Valdivia-Silva JE, 2009, CANCER LETT, V283, P176, DOI 10.1016/j.canlet.2009.03.040; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Wai PY, 2008, CANCER METAST REV, V27, P103, DOI 10.1007/s10555-007-9104-9; WANG M, 1991, DIFFERENTIATION, V48, P115, DOI 10.1111/j.1432-0436.1991.tb00250.x; Weckermann D, 2001, J UROLOGY, V166, P699, DOI 10.1016/S0022-5347(05)66046-6; Wurth R, 2015, TRANSL ONCOL, V8, P358, DOI 10.1016/j.tranon.2015.07.002; Xu JC, 2001, CANCER RES, V61, P1563; Yu DD, 2015, ONCOTARGET, V6, P42687, DOI 10.18632/oncotarget.5883; Zhao Y, 2014, INT J BIOL SCI, V10, P614, DOI 10.7150/ijbs.8389	47	28	28	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 18	2017	36	20					2846	2856		10.1038/onc.2016.436	http://dx.doi.org/10.1038/onc.2016.436			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EV3ZM	27991924	Green Accepted			2022-12-26	WOS:000401697800007
J	Kafkova, L; Debler, EW; Fisk, JC; Jain, K; Clarke, SG; Read, LK				Kafkova, Lucie; Debler, Erik W.; Fisk, John C.; Jain, Kanishk; Clarke, Steven G.; Read, Laurie K.			The Major Protein Arginine Methyltransferase in Trypanosoma brucei Functions as an Enzyme-Prozyme Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-ADENOSYLMETHIONINE DECARBOXYLASE; REGULATORY SUBUNIT PROZYME; SUBSTRATE-SPECIFICITY; IN-VIVO; ALLOSTERIC ACTIVATION; N-METHYLTRANSFERASE; PROTEOMIC ANALYSIS; HUMAN INTERACTOME; METHYLATION; RNA	Prozymes are catalytically inactive enzyme paralogs that dramatically stimulate the function of weakly active enzymes through complex formation. The two prozymes described to date reside in the polyamine biosynthesis pathway of the human parasite Trypanosoma brucei, an early branching eukaryote that lacks transcriptional regulation and regulates its proteome through posttranscriptional and posttranslational means. Arginine methylation is a common posttranslational modification in eukaryotes catalyzed by protein arginine methyltransferases (PRMTs) that are typically thought to function as homodimers. Wedemonstrate that a major T. brucei PRMT, TbPRMT1, functions as a heterotetrameric enzyme-prozyme pair. The inactive PRMT paralog, TbPRMT1(PRO), is essential for catalytic activity of the TbPRMT1(ENZ) subunit. Mutational analysis definitively demonstrates that TbPRMT1(ENZ) is the cofactor-binding subunit and carries all catalytic activity of the complex. Our results are the first demonstration of an obligate heteromeric PRMT, and they suggest that enzyme-prozyme organization is expanded in trypanosomes as a posttranslational means of enzyme regulation.	[Kafkova, Lucie; Fisk, John C.; Read, Laurie K.] SUNY Buffalo, Witebsky Ctr Microbial Pathogenesis & Immunol, Dept Microbiol & Immunol, Buffalo, NY 14214 USA; [Kafkova, Lucie; Fisk, John C.; Read, Laurie K.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Buffalo, NY 14214 USA; [Debler, Erik W.] Rockefeller Univ, Cell Biol Lab, New York, NY 10065 USA; [Jain, Kanishk; Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Jain, Kanishk; Clarke, Steven G.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Rockefeller University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Read, LK (corresponding author), SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Microbiol & Immunol, Buffalo, NY 14214 USA.	lread@buffalo.edu		Jain, Kanishk/0000-0001-8039-0464; Debler, Erik/0000-0002-2587-2150; Kafkova, Lucie/0000-0001-9072-8019	National Institutes of Health [R01 AI060260, R01 GM026020]; National Institutes of Health Ruth L. Kirschstein National Service [GM007185]; American Heart Association [15PRE24480155]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060260, R01AI061580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185, R01GM026020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Ruth L. Kirschstein National Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 AI060260 (to L. K. R.) and R01 GM026020 (to S. G. C.), National Institutes of Health Ruth L. Kirschstein National Service Award GM007185 to (K. J.), and American Heart Association Predoctoral Fellowship 15PRE24480155 (to L. K.). The authors declare that they havenoconflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adrain C, 2012, NAT REV MOL CELL BIO, V13, P489, DOI 10.1038/nrm3392; BALTZ T, 1985, EMBO J, V4, P1273, DOI 10.1002/j.1460-2075.1985.tb03772.x; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bilbe G, 2015, SCIENCE, V348, P974, DOI 10.1126/science.aaa3683; Cavalier-Smith T, 2010, BIOL LETTERS, V6, P342, DOI 10.1098/rsbl.2009.0948; Daniels JP, 2010, MICROBIOL MOL BIOL R, V74, P552, DOI 10.1128/MMBR.00024-10; Debler EW, 2016, P NATL ACAD SCI USA, V113, P2068, DOI 10.1073/pnas.1525783113; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; Fisk JC, 2013, MOL CELL PROTEOMICS, V12, P302, DOI 10.1074/mcp.M112.022533; Fisk JC, 2011, EUKARYOT CELL, V10, P1013, DOI 10.1128/EC.05103-11; Fisk JC, 2010, EUKARYOT CELL, V9, P866, DOI 10.1128/EC.00018-10; Fisk JC, 2009, J BIOL CHEM, V284, P11590, DOI 10.1074/jbc.M807279200; Fritz M, 2015, NUCLEIC ACIDS RES, V43, P8013, DOI 10.1093/nar/gkv731; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Hadjikyriacou A, 2015, J BIOL CHEM, V290, P16723, DOI 10.1074/jbc.M115.659433; Hasegawa M, 2014, FEBS LETT, V588, P1942, DOI 10.1016/j.febslet.2014.03.053; Hashimi H, 2009, RNA, V15, P588, DOI 10.1261/rna.1411809; Hayman ML, 2001, NUCLEIC ACIDS RES, V29, P5216, DOI 10.1093/nar/29.24.5216; Herrmann F, 2009, J CELL SCI, V122, P667, DOI 10.1242/jcs.039933; Hung CJ, 2007, J BIOCHEM MOL BIOL, V40, P617; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Ivanov IP, 2010, J MOL EVOL, V70, P289, DOI 10.1007/s00239-010-9331-5; Iyer LM, 2016, BIOESSAYS, V38, P27, DOI 10.1002/bies.201500104; Keating J, 2015, ACTA TROP, V150, P4, DOI 10.1016/j.actatropica.2015.06.003; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Lee WC, 2015, BIOCHEMISTRY-US, V54, P7514, DOI 10.1021/acs.biochem.5b00995; Lim Y, 2005, BBA-GEN SUBJECTS, V1723, P240, DOI 10.1016/j.bbagen.2005.02.015; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Lott K, 2015, NUCLEIC ACIDS RES, V43, P5501, DOI 10.1093/nar/gkv428; Lott K, 2014, MICROBIOLOGYOPEN, V3, P595, DOI 10.1002/mbo3.191; Lott K, 2013, J PROTEOMICS, V91, P210, DOI 10.1016/j.jprot.2013.07.010; Lueong S, 2016, MOL MICROBIOL, V100, P457, DOI 10.1111/mmi.13328; McBride AE, 2000, J BIOL CHEM, V275, P3128, DOI 10.1074/jbc.275.5.3128; Miranda TB, 2004, J BIOL CHEM, V279, P22902, DOI 10.1074/jbc.M312904200; Morriswood B, 2013, EUKARYOT CELL, V12, P356, DOI 10.1128/EC.00326-12; Neault M, 2012, NUCLEIC ACIDS RES, V40, P9513, DOI 10.1093/nar/gks764; Nett IRE, 2009, MOL CELL PROTEOMICS, V8, P1527, DOI 10.1074/mcp.M800556-MCP200; Niu LF, 2008, PLANT PHYSIOL, V148, P490, DOI 10.1104/pp.108.124727; Pak ML, 2011, BIOCHEMISTRY-US, V50, P8226, DOI 10.1021/bi200644c; Pasternack DA, 2007, EUKARYOT CELL, V6, P1665, DOI 10.1128/EC.00133-07; Pelletier M, 2005, MOL BIOCHEM PARASIT, V144, P206, DOI 10.1016/j.molbiopara.2005.08.015; Pelletier M, 2001, MOL BIOCHEM PARASIT, V118, P49, DOI 10.1016/S0166-6851(01)00367-X; Pils B, 2004, J MOL BIOL, V340, P399, DOI 10.1016/j.jmb.2004.04.063; Read LK, 2016, WIRES RNA, V7, P33, DOI 10.1002/wrna.1313; Rho J, 2001, J BIOL CHEM, V276, P11393, DOI 10.1074/jbc.M008660200; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Nguyen S, 2015, J BIOL CHEM, V290, P19987, DOI 10.1074/jbc.M115.656785; Nguyen S, 2013, J BIOL CHEM, V288, P15256, DOI 10.1074/jbc.M113.461137; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Toma-Fukai S, 2016, J MOL BIOL, V428, P1197, DOI 10.1016/j.jmb.2016.02.007; Troffer-Charlier N, 2007, EMBO J, V26, P4391, DOI 10.1038/sj.emboj.7601855; Urbaniak MD, 2013, J PROTEOME RES, V12, P2233, DOI 10.1021/pr400086y; Velez N, 2013, J BIOL CHEM, V288, P5232, DOI 10.1074/jbc.M112.442475; VICKERMAN K, 1985, BRIT MED BULL, V41, P105, DOI 10.1093/oxfordjournals.bmb.a072036; Wang CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087267; Wang P, 2016, MOL CELL, V63, P306, DOI 10.1016/j.molcel.2016.05.041; Wang X, 2016, NATURE, V534, P575, DOI 10.1038/nature18298; Wang YC, 2015, MOL PHYLOGENET EVOL, V84, P101, DOI 10.1016/j.ympev.2014.12.002; Weimann M, 2013, NAT METHODS, V10, P339, DOI [10.1038/NMETH.2397, 10.1038/nmeth.2397]; Weiss VH, 2000, NAT STRUCT BIOL, V7, P1165; Willert EK, 2007, P NATL ACAD SCI USA, V104, P8275, DOI 10.1073/pnas.0701111104; Willert EK, 2009, MOL BIOCHEM PARASIT, V168, P1, DOI 10.1016/j.molbiopara.2009.05.009; Willert EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000183; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Xiao YJ, 2013, MOL MICROBIOL, V88, P846, DOI 10.1111/mmi.12226; Yang YZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7428; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhang X, 2000, J HYDRAULIC ENG, V3, P3, DOI DOI 10.3321/J.ISSN:1000-0534.2000.03.003.(IN	70	16	16	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2089	2100		10.1074/jbc.M116.757112	http://dx.doi.org/10.1074/jbc.M116.757112			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	27998975	hybrid, Green Published			2022-12-26	WOS:000395530300004
J	Bigaud, M; Dincer, Z; Bollbuck, B; Dawson, J; Beckmann, N; Beerli, C; Fishli-Cavelti, G; Nahler, M; Angst, D; Janser, P; Otto, H; Rosner, E; Hersperger, R; Bruns, C; Quancard, J				Bigaud, Marc; Dincer, Zuhal; Bollbuck, Birgit; Dawson, Janet; Beckmann, Nicolau; Beerli, Christian; Fishli-Cavelti, Gina; Nahler, Michaela; Angst, Daniela; Janser, Philipp; Otto, Heike; Rosner, Elisabeth; Hersperger, Rene; Bruns, Christian; Quancard, Jean			Pathophysiological Consequences of a Break in S1P1-Dependent Homeostasis of Vascular Permeability Revealed by S1P1 Competitive Antagonism	PLoS One			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTORS; SELECTIVE S1P(1) ANTAGONIST; IN-VIVO; MECHANISTIC INSIGHTS; LYMPHOCYTE EGRESS; FTY720; LUNG; RATS; SPHINGOSINE-1-PHOSPHATE; IMMUNOSUPPRESSANT	Rational Homeostasis of vascular barriers depends upon sphingosine 1-phosphate (S1P) signaling via the S1P1 receptor. Accordingly, S1P1 competitive antagonism is known to reduce vascular barrier integrity with still unclear pathophysiological consequences. This was explored in the present study using NIBR-0213, a potent and selective S1P1 competitive antagonist. Results NIBR-0213 was tolerated at the efficacious oral dose of 30 mg/kg BID in the rat adjuvant-induced arthritis (AiA) model, with no sign of labored breathing. However, it induced dose-dependent acute vascular pulmonary leakage and pleural effusion that fully resolved within 3-4 days, as evidenced by MRI monitoring. At the supra-maximal oral dose of 300 mg/kg QD, NIBR-0213 impaired lung function (with increased breathing rate and reduced tidal volume) within the first 24 hrs. Two weeks of NIBR-0213 oral dosing at 30, 100 and 300 mg/kg QD induced moderate pulmonary changes, characterized by alveolar wall thickening, macrophage accumulation, fibrosis, micro-hemorrhage, edema and necrosis. In addition to this picture of chronic inflammation, perivascular edema and myofiber degeneration observed in the heart were also indicative of vascular leakage and its consequences. Conclusions Overall, these observations suggest that, in the rat, the lung is the main target organ for the S1P1 competitive antagonism-induced acute vascular leakage, which appears first as transient and asymptomatic but could lead, upon chronic dosing, to lung remodeling with functional impairments. Hence, this not only raises the question of organ specificity in the homeostasis of vascular barriers, but also provides insight into the pre-clinical evaluation of a potential safety window for S1P1 competitive antagonists as drug candidates.	[Bigaud, Marc; Dincer, Zuhal; Bollbuck, Birgit; Dawson, Janet; Beckmann, Nicolau; Beerli, Christian; Fishli-Cavelti, Gina; Nahler, Michaela; Angst, Daniela; Janser, Philipp; Otto, Heike; Rosner, Elisabeth; Hersperger, Rene; Bruns, Christian; Quancard, Jean] Novartis Inst Biomed Res Autoimmun Transplantat &, Basel, Switzerland	Novartis	Bigaud, M (corresponding author), Novartis Inst Biomed Res Autoimmun Transplantat &, Basel, Switzerland.	marc.bigaud@novartis.com	Beckmann, Nicolau/H-7616-2019	Dawson, Janet/0000-0003-4615-4091	NIBR	NIBR	NIBR provided support in the form of salaries to all authors (MB, ZD, BB, JD, NB, CB, GFC, MN, DA, PJ, HO, ER, RH, CB, JQ) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allende ML, 2002, BIOCHIM BIOPHYS ACTA, V582, P222; Angst D, 2012, J MED CHEM, V55, P9722, DOI 10.1021/jm3009508; Beckmann N, 2002, AM J PHYSIOL-LUNG C, V283, pL22, DOI 10.1152/ajplung.00373.2001; Beckmann N, 2001, MAGNET RESON MED, V45, P88, DOI 10.1002/1522-2594(200101)45:1<88::AID-MRM1013>3.0.CO;2-N; Berst F, 2007, WO Patent, Patent No. 2008028937; Bigaud M, 2014, BBA-MOL CELL BIOL L, V1841, P745, DOI 10.1016/j.bbalip.2013.11.001; Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Camm J, 2014, AM HEART J, V168, P632, DOI 10.1016/j.ahj.2014.06.028; Curry FRE, 2013, ACTA PHYSIOL, V207, P628, DOI 10.1111/apha.12076; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Fujii Y, 2012, BBA-MOL CELL BIOL L, V1821, P600, DOI 10.1016/j.bbalip.2011.12.006; Fujii Y, 2012, J IMMUNOL, V188, P206, DOI 10.4049/jimmunol.1101537; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Hla T, 2011, NEUROLOGY, V76, pS3, DOI 10.1212/WNL.0b013e31820d5ec1; Hoymann Heinz Gerd, 2007, Journal of Pharmacological and Toxicological Methods, V55, P16, DOI 10.1016/j.vascn.2006.04.006; Huggins JT, 2004, CLIN CHEST MED, V25, P141, DOI 10.1016/S0272-5231(03)00125-4; Janes K, 2014, J BIOL CHEM, V289, P21082, DOI 10.1074/jbc.M114.569574; Koyrakh L, 2005, AM J TRANSPLANT, V5, P529, DOI 10.1111/j.1600-6143.2005.00754.x; Lee JF, 2009, AM J PHYSIOL-HEART C, V296, pH33, DOI 10.1152/ajpheart.00097.2008; Light RW, 2011, MED CLIN N AM, V95, P1055, DOI 10.1016/j.mcna.2011.08.005; Markov AG, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00221; Marsolais D, 2009, NAT REV DRUG DISCOV, V8, P297, DOI 10.1038/nrd2356; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Matsuura M, 2000, INFLAMM RES, V49, P404, DOI 10.1007/s000110050608; McVerry BJ, 2005, CELL SIGNAL, V17, P131, DOI 10.1016/j.cellsig.2004.08.006; Miserocchi G, 2009, EUR RESPIR REV, V18, P244, DOI 10.1183/09059180.00002709; Oo ML, 2011, J CLIN INVEST, V121, P2290, DOI 10.1172/JCI45403; PEARSON CM, 1956, P SOC EXP BIOL MED, V91, P95, DOI 10.3181/00379727-91-22179; Quancard J, 2012, CHEM BIOL, V19, P1142, DOI 10.1016/j.chembiol.2012.07.016; Sanchez T, 2003, J BIOL CHEM, V278, P47281, DOI 10.1074/jbc.M306896200; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Scotton CJ, 2009, J CLIN INVEST, V119, P2550, DOI 10.1172/JCI33288; Shea BS, 2010, AM J RESP CELL MOL, V43, P662, DOI 10.1165/rcmb.2009-0345OC; Singleton PA, 2006, J BIOL CHEM, V281, P34381, DOI 10.1074/jbc.M603680200; Tigani B, 2002, BIOCHEM BIOPH RES CO, V292, P216, DOI 10.1006/bbrc.2002.6633; Wilkerson BA, 2012, J BIOL CHEM, V287, P44645, DOI 10.1074/jbc.M112.423426	37	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168252	10.1371/journal.pone.0168252	http://dx.doi.org/10.1371/journal.pone.0168252			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005953	gold, Green Published, Green Submitted			2022-12-26	WOS:000392843200040
J	Cattani, AM; Siqueira, FM; Guedes, RLM; Schrank, IS				Cattani, Amanda Malvessi; Siqueira, Franciele Maboni; Muniz Guedes, Rafael Lucas; Schrank, Irene Silveira			Repetitive Elements in Mycoplasma hyopneumoniae Transcriptional Regulation	PLOS ONE			English	Article							TANDEM REPEATS; ANTIGENIC VARIATION; PHASE VARIATION; PROKARYOTIC GENOMES; BACTERIAL GENOMES; GENE-EXPRESSION; MOLECULAR-BASIS; DNA-SEQUENCES; FREQUENCY; EVOLUTION	Transcriptional regulation, a multiple-step process, is still poorly understood in the important pig pathogen Mycoplasma hyopneumoniae. Basic motifs like promoters and terminators have already been described, but no other cis-regulatory elements have been found. DNA repeat sequences have been shown to be an interesting potential source of cis-regulatory elements. In this work, a genome-wide search for tandem and palindromic repetitive elements was performed in the intergenic regions of all coding sequences from M. hyopneumoniae strain 7448. Computational analysis demonstrated the presence of 144 tandem repeats and 1,171 palindromic elements. The DNA repeat sequences were distributed within the 5' upstream regions of 86% of transcriptional units of M. hyopneumoniae strain 7448. Comparative analysis between distinct repetitive sequences found in related mycoplasma genomes demonstrated different percentages of conservation among pathogenic and nonpathogenic strains. qPCR assays revealed differential expression among genes showing variable numbers of repetitive elements. In addition, repeats found in 206 genes already described to be differentially regulated under different culture conditions of M. hyopneumoniae strain 232 showed almost 80% conservation in relation to M. hyopneumoniae strain 7448 repeats. Altogether, these findings suggest a potential regulatory role of tandem and palindromic DNA repeats in the M. hyopneumoniae transcriptional profile.	[Cattani, Amanda Malvessi; Siqueira, Franciele Maboni; Schrank, Irene Silveira] Univ Fed Rio Grande do Sul, Programa Posgrad Biol Celular & Mol, Ctr Biotecnol, Porto Alegre, RS, Brazil; [Muniz Guedes, Rafael Lucas] Lab Nacl Comp Cient, Lab Bioinformat, Petropolis, RJ, Brazil; [Schrank, Irene Silveira] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Biol Mol & Biotecnol, Ctr Biotecnol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Laboratorio Nacional de Computacao Cientifica (LNCC); Universidade Federal do Rio Grande do Sul	Schrank, IS (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Biol Celular & Mol, Ctr Biotecnol, Porto Alegre, RS, Brazil.; Schrank, IS (corresponding author), Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Biol Mol & Biotecnol, Ctr Biotecnol, Porto Alegre, RS, Brazil.	irene@cbiot.ufrgs.br	Siqueira, Franciele M/K-4043-2014; Guedes, Rafael Lucas/P-3029-2015	Siqueira, Franciele M/0000-0001-7282-6117; Muniz Guedes, Rafael Lucas/0000-0002-9163-6674	Coordenacao de Apoio de Pessoal de Nivel Superior - CAPES	Coordenacao de Apoio de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by Coordenacao de Apoio de Pessoal de Nivel Superior - CAPES. CAPES-Biologia Computacional (Process number: 23038.010043/2013-02) and MCTI/CNPq/Universal (Process number: 445228/2014-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achaz G, 2002, NUCLEIC ACIDS RES, V30, P2987, DOI 10.1093/nar/gkf391; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arraes FBM, 2007, GENET MOL BIOL, V30, P182, DOI 10.1590/S1415-47572007000200004; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bayliss CD, 2012, ANN NY ACAD SCI, V1267, P39, DOI 10.1111/j.1749-6632.2012.06584.x; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Borges CL, 2007, GENET MOL BIOL, V30, P212, DOI 10.1590/S1415-47572007000200007; Brazda V, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-33; Chang LJ, 2008, BIOCHEM BIOPH RES CO, V367, P213, DOI 10.1016/j.bbrc.2007.12.124; Chen CL, 2009, NUCLEIC ACIDS RES, V37, P3756, DOI 10.1093/nar/gkp230; Citti C, 2010, FUTURE MICROBIOL, V5, P1073, DOI 10.2217/FMB.10.71; da Maia Luciano Carlos, 2008, Int J Plant Genomics, V2008, P412696, DOI 10.1155/2008/412696; Ferreira HB, 2007, GENET MOL BIOL, V30, P245, DOI 10.1590/S1415-47572007000200012; Freund T, 2013, FINDING APPROXIMATE; Fritsch TE, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1468-6; Gemayel R, 2012, GENES-BASEL, V3, P461, DOI 10.3390/genes3030461; Gosney F, 2011, VET MICROBIOL, V147, P220, DOI 10.1016/j.vetmic.2010.06.009; Huang YJ, 2014, DNA RES, V21, P285, DOI 10.1093/dnares/dst057; Kuhnert P, 2014, VET MICROBIOL, V174, P261, DOI 10.1016/j.vetmic.2014.08.022; Liu L, 2002, J BACTERIOL, V184, P1335, DOI 10.1128/JB.184.5.1335-1339.2002; Liu L, 2000, INFECT IMMUN, V68, P871, DOI 10.1128/IAI.68.2.871-876.2000; Liu W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-80; Liu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035698; Liu W, 2011, J BACTERIOL, V193, P1016, DOI 10.1128/JB.01305-10; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lysnyansky I, 1996, J BACTERIOL, V178, P5395, DOI 10.1128/jb.178.18.5395-5401.1996; Ma L, 2012, J MED MICROBIOL, V61, P191, DOI 10.1099/jmm.0.030858-0; Ma LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015660; Madsen ML, 2008, INFECT IMMUN, V76, P658, DOI 10.1128/IAI.01291-07; Madsen ML, 2006, MICROBIOL-SGM, V152, P937, DOI 10.1099/mic.0.28674-0; Madsen ML, 2006, INFECT IMMUN, V74, P160, DOI 10.1128/IAI.74.1.160-166.2006; Minion FC, 2004, J BACTERIOL, V186, P7123, DOI 10.1128/JB.186.21.7123-7133.2004; Moitinho-Silva L, 2012, VET MICROBIOL, V154, P282, DOI 10.1016/j.vetmic.2011.07.009; Mrazek J, 2006, MOL BIOL EVOL, V23, P1370, DOI 10.1093/molbev/msk023; Mrazek J, 2006, BIOINFORMATICS, V22, P3099, DOI 10.1093/bioinformatics/btl551; Musatovova O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047625; Noormohammadi AH, 1997, INFECT IMMUN, V65, P2542, DOI 10.1128/IAI.65.7.2542-2547.1997; Oneal MJ, 2008, MICROBIOL-SGM, V154, P2581, DOI 10.1099/mic.0.2008/020230-0; Peak IRA, 1996, FEMS MICROBIOL LETT, V137, P109, DOI 10.1111/j.1574-6968.1996.tb08091.x; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rocha EPC, 1999, MOL BIOL EVOL, V16, P1219, DOI 10.1093/oxfordjournals.molbev.a026212; Rocha EPC, 2002, NUCLEIC ACIDS RES, V30, P2031, DOI 10.1093/nar/30.9.2031; Schafer ER, 2007, MICROBIOL-SGM, V153, P3785, DOI 10.1099/mic.0.2007/011387-0; Simmons WL, 2004, INFECT IMMUN, V72, P6846, DOI 10.1128/IAI.72.12.6846-6851.2004; Siqueira FM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110327; Siqueira FM, 2014, MOL BIOL REP, V41, P5395, DOI 10.1007/s11033-014-3411-3; Siqueira FM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-175; Siqueira FM, 2011, DNA RES, V18, P413, DOI 10.1093/dnares/dsr028; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Thacker Eileen L., 2004, Animal Health Research Reviews, V5, P317, DOI 10.1079/AHR200491; Theiss P, 1997, J BACTERIOL, V179, P4013, DOI 10.1128/jb.179.12.4013-4022.1997; Treangen TJ, 2009, FEMS MICROBIOL REV, V33, P539, DOI 10.1111/j.1574-6976.2009.00169.x; van Belkum A, 1998, MICROBIOL MOL BIOL R, V62, P275, DOI 10.1128/MMBR.62.2.275-293.1998; Vasconcelos ATR, 2005, J BACTERIOL, V187, P5568, DOI 10.1128/JB.187.16.5568-5577.2005; Weber SD, 2012, DNA RES, V19, P103, DOI 10.1093/dnares/dsr045; YOGEV D, 1991, EMBO J, V10, P4069, DOI 10.1002/j.1460-2075.1991.tb04983.x; Zhang QJ, 1996, INFECT IMMUN, V64, P2737, DOI 10.1128/IAI.64.7.2737-2744.1996; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	58	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168626	10.1371/journal.pone.0168626	http://dx.doi.org/10.1371/journal.pone.0168626			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005945	Green Submitted, gold, Green Published			2022-12-26	WOS:000392843200071
J	Guo, S; Zeng, C; Yan, MJ; Han, YC; Xia, DD; Sun, GX; Li, LJ; Yang, MJ; Tan, J				Guo, Song; Zeng, Cheng; Yan, Meijun; Han, Yingchao; Xia, Dongdong; Sun, Guixin; Li, Lijun; Yang, Mingjie; Tan, Jun			A Biomechanical Stability Study of Extraforaminal Lumbar Interbody Fusion on the Cadaveric Lumbar Spine Specimens	PLOS ONE			English	Article							PEDICLE SCREW FIXATION; DEGENERATIVE DISC DISEASE; BACK MUSCLE INJURY; POSTEROLATERAL FUSION; TRANSLAMINAR SCREW; SURGERY; SPONDYLOLISTHESIS; DECOMPRESSION; OUTCOMES	Background Transforaminal lumbar interbody fusion (TLIF) is an effective surgery for lumbar degenerative disease. However, this fusion technique requires resection of inferior facet joint to provide access for superior facet joint resection, which results in reduced lumbar spinal stability and unnecessary trauma. We have previously developed extraforaminal lumbar interbody fusion (ELIF) that can avoid back muscle injury with direct nerve root decompression. This study aims to show that ELIF enhances lumbar spinal stability in comparison to TLIF by comparing lumbar spinal stability of L4-L5 range of motion (ROM) on 12 cadaveric spine specimens after performing TLIF or ELIF. Methods 12 cadaveric spine specimens were randomly divided and treated in accordance with the different internal fixations, including ELIF with a unilateral pedicle screw (ELIF+UPS), TLIF with a unilateral pedicle screw (TLIF+UPS), TLIF with a bilateral pedicle screw (TLIF+BPS), ELIF with a unilateral pedicle screw and translaminar facet screw (ELIF+UPS+TLFS) and ELIF with a bilateral pedicle screw (ELIF+BPS). The treatment groups were exposed to a 400-N load and 6 N.m movement force to calculate the angular displacement of L4-L5 during anterior flexion, posterior extension, lateral flexion and rotation operation conditions. Results The ROM in ELIF+UPS group was smaller than that of TLIF+UPS group under all operating conditions, with the significant differences in left lateral flexion and right rotation by 36.15% and 25.97% respectively. The ROM in ELIF+UPS group was higher than that in TLIF+BPS group. The ROM in the ELIF+UPS+TLFS group was much smaller than that in the ELIF +UPS group, but was not significantly different than that in the TLIF+BPS group. Conclusions Despite that TLIF+BPS has great stability, which can be comparable by that of ELIF+UPS. Additionally, ELIF stability can be further improved by using translaminar facet screws without causing more tissue damage to patient.	[Guo, Song; Zeng, Cheng; Yan, Meijun; Han, Yingchao; Xia, Dongdong; Li, Lijun; Yang, Mingjie; Tan, Jun] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Spine, Shanghai, Peoples R China; [Sun, Guixin] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Traumatol, Shanghai, Peoples R China	Tongji University; Tongji University	Yang, MJ; Tan, J (corresponding author), Tongji Univ, Sch Med, Shanghai East Hosp, Dept Spine, Shanghai, Peoples R China.	yangmingjietj2015@163.com; tanjuntj2012@gmail.com	Yan, Meijun/AAE-6966-2019	Yan, Meijun/0000-0002-9517-2854	Programs for Academic Leaders in Shanghai Pudong New Area [PWRd-2011-02, PWRI2012-03]; Projects of Shanghai Municipal Commission of Health and Family Planning [201440049, 2013025]; Projects of Key Faculties Construction of Pudong Public Health Bureau of Shanghai [PWXZ2014-02]	Programs for Academic Leaders in Shanghai Pudong New Area; Projects of Shanghai Municipal Commission of Health and Family Planning; Projects of Key Faculties Construction of Pudong Public Health Bureau of Shanghai	This work was supported by: Jun Tan, Programs for Academic Leaders in Shanghai Pudong New Area (PWRd-2011-02, PWRI2012-03), http://weisheng.pudong.gov.cn/portal/index/index.htm, this funder is used to study design; Lijun Li, Projects of Shanghai Municipal Commission of Health and Family Planning (201440049, 2013025), http://www.wsjsw.gov.cn/wsj/, this funder is used to data collection and analysis; and Mingjie Yang, Projects of Key Faculties Construction of Pudong Public Health Bureau of Shanghai (PWXZ2014-02), http:// weisheng.pudong.gov.cn/portal/index/index.htm, this funder is used to preparation of the manuscript.	Branch CL, 2000, CLIN NEUROSURG, V47, P252; Chin KR, 2015, SPINE J, V15, P1077, DOI 10.1016/j.spinee.2013.06.103; Choi YS, 2009, ASIAN SPINE J, V3, P39, DOI 10.4184/asj.2009.3.1.39; Grob D, 2009, J BONE JOINT SURG BR, V91B, P1347, DOI 10.1302/0301-620X.91B10.22195; HARMS J, 1982, Z ORTHOP GRENZGEB, V120, P343, DOI 10.1055/s-2008-1051624; Harms JG, 1998, ORTHOP TRAUMATOL, V6, P88; KAWAGUCHI Y, 1994, SPINE, V19, P2590, DOI 10.1097/00007632-199411001-00017; Kawaguchi Y, 1996, SPINE, V21, P941, DOI 10.1097/00007632-199604150-00007; Kim JW, 2010, J CRIT SPINE CASES, V3, P144; KING D, 1948, J BONE JOINT SURG AM, V30-A, P560, DOI 10.2106/00004623-194830030-00003; [李立钧 Li Lijun], 2013, [中华创伤骨科杂志, Chinese Journal of Orthopaedic Trauma], V15, P50; Liu ZD, J ORTHOP SURG RES, V15; Malham GM, 2015, EUR SPINE J, V24, pS339, DOI 10.1007/s00586-015-3807-3; Nakashima H, 2015, SPINE, V40, pE831, DOI 10.1097/BRS.0000000000000917; Ntoukas V, 2010, MINIM INVAS NEUROSUR, V53, P21, DOI 10.1055/s-0030-1247560; PANJABI MM, 1988, SPINE, V13, P1129, DOI 10.1097/00007632-198810000-00013; Phillips FM, 2013, SPINE, V38, pE409, DOI 10.1097/BRS.0b013e3182877f11; Quint U, 2008, EUR SPINE J, V17, P1705, DOI 10.1007/s00586-008-0787-6; Rao PJ, 2015, NEUROSURGERY, V76, P7, DOI 10.1227/NEU.0000000000000561; Ruetten S, 2013, OPER ORTHOP TRAUMATO, V25, P31, DOI 10.1007/s00064-012-0195-2; Sakaura H, 2013, J NEUROSURG-SPINE, V19, P90, DOI 10.3171/2013.4.SPINE12651; Schleicher P, 2008, J NEUROSURG-SPINE, V9, P363, DOI 10.3171/SPI.2008.9.10.363; Sethi A, 2009, EUR SPINE J, V18, P430, DOI 10.1007/s00586-008-0825-4; Slucky Andrew V, 2006, Spine J, V6, P78, DOI 10.1016/j.spinee.2005.08.003; Suk SI, 1997, SPINE, V22, P210, DOI 10.1097/00007632-199701150-00016; Tai CL, 2008, BMC MUSCULOSKELET DI, V9; Talia AJ, 2015, J CLIN NEUROSCI, V22, P243, DOI 10.1016/j.jocn.2014.08.008; Tang SJ, 2012, TURK NEUROSURG, V22, P156, DOI 10.5137/1019-5149.JTN.4214-11.1; Tuli SK, 2005, ORTHOPEDICS, V28, P773; Weiler C, 2011, BMC RES NOTES, V16, P1; Wittayapairoj K, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/1749-799X-9-33; Yang Ming-jie, 2012, Zhonghua Wai Ke Za Zhi, V50, P62; Yang MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105646	33	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168498	10.1371/journal.pone.0168498	http://dx.doi.org/10.1371/journal.pone.0168498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005935	Green Published, Green Submitted, gold			2022-12-26	WOS:000392843200061
J	Hamy, AS; Bonsang-Kitzis, H; Lae, M; Moarii, M; Sadacca, B; Pinheiro, A; Galliot, M; Abecassis, J; Laurent, C; Reyal, F				Hamy, Anne-Sophie; Bonsang-Kitzis, Helene; Lae, Marick; Moarii, Matahi; Sadacca, Benjamin; Pinheiro, Alice; Galliot, Marion; Abecassis, Judith; Laurent, Cecile; Reyal, Fabien			A Stromal Immune Module Correlated with the Response to Neoadjuvant Chemotherapy, Prognosis and Lymphocyte Infiltration in HER2-Positive Breast Carcinoma Is Inversely Correlated with Hormonal Pathways	PLOS ONE			English	Article							PATHOLOGICAL COMPLETE RESPONSE; GENE-EXPRESSION; SEX-DIFFERENCES; CANCER; IDENTIFICATION; TRASTUZUMAB; SIGNATURE; CELLS; 17-BETA-ESTRADIOL; SYNERGIZES	Introduction HER2-positive breast cancer (BC) is a heterogeneous group of aggressive breast cancers, the prognosis of which has greatly improved since the introduction of treatments targeting HER2. However, these tumors may display intrinsic or acquired resistance to treatment, and classifiers of HER2-positive tumors are required to improve the prediction of prognosis and to develop novel therapeutic interventions. Methods We analyzed 2893 primary human breast cancer samples from 21 publicly available data sets and developed a six-metagene signature on a training set of 448 HER2-positive BC. We then used external public datasets to assess the ability of these metagenes to predict the response to chemotherapy (Ignatiadis dataset), and prognosis (METABRIC dataset). Results We identified a six-metagene signature (138 genes) containing metagenes enriched in different gene ontologies. The gene clusters were named as follows: Immunity, Tumor suppressors/proliferation, Interferon, Signal transduction, Hormone/survival and Matrix clusters. In all datasets, the Immunity metagene was less strongly expressed in ER-positive than in ER-negative tumors, and was inversely correlated with the Hormonal/survival meta gene. Within the signature, multivariate analyses showed that strong expression of the "Immunity" metagene was associated with higher pCR rates after NAC (OR = 3.71[1.28-11.91], p=0.019) than weak expression, and with a better prognosis in HER2-positive/ER-negative breast cancers (HR = 0.58 [0.36-0.94], p = 0.026). Immunity metagene expression was associated with the presence of tumor-infiltrating lymphocytes (TILs). Conclusion The identification of a predictive and prognostic immune module in HER2-positive BC confirms the need for clinical testing for immune checkpoint modulators and vaccines for this specific subtype. The inverse correlation between Immunity and hormone pathways opens research perspectives and deserves further investigation.	[Hamy, Anne-Sophie; Bonsang-Kitzis, Helene; Sadacca, Benjamin; Pinheiro, Alice; Galliot, Marion; Abecassis, Judith; Laurent, Cecile; Reyal, Fabien] PSL Res Univ, Inst Curie, Translat Res Dept,Immun & Canc U932, Residual Tumor & Response Treatment Lab,LabRT2,IN, Paris, France; [Bonsang-Kitzis, Helene; Reyal, Fabien] Inst Curie, Dept Surg, Paris, France; [Lae, Marick] Inst Curie, Dept Tumor Biol, Paris, France; [Moarii, Matahi; Abecassis, Judith] PSL Res Univ, CBIO Ctr Computat Biol, Mines ParisTech, Mines Paristech, Fontainebleau, France; [Moarii, Matahi; Abecassis, Judith] INSERM, Inst Curie, U900, Paris, France; [Sadacca, Benjamin] Univ Evry Val Essonne, Lab Math & Modelisat Evry, Evry, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Reyal, F (corresponding author), PSL Res Univ, Inst Curie, Translat Res Dept,Immun & Canc U932, Residual Tumor & Response Treatment Lab,LabRT2,IN, Paris, France.; Reyal, F (corresponding author), Inst Curie, Dept Surg, Paris, France.	fabien.reyal@curie.fr		Laurent, Cecile/0000-0002-3022-2283; HAMY, Anne-Sophie/0000-0003-4430-3022; MOARII, Matahi/0000-0001-6011-9212	ITMO-INSERM-AVIESAN cancer translational research grant; Site de Recherche Integree en Cancerologie/INstitut National du Cancer [InCa-DGOS-4654]	ITMO-INSERM-AVIESAN cancer translational research grant; Site de Recherche Integree en Cancerologie/INstitut National du Cancer	A-S Hamy-Petit was supported by an ITMO-INSERM-AVIESAN cancer translational research grant. Funding was also obtained from the Site de Recherche Integree en Cancerologie/INstitut National du Cancer (InCa-DGOS-4654). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexe G, 2007, CANCER RES, V67, P10669, DOI 10.1158/0008-5472.CAN-07-0539; Arruvito L, 2007, J IMMUNOL, V178, P2572, DOI 10.4049/jimmunol.178.4.2572; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bonsang-Kitzis H, 2015, ONCOIMMUNOL; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Burstein MD, 2014, CLIN CANC RES OFF J; Cook IF, 2008, VACCINE, V26, P3551, DOI 10.1016/j.vaccine.2008.04.054; Cun YP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-69; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; de Cremoux P, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-215; Denkert C, 2015, J CLIN ONCOL, V33, P983, DOI 10.1200/JCO.2014.58.1967; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Doane AS, 2006, ONCOGENE, V25, P3994, DOI 10.1038/sj.onc.1209415; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Frohlich H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025364; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gatza ML, 2010, P NATL ACAD SCI USA, V107, P6994, DOI 10.1073/pnas.0912708107; Giefing-Kroll C, 2015, AGING CELL, V14, P309, DOI 10.1111/acel.12326; Giuliano M, 2013, BREAST CARE, V8, P256, DOI 10.1159/000354253; Gong Y, 2007, LANCET ONCOL, V8, P203, DOI 10.1016/S1470-2045(07)70042-6; Gu-Trantien C, 2013, J CLIN INVEST, V123, P2873, DOI 10.1172/JCI67428; Hao S, 2007, INT IMMUNOPHARMACOL, V7, P1765, DOI 10.1016/j.intimp.2007.09.017; Ignatiadis M, 2012, J CLIN ONCOL, V30, P1996, DOI 10.1200/JCO.2011.39.5624; Isella C, 2015, NAT GENET, P1; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Karn T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028403; Klein SL, 2000, NEUROSCI BIOBEHAV R, V24, P627, DOI 10.1016/S0149-7634(00)00027-0; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lehmann-Che J, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3421; Lockshin MD, 2006, LUPUS, V15, P753, DOI 10.1177/0961203306069353; Loi S, 2014, ANN ONCOL, V25, P1544, DOI 10.1093/annonc/mdu112; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Mo R, 2005, J IMMUNOL, V174, P6023, DOI 10.4049/jimmunol.174.10.6023; Palmer C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-115; Perez E, 2014, STROMAL TUMOR INFILT; Perez EA, 2015, J CLIN ONCOL OFF J A; R Core Team, 2020, R LANG ENV STAT COMP; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Rody A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3035; Rody A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2234; Sabatier R, 2015, ONCOTARGET, V6, P5449, DOI 10.18632/oncotarget.3216; Sabatier R, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-86; Sakiani S, 2013, NAT REV ENDOCRINOL, V9, P56, DOI 10.1038/nrendo.2012.206; Salgado R, 2015, ANN ONCOL, V26, P259, DOI 10.1093/annonc/mdu450; Salgado R, 2015, JAMA ONCOL, V1, P448, DOI 10.1001/jamaoncol.2015.0830; Servant Nicolas, 2010, BMC Res Notes, V3, P277, DOI 10.1186/1756-0500-3-277; Siracusa MC, 2008, J IMMUNOL, V180, P1423, DOI 10.4049/jimmunol.180.3.1423; Sota Y, 2014, ANN ONCOL, V25, P100, DOI 10.1093/annonc/mdt427; Staaf J, 2010, J CLIN ONCOL, V28, P1813, DOI 10.1200/JCO.2009.22.8775; Stagg J, 2011, P NATL ACAD SCI USA, V108, P7142, DOI 10.1073/pnas.1016569108; Stoll G, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27884; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; Wang QF, 2012, CANCER RES, V72, P4417, DOI 10.1158/0008-5472.CAN-12-1339-T; West NR, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3072	56	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0167397	10.1371/journal.pone.0167397	http://dx.doi.org/10.1371/journal.pone.0167397			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005906	gold, Green Submitted, Green Published			2022-12-26	WOS:000392843200015
J	Johnson, HR; Trinidad, DD; Guzman, S; Khan, Z; Parziale, JV; DeBruyn, JM; Lents, NH				Johnson, Hunter R.; Trinidad, Donovan D.; Guzman, Stephania; Khan, Zenab; Parziale, James V.; DeBruyn, Jennifer M.; Lents, Nathan H.			A Machine Learning Approach for Using the Postmortem Skin Microbiome to Estimate the Postmortem Interval	PLOS ONE			English	Article								Research on the human microbiome, the microbiota that live in, on, and around the human person, has revolutionized our understanding of the complex interactions between microbial life and human health and disease. The microbiome may also provide a valuable tool in forensic death investigations by helping to reveal the postmortem interval (PMI) of a decedent that is discovered after an unknown amount of time since death. Current methods of estimating PMI for cadavers discovered in uncontrolled, unstudied environments have substantial limitations, some of which may be overcome through the use of microbial indicators. In this project, we sampled the microbiomes of decomposing human cadavers, focusing on the skin microbiota found in the nasal and ear canals. We then developed several models of statistical regression to establish an algorithm for predicting the PMI of microbial samples. We found that the complete data set, rather than a curated list of indicator species, was preferred for training the regressor. We further found that genus and family, rather than species, are the most informative taxonomic levels. Finally, we developed a k-nearest- neighbor regressor, tuned with the entire data set from all nasal and ear samples, that predicts the PMI of unknown samples with an average error of 55 accumulated degree days (ADD). This study outlines a machine learning approach for the use of necrobiome data in the prediction of the PMI and thereby provides a successful proof-of- concept that skin microbiota is a promising tool in forensic death investigations.	[Johnson, Hunter R.; Khan, Zenab] CUNY, John Jay Coll, Dept Math & Comp Sci, New York, NY 10019 USA; [Trinidad, Donovan D.; Guzman, Stephania; Khan, Zenab; Parziale, James V.; Lents, Nathan H.] CUNY, John Jay Coll, Dept Sci, New York, NY 10019 USA; [DeBruyn, Jennifer M.] Univ Tennessee, Dept Biosyst Engn & Soil Sci, Knoxville, TN 37996 USA	City University of New York (CUNY) System; City University of New York (CUNY) System; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Lents, NH (corresponding author), CUNY, John Jay Coll, Dept Sci, New York, NY 10019 USA.	NLENTS@jjay.cuny.edu	DeBruyn, Jennifer M./A-8813-2010	DeBruyn, Jennifer M./0000-0002-2993-4144; Trinidad, Donovan/0000-0002-1439-9927; Parziale, James/0000-0002-4633-0078	PSC-CUNY Research Award Program [67672-00-45]; John Jay College Office for the Advancement of Research; PRISM program at John Jay College - Title V and HSI-STEM programs of the US Department of Education; New York state CSTEP Program	PSC-CUNY Research Award Program; John Jay College Office for the Advancement of Research; PRISM program at John Jay College - Title V and HSI-STEM programs of the US Department of Education; New York state CSTEP Program	Reagents, supplies, and sequencing was made by possible by a grant to NHL from the PSC-CUNY Research Award Program (67672-00-45) and the Seed Funding Program from the John Jay College Office for the Advancement of Research. Student stipends to DT, SG, ZK, and JP were provided by the PRISM program at John Jay College, funded by the Title V and HSI-STEM programs of the US Department of Education and the New York state CSTEP Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basak D., 2007, NEURAL INF PROCESS L, V11, P203; Bashan A, 2016, NATURE, V534, P259, DOI 10.1038/nature18301; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carter DO, 2015, FORENSIC SCI MED PAT, V11, P202, DOI 10.1007/s12024-015-9667-7; Christopher M., 2006, PATTERN RECOGNITION; Cobaugh KL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130201; Ethem Alpaydin, 2009, INTRO MACHINE LEARNI; Finley SJ, 2016, MICROB ECOL, V71, P524, DOI 10.1007/s00248-015-0725-1; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hauther KA, 2015, J FORENSIC SCI, V60, P1234, DOI 10.1111/1556-4029.12828; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Hyde ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077733; Jorth P, 2014, MBIO, V5, DOI 10.1128/mBio.01012-14; Metcalf JL, 2016, SCIENCE, V351, P158, DOI 10.1126/science.aad2646; Metcalf JL, 2013, ELIFE, V2, DOI 10.7554/eLife.01104; Michaud JP, 2011, J FORENSIC SCI, V56, P229, DOI 10.1111/j.1556-4029.2010.01559.x; Oh J, 2016, CELL, V165, P854, DOI 10.1016/j.cell.2016.04.008; Pechal JL, 2014, INT J LEGAL MED, V128, P193, DOI 10.1007/s00414-013-0872-1; Pechal JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079035; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344	24	56	63	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0167370	10.1371/journal.pone.0167370	http://dx.doi.org/10.1371/journal.pone.0167370			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005908	gold, Green Published			2022-12-26	WOS:000392843200014
J	Rovozzo, R; Korza, G; Baker, MW; Li, M; Bhattacharyya, A; Barbarese, E; Carson, JH				Rovozzo, Rene; Korza, George; Baker, Mei W.; Li, Meng; Bhattacharyya, Anita; Barbarese, Elisa; Carson, John H.			CGG Repeats in the 5 ' UTR of FMR1 RNA Regulate Translation of Other RNAs Localized in the Same RNA Granules	PLoS One			English	Article							TREMOR ATAXIA SYNDROME; FRAGILE-X PREMUTATION; FLUORESCENCE CORRELATION SPECTROSCOPY; ATG RAN TRANSLATION; MESSENGER-RNA; SURVEILLANCE PATHWAY; DROSOPHILA MODEL; PROTEIN-KINASE; GENE; NEURODEGENERATION	CGG repeats in the 5'UTR of Fragile X Mental Retardation 1 (FMR1) RNA mediate RNA localization and translation in granules. Large expansions of CGG repeats (>200 repeats) in FMR1, referred to as full mutations, are associated with fragile X syndrome (FXS). Smaller expansions (55-200 repeats), referred to as premutations, are associated with fragile X tremor ataxia syndrome (FXTAS) and fragile X premature ovarian insufficiency (FXPOI). TMPyP4 is a porphyrin ring compound that destabilizes CGG repeat RNA secondary structure. Here we show that exogenous CGG repeat RNA by itself, lacking the FMRP ORF, microinjected into hippocampal neurons is localized in RNA granules and inhibits translation of ARC RNA, which is localized in the same granules. TMPyP4 rescues translation of ARC RNA in granules. We also show that in human premutation fibroblasts with endogenous CGG repeat expansions in the FMR1 gene, translation of ARC RNA is inhibited and calcium homeostasis is disrupted and both phenotypes are rescued by TMPyP4. Inhibition of granule translation by expanded CGG repeats and rescue of granule translation by TMPy4, represent potential pathogenic mechanism and therapeutic strategy, respectively, for FXTAS and FXPOI.	[Rovozzo, Rene; Carson, John H.] UConn Hlth, Ctr Cell Anal & Modeling, Farmington, CT 06030 USA; [Korza, George] UConn Hlth, Dept Mol Biol & Biophys, Farmington, CT USA; [Baker, Mei W.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Wisconsin State Lab Hyg,Newborn Screening Lab, Madison, WI USA; [Li, Meng; Bhattacharyya, Anita] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Barbarese, Elisa] UConn Hlth, Dept Neurosci, Farmington, CT USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Carson, JH (corresponding author), UConn Hlth, Ctr Cell Anal & Modeling, Farmington, CT 06030 USA.	jcarson@nso2.uchc.edu	Resource Center, NINDS Human Genetics/AGF-2474-2022; Sander-Effron, Samuel/AAX-2231-2020	Li, Meng/0000-0002-0145-5440; Bhattacharyya, Anita/0000-0002-0360-7145	National Institutes of Health [RR13186, NS19943, UL1TR000427]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health, RR13186 (JHC), National Institutes of Health, NS19943 (EB), and National Institutes of Health, UL1TR000427 (AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON JJ, 1993, ARCH BIOCHEM BIOPHYS, V301, P396, DOI 10.1006/abbi.1993.1162; Andrew EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066242; BARBER GN, 1993, P NATL ACAD SCI USA, V90, P4621, DOI 10.1073/pnas.90.10.4621; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Battle A, 2015, SCIENCE, V347, P664, DOI 10.1126/science.1260793; Cao ZY, 2013, J BIOL CHEM, V288, P13831, DOI 10.1074/jbc.M112.441055; Cenik C, 2015, GENOME RES, V25, P1610, DOI 10.1101/gr.193342.115; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cleary JD, 2013, HUM MOL GENET, V22, pR45, DOI 10.1093/hmg/ddt371; Cleary JD, 2014, CURR OPIN GENET DEV, V26, P6, DOI 10.1016/j.gde.2014.03.002; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Elkon R, 2015, EMBO REP, V16, P1723, DOI 10.15252/embr.201540717; Filipovic-Sadic S, 2010, CLIN CHEM, V56, P399, DOI 10.1373/clinchem.2009.136101; Galloway JN, 2014, HUM MOL GENET, V23, P5906, DOI 10.1093/hmg/ddu314; Gao YZ, 2008, MOL BIOL CELL, V19, P2311, DOI 10.1091/mbc.E07-09-0914; Garcia-Arocena D, 2010, HUM MOL GENET, V19, pR83, DOI 10.1093/hmg/ddq166; Harigaya Y, 2010, WIRES RNA, V1, P132, DOI 10.1002/wrna.17; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Iwasaki S, 2016, NATURE, V534, P558, DOI 10.1038/nature17978; Jang C, 2015, GENOME RES, V25, P1836, DOI 10.1101/gr.191296.115; Jin P, 2007, NEURON, V55, P556, DOI 10.1016/j.neuron.2007.07.020; Kearse MG, 2016, MOL CELL, V62, P314, DOI 10.1016/j.molcel.2016.02.034; Kenneson A, 2001, HUM MOL GENET, V10, P1449, DOI 10.1093/hmg/10.14.1449; Kiliszek A, 2011, NUCLEIC ACIDS RES, V39, P7308, DOI 10.1093/nar/gkr368; Korb E, 2013, NAT NEUROSCI, V16, P874, DOI 10.1038/nn.3429; Kozlowski P, 2010, NUCLEIC ACIDS RES, V38, P4027, DOI 10.1093/nar/gkq127; Kwon S, 1999, J CELL BIOL, V147, P247, DOI 10.1083/jcb.147.2.247; Levin MK, 2004, DIFFERENTIATION, V72, P1, DOI 10.1111/j.1432-0436.2004.07201002.x; Liu J, 2012, HUM MOL GENET, V21, P3795, DOI 10.1093/hmg/dds207; Loomis EW, 2013, GENOME RES, V23, P121, DOI 10.1101/gr.141705.112; McMurray CT, 2010, NAT REV GENET, V11, P786, DOI 10.1038/nrg2828; Miramon H, 2010, ANAL CHEM, V82, P394, DOI 10.1021/ac902211f; Morris MJ, 2012, NUCLEIC ACIDS RES, V40, P4137, DOI 10.1093/nar/gkr1308; Muslimov IA, 2011, J CELL BIOL, V194, P441, DOI 10.1083/jcb.201010027; Ofer N, 2009, NUCLEIC ACIDS RES, V37, P2712, DOI 10.1093/nar/gkp130; Paradise A, 2007, J MOL BIOL, V365, P50, DOI 10.1016/j.jmb.2006.09.089; POOT M, 1985, GERONTOLOGY, V31, P158, DOI 10.1159/000212697; Reid DW, 2015, RNA BASED METHODS VI, V91, P69; Seltzer MM, 2012, AM J MED GENET B, V159B, P589, DOI 10.1002/ajmg.b.32065; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.05033; Sofola OA, 2007, NEURON, V55, P565, DOI 10.1016/j.neuron.2007.07.021; Sullivan SD, 2011, SEMIN REPROD MED, V29, P299, DOI 10.1055/s-0031-1280915; Tanenbaum ME, 2015, ELIFE, V4, DOI 10.7554/eLife.07957; Tassone F, 2000, AM J MED GENET, V91, P144, DOI 10.1002/(SICI)1096-8628(20000313)91:2<144::AID-AJMG14>3.0.CO;2-V; Tassone Flora, 2004, RNA Biol, V1, P103, DOI 10.4161/rna.1.2.1035; Tatavarty V, 2012, MOL BIOL CELL, V23, P918, DOI 10.1091/mbc.E11-07-0622; Tirosh O, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005288; Todd PK, 2013, NEURON, V78, P440, DOI 10.1016/j.neuron.2013.03.026; Vasudevan S, 2002, BIOESSAYS, V24, P785, DOI 10.1002/bies.10153; Werner A, 2015, NATURE, V525, P523, DOI 10.1038/nature14978; Wiita AP, 2013, ELIFE, V2, DOI 10.7554/eLife.01236; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	52	13	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168204	10.1371/journal.pone.0168204	http://dx.doi.org/10.1371/journal.pone.0168204			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005950	Green Published, gold, Green Submitted			2022-12-26	WOS:000392843200036
J	Vavilala, MS; Lujan, SB; Qiu, Q; Petroni, GJ; Ballarini, NM; Guadagnoli, N; Depetris, MA; Faguaga, GA; Baggio, GM; Busso, LO; Garcia, ME; Carrillo, OR; Medici, PL; Saenz, SS; Vanella, EE; Fabio, A; Bell, MJ				Vavilala, Monica S.; Lujan, Silvia B.; Qiu, Qian; Petroni, Gustavo J.; Ballarini, Nicolas M.; Guadagnoli, Nahuel; Alejandra Depetris, Maria; Faguaga, Gabriela A.; Baggio, Gloria M.; Busso, Leonardo O.; Garcia, Mirta E.; Gonzalez Carrillo, Osvaldo R.; Medici, Paula L.; Saenz, Silvia S.; Vanella, Elida E.; Fabio, Anthony; Bell, Michael J.			Benchmarking Prehospital and Emergency Department Care for Argentine Children with Traumatic Brain Injury: For the South American Guideline Adherence Group	PLOS ONE			English	Article							SYSTEM-DEVELOPMENT; OUTCOMES; PERFORMANCE; MORTALITY	Objective There is little information on the type of early care provided to children with traumatic brain injury (TBI) in low middle income countries. We benchmarked early prehospital [PH] and emergency department [ED] pediatric TBI care in Argentina. Methods We conducted a secondary analysis of data from patients previously enrolled in a prospective seven center study of children with TBI. Eligible participants were patients 0-18 years, and had diagnosis of TBI (admission Glasgow Coma scale score [GCS] < 13 or with GCS 14-15 and abnormal head CT scan within 48 hours of admission, and head AIS > 0). Outcomes were transport type, transport time, PH and ED adherence to best practice, and discharge Pediatric Cerebral Performance Category Scale (PCPC) and Pediatric Overall Performance category Scale (POPC). Results Of the 366 children, mean age was 8.7 (5.0) years, 58% were male, 90% had isolated TBI and 45.4% were transported by private vehicle. 50 (34.7%) of the 144 children with severe TBI (39.3% of all TBI patients) were transported by private vehicle. Most (267; 73%) patients received initial TBI care at an index hospital prior to study center admission, including children with severe (81.9%) TBI. Transport times were shorter for those patients who were directly transported by ambulance to study center than for the whole cohort (1.4 vs.5.5 hours). Ambulance blood pressure data were recorded in 30.9%. ED guideline adherence rate was higher than PH guideline adherence rate (84.8% vs. 26.4%). For patients directly transferred from scene to study trauma centers, longer transport time was associated with worse discharge outcome (PCPC aOR 1.10 [1.04, 1.18] and (POPC aOR 1.10 [1.04, 1.18]). There was no relationship between PH or ED TBI guideline adherence rate and discharge POPC and PCPC. Conclusion This study benchmarks early pediatric TBI care in Argentina and shows that many critically injured children with TBI do not receive timely or best practice PH care, that PH guideline adherence rate is low and that longer transport time was associated with poor discharge outcomes for patients with direct transfer status. There is an urgent need to improve the early care of children with TBI in Argentina, especially timely transportation to a hospital.	[Vavilala, Monica S.; Qiu, Qian] Univ Washington, Harborview Injury Prevent & Res Ctr, Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Lujan, Silvia B.; Petroni, Gustavo J.; Ballarini, Nicolas M.; Guadagnoli, Nahuel; Alejandra Depetris, Maria] Ctr Informat Invest Clin, Rosario, Santa Fe, Argentina; [Lujan, Silvia B.; Petroni, Gustavo J.] Hosp Emergencias Dr Clemente Alvarez, Rosario, Santa Fe, Argentina; [Faguaga, Gabriela A.; Baggio, Gloria M.] Hosp Ninos Victor J Vilela, Rosario, Santa Fe, Argentina; [Busso, Leonardo O.] Hosp El Cruce Ezpeleta Oeste, Buenos Aires, DF, Argentina; [Garcia, Mirta E.] Hosp Ninos Sor Maria Ludov, La Plata, Buenos Aires, Argentina; [Gonzalez Carrillo, Osvaldo R.] Hosp Ninos Dr Orlando Alassia, Santa Fe, Santa Fe, Argentina; [Medici, Paula L.] Hosp Interzonal Especializado Materno Infantil Dr, Mar Del Plata, Buenos Aires, Argentina; [Saenz, Silvia S.] Hosp Ninos Santisima Trinidad Cordoba, Cordoba, Argentina; [Vanella, Elida E.] Hosp Pediatr Dr Humberto Notti, Mendoza, Argentina; [Fabio, Anthony] Univ Pittsburgh, Epidemiol Data Coordinating Ctr, Grad Sch Publ Hlth, Pittsburgh, PA 15260 USA; [Bell, Michael J.] Univ Pittsburgh, Neurol Surg & Pediat Crit Care Med, Pittsburgh, PA 15260 USA	University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vavilala, MS (corresponding author), Univ Washington, Harborview Injury Prevent & Res Ctr, Anesthesiol & Pain Med, Seattle, WA 98195 USA.	vavilala@uw.edu		Fabio, Anthony/0000-0002-6808-4939; Ballarini, Nicolas/0000-0002-3432-8931	National Institute of Neurological Disorders and Stroke (NINDS) [R01 NS072308-06, NS081041]	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institute of Neurological Disorders and Stroke (NINDS) R01 NS072308-06 (Vavilala) and NS081041 (Bell, Vavilala, Fabio). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, GUID TRAUM QUAL IMPR; [Anonymous], 2011, CATEGORIZACION CTR A; Burton A., 2016, LANCET NEUROL; Callese TE, 2015, J SURG RES, V193, P300, DOI 10.1016/j.jss.2014.09.040; Carney NA, 2016, PEDIAT CRIT CARE MED; Cole TB, 2004, JAMA-J AM MED ASSOC, V291, P2531, DOI 10.1001/jama.291.21.2531; DiRusso S, 2001, J TRAUMA, V51, P294, DOI 10.1097/00005373-200108000-00011; Emmanuel G, 1998, QUAL HEALTH CARE, V7, P12; Freeman C, 2002, QUAL SAF HEALTH CARE, V11, P239, DOI 10.1136/qhc.11.3.239; Gupta D, 2016, WORLD NEUROSURG, V89, P169, DOI 10.1016/j.wneu.2015.12.097; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kannan N, TIMELY HEMODYNAMIC R; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Mock C, 2005, J TRAUMA, V59, P1243, DOI 10.1097/01.ta.0000197290.02807.de; Mock CN, 1998, J TRAUMA, V44, P804, DOI 10.1097/00005373-199805000-00011; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Petroni G, 2010, J TRAUMA, V68, P564, DOI 10.1097/TA.0b013e3181ce1eed; Pollack MM, 2014, JAMA PEDIATR, V168, P671, DOI 10.1001/jamapediatrics.2013.5316; Rondina C, 2005, J HEAD TRAUMA REHAB, V20, P368, DOI 10.1097/00001199-200507000-00008; Shrestha GS, 2016, CURR OPIN CRIT CARE, V22, P100, DOI 10.1097/MCC.0000000000000285; Stewart BT, 2016, J VASC SURG; Tansley G, 2016, PREHOSP EMERG CARE, V13, P1; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; World Health Organization, 2015, VIOL INJ PREV INJ VI	25	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0166478	10.1371/journal.pone.0166478	http://dx.doi.org/10.1371/journal.pone.0166478			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005912	gold, Green Published, Green Submitted			2022-12-26	WOS:000392843200007
J	Song, FB; Wang, LM; Zhu, WB; Fu, JJ; Dong, JJ; Dong, ZJ				Song, Feibiao; Wang, Lanmei; Zhu, Wenbin; Fu, Jianjun; Dong, Juanjuan; Dong, Zaijie			A Novel igf3 Gene in Common Carp (Cyprinus carpio): Evidence for Its Role in Regulating Gonadal Development	PLOS ONE			English	Article							17-ALPHA-ETHINYLESTRADIOL EE2; OOCYTE MATURATION; GROWTH; ZEBRAFISH; EXPRESSION; HORMONE; DIFFERENTIATION; DUPLICATION; PROTEINS; CLONING	Since the insulin-like growth factor 3 (igf3) gene was recently discovered in fish ovary, its function in the gonads has received much attention. In this study, we isolated two igf3 sub-types from common carp (Cyprinus carpio), which comprised full-length cDNA of 707 and 1153 nucleotides encoding 205 and 198 amino acids (aa), respectively. The Igf3 aa sequence had the highest gene homology of 72% with the corresponding sequence in zebrafish (Danio rerio). Phylogenetic tree construction revealed that the C. carpio igf3 gene was first clustered with D. rerio and then with other teleost species. Igf3 mRNA was widely expressed, with expression being highest in the gonads and blood. In the gonad development stage, igf3a mRNA expression was highest in the maturity and recession stage of the ovary, and decline phase of the testis, while igf3b was highest in the recession and fully mature periods of the ovaries and testes, respectively. Western blotting of testis protein samples showed two bands of approximately 21 kDa and 34 kDa corresponding to the calculated molecular mass of the two Igf3 subtypes; no signal was detected in the ovary. The Igf3 protein was localized in the ovary granulosa cells and testis spermatogonium and spermatids. 17 beta-Ethinylestradiol treatment increased both ovary and testis igf3 mRNA expression. These findings suggest that Igf3 may play an important role in C. carpio gonadal development.	[Song, Feibiao; Dong, Juanjuan; Dong, Zaijie] Nanjing Agr Univ, Wuxi Fisheries Coll, Wuxi, Jiangsu, Peoples R China; [Wang, Lanmei; Zhu, Wenbin; Fu, Jianjun; Dong, Zaijie] Chinese Acad Fishery Sci, Freshwater Fisheries Res Ctr, Key Lab Freshwater Fisheries & Germplasm Resource, Minist Agr, Wuxi, Jiangsu, Peoples R China	Nanjing Agricultural University; Chinese Academy of Fishery Sciences; Freshwater Fisheries Research Center, CAFS; Ministry of Agriculture & Rural Affairs	Dong, ZJ (corresponding author), Nanjing Agr Univ, Wuxi Fisheries Coll, Wuxi, Jiangsu, Peoples R China.; Dong, ZJ (corresponding author), Chinese Acad Fishery Sci, Freshwater Fisheries Res Ctr, Key Lab Freshwater Fisheries & Germplasm Resource, Minist Agr, Wuxi, Jiangsu, Peoples R China.	dongzj@ffrc.cn	DONG, Zaijie/V-2380-2019; Dong, Zaijie/AAW-9998-2020	DONG, Zaijie/0000-0001-5428-1053; 	National Nonprofit Institute Research Grant of CATAS-TCGRI [2015JBFR01]; Chinese Earmarked Fund for Modern Agro-Industry Technology Research System [CARS-46]; National Science & Technology Pillar Program during the Twelfth Five-year Plan Period [2012BAD26B02]	National Nonprofit Institute Research Grant of CATAS-TCGRI; Chinese Earmarked Fund for Modern Agro-Industry Technology Research System; National Science & Technology Pillar Program during the Twelfth Five-year Plan Period	The National Nonprofit Institute Research Grant of CATAS-TCGRI (2015JBFR01) supported the study design and preparation of the manuscript; the Chinese Earmarked Fund for Modern Agro-Industry Technology Research System (CARS-46) supported the research and data analysis; the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (2012BAD26B02) supported the materials.	Amaral IPG, 2011, J EXP BIOL, V214, P2125, DOI 10.1242/jeb.053298; Berishvili G, 2010, GEN COMP ENDOCR, V167, P128, DOI 10.1016/j.ygcen.2010.01.023; Carnevali O, 2005, MOL REPROD DEV, V71, P12, DOI 10.1002/mrd.20122; CARR JM, 1995, J ENDOCRINOL, V145, P545, DOI 10.1677/joe.0.1450545; COCHRAN RC, 1992, J EXP ZOOL, V261, P143, DOI 10.1002/jez.1402610205; Dong ZJ, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0256-2; Filby AL, 2006, J MOL ENDOCRINOL, V37, P121, DOI 10.1677/jme.1.01997; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kwok HF, 2005, BIOL REPROD, V72, P1370, DOI 10.1095/biolreprod.104.038190; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li JZ, 2015, MOL ENDOCRINOL, V29, P373, DOI 10.1210/me.2014-1218; Li JZ, 2011, BIOL REPROD, V84, P476, DOI 10.1095/biolreprod.110.086363; Li MH, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096248; Lin H.R., 2007, FISH PHYSL; LIN YWP, 1987, GEN COMP ENDOCR, V67, P126, DOI 10.1016/0016-6480(87)90212-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macqueen DJ, 2013, MOL BIOL EVOL, V30, P1060, DOI 10.1093/molbev/mst017; Mei J, 2015, SCI CHINA LIFE SCI, V58, P124, DOI 10.1007/s11427-014-4797-9; Nelson SN, 2010, GEN COMP ENDOCR, V168, P111, DOI 10.1016/j.ygcen.2010.04.020; Nobrega RH, 2015, ENDOCRINOLOGY, V156, P3804, DOI 10.1210/en.2015-1157; Reinecke M, 2010, J FISH BIOL, V76, P1233, DOI 10.1111/j.1095-8649.2010.02605.x; Reinecke M, 2010, BIOL REPROD, V82, P656, DOI 10.1095/biolreprod.109.080093; Riley LG, 2004, COMP BIOCHEM PHYS C, V138, P177, DOI 10.1016/j.cca.2004.07.009; Shved N, 2008, TOXICOL SCI, V106, P93, DOI 10.1093/toxsci/kfn150; Shved N, 2007, J ENDOCRINOL, V195, P513, DOI 10.1677/JOE-07-0295; Shved N, 2009, FISH SHELLFISH IMMUN, V26, P524, DOI 10.1016/j.fsi.2009.02.003; Wang DS, 2008, BIOCHEM BIOPH RES CO, V367, P336, DOI 10.1016/j.bbrc.2007.12.136; Wang W., 2000, CULTURE ENHANCEMENT; Yang HR, 2015, COMP BIOCHEM PHYS B, V186, P68, DOI 10.1016/j.cbpb.2015.04.005; Yu SMY, 2007, BIOL REPROD, P81; [周立斌 ZHOU Libin], 2007, [中山大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Sunyatseni], V46, P69; Zou SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007026	32	24	29	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168874	10.1371/journal.pone.0168874	http://dx.doi.org/10.1371/journal.pone.0168874			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002497	Green Published, gold, Green Submitted			2022-12-26	WOS:000392853100073
J	Xue, YS; Zhang, HY; Sun, XF; Zhu, MJ				Xue, Yansong; Zhang, Hanying; Sun, Xiaofei; Zhu, Mei-Jun			Metformin Improves Ileal Epithelial Barrier Function in Interleukin-10 Deficient Mice	PLOS ONE			English	Article							PROTEIN-KINASE PROMOTES; FACTOR-KAPPA-B; SIGNALING PATHWAYS; TIGHT JUNCTIONS; MUCUS LAYERS; BETA-CATENIN; PANETH CELLS; DIFFERENTIATION; INFLAMMATION; COLITIS	Background and aims The impairment of intestinal epithelial barrier is the main etiologic factor of inflammatory bowel disease. The proper intestinal epithelial proliferation and differentiation is crucial for maintaining intestinal integrity. Metformin is a common anti-diabetic drug. The objective is to evaluate the protective effects of metformin on ileal epithelial barrier integrity using interleukin-10 deficient (IL10KO) mice. Methods Wild-type and IL10KO mice were fed with/without metformin for 6 weeks and then ileum was collected for analyses. The mediatory role of AMP-activated protein kinase (AMPK) was further examined by gain and loss of function study in vitro. Results Compared to wild-type mice, IL10KO mice had increased proliferation, reduced goblet cell and Paneth cell lineage differentiation in the ileum tissue, which was accompanied with increased crypt expansion. Metformin supplementation mitigated intestinal cell proliferation, restored villus/crypt ratio, increased goblet cell and Paneth cell differentiation and improved barrier function. In addition, metformin supplementation in IL10KO mice suppressed macrophage pro-inflammatory activity as indicated by reduced M1 macrophage abundance and decreased pro-inflammatory cytokine IL-1 beta, TNF-alpha and IFN-gamma expressions. As a target of metformin, AMPK phosphorylation was enhanced in mice treated with metformin, regardless of mouse genotypes. In correlation, the mRNA level of differentiation regulator including bmp4, bmpr2 and math1 were also increased in IL10KO mice supplemented with metformin, which likely explains the enhanced epithelial differentiation in IL10KO mice with metformin. Consistently, in Caco-2 cells, metformin promoted claudin-3 and E-cadherin assembly and mitigated TNF-alpha-induced fragmentation of tight junction proteins. Gain and loss of function assay also demonstrated AMPK was correlated with epithelial differentiation and proliferation. Conclusions Metformin supplementation promotes secretory cell lineage differentiation, suppresses inflammation and improves epithelial barrier function in IL10KO mice likely through activation of AMPK, showing its beneficial effects on gut epithelial.	[Xue, Yansong; Zhang, Hanying; Sun, Xiaofei; Zhu, Mei-Jun] Washington State Univ, Sch Food Sci, Pullman, WA 99164 USA; [Xue, Yansong; Sun, Xiaofei; Zhu, Mei-Jun] Univ Idaho, Sch Food Sci, Moscow, ID 83843 USA	Washington State University; Idaho; University of Idaho	Zhu, MJ (corresponding author), Washington State Univ, Sch Food Sci, Pullman, WA 99164 USA.; Zhu, MJ (corresponding author), Univ Idaho, Sch Food Sci, Moscow, ID 83843 USA.	meijun.zhu@wsu.edu	Sun, Xiaofei/S-9786-2018	Sun, Xiaofei/0000-0002-4835-9309	National Institutes of Health [R15HD073864]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R15HD073864] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health (http://www.nih.gov/) Grants R15HD073864. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auclair BA, 2007, GASTROENTEROLOGY, V133, P887, DOI 10.1053/j.gastro.2007.06.066; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Biswas A, 2010, P NATL ACAD SCI USA, V107, P14739, DOI 10.1073/pnas.1003363107; Cario E, 2004, GASTROENTEROLOGY, V127, P224, DOI 10.1053/j.gastro.2004.04.015; Chung YC, 2003, J SURG ONCOL, V83, P222, DOI 10.1002/jso.10269; Correa I, 2009, J LEUKOCYTE BIOL, V85, P896, DOI 10.1189/jlb.1108698; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Edelblum KL, 2009, CURR OPIN PHARMACOL, V9, P715, DOI 10.1016/j.coph.2009.06.022; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Forouzandeh F, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001202; Fu X, 2013, MOL CELL BIOL, V33, P4517, DOI 10.1128/MCB.01078-13; Geier MS, 2009, DIGEST DIS SCI, V54, P1222, DOI 10.1007/s10620-008-0495-4; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Heath JK, 2010, CURR TOP DEV BIOL, V90, P159, DOI 10.1016/S0070-2153(10)90004-5; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Isoda K, 2006, ARTERIOSCL THROM VAS, V26, P611, DOI 10.1161/01.ATV.0000201938.78044.75; Jang WG, 2011, BIOCHEM BIOPH RES CO, V404, P1004, DOI 10.1016/j.bbrc.2010.12.099; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kanazawa I, 2008, BIOCHEM BIOPH RES CO, V375, P414, DOI 10.1016/j.bbrc.2008.08.034; Keubler LM, 2015, INFLAMM BOWEL DIS, V21, P1967, DOI 10.1097/MIB.0000000000000468; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Koh SJ, 2014, J GASTROEN HEPATOL, V29, P502, DOI 10.1111/jgh.12435; Lee S, 2015, INT J NANOMED, V10, P3, DOI 10.2147/IJN.S91389; Li XX, 2008, ARTERIOSCL THROM VAS, V28, P1789, DOI 10.1161/ATVBAHA.108.172452; MACDONALD TT, 1994, CURR BIOL, V4, P261, DOI 10.1016/S0960-9822(00)00060-9; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; Maloum F, 2011, AM J PHYSIOL-GASTR L, V300, pG1065, DOI 10.1152/ajpgi.00176.2010; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Mehta S, 2015, CELL TISSUE RES, V360, P749, DOI 10.1007/s00441-014-1994-6; Mei M, 2015, CELL SIGNAL, V27, P1915, DOI 10.1016/j.cellsig.2015.07.002; Mithieux G, 2006, BIOCHEM PHARMACOL, V72, P198, DOI 10.1016/j.bcp.2006.04.020; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Patel RM, 2012, AM J PATHOL, V180, P626, DOI 10.1016/j.ajpath.2011.10.025; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Rigby RJ, 2007, ONCOGENE, V26, P4833, DOI 10.1038/sj.onc.1210286; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Sancho E, 2003, CURR OPIN CELL BIOL, V15, P763, DOI 10.1016/j.ceb.2003.10.012; Scheinin T, 2003, CLIN EXP IMMUNOL, V133, P38, DOI 10.1046/j.1365-2249.2003.02193.x; Seth A, 2007, J BIOL CHEM, V282, P11487, DOI 10.1074/jbc.M610597200; Soderholm JD, 2002, GUT, V50, P307, DOI 10.1136/gut.50.3.307; Steinberg GR, 2006, CELL METAB, V4, P465, DOI 10.1016/j.cmet.2006.11.005; Stoll G, 2004, J NEUROIMMUNOL, V149, P142, DOI 10.1016/j.jneuroim.2003.12.024; Strugala V, 2008, INT J CLIN PRACT, V62, P762, DOI 10.1111/j.1742-1241.2007.01665.x; Sun X, 2016, FASEB J S, V30; Tagore A, 1999, TISSUE ANTIGENS, V54, P386, DOI 10.1034/j.1399-0039.1999.540408.x; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Vazquez-Martin A, 2012, CELL CYCLE, V11, P974, DOI 10.4161/cc.11.5.19450; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wehkamp J, 2007, J IMMUNOL, V179, P3109, DOI 10.4049/jimmunol.179.5.3109; WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220; Xue Y, 2014, J NUTR BIOCHEM, V25, P758, DOI 10.1016/j.jnutbio.2014.03.009; Yang G, 2015, BRIT J NUTR, V114, P15, DOI 10.1017/S0007114515001415; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375; Zhu HM, 2016, FOOD CONTROL, V66, P291, DOI 10.1016/j.foodcont.2016.02.013; Zhu MJ, 2007, PLACENTA, V28, P1192, DOI 10.1016/j.placenta.2007.05.004	68	34	34	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168670	10.1371/journal.pone.0168670	http://dx.doi.org/10.1371/journal.pone.0168670			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002460	Green Published, gold			2022-12-26	WOS:000392853100062
J	Bae, K; Cho, GE; Yoon, JM; Kang, SW				Bae, Kunho; Cho, Ga Eun; Yoon, Je Moon; Kang, Se Woong			Optical Coherence Tomographic Features and Prognosis of Pneumatic Displacement for Submacular Hemorrhage	PLoS One			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; POLYPOIDAL CHOROIDAL VASCULOPATHY; ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; SUBRETINAL HEMORRHAGE; INTRAVITREAL INJECTION; NATURAL-HISTORY; EXPANSILE GAS; MANAGEMENT; LESIONS	Purpose To identify prognostic factors, including optical coherence tomographic features, of visual outcome in exudative age-related macular degeneration with submacular hemorrhage treated with pneumatic displacement. Methods This retrospective interventional case series included 37 eyes with exudative age-related macular degeneration and submacular hemorrhage, all of which underwent pneumatic displacement. The best-corrected visual acuity (BCVA) was measured at diagnosis and at 3 and 6 months after treatment. In addition to demographic and funduscopic parameters, tomographic features such as reflectance of the submacular hemorrhage were analyzed with regard to BCVA at 6 months. Results After pneumatic displacement and a subsequent treatment such as laser or anti-vascular endothelial growth factor therapy, the BCVA at 3 and 6 months improved significantly (P < 0.001, respectively). Higher baseline BCVA (P < 0.001), shorter symptom duration (P = 0.007), and younger age (P = 0.014) were significant positive prognostic factors on regression analysis. Among optical coherence tomography characteristics, reflectance of the submacular hemorrhage, the shortest radius of the submacular hemorrhage centered on the fovea, and defects in the ellipsoid zone, and external limiting membrane affected the BCVA at 6 months (P < 0.05). Conclusion A favorable visual outcome was demonstrated after initial pneumatic displacement and subsequent treatment for submacular hemorrhage. The submacular hemorrhages exhibiting lower reflectance on optical coherence tomography and a smaller shortest radius from the foveal center were found to be good candidates for pneumatic displacement.	[Bae, Kunho; Cho, Ga Eun; Yoon, Je Moon; Kang, Se Woong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Kang, SW (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea.	swkang@skku.edu						Avery RL, 1996, RETINA-J RET VIT DIS, V16, P183, DOI 10.1097/00006982-199616030-00001; BENNETT SR, 1990, AM J OPHTHALMOL, V109, P33, DOI 10.1016/S0002-9394(14)75575-8; Bressler NM, 2004, OPHTHALMOLOGY, V111, P1993, DOI 10.1016/j.ophtha.2004.07.023; Chen CY, 2007, RETINA-J RET VIT DIS, V27, P321, DOI 10.1097/01.iae.0000237586.48231.75; Chen SN, 2003, OPHTHALMOLOGY, V110, P704, DOI 10.1016/S0161-6420(02)01979-6; Fang IM, 2009, EYE, V23, P397, DOI 10.1038/sj.eye.6703017; Fujikawa M, 2013, RETINA-J RET VIT DIS, V33, P1908, DOI 10.1097/IAE.0b013e318287d99d; Hassan AS, 1999, OPHTHALMOLOGY, V106, P1900, DOI 10.1016/S0161-6420(99)90399-8; Hattenbach LO, 2001, OPHTHALMOLOGY, V108, P1485, DOI 10.1016/S0161-6420(01)00648-0; Honda S, 2009, OPHTHALMOLOGICA, V223, P333, DOI 10.1159/000221837; Kamei M, 1996, AM J OPHTHALMOL, V121, P267, DOI 10.1016/S0002-9394(14)70274-0; Kim JH, 2014, OPHTHALMOLOGY, V121, P926, DOI 10.1016/j.ophtha.2013.11.004; Kim JH, 2013, AM J OPHTHALMOL, V156, P974, DOI 10.1016/j.ajo.2013.06.013; Kokame GT, 2000, AM J OPHTHALMOL, V129, P546, DOI 10.1016/S0002-9394(99)00474-2; Krepler K, 2000, RETINA-J RET VIT DIS, V20, P251, DOI 10.1097/00006982-200005000-00004; Mayer WJ, 2013, ACTA OPHTHALMOL, V91, P274, DOI 10.1111/j.1755-3768.2011.02264.x; Meyer CH, 2008, ACTA OPHTHALMOL, V86, P490, DOI 10.1111/j.1600-0420.2007.01125.x; Mizutani T, 2011, GRAEF ARCH CLIN EXP, V249, P1153, DOI 10.1007/s00417-011-1649-1; Ohji M, 1998, ARCH OPHTHALMOL-CHIC, V116, P1326, DOI 10.1001/archopht.116.10.1326; Olivier S, 2004, OPHTHALMOLOGY, V111, P1201, DOI 10.1016/j.ophtha.2003.10.020; Schulze SD, 2002, GRAEF ARCH CLIN EXP, V240, P717, DOI 10.1007/s00417-002-0516-5; Scupola A, 1999, OPHTHALMOLOGICA, V213, P97, DOI 10.1159/000027400; Shin JY, 2015, AM J OPHTHALMOL, V159, P904, DOI 10.1016/j.ajo.2015.01.024; Sho K, 2003, ARCH OPHTHALMOL-CHIC, V121, P1392, DOI 10.1001/archopht.121.10.1392; Yamashiro K, 2012, AM J OPHTHALMOL, V154, P125, DOI 10.1016/j.ajo.2012.01.010	25	6	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168474	10.1371/journal.pone.0168474	http://dx.doi.org/10.1371/journal.pone.0168474			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992524	Green Submitted, Green Published, gold			2022-12-26	WOS:000392842600064
J	Park, SY; Kim, HY; Park, HJ; Shin, HK; Hong, KW; Kim, CD				Park, So Youn; Kim, Hae Young; Park, Hee Jeong; Shin, Hwa Kyoung; Hong, Ki Whan; Kim, Chi Dae			Concurrent Treatment with Taxifolin and Cilostazol on the Lowering of beta-Amyloid Accumulation and Neurotoxicity via the Suppression of P-JAK2/P-STAT3/NF-kappa B/BACE1 Signaling Pathways	PLOS ONE			English	Article							NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; TRANSCRIPTION FACTOR; ADHESION MOLECULES; TERMINAL FRAGMENT; ENDOTHELIAL-CELLS; A-BETA; EXPRESSION	Taxifolin is a potent flavonoid that exerts anti-oxidative effect, and cilostazol increases intracellular cAMP levels by inhibiting phosphodiesterase 3 that shows antiinflammatory actions. BACE1 (beta-site APP cleaving enzyme 1) is the rate-limiting enzyme responsible for the beta-cleavage of amyloid precursor proteins to A beta peptides. In this study, endogenous A beta and C99 accumulation was explored in N2a Swe cells exposed to 1% FBS medium. Increased A beta and C99 levels were significantly attenuated by taxifolin alone and in combination with cilostazol. Increased phosphorylated JAK2 at Tyr1007/1008 (P-JAK), phosphorylated STAT3 at Tyr 705 (P-STAT3) expressions and increased expressions of BACE1 mRNA and protein in the activated N2a Swe cells were significantly attenuated by taxifolin (10 similar to 50 mu M), cilostazol (10 similar to 50 mu M) alone and in combination at minimum concentrations. In these cells, decreased cytosol I kappa B alpha expression was elevated, and increased nuclear NF-kappa B p65 level and nuclear NF-kappa B p65 DNA binding activity were significantly reduced by taxifolin and cilostazol in a similar manner. Following STAT3 gene (similar to 70% reduction) knockdown in N2a cells, A beta-induced nuclear NF-kappa B and BACE1 expressions were not observed. Taxifolin, cilostazol, or resveratrol significantly stimulated SIRT1 protein expression. In SIRT1 gene-silenced (similar to 50%) N2a cells, taxifolin, cilostazol, and resveratrol all failed to suppress A beta(1-42)-stimulated P-STAT3 and BACE1 expression. Consequently, taxifolin and cilostazol were found to significantly decrease lipopolysaccharide (1-10 mu g/ml)-induced iNOS and COX-2 expressions, and nitrite production in cultured BV-2 microglia cells and to increase N2a cell viability. In conclusion, taxifolin and cilostazol strongly inhibited amyloidogenesis in a synergistic manner by suppressing P-JAK2/P-STAT3-coupled NF kappa.B-linked BACE1 expression via the upregulation of SIRT1.	[Park, So Youn; Kim, Chi Dae] Pusan Natl Univ, Sch Med, Dept Pharmacol, Gyeongsangnam Do, South Korea; [Park, So Youn; Kim, Hae Young; Park, Hee Jeong; Hong, Ki Whan; Kim, Chi Dae] Pusan Natl Univ, Gene & Cell Therapy Res Ctr Vessel Associated Dis, Gyeongsangnam Do, South Korea; [Shin, Hwa Kyoung] Pusan Natl Univ, Div Meridian & Struct Med, Gyeongsangnam Do, South Korea	Pusan National University; Pusan National University; Pusan National University	Kim, CD (corresponding author), Pusan Natl Univ, Sch Med, Dept Pharmacol, Gyeongsangnam Do, South Korea.; Kim, CD (corresponding author), Pusan Natl Univ, Gene & Cell Therapy Res Ctr Vessel Associated Dis, Gyeongsangnam Do, South Korea.	chidkim@pusan.ac.kr			National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2016R1A2B2011509, NRF-2016R1C1B2007691]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (NRF-2016R1A2B2011509 and NRF-2016R1C1B2007691).	Anekonda TS, 2006, J NEUROCHEM, V96, P305, DOI 10.1111/j.1471-4159.2005.03492.x; Bauer MKA, 1997, EUR J BIOCHEM, V243, P726, DOI 10.1111/j.1432-1033.1997.00726.x; Buggia-Prevot V, 2008, J BIOL CHEM, V283, P10037, DOI 10.1074/jbc.M706579200; CHECLER F, 1995, J NEUROCHEM, V65, P1431; Chen CH, 2012, INT J NEUROPSYCHOPH, V15, P77, DOI 10.1017/S1461145711000149; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chittezhath M, 2008, MOL CANCER THER, V7, P1817, DOI 10.1158/1535-7163.MCT-08-0256; Cho HJ, 2009, BIOCHEM BIOPH RES CO, V386, P175, DOI 10.1016/j.bbrc.2009.06.006; Choi SH, 2009, TRENDS PHARMACOL SCI, V30, P174, DOI 10.1016/j.tips.2009.01.002; Ferrer I, 1998, NEUROPATH APPL NEURO, V24, P271; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Fusco S, 2012, P NATL ACAD SCI USA, V109, P621, DOI 10.1073/pnas.1109237109; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Julien C, 2009, J NEUROPATH EXP NEUR, V68, P48, DOI 10.1097/NEN.0b013e3181922348; Kaltschmidt B, 1997, P NATL ACAD SCI USA, V94, P2642, DOI 10.1073/pnas.94.6.2642; Kim YM, 1997, BIOCHEM BIOPH RES CO, V236, P655, DOI 10.1006/bbrc.1997.7031; Lauritzen I, 2012, J NEUROSCI, V32, P16243, DOI 10.1523/JNEUROSCI.2775-12.2012; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Lee HR, 2014, J NEUROSCI RES, V92, P1581, DOI 10.1002/jnr.23421; Lee HR, 2014, J NEUROSCI RES, V92, P206, DOI 10.1002/jnr.23310; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Maezawa I, 2004, J NEUROCHEM, V91, P1312, DOI 10.1111/j.1471-4159.2004.02818.x; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Paris D, 2007, NEUROSCI LETT, V415, P11, DOI 10.1016/j.neulet.2006.12.029; Park SY, 2006, J PHARMACOL EXP THER, V317, P1238, DOI 10.1124/jpet.105.098509; Park SH, 2011, BIOCHEM BIOPH RES CO, V408, P602, DOI 10.1016/j.bbrc.2011.04.068; Park SY, 2005, J PHARMACOL EXP THER, V312, P1241, DOI 10.1124/jpet.104.077826; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Sastre M, 2006, INT J DEV NEUROSCI, V24, P167, DOI 10.1016/j.ijdevneu.2005.11.014; Shimmyo Y, 2008, NEUROREPORT, V19, P1329, DOI 10.1097/WNR.0b013e32830b8ae1; Stockley JH, 2006, FEBS LETT, V580, P6550, DOI 10.1016/j.febslet.2006.10.076; Valerio A, 2006, EUR J NEUROSCI, V23, P1711, DOI 10.1111/j.1460-9568.2006.04722.x; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wang YH, 2006, J BIOMED SCI, V13, P127, DOI 10.1007/s11373-005-9031-0; Weidmann AE, 2012, EUR J PHARMACOL, V684, P19, DOI 10.1016/j.ejphar.2012.03.035; Yeo SJ, 2003, J BIOL CHEM, V278, P40590, DOI 10.1074/jbc.M306280200; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093	42	18	19	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168286	10.1371/journal.pone.0168286	http://dx.doi.org/10.1371/journal.pone.0168286			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977755	Green Published, gold			2022-12-26	WOS:000391217400088
J	Phillips, AN; Cambiano, V; Nakagawa, F; Bansi-Matharu, L; Sow, PS; Ehrenkranz, P; Ford, D; Mugurungi, O; Apollo, T; Murungu, J; Bangsberg, DR; Revill, P				Phillips, Andrew N.; Cambiano, Valentina; Nakagawa, Fumiyo; Bansi-Matharu, Loveleen; Sow, Papa Salif; Ehrenkranz, Peter; Ford, Deborah; Mugurungi, Owen; Apollo, Tsitsi; Murungu, Joseph; Bangsberg, David R.; Revill, Paul			Cost Effectiveness of Potential ART Adherence Monitoring Interventions in Sub-Saharan Africa	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; MIDDLE-INCOME COUNTRIES; DRUG-RESISTANCE; VIROLOGICAL FAILURE; SOUTH-AFRICA; VIRAL LOAD; HIV CARE; COHORT; PATTERNS; PEOPLE	Background Interventions based around objective measurement of adherence to antiretroviral drugs for HIV have potential to improve adherence and to enable differentiation of care such that clinical visits are reduced in those with high adherence. It would be useful to understand the approximate upper limit of cost that could be considered for such interventions of a given effectiveness in order to be cost effective. Such information can guide whether to implement an intervention in the light of a trial showing a certain effectiveness and cost. Methods An individual-based model, calibrated to Zimbabwe, which incorporates effects of adherence and resistance to antiretroviral therapy, was used to model the potential impact of adherence monitoring-based interventions on viral suppression, death rates, disability adjusted life years and costs. Potential component effects of the intervention were: enhanced average adherence when on ART, reduced risk of ART discontinuation, and reduced risk of resistance acquisition. We considered a situation in which viral load monitoring is not available and one in which it is. In the former case, it was assumed that care would be differentiated based on the adherence level, with fewer clinic visits in those demonstrated to have high adherence. In the latter case, care was assumed to be primarily differentiated according to viral load level. The maximum intervention cost required to be cost effective was calculated based on a cost effectiveness threshold of $500 per DALY averted. Findings In the absence of viral load monitoring, an adherence monitoring-based intervention which results in a durable 6% increase in the proportion of ART experienced people with viral load < 1000 cps/mL was cost effective if it cost up to $ 50 per person-year on ART, mainly driven by the cost savings of differentiation of care. In the presence of viral load monitoring availability, an intervention with a similar effect on viral load suppression was cost-effective when costing $23-$32 per year, depending on whether the adherence intervention is used to reduce the level of need for viral load measurement. Conclusion The cost thresholds identified suggest that there is clear scope for adherence monitoring-based interventions to provide net population health gain, with potential cost-effective use in situations where viral load monitoring is or is not available. Our results guide the implementation of future adherence monitoring interventions found in randomized trials to have health benefit.	[Phillips, Andrew N.; Cambiano, Valentina; Nakagawa, Fumiyo; Bansi-Matharu, Loveleen] UCL, Res Dept Infect & Populat Hlth, London, England; [Sow, Papa Salif; Ehrenkranz, Peter] Bill & Melinda Gates Fdn, Seattle, WA USA; [Ford, Deborah] UCL, Inst Clin Trials & Methodol, London, England; [Mugurungi, Owen; Apollo, Tsitsi; Murungu, Joseph] Minist Hlth Child Care, Harare, Zimbabwe; [Bangsberg, David R.] Portland State Univ, Oregon Hlth Sci Univ, Sch Publ Hlth, Portland, OR 97207 USA; [Revill, Paul] Univ York, Ctr Hlth Econ, York, N Yorkshire, England	University of London; University College London; Bill & Melinda Gates Foundation; University of London; University College London; Oregon Health & Science University; Portland State University; University of York - UK	Phillips, AN (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	andrew.phillips@ucl.ac.uk	Phillips, Andrew N/B-4427-2008	Phillips, Andrew N/0000-0003-2384-4807; Revill, Paul/0000-0001-8632-0600	Bill & Melinda Gates Foundation [42889]; Medical Research Council [MC_UU_12023/23] Funding Source: researchfish	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Bill & Melinda Gates Foundation, Investment ID 42889. PSS and PE from the Foundation determined the overall study question in collaboration with the other authors. PSS and PE from the Foundation encouraged manuscript submission but this was the final decision of AP with all the authors.	Barnighausen T, 2011, LANCET INFECT DIS, V11, P942, DOI 10.1016/S1473-3099(11)70181-5; Bangsberg DR, 2006, AIDS, V20, P223, DOI 10.1097/01.aids.0000199825.34241.49; Bangsberg DR, 2004, J ANTIMICROB CHEMOTH, V53, P696, DOI 10.1093/jac/dkh162; Blaschke TF, 2012, ANNU REV PHARMACOL, V52, P275, DOI 10.1146/annurev-pharmtox-011711-113247; Bonner K, 2013, JAIDS-J ACQ IMM DEF, V64, P74, DOI 10.1097/QAI.0b013e31829f05ac; Cambiano V, 2014, AIDS, V28, pS15, DOI 10.1097/QAD.0000000000000082; Cambiano V, 2010, AIDS, V24, P1153, DOI 10.1097/QAD.0b013e32833847af; Campbell JI, 2015, CURR HIV-AIDS REP, V12, P523, DOI 10.1007/s11904-015-0282-8; Carrieri P, 2001, J ACQ IMMUN DEF SYND, V28, P232, DOI 10.1097/00042560-200111010-00005; Chaiyachati KH, 2014, AIDS, V28, pS187, DOI 10.1097/QAD.0000000000000252; Chi BH, 2009, INT J EPIDEMIOL, V38, P746, DOI 10.1093/ije/dyp004; Claxton K, 2010, 54 U YORK CTR HLTH E, P54; Daniels MJ, 1997, STAT MED, V16, P1965, DOI 10.1002/(SICI)1097-0258(19970915)16:17<1965::AID-SIM630>3.3.CO;2-D; Demonceau J, 2013, DRUGS, V73, P545, DOI 10.1007/s40265-013-0041-3; Duncombe C, 2015, TROP MED INT HEALTH, V20, P430, DOI 10.1111/tmi.12460; El-Khatib Z, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-88; Fox MP, 2012, JAIDS-J ACQ IMM DEF, V60, P428, DOI 10.1097/QAI.0b013e3182557785; Genberg BL, 2012, AIDS, V26, P1415, DOI 10.1097/QAD.0b013e328354bed6; Glass TR, 2010, JAIDS-J ACQ IMM DEF, V54, P197, DOI 10.1097/QAI.0b013e3181ca48bf; Grund B for the SMART Study Group, 2006, 16 INT AIDS C AUG 13; Haberer JE, 2016, 11 INT C HIV TREAT P; Haberer JE, 2013, AIDS, V27, P2166, DOI 10.1097/QAD.0b013e328363b53f; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Hassan AS, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-9; Hoffmann CJ, 2014, TROP MED INT HEALTH, V19, P236, DOI 10.1111/tmi.12237; Hoffmann CJ, 2009, CLIN INFECT DIS, V49, P1928, DOI 10.1086/648444; Hoffmann CJ, 2013, TROP MED INT HLTH; Hyle EP, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001725; Johannessen A, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-108; Kessler J, 2015, VALUE HEALTH, V18, P946, DOI 10.1016/j.jval.2015.09.2940; Kleeberger CA, 2004, AIDS, V18, P683, DOI 10.1097/00002030-200403050-00013; Kobin AB, 2011, ANN PHARMACOTHER, V45, P372, DOI 10.1345/aph.1P587; Kranzer K, 2011, TROP MED INT HEALTH, V16, P1297, DOI 10.1111/j.1365-3156.2011.02828.x; Kranzer K, 2010, JAIDS-J ACQ IMM DEF, V55, pE17, DOI 10.1097/QAI.0b013e3181f275fd; Lazo M, 2007, CLIN INFECT DIS, V45, P1377, DOI 10.1086/522762; Levine AJ, 2005, AIDS BEHAV, V9, P355, DOI 10.1007/s10461-005-9009-y; Li JZ, 2014, AIDS, V28, P181, DOI 10.1097/QAD.0000000000000123; Mackie NE, 2010, J INFECT DIS, V201, P1303, DOI 10.1086/651618; Mannheimer S, 2002, CLIN INFECT DIS, V34, P1115, DOI 10.1086/339074; Mathes T, 2013, INT J TECHNOL ASSESS, V29, P227, DOI 10.1017/S0266462313000317; Meresse M, 2014, HIVMED; MSF Access Campaign, 2014, UNT WEB ANT PRIC RED; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; Orrell C, 2007, ANTIVIR THER, V12, P83; Orrell C, 2015, JAIDS-J ACQ IMM DEF, V70, P495, DOI 10.1097/QAI.0000000000000770; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pellowski JA, 2012, CURR HIV-AIDS REP, V9, P326, DOI 10.1007/s11904-012-0133-9; Petersen ML, 2007, CLIN INFECT DIS, V45, P908, DOI 10.1086/521250; Phillips AN, 1997, AIDS, V11, P169, DOI 10.1097/00002030-199702000-00006; Phillips A, 2015, NATURE, V528, pS68, DOI 10.1038/nature16046; Phillips AN, 2011, AIDS, V25, P843, DOI 10.1097/QAD.0b013e328344037a; Roberts T, 2016, CLIN INFECT DIS; Rosenblum M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007196; Rutstein SE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124748; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Siapka M, 2014, B WORLD HEALTH ORGAN, V92, P499, DOI 10.2471/BLT.13.127639; Tagar E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108304; Tassie JM, 2010, JAIDS-J ACQ IMM DEF, V54, P437, DOI 10.1097/QAI.0b013e3181d73e1b; Tran D.-X. T., 2014, BIOMEDICAL RES THERA, V1, P1, DOI DOI 10.1039/C4P00104D; Usitalo A, 2014, AIDS CARE, V26, P107, DOI 10.1080/09540121.2013.802280; von Wyl V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077691; Wandeler G, 2012, JAIDS-J ACQ IMM DEF, V59, pE9, DOI 10.1097/QAI.0b013e31823edb6a; Ware NC, 2016, AIDS, V30, P1287, DOI 10.1097/QAD.0000000000001035; Woods E, COUNTRY LEVEL COST E	64	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0167654	10.1371/journal.pone.0167654	http://dx.doi.org/10.1371/journal.pone.0167654			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977702	Green Published, Green Accepted, gold			2022-12-26	WOS:000391217400025
J	Bedau, T; Peters, F; Prox, J; Arnold, P; Schmidt, F; Finkernagel, M; Kollmann, S; Wichert, R; Otte, A; Ohler, A; Stirnberg, M; Lucius, R; Koudelka, T; Tholey, A; Biasin, V; Pietrzik, CU; Kwapiszewska, G; Becker-Pauly, C				Bedau, Tillmann; Peters, Florian; Prox, Johannes; Arnold, Philipp; Schmidt, Frederike; Finkernagel, Malin; Koellmann, Sandra; Wichert, Rielana; Otte, Anna; Ohler, Anke; Stirnberg, Marit; Lucius, Ralph; Koudelka, Tomas; Tholey, Andreas; Biasin, Valentina; Pietrzik, Claus U.; Kwapiszewska, Grazyna; Becker-Pauly, Christoph			Ectodomain shedding of CD99 within highly conserved regions is mediated by the metalloprotease meprin beta and promotes transendothelial cell migration	FASEB JOURNAL			English	Article						proteolysis; inflammation; TEM; adhesion molecule	INTESTINAL INFLAMMATION; EXTRACELLULAR-MATRIX; LEUKOCYTE DIAPEDESIS; MIC2 EXPRESSION; EWINGS-SARCOMA; CLEAVAGE SITE; IN-VIVO; PEPTIDE; SURFACE; ADAM17	The adhesion molecule CD99 is essential for the transendothelial migration of leukocytes. In this study, we used biochemical and cellular assays to show that CD99 undergoes ectodomain shedding by the metalloprotease meprin beta and subsequent intramembrane proteolysis by gamma-secretase. The cleavage site in CD99 was identified by mass spectrometry within an acidic region highly conserved through different vertebrate species. This finding fits perfectly to the unique cleavage specificity of meprin beta with a strong preference for aspartate residues and suggests coevolution of protease and substrate. We hypothesized that limited CD99 cleavage by meprin beta would alter cellular transendothelial migration (TEM) behavior in tissue remodeling processes, such as inflammation and cancer. Indeed, meprin beta induced cell migration of Lewis lung carcinoma cells in an in vitro TEM assay. Accordingly, deficiency of meprin beta in Mep1b(-/-) mice resulted in significantly increased CD99 protein levels in the lung. Therefore, meprin beta could serve as a therapeutic target, given that in aproof-of-concept approach we showed accumulation of CD99 protein in lungs of meprin beta inhibitortreated mice.- Bedau, T., Peters, F., Prox, J., Arnold, P., Schmidt, F., Finkernagel, M., Kollmann, S., Wichert, R., Otte, A., Ohler, A., Stirnberg, M., Lucius, R., Koudelka, T., Tholey, A., Biasin, V., Pietrzik, C. U., Kwapiszewska, G., Becker- Pauly, C. Ectodomain shedding of CD99 within highly conserved regions is mediated by the metalloprotease meprin b and promotes transendothelial cell migration.	[Bedau, Tillmann; Peters, Florian; Prox, Johannes; Schmidt, Frederike; Finkernagel, Malin; Koellmann, Sandra; Wichert, Rielana; Otte, Anna; Becker-Pauly, Christoph] Univ Kiel, Inst Biochem, Unit Degrad ProteaseWeb, Kiel, Germany; [Arnold, Philipp; Lucius, Ralph] Univ Kiel, Inst Anat, Kiel, Germany; [Koudelka, Tomas; Tholey, Andreas] Univ Kiel, Inst Expt Med, Kiel, Germany; [Pietrzik, Claus U.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Pathobiochem, Mainz, Germany; [Stirnberg, Marit] Univ Bonn, Inst Pharmaceut, Bonn, Germany; [Biasin, Valentina; Kwapiszewska, Grazyna] Ludwig Boltzmann Inst, Lung Vasc Res, Graz, Austria	University of Kiel; University of Kiel; University of Kiel; Johannes Gutenberg University of Mainz; University of Bonn; Ludwig Boltzmann Institute	Becker-Pauly, C (corresponding author), Otto Hahn Pl 9, D-24118 Kiel, Germany.	cbeckerpauly@biochem.uni-kiel.de	Tholey, Andreas/B-3407-2010; Becker-Pauly, Christoph/B-7569-2011; Biasin, Valentina/AAG-7780-2020; Lucius, Ralph/B-1614-2010	Tholey, Andreas/0000-0002-8687-6817; Biasin, Valentina/0000-0002-6277-1463; Kwapiszewska, grazyna/0000-0003-0518-9079; Trabold, Malin/0000-0001-6458-0567	Deutsche Forschungsgemeinschaft (DFG) [SFB877]; Proteolysis as a Regulatory Event in Pathophysiology [PI379/6-1, PI379/5-2, BE4086/2-1, BE4086/5-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Proteolysis as a Regulatory Event in Pathophysiology	The authors thank Dietmar Vestweber (Max Planck Institute of Molecular Biomedicine, Munster, Germany) for the murine CD99 antibody and cDNA, Dominique Mazzocut (Institut de Biologie et Chimie des Proteines, Lyon, France) for the N-terminal Edman sequencing; Stefan Dusterhoft (University of Oxford, Oxford, United Kingdom) for technical help with HPLC, and Dirk Schmidt-Arras (University of Kiel) for LLC cells. This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant SFB877, "Proteolysis as a Regulatory Event in Pathophysiology" (Projects A9 and Z2), Grants PI379/6-1 and PI379/5-2 (to C.U.P.) and Grants BE4086/2-1 and BE4086/5-1 (to C.B.P.). The authors declare no conflicts of interest.	AMBROS IM, 1991, CANCER, V67, P1886, DOI 10.1002/1097-0142(19910401)67:7<1886::AID-CNCR2820670712>3.0.CO;2-U; Arnold P, 2015, FASEB J, V29, P3549, DOI 10.1096/fj.15-272310; Arolas JL, 2012, P NATL ACAD SCI USA, V109, P16131, DOI 10.1073/pnas.1211076109; Banerjee S, 2008, J BIOL CHEM, V283, P31371, DOI 10.1074/jbc.M802814200; Becker C, 2003, BIOL CHEM, V384, P825, DOI 10.1515/BC.2003.092; Becker-Pauly C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009233; Biasin V, 2014, J PATHOL, V233, P7, DOI 10.1002/path.4303; Bien J, 2012, J BIOL CHEM, V287, P33304, DOI 10.1074/jbc.M112.395608; Bixel G, 2004, BLOOD, V104, P3205, DOI 10.1182/blood-2004-03-1184; Bixel MG, 2010, BLOOD, V116, P1172, DOI 10.1182/blood-2009-12-256388; Brandenburg LO, 2008, J NEUROPATH EXP NEUR, V67, P1041, DOI 10.1097/NEN.0b013e31818b4801; Broder C, 2013, P NATL ACAD SCI USA, V110, P14219, DOI 10.1073/pnas.1305464110; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; Crisman JM, 2004, J IMMUNOL, V172, P4510, DOI 10.4049/jimmunol.172.7.4510; Dreymueller D, 2015, AM J PHYSIOL-LUNG C, V308, pL325, DOI 10.1152/ajplung.00294.2014; Dreymueller D, 2012, EMBO MOL MED, V4, P412, DOI 10.1002/emmm.201200217; Dufour EM, 2008, CELL COMMUN ADHES, V15, P351, DOI 10.1080/15419060802442191; DWORZAK MN, 1994, BLOOD, V83, P415, DOI 10.1182/blood.V83.2.415.bloodjournal832415; Eldering JA, 1997, EUR J BIOCHEM, V247, P920, DOI 10.1111/j.1432-1033.1997.00920.x; FELLINGER EJ, 1991, CANCER RES, V51, P336; Herzog C, 2009, BIOCHEM BIOPH RES CO, V379, P904, DOI 10.1016/j.bbrc.2008.12.161; Huguenin M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002153; Jackle F, 2015, BIOCHEM J, V470, P91, DOI 10.1042/BJ20141417; Jefferson T, 2013, CELL MOL LIFE SCI, V70, P309, DOI 10.1007/s00018-012-1106-2; Keiffer TR, 2014, J BIOL CHEM, V289, P7580, DOI 10.1074/jbc.M113.546309; Kleifeld O, 2010, NAT BIOTECHNOL, V28, P281, DOI 10.1038/nbt.1611; Kronenberg D, 2010, J INVEST DERMATOL, V130, P2727, DOI 10.1038/jid.2010.202; Lou O, 2007, J IMMUNOL, V178, P1136, DOI 10.4049/jimmunol.178.2.1136; Manara MC, 2006, MOL BIOL CELL, V17, P1910, DOI 10.1091/mbc.E05-10-0971; Manes TD, 2011, J IMMUNOL, V186, P1763, DOI 10.4049/jimmunol.1002835; Muller WA, 2016, CURR OPIN IMMUNOL, V38, P24, DOI 10.1016/j.coi.2015.10.006; Norman LP, 2003, MOL CELL BIOL, V23, P1221, DOI 10.1128/MCB.23.4.1221-1230.2003; Park SH, 2005, GENE, V353, P177, DOI 10.1016/j.gene.2005.04.023; Rocchi A, 2010, J CLIN INVEST, V120, P668, DOI 10.1172/JCI36667; Schenkel AR, 2002, NAT IMMUNOL, V3, P143, DOI 10.1038/ni749; Schonherr C, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0084-5; Schutte A, 2014, P NATL ACAD SCI USA, V111, P12396, DOI 10.1073/pnas.1407597111; Scotlandi K, 2007, ONCOGENE, V26, P6604, DOI 10.1038/sj.onc.1210481; Sohn HW, 2001, J IMMUNOL, V166, P787, DOI 10.4049/jimmunol.166.2.787; Suh YH, 2003, GENE, V307, P63, DOI 10.1016/S0378-1119(03)00401-3; Tucher J, 2014, J PROTEOME RES, V13, P2205, DOI 10.1021/pr401135u; Vestweber D, 2015, NAT REV IMMUNOL, V15, P692, DOI 10.1038/nri3908; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Watson RL, 2015, J EXP MED, V212, P1021, DOI 10.1084/jem.20150354; Winger RC, 2016, J IMMUNOL, V196, P1443, DOI 10.4049/jimmunol.1501634	45	24	24	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1226	+		10.1096/fj.201601113R	http://dx.doi.org/10.1096/fj.201601113R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	28003343				2022-12-26	WOS:000395671200034
J	McSorley, E; McCloy, R; Williams, L				McSorley, Eugene; McCloy, Rachel; Williams, Louis			The Concurrent Programming of Saccades	PLoS One			English	Article							VISUAL-SEARCH TASK; EYE-MOVEMENTS; REFLEXIVE SACCADES; TARGET SELECTION; SUPERIOR COLLICULUS; SEQUENCES; ATTENTION; VOLUNTARY; GENERATION; OBJECT	Sequences of saccades have been shown to be prepared concurrently however it remains unclear exactly what aspects of those saccades are programmed in parallel. To examine this participants were asked to make one or two target-driven saccades: a reflexive saccade; a voluntary saccade; a reflexive then a voluntary saccade; or vice versa. During the first response the position of a second target was manipulated. The new location of the second saccade target was found to impact on second saccade latencies and second saccade accuracy showing that some aspects of the second saccade program are prepared in parallel with the first. However, differences were found in the specific pattern of effects for each sequence type. These differences fit well within a general framework for saccade control in which a common priority map for saccade control is computed and the influence of saccade programs on one another depends not so much on the types of saccade being produced but rather on the rate at which their programs develop.	[McSorley, Eugene; McCloy, Rachel; Williams, Louis] Univ Reading, Sch Psychol & Clin Language Sci, Reading, Berks, England	University of Reading	McSorley, E (corresponding author), Univ Reading, Sch Psychol & Clin Language Sci, Reading, Berks, England.	e.mcsorley@reading.ac.uk	Williams, Louis/W-3373-2019		British Academy [SG SG142865]	British Academy	This work was supported by the British Academy, Grant No. SG SG142865. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amador N, 1998, J NEUROPHYSIOL, V80, P1775, DOI 10.1152/jn.1998.80.4.1775; Awh E, 2012, TRENDS COGN SCI, V16, P1; Baldauf D, 2008, EXP BRAIN RES, V184, P411, DOI 10.1007/s00221-007-1114-x; Beauvillain C, 2005, EXP BRAIN RES, V165, P315, DOI 10.1007/s00221-005-2308-8; BECKER W, 1979, VISION RES, V19, P967, DOI 10.1016/0042-6989(79)90222-0; Bhutani N, 2013, J NEUROSCI, V33, P9985, DOI 10.1523/JNEUROSCI.4934-12.2013; Bhutani N, 2012, J NEUROPHYSIOL, V108, P3161, DOI 10.1152/jn.00344.2012; BURR DC, 1982, J PHYSIOL-LONDON, V333, P1; De Vries JP, 2014, PSYCHOL SCI, V25, P215, DOI 10.1177/0956797613497020; Engbert R, 2005, PSYCHOL REV, V112, P777, DOI 10.1037/0033-295X.112.4.777; Fecteau JH, 2006, TRENDS COGN SCI, V10, P382, DOI 10.1016/j.tics.2006.06.011; Findlay JM, 2001, VISION RES, V41, P87, DOI 10.1016/S0042-6989(00)00236-4; Findlay JM, 1999, BEHAV BRAIN SCI, V22, P661, DOI 10.1017/S0140525X99002150; Gersch TM, 2009, VISION RES, V49, P1256, DOI 10.1016/j.visres.2007.10.030; Gersch TM, 2004, VISION RES, V44, P1469, DOI 10.1016/j.visres.2003.12.014; Godijn R, 2003, J EXP PSYCHOL HUMAN, V29, P882, DOI 10.1037/0096-1523.29.5.882; Godijn R, 2002, PSYCHOL RES-PSYCH FO, V66, P234, DOI 10.1007/s00426-002-0098-1; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; Hayhoe M, 2005, TRENDS COGN SCI, V9, P188, DOI 10.1016/j.tics.2005.02.009; Hayhoe MM, 1998, VISION RES, V38, P125, DOI 10.1016/S0042-6989(97)00116-8; Hooge LTC, 1996, PERCEPT PSYCHOPHYS, V58, P969, DOI 10.3758/BF03206825; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; LAND MF, 1998, VISION ACTION, P163; Land MF, 2006, PROG RETIN EYE RES, V25, P296, DOI 10.1016/j.preteyeres.2006.01.002; Lavergne L, 2012, J VISION, V12, DOI [10.1167/12.6.6, 10.1167/12.6/6]; Lavergne L, 2008, BRAIN RES, V1245, P82, DOI 10.1016/j.brainres.2008.09.065; McPeek RM, 2000, VISION RES, V40, P2499, DOI 10.1016/S0042-6989(00)00102-4; McPeek RM, 2001, VISION RES, V41, P785, DOI 10.1016/S0042-6989(00)00287-X; McPeek RM, 2002, J NEUROPHYSIOL, V87, P1805, DOI 10.1152/jn.00501.2001; Mokler A, 1999, EXP BRAIN RES, V125, P511, DOI 10.1007/s002210050709; Mort DJ, 2003, NEUROIMAGE, V18, P231, DOI 10.1016/S1053-8119(02)00028-9; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Reich ED, 2012, PSYCHOL REV, V119, P155, DOI 10.1037/a0026473; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; Theeuwes J, 1998, PSYCHOL SCI, V9, P379, DOI 10.1111/1467-9280.00071; Trappenberg TP, 2001, J COGNITIVE NEUROSCI, V13, P256, DOI 10.1162/089892901564306; Trukenbrod HA, 2012, J VISION, V12, DOI 10.1167/12.1.5; Vergilino D, 2000, VISION RES, V40, P3527, DOI 10.1016/S0042-6989(00)00192-9; Vergilino D, 2001, VISION RES, V41, P3547, DOI 10.1016/S0042-6989(01)00225-5; Vergilino-Perez D, 2004, COGNITIVE BRAIN RES, V20, P525, DOI 10.1016/j.cogbrainres.2004.03.022; Vergilino-Perez D, 2004, PSYCHON B REV, V11, P332, DOI 10.3758/BF03196579; Vergilino-Perez D, 2003, EXP BRAIN RES, V150, P255, DOI 10.1007/s00221-003-1418-4; Vergilino-Perez D, 2006, VISION RES, V46, P2204, DOI 10.1016/j.visres.2005.11.034; VIVIANI P, 1982, J EXP PSYCHOL HUMAN, V8, P113, DOI 10.1037/0096-1523.8.1.113; Walker R, 2000, EXP BRAIN RES, V130, P540, DOI 10.1007/s002219900285; Walker R, 2006, VISION RES, V46, P2082, DOI 10.1016/j.visres.2005.12.009; Weber H, 1998, EXP BRAIN RES, V120, P417, DOI 10.1007/s002210050415; Zimmermann E, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00132; Zimmermann E, 2015, EXP BRAIN RES, V233, P577, DOI 10.1007/s00221-014-4138-z	50	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168724	10.1371/journal.pone.0168724	http://dx.doi.org/10.1371/journal.pone.0168724			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QH	28005964	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000392843200088
J	Zhang, M; Schmitt-Ulms, G; Sato, C; Xi, ZR; Zhang, YL; Zhou, Y; St George-Hyslop, P; Rogaeva, E				Zhang, Ming; Schmitt-Ulms, Gerold; Sato, Christine; Xi, Zhengrui; Zhang, Yalun; Zhou, Ye; St George-Hyslop, Peter; Rogaeva, Ekaterina			Drug Repositioning for Alzheimer's Disease Based on Systematic 'omics' Data Mining	PLOS ONE			English	Article							MIGRATION INHIBITORY FACTOR; EPIGENETIC AGE; GENE-EXPRESSION; MOUSE MODELS; RISK-FACTOR; CD33; INFORMATION; DISCOVERY; VARIANTS; NETWORKS	Traditional drug development for Alzheimer's disease (AD) is costly, time consuming and burdened by a very low success rate. An alternative strategy is drug repositioning, redirecting existing drugs for another disease. The large amount of biological data accumulated to date warrants a comprehensive investigation to better understand AD pathogenesis and facilitate the process of anti-AD drug repositioning. Hence, we generated a list of anti-AD protein targets by analyzing the most recent publically available 'omics' data, including genomics, epigenomics, proteomics and metabolomics data. The information related to AD pathogenesis was obtained from the OMIM and PubMed databases. Drug-target data was extracted from the DrugBank and Therapeutic Target Database. We generated a list of 524 AD-related proteins, 18 of which are targets for 75 existing drugs-novel candidates for repurposing as anti-AD treatments. We developed a ranking algorithm to prioritize the anti-AD targets, which revealed CD33 and MIF as the strongest candidates with seven existing drugs. We also found 7 drugs inhibiting a known anti-AD target (acetylcholinesterase) that may be repurposed for treating the cognitive symptoms of AD. The CAD protein and 8 proteins implicated by two 'omics' approaches (ABCA7, APOE, BIN1, PICALM, CELF1, INPP5D, SPON1, and SOD3) might also be promising targets for anti-AD drug development. Our systematic 'omics' mining suggested drugs with novel anti-AD indications, including drugs modulating the immune system or reducing neuroinflammation that are particularly promising for AD intervention. Furthermore, the list of 524 AD-related proteins could be useful not only as potential anti-AD targets but also considered for AD biomarker development.	[Zhang, Ming; Schmitt-Ulms, Gerold; Sato, Christine; Xi, Zhengrui; Zhang, Yalun; Zhou, Ye; St George-Hyslop, Peter; Rogaeva, Ekaterina] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [St George-Hyslop, Peter; Rogaeva, Ekaterina] Univ Toronto, Div Neurol, Dept Med, Toronto, ON, Canada; [St George-Hyslop, Peter] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [St George-Hyslop, Peter] Univ Cambridge, Dept Clin Neurosci, Cambridge, England	University of Toronto; University of Toronto; University of Cambridge; University of Cambridge	Zhang, M (corresponding author), Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada.	mingr.zhang@utoronto.ca		St George-Hyslop, Peter/0000-0003-0796-7209	Wellcome Trust; Medical Research Council; Ontario Research Fund; Canadian Institute of Health Research; National Institute of Health Research Cambridge Biomedical Research Unit in Dementia; National Institutes of Health; Alzheimer Society of Ontario	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ontario Research Fund; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Institute of Health Research Cambridge Biomedical Research Unit in Dementia; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Society of Ontario	This work was supported by Wellcome Trust, Medical Research Council, Ontario Research Fund, Canadian Institute of Health Research, National Institute of Health Research Cambridge Biomedical Research Unit in Dementia, National Institutes of Health, and Alzheimer Society of Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen N, 1999, ARCH NEUROL-CHICAGO, V56, P673, DOI 10.1001/archneur.56.6.673; Andronis C, 2011, BRIEF BIOINFORM, V12, P357, DOI 10.1093/bib/bbr005; Bacher M, 2010, MOL MED, V16, P116, DOI 10.2119/molmed.2009.00123; Baruch K, 2016, NAT MED, V22, P135, DOI 10.1038/nm.4022; Bradshaw EM, 2013, NAT NEUROSCI, V16, P848, DOI 10.1038/nn.3435; Bryan KJ, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-13; Burns A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b158; Butterfield DA, 2003, CNS DRUGS, V17, P641, DOI 10.2165/00023210-200317090-00004; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chindelevitch L, 2012, BIOINFORMATICS, V28, P1114, DOI 10.1093/bioinformatics/bts090; Corbett Anne, 2015, Front Biosci (Schol Ed), V7, P184; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cowan AJ, 2013, FRONT BIOSCI-LANDMRK, V18, P1312, DOI 10.2741/4181; Cox GM, 2013, J IMMUNOL, V191, P1043, DOI 10.4049/jimmunol.1200485; Craig-Schapiro R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018850; Cummings JL, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt269; Doens D, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-48; Garnache-Ottou F, 2005, BLOOD, V105, P1256, DOI 10.1182/blood-2004-06-2416; Ghani M., 2014, NEURODEGENER DIS, P27; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Holscher C, 2011, BIOCHEM SOC T, V39, P891, DOI 10.1042/BST0390891; Horvath S, 2015, AGING-US, V7, P1130, DOI 10.18632/aging.100859; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Huang H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S6-S17; Jo S, 2014, NAT MED, V20, P886, DOI 10.1038/nm.3639; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kim WS, 2006, NEUROREPORT, V17, P891, DOI 10.1097/01.wnr.0000221833.41340.cd; Lajaunias F, 2005, EUR J IMMUNOL, V35, P243, DOI 10.1002/eji.200425273; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Levine ME, 2015, AGING-US, V7, P1198, DOI 10.18632/aging.100864; Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074; Liu RL, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-286; Lu AT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10561; Luo H, 2011, NUCLEIC ACIDS RES, V39, pW492, DOI 10.1093/nar/gkr299; Malik M, 2015, HUM MOL GENET, V24, P3557, DOI 10.1093/hmg/ddv092; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Sanseau P, 2012, NAT BIOTECHNOL, V30, P317, DOI 10.1038/nbt.2151; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Triantaphyllou E., 2000, MULTICRITERIA DECISI, VVolume 44; Wang WH, 2014, BIOINFORMATICS, V30, P2923, DOI 10.1093/bioinformatics/btu403; Wang ZY, 2013, NAT BIOTECHNOL, V31, P1080, DOI 10.1038/nbt.2758; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Xi ZR, 2014, NEUROLOGY, V83, P1476, DOI 10.1212/WNL.0000000000000886; Yang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028025; Yang L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002016; Zhang M, 2016, J NEUROLOGY NEUROSUR; Zhang M, 2015, BRAIN, V138, DOI 10.1093/brain/awv082; Zhang M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126082; Zhu F, 2012, NUCLEIC ACIDS RES, V40, pD1128, DOI 10.1093/nar/gkr797	52	47	47	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168812	10.1371/journal.pone.0168812	http://dx.doi.org/10.1371/journal.pone.0168812			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005991	Green Submitted, gold, Green Published			2022-12-26	WOS:000392843200098
J	Bent, ZW; Poorey, K; LaBauve, AE; Hamblin, R; Williams, KP; Meagher, RJ				Bent, Zachary W.; Poorey, Kunal; LaBauve, Annette E.; Hamblin, Rachelle; Williams, Kelly P.; Meagher, Robert J.			A Rapid Spin Column-Based Method to Enrich Pathogen Transcripts from Eukaryotic Host Cells Prior to Sequencing	PLOS ONE			English	Article							CARBAPENEM-RESISTANT ENTEROBACTERIACEAE; DUAL RNA-SEQ; KLEBSIELLA-PNEUMONIAE; GENE-EXPRESSION; SELECTIVE CAPTURE; VIRULENCE FACTOR; MACROPHAGES; INFECTION; EPIDEMIOLOGY	When analyzing pathogen transcriptomes during the infection of host cells, the signal-to-background (pathogen-to-host) ratio of nucleic acids (NA) in infected samples is very small. Despite the advancements in next-generation sequencing, the minute amount of pathogen NA makes standard RNA-seq library preps inadequate for effective gene-level analysis of the pathogen in cases with low bacterial loads. In order to provide a more complete picture of the pathogen transcriptome during an infection, we developed a novel pathogen enrichment technique, which can enrich for transcripts from any cultivable bacteria or virus, using common, readily available laboratory equipment and reagents. To evenly enrich for pathogen transcripts, we generate biotinylated pathogen-targeted capture probes in an enzymatic process using the entire genome of the pathogen as a template. The capture probes are hybridized to a strand-specific cDNA library generated from an RNA sample. The biotinylated probes are captured on a monomeric avidin resin in a miniature spin column, and enriched pathogen-specific cDNA is eluted following a series of washes. To test this method, we performed an in vitro time-course infection using Klebsiella pneumoniae to infect murine macrophage cells. K. pneumoniae transcript enrichment efficiency was evaluated using RNA-seq. Bacterial transcripts were enriched up to similar to 400-fold, and allowed the recovery of transcripts from similar to 2000-3600 genes not observed in untreated control samples. These additional transcripts revealed interesting aspects of K. pneumoniae biology including the expression of putative virulence factors and the expression of several genes responsible for antibiotic resistance even in the absence of drugs.	[Bent, Zachary W.; Poorey, Kunal; Hamblin, Rachelle; Williams, Kelly P.] Sandia Natl Labs, Dept Syst Biol, Livermore, CA 94551 USA; [LaBauve, Annette E.; Meagher, Robert J.] Sandia Natl Labs, Biotechnol & Bioengn Dept, Livermore, CA 94551 USA; [Bent, Zachary W.] 10X Genom, Pleasanton, CA 94566 USA	United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Sandia National Laboratories	Bent, ZW (corresponding author), Sandia Natl Labs, Dept Syst Biol, Livermore, CA 94551 USA.; Meagher, RJ (corresponding author), Sandia Natl Labs, Biotechnol & Bioengn Dept, Livermore, CA 94551 USA.; Bent, ZW (corresponding author), 10X Genom, Pleasanton, CA 94566 USA.	zachwbent@gmail.com; rmeaghe@sandia.gov		Meagher, Robert/0000-0002-6262-2126	Sandia National Laboratories Laboratory Directed Research and Development (LDRD) [173021]; U.S. Department of Energy's National Nuclear Security Administration [DE-AC04-94AL85000]	Sandia National Laboratories Laboratory Directed Research and Development (LDRD); U.S. Department of Energy's National Nuclear Security Administration(National Nuclear Security Administration)	This work was funded by Sandia National Laboratories Laboratory Directed Research and Development (LDRD) Project 173021 (RJM). Sandia National Laboratories is a multi-program laboratory managed and operated by Sandia Corporation, a wholly owned subsidiary of Lockheed Martin Corporation, for the U.S. Department of Energy's National Nuclear Security Administration under Contract DE-AC04-94AL85000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P750; Avican K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004600; Baddal B, 2015, MBIO, V6, DOI 10.1128/mBio.01765-15; Bent ZW, 2015, INFECT IMMUN, V83, P2672, DOI 10.1128/IAI.02922-14; Bent ZW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077834; Bent ZW, 2013, ANAL BIOCHEM, V438, P90, DOI 10.1016/j.ab.2013.03.008; Brady RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124877; Cano V, 2015, CELL MICROBIOL, V17, P1537, DOI 10.1111/cmi.12466; Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110; Cortes G, 2002, INFECT IMMUN, V70, P2583, DOI 10.1128/IAI.70.5.2583-2590.2002; Courcelle J, 2001, GENETICS, V158, P41; Date SV, 2014, J INFECT DIS, V209, P1542, DOI 10.1093/infdis/jit668; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Faucher SP, 2006, P NATL ACAD SCI USA, V103, P1906, DOI 10.1073/pnas.0509183103; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Graham JE, 1999, P NATL ACAD SCI USA, V96, P11554, DOI 10.1073/pnas.96.20.11554; Gu W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0904-5; Guh AY, 2014, EXPERT REV ANTI-INFE, V12, P565, DOI 10.1586/14787210.2014.902306; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; GYLES CL, 1977, SCIENCE, V198, P198, DOI 10.1126/science.333581; He SM, 2010, NAT METHODS, V7, P807, DOI [10.1038/nmeth.1507, 10.1038/NMETH.1507]; Hudson CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099209; Istivan TS, 2006, MICROBIOL-SGM, V152, P1263, DOI 10.1099/mic.0.28609-0; Jacob JT, 2013, MMWR-MORBID MORTAL W, V62, P165; Kawahara Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049423; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Langevin SA, 2013, RNA BIOL, V10, P502, DOI 10.4161/rna.24284; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawlor MS, 2007, INFECT IMMUN, V75, P1463, DOI 10.1128/IAI.00372-06; Lery LMS, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-41; Li J, 2014, SCI REP-UK, V4, DOI 10.1038/srep06216; Mandlik A, 2011, CELL HOST MICROBE, V10, P165, DOI 10.1016/j.chom.2011.07.007; Minato Y, 2013, INFECT IMMUN, V81, P3163, DOI 10.1128/IAI.00071-13; NASSIF X, 1989, MOL MICROBIOL, V3, P1349, DOI 10.1111/j.1365-2958.1989.tb00116.x; Ordas A, 2011, FISH SHELLFISH IMMUN, V31, P716, DOI 10.1016/j.fsi.2010.08.022; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Shon AS, 2013, VIRULENCE, V4, P107, DOI 10.4161/viru.22718; Srikumar S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005262; Stahl J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138360; Tangden T, 2015, J INTERN MED, V277, P501, DOI 10.1111/joim.12342; Tiemey L, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00085; Tomas A, 2015, J BIOL CHEM, V290, P16678, DOI 10.1074/jbc.M114.621292; van Dijk EL, 2014, TRENDS GENET, V30, P418, DOI 10.1016/j.tig.2014.07.001; VanderNoot VA, 2012, BIOTECHNIQUES, V53, P373, DOI 10.2144/000113937; Waddell SJ, 2007, CURR OPIN MICROBIOL, V10, P297, DOI 10.1016/j.mib.2007.05.013; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Westermann AJ, 2016, NATURE, V529, P496, DOI 10.1038/nature16547; Westermann AJ, 2012, NAT REV MICROBIOL, V10, P618, DOI 10.1038/nrmicro2852; Wilk E, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1867-8; YANCEY RJ, 1979, INFECT IMMUN, V24, P174, DOI 10.1128/IAI.24.1.174-180.1979	51	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168788	10.1371/journal.pone.0168788	http://dx.doi.org/10.1371/journal.pone.0168788			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002481	Green Published, Green Submitted, gold			2022-12-26	WOS:000392853100069
J	Galgani, JE; Gomez, C; Mizgier, ML; Gutierrez, J; Santos, JL; Olmos, P; Mari, A				Galgani, Jose E.; Gomez, Carmen; Mizgier, Maria L.; Gutierrez, Juan; Santos, Jose L.; Olmos, Pablo; Mari, Andrea			Assessment of the Role of Metabolic Determinants on the Relationship between Insulin Sensitivity and Secretion	PLoS One			English	Article							PANCREATIC BETA-CELLS; SKELETAL-MUSCLE; GLUCOSE-HOMEOSTASIS; DIABETIC-PATIENTS; HEALTHY-SUBJECTS; K+ CHANNELS; HUMANS; INTERLEUKIN-6; RESISTANCE; TOLERANCE	Background Insulin secretion correlates inversely with insulin sensitivity, which may suggest the existence of a crosstalk between peripheral organs and pancreas. Such interaction might be mediated through glucose oxidation that may drive the release of circulating factors with action on insulin secretion. Aim To evaluate the association between whole-body carbohydrate oxidation and circulating factors with insulin secretion to consecutive oral glucose loading in non-diabetic individuals. Methods Carbohydrate oxidation was measured after an overnight fast and for 6 hours after two 3-h apart 75-g oral glucose tolerance tests (OGTT) in 53 participants (24/29 males/females; 34 +/-9 y; 274kg/m(2)). Insulin secretion was estimated by deconvolution of serum C-peptide concentration, beta cell function by mathematical modelling and insulin sensitivity from an OGTT. Circulating lactate, free-fatty acids (FFA) and candidate chemokines were assessed before and after OGTT. The effect of recombinant RANTES (regulated on activation, normal T cell expressed and secreted) and IL8 (interleukin 8) on insulin secretion from isolated mice islets was also measured. Results Carbohydrate oxidation assessed over the 6-h period did not relate with insulin secretion (r = -0.11; p = 0.45) or p cell function indexes. Circulating lactate and FFA showed no association with 6-h insulin secretion. Circulating chemokines concentration increased upon oral glucose stimulation. Insulin secretion associated with plasma IL6 (r = 0.35; p<0.05), RANTES (r = 0.30; p<0.05) and IL8 (r = 0.41; p<0.05) determined at 60 min OGTT. IL8 was independently associated with in vivo insulin secretion; however, it did not affect in vitro insulin secretion. Conclusion Whole-body carbohydrate oxidation appears to have no influence on insulin secretion or putative circulating mediators. IL8 may be a potential factor influencing insulin secretion.	[Galgani, Jose E.; Gomez, Carmen; Mizgier, Maria L.; Gutierrez, Juan; Santos, Jose L.; Olmos, Pablo] Pontificia Univ Catolica Chile, Escuela Med, Dept Nutr Diabet & Metab, Santiago, Chile; [Galgani, Jose E.] Pontificia Univ Catolica Chile, Escuela Med, UDA Ciencias Salud Carrera Nutr & Dietet, Santiago, Chile; [Mari, Andrea] CNR, Ist Neurosci, Padua, Italy	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Consiglio Nazionale delle Ricerche (CNR)	Galgani, JE (corresponding author), Pontificia Univ Catolica Chile, Escuela Med, Dept Nutr Diabet & Metab, Santiago, Chile.; Galgani, JE (corresponding author), Pontificia Univ Catolica Chile, Escuela Med, UDA Ciencias Salud Carrera Nutr & Dietet, Santiago, Chile.	jgalgani@uc.cl	Mizgier, Maria/AAU-7804-2021; Santos, Jose Luis/D-1818-2017	Mizgier, Maria Luisa/0000-0002-6396-8823; Santos, Jose Luis/0000-0003-2895-0369	Fondo Nacional de Desarrollo Cientifico y Tecnologico [1130217]; Vicerrectoria Academica Pontificia Universidad de Chile	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Vicerrectoria Academica Pontificia Universidad de Chile	The work was supported by the following: Fondo Nacional de Desarrollo Cientifico y Tecnologico 1130217, http://www.conicyt.cl/fondecyt/ (JEG); Vicerrectoria Academica Pontificia Universidad de Chile, http://investigacion.uc.cl/ (JEG).	Akiyoshi H, 1999, HORM METAB RES, V31, P257, DOI 10.1055/s-2007-978728; Andreozzi F, 2006, DIABETES, V55, P2021, DOI 10.2337/db06-0063; Araujo EP, 2004, J ENDOCRINOL, V181, P25, DOI 10.1677/joe.0.1810025; Aspinwall CA, 1999, J BIOL CHEM, V274, P6360, DOI 10.1074/jbc.274.10.6360; BARON AD, 1988, AM J PHYSIOL, V255, pE769, DOI 10.1152/ajpendo.1988.255.6.E769; Bonuccelli S, 2009, AM J PHYSIOL-ENDOC M, V297, pE532, DOI 10.1152/ajpendo.00127.2009; Bouche C, 2010, P NATL ACAD SCI USA, V107, P4770, DOI 10.1073/pnas.1000002107; Bouzakri K, 2011, DIABETES, V60, P1111, DOI 10.2337/db10-1178; Choi HJ, 2013, DIABETES RES CLIN PR, V99, pE27, DOI 10.1016/j.diabres.2012.01.005; CONSOLI A, 1992, METABOLISM, V41, P176, DOI 10.1016/0026-0495(92)90148-4; Corpeleijn E, 2005, J CLIN ENDOCR METAB, V90, P5819, DOI 10.1210/jc.2005-0668; Eckardt K, 2014, DIABETOLOGIA, V57, P1087, DOI 10.1007/s00125-014-3224-x; El Ouaamari A, 2013, CELL REP, V3, P401, DOI 10.1016/j.celrep.2013.01.007; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; FERRANNINI E, 1985, DIABETES, V34, P580, DOI 10.2337/diabetes.34.6.580; Franckhauser S, 2008, DIABETOLOGIA, V51, P1306, DOI 10.1007/s00125-008-0998-8; Galgani JE, 2014, METABOLISM, V63, P1426, DOI 10.1016/j.metabol.2014.08.002; Galgani JE, 2013, J CLIN ENDOCR METAB, V98, pE646, DOI 10.1210/jc.2012-3111; Gallucci S, 1998, INT IMMUNOL, V10, P267, DOI 10.1093/intimm/10.3.267; Halperin F, 2012, DIABETES, V61, P301, DOI 10.2337/db11-1067; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Hartwig S, 2014, BBA-PROTEINS PROTEOM, V1844, P1011, DOI 10.1016/j.bbapap.2013.08.004; Hirner S, 2008, J MOL BIOL, V379, P666, DOI 10.1016/j.jmb.2008.03.049; IVERSEN J, 1971, DIABETES, V20, P1; JEQUIER E, 1987, ANNU REV NUTR, V7, P187, DOI 10.1146/annurev.nu.07.070187.001155; Khan FA, 2001, DIABETES, V50, P2192, DOI 10.2337/diabetes.50.10.2192; Kim J, 2002, AM J CLIN NUTR, V76, P378, DOI 10.1093/ajcn/76.2.378; Kutlu B, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-3; Lee YS, 2013, CELL, V153, P413, DOI 10.1016/j.cell.2013.03.001; Liu B, 2013, DIABETOLOGIA, V56, P2467, DOI 10.1007/s00125-013-3022-x; Lopez X, 2011, J CLIN ENDOCR METAB, V96, P3811, DOI 10.1210/jc.2011-0627; LOVEJOY J, 1992, METABOLISM, V41, P22, DOI 10.1016/0026-0495(92)90185-D; Mari A, 2006, HORM METAB RES, V38, P838, DOI 10.1055/s-2006-956505; Mari A, 2002, DIABETES, V51, pS221, DOI 10.2337/diabetes.51.2007.S221; MEATS JE, 1989, J MOL ENDOCRINOL, V3, P121, DOI 10.1677/jme.0.0030121; Mizgier ML, 2014, OBES REV, V15, P587, DOI 10.1111/obr.12166; Modi WS, 1999, MOL BIOL EVOL, V16, P180, DOI 10.1093/oxfordjournals.molbev.a026101; Nappo F, 2002, J AM COLL CARDIOL, V39, P1145, DOI 10.1016/S0735-1097(02)01741-2; Pedersen BK, 2013, COMPR PHYSIOL, V3, P1337, DOI 10.1002/cphy.c120033; Persaud SJ, 2002, FEBS LETT, V510, P225, DOI 10.1016/S0014-5793(01)03268-9; Schadewaldt P, 2013, AM J CLIN NUTR, V97, P763, DOI 10.3945/ajcn.112.035014; Tsigos C, 1997, J CLIN ENDOCR METAB, V82, P4167, DOI 10.1210/jc.82.12.4167; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Yi P, 2013, CELL, V153, P747, DOI 10.1016/j.cell.2013.04.008	44	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168352	10.1371/journal.pone.0168352	http://dx.doi.org/10.1371/journal.pone.0168352			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002466	gold, Green Published, Green Submitted			2022-12-26	WOS:000392853100040
J	Jonsson, KI; Hygum, TL; Andersen, KN; Clausen, LKB; Mobjerg, N				Jonsson, K. Ingemar; Hygum, Thomas L.; Andersen, Kasper N.; Clausen, Lykke K. B.; Mobjerg, Nadja			Tolerance to Gamma Radiation in the Marine Heterotardigrade, Echiniscoides sigismundi	PLOS ONE			English	Article							DESICCATION TOLERANCE; IONIZING-RADIATION; TARDIGRADES; CRYPTOBIOSIS; RESISTANCE	Tardigrades belong to the most radiation tolerant animals on Earth, as documented by a number of studies using both low-LET and high-LET ionizing radiation. Previous studies have focused on semi-terrestrial species, which are also very tolerant to desiccation. The predominant view on the reason for the high radiation tolerance among these semi-terrestrial species is that it relies on molecular mechanisms that evolved as adaptations for surviving dehydration. In this study we report the first study on radiation tolerance in a marine tardigrade, Echiniscoides sigismundi. Adult specimens in the hydrated active state were exposed to doses of gamma radiation from 100 to 5000 Gy. The results showed little effect of radiation at 100 and 500 Gy but a clear decline in activity at 1000 Gy and higher. The highest dose survived was 4000 Gy, at which ca. 8% of the tardigrades were active 7 days after irradiation. LD50 in the first 7 days after irradiation was in the range of 1100-1600 Gy. Compared to previous studies on radiation tolerance in semi-terrestrial and limnic tardigrades, Echiniscoides sigismundiseems to have a lower tolerance. However, the species still fits into the category of tardigrades that have high tolerance to both desiccation and radiation, supporting the hypothesis that radiation tolerance is a by-product of adaptive mechanisms to survive desiccation. More studies on radiation tolerance in tardigrade species adapted to permanently wet conditions, both marine and freshwater, are needed to obtain a more comprehensive picture of the patterns of radiation tolerance.	[Jonsson, K. Ingemar] Kristianstad Univ, Sch Educ & Environm, Kristianstad, Sweden; [Hygum, Thomas L.; Andersen, Kasper N.; Clausen, Lykke K. B.; Mobjerg, Nadja] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Kristianstad University; University of Copenhagen	Jonsson, KI (corresponding author), Kristianstad Univ, Sch Educ & Environm, Kristianstad, Sweden.; Mobjerg, N (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	ingemar.jonsson@hkr.se; nmobjerg@bio.ku.dk	Møbjerg, Nadja/M-2646-2014; Møbjerg, Nadja/AAT-4788-2021; /D-7669-2015	Møbjerg, Nadja/0000-0002-5845-9047; Møbjerg, Nadja/0000-0002-5845-9047; Keldsted Bogsted Hvidepil, Lykke/0000-0002-6954-3914; Jonsson, K. Ingemar/0000-0002-1732-0372; /0000-0002-3393-0621	Danish Council for Independent Research [DFF - 4090-00145]	Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	The current study was supported by The Danish Council for Independent Research (http.//ufm.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-independent-research; grant-ID: DFF - 4090-00145 to NM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altiero T, 2011, J ZOOL SYST EVOL RES, V49, P104, DOI 10.1111/j.1439-0469.2010.00607.x; [Anonymous], 109 NCRP; Baumann H., 1922, Zoologische Jahrbuecher Jena Abteilungen f Systematik, V45, P501; Beltran-Pardo E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133658; Beltran-Pardo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072098; Bolus N E, 2001, J Nucl Med Technol, V29, P67; Clausen LKB, 2014, HELGOLAND MAR RES, V68, P531, DOI 10.1007/s10152-014-0409-0; Clegg JS, 2005, INTEGR COMP BIOL, V45, P715, DOI 10.1093/icb/45.5.715; CROWE JH, 1967, T AM MICROSC SOC, V86, P286, DOI 10.2307/3224595; Dallas LJ, 2012, RADIAT RES, V177, P693, DOI 10.1667/RR2687.1; Gladyshev E, 2008, P NATL ACAD SCI USA, V105, P5139, DOI 10.1073/pnas.0800966105; Hashimoto T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12808; Heidemann NWT, 2016, ZOOL J LINN SOC-LOND, V178, P912, DOI 10.1111/zoj.12502; Horikawa DD, 2006, INT J RADIAT BIOL, V82, P843, DOI 10.1080/09553000600972956; Horikawa DD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064793; Horikawa DD, 2012, ASTROBIOLOGY, V12, P283, DOI 10.1089/ast.2011.0669; Hygum TL, 2016, ZOOL J LINN SOC-LOND, V178, P907, DOI 10.1111/zoj.12444; IWASAKI T, 1964, J Radiat Res, V5, P69, DOI 10.1269/jrr.5.69; Jonsson I, 2013, J LIMNOL, V72, P73, DOI 10.4081/jlimnol.2013.s1.e9; Jonsson KI, 2008, CURR BIOL, V18, pR729, DOI 10.1016/j.cub.2008.06.048; Jonsson KI, 2005, INT J RADIAT BIOL, V81, P649, DOI 10.1080/09553000500368453; Jonsson KI, 2003, PHYSIOL BIOCHEM ZOOL, V76, P429; Mattimore V, 1996, J BACTERIOL, V178, P633, DOI 10.1128/jb.178.3.633-637.1996; May RM, 1964, B BIOL FR BELG, V98, P18; Mobjerg N, 2011, ACTA PHYSIOL, V202, P409, DOI 10.1111/j.1748-1716.2011.02252.x; Nilsson EJC, 2010, INT J RADIAT BIOL, V86, P420, DOI 10.3109/09553000903568001; Watanabe M, 2006, INT J RADIAT BIOL, V82, P835, DOI 10.1080/09553000600979100; Wright JC, 2001, ZOOL ANZ, V240, P563, DOI 10.1078/0044-5231-00068; WRIGHT JC, 1989, J EXP BIOL, V142, P267; WRIGHT JC, 1992, BIOL REV, V67, P1, DOI 10.1111/j.1469-185X.1992.tb01657.x	30	12	12	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168884	10.1371/journal.pone.0168884	http://dx.doi.org/10.1371/journal.pone.0168884			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997621	Green Published, gold, Green Submitted			2022-12-26	WOS:000392842900082
J	Vargas, T; Moreno-Rubio, J; Herranz, J; Cejas, P; Molina, S; Mendiola, M; Burgos, E; Custodio, AB; De Miguel, M; Martin-Hernandez, R; Reglero, G; Feliu, J; de Molina, AR				Vargas, Teodoro; Moreno-Rubio, Juan; Herranz, Jesus; Cejas, Paloma; Molina, Susana; Mendiola, Marta; Burgos, Emilio; Custodio, Ana B.; De Miguel, Maria; Martin-Hernandez, Roberto; Reglero, Guillermo; Feliu, Jaime; Ramirez de Molina, Ana			3 ' UTR Polymorphism in ACSL1 Gene Correlates with Expression Levels and Poor Clinical Outcome in Colon Cancer Patients	PLoS One			English	Article							BODY-MASS INDEX; COLORECTAL-CANCER; ADJUVANT CHEMOTHERAPY; METABOLIC SYNDROME; STAGE-II; LIPID-METABOLISM; RISK; PROGNOSIS; SURVIVAL; CARCINOMA	Strong evidence suggests that lipid metabolism (LM) has an essential role in tumor growth to support special energetic and structural requirements of tumor cells. Recently, overexpression of LM-related genes, apolipoproteins related to metabolic syndrome, and ACSL/SCD network involved in fatty acid activation have been proposed as prognostic markers of colon cancer (CC). Furthermore, activation of this latter lipid network has been recently demonstrated to confer invasive and stem cell properties to tumor cells promoting tumor aggressiveness and patient relapse. With the aim of elucidating whether any genetic variation within these genes could influence basal expression levels and consequent susceptibility to relapse, we genotype, in 284 CC patients, 57 polymorphisms located in the 7 genes of these lipid networks previously associated with worse clinical outcome of CC patients (ABCA1, ACSL1, AGPAT1, APOA2, APOC1, APOC2 and SCD), some of them related to CC aggressiveness. After adjusting with clinical confounding factors and multiple comparisons, an association between genotype and disease-free survival (DFS) was shown for rs8086 in 3'-UTR of ACSL1 gene (HR 3.08; 95% CI 1.69-5.63; adjusted p = 0.046). Furthermore, the risk T/T genotype had significantly higher ACSL1 gene expression levels than patients carrying C/T or C/C genotype (means = 5.34; 3.73; 2.37 respectively; p-value (ANOVA) = 0.019), suggesting a functional role of this variant. Thus, we have identified a "risk genotype" of ACSL1 gene that confers constitutive high levels of the enzyme, which is involved in the activation of fatty acids through conversion to acyl-CoA and has been recently related to increased invasiveness of tumor cells. These results suggest that rs8086 of ACSL1 could be a promising prognostic marker in CC patients, reinforcing the relevance of LM in the progression of CC.	[Vargas, Teodoro; Moreno-Rubio, Juan; Molina, Susana; Reglero, Guillermo; Ramirez de Molina, Ana] CEI UAM CSIC, IMDEA Food Inst, Mol Oncol, Madrid, Spain; [Moreno-Rubio, Juan] Infanta Sofia Univ Hosp, POL, Madrid, Spain; [Moreno-Rubio, Juan; Cejas, Paloma; De Miguel, Maria] La Paz Univ Hosp IdiPAZ, Translat Oncol Lab, Madrid, Spain; [Herranz, Jesus; Martin-Hernandez, Roberto] CEI UAM CSIC, IMDEA Food Inst, Biostat & Bioinformat Unit, Madrid, Spain; [Cejas, Paloma] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Burgos, Emilio] La Paz Univ Hosp IdiPAZ, Dept Pathol, Madrid, Spain; [Custodio, Ana B.; Feliu, Jaime] La Paz Univ Hosp IdiPAZ, Med Oncol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Hospital Universitario Infanta Sofia; Hospital Universitario La Paz; Consejo Superior de Investigaciones Cientificas (CSIC); Harvard University; Dana-Farber Cancer Institute; Hospital Universitario La Paz; Hospital Universitario La Paz	de Molina, AR (corresponding author), CEI UAM CSIC, IMDEA Food Inst, Mol Oncol, Madrid, Spain.	ana.ramirez@imdea.org	MARTIN-HERNANDEZ, ROBERTO/M-8161-2014; de Molina, Ana Ramirez/AAA-3848-2019; Molina, Susana/M-8969-2014; Reglero, Guillermo/K-6658-2014; Moreno-Rubio, Juan/M-4597-2015	MARTIN-HERNANDEZ, ROBERTO/0000-0002-2723-6289; Molina, Susana/0000-0001-7737-5562; Reglero, Guillermo/0000-0002-7730-3486; Moreno-Rubio, Juan/0000-0003-3335-8749	Ministerio de Economia y Competitividad (Plan Nacional I+D+i) [AGL2013-48943-C2]; Comunidad de Madrid (ALIBIRD-CM) [P2013/ABI-2728]; European Union Structural Funds	Ministerio de Economia y Competitividad (Plan Nacional I+D+i); Comunidad de Madrid (ALIBIRD-CM)(Comunidad de Madrid); European Union Structural Funds(European Commission)	This work was funded by the Ministerio de Economia y Competitividad (Plan Nacional I+D+i AGL2013-48943-C2); Comunidad de Madrid (P2013/ABI-2728. ALIBIRD-CM); and European Union Structural Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absenger G, 2014, PHARMACOGENOMICS J, V14, P130, DOI 10.1038/tpj.2013.15; Bardou M, 2013, GUT, V62, P933, DOI 10.1136/gutjnl-2013-304701; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; GLOBOCAN_Project, GLOBOCAN 2012 EST CA; Gong ZH, 2009, INT J COLORECTAL DIS, V24, P647, DOI 10.1007/s00384-009-0656-8; Hahn-Stromberg V, 2014, APMIS, V122, P636, DOI 10.1111/apm.12211; Hull M, 2013, GUT; Igal RA, 2010, CARCINOGENESIS, V31, P1509, DOI 10.1093/carcin/bgq131; Kazama S, 2015, ANTICANCER RES, V35, P2983; Kim JH, 2007, CANCER EPIDEM BIOMAR, V16, P1543, DOI 10.1158/1055-9965.EPI-07-0199; Liesenfeld DB, 2015, AM J CLIN NUTR; Lu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111061; Mashima T, 2009, CANCER SCI, V100, P1556, DOI 10.1111/j.1349-7006.2009.01203.x; Ning Y, 2014, MOL CANCER THER, V13, P528, DOI 10.1158/1535-7163.MCT-13-0646; Pais R, 2009, WORLD J GASTROENTERO, V15, P5141, DOI 10.3748/wjg.15.5141; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Sanchez-Martinez R, 2015, ONCOTARGET, V6, P38719, DOI 10.18632/oncotarget.5340; Sinicrope FA, 2013, CANCER-AM CANCER SOC, V119, P1528, DOI 10.1002/cncr.27938; Sinicrope FA, 2010, CLIN CANCER RES, V16, P1884, DOI 10.1158/1078-0432.CCR-09-2636; Suh KW, 2005, J GASTROINTEST SURG, V9, P336, DOI 10.1016/j.gassur.2004.09.030; Szkandera J, 2014, CLIN CANCER RES, V20, P1687, DOI 10.1158/1078-0432.CCR-13-1517; Vargas T, 2015, ONCOTARGET, V6, P7348, DOI 10.18632/oncotarget.3130; Vargas T, 2014, MOL ONCOL, V8, P1469, DOI 10.1016/j.molonc.2014.05.015; Vymetalkova V, 2014, MUTAGENESIS, V29, P259, DOI 10.1093/mutage/geu014; Wang YBN, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0975-7; Watson MA, 2003, CLIN SCI, V104, P537, DOI 10.1042/CS20020329; Wilkening S, 2008, CARCINOGENESIS, V29, P1202, DOI 10.1093/carcin/bgn101; Zaanan A, 2014, J CANCER, V5, P425, DOI 10.7150/jca.8594	28	19	20	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168423	10.1371/journal.pone.0168423	http://dx.doi.org/10.1371/journal.pone.0168423			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992526	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842600057
J	Chevaleyre, C; Riou, M; Brea, D; Vandebrouck, C; Barc, C; Pezant, J; Melo, S; Olivier, M; Delaunay, R; Boulesteix, O; Berthon, P; Rossignol, C; Gaillard, JB; Becq, F; Gauthier, F; Si-Tahar, M; Meurens, F; Berri, M; Caballero-Posadas, I; Attucci, S				Chevaleyre, Claire; Riou, Mickael; Brea, Deborah; Vandebrouck, Clarisse; Barc, Celine; Pezant, Jeremy; Melo, Sandrine; Olivier, Michel; Delaunay, Remy; Boulesteix, Olivier; Berthon, Patricia; Rossignol, Christelle; Gaillard, Julien Burlaud; Becq, Frederic; Gauthier, Francis; Si-Tahar, Mustapha; Meurens, Francois; Berri, Mustapha; Caballero-Posadas, Ignacio; Attucci, Sylvie			The Pig: A Relevant Model for Evaluating the Neutrophil Serine Protease Activities during Acute Pseudomonas aeruginosa Lung Infection	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CYSTIC-FIBROSIS; MOUSE MODELS; IN-VIVO; MECHANICAL VENTILATION; INFLAMMATORY RESPONSE; PNEUMONIA; ELASTASE; LIPOPOLYSACCHARIDE; PROTEINASE-3	The main features of lung infection and inflammation are a massive recruitment of neutrophils and the subsequent release of neutrophil serine proteases (NSPs). Anti-infectious and/or anti-inflammatory treatments must be tested on a suitable animal model. Mice models do not replicate several aspects of human lung disease. This is particularly true for cystic fibrosis (CF), which has led the scientific community to a search for new animal models. We have shown that mice are not appropriate for characterizing drugs targeting neutrophil-dependent inflammation and that pig neutrophils and their NSPs are similar to their human homologues. We induced acute neutrophilic inflammatory responses in pig lungs using Pseudomonas aeruginosa, an opportunistic respiratory pathogen. Blood samples, nasal swabs and bronchoalveolar lavage fluids (BALFs) were collected at 0, 3, 6 and 24 h post-insfection (p.i.) and biochemical parameters, serum and BAL cytokines, bacterial cultures and neutrophil activity were evaluated. The release of proinflammatory mediators, biochemical and hematological blood parameters, cell recruitment and bronchial reactivity, peaked at 6h p.i.. We also used synthetic substrates specific for human neutrophil proteases to show that the activity of pig NSPs in BALFs increased. These proteases were also detected at the surface of lung neutrophils using anti-human NSP antibodies. Pseudomonas aeruginosa-induced lung infection in pigs results in a neutrophilic response similar to that described for cystic fibrosis and ventilator-associated pneumonia in humans. Altogether, this indicates that the pig is an appropriate model for testing anti-infectious and/or anti-inflammatory drugs to combat adverse proteolytic effects of neutrophil in human lung diseases.	[Chevaleyre, Claire; Melo, Sandrine; Olivier, Michel; Berthon, Patricia; Rossignol, Christelle; Berri, Mustapha; Caballero-Posadas, Ignacio] Univ Tours, ISP, INRA, UMR 1282, Nouzilly, France; [Riou, Mickael; Barc, Celine; Pezant, Jeremy; Delaunay, Remy; Boulesteix, Olivier] INRA, Plateforme Infectiol Expt UE PFIE 1277, Nouzilly, France; [Brea, Deborah; Gauthier, Francis; Si-Tahar, Mustapha; Attucci, Sylvie] Ctr Etud Pathol Resp, INSERM, UMR 1100, Tours, France; [Vandebrouck, Clarisse; Becq, Frederic] Univ Poitiers, CNRS, Lab Signalisat & Transports Ion Membranaires, Poitiers, France; [Gaillard, Julien Burlaud] Univ Tours, Dept Microscopies Plateau Technol Anal Syst Biol, Tours, France; [Meurens, Francois] Nantes Atlantic Natl Coll Vet Med Food Sci & Engn, Oniris, BioEpAR, Nantes 3, France	INRAE; Universite de Tours; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; Universite de Tours; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique	Attucci, S (corresponding author), Ctr Etud Pathol Resp, INSERM, UMR 1100, Tours, France.	attucci@univ-tours.fr	Becq, Frederic/P-9233-2016; Meurens, Francois JMA/J-3829-2019; SI-TAHAR, Mustapha/L-4149-2014; Si-Tahar, Mustapha/W-8034-2019; vandebrouck, clarisse/P-9463-2016	Becq, Frederic/0000-0003-3915-0973; Meurens, Francois JMA/0000-0002-0353-4871; SI-TAHAR, Mustapha/0000-0002-5792-7742; Si-Tahar, Mustapha/0000-0002-5792-7742; Barc, Celine/0000-0002-5912-4652; Vandebrouck, clarisse/0000-0002-9401-0546; Caballero, Ignacio/0000-0002-0628-4134	Region Centre Val de Loire [201100067854]; Vaincre la Mucoviscidose [RF20110600573]	Region Centre Val de Loire(Region Centre-Val de Loire); Vaincre la Mucoviscidose	Region Centre Val de Loire (Grant no 201100067854) MR. Vaincre la Mucoviscidose (Grant noRF20110600573) SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner B, 2010, J MOL MED, V88, P653, DOI 10.1007/s00109-010-0610-9; Attucci S, 2002, BIOCHEM J, V366, P965, DOI 10.1042/BJ20020321; Balloy V, 2007, J INFECT DIS, V196, P289, DOI 10.1086/518610; Balows A, 1991, MANUAL CLIN MICROBIO; Brea D, 2012, BIOCHEM J, V447, P363, DOI 10.1042/BJ20120818; Cole N, 2001, INFECT IMMUN, V69, P4116, DOI 10.1128/IAI.69.6.4116-4119.2001; Collie D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067677; Conese Massimo, 2003, J Cyst Fibros, V2, P129, DOI 10.1016/S1569-1993(03)00063-8; Cook DP, 2016, AM J RESP CRIT CARE, V193, P417, DOI 10.1164/rccm.201508-1562OC; Corvol H, 2003, AM J PHYSIOL-LUNG C, V284, pL997, DOI 10.1152/ajplung.00156.2002; Craig A, 2009, INFECT IMMUN, V77, P568, DOI 10.1128/IAI.00832-08; Downey DG, 2009, THORAX, V64, P81, DOI 10.1136/thx.2007.082388; Drescher B, 2013, VIRUS RES, V171, P1, DOI 10.1016/j.virusres.2012.11.002; Elferink Ronald Oude, 2009, J Hepatol, V50, P838, DOI 10.1016/j.jhep.2008.12.014; Fielding CA, 2008, J IMMUNOL, V181, P2189, DOI 10.4049/jimmunol.181.3.2189; Greene CM, 2009, BRIT J PHARMACOL, V158, P1048, DOI 10.1111/j.1476-5381.2009.00448.x; Griese M, 2008, EUR RESPIR J, V32, P783, DOI 10.1183/09031936.00146807; Guilbault C, 2007, AM J RESP CELL MOL, V36, P1, DOI 10.1165/rcmb.2006-0184TR; Hajjar E, 2007, FEBS LETT, V581, P5685, DOI 10.1016/j.febslet.2007.11.029; Hansen MS, 2010, J COMP PATHOL, V143, P120, DOI 10.1016/j.jcpa.2010.01.012; Kalupov T, 2009, J BIOL CHEM, V284, P34084, DOI 10.1074/jbc.M109.042903; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Korkmaz B, 2005, AM J RESP CELL MOL, V32, P553, DOI 10.1165/rcmb.2004-0374OC; Korkmaz B, 2004, AM J RESP CELL MOL, V30, P801, DOI 10.1165/rcmb.2003-0139OC; Korkmaz B, 2013, INT IMMUNOPHARMACOL, V17, P1198, DOI 10.1016/j.intimp.2013.07.003; Lavoie EG, 2011, MICROBES INFECT, V13, P1133, DOI 10.1016/j.micinf.2011.07.011; Bassi GL, 2014, ANESTHESIOLOGY, V120, P1205, DOI 10.1097/ALN.0000000000000222; Luna CM, 2007, CHEST, V132, P523, DOI 10.1378/chest.07-0185; Natarajan S, 2008, J IMMUNOL, V181, P8402, DOI 10.4049/jimmunol.181.12.8402; Ng HP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106813; Norez C, 2014, PULM PHARMACOL THER, V27, P38, DOI 10.1016/j.pupt.2013.06.008; Parameswaran GI, 2012, FUTURE MICROBIOL, V7, P1129, DOI [10.2217/fmb.12.88, 10.2217/FMB.12.88]; PAVAUX C, 1987, RECL MED VET, V163, P341; Petit-Bertron AF, 2008, CYTOKINE, V41, P54, DOI 10.1016/j.cyto.2007.10.012; Pham CTN, 2008, INT J BIOCHEM CELL B, V40, P1317, DOI 10.1016/j.biocel.2007.11.008; Piriou-Guzylack L, 2008, VET RES, V39, DOI 10.1051/vetres:2008030; Quint JK, 2007, J ALLERGY CLIN IMMUN, V119, P1065, DOI 10.1016/j.jaci.2006.12.640; Ramphal R, 2008, J IMMUNOL, V181, P586, DOI 10.4049/jimmunol.181.1.586; Riou M, 2010, INT J ANTIMICROB AG, V36, P513, DOI 10.1016/j.ijantimicag.2010.08.005; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Sibila O, 2008, EUR RESPIR J, V32, P1037, DOI 10.1183/09031936.00009208; Sibila O, 2007, EUR RESPIR J, V30, P1167, DOI 10.1183/09031936.00053607; Sousa AM, 2014, PATHOGENS, V3, P680, DOI 10.3390/pathogens3030680; Stockley RA, 1999, AM J RESP CRIT CARE, V160, pS49, DOI 10.1164/ajrccm.160.supplement_1.13; Stoltz DA, 2015, NEW ENGL J MED, V372, P351, DOI 10.1056/NEJMra1300109; Stoltz DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000928; Takao K, 2015, P NATL ACAD SCI USA, V112, P1167, DOI 10.1073/pnas.1401965111; Vandebrouck C, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-113; Vaneker M, 2007, ANESTHESIOLOGY, V107, P419, DOI 10.1097/01.anes.0000278908.22686.01; Wilke M, 2011, J CYST FIBROS, V10, pS152, DOI 10.1016/S1569-1993(11)60020-9; Wilkinson TS, 2012, CHEST, V142, P1425, DOI 10.1378/chest.11-3273; Williams BJ, 2010, RESPIROLOGY, V15, P1037, DOI 10.1111/j.1440-1843.2010.01819.x; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847	54	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168577	10.1371/journal.pone.0168577	http://dx.doi.org/10.1371/journal.pone.0168577			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992534	Green Published, Green Submitted, gold			2022-12-26	WOS:000392758000060
J	Lemaitre, G; Houix, O; Voisin, F; Misdariis, N; Susini, P				Lemaitre, Guillaume; Houix, Olivier; Voisin, Frederic; Misdariis, Nicolas; Susini, Patrick			Vocal Imitations of Non-Vocal Sounds	PLOS ONE			English	Article							QUALITY; SPEECH; NOISE; IDENTIFICATION; CONSEQUENCES; DESCRIPTORS; DIMENSIONS; PERCEPTION; MECHANISMS; BEHAVIOR	Imitative behaviors are widespread in humans, in particular whenever two persons communicate and interact. Several tokens of spoken languages (onomatopoeias, ideophones, and phonesthemes) also display different degrees of iconicity between the sound of a word and what it refers to. Thus, it probably comes at no surprise that human speakers use a lot of imitative vocalizations and gestures when they communicate about sounds, as sounds are notably difficult to describe. What is more surprising is that vocal imitations of non-vocal everyday sounds (e.g. the sound of a car passing by) are in practice very effective: listeners identify sounds better with vocal imitations than with verbal descriptions, despite the fact that vocal imitations are inaccurate reproductions of a sound created by a particular mechanical system (e.g. a car driving by) through a different system (the voice apparatus). The present study investigated the semantic representations evoked by vocal imitations of sounds by experimentally quantifying how well listeners could match sounds to category labels. The experiment used three different types of sounds: recordings of easily identifiable sounds (sounds of human actions and manufactured products), human vocal imitations, and computational "auditory sketches" (created by algorithmic computations). The results show that performance with the best vocal imitations was similar to the best auditory sketches for most categories of sounds, and even to the referent sounds themselves in some cases. More detailed analyses showed that the acoustic distance between a vocal imitation and a referent sound is not sufficient to account for such performance. Analyses suggested that instead of trying to reproduce the referent sound as accurately as vocally possible, vocal imitations focus on a few important features, which depend on each particular sound category. These results offer perspectives for understanding how human listeners store and access long-term sound representations, and sets the stage for the development of human-computer interfaces based on vocalizations.	[Lemaitre, Guillaume; Houix, Olivier; Voisin, Frederic; Misdariis, Nicolas; Susini, Patrick] STMS IRCAM CNRS UPMC, Equipe Percept & Design Sonores, Inst Rech & Coordinat Acoust Mus, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Lemaitre, G (corresponding author), STMS IRCAM CNRS UPMC, Equipe Percept & Design Sonores, Inst Rech & Coordinat Acoust Mus, Paris, France.	GuillaumeJLemaitre@gmail.com	Voisin, Frédéric/AAS-6265-2020; Voisin, Frédéric/Q-7318-2017	Voisin, Frédéric/0000-0002-7879-5304; Voisin, Frédéric/0000-0002-7879-5304; Lemaitre, Guillaume/0000-0001-5442-6857	Future and Emerging Technologies (FET) programme within European Commission [618067]	Future and Emerging Technologies (FET) programme within European Commission	This work was financed by the Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission (grant number: 618067, SkAT-VG).	Agus TR, 2012, J ACOUST SOC AM, V131, P4124, DOI 10.1121/1.3701865; Agus TR, 2010, NEURON, V66, P610, DOI 10.1016/j.neuron.2010.04.014; Aucouturier J.-J., 2012, 13 INT SOC MUSIC INF, P397; Augoyard JF, 2001, ESPACE URBAIN METHOD, P127; Bernardini N, 2000, P COST G 6 C DIG AUD; Brass M, 2005, TRENDS COGN SCI, V9, P489, DOI 10.1016/j.tics.2005.08.007; Caclin A, 2006, J COGNITIVE NEUROSCI, V18, P1959, DOI 10.1162/jocn.2006.18.12.1959; Camacho A, 2008, J ACOUST SOC AM, V124, P1638, DOI 10.1121/1.2951592; Cartwright M, 2015, CHI 2015: PROCEEDINGS OF THE 33RD ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P43, DOI 10.1145/2702123.2702387; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Chi T, 2005, J ACOUST SOC AM, V118, P887, DOI 10.1121/1.1945807; Corballis MC, 2002, HAND MOUTH ORIGINS L; de Saussure F., 1916, COURS LINGUISTIQUE G; De Torcy T, 2014, LOGOP PHONIATR VOCO, V39, P38, DOI 10.3109/14015439.2013.784801; Del Piccolo A, 2016, J MULTIMODAL USER IN, P1; Delle Monache S., 2015, P 21 INT C AUD DISPL, P58; Esling P, 2013, IEEE T AUDIO SPEECH, V21, P2057, DOI 10.1109/TASL.2013.2265086; Eysenck M. W., 2000, COGNITIVE PSYCHOL ST, V4; Assaneo MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028317; Gentilucci M, 2007, NEUROPSYCHOLOGIA, V45, P608, DOI 10.1016/j.neuropsychologia.2006.04.004; Gillet O, 2005, J INTELL INF SYST, V24, P159, DOI 10.1007/s10844-005-0321-9; Helgason P., 2014, P FONETIK, P83; Heyes C, 2001, TRENDS COGN SCI, V5, P253, DOI 10.1016/S1364-6613(00)01661-2; Houix O, 2016, P AUD MOSTL; Houix O, 2012, J EXP PSYCHOL-APPL, V18, P52, DOI 10.1037/a0026240; Hutchins S, 2012, MUSIC PERCEPT, V30, P147, DOI 10.1525/MP.2012.30.2.147; Ih JG, 2003, NOISE CONTROL ENG J, V51, P244, DOI 10.3397/1.2839720; Isnard V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150313; Iwasaki N, 2007, SEKAI NO NIHONGO KYO, V17, P53; Jeon JY, 2007, APPL ACOUST, V68, P1118, DOI 10.1016/j.apacoust.2006.06.005; KLINGHOLZ F, 1993, J VOICE, V7, P118, DOI 10.1016/S0892-1997(05)80340-6; Kuhl PK, 1996, J ACOUST SOC AM, V100, P2425, DOI 10.1121/1.417951; Ku┬hler W., 1947, GESTALT PSYCHOL; Larsson M, 2015, ANIM COGN, V18, P993, DOI 10.1007/s10071-015-0885-x; Leite RP, 2009, APPL ACOUST, V70, P636, DOI 10.1016/j.apacoust.2008.06.010; Lemaitre G, 2016, J ACOUST SOC AM, V139, P290, DOI 10.1121/1.4939738; Lemaitre G, 2015, APPL ACOUST, V95, P1, DOI 10.1016/j.apacoust.2015.02.011; Lemaitre G, 2014, LECT NOTES COMPUT SC, V8905, P558, DOI 10.1007/978-3-319-12976-1_34; Lemaitre G, 2014, J ACOUST SOC AM, V135, P862, DOI 10.1121/1.4861245; Lemaitre G, 2013, EXP BRAIN RES, V226, P253, DOI 10.1007/s00221-013-3430-7; Lemaitre G, 2012, J ACOUST SOC AM, V131, P1337, DOI 10.1121/1.3675946; Lemaitre G, 2011, ECOL PSYCHOL, V23, P267, DOI 10.1080/10407413.2011.617225; Lemaitre G, 2010, J EXP PSYCHOL-APPL, V16, P16, DOI 10.1037/a0018762; Lemaitre G, 2009, ACTA ACUST UNITED AC, V95, P356, DOI 10.3813/AAA.918158; Lesaffre M, 2004, COMPUTING MUSICOLOGY, V13, P129; Ma WY, 2015, P NATL ACAD SCI USA, V112, P14563, DOI 10.1073/pnas.1515087112; Macmillan NA, 2005, DETECTION THEORY USE; Mantell JT, 2013, COGNITION, V127, P177, DOI 10.1016/j.cognition.2012.12.008; Marchetto E, 2015, INT CONF DIGIT AUDIO, P207; MCADAMS S, 1995, PSYCHOL RES-PSYCH FO, V58, P177, DOI 10.1007/BF00419633; McAdams S., 1993, THINKING SOUND COGNI, P146, DOI DOI 10.1093/ACPROF:OSO/9780198522577.003.0006; Meltzoff A. N, 2002, THE IMITATIVE MIND D, V6; Mercado E, 2014, COMP COGN BEHAV REV, V9, DOI 10.3819/ccbr.2014.90002; Miller RM, 2010, ATTEN PERCEPT PSYCHO, V72, P1614, DOI 10.3758/APP.72.6.1614; Misdariis N., 2012, P ACOUSTICS 2012 NAN, P1045; Misdariis N, 2010, EURASIP J AUDIO SPEE, DOI 10.1155/2010/362013; Moore BCJ, 2003, J PHONETICS, V31, P563, DOI 10.1016/S0095-4470(03)00011-1; Nielsen A, 2011, CAN J EXP PSYCHOL, V65, P115, DOI 10.1037/a0022268; Ohno M, 2004, P 18 INT C AC ICA 20, P3295; Pachet F, 2009, EURASIP J AUDIO SPEE, DOI 10.1155/2009/153017; Pardo JS, 2006, J ACOUST SOC AM, V119, P2382, DOI 10.1121/1.2178720; Parizet E, 2004, ACTA ACUST UNITED AC, V90, P987; Parizet E, 2008, APPL ACOUST, V69, P12, DOI 10.1016/j.apacoust.2006.09.004; Patel Aniruddh D, 2003, P 15 INT C PHON SCI, P925; Patil K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002759; Peeters G, 2011, J ACOUST SOC AM, V130, P2902, DOI 10.1121/1.3642604; Peeters G, 2010, IEEE T AUDIO SPEECH, V18, P675, DOI 10.1109/TASL.2009.2038809; Perlman M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150152; Pfordresher PQ, 2007, MUSIC PERCEPT, V25, P95, DOI 10.1525/MP.2007.25.2.95; Pfordresher PQ, 2014, COGNITIVE PSYCHOL, V70, P31, DOI 10.1016/j.cogpsych.2013.12.005; Pfordresher PQ, 2010, J ACOUST SOC AM, V128, P2182, DOI 10.1121/1.3478782; Porcello T, 2004, SOC STUD SCI, V34, P733, DOI 10.1177/0306312704047328; Pressnitzer D, 2015, ENCY COMPUTATIONAL N, P128; Revis J, 2013, J VOICE, V27, DOI 10.1016/j.jvoice.2013.01.008; Rhodes Richard, 1994, SOUND SYMBOLISM, P276, DOI [10.1017/CBO9780511751806.019, DOI 10.1017/CB09780511751806.019]; Rocchesso Davide, 2015, ACM Interactions, V22, P32, DOI 10.1145/2685501; Roebel A., 2008, J ACOUST SOC AM, V123, P3803, DOI [10.1121/1.2935499, DOI 10.1121/1.2935499]; Sapthavee A, 2014, J VOICE, V28, DOI 10.1016/j.jvoice.2013.11.007; Sato T, 2005, P FOR AC BUD HUNG, P1763; Schmidtke DS, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00080; Schwarz D, 1999, P ICMC, P351; Siedenburg K, 2016, J NEW MUSIC RES, V45, P27, DOI 10.1080/09298215.2015.1132737; Sobkowiak W., 1990, STUDIA ANGLICA POSNA, V23, P15; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Stanton N., 1999, HUMAN FACTORS AUDITO; Subiaul F, 2012, DEV PSYCHOL, V48, P1165, DOI 10.1037/a0026646; Suied C, 2008, J EXP PSYCHOL-APPL, V14, P201, DOI 10.1037/1076-898X.14.3.201; Suied C, 2013, LECT NOTES COMPUT SC, V7900, P154, DOI 10.1007/978-3-642-41248-6_9; Sundaram S, 2008, 2008 IEEE INTERNATIONAL CONFERENCE ON MULTIMEDIA AND EXPO, VOLS 1-4, P1341, DOI 10.1109/ICME.2008.4607691; Takada M, 2001, P INT C AC ICA 2001; Takada M, 2010, EURASIP J AUDIO SPEE, DOI 10.1155/2010/674248; Takada M, 2006, ACOUST SCI TECHNOL, V27, P67, DOI 10.1250/ast.27.67; WARD PH, 1969, ANN OTO RHINOL LARYN, V78, P771, DOI 10.1177/000348946907800409; Wilson M, 2001, PSYCHOL BULL, V127, P543, DOI 10.1037/0033-2909.127.4.543; WRIGHT P, 1971, J APPL PSYCHOL, V55, P244, DOI 10.1037/h0031025; YANG XW, 1992, IEEE T INFORM THEORY, V38, P824, DOI 10.1109/18.119739; Yoshida H, 2012, J COGN DEV, V13, P232, DOI 10.1080/15248372.2011.573515; Zentall TR, 2003, CURR DIR PSYCHOL SCI, V12, P91, DOI 10.1111/1467-8721.01237; Zuchowski R., 1998, STUD ANGLICA POSNANI, V33, P475	99	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168167	10.1371/journal.pone.0168167	http://dx.doi.org/10.1371/journal.pone.0168167			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EI8LN	27992480	Green Published, gold, Green Submitted			2022-12-26	WOS:000392758000029
J	Myburgh, E; Ritchie, R; Goundry, A; O'Neill, K; Marchesi, F; Devaney, E				Myburgh, Elmarie; Ritchie, Ryan; Goundry, Amy; O'Neill, Kerry; Marchesi, Francesco; Devaney, Eileen			Attempts to Image the Early Inflammatory Response during Infection with the Lymphatic Filarial Nematode Brugia pahangi in a Mouse Model	PLOS ONE			English	Article							IN-VIVO; 3RD-STAGE LARVA; RESISTANCE; MALAYI; L3; EOSINOPHILS; MODULATION; MECHANISMS; PARASITES; PROTEINS	Helminth parasites remain a major constraint upon human health and well-being in many parts of the world. Treatment of these infections relies upon a very small number of therapeutics, most of which were originally developed for use in animal health. A lack of high throughput screening systems, together with limitations of available animal models, has restricted the development of novel chemotherapeutics. This is particularly so for filarial nematodes, which are long-lived parasites with a complex cycle of development. In this paper, we describe attempts to visualise the immune response elicited by filarial parasites in infected mice using a non-invasive bioluminescence imaging reagent, luminol, our aim being to determine whether such a model could be developed to discriminate between live and dead worms for in vivo compound screening. We show that while imaging can detect the immune response elicited by early stages of infection with L3, it was unable to detect the presence of adult worms or, indeed, later stages of infection with L3, despite the presence of worms within the lymphatic system of infected animals. In the future, more specific reagents that detect secreted products of adult worms may be required for developing screens based upon live imaging of infected animals.	[Myburgh, Elmarie; Ritchie, Ryan; Goundry, Amy] Univ Glasgow, Coll Med Vet & Life Sci, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [O'Neill, Kerry; Devaney, Eileen] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Garscube Estate, Glasgow, Lanark, Scotland; [Marchesi, Francesco] Univ Glasgow, Sch Vet Med, Garscube Estate, Glasgow, Lanark, Scotland; [Myburgh, Elmarie; Goundry, Amy] Univ York, Ctr Immunol & Infect, Dept Biol, Heslington, Yorks, England	University of Glasgow; University of Glasgow; University of Glasgow; University of York - UK	Myburgh, E (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.; Devaney, E (corresponding author), Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Garscube Estate, Glasgow, Lanark, Scotland.; Marchesi, F (corresponding author), Univ Glasgow, Sch Vet Med, Garscube Estate, Glasgow, Lanark, Scotland.	Elmarie.myburgh@york.ac.uk; Francesco.marchesi@glasgow.ac.uk; eileen.devaney@glasgow.ac.uk	Marchesi, Francesco/ABF-9255-2021	Marchesi, Francesco/0000-0003-1179-5788; Myburgh, Elmarie/0000-0002-2007-5902; Goundry, Amy/0000-0003-3406-4689	Bill and Melinda Gates Foundation [OPP1098441]; MRC [MW K019384]; Wellcome Trust [104111]; MRC [MR/K019384/2, MR/K019384/1] Funding Source: UKRI; Medical Research Council [MR/K019384/1, MR/K019384/2] Funding Source: researchfish; Bill & Melinda Gates Foundation � Grand Challenges Explorations Initiative [OPP1098441] Funding Source: researchfish	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Bill & Melinda Gates Foundation � Grand Challenges Explorations Initiative	This study was supported by a grant to EM and ED from the Bill and Melinda Gates Foundation (ref: OPP1098441). EM and AG were supported by a grant from the MRC (ref: MW K019384) and core funding from the Wellcome Trust (104111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennuru S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000410; Blum G, 2007, NAT CHEM BIOL, V3, P668, DOI 10.1038/nchembio.2007.26; Boyd A, 2013, INFECT IMMUN, V81, P1420, DOI 10.1128/IAI.01301-12; Chirgwin SR, 2006, J PARASITOL, V92, P46, DOI 10.1645/GE-599R.1; Davies SJ, 2005, INT J PARASITOL, V35, P851, DOI 10.1016/j.ijpara.2005.02.017; Devaney E, 2000, MICROBES INFECT, V2, P1363, DOI 10.1016/S1286-4579(00)01290-9; Devaney E, 2002, PARASITE IMMUNOL, V24, P29, DOI 10.1046/j.0141-9838.2001.00433.x; Geary TG, 2010, INT J PARASITOL, V40, P1, DOI 10.1016/j.ijpara.2009.11.001; Gillan V, 2004, PARASITE IMMUNOL, V26, P359, DOI 10.1111/j.0141-9838.2004.00714.x; Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886; Haller J, 2008, J APPL PHYSIOL, V104, P795, DOI 10.1152/japplphysiol.00959.2007; Hansen RDE, 2011, P ROY SOC B-BIOL SCI, V278, P2293, DOI 10.1098/rspb.2010.2367; Hewitson JR, 2008, MOL BIOCHEM PARASIT, V160, P8, DOI 10.1016/j.molbiopara.2008.02.007; Higazi Tarig B, 2013, Methods Mol Biol, V940, P103, DOI 10.1007/978-1-62703-110-3_9; Horn D, 2014, PARASITOLOGY, V141, P77, DOI 10.1017/S0031182013000243; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; HOWELLS RE, 1983, ACTA TROP, V40, P341; JECOCK RM, 1992, MOL BIOCHEM PARASIT, V56, P219, DOI 10.1016/0166-6851(92)90171-F; Lewis MD, 2015, J BIOMOL SCREEN, V20, P36, DOI 10.1177/1087057114552623; Linares M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0962-2; MacDonald AS, 1998, J IMMUNOL, V160, P4124; Mann VH, 2014, TRANSGENIC RES, V23, P539, DOI 10.1007/s11248-013-9779-3; Mann VH, 2010, PARASITOLOGY, V137, P451, DOI 10.1017/S0031182009991211; Marcellino C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001494; Martin C, 2000, INFECT IMMUN, V68, P3651, DOI 10.1128/IAI.68.6.3651-3656.2000; McSorley HJ, 2013, INT J PARASITOL, V43, P301, DOI 10.1016/j.ijpara.2012.11.011; Meyerholz DK, 2009, TOXICOL PATHOL, V37, P249, DOI 10.1177/0192623308329342; Myburgh E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002384; Oliveira SHP, 2002, J LEUKOCYTE BIOL, V71, P1019; Osborne J, 1998, INT IMMUNOL, V10, P1583, DOI 10.1093/intimm/10.10.1583; Osborne J, 1996, INFECT IMMUN, V64, P3461, DOI 10.1128/IAI.64.9.3461-3466.1996; Porthouse KH, 2006, INFECT IMMUN, V74, P2366, DOI 10.1128/IAI.74.4.2366-2372.2006; Prichard RK, 2007, PARASITOLOGY, V134, P1123, DOI 10.1017/S0031182007000091; Prichard RK, 2007, PARASITOLOGY, V134, P1073, DOI 10.1017/S0031182007000078; Scales HE, 2016, RHEUMATOLOGY, V55, P564, DOI 10.1093/rheumatology/kev361; Shao HG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002871; Simons JE, 2005, EUR J IMMUNOL, V35, P189, DOI 10.1002/eji.200425541; Specht S, 2011, J IMMUNOL, V186, P4845, DOI 10.4049/jimmunol.1000612; Storey B, 2014, INT J PARASITOL-DRUG, V4, P233, DOI 10.1016/j.ijpddr.2014.08.003; Tseng JC, 2012, CHEM BIOL, V19, P1199, DOI 10.1016/j.chembiol.2012.08.007	40	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168602	10.1371/journal.pone.0168602	http://dx.doi.org/10.1371/journal.pone.0168602			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992545	Green Accepted, gold, Green Published			2022-12-26	WOS:000392758000065
J	Kim, K; Kim, K; Park, SM				Kim, Keyhoon; Kim, Kyuwoong; Park, Sang Min			Association between the Prevalence of Metabolic Syndrome and the Level of Coffee Consumption among Korean Women	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; NATIONAL-HEALTH; DECAFFEINATED COFFEE; PROSPECTIVE COHORT; INSULIN-SECRETION; RISK; ADULTS; CAFFEINE; POPULATION; DISEASE	Background As coffee consumption is increasing remarkably over the past decade, the health effects concerning the coffee drinking has gained a wide attention across the nation. However, there is not a true consensus regarding the effects of coffee on metabolic disease. Therefore, this study aims to examine the association between coffee intake and the risk of metabolic syndrome in Korean women Methods We used publicly accessible datasets collected through Korean National Health and Nutrition Examination Survey (KNHANES). Among 20,435 individuals from five consecutive years' worth of data from 2007 to 2011, only 15,691 subjects qualified for statistical analysis upon applying the exclusion criteria. We carried out the statistical analysis utilizing SPSS Statistics version 13.0 (IBM Corp., Armonk, NY.) and STATA statistical software release 13.0 (STATA Corp., College Station, TX). Results We found that the frequency of coffee intake inversely correlates with the prevalence of metabolic syndrome in women. Upon adjusting for life-style factors, socioeconomic status, and nutritional profile, the subjects from the highest coffee consumption quartile exhibited 40% lower odds of suffering from metabolic syndrome compared to those in the control (OR = 0.75; 95% CI = 0.67 +/- 0.84; P for trend < 0.001). Also, we observed that age-and BMI-adjusted HOMA-IR decreased as the coffee consumption increased (P for trend < 0.001). Conclusion The findings of our study suggest that coffee consumption might be associated with reduction of metabolic syndrome in Korean women. To elucidate this cross-sectional association between coffee consumption and metabolic syndrome in women, cohort studies are warranted to confirm this relationship.	[Kim, Keyhoon; Park, Sang Min] Seoul Natl Univ, Coll Med, Dept Med, Seoul, South Korea; [Kim, Kyuwoong; Park, Sang Min] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Biomed Sci Bldg, Seoul, South Korea; [Park, Sang Min] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Family Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Park, SM (corresponding author), Seoul Natl Univ, Coll Med, Dept Med, Seoul, South Korea.; Park, SM (corresponding author), Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Biomed Sci Bldg, Seoul, South Korea.; Park, SM (corresponding author), Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Family Med, Seoul, South Korea.	smpark.snuh@gmail.com	Park, Sang Min/V-9194-2019		National Research Foundation of Korea	National Research Foundation of Korea(National Research Foundation of Korea)	We would like to thank Korea Centers for Disease Control and Prevention for providing the national health survey data and the participants of KNHANES. Kyuwoong Kim received a scholarship from the BK21-plus education program provided by the National Research Foundation of Korea. We would also like to thank Ha Young Chung for professional scientific editing.	Akash MSH, 2014, NUTRITION, V30, P755, DOI 10.1016/j.nut.2013.11.020; Antuna-Puente B, 2011, DIABETES METAB, V37, P179, DOI 10.1016/j.diabet.2011.01.002; Bae YJ, 2010, NUTR RES PRACT, V4, P121, DOI 10.4162/nrp.2010.4.2.121; Bamia C, 2015, INT J CANCER, V136, P1899, DOI 10.1002/ijc.29214; Bhupathiraju SN, 2014, DIABETOLOGIA, V57, P1346, DOI 10.1007/s00125-014-3235-7; Choi E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147762; Ciol MA, 2006, ARCH PHYS MED REHAB, V87, P299, DOI 10.1016/j.apmr.2005.09.021; Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925; Erem C, 2008, ENDOCRINE, V33, P9, DOI 10.1007/s12020-008-9044-3; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Gallus S, 2002, ANN EPIDEMIOL, V12, P202, DOI 10.1016/S1047-2797(01)00304-0; Health NIO, 2001, NIH PUBLICATION, V1, P3670; Health UDo Services H., 2010, NIH PUB; Hino A, 2007, DIABETES RES CLIN PR, V76, P383, DOI 10.1016/j.diabres.2006.09.033; Jiang X., 2013, EUROPEAN J NUTR, V53, P25, DOI DOI 10.1007/S00394-013-0603-X; Kim HJ, 2014, DIABETES RES CLIN PR, V106, P145, DOI 10.1016/j.diabres.2014.07.007; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lann D, 2007, MED CLIN N AM, V91, P1063, DOI 10.1016/j.mcna.2007.06.012; Lee JH, 2016, KOREAN J FAM MED, V37, P7, DOI 10.4082/kjfm.2016.37.1.7; Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109; Lof M, 2015, EUR J EPIDEMIOL, V30, P1027, DOI 10.1007/s10654-015-0052-3; Loftfield E, 2015, AM J EPIDEMIOL, V182, P1010, DOI 10.1093/aje/kwv146; Matsuda Y, 2011, BIOSCI BIOTECH BIOCH, V75, P2309, DOI 10.1271/bbb.110452; Matsuura H, 2012, J EPIDEMIOL, V22, P160, DOI 10.2188/jea.JE20110068; Mellbye FB, 2015, J NAT PROD, V78, P2447, DOI 10.1021/acs.jnatprod.5b00481; Morakinyo A O, 2013, Niger J Physiol Sci, V28, P179; Muzio F, 2005, DIABETES CARE, V28, P1485, DOI 10.2337/diacare.28.6.1485; Nordenvall C, 2015, CLIN GASTROENTEROL H, V13, P1096, DOI 10.1016/j.cgh.2014.09.029; Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083; Park HS, 2008, OBES REV, V9, P104, DOI 10.1111/j.1467-789X.2007.00421.x; Park HS, 2004, INT J EPIDEMIOL, V33, P328, DOI 10.1093/ije/dyh032; Park YW, 2003, ARCH INTERN MED, V163, P427, DOI 10.1001/archinte.163.4.427; Rhee JJ, 2016, AM J CLIN NUTR, V103, P210, DOI 10.3945/ajcn.115.120147; Riediger ND, 2011, CAN MED ASSOC J, V183, pE1127, DOI 10.1503/cmaj.110070; Rodrigues AD, 2013, CLIMACTERIC, V16, P96, DOI 10.3109/13697137.2012.659099; Ross GW, 2000, JAMA-J AM MED ASSOC, V283, P2674, DOI 10.1001/jama.283.20.2674; Siller AB, 2006, P 31 ANN SAS US GROU; Song F, 2016, NFS J, V4, P9, DOI DOI 10.1016/J.NFS.2016.04.002; Takami H, 2013, J EPIDEMIOL, V23, P12, DOI 10.2188/jea.JE20120053; Wu TY, 2005, DIABETES CARE, V28, P1390, DOI 10.2337/diacare.28.6.1390	40	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0167007	10.1371/journal.pone.0167007	http://dx.doi.org/10.1371/journal.pone.0167007			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977716	gold, Green Published, Green Submitted			2022-12-26	WOS:000391217400010
J	Kumar, R; Hazan, A; Geron, M; Steinberg, R; Livni, L; Matzner, H; Priel, A				Kumar, Rakesh; Hazan, Adina; Geron, Matan; Steinberg, Rebbeca; Livni, Lital; Matzner, Henry; Priel, Avi			Activation of transient receptor potential vanilloid 1 by lipoxygenase metabolites depends on PKC phosphorylation	FASEB JOURNAL			English	Article						eicosanoids; inflammatory pain; TRP channels; endovanilloids; Gq-GPCR	RAT SENSORY NEURONS; CAPSAICIN RECEPTOR; TRPV1 CHANNELS; ION-CHANNEL; PAIN; BRADYKININ; INHIBITION; HEAT; SENSITIZATION; NOCICEPTORS	Peripheral neuronal activation by inflammatory mediators is a multifaceted physiological response that involves a multitude of regulated cellular functions. One key pathway that has been shown to be involved in inflammatory pain isGq/GPCR, whose activation by inflammatory mediators is followed by the regulated response of the cation channel transient receptor potential vanilloid 1 (TRPV1). However, the mechanism that underlies TRPV1 activation downstream of the Gq/GPCR pathway has yet to be fully defined. In this study, we employ pharmacological and molecular biology tools to dissect this activation mechanism via perforated-patch recordings and calcium imaging of both neurons and a heterologous system. We showed that TRPV1 activity downstream of Gq/GPCR activation only produced a subdued current, which was noticeably different from the robust current that is typical of TRPV1 activation by exogenous stimuli. Moreover, we specifically demonstrated that 2 pathways downstream of Gq/GPCR signaling, namely endovanilloid production by lipoxygenases and channel phosphorylation by PKC, converge on TRPV1 to evoke a tightly regulated response. Of importance, we show that only when both pathways are acting on TRPV1 is the inflammatory-mediated response achieved. We propose that the requirement of multiple signaling events allows subdued TRPV1 activation to evoke regulated neuronal response during inflammation.- KumarR., Hazan, A., Geron, M., Steinberg, R., Livni, L., Matzner, H., Priel, A. Activation of transient receptor potential vanilloid 1 by lipoxygenase metabolites depends on PKC phosphorylation.	[Kumar, Rakesh; Hazan, Adina; Geron, Matan; Steinberg, Rebbeca; Livni, Lital; Matzner, Henry; Priel, Avi] Hebrew Univ Jerusalem, Fac Med, Inst Drug Res, Sch Pharm, Jerusalem, Israel	Hebrew University of Jerusalem	Priel, A (corresponding author), Hebrew Univ Jerusalem, Sch Pharm, Fac Med, Inst Drug Res,Pharmacol Sect, Pharm Bldg,2nd Floor,Room 231,Ein Karem Campus, IL-91120 Jerusalem, Israel.	avip@ekmd.huji.ac.il	Priel, Avi/ABB-1721-2020; kumar, rakesh/ABE-8708-2020	Priel, Avi/0000-0002-6105-5035; kumar, rakesh/0000-0001-9693-4374; Geron, Matan/0000-0001-5609-1480	Israel Science Foundation [1721/12, 1368/12, 1444/16]; Brettler Center; David R. Bloom Center; School of Pharmacy (The Hebrew University of Jerusalem); Jerusalem Brain Committee Postdoctoral Fellowship	Israel Science Foundation(Israel Science Foundation); Brettler Center; David R. Bloom Center; School of Pharmacy (The Hebrew University of Jerusalem); Jerusalem Brain Committee Postdoctoral Fellowship	The authors thank A.P.'s laboratory for insightful comments. This work was supported by the Israel Science Foundation (Grants 1721/12, 1368/12, and 1444/16; to A.P.), the Brettler Center and David R. Bloom Center, School of Pharmacy (The Hebrew University of Jerusalem; to A.P.), a Jerusalem Brain Committee Postdoctoral Fellowship (to R.K.),	AKAIKE N, 1994, JPN J PHYSIOL, V44, P433, DOI 10.2170/jjphysiol.44.433; Bae C, 2016, ELIFE, V5, DOI 10.7554/eLife.11273; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Berjukow S, 1996, BRIT J PHARMACOL, V118, P748, DOI 10.1111/j.1476-5381.1996.tb15463.x; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Blair NT, 2003, J NEUROSCI, V23, P10338; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; CAHALAN M, 1992, METHOD ENZYMOL, V207, P3; Cao E, 2013, NEURON, V77, P667, DOI 10.1016/j.neuron.2012.12.016; CARDENAS CG, 1995, J NEUROPHYSIOL, V74, P1870, DOI 10.1152/jn.1995.74.5.1870; Carr MJ, 2003, J PHARMACOL EXP THER, V304, P1275, DOI 10.1124/jpet.102.043422; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Colton C. K., 2007, V179, P173; Cummins TR, 2009, NAT PROTOC, V4, P1103, DOI 10.1038/nprot.2009.91; Di Marzo V, 2002, CURR OPIN NEUROBIOL, V12, P372, DOI 10.1016/S0959-4388(02)00340-9; DICKENSON AH, 1991, BRIT J PHARMACOL, V104, P1045, DOI 10.1111/j.1476-5381.1991.tb12547.x; Gudes S, 2015, J NEUROPHYSIOL, V113, P601, DOI 10.1152/jn.00652.2014; Hazan A, 2015, SCI REP-UK, V5, DOI 10.1038/srep12278; HORN R, 1992, METHOD ENZYMOL, V207, P149; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; JORDT SE, 2002, Patent No. 108421; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; KORN SJ, 1990, MOL PHARMACOL, V38, P524; Kumar R, 2016, J BIOL CHEM, V291, P13855, DOI 10.1074/jbc.M116.726372; Le Pichon CE, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00021; Lee HM, 2014, DRUG DISCOV TODAY, V19, P469, DOI 10.1016/j.drudis.2013.10.018; Liang YF, 2001, J PHYSIOL-LONDON, V532, P229, DOI 10.1111/j.1469-7793.2001.0229g.x; Linley JE, 2010, PFLUG ARCH EUR J PHY, V459, P657, DOI 10.1007/s00424-010-0784-6; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; Lundius EG, 2010, J NEUROSCI, V30, P4369, DOI 10.1523/JNEUROSCI.0378-10.2010; Mandadi S, 2006, PAIN, V123, P106, DOI 10.1016/j.pain.2006.02.016; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; Minke B, 2010, J NEUROGENET, V24, P216, DOI 10.3109/01677063.2010.514369; Nilius B, 2008, EMBO J, V27, P2809, DOI 10.1038/emboj.2008.217; Petho G, 2001, EUR J NEUROSCI, V14, P210, DOI 10.1046/j.0953-816x.2001.01651.x; Petho G, 2012, PHYSIOL REV, V92, P1699, DOI 10.1152/physrev.00048.2010; Priel A, 2004, J GEN PHYSIOL, V123, P281, DOI 10.1085/jgp.200308986; Priel A, 2006, NEURON, V52, P1037, DOI 10.1016/j.neuron.2006.12.006; Roberson DP, 2013, NAT NEUROSCI, V16, P910, DOI 10.1038/nn.3404; Rohacs T, 2008, MOL NEUROBIOL, V37, P153, DOI 10.1007/s12035-008-8027-y; Rohacs T, 2015, PFLUG ARCH EUR J PHY, V467, P1851, DOI 10.1007/s00424-015-1695-3; Roth BL, 2016, NEURON, V89, P683, DOI 10.1016/j.neuron.2016.01.040; Shim WS, 2007, J NEUROSCI, V27, P2331, DOI 10.1523/JNEUROSCI.4643-06.2007; Shin J, 2002, P NATL ACAD SCI USA, V99, P10150, DOI 10.1073/pnas.152002699; Sisignano M, 2014, PROG LIPID RES, V53, P93, DOI 10.1016/j.plipres.2013.11.002; Studer M, 2010, J PHYSIOL-LONDON, V588, P3743, DOI 10.1113/jphysiol.2010.190611; Sugiura T, 2002, J NEUROPHYSIOL, V88, P544, DOI 10.1152/jn.2002.88.1.544; Tappe-Theodor A, 2012, PAIN, V153, P184, DOI 10.1016/j.pain.2011.10.014; Ufret-Vincenty CA, 2015, J GEN PHYSIOL, V145, P431, DOI 10.1085/jgp.201511354; van der Stelt M, 2004, EUR J BIOCHEM, V271, P1827, DOI 10.1111/j.1432-1033.2004.04081.x; van Rossum DB, 2009, CELL CALCIUM, V45, P535, DOI 10.1016/j.ceca.2009.02.008; Veldhuis NA, 2015, PHARMACOL REV, V67, P36, DOI 10.1124/pr.114.009555; Vellani V, 2008, NEUROPHARMACOLOGY, V55, P1274, DOI 10.1016/j.neuropharm.2008.01.010; Woo DH, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-42; Xu ZZ, 2010, NAT MED, V16, P592, DOI 10.1038/nm.2123; Yeung J, 2012, MOL PHARMACOL, V81, P420, DOI 10.1124/mol.111.075630; Zhang XM, 2012, NAT CELL BIOL, V14, P850, DOI 10.1038/ncb2529; Zygmunt PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081618	59	17	18	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1238	+		10.1096/fj.201601132R	http://dx.doi.org/10.1096/fj.201601132R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27986808				2022-12-26	WOS:000395671200035
J	Morii, M; Kubota, S; Honda, T; Yuki, R; Morinaga, T; Kuga, T; Tomonaga, T; Yamaguchi, N; Yamaguchi, N				Morii, Mariko; Kubota, Sho; Honda, Takuya; Yuki, Ryuzaburo; Morinaga, Takao; Kuga, Takahisa; Tomonaga, Takeshi; Yamaguchi, Noritaka; Yamaguchi, Naoto			Src Acts as an Effector for Ku70-dependent Suppression of Apoptosis through Phosphorylation of Ku70 at Tyr-530	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylation; apoptosis; phosphotyrosine signaling; Src; tyrosine-protein kinase (tyrosine kinase); Ku70	MEDIATED TYROSINE PHOSPHORYLATION; C-SRC; CELL-DEATH; SIGNALING PATHWAY; FAMILY KINASES; CANCER-CELLS; NUCLEAR-LOCALIZATION; LYSINE ACETYLATION; PLASMA-MEMBRANE; BREAK REPAIR	Src-family tyrosine kinases are widely expressed in many cell types and participate in a variety of signal transduction pathways. Despite the significance of Src in suppression of apoptosis, its mechanism remains poorly understood. Here we show that Src acts as an effector for Ku70-dependent suppression of apoptosis. Inhibition of endogenous Src activity promotes UV-induced apoptosis, which is impaired by Ku70 knockdown. Src phosphorylates Ku70 at Tyr-530, being close to the possible acetylation sites involved in promotion of apoptosis. Src-mediated phosphorylation of Ku70 at Tyr-530 decreases acetylation of Ku70, whereas Src inhibition augments acetylation of Ku70. Importantly, knockdown-rescue experiments with stable Ku70 knockdown cells show that the nonphosphorylatable Y530F mutant of Ku70 reduces the ability of Ku70 to suppress apoptosis accompanied by augmentation of Ku70 acetylation. Our results reveal that Src plays a protective role against hyperactive apoptotic cell death by reducing apoptotic susceptibility through phosphorylation of Ku70 at Tyr-530.	[Morii, Mariko; Kubota, Sho; Honda, Takuya; Yuki, Ryuzaburo; Morinaga, Takao; Yamaguchi, Noritaka; Yamaguchi, Naoto] Chiba Univ, Mol Cell Biol Lab, Grad Sch Pharmaceut Sci, Chiba 2608675, Japan; [Tomonaga, Takeshi; Yamaguchi, Noritaka] Natl Inst Biomed Innovat Hlth & Nutr, Lab Proteome Res, Ibaraki, Osaka 5670085, Japan	Chiba University	Yamaguchi, N (corresponding author), Chiba Univ, Mol Cell Biol Lab, Grad Sch Pharmaceut Sci, Chuo Ku, Inohana 1-8-1, Chiba 2608675, Japan.	nyama@faculty.chiba-u.jp	Kuga, Takahisa/AAX-9334-2020	Honda, Takuya/0000-0002-7141-0088; Kubota, Sho/0000-0001-6119-1259	Japanese Ministry of Education, Culture, Sports, Science, and Technology; LGS Program for Leading Graduate Schools (Chiba University Nurture of Creative Research Leaders in Immune System Regulation and Innovative Therapeutics); Chiba Foundation for Health Promotion and Disease Prevention; Japan Foundation for Applied Enzymology;  [15K07922];  [16K08227];  [16J04363];  [16J04141]; Grants-in-Aid for Scientific Research [16J04363, 15K19545, 26460081, 16J04141] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); LGS Program for Leading Graduate Schools (Chiba University Nurture of Creative Research Leaders in Immune System Regulation and Innovative Therapeutics); Chiba Foundation for Health Promotion and Disease Prevention; Japan Foundation for Applied Enzymology; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research 15K07922 (to Na. Y.) and 16K08227 (to No. Y.) and the LGS Program for Leading Graduate Schools (Chiba University Nurture of Creative Research Leaders in Immune System Regulation and Innovative Therapeutics), the Global COE Program (Global Center for Education and Research in Immune Regulation and Treatment) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology, the Chiba Foundation for Health Promotion and Disease Prevention (to No. Y.), and the Japan Foundation for Applied Enzymology (to Na. Y.). The authors declare that they have no conflicts of interest with the contents of this article.; LGS research assistants supported by Grants-in-aid for the Japan Society for the Promotion of Science (JSPS) Research Fellow 16J04363 (to M.M.) and 16J04141 (to T.H.).	Aoyama K, 2015, CELL BIOL INT, V39, P446, DOI 10.1002/cbin.10413; Aoyama K, 2013, EXP CELL RES, V319, P3251, DOI 10.1016/j.yexcr.2013.09.003; Aoyama K, 2011, EXP CELL RES, V317, P2874, DOI 10.1016/j.yexcr.2011.09.013; Bijlmakers MJJE, 1997, J CELL BIOL, V137, P1029, DOI 10.1083/jcb.137.5.1029; BJORGE JD, 1995, J BIOL CHEM, V270, P24222, DOI 10.1074/jbc.270.41.24222; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Cans C, 2000, BIOCHEM PHARMACOL, V60, P1203, DOI 10.1016/S0006-2952(00)00434-2; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; Chen CS, 2007, CANCER RES, V67, P5318, DOI 10.1158/0008-5472.CAN-06-3996; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Com E, 2007, MOL CELL PROTEOMICS, V6, P1842, DOI 10.1074/mcp.M700119-MCP200; Corcoran A, 2013, FEBS J, V280, P1944, DOI 10.1111/febs.12224; Cursi S, 2006, EMBO J, V25, P1895, DOI 10.1038/sj.emboj.7601085; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Dumitru R, 2012, MOL CELL, V46, P573, DOI 10.1016/j.molcel.2012.04.002; Fattah FJ, 2008, P NATL ACAD SCI USA, V105, P8703, DOI 10.1073/pnas.0712060105; Fessart D, 2005, MOL ENDOCRINOL, V19, P491, DOI 10.1210/me.2004-0246; Fukumoto Y, 2010, CYTOTECHNOLOGY, V62, P73, DOI 10.1007/s10616-010-9259-z; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; GILLET G, 1995, EMBO J, V14, P1372, DOI 10.1002/j.1460-2075.1995.tb07123.x; Grishin AV, 2001, P NATL ACAD SCI USA, V98, P10172, DOI 10.1073/pnas.191130798; Hasegawa H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116048; Honda T, 2016, SCI REP-UK, V6, DOI 10.1038/srep38751; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Ikeda K, 2008, EXP CELL RES, V314, P3392, DOI 10.1016/j.yexcr.2008.08.019; Ishibashi K, 2013, J CELL SCI, V126, P625, DOI 10.1242/jcs.116277; Iwama A, 1996, EMBO J, V15, P5866, DOI 10.1002/j.1460-2075.1996.tb00973.x; Johnson D, 2000, CELL DEATH DIFFER, V7, P685, DOI 10.1038/sj.cdd.4400700; KAPLAN KB, 1992, J CELL BIOL, V118, P321, DOI 10.1083/jcb.118.2.321; Kasahara K, 2004, J CELL BIOL, V165, P641, DOI 10.1083/jcb.200403011; Kasahara K, 2007, J CELL PHYSIOL, V211, P220, DOI 10.1002/jcp.20931; Kasahara K, 2007, EXP CELL RES, V313, P2651, DOI 10.1016/j.yexcr.2007.05.001; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Kubota S, 2015, J BIOL CHEM, V290, P10891, DOI 10.1074/jbc.M115.643882; Kubota S, 2013, J BIOL CHEM, V288, P17871, DOI 10.1074/jbc.M112.437756; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; LEY SC, 1994, J CELL BIOL, V125, P639, DOI 10.1083/jcb.125.3.639; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lopez J, 2012, CELL DEATH DIFFER, V19, P1459, DOI 10.1038/cdd.2012.21; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Matsuda D, 2006, EXP CELL RES, V312, P1205, DOI 10.1016/j.yexcr.2006.02.003; Mazumder S, 2007, MOL CELL BIOL, V27, P3511, DOI 10.1128/MCB.01448-06; Mera A, 1999, J BIOL CHEM, V274, P15766, DOI 10.1074/jbc.274.22.15766; MOHN H, 1995, BIOCHEM J, V309, P657; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Morii M, 2015, CELL BIOL INT, V39, P923, DOI 10.1002/cbin.10460; Morinaga T, 2014, J BIOL CHEM, V289, P26327, DOI 10.1074/jbc.M114.580001; Nakayama Y, 2012, J BIOL CHEM, V287, P24905, DOI 10.1074/jbc.M112.341578; Nakayama Y, 2009, EXP CELL RES, V315, P2515, DOI 10.1016/j.yexcr.2009.06.007; Obata Y, 2010, J CELL SCI, V123, P2649, DOI 10.1242/jcs.066266; Reginato MJ, 2005, MOL CELL BIOL, V25, P4591, DOI 10.1128/MCB.25.11.4591-4601.2005; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sasaki H, 2014, ARCH BIOCHEM BIOPHYS, V550, P12, DOI 10.1016/j.abb.2014.03.012; Sato I, 2009, J CELL SCI, V122, P965, DOI 10.1242/jcs.034843; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; Shen YH, 2001, P NATL ACAD SCI USA, V98, P1543, DOI 10.1073/pnas.041588198; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Soeda S, 2013, EXP CELL RES, V319, P1382, DOI 10.1016/j.yexcr.2013.02.023; Subramanian C, 2005, P NATL ACAD SCI USA, V102, P4842, DOI 10.1073/pnas.0408351102; Subramanian C, 2007, NEOPLASIA, V9, P495, DOI 10.1593/neo.07262; Subramanian C, 2011, NEOPLASIA, V13, P726, DOI 10.1593/neo.11558; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Tada J, 1999, BLOOD, V93, P3723, DOI 10.1182/blood.V93.11.3723.411k02_3723_3735; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Takahashi A, 2009, EXP CELL RES, V315, P1117, DOI 10.1016/j.yexcr.2009.02.010; Tamura T, 2000, INT IMMUNOL, V12, P1205, DOI 10.1093/intimm/12.8.1205; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Yamaguchi N, 2001, J CELL SCI, V114, P1631; Yamaguchi N, 2017, J CELL BIOCHEM, V118, P1453, DOI 10.1002/jcb.25804; Yamaguchi N, 2015, BIOCHEM J, V471, P67, DOI 10.1042/BJ20150372; YAMANASHI Y, 1987, MOL CELL BIOL, V7, P237, DOI 10.1128/MCB.7.1.237; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yuki R, 2015, J CELL BIOCHEM, V116, P954, DOI 10.1002/jcb.25046; Zhang SY, 2012, TRENDS PHARMACOL SCI, V33, P122, DOI 10.1016/j.tips.2011.11.002	87	12	12	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1648	1665		10.1074/jbc.M116.753202	http://dx.doi.org/10.1074/jbc.M116.753202			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27998981	Green Published, hybrid			2022-12-26	WOS:000395515600010
J	Moerman, R; Roger, N; De Jonghe, R; Michez, D; Vanderplanck, M				Moerman, Romain; Roger, Nathalie; De Jonghe, Roland; Michez, Denis; Vanderplanck, Maryse			Interspecific Variation in Bumblebee Performance on Pollen Diet: New Insights for Mitigation Strategies	PLOS ONE			English	Article							BOMBUS-TERRESTRIS; COLONY DEVELOPMENT; PROTEIN-CONTENT; NUTRITIVE-VALUE; HYMENOPTERA; BEES; DECLINE; RARITY; PLANTS; MIXES	Bumblebees (i.e. Bombus genus) are major pollinators of flowering wild plants and crops. Although many species are currently in decline, a number of them remain stable or are even expanding. One factor potentially driving changes in bumblebee distribution is the suitability of plant communities. Actually, bees probably have specific nutritional requirements that could shape their floral choices and constraint them in the current context of global change. However, most studies primarily focus on one bumblebee species at a time, making comparative studies scarce. Herein we performed comparative bioassays on three bumblebee species (i.e. Bombus hypnorum, B. pratorum and B. terrestris) fed on three different pollen diets with distinct nutritive content (Cistus, Erica and Sa/ixpollen diets). Micro-colony performance was compared through different developmental and resource collection parameters for understanding the impact of change in pollen diet on different bumblebee species. The evidence suggests that B. terrestris is by far the most competitive species because of its performance compared to the other species, regardless of pollen diet. Our results also highlight a Bombus species effect as pollen diet impacts the micro-colonies in different ways according to the actual bumblebee species. Such interspecific variation in Bombus performance in response to a dietetic change underlines the importance of considering different bumblebee species in mitigation strategies. Such comparative studies are good advice for developing appropriate suites of plant species that can benefit threatened species while supporting stable or expanding ones.	[Moerman, Romain] Univ Libre Bruxelles, Evolut Biol & Ecol, 50 Ave FD Roosevelt, Brussels, Belgium; [Moerman, Romain; Roger, Nathalie; De Jonghe, Roland; Michez, Denis; Vanderplanck, Maryse] Univ Mons, Res Inst Biosci, Zool Lab, 20 Pl Parc, Mons, Belgium	Universite Libre de Bruxelles; University of Mons	Moerman, R (corresponding author), Univ Libre Bruxelles, Evolut Biol & Ecol, 50 Ave FD Roosevelt, Brussels, Belgium.; Moerman, R (corresponding author), Univ Mons, Res Inst Biosci, Zool Lab, 20 Pl Parc, Mons, Belgium.	romain.moerman@umons.ac.be	Michez, Denis/L-1370-2019; Vanderplanck, Maryse/K-1072-2019	Michez, Denis/0000-0001-8880-1838; Vanderplanck, Maryse/0000-0002-0110-8019	FRS-FNRS (Fonds de la Recherche Scientifique) FRFC [2.4.613.12.]; FRIA (Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture)	FRS-FNRS (Fonds de la Recherche Scientifique) FRFC(Fonds de la Recherche Scientifique - FNRS); FRIA (Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture)(Fonds de la Recherche Scientifique - FNRS)	This study was partially funded by FRS-FNRS (Fonds de la Recherche Scientifique) FRFC project 2.4.613.12. and FRIA (Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture). MV is a postdoctoral researcher at the F.R.S.-FNRS and NR is a PhD student at the FRIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, EUROPEAN RED LIST BE, DOI DOI 10.2779/77003; Baloglu GH, 2015, J APIC SCI, V59, P83, DOI 10.1515/JAS-2015-0009; Bees Wasps and Ants Recording Society, 2014, BOMB HYPN; Behmer ST, 2008, P NATL ACAD SCI USA, V105, P1977, DOI 10.1073/pnas.0711870105; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Carvalheiro LG, 2013, ECOL LETT, V16, P870, DOI 10.1111/ele.12121; CNAANI J, 1994, INSECT SOC, V41, P301, DOI 10.1007/BF01242301; CORBET SA, 1991, BEE WORLD, V72, P47, DOI 10.1080/0005772X.1991.11099079; Crowther LP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107568; Ellers J, 1996, NETH J ZOOL, V46, P227, DOI 10.1163/156854295X00186; Garibaldi LA, 2016, SCIENCE, V351, P388, DOI 10.1126/science.aac7287; Genissel A, 2002, ENTOMOL EXP APPL, V104, P329, DOI 10.1023/A:1021279220995; Goulson D, 2005, BIOL CONSERV, V122, P1, DOI 10.1016/j.biocon.2004.06.017; Goulson D, 2008, BIODIVERS CONSERV, V17, P3269, DOI 10.1007/s10531-008-9428-y; Goulson Dave, 2001, British Journal of Entomology and Natural History, V14, P129; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Harmon-Threatt AN, 2015, ECOL ENTOMOL, V40, P471, DOI 10.1111/een.12211; Hetru Charles, 1998, P40; Inari N, 2005, POPUL ECOL, V47, P77, DOI 10.1007/s10144-004-0205-9; Kerr JT, 2015, SCIENCE, V349, P177, DOI 10.1126/science.aaa7031; Kleijn D, 2008, ECOLOGY, V89, P1811, DOI 10.1890/07-1275.1; Korner P, 2005, ENTOMOL SCI, V8, P151, DOI 10.1111/j.1479-8298.2005.00113.x; Kriesell L, 2017, APIDOLOGIE, V48, P102, DOI 10.1007/s13592-016-0454-6; Lecocq T, 2016, CONSERVATION LETT; Mayer C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050353; MICHENER C D, 1974, P404; Moerman R, 2016, J ECON ENTOMOL, V109, P25, DOI 10.1093/jee/tov279; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Pelletier L, 2003, OIKOS, V103, P688, DOI 10.1034/j.1600-0706.2003.12592.x; Plowright C.M.S., 1999, P21; Ponchau O, 2006, ANN SOC ENTOMOL FR, V42, P207, DOI 10.1080/00379271.2006.10700624; R Core Team, 2021, R LANGUAGE ENV STAT; RASMONT P, 1988, ANN SOC ROY ZOOL BEL, V118, P141; Rasmont P, 2008, ANN SOC ENTOMOL FR, V44, P243, DOI 10.1080/00379271.2008.10697559; Rasmont Pierre, 2015, BioRisk, V10, P3; REGALI A, 1995, APIDOLOGIE, V26, P273, DOI 10.1051/apido:19950401; Roger N, 2016, GLOBAL CHANGE BIOL; Roulston TH, 2000, PLANT SYST EVOL, V222, P187, DOI 10.1007/BF00984102; Roulston TH, 2000, ECOL MONOGR, V70, P617, DOI 10.1890/0012-9615(2000)070[0617:WGPCOP]2.0.CO;2; Scheper J, 2014, P NATL ACAD SCI USA, V111, P17552, DOI 10.1073/pnas.1412973111; Somme L, 2015, APIDOLOGIE, V46, P92, DOI 10.1007/s13592-014-0307-0; Stabler D, 2015, J EXP BIOL, V218, P793, DOI 10.1242/jeb.114249; SUTCLIFFE GH, 1990, CAN J ZOOL, V68, P1120, DOI 10.1139/z90-166; SUTCLIFFE GH, 1988, CAN ENTOMOL, V120, P1051, DOI 10.4039/Ent1201051-12; Tasei JN, 2008, APIDOLOGIE, V39, P397, DOI 10.1051/apido:2008017; Tasei JN, 2008, J ECON ENTOMOL, V101, P1737, DOI 10.1603/0022-0493-101.6.1737; Torreta JP, 2016, T AM ENTOMOLOGICAL S; Vanderplanck M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086209; Vaudo AD, 2016, P NATL ACAD SCI US; Vaudo AD, 2015, CURR OPIN INSECT SCI, V10, P133, DOI 10.1016/j.cois.2015.05.008; Vesterlund SR, 2014, INSECT SOC, V61, P265, DOI 10.1007/s00040-014-0351-9; Williams PH, 2008, APIDOLOGIE, V39, P46, DOI 10.1051/apido:2007052; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025; Winfree R, 2007, ECOL LETT, V10, P1105, DOI 10.1111/j.1461-0248.2007.01110.x; Woodcock BA, 2016, NATURE COMMUNICATION; Yoon HyungJoo, 2005, International Journal of Industrial Entomology, V11, P99	57	16	16	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168462	10.1371/journal.pone.0168462	http://dx.doi.org/10.1371/journal.pone.0168462			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005943	gold, Green Published, Green Submitted			2022-12-26	WOS:000392843200055
J	Hirayama, J; Hyvarinen, A; Kiviniemi, V; Kawanabe, M; Yamashita, O				Hirayama, Jun-ichiro; Hyvarinen, Aapo; Kiviniemi, Vesa; Kawanabe, Motoaki; Yamashita, Okito			Characterizing Variability of Modular Brain Connectivity with Constrained Principal Component Analysis	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; NETWORKS	Characterizing the variability of resting-state functional brain connectivity across subjects and/or over time has recently attracted much attention. Principal component analysis (PCA) serves as a fundamental statistical technique for such analyses. However, performing PCA on high-dimensional connectivity matrices yields complicated "eigenconnectivity" patterns, for which systematic interpretation is a challenging issue. Here, we overcome this issue with a novel constrained PCA method for connectivity matrices by extending the idea of the previously proposed orthogonal connectivity factorization method. Our new method, modular connectivity factorization (MCF), explicitly introduces the modularity of brain networks as a parametric constraint on eigenconnectivity matrices. In particular, MCF analyzes the variability in both intra-and inter-module connectivities, simultaneously finding network modules in a principled, data-driven manner. The parametric constraint provides a compact module based visualization scheme with which the result can be intuitively interpreted. We develop an optimization algorithm to solve the constrained PCA problem and validate our method in simulation studies and with a resting-state functional connectivity MRI dataset of 986 subjects. The results show that the proposed MCF method successfully reveals the underlying modular eigenconnectivity patterns in more general situations and is a promising alternative to existing methods.	[Hirayama, Jun-ichiro; Kawanabe, Motoaki; Yamashita, Okito] Adv Telecommun Res Inst Int ATR, Brain Informat Commun Res Lab Grp, Kyoto, Japan; [Hyvarinen, Aapo] Univ Helsinki, Dept Comp Sci HIIT, Helsinki, Finland; [Hyvarinen, Aapo] UCL, Gatsby Computat Neurosci Unit, London, England; [Kiviniemi, Vesa] Oulu Univ Hosp, Dept Diagnost Radiol, Oulu, Finland; [Hirayama, Jun-ichiro; Kawanabe, Motoaki; Yamashita, Okito] RIKEN Ctr Adv Integrated Intelligence Res, Wako, Saitama, Japan	Advanced Telecommunications Research Institute International; University of Helsinki; University of London; University College London; University of Oulu; RIKEN	Hirayama, J (corresponding author), Adv Telecommun Res Inst Int ATR, Brain Informat Commun Res Lab Grp, Kyoto, Japan.; Hirayama, J (corresponding author), RIKEN Ctr Adv Integrated Intelligence Res, Wako, Saitama, Japan.	hirayama@atr.jp	Yamashita, Okito/ABW-9839-2022; Hirayama, Jun-ichiro/AAR-6223-2020	Hyvarinen, Aapo/0000-0002-5806-4432; Yamashita, Okito/0000-0002-6039-3657	National Institute of Information and Communications Technology; Japan Science and Technology Agency (JST); KAKENHI from Japan Society for the Promotion of Science (JSPS) [25730155, 15H02759]; Academy of Finland Centre-of-Excellence in Inverse Problems	National Institute of Information and Communications Technology; Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); KAKENHI from Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Academy of Finland Centre-of-Excellence in Inverse Problems	This work was partially supported by a contract with the National Institute of Information and Communications Technology entitled, "Development of network dynamics modeling methods for human brain data simulation systems," Strategic International Collaborative Research Program (SICORP) from Japan Science and Technology Agency (JST), and KAKENHI 25730155, 15H02759 from Japan Society for the Promotion of Science (JSPS). AH was funded by the Academy of Finland Centre-of-Excellence in Inverse Problems. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander-Bloch AF, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00147; Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Bertsekas D., 1999, NONLINEAR PROGRAMMIN; Brown J, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00028; Carvalho CM, 2007, BAYESIAN ANAL, V2, P69, DOI 10.1214/07-BA204; Cichocki A., 2009, NONNEGATIVE MATRIX T, DOI DOI 10.1002/9780470747278; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Edelman A, 1998, SIAM J MATRIX ANAL A, V20, P303, DOI 10.1137/S0895479895290954; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Gonzalez-Castillo J, 2015, P NATL ACAD SCI USA, V112, P8762, DOI 10.1073/pnas.1501242112; Hirayama J, 2016, MACHINE LEARNING; HOLLAND PW, 1983, SOC NETWORKS, V5, P109, DOI 10.1016/0378-8733(83)90021-7; Horev I., 2015, P 4 AS C MACH LEARN, P1; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; Hyvarinen A, 2016, NEURAL COMPUT, V28, P445, DOI 10.1162/NECO_a_00810; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; Journee M, 2010, J MACH LEARN RES, V11, P517; Kiviniemi V, 2011, BRAIN CONNECT, V1, P339, DOI 10.1089/brain.2011.0036; Kolar M, 2010, ANN APPL STAT, V4, P94, DOI 10.1214/09-AOAS308; Leonardi N, 2013, NEUROIMAGE, V83, P937, DOI 10.1016/j.neuroimage.2013.07.019; Liu XM, 2013, BIOSCI TRENDS, V7, P101, DOI 10.5582/bst.2013.v7.2.101; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Monti RP, 2014, NEUROIMAGE, V103, P427, DOI 10.1016/j.neuroimage.2014.07.033; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; Ponce-Alvarez A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004100; Robinson LF, 2012, DETECTING TIME DEPEN; Robinson LF, 2015, NEUROIMAGE, V108, P274, DOI 10.1016/j.neuroimage.2014.12.034; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Xing EP, 2010, ANN APPL STAT, V4, P535, DOI 10.1214/09-AOAS311; Xuan X., 2007, P 24 INT C MACH LEAR, P1055, DOI DOI 10.1145/1273496.1273629; Yaesoubi M, 2015, NEUROIMAGE, V107, P85, DOI 10.1016/j.neuroimage.2014.11.054; Yang J, 2004, IEEE T PATTERN ANAL, V26, P131, DOI 10.1109/TPAMI.2004.1261097; Yang TB, 2011, MACH LEARN, V82, P157, DOI 10.1007/s10994-010-5214-7; Yu SX, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P313, DOI 10.1109/iccv.2003.1238361; Zhou SH, 2010, MACH LEARN, V80, P295, DOI 10.1007/s10994-010-5180-0; Zou H, 2006, J COMPUT GRAPH STAT, V15, P265, DOI 10.1198/106186006X113430	41	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168180	10.1371/journal.pone.0168180	http://dx.doi.org/10.1371/journal.pone.0168180			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002474	Green Published, Green Submitted, gold			2022-12-26	WOS:000392853100033
J	Cobiac, LJ; Scarborough, P; Kaur, A; Rayner, M				Cobiac, Linda J.; Scarborough, Peter; Kaur, Asha; Rayner, Mike			The Eatwell Guide: Modelling the Health Implications of Incorporating New Sugar and Fibre Guidelines	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; VEGETABLE CONSUMPTION; VASCULAR MORTALITY; COST-EFFECTIVENESS; BLOOD CHOLESTEROL; INDIVIDUAL DATA; CANCER RISK; METAANALYSIS; PRESSURE; DISEASE	Objective To model population health impacts of dietary changes associated with the redevelopment of the UK food-based dietary guidelines (the 'Eatwell Guide'). Method Using multi-state lifetable methods, we modelled the impact of dietary changes on cardiovascular disease, diabetes and cancers over the lifetime of the current UK population. From this model, we determined change in life expectancy and disability-adjusted life years (DALYs) that could be averted. Results Changing the average diet to that recommended in the new Eatwell Guide, without increasing total energy intake, could increase average life expectancy by 5.4 months (95% uncertainty interval: 4.7 to 6.2) for men and 4.0 months (3.4 to 4.6) for women; and avert 17.9 million (17.6 to 18.2) DALYs over the lifetime of the current population. A large proportion of the health benefits are from prevention of type 2 diabetes, with 440,000 (400,000 to 480,000) new cases prevented in men and 340,000 (310,000 to 370,000) new cases prevented in women, over the next ten years. Prevention of cardiovascular diseases and colorectal cancer is also large. However, if the diet recommended in the new Eatwell Guide is achieved with an accompanying increase in energy intake (and thus an increase in body mass index), around half the potential improvements in population health will not be realised. Conclusions The dietary changes required to meet recommendations in the Eatwell Guide, which include eating more fruits and vegetables and less red and processed meats and dairy products, are large. However, the potential population health benefits are substantial.	[Cobiac, Linda J.] Univ Melbourne, Sch Populat & Global Hlth, Ctr Hlth Policy, Melbourne, Vic, Australia; [Cobiac, Linda J.; Scarborough, Peter; Kaur, Asha; Rayner, Mike] Univ Oxford, Nuffield Dept Populat Hlth, British Heart Fdn, Ctr Populat Approaches Noncommunicable Dis Preven, Oxford, England	University of Melbourne; University of Oxford	Cobiac, LJ (corresponding author), Univ Melbourne, Sch Populat & Global Hlth, Ctr Hlth Policy, Melbourne, Vic, Australia.; Cobiac, LJ (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, British Heart Fdn, Ctr Populat Approaches Noncommunicable Dis Preven, Oxford, England.	linda.cobiac@unimelb.edu.au	Scarborough, Peter/ABD-6111-2021	Scarborough, Peter/0000-0002-2378-2944; Kaur, Asha/0000-0003-0617-2287	SUSDIET Research Project: Towards Sustainable Diets in Europe; British Heart Foundation [FS/15/34/31656] Funding Source: researchfish	SUSDIET Research Project: Towards Sustainable Diets in Europe; British Heart Foundation(British Heart Foundation)	The dietary scenarios that we evaluated in this health modelling study, were based on work that was commissioned by Public Health England. Public Health England provided data and were involved in discussions around the methods and analyses of that work, which has been separately submitted for publication. Public Health England did not fund the development of the health model or modelling of health outcomes in this study. They had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The population health model was developed with support from the SUSDIET Research Project: Towards Sustainable Diets in Europe (https://www6.inra.fr/sustainablediets).; The authors would like to acknowledge Public Health England for their input in developing the dietary scenarios that we have evaluated in this study. The population health model was developed with support from the SUSDIET Research Project: Towards Sustainable Diets in Europe (https://www6.inra.fr/sustainablediets).	Audsley E., 2010, LOW CAN WE GO ASSESS; Aune D, 2009, DIABETOLOGIA, V52, P2277, DOI 10.1007/s00125-009-1481-x; Aune D, 2012, ANN ONCOL; Aune D, 2013, CANCER CAUSE CONTROL, V24, P611, DOI 10.1007/s10552-012-0139-z; Aune D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6617; Christiansen E, 2002, EUR J CLIN INVEST, V32, P826, DOI 10.1046/j.1365-2362.2002.01036.x; Clarke R, 1997, BRIT MED J, V314, P112, DOI 10.1136/bmj.314.7074.112; Cobiac LJ, 2013, ANNU REV NUTR, V33, P373, DOI 10.1146/annurev-nutr-071812-161133; Cobiac LJ, 2010, HEART, V96, P1920, DOI 10.1136/hrt.2010.199240; Cogswell ME, 2016, N ENGL J MED; Committee on Climate Change, 2008, BUILD LOW CARB EC UK; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Dauchet L, 2005, NEUROLOGY, V65, P1193, DOI 10.1212/01.wnl.0000180600.09719.53; Dauchet L, 2006, J NUTR, V136, P2588, DOI 10.1093/jn/136.10.2588; Diabetes UK, 2014, COST DIAB REP; FAO, 2016, VAL AGR PROD; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Gonzalez AD, 2011, FOOD POLICY, V36, P562, DOI 10.1016/j.foodpol.2011.07.003; He FJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1325; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Macdiarmid JI, 2012, AM J CLIN NUTR, V96, P632, DOI 10.3945/ajcn.112.038729; Mann J, 2014, AM J CLIN NUTR; Mente A, 2016, LANCET; NatCen Social Research Medical Research Council Human Nutrition Research & University College London Medical School, 2015, NAT DIET NUTR SURV Y; Newton JN, 2015, LANCET, V386, P2257, DOI 10.1016/S0140-6736(15)00195-6; Norat T, 2011, WCRF AICR SYSTEMATIC; Perignon M, 2016, PUBLIC HEALTH NUTR, V19, P2662, DOI 10.1017/S1368980016000653; Public Health England in association with the Welsh Government FSSatFSAiNI, 2016, THE EATW GTUID; Scarborough P, EATWELLL GUIDE MODEL; Scarborough P, 2014, CLIMATIC CHANGE, V125, P179, DOI 10.1007/s10584-014-1169-1; Scientific Advisory Committee on Nutrition, 2015, CARB HLTH; Song P, 2014, J CANCER RES CLIN, V140, P979, DOI 10.1007/s00432-014-1637-z; Threapleton DE, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6879; Vieira AR, 2016, ANN ONCOL, V27, P81, DOI 10.1093/annonc/mdv381; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wilson N, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0161-1; Wilson N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059648; World Bank, 2016, AGR VAL ADD GDP; World Health Organization, 2015, GUID SUG INT AD CHIL; Zhang ZZ, 2013, GASTROENTEROLOGY, V145, P113, DOI 10.1053/j.gastro.2013.04.001; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	43	25	25	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0167859	10.1371/journal.pone.0167859	http://dx.doi.org/10.1371/journal.pone.0167859			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997546	Green Published, gold			2022-12-26	WOS:000392842900015
J	Salama, A; Hegazy, R; Hassan, A				Salama, Abeer; Hegazy, Rehab; Hassan, Azza			Intranasal Chromium Induces Acute Brain and Lung Injuries in Rats: Assessment of Different Potential Hazardous Effects of Environmental and Occupational Exposure to Chromium and Introduction of a Novel Pharmacological and Toxicological Animal Model	PLOS ONE			English	Article							HEXAVALENT CHROMIUM; ACCUMULATION; MECHANISMS; TOXICITY; PHOSPHORYLATION; CARCINOGENICITY; INSTILLATION; PARTICLES; AKT	Chromium (Cr) is used in many industries and it is widely distributed in the environment. Exposure to Cr dust has been reported among workers at these industries. Beside its hazardous effects on the lungs, brain injury could be induced, as the absorption of substances through the nasal membrane has been found to provide them a direct delivery to the brain. We investigated the distribution and the effects of Cr in both brain and lung following the intranasal instillation of potassium dichromate (inPDC) in rats. Simultaneously, we used the common intraperitoneal (ipPDC) rat model of acute Cr-toxicity for comparison. Thirty male Wistar rats were randomly allocated into five groups (n = 6); each received a single dose of saline, ipPDC (15 mg/kg), or inPDC in three dose levels: 0.5, 1, or 2 mg/kg. Locomotor activity was assessed before and 24 h after PDC administration, then, the lungs and brain were collected for biochemical, histopathological, and immunohistochemical investigations. Treatment of rats with ipPDC resulted in a recognition of 36% and 31% of the injected dose of Cr in the brain and lung tissues, respectively. In inPDC-treated rats, targeting the brain by Cr was increased in a dose-dependent manner to reach 46% of the instilled dose in the group treated with the highest dose. Moreover, only this high dose of inPDC resulted in a delivery of a significant concentration of Cr, which represented 42% of the instilled dose, to the lungs. The uppermost alteration in the rats locomotor activity as well as in the brain and lung histopathological features and contents of oxidative stress biomarkers, interleukin-1p (IL-1(3), phosphorylated protein kinase B (PKB), and cyclooxygenase 2 (COX-2) were observed in the rats treated with inPDC (2 mg/kg). The findings revealed that these toxic manifestations were directly proportional to the delivered concentration of Cr to the tissue. In conclusion, the study showed that a comparably higher concentrations of Cr and more elevated levels of oxidative stress and inflammatory markers were observed in brain and lung tissues of rats subjected to inPDC in a dose that is just 0.13 that of ipPDC dose commonly used in Cr-induced toxicity studies. Therefore, the study suggests a high risk of brain-targeting injury among individuals environmentally or occupationally exposed to Cr dust, even in low doses, and an additional risk of lung injury with higher Cr concentrations. Moreover, the study introduces inPDC (2 mg/kg)-instillation as a new experimental animal model suitable to study the acute brain and lung toxicities induced by intranasal exposure to Cr compounds.	[Salama, Abeer; Hegazy, Rehab] Natl Res Ctr, Dept Pharmacol, Div Med, Giza, Egypt; [Hassan, Azza] Cairo Univ, Dept Pathol, Fac Vet Med, Giza, Egypt	Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); Cairo University	Hegazy, R (corresponding author), Natl Res Ctr, Dept Pharmacol, Div Med, Giza, Egypt.	rehab_hegazy@hotmail.com		Hegazy, Rehab/0000-0002-2586-2104; Salama, Abeer/0000-0001-9870-5583				Alsarra IA, 2011, ARCH PHARM RES, V34, P573, DOI 10.1007/s12272-011-0407-6; Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P173, DOI 10.1081/CLT-100102418; Block ML, 2009, TRENDS NEUROSCI, V32, P506, DOI 10.1016/j.tins.2009.05.009; Broom Oliver Jay, 2009, Ugeskr Laeger, V171, P243; Calderon-Garciduenas L, 2008, TOXICOL PATHOL, V36, P289, DOI 10.1177/0192623307313011; Calderon-Garciduenas L, 2013, EXP TOXICOL PATHOL, V65, P503, DOI 10.1016/j.etp.2012.02.006; Choi JI, 2010, PAIN, V149, P243, DOI 10.1016/j.pain.2010.02.008; Dayan AD, 2001, HUM EXP TOXICOL, V20, P439, DOI 10.1191/096032701682693062; DIAZMAYANS J, 1986, COMP BIOCHEM PHYS C, V83, P191, DOI 10.1016/0742-8413(86)90035-6; Drury R.A.B., 1967, CARLETONS HISTOLOGIC, P432; Fatima S, 2007, CLIN CHIM ACTA, V386, P94, DOI 10.1016/j.cca.2007.08.006; French C, 1997, DRUG CHEM TOXICOL, V20, P375, DOI 10.3109/01480549709003894; Gianutsos G, 1997, FUND APPL TOXICOL, V37, P102, DOI 10.1006/faat.1997.2306; Hao SY, 2016, MOLECULES, V21, DOI 10.3390/molecules21030325; Hegazy R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151486; Horie M, 2016, ANTIOXIDANTS-BASEL, V5, DOI 10.3390/antiox5010004; Huang LH, 2014, AEROSOL AIR QUAL RES, V14, P1939, DOI 10.4209/aaqr.2013.10.0312; ISHIKAWA Y, 1994, CANCER RES, V54, P2342; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; KAUPPILA T, 1991, EUR J PHARMACOL, V205, P177, DOI 10.1016/0014-2999(91)90817-A; Kaur P, 2016, ARTIF CELL NANOMED B, V44, P1167, DOI 10.3109/21691401.2015.1012260; Keane M, 2015, J OCCUPATIONAL ENV H; Kelly MA, 1998, J NEUROSCI, V18, P3470; Kleinman MT, 2008, TOXICOL LETT, V178, P127, DOI 10.1016/j.toxlet.2008.03.001; Kowalska S, 1983, Med Pr, V34, P171; Malik AS, 2003, J NEUROTRAUM, V20, P463, DOI 10.1089/089771503765355531; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mustafa G, 2016, DRUG DELIV, V23, P933, DOI 10.3109/10717544.2014.923064; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Pesch B, 2015, INT J HYG ENVIR HEAL, V218, P500, DOI 10.1016/j.ijheh.2015.04.004; Rajaram MVS, 2006, J IMMUNOL, V177, P6317, DOI 10.4049/jimmunol.177.9.6317; Salama A. A. A., 2014, Journal of Chemical and Pharmaceutical Research, V6, P168; Schneider BC, 2012, TOXICOL APPL PHARM, V259, P38, DOI 10.1016/j.taap.2011.12.001; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Suliburska J, 2014, BIOL TRACE ELEM RES, V157, P60, DOI 10.1007/s12011-013-9864-8; Sunderman FW, 2001, ANN CLIN LAB SCI, V31, P3; Tatem KS, 2014, JOVE-J VIS EXP, DOI 10.3791/51785; Toya T, 1999, IND HEALTH, V37, P36, DOI 10.2486/indhealth.37.36; Urbano AM, 2012, CURR DRUG METAB, V13, P284; Vichai V, 2005, INFLAMM RES, V54, P163, DOI 10.1007/s00011-004-1338-1; Wang Tianjing, 2015, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V33, P414; Wen RX, 2016, J APPL TOXICOL, V36, P445, DOI 10.1002/jat.3260; Werner ML, 2007, ENVIRON SCI TECHNOL, V41, P4919, DOI 10.1021/es070430q; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; Yoon JY, 2015, PHARMACOGN MAG, V11, P477, DOI [10.4103/0973-1296.60454, 10.4103/0973-1296.160454]	45	41	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168688	10.1371/journal.pone.0168688	http://dx.doi.org/10.1371/journal.pone.0168688			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997619	gold, Green Submitted, Green Published			2022-12-26	WOS:000392842900068
J	Sankar, CP; Asharaf, S; Kumar, KS				Sankar, C. Prem; Asharaf, S.; Kumar, K. Satheesh			Learning from Bees: An Approach for Influence Maximization on Viral Campaigns	PLOS ONE			English	Article							ALGORITHM	Maximisation of influence propagation is a key ingredient to any viral marketing or sociopolitical campaigns. However, it is an NP-hard problem, and various approximate algorithms have been suggested to address the issue, though not largely successful. In this paper, we propose a bio-inspired approach to select the initial set of nodes which is significant in rapid convergence towards a sub-optimal solution in minimal runtime. The performance of the algorithm is evaluated using the re-tweet network of the hashtag #KissofLove on Twitter associated with the non-violent protest against the moral policing spread to many parts of India. Comparison with existing centrality based node ranking process the proposed method significant improvement on influence propagation. The proposed algorithm is one of the hardly few bio-inspired algorithms in network theory. We also report the results of the exploratory analysis of the network kiss of love campaign.	[Sankar, C. Prem; Kumar, K. Satheesh] Univ Kerala, Dept Futures Studies, Kariyavattom 695581, Kerala, India; [Asharaf, S.] IIITM K, Thiruvananthapuram 695581, Kerala, India	University of Kerala	Kumar, KS (corresponding author), Univ Kerala, Dept Futures Studies, Kariyavattom 695581, Kerala, India.	kskumar@keralauniversity.ac.in	c, Prem Sankar/N-6643-2014	KUMAR P, SATHEESH/0000-0003-3643-3644; C, Prem Sankar/0000-0002-7053-0651				Achananuparp P, 2012, ACM TRANS MANAG INF, V3, DOI 10.1145/2361256.2361258; Akay B, 2012, INFORM SCIENCES, V192, P120, DOI 10.1016/j.ins.2010.07.015; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bojic I., 2012, COMPUTATIONAL SOCIAL, P51, DOI [10.1007/978-1-4471-4054-2_3, DOI 10.1007/978-1-4471-4054-2_3]; Brajevic I, 2013, J INTELL MANUF, V24, P729, DOI 10.1007/s10845-011-0621-6; Cha M., 2010, ICWSM, P10, DOI DOI 10.1093/JSCR/2010.10.10; Dorigo M, 1999, ARTIF LIFE, V5, P137, DOI 10.1162/106454699568728; Gao C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066732; Gonzalez-Bailon S, 2013, AM BEHAV SCI; Halim AH, 2014, NNGT J INT J INFORM, V1, P1; Jansen BJ, 2009, J AM SOC INF SCI TEC, V60, P2169, DOI 10.1002/asi.21149; Karaboga D., 2005, IDEA BASED HONEY BEE, DOI 10.1.1.714.4934; Karaboga D, 2007, J GLOBAL OPTIM, V39, P459, DOI 10.1007/s10898-007-9149-x; Karaboga D, 2009, APPL MATH COMPUT, V214, P108, DOI 10.1016/j.amc.2009.03.090; Kempe D, 2005, LECT NOTES COMPUT SC, V3580, P1127, DOI 10.1007/11523468_91; Kempe D., 2015, THEORY COMPUT, V11, P105, DOI [DOI 10.4086/T0C.2015.V011A004, 10.4086/toc.2015.v011a004, DOI 10.4086/TOC.2015.V011A004]; Kempe D, 2003, P 9 ACM SIGKDD INT C, V2003, P137, DOI DOI 10.1145/956750.956769; Kennedy J., 1995, P ICNN 95 INT C NEUR, P1942; Lambiotte R., 2008, LAPLACIAN DYNAMICS M; Narayanam R, 2011, IEEE T AUTOM SCI ENG, V8, P130, DOI 10.1109/TASE.2010.2052042; Nikolaev A, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P225, DOI 10.1145/2939672.2939681; Omkar SN, 2011, APPL SOFT COMPUT, V11, P489, DOI 10.1016/j.asoc.2009.12.008; Pan QK, 2011, INFORM SCIENCES, V181, P2455, DOI 10.1016/j.ins.2009.12.025; Pei S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05547; Richardson M., 2002, P 8 ACM SIGKDD INT C, P61, DOI DOI 10.1145/775047.775057; Rivero J, 2012, APPL INTELL, V36, P899, DOI 10.1007/s10489-011-0304-1; Rogers EM, 2004, J HEALTH COMMUN, V9, P13, DOI 10.1080/10810730490271449; Singh A, 2009, APPL SOFT COMPUT, V9, P625, DOI 10.1016/j.asoc.2008.09.001; Teodorovic DA, 2003, TRANSPORT PLAN TECHN, V26, P289, DOI 10.1080/0308106032000154593; Weng J., 2010, P 3 ACM INT C WEB SE, P261, DOI [10.1145/1718487.1718520, DOI 10.1145/1718487.1718520]; Wu F, 2004, PHYSICA A, V337, P327, DOI 10.1016/j.physa.2004.01.030; Wu XJ, 2012, APPL MECH MATER, V102-102, P315, DOI 10.4028/www.scientific.net/AMM.101-102.315; Xu CF, 2010, AEROSP SCI TECHNOL, V14, P535, DOI 10.1016/j.ast.2010.04.008; Yang X.-S., 2013, BRIEF REV NATURE INS; Zhang B, 2013, INT J MODEL IDENTIF, V18, P349; Zhang XY, 2014, IEEE T MAGN, V50, DOI 10.1109/TMAG.2013.2285161; Zhu YQ, 2015, J COMB OPTIM, V30, P97, DOI 10.1007/s10878-013-9635-7	37	25	26	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168125	10.1371/journal.pone.0168125	http://dx.doi.org/10.1371/journal.pone.0168125			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992472	gold, Green Published, Green Submitted			2022-12-26	WOS:000392842600037
J	Siebert, A; Goren, I; Pfeilschifter, J; Frank, S				Siebert, Anna; Goren, Itamar; Pfeilschifter, Josef; Frank, Stefan			Anti-Inflammatory Effects of Rosiglitazone in Obesity-Impaired Wound Healing Depend on Adipocyte Differentiation	PLOS ONE			English	Article							GROWTH-FACTOR EXPRESSION; ACTIVATED-RECEPTOR-GAMMA; DIABETIC OB/OB MICE; PPAR-GAMMA; NITRIC-OXIDE; CULTURED KERATINOCYTES; INSULIN-RESISTANCE; ADIPOSE-TISSUE; POTENTIAL ROLE; SKIN REPAIR	Combined diabetes-obesity syndromes severely impair regeneration of acute skin wounds in mouse models. This study assessed the contribution of subcutaneous adipose tissue to exacerbated wound inflammatory conditions. Genetically obese (ob/ob) mice showed an increased expression of positive transcriptional effectors of adipocyte differentiation such as Kruppel-like factor (KLF)-5 and peroxisome proliferator-activated receptor (PPAR)-gamma and an associated expression of leptin and fatty acid-binding protein (FABP)-4, but also CXCL2 in isolated subcutaneous fat. This observation in obese mice is in keeping with differentially elevated levels of KLF-5, PPAR-gamma, leptin, FABP-4 and CXCL2 in in vitro-differentiated 3T3-L1 adipocytes. Notably, CXCL2 expression restrictively appeared upon cytokine (IL-1 beta/TNF-alpha) stimulation only in mature, but not immature 3T3-L1 adipocytes. Of importance, the critical regulator of adipocyte maturation, PPAR-gamma, was merely expressed in the final phase of in-vitro induced adipocyte differentiation from 3T3-L1 pre-adipocytes. Consistently, the PPAR-gamma agonist rosiglitazone suppressed cytokine-induced CXCL2 release from mature adipocytes, but not from early 3T3-L1 adipocyte stages. The inhibitory effect of PPAR-gamma activation on CXCL2 release appeared to be a general anti-inflammatory effect in mature adipocytes, as cytokine-induced cyclooxygenase (Cox)-2 was simultaneously repressed by rosiglitazone. In accordance with these findings, oral administration of rosiglitazone to wounded obese mice significantly changed subcutaneous adipocyte morphology, reduced wound CXCL2 and Cox-2 expression and improved tissue regeneration. Thus, our data suggest that PPAR-gamma might provide a target to suppress inflammatory signals from mature adipocytes, which add to the prolonged wound inflammation observed in diabetes-obesity conditions.	[Siebert, Anna; Goren, Itamar; Pfeilschifter, Josef; Frank, Stefan] Klinikum Johann Wolfgang Goethe Univ, Pharmazentrum Frankfurt ZAFES, Theodor Stern Kai 7, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital	Goren, I (corresponding author), Klinikum Johann Wolfgang Goethe Univ, Pharmazentrum Frankfurt ZAFES, Theodor Stern Kai 7, Frankfurt, Germany.	goren@chemie.uni-frankfurt.de			Deutsche Forschungsgemeinschaft (DFG) [GRK 1172]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Support was provided by Deutsche Forschungsgemeinschaft (DFG), GRK 1172, http://www.dfg.de/, to SF and JP.	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; APELQVIST J, 1993, J INTERN MED, V233, P485, DOI 10.1111/j.1365-2796.1993.tb01003.x; Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Carrington AL, 2001, DIABETES CARE, V24, P216, DOI 10.2337/diacare.24.2.216; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; deMora JF, 1997, MOL CELL BIOL, V17, P6068, DOI 10.1128/MCB.17.10.6068; DISTEL RJ, 1987, CELL, V49, P835, DOI 10.1016/0092-8674(87)90621-0; Faglia E, 2001, DIABETES CARE, V24, P78, DOI 10.2337/diacare.24.1.78; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Frank S, 1999, FASEB J, V13, P2002, DOI 10.1096/fasebj.13.14.2002; FRANK S, 1995, J BIOL CHEM, V270, P12607, DOI 10.1074/jbc.270.21.12607; Frank S, 2000, J CLIN INVEST, V106, P501, DOI 10.1172/JCI9148; GELOEN A, 1989, AM J PHYSIOL, V257, pE547, DOI 10.1152/ajpendo.1989.257.4.E547; GOODSON WH, 1986, DIABETES, V35, P491, DOI 10.2337/diab.35.4.491; Goren I, 2006, AM J PATHOL, V168, P765, DOI 10.2353/ajpath.2006.050293; Goren I, 2003, DIABETES, V52, P2821, DOI 10.2337/diabetes.52.11.2821; Goren I, 2007, J INVEST DERMATOL, V127, P2259, DOI 10.1038/sj.jid.5700842; Goren I, 2009, J INVEST DERMATOL, V129, P752, DOI 10.1038/jid.2008.230; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; GREENHALGH DG, 1990, AM J PATHOL, V136, P1235; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Henry RR, 1997, ENDOCRIN METAB CLIN, V26, P553, DOI 10.1016/S0889-8529(05)70267-X; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; Jequier E, 2002, ANN NY ACAD SCI, V967, P379, DOI 10.1111/j.1749-6632.2002.tb04293.x; Kampfer H, 2001, LAB INVEST, V81, P361, DOI 10.1038/labinvest.3780244; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kloting N, 2014, REV ENDOCR METAB DIS, V15, P277, DOI 10.1007/s11154-014-9301-0; Kralisch S, 2013, DIABETOLOGIA, V56, P10, DOI 10.1007/s00125-012-2737-4; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Kumar A, 2015, FUTURE MED CHEM, V7, P2065, DOI 10.4155/fmc.15.132; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; LEIBOVICH SJ, 1975, AM J PATHOL, V78, P71; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Ptasinska A, 2007, FASEB J, V21, P950, DOI 10.1096/fj.06-6822com; Rangwala SM, 2003, DEV CELL, V5, P657, DOI 10.1016/S1534-5807(03)00274-0; Rangwala SM, 2004, TRENDS PHARMACOL SCI, V25, P331, DOI 10.1016/j.tips.2004.03.012; Reiber GE, 1998, AM J SURG, V176, p5S, DOI 10.1016/S0002-9610(98)00181-0; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Sakaue H, 2004, J BIOL CHEM, V279, P39951, DOI 10.1074/jbc.M407353200; SALE EM, 1995, EMBO J, V14, P674, DOI 10.1002/j.1460-2075.1995.tb07046.x; Sarjeant K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008417; Seitz O, 2010, EXP DIABETES RES, DOI 10.1155/2010/476969; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Siegmund B, 2002, GASTROENTEROLOGY, V122, P2011, DOI 10.1053/gast.2002.33631; SIMPSON DM, 1972, J CLIN INVEST, V51, P2009, DOI 10.1172/JCI107007; Stallmeyer B, 1999, J INVEST DERMATOL, V113, P1090, DOI 10.1046/j.1523-1747.1999.00784.x; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; TSUBOI R, 1990, J EXP MED, V172, P245, DOI 10.1084/jem.172.1.245; WAHL SM, 1974, AM J PATHOL, V75, P73; Walsh JW, 2015, DIAB MED; Wang SB, 2016, PHARMACOL RES, V111, P76, DOI 10.1016/j.phrs.2016.02.028; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; WERNER S, 1994, J INVEST DERMATOL, V103, P469, DOI 10.1111/1523-1747.ep12395564; Wetzler C, 2000, J INVEST DERMATOL, V115, P245, DOI 10.1046/j.1523-1747.2000.00029.x; WIDMER U, 1993, J IMMUNOL, V150, P4996; Wright MB, 2014, MOL ENDOCRINOL, V28, P1756, DOI 10.1210/me.2013-1427; Yaacob NS, 2009, J CLIN IMMUNOL, V29, P595, DOI 10.1007/s10875-009-9300-1; Zebisch K, 2012, ANAL BIOCHEM, V425, P88, DOI 10.1016/j.ab.2012.03.005; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zick Y, 2001, TRENDS CELL BIOL, V11, P437, DOI 10.1016/S0962-8924(01)02129-8; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	70	11	12	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168562	10.1371/journal.pone.0168562	http://dx.doi.org/10.1371/journal.pone.0168562			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992530	Green Published, gold, Green Submitted			2022-12-26	WOS:000392842600076
J	Tellapragada, C; Kamthan, A; Shaw, T; Vandana, KE; Kumar, S; Bhat, V; Mukhopadhyay, C				Tellapragada, Chaitanya; Kamthan, Aayushi; Shaw, Tushar; Vandana, K. E.; Kumar, Subodh; Bhat, Vinod; Mukhopadhyay, Chiranjay			Unravelling the Molecular Epidemiology and Genetic Diversity among Burkholderia pseudomallei Isolates from South India Using Multi-Locus Sequence Typing	PLoS One			English	Article							MELIOIDOSIS	There is a slow but steady rise in the case detection rates of melioidosis from various parts of the Indian sub-continent in the past two decades. However, the epidemiology of the disease in India and the surrounding South Asian countries remains far from well elucidated. Multi-locus sequence typing (MLST) is a useful epidemiological tool to study the genetic relatedness of bacterial isolates both with-in and across the countries. With this background, we studied the molecular epidemiology of 32 Burkholderia pseudomallei isolates (31 clinical and 1 soil isolate) obtained during 2006-2015 from various parts of south India using multi-locus sequencing typing and analysis. Of the 32 isolates included in the analysis, 30 (93.7%) had novel allelic profiles that were not reported previously. Sequence type (ST) 1368 (n = 15, 46.8%) with allelic profile (1, 4, 6, 4, 1, 1, 3) was the most common genotype observed. We did not observe a genotypic association of STs with geographical location, type of infection and year of isolation in the present study. Measure of genetic differentiation (F-ST) between Indian and the rest of world isolates was 0.14413. Occurrence of the same ST across three adjacent states of south India suggest the dispersion of B.pseudomallei across the south western coastal part of India with limited geographical clustering. However, majority of the STs reported from the present study remained as "outliers" on the eBURST "Population snapshot", suggesting the genetic diversity of Indian isolates from the Australasian and Southeast Asian isolates.	[Tellapragada, Chaitanya; Shaw, Tushar; Vandana, K. E.; Mukhopadhyay, Chiranjay] Manipal Univ, Kasturba Med Coll, Dept Microbiol, Manipal, India; [Kamthan, Aayushi; Kumar, Subodh] Def Res & Dev Org, Div Microbiol, Gwalior, India; [Bhat, Vinod] Manipal Univ, Kasturba Med Coll, Dept Community Med, Manipal, India	Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; Defence Research & Development Organisation (DRDO); Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal	Mukhopadhyay, C (corresponding author), Manipal Univ, Kasturba Med Coll, Dept Microbiol, Manipal, India.	chiranjay.m@manipal.edu	Shaw, Tushar/AAP-7846-2020; Tellapragada, Chaitanya/AAS-1232-2021; Mukhopadhyay, Chiranjay/GLU-2887-2022	Mukhopadhyay, Chiranjay/0000-0003-0402-1143; Tellapragada, chaitanya/0000-0002-0117-5369; Kumar, Subodh/0000-0002-8764-3361	Indian Council of Medical Research [2012-0465]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	The study was funded by Indian Council of Medical Research (2012-0465). Part of the work was also carried out at Defense Research and Development Organization India where experiment and data analysis was carried. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anuradha K, 2003, Indian J Med Microbiol, V21, P129; Corea EM, 2016, AM J TROP MED HYG, V94, P292, DOI 10.4269/ajtmh.15-0567; Currie BJ, 2000, CLIN INFECT DIS, V31, P981, DOI 10.1086/318116; Godoy D, 2003, J CLIN MICROBIOL, V41, P2068, DOI 10.1128/JCM.41.5.2068-2079.2003; Gopalakrishnan R., 2013, Journal of the Association of Physicians of India, V61, P24; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Limmathurotsakul D, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.8, 10.1038/nmicrobiol.2015.8]; McCombie RL, 2006, J CLIN MICROBIOL, V44, P2951, DOI 10.1128/JCM.00725-06; Mukhopadhyay C, 2011, AM J TROP MED HYG, V85, P121, DOI 10.4269/ajtmh.2011.11-0166; Pearson T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-78; Vandana K, 2010, MELIOIDOSIS SO INDIA	11	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168331	10.1371/journal.pone.0168331	http://dx.doi.org/10.1371/journal.pone.0168331			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992477	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842600049
J	Liu, RS; Wang, J; Shang, XK; Wang, YY; Su, ZX; Cai, Y				Liu, Risheng; Wang, Jing; Shang, Xiaoke; Wang, Yiyang; Su, Zhixun; Cai, Yu			Sparse Coding and Counting for Robust Visual Tracking	PLOS ONE			English	Article							OBJECT TRACKING; PURSUIT	In this paper, we propose a novel sparse coding and counting method under Bayesian framework for visual tracking. In contrast to existing methods, the proposed method employs the combination of L-0 and L-1 norm to regularize the linear coefficients of incrementally updated linear basis. The sparsity constraint enables the tracker to effectively handle difficult challenges, such as occlusion or image corruption. To achieve real-time processing, we propose a fast and efficient numerical algorithm for solving the proposed model. Although it is an NP-hard problem, the proposed accelerated proximal gradient (APG) approach is guaranteed to converge to a solution quickly. Besides, we provide a closed solution of combining L-0 and L-1 regularized representation to obtain better sparsity. Experimental results on challenging video sequences demonstrate that the proposed method achieves state-of-the-art results both in accuracy and speed.	[Liu, Risheng] Dalian Univ Technol, Sch Software Technol, Dalian, Liaoning Provin, Peoples R China; [Liu, Risheng] Key Lab Ubiquitous Network & Serv Software Liaoni, Dalian, Liaoning Provin, Peoples R China; [Wang, Jing; Wang, Yiyang; Su, Zhixun; Cai, Yu] Dalian Univ Technol, Sch Math Sci, Dalian, Liaoning Provin, Peoples R China; [Shang, Xiaoke] Luxun Acad Fine Arts, Dalian Campus, Dalian, Liaoning Provin, Peoples R China	Dalian University of Technology; Dalian University of Technology; Lu Xun Academy of Fine Arts	Liu, RS (corresponding author), Dalian Univ Technol, Sch Software Technol, Dalian, Liaoning Provin, Peoples R China.; Liu, RS (corresponding author), Key Lab Ubiquitous Network & Serv Software Liaoni, Dalian, Liaoning Provin, Peoples R China.	rsliu@dlut.edu.cn		Wang, Yiyang/0000-0002-8924-3468	National Natural Science Foundation of China [61672125, 61300086, 61432003]; Fundamental Research Funds for the Central Universities [DUT15QY15]; Hong Kong Scholar Program [XJ2015008]; National Science and Technology Major Project [2013ZX04005-021, 2014ZX001011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Hong Kong Scholar Program; National Science and Technology Major Project	This work is partially supported by the National Natural Science Foundation of China (Nos. 61672125, 61300086, 61432003), the Fundamental Research Funds for the Central Universities (DUT15QY15), the Hong Kong Scholar Program (No. XJ2015008), and National Science and Technology Major Project (Nos. 2013ZX04005-021, 2014ZX001011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babenko B, 2009, PROC CVPR IEEE, P983, DOI 10.1109/CVPRW.2009.5206737; Bai QX, 2013, IEEE I CONF COMP VIS, P2040, DOI 10.1109/ICCV.2013.255; BAO CL, 2012, PROC CVPR IEEE, P1830, DOI DOI 10.1109/CVPR.2012.6247881; Hare S, 2011, IEEE I CONF COMP VIS, P263, DOI 10.1109/ICCV.2011.6126251; Jepson AD, 2003, IEEE T PATTERN ANAL, V25, P1296, DOI 10.1109/TPAMI.2003.1233903; Jia X, 2012, PROC CVPR IEEE, P1822, DOI 10.1109/CVPR.2012.6247880; Jin W, 2014, IEEE INT CON MULTI; Kalal Z, 2012, IEEE T PATTERN ANAL, V34, P1409, DOI 10.1109/TPAMI.2011.239; Levy A, 2000, IEEE T IMAGE PROCESS, V9, P1371, DOI 10.1109/83.855432; Lin Z., 2009, P COMP ADV MULT AD P; Liu BY, 2010, LECT NOTES COMPUT SC, V6314, P624; Liu RS, 2014, IEEE MULTIMEDIA, V21, P47, DOI 10.1109/MMUL.2014.49; Liu RS, 2014, NEUROCOMPUTING, V142, P529, DOI 10.1016/j.neucom.2014.03.046; Liu R, 2009, IEEE I CONF COMP VIS, P1459, DOI 10.1109/ICCV.2009.5459285; Lu XQ, 2013, IEEE T NEUR NET LEAR, V24, P929, DOI 10.1109/TNNLS.2013.2245914; Mei X, 2009, IEEE I CONF COMP VIS, P1436, DOI 10.1109/ICCV.2009.5459292; Pan J, 2013, BMVC; Ross DA, 2008, INT J COMPUT VISION, V77, P125, DOI 10.1007/s11263-007-0075-7; Tseng P., 2008, SIAM J OPTIMIZ UNPUB; Vojfr T., 2014, REGISTRATION RECOGNI, P113, DOI DOI 10.1007/978-3-642-44907-9_6; Wang D, 2013, PROC CVPR IEEE, P2371, DOI 10.1109/CVPR.2013.307; Wang D, 2013, IEEE T IMAGE PROCESS, V22, P314, DOI 10.1109/TIP.2012.2202677; Wu Y, 2013, PROC CVPR IEEE, P2411, DOI 10.1109/CVPR.2013.312; Zhang CC, 2014, NEUROCOMPUTING, V131, P237, DOI 10.1016/j.neucom.2013.10.020; Zhang L, 2013, PROC CVPR IEEE, P1838, DOI 10.1109/CVPR.2013.240; Zhang TZ, 2013, INT J COMPUT VISION, V101, P367, DOI 10.1007/s11263-012-0582-z; ZHANG TZ, 2015, PROC CVPR IEEE, P150, DOI DOI 10.1109/CVPR.2015.7298610; Zhong W, 2012, PROC CVPR IEEE, P1838, DOI 10.1109/CVPR.2012.6247882	28	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168093	10.1371/journal.pone.0168093	http://dx.doi.org/10.1371/journal.pone.0168093			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992474	gold, Green Published, Green Submitted			2022-12-26	WOS:000392758000027
J	Tavares, DC; de Moura, JF; Siciliano, S				Tavares, Davi Castro; de Moura, Jailson Fulgencio; Siciliano, Salvatore			Environmental Predictors of Seabird Wrecks in a Tropical Coastal Area	PLOS ONE			English	Article							BEACHED BIRD SURVEYS; BOOBY SULA-LEUCOGASTER; MARINE OIL POLLUTION; CLIMATE-CHANGE; BODY-SIZE; WATER CLARITY; SEA; INGESTION; MORTALITY; PRODUCTIVITY	Beached bird surveys have been widely used to monitor the impact of oil pollution in the oceans. However, separating the combined effects of oil pollution, environmental variables and methodological aspects of beach monitoring on seabird stranding patterns is a challenging task. The effects of a comprehensive set of oceanographic and climatic variables and oil pollution on seabird strandings in a tropical area of Brazil were investigated herein, using two robust and innovative methods: Generalized Linear Mixed Models and Structural Equation Modeling. We assessed strandings of four resident seabird species along 480 km of beaches divided into 11 sampling areas, between November 2010 and September 2013. We found that increasing the distance from the nearest breeding island reduce the seabird stranding events. Storm activity and biological productivity were the most important factors affecting the stranding events of brown boobies Sula leucogaster, Cabot's terns Thalasseus acuflavidus and kelp gulls Larus dominicanus. These species are also indirectly affected by warm tropical waters, which reduce chlorophyll-a concentrations. Beach surveys are, thus, useful to investigate the mortality rates of resident species near breeding sites, where individuals are more abundant and exposed to local factors associated with at-sea mortality. In contrast, conservation actions and monitoring programs for far-ranging seabird species are needed in more distant foraging areas. Furthermore, beach monitoring programs investigating the impact of oil pollution on seabirds need to account for the effects of environmental factors on stranding patterns. The present study also demonstrated that seabirds inhabiting tropical coastal waters are sensitive to climate conditions such as adverse weather, which are expected to increase in frequency and intensity in next decades.	[Tavares, Davi Castro] Univ Estadual Norte Fluminense, Lab Ciencias Ambientais, Campos Dos Goytacazes, RJ, Brazil; [de Moura, Jailson Fulgencio] Leibniz Ctr Trop Marine Ecol, Syst Ecol Grp, Bremen, Germany; [Siciliano, Salvatore] Fiocruz MS, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil	Universidade Estadual do Norte Fluminense; Leibniz Zentrum fur Marine Tropenforschung (ZMT); Fundacao Oswaldo Cruz	Tavares, DC (corresponding author), Univ Estadual Norte Fluminense, Lab Ciencias Ambientais, Campos Dos Goytacazes, RJ, Brazil.	wetlandbirdsbrazil@gmail.com	Siciliano, Salvatore/ABD-3352-2020; Siciliano, Salvatore/H-7670-2015; Moura, Jailson F./O-4315-2019; Tavares, Davi Castro/H-7960-2015	Siciliano, Salvatore/0000-0002-0124-8070; Moura, Jailson F./0000-0003-3601-3957; Tavares, Davi Castro/0000-0002-6811-9572	CAPES; Alexander von Humboldt Foundation [BEX 0128/ 14-7]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	JF Moura gratefully acknowledges CAPES and the Alexander von Humboldt Foundation for financial support (Proc. BEX 0128/ 14-7). DC Tavares is supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES.	Adams J, 2010, MAR BIOL, V157, P915, DOI 10.1007/s00227-009-1367-y; Ainley D. G., 1977, ADAPTATIONS ANTARCTI, P669; Alves VS, 2004, AVES MARINHAS INSULA, P83; Ancona S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072665; Anderson Orea R. J., 2011, Endangered Species Research, V14, P91, DOI 10.3354/esr00347; ASCHOFF J, 1981, COMP BIOCHEM PHYS A, V69, P611, DOI 10.1016/0300-9629(81)90145-6; BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; Bakun A., 1973, COASTAL UPWELLING IN, P103; Bandalos DL, 2014, STRUCT EQU MODELING, V21, P102, DOI 10.1080/10705511.2014.859510; Baptist MJ, 2010, IBIS, V152, P815, DOI 10.1111/j.1474-919X.2010.01054.x; BLUEWEISS L, 1978, OECOLOGIA, V37, P257, DOI 10.1007/BF00344996; BOERSMA PD, 1986, SCIENCE, V231, P373, DOI 10.1126/science.231.4736.373; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Briggs KT, 1997, ICES J MAR SCI, V54, P718, DOI 10.1006/jmsc.1997.0254; Bugoni L, 2007, WILSON J ORNITHOL, V119, P725, DOI 10.1676/06-141.1; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Camphysen CJ, 2001, ENVIRON POLLUT, V112, P443, DOI 10.1016/S0269-7491(00)00138-X; Cardoso Maria Duarte, 2014, Aquatic Biosystems, V10, P6, DOI 10.1186/2046-9063-10-6; Castege I, 2007, ARDEOLA, V54, P289; Chambers LE, 2011, EMU, V111, P235, DOI 10.1071/MU10033; Chapin FS, 2016, ECOLOGY; Coelho EP, 2004, AVES MARINHAS INSULA, P233; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; Davies RG, 2010, GLOBAL ECOL BIOGEOGR, V19, P98, DOI 10.1111/j.1466-8238.2009.00498.x; Dawson W. L., 1911, Condor Hollywood, V13, DOI 10.2307/1361963; de Moura JF, 2015, MAR POLLUT BULL, V95, P402, DOI 10.1016/j.marpolbul.2015.03.038; de Moura Jailson Fulgencio, 2009, Marine Biodiversity Records, V2, pe66, DOI 10.1017/S1755267209000803; Edenhofer O., 2014, CONTRIBUTION WORKING; Efe MA, 2011, REV BRAS ORNITOL, V19, P358; Epskamp S, 2015, STRUCT EQU MODELING, V22, P474, DOI 10.1080/10705511.2014.937847; Fiedler PC, 2013, MAR ECOL PROG SER, V484, P1, DOI 10.3354/meps10378; Finney SK, 1999, J AVIAN BIOL, V30, P23, DOI 10.2307/3677239; Fonderflick J, 2015, BIOL CONSERV, V192, P120, DOI 10.1016/j.biocon.2015.09.012; Ford R. Glenn, 2009, Marine Ornithology, V37, P205; Ford R. Glenn, 2006, Marine Ornithology, V34, P91; Fort J, 2015, SCI TOTAL ENVIRON, V527, P448, DOI 10.1016/j.scitotenv.2015.05.018; Fulmer EB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134734; Garcia-Borboroglu P, 2006, MAR POLLUT BULL, V52, P193, DOI 10.1016/j.marpolbul.2005.11.004; Garcia-Borboroglu P, 2010, MAR POLLUT BULL, V60, P1652, DOI 10.1016/j.marpolbul.2010.07.006; Garthe S, 2009, MAR ECOL PROG SER, V391, P243, DOI 10.3354/meps08170; Geraci J. R., 2005, MARINE MAMMALS ASHOR; Godoy JM, 2014, J ENVIRON RADIOACTIV, V135, P108, DOI 10.1016/j.jenvrad.2014.04.008; Gomez-Gesteira M, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003331; Grace J.B., 2006, STRUCT EQ MOD NAT; Grace JB, 2016, NATURE, V529, P390, DOI 10.1038/nature16524; Grace JB, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00048.1; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Hampton Steve, 2006, Marine Ornithology, V34, P109; Haney JC, 2014, MAR ECOL PROG SER, V513, P239, DOI 10.3354/meps10839; HANEY JC, 1988, MAR ECOL PROG SER, V49, P1, DOI 10.3354/meps049001; Hansen JE, 2001, FISH OCEANOGR, V10, P193, DOI 10.1046/j.1365-2419.2001.00166.x; Hart KM, 2006, BIOL CONSERV, V129, P283, DOI 10.1016/j.biocon.2005.10.047; Hass T, 2012, MAR ECOL PROG SER, V454, P251, DOI 10.3354/meps09723; Henkel LA, 2006, J FIELD ORNITHOL, V77, P151, DOI 10.1111/j.1557-9263.2006.00035.x; Henkel LA, 2014, MAR POLLUT BULL, V79, P155, DOI 10.1016/j.marpolbul.2013.12.023; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hyrenbach KD, 2007, DEEP-SEA RES PT I, V54, P1129, DOI 10.1016/j.dsr.2007.05.002; IPCC, 2007, SYNTH REP 4 ASS REP; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Krueger Lucas, 2011, Oecologia Australis, V15, P51; LANGHAM NP, 1986, EMU, V86, P23, DOI 10.1071/MU9860023; Lavers JL, 2014, ENVIRON POLLUT, V187, P124, DOI 10.1016/j.envpol.2013.12.020; Long DG., 1994, DISPLAY COMPUTATION; Madsen V, 2007, AM NAT, V169, pS93, DOI 10.1086/510096; Mateus M, 2014, FORENSIC SCI INT, V238, pE15, DOI 10.1016/j.forsciint.2014.02.026; MATSUURA Y, 1975, Boletim do Instituto Oceanografico, V24, P31; Maurel N, 2016, GLOBAL ECOL BIOGEOGR; Mohriak WU, 2012, GEOL SOC SPEC PUBL, V363, P131, DOI 10.1144/SP363.7; Morrison KW, 2011, AUK, V128, P707, DOI 10.1525/auk.2011.10198; Moura JF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146108; Moura JF, 2012, BIODIVERS CONSERV, P263; Munilla I, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00020.1; Newman Scott H., 2006, Marine Ornithology, V34, P87; Newton I, 2006, J ORNITHOL, V147, P146, DOI 10.1007/s10336-006-0058-4; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Newton KM, 2009, MAR ECOL PROG SER, V392, P295, DOI 10.3354/meps08152; Nummi P, 2013, IBIS, V155, P68, DOI 10.1111/ibi.12013; O'Hara P. D., 2006, Marine Ornithology, V34, P133; Page G.W., 1990, Studies in Avian Biology, P164; Paleczny M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129342; Parrish JK, 2007, MAR ECOL PROG SER, V352, P275, DOI 10.3354/meps07077; Phillips RA, 2010, BIOL CONSERV, V143, P501, DOI 10.1016/j.biocon.2009.11.020; Prado JHF, 2013, ECOL INDIC, V32, P35, DOI 10.1016/j.ecolind.2013.03.005; Rosseel Y, 2013, LAVAAN LATENT VARIAB; Schreiber Elizabeth, 2002, BIOL MARINE BIRDS, DOI 10.1201/9781420036305; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Schwing FB, 1996, NOAA TECH MEMO NMFS; Seys J, 2002, MAR POLLUT BULL, V44, P322, DOI 10.1016/S0025-326X(01)00262-4; Shealer D., 1999, BIRDS N AM, P566; Soanes LM, 2016, MAR POLICY, V70, P85, DOI 10.1016/j.marpol.2016.04.019; Speakman JR, 2005, J EXP BIOL, V208, P1717, DOI 10.1242/jeb.01556; Sydeman WJ, 2015, SCIENCE, V350, P772, DOI 10.1126/science.aac9874; Tavares DC, 2016, ECOL INDIC, V70, P10, DOI 10.1016/j.ecolind.2016.06.005; Tavares DC, 2015, BIOL CONSERV, V186, P12, DOI 10.1016/j.biocon.2015.02.027; Tavares Davi Castro, 2013, Check List, V9, P806; Tavares Davi Castro, 2013, Journal of Threatened Taxa, V5, P4586; Valentin JL, 2001, ECOL STU AN, V144, P97; Verlis KM, 2014, MAR POLLUT BULL, V87, P180, DOI 10.1016/j.marpolbul.2014.07.060; Verwey J., 1915, LEVENDE NAT, V20; Votier SC, 2008, J ANIM ECOL, V77, P974, DOI 10.1111/j.1365-2656.2008.01421.x; Votier SC, 2005, ECOL LETT, V8, P1157, DOI 10.1111/j.1461-0248.2005.00818.x; Weimerskirch H, 2008, MAR ECOL PROG SER, V362, P291, DOI 10.3354/meps07424; Weimerskirch H, 2012, SCIENCE, V335, P211, DOI 10.1126/science.1210270; Weimerskirch H, 2009, MAR ECOL PROG SER, V391, P267, DOI 10.3354/meps07981; Wiese FK, 2003, MAR POLLUT BULL, V46, P1090, DOI 10.1016/S0025-326X(03)00250-9; Wiese Francis K., 2006, Marine Ornithology, V34, P157; Wilhelm SI, 2009, MAR POLLUT BULL, V58, P249, DOI 10.1016/j.marpolbul.2008.09.018; Wolf SG, 2010, GLOBAL CHANGE BIOL, V16, P1923, DOI 10.1111/j.1365-2486.2010.02194.x; Wolfaardt Anton C., 2012, Marine Ornithology, V40, P129; Woodruff JD, 2013, NATURE, V504, P44, DOI 10.1038/nature12855; Zuur Alain F., 2009, P1; Zydelis R, 2009, BIOL CONSERV, V142, P1269, DOI 10.1016/j.biocon.2009.02.025	112	21	21	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168717	10.1371/journal.pone.0168717	http://dx.doi.org/10.1371/journal.pone.0168717			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992578	Green Published, Green Submitted, gold			2022-12-26	WOS:000392758000075
J	Ibrahim, J; Eisen, JA; Jospin, G; Coil, DA; Khazen, G; Tokajian, S				Ibrahim, Joe; Eisen, Jonathan A.; Jospin, Guillaume; Coil, David A.; Khazen, Georges; Tokajian, Sima			Genome Analysis of Streptococcus pyogenes Associated with Pharyngitis and Skin Infections	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; SHOCK-LIKE SYNDROME; MOLECULAR CHARACTERIZATION; SIGMA-FACTOR; EMM TYPE; TETRACYCLINE RESISTANCE; ERYTHROMYCIN RESISTANCE; REDUCED SUSCEPTIBILITY; SUPERANTIGEN GENE; IMMUNE EVASION	Streptococcus pyogenes is a very important human pathogen, commonly associated with skin or throat infections but can also cause life-threatening situations including sepsis, streptococcal toxic shock syndrome, and necrotizing fasciitis. Various studies involving typing and molecular characterization of S. pyogenes have been published to date; however next-generation sequencing (NGS) studies provide a comprehensive collection of an organism's genetic variation. In this study, the genomes of nine S. pyogenes isolates associated with pharyngitis and skin infection were sequenced and studied for the presence of virulence genes, resistance elements, prophages, genomic recombination, and other genomic features. Additionally, a comparative phylogenetic analysis of the isolates with global clones highlighted their possible evolutionary lineage and their site of infection. The genomes were found to also house a multitude of features including gene regulation systems, virulence factors and antimicrobial resistance mechanisms.	[Ibrahim, Joe; Tokajian, Sima] Lebanese Amer Univ, Sch Arts & Sci, Dept Nat Sci, Byblos, Lebanon; [Eisen, Jonathan A.; Jospin, Guillaume; Coil, David A.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Khazen, Georges] Lebanese Amer Univ, Sch Arts & Sci, Dept Comp Sci & Math, Byblos, Lebanon	Lebanese American University; University of California System; University of California Davis; Lebanese American University	Tokajian, S (corresponding author), Lebanese Amer Univ, Sch Arts & Sci, Dept Nat Sci, Byblos, Lebanon.	stokajian@lau.edu.lb	Khazen, Georges/AAC-2923-2020; Tokajian, Sima T/G-9644-2018; Eisen, Jonathan A./H-2706-2019	Tokajian, Sima T/0000-0002-3653-8940; Eisen, Jonathan A./0000-0002-0159-2197; Khazen, Geroges/0000-0002-9244-2978; Jospin, Guillaume/0000-0002-8746-2632; Ibrahim, Joe/0000-0001-9728-5273				Agniswamy J, 2004, J BIOL CHEM, V279, P52789, DOI 10.1074/jbc.M410698200; Akesson P, 1996, J BIOL CHEM, V271, P1081, DOI 10.1074/jbc.271.2.1081; Albrich WC, 2004, EMERG INFECT DIS, V10, P514, DOI 10.3201/eid1003.030252; Ardanuy C, 2010, J ANTIMICROB CHEMOTH, V65, P634, DOI 10.1093/jac/dkq006; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Aziz RK, 2004, MOL MICROBIOL, V54, P184, DOI 10.1111/j.1365-2958.2004.04255.x; Bahnan W, 2011, J MED MICROBIOL, V60, P98, DOI 10.1099/jmm.0.023317-0; Banks DJ, 2004, J INFECT DIS, V190, P727, DOI 10.1086/422697; Banks DJ, 2003, J INFECT DIS, V188, P1898, DOI 10.1086/379897; Ben Zakour NL, 2012, J CLIN MICROBIOL, V50, P2224, DOI 10.1128/JCM.00675-12; Beres SB, 2006, P NATL ACAD SCI USA, V103, P7059, DOI 10.1073/pnas.0510279103; Beres SB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000800; Bessen DE, 2002, INFECT IMMUN, V70, P1159, DOI 10.1128/IAI.70.3.1159-1167.2002; Bisno A.L., 1980, STREPTOCOCCAL DISEAS, P789; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; Brenciani A, 2010, ANTIMICROB AGENTS CH, V54, P221, DOI 10.1128/AAC.00499-09; Canchaya C, 2004, MOL MICROBIOL, V53, P9, DOI 10.1111/j.1365-2958.2004.04113.x; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chan JCK, 2009, PATHOLOGY, V41, P681, DOI 10.3109/00313020903257723; CHEN CC, 1990, J BIOL CHEM, V265, P3161; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Christensen BB, 1999, J BACTERIOL, V181, P2683, DOI 10.1128/JB.181.9.2683-2688.1999; Coil D, 2015, BIOINFORMATICS, V31, P587, DOI 10.1093/bioinformatics/btu661; Commons R, 2008, J MED MICROBIOL, V57, P1238, DOI 10.1099/jmm.0.2008/001156-0; Commons RJ, 2014, TRENDS MOL MED, V20, P48, DOI 10.1016/j.molmed.2013.10.004; Cosentino S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077302; CROOKE E, 1993, J MOL BIOL, V233, P16, DOI 10.1006/jmbi.1993.1481; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dalton TL, 2004, J BACTERIOL, V186, P3928, DOI 10.1128/JB.186.12.3928-3937.2004; Darling AE, 2014, PEERJ, V2, DOI 10.7717/peerj.243; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Davies MR, 2015, NAT GENET, V47, P84, DOI 10.1038/ng.3147; DeLasPenas A., 1997, J BACTERIOL, V179, P6862, DOI [10.1128/jb.179.21.6862-6864.1997, DOI 10.1128/JB.179.21.6862-6864.1997]; Enright MC, 2001, INFECT IMMUN, V69, P2416, DOI 10.1128/IAI.69.4.2416-2427.2001; Farmand S, 2012, EUR J CLIN MICROBIOL, V31, P707, DOI 10.1007/s10096-011-1362-3; Feklistov A, 2014, ANNU REV MICROBIOL, V68, P357, DOI 10.1146/annurev-micro-092412-155737; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Fischetti VA, 2007, TRENDS MICROBIOL, V15, P297, DOI 10.1016/j.tim.2007.05.003; Fittipaldi N, 2012, AM J PATHOL, V180, P1522, DOI 10.1016/j.ajpath.2011.12.037; Gao F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-79; Gao F, 2013, NUCLEIC ACIDS RES, V41, pD90, DOI 10.1093/nar/gks990; Gase K, 1999, INFECT IMMUN, V67, P4725, DOI 10.1128/IAI.67.9.4725-4731.1999; Giovanetti E, 2012, ANTIMICROB AGENTS CH, V56, P591, DOI 10.1128/AAC.05352-11; Green NM, 2005, J INFECT DIS, V192, P760, DOI 10.1086/430618; Hoe NP, 2001, J INFECT DIS, V183, P633, DOI 10.1086/318543; Holden MTG, 2007, J BACTERIOL, V189, P1473, DOI 10.1128/JB.01227-06; HOLLINGSHEAD SK, 1993, MOL MICROBIOL, V8, P707, DOI 10.1111/j.1365-2958.1993.tb01614.x; Homuth G, 1997, J BACTERIOL, V179, P1153, DOI 10.1128/jb.179.4.1153-1164.1997; Hondorp ER, 2007, MOL MICROBIOL, V66, P1056, DOI 10.1111/j.1365-2958.2007.06006.x; Hondorp ER, 2013, MOL MICROBIOL, V88, P1176, DOI 10.1111/mmi.12250; HORSTMANN RD, 1988, P NATL ACAD SCI USA, V85, P1657, DOI 10.1073/pnas.85.5.1657; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Ikebe T, 2002, INFECT IMMUN, V70, P3227, DOI 10.1128/IAI.70.6.3227-3233.2002; Imohl M, 2010, FEMS IMMUNOL MED MIC, V58, P389, DOI 10.1111/j.1574-695X.2010.00652.x; Inagaki Y, 2000, J INFECT DIS, V181, P975, DOI 10.1086/315299; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Karaky NM, 2014, J MED MICROBIOL, V63, P1197, DOI 10.1099/jmm.0.063412-0; Kratovac Z, 2007, J BACTERIOL, V189, P1299, DOI 10.1128/JB.01301-06; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Lei BF, 2001, NAT MED, V7, P1298, DOI 10.1038/nm1201-1298; Lewis T, 2010, J HOSP INFECT, V75, P37, DOI 10.1016/j.jhin.2010.01.012; Li W, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2470; Lizano S, 2007, J BACTERIOL, V189, P1426, DOI 10.1128/JB.01179-06; Luca-Harari B, 2008, J CLIN MICROBIOL, V46, P79, DOI 10.1128/JCM.01626-07; Luca-Harari B, 2009, J CLIN MICROBIOL, V47, P1155, DOI 10.1128/JCM.02155-08; Luo P, 2003, J BACTERIOL, V185, P349, DOI 10.1128/JB.185.1.349-358.2003; Malhotra-Kumar S, 2005, ANTIMICROB AGENTS CH, V49, P4798, DOI 10.1128/AAC.49.11.4798-4800.2005; McAleese F, 2005, ANTIMICROB AGENTS CH, V49, P1865, DOI 10.1128/AAC.49.5.1865-1871.2005; McCormick JK, 2001, INFECT IMMUN, V69, P1381, DOI 10.1128/IAI.69.3.1381-1388.2001; McGregor KF, 2004, J BACTERIOL, V186, P4285, DOI 10.1128/JB.186.13.4285-4294.2004; MCIVER KS, 1995, J BACTERIOL, V177, P6619, DOI 10.1128/jb.177.22.6619-6624.1995; Mihaila-Amrouche L, 2004, J CLIN MICROBIOL, V42, P3844, DOI 10.1128/JCM.42.8.3844-3846.2004; Miyoshi-Akiyama T, 2005, J INFECT DIS, V192, P107, DOI 10.1086/430617; Montes M, 2010, ANTIMICROB AGENTS CH, V54, P93, DOI 10.1128/AAC.00780-09; Musser JM, 2009, J CLIN INVEST, V119, P2455, DOI 10.1172/JCI38095; Musser JM, 2005, AM J PATHOL, V167, P1461, DOI 10.1016/S0002-9440(10)61232-1; Nakagawa I, 2003, GENOME RES, V13, P1042, DOI 10.1101/gr.1096703; Nizet V, 2000, INFECT IMMUN, V68, P4245, DOI 10.1128/IAI.68.7.4245-4254.2000; OFEK I, 1972, INFECT IMMUN, V6, P459, DOI 10.1128/IAI.6.4.459-464.1972; Okumura CYM, 2013, MBIO, V4, DOI 10.1128/mBio.00499-13; Opdyke JA, 2001, MOL MICROBIOL, V42, P495, DOI 10.1046/j.1365-2958.2001.02657.x; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Perez-Trallero E, 2011, ANTIMICROB AGENTS CH, V55, P2406, DOI 10.1128/AAC.01665-10; Phadtare S, 2004, CURR ISSUES MOL BIOL, V6, P125; Pichichero ME, 2007, OTOLARYNG HEAD NECK, V137, P851, DOI 10.1016/j.otohns.2007.07.033; PLUMMER T H JR, 1991, Glycobiology, V1, P257, DOI 10.1093/glycob/1.3.257; PODBIELSKI A, 1994, MED MICROBIOL IMMUN, V183, P239, DOI 10.1007/BF00198458; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Proft T, 2000, J EXP MED, V191, P1765, DOI 10.1084/jem.191.10.1765; Rantala S, 2012, EUR J CLIN MICROBIOL, V31, P859, DOI 10.1007/s10096-011-1385-9; Ribardo DA, 2006, MOL MICROBIOL, V62, P491, DOI 10.1111/j.1365-2958.2006.05381.x; Richter S, 1998, MOL GEN GENET, V257, P534, DOI 10.1007/s004380050679; Robinson NP, 2005, FEBS J, V272, P3757, DOI 10.1111/j.1742-4658.2005.04768.x; Sanderson-Smith M, 2014, J INFECT DIS, V210, P1325, DOI 10.1093/infdis/jiu260; Schulze K, 2006, VACCINE, V24, P6088, DOI 10.1016/j.vaccine.2006.05.024; Seppala H, 1998, ANTIMICROB AGENTS CH, V42, P257; Sjogren J, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-120; Sjogren J, 2013, BIOCHEM J, V455, P107, DOI 10.1042/BJ20130126; Spaulding AR, 2013, CLIN MICROBIOL REV, V26, P422, DOI 10.1128/CMR.00104-12; Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1; STEVENS DL, 1989, NEW ENGL J MED, V321, P1, DOI 10.1056/NEJM198907063210101; Stollerman GH, 1997, LANCET, V349, P935, DOI 10.1016/S0140-6736(96)06364-7; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Suzuki T, 2000, J APPL MICROBIOL, V88, P555, DOI 10.1046/j.1365-2672.2000.00840.x; Takaya A, 2004, INFECT IMMUN, V72, P1364, DOI 10.1128/IAI.72.3.1364-1373.2004; Timmer AM, 2009, J BIOL CHEM, V284, P862, DOI 10.1074/jbc.M804632200; Tokajian Sima, 2014, Genome Announc, V2, DOI 10.1128/genomeA.00358-14; Trevino J, 2009, INFECT IMMUN, V77, P3141, DOI 10.1128/IAI.01560-08; Tritt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042304; Twisselmann B, 2000, EURO SURVEILL, V4; Van Heirstraeten L, 2012, J ANTIMICROB CHEMOTH, V67, P2602, DOI 10.1093/jac/dks281; Vojtek I, 2008, J INFECT DIS, V197, P225, DOI 10.1086/524687; Wajima T, 2008, J MED MICROBIOL, V57, P1383, DOI 10.1099/jmm.0.2008/002642-0; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Walker MJ, 2014, CLIN MICROBIOL REV, V27, P264, DOI 10.1128/CMR.00101-13; WANG H, 1995, MICROB PATHOGENESIS, V18, P153, DOI 10.1016/S0882-4010(95)90013-6; Wargo MJ, 2008, J BACTERIOL, V190, P2690, DOI 10.1128/JB.01393-07; Wong SSY, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.9; Wu DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077033; Yan SS, 2008, DIAGN MICR INFEC DIS, V62, P205, DOI 10.1016/j.diagmicrobio.2008.04.018; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zheng PX, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00149-12; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	124	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168177	10.1371/journal.pone.0168177	http://dx.doi.org/10.1371/journal.pone.0168177			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977735	gold, Green Published			2022-12-26	WOS:000391217400072
J	Wahn, B; Ferris, DP; Hairston, WD; Konig, P				Wahn, Basil; Ferris, Daniel P.; Hairston, W. David; Koenig, Peter			Pupil Sizes Scale with Attentional Load and Task Experience in a Multiple Object Tracking Task	PLOS ONE			English	Article							LOCUS-COERULEUS; DILATION; EYE; PERFORMANCE; RESPONSES; DIAMETER; REVEALS	Previous studies have related changes in attentional load to pupil size modulations. However, studies relating changes in attentional load and task experience on a finer scale to pupil size modulations are scarce. Here, we investigated how these changes affect pupil sizes. To manipulate attentional load, participants covertly tracked between zero and five objects among several randomly moving objects on a computer screen. To investigate effects of task experience, the experiment was conducted on three consecutive days. We found that pupil sizes increased with each increment in attentional load. Across days, we found systematic pupil size reductions. We compared the model fit for predicting pupil size modulations using attentional load, task experience, and task performance as predictors. We found that a model which included attentional load and task experience as predictors had the best model fit while adding performance as a predictor to this model reduced the overall model fit. Overall, results suggest that pupillometry provides a viable metric for precisely assessing attentional load and task experience in visuospatial tasks.	[Wahn, Basil; Koenig, Peter] Univ Osnabruck, Inst Cognit Sci, Osnabruck, Germany; [Ferris, Daniel P.] Univ Michigan, Sch Kinesiol, Human Neuromech Lab, Ann Arbor, MI 48109 USA; [Hairston, W. David] US Army Res Lab, Human Res & Engn Directorate, Aberdeen, MD USA; [Koenig, Peter] Univ Med Ctr Hamburg Eppendorf, Ctr Med Expt, Dept Neurophysiol & Pathophysiol, Hamburg, Germany	University Osnabruck; University of Michigan System; University of Michigan; United States Department of Defense; United States Army; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL); University of Hamburg; University Medical Center Hamburg-Eppendorf	Wahn, B (corresponding author), Univ Osnabruck, Inst Cognit Sci, Osnabruck, Germany.	bwahn@uos.de	König, Peter/ABB-2380-2020; Ferris, Daniel P/A-9624-2008; Wahn, Basil/AAV-5770-2021; Ferris, Daniel P./N-6436-2019	König, Peter/0000-0003-3654-5267; Ferris, Daniel P/0000-0001-6373-6021; Ferris, Daniel P./0000-0001-6373-6021; Wahn, Basil/0000-0002-0318-7160	H2020 - H2020-FETPROACT [641321]; ERC-AdG [269716]; Cognition and Neuroergonomics Collaborative Technology Alliance [ARL W91 1NF-10-2-0022]	H2020 - H2020-FETPROACT; ERC-AdG; Cognition and Neuroergonomics Collaborative Technology Alliance	We gratefully acknowledge the support by H2020 - H2020-FETPROACT-2014 641321 - socSMCs (for BW), ERC-2010-AdG \#269716 - MULTISENSE (for PK), and the Cognition and Neuroergonomics Collaborative Technology Alliance ARL W91 1NF-10-2-0022 (for DPF and WDH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	AHERN S, 1979, SCIENCE, V205, P1289, DOI 10.1126/science.472746; Ahern S., 1981, INTELLIGENCE LEARNIN, P121, DOI DOI 10.1007/978-1-4684-1083-9_9; Alnaes D, 2014, J VISION, V14, DOI 10.1167/14.4.1; Arrighi R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00056; Attar N, 2016, MEM COGNITION, P1; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beatty J., 2000, HDB PSYCHOPHYSIOLOGY, P142; Binda P, 2015, TRENDS COGN SCI, V19, P1, DOI 10.1016/j.tics.2014.11.002; Bouret S, 2005, TRENDS NEUROSCI, V28, P574, DOI 10.1016/j.tins.2005.09.002; Bradshaw J, 1967, PUPIL SIZE MEASURE A; Causse M, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00240; Cavanagh P, 2005, TRENDS COGN SCI, V9, P349, DOI 10.1016/j.tics.2005.05.009; de Gee JW, 2014, P NATL ACAD SCI USA, V111, pE618, DOI 10.1073/pnas.1317557111; Einhauser Wolfgang, 2010, Front Hum Neurosci, V4, P18, DOI 10.3389/fnhum.2010.00018; Geng JJ, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00435; Gilzenrat MS, 2010, COGN AFFECT BEHAV NE, V10, P252, DOI 10.3758/CABN.10.2.252; Granholm E, 2004, INT J PSYCHOPHYSIOL, V52, P1, DOI 10.1016/j.ijpsycho.2003.12.001; Heinrich W., 1896, Z PSYCHOL PHYSL SINN, P342; HESS EH, 1964, SCIENCE, V143, P1190, DOI 10.1126/science.143.3611.1190; HOEKS B, 1993, BEHAV RES METH INSTR, V25, P16, DOI 10.3758/BF03204445; HYONA J, 1995, Q J EXP PSYCHOL-A, V48, P598; Johnson EL, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00218; KAHNEMAN D, 1966, SCIENCE, V154, P1583, DOI 10.1126/science.154.3756.1583; Karatekin C, 2004, PSYCHOPHYSIOLOGY, V41, P175, DOI 10.1111/j.1469-8986.2004.00147.x; Kietzmann TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022614; Kloosterman NA, 2015, EUR J NEUROSCI, V41, P1068, DOI 10.1111/ejn.12859; Konstantopoulos P, 2010, ACCIDENT ANAL PREV, V42, P827, DOI 10.1016/j.aap.2009.09.022; Laeng Bruno, 2012, Proc Natl Acad Sci U S A, V109, P2162, DOI 10.1073/pnas.1118298109; Lisi M, 2015, BIOL PSYCHOL, V112, P39, DOI 10.1016/j.biopsycho.2015.10.002; LOEWENFELD I. E., 1958, DOCUMENTA OPHTHALMOL, V12, P185, DOI 10.1007/BF00913471; Mathot S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148805; Mathot S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078168; Murphy PR, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003854; Naber M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00919; PAYNE DT, 1968, PERCEPT PSYCHOPHYS, V4, P139, DOI 10.3758/BF03210453; Porter G, 2007, Q J EXP PSYCHOL, V60, P211, DOI 10.1080/17470210600673818; Preuschoff K, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00115; Privitera CM, 2010, J VISION, V10, DOI 10.1167/10.10.3; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Rajkowski J, 2004, J NEUROPHYSIOL, V92, P361, DOI 10.1152/jn.00673.2003; Samuels ER, 2008, CURR NEUROPHARMACOL, V6, P235, DOI 10.2174/157015908785777229; Schneider KA, 2009, J NEUROSCI, V29, P1784, DOI 10.1523/JNEUROSCI.4452-08.2009; Sirois S, 2014, WIRES COGN SCI, V5, P679, DOI 10.1002/wcs.1323; Tsai YF, 2007, AVIAT SPACE ENVIR MD, V78, pB176; Twisk J. W. R., 2006, Applied multilevel analysis: a practical guide; Unsworth N, 2016, COGN AFFECT BEHAV NE, P1; van Rijn H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051134; Vanderhasselt MA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00207; Wahn B., 2016, COGSCI, P2747; Wahn B, 2015, ERGONOMICS; Wahn B, 2016, FRONT INTEGR NEUROSC, V10, DOI 10.3389/fnint.2016.00013; Wahn B, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01084; Wahn B, 2015, MULTISENS RES, V28, P371, DOI 10.1163/22134808-00002482; Wang CA, 2015, CURR OPIN NEUROBIOL, V33, P134, DOI 10.1016/j.conb.2015.03.018; Wierda SM, 2012, P NATL ACAD SCI USA, V109, P8456, DOI 10.1073/pnas.1201858109; Zylberberg A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00316	56	45	45	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168087	10.1371/journal.pone.0168087	http://dx.doi.org/10.1371/journal.pone.0168087			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7HN	27977762	Green Published, gold, Green Submitted			2022-12-26	WOS:000391217400056
J	Ma, SB; Ming, ZP; Gong, AY; Wang, Y; Chen, XQ; Hu, GK; Zhou, R; Shibata, A; Swanson, PC; Chen, XM				Ma, Shibin; Ming, Zhenping; Gong, Ai-Yu; Wang, Yang; Chen, Xiqiang; Hu, Guoku; Zhou, Rui; Shibata, Annemarie; Swanson, Patrick C.; Chen, Xian-Ming			A long noncoding RNA, lincRNA-Tnfaip3, acts as a coregulator of NF-kappa B to modulate inflammatory gene transcription in mouse macrophages	FASEB JOURNAL			English	Article						lincRNAs; Hmgb1; inflammation; histone modifications	PROTEIN-CHROMATIN INTERACTIONS; MEDIATED DOWN-REGULATION; HMGB1; COMPLEXES; LOC100130476; DYNAMICS; INSIGHTS; REVEALS; BINDING; SWI/SNF	Long intergenic noncoding RNAs (lincRNAs) are long noncoding transcripts (>200 nt) from the intergenic regions of annotated protein-coding genes. We report here that the lincRNA gene lincRNA-Tnfaip3, located at mouse chromosome 10 proximal to the tumor necrosis factor alpha-induced protein 3 (Tnfaip3) gene, is an early-primary response gene controlled by nuclear factor-kappa B (NF-kappa B) signaling in murine macrophages. Functionally, lincRNA-Tnfaip3 appears to mediate both the activation and repression of distinct classes of inflammatory genes in macrophages. Specifically, induction of lincRNA-Tnfaip3 is required for the transactivation of NF-kappa B-regulated inflammatory genes in response to bacterial LPSs stimulation. LincRNA-Tnfaip3 physically interacts with the high-mobility group box 1 (Hmgb1), assembling a NF-kappa B/Hmgb1/lincRNA-Tnfaip3 complex in macrophages after LPS stimulation. This resultantNF-kappa B/Hmgb1/lincRNA-Tnfaip3 complex can modulate Hmgb1-associated histone modifications and, ultimately, transactivation of inflammatory genes in mouse macrophages in response to microbial challenge. Therefore, our data indicate a new regulatory role of NF-kappa Binduced lincRNA-Tnfaip3 to act as a coactivator of NF-kappa B for the transcription of inflammatory genes in innate immune cells throughmodulation of epigenetic chromatin remodeling.- Ma, S., Ming, Z., Gong, A.- Y., Wang, Y., Chen, X., Hu, G., Zhou, R., Shibata, A., Swanson, P. C., Chen, X.- M. A long noncoding RNA, LincRNA- Tnfaip3, acts as a coregulator of NF- kB to modulate inflammatory gene transcription in mouse macrophages.	[Ma, Shibin; Ming, Zhenping; Gong, Ai-Yu; Wang, Yang; Chen, Xiqiang; Hu, Guoku; Swanson, Patrick C.; Chen, Xian-Ming] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE USA; [Shibata, Annemarie] Creighton Univ, Dept Biol, Coll Arts & Sci, Omaha, NE 68178 USA; [Ming, Zhenping; Zhou, Rui] Wuhan Univ, Sch Basic Med Sci, Dept Med Parasitol, Wuhan, Hubei, Peoples R China; [Hu, Guoku] Univ Nebraska, Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA	Creighton University; Creighton University; Wuhan University; University of Nebraska System; University of Nebraska Medical Center	Chen, XM (corresponding author), Creighton Univ, Sch Med, Med Microbiol & Immunol, Criss 2,Room 529,2500 Calif Plaza, Omaha, NE 68178 USA.	xianmingchen@creighton.edu	Hu, Guoku/AAG-7233-2019	Hu, Guoku/0000-0002-4792-0416	National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases [AI095532, AI116323]; Creighton University through the Nebraska Department of Health and Human Services [LB595]; NIH National Center for Research Resources [G20RR024001]; NATIONAL CENTER FOR RESEARCH RESOURCES [G20RR024001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI116323, U01AI095532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103509] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Creighton University through the Nebraska Department of Health and Human Services; NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Andrew D. Badley (Mayo Clinic, Rochester, NY, USA) for providing the p65 and Ikk alpha-mutant plasmids and Barbara L. Bittner (Creighton University) for assistance in writing the manuscript. This work was supported by funding from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (Grants AI095532 and AI116323), by revenue from Nebraska's excise tax on cigarettes awarded to Creighton University through the Nebraska Department of Health and Human Services (DHHS; LB595 to X.-M.C.), and by Grant G20RR024001 from the NIH National Center for Research Resources. The content of this research is solely the responsibility of the authors and does not necessarily represent the official views of the State of Nebraska, DHHS, National Center for Research Resources, or the NIH. The authors declare no conflicts of interest.	Agresti A, 2005, MOL CELL, V18, P109, DOI 10.1016/j.molcel.2005.03.005; Agresti A, 2003, BIOCHEM BIOPH RES CO, V302, P421, DOI 10.1016/S0006-291X(03)00184-0; Ando H, 2000, J PHARMACOL EXP THER, V294, P1043; Barton GM, 2008, J CLIN INVEST, V118, P413, DOI 10.1172/JCI34431; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Bohrer H, 1997, J CLIN INVEST, V100, P972, DOI 10.1172/JCI119648; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Catez F, 2004, MOL CELL BIOL, V24, P4321, DOI 10.1128/MCB.24.10.4321-4328.2004; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Dempsey L. A., 2013, NAT IMMUNOL, V14, P1036; Fowler T, 2011, MOL CELL, V44, P348, DOI 10.1016/j.molcel.2011.09.014; Garmire LX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024051; Gerlitz G, 2009, BIOCHEM CELL BIOL, V87, P127, DOI 10.1139/O08-110; Guo W, 2016, DIGEST LIVER DIS, V48, P961, DOI 10.1016/j.dld.2016.05.010; Guo W, 2016, CLIN EXP METASTAS, V33, P497, DOI 10.1007/s10585-016-9794-x; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Haddad JJ, 2011, CELL IMMUNOL, V271, P5, DOI 10.1016/j.cellimm.2011.06.021; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Hu GK, 2016, J IMMUNOL, V196, P2799, DOI 10.4049/jimmunol.1502146; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kimura H, 2013, J HUM GENET, V58, P439, DOI 10.1038/jhg.2013.66; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Moran VA, 2012, NUCLEIC ACIDS RES, V40, P6391, DOI 10.1093/nar/gks296; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; Natoli G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000224; Peng XX, 2010, MBIO, V1, DOI 10.1128/mBio.00206-10; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Rapicavoli NA, 2013, ELIFE, V2, DOI 10.7554/eLife.00762; Schreiber J, 2006, P NATL ACAD SCI USA, V103, P5899, DOI 10.1073/pnas.0510996103; Sen R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000257; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; Tan BCM, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-57; Tong Q, 2016, FASEB J, V30, P1187, DOI 10.1096/fj.15-279166; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wang HH, 2001, AM J RESP CRIT CARE, V164, P1768, DOI 10.1164/ajrccm.164.10.2106117; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	43	51	57	0	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1215	1225		10.1096/fj.201601056R	http://dx.doi.org/10.1096/fj.201601056R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27979905	Green Published			2022-12-26	WOS:000395671200033
J	Chin, S; Yang, DH; Miles, AJ; Eckford, PDW; Molinski, S; Wallace, BA; Bear, CE				Chin, Stephanie; Yang, Donghe; Miles, Andrew J.; Eckford, Paul D. W.; Molinski, Steven; Wallace, B. A.; Bear, Christine E.			Attenuation of Phosphorylation-dependent Activation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) by Disease-causing Mutations at the Transmission Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cysteine-mediated cross-linking; cystic fibrosis transmembrane conductance regulator (CFTR); ion channel; phosphorylation; spectroscopy; synchrotron radiation circular dichroism	NUCLEOTIDE-BINDING DOMAIN; I-TASSER SERVER; CIRCULAR-DICHROISM; PROTEIN-STRUCTURE; R-DOMAIN; CHANNEL; DELTA-F508; STABILITY; MODEL; SITES	Cystic fibrosis transmembrane conductance regulator (CFTR) is a multidomain membrane protein that functions as a phosphorylation-regulated anion channel. The interface between its two cytosolic nucleotide binding domains and coupling helices conferred by intracellular loops extending from the channel pore domains has been referred to as a transmission interface and is thought to be critical for the regulated channel activity of CFTR. Phosphorylation of the regulatory domain of CFTR by protein kinase A (PKA) is required for its channel activity. However, it was unclear if phosphorylation modifies the transmission interface. Here, we studied purified full-length CFTR protein using spectroscopic techniques to determine the consequences of PKA-mediated phosphorylation. Synchrotron radiation circular dichroism spectroscopy confirmed that purified full-length wild-type CFTR is folded and structurally responsive to phosphorylation. Intrinsic tryptophan fluorescence studies of CFTR showed that phosphorylation reduced iodide-mediated quenching, consistent with an effect of phosphorylation in burying tryptophans at the transmission interface. Importantly, the rate of phosphorylation-dependent channel activation was compromised by the introduction of disease-causing mutations in either of the two coupling helices predicted to interact with nucleotide binding domain 1 at the interface. Together, these results suggest that phosphorylation modifies the interface between the catalytic and pore domains of CFTR and that this modification facilitates CFTR channel activation.	[Chin, Stephanie; Yang, Donghe; Eckford, Paul D. W.; Molinski, Steven; Bear, Christine E.] Hosp Sick Children, Programme Mol Struct & Funct, Toronto, ON M5G 0A4, Canada; [Chin, Stephanie; Molinski, Steven; Bear, Christine E.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Miles, Andrew J.; Wallace, B. A.] Univ London, Inst Struct & Mol Biol, Birkbeck Coll, London WC1E 7HX, England; [Bear, Christine E.] Univ Toronto, Dept Physiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of London; Birkbeck University London; University of Toronto	Bear, CE (corresponding author), Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Programme Mol Struct & Funct, 686 Bay St,Rm 209420 U West, Toronto, ON M5G 0A4, Canada.	bear@sickkids.ca	Molinski, Steven V/J-9509-2015; Eckford, Paul/ABE-9189-2021; Wallace, B A/C-3753-2008	Wallace, B A/0000-0001-9649-5092; Molinski, Steven/0000-0001-9215-8232	NSERC (Natural Science and Engineering Research Council); CIHR (Canadian Institutes of Health Research); UK Biotechnology and Biological Sciences Research Council; ISA synchrotron; BBSRC [BB/J019135/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/02959, BB/J019135/1] Funding Source: researchfish	NSERC (Natural Science and Engineering Research Council)(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR (Canadian Institutes of Health Research)(Canadian Institutes of Health Research (CIHR)); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ISA synchrotron; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from NSERC (Natural Science and Engineering Research Council; to S.C.) and CIHR (Canadian Institutes of Health Research). This work was also supported by a grant from the UK Biotechnology and Biological Sciences Research Council (to B.A.W.) and by beamtime grants from the ISA synchrotron (to B.A.W.). The authors declare that they have no conflicts of interest with the contents of this article.	Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Chang XB, 2008, J CELL SCI, V121, P2814, DOI 10.1242/jcs.028951; Chappe V, 2005, EMBO J, V24, P2730, DOI 10.1038/sj.emboj.7600747; Charalambous K, 2009, BBA-BIOMEMBRANES, V1788, P1279, DOI 10.1016/j.bbamem.2009.02.005; Corradi V, 2015, J BIOL CHEM, V290, P22891, DOI 10.1074/jbc.M115.665125; Dalton J, 2012, J CHEM INF MODEL, V52, P1842, DOI 10.1021/ci2005884; Dawson JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074347; DeLano W. L, 2016, PYMOL MOL GRAPHICS S; Di Bartolo ND, 2011, J BIOL CHEM, V286, P18807, DOI 10.1074/jbc.M110.176891; DiBartolo N, 2011, BIOCHEM SOC T, V39, P751, DOI 10.1042/BST0390751; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; DULHANTY AM, 1994, BIOCHEMISTRY-US, V33, P4072, DOI 10.1021/bi00179a036; Eckford PDW, 2008, J BIOL CHEM, V283, P12840, DOI 10.1074/jbc.M708274200; Eckford PDW, 2015, JOVE-J VIS EXP, DOI 10.3791/52427; Eckford PDW, 2012, J BIOL CHEM, V287, P36639, DOI 10.1074/jbc.M112.393637; Eggensperger S, 2014, J BIOL CHEM, V289, P33098, DOI 10.1074/jbc.M114.592832; Ehrhardt A, 2016, J BIOL CHEM, V291, P1854, DOI 10.1074/jbc.M115.704809; Gao XL, 2015, P NATL ACAD SCI USA, V112, P2461, DOI 10.1073/pnas.1420676112; Golin J, 2015, BIOCHEM J, V467, P353, DOI 10.1042/BJ20150042; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; Hegedus T, 2009, BBA-BIOMEMBRANES, V1788, P1341, DOI 10.1016/j.bbamem.2009.03.015; Hudson RP, 2012, J BIOL CHEM, V287, P28480, DOI 10.1074/jbc.M112.371138; Kanelis V, 2010, EMBO J, V29, P263, DOI 10.1038/emboj.2009.329; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Liang XB, 2012, MOL BIOL CELL, V23, P996, DOI 10.1091/mbc.E11-08-0662; Linsdell Paul, 2017, Adv Exp Med Biol, V925, P13, DOI 10.1007/5584_2016_33; Loo TW, 2008, J BIOL CHEM, V283, P28190, DOI 10.1074/jbc.M805834200; Loo TW, 2015, J BIOL CHEM, V290, P16954, DOI 10.1074/jbc.M115.652602; Loo TW, 2011, METHODS MOL BIOL, V741, P23, DOI 10.1007/978-1-61779-117-8_3; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Mihalyi C, 2016, ELIFE, V5, DOI 10.7554/eLife.18164; Miles AJ, 2005, PROTEIN SCI, V14, P368, DOI 10.1110/ps.041019905; Miles AJ, 2003, SPECTROSC-INT J, V17, P653, DOI 10.1155/2003/379137; Molinski SV, 2015, J BIOMOL SCREEN, V20, P1204, DOI 10.1177/1087057115605834; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Ostedgaard LS, 2001, J BIOL CHEM, V276, P7689, DOI 10.1074/jbc.R100001200; Pasyk S, 2015, PROTEOMICS, V15, P447, DOI 10.1002/pmic.201400218; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schlamadinger DE, 2011, JOVE-J VIS EXP, DOI 10.3791/2669; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Sorum B, 2015, CELL, V163, P724, DOI 10.1016/j.cell.2015.09.052; Veit G, 2016, MOL BIOL CELL, V27, P424, DOI 10.1091/mbc.E14-04-0935; Wang F, 2000, J PHYSIOL-LONDON, V524, P637, DOI 10.1111/j.1469-7793.2000.00637.x; Yang JY, 2016, J MOL BIOL, V428, P693, DOI 10.1016/j.jmb.2015.09.024; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang L, 2009, J STRUCT BIOL, V167, P242, DOI 10.1016/j.jsb.2009.06.004; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Z, 2016, CELL, V167, P1586, DOI 10.1016/j.cell.2016.11.014	53	6	6	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1988	1999		10.1074/jbc.M116.762633	http://dx.doi.org/10.1074/jbc.M116.762633			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28003367	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000395515600036
J	Jorgensen, S; Have, CT; Underwood, CR; Johansen, LD; Wellendorph, P; Gjesing, AP; Jorgensen, CV; Quan, S; Rui, G; Inoue, A; Linneberg, A; Grarup, N; Jun, W; Pedersen, O; Hansen, T; Brauner-Osborne, H				Jorgensen, Stine; Have, Christian Theil; Underwood, Christina Rye; Johansen, Lars Dan; Wellendorph, Petrine; Gjesing, Anette Prior; Jorgensen, Christinna V.; Quan, Shi; Rui, Gao; Inoue, Asuka; Linneberg, Allan; Grarup, Niels; Jun, Wang; Pedersen, Oluf; Hansen, Torben; Brauner-Osborne, Hans			Genetic Variations in the Human G Protein-coupled Receptor Class C, Group 6, Member A (GPRC6A) Control Cell Surface Expression and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID RECEPTOR; L-ARGININE; CLONING; OSTEOCALCIN; GPCR; MICE; DIET	GPRC6A is a G protein-coupled receptor activated by Lamino acids, which, based on analyses of knock-out mice, has been suggested to have physiological functions in metabolism and testicular function. The human ortholog is, however, mostly retained intracellularly in contrast to the cell surface-expressed murine and goldfish orthologs. The latter orthologs are G(q)-coupled and lead to intracellular accumulation of inositol phosphates and calcium release. In the present study we cloned the bonobo chimpanzee GPRC6A receptor, which is 99% identical to the human receptor, and show that it is cell surface-expressed and functional. By analyses of chimeric human/mouse and human/bonobo receptors, bonobo receptor mutants, and the single nucleotide polymorphism database at NCBI, we identify an insertion/deletion variation in the third intracellular loop responsible for the intracellular retention and lack of function of the human ortholog. Genetic analyses of the 1000 genome database and the Inter99 cohort of 6,000 Danes establish the distribution of genotypes among ethnic groups, showing that the cell surface-expressed and functional variant is much more prevalent in the African population than in European and Asian populations and that this variant is partly linked with a stop codon early in the receptor sequence (rs6907580, amino acid position 57). In conclusion, our data solve a more than decade-old question of why the cloned human GPRC6A receptor is not cell surface-expressed and functional and provide a genetic framework to study human phenotypic traits in large genome sequencing projects linked with physiological measurement and biomarkers.	[Jorgensen, Stine; Underwood, Christina Rye; Johansen, Lars Dan; Wellendorph, Petrine; Jorgensen, Christinna V.; Brauner-Osborne, Hans] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Univ Pk 2, DK-2100 Copenhagen, Denmark; [Have, Christian Theil; Gjesing, Anette Prior; Grarup, Niels; Pedersen, Oluf; Hansen, Torben] Univ Copenhagen, Fac Hlth & Med Sci, Sect Metab Genet, Novo Nordisk Fdn,Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark; [Quan, Shi; Rui, Gao; Jun, Wang] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Inoue, Asuka] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Mol & Cellular Biochem, Sendai, Miyagi 9808578, Japan; [Inoue, Asuka] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan; [Linneberg, Allan] Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark; [Linneberg, Allan] Rigshosp, Dept Clin Expt Res, DK-2100 Copenhagen, Denmark; [Linneberg, Allan] Univ Copenhagen, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark	University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; Beijing Genomics Institute (BGI); Tohoku University; Japan Science & Technology Agency (JST); Rigshospitalet; University of Copenhagen; University of Copenhagen	Brauner-Osborne, H (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Univ Pk 2, DK-2100 Copenhagen, Denmark.	hbo@sund.ku.dk	Grarup, Niels/K-2807-2015; Pedersen, Oluf/Z-1731-2019; Pedersen, Oluf/AAG-8015-2020; Gjesing, Anette/ACC-7521-2022; Brauner-Osborne, Hans/D-7260-2011; Wellendorph, Petrine/H-8328-2015	Grarup, Niels/0000-0001-5526-1070; Pedersen, Oluf/0000-0002-3321-3972; Gjesing, Anette/0000-0003-4580-1576; Hansen, Torben/0000-0001-8748-3831; Brauner-Osborne, Hans/0000-0001-9495-7388; Have, Christian Theil/0000-0002-8634-4781; Jorgensen, Christinna Vangsgaard/0000-0001-6089-899X; Wellendorph, Petrine/0000-0002-5455-8013; Linneberg, Allan/0000-0002-0994-0184	Danish Council for Independent Research, Medical Sciences; Novo Nordisk Foundation; Lundbeck Foundation; Japan Science and Technology Agency; Precursory Research for Embryonic Science and Technology; AstraZeneca; Lundbeck Foundation [R171-2014-505] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0010365] Funding Source: researchfish	Danish Council for Independent Research, Medical Sciences(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Precursory Research for Embryonic Science and Technology; AstraZeneca(AstraZeneca); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by funds from the Danish Council for Independent Research, Medical Sciences (to H.B.-O.), the Novo Nordisk Foundation (to H.B.-O.), the Lundbeck Foundation (to C.R.U.), the Japan Science and Technology Agency, Precursory Research for Embryonic Science and Technology (to A.I.), and AstraZeneca (to H.B.-O.). The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent research center at the University of Copenhagen and is partially funded by an unrestricted donation from the Novo Nordisk Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Alamshah A, 2016, DIABETES OBES METAB, V18, P508, DOI 10.1111/dom.12644; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Christiansen B, 2007, BRIT J PHARMACOL, V150, P798, DOI 10.1038/sj.bjp.0707121; Clemmensen C, 2014, BRIT J PHARMACOL, V171, P1129, DOI 10.1111/bph.12365; Clemmensen C., 2016, DIABETES OB IN PRESS; Clemmensen C, 2013, PHYSIOL BEHAV, V118, P144, DOI 10.1016/j.physbeh.2013.05.015; Clemmensen C, 2013, J ENDOCRINOL, V217, P151, DOI 10.1530/JOE-12-0550; Exome Variant Server, NHLBI GO EX SEQ PROJ; Faure H, 2009, CELL CALCIUM, V46, P323, DOI 10.1016/j.ceca.2009.09.004; Gao R, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-13; Hewavitharana T, 2012, CELL SIGNAL, V24, P25, DOI 10.1016/j.cellsig.2011.08.014; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Isberg V, 2015, TRENDS PHARMACOL SCI, V36, P22, DOI 10.1016/j.tips.2014.11.001; Jacobsen SE, 2013, J PHARMACOL EXP THER, V347, P298, DOI 10.1124/jpet.113.206276; Jong YJI, 2014, MOL PHARMACOL, V86, P774, DOI 10.1124/mol.114.094763; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kinsey-Jones JS, 2015, OBESITY, V23, P1194, DOI 10.1002/oby.21083; Kuang DH, 2005, J NEUROCHEM, V93, P383, DOI 10.1111/j.1471-4159.2005.03025.x; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Norskov-Lauritsen L, 2015, FEBS LETT, V589, P588, DOI 10.1016/j.febslet.2015.01.019; Oury F, 2013, J CLIN INVEST, V123, P2421, DOI 10.1172/JCI65952; Oury F, 2011, CELL, V144, P796, DOI 10.1016/j.cell.2011.02.004; Pagano A, 2001, J NEUROSCI, V21, P1189; Pi M, 2005, J BIOL CHEM, V280, P40201, DOI 10.1074/jbc.M505186200; Pi M, 2012, ENDOCRINOLOGY, V153, P4608, DOI 10.1210/en.2012-1301; Pi M, 2012, ENDOCRINOLOGY, V153, P2062, DOI 10.1210/en.2011-2117; Pi M, 2012, PROSTATE, V72, P399, DOI 10.1002/pros.21442; Pi M, 2011, J BONE MINER RES, V26, P1680, DOI 10.1002/jbmr.390; Pi M, 2010, J BIOL CHEM, V285, P39953, DOI 10.1074/jbc.M110.158063; Pi M, 2010, J BONE MINER RES, V25, P1092, DOI 10.1359/jbmr.091037; Pi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003858; Rossol M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2339; Rueda P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146846; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Smajilovic S, 2013, AMINO ACIDS, V44, P383, DOI 10.1007/s00726-012-1341-8; Wellendorph P, 2005, MOL PHARMACOL, V67, P589, DOI 10.1124/mol.104.007559; Wellendorph P, 2004, GENE, V335, P37, DOI 10.1016/j.gene.2004.03.003; Wellendorph P, 2007, GENE, V396, P257, DOI 10.1016/j.gene.2007.03.008; Wellendorph P, 2009, J MOL ENDOCRINOL, V42, P215, DOI 10.1677/JME-08-0149	41	18	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1524	1534		10.1074/jbc.M116.756577	http://dx.doi.org/10.1074/jbc.M116.756577			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27986810	Green Published, hybrid			2022-12-26	WOS:000393339800031
J	Gradl, R; Zanette, I; Ruiz-Yaniz, M; Dierolf, M; Rack, A; Zaslansky, P; Pfeiffer, F				Gradl, Regine; Zanette, Irene; Ruiz-Yaniz, Maite; Dierolf, Martin; Rack, Alexander; Zaslansky, Paul; Pfeiffer, Franz			Mass Density Measurement of Mineralized Tissue with Grating-Based X-Ray Phase Tomography	PLOS ONE			English	Article							QUANTITATIVE PHASE; ELECTRON-DENSITY; DENTAL ENAMEL; MICROTOMOGRAPHY; SOUND; BONE	Establishing the mineral content distribution in highly mineralized tissues, such as bones and teeth, is fundamental in understanding a variety of structural questions ranging from studies of the mechanical properties to improved pathological investigations. However, non-destructive, volumetric and quantitative density measurements of mineralized samples, some of which may extend several mm in size, remain challenging. Here, we demonstrate the potential of grating-based x-ray phase tomography to gain insight into the three-dimensional mass density distribution of tooth tissues in a non-destructive way and with a sensitivity of 85 mg/cm(3). Density gradients of 13 - 19% over 1 - 2 mm within typical samples are detected, and local variations in density of 0.4 g/cm(3) on a length scale of 0.1 mm are revealed. This method proves to be an excellent quantitative tool for investigations of subtle differences in mineral content of mineralized tissues that can change following treatment or during ageing and healing.	[Gradl, Regine; Zanette, Irene; Ruiz-Yaniz, Maite; Dierolf, Martin; Pfeiffer, Franz] Tech Univ Munich, Dept Phys, D-85748 Garching, Germany; [Gradl, Regine; Zanette, Irene; Ruiz-Yaniz, Maite; Dierolf, Martin; Pfeiffer, Franz] Tech Univ Munich, Inst Med Engn, D-85748 Garching, Germany; [Zanette, Irene] Diamond Light Source, Harwell Sci & Innovat Campus, Didcot OX11 0DE, Oxon, England; [Ruiz-Yaniz, Maite; Rack, Alexander] European Synchrotron, CS40220, F-38043 Grenoble 9, France; [Zaslansky, Paul] Charite Univ Med Berlin, Julius Wolff Inst, D-13353 Berlin, Germany; [Zaslansky, Paul] Charite Univ Med Berlin, Ctr Musculoskeletal Surg, D-13353 Berlin, Germany; [Pfeiffer, Franz] Tech Univ Munich, Klinikum Rechts Isar, Inst Diagnost & Intervent Radiol, D-81675 Munich, Germany	Technical University of Munich; Technical University of Munich; Diamond Light Source; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technical University of Munich	Gradl, R (corresponding author), Tech Univ Munich, Dept Phys, D-85748 Garching, Germany.; Gradl, R (corresponding author), Tech Univ Munich, Inst Med Engn, D-85748 Garching, Germany.	regine.gradl@tum.de	Dierolf, Martin J/B-9816-2008; zaslansky, paul/AAB-7322-2021; Alexander, Rack/C-9397-2012	Dierolf, Martin J/0000-0001-5150-2949; zaslansky, paul/0000-0002-8714-4992; Alexander, Rack/0000-0001-9486-3621; Zanette, Irene/0000-0001-6096-6059	DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP); DFG Gottfried Wilhelm Leibniz program; DFG [SPP1420]; Diamond Light Source	DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP)(German Research Foundation (DFG)); DFG Gottfried Wilhelm Leibniz program(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Diamond Light Source	FP was funded by DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP), the DFG Gottfried Wilhelm Leibniz program, and PZ was funded by the DFG funding through SPP1420. The funder (Diamond Light Source) provided support in the form of salaries for authors [IZ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Angker L, 2004, ARCH ORAL BIOL, V49, P99, DOI 10.1016/j.archoralbio.2003.08.006; ANGMAR B, 1963, J ULTRA MOL STRUCT R, V8, P12, DOI 10.1016/S0022-5320(63)80017-9; Arola DD, 2006, BIOMATERIALS, V27, P2131, DOI 10.1016/j.biomaterials.2005.10.005; Bartlett John D, 2013, ISRN Dent, V2013, P684607, DOI 10.1155/2013/684607; Bauerlein E., 2007, HDB BIOMINERALIZATIO; Bech M, 2010, PHYS MED BIOL, V55, P5529, DOI 10.1088/0031-9155/55/18/017; Boyes ED, 2000, MICROSC MICROANAL, V6, P307; Cloetens P, 1999, APPL PHYS LETT, V75, P2912, DOI 10.1063/1.125225; Cuy JL, 2002, ARCH ORAL BIOL, V47, P281, DOI 10.1016/S0003-9969(02)00006-7; Davis GR, 2013, J DENT, V41, P475, DOI 10.1016/j.jdent.2013.01.010; Deyhle Hans, 2015, Dent J (Basel), V3, P111, DOI 10.3390/dj3040111; Dowker SEP, 2004, CARIES RES, V38, P514, DOI 10.1159/000080580; Dowker SEP, 2006, EUR J ORAL SCI, V114, P353, DOI 10.1111/j.1600-0722.2006.00315.x; Elliott JC, 1998, CONNECT TISSUE RES, V38, P61, DOI 10.3109/03008209809017022; GARBEROGLIO R, 1976, ARCH ORAL BIOL, V21, P355, DOI 10.1016/S0003-9969(76)80003-9; Herzen J, 2009, OPT EXPRESS, V17, P10010, DOI 10.1364/OE.17.010010; Jensen TH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054047; Kinney JH, 2005, BIOMATERIALS, V26, P3363, DOI 10.1016/j.biomaterials.2004.09.004; Langer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035691; Marten A, 2010, BIOMATERIALS, V31, P5479, DOI 10.1016/j.biomaterials.2010.03.030; Manly RS, 1939, DENSITY DENT HARD TI, P203, DOI 10.1177/00220345390180030301; Momose A, 2003, JPN J APPL PHYS 2, V42, pL866, DOI 10.1143/JJAP.42.L866; PASHLEY DH, 1989, SCANNING MICROSCOPY, V3, P161; Pfeiffer F, 2008, NAT MATER, V7, P134, DOI 10.1038/nmat2096; Pfeiffer F, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108105; Qi ZH, 2010, PHYS MED BIOL, V55, P2669, DOI 10.1088/0031-9155/55/9/016; Reznikova E, 2008, MICROSYST TECHNOL, V14, P1683, DOI 10.1007/s00542-007-0507-x; Roschger P, 2008, BONE, V42, P456, DOI 10.1016/j.bone.2007.10.021; Sarapata A, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4898052; Sarapata A, 2015, OPT EXPRESS, V23, P523, DOI 10.1364/OE.23.000523; Schmitz JE, 2014, J DENT RES, V93, P256, DOI 10.1177/0022034513520548; Schwass DR, 2009, CARIES RES, V43, P314, DOI 10.1159/000226230; SHRIMPTON PC, 1981, PHYS MED BIOL, V26, P907, DOI 10.1088/0031-9155/26/5/010; Tapfer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058439; Velroyen A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109562; WEIDMANN SM, 1967, ARCH ORAL BIOL, V12, P85, DOI 10.1016/0003-9969(67)90145-8; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Weitkamp T, 2005, OPT EXPRESS, V13, P6296, DOI 10.1364/OPEX.13.006296; Weitkamp T, 2010, AIP CONF PROC, V1221, P33, DOI 10.1063/1.3399253; Willner M, 2013, OPT EXPRESS, V21, P4155, DOI 10.1364/OE.21.004155; Zanette I, 2015, SCI REP-UK, V5, DOI 10.1038/srep09210; Zanette I, 2011, PHYS STATUS SOLIDI A, V208, P2526, DOI 10.1002/pssa.201184276	42	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167797	10.1371/journal.pone.0167797	http://dx.doi.org/10.1371/journal.pone.0167797			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002416	Green Published, gold, Green Submitted			2022-12-26	WOS:000392853100023
J	Lai, XL; Friedman, A				Lai, Xiulan; Friedman, Avner			Exosomal miRs in Lung Cancer: A Mathematical Model	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; FACTOR RECEPTOR MUTATIONS; BINDING PROTEIN HUR; CROSS-TALK; GROWTH; EXPRESSION; EGFR; RAS; INVASION; PATHWAYS	Lung cancer, primarily non-small-cell lung cancer (NSCLC), is the leading cause of cancer deaths in the United States and worldwide. While early detection significantly improves five-year survival, there are no reliable diagnostic tools for early detection. Several exosomal microRNAs (miRs) are overexpressed in NSCLC, and have been suggested as potential biomarkers for early detection. The present paper develops a mathematical model for early stage of NSCLC with emphasis on the role of the three highest overexpressed miRs, namely miR-21, miR-205 and miR-155. Simulations of the model provide quantitative relationships between the tumor volume and the total mass of each of the above miRs in the tumor. Because of the positive correlation between these miRs in the tumor tissue and in the blood, the results of the paper may be viewed as a first step toward establishing a combination of miRs 21, 205, 155 and possibly other miRs as serum biomarkers for early detection of NSCLC.	[Lai, Xiulan] Renmin Univ China, Inst Math Sci, Beijing, Peoples R China; [Friedman, Avner] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Friedman, Avner] Ohio State Univ, Dept Math, 231 W 18th Ave, Columbus, OH 43210 USA	Renmin University of China; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Lai, XL (corresponding author), Renmin Univ China, Inst Math Sci, Beijing, Peoples R China.	xiulanlai@ruc.edu.cn	Lai, Xiula/GMX-1854-2022		Mathematical Biosciences Institute; National Science Foundation [DMS 0931642]; National Natural Science Foundation of China [11501568]; Fundamental Research Funds for the Central Universities; Research Funds of Renmin University of China	Mathematical Biosciences Institute; National Science Foundation(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Research Funds of Renmin University of China	AF is supported by the Mathematical Biosciences Institute and the National Science Foundation (Grant DMS 0931642). XL is supported by the National Natural Science Foundation of China (Grant No. 11501568), the Fundamental Research Funds for the Central Universities and the Research Funds of Renmin University of China, and the Mathematical Biosciences Institute and the National Science Foundation (Grant DMS 0931642).	Akinleye A, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-27; Ali A, 2013, CURR ONCOL, V20, pE300, DOI 10.3747/co.20.1481; An TX, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27522; [Anonymous], QUEST DIAGN; Bader AG, 2011, GENE THER, V18, P1121, DOI 10.1038/gt.2011.79; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Bratton SB, 2010, J CELL SCI, V123, P3209, DOI 10.1242/jcs.073643; CALLANS LS, 1995, ANN SURG ONCOL, V2, P38, DOI 10.1007/BF02303700; Cantrell DA, 2001, J CELL SCI, V114, P1439; Dearden S, 2013, ANN ONCOL, V24, P2371, DOI 10.1093/annonc/mdt205; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Faratian D, 2009, CANCER RES, V69, P6713, DOI 10.1158/0008-5472.CAN-09-0777; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Florea Ana-Maria, 2011, Cancers (Basel), V3, P1351, DOI 10.3390/cancers3011351; Frydrychowicz M, 2015, SCAND J IMMUNOL, V81, P2, DOI 10.1111/sji.12247; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Fumarola C, 2014, BIOCHEM PHARMACOL, V90, P197, DOI 10.1016/j.bcp.2014.05.011; Gao CF, 2005, P NATL ACAD SCI USA, V102, P10528, DOI 10.1073/pnas.0504367102; Gil-Henn H, 2013, ONCOGENE, V32, P2622, DOI 10.1038/onc.2012.284; Hao WR, 2014, P NATL ACAD SCI USA, V111, P16065, DOI 10.1073/pnas.1417789111; Hao WR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090497; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Jain HV, 2011, P NATL ACAD SCI USA, V108, P19701, DOI 10.1073/pnas.1115750108; Jo U, 2014, ONCOTARGET, V5, P1265, DOI 10.18632/oncotarget.1711; Kam Y, 2012, J CELL PHYSIOL, V227, P431, DOI 10.1002/jcp.22766; Kang HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053663; Kaur H, 2006, BIOCHEM J, V393, P235, DOI 10.1042/BJ20051022; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028293; Komatsu S, 2011, BRIT J CANCER, V105, P104, DOI 10.1038/bjc.2011.198; Komatsu S, 2013, ANTICANCER RES, V33, P271; Leander R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002757; Lee JH, 2008, INT J MOL MED, V21, P91; Legewie S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.29; Lei L, 2013, ONCOL REP, V30, P2897, DOI 10.3892/or.2013.2755; Li B, 2014, LUNG CANCER, V83, P146, DOI 10.1016/j.lungcan.2013.11.003; Liao KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091844; Liu R, 2012, J TOXICOL ENV HEAL A, V75, P1154, DOI 10.1080/15287394.2012.699856; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Marinov M, 2007, CRIT REV ONCOL HEMAT, V63, P172, DOI 10.1016/j.critrevonc.2007.04.002; Matus DQ, 2015, DEV CELL, V35, P162, DOI 10.1016/j.devcel.2015.10.002; McDonald D., 2010, UNDERSTANDING MIRNA; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Meyer R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00451; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Papadimitrakopoulou V, 2006, J THORAC ONCOL, V1, P749, DOI 10.1016/S1556-0864(15)30399-3; Peters S, 2014, CANCER TREAT REV, V40, P917, DOI 10.1016/j.ctrv.2014.06.010; Properzi F, 2013, BIOMARK MED, V7, P769, DOI 10.2217/bmm.13.63; Quaranta V, 2008, SEMIN CANCER BIOL, V18, P338, DOI 10.1016/j.semcancer.2008.03.018; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Reubold TF, 2009, J BIOL CHEM, V284, P32717, DOI 10.1074/jbc.M109.014027; Riches A, 2014, EUR J CANCER, V50, P1025, DOI 10.1016/j.ejca.2013.12.019; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Salamon RS, 2013, BIOESSAYS, V35, P602, DOI 10.1002/bies.201200176; Satoh M, 2002, STROKE, V33, P775, DOI 10.1161/hs0302.103734; Schumacher C, 1998, MOL PHARMACOL, V53, P97, DOI 10.1124/mol.53.1.97; Sgambato A, 2012, CURR MED CHEM, V19, P3337, DOI 10.2174/092986712801215973; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shen H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103305; Shui YB, 2003, INVEST OPHTH VIS SCI, V44, P3911, DOI 10.1167/iovs.02-1226; Shukla S, 2014, NEOPLASIA, V16, P115, DOI 10.1593/neo.14184; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Siegelin MD, 2014, LAB INVEST, V94, P129, DOI 10.1038/labinvest.2013.147; Soengas MS, 1999, SCIENCE, V284, P156, DOI 10.1126/science.284.5411.156; Sorkin A, 2010, CURR PROTOC CELL BIO, DOI [10. 1002/0471143030. cb1514s46, DOI 10.1002/0471143030.CB1514S46]; Szomolay B, 2012, J THEOR BIOL, V303, P141, DOI 10.1016/j.jtbi.2012.03.024; Tamura K, 2005, EXPERT OPIN PHARMACO, V6, P985, DOI 10.1517/14656566.6.6.985; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; von Roretz C, 2013, CELL DEATH DIFFER, V20, P154, DOI 10.1038/cdd.2012.111; Vreeland AC, 2014, MOL CELL BIOL, V34, P2135, DOI 10.1128/MCB.00281-14; Wang PY, 2010, BIOCHEM J, V426, P293, DOI 10.1042/BJ20091459; Weaver BA, 2014, MOL BIOL CELL, V25, P2677, DOI 10.1091/mbc.E14-04-0916; Yang Y, 2015, CANCER GENE THER, V22, P23, DOI 10.1038/cgt.2014.66; Yip PY, 2015, TRANSL LUNG CANCER R, V4, P165, DOI 10.3978/j.issn.2218-6751.2015.01.04; YOUNG ME, 1980, BIOTECHNOL BIOENG, V22, P947, DOI 10.1002/bit.260220504; Yung BC, 2016, MOL PHARMACEUT, V13, P653, DOI 10.1021/acs.molpharmaceut.5b00878; Zang YS, 2012, CANCER GENE THER, V19, P773, DOI 10.1038/cgt.2012.60; Zhang GY, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-440; Zhang JG, 2010, CLIN CHIM ACTA, V411, P846, DOI 10.1016/j.cca.2010.02.074; Zhao W, 2015, INT J CLIN EXP MED, V8, P14759	83	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167706	10.1371/journal.pone.0167706	http://dx.doi.org/10.1371/journal.pone.0167706			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002496	Green Published, gold, Green Submitted			2022-12-26	WOS:000392853100017
J	Svagan, AJ; Kusic, A; De Gobba, C; Larsen, FH; Sassene, P; Zhou, Q; van de Weert, M; Mullertz, A; Jorgensen, B; Ulvskov, P				Svagan, Anna J.; Kusic, Anja; De Gobba, Cristian; Larsen, Flemming H.; Sassene, Philip; Zhou, Qi; van de Weert, Marco; Mullertz, Anette; Jorgensen, Bodil; Ulvskov, Peter			Rhamnogalacturonan-I Based Microcapsules for Targeted Drug Release	PLOS ONE			English	Article							POLYSACCHARIDES; POLYURETHANE; DELIVERY; SOLUBILIZATION; DIISOCYANATE; SPECTROSCOPY; ABSORPTION; EXPRESSION; DIGESTION; CAPSULES	Drug targeting to the colon via the oral administration route for local treatment of e.g. inflammatory bowel disease and colonic cancer has several advantages such as needle-free administration and low infection risk. A new source for delivery is plant-polysaccharide based delivery platforms such as Rhamnogalacturonan-I (RG-I). In the gastro-intestinal tract the RG-I is only degraded by the action of the colonic microflora. For assessment of potential drug delivery properties, RG-I based microcapsules (similar to 1 mu m in diameter) were prepared by an interfacial poly-addition reaction. The cross-linked capsules were loaded with a fluorescent dye (model drug). The capsules showed negligible and very little in vitro release when subjected to media simulating gastric and intestinal fluids, respectively. However, upon exposure to a cocktail of commercial RG-I cleaving enzymes, similar to 9 times higher release was observed, demonstrating that the capsules can be opened by enzymatic degradation. The combined results suggest a potential platform for targeted drug delivery in the terminal gastro-intestinal tract.	[Svagan, Anna J.; Kusic, Anja; Sassene, Philip; van de Weert, Marco; Mullertz, Anette] Univ Copenhagen, Dept Pharm, Copenhagen, Denmark; [De Gobba, Cristian; Larsen, Flemming H.] Univ Copenhagen, Dept Food Sci, Copenhagen, Denmark; [Zhou, Qi] Royal Inst Technol KTH, Sch Biotechnol, Stockholm, Sweden; [Jorgensen, Bodil; Ulvskov, Peter] Univ Copenhagen, Dept Plant & Environm Sci, Copenhagen, Denmark; [Svagan, Anna J.] Royal Inst Technol KTH, Dept Fibre & Polymertechnol, Stockholm, Sweden	University of Copenhagen; University of Copenhagen; Royal Institute of Technology; University of Copenhagen; Royal Institute of Technology	Svagan, AJ (corresponding author), Univ Copenhagen, Dept Pharm, Copenhagen, Denmark.; Svagan, AJ (corresponding author), Royal Inst Technol KTH, Dept Fibre & Polymertechnol, Stockholm, Sweden.	svagan@kth.se	Zhou, Qi/B-9095-2013; Larsen, Flemming/A-5255-2015; De Gobba, Cristian/M-5178-2014; van de Weert, Marco/AGR-7726-2022; Ulvskov, Peter/I-1228-2014; Müllertz, Anette/ABF-6935-2021; Jorgensen, Bodil/F-6551-2014	Zhou, Qi/0000-0001-9832-027X; Larsen, Flemming/0000-0001-5180-6870; De Gobba, Cristian/0000-0002-2774-5876; Ulvskov, Peter/0000-0003-3776-818X; Müllertz, Anette/0000-0003-3020-8892; Jorgensen, Bodil/0000-0002-0453-1277; Svagan (Hanner), Anna J./0000-0002-4583-723X	Danish Council for Independent Research	Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	This work was supported by the Danish Council for Independent Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Lorenzo C, 2013, ADV DRUG DELIVER REV, V65, P1148, DOI 10.1016/j.addr.2013.04.016; Armand M, 1996, AM J PHYSIOL-GASTR L, V271, pG172, DOI 10.1152/ajpgi.1996.271.1.G172; Assifaoui A, 2013, ACTA BIOMATER, V9, P6218, DOI 10.1016/j.actbio.2012.11.031; Assifaoui A, 2011, CARBOHYD POLYM, V85, P388, DOI 10.1016/j.carbpol.2011.02.037; Baier G, 2010, BIOMACROMOLECULES, V11, P960, DOI 10.1021/bm901414k; BENNETT AE, 1995, J CHEM PHYS, V103, P6951, DOI 10.1063/1.470372; Bergstrom CAS, 2014, EUR J PHARM SCI, V57, P173, DOI 10.1016/j.ejps.2013.10.015; Berthelsen R, 2015, MOL PHARMACEUT, V12, P1062, DOI 10.1021/mp500545k; Boulet JC, 2007, CARBOHYD POLYM, V69, P79, DOI 10.1016/j.carbpol.2006.09.003; Buchanan BB, 2007, BIOCH MOL BIOL PLANT; Byg I, 2012, FOOD CHEM, V131, P1207, DOI 10.1016/j.foodchem.2011.09.106; CARRIERE F, 1993, GASTROENTEROLOGY, V105, P876, DOI 10.1016/0016-5085(93)90908-U; Desilets S, 1997, J POLYM SCI POL CHEM, V35, P2991, DOI 10.1002/(SICI)1099-0518(199710)35:14<2991::AID-POLA20>3.0.CO;2-D; Ei-Gibaly I, 2002, INT J PHARM, V232, P199, DOI 10.1016/S0378-5173(01)00903-6; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Humblet-Hua NPK, 2012, J AGR FOOD CHEM, V60, P9502, DOI 10.1021/jf3024529; Kwon OJ, 2007, J APPL POLYM SCI, V103, P1544, DOI 10.1002/app.25363; Li SS, 2015, CHINESE J POLYM SCI, V33, P1196, DOI 10.1007/s10118-015-1670-7; Manderson K, 2005, APPL ENVIRON MICROB, V71, P8383, DOI 10.1128/AEM.71.12.8383-8389.2005; Marquis M, 2015, CARBOHYD POLYM, V116, P189, DOI 10.1016/j.carbpol.2014.01.083; Maxwell EG, 2015, CARBOHYD POLYM, V132, P546, DOI 10.1016/j.carbpol.2015.06.082; METZ G, 1994, J MAGN RESON SER A, V110, P219, DOI 10.1006/jmra.1994.1208; Molgaard SL, 2014, CARBOHYD POLYM, V114, P179, DOI 10.1016/j.carbpol.2014.08.011; Munjeri O, 1997, J CONTROL RELEASE, V46, P273, DOI 10.1016/S0168-3659(96)01607-0; Natrajan VK, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/1/015401; Orfila C, 2012, PLANTA, V236, P185, DOI 10.1007/s00425-012-1596-z; Rueda L, 2011, COMPOS SCI TECHNOL, V71, P1953, DOI 10.1016/j.compscitech.2011.09.014; Sassene P, 2014, AAPS J, V16, P1344, DOI 10.1208/s12248-014-9672-x; SCHOLS HA, 1994, CARBOHYD RES, V256, P97, DOI 10.1016/0008-6215(94)84230-2; Svagan AJ, 2016, CARBOHYD POLYM, V136, P292, DOI 10.1016/j.carbpol.2015.09.040; Thomassen LV, 2011, ENZYME MICROB TECH, V49, P289, DOI 10.1016/j.enzmictec.2011.06.006; Vertzoni M, 2005, EUR J PHARM BIOPHARM, V60, P413, DOI 10.1016/j.ejpb.2005.03.002; Yiamsawas D, 2014, RSC ADV, V4, P11661, DOI 10.1039/c3ra47971d; Zangenberg NH, 2001, EUR J PHARM SCI, V14, P115, DOI 10.1016/S0928-0987(01)00169-5; Zhang ML, 2014, P NATL ACAD SCI USA, V111, pE3708, DOI 10.1073/pnas.1406156111	35	9	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168050	10.1371/journal.pone.0168050	http://dx.doi.org/10.1371/journal.pone.0168050			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992455	Green Published, gold, Green Submitted			2022-12-26	WOS:000392842600030
J	Holczer, M; Banhegyi, G; Kapuy, O				Holczer, Marianna; Banhegyi, Gabor; Kapuy, Orsolya			GADD34 Keeps the mTOR Pathway Inactivated in Endoplasmic Reticulum Stress Related Autophagy	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; TUBEROUS SCLEROSIS COMPLEX; INDUCED GENE-EXPRESSION; MAMMALIAN TARGET; CELL-SURVIVAL; ALPHA-SUBUNIT; ER STRESS; RESVERATROL; APOPTOSIS; TRANSLATION	The balance of protein synthesis and proteolysis (i.e. proteostasis) is maintained by a complex regulatory network in which mTOR (mechanistic target of rapamycin serine/threonine kinase) pathway and unfolded protein response are prominent positive and negative actors. The interplay between the two systems has been revealed; however the mechanistic details of this crosstalk are largely unknown. The aim of the present study was to investigate the elements of crosstalk during endoplasmic reticulum stress and to verify the key role of GADD34 in the connection with the mTOR pathway. Here, we demonstrate that a transient activation of autophagy is present in endoplasmic reticulum stress provoked by thapsigargin or tunicamycin, which is turned into apoptotic cell death. The transient phase can be characterized by the elevation of the autophagic marker LC3II/I, by mTOR inactivation, AMP-activated protein kinase activation and increased GADD34 level. The switch from autophagy to apoptosis is accompanied with the appearance of apoptotic markers, mTOR reactivation, AMP-activated protein kinase inactivation and a decrease in GADD34. Inhibition of autophagy by 3-methyladenine shortens the transient phase, while inhibition of mTOR by rapamycin or resveratrol prolongs it. Inhibition of GADD34 by guanabenz or transfection of the cells with siGADD34 results in down-regulation of autophagy-dependent survival and a quick activation of mTOR, followed by apoptotic cell death. The negative effect of GADD34 inhibition is diminished when guanabenz or siGADD34 treatment is combined with rapamycin or resveratrol addition. These data confirm that GADD34 constitutes a mechanistic link between endoplasmic reticulum stress and mTOR inactivation, therefore promotes cell survival during endoplasmic reticulum stress.	[Holczer, Marianna; Banhegyi, Gabor; Kapuy, Orsolya] Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, Budapest, Hungary	Semmelweis University	Kapuy, O (corresponding author), Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, Budapest, Hungary.	kapuy.orsolya@med.semmelweis-univ.hu			Hungarian Academy of Sciences; Hungarian Scientific Research Fund [OTKA-PD 104110, OTKA 112696]; COST (European Cooperation in Science and Technology) [PROTEOSTASIS BM1307]	Hungarian Academy of Sciences(Hungarian Academy of Sciences); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); COST (European Cooperation in Science and Technology)(European Cooperation in Science and Technology (COST))	Support was provided by Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences (to OK); Hungarian Scientific Research Fund (OTKA-PD 104110 and OTKA 112696); and MedInProt grant of the Hungarian Academy of Sciences.; The authors are thankful to M. Marton and A. Kurucz (Semmelweis University, Budapest, Hungary) for their technical assistance. O.K. is grateful to Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. This study was supported by the Hungarian Scientific Research Fund (OTKA-PD 104110 and OTKA 112696) and by a MedInProt grant of the Hungarian Academy of Sciences. This article is based upon work from COST Action (PROTEOSTASIS BM1307), supported by COST (European Cooperation in Science and Technology).	Adler HT, 1999, MOL CELL BIOL, V19, P7050; Alayev A, 2015, ANN NY ACAD SCI, V1348, P116, DOI 10.1111/nyas.12829; Alberts B., 2002, MOL BIOL CELL, V4th; Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Appenzeller-Herzog C, 2012, TRENDS CELL BIOL, V22, P274, DOI 10.1016/j.tcb.2012.02.006; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Garcia-Huerta P, 2016, BRAIN RES, V1649, P173, DOI 10.1016/j.brainres.2016.02.052; Ghosh HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009199; Gorlach A, 2006, ANTIOXID REDOX SIGN, V8, P1391, DOI 10.1089/ars.2006.8.1391; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Holczer M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/319589; Hyrskyluoto A, 2012, EXP CELL RES, V318, P33, DOI 10.1016/j.yexcr.2011.08.020; Ito S, 2015, SCI REP-UK, V5, DOI 10.1038/srep08327; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Jung CH, 2011, AUTOPHAGY, V7, P1212, DOI 10.4161/auto.7.10.16660; Kapuy O, 2014, FEBS OPEN BIO, V4, P704, DOI 10.1016/j.fob.2014.07.006; Kapuy O, 2013, MOL BIOSYST, V9, P296, DOI 10.1039/c2mb25261a; Kato H, 2012, CELL DEATH DIFFER, V19, P310, DOI 10.1038/cdd.2011.98; Kojima E, 2003, FASEB J, V17, P1573, DOI 10.1096/fj.02-1184fje; Li Y, 2011, MATH PROBL ENG, V2011, DOI 10.1155/2011/575036; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mukai R, 2014, ONCOGENE, V33, P2317, DOI 10.1038/onc.2013.181; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Park D, 2016, SCI REPORTS, V6; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Pasinetti GM, 2011, EXP NEUROL, V232, P1, DOI 10.1016/j.expneurol.2011.08.014; Ravikumar B, 2006, HUM MOL GENET, V15, P1209, DOI 10.1093/hmg/ddl036; Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tambe Y, 2012, CANCER LETT, V314, P82, DOI 10.1016/j.canlet.2011.09.015; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Uddin MN, 2011, BIOCHEM BIOPH RES CO, V407, P692, DOI 10.1016/j.bbrc.2011.03.077; Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Watanabe R, 2007, INT J MOL MED, V19, P475; Watanabe R, 2011, J NUCL MED, V52, P497, DOI 10.2967/jnumed.111.089623; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	50	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168359	10.1371/journal.pone.0168359	http://dx.doi.org/10.1371/journal.pone.0168359			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992581	Green Published, gold			2022-12-26	WOS:000392758000039
J	Jorger, AK; Liu, L; Fehlner, K; Weisser, T; Cheng, ZJ; Lu, M; Hochst, B; Bolzer, A; Wang, BC; Hartmann, D; Assfalg, V; Sunami, Y; Schlitter, AM; Friess, H; Huser, N; Laschinger, M				Joerger, Ann-Kathrin; Liu, Lei; Fehlner, Karin; Weisser, Tanja; Cheng, Zhangjun; Lu, Miao; Hoechst, Bastian; Bolzer, Andreas; Wang, Baocai; Hartmann, Daniel; Assfalg, Volker; Sunami, Yoshiaki; Schlitter, Anna Melissa; Friess, Helmut; Hueser, Norbert; Laschinger, Melanie			Impact of NKT Cells and LFA-1 on Liver Regeneration under Subseptic Conditions	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; FUNCTION-ASSOCIATED ANTIGEN-1; PARTIAL-HEPATECTOMY; T-CELLS; HEPATOCYTE REGENERATION; MICE; ACTIVATION; ENDOTOXIN; RECEPTOR; INJURY	Background Activation of the immune system in terms of subseptic conditions during liver regeneration is of paramount clinical importance. However, little is known about molecular mechanisms and their mediators that control hepatocyte proliferation. We sought to determine the functional role of immune cells, especially NKT cells, in response to partial hepatectomy (PH), and to uncover the impact of the integrin lymphocyte function-associated antigen-1 (LFA-1) on liver regeneration in a subseptic setting. Methods Wild-type (WT) and LFA-1(-/-) mice underwent a 2/3 PH and low-dose lipopolysaccharid (LPS) application. Hepatocyte proliferation, immune cell infiltration, and cytokine profile in the liver parenchyma were determined. Results Low-dose LPS application after PH results in a significant delay of liver regeneration between 48h and 72h, which is associated with a reduced number of CD3(+) cells within the regenerating liver. In absence of LFA-1, an impaired regenerative capacity was observed under low-dose LPS application. Analysis of different leukocyte subpopulations showed less CD3(+)NK1.1(+) NKT cells in the liver parenchyma of LFA-1(-/-) mice after PH and LPS application compared to WT controls, while CD3(-)NK1.1(+) NK cells markedly increased. Concordantly with this observation, lower levels of NKT cell related cytokines IL-12 and IL-23 were expressed in the regenerating liver of LFA-1(-/-) mice, while the expression of NK cell-associated CCL5 and IL-10 was increased compared to WT mice. Conclusion A subseptic situation negatively alters hepatocyte proliferation. Within this scenario, we suggest an important impact of NKT cells and postulate a critical function for LFA-1 during processes of liver regeneration.	[Joerger, Ann-Kathrin; Liu, Lei; Fehlner, Karin; Weisser, Tanja; Cheng, Zhangjun; Lu, Miao; Wang, Baocai; Hartmann, Daniel; Assfalg, Volker; Sunami, Yoshiaki; Friess, Helmut; Hueser, Norbert; Laschinger, Melanie] Tech Univ Munich, Klinikum Rechts Isar, Dept Surg, Munich, Germany; [Hoechst, Bastian] Tech Univ Munich, Klinikum Rechts Isar, Inst Mol Immunol, Munich, Germany; [Bolzer, Andreas] ZEISS Grp, Carl Zeiss Microscopy, Munich, Germany; [Schlitter, Anna Melissa] Tech Univ Munich, Inst Pathol, Munich, Germany; [Liu, Lei; Cheng, Zhangjun] Southeast Univ, Affiliated Zhongda Hosp, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China	Technical University of Munich; Technical University of Munich; Technical University of Munich; Southeast University - China	Huser, N (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Surg, Munich, Germany.	norbert.hueser@tum.de	Sunami, Yoshiaki/G-5313-2012; Höchst, Bastian/ABG-2094-2020; Schlitter, Anna Melissa/AAX-3449-2021; Sunami, Yoshiaki/AAT-5931-2020	Sunami, Yoshiaki/0000-0002-1235-7512; Höchst, Bastian/0000-0002-5567-1173; Sunami, Yoshiaki/0000-0002-1235-7512	Deutsche Forschungsgemeinschaft DFG [SFB 914, A4]; Gesellschaft fur Gastroenterologie in Bayern e.V.; ZEISS	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Gesellschaft fur Gastroenterologie in Bayern e.V.; ZEISS	M.L. received a grant from the Deutsche Forschungsgemeinschaft DFG (SFB 914, project A4) D.H. and N.H. have received a grant from the Gesellschaft fur Gastroenterologie in Bayern e.V. Andreas Bolzer is employed by Carl Zeiss Microscopy, ZEISS group. Carl Zeiss Microscopy, ZEISS group provided support in the form of salary for author AB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section	Ajuebor MN, 2007, AM J PATHOL, V170, P1975, DOI 10.2353/ajpath.2007.060690; Anders RA, 2005, J IMMUNOL, V175, P1295, DOI 10.4049/jimmunol.175.2.1295; Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; BERGESE SD, 1994, TRANSPLANTATION, V57, P711, DOI 10.1097/00007890-199403150-00013; Berlin-Rufenach C, 1999, J EXP MED, V189, P1467, DOI 10.1084/jem.189.9.1467; Bertolino P, 2005, HEPATOLOGY, V42, P1063, DOI 10.1002/hep.20885; CORNELL RP, 1985, AM J PHYSIOL, V249, pR551, DOI 10.1152/ajpregu.1985.249.5.R551; CORNELL RP, 1985, AM J PHYSIOL, V249, pR563, DOI 10.1152/ajpregu.1985.249.5.R563; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; DAHMEN U, 1995, TRANSPLANTATION, V60, P577, DOI 10.1097/00007890-199509270-00010; DANDREA A, 1993, J EXP MED, V178, P1041, DOI 10.1084/jem.178.3.1041; DeAngelis RA, 2012, J IMMUNOL, V188, P641, DOI 10.4049/jimmunol.1101925; Emoto M, 2000, EUR J IMMUNOL, V30, P3049, DOI 10.1002/1521-4141(200010)30:10<3049::AID-IMMU3049>3.0.CO;2-F; Emoto M, 1999, J IMMUNOL, V162, P5094; Emoto M, 2003, J IMMUNOL, V171, P584, DOI 10.4049/jimmunol.171.2.584; Fogler WE, 1996, J IMMUNOL, V156, P4707; Graubardt N, 2013, HEPATOLOGY, V57, P1969, DOI 10.1002/hep.26008; HEWETT JA, 1992, LAB INVEST, V66, P347; Higgins GM, 1931, ARCH PATHOL, V12, P186; Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876; Hosoya S, 2013, AM J PHYSIOL-GASTR L, V304, pG293, DOI 10.1152/ajpgi.00083.2012; Iesalnieks I, 2000, VISZERALCHIRURGIE, V35, P392; Ito H, 2003, HEPATOLOGY, V38, P1116, DOI 10.1053/jhep.2003.50471; JAESCHKE H, 1991, AM J PHYSIOL, V261, pG1051, DOI 10.1152/ajpgi.1991.261.6.G1051; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Knolle PA, 2000, IMMUNOL REV, V174, P21, DOI 10.1034/j.1600-0528.2002.017408.x; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Li X, 2004, BRIT J PHARMACOL, V141, P709, DOI 10.1038/sj.bjp.0705634; Malato Y, 2012, GASTROENTEROLOGY, V143, P1597, DOI 10.1053/j.gastro.2012.08.030; Marcos A, 2000, TRANSPLANTATION, V69, P1375, DOI 10.1097/00007890-200004150-00028; Marra F, 2014, GASTROENTEROLOGY, V147, P577, DOI 10.1053/j.gastro.2014.06.043; Matsuda JL, 2002, NAT IMMUNOL, V3, P966, DOI 10.1038/ni837; McNab G, 1996, GASTROENTEROLOGY, V110, P522, DOI 10.1053/gast.1996.v110.pm8566600; Minagawa M, 2000, HEPATOLOGY, V31, P907, DOI 10.1053/he.2000.5850; Moreno C, 2005, HEPATOLOGY, V42, P854, DOI 10.1002/hep.20865; Morris MA, 2004, CURR MOL MED, V4, P431, DOI 10.2174/1566524043360609; Nakashima H, 2006, GASTROENTEROLOGY, V131, P1573, DOI 10.1053/j.gastro.2006.08.028; Perona-Wright G, 2009, CELL HOST MICROBE, V6, P503, DOI 10.1016/j.chom.2009.11.003; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Rachitskaya AV, 2008, J IMMUNOL, V180, P5167, DOI 10.4049/jimmunol.180.8.5167; Riehle KJ, 2008, J EXP MED, V205, P91, DOI 10.1084/jem.20070820; Rudich N, 2009, LIVER INT, V29, P1273, DOI 10.1111/j.1478-3231.2009.02048.x; Selzner N, 2003, GASTROENTEROLOGY, V124, P692, DOI 10.1053/gast.2003.50098; Slotta JE, 2010, J SURG RES, V162, P184, DOI 10.1016/j.jss.2009.03.057; Su GL, 2004, DIGEST DIS SCI, V49, P843, DOI 10.1023/B:DDAS.0000030097.52476.aa; Sun R, 2004, GASTROENTEROLOGY, V127, P1525, DOI 10.1053/j.gastro.2004.08.055; Tumanov AV, 2009, GASTROENTEROLOGY, V136, P694, DOI 10.1053/j.gastro.2008.09.015; Vaquero J, 2011, HEPATOLOGY, V54, P597, DOI 10.1002/hep.24420; Yin S, 2011, AM J PATHOL, V178, P1614, DOI 10.1016/j.ajpath.2011.01.001; Zhai Y, 2008, TRANSPLANTATION, V85, P1016, DOI 10.1097/TP.0b013e3181684248	50	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168001	10.1371/journal.pone.0168001	http://dx.doi.org/10.1371/journal.pone.0168001			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977747	Green Published, Green Submitted, gold			2022-12-26	WOS:000391217400048
J	Marken, JP; Halleran, AD; Rahman, A; Odorizzi, L; LeFew, MC; Golino, CA; Kemper, P; Saha, MS				Marken, John P.; Halleran, Andrew D.; Rahman, Atiqur; Odorizzi, Laura; LeFew, Michael C.; Golino, Caroline A.; Kemper, Peter; Saha, Margaret S.			A Markovian Entropy Measure for the Analysis of Calcium Activity Time Series	PLOS ONE			English	Article							DIFFERENTIATION; DECONVOLUTION; XENOPUS; SCALE	Methods to analyze the dynamics of calcium activity often rely on visually distinguishable features in time series data such as spikes, waves, or oscillations. However, systems such as the developing nervous system display a complex, irregular type of calcium activity which makes the use of such methods less appropriate. Instead, for such systems there exists a class of methods (including information theoretic, power spectral, and fractal analysis approaches) which use more fundamental properties of the time series to analyze the observed calcium dynamics. We present a new analysis method in this class, the Markovian Entropy measure, which is an easily implementable calcium time series analysis method which represents the observed calcium activity as a realization of a Markov Process and describes its dynamics in terms of the level of predictability underlying the transitions between the states of the process. We applied our and other commonly used calcium analysis methods on a dataset from Xenopus laevis neural progenitors which displays irregular calcium activity and a dataset from murine synaptic neurons which displays activity time series that are well-described by visually-distinguishable features. We find that the Markovian Entropy measure is able to distinguish between biologically distinct populations in both datasets, and that it can separate biologically distinct populations to a greater extent than other methods in the dataset exhibiting irregular calcium activity. These results support the benefit of using the Markovian Entropy measure to analyze calcium dynamics, particularly for studies using time series data which do not exhibit easily distinguishable features.	[Marken, John P.; Halleran, Andrew D.; LeFew, Michael C.; Golino, Caroline A.] Coll William & Mary, Dept Math, Williamsburg, VA 23185 USA; [Halleran, Andrew D.; Odorizzi, Laura; LeFew, Michael C.; Golino, Caroline A.; Saha, Margaret S.] Coll William & Mary, Dept Biol, Williamsburg, VA 23185 USA; [Rahman, Atiqur; Kemper, Peter] Coll William & Mary, Dept Comp Sci, Williamsburg, VA 23185 USA; [Halleran, Andrew D.] CALTECH, Dept Bioengn, Pasadena, CA 91125 USA; [Odorizzi, Laura] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA	William & Mary; William & Mary; William & Mary; California Institute of Technology; University of Texas System; University of Texas Health San Antonio	Saha, MS (corresponding author), Coll William & Mary, Dept Biol, Williamsburg, VA 23185 USA.	mssaha@wm.edu	Rahman, Md Atiqur/GSE-2794-2022	Saha, Margaret/0000-0003-0096-2667; Halleran, Andrew/0000-0001-8720-1451; Marken, John/0000-0001-9696-088X	National Institutes of Health [R15NS067566, 1R15HD077624-01]; National Science Foundation [1257895]; Howard Hughes Medical Institute [52006919]; Arnold and Mabel Beckman Foundation Beckman Scholar Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R15HD077624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS067566] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Arnold and Mabel Beckman Foundation Beckman Scholar Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institutes of Health grants R15NS067566 and 1R15HD077624-01 to MS, National Science Foundation grant 1257895 to MS, Howard Hughes Medical Institute grant 52006919 to the College of William and Mary, Arnold and Mabel Beckman Foundation Beckman Scholar Award to AH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bickenbach F, 2003, INT REGIONAL SCI REV, V26, P363, DOI 10.1177/0160017603253789; Cline HT, 2012, DEV NEUROBIOL, V72, P463, DOI 10.1002/dneu.22012; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cover T. M., 1991, Elements of information theory, DOI 10.1002/0471200611; Eilers PH, 2005, BASELINE CORRECTION, V1, P1, DOI DOI 10.1021/AC034173T; Freeman J, 2014, NAT METHODS, V11, P941, DOI [10.1038/NMETH.3041, 10.1038/nmeth.3041]; Gorbunova YV, 2002, NATURE, V418, P93, DOI 10.1038/nature00835; GU XN, 1994, J NEUROSCI, V14, P6325; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Jenkins G., 1968, SPECTRAL ANAL ITS AP; Khodagholy D, 2015, NAT NEUROSCI, V18, P310, DOI 10.1038/nn.3905; LECHLEITER J, 1991, SCIENCE, V252, P123, DOI 10.1126/science.2011747; Marken J, MARKOVIAN ENTROPY ME; Michod D, 2012, NEURON, V74, P122, DOI 10.1016/j.neuron.2012.02.021; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Nakano T, 2009, L N INST COMP SCI SO, V20, P29; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Onativia J, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/4/046017; Pahle J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-139; Pnevmatikakis EA, 2016, NEURON, V89, P285, DOI 10.1016/j.neuron.2015.11.037; Prank K, 2000, BIOSYSTEMS, V55, P15, DOI 10.1016/S0303-2647(99)00078-7; Qian B., 2004, IASTED C FIN ENG APP, P203; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Root CM, 2008, J NEUROSCI, V28, P4777, DOI 10.1523/JNEUROSCI.4873-07.2008; Rosenbaum Sara, 2011, Issue Brief (Commonw Fund), V3, P1, DOI 10.1101/cshperspect.a004259; Ruffault PL, 2015, ELIFE, V4, DOI 10.7554/eLife.07051; Salles A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003245; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Smaili SS, 2013, CURR MOL MED, V13, P252; SPITZER NC, 1995, J NEUROBIOL, V26, P316, DOI 10.1002/neu.480260304; Theis L., 2015, ARXIV PREPRINT ARXIV; Vogelstein JT, 2010, J NEUROPHYSIOL, V104, P3691, DOI 10.1152/jn.01073.2009; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874	37	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168342	10.1371/journal.pone.0168342	http://dx.doi.org/10.1371/journal.pone.0168342			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977764	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000391217400098
J	Yu, ZX; Mouillesseaux, KP; Kushner, EJ; Bautch, VL				Yu, Zhixian; Mouillesseaux, Kevin P.; Kushner, Erich J.; Bautch, Victoria L.			Tumor-Derived Factors and Reduced p53 Promote Endothelial Cell Centrosome Over-Duplication	PLOS ONE			English	Article							MORPHOGENETIC PROTEIN-RECEPTOR; HYPOXIA; GROWTH; CANCER; INTERLEUKIN-8; ANGIOGENESIS; INFLAMMATION; ACTIVATION; EXPRESSION; DELETION	Approximately 30% of tumor endothelial cells have over-duplicated (>2) centrosomes, which may contribute to abnormal vessel function and drug resistance. Elevated levels of vascular endothelial growth factor A induce excess centrosomes in endothelial cells, but how other features of the tumor environment affect centrosome over-duplication is not known. To test this, we treated endothelial cells with tumor-derived factors, hypoxia, or reduced p53, and assessed centrosome numbers. We found that hypoxia and elevated levels of bone morphogenetic protein 2, 6 and 7 induced excess centrosomes in endothelial cells through BMPR1A and likely via SMAD signaling. In contrast, inflammatory mediators IL-8 and lipopolysaccharide did not induce excess centrosomes. Finally, down-regulation in endothelial cells of p53, a critical regulator of DNA damage and proliferation, caused centrosome over-duplication. Our findings suggest that some tumor-derived factors and genetic changes in endothelial cells contribute to excess centrosomes in tumor endothelial cells.	[Yu, Zhixian; Bautch, Victoria L.] Univ North Carolina Chapel Hill, Curriculum Genet & Mol Biol, Chapel Hill, NC 27514 USA; [Mouillesseaux, Kevin P.; Kushner, Erich J.; Bautch, Victoria L.] Univ North Carolina Chapel Hill, Dept Biol, Chapel Hill, NC 27514 USA; [Bautch, Victoria L.] Univ North Carolina Chapel Hill, McAllister Heart Inst, Chapel Hill, NC 27514 USA; [Mouillesseaux, Kevin P.] StrideBio, Durham, NC USA; [Kushner, Erich J.] Univ Denver, Dept Biol Sci, Denver, CO 80208 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Denver	Bautch, VL (corresponding author), Univ North Carolina Chapel Hill, Curriculum Genet & Mol Biol, Chapel Hill, NC 27514 USA.; Bautch, VL (corresponding author), Univ North Carolina Chapel Hill, Dept Biol, Chapel Hill, NC 27514 USA.; Bautch, VL (corresponding author), Univ North Carolina Chapel Hill, McAllister Heart Inst, Chapel Hill, NC 27514 USA.	bautch@med.unc.edu			NIH-NHLBI [HL116719, HL43174]	NIH-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the NIH-NHLBI (HL116719 and HL43174). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akino T, 2009, AM J PATHOL, V175, P2657, DOI 10.2353/ajpath.2009.090202; An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Bobinac D, 2005, CROAT MED J, V46, P389; Brat DJ, 2005, NEURO-ONCOLOGY, V7, P122, DOI 10.1215/S1152851704001061; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; David L, 2009, CYTOKINE GROWTH F R, V20, P203, DOI 10.1016/j.cytogfr.2009.05.001; Dudley AC, 2008, BRIT J CANCER, V99, P118, DOI 10.1038/sj.bjc.6604465; Dudley AC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006536; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; Gaussin V, 2005, CIRC RES, V97, P219, DOI 10.1161/01.RES.0000177862.85474.63; Gaussin V, 2002, P NATL ACAD SCI USA, V99, P2878, DOI 10.1073/pnas.042390499; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hida K, 2004, CANCER RES, V64, P8249, DOI 10.1158/0008-5472.CAN-04-1567; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Kushner EJ, 2016, MOL BIOL CELL, V27, P1911, DOI 10.1091/mbc.E15-09-0645; Kushner EJ, 2014, J CELL BIOL, V206, P257, DOI 10.1083/jcb.201311013; LIU YX, 1995, CIRC RES, V77, P638, DOI 10.1161/01.RES.77.3.638; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; MARTICH GD, 1993, IMMUNOBIOLOGY, V187, P403, DOI 10.1016/S0171-2985(11)80353-0; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Roberts DM, 2004, MOL CELL BIOL, V24, P10515, DOI 10.1128/MCB.24.24.10515-10528.2004; Taylor SM, 2010, BLOOD, V116, P3108, DOI 10.1182/blood-2010-01-266197; Upton PD, 2008, MOL PHARMACOL, V73, P539, DOI 10.1124/mol.107.041673; Vaupel P, 2004, ONCOLOGIST, V9, P4, DOI 10.1634/theoncologist.9-90005-4; Wang RN, 2014, GENES DIS, V1, P87, DOI 10.1016/j.gendis.2014.07.005; Yi SE, 2000, DEVELOPMENT, V127, P621; Yu PB, 2005, J BIOL CHEM, V280, P24443, DOI 10.1074/jbc.M502825200; Yuan A, 2005, FRONT BIOSCI-LANDMRK, V10, P853, DOI 10.2741/1579; Zhang XJ, 2010, FRONT BIOSCI-LANDMRK, V15, P151, DOI 10.2741/3612	35	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168334	10.1371/journal.pone.0168334	http://dx.doi.org/10.1371/journal.pone.0168334			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977771	Green Published, gold, Green Submitted			2022-12-26	WOS:000391217400094
J	Klayman, LM; Wedegaertner, PB				Klayman, Lauren M.; Wedegaertner, Philip B.			Inducible Inhibition of G Reveals Localization-dependent Functions at the Plasma Membrane and Golgi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell biology; G protein; Golgi; intracellular trafficking; protein trafficking (Golgi); signal transduction	PROTEIN-KINASE-D; HETEROTRIMERIC G-PROTEINS; BETA-GAMMA-SUBUNITS; CELL-SURFACE; TRANSPORT CARRIERS; SPONGE METABOLITE; RECEPTOR KINASE; PKD; ILIMAQUINONE; COMPLEX	Heterotrimeric G proteins signal at a variety of endomembrane locations, in addition to their canonical function at the cytoplasmic surface of the plasma membrane (PM), where they are activated by cell surface G protein-coupled receptors. Here we focus on signaling at the Golgi, where activates a signaling cascade, ultimately resulting in vesicle fission from the trans-Golgi network (TGN). To develop a novel molecular tool for inhibiting endogenous in a spatial-temporal manner, we take advantage of a lipid association mutant of the widely used inhibitor GRK2ct (GRK2ct-KERE) and the FRB/FKBP heterodimerization system. We show that GRK2ct-KERE cannot inhibit function when expressed in cells, but recruitment to a specific membrane location recovers the ability of GRK2ct-KERE to inhibit signaling. PM-recruited GRK2ct-KERE inhibits lysophosphatidic acid-induced phosphorylation of Akt, whereas Golgi-recruited GRK2ct-KERE inhibits cargo transport from the TGN to the PM. Moreover, we show that Golgi-recruited GRK2ct-KERE inhibits model basolaterally targeted but not apically targeted cargo delivery, for both PM-destined and secretory cargo, providing the first evidence of selectivity in terms of cargo transport regulated by . Last, we show that Golgi fragmentation induced by ilimaquinone and nocodazole is blocked by inhibition, demonstrating that is a key regulator of multiple pathways that impact Golgi morphology. Thus, we have developed a new molecular tool, recruitable GRK2ct-KERE, to modulate signaling at specific subcellular locations, and we demonstrate novel cargo selectivity for regulation of TGN to PM transport and a novel role for in mediating Golgi fragmentation.	[Klayman, Lauren M.; Wedegaertner, Philip B.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St,839 BLSB, Philadelphia, PA 19107 USA	Jefferson University	Wedegaertner, PB (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St,839 BLSB, Philadelphia, PA 19107 USA.	Philip.Wedegaertner@jefferson.edu			National Institutes of Health [GM56444]; American Heart Association [14PRE19980023]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056444, R56GM056444] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM56444 (to P.B.W.). This work was also supported by American Heart Association Grant 14PRE19980023 (to L.M.K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anel A. M., 2007, BIOCHEM J, V406, P157; Anel AMD, 2005, J CELL BIOL, V169, P83, DOI 10.1083/jcb.200412089; Axelsson MAB, 2004, MOL BIOL CELL, V15, P1843, DOI 10.1091/mbc.E03-07-0459; Belshaw PJ, 1996, P NATL ACAD SCI USA, V93, P4604, DOI 10.1073/pnas.93.10.4604; Bossard C, 2007, J CELL BIOL, V179, P1123, DOI 10.1083/jcb.200703166; Carman CV, 2000, J BIOL CHEM, V275, P10443, DOI 10.1074/jbc.275.14.10443; De Matteis MA, 2011, NEW ENGL J MED, V365, P927, DOI 10.1056/NEJMra0910494; Dinter A, 1998, HISTOCHEM CELL BIOL, V109, P571, DOI 10.1007/s004180050256; Farber-Katz SE, 2014, CELL, V156, P413, DOI 10.1016/j.cell.2013.12.023; Fuchs YF, 2009, TRAFFIC, V10, P858, DOI 10.1111/j.1600-0854.2009.00918.x; Giannotta M, 2012, EMBO J, V31, P2869, DOI 10.1038/emboj.2012.134; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Haase G, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00448; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Heuer D, 2009, NATURE, V457, P731, DOI 10.1038/nature07578; Hewavitharana T, 2012, CELL SIGNAL, V24, P25, DOI 10.1016/j.cellsig.2011.08.014; Irannejad R, 2010, J BIOL CHEM, V285, P32393, DOI 10.1074/jbc.M110.154963; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Jamora C, 1997, CELL, V91, P617, DOI 10.1016/S0092-8674(00)80449-3; Jensen DD, 2016, J BIOL CHEM, V291, P11285, DOI 10.1074/jbc.M115.710681; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Kienzle C, 2013, MOL BIOL CELL, V24, P222, DOI 10.1091/mbc.E12-03-0198; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; Krumins AM, 2006, J BIOL CHEM, V281, P10250, DOI 10.1074/jbc.M511551200; Lee HY, 2015, MAR DRUGS, V13, P543, DOI 10.3390/md13010543; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Lu PH, 2007, EUR J PHARMACOL, V556, P45, DOI 10.1016/j.ejphar.2006.10.061; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Montoya V, 2007, CELL MOTIL CYTOSKEL, V64, P936, DOI 10.1002/cm.20234; Musch A, 1996, J CELL BIOL, V133, P543, DOI 10.1083/jcb.133.3.543; O'Neill PR, 2014, MOL BIOL CELL, V25, P2305, DOI 10.1091/mbc.E14-04-0870; Paladino S, 2004, J CELL BIOL, V167, P699, DOI 10.1083/jcb.200407094; Pandey KN, 2010, CURR OPIN BIOTECH, V21, P611, DOI 10.1016/j.copbio.2010.08.007; Riaz A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020215; Saini DK, 2009, TRENDS PHARMACOL SCI, V30, P278, DOI 10.1016/j.tips.2009.04.001; Saini DK, 2010, P NATL ACAD SCI USA, V107, P11417, DOI 10.1073/pnas.1003042107; Sharlow ER, 2008, J BIOL CHEM, V283, P33516, DOI 10.1074/jbc.M805358200; Sonoda H, 2007, J BIOL CHEM, V282, P34085, DOI 10.1074/jbc.M705593200; Sumara G, 2009, CELL, V136, P235, DOI 10.1016/j.cell.2008.11.018; TAKIZAWA PA, 1993, CELL, V73, P1079, DOI 10.1016/0092-8674(93)90638-7; VEIT B, 1993, J CELL BIOL, V122, P1197, DOI 10.1083/jcb.122.6.1197; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090	43	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1773	1784		10.1074/jbc.M116.750430	http://dx.doi.org/10.1074/jbc.M116.750430			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27994056	hybrid, Green Published			2022-12-26	WOS:000395515600019
J	Xi, G; Wai, C; White, MF; Clemmons, DR				Xi, Gang; Wai, Christine; White, Morris F.; Clemmons, David R.			Down-regulation of Insulin Receptor Substrate 1 during Hyperglycemia Induces Vascular Smooth Muscle Cell Dedifferentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						atherosclerosis; diabetes; insulin receptor substrate 1 (IRS-1); insulin resistance; myocardin; vascular smooth muscle cells	GROWTH-FACTOR-I; SERINE/THREONINE PHOSPHORYLATION; TYROSINE PHOSPHORYLATION; OXIDIZED PHOSPHOLIPIDS; ENDOTHELIAL-CELLS; MAMMALIAN TARGET; ANGIOTENSIN-II; ACTIVATION; DIFFERENTIATION; RESISTANCE	Diabetes is a major risk factor for the development of atherosclerosis, but the mechanism by which hyperglycemia accelerates lesion development is not well defined. Insulin and insulin-like growth factor I (IGF-I) signal through the scaffold protein insulin receptor substrate 1 (IRS-1). In diabetes, IRS-1 is down-regulated, and cells become resistant to insulin. Under these conditions, the IGF-I receptor signals through an alternate scaffold protein, SHPS-1, resulting in pathophysiologic stimulation of vascular smooth muscle cell (VSMC) migration and proliferation. These studies were undertaken to determine whether IRS-1 is functioning constitutively to maintain VSMCs in their differentiated state and, thereby, inhibit aberrant signaling. Here we show that deletion of IRS-1 expression in VSMCs in non-diabetic mice results in dedifferentiation, SHPS-1 activation, and aberrant signaling and that these changes parallel those that occur in response to hyperglycemia. The mice showed enhanced sensitivity to IGF-I stimulation of VSMC proliferation and a hyperproliferative response to vascular injury. KLF4, a transcription factor that induces VSMC dedifferentiation, was up-regulated in IRS-1(-/-) mice, and the differentiation inducer myocardin was undetectable. Importantly, these changes were replicated in wild-type mice during hyperglycemia. These findings illuminate a new function of IRS-1: that of maintaining cells in their normal, differentiated state. Because IRS-1 is down-regulated in states of insulin resistance that occur in response to metabolic stresses such as obesity and cytokine stimulation, the findings provide a mechanism for understanding how patients with metabolic stress and/or diabetes are predisposed to developing vascular complications.	[Xi, Gang; Wai, Christine; Clemmons, David R.] Univ N Carolina, Div Endocrinol, Dept Med, Sch Med, Chapel Hill, NC 27599 USA; [White, Morris F.] Harvard Med Sch, Div Endocrinol, Dept Med, Childrens Hosp, Boston, MA 02115 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Harvard University; Boston Children's Hospital; Harvard Medical School	Clemmons, DR (corresponding author), Univ N Carolina, Div Endocrinol, CB 7170,8024 Burnett Womack, Chapel Hill, NC 27599 USA.	david_clemmons@med.unc.edu			National Institutes of Health [AG02331, EY021943]; NATIONAL EYE INSTITUTE [R42EY021943, R41EY021943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG002331, R01AG002331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants AG02331 and EY021943. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali MS, 2013, J CEREBR BLOOD F MET, V33, P1564, DOI 10.1038/jcbfm.2013.109; Berk BC, 2001, ANN NY ACAD SCI, V947, P93; Carvalho Eugenia, 2001, FASEB Journal, V15, P1101; Cester N, 1996, EUR J CLIN INVEST, V26, P569, DOI 10.1046/j.1365-2362.1996.1750526.x; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Ding M, 2011, ARTERIOSCL THROM VAS, V31, P1403, DOI 10.1161/ATVBAHA.110.216804; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Galkina EV, 2012, ARTERIOSCL THROM VAS, V32, P247, DOI 10.1161/ATVBAHA.111.240358; Garvey SM, 2010, J PHARMACOL EXP THER, V333, P34, DOI 10.1124/jpet.109.163949; Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774; Hancer NJ, 2014, J BIOL CHEM, V289, P12467, DOI 10.1074/jbc.M114.554162; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Lee J, 2010, AM J PHYSIOL-HEART C, V298, pH310, DOI 10.1152/ajpheart.00359.2009; Lee S, 2008, ENDOCRINOLOGY, V149, P2451, DOI 10.1210/en.2007-1595; Lightell DJ, 2011, ENDOCRINOLOGY, V152, P651, DOI 10.1210/en.2010-0722; Lin XY, 2004, J CLIN INVEST, V114, P908, DOI [10.1172/JCI22217, 10.1172/JCI200422217]; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Longobardi L, 2009, GROWTH FACTORS, V27, P309, DOI 10.1080/08977190903138874; Maile LA, 2006, MOL ENDOCRINOL, V20, P405, DOI 10.1210/me.2005-0241; Maile LA, 2002, J BIOL CHEM, V277, P8955, DOI 10.1074/jbc.M109258200; Maile LA, 2008, DIABETES, V57, P2637, DOI 10.2337/db08-0326; Maile LA, 2007, ENDOCRINOLOGY, V148, P2435, DOI 10.1210/en.2006-1440; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Nemoto S, 2014, ATHEROSCLEROSIS, V233, P64, DOI 10.1016/j.atherosclerosis.2013.12.032; Ordonez P, 2008, J STEROID BIOCHEM, V111, P287, DOI 10.1016/j.jsbmb.2008.07.001; Pidkovka NA, 2007, CIRC RES, V101, P792, DOI 10.1161/CIRCRESAHA.107.152736; Radhakrishnan Y, 2008, J BIOL CHEM, V283, P16320, DOI 10.1074/jbc.M801687200; Radhakrishnan Y, 2011, MOL ENDOCRINOL, V25, P1636, DOI 10.1210/me.2011-0035; Raphel L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044052; SAAD MJA, 1992, J CLIN INVEST, V90, P1839, DOI 10.1172/JCI116060; Salt IP, 2003, J BIOL CHEM, V278, P18791, DOI 10.1074/jbc.M210618200; Stohr O, 2011, BBA-MOL BASIS DIS, V1812, P573, DOI 10.1016/j.bbadis.2011.02.006; SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418; Talasila A, 2013, ARTERIOSCL THROM VAS, V33, P2355, DOI 10.1161/ATVBAHA.112.301000; Taniyama Y, 2005, ARTERIOSCL THROM VAS, V25, P1142, DOI 10.1161/01.ATV.0000164313.17167.df; Thomas SS, 2013, KIDNEY INT, V84, P308, DOI 10.1038/ki.2013.97; Thum T, 2000, FASEB J, V14, P740, DOI 10.1096/fasebj.14.5.740; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; Xi G, 2008, MOL ENDOCRINOL, V22, P2162, DOI 10.1210/me.2008-0079; Xi G, 2012, DIABETES, V61, P104, DOI 10.2337/db11-0990; Yoshida T, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000230; Yoshida T, 2008, AM J PHYSIOL-CELL PH, V295, pC1175, DOI 10.1152/ajpcell.00288.2008; Yu Qiujun, 2014, Cardiovasc Res, V103, P238, DOI 10.1093/cvr/cvu132; Zhang H, 2000, J BIOL CHEM, V275, P22558, DOI 10.1074/jbc.M000412200; Zhao Y, 2011, AM J PHYSIOL-CELL PH, V300, pC1375, DOI 10.1152/ajpcell.00670.2008; Zheng XL, 2014, ARCH BIOCHEM BIOPHYS, V543, P48, DOI 10.1016/j.abb.2013.12.015	48	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					2009	2020		10.1074/jbc.M116.758987	http://dx.doi.org/10.1074/jbc.M116.758987			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28003360	Green Published, hybrid			2022-12-26	WOS:000395515600038
J	Hart, SA; Ganley, CM; Purpura, DJ				Hart, Sara A.; Ganley, Colleen M.; Purpura, David J.			Understanding the Home Math Environment and Its Role in Predicting Parent Report of Children's Math Skills	PLoS One			English	Article							EARLY NUMERACY SKILLS; CHINESE-AMERICAN; NUMBER SENSE; EUROPEAN-AMERICAN; WRITTEN LANGUAGE; PRIMARY-SCHOOL; LITERACY; MATHEMATICS; ACHIEVEMENT; PERFORMANCE	There is a growing literature concerning the role of the home math environment in children's math development. In this study, we examined the relation between these constructs by specifically addressing three goals. The first goal was to identify the measurement structure of the home math environment through a series of confirmatory factor analyses. The second goal was to examine the role of the home math environment in predicting parent report of children's math skills. The third goal was to test a series of potential alternative explanations for the relation between the home math environment and parent report of children's skills, specifically the direct and indirect role of household income, parent math anxiety, and parent math ability as measured by their approximate number system performance. A final sample of 339 parents of children aged 3 through 8 drawn from Mechanical Turk answered a questionnaire online. The best fitting model of the home math environment was a bifactor model with a general factor representing the general home math environment, and three specific factors representing the direct numeracy environment, the indirect numeracy environment, and the spatial environment. When examining the association of the home math environment factors to parent report of child skills, the general home math environment factor and the spatial environment were the only significant predictors. Parents who reported doing more general math activities in the home reported having children with higher math skills, whereas parents who reported doing more spatial activities reported having children with lower math skills.	[Hart, Sara A.; Ganley, Colleen M.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; [Hart, Sara A.] Florida State Univ, Florida Ctr Reading Res, Tallahassee, FL 32306 USA; [Ganley, Colleen M.] Florida State Univ, Florida Ctr Res Sci Technol Engn & Math, Learning Syst Inst, Tallahassee, FL 32306 USA; [Purpura, David J.] Purdue Univ, Human Dev & Family Studies, W Lafayette, IN 47907 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Hart, SA (corresponding author), Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA.; Hart, SA (corresponding author), Florida State Univ, Florida Ctr Reading Res, Tallahassee, FL 32306 USA.	hart@psy.fsu.edu		Ganley, Colleen/0000-0002-8902-9189; Hart, Sara/0000-0001-9793-0420				Anders Y, 2012, EARLY CHILD RES Q, V27, P231, DOI 10.1016/j.ecresq.2011.08.003; Benavides-Varela S, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00094; Berkowitz T, 2015, SCIENCE, V350, P196, DOI 10.1126/science.aac7427; Blevins-Knabe B., 2000, EARLY CHILD DEV CARE, V165, P41, DOI 10.1080/0300443001650104; BlevinsKnabe B, 1996, EARLY DEV PARENTING, V5, P35, DOI 10.1002/(SICI)1099-0917(199603)5:1<35::AID-EDP113>3.0.CO;2-0; Bradley RH, 2001, CHILD DEV, V72, P1844, DOI 10.1111/1467-8624.t01-1-00382; Burgess SR, 2002, READ RES QUART, V37, P408, DOI 10.1598/RRQ.37.4.4; Casad BJ, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01597; Casey BM, 2014, EARLY CHILD RES Q, V29, P636, DOI 10.1016/j.ecresq.2014.07.005; Dearing E, 2012, EARLY CHILD RES Q, V27, P458, DOI 10.1016/j.ecresq.2012.01.002; Frijters JC, 2000, J EDUC PSYCHOL, V92, P466, DOI 10.1037/0022-0663.92.3.466; Geary DC, 2004, J LEARN DISABIL-US, V37, P4, DOI 10.1177/00222194040370010201; Gulick ME, 2012, THESIS; Gunderson EA, 2011, DEVELOPMENTAL SCI, V14, P1021, DOI 10.1111/j.1467-7687.2011.01050.x; Halberda J, 2008, DEV PSYCHOL, V44, P1457, DOI 10.1037/a0012682; Halberda J, 2012, P NATL ACAD SCI USA, V109, P11116, DOI 10.1073/pnas.1200196109; Halberda J, 2008, LANG LEARN DEV, V4, P99, DOI 10.1080/15475440801922099; Hart B., 1995, MEANINGFUL DIFFERENC; Hart SA, 2009, J EDUC PSYCHOL, V101, P388, DOI 10.1037/a0015115; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huntsinger CS, 1997, INT J BEHAV DEV, V21, P371, DOI 10.1080/016502597384929; Huntsinger CS, 1998, DEV PSYCHOL, V34, P747, DOI 10.1037/0012-1649.34.4.747; Huntsinger CS, 2000, J EDUC PSYCHOL, V92, P745, DOI 10.1037//0022-0663.92.4.745; Inglis M, 2011, PSYCHON B REV, V18, P1222, DOI 10.3758/s13423-011-0154-1; Kirby J., 2008, EXCEPTIONALITY ED CH, V18, P112; Kleemans T, 2012, EARLY CHILD RES Q, V27, P471, DOI 10.1016/j.ecresq.2011.12.004; LeFevre J, 2002, EARLY CHILD DEV CARE, V172, P293; LeFevre JA, 2010, INT J EARLY YEARS ED, V18, P55, DOI 10.1080/09669761003693926; LeFevre JA, 2010, CHILD DEV, V81, P1753, DOI 10.1111/j.1467-8624.2010.01508.x; LeFevre JA, 2009, CAN J BEHAV SCI, V41, P55, DOI 10.1037/a0014532; Levine SC, 2012, DEV PSYCHOL, V48, P530, DOI 10.1037/a0025913; Levine SC, 2010, DEV PSYCHOL, V46, P1309, DOI 10.1037/a0019671; Libertus ME, 2009, CURR DIR PSYCHOL SCI, V18, P346, DOI 10.1111/j.1467-8721.2009.01665.x; Maloney EA, 2015, PSYCHOL SCI, V26, P1480, DOI 10.1177/0956797615592630; Manolitsis G, 2013, EARLY CHILD RES Q, V28, P692, DOI 10.1016/j.ecresq.2013.05.004; Melhuish EC, 2008, J SOC ISSUES, V64, P95, DOI 10.1111/j.1540-4560.2008.00550.x; Missall K, 2015, EARLY EDUC DEV, V26, P356, DOI 10.1080/10409289.2015.968243; Morrison FJ, 2009, MERRILL PALMER QUART, V55, P361; Muthen B., 2010, MPLUS USERS GUIDE; Niklas F, 2014, EUR J PSYCHOL EDUC, V29, P327, DOI 10.1007/s10212-013-0201-6; PLOMIN R, 1977, PSYCHOL BULL, V84, P309, DOI 10.1037/0033-2909.84.2.309; Pomerantz EM, 2007, REV EDUC RES, V77, P373, DOI 10.3102/003465430305567; Pruden SM, 2011, DEVELOPMENTAL SCI, V14, P1417, DOI 10.1111/j.1467-7687.2011.01088.x; Reise SP, 2010, J PERS ASSESS, V92, P544, DOI 10.1080/00223891.2010.496477; RESNICK LB, 1989, AM PSYCHOL, V44, P162, DOI 10.1037/0003-066X.44.2.162; SCARBOROUGH HS, 1991, J LEARN DISABIL, V24, P508, DOI 10.1177/002221949102400811; SCARR S, 1983, CHILD DEV, V54, P424, DOI 10.2307/1129703; Senechal M, 2002, CHILD DEV, V73, P445, DOI 10.1111/1467-8624.00417; Senechal M, 1998, READ RES QUART, V33, P96, DOI 10.1598/RRQ.33.1.5; Sirin SR, 2005, REV EDUC RES, V75, P417, DOI 10.3102/00346543075003417; Skwarchuk SL, 2014, J EXP CHILD PSYCHOL, V121, P63, DOI 10.1016/j.jecp.2013.11.006; Skwarchuk SL, 2009, EARLY CHILD EDUC J, V37, P189, DOI 10.1007/s10643-009-0340-1; Soni A., 2015, INT J APPL SOCIOLOGY, V5, P159; Willcutt EG, 2011, PSYCHOL ASSESSMENT, V23, P778, DOI 10.1037/a0023290; Zippert EL, 2016, INFANT CHILD DEV	55	50	51	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168227	10.1371/journal.pone.0168227	http://dx.doi.org/10.1371/journal.pone.0168227			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QH	28005925	Green Published, Green Submitted, gold			2022-12-26	WOS:000392843200038
J	Mallet, KH; Shamloul, RM; Corbett, D; Finestone, HM; Hatcher, S; Lumsden, J; Momoli, F; Shamy, MCF; Stotts, G; Swartz, RH; Yang, C; Dowlatshahi, D				Mallet, Karen H.; Shamloul, Rany M.; Corbett, Dale; Finestone, Hillel M.; Hatcher, Simon; Lumsden, Jim; Momoli, Franco; Shamy, Michel C. F.; Stotts, Grant; Swartz, Richard H.; Yang, Christine; Dowlatshahi, Dar			RecoverNow: Feasibility of a Mobile Tablet Based Rehabilitation Intervention to Treat Post-Stroke Communication Deficits in the Acute Care Setting	PLOS ONE			English	Article							STROKE REHABILITATION; APHASIA THERAPY; IPAD; PROGRAM; TECHNOLOGY	Background Approximately 40% of patients diagnosed with stroke experience some degree of aphasia. With limited health care resources, patients' access to speech and language therapies is often delayed. We propose using mobile-platform technology to initiate early speech-language therapy in the acute care setting. For this pilot, our objective was to assess the feasibility of a tablet-based speech-language therapy for patients with communication deficits following acute stroke. Methods We enrolled consecutive patients admitted with a stroke and communication deficits with NIHSS score >= 1 on the best language and/or dysarthria parameters. We excluded patients with severe comprehension deficits where communication was not possible. Following baseline assessment by a speech-language pathologist (SLP), patients were provided with a mobile tablet programmed with individualized therapy applications based on the assessment, and instructed to use it for at least one hour per day. Our objective was to establish feasibility by measuring recruitment rate, adherence rate, retention rate, protocol deviations and acceptability. Results Over 6 months, 143 patients were admitted with a new diagnosis of stroke: 73 had communication deficits, 44 met inclusion criteria, and 30 were enrolled into RecoverNow (median age 62, 26.6% female) for a recruitment rate of 68% of eligible participants. Participants received mobile tablets at a mean 6.8 days from admission [SEM 1.6], and used them for a mean 149.8 minutes/day [SEM 19.1]. In-hospital retention rate was 97%, and 96% of patients scored the mobile tablet-based communication therapy as at least moderately convenient 3/5 or better with 5/5 being most "convenient". Conclusions Individualized speech-language therapy delivered by mobile tablet technology is feasible in acute care.	[Mallet, Karen H.; Lumsden, Jim] Champlain Reg Stroke Network, Ottawa, ON, Canada; [Mallet, Karen H.; Lumsden, Jim; Shamy, Michel C. F.; Stotts, Grant; Dowlatshahi, Dar] Ottawa Hosp, Ottawa, ON, Canada; [Mallet, Karen H.; Shamloul, Rany M.; Momoli, Franco; Shamy, Michel C. F.; Stotts, Grant; Dowlatshahi, Dar] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Corbett, Dale; Finestone, Hillel M.; Hatcher, Simon; Momoli, Franco; Shamy, Michel C. F.; Stotts, Grant; Yang, Christine; Dowlatshahi, Dar] Univ Ottawa, Brain & Mind Res Inst, Ottawa, ON, Canada; [Corbett, Dale; Finestone, Hillel M.; Dowlatshahi, Dar] Canadian Partnership Stroke Recovery, Ottawa, ON, Canada; [Finestone, Hillel M.; Yang, Christine] Elisabeth Bruyere Hosp, Ottawa, ON, Canada; [Momoli, Franco] Childrens Hosp, Eastern Ontario Res Inst, Ottawa, ON, Canada; [Swartz, Richard H.] Univ Toronto, Toronto, ON, Canada; [Mallet, Karen H.] Ottawa Hosp, Champlain Reg Stroke Network, 1053 Carling Ave, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute	Mallet, KH (corresponding author), Champlain Reg Stroke Network, Ottawa, ON, Canada.; Mallet, KH (corresponding author), Ottawa Hosp, Ottawa, ON, Canada.; Mallet, KH (corresponding author), Ottawa Hosp, Res Inst, Ottawa, ON, Canada.; Mallet, KH (corresponding author), Ottawa Hosp, Champlain Reg Stroke Network, 1053 Carling Ave, Ottawa, ON, Canada.	kmallet@toh.on.ca	Corbett, Dale/D-6625-2011	Corbett, Dale/0000-0003-0217-4576; Dowlatshahi, Dar/0000-0003-1379-3612; Swartz, Rick/0000-0001-6571-5531; Yang, Christine/0000-0002-9059-5452	University of Ottawa Brain and Mind Research Institute	University of Ottawa Brain and Mind Research Institute	Support was provided by the University of Ottawa Brain and Mind Research Institute [http://www.uottawa.ca/brain/] to DD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakheit AMO, 2007, CLIN REHABIL, V21, P941, DOI 10.1177/0269215507078452; Bernhardt J, 2004, STROKE, V35, P1005, DOI 10.1161/01.STR.0000120727.40792.40; Bhogal SK, 2003, STROKE, V34, P987, DOI 10.1161/01.STR.0000062343.64383.D0; Brady MC, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000425.pub4, 10.1002/14651858.CD000425.pub3]; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Casaubon LK, 2016, INT J STROKE, V11, P239, DOI 10.1177/1747493015622461; Choi YH, 2016, TELEMED E-HEALTH, V22, P434, DOI 10.1089/tmj.2015.0138; Cook DJ, 2014, TELEMED E-HEALTH, V20, P312, DOI 10.1089/tmj.2013.0219; Dawson AS, 2013, CANADIAN BEST PRACTI; Des Roches CA, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01015; Dickey L, 2010, ARCH PHYS MED REHAB, V91, P196, DOI 10.1016/j.apmr.2009.09.020; FEIGENSON JS, 1977, NEW YORK STATE J MED, V77, P1426; Godecke E, 2012, INT J STROKE, V7, P635, DOI 10.1111/j.1747-4949.2011.00631.x; Godecke E, 2014, INT J LANG COMM DIS, V49, P149, DOI 10.1111/1460-6984.12074; Godecke E, 2013, SEMIN SPEECH LANG, V34, P129, DOI 10.1055/s-0033-1358369; Goodglass H, 2001, ASSESSMENT APHASIA R, V3rd; HAYES SH, 1986, ARCH PHYS MED REHAB, V67, P319; Heart and Stroke Foundation, 2014, TOG RIS TID ADV STRO; Hoover EL, 2014, SEMIN SPEECH LANG, V35, P25, DOI 10.1055/s-0033-1362990; Kaplan E, 2001, BOSTON NAMING TEST; Kertesz A., 2007, W APHASIA BATTERY; Kertesz A, 2007, W APHASIA BATTERY BE; Kiran S, 2014, SEMIN SPEECH LANG, V35, P38, DOI 10.1055/s-0033-1362995; Kurland J, 2014, SEMIN SPEECH LANG, V35, P51, DOI 10.1055/s-0033-1362991; O'Leary KJ, 2016, J AM MED INFORM ASSN, V23, P159, DOI 10.1093/jamia/ocv058; OTTENBACHER KJ, 1993, ARCH NEUROL-CHICAGO, V50, P37, DOI 10.1001/archneur.1993.00540010033014; Paolucci S, 2000, ARCH PHYS MED REHAB, V81, P695, DOI 10.1053/apmr.2000.5583; Rand D, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0796-9; Ross- Swain D., 1986, ROSS INFORM PROCESSI; Routhier S, 2014, APHASIOLOGY, P1, DOI DOI 10.1177/1545968313517753; Salter K, EVIDENCE BASED REV S; Saposnik G, 2014, INT J STROKE, V9, P956, DOI 10.1111/ijs.12328; Stark BC, 2018, NEUROPSYCHOL REHABIL, V28, P818, DOI 10.1080/09602011.2016.1146150; Swigert N, 1997, SOURCE DYSARTHRIA; van der Meulen I, 2014, NEUROREHAB NEURAL RE, V28, P536, DOI 10.1177/1545968313517753; White JH, 2015, DISABIL REHABIL, V37, P593, DOI 10.3109/09638288.2014.935876	36	26	26	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167950	10.1371/journal.pone.0167950	http://dx.doi.org/10.1371/journal.pone.0167950			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002479	Green Published, gold, Green Submitted			2022-12-26	WOS:000392853100028
J	Saravanakumar, K; Yu, CJ; Dou, K; Wang, M; Li, YQ; Chen, J				Saravanakumar, Kandasamy; Yu, Chuanjin; Dou, Kai; Wang, Meng; Li, Yaqian; Chen, Jie			Biodiversity of Trichoderma Community in the Tidal Flats and Wetland of Southeastern China	PLoS One			English	Article							DIVERSITY; IDENTIFICATION; SPONGE; KONINGII; WHEAT	To investigate the biodiversity of Trichoderma (Hypocreaceae) and their relation to sediment physical and chemical properties, we collected a total of 491 sediment samples from coastal wetlands (tidal flat and wetland) in Southeast China. Further, we applied two types of molecular approaches such as culture dependent and independent methods for identification of Trichoderma spp. A total of 254 isolates were obtained and identified to 13 species such as T. aureoviride, T. asperellum, T. harzianum, T. atroviride, T. koningiopsis, T. longibrachiatum, T. koningii. T. tawa, T. viridescens, T. virens, T. hamatum, T. viride, and T. velutinum by the culture-dependent (CD) method of these, T. tawa was newly described in China. Subsequently, the culture indepented method of 454 pyrosequencing analysis revealed a total of six species such as T. citrinoviride, T. virens, T. polysporum, T. harzianumlHypocrea fixiiand two unknown species. Notably, T. citrinoviride and T. polysporum were not found by the CD method. Therefore, this work revealed that the combination of these two methods could show the higher biodiversity of Trichoderma spp., than either of this method alone. Among the sampling sites, Hangzhou, Zhejiang Province, exhibited rich biodiversity and low in Fengxian. Correlation and Redundancy discriminant analysis (RDA) revealed that sediment properties of temperature, redox potential (Eh) and pH significantly influenced the biodiversity of Trichoderma spp.	[Saravanakumar, Kandasamy; Yu, Chuanjin; Dou, Kai; Wang, Meng; Li, Yaqian; Chen, Jie] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai, Peoples R China; [Saravanakumar, Kandasamy; Yu, Chuanjin; Dou, Kai; Wang, Meng; Li, Yaqian; Chen, Jie] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai, Peoples R China; [Saravanakumar, Kandasamy; Yu, Chuanjin; Dou, Kai; Wang, Meng; Li, Yaqian; Chen, Jie] Minist Agr, Key Lab Urban Agr South, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Ministry of Agriculture & Rural Affairs	Li, YQ (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai, Peoples R China.; Li, YQ (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai, Peoples R China.; Li, YQ (corresponding author), Minist Agr, Key Lab Urban Agr South, Shanghai, Peoples R China.	lauren@sjtu.edu.cn	Saravanakumar, Kandasamy/P-6745-2018	Saravanakumar, Kandasamy/0000-0002-4465-4378; Dou, Kai/0000-0003-2665-0231	special project of basic work for science and technology [2014FY120900]; key project of the basic research of Shanghai Municipal Science and Technology Commission [12JC1404600]; special fund of modern agricultural industry technology system [CARS-02]	special project of basic work for science and technology; key project of the basic research of Shanghai Municipal Science and Technology Commission; special fund of modern agricultural industry technology system	We thank the financial support from the special project of basic work for science and technology (2014FY120900), the key project of the basic research of Shanghai Municipal Science and Technology Commission (12JC1404600), and the special fund of modern agricultural industry technology system (CARS-02).	Amagata T, 1998, J ANTIBIOT, V51, P33, DOI 10.7164/antibiotics.51.33; Bahram M, 2012, NEW PHYTOL, V193, P465, DOI 10.1111/j.1469-8137.2011.03927.x; Blaszczyk L, 2011, J APPL GENET, V52, P233, DOI 10.1007/s13353-011-0039-z; BOUYOUCOS GJ, 1962, AGRON J, V54, P464, DOI 10.2134/agronj1962.00021962005400050028x; Brewer D., 1993, Proceedings of the Nova Scotian Institute of Science, V40, P29; Burtseva Y, 2006, J APPL PHYCOL, V18, P375, DOI 10.1007/s10811-006-9043-9; Carbone I, 1999, MYCOLOGIA, V91, P553, DOI 10.2307/3761358; Carvajal LH, 2011, THESIS; Chaverri P, 2015, MYCOLOGIA, V107, P558, DOI 10.3852/14-147; Chelkowski J, 2003, J APPL GENET, V44, P323; Christensen M., 1981, FUNGAL COMMUNITY ITS, P201; Cummings NJ, 2016, MYCOL PROG, V15, DOI 10.1007/s11557-016-1192-x; Daghino S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044233; De Respinis S, 2010, MYCOL PROG, V9, P79, DOI 10.1007/s11557-009-0621-5; Doohan FM, 1998, PLANT PATHOL, V47, P197, DOI 10.1046/j.1365-3059.1998.00218.x; DRUZHININA I, 2004, TRICHOBLAST VERSION; Druzhinina Irina, 2005, J Zhejiang Univ Sci B, V6, P100, DOI 10.1631/jzus.2005.B0100; Druzhinina IS, 2005, FUNGAL GENET BIOL, V42, P813, DOI 10.1016/j.fgb.2005.06.007; Eck R.V., 1966, ATLAS PROTEIN SEQUEN; El Wakeel SK., 1957, J CONS PERM INT EXPL, V22, P180, DOI [10.1093/icesjms/22.2.180, DOI 10.1093/ICESJMS/22.2.180]; Gams W, 1998, TRICHODERMA GLIOCLAD, V1, P3, DOI DOI 10.4324/9780203483558; Gil SV, 2009, MICROBIOL RES, V164, P196, DOI 10.1016/j.micres.2006.11.022; He ZiDian, 2010, Acta Phytophylacica Sinica, V37, P459; Hjeljord L, 1998, TRICHODERMA GLIOCLAD, V2, P131; Jaklitsch WM, 2014, STUD MYCOL, V80, P1, DOI DOI 10.1016/J.SIMYC0.2014.11.001; KOBAYASHI M, 1993, TETRAHEDRON LETT, V34, P7925, DOI 10.1016/S0040-4039(00)61513-7; Kubicek CP, 2008, J ZHEJIANG UNIV-SC B, V9, P753, DOI 10.1631/jzus.B0860015; Kubicek CP, 2003, FUNGAL GENET BIOL, V38, P310, DOI 10.1016/S1087-1845(02)00583-2; Kullnig-Gradinger CM, 2002, MYCOL RES, V106, P757, DOI 10.1017/S0953756202006172; Landreau A, 2002, J MICROBIOL METH, V48, P181, DOI 10.1016/S0167-7012(01)00322-0; [李广记 Li Guangji], 2010, [微生物学通报, Microbiology], V37, P1663; Nei M., 2000, MOL EVOLUTION PHYLOG; Pan Z, 2010, J ZHEJIANG U AGR LIF, V6, P405; Paz Z, 2010, FUNGAL DIVERS, V42, P17, DOI 10.1007/s13225-010-0020-x; Samuels G, 2002, MYCOLOGIA, V94, P146, DOI 10.2307/3761854; Samuels GJ, 2006, STUD MYCOL, P67, DOI 10.3114/sim.2006.56.03; Samuels GJ, 2010, MYCOLOGIA, V102, P944, DOI 10.3852/09-243; Samuels GJ, 2009, TRICHODERMA ONLINE S; Sivasithamparam K., 1998, TRICHODERMA GLIOCLAD, V1, P139; Studholme DJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00258; Sun RY, 2012, J APPL GENET, V53, P343, DOI 10.1007/s13353-012-0093-1; Sun S., 2009, ASIAN J TRADIT MED, V4, P123; Sun Z, 2014, SCI REP-UK, V4, DOI 10.1038/srep06966; Syed SS, 2003, PHYTOPATHOL MEDITERR, V42, P135; Tamura K, 2013, MOL BIOL EVOL, V5, P1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vinale F, 2008, SOIL BIOL BIOCHEM, V40, P1, DOI 10.1016/j.soilbio.2007.07.002; Wang GY, 2008, ANTON LEEUW INT J G, V93, P163, DOI 10.1007/s10482-007-9190-2; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wen C, 1992, ACTA PHYTOPATHOLOGIC, V4, P306; Wen C. J., 1993, Acta Mycologica Sinica, V12, P118; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; WIDDEN P, 1988, MYCOLOGIA, V80, P795, DOI 10.2307/3807557; Wiese J, 2011, MAR DRUGS, V9, P561, DOI 10.3390/md9040561; [吴小平 WU Xiaoping], 2008, [农业生物技术学报, Journol of Agricultural Biotechnology], V16, P1048; Wuczkowski M, 2003, MICROBIOL RES, V158, P125, DOI 10.1078/0944-5013-00193; Xia C, 2009, BIODIVERSITY RES GEN; Yu HaoLong, 2010, Guangxi Agricultural Sciences, V41, P703; [Yuan Zhilin 袁志林], 2008, [菌物学报, Mygosystema], V27, P608; Zelazowska M, 2009, ENVIRON MICROBIOL, V11, P35, DOI [10.1111/j.1462-2920.2008.01736.x, DOI 10.1111/J.1462-2920.2008.01736.X]; Zelazowska M, 2010, BMC EVOL BIOL, V10, P94, DOI [10.1186/1471-2148-10-94, DOI 10.1186/1471-2148-10-94]; Zelazowska M, 2010, APPL ENVIRON MICROB, V76, P7259, DOI [10.1128/AEM.01184-10, DOI 10.1128/AEM.01184-10]; Zhang CL, 2005, FEMS MICROBIOL LETT, V251, P251, DOI 10.1016/j.femsle.2005.08.034; Zhu ZX, 2014, MYCOSYSTEMA, V6, P1136	64	18	19	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168020	10.1371/journal.pone.0168020	http://dx.doi.org/10.1371/journal.pone.0168020			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002436	gold, Green Published, Green Submitted			2022-12-26	WOS:000392853100031
J	Slawinska, A; Plowiec, A; Siwek, M; Jaroszewski, M; Bednarczyk, M				Slawinska, Anna; Plowiec, Arkadiusz; Siwek, Maria; Jaroszewski, Marcin; Bednarczyk, Marek			Long-Term Transcriptomic Effects of Prebiotics and Synbiotics Delivered In Ovo in Broiler Chickens	PLOS ONE			English	Article							HUMAN COLONIC MICROBIOTA; GENE-EXPRESSION; BIFIDOBACTERIUM-BIFIDUM; DIETARY MODULATION; ENZYMATIC-ACTIVITY; LYMPHOID-TISSUES; GUT; PROBIOTICS; BIOINFORMATICS; MIXTURE	In ovo delivery of prebiotics and synbiotics in chickens allows for the development of intestinal microflora prior to hatching, which boosts their robustness. The goal of this study was to determine the transcriptomic profile of the spleen (S), cecal tonsils (CT), and large intestine (LI) of adult chickens injected with prebiotics and synbiotics in ovo. On day 12 of embryo development, incubating eggs were injected with prebiotics: inulin alone (P1) or in combination with Lactococcus lactis subsp. lactis IBB2955 (S1), galactooligosaccharides (GOS) alone (P2) or in combination with Lactococcus lactis subsp. cremoris IBB477 (S2); control group (C) was mock injected with physiological saline. Gene expression analysis was conducted using an Affymetrix Chicken Gene 1.1 ST Array Strip. Most of the differentially expressed genes (DEG) were detected in the cecal tonsils of P2 (378 DEG), and were assigned to gene ontology categories: lymphocyte proliferation, activation and differentiation, and cytokine production. Ingenuity pathway analysis of the DEG (CT of P2) indicated the inhibition of humoral and cellular immune responses, e.g., role of NFAT in regulation of immune responses, phagocytosis, production of nitric oxide, NF-kappa B, IL-8, and CXCR4 signaling. The DEG with the highest up-regulation from S1 and P2 were involved in gene expression (PAPOLA, RPL27A, RPLP1, and RPS29) from P1 and P2 in transport (BEST4, SLC9A3, and SLC13A2), metabolism (OGT, ALPP, CA4, and CA7), signaling (FGG, G3BP2, UBB, G3BP2, CACNA1G, and ATP6V0A4), and immune responses (MSMB, LGALS3, CABIN1, CXCR5, PAX5, and TNFRSF14). Two DEG influencing the complement system (SERPING1 and MIR1674) were down-regulated in P2 and S1. In conclusion, GOS injected in ovo provided the most potent stimulation of the host transcriptome. This is likely due to its strong bifidogenic effect, which triggers proliferation of indigenous embryonic microflora in ovo, and indirectly influences gene expression regulation in host tissues, especially cecal tonsils.	[Slawinska, Anna; Plowiec, Arkadiusz; Siwek, Maria; Bednarczyk, Marek] UTP Univ Sci & Technol, Dept Anim Biochem & Biotechnol, Mazowiecka 28, Bydgoszcz, Poland; [Jaroszewski, Marcin] Adam Mickiewicz Univ, Dept Human Mol Genet, Umultowska 89, Poznan, Poland	Bydgoszcz University of Science & Technology; Adam Mickiewicz University	Bednarczyk, M (corresponding author), UTP Univ Sci & Technol, Dept Anim Biochem & Biotechnol, Mazowiecka 28, Bydgoszcz, Poland.	marbed13@op.pl	Siwek, Maria/AAG-8929-2019; Slawinska, Anna/B-3781-2016	Siwek, Maria/0000-0003-4148-5174; Slawinska, Anna/0000-0002-5706-6145	National Science Centre in Cracow, Poland [UMO-2011/01/B/NZ9/00642, UMO-2013/11/B/NZ9/00783]	National Science Centre in Cracow, Poland	The study was conducted with support of National Science Centre in Cracow, Poland (https://www.ncn.gov.pl) grants numbers: UMO-2011/01/B/NZ9/00642 and UMO-2013/11/B/NZ9/00783. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballou AL, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00002; Bansal T, 2010, P NATL ACAD SCI USA, V107, P228, DOI 10.1073/pnas.0906112107; Bar-Shira E, 2006, DEV COMP IMMUNOL, V30, P930, DOI 10.1016/j.dci.2005.12.002; Bednarczyk M, 2016, ANIMAL, P1; Bednarczyk M, 2011, B VET I PULAWY, V55, P465; Carbajal-Franco E, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/837859; Cardeal PC, 2015, WORLD POULTRY SCI J, V71, P655, DOI 10.1017/S0043933915002445; Carvalho B, 2007, BIOSTATISTICS, V8, P485, DOI 10.1093/biostatistics/kxl042; Cesta MF, 2006, TOXICOL PATHOL, V34, P599, DOI 10.1080/01926230600865531; Chichlowski M, 2007, INT J POULTRY SCI, V6, P10; Chistiakov DA, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00781; Clark LC, 2014, CELL MICROBIOL, V16, P27, DOI 10.1111/cmi.12234; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Cryan JF, 2011, NEUROGASTROENT MOTIL, V23, P187, DOI 10.1111/j.1365-2982.2010.01664.x; Friedman A, 2003, WORLD POULTRY SCI J, V59, P209, DOI 10.1079/WPS20030013; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibson GR, 2004, NUTR RES REV, V17, P259, DOI 10.1079/NRR200479; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Hardy H, 2013, NUTRIENTS, V5, P1869, DOI 10.3390/nu5061869; Hu ZL, 2008, ONLINE J BIOINFORMAT, V9, P108, DOI DOI 10.1186/1471-2105-13-134; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jeurissen SHM, 1999, POULTRY SCI, V78, P965, DOI 10.1093/ps/78.7.965; Julia A, 2014, HUM MOL GENET, V23, P6927, DOI 10.1093/hmg/ddu398; Lan Y, 2005, WORLD POULTRY SCI J, V61, P95, DOI 10.1079/WPS200445; LANDSVERK T, 1987, IMMUNOL CELL BIOL, V65, P425, DOI 10.1038/icb.1987.49; Lillehoj HS, 1996, CLIN MICROBIOL REV, V9, P349, DOI 10.1128/CMR.9.3.349; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madej JP, 2016, POULTRY SCI, V95, P19, DOI 10.3382/ps/pev291; Madej JP, 2015, POULTRY SCI, V94, P1209, DOI 10.3382/ps/pev076; Maiorano G, 2012, POULTRY SCI, V91, P2963, DOI 10.3382/ps.2012-02208; Moran ET, 2007, POULTRY SCI, V86, P1043, DOI 10.1093/ps/86.5.1043; NURMI E, 1973, NATURE, V241, P210, DOI 10.1038/241210a0; Ohta Y, 2001, POULTRY SCI, V80, P1425, DOI 10.1093/ps/80.10.1425; Oliveros, 2007, VENNY INTERACTIVE TO; Pan D, 2014, GUT MICROBES, V5, P108, DOI 10.4161/gmic.26945; Park AM, 2016, INFECT IMMUN; Pilarski R, 2005, FOLIA BIOL-KRAKOW, V53, P13, DOI 10.3409/1734916054663474; Plowiec A, 2015, AM J VET RES, V76, P975, DOI 10.2460/ajvr.76.11.975; Pruszynska-Oszmalek E, 2015, POULTRY SCI, V94, P1909, DOI 10.3382/ps/pev162; Rashidi H, 2009, BIOESSAYS, V31, P459, DOI 10.1002/bies.200800168; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Schippa S, 2014, NUTRIENTS, V6, P5786, DOI 10.3390/nu6125786; Schrezenmeir J, 2001, AM J CLIN NUTR, V73, p361S, DOI 10.1093/ajcn/73.2.361s; Searle LEJ, 2010, J MED MICROBIOL, V59, P1428, DOI 10.1099/jmm.0.022780-0; Searle LEJ, 2009, J MED MICROBIOL, V58, P37, DOI 10.1099/jmm.0.004390-0; SHARMA JM, 1987, AVIAN DIS, V31, P570, DOI 10.2307/1590742; Shreiner AB, 2015, CURR OPIN GASTROEN, V31, P69, DOI 10.1097/MOG.0000000000000139; Slawinska A, 2016, ANIM SCI PAP REP, P34; Slawinska A, 2014, FOLIA BIOL-KRAKOW, V62, P277, DOI 10.3409/fb62_3.277; Smirnov A, 2006, POULTRY SCI, V85, P669, DOI 10.1093/ps/85.4.669; Smith A.L., 2014, AVIAN IMMUNOLOGY EDI, VSecond Edition, P227, DOI [10.1016/b978-0-12-396965-1.00013-3, DOI 10.1016/B978-0-12-396965-1.00013-3]; Tako E, 2004, POULTRY SCI, V83, P2023, DOI 10.1093/ps/83.12.2023; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Tzortzis G, 2005, J NUTR, V135, P1726, DOI 10.1093/jn/135.7.1726; Tzortzis G, 2009, AGRO FOOD IND HI TEC, V20, P43; Uni Z, 2005, POULTRY SCI, V84, P764, DOI 10.1093/ps/84.5.764; Villaluenga CM, 2004, FOLIA BIOL-KRAKOW, V52, P135, DOI 10.3409/1734916044527502; Walker WA, 1998, J NUTR BIOCHEM, V9, P668, DOI 10.1016/S0955-2863(98)00058-8; Yair R, 2015, POULTRY SCI, V94, P2695, DOI 10.3382/ps/pev252; Yair R, 2011, POULTRY SCI, V90, P1523, DOI 10.3382/ps.2010-01283; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yegani M, 2008, POULTRY SCI, V87, P2052, DOI 10.3382/ps.2008-00091	64	34	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168899	10.1371/journal.pone.0168899	http://dx.doi.org/10.1371/journal.pone.0168899			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002487	Green Submitted, gold, Green Published			2022-12-26	WOS:000392853100075
J	Densmore-McCulloch, JA; Thompson, DL; Fraser, LH				Densmore-McCulloch, Justine A.; Thompson, Donald L.; Fraser, Lauchlan H.			Short-Term Effects of Changing Precipitation Patterns on Shrub-Steppe Grasslands: Seasonal Watering Is More Important than Frequency of Watering Events	PLOS ONE			English	Article							PLANT-SPECIES DIVERSITY; CLIMATE-CHANGE; PRODUCTIVITY RESPONSES; RAINFALL VARIABILITY; PULSE DYNAMICS; ECOSYSTEMS; VEGETATION; COMMUNITY; RICHNESS; GRADIENT	Climate change is expected to alter precipitation patterns. Droughts may become longer and more frequent, and the timing and intensity of precipitation may change. We tested how shifting precipitation patterns, both seasonally and by frequency of events, affects soil nitrogen availability, plant biomass and diversity in a shrub-steppe temperate grassland along a natural productivity gradient in Lac du Bois Grasslands Protected Area near Kamloops, British Columbia, Canada. We manipulated seasonal watering patterns by either exclusively watering in the spring or the fall. To simulate spring precipitation we restricted precipitation inputs in the fall, then added 50% more water than the long term average in the spring, and vice-versa for the fall precipitation treatment. Overall, the amount of precipitation remained roughly the same. We manipulated the frequency of rainfall events by either applying water weekly (frequent) or monthly (intensive). After 2 years, changes in the seasonality of watering had greater effects on plant biomass and diversity than changes in the frequency of watering. Fall watering reduced biomass and increased species diversity, while spring watering had little effect. The reduction in biomass in fall watered treatments was due to a decline in grasses, but not forbs. Plant available N, measured by Plant Root Simulator (PRS)-probes, increased from spring to summer to fall, and was higher in fall watered treatments compared to spring watered treatments when measured in the fall. The only effect observed due to frequency of watering events was greater extractable soil N in monthly applied treatments compared to weekly watering treatments. Understanding the effects of changing precipitation patterns on grasslands will allow improved grassland conservation and management in the face of global climatic change, and here we show that if precipitation is more abundant in the fall, compared to the spring, grassland primary productivity will likely be negatively affected.	[Densmore-McCulloch, Justine A.; Fraser, Lauchlan H.] Thompson Rivers Univ, Dept Nat Resource Sci, Kamloops, BC, Canada; [Thompson, Donald L.] Agr & Agri Food Canada, Lethbridge, AB, Canada	Agriculture & Agri Food Canada	Fraser, LH (corresponding author), Thompson Rivers Univ, Dept Nat Resource Sci, Kamloops, BC, Canada.	lfraser@tru.ca			Future Forest Ecosystem Scientific Council (FFESC) grant [007_Fraser]; Natural Sciences and Engineering Research Council (NSERC) [312155-2011]; NSERC Industrial Postgraduate Scholarship; Grasslands Conservation Council of BC	Future Forest Ecosystem Scientific Council (FFESC) grant; Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Industrial Postgraduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Grasslands Conservation Council of BC	This research was supported by: 1. A Future Forest Ecosystem Scientific Council (FFESC) grant to LHF (#007_Fraser). 2. A Natural Sciences and Engineering Research Council (NSERC) Discovery Grant to LHF (#312155-2011). 3. An NSERC Industrial Postgraduate Scholarship in partnership with the Grasslands Conservation Council of BC to JAD.r We thank Cameron Carlyle, Tessa Jongbloets, Anna Sapozhnikova, Amanda Schmidt and Laurenz Teuber for assistance in the field. This research was supported by a Future Forest Ecosystem Scientific Council (FFESC) grant and a Natural Sciences and Engineering Research Council (NSERC) Discovery Grant to L. Fraser, as well as an NSERC Industrial Postgraduate Scholarship in partnership with the Grasslands Conservation Council of BC to J. Densmore-McCulloch. This study was conducted under permit # 102724 from BC Ministry of Environment, Parks and Protected Areas Division.	Adler PB, 2007, OIKOS, V116, P221, DOI [10.1111/j.2006.0030-1299.15327.x, 10.1111/j.0030-1299.2007.15327.x]; Asner GP, 2004, ANNU REV ENV RESOUR, V29, P261, DOI 10.1146/annurev.energy.29.062403.102142; Austin AT, 2004, OECOLOGIA, V141, P221, DOI 10.1007/s00442-004-1519-1; Bates JD, 2006, J ARID ENVIRON, V64, P670, DOI 10.1016/j.jaridenv.2005.06.026; Bloor JMG, 2012, PERSPECT PLANT ECOL, V14, P193, DOI 10.1016/j.ppees.2011.12.001; Bond WJ, 2010, BIOL CONSERV, V143, P2395, DOI 10.1016/j.biocon.2009.12.012; Carlyle C, 2014, OECOLOGIA, V174, P1065, DOI 10.1007/s00442-013-2833-2; Carlyle CN, 2011, ECOSYSTEMS, V14, P489, DOI 10.1007/s10021-011-9425-y; Collins SL, 2008, J ECOL, V96, P413, DOI 10.1111/j.1365-2745.2008.01362.x; Dijkstra FA, 2012, OECOLOGIA, V170, P799, DOI 10.1007/s00442-012-2336-6; Dunne JA, 2004, ECOLOGY, V85, P904, DOI 10.1890/03-8003; Fay PA, 2003, OECOLOGIA, V137, P245, DOI 10.1007/s00442-003-1331-3; Fraser LH, 2015, SCIENCE, V349, P302, DOI 10.1126/science.aab3916; Fry EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057027; GENTRY AH, 1982, ANN MO BOT GARD, V69, P557, DOI 10.2307/2399084; Goedhart CM, 2010, PLANT SOIL, V327, P213, DOI 10.1007/s11104-009-0048-4; Goldberg D, 1997, J ECOL, V85, P409, DOI 10.2307/2960565; Grime JP, 2000, SCIENCE, V289, P762, DOI 10.1126/science.289.5480.762; GUREVITCH J, 2006, ECOLOGY PLANTS; Heisler-White JL, 2008, OECOLOGIA, V158, P129, DOI 10.1007/s00442-008-1116-9; Heisler-White JL, 2009, GLOBAL CHANGE BIOL, V15, P2894, DOI 10.1111/j.1365-2486.2009.01961.x; Intergovernmental Panel on Climate Change, 2014, WORKING GROUP 1 CONT; Iovieno P, 2008, FEMS MICROBIOL ECOL, V65, P400, DOI 10.1111/j.1574-6941.2008.00524.x; Knapp AK, 2002, SCIENCE, V298, P2202, DOI 10.1126/science.1076347; Knapp AK, 2017, GLOBAL CHANGE BIOL, V23, P1774, DOI 10.1111/gcb.13504; Knapp AK, 2012, BIOSCIENCE, V62, P377, DOI 10.1525/bio.2012.62.4.9; Kochy M, 2004, PLANT ECOL, V174, P197, DOI 10.1023/B:VEGE.0000049098.74147.57; Lee RN, 2014, BOTANY, V92, P837, DOI 10.1139/cjb-2014-0107; Maestre FT, 2012, PHILOS T R SOC B, V367, P3062, DOI 10.1098/rstb.2011.0323; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; Murray S., 2000, PILOT ANAL GLOBAL EC; Nippert JB, 2006, PLANT ECOL, V184, P65, DOI 10.1007/s11258-005-9052-9; Novoplansky A, 2001, J VEG SCI, V12, P199, DOI 10.2307/3236604; Prevey JS, 2014, J ECOL, V102, P1549, DOI 10.1111/1365-2745.12320; SALA OE, 1988, ECOLOGY, V69, P40, DOI 10.2307/1943158; Schwinning S, 2004, OECOLOGIA, V141, P191, DOI 10.1007/s00442-004-1683-3; Spence LA, 2016, J VEG SCI, V27, P249, DOI 10.1111/jvs.12349; Suttle KB, 2007, SCIENCE, V315, P640, DOI 10.1126/science.1136401; VANRYSWYK AL, 1966, CAN J PLANT SCI, V46, P35, DOI 10.4141/cjps66-005; von Wehrden H, 2012, ECOL APPL, V22, P393, DOI 10.1890/11-0802.1; WELKER JM, 1991, THEOR APPL CLIMATOL, V44, P229, DOI 10.1007/BF00868178; Weltzin JF, 2003, BIOSCIENCE, V53, P941, DOI 10.1641/0006-3568(2003)053[0941:ATROTE]2.0.CO;2; Western Ag Innovations Inc, 2010, PLANT ROOT SIM PRS T; White SR, 2012, BIOL LETTERS, V8, P484, DOI 10.1098/rsbl.2011.0956; Yahdjian L, 2002, OECOLOGIA, V133, P95, DOI 10.1007/s00442-002-1024-3	45	11	11	5	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168663	10.1371/journal.pone.0168663	http://dx.doi.org/10.1371/journal.pone.0168663			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997611	Green Published, gold, Green Submitted			2022-12-26	WOS:000392842900067
J	Agniswamy, J; Louis, JM; Roche, J; Harrison, RW; Weber, IT				Agniswamy, Johnson; Louis, John M.; Roche, Julien; Harrison, Robert W.; Weber, Irene T.			Structural Studies of a Rationally Selected Multi-Drug Resistant HIV-1 Protease Reveal Synergistic Effect of Distal Mutations on Flap Dynamics	PLOS ONE			English	Article							VIRUS TYPE-1 PROTEASE; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURES; CLINICAL INHIBITORS; BINDING; MUTANTS; COMPLEXES; DARUNAVIR; V82A; CONFORMATION	We report structural analysis of HIV protease variant PRS17 which was rationally selected by machine learning to represent wide classes of highly drug-resistant variants. Crystal structures were solved of PRS17 in the inhibitor-free form and in complex with antiviral inhibitor, darunavir. Despite its 17 mutations, PRS17 has only one mutation (V82S) in the inhibitor/substrate binding cavity, yet exhibits high resistance to all clinical inhibitors. PRS17 has none of the major mutations (I47V, I50V, I54ML, L76V and I84V) associated with darunavir resistance, but has 10,000-fold weaker binding affinity relative to the wild type PR. Comparable binding affinity of 8000-fold weaker than PR is seen for drug resistant mutant PR20, which bears 3 mutations associated with major resistance to darunavir (I47V, I54L and I84V). Inhibitor-free PRS17 shows an open flap conformation with a curled tip correlating with G48V flap mutation. NMR studies on inactive PRD25NS17 unambiguously confirm that the flaps adopt mainly an open conformation in solution very similar to that in the inhibitor-free crystal structure. In PRS17 , the hinge loop cluster of mutations, E35D, M36I and S37D, contributes to the altered flap dynamics by a mechanism similar to that of PR20. An additional K20R mutation anchors an altered conformation of the hinge loop. Flap mutations M46L and G48V in PRS17 /DRV complex alter the Phe53 conformation by steric hindrance between the side chains. Unlike the L10F mutation in PR20, L10I in PRS17 does not break the inter-subunit ion pair or diminish the dimer stability, consistent with a very low dimer dissociation constant comparable to that of wild type PR. Distal mutations A71V, L90M and I93L propagate alterations to the catalytic site of PRS17 . PRS17 exhibits a molecular mechanism whereby mutations act synergistically to alter the flap dynamics resulting in significantly weaker binding yet maintaining active site contacts with darunavir.	[Agniswamy, Johnson; Harrison, Robert W.; Weber, Irene T.] Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA; [Louis, John M.; Roche, Julien] NIDDK, Chem Phys Lab, NIH, DHHS, Bethesda, MD 20892 USA; [Roche, Julien] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA USA; [Harrison, Robert W.] Georgia State Univ, Dept Comp Sci, Atlanta, GA 30303 USA; [Weber, Irene T.] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Iowa State University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Weber, IT (corresponding author), Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA.; Weber, IT (corresponding author), Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA.	iweber@gsu.edu		Harrison, Robert/0000-0003-2449-1214; Agniswamy, Johnson/0000-0002-3053-5677; Louis, John M/0000-0002-0052-1899	National Institutes of Health [GM062920]; Intramural Research Program of the NIDDK, National Institutes of Health (NIH); Intramural AIDS-Targeted Antiviral Program of the Office of the Director, NIH; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM062920] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIDDK, National Institutes of Health (NIH); Intramural AIDS-Targeted Antiviral Program of the Office of the Director, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research was supported in part by the National Institutes of Health grant GM062920 (ITW, RWH) and by the Intramural Research Program of the NIDDK, National Institutes of Health (NIH), Intramural AIDS-Targeted Antiviral Program of the Office of the Director, NIH (JML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Jane M. Sayer for discussions and critical reading of the manuscript, and Annie Aniana for technical assistance. We thank the staff at the Southeast Regional-Collaborative Access Team (SER-CAT) at the Advanced Photon Source, Argonne National Laboratory, for assistance during X-ray data collection. Supporting institutions may be found at http://www.ser-cat.org/members.html. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. W-31-109-Eng-38.	Agniswamy J, 2013, J MED CHEM, V56, P4017, DOI 10.1021/jm400231v; Agniswamy J, 2012, BIOCHEMISTRY-US, V51, P2819, DOI 10.1021/bi2018317; Bax A, 2005, CURR OPIN STRUC BIOL, V15, P563, DOI 10.1016/j.sbi.2005.08.006; Chetty S, 2016, J BIOMOL STRUCT DYN, V34, P135, DOI 10.1080/07391102.2015.1018326; De Clercq E, 2009, INT J ANTIMICROB AG, V33, P307, DOI 10.1016/j.ijantimicag.2008.10.010; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dierynck I, 2007, J VIROL, V81, P13845, DOI 10.1128/JVI.01184-07; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flor-Parra F, 2011, AIDS RES HUM RETROV, V27, P65, DOI 10.1089/aid.2010.0072; Freedberg DI, 2002, PROTEIN SCI, V11, P221, DOI 10.1110/ps.33202; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Goddard TD, 2010, SPARKY 3; Heaslet H, 2007, ACTA CRYSTALLOGR D, V63, P866, DOI 10.1107/S0907444907029125; Huang LQ, 2009, J VIROL, V83, P7789, DOI 10.1128/JVI.00473-09; Ishima R, 2007, J BIOL CHEM, V282, P17190, DOI 10.1074/jbc.M701304200; Koh Y, 2003, ANTIMICROB AGENTS CH, V47, P3123, DOI 10.1128/AAC.47.10.3123-3129.2003; Kovalevsky AY, 2006, J MOL BIOL, V363, P161, DOI 10.1016/j.jmb.2006.08.007; Kovalevsky AY, 2006, J MED CHEM, V49, P1379, DOI 10.1021/jm050943c; Lakomek NA, 2012, J BIOMOL NMR, V53, P209, DOI 10.1007/s10858-012-9626-5; Liu FL, 2008, J MOL BIOL, V381, P102, DOI 10.1016/j.jmb.2008.05.062; Liu FL, 2006, J MOL BIOL, V358, P1191, DOI 10.1016/j.jmb.2006.02.076; Louis JM, 2016, J MOL BIOL, V428, P2780, DOI 10.1016/j.jmb.2016.05.005; Louis JM, 2015, BIOCHEMISTRY-US, V54, P5414, DOI 10.1021/acs.biochem.5b00759; Louis JM, 2011, P NATL ACAD SCI USA, V108, P9072, DOI 10.1073/pnas.1102278108; Louis JM, 2009, PROTEIN SCI, V18, P2442, DOI 10.1002/pro.261; Mahalingam B, 1999, EUR J BIOCHEM, V263, P238, DOI 10.1046/j.1432-1327.1999.00514.x; Mahalingam B, 2004, EUR J BIOCHEM, V271, P1516, DOI 10.1111/j.1432-1033.2004.04060.x; Maltsev AS, 2014, J AM CHEM SOC, V136, P3752, DOI 10.1021/ja4132642; MANCHESTER M, 1994, J BIOL CHEM, V269, P7689; May M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6016; May MT, 2014, AIDS, V28, P1193, DOI 10.1097/QAD.0000000000000243; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Meher BR, 2012, J PHYS CHEM B, V116, P1884, DOI 10.1021/jp2074804; Meiselbach H, 2007, J MOL MODEL, V13, P297, DOI 10.1007/s00894-006-0121-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakashima M, 2016, FRONT MICROBIOL, V7, DOI [10.3389/fmicb.2016,00061, 10.3389/fmicb.2016.00061]; Ode H, 2007, J MOL BIOL, V370, P598, DOI 10.1016/j.jmb.2007.04.081; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park JH, 2016, BIOCHEMISTRY-US, V55, P2390, DOI 10.1021/acs.biochem.6b00012; Roche J, 2015, CHEMBIOCHEM, V16, P214, DOI 10.1002/cbic.201402585; Sayer JM, 2010, PROTEIN SCI, V19, P2055, DOI 10.1002/pro.486; Shen CH, 2015, J MOL GRAPH MODEL, V62, P87, DOI 10.1016/j.jmgm.2015.09.006; Shen CH, 2010, FEBS J, V277, P3699, DOI 10.1111/j.1742-4658.2010.07771.x; Skalova T, 2006, J MED CHEM, V49, P5777, DOI 10.1021/jm0605583; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tie YF, 2007, PROTEINS, V67, P232, DOI 10.1002/prot.21304; Tzoupis H, 2013, J CHEM THEORY COMPUT, V9, P1754, DOI 10.1021/ct301063k; Weber IT, 2015, FUTURE MED CHEM, V7, P1023, DOI [10.4155/FMC.15.44, 10.4155/fmc.15.44]; Weber IT, 2009, VIRUSES-BASEL, V1, P1110, DOI 10.3390/v1031110; Wensing Annemarie M, 2015, Top Antivir Med, V23, P132; Yu X. C., 2014, SCI CHINA EARTH SCI, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0083080; Yu X, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/619290; Yu Xiaxia, 2013, Proc SIAM Int Conf Data Min, V2013, P342	53	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168616	10.1371/journal.pone.0168616	http://dx.doi.org/10.1371/journal.pone.0168616			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992544	gold, Green Submitted, Green Published			2022-12-26	WOS:000392758000067
J	Krause, ET				Krause, E. Tobias			Colour Cues That Are Not Directly Attached to the Body of Males Do Not Influence the Mate Choice of Zebra Finches	PLOS ONE			English	Article							REPUTED BAND ATTRACTIVENESS; SEX-RATIO MANIPULATION; COURTSHIP DISPLAY; VIDEO IMAGES; PREFERENCES; SONG	Mate choice decisions of female zebra finches are generally thought to rely on the assessment of male quality, which includes the specific ornamentation of males. A commonly used paradigm to experimentally manipulate a male's attractiveness is to add a coloured leg ring to the bird. Some studies have shown that female zebra finches prefer or alter their investment in males that have an additional red leg ring compared with males with green leg rings. Whether the coloured artificial ornaments need to be attached to the male's body or whether environmental colouration could have a similar effect on male attractiveness remains unclear. Here, I investigated this novel context to determine whether female choice between males is affected by environmental colour cues that are not directly attached to the male's body in four experiments involving 220 zebra finches (Taeniopygia guttata). A first experiment revealed that females chose males with red colour cues in the environmental background over males with green cues in the background. Based on this finding, I conducted follow-up experiments to obtain a deeper understanding of how environmental colour cues affect mate choice. Therefore, I examined whether female choice behaviour or male behaviour was altered in two additional experiments. Both experiments failed to show any effects of environmental colour cues on female choice or on male behaviour. Therefore, I replicated the initial experiment in a fourth experiment. Again replication failed; thus, the initial results indicating that environmental colouration affects mate choice behaviour of female zebra finches were not supported by the three subsequent experiments; thus, the outcome of the first experiment seems to be a false positive. Taking my results together, I found no robust support for the idea that environmental colour cues that are not directly attached to the body of male zebra finches affect female mate choice decisions.	[Krause, E. Tobias] Univ Bielefeld, Dept Anim Behav, Konsequenz 45, Bielefeld, Germany; [Krause, E. Tobias] Friedrich Loeffler Inst, Inst Anim Welf & Anim Husb, Dornbergstr 25-27, Greifswald, Germany	University of Bielefeld; Friedrich Loeffler Institute	Krause, ET (corresponding author), Univ Bielefeld, Dept Anim Behav, Konsequenz 45, Bielefeld, Germany.; Krause, ET (corresponding author), Friedrich Loeffler Inst, Inst Anim Welf & Anim Husb, Dornbergstr 25-27, Greifswald, Germany.	tobias.krause@fli.de	Krause, E. Tobias/A-9900-2009	Krause, E. Tobias/0000-0002-8327-3711	Deutsche Forschungsgemeinschaft; Bielefeld University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bielefeld University	The author acknowledges support for the Article Processing Charge from the Deutsche Forschungsgemeinschaft and the Open Access Publication Fund of Bielefeld University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adret P, 1997, J COMP PSYCHOL, V111, P115; BURLEY N, 1986, EVOLUTION, V40, P1191, DOI 10.1111/j.1558-5646.1986.tb05744.x; BURLEY N, 1981, SCIENCE, V211, P721, DOI 10.1126/science.211.4483.721; BURLEY N, 1987, ETHOLOGY, V76, P133; BURLEY N, 1982, ANIM BEHAV, V30, P444, DOI 10.1016/S0003-3472(82)80055-9; BURLEY N, 1986, ANIM BEHAV, V34, P1732, DOI 10.1016/S0003-3472(86)80260-3; BURLEY N, 1988, ANIM BEHAV, V36, P1235, DOI 10.1016/S0003-3472(88)80085-X; Caspers BA, 2015, BEHAV ECOL SOCIOBIOL, V69, P1827, DOI 10.1007/s00265-015-1995-9; COLLINS SA, 1994, BEHAV ECOL SOCIOBIOL, V35, P21, DOI 10.1007/s002650050065; DeKogel CH, 1996, ANIM BEHAV, V51, P699, DOI 10.1006/anbe.1996.0073; Fleishman L.J., 2000, Acta Ethologica, V3, P15, DOI 10.1007/s102110000025; Forstmeier W, 2004, ANIM BEHAV, V68, P1017, DOI 10.1016/j.anbehav.2004.02.007; Galoch Zdzislaw, 2006, Ornithological Science, V5, P57, DOI 10.2326/osj.5.57; Galoch Z, 2007, BEHAV PROCESS, V74, P21, DOI 10.1016/j.beproc.2006.09.002; Gil D, 1999, SCIENCE, V286, P126, DOI 10.1126/science.286.5437.126; Griffith SC, 2010, ANIM BEHAV, V79, P261, DOI 10.1016/j.anbehav.2009.11.031; Ikebuchi M, 1999, ZOOL SCI, V16, P63, DOI 10.2108/zsj.16.63; Immelmann K., 1959, Zool Jb (Abt Syst), V86, P437; IMMELMANN K, 1982, SCIENCE, V215, P422, DOI 10.1126/science.215.4531.422; Jennions MD, 1998, ANIM BEHAV, V55, P61, DOI 10.1006/anbe.1997.0579; Miazzi F., 2012, THESIS; Pariser EC, 2010, BEHAV ECOL, V21, P264, DOI 10.1093/beheco/arp185; Quinn GP, 2003, EXPT DESIGN DATA ANA; Riebel K, 2009, ADV STUD BEHAV, V40, P197, DOI 10.1016/S0065-3454(09)40006-8; Ritschard M, 2010, ANIM BEHAV, V79, P877, DOI 10.1016/j.anbehav.2009.12.038; Rutstein AN, 2007, ANIM BEHAV, V74, P1277, DOI 10.1016/j.anbehav.2007.02.022; Rutstein AN, 2004, ANIM BEHAV, V68, P1087, DOI 10.1016/j.anbehav.2004.02.011; Seguin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037785; SOMA M, 2015, FRONT ECOL EVOL, V3, DOI DOI 10.3389/FEV0.2015.00004; Specht R, 2010, AVISOTT SAS LAB PRO; Swaddle JP, 2006, ANIM BEHAV, V72, P161, DOI 10.1016/j.anbehav.2005.12.005; THISSEN D, 1982, SCIENCE, V215, P423, DOI 10.1126/science.215.4531.423; Witte K, 2003, ANIM BEHAV, V65, P195, DOI 10.1006/anbe.2002.2009; Witte K., 2004, PROXIMATE CONTRO AVI, P13; Witte K, 2006, BEHAVIOUR, V143, P969, DOI 10.1163/156853906778623626; Witte K, 2006, ETHOL ECOL EVOL, V18, P195, DOI 10.1080/08927014.2006.9522707; Zann RA., 1996, ZEBRA FINCH SYNTHESI; Zanollo V, 2013, ETHOLOGY, V119, P344, DOI 10.1111/eth.12071	38	0	0	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0167674	10.1371/journal.pone.0167674	http://dx.doi.org/10.1371/journal.pone.0167674			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7HN	27977719	Green Submitted, gold, Green Published			2022-12-26	WOS:000391217400026
J	Liu, HY; Wang, G; Yang, LL; Qu, JJ; Yang, ZH; Zhou, XY				Liu, Hongying; Wang, Gang; Yang, Lili; Qu, Jianjun; Yang, Zhihui; Zhou, Xiangyu			Knockdown of Long Non-Coding RNA UCA1 Increases the Tamoxifen Sensitivity of Breast Cancer Cells through Inhibition of Wnt/beta-Catenin Pathway	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; DRUG-RESISTANCE; GROWTH	Acquired resistance to tamoxifen remains a major obstacle in breast cancer (BC) treatment, since the underlying mechanism has not been fully elucidated. The long non-coding RNA (lncRNA) urothelial carcinoma-associated 1 (UCA1) has been recently shown to be dysregulated and plays important roles in progression of breast cancer. In the present study, we aimed to investigate the biological role and clinical significance of UCA1 in BC drug resistance. Hence, we used quantitative PCR assay to evaluate the UCA1 expression in tissues from patients with BC as well as established tamoxifen-resistant BC cell lines in vitro. We tested the viability, invasive ability and apoptosis rate in MCF-7 and T47D cells using MTT assay, transwell assay and flow cytometry assay, respectively. The influence of UCA1 on tumorigenesis was monitored by in vivo mice xenograft model. The activation of Wnt/beta-catenin signaling pathway was evaluated by immunofluorescence assay, western blot assay and luciferase reporter assay, respectively. We found that the expression of UCA1 positively correlated with the pathological grade and mortality of breast cancer patients, moreover, expressions of UCA1 was increased significantly in the tamoxifen-resistant cell lines compared with the wild type parental cells. Ectopic expression of UCA1 promoted cell survival and resistance to tamoxifen treatment, whereas inhibition of UCA1 enhanced tamoxifen sensitivity of BC cells and induced more apoptotic cells. In addition, tamoxifen-resistant cells exhibited increased Wnt signaling activation as measured by the TOP/FOP Wnt luciferase reporter assay and beta-catenin protein level compared with parental MCF-7 and T47D cells, respectively. In line with these data, UCA1 depletion attenuated the activity of Wnt/beta-catenin pathway activation and the tumorigenicity of the tamoxifen-resistant BC cells. Taken together, our data highlights the pivotal role of UCA1-Wnt/beta-catenin signaling pathway in the tamoxifen resistance in breast cancer, which could be targeted to improve the effectiveness and efficacy of tamoxifen treatment in breast cancer.	[Liu, Hongying; Wang, Gang; Yang, Lili] Weifang Med Univ, Dept Genet, Weifang, Shandong, Peoples R China; [Qu, Jianjun] Weifang Peoples Hosp, Dept Surg Oncol, Weifang, Shandong, Peoples R China; [Yang, Zhihui] SouthWest Med Univ China, Dept Pathol, Luzhou, Sichuan, Peoples R China; [Zhou, Xiangyu] South Med Univ China, Dept Vasc & Thyroid Surg, Affiliated Hosp, Luzhou, Sichuan, Peoples R China	Weifang Medical University	Liu, HY (corresponding author), Weifang Med Univ, Dept Genet, Weifang, Shandong, Peoples R China.; Zhou, XY (corresponding author), South Med Univ China, Dept Vasc & Thyroid Surg, Affiliated Hosp, Luzhou, Sichuan, Peoples R China.	liuhongyingwf@163.com; xiangyuzhou971@126.com			Health and Family Planning Commission of Shandong Province Research Foundation [2015WSB27009]; Sichuan Provincial Science and Technology Foundation [2014JY0004]	Health and Family Planning Commission of Shandong Province Research Foundation; Sichuan Provincial Science and Technology Foundation	This work was supported by Health and Family Planning Commission of Shandong Province Research Foundation (2015WSB27009) and Sichuan Provincial Science and Technology Foundation (2014JY0004).	Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Cui JJ, 2012, CURR PHARM DESIGN, V18, P2464, DOI 10.2174/13816128112092464; Czerwinska Patrycja, 2015, Contemp Oncol (Pozn), V19, pA7, DOI 10.5114/wo.2014.47126; Deniz E, 2016, FUNCT INTEGR GENOMIC; Fan P, 2007, CANCER RES, V67, P1352, DOI 10.1158/0008-5472.CAN-06-1020; Fan Y, 2014, FEBS J, V281, P1750, DOI 10.1111/febs.12737; Fu X, 2016, ONCOTARGETS THER, V9, DOI 10.2147/OTT.S100633; Gao YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082436; Huang J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.541; Hurvitz SA, 2008, CANCER-AM CANCER SOC, V113, P2385, DOI 10.1002/cncr.23875; Kouzmenko AP, 2004, J BIOL CHEM, V279, P40255, DOI 10.1074/jbc.C400331200; Mahmoodzadeh S, 2006, FASEB J, V20, P926, DOI 10.1096/fj.05-5148com; McCrea E, 2016, PHARM RES; Ojo D, 2015, CURR MED CHEM, V22, P2360, DOI 10.2174/0929867322666150416095744; Raha P, 2011, EPIGENOMICS-UK, V3, P451, DOI [10.2217/epi.11.72, 10.2217/EPI.11.72]; Sang XB, 2016, ONCOLOGY REPORTS; Shooshtarizadeh T, 2016, PATHOLOGY RES PRACTI; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tuo YL, 2015, EUR REV MED PHARMACO, V19, P3403; Wang XS, 2006, CLIN CANCER RES, V12, P4851, DOI 10.1158/1078-0432.CCR-06-0134; Wang YY, 2015, CELL STEM CELL, V16, P413, DOI 10.1016/j.stem.2015.03.003; Wei ZT, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0842-9; Wilusz JE, 2016, BBA-GENE REGUL MECH, V1859, P128, DOI 10.1016/j.bbagrm.2015.06.003; Xia HP, 2014, CURR MED CHEM, V21, P3029, DOI 10.2174/0929867321666140414101939; Xue M, 2016, J CANCER RES CLIN, V142, P1407, DOI 10.1007/s00432-015-2042-y; Yin L, 2016, STEROIDS, V111, P95, DOI 10.1016/j.steroids.2016.01.019; Zhang ZY, 2016, CANCER LETT, V376, P62, DOI 10.1016/j.canlet.2016.03.022; Zhou Y, 2005, ENDOCR-RELAT CANCER, V12, pS37, DOI 10.1677/erc.1.00977	28	75	81	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168406	10.1371/journal.pone.0168406	http://dx.doi.org/10.1371/journal.pone.0168406			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977766	Green Published, Green Submitted, gold			2022-12-26	WOS:000391217400105
J	Hu, XT; Zhu, BL; Zhao, LG; Wang, JW; Liu, L; Lai, YJ; He, L; Deng, XJ; Chen, GJ				Hu, Xiao-Tong; Zhu, Bing-Lin; Zhao, Li-Ge; Wang, Jing-Wen; Liu, Lu; Lai, Yu-Jie; He, Ling; Deng, Xiao-Juan; Chen, Guo-Jun			Histone deacetylase inhibitor apicidin increases expression of the alpha-secretase ADAM10 through transcription factor USF1-mediated mechanisms	FASEB JOURNAL			English	Article						Alzheimer's disease; HDAC2/3; ERK	UPSTREAM STIMULATORY FACTOR; DISEASE MOUSE MODEL; A-BETA PRODUCTION; ALZHEIMERS-DISEASE; GENE-TRANSCRIPTION; CORTICAL-NEURONS; DIFFERENTIAL REGULATION; SYNAPTIC PLASTICITY; OXIDATIVE STRESS; DRUG DEVELOPMENT	ADAM10 (a disintegrin and metalloproteinase domain-containing protein 10) is the alpha-secretase that is involved in APP(beta-amyloid precursor protein) processing. Enhancement of the nonamyloidogenic APP pathway by ADAM10 provides therapeutic potential for Alzheimer's disease (AD). By using high-throughput screening that targeted ADAM10, we determined that apicidin-an inhibitor of HDACs(histone deacetylases)-significantly increased mRNA and protein levels of ADAM10 in SH-SY5Y cells. A luciferase assay revealed that the nucleotides 2444 to 2300 in the ADAM10 promoter were sufficient to mediate this effect. In addition, knockdown of USF1 (upstream transcription factor 1) and HDAC2/3 prevented apicidin regulation of ADAM10. Moreover, USF1 acetylation was increased by apicidin, which enhanced the association of USF1 with HDAC2/3 and with the ADAM10 promoter. We further found that apicidin did not affect the phosphorylation of ERK or USF1; however, ERK inhibitor U0126 blocked the effect of apicidin on ADAM10. Finally, apicidin increased the level of a-site C-terminal fragment from APP and reduced the production of b-amyloid peptide 1-42. Collectively, our study provides evidence that ADAM10 expression can be regulated by HDAC2/3 inhibitor apicidin via USF1-dependent mechanisms in which ERK signaling plays an important role. Thus, HDAC regulation of ADAM10 might shed new light on the understanding of AD pathology.-Hu, X.-T., Zhu, B.-L., Zhao, L.-G., Wang, J.-W., Liu, L., Lai, Y.-J., He, L., Deng, X.-J., Chen, G.-J. Histone deacetylase inhibitor apicidin increases expression of the a-secretase ADAM10 through transcription factor USF1-mediated mechanisms. FASEB J. 31, 1482-1493 (2017). www.fasebj.org	[Hu, Xiao-Tong; Zhu, Bing-Lin; Zhao, Li-Ge; Wang, Jing-Wen; Liu, Lu; Lai, Yu-Jie; He, Ling; Deng, Xiao-Juan; Chen, Guo-Jun] Chongqing Med Univ, Dept Neurol, Chongqing Key Lab Neurol, Affiliated Hosp 1, 1 Youyi Rd, Chongqing 400016, Peoples R China	Chongqing Medical University	Chen, GJ (corresponding author), Chongqing Med Univ, Dept Neurol, Chongqing Key Lab Neurol, Affiliated Hosp 1, 1 Youyi Rd, Chongqing 400016, Peoples R China.	woodchen2015@163.com	wang, jing/GRS-7509-2022	Chen, Guo-Jun/0000-0001-8148-9810; Zhu, Binglin/0000-0002-3244-1754	National Natural Science Foundation of China [81171197, 81220108010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grants 81171197 and 81220108010 from the National Natural Science Foundation of China. The authors declare no conflicts of interest.	Ahn MY, 2011, ORAL ONCOL, V47, P1032, DOI 10.1016/j.oraloncology.2011.07.027; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Bang SY, 2015, STEM CELLS DEV, V24, P520, DOI 10.1089/scd.2014.0218; Bardai FH, 2011, J NEUROSCI, V31, P1746, DOI 10.1523/JNEUROSCI.5704-10.2011; Bauden M, 2015, TOXICOL LETT, V236, P8, DOI 10.1016/j.toxlet.2015.03.017; Chami B, 2016, METAB BRAIN DIS, V31, P497, DOI 10.1007/s11011-016-9806-1; Chen WG, 2003, J NEUROSCI, V23, P2572; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Citron BA, 2008, J NEUROSCI RES, V86, P2499, DOI 10.1002/jnr.21695; Corre S, 2005, PIGM CELL RES, V18, P337, DOI 10.1111/j.1600-0749.2005.00262.x; Corre S, 2009, J BIOL CHEM, V284, P18851, DOI 10.1074/jbc.M808605200; Cortes-Mendoza J, 2013, INT J DEV NEUROSCI, V31, P359, DOI 10.1016/j.ijdevneu.2013.04.003; Dickson ME, 2008, CIRC RES, V103, P940, DOI 10.1161/CIRCRESAHA.108.180653; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Endres K, 2012, EXP BRAIN RES, V217, P343, DOI 10.1007/s00221-011-2885-7; Endres K, 2010, FEBS J, V277, P1585, DOI 10.1111/j.1742-4658.2010.07566.x; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fukuchi M, 2009, NEUROSCI RES, V65, P35, DOI 10.1016/j.neures.2009.05.002; Grinan-Ferre C, 2016, AGING-US, V8, P664, DOI 10.18632/aging.100906; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; HUNT DF, 1992, SCIENCE, V256, P1817, DOI 10.1126/science.1319610; Izzo A, 2010, BRIEF FUNCT GENOMICS, V9, P429, DOI 10.1093/bfgp/elq024; Jouannet S, 2016, CELL MOL LIFE SCI, V73, P1895, DOI 10.1007/s00018-015-2111-z; Juttner S, 2003, CELL MICROBIOL, V5, P821, DOI 10.1046/j.1462-5822.2003.00324.x; Kim J, 2010, J BIOL CHEM, V285, P22917, DOI 10.1074/jbc.M110.126649; KOVACS DM, 1995, HUM MOL GENET, V4, P1527, DOI 10.1093/hmg/4.9.1527; Kutz SM, 2006, EXP CELL RES, V312, P1093, DOI 10.1016/j.yexcr.2005.12.027; Kyrylenko S, 2003, CELL MOL LIFE SCI, V60, P1990, DOI 10.1007/s00018-003-3090-z; Lauffer BEL, 2013, J BIOL CHEM, V288, P26926, DOI 10.1074/jbc.M113.490706; Lichtenthaler SF, 2011, J NEUROCHEM, V116, P10, DOI 10.1111/j.1471-4159.2010.07081.x; Liu SJ, 2008, BLOOD, V111, P2364, DOI 10.1182/blood-2007-08-110171; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Marcinkiewicz M, 2000, J NEUROCHEM, V75, P2133, DOI 10.1046/j.1471-4159.2000.0752133.x; Marinova Z, 2011, NEUROPHARMACOLOGY, V60, P1109, DOI 10.1016/j.neuropharm.2010.09.022; Marinova Z, 2009, J NEUROCHEM, V111, P976, DOI 10.1111/j.1471-4159.2009.06385.x; Mizuno M, 2000, J NEUROSCI, V20, P7116, DOI 10.1523/JNEUROSCI.20-18-07116.2000; Moss ML, 2007, J BIOL CHEM, V282, P35712, DOI 10.1074/jbc.M703231200; Nagai K, 2015, NEUROTOXICOL TERATOL, V48, P33, DOI 10.1016/j.ntt.2015.01.006; Nam K, 2015, CELL SIGNAL, V27, P1882, DOI 10.1016/j.cellsig.2015.05.002; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; Park KY, 2008, J BIOL CHEM, V283, P5441, DOI 10.1074/jbc.M708662200; Penney J, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.aaa0069; Plum L, 2005, TRENDS ENDOCRIN MET, V16, P59, DOI 10.1016/j.tem.2005.01.008; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Postina R, 2012, J NEUROCHEM, V120, P46, DOI 10.1111/j.1471-4159.2011.07459.x; Prinzen C, 2005, FASEB J, V19, P1522, DOI 10.1096/fj.04-3619fje; Qing H, 2008, J EXP MED, V205, P2781, DOI 10.1084/jem.20081588; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Renault MA, 2005, J BIOL CHEM, V280, P2708, DOI 10.1074/jbc.M411786200; Ricobaraza A, 2009, NEUROPSYCHOPHARMACOL, V34, P1721, DOI 10.1038/npp.2008.229; Ryu H, 2003, J NEUROSCI, V23, P3597; Schneider LS, 2014, J INTERN MED, V275, P251, DOI 10.1111/joim.12191; Schuck F, 2016, J ALZHEIMERS DIS, V50, P817, DOI 10.3233/JAD-150737; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spilsbury A, 2015, J NEUROSCI, V35, P1659, DOI 10.1523/JNEUROSCI.2925-14.2015; Tippmann F, 2009, FASEB J, V23, P1643, DOI 10.1096/fj.08-121392; van der Heide LP, 2006, PROG NEUROBIOL, V79, P205, DOI 10.1016/j.pneurobio.2006.06.003; Villemagne VL, 2015, LANCET NEUROL, V14, P114, DOI 10.1016/S1474-4422(14)70252-2; Wang Meijuan, 2015, Shanghai Arch Psychiatry, V27, P263, DOI 10.11919/j.issn.1002-0829.215100; Wang X, 2014, NEUROENDOCRINOL LETT, V35, P224; Xiao QX, 2002, AM J PHYSIOL-HEART C, V283, pH213, DOI 10.1152/ajpheart.01085.2001; Yamanaka T, 2016, FEBS J, V283, P1077, DOI 10.1111/febs.13650	66	18	18	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1482	1493		10.1096/fj.201600961RR	http://dx.doi.org/10.1096/fj.201600961RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28003340				2022-12-26	WOS:000398504300017
J	Kuan, YC; Hashidume, T; Shibata, T; Uchida, K; Shimizu, M; Inoue, J; Sato, R				Kuan, Yen-Chou; Hashidume, Tsutomu; Shibata, Takahiro; Uchida, Koji; Shimizu, Makoto; Inoue, Jun; Sato, Ryuichiro			Heat Shock Protein 90 Modulates Lipid Homeostasis by Regulating the Stability and Function of Sterol Regulatory Element-binding Protein (SREBP) and SREBP Cleavage-activating Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY LIVER; PPAR-GAMMA; HSP90; SCAP; INHIBITION; METABOLISM; COMPLEXES; REVEALS; DOMAINS; CELLS	Sterol regulatory element-binding proteins (SREBPs) are the key transcription factors that modulate lipid biosynthesis. SREBPs are synthesized as endoplasmic reticulum-bound precursors that require proteolytic activation in the Golgi apparatus. The stability and maturation of precursor SREBPs depend on their binding to SREBP cleavage-activating protein (SCAP), which escorts the SCAP-SREBP complex to the Golgi apparatus. In this study, we identified heat shock protein (HSP) 90 as a novel SREBP regulator that binds to and stabilizes SCAP-SREBP. In HepG2 cells, HSP90 inhibition led to proteasome-dependent degradation of SCAP-SREBP, which resulted in the down-regulation of SREBP target genes and the reduction in intracellular triglyceride and cholesterol levels. Wealso demonstrated in vivo that HSP90 inhibition decreased SCAP-SREBP protein, down-regulated SREBP target genes, and reduced lipids levels in mouse livers. We propose that HSP90 plays an indispensable role in SREBP regulation by stabilizing the SCAP-SREBP complex, facilitating the activation of SREBP to maintain lipids homeostasis.	[Kuan, Yen-Chou; Hashidume, Tsutomu; Shimizu, Makoto; Inoue, Jun; Sato, Ryuichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Food Biochem Lab, Tokyo 1138657, Japan; [Sato, Ryuichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Nutri Life Sci Lab, Dept Appl Biol Chem, Tokyo 1138657, Japan; [Shibata, Takahiro; Uchida, Koji] Nagoya Univ, Dept Appl Mol Biosci, Grad Sch Bioagr Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan; [Sato, Ryuichiro] Japan Agcy Med Res & Dev, AMED CREST, Chiyoda Ku, Tokyo 1000004, Japan	University of Tokyo; University of Tokyo; Nagoya University	Sato, R (corresponding author), Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	aroysato@mail.ecc.u-tokyo.ac.jp	; Shibata, Takahiro/I-6872-2014	Kuan, Yen-Chou/0000-0001-6870-0685; Shibata, Takahiro/0000-0003-3194-607X; Uchida, Koji/0000-0003-3894-5299	JSPS KAKENHI [15H05781]; Cross-ministerial Strategic Innovation Promotion Program [14533567]; Japanese Agency for Medical Research and Development [16gm0910008h0001]; Tojuro Iijima Foundation for Food Science and Technology; Grants-in-Aid for Scientific Research [17F17100] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Cross-ministerial Strategic Innovation Promotion Program; Japanese Agency for Medical Research and Development; Tojuro Iijima Foundation for Food Science and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant-in-Aid for Scientific Research (S) 15H05781, Cross-ministerial Strategic Innovation Promotion Program Grant 14533567, and Japanese Agency for Medical Research and Development Grant 16gm0910008h0001 (to R.S.), and a Research Grant from the Tojuro Iijima Foundation for Food Science and Technology (to Y.-C.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Ambade A, 2014, J HEPATOL, V61, P903, DOI 10.1016/j.jhep.2014.05.024; Bhat R, 2014, J MED CHEM, V57, P8718, DOI 10.1021/jm500823a; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Chehab M, 2015, ONCOTARGET, V6, P8454, DOI 10.18632/oncotarget.3502; Chen CY, 2006, MOL BIOL CELL, V17, P3494, DOI 10.1091/mbc.E05-12-1096; Chen LT, 2010, CELL HOST MICROBE, V7, P185, DOI 10.1016/j.chom.2010.02.008; Cheng CM, 2015, CANCER CELL, V28, P569, DOI 10.1016/j.ccell.2015.09.021; Donnelly BF, 2013, J BIOL CHEM, V288, P13124, DOI 10.1074/jbc.M113.455394; Espenshade PJ, 2006, J CELL SCI, V119, P973, DOI 10.1242/jcs02866; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Gong X, 2016, CELL RES, V26, P1197, DOI 10.1038/cr.2016.123; Inoue Jun, 2013, Biomol Concepts, V4, P417, DOI 10.1515/bmc-2013-0009; Johnson JL, 2012, BBA-MOL CELL RES, V1823, P607, DOI 10.1016/j.bbamcr.2011.09.020; Kim HR, 1999, IUBMB LIFE, V48, P429, DOI 10.1080/713803536; Li JJ, 2016, ONCOTARGET, V7, P52392, DOI 10.18632/oncotarget.10721; Miyata S, 2015, J BIOL CHEM, V290, P20565, DOI 10.1074/jbc.M115.656975; Nguyen MT, 2013, CELL DEATH DIFFER, V20, P1654, DOI 10.1038/cdd.2013.129; Nohturfft A, 2009, ANNU REV CELL DEV BI, V25, P539, DOI 10.1146/annurev.cellbio.24.110707.175344; Proia DA, 2015, CANCER IMMUNOL RES, V3, P583, DOI 10.1158/2326-6066.CIR-15-0057; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Ru P, 2016, CELL REP, V16, P1527, DOI 10.1016/j.celrep.2016.07.017; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; Shao W, 2014, J BIOL CHEM, V289, P7547, DOI 10.1074/jbc.M113.545699; Stankiewicz Marta, 2012, Biomol Concepts, V3, P79, DOI 10.1515/bmc.2011.054; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wheeler MC, 2014, J LIPID RES, V55, P1702, DOI 10.1194/jlr.M048918; Ye J, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004754; Zhang L, 2014, ONCOTARGET, V5, P1132, DOI 10.18632/oncotarget.1584; Zhang YX, 2016, J BIOL CHEM, V291, P12888, DOI 10.1074/jbc.M116.729798; Zhang YX, 2013, J BIOL CHEM, V288, P14059, DOI 10.1074/jbc.M113.469528	34	43	44	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					3016	3028		10.1074/jbc.M116.767277	http://dx.doi.org/10.1074/jbc.M116.767277			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28003358	Green Published, hybrid			2022-12-26	WOS:000395535100040
J	Draheim, KM; Huet-Calderwood, C; Simon, B; Calderwood, DA				Draheim, Kyle M.; Huet-Calderwood, Clotilde; Simon, Bertrand; Calderwood, David A.			Nuclear Localization of Integrin Cytoplasmic Domain-associated Protein-1 (ICAP1) Influences (SS)1 Integrin Activation and Recruits Krev/Interaction Trapped-1 (KRIT1) to the Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell compartmentalization; cerebral cavernous malformation; integrin; KRIT1 (Krev interaction trapped); protein targeting; ICAP1 (integrin cytoplasmic domain-associated protein)	CEREBRAL CAVERNOUS MALFORMATIONS; VASCULAR INTEGRITY; CCM PATHOGENESIS; RHO KINASE; CELL; COMPLEX; BINDING; RAP1; FIBRONECTIN; PROLIFERATION	Binding of ICAP1 (integrin cytoplasmic domain-associated protein-1) to the cytoplasmic tails of 1 integrins inhibits integrin activation. ICAP1 also binds to KRIT1 (Krev interaction trapped-1), a protein whose loss of function leads to cerebral cavernous malformation, a cerebrovascular dysplasia occurring in up to 0.5% of the population. We previously showed that KRIT1 functions as a switch for 1 integrin activation by antagonizing ICAP1-mediated inhibition of integrin activation. Here we use overexpression studies, mutagenesis, and flow cytometry to show that ICAP1 contains a functional nuclear localization signal and that nuclear localization impairs the ability of ICAP1 to suppress integrin activation. Moreover, we find that ICAP1 drives the nuclear localization of KRIT1 in a manner dependent upon a direct ICAP1/KRIT1 interaction. Thus, nuclear-cytoplasmic shuttling of ICAP1 influences both integrin activation and KRIT1 localization, presumably impacting nuclear functions of KRIT1.	[Draheim, Kyle M.; Huet-Calderwood, Clotilde; Simon, Bertrand; Calderwood, David A.] Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA; [Calderwood, David A.] Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA	Yale University; Yale University	Calderwood, DA (corresponding author), Yale Univ, Sch Med, Dept Pharmacol & Cell Biol, POB 208066,333 Cedar St, New Haven, CT 06520 USA.	david.calderwood@yale.edu	Calderwood, David A/AAC-6954-2019	Calderwood, David A/0000-0002-0791-4142; Simon, Bertrand/0000-0002-1825-053X	National Institutes of Health Grants [R01NS085078, F32HL127948]; American Cancer Society Grant [122171-PF-12-051-01-CSM]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL127948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085078] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Grant(American Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01NS085078 (to D. A. C.) and F32HL127948 ( to K. M. D.) and by American Cancer Society Grant 122171-PF-12-051-01-CSM (to K. M. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health	Baycin-Hizal D, 2012, J PROTEOME RES, V11, P5265, DOI 10.1021/pr300476w; Beraud-Dufour S, 2007, FEBS J, V274, P5518, DOI 10.1111/j.1742-4658.2007.06068.x; Borikova AL, 2010, J BIOL CHEM, V285, P11760, DOI 10.1074/jbc.C109.097220; Bouaouina M, 2011, METHODS MOL BIOL, V757, P325, DOI 10.1007/978-1-61779-166-6_20; Bouis Diane, 2001, Angiogenesis, V4, P91, DOI 10.1023/A:1012259529167; Bouvard D, 2006, EUR J CELL BIOL, V85, P275, DOI 10.1016/j.ejcb.2005.10.005; Bouvard D, 2003, J BIOL CHEM, V278, P6567, DOI 10.1074/jbc.M211258200; Bouvard D, 2007, DEVELOPMENT, V134, P2615, DOI 10.1242/dev.000877; Brunner M, 2011, J CELL BIOL, V194, P307, DOI 10.1083/jcb.201007108; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cavalcanti DD, 2012, J NEUROSURG, V116, P122, DOI 10.3171/2011.8.JNS101241; Draheim KM, 2014, J CELL SCI, V127, P701, DOI 10.1242/jcs.138388; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Faurobert E, 2013, J CELL BIOL, V202, P545, DOI 10.1083/jcb.201303044; Fisher OS, 2014, CELL MOL LIFE SCI, V71, P1881, DOI 10.1007/s00018-013-1532-9; Fournier HN, 2005, MOL BIOL CELL, V16, P1859, DOI 10.1091/mbc.E04-08-0744; Francalanci F, 2009, EXP CELL RES, V315, P285, DOI 10.1016/j.yexcr.2008.10.006; Fu CL, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn167; Gingras AR, 2013, J BIOL CHEM, V288, P23639, DOI 10.1074/jbc.M113.462911; Gingras AR, 2012, J CELL BIOL, V199, P39, DOI 10.1083/jcb.201205109; Glading A, 2007, J CELL BIOL, V179, P247, DOI 10.1083/jcb.200705175; Glading AJ, 2010, DIS MODEL MECH, V3, P73, DOI 10.1242/dmm.003293; Goitre L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011786; Gunel M, 2002, P NATL ACAD SCI USA, V99, P10677, DOI 10.1073/pnas.122354499; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Huveneers S, 2008, J CELL SCI, V121, P2452, DOI 10.1242/jcs.033001; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Iwamoto DV, 2015, CURR OPIN CELL BIOL, V36, P41, DOI 10.1016/j.ceb.2015.06.009; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Lad Y, 2007, METHOD ENZYMOL, V426, P69, DOI 10.1016/S0076-6879(07)26004-5; Lampugnani MG, 2010, J CELL SCI, V123, P1073, DOI 10.1242/jcs.059329; Liu WZ, 2013, ACTA CRYSTALLOGR F, V69, P494, DOI 10.1107/S1744309113010762; Liu WZ, 2013, MOL CELL, V49, P719, DOI 10.1016/j.molcel.2012.12.005; Marzo S, 2014, EUR J HISTOCHEM, V58, P62, DOI 10.4081/ejh.2014.2358; McDonald DA, 2014, HUM MOL GENET, V23, P4357, DOI 10.1093/hmg/ddu153; Millon-Fremillon A, 2008, J CELL BIOL, V180, P427, DOI 10.1083/jcb.200707142; Millon-Fremillon A, 2013, J BIOL CHEM, V288, P20248, DOI 10.1074/jbc.M113.455956; Morse EM, 2014, BIOCHEMISTRY-US, V53, P810, DOI 10.1021/bi401596q; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Pozzati E, 1996, NEUROSURGERY, V38, P662, DOI 10.1227/00006123-199604000-00006; Revencu N, 2006, J MED GENET, V43, P716, DOI 10.1136/jmg.2006.041079; Riant F, 2013, NEUROGENETICS, V14, P133, DOI 10.1007/s10048-013-0362-0; RIGAMONTI D, 1988, NEW ENGL J MED, V319, P343, DOI 10.1056/NEJM198808113190605; Shaiken TE, 2014, SCI REP-UK, V4, DOI 10.1038/srep04923; Stahl S, 2008, HUM MUTAT, V29, P709, DOI 10.1002/humu.20712; Stockton RA, 2010, J EXP MED, V207, P881, DOI 10.1084/jem.20091258; Tanriover G, 2013, CLIN NEUROL NEUROSUR, V115, P438, DOI 10.1016/j.clineuro.2012.06.023; Tozer EC, 1996, J BIOL CHEM, V271, P21978, DOI 10.1074/jbc.271.36.21978; Tu X, 2002, J BIOL CHEM, V277, P44357, DOI 10.1074/jbc.M208001200; Voss K, 2007, NEUROGENETICS, V8, P249, DOI 10.1007/s10048-007-0098-9; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Wustehube J, 2010, P NATL ACAD SCI USA, V107, P12640, DOI 10.1073/pnas.1000132107; Ye F, 2014, FRONT MED-PRC, V8, P6, DOI 10.1007/s11684-014-0317-3; Zawistowski JS, 2002, HUM MOL GENET, V11, P389, DOI 10.1093/hmg/11.4.389; Zawistowski JS, 2005, HUM MOL GENET, V14, P2521, DOI 10.1093/hmg/ddi256; Zhang J, 2001, HUM MOL GENET, V10, P2953, DOI 10.1093/hmg/10.25.2953; Zhang J, 2008, NEUROSURGERY, V63, P571, DOI 10.1227/01.NEU.0000325255.30268.B0; Zhang J, 2007, NEUROSURGERY, V60, P353, DOI 10.1227/01.NEU.0000249268.11074.83; Zovein AC, 2010, DEV CELL, V18, P39, DOI 10.1016/j.devcel.2009.12.006	61	15	16	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1884	1898		10.1074/jbc.M116.762393	http://dx.doi.org/10.1074/jbc.M116.762393			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28003363	hybrid, Green Published			2022-12-26	WOS:000395515600028
J	Galon-Tilleman, H; Yang, H; Bednarek, MA; Spurlock, SM; Paavola, KJ; Ko, B; To, C; Luo, J; Tian, H; Jermutus, L; Grimsby, J; Rondinone, CM; Konkar, A; Kaplan, DD				Galon-Tilleman, Hadas; Yang, Hong; Bednarek, Maria A.; Spurlock, Sandra M.; Paavola, Kevin J.; Ko, Brian; To, Carmen; Luo, Jian; Tian, Hui; Jermutus, Lutz; Grimsby, Joseph; Rondinone, Cristina M.; Konkar, Anish; Kaplan, Daniel D.			Apelin-36 Modulates Blood Glucose and Body Weight Independently of Canonical APJ Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiovascular; diabetes; G protein-coupled receptor (GPCR); metabolic syndrome; obesity; signal transduction; apelin; APJ; ligand-receptor promiscuity; metabolic syndrome	HEART-FAILURE; CARDIOVASCULAR FUNCTION; ENDOGENOUS LIGAND; HETERODIMERIZATION; ANTAGONIZES; PEPTIDE; BINDING; ROLES	Apelin-36 was discovered as the endogenous ligand for the previously orphan receptor APJ. Apelin-36 has been linked to two major types of biological activities: cardiovascular (stimulation of cardiac contractility and suppression of blood pressure) and metabolic (improving glucose homeostasis and lowering body weight). It has been assumed that both of these activities are modulated through APJ. Here, we demonstrate that the metabolic activity of apelin-36 can be separated from canonical APJ activation. We developed a series of apelin-36 variants in which evolutionarily conserved residues were mutated, and evaluated their ability to modulate glucose homeostasis and body weight in chronic mouse models. We found that apelin-36(L28A) retains full metabolic activity, but is 100-fold impaired in its ability to activate APJ. In contrast to its full metabolic activity, apelin-36(L28A) lost the ability to suppress blood pressure in spontaneously hypertensive rats (SHR). We took advantage of these findings to develop a longer-acting variant of apelin-36 that could modulate glucose homeostasis without impacting blood pressure (or activating APJ). Apelin-36-[L28C(30kDa-PEG)] is 10,000-fold less potent than apelin-36 at activating the APJ receptor but retains its ability to significantly lower blood glucose and improve glucose tolerance in diet-induced obese mice. Apelin-36-[L28C(30kDa-PEG)] provides a starting point for the development of diabetes therapeutics that are devoid of the blood pressure effects associated with canonical APJ activation.	[Galon-Tilleman, Hadas; Yang, Hong; Spurlock, Sandra M.; Paavola, Kevin J.; Ko, Brian; To, Carmen; Luo, Jian; Tian, Hui; Kaplan, Daniel D.] NGM Biopharmaceut, 333 Oyster Point Blvd, South San Francisco, CA 94080 USA; [Bednarek, Maria A.; Jermutus, Lutz] MedImmune Ltd, Dept Antibody Discovery & Prot Engn, Cambridge CB21 6GH, England; [Grimsby, Joseph; Rondinone, Cristina M.; Konkar, Anish] MedImmune LLC, Dept Cardiovasc & Metab Dis Res, Gaithersburg, MD 20878 USA	AstraZeneca; Medimmune; AstraZeneca; Medimmune	Kaplan, DD (corresponding author), NGM Biopharmaceut, 333 Oyster Point Blvd, South San Francisco, CA 94080 USA.	dkaplan@ngmbio.com	Jermutus, Lutz/AAU-2047-2020	Kaplan, Daniel/0000-0001-8297-560X				Bai B, 2014, J CELL MOL MED, V18, P2071, DOI 10.1111/jcmm.12404; Bai B, 2014, CELL SIGNAL, V26, P1549, DOI 10.1016/j.cellsig.2014.03.022; Castan-Iaurell I, 2012, TRENDS ENDOCRIN MET, V23, P234, DOI 10.1016/j.tem.2012.02.005; Castan-Laurell I, 2011, ENDOCRINE, V40, P1, DOI 10.1007/s12020-011-9507-9; Ceraudo E, 2014, J BIOL CHEM, V289, P24599, DOI 10.1074/jbc.M113.541698; Chandrasekaran B, 2008, EUR J HEART FAIL, V10, P725, DOI 10.1016/j.ejheart.2008.06.002; Charo DN, 2009, AM J PHYSIOL-HEART C, V297, pH1904, DOI 10.1152/ajpheart.00686.2009; Chng SC, 2013, DEV CELL, V27, P672, DOI 10.1016/j.devcel.2013.11.002; Chun HJ, 2008, J CLIN INVEST, V118, P3343, DOI 10.1172/JCI34871; De Mota N, 2000, NEUROENDOCRINOLOGY, V72, P400, DOI 10.1159/000054609; Fan XJ, 2003, BIOCHEMISTRY-US, V42, P10163, DOI 10.1021/bi030049s; Fonseca VA, 2009, DIABETES CARE, V32, pS151, DOI 10.2337/dc09-S301; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405; International Diabetes Federation, 2015, IDF DIABETES ATLAS, P50; Japp AG, 2010, CIRCULATION, V121, P1818, DOI 10.1161/CIRCULATIONAHA.109.911339; Jia ZQ, 2012, PEPTIDES, V38, P181, DOI 10.1016/j.peptides.2012.09.003; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Kawamata Y, 2001, BBA-MOL CELL RES, V1538, P162, DOI 10.1016/S0167-4889(00)00143-9; Kleinz MJ, 2005, PHARMACOL THERAPEUT, V107, P198, DOI 10.1016/j.pharmthera.2005.04.001; Kuba K, 2007, CIRC RES, V101, pE32, DOI 10.1161/CIRCRESAHA.107.158659; Lee DK, 2005, ENDOCRINOLOGY, V146, P231, DOI 10.1210/en.2004-0359; Medhurst AD, 2003, J NEUROCHEM, V84, P1162, DOI 10.1046/j.1471-4159.2003.01587.x; Messari SE, 2004, J NEUROCHEM, V90, P1290, DOI 10.1111/j.1471-4159.2004.02591.x; Murza A, 2012, CHEMMEDCHEM, V7, P318, DOI 10.1002/cmdc.201100492; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Scimia MC, 2012, NATURE, V488, P394, DOI 10.1038/nature11263; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Yang PR, 2015, TRENDS PHARMACOL SCI, V36, P560, DOI 10.1016/j.tips.2015.06.002; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	33	24	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1925	1933		10.1074/jbc.M116.748103	http://dx.doi.org/10.1074/jbc.M116.748103			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27994053	Green Published, hybrid			2022-12-26	WOS:000395515600031
J	Timm, KN; Hu, DE; Williams, M; Wright, AJ; Kettunen, MI; Kennedy, BWC; Larkin, TJ; Dzien, P; Marco-Rius, I; Bohndiek, SE; Brindle, KM				Timm, Kerstin N.; Hu, De-En; Williams, Michael; Wright, Alan J.; Kettunen, Mikko I.; Kennedy, Brett W. C.; Larkin, Timothy J.; Dzien, Piotr; Marco-Rius, Irene; Bohndiek, Sarah E.; Brindle, Kevin M.			Assessing Oxidative Stress in Tumors by Measuring the Rate of Hyperpolarized [1-C-13]Dehydroascorbic Acid Reduction Using C-13 Magnetic Resonance Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDOX STATUS; VITAMIN-C; IN-VIVO; GLUTATHIONE SYNTHESIS; DEHYDROASCORBIC ACID; BUTHIONINE SULFOXIMINE; TETRAZOLIUM SALT; CELL METABOLISM; CONTRAST AGENTS; CANCER	Rapid cancer cell proliferation promotes the production of reducing equivalents, which counteract the effects of relatively high levels of reactive oxygen species. Reactive oxygen species levels increase in response to chemotherapy and cell death, whereas an increase in antioxidant capacity can confer resistance to chemotherapy and is associated with an aggressive tumor phenotype. The pentose phosphate pathway is a major site of NADPH production in the cell, which is used to maintain the main intracellular antioxidant, glutathione, in its reduced state. Previous studies have shown that the rate of hyperpolarized [1-C-13]dehydroascorbic acid (DHA) reduction, which can be measured in vivo using non-invasive C-13 magnetic resonance spectroscopic imaging, is increased in tumors and that this is correlated with the levels of reduced glutathione. We show here that the rate of hyperpolarized [1-C-13]DHA reduction is increased in tumors that have been oxidatively prestressed by depleting the glutathione pool by buthionine sulfoximine treatment. This increase was associated with a corresponding increase in pentose phosphate pathway flux, assessed using C-13-labeled glucose, and an increase in glutaredoxin activity, which catalyzes the glutathione-dependent reduction of DHA. These results show that the rate of DHA reduction depends not only on the level of reduced glutathione, but also on the rate of NADPH production, contradicting the conclusions of some previous studies. Hyperpolarized [1-C-13]DHA can be used, therefore, to assess the capacity of tumor cells to resist oxidative stress in vivo. However, DHA administration resulted in transient respiratory arrest and cardiac depression, which may prevent translation to the clinic.	[Timm, Kerstin N.; Hu, De-En; Kettunen, Mikko I.; Kennedy, Brett W. C.; Larkin, Timothy J.; Dzien, Piotr; Marco-Rius, Irene; Brindle, Kevin M.] Univ Cambridge, Dept Biochem, Cambridge CB2 0RE, England; [Timm, Kerstin N.; Hu, De-En; Williams, Michael; Wright, Alan J.; Kettunen, Mikko I.; Kennedy, Brett W. C.; Larkin, Timothy J.; Dzien, Piotr; Marco-Rius, Irene; Bohndiek, Sarah E.; Brindle, Kevin M.] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England; [Bohndiek, Sarah E.] Univ Cambridge, Dept Phys, Cambridge CB2 0RE, England	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge	Brindle, KM (corresponding author), Canc Res UK, Cambridge Inst, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 0RE, England.	kmb1001@cam.ac.uk	Bohndiek, Sarah/S-9416-2019; Kettunen, Mikko I/K-2299-2012; Marco-Rius, Irene/ABB-5520-2020; Timm, Kerstin/AAW-7262-2020	Kettunen, Mikko I/0000-0002-2004-660X; Marco-Rius, Irene/0000-0001-5076-8526; Timm, Kerstin/0000-0001-9136-7518; Bohndiek, Sarah/0000-0003-0371-8635	Medical Research Council and Cancer Research UK; Cancer Research UK; European Union Seventh Framework Programme [FP7/2007-2013, 264780]; Cancer Research UK Programme [C14303/A17197]; CRUK-EPSRC Imaging Centre in Cambridge and Manchester [C197/A16465]; Cancer Research UK [16465, 17242] Funding Source: researchfish	Medical Research Council and Cancer Research UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); European Union Seventh Framework Programme(European Commission); Cancer Research UK Programme(Cancer Research UK); CRUK-EPSRC Imaging Centre in Cambridge and Manchester(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Cancer Research UK(Cancer Research UK)	Recipient of Medical Research Council and Cancer Research UK studentships.; Recipient of a Cancer Research UK studentship.; Supported by European Union Seventh Framework Programme Grant FP7/2007-2013 under the Marie Curie Initial Training Network METAFLUX (Project 264780).; Work in this author's laboratory is supported by Cancer Research UK Programme Grant C14303/A17197 and the CRUK-EPSRC Imaging Centre in Cambridge and Manchester (Grant C197/A16465).	Agus DB, 1999, CANCER RES, V59, P4555; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Bobko AA, 2012, MAGN RESON MED, V67, P1827, DOI 10.1002/mrm.23196; Bohndiek SE, 2011, J AM CHEM SOC, V133, P11795, DOI 10.1021/ja2045925; Boren J, 2001, J BIOL CHEM, V276, P37747; BRITTEN RA, 1992, INT J RADIAT ONCOL, V22, P769, DOI 10.1016/0360-3016(92)90521-I; BURDON RH, 1993, FREE RADICAL RES COM, V18, P369, DOI 10.3109/10715769309147503; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cisternas P, 2014, J NEUROCHEM, V129, P663, DOI 10.1111/jnc.12663; Cosentino C, 2011, EMBO J, V30, P546, DOI 10.1038/emboj.2010.330; Couto N, 2016, FREE RADICAL BIO MED, V95, P27, DOI 10.1016/j.freeradbiomed.2016.02.028; Day SE, 2007, NAT MED, V13, P1382, DOI 10.1038/nm1650; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Do QN, 2014, CHEMMEDCHEM, V9, P1116, DOI 10.1002/cmdc.201402034; Fiorani M, 2013, J NUTR BIOCHEM, V24, P467, DOI 10.1016/j.jnutbio.2012.01.009; Fritz H, 2014, INTEGR CANCER THER, V13, P280, DOI 10.1177/1534735414534463; Galaris D, 1997, FREE RADICAL BIO MED, V22, P657, DOI 10.1016/S0891-5849(96)00382-6; GRIFFITH OW, 1982, J BIOL CHEM, V257, P13704; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Halliwell B., 2007, FREE RADICAL BIO MED, P162; Harris T, 2013, NMR BIOMED, V26, P1831, DOI 10.1002/nbm.3024; Hyodo F, 2008, J PHARM PHARMACOL, V60, P1049, DOI 10.1211/jpp.60.8.0011; Ilangovan G, 2002, MOL CELL BIOCHEM, V234, P393, DOI 10.1023/A:1015967305659; Kaiser LG, 2010, J MAGN RESON, V202, P259, DOI 10.1016/j.jmr.2009.11.013; Keller MA, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.20145228; Keshari KR, 2015, DIABETES, V64, P344, DOI 10.2337/db13-1829; Keshari KR, 2013, J NUCL MED, V54, P922, DOI 10.2967/jnumed.112.115402; Keshari KR, 2011, P NATL ACAD SCI USA, V108, P18606, DOI 10.1073/pnas.1106920108; Kim JH, 2014, RADIAT ONCOL J, V32, P103, DOI 10.3857/roj.2014.32.3.103; Kuppusamy P, 2002, CANCER RES, V62, P307; Lau ATY, 2008, J CELL BIOCHEM, V104, P657, DOI 10.1002/jcb.21655; Li LZ, 2012, J BIOENERG BIOMEMBR, V44, P645, DOI 10.1007/s10863-012-9469-5; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; Linster CL, 2007, FEBS J, V274, P1, DOI 10.1111/j.1742-4658.2006.05607.x; Lumata L, 2011, PHYS MED BIOL, V56, pN85, DOI 10.1088/0031-9155/56/5/N01; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; May JM, 1996, FREE RADICAL BIO MED, V20, P543, DOI 10.1016/0891-5849(95)02130-2; Meier S, 2011, MOL BIOSYST, V7, P2834, DOI 10.1039/c1mb05202k; Nelson SJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006070; Okazawa H, 2014, Q J NUCL MED MOL IM, V58, P387; PATTERSON JW, 1951, AM J PHYSIOL, V167, P119, DOI 10.1152/ajplegacy.1951.167.1.119; RAAP AK, 1983, HISTOCHEM J, V15, P977, DOI 10.1007/BF01002493; Raftos JE, 2010, J BIOL CHEM, V285, P23557, DOI 10.1074/jbc.M109.067017; Ralser M, 2009, NAT BIOTECHNOL, V27, P604, DOI 10.1038/nbt0709-604; Rodrigues TB, 2014, NAT MED, V20, P93, DOI 10.1038/nm.3416; RUSSO A, 1986, CANCER RES, V46, P2845; Savini I, 2000, BIOCHEM J, V345, P665, DOI 10.1042/0264-6021:3450665; Song JH, 2001, BRAIN RES, V895, P66, DOI 10.1016/S0006-8993(01)02029-7; Stincone A, 2015, BIOL REV, V90, P927, DOI 10.1111/brv.12140; Timm KN, 2015, MAGN RESON MED, V74, P1543, DOI 10.1002/mrm.25561; Witney TH, 2010, BRIT J CANCER, V103, P1400, DOI 10.1038/sj.bjc.6605945; Witney TH, 2011, J BIOL CHEM, V286, P24572, DOI 10.1074/jbc.M111.237727; Witney TH, 2010, BIOCHEM SOC T, V38, P1220, DOI 10.1042/BST0381220; Zhu PJ, 2008, RAPID COMMUN MASS SP, V22, P432, DOI 10.1002/rcm.3380; Zitka O, 2012, ONCOL LETT, V4, P1247, DOI 10.3892/ol.2012.931	57	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1737	1748		10.1074/jbc.M116.761536	http://dx.doi.org/10.1074/jbc.M116.761536			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27994059	hybrid, Green Published			2022-12-26	WOS:000395515600016
J	Zhao, X; Khurana, S; Charkraborty, S; Tian, YQ; Sedor, JR; Bruggman, LA; Kao, HY				Zhao, Xuan; Khurana, Simran; Charkraborty, Sharmistha; Tian, Yuqian; Sedor, John R.; Bruggman, Leslie A.; Kao, Hung-Ying			Actinin 4 (ACTN4) Regulates Glucocorticoid Receptor-mediated Transactivation and Transrepression in Podocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glucocorticoid receptor; podocyte; transcription coactivator; transcription corepressor; translation control; actinin 4; podocyte; transactivation; transrepression	FOCAL SEGMENTAL GLOMERULOSCLEROSIS; HEAT-SHOCK PROTEINS; GLOMERULAR-DISEASES; NEPHROTIC SYNDROME; ALPHA-ACTININ-4; GENES; ALPHA; TRANSCRIPTION; MECHANISMS; MUTATIONS	Glucocorticoids are a general class of steroids that possess renoprotective activity in glomeruli through their interaction with the glucocorticoid receptor. However, the mechanisms by which glucocorticoids ameliorate proteinuria and glomerular disease are not well understood. In this study, we demonstrated that actinin 4 (ACTN4), an actin-cross-linking protein known to coordinate cytoskeletal organization, interacts with the glucocorticoid receptor (GR) in the nucleus of human podocytes (HPCs), a key cell type in the glomerulus critical for kidney filtration function. The GR-ACTN4 complex enhances glucocorticoid response element (GRE)-driven reporter activity. Stable knockdown of ACTN4 by shRNA in HPCs significantly reduces dexamethasone-mediated induction of GR target genes and GRE-driven reporter activity without disrupting dexamethasone-induced nuclear translocation of GR. Synonymous mutations or protein expression losses in ACTN4 are associated with kidney diseases, including focal segmental glomerulosclerosis, characterized by proteinuria and podocyte injury. We found that focal segmental glomerulosclerosis-linked ACTN4 mutants lose their ability to bind liganded GR and support GRE-mediated transcriptional activity. Mechanistically, GR and ACTN4 interact in the nucleus of HPCs. Furthermore, disruption of the LXXLL nuclear receptor-interacting motif present in ACTN4 results in reduced GR interaction and dexamethasone-mediated transactivation of a GRE reporter while still maintaining its actin-binding activity. In contrast, an ACTN4 isoform, ACTN4 (Iso), that loses its actin-binding domain is still capable of potentiating a GRE reporter. Dexamethasone induces the recruitment of ACTN4 and GR to putative GREs in dexamethasone-transactivated promoters, SERPINE1, ANGPLT4, CCL20, and SAA1 as well as the NF-B (p65) binding sites on GR-transrepressed promoters such as IL-1, IL-6, and IL-8. Taken together, our data establish ACTN4 as a transcriptional co-regulator that modulates both dexamethasone-transactivated and -transrepressed genes in podocytes.	[Zhao, Xuan; Khurana, Simran; Charkraborty, Sharmistha; Tian, Yuqian; Kao, Hung-Ying] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Kao, Hung-Ying] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Sedor, John R.; Bruggman, Leslie A.] Case Western Reserve Univ, Sch Med, Rammelkamp Ctr Educ & Res, Cleveland, OH 44106 USA; [Sedor, John R.; Bruggman, Leslie A.] Case Western Reserve Univ, Sch Med, Dept Med, MetroHlth Med Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; MetroHealth System; Case Western Reserve University; MetroHealth System	Kao, HY (corresponding author), Case Western Reserve Univ, 10900 Euclid Ave, Cleveland, OH 44106 USA.	hxk43@cwru.edu			National Institutes of Health [R01 DK078965]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK078965. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	An HT, 2014, J BIOL CHEM, V289, P4969, DOI 10.1074/jbc.M113.515395; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Bose B, 2014, CLIN J AM SOC NEPHRO, V9, P626, DOI 10.2215/CJN.05810513; Chakraborty S, 2006, J BIOL CHEM, V281, P35070, DOI 10.1074/jbc.M602474200; Cheng XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060213; Clement LC, 2011, NAT MED, V17, P117, DOI 10.1038/nm.2261; Coppo R, 2013, CONTRIB NEPHROL, V181, P84, DOI 10.1159/000348637; Dai SC, 2010, NEPHROL DIAL TRANSPL, V25, P824, DOI 10.1093/ndt/gfp394; Dai SC, 2009, NEPHRON CLIN PRACT, V111, pC87, DOI 10.1159/000191198; De Bosscher K, 2000, J NEUROIMMUNOL, V109, P16, DOI 10.1016/S0165-5728(00)00297-6; Eichler TE, 2005, TOXICOL SCI, V84, P120, DOI 10.1093/toxsci/kfi048; Feng D, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0036-8; Gershoni-Baruch R, 2003, ARTHRITIS RHEUM, V48, P1149, DOI 10.1002/art.10944; Grgic I, 2014, KIDNEY INT, V86, P1116, DOI 10.1038/ki.2014.204; Heitzer MD, 2007, REV ENDOCR METAB DIS, V8, P321, DOI 10.1007/s11154-007-9059-8; Huang Y, 2008, J AM SOC NEPHROL, V19, P329, DOI 10.1681/ASN.2007040510; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Khurana S, 2012, J BIOL CHEM, V287, P35418, DOI 10.1074/jbc.M112.401364; Khurana S, 2012, J BIOL CHEM, V287, P12027, DOI 10.1074/jbc.M112.345421; Khurana S, 2011, J BIOL CHEM, V286, P1850, DOI 10.1074/jbc.M110.162107; Kirschke E, 2014, CELL, V157, P1685, DOI 10.1016/j.cell.2014.04.038; Korbet SM, 2012, J AM SOC NEPHROL, V23, P1769, DOI 10.1681/ASN.2012040389; Korbet SM, 2012, CLIN J AM SOC NEPHRO, V7, P1545, DOI 10.2215/CJN.08290812; Liu ZM, 2011, J BIOL CHEM, V286, P30795, DOI 10.1074/jbc.M111.255984; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Pani A, 2013, AUTOIMMUN REV, V12, P848, DOI 10.1016/j.autrev.2012.11.012; PRATT WB, 1993, J BIOL CHEM, V268, P21455; Reichardt HM, 2001, EMBO J, V20, P7168, DOI 10.1093/emboj/20.24.7168; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Smith LJ, 1996, ARCH INTERN MED, V156, P2181, DOI 10.1001/archinte.156.19.2181; Thorn CF, 2003, EUR J IMMUNOL, V33, P2630, DOI 10.1002/eji.200323985; Villa L, 2013, J PATHOL, V229, P672, DOI 10.1002/path.4151; Wada T, 2005, J AM SOC NEPHROL, V16, P2615, DOI 10.1681/ASN.2005020142; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Xing CY, 2006, KIDNEY INT, V70, P1038, DOI 10.1038/sj.ki.5001655; Yao J, 2004, PLOS BIOL, V2, P787, DOI 10.1371/journal.pbio.0020167; Zahran AM, 2014, RENAL FAILURE, V36, P1067, DOI 10.3109/0886022X.2014.917936; Zhao X, 2015, J BIOL CHEM, V290, P338, DOI 10.1074/jbc.M114.597260	39	23	25	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1637	1647		10.1074/jbc.M116.755546	http://dx.doi.org/10.1074/jbc.M116.755546			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27998979	Green Published, hybrid			2022-12-26	WOS:000395515600009
J	Sweeney, CG; Tremblay, BP; Stockner, T; Sitte, HH; Melikian, HE				Sweeney, Carolyn G.; Tremblay, Bradford P.; Stockner, Thomas; Sitte, Harald H.; Melikian, Haley E.			Dopamine Transporter Amino and Carboxyl Termini Synergistically Contribute to Substrate and Inhibitor Affinities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SEROTONIN TRANSPORTER; NEUROTRANSMITTER TRANSPORTERS; MONOAMINE TRANSPORTERS; PROTEIN-KINASE; C-TERMINUS; N-TERMINUS; SALT BRIDGE; RESIDUES; INTERNALIZATION; AMPHETAMINES	Extracellular dopamine and serotonin concentrations are determined by the presynaptic dopamine (DAT) and serotonin (SERT) transporters, respectively. Numerous studies have investigated the DAT and SERT structural elements contributing to inhibitor and substrate binding. To date, crystallographic studies have focused on conserved transmembrane domains, where multiple substrate binding and translocation features are conserved. However, it is unknown what, if any, role the highly divergent intracellular N and C termini contribute to these processes. Here, we used chimeric proteins to test whether DAT and SERT N and C termini contribute to transporter substrate and inhibitor affinities. Replacing the DATN terminus with that of SERT had no effect on DA transport V-max but significantly decreased DAT substrate affinities for DA and amphetamine. Similar losses in uptake inhibition were observed for small DAT inhibitors, whereas substituting the DAT C terminus with that of SERT affected neither substrate nor inhibitor affinities. In contrast, the N-terminal substitution was completely tolerated by the larger DAT inhibitors, which exhibited no loss in apparent affinity. Remarkably, all affinity losses were rescued in DAT chimeras encoding both SERT N and C termini. The sensitivity to amino-terminal substitution was specific for DAT, because replacing the SERT N and/or C termini affected neither substrate nor inhibitor affinities. Taken together, these findings provide compelling experimental evidence that DAT N and C termini synergistically contribute to substrate and inhibitor affinities.	[Sweeney, Carolyn G.; Tremblay, Bradford P.; Melikian, Haley E.] Univ Massachusetts, Sch Med, Dept Psychiat, Brudnick Neuropsychiat Res Inst, 303 Belmont St, Worcester, MA 01604 USA; [Stockner, Thomas; Sitte, Harald H.] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, A-1090 Vienna, Austria	University of Massachusetts System; University of Massachusetts Worcester; Medical University of Vienna	Melikian, HE (corresponding author), Univ Massachusetts, Sch Med, Dept Psychiat, Brudnick Neuropsychiat Res Inst, 303 Belmont St, Worcester, MA 01604 USA.	haley.melikian@umassmed.edu	Stockner, Thomas/A-9509-2014; Sitte, Harald/N-2681-2013; Melikian, Haley/S-8301-2016	Stockner, Thomas/0000-0002-7071-8283; Sitte, Harald/0000-0002-1339-7444; Melikian, Haley/0000-0002-9694-5556	National Institutes of Health [DA15169, DA039592]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015169, F31DA039592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by National Institutes of Health Grants DA15169 (to H. E. M.) and DA039592 (C. G. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALI SA, 1995, BIOTECHNIQUES, V18, P746; Bermingham DP, 2016, PHARMACOL REV, V68, P888, DOI 10.1124/pr.115.012260; Boudanova E, 2008, MOL CELL NEUROSCI, V39, P211, DOI 10.1016/j.mcn.2008.06.011; Buchmayer F, 2013, P NATL ACAD SCI USA, V110, P11642, DOI 10.1073/pnas.1220552110; Cartier E, 2015, EBIOMEDICINE, V2, P135, DOI 10.1016/j.ebiom.2015.01.007; Chen NH, 2001, J NEUROCHEM, V77, P1116, DOI 10.1046/j.1471-4159.2001.00312.x; Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; Farhan H, 2007, J BIOL CHEM, V282, P7679, DOI 10.1074/jbc.M609720200; Fenollar-Ferrer C, 2014, BIOCHEMISTRY-US, V53, P5444, DOI 10.1021/bi500637f; Freyberg Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10652; Gaffaney JD, 2014, NEUROCHEM INT, V73, P16, DOI 10.1016/j.neuint.2013.11.003; German CL, 2015, PHARMACOL REV, V67, P1005, DOI 10.1124/pr.114.010397; Gu HH, 2001, MOL BIOL CELL, V12, P3797, DOI 10.1091/mbc.12.12.3797; Guptaroy B, 2011, MOL PHARMACOL, V79, P520, DOI 10.1124/mol.110.069039; Guptaroy B, 2009, MOL PHARMACOL, V75, P514, DOI 10.1124/mol.108.048744; Hamilton PJ, 2014, NAT CHEM BIOL, V10, P582, DOI [10.1038/NCHEMBIO.1545, 10.1038/nchembio.1545]; Holton KL, 2005, NAT NEUROSCI, V8, P881, DOI 10.1038/nn1478; Khelashvili G, 2015, ACS CHEM NEUROSCI, V6, P1825, DOI 10.1021/acschemneuro.5b00179; Khelashvili G, 2015, PROTEINS, V83, P952, DOI 10.1002/prot.24792; Khoshbouei H, 2004, PLOS BIOL, V2, P387, DOI 10.1371/journal.pbio.0020078; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Koban F, 2015, J BIOL CHEM, V290, P13263, DOI 10.1074/jbc.M115.641357; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; Miranda M, 2007, MOL BIOL CELL, V18, P313, DOI 10.1091/mbc.E06-08-0704; Moritz AE, 2013, J BIOL CHEM, V288, P20, DOI 10.1074/jbc.M112.407874; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Porzgen P, 2001, MOL PHARMACOL, V59, P83; Prasad HC, 2009, PHILOS T R SOC B, V364, P163, DOI 10.1098/rstb.2008.0143; Prasad HC, 2005, P NATL ACAD SCI USA, V102, P11545, DOI 10.1073/pnas.0501432102; Rickhag M, 2013, J BIOL CHEM, V288, P27534, DOI 10.1074/jbc.M112.441295; Rickhag M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2568; Sakrikar D, 2012, J NEUROSCI, V32, P5385, DOI 10.1523/JNEUROSCI.6033-11.2012; Seimandi M, 2013, J NEUROSCI, V33, P16189, DOI 10.1523/JNEUROSCI.0076-13.2013; Sitte HH, 2015, TRENDS PHARMACOL SCI, V36, P41, DOI 10.1016/j.tips.2014.11.006; Sitte HH, 2010, J NEUROCHEM, V112, P340, DOI 10.1111/j.1471-4159.2009.06474.x; Sitte HH, 2004, MOL INTERV, V4, P38, DOI 10.1124/mi.4.1.38; Sorkina T, 2009, J NEUROSCI, V29, P1361, DOI 10.1523/JNEUROSCI.3250-08.2009; Sucic S, 2013, J BIOL CHEM, V288, P5330, DOI 10.1074/jbc.M112.408237; Sucic S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230037; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; Vaughan RA, 2013, TRENDS PHARMACOL SCI, V34, P489, DOI 10.1016/j.tips.2013.07.005; Vuorenpaa A, 2016, J BIOL CHEM, V291, P5634, DOI 10.1074/jbc.M115.702050; Wang KH, 2015, NATURE, V521, P322, DOI 10.1038/nature14431; Wu S, 2015, P NATL ACAD SCI USA, V112, P15480, DOI 10.1073/pnas.1512957112; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	48	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1302	1309		10.1074/jbc.M116.762872	http://dx.doi.org/10.1074/jbc.M116.762872			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27986813	Green Published, hybrid			2022-12-26	WOS:000393339800013
J	Tran, BX; Hwang, JN; Nguyen, LH; Nguyen, AT; Latkin, NRK; Tran, NK; Thuc, VTM; Nguyen, HLT; Phan, HTT; Le, HT; Tran, TD; Latkin, CA				Bach Xuan Tran; Hwang, Jongnam; Long Hoang Nguyen; Anh Tuan Nguyen; Latkin, Noah Reed Knowlton; Ngoc Kim Tran; Vu Thi Minh Thuc; Huong Lan Thi Nguyen; Huong Thu Thi Phan; Huong Thi Le; Tho Dinh Tran; Latkin, Carl A.			Impact of Socioeconomic Inequality on Access, Adherence, and Outcomes of Antiretroviral Treatment Services for People Living with HIV/AIDS in Vietnam	PLOS ONE			English	Article							HEALTH-CARE; HIV; THERAPY; MORTALITY; DETERMINANTS; POPULATION; INITIATION; ADULTS; VIRUS	Background Ensuring an equal benefit across different patient groups is necessary while scaling up free-of-charge antiretroviral treatment (ART) services. This study aimed to measure the disparity in access, adherence, and outcomes of ART in Vietnam and the effects of socioeconomic status (SES) characteristics on the levels of inequality. Methods A cross-sectional study was conducted in 1133 PLWH in Vietnam. ART access, adherence, and treatment outcomes were self-reported using a structured questionnaire. Wealth-related inequality was calculated using a concentration index, and a decomposition analysis was used to determine the contribution of each SES variable to inequality in access, adherence, and outcomes of ART. Results Based on SES, minor inequality was found in ART access and adherence while there was considerable inequality in ART outcomes. Poor people were more likely to start treatment early, while rich people had better adherence and overall treatment outcomes. Decomposition revealed that occupation and education played important roles in inequality in ART access, adherence, and treatment outcomes Conclusion The findings suggested that health services should be integrated into the ART regimen. Furthermore, occupational orientation and training courses should be provided to reduce inequality in ART access, adherence, and treatment outcomes.	[Bach Xuan Tran; Huong Thi Le] Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam; [Bach Xuan Tran; Latkin, Noah Reed Knowlton; Latkin, Carl A.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Hwang, Jongnam] Daegu Univ, Dept Hlth Promot, Gyongsan, South Korea; [Long Hoang Nguyen] Vietnam Natl Univ, Sch Med & Pharm, Hanoi, Vietnam; [Anh Tuan Nguyen; Huong Lan Thi Nguyen] Duy Tan Univ, Inst Global Hlth Innovat, Da Nang, Vietnam; [Ngoc Kim Tran] Woolcock Med Res Inst, Hanoi, Vietnam; [Vu Thi Minh Thuc] Natl Otolaryngol Hosp, Dept Immunol & Allergy, Hanoi, Vietnam; [Huong Thu Thi Phan] Minist Hlth, Author HIV AIDS Control, Hanoi, Vietnam; [Tho Dinh Tran] Vietnam Germany Hosp, Dept Hepatobiliary Surg, Hanoi, Vietnam	Hanoi Medical University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Daegu University; Vietnam National University Hanoi; Duy Tan University	Tran, BX (corresponding author), Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam.; Tran, BX (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	bach@hmu.edu.vn	Nguyen, Huy/GWQ-6433-2022; Nguyen, Huy/AAF-9560-2019; Hwang, Jongnam/GLQ-6437-2022	Nguyen, Huy/0000-0002-5896-9661; Hwang, Jongnam/0000-0001-7078-9244; Tran Kim, Ngoc/0000-0001-7521-5813				Alaba O, 2014, INT J ENV RES PUB HE, V11, P3387, DOI 10.3390/ijerph110303387; Duong AT, 2014, JAIDS-J ACQ IMM DEF, V65, pE1, DOI 10.1097/QAI.0b013e3182a17d15; Tran BX, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-014-0640-z; Tran BX, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.20690; Tran BX, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI [10.3402/gha.v6i0.19570, 10.3402/gha.v6i0.18619]; Tran BX, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-132; Tran BX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041062; Tran BX, 2011, AIDS CARE, V23, P1236, DOI 10.1080/09540121.2011.555749; Beral V, 2004, AIDS, V18, P51, DOI [10.1097/00002030-200401020-00006, 10.1097/01.aids.0000096908.73209.5d]; Braveman PA, 2010, AM J PUBLIC HEALTH, V100, pS186, DOI 10.2105/AJPH.2009.166082; Castelnuovo B, 2009, CLIN INFECT DIS, V49, P965, DOI 10.1086/605500; Control VAoHA, 2016, ANN REV HIV AIDS CON; Tran DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051289; Dray-Spira R, 2003, AIDS, V17, P283, DOI 10.1097/00002030-200302140-00001; Duc Duong Bui, 2011, ADAPTING TREATMENT 2; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Entezarmahdi R, 2014, INT J PREVENTIVE MED, V5, P414; equity PfH, 2011, HLTH EQ VIETN TARG E; Giordano TP, 2004, HIV CLIN TRIALS, V5, P74, DOI 10.1310/JFXH-G3X2-EYM6-D6UG; Girardi E, 2004, JAIDS-J ACQ IMM DEF, V36, P951, DOI 10.1097/00126334-200408010-00009; Go Vietnam, 2012, VIETN AIDS RESP PROG; Group E, 2011, EQ 5D 5L USER GUIDE; Health VMo Group HP, 2013, JOINT ANN HLTH REV 2; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jain MK, 2009, CLIN INFECT DIS, V48, P1772, DOI 10.1086/599111; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2016, GLOB AIDS UPD 2016; Kobin AB, 2011, ANN PHARMACOTHER, V45, P372, DOI 10.1345/aph.1P587; Lim T, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18637; Lim TW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090723; Lodi S, 2014, AIDS, V28, P2297, DOI 10.1097/QAD.0000000000000410; May M, 2011, IMPACT LATE DIAGNOSI; Mitchell CG, 2004, SOC WORK, V49, P469, DOI 10.1093/sw/49.3.469; Montarroyos UR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084276; National Committee for AIDS DaPPaC, 2012, NAT STRAT HIV AIDS P; Olaleye A, 2013, AJAR-AFR J AIDS RES, V12, P85, DOI 10.2989/16085906.2013.851718; Posse M, 2008, TROP MED INT HEALTH, V13, P904, DOI 10.1111/j.1365-3156.2008.02091.x; Rougemont Mathieu, 2009, AIDS Res Ther, V6, P21, DOI 10.1186/1742-6405-6-21; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Schmitt JK, 2004, SOUTH MED J, V97, P329, DOI 10.1097/01.SMJ.0000118132.01508.F0; Scott VE, 2005, SAMJ S AFR MED J, V95, P109; Sobrino-Vegas P, 2012, ANTIVIR THER, V17, P1, DOI 10.3851/IMP1939; Sozmen K, 2014, IRAN J PUBLIC HEALTH, V43, P736; Suthar AB, 2014, AIDS, V28, pS175, DOI 10.1097/QAD.0000000000000259; Tran BX, 2013, TROP MED INT HEALTH, V18, P212, DOI 10.1111/tmi.12032; Turner BJ, 2002, J INFECT DIS, V185, pS143, DOI 10.1086/340197; VAAC VAoHAC, 2014, REP CURR SIT HIV INF; Vu VT, 2011, AIDS CARE, V23, P139, DOI 10.1080/09540121.2010.507741; WAGSTAFF A, 1991, SOC SCI MED, V33, P545, DOI 10.1016/0277-9536(91)90212-U; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2011, TREATM 2 0 CAT NEXT; Zwahlen M, 2009, INT J EPIDEMIOL, V38, P1624, DOI 10.1093/ije/dyp306	51	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168687	10.1371/journal.pone.0168687	http://dx.doi.org/10.1371/journal.pone.0168687			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QH	28005937	Green Submitted, gold, Green Published			2022-12-26	WOS:000392843200081
J	Wong, C; Jiang, MH; You, JHS				Wong, Carlos; Jiang, Minghuan; You, Joyce H. S.			Potential Cost-Effectiveness of an Influenza Vaccination Program Offering Microneedle Patch for Vaccine Delivery in Children	PLoS One			English	Article							SEASONAL INFLUENZA; ATTACK RATE; HONG-KONG; INFECTION; IMMUNOGENICITY; COMPLICATIONS; EPIDEMIOLOGY; SAFETY; ADULTS; IMPACT	Objective The influenza vaccine coverage rate of children is low in Hong Kong. Microneedle patches (MNPs) is a technology under development for painless delivery of vaccines. This study aimed to examine the potential clinical outcomes and direct medical costs of an influenza program offering MNP vaccine to children who have declined intramuscular (IM) vaccine in Hong Kong. Methods A decision model was designed to compare potential outcomes between IM vaccine program and a program offering MNP vaccine to those declined IM vaccine (IM/MNP program) in a hypothetical cohort of children over one-year time horizon. The model outcomes included direct medical cost, influenza infection rate, mortality rate, and quality-adjusted life-years (QALYs) loss. Model inputs were retrieved from published literature. Sensitivity analyses were performed to examine the robustness of model results. Results In base-case analysis, IM/MNP program was more costly per child (USD19.13 versus USD13.69; USD1 = HKD7.8) with lower influenza infection rate (98.9 versus 124.8 per 1,000 children), hospitalization rate (0.83 versus 1.05 per 1,000 children) and influenzarelated mortality rate (0.00042 versus 0.00052 per 1,000 children) when compared to IM program. The incremental cost per QALY saved (ICER) of IM/MNP program versus IM program was 27,200 USD/QALY. Using gross domestic product (GDP) per capita of Hong Kong (USD40,594) as threshold of willingness-to-pay (WTP) per QALY, one-way sensitivity analysis found ICER of IM/MNP to exceed WTP when duration of illness in outpatient setting was <5.7 days or cost per MNP vaccine was >1.39-time of IM vaccine cost. In 10,000 Monte Carlo simulations, IM/MNP program was the preferred option in 57.28% and 91.68% of the time, using 1x and 3x GDP per capita as WTP threshold, respectively. Conclusion Acceptance of IM/MNP program as the preferred program was subject to the WTP threshold, duration of illness in outpatient settings, and cost of MNP vaccine.	[Wong, Carlos; Jiang, Minghuan; You, Joyce H. S.] Chinese Univ Hong Kong, Sch Pharm, Fac Med, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong	You, JHS (corresponding author), Chinese Univ Hong Kong, Sch Pharm, Fac Med, Shatin, Hong Kong, Peoples R China.	joyceyou@cuhk.edu.hk	You, Joyce H. S./C-2984-2008	You, Joyce H. S./0000-0002-5763-7403				Ampofo K, 2006, PEDIATRICS, V118, P2409, DOI 10.1542/peds.2006-1475; [Anonymous], 2016, FLU EXPR; Census and Statistics Department the Government of Hong Kong, 2016, POPULATION PROJECTIO; Chan D, 2013, COMMUNICABLE DIS WAT, V10, P74; Garnacho-Montero J, 2013, J AM GERIATR SOC, V61, P350, DOI 10.1111/jgs.12152; Gold MR, 1998, MED CARE, V36, P778, DOI 10.1097/00005650-199806000-00002; Greenberg DP, 2014, PEDIATR INFECT DIS J, V33, P630, DOI 10.1097/INF.0000000000000254; Hon KL, 2016, NPJ PRIM CARE RESP M, V26, DOI 10.1038/npjpcrm.2016.11; Jayasundara K, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0670-5; Kenney RT, 2004, NEW ENGL J MED, V351, P2295, DOI 10.1056/NEJMoa043540; Kim YC, 2012, ADV DRUG DELIVER REV, V64, P1547, DOI 10.1016/j.addr.2012.04.005; Kwong JC, 2015, VACCINE, V33, P535, DOI 10.1016/j.vaccine.2014.11.044; Lee BY, 2015, VACCINE, V33, P4727, DOI 10.1016/j.vaccine.2015.02.076; Lee BY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011284; Lee BY, 2010, AM J MANAG CARE, V16, pE75; Leung MK, COST EFFECTIVENESS I; Loughlin J, 2003, PHARMACOECONOMICS, V21, P273, DOI 10.2165/00019053-200321040-00005; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Norman JJ, 2014, VACCINE, V32, P1856, DOI 10.1016/j.vaccine.2014.01.076; Petrie JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075339; Pileggi C, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1161-z; Tsolia MN, 2006, VACCINE, V24, P5970, DOI 10.1016/j.vaccine.2006.05.006; Vellozzi C, 2014, CLIN INFECT DIS, V58, P1149, DOI 10.1093/cid/ciu005; Viboud C, 2004, BRIT J GEN PRACT, V54, P684; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740; You JHS, 2015, HUM VACC IMMUNOTHER, V11, P564, DOI 10.1080/21645515.2015.1011016	27	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0169030	10.1371/journal.pone.0169030	http://dx.doi.org/10.1371/journal.pone.0169030			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006012	gold, Green Published, Green Submitted			2022-12-26	WOS:000392843200127
J	Allport, SA; Kikah, N; Abu Saif, N; Ekokobe, F; Atem, FD				Allport, Shannon Anjelica; Kikah, Ngum; Abu Saif, Nessim; Ekokobe, Fonkem; Atem, Folefac D.			Parental Age of Onset of Cardiovascular Disease as a Predictor for Offspring Age of Onset of Cardiovascular Disease	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; JOINT TASK-FORCE; MYOCARDIAL-INFARCTION; FAMILY-HISTORY; REGRESSION CALIBRATION; LOGISTIC-REGRESSION; RISK-FACTOR; CLINICAL-PRACTICE; ARTERY DISEASE; TRANSMISSION	Objective The risk for cardiovascular disease (CVD) is higher for individuals with a first-degree relative who developed premature CVD (with a threshold at age 55 years for a male or 65 years for a female). However, little is known about the effect that each unit increase or decrease of maternal or paternal age of onset of CVD has on offspring age of onset of CVD. We hypothesized that there is an association between maternal and paternal age of onset of CVD and offspring age of onset of CVD. Methods We used the Framingham Heart Study database and performed conditional imputation for CVD-censored parental age (i.e. parents that didn't experience onset of CVD) and Cox proportional regression analysis, with offspring's age of onset of CVD as the dependent variable and parental age of onset of CVD as the primary predictor. Modifiable risk factors in offspring, such as cigarette smoking, body mass index (BMI), diabetes mellitus, systolic blood pressure (SBP), high-density lipoprotein (HDL) level, and low-density lipoprotein (LDL) level, were controlled for. Separate analyses were performed for the association between maternal age of onset of CVD and offspring age of onset of CVD and the association between paternal age of onset of CVD and offspring age of onset of CVD. Results Parental age of onset of CVD was predictive of offspring age of onset of CVD for maternal age of onset of CVD (P < .0001; N = 1401) and for paternal age of onset of CVD (P = 0.0134; N = 1221). A negative estimate of the coefficient of interest signifies that late onset of cardiovascular events in parents is protective of onset of CVD in offspring. Cigarette smoking and HDL level were important associated confounders. Conclusions Offspring age of onset of cardiovascular disease is significantly associated with both maternal and paternal age of onset CVD. The incorporation of the parameters, maternal or paternal age of onset of CVD, into risk estimate calculators may improve accuracy of identification of high-risk patients in clinical settings.	[Allport, Shannon Anjelica] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Allport, Shannon Anjelica; Kikah, Ngum; Abu Saif, Nessim; Atem, Folefac D.] Univ Texas Hlth Sci Ctr, Sch Publ Hlth, Dallas, TX USA; [Abu Saif, Nessim] Trinity Sch Med, Kingstown, St Vincent; [Ekokobe, Fonkem] Texas A&M Hlth Sci Ctr, Sch Med, Dallas, TX USA	University of Pennsylvania; Pennsylvania Medicine; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Allport, SA (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.; Allport, SA (corresponding author), Univ Texas Hlth Sci Ctr, Sch Publ Hlth, Dallas, TX USA.	sallport@mail.med.upenn.edu		Markus, Shannon/0000-0003-1428-1133				[Anonymous], 2009, TAB NAT HOSP D UNPUB; [Anonymous], 2012, MATT YOUR HEART; Austin PC, 2004, STAT MED, V23, P411, DOI 10.1002/sim.1601; Brindle PM, 2005, BRIT J GEN PRACT, V55, P838; Chow CK, 2011, J AM COLL CARDIOL, V57, P619, DOI 10.1016/j.jacc.2010.07.054; Cipriani V, 2010, EUR J INTERN MED, V21, P511, DOI 10.1016/j.ejim.2010.07.017; Clayton DG, 1992, MODELS ANAL COHORT C, P301; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; COX DR, 1972, J R STAT SOC B, V34, P187; Crouch MA, 2005, PRIMARY CARE, V32, P995, DOI 10.1016/j.pop.2005.09.008; De Backer G, 2003, EUR J CARDIOV PREV R, V10, pS1, DOI 10.1097/01.hjr.0000087913.96265.e2; DONAHUE RP, 1987, LANCET, V1, P821; Dupuy JF, 2009, J STAT PLAN INFER, V139, P317, DOI 10.1016/j.jspi.2008.04.024; Durrington P, 1998, JOINT BRIT RECOMMEND; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Huang SYH, 2005, STAT SINICA, V15, P685; KANNEL W B, 1965, R I Med J, V48, P243; Keil U, 2000, BASIC RES CARDIOL, V95, P52; KEYS A, 1970, CIRCULATION, V41, pI1; Kinra S, 2003, HEART, V89, P834, DOI 10.1136/heart.89.8.834; Leander K, 2001, EPIDEMIOLOGY, V12, P215, DOI 10.1097/00001648-200103000-00014; MANSON JAE, 1990, NEW ENGL J MED, V322, P882, DOI 10.1056/NEJM199003293221303; Michos ED, 2006, ATHEROSCLEROSIS, V184, P201, DOI 10.1016/j.atherosclerosis.2005.04.004; MYERS RH, 1990, AM HEART J, V120, P963, DOI 10.1016/0002-8703(90)90216-K; Nasir K, 2004, CIRCULATION, V110, P2150, DOI 10.1161/01.CIR.0000144464.11080.14; NEATON JD, 1992, ARCH INTERN MED, V152, P56, DOI 10.1001/archinte.152.1.56; Nielsen M, 2013, EUR HEART J, V34, P1198, DOI 10.1093/eurheartj/ehs475; Prabhakaran D, 2012, MT SINAI J MED, V79, P721, DOI 10.1002/msj.21348; PRENTICE RL, 1982, BIOMETRIKA, V69, P331, DOI 10.1093/biomet/69.2.331; Rigobon R, 2009, J BUS ECON STAT, V27, P340, DOI 10.1198/jbes.2009.06119; RIMM EB, 1992, LANCET, V338, P464; ROSNER B, 1990, AM J EPIDEMIOL, V132, P734, DOI 10.1093/oxfordjournals.aje.a115715; Scheuner MT, 2003, GENET MED, V5, P269, DOI 10.1097/01.GIM.0000079364.98247.26; SCHILDKRAUT JM, 1989, AM J CARDIOL, V64, P555, DOI 10.1016/0002-9149(89)90477-3; Seshadri S, 2010, CIRCULATION, V121, P1304, DOI 10.1161/CIRCULATIONAHA.109.854240; Sesso HD, 2001, CIRCULATION, V104, P393, DOI 10.1161/hc2901.093115; Spiegelman D, 2001, STAT MED, V20, P139, DOI 10.1002/1097-0258(20010115)20:1<139::AID-SIM644>3.0.CO;2-K; Stocks NP, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0328-4; Sundquist K, 2006, AM J PREV MED, V30, P480, DOI 10.1016/j.amepre.2006.01.010; Topol EJ, 2006, HUM MOL GENET, V15, pR117, DOI 10.1093/hmg/ddl183; TSIATIS AA, 1995, J AM STAT ASSOC, V90, P27, DOI 10.2307/2291126; Weijmans M, 2015, INT J CARDIOL, V179, P409, DOI 10.1016/j.ijcard.2014.11.017; Weller EA, 2007, J STAT PLAN INFER, V137, P449, DOI 10.1016/j.jspi.2006.01.009; Williams RR, 2001, AM J CARDIOL, V87, P129, DOI 10.1016/S0002-9149(00)01303-5; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wood D, 1998, ATHEROSCLEROSIS, V140, P199, DOI 10.1016/S0021-9150(98)90209-X	46	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0163334	10.1371/journal.pone.0163334	http://dx.doi.org/10.1371/journal.pone.0163334			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002456	Green Published, gold, Green Submitted			2022-12-26	WOS:000392853100001
J	Gomes-Pepe, ES; Sierra, EGM; Pereira, MR; Castellane, TCL; Lemos, EGD				Gomes-Pepe, Elisangela Soares; Machado Sierra, Elwi Guillermo; Pereira, Mariana Rangel; Luque Castellane, Tereza Cristina; de Macedo Lemos, Eliana Gertrudes			Bg10: A Novel Metagenomics Alcohol-Tolerant and Glucose-Stimulated GH1 SS-Glucosidase Suitable for Lactose-Free Milk Preparation	PLOS ONE			English	Article							EXTRACELLULAR BETA-GLUCOSIDASE; BIOCHEMICAL-CHARACTERIZATION; SUBSTRATE-SPECIFICITY; NUCLEOTIDE-SEQUENCE; STREPTOMYCES SP; PURIFICATION; EXPRESSION; GENE; CLONING; CELLULOSE	New SS-glucosidases with product (glucose) or ethanol tolerances are greatly desired to make industrial processes more marketable and efficient. Therefore, this report describes the in silico/vitro characterization of Bg10, a metagenomically derived homodimeric SS-glucosidase that exhibited a V-max of 10.81 +/- 0.43 mu M min(-1), K-cat of 175.1 +/- 6.91 min(-1), and K-m of 0.49 +/- 0.12 mM at a neutral pH and 37 degrees C when pNP-SS-D-glucopyranoside was used as the substrate, and the enzyme retained greater than 80% activity within the respective pH and temperature ranges of 6.5 to 8.0 and 35 to 40 degrees C. The enzyme was stimulated by its product, glucose; consequently, the Bg10 activity against 50 and 100 mM of glucose were increased by 36.8% and 22%, respectively, while half of the activity was retained at 350 mM. Moreover, the Bg10 was able to hydrolyse 55% (milk sample) and 100% (purified sugar) of the lactose at low (6 degrees C) and optimum (37 degrees C) temperatures, respectively, suggesting the possibility of further optimization of the reaction for lactose-free dairy production. In addition, the enzyme was able to fully hydrolyse 40 mM of cellobiose at one hour and was tolerant to ethanol up to concentrations of 500 mM (86% of activity), while a 1 M concentration still resulted in 41% residual activity, which could be interesting for biofuel production.	[Gomes-Pepe, Elisangela Soares; Machado Sierra, Elwi Guillermo; Pereira, Mariana Rangel; Luque Castellane, Tereza Cristina; de Macedo Lemos, Eliana Gertrudes] Sao Paulo State Univ Unesp, Dept Technol, Sch Agr & Vet Sci, Via Acesso Prof Paulo Donato Castellane S-N,Km 5, Jaboticabal, SP, Brazil; [Gomes-Pepe, Elisangela Soares; Machado Sierra, Elwi Guillermo; Pereira, Mariana Rangel; Luque Castellane, Tereza Cristina; de Macedo Lemos, Eliana Gertrudes] UNESP Jaboticabal, Mol Biol Lab, Inst Res Bioenergy IPBEN, Jaboticabal, SP, Brazil; [Gomes-Pepe, Elisangela Soares] UNESP, Agr Microbiol Postgrad Program, Jaboticabal, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista	Lemos, EGD (corresponding author), Sao Paulo State Univ Unesp, Dept Technol, Sch Agr & Vet Sci, Via Acesso Prof Paulo Donato Castellane S-N,Km 5, Jaboticabal, SP, Brazil.; Lemos, EGD (corresponding author), UNESP Jaboticabal, Mol Biol Lab, Inst Res Bioenergy IPBEN, Jaboticabal, SP, Brazil.	egerle@fcav.unesp.br	Gomes-Pepe, Elisângela/C-4003-2013; LEMOS, ELIANA GM/A-3604-2008; Pereira, Mariana/GSE-3546-2022; de Macedo Lemos, Eliana Gertrudes/AAA-4225-2020; machado, elwi G/G-5228-2017	Gomes-Pepe, Elisângela/0000-0003-4401-3869; LEMOS, ELIANA GM/0000-0002-1119-7748; de Macedo Lemos, Eliana Gertrudes/0000-0002-1119-7748; Luque Castellane, Tereza Cristina/0000-0002-7290-5314; Machado Sierra, Elwi Guillermo/0000-0003-3639-1990	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP [ESGP 2011/10981-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, ESGP 2011/10981-3, FAPESP (http://www.fapesp.br/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaro VR, 2013, SCI CHROMATOGR, V5, P137, DOI DOI 10.4322/SC.2013.010; Ahn DH, 1997, BIOTECHNOL LETT, V19, P483, DOI 10.1023/A:1018360530691; Amorim HV, 2011, APPL MICROBIOL BIOT, V91, P1267, DOI 10.1007/s00253-011-3437-6; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baffi MA, 2013, APPL BIOCHEM BIOTECH, V169, P493, DOI 10.1007/s12010-012-9991-2; Baffi MA, 2013, APPL BIOCHEM BIOTECH, V171, P1681, DOI 10.1007/s12010-013-0471-0; Bhiri F, 2008, APPL BIOCHEM BIOTECH, V149, P169, DOI 10.1007/s12010-008-8146-y; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; da Silveira EL, 2006, PESQUI AGROPECU BRAS, V41, P1507, DOI 10.1590/S0100-204X2006001000008; Daroit DJ, 2008, J MICROBIOL BIOTECHN, V18, P933; Dashtban M, 2010, CRIT REV BIOTECHNOL, V30, P302, DOI 10.3109/07388551.2010.490938; de Giuseppe PO, 2014, ACTA CRYSTALLOGR D, V70, P1631, DOI 10.1107/S1399004714006920; During MJ, 1998, NAT MED, V4, P1131, DOI 10.1038/2625; Gao J, 2014, J BACTERIOL, V196, P4103, DOI 10.1128/JB.02194-14; Gomes Elisângela Soares, 2013, Braz. J. Microbiol., V44, P1007, DOI 10.1590/S1517-83822013000400002; Gonzalez-Pombo P, 2014, FOOD CHEM, V143, P185, DOI 10.1016/j.foodchem.2013.07.107; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gu MZ, 2013, APPL BIOCHEM BIOTECH, V170, P1713, DOI 10.1007/s12010-013-0301-4; Guasch A, 1999, ACTA CRYSTALLOGR D, V55, P679, DOI 10.1107/S0907444998013833; Howarth RW, 2009, SCI ANAL IMPLICATION, P9; Jiang CJ, 2009, J MICROBIOL, V47, P542, DOI 10.1007/s12275-009-0024-y; Karnaouri A, 2013, PEERJ, V1, DOI 10.7717/peerj.46; Karnchanatat A, 2007, FEMS MICROBIOL LETT, V270, P162, DOI 10.1111/j.1574-6968.2007.00662.x; KIM HK, 1989, ENZYME MICROB TECH, V11, P313, DOI 10.1016/0141-0229(89)90048-3; Klein-Marcuschamer D, 2012, BIOTECHNOL BIOENG, V109, P1083, DOI 10.1002/bit.24370; Kren V, 2008, FEMS MICROBIOL REV, V32, P858, DOI 10.1111/j.1574-6976.2008.00124.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-3; Li B, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-73; Lorenz P, 2005, NAT REV MICROBIOL, V3, P510, DOI 10.1038/nrmicro1161; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; Marana SR, 2006, IUBMB LIFE, V58, P63, DOI 10.1080/15216540600617156; Mason OU, 2012, ISME J, V6, P1715, DOI 10.1038/ismej.2012.59; Mateus N., 2009, REV REAL ACAD GALEGA, VXXVIII; Miller CS, 2008, BIOINFORMATICS, V24, P1575, DOI 10.1093/bioinformatics/btn248; Nigam PS, 2011, PROG ENERG COMBUST, V37, P52, DOI 10.1016/j.pecs.2010.01.003; Nunoura N, 1997, J FERMENT BIOENG, V83, P309, DOI 10.1016/S0922-338X(97)80134-1; Nunoura N, 1996, BIOSCI BIOTECH BIOCH, V60, P2011, DOI 10.1271/bbb.60.2011; PEREZPONS JA, 1994, EUR J BIOCHEM, V223, P557, DOI 10.1111/j.1432-1033.1994.tb19025.x; Pokusaeva K, 2011, APPL ENVIRON MICROB, V77, P1681, DOI 10.1128/AEM.01786-10; R Core Team, 2021, R LANGUAGE ENV STAT; Riou C, 1998, APPL ENVIRON MICROB, V64, P3607; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Simon C, 2011, APPL ENVIRON MICROB, V77, P1153, DOI 10.1128/AEM.02345-10; Singh D, 2006, GENE, V376, P13, DOI 10.1016/j.gene.2005.12.035; Singh G, 2015, 3 BIOTECH, V6, DOI 10.1007/s13205-015-0328-z; Singhania RR, 2013, BIORESOURCE TECHNOL, V127, P500, DOI 10.1016/j.biortech.2012.09.012; Sleator RD, 2010, ARCH MICROBIOL, V192, P151, DOI 10.1007/s00203-010-0549-9; Smith HE, 2011, BIOTECHNIQUES, V50, P96, DOI 10.2144/000113600; Sonia KG, 2008, WORLD J MICROB BIOT, V24, P599, DOI 10.1007/s11274-007-9512-6; Uchiyama T, 2013, J BIOL CHEM, V288, P18325, DOI 10.1074/jbc.M113.471342; Vallmitjana M, 2001, BIOCHEMISTRY-US, V40, P5975, DOI 10.1021/bi002947j; Wilkins MR, 1999, METH MOL B, V112, P531; Xia Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053779; Yang SQ, 2008, J AGR FOOD CHEM, V56, P602, DOI 10.1021/jf072279+; Yang Y, 2015, MULTIMED TOOLS APPL, P1; Yoon JJ, 2008, J MICROBIOL, V46, P51, DOI 10.1007/s12275-007-0230-4; Zanoelo FF, 2004, FEMS MICROBIOL LETT, V240, P137, DOI 10.1016/j.femsle.2004.09.021; Zhang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082437	60	13	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167932	10.1371/journal.pone.0167932	http://dx.doi.org/10.1371/journal.pone.0167932			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002476	Green Submitted, Green Published, gold			2022-12-26	WOS:000392853100026
J	Marti, HP; Jeffs, A; Scherer, A; Leader, J; Leader, C; Bedford, J; Walker, R				Marti, Hans-Peter; Jeffs, Aaron; Scherer, Andreas; Leader, John; Leader, Catherine; Bedford, Jennifer; Walker, Robert			Renal Fibrosis mRNA Classifier: Validation in Experimental Lithium-Induced Interstitial Fibrosis in the Rat Kidney	PLoS One			English	Article							GROWTH-FACTOR-BETA; ALTERED EXPRESSION; MATRIX METALLOPROTEINASES; THERAPEUTIC TARGETS; INDUCED NDI; CD44; NEPHROPATHY; GENES; CELLS; METZINCINS	Accurate diagnosis of fibrosis is of paramount clinical importance. A human fibrosis classifier based on metzincins and related genes (MARGS) was described previously. In this investigation, expression changes of MARGS genes were explored and evaluated to examine whether the MARGS-based algorithm has any diagnostic value in a rat model of lithium nephropathy. Male Wistar rats (n = 12) were divided into 2 groups (n = 6). One group was given a diet containing lithium (40 mmol/kg food for 7 days, followed by 60mmol/kg food for the rest of the experimental period), while a control group (n = 6) was fed a normal diet. After six months, animals were sacrificed and the renal cortex and medulla of both kidneys removed for analysis. Gene expression changes were analysed using 24 GeneChip Affymetrix Rat Exon 1.0 ST arrays. Statistically relevant genes (p-value<0.05, fold change>1.5, t-test) were further examined. Matrix metalloproteinase-2 (MMP2), CD44, and nephroblastoma overexpressed gene (NOV) were overexpressed in the medulla and cortex of lithium fed rats compared to the control group. TGF beta 2 was overrepresented in the cortex of lithium fed animals 1.5-fold, and 1.3-fold in the medulla of the same animals. In Gene Set Enrichment Analysis (GSEA), both the medulla and cortex of lithium-fed animals showed an enrichment of the MARGS, TGF beta network, and extracellular matrix (ECM) gene sets, while the cortex expression signature was enriched in additional fibrosis-related-genes and the medulla was also enriched in immune response pathways. Importantly, the MARGS-based fibrosis classifier was able to classify all samples correctly. Immunohistochemistry and qPCR confirmed the up-regulation of NOV, CD44, and TGF beta 2. The MARGS classifier represents a cross-organ and cross-species classifier of fibrotic conditions and may help to design a test to diagnose and to monitor fibrosis. The results also provide evidence for a common pathway in the pathogenesis of fibrosis.	[Marti, Hans-Peter] Univ Bergen, Dept Clin Med, Bergen, Norway; [Marti, Hans-Peter] Haukeland Hosp, Bergen, Norway; [Jeffs, Aaron] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Scherer, Andreas] Spheromics Inc, Kontiolahti, Finland; [Leader, John; Leader, Catherine; Bedford, Jennifer; Walker, Robert] Univ Otago, Dept Med, Dunedin, New Zealand	University of Bergen; University of Otago; University of Otago	Walker, R (corresponding author), Univ Otago, Dept Med, Dunedin, New Zealand.	rob.walker@otago.ac.nz	Walker, Robert J/B-1498-2010; Scherer, Andreas/ABD-8660-2020	Walker, Robert J/0000-0003-3366-0956; Scherer, Andreas/0000-0002-4254-7122	Maurice and Phyllis Paykel Trust; Otago Medical Resarch Foundation; Novartis Foundation for Medical-Biological Research	Maurice and Phyllis Paykel Trust; Otago Medical Resarch Foundation; Novartis Foundation for Medical-Biological Research	This study was funded in part from the Maurice and Phyllis Paykel Trust, the Otago Medical Resarch Foundation and Novartis Foundation for Medical-Biological Research. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Benigni A, 2006, NEPHRON EXP NEPHROL, V104, pE158, DOI 10.1159/000094967; Benini S, 2005, ONCOGENE, V24, P4349, DOI 10.1038/sj.onc.1208620; Berthier CC, 2006, KIDNEY INT, V69, P358, DOI 10.1038/sj.ki.5000049; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Bourguignon LYW, 2002, J BIOL CHEM, V277, P39703, DOI 10.1074/jbc.M204320200; Chevalier G, 1998, AM J PATHOL, V152, P1563; Christensen BM, 2006, AM J PHYSIOL-RENAL, V291, pF39, DOI 10.1152/ajprenal.00383.2005; El Chaar M, 2007, AM J PHYSIOL-RENAL, V292, pF1291, DOI 10.1152/ajprenal.00327.2005; Finne K, 2016, NEPHRON, V132, P70, DOI 10.1159/000442825; Florquin S, 2002, AM J KIDNEY DIS, V39, P407, DOI 10.1053/ajkd.2002.30563; Guan QN, 2013, AM J PHYSIOL-RENAL, V305, pF199, DOI 10.1152/ajprenal.00665.2012; Kers J, 2010, TRANSPLANTATION, V90, P502, DOI 10.1097/TP.0b013e3181e86b42; Kirimca F, 2001, SCAND J UROL NEPHROL, V35, P509; Kotnik P, 2005, AM J PHYSIOL-RENAL, V288, pF1053, DOI 10.1152/ajprenal.00114.2004; Kwiatkowska E, 2016, KIDNEY BLOOD PRESS R, V41, P288, DOI 10.1159/000443431; Kwon TH, 2000, AM J PHYSIOL-RENAL, V279, pF552, DOI 10.1152/ajprenal.2000.279.3.F552; Laurent M, 2003, FASEB J, V17, P1919, DOI 10.1096/fj.02-1023fje; Lin CG, 2005, J BIOL CHEM, V280, P8229, DOI 10.1074/jbc.M404903200; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Marti HP, 2014, NEPHROL DIAL TRANSPL, V29, P1177, DOI 10.1093/ndt/gfu027; MARTI HP, 1994, AM J PATHOL, V144, P82; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Negi LM, 2012, J DRUG TARGET, V20, P561, DOI 10.3109/1061186X.2012.702767; Rodrigo E, 2000, NEPHROL DIAL TRANSPL, V15, P2041, DOI 10.1093/ndt/15.12.2041; Rodder S, 2009, AM J TRANSPLANT, V9, P517, DOI 10.1111/j.1600-6143.2008.02512.x; Rodder S, 2011, VIRCHOWS ARCH, V458, P487, DOI 10.1007/s00428-011-1052-7; Rojek A, 2005, AM J PHYSIOL-RENAL, V288, pF1276, DOI 10.1152/ajprenal.00305.2004; Rouschop KMA, 2004, J AM SOC NEPHROL, V15, P674, DOI 10.1097/01.ASN.0000115703.30835.96; RoyChaudhury P, 1996, KIDNEY INT, V50, P272, DOI 10.1038/ki.1996.312; Schnaper HW, 2003, AM J PHYSIOL-RENAL, V284, pF243, DOI 10.1152/ajprenal.00300.2002; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Tzeng HE, 2011, J CELL PHYSIOL, V226, P3181, DOI 10.1002/jcp.22672; Wagrowska-Danilewicz Malgorzata, 2002, Polish Journal of Pathology, V53, P155; Walker RJ, 2013, AM J PHYSIOL-RENAL, V304, pF300, DOI 10.1152/ajprenal.00182.2012; Wanga S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136276; Yanagita M, 2012, NEPHROL DIAL TRANSPL, V27, P3686, DOI 10.1093/ndt/gfs381; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Yeger H, 2007, J CELL COMMUN SIGNAL, V1, P159, DOI 10.1007/s12079-008-0022-6; Yokoi H, 2001, AM J KIDNEY DIS, V38, pS134, DOI 10.1053/ajkd.2001.27422; Yu L, 2003, KIDNEY INT, V64, P844, DOI 10.1046/j.1523-1755.2003.00162.x; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Zeisberg M, 2001, AM J PATHOL, V159, P1313, DOI 10.1016/S0002-9440(10)62518-7	42	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168240	10.1371/journal.pone.0168240	http://dx.doi.org/10.1371/journal.pone.0168240			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002484	gold, Green Published, Green Submitted			2022-12-26	WOS:000392853100036
J	Chang, JC; Federle, MJ				Chang, Jennifer C.; Federle, Michael J.			PptAB Exports Rgg Quorum-Sensing Peptides in Streptococcus	PLOS ONE			English	Article							BACILLUS-SUBTILIS; ABC TRANSPORTER; COMPETENCE; PYOGENES; PHEROMONE; IDENTIFICATION; TRANSFORMATION; EXPRESSION; PROTEINS; PATHWAY	A transposon mutagenesis screen designed to identify mutants that were defective in peptide- pheromone signaling of the Rgg2/Rgg3 pathway in Streptococcus pyogenes generated insertions in sixteen loci displaying diminished reporter activity. Fourteen unique transposon insertions were mapped to pptAB, an ABC-type transporter recently described to export sex pheromones of Enterococcus faecalis. Consistent with an idea that PptAB exports signaling peptides, the pheromones known as SHPs (short hydrophobic peptides) were no longer detected in cell-free culture supernatants in a generated deletion mutant of pptAB. PptAB exporters are conserved among the Firmicutes, but their function and substrates remain unclear. Therefore, we tested a pptAB mutant generated in Streptococcus mutans and found that while secretion of heterologously expressed SHP peptides required PptAB, secretion of the S. mutans endogenous pheromone XIP (sigX inducing peptide) was only partially disrupted, indicating that a secondary secretion pathway for XIP exists.	[Chang, Jennifer C.; Federle, Michael J.] Univ Illinois, Coll Pharm, Ctr Biomol Sci, Dept Med Chem & Pharmacognosy, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Federle, MJ (corresponding author), Univ Illinois, Coll Pharm, Ctr Biomol Sci, Dept Med Chem & Pharmacognosy, Chicago, IL 60607 USA.	mfederle@uic.edu	Federle, Michael J./E-5522-2017	Chang, Jennifer/0000-0002-6175-1284	NIH NIAID [AI091779]; Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Dieseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091779] Funding Source: NIH RePORTER	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Dieseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by grants from the NIH NIAID #AI091779 and the Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Dieseases.	Aggarwal C, 2014, J BIOL CHEM, V289, P22427, DOI 10.1074/jbc.M114.583989; Chang JC, 2015, MOL MICROBIOL, V97, P1097, DOI 10.1111/mmi.13088; Chang JC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002190; Chaussee MS, 1999, INFECT IMMUN, V67, P1715; Cook LC, 2013, MBIO, V4, DOI 10.1128/mBio.00382-13; Degnan BA, 2000, INFECT IMMUN, V68, P2441, DOI 10.1128/IAI.68.5.2441-2448.2000; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; Desai K, 2012, J BACTERIOL, V194, P3774, DOI 10.1128/JB.00337-12; Fontaine L, 2015, INFECT GENET EVOL, V33, P343, DOI 10.1016/j.meegid.2014.09.010; Gardan R, 2013, J BACTERIOL, V195, P1845, DOI 10.1128/JB.02196-12; Guo Q, 2014, J BACTERIOL, V196, P227, DOI 10.1128/JB.00995-13; Hale JDF, 2005, J BACTERIOL, V187, P5036, DOI 10.1128/JB.187.14.5036-5039.2005; Hidalgo-Grass C, 2002, MOL MICROBIOL, V46, P87, DOI 10.1046/j.1365-2958.2002.03127.x; Hollands A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004102; Howell-Adams B, 2000, MOL MICROBIOL, V37, P1146, DOI 10.1046/j.1365-2958.2000.02067.x; Jonsson IM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014209; Khan R, 2012, J BACTERIOL, V194, P3781, DOI 10.1128/JB.00624-12; KONTINEN VP, 1988, J GEN MICROBIOL, V134, P2333; LaSarre B, 2013, J BACTERIOL, V195, P4310, DOI 10.1128/JB.00684-13; Leskela S, 1996, MICROBIOL-SGM, V142, P71, DOI 10.1099/13500872-142-1-71; Leskela S, 1999, MOL MICROBIOL, V31, P533, DOI 10.1046/j.1365-2958.1999.01194.x; Lyon WR, 1998, EMBO J, V17, P6263, DOI 10.1093/emboj/17.21.6263; Marks LR, 2014, J INFECT DIS, V210, P25, DOI 10.1093/infdis/jiu058; Mashburn-Warren L, 2012, J BACTERIOL, V194, P4589, DOI 10.1128/JB.00830-12; Mashburn-Warren L, 2010, MOL MICROBIOL, V78, P589, DOI 10.1111/j.1365-2958.2010.07361.x; McIver KS, 2013, CURR PROTOC MICROBIO, V30; Perez-Pascual D, 2015, MBIO, V6, DOI 10.1128/mBio.02306-14; Shanker E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005979; VANDERIJN I, 1980, INFECT IMMUN, V27, P444, DOI 10.1128/IAI.27.2.444-448.1980; Varahan S, 2014, MBIO, V5, DOI 10.1128/mBio.01726-14; Wenderska IB, 2012, FEMS MICROBIOL LETT, V336, P104, DOI 10.1111/j.1574-6968.2012.02660.x; Wilkening RV, 2016, MOL MICROBIOL, V99, P71, DOI 10.1111/mmi.13216	32	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168461	10.1371/journal.pone.0168461	http://dx.doi.org/10.1371/journal.pone.0168461			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992504	gold, Green Submitted, Green Published			2022-12-26	WOS:000392842600061
J	Gorin, S; Kowialiewski, B; Majerus, S				Gorin, Simon; Kowialiewski, Benjamin; Majerus, Steve			Domain-Generality of Timing-Based Serial Order Processes in Short-Term Memory: New Insights from Musical and Verbal Domains	PLoS One			English	Article							WORKING-MEMORY; IRRELEVANT SPEECH; PHONOLOGICAL SIMILARITY; INDIVIDUAL-DIFFERENCES; SEQUENCE PRODUCTION; TONAL SEQUENCES; PITCH STRUCTURE; NETWORK MODEL; INFORMATION; RECALL	Several models in the verbal domain of short-term memory (STM) consider a dissociation between item and order processing. This view is supported by data demonstrating that different types of time-based interference have a greater effect on memory for the order of to be-remembered items than on memory for the items themselves. The present study investigated the domain-generality of the item versus serial order dissociation by comparing the differential effects of time-based interfering tasks, such as rhythmic interference and articulatory suppression, on item and order processing in verbal and musical STM domains. In Experiment 1, participants had to maintain sequences of verbal or musical information in STM, followed by a probe sequence, this under different conditions of interference (no-interference, rhythmic interference, articulatory suppression). They were required to decide whether all items of the probe list matched those of the memory list (item condition) or whether the order of the items in the probe sequence matched the order in the memory list (order condition). In Experiment 2, participants performed a serial order probe recognition task for verbal and musical sequences ensuring sequential maintenance processes, under no-interference or rhythmic interference conditions. For Experiment 1, serial order recognition was not significantly more impacted by interfering tasks than was item recognition, this for both verbal and musical domains. For Experiment 2, we observed selective interference of the rhythmic interference condition on both musical and verbal order STM tasks. Overall, the results suggest a similar and selective sensitivity to time-based interference for serial order STM in verbal and musical domains, but only when the STM tasks ensure sequential maintenance processes.	[Gorin, Simon; Kowialiewski, Benjamin; Majerus, Steve] Univ Liege, Fac Psychol Speech Therapy & Educ Sci, Psychol & Neurosci Cognit Res Unit PsyNCog, Liege, Belgium; [Gorin, Simon; Kowialiewski, Benjamin; Majerus, Steve] Fund Sci Res FNRS, Brussels, Belgium	University of Liege	Gorin, S (corresponding author), Univ Liege, Fac Psychol Speech Therapy & Educ Sci, Psychol & Neurosci Cognit Res Unit PsyNCog, Liege, Belgium.; Gorin, S (corresponding author), Fund Sci Res FNRS, Brussels, Belgium.	simon.gorin@ulg.ac.be	Kowialiewski, Benjamin/GLS-7853-2022; Gorin, Simon/ABD-9481-2020	Kowialiewski, Benjamin/0000-0002-7743-761X; Gorin, Simon/0000-0001-7462-0446; Majerus, Steve/0000-0002-8206-8097	Fund for Scientific Research-FNRS under a FRESH; Belgian Science Policy Office (BELSPO) [PAI-IUAPP7/11]; University of Liege [ARC12/17/01REST]	Fund for Scientific Research-FNRS under a FRESH(Fonds de la Recherche Scientifique - FNRS); Belgian Science Policy Office (BELSPO)(Belgian Federal Science Policy Office); University of Liege(University of Liege)	This research was supported by the Fund for Scientific Research-FNRS under a FRESH grant to SG (www.frs-fnrs.be); the Belgian Science Policy Office (BELSPO) under a PAI-IUAPP7/11 grant to SM (www.belspo.be); and the University of Liege under a ARC12/17/01REST grant to SM (www.ulg.ac.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamse E, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00932; [Anonymous], 2014, R LANG ENV STAT COMP; Attout L, 2012, APHASIOLOGY, V26, P355, DOI 10.1080/02687038.2011.604303; Banbury SP, 2001, HUM FACTORS, V43, P12, DOI 10.1518/001872001775992462; Beaman CP, 1997, J EXP PSYCHOL LEARN, V23, P459, DOI 10.1037/0278-7393.23.2.459; Beaman CP, 1998, Q J EXP PSYCHOL-A, V51, P615, DOI 10.1080/713755774; Besson M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00094; Blalock LD, 2015, ATTEN PERCEPT PSYCHO, V77, P1143, DOI 10.3758/s13414-014-0823-z; Botvinick M, 2007, J NEUROSCI, V27, P8636, DOI 10.1523/JNEUROSCI.2110-07.2007; Botvinick MM, 2006, PSYCHOL REV, V113, P201, DOI 10.1037/0033-295X.113.2.201; Brown GDA, 2000, PSYCHOL REV, V107, P127, DOI 10.1037/0033-295X.107.1.127; Burgess N, 1999, PSYCHOL REV, V106, P551, DOI 10.1037/0033-295X.106.3.551; Burgess N, 2006, J MEM LANG, V55, P627, DOI 10.1016/j.jml.2006.08.005; Camos V, MEMORY IN PRESS; Campoy G, 2015, Q J EXP PSYCHOL, V68, P759, DOI 10.1080/17470218.2014.966248; Cason N, 2015, NEUROPSYCHOLOGY, V29, P102, DOI 10.1037/neu0000115; Davies J., 1977, PSYCHOL MUSIC, V5, P3, DOI DOI 10.1177/030573567752001; DAVIES JB, 1977, J ACOUST SOC AM, V61, P534, DOI 10.1121/1.381295; DEUTSCH D, 1970, SCIENCE, V168, P1604, DOI 10.1126/science.168.3939.1604; DEUTSCH D, 1980, PERCEPT PSYCHOPHYS, V28, P381, DOI 10.3758/BF03204881; DEWAR KM, 1977, J EXP PSYCHOL-HUM L, V3, P60, DOI 10.1037/0278-7393.3.1.60; Dienes Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00781; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; Farrell S, 2004, J MEM LANG, V51, P115, DOI 10.1016/S0749-596X(04)00029-4; Farrell S, 2002, PSYCHON B REV, V9, P59, DOI 10.3758/BF03196257; Flaugnacco E, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00392; Gordon RL, 2015, DEVELOPMENTAL SCI, V18, P635, DOI 10.1111/desc.12230; Goswami U, 2011, TRENDS COGN SCI, V15, P3, DOI 10.1016/j.tics.2010.10.001; Hartley T, 2016, COGNITIVE PSYCHOL, V87, P135, DOI 10.1016/j.cogpsych.2016.05.001; Hausen M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00566; Henson R, 2003, Q J EXP PSYCHOL-A, V56, P1307, DOI 10.1080/02724980244000747; Henson R.N., 1996, THESIS; Henson RNA, 1998, COGNITIVE PSYCHOL, V36, P73, DOI 10.1006/cogp.1998.0685; Henson RNA, 1999, INT J PSYCHOL, V34, P403, DOI 10.1080/002075999399756; Henson RNA, 2000, NEUROPSYCHOLOGIA, V38, P426, DOI 10.1016/S0028-3932(99)00098-6; Hurlstone MJ, 2014, PSYCHOL BULL, V140, P339, DOI 10.1037/a0034221; Huss M, 2011, CORTEX, V47, P674, DOI 10.1016/j.cortex.2010.07.010; Johnson VE, 2013, P NATL ACAD SCI USA, V110, P19313, DOI 10.1073/pnas.1313476110; JONES DM, 1993, J EXP PSYCHOL LEARN, V19, P369, DOI 10.1037/0278-7393.19.2.369; Kraus N, 2015, TRENDS COGN SCI, V19, P642, DOI 10.1016/j.tics.2015.08.017; Krumhansl C.L., 1990, COGNITIVE FDN MUSICA, P77; Larsen JD, 2003, Q J EXP PSYCHOL-A, V56, P1249, DOI 10.1080/02724980244000765; LEE CL, 1981, J EXP PSYCHOL-HUM L, V7, P149, DOI 10.1037/0278-7393.7.3.149; Macken B, 2014, J EXP PSYCHOL LEARN, V40, P1257, DOI 10.1037/a0036845; MACKEN WJ, 1995, J EXP PSYCHOL LEARN, V21, P436, DOI 10.1037/0278-7393.21.2.436; Majerus S, 2006, NEUROIMAGE, V32, P880, DOI 10.1016/j.neuroimage.2006.03.048; Majerus S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00357; Majerus S, 2009, INTERACTIONS BETWEEN SHORT-TERM AND LONG-TERM MEMORY IN THE VERBAL DOMAIN, P244; Majerus S, 2010, J COGNITIVE NEUROSCI, V22, P2570, DOI 10.1162/jocn.2009.21378; Martin N, 2004, COGN NEUROPSYCHOL, V21, P213, DOI 10.1080/02643290342000447; Mathias B, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01040; Mathot S, 2012, BEHAV RES METHODS, V44, P314, DOI 10.3758/s13428-011-0168-7; Morey RD, 2015, PACKAGE BAYESFACTOR; Mullensiefen D., 2011, MUSIC MIND ESSAYS HO, P161; Nairne JS, 2004, J MEM LANG, V50, P113, DOI 10.1016/j.jml.2003.09.005; Ng HLH, 2002, Q J EXP PSYCHOL-A, V55, P391, DOI 10.1080/02724980143000343; Oberauer K, 2012, PSYCHON B REV, V19, P779, DOI 10.3758/s13423-012-0272-4; Page MPA, 1998, PSYCHOL REV, V105, P761, DOI 10.1037/0033-295X.105.4.761-781; Palmer C, 2003, PSYCHOL REV, V110, P683, DOI 10.1037/0033-295X.110.4.683; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; Patel AD, 2014, HEARING RES, V308, P98, DOI 10.1016/j.heares.2013.08.011; Peretz I, 2003, NAT NEUROSCI, V6, P688, DOI 10.1038/nn1083; Peretz I, 2015, PHILOS T R SOC B, V370, P68, DOI 10.1098/rstb.2014.0090; Pfordresher PQ, 2007, COGNITIVE SCI, V31, P63, DOI 10.1080/03640210709336985; POIRIER M, 1995, Q J EXP PSYCHOL-A, V48, P384, DOI 10.1080/14640749508401396; Poirier M, 1996, CAN J EXP PSYCHOL, V50, P408, DOI 10.1037/1196-1961.50.4.408; Prince JB, 2014, J EXP PSYCHOL HUMAN, V40, P2319, DOI 10.1037/a0038010; Prince JB, 2014, J EXP PSYCHOL HUMAN, V40, P2073, DOI 10.1037/a0037730; Prince JB, 2009, MEM COGNITION, V37, P368, DOI 10.3758/MC.37.3.368; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Rudner M, 2009, SCAND J PSYCHOL, V50, P495, DOI 10.1111/j.1467-9450.2009.00744.x; RYAN J, 1969, Q J EXP PSYCHOL, V21, P137, DOI 10.1080/14640746908400206; Saint-Aubin J, 1999, Q J EXP PSYCHOL-A, V52, P367, DOI 10.1080/027249899391115; Saito S, 2001, MEMORY, V9, P313, DOI 10.1080/09658210143000164; Saito S, 1998, JPN PSYCHOL RES, V40, P10, DOI 10.1111/1468-5884.00070; SAITO S, 1994, MEM COGNITION, V22, P181; Schendel ZA, 2007, MEM COGNITION, V35, P640, DOI 10.3758/BF03193302; Schulze K, 2013, MEMORY, V21, P377, DOI 10.1080/09658211.2012.731070; Schulze K, 2011, HUM BRAIN MAPP, V32, P771, DOI 10.1002/hbm.21060; Siedenburg K, 2016, MEMORY, P1; Strait D, 2011, MUSIC PERCEPT, V29, P133, DOI 10.1525/MP.2011.29.2.133; Surprenant AM, 2008, CAN J EXP PSYCHOL, V62, P141, DOI 10.1037/1196-1961.62.3.141; Tillmann B, 2016, BRAIN RES, V1640, P251, DOI 10.1016/j.brainres.2015.10.035; Tse CS, 2009, MEMORY, V17, P874, DOI 10.1080/09658210903376250; Vousden JI, 2000, COGNITIVE PSYCHOL, V41, P101, DOI 10.1006/cogp.2000.0739; Wagenmakers E.J, 2014, BAYESIAN COGNITIVE M, DOI DOI 10.1017/CBO9781139087759; Wagenmakers E.-J, 2008, BAYESIAN EVALUATION, P181, DOI [10.1007/978-0-387-09612-4_9, DOI 10.1007/978-0-387-09612-4_9, 10.1007/978-0-387-09612-4, DOI 10.1007/978-0-387-09612-4]; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105; Williamson VJ, 2010, PSYCHOL MUSIC, V38, P331, DOI 10.1177/0305735609351918; Williamson VJ, 2010, MEM COGNITION, V38, P163, DOI 10.3758/MC.38.2.163; Zatorre RJ, 2008, PHILOS T R SOC B, V363, P1087, DOI 10.1098/rstb.2007.2161	91	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168699	10.1371/journal.pone.0168699	http://dx.doi.org/10.1371/journal.pone.0168699			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QC	27992565	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842600090
J	Pang, YL; Ali, J; Wang, XQ; Franje, NJ; Revilleza, JE; Xu, JL; Li, ZK				Pang, Yunlong; Ali, Jauhar; Wang, Xiaoqian; Franje, Neil Johann; Revilleza, Jastin Edrian; Xu, Jianlong; Li, Zhikang			Relationship of Rice Grain Amylose, Gelatinization Temperature and Pasting Properties for Breeding Better Eating and Cooking Quality of Rice Varieties	PLOS ONE			English	Article							STARCH PHYSICOCHEMICAL PROPERTIES; NONWAXY RICE; VISCOSITY; TRAITS	A total of 787 non-waxy rice lines-116 hybrids and 671 inbreds-were used to study the apparent amylose content (AAC), gelatinization temperature (GT), and rapid visco analyzer (RVA) pasting viscosity properties of rice starch to understand their importance in breeding better rice varieties. The investigated traits showed a wide range of diversity for both hybrid (HG) and inbred (IG) groups. The combinations of the different categories of AAC and GT were random in HG but were non-random in IG. For inbred lines, the high level of AAC tended to combine with the low level of GT, the intermediate level of AAC tended to have high or intermediate GT, and the low level of AAC tended to have high or low GT. Some stable correlations of the AAC, GT, and RVA properties may be the results derived from the physicochemical relationships among these traits, which rice breeders could utilize for selection in advanced breeding generations. Through cluster analysis, IG and HG were divided into 52 and 31 sub-clusters, respectively. Identifying the cultivars having AAC, GT, and RVA properties similar to that of popular high-quality rice varieties seems to be an interesting strategy and could be directly used for adaptation trials to breed high-quality rice varieties in targeted areas in a more customized manner.	[Pang, Yunlong; Wang, Xiaoqian; Xu, Jianlong; Li, Zhikang] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China; [Pang, Yunlong; Ali, Jauhar; Wang, Xiaoqian; Franje, Neil Johann; Revilleza, Jastin Edrian] Int Rice Res Inst, Manila, Philippines	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; CGIAR; International Rice Research Institute (IRRI)	Ali, J (corresponding author), Int Rice Res Inst, Manila, Philippines.	j.ali@irri.org	Xu, Jianlong/AAI-8310-2020; Ali, Jauhar Ali or A. Jauhar/E-4432-2012	Ali, Jauhar Ali or A. Jauhar/0000-0002-3177-2607	Bill & Melinda Gates Foundation [OPP1130530-1]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This research was supported by grant to ZL on "Green Super Rice project for resource poor rice farmers in Africa and Asia" from Bill & Melinda Gates Foundation (OPP1130530-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AACC International, 1997, APPR METH AN; Allahgholipour M, 2006, PLANT BREEDING, V125, P357, DOI 10.1111/j.1439-0523.2006.01252.x; Bao JS, 2012, CEREAL FOOD WORLD, V57, P148, DOI 10.1094/CFW-57-4-0148; Bao JS, 2006, STARCH-STARKE, V58, P259, DOI 10.1002/star.200500469; Calingacion M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085106; Charrad M, 2014, J STAT SOFTW, V61, P1; Chen MH, 2008, J CEREAL SCI, V48, P781, DOI 10.1016/j.jcs.2008.05.004; Han XZ, 2001, J CEREAL SCI, V34, P279, DOI 10.1006/jcrs.2001.0374; Hossain MS, 2009, SCIENCEASIA, V35, P320, DOI 10.2306/scienceasia1513-1874.2009.35.320; Hsu YC, 2014, MOL BREEDING, V34, P655, DOI 10.1007/s11032-014-0065-8; IRRI, 2013, STANDARD EVALUATION, P46; Jiranuntakul W, 2011, J FOOD ENG, V104, P246, DOI 10.1016/j.jfoodeng.2010.12.016; Jr FEH, 2015, HMISC HARRELL MISCEL; Juliano B.O., 1993, GRAIN QUALITY EVALUA; Juliano BO, 1985, CRITERIA TEST RICE G, P443; Juliano BO, 1972, PHYSICOCHEMICAL PROP, P389; Kong XL, 2015, FOOD CHEM, V172, P433, DOI 10.1016/j.foodchem.2014.09.085; Lestari P, 2009, J AGR FOOD CHEM, V57, P2754, DOI 10.1021/jf803804k; LITTLE RR, 1958, CEREAL CHEM, V35, P111; R Core Team, 2013, R LANG ENV STAT COMP; Sun MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018385; Tan YF, 1999, THEOR APPL GENET, V99, P642, DOI 10.1007/s001220051279; Tian ZX, 2009, P NATL ACAD SCI USA, V106, P21760, DOI 10.1073/pnas.0912396106; Wang LQ, 2007, THEOR APPL GENET, V115, P463, DOI 10.1007/s00122-007-0580-7; Wu DX, 2011, ACTA AGRONOMICA SINI, V27, P165; Xu FF, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0296-3; Xu FF, 2013, J AGR FOOD CHEM, V61, P10110, DOI 10.1021/jf4029688; Yan ChangJie, 2005, Rice Science, V12, P39; Yang F, 2014, MOL BREEDING, V34, P1747, DOI 10.1007/s11032-014-0135-y; Zhou ZK, 2002, INT J FOOD SCI TECH, V37, P849, DOI 10.1046/j.1365-2621.2002.00625.x	30	43	45	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168483	10.1371/journal.pone.0168483	http://dx.doi.org/10.1371/journal.pone.0168483			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992591	gold, Green Published, Green Submitted			2022-12-26	WOS:000392842600067
J	Szekely, A; Kotyuk, E; Bircher, J; Vereczkei, A; Balota, DA; Sasvari-Szekely, M; Ronai, Z				Szekely, Anna; Kotyuk, Eszter; Bircher, Julianna; Vereczkei, Andrea; Balota, David A.; Sasvari-Szekely, Maria; Ronai, Zsolt			Association between Age and the 7 Repeat Allele of the Dopamine D4 Receptor Gene	PLoS One			English	Article							DEFICIT HYPERACTIVITY DISORDER; GENOME-WIDE ASSOCIATION; HUMAN PERSONALITY; 4TH COMPONENT; DRD4 GENE; LONGEVITY; POPULATION; COMPLEMENT; ADHD; POLYMORPHISMS	Longevity is in part (25%) inherited, and genetic studies aim to uncover allelic variants that play an important role in prolonging life span. Results to date confirm only a few gene variants associated with longevity, while others show inconsistent results. However, GWAS studies concentrate on single nucleotide polymorphisms, and there are only a handful of studies investigating variable number of tandem repeat variations related to longevity. Recently, Grady and colleagues (2013) reported a remarkable (66%) accumulation of those carrying the 7 repeat allele of the dopamine D4 receptor gene in a large population of 90109 years old Californian centenarians, as compared to an ancestry-matched young population. In the present study we demonstrate the same association using continuous age groups in an 18-97 years old Caucasian sample (N = 1801, p = 0.007). We found a continuous pattern of increase from 18-75, however frequency of allele 7 carriers decreased in our oldest age groups. Possible role of gene-environment interaction effects driven by historical events are discussed. In accordance with previous findings, we observed association preferentially in females (p = 0.003). Our results underlie the importance of investigating non disease related genetic variants as inherited components of longevity, and confirm, that the 7-repeat allele of the dopamine D4 receptor gene is a longevity enabling genetic factor, accumulating in the elderly female population.	[Szekely, Anna; Kotyuk, Eszter; Bircher, Julianna] Eotvos Lorand Univ, Inst Psychol, Budapest, Hungary; [Kotyuk, Eszter] Hungarian Acad Sci, Postdoctoral Res Program, Budapest, Hungary; [Bircher, Julianna] Eotvos Lorand Univ, Doctoral Sch Psychol, Budapest, Hungary; [Vereczkei, Andrea; Sasvari-Szekely, Maria; Ronai, Zsolt] Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, Budapest, Hungary; [Balota, David A.] Washington Univ, Dept Psychol, St Louis, MO 63130 USA	Eotvos Lorand University; Hungarian Academy of Sciences; Eotvos Lorand University; Semmelweis University; Washington University (WUSTL)	Kotyuk, E (corresponding author), Eotvos Lorand Univ, Inst Psychol, Budapest, Hungary.; Kotyuk, E (corresponding author), Hungarian Acad Sci, Postdoctoral Res Program, Budapest, Hungary.	kotyuk.eszter@ppk.elte.hu	Kotyuk, Eszter/K-3116-2018; Bircher, Julianna/Q-5759-2019	Kotyuk, Eszter/0000-0002-6630-087X; 	Hungarian Scientific Research Fund (OTKA) [K100845]; Molecule Foundation; Hungarian Academy of Sciences	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Molecule Foundation; Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by the Hungarian Scientific Research Fund (OTKA K100845) and we thank support of the Molecule Foundation and the postdoctoral scholarship awarded to Eszter Kotyuk by the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005; [Anonymous], 1991, REGIO KISEBBSEGTUDOM, V2; Arason GJ, 2003, ANN NY ACAD SCI, V1010, P496, DOI 10.1196/annals.1299.091; Beekman M, 2010, P NATL ACAD SCI USA, V107, P18046, DOI 10.1073/pnas.1003540107; Bonferroni C.E, 1936, PUBBL R 1 SUPER SCI, V8, P3; Boor K, 2002, CURR MED CHEM, V9, P793, DOI 10.2174/0929867024606821; Brooks-Wilson AR, 2013, HUM GENET, V132, P1323, DOI 10.1007/s00439-013-1342-z; Chang FM, 1996, HUM GENET, V98, P91, DOI 10.1007/s004390050166; Chen CS, 1999, EVOL HUM BEHAV, V20, P309, DOI 10.1016/S1090-5138(99)00015-X; Ding YC, 2002, P NATL ACAD SCI USA, V99, P309, DOI 10.1073/pnas.012464099; Eaton NR, 2012, J GERONTOL A-BIOL, V67, P480, DOI 10.1093/gerona/gls090; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; Ebstein RP, 2006, MOL PSYCHIATR, V11, P427, DOI 10.1038/sj.mp.4001814; Everitt B.S., 1992, ANAL CONTINGENCY TAB; Ewbank DC, 2004, J GERONTOL A-BIOL, V59, P16; Frank MJ, 2011, NEUROPSYCHOPHARMACOL, V36, P133, DOI 10.1038/npp.2010.96; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Gierman HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112430; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Grady DL, 2013, J NEUROSCI, V33, P286, DOI 10.1523/JNEUROSCI.3515-12.2013; Grady DL, 2003, MOL PSYCHIATR, V8, P536, DOI 10.1038/sj.mp.4001350; Hablicsek L., 2007, STATISZTIKAI SZEMLE, V85, P172; Hardy GH, 1908, SCIENCE, V28, P49, DOI 10.1126/science.28.706.49; Kawas Claudia H., 2006, Current Alzheimer Research, V3, P411, DOI 10.2174/156720506779025233; Kotler M, 1997, MOL PSYCHIATR, V2, P251, DOI 10.1038/sj.mp.4000248; Kotyuk E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080613; KRAMER J, 1991, HUM GENET, V86, P595; Li DW, 2006, HUM MOL GENET, V15, P2276, DOI 10.1093/hmg/ddl152; McGeary J, 2009, PHARMACOL BIOCHEM BE, V93, P222, DOI 10.1016/j.pbb.2009.03.010; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Munafo MR, 2008, BIOL PSYCHIAT, V63, P197, DOI 10.1016/j.biopsych.2007.04.006; Murabito JM, 2012, J GERONTOL A-BIOL, V67, P470, DOI 10.1093/gerona/gls089; Nemoda Z, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-4; Paterson AD, 1999, NEUROPSYCHOPHARMACOL, V21, P3, DOI 10.1016/S0893-133X(98)00115-8; Perls T, 2000, J AM GERIATR SOC, V48, P1483, DOI 10.1111/jgs.2000.48.11.1483; Perls T, 2003, EXP GERONTOL, V38, P725, DOI 10.1016/S0531-5565(03)00098-6; Ronai Z, 2000, ELECTROPHORESIS, V21, P2058, DOI 10.1002/1522-2683(20000601)21:10<2058::AID-ELPS2058>3.0.CO;2-1; Sebastiani P., 2010, SCIENCE, V2010; Sebastiani Paola, 2012, Frontiers in Genetics, V3, P277, DOI 10.3389/fgene.2012.00277; Seeman TE, 2004, SOC SCI MED, V58, P1985, DOI 10.1016/S0277-9536(03)00402-7; Swanson JM, 1998, MOL PSYCHIATR, V3, P38, DOI 10.1038/sj.mp.4000354; Szekely A, 2004, AM J MED GENET B, V126B, P106, DOI 10.1002/ajmg.b.20134; Szekely A, 2011, GENES BRAIN BEHAV, V10, P129, DOI 10.1111/j.1601-183X.2010.00645.x; Szilagyi A, 2008, CYTOGENET GENOME RES, V123, P118, DOI 10.1159/000184699; VANTOL HHM, 1992, NATURE, V358, P149; Varga G, 2012, AM J MED GENET B, V159B, P281, DOI 10.1002/ajmg.b.32025; Yu W, 2008, NAT GENET, V40, P124, DOI 10.1038/ng0208-124	48	4	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0167753	10.1371/journal.pone.0167753	http://dx.doi.org/10.1371/journal.pone.0167753			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992450	Green Published, gold, Green Submitted			2022-12-26	WOS:000392842600022
J	Heslop, R; Bojang, AL; Jarju, S; Mendy, J; Mulwa, S; Secka, O; Mendy, FS; Owolabi, O; Kampmann, B; Sutherland, JS				Heslop, Rhiannon; Bojang, Adama L.; Jarju, Sheikh; Mendy, Joseph; Mulwa, Sarah; Secka, Ousman; Mendy, Francis S.; Owolabi, Olumuyiwa; Kampmann, Beate; Sutherland, Jayne S.			Changes in Host Cytokine Patterns of TB Patients with Different Bacterial Loads Detected Using S-16 rRNA Analysis	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; SPUTUM; BIOMARKERS; RESPONSES; DISEASE	Background Tuberculosis (TB) has overtaken HIV as the biggest infectious disease killer, with the majority of deaths occurring in sub-Saharan Africa. However it is unknown how differences in bacterial load alter host immune profiles in the sputum and blood of TB patients. Methods S-16 ribosomal RNA analysis was used to determine bacterial load in sputum samples obtained from 173 patients with active TB (57 pre-treatment and 116 post-treatment). Host analyte concentrations in sputum and Mycobacterium tuberculosis (Mtb) antigen stimulated whole blood assay supernatants were analysed using multiplex cytokine arrays. Results Multiple logistic regression adjusting for age, sex and HIV status showed highly significant correlation of bacterial load with IL1 beta, IL2, IL1RA, IL4, IL6, IL8, IL9, IL15, IL17, EOTAX, FGF, IFN-gamma, GCSF, MCP1, M1P1 alpha, M1P1 beta, PDGF, TNF alpha, VEGF in sputum. With increasing time on treatment, FGF levels in sputum displayed the most significant inverse correlation with reduction in bacterial load. Conclusions We show that differences in bacterial load correlates with changes in several host biomarkers. These findings have implications for development of tests for TB diagnosis and treatment response.	[Heslop, Rhiannon; Bojang, Adama L.; Jarju, Sheikh; Mendy, Joseph; Mulwa, Sarah; Secka, Ousman; Mendy, Francis S.; Owolabi, Olumuyiwa; Kampmann, Beate; Sutherland, Jayne S.] Med Res Council MRC Unit, Vaccines & Immun Theme, Banjul, Gambia; [Heslop, Rhiannon] Univ Manchester, Manchester, Lancs, England	University of London; London School of Hygiene & Tropical Medicine; University of Manchester	Sutherland, JS (corresponding author), Med Res Council MRC Unit, Vaccines & Immun Theme, Banjul, Gambia.	jsutherland@mrc.gm		Heslop, Rhiannon/0000-0002-4332-4393; Sutherland, Jayne/0000-0002-7083-4997	United Kingdom (UK) Medical Research Council (MRC); UK Department for International Development (DFID) under MRC/DFID; MRC [MC_U190071468, MC_UP_A900_1122] Funding Source: UKRI; Medical Research Council [MC_UP_A900_1122, MC_U190071468] Funding Source: researchfish; National Institute for Health Research [SRF-2009-02-07] Funding Source: researchfish	United Kingdom (UK) Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under MRC/DFID; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was jointly supported by the United Kingdom (UK) Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; El-Sony A, 2002, INT J TUBERC LUNG D, V6, P91; Honeyborne I, 2014, J CLIN MICROBIOL, V52, P3064, DOI 10.1128/JCM.01128-14; Kunnath-Velayudhan S, 2010, P NATL ACAD SCI USA, V107, P14703, DOI 10.1073/pnas.1009080107; Lohmann EM, 2012, INT J TUBERC LUNG D, V16, P1477, DOI 10.5588/ijtld.12.0129; Mihret A, 2013, J INFECTION, V66, P357, DOI 10.1016/j.jinf.2012.11.005; Ota MOC, 2014, EUR RESPIR J, V44, P254, DOI 10.1183/09031936.00209913; Palaci M, 2007, J CLIN MICROBIOL, V45, P4064, DOI 10.1128/JCM.01780-07; Sundaramurthy V, 2007, MICROBES INFECT, V9, P1671, DOI 10.1016/j.micinf.2007.09.007; Sutherland JS, HIGHLY ACCURATE DIAG; Theron G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037436; Tsao TCY, 2000, CHEST, V117, P103, DOI 10.1378/chest.117.1.103; Wallis RS, 2013, LANCET INFECT DIS, V13, P362, DOI 10.1016/S1473-3099(13)70034-3; Young JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011237	14	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168272	10.1371/journal.pone.0168272	http://dx.doi.org/10.1371/journal.pone.0168272			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992487	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000392758000035
J	Xiao, YM; Zhang, XF; Fan, SH; Cui, GH; Shen, ZY				Xiao, Yimin; Zhang, Xiaofei; Fan, Shihao; Cui, Guanghao; Shen, Zhenya			MicroRNA-497 Inhibits Cardiac Hypertrophy by Targeting Sirt4	PLOS ONE			English	Article							HEART-FAILURE; APOPTOSIS; PATHWAY	Cardiac hypertrophy is an adaptive enlargement of the myocardium in response to overload pressure of heart. From abundant studies, a conclusion is drawn that many microRNAs (miRNAs) are associated with cardiac hypertrophy and heart failure. To investigate the role of microRNA-497 (miR-497) in myocardial hypertrophy, two models were established in this study from cell level to integral level. Cardiac hypertrophy was induced by using angiotensin II (Ang II) in vitro and was created by transverse abdominal aortic constriction (TAC) in vivo. There was a significant decrease expression of miR-497 in cardiac hypertrophy models. Moreover, overexpression of miR-497 inhibited myocardial hypertrophy both in vitro and in vivo without heart function variation. In addition, luciferase reporter assays demonstrated that Sirt4 was a direct target gene of miR-497. Taking together, our study indicates that miR-497 modulates cardiac hypertrophy by targeting Sirt4 and may serve as a potential therapeutic substance in the course.	[Xiao, Yimin; Zhang, Xiaofei; Fan, Shihao; Cui, Guanghao; Shen, Zhenya] Soochow Univ, Affiliated Hosp 1, Dept Cardiovasc Surg, Suzhou, Peoples R China; [Xiao, Yimin; Zhang, Xiaofei; Fan, Shihao; Cui, Guanghao; Shen, Zhenya] Soochow Univ, Inst Cardiovasc Sci, Suzhou, Peoples R China; [Xiao, Yimin; Zhang, Xiaofei; Fan, Shihao] Shanghai Yodak Cardiothrac Hosp, Dept Cardiovasc Surg, Shanghai, Peoples R China	Soochow University - China; Soochow University - China	Shen, ZY (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Cardiovasc Surg, Suzhou, Peoples R China.; Shen, ZY (corresponding author), Soochow Univ, Inst Cardiovasc Sci, Suzhou, Peoples R China.	uuzyshen@aliyun.com						Communal C, 1998, CIRCULATION, V98, P1329, DOI 10.1161/01.CIR.98.13.1329; Ge L, 2016, ONCOL LETT, V11, P2207, DOI 10.3892/ol.2016.4162; Greco CM, 2015, NAT REV CARDIOL, V12, P488, DOI 10.1038/nrcardio.2015.71; Kamo T, 2015, CIRC RES, V117, P89, DOI 10.1161/CIRCRESAHA.117.305349; Li XX, 2015, ONCOTARGET, V6, P18829, DOI 10.18632/oncotarget.4774; Liu J, 2016, DNA CELL BIOL; Liu Q, 2016, MOL MED REP, V14, P439, DOI 10.3892/mmr.2016.5256; Luo YX, 2016, EUROPEAN HEART J; Lv DC, 2015, MINI-REV MED CHEM, V15, P475, DOI 10.2174/1389557515666150324124751; Mukku RB, 2016, J CARD FAIL, V22, P439, DOI 10.1016/j.cardfail.2016.04.009; Ono K, 2015, ADV EXP MED BIOL, V888, P197, DOI 10.1007/978-3-319-22671-2_10; POTTER GD, 1989, J PEDIATR GASTR NUTR, V8, P516, DOI 10.1097/00005176-198905000-00016; Raut SK, 2016, MOL CELL BIOCHEM, V417, P191, DOI 10.1007/s11010-016-2729-7; Shimizu I, 2016, J MOL CELLULAR CARDI; Sun XM, 2015, INT J CLIN EXP PATHO, V8, P14500; Tarantino G, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/920676; Tijsen AJ, 2014, CARDIOVASC RES, V104, P61, DOI 10.1093/cvr/cvu184; Vegter EL, 2016, EUR J HEART FAIL, V18, P457, DOI 10.1002/ejhf.495; Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003; Yang L, 2016, J BIOL CHEM; Zhu YM, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-15	21	35	39	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168078	10.1371/journal.pone.0168078	http://dx.doi.org/10.1371/journal.pone.0168078			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992564	Green Submitted, Green Published, gold			2022-12-26	WOS:000392758000025
J	Siritongsuk, P; Hongsing, N; Thammawithan, S; Daduang, S; Klaynongsruang, S; Tuanyok, A; Patramanon, R				Siritongsuk, Pawinee; Hongsing, Nuttaya; Thammawithan, Saengrawee; Daduang, Sakda; Klaynongsruang, Sompong; Tuanyok, Apichai; Patramanon, Rina			Two-Phase Bactericidal Mechanism of Silver Nanoparticles against Burkholderia pseudomallei	PLOS ONE			English	Article							ESCHERICHIA-COLI; ANTIBACTERIAL ACTIVITY; BIOFILM FORMATION; WOUND DRESSINGS; MELIOIDOSIS; SUSCEPTIBILITY; RESISTANCE; RELEASE; NANOMATERIALS; VIABILITY	Silver nanoparticles (AgNPs) have a strong antimicrobial activity against a variety of pathogenic bacteria. The killing mechanism of AgNPs involves direct physical membrane destruction and subsequent molecular damage from both AgNPs and released Ag+. Burkholderia pseudomallei is the causative agent of melioidosis, an endemic infectious disease primarily found in northern Australia and Southeast Asia. B. pseudomallei is intrinsically resistant to most common antibiotics. In this study, the antimicrobial activity and mechanism of AgNPs (10-20 nm) against B. pseudomallei were investigated. The MIC and MBC for nine B. pseudomallei strains ranged from 32-48 mu g/mL and 96-128 mu g/mL, respectively. Concentrations of AgNPs less than 256 mu g/mL were not toxic to human red blood cells. AgNPs exhibited a two-phase mechanism: cell death induction and ROS induction. The first phase was a rapid killing step within 5 min, causing the direct damage of the cytoplasmic membrane of the bacterial cells, as observed by a time-kill assay and fluorescence microscopy. During the period of 5-30 min, the cell surface charge was rapidly neutralized from -8.73 and -7.74 to 2.85 and 2.94 mV in two isolates of B. pseudomallei, as revealed by zeta potential measurement. Energy-dispersive X-ray (EDX) spectroscopy showed the silver element deposited on the bacterial membrane, and TEM micrographs of the AgNP-treated B. pseudomallei cells showed severe membrane damage and cytosolic leakage at 1/5 MIC and cell bursting at MBC. During the killing effect the released Ag+ from AgNPs was only 3.9% from the starting AgNPs concentration as observed with ICP-OES experiment. In the second phase, the ROS induction occurred 1-4 hr after the AgNP treatment. Altogether, we provide direct kinetic evidence of the AgNPs killing mechanism, by which cell death is separable from the ROS induction and AgNPs mainly contributes in the killing action. AgNPs may be considered a potential candidate to develop a novel alternative agent for melioidosis treatment with fast action.	[Siritongsuk, Pawinee; Hongsing, Nuttaya; Thammawithan, Saengrawee; Klaynongsruang, Sompong; Patramanon, Rina] Khon Kaen Univ, Dept Biochem, Fac Sci, Khon Kaen, Thailand; [Siritongsuk, Pawinee; Hongsing, Nuttaya; Daduang, Sakda; Klaynongsruang, Sompong; Patramanon, Rina] Khon Kaen Univ, Prot & Prote Res Ctr Commercial & Ind Purposes, Khon Kaen, Thailand; [Daduang, Sakda] Khon Kaen Univ, Fac Pharmaceut Sci, Khon Kaen, Thailand; [Tuanyok, Apichai] Univ Florida, Coll Vet Med, Gainesville, FL USA; [Tuanyok, Apichai] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA	Khon Kaen University; Khon Kaen University; Khon Kaen University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Patramanon, R (corresponding author), Khon Kaen Univ, Dept Biochem, Fac Sci, Khon Kaen, Thailand.; Patramanon, R (corresponding author), Khon Kaen Univ, Prot & Prote Res Ctr Commercial & Ind Purposes, Khon Kaen, Thailand.	narin@kku.ac.th	Daduang, Sakda/L-5446-2019	Klaynongsruang, Sompong/0000-0003-2872-1291	Protein and Proteomics Research Center for Commercial and Industrial Purposes, Khon Kaen University; Research and Researchers for Industries (RRi) Grant, Thailand Research Fund	Protein and Proteomics Research Center for Commercial and Industrial Purposes, Khon Kaen University; Research and Researchers for Industries (RRi) Grant, Thailand Research Fund	This work was supported by scholarship from the Protein and Proteomics Research Center for Commercial and Industrial Purposes, Khon Kaen University and Research and Researchers for Industries (RRi) Grant, Thailand Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves CS, 2010, J BIOL CHEM, V285, P27536, DOI 10.1074/jbc.M110.130955; Anjum S, 2016, INT J NANOMED, V11, P1663, DOI 10.2147/IJN.S105532; Anutrakunchai C, 2015, TROP BIOMED, V32, P300; Cao HL, 2010, WIRES NANOMED NANOBI, V2, P670, DOI 10.1002/wnan.113; Chaloupka K, 2010, TRENDS BIOTECHNOL, V28, P580, DOI 10.1016/j.tibtech.2010.07.006; Cho KH, 2005, ELECTROCHIM ACTA, V51, P956, DOI 10.1016/j.electacta.2005.04.071; Crowe A, 2014, INT J ANTIMICROB AG, V44, P160, DOI 10.1016/j.ijantimicag.2014.04.012; Currie BJ, 2000, CLIN INFECT DIS, V31, P981, DOI 10.1086/318116; DeShazer D, 2004, J BACTERIOL, V186, P3938, DOI 10.1128/JB.186.12.3938-3950.2004; Dobias J, 2013, ENVIRON SCI TECHNOL, V47, P4140, DOI 10.1021/es304023p; Durairaj R, 2012, WORLD ACAD SCI ENG T, P210, DOI [10.12659/MSMBR.883835, DOI 10.12659/MSMBR.883835]; Dwyer DJ, 2012, MOL CELL, V46, P561, DOI 10.1016/j.molcel.2012.04.027; Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3; Gottschalk F, 2010, ENVIRON TOXICOL CHEM, V29, P1036, DOI 10.1002/etc.135; Grigor'eva A, 2013, BIOMETALS, V26, P479, DOI 10.1007/s10534-013-9633-3; Gupta A, 1998, NAT BIOTECHNOL, V16, P888, DOI 10.1038/nbt1098-888; Guzman M, 2012, NANOMED-NANOTECHNOL, V8, P37, DOI 10.1016/j.nano.2011.05.007; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Isshiki Y, 1998, CARBOHYD RES, V313, P21, DOI 10.1016/S0008-6215(98)00179-7; Kager LM, 2014, EXPERT REV ANTI-INFE, V12, P993, DOI 10.1586/14787210.2014.928198; Kalishwaralal K, 2010, COLLOID SURFACE B, V79, P340, DOI 10.1016/j.colsurfb.2010.04.014; Kanthawong S, 2012, INT J ANTIMICROB AG, V39, P39, DOI 10.1016/j.ijantimicag.2011.09.010; Kanthawong S, 2009, INT J ANTIMICROB AG, V34, P309, DOI 10.1016/j.ijantimicag.2009.05.012; Karlsson HL, 2013, TOXICOLOGY, V313, P59, DOI 10.1016/j.tox.2013.07.012; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Kostenko V, 2010, ANTIMICROB AGENTS CH, V54, P5120, DOI 10.1128/AAC.00825-10; Lara HH, 2010, WORLD J MICROB BIOT, V26, P615, DOI 10.1007/s11274-009-0211-3; LEELARASAMEE A, 1989, REV INFECT DIS, V11, P413; Li QL, 2008, WATER RES, V42, P4591, DOI 10.1016/j.watres.2008.08.015; Li WR, 2010, APPL MICROBIOL BIOT, V85, P1115, DOI 10.1007/s00253-009-2159-5; Li XZ, 1997, J BACTERIOL, V179, P6127, DOI 10.1128/JB.179.19.6127-6132.1997; Limmathurotsakul D, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.8, 10.1038/nmicrobiol.2015.8]; Lok CN, 2006, J PROTEOME RES, V5, P916, DOI 10.1021/pr0504079; Madhongsa K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002267; Maillard JY, 2013, CRIT REV MICROBIOL, V39, P373, DOI 10.3109/1040841X.2012.713323; Marcato PD, 2008, J NANOSCI NANOTECHNO, V8, P2216, DOI 10.1166/jnn.2008.274; Mei L, 2013, BIOMATERIALS, V34, P10328, DOI 10.1016/j.biomaterials.2013.09.045; Mirzajani F, 2011, RES MICROBIOL, V162, P542, DOI 10.1016/j.resmic.2011.04.009; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Novem V, 2009, CLIN VACCINE IMMUNOL, V16, P1420, DOI 10.1128/CVI.00472-08; Peacock SJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001488; Percival Steven L, 2007, Int Wound J, V4, P186, DOI 10.1111/j.1742-481X.2007.00296.x; Prabhu S, 2012, INT NANO LETT, V2, DOI 10.1186/2228-5326-2-32; Rai MK, 2012, J APPL MICROBIOL, V112, P841, DOI 10.1111/j.1365-2672.2012.05253.x; Reidy B, 2013, MATERIALS, V6, P2295, DOI 10.3390/ma6062295; Sarovich Derek S, 2012, Infect Drug Resist, V5, P129, DOI 10.2147/IDR.S35529; Schweizer HP, 2012, FUTURE MICROBIOL, V7, P1389, DOI [10.2217/fmb.12.116, 10.2217/FMB.12.116]; Silipo A, 2005, GLYCOBIOLOGY, V15, P561, DOI 10.1093/glycob/cwi029; Silva RD, 2005, MOL MICROBIOL, V58, P824, DOI 10.1111/j.1365-2958.2005.04868.x; Silver S, 2006, J IND MICROBIOL BIOT, V33, P627, DOI 10.1007/s10295-006-0139-7; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Thomas R, 2014, BRAZ J MICROBIOL, V45, P1221, DOI 10.1590/S1517-83822014000400012; Thomas V, 2007, J COLLOID INTERF SCI, V315, P389, DOI 10.1016/j.jcis.2007.06.068; Tiede K, 2008, FOOD ADDIT CONTAM A, V25, P795, DOI 10.1080/02652030802007553; Tunpiboonsak S, 2010, J MICROBIOL, V48, P63, DOI 10.1007/s12275-010-9138-5; Wong KKY, 2010, MEDCHEMCOMM, V1, P125, DOI 10.1039/c0md00069h; Xiu ZM, 2012, NANO LETT, V12, P4271, DOI 10.1021/nl301934w; Xu HY, 2012, BIOMETALS, V25, P45, DOI 10.1007/s10534-011-9482-x; You CG, 2012, MOL BIOL REP, V39, P9193, DOI 10.1007/s11033-012-1792-8; Zhao GJ, 1998, BIOMETALS, V11, P27, DOI 10.1023/A:1009253223055	60	41	41	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168098	10.1371/journal.pone.0168098	http://dx.doi.org/10.1371/journal.pone.0168098			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977746	Green Submitted, Green Published, gold			2022-12-26	WOS:000391217400060
J	Slaker, M; Barnes, J; Sorg, BA; Grimm, JW				Slaker, Megan; Barnes, Jesse; Sorg, Barbara A.; Grimm, Jeffrey W.			Impact of Environmental Enrichment on Perineuronal Nets in the Prefrontal Cortex following Early and Late Abstinence from Sucrose Self-Administration in Rats	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; INDUCED REINSTATEMENT; SEEKING BEHAVIOR; DRUG-ADDICTION; VISUAL-CORTEX; COCAINE; PLASTICITY; AMPHETAMINE; PARVALBUMIN; BRAIN	Perineuronal nets (PNNs) are aggregates of extracellular matrix that form structures surrounding a subset of GABAergic interneurons. The staining intensity of PNNs appears to be related to plasticity. Environmental enrichment (EE) influences plasticity during adulthood: EE decreases the rewarding effects of drugs of abuse and diminishes both drug- and sucrose-seeking behavior. We determined the impact of EE on PNN intensity in the medial prefrontal cortex (mPFC) in rats trained to self-administer sucrose. We examined the number and intensity of PNNs within the prelimbic (PL), infralimbic (IL), and orbitofrontal (OF) regions of the mPFC of adult Long-Evans rats that were trained for sucrose self-administration followed by acute or chronic EE during abstinence and a cue-induced reinstatement test. Rats exposed to EE prior to a cue-induced reinstatement of sucrose seeking had an increase in PNN staining compared with rats in standard housing. Conversely, naive rats given 1 day of EE had a decrease in PNN intensity in the PL, no change in the IL, and an increase in the OF. Our findings demonstrate that EE increases PNN intensity in the mPFC after sucrose training, suggesting that training enhances the ability of EE to increase PNN intensity. We further demonstrate an interaction between time of abstinence, duration of EE exposure, and cue-induced reinstatement. Our results suggest that increased PNN intensity after EE may alter the excitatory/inhibitory balance of mPFC neurons such that rats are less responsive to a sucrose cue.	[Slaker, Megan; Sorg, Barbara A.] Washington State Univ, Dept Integrat Physiol & Neurosci, Vancouver, WA 98686 USA; [Slaker, Megan; Sorg, Barbara A.] Washington State Univ, Translat Addict Res Ctr, Vancouver, WA 98686 USA; [Barnes, Jesse] Washington State Univ, Dept Integrat Physiol & Neurosci, Pullman, WA 99164 USA; [Barnes, Jesse; Grimm, Jeffrey W.] Western Washington Univ, Dept Psychol, Bellingham, WA 98225 USA; [Barnes, Jesse; Grimm, Jeffrey W.] Western Washington Univ, Behav Neurosci Program, Bellingham, WA 98225 USA	Washington State University; Washington State University; Washington State University; Western Washington University; Western Washington University	Sorg, BA (corresponding author), Washington State Univ, Dept Integrat Physiol & Neurosci, Vancouver, WA 98686 USA.; Sorg, BA (corresponding author), Washington State Univ, Translat Addict Res Ctr, Vancouver, WA 98686 USA.	sorg@vetmed.wsu.edu		Sorg, Barbara/0000-0002-4913-4910; Slaker, Megan/0000-0003-1757-5321	NIH [DA033404, DA016285]; NATIONAL INSTITUTE ON DRUG ABUSE [R15DA016285, R01DA033404] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by NIH Grant DA033404 (BAS) and NIH Grant DA016285 (JWG). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER BK, 1978, PSYCHOPHARMACOLOGY, V58, P175, DOI 10.1007/BF00426903; Balmer TS, 2009, J NEUROSCI, V29, P12878, DOI 10.1523/JNEUROSCI.2974-09.2009; Bardo MT, 2001, PSYCHOPHARMACOLOGY, V155, P278; BOWLING SL, 1993, NEUROPHARMACOLOGY, V32, P885, DOI 10.1016/0028-3908(93)90144-R; BRUCKNER G, 1994, BRAIN RES, V658, P67; BRUCKNER G, 1993, GLIA, V8, P183, DOI 10.1002/glia.440080306; Cass DK, 2013, BIOL PSYCHIAT, V74, P490, DOI 10.1016/j.biopsych.2013.02.021; Chauvet C, 2011, NEUROSCIENCE, V184, P88, DOI 10.1016/j.neuroscience.2011.03.068; Chauvet C, 2009, NEUROPSYCHOPHARMACOL, V34, P2767, DOI 10.1038/npp.2009.127; Donato F, 2013, NATURE, V504, P272, DOI 10.1038/nature12866; Foscarin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016666; Green TA, 2002, PSYCHOPHARMACOLOGY, V162, P373, DOI 10.1007/s00213-002-1134-y; Grimm JW, 2008, BEHAV PHARMACOL, V19, P777, DOI 10.1097/FBP.0b013e32831c3b18; Grimm JW, 2016, BRAIN STRUCT FUNCT, V221, P2817, DOI 10.1007/s00429-015-1074-z; Grimm JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054164; LALUMIERE RT, 2012, THE EUROPEAN JOURNAL, V35, P614, DOI DOI 10.1111/J.1460-9568.2012.07991.X; Madinier A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093121; McFarland K, 2003, J NEUROSCI, V23, P3531; Orsini CA, 2015, NEUROSCI BIOBEHAV R, V58, P147, DOI 10.1016/j.neubiorev.2015.04.009; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Scali M, 2012, EXP GERONTOL, V47, P337, DOI 10.1016/j.exger.2012.01.007; Schoenbaum G, 2006, TRENDS NEUROSCI, V29, P116, DOI 10.1016/j.tins.2005.12.006; Slaker M, 2015, J NEUROSCI, V35, P4190, DOI 10.1523/JNEUROSCI.3592-14.2015; Slaker ML, 2016, IBRO REP, V1, P54, DOI 10.1016/j.ibror.2016.10.001; Smith ACW, 2015, BRAIN RES, V1628, P29, DOI 10.1016/j.brainres.2015.03.027; Solbakk AK, 2014, SCAND J PSYCHOL, V55, P233, DOI 10.1111/sjop.12106; Solinas M, 2009, NEUROPSYCHOPHARMACOL, V34, P1102, DOI 10.1038/npp.2008.51; Solinas M, 2008, P NATL ACAD SCI USA, V105, P17145, DOI 10.1073/pnas.0806889105; Thiel KJ, 2011, PHARMACOL BIOCHEM BE, V97, P595, DOI 10.1016/j.pbb.2010.09.014; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Wislowska-Stanek A, 2013, BEHAV BRAIN RES, V253, P337, DOI 10.1016/j.bbr.2013.07.042; Xue YX, 2014, J NEUROSCI, V34, P6647, DOI 10.1523/JNEUROSCI.5390-13.2014; Yamada J, 2014, EUROPEAN J NEUROSCIE; Zanca RM, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00303	36	38	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168256	10.1371/journal.pone.0168256	http://dx.doi.org/10.1371/journal.pone.0168256			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977779	gold, Green Submitted, Green Published			2022-12-26	WOS:000391217400083
J	Mateo, F; Arenas, EJ; Aguilar, H; Serra-Musach, J; de Garibay, GR; Boni, J; Maicas, M; Du, S; Iorio, F; Herranz-Ors, C; Islam, A; Prado, X; Llorente, A; Petit, A; Vidal, A; Catala, I; Soler, T; Venturas, G; Rojo-Sebastian, A; Serra, H; Cuadras, D; Blanco, I; Lozano, J; Canals, F; Sieuwerts, AM; de Weerd, V; Look, MP; Puertas, S; Garcia, N; Perkins, AS; Bonifaci, N; Skowron, M; Gomez-Baldo, L; Hernandez, V; Martinez-Aranda, A; Martinez-Iniesta, M; Serrat, X; Ceron, J; Brunet, J; Barretina, MP; Gil, M; Falo, C; Fernandez, A; Morilla, I; Pernas, S; Pla, MJ; Andreu, X; Segui, MA; Ballester, R; Castella, E; Nellist, M; Morales, S; Valls, J; Velasco, A; Matias-Guiu, X; Figueras, A; Sanchez-Mut, JV; Sanchez-Cespedes, M; Cordero, A; Gomez-Miragaya, J; Palomero, L; Gomez, A; Gajewski, TF; Cohen, EEW; Jesiotr, M; Bodnar, L; Quintela-Fandino, M; Lopez-Bigas, N; Valdes-Mas, R; Puente, XS; Vinals, F; Casanovas, O; Graupera, M; Hernandez-Losa, J; Cajal, SRY; Garcia-Alonso, L; Saez-Rodriguez, J; Esteller, M; Sierra, A; Martin-Martin, N; Matheu, A; Carracedo, A; Gonzalez-Suarez, E; Nanjundan, M; Cortes, J; Lazaro, C; Odero, MD; Martens, JWM; Moreno-Bueno, G; Barcellos-Hoff, MH; Villanueva, A; Gomis, RR; Pujana, MA				Mateo, F.; Arenas, E. J.; Aguilar, H.; Serra-Musach, J.; de Garibay, G. Ruiz; Boni, J.; Maicas, M.; Du, S.; Iorio, F.; Herranz-Ors, C.; Islam, A.; Prado, X.; Llorente, A.; Petit, A.; Vidal, A.; Catala, I.; Soler, T.; Venturas, G.; Rojo-Sebastian, A.; Serra, H.; Cuadras, D.; Blanco, I.; Lozano, J.; Canals, F.; Sieuwerts, A. M.; de Weerd, V.; Look, M. P.; Puertas, S.; Garcia, N.; Perkins, A. S.; Bonifaci, N.; Skowron, M.; Gomez-Baldo, L.; Hernandez, V.; Martinez-Aranda, A.; Martinez-Iniesta, M.; Serrat, X.; Ceron, J.; Brunet, J.; Barretina, M. P.; Gil, M.; Falo, C.; Fernandez, A.; Morilla, I.; Pernas, S.; Pla, M. J.; Andreu, X.; Segui, M. A.; Ballester, R.; Castella, E.; Nellist, M.; Morales, S.; Valls, J.; Velasco, A.; Matias-Guiu, X.; Figueras, A.; Sanchez-Mut, J. V.; Sanchez-Cespedes, M.; Cordero, A.; Gomez-Miragaya, J.; Palomero, L.; Gomez, A.; Gajewski, T. F.; Cohen, E. E. W.; Jesiotr, M.; Bodnar, L.; Quintela-Fandino, M.; Lopez-Bigas, N.; Valdes-Mas, R.; Puente, X. S.; Vinals, F.; Casanovas, O.; Graupera, M.; Hernandez-Losa, J.; Ramon y Cajal, S.; Garcia-Alonso, L.; Saez-Rodriguez, J.; Esteller, M.; Sierra, A.; Martin-Martin, N.; Matheu, A.; Carracedo, A.; Gonzalez-Suarez, E.; Nanjundan, M.; Cortes, J.; Lazaro, C.; Odero, M. D.; Martens, J. W. M.; Moreno-Bueno, G.; Barcellos-Hoff, M. H.; Villanueva, A.; Gomis, R. R.; Pujana, M. A.			Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition	ONCOGENE			English	Article							BREAST-CANCER; MAMMARY STEM; MESENCHYMAL TRANSITION; EMBRYONIC STEM; SELF-RENEWAL; EXPRESSION; GENES; PATHWAY; TARGET; MOUSE	Inhibitors of the mechanistic target of rapamycin (mTOR) are currently used to treat advanced metastatic breast cancer. However, whether an aggressive phenotype is sustained through adaptation or resistance to mTOR inhibition remains unknown. Here, complementary studies in human tumors, cancer models and cell lines reveal transcriptional reprogramming that supports metastasis in response to mTOR inhibition. This cancer feature is driven by EVI1 and SOX9. EVI1 functionally cooperates with and positively regulates SOX9, and promotes the transcriptional upregulation of key mTOR pathway components (REHB and RAPTOR) and of lung metastasis mediators (FSCN1 and SPARC). The expression of EVI1 and SOX9 is associated with stem cell-like and metastasis signatures, and their depletion impairs the metastatic potential of breast cancer cells. These results establish the mechanistic link between resistance to mTOR inhibition and cancer metastatic potential, thus enhancing our understanding of mTOR targeting failure.	[Mateo, F.; Aguilar, H.; Serra-Musach, J.; de Garibay, G. Ruiz; Boni, J.; Herranz-Ors, C.; Prado, X.; Llorente, A.; Garcia, N.; Bonifaci, N.; Skowron, M.; Gomez-Baldo, L.; Palomero, L.; Pujana, M. A.] Bellvitge Inst Biomed Res IDIBELL, Catalan Inst Oncol ICO, Breast Canc & Syst Biol Lab, Program Canc Therapeut Resistance ProCURE, Barcelona, Spain; [Arenas, E. J.; Gomis, R. R.] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Oncol Program, Baldiri Reixac 10, Barcelona 08028, Spain; [Maicas, M.; Odero, M. D.] Univ Navarra, Ctr Appl Med Res CIMA, Pamplona, Spain; [Maicas, M.; Odero, M. D.] Univ Navarra, Dept Biochem & Genet, Pamplona, Spain; [Du, S.; Barcellos-Hoff, M. H.] NYU, Sch Med, Dept Radiat Oncol, New York, NY 10003 USA; [Iorio, F.; Garcia-Alonso, L.; Saez-Rodriguez, J.] European Bioinformat Inst, European Mol Biol Lab, Wellcome Trust Genome Campus, Cambridge, England; [Iorio, F.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, England; [Islam, A.] Univ Dhaka, Dept Genet Engn & Biotechnol, Dhaka, Bangladesh; [Petit, A.; Vidal, A.; Catala, I.; Soler, T.; Venturas, G.] Univ Hosp Bellvitge, IDIBELL, Dept Pathol, Barcelona, Spain; [Rojo-Sebastian, A.] MD Anderson Canc Ctr, Dept Pathol, Madrid, Spain; [Serra, H.; Figueras, A.; Vinals, F.] ICO, Angiogenesis Res Grp, ProCURE, IDIBELL, Barcelona, Spain; [Cuadras, D.] IDIBELL, Stat Unit, Barcelona, Spain; [Blanco, I.; Lazaro, C.] IDIBELL, ICO, Hereditary Canc Programme, Barcelona, Spain; [Lozano, J.] Univ Malaga, Dept Mol Biol & Biochem, Malaga, Spain; [Lozano, J.] Univ Hosp Virgen de la Victoria, Mediterranean Inst Adv Biotechnol & Hlth Res IBIM, Mol Oncol Lab, Malaga, Spain; [Canals, F.] Vall Hebron Univ, Vall Hebron Inst Oncol, ProteoRed Inst Salud Carlos 3, Prote Lab, Barcelona, Spain; [Sieuwerts, A. M.; de Weerd, V.; Look, M. P.; Martens, J. W. M.] Erasmus Univ, Med Ctr, Daniel den Hoed Canc Ctr, Canc Genom Ctr,Dept Med Oncol, Rotterdam, Netherlands; [Puertas, S.; Martinez-Iniesta, M.; Villanueva, A.] IDIBELL, ICO, Chemoresistance & Predict Factors Lab, ProCURE, Barcelona, Spain; [Perkins, A. S.] Univ Rochester, Med Ctr, Sch Med & Dent, Rochester, NY USA; [Hernandez, V.; Martinez-Aranda, A.] IDIBELL, Biol Clues Invas & Metastat Phenotype Lab, Barcelona, Spain; [Serrat, X.; Ceron, J.] IDIBELL, Canc & Human Mol Genet, Barcelona, Spain; [Brunet, J.] Girona Biomed Res Inst IDIBGI, ICO, Hereditary Canc Programme, Girona, Spain; [Barretina, M. P.] IDIBGI, ICO, Dept Med Oncol, Girona, Spain; [Gil, M.; Falo, C.; Fernandez, A.; Morilla, I.; Pernas, S.] IDIBELL, ICO, Dept Med Oncol, Barcelona, Spain; [Pla, M. J.] Univ Hosp Bellvitge, IDIBELL, Dept Gynecol, Barcelona, Spain; [Andreu, X.] Parc Tauli Hosp Consortium, Dept Pathol, Barcelona, Spain; [Segui, M. A.] Parc Tauli Hosp Consortium, Med Oncol Serv, Barcelona, Spain; [Ballester, R.] Univ Hosp Germans Trias & Pujol, Germans Trias & Pujol Res Inst IGTP, ICO, Dept Radiat Oncol, Barcelona, Spain; [Castella, E.] Univ Hosp Germans Trias & Pujol, IGTP, ICO, Dept Pathol, Barcelona, Spain; [Nellist, M.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Valls, J.; Velasco, A.; Matias-Guiu, X.] Univ Lleida, Hosp Arnau de Vilanova, Biomed Res Inst Lleida IRB Lleida, Lleida, Spain; [Sanchez-Mut, J. V.; Sanchez-Cespedes, M.; Cordero, A.; Gomez-Miragaya, J.] IDIBELL, Canc Epigenet & Biol Program PEBC, Barcelona, Spain; [Gajewski, T. F.] Univ Chicago, Dept Pathol, Chicago, IL 60611 USA; [Gajewski, T. F.] Univ Chicago, Dept Med, Chicago, IL USA; [Cohen, E. E. W.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92037 USA; [Jesiotr, M.] Mil Inst Med, Dept Pathol, Warsaw, Poland; [Bodnar, L.] Mil Inst Med, Dept Oncol, Warsaw, Poland; [Quintela-Fandino, M.] Spanish Natl Canc Res Ctr CNIO, Breast Canc Clin Res Unit, Madrid, Spain; [Lopez-Bigas, N.] Pompeu Fabra Univ UPF, Dept Expt & Hlth Sci, Barcelona Biomed Res Pk, Barcelona, Spain; [Lopez-Bigas, N.; Esteller, M.; Gomis, R. R.] ICREA, Barcelona, Spain; [Valdes-Mas, R.; Puente, X. S.] Univ Oviedo, Univ Inst Oncol Asturias, Dept Biochem & Mol Biol, Oviedo, Spain; [Hernandez-Losa, J.; Ramon y Cajal, S.] Vall Hebron Univ Hosp, Dept Pathol, Barcelona, Spain; [Esteller, M.] Univ Barcelona, Sch Med, Dept Physiol Sci 2, Barcelona, Spain; [Sierra, A.] Cent Univ Catalonia, Univ Vic, Fac Sci & Tech,Mol & Translat Oncol Lab, Biomed Res Inst August Pi & Sunyer IDIBAPS,Biomed, Barcelona, Spain; [Sierra, A.] Cent Univ Catalonia, Univ Vic, Fac Sci & Tech, Syst Biol Dept, Barcelona, Spain; [Martin-Martin, N.; Carracedo, A.] Ctr Cooperat Res Biosci CIC bioGUNE, Derio, Spain; [Matheu, A.] Biodonostia Res Inst, Oncol Dept, Oncol Sect, San Sebastian, Spain; [Matheu, A.; Carracedo, A.] Basque Fdn Sci, Ikerbasque, Bilbao, Spain; [Carracedo, A.] Univ Basque Country UPV EHU, Dept Biochem & Mol Biol, Bilbao, Spain; [Nanjundan, M.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL USA; [Cortes, J.] Vall Hebron Univ Hosp, VHIO, Dept Med Oncol, Barcelona, Spain; [Moreno-Bueno, G.] Autonomous Univ Madrid UAM, Hosp La Paz Inst Hlth Res IdiPAZ, Dept Biochem, Biomed Res Inst Alberto Sols Spanish Natl Res Cou, Madrid, Spain; [Moreno-Bueno, G.] MD Anderson Int Fdn, Madrid, Spain	Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Navarra; University of Navarra; New York University; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; Wellcome Trust Sanger Institute; University of Dhaka; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of Texas System; UTMD Anderson Cancer Center; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Universidad de Malaga; Vall d'Hebron Institut d'Oncologia (VHIO); Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; University of Rochester; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Erasmus University Rotterdam; Erasmus MC; Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; University of Chicago; University of Chicago; University of California System; University of California San Diego; Military Institute of Aviation Medicine; Military Institute of Aviation Medicine; Centro Nacional de Investigaciones Oncologicas (CNIO); Pompeu Fabra University; ICREA; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Hospital Universitari Vall d'Hebron; University of Barcelona; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); CIC bioGUNE; Basque Foundation for Science; University of Basque Country; State University System of Florida; University of South Florida; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); University of Texas System; UTMD Anderson Cancer Center	Gomis, RR (corresponding author), Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Oncol Program, Baldiri Reixac 10, Barcelona 08028, Spain.; Gomis, RR (corresponding author), Hosp Duran & Reynals, Catalan Inst Oncol, IDIBELL, ProCURE, Gran via 199, E-08028 Barcelona, Spain.	roger.gomis@irbbarcelona.org; mapujana@iconcologia.net	Graupera, Mariona/J-1122-2017; Vinals, Francesc/P-6278-2019; Iorio, Francesco/H-3284-2019; Valdés-Mas, Rafael/AAC-2879-2021; Mateo, Francesca/K-7746-2015; Rojo, Alejandro/Y-9674-2019; Boni, Jacopo/I-9587-2016; Vidal, August/N-4662-2016; Viñals, Francesc/F-5928-2016; matias-guiu, xavier/C-3039-2009; GARCIA, CONXI LAZARO/Q-2410-2016; Sanchez-Mut, Jose V./A-8651-2019; Pujana, Miquel Angel/N-3127-2014; VELASCO, ANA/AGH-3671-2022; Gonzalez-Suarez, Eva/L-6298-2014; Blanco, Ignacio/D-2565-2013; Sanchez-Cespedes, Montse/H-8485-2012; Odero/ABG-9860-2020; Lopez-Bigas, Nuria/F-6193-2011; bonifaci, nuria/B-8104-2019; Petit, Anna/GYU-5229-2022; Esteller, Manel/L-5956-2014; MORALES, SERAFIN/L-7216-2019; Moreno-Bueno, Gema/K-9354-2016; Castellà, Eva/K-4140-2017; Ramon y Cajal, Santiago/H-4955-2016; Puente, Xosé S./ADB-0672-2022; Lozano, José/C-2760-2014; Javier, Hernandez Losa/C-1173-2008; Skowron, Margaretha/N-6141-2018; Saez-Rodriguez, Julio/H-7114-2019; Blanco, Ignacio/AAN-5426-2021; Casanovas, Alex Cordero/AAA-8157-2020; Valls, Joan/GXM-6532-2022; Gomis, Roger R/E-9788-2016; de Garibay, Gorka Ruiz/AAB-6579-2020; Morilla, Idoia/P-6155-2019; Carracedo, Arkaitz/F-7029-2011; ceron, julian/AAA-8008-2019; Maicas, Miren/A-9836-2017; Brunet, Joan/C-5292-2018; Palomero, Luis/K-1058-2017; Casanovas, Oriol/L-5210-2014; Herranz, Carmen/K-1043-2017	Graupera, Mariona/0000-0003-4608-4185; Iorio, Francesco/0000-0001-7063-8913; Valdés-Mas, Rafael/0000-0002-0737-5425; Mateo, Francesca/0000-0002-2342-7010; Rojo, Alejandro/0000-0001-6439-3518; Vidal, August/0000-0001-5727-2099; Viñals, Francesc/0000-0002-9918-6751; matias-guiu, xavier/0000-0002-7201-6605; GARCIA, CONXI LAZARO/0000-0002-7198-5906; Sanchez-Mut, Jose V./0000-0002-9292-8521; Pujana, Miquel Angel/0000-0003-3222-4044; VELASCO, ANA/0000-0003-3142-145X; Gonzalez-Suarez, Eva/0000-0003-0858-8171; Blanco, Ignacio/0000-0002-7414-7481; Sanchez-Cespedes, Montse/0000-0002-6045-5627; Odero/0000-0002-8858-2054; Lopez-Bigas, Nuria/0000-0003-4925-8988; bonifaci, nuria/0000-0002-8193-6825; Esteller, Manel/0000-0003-4490-6093; MORALES, SERAFIN/0000-0001-7445-4193; Moreno-Bueno, Gema/0000-0002-5030-6687; Ramon y Cajal, Santiago/0000-0002-3867-1390; Puente, Xosé S./0000-0001-9525-1483; Lozano, José/0000-0002-8187-2833; Javier, Hernandez Losa/0000-0003-1526-3201; Skowron, Margaretha/0000-0003-2152-384X; Saez-Rodriguez, Julio/0000-0002-8552-8976; Blanco, Ignacio/0000-0002-7414-7481; Gomis, Roger R/0000-0001-6473-2858; de Garibay, Gorka Ruiz/0000-0001-9936-8419; Morilla, Idoia/0000-0001-8237-5073; Carracedo, Arkaitz/0000-0001-5957-1260; Maicas, Miren/0000-0003-1404-5552; Gomez-Miragaya, Jorge/0000-0003-1801-4681; ARENAS LAHUERTA, ENRIQUE JAVIER/0000-0001-7076-2666; Serrat Farran, Xenia/0000-0001-7611-5400; SEGUI PALMER, MIQUEL ANGEL/0000-0002-5103-6746; Ceron, Julian/0000-0003-4739-2243; Islam, Abul/0000-0002-7274-0855; Garcia-Alonso, Luz/0000-0002-7863-9619; Brunet, Joan/0000-0003-1945-3512; Palomero, Luis/0000-0002-9144-1017; Martinez-Iniesta, Maria/0000-0001-6252-6671; Boni, Jacopo/0000-0003-2626-9393; Cuadras, Daniel/0000-0001-8780-1764; Casanovas, Oriol/0000-0002-4298-3995; quintela-fandino, miguel/0000-0003-1648-1964; Valls, Joan/0000-0002-4806-7568; Herranz, Carmen/0000-0002-2866-0321; Sierra, Angels/0000-0003-1023-3492; Llorente, Alicia/0000-0002-6056-0566	Scientific Foundation 'Asociacion Espanola Contra el Cancer' (AECC, Stable Coordinated Group, Hereditary Cancer); BBVA Foundation; Eugenio Rodriguez Pascual Foundation; Generalitat de Catalunya AGAUR SGR [283, 290, 312, 364, 530, 535]; Spanish Ministry of Health ISCIII FIS [PI10/00057, PI10/00222, PI10/01422, PI12/01528, PI13/00132, PI14/00336]; ISCIII RTICC [RD06/0020/1051, RD12/0036/0007, RD12/0036/0008, RD12/0036/0063]; Spanish Ministry of Science and Innovation, 'Fondo Europeo de Desarrollo Regional (FEDER), una manera de hacer Europa', MINECO [SAF2010-20203, SAF2013-46196]; Telemaraton 'Todos Somos Raros, Todos Somos Unicos' [P35]; 'la Caixa' PhD fellowship program; EMBL-EBI; Wellcome Trust Sanger Institute Postdoctoral (ESPOD); NL-B; ME; RRG; ICREA; ICREA Funding Source: Custom	Scientific Foundation 'Asociacion Espanola Contra el Cancer' (AECC, Stable Coordinated Group, Hereditary Cancer); BBVA Foundation(BBVA Foundation); Eugenio Rodriguez Pascual Foundation; Generalitat de Catalunya AGAUR SGR; Spanish Ministry of Health ISCIII FIS(Spanish Government); ISCIII RTICC(Instituto de Salud Carlos III); Spanish Ministry of Science and Innovation, 'Fondo Europeo de Desarrollo Regional (FEDER), una manera de hacer Europa', MINECO; Telemaraton 'Todos Somos Raros, Todos Somos Unicos'; 'la Caixa' PhD fellowship program; EMBL-EBI; Wellcome Trust Sanger Institute Postdoctoral (ESPOD); NL-B; ME; RRG; ICREA(ICREA); ICREA(ICREA)	We thank Ander Urruticoechea, Gabriel Capella and George Thomas for helpful discussion; Ana Isabel Extremera, Antoni Xaubet and Julio Ancochea for administrative support; and Sebastien Tosi from the Advanced Digital Microscopy Facility at IRB Barcelona for image analysis. We also thank Xiyun Deng, Yanna Cao, Tien C Ko, Yi Zhang (The University of Texas Health Science Centre at Houston) and Adrian W Moore (RIKEN Brain Science Institute) for their support in evaluating antibodies against EVI1. This study was supported by the following bodies and grants: the Scientific Foundation 'Asociacion Espanola Contra el Cancer' (AECC, Stable Coordinated Group, Hereditary Cancer); the BBVA Foundation; the Eugenio Rodriguez Pascual Foundation grant 2012; Generalitat de Catalunya AGAUR SGR 2012 grants 283, 290 and 312, and SGR 2014 grants 364, 530, and 535; Spanish Ministry of Health ISCIII FIS grants PI10/00057, PI10/00222, PI10/01422, PI12/01528, PI13/00132, and PI14/00336. ISCIII RTICC grants RD06/0020/1051, RD12/0036/0007, RD12/0036/0008 and RD12/0036/0063; Spanish Ministry of Science and Innovation, 'Fondo Europeo de Desarrollo Regional (FEDER), una manera de hacer Europa', MINECO grants SAF2010-20203 and SAF2013-46196; and the Telemaraton 2014 'Todos Somos Raros, Todos Somos Unicos' grant P35. EJA was supported by 'la Caixa' PhD fellowship program, F Iorio was supported by a fellowship from the EMBL-EBI and the Wellcome Trust Sanger Institute Postdoctoral (ESPOD) program, and NL-B, ME and RRG were supported by ICREA. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, either in the submission form or the text of the manuscript.	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bard-Chapeau EA, 2013, P NATL ACAD SCI USA, V110, pE2885, DOI 10.1073/pnas.1309310110; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bhola NE, 2016, CANCER RES, V76, P440, DOI 10.1158/0008-5472.CAN-15-1640-T; Campone M, 2013, EUR J CANCER, V49, P2621, DOI 10.1016/j.ejca.2013.04.011; Cariati M, 2008, INT J CANCER, V122, P298, DOI 10.1002/ijc.23103; Chandarlapaty S, 2012, CANCER DISCOV, V2, P311, DOI 10.1158/2159-8290.CD-12-0018; Chao CH, 2014, J CLIN INVEST, V124, P3093, DOI 10.1172/JCI73351; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Dutta P, 2013, MOL ONCOL, V7, P647, DOI 10.1016/j.molonc.2013.02.008; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Hagerstrand D, 2013, CANCER DISCOV, V3, P1044, DOI 10.1158/2159-8290.CD-12-0592; Holder AM, 2015, ONCOTARGET, V6, P19500, DOI 10.18632/oncotarget.3669; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang RX, 2015, MOL CELL BIOCHEM, V404, P251, DOI 10.1007/s11010-015-2384-4; Issa A, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3379; Janssen EAM, 2003, J PATHOL, V201, P555, DOI 10.1002/path.1475; Kataoka K, 2011, J EXP MED, V208, P2402, DOI 10.1084/jem.20110447; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koren S, 2015, NATURE, V525, P114, DOI 10.1038/nature14669; Kormish JD, 2010, DEV DYNAM, V239, P56, DOI 10.1002/dvdy.22046; Larsimont JC, 2015, CELL STEM CELL, V17, P60, DOI 10.1016/j.stem.2015.05.008; Lawson DA, 2015, NATURE, V526, P131, DOI 10.1038/nature15260; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Ma JH, 2010, J CLIN INVEST, V120, P103, DOI 10.1172/JCI37964; Malhotra GK, 2014, BMC DEV BIOL, V14, DOI 10.1186/s12861-014-0047-4; Malladi S, 2016, CELL, V165, P45, DOI 10.1016/j.cell.2016.02.025; Markman B, 2010, ONCOTARGET, V1, P530, DOI 10.18632/oncotarget.188; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Morales M, 2014, EMBO MOL MED, V6, P865, DOI 10.15252/emmm.201303675; Nasr Z, 2013, ONCOGENE, V32, P861, DOI 10.1038/onc.2012.105; Palafox M, 2012, CANCER RES, V72, P2879, DOI 10.1158/0008-5472.CAN-12-0044; Patel JB, 2011, ONCOGENE, V30, P1290, DOI 10.1038/onc.2010.510; Piva M, 2014, EMBO MOL MED, V6, P66, DOI 10.1002/emmm.201303411; Pool SE, 2013, CANCER RES, V73, P12, DOI 10.1158/0008-5472.CAN-11-2089; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Rodrik-Outmezguine VS, 2016, NATURE, V534, P272, DOI 10.1038/nature17963; de Garibay GR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132546; Sflomos G, 2016, CANCER CELL, V29, P407, DOI 10.1016/j.ccell.2016.02.002; Stavropoulou V, 2016, CANCER CELL, V30, P43, DOI 10.1016/j.ccell.2016.05.011; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Van Keymeulen A, 2015, NATURE, V525, P119, DOI 10.1038/nature14665; Witten IH, 1999, P ICONIP ANZIIS ANNE, V99, P192; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Yang ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028405; Ye X, 2015, NATURE, V525, P256, DOI 10.1038/nature14897; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	59	27	27	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 11	2017	36	19					2737	2749		10.1038/onc.2016.427	http://dx.doi.org/10.1038/onc.2016.427			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EU6CF	27991928	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000401120900011
J	Liu, Q; Chen, YW; Shen, C; Xiao, YT; Wang, YT; Liu, ZG; Liu, XB				Liu, Qian; Chen, Yuwei; Shen, Chun; Xiao, Yating; Wang, Yutang; Liu, Zhigang; Liu, Xuebo			Chicoric acid supplementation prevents systemic inflammation- induced memory impairment and amyloidogenesis via inhibition of NF-kappa B	FASEB JOURNAL			English	Article						amyloid peptides accumulation; lipopolysaccharide; natural phenolic acid; neuroinflammation; NF-kappa B transcriptional pathway	ALZHEIMERS-DISEASE; AMYLOID-BETA; COGNITIVE IMPAIRMENT; TRANSGENIC MOUSE; NEUROINFLAMMATION; CELLS; RESPONSES; PATHWAY; INACTIVATION; HIPPOCAMPUS	Chicoric acid (CA), a natural phenolic acid extracted from chicory and the echinacea (purple coneflower) plant (Echinacea purpurea), has been regarded as a nutraceutical that has powerful antioxidant and antiobesity activities. We investigated the inhibitory effects of CA on systemic inflammation-induced neuroinflammation, amyloidogenesis, and cognitive impairment. C57BL/6J mice were treated with 0.05% CA in the drinking water for 45 d. The mice were then treated by intraperitoneal injection of lipopolysaccharide (LPS). It was found that CA prevented LPS-induced memory impairment and neuronal loss through behavioral tests and histological examination. Furthermore, amyloidogenesis in the CNS was detected. The results showed that CA prevented LPS-induced increases in amyloid beta (1-42 specific) (A beta(1-42)) accumulation, levels of amyloid precursor protein, and neuronal beta-secretase 1 (BACE1), aswell as the equilibrium cholinergic system in mouse brain. Moreover, CA down regulated LPS-induced glial overactivation by inhibiting the MAPK and NF-kappa B pathway. Consequently, CA reduced the levels of NF-kappa B transcriptionally regulated inflammatory mediators and cytokines such as iNOS, cyclooxygenase-2 (COX-2), IL-1 beta, and TNF-alpha in both mouse brain and BV2 microglial cells. These results demonstrated that CA alleviated memory impairment and amyloidogenesis triggered by LPS through suppressing NF-kB transcriptional pathway, suggesting that CA might be a plausible therapeutic intervention for neuroinflammationrelated diseases such as Alzheimer disease.-Liu, Q., Chen, Y., Shen, C., Xiao, Y., Wang, Y., Liu, Z., Liu, X. Chicoric acid supplementation prevents systemic inflammation-induced memory impairment and amyloidogenesis via inhibition of NF-kB. FASEB J. 31, 1494-1507 (2017). www.fasebj.org	[Liu, Qian; Chen, Yuwei; Shen, Chun; Xiao, Yating; Wang, Yutang; Liu, Zhigang; Liu, Xuebo] Northwest A&F Univ, Coll Food Sci & Engn, Lab Funct Chem & Nutr Food, Yangling, Peoples R China	Northwest A&F University - China	Liu, ZG; Liu, XB (corresponding author), Northwest A&F Univ, Coll Food Sci & Engn, Xinong Rd 22, Yangling 712100, Peoples R China.	zhigangliu@nwsuaf.edu.cn; xueboliu@aliyun.com	Liu, Zhigang/H-4818-2016	Liu, Zhigang/0000-0002-6863-6561; Chen, Yuwei/0000-0001-5329-2180	National Key Research and Development Program of China [2016YFD0400601]; National Natural Science Foundation of China [31671859]; Scientific Startup Funds for Doctors of Northwest Agriculture and Forestry University [Z109021611]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Startup Funds for Doctors of Northwest Agriculture and Forestry University	The authors thank the National Key Research and Development Program of China (Grant 2016YFD0400601), the National Natural Science Foundation of China (Grant 31671859), and Scientific Startup Funds for Doctors of Northwest Agriculture and Forestry University (Grant Z109021611).	Baker-Nigh A, 2015, BRAIN, V138, P1722, DOI 10.1093/brain/awv024; Chen CH, 2012, INT J NEUROPSYCHOPH, V15, P77, DOI 10.1017/S1461145711000149; Da Mesquita S, 2016, NEUROSCI BIOBEHAV R, V68, P547, DOI 10.1016/j.neubiorev.2016.06.014; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Fernandez-Perez EJ, 2016, CURR PHARM DESIGN, V22, P1295, DOI 10.2174/138161282210160304111702; Foley AM, 2015, J ALZHEIMERS DIS, V44, P787, DOI 10.3233/JAD-142208; Gu SM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0344-2; He XL, 2016, PHARMACOL REP, V68, P975, DOI 10.1016/j.pharep.2016.05.006; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Hernandez-Guillamon M, 2015, J BIOL CHEM, V290, P15078, DOI 10.1074/jbc.M114.610931; Hooten KG, 2015, NEUROTHERAPEUTICS, V12, P364, DOI 10.1007/s13311-014-0329-3; Jiang YM, 2008, MOL IMMUNOL, V45, P1557, DOI 10.1016/j.molimm.2007.10.008; Kour K, 2011, PHARMACOL BIOCHEM BE, V99, P342, DOI 10.1016/j.pbb.2011.05.008; Lee JW, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-37; Lee JW, 2012, KOREAN J PHYSIOL PHA, V16, P107, DOI 10.4196/kjpp.2012.16.2.107; Lee M, 2015, NEUROBIOL AGING, V36, P42, DOI 10.1016/j.neurobiolaging.2014.07.024; Liu Q, 2015, FOOD FUNCT, V6, P1928, DOI 10.1039/c5fo00073d; Lloret A, 2015, FREE RADICAL BIO MED, V83, P186, DOI 10.1016/j.freeradbiomed.2015.02.028; McAfoose J, 2009, NEUROSCI BIOBEHAV R, V33, P355, DOI 10.1016/j.neubiorev.2008.10.005; Minter MR, 2016, J NEUROCHEM, V136, P457, DOI 10.1111/jnc.13411; Catorce MN, 2016, CURR NEUROPHARMACOL, V14, P155, DOI 10.2174/1570159X14666151204122017; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; Park CM, 2011, EUR J PHARMACOL, V660, P454, DOI 10.1016/j.ejphar.2011.04.007; Petrov D, 2016, MOL NEUROBIOL, V53, P6183, DOI 10.1007/s12035-015-9522-6; PLOTKIN DA, 1986, PROG BRAIN RES, V65, P91, DOI 10.1016/S0079-6123(08)60644-5; Ruxton K, 2015, BRIT J CLIN PHARMACO, V80, P209, DOI 10.1111/bcp.12617; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shi ZM, 2016, J NEUROL SCI, V366, P127, DOI 10.1016/j.jns.2016.05.022; Silverman HA, 2014, MOL MED, V20, P601, DOI 10.2119/molmed.2014.00147; Siwak-Tapp CT, 2007, NEUROBIOL LEARN MEM, V88, P249, DOI 10.1016/j.nlm.2007.05.001; Soreq H, 2015, TRENDS NEUROSCI, V38, P448, DOI 10.1016/j.tins.2015.05.007; Spagnuolo C, 2016, CURR TOP MED CHEM, V16, P1943, DOI 10.2174/1568026616666160204122449; Szwajgier D, 2013, Z NATURFORSCH C, V68, P125, DOI 10.5560/ZNC.2013.68c0125; Tata AM, 2014, CNS NEUROL DISORD-DR, V13, P1294, DOI 10.2174/1871527313666140917121132; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; Triaca V, 2016, AGING CELL, V15, P661, DOI 10.1111/acel.12473; Villegas-Llerena C, 2016, CURR OPIN NEUROBIOL, V36, P74, DOI 10.1016/j.conb.2015.10.004; Wang YT, 2016, J CHROMATOGR B, V1031, P139, DOI 10.1016/j.jchromb.2016.07.045; Wu WQ, 2015, MOL NUTR FOOD RES, V59, P1663, DOI 10.1002/mnfr.201500109; Xiao HF, 2013, FOOD RES INT, V54, P345, DOI 10.1016/j.foodres.2013.07.033; Xiao HF, 2013, J AGR FOOD CHEM, V61, P1509, DOI 10.1021/jf3050268; Zhu D, 2015, J AGR FOOD CHEM, V63, P10903, DOI 10.1021/acs.jafc.5b04533	42	81	85	4	49	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1494	1507		10.1096/fj.201601071R	http://dx.doi.org/10.1096/fj.201601071R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28003341				2022-12-26	WOS:000398504300018
J	Chen, J; Wu, XT; Yao, LK; Yan, L; Zhang, L; Qiu, JH; Liu, XF; Jia, SJ; Meng, AM				Chen, Jing; Wu, Xiaotong; Yao, Likun; Yan, Lu; Zhang, Lin; Qiu, Juhui; Liu, Xingfeng; Jia, Shunji; Meng, Anming			Impairment of Cargo Transportation Caused by gbf1 Mutation Disrupts Vascular Integrity and Causes Hemorrhage in Zebrafish Embryos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; BREFELDIN-A; ENDOPLASMIC-RETICULUM; CELL-DEATH; IN-VIVO; INTRACELLULAR-TRANSPORT; LIPID DROPLETS; ARF PROTEINS; GOLGI; ER	ADP-ribosylation factor GTPases are activated by guanine nucleotide exchange factors including Gbf1 (Golgi brefeldin A-resistant factor 1) and play important roles in regulating organelle structure and cargo-selective vesicle trafficking. However, the developmental role of Gbf1 in vertebrates remains elusive. In this study, we report the zebrafish mutant line tsu3994 that arises from N-ethyl-N-nitrosourea (ENU)-mediated mutagenesis and is characterized by prominent intracerebral and trunk hemorrhage. The mutant embryos develop hemorrhage accompanied by fewer pigments and shorter caudal fin at day 2 of development. The hemorrhage phenotype is caused by vascular breakage in a cell autonomous fashion. Positional cloning identifies a T -> G nucleotide substitution in the 23rd exon of the gbf1 locus, resulting in a leucine -> arginine substitution (L1246R) in the HDS2 domain. The mutant phenotype is mimicked by gbf1 knockouts and morphants, suggesting a nature of loss of function. Experimental results in mammalian cells show that the mutant form Gbf1(L1246R) is unable to be recruited to the Golgi apparatus and fails to activate Arf1 for recruiting COPI complex. The hemorrhage in tsu3994 mutants can be prevented partially and temporally by treating with the endoplasmic reticulum stress/apoptosis inhibitor tauroursodeoxycholic acid or by knocking down the proapoptotic gene baxb. Therefore, endothelial endoplasmic reticulum stress and subsequent apoptosis induced by gbf1 deficiency may account for the vascular collapse and hemorrhage.	[Chen, Jing; Wu, Xiaotong; Yao, Likun; Yan, Lu; Zhang, Lin; Qiu, Juhui; Liu, Xingfeng; Jia, Shunji; Meng, Anming] Tsinghua Univ, Lab Mol Dev Biol, State Key Lab Membrane Biol, Tsinghua Peking Ctr Life Sci,Sch Life Sci, Beijing 100084, Peoples R China	Tsinghua University	Meng, AM (corresponding author), Tsinghua Univ, Lab Mol Dev Biol, State Key Lab Membrane Biol, Tsinghua Peking Ctr Life Sci,Sch Life Sci, Beijing 100084, Peoples R China.	mengam@mail.tsinghua.edu.cn	Wu, Xiaotong/AAH-4566-2021; Meng, Anming/A-4785-2012	Wu, Xiaotong/0000-0002-4109-9444; Chen, Jing/0000-0001-5540-0878; Meng, Anming/0000-0001-7228-3431; Yao, Likun/0000-0002-2798-7285	National Natural Science Foundation; China Grant [31330052]; Major Science Programs of the Ministry of Science and Technology of the People's Republic of China Grants [2012CB945101, 2011CB943800]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); China Grant; Major Science Programs of the Ministry of Science and Technology of the People's Republic of China Grants	This work was supported by National Natural Science Foundation of thus could serve as an anti-infection target. However, the China Grant 31330052 and Major Science Programs of the Ministry of Science and Technology of the People's Republic of China Grants 2012CB945101 and 2011CB943800. The authors declare that they have no conflicts of interest with the contents of this article.	Aridor M, 2002, TRAFFIC, V3, P781, DOI 10.1034/j.1600-0854.2002.31103.x; Aridor M, 2000, TRAFFIC, V1, P836, DOI 10.1034/j.1600-0854.2000.011104.x; Aridor M, 2007, ADV DRUG DELIVER REV, V59, P759, DOI 10.1016/j.addr.2007.06.002; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Belov GA, 2010, CELL MICROBIOL, V12, P1463, DOI 10.1111/j.1462-5822.2010.01482.x; Bouvet S, 2013, J CELL SCI, V126, P4794, DOI 10.1242/jcs.134254; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cherfils J, 2005, BIOCHEM SOC T, V33, P635, DOI 10.1042/BST0330635; Citterio C, 2008, P NATL ACAD SCI USA, V105, P2877, DOI 10.1073/pnas.0712224105; Claude A, 1999, J CELL BIOL, V146, P71, DOI 10.1083/jcb.146.1.71; D'Arcangelo JG, 2013, BBA-MOL CELL RES, V1833, P2464, DOI 10.1016/j.bbamcr.2013.02.003; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; de Wilde AH, 2015, J VIROL, V89, P8318, DOI 10.1128/JVI.01029-15; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Garcia-Mata R, 2003, MOL BIOL CELL, V14, P2250, DOI 10.1091/mbc.E02-11-0730; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goueslain L, 2010, J VIROL, V84, P773, DOI 10.1128/JVI.01190-09; Huizing M, 2008, ANNU REV GENOM HUM G, V9, P359, DOI 10.1146/annurev.genom.9.081307.164303; Iglesias NG, 2015, TRAFFIC, V16, P962, DOI 10.1111/tra.12305; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Jia SJ, 2008, J BIOL CHEM, V283, P2418, DOI 10.1074/jbc.M707578200; Jin P, 2004, CHINESE SCI BULL, V49, P2154, DOI 10.1360/982004-188; Kawamoto K, 2002, TRAFFIC, V3, P483, DOI 10.1034/j.1600-0854.2002.30705.x; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kratz E, 2006, CELL DEATH DIFFER, V13, P1631, DOI 10.1038/sj.cdd.4402016; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Li X, 2009, BLOOD, V114, P5464, DOI 10.1182/blood-2009-06-227777; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Liu XF, 2016, METHODS MOL BIOL, V1344, P275, DOI 10.1007/978-1-4939-2966-5_17; Liu XF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2762; Manolea F, 2008, MOL BIOL CELL, V19, P523, DOI 10.1091/mbc.E07-04-0394; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mouratou B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-20; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Myers KR, 2008, TRENDS CELL BIOL, V18, P184, DOI 10.1016/j.tcb.2008.02.002; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Popoff V, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005231; Pyati UJ, 2011, DEV CELL, V21, P492, DOI 10.1016/j.devcel.2011.07.012; Quilty D, 2014, J CELL SCI, V127, P354, DOI 10.1242/jcs.130591; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Saenz JB, 2009, NAT CHEM BIOL, V5, P157, DOI 10.1038/nchembio.144; Schimmoller F, 1997, CURR BIOL, V7, pR235, DOI 10.1016/S0960-9822(06)00109-6; Szul T, 2005, TRAFFIC, V6, P374, DOI 10.1111/j.1600-0854.2005.00282.x; Szul T, 2007, J CELL SCI, V120, P3929, DOI 10.1242/jcs.010769; Toruno C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088151; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Wang Su-Fang, 2012, Enzyme Res, V2012, P192867, DOI 10.1155/2012/192867; Wei AH, 2013, J DERMATOL, V40, P325, DOI 10.1111/1346-8138.12025; Wright J, 2014, CELL MOL LIFE SCI, V71, P3419, DOI 10.1007/s00018-014-1602-7; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yie Q, 2002, HEPATOLOGY, V36, P592, DOI 10.1053/jhep.2002.35441; Zhou Y, 2011, METHOD CELL BIOL, V104, P287, DOI 10.1016/B978-0-12-374814-0.00016-1	55	12	12	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2315	2327		10.1074/jbc.M116.767608	http://dx.doi.org/10.1074/jbc.M116.767608			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28003365	Green Published, hybrid			2022-12-26	WOS:000395530300023
J	Llansola-Portoles, MJ; Sobotka, R; Kish, E; Shukla, MK; Pascal, AA; Polivka, T; Robert, B				Llansola-Portoles, Manuel J.; Sobotka, Roman; Kish, Elizabeth; Shukla, Mahendra Kumar; Pascal, Andrew A.; Polivka, Tomas; Robert, Bruno			Twisting a beta-Carotene, an Adaptive Trick from Nature for Dissipating Energy during Photoprotection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; RESONANCE RAMAN-SPECTRA; PHOTOSYSTEM-II; HIGHER-PLANTS; SPECTROSCOPIC PROPERTIES; ELECTRONIC ABSORPTION; ANTENNA PROTEINS; CHLOROPHYLL; BINDING; CONFIGURATION	Cyanobacteria possess a family of one-helix high light-inducible proteins (Hlips) that are homologous to light-harvesting antenna of plants and algae. An Hlip protein, high light-inducible protein D (HliD) purified as a small complex with the Ycf39 protein is evaluated using resonance Raman spectroscopy. We show that the HliD binds two different beta-carotenes, each present in two non-equivalent binding pockets with different conformations, having their (0,0) absorption maxima at 489 and 522 nm, respectively. Both populations of beta-carotene molecules were in all-trans configuration and the absorption position of the farthest blue-shifted beta-carotene was attributed entirely to the polarizability of the environment in its binding pocket. In contrast, the absorption maximum of the red-shifted beta-carotene was attributed to two different factors: the polarizability of the environment in its binding pocket and, more importantly, to the conformation of its beta-rings. This second beta-carotene has highly twisted beta-rings adopting a flat conformation, which implies that the effective conjugation length N is extended up to 10.5 modifying the energetic levels. This increase in N will also result in a lower S-1 energy state, which may provide a permanent energy dissipation channel. Analysis of the carbonyl stretching region for chlorophyll a excitations indicates that the HliD binds six chlorophyll a molecules in five non-equivalent binding sites, with at least one chlorophyll a presenting a slight distortion to its macrocycle. The binding modes and conformations of HliD-bound pigments are discussed with respect to the known structures of LHCII and CP29.	[Llansola-Portoles, Manuel J.; Kish, Elizabeth; Pascal, Andrew A.; Robert, Bruno] Univ Paris Saclay, Univ Paris Sud, CNRS, I2BC,CEA, F-91198 Gif Sur Yvette, France; [Sobotka, Roman; Shukla, Mahendra Kumar] Acad Sci Czech Republ, Inst Microbiol, Ctr Algatech, Trebon 37981, Czech Republic; [Polivka, Tomas] Univ South Bohemia, Fac Sci, Inst Phys & Biophys, Ceske Budejovice 37001, Czech Republic	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Llansola-Portoles, MJ (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, I2BC,CEA, F-91198 Gif Sur Yvette, France.	manuel.llansola@cea.fr	Sobotka, Roman/J-3077-2014; Polivka, Tomas/G-9564-2014; pascal, andrew a/B-6186-2014; Llansola-Portoles, Manuel J./ABI-1060-2020; Robert, Bruno/D-1264-2012; Shukla, Mahendra Kumar/J-5994-2014	Sobotka, Roman/0000-0001-5909-3879; Polivka, Tomas/0000-0002-6176-0420; pascal, andrew a/0000-0002-1844-6065; Llansola-Portoles, Manuel J./0000-0002-8065-9459; Robert, Bruno/0000-0001-5999-4538; Shukla, Mahendra Kumar/0000-0002-6858-1441	French National Infrastructure for Integrated Structural Biology (FRISBI); Czech Science Foundation [P501/12/G055, 14-13967S]	French National Infrastructure for Integrated Structural Biology (FRISBI); Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by the French National Infrastructure for Integrated Structural Biology (FRISBI) and Grants P501/12/G055 and 14-13967S from the Czech Science Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Andreeva A, 2011, SPECTROCHIM ACTA A, V78, P1261, DOI 10.1016/j.saa.2010.12.071; Bhaya D, 2002, FEMS MICROBIOL LETT, V215, P209, DOI 10.1111/j.1574-6968.2002.tb11393.x; Blankenship R. E., 2014, MOL MECH PHOTOSYNTHE; Bode S, 2009, P NATL ACAD SCI USA, V106, P12311, DOI 10.1073/pnas.0903536106; Chidgey JW, 2014, PLANT CELL, V26, P1267, DOI 10.1105/tpc.114.124495; DemmigAdams B, 2014, NONPHOTOCHEMICAL QUE; DOLGANOV NAM, 1995, P NATL ACAD SCI USA, V92, P636, DOI 10.1073/pnas.92.2.636; Engelken J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-233; FEILER U, 1994, J RAMAN SPECTROSC, V25, P365, DOI 10.1002/jrs.1250250513; Fuciman M, 2015, J PHYS CHEM B, V119, P1457, DOI 10.1021/jp512354r; FUJIWARA M, 1986, J PHYS CHEM-US, V90, P5646, DOI 10.1021/j100280a033; Gust D, 2008, MRS BULL, V33, P383, DOI 10.1557/mrs2008.78; He QF, 2001, J BIOL CHEM, V276, P306, DOI 10.1074/jbc.M008686200; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Knoppova J, 2014, PLANT CELL, V26, P1200, DOI 10.1105/tpc.114.123919; Komenda J, 2016, BBA-BIOENERGETICS, V1857, P288, DOI 10.1016/j.bbabio.2015.08.011; Koyama Y, 1999, ADV PHOTOSYNTH, V8, P161; KOYAMA Y, 1983, PHOTOBIOCH PHOTOBIOP, V5, P139; Lapouge K, 1998, J RAMAN SPECTROSC, V29, P977, DOI 10.1002/(SICI)1097-4555(199810/11)29:10/11<977::AID-JRS325>3.0.CO;2-K; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; LUTZ M, 1987, BIOCHIM BIOPHYS ACTA, V894, P423, DOI 10.1016/0005-2728(87)90121-6; LUTZ M, 1977, BIOCHIM BIOPHYS ACTA, V460, P408, DOI 10.1016/0005-2728(77)90081-0; Lutz M., 1991, CHLOROPHYLLS, P855; Macernis M, 2015, J PHYS CHEM A, V119, P56, DOI 10.1021/jp510426m; Macernis M, 2014, J PHYS CHEM A, V118, P1817, DOI 10.1021/jp406449c; Mendes-Pinto MM, 2013, J PHYS CHEM B, V117, P11015, DOI 10.1021/jp309908r; Mendes-Pinto MM, 2013, J BIOL CHEM, V288, P18758, DOI 10.1074/jbc.M112.423681; Muller MG, 2010, CHEMPHYSCHEM, V11, P1289, DOI 10.1002/cphc.200900852; Naveke A, 1997, J RAMAN SPECTROSC, V28, P599, DOI 10.1002/(SICI)1097-4555(199708)28:8<599::AID-JRS136>3.0.CO;2-C; Neilson JAD, 2010, PHOTOSYNTH RES, V106, P57, DOI 10.1007/s11120-010-9576-2; Niedzwiedzki DM, 2016, BBA-BIOENERGETICS, V1857, P1430, DOI 10.1016/j.bbabio.2016.04.280; Pascal A, 2000, J BIOL CHEM, V275, P22031, DOI 10.1074/jbc.M000658200; Pascoal AJ, 2014, COLOQUIO-LETRAS, P245; Polivka T, 2005, BIOCHEMISTRY-US, V44, P3994, DOI 10.1021/bi047473t; Polivka T, 2004, CHEM REV, V104, P2021, DOI 10.1021/cr020674n; Polivka T, 2009, BIOPHYS J, V96, P2268, DOI 10.1016/j.bpj.2009.01.004; Robert B, 1999, ADV PHOTOSYNTH, V8, P189; Robert B., 1996, BIOPHYSICAL TECHNIQU, P161; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2016, PLANT PHYSIOL, V170, P1903, DOI 10.1104/pp.15.01935; Ruban AV, 1999, J BIOL CHEM, V274, P10458, DOI 10.1074/jbc.274.15.10458; Ruban AV, 2002, J BIOL CHEM, V277, P42937, DOI 10.1074/jbc.M207823200; Ruban AV, 2001, J BIOL CHEM, V276, P24862, DOI 10.1074/jbc.M103263200; Staleva H, 2015, NAT CHEM BIOL, V11, P287, DOI [10.1038/nchembio.1755, 10.1038/NCHEMBIO.1755]; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Yao D, 2007, J BIOL CHEM, V282, P267, DOI 10.1074/jbc.M605463200	46	33	33	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1396	1403		10.1074/jbc.M116.753723	http://dx.doi.org/10.1074/jbc.M116.753723			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27994060	hybrid, Green Published			2022-12-26	WOS:000393339800021
J	Baldry, M; Nielsen, A; Bojer, MS; Zhao, Y; Friberg, C; Ifrah, D; Heede, NG; Larsen, TO; Frokiaer, H; Frees, D; Zhang, LX; Dai, HQ; Ingmer, H				Baldry, Mara; Nielsen, Anita; Bojer, Martin S.; Zhao, Yu; Friberg, Cathrine; Ifrah, Dan; Heede, Nina Glasser; Larsen, Thomas O.; Frokiaer, Hanne; Frees, Dorte; Zhang, Lixin; Dai, Huanqin; Ingmer, Hanne			Norlichexanthone Reduces Virulence Gene Expression and Biofilm Formation in Staphylococcus aureus	PLOS ONE			English	Article							DNA-BINDING; DETERMINANT EXPRESSION; GENOME SEQUENCE; IDENTIFICATION; TRANSCRIPTION; INHIBITION; MECHANISMS; RESISTANCE; EVOLUTION; INFECTION	Staphylococcus aureus is a serious human pathogen and antibiotic resistant, community-associated strains, such as the methicillin resistant S. aureus (MRSA) strain USA300, continue to spread. To avoid resistance, anti-virulence therapy has been proposed where toxicity is targeted rather than viability. Previously we have shown that norlichexanthone, a small non-reduced tricyclic polyketide produced by fungi and lichens, reduces expression of hla encoding a-hemolysin as well as the regulatory RNAIII of the agr quorum sensing system in S. aureus 8325-4. The aim of the present study was to further characterise the mode of action of norlichexanthone and its effect on biofilm formation. We find that norlichexanthone reduces expression of both hla and RNAIII also in strain USA300. Structurally, norlichexanthone resembles.-hydroxyemodin that recently was shown to bind the agr two component response regulator, AgrA, which controls expression of RNAIII and the phenol soluble modulins responsible for human neutrophil killing. We show that norlichexanthone reduces S. aureus toxicity towards human neutrophils and interferes directly with AgrA binding to its DNA target. In contrast to.-hydroxyemodin however, norlichexanthone reduces staphylococcal biofilm formation. Transcriptomic analysis revealed that genes regulated by the SaeRS two-component system are repressed by norlichexanthone when compared to untreated cells, an effect that was mitigated in strain Newman carrying a partially constitutive SaeRS system. Our data show that norlichexanthone treatment reduces expression of key virulence factors in CA-MRSA strain USA300 via AgrA binding and represses biofilm formation.	[Baldry, Mara; Nielsen, Anita; Bojer, Martin S.; Friberg, Cathrine; Ifrah, Dan; Heede, Nina Glasser; Frokiaer, Hanne; Frees, Dorte; Ingmer, Hanne] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg C, Denmark; [Zhao, Yu; Zhang, Lixin; Dai, Huanqin] Chinese Acad Sci, Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing, Peoples R China; [Larsen, Thomas O.] Tech Univ Denmark, Dept Syst Biol, Ctr Microbial Biotechnol, Lyngby, Denmark; [Friberg, Cathrine] Novo Nordisk, Gentofte, Denmark; [Ifrah, Dan] Agilent Technol, Glostrup, Denmark; [Heede, Nina Glasser] Gentofte Univ Hosp, Hellerup, Denmark	University of Copenhagen; Chinese Academy of Sciences; Institute of Microbiology, CAS; Technical University of Denmark; Agilent Technologies; University of Copenhagen; Herlev & Gentofte Hospital	Ingmer, H (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg C, Denmark.; Dai, HQ (corresponding author), Chinese Acad Sci, Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing, Peoples R China.	daihuanqin@139.com; hi@sund.ku.dk		Baldry, Mara/0000-0001-6005-1078; Frokiaer, Hanne/0000-0003-1472-9698; Bojer, Martin Saxtorph/0000-0002-8488-9593; Ingmer, Hanne/0000-0002-8350-5631; Frees, Dorte/0000-0003-4946-2890; Zhang, Lixin/0000-0003-0894-9520; Larsen, Thomas Ostenfeld/0000-0002-3362-5707	Seventh framework programme; Danmarks Grundforskningsfond [DNRF 120]; Danish Council for Independent Research [1337-00129, 1335-00772, 12-127417]	Seventh framework programme(European Commission); Danmarks Grundforskningsfond(Danmarks Grundforskningsfond); Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	Seventh framework programme supported Mara Baldry, Danmarks Grundforskningsfond supported Hanne Ingmer, DNRF 120, Danish Council for Independent Research 1337-00129 and 1335-00772 supported Martin Bojer, and Danish Council for Independent Research 12-127417 supported Hanne Ingmer.	Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; Chan PF, 1998, MICROBIOL-SGM, V144, P2469, DOI 10.1099/00221287-144-9-2469; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; Daly SM, 2015, ANTIMICROB AGENTS CH, V59, P2223, DOI 10.1128/AAC.04564-14; del Pozo JL, 2007, CLIN PHARMACOL THER, V82, P204, DOI 10.1038/sj.clpt.6100247; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; FISCHETTI VA, 2000, GRAM POSITIVE PATHOG; Frees D, 2004, MOL MICROBIOL, V54, P1445, DOI 10.1111/j.1365-2958.2004.04368.x; Geiger T, 2008, J BACTERIOL, V190, P3419, DOI 10.1128/JB.01927-07; Geisinger E, 2009, P NATL ACAD SCI USA, V106, P1216, DOI 10.1073/pnas.0807760106; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; George EA, 2007, CHEMBIOCHEM, V8, P847, DOI 10.1002/cbic.200700023; Gordon CP, 2013, J MED CHEM, V56, P1389, DOI 10.1021/jm3014635; Graves SF, 2010, J MOL MED, V88, P109, DOI 10.1007/s00109-009-0573-x; Haaber J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041075; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Jelsbak L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012752; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; Kobayashi SD, 2011, J INFECT DIS, V204, P937, DOI 10.1093/infdis/jir441; Leonard PG, 2012, BIOCHEMISTRY-US, V51, P10035, DOI 10.1021/bi3011785; Lowy FD, 1998, NEW ENGL J MED, V339, P13; Mainiero M, 2010, J BACTERIOL, V192, P613, DOI 10.1128/JB.01242-09; Mansson M, 2011, MAR DRUGS, V9, P2537, DOI 10.3390/md9122537; McCarthy DJ, 2009, BIOINFORMATICS, V25, P765, DOI 10.1093/bioinformatics/btp053; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Mrak LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038453; Neumann Y, 2015, ARCH MICROBIOL, V197, P245, DOI 10.1007/s00203-014-1048-1; Nicod SS, 2014, NUCLEIC ACIDS RES, V42, P12523, DOI 10.1093/nar/gku1015; Nielsen A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084992; Nielsen A, 2010, ANTIMICROB AGENTS CH, V54, P509, DOI 10.1128/AAC.00940-09; Nielsen Lene N, 2012, BMC Res Notes, V5, P457, DOI 10.1186/1756-0500-5-457; Novick RP, 2003, MICROBIOL-SGM, V149, P2709, DOI 10.1099/mic.0.26575-0; NOVICK RP, 1967, J EXP MED, V125, P45, DOI 10.1084/jem.125.1.45; Peres V, 2000, PHYTOCHEMISTRY, V55, P683, DOI 10.1016/S0031-9422(00)00303-4; Periasamy S, 2012, P NATL ACAD SCI USA, V109, P1281, DOI 10.1073/pnas.1115006109; Pohl K, 2009, J BACTERIOL, V191, P2953, DOI 10.1128/JB.01492-08; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Strommenger B, 2013, J ANTIMICROBIAL CHEM; Sully EK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004174; Sun F, 2010, J BACTERIOL, V192, P2111, DOI 10.1128/JB.01524-09; Vanassche T, 2012, THROMB HAEMOSTASIS, V107, P1107, DOI 10.1160/TH11-12-0891; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Vuong C, 2000, J INFECT DIS, V182, P1688, DOI 10.1086/317606; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656	47	36	36	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168305	10.1371/journal.pone.0168305	http://dx.doi.org/10.1371/journal.pone.0168305			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005941	gold, Green Published, Green Submitted			2022-12-26	WOS:000392843200043
J	Kang, JH; Kim, SH; Kim, YH; Rha, SE; Hur, BY; Han, JK				Kang, Ji Hee; Kim, Se Hyung; Kim, Young Hoon; Rha, Sung Eun; Hur, Bo Yun; Han, Joon Koo			CT Features of Colorectal Schwannomas: Differentiation from Gastrointestinal Stromal Tumors	PLoS One			English	Article							PATHOLOGICAL CORRELATION; IMAGING FEATURES; LEIOMYOSARCOMAS; RECTUM; TRACT; COLON	Purpose To find differential CT features of colorectal schwannomas from gastrointestinal stromal tumors (GISTs). Materials and Methods CT features of 13 pathologically proven colorectal schwannomas and 21 GISTs were retrospectively reviewed. The following CT items were analyzed: size, longitudinal and transverse location, shape, margin, homogeneity, necrosis, surface ulceration, calcification, degree of attenuation, the presence of enlarged lymph node (LN), and metastasis. Among the features, significant variables were evaluated using univariate statistical tests. The optimal cut-off point of tumor size was obtained by ROC analysis. Binary logistic regression analysis was used to find the most independent CT variables. Results Small size, nonrectum location, smooth margin, homogeneous high attenuation without necrosis, and the presence of enlarged LNs were found to be significant variables to differentiate schwannomas from GISTs (P<0.05). The optimized cut-off point for tumor size in distinguishing GISTs from schwannomas was 3.9 cm (AUC = 0.808, sensitivity = 66.7%, specificity = 92.3%, P<0.0001). Binary regression analysis revealed that only nonrectum location remained independent predictor for schwannomas differentiated from GISTs (odds ratio = 31.667, P = 0.001). Conclusion Colorectal schwannomas usually located in non -rectum and appear as small subepithelial nodules showing homogeneous high attenuation and smooth margin. Schwannomas exclusively accompany with enlarged LNs.	[Kang, Ji Hee; Kim, Se Hyung; Han, Joon Koo] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Kim, Se Hyung; Han, Joon Koo] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Kim, Young Hoon] Seoul Natl Univ, Bundang Hosp, Dept Radiol, Seongnam, South Korea; [Rha, Sung Eun] Catholic Univ Korea, Dept Radiol, Seoul, South Korea; [Hur, Bo Yun] Natl Canc Ctr, Dept Radiol, Goyang, South Korea; [Han, Joon Koo] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Catholic University of Korea; National Cancer Center - Korea (NCC); Seoul National University (SNU)	Kim, SH (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea.; Kim, SH (corresponding author), Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea.	shkim7071@gmail.com			Basic Science Research Program through the National Research Foundation of Korea [NRF] - Ministry of Science, ICT & Future Planning [2013R1A1A3005937]	Basic Science Research Program through the National Research Foundation of Korea [NRF] - Ministry of Science, ICT & Future Planning	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea [NRF] funded by the Ministry of Science, ICT & Future Planning [2013R1A1A3005937]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi JW, 2012, KOREAN J RADIOL, V13, P425, DOI 10.3348/kjr.2012.13.4.425; Choi YR, 2014, EUR J RADIOL, V83, P250, DOI 10.1016/j.ejrad.2013.10.028; DAIMARU Y, 1988, HUM PATHOL, V19, P257, DOI 10.1016/S0046-8177(88)80518-5; Edge SB, 2010, AM JOINT COMMITTEE C, P175; Hou YY, 2006, HISTOPATHOLOGY, V48, P536, DOI 10.1111/j.1365-2559.2006.02370.x; Jiang ZX, 2013, WORLD J GASTROENTERO, V19, P3108, DOI 10.3748/wjg.v19.i20.3108; Koch MR, 2013, CANCER IMAGING, V12, P557, DOI 10.1102/1470-7330.2012.0048; Miettinen M, 2000, AM J SURG PATHOL, V24, P1339, DOI 10.1097/00000478-200010000-00003; Miettinen M, 2001, VIRCHOWS ARCH, V438, P1, DOI 10.1007/s004280000338; Miettinen M, 2001, AM J SURG PATHOL, V25, P1121, DOI 10.1097/00000478-200109000-00002; Miettinen M, 2001, AM J SURG PATHOL, V25, P846, DOI 10.1097/00000478-200107000-00002; Miettinen M, 2006, SEMIN DIAGN PATHOL, V23, P70, DOI 10.1053/j.semdp.2006.09.001; Miettinen MS, 2000, WHO CLASSIFICATION T, P62	13	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0166377	10.1371/journal.pone.0166377	http://dx.doi.org/10.1371/journal.pone.0166377			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005903	Green Submitted, gold, Green Published			2022-12-26	WOS:000392843200006
J	Burritt, NL; Foss, NJ; Neeno-Eckwall, EC; Church, JO; Hilger, AM; Hildebrand, JA; Warshauer, DM; Perna, NT; Burritt, JB				Burritt, Nancy L.; Foss, Nicole J.; Neeno-Eckwall, Eric C.; Church, James O.; Hilger, Anna M.; Hildebrand, Jacob A.; Warshauer, David M.; Perna, Nicole T.; Burritt, James B.			Sepsis and Hemocyte Loss in Honey Bees (Apis mellifera) Infected with Serratia marcescens Strain Sicaria	PLOS ONE			English	Article							POLYPHASIC TAXONOMY; VARROA-DESTRUCTOR; COLONIES; EXPRESSION; PATHOGENS; MICROBES; DYNAMICS; GENOMICS; COLLAPSE; PROTEASE	Global loss of honey bee colonies is threatening the human food supply. Diverse pathogens reduce honey bee hardiness needed to sustain colonies, especially in winter. We isolated a free-living Gram negative bacillus from hemolymph of worker honey bees (Apis mellifera) found separated from winter clusters. In some hives, greater than 90% of the dying bees detached from the winter cluster were found to contain this bacterium in their hemolymph. Throughout the year, the same organism was rarely found in bees engaged in normal hive activities, but was detected in about half of Varroa destructor mites obtained from colonies that housed the septic bees. Flow cytometry of hemolymph from septic bees showed a significant reduction of plasmatocytes and other types of hemocytes. Interpretation of the l6S rRNA sequence of the bacterium indicated that it belongs to the Serratia genus of Gramnegative Gammaproteobacteria, which has not previously been implicated as a pathogen of adult honey bees. Complete genome sequence analysis of the bacterium supported its classification as a novel strain of Serratia marcescens, which was designated as S. marcescens strain sicaria (Ss1). When compared with other strains of S. marcescens, Ss1 demonstrated several phenotypic and genetic differences, including 65 genes not previously found in other Serratia genomes. Some of the unique genes we identified in Ss1 were related to those from bacterial insect pathogens and commensals. Recovery of this organism extends a complex pathosphere of agents which may contribute to failure of honey bee colonies.	[Burritt, Nancy L.; Foss, Nicole J.; Hilger, Anna M.; Hildebrand, Jacob A.; Burritt, James B.] Univ Wisconsin Stout, Dept Biol, Menomonie, WI 54751 USA; [Neeno-Eckwall, Eric C.] Univ Wisconsin, Ctr Biotechnol, Madison, WI 53705 USA; [Church, James O.] La Salle Univ, Dept Biol, Philadelphia, PA 19141 USA; [Warshauer, David M.] Univ Wisconsin, Wisconsin State Lab Hyg, Madison, WI 53706 USA; [Perna, Nicole T.] Univ Wisconsin, Genome Ctr Wisconsin, Madison, WI USA	University of Wisconsin System; University of Wisconsin Stout; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Burritt, JB (corresponding author), Univ Wisconsin Stout, Dept Biol, Menomonie, WI 54751 USA.	burrittj@uwstout.edu		Perna, Nicole/0000-0001-8208-0929	Honey Bee Health Task Force of the North American Pollinator Protection Campaign; State of Wisconsin; Direct For Biological Sciences [0936214] Funding Source: National Science Foundation	Honey Bee Health Task Force of the North American Pollinator Protection Campaign; State of Wisconsin; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors wish to acknowledge funding from the Honey Bee Health Task Force of the North American Pollinator Protection Campaign to JBB and the State of Wisconsin for funding biotechnology applications in the classroom. The opinions expressed are those of the authors and do not necessarily reflect the views of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe E, 2011, VIRULENCE, V2, P158, DOI 10.4161/viru.2.2.15337; Abebe-Akele F, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1697-8; Altincicek B, 2008, J IMMUNOL, V181, P2705, DOI 10.4049/jimmunol.181.4.2705; Babendreier D, 2007, FEMS MICROBIOL ECOL, V59, P600, DOI 10.1111/j.1574-6941.2006.00249.x; Betti MI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110237; Boncristiani H, 2012, J INSECT PHYSIOL, V58, P613, DOI 10.1016/j.jinsphys.2011.12.011; Breeze TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082996; Brutscher LM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005757; Budge GE, 2014, ISME J, V8, P1588, DOI 10.1038/ismej.2014.20; Cavigli I, 2016, APIDOLOGIE, V47, P251, DOI 10.1007/s13592-015-0395-5; Clermont A, 2015, SCI TOTAL ENVIRON, V532, P1, DOI 10.1016/j.scitotenv.2015.05.128; COLWELL RR, 1970, J BACTERIOL, V104, P410, DOI 10.1128/JB.104.1.410-433.1970; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; Dennis B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150055; Di Prisco G, 2016, P NATL ACAD SCI USA, V113, P3203, DOI 10.1073/pnas.1523515113; Edwards PR, 1986, IDENTIFICATION ENTER; ELSANOUSI SM, 1987, J GEN MICROBIOL, V133, P215; Evans JD, 2011, TRENDS MICROBIOL, V19, P614, DOI 10.1016/j.tim.2011.09.003; Evans JD, 2010, J INVERTEBR PATHOL, V103, pS62, DOI 10.1016/j.jip.2009.06.019; Fischer Steve, 2011, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0612s35; Forfert N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140337; Frey E, 2014, J ECON ENTOMOL, V107, P508, DOI 10.1603/EC13381; Gaetschenberger H, 2012, J EXP BIOL, V215, P1313, DOI 10.1242/jeb.065276; Genersch E, 2010, VET RES, V41, DOI 10.1051/vetres/2010027; GENG CX, 1989, DEV COMP IMMUNOL, V13, P17, DOI 10.1016/0145-305X(89)90012-8; GLINSKI ZF, 1990, J APICULT RES, V29, P107; Guidugli KR, 2005, FEBS LETT, V579, P4961, DOI 10.1016/j.febslet.2005.07.085; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hawthorne DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026796; Human H, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.10; Ishii K, 2014, J BIOL CHEM, V289, P5876, DOI 10.1074/jbc.M113.544536; Ishii K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089917; Jeyaprakash A, 2003, J INVERTEBR PATHOL, V84, P96, DOI 10.1016/j.jip.2003.08.007; Kwong WK, 2016, NAT REV MICROBIOL, V14, P374, DOI 10.1038/nrmicro.2016.43; Lundin O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136928; Marringa WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108486; Martin SJ, 2001, J APPL ECOL, V38, P1082, DOI 10.1046/j.1365-2664.2001.00662.x; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Moran NA, 2015, CURR OPIN INSECT SCI, V10, P22, DOI 10.1016/j.cois.2015.04.003; Mordecai GJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34983; Munch D, 2015, EXP GERONTOL; Petersen LM, 2014, J BACTERIOL, V196, P3923, DOI 10.1128/JB.01908-14; Petersen LM, 2012, APPL ENVIRON MICROB, V78, P8840, DOI 10.1128/AEM.02580-12; Pineda-Castellanos ML, 2015, PATHOGENS, V4, P210, DOI 10.3390/pathogens4020210; Porrini C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155411; Roberts KE, 2014, J INVERTEBR PATHOL, V121, P1, DOI 10.1016/j.jip.2014.06.004; Rodriguez-R, 2016, PEERJ, V4; Runckel C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095057; Salmela H, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005015; Sanchez-Bayo F, 2016, ENVIRON INT, V89-90, P7, DOI 10.1016/j.envint.2016.01.009; Schonrich G, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00366; Schwarz RS, 2014, MICROBIOLOGYOPEN, V3, P341, DOI 10.1002/mbo3.172; Sentausa E, 2013, CLIN MICROBIOL INFEC, V19, P790, DOI 10.1111/1469-0691.12181; Shanks RMQ, 2015, INFECT IMMUN, V83, P2907, DOI 10.1128/IAI.03096-14; Smith KM, 2013, ECOHEALTH, V10, P434, DOI 10.1007/s10393-013-0870-2; Stabentheiner A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008967; Sumpter DJT, 2000, J THEOR BIOL, V204, P1, DOI 10.1006/jtbi.1999.1063; Thompson CC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-913; Tu S, 2010, J INVERTEBR PATHOL, V104, P75, DOI 10.1016/j.jip.2010.02.002; Vandamme P, 1996, MICROBIOL REV, V60, P407, DOI 10.1128/MMBR.60.2.407-438.1996; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; YAGUPSKY P, 1990, CLIN MICROBIOL REV, V3, P269, DOI 10.1128/CMR.3.3.269-279.1990; Youngsteadt E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142031	65	40	42	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167752	10.1371/journal.pone.0167752	http://dx.doi.org/10.1371/journal.pone.0167752			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002470	gold, Green Published, Green Submitted			2022-12-26	WOS:000392853100020
J	Meza-Rios, A; Garcia-Benavides, L; Garcia-Banuelos, J; Salazar-Montes, A; Armendariz-Borunda, J; Sandoval-Rodriguez, A				Meza-Rios, Alejandra; Garcia-Benavides, Leonel; Garcia-Banuelos, Jesus; Salazar-Montes, Adriana; Armendariz-Borunda, Juan; Sandoval-Rodriguez, Ana			Simultaneous Administration of ADSCs-Based Therapy and Gene Therapy Using Ad-huPA Reduces Experimental Liver Fibrosis	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ADENOVIRAL VECTORS; UROKINASE; EXPRESSION; CIRRHOSIS; CHEMOKINES	Background and Aims hADSCs transplantation in cirrhosis models improves liver function and reduces fibrosis. In addition, Ad-huPA gene therapy diminished fibrosis and increased hepatocyte regeneration. In this study, we evaluate the combination of these therapies in an advanced liver fibrosis experimental model. Methods hADSCs were expanded and characterized before transplantation. Ad-huPA was simultaneously administrated via the ileac vein. Animals were immunosuppressed by CsA 24 h before treatment and until sacrifice at 10 days post-treatment. huPA liver expression and hADSCs biodistribution were evaluated, as well as the percentage of fibrotic tissue, hepatic mRNA levels of Col-alpha I, TGF-beta 1, CTGF, alpha-SMA, PAI-I, MMP2 and serum levels of ALT, AST and albumin. Results hADSCs homed mainly in liver, whereas huPA expression was similar in Ad-huPA and hADSCs/Ad-huPA groups. hADSCs, Ad-huPA and hADSCs/Ad-huPA treatment improves albumin levels, reduces liver fibrosis and diminishes Collagen alpha 1, CTGF and alpha-SMA mRNA liver levels. ALT and AST serum levels showed a significant decrease exclusively in the hADSCs group. Conclusions These results showed that combinatorial effect of cell and gene-therapy does not improve the antifibrogenic effects of individual treatments, whereas hADSCs transplantation seems to reduce liver fibrosis in a greater proportion.	[Meza-Rios, Alejandra; Garcia-Banuelos, Jesus; Salazar-Montes, Adriana; Armendariz-Borunda, Juan; Sandoval-Rodriguez, Ana] Univ Guadalajara, Hlth Sci Univ Ctr, Inst Mol Biol Med, Dept Mol Biol & Genom, Guadalajara, Jalisco, Mexico; [Garcia-Benavides, Leonel] Univ Guadalajara, Hlth Sci Univ Ctr, Dept Physiol, Unit Cardiovasc Invest, Guadalajara, Jalisco, Mexico; [Armendariz-Borunda, Juan] INNOVARE, Guadalajara, Jalisco, Mexico	Universidad de Guadalajara; Universidad de Guadalajara	Armendariz-Borunda, J; Sandoval-Rodriguez, A (corresponding author), Univ Guadalajara, Hlth Sci Univ Ctr, Inst Mol Biol Med, Dept Mol Biol & Genom, Guadalajara, Jalisco, Mexico.; Armendariz-Borunda, J (corresponding author), INNOVARE, Guadalajara, Jalisco, Mexico.	armdbo@gmail.com; anasol44@hotmail.com	Armendáriz-Borunda, Juan/AAU-1471-2021; Garcia Benavides, Leonel/GPP-7463-2022; garcia, leonel/V-9040-2017; Meza-Rios, Alejandra/Q-6629-2019; Garcia-Banuelos, Jesus/W-2927-2019	Garcia Benavides, Leonel/0000-0001-8087-3597; garcia, leonel/0000-0001-8087-3597; Meza-Rios, Alejandra/0000-0002-1322-1684; Sandoval-Rodriguez, Ana/0000-0003-1708-1495	CONACYT [103772, 183039]; Innovare	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Innovare	The funders (CONACYT Grant 103772 to ASR and 183039 to JAB) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Also, the funder (Innovare) provided support in the form of salaries for author JAB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Armendariz-Borunda J, 2011, J BIOSCI BIOENG, V112, P415, DOI 10.1016/j.jbiosc.2011.07.018; Baek SJ, 2011, EXP MOL MED, V43, P596, DOI 10.3858/emm.2011.43.10.069; Banas A, 2009, J GASTROEN HEPATOL, V24, P70, DOI 10.1111/j.1440-1746.2008.05496.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bueno M, 2006, J GENE MED, V8, P1291, DOI 10.1002/jgm.961; Carmeliet P, 1997, NAT GENET, V17, P439, DOI 10.1038/ng1297-439; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cui L, 2007, TISSUE ENG, V13, P1185, DOI 10.1089/ten.2006.0315; Fiore EJ, 2015, STEM CELLS DEV, V24, P791, DOI 10.1089/scd.2014.0174; Garcia-Banuelos J, 2002, GENE THER, V9, P127, DOI 10.1038/sj.gt.3301647; Harn HJ, 2012, CELL TRANSPLANT, V21, P2753, DOI 10.3727/096368912X652959; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Kamada Y, 2009, AM J PHYSIOL-GASTR L, V296, pG157, DOI 10.1152/ajpgi.90463.2008; LEE YG, 2008, J TISSUE ENG REGEN M, V5, P613; Li H, 2011, J HEPATOL, V54, P930, DOI 10.1016/j.jhep.2010.07.051; Lin HW, 2011, MATH PROBL ENG, V2011, DOI 10.1155/2011/402437; Lue J, 2010, LIVER INT, V30, P913, DOI 10.1111/j.1478-3231.2010.02231.x; Mohammadzadeh A, 2014, INT IMMUNOPHARMACOL, V20, P316, DOI 10.1016/j.intimp.2014.03.003; Muruve DA, 1999, HUM GENE THER, V10, P965, DOI 10.1089/10430349950018364; NALDINI L, 1992, EMBO J, V11, P4825, DOI 10.1002/j.1460-2075.1992.tb05588.x; Parekkadan B, 2007, BIOCHEM BIOPH RES CO, V363, P247, DOI 10.1016/j.bbrc.2007.05.150; Salgado AJ, 2010, CURR STEM CELL RES T, V5, P103; Salgado S, 2000, MOL THER, V2, P545, DOI 10.1006/mthe.2000.0210; Wang Y, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-133; Yu Y, 2007, MOL THER, V15, P1382, DOI 10.1038/sj.mt.6300202; Zuk, 2013, ISRN STEM CELLS, DOI [10.1155/2013/713959, DOI 10.1155/2013/713959]	26	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0166849	10.1371/journal.pone.0166849	http://dx.doi.org/10.1371/journal.pone.0166849			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992438	Green Submitted, gold, Green Published			2022-12-26	WOS:000392758000009
J	Qin, F; Liu, DX; Sun, BD; Ruan, L; Ma, ZH; Wang, HG				Qin, Feng; Liu, Dongxia; Sun, Bingda; Ruan, Liu; Ma, Zhanhong; Wang, Haiguang			Identification of Alfalfa Leaf Diseases Using Image Recognition Technology	PLOS ONE			English	Article							FEATURES; MACHINE	Common leaf spot (caused by Pseudopeziza medicaginis), rust (caused by Uromyces striatus), Leptosphaerulina leaf spot (caused by Leptosphaerulina briosiana) and Cercospora leaf spot (caused by Cercospora medicaginis) are the four common types of alfalfa leaf diseases. Timely and accurate diagnoses of these diseases are critical for disease management, alfalfa quality control and the healthy development of the alfalfa industry. In this study, the identification and diagnosis of the four types of alfalfa leaf diseases were investigated using pattern recognition algorithms based on image-processing technology. A sub-image with one or multiple typical lesions was obtained by artificial cutting from each acquired digital disease image. Then the sub-images were segmented using twelve lesion segmentation methods integrated with clustering algorithms (including K_means clustering, fuzzy C-means clustering and K_median clustering) and supervised classification algorithms (including logistic regression analysis, Naive Bayes algorithm, classification and regression tree, and linear discriminant analysis). After a comprehensive comparison, the segmentation method integrating the K_median clustering algorithm and linear discriminant analysis was chosen to obtain lesion images. After the lesion segmentation using this method, a total of 129 texture, color and shape features were extracted from the lesion images. Based on the features selected using three methods (ReliefF, 1R and correlation-based feature selection), disease recognition models were built using three supervised learning methods, including the random forest, support vector machine (SVM) and K-nearest neighbor methods. A comparison of the recognition results of the models was conducted. The results showed that when the ReliefF method was used for feature selection, the SVM model built with the most important 45 features (selected from a total of 129 features) was the optimal model. For this SVM model, the recognition accuracies of the training set and the testing set were 97.64% and 94.74%, respectively. Semi-supervised models for disease recognition were built based on the 45 effective features that were used for building the optimal SVM model. For the optimal semi-supervised models built with three ratios of labeled to unlabeled samples in the training set, the recognition accuracies of the training set and the testing set were both approximately 80%. The results indicated that image recognition of the four alfalfa leaf diseases can be implemented with high accuracy. This study provides a feasible solution for lesion image segmentation and image recognition of alfalfa leaf disease.	[Qin, Feng; Ruan, Liu; Ma, Zhanhong; Wang, Haiguang] China Agr Univ, Dept Plant Pathol, Beijing, Peoples R China; [Liu, Dongxia] Hebei North Univ, Coll Agr & Forestry Sci & Technol, Zhangjiakou, Hebei Province, Peoples R China; [Sun, Bingda] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China	China Agricultural University; Hebei North University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Wang, HG (corresponding author), China Agr Univ, Dept Plant Pathol, Beijing, Peoples R China.	wanghaiguang@cau.edu.cn	Ma, Zhanhong/AAY-4348-2021; Da Sun, Bing/AAT-7712-2020	Ma, Zhanhong/0000-0002-4910-5001	Special Fund for Agro-scientific Research in the Public Interest [201303057]	Special Fund for Agro-scientific Research in the Public Interest	HGW received Special Fund for Agro-scientific Research in the Public Interest (grant number 201303057). The URL of the funder's website is http://www.kjs.moa.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, orpreparation of the manuscript.	Aji Alham F., 2013, International Journal of Computer Theory and Engineering, V5, P528, DOI 10.7763/IJCTE.2013.V5.743; Barbedo JGA, 2016, BIOSYST ENG, V144, P52, DOI 10.1016/j.biosystemseng.2016.01.017; Barbedo JGA, 2014, PLANT DIS, V98, P1709, DOI 10.1094/PDIS-03-14-0290-RE; Atoum Y, 2016, PATTERN RECOGN, V53, P287, DOI 10.1016/j.patcog.2015.11.021; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Camargo A, 2009, BIOSYST ENG, V102, P9, DOI 10.1016/j.biosystemseng.2008.09.030; Camargo A, 2009, COMPUT ELECTRON AGR, V66, P121, DOI 10.1016/j.compag.2009.01.003; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Dubey Shiv Ram, 2014, International Journal of Computer Vision and Image Processing, V4, P52, DOI 10.4018/ijcvip.2014040104; Gonzalez R. C., 2007, DIGITAL IMAGE PROCES; Gonzalez R. C., 2005, DIGITAL IMAGE PROCES; Hall M. A., 1999, Proceedings of the Twelfth International Florida AI Research Society Conference, P235; Kononenko I., 1994, EUR C MACH LEARN, V784, P171, DOI DOI 10.1007/3-540-57868-4_57; Leiva-Valenzuela GA, 2013, FOOD CONTROL, V33, P166, DOI 10.1016/j.foodcont.2013.02.025; Li GuanLin, 2012, Journal of China Agricultural University, V17, P72; Li YZ, 2015, METHODS DIAGNOSE INV; Liu AP, 2005, PESTS THEIR CONTROL; Liu Lu, 2008, Computer Engineering and Applications, V44, P32; Mao HanPing, 2008, Transactions of the Chinese Society of Agricultural Engineering, V24, P136; Mao HanPing, 2003, Nongye Jixie Xuebao = Transactions of the Chinese Society of Agricultural Machinery, V34, P73; Omrani E, 2014, MEASUREMENT, V55, P512, DOI 10.1016/j.measurement.2014.05.033; Patil JK, 2011, J ADV BIOINFORM APPL, V2, P135; Patil S. B., 2011, INT J ENG TECHNOLOGY, V3, P297, DOI 10.7763/IJET.2011.V3.241; Phadikar S, 2013, COMPUT ELECTRON AGR, V90, P76, DOI 10.1016/j.compag.2012.11.001; Powers D. M, 2011, ARXIV201016061; Pydipati R, 2006, COMPUT ELECTRON AGR, V52, P49, DOI 10.1016/j.compag.2006.01.004; [屈赟 Qu Yun], 2015, [河北农业大学学报, Journal of Agricultural University of Hebei], V38, P102; Rosenberg C, 2005, WACV 2005: SEVENTH IEEE WORKSHOP ON APPLICATIONS OF COMPUTER VISION, PROCEEDINGS, P29; Samac DA, 2014, COMPENDIUM ALFALFA D; Sankaran S, 2010, COMPUT ELECTRON AGR, V72, P1, DOI 10.1016/j.compag.2010.02.007; Schaad NW, 2002, CAN J PLANT PATHOL, V24, P250; Song Y, 2007, LECT NOTES ARTIF INT, V4702, P248; Story D, 2010, COMPUT ELECTRON AGR, V74, P238, DOI 10.1016/j.compag.2010.08.010; STRICKER M, 1995, P SOC PHOTO-OPT INS, V2410, P381, DOI 10.1117/12.205308; Tan W.X., 2015, T CSAM, V46, P20, DOI 10.6041/j.issn.1000-1298.2015.01.004; Tian YouWen, 2007, Transactions of the Chinese Society of Agricultural Engineering, V23, P175; Torgo L., 2010, DATA MINING R LEARNI; Wang XY, 2012, NEURAL NETWORKS, V33, P148, DOI 10.1016/j.neunet.2012.04.012; Witten IH, 2014, DATA MINING PRACTICA; Xia YQ, 2014, J ZHENGZHOU U LIGHT, V29, P71; Xu GL, 2011, PATTERN RECOGN LETT, V32, P1584, DOI 10.1016/j.patrec.2011.04.020; [叶海建 Ye Haijian], 2016, [农业机械学报, Transactions of the Chinese Society for Agricultural Machinery], V47, P270; Zhang JianHua, 2012, Transactions of the Chinese Society of Agricultural Engineering, V28, P161; Zhang M, 2011, PATTERN RECOGN LETT, V32, P2036, DOI 10.1016/j.patrec.2011.08.003; Zhao YuXia, 2007, Scientia Agricultura Sinica, V40, P698; Zheng Jiao, 2015, Computer Engineering and Science, V37, P1366, DOI 10.3969/j.issn.1007-130X.2015.07.023; Zhou R, 2015, COMPUT ELECTRON AGR, V116, P65, DOI 10.1016/j.compag.2015.05.020	50	55	59	5	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168274	10.1371/journal.pone.0168274	http://dx.doi.org/10.1371/journal.pone.0168274			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977767	gold, Green Published, Green Submitted			2022-12-26	WOS:000391217400086
J	Wang, ZW; Huang, B; Dong, H; Zhao, QP; Zhu, SH; Xia, WL; Xu, SB; Xie, YX; Cui, XX; Tang, M; Men, QF; Yang, ZY; Li, C; Zhu, XL; Han, HY				Wang, Ziwen; Huang, Bing; Dong, Hui; Zhao, Qiping; Zhu, Shunhai; Xia, Weili; Xu, Shuaibin; Xie, Yuxiang; Cui, Xiaoxia; Tang, Min; Men, Qifei; Yang, Zhiyuang; Li, Cong; Zhu, Xuelong; Han, Hongyu			Molecular Characterization and Functional Analysis of a Novel Calcium-Dependent Protein Kinase 4 from Eimeria tenella	PLOS ONE			English	Article							STAGE-SPECIFIC EXPRESSION; PLASMODIUM-FALCIPARUM; PARASITOPHOROUS VACUOLE; SELECTIVE INHIBITORS; HOST-CELL; GONDII; IDENTIFICATION; PARASITE; CDPK; PURIFICATION	Eimeria tenella is an obligate intracellular parasite that actively invades cecal epithelial cells of chickens. The basis of cell invasion is not completely understood, but some key molecules of host cell invasion have been discovered. This paper investigated the characteristics of calcium-dependent protein kinase 4 (EtCDPK4), a critical molecule in E. tenella invasion of host cells. A full-length EtCDPK4 cDNA was identified from E. tenella using rapid amplification of cDNA ends. EtCDPK4 had an open reading frame of 1803 bp encoding a protein of 600 amino acids. Quantitative real-time PCR and western blotting were used to explore differences in EtCDPK4 transcription and translation in four developmental stages of E. tenella. EtCDPK4 was expressed at higher levels in sporozoites, but translation was higher in second-generation merozoites. In vitro invasion inhibition assays explored whether EtCDPK4 was involved in invasion of DF-1 cells by E. tenella sporozoites. Polyclonal antibodies against recombinant EtCDPK4 (rEtCDPK4) inhibited parasite invasion, decreasing it by approximately 52%. Indirect immunofluorescence assays explored EtCDPK4 distribution during parasite development after E. tenella sporozoite invasion of DF-1 cells in vitro. The results showed that EtCDPK4 might be important in sporozoite invasion and development. To analyze EtCDPK4 functional domains according to the structural characteristics of EtCDPK4 and study the kinase activity of rEtCDPK4, an in vitro phosphorylation system was established. We verified that rEtCDPK4 was a protein kinase that was completely dependent on Ca2+ for enzyme activity. Specific inhibitors of rEtCDPK4 activity were screened by kinase activity in vitro. Some specific inhibitors were applied to assays of DF-1 cell invasion by E. tenella sporozoites to confirm that the inhibitors functioned in vitro. W-7, H-7, H-89, and myristoylated peptide inhibited DF-1 invasion by E. tenella sporozoites. The experimental results showed that EtCDPK4 may be involved in E. tenella invasion of chicken cecal epithelial cells.	[Wang, Ziwen; Huang, Bing; Dong, Hui; Zhao, Qiping; Zhu, Shunhai; Xia, Weili; Xu, Shuaibin; Xie, Yuxiang; Cui, Xiaoxia; Tang, Min; Men, Qifei; Yang, Zhiyuang; Li, Cong; Zhu, Xuelong; Han, Hongyu] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Key Lab Anim Parasitol, Minist Agr, Shanghai, Peoples R China; [Huang, Bing] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Han, HY (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Key Lab Anim Parasitol, Minist Agr, Shanghai, Peoples R China.	hhysh@shvri.ac.cn			National Natural Science Foundation of China [31572266, 31272557]; Central Public Welfare Research Institutions and Basic Scientific Research Business Expenses [2016JB10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Central Public Welfare Research Institutions and Basic Scientific Research Business Expenses	This work was supported by the National Natural Science Foundation of China (Grant No. 31572266, No. 31272557) and Central Public Welfare Research Institutions and Basic Scientific Research Business Expenses (No. 2016JB10).	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Alcala-Canto Y, 2014, BRIT POULTRY SCI, V55, P44, DOI 10.1080/00071668.2013.872770; Allwood EG, 2002, PLANT MOL BIOL, V49, P533, DOI 10.1023/A:1015502117870; Azevedo MF, 2013, BIOCHEM J, V452, P433, DOI 10.1042/BJ20130124; Bansal A, 2013, J BIOL CHEM, V288, P1590, DOI 10.1074/jbc.M112.411934; Belli SL, 2005, PROTEOMICS, V5, P918, DOI 10.1002/pmic.200401161; Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; Billker O, 2009, CELL HOST MICROBE, V5, P612, DOI 10.1016/j.chom.2009.05.017; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645; Coppi A, 2007, CELL HOST MICROBE, V2, P316, DOI 10.1016/j.chom.2007.10.002; Dammann C, 2003, PLANT PHYSIOL, V132, P1840, DOI 10.1104/pp.103.020008; Daszak P, 1999, PARASITOL TODAY, V15, P67, DOI 10.1016/S0169-4758(98)01379-9; Donald RGK, 2006, MOL BIOCHEM PARASIT, V149, P86, DOI 10.1016/j.molbiopara.2006.05.003; Dunn PPJ, 1996, PARASITOLOGY, V113, P439, DOI 10.1017/S0031182000081506; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; EICHHOLTZ T, 1993, J BIOL CHEM, V268, P1982; Elmore SA, 2010, TRENDS PARASITOL, V26, P190, DOI 10.1016/j.pt.2010.01.009; Entzeroth R, 1998, INT J PARASITOL, V28, P1015, DOI 10.1016/S0020-7519(98)00079-4; Etzold M, 2014, PARASITOL RES, V113, P2525, DOI 10.1007/s00436-014-3902-0; Fetterer RH, 2007, J PARASITOL, V93, P333, DOI 10.1645/GE-824R1.1; Garrison E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003049; Han HY, 2013, PARASITOLOGY, V140, P746, DOI 10.1017/S0031182012002107; Harper JF, 2005, NAT REV MOL CELL BIO, V6, P555, DOI 10.1038/nrm1679; HARPER JF, 1991, SCIENCE, V252, P951, DOI 10.1126/science.1852075; HARPER JF, 1994, BIOCHEMISTRY-US, V33, P7267, DOI 10.1021/bi00189a031; Hettenhausen C, 2016, SCI REP-UK, V6, DOI 10.1038/srep18973; Hrabak EM, 1996, PLANT MOL BIOL, V31, P405, DOI 10.1007/BF00021802; Huang Y, 1999, ACTA BIOCH BIOPH SIN, V31, P572; Hui R, 2015, TRENDS PHARMACOL SCI, V36, P452, DOI 10.1016/j.tips.2015.04.011; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; Jahn D, 2009, PARASITOL RES, V105, P655, DOI 10.1007/s00436-009-1437-6; Jiang Lian-lian, 2011, Zhongguo Shouyi Kexue, V41, P551; Jiang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041115; Jiang LL, 2012, PARASITOL RES, V110, P865, DOI 10.1007/s00436-011-2568-0; Kaminski T, 2004, DOMEST ANIM ENDOCRIN, V27, P379, DOI 10.1016/j.domaniend.2004.05.001; Katrib M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-685; Keyloun KR, 2014, PARASITOLOGY, V141, P1499, DOI 10.1017/S0031182014000857; Kieschnick H, 2001, J BIOL CHEM, V276, P12369, DOI 10.1074/jbc.M011045200; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Kumar P, 2014, J BIOL CHEM, V289, P20386, DOI 10.1074/jbc.M114.561670; Labbe M, 2006, INT J PARASITOL, V36, P1443, DOI 10.1016/j.ijpara.2006.08.011; Leclercq J, 2005, J EXP BOT, V56, P25, DOI 10.1093/jxb/eri003; Li JL, 2000, BBA-GENE STRUCT EXPR, V1491, P341, DOI 10.1016/S0167-4781(00)00032-4; Lourido S, 2012, EMBO J, V31, P4524, DOI 10.1038/emboj.2012.299; Lourido S, 2010, NATURE, V465, P359, DOI 10.1038/nature09022; Matsubayashi M, 2012, PARASITOLOGY, V139, P1553, DOI 10.1017/S0031182012001072; Mccoy JM, 2013, PLOS PATHOG, V8, P155; MICHALSKI WP, 1992, INT J PARASITOL, V22, P1157, DOI 10.1016/0020-7519(92)90035-J; MIELKE D, 1991, Angewandte Parasitologie, V32, P39; Moreno SNJ, 2003, CURR OPIN MICROBIOL, V6, P359, DOI 10.1016/S1369-5274(03)00091-2; Morlon-Guyot J, 2014, CELL MICROBIOL, V16, P95, DOI 10.1111/cmi.12186; Moskes C, 2004, MOL MICROBIOL, V54, P676, DOI 10.1111/j.1365-2958.2004.04313.x; Nagamune K, 2006, MOL BIOL EVOL, V23, P1613, DOI 10.1093/molbev/msl026; Nemoto K, 2015, J BIOL CHEM, V290, P16665, DOI 10.1074/jbc.M114.617274; Ojo KK, 2010, NAT STRUCT MOL BIOL, V17, P602, DOI 10.1038/nsmb.1818; Osuna L, 2004, BIOCHEM BIOPH RES CO, V314, P428, DOI 10.1016/j.bbrc.2003.12.103; Peroval M, 2006, INT J PARASITOL, V36, P1205, DOI 10.1016/j.ijpara.2006.04.006; Podell S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-37; Ranjan R, 2009, J BIOL CHEM, V284, P15267, DOI 10.1074/jbc.M900656200; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Salowe SP, 2002, BIOCHEMISTRY-US, V41, P4385, DOI 10.1021/bi0156658; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Sasai K, 2008, J PARASITOL, V94, P1432, DOI 10.1645/GE-1558.1; Sebastian S, 2012, CELL HOST MICROBE, V12, P9, DOI 10.1016/j.chom.2012.05.014; Shirley MW, 2004, TRENDS PARASITOL, V20, P199, DOI 10.1016/j.pt.2004.02.005; Siden-Kiamos I, 2006, MOL MICROBIOL, V60, P1355, DOI 10.1111/j.1365-2958.2006.05189.x; Tabares E, 2004, MOL BIOCHEM PARASIT, V135, P123, DOI 10.1016/j.molbiopara.2004.01.013; Tomley F, 1997, METHODS, V13, P171, DOI 10.1006/meth.1997.0509; Treeck M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004197; Wernimont AK, 2010, NAT STRUCT MOL BIOL, V17, P596, DOI 10.1038/nsmb.1795; Wilson PAG, 2007, J EUKARYOT MICROBIOL, V8, P410; XIE MQ, 1990, PARASITOL RES, V76, P566, DOI 10.1007/BF00932562; Zhang TG, 2005, J PLANT PHYSIOL, V162, P1149, DOI 10.1016/j.jplph.2004.12.010; Zhang ZS, 2014, ACS MED CHEM LETT, V5, P40, DOI 10.1021/ml400315s; ZHAO Y, 1994, MOL BIOCHEM PARASIT, V66, P329, DOI 10.1016/0166-6851(94)90159-7; ZHAO Y, 1994, BIOCHEMISTRY-US, V33, P3714, DOI 10.1021/bi00178a031	77	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168132	10.1371/journal.pone.0168132	http://dx.doi.org/10.1371/journal.pone.0168132			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977727	Green Published, gold, Green Submitted			2022-12-26	WOS:000391217400065
J	Yamaguchi, M; Steeves, EA; Shipley, C; Hopkins, LC; Cheskin, LJ; Gittelsohn, J				Yamaguchi, Miwa; Steeves, Elizabeth Anderson; Shipley, Cara; Hopkins, Laura C.; Cheskin, Lawrence J.; Gittelsohn, Joel			Inconsistency between Self-Reported Energy Intake and Body Mass Index among Urban, African-American Children	PLOS ONE			English	Article							BASAL METABOLIC-RATE; LOW-INCOME; GOLDBERG CUTOFF; QUESTIONNAIRE; VALIDITY; OVERWEIGHT; OBESITY; RELIABILITY; CONSUMPTION; DESIGN	Background To prevent obesity, it is important to assess dietary habits through self-reported energy intake (EI) in children. We investigated how EI is associated with body mass index and which elements of dietary habits and status are associated with EI among African-American (AA) children. Methods We assessed and included data from 218 10-14-year-old AA children in Baltimore, MD, USA. EI was calculated using a food frequency questionnaire. The basal metabolic rate (BMR) was used as the predicted minimal rate of energy expenditure of children. A fully adjusted multiple logistic regression was used to determine the prevalence of obesity (>= 95th BMI-for-age percentile) among the quartiles of EI/BMR ratio using the third quartile for the reference. The differences in the age-adjusted mean EI/BMR among the categories of dietary habits, social support, and socio economic status were analyzed using a general linear model. Results Children with the lowest EI/BMR had significantly higher adjusted odds ratio (aOR) of obesity as compared to those in the third quartile of EI/BMR (boys aOR 4.3; 95% confidence interval 1.08, 20 and girls aOR 4.1; 1.02, 21). In girls, the adjusted mean EI/BMR in the group that prepared food less than the means (3.8 times/week) was significantly lower than the group that prepared food over the means (P = 0.03). Further, the group that reported eating breakfast under 4 times/week indicated an adjusted mean EI/BMR lower than the group that ate breakfast over 5 times/week in both sexes. Conclusions When EI was under-reported with reference to BMR, we may observe high prevalence of obesity. Further, food preparation by children and frequent consumption of breakfast may instill food cognition with usual dietary habits. Therefore, holistic assessments including dietary habits are required to examine self-reported food intake especially among overweight/obese children.	[Yamaguchi, Miwa] Natl Inst Biomed Innovat Hlth & Nutr, Natl Inst Hlth & Nutr, Dept Nutr Sci, Tokyo, Japan; [Steeves, Elizabeth Anderson; Shipley, Cara; Hopkins, Laura C.; Cheskin, Lawrence J.; Gittelsohn, Joel] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth Global Obes Prevent Johns Hopkins, Baltimore, MD USA	National Institute of Health & Nutrition - Japan; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Yamaguchi, M (corresponding author), Natl Inst Biomed Innovat Hlth & Nutr, Natl Inst Hlth & Nutr, Dept Nutr Sci, Tokyo, Japan.	miwayama@nih.go.jp	Cheskin, Lawrence/AAM-1094-2021	Cheskin, Lawrence/0000-0003-0262-1030	Global Obesity Prevention Center (GOPC) at Johns Hopkins; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Office of the Director, National Institutes of Health (OD) [U54HD070725]	Global Obesity Prevention Center (GOPC) at Johns Hopkins; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Office of the Director, National Institutes of Health (OD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research reported in this publication was supported by the Global Obesity Prevention Center (GOPC) at Johns Hopkins, and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the Office of the Director, National Institutes of Health (OD) under award number U54HD070725. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], 1985, World Health Organ Tech Rep Ser, V724, P1; Bandini LG, 2003, AM J CLIN NUTR, V78, P480, DOI 10.1093/ajcn/78.3.480; Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376; Black AE, 2000, EUR J CLIN NUTR, V54, P395, DOI 10.1038/sj.ejcn.1600971; BLOCK G, 1986, AM J EPIDEMIOL, V124, P453, DOI 10.1093/oxfordjournals.aje.a114416; Centers for Disease Control and Prevention. Baltimore MD, 2016, BALT MD HIGH SCH YOU, V5, P25; Champagne CM, 1998, J AM DIET ASSOC, V98, P426, DOI 10.1016/S0002-8223(98)00097-2; Crews DC, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-192; Croezen S, 2009, EUR J CLIN NUTR, V63, P405, DOI 10.1038/sj.ejcn.1602950; Cullen KW, 2008, J AM DIET ASSOC, V108, P862, DOI 10.1016/j.jada.2008.02.015; Dennisuk LA, 2011, AM J PREV MED, V40, P625, DOI 10.1016/j.amepre.2011.02.015; Field AE, 1999, PUBLIC HEALTH NUTR, V2, P293, DOI 10.1017/S1368980099000397; Garriguet Didier, 2008, Health Rep, V19, P37; Gittelsohn J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-942; GOLDBERG GR, 1991, EUR J CLIN NUTR, V45, P569; Hallstrom L, 2011, APPETITE, V56, P649, DOI 10.1016/j.appet.2011.02.019; Hare ME, 2012, CHILD OBES, V8, P551, DOI 10.1089/chi.2011.0117; Iannotti RJ, 2013, PEDIATRICS, V132, P606, DOI 10.1542/peds.2013-1488; Kolodziejczyk JK, 2012, J PEDIATR GASTR NUTR, V55, P4, DOI 10.1097/MPG.0b013e318251550e; Lanctot JQ, 2008, OBESITY, V16, P1407, DOI 10.1038/oby.2008.222; Lazarus R, 1996, AM J CLIN NUTR, V63, P500, DOI 10.1093/ajcn/63.4.500; Lin BH, 1996, DIETS AM CHILDREN IN, V746; Livingstone MBE, 2004, BRIT J NUTR, V92, pS213, DOI 10.1079/BJN20041169; Livingstone MBE, 2000, P NUTR SOC, V59, P279, DOI 10.1017/S0029665100000318; Marshall TA, 2008, J AM DIET ASSOC, V108, P465, DOI 10.1016/j.jada.2007.12.002; Moore GF, 2008, J AM DIET ASSOC, V108, P1865, DOI 10.1016/j.jada.2008.08.012; Moore L, 2005, EUR J CLIN NUTR, V59, P809, DOI 10.1038/sj.ejcn.1602146; National Center for Health Statistics, 2002, VITAL HLTH STAT, V11; NutritionQuest, 2016, BLOCK QUEST, V5, P25; Pannacciulli N, 2007, AM J CLIN NUTR, V86, P625; Rosenkranz RR, 2008, NUTR REV, V66, P123, DOI 10.1111/j.1753-4887.2008.00017.x; Steeves ETA, 2016, PUBLIC HEALTH NUTR, V19, P3406, DOI 10.1017/S1368980016001701; van der Horst K, 2014, APPETITE, V79, P18, DOI 10.1016/j.appet.2014.03.030; Vance VA, 2009, PUBLIC HEALTH NUTR, V12, P222, DOI 10.1017/S1368980008003108; Wang Y, 2002, EUR J CLIN NUTR, V56, P973, DOI 10.1038/sj.ejcn.1601415; Wong WW, 1996, J APPL PHYSIOL, V81, P2407, DOI 10.1152/jappl.1996.81.6.2407; Worsley A, 2002, ASIA PAC J CLIN NUTR, V11, pS579, DOI 10.1046/j.1440-6047.11.supp3.7.x	37	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168303	10.1371/journal.pone.0168303	http://dx.doi.org/10.1371/journal.pone.0168303			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977776	Green Published, Green Submitted, gold			2022-12-26	WOS:000391217400090
J	Yang, Y; Kelly, PJ; Bai, JF; Zhang, R; Wang, CM				Yang, Yi; Kelly, Patrick John; Bai, Jianfa; Zhang, Rong; Wang, Chengming			First Molecular Characterization of Bovine Leukemia Virus Infections in the Caribbean	PLOS ONE			English	Article							SOMATIC-CELL SCORE; ENV GENE; PHYLOGENETIC ANALYSIS; NATURAL TRANSMISSION; AMBLYOMMA-VARIEGATUM; ENVELOPE PROTEIN; DAIRY HERDS; CATTLE; MILK; GP51	Bovine leukemia virus (BLV) is a retrovirus that causes enzootic bovine leucosis. To investigate the presence and genetic variability of BLV in the Caribbean for the first time, we preformed fluorescence resonance energy transfer (FRET)-PCR for the pol of BLV on DNA from whole blood of cattle from Dominica, Montserrat, Nevis and St. Kitts. Standard PCRs with primers for the env were used for phylogenetic analysis of BLV in positive animals. We found FRET-PCR positive cattle (12.6%, 41/325) on Dominica (5.2%; 4/77) and St. Kitts (19.2%; 37/193) but not on Montserrat (0%, 0/12) or Nevis (0%, 0/43). Positive animals were cows on farms where animals were raised intensively. Phylogenetic analysis using the neighbor-joining (NJ) method on partial and full-length env sequences obtained for strains from Dominica (n = 2) and St. Kitts (n = 5) and those available in GenBank (n = 90) (genotypes 1-10) revealed the Caribbean strains belonged to genotype 1 (98-100% sequence homology). Ours is the first molecular characterization of BLV infections in the Caribbean and the first description of genotype 1 in the region.	[Yang, Yi; Zhang, Rong; Wang, Chengming] Yangzhou Univ, Coll Vet Med, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China; [Yang, Yi; Bai, Jianfa] Kansas State Univ, Coll Vet Med, Dept Vet Diagnost Lab, Manhattan, KS 66506 USA; [Kelly, Patrick John] Ross Univ, Sch Vet Med, Basseterre, St Kitts & Nevi; [Wang, Chengming] Auburn Univ, Coll Vet Med, Dept Pathobiol, Auburn, AL 36849 USA	Yangzhou University; Kansas State University; Auburn University System; Auburn University	Wang, CM (corresponding author), Yangzhou Univ, Coll Vet Med, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China.; Bai, JF (corresponding author), Kansas State Univ, Coll Vet Med, Dept Vet Diagnost Lab, Manhattan, KS 66506 USA.; Wang, CM (corresponding author), Auburn Univ, Coll Vet Med, Dept Pathobiol, Auburn, AL 36849 USA.	jbai@vet.ksu.edu; wangche@auburn.edu	Bai, Jianfa/M-7830-2019	Bai, Jianfa/0000-0002-0021-3036; Yang, Yi/0000-0002-5214-5856	National Natural Science Foundation of China [31272575]; Program granted for Scientific Innovation Research of College Graduate in Jiangsu province [KYZZ16_0496]; Priority Academic Program Development of Jiangsu Higher Education Institutions; China Scholarship Council	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program granted for Scientific Innovation Research of College Graduate in Jiangsu province; Priority Academic Program Development of Jiangsu Higher Education Institutions; China Scholarship Council(China Scholarship Council)	This work was supported by the National Natural Science Foundation of China (31272575) to CW; Program granted for Scientific Innovation Research of College Graduate in Jiangsu province (KYZZ16_0496) to YY; The Priority Academic Program Development of Jiangsu Higher Education Institutions to CW; China Scholarship Council to YY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla EA, 2016, J DAIRY SCI, V99, P2005, DOI 10.3168/jds.2015-9833; Balic D, 2012, ARCH VIROL, V157, P1281, DOI 10.1007/s00705-012-1300-4; Bartlett PC, 2013, J DAIRY SCI, V96, P1591, DOI 10.3168/jds.2012-5930; CALLEBAUT I, 1993, J VIROL, V67, P5321, DOI 10.1128/JVI.67.9.5321-5327.1993; Camargos MF, 2007, VIRUS GENES, V34, P343, DOI 10.1007/s11262-006-0011-x; Camargos MF, 2002, J VET MED B, V49, P325, DOI 10.1046/j.1439-0450.2002.00582.x; DA Y, 1993, P NATL ACAD SCI USA, V90, P6538, DOI 10.1073/pnas.90.14.6538; DIMMOCK CK, 1991, AUST VET J, V68, P230, DOI 10.1111/j.1751-0813.1991.tb03213.x; Felmer R, 2005, VET MICROBIOL, V108, P39, DOI 10.1016/j.vetmic.2005.04.005; FRENCH S, 1983, J MOL EVOL, V19, P171, DOI 10.1007/BF02300754; Hemmatzadeh F, 2007, VET RES COMMUN, V31, P783, DOI 10.1007/s11259-007-0012-9; Hopkins SG, 1997, VET CLIN N AM-FOOD A, V13, P107; Inabe K, 1999, J VIROL, V73, P1293, DOI 10.1128/JVI.73.2.1293-1301.1999; Johnston ER, 2000, J VIROL, V74, P2930, DOI 10.1128/JVI.74.6.2930-2935.2000; Kelly PJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-182; Kelly PJ, 2011, J MED ENTOMOL, V48, P485, DOI 10.1603/ME10172; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lee E, 2016, INFECT GENET EVOL, V41, P245, DOI 10.1016/j.meegid.2016.04.010; Li J, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0560-0; Licursi M, 2003, VET MICROBIOL, V96, P17, DOI 10.1016/S0378-1135(03)00202-5; MAMOUN RZ, 1990, J VIROL, V64, P4180, DOI 10.1128/JVI.64.9.4180-4188.1990; Mekata H, 2015, VET REC, V176, P254, DOI 10.1136/vr.102464; MILLER JM, 1979, J NATL CANCER I, V62, P425; Monti G, 2005, ARCH VIROL, V150, P443, DOI 10.1007/s00705-004-0437-1; Moratorio G, 2010, ARCH VIROL, V155, P481, DOI 10.1007/s00705-010-0606-3; Ochirkhuu N, 2016, ARCH VIROL, V161, P985, DOI 10.1007/s00705-015-2676-8; Polat M, 2016, ARCH VIROL; Polat M, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0239-z; Polat M, 2015, ARCH VIROL, V160, P285, DOI 10.1007/s00705-014-2280-3; Rodriguez SM, 2009, J GEN VIROL, V90, P2788, DOI 10.1099/vir.0.011791-0; Rola-Luszczak M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058705; SAGATA N, 1984, EMBO J, V3, P3231, DOI 10.1002/j.1460-2075.1984.tb02283.x; Wang CM, 2010, J CLIN MICROBIOL, V48, P1667, DOI 10.1128/JCM.00227-10; Yang Y, 2016, J DAIRY SCI, V99, P3688, DOI 10.3168/jds.2015-10580; Zhao XR, 2007, VIROLOGY, V366, P150, DOI 10.1016/j.virol.2007.03.058	35	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168379	10.1371/journal.pone.0168379	http://dx.doi.org/10.1371/journal.pone.0168379			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977761	gold, Green Published, Green Submitted			2022-12-26	WOS:000391217400104
J	Wang, T; Xu, X; Xu, Q; Ren, J; Shen, S; Fan, C; Hou, Y				Wang, T.; Xu, X.; Xu, Q.; Ren, J.; Shen, S.; Fan, C.; Hou, Y.			miR-19a promotes colitis-associated colorectal cancer by regulating tumor necrosis factor alpha-induced protein 3-NF-kappa B feedback loops	ONCOGENE			English	Article							NF-KAPPA-B; MOUSE MODEL; TNF-ALPHA; LINEAR POLYUBIQUITIN; DOWN-REGULATION; BREAST-CANCER; COLON-CANCER; A20; ACTIVATION; INHIBITION	Chronic inflammation is believed to have a crucial role in colon cancer development. MicroRNA (miRNA) deregulation is common in human colorectal cancers, but little is known regarding whether miRNA drives tumor progression by regulating inflammation. Here, we showed that miR-19a can promote colitis and colitis-associated colon cancer (CAC) development using a CAC mouse model and an acute colitis mouse model. Tumor necrosis factor-a (TNF-a) stimulation can increase miR-19a expression, and upregulated miR-19a can in turn activate nuclear factor (NF)-kappa B signaling and TNF-a production by targeting TNF alpha-induced protein 3 (TNFAIP3). miR-19a inhibition can also alleviate CAC in vivo. Moreover, the regulatory effects of miR-19a on TNFAIP3 and NF-kappa B signaling were confirmed using tumor samples from patients with colon cancer. These new findings demonstrate that miR-19a has a direct role in upregulating NF-kappa B signaling and that miR-19a has roles in inflammation and CAC.	[Wang, T.; Xu, Q.; Ren, J.; Shen, S.; Hou, Y.] Nanjing Univ, Sch Med, State Key Lab Pharmaceut Biotechnol, Div Immunol, Nanjing 210093, Jiangsu, Peoples R China; [Wang, T.; Shen, S.; Hou, Y.] Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China; [Wang, T.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Xu, X.; Fan, C.] Nanjing Univ, Sch Med, Jinling Hosp, Gen Surg, Nanjing 210093, Jiangsu, Peoples R China	Nanjing University; University of Texas System; UTMD Anderson Cancer Center; Nanjing University	Shen, S; Hou, Y (corresponding author), Nanjing Univ, Sch Med, State Key Lab Pharmaceut Biotechnol, Div Immunol, Nanjing 210093, Jiangsu, Peoples R China.; Fan, C (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Gen Surg, Nanjing 210093, Jiangsu, Peoples R China.	shensn@nju.edu.cn; fancg2002@hotmail.com; yayihou@nju.edu.cn			National Natural Science Foundation of China [81572354, 81571800, 81371680]; Natural Science Foundation of Jiangsu Province [BK20161400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was partially supported by grants from the National Natural Science Foundation of China (81572354, 81571800, and 81371680) and Natural Science Foundation of Jiangsu Province (BK20161400).	Ahmed FE, 2014, EXPERT REV ANTICANC, V14, P463, DOI 10.1586/14737140.2014.869479; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Bi LK, 2010, J BIOL CHEM, V285, P25969, DOI 10.1074/jbc.M110.131300; Burisch J, 2015, SCAND J GASTROENTERO, V50, P942, DOI 10.3109/00365521.2015.1014407; Cellura D, 2015, MOL CANCER RES, V13, P1095, DOI 10.1158/1541-7786.MCR-14-0466; Chen B, 2013, SCAND J GASTROENTERO, V48, P815, DOI 10.3109/00365521.2013.800991; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Fluckiger A, 2016, ONCOGENE, V35, P4611, DOI 10.1038/onc.2015.523; Gantier MP, 2012, NUCLEIC ACIDS RES, V40, P8048, DOI 10.1093/nar/gks521; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Guina T, 2015, ANN NY ACAD SCI, V1340, P95, DOI 10.1111/nyas.12734; Hamilton MP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3730; HAYASHITA Y, 2005, CANCER RES, V65, P9628, DOI [DOI 10.1158/0008-5472.CAN-05-2352, 10.1158/0008-5472.CAN-05-2352]; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Huang LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13350; Ishikawa TO, 2010, CARCINOGENESIS, V31, P729, DOI 10.1093/carcin/bgq002; Ito Y, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1315-9; Jiang H, 2014, AM J PATHOL, V184, P1355, DOI 10.1016/j.ajpath.2014.01.037; Jiang LL, 2012, J CLIN INVEST, V122, P33, DOI 10.1172/JCI58849; Jin LJ, 2014, BREAST CANCER RES TR, V146, P41, DOI 10.1007/s10549-014-2978-7; Jung SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3562; Kanaan Z, 2012, HUM MUTAT, V33, P551, DOI 10.1002/humu.22021; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Kim SW, 2012, P NATL ACAD SCI USA, V109, P7865, DOI 10.1073/pnas.1200081109; Knudsen KN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140503; Landers CJ, 2002, GASTROENTEROLOGY, V123, P689, DOI 10.1053/gast.2002.35379; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; Liu KJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/867537; Liu M, 2011, INT J ONCOL, V38, P1013, DOI 10.3892/ijo.2011.924; Lu T, 2015, CANCER RES, V75, P3692, DOI 10.1158/0008-5472.CAN-15-1022; Ma HB, 2016, CANCER LETT, V376, P293, DOI 10.1016/j.canlet.2016.04.011; Mihailovich M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9725; Nakshatri H, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.569; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Shao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062223; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Simpson LJ, 2014, NAT IMMUNOL, V15, P1162, DOI 10.1038/ni.3026; Skaug B, 2011, MOL CELL, V44, P559, DOI 10.1016/j.molcel.2011.09.015; Song LB, 2012, J CLIN INVEST, V122, P3563, DOI 10.1172/JCI62339; Su JL, 2010, CANCER RES, V70, P5096, DOI 10.1158/0008-5472.CAN-09-4148; Tokunaga F, 2012, EMBO J, V31, P3856, DOI 10.1038/emboj.2012.241; Verhelst K, 2012, EMBO J, V31, P3845, DOI 10.1038/emboj.2012.240; Vlantis K, 2011, J CLIN INVEST, V121, P2781, DOI 10.1172/JCI45349; Wang TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043268; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Yamagishi M, 2012, CANCER CELL, V21, P121, DOI 10.1016/j.ccr.2011.12.015; Zhang J, 2012, BRIT J CANCER, V107, P352, DOI 10.1038/bjc.2012.251; Zhu HQ, 2015, CARCINOGENESIS, V36, P1213, DOI 10.1093/carcin/bgv112	51	36	38	0	16	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 8	2017	36	23					3240	3251		10.1038/onc.2016.468	http://dx.doi.org/10.1038/onc.2016.468			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EW9WJ	27991929				2022-12-26	WOS:000402869800004
J	Carter, JJ; Fretwell, LV; Woolard, J				Carter, Joanne J.; Fretwell, Laurice V.; Woolard, Jeanette			Effects of 4 multitargeted receptor tyrosine kinase inhibitors on regional hemodynamics in conscious, freely moving rats	FASEB JOURNAL			English	Article						cancer therapy; hypertension; RTKI; VEGF; regional hemodynamics	GROWTH-FACTOR RECEPTOR; SIGNALING PATHWAY INHIBITORS; FACTOR VEGF RECEPTORS; RENAL-CELL CARCINOMA; BLOOD-PRESSURE; INDUCED HYPERTENSION; TARGETED THERAPIES; SUNITINIB; CANCER; TOXICITY	VEGF inhibitors, including receptor tyrosine kinase inhibitors, are used as adjunct therapies in a number of cancer treatments. An emerging issue with these drugs is that most cause hypertension. To gain insight into the physiological mechanisms involved, we evaluated their regional hemodynamic effects in conscious rats. Male Sprague Dawley rats (350-450 g) were chronically implanted with pulsed Doppler flow probes (renal and mesenteric arteries, and the descending abdominal aorta) and catheters (jugular vein, peritoneal cavity, and distal abdominal aorta). Regional hemodynamics were measured over 4 d, before and after daily administration of cediranib (3 and 6 mg/kg, 3 and 6 mg/kg/h for 1 h, i.v.), sorafenib (10 and 20 mg/kg, 10 and 20 mg kg/h for 1 h, i.v.), pazopanib (30 and100mg/kg, i.p.), or vandetanib (12.5 and 25mg/kg, i.p.). All drugs evoked significant increases (P < 0.05; n = 7-8) in mean arterial pressure, which were generally accompanied by significant mesenteric and hindquarters, but not renal, vasoconstrictions. The hypertensive effects of cediranib were unaffected by losartan (10 mg/kg/h), bosentan (20 mg/kg/h), or a combination of phentolamine and propranolol (each 1 mg/kg/h), suggesting a need for new strategies to overcome them.- Carter, J. J., Fretwell, L. V., Woolard, J. Effects of 4 multitargetedreceptor tyrosinekinase inhibitors on regional hemodynamics in conscious, freelymoving rats.	[Carter, Joanne J.] Univ Nottingham, Queens Med Ctr, Sch Med, Sch Life Sci,Cell Signalling Res Grp, Nottingham, England; [Fretwell, Laurice V.; Woolard, Jeanette] De Montfort Univ, Fac Hlth & Life Sci, Leicester, Leics, England	University of Nottingham; De Montfort University	Woolard, J (corresponding author), Queens Med Ctr, Sch Life Sci, Sch Med, Nottingham NG7 2UH, England.	jeanette.woolard@nottingham.ac.uk		Fretwell, Laurice/0000-0001-7860-8751; Woolard, Jeanette/0000-0001-5406-6847	Biotechnology and Biological Sciences Research Council [BB/L19418]; University of Nottingham; School of Biomedical Sciences	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Nottingham; School of Biomedical Sciences	This work was supported by the Biotechnology and Biological Sciences Research Council (Grant BB/L19418); the authors thank the University of Nottingham and the School of Biomedical Sciences for financial support. The authors also thank Professor Emerita S. Gardiner and Professor S. Hill (University of Nottingham) for critical reading.	Aad SA, 2015, CRIT REV ONCOL HEMAT, V93, P28, DOI 10.1016/j.critrevonc.2014.08.004; Bie P, 2017, ACTA PHYSIOL, V219, P288, DOI 10.1111/apha.12718; Blasi E, 2012, CARDIOVASC THER, V30, P287, DOI 10.1111/j.1755-5922.2011.00278.x; BOUDIER HAJS, 1992, J HYPERTENS, V10, pS147; Carter JJ, 2015, BRIT J PHARMACOL, V172, P3141, DOI 10.1111/bph.13116; Chu TF, 2007, LANCET, V370, P2011, DOI 10.1016/S0140-6736(07)61865-0; Curwen JO, 2008, CLIN CANCER RES, V14, P3124, DOI 10.1158/1078-0432.CCR-07-4783; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Eschenhagen T, 2011, EUR J HEART FAIL, V13, P1, DOI 10.1093/eurjhf/hfq213; Eskens FALM, 2006, EUR J CANCER, V42, P3127, DOI 10.1016/j.ejca.2006.09.015; Facemire CS, 2009, HYPERTENSION, V54, P652, DOI 10.1161/HYPERTENSIONAHA.109.129973; Ferrara N, 2009, EUR CYTOKINE NETW, V20, P158, DOI 10.1684/ecn.2009.0170; Fretwell LV, 2013, BRIT J PHARMACOL, V169, P1279, DOI 10.1111/bph.12203; Gardiner SM, 2010, BRIT J PHARMACOL, V161, P92, DOI 10.1111/j.1476-5381.2010.00867.x; Gardiner S M, 1993, Blood Press, V2, P228, DOI 10.3109/08037059309077556; Gardiner SM, 1996, BRIT J PHARMACOL, V118, P352, DOI 10.1111/j.1476-5381.1996.tb15409.x; Grossman E, 2012, AM J MED, V125, P14, DOI 10.1016/j.amjmed.2011.05.024; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Isobe T, 2014, J TOXICOL SCI, V39, P237, DOI 10.2131/jts.39.237; Kappers MHW, 2011, HYPERTENSION, V58, P295, DOI 10.1161/HYPERTENSIONAHA.111.173559; Kappers MHW, 2010, HYPERTENSION, V56, P675, DOI 10.1161/HYPERTENSIONAHA.109.149690; Kappers MHW, 2009, J HYPERTENS, V27, P2297, DOI 10.1097/HJH.0b013e3283309b59; Kruzliak P, 2013, ANGIOGENESIS, V16, P289, DOI 10.1007/s10456-012-9327-4; Lankhorst S, 2015, HYPERTENSION, V66, P543, DOI 10.1161/HYPERTENSIONAHA.115.05435; Lankhorst S, 2014, HYPERTENSION, V64, P1282, DOI 10.1161/HYPERTENSIONAHA.114.04187; Maitland ML, 2010, JNCI-J NATL CANCER I, V102, P596, DOI 10.1093/jnci/djq091; Matsumoto T, 2006, J ATHEROSCLER THROMB, V13, P130, DOI 10.5551/jat.13.130; Motzer RJ, 2006, J CLIN ONCOL, V24, P16, DOI 10.1200/JCO.2005.02.2574; Musumeci F, 2012, J MED CHEM, V55, P10797, DOI 10.1021/jm301085w; Noon JP, 1997, J CLIN INVEST, V99, P1873, DOI 10.1172/JCI119354; Pouessel D, 2008, EUR UROL, V53, P376, DOI 10.1016/j.eururo.2007.08.053; Riely G, 2007, CLIN CANCER RES, V13, p4623S, DOI 10.1158/1078-0432.CCR-07-0544; Robinson ES, 2010, HYPERTENSION, V56, P1131, DOI 10.1161/HYPERTENSIONAHA.110.160481; Sane David C., 2004, Angiogenesis, V7, P193, DOI 10.1007/s10456-004-2699-3; Schmidt C, 2015, JNCI-J NATL CANCER I, V107, P6; Shibuya Masabumi, 2011, Genes Cancer, V2, P1097, DOI 10.1177/1947601911423031; Snider KL, 2009, TARGET ONCOL, V4, P67, DOI 10.1007/s11523-009-0106-0; Stone RL, 2010, LANCET ONCOL, V11, P465, DOI 10.1016/S1470-2045(09)70362-6; THEODORSSONNORHEIM E, 1987, COMPUT BIOL MED, V17, P85, DOI 10.1016/0010-4825(87)90003-5; Vaklavas C, 2010, ONCOLOGIST, V15, P130, DOI 10.1634/theoncologist.2009-0252; Veronese ML, 2006, J CLIN ONCOL, V24, P1363, DOI 10.1200/JCO.2005.02.0503; Viola D, 2016, ENDOCR-RELAT CANCER, V23, pR185, DOI 10.1530/ERC-15-0555; Widakowich C, 2007, ONCOLOGIST, V12, P1443, DOI 10.1634/theoncologist.12-12-1443; WIDDOP RE, 1993, BRIT J PHARMACOL, V108, P684, DOI 10.1111/j.1476-5381.1993.tb12861.x; Woolard J, 2004, J PHARMACOL EXP THER, V308, P1102, DOI 10.1124/jpet.103.061259; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491	46	15	16	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1193	1203		10.1096/fj.201600749R	http://dx.doi.org/10.1096/fj.201600749R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27986807	hybrid, Green Published			2022-12-26	WOS:000395671200031
J	Martin, PM; Cifuentes-Diaz, C; Devaux, J; Garcia, M; Bureau, J; Thomasseau, S; Klingler, E; Girault, JA; Goutebroze, L				Martin, Pierre-Marie; Cifuentes-Diaz, Carmen; Devaux, Jerome; Garcia, Marta; Bureau, Jocelyne; Thomasseau, Sylvie; Klingler, Esther; Girault, Jean-Antoine; Goutebroze, Laurence			Schwannomin-interacting Protein 1 Isoform IQCJ-SCHIP1 Is a Multipartner Ankyrin- and Spectrin-binding Protein Involved in the Organization of Nodes of Ranvier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AXON INITIAL SEGMENTS; BETA-IV-SPECTRIN; SUBCORTICAL CYTOSKELETON PERIODICITY; TUMOR-SUPPRESSOR SCHWANNOMIN/MERLIN; PERIPHERAL NERVOUS-SYSTEM; MOLECULAR-ORGANIZATION; CHROMOSOME 3Q25-27; MYELINATED AXONS; SODIUM-CHANNELS; DOMAINS	The nodes of Ranvier are essential regions for action potential conduction in myelinated fibers. They are enriched in multimolecular complexes composed of voltage-gated Nav and Kv7 channels associated with cell adhesion molecules. Cytoskeletal proteins ankyrin-G (AnkG) and beta IV-spectrin control the organization of these complexes and provide mechanical support to the plasma membrane. IQCJ-SCHIP1 is a cytoplasmic protein present in axon initial segments and nodes of Ranvier. It interacts with AnkG and is absent from nodes and axon initial segments of beta IV-spectrin and AnkG mutant mice. Here, we show that IQCJ-SCHIP1 also interacts with beta IV-spectrin and Kv7.2/3 channels and self-associates, suggesting a scaffolding role in organizing nodal proteins. IQCJ-SCHIP1 binding requires a beta IV-spectrin-specific domain and Kv7 channel 1-5-10 calmodulin-binding motifs. We then investigate the role of IQCJ-SCHIP1 in vivo by studying peripheral myelinated fibers in Schip1 knock-out mutant mice. The major nodal proteins are normally enriched at nodes in these mice, indicating that IQCJ-SCHIP1 is not required for their nodal accumulation. However, morphometric and ultrastructural analyses show an altered shape of nodes similar to that observed in beta IV-spectrin mutant mice, revealing that IQCJ-SCHIP1 contributes to nodal membrane-associated cytoskeleton organization, likely through its interactions with the AnkG/beta IV-spectrin network. Our work reveals that IQCJ-SCHIP1 interacts with several major nodal proteins, and we suggest that it contributes to a higher organizational level of the AnkG/beta IV-spectrin network critical for node integrity.	[Martin, Pierre-Marie; Cifuentes-Diaz, Carmen; Garcia, Marta; Bureau, Jocelyne; Thomasseau, Sylvie; Klingler, Esther; Girault, Jean-Antoine] INSERM, UMR S 839, F-75005 Paris, France; [Martin, Pierre-Marie; Cifuentes-Diaz, Carmen; Garcia, Marta; Bureau, Jocelyne; Thomasseau, Sylvie; Klingler, Esther; Girault, Jean-Antoine; Goutebroze, Laurence] UPMC, Sorbonne Univ, UMR S 839, F-75005 Paris, France; [Martin, Pierre-Marie; Cifuentes-Diaz, Carmen; Garcia, Marta; Bureau, Jocelyne; Thomasseau, Sylvie; Klingler, Esther; Girault, Jean-Antoine; Goutebroze, Laurence] Inst Fer Moulin, F-75005 Paris, France; [Devaux, Jerome] Aix Marseille Univ, CNRS, CRN2M, F-13344 Marseille, France; [Klingler, Esther] Univ Geneva, Dept Basic Neurosci, CH-1211 Geneva, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Geneva	Goutebroze, L (corresponding author), UPMC, INSERM, UMR S 839, Inst Fer Moulin, 17 Rue Fer Moulin, F-75005 Paris, France.	laurence.goutebroze@inserm.fr	Devaux, jerome/X-8581-2019; Girault, Jean-Antoine/F-7518-2013	Devaux, jerome/0000-0001-6383-4334; Girault, Jean-Antoine/0000-0002-7900-1705; Goutebroze, laurence/0000-0002-8712-000X; Klingler, Esther/0000-0002-6577-1362; marta, garcia/0000-0003-1367-6459; Cifuentes Diaz, Carmen/0000-0003-2563-2082	DIM NeRF from Region Ile-de-France (NERF) [10016908]; Fondation pour la Recherche Medicale/Rotary "Espoir en tete"	DIM NeRF from Region Ile-de-France (NERF)(Region Ile-de-France); Fondation pour la Recherche Medicale/Rotary "Espoir en tete"(Fondation pour la Recherche Medicale)	Equipment at the Institut du Fer a Moulin was supported in part by DIM NeRF from Region Ile-de-France (NERF, 10016908) and by the Fondation pour la Recherche Medicale/Rotary "Espoir en tete." We are grateful to R. Boukhari, N. Roblot, Y. Bertelle, A. Rousseau, M. Savariradjane, and T. Eirinopoulou (Institut du Fer a Moulin Cell and Tissue Imaging facility) for animal care and assistance with microscopes. The teams of J.-A.G. and L. G. are affiliated with the Paris School of Neuroscience (ENP) and the Bio-Psy laboratory of excellence.	Auranen M, 2003, MOL PSYCHIATR, V8, P879, DOI 10.1038/sj.mp.4001299; Bennett V, 2013, CURR TOP MEMBR, V72, P1, DOI 10.1016/B978-0-12-417027-8.00001-5; Berghs S, 2000, J CELL BIOL, V151, P985, DOI 10.1083/jcb.151.5.985; Brechet A, 2008, J CELL BIOL, V183, P1101, DOI 10.1083/jcb.200805169; Buttermore ED, 2013, J NEUROSCI RES, V91, P603, DOI 10.1002/jnr.23197; Chua JJE, 2012, P NATL ACAD SCI USA, V109, P5862, DOI 10.1073/pnas.1113819109; Chung HL, 2016, DEV CELL, V36, P511, DOI 10.1016/j.devcel.2016.02.004; Cifuentes-Diaz C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025043; Coon H, 2005, HUM HERED, V60, P220, DOI 10.1159/000090546; D'Este E, 2016, SCI REP-UK, V6, DOI 10.1038/srep22741; D'Este E, 2015, CELL REP, V10, P1246, DOI 10.1016/j.celrep.2015.02.007; DEMEDINACELI L, 1982, EXP NEUROL, V77, P634, DOI 10.1016/0014-4886(82)90234-5; Denisenko N, 2008, J NEUROSCI, V28, P10472, DOI 10.1523/JNEUROSCI.2537-08.2008; Denisenko-Nehrbass N, 2003, J NEUROCHEM, V84, P209, DOI 10.1046/j.1471-4159.2003.01503.x; Devaux JJ, 2010, J PHYSIOL-LONDON, V588, P4719, DOI 10.1113/jphysiol.2010.196022; Fujita T, 2007, BIOCHEM BIOPH RES CO, V361, P605, DOI 10.1016/j.bbrc.2007.07.050; Goutebroze L, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-29; Goutebroze L, 2000, MOL CELL BIOL, V20, P1699, DOI 10.1128/MCB.20.5.1699-1712.2000; Haitin Y, 2008, J PHYSIOL-LONDON, V586, P1803, DOI 10.1113/jphysiol.2007.149187; He M, 2014, J CELL BIOL, V206, P273, DOI 10.1083/jcb.201401016; Ho TSY, 2014, NAT NEUROSCI, V17, P1664, DOI 10.1038/nn.3859; Holleran EA, 2001, J BIOL CHEM, V276, P36598, DOI 10.1074/jbc.M104838200; Hu VW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-118; Ikuta J, 2007, BIOCHEM BIOPH RES CO, V353, P127, DOI 10.1016/j.bbrc.2006.11.142; Jenkins PM, 2015, P NATL ACAD SCI USA, V112, P957, DOI 10.1073/pnas.1416544112; Klingler E, 2015, DEVELOPMENT, V142, P2026, DOI 10.1242/dev.119248; Komada M, 2002, J CELL BIOL, V156, P337, DOI 10.1083/jcb.200110003; Kwasnicka-Crawford DA, 2006, BIOCHEM BIOPH RES CO, V350, P890, DOI 10.1016/j.bbrc.2006.09.136; Lacas-Gervais S, 2004, J CELL BIOL, V166, P983, DOI 10.1083/jcb.200408007; Leterrier C, 2015, CELL REP, V13, P2781, DOI 10.1016/j.celrep.2015.11.051; Liu WJ, 2014, MOL CELL NEUROSCI, V58, P40, DOI 10.1016/j.mcn.2013.12.005; Lonigro A, 2009, BRAIN, V132, P260, DOI 10.1093/brain/awn281; Lorenzo DN, 2010, J CELL BIOL, V189, P143, DOI 10.1083/jcb.200905158; Martin PM, 2008, J NEUROSCI, V28, P6111, DOI 10.1523/JNEUROSCI.1044-08.2008; Menegoz M, 1997, NEURON, V19, P319, DOI 10.1016/S0896-6273(00)80942-3; Muresan V, 2001, MOL CELL, V7, P173, DOI 10.1016/S1097-2765(01)00165-4; Ogawa Y, 2006, J NEUROSCI, V26, P5230, DOI 10.1523/JNEUROSCI.0425-06.2006; Ozmen S, 2002, PLAST RECONSTR SURG, V109, P1760; Papandreou MJ, 2015, J NEUROCHEM, V134, P527, DOI 10.1111/jnc.13158; Parkinson NJ, 2001, NAT GENET, V29, P61, DOI 10.1038/ng710; Patil A, 2006, FEBS LETT, V580, P2041, DOI 10.1016/j.febslet.2006.03.003; Perisic L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122067; Salzer JL, 2008, GLIA, V56, P1532, DOI 10.1002/glia.20750; Schulz A, 2014, BRAIN, V137, P420, DOI 10.1093/brain/awt327; Traka M, 2003, J CELL BIOL, V162, P1161, DOI 10.1083/jcb.200305078; Tse WT, 2001, J BIOL CHEM, V276, P23974, DOI 10.1074/jbc.M009307200; Uemoto Y, 2007, J BIOL CHEM, V282, P6548, DOI 10.1074/jbc.M609223200; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Xu MX, 2015, J BIOL CHEM, V290, P16619, DOI 10.1074/jbc.M115.638932; Yang Y, 2004, J NEUROSCI, V24, P7230, DOI 10.1523/JNEUROSCI.2125-04.2004; Zhang CS, 2016, CURR OPIN NEUROBIOL, V39, P116, DOI 10.1016/j.conb.2016.05.001; Zimmermann H, 1996, MICROSC RES TECHNIQ, V34, P462, DOI 10.1002/(SICI)1097-0029(19960801)34:5<462::AID-JEMT6>3.0.CO;2-O; Zollinger DR, 2015, ANNU REV CELL DEV BI, V31, P647, DOI 10.1146/annurev-cellbio-100913-013107	53	3	5	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2441	2456		10.1074/jbc.M116.758029	http://dx.doi.org/10.1074/jbc.M116.758029			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	27979964	Green Published, hybrid			2022-12-26	WOS:000395530300032
J	Pickering, RT; Lee, MJ; Karastergiou, K; Gower, A; Fried, SK				Pickering, R. Taylor; Lee, Mi-Jeong; Karastergiou, Kalypso; Gower, Adam; Fried, Susan K.			Depot Dependent Effects of Dexamethasone on Gene Expression in Human Omental and Abdominal Subcutaneous Adipose Tissues from Obese Women	PLOS ONE			English	Article							GLUCOCORTICOID-RECEPTOR; BODY-FAT; EXTRACELLULAR-MATRIX; INSULIN-RESISTANCE; VISCERAL OBESITY; INFLAMMATION; PHOSPHORYLATION; ADIPOGENESIS; MODULATION; BINDING	Glucocorticoids promote fat accumulation in visceral compared to subcutaneous depots, but the molecular mechanisms involved remain poorly understood. To identify long-term changes in gene expression that are differentially sensitive or responsive to glucocorticoids in these depots, paired samples of human omental (Om) and abdominal subcutaneous (Abdsc) adipose tissues obtained from obese women during elective surgery were cultured with the glucocorticoid receptor agonist dexamethasone (Dex, 0, 1, 10, 25 and 1000 nM) for 7 days. Dex regulated 32% of the 19,741 genes on the array, while 53% differed by Depot and 2.5% exhibited a Depot*Dex concentration interaction. Gene set enrichment analysis showed Dex regulation of the expected metabolic and inflammatory pathways in both depots. Cluster analysis of the 460 transcripts that exhibited an interaction of Depot and Dex concentration revealed sets of mRNAs for which the responses to Dex differed in magnitude, sensitivity or direction between the two depots as well as mRNAs that responded to Dex only in one depot. These transcripts were also clearly depot different in fresh adipose tissue and are implicated in processes that could affect adipose tissue distribution or functions (e.g. adipogenesis, triacylglycerol synthesis and storage, insulin action). Elucidation of the mechanisms underlying the depot differences in the effect of Dex on the expression of specific genes and pathways that regulate adipose function may offer novel insights into understanding the biology of visceral adipose tissues and their links to metabolic health.	[Pickering, R. Taylor; Lee, Mi-Jeong; Karastergiou, Kalypso; Fried, Susan K.] Boston Univ, Sch Med, Dept Med, Obes Ctr, Boston, MA 02118 USA; [Gower, Adam] Boston Univ, Clin Translat Sci Inst, Boston, MA 02215 USA	Boston University; Boston University	Fried, SK (corresponding author), Boston Univ, Sch Med, Dept Med, Obes Ctr, Boston, MA 02118 USA.	susan.fried@mssm.edu	Lee, Mi-Jeong/ABE-1084-2020; Lee, Mi-Jeong/GXV-9843-2022	Lee, Mi-Jeong/0000-0002-8171-7913; Lee, Mi-Jeong/0000-0002-8171-7913; Pickering, Richard/0000-0002-5243-4068; Gower, Adam/0000-0002-6122-7511; Karastergiou, Kalypso/0000-0002-1790-065X; Karastergiou, Aris/0000-0002-1434-9786	National Institutes of Health [RO1 DK08084, T32 DK007201, P30DK46200, U54 TR001012]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007201, R01DK080448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by the National Institutes of Health (https://www.nih.gov/), RO1 DK08084, T32 DK007201, P30DK46200 and U54 TR001012.	Aluwihare P, 2009, J CELL SCI, V122, P227, DOI 10.1242/jcs.035246; Arase T, 2009, J IMMUNOL, V182, P7074, DOI 10.4049/jimmunol.0900001; Arner P, 2013, J CLIN ENDOCR METAB, V98, pE897, DOI 10.1210/jc.2012-4106; Berendsen AD, 2011, P NATL ACAD SCI USA, V108, P17022, DOI 10.1073/pnas.1110629108; Catalan V, 2012, J CLIN ENDOCR METAB, V97, pE1880, DOI 10.1210/jc.2012-1670; Chau YY, 2014, NAT CELL BIOL, V16, P367, DOI 10.1038/ncb2922; Chen WW, 2008, MOL ENDOCRINOL, V22, P1754, DOI 10.1210/me.2007-0219; Chodankar R, 2014, P NATL ACAD SCI USA, V111, P4007, DOI 10.1073/pnas.1400522111; Corradetti MN, 2005, J BIOL CHEM, V280, P9769, DOI 10.1074/jbc.C400557200; Darimont C, 2008, INT J OBESITY, V32, P112, DOI 10.1038/sj.ijo.0803688; Drews F, 2008, BBA-MOL CELL RES, V1783, P34, DOI 10.1016/j.bbamcr.2007.08.004; Drolet R, 2008, INT J OBESITY, V32, P283, DOI 10.1038/sj.ijo.0803708; Du BW, 2013, J BIOL CHEM, V288, P3036, DOI 10.1074/jbc.M112.440370; Fried SK, 2000, METH MOL B, V155, P197; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; FRIED SK, 1993, J CLIN INVEST, V92, P2191, DOI 10.1172/JCI116821; GARNER JA, 1988, BRAIN RES, V458, P309, DOI 10.1016/0006-8993(88)90473-8; Geer EB, 2012, J CLIN ENDOCR METAB, V97, P1702, DOI 10.1210/jc.2011-3123; Geer EB, 2010, CLIN ENDOCRINOL, V73, P469, DOI 10.1111/j.1365-2265.2010.03829.x; Gesta S, 2006, P NATL ACAD SCI USA, V103, P6676, DOI 10.1073/pnas.0601752103; Grandl G, 2016, MOL METAB, V5, P937, DOI 10.1016/j.molmet.2016.07.008; Hara T, 2016, J CELL BIOCH; Hardy OT, 2011, SURG OBES RELAT DIS, V7, P60, DOI 10.1016/j.soard.2010.05.013; Hashimoto I, 2006, OBESITY, V14, P799, DOI 10.1038/oby.2006.93; Hsu MH, 2007, DRUG METAB REV, V39, P515, DOI 10.1080/03602530701468573; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jeimy SB, 2008, THROMB HAEMOSTASIS, V100, P1058, DOI 10.1160/TH08-05-0307; Kong P, 2013, AM J PHYSIOL-ENDOC M, V305, pE439, DOI 10.1152/ajpendo.00006.2013; Le Jan S, 2006, FEBS LETT, V580, P3395, DOI 10.1016/j.febslet.2006.05.011; Lee MJ, 2014, INT J OBESITY, V38, P1228, DOI 10.1038/ijo.2014.6; Lee MJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE858, DOI 10.1152/ajpendo.00439.2006; Lee MJ, 2013, MOL ASPECTS MED, V34, P1, DOI 10.1016/j.mam.2012.10.001; Lee MJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE571, DOI 10.1152/ajpendo.00231.2010; Lessard J, 2014, ADIPOCYTE, V3, P197, DOI 10.4161/adip.29385; Magnusson B, 2010, BIOCHEM BIOPH RES CO, V395, P373, DOI 10.1016/j.bbrc.2010.04.022; Moreno-Navarrete JM, 2011, J CLIN ENDOCR METAB, V96, pE1816, DOI 10.1210/jc.2011-0310; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Matsuo Y, 2015, METABOLISM, V64, P1490, DOI 10.1016/j.metabol.2015.07.016; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nie T, 2012, FEBS LETT, V586, P3618, DOI 10.1016/j.febslet.2012.08.006; Nishimura S, 2014, DIABETES, V63, P4154, DOI 10.2337/db13-1694; Nishizuka M, 2008, FEBS LETT, V582, P3201, DOI 10.1016/j.febslet.2008.08.011; Nye CK, 2008, J BIOL CHEM, V283, P27565, DOI 10.1074/jbc.M804393200; Patel R, 2014, MOL ENDOCRINOL, V28, P999, DOI 10.1210/me.2014-1062; Regazzetti C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052154; Robciuc MR, 2016, CELL METAB, V23, P712, DOI 10.1016/j.cmet.2016.03.004; Roqueta-Rivera M, 2016, CELL METAB, V24, P474, DOI 10.1016/j.cmet.2016.07.025; Rump A, 2004, J BIOL CHEM, V279, P9190, DOI 10.1074/jbc.M312372200; Shan DD, 2010, J LIPID RES, V51, P1971, DOI 10.1194/jlr.M006304; Shitaye HS, 2010, MATRIX BIOL, V29, P549, DOI 10.1016/j.matbio.2010.05.006; Singh P, 2015, OBESITY, V23, P2286, DOI 10.1002/oby.21251; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang T, 2013, CONNECT TISSUE RES, V54, P5, DOI 10.3109/03008207.2012.715700; Tchernof A, 2006, DIABETES, V55, P1353, DOI 10.2337/db05-1439; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Tews D, 2014, MOL CELL ENDOCRINOL, V395, P41, DOI 10.1016/j.mce.2014.07.011; Umemoto E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083681; Vandevyver S, 2014, ENDOCR REV, V35, P671, DOI 10.1210/er.2014-1010; Vockley CM, 2016, CELL, V166, P1269, DOI 10.1016/j.cell.2016.07.049; WAJCHENBERG BL, 1995, J CLIN ENDOCR METAB, V80, P2791, DOI 10.1210/jc.80.9.2791; Ward MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050554; Wellen KE, 2007, CELL, V129, P537, DOI 10.1016/j.cell.2007.02.049; Wu Q, 2015, MOL MED REP, V12, P5891, DOI 10.3892/mmr.2015.4117; Xu JF, 2012, J IMMUNOL, V189, P1992, DOI 10.4049/jimmunol.1103207; Yamamoto Y, 2010, OBESITY, V18, P872, DOI 10.1038/oby.2009.512; Yang RZ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1253, DOI 10.1152/ajpendo.00572.2004; Yasmeen R, 2012, BBA-MOL CELL BIOL L, V1821, P190, DOI 10.1016/j.bbalip.2011.06.004; Yoo HJ, 2013, J CLIN ENDOCR METAB, V98, P2897, DOI 10.1210/jc.2012-4297; Yu CY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015188; Zaragosi LE, 2010, DIABETES, V59, P2513, DOI 10.2337/db10-0013; Zhou S, 2014, CURR MED CHEM, V21, P1212, DOI 10.2174/0929867321666131218093327	72	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0167337	10.1371/journal.pone.0167337	http://dx.doi.org/10.1371/journal.pone.0167337			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005982	Green Submitted, gold, Green Published			2022-12-26	WOS:000392843200013
J	Meduri, F; Beretta-Piccoli, M; Calanni, L; Segreto, V; Giovanetti, G; Barbero, M; Cescon, C; D'Antona, G				Meduri, Federico; Beretta-Piccoli, Matteo; Calanni, Luca; Segreto, Valentina; Giovanetti, Giuseppe; Barbero, Marco; Cescon, Corrado; D'Antona, Giuseppe			Inter-Gender sEMG Evaluation of Central and Peripheral Fatigue in Biceps Brachii of Young Healthy Subjects	PLoS One			English	Article							FIBER CONDUCTION-VELOCITY; HUMAN VASTUS LATERALIS; MAXIMAL VOLUNTARY CONTRACTIONS; MOTOR-UNIT SYNCHRONIZATION; SURFACE EMG VARIABLES; MUSCLE FATIGUE; ISOMETRIC CONTRACTIONS; SEX-DIFFERENCES; SUBMAXIMAL CONTRACTIONS; PERCEIVED EXERTION	Purpose The purpose of the present study was to evaluate inter-arm and inter-gender differences in fractal dimension (FD) and conduction velocity (CV) obtained from multichannel surface electromyographic (sEMG) recordings during sustained fatiguing contractions of the biceps brachii. Methods A total of 20 recreationally active males (24 +/- 6 years) and 18 recreationally active females (22 +/- 9 years) performed two isometric contractions at 120 degrees elbow joint angle: (1) at 20% maximal voluntary contraction (MVC) for 90 s, and (2) at 60% MVC until exhaustion the time to perform the task has been measured. Signals from sEMG were detected from the biceps brachii using bidimensional arrays of 64 electrodes and initial values and rate of change of CV and FD of the sEMG signal were calculated. Results No difference between left and right sides and no statistically significant interaction effect of sides with gender were found for all parameters measured. A significant inter-gender difference was found for MVC (p<0.0001). Initial values of CV were higher in females than in males at both force levels (20% MCV: p<0.0001; 60% MCV: p<0.05) whereas a lower initial estimate of FD was observed in females compared to males (20% MCV: p<0.05; 60% MCV: p<0.0001). No difference in CV and FD slopes was found at 20% MVC between genders. At 60% MVC significantly lower CV and FD slopes (CV and FD: p<0.05) and a more protracted time to exhaustion were found in females than in males (p<0.0001). When considering time to exhaustion at both levels of contraction no difference in percentage change (Delta%) of CV and FD slopes was found between genders (p>0.05). During the sustained 60% MVC no statistical correlation was found between MVC and CV or FD initial estimates nor between MVC and CV or FD slopes both in males and females whereas. A significant positive correlation between CV and FD slopes was found in both genders (males: r = 0,61; females: r = 0,55). Conclusions Fatigue determines changes in FD and CV values in biceps brachii during sustained contractions at 60% MVC. In particular males show greater increase in the rate of change of CV and FD than females whereas no difference in percentage change of these sEMG descriptors of fatigue was found. A significant correlation between FD and CV slopes found in both genders highlights that central and peripheral myoelectric components of fatigue may interact during submaximal isometric contractions.	[Meduri, Federico; Calanni, Luca; Segreto, Valentina; Giovanetti, Giuseppe; D'Antona, Giuseppe] Univ Pavia, Dept Publ Hlth Mol & Forens Med, Pavia, Italy; [Meduri, Federico; Calanni, Luca; Segreto, Valentina; Giovanetti, Giuseppe; D'Antona, Giuseppe] Univ Pavia, Sport Med Ctr Voghera, Pavia, Italy; [Beretta-Piccoli, Matteo; Barbero, Marco; Cescon, Corrado] Univ Appl Sci & Arts Southern Switzerland, Dept Business Econ Hlth & Social Care, 2rLab, Manno, Switzerland	University of Pavia; University of Pavia	D'Antona, G (corresponding author), Univ Pavia, Dept Publ Hlth Mol & Forens Med, Pavia, Italy.; D'Antona, G (corresponding author), Univ Pavia, Sport Med Ctr Voghera, Pavia, Italy.	gdantona@unipv.it	Barbero, Marco/G-3667-2010; Barbero, Marco/AAF-9467-2020	Barbero, Marco/0000-0001-8579-0686; Barbero, Marco/0000-0001-8579-0686; D'Antona, Giuseppe/0000-0002-0683-5565; Cescon, Corrado/0000-0002-1632-6684; Beretta-Piccoli, Matteo/0000-0003-4794-2540; Calanni Pileri, Luca/0000-0003-1695-8398	Association Frangaise Myopathies, Paris, France [17191]	Association Frangaise Myopathies, Paris, France	This study was supported by Association Frangaise Myopathies (http://www.afm-telethon.com), Paris, France (grant 17191 to GD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam A, 2003, J NEUROPHYSIOL, V90, P2919, DOI 10.1152/jn.00179.2003; ALLEN GM, 1995, MUSCLE NERVE, V18, P593, DOI 10.1002/mus.880180605; Andreassen S, 1987, Electroencephalogr Clin Neurophysiol Suppl, V39, P13; Arjunan SP, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/197960; BARNES WS, 1980, ERGONOMICS, V23, P351, DOI 10.1080/00140138008924748; Barry BK, 2007, INTEGR COMP BIOL, V47, P465, DOI 10.1093/icb/icm047; Bazzucchi I, 2004, MUSCLE NERVE, V30, P626, DOI 10.1002/mus.20151; Beretta-Piccoli M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123921; Bernardi M, 1997, Electromyogr Clin Neurophysiol, V37, P3; BIGLANDRITCHIE B, 1978, CLIN SCI MOL MED, V54, P609, DOI 10.1042/cs0540609; BIGLANDRITCHIE B, 1983, J NEUROPHYSIOL, V50, P313, DOI 10.1152/jn.1983.50.1.313; Bilodeau M, 1994, Electromyogr Clin Neurophysiol, V34, P149; Blijham PJ, 2006, J APPL PHYSIOL, V100, P1837, DOI 10.1152/japplphysiol.01009.2005; Boccia G, 2016, PHYSIOL MEAS, V37, P162, DOI 10.1088/0967-3334/37/1/162; BORG G, 1982, INT J SPORTS MED, V3, P153, DOI 10.1055/s-2008-1026080; BOUISSOU P, 1989, J APPL PHYSIOL, V67, P1245, DOI 10.1152/jappl.1989.67.3.1245; BRODY LR, 1991, J APPL PHYSIOL, V71, P1878, DOI 10.1152/jappl.1991.71.5.1878; Clark BC, 2003, J APPL PHYSIOL, V94, P2263, DOI 10.1152/japplphysiol.00926.2002; Contessa P, 2009, J APPL PHYSIOL, V107, P235, DOI 10.1152/japplphysiol.00035.2009; DATTA AK, 1991, J PHYSIOL-LONDON, V432, P401, DOI 10.1113/jphysiol.1991.sp018391; DE LUCA CJ, 1984, CRIT REV BIOMED ENG, V11, P251; Dedering A, 2000, J ELECTROMYOGR KINES, V10, P151, DOI 10.1016/S1050-6411(00)00009-2; Enoka RM, 2008, J PHYSIOL-LONDON, V586, P11, DOI 10.1113/jphysiol.2007.139477; FALLENTIN N, 1993, EUR J APPL PHYSIOL O, V67, P335, DOI 10.1007/BF00357632; Farina D, 2004, J APPL PHYSIOL, V97, P2035, DOI 10.1152/japplphysiol.00606.2004; Farina D, 2004, MED BIOL ENG COMPUT, V42, P432, DOI 10.1007/BF02350984; Farina D, 2003, IEEE T BIO-MED ENG, V50, P1340, DOI 10.1109/TBME.2003.819847; Gandevia SC, 1996, J PHYSIOL-LONDON, V490, P529, DOI 10.1113/jphysiol.1996.sp021164; GITTER JA, 1995, J NEUROSCI METH, V58, P103, DOI 10.1016/0165-0270(94)00164-C; Gonzalez-Izal M, 2012, J ELECTROMYOGR KINES, V22, P501, DOI 10.1016/j.jelekin.2012.02.019; Holtermann A, 2009, J ELECTROMYOGR KINES, V19, P232, DOI 10.1016/j.jelekin.2007.08.008; Hunter SK, 2014, ACTA PHYSIOL, V210, P768, DOI 10.1111/apha.12234; Hunter SK, 2006, J APPL PHYSIOL, V101, P140, DOI 10.1152/japplphysiol.01567.2005; Hunter SK, 2009, EXERC SPORT SCI REV, V37, P113, DOI 10.1097/JES.0b013e3181aa63e2; Hunter SK, 2004, J APPL PHYSIOL, V96, P2125, DOI 10.1152/japplphysiol.01342.2003; Hunter SK, 2001, J APPL PHYSIOL, V91, P2686, DOI 10.1152/jappl.2001.91.6.2686; Inglis JG, 2013, J ELECTROMYOGR KINES, V23, P1289, DOI 10.1016/j.jelekin.2013.09.005; Keller ML, 2011, MED SCI SPORT EXER, V43, P1873, DOI 10.1249/MSS.0b013e318216ebd4; Kent-Braun JA, 1999, EUR J APPL PHYSIOL O, V80, P57, DOI 10.1007/s004210050558; KentBraun JA, 1996, MUSCLE NERVE, V19, P861, DOI 10.1002/(SICI)1097-4598(199607)19:7<861::AID-MUS8>3.0.CO;2-7; Kleine BU, 2001, J APPL PHYSIOL, V91, P1588, DOI 10.1152/jappl.2001.91.4.1588; Kollmitzer J, 1999, CLIN NEUROPHYSIOL, V110, P725, DOI 10.1016/S1388-2457(98)00050-9; KOMI PV, 1979, EUR J APPL PHYSIOL, V42, P41, DOI 10.1007/BF00421103; Kumar DK, 2011, IEEE T NEUR SYS REH, V19, P578, DOI 10.1109/TNSRE.2011.2163527; KUPA EJ, 1995, J APPL PHYSIOL, V79, P23, DOI 10.1152/jappl.1995.79.1.23; LINSSEN WHJP, 1993, MUSCLE NERVE, V16, P849, DOI 10.1002/mus.880160808; Mannion AF, 1998, SPINE, V23, P576, DOI 10.1097/00007632-199803010-00010; Martin PG, 2007, PFLUG ARCH EUR J PHY, V454, P957, DOI 10.1007/s00424-007-0243-1; Merletti R, 2004, DIGESTION, V69, P112, DOI 10.1159/000077877; Merletti R, 1998, MUSCLE NERVE, V21, P184; Merletti R, 1996, J ORTHOP SPORT PHYS, V24, P342, DOI 10.2519/jospt.1996.24.6.342; Merletti R, 2016, BIOPHYSICS GENERATIO, P30; Mesin L, 2009, J ELECTROMYOGR KINES, V19, P851, DOI 10.1016/j.jelekin.2008.08.003; MILLER AEJ, 1993, EUR J APPL PHYSIOL O, V66, P254, DOI 10.1007/BF00235103; Ng JKF, 1996, ARCH PHYS MED REHAB, V77, P259, DOI 10.1016/S0003-9993(96)90108-2; Nybo L, 2004, PROG NEUROBIOL, V72, P223, DOI 10.1016/j.pneurobio.2004.03.005; Rainoldi A, 1999, J ELECTROMYOGR KINES, V9, P105, DOI 10.1016/S1050-6411(98)00042-X; Rainoldi A, 2001, J ELECTROMYOGR KINES, V11, P425, DOI 10.1016/S1050-6411(01)00022-0; Roepstorff C, 2006, J PHYSIOL-LONDON, V574, P125, DOI 10.1113/jphysiol.2006.108720; Russ DW, 2003, J APPL PHYSIOL, V94, P2414, DOI 10.1152/japplphysiol.01145.2002; SADAMOTO T, 1983, EUR J APPL PHYSIOL O, V51, P395, DOI 10.1007/BF00429076; SADOYAMA T, 1988, EUR J APPL PHYSIOL O, V57, P767, DOI 10.1007/BF01076001; Salomoni S, 2008, IEEE ENG MED BIO, P2598, DOI 10.1109/IEMBS.2008.4649732; Schillings ML, 2003, EUR J APPL PHYSIOL, V90, P562, DOI 10.1007/s00421-003-0913-4; Semmler JG, 2000, J NEUROPHYSIOL, V84, P358, DOI 10.1152/jn.2000.84.1.358; Semmler JG, 2002, EXERC SPORT SCI REV, V30, P8, DOI 10.1097/00003677-200201000-00003; SIMONEAU JA, 1989, AM J PHYSIOL, V257, pE567, DOI 10.1152/ajpendo.1989.257.4.E567; Talebinejad M, 2010, J ELECTROMYOGR KINES, V20, P433, DOI 10.1016/j.jelekin.2009.06.002; Troiano A, 2008, GAIT POSTURE, V28, P179, DOI 10.1016/j.gaitpost.2008.04.002; Vila-Cha C, 2010, J APPL PHYSIOL, V109, P1455, DOI 10.1152/japplphysiol.01213.2009; Yoon T, 2007, MUSCLE NERVE, V36, P515, DOI 10.1002/mus.20844	71	5	5	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168443	10.1371/journal.pone.0168443	http://dx.doi.org/10.1371/journal.pone.0168443			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002429	gold, Green Published, Green Submitted			2022-12-26	WOS:000392853100046
J	Robertson, JE; Lisonkova, S; Lee, T; De Silva, DA; von Dadelszen, P; Synnes, AR; Joseph, KS; Liston, RM; Magee, LA				Robertson, Julie E.; Lisonkova, Sarka; Lee, Tang; De Silva, Dane A.; von Dadelszen, Peter; Synnes, Anne R.; Joseph, K. S.; Liston, Robert M.; Magee, Laura A.		Canadian Perinatal Network Grp; Canadian Neonatal Network	Fetal, Infant and Maternal Outcomes among Women with Prolapsed Membranes Admitted before 29 Weeks Gestation	PLoS One			English	Article							EMERGENCY CERCLAGE; PRETERM BIRTH; SHORT CERVIX; BED REST; CONTROLLED-TRIAL; PREGNANCY; 2ND-TRIMESTER; PROGESTERONE; DELIVERY; LENGTH	Background Few studies have examined fetal, infant and maternal mortality and morbidity among pregnant women at very early gestation with an open cervix and prolapsed membranes. We carried out a study describing the outcomes of women hospitalized with prolapsed membranes at 22-28 weeks' gestation. Methods We prospectively recruited women with singleton pregnancies admitted at 22-28 weeks' gestation to tertiary hospitals of the Canadian Perinatal Network between 2005 and 2009. Time-to-delivery, perinatal death, neonatal intensive care unit (NICU) admission, severe neonatal morbidity and severe maternal morbidity were compared between women admitted at 22-25 vs. 26-28 weeks gestation. Logistic regression was used to estimate adjusted odds ratios (AOR) and 95% confidence intervals. Results 129 women at 22-25 weeks gestation and 65 women at 26-28 weeks gestation were admitted to hospital and the median time-to-delivery was 4 days in both groups. Stillbirth rates were 12.4% vs 4.6% among women admitted at earlier vs later gestation (AOR 2.8, 95% CI 0.5-14.8), while perinatal death rates were 38.0% vs 6.1% (AOR 14.1, 95% CI 3.5-59.0), respectively. There were no significant differences in NICU admission and severe morbidity among live-born infants; 89.4% and 82.3% died or were admitted to NICU, (P value 0.18), and 53.9% vs 44.0% of NICU infants had severe neonatal morbidity (P value 0.28). Antibiotics, tocolysis and cerclage did not have a significant effect on perinatal death. Maternal death or severe maternal morbidity occurred in 8.5% and 6.2% of women admitted at 22-25 vs 26-28 weeks (AOR 1.2, 95% CI 0.4-4.2). Conclusion Perinatal mortality among women with prolapsed membranes at very early gestation is high, although significantly lower among those admitted at a relatively later gestational age. Rates of adverse maternal outcomes are also high. This information can be used to counsel women with prolapsed membranes at 22 to 28 weeks gestation.	[Robertson, Julie E.; Lisonkova, Sarka; Lee, Tang; von Dadelszen, Peter; Joseph, K. S.; Liston, Robert M.; Magee, Laura A.] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC, Canada; [Robertson, Julie E.; Lisonkova, Sarka; Lee, Tang; von Dadelszen, Peter; Synnes, Anne R.; Joseph, K. S.; Liston, Robert M.; Magee, Laura A.] British Columbias Childrens & Womens Hosp & Hlth, Vancouver, BC, Canada; [De Silva, Dane A.; Joseph, K. S.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Synnes, Anne R.] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Robertson, JE (corresponding author), Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC, Canada.; Robertson, JE (corresponding author), British Columbias Childrens & Womens Hosp & Hlth, Vancouver, BC, Canada.	jrobertson3@cw.bc.ca	Lee, Shoo K/P-3016-2015; De Silva, Dane/AAC-9050-2022; von Dadelszen, Peter/AAP-7480-2021	De Silva, Dane/0000-0001-6558-2716; Lisonkova, Sarka/0000-0002-1220-310X; von Dadelszen, Peter/0000-0003-4136-3070; Joseph, K.S./0000-0003-2317-5607	Canadian Institutes of Health Research [MOP115445, APR-126338]; Ontario Ministry of Health and Long-term Care; Child and Family Research Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long-term Care(Ministry of Health and Long-Term Care, Ontario); Child and Family Research Institute	This study was funded by the Canadian Institutes of Health Research (MOP115445) and the Ontario Ministry of Health and Long-term Care. KSJ is supported by the Child and Family Research Institute and by a Chair award in maternal, fetal and infant health services research from the Canadian Institutes of Health Research (APR-126338). Open access costs for this publication were provided by the Canadian Institutes of Health Research (APR-126338). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts J M, 1995, Obstet Gynecol Surv, V50, P459, DOI 10.1097/00006254-199506000-00022; Althuisius SM, 2003, AM J OBSTET GYNECOL, V189, P907, DOI 10.1067/S0002-9378(03)00718-X; Andrews WW, 2000, OBSTET GYNECOL, V95, P222, DOI 10.1016/S0029-7844(99)00483-4; Bujold E, 2008, J OBSTET GYNAECOL CA, V30, P882, DOI 10.1016/S1701-2163(16)32967-X; Costeloe K, 2000, PEDIATRICS, V106, P659, DOI 10.1542/peds.106.4.659; Daskalakis G, 2006, OBSTET GYNECOL, V107, P221, DOI 10.1097/01.AOG.0000187896.04535.e6; Fonseca EB, 2007, NEW ENGL J MED, V357, P462, DOI 10.1056/NEJMoa067815; Goya M, 2012, LANCET, V379, P1800, DOI 10.1016/S0140-6736(12)60030-0; Hassan SS, 2011, ULTRASOUND OBST GYN, V38, P18, DOI 10.1002/uog.9017; Heath VCF, 1998, ULTRASOUND OBST GYN, V12, P312, DOI 10.1046/j.1469-0705.1998.12050312.x; IAMS JD, 1995, AM J OBSTET GYNECOL, V172, P1097, DOI 10.1016/0002-9378(95)91469-2; Joseph KS., 2014, CURR EPIDEMIOL REP, V1, P1, DOI [10.1007/s40471-013-0004-y, DOI 10.1007/S40471-013-0004-Y]; Lee SE, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.11.047; Novy MJ, 2001, AM J OBSTET GYNECOL, V184, P1447, DOI 10.1067/mob.2001.114854; OLATUNBOSUN OA, 1995, INT SURG, V80, P170; Stupin JH, 2008, EUR J OBSTET GYN R B, V139, P32, DOI 10.1016/j.ejogrb.2007.11.009; Ventolini G, 2009, J PERINATOL, V29, P276, DOI 10.1038/jp.2008.221; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601	18	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168285	10.1371/journal.pone.0168285	http://dx.doi.org/10.1371/journal.pone.0168285			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002467	Green Published, gold, Green Submitted			2022-12-26	WOS:000392853100037
J	Bocharov, G; Meyerhans, A; Bessonov, N; Trofimchuk, S; Volpert, V				Bocharov, Gennady; Meyerhans, Andreas; Bessonov, Nickolai; Trofimchuk, Sergei; Volpert, Vitaly			Spatiotemporal Dynamics of Virus Infection Spreading in Tissues	PLOS ONE			English	Article							COMBINED ANTIRETROVIRAL THERAPY; T-CELL EXHAUSTION; TRAVELING-WAVES; IMMUNE-RESPONSE; DIFFUSION-EQUATIONS; ASYMPTOTIC-BEHAVIOR; ADAPTIVE IMMUNITY; PATTERN-FORMATION; HIV-INFECTION; TIME-DELAY	Virus spreading in tissues is determined by virus transport, virus multiplication in host cells and the virus-induced immune response. Cytotoxic T cells remove infected cells with a rate determined by the infection level. The intensity of the immune response has a bell-shaped dependence on the concentration of virus, i.e., it increases at low and decays at high infection levels. A combination of these effects and a time delay in the immune response determine the development of virus infection in tissues like spleen or lymph nodes. The mathematical model described in this work consists of reaction-diffusion equations with a delay. It shows that the different regimes of infection spreading like the establishment of a low level infection, a high level infection or a transition between both are determined by the initial virus load and by the intensity of the immune response. The dynamics of the model solutions include simple and composed waves, and periodic and aperiodic oscillations. The results of analytical and numerical studies of the model provide a systematic basis for a quantitative understanding and interpretation of the determinants of the infection process in target organs and tissues from the image-derived data as well as of the spatiotemporal mechanisms of viral disease pathogenesis, and have direct implications for a biopsy-based medical testing of the chronic infection processes caused by viruses, e.g. HIV, HCV and HBV.	[Bocharov, Gennady; Meyerhans, Andreas; Volpert, Vitaly] Russian Acad Sci, Inst Numer Math, Moscow, Russia; [Meyerhans, Andreas] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Infect Biol Lab, Barcelona, Spain; [Meyerhans, Andreas] ICREA, Pg Lluis Co 23, Barcelona, Spain; [Bessonov, Nickolai] Russian Acad Sci, Inst Problems Mech Engn, St Petersburg, Russia; [Trofimchuk, Sergei] Univ Talca, Inst Matemat & Fis, Talca, Chile; [Volpert, Vitaly] Univ Lyon 1, UMR CNRS 5208, Inst Camille Jordan, Villeurbanne, France; [Volpert, Vitaly] INRIA Lyon La Doua, INRIA Team Dracula, Villeurbanne, France; [Volpert, Vitaly] UMI 2615 CNRS, Lab Poncelet, Moscow, Russia; [Bocharov, Gennady] Gamaleya Ctr Epidemiol & Microbiol, Moscow, Russia; [Bocharov, Gennady] RUDN Univ, Moscow, Russia	Russian Academy of Sciences; Pompeu Fabra University; ICREA; Russian Academy of Sciences; Universidad de Talca; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Ecole Centrale de Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Universite Jean Monnet; Russian Academy of Medical Sciences; Gamaleya National Research Center for Epidemiology & Microbiology, RAMS; Peoples Friendship University of Russia	Bocharov, G (corresponding author), Russian Acad Sci, Inst Numer Math, Moscow, Russia.; Bocharov, G (corresponding author), Gamaleya Ctr Epidemiol & Microbiol, Moscow, Russia.; Bocharov, G (corresponding author), RUDN Univ, Moscow, Russia.	bocharov@m.inm.ras.ru	Bocharov, Gennady/H-1832-2016; Bocharov, Gennady/AAN-7508-2020; Bocharov, Gennady/AGA-7312-2022; Volpert, Vitaly/E-2969-2019; Bocharov, Gennady/GSN-1705-2022; Trofimchuk, Sergei/A-1111-2008; Bocharov, Gennady/T-1322-2017	Bocharov, Gennady/0000-0002-5049-0656; Bocharov, Gennady/0000-0002-5049-0656; Bocharov, Gennady/0000-0002-5049-0656; Bocharov, Gennady/0000-0002-5049-0656; Trofimchuk, Sergei/0000-0003-1605-222X	Russian Science Foundation [15-11-00029]; Spanish Ministry of Economy and Competitiveness; FEDER [SAF2013-46077-R]; FONDECYT (Chile) project [1150480]; ICREA Funding Source: Custom	Russian Science Foundation(Russian Science Foundation (RSF)); Spanish Ministry of Economy and Competitiveness(Spanish Government); FEDER(European Commission); FONDECYT (Chile) project(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); ICREA(ICREA)	The research was funded by the Russian Science Foundation (Grant no. 15-11-00029) to G. B., A.M., V.V. A.M. was also partially supported by a grant from the Spanish Ministry of Economy and Competitiveness and FEDER (Grant no. SAF2013-46077-R). S.T. and V.V. were also partially supported by FONDECYT (Chile) project 1150480. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The research was funded by the Russian Science Foundation (Grant no. 15-11-00029) to G. B., A.M., V.V. A.M. was also partially supported by a grant from the Spanish Ministry of Economy and Competitiveness and FEDER (Grant no. SAF2013-46077-R). S.T. and V.V. were also partially supported by FONDECYT (Chile) project 1150480.	Baldazzi V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-387; Beauchemin C, 2006, J THEOR BIOL, V242, P464, DOI 10.1016/j.jtbi.2006.03.014; Berestycki H, 2009, NONLINEARITY, V22, P2813, DOI 10.1088/0951-7715/22/12/002; Bertoletti A, 2016, J HEPATOL, V64, pS71, DOI 10.1016/j.jhep.2016.01.026; Blancou P, 2001, P NATL ACAD SCI USA, V98, P13237, DOI 10.1073/pnas.231348598; Bocharov G, 2005, TRANSFUS MED HEMOTH, V32, P304, DOI 10.1159/000089117; Bocharov G, 2004, J VIROL, V78, P2247, DOI 10.1128/JVI.78.5.2247-2254.2004; Boulle M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005964; Canini L, 2014, J PHARMACOKINET PHAR, V41, P431, DOI 10.1007/s10928-014-9363-3; Culshaw RV, 2003, J MATH BIOL, V46, P425, DOI 10.1007/s00285-002-0191-5; Ducrot A, 2014, J DIFFER EQUATIONS, V256, P3115, DOI 10.1016/j.jde.2014.01.033; Duehring D, 2007, J DYN DIFFER EQU, V19, P457, DOI 10.1007/s10884-006-9048-8; Dunia R, 2013, J MATH BIOL, V67, P1425, DOI 10.1007/s00285-012-0593-y; Fang J, 2015, J EUR MATH SOC, V17, P2243, DOI 10.4171/JEMS/556; FENNER F, 1948, LANCET, V252, P915, DOI 10.1016/S0140-6736(48)91599-2; Funk GA, 2005, J THEOR BIOL, V233, P221, DOI 10.1016/j.jtbi.2004.10.004; Germain RN, 2011, NAT IMMUNOL, V12, P369, DOI 10.1038/ni0511-369; Gomez A, 2014, J LOND MATH SOC, V89, P47, DOI 10.1112/jlms/jdt050; Gourley S. A., 2004, J MATH SCI-U TOKYO, V124, P5119, DOI [10.1023/B:JOTH.0000047249.39572.6d, DOI 10.1023/B:JOTH.0000047249.39572.6D]; Graw F, 2015, J VIROL, V89, P6551, DOI 10.1128/JVI.00016-15; Grossman Z, 2006, NAT MED, V12, P289, DOI 10.1038/nm1380; Grossman Z, 1999, NAT MED, V5, P1099, DOI 10.1038/13410; Grossman Z, 2015, ANNU REV IMMUNOL, V33, P677, DOI 10.1146/annurev-immunol-032712-100027; Haseltine EL, 2008, B MATH BIOL, V70, P1730, DOI 10.1007/s11538-008-9316-3; Hasik K, 2014, DISCRETE CONT DYN-A, V34, P3511, DOI 10.3934/dcds.2014.34.3511; Jankovic M, 2016, THEOR POPUL BIOL, V110, P51, DOI 10.1016/j.tpb.2016.04.004; Kumberger P, 2016, FEBS LETT, V590, P1972, DOI 10.1002/1873-3468.12095; Lamers SL, 2016, J VIROL, V90, P8968, DOI 10.1128/JVI.00674-16; Levin D, 2016, J THEOR BIOL, V398, P52, DOI 10.1016/j.jtbi.2016.02.022; Li L, 2015, APPL MATH COMPUT, V258, P342, DOI 10.1016/j.amc.2015.02.006; Li QS, 2009, SCIENCE, V323, P1726, DOI 10.1126/science.1168676; Likhoshvai VA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S12-S1; Mandl JN, 2014, CURR OPIN IMMUNOL, V29, P8, DOI 10.1016/j.coi.2014.03.002; MARTIN RH, 1990, T AM MATH SOC, V321, P1, DOI 10.2307/2001590; Medyukhina A, 2015, CYTOM PART A, V87A, P462, DOI 10.1002/cyto.a.22638; Morozov AY, 2016, J THEOR BIOL, V396, P116, DOI 10.1016/j.jtbi.2016.02.016; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Nakaoka S, 2016, J MATH BIOL, V72, P909, DOI 10.1007/s00285-015-0940-x; Nowak MA., 2000, VIRUS DYNAMICS MATH; Paul WE, 2013, COLD SH Q B, V78, P265, DOI 10.1101/sqb.2013.78.020198; Perelson AS, 1999, SIAM REV, V41, P3, DOI 10.1137/S0036144598335107; Pienaar E, 2015, J THEOR BIOL, V367, P166, DOI 10.1016/j.jtbi.2014.11.021; Prokopiou SA, 2014, COMPUTATION, V2, P159, DOI 10.3390/computation2040159; Pulverer JE, 2010, J VIROL, V84, P8626, DOI 10.1128/JVI.00303-10; Qi H, 2014, ANNU REV CELL DEV BI, V30, P141, DOI 10.1146/annurev-cellbio-100913-013254; Richter K, 2012, EUR J IMMUNOL, V42, P2290, DOI 10.1002/eji.201142275; Rose R, 2016, J VIROL, V90, P8984, DOI 10.1128/JVI.00684-16; Rothenberger MK, 2015, P NATL ACAD SCI USA, V112, pE1126, DOI 10.1073/pnas.1414926112; SCHAAF KW, 1987, T AM MATH SOC, V302, P587; Scully EP, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85433; Shiwang MA, 2007, J DYN DIFFER EQU, V19, P391, DOI 10.1007/s10884-006-9065-7; Smith H, 2011, INTRO DELAY DIFFEREN; Smith HL, 2000, SIAM J MATH ANAL, V31, P514, DOI 10.1137/S0036141098346785; Stancevic O, 2013, B MATH BIOL, V75, P774, DOI 10.1007/s11538-013-9834-5; Strain MC, 2002, J THEOR BIOL, V218, P85, DOI 10.1006/jtbi.2002.3055; Su B, 2009, COMPUT MATH METHOD M, V10, P9, DOI 10.1080/17486700801982713; Sun GQ, 2012, NONLINEAR DYNAM, V69, P1097, DOI 10.1007/s11071-012-0330-5; Sun GQ, 2016, NONLINEAR DYNAM, V85, P1, DOI 10.1007/s11071-016-2671-y; Sun GQ, 2016, NONLINEAR DYNAM, V83, P811, DOI 10.1007/s11071-015-2369-6; Sun GQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11246; Sun GQ, 2012, APPL MATH COMPUT, V218, P11151, DOI 10.1016/j.amc.2012.04.071; Sun Gui-Quan, PHYS LIFE REV; Tan A, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a021428; Tang JY, 2013, EUR J IMMUNOL, V43, P1407, DOI 10.1002/eji.201243119; Trofimchuk E, 2008, J DIFFER EQUATIONS, V245, P2307, DOI 10.1016/j.jde.2008.06.023; Trofimchuk E, 2013, J DIFFER EQUATIONS, V254, P3690, DOI 10.1016/j.jde.2013.02.005; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; Volpert A. I., 1994, TRANSLATIONS MATH MO, V140; Volpert V, 2009, PHYS LIFE REV, V6, P267, DOI 10.1016/j.plrev.2009.10.002; Volpert V., 2014, ELLIPTIC PARTIAL DIF, V2; Wang ZC, 2007, J DIFFER EQUATIONS, V238, P153, DOI 10.1016/j.jde.2007.03.025; Watanabe T, 2010, J VIRAL HEPATITIS, V17, P453, DOI 10.1111/j.1365-2893.2010.01313.x; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wu J., 1996, APPL MATH SCI, V119, DOI [10.1007/978-1-4612-4050-1, DOI 10.1007/978-1-4612-4050-1]; Zhang CW, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004179; Zinkernagel RM, 2004, SCAND J IMMUNOL, V60, P9, DOI 10.1111/j.0300-9475.2004.01460.x; ZINKERNAGEL RM, 1985, BRIT MED BULL, V41, P92, DOI 10.1093/oxfordjournals.bmb.a072033; Zinkernagel RM, 2001, SCIENCE, V293, P251, DOI 10.1126/science.1063005; Zuniga EI, 2015, ANNU REV VIROL, V2, P573, DOI 10.1146/annurev-virology-100114-055226	79	24	25	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168576	10.1371/journal.pone.0168576	http://dx.doi.org/10.1371/journal.pone.0168576			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997613	Green Published, gold, Green Submitted			2022-12-26	WOS:000392842900061
J	Lahey, T; Laddy, D; Hill, K; Schaeffer, J; Hogg, A; Keeble, J; Dagg, B; Ho, MM; Arbeit, RD; von Reyn, CF				Lahey, Timothy; Laddy, Dominick; Hill, Krystal; Schaeffer, Jacqueline; Hogg, Alison; Keeble, James; Dagg, Belinda; Ho, Mei Mei; Arbeit, Robert D.; von Reyn, C. Fordham			Immunogenicity and Protective Efficacy of the DAR-901 Booster Vaccine in a Murine Model of Tuberculosis	PLOS ONE			English	Article							HIV-ASSOCIATED TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; ANIMAL-MODELS; BCG; VACCAE; PREVENTION; INFECTION; ANTIGENS; TRIAL	Background The development of a novel tuberculosis vaccine is a leading global health priority. SRL172, an inactivated, whole-cell mycobacterial vaccine, was safe, immunogenic and reduced the incidence of culture-confirmed tuberculosis in a phase III trial in HIV-infected and BCG immunized adults in Tanzania. Here we describe the immunogenicity and protective efficacy of DAR-901, a booster vaccine against tuberculosis manufactured from the same seed strain using a new scalable method. Methods We evaluated IFN-gamma responses by ELISpot and antibody responses by enzyme linked immunosorbent assay in C57BL/6 and BALB/c mice after three doses of DAR-901. In an aerosol challenge model, we evaluated the protective efficacy of the DAR-901 booster in C57BL/6 mice primed with BCG and boosted with two doses of DAR-901 at 4 dosage levels in comparison with homologous BCG boost. Results DAR-901 vaccination elicited IFN-gamma responses to mycobacterial antigen preparations derived from both DAR-901 and Mycobacterium tuberculosis. DAR-901 immunization enhanced antibody responses to DAR-901 but not Mycobacterium tuberculosis lysate or purified protein derivative. Among animals primed with BCG, boosting with DAR-901 at 1 mg provided greater protection against aerosol challenge than a homologous BCG boost (lungs P = 0.036, spleen P = 0.028). Conclusions DAR-901 induces cellular and humoral immunity and boosts protection from M. tuberculosis compared to a homologous BCG boost.	[Lahey, Timothy; von Reyn, C. Fordham] Dartmouths Geisel Sch Med, 1 Med Ctr Dr, Lebanon, NH 03766 USA; [Laddy, Dominick; Hill, Krystal; Schaeffer, Jacqueline; Hogg, Alison] Aeras, 1405 Res Blvd, Rockville, MD USA; [Keeble, James; Dagg, Belinda; Ho, Mei Mei] MHRA NIBSC, Bacteriol Div, Potters Bar, Herts, England; [Arbeit, Robert D.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Hill, Krystal] IDT Biol, 1405 Res Blvd, Rockville, MD USA; [Hogg, Alison] Emergent Biosolut, 400 Profess Dr 100, Gaithersburg, MD USA	National Institute for Biological Standards & Control; Tufts University	Lahey, T (corresponding author), Dartmouths Geisel Sch Med, 1 Med Ctr Dr, Lebanon, NH 03766 USA.	Timothy.Lahey@Dartmouth.edu			Aeras; Dartmouth College	Aeras; Dartmouth College	This work was funded by grants from Aeras (aeras.org) and Dartmouth College (dartmouth.edu) to CFvR. Neither grant had a specific number assigned to it.	AbouZeid C, 1997, INFECT IMMUN, V65, P1856, DOI 10.1128/IAI.65.5.1856-1862.1997; Achkar JM, 2013, CELL HOST MICROBE, V13, P250, DOI 10.1016/j.chom.2013.02.009; Dharmadhikari AS, 2008, AM J RESP CELL MOL, V39, P503, DOI 10.1165/rcmb.2008-0154TR; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Kaufmann SHE, 2014, LANCET RESP MED, V2, P301, DOI 10.1016/S2213-2600(14)70033-5; Kaufmann SHE, 2010, LANCET, V375, P2110, DOI 10.1016/S0140-6736(10)60393-5; Khera AK, 2015, J IMMUNOLOGY; Knight GM, 2014, P NATL ACAD SCI USA, V111, P15520, DOI 10.1073/pnas.1404386111; Laddy DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002517; Lahey T, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.TNMI7-0003-2016; Lahey T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022074; Lahey T, 2010, VACCINE, V28, P7652, DOI 10.1016/j.vaccine.2010.09.041; Lahey T, 2010, J INFECT DIS, V202, P1265, DOI 10.1086/656332; Lalvani A, 2013, THORAX, V68, P1092, DOI 10.1136/thoraxjnl-2013-203456; Lu LL, 2016, CELL, V167, P433, DOI 10.1016/j.cell.2016.08.072; Lu LL, 2016, CELL; McShane H, 2014, TUBERCULOSIS, V94, P105, DOI 10.1016/j.tube.2013.11.003; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; PONNIGHAUS JM, 1992, LANCET, V339, P636, DOI 10.1016/0140-6736(92)90794-4; Rodrigues LC, 2005, LANCET, V366, P1290, DOI 10.1016/S0140-6736(05)67145-0; Skinner MA, 1997, INFECT IMMUN, V65, P4525, DOI 10.1128/IAI.65.11.4525-4530.1997; STANFORD JL, 1991, APMIS, V99, P103, DOI 10.1111/j.1699-0463.1991.tb05127.x; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Verreck FAW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005264; von Reyn CF, 2010, AIDS, V24, P675, DOI 10.1097/QAD.0b013e3283350f1b; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Vuola JM, 2003, AIDS, V17, P2351, DOI 10.1097/00002030-200311070-00010; Waddell RD, 2000, CLIN INFECT DIS, V30, pS309, DOI 10.1086/313880; WHO, 2014, GLOB TUB REP 2014; Young DL, 2009, EUR J IMMUNOL, V39, P2011, DOI 10.1002/eji.200939542; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	33	22	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168521	10.1371/journal.pone.0168521	http://dx.doi.org/10.1371/journal.pone.0168521			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997597	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842900054
J	Li, SY; Zhao, LM; Xu, WY; Jiang, ZH; Kang, J; Wang, FZ; Xin, FJ				Li, Shuying; Zhao, Leiming; Xu, Wenyi; Jiang, Zhonghao; Kang, Jun; Wang, Fengzhong; Xin, Fengjiao			Identification and Characterisation of a Novel Protein FIP-sch3 from Stachybotrys chartarum	PLOS ONE			English	Article							FUNGAL IMMUNOMODULATORY PROTEIN; LUNG-CANCER CELLS; FUNCTIONAL-CHARACTERIZATION; RECOMBINANT EXPRESSION; FLAMMULINA-VELUTIPES; GANODERMA-TSUGAE; BREAST-CANCER; GENE CLONING; TUMOR-GROWTH; FIP-FVE	In this study, a novel FIP named FIP-sch3 has been identified and characterised. FIP-sch3 was identified in the ascomycete Stachybotrys chartarum, making it the second FIP to be identified outside the order of Basidiomycota. Recombinant FIP-sch3 (rFIP-shc3) was produced in Escherichia co/iand purified using GST-affinity magnetic beads. The bioactive characteristics of FIP-sch3 were compared to those of well-known FIPs LZ-8 from Ganoderma lucidum and FIP-fve from Flammulina velutipes, which were produced and purified using the same method. The purified rFIP-sch3 exhibited a broad spectrum of anti-tumour activity in several types of tumour cells but had no cytotoxicity in normal human embryonic kidney 293 cells. Assays that were implemented to study these properties indicated that rFIP-sch3 significantly suppressed cell proliferation, induced apoptosis and inhibited cell migration in human lung adenocarcinoma A549 cells. The anti-tumour effects of rFIP-sch3 in A549 cells were comparable to those of rLZ-8, but they were significantly greater than those of rFIP-fve. Molecular assays that were built on real-time PCR further revealed potential mechanisms related to apoptosis and migration and that underlie phenotypic effects. These results indicate that FIP-shc3 has a unique anti-tumour bioactive profile, as do other FIPs, which provide a foundation for further studies on anti-tumour mechanisms. Importantly, this study also had convenient access to FIP-sch3 with potential human therapeutic applications.	[Li, Shuying; Zhao, Leiming; Xu, Wenyi; Jiang, Zhonghao; Wang, Fengzhong; Xin, Fengjiao] Chinese Acad Agr Sci, Inst Food Sci & Technol, Beijing, Peoples R China; [Kang, Jun] Tianjin Univ, Sch Life Sci, Tianjin, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Food Science & Technology, CAAS; Tianjin University	Wang, FZ; Xin, FJ (corresponding author), Chinese Acad Agr Sci, Inst Food Sci & Technol, Beijing, Peoples R China.	wangfengzhong@sina.com; 2002hongzhi30@163.com	zhao, leiming/HFZ-7937-2022; li, shuying/GLR-8636-2022					Aramini JM, 2008, PROTEINS, V72, P526, DOI 10.1002/prot.22064; Asada M, 2008, INT J CANCER, V123, P511, DOI 10.1002/ijc.23562; Bastiaan-Net S, 2013, INT IMMUNOPHARMACOL, V15, P167, DOI 10.1016/j.intimp.2012.11.003; BASU S, 1995, J NEUROIMMUNOL, V60, P1, DOI 10.1016/0165-5728(95)00044-3; Bizzozero L, 2014, CELL DEATH DIFFER, V21, P507, DOI 10.1038/cdd.2013.173; Borcherding DC, 2016, ONCOGENE, V35, P3103, DOI 10.1038/onc.2015.369; Carpinteiro A, 2008, CANCER LETT, V264, P1, DOI 10.1016/j.canlet.2008.02.020; Chang HH, 2009, J AGR FOOD CHEM, V57, P6129, DOI 10.1021/jf9011399; Chang YC, 2013, J AGR FOOD CHEM, V61, P12044, DOI 10.1021/jf4030272; Chiu LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125774; Cong WR, 2014, APPL MICROBIOL BIOT, V98, P5967, DOI 10.1007/s00253-014-5539-4; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Hsin IL, 2011, AUTOPHAGY, V7, P873, DOI 10.4161/auto.7.8.15698; Hsu HC, 1997, BIOCHEM J, V323, P557, DOI 10.1042/bj3230557; Ivanova H, 2014, BBA-MOL CELL RES, V1843, P2164, DOI 10.1016/j.bbamcr.2014.03.007; Jarvis BB, 2003, PHYTOCHEMISTRY, V64, P53, DOI 10.1016/S0031-9422(03)00275-9; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kim YH, 2006, ONCOGENE, V25, P130, DOI 10.1038/sj.onc.1208997; KINO K, 1989, J BIOL CHEM, V264, P472; KO JL, 1995, EUR J BIOCHEM, V228, P244, DOI 10.1111/j.1432-1033.1995.tb20256.x; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Li F, 2012, PROTEIN EXPRES PURIF, V82, P339, DOI 10.1016/j.pep.2012.01.015; Li QZ, 2011, CRIT REV BIOTECHNOL, V31, P365, DOI 10.3109/07388551.2010.543967; Li SY, 2015, FOOD CHEM TOXICOL, V78, P64, DOI 10.1016/j.fct.2015.01.013; Li SY, 2014, INT J MOL SCI, V15, P17751, DOI 10.3390/ijms151017751; Liao CH, 2008, FOOD CHEM TOXICOL, V46, P1851, DOI 10.1016/j.fct.2008.01.044; Lin CH, 2010, PROCESS BIOCHEM, V45, P1537, DOI 10.1016/j.procbio.2010.06.006; Lin JW, 2016, J CHEM TECHNOL BIOT, V91, P2761, DOI 10.1002/jctb.4881; Lin WH, 1997, J BIOL CHEM, V272, P20044, DOI 10.1074/jbc.272.32.20044; Lin YC, 2015, CLIN CANCER RES, V21, P428, DOI 10.1158/1078-0432.CCR-14-1150; Maraver A, 2012, CANCER CELL, V22, P222, DOI 10.1016/j.ccr.2012.06.014; OBEID LM, 1995, J CELL BIOCHEM, V58, P191, DOI 10.1002/jcb.240580208; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Paaventhan P, 2003, J MOL BIOL, V332, P461, DOI 10.1016/S0022-2836(03)00923-9; Renton A, 2003, CARCINOGENESIS, V24, P1177, DOI 10.1093/carcin/bgg044; Robles AI, 2014, CANCER PREV RES, V7, P1210, DOI 10.1158/1940-6207.CAPR-14-0158; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Semeiks J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-590; Sheu F, 2004, FOOD CHEM, V87, P593, DOI 10.1016/j.foodchem.2004.01.015; Soans E, 2014, ANTICANCER RES, V34, P3271; Sung HY, 2010, INT J RADIAT BIOL, V86, P780, DOI 10.3109/09553002.2010.484481; Tai CJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-95; Wang XQ, 2015, CELL BIOCHEM BIOPHYS, V73, P527, DOI 10.1007/s12013-015-0696-3; Wang XF, 2012, CURR TOP NUTRACEUT R, V10, P1; Wu CT, 2011, CARCINOGENESIS, V32, P1890, DOI 10.1093/carcin/bgr221; Xu H, 2016, J AGR FOOD CHEM, V64, P2690, DOI 10.1021/acs.jafc.6b00539; Zhou XW, 2009, INT J MED MUSHROOMS, V11, P77, DOI 10.1615/IntJMedMushr.v11.i1.90	47	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168436	10.1371/journal.pone.0168436	http://dx.doi.org/10.1371/journal.pone.0168436			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997578	gold, Green Published, Green Submitted			2022-12-26	WOS:000392842900045
J	Yang, YL; Yao, BL; Lei, M; Dan, D; Li, RZ; Van Horn, M; Chen, X; Li, Y; Ye, T				Yang, Yanlong; Yao, Baoli; Lei, Ming; Dan, Dan; Li, Runze; Van Horn, Mark; Chen, Xun; Li, Yang; Ye, Tong			Two-Photon Laser Scanning Stereomicroscopy for Fast Volumetric Imaging	PLOS ONE			English	Article							MICROSCOPY; SOFTWARE; DEEP	Bessel beams have been successfully used in two-photon laser scanning fluorescence microscopy to extend the depth of field (EDF), which makes it possible to observe fast events volumetrically. However, the depth information is lost due to integration of fluorescence signals along the propagation direction. We describe the design and implementation of two-photon lasers scanning stereomicroscopy, which allows viewing dynamic processes in three-dimensional (3D) space stereoscopically in real-time with shutter glasses at the speed of 1.4 volumes per second. The depth information can be appreciated by human visual system or be recovered with correspondence algorithms for some cases.	[Yang, Yanlong; Yao, Baoli; Lei, Ming; Dan, Dan; Li, Runze] Chinese Acad Sci, Xian Inst Opt & Precis Mech, State Key Lab Transient Opt & Photon, Xian, Peoples R China; [Van Horn, Mark] Med Univ South Carolina, Dept Radiol, Charleston, SC USA; [Chen, Xun; Li, Yang; Ye, Tong] Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA; [Chen, Xun; Li, Yang; Ye, Tong] Clemson Univ, COMSET, Clemson, SC 29634 USA; [Ye, Tong] Med Univ South Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA	Chinese Academy of Sciences; Xi'an Institute of Optics & Precision Mechanics, CAS; State Key Laboratory of Transient Optics & Photonics; Medical University of South Carolina; Clemson University; Clemson University; Medical University of South Carolina	Yao, BL (corresponding author), Chinese Acad Sci, Xian Inst Opt & Precis Mech, State Key Lab Transient Opt & Photon, Xian, Peoples R China.; Ye, T (corresponding author), Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA.; Ye, T (corresponding author), Clemson Univ, COMSET, Clemson, SC 29634 USA.; Ye, T (corresponding author), Med Univ South Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA.	yaobl@opt.ac.cn; ye7@clemson.edu	Li, Runze/ABF-1320-2020; Ye, Tong/ABG-8560-2021; Ye, Tong/A-8251-2010; Yao, Baoli/AAB-4606-2021	Li, Runze/0000-0002-0154-2202; Ye, Tong/0000-0003-1017-6969; Ye, Tong/0000-0003-1017-6969; 	National Institute of General Medical Sciences [R21GM104683, P20GM103499]; National Science Foundation [1539034]; National Natural Science Foundation of China (NSFC) [81427802, 61275191, 61522511]; Office of Integrative Activities [1539034] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM104683, P20GM103499] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by R21GM104683, National Institute of General Medical Sciences https://taggs.hhs.gov/Detail/AwardDetail?arg_AwardNum=R21GM104683&arg_ProgOfficeCode=127, P20GM103499, National Institute of General Medical Sciences, 1539034, National Science Foundation; http://www.nsf.gov/awardsearch/showAward?AWD_ID=1539034&HistoricalAwards=false, and National Natural Science Foundation of China (NSFC) (81427802, 61275191 and 61522511) https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list#.	Bewersdorf J, 1998, OPT LETT, V23, P655, DOI 10.1364/OL.23.000655; Bingen P, 2011, OPT EXPRESS, V19, P23716, DOI 10.1364/OE.19.023716; Botcherby EJ, 2006, OPT COMMUN, V268, P253, DOI 10.1016/j.optcom.2006.07.026; Brzobohaty O, 2008, OPT EXPRESS, V16, P12688, DOI 10.1364/OE.16.012688; Cha JW, 2015, AIP ADV, V5, DOI 10.1063/1.4916040; Cizmar T, 2009, OPT EXPRESS, V17, P15558, DOI 10.1364/OE.17.015558; Curran A, 2014, OPTICA, V1, P223, DOI 10.1364/OPTICA.1.000223; Davies E., 2005, MACHINE VISION THEOR, V3rd; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Deschout H, 2014, NAT METHODS, V11, P253, DOI 10.1038/nmeth.2843; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Ji N, 2016, NAT NEUROSCI, V19, P1154, DOI 10.1038/nn.4358; Ji N, 2008, CURR OPIN NEUROBIOL, V18, P605, DOI 10.1016/j.conb.2009.03.009; Kai Wicker, 2010, NANOSCOPY MULTIDIMEN; Kak A. C., 2001, PRINCIPLES COMPUTERI; Katona G, 2012, NAT METHODS, V9, P201, DOI [10.1038/NMETH.1851, 10.1038/nmeth.1851]; Kong LJ, 2015, NAT METHODS, V12, P759, DOI [10.1038/nmeth.3476, 10.1038/NMETH.3476]; Mahou P, 2014, NAT METHODS, V11, P600, DOI 10.1038/nmeth.2963; Pawley J.B., 2006, HDB BIOL CONFOCAL MI, DOI [10.1007/978-0-387-45524-2_23, 10.1007/978-0-387-45524-2, DOI 10.1007/978-0-387-45524-2]; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Saleh B., 2011, INTRO SUBSURFACE IMA; Scharstein D, 2002, INT J COMPUT VISION, V47, P7, DOI 10.1023/A:1014573219977; SHEPPARD CJR, 1978, IEE PROC-H, V2, P105, DOI 10.1049/ij-moa.1978.0023; Shimozawa T, 2013, P NATL ACAD SCI USA, V110, P3399, DOI 10.1073/pnas.1216696110; Solomon C, 2011, FUNDAMENTALS DIGITAL, V1st, DOI 10.1002/9780470689776; Theriault G, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00139; Tinevez J-Y, METHODS; Truong TV, 2011, NAT METHODS, V8, P757, DOI 10.1038/nmeth.1652; Wolf S, 2015, NAT METHODS, V12, P379, DOI 10.1038/nmeth.3371; Yang YL, 2013, PROC SPIE, V8588, DOI 10.1117/12.2002850; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	32	10	11	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168885	10.1371/journal.pone.0168885	http://dx.doi.org/10.1371/journal.pone.0168885			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997624	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842900083
J	Canepa, GE; Molina-Cruz, A; Barillas-Mury, C				Canepa, Gaspar E.; Molina-Cruz, Alvaro; Barillas-Mury, Carolina			Molecular Analysis of Pfs47-Mediated Plasmodium Evasion of Mosquito Immunity	PLoS One			English	Article							VECTOR ANOPHELES-GAMBIAE; FALCIPARUM; COMPLEMENT; SELECTION; SYSTEM	Malaria is a life-threatening disease caused by Plasmodium falciparum parasites that is transmitted through the bites of infected anopheline mosquitoes. P. falciparum dispersal from Africa, as a result of human migration, required adaptation of the parasite to several different indigenous anopheline species. The mosquito immune system can greatly limit infection and P. falciparum evolved a strategy to evade these responses that is mediated by the Pfs47 gene. Pfs47 is a polymorphic gene with signatures of diversifying selection and a strong geographic genetic structure at a continental level. Here, we investigated the role of single four amino acid differences between the Pfs47 gene from African (GB4 and NF54) and a New World (7G8) strains that differ drastically in their ability to evade the immune system of A. gambiae L35 refractory mosquitoes. Wild type NF54 and GB4 parasites can survive in this mosquito strain, while 7G8 parasites are eliminated. Our studies indicate that replacement in any of these four single amino acids in Pfs47 from the NF54 strain by those present in 7G8, completely disrupts the ability of NF54 parasites to hide from the mosquito immune system. One of these amino acid replacements had the opposite effect on A. albimanus mosquitoes, and enhanced infection. We conclude that malaria transmission involves a complex interplay between the genetic background of the parasite and the mosquito and that Pfs47 can be critical in this interaction as it mediates Plasmodium immune evasion through molecular interactions that need to be precise in some parasite/vector combinations.	[Canepa, Gaspar E.; Molina-Cruz, Alvaro; Barillas-Mury, Carolina] NINDS, Lab Malaria & Vector Res, NIH, Rockville, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Barillas-Mury, C (corresponding author), NINDS, Lab Malaria & Vector Res, NIH, Rockville, MD 20892 USA.	cbarillas@niaid.nih.gov		Canepa, Gaspar/0000-0002-4195-8835	Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000947] Funding Source: NIH RePORTER	Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjalley SH, 2010, METHODS MOL BIOL, V634, P87, DOI 10.1007/978-1-60761-652-8_6; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Caro F, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-22; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; Eldering M, 2016, SCI REP-UK, V6, DOI 10.1038/srep20440; FELDMANN AM, 1989, MED VET ENTOMOL, V3, P41, DOI 10.1111/j.1365-2915.1989.tb00473.x; Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005; Garver LS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003622; Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Molina-Cruz A, 2012, P NATL ACAD SCI US; Molina-Cruz A, 2015, P NATL ACAD SCI USA, V112, P15178, DOI 10.1073/pnas.1520426112; Molina-Cruz A, 2014, MEM I OSWALDO CRUZ, V109, P662, DOI 10.1590/0074-0276130553; Molina-Cruz A, 2013, SCIENCE, V340, P984, DOI 10.1126/science.1235264; Oliveira GD, 2012, SCIENCE, V335, P856, DOI 10.1126/science.1209678; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; Ramphul UN, 2015, P NATL ACAD SCI USA, V112, P1273, DOI 10.1073/pnas.1423586112; Sinka ME, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-69; World Health Organization, 2015, WORLD MAL REP 2015	20	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168279	10.1371/journal.pone.0168279	http://dx.doi.org/10.1371/journal.pone.0168279			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992481	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842600046
J	Voogd, C; Brian, LA; Varkonyi-Gasic, E				Voogd, Charlotte; Brian, Lara A.; Varkonyi-Gasic, Erika			Two Subclasses of Differentially Expressed TPS1 Genes and Biochemically Active TPS1 Proteins May Contribute to Sugar Signalling in Kiwifruit Actinidia chinensis	PLOS ONE			English	Article							TUBBY-LIKE PROTEINS; TREHALOSE METABOLISM; TREHALOSE-6-PHOSPHATE PHOSPHATASE; ARABIDOPSIS-THALIANA; SMALL AUXIN; ENVIRONMENTAL SIGNALS; VEGETATIVE GROWTH; CELL EXPANSION; FLORAL DIP; FAMILY	Trehalose metabolism and its intermediate trehalose-6-phosphate (T6P) are implicated in sensing and signalling sucrose availability. Four class I TREHALOSE-6-PHOSPHATE SYNTHASE (TPS1) genes were identified in kiwifruit, three of which have both the TPS and trehalose-6-phosphate phosphatase (TPP) domain, while the fourth gene gives rise to a truncated transcript. The transcript with highest sequence homology to Arabidopsis TPS1, designated TPS1.1a was the most highly abundant TPS1 transcript in all examined kiwifruit tissues. An additional exon giving rise to a small N-terminal extension was found for two of the TPS1 transcripts, designated TPS1.2a and TPS1.2b. Homology in sequence and gene structure with TPS1 genes from Solanaceae suggests they belong to a separate, asterid-specific class I TPS subclade. Expression of full-length and potential splice variants of these two kiwifruit TPS1.2 transcripts was sufficient to substitute for the lack of functional TPS1 in the yeast tps1. tps2. mutant, but only weak complementation was detected in the yeast tps1. mutant, and no or very weak complementation was obtained with the TPS1.1a construct. Transgenic Arabidopsis lines expressing kiwifruit TPS1.2 under the control of 35S promoter exhibited growth and morphological defects. We investigated the responses of plants to elevated kiwifruit TPS1 activity at the transcriptional level, using transient expression of TPS1.2a in Nicotiana benthamiana leaves, followed by RNA-seq. Differentially expressed genes were identified as candidates for future functional analyses.	[Voogd, Charlotte; Brian, Lara A.; Varkonyi-Gasic, Erika] New Zealand Inst Plant & Food Res Ltd Plant & Foo, Auckland Mail Ctr, Auckland, New Zealand	New Zealand Institute for Plant & Food Research Ltd	Varkonyi-Gasic, E (corresponding author), New Zealand Inst Plant & Food Res Ltd Plant & Foo, Auckland Mail Ctr, Auckland, New Zealand.	erika.varkonyi-gasic@plantandfood.co.nz	Varkonyi-Gasic, Erika/R-9920-2017	Varkonyi-Gasic, Erika/0000-0002-1068-4085; Voogd, Charlotte/0000-0003-1520-6469	Plant & Food Research Discovery Science grant [1469]	Plant & Food Research Discovery Science grant	Support was provided by Plant & Food Research Discovery Science grant 1469.; The yeast strains were kindly provided by J.M. Thevelein from the Katholieke Universiteit Leuven, Belgium. We thank Cyril Brendolise for the pURA3 construct, Peggy Kashuba for plant material, Ben Warren, Amali Thrimawithana and Cecilia Deng for bioinformatics advice, Monica Dragulescu and the glasshouse staff for plant maintenance, Andrew Allen for helpful discussions and Anne Gunson for critical reading of the manuscript. This work was funded by the Plant & Food Research Discovery Science grant 1469.	Ahveninen J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3585; Almeida AM, 2007, IN VITRO CELL DEV-PL, V43, P167, DOI 10.1007/s11627-006-9024-3; Avonce N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-109; Bao Y, 2014, PLANT MOL BIOL, V86, P471, DOI 10.1007/s11103-014-0241-6; Chae K, 2012, PLANT J, V71, P684, DOI 10.1111/j.1365-313X.2012.05024.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Crowhurst RN, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-351; Delatte TL, 2011, PLANT PHYSIOL, V157, P160, DOI 10.1104/pp.111.180422; Eastmond PJ, 2002, PLANT J, V29, P225, DOI 10.1046/j.1365-313x.2002.01220.x; Egea-Cortines M, 1999, EMBO J, V18, P5370, DOI 10.1093/emboj/18.19.5370; Farrar K, 2003, PLANT J, V33, P61, DOI 10.1046/j.1365-313X.2003.01608.x; Gangappa SN, 2014, TRENDS PLANT SCI, V19, P460, DOI 10.1016/j.tplants.2014.01.010; Glinski M, 2005, MOL CELL PROTEOMICS, V4, P1614, DOI 10.1074/mcp.M500134-MCP200; Goddijn OJM, 1999, TRENDS PLANT SCI, V4, P315, DOI 10.1016/S1360-1385(99)01446-6; Gomez LD, 2006, PLANT J, V46, P69, DOI 10.1111/j.1365-313X.2006.02662.x; Gomez LD, 2010, PLANT J, V64, P1, DOI 10.1111/j.1365-313X.2010.04312.x; Gonzalez-Fontes A, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.26114; Hellens RP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-13; Henry C, 2014, J EXP BOT, V65, P5959, DOI 10.1093/jxb/eru335; HOHMANN S, 1993, CURR GENET, V23, P281, DOI 10.1007/BF00310888; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Iturriaga G, 2009, INT J MOL SCI, V10, P3793, DOI 10.3390/ijms10093793; Kant S, 2009, PLANT SIGNAL BEHAV, V4, P1174, DOI 10.4161/psb.4.12.10043; Kant S, 2009, PLANT PHYSIOL, V151, P691, DOI 10.1104/pp.109.143875; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kolbe A, 2005, P NATL ACAD SCI USA, V102, P11118, DOI 10.1073/pnas.0503410102; Kondrak M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-74; Kondrak M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023466; Kong YY, 2013, PLANT CELL PHYSIOL, V54, P609, DOI 10.1093/pcp/pct028; Kretzschmar T, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.124, 10.1038/nplants.2015.124]; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li P, 2008, PHYSIOL PLANTARUM, V133, P544, DOI 10.1111/j.1399-3054.2008.01101.x; Licausi F, 2013, NEW PHYTOL, V199, P639, DOI 10.1111/nph.12291; Lisso J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00219; Liu DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046451; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lunn JE, 2007, FUNCT PLANT BIOL, V34, P550, DOI 10.1071/FP06315; Lunn JE, 2014, PLANT J, V79, P544, DOI 10.1111/tpj.12509; Ma JK, 2011, NEW PHYTOL, V191, P733, DOI 10.1111/j.1469-8137.2011.03735.x; Markakis MN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082596; Martinez-Trujillo M, 2004, PLANT MOL BIOL REP, V22, P63, DOI 10.1007/BF02773350; Martins MCM, 2013, PLANT PHYSIOL, V163, P1142, DOI 10.1104/pp.113.226787; Mi H, 2015, NUCL ACIDS RES; NEVES MJ, 1995, CURR GENET, V27, P110, DOI 10.1007/BF00313424; Nuccio ML, 2015, NAT BIOTECHNOL, V33, P862, DOI 10.1038/nbt.3277; O'Hara LE, 2013, MOL PLANT, V6, P261, DOI 10.1093/mp/sss120; Paul MJ, 2008, ANNU REV PLANT BIOL, V59, P417, DOI 10.1146/annurev.arplant.59.032607.092945; Pellny TK, 2004, PLANT BIOTECHNOL J, V2, P71, DOI 10.1111/j.1467-7652.2004.00053.x; Petitjean M, 2015, J BIOL CHEM, V290, P16177, DOI 10.1074/jbc.M115.653899; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ponnu J, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00070; Ramon M, 2009, PLANT CELL ENVIRON, V32, P1015, DOI 10.1111/j.1365-3040.2009.01985.x; Rangan L, 2008, MOL BIOTECHNOL, V39, P207, DOI 10.1007/s12033-008-9036-9; Reitz MU, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25198; Reitz MU, 2012, PLANT PHYSIOL, V160, P349, DOI 10.1104/pp.112.201319; Ren H, 2015, MOL PLANT, V8, P1153, DOI 10.1016/j.molp.2015.05.003; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Ruijter JM, 2014, MICROCHIM ACTA, V181, P1689, DOI 10.1007/s00604-013-1155-8; Satoh-Nagasawa N, 2006, NATURE, V441, P227, DOI 10.1038/nature04725; Schluepmann H, 2003, P NATL ACAD SCI USA, V100, P6849, DOI 10.1073/pnas.1132018100; Schroder F, 2011, PLANT PHYSIOL, V156, P1620, DOI 10.1104/pp.111.177204; Schroder F, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-20; Shen HS, 2007, BIOCHEM BIOPH RES CO, V362, P425, DOI 10.1016/j.bbrc.2007.08.026; Spartz AK, 2014, PLANT CELL, V26, P2129, DOI 10.1105/tpc.114.126037; Spartz AK, 2012, PLANT J, V70, P978, DOI 10.1111/j.1365-313X.2012.04946.x; Stefanowicz K, 2012, FEBS OPEN BIO, V2, P151, DOI 10.1016/j.fob.2012.06.002; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Tuomi JM, 2010, METHODS, V50, P313, DOI 10.1016/j.ymeth.2010.02.003; Van Dijck P, 2015, TREHALOSE 6 PHOSPHAT, P283; van Dijken AJH, 2004, PLANT PHYSIOL, V135, P969, DOI 10.1104/pp.104.039743; Van Houtte H, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23209; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vandesteene L, 2012, PLANT PHYSIOL, V160, P884, DOI 10.1104/pp.112.201400; Vandesteene L, 2010, MOL PLANT, V3, P406, DOI 10.1093/mp/ssp114; Varkonyi-Gasic E, 2013, NEW PHYTOL, V198, P732, DOI 10.1111/nph.12162; Wahl V, 2013, SCIENCE, V339, P704, DOI 10.1126/science.1230406; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Xie DW, 2015, J GENET, V94, P55, DOI 10.1007/s12041-015-0495-z; Yadav UP, 2014, J EXP BOT, V65, P1051, DOI 10.1093/jxb/ert457; Yang HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042438; Zang BS, 2011, PLANT MOL BIOL, V76, P507, DOI 10.1007/s11103-011-9781-1	81	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168075	10.1371/journal.pone.0168075	http://dx.doi.org/10.1371/journal.pone.0168075			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992562	gold, Green Published, Green Submitted			2022-12-26	WOS:000392842600033
J	Gaines, TA; Barker, AL; Patterson, EL; Westra, P; Westra, EP; Wilson, RG; Jha, P; Kumar, V; Kniss, AR				Gaines, Todd A.; Barker, Abigail L.; Patterson, Eric L.; Westra, Philip; Westra, Eric P.; Wilson, Robert G.; Jha, Prashant; Kumar, Vipan; Kniss, Andrew R.			EPSPS Gene Copy Number and Whole-Plant Glyphosate Resistance Level in Kochia scoparia	PLOS ONE			English	Article							BETA-VULGARIS; SUGAR-BEET; AMPLIFICATION; SYNTHASE	Glyphosate-resistant (GR) Kochia scoparia has evolved in dryland chemical fallow systems throughout North America and the mechanism of resistance involves 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) gene duplication. Agricultural fields in four states were surveyed for K. scoparia in 2013 and tested for glyphosate-resistance level and EPSPS gene copy number. Glyphosate resistance was confirmed in K. scoparia populations collected from sugarbeet fields in Colorado, Wyoming, and Nebraska, and Montana. Glyphosate resistance was also confirmed in K. scoparia accessions collected from wheat-fallow fields in Montana. All GR samples had increased EPSPS gene copy number, with median population values up to 11 from sugarbeet fields and up to 13 in Montana wheat-fallow fields. The results indicate that glyphosate susceptibility can be accurately diagnosed using EPSPS gene copy number.	[Gaines, Todd A.; Barker, Abigail L.; Patterson, Eric L.; Westra, Philip; Westra, Eric P.] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Wilson, Robert G.] Univ Nebraska, Dept Agron & Hort, Scottsbluff, NE USA; [Jha, Prashant; Kumar, Vipan] Montana State Univ, Southern Agr Res Ctr, Huntley, MT USA; [Kniss, Andrew R.] Univ Wyoming, Dept Plant Sci, Laramie, WY 82071 USA	Colorado State University; University of Nebraska System; Montana State University System; Montana State University Bozeman; University of Wyoming	Kniss, AR (corresponding author), Univ Wyoming, Dept Plant Sci, Laramie, WY 82071 USA.	akniss@uwyo.edu	Kumar, Vipan/N-1879-2019; Gaines, Todd/A-8998-2008; Kniss, Andrew/B-3247-2010	Kumar, Vipan/0000-0002-8301-5878; Gaines, Todd/0000-0003-1485-7665; Patterson, Eric/0000-0001-7111-6287; Kniss, Andrew/0000-0003-2551-4959	Western Sugar Cooperative Joint Grower Research Committee; USDA National Institute of Food and Agriculture [WYO-528-14, COL00719, MONB00658]; Montana Wheat and Barley Committee [4W6112]	Western Sugar Cooperative Joint Grower Research Committee; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Montana Wheat and Barley Committee	Research described in this manuscript was supported by the following funding sources: Western Sugar Cooperative Joint Grower Research Committee; USDA National Institute of Food and Agriculture, Hatch project WYO-528-14 to the Wyoming Agricultural Experiment Station, Hatch project COL00719 to the Colorado State University Agricultural Experiment Station, Hatch project MONB00658 to the Montana Agricultural Experiment Station; Montana Wheat and Barley Committee (grant #4W6112). Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the National Institute of Food and Agriculture (NIFA) or the United States Department of Agriculture (USDA). Western Sugar staff participated in the collection of plant material used in this research. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Beckie HJ, 2015, CAN J PLANT SCI, V95, P345, DOI [10.4141/CJPS-2014-328, 10.4141/cjps-2014-328]; Beckie HJ, 2013, WEED SCI, V61, P310, DOI 10.1614/WS-D-12-00140.1; Chahal P. S., 2015, Journal of Agricultural Science (Toronto), V7, P1; Coburn C, 2016, P W SOC WEED SCI, V69, P65; Forcella F., 1985, Weeds Today, V16, P4; Friesen LF, 2009, CAN J PLANT SCI, V89, P141, DOI 10.4141/CJPS08057; Gaines TA, 2015, P W SOC WEED SCI, V68, P127; Godar AS, 2015, WEED SCI, V63, P587, DOI 10.1614/WS-D-14-00145.1; Heap I., 2015, INT SURVEY HERBICIDE; Jugulam M, 2014, PLANT PHYSIOL, V166, P1200, DOI 10.1104/pp.114.242826; Khan M. F. R., 2010, Outlooks on Pest Management, V21, P38, DOI 10.1564/21feb10; Kniss A. R., 2010, Journal of Sugar Beet Research, V47, P127, DOI 10.5274/jsbr.47.3.127; Kniss AR, 2007, WEED SCI, V55, P572, DOI 10.1614/WS-07-002.1; Kniss AR, 2004, WEED TECHNOL, V18, P388, DOI 10.1614/WT-03-119R; Kumar V, 2015, WEED SCI, V63, P758, DOI 10.1614/WS-D-15-00021.1; Kumar V, 2014, WEED TECHNOL, V28, P122, DOI 10.1614/WT-D-13-00115.1; Mengistu LW, 2002, WEED SCI, V50, P498, DOI 10.1614/0043-1745(2002)050[0498:GDOK]2.0.CO;2; MESBAH A, 1994, WEED TECHNOL, V8, P754, DOI 10.1017/S0890037X00028645; Sammons RD, 2014, PEST MANAG SCI, V70, P1367, DOI 10.1002/ps.3743; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; STALLINGS GP, 1995, WEED SCI, V43, P95, DOI 10.1017/S0043174500080887; Varanasi VK, 2015, PEST MANAG SCI, V71, P1207, DOI 10.1002/ps.4034; Vila-Aiub MM, 2014, PLANTA, V239, P793, DOI 10.1007/s00425-013-2022-x; Waite J, 2013, WEED SCI, V61, P193, DOI 10.1614/WS-D-12-00101.1; Wiersma AT, 2015, PLANTA, V241, P463, DOI 10.1007/s00425-014-2197-9; Wilson RG, 2002, WEED TECHNOL, V16, P66, DOI 10.1614/0890-037X(2002)016[0066:IOGAGO]2.0.CO;2	26	26	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168295	10.1371/journal.pone.0168295	http://dx.doi.org/10.1371/journal.pone.0168295			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992501	Green Submitted, Green Published, gold			2022-12-26	WOS:000392758000036
J	Neubeck, A; Sjoberg, S; Price, A; Callac, N; Schnurer, A				Neubeck, Anna; Sjoberg, Susanne; Price, Alex; Callac, Nolwenn; Schnurer, Anna			Effect of Nickel Levels on Hydrogen Partial Pressure and Methane Production in Methanogens	PLOS ONE			English	Article							ANAEROBIC-DIGESTION PROCESS; CARBON-MONOXIDE; COBALT; BIOAVAILABILITY; MOLYBDENUM; SPECIATION; OXIDATION; EMISSION; DEHYDROGENASE; AVAILABILITY	Hydrogen (H-2) consumption and methane (CH4) production in pure cultures of three different methanogens were investigated during cultivation with 0, 0.2 and 4.21 mu M added nickel (Ni). The results showed that the level of dissolved Ni in the anaerobic growth medium did not notably affect CH4 production in the cytochrome-free methanogenic species Methanobacterium bryantii and Methanoculleus bourgensis MAB1, but affected CH4 formation rate in the cytochrome-containing Methanosarcina barkeri grown on H-2 and CO2. Methanosarcina barkeri also had the highest amounts of Ni in its cells, indicating that more Ni is needed by cytochrome-containing than by cytochrome-free methanogenic species. The concentration of Ni affected threshold values of H-2 partial pressure (pH(2)) for all three methanogen species studied, with M. bourgensis MAB1 reaching pH(2) values as low as 0.1 Pa when Ni was available in amounts used in normal anaerobic growth medium. To our knowledge, this is the lowest pH(2) threshold recorded to date in pure methanogen culture, which suggests that M. bourgensis MAB1 have a competitive advantage over other species through its ability to grow at low H-2 concentrations. Our study has implications for research on the H-2-driven deep subsurface biosphere and biogas reactor performance.	[Neubeck, Anna; Sjoberg, Susanne; Callac, Nolwenn] Stockholm Univ, Dept Geol Sci, Stockholm, Sweden; [Price, Alex] Open Univ, Dept Phys Sci, Milton Keynes, Bucks, England; [Schnurer, Anna] Swedish Univ Agr Sci, Dept Microbiol, Bioctr, Uppsala, Sweden	Stockholm University; Open University - UK; Swedish University of Agricultural Sciences	Neubeck, A (corresponding author), Stockholm Univ, Dept Geol Sci, Stockholm, Sweden.	anna.neubeck@geo.su.se	; Callac, Nolwenn/O-3579-2016	Schnurer, Anna/0000-0003-0038-553X; Neubeck, Anna/0000-0002-1291-5529; Callac, Nolwenn/0000-0002-7578-3455	Swedish National Space Board [DNR-100/13]; Royal Swedish Academy of Sciences; Formas [2012-807]	Swedish National Space Board; Royal Swedish Academy of Sciences; Formas(Swedish Research Council Formas)	This work was supported by the Swedish National Space Board (Project number DNR-100/13) (http://www.rymdstyrelsen.se/), the Royal Swedish Academy of Sciences (http://www.kva.se/), and Formas (2012-807) (http://www.formas.se/).	Afting C, 2000, ARCH MICROBIOL, V174, P225, DOI 10.1007/s002030000197; BHATTACHARYA SK, 1989, ENVIRON TECHNOL LETT, V10, P725, DOI 10.1080/09593338909384791; Chen Y, 2008, BIORESOURCE TECHNOL, V99, P4044, DOI 10.1016/j.biortech.2007.01.057; Choong YY, 2016, BIORESOURCE TECHNOL, V209, P369, DOI 10.1016/j.biortech.2016.03.028; CONRAD R, 1990, ARCH MICROBIOL, V155, P94, DOI 10.1007/BF00291281; Costa KC, 2014, CURR OPIN BIOTECH, V29, P70, DOI 10.1016/j.copbio.2014.02.012; DIEKERT G, 1981, J BACTERIOL, V148, P459, DOI 10.1128/JB.148.2.459-464.1981; Dwyer FP, 1964, FRONT MATTER CHELATI; FERRY JG, 1992, J BACTERIOL, V174, P5489, DOI 10.1128/JB.174.17.5489-5495.1992; FLORENCIO L, 1993, J FERMENT BIOENG, V75, P368, DOI 10.1016/0922-338X(93)90136-V; FLORENCIO L, 1994, APPL ENVIRON MICROB, V60, P227, DOI 10.1128/AEM.60.1.227-234.1994; Fournier GP, 2008, J BACTERIOL, V190, P1124, DOI 10.1128/JB.01382-07; Gonzalez-Gil G, 1999, APPL ENVIRON MICROB, V65, P1789; Gonzalez-Gil G, 2003, BIOTECHNOL BIOENG, V82, P134, DOI 10.1002/bit.10551; Haarstad K, 2006, J AIR WASTE MANAGE, V56, P575, DOI 10.1080/10473289.2006.10464470; Hellebrand HJ, 2001, NUTR CYCL AGROECOSYS, V60, P79, DOI 10.1023/A:1012666929651; Karadagli F, 2006, THERMODYNAMIC KINETI, V18, P439, DOI [10.1007/s10532-006-9073-7, DOI 10.1007/S10532-006-9073-7]; Karadagli F, 2007, BIODEGRADATION, V18, P453, DOI 10.1007/s10532-006-9078-2; Konhauser KO, 2015, ASTROBIOLOGY, V15, P804, DOI 10.1089/ast.2015.1301; Konhauser KO, 2009, NATURE, V458, P750, DOI 10.1038/nature07858; Kral TA, 1998, ORIGINS LIFE EVOL B, V28, P311, DOI 10.1023/A:1006552412928; KRZYCKI J, 1980, CURR MICROBIOL, V3, P243, DOI 10.1007/BF02602456; Kung Y, 2011, CURR OPIN CHEM BIOL, V15, P276, DOI 10.1016/j.cbpa.2010.11.005; Laskin AI, 1983, ADV APPL MICROBIOLOG; Lee MJ, 1988, WATER RESOUR RES, V54, P6; Li M, 2011, MATH PROBL ENG, V2011, DOI 10.1155/2011/657839; Liu YC, 2012, TRENDS MICROBIOL, V20, P251, DOI 10.1016/j.tim.2012.02.002; LOVLEY DR, 1982, APPL ENVIRON MICROB, V43, P1373, DOI 10.1128/AEM.43.6.1373-1379.1982; LOVLEY DR, 1985, APPL ENVIRON MICROB, V49, P1530, DOI 10.1128/AEM.49.6.1530-1531.1985; Morris BE, 2013, FEMS MICROBIOL REV, V37, P384, DOI 10.1111/1574-6976.12019; Muller B, 2016, BIOTECHNOL BIOFUELS, V9, P1363; Muller B, 2015, BIOTECHNOL BIOFUELS, V8, P1; MURRAY WD, 1981, APPL ENVIRON MICROB, V42, P502, DOI 10.1128/AEM.42.3.502-505.1981; Narihiro T, 2011, MICROB BIOTECHNOL, V4, P585, DOI 10.1111/j.1751-7915.2010.00239.x; Pramanik P, 2013, CHEMOSPHERE, V90, P873, DOI 10.1016/j.chemosphere.2012.07.008; Scheller S, 2010, NATURE, V465, P606, DOI 10.1038/nature09015; SCHERER P, 1983, BIOL TRACE ELEM RES, V5, P149, DOI 10.1007/BF02916619; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262, DOI 10.1128/.61.2.262-280.1997; Schnurer A, 1999, FEMS MICROBIOL ECOL, V29, P249; SCHONHEIT P, 1979, ARCH MICROBIOL, V123, P105, DOI 10.1007/BF00403508; Shagufta J., 2007, ENV BIOTECHNOLOGY; SPEECE RE, 1983, WATER RES, V17, P677, DOI 10.1016/0043-1354(83)90237-3; Sprenger WW, 2007, FEMS MICROBIOL ECOL, V60, P266, DOI 10.1111/j.1574-6941.2007.00287.x; Thauer RK, 1996, CHEM REV, V96, P3031, DOI 10.1021/cr9500601; THAUER RK, 1977, BACTERIOL REV, V41, P100, DOI 10.1128/MMBR.41.1.100-180.1977; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; Thauer RK, 2010, ANNU REV BIOCHEM, V79, P507, DOI 10.1146/annurev.biochem.030508.152103; Vandergheynst JS, 1998, ENVIRON SCI TECHNOL, V32, P3713, DOI 10.1021/es980156n; Weng LP, 2003, ENVIRON TOXICOL CHEM, V22, P2180, DOI 10.1897/02-116; Westerholm M., 2012, THESIS; Westerholm M, 2016, BIORESOURCE TECHNOL, V218, P761, DOI 10.1016/j.biortech.2016.07.029; Westerholm M, 2010, FEMS MICROBIOL LETT, V309, P100, DOI 10.1111/j.1574-6968.2010.02023.x; Wichard T, 2009, NAT GEOSCI, V2, P625, DOI 10.1038/NGEO589; Yekta SS, 2014, APPL GEOCHEM, V47, P61, DOI 10.1016/j.apgeochem.2014.05.001; ZEHNDER AJB, 1980, ARCH MICROBIOL, V124, P1, DOI 10.1007/BF00407022; ZIRNGIBL C, 1990, FEBS LETT, V261, P112, DOI 10.1016/0014-5793(90)80649-4	56	15	16	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168357	10.1371/journal.pone.0168357	http://dx.doi.org/10.1371/journal.pone.0168357			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992585	gold, Green Published, Green Submitted			2022-12-26	WOS:000392758000038
J	Nishijima, T; Teruya, K; Shibata, S; Yanagawa, Y; Kobayashi, T; Mizushima, D; Aoki, T; Kinai, E; Yazaki, H; Tsukada, K; Genka, I; Kikuchi, Y; Oka, S; Gatanaga, H				Nishijima, Takeshi; Teruya, Katsuji; Shibata, Satoshi; Yanagawa, Yasuaki; Kobayashi, Taiichiro; Mizushima, Daisuke; Aoki, Takahiro; Kinai, Ei; Yazaki, Hirohisa; Tsukada, Kunihisa; Genka, Ikumi; Kikuchi, Yoshimi; Oka, Shinichi; Gatanaga, Hiroyuki			Incidence and Risk Factors for Incident Syphilis among HIV-1-Infected Men Who Have Sex with Men in a Large Urban HIV Clinic in Tokyo, 2008-2015	PLOS ONE			English	Article							DIAGNOSIS; COHORT; VIRUS	Background The epidemiology of incident syphilis infection among HIV-1-infected men who have sex with men (MSM) largely remains unknown. Methods The incidence and risk factors for incident syphilis (positive TPHA and RPR>=1: 8) among HIV-1-infected MSM who visited a large HIV clinic in Tokyo for the first time between 2008 and 2013 were determined, using clinical data and stored blood samples taken every three months for screening and determination of the date of incident syphilis. Poisson regression compared the incidence of syphilis at different observation periods. Results Of 885 HIV-1-infected MSM with baseline data, 34% either presented with active syphilis at baseline (21%) or became infected with syphilis during follow-up (13%). After excluding 214 patients (MSM with syphilis at baseline (n = 190) and no follow-up syphilis test (n = 24)), of 671 men, 112 (17%) developed incident syphilis with an incidence of 43.7/1,000 person-years [95% CI, 36.5-52.3]. The incidence decreased slightly during observation period although the trend was not significant (2008-2009: 48.2/1,000 person-years, 2010-2011: 51.1/1,000 person-years, 2012-2013: 42.6/1,000 person-years, 2014 to 2015: 37.9/1,000 person-years, p = 0.315). Multivariable analysis identified young age (< 33 years versus > 40, HR 4.0, 95% CI 2.22-7.18, p<0.001), history of syphilis at baseline (HR 3.0, 95% CI 2.03-4.47, p<0.001), positive anti-amoeba antibody (HR 1.8, 95% CI 1.17-2.68, p = 0.006), and high baseline CD4 count (CD4 >= 350 /mu L versus CD4 < 200, HR 1.6, 95% CI 1.00-2.53, p = 0.050) as risk factors for incident syphilis. Incidence of syphilis was particularly high among young patients (age < 33 years: 60.1/1,000 person-years). Interestingly, 37% of patients with incident syphilis were asymptomatic. Conclusions Although incidence of syphilis did not increase during the observation period, it was high among HIV-1-infected MSM, especially among young HIV-1-infected MSM and those with history of syphilis, in Tokyo. Regular screening for syphilis needs to be strictly applied to this population.	[Nishijima, Takeshi; Teruya, Katsuji; Shibata, Satoshi; Yanagawa, Yasuaki; Kobayashi, Taiichiro; Mizushima, Daisuke; Aoki, Takahiro; Kinai, Ei; Yazaki, Hirohisa; Tsukada, Kunihisa; Genka, Ikumi; Kikuchi, Yoshimi; Oka, Shinichi; Gatanaga, Hiroyuki] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan	National Center for Global Health & Medicine - Japan	Nishijima, T (corresponding author), Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan.	tnishiji@acc.ncgm.go.jp		KOBAYASHI, TAIICHIRO/0000-0002-1239-0275; yanagawa, yasuaki/0000-0002-3723-2425	Grant for National Center for Global Health and Medicine [28-1102]	Grant for National Center for Global Health and Medicine	This work was supported by a Grant for National Center for Global Health and Medicine (28-1102), which was received by HG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], INF DIS WEEKL REP JA; [Anonymous], INF DIS WEEKL REP JA; [Anonymous], 2015, REP SEX TRANSM INF C; [Anonymous], EURO SURVEILL; Van der Meer JTM, 2009, SEX TRANSM DIS, V36, P84, DOI 10.1097/OLQ.0b013e318186debb; Burchell AN, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1098-2; Hu QH, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0658-1; Janier M, 2014, J EUR ACAD DERMATOL, V28, P1581, DOI 10.1111/jdv.12734; Jansen K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142515; Kenyon C, 2014, EUROSURVEILLANCE, V19, P22, DOI 10.2807/1560-7917.ES2014.19.45.20958; Komatsu H, 2014, WORLD J GASTROENTERO, V20, P8998, DOI 10.3748/wjg.v20.i27.8998; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Nishijima T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143874; Nishijima T, 2014, JAIDS-J ACQ IMM DEF, V65, P213, DOI 10.1097/QAI.0000000000000044; Nishijima T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081960; Patton ME, 2014, MMWR-MORBID MORTAL W, V63, P402; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Thurnheer MC, 2010, AIDS, V24, P1907, DOI 10.1097/QAD.0b013e32833bfe21; Yanagawa Y, 2016, AM J TROP MED HYG, V95, P604, DOI 10.4269/ajtmh.16-0134; Yang BR, 2013, SEX TRANSM DIS, V40, P957, DOI 10.1097/OLQ.0000000000000056	20	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168642	10.1371/journal.pone.0168642	http://dx.doi.org/10.1371/journal.pone.0168642			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992604	Green Published, gold			2022-12-26	WOS:000392758000070
J	Cantarutti, A; Merlino, L; Monzani, E; Giaquinto, C; Corrao, G				Cantarutti, Anna; Merlino, Luca; Monzani, Emiliano; Giaquinto, Carlo; Corrao, Giovanni			Is the Risk of Preterm Birth and Low Birth Weight Affected by the Use of Antidepressant Agents during Pregnancy? A Population-Based Investigation	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITORS; MATERNAL DEPRESSION; IMPACT; METAANALYSIS; EXPOSURE; ESTRIOL; SMOKING; GROWTH; WOMEN	Background Untreated depression during pregnancy increases the risk of morbidity and mortality in the mother and child. Therefore, specific treatments are required for this population. Objective The study aimed to investigating the effect of antidepressant medication used during pregnancy with reference to the risk of preterm birth (PTB) and low birth weight (LBW). Methods A population-based study was carried out with data provided by the healthcare utilization database of Lombardy, an Italian region with about ten million inhabitants. The study included 384,673 births from 2005 to 2010. Maternal use of antidepressants before and during pregnancy was investigated. Log-binomial regression was used to estimate the association between the use of antidepressants during pregnancy, compared to the non-use or use just before pregnancy, and the prevalence ratio of PTB and LBW. Results Women who used antidepressants during pregnancy had a 20% (95% CI: 10-40%) increased prevalence of both PTB and LBW compared to those who never used antidepressants. There was no evidence that women who used antidepressants during pregnancy had a higher prevalence of the considered outcomes compared to women who used antidepressants before pregnancy, but stopped during pregnancy. Such findings were confirmed by considering separately the effects of SSRIs and other antidepressants together. Conclusions Our findings suggest that depression in itself, rather than antidepressant medication, might be implicated in the causal pathway of PTB and LBW.	[Cantarutti, Anna; Corrao, Giovanni] Univ Milano Bicocca, Div Biostat Epidemiol & Publ Hlth, Dept Stat & Quantitat Methods, Lab Healthcare Res & Pharmacoepidemiol, Milan, Italy; [Merlino, Luca] Operat Unit Terr Hlth Serv, Milan, Italy; [Monzani, Emiliano] Ca Granda Niguarda Hosp, Dept Mental Hlth, Milan, Italy; [Giaquinto, Carlo] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy	University of Milano-Bicocca; University of Padua	Cantarutti, A (corresponding author), Univ Milano Bicocca, Div Biostat Epidemiol & Publ Hlth, Dept Stat & Quantitat Methods, Lab Healthcare Res & Pharmacoepidemiol, Milan, Italy.	a.cantarutti@campus.unimib.it	Giaquinto, Carlo/AAB-5016-2020	MERLINO, Luca Giuseppe/0000-0001-9232-9994; GIAQUINTO, CARLO/0000-0001-9365-0413	Italian Ministry for University and Research "Fondo d'Ateneo per la Ricerca" [2014-ATE-0232]	Italian Ministry for University and Research "Fondo d'Ateneo per la Ricerca"	This study was funded by grants from the Italian Ministry for University and Research "Fondo d'Ateneo per la Ricerca" portion, year 2014. Grant number: 2014-ATE-0232.	Alwan S, 2011, J CLIN PHARMACOL, V51, P264, DOI 10.1177/0091270010373928; American Psychiatric Association (APA), 2010, PRACTICE GUIDELINE T, V3rd; Barker ED, 2012, BRIT J PSYCHIAT, V200, P124, DOI 10.1192/bjp.bp.111.092346; Cinciripini PM, 2010, J CONSULT CLIN PSYCH, V78, P44, DOI 10.1037/a0018168; Corrao G, 2015, HYPERTENSION, V65, P490, DOI 10.1161/HYPERTENSIONAHA.114.04858; Davis RL, 2007, PHARMACOEPIDEM DR S, V16, P1086, DOI 10.1002/pds.1462; de Bernabe JV, 2004, EUR J OBSTET GYN R B, V116, P3, DOI 10.1016/j.ejogrb.2004.03.007; El Marroun H, 2012, ARCH GEN PSYCHIAT, V69, P706, DOI 10.1001/archgenpsychiatry.2011.2333; Ferreira E, 2007, PEDIATRICS, V119, P52, DOI 10.1542/peds.2006-2133; Field T, 2010, INFANT BEHAV DEV, V33, P1, DOI 10.1016/j.infbeh.2009.10.005; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Huang H, 2014, GEN HOSP PSYCHIAT, V36, P13, DOI 10.1016/j.genhosppsych.2013.08.002; Jensen HM, 2013, PSYCHOPHARMACOLOGY, V228, P199, DOI 10.1007/s00213-013-3029-5; Kallen B, 2004, ARCH PEDIAT ADOL MED, V158, P312, DOI 10.1001/archpedi.158.4.312; Kallen K, 2001, EUR J PUBLIC HEALTH, V11, P329, DOI 10.1093/eurpub/11.3.329; Lattimore Keri A, 2005, J Perinatol, V25, P595; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; Lund N, 2009, ARCH PEDIAT ADOL MED, V163, P949, DOI 10.1001/archpediatrics.2009.164; Magnus MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116362; Maschi S, 2008, BJOG-INT J OBSTET GY, V115, P283, DOI 10.1111/j.1471-0528.2007.01518.x; MCGREGOR JA, 1995, AM J OBSTET GYNECOL, V173, P1337, DOI 10.1016/0002-9378(95)91383-1; Olivier JDA, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00073; Preti A, 2000, J AFFECT DISORDERS, V61, P101, DOI 10.1016/S0165-0327(99)00185-8; Ramos E, 2010, CAN J PSYCHIAT, V55, P643; Rampono J, 2009, PHARMACOPSYCHIATRY, V42, P95, DOI 10.1055/s-0028-1103296; Ross LE, 2013, JAMA PSYCHIAT, V70, P436, DOI 10.1001/jamapsychiatry.2013.684; Simon GE, 2002, AM J PSYCHIAT, V159, P2055, DOI 10.1176/appi.ajp.159.12.2055; Suri R, 2008, BIOL PSYCHIAT, V64, P533, DOI 10.1016/j.biopsych.2008.04.015; Tata LJ, 2005, HEART, V91, P465, DOI 10.1136/hrt.2004.037457; Udechuku A, 2010, AUST NZ J PSYCHIAT, V44, P978, DOI 10.3109/00048674.2010.507543; Verret-Chalifour J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117512; Wen SW, 2006, AM J OBSTET GYNECOL, V194, P961, DOI 10.1016/j.ajog.2006.02.019; Wisner KL, 2009, AM J PSYCHIAT, V166, P557, DOI 10.1176/appi.ajp.2008.08081170; Yonkers KA, 2012, EPIDEMIOLOGY, V23, P677, DOI 10.1097/EDE.0b013e31825838e9; Yonkers KA, 2011, OBSTET GYNECOL, V117, P961, DOI 10.1097/AOG.0b013e31821187a7	36	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168115	10.1371/journal.pone.0168115	http://dx.doi.org/10.1371/journal.pone.0168115			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7HN	27977749	Green Published, gold, Green Submitted			2022-12-26	WOS:000391217400063
J	Langness, S; Costantini, TW; Morishita, K; Eliceiri, BP; Coimbra, R				Langness, Simone; Costantini, Todd W.; Morishita, Koji; Eliceiri, Brian P.; Coimbra, Raul			Modulating the Biologic Activity of Mesenteric Lymph after Traumatic Shock Decreases Systemic Inflammation and End Organ Injury	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; NERVE-STIMULATION PROTECTS; RESPONSE SYNDROME SIRS; ACUTE LUNG INJURY; HEMORRHAGIC-SHOCK; DUCT LIGATION; VAGUS NERVE; BACTERIAL TRANSLOCATION; CIRCULATING NEUTROPHILS; INTRAVENOUS-INJECTION	Introduction Trauma/hemorrhagic shock (T/HS) causes the release of pro-inflammatory mediators into the mesenteric lymph (ML), triggering a systemic inflammatory response and acute lung injury (ALI). Direct and pharmacologic vagal nerve stimulation prevents gut barrier failure and alters the biologic activity of ML after injury. We hypothesize that treatment with a pharmacologic vagal agonist after T/HS would attenuate the biologic activity of ML and prevent ALI. Methods ML was collected from male Sprague-Dawley rats after T/HS, trauma-sham shock (T/SS) or T/HS with administration of the pharmacologic vagal agonist CPSI-121. ML samples from each experimental group were injected into naive mice to assess biologic activity. Blood samples were analyzed for changes in STAT3 phosphorylation (pSTAT3). Lung injury was characterized by histology, permeability and immune cell recruitment. Results T/HS lymph injected in naive mice caused a systemic inflammatory response characterized by hypotension and increased circulating monocyte pSTAT3 activity. Injection of T/HS lymph also resulted in ALI, confirmed by histology, lung permeability and increased recruitment of pulmonary macrophages and neutrophils to lung parenchyma. CPSI-121 attenuated T/HS lymph-induced systemic inflammatory response and ALI with stable hemodynamics and similar monocyte pSTAT3 levels, lung histology, lung permeability and lung immune cell recruitment compared to animals injected with lymph from T/SS. Conclusion Treatment with CPSI-121 after T/HS attenuated the biologic activity of the ML and decreased ALI. Given the superior clinical feasibility of utilizing a pharmacologic approach to vagal nerve stimulation, CPSI-121 is a potential treatment strategy to limit end organ dysfunction after injury.	[Langness, Simone; Costantini, Todd W.; Eliceiri, Brian P.; Coimbra, Raul] Univ Calif San Diego, Dept Surg, Div Trauma Surg Crit Care Burns & Acute Care Surg, San Diego, CA 92103 USA; [Morishita, Koji] Tokyo Med & Dent Univ, Div Acute Crit Care & Disaster Med, Tokyo, Japan	University of California System; University of California San Diego; Tokyo Medical & Dental University (TMDU)	Coimbra, R (corresponding author), Univ Calif San Diego, Dept Surg, Div Trauma Surg Crit Care Burns & Acute Care Surg, San Diego, CA 92103 USA.	rcoimbra@ucsd.edu	Coimbra, Raul/AAP-3019-2020	Coimbra, Raul/0000-0002-3759-6851; Eliceiri, Brian/0000-0003-1811-1916; Langness, Simone/0000-0001-7206-5186				Adams CA, 2002, SHOCK, V18, P513, DOI 10.1097/00024382-200212000-00005; Albertsmeier Markus, 2014, Viszeralmedizin, V30, P91, DOI 10.1159/000360149; Altshuler AE, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.109; BAKER JW, 1988, J TRAUMA, V28, P896, DOI 10.1097/00005373-198807000-00002; BEAL AL, 1994, JAMA-J AM MED ASSOC, V271, P226, DOI 10.1001/jama.271.3.226; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bone RC, 1996, ANN INTERN MED, V125, P680, DOI 10.7326/0003-4819-125-8-199610150-00009; Condon M, 2011, J TRAUMA, V70, P489, DOI 10.1097/TA.0b013e31820329d8; Costantini TW, 2010, AM J PHYSIOL-GASTR L, V299, pG1308, DOI 10.1152/ajpgi.00156.2010; D'Alessandro A, 2014, SHOCK, V42, P509, DOI 10.1097/SHK.0000000000000259; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Deitch EA, 2006, SHOCK, V25, P460, DOI 10.1097/01.shk.0000209551.88215.1e; Deitch EA, 2006, FRONT BIOSCI-LANDMRK, V11, P520, DOI 10.2741/1816; Deitch EA, 2001, SHOCK, V16, P290, DOI 10.1097/00024382-200116040-00010; Deitch EA, 2001, SURGERY, V129, P39, DOI 10.1067/msy.2001.109119; Deitch EA, 2010, ANN NY ACAD SCI, V1207, pE103, DOI 10.1111/j.1749-6632.2010.05713.x; Deree J, 2007, J SURG RES, V143, P99, DOI 10.1016/j.jss.2007.03.083; Gaudilliere B, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009701; Goto-Inoue N, 2012, ANAL BIOANAL CHEM, V403, P1863, DOI 10.1007/s00216-012-5809-x; Kittel B, 2004, EXP TOXICOL PATHOL, V55, P413, DOI 10.1078/0940-2993-00349; Krzyzaniak M, 2012, J TRAUMA ACUTE CARE, V72, P355, DOI 10.1097/TA.0b013e31824484fe; Krzyzaniak M, 2011, J TRAUMA, V70, P1168, DOI 10.1097/TA.0b013e318216f754; Lagan AL, 2008, AM J PHYSIOL-LUNG C, V294, pL161, DOI 10.1152/ajplung.00169.2007; LAMY M, 1976, AM REV RESPIR DIS, V114, P267; Levy G, 2013, SHOCK, V39, P39, DOI 10.1097/SHK.0b013e31827b450d; LOKEN MR, 1990, CYTOMETRY, V11, P453, DOI 10.1002/cyto.990110402; Lopez NE, 2012, SHOCK, V38, P294, DOI 10.1097/SHK.0b013e31825f5fb2; Magnotti LJ, 1998, ANN SURG, V228, P518, DOI 10.1097/00000658-199810000-00008; Magnotti LJ, 1999, ARCH SURG-CHICAGO, V134, P1333, DOI 10.1001/archsurg.134.12.1333; Matthay MA, 2005, AM J RESP CELL MOL, V33, P319, DOI 10.1165/rcmb.F305; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Minei JP, 2012, CRIT CARE MED, V40, P1129, DOI 10.1097/CCM.0b013e3182376e9f; MOORE EE, 1994, J TRAUMA, V37, P881, DOI 10.1097/00005373-199412000-00002; MOORE FA, 1991, J TRAUMA, V31, P629, DOI 10.1097/00005373-199105000-00006; Morishita K, 2015, AM J PHYSIOL-GASTR L, V309, pG202, DOI 10.1152/ajpgi.00097.2015; Morishita K, 2015, J TRAUMA ACUTE CARE, V78, P52, DOI 10.1097/TA.0000000000000489; Morishita K, 2014, J TRAUMA ACUTE CARE, V76, P610, DOI 10.1097/TA.0000000000000137; Morishita K, 2012, J TRAUMA ACUTE CARE, V72, P1541, DOI 10.1097/TA.0b013e318256df15; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Park JS, 2014, ARTHRITIS RHEUMATOL, V66, P918, DOI 10.1002/art.38305; Qin X, 2012, AM J PHYSIOL-GASTR L, V303, pG969, DOI 10.1152/ajpgi.00290.2012; Radu M, 2013, JOVE-J VIS EXP, DOI 10.3791/50062; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Reino DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014829; Reys LG, 2013, LIFE SCI, V92, P783, DOI 10.1016/j.lfs.2013.02.009; RUNCIMAN WB, 1984, ANAESTH INTENS CARE, V12, P193, DOI 10.1177/0310057X8401200302; Sambol JT, 2002, SHOCK, V18, P272, DOI 10.1097/00024382-200209000-00012; Sambol JT, 2009, J APPL PHYSIOL, V106, P57, DOI 10.1152/japplphysiol.90937.2008; Senthil M, 2007, ANN SURG, V246, P822, DOI 10.1097/SLA.0b013e3180caa3af; Senthil M, 2006, J TRAUMA, V60, P958, DOI 10.1097/01.ta.0000215500.00018.47; Simeone-Penney MC, 2007, J IMMUNOL, V178, P6191, DOI 10.4049/jimmunol.178.10.6191; Suliburk J, 2008, EUR SURG RES, V40, P184, DOI 10.1159/000110859; Ulloa L, 2005, NAT REV DRUG DISCOV, V4, P673, DOI 10.1038/nrd1797; Upperman JS, 1998, SHOCK, V10, P407, DOI 10.1097/00024382-199812000-00005; Varela JE, 2003, SHOCK, V20, P476, DOI 10.1097/01.SHK.0000094036.09886.9b; Vasamsetti SB, 2015, DIABETES, V64, P2028, DOI 10.2337/db14-1225; Vermaelen K, 2004, CYTOM PART A, V61A, P170, DOI 10.1002/cyto.a.20064; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu DZ, 2004, CRIT CARE MED, V32, P760, DOI 10.1097/01.CCM.0000114815.88622.9D; Zaets SB, 2003, J SURG RES, V109, P51, DOI 10.1016/S0022-4804(02)00024-0; Zallen G, 1999, J SURG RES, V83, P83, DOI 10.1006/jsre.1999.5569; ZIMMERMAN GA, 1984, AM REV RESPIR DIS, V129, P798, DOI 10.1164/arrd.1984.129.5.798	63	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168322	10.1371/journal.pone.0168322	http://dx.doi.org/10.1371/journal.pone.0168322			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977787	gold, Green Published, Green Submitted			2022-12-26	WOS:000391217400093
J	Montesantos, S; Katz, I; Pichelin, M; Caillibotte, G				Montesantos, Spyridon; Katz, Ira; Pichelin, Marine; Caillibotte, Georges			The Creation and Statistical Evaluation of a Deterministic Model of the Human Bronchial Tree from HRCT Images	PLOS ONE			English	Article							RESOLUTION COMPUTED-TOMOGRAPHY; HUMAN-LUNG; AEROSOL DEPOSITION; AIRWAY DIMENSIONS; 3-DIMENSIONAL MODEL; COMPUTATIONAL MODEL; CONDUCTING AIRWAYS; WALL THICKNESS; MORPHOLOGY; CT	A quantitative description of the morphology of lung structure is essential prior to any form of predictive modeling of ventilation or aerosol deposition implemented within the lung. The human lung is a very complex organ, with airway structures that span two orders of magnitude and having a multitude of interfaces between air, tissue and blood. As such, current medical imaging protocols cannot provide medical practitioners and researchers with in-vivo knowledge of deeper lung structures. In this work a detailed algorithm for the generation of an individualized 3D deterministic model of the conducting part of the human tracheo-bronchial tree is described. Distinct initial conditions were obtained from the high-resolution computed tomography (HRCT) images of seven healthy volunteers. The algorithm developed is fractal in nature and is implemented as a self-similar space sub-division procedure. The expansion process utilizes physiologically realistic relationships and thresholds to produce an anatomically consistent human airway tree. The model was validated through extensive statistical analysis of the results and comparison of the most common morphological features with previously published morphometric studies and other equivalent models. The resulting trees were shown to be in good agreement with published human lung geometric characteristics and can be used to study, among other things, structure-function relationships in simulation studies.	[Montesantos, Spyridon; Katz, Ira; Pichelin, Marine; Caillibotte, Georges] Air Liquide Sante Int, Med R&D, Paris Saclay, France; [Katz, Ira] Lafayette Coll, Dept Mech Engn, Easton, PA 18042 USA	Air Liquide; UDICE-French Research Universities; Universite Paris Saclay; Lafayette College	Montesantos, S (corresponding author), Air Liquide Sante Int, Med R&D, Paris Saclay, France.	Spyridon.montesantos@airliquide.com			Medical R&D, Air Liquide Sante International, Paris Saclay, France	Medical R&D, Air Liquide Sante International, Paris Saclay, France	The study was conducted by member of the scientific team of Medical R&D, Air Liquide Sante International, Paris Saclay, France. The funder provided support in the form of salaries of authors Spyridon Montesantos (SM), Ira Katz (IK), Marine Pichelin (MP) and Georges Cailliobotte (GC) but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	AIKAWA T, 1992, CHEST, V101, P916, DOI 10.1378/chest.101.4.916; Aysola RS, 2008, CHEST, V134, P1183, DOI 10.1378/chest.07-2779; Bakker ME, 2012, RESP MED, V106, P677, DOI 10.1016/j.rmed.2011.11.013; Bordas R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144105; Boyden EA, 1955, SEGMENTAL ANATOMY LU; Brillet Pierre-Yves, 2008, Int J Chron Obstruct Pulmon Dis, V3, P97; Carroll JRD, 2006, EUR RESPIR J, V28, P712, DOI 10.1183/09031936.06.00012405; Conway J, 2012, J AEROSOL SCI, V52, P1, DOI 10.1016/j.jaerosci.2012.04.006; Darquenne C, 2011, J APPL PHYSIOL, V111, P48, DOI 10.1152/japplphysiol.00796.2010; Dubsky S, 2015, ADV DRUG DELIV REV; Escolar JD, 2007, HISTOL HISTOPATHOL, V22, P43, DOI 10.14670/HH-22.43; Farkas A, 2008, COMPUT BIOL MED, V38, P508, DOI 10.1016/j.compbiomed.2008.01.014; Fleming J, 2011, J AEROSOL MED PULM D, V24, P49, DOI 10.1089/jamp.2010.0843; Florens M, 1985, J APPL PHYSL BETHESD, V110, P756, DOI DOI 10.1152/JAPPLPHYSI0L; Gemci T, 2008, J BIOMECH, V41, P2047, DOI 10.1016/j.jbiomech.2007.12.019; Gupta S, 2014, J ALLERGY CLIN IMMUN, V133, P729, DOI 10.1016/j.jaci.2013.09.039; HAEFELIBLEUER B, 1988, ANAT RECORD, V220, P401, DOI 10.1002/ar.1092200410; HANSEN JE, 1975, J APPL PHYSIOL, V38, P990, DOI 10.1152/jappl.1975.38.6.990; Hasegawa M, 2006, AM J RESP CRIT CARE, V173, P1309, DOI 10.1164/rccm.200601-037OC; HORSFIELD K, 1967, B MATH BIOPHYS, V29, P245, DOI 10.1007/BF02476898; HORSFIELD K, 1987, THORAX, V42, P383, DOI 10.1136/thx.42.5.383; HORSFIELD K, 1981, B MATH BIOL, V43, P101, DOI 10.1016/S0092-8240(81)80010-9; HORSFIELD K, 1968, J APPL PHYSIOL, V24, P373, DOI 10.1152/jappl.1968.24.3.373; HORSFIELD K, 1976, B MATH BIOL, V38, P305, DOI 10.1007/BF02459562; KAMIYA A, 1974, B MATH BIOL, V36, P311, DOI 10.1007/BF02461331; Katz I, 2014, J AEROSOL MED PULM D, V27, P71, DOI 10.1089/jamp.2013.1072; Kim M, 2015, INT J NUMER METH BIO, V31, DOI 10.1002/cnm.2730; King GG, 2000, AM J RESP CRIT CARE, V161, P574, DOI 10.1164/ajrccm.161.2.9812073; Kitaoka H, 1999, J APPL PHYSIOL, V87, P2207, DOI 10.1152/jappl.1999.87.6.2207; KOBLINGER L, 1985, PHYS MED BIOL, V30, P541, DOI 10.1088/0031-9155/30/6/004; KOBLINGER L, 1990, J AEROSOL SCI, V21, P661, DOI 10.1016/0021-8502(90)90121-D; Kosciuch J, 2009, J PHYSIOL PHARMACOL, V60, P71; Litzlbauer HD, 2010, ANAT REC, V293, P1607, DOI 10.1002/ar.21161; Ma BS, 2009, J AEROSOL SCI, V40, P403, DOI 10.1016/j.jaerosci.2009.01.002; Majoral C, 2014, J AEROSOL MED PULM D, V27, P349, DOI 10.1089/jamp.2013.1065; Mandelbrot B.B., 1983, FRACTAL GEOMETRY NAT, V1; Martonen TB, 2007, J PHARM SCI-US, V96, P603, DOI 10.1002/jps.20707; MARTONEN TB, 1995, COMPUT BIOL MED, V25, P431, DOI 10.1016/0010-4825(95)00027-2; Matsuoka S, 2008, RADIOLOGY, V248, P1042, DOI 10.1148/radiol.2491071650; Mauroy B, 2004, NATURE, V427, P633, DOI 10.1038/nature02287; McDonough JE, 2015, J APPL PHYSIOL, V118, P1429, DOI 10.1152/japplphysiol.01017.2014; Mead-Hunter R, 2013, J AEROSOL SCI, V64, P48, DOI 10.1016/j.jaerosci.2013.05.006; Montaudon M, 2007, J ANAT, V211, P579, DOI 10.1111/j.1469-7580.2007.00811.x; Montaudon M, 2009, RADIOLOGY, V253, P844, DOI 10.1148/radiol.2533090303; Monteiro A, 2014, INT J MORPHOL, V32, P312, DOI 10.4067/s0717-95022014000100050; Montesantos S, 2013, ANAT REC, V296, P852, DOI 10.1002/ar.22695; Montesantos S, 2010, J AEROSOL MED PULM D, V23, P59, DOI 10.1089/jamp.2009.0765; Murray CD, 1926, P NATL ACAD SCI USA, V12, P299, DOI 10.1073/pnas.12.5.299; PHALEN RF, 1978, ANAT RECORD, V190, P167, DOI 10.1002/ar.1091900202; PHALEN RF, 1985, ANAT RECORD, V212, P368, DOI 10.1002/ar.1092120408; Phillips CG, 1997, RESP PHYSIOL, V107, P85, DOI 10.1016/S0034-5687(96)02506-6; Pichelin M, 2012, AEROSOL SCI TECH, V46, P70, DOI 10.1080/02786826.2011.605816; Sauret V, 1999, PHYS MED BIOL, V44, P1625, DOI 10.1088/0031-9155/44/7/304; Sauret V, 2002, J ANAT, V200, P123, DOI 10.1046/j.0021-8782.2001.00018.x; Schmidt A, 2004, COMPUT MED IMAG GRAP, V28, P203, DOI 10.1016/j.compmedimag.2004.01.001; SCHREIDER JP, 1981, AM J ANAT, V162, P221, DOI 10.1002/aja.1001620304; Schroeter JD, 2002, COMPUT MED IMAG GRAP, V26, P237, DOI 10.1016/S0895-6111(02)00014-9; Slomine B., 2021, APA 2021 CONVENTION; SOONG TT, 1979, RESP PHYSIOL, V37, P161, DOI 10.1016/0034-5687(79)90068-9; Strahler A.N., 1953, EOS T AM GEOPHYS UN, V34, P345; Swan AJ, 2012, J THEOR BIOL, V300, P222, DOI 10.1016/j.jtbi.2012.01.042; Tawhai MH, 2000, ANN BIOMED ENG, V28, P793, DOI 10.1114/1.1289457; Tawhai MH, 2004, J APPL PHYSIOL, V97, P2310, DOI 10.1152/japplphysiol.00520.2004; Tgavalekos NT, 2003, ANN BIOMED ENG, V31, P363, DOI 10.1114/1.1557972; THURLBECK A, 1980, RESP PHYSIOL, V41, P173, DOI 10.1016/0034-5687(80)90050-X; Tschirren J, 2005, IEEE T MED IMAGING, V24, P1529, DOI 10.1109/TMI.2005.857654; Venegas JG, 2005, NATURE, V434, P777, DOI 10.1038/nature03490; WANG CY, 1992, MATH COMPUT MODEL, V16, P91, DOI 10.1016/0895-7177(92)90050-U; Weibel ER, 1963, GEOMETRY DIMENSIONS, P110; YEH HC, 1980, B MATH BIOL, V42, P461, DOI 10.1007/BF02460796; Yin YB, 2013, J COMPUT PHYS, V244, P168, DOI 10.1016/j.jcp.2012.12.007	71	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168026	10.1371/journal.pone.0168026	http://dx.doi.org/10.1371/journal.pone.0168026			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977730	Green Published, Green Submitted, gold			2022-12-26	WOS:000391217400049
J	Sadeghi, M; Ranjbar, B; Ganjalikhany, MR; Khan, FM; Schmitz, U; Wolkenhauer, O; Gupta, SK				Sadeghi, Mehdi; Ranjbar, Bijan; Ganjalikhany, Mohamad Reza; Khan, Faiz M.; Schmitz, Ulf; Wolkenhauer, Olaf; Gupta, Shailendra K.			MicroRNA and Transcription Factor Gene Regulatory Network Analysis Reveals Key Regulatory Elements Associated with Prostate Cancer Progression	PLOS ONE			English	Article							PROGESTERONE-RECEPTOR EXPRESSION; TUMOR-SUPPRESSOR; BREAST-CANCER; TARGET GENES; STAT3; CELLS; AP-1; OVEREXPRESSION; APOPTOSIS; BCL-2	Technological and methodological advances in multi-omics data generation and integration approaches help elucidate genetic features of complex biological traits and diseases such as prostate cancer. Due to its heterogeneity, the identification of key functional components involved in the regulation and progression of prostate cancer is a methodological challenge. In this study, we identified key regulatory interactions responsible for primary to metastasis transitions in prostate cancer using network inference approaches by integrating patient derived transcriptomic and miRomics data into gene/miRNA/transcription factor regulatory networks. One such network was derived for each of the clinical states of prostate cancer based on differentially expressed and significantly correlated gene, miRNA and TF pairs from the patient data. We identified key elements of each network using a network analysis approach and validated our results using patient survival analysis. We observed that HOXD10, BCL2 and PGR are the most important factors affected in primary prostate samples, whereas, in the metastatic state, STAT3, JUN and JUNB are playing a central role. Benefiting integrative networks our analysis suggests that some of these molecules were targeted by several overexpressed miRNAs which may have a major effect on the dysregulation of these molecules. For example, in the metastatic tumors five miRNAs (miR-671-5p, miR-665, miR-663, miR-512-3p and miR-371-5p) are mainly responsible for the dysregulation of STAT3 and hence can provide an opportunity for early detection of metastasis and development of alternative therapeutic approaches. Our findings deliver new details on key functional components in prostate cancer progression and provide opportunities for the development of alternative therapeutic approaches.	[Sadeghi, Mehdi; Ranjbar, Bijan] Tarbiat Modares Univ, Fac Biol Sci, Dept Biophys, Tehran, Iran; [Ganjalikhany, Mohamad Reza] Univ Isfahan, Dept Biol, Fac Sci, Esfahan, Iran; [Khan, Faiz M.; Wolkenhauer, Olaf; Gupta, Shailendra K.] Univ Rostock, Dept Syst Biol & Bioinformat, Rostock, Germany; [Schmitz, Ulf] Univ Sydney, Centenary Inst, Gene & Stem Cell Therapy Program, Camperdown, NSW, Australia; [Schmitz, Ulf] Univ Sydney, Sydney Med Sch, Camperdown, NSW, Australia; [Wolkenhauer, Olaf] Univ Stellenbosch, Wallenberg Res Ctr, Stellenbosch Inst Adv Study STIAS, Stellenbosch, South Africa; [Gupta, Shailendra K.] CSIR, Indian Inst Toxicol Res, Dept Bioinformat, Lucknow, Uttar Pradesh, India	Tarbiat Modares University; University of Isfahan; University of Rostock; University of Sydney; Centenary Institute; University of Sydney; Stellenbosch University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR)	Ranjbar, B (corresponding author), Tarbiat Modares Univ, Fac Biol Sci, Dept Biophys, Tehran, Iran.	ranjbarb@modares.ac.ir	Schmitz, Ulf/B-5400-2010; sadeghi, mehdi/M-8507-2017; Ganjalikhany, Mohamad Reza/AAB-7845-2021; Sadeghi, Mehdi/AAY-7517-2021	Schmitz, Ulf/0000-0001-5806-4662; sadeghi, mehdi/0000-0001-6704-4591; Ganjalikhany, Mohamad Reza/0000-0002-6865-0814; Sadeghi, Mehdi/0000-0001-6704-4591; Gupta, Shailendra/0000-0002-3470-3260	German Federal Ministry of Education and Research (BMBF) [eBio: SysMet [0316171], eBio:MelEVIR [031L0073A]]; Council of Scientific and Industrial Research (CSIR) [BSC0121, BSC0111]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	We acknowledge Vice Chancellor for Research and Technology of the Tarbiat Modares University. OW, FMK and SKG acknowledge the German Federal Ministry of Education and Research (BMBF) as part of the projects eBio: SysMet [0316171] and eBio:MelEVIR [031L0073A]. SKG acknowledges the Council of Scientific and Industrial Research (CSIR) network projects GENESIS [BSC0121] and INDEPTH [BSC0111].	Abell K, 2005, CELL CYCLE, V4, P897, DOI 10.4161/cc.4.7.1837; Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Avalle Lidia, 2012, JAKSTAT, V1, P65, DOI 10.4161/jkst.20045; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bakkar A, 2016, MOL BIOL REP, V43, P229, DOI 10.1007/s11033-016-3948-4; Banerjee K, 2016, INT J CANCER, V138, P2570, DOI 10.1002/ijc.29923; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barton BE, 2004, MOL CANCER THER, V3, P11; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Birner P, 2015, CELL DEATH DIFFER, V22, P522, DOI 10.1038/cdd.2014.232; Blando JM, 2011, NEOPLASIA, V13, P254, DOI 10.1593/neo.101388; Bonkhoff H, 2001, PROSTATE, V48, P285, DOI 10.1002/pros.1108; Cai Yimei, 2009, Genomics Proteomics & Bioinformatics, V7, P147, DOI 10.1016/S1672-0229(08)60044-3; Carpenter RL, 2014, CANCERS, V6, P897, DOI 10.3390/cancers6020897; Cha YJ, 2016, PROSTATE, V76, P937, DOI 10.1002/pros.23183; Chou C-H, 2015, NUCL ACIDS RES; Culig Z., 2016, EUROPEAN UROLOGY; Dasgupta Subhamoy, 2012, J Carcinog, V11, P4, DOI 10.4103/1477-3163.93001; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Don-Doncow N, 2016, EUR UROL; Esber N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140795; Esposito S, 2015, ONCOTARGET, V6; Gitenay D, 2009, FUTURE ONCOL, V5, P993, DOI 10.2217/FON.09.67; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Gurel B, 2008, MODERN PATHOL, V21, P1156, DOI 10.1038/modpathol.2008.111; Hawksworth D, 2010, PROSTATE CANCER P D, V13, P311, DOI 10.1038/pcan.2010.31; Ho HH, 2006, J BIOL CHEM, V281, P14111, DOI 10.1074/jbc.M511797200; Horvath CM, 2000, TRENDS BIOCHEM SCI, V25, P496, DOI 10.1016/S0968-0004(00)01624-8; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Jarnicki A, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-14; Jiao L, 2014, J CELL PHYSIOL, V229, P834, DOI 10.1002/jcp.24510; Jin Y, 2015, INT J ONCOL, V47, P1594, DOI 10.3892/ijo.2015.3114; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Karantanos T, 2013, ONCOGENE, V32, P5501, DOI 10.1038/onc.2013.206; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kavlashvili T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148912; Kawamura N, 2015, ONCOTARGET, V6, P22361, DOI 10.18632/oncotarget.4293; Kim YR, 2016, ONCOL REP, V35, P2011, DOI 10.3892/or.2016.4563; Knox SS, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-11; Konishi N, 2008, CLIN CANCER RES, V14, P4408, DOI 10.1158/1078-0432.CCR-07-4120; Lai X, 2012, NUCLEIC ACIDS RES, V40, P8818, DOI 10.1093/nar/gks657; Li ML, 2016, ONCOL LETT, V11, P817, DOI 10.3892/ol.2015.3924; Lin YT, 2007, CELL RES, V17, P531, DOI 10.1038/cr.2007.12; Ling XY, 2005, CANCER RES, V65, P2532, DOI 10.1158/0008-5472.CAN-04-2425; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Lonergan Peter E, 2011, J Carcinog, V10, P20, DOI 10.4103/1477-3163.83937; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Martinez NJ, 2008, GENE DEV, V22, P2535, DOI 10.1101/gad.1678608; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mehta HH, 2011, CANCER RES, V71, P5154, DOI 10.1158/0008-5472.CAN-10-4513; Nair S, 2010, ACTA PHARMACOL SIN, V31, P1223, DOI 10.1038/aps.2010.147; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nowak DG, 2015, CANCER DISCOV, V5, P636, DOI 10.1158/2159-8290.CD-14-1113; Nunez YO, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-725; Ouyang X, 2008, CANCER RES, V68, P2132, DOI 10.1158/0008-5472.CAN-07-6055; Palladinetti P, 2008, ATLAS GENET CYTOGENE, P367; Pencik J, 2015, STAT3 REGULATED ARF, V6; RAFFO AJ, 1995, CANCER RES, V55, P4438; Ramachandran S, 2005, ONCOGENE, V24, P188, DOI 10.1038/sj.onc.1207906; Ravani P, 2010, CLIN J AM SOC NEPHRO, V5, P1243, DOI 10.2215/CJN.06190809; Ritchie MD, 2015, NAT REV GENET, V16, P85, DOI 10.1038/nrg3868; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roca H, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-29; Schmelz M, 2002, NEOPLASIA, V4, P243, DOI 10.1038/sj.neo.7900223; Schuringa JJ, 2001, CYTOKINE, V14, P78, DOI 10.1006/cyto.2001.0856; Senapati S, 2009, ATLAS GENET CYTOGENE, P204; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Taylor BS, 2011, INTEGRATIVE GENOMIC, V18, P11; Thomsen MK, 2015, CELL DEATH DIFFER, V22, P574, DOI 10.1038/cdd.2014.213; Toualbi K, 2007, ONCOGENE, V26, P3492, DOI 10.1038/sj.onc.1210133; Tsang J, 2015, MOL CELL ELSEVIER, V26, P753; Tu WH, 2003, NEOPLASIA, V5, P267, DOI 10.1016/S1476-5586(03)80058-1; Vanhara P, 2012, PROSTATE CANCER P D, V15, P320, DOI 10.1038/pcan.2012.6; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vera J, 2013, CANCER RES, V73, P3511, DOI 10.1158/0008-5472.CAN-12-4095; Virolle T, 2003, J BIOL CHEM, V278, P11802, DOI 10.1074/jbc.M210279200; Wang LJ, 2012, MOL MED, V18, P389, DOI 10.2119/molmed.2011.00172; Xiong AL, 2014, CANCERS, V6, P926, DOI 10.3390/cancers6020926; Yin P, 2007, J CLIN ENDOCR METAB, V92, P4459, DOI 10.1210/jc.2007-0725; Yu Y, 2015, PROSTATE, V75, P1043, DOI 10.1002/pros.22988; Yu Y, 2013, J CLIN ENDOCR METAB, V98, P2887, DOI 10.1210/jc.2012-4000; Zhang DT, 2014, TUMOR BIOL, V35, P3333, DOI 10.1007/s13277-013-1439-y	86	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168760	10.1371/journal.pone.0168760	http://dx.doi.org/10.1371/journal.pone.0168760			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005952	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000392843200091
J	Farah, CA; Rourke, B; Shin, U; Ferguson, L; Luna, MJ; Sossin, WS				Farah, Carole A.; Rourke, Bryan; Shin, Unkyung; Ferguson, Larissa; Luna, Maria Jose; Sossin, Wayne S.			Investigating the Potential Signaling Pathways That Regulate Activation of the Novel PKC Downstream of Serotonin in Aplysia	PLOS ONE			English	Article							PROTEIN-KINASE-C; LONG-TERM FACILITATION; GROWTH-FACTOR RECEPTOR; APL-II; PRESYNAPTIC FACILITATION; NONDEPRESSED SYNAPSES; SYNAPTIC FACILITATION; ISOFORM SPECIFICITY; TRANSLOCATION; DISHABITUATION	Activation of the novel PKC Apl ll in sensory neurons by serotonin (5HT) underlies the ability of 5HT to reverse synaptic depression, but the pathway from 5HT to PKC Apl ll activation remains unclear. Here we find no evidence for the Ap/ysia-specific B receptors, or for adenylate cyclase activation, to translocate fluorescently-tagged PKC Apl II. Using an anti-PKC Apl ll antibody, we monitor translocation of endogenous PKC Apl ll and determine the dose response for PKC Apl I I translocation, both in isolated sensory neurons and sensory neurons coupled with motor neurons. Using this assay, we confirm an important role for tyrosine kinase activation in 5HT mediated PKC Apl II translocation, but rule out roles for intracellular tyrosine kinases, epidermal growth factor (EGF) receptors and Trk kinases in this response. A partial inhibition of translocation by a fibroblast growth factor (FGF)-receptor inhibitor led us to clone the Aplysia FGF receptor. Since a number of related receptors have been recently characterized, we use bioinformatics to define the relationship between these receptors and find a single FGF receptor orthologue in Aplysia. However, expression of the FGF receptor did not affect translocation or allow it in motor neurons where 5HT does not normally cause PKC Apl II translocation. These results suggest that additional receptor tyrosine kinases (RTKs) or other molecules must also be involved in translocation of PKC Apl II.	[Farah, Carole A.; Rourke, Bryan; Shin, Unkyung; Ferguson, Larissa; Luna, Maria Jose; Sossin, Wayne S.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada	McGill University	Sossin, WS (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada.	wayne.sossin@mcgill.ca		Sossin, Wayne/0000-0003-1927-9315; Ferguson, Larissa/0000-0003-4274-8634	Canadian Institute of Health Research Grant [MOP 12046]	Canadian Institute of Health Research Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institute of Health Research Grant MOP 12046 to WSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey CH, 2008, PROG BRAIN RES, V169, P179, DOI 10.1016/S0079-6123(07)00010-6; Bougie JK, 2009, J NEUROCHEM, V109, P1129, DOI 10.1111/j.1471-4159.2009.06045.x; BRAHA O, 1990, P NATL ACAD SCI USA, V87, P2040, DOI 10.1073/pnas.87.5.2040; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; CASTELLUCCI V, 1970, SCIENCE, V167, P1745, DOI 10.1126/science.167.3926.1745; Cesare P, 1999, NEURON, V23, P617, DOI 10.1016/S0896-6273(00)80813-2; Dunn TW, 2013, J NEUROPHYSIOL, V110, P2071, DOI 10.1152/jn.00217.2013; Dunn TW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136907; Emptage NJ, 1996, J NEUROPHYSIOL, V75, P843, DOI 10.1152/jn.1996.75.2.843; Evellin Sandrine, 2004, Methods Mol Biol, V284, P259; Farah CA, 2008, MOL CELL BIOL, V28, P4719, DOI 10.1128/MCB.00178-08; Farah CA, 2015, EUR J NEUROSCI, V41, P328, DOI 10.1111/ejn.12794; Farah CA, 2011, JOVE-J VIS EXP, DOI 10.3791/2516; Farah CA, 2012, J NEUROCHEM, V123, P360, DOI 10.1111/j.1471-4159.2012.07930.x; FUKAZAWA H, 1994, FEBS LETT, V340, P155, DOI 10.1016/0014-5793(94)80127-4; GHIRARDI M, 1995, NEURON, V14, P413, DOI 10.1016/0896-6273(95)90297-X; GHIRARDI M, 1992, NEURON, V9, P479, DOI 10.1016/0896-6273(92)90185-G; GOLDBERG DJ, 1995, J NEUROBIOL, V27, P553, DOI 10.1002/neu.480270409; GOLDSMITH BA, 1991, P NATL ACAD SCI USA, V88, P9021, DOI 10.1073/pnas.88.20.9021; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hislop J, 2004, J NEUROBIOL, V60, P127, DOI 10.1002/neu.20004; HOCHNER B, 1986, P NATL ACAD SCI USA, V83, P8794, DOI 10.1073/pnas.83.22.8794; Hucho TB, 2005, J NEUROSCI, V25, P6119, DOI 10.1523/JNEUROSCI.0285-05.2005; Hunter T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020644; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kassabov SR, 2013, CELL REP, V3, P1213, DOI 10.1016/j.celrep.2013.03.008; KIM BY, 1995, BIOCHEM BIOPH RES CO, V212, P1061, DOI 10.1006/bbrc.1995.2077; KRUGER KE, 1991, J NEUROSCI, V11, P2303; Lee YS, 2009, P NATL ACAD SCI USA, V106, P14634, DOI 10.1073/pnas.0907502106; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; LI XC, 1995, J NEUROSCI, V15, P7585; Manseau F, 2001, J NEUROSCI, V21, P1247; Marinesco S, 2002, J NEUROSCI, V22, P2299, DOI 10.1523/JNEUROSCI.22-06-02299.2002; MIZUNO K, 1993, FEBS LETT, V330, P114, DOI 10.1016/0014-5793(93)80254-R; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Nagakura I, 2010, J NEUROCHEM, V115, P994, DOI 10.1111/j.1471-4159.2010.06986.x; Naqib F, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002324; Okochi Y, 2005, EMBO J, V24, P2127, DOI 10.1038/sj.emboj.7600697; Ormond J, 2004, NEURON, V44, P715, DOI 10.1016/j.neuron.2004.11.001; Pollak DD, 2014, AMINO ACIDS, V46, P2477, DOI 10.1007/s00726-014-1803-2; Sossin WS, 2007, LEARN MEMORY, V14, P236, DOI 10.1101/lm.469707; Tamvacakis AN, 2015, LEARN MEMORY, V22, P617, DOI 10.1101/lm.038158.115; Wan Q, 2012, NAT NEUROSCI, V15, P1144, DOI 10.1038/nn.3158; WHALEN MM, 1993, IMMUNOLOGY, V79, P542; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Zhao YL, 2006, J NEUROSCI, V26, P8847, DOI 10.1523/JNEUROSCI.1919-06.2006	46	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168411	10.1371/journal.pone.0168411	http://dx.doi.org/10.1371/journal.pone.0168411			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002451	Green Published, Green Submitted, gold			2022-12-26	WOS:000392853100044
J	Galante, R; Rediguieri, CF; Kikuchi, IS; Vasquez, PAS; Colaco, R; Serro, AP; Pinto, TJA				Galante, Raquel; Rediguieri, Carolina F.; Kikuchi, Irene Satiko; Vasquez, Pablo A. S.; Colaco, Rogerio; Serro, Ana Paula; Pinto, Terezinha J. A.			About the Sterilization of Chitosan Hydrogel Nanoparticles	PLOS ONE			English	Article							TRIPOLYPHOSPHATE CS/TPP NANOPARTICLES; DRUG-DELIVERY; BIOMEDICAL APPLICATIONS; GLUCOSE COMPLEX; OZONE; CHALLENGES; EFFICIENCY; NANOGELS	In the last years, nanostructured biomaterials have raised a great interest as platforms for delivery of drugs, genes, imaging agents and for tissue engineering applications. In particular, hydrogel nanoparticles (HNP) associate the distinctive features of hydrogels (high water uptake capacity, biocompatibility) with the advantages of being possible to tailor its physicochemical properties at nano-scale to increase solubility, immunocompatibility and cellular uptake. In order to be safe, HNP for biomedical applications, such as injectable or ophthalmic formulations, must be sterile. Literature is very scarce with respect to sterilization effects on nanostructured systems, and even more in what concerns HNP. This work aims to evaluate the effect and effectiveness of different sterilization methods on chitosan (CS) hydrogel nanoparticles. In addition to conventional methods (steam autoclave and gamma irradiation), a recent ozone-based method of sterilization was also tested. A model chitosan-tripolyphosphate (TPP) hydrogel nanoparticles (CS-HNP), with a broad spectrum of possible applications was produced and sterilized in the absence and in the presence of protective sugars (glucose and mannitol). Properties like size, zeta potential, absorbance, morphology, chemical structure and cytotoxicity were evaluated. It was found that the CS-HNP degrade by autoclaving and that sugars have no protective effect. Concerning gamma irradiation, the formation of agglomerates was observed, compromising the suspension stability. However, the nanoparticles resistance increases considerably in the presence of the sugars. Ozone sterilization did not lead to significant physical adverse effects, however, slight toxicity signs were observed, contrarily to gamma irradiation where no detectable changes on cells were found. Ozonation in the presence of sugars avoided cytotoxicity. Nevertheless, some chemical alterations were observed in the nanoparticles.	[Galante, Raquel; Rediguieri, Carolina F.; Kikuchi, Irene Satiko; Pinto, Terezinha J. A.] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Farm, Butanta, SP, Brazil; [Galante, Raquel; Colaco, Rogerio; Serro, Ana Paula] Univ Lisbon, Inst Super Tecn, Ctr Quim Estrutural, Lisbon, Portugal; [Rediguieri, Carolina F.] Agencia Nacl Vigilaancia Sanit, Brasilia, DF, Brazil; [Vasquez, Pablo A. S.] Ctr Tecnol Radiacoes, Inst Pesquisas Energet & Nucl, Butanta, SP, Brazil; [Colaco, Rogerio] Univ Lisbon, Inst Super Tecn, Dept Engn Mecan, Lisbon, Portugal; [Colaco, Rogerio] Univ Lisbon, Inst Super Tecn, IDMEC, Lisbon, Portugal; [Serro, Ana Paula] Ctr Invest Interdisciplinar Egas Moniz, Inst Super Ciencias Saude Egas Moniz, Monte De Caparica, Caparica, Portugal	Universidade de Sao Paulo; Universidade de Lisboa; Instituto Superior Tecnico; Comissao Nacional de Energia Nuclear (CNEN); Instituto de Pesquisas Energeticas e Nucleares (IPEN); Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico; Instituto Superior de Ciencias da Saude Egas Moniz	Serro, AP (corresponding author), Univ Lisbon, Inst Super Tecn, Ctr Quim Estrutural, Lisbon, Portugal.; Serro, AP (corresponding author), Ctr Invest Interdisciplinar Egas Moniz, Inst Super Ciencias Saude Egas Moniz, Monte De Caparica, Caparica, Portugal.	anapaula.serro@tecnico.ulisboa.pt	Kikuchi, Irene S./A-4863-2013; de Jesus Andreoli Pinto, Terezinha/AAR-2389-2020; GALANTE, RAQUEL S.C./K-2512-2014; Vasquez, Pablo/C-3862-2016; Pinto, Terezinha JA/C-4777-2012; Serro, Ana/H-7797-2012; Colaco, Rogerio/B-5432-2013	Kikuchi, Irene S./0000-0002-5223-1308; de Jesus Andreoli Pinto, Terezinha/0000-0002-0238-8227; GALANTE, RAQUEL S.C./0000-0001-8616-4775; Vasquez, Pablo/0000-0003-4168-1626; Colaco, Rogerio/0000-0002-5529-1621; Serro, Ana/0000-0002-6179-9296; Colaco, Rogerio/0000-0001-7374-6741	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [140863/2014, 400455/2014-5]; projects M-ERA; Fundacao para a Ciencia e Tecnologia [NET/0005/2012, PTDC/CTM-BIO/3640/2014]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); projects M-ERA; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was supported by PhD grant 140863/2014 and project 400455/2014-5, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://cnpq.br/) and projects M-ERA. NET/0005/2012 and PTDC/CTM-BIO/3640/2014, Fundacao para a Ciencia e Tecnologia (http://www.fct.pt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hafez SM, 2014, INT J BIOL MACROMOL, V64, P334, DOI 10.1016/j.ijbiomac.2013.11.041; Audenaert WTM, 2010, CHEM ENG J, V157, P551, DOI 10.1016/j.cej.2009.12.051; Azadi A, 2015, INT J BIOL MACROMOL, V79, P326, DOI 10.1016/j.ijbiomac.2015.05.001; Brink B, 1991, OZONE WATER TREATMEN; Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4; Cataldo F, 2007, INT J BIOL MACROMOL, V41, P210, DOI 10.1016/j.ijbiomac.2007.02.008; De Campos AM, 2001, INT J PHARMACEUT, V224, P54, DOI 10.1016/j.msec.2012.12.066; Dick HB, 2000, ASEPTIC PRODUCTION V, P97; Dufresne S., 2004, AM J INFECT CONTROL, V32, pE26, DOI [10.1016/j.ajic.2004.04.038, DOI 10.1016/J.AJIC.2004.04.038]; Dufresne S, 2008, AM J INFECT CONTROL, V36, P291, DOI 10.1016/j.ajic.2007.06.006; Franca A, 2010, SMALL, V6, P89, DOI 10.1002/smll.200901006; Gao PS, 2013, CARBOHYD POLYM, V95, P371, DOI 10.1016/j.carbpol.2013.03.029; Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002; Hassani S, 2015, COLLOID SURFACE A, V482, P34, DOI 10.1016/j.colsurfa.2015.04.006; HEUSINGER H, 1987, Z LEBENSM UNTERS FOR, V185, P106, DOI 10.1007/BF01850087; HOIGNE J, 1985, WATER RES, V19, P993, DOI 10.1016/0043-1354(85)90368-9; Honary S, 2013, TROP J PHARM RES, V12, P265, DOI 10.4314/tjpr.v12i2.20; Jarry C, 2002, CHEM PHARM B TOKYO, V50; Jayakumar R, 2010, CARBOHYD POLYM, V82, P227, DOI 10.1016/j.carbpol.2010.04.074; Jiang YJ, 2014, BIOMATERIALS, V35, P4969, DOI 10.1016/j.biomaterials.2014.03.001; Jing ZW, 2016, BIOMATERIALS, V84, P276, DOI 10.1016/j.biomaterials.2016.01.045; Kanatt SR, 2008, FOOD CHEM, V106, P521, DOI 10.1016/j.foodchem.2007.06.036; Karajanagi SS, 2011, BIOTECHNOL BIOENG, V108, P1716, DOI 10.1002/bit.23105; Kean T, 2010, ADV DRUG DELIVER REV, V62, P3, DOI 10.1016/j.addr.2009.09.004; Killeen S., 2012, SURGERY OXFORD, V30, P687; Kitazaki S, 2014, VACUUM, V110, P217, DOI 10.1016/j.vacuum.2014.06.014; Laverty G, 2012, CHARACTERISTICS TREA, V51, P79; Lerouge S, 2012, WOODH PUBL SER BIOM, V46, P1; Li J, 2012, CARBOHYD POLYM, V87, P1670, DOI 10.1016/j.carbpol.2011.09.074; Loncar B, 2009, ARCH MED RES, V40, P136, DOI 10.1016/j.arcmed.2008.11.002; Mata-Alvarez J., BIOMETHANIZATION ORG, V4, DOI [10.2166/9781780402994, DOI 10.2166/9781780402994]; Morris GA, 2011, CARBOHYD POLYM, V84, P1430, DOI 10.1016/j.carbpol.2011.01.044; O'Donnell C, 2012, STATUS TRENDS OZONE, P1; Pharmacopeia US, 2016, USP39NF34, P167; Pharmacopeia US, 2016, USP39NF34, P136; Pharmacopeia US, 2016, USP 39 NF 34, P589; PHILLIPS GO, 1963, J CHEM SOC, P297, DOI 10.1039/jr9630000297; Rediguieri C., 2016, TISSUE ENG C; Rogers WJ, 2012, WOODH PUBL SER BIOM, V46, P151; Rogers W.J., 2012, STERILISATION BIOMAT, P352; Rutala WA, 2008, GUIDELINE DISINFECTI, P69; Sarkar SD, 2013, MAT SCI ENG C-MATER, V33, P1446, DOI 10.1016/j.msec.2012.12.066; Serro AP, 2003, BIOMATERIALS, V24, P4749, DOI 10.1016/S0142-9612(03)00372-7; Silva CLM, ETHYLENE OXIDE EO ST; Sipoli CC, 2015, BIOCHEM ENG J, V94, P65, DOI 10.1016/j.bej.2014.11.008; Talbot P, 2012, WATER RES, V46, P5893, DOI 10.1016/j.watres.2012.07.052; U. S. Environmental Protection Agency (US EPA), 1999, GUID MAN ALT DIS OX, P1; Uzun H, 2012, FOOD CHEM, V134, P647, DOI 10.1016/j.foodchem.2012.02.146; Vetten MA, 2014, NANOMED-NANOTECHNOL, V10, P1391, DOI 10.1016/j.nano.2014.03.017; Vimal S, 2014, AQUACULTURE, V420, P240, DOI 10.1016/j.aquaculture.2013.11.017; Vimal S, 2013, ACTA TROP, V128, P486, DOI 10.1016/j.actatropica.2013.07.013; Xu YM, 2003, INT J PHARMACEUT, V250, P215, DOI 10.1016/S0378-5173(02)00548-3	52	25	26	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168862	10.1371/journal.pone.0168862	http://dx.doi.org/10.1371/journal.pone.0168862			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002493	Green Published, Green Submitted, gold			2022-12-26	WOS:000392853100072
J	Huang, WC; Chen, HL; Chen, HY; Peng, KP; Lee, Y; Huang, LM; Chang, LY; Liu, FT				Huang, Wen-Chan; Chen, Hung-Lin; Chen, Huan-Yuan; Peng, Kuan-Po; Lee, Yungling; Huang, Li-Min; Chang, Luan-Yin; Liu, Fu-Tong			Galectin-3 and Its Genetic Variation rs4644 Modulate Enterovirus 71 Infection	PLOS ONE			English	Article							CLINICAL-FEATURES; ADIPOSE-TISSUE; MOUTH-DISEASE; ASSOCIATION; CHILDREN; SUSCEPTIBILITY; POLYMORPHISM; EXPRESSION; THERAPY; TAIWAN	Galectin-3, a chimeric type P-galactoside-binding protein, is known to modulate viral infection; however, its role in enterovirus 71 (EV71) infection has not been investigated. We generated galectin-3 null rhabdomyosarcoma (RD) cells and evaluated whether EV71 infection would be affected. In galectin-3 null cells, the released and intracellular EV71 viral loads were suppressed after 24 h of infection, and cell death rates were significantly lower, while cell proliferation remained unaltered. In addition, RD cells expressing a nonsynonymous genetic variant of galectin-3, rs4644 (LGALS3 +191C/A, P64H), produced lower virus titers than those with wild-type galectin-3 (C allele). To clarify whether the in vitro viral load reduction correlates with clinical severity, we enrolled children with laboratory-confirmed EV71 infection. Since hyperglycemia is an indicator of severe EV71 infection in children, 152 of 401 enrolled children had glucose examinations at admission, and 59 subjects had serum glucose levels >= 150 mg/dL. In comparison to the rs4644 AA genotype (2.2 +/- 0.06 log(10) mg/dL), serum glucose levels during EV71 infection were higher in patients with CC (2.4 +/- 0.17 log(10) mg/dL, p = 0.03) and CA (2.4 +/- 0.15 log(10) mg/dL, p = 0.02) genotypes, respectively. These findings suggest that the rs4644 AA genotype of galectin-3 might exert a protective effect. In summary, galectin-3 affects EV71 replication in our cellular model and its variant, rs4644, is associated with hyperglycemia in the clinical setting. The underlying mechanism and its potential therapeutic application warrant further investigation.	[Huang, Wen-Chan; Chen, Hung-Lin; Chen, Huan-Yuan; Lee, Yungling; Liu, Fu-Tong] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Huang, Wen-Chan; Huang, Li-Min; Chang, Luan-Yin] Natl Taiwan Univ, Dept Pediat, Natl Taiwan Univ Hosp, Taipei, Taiwan; [Huang, Wen-Chan; Huang, Li-Min; Chang, Luan-Yin] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Huang, Wen-Chan] Natl Taiwan Univ, PhD Program Translat Med, Taipei, Taiwan; [Huang, Wen-Chan] Acad Sinica, Taipei, Taiwan; [Peng, Kuan-Po] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Lee, Yungling] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Taipei, Taiwan; [Liu, Fu-Tong] Univ Calif Davis, Dept Dermatol, Sacramento, CA 95817 USA	Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Taiwan University; University of California System; University of California Davis	Liu, FT (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.; Chang, LY (corresponding author), Natl Taiwan Univ, Dept Pediat, Natl Taiwan Univ Hosp, Taipei, Taiwan.; Chang, LY (corresponding author), Natl Taiwan Univ, Coll Med, Taipei, Taiwan.; Liu, FT (corresponding author), Univ Calif Davis, Dept Dermatol, Sacramento, CA 95817 USA.	lychang@ntu.edu.tw; ftliu@ibms.sinica.edu.tw	Liu, FU-TONG/A-5749-2019; Lee, Yungling/S-7011-2018; Peng, Kuan-Po/V-3773-2018	Liu, FU-TONG/0000-0002-3354-1001; Lee, Yungling/0000-0002-2234-9479; Peng, Kuan-Po/0000-0002-2718-3738; HUANG, LI-MIN/0000-0002-9291-260X; CHANG, LUAN-YIN/0000-0003-2632-1956	National Science Council of Taiwan [NSC 101-2321-B-002-004]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported in part by grants from National Science Council of Taiwan (NSC 101-2321-B-002-004). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Baek JH, 2015, ENDOCRINOLOGY, V156, P147, DOI 10.1210/en.2014-1374; Balan V, 2008, CANCER RES, V68, P10045, DOI 10.1158/0008-5472.CAN-08-3224; Bieche I, 2005, VIROLOGY, V332, P130, DOI 10.1016/j.virol.2004.11.009; Branco RG, 2007, PEDIATR CRIT CARE ME, V8, P546, DOI 10.1097/01.PCC.0000288712.67749.45; Chang LY, 2008, PEDIATRICS, V122, P1271, DOI 10.1542/peds.2007-3735; Chang LY, 2004, JAMA-J AM MED ASSOC, V291, P222, DOI 10.1001/jama.291.2.222; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; Chen HY, 2014, CURR OPIN MICROBIOL, V17, P75, DOI 10.1016/j.mib.2013.11.006; Cheng HY, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-417; Cheng ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113234; Cong H, 2016, J VIROL; De La Vega FA, 2005, MUTAT RES-FUND MOL M, V573, P111, DOI 10.1016/j.mrfmmm.2005.01.008; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Fukumori T, 2006, CANCER RES, V66, P3114, DOI 10.1158/0008-5472.CAN-05-3750; Ho HY, 2008, J GEN VIROL, V89, P2080, DOI 10.1099/vir.0.2008/001404-0; Hsia SH, 2005, PEDIATR INFECT DIS J, V24, P331, DOI 10.1097/01.inf.0000157219.19674.98; Hsu DK, 1999, INT J CANCER, V81, P519, DOI 10.1002/(SICI)1097-0215(19990517)81:4<519::AID-IJC3>3.3.CO;2-S; Hsu DK, 2002, GLYCOCONJUGATE J, V19, P507, DOI 10.1023/B:GLYC.0000014080.95829.52; Huang WC, 2014, J MICROBIOL IMMUNOL; Huang WC, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-209; Huang WC, 2012, J MICROBIOL IMMUNOL, V45, P96, DOI 10.1016/j.jmii.2011.09.025; Iacobini C, 2011, J HEPATOL, V54, P975, DOI 10.1016/j.jhep.2010.09.020; Kassab S, 2013, EMERG INFECT DIS, V19, P1345, DOI [10.3201/eid1907.130202, 10.3201/eid1908.130202]; Kiwaki K, 2007, OBESITY, V15, P32, DOI 10.1038/oby.2007.526; Lin TY, 2002, CLIN INFECT DIS, V34, pS52, DOI 10.1086/338819; Lu J, 2011, WORLD J GASTROENTERO, V17, P4135, DOI 10.3748/wjg.v17.i36.4135; Lv TG, 2013, INFLAMMATION, V36, P977, DOI 10.1007/s10753-013-9629-8; Manolio TA, 2009, ANNU REV MED, V60, P443, DOI 10.1146/annurev.med.60.061907.093117; Shen GQ, 2009, METHODS MOL BIOL, V578, P293, DOI 10.1007/978-1-60327-411-1_19; Soepandi PZ, 2010, CHEST, V138, P665, DOI 10.1378/chest.09-2644; Trompet S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.05.001; Wang SF, 2014, GLYCOBIOLOGY, V24, P1022, DOI 10.1093/glycob/cwu064; Willson DF, 2003, J PEDIATR-US, V143, pS142, DOI 10.1067/S0022-3476(03)00514-6; Yang J, 2012, SCAND J INFECT DIS, V44, P465, DOI 10.3109/00365548.2011.649490; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737; Yu F, 2002, J BIOL CHEM, V277, P15819, DOI 10.1074/jbc.M200154200; Zou RR, 2015, SCI REP-UK, V5, DOI 10.1038/srep18541	38	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168627	10.1371/journal.pone.0168627	http://dx.doi.org/10.1371/journal.pone.0168627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002441	Green Published, gold, Green Submitted			2022-12-26	WOS:000392853100059
J	Komnik, I; Peters, M; Funken, J; David, S; Weiss, S; Potthast, W				Komnik, Igor; Peters, Markus; Funken, Johannes; David, Sina; Weiss, Stefan; Potthast, Wolfgang			Non-Sagittal Knee Joint Kinematics and Kinetics during Gait on Level and Sloped Grounds with Unicompartmental and Total Knee Arthroplasty Patients	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; FIXED BEARING; REPLACEMENT; WALKING; BIOMECHANICS; ROTATION; DIFFERENCE; DYNAMICS; OUTCOMES; PATTERN	After knee arthroplasty (KA) surgery, patients experience abnormal kinematics and kinetics during numerous activities of daily living. Biomechanical investigations have focused primarily on level walking, whereas walking on sloped surfaces, which is stated to affect knee kinematics and kinetics considerably, has been neglected to this day. This study aimed to analyze over-ground walking on level and sloped surfaces with a special focus on transverse and frontal plane knee kinematics and kinetics in patients with KA. A three-dimensional (3D) motion analysis was performed by means of optoelectronic stereophogrammetry 1.8 +/- 0.4 years following total knee arthroplasty (TKA) and unicompartmental arthroplasty surgery (UKA). AnyBody (TM) Modeling System was used to conduct inverse dynamics. The TKA group negotiated the decline walking task with reduced peak knee internal rotation angles compared with a healthy control group (CG). First-peak knee adduction moments were diminished by 27% (TKA group) and 22% (UKA group) compared with the CG during decline walking. No significant differences were detected between the TKA and UKA groups, regardless of the locomotion task. Decline walking exposed apparently more abnormal knee frontal and transverse plane adjustments in KA patients than level walking compared with the CG. Hence, walking on sloped surfaces should be included in further motion analysis studies investigating KA patients in order to detect potential deficits that might be not obvious during level walking.	[Komnik, Igor; Peters, Markus; Funken, Johannes; David, Sina; Potthast, Wolfgang] German Sport Univ Cologne, Inst Biomech & Orthopaed, Cologne, Nordrhein Westf, Germany; [Weiss, Stefan] ARCUS Clin Pforzheim, Pforzheim, Baden Wurttembe, Germany	German Sport University Cologne	Komnik, I (corresponding author), German Sport Univ Cologne, Inst Biomech & Orthopaed, Cologne, Nordrhein Westf, Germany.	i.komnik@dshs-koeln.de	Funken, Johannes/AAR-8238-2020	Funken, Johannes/0000-0002-0093-8686; David, Sina/0000-0002-9741-7202	ARCUS Clinics Pforzheim; graduate college of the German Sport University; "Verein fur Wissenschaft and Weiterbildung in der Orthopadie e.V." (English: "Science and Advanced Training Society in the field of orthopedics")	ARCUS Clinics Pforzheim; graduate college of the German Sport University; "Verein fur Wissenschaft and Weiterbildung in der Orthopadie e.V." (English: "Science and Advanced Training Society in the field of orthopedics")	The study was supported by ARCUS Clinics Pforzheim. All knee arthroplasty subjects, who participated in the current study, were operated in the mentioned institution. ARCUS Clinics Pforzheim provided support in the form of salary for the author SW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of SW are articulated in the "author contributions" section. The graduate college of the German Sport University funded the PhD studies for the corresponding author IK in the form of salary (http://www.dshskoeln.de/visitenkarte/einrichtung/graduiertenkolleg-mechanobiologie/). The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. "Verein fur Wissenschaft and Weiterbildung in der Orthopadie e.V." (English: "Science and Advanced Training Society in the field of orthopedics") funded the knee arthroplasty subject's accommodation and travel costs to Cologne (http://www.sportklinik.de/wissepschaft_publikation/). The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBREKTSSON BEJ, 1990, J BONE JOINT SURG BR, V72, P252, DOI 10.1302/0301-620X.72B2.2312565; Amin S, 2004, ARTHRIT RHEUM-ARTHR, V51, P371, DOI 10.1002/art.20396; ANDRIACCHI TP, 1982, J BONE JOINT SURG AM, V64, P1328, DOI 10.2106/00004623-198264090-00008; Argenson JNA, 2002, J ARTHROPLASTY, V17, P1049, DOI 10.1054/arth.2002.34527; Astephen JL, 2008, J BIOMECH, V41, P868, DOI 10.1016/j.jbiomech.2007.10.016; Astephen JL, 2005, CLIN BIOMECH, V20, P209, DOI 10.1016/j.clinbiomech.2004.09.007; Benedetti MG, 2003, CLIN BIOMECH, V18, P871, DOI 10.1016/S0268-0033(03)00146-3; Capella M, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2015.12.64; CLIFT SE, 1989, BIOMATERIALS, V10, P329, DOI 10.1016/0142-9612(89)90074-4; Cohen J.E., 1988, STAT POWER ANAL BEHA; Collier MB, 2007, J BONE JOINT SURG AM, V89A, P1306, DOI 10.2106/JBJS.F.00667; Della Croce U, 2005, GAIT POSTURE, V21, P226, DOI 10.1016/j.gaitpost.2004.05.003; Fisher N, 2006, KNEE, V13, P296, DOI 10.1016/j.knee.2006.03.004; Franz JR, 2014, GAIT POSTURE, V39, P135, DOI 10.1016/j.gaitpost.2013.06.012; Fraser JF, 2015, J KNEE SURG, V28, P139, DOI 10.1055/s-0034-1398375; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Hassaballa MA, 2007, MED SCI MONITOR, V13, pCR77; Huang Chun-Hsiung, 2007, J Orthop Surg Res, V2, P1, DOI 10.1186/1749-799X-2-1; Hunt NC, 2015, BONE JOINT J, V97B, P642, DOI 10.1302/0301-620X.97B5.34999; Hurst JM, 2014, CLIN SPORT MED, V33, P105, DOI 10.1016/j.csm.2013.06.004; Jiang C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147865; Jones GG, 2016, BONE JOINT J, V98B, P16, DOI 10.1302/0301-620X.98B10.BJJ.2016.0473.R1; Jung MC, 2014, KNEE SURG SPORT TR A, V22, P1879, DOI 10.1007/s00167-014-3064-8; Kellis E, 1998, SPORTS MED, V25, P37, DOI 10.2165/00007256-199825010-00004; Komnik I, 2015, GAIT POSTURE, V41, P370, DOI 10.1016/j.gaitpost.2015.01.019; KRAEMER WJ, 1995, J ARTHROPLASTY, V10, P227, DOI 10.1016/S0883-5403(05)80132-9; KUSTER M, 1995, CLIN BIOMECH, V10, P79, DOI 10.1016/0268-0033(95)92043-L; Lay AN, 2006, J BIOMECH, V39, P1621, DOI 10.1016/j.jbiomech.2005.05.005; Leffler J, 2012, GAIT POSTURE, V36, P454, DOI 10.1016/j.gaitpost.2012.04.008; Li MG, 2006, KNEE, V13, P365, DOI 10.1016/j.knee.2006.05.003; Lombardi AV, 2014, BONE JOINT J, V96B, P101, DOI 10.1302/0301-620X.96B11.34350; Lund M.E., 2015, INT BIOMECH, V2, P1, DOI [10.1080/23335432.2014.993706, DOI 10.1080/23335432.2014.993706]; MacWilliams BA, 1999, J ORTHOPAED RES, V17, P817, DOI 10.1002/jor.1100170605; McClelland JA, 2007, KNEE, V14, P253, DOI 10.1016/j.knee.2007.04.003; McClelland JA, 2011, KNEE, V18, P151, DOI 10.1016/j.knee.2010.04.005; McIntosh AS, 2006, J BIOMECH, V39, P2491, DOI 10.1016/j.jbiomech.2005.07.025; Milner CE, 2009, J ORTHOP SCI, V14, P114, DOI 10.1007/s00776-008-1285-8; Miyazaki T, 2002, ANN RHEUM DIS, V61, P617, DOI 10.1136/ard.61.7.617; Pandit H, 2008, KNEE, V15, P101, DOI 10.1016/j.knee.2007.11.008; Papagiannis GI, 2016, J ARTHROPLASTY; Patil S, 2005, J BONE JOINT SURG AM, V87A, P332, DOI 10.2106/JBJS.C.01467; PENNOCK GR, 1990, J BIOMECH, V23, P1209, DOI 10.1016/0021-9290(90)90378-G; Redfern MS, 2001, ERGONOMICS, V44, P1138, DOI 10.1080/00140130110085547; Riddle DL, 2008, J ARTHROPLASTY, V23, P408, DOI 10.1016/j.arth.2007.04.012; Schroder C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/185142; Schroer WC, 2013, J ARTHROPLASTY, V28, P116, DOI 10.1016/j.arth.2013.04.056; Shabani B, 2015, KNEE SURG SPORT TR A, V23, P3259, DOI 10.1007/s00167-014-3169-0; Shakespeare D, 2003, KNEE, V10, P357, DOI 10.1016/S0968-0160(03)00046-2; Standifird TW, 2014, J ARTHROPLASTY, V29, P1857, DOI 10.1016/j.arth.2014.03.040; Takeda K, 2014, J BIOMECH, V47, P2526, DOI 10.1016/j.jbiomech.2014.03.027; Urwin SG, 2014, KNEE, V21, P391, DOI 10.1016/j.knee.2013.10.007; Verra WC, 2015, ACTA ORTHOP, V86, P195, DOI 10.3109/17453674.2014.973329; WASIELEWSKI RC, 1994, CLIN ORTHOP RELAT R, P31; Watanabe T, 2014, J ORTHOP SCI, V19, P552, DOI 10.1007/s00776-014-0578-3; Willis-Owen CA, 2009, KNEE, V16, P473, DOI 10.1016/j.knee.2009.04.006; Winter DA, 2009, BIOMECHANICS MOTOR C, Vxiv, P370; Worsley P, 2013, CLIN BIOMECH, V28, P892, DOI 10.1016/j.clinbiomech.2013.07.014; Wu JL, 2010, AM J SPORT MED, V38, P1475, DOI 10.1177/0363546510364240; Wunschel M, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-29; Zurcher AW, 2014, KNEE, V21, P960, DOI 10.1016/j.knee.2014.05.007	60	13	14	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168566	10.1371/journal.pone.0168566	http://dx.doi.org/10.1371/journal.pone.0168566			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002437	Green Published, gold, Green Submitted			2022-12-26	WOS:000392853100055
J	Shin, HJ; Kim, MJ; Kim, HY; Roh, YH; Lee, MJ				Shin, Hyun Joo; Kim, Myung-Joon; Kim, Ha Yan; Roh, Yun Ho; Lee, Mi-Jung			Optimal Acquisition Number for Hepatic Shear Wave Velocity Measurements in Children	PLOS ONE			English	Article							RADIATION FORCE IMPULSE; LIVER FIBROSIS; ULTRASOUND ELASTOGRAPHY; TRANSIENT ELASTOGRAPHY; SPLEEN STIFFNESS; REPRODUCIBILITY; REPEATABILITY; ELASTICITY; ACCURACY; TIMES	Objective To investigate the minimum optimal acquisition number of hepatic shear wave velocities (SWVs) on ultrasound elastography in children. Materials and Methods We prospectively performed hepatic supersonic shear wave elastography in children of four groups (group A-C, healthy children, group A with 0-5 years old; group B with 6-10 years old; group C with 11-18 years old; and group D, children with previous Kasai operation) with free breathing (FB) and breath holding (BH) status, if possible. SWVs were measured fifteen times for each child at a 4 cm depth for the right lobe using a 1-6 MHz convex transducer. Mean SWVs from three, five, and seven acquisitions were compared to the mean SWV from fifteen measurements, using an intraclass correlation coefficient (ICC) analyzed with the 1,000 times bootstrap method. Results Total eighty-eight children were included (25 children in group A, 30 children in group B, 21 children in group C, and 12 children in group D). The mean SWVs from fifteen measurements in FB status were 5.5-1.3 kPa for groups A-C together and 8.0 +/- 2.2 kPa for group D. For all groups together, mean SWVs from the three (ICC 0.944 and 0.937), five (ICC 0.958 and 0.938) and seven (ICC 0.969 and 0.941) acquisitions demonstrated almost perfect agreement with the reference of fifteen acquisitions in both FB and BH status, respectively. A subgroup analysis showed three measurements were in almost perfect agreement during FB for groups B-D and strong agreement (ICC 0.675) for group A. Conclusion Three acquisitions can be enough for hepatic SWVs in children more than 6 years old regardless of breathing status or hepatic pathology. More acquisitions are recommended for children under the age of 5 years during FB.	[Shin, Hyun Joo; Kim, Myung-Joon; Lee, Mi-Jung] Severance Childrens Hosp, Dept Radiol, Seoul, South Korea; [Shin, Hyun Joo; Kim, Myung-Joon; Lee, Mi-Jung] Severance Childrens Hosp, Res Inst Radiol Sci, Seoul, South Korea; [Kim, Ha Yan; Roh, Yun Ho] Yonsei Univ, Coll Med, Biostat Collaborat Unit, Seoul, South Korea	Yonsei University; Yonsei University Health System	Lee, MJ (corresponding author), Severance Childrens Hosp, Dept Radiol, Seoul, South Korea.; Lee, MJ (corresponding author), Severance Childrens Hosp, Res Inst Radiol Sci, Seoul, South Korea.	mjl1213@yuhs.ac	Shin, Hyun Joo/AAG-2016-2019	Shin, Hyun Joo/0000-0002-7462-2609; Kim, Myung-Joon/0000-0002-4608-0275; Lee, Mi-Jung/0000-0003-3244-9171				Barr RG, 2015, RADIOLOGY, V276, P845, DOI 10.1148/radiol.2015150619; Cha SW, 2014, J ULTRAS MED, V33, P53, DOI 10.7863/ultra.33.1.53; Choi SH, 2016, ULTRASONICS, V72, P158, DOI 10.1016/j.ultras.2016.08.005; Dillman JR, 2015, PEDIATR RADIOL, V45, P376, DOI 10.1007/s00247-014-3150-6; Ferraioli G, 2015, ULTRASOUND MED BIOL, V41, P1161, DOI 10.1016/j.ultrasmedbio.2015.03.007; Ferraioli G, 2014, EUR RADIOL, V24, P1283, DOI 10.1007/s00330-014-3140-y; Ferraioli G, 2012, HEPATOLOGY, V56, P2125, DOI 10.1002/hep.25936; Ferraioli G, 2012, EUR J RADIOL, V81, P3102, DOI 10.1016/j.ejrad.2012.05.030; Fontanilla T, 2014, ULTRASOUND MED BIOL, V40, P470, DOI 10.1016/j.ultrasmedbio.2013.10.024; Friedrich-Rust M, 2009, RADIOLOGY, V252, P595, DOI 10.1148/radiol.2523081928; Gennisson J-L, 2013, Diagn Interv Imaging, V94, P487, DOI 10.1016/j.diii.2013.01.022; Huang ZP, 2014, WORLD J GASTROENTERO, V20, P9578, DOI 10.3748/wjg.v20.i28.9578; Lee MJ, 2013, EUR J RADIOL, V82, pE290, DOI 10.1016/j.ejrad.2013.01.018; Park MK, 2014, ULTRASONOGRAPHY, V33, P26, DOI 10.14366/usg.13017; PICCININO F, 1986, J HEPATOL, V2, P165, DOI 10.1016/S0168-8278(86)80075-7; Pinto RB, 2015, WORLD J HEPATOL, V7, P392, DOI 10.4254/wjh.v7.i3.392; Rizzo L, 2011, AM J GASTROENTEROL, V106, P2112, DOI 10.1038/ajg.2011.341; Sohn B, 2014, ULTRASONOGRAPHY, V33, P116, DOI 10.14366/usg.14002; Sporea I, 2013, MED ULTRASON, V15, P268; Zaleska-Dorobisz U, 2014, ADV CLIN EXP MED, V23, P645, DOI 10.17219/acem/26301; Zeng J, 2014, EUR RADIOL, V24, P2572, DOI 10.1007/s00330-014-3292-9	21	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168758	10.1371/journal.pone.0168758	http://dx.doi.org/10.1371/journal.pone.0168758			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002480	Green Submitted, gold, Green Published			2022-12-26	WOS:000392853100064
J	de Alvarenga, EC; Fonseca, MD; Carvalho, CC; Florentino, RM; Franca, A; Matias, E; Guimaraes, PB; Batista, C; Freire, V; Carmona, AK; Pesquero, JB; de Paula, AM; Foureaux, G; Leite, MD				de Alvarenga, Erika Costa; Fonseca, Matheus de Castro; Carvalho, Clarissa Coelho; Florentino, Rodrigo Machado; Franca, Andressa; Matias, Eveline; Guimaraes, Paola Bianchi; Batista, Carolina; Freire, Valder; Carmona, Adriana Karaoglanovic; Pesquero, Joao Bosco; de Paula, Ana Maria; Foureaux, Giselle; Leite, Maria de Fatima			Angiotensin Converting Enzyme Regulates Cell Proliferation and Migration	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION; RECEPTOR BLOCKERS; SWISS 3T3-CELLS; CALCIUM SIGNALS; ACE-INHIBITORS; C-BETA; SYSTEM; ACTIVATION; MECHANISMS; CANCER	Background The angiotensin-I converting enzyme (ACE) plays a central role in the renin-angiotensin system, acting by converting the hormone angiotensin-I to the active peptide angiotensin-II (Ang-II). More recently, ACE was shown to act as a receptor for Ang-II, and its expression level was demonstrated to be higher in melanoma cells compared to their normal counterparts. However, the function that ACE plays as an Ang-II receptor in melanoma cells has not been defined yet. Aim Therefore, our aim was to examine the role of ACE in tumor cell proliferation and migration. Results We found that upon binding to ACE, Ang-II internalizes with a faster onset compared to the binding of Ang-II to its classical AT1 receptor. We also found that the complex Ang-II/ACE translocates to the nucleus, through a clathrin-mediated process, triggering a transient nuclear Ca2+ signal. In silico studies revealed a possible interaction site between ACE and phospholipase C (PLC), and experimental results in CHO cells, demonstrated that the beta 3 isoform of PLC is the one involved in the Ca2+ signals induced by Ang-II/ACE interaction. Further studies in melanoma cells (TM-5) showed that Ang-II induced cell proliferation through ACE activation, an event that could be inhibited either by ACE inhibitor (Lisinopril) or by the silencing of ACE. In addition, we found that stimulation of ACE by Ang-II caused the melanoma cells to migrate, at least in part due to decreased vinculin expression, a focal adhesion structural protein. Conclusion ACE activation regulates melanoma cell proliferation and migration.	[de Alvarenga, Erika Costa; Fonseca, Matheus de Castro; Carvalho, Clarissa Coelho; Florentino, Rodrigo Machado; Franca, Andressa; Foureaux, Giselle; Leite, Maria de Fatima] Univ Fed Minas Gerais, Dept Physiol & Biophys, Belo Horizonte, MG, Brazil; [de Alvarenga, Erika Costa] Univ Fed Sao Joao del Rei, Dept Nat Sci, Sao Joao Del Rei, MG, Brazil; [Matias, Eveline; Freire, Valder] Univ Fed Ceara, Dept Phys, Fortaleza, CE, Brazil; [Guimaraes, Paola Bianchi; Batista, Carolina; Carmona, Adriana Karaoglanovic; Pesquero, Joao Bosco] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, SP, Brazil; [de Paula, Ana Maria] Univ Fed Minas Gerais, Dept Phys, Belo Horizonte, MG, Brazil; [Foureaux, Giselle] Univ Fed Minas Gerais, Dept Morphol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Sao Joao del-Rei; Universidade Federal do Ceara; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Leite, MD (corresponding author), Univ Fed Minas Gerais, Dept Physiol & Biophys, Belo Horizonte, MG, Brazil.	leitemd@ufmg.br	Freire, Valder Nogueira/GLV-3915-2022; de Fatima Leite, Maria/AAK-2555-2021; Carmona, Adriana K/D-2240-2012; Bezerra, Eveline Matias/M-3962-2014; De Paula, Alfredo Maurício Batista/K-3015-2012; Freire, Valder N/D-1136-2013; Alvarenga, Erika Costa/P-7596-2018; Fonseca, Matheus/GYU-2786-2022; de Paula, Ana Maria/D-2437-2010; Fonseca, Matheus C./L-8006-2017; Fonseca, Matheus C./O-9213-2019	Freire, Valder Nogueira/0000-0001-7867-3908; Carmona, Adriana K/0000-0003-3311-5456; Bezerra, Eveline Matias/0000-0002-2210-0526; De Paula, Alfredo Maurício Batista/0000-0002-8715-0030; Freire, Valder N/0000-0001-7867-3908; Alvarenga, Erika Costa/0000-0002-9480-9761; de Paula, Ana Maria/0000-0002-8551-5948; Fonseca, Matheus C./0000-0001-9048-9775; Fonseca, Matheus C./0000-0001-9048-9775	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); INCT Nanocarbono - UFMG (Brazil)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); INCT Nanocarbono - UFMG (Brazil)	This research was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and INCT Nanocarbono - UFMG (Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya KR, 2003, NAT REV DRUG DISCOV, V2, P891, DOI 10.1038/nrd1227; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Amaya MJ, 2014, HEPATOLOGY, V59, P274, DOI 10.1002/hep.26609; Andrade LM, 2012, J CANC SCI THER, V4, P131, DOI DOI 10.4172/1948-5956.1000127; Azizi M, 2000, J HYPERTENS, V18, P1139, DOI 10.1097/00004872-200018080-00020; Bhuiyan MA, 2010, J PHARMACOL SCI, V112, P459, DOI 10.1254/jphs.09343SC; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Caughey GH, 2007, IMMUNOL REV, V217, P141, DOI 10.1111/j.1600-065X.2007.00509.x; Christian JB, 2008, JNCI-J NATL CANCER I, V100, P1223, DOI 10.1093/jnci/djn262; COCCO L, 1988, BIOCHEM BIOPH RES CO, V154, P1266, DOI 10.1016/0006-291X(88)90276-8; Correa M, 2005, INT J CANCER, V114, P356, DOI 10.1002/ijc.20673; Damsky WE, 2014, ONCOGENE, V33, P2413, DOI 10.1038/onc.2013.194; De Groot-Besseling RRJ, 2004, INT J CANCER, V112, P329, DOI 10.1002/ijc.20400; Deshayes F, 2005, TRENDS ENDOCRIN MET, V16, P293, DOI 10.1016/j.tem.2005.07.009; DIVECHA N, 1991, EMBO J, V10, P3207, DOI 10.1002/j.1460-2075.1991.tb04883.x; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Echevarria W, 2003, NAT CELL BIOL, V5, P440, DOI 10.1038/ncb980; Egami K, 2003, J CLIN INVEST, V112, P67, DOI 10.1172/JCI200316645; FERRARIO CM, 1990, J CARDIOVASC PHARM, V15, pS1, DOI 10.1097/00005344-199000153-00001; Fleming I, 2006, CIRC RES, V98, P887, DOI 10.1161/01.RES.0000217340.40936.53; Fuchs S, 2008, HYPERTENSION, V51, P267, DOI 10.1161/HYPERTENSIONAHA.107.097865; Fyhrquist F, 2008, J INTERN MED, V264, P224, DOI 10.1111/j.1365-2796.2008.01981.x; George AJ, 2010, NAT REV CANCER, V10, P745, DOI 10.1038/nrc2945; Gomes DA, 2008, J BIOL CHEM, V283, P4344, DOI 10.1074/jbc.M706550200; Gonzalez-Villalobos RA, 2013, J CLIN INVEST, V123, P2011, DOI 10.1172/JCI65460; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Guimaraes PB, 2001, HYPERTENSION, V57, P965; Hooper NM, 2003, NAT STRUCT BIOL, V10, P155, DOI 10.1038/nsb0303-155; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Inducible K, 2003, NATURE, V1429, P1427; Izaurralde E, 1998, RNA, V4, P351; JOHNSTON CI, 1993, KIDNEY INT, V44, pS59; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Kapoor M, 2008, J CLIN INVEST, V118, P3279, DOI 10.1172/JCI35381; Kim CG, 1996, J BIOL CHEM, V271, P21187, DOI 10.1074/jbc.271.35.21187; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Kohlstedt K, 2005, HYPERTENSION, V45, P126, DOI 10.1161/01.HYP.0000150159.48992.11; Kohlstedt K, 2004, CIRC RES, V94, P60, DOI 10.1161/01.RES.0000107195.13573.E4; Koss H, 2014, TRENDS BIOCHEM SCI, V39, P603, DOI 10.1016/j.tibs.2014.09.004; Kule CE, 2004, REGUL PEPTIDES, V120, P141, DOI 10.1016/j.regpep.2004.03.001; Ladeira MS, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/38/385101; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; LEITE MF, 1994, AM J PHYSIOL-HEART C, V267, pH2193, DOI 10.1152/ajpheart.1994.267.6.H2193; Lever AF, 1998, LANCET, V352, P179, DOI 10.1016/S0140-6736(98)03228-0; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lucero HA, 2010, J BIOL CHEM, V285, P5555, DOI 10.1074/jbc.M109.074740; MANZOLI L, 1995, CANCER RES, V55, P2978; MARTELLI AM, 1992, NATURE, V358, P242, DOI 10.1038/358242a0; Masuyer G, 2014, BIOL CHEM, V395, P1135, DOI 10.1515/hsz-2014-0157; Masuyer G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00717; MENARD J, 1991, HYPERTENSION, V18, P257, DOI 10.1161/01.HYP.18.3.257; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Oliveira AG, 2014, PHYSIOLOGY, V29, P361, DOI 10.1152/physiol.00056.2013; Petrel C, 2009, MOL CELL ENDOCRINOL, V302, P176, DOI 10.1016/j.mce.2008.10.049; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Ritter JM, 2011, BRIT J CLIN PHARMACO, V71, P313, DOI 10.1111/j.1365-2125.2011.03918.x; Rodrigues MA, 2009, BRAZ J MED BIOL RES, V42, P17, DOI 10.1590/S0100-879X2008005000050; Rodrigues MA, 2008, HEPATOLOGY, V48, P1621, DOI 10.1002/hep.22424; Rodrigues MA, 2007, J BIOL CHEM, V282, P17061, DOI 10.1074/jbc.M700490200; Rodrigues-Ferreira S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035667; Sabatini RA, 2007, ANAL BIOCHEM, V363, P255, DOI 10.1016/j.ab.2007.01.020; Sica Domenic A, 2007, J Clin Hypertens (Greenwich), V9, P78; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Stergiou GS, 2000, J CARDIOVASC PHARM, V35, P937, DOI 10.1097/00005344-200006000-00017; Taddei S, 2015, AM J CARDIOVASC DRUG, V15, P185, DOI 10.1007/s40256-015-0116-5; Thievessen I, 2015, FASEB J, V29, P4555, DOI 10.1096/fj.14-268235; THOMAS WG, 1995, J BIOL CHEM, V270, P22153, DOI 10.1074/jbc.270.38.22153; Touyz RM, 2000, PHARMACOL REV, V52, P639; van Esch JHM, 2005, HYPERTENSION, V45, P120, DOI 10.1161/01.HYP.0000151323.93372.f5; VANDENMEIRACKER AH, 1992, J HYPERTENS, V10, P803; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438; Wang RF, 2012, EXP EYE RES, V94, P146, DOI 10.1016/j.exer.2011.11.019; Watermeyer J. M., 2009, CURRENT ENZYME INHIB, V5, P134, DOI DOI 10.2174/157340809789071155; Yasumatsu R, 2004, J CANCER RES CLIN, V130, P567, DOI 10.1007/s00432-004-0582-7; YORK JD, 1994, J BIOL CHEM, V269, P19992	77	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0165371	10.1371/journal.pone.0165371	http://dx.doi.org/10.1371/journal.pone.0165371			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992423	Green Published, gold			2022-12-26	WOS:000392842600004
J	Luiz, LB; Brito, CLD; Debon, LM; Brandalise, LN; de Azevedo, JT; Monbach, KD; Heberle, LS; Mottin, CC				Luiz, Luciano Billodre; de Souza Brito, Cesar Luis; Debon, Leticia Manoel; Brandalise, Livia Nora; de Azevedo, Juliana Tainski; Monbach, Karin Daniele; Heberle, Luisa Schmidt; Mottin, Claudio Cora			Variation of Binge Eating One Year after Rouxen-Y Gastric Bypass and Its Relationship with Excess Weight Loss	PLOS ONE			English	Article							BARIATRIC SURGERY CANDIDATES; PSYCHIATRIC-DISORDERS; FOLLOW-UP; OUTCOMES; RESPONSIVITY; BEHAVIOR; INCREASES; OBESITY; SCALE; FOODS	Background Bariatric surgery is the most effective treatment for obesity classes II and III. However, some patients do not get the desired results or initially lose and then regain the lost weight. Identifying these individuals early on and treating them adequately remains a challenge. As binge eating directly affects food intake, the study of this symptom and its relation to bariatric surgery and its results is increasing, because it appears to have an influence on the results of surgery. Objectives This study aimed to see how binge eating changes, measured with the Binge Eating Scale, interferes in the % excess weight loss one year after Roux-en-Y gastric bypass. Methods We conducted a cross-sectional study with 149 patients older than 18 years who were evaluated one year after undergoing Roux-en-Y gastric bypass. The variation in the intensity of binge eating was measured with the pre- and postoperative Binge Eating Scale scores. Results The variation of one unit in the Binge Eating Scale implied an inverse variation of 0.41% of % excess weight loss (p<0.05). The correlation coefficient between the variation of binge eating and the % excess weight loss was -0.186 (p = 0.033). The correlation coefficient between the binge eating symptoms one year after surgery and the % excess weight loss was -0.353 (p<0.001). Conclusions There was a correlation between the variation of binge eating one year after gastric bypass and the % excess weight loss. The correlation between binge eating and the % excess weight loss was greater after the surgery than it was at the preoperative stage. This study provides new, valuable information on the intensity and variation of binge eating symptoms one year after gastric bypass, which, to the best of our knowledge, have not been studied in depth earlier.	[Luiz, Luciano Billodre; de Souza Brito, Cesar Luis; Debon, Leticia Manoel; Brandalise, Livia Nora; de Azevedo, Juliana Tainski; Monbach, Karin Daniele; Heberle, Luisa Schmidt; Mottin, Claudio Cora] Pontificial Catholic Univ Rio Grande Sul, Sao Lucas Hosp, Ctr Obes & Metab Syndrome, Porto Alegre, RS, Brazil; [de Souza Brito, Cesar Luis; Mottin, Claudio Cora] Pontificial Catholic Univ Rio Grande Sul, Fac Med, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul	Luiz, LB (corresponding author), Pontificial Catholic Univ Rio Grande Sul, Sao Lucas Hosp, Ctr Obes & Metab Syndrome, Porto Alegre, RS, Brazil.	lbluiz@icloud.com	de Souza Brito, Cesar Luis/AAG-9984-2019	de Souza Brito, Cesar Luis/0000-0002-2509-7270				Beck NN, 2012, EAT BEHAV, V13, P394, DOI 10.1016/j.eatbeh.2012.06.001; Berridge KC, 2010, BRAIN RES, V1350, P43, DOI 10.1016/j.brainres.2010.04.003; Bocchieri-Ricciardi LE, 2006, OBES SURG, V16, P1198, DOI 10.1381/096089206778392194; Bruce AS, 2014, OBESITY, V22, P337, DOI 10.1002/oby.20630; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Frank S, 2014, INT J OBESITY, V38, P341, DOI 10.1038/ijo.2013.60; Freitas Silvia, 2001, Revista Brasileira de Psiquiatria, V23, P215; GORMALLY J, 1982, ADDICT BEHAV, V7, P47, DOI 10.1016/0306-4603(82)90024-7; Grupski AE, 2013, OBES SURG, V23, P1, DOI 10.1007/s11695-011-0537-4; Hood MM, 2013, SURG OBES RELAT DIS, V9, P942, DOI 10.1016/j.soard.2012.06.013; Karmali S, 2013, OBES SURG, V23, P1922, DOI 10.1007/s11695-013-1070-4; Larsen JK, 2004, OBES SURG, V14, P1111, DOI 10.1381/0960892041975587; Livhits M, 2012, OBES SURG, V22, P70, DOI 10.1007/s11695-011-0472-4; Meany G, 2014, EUR EAT DISORD REV, V22, P87, DOI 10.1002/erv.2273; Ochner CN, 2012, NEUROSCIENCE, V209, P128, DOI 10.1016/j.neuroscience.2012.02.030; Petry NM, 2008, PSYCHOSOM MED, V70, P288, DOI 10.1097/PSY.0b013e3181651651; Sallet PC, 2007, OBES SURG, V17, P445, DOI 10.1007/s11695-007-9077-3; Scholtz S, 2007, OBES SURG, V17, P1220, DOI 10.1007/BF02802094; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824; Stice E, 2013, NEUROIMAGE, V67, P322, DOI 10.1016/j.neuroimage.2012.11.028; Stice E, 2010, NEUROIMAGE, V50, P1618, DOI 10.1016/j.neuroimage.2010.01.081; Wadden TA, 2011, OBESITY, V19, P1220, DOI 10.1038/oby.2010.336; White MA, 2010, J CLIN PSYCHIAT, V71, P175, DOI 10.4088/JCP.08m04328blu; Williams LJ, 2009, J AFFECT DISORDERS, V118, P173, DOI 10.1016/j.jad.2009.02.001; Wood KV, 2012, APPETITE, V59, P177, DOI 10.1016/j.appet.2012.04.019	25	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0167577	10.1371/journal.pone.0167577	http://dx.doi.org/10.1371/journal.pone.0167577			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992541	gold, Green Published, Green Submitted			2022-12-26	WOS:000392842600015
J	Reineri, S; Agati, S; Miano, V; Sani, M; Berchialla, P; Ricci, L; Iannello, A; Tarrero, LC; Cutrupi, S; De Bortoli, M				Reineri, Stefania; Agati, Silvia; Miano, Valentina; Sani, Monica; Berchialla, Paola; Ricci, Laura; Iannello, Andrea; Tarrero, Lucia Coscujuela; Cutrupi, Santina; De Bortoli, Michele			A Novel Functional Domain of Tab2 Involved in the Interaction with Estrogen Receptor Alpha in Breast Cancer Cells	PLoS One			English	Article							NF-KAPPA-B; ADAPTER PROTEIN; PATHWAY; TAK1; IL-1; PHOSPHORYLATION; ACTIVATION; RESISTANCE; KINASE; ROLES	Tab2, originally described as a component of the inflammatory pathway, has been implicated in phenomena of gene de-repression in several contexts, due to its ability to interact with the NCoR corepressor. Tab2 interacts also with steroid receptors and dismisses NCoR from antagonist-bound Estrogen and Androgen Receptors on gene regulatory regions, thus modifying their transcriptional activity and leading to pharmacological resistance in breast and prostate cancer cells. We demonstrated previously that either Tab2 knock-down, or a peptide mimicking the Estrogen Receptor alpha domain interacting with Tab2, restore the antiproliferative response to Tamoxifen in Tamoxifen-resistant breast cancer cells. In this work, we map the domain of Tab2 responsible of Estrogen Receptor alpha interaction. First, using both co-immunoprecipitation and pull-down with recombinant proteins, we found that the central part of Tab2 is primarily responsible for this interaction, and that this region also interacts with Androgen Receptor. Then, we narrowed down the essential interaction region by means of competition assays using recombinant protein pull-down. The interaction motif was finally identified as a small region adjacent to, but not overlapping, the Tab2 MEKK1 phosphorylation sites. A synthetic peptide mimicking this motif efficiently displaced Tab2 from interacting with recombinant Estrogen Receptor alpha in vitro, prompting us to test its efficacy using derivatives of the MCF7 breast carcinoma cell lines that are spontaneously resistant to Tamoxifen. Indeed, we observed that this mimic peptide, made cell-permeable by addition of the TAT minimal carrier domain, reduced the growth of Tamoxifen-resistant MCF7 cells in the presence of Tamoxifen. These data indicate a novel functional domain of the Tab2 protein with potential application in drug design.	[Reineri, Stefania; Miano, Valentina; Berchialla, Paola; Ricci, Laura; Iannello, Andrea; Tarrero, Lucia Coscujuela; Cutrupi, Santina; De Bortoli, Michele] Univ Turin, Dept Clin & Biol Sci, Turin, Italy; [Agati, Silvia; Ricci, Laura] Bioind Pk Silvano Fumero, Turin, Italy; [Miano, Valentina; Cutrupi, Santina; De Bortoli, Michele] Univ Turin, Ctr Mol Syst Biol, Turin, Italy; [Sani, Monica] CNR, Icrm Inst Chem Mol Recognit, Milan, Italy	University of Turin; University of Turin; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR)	De Bortoli, M (corresponding author), Univ Turin, Dept Clin & Biol Sci, Turin, Italy.; De Bortoli, M (corresponding author), Univ Turin, Ctr Mol Syst Biol, Turin, Italy.	michele.debortoli@unito.it	MIANO, VALENTINA/AGB-5923-2022; cutrupi, santina/AAC-4479-2022; Berchialla, Paola/A-3208-2009; Miano, Valentina/K-3716-2018	MIANO, VALENTINA/0000-0002-0260-5885; Berchialla, Paola/0000-0001-5835-5638; Miano, Valentina/0000-0002-0260-5885; Iannello, Andrea/0000-0001-8940-1406; CUTRUPI, SANTINA/0000-0002-2358-5852; De Bortoli, Michele/0000-0002-6666-9052	AIRC (Associazione Italiana per la Ricerca sul Cancro) [IG 15600]; Fondazione CRT [2014.1854]; Universita degli Studi di Torino, Ricerca Locale	AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); Fondazione CRT(Fondazione CRT); Universita degli Studi di Torino, Ricerca Locale	Support was provided by AIRC (Associazione Italiana per la Ricerca sul Cancro, www.airc.it) grant IG 15600, to MDB, project concerning molecules determining subtypes of breast cancer; Fondazione CRT (www.fondazionecrt.it) grant 2014.1854, to MDB, project on IncRNAs expression to characterize breast cancer subtypes; and Universita degli Studi di Torino, Ricerca Locale 2014, to MDB, project on Molecular Determinants of Human Disease.	Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Bian YY, 2014, J PROTEOMICS, V96, P253, DOI 10.1016/j.jprot.2013.11.014; Broglie P, 2010, J BIOL CHEM, V285, P2333, DOI 10.1074/jbc.M109.090522; Brosens JJ, 2006, CELL, V124, P466, DOI 10.1016/j.cell.2006.01.023; Cutrupi S, 2012, ONCOGENE, V31, P4353, DOI 10.1038/onc.2011.627; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Mendoza H, 2008, BIOCHEM J, V409, P711, DOI 10.1042/BJ20071149; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; Shin MS, 2009, BBA-MOL CELL RES, V1793, P1156, DOI 10.1016/j.bbamcr.2009.04.005; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Thrane S, 2013, BREAST CANCER RES TR, V139, P71, DOI 10.1007/s10549-013-2485-2; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; Wang B, 2003, J BIOL CHEM, V278, P20225, DOI 10.1074/jbc.M300459200; Zhu P, 2006, CELL, V124, P615, DOI 10.1016/j.cell.2005.12.032	20	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168639	10.1371/journal.pone.0168639	http://dx.doi.org/10.1371/journal.pone.0168639			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992601	Green Submitted, Green Published, gold			2022-12-26	WOS:000392842600084
J	Akinola, M; Fridman, I; Mor, S; Morris, MW; Crum, AJ				Akinola, Modupe; Fridman, Ilona; Mor, Shira; Morris, Michael W.; Crum, Alia J.			Adaptive Appraisals of Anxiety Moderate the Association between Cortisol Reactivity and Performance in Salary Negotiations	PLOS ONE			English	Article							DECISION-MAKING; GENDER-DIFFERENCES; STRESS; RESPONSES; EMOTION; BEHAVIOR; OUTCOMES; AROUSAL; THREAT; BRAIN	Prior research suggests that stress can be harmful in high-stakes contexts such as negotiations. However, few studies actually measure stress physiologically during negotiations, nor do studies offer interventions to combat the potential negative effects of heightened physiological responses in negotiation contexts. In the current research, we offer evidence that the negative effects of cortisol increases on negotiation performance can be reduced through a reappraisal of anxiety manipulation. We experimentally induced adaptive appraisals by randomly assigning 97 male and female participants to receive either instructions to appraise their anxiety as beneficial to the negotiation or no specific instructions on how to appraise the situation. We also measured participants' cortisol responses prior to and following the negotiation. Results revealed that cortisol increases were positively related to negotiation performance for participants who were told to view anxiety as beneficial, and not detrimental, for negotiation performance (appraisal condition). In contrast, cortisol increases were negatively related to negotiation performance for participants given no instructions on appraising their anxiety (control condition). These findings offer a means through which to combat the potentially deleterious effects of heightened cortisol reactivity on negotiation outcomes.	[Akinola, Modupe; Fridman, Ilona; Morris, Michael W.] Columbia Univ, Columbia Business Sch, New York, NY 10027 USA; [Mor, Shira] Tel Aviv Univ, Tel Aviv, Israel; [Crum, Alia J.] Stanford Univ, Dept Psychol, Stanford, CA USA	Columbia University; Tel Aviv University; Stanford University	Akinola, M (corresponding author), Columbia Univ, Columbia Business Sch, New York, NY 10027 USA.	makinola@columbia.edu		Akinola, Modupe/0000-0002-1219-2543				Akinola M, 2014, SOC PSYCHOL PERS SCI, V5, P43, DOI 10.1177/1948550613485604; Akinola M, 2012, BEHAV NEUROSCI, V126, P167, DOI 10.1037/a0026657; [Anonymous], 2011, GETTING YES NEGOTIAT; Babcock L., 2012, GENDER DIFFERENCES P, P239; Beltzer ML, 2014, EMOTION, V14, P761, DOI 10.1037/a0036326; Blascovich J., 2010, HDB SOCIAL PSYCHOL, V5th ed., P194, DOI DOI 10.1002/9780470561119.SOCPSY001006; Bos MGN, 2014, PSYCHONEUROENDOCRINO, V50, P72, DOI 10.1016/j.psyneuen.2014.07.030; Bowles HR, 2007, ORGAN BEHAV HUM DEC, V103, P84, DOI 10.1016/j.obhdp.2006.09.001; Brooks AW, 2011, ORGAN BEHAV HUM DEC, V115, P43, DOI 10.1016/j.obhdp.2011.01.008; Cahill L, 2003, LEARN MEMORY, V10, P270, DOI 10.1101/lm.62403; Crum AJ, 2013, J PERS SOC PSYCHOL, V104, P716, DOI 10.1037/a0031201; DALY JA, 1989, PERS INDIV DIFFER, V10, P903, DOI 10.1016/0191-8869(89)90025-1; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Galinsky AD, 2002, PERS SOC PSYCHOL B, V28, P271, DOI 10.1177/0146167202282012; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Hancock PA, 2005, THEOR ISS ERGON SCI, V6, P193, DOI 10.1080/14639220512331325747; Hayes A. F., 2013, INTRODUCTION TO MEDI; Jamieson JP, 2013, CURR DIR PSYCHOL SCI, V22, P51, DOI 10.1177/0963721412461500; Jamieson JP, 2010, J EXP SOC PSYCHOL, V46, P208, DOI 10.1016/j.jesp.2009.08.015; Josephs RA, 2006, J PERS SOC PSYCHOL, V90, P999, DOI 10.1037/0022-3514.90.6.999; Kassam KS, 2009, PSYCHOL SCI, V20, P1394, DOI 10.1111/j.1467-9280.2009.02455.x; Kray LJ, 2002, ORGAN BEHAV HUM DEC, V87, P386, DOI 10.1006/obhd.2001.2979; Lautenbach F, 2014, PSYCHONEUROENDOCRINO, V42, P218, DOI 10.1016/j.psyneuen.2014.01.011; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Mauss IB, 2005, EMOTION, V5, P175, DOI 10.1037/1528-3542.5.2.175; Mazei J, 2015, PSYCHOL BULL, V141, P85, DOI 10.1037/a0038184; McEwen BS, 2005, METABOLISM, V54, P20, DOI 10.1016/j.metabol.2005.01.008; Mendes WB, 2008, J PERS SOC PSYCHOL, V94, P278, DOI 10.1037/0022-3514.94.2.278; Mor S., 2014, IRON FIST VELVET GLO; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; O'Connor KM, 2010, J EXP SOC PSYCHOL, V46, P729, DOI 10.1016/j.jesp.2010.04.007; Page-Gould E, 2015, GROUP PROCESS INTERG, V18, P366, DOI 10.1177/1368430214556371; Radenbach C, 2015, PSYCHONEUROENDOCRINO, V53, P268, DOI 10.1016/j.psyneuen.2014.12.017; SCHACHTER S, 1962, PSYCHOL REV, V69, P379, DOI 10.1037/h0046234; Schaerer M, 2015, PSYCHOL SCI, V26, P170, DOI 10.1177/0956797614558718; Selye H, 1950, PHYSL PATHOLOGY EXPO; Senn S, 2006, STAT MED, V25, P4334, DOI 10.1002/sim.2682; Smyth N, 2013, SOC PERSONAL PSYCHOL, V7, P605, DOI 10.1111/spc3.12057; Starcke K, 2011, PSYCHONEUROENDOCRINO, V36, P210, DOI 10.1016/j.psyneuen.2010.07.010; Starcke K, 2008, BEHAV NEUROSCI, V122, P1352, DOI 10.1037/a0013281; Stuhlmacher AF, 2006, GENDER COMMUNICATION, P211; TOMAKA J, 1993, J PERS SOC PSYCHOL, V65, P248, DOI 10.1037/0022-3514.65.2.248; van den Bos R, 2009, PSYCHONEUROENDOCRINO, V34, P1449, DOI 10.1016/j.psyneuen.2009.04.016	43	13	13	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0167977	10.1371/journal.pone.0167977	http://dx.doi.org/10.1371/journal.pone.0167977			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8LN	27992484	Green Published, Green Submitted, gold			2022-12-26	WOS:000392758000019
J	Feng, LP; Ransom, CE; Nazzal, MK; Allen, TK; Li, YJ; Truong, T; Potts, LC; Seed, PC; Murtha, AP				Feng, Liping; Ransom, Carla E.; Nazzal, Matthew K.; Allen, Terrence K.; Li, Yi-Ju; Truong, Tracy; Potts, Lauren C.; Seed, Patrick C.; Murtha, Amy P.			The Role of Progesterone and a Novel Progesterone Receptor, Progesterone Receptor Membrane Component 1, in the Inflammatory Response of Fetal Membranes to Ureaplasma parvum Infection	PLOS ONE			English	Article							PRETERM PREMATURE RUPTURE; AMNIOTIC-FLUID; INTRAUTERINE INFECTION; HUMAN-PLACENTA; UREALYTICUM; EXPRESSION; CHORIOAMNIONITIS; ASSOCIATION; CELLS; BIRTH	Ureaplasma parvum (U. parvum) is gaining recognition as an important pathogen for chorioamnionitis and preterm premature rupture of membranes. We aimed to investigate the roles of progesterone (P4) and a novel progesterone receptor, progesterone receptor membrane component 1 (PGRMC1), in the response of fetal membranes to U. parvum. Fetal membrane cells (amnion, chorion and decidua) were isolated and confirmed to be free of Mycoplasmataceae. Cells were treated with U. parvum (5x10(6) CFU), and adherence was quantified by qPCR. Amnion and chorion cells were transfected with scrambled siRNA or validated PGRMC1 siRNA for 72h. Cells were then treated with U. parvum for 4h with or without pretreatment with P4 (10(-7) M) or ethanol for 1h. Interleukin-8 (IL-8), matrix metalloproteinase 9 (MMP9) and cyclooxygenase (COX-2) mRNA expression were quantified by qRT-PCR. Culture medium was harvested and analyzed for IL-8 and prostaglandin (PGE2) secretion by ELISA and MMP9 activity by zymography. U. parvum had a mean adherence of 15.0+/-0.6%, 16.9+/-3.7% and 4.7+/-0.3% in cultured amnion, chorion and decidua cells, respectively. Exposure to U. parvum elicited significant inflammatory responses including induction of IL-8, COX-2, PGE2 and MMP9. A possible role of PGRMC1 was identified in the inhibition of U. parvum-stimulated COX-2 and MMP9 mRNA expression in chorion cells and MMP9 activity in amnion cells. On the other hand, it might enhance the U. parvum-stimulated IL-8 protein secretion in amnion cells. P4, mediated through PGRMC1, significantly inhibited U. Parvum-induced MMP9 mRNA and COX-2 mRNA expression in chorion cells. P4 appeared to attenuate U. parvum induced IL-8 mRNA expression in chorion cells, but this P4 effect might not mediated through PGRMC1. In summary, U. parvum preferentially adheres to and induces inflammatory responses in chorion and amnion cells. P4 and PGRMC1 appear to differentially modulate the inflammatory responses induced by U. parvum among amnion and chorion cells.	[Feng, Liping; Ransom, Carla E.; Nazzal, Matthew K.; Potts, Lauren C.; Murtha, Amy P.] Duke Univ, Dept Obstet & Gynecol, Durham, NC 27708 USA; [Allen, Terrence K.] Duke Univ, Dept Anesthesiol, Durham, NC USA; [Li, Yi-Ju; Truong, Tracy] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA; [Seed, Patrick C.] Duke Univ, Dept Pediat, Durham, NC 27706 USA	Duke University; Duke University; Duke University; Duke University	Feng, LP (corresponding author), Duke Univ, Dept Obstet & Gynecol, Durham, NC 27708 USA.	feng0007@mc.duke.edu		Li, Yi-Ju/0000-0001-6996-4834	Charles Hammond Fund of the Department of Obstetrics and Gynecology, Duke University [564]; National Center for Advancing Translational Sciences of the National Institutes of Health [565, 566 KL2TR001115]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001115, UL1TR001117] Funding Source: NIH RePORTER	Charles Hammond Fund of the Department of Obstetrics and Gynecology, Duke University; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was funded by the Charles Hammond Fund of the Department of Obstetrics 564 and Gynecology, Duke University. This study was also supported by the National Center for 565 Advancing Translational Sciences of the National Institutes of Health under Award Number 566 KL2TR001115. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TK, 2014, REPROD SCI, V21, P260, DOI 10.1177/1933719113493514; Allen TK, 2015, ANESTHESIA ANALGESIA; Breugelmans M, 2010, ACTA OBSTET GYN SCAN, V89, P256, DOI 10.3109/00016340903418769; Cahill MA, 2007, J STEROID BIOCHEM, V105, P16, DOI 10.1016/j.jsbmb.2007.02.002; Canzoneri BJ, 2013, REPROD SCI, V20, P1246, DOI 10.1177/1933719113483009; Casey ML, 1996, BIOL REPROD, V55, P1253, DOI 10.1095/biolreprod55.6.1253; CASSELL GH, 1993, CLIN MICROBIOL REV, V6, P69, DOI 10.1128/CMR.6.1.69-87.1993; CASSELL GH, 1988, PEDIATR INFECT DIS J, V7, P535; CHEROUNY PH, 1993, AM J OBSTET GYNECOL, V169, P1299, DOI 10.1016/0002-9378(93)90297-V; Cultrera R, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-166; DAXENBICHLER G, 1990, ANN NY ACAD SCI, V595, P440, DOI 10.1111/j.1749-6632.1990.tb34330.x; DiGiulio DB, 2015, P NATL ACAD SCI USA, V112, P11060, DOI 10.1073/pnas.1502875112; DiGiulio DB, 2012, SEMIN FETAL NEONAT M, V17, P2, DOI 10.1016/j.siny.2011.10.001; ElMaradny E, 1996, AM J OBSTET GYNECOL, V174, P843, DOI 10.1016/S0002-9378(96)70311-3; Falkenstein E, 2000, EUR J CLIN INVEST, V30, P51, DOI 10.1046/j.1365-2362.2000.0300s3051.x; Feng L, 2014, PLACENTA, V35, P331, DOI 10.1016/j.placenta.2014.03.008; Ferrand PE, 2002, MOL HUM REPROD, V8, P494, DOI 10.1093/molehr/8.5.494; Flores-Espinosa P, 2014, AM J REPROD IMMUNOL, V71, P61, DOI 10.1111/aji.12163; Fortner KB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083338; Fortunato S, 2001, AM J OBSTET GYNECOL, V185, pS141, DOI 10.1016/S0002-9378(01)80252-0; Fortunato SJ, 2001, AM J OBSTET GYNECOL, V184, P1399, DOI 10.1067/mob.2001.115122; George RB, 2008, AM J PERINAT, V25, P29, DOI 10.1055/s-2007-1004828; Gerber S, 2003, J INFECT DIS, V187, P518, DOI 10.1086/368205; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Hassan SS, 2011, ULTRASOUND OBST GYN, V38, P18, DOI 10.1002/uog.9017; Havelock OC, 2005, BIOL REPROD, V72, P707, DOI 10.1095/biolreprod.104.032979; Kasper DC, 2010, DIAGN MICR INFEC DIS, V67, P117, DOI 10.1016/j.diagmicrobio.2009.12.023; Klein SL, 2004, PARASITE IMMUNOL, V26, P247, DOI 10.1111/j.0141-9838.2004.00710.x; Knox CL, 2010, BIOL REPROD, V83, P415, DOI 10.1095/biolreprod.109.083121; Knox CL, 1998, J CLIN MICROBIOL, V36, P3032, DOI 10.1128/JCM.36.10.3032-3039.1998; Kota Sunil K, 2013, Indian J Endocrinol Metab, V17, P50, DOI 10.4103/2230-8210.107841; Kumar D, 2006, BIOL REPROD, V74, P29, DOI 10.1095/biolreprod.105.045328; LAATIKAINEN T, 1981, J STEROID BIOCHEM, V14, P519, DOI 10.1016/0022-4731(81)90024-8; Li W, 2007, BIOL REPROD, V76, P654, DOI 10.1095/biolreprod.106.057034; Loudon JAZ, 2003, BIOL REPROD, V69, P331, DOI 10.1095/biolreprod.102.013698; MAZOR M, 1994, AM J OBSTET GYNECOL, V171, P231, DOI 10.1016/0002-9378(94)90474-X; Meis PJ, 2003, NEW ENGL J MED, V348, P2379, DOI 10.1056/NEJMoa035140; Meng Y, 2016, REPRODUCTIVE SCIENCE; Mercer BM, 2005, OBSTET GYN CLIN N AM, V32, P411, DOI 10.1016/j.ogc.2005.03.003; Merlino A, 2009, REPROD SCI, V16, P357, DOI 10.1177/1933719108328616; Meyer C, 1996, EUR J BIOCHEM, V239, P726, DOI 10.1111/j.1432-1033.1996.0726u.x; Mills AA, 2006, AM J OBSTET GYNECOL, V195, P998, DOI 10.1016/j.ajog.2006.06.040; Miura Y, 2014, ANTIMICROB AGENTS CH, V58, P5413, DOI 10.1128/AAC.03187-14; Mueck AO, 2014, J STEROID BIOCHEM, V142, P62, DOI 10.1016/j.jsbmb.2013.08.011; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Murtha A P, 2002, Infect Dis Obstet Gynecol, V10, P93, DOI 10.1155/S106474490200008X; Murtha AP, 2006, AM J OBSTET GYNECOL, V195, P1249, DOI 10.1016/j.ajog.2006.09.002; Namba F, 2010, PEDIATR RES, V67, P166, DOI 10.1203/PDR.0b013e3181c6e58e; Novy MJ, 2009, REPROD SCI, V16, P56, DOI 10.1177/1933719108325508; Oue S, 2009, ARCH DIS CHILD-FETAL, V94, pF17, DOI 10.1136/adc.2008.138321; Oyen ML, 2006, AM J OBSTET GYNECOL, V195, P510, DOI 10.1016/j.ajog.2006.02.010; Peltier MR, 2008, AM J REPROD IMMUNOL, V60, P346, DOI 10.1111/j.1600-0897.2008.00633.x; Peluso JJ, 2006, ENDOCRINOLOGY, V147, P3133, DOI 10.1210/en.2006-0114; Peluso JJ, 2008, ENDOCRINOLOGY, V149, P534, DOI 10.1210/en.2007-1050; Potts LC, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.137596; Robinson DP, 2012, HORM BEHAV, V62, P263, DOI 10.1016/j.yhbeh.2012.02.023; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; SAADA AB, 1991, INFECT IMMUN, V59, P467, DOI 10.1128/IAI.59.1.467-469.1991; Shimizu T, 2008, MICROBIOL-SGM, V154, P1318, DOI 10.1099/mic.0.2007/016212-0; SMITH DGE, 1994, MICROBIOL-UK, V140, P2893, DOI 10.1099/00221287-140-10-2893; Tarrant WP, 2009, J CLIN MICROBIOL, V47, P1965, DOI 10.1128/JCM.00352-09; Thomas P, 2008, FRONT NEUROENDOCRIN, V29, P292, DOI 10.1016/j.yfrne.2008.01.001; Torres-Morquecho A, 2010, AFR J MICROBIOL RES, V4, P480; Triantafilou M, 2013, PLOS ONE, V8, DOI [10.1371/annotation/1dc00176-e096-4621-9494-2d848dac8262, 10.1371/journal.pone.0061199]; Uchide N, 2005, MED SCI MONITOR, V11, pRA7; Viscardi RM, 2010, CLIN PERINATOL, V37, P393, DOI 10.1016/j.clp.2009.12.003; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; Waites KB, 2005, CLIN MICROBIOL REV, V18, P757, DOI 10.1128/CMR.18.4.757-789.2005; Wira CR, 2015, NAT REV IMMUNOL, V15, P217, DOI 10.1038/nri3819	69	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168102	10.1371/journal.pone.0168102	http://dx.doi.org/10.1371/journal.pone.0168102			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977732	Green Published, gold, Green Submitted			2022-12-26	WOS:000391217400061
J	Huang, XN; Chang, JJ; Feng, WW; Xu, YQ; Xu, T; Tang, H; Wang, HS; Pan, XP				Huang, Xiaona; Chang, Jenjen; Feng, Weiwei; Xu, Yiqun; Xu, Tao; Tang, He; Wang, Huishan; Pan, Xiaoping			Development of a New Growth Standard for Breastfed Chinese Infants: What Is the Difference from the WHO Growth Standards?	PLOS ONE			English	Article							BIRTH; CHILDREN; WEIGHT; HEIGHT	The objectives of this longitudinal study were to examine the trajectory of breastfed infants' growth in China to update growth standards for early childhood, and to compare these updated Chinese growth standards with the growth standards recommended by the World Health Organization (WHO) in 2006. This longitudinal cohort study enrolled 1,840 healthy breastfed infants living in an "optimal" environment favorable to growth and followed up until one year of age from 2007 to 2010. The study subjects were recruited from 60 communities in twelve cities in China. A participating infant's birth weight was measured within the first hour of the infant's life, and birth length and head circumference within 24 hours after birth. Repeated weekly and monthly anthropometric measurements were also taken. Multilevel (ML) modelling via MLwiN2.25 was fitted to estimate the growth curves of weight-for-age (WFA), length-for-age (LFA), and head circumference-for-age (HFA) for the study sample as a whole and by child sex, controlling for mode of delivery, the gravidity and parity of the mother, infant's physical measurements at birth, infant's daily food intaking frequency per day, infant's medical conditions, the season when the infant's physical measurement was taken, parents' ages, heights, and attained education, and family structure and income per month. During the first four weeks after birth, breastfed infants showed an increase in weight, length, and head circumference of 1110g, 4.9 cm, and 3.2 cm, respectively, among boys, and 980 g, 4.4 cm, and 2.8 cm, respectively, among girls. Throughout infancy, the total growth for these three was 6930 g, 26.4 cm, and 12.5 cm, respectively, among boys, and 6480 g, 25.5 cm, and 11.7 cm, respectively, among girls. As expected, there was a significant sex difference in growth during the first year. In comparison with the WHO growth standards, breastfed children in our study were heavier in weight, longer in length, and bigger in head circumference, with the exception of a few age points during the first two to four months on the upper two percentile curves. Our data suggested the growth curves for breastfed infants in China were significantly different in comparison with those based on the WHO standards. The adoption of the WHO infant growth standards among Chinese infants, as well as the methods used in the development of such growth standards in China, need careful and coordinated consideration.	[Huang, Xiaona; Feng, Weiwei; Xu, Yiqun; Xu, Tao; Tang, He; Wang, Huishan] Chinese Dis Prevent Control Ctr, Dept Children Hlth, Natl Ctr Women & Children Hlth, Beijing, Peoples R China; [Chang, Jenjen] St Louis Univ, Coll Publ Hlth & Social Justice, Dept Epidemiol, St Louis, MO 63103 USA; [Pan, Xiaoping] Chinese Dis Prevent Control Ctr, Natl Ctr Women & Children Hlth, Dept Epidemiol, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for Women & Children's Health, Chinese Center for Disease Control & Prevention; Saint Louis University; Chinese Center for Disease Control & Prevention; National Center for Women & Children's Health, Chinese Center for Disease Control & Prevention	Wang, HS (corresponding author), Chinese Dis Prevent Control Ctr, Dept Children Hlth, Natl Ctr Women & Children Hlth, Beijing, Peoples R China.	wanghuishan@chinawch.org.cn			Ministry of Science and Technology of the People's Republic of China; Ministry of Health of the People's Republic of China	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Ministry of Health of the People's Republic of China	This study was funded by the Ministry of Science and Technology of the People's Republic of China for funding, and also supported by the the Ministry of Health of the Peoples Republic of China. All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argnani L, 2008, COLLEGIUM ANTROPOL, V32, P807; Chen Chun-ming, 2006, Wei Sheng Yan Jiu, V35, P762; Coordinating Study Group of Nine Cities on Physical Growth and Development of Children, 2007, Zhonghua Er Ke Za Zhi, V45, P609; de Onis M, 2003, ACTA PAEDIATR, V92, P413, DOI 10.1111/j.1651-2227.2003.tb00570.x; de Onis M, 2006, ACTA PAEDIATR, V95, P16, DOI 10.1080/08035320500495423; Onis M, 2006, ACTA PAEDIATR, V95, P7, DOI 10.1080/08035320500495407; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27; de Onis M, 2012, PUBLIC HEALTH NUTR, V15, P1603, DOI 10.1017/S136898001200105X; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS15; Del-Rio-Navarro BE, 2007, EUR J CLIN NUTR, V61, P963, DOI 10.1038/sj.ejcn.1602612; Dewey KG, 2006, ACTA PAEDIATR, V95, P27, DOI 10.1080/08035320500495456; Ding ZY, 1996, CHIN J PEDIAT, V34, P93; Elmali F, 2012, PEDIATR NEUROL, V46, P307, DOI 10.1016/j.pediatrneurol.2012.02.016; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Garza Cutberto, 2004, Food Nutr Bull, V25, pS5; GOLDSTEIN H, 1986, ANN HUM BIOL, V13, P129, DOI 10.1080/03014468600008271; Hui LL, 2008, ARCH DIS CHILD, V93, P561, DOI 10.1136/adc.2007.119826; Iowne B, 2006, HUMAN GROWTH DEV, P103; Juliusson PB, 2011, ARCH DIS CHILD, V96, P916, DOI 10.1136/adc.2009.166157; Malkoc I, 2012, J CLIN RES PEDIATR E, V4, P14, DOI 10.4274/jcrpe.559; Marwaha RK, 2011, NATL MED J INDIA, V24, P269; Natale V, 2014, BMJ OPEN, V8, P4, DOI DOI 10.1136/BMJ0PEN-2013-003735; Roelants M, 2009, ANN HUM BIOL, V36, P680, DOI 10.3109/03014460903049074; Roelants M, 2010, ANN HUM BIOL, V37, P2, DOI 10.3109/03014460903458080; Rosario AS, 2011, ANN HUM BIOL, V38, P121, DOI 10.3109/03014460.2010.521193; Saari A, 2011, ANN MED, V43, P235, DOI 10.3109/07853890.2010.515603; The Division of Maternal and Child Health and Community Health Under Ministry of Health twgonccpds Capital Institute of Pediatrics, 2008, NAT GROWTH SURV CHIL; Victora CG, 1998, J NUTR, V128, P1134, DOI 10.1093/jn/128.7.1134; Victora CG, 2000, ACTA PAEDIATR, V89, P215, DOI 10.1080/080352500750028861; WHO, 2006, CHILD GROWTH STAND L; WHO Multicentre Growth Reference Study Group, 2007, WHO CHILD GROWTH STA; Wikland KA, 2002, ACTA PAEDIATR, V91, P739, DOI 10.1080/08035250213216; World Health Organization, 1997, WORLD HLTH REP 1996, P1; Wright C, 2008, ARCH DIS CHILD, V93, P566, DOI 10.1136/adc.2007.126854; Zong XN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059569	35	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0167816	10.1371/journal.pone.0167816	http://dx.doi.org/10.1371/journal.pone.0167816			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977706	Green Published, Green Submitted, gold			2022-12-26	WOS:000391217400035
J	Schmajuk, G; Tonner, C; Miao, YH; Yazdany, J; Gannon, J; Boscardin, WJ; Daikh, DI; Steinman, MA				Schmajuk, Gabriela; Tonner, Chris; Miao, Yinghui; Yazdany, Jinoos; Gannon, Jacqueline; Boscardin, W. John; Daikh, David I.; Steinman, Michael A.			Folic Acid Supplementation Is Suboptimal in a National Cohort of Older Veterans Receiving Low Dose Oral Methotrexate	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; PSORIATIC-ARTHRITIS; MONOTHERAPY; ADHERENCE	Objectives Co-prescription of folic acid in patients receiving low dose oral methotrexate is recommended because it reduces adverse events and prolongs the use of methotrexate (MTX). However, little is known about how often new users of methotrexate are co-prescribed folic acid, and what factors are associated with its use. We aimed to determine the prevalence, predictors of, and persistence of folic acid use in a population-based cohort of MTX users with rheumatic diseases. Methods Using a national, administrative database of patients seen through the Veterans Health Administration (VHA) that included pharmacy and laboratory data, we performed an observational cohort study of veterans over 65 years old who were new users of MTX. We used log-binomial regression to identify independent predictors of folic acid use and Kaplan Meyer survival analysis to examine persistence of folic acid over time. Results We studied 2467 incident users of MTX. 27% of patients were not prescribed folic acid through the VHA pharmacy within 30 days of MTX initiation. Patients who did not see a rheumatologist were 23% less likely to receive folic acid compared to patients who did have a rheumatologist visit during the baseline period (RR (95% CI) 0.77 (0.72, 0.82). These results remained unchanged even after adjusting for demographic, clinical, and other factors (adjusted RR (95% CI) 0.78 (0.74, 0.85)). After 20 months, only 50% of patients continued to receive folic acid. Conclusions In a nationwide VHA cohort of new users of oral MTX, many patients did not receive folic acid or discontinued it over time. Rheumatologists were more likely to prescribe folic acid than other providers. These data highlight the need to improve patient safety for users of methotrexate by standardizing workflows for folic acid supplementation.	[Schmajuk, Gabriela; Tonner, Chris; Yazdany, Jinoos; Boscardin, W. John; Daikh, David I.; Steinman, Michael A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Schmajuk, Gabriela; Miao, Yinghui; Daikh, David I.; Steinman, Michael A.] Vet Affairs Med Ctr, Dept Med, San Francisco, CA 94121 USA; [Gannon, Jacqueline] Yale Univ, Sch Publ Hlth, New Haven, CT USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Yale University	Schmajuk, G (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Schmajuk, G (corresponding author), Vet Affairs Med Ctr, Dept Med, San Francisco, CA 94121 USA.	Gabriela.schmajuk@ucsf.edu		Gannon, Jacqueline/0000-0003-0318-3503	National Institutes of Health [K23AR063770, K24AG049057]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS024412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR063770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K24AG049057, P30AG044281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health K23AR063770 (GS) and K24AG049057 (MAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dabagh A, 2013, AM J CLIN DERMATOL, V14, P155, DOI 10.1007/s40257-013-0017-9; Andrade SE, 2006, PHARMACOEPIDEM DR S, V15, P565, DOI 10.1002/pds.1230; Asgari MM, 2013, PHARMACOEPIDEM DR S, V22, P842, DOI 10.1002/pds.3447; Barton JL, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4340; Borzecki AM, 2004, AM J MED QUAL, V19, P201, DOI 10.1177/106286060401900504; Cannon GW, 2011, ARTHRIT CARE RES, V63, P1680, DOI 10.1002/acr.20629; Cox E, 2009, VALUE HEALTH, V12, P1053, DOI 10.1111/j.1524-4733.2009.00601.x; Crowson CS, 2011, ARTHRITIS RHEUM-US, V63, P633, DOI 10.1002/art.30155; Curtis JR, 2010, ANN RHEUM DIS, V69, P43, DOI 10.1136/ard.2008.101378; Davis SA, 2013, J DRUGS DERMATOL, V12, P546; Desai SP, 2011, ARTHRITIS RHEUM-US, V63, P3649, DOI 10.1002/art.30605; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Hoadley JF, 2012, HEALTH AFFAIR, V31, P2266, DOI 10.1377/hlthaff.2012.0019; Johnson ES., 2012, AHRQ PUBLICATION; Kohler MJ, 2013, J GEN INTERN MED, V28, P825, DOI 10.1007/s11606-013-2360-1; Mendes FD, 2007, AM J GASTROENTEROL, V102, P344, DOI 10.1111/j.1572-0241.2006.00947.x; Nikiphorou E, 2014, CLIN RHEUMATOL, V33, P609, DOI 10.1007/s10067-014-2546-x; QUAM L, 1993, MED CARE, V31, P498, DOI 10.1097/00005650-199306000-00003; Salliot C, 2009, ANN RHEUM DIS, V68, P1100, DOI 10.1136/ard.2008.093690; Schmajuk G, 2007, ARTHRIT RHEUM-ARTHR, V57, P928, DOI 10.1002/art.22890; Schmajuk G, 2014, ARTHRIT CARE RES, V66, P1159, DOI 10.1002/acr.22294; Shea B, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000951.pub2; Singh JA, 2013, COCHRANE DB SYST REV, V7; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Sokka T, 2010, CLIN EXP RHEUMATOL, V28, pS13; Steinman MA, 2012, J AM GERIATR SOC, V60, P1872, DOI 10.1111/j.1532-5415.2012.04158.x; Yazdany J, 2014, ARTHRIT CARE RES, V66, P1447, DOI 10.1002/acr.22312; YOLA M, 1994, J CLIN EPIDEMIOL, V47, P731, DOI 10.1016/0895-4356(94)90170-8	29	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168369	10.1371/journal.pone.0168369	http://dx.doi.org/10.1371/journal.pone.0168369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977768	Green Published, Green Submitted, gold			2022-12-26	WOS:000391217400102
J	Wang, SA; Wang, YC; Chuang, YP; Huang, YH; Su, WC; Chang, WC; Hung, JJ				Wang, S-A; Wang, Y-C; Chuang, Y-P; Huang, Y-H; Su, W-C; Chang, W-C; Hung, J-J			EGF-mediated inhibition of ubiquitin-specific peptidase 24 expression has a crucial role in tumorigenesis	ONCOGENE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; LUNG-CARCINOMA; CELL-CYCLE; CANCER; BAX; DISEASE; ASSOCIATION; APOPTOSIS; USP24; USP40	In this study, several cancer-related proteins (Bax, p300, E2F4 and securin) have been proven to be substrates of ubiquitin-specific peptidase 24 (USP24), and relevance has been shown between USP24 and its substrates in samples from clinical lung cancer patients. Silencing USP24 increases the cancer formation by inhibiting cellular apoptosis and increasing cellular proliferation. Epidermal growth factor ( EGF) treatment, and the Kras(G12D) and EGFR(L858R) mutations decrease USP24 protein stability via EGF- or CDK1-mediated phosphorylation at Ser1616, Ser2047 and Ser2604. Knockdown of USP24 decreases Bax and p300 levels, and reduces Ku70 acetylation, thereby preventing cancer cell apoptosis. In addition, knockdown of USP24 increases cell cycle progression by enhancing the G1-S transition and metaphase-anaphase transition. The molecular mechanism involves a decrease in the USP24 level, which reduces the expression of E2F4 and its partner TFDP1, and thus increases the G1/S transition. In conclusion, the USP24 level was decreased during the early stage of cancer and the mitotic stage of the cell cycle to regulate its substrates p300, Bax, E2F4 and securin, resulting in decreased cell apoptosis and increased cell cycle progression and, thus, cancer formation.	[Wang, S-A; Huang, Y-H; Hung, J-J] Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Coll Biosci & Biotechnol, Tainan, Taiwan; [Wang, S-A; Hung, J-J] Natl Cheng Kung Univ, Dept Biotechnol & Bioind Sci, Coll Biosci & Biotechnol, Tainan, Taiwan; [Wang, Y-C; Hung, J-J] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan, Taiwan; [Chuang, Y-P] Natl Cheng Kung Univ, Dept Pharmacol, Tainan, Taiwan; [Su, W-C] Natl Cheng Kung Univ, Dept Internal Med, Coll Med & Hosp, Tainan, Taiwan; [Chang, W-C] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan; [Chang, W-C; Hung, J-J] Taipei Med Univ, PhD Program Neural Regenerat Med, Taipei, Taiwan; [Hung, J-J] Natl Cheng Kung Univ, Ctr Infect Dis & Signal Transduct, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Taipei Medical University; Taipei Medical University; National Cheng Kung University	Hung, JJ (corresponding author), Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Tainan 701, Taiwan.	petehung@mail.ncku.edu.tw		Wang, Shao-an/0000-0002-5473-4195; Wang, Yi-Chang/0000-0001-9346-5234; Su, Wu-Chou/0000-0003-2953-4105	Ministry of Science and Technology, Taiwan [104-2923-B-038-002-MY3, 103-2320-B-006-035-MY3, 103-2321-B-006-023]; Taiwan Protein Project [MOST105-0210-01-12-01]; National Cheng Kung University Hospital [DOH105-TD-PB-111-NSC101]; Tissue Bank, Research Center of Clinical Medicine, National Cheng Kung University Hospital	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Taiwan Protein Project; National Cheng Kung University Hospital; Tissue Bank, Research Center of Clinical Medicine, National Cheng Kung University Hospital	We are grateful for the support from the Tissue Bank, Research Center of Clinical Medicine, National Cheng Kung University Hospital. We would also like to acknowledge the TCGA Research Network for providing mRNA sequencing data. This work was supported by the grants (104-2923-B-038-002-MY3, 103-2320-B-006-035-MY3 and 103-2321-B-006-023) obtained from the Ministry of Science and Technology, Taiwan. This work was also supported by the Taiwan Protein Project (MOST105-0210-01-12-01). This work was also supported by the grants DOH105-TD-PB-111-NSC101 obtained from National Cheng Kung University Hospital.	Amsel AD, 2008, P NATL ACAD SCI USA, V105, P5117, DOI 10.1073/pnas.0706700105; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Blons H, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-25; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Garg AV, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003699; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Heideker J, 2015, BIOCHEM J, V465, P1, DOI 10.1042/BJ20140496; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Li YH, 2006, HUM MUTAT, V27, P1017, DOI 10.1002/humu.20382; Liu CC, 2014, NUCLEIC ACIDS RES, V42, P9543, DOI 10.1093/nar/gku675; Lukas J, 2004, NATURE, V432, P564, DOI 10.1038/432564a; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Pawlowski J, 2000, P NATL ACAD SCI USA, V97, P529, DOI 10.1073/pnas.97.2.529; SUN JZ, 1995, CANCER RES, V55, P4243; Takahashi Y, 2000, GENE DEV, V14, P804; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wang YC, 2016, ONCOGENE, V35, P3669, DOI 10.1038/onc.2015.432; Wang YQ, 2015, AUTOPHAGY, V11, P595, DOI 10.1080/15548627.2015.1034408; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Wu YR, 2010, CLIN CHIM ACTA, V411, P955, DOI 10.1016/j.cca.2010.03.013; Zhang YH, 1997, GENOMICS, V39, P95, DOI 10.1006/geno.1996.4473; Zhao B, 2012, EUR NEUROL, V68, P181, DOI 10.1159/000339641; Zhao GY, 2015, TUMOR BIOL, V36, P1721, DOI 10.1007/s13277-014-2773-4	26	13	15	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 25	2017	36	21					2930	2945		10.1038/onc.2016.445	http://dx.doi.org/10.1038/onc.2016.445			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EV7ZP	27991932	Green Published, hybrid			2022-12-26	WOS:000402000400002
J	Dawar, S; Lim, Y; Puccini, J; White, M; Thomas, P; Bouchier-Hayes, L; Green, DR; Dorstyn, L; Kumar, S				Dawar, S.; Lim, Y.; Puccini, J.; White, M.; Thomas, P.; Bouchier-Hayes, L.; Green, D. R.; Dorstyn, L.; Kumar, S.			Caspase-2-mediated cell death is required for deleting aneuploid cells	ONCOGENE			English	Article							POLO-LIKE KINASE; SPINDLE ASSEMBLY CHECKPOINT; STRESS-INDUCED APOPTOSIS; DNA-DAMAGE RESPONSE; MITOTIC CATASTROPHE; CHROMOSOMAL INSTABILITY; TUMOR SUPPRESSION; MECHANISM; CANCER; ACTIVATION	Caspase-2, one of the most evolutionarily conserved of the caspase family, has been implicated in maintenance of chromosomal stability and tumour suppression. Caspase-2 deficient (Casp2(-/-)) mice develop normally but show premature ageing-related traits and when challenged by certain stressors, succumb to enhanced tumour development and aneuploidy. To test how caspase-2 protects against chromosomal instability, we utilized an ex vivo system for aneuploidy where primary splenocytes from Casp2(-/-)mice were exposed to anti-mitotic drugs and followed up by live cell imaging. Our data show that caspase-2 is required for deleting mitotically aberrant cells. Acute silencing of caspase-2 in cultured human cells recapitulated these results. We further generated Casp2(C320S) mutant mice to demonstrate that caspase-2 catalytic activity is essential for its function in limiting aneuploidy. Our results provide direct evidence that the apoptotic activity of caspase-2 is necessary for deleting cells with mitotic aberrations to limit aneuploidy.	[Dawar, S.; Lim, Y.; Puccini, J.; Dorstyn, L.; Kumar, S.] Univ South Australia, Ctr Canc Biol, Frome Rd, Adelaide, SA 5001, Australia; [Puccini, J.] NYU, Dept Biochem & Mol Pharmacol, New York, NY USA; [Puccini, J.] NYU, Dept Med, 550 1St Ave, New York, NY 10016 USA; [White, M.; Thomas, P.] Univ Adelaide, Sch Biol Sci, SA Genome Editing Facil, Adelaide, SA, Australia; [White, M.; Thomas, P.] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia; [Bouchier-Hayes, L.] Baylor Coll Med, Dept Pediat Hematol, Houston, TX 77030 USA; [Green, D. R.] St Jude Childrens Res Hosp, Immunol Dept, 332 N Lauderdale St, Memphis, TN 38105 USA	Centre for Cancer Biology; University of South Australia; New York University; New York University; University of Adelaide; Robinson Research Institute; University of Adelaide; Baylor College of Medicine; St Jude Children's Research Hospital	Kumar, S (corresponding author), Univ South Australia, Ctr Canc Biol, Frome Rd, Adelaide, SA 5001, Australia.	sharad.kumar@unisa.edu.au	Dorstyn, Loretta/F-3673-2013; Bouchier-Hayes, Lisa/T-9491-2019; Kumar, Sharad/AAX-7787-2020; Dawar, Swati/AAX-1062-2021; Green, Douglas R/N-8083-2018	Dorstyn, Loretta/0000-0001-9886-0989; Bouchier-Hayes, Lisa/0000-0003-3886-5977; Kumar, Sharad/0000-0001-7126-9814; Green, Douglas R/0000-0002-7332-1417; Lim, Yoon/0000-0003-1110-1969	National Health and Medical Research Council [1043057]; UniSA Presidential Award;  [1103006]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); UniSA Presidential Award; 	We thank staff at the SA Pathology animal resource facility for help in maintaining the mouse strains and members of our laboratory for discussions and useful comments. Funding for this work was provided by the National Health and Medical Research Council project grant (1043057) and a Senior Principal Research Fellowship (1103006) to Sharad Kumar. Loretta Dorstyn was a Cancer Council Research Fellow and Swati Dawar is supported by a UniSA Presidential Award.	Andersen JL, 2009, EMBO J, V28, P3216, DOI 10.1038/emboj.2009.253; Baliga BC, 2004, CELL DEATH DIFFER, V11, P1234, DOI 10.1038/sj.cdd.4401492; Belkhiri A, 2012, CLIN CANCER RES, V18, P3889, DOI 10.1158/1078-0432.CCR-11-3182; Bouchier-Hayes L, 2009, MOL CELL, V35, P830, DOI 10.1016/j.molcel.2009.07.023; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; Castedo M, 2004, ONCOGENE, V23, P4362, DOI 10.1038/sj.onc.1207572; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Choi M, 2015, CANCER LETT, V357, P591, DOI 10.1016/j.canlet.2014.12.023; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Decordier I, 2002, MUTAGENESIS, V17, P337, DOI 10.1093/mutage/17.4.337; Decordier I, 2008, MUTAT RES-GEN TOX EN, V651, P30, DOI 10.1016/j.mrgentox.2007.10.016; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; Dorstyn L, 2012, CELL DEATH DIFFER, V19, P1288, DOI 10.1038/cdd.2012.36; Dorstyn L, 2014, METHODS MOL BIOL, V1133, P71, DOI 10.1007/978-1-4939-0357-3_4; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Geigl JB, 2008, TRENDS GENET, V24, P64, DOI 10.1016/j.tig.2007.11.006; Giam M, 2015, CELL DIV, V10, DOI 10.1186/s13008-015-0009-7; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; HAMANAKA R, 1995, J BIOL CHEM, V270, P21086, DOI 10.1074/jbc.270.36.21086; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ho LH, 2008, ONCOGENE, V27, P3393, DOI 10.1038/sj.onc.1211005; Ho LH, 2009, P NATL ACAD SCI USA, V106, P5336, DOI 10.1073/pnas.0811928106; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kaufmann T, 2007, CELL, V129, P423, DOI 10.1016/j.cell.2007.03.017; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kumar S, 2009, NAT REV CANCER, V9, P897, DOI 10.1038/nrc2745; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Li M, 2009, CELL CYCLE, V8, P3440, DOI 10.4161/cc.8.21.9688; Lu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012963; Manzl C, 2012, CELL DEATH DIFFER, V19, P1722, DOI 10.1038/cdd.2012.54; Mendelsohn AR, 2002, P NATL ACAD SCI USA, V99, P6871, DOI 10.1073/pnas.072290599; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; O'Reilly LA, 2002, CELL DEATH DIFFER, V9, P832, DOI 10.1038/sj.cdd.4401033; Palmisiano ND, 2015, AM J HEMATOL, V90, P1071, DOI 10.1002/ajh.24177; Parsons MJ, 2013, CELL DEATH DIFFER, V20, P1174, DOI 10.1038/cdd.2013.38; Parsons MJ., 2015, COLD SPRING HARB PRO, V2015; Peterson SE, 2012, J NEUROSCI, V32, P16213, DOI 10.1523/JNEUROSCI.3706-12.2012; Puccini J, 2013, CELL DEATH DIFFER, V20, P1133, DOI 10.1038/cdd.2013.87; Puccini J, 2013, P NATL ACAD SCI USA, V110, P19920, DOI 10.1073/pnas.1311947110; Ren KQ, 2012, J BIOL CHEM, V287, P14792, DOI 10.1074/jbc.M112.347625; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Shalini S, 2016, CELL DEATH DIFFER, V23, P1727, DOI 10.1038/cdd.2016.81; Shalini S, 2015, CELL DEATH DIFFER, V22, P526, DOI 10.1038/cdd.2014.216; Shalini S, 2012, CELL DEATH DIFFER, V19, P1370, DOI 10.1038/cdd.2012.13; Taghiyev Agshin F, 2011, Genes Cancer, V2, P745, DOI 10.1177/1947601911426007; Terry MR, 2015, CELL DEATH DIFFER, V22, P719, DOI 10.1038/cdd.2014.159; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Wasch R, 2010, RECENT RESULTS CANC, V184, P215, DOI 10.1007/978-3-642-01222-8_15; Wang Q, 2002, MOL CELL BIOL, V22, P3450, DOI 10.1128/MCB.22.10.3450-3459.2002; Yoo BH, 2011, J BIOL CHEM, V286, P38894, DOI 10.1074/jbc.M111.290692; Zhang YP, 2007, MECH AGEING DEV, V128, P213, DOI 10.1016/j.mad.2006.11.030	54	42	42	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 11	2017	36	19					2704	2714		10.1038/onc.2016.423	http://dx.doi.org/10.1038/onc.2016.423			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EU6CF	27991927	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000401120900008
J	Leech, CA; Kopp, RF; Nelson, HA; Nandi, J; Roe, MW				Leech, Colin A.; Kopp, Richard F.; Nelson, Heather A.; Nandi, Jyotirmoy; Roe, Michael W.			Stromal Interaction Molecule 1 (STIM1) Regulates ATP-sensitive Potassium (K-ATP) and Store-operated Ca2+ Channels in MIN6 beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFONYLUREA RECEPTOR 1; ENDOPLASMIC-RETICULUM; INSULIN-SECRETION; ION CHANNELS; INTRACELLULAR CA2+; SLOW OSCILLATIONS; TRPC CHANNELS; CALCIUM; ENTRY; ORAI1	Stromal interaction molecule 1 (STIM1) regulates store-operated Ca2+ entry (SOCE) and other ion channels either as an endoplasmic reticulum Ca2+-sensing protein or when present in the plasma membrane. However, the role of STIM1 in insul-insecreting beta-cells is unresolved. We report that lowering expression of STIM1, the gene that encodes STIM1, in insulin-secreting MIN6 beta-cells with RNA interference inhibits SOCE and ATP-sensitive K+ (KATP) channel activation. The effects of STIM1 knockdown were reversed by transduction of MIN6 cells with an adenovirus gene shuttle vector that expressed human STIM1. Immunoprecipitation studies revealed that STIM1 binds to nucleotide binding fold-1 (NBF1) of the sulfonylurea receptor 1 (SUR1) subunit of the K-ATP channel. Binding of STIM1 to SUR1 was enhanced by poly-lysine. Our data indicate that SOCE and K-ATP channel activity are regulated by STIM1. This suggests that STIM1 is a multifunctional signaling effector that participates in the control of membrane excitability and Ca2+ signaling events in beta-cells.	[Leech, Colin A.; Kopp, Richard F.; Nandi, Jyotirmoy; Roe, Michael W.] SUNY Upstate Med Univ, Dept Med, 505 Irving Ave, Syracuse, NY 13210 USA; [Nelson, Heather A.; Roe, Michael W.] SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Roe, MW (corresponding author), SUNY Upstate Med Univ, Dept Med, 505 Irving Ave, Syracuse, NY 13210 USA.	roem@upstate.edu		Nelson, Heather/0000-0002-4622-2923; Kopp, Richard/0000-0001-8190-1748	National Institutes of Health [R01DK074966, R01DK092616]; American Diabetes Association [1-12-BS-109]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074966, R01DK092616] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK074966 (to M. W. R.) and R01DK092616 (to M. W. R.). This work was also supported by American Diabetes Association Research Grant 1-12-BS-109 (to C. A. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health National Institutes of Health/NIDDK or the American Diabetes Association.	Ambily A, 2014, CELL SIGNAL, V26, P502, DOI 10.1016/j.cellsig.2013.11.025; Ambudkar IS, 2007, PFLUG ARCH EUR J PHY, V455, P187, DOI 10.1007/s00424-007-0252-0; Berna-Erro A, 2012, ADV EXP MED BIOL, V740, P349, DOI 10.1007/978-94-007-2888-2_15; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Carrillo E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120431; Chang N, 2011, J BIOL CHEM, V286, P23308, DOI 10.1074/jbc.M111.217950; Cheng H, 2007, CELL CALCIUM, V41, P51, DOI 10.1016/j.ceca.2006.04.032; CHOW RH, 1995, J PHYSIOL-LONDON, V485, P607, DOI 10.1113/jphysiol.1995.sp020756; Colsoul B, 2010, P NATL ACAD SCI USA, V107, P5208, DOI 10.1073/pnas.0913107107; Darbellay B, 2011, J CELL BIOL, V194, P335, DOI 10.1083/jcb.201012157; Dionisio N, 2015, BBA-MOL CELL RES, V1853, P1145, DOI 10.1016/j.bbamcr.2015.02.014; Drews G, 2010, ADV EXP MED BIOL, V654, P115, DOI 10.1007/978-90-481-3271-3_7; Enklaar T, 2010, ISLETS, V2, P337, DOI 10.4161/isl.2.5.13140; Furman B, 2010, ADV EXP MED BIOL, V654, P281, DOI 10.1007/978-90-481-3271-3_13; Gomez-Lagunas F, 2003, P NATL ACAD SCI USA, V100, P347, DOI 10.1073/pnas.0237122100; Harbeck Mark C, 2006, Sci STKE, V2006, ppl6, DOI 10.1126/stke.3532006pl6; Hartzell CA, 2016, ELIFE, V5, DOI 10.7554/eLife.14850; Harvey J, 2000, J PHYSIOL-LONDON, V527, P95, DOI 10.1111/j.1469-7793.2000.00095.x; Henquin JC, 2009, DIABETES OBES METAB, V11, P168, DOI 10.1111/j.1463-1326.2009.01109.x; Hodeify R, 2015, J CELL SCI, V128, P3143, DOI 10.1242/jcs.172320; Hogan PG, 2015, CELL CALCIUM, V58, P357, DOI 10.1016/j.ceca.2015.07.001; Hooper R, 2013, PFLUG ARCH EUR J PHY, V465, P1383, DOI 10.1007/s00424-013-1270-8; Horinouchi T, 2012, BIOCHEM BIOPH RES CO, V428, P252, DOI 10.1016/j.bbrc.2012.10.034; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Huang YS, 2009, LASERS ELECTRO-OPT R, P1; Islam MS, 2011, ADV EXP MED BIOL, V704, P811, DOI 10.1007/978-94-007-0265-3_42; Jacobson D. A., 2007, V179, P409; Jairaman A, 2013, CHANNELS, V7, P402, DOI 10.4161/chan.25292; Jardin I, 2008, CHANNELS, V2, P401, DOI 10.4161/chan.2.6.7055; Kang YH, 2011, J BIOL CHEM, V286, P5876, DOI 10.1074/jbc.M109.089607; Kieffer TJ, 1997, DIABETES, V46, P1087, DOI 10.2337/diabetes.46.6.1087; Klein A, 2005, BRIT J PHARMACOL, V145, P907, DOI 10.1038/sj.bjp.0706252; Koriyama N, 2000, DIABETES, V49, P1830, DOI 10.2337/diabetes.49.11.1830; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Leech C. A., 2014, ISLETS OF LANGERHANS, P337; LEECH CA, 1994, ENDOCRINOLOGY, V135, P365, DOI 10.1210/en.135.1.365; Leech CA, 2011, PROG BIOPHYS MOL BIO, V107, P236, DOI 10.1016/j.pbiomolbio.2011.07.005; Liang T, 2014, J BIOL CHEM, V289, P6028, DOI 10.1074/jbc.M113.511808; Liao YY, 2009, P NATL ACAD SCI USA, V106, P3202, DOI 10.1073/pnas.0813346106; Liu WJ, 2013, MATH BIOSCI, V243, P240, DOI 10.1016/j.mbs.2013.03.004; Lopez JJ, 2016, BBA-MOL CELL RES, V1863, P2037, DOI 10.1016/j.bbamcr.2016.04.024; Maechler P, 1999, J BIOL CHEM, V274, P12583, DOI 10.1074/jbc.274.18.12583; Manna PT, 2010, J BIOL CHEM, V285, P5963, DOI 10.1074/jbc.M109.066902; Marigo V, 2009, MOL CELL ENDOCRINOL, V299, P194, DOI 10.1016/j.mce.2008.11.011; Martin ACL, 2009, MOL PHARMACOL, V75, P830, DOI 10.1124/mol.108.051748; Masia R, 2007, CHANNELS, V1, P315, DOI 10.4161/chan.5083; McNally BA, 2012, J PHYSIOL-LONDON, V590, P4179, DOI 10.1113/jphysiol.2012.233098; Mears D, 2004, J MEMBRANE BIOL, V197, P59, DOI 10.1007/s00232-003-0642-y; Mignen O, 2007, J PHYSIOL-LONDON, V579, P703, DOI 10.1113/jphysiol.2006.122432; Moccia F, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00153; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; Park SH, 2013, P NATL ACAD SCI USA, V110, P12673, DOI 10.1073/pnas.1216351110; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Redondo PC, 2015, INT REV CEL MOL BIO, V316, P183, DOI 10.1016/bs.ircmb.2015.01.007; Ren JH, 2013, AM J PHYSIOL-ENDOC M, V305, pE805, DOI 10.1152/ajpendo.00046.2013; ROE MW, 1994, AM J PHYSIOL, V266, pE852, DOI 10.1152/ajpendo.1994.266.6.E852; Roe MW, 1998, J BIOL CHEM, V273, P10402, DOI 10.1074/jbc.273.17.10402; Saitoh N, 2011, J CELL BIOCHEM, V112, P147, DOI 10.1002/jcb.22910; Salido GM, 2011, ADV EXP MED BIOL, V704, P413, DOI 10.1007/978-94-007-0265-3_23; Shibasaki T, 2004, J BIOL CHEM, V279, P7956, DOI 10.1074/jbc.M309068200; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Sivaprasadarao A, 2007, BIOCHEM SOC T, V35, P1055, DOI 10.1042/BST0351055; SMITH PA, 1993, J GEN PHYSIOL, V101, P767, DOI 10.1085/jgp.101.5.767; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Tamarina NA, 2008, CELL CALCIUM, V44, P533, DOI 10.1016/j.ceca.2008.03.007; Tanahashi Y, 2016, J VET MED SCI, V78, P203, DOI 10.1292/jvms.15-0346; Tengholm A, 1999, J BIOL CHEM, V274, P36883, DOI 10.1074/jbc.274.52.36883; Tian G, 2012, J BIOL CHEM, V287, P9862, DOI 10.1074/jbc.M111.292854; Varadi A, 2002, DIABETES, V51, pS190, DOI 10.2337/diabetes.51.2007.S190; Wang XZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4183; Wang Y, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1089; WORLEY JF, 1994, J BIOL CHEM, V269, P14359; WORLEY JF, 1994, J BIOL CHEM, V269, P32055; Yang SN, 2014, CELL MOL LIFE SCI, V71, P4149, DOI 10.1007/s00018-014-1680-6; Yeung-Yam-Wah V, 2010, CELL CALCIUM, V47, P77, DOI 10.1016/j.ceca.2009.11.007; Yuan JP, 2009, CHANNELS, V3, P221, DOI 10.4161/chan.3.4.9198; Zeng WZ, 2008, MOL CELL, V32, P439, DOI 10.1016/j.molcel.2008.09.020; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	79	6	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2266	2277		10.1074/jbc.M116.767681	http://dx.doi.org/10.1074/jbc.M116.767681			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28003364	Green Published, hybrid			2022-12-26	WOS:000395530300019
J	Fourati, Z; Ruza, RR; Laverty, D; Drege, E; Delarue-Cochin, S; Joseph, D; Koehl, P; Smart, T; Delarue, M				Fourati, Zaineb; Ruza, Reinis Reinholds; Laverty, Duncan; Drege, Emmanuelle; Delarue-Cochin, Sandrine; Joseph, Delphine; Koehl, Patrice; Smart, Trevor; Delarue, Marc			Barbiturates Bind in the GLIC Ion Channel Pore and Cause Inhibition by Stabilizing a Closed State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anesthesia; crystallography; electrophysiology; membrane protein; structural biology; x-ray crystallography; ligand-gated ion channels; barbiturates	NICOTINIC ACETYLCHOLINE-RECEPTOR; GLOEOBACTER-VIOLACEUS; GENERAL-ANESTHETICS; GABA(A) RECEPTORS; MECHANISM; PROPOFOL; BEAMLINE; CONFORMATION; SITES	Barbiturates induce anesthesia by modulating the activity of anionic and cationic pentameric ligand-gated ion channels (pLGICs). Despite more than a century of use in clinical practice, the prototypic binding site for this class of drugs within pLGICs is yet to be described. In this study, we present the first X-ray structures of barbiturates bound to GLIC, a cationic prokaryotic pLGIC with excellent structural homology to other relevant channels sensitive to general anesthetics and, as shown here, to barbiturates, at clinically relevant concentrations. Several derivatives of barbiturates containing anomalous scatterers were synthesized, and these derivatives helped us unambiguously identify a unique barbiturate binding site within the central ion channel pore in a closed conformation. In addition, docking calculations around the observed binding site for all three states of the receptor, including a model of the desensitized state, showed that barbiturates preferentially stabilize the closed state. The identification of this pore binding site sheds light on the mechanism of barbiturate inhibition of cationic pLGICs and allows the rationalization of several structural and functional features previously observed for barbiturates.	[Fourati, Zaineb; Ruza, Reinis Reinholds; Delarue, Marc] CNRS, UMR 3528, Inst Pasteur, Unite Dynam Struct Macromol, F-75015 Paris, France; [Laverty, Duncan; Smart, Trevor] UCL, Dept Neurosci Physiol & Pharmacol, Mortimer St, London WC1E 6BT, England; [Drege, Emmanuelle; Delarue-Cochin, Sandrine; Joseph, Delphine] Univ Paris Sud, CNRS, UMR 8076, BioCIS,Fac Pharm, F-92296 Chatenay Malabry, France; [Koehl, Patrice] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of London; University College London; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; University of California System; University of California Davis	Smart, T (corresponding author), UCL, Gower St, London WC1E 6BT, England.; Delarue, M (corresponding author), Inst Pasteur, 25 Rue Dr Roux, F-75015 Paris, France.	t.smart@ucl.ac.uk; delarue@pasteur.fr		Ruza, Reinis/0000-0002-0509-3512; Fourati, Zaineb/0000-0002-2316-4142	'Agence Nationale de la Recherche' grant "Pentagate"; Medical Research Council [1068348] Funding Source: researchfish	'Agence Nationale de la Recherche' grant "Pentagate"(French National Research Agency (ANR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the 'Agence Nationale de la Recherche' grant "Pentagate" (to M.D. and D.J.). The authors declare that they have no conflicts of interest with the contents of this article.	Arias HR, 2001, MOL PHARMACOL, V60, P497; Ascone I, 2007, AIP CONF PROC, V882, P872; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiara DC, 2014, BIOCHEMISTRY-US, V53, P135, DOI 10.1021/bi401492k; Chiara DC, 2013, J BIOL CHEM, V288, P19343, DOI 10.1074/jbc.M113.479725; Dacosta CJB, 2013, STRUCTURE, V21, P1271, DOI 10.1016/j.str.2013.06.019; de Sanctis D, 2012, J SYNCHROTRON RADIAT, V19, P455, DOI 10.1107/S0909049512009715; Dent JA, 2010, ADV EXP MED BIOL, V683, P11; Duran D., 2013, Journal of Physics: Conference Series, V425, DOI 10.1088/1742-6596/425/1/012005; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Forman SA, 2011, CAN J ANESTH, V58, P191, DOI 10.1007/s12630-010-9419-9; Franks NP, 2015, ANESTHESIOLOGY, V122, P787, DOI 10.1097/ALN.0000000000000588; Gingrich KJ, 2009, J GEN PHYSIOL, V133, P171, DOI 10.1085/jgp.200810081; Gonzalez-Gutierrez G, 2013, P NATL ACAD SCI USA, V110, P18716, DOI 10.1073/pnas.1313156110; Hadipour-Jahromy M, 2003, EUR J PHARMACOL, V477, P81, DOI 10.1016/j.ejphar.2003.08.017; Hamouda AK, 2014, MOL PHARMACOL, V85, P735, DOI 10.1124/mol.113.090985; Jenkins A, 1996, BRIT J PHARMACOL, V117, P1507, DOI 10.1111/j.1476-5381.1996.tb15314.x; Johnson WD, 2012, J PHARMACOL EXP THER, V340, P445, DOI 10.1124/jpet.111.188037; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; KOEHL P, 1994, J MOL BIOL, V239, P249, DOI 10.1006/jmbi.1994.1366; Kolodny R, 2002, J MOL BIOL, V323, P297, DOI 10.1016/S0022-2836(02)00942-7; Laurent B, 2016, STRUCTURE, V24, P595, DOI 10.1016/j.str.2016.02.014; LeBard DN, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002532; Lehmann H E, 1972, Curr Psychiatr Ther, V12, P70; Loscher W, 2012, EPILEPSIA, V53, P12, DOI 10.1111/epi.12025; Lopez-Munoz Francisco, 2005, Neuropsychiatr Dis Treat, V1, P329; Lopez-Munoz Francisco, 2005, Ann Clin Psychiatry, V17, P113, DOI 10.1080/10401230591002002; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Murphy JA, 2007, ORG LETT, V9, P3233, DOI 10.1021/ol071049d; Nardou R, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00016; Nurizzo D, 2006, J SYNCHROTRON RADIAT, V13, P227, DOI 10.1107/S0909049506004341; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Oakley S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032070; OLSEN RW, 1986, LIFE SCI, V39, P1969, DOI 10.1016/0024-3205(86)90320-6; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prevost MS, 2012, NAT STRUCT MOL BIOL, V19, P642, DOI 10.1038/nsmb.2307; Sauguet L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149795; Sauguet L, 2013, EMBO J, V32, P728, DOI 10.1038/emboj.2013.17; Schober A, 2010, BRIT J PHARMACOL, V161, P365, DOI 10.1111/j.1476-5381.2010.00886.x; Spurny R, 2012, P NATL ACAD SCI USA, V109, pE3028, DOI 10.1073/pnas.1208208109; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; Weng Y, 2010, ANESTH ANALG, V110, P59, DOI 10.1213/ANE.0b013e3181c4bc69; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; YOST CS, 1993, CELL MOL NEUROBIOL, V13, P159, DOI 10.1007/BF00735372; Zeller A., 2008, V182, P31, DOI 10.1007/978-3-540-74806-9_2; Zhou Cheng, 2012, World J Crit Care Med, V1, P80, DOI 10.5492/wjccm.v1.i3.80	49	15	15	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1550	1558		10.1074/jbc.M116.766964	http://dx.doi.org/10.1074/jbc.M116.766964			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27986812	Green Published, hybrid			2022-12-26	WOS:000395515600002
J	Brooks, HL; Pontefract, SK; Vallance, HK; Hirsch, CA; Hughes, E; Ferner, RE; Marriott, JF; Coleman, JJ				Brooks, Hannah L.; Pontefract, Sarah K.; Vallance, Hannah K.; Hirsch, Christine A.; Hughes, Elizabeth; Ferner, Robin E.; Marriott, John F.; Coleman, Jamie J.			Perceptions and Impact of Mandatory eLearning for Foundation Trainee Doctors: A Qualitative Evaluation	PLOS ONE			English	Article							TECHNOLOGY ACCEPTANCE MODEL; VIEWS	Background Junior doctors in the UK must complete various educational components during their two year Foundation training programme. It is important that mandatory learning is informative and engaging. The aim of this study was to evaluate trainee doctors' perceptions of a Technology Enhanced Learning (TEL) programme developed to improve prescribing competency. Method Focus groups and interviews were conducted at three hospital sites in the West Midlands. Codes, sub-themes and themes were determined using deductive and inductive thematic analysis. Results Data were collected from 38 Foundation trainee doctors. Results revealed major themes relating to prescribing education, the user experience and user engagement. Key findings included the positive impact of preparedness following undergraduate education on the user experience of the TEL programme at the postgraduate level; the impact of content, structure, and individual learning needs and styles on the user experience; and the impact of motivation and time on engagement. Most trainees engaged with the programme owing to its mandatory nature; however, some trainees also used the programme voluntarily, for example, to acquire knowledge prior to starting a new placement. Conclusions It is important to ensure that learners are willing to engage with mandatory TEL, and that they have the time and motivation to do so. It is also important to ensure that learners have a positive user experience and that in designing TEL individual differences in learning styles and needs are taken into account. These findings have implications for educators and system developers in the construction and design of mandatory eLearning programmes.	[Brooks, Hannah L.; Pontefract, Sarah K.; Vallance, Hannah K.; Hirsch, Christine A.; Ferner, Robin E.; Marriott, John F.; Coleman, Jamie J.] Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Pontefract, Sarah K.; Coleman, Jamie J.] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England; [Hughes, Elizabeth] Hlth Educ England, Birmingham, W Midlands, England; [Ferner, Robin E.] Sandwell & West Birmingham NHS Trust, West Midlands Ctr Adverse Drug React, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Pontefract, SK (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England.; Pontefract, SK (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England.	s.k.pontefract@bham.ac.uk		Ferner, Robin/0000-0003-3769-1346; Pontefract, Sarah Katie/0000-0002-0344-4075; Coleman, Jamie/0000-0002-7512-5153	Health Education England's West Midland Team	Health Education England's West Midland Team	This study was funded by Health Education England's West Midland Team. This article presents independent research. The views expressed are those of the author(s) and not necessarily those of Health Education England or NHS England. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnes S, 2016, ACAD MED; Brooks HL, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0651-z; Davis F.D., 1986, TECHNOLOGY ACCEPTANC; Goldacre MJ, 2014, POSTGRAD MED J, V90, P63, DOI 10.1136/postgradmedj-2012-131321; Han WH, 2006, SCOT MED J, V51, P27; Hortsch M, 2015, MED TEACH, V37, P507, DOI 10.3109/0142159X.2014.1001341; Jenner LE, 2014, MED TEACH, P1; KEOGH MJ, 2010, BJMP, V3, P306; Kirkpatrick DL, 2009, EVALUATING TRAINING; Patton MQ, 1999, HEALTH SERV RES, V34, P1189; Patton MQ, 2005, QUALITATIVE RES EVAL; Rothwell C, 2012, BRIT J CLIN PHARMACO, V73, P194, DOI 10.1111/j.1365-2125.2011.04061.x; Ruiz JG, 2006, ACAD MED, V81, P207, DOI 10.1097/00001888-200603000-00002; T Dornan, 2009, DEPTH INVESTIGATION; Venkatesh V, 2000, MANAGE SCI, V46, P186, DOI 10.1287/mnsc.46.2.186.11926; Venkatesh V, 2008, DECISION SCI, V39, P273, DOI 10.1111/j.1540-5915.2008.00192.x; Walsh K, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.333.5555; Watmough S, 2009, BMC MED EDUC, V9, DOI 10.1186/1472-6920-9-64; Zehry K, 2011, PROCD SOC BEHV, V15, P3163, DOI 10.1016/j.sbspro.2011.04.265; Zhang MWB, 2014, TECHNOL HEALTH CARE, V22, P847, DOI 10.3233/THC-140861	20	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168558	10.1371/journal.pone.0168558	http://dx.doi.org/10.1371/journal.pone.0168558			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005938	gold, Green Published, Green Submitted			2022-12-26	WOS:000392843200064
J	Dreano, D; Raitsos, DE; Gittings, J; Krokos, G; Hoteit, I				Dreano, Denis; Raitsos, Dionysios E.; Gittings, John; Krokos, George; Hoteit, Ibrahim			The Gulf of Aden Intermediate Water Intrusion Regulates the Southern Red Sea Summer Phytoplankton Blooms	PLOS ONE			English	Article							SEASONAL OVERTURNING CIRCULATION; STABLE-ISOTOPE RATIOS; ENVIRONMENTAL GRADIENTS; CHLOROPHYLL; MODIS; VARIABILITY; PHENOLOGY; ECOLOGY; IMPACT; CARBON	Knowledge on large-scale biological processes in the southern Red Sea is relatively limited, primarily due to the scarce in situ, and satellite-derived chlorophyll-a (Chl-a) datasets. During summer, adverse atmospheric conditions in the southern Red Sea (haze and clouds) have long severely limited the retrieval of satellite ocean colour observations. Recently, a new merged ocean colour product developed by the European Space Agency (ESA)-the Ocean Color Climate Change Initiative (OC-CCI)-has substantially improved the southern Red Sea coverage of Chl-a, allowing the discovery of unexpected intense summer blooms. Here we provide the first detailed description of their spatiotemporal distribution and report the mechanisms regulating them. During summer, the monsoon-driven wind reversal modifies the circulation dynamics at the Bab-el-Mandeb strait, leading to a subsurface influx of colder, fresher, nutrient-rich water from the Indian Ocean. Using satellite observations, model simulation outputs, and in situ datasets, we track the pathway of this intrusion into the extensive shallow areas and coral reef complexes along the basin's shores. We also provide statistical evidence that the subsurface intrusion plays a key role in the development of the southern Red Sea phytoplankton blooms.	[Dreano, Denis; Hoteit, Ibrahim] King Abdullah Univ Sci & Technol, Comp Elect & Math Sci & Engn Div, Thuwal, Saudi Arabia; [Raitsos, Dionysios E.] Plymouth Marine Lab, Remote Sensing Grp, Plymouth, Devon, England; [Raitsos, Dionysios E.] Plymouth Marine Lab, Natl Ctr Earth Observat, Plymouth, Devon, England; [Gittings, John] King Abdullah Univ Sci & Technol, Biol & Environm Sci & Engn Div, Thuwal, Saudi Arabia; [Krokos, George; Hoteit, Ibrahim] King Abdullah Univ Sci & Technol, Phys Sci & Engn Div, Thuwal, Saudi Arabia	King Abdullah University of Science & Technology; Plymouth Marine Laboratory; Plymouth Marine Laboratory; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC National Centre for Earth Observation; King Abdullah University of Science & Technology; King Abdullah University of Science & Technology	Hoteit, I (corresponding author), King Abdullah Univ Sci & Technol, Comp Elect & Math Sci & Engn Div, Thuwal, Saudi Arabia.; Hoteit, I (corresponding author), King Abdullah Univ Sci & Technol, Phys Sci & Engn Div, Thuwal, Saudi Arabia.	ibrahim.hoteit@kaust.edu.sa	Krokos, George/AAK-5612-2020; Raitsos, Dionysios/AAA-3031-2021	Krokos, George/0000-0001-7428-0066; Raitsos, Dionysios/0000-0002-6714-2180; Dreano, Denis/0000-0001-7956-5538; Hoteit, Ibrahim/0000-0002-3751-4393; Gittings, John/0000-0003-4183-3482	King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia; NERC's UK National Centre for Earth Observation; NERC [pml010007, pml010009, nceo020006] Funding Source: UKRI; Natural Environment Research Council [nceo020006, pml010009, pml010007] Funding Source: researchfish	King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia(King Abdullah University of Science & Technology); NERC's UK National Centre for Earth Observation; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia. D.R.E. is funded through the NERCs UK National Centre for Earth Observation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abualnaja Y, 2015, J CLIMATE; Acker J, 2008, J MARINE SYST, V69, P191, DOI 10.1016/j.jmarsys.2005.12.006; Saafani MA, 2007, J OCEANOGR, V63, P1, DOI 10.1007/s10872-007-0001-1; Barbini R, 2004, INT J REMOTE SENS, V25, P2095, DOI 10.1080/01431160310001618086; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Berumen ML, 2013, CORAL REEFS, V32, P737, DOI 10.1007/s00338-013-1055-8; BOYER TP, 2002, WORLD OCEAN ATLAS 20, V2; Brewin RJW, 2015, REMOTE SENS ENVIRON, V165, P64, DOI 10.1016/j.rse.2015.04.024; Brewin RJW, 2013, REMOTE SENS ENVIRON, V136, P218, DOI 10.1016/j.rse.2013.04.018; Churchill JH, 2014, J MAR RES, V72, P165, DOI 10.1357/002224014814901994; DiBattista J.D., 2015, J BIOGEOGR; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Gitting J, REMOTE SENS IN PRESS; IOCCG S, 2000, REPORTS INT OCEAN CO, V3; James G., 2014, INTRO STAT LEARNING; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kohl A, 2008, J PHYS OCEANOGR, V38, P1913, DOI 10.1175/2008JPO3775.1; Kurten B, 2016, PROG OCEANOGR, V140, P69, DOI 10.1016/j.pocean.2015.11.003; Kuerten B, 2014, J SEA RES, V85, P379, DOI 10.1016/j.seares.2013.07.008; Langodan S, 2016, OCEAN ENG, V116, P200, DOI 10.1016/j.oceaneng.2016.02.020; Langodan S, 2014, J PHYS OCEANOGR, V44, P3139, DOI 10.1175/JPO-D-13-0242.1; Lo JCF, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009216; Lo-Yat A, 2011, GLOBAL CHANGE BIOL, V17, P1695, DOI 10.1111/j.1365-2486.2010.02355.x; Longhurst A.R, 2007, EC GEOGR SEA 2 ED; Nanninga GB, 2014, MOL ECOL, V23, P591, DOI 10.1111/mec.12623; National Climatic Data Center, GHRSST LEV 4 AVHRR O; Papadopoulos VP, 2013, J CLIMATE, V26, P1685, DOI 10.1175/JCLI-D-12-00267.1; Papadopoulos VP, J GEOPHYS RES OCEANS; PATZERT WC, 1974, DEEP-SEA RES, V21, P109, DOI 10.1016/0011-7471(74)90068-0; Platt T, 2003, NATURE, V423, P398, DOI 10.1038/423398b; Racault MF, 2015, REMOTE SENS ENVIRON, V160, P222, DOI 10.1016/j.rse.2015.01.019; Raitsos DE, 2015, GEOPHYS RES LETT, V42, P855, DOI 10.1002/2014GL062882; Raitsos DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064909; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; SHAIKH EA, 1986, MAR BIOL, V92, P405, DOI 10.1007/BF00392681; Shen CY, 2014, INT J REMOTE SENS, V35, P4127, DOI 10.1080/01431161.2014.916056; Skamarock W., 2005, DESCRIPTION ADV RES; Sofianos SS, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003886; Sofianos SS, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001184; SOUVERMEZOGLOU E, 1989, J MAR RES, V47, P441, DOI 10.1357/002224089785076244; Spalding M. D., 2001, WORLD ATLAS CORAL RE; STEPHENS C, 2002, WORLD OCEAN ATLAS 20, V1; Triantafyllou G, 2014, J GEOPHYS RES-OCEANS, V119, P1791, DOI 10.1002/2013JC009641; Viswanadhapalli Y, 2016, INT J CLIMATOL, V37, P1; Wang B, 2001, J CLIMATE, V14, P4073, DOI 10.1175/1520-0442(2001)014<4073:IVOTAS>2.0.CO;2; Yao F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138213; Yao FC, 2014, J GEOPHYS RES-OCEANS, V119, P2238, DOI 10.1002/2013JC009004; Yao FC, 2014, J GEOPHYS RES-OCEANS, V119, P2263, DOI 10.1002/2013JC009331; Zhan P, 2015, ENVIRON SCI ENG, P501, DOI 10.1007/978-3-319-13203-7_21; Zhan P, 2014, J GEOPHYS RES-OCEANS, V119, P3909, DOI 10.1002/2013JC009563	50	44	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168440	10.1371/journal.pone.0168440	http://dx.doi.org/10.1371/journal.pone.0168440			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006006	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000392843200050
J	Jiao, L; Su, M; Chen, L; Wang, YG; Zhu, HL; Dai, HQ				Jiao, Li; Su, Ming; Chen, Liao; Wang, Yuangang; Zhu, Hongli; Dai, Hongqi			Natural Cellulose Nanofibers As Sustainable Enhancers in Construction Cement	PLOS ONE			English	Article							FIBER-REINFORCED CEMENT; MECHANICAL-PROPERTIES; GLASS-FIBER; MICROCRYSTALLINE CELLULOSE; CARBON NANOTUBE; HYDRATION; COMPOSITES; MICROSTRUCTURE; FRACTURE; POLYSACCHARIDES	Cement is one of the mostly used construction materials due to its high durability and low cost, but it suffers from brittle fracture and facile crack initiation. This article describes the use of naturally-derived renewable cellulose nanofibers (CNFs) to reinforce cement. The effects of CNFs on the mechanical properties, degree of hydration (DOH), and microstructure of cement pastes have been studied. It is found that an addition of 0.15% by weight of CNFs leads to a 15% and 20% increase in the flexural and compressive strengths of cement paste. The enhancement in mechanical strength is attributed to high DOH and dense microstructure of cement pastes after adding CNFs.	[Jiao, Li; Dai, Hongqi] Nanjing Forestry Univ, Dept Pulp & Paper Engn, Nanjing, Jiangsu, Peoples R China; [Jiao, Li; Su, Ming] Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA; [Chen, Liao; Zhu, Hongli] Northeastern Univ, Dept Mech & Ind Engn, Boston, MA 02115 USA; [Wang, Yuangang] Nanjing Forestry Univ, Dept Civil Engn, Nanjing, Jiangsu, Peoples R China	Nanjing Forestry University; Northeastern University; Northeastern University; Nanjing Forestry University	Dai, HQ (corresponding author), Nanjing Forestry Univ, Dept Pulp & Paper Engn, Nanjing, Jiangsu, Peoples R China.	hgdhq@njfu.edu.cn	Wang, Yuan/HHC-1520-2022; Lv, Yuanjie/AER-0767-2022		Introduction of Advanced International Project of Forestry Science and Technology [2015454]; National Natural Science Foundation of China [31470599]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Nanjing Forestry University Innovation fund program for the Doctorate Fellowship Foundation and Innovation program of Jiangsu province [KYZZ15-0254]	Introduction of Advanced International Project of Forestry Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Nanjing Forestry University Innovation fund program for the Doctorate Fellowship Foundation and Innovation program of Jiangsu province	This work was supported by the Introduction of Advanced International Project of Forestry Science and Technology (Grant number: 2015454), the National Natural Science Foundation of China (Grant Number: 31470599) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). We thank the Nanjing Forestry University Innovation fund program for the Doctorate Fellowship Foundation and Innovation program KYZZ15-0254 of Jiangsu province for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azeredo HMC, 2010, J FOOD SCI, V75, pN1, DOI 10.1111/j.1750-3841.2009.01386.x; Balbosh A, 2006, J PROSTHET DENT, V95, P218, DOI 10.1016/j.prosdent.2006.01.006; Batalin BS, 2014, GLASS CERAM+, V71, P294, DOI 10.1007/s10717-014-9672-4; Bentz Dale P., 2009, J MATER CIVIL ENG, V21, P521; Bentz DP, 2006, CEMENT CONCRETE RES, V36, P238, DOI 10.1016/j.cemconres.2005.04.014; Bondeson D, 2006, CELLULOSE, V13, P171, DOI 10.1007/s10570-006-9061-4; Cao Y, 2015, CEMENT CONCRETE COMP, V56, P73, DOI 10.1016/j.cemconcomp.2014.11.008; Chakraborty S, 2013, IND ENG CHEM RES, V52, P1252, DOI 10.1021/ie300607r; Chen LH, 2015, CELLULOSE, V22, P1753, DOI 10.1007/s10570-015-0615-1; Chung DDL, 2001, COMPOS INTERFACE, V8, P67, DOI 10.1163/15685540052543665; Chung DDL, 2001, COMPOSITES B, V31, P511; Das S, 2015, CONSTR BUILD MATER, V93, P360, DOI 10.1016/j.conbuildmat.2015.06.011; Escalante-Garcia JI, 2001, CEMENT CONCRETE RES, V31, P695, DOI 10.1016/S0008-8846(01)00471-9; Farzanian K, 2016, CONSTR BUILD MATER, V109, P156, DOI 10.1016/j.conbuildmat.2015.12.082; Fujisawa S, 2011, CARBOHYD POLYM, V84, P579, DOI 10.1016/j.carbpol.2010.12.029; Hoyos CG, 2013, MATER DESIGN, V51, P810, DOI 10.1016/j.matdes.2013.04.060; Habibi Y, 2006, CELLULOSE, V13, P679, DOI 10.1007/s10570-006-9075-y; Isogai A, 2011, NANOSCALE, V3, P71, DOI 10.1039/c0nr00583e; Iwamoto S, 2009, BIOMACROMOLECULES, V10, P2571, DOI 10.1021/bm900520n; Jacobsen J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02667; Jo BW, 2015, SCI REP-UK, V5, DOI 10.1038/srep07837; Jonoobi M, 2010, COMPOS SCI TECHNOL, V70, P1742, DOI 10.1016/j.compscitech.2010.07.005; Klemm D, 2011, ANGEW CHEM INT EDIT, V50, P5438, DOI 10.1002/anie.201001273; Kordkheili HY, 2015, J FORESTRY RES, V26, P247, DOI 10.1007/s11676-014-0003-y; Lam L, 2000, CEMENT CONCRETE RES, V30, P747, DOI 10.1016/S0008-8846(00)00213-1; Lootens D, 2016, CEMENT CONCRETE COMP, V68, P9, DOI 10.1016/j.cemconcomp.2016.02.010; MacVicar R, 1999, CEMENT CONCRETE COMP, V21, P189, DOI 10.1016/S0958-9465(98)00050-X; Merta I, 2013, CONSTR BUILD MATER, V40, P991, DOI 10.1016/j.conbuildmat.2012.11.060; Mohammadkazemi F, 2015, CONSTR BUILD MATER, V101, P958, DOI 10.1016/j.conbuildmat.2015.10.093; Mohammed MS, 2014, PIGM RESIN TECHNOL, V43, P104, DOI 10.1108/PRT-05-2013-0038; Olivito RS, 2014, MATER DESIGN, V57, P258, DOI 10.1016/j.matdes.2013.11.023; Onuaguluchi O, 2016, CEMENT CONCRETE COMP, V68, P96, DOI 10.1016/j.cemconcomp.2016.02.014; Pane I, 2005, CEMENT CONCRETE RES, V35, P1155, DOI 10.1016/j.cemconres.2004.10.027; Peschard A, 2006, J EUR CERAM SOC, V26, P1439, DOI 10.1016/j.jeurceramsoc.2005.02.005; Peschard A, 2004, CEMENT CONCRETE RES, V34, P2153, DOI 10.1016/j.cemconres.2004.04.001; Poinot T, 2015, CEMENT CONCRETE RES, V70, P50, DOI 10.1016/j.cemconres.2015.01.004; Pourjavadi A, 2013, CEMENT CONCRETE COMP, V37, P196, DOI 10.1016/j.cemconcomp.2012.10.005; Reis JML, 2006, CONSTR BUILD MATER, V20, P673, DOI 10.1016/j.conbuildmat.2005.02.008; Rybin VA, 2016, CORROS SCI, V102, P503, DOI 10.1016/j.corsci.2015.11.004; Saito T, 2007, BIOMACROMOLECULES, V8, P2485, DOI 10.1021/bm0703970; Saito T, 2006, BIOMACROMOLECULES, V7, P1687, DOI 10.1021/bm060154s; Savastano H, 2005, CEMENT CONCRETE COMP, V27, P583, DOI 10.1016/j.cemconcomp.2004.09.009; Sedan D, 2008, J EUR CERAM SOC, V28, P183, DOI 10.1016/j.jeurceramsoc.2007.05.019; da Fonseca BS, 2015, J MATER CIVIL ENG, V27, DOI 10.1061/(ASCE)MT.1943-5533.0001039; Toledo RD, 2000, CEMENT CONCRETE COMP, V22, P127, DOI 10.1016/S0958-9465(99)00039-6; Wang SQ, 2009, J APPL POLYM SCI, V113, P1270, DOI 10.1002/app.30072; Wei JQ, 2016, CORROS SCI, V106, P1, DOI 10.1016/j.corsci.2016.01.020; Wei JQ, 2016, CEMENT CONCRETE RES, V81, P94, DOI 10.1016/j.cemconres.2015.12.001; Xie XL, 2015, COMPOS PART B-ENG, V78, P153, DOI 10.1016/j.compositesb.2015.03.086; Xu SL, 2015, CONSTR BUILD MATER, V76, P16, DOI 10.1016/j.conbuildmat.2014.11.049; Yi XW, 2015, GEOTEXT GEOMEMBRANES, V43, P207, DOI 10.1016/j.geotexmem.2015.03.003; Yu R, 2014, CEMENT CONCRETE RES, V56, P29, DOI 10.1016/j.cemconres.2013.11.002; Zimmermann T, 2010, CARBOHYD POLYM, V79, P1086, DOI 10.1016/j.carbpol.2009.10.045	53	49	51	6	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168422	10.1371/journal.pone.0168422	http://dx.doi.org/10.1371/journal.pone.0168422			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005917	Green Published, Green Submitted, gold			2022-12-26	WOS:000392843200049
J	Yu, XJ; Wang, CY; Hu, HJ; Liu, HF				Yu, Xingjian; Wang, Chenye; Hu, Hongjie; Liu, Huafeng			Low Dose PET Image Reconstruction with Total Variation Using Alternating Direction Method	PLOS ONE			English	Article							TOTAL VARIATION MINIMIZATION; AUGMENTED LAGRANGIAN METHOD; BAYESIAN RECONSTRUCTION; ALGORITHM; SHRINKAGE	In this paper, a total variation (TV) minimization strategy is proposed to overcome the problem of sparse spatial resolution and large amounts of noise in low dose positron emission tomography (PET) imaging reconstruction. Two types of objective function were established based on two statistical models of measured PET data, least-square (LS) TV for the Gaussian distribution and Poisson-TV for the Poisson distribution. To efficiently obtain high quality reconstructed images, the alternating direction method (ADM) is used to solve these objective functions. As compared with the iterative shrinkage/thresholding (1ST) based algorithms, the proposed ADM can make full use of the TV constraint and its convergence rate is faster. The performance of the proposed approach is validated through comparisons with the expectation-maximization (EM) method using synthetic and experimental biological data. In the comparisons, the results of both LS-TV and Poisson-TV are taken into consideration to find which models are more suitable for PET imaging, in particular low-dose PET. To evaluate the results quantitatively, we computed bias, variance, and the contrast recovery coefficient (CRC) and drew profiles of the reconstructed images produced by the different methods. The results show that both Poisson-TV and LS-TV can provide a high visual quality at a low dose level. The bias and variance of the proposed LS-TV and Poisson-TV methods are 20% to 74% less at all counting levels than those of the EM method. Poisson TV gives the best performance in terms of high-accuracy reconstruction with the lowest bias and variance as compared to the ground truth (14.3% less bias and 21.9% less variance). In contrast, LS-TV gives the best performance in terms of the high contrast of the reconstruction with the highest CRC.	[Yu, Xingjian; Wang, Chenye; Liu, Huafeng] Zhejiang Univ, Dept Opt Engn, State Key Lab Modern Opt Instrumentat, Hangzhou, Zhejiang, Peoples R China; [Hu, Hongjie] Zhejiang Univ, Sir Run Run Shaw Hosp, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Liu, HF (corresponding author), Zhejiang Univ, Dept Opt Engn, State Key Lab Modern Opt Instrumentat, Hangzhou, Zhejiang, Peoples R China.	liuhf@zju.edu.cn			National Natural Science Foundation of China [61427807, 61271083, 61525106]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2016YFC1300302]; Shenzhen Innovation Funding [SGLH20131010110119871]; Zhejiang Province Science and Technology Projects [2015C33061]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Shenzhen Innovation Funding; Zhejiang Province Science and Technology Projects	This work is supported in part by the National Natural Science Foundation of China (No: 61427807, 61271083,61525106), by National Key Technology Research and Development Program of the Ministry of Science and Technology of China (No: 2016YFC1300302), by the Shenzhen Innovation Funding (SGLH20131010110119871), by Zhejiang Province Science and Technology Projects (No: 2015C33061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh F, 2003, MATH PROGRAM, V95, P3, DOI 10.1007/s10107-002-0339-5; BAILEY DL, 1994, PHYS MED BIOL, V39, P411, DOI 10.1088/0031-9155/39/3/009; BARZILAI J, 1988, IMA J NUMER ANAL, V8, P141, DOI 10.1093/imanum/8.1.141; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Bioucas-Dias JM, 2007, IEEE T IMAGE PROCESS, V16, P2992, DOI 10.1109/TIP.2007.909319; Burger M, 2014, INVERSE PROBL, V30, DOI 10.1088/0266-5611/30/10/105003; Chambolle A, 1997, NUMER MATH, V76, P167, DOI 10.1007/s002110050258; Chambolle A, 2004, J MATH IMAGING VIS, V20, P89; Chan T, 2006, HANDBOOK OF MATHEMATICAL MODELS IN COMPUTER VISION, P17, DOI 10.1007/0-387-28831-7_2; Chan TF, 2006, SIAM J APPL MATH, V66, P1632, DOI 10.1137/040615286; Chen CH, 2012, IMA J NUMER ANAL, V32, P227, DOI 10.1093/imanum/drq039; Cheng JC, 2012, MED PHYS, V39, P1029, DOI 10.1118/1.3678489; Cheng-Liao JX, 2011, PHYS MED BIOL, V56, P6899, DOI 10.1088/0031-9155/56/21/009; Christe SA, 2012, ARXIV12012542; Elad M, 2006, IEEE T INFORM THEORY, V52, P5559, DOI 10.1109/TIT.2006.885522; Fessler J. A., 2012, IMAGE RECONSTRUCTION; FESSLER JA, 1994, IEEE T MED IMAGING, V13, P290, DOI 10.1109/42.293921; Figueiredo Mario A. T., 2011, P 28 INT C MACH LEAR, P169; Gaitanis A, 2010, COMPUT MED IMAG GRAP, V34, P131, DOI 10.1016/j.compmedimag.2009.07.006; Gill PE, 2012, COMPUT OPTIM APPL, V51, P1, DOI 10.1007/s10589-010-9339-1; Goldfarb D, 2005, SIAM J SCI COMPUT, V27, P622, DOI 10.1137/040608982; GREEN PJ, 1990, IEEE T MED IMAGING, V9, P84, DOI 10.1109/42.52985; HEBERT T, 1989, IEEE T MED IMAGING, V8, P194, DOI 10.1109/42.24868; Henry T, 2012, MED IMAGING PRINCIPL; Hestenes M. R., 1969, Journal of Optimization Theory and Applications, V4, P303, DOI 10.1007/BF00927673; HUDSON HM, 1994, IEEE T MED IMAGING, V13, P601, DOI 10.1109/42.363108; Jan S, 2004, PHYS MED BIOL, V49, P4543, DOI 10.1088/0031-9155/49/19/007; Meza JC, 2010, WIRES COMPUT STAT, V2, P719, DOI 10.1002/wics.117; MUMCUOGLU EU, 1994, IEEE T MED IMAGING, V13, P687, DOI 10.1109/42.363099; Mumcuoglu EU, 1996, PHYS MED BIOL, V41, P1777, DOI 10.1088/0031-9155/41/9/015; Osher S, 2005, MULTISCALE MODEL SIM, V4, P460, DOI 10.1137/040605412; Powell M.J., 1967, METHOD NONLINEAR CON; Sawatzky A, 2009, LECT NOTES COMPUT SC, V5702, P533, DOI 10.1007/978-3-642-03767-2_65; Shepp L A, 1982, IEEE Trans Med Imaging, V1, P113, DOI 10.1109/TMI.1982.4307558; Stutzer K, 2013, PHYS MED BIOL, V58, DOI 10.1088/0031-9155/58/15/5085; Tomioka R, 2011, J MACH LEARN RES, V12, P1537; Vese LA, 2003, J SCI COMPUT, V19, P553, DOI 10.1023/A:1025384832106; Wang YL, 2008, SIAM J IMAGING SCI, V1, P248, DOI 10.1137/080724265; Wu CL, 2011, INVERSE PROBL IMAG, V5, P237, DOI 10.3934/ipi.2011.5.237; Wu CL, 2010, SIAM J IMAGING SCI, V3, P300, DOI 10.1137/090767558; Yang JF, 2010, IEEE J-STSP, V4, P288, DOI 10.1109/JSTSP.2010.2042333; Ye XJ, 2011, IEEE T MED IMAGING, V30, P1055, DOI 10.1109/TMI.2010.2073717; Yuan YX., 2008, AMSIP STUD ADV MATH, V42, P785; Zhou J, 2008, COMPUT MED IMAG GRAP, V32, P710, DOI 10.1016/j.compmedimag.2008.08.008	44	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0166871	10.1371/journal.pone.0166871	http://dx.doi.org/10.1371/journal.pone.0166871			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005929	Green Published, Green Submitted, gold			2022-12-26	WOS:000392843200008
J	Kavitha, MS; Park, SY; Heo, MS; Chien, SI				Kavitha, Muthu Subash; Park, Soon-Yong; Heo, Min-Suk; Chien, Sung-Il			Distributional Variations in the Quantitative Cortical and Trabecular Bone Radiographic Measurements of Mandible, between Male and Female Populations of Korea, and its Utilization	PLOS ONE			English	Article							MINERAL DENSITY; FRACTAL DIMENSION; RADIOMORPHOMETRIC INDEXES; PANORAMIC RADIOGRAPHS; OSTEOPOROSIS; WOMEN; RISK; FRACTURES; DIAGNOSIS; MEN	It is important to investigate the irregularities in aging-associated changes in bone, between men and women for bone strength and osteoporosis. The purpose of this study was to characterize the changes and associations of mandibular cortical and trabecular bone measures of men and women based on age and to the evaluation of cortical shape categories, in a large Korean population. Panoramic radiographs of 1047 subjects (603 women and 444 men) aged between 15 to 90 years were used. Mandibular cortical width (MCW), mandibular cortical index (MCI), and fractal dimensions (FD) of the molar, premolar, and anterior regions of the mandibular trabecular bone were measured. Study subjects were grouped into six 10-years age groups. A local linear regression smoothing with bootstrap resampling for robust fitting of data was used to estimate the relationship between radiographic mandibular variables and age groups as well as genders. The mean age of women (49.56 +/- 19.5 years) was significantly higher than that of men (45.57 +/- 19.6 years). The MCW of men and women (3.17mm and 2.91mm, respectively, p < 0.0001) was strongly associated with age and MCI. Indeed, trabecular measures also correlated with age in men (r>-0.140, p = 0.003), though not as strongly as in women (r>-0.210, p < 0.0001). In men aged over 55 years, only MCW was significantly associated (r=-0.412, p < 0.0001). Furthermore, by comparison of mandibular variables from different age groups and MCI categories, the results suggest that MCW was detected to be strongly associated in both men and women for the detection of bone strength and osteoporosis. The FD measures revealed relatively higher association with age among women than men, but not as strong as MCW.	[Kavitha, Muthu Subash; Chien, Sung-Il] Kyungpook Natl Univ, Dept Comp Vis & Image Proc, Sch Elect Engn, Daegu, South Korea; [Park, Soon-Yong] Kyungpook Natl Univ, Dept Comp & Robot Vis, Sch Comp Sci & Engn, Daegu, South Korea; [Heo, Min-Suk] Seoul Natl Univ, Sch Dent, Dept Oral & Maxillofacial Radiol, Seoul, South Korea	Kyungpook National University; Kyungpook National University; Seoul National University (SNU)	Chien, SI (corresponding author), Kyungpook Natl Univ, Dept Comp Vis & Image Proc, Sch Elect Engn, Daegu, South Korea.; Heo, MS (corresponding author), Seoul Natl Univ, Sch Dent, Dept Oral & Maxillofacial Radiol, Seoul, South Korea.	hmslsh@snu.ac.kr; sichien@ee.knu.ac.kr	Kavitha, M.S./AAI-6438-2020; Park, Soon-Yong/HGV-2374-2022	Kavitha, Muthu Subash/0000-0002-1676-561X; Heo, Min-Suk/0000-0003-3406-0645	BK21 Plus project - Ministry of Education, Korea [21A20131600011]	BK21 Plus project - Ministry of Education, Korea	This study was supported by the BK21 Plus project funded by the Ministry of Education, Korea (21A20131600011).	Alman AC, 2012, OSTEOPOROSIS INT, V23, P1631, DOI 10.1007/s00198-011-1678-y; Amer ME, 2012, IMAGNG SCI DENT, V42, P5, DOI 10.5624/isd.2012.42.1.5; Apolinario AC, 2016, DENTOMAXILLOFAC RAD, V45, DOI 10.1259/dmfr.20150400; Bollen AM, 2000, ORAL SURG ORAL MED O, V90, P518, DOI 10.1067/moe.2000.107802; Demirbas AK, 2008, ORAL SURG ORAL MED O, V106, pE41, DOI 10.1016/j.tripleo.2008.03.007; Drozdzowska B, 2002, DENTOMAXILLOFAC RAD, V31, P361, DOI 10.1038/sj.dmfr.4600729; Gulsahi A, 2008, DENTOMAXILLOFAC RAD, V37, P288, DOI 10.1259/dmfr/19491030; Gulsahi A, 2010, DENTOMAXILLOFAC RAD, V39, P284, DOI 10.1259/dmfr/20522657; Kanis JA, 2002, LANCET, V359, P1929, DOI 10.1016/S0140-6736(02)08761-5; Kavitha MS, 2016, DENTOMAXILLOFAC RAD, V45, DOI 10.1259/dmfr.20160076; Kavitha MS, 2015, OR SURG OR MED OR PA, V119, P346, DOI 10.1016/j.oooo.2014.11.009; Kazakia GJ, 2013, BONE, V52, P623, DOI 10.1016/j.bone.2012.10.031; Kim J, 2016, EC BURDEN OSTEOPOROT, V9C, P36; KLEMETTI E, 1994, SCAND J DENT RES, V102, P68; Koh KJ, 2012, IMAGNG SCI DENT, V42, P231, DOI 10.5624/isd.2012.42.4.231; Nguyen TV, 2004, MED J AUSTRALIA, V180, pS18; Okabe S, 2008, ORAL SURG ORAL MED O, V106, P433, DOI 10.1016/j.tripleo.2007.09.013; Oliveira ML, 2013, CLIN ORAL INVEST, V17, P1847, DOI 10.1007/s00784-012-0882-2; Park C, 2011, J BONE MINER METAB, V29, P744, DOI 10.1007/s00774-011-0279-3; Poole KES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016190; Roberts M, 2011, OSTEOPOROSIS INT, V22, P1915, DOI 10.1007/s00198-010-1410-3; Roberts MG, 2013, IEEE T BIO-MED ENG, V60, P2384, DOI 10.1109/TBME.2013.2256908; Rushton VE, 1996, J DENT, V24, P185, DOI 10.1016/0300-5712(95)00055-0; Sapthagirivasan V, 2013, COMPUT BIOL MED, V43, P1910, DOI 10.1016/j.compbiomed.2013.09.002; Scheiner S, 2015, COMPUT MED IMAG GRAP, V45, P36, DOI 10.1016/j.compmedimag.2015.06.005; Sharma G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144180; Sindeaux R, 2014, MATURITAS, V77, P142, DOI 10.1016/j.maturitas.2013.10.011; TAGUCHI A, 1995, ORAL SURG ORAL MED O, V79, P127, DOI 10.1016/S1079-2104(05)80088-5; Walsh J, 2011, INT J BIOL MED SCI, V1, P33; Watanabe Plauto Christopher Aranha, 2007, Int. J. Morphol., V25, P875, DOI 10.4067/S0717-95022007000400031; White SC, 2000, DENTOMAXILLOFAC RAD, V29, P119, DOI 10.1038/sj.dmfr.4600516; Yamada S, 2015, ORAL DIS, V21, P335, DOI 10.1111/odi.12282; Yasar F, 2006, DENTOMAXILLOFAC RAD, V35, P1, DOI 10.1259/dmfr/97652136	33	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167992	10.1371/journal.pone.0167992	http://dx.doi.org/10.1371/journal.pone.0167992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002443	Green Submitted, gold, Green Published			2022-12-26	WOS:000392853100030
J	Marcenaro, D; Valkonen, JPT				Marcenaro, Delfia; Valkonen, Jari P. T.			Seedborne Pathogenic Fungi in Common Bean (Phaseolus vulgaris cv. INTA Rojo) in Nicaragua	PLOS ONE			English	Article							F-SP PHASEOLI; LASIODIPLODIA-THEOBROMAE; RHIZOCTONIA-BATATICOLA; FUSARIUM-INCARNATUM; 1ST REPORT; ROOT-ROT; DIVERSITY; DISEASE; FRUIT; BOTRYOSPHAERIACEAE	Common bean (Phaseolus vulgaris L.) is an important legume with high nutritional value. In Nicaragua, certified healthy seeds of local bean varieties are not available, and seedborne fungi have gained little attention. Here, were surveyed seedborne pathogenic fungi in an important local bean cultivar, `INTA Rojo'. Beans grown in the four main production areas in Nicaragua (Boaco, Carazo, Estelf, Matagalpa) for future use as seed stock were sampled from four seed storehouses and six seed lots. A total of 133 fungal strains were isolated from surface-sterilized beans and inoculated to healthy lima beans (Phaseolus lunatus) under controlled conditions. Eighty-seven isolates caused symptoms of varying severity in the seedlings, including discoloration, necrotic lesions, cankers, rot, and lethal necrosis. Pathogenic isolates were divided into eight phenotypically distinguishable groups based on morphology and growth characteristics on artificial growth medium, and further identified by analysis of the internal transcribed spacer sequences (ITS1 and ITS2) of the ribosomal RNA genes. The pathogenic isolates belonged to eight genera. Fusarium spp. (F. chlamydosporum, F. equiseti, F. incarnatum), Lasiodiplodia theobromae, Macrophomina phaseolina, and Penicillium citrinum were the most damaging and common fungi found in the seed lots. Furthermore, Corynespora cassiicola, Colletotrichum capsisi, Colletotrichum gloeosporioides, Aspergillus flavus, and Diaporthe sp. (Phomopsis) were seedborne in cultivar `INTA Rojo' and found to be pathogenic to bean seedlings. This study reveals, for the first time, many seedborne pathogenic fungi in beans in Nicaragua; furthermore, prior to this study, little information was available concerning F. equiseti, F. incarnatum, L. theobromae, C. cassiicola, and Diaporthespp. as seedborne pathogens of common bean. Our results lay the basis for developing diagnostic tools for seed health inspection and for further study of the epidemiology, ecology, and control of the pathogenic fungi of common beans in the field.	[Marcenaro, Delfia] Nicaraguan Inst Agr Technol CNIAB INTA, Managua, Nicaragua; [Marcenaro, Delfia; Valkonen, Jari P. T.] Univ Helsinki, Dept Agr Sci, Latokartanonkaari 7, Helsinki, Finland	University of Helsinki	Valkonen, JPT (corresponding author), Univ Helsinki, Dept Agr Sci, Latokartanonkaari 7, Helsinki, Finland.	jari.valkonen@helsinki.fi		Valkonen, Jari/0000-0002-3704-9911	Ministry for Foreign Affairs of Finland [36419901, 36421515]; Nicaraguan Institute of Agricultural Technology (INTA)	Ministry for Foreign Affairs of Finland; Nicaraguan Institute of Agricultural Technology (INTA)	This work was supported financially by Ministry for Foreign Affairs of Finland (grants 36419901 and 36421515 to JPTV) having no role in data collection and analysis, decision to publish, or preparation of the manuscript, and Nicaraguan Institute of Agricultural Technology (INTA) supported financially collection of research material but had no role in decision to publish, or preparation of the manuscript.	Agrios GN, 2005, PLANT PATHOLOGY; Anderson IC, 2007, J MICROBIOL METH, V68, P248, DOI 10.1016/j.mimet.2006.08.005; [Anonymous], 1990, AVRDC PUBL, V90-328; [Anonymous], 2006, MANUAL DIFFUSION TEC, P84; Aoki T, 2014, J GEN PLANT PATHOL, V80, P189, DOI 10.1007/s10327-014-0509-3; Arauz LF, 1986, DIAGNOSTICO INCIDENC, V10, P89; Ausubel FM, 1995, SHORT PROTOCOLS MOL, V3rd; Booth C., 1978, FUSARIUM EQUISETI IM; BOSCH U, 1992, APPL ENVIRON MICROB, V58, P3233, DOI 10.1128/AEM.58.10.3233-3239.1992; BROOKS F, 2004, 41 AM SAM COMM COLL; Rosado AWC, 2016, PLANT DIS, V100, P561, DOI 10.1094/PDIS-03-15-0242-RE; Cavalcante RD, 2014, EUR J PLANT PATHOL, V140, P251, DOI 10.1007/s10658-014-0459-9; Chaudhary R. G., 2002, Indian Journal of Pulses Research, V15, P193; Chen YY, 2013, PLANT PATHOL, V62, P900, DOI 10.1111/j.1365-3059.2012.02692.x; DELGADO G., 2011, MYCOTAXON, V115, P534; DHINGRA OD, 1972, PHYTOPATHOLOGY, V62, P1108; Dickman MB, 2000, FUNGAL PATHOLOGY, P127; Dixon LJ, 2009, PHYTOPATHOLOGY, V99, P1015, DOI 10.1094/PHYTO-99-9-1015; Domsch K. H., 1980, COMPENDIUM SOIL FUNG, V2; Domsch KH, 1980, COMPENDIUM SOIL FUNG; dos Santos TT, 2016, J APPL MICROBIOL, V120, P388, DOI 10.1111/jam.12985; Dugan FM, 2016, J PHYTOPATHOL, V164, P65, DOI 10.1111/jph.12384; ECHAVEZBADEL R, 1991, J AGR U PUERTO RICO, V75, P419; Farr DF., FUNGAL DATABASES; Goswami RS, 2008, CAN J PLANT PATHOL, V30, P155, DOI 10.1080/07060660809507506; Graham PH, 1997, FIELD CROP RES, V53, P131, DOI 10.1016/S0378-4290(97)00112-3; Guo KF, 2016, PLANT DIS, V100, P529, DOI 10.1094/PDIS-06-15-0694-PDN; Henrique FH, 2015, BRAGANTIA, V74, P84, DOI 10.1590/1678-4499.0265; INTA (Instituto Nicaraguense de Tecnologia Agropecuaria), 2002, GUIA TECN CULT GRAN; ISTA, 1999, SEED SCI TECHNOL, V31, P1; Jimenez OR, 2012, SEED SCI TECHNOL, V40, P73, DOI 10.15258/sst.2012.40.1.08; Jimenez OR, 2013, PLANT BREEDING, V132, P205, DOI 10.1111/pbr.12041; KONING G, 1995, PLANT DIS, V79, P754, DOI 10.1094/PD-79-0754D; Kwon Jin-Hyeuk, 2005, The Plant Pathology Journal, V21, P164; Lehtonen MJ, 2008, PLANT PATHOL, V57, P141, DOI 10.1111/j.1365-3059.2007.01694.x; Lima Joilson Silva, 2013, Summa phytopathol., V39, P81, DOI 10.1590/S0100-54052013000200001; Lisboa WS, 2016, AUSTRALAS PLANT DIS, V11, DOI 10.1007/s13314-016-0203-8; Machado AR, 2014, TROP PLANT PATHOL, V39, P464, DOI 10.1590/S1982-56762014000600008; Mancini V, 2016, PLANT PATHOL, V65, P691, DOI 10.1111/ppa.12515; Marques MW, 2013, FUNGAL DIVERS, V61, P181, DOI 10.1007/s13225-013-0231-z; Martinez-Garnica M, 2014, REV FAC AGRON LUZ, V31, P539; Munimbazi C, 1996, J FOOD PROTECT, V59, P869, DOI 10.4315/0362-028X-59.8.869; Naseri B, 2008, INT J PEST MANAGE, V61, P60; Navas M, 2015, REV FACULTAD AGRONOM, V21, P121; Okoth S., 2010, J YEAST FUNGAL RES, V1, P35; Prester L, 2011, ARH HIG RADA TOKSIKO, V62, P371, DOI 10.2478/10004-1254-62-2011-2126; Probst C, 2010, J APPL MICROBIOL, V108, P600, DOI 10.1111/j.1365-2672.2009.04458.x; Punithalingam E., 1976, BOTRYDIPLODIA THEOBR; Punithalingam E., 1980, BIBLIOTHECA MYCOLOGI; Ramdial H, 2016, PLANT DIS, V100, P526, DOI 10.1094/PDIS-05-15-0550-PDN; Reddy E. C. S., 2011, INT J APPL BIOL PHAR, V2, P180; Rodrigues AAC, 2005, MYCOPATHOLOGIA, V159, P79, DOI 10.1007/s11046-004-7138-x; Santalla M, 1999, J AGRON CROP SCI, V183, P263, DOI 10.1046/j.1439-037x.1999.00348.x; Schwartz HF, 2005, COMPENDIUM BEAN DIS; SEIFERT K, 1996, FUSARIUM INTERACTIVE; Sexton ZF, 2016, CROP PROT, V81, P9, DOI 10.1016/j.cropro.2015.11.012; Sharma Mamta, 2015, Archives of Phytopathology and Plant Protection, V48, P797, DOI 10.1080/03235408.2016.1140564; Silvestro LB, 2013, SPAN J AGRIC RES, V11, P72, DOI 10.5424/2013111-3081; Slippers Bernard, 2007, Fungal Biology Reviews, V21, P90, DOI 10.1016/j.fbr.2007.06.002; Smith K.L., 2000, OHIO VEGETABLE PRODU, P166; Su G, 2001, PHYTOPATHOLOGY, V91, P120, DOI 10.1094/PHYTO.2001.91.2.120; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teramoto A, 2013, TROP PLANT PATHOL, V38, P68, DOI 10.1590/S1982-56762013000100011; Terashima Yoshie, 2002, Mycoscience, V43, P261, DOI 10.1007/s102670200038; Thompson SM, 2015, PERSOONIA, V35, P39, DOI 10.3767/003158515X687506; TSENG TC, 1995, BOT BULL ACAD SINICA, V36, P229; VALKONEN JPT, 1990, PLANT PATHOL, V39, P510, DOI 10.1111/j.1365-3059.1990.tb02527.x; van Diepeningen AD, 2016, MYCOPATHOLOGIA, V181, P161, DOI 10.1007/s11046-016-9993-7; von Arx JA, 1974, GENERA FUNGI SPORULA; WALLER JM, 2002, PLANT PATHOLOGISTS P; WEBSTER J, 2007, INTRO FUNGI; White DG, 1999, COMPENDIUM CORN DIS; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wyllie TD, 1988, COMPENDIUM SOYBEAN D, P30; Yang HC, 2015, PLANT DIS, V99, P143, DOI 10.1094/PDIS-03-14-0228-RE; You MP, 2011, FUNCT PLANT BIOL, V38, P984, DOI 10.1071/FP11137	77	21	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168662	10.1371/journal.pone.0168662	http://dx.doi.org/10.1371/journal.pone.0168662			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997595	Green Published, gold, Green Submitted			2022-12-26	WOS:000392842900066
J	Sekar, SKV; Pagliazzi, M; Negredo, E; Martelli, F; Farina, A; Dalla Mora, A; Lindner, C; Farzam, P; Perez-Alvarez, N; Puig, J; Taroni, P; Pifferi, A; Durduran, T				Sekar, Sanathana Konugolu Venkata; Pagliazzi, Marco; Negredo, Eugenia; Martelli, Fabrizio; Farina, Andrea; Dalla Mora, Alberto; Lindner, Claus; Farzam, Parisa; Perez-Alvarez, Nuria; Puig, Jordi; Taroni, Paola; Pifferi, Antonio; Durduran, Turgut			In Vivo, Non-Invasive Characterization of Human Bone by Hybrid Broadband (600-1200 nm) Diffuse Optical and Correlation Spectroscopies	PLOS ONE			English	Article							TIME-RESOLVED REFLECTANCE; PENETRATION DEPTH; TISSUE; DENSITY; LIGHT; OSTEOPOROSIS; TOMOGRAPHY; ABSORPTION; SCATTERING; DIAGNOSIS	Non-invasive in vivo diffuse optical characterization of human bone opens a new possibility of diagnosing bone related pathologies. We present an in vivo characterization performed on seventeen healthy subjects at six different superficial bone locations: radius distal, radius proximal, ulna distal, ulna proximal, trochanter and calcaneus. A tailored diffuse optical protocol for high penetration depth combined with the rather superficial nature of considered tissues ensured the effective probing of the bone tissue. Measurements were performed using a broadband system for Time-Resolved Diffuse Optical Spectroscopy (TRS) to assess mean absorption and reduced scattering spectra in the 600-1200 nm range and Diffuse Correlation Spectroscopy (DCS) to monitor microvascular blood flow. Significant variations among tissue constituents were found between different locations; with radius distal rich of collagen, suggesting it as a prominent location for bone related measurements, and calcaneus bone having highest blood flow among the body locations being considered. By using TRS and DCS together, we are able to probe the perfusion and oxygen consumption of the tissue without any contrast agents. Therefore, we predict that these methods will be able to evaluate the impairment of the oxygen metabolism of the bone at the point-of-care.	[Sekar, Sanathana Konugolu Venkata; Farina, Andrea; Dalla Mora, Alberto; Taroni, Paola; Pifferi, Antonio] Politecn Milan, Dipartimento Fis, Milan, Italy; [Pagliazzi, Marco; Lindner, Claus; Farzam, Parisa; Durduran, Turgut] Barcelona Inst Sci & Technol, ICFO Inst Ciencies Foton, Barcelona, Spain; [Negredo, Eugenia; Perez-Alvarez, Nuria; Puig, Jordi] Germans Trias & Pujol Univ Hosp, Lluita Sida Fdn, Badalona, Spain; [Negredo, Eugenia; Perez-Alvarez, Nuria; Puig, Jordi] Univ Autonoma Barcelona, Barcelona, Spain; [Negredo, Eugenia] Univ Vic, Univ Cent Catalunya, Barcelona, Spain; [Martelli, Fabrizio] Univ Florence, Dipartimento Fis & Astron, Florence, Italy; [Farina, Andrea] CNR, Ist Foton & Nanotecnol, Milan, Italy; [Perez-Alvarez, Nuria] Univ Politecn Cataluna, Stat & Operat Res Dept, Barcelona, Spain; [Durduran, Turgut] ICREA, Barcelona, Spain	Polytechnic University of Milan; Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); Autonomous University of Barcelona; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); University of Florence; Consiglio Nazionale delle Ricerche (CNR); Universitat Politecnica de Catalunya; ICREA	Sekar, SKV (corresponding author), Politecn Milan, Dipartimento Fis, Milan, Italy.	sanathana.konugolu@polimi.it	Sekar, Sanathana Konugolu Venkata/P-5123-2017; Mora, Alberto Dalla/B-1393-2010; Mora, Alberto Dalla/AAA-7684-2020; Perez-Alvarez, Nuria/O-9244-2014; Farina, Andrea/I-1250-2012; Taroni, Paola/C-4709-2012; Pifferi, Antonio/C-4688-2012; Lindner, Claus/G-4601-2015; Durduran, Turgut/N-7768-2015	Sekar, Sanathana Konugolu Venkata/0000-0003-0912-1282; Mora, Alberto Dalla/0000-0002-2783-6217; Mora, Alberto Dalla/0000-0002-2783-6217; Perez-Alvarez, Nuria/0000-0001-6582-1553; Farina, Andrea/0000-0002-3180-6328; Taroni, Paola/0000-0001-7486-0001; Pifferi, Antonio/0000-0002-2261-2089; Lindner, Claus/0000-0002-9878-037X; Negredo, Eugenia/0000-0001-5298-1734; Durduran, Turgut/0000-0001-5838-1027	EC [317526]; Fundacio CELLEX Barcelona; Obra social "la Caixa" Foundation (LlumMedBcn); Severo Ochoa [SEV-2015-0522]; LASERLAB-EUROPE IV; Ministerio de Economia y Competitividad del Gobierno de Espana [MTM2015-64465-C2-1-R]; Departament d'Economia i Coneixement de la Generalitat de Catalunya [2014 SGR 464]; ICREA Funding Source: Custom	EC(European CommissionEuropean Commission Joint Research Centre); Fundacio CELLEX Barcelona(Foundation CELLEXEuropean Commission); Obra social "la Caixa" Foundation (LlumMedBcn); Severo Ochoa; LASERLAB-EUROPE IV; Ministerio de Economia y Competitividad del Gobierno de Espana(Spanish Government); Departament d'Economia i Coneixement de la Generalitat de Catalunya(Generalitat de Catalunya); ICREA(ICREA)	The research leading to these results has partially received funding from the EC's Seventh Framework Programme under the projects OILTEBIA (grant agreement n. 317526), Fundacio CELLEX Barcelona, Obra social "la Caixa" Foundation (LlumMedBcn), "Severo Ochoa" (SEV-2015-0522), LASERLAB-EUROPE IV, Ministerio de Economia y Competitividad del Gobierno de Espana (grant MTM2015-64465-C2-1-R) and Departament d'Economia i Coneixement de la Generalitat de Catalunya (2014 SGR 464). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research leading to these results has partially received funding from the EC's Seventh Framework Programme under the projects OILTEBIA (grant agreement n. 317526), Fundacio CELLEX Barcelona, Obra social "la Caixa" Foundation (LlumMedBcn), "Severo Ochoa" (SEV-2015-0522), LASERLAB-EUROPE IV, Ministerio de Economia y Competitividad del Gobierno de Espana (grant MTM2015-64465-C2-1-R) and Departament d'Economia i Coneixement de la Generalitat de Catalunya (2014 SGR 464).	Baker WB, 2014, BIOMED OPT EXPRESS, V5, P4053, DOI 10.1364/BOE.5.004053; Bauer DC, 1997, ARCH INTERN MED, V157, P629, DOI 10.1001/archinte.157.6.629; Beck Thomas J, 2007, Curr Osteoporos Rep, V5, P49; Blake GM, 2007, POSTGRAD MED J, V83, P509, DOI 10.1136/pgmj.2007.057505; Bluestone AY, 2001, OPT EXPRESS, V9, P272, DOI 10.1364/OE.9.000272; BOAS DA, 1995, PHYS REV LETT, V75, P1855, DOI 10.1103/PhysRevLett.75.1855; Boas DA, 1997, J OPT SOC AM A, V14, P192, DOI 10.1364/JOSAA.14.000192; Boonen S, 1997, J INTERN MED, V242, P323, DOI 10.1046/j.1365-2796.1997.00242.x; Choe R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099683; Contini D, 1997, APPL OPTICS, V36, P4587, DOI 10.1364/AO.36.004587; Cubeddu R, 2001, APPL SPECTROSC, V55, P1368, DOI 10.1366/0003702011953496; Dalla Mora A, 2015, OPT EXPRESS, V23, P13937, DOI 10.1364/OE.23.013937; Del Bianco S, 2002, PHYS MED BIOL, V47, P4131, DOI 10.1088/0031-9155/47/23/301; Durduran T, 2002, PHYS MED BIOL, V47, P2847, DOI 10.1088/0031-9155/47/16/302; Durduran T, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/7/076701; Farina A, 2015, BIOMED OPT EXPRESS, V6, P2609, DOI 10.1364/BOE.6.002609; Farzam P, 2014, PHYSIOL MEAS, V35, P1469, DOI 10.1088/0967-3334/35/7/1469; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Grabtchak S., 2012, BIOMED OPT EXP, V3, P2059; Griffith JF, 2005, RADIOLOGY, V236, P945, DOI 10.1148/radiol.2363041425; Han SF, 2015, BIOMED OPT EXPRESS, V6, P2695, DOI 10.1364/BOE.6.002695; Link TM, 1998, J BONE MINER RES, V13, P1175, DOI 10.1359/jbmr.1998.13.7.1175; Margallo-Balbas E, 2010, PHYS MED BIOL, V55, P4917, DOI 10.1088/0031-9155/55/17/003; Martelli F, 2016, SCI REP-UK, V6, DOI 10.1038/srep27057; Matousek P, 2009, ANALYST, V134, P1058, DOI 10.1039/b821100k; Min JY, 2007, J CLIN DENSITOM, V10, P184, DOI 10.1016/j.jocd.2006.12.004; Montejo LD, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.7.076001; Morris MD, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1827605; Mourant JR, 1997, APPL OPTICS, V36, P949, DOI 10.1364/AO.36.000949; PATTERSON MS, 1989, APPL OPTICS, V28, P2331, DOI 10.1364/AO.28.002331; Pifferi A, 2004, J BIOMED OPT, V9, P474, DOI 10.1117/1.1691029; Pifferi A, 2001, OPT LETT, V26, P1963, DOI 10.1364/OL.26.001963; Pifferi A, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2735567; POGUE BW, 1994, PHYS MED BIOL, V39, P1157, DOI 10.1088/0031-9155/39/7/008; SEIBEL MJ, 1992, TRENDS ENDOCRIN MET, V3, P263, DOI 10.1016/1043-2760(92)90129-O; Sekar SKV, 2016, IEEE J SEL TOP QUANT, V22, DOI 10.1109/JSTQE.2015.2506613; Sekar SKV, 2015, PROC SPIE, V9538, DOI 10.1117/12.2183724; Sekar SKV, 2015, PROC SPIE, V9538, DOI 10.1117/12.2183835; Selb J, 2014, NEUROPHOTONICS, V1, DOI 10.1117/1.NPh.1.1.015005; Seldin DW, 1987, COMP BONE DENSITY ME, P168; Taroni P, 2009, OPT EXPRESS, V17, P15932, DOI 10.1364/OE.17.015932; Torricelli A, 2001, PHYS MED BIOL, V46, P2227, DOI 10.1088/0031-9155/46/8/313; Torricelli A, 2014, NEUROIMAGE, V85, P28, DOI 10.1016/j.neuroimage.2013.05.106; Tromberg BJ, 2008, MED PHYS, V35, P2443, DOI 10.1118/1.2919078	44	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168426	10.1371/journal.pone.0168426	http://dx.doi.org/10.1371/journal.pone.0168426			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997565	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842900042
J	Du, ZY; Guo, W; Yang, RL; Tang, XD; Ji, T; Li, DS				Du, Zhiye; Guo, Wei; Yang, Rongli; Tang, Xiaodong; Ji, Tao; Li, Dasen			What Is the Value of Surgical Intervention for Sacral Metastases?	PLOS ONE			English	Article							QUALITY-OF-LIFE; SPINAL-CORD COMPRESSION; TUMOR RESECTION; BLOOD-LOSS; RADIOTHERAPY; CANCER; SURGERY; MANAGEMENT; TOXICITY; ONCOLOGY	Objective To investigate the impact of surgery on local control and quality of life for patients with sacral metastases and to determine whether the complications of surgery were acceptable. Methods Curettage for metastatic lesions of the sacrum was performed in 154 patients with obvious sacral nerve compression symptoms between July 1997 and July 2014. Potential risk factors were evaluated in univariate analysis for associations with local control; multivariate conditional logistic regression was used to identify the combined effects. Complications were recorded. The pre-and postoperative visual analogue scale of pain, Eastern Cooperative Oncology Group (ECOG) scores, and quality of life scores were collected to evaluate the impact of surgery. Results The cumulative survival rates were 71.8%, 41.1%, and 22.5% and the local control rates were 95.4%, 90.9%, and 79.4% at 6, 12, and 24 months, respectively. Tumors with rapid growth, the lack of preoperative radiotherapy, and application of aortic balloon occlusion were significantly associated with good local control. There were 29 (18.8%) complications related to surgery. The mean pain scores were 7.04 preoperatively, 1.66 at 1 month postoperatively (p = 0.003), and 1.51 at 3 months postoperatively (p = 0.002). The mean ECOG scores were 2.82 preoperatively and 1.47 3 months postoperatively (p < 0.001). There were significant improvements from preoperatively to 3 months postoperatively in global health status (43.3 vs. 52.1), pain (62.0 vs. 33.2), and constipation (51.4 vs. 30.3) (p< 0.001). Conclusions Surgery for sacral metastasis is effective to palliate pain rapidly and improve constipation and quality of life and has a low rate of complications.	[Du, Zhiye] Peking Univ, Dept Musculoskeletal Tumor Ctr, Beijing 100871, Peoples R China; Peoples Hosp, Beijing, Peoples R China	Peking University	Guo, W (corresponding author), Peking Univ, Dept Musculoskeletal Tumor Ctr, Beijing 100871, Peoples R China.	bonetumor@163.com	Li, D/N-4549-2019; Ji, Tao/AAI-2685-2020	Ji, Tao/0000-0001-6876-7361; Guo, Wei/0000-0003-2471-5767				AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Cella D F, 1996, Oncology (Williston Park), V10, P233; Chang EL, 2007, J NEUROSURG-SPINE, V7, P151, DOI 10.3171/SPI-07/08/151; Cummings BJ, INT J RAD ONCOL BIOL, V9, P633; Du Zhi-Ye, 2010, Orthop Surg, V2, P241, DOI 10.1111/j.1757-7861.2010.00095.x; Falicov A, 2006, SPINE, V31, P2849, DOI 10.1097/01.brs.0000245838.37817.40; Feiz-Erfan I, 2012, J NEUROSURG-SPINE, V17, P285, DOI 10.3171/2012.7.SPINE09351; FELDENZER JA, 1989, NEUROSURGERY, V25, P884, DOI 10.1227/00006123-198912000-00006; Gerszten PC, 2007, SPINE, V32, P193, DOI 10.1097/01.brs.0000251863.76595.a2; GILINSKY NH, 1983, Q J MED, V52, P40; Guo W, 2009, SPINE, V34, P1025, DOI 10.1097/BRS.0b013e31819d4127; Janjan N, 2001, SEMIN ONCOL, V28, P28, DOI 10.1053/sonc.2001.25444; Ji T, 2011, J BONE JOINT SURG BR, V93B, P1104, DOI 10.1302/0301-620X.93B8.26155; JOSEPH DL, 1973, ARCH OTOLARYNGOL, V97, P381; KETCHAM AS, 1969, AM J SURG, V118, P691, DOI 10.1016/0002-9610(69)90214-1; Kollender Y, 2003, CANCER-AM CANCER SOC, V97, P2830, DOI 10.1002/cncr.11383; Lawrence Jr W, CANCER, V33, P318; Li DS, 2013, EUR SPINE J, V22, P2069, DOI 10.1007/s00586-013-2765-x; Loblaw DA, 1998, J CLIN ONCOL, V16, P1613, DOI 10.1200/JCO.1998.16.4.1613; MAAS JM, 1948, AM J OBSTET GYNECOL, V56, P249, DOI 10.1016/0002-9378(48)90267-1; Maranzano E, 2003, TUMORI, V89, P469, DOI 10.1177/030089160308900502; Mi C, 2005, SPINE, V30, pE614, DOI 10.1097/01.brs.0000182111.64825.0f; Mizumoto M, 2011, INT J RADIAT ONCOL, V79, P208, DOI 10.1016/j.ijrobp.2009.10.056; Nader R, 2004, NEUROSURG CLIN N AM, V15, P453, DOI 10.1016/j.nec.2004.04.009; OBrien PC, 1997, RADIOTHER ONCOL, V45, P117, DOI 10.1016/S0167-8140(97)00146-1; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Ozdemir MH, 1999, EUR J SURG ONCOL, V25, P44, DOI 10.1053/ejso.1998.0598; Patchell RA, 2005, LANCET, V366, P643, DOI 10.1016/S0140-6736(05)66954-1; Piccioli A, 2014, INJURY, V45, P412, DOI 10.1016/j.injury.2013.09.025; PILEPICH MV, 1984, INT J RADIAT ONCOL, V10, P1861, DOI 10.1016/0360-3016(84)90263-3; Quraishi NA, 2010, J BONE JOINT SURG BR, V92B, P1054, DOI 10.1302/0301-620X.92B8.22296; Quraishi NA, 2012, EUR SPINE J, V21, P1984, DOI 10.1007/s00586-012-2394-9; Rades D, 2005, RADIOTHER ONCOL, V75, P70, DOI 10.1016/j.radonc.2004.12.013; Raque GH, 2001, J SURG ONCOL, V76, P301, DOI 10.1002/jso.1050; SMIT WGJM, 1990, INT J RADIAT ONCOL, V18, P23, DOI 10.1016/0360-3016(90)90262-I; Tang XD, 2010, J BONE JOINT SURG AM, V92A, P1747, DOI 10.2106/JBJS.I.01333; Tang XD, 2009, CLIN ORTHOP RELAT R, V467, P1599, DOI 10.1007/s11999-008-0483-1; Tomita K, 2006, J ORTHOP SCI, V11, P3, DOI 10.1007/s00776-005-0964-y; Wu JA, 2010, CANCER-AM CANCER SOC, V116, P3875, DOI 10.1002/cncr.25126; XU RM, 1995, J SPINAL DISORD, V8, P352	40	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168313	10.1371/journal.pone.0168313	http://dx.doi.org/10.1371/journal.pone.0168313			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992502	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842600048
J	Park, L				Park, Leeyoung			Evidence of Recent Intricate Adaptation in Human Populations	PLOS ONE			English	Article							CLASSIC SELECTIVE SWEEPS; ESTIMATING F-STATISTICS; NATURAL-SELECTION; HUMAN GENOME; POSITIVE SELECTION; PROTEIN FAMILIES; RARE VARIANTS; COPY NUMBER; GENE; DIFFERENTIATION	Recent human adaptations have shaped population differentiation in genomic regions containing putative functional variants, mostly located in predicted regulatory elements. However, their actual functionalities and the underlying mechanism of recent adaptation remain poorly understood. In the current study, regions of genes and repeats were investigated for functionality depending on the degree of population differentiation, F-ST or Delta DAF (a difference in derived allele frequency). The high FST in the 5 A or 3 A untranslated regions (UTRs), in particular, confirmed that population differences arose mainly from differences in regulation. Expression quantitative trait loci (eQTL) analyses using lymphoblastoid cell lines indicated that the majority of the highly population-specific regions represented cis-and/or trans-eQTL. However, groups having the highest Delta DAFs did not necessarily have higher proportions of eQTL variants; in these groups, the patterns were complex, indicating recent intricate adaptations. The results indicated that East Asian (EAS) and European populations (EUR) experienced mutual selection pressures. The mean derived allele frequency of the high Delta DAF groups suggested that EAS and EUR underwent strong adaptation; however, the African population in Africa (AFR) experienced slight, yet broad, adaptation. The DAF distributions of variants in the gene regions showed clear selective pressure in each population, which implies the existence of more recent regulatory adaptations in cells other than lymphoblastoid cell lines. In-depth analysis of population-differentiated regions indicated that the coding gene, RNF135, represented a trans-regulation hotspot via cis-regulation by the population-specific variants in the region of selective sweep. Together, the results provide strong evidence of actual intricate adaptation of human populations via regulatory manipulation.	[Park, Leeyoung] Yonsei Univ, Nat Sci Res Inst, Seoul, South Korea	Yonsei University	Park, L (corresponding author), Yonsei Univ, Nat Sci Res Inst, Seoul, South Korea.	lypark@yonsei.ac.kr			National Research Foundation of Korea (NRF) grants - Korean Government (MSIP) [2013R1A1A3006685, 2014K2A7A1044502, 2015R1D1A1A01059302]; Korea Institute of Science and Technology Information (KISTI) [KSC-2014-C2-019]	National Research Foundation of Korea (NRF) grants - Korean Government (MSIP); Korea Institute of Science and Technology Information (KISTI)(Korea Institute of Science & Technology Information (KISTI))	This work was supported by the National Research Foundation of Korea (NRF) grants funded by the Korean Government (MSIP) (2013R1A1A3006685, 2014K2A7A1044502, and 2015R1D1A1A01059302). The supercomputing resources were supported by the Korea Institute of Science and Technology Information (KISTI), with grant no. KSC-2014-C2-019.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; Bhatia G, 2013, GENOME RES, V23, P1514, DOI 10.1101/gr.154831.113; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Colonna V, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r88; Coop G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000500; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Douglas J, 2007, NAT GENET, V39, P963, DOI 10.1038/ng2083; Duforet-Frebourg N, 2016, MOL BIOL EVOL, V33, P1082, DOI 10.1093/molbev/msv334; Fagny M, 2014, MOL BIOL EVOL, V31, P1850, DOI 10.1093/molbev/msu118; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Granka JM, 2012, GENETICS, V192, P1049, DOI 10.1534/genetics.112.144071; Grossman SR, 2013, CELL, V152, P703, DOI 10.1016/j.cell.2013.01.035; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Hernandez RD, 2011, SCIENCE, V331, P920, DOI 10.1126/science.1198878; HUDSON RR, 1992, GENETICS, V132, P583; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kudaravalli S, 2009, MOL BIOL EVOL, V26, P649, DOI 10.1093/molbev/msn289; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lee C, 2007, NAT GENET, V39, pS48, DOI 10.1038/ng2092; Liu XY, 2013, AM J HUM GENET, V92, P866, DOI 10.1016/j.ajhg.2013.04.021; Marth GT, 2004, GENETICS, V166, P351, DOI 10.1534/genetics.166.1.351; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Nei M., 2000, MOL EVOLUTION PYLOGE; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Nielsen R, 2009, GENOME RES, V19, P838, DOI 10.1101/gr.088336.108; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Park L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128186; Park L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046603; Pertile MD, 2009, GENOME RES, V19, P2202, DOI 10.1101/gr.092080.109; Racimo F, 2014, MOL BIOL EVOL, V31, P3344, DOI 10.1093/molbev/msu255; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Schwartz RS, 2001, NEW ENGL J MED, V344, P1392, DOI 10.1056/NEJM200105033441810; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Tastet J, 2015, PSYCHIAT GENET, V25, P263, DOI 10.1097/YPG.0000000000000100; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thomsen H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154259; Tromer E, 2015, GENOME BIOL EVOL; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Weir BS, 2012, PHILOS SCI, V79, P637, DOI 10.1086/667904; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; Winnefeld M, 2012, J INVEST DERMATOL, V132, P466, DOI 10.1038/jid.2011.323; Xue YL, 2009, GENETICS, V183, P1065, DOI 10.1534/genetics.109.107722; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371	54	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0165870	10.1371/journal.pone.0165870	http://dx.doi.org/10.1371/journal.pone.0165870			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992444	Green Published, gold, Green Submitted			2022-12-26	WOS:000392842600007
J	Rossini, BC; Oliveira, CAM; de Melo, FAG; Bertaco, VD; de Astarloa, JMD; Rosso, JJ; Foresti, F; Oliveira, C				Rossini, Bruno Cesar; Miranda Oliveira, Carlos Alexandre; Goncalves de Melo, Filipe Augusto; Bertaco, Vinicius de Araujo; Diaz de Astarloa, Juan M.; Rosso, Juan J.; Foresti, Fausto; Oliveira, Claudio			Highlighting Astyanax Species Diversity through DNA Barcoding	PLOS ONE			English	Article							FRESH-WATER FISHES; RIO-PARANA SYSTEM; CHARACIFORMES CHARACIDAE; OSTARIOPHYSI CHARACIFORMES; TELEOSTEI CHARACIFORMES; BRAZIL OSTARIOPHYSI; DELIMITATION METHOD; REDESCRIPTION; BASIN; EIGENMANN	DNA barcoding has been used extensively to solve taxonomic questions and identify new species. Neotropical fishes are found in a wide variety of shapes and sizes, with a large number of species yet to be described, many of which are very difficult to identify. Characidae is the most species-rich family of the Characiformes, and many of its genera are affected by taxonomic uncertainties, including the widely-distributed, species-rich genus Astyanax. In this study, we present an extensive analysis of Astyanax covering almost its entire area of occurrence, based on DNA barcoding. The use of different approaches (ABGD, GMYC and BIN) to the clustering of the sequences revealed ample consistency in the results obtained by the initial cutoff value of 2% divergence for putative species in the Neighbor-Joining analysis using the Kimura-2-parameter model. The results indicate the existence of five Astyanax lineages. Some groups, such as that composed by the trans-Andean forms, are mostly composed of well-defined species, and in others a number of nominal species are clustered together, hampering the delimitation of species, which in many cases proved impossible. The results confirm the extreme complexity of the systematics of the genus Astyanax and show that DNA barcoding can be an useful tool to address these complexes questions.	[Rossini, Bruno Cesar; Foresti, Fausto; Oliveira, Claudio] UNESP Univ Estadual Paulista, Dept Morfol, Lab Biol & Genet Peixes, Botucatu, SP, Brazil; [Rossini, Bruno Cesar] UNESP Univ Estadual Paulista, Inst Biotecnol, Botucatu, SP, Brazil; [Miranda Oliveira, Carlos Alexandre] Univ Estadual Maringa, Programa Posgrad Ecol Ambientes Aquat Continental, Maringa, Parana, Brazil; [Goncalves de Melo, Filipe Augusto] Univ Estadual Piau, Campus Alexandre Alves Oliveira, Parnaiba, Piaui, Brazil; [Bertaco, Vinicius de Araujo] Museu Ciencias Nat, Fundacao Zoobot Rio Grande Sul, Porto Alegre, RS, Brazil; [Diaz de Astarloa, Juan M.; Rosso, Juan J.] Univ Nacl Mar Plata, CONICET, Inst Invest Marinas & Costeras, Grp Biotaxon Morfol & Mol Peces, Buenos Aires, DF, Argentina	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual de Maringa; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Mar del Plata	Rossini, BC (corresponding author), UNESP Univ Estadual Paulista, Dept Morfol, Lab Biol & Genet Peixes, Botucatu, SP, Brazil.; Rossini, BC (corresponding author), UNESP Univ Estadual Paulista, Inst Biotecnol, Botucatu, SP, Brazil.	bu_rossini@yahoo.com.br	Bertaco, Vinicius A./B-8899-2013; de Astarloa, Juan Diaz/F-5395-2012; Oliveira, Claudio/D-7713-2012; Rossini, Bruno C/M-4704-2014; Rossini, Bruno Cesar Cesar/AAX-6765-2021; Rosso, Juan Jose/ABC-5504-2020	Oliveira, Claudio/0000-0002-7010-8880; Rossini, Bruno Cesar Cesar/0000-0002-5685-9610; Rosso, Juan Jose/0000-0001-6730-9385	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [00264-2/2011, 2010/17009-2]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [D1009]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [303854/2009-0]; Coordenadoria de Aperfeicoamento do Ensino Superior	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenadoria de Aperfeicoamento do Ensino Superior	This investigation was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (www.fapesp.br; grant number 00264-2/2011 for BCR and 2010/17009-2 for CO), Consejo Nacional de Investigaciones Cientificas y Tecnicas (http://www.conicet.gov.ar/; grant number D1009 for JMDA), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://cnpq.br/; grant number 303854/2009-0 for CO) and Coordenadoria de Aperfeicoamento do Ensino Superior (https://www.capes.gov.br/).	Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P3; [Anonymous], 2014, TRACER V1 6; [Anonymous], CATALOG FISHES; Barley AJ, 2016, MOL ECOL, V25, P1944, DOI 10.1111/mec.13590; Bertaco VA, 2006, NEOTROP ICHTHYOL, V4, P53, DOI 10.1590/S1679-62252006000100004; Bertaco VA, 2010, NEOTROP ICHTHYOL, V8, P7, DOI 10.1590/S1679-62252010000100002; Bertaco Vinicius Araujo, 2001, Ichthyological Exploration of Freshwaters, V12, P221; Buckup PA, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P203; Camelier P, 2014, J FISH BIOL, V84, P475, DOI 10.1111/jfb.12295; Casciotta Jorge R., 2003, Ichthyological Exploration of Freshwaters, V14, P329; Casciotta JR, 2005, REV SUISSE ZOOL, V112, P401, DOI 10.5962/bhl.part.80305; Castro RMC, 2004, P BIOL SOC WASH, V117, P330; Costa-Silva GJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135075; Cuvier LB., 1819, MEMOIRS, V5, P352; Cuvier LB, 1848, MEMOIRS MUSEUM HIST, V22, P1; de Carvalho DC, 2011, MITOCHONDR DNA, V22, P80, DOI 10.3109/19401736.2011.588214; de Lucena CAS, 2013, NEOTROP ICHTHYOL, V11, P537, DOI 10.1590/S1679-62252013000300007; De Lucena CAS, 2016, ZOOTAXA, V4072, P101, DOI 10.11646/zootaxa.4072.1.5; de Melo FAG, 2006, NEOTROP ICHTHYOL, V4, P45, DOI 10.1590/S1679-62252006000100003; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eigenmann C. H., 1914, Indiana University Studies Bloomington, V19; Eigenmann C.H., 1921, Memoirs Museum of Comparative Zoology Cambridge Mass, V43, P209; Eigenmann C.H., 1911, ANN CARNEGIE MUS, V8, P164; EIGENMANN CARL H., 1927, MEM MUS COMP ZOOL, V43, P311; Eigenmann CH, 1917, MEMOIRS MUSEUM COMP, V23, P1; Ezard T, 2009, PACKAGE SPLITS SPECI; Fernandes CA, 2004, HEREDITAS, V141, P328; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Garavello JC, 2010, BRAZ J BIOL, V70, P847, DOI 10.1590/S1519-69842010000400016; Garutti V., 1999, Revista Brasileira de Biologia, V59, P585; Garutti V, 1995, THESIS; Garutti V, 2000, SERIE ZOOLOGIA, V13, P65; Garutti V, 2009, NEOTROP ICHTHYOL, V7, P371, DOI 10.1590/S1679-62252009000300003; Garutti Valdener, 1997, Papeis Avulsos de Zoologia (Sao Paulo), V40, P217; Gery J., 1977, CHARACOIDS WORLD; Gross JB, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-105; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Kekkonen M, 2014, MOL ECOL RESOUR, V14, P706, DOI 10.1111/1755-0998.12233; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kingman J., 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Kullander S.O., 2003, CHECK LIST FRESHWATE, P605; Lakra WS, 2011, MOL ECOL RESOUR, V11, P60, DOI 10.1111/j.1755-0998.2010.02894.x; Lara A, 2010, MOL ECOL RESOUR, V10, P421, DOI 10.1111/j.1755-0998.2009.02785.x; Lima F. C. T., 2003, CHECK LIST FRESHWATE, P106, DOI DOI 10.1590/S1679-62252003000100003; Mabragana E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028655; Mirande JM, 2010, NEOTROP ICHTHYOL, V8, P385, DOI 10.1590/S1679-62252010000300001; Marinho MMF, 2013, ZOOTAXA, V3652, P475, DOI 10.11646/zootaxa.3652.4.5; Medrado AS, 2008, GENET MOL BIOL, V31, P208, DOI 10.1590/S1415-47572008000200007; Melo BF, 2011, NEOTROP ICHTHYOL, V9, P49, DOI 10.1590/S1679-62252011000100002; MELO F. A. G., 2001, ARQ MUS NAC, V59, P1; Melo FAG, 2005, THESIS; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miquelarena AM, 2005, REV SUISSE ZOOL, V112, P661, DOI 10.5962/bhl.part.80319; Miya M, 2000, MOL PHYLOGENET EVOL, V17, P437, DOI 10.1006/mpev.2000.0839; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; MOREIRA O, 1991, REV BRAS GENET, V14, P331; Peres WAM, 2012, REV FISH BIOL FISHER, V22, P519, DOI 10.1007/s11160-011-9246-2; Oliveira C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-275; Ornelas-Garcia Claudia Patricia, 2008, BMC Evol Biol, V8, P340, DOI 10.1186/1471-2148-8-340; Pavanelli CS, 2009, NEOTROP ICHTHYOL, V7, P569, DOI 10.1590/S1679-62252009000400003; Pazza R, 2008, J FISH BIOL, V72, P2002, DOI 10.1111/j.1095-8649.2008.01837.x; Pereira LHG, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-20; Pereira LHG, 2011, MITOCHONDR DNA, V22, P71, DOI 10.3109/19401736.2010.532213; Pie MR, 2009, J FISH BIOL, V75, P2357, DOI 10.1111/j.1095-8649.2009.02438.x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Powell JR, 2012, METHODS ECOL EVOL, V3, P1, DOI 10.1111/j.2041-210X.2011.00122.x; Puillandre N, 2012, MOL ECOL, V21, P2671, DOI 10.1111/j.1365-294X.2012.05559.x; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Rosso JJ, 2012, MOL ECOL RESOUR, V12, P999, DOI 10.1111/1755-0998.12010; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schultz Leonard P, 1944, PROC U S NATION MUS, V95, P235; Soneira P, 2010, NEOTROP ICHTHYOL, V8, P779; Tagliacollo Victor A., 2011, Zootaxa, V2749, P40; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Valdez-Moreno M, 2009, J FISH BIOL, V74, P377, DOI 10.1111/j.1095-8649.2008.02077.x; Vari RP, 2007, COPEIA, P150, DOI 10.1643/0045-8511(2007)7[150:NSOAOC]2.0.CO;2; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002; Zanata AM, 2009, NEOTROP ICHTHYOL, V7, P175, DOI 10.1590/S1679-62252009000200007; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zinger L, 2016, MOL ECOL, V25, P1908, DOI 10.1111/mec.13639	91	55	58	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0167203	10.1371/journal.pone.0167203	http://dx.doi.org/10.1371/journal.pone.0167203			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992537	Green Published, gold, Green Submitted			2022-12-26	WOS:000392842600012
J	Marini, S; Limongelli, I; Rizzo, E; Malovini, A; Errichiello, E; Vetro, A; Da, T; Zuffardi, O; Bellazzi, R				Marini, Simone; Limongelli, Ivan; Rizzo, Ettore; Malovini, Alberto; Errichiello, Edoardo; Vetro, Annalisa; Da, Tan; Zuffardi, Orsetta; Bellazzi, Riccardo			A Data Fusion Approach to Enhance Association Study in Epilepsy	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RARE-VARIANT ASSOCIATION; RHEUMATOID-ARTHRITIS; MOLECULAR DIAGNOSIS; GENETIC-VARIATION; COMMON VARIANTS; SEQUENCE; RISK; MUTATIONS; RESOURCE	Among the scientific challenges posed by complex diseases with a strong genetic component, two stand out. One is unveiling the role of rare and common genetic variants; the other is the design of classification models to improve clinical diagnosis and predictive models for prognosis and personalized therapies. In this paper, we present a data fusion framework merging gene, domain, pathway and protein-protein interaction data related to a next generation sequencing epilepsy gene panel. Our method allows integrating association information from multiple genomic sources and aims at highlighting the set of common and rare variants that are capable to trigger the occurrence of a complex disease. When compared to other approaches, our method shows better performances in classifying patients affected by epilepsy.	[Marini, Simone] Kyoto Univ, Bioinformat Ctr, Inst Chem Res, Kyoto, Japan; [Marini, Simone; Da, Tan; Bellazzi, Riccardo] Univ Pavia, Dept Elect Comp & Biomed Engn, Pavia, Italy; [Limongelli, Ivan; Vetro, Annalisa; Zuffardi, Orsetta] IRCCS Fdn San Matteo, Genom Core Ctr, Pavia, Italy; [Limongelli, Ivan; Rizzo, Ettore] EnGenome Srl, Via Ferrata 5, Pavia, Italy; [Limongelli, Ivan; Rizzo, Ettore; Bellazzi, Riccardo] Univ Pavia, Ctr Hlth Technol, Pavia, Italy; [Malovini, Alberto; Bellazzi, Riccardo] IRCCS Fdn S Maugeri, Pavia, Italy; [Errichiello, Edoardo; Vetro, Annalisa; Zuffardi, Orsetta] Univ Pavia, Dept Mol Med, Pavia, Italy	Kyoto University; University of Pavia; IRCCS Fondazione San Matteo; University of Pavia; Istituti Clinici Scientifici Maugeri IRCCS; University of Pavia	Marini, S (corresponding author), Kyoto Univ, Bioinformat Ctr, Inst Chem Res, Kyoto, Japan.; Marini, S (corresponding author), Univ Pavia, Dept Elect Comp & Biomed Engn, Pavia, Italy.	simone.marini@unipv.it	Errichiello, Edoardo/K-8360-2019; Vetro, Annalisa/J-8203-2018; Malovini, Alberto/I-8727-2018; Bellazzi, Riccardo/J-6432-2018	Vetro, Annalisa/0000-0003-2437-7526; Malovini, Alberto/0000-0003-2857-5773; Bellazzi, Riccardo/0000-0002-6974-9808; Marini, Simone/0000-0002-5704-3533; Errichiello, Edoardo/0000-0001-6346-1988	University of Pavia; Telethon Italy [GGP13060]; University of Pavia: "Centre for Health Technologies"	University of Pavia; Telethon Italy(Fondazione Telethon); University of Pavia: "Centre for Health Technologies"	AV benefits of a research position granted by the University of Pavia in the context of the strategic plan: "Towards a governance model for the international migration: an interdisciplinary and diachronic perspective; OZ was supported by Telethon Italy Grant GGP13060. SM is an International Research Fellow of the Japan Society for the Promotion of Science. The work was partly supported by the strategic plan of the University of Pavia: "Centre for Health Technologies". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Anney RJL, 2014, LANCET NEUROL, V13, P893, DOI 10.1016/S1474-4422(14)70171-1; Auer PL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0138-2; Baum L, 2014, HUM GENET, V133, P651, DOI 10.1007/s00439-013-1405-1; Beleites C, 2013, ANAL CHIM ACTA, V760, P25, DOI 10.1016/j.aca.2012.11.007; Biscarini F, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0197-5; Chatr-aryamontri A, 2015, NUCLEIC ACIDS RES, V43, pD470, DOI 10.1093/nar/gku1204; Chiewthanakul P, 2015, EPILEPSY BEHAV, V49, P155, DOI 10.1016/j.yebeh.2015.04.061; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Clarke GM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003694; Curtis D, 2016, ANN HUM GENET, V80, P38, DOI 10.1111/ahg.12135; de Kovel CGF, 2010, EPILEPSY RES, V89, P286, DOI 10.1016/j.eplepsyres.2010.01.013; Della Mina E, 2015, EUR J HUM GENET, V23, P354, DOI 10.1038/ejhg.2014.92; Deprez L, 2008, EPILEPSIA, V49, P500, DOI 10.1111/j.1528-1167.2007.01415.x; Dering C, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00323; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Diogo D, 2013, AM J HUM GENET, V92, P15, DOI 10.1016/j.ajhg.2012.11.012; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; EpiPM Consortium, 2016, LANCET NEUROL, V15, P241, DOI 10.1016/S1474-4422(15)00199-4; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Heinzen EL, 2012, AM J HUM GENET, V91, P293, DOI 10.1016/j.ajhg.2012.06.016; Hesdorffer DC, 2011, NEUROLOGY, V76, P23, DOI 10.1212/WNL.0b013e318204a36a; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hormozdiari F, 2015, GENOME RES, V25, P142, DOI 10.1101/gr.178855.114; Ionita-Laza I, 2013, AM J HUM GENET, V92, P841, DOI 10.1016/j.ajhg.2013.04.015; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kasperaviciute D, 2010, BRAIN; Klassen T, 2011, CELL, V145, P1036, DOI 10.1016/j.cell.2011.05.025; Klei L, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-9; Larsen J, 2015, EPILEPSIA, V56, pE203, DOI 10.1111/epi.13222; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Leu C, 2012, EPILEPSIA, V53, P308, DOI 10.1111/j.1528-1167.2011.03379.x; Limongelli I, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0554-8; Ma L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003321; Martin HC, 2014, HUM MOL GENET, V23, P3200, DOI 10.1093/hmg/ddu030; Meng H. B., 2015, J HARBIN ENG U, V36, P1, DOI DOI 10.1002/HUMU.22782; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miller ML, 2015, CELL SYST, V1, P197, DOI 10.1016/j.cels.2015.08.014; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Moutsianas L, 2014, BRIEF FUNCT GENOMICS, V13, P362, DOI 10.1093/bfgp/elu012; Oliveira MS, 2010, BRAIN RES, V1348, P187, DOI 10.1016/j.brainres.2010.05.095; Pane M, 2013, NEUROMUSCULAR DISORD, V23, P313, DOI 10.1016/j.nmd.2013.01.011; Poduri A, 2011, CURR OPIN GENET DEV, V21, P325, DOI 10.1016/j.gde.2011.01.005; Rosenthal Robert, 1984, ESSENTIALS BEHAV RES; Russu A, 2012, J AM MED INFORM ASSN, V19, pE13, DOI 10.1136/amiajnl-2011-000741; Spillane J, 2016, J NEUROL NEUROSUR PS, V87, P37, DOI 10.1136/jnnp-2015-311233; Tatonetti NP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S9-S9; Urrutia E, 2015, STAT INTERFACE, V8, P495, DOI 10.4310/SII.2015.v8.n4.a8; Uusimaa J, 2013, EPILEPSIA, V54, P1002, DOI 10.1111/epi.12115; van Dijk EL, 2014, TRENDS GENET, V30, P418, DOI 10.1016/j.tig.2014.07.001; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wu GD, 2013, GENET EPIDEMIOL, V37, P478, DOI 10.1002/gepi.21728; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yu W, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-16; Zhao Q, 2015, BRIEF BIOINFORM, V16, P291, DOI 10.1093/bib/bbu003; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	60	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0164940	10.1371/journal.pone.0164940	http://dx.doi.org/10.1371/journal.pone.0164940			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27984588	Green Published, Green Submitted, gold			2022-12-26	WOS:000392758000002
J	Yang, J; Teng, YG; Song, LT; Zuo, R				Yang, Jie; Teng, Yanguo; Song, Liuting; Zuo, Rui			Tracing Sources and Contamination Assessments of Heavy Metals in Road and Foliar Dusts in a Typical Mining City, China	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; STREET DUST; SIZE-DISTRIBUTION; URBAN; POLLUTION; SPECIATION; SEDIMENTS; DENSITY; SOILS	Road and foliar dust samples from four land-use districts of Panzhihua City, a famous V-Ti magnetite production area of China, were collected to investigate the sources and distribution characteristics of 9 heavy metals (V, Pb, Cd, Cu, Zn, Ni, Cr, Fe, and Mn). The results suggest that foliar samples had smaller particle size and higher heavy metal contents than road dusts. The contamination assessments of heavy metals were as follows: Pb and V (significant enrichment) > Zn, Ni, Cr, Fe, and Mn (moderate enrichment) > Cd and Ni (minimal enrichment). Statistical analyses showed Pb, as the primary pollution element, originated from waste incineration and lead-fuel combustion. The sources of Zn, Ni, Cr, Fe, V, and Mn were fugitive dust and traffic activities. Potential origins of Cu were corrosion of alloys used in vehicle components, vehicle covers, or other metallic surfaces and materials. The sources of Cd were different from any other heavy metals. Traffic and industrial activities were the main anthropogenic origins of heavy metals in dusts of Panzhihua, and more attention should be paid to heavy metal pollution in agricultural area.	[Yang, Jie; Teng, Yanguo; Song, Liuting; Zuo, Rui] Beijing Normal Univ, Coll Water Sci, Beijing, Peoples R China; [Yang, Jie; Teng, Yanguo; Song, Liuting; Zuo, Rui] Minist Educ, Engn Res Ctr Groundwater Pollut Control & Remedia, Beijing, Peoples R China	Beijing Normal University	Yang, J (corresponding author), Beijing Normal Univ, Coll Water Sci, Beijing, Peoples R China.; Yang, J (corresponding author), Minist Educ, Engn Res Ctr Groundwater Pollut Control & Remedia, Beijing, Peoples R China.	yangjie@bnu.edu.cn			Major Science and Technology Program for Water Pollution Control and Treatment [2014ZX07201-010]; National Natural Science Foundation of China [41403085]	Major Science and Technology Program for Water Pollution Control and Treatment; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Major Science and Technology Program for Water Pollution Control and Treatment (No. 2014ZX07201-010), and the National Natural Science Foundation of China (No. 41403085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JA, 2015, CHEMOSPHERE, V134, P328, DOI 10.1016/j.chemosphere.2015.04.038; Ahmed F, 2006, ATMOS ENVIRON, V40, P3835, DOI 10.1016/j.atmosenv.2006.03.004; [Anonymous], 1995, 11466 ISO; Cheng Y, 2015, PARTICUOLOGY, V18, P96, DOI 10.1016/j.partic.2013.10.003; Del Rio-Salas R, 2012, ATMOS ENVIRON, V60, P202, DOI 10.1016/j.atmosenv.2012.06.061; Deletic A, 2005, J ENVIRON ENG, V131, P49, DOI 10.1061/(ASCE)0733-9372(2005)131:1(49); Duong TTT, 2011, J ENVIRON MANAGE, V92, P554, DOI 10.1016/j.jenvman.2010.09.010; Ferreira-Baptista L, 2005, ATMOS ENVIRON, V39, P4501, DOI 10.1016/j.atmosenv.2005.03.026; FreerSmith PH, 1997, ENVIRON POLLUT, V95, P27, DOI 10.1016/S0269-7491(96)00119-4; Gowd SS, 2010, J HAZARD MATER, V174, P113, DOI 10.1016/j.jhazmat.2009.09.024; Grousset FE, 2005, CHEM GEOL, V222, P149, DOI 10.1016/j.chemgeo.2005.05.006; Gunawardana C, 2012, CHEMOSPHERE, V87, P163, DOI 10.1016/j.chemosphere.2011.12.012; Han YM, 2006, SCI TOTAL ENVIRON, V355, P176, DOI 10.1016/j.scitotenv.2005.02.026; Hyeong K, 2011, CHEM GEOL, V286, P240, DOI 10.1016/j.chemgeo.2011.05.009; JIRIES A, 2003, ENVIRONMENTALIST, V23, P205, DOI DOI 10.1023/B:ENVR.0000017390.93161.99; Kumar M, 2013, GEODERMA, V211, P8, DOI 10.1016/j.geoderma.2013.07.004; Lee PK, 2013, CHEMOSPHERE, V91, P1018, DOI 10.1016/j.chemosphere.2013.01.074; Li HY, 2015, J ENVIRON SCI-CHINA, V32, P228, DOI 10.1016/j.jes.2014.11.014; Li ZG, 2013, ENVIRON POLLUT, V182, P408, DOI 10.1016/j.envpol.2013.07.041; Lim JH, 2002, ATMOS ENVIRON, V40, P7810; Lu XW, 2009, J HAZARD MATER, V161, P1058, DOI 10.1016/j.jhazmat.2008.04.052; Manno E, 2006, ATMOS ENVIRON, V40, P5929, DOI 10.1016/j.atmosenv.2006.05.020; Murakami M, 2005, CHEMOSPHERE, V61, P783, DOI 10.1016/j.chemosphere.2005.04.003; Onder S, 2006, ATMOS ENVIRON, V40, P1122, DOI 10.1016/j.atmosenv.2005.11.006; Prichard HM, 2009, SCI TOTAL ENVIRON, V407, P1715, DOI 10.1016/j.scitotenv.2008.10.042; Qiu Y, 2009, CHEMOSPHERE, V75, P447, DOI 10.1016/j.chemosphere.2008.12.061; Saeedi M, 2012, J HAZARD MATER, V227, P9, DOI 10.1016/j.jhazmat.2012.04.047; Salonen VP, 2007, APPL GEOCHEM, V22, P906, DOI 10.1016/j.apgeochem.2007.02.003; Shi GT, 2008, ENVIRON POLLUT, V156, P251, DOI 10.1016/j.envpol.2008.02.027; Simon E, 2011, ENVIRON POLLUT, V159, P1229, DOI 10.1016/j.envpol.2011.01.034; Singh AK, 2011, ENVIRON EARTH SCI, V62, P1447, DOI 10.1007/s12665-010-0630-3; Sun YB, 2010, J HAZARD MATER, V174, P455, DOI 10.1016/j.jhazmat.2009.09.074; Teng YG, 2011, ENVIRON MONIT ASSESS, V176, P605, DOI 10.1007/s10661-010-1607-0; Thorpe A, 2008, SCI TOTAL ENVIRON, V400, P270, DOI 10.1016/j.scitotenv.2008.06.007; Tomasevic M, 2005, CHEMOSPHERE, V61, P753, DOI 10.1016/j.chemosphere.2005.03.077; Wang W, 2013, J HAZARD MATER, V263, P627, DOI 10.1016/j.jhazmat.2013.10.023; Wei BG, 2010, ENVIRON MONIT ASSESS, V160, P33, DOI 10.1007/s10661-008-0655-1; World Health Organization, 1988, VAN ENV HLTH CRIT; World Health Organization (WHO), 2001, VAN PENT OTH IN VAN; Yasir F, 2009, PAK MICROCHEM J, V92, P186; Zhang DY, 2014, J TAIWAN INST CHEM E, V45, P2447, DOI 10.1016/j.jtice.2014.04.018; Zhao HT, 2010, J HAZARD MATER, V183, P203, DOI 10.1016/j.jhazmat.2010.07.012; [赵勇 Zhao Yong], 2002, [华中农业大学学报, Journal of Huazhong Agricultural University], V21, P582	43	30	31	7	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168528	10.1371/journal.pone.0168528	http://dx.doi.org/10.1371/journal.pone.0168528			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992518	Green Published, Green Submitted, gold			2022-12-26	WOS:000392758000058
J	Seo, KH; Bartley, GE; Tam, C; Kim, HS; Kim, DH; Chon, JW; Kim, H; Yokoyama, W				Seo, Kun-Ho; Bartley, Glenn E.; Tam, Christina; Kim, Hong-Seok; Kim, Dong-Hyeon; Chon, Jung-Whan; Kim, Hyunsook; Yokoyama, Wallace			Chardonnay Grape Seed Flour Ameliorates Hepatic Steatosis and Insulin Resistance via Altered Hepatic Gene Expression for Oxidative Stress, Inflammation, and Lipid and Ceramide Synthesis in Diet-Induced Obese Mice	PLOS ONE			English	Article							FATTY LIVER-DISEASE; ADIPOSE-TISSUE; HYDROXYPROPYL METHYLCELLULOSE; NONALCOHOLIC STEATOHEPATITIS; PLASMA-CHOLESTEROL; METABOLIC SYNDROME; DEFICIENT MICE; WEIGHT-LOSS; GREEN TEA; EXTRACT	To identify differentially expressed hepatic genes contributing to the improvement of high-fat (HF) diet-induced hepatic steatosis and insulin resistance following supplementation of partially defatted flavonoid-rich Chardonnay grape seed flour (ChrSd), diet-induced obese (DIO) mice were fed HF diets containing either ChrSd or microcrystalline cellulose (MCC, control) for 5 weeks. The 2-h insulin area under the curve was significantly lowered by ChrSd, indicating that ChrSd improved insulin sensitivity. ChrSd intake also significantly reduced body weight gain, liver and adipose tissue weight, hepatic lipid content, and plasma low-density lipoprotein (LDL)-cholesterol, despite a significant increase in food intake. Exon microarray analysis of hepatic gene expression revealed down-regulation of genes related to triglyceride and ceramide synthesis, immune response, oxidative stress, and inflammation and upregulation of genes related to fatty acid oxidation, cholesterol, and bile acid synthesis. In conclusion, the effects of ChrSd supplementation in a HF diet on weight gain, insulin resistance, and progression of hepatic steatosis in DIO mice were associated with modulation of hepatic genes related to oxidative stress, inflammation, ceramide synthesis, and lipid and cholesterol metabolism.	[Seo, Kun-Ho; Kim, Hong-Seok; Kim, Dong-Hyeon; Chon, Jung-Whan] Konkuk Univ, Coll Vet Med, Seoul, South Korea; [Bartley, Glenn E.; Tam, Christina; Yokoyama, Wallace] ARS, USDA, Albany, CA USA; [Kim, Hyunsook] Hanyang Univ, Dept Food & Nutr, Seoul, South Korea	Konkuk University; United States Department of Agriculture (USDA); Hanyang University	Kim, H (corresponding author), Hanyang Univ, Dept Food & Nutr, Seoul, South Korea.	hyunsk15@hanyang.ac.kr	Seo, Kun-Ho/AAQ-2666-2020	Kim, Hyunsook/0000-0001-7345-4167; Kim, Dong-Hyeon/0000-0003-0585-2432	National Research Foundation of Korea (NRF) - Korea government (MSIP) [2015R1A2A2A01005017]; National Institute of Food and Agriculture (NIFA) Small Business Innovation Research Program Phase I grant (NIFA/SBIR) [2013-00549]	National Research Foundation of Korea (NRF) - Korea government (MSIP); National Institute of Food and Agriculture (NIFA) Small Business Innovation Research Program Phase I grant (NIFA/SBIR)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No.2015R1A2A2A01005017) and partly by a National Institute of Food and Agriculture (NIFA) Small Business Innovation Research Program Phase I grant (NIFA/SBIR 2013-00549).	Babenko NA, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-1; Bartley GE, 2010, J NUTR, V140, P1255, DOI 10.3945/jn.109.118349; Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677; Brabant G, 2005, FASEB J, V19, P1048, DOI 10.1096/fj.04-2846fje; Chagnon YC, 1997, MOL MED, V3, P663, DOI 10.1007/BF03401705; Charradi K, 2014, DIGEST DIS SCI, V59, P1768, DOI 10.1007/s10620-014-3128-0; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Choquet H, 2010, GENOME MED, V2, DOI 10.1186/gm157; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; De Ceuninck F, 2013, BRIT J PHARMACOL, V168, P339, DOI 10.1111/j.1476-5381.2012.02184.x; De Groote D, 2012, ANN NUTR METAB, V61, P15, DOI 10.1159/000338634; Decorde K, 2009, MOL NUTR FOOD RES, V53, P659, DOI 10.1002/mnfr.200800165; Fernandez-Iglesias A, 2014, MOL NUTR FOOD RES, V58, P727, DOI 10.1002/mnfr.201300455; Ferre T, 2003, DIABETOLOGIA, V46, P1662, DOI 10.1007/s00125-003-1244-z; German JB, 1996, NUTR RES, V16, P1239, DOI 10.1016/0271-5317(96)00127-3; Gonzalez-Gallego J, 2010, BRIT J NUTR, V104, pS15, DOI 10.1017/S0007114510003910; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Hogan S, 2010, J AGR FOOD CHEM, V58, P11250, DOI 10.1021/jf102759e; Hokayem M, 2013, DIABETES CARE, V36, P1454, DOI 10.2337/dc12-1652; Holers VM, 2000, IMMUNOPHARMACOLOGY, V49, P125, DOI 10.1016/S0162-3109(00)80298-2; HORTON JD, 1994, J CLIN INVEST, V93, P2084, DOI 10.1172/JCI117203; Ji C, 2011, HEPATOLOGY, V54, P229, DOI 10.1002/hep.24368; Joven J, 2012, BBA-GEN SUBJECTS, V1820, P894, DOI 10.1016/j.bbagen.2012.03.020; Kadowaki T, 2014, BIOCHEM BIOPH RES CO, V446, P212, DOI 10.1016/j.bbrc.2014.02.089; Kamba A, 2013, CURR MOL MED, V13, P1110; Kar P, 2009, DIABETIC MED, V26, P526, DOI 10.1111/j.1464-5491.2009.02727.x; Kempf T, 2012, EUR J ENDOCRINOL, V167, P671, DOI 10.1530/EJE-12-0466; Khoshbaten Manouchehr, 2010, Saudi J Gastroenterol, V16, P194, DOI 10.4103/1319-3767.65197; Kim H, 2015, J AGR FOOD CHEM, V63, P1460, DOI 10.1021/jf5026373; Kim H, 2014, J AGR FOOD CHEM, V62, P1919, DOI 10.1021/jf404832s; Kim H, 2013, J AGR FOOD CHEM, V61, P6404, DOI 10.1021/jf400545w; Kim SJ, 2012, J NUTR BIOCHEM, V23, P113, DOI 10.1016/j.jnutbio.2010.10.012; LAMUELARAVENTOS RM, 1994, AM J ENOL VITICULT, V45, P1; Lee YS, 2010, J BIOL CHEM, V285, P22174, DOI 10.1074/jbc.M109.085464; Liu ZH, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-32; Marcolin E, 2012, J NUTR, V142, P1821, DOI 10.3945/jn.112.165274; Masterjohn C, 2012, NUTR REV, V70, P41, DOI 10.1111/j.1753-4887.2011.00440.x; McArdle Maeve A, 2013, Front Endocrinol (Lausanne), V4, P52, DOI 10.3389/fendo.2013.00052; Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141; O'Doherty RM, 1999, DIABETES, V48, P2022, DOI 10.2337/diabetes.48.10.2022; Ohyama K, 2011, ANN NUTR METAB, V58, P250, DOI 10.1159/000330444; Park Su-Hui, 2008, Nutr Res Pract, V2, P227, DOI 10.4162/nrp.2008.2.4.227; Peter A, 2011, J CLIN ENDOCR METAB, V96, pE1126, DOI 10.1210/jc.2010-2017; Procaccini C, 2010, CURR PHARM DESIGN, V16, P1902, DOI 10.2174/138161210791208884; Radonjic M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006646; Rahimi RS, 2013, NUTR CLIN PRACT, V28, P40, DOI 10.1177/0884533612470464; Ress C, 2010, EUR CYTOKINE NETW, V21, P65, DOI 10.1684/ecn.2009.0177; Rinella Mary E, 2014, Gastroenterol Hepatol (N Y), V10, P219; Savini I, 2013, INT J MOL SCI, V14, P10497, DOI 10.3390/ijms140510497; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Soobrattee MA, 2005, MUTAT RES-FUND MOL M, V579, P200, DOI 10.1016/j.mrfmmm.2005.03.023; Takaishi K, 2004, P NATL ACAD SCI USA, V101, P7106, DOI 10.1073/pnas.0401715101; Tomaru U, 2012, AM J PATHOL, V180, P963, DOI 10.1016/j.ajpath.2011.11.012; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Valenti L, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/145421; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Waller-Evans H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082825; Warne JP, 2011, CELL METAB, V14, P791, DOI 10.1016/j.cmet.2011.11.001; Xia EQ, 2010, INT J MOL SCI, V11, P622, DOI 10.3390/ijms11020622; Yamamoto M, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/240365; Yilmaz Y, 2004, J AGR FOOD CHEM, V52, P255, DOI 10.1021/jf030117h; Yogalakshmi B, 2013, J LIPIDS, V2013, DOI 10.1155/2013/153897; Yunoki K, 2008, J AGR FOOD CHEM, V56, P12052, DOI 10.1021/jf8026217	65	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0167680	10.1371/journal.pone.0167680	http://dx.doi.org/10.1371/journal.pone.0167680			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977712	Green Published, Green Submitted, gold			2022-12-26	WOS:000391217400027
J	Shimotsuma, Y; Tanaka, M; Izawa, T; Yamate, J; Kuwamura, M				Shimotsuma, Yukako; Tanaka, Miyuu; Izawa, Takeshi; Yamate, Jyoji; Kuwamura, Mitsuru			Enhanced Expression of Trib3 during the Development of Myelin Breakdown in dmy Myelin Mutant Rats	PLOS ONE			English	Article							TRB3; MUTATION; STRESS; GENE; TRIBBLES; IDENTIFICATION; REMYELINATION; ACTIVATION; DELETION; CELLS	The demyelination (dmy) rat exhibits hind limb ataxia and severe myelin breakdown in the central nervous system. The causative gene of dmy rats is the MRS2 magnesium transporter gene. Tribbles homolog 3 (Trib3) is a pseudokinase molecule that modifies certain signal pathways, and its expression is increased in response to various stresses. Here we sought to clarify the mechanism of myelin breakdown by focusing Trib3, which is remarkably up-regulated in dmy rats. The expression of Trib3 mRNA was significantly increased at 4, 5, 6, 7 and 8 weeks of age in the dmy rats, prior to the prominent myelin breakdown between 7 and 10 weeks of age. The expression level of Trib3 was increased concurrently with the progression of the clinical and pathological conditions in the dmy rats. Double immunofluorescence demonstrated that TRIB3 was mainly expressed in neurons and oligodendrocytes and localized in the Golgi apparatus. Our findings indicate that Trib3 may be associated with the pathogenic mechanism of dmy rats.	[Shimotsuma, Yukako; Tanaka, Miyuu; Izawa, Takeshi; Yamate, Jyoji; Kuwamura, Mitsuru] Osaka Prefecture Univ, Lab Vet Pathol, Izumisano City, Osaka, Japan	Osaka Metropolitan University	Kuwamura, M (corresponding author), Osaka Prefecture Univ, Lab Vet Pathol, Izumisano City, Osaka, Japan.	kuwamura@vet.osakafu-u.ac.jp	Shimotsuma, Yasuhiko/AAF-6335-2021	Shimotsuma, Yasuhiko/0000-0003-0588-3167; Izawa, Takeshi/0000-0003-3236-6050	Japan Society for Promotion of Science (JSPS) [23380180, 15H04595]	Japan Society for Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for Promotion of Science (JSPS) (URL: https://www.jsps.go.jp/english/) grant numbers: JSPS; no. 23380180 and 15H04595 to MK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aime P, 2015, J NEUROSCI, V35, P10731, DOI 10.1523/JNEUROSCI.0614-15.2015; Bowers AJ, 2003, ONCOGENE, V22, P2823, DOI 10.1038/sj.onc.1206367; Bruck W, 2003, J NEUROL SCI, V206, P181, DOI 10.1016/s0022-510x(02)00191-0; Corcoran CA, 2005, CANCER BIOL THER, V4, P1063, DOI 10.4161/cbt.4.10.2205; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; DUNCAN ID, 1992, J NEUROCYTOL, V21, P870, DOI 10.1007/BF01191684; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; Izawa T, 2010, BRAIN RES, V1349, P105, DOI 10.1016/j.brainres.2010.06.030; KIMURA M, 1985, J NEUROCHEM, V44, P692, DOI 10.1111/j.1471-4159.1985.tb12870.x; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; Kuramoto T, 1996, MAMM GENOME, V7, P890, DOI 10.1007/s003359900263; Kuramoto T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001262; Kuwamura M, 2004, BRAIN RES, V1022, P110, DOI 10.1016/j.brainres.2004.07.007; Kuwamura M, 2002, LAB INVEST, V82, P1279, DOI 10.1097/01.LAB.0000032375.70196.26; Kuwamura M, 2011, BRAIN RES, V1389, P161, DOI 10.1016/j.brainres.2011.03.009; Lange PS, 2008, J EXP MED, V205, P1227, DOI 10.1084/jem.20071460; Lin WS, 2005, J CELL BIOL, V169, P603, DOI 10.1083/jcb.200502086; Lorente M, 2009, GLIA, V57, P1374, DOI 10.1002/glia.20856; Mayumi-Matsuda K, 1999, BIOCHEM BIOPH RES CO, V258, P260, DOI 10.1006/bbrc.1999.0576; Mc Guire C, 2010, J IMMUNOL, V185, P7646, DOI 10.4049/jimmunol.1000930; Morse E, 2010, AM J PHYSIOL-RENAL, V299, pF965, DOI 10.1152/ajprenal.00236.2010; Nakane Y, 2002, EXP ANIM TOKYO, V51, P149, DOI 10.1538/expanim.51.149; NAVE KA, 1987, J NEUROCHEM, V49, P1873, DOI 10.1111/j.1471-4159.1987.tb02449.x; O'Connor LT, 1999, J NEUROSCI, V19, P3404; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Ord D, 2005, BIOCHEM BIOPH RES CO, V330, P210, DOI 10.1016/j.bbrc.2005.02.149; Park S, 2003, J ENDOCRINOL INVEST, V26, P132, DOI 10.1007/BF03345141; Schwarzer R, 2006, CELL SIGNAL, V18, P899, DOI 10.1016/j.cellsig.2005.08.002; Shimizu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042721; SIMONS R, 1990, ANN NY ACAD SCI, V605, P146, DOI 10.1111/j.1749-6632.1990.tb42389.x; Stahnke T, 2007, J MOL NEUROSCI, V32, P25, DOI 10.1007/s12031-007-0005-8; Tanaka M, 2014, GLIA, V62, P1530, DOI 10.1002/glia.22698; Tokuda S, 2004, EXP ANIM TOKYO, V53, P73, DOI 10.1538/expanim.53.73; Wasef SZY, 2006, AM J PHYSIOL-ENDOC M, V291, pE1274, DOI 10.1052/ajpendo.00117.2006	35	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168250	10.1371/journal.pone.0168250	http://dx.doi.org/10.1371/journal.pone.0168250			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977799	Green Published, gold, Green Submitted			2022-12-26	WOS:000391217400081
J	Pelechrinis, K; Papalexakis, E				Pelechrinis, Konstantinos; Papalexakis, Evangelos			The Anatomy of American Football: Evidence from 7 Years of NFL Game Data	PLoS One			English	Article								How much does a fumble affect the probability of winning an American football game? How balanced should your offense be in order to increase the probability of winning by 10%? These are questions for which the coaching staff of National Football League teams have a clear qualitative answer. Turnovers are costly; turn the ball over several times and you will certainly lose. Nevertheless, what does "several" mean? How "certain" is certainly? In this study, we collected play-by-play data from the past 7 NFL seasons, i.e., 2009-2015, and we build a descriptive model for the probability of winning a game. Despite the fact that our model incorporates simple box score statistics, such as total offensive yards, number of turnovers etc., its overall cross-validation accuracy is 84%. Furthermore, we combine this descriptive model with a statistical bootstrap module to build FPM (short for Football Prediction Matchup) for predicting future match-ups. The contribution of FPM is pertinent to its simplicity and transparency, which however does not sacrifice the system's performance. In particular, our evaluations indicate that our prediction engine performs on par with the current state-of-the-art systems (e.g., ESPN's FPI and Microsoft's Cortana). The latter are typically proprietary but based on their components described publicly they are significantly more complicated than FPM. Moreover, their proprietary nature does not allow for a head-to-head comparison in terms of the core elements of the systems but it should be evident that the features incorporated in FPM are able to capture a large percentage of the observed variance in NFL games.	[Pelechrinis, Konstantinos] Univ Pittsburgh, Sch Informat Sci, Pittsburgh, PA 15260 USA; [Papalexakis, Evangelos] Univ Calif Riverside, Dept Comp Sci & Engn, Riverside, CA 92521 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Riverside	Pelechrinis, K (corresponding author), Univ Pittsburgh, Sch Informat Sci, Pittsburgh, PA 15260 USA.	kpele@pitt.edu	Pelechrinis, Konstantinos/ACX-4835-2022	Pelechrinis, Konstantinos/0000-0002-6443-3935; Papalexakis, Evangelos/0000-0002-3411-8483				Agresti A, 2007, WILEY SERIES PROBABI, DOI [10.1002/0470114754, DOI 10.1002/0470114754]; Alamar BC, 2008, J QUANT ANAL SPORTS, V4, DOI 10.2202/1559-0410.1113; [Anonymous], INTRO BOOTSTRAP, DOI DOI 10.1007/978-1-4899-4541-9; [Anonymous], 2015, GAM THEOR AM FOOTB D; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Bing M, 2016, LOOKING AHEAD BING; BRADLEY RA, 1952, BIOMETRIKA, V39, P324, DOI 10.1093/biomet/39.3-4.324; Clark T, 2013, 7 ANN MIT SLOAN SPOR; Cohea C., 2011, SPORTSCIENCE, V15, P19; Correia V, 2011, HUM MOVEMENT SCI, V30, P984, DOI 10.1016/j.humov.2010.07.008; ESPN, 2016, GUID NFL FPI; GILOVICH T, 1985, COGNITIVE PSYCHOL, V17, P295, DOI 10.1016/0010-0285(85)90010-6; Glickman ME, 1998, J AM STAT ASSOC, V93, P25, DOI 10.2307/2669599; Hochstedler J., 2016, MIT SLOAN SPORTS AN; KAHNEMAN D, 1973, PSYCHOL REV, V80, P237, DOI 10.1037/h0034747; Lamb C.W., 2012, ESSENTIALS MARKETING; Nerd FF, 2015, NFL PICKS ACCURACY L; Pelechrinis K., 2016, ACM SIGKDD WORKSH LA; Pfitzner C, 2014, SPORT J; Stair A, 2008, EC B, V26, P1; Tower N, 2016, CORTANA PREDICTIONS; Warner J., 2010, PREDICTING MARGIN VI	23	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168716	10.1371/journal.pone.0168716	http://dx.doi.org/10.1371/journal.pone.0168716			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QH	28005971	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000392843200086
J	Kaguelidou, F; Alberti, C; Biran, V; Bourdon, O; Farnoux, C; Zohar, S; Jacqz-Aigrain, E				Kaguelidou, Florentia; Alberti, Corinne; Biran, Valerie; Bourdon, Olivier; Farnoux, Caroline; Zohar, Sarah; Jacqz-Aigrain, Evelyne			Dose-Finding Study of Omeprazole on Gastric pH in Neonates with Gastro-Esophageal Acid Reflux Using a Bayesian Sequential Approach	PLoS One			English	Article							PROTON-PUMP INHIBITORS; CONTINUAL REASSESSMENT METHOD; BIRTH-WEIGHT INFANTS; CLINICAL-TRIALS; PRETERM INFANTS; CHILDREN; PHARMACOKINETICS; THERAPY; DISEASE; RISK	Objective Proton pump inhibitors are frequently administered on clinical symptoms in neonates but benefit remains controversial. Clinical trials validating omeprazole dosage in neonates are limited. The objective of this trial was to determine the minimum effective dose (MED) of omeprazole to treat pathological acid reflux in neonates using reflux index as surrogate marker. Design Double blind dose-finding trial with continual reassessment method of individual dose administration using a Bayesian approach, aiming to select drug dose as close as possible to the predefined target level of efficacy (with a credibility interval of 95%). Setting Neonatal Intensive Care unit of the Robert Debre University Hospital in Paris, France. Patients Neonates with a postmenstrual age >= 35 weeks and a pathologic 24-hour intra-esophageal pH monitoring defined by a reflux index >= 5% over 24 hours were considered for participation. Recruitment was stratified to 3 groups according to gestational age at birth. Intervention Five preselected doses of oral omeprazole from 1 to 3 mg/kg/day. Main outcome measures Primary outcome, measured at 35 weeks postmenstrual age or more, was a reflux index <5% during the 24-h pH monitoring registered 72 +/- 24 hours after omeprazole initiation. Results Fifty-four neonates with a reflux index ranging from 5.06 to 27.7% were included. Median age was 37.5 days and median postmenstrual age was 36 weeks. In neonates born at less than 32 weeks of GA (n = 30), the MED was 2.5mg/kg/day with an estimated mean posterior probability of success of 97.7% (95% credibility interval: 90.3-99.7%). The MED was 1 mg/ kg/day for neonates born at more than 32 GA (n = 24). Conclusions Omeprazole is extensively prescribed on clinical symptoms but efficacy is not demonstrated while safety concerns do exist. When treatment is required, the daily dose needs to be validated in preterm and term neonates. Optimal doses of omeprazole to increase gastric pH and decrease reflux index below 5% over 24 hours, determined using an adaptive Bayesian design differ among neonates. Both gestational and postnatal ages account for these differences but their differential impact on omeprazole doses remains to be determined.	[Kaguelidou, Florentia; Jacqz-Aigrain, Evelyne] Hop Robert Debre, AP HP, Dept Pediat Pharmacol & Pharmacogenet, Paris, France; [Kaguelidou, Florentia; Alberti, Corinne; Jacqz-Aigrain, Evelyne] Hop Robert Debre, INSERM, CIC1426, Paris, France; [Kaguelidou, Florentia; Jacqz-Aigrain, Evelyne] Univ Paris 7 Diderot, Sorbonne Paris Cite, ED 563, EA7323, Paris, France; [Alberti, Corinne] Hop Robert Debre, AP HP, Dept Clin Epidemiol, Paris, France; [Alberti, Corinne; Biran, Valerie] Univ Paris 7 Diderot, Sorbonne Paris Cite, France UMR S 1123, Paris, France; [Alberti, Corinne] ECEVE, Paris, France; [Biran, Valerie; Farnoux, Caroline] Hop Robert Debre, AP HP, Dept Neonatol, Paris, France; [Bourdon, Olivier] Hop Robert Debre, AP HP, Dept Pharm, Paris, France; [Bourdon, Olivier] Univ Paris 5 Descartes, Paris, France; [Bourdon, Olivier] Univ Paris 13, Sorbonne Paris Cite, Lab Educ & Prat Sante, EA 3412, Paris, France; [Zohar, Sarah] Univ Paris 6 Pierre & Marie Curie, Paris, France; [Zohar, Sarah] INSERM, Paris, France; [Zohar, Sarah] Ctr Rech Cordeliers, U1138, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Jacqz-Aigrain, E (corresponding author), Hop Robert Debre, AP HP, Dept Pediat Pharmacol & Pharmacogenet, Paris, France.; Jacqz-Aigrain, E (corresponding author), Hop Robert Debre, INSERM, CIC1426, Paris, France.; Jacqz-Aigrain, E (corresponding author), Univ Paris 7 Diderot, Sorbonne Paris Cite, ED 563, EA7323, Paris, France.	evelyne.jacqz-aigrain@aphp.fr	Zohar, Sarah/A-5026-2016; Biran, Valerie/GQY-8192-2022; Bourdon, Olivier/AHA-7107-2022; Zohar, Sarah/ACE-9228-2022; Jacqz-Aigrain, Evelyne/AAW-7089-2021	Zohar, Sarah/0000-0002-8429-2340; Jacqz-Aigrain, Evelyne/0000-0002-4285-7067	Hospital Clinical Research Program (Ministry of Health) [AOM05123]	Hospital Clinical Research Program (Ministry of Health)	The study was funded by a grant from the Hospital Clinical Research Program (Ministry of Health, AOM05123) given to EJA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson T, 2000, AM J GASTROENTEROL, V95, P3101; Barron JJ, 2007, J PEDIATR GASTR NUTR, V45, P421, DOI 10.1097/MPG.0b013e31812e0149; Bishop J, 2007, J PEDIATR GASTR NUTR, V45, P50, DOI 10.1097/MPG.0b013e318049cbcc; Boyle JT, 2003, J PEDIATR GASTR NUTR, V37, pS12, DOI 10.1097/00005176-200311001-00004; Canani RB, 2006, PEDIATRICS, V117, pE817, DOI 10.1542/peds.2005-1655; Canani RB, 2010, CURR OPIN GASTROEN, V26, P31, DOI 10.1097/MOG.0b013e328333d781; Desfrere L, 2005, J CLIN PHARM THER, V30, P121, DOI 10.1111/j.1365-2710.2005.00630.x; Fabre E, 1998, BRIT J CLIN PHARMACO, V46, P395, DOI 10.1046/j.1365-2125.1998.00788.x; Famularo G, 2013, EXPERT OPIN DRUG SAF, V12, P709, DOI 10.1517/14740338.2013.809062; George I, 2011, PEDIATR NEPHROL, V26, P1843, DOI 10.1007/s00467-011-1883-0; Guillet R, 2006, PEDIATRICS, V117, pE137, DOI 10.1542/peds.2005-1543; Hassall E, 2000, J PEDIATR-US, V137, P800, DOI 10.1067/mpd.2000.109607; HYMAN PE, 1985, J PEDIATR-US, V106, P467, DOI 10.1016/S0022-3476(85)80682-X; Kearns GL, 2003, NEW ENGL J MED, V349, P1157, DOI 10.1056/NEJMra035092; KELLY EJ, 1993, EARLY HUM DEV, V35, P215, DOI 10.1016/0378-3782(93)90108-7; Litalien C, 2005, CLIN PHARMACOKINET, V44, P441, DOI 10.2165/00003088-200544050-00001; Malcolm WF, 2008, PEDIATRICS, V121, P22, DOI 10.1542/peds.2007-0381; Mitchell DJ, 2001, ARCH DIS CHILD, V84, P273, DOI 10.1136/adc.84.3.273; Omari TI, 2002, GUT, V51, P475, DOI 10.1136/gut.51.4.475; Orenstein SR, 2007, J PEDIATR GASTR NUTR, V45, P395, DOI 10.1097/MPG.0b013e31812e011d; Pressler RM, 2015, LANCET NEUROL, V14, P469, DOI 10.1016/S1474-4422(14)70303-5; Rhodin MM, 2009, PEDIATR NEPHROL, V24, P67, DOI 10.1007/s00467-008-0997-5; Sachs G, 2006, ALIMENT PHARM THERAP, V23, P2, DOI 10.1111/j.1365-2036.2006.02943.x; Saiman L, 2001, PEDIATR INFECT DIS J, V20, P1119, DOI 10.1097/00006454-200112000-00005; Shakhnovich V, 2012, CLIN PHARMACOL THER, V92, P388, DOI 10.1038/clpt.2012.86; Spiegelhalter DJ, 1999, BRIT MED J, V319, P508, DOI 10.1136/bmj.319.7208.508; Treluyer JM, 2005, J CLIN PHARM THER, V30, P479, DOI 10.1111/j.1365-2710.2005.00678.x; van der Pol RJ, 2011, PEDIATRICS, V127, P925, DOI 10.1542/peds.2010-2719; Vandenplas Y, 2009, J PEDIATR GASTR NUTR, V49, P498, DOI 10.1097/MPG.0b013e3181b7f563; Ward RM, 2013, PEDIATR DRUGS, V15, P119, DOI 10.1007/s40272-013-0012-x; Zohar S, 2003, COMPUT METH PROG BIO, V72, P117, DOI 10.1016/S0169-2607(02)00120-7; Zohar S, 2008, CONTEMP CLIN TRIALS, V29, P608, DOI 10.1016/j.cct.2007.11.005; Zohar Sarah, 2003, J Biopharm Stat, V13, P87, DOI 10.1081/BIP-120017728; Zohar S, 2011, STAT MED, V30, P2109, DOI 10.1002/sim.4121	34	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0166207	10.1371/journal.pone.0166207	http://dx.doi.org/10.1371/journal.pone.0166207			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002471	Green Published, Green Submitted, gold			2022-12-26	WOS:000392853100004
J	Starr, RM; Gleason, MG; Marks, CI; Kline, D; Rienecke, S; Denney, C; Tagini, A; Field, JC				Starr, Richard M.; Gleason, Mary G.; Marks, Corina I.; Kline, Donna; Rienecke, Steve; Denney, Christian; Tagini, Anne; Field, John C.			Targeting Abundant Fish Stocks while Avoiding Overfished Species: Video and Fishing Surveys to Inform Management after Long-Term Fishery Closures	PLOS ONE			English	Article							ROCKFISH SEBASTES SPP.; HABITAT; PRODUCTIVITY; ASSESSMENTS; EXTINCTION; BEHAVIOR; DENSITY; INDEXES; THREATS; TRAWLS	Historically, it has been difficult to balance conservation goals and yield objectives when managing multispecies fisheries that include stocks with various vulnerabilities to fishing. As managers try to maximize yield in mixed-stock fisheries, exploitation rates can lead to less productive stocks becoming overfished. In the late 1990s, population declines of several U.S. West Coast groundfish species caused the U.S. Pacific Fishery Management Council to create coast-wide fishery closures, known as Rockfish Conservation Areas, to rebuild overfished species. The fishery closures and other management measures successfully reduced fishing mortality of these species, but constrained fishing opportunities on abundant stocks. Restrictive regulations also caused the unintended consequence of reducing fishery -dependent data available to assess population status of fished species. As stocks rebuild, managers are faced with the challenge of increasing fishing opportunities while minimizing fishing mortality on rebuilding species. We designed a camera system to evaluate fishes in coastal habitats and used experimental gear and fishing techniques paired with video surveys to determine if abundant species could be caught in rocky habitats with minimal catches of co-occurring rebuilding species. We fished a total of 58 days and completed 741 sets with vertical hook-and-line fishing gear. We also conducted 299 video surveys in the same locations where fishing occurred. Comparison of fishing and stereo-video surveys indicated that fishermen could fish with modified hook-and-line gear to catch abundant species while limiting bycatch of rebuilding species. As populations of overfished species continue to recover along the U.S. West Coast, it is important to improve data collection, and video and fishing surveys may be key to assessing species that occur in rocky habitats.	[Starr, Richard M.] Calif Sea Grant Program, Moss Landing, CA 95039 USA; [Starr, Richard M.; Marks, Corina I.; Kline, Donna; Denney, Christian; Tagini, Anne] Moss Landing Marine Labs, Pob 450, Moss Landing, CA 95039 USA; [Gleason, Mary G.; Rienecke, Steve] Nature Conservancy, Monterey, CA USA; [Field, John C.] Natl Marine Fisheries Serv, Fisheries Ecol Div, Southwest Fishery Sci Ctr, NOAA, Santa Cruz, CA USA	Moss Landing Marine Laboratories; Nature Conservancy; National Oceanic Atmospheric Admin (NOAA) - USA	Starr, RM (corresponding author), Calif Sea Grant Program, Moss Landing, CA 95039 USA.; Starr, RM (corresponding author), Moss Landing Marine Labs, Pob 450, Moss Landing, CA 95039 USA.	starr@mlml.calstate.edu			Nature Conservancy; Resources Legacy Fund; Gordon and Betty Moore Foundation; Environmental Defense Fund; California Sea Grant Program; NMFS National Cooperative Research Program; NOAA Saltonstall-Kennedy Grant [13-SWR-008]	Nature Conservancy; Resources Legacy Fund; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Environmental Defense Fund; California Sea Grant Program; NMFS National Cooperative Research Program; NOAA Saltonstall-Kennedy Grant	Funding for this research was provided by The Nature Conservancy and private donors, Resources Legacy Fund, the Gordon and Betty Moore Foundation, Environmental Defense Fund, California Sea Grant Program, the NMFS National Cooperative Research Program, and a NOAA Saltonstall-Kennedy Grant #13-SWR-008 to the San Jose State University Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Amend M, 2001, NEARSHORE ROCKY REEF; Ault JS, 2013, FISH RES, V144, P28, DOI 10.1016/j.fishres.2012.10.007; Berkeley SA, 2004, FISHERIES, V29, P23, DOI 10.1577/1548-8446(2004)29[23:FSVPOA]2.0.CO;2; Bohnsack J.A., 1986, NOAA TECH REP NMFS, V41, P21; Burgess MG, 2013, P NATL ACAD SCI USA, V110, P15943, DOI 10.1073/pnas.1314472110; Cailliet GM, 1999, OCEANOL ACTA, V22, P579, DOI 10.1016/S0399-1784(00)88949-5; Cappo M, 2004, J EXP MAR BIOL ECOL, V302, P123, DOI 10.1016/j.jembe.2003.10.006; Cappo M, 2003, AQUATIC PROTECTED AR, P455; Clark WG, 2002, N AM J FISH MANAGE, V22, P251, DOI 10.1577/1548-8675(2002)022<0251:FRTYL>2.0.CO;2; Cope JM, 2011, N AM J FISH MANAGE, V31, P589, DOI 10.1080/02755947.2011.591264; Cope JM, 2013, DATA MODERATE STOCK; Dick EJ, 2013, STATUS PRODUCTIVITY; Dougherty DT, 2013, CAN J FISH AQUAT SCI, V70, P49, DOI 10.1139/cjfas-2012-0042; Easton RR, 2015, MAR COAST FISH, V7, P87, DOI 10.1080/19425120.2015.1007184; Field JC, 2006, FISH FISH, V7, P284, DOI 10.1111/j.1467-2979.2006.00226.x; Field JC, 2006, MAR POLICY, V30, P552, DOI 10.1016/j.marpol.2005.07.004; FRANCIS R C, 1986, North American Journal of Fisheries Management, V6, P453, DOI 10.1577/1548-8659(1986)6<453:TFBPIW>2.0.CO;2; Hamel OS, 2009, STATUS FUTURE PROSPE; Hannah RW, 2008, OREGON DEP FISH WILD, V2008-03; He X, 2015, STATUS BOCACCIO SEBA; Hilborn R, 2004, B MAR SCI, V74, P493; Holland DS, 2012, ECOL ECON, V78, P132, DOI 10.1016/j.ecolecon.2012.04.010; Holland DS, 2010, NAT RESOUR MODEL, V23, P494, DOI 10.1111/j.1939-7445.2010.00071.x; Johnson KA, 2001, CAL COOP OCEAN FISH, V42, P153; Jones DT, 2012, FISH B-NOAA, V110, P332; Keller AA, 2014, MAR ECOL PROG SER, V501, P169, DOI 10.3354/meps10674; Keller AA, 2012, FISH B-NOAA, V110, P205; Laidig TE, 2013, FISH B-NOAA, V111, P54, DOI 10.7755/FB.111.1.5; Lauth RR, 2004, FISH RES, V70, P39, DOI 10.1016/j.fishres.2004.06.009; Leising AW, 2015, CAL COOP OCEAN FISH, V56, P31; Liberman AM, 2005, AM J EVAL, V26, P253, DOI 10.1177/1098214005275825; Love M. S., 2002, ROCKFISHES NE PACIFI; MacCall AD, 2002, N AM J FISH MANAGE, V22, P272, DOI 10.1577/1548-8675(2002)022<0272:UOKBPM>2.0.CO;2; MacCall AD., 1990, DYNAMIC GEOGRAPHY MA; Marks CI, 2015, CAL COOP OCEAN FISH, P56; Mason J, 2012, MAR POLICY, V36, P1054, DOI 10.1016/j.marpol.2012.03.002; de Mitcheson YS, 2013, FISH FISH, V14, P119, DOI 10.1111/j.1467-2979.2011.00455.x; MURAWSKI SA, 1991, FISHERIES, V16, P5, DOI 10.1577/1548-8446(1991)016<0005:CWMOMF>2.0.CO;2; Ono K, 2015, CAN J FISH AQUAT SCI, V72, P1177, DOI 10.1139/cjfas-2014-0146; Ono K, 2015, ICES J MAR SCI, V72, P31, DOI 10.1093/icesjms/fsu007; Patrick WS, 2010, FISH B-NOAA, V108, P305; Pearson DE, 2000, SC0001 NAT MAR FISH; Ralston S, 2002, N AM J FISH MANAGE, V22, P249, DOI 10.1577/1548-8675(2002)022<0249:WCGHP>2.0.CO;2; Ralston S, 2013, FISH OCEANOGR, V22, P288, DOI 10.1111/fog.12022; Rooper CN, 2015, FISH RES, V172, P157, DOI 10.1016/j.fishres.2015.07.012; Smith SG, 2011, FISH RES, V109, P25, DOI 10.1016/j.fishres.2011.01.012; Stoner AW, 2008, CAN J FISH AQUAT SCI, V65, P1230, DOI 10.1139/F08-032; Taylor IG, 2011, STATUS US YELLOWEYE; Thorson J, 2015, STATUS CANARY ROCKFI; Thorson JT, 2012, ICES J MAR SCI, V69, P635, DOI 10.1093/icesjms/fss003; Tissot BN, 2008, MARINE HABITAT MAPPI; Yoklavich MM, 2007, CAN J FISH AQUAT SCI, V64, P1795, DOI 10.1139/F07-145; Yoklavich MM, 2008, MARINE HABITAT MAPPI	54	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168645	10.1371/journal.pone.0168645	http://dx.doi.org/10.1371/journal.pone.0168645			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002499	Green Published, gold, Green Submitted			2022-12-26	WOS:000392853100060
J	Cohen, O; Oberhardt, M; Yizhak, K; Ruppin, E				Cohen, Osher; Oberhardt, Matthew; Yizhak, Keren; Ruppin, Eytan			Essential Genes Embody Increased Mutational Robustness to Compensate for the Lack of Backup Genetic Redundancy	PLOS ONE			English	Article							ESCHERICHIA-COLI; CODON USAGE; TRANSLATION EFFICIENCY; NONESSENTIAL GENES; ACETYLATION; EVOLUTION; CONSEQUENCES; MODELS; LEVEL; CELLS	Genetic robustness is a hallmark of cells, occurring through many mechanisms and at many levels. Essential genes lack the common robustness mechanism of genetic redundancy (i.e., existing alongside other genes with the same function), and thus appear at first glance to leave cells highly vulnerable to genetic or environmental perturbations. Here we explore a hypothesis that cells might protect against essential gene loss through mechanisms that occur at various cellular levels aside from the level of the gene. Using Escherichia coli and Saccharomyces cerevisiae as models, we find that essential genes are enriched over nonessential genes for properties we call "coding efficiency"and "coding robustness", denoting respectively a gene's efficiency of translation and robustness to non-synonymous mutations. The coding efficiency levels of essential genes are highly positively correlated with their evolutionary conservation levels, suggesting that this feature plays a key role in protecting conserved, evolutionarily important genes. We then extend our hypothesis into the realm of metabolic networks, showing that essential metabolic reactions are encoded by more "robust" genes than non-essential reactions, and that essential metabolites are produced by more reactions than non-essential metabolites. Taken together, these results testify that robustness at the gene-loss level and at the mutation level (and more generally, at two cellular levels that are usually treated separately) are not decoupled, but rather, that cellular vulnerability exposed due to complete gene loss is compensated by increased mutational robustness. Why some genes are backed up primarily against loss and others against mutations still remains an open question.	[Cohen, Osher; Yizhak, Keren; Ruppin, Eytan] Tel Aviv Univ, Sch Comp Sci, Tel Aviv, Israel; [Cohen, Osher; Yizhak, Keren; Ruppin, Eytan] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Oberhardt, Matthew; Ruppin, Eytan] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; University System of Maryland; University of Maryland College Park	Ruppin, E (corresponding author), Tel Aviv Univ, Sch Comp Sci, Tel Aviv, Israel.; Ruppin, E (corresponding author), Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.; Ruppin, E (corresponding author), Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA.	eyruppin@gmail.com	Ruppin, Eytan/R-9698-2017	Ruppin, Eytan/0000-0002-7862-3940	EU; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation [41/11]; CONTIBUGS EU bacterial research grants	EU(European Commission); I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation); CONTIBUGS EU bacterial research grants	ER gratefully acknowledges support from the EU FP7 INFECT project, the I-CORE Program of the Planning and Budgeting Committee, the Israel Science Foundation (grant No 41/11), and CONTIBUGS EU bacterial research grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, FUNCTIONAL PROFILING; Aung Hnin W, 2013, Ind Biotechnol (New Rochelle N Y), V9, P215; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Borenstein E, 2006, P NATL ACAD SCI USA, V103, P6593, DOI 10.1073/pnas.0510600103; Dayhoff M., 1978, ATLAS PROTEIN SEQUEN; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Freilich S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000690; Geijer C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-554; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Gong XD, 2008, MOL GENET GENOMICS, V279, P87, DOI 10.1007/s00438-007-0298-x; Hashimoto M, 2005, MOL MICROBIOL, V55, P137, DOI 10.1111/j.1365-2958.2004.04386.x; Hu LI, 2010, MOL MICROBIOL, V77, P15, DOI 10.1111/j.1365-2958.2010.07204.x; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Ish-Am O, 2013, THESIS; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Joyce AR, 2006, J BACTERIOL, V188, P8259, DOI 10.1128/JB.00740-06; Kanaya S, 1999, GENE, V238, P143, DOI 10.1016/S0378-1119(99)00225-5; Kim PJ, 2007, P NATL ACAD SCI USA, V104, P13638, DOI 10.1073/pnas.0703262104; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Lewis NE, 2009, J BACTERIOL, V191, P3437, DOI 10.1128/JB.00034-09; Li R, 2010, MOL MICROBIOL, V76, P1162, DOI 10.1111/j.1365-2958.2010.07125.x; Liang WX, 2011, MOL CELL, V44, P160, DOI 10.1016/j.molcel.2011.06.037; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; ROBINSON M, 1984, NUCLEIC ACIDS RES, V12, P6663, DOI 10.1093/nar/12.17.6663; Sablok G, 2013, GENOMICS, V101, P290, DOI 10.1016/j.ygeno.2013.02.008; SORENSEN MA, 1989, J MOL BIOL, V207, P365, DOI 10.1016/0022-2836(89)90260-X; Suthers PF, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.56; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; VARENNE S, 1984, J MOL BIOL, V180, P549, DOI 10.1016/0022-2836(84)90027-5; Waldman YY, 2010, NUCLEIC ACIDS RES, V38, P2964, DOI 10.1093/nar/gkq009; Wall DP, 2005, P NATL ACAD SCI USA, V102, P5483, DOI 10.1073/pnas.0501761102; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Wang Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000329; Wilke CO, 2003, MUTAT RES-FUND MOL M, V522, P3, DOI 10.1016/S0027-5107(02)00307-X; Zhang K, 2013, J PROTEOME RES, V12, P844, DOI 10.1021/pr300912q; Zhou T, 2009, MOL BIOL EVOL, V26, P1571, DOI 10.1093/molbev/msp070	42	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168444	10.1371/journal.pone.0168444	http://dx.doi.org/10.1371/journal.pone.0168444			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997585	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842900047
J	McCarrey, JR; Lehle, JD; Raju, SS; Wang, YF; Nilsson, EE; Skinner, MK				McCarrey, John R.; Lehle, Jake D.; Raju, Seetha S.; Wang, Yufeng; Nilsson, Eric E.; Skinner, Michael K.			Tertiary Epimutations - A Novel Aspect of Epigenetic Transgenerational Inheritance Promoting Genome Instability	PLOS ONE			English	Article							ENDOCRINE DISRUPTOR VINCLOZOLIN; GENETIC INTEGRITY; CHROMATIN-STRUCTURE; MUTATION FREQUENCY; TRANSGENIC MICE; METHYLATION; EPIGENOME; DISEASE; INTERVALS; HEALTH	Exposure to environmental factors can induce the epigenetic transgenerational inheritance of disease. Alterations to the epigenome termed "epimutations" include "primary epimutations" which are epigenetic alterations in the absence of genetic change and "secondary epimutations" which form following an initial genetic change. To determine if secondary epimutations contribute to transgenerational transmission of disease following in utero exposure to the endocrine disruptor vinclozolin, we exposed pregnant female rats carrying the lad mutation-reporter transgene to vinclozolin and assessed the frequency of mutations in kidney tissue and sperm recovered from F1 and F3 generation progeny. Our results confirm that vinclozolin induces primary epimutations rather than secondary epimutations, but also suggest that some primary epimutations can predispose a subsequent accelerated accumulation of genetic mutations in F3 generation descendants that have the potential to contribute to transgenerational phenotypes. We therefore propose the existence of "tertiary epimutations" which are initial primary epimutations that promote genome instability leading to an accelerated accumulation of genetic mutations.	[McCarrey, John R.; Lehle, Jake D.; Raju, Seetha S.; Wang, Yufeng] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA; [Nilsson, Eric E.; Skinner, Michael K.] Washington State Univ, Ctr Reprod Biol, Sch Biol Sci, Pullman, WA USA	University of Texas System; University of Texas at San Antonio (UTSA); Washington State University	McCarrey, JR (corresponding author), Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA.	John.McCarrey@utsa.edu	Nilsson, Eric/AAR-5021-2020	Wang, Yufeng/0000-0002-9959-4149	Kleberg Foundation; NIH/NIEHS; John Templeton Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM100806] Funding Source: NIH RePORTER	Kleberg Foundation; NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); John Templeton Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Kleberg Foundation grant to JRM (http://www.klebergfoundation.org), NIH/NIEHS grant to MKS (http://www.niehs.nih.gov), and John Templeton Foundation grant to MKS and JRM (https://www.templeton.org).	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Almal SH, 2012, J HUM GENET, V57, P6, DOI 10.1038/jhg.2011.108; Anway MD, 2006, ENDOCRINOLOGY, V147, P5515, DOI 10.1210/en.2006-0640; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Bhandari RK, 2015, GEN COMP ENDOCR, V214, P195, DOI 10.1016/j.ygcen.2014.09.014; Blaze J, 2015, SEMIN CELL DEV BIOL, V43, P76, DOI 10.1016/j.semcdb.2015.04.004; Braunschweig M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030583; Brun JM, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0303-z; Caperton L, 2007, P NATL ACAD SCI USA, V104, P5085, DOI 10.1073/pnas.0611642104; Chen IC, 2016, STEM CELLS DEV, V25, P1698, DOI 10.1089/scd.2016.0221; COLLINS DW, 1994, GENOMICS, V20, P386, DOI 10.1006/geno.1994.1192; Cooper DJ, 2014, STEM CELL RES, V13, P508, DOI 10.1016/j.scr.2014.09.006; de Waal E, 2012, P NATL ACAD SCI USA, V109, P4163, DOI 10.1073/pnas.1201990109; DYCAICO MJ, 1994, MUTAT RES, V307, P461, DOI 10.1016/0027-5107(94)90257-7; Fay MP, 2010, R J, V2, P53; Feinberg AP, 2004, SEMIN CANCER BIOL, V14, P427, DOI 10.1016/j.semcancer.2004.06.005; Friedberg EC, DNA REPAIR MUTAGENES, V2nd; Guerrero-Bosagna C, 2014, PLOS ONE; Guerrero-Bosagna C, 2012, REPROD TOXICOL, V34, P694, DOI 10.1016/j.reprotox.2012.09.005; Haque MM, 2015, PLOS ONE; Hashimshony T, 2003, NAT GENET, V34, P187, DOI 10.1038/ng1158; Hirji K., 2006, EXACT ANAL DISCRETE; Hrelia P, 1996, MUTAGENESIS, V11, P445, DOI 10.1093/mutage/11.5.445; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kaati G, 2007, EUR J HUM GENET, V15, P784, DOI 10.1038/sj.ejhg.5201832; Kelly WG, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-6; KOHLER SW, 1991, ENVIRON MOL MUTAGEN, V18, P316, DOI 10.1002/em.2850180421; KOHLER SW, 1991, P NATL ACAD SCI USA, V88, P7958, DOI 10.1073/pnas.88.18.7958; Lee HJ, 2014, CELL STEM CELL, V14, P710, DOI 10.1016/j.stem.2014.05.008; Lutsenko E, 1999, MUTAT RES-REV MUTAT, V437, P11, DOI 10.1016/S1383-5742(99)00065-4; Ma J, 2015, TOXICOL APPL PHARM, V289, P193, DOI 10.1016/j.taap.2015.09.024; Macia A, 2011, MOL CELL BIOL, V31, P300, DOI 10.1128/MCB.00561-10; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031901; McCarrey JR, 2015, SCIENCE, V350, P634, DOI 10.1126/science.aad5138; McCarrey JR, 2014, MOL CELL ENDOCRINOL, V398, P13, DOI 10.1016/j.mce.2014.07.016; McCarrey JR, 2012, MOL CELL ENDOCRINOL, V354, P9, DOI 10.1016/j.mce.2011.09.014; Miyake K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066729; Muller-Hill B, 1975, Prog Biophys Mol Biol, V30, P227; Murphey P, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103481; Murphey P, 2009, P NATL ACAD SCI USA, V106, P4731, DOI 10.1073/pnas.0900687106; Nilsson EE, 2008, REPRODUCTION, V135, P713, DOI 10.1530/REP-07-0542; Nilsson EE, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.134817; Peters AHFM, 2005, CURR OPIN CELL BIOL, V17, P230, DOI 10.1016/j.ceb.2005.02.006; PROVOST GS, 1993, MUTAT RES, V288, P133; Rando OJ, 2016, COLD SPRING HARB PER; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Schuster A, 2016, ENV EPIGENETICS; Siklenka K, 2015, SCIENCE, V350, DOI 10.1126/science.aab2006; Skinner MK, 2008, REPROD TOXICOL, V25, P2, DOI 10.1016/j.reprotox.2007.09.001; Skinner MK, 2016, NAT REV ENDOCRINOL, V12, P68, DOI 10.1038/nrendo.2015.206; Skinner MK, 2015, EPIGENETICS-US, V10, P762, DOI 10.1080/15592294.2015.1062207; Skinner MK, 2014, MOL CELL ENDOCRINOL, V398, P4, DOI 10.1016/j.mce.2014.07.019; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; SKINNER MK, 2014, BMC GENOMICS, V15; Smerdon MJ, 1991, CURR OPIN CELL BIOL, V3, P422, DOI 10.1016/0955-0674(91)90069-B; SVED J, 1990, P NATL ACAD SCI USA, V87, P4692, DOI 10.1073/pnas.87.12.4692; Tang MHE, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00197; Valentine CR, 2010, MUTAT RES-REV MUTAT, V705, P205, DOI 10.1016/j.mrrev.2010.07.001; Walter CA, 1998, P NATL ACAD SCI USA, V95, P10015, DOI 10.1073/pnas.95.17.10015; Whitelaw NC, 2008, CURR OPIN GENET DEV, V18, P273, DOI 10.1016/j.gde.2008.07.001; Wu JT, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-305; Xing YL, 2007, PLOS GENET, V3, P1598, DOI 10.1371/journal.pgen.0030151; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; Youngson NA, 2015, ASIAN J ANDROL	65	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168038	10.1371/journal.pone.0168038	http://dx.doi.org/10.1371/journal.pone.0168038			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992467	Green Published, gold, Green Submitted			2022-12-26	WOS:000392842600028
J	Todorov, T; Balakrishnan, P; Savov, A; Socha, P; Schmidt, HHJ				Todorov, Theodor; Balakrishnan, Prahlad; Savov, Alexey; Socha, Piotr; Schmidt, Hartmut H. J.			Intragenic Deletions in ATP7B as an Unusual Molecular Genetics Mechanism of Wilson's Disease Pathogenesis	PLoS One			English	Article							HOMOZYGOSITY; MUTATIONS; SEQUENCES; DIAGNOSIS; ELEMENTS; DATABASE; PATIENT; DNA	Wilson's disease (WD) is an autosomal recessive disorder caused by mutations in the ATP7B resulting in copper overload in the liver and brain. Direct sequencing is routinely used to confirm WD diagnosis; however, partial and whole gene deletions in the heterozygous state cannot be detected by exon amplification since the normal allele will mask its presence. The aim of the present work was to search for unusual mutational events in the unexplained WD cases and to provide insight into the mechanisms. Out of 1420 clinically and biochemically confirmed WD samples received between 2000 and 2014 for routine mutation analysis, we were unable to detect mutant alleles in 142 samples, after extensive sequencing analysis. We used selective amplification and MLPA to identify the partial gene deletions and identified three different partial gene deletions in seven different families. All three deletions were fully characterized at the DNA sequence level. We report the first hemizygous case with WD due to intragenic deletion in the ATP7B (c.3134_3556+689de1). This novel deletion resulted from an excision event mediated by consensus sequences in an AluSq2 repeat element and could be traced to micro homologous end joining (MMEJ). Finally, we determined the prevalence of the three deletions in DNA samples from a multinational group of WD patients. Our results emphasize the need for searching mutant alleles beyond routine methods and highlight that large ATP7B deletions are rare, but account for a detectable proportion in some WD patients. Screening for gene aberrations will further improve mutation detection in patients with unidentified ATP7B mutations presenting with clinical manifestations of WD.	[Todorov, Theodor; Schmidt, Hartmut H. J.] Univ Munster, Dept Transplantat Med, Munster, Germany; [Balakrishnan, Prahlad] Sir Ganga Ram Hosp, Inst Med Genet & Genom, New Delhi, India; [Savov, Alexey] NGL, Sofia, Bulgaria; [Socha, Piotr] Childrens Mem Hlth Inst, Dept Gastroenterol Hepatol & Immunol, Warsaw, Poland; [Balakrishnan, Prahlad] Med Sci & Res Ctr, Dept Paediat Genet, Amrita Inst, Ponekkara PO, Kochi, Kerala, India	University of Munster; Children's Memorial Health Institute; Amrita Vishwa Vidyapeetham	Balakrishnan, P (corresponding author), Sir Ganga Ram Hosp, Inst Med Genet & Genom, New Delhi, India.; Balakrishnan, P (corresponding author), Med Sci & Res Ctr, Dept Paediat Genet, Amrita Inst, Ponekkara PO, Kochi, Kerala, India.	bprahlad@gmail.com	Todorov, Theodor/K-9672-2018; Todorov, Theodor/GWC-6426-2022; Balakrishnan, Prahald/AAX-5341-2020	Todorov, Theodor/0000-0002-0548-5487; Balakrishnan, Prahald/0000-0003-0740-5476; Socha, Piotr/0000-0002-1621-464X; Schmidt, Hartmut/0000-0002-2402-7764	European Commission (WilsonIndia project) [247506]; Eurowilson Project [LSHM-CT2004 503430]	European Commission (WilsonIndia project); Eurowilson Project	PB was partly funded by European Commission (WilsonIndia project 247506). In addition to funding from WilsonIndia project 247506, Professor Hartmut HJ Schmidt, also received grant from Eurowilson Project (www.eurowilson.org): LSHM-CT2004 503430. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bost M, 2012, J TRACE ELEM MED BIO, V26, P97, DOI 10.1016/j.jtemb.2012.04.024; Chen JM, 2010, SEMIN CANCER BIOL, V20, P222, DOI 10.1016/j.semcancer.2010.05.007; Coffey AJ, 2013, BRAIN, V136, P1476, DOI 10.1093/brain/awt035; Ferenci P, 2003, LIVER INT, V23, P139, DOI 10.1034/j.1600-0676.2003.00824.x; Ferenci P, 2006, HUM GENET, V120, P151, DOI 10.1007/s00439-006-0202-5; Hoste C, 2010, HUM MUTAT, V31, pE1304, DOI 10.1002/humu.21227; Incollu S, 2011, MOL CELL PROBE, V25, P195, DOI 10.1016/j.mcp.2011.07.003; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; KRAWCZAK M, 1991, HUM GENET, V86, P425; Mameli E, 2015, GENE, V569, P276, DOI 10.1016/j.gene.2015.05.067; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Moller LB, 2005, AM J MED GENET A, V138A, P340, DOI 10.1002/ajmg.a.30977; Moller LB, 2011, EUR J HUM GENET, V19, P935, DOI 10.1038/ejhg.2011.80; Moller LB, 2009, BIOCHIMIE, V91, P1273, DOI 10.1016/j.biochi.2009.05.011; Riley D, 2001, NEUROLOGY, V57, P141, DOI 10.1212/WNL.57.1.141; Smit A, 1996, REPEATMASKER OPEN 30; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; van Zelm MC, 2008, AM J HUM GENET, V82, P320, DOI 10.1016/j.ajhg.2007.10.011; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031	19	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168372	10.1371/journal.pone.0168372	http://dx.doi.org/10.1371/journal.pone.0168372			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992490	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842600052
J	Xing, F; Matsumiya, T; Shiba, Y; Hayakari, R; Yoshida, H; Imaizumi, T				Xing, Fei; Matsumiya, Tomoh; Shiba, Yuko; Hayakari, Ryo; Yoshida, Hidemi; Imaizumi, Tadaatsu			Non-Canonical Role of IKK alpha in the Regulation of STAT1 Phosphorylation in Antiviral Signaling	PLoS One			English	Article							NF-KAPPA-B; INDUCIBLE GENE-I; DOUBLE-STRANDED-RNA; HEPATITIS-C VIRUS; ADAPTER PROTEIN; INNATE IMMUNITY; KINASE-ALPHA; BETA SUBUNIT; ACTIVATION; EXPRESSION	Non-self RNA is recognized by retinoic acid-inducible gene-I (RIG-1)-like receptors (RLRs), inducing type I interferons (IFNs). Type I IFN promotes the expression of IFN-stimulated genes (ISGs), which requires the activation of signal transducer and activator of transcription -1 (STAT1). We previously reported that dsRNA induced STAT1 phosphorylation via a type I IFN-independent pathway in addition to the well-known type I IFN-dependent pathway. IKB kinase a (IKK alpha) is involved in antiviral signaling induced by dsRNA; however, its role is incompletely understood. Here, we explored the function of IKKa in RLR-mediated STAT1 phosphorylation. Silencing of IKKa markedly decreased the level of IFN-beta and STAT1 phosphorylation inHeH response to dsRNA. However, the inhibition of IKKa did not alter the RLR signaling-mediated dimerization of interferon responsive factor 3 (IRF3) or the nuclear translocation of nuclear factor-KB (NFKB). These results suggest a non-canonical role of IKKa in RLR signaling. Furthermore, phosphorylation of STAT1 was suppressed by IKKa knockdown in cells treated with a specific neutralizing antibody for the type I IFN receptor (IFNAR) and in IFNAR-deficient cells. Collectively, the dual regulation of STAT1 by IKKa in antiviral signaling suggests a role for IKKa in the fine-tuning of antiviral signaling in response to non-self RNA.	[Xing, Fei; Matsumiya, Tomoh; Shiba, Yuko; Hayakari, Ryo; Yoshida, Hidemi; Imaizumi, Tadaatsu] Hirosaki Univ, Grad Sch Med, Dept Vasc Biol, Inst Brain Sci, Hirosaki, Aomori, Japan	Hirosaki University	Matsumiya, T (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Vasc Biol, Inst Brain Sci, Hirosaki, Aomori, Japan.	tomo1027@hirosaki-u.ac.jp	Matsumiya, Tomoh/ABA-5861-2021					Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amaya M, 2014, PATHOG DIS, V72, P32, DOI 10.1111/2049-632X.12210; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Brierley MM, 2005, J INTERF CYTOK RES, V25, P733, DOI 10.1089/jir.2005.25.733; CHENKIANG S, 1993, CURR OPIN IMMUNOL, V5, P124, DOI 10.1016/0952-7915(93)90091-6; de Weerd NA, 2007, J BIOL CHEM, V282, P20053, DOI 10.1074/jbc.R700006200; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Dempoya J, 2012, J VIROL, V86, P12760, DOI 10.1128/JVI.01881-12; Dong W, 2012, NUCLEIC ACIDS RES, V40, P2940, DOI 10.1093/nar/gkr1216; Fink Karin, 2013, JAKSTAT, V2, pe27521, DOI 10.4161/jkst.27521; Gregory D, 2004, J VIROL, V78, P13582, DOI 10.1128/JVI.78.24.13582-13590.2004; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; Huang WC, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-3; Imaizumi T, 2010, NEPHROL DIAL TRANSPL, V25, P3534, DOI 10.1093/ndt/gfq270; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kerr IM, 2003, FEBS LETT, V546, P1, DOI 10.1016/S0014-5793(03)00411-3; Kubota K, 2006, ORAL MICROBIOL IMMUN, V21, P399, DOI 10.1111/j.1399-302X.2006.00326.x; Li QS, 2013, NAT MED, V19, P722, DOI 10.1038/nm.3190; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Liu F, 2012, IMMUNOL REV, V246, P239, DOI 10.1111/j.1600-065X.2012.01107.x; Mancino A, 2013, EMBO J, V32, P816, DOI 10.1038/emboj.2013.28; Matsumiya T, 2010, CRIT REV IMMUNOL, V30, P489, DOI 10.1615/CritRevImmunol.v30.i6.10; Mattioli I, 2004, J IMMUNOL, V172, P6336, DOI 10.4049/jimmunol.172.10.6336; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; Nichols DB, 2006, J VIROL, V80, P578, DOI 10.1128/JVI.80.2.578-586.2006; Rudolph D, 2000, GENE DEV, V14, P854; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Teijaro JR, 2016, CURR OPIN VIROL, V16, P31, DOI 10.1016/j.coviro.2016.01.001; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Waelchli R, 2006, BIOORG MED CHEM LETT, V16, P108, DOI 10.1016/j.bmcl.2005.09.035; Xing F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045136; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Yu FF, 2010, MOL IMMUNOL, V47, P2330, DOI 10.1016/j.molimm.2010.05.282; Zhang YB, 2012, DEV COMP IMMUNOL, V38, P193, DOI 10.1016/j.dci.2012.06.003; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	45	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168696	10.1371/journal.pone.0168696	http://dx.doi.org/10.1371/journal.pone.0168696			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992555	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842600089
J	Xing, SH; Meng, XX; Zhou, LH; Mujahid, H; Zhao, CF; Zhang, YD; Wang, CL; Peng, ZH				Xing, Shihai; Meng, Xiaoxi; Zhou, Lihui; Mujahid, Hana; Zhao, Chunfang; Zhang, Yadong; Wang, Cailin; Peng, Zhaohua			Proteome Profile of Starch Granules Purified from Rice (Oryza sativa) Endosperm	PLoS One			English	Article							BIOSYNTHETIC-ENZYMES; LYSINE ACETYLATION; GENE-EXPRESSION; ADP-GLUCOSE; SYNTHASE-I; MAIZE; PROTEINS; METABOLISM; EVOLUTION; PATHWAY	Starch is the most important food energy source in cereals. Many of the known enzymes involved in starch biosynthesis are partially or entirely granule-associated in the endosperm. Studying the proteome of rice starch granules is critical for us to further understand the mechanisms underlying starch biosynthesis and packaging of starch granules in rice amyloplasts, consequently for the improvement of rice grain quality. In this article, we developed a protocol to purify starch granules from mature rice endosperm and verified the quality of purified starch granules by microscopy observations, I-2 staining, and Western blot analyses. In addition, we found the phenol extraction method was superior to Tris-HCl buffer extraction method with respect to the efficiency in recovery of starch granule associated proteins. LCMS/MS analysis showed identification of already known starch granule associated proteins with high confidence. Several proteins reported to be involved in starch synthesis in prior genetic studies in plants were also shown to be enriched with starch granules, either directly or indirectly, in our studies. In addition, our results suggested that a few additional candidate proteins may also be involved in starch synthesis. Furthermore, our results indicated that some starch synthesis pathway proteins are subject to protein acetylation modification. GO analysis and KEGG pathway enrichment analysis showed that the identified proteins were mainly located in plastids and involved in carbohydrate metabolism. This study substantially advances the understanding of the starch granule associated proteome in rice and post translational regulation of some starch granule associated proteins.	[Xing, Shihai; Zhou, Lihui; Zhao, Chunfang; Zhang, Yadong; Wang, Cailin; Peng, Zhaohua] Jiangsu Acad Agr Sci, Jiangsu High Qual Rice Res & Dev Ctr, Inst Food Crops, Nanjing Branch China Natl Ctr Rice Improvement, Nanjing, Jiangsu, Peoples R China; [Xing, Shihai; Meng, Xiaoxi; Mujahid, Hana; Zhang, Yadong; Peng, Zhaohua] Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Starkville, MS 39762 USA	Jiangsu Academy of Agricultural Sciences; Mississippi State University	Wang, CL (corresponding author), Jiangsu Acad Agr Sci, Jiangsu High Qual Rice Res & Dev Ctr, Inst Food Crops, Nanjing Branch China Natl Ctr Rice Improvement, Nanjing, Jiangsu, Peoples R China.; Peng, ZH (corresponding author), Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Starkville, MS 39762 USA.	clwang@jaas.ac.cn; zp7@BCH.msstate.edu	Meng, Xiaoxi/AAR-9754-2020	Meng, Xiaoxi/0000-0001-7217-2037	Agriculture and Food Research Initiative competitive grant of the USDA National Institute of Food and Agriculture [2011-67013-30125]; National Natural Science Foundation of China [31271678]; Jiangsu Agricultural Scientific Self-Innovation Fund [CX[11]4023]; Jiangsu Province Postdoctoral Science Foundation [1402003A]; Fundamental Research Funds for JARS [ZX(15)4003]	Agriculture and Food Research Initiative competitive grant of the USDA National Institute of Food and Agriculture; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Agricultural Scientific Self-Innovation Fund; Jiangsu Province Postdoctoral Science Foundation; Fundamental Research Funds for JARS	This research is supported by the Agriculture and Food Research Initiative competitive grant (2011-67013-30125) of the USDA National Institute of Food and Agriculture to Zhaohua Peng, the National Natural Science Foundation of China (No. 31271678) and Jiangsu Agricultural Scientific Self-Innovation Fund (Grant No. CX[11]4023) to Cailin Wang, Jiangsu Province Postdoctoral Science Foundation (1402003A) to Shihai Xing, and the Fundamental Research Funds for JARS (ZX(15)4003) to Lihui Zhou.	Ahmed Z, 2015, PLANT SCI, V233, P95, DOI 10.1016/j.plantsci.2014.12.016; Ball S, 1996, CELL, V86, P349, DOI 10.1016/S0092-8674(00)80107-5; Ball SG, 2003, ANNU REV PLANT BIOL, V54, P207, DOI 10.1146/annurev.arplant.54.031902.134927; Balmer Y, 2006, P NATL ACAD SCI USA, V103, P2988, DOI 10.1073/pnas.0511040103; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Baunsgaard L, 2005, PLANT J, V41, P595, DOI 10.1111/j.1365-313X.2004.02322.x; Bergeron JJ, 2007, NAT BIOTECHNOL, V25, P61, DOI 10.1038/nbt0107-61; Biselli C, 2014, RICE, V7, DOI 10.1186/1939-8433-7-1; Butler CA, 2015, J PROTEOMICS, V128, P352, DOI 10.1016/j.jprot.2015.08.015; CAO HP, 1995, PHYSIOL PLANTARUM, V95, P176, DOI 10.1111/j.1399-3054.1995.tb00825.x; Cao H, 2015, J PROTEOMICS, V112, P95, DOI 10.1016/j.jprot.2014.08.002; Chen GX, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0198-2; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Comparot-Moss S, 2009, J EXP BOT, V60, P2481, DOI 10.1093/jxb/erp141; Dian WM, 2005, J EXP BOT, V56, P623, DOI 10.1093/jxb/eri065; Dian WM, 2003, PLANTA, V218, P261, DOI 10.1007/s00425-003-1101-9; Duan MJ, 2005, PLANT MOL BIOL, V59, P165, DOI 10.1007/s11103-004-7507-3; EVANS HJ, 1968, P NATL ACAD SCI USA, V61, P1448, DOI 10.1073/pnas.61.4.1448; Fitzgerald MA, 2009, TRENDS PLANT SCI, V14, P133, DOI 10.1016/j.tplants.2008.12.004; Friso G, 2015, PLANT PHYSIOL, V169, P1469, DOI 10.1104/pp.15.01378; Fujita N, 2009, J EXP BOT, V60, P1009, DOI 10.1093/jxb/ern349; Grimaud F, 2008, J EXP BOT, V59, P3395, DOI 10.1093/jxb/ern198; Hanashiro I, 2008, PLANT CELL PHYSIOL, V49, P925, DOI 10.1093/pcp/pcn066; Hennen-Bierwagen TA, 2009, PLANT PHYSIOL, V149, P1541, DOI 10.1104/pp.109.135293; James MG, 2003, CURR OPIN PLANT BIOL, V6, P215, DOI 10.1016/S1369-5266(03)00042-6; Kang K, 2009, PLANT PHYSIOL, V150, P1380, DOI 10.1104/pp.109.138552; Koziol AG, 2012, J PROTEOMICS, V75, P993, DOI 10.1016/j.jprot.2011.10.019; KUIPERS AGJ, 1994, PLANT CELL, V6, P43, DOI 10.1105/tpc.6.1.43; Li GS, 2008, ELECTROPHORESIS, V29, P604, DOI 10.1002/elps.200700412; MuForster C, 1996, PLANT PHYSIOL, V111, P821, DOI 10.1104/pp.111.3.821; Nagai YS, 2009, PLANT CELL PHYSIOL, V50, P635, DOI 10.1093/pcp/pcp021; Nakamura Y, 2002, PLANT CELL PHYSIOL, V43, P718, DOI 10.1093/pcp/pcf091; NAKAMURA Y, 1989, PLANT CELL PHYSIOL, V30, P833, DOI 10.1093/oxfordjournals.pcp.a077813; Nallamilli BRR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089283; Ohdan T, 2005, J EXP BOT, V56, P3229, DOI 10.1093/jxb/eri292; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Pilling E, 2003, PLANT PHYSIOL, V132, P365, DOI 10.1104/pp.102.018044; Pinheiro C, 2013, J PROTEOME RES, V12, P3152, DOI 10.1021/pr400012t; Quandt A., 2014, EUPA OPEN PROTEOMICS, V5, P21; Sabelli PA, 2009, PLANT PHYSIOL, V149, P14, DOI 10.1104/pp.108.129437; Satoh H, 2008, PLANT CELL, V20, P1833, DOI 10.1105/tpc.107.054007; Seifert GJ, 2004, CURR OPIN PLANT BIOL, V7, P277, DOI 10.1016/j.pbi.2004.03.004; Shannon JC, 1998, PLANT PHYSIOL, V117, P1235, DOI 10.1104/pp.117.4.1235; She KC, 2010, PLANT CELL, V22, P3280, DOI 10.1105/tpc.109.070821; Sikka VK, 2001, PLANT SCI, V161, P461, DOI 10.1016/S0168-9452(01)00431-9; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; STAMOVA BS, 2009, INT J PLANT GENOMICS; Sun MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018385; Tan F, 2011, J PROTEOME RES, V10, P551, DOI 10.1021/pr100748e; Tanaka N, 2004, PLANT BIOTECHNOL J, V2, P507, DOI 10.1111/j.1467-7652.2004.00097.x; Tian ZX, 2009, P NATL ACAD SCI USA, V106, P21760, DOI 10.1073/pnas.0912396106; TSAI CY, 1974, PHYTOCHEMISTRY, V13, P885, DOI 10.1016/S0031-9422(00)91418-3; Tuli Leepika, 2009, J Proteomics Bioinform, V2, P416; Umemoto T, 2005, FUNCT PLANT BIOL, V32, P763, DOI 10.1071/FP04214; Wang SJ, 2013, STARCH-STARKE, V65, P186, DOI 10.1002/star.201200093; Wang Z, 2002, MOL PLANT BREEDING, V1, P231; Wani AA, 2012, COMPR REV FOOD SCI F, V11, P417, DOI 10.1111/j.1541-4337.2012.00193.x; Xiong Y, 2012, J CELL BIOL, V198, P155, DOI 10.1083/jcb.201202056; Yang YH, 2013, GENET MOL BIOL, V36, P87, DOI 10.1590/S1415-47572013000100012; Yu GQ, 2011, MOL BIOL EVOL, V28, P659, DOI 10.1093/molbev/msq243; Yu Y, 1998, PLANT PHYSIOL, V116, P1451, DOI 10.1104/pp.116.4.1451; Zeeman SC, 2007, BIOCHEM J, V401, P13, DOI 10.1042/BJ20061393; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301; Zhang XL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-96; Zhou SR, 2013, CURR OPIN PLANT BIOL, V16, P236, DOI 10.1016/j.pbi.2013.03.001	65	25	25	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168467	10.1371/journal.pone.0168467	http://dx.doi.org/10.1371/journal.pone.0168467			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992503	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842600062
J	O'Brien, P; Corpe, CP				O'Brien, Patrick; Corpe, Christopher Peter			Acute Effects of Sugars and Artificial Sweeteners on Small Intestinal Sugar Transport: A Study Using CaCo-2 Cells As an In Vitro Model of the Human Enterocyte	PLOS ONE			English	Article							RAT SMALL-INTESTINE; GLUCOSE-ABSORPTION; TASTE RECEPTORS; NONNUTRITIVE SWEETENERS; DIFFERENTIAL EXPRESSION; HEALTHY-SUBJECTS; GLUT2; FRUCTOSE; T1R3; SECRETION	Background The gastrointestinal tract is responsible for the assimilation of nutrients and plays a key role in the regulation of nutrient metabolism and energy balance. The molecular mechanisms by which intestinal sugar transport are regulated are controversial. Based on rodent studies, two models currently exist that involve activation of the sweet-taste receptor, T1R2/3: an indirect model, whereby luminal carbohydrates activate T1R2/3 expressed on enteroendo-crine cells, resulting in the release of gut peptides which in turn regulate enterocyte sugar transport capacity; and a direct model, whereby T1R2/3 expressed on the enterocyte regulates enterocyte function. Aims To study the direct model of intestinal sugar transport using CaCo-2 cells, a well-established in vitro model of the human enterocyte. Methods Uptake of 10mM C-14 D-Glucose and D-Fructose into confluent CaCo-2/TC7 cells was assessed following 3hr preincubation with sugars and artificial sweeteners in the presence and absence of the sweet taste receptor inhibitor, lactisole. Expression of the intestinal sugar transporters and sweet-taste receptors were also determined by RT-PCR. Results In response to short term changes in extracellular glucose and glucose/fructose concentrations (2.5mM to 75mM) carrier-mediated sugar uptake mediated by SGLT1 and/or the facilitative hexose transporters (GLUT1,2,3 and 5) was increased. Lactisole and artificial sweeteners had no effect on sugar transport regulated by glucose alone; however, lactisole increased glucose transport in cells exposed to glucose/fructose. RT-PCR revealed Tas1r3 and SGLT3 gene expression in CaCo-2/TC7 cells, but not Tas1r2. Conclusions In the short term, enterocyte sugar transport activities respond directly to extracellular glucose levels, but not fructose or artificial sweeteners. We found no evidence of a functional heterodimeric sweet taste receptor, T1R2/3 in CaCo-2 cells. However, when glucose/fructose is administered together there is an inhibitory effect on glucose transport possibly mediated by T1R3.	[O'Brien, Patrick; Corpe, Christopher Peter] Kings Coll London, Diabet & Nutr Sci Div, Diet & Cardiovasc Hlth Grp, London, England	University of London; King's College London	Corpe, CP (corresponding author), Kings Coll London, Diabet & Nutr Sci Div, Diet & Cardiovasc Hlth Grp, London, England.	christopher.corpe@kcl.ac.uk		corpe, christopher/0000-0003-1994-8312	King's College London PhD studentship; King's College London	King's College London PhD studentship; King's College London	This work was supported by King's College London PhD studentship. Open access for this article was funded by King's College London.	BLAIS A, 1987, J MEMBRANE BIOL, V99, P113, DOI 10.1007/BF01871231; Bryant CE, 2014, EUR J CLIN NUTR, V68, P629, DOI 10.1038/ejcn.2014.19; BURANT CF, 1994, AM J PHYSIOL, V267, pG71, DOI 10.1152/ajpgi.1994.267.1.G71; CHANTRET I, 1994, J CELL SCI, V107, P213; Corpe CP, 1996, AM J PHYSIOL-GASTR L, V271, pG211, DOI 10.1152/ajpgi.1996.271.1.G211; Corpe CP, 1998, BBA-MOL CELL RES, V1402, P229, DOI 10.1016/S0167-4889(97)00155-9; Diez-Sampedro A, 2003, P NATL ACAD SCI USA, V100, P11753, DOI 10.1073/pnas.1733027100; Ferraris RP, 2001, BIOCHEM J, V360, P265, DOI 10.1042/0264-6021:3600265; Gorboulev V, 2012, DIABETES, V61, P187, DOI 10.2337/db11-1029; Groen J, 1937, J CLIN INVEST, V16, P245, DOI 10.1172/JCI100854; Hamano K, 2015, J ENDOCRINOL, V226, P57, DOI 10.1530/JOE-15-0102; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Kellett GL, 2008, ANNU REV NUTR, V28, P35, DOI 10.1146/annurev.nutr.28.061807.155518; Kellett GL, 2000, BIOCHEM J, V350, P155, DOI 10.1042/0264-6021:3500155; Le Gall M, 2007, J CELL PHYSIOL, V213, P834, DOI 10.1002/jcp.21245; LEVIN RJ, 1994, AM J CLIN NUTR, V59, p690S, DOI 10.1093/ajcn/59.3.690S; Mace OJ, 2007, J PHYSIOL-LONDON, V582, P379, DOI 10.1113/jphysiol.2007.130906; MAHRAOUI L, 1994, BIOCHEM J, V298, P629, DOI 10.1042/bj2980629; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Pepino MY, 2015, PHYSIOL BEHAV, V152, P450, DOI 10.1016/j.physbeh.2015.06.024; Pepino MY, 2013, DIABETES CARE, V36, P2530, DOI 10.2337/dc12-2221; Phillips LK, 2011, ANN NY ACAD SCI, V1243, P1, DOI 10.1111/j.1749-6632.2012.06491.x; Renwick AG, 2010, BRIT J NUTR, V104, P1415, DOI 10.1017/S0007114510002540; Stumpel F, 2001, P NATL ACAD SCI USA, V98, P11330, DOI 10.1073/pnas.211357698; Suez J, 2014, NATURE, V514, P181, DOI 10.1038/nature13793; Temizkan S, 2015, EUR J CLIN NUTR, V69, P162, DOI 10.1038/ejcn.2014.208; Thomson ABR, 1997, DIGEST DIS SCI, V42, P470, DOI 10.1023/A:1018874404762; TRUSWELL AS, 1988, AM J CLIN NUTR, V48, P1424, DOI 10.1093/ajcn/48.6.1424; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; Zheng Y, 2012, SURGERY, V151, P13, DOI 10.1016/j.surg.2011.07.010; Zukerman S, 2009, AM J PHYSIOL-REG I, V296, pR866, DOI 10.1152/ajpregu.90870.2008	31	17	17	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0167785	10.1371/journal.pone.0167785	http://dx.doi.org/10.1371/journal.pone.0167785			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992462	Green Submitted, Green Published, gold			2022-12-26	WOS:000392758000016
J	Thankam, FG; Boosani, CS; Dilisio, MF; Dietz, NE; Agrawal, DK				Thankam, Finosh G.; Boosani, Chandra S.; Dilisio, Matthew F.; Dietz, Nicholas E.; Agrawal, Devendra K.			MicroRNAs Associated with Shoulder Tendon Matrisome Disorganization in Glenohumeral Arthritis	PLOS ONE			English	Article							ROTATOR CUFF; AORTIC-ANEURYSM; EXPRESSION; CELLS; NETWORKANALYST; MIR-29; TISSUE; GENES	The extracellular matrix (ECM) provides core support which is essential for the cell and tissue architectural development. The role of ECM in many pathological conditions has been well established and ECM-related abnormalities leading to serious consequences have been identified. Though much has been explored in regards to the role of ECM in soft tissue associated pathologies, very little is known about its role in inflammatory disorders in tendon. In this study, we performed microRNA (miRNA) expression analysis in the long head of the human shoulder biceps tendon to identify key genes whose expression was altered during inflammation in patients with glenohumeral arthritis. We identified differential regulation of matrix metalloproteinases (MMPs) that could be critical in collagen type replacement during tendinopathy. The miRNA profiling showed consistent results between the groups and revealed significant changes in the expression of seven different miRNAs in the inflamed tendons. Interestingly, all of these seven miRNAs were previously reported to have either a direct or indirect role in regulating the ECM organization in other pathological disorders. In addition, these miRNAs were also found to alter the expression levels of MMPs, which are the key matrix degrading enzymes associated with ECM-related abnormalities and pathologies. To our knowledge, this is the first report which identifies specific miRNAs associated with inflammation and the matrix reorganization in the tendons. Furthermore, the findings also support the potential role of these miRNAs in altering the collagen type ratio in the tendons during inflammation which is accompanied with differential expression of MMPs.	[Thankam, Finosh G.; Boosani, Chandra S.; Agrawal, Devendra K.] Creighton Univ, Sch Med, Dept Clin & Translat Sci, Omaha, NE 68102 USA; [Dilisio, Matthew F.] Creighton Univ, Sch Med, Dept Orthoped Surg, Omaha, NE USA; [Dietz, Nicholas E.] Creighton Univ, Sch Med, Dept Pathol, Omaha, NE USA	Creighton University; Creighton University; Creighton University	Agrawal, DK (corresponding author), Creighton Univ, Sch Med, Dept Clin & Translat Sci, Omaha, NE 68102 USA.	dkagr@creighton.edu	Agrawal, Devendra/GLR-3925-2022	Agrawal, Devendra/0000-0001-5445-0013; Boosani, Chandra/0000-0001-6904-8203	National Heart, Lung and Blood Institute, National Institutes of Health, USA [R01 HL112597, R01HL116042, R01 HL120659]; President's Haddix grant	National Heart, Lung and Blood Institute, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); President's Haddix grant	This work was supported by research grants R01 HL112597, R01HL116042, and R01 HL120659 to DK Agrawal from the National Heart, Lung and Blood Institute, National Institutes of Health, USA and President's Haddix grant to MF Dilisio. The content of this review article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agrawal T, 2013, CLIN EXP ALLERGY; Aro AA, 2015, ANAT REC, V298, P428, DOI 10.1002/ar.23057; Benson RT, 2010, J BONE JOINT SURG BR, V92B, P448, DOI 10.1302/0301-620X.92B3.23074; Bhatt K, 2011, AM J PHYSIOL-RENAL, V300, pF602, DOI 10.1152/ajprenal.00727.2010; Blaine TA, 2005, J SHOULDER ELB SURG, V14, p84S, DOI 10.1016/j.jse.2004.09.022; Bronze-da-Rocha E, 2014, BIOMED RES INT, V2014, P1; Chaturvedi T P, 2009, Indian J Dent Res, V20, P107; Cushing L, 2011, AM J RESP CELL MOL, V45, P287, DOI 10.1165/rcmb.2010-0323OC; DE Giorgi Silvana, 2014, Joints, V2, P26; Fassan M, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2348; Franceschi F, 2008, BRIT J SPORT MED, V42, P742, DOI 10.1136/bjsm.2007.040931; Gardner K, 2008, DISABIL REHABIL, V30, P1523, DOI 10.1080/09638280701785395; Goodier HCJ, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0947-8; Gupta GK, 2012, EXP MOL PATHOL, V93, P82, DOI 10.1016/j.yexmp.2012.04.006; He XJ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-218; Jiang YG, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-36; Jing D, 2015, INT J ORAL SCI, V7, P131, DOI 10.1038/ijos.2015.22; Kriegel AJ, 2010, NUCLEIC ACIDS RES, V38, P8338, DOI 10.1093/nar/gkq718; Lee YS, 2009, EXP MOL MED, V41, P259, DOI 10.3858/emm.2009.41.4.029; Li LQ, 2013, CANCER BIOL THER, V14, P796, DOI 10.4161/cbt.25936; Lin TW, 2004, J BIOMECH, V37, P865, DOI 10.1016/j.jbiomech.2003.11.005; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019139; Lopez-Camarillo C, 2012, INT J MOL SCI, V13, P1347, DOI 10.3390/ijms13021347; Lopez-Ramirez MA, 2016, FASEB J, V30, P2662, DOI 10.1096/fj.201600435RR; Ma L, 2016, SCI REP-UK, V6, DOI 10.1038/srep31535; Millar NL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7774; Minna E, 2014, ONCOTARGET, V5, P2513, DOI 10.18632/oncotarget.1830; Noren Hooten N, 2013, AGING-US, V5, P725, DOI 10.18632/aging.100603; Pandey V, 2015, ASIA-PAC J SPORT MED, V2, P1, DOI 10.1016/j.asmart.2014.11.003; Pasternak B, 2007, ACTA ORTHOP, V78, P680, DOI 10.1080/17453670710014392; Pearce WH, 2006, ANN NY ACAD SCI, V1085, P117, DOI 10.1196/annals.1383.025; Pei H, 2015, EUR J VASC ENDOVASC, V49, P52, DOI 10.1016/j.ejvs.2014.10.018; Potenza N, 2011, NUCLEIC ACIDS RES, V39, P5157, DOI 10.1093/nar/gkr067; Rao VH, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.224; Rozalski M, 2016, POSTEP DERM ALERGOL, V33, P157, DOI 10.5114/ada.2016.60606; Rutnam ZJ, 2013, MATRIX BIOL, V32, P74, DOI 10.1016/j.matbio.2012.11.003; Sanchez-Jimenez C, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-4; Shen J, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.2; Suh EJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r121; Tang QM, 2014, SCI REP-UK, V4, DOI 10.1038/srep05515; Thankam FG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165492; Tomankova T, 2012, SCAND J IMMUNOL, V75, P129, DOI 10.1111/j.1365-3083.2011.02650.x; Tomiosso TC, 2009, CELL TISSUE RES, V337, P235, DOI 10.1007/s00441-009-0819-5; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Voloshin I, 2005, ARTHROSCOPY, V21, P1076, DOI 10.1016/j.arthro.2005.05.017; Wei QQ, 2013, IUBMB LIFE, V65, P602, DOI 10.1002/iub.1174; Wentz-Hunter K K, 2011, Mol Biol Int, V2011, P839872, DOI 10.4061/2011/839872; Xia JG, 2015, NAT PROTOC, V10, P823, DOI 10.1038/nprot.2015.052; Xia JG, 2014, NUCLEIC ACIDS RES, V42, pW167, DOI 10.1093/nar/gku443; Xu M, 2015, MOL THER, V23, P89, DOI 10.1038/mt.2014.197; Xue ML, 2015, ADV WOUND CARE, V4, P119, DOI 10.1089/wound.2013.0485	52	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168077	10.1371/journal.pone.0168077	http://dx.doi.org/10.1371/journal.pone.0168077			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992561	gold, Green Published, Green Submitted			2022-12-26	WOS:000392758000024
J	Hou, Q; Zhou, LL; Tang, JJ; Ma, N; Xu, AC; Tang, J; Zheng, DD; Chen, XG; Chen, F; Dong, XD; Tu, LL				Hou, Qiang; Zhou, Linglin; Tang, Jiajia; Ma, Nan; Xu, Ancong; Tang, Jiang; Zheng, Dandan; Chen, Xiaogang; Chen, Feng; Dong, Xiang Da; Tu, LiLi			LGR4 Is a Direct Target of MicroRNA-34a and Modulates the Proliferation and Migration of Retinal Pigment Epithelial ARPE-19 Cells	PLOS ONE			English	Article							DOWN-REGULATION; GPR48; GENE; CANCER; EXPRESSION; EGFR	The pathology of proliferative vitreoretinopathy and proliferative diabetic retinopathy is linked to proliferation, migration, and adhesion of the retinal pigment epithelium. MicroRNA-34a (miR-34a) expression modulates changes in proliferation and migration of retinal pigment epithelial cell line ARPE-19. In this study, we determined that miR-34a interacts with LGR4, identified by bioinformatics using TargetScan Human 5.0, to affect these changes. Double luciferase gene reporter assay confirmed miR-34a involvement in mediating control. miR-34a mimic transfection decreased LGR4 expression. Western blot analysis documented corresponding protein expression inhibition. MTS, Ki67 immunostaining, scratch and transwell testing, along with attachment assay showed that miR-34a upregulation inhibited ARPE-19 cell proliferation, migration and attachment partly through downregulation of LGR4 protein expression. Western blot analysis revealed that both miR-34a upregulation and LGR4 downregulation induced declines in E2F1, p-CDC2, CDK2, CDK4 and CDK6 protein expression. Taken together, miR-34a gene expression upregulation inhibits ARPE-19 cell proliferation, migration and adhesion partly by suppressing LGR4 expression. These results substantiate earlier indications that both miR-34a and LGR4 are potential drug targets to prevent fibrosis in a clinical setting.	[Hou, Qiang; Zhou, Linglin; Tang, Jiajia; Ma, Nan; Xu, Ancong; Tang, Jiang; Zheng, Dandan; Chen, Xiaogang; Chen, Feng; Tu, LiLi] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Hosp Eye, Wenzhou, Zhejiang, Peoples R China; [Hou, Qiang; Zhou, Linglin; Tang, Jiajia; Ma, Nan; Xu, Ancong; Tang, Jiang; Zheng, Dandan; Chen, Xiaogang; Chen, Feng; Tu, LiLi] Minist Hlth Peoples Republ China, State Key Lab, Zhejiang Prov Key Lab Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Hou, Qiang; Zhou, Linglin; Tang, Jiajia; Ma, Nan; Xu, Ancong; Tang, Jiang; Zheng, Dandan; Chen, Xiaogang; Chen, Feng; Tu, LiLi] Minist Hlth Peoples Republ China, Key Lab Vis Sci, Zhejiang Prov Key Lab Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Dong, Xiang Da] Westchester Med Ctr, Dept Surg, Valhalla, NY USA	Wenzhou Medical University; Westchester Medical Center	Tu, LL (corresponding author), Wenzhou Med Univ, Sch Ophthalmol & Optometry, Hosp Eye, Wenzhou, Zhejiang, Peoples R China.; Tu, LL (corresponding author), Minist Hlth Peoples Republ China, State Key Lab, Zhejiang Prov Key Lab Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China.; Tu, LL (corresponding author), Minist Hlth Peoples Republ China, Key Lab Vis Sci, Zhejiang Prov Key Lab Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China.	tulili@mail.eye.ac.cn	ma, nan/AAF-6968-2020	ma, nan/0000-0003-4006-1003	National Natural Science Foundation of China [81100671]; Zhejiang Provincial Natural Science Foundation of China [LY16H120009, Y2110609]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	National Natural Science Foundation of China Grant 81100671, Zhejiang Provincial Natural Science Foundation of China Grant LY16H120009 and Y2110609 for Q.Hou.	Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Gao Y, 2006, CANCER RES, V66, P11623, DOI 10.1158/0008-5472.CAN-06-2629; He SK, 2010, INVEST OPHTH VIS SCI, V51, P543, DOI 10.1167/iovs.09-3475; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Hou Q, 2013, INVEST OPHTH VIS SCI, V54, P6481, DOI 10.1167/iovs.13-11873; Hsu PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106804; Jin C, 2008, INVEST OPHTH VIS SCI, V49, P4245, DOI 10.1167/iovs.08-1860; Jun JH, 2016, INVEST OPHTH VIS SCI, V57, P12, DOI 10.1167/iovs.15-17111; Kuznetsova AV, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/801787; Li MY, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.10; Liang F, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0486-1; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mohri Y, 2011, DEV DYNAM, V240, P1626, DOI 10.1002/dvdy.22651; Pastor JC, 2002, PROG RETIN EYE RES, V21, P127, DOI 10.1016/S1350-9462(01)00023-4; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Styrkarsdottir U, 2013, NATURE, V497, P517, DOI 10.1038/nature12124; Van Schoore G, 2005, HISTOCHEM CELL BIOL, V124, P35, DOI 10.1007/s00418-005-0002-3; Wang ZL, 2010, FEBS LETT, V584, P4057, DOI 10.1016/j.febslet.2010.08.028; Weng JS, 2008, P NATL ACAD SCI USA, V105, P6081, DOI 10.1073/pnas.0708257105; Wu JH, 2013, CARCINOGENESIS, V34, P2861, DOI 10.1093/carcin/bgt229; Zebisch M, 2015, J STRUCT BIOL, V191, P149, DOI 10.1016/j.jsb.2015.05.008; Zhu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119599; Zhu YB, 2013, ASIAN PAC J CANCER P, V14, P4775, DOI 10.7314/APJCP.2013.14.8.4775	28	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168320	10.1371/journal.pone.0168320	http://dx.doi.org/10.1371/journal.pone.0168320			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977785	Green Submitted, Green Published, gold			2022-12-26	WOS:000391217400092
J	Kang, EJ; Seo, JH; Kim, LY; Park, GU; Oh, MJ; Park, PJ; Cho, GJ				Kang, Eun Joo; Seo, Jae Hong; Kim, Log Young; Park, Geun U.; Oh, Min-Jeong; Park, Pyoung-Jae; Cho, Geum Joon			Pregnancy-Associated Risk Factors of Postpartum Breast Cancer in Korea: A Nationwide Health Insurance Database Study	PLOS ONE			English	Article							TRANSIENT INCREASE; OXYTOCIN; PROLIFERATION; PROGNOSIS; CELLS; METASTASIS; INVOLUTION; DIAGNOSIS; SURVIVAL; FEATURES	Patients with postpartum breast cancer have been reported to have a poor prognosis. The present study aimed to evaluate the pregnancy-related risk factors of postpartum breast cancer in Korea. We collected patient data from the Korea National Health Insurance (KNHI) Claims Database of the Health Insurance Review and Assessment Service (HIRA) for the 2009-2013 period. We evaluated the pregnancy-related risk factors for postpartum breast cancer in two population groups. For Group 1 (women who had given birth during the 2010-2012 period), data on those who were diagnosed with breast cancer from childbirth to 1-year postpartum were extracted. For Group 2, we extracted the data of women who gave birth in 2010 and traced them until December 31, 2013. In Group 1, 1,384,551 deliveries and 317 postpartum breast cancer patients were recorded in Korea between January 1, 2010, and December 31, 2012. Women aged >= 35 years (Odds Ratio [OR], 2.003; 95% Confidence Interval [CI], 1.567-2.560) and those who gave birth via cesarean delivery (OR, 1.237; 95% CI, 0.986-1.553) were considered to be at a higher risk for breast cancer. Lower risk was noted in primiparous women (OR, 0.737; 95% CI, 0.585-0.928). In Group 2, the data of 457,924 women who gave birth in 2010 were traced until December 31, 2013. Among them, 655 patients were diagnosed with breast cancer, and age >= 35 years and cesarean delivery were associated with an higher risk of breast cancer, whereas primiparous status was associated with a lower risk of breast cancer. In conclusion, older age (>= 35 years) and cesarean delivery are significant risk factors for postpartum breast cancer, and primiparous women have a lower risk of developing postpartum breast cancer.	[Kang, Eun Joo; Seo, Jae Hong] Korea Univ, Coll Med, Guro Hosp, Div Hematooncol,Dept Internal Med, Seoul, South Korea; [Kim, Log Young] Hlth Insurance Review & Assessment Serv Korea, Seoul, South Korea; [Park, Geun U.] Chung Ang Univ, Dept Appl Stat, Seoul, South Korea; [Oh, Min-Jeong; Cho, Geum Joon] Korea Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Park, Pyoung-Jae] Korea Univ, Coll Med, Div Transplant & Vasc Surg, Dept Surg,Guro Hosp, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Chung Ang University; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Cho, GJ (corresponding author), Korea Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.; Park, PJ (corresponding author), Korea Univ, Coll Med, Div Transplant & Vasc Surg, Dept Surg,Guro Hosp, Seoul, South Korea.	pyoungjaepark@gmail.com; md_cho@hanmail.net		Kang, Eun Joo/0000-0003-0702-3400				Albrektsen G, 2005, BRIT J CANCER, V92, P167, DOI 10.1038/sj.bjc.6602302; Anderson WF, 2007, CANCER CAUSE CONTROL, V18, P439, DOI 10.1007/s10552-006-0092-9; Andersson TML, 2015, CANCER-AM CANCER SOC, V121, P2072, DOI 10.1002/cncr.29325; Andersson TML, 2009, OBSTET GYNECOL, V114, P568, DOI 10.1097/AOG.0b013e3181b19154; Asgeirsson KS, 2011, ACTA OBSTET GYN SCAN, V90, P158, DOI 10.1111/j.1600-0412.2010.01035.x; Azim HA, 2012, CANCER TREAT REV, V38, P834, DOI 10.1016/j.ctrv.2012.06.004; Azim HA, 2012, ACTA ONCOL, V51, P653, DOI 10.3109/0284186X.2011.636069; Callihan EB, 2013, BREAST CANCER RES TR, V138, P549, DOI 10.1007/s10549-013-2437-x; Cassoni P, 2002, INT J ONCOL, V21, P375; Cassoni P, 1997, INT J CANCER, V72, P340, DOI 10.1002/(SICI)1097-0215(19970717)72:2<340::AID-IJC23>3.0.CO;2-I; CASSONI P, 1994, VIRCHOWS ARCH, V425, P467; Cassoni P, 2006, MOL CANCER RES, V4, P351, DOI 10.1158/1541-7786.MCR-06-0024; DEGEEST K, 1985, J PERINAT MED, V13, P3, DOI 10.1515/jpme.1985.13.1.3; Dimitrakakis C, 2013, BREAST CARE, V8, P203, DOI 10.1159/000352093; Genin AS, 2012, BREAST, V21, P550, DOI 10.1016/j.breast.2012.05.002; Gudjonsson T, 2005, J MAMMARY GLAND BIOL, V10, P261, DOI 10.1007/s10911-005-9586-4; Hou NQ, 2013, BREAST CANCER RES TR, V138, P633, DOI 10.1007/s10549-013-2434-0; Imanieh MH, 2014, EUR J PHARMACOL, V741, P112, DOI 10.1016/j.ejphar.2014.07.053; Jesmin E, 2015, Mymensingh Med J, V24, P750; Jinda S, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3633; Jung KW, 2016, CANCER RES TREAT, V48, P451, DOI 10.4143/crt.2016.092; Kalan I, 2010, BREAST, V19, P67, DOI 10.1016/j.breast.2009.10.010; Key TJ, 2001, LANCET ONCOL, V2, P133, DOI 10.1016/S1470-2045(00)00254-0; Kim M, 2013, J NANOMATER, V2013, DOI 10.1155/2013/138083; KUWABARA Y, 1987, ARCH GYNECOL OBSTET, V241, P13, DOI 10.1007/BF00931436; Lambe M, 1995, BRIT MED J, V311, P1607, DOI 10.1136/bmj.311.7020.1607; LAMBE M, 1994, NEW ENGL J MED, V331, P5, DOI 10.1056/NEJM199407073310102; Largent JA, 2005, BREAST CANCER RES, V7, pR541, DOI 10.1186/bcr1198; Lau Y, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0142861, 10.1371/journal.pone.0138694]; Lee YY, 2012, BJOG-INT J OBSTET GY, V119, P1572, DOI 10.1111/j.1471-0528.2012.03475.x; Liu Q, 2002, CANCER CAUSE CONTROL, V13, P299, DOI 10.1023/A:1015287208222; Lyons TR, 2014, J CLIN INVEST, V124, P3901, DOI 10.1172/JCI73777; Lyons TR, 2009, J MAMMARY GLAND BIOL, V14, P87, DOI 10.1007/s10911-009-9119-7; Martinson HA, 2015, INT J CANCER, V136, P1803, DOI 10.1002/ijc.29181; Murphy CG, 2012, CANCER-AM CANCER SOC, V118, P3254, DOI 10.1002/cncr.26654; MURRELL TGC, 1995, BREAST CANCER RES TR, V35, P225, DOI 10.1007/BF00668213; Pavlidis N, 2005, CANCER TREAT REV, V31, P439, DOI 10.1016/j.ctrv.2005.04.010; Pollan M, 2010, BREAST CANCER RES TR, V123, P3, DOI 10.1007/s10549-010-1098-2; Pollan M, 2009, JNCI-J NATL CANCER I, V101, P1584, DOI 10.1093/jnci/djp358; Rodriguez AO, 2008, OBSTET GYNECOL, V112, P71, DOI 10.1097/AOG.0b013e31817c4ebc; Smith LH, 2003, AM J OBSTET GYNECOL, V189, P1128, DOI 10.1067/S0002-9378(03)00537-4; Wang P, 2015, J NEUROIMMUNOL, V289, P152, DOI 10.1016/j.jneuroim.2015.11.001; Yankaskas Bonnie C, 2005, Breast Dis, V23, P3	43	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168469	10.1371/journal.pone.0168469	http://dx.doi.org/10.1371/journal.pone.0168469			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977789	Green Submitted, Green Published, gold			2022-12-26	WOS:000391217400110
J	Khairy, H; Meinert, C; Wubbeler, JH; Poehlein, A; Daniel, R; Voigt, B; Riedel, K; Steinbuchel, A				Khairy, Heba; Meinert, Christina; Wuebbeler, Jan Hendrik; Poehlein, Anja; Daniel, Rolf; Voigt, Birgit; Riedel, Katharina; Steinbuechel, Alexander			Genome and Proteome Analysis of Rhodococcus erythropolis MI2: Elucidation of the 4,4 '- Dithiodibutyric Acid Catabolism	PLOS ONE			English	Article							COMPARATIVE-ANALYSIS SYSTEM; GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; FUNCTIONAL-CHARACTERIZATION; MYCOBACTERIUM-TUBERCULOSIS; PSEUDOMONAS-OLEOVORANS; SIGNAL PEPTIDES; RESISTANCE; RHODANESE; VIRULENCE	Rhodococcus erythropolis MI2 has the extraordinary ability to utilize the xenobiotic 4,4'-dithiodibutyric acid (DTDB). Cleavage of DTDB by the disulfide-reductase Nox, which is the only verified enzyme involved in DTDB-degradation, raised 4-mercaptobutyric acid (4MB). 4MB could act as building block of a novel polythioester with unknown properties. To completely unravel the catabolism of DTDB, the genome of R. erythropolis MI2 was sequenced, and subsequently the proteome was analyzed. The draft genome sequence consists of approximately 7.2 Mbp with an overall G+C content of 62.25% and 6,859 predicted protein-encoding genes. The genome of strain MI2 is composed of three replicons: one chromosome and two megaplasmids with sizes of 6.45, 0.4 and 0.35 Mbp, respectively. When cells of strain MI2 were cultivated with DTDB as sole carbon source and compared to cells grown with succinate, several interesting proteins with significantly higher expression levels were identified using 2D-PAGE and MALDI-TOF mass spectrometry. A putative luciferase-like monooxygenase-class F420-dependent oxidoreductase (RERY_05640), which is encoded by one of the 126 monooxygenase-encoding genes of the MI2-genome, showed a 3-fold increased expression level. This monooxygenase could oxidize the intermediate 4MB into 4-oxo-4-sulfanylbutyric acid. Next, a desulfurization step, which forms succinic acid and volatile hydrogen sulfide, is proposed. One gene coding for a putative desulfhydrase (RERY_06500) was identified in the genome of strain MI2. However, the gene product was not recognized in the proteome analyses. But, a significant expression level with a ratio of up to 7.3 was determined for a putative sulfide: quinone oxidoreductase (RERY_02710), which could also be involved in the abstraction of the sulfur group. As response to the toxicity of the intermediates, several stress response proteins were strongly expressed, including a superoxide dismutase (RERY_05600) and an osmotically induced protein (RERY_02670). Accordingly, novel insights in the catabolic pathway of DTDB were gained.	[Khairy, Heba; Meinert, Christina; Wuebbeler, Jan Hendrik; Steinbuechel, Alexander] Westfalische Wilhelms Univ Munster, Inst Mol Mikrobiol & Biotechnol, Munster, Germany; [Khairy, Heba] Univ Alexandria, Fac Sci, Dept Bot & Microbiol, Alexandria, Egypt; [Poehlein, Anja; Daniel, Rolf] Georg August Univ Gottingen, Inst Mikrobiol & Genet, Dept Genom & Appl Microbiol, Gottingen, Germany; [Poehlein, Anja; Daniel, Rolf] Georg August Univ Gottingen, Inst Mikrobiol & Genet, Gottingen Genom Lab, Gottingen, Germany; [Voigt, Birgit; Riedel, Katharina] Ernst Moritz Arndt Univ Greifswald, Inst Mikrobiol, Greifswald, Germany; [Steinbuechel, Alexander] King Abdulaziz Univ, Fac Environm Sci, Jeddah, Saudi Arabia	University of Munster; Egyptian Knowledge Bank (EKB); Alexandria University; University of Gottingen; University of Gottingen; Ernst Moritz Arndt Universitat Greifswald; King Abdulaziz University	Steinbuchel, A (corresponding author), Westfalische Wilhelms Univ Munster, Inst Mol Mikrobiol & Biotechnol, Munster, Germany.; Steinbuchel, A (corresponding author), King Abdulaziz Univ, Fac Environm Sci, Jeddah, Saudi Arabia.	steinbu@uni-muenster.de	Daniel, Rolf/AAQ-5933-2021	Daniel, Rolf/0000-0002-8646-7925; Poehlein, Anja/0000-0002-2473-6202; Khairy, Heba/0000-0001-6072-8202; Riedel, Katharina/0000-0002-4629-3019				Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bartels A, 2007, PLANT PHYSIOL BIOCH, V45, P178, DOI 10.1016/j.plaphy.2007.02.005; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; BERNI R, 1991, FREE RADICAL RES COM, V15, P203, DOI 10.3109/10715769109049142; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANDL H, 1988, APPL ENVIRON MICROB, V54, P1977, DOI 10.1128/AEM.54.8.1977-1982.1988; CARFI A, 1995, EMBO J, V14, P4914, DOI 10.1002/j.1460-2075.1995.tb00174.x; Chan LK, 2009, J BACTERIOL, V191, P1026, DOI 10.1128/JB.01154-08; Cussiol JRR, 2010, J BIOL CHEM, V285, P21943, DOI 10.1074/jbc.M110.117283; de Carvalho CCCR, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00290; de Carvalho CCCR, 2012, RES MICROBIOL, V163, P125, DOI 10.1016/j.resmic.2011.11.003; de Carvalho CCCR, 2005, FEMS MICROBIOL ECOL, V51, P389, DOI 10.1016/j.femsec.2004.09.010; Elbanna K, 2004, ARCH MICROBIOL, V182, P212, DOI 10.1007/s00203-004-0715-z; Falkenby LG, 2011, FEMS MICROBIOL LETT, V323, P142, DOI 10.1111/j.1574-6968.2011.02370.x; Felce J, 2004, J MOL MICROB BIOTECH, V8, P169, DOI 10.1159/000085789; Fisher AJ, 1996, J BIOL CHEM, V271, P21956, DOI 10.1074/jbc.271.36.21956; Friedrich CG, 2001, APPL ENVIRON MICROB, V67, P2873, DOI 10.1128/AEM.67.7.2873-2882.2001; Garcia-Alcalde F, 2012, BIOINFORMATICS, V28, P2678, DOI 10.1093/bioinformatics/bts503; Goodfellow M, 1998, ANTON LEEUW INT J G, V74, P3, DOI 10.1023/A:1001730725003; GOODFELLOW M, 1977, J GEN MICROBIOL, V100, P99, DOI 10.1099/00221287-100-1-99; Griesbeck C., 2000, RECENT RES DEV MICRO, VVolume 4, P129; GUTIERREZ C, 1991, J MOL BIOL, V220, P959, DOI 10.1016/0022-2836(91)90366-E; Hara H, 2010, APPL ENVIRON MICROB, V76, P1516, DOI 10.1128/AEM.02621-09; HELD KD, 1994, RADIAT RES, V139, P15, DOI 10.2307/3578727; Imbernon L, 2015, POLYM CHEM-UK, V6, P4271, DOI 10.1039/c5py00459d; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Jang LS, 2006, SENSOR MATER, V18, P367; Kanayama N, 2000, LANGMUIR, V16, P577, DOI 10.1021/la990182e; Kato M, 2005, BIOMACROMOLECULES, V6, P2275, DOI 10.1021/bm050168i; Kawada J, 2003, BIOMACROMOLECULES, V4, P1698, DOI 10.1021/bm0341327; Khairy H, NADH FLAVIN IN PRESS; Khairy H, 2015, APPL ENVIRON MICROB, V81, P8294, DOI 10.1128/AEM.02059-15; Kim DY, 2005, BIOMACROMOLECULES, V6, P897, DOI 10.1021/bm049334x; Kim IS, 2002, BIOTECHNOL BIOENG, V80, P650, DOI 10.1002/bit.10421; Komaki H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-323; Kriszt B, 2012, J BACTERIOL, V194, P1247, DOI 10.1128/JB.06603-11; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Larkin MJ, 2005, CURR OPIN BIOTECH, V16, P282, DOI 10.1016/j.copbio.2005.04.007; Lesniak J, 2003, PROTEIN SCI, V12, P2838, DOI 10.1110/ps.03375603; Lesniak J, 2002, EMBO J, V21, P6649, DOI 10.1093/emboj/cdf670; Letek M, 2008, J BACTERIOL, V190, P5797, DOI 10.1128/JB.00468-08; Letek M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001145; Luo GX, 1994, J BIOL CHEM, V269, P399; Maier S, 2015, CHEMBIOCHEM, V16, P1175, DOI 10.1002/cbic.201500048; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD560, DOI 10.1093/nar/gkt963; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Matthies A, 2005, BIOCHEMISTRY-US, V44, P7912, DOI 10.1021/bi0503448; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nandi DL, 2000, INT J BIOCHEM CELL B, V32, P465, DOI 10.1016/S1357-2725(99)00035-7; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Oh-oka H., 2004, ENCY BIOL CHEM, P321; Onwueme KC, 2005, J BACTERIOL, V187, P4760, DOI 10.1128/JB.187.14.4760-4766.2005; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Poole LB, 2005, ARCH BIOCHEM BIOPHYS, V433, P240, DOI 10.1016/j.abb.2004.09.006; Prat L, 2012, FEBS J, V279, P2754, DOI 10.1111/j.1742-4658.2012.08660.x; Raberg M, 2008, APPL ENVIRON MICROB, V74, P4477, DOI 10.1128/AEM.00440-08; Rabilloud T, 1999, ELECTROPHORESIS, V20, P3603, DOI 10.1002/(SICI)1522-2683(19991201)20:18&lt;3603::AID-ELPS3603&gt;3.0.CO;2-V; Renato J, 2003, J BIOL CHEM, V278, P11570, DOI 10.1074/jbc.M300252200; Riemenschneider A, 2005, FEBS J, V272, P1291, DOI 10.1111/j.1742-4658.2005.04567.x; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sambrook J., 2001, MOL CLONING LAB MANU; SCHLEGEL HG, 1961, NATURE, V191, P463, DOI 10.1038/191463a0; SCHLEGEL HG, 1961, ARCH MIKROBIOL, V38, P209, DOI 10.1007/BF00422356; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Segura A, 2012, CURR OPIN BIOTECH, V23, P415, DOI 10.1016/j.copbio.2011.11.015; Sekine M, 2006, ENVIRON MICROBIOL, V8, P334, DOI 10.1111/j.1462-2920.2005.00899.x; Selengut JD, 2010, J BACTERIOL, V192, P5788, DOI 10.1128/JB.00425-10; Simeone R, 2007, FEBS J, V274, P1957, DOI 10.1111/j.1742-4658.2007.05740.x; Steeves CH, 2011, PROTEOMICS, V11, P2027, DOI 10.1002/pmic.201000631; Theissen U, 2003, MOL BIOL EVOL, V20, P1564, DOI 10.1093/molbev/msg174; TIMM A, 1990, APPL MICROBIOL BIOT, V33, P296, DOI 10.1007/BF00164525; Torres S, 2011, BIOTECHNOL ADV, V29, P442, DOI 10.1016/j.biotechadv.2011.04.002; van der Geize R, 2004, CURR OPIN MICROBIOL, V7, P255, DOI 10.1016/j.mib.2004.04.001; Wang ZL, 2011, WORLD J MICROB BIOT, V27, P1965, DOI 10.1007/s11274-011-0656-z; WESTLEY J, 1983, FUND APPL TOXICOL, V3, P377, DOI 10.1016/S0272-0590(83)80008-6; Wolf C, 2008, PROTEOMICS, V8, P3139, DOI 10.1002/pmic.200701062; Wubbeler JH, 2014, CURR OPIN BIOTECH, V29, P85, DOI 10.1016/j.copbio.2014.02.017; Wubbeler JH, 2010, MICROBIOL-SGM, V156, P1221, DOI 10.1099/mic.0.036178-0; Yang JC, 2007, PLASMID, V57, P55, DOI 10.1016/j.plasmid.2006.08.002	87	7	8	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0167539	10.1371/journal.pone.0167539	http://dx.doi.org/10.1371/journal.pone.0167539			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977722	Green Published, Green Submitted, gold			2022-12-26	WOS:000391217400022
J	Tokunaga, E; Yamashita, N; Tanaka, K; Inoue, Y; Akiyoshi, S; Saeki, H; Oki, E; Kitao, H; Maehara, Y				Tokunaga, Eriko; Yamashita, Nami; Tanaka, Kimihiro; Inoue, Yuka; Akiyoshi, Sayuri; Saeki, Hiroshi; Oki, Eiji; Kitao, Hiroyuki; Maehara, Yoshihiko			Expression of APOBEC3B mRNA in Primary Breast Cancer of Japanese Women	PLOS ONE			English	Article							DELETION POLYMORPHISM; RESTRICTION FACTORS; GENES; MUTAGENESIS; MUTATIONS; TP53; RISK; ASSOCIATION; PROGNOSIS; IMPACT	Recent studies have identified the apolipoprotein B mRNA-editing enzyme catalytic poly-peptide-like 3B (APOBEC3B) as a source of mutations in various malignancies. APOBEC3B is overexpressed in several human cancer types, including breast cancer. In this study, we analyzed APOBEC3B mRNA expression in 305 primary breast cancers of Japanese women using quantitative reverse transcription-PCR, and investigated the relationships between the APOBEC3B mRNA expression and clinicopathological characteristics, prognosis, and TP53 mutations. The expression of APOBEC3B mRNA was detected in 277 tumors and not detected in 28 tumors. High APOBEC3B mRNA expression was significantly correlated with ER-and PR-negativity, high grade and high Ki67 index. The APOBEC3B mRNA expression was highest in the triple-negative and lowest in the hormone receptorpositive/ HER2-negative subtypes. The TP53 gene was more frequently mutated in the tumors with high APOBEC3B mRNA expression. High APOBEC3B mRNA expression was significantly associated with poor recurrence-free survival in all cases and the ER-positive cases. These findings were almost consistent with the previous reports from the Western countries. In conclusion, high APOBEC3B mRNA expression was related to the aggressive phenotypes of breast cancer, high frequency of TP53 mutation and poor prognosis, especially in ER-positive tumors.	[Tokunaga, Eriko; Yamashita, Nami; Tanaka, Kimihiro; Inoue, Yuka; Akiyoshi, Sayuri; Saeki, Hiroshi; Oki, Eiji; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, Fukuoka, Japan; [Kitao, Hiroyuki] Kyushu Univ, Grad Sch Med Sci, Dept Mol Oncol, Higashi Ku, Fukuoka, Japan; [Tokunaga, Eriko; Akiyoshi, Sayuri] Natl Hosp Org, Kyushu Canc Ctr, Dept Breast Oncol, Minami Ku, Fukuoka, Japan	Kyushu University; Kyushu University; Kyushu Cancer Center	Tokunaga, E (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, Fukuoka, Japan.; Tokunaga, E (corresponding author), Natl Hosp Org, Kyushu Canc Ctr, Dept Breast Oncol, Minami Ku, Fukuoka, Japan.	eriko@surg2.med.kyuhsu-u.ac.jp; tokunaga.e@nk-cc.go.jp			JSPS KAKENHI [23591896]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 23591896.	Borresen-Dale AL, 2003, HUM MUTAT, V21, P292, DOI 10.1002/humu.10174; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Cescon DW, 2015, P NATL ACAD SCI USA, V112, P2841, DOI 10.1073/pnas.1424869112; Harris RS, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-014-0498-3; Henderson S, 2015, TRENDS MOL MED, V21, P274, DOI 10.1016/j.molmed.2015.02.007; Hisamatsu Y, 2012, ANN SURG ONCOL, V19, P1145, DOI 10.1245/s10434-011-2094-4; Kidd JM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030063; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kuong KJ, 2013, NAT GENET, V45, P964, DOI 10.1038/ng.2736; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Leonard B, 2013, CANCER RES, V73, P7222, DOI 10.1158/0008-5472.CAN-13-1753; Long JR, 2013, JNCI-J NATL CANCER I, V105, P573, DOI 10.1093/jnci/djt018; Middlebrooks CD, 2016, NAT GENET, V48, P1330, DOI 10.1038/ng.3670; Nik-Zainal S, 2014, NAT GENET, V46, P487, DOI 10.1038/ng.2955; Okada S, 2012, ANN SURG ONCOL, V19, P1499, DOI 10.1245/s10434-011-2166-5; Olivier M, 2006, CLIN CANCER RES, V12, P1157, DOI 10.1158/1078-0432.CCR-05-1029; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Refsland EW, 2013, CURR TOP MICROBIOL, V371, P1, DOI 10.1007/978-3-642-37765-5_1; Saeki H, 2011, CLIN CANCER RES, V17, P1731, DOI 10.1158/1078-0432.CCR-10-1996; Sieuwerts AM, 2014, HORM CANCER-US, V5, P405, DOI 10.1007/s12672-014-0196-8; Silwal-Pandit L, 2014, CLIN CANCER RES, V20, P3569, DOI 10.1158/1078-0432.CCR-13-2943; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; Tsuboi M, 2015, BREAST CANC; Xuan D, 2013, CARCINOGENESIS, V34, P2240, DOI 10.1093/carcin/bgt185	26	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168090	10.1371/journal.pone.0168090	http://dx.doi.org/10.1371/journal.pone.0168090			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977754	Green Submitted, Green Published, gold			2022-12-26	WOS:000391217400057
J	Pomeroy, EJ; Lee, LA; Lee, RDW; Schirm, DK; Temiz, NA; Ma, J; Gruber, TA; Diaz-Flores, E; Moriarity, BS; Downing, JR; Shannon, KM; Largaespada, DA; Eckfeldt, CE				Pomeroy, E. J.; Lee, L. A.; Lee, R. D. W.; Schirm, D. K.; Temiz, N. A.; Ma, J.; Gruber, T. A.; Diaz-Flores, E.; Moriarity, B. S.; Downing, J. R.; Shannon, K. M.; Largaespada, D. A.; Eckfeldt, C. E.			Ras oncogene-independent activation of RALB signaling is a targetable mechanism of escape from NRAS(V12) oncogene addiction in acute myeloid leukemia	ONCOGENE			English	Article							PANCREATIC-CANCER GROWTH; TYROSINE KINASE; MEK INHIBITION; TARGETING RAS; SELF-RENEWAL; RESISTANCE; MELANOMA; CELLS; KRAS; BRAF	Somatic mutations that lead to constitutive activation of NRAS and KRAS proto-oncogenes are among the most common in human cancer and frequently occur in acute myeloid leukemia (AML). An inducible NRAS(V12)-driven AML mouse model has established a critical role for continued NRAS(V12) expression in leukemia maintenance. In this model genetic suppression of NRAS(V12) expression results in rapid leukemia remission, but some mice undergo spontaneous relapse with NRAS(V12)-independent (NRI) AMLs providing an opportunity to identify mechanisms that bypass the requirement for Ras oncogene activity and drive leukemia relapse. We found that relapsed NRI AMLs are devoid of NRAS(V12) expression and signaling through the major oncogenic Ras effector pathways, phosphatidylinositol-3-kinase and mitogen-activated protein kinase, but express higher levels of an alternate Ras effector, Ralb, and exhibit NRI phosphorylation of the RALB effector TBK1, implicating RALB signaling in AML relapse. Functional studies confirmed that inhibiting CDK5-mediated RALB activation with a clinically relevant experimental drug, dinaciclib, led to potent RALB-dependent antileukemic effects in human AML cell lines, induced apoptosis in patient-derived AML samples in vitro and led to a 2-log reduction in the leukemic burden in patient-derived xenograft mice. Furthermore, dinaciclib potently suppressed the clonogenic potential of relapsed NRI AMLs in vitro and prevented the development of relapsed AML in vivo. Our findings demonstrate that Ras oncogene-independent activation of RALB signaling is a therapeutically targetable mechanism of escape from NRAS oncogene addiction in AML.	[Pomeroy, E. J.; Lee, L. A.; Lee, R. D. W.; Schirm, D. K.; Eckfeldt, C. E.] Univ Minnesota, Sch Med, Div Hematol Oncol & Transplantat, Dept Med, 420 Delaware St SE,MMC 480,PWB 14-242, Minneapolis, MN 55455 USA; [Temiz, N. A.; Moriarity, B. S.; Largaespada, D. A.; Eckfeldt, C. E.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA; [Ma, J.; Gruber, T. A.; Downing, J. R.] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Gruber, T. A.] St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Diaz-Flores, E.; Shannon, K. M.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Moriarity, B. S.; Largaespada, D. A.] Dept Pediat, Div Hematol & Oncol, Minneapolis, MN USA; [Largaespada, D. A.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of California System; University of California San Francisco; University of Minnesota System; University of Minnesota Twin Cities	Eckfeldt, CE (corresponding author), Univ Minnesota, Sch Med, Div Hematol Oncol & Transplantat, Dept Med, 420 Delaware St SE,MMC 480,PWB 14-242, Minneapolis, MN 55455 USA.	eckf0002@umn.edu	Downing, James R./N-8102-2018; Gruber, Tanja/AAH-1248-2021	Lee, Lindsey/0000-0002-7082-5484; Eckfeldt, Craig/0000-0003-2834-0421; Pomeroy, Emily/0000-0001-7690-3570	University of Minnesota Masonic Cancer Center; National Cancer Institute [P30CA77598]; Minnesota Masonic Charities; Killebrew-Thompson Memorial Fund; University of Minnesota Department of Medicine, Division of Hematology Oncology and Transplantation; University of Minnesota Foundation (CEE); Leukemia and Lymphoma Society of America Specialized Center of Research [LLS7019-04]; National Heart Lung and Blood Institute [T32HL007062]; NATIONAL CANCER INSTITUTE [P30CA077598, P30CA016672] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007062] Funding Source: NIH RePORTER	University of Minnesota Masonic Cancer Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Minnesota Masonic Charities; Killebrew-Thompson Memorial Fund; University of Minnesota Department of Medicine, Division of Hematology Oncology and Transplantation; University of Minnesota Foundation (CEE); Leukemia and Lymphoma Society of America Specialized Center of Research(Leukemia and Lymphoma Society); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by funding from the University of Minnesota Masonic Cancer Center and Academic Health Center Flow Cytometry Resource, Research Animal Resources, Heme Malignancy Tissue Bank and Imaging Center that are supported by the National Cancer Institute (P30CA77598), Minnesota Masonic Charities and the Killebrew-Thompson Memorial Fund; the University of Minnesota Department of Medicine, Division of Hematology Oncology and Transplantation and the University of Minnesota Foundation (CEE); Leukemia and Lymphoma Society of America Specialized Center of Research LLS7019-04 (DAL); National Heart Lung and Blood Institute T32HL007062 (CEE). DAL and KMS are American Cancer Society Research Professors.	Baker A, 2016, CANCER RES, V76, P1158, DOI 10.1158/0008-5472.CAN-15-1070; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Berns K, 2012, DRUG RESIST UPDATE, V15, P268, DOI 10.1016/j.drup.2012.10.002; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Bowen DT, 2005, BLOOD, V106, P2113, DOI 10.1182/blood-2005-03-0867; Braun BS, 2008, CLIN CANCER RES, V14, P2249, DOI 10.1158/1078-0432.CCR-07-1005; Braun BS, 2004, P NATL ACAD SCI USA, V101, P597, DOI 10.1073/pnas.0307203101; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Collins CT, 2016, ONCOGENE, V35, P1090, DOI 10.1038/onc.2015.174; Collins C, 2014, P NATL ACAD SCI USA, V111, P9899, DOI 10.1073/pnas.1402238111; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Eckfeldt CE, 2016, RALB PROVIDES CRITIC; Feldmann G, 2011, CANCER BIOL THER, V12, P598, DOI 10.4161/cbt.12.7.16475; Feldmann G, 2010, CANCER RES, V70, P4460, DOI 10.1158/0008-5472.CAN-09-1107; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Frohling S, 2005, J CLIN ONCOL, V23, P6285, DOI 10.1200/JCO.2005.05.010; Gu TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019169; Huw LY, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.46; Iyengar S, 2013, BLOOD, V121, P2274, DOI 10.1182/blood-2012-10-460832; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim WI, 2009, BLOOD, V113, P1086, DOI 10.1182/blood-2008-01-132316; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li Q, 2011, BLOOD, V117, P2022, DOI 10.1182/blood-2010-04-280750; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; Lin LP, 2015, NAT GENET, V47, P250, DOI 10.1038/ng.3218; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Martelli AM, 2006, LEUKEMIA, V20, P911, DOI 10.1038/sj.leu.2404245; Patel JP, 2012, HEMATOL-AM SOC HEMAT, P28, DOI 10.1182/asheducation-2012.1.28; Peschard P, 2012, CURR BIOL, V22, P2063, DOI 10.1016/j.cub.2012.09.013; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Rahrmann EP, 2014, AM J PATHOL, V184, P2082, DOI 10.1016/j.ajpath.2014.04.006; Redell MS, 2011, BLOOD, V117, P5701, DOI 10.1182/blood-2010-04-280123; Ricciardi MR, 2005, LEUKEMIA, V19, P1543, DOI 10.1038/sj.leu.2403859; Rushworth SA, 2014, BLOOD, V123, P1229, DOI 10.1182/blood-2013-06-511154; Sachs Z, 2014, BLOOD, V124, P3274, DOI 10.1182/blood-2013-08-521708; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Swarbrick A, 2008, P NATL ACAD SCI USA, V105, P5402, DOI 10.1073/pnas.0801505105; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Tomasson MH, 2008, BLOOD, V111, P4797, DOI 10.1182/blood-2007-09-113027; Torti D, 2011, EMBO MOL MED, V3, P623, DOI 10.1002/emmm.201100176; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Van Meter MEM, 2007, BLOOD, V109, P3945, DOI 10.1182/blood-2006-09-047530; Vigil D, 2010, J BIOL CHEM, V285, P34729, DOI 10.1074/jbc.M110.116756; Yan C, 2014, NATURE, V515, P443, DOI 10.1038/nature13713; Zhao Z, 2010, GENE DEV, V24, P1389, DOI 10.1101/gad.1940710; Zhu ZH, 2014, CANCER DISCOV, V4, P452, DOI 10.1158/2159-8290.CD-13-0646	52	6	7	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 8	2017	36	23					3263	3273		10.1038/onc.2016.471	http://dx.doi.org/10.1038/onc.2016.471			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EW9WJ	27991934	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000402869800006
J	Heinemann, AS; Pirr, S; Fehlhaber, B; Mellinger, L; Burgmann, J; Busse, M; Ginzel, M; Friesenhagen, J; von Kockritz-Blickwede, M; Ulas, T; von Kaisenberg, CS; Johannes, R; Vogl, T; Viemann, D				Heinemann, Anna S.; Pirr, Sabine; Fehlhaber, Beate; Mellinger, Lara; Burgmann, Johanna; Busse, Mandy; Ginzel, Marco; Friesenhagen, Judith; von Koeckritz-Blickwede, Maren; Ulas, Thomas; von Kaisenberg, Constantin S.; Roth, Johannes; Vogl, Thomas; Viemann, Dorothee			In neonates S100A8/S100A9 alarmins prevent the expansion of a specific inflammatory monocyte population promoting septic shock	FASEB JOURNAL			English	Article						calprotectin; MDSC; myeloid cells; newborn; sepsis	HLA-DR EXPRESSION; SUPPRESSOR-CELLS; IMMUNE-RESPONSES; MYELOID CELLS; CANCER STAGE; INNATE; CORRELATE; DIFFERENTIATION; ACCUMULATION; INFECTION	The high susceptibility of newborn infants to sepsis is ascribed to an immaturity of the neonatal immune system, but the molecular mechanisms remain unclear. Newborn monocytes massively release the alarmins S100A8/S100A9. In adults, these are major regulators of immunosuppressive myeloid-derived suppressor cells (MDSCs). We investigated whether S100A8/S100A9 cause an expansion of monocytic MDSCs (Mo-MDSCs) in neonates, thereby contributing to an immunocompromised state. Mo-MDSCs have been assigned to CD14(+)/human leukocyte antigen (HLA)-DR-/low/CD33(+) monocytes in humans and to CD11b(+)/Gr-1(int)/Ly6G(-)/Ly6C(hi) cells in mice. We found monocytes with these phenotypes significantly expanded in their respective newborns. Functionally, however, they did not prove immunosuppressive but rather responded inflammatorily to microbial stimulation. Their expansion did not correlate with high S100A8/S100A9 levels in cord blood. Murine studies revealed an excessive expansion of CD11b(+)/Gr-1(int)/Ly6G(-)/ Ly6C(hi) monocytes in S100A9(-/-) neonates compared to wild-type neonates. This strong baseline expansion was associated with hyperinflammatory responses during endotoxemia and fatal septic courses. Treating S100A9(-/-) neonates directly after birth with S100A8/S100A9 alarmins prevented excessive expansion of this inflammatory monocyte population and death from septic shock. Our data suggest that a specific population of inflammatory monocytes promotes fatal courses of sepsis in neonates if its expansion is not regulated by S100A8/S100A9 alarmins.- Heinemann, A. S., Pirr, S., Fehlhaber, B., Mellinger, L., Burgmann, J., Busse, M., Ginzel, M., Friesenhagen, J., von Kockritz-Blickwede, M., Ulas, T., vonKaisenberg, C. S., Roth, J., Vogl, T., Viemann, D. InneonatesS100A8/S100A9alarminsprevent theexpansion of a specific inflammatorymonocyte population promoting septic shock.	[Heinemann, Anna S.; Pirr, Sabine; Fehlhaber, Beate; Mellinger, Lara; Burgmann, Johanna; Busse, Mandy; Ginzel, Marco; Friesenhagen, Judith; Viemann, Dorothee] Hannover Med Sch, Dept Pediat Pneumol Allergy & Neonatol, Carl Neuberg Str 1, D-30625 Hannover, Germany; [von Kaisenberg, Constantin S.] Hannover Med Sch, Dept Gynecol & Prenatal Med, Hannover, Germany; [von Koeckritz-Blickwede, Maren] Univ Vet Med Hannover, Dept Physiol Chem, Hannover, Germany; [von Koeckritz-Blickwede, Maren] Univ Vet Med Hannover, Res Ctr Emerging Infect & Zoonoses RIZ, Hannover, Germany; [Ulas, Thomas] Univ Bonn, Life & Med Sci Inst, Genom & Immunoregulat, Bonn, Germany; [Roth, Johannes; Vogl, Thomas] Univ Munster, Inst Immunol, Munster, Germany; [Roth, Johannes; Vogl, Thomas] Univ Munster, Interdisciplinary Ctr Clin Res, Munster, Germany	Hannover Medical School; Hannover Medical School; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Bonn; University of Munster; University of Munster	Viemann, D (corresponding author), Hannover Med Sch, Dept Pediat Pneumol Allergy & Neonatol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	viemann.dorothee@mh-hannover.de	von Kaisenberg, Constantin/AAR-2756-2021	Viemann, Dorothee/0000-0002-9009-3559; Ginzel, Marco/0000-0002-4439-1133	Appenrodt Foundation; German Research Foundation [VI 538/6-1]; Volkswagen Foundation; Interdisciplinary Center of Clinical Research of the University of Muenster [Vo2/004/14, Ro2/004/10]; German Federal Ministry of Education and Research	Appenrodt Foundation; German Research Foundation(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen); Interdisciplinary Center of Clinical Research of the University of Muenster; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The authors thank A. Weitz (Hannover Medical School) and D. Lagemann (University of Munster) for technical support, and Dr. T. Price (Hannover Medical School) for critically reading the manuscript. This work was supported, in part, by grants from the Appenrodt Foundation, the German Research Foundation (VI 538/6-1), and the Volkswagen Foundation (to D.V.); by grants from the Interdisciplinary Center of Clinical Research of the University of Muenster (Vo2/004/14 and Ro2/004/10; to T.V. and J.R.); and by grants from the German Federal Ministry of Education and Research (AID-Net), and the German Research Foundation (CRC Transregio 128-A2, CRC 1009 B8 and B9; to T.V.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austermann J, 2015, CELL REP, V11, P849, DOI 10.1016/j.celrep.2015.04.040; Azizia M, 2012, PEDIATRICS, V129, pE967, DOI 10.1542/peds.2011-1579; Bao Y, 2015, MOL MED REP, V11, P2322, DOI 10.3892/mmr.2014.2927; Chen XH, 2013, J CLIN INVEST, V123, P4595, DOI 10.1172/JCI67580; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; D'Aveni M, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010435; Damuzzo V, 2015, CYTOM PART B-CLIN CY, V88, P77, DOI [10.1002/cyto.b.21206, 10.1002/cytob.21206]; Delano MJ, 2007, J EXP MED, V204, P1463, DOI 10.1084/jem.20062602; Derive M, 2012, INTENS CARE MED, V38, P1040, DOI 10.1007/s00134-012-2574-4; Diaz-Montero CM, 2014, SEMIN ONCOL, V41, P174, DOI 10.1053/j.seminoncol.2014.02.003; Dowling DJ, 2014, TRENDS IMMUNOL, V35, P299, DOI 10.1016/j.it.2014.04.007; Drews-Elger K, 2014, BREAST CANCER RES TR, V148, P41, DOI 10.1007/s10549-014-3122-4; Duffy A, 2013, CANCER IMMUNOL IMMUN, V62, P299, DOI 10.1007/s00262-012-1332-3; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Frosch M, 2000, ARTHRITIS RHEUM-US, V43, P628, DOI 10.1002/1529-0131(200003)43:3<628::AID-ANR20>3.0.CO;2-X; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Genel F, 2010, J INFECTION, V60, P224, DOI 10.1016/j.jinf.2009.12.004; Gervassi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107816; Gorgun GT, 2013, BLOOD, V121, P2975, DOI 10.1182/blood-2012-08-448548; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Kanakoudi-Tsakalidou F, 2001, CLIN EXP IMMUNOL, V123, P402, DOI 10.1046/j.1365-2249.2001.01471.x; Kostlin N, 2014, EUR J IMMUNOL, V44, P2582, DOI 10.1002/eji.201344200; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; Kotsakis A, 2012, J IMMUNOL METHODS, V381, P14, DOI 10.1016/j.jim.2012.04.004; Lee JA, 2008, CYTOM PART A, V73A, P926, DOI 10.1002/cyto.a.20623; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Lewis DB, 1998, IMMUNOL ALLERGY CLIN, V18, P291, DOI 10.1016/S0889-8561(05)70006-0; Li HQ, 2009, J IMMUNOL, V182, P240, DOI 10.4049/jimmunol.182.1.240; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Luyckx A, 2012, CLIN IMMUNOL, V143, P83, DOI 10.1016/j.clim.2012.01.011; Manitz MP, 2003, MOL CELL BIOL, V23, P1034, DOI 10.1128/MCB.23.3.1034-1043.2003; Ng PC, 2006, BIOL NEONATE, V89, P75, DOI 10.1159/000088288; Nguyen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010407; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Petersen B, 2013, EMBO J, V32, P100, DOI 10.1038/emboj.2012.309; Pradhan R, 2015, CYTOMETRY B; Rieber N, 2013, CLIN EXP IMMUNOL, V174, P45, DOI 10.1111/cei.12143; Rieber N, 2015, CELL HOST MICROBE, V17, P507, DOI 10.1016/j.chom.2015.02.007; Sander LE, 2010, J EXP MED, V207, P1453, DOI 10.1084/jem.20091474; Shane AL, 2014, J INFECTION, V68, pS24, DOI 10.1016/j.jinf.2013.09.011; Shen L, 2015, CANCER IMMUNOL RES, V3, P136, DOI 10.1158/2326-6066.CIR-14-0036; Srivastava MK, 2010, CANCER RES, V70, P68, DOI 10.1158/0008-5472.CAN-09-2587; Tissieres P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032863; Vasquez-Dunddel D, 2013, J CLIN INVEST, V123, P1580, DOI 10.1172/JCI60083; Viemann D, 2005, PEDIATR RES, V58, P654, DOI 10.1203/01.PDR.0000180544.02537.FD; Viemann D, 2005, BLOOD, V105, P2955, DOI 10.1182/blood-2004-07-2520; Viemann D, 2004, BLOOD, V103, P3365, DOI 10.1182/blood-2003-09-3296; Viemann D, 2007, BLOOD, V109, P2453, DOI 10.1182/blood-2006-08-040444; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wang L, 2013, J IMMUNOL, V190, P794, DOI 10.4049/jimmunol.1202088; Wu LY, 2011, AM J PATHOL, V179, P2131, DOI 10.1016/j.ajpath.2011.06.028; Yeager ME, 2012, CHEST, V141, P944, DOI 10.1378/chest.11-0205; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Youn JI, 2013, NAT IMMUNOL, V14, P211, DOI 10.1038/ni.2526; Yu JP, 2013, J IMMUNOL, V190, P3783, DOI 10.4049/jimmunol.1201449; Yuan XK, 2011, J INT MED RES, V39, P1381, DOI 10.1177/147323001103900424; Zhao J, 2008, P NATL ACAD SCI USA, V105, P7528, DOI 10.1073/pnas.0800152105	58	27	30	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1153	+		10.1096/fj.201601083R	http://dx.doi.org/10.1096/fj.201601083R			27	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27993995				2022-12-26	WOS:000395671200028
J	Mojumdar, A; De March, M; Marino, F; Onesti, S				Mojumdar, Aditya; De March, Matteo; Marino, Francesca; Onesti, Silvia			The Human RecQ4 Helicase Contains a Functional RecQ C-terminal Region (RQC) That Is Essential for Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROTHMUND-THOMSON-SYNDROME; SMALL-ANGLE SCATTERING; ESCHERICHIA-COLI RECQ; ZINC-BINDING DOMAIN; WINGED-HELIX DOMAIN; DNA HELICASE; BIOCHEMICAL-CHARACTERIZATION; STRUCTURAL MECHANISMS; BLOOMS-SYNDROME; RNA HELICASE	RecQ helicases are essential in the maintenance of genome stability. Five paralogues (RecQ1, Bloom, Werner, RecQ4, and RecQ5) are found in human cells, with distinct but overlapping roles. Mutations in human RecQ4 give rise to three distinct genetic disorders (Rothmund-Thomson, RAPADILINO, and Baller-Gerold syndromes), characterized by genetic instability, growth deficiency, and predisposition to cancer. Previous studies suggested that RecQ4 was unique because it did not seem to contain a RecQ C-terminal region (RQC) found in the other RecQ paralogues; such a region consists of a zinc domain and a winged helix domain and plays an important role in enzyme activity. However, our recent bioinformatic analysis identified in RecQ4 a putative RQC. To experimentally confirm this hypothesis, we report the purification and characterization of the catalytic core of human RecQ4. Inductively coupled plasmaatomic emission spectrometry detected the unusual presence of two zinc clusters within the zinc domain, consistent with the bioinformatic prediction. Analysis of site-directed mutants, targeting key RQC residues (putative zinc ligands and the aromatic residue predicted to be at the tip of the winged helix beta- hairpin), showed a decrease in DNA binding, unwinding, and annealing, as expected for a functional RQC domain. Low resolution structural information obtained by small angle X- ray scattering data suggests that RecQ4 interacts with DNA in a manner similar to RecQ1, whereas the winged helix domain may assume alternative conformations, as seen in the bacterial enzymes. These combined results experimentally confirm the presence of a functional RQC domain in human RecQ4.	[Mojumdar, Aditya; De March, Matteo; Marino, Francesca; Onesti, Silvia] Elettra Sincrotrone Trieste, Struct Biol Lab, I-34149 Trieste, Italy; [Mojumdar, Aditya] Univ Trieste, Dipartimento Scienze Vita, I-34127 Trieste, Italy	Elettra Sincrotrone Trieste; University of Trieste	Onesti, S (corresponding author), Elettra Sincrotrone Trieste, SS 14-km 163,5 AREA Sci Pk, I-34149 Trieste, Italy.	silvia.onesti@elettra.eu		Onesti, Silvia/0000-0002-0612-7948; Mojumdar, Aditya/0000-0003-0254-6958; De March, Matteo/0000-0002-3447-957X	Associazione Italiana per la Ricerca sul Cancro Grants [IG10646, IG14718]; ICTP TRIL fellowship programme; Cross-Border Cooperation Programme Italy-Slovenia by the European Regional Development Fund; national funds (PROTEO); European Community [283570]	Associazione Italiana per la Ricerca sul Cancro Grants(Fondazione AIRC per la ricerca sul cancro); ICTP TRIL fellowship programme; Cross-Border Cooperation Programme Italy-Slovenia by the European Regional Development Fund; national funds (PROTEO); European Community(European Commission)	This work was supported by Associazione Italiana per la Ricerca sul Cancro Grants IG10646 and IG14718, the ICTP TRIL fellowship programme, the Cross-Border Cooperation Programme Italy-Slovenia 2007-2013 by the European Regional Development Fund and national funds (PROTEO), and the European Community's Seventh Framework Programme (2007-2013) under BioStruct-X Grant Agreement 283570. The authors declare that they have no conflicts of interest with the contents of this article.	Arora A, 2016, J PATHOL, V238, P495, DOI 10.1002/path.4681; Bhattacharyya B, 2014, PROTEIN SCI, V23, P1498, DOI 10.1002/pro.2533; Capp C, 2009, J BIOL CHEM, V284, P30845, DOI 10.1074/jbc.M109.008052; Cejka Petr, 2010, J Biol Chem, V285, P8290, DOI 10.1074/jbc.M109.083196; CHAN KM, 1986, ANAL BIOCHEM, V157, P375, DOI 10.1016/0003-2697(86)90640-8; Croteau DL, 2014, ANNU REV BIOCHEM, V83, P519, DOI 10.1146/annurev-biochem-060713-035428; de Renty C, 2017, AGEING RES REV, V33, P36, DOI 10.1016/j.arr.2016.05.010; Fang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069600; Fourme R., 2004, 8 INT C BIOL SYNCHR; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Guo RB, 2005, NUCLEIC ACIDS RES, V33, P3109, DOI 10.1093/nar/gki619; Huang YL, 2002, J BIOL CHEM, V277, P12810, DOI 10.1074/jbc.M200182200; Keijzers G, 2014, CRIT REV BIOCHEM MOL, V49, P463, DOI 10.3109/10409238.2014.942450; Kitano K, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00366; Kitano K, 2010, STRUCTURE, V18, P177, DOI 10.1016/j.str.2009.12.011; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Larizza L, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-2; Larsen NB, 2013, ADV EXP MED BIOL, V973, P161, DOI 10.1007/978-1-4614-5037-5_8; Liu JL, 2004, J BIOL CHEM, V279, P42794, DOI 10.1074/jbc.M405008200; Lucic B, 2011, NUCLEIC ACIDS RES, V39, P1703, DOI 10.1093/nar/gkq1031; Macris MA, 2006, DNA REPAIR, V5, P172, DOI 10.1016/j.dnarep.2005.09.005; Marino F, 2016, SCI REP-UK, V6, DOI 10.1038/srep21501; Marino F, 2013, BIOPHYS CHEM, V177, P34, DOI 10.1016/j.bpc.2013.02.009; Mo DL, 2016, CANCER RES, V76, P3057, DOI 10.1158/0008-5472.CAN-15-2361; Oshima J., 2016, AGEING RES REV; Pike ACW, 2015, P NATL ACAD SCI USA, V112, P4286, DOI 10.1073/pnas.1417594112; Rossi ML, 2010, DNA REPAIR, V9, P796, DOI 10.1016/j.dnarep.2010.04.003; Sami F, 2016, MUTAT RES-FUND MOL M, V790, P8, DOI 10.1016/j.mrfmmm.2016.05.005; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Su YR, 2010, CANCER RES, V70, P9207, DOI 10.1158/0008-5472.CAN-10-1743; Suhasini AN, 2013, ADV EXP MED BIOL, V973, P123, DOI 10.1007/978-1-4614-5037-5_6; Suzuki T, 2009, J BIOCHEM, V146, P327, DOI 10.1093/jb/mvp074; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tani H, 2010, BIOCHEM BIOPH RES CO, V393, P131, DOI 10.1016/j.bbrc.2010.01.100; UMEZU K, 1990, P NATL ACAD SCI USA, V87, P5363, DOI 10.1073/pnas.87.14.5363; Unger T, 2010, J STRUCT BIOL, V172, P34, DOI 10.1016/j.jsb.2010.06.016; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Yin JH, 2004, HUM MOL GENET, V13, P2421, DOI 10.1093/hmg/ddh269	40	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4176	4184		10.1074/jbc.M116.767954	http://dx.doi.org/10.1074/jbc.M116.767954			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	27998982	Green Published, hybrid			2022-12-26	WOS:000395837100016
J	Hantouche, C; Williamson, B; Valinsky, WC; Solomon, J; Shrier, A; Young, JC				Hantouche, Christine; Williamson, Brittany; Valinsky, William C.; Solomon, Joshua; Shrier, Alvin; Young, Jason C.			Bag1 Co-chaperone Promotes TRC8 E3 Ligase-dependent Degradation of Misfolded Human Ether a Go-Go-related Gene (hERG) Potassium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; SIGNAL PEPTIDE PEPTIDASE; UBIQUITIN LIGASE; QUALITY-CONTROL; RING FINGER; K+ CHANNELS; PROTEIN; HSP70; GP78; TRAFFICKING	Cardiac long QT syndrome type 2 is caused by mutations in the human ether a go-go-related gene (hERG) potassium channel, many of which cause misfolding and degradation at the endoplasmic reticulum instead of normal trafficking to the cell surface. The Hsc70/Hsp70 chaperones assist the folding of the hERG cytosolic domains. Here, we demonstrate that the Hsp70 nucleotide exchange factor Bag1 promotes hERG degradation by the ubiquitin-proteasome system at the endoplasmic reticulum to regulate hERG levels and channel activity. Dissociation of hERG complexes containing Hsp70 and the E3 ubiquitin ligase CHIP requires the interaction of Bag1 with Hsp70, but this does not involve the Bag1 ubiquitin-like domain. The interaction with Bag1 then shifts hERG degradation to the membrane-anchored E3 ligase TRC8 and its E2-conjugating enzyme Ube2g2, as determined by siRNA screening. TRC8 interacts through the transmembrane region with hERG and decreases hERG functional expression. TRC8 also mediates degradation of the mis-folded hERG-G601S disease mutant, but pharmacological stabilization of the mutant structure prevents degradation. Our results identify TRC8 as a previously unknown Hsp70-independent quality control E3 ligase for hERG.	[Hantouche, Christine; Valinsky, William C.; Solomon, Joshua; Shrier, Alvin] McGill Univ, Dept Physiol, Montreal, PQ H3G 0B1, Canada; [Williamson, Brittany; Young, Jason C.] McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada; [Hantouche, Christine; Williamson, Brittany; Valinsky, William C.; Solomon, Joshua; Shrier, Alvin; Young, Jason C.] McGill Univ, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada	McGill University; McGill University; McGill University	Shrier, A (corresponding author), McGill Univ, Dept Physiol, 3649 Promenade Sir William Osler, Montreal, PQ H3G 1Y6, Canada.; Young, JC (corresponding author), McGill Univ, Dept Biochem, 3649 Promenade Sir William Osler,Rm 467, Montreal, PQ H3G 1Y6, Canada.	alvin.shrier@mcgill.ca; jason.young2@mcgill.ca		Valinsky, Corey/0000-0001-7736-9146	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Supported by the Canadian Institutes of Health Research.	Aizawa S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11379; Akhavan A, 2005, J CELL SCI, V118, P2803, DOI 10.1242/jcs.02423; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Apaja PM, 2013, MOL BIOL CELL, V24, P3787, DOI 10.1091/mbc.E13-07-0417; Baaklini I, 2012, J BIOL CHEM, V287, P41939, DOI 10.1074/jbc.M112.413278; Boname JM, 2014, J CELL BIOL, V205, P847, DOI 10.1083/jcb.201312009; Brauweiler A, 2007, ONCOGENE, V26, P2263, DOI 10.1038/sj.onc.1210017; Burr ML, 2011, P NATL ACAD SCI USA, V108, P2034, DOI 10.1073/pnas.1016229108; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Chen CY, 2014, EMBO J, V33, P2492, DOI 10.15252/embj.201488208; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Ficker E, 2002, J BIOL CHEM, V277, P4989, DOI 10.1074/jbc.M107345200; Furutani M, 1999, CIRCULATION, V99, P2290, DOI 10.1161/01.CIR.99.17.2290; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Gao YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057282; Gemmill RM, 2002, ONCOGENE, V21, P3507, DOI 10.1038/sj.onc.1205437; Gong QM, 2006, J BIOL CHEM, V281, P4069, DOI 10.1074/jbc.M511765200; Gong QM, 2002, AM J PHYSIOL-HEART C, V283, pH77, DOI 10.1152/ajpheart.00008.2002; Hampton RY, 2012, CURR OPIN CELL BIOL, V24, P460, DOI 10.1016/j.ceb.2012.05.010; Hartman IZ, 2010, J BIOL CHEM, V285, P19288, DOI 10.1074/jbc.M110.134213; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Hohfeld J, 1997, EMBO J, V16, P6209, DOI 10.1093/emboj/16.20.6209; Hsu JL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004811; Jehle J, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.77; Jo Y, 2013, MOL BIOL CELL, V24, P169, DOI 10.1091/mbc.E12-07-0564; Jo Y, 2011, P NATL ACAD SCI USA, V108, P20503, DOI 10.1073/pnas.1112831108; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kanelakis KC, 1999, J BIOL CHEM, V274, P34134, DOI 10.1074/jbc.274.48.34134; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Knapp RT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085415; Knapp RT, 2012, BIOCHEM J, V441, P297, DOI 10.1042/BJ20111456; Li PL, 2015, J MOL CELL CARDIOL, V86, P138, DOI 10.1016/j.yjmcc.2015.07.018; Li PL, 2011, CIRC RES, V108, P458, DOI 10.1161/CIRCRESAHA.110.227835; Lin PH, 2013, ONCOGENE, V32, P2325, DOI 10.1038/onc.2012.244; Liu TF, 2012, CELL METAB, V16, P213, DOI 10.1016/j.cmet.2012.06.014; Mata-Greenwood E, 2013, ARTERIOSCL THROM VAS, V33, P1046, DOI 10.1161/ATVBAHA.113.301247; Matsumura Y, 2011, MOL BIOL CELL, V22, P2797, DOI 10.1091/mbc.E11-02-0137; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Morishima Y, 2008, HUM MOL GENET, V17, P3942, DOI 10.1093/hmg/ddn296; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Sondermann H, 2002, J BIOL CHEM, V277, P33220, DOI 10.1074/jbc.M204624200; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Soss SE, 2011, J BIOL CHEM, V286, P21277, DOI 10.1074/jbc.M111.224006; Sroka K, 2009, J NEUROCHEM, V111, P801, DOI 10.1111/j.1471-4159.2009.06363.x; Stagg HR, 2009, J CELL BIOL, V186, P685, DOI 10.1083/jcb.200906110; Sultana R, 2013, FEBS OPEN BIO, V3, P394, DOI 10.1016/j.fob.2013.09.003; Sultana R, 2012, EXP CELL RES, V318, P53, DOI 10.1016/j.yexcr.2011.09.010; Takayama S, 2001, NAT CELL BIOL, V3, pE237, DOI 10.1038/ncb1001-e237; Taldone T, 2014, TRENDS PHARMACOL SCI, V35, P48, DOI 10.1016/j.tips.2014.09.001; Tsai YC, 2012, MOL BIOL CELL, V23, P4484, DOI 10.1091/mbc.E12-08-0631; Tsukahara F, 2010, BLOOD, V116, P3582, DOI 10.1182/blood-2009-10-249623; Tzankov S, 2008, J BIOL CHEM, V283, P27100, DOI 10.1074/jbc.M803923200; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Walker VE, 2010, J BIOL CHEM, V285, P3319, DOI 10.1074/jbc.M109.024000; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Young JC, 2014, DIS MODEL MECH, V7, P319, DOI 10.1242/dmm.014001; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041	64	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2287	2300		10.1074/jbc.M116.752618	http://dx.doi.org/10.1074/jbc.M116.752618			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	27998983	Green Published, hybrid			2022-12-26	WOS:000395530300021
J	Szczyrba, J; Niesen, A; Wagner, M; Wandernoth, PM; Aumuller, G; Wennemuth, G				Szczyrba, Jaroslaw; Niesen, Anne; Wagner, Mathias; Wandernoth, Petra M.; Aumueller, Gerhard; Wennemuth, Gunther			Neuroendocrine Cells of the Prostate Derive from the Neural Crest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						development; neuroendocrinology; neurogenesis; prostate; Wnt pathway; neural crest; neuroendocrine cells; WNT1	UROGENITAL DUCT SYSTEM; REGIONAL-DISTRIBUTION; ENDOCRINE-CELLS; CHROMOGRANIN-A; MALE-RAT; DIFFERENTIATION; ORIGIN; CANCER; CALCITONIN; PEPTIDE	The histogenesis of prostatic neuroendocrine cells is controversial: a stem cell hypothesis with a urogenital sinus-derived progeny of all prostatic epithelial cells is opposed by a dual origin hypothesis, favoring the derivation of neuroendocrine cells from the neural crest, with the secretory and basal cells being of urogenital sinus origin. A computer-assisted 3D reconstruction was used to analyze the distribution of chromogranin A immunoreactive cells in serial sections of human fetal prostate specimens (gestation weeks 18 and 25). Immunohistochemical double labeling studies with YFP and serotonin antisera combined with electron microscopy were carried out on double-transgenic Wnt1-Cre/ROSA26-YFP mice showing stable YFP expression in all neural crest-derived cell populations despite loss of Wnt1 expression. 3D reconstruction of the distribution pattern of neuroendocrine cells in the human fetal prostate indicates a migration of paraganglionic cells passing the stroma and reaching the prostate ducts. Double-transgenic mice showed 55% double labeling of periurethral neuroendocrine cells expressing both serotonin and YFP, whereas single serotonin labeling was observed in 36% and exclusive YFP labeling in 9%. The results favor the assumption of a major fraction of neural crest-derived neuroendocrine cells in both the human and murine prostates.	[Szczyrba, Jaroslaw; Niesen, Anne; Wandernoth, Petra M.; Wennemuth, Gunther] Univ Duisburg Essen, Univ Hosp, Inst Anat, D-45147 Essen, Germany; [Wagner, Mathias] Univ Saarland, Sch Med, Inst Pathol, D-66421 Homburg, Germany; [Aumueller, Gerhard] Philipps Univ Marburg, Dept Anat & Cell Biol, Robert Koch Str 8, D-35037 Marburg, Germany	University of Duisburg Essen; Saarland University; Philipps University Marburg	Wennemuth, G (corresponding author), Univ Duisburg Essen, Univ Hosp, Inst Anat, D-45147 Essen, Germany.	gunther.wennemuth@uk-essen.de	Dankert, Jaroslaw Thomas/A-2400-2017; Dankert, Jaroslaw Thomas/GWV-8070-2022	Dankert, Jaroslaw Thomas/0000-0002-5950-0742; Dankert, Jaroslaw Thomas/0000-0002-5950-0742; Wennemuth, Gunther/0000-0003-3313-2475				ABRAHAMSSON PA, 1989, PROSTATE, V14, P71, DOI 10.1002/pros.2990140109; Abrahamsson PA, 1999, ENDOCR-RELAT CANCER, V6, P503, DOI 10.1677/erc.0.0060503; ABRAHAMSSON PA, 1989, PATHOL RES PRACT, V185, P373, DOI 10.1016/S0344-0338(89)80016-0; Aumuller G, 2012, PROSTATE, V72, P326, DOI 10.1002/pros.21437; Aumuller G, 2001, PROSTATE, V46, P108, DOI 10.1002/1097-0045(20010201)46:2<108::AID-PROS1014>3.0.CO;2-9; Aumuller G, 1999, UROLOGY, V53, P1041, DOI 10.1016/S0090-4295(98)00631-1; Aumuller G., 1979, HDB MIKROSKOPISCHEN, P1; Bjerknes M, 2012, DEV BIOL, V362, P194, DOI 10.1016/j.ydbio.2011.12.009; Bonkhoff H, 1996, PROSTATE, V28, P98; BONKHOFF H, 1995, HUM PATHOL, V26, P167, DOI 10.1016/0046-8177(95)90033-0; Cassiman D, 2006, J HEPATOL, V44, P1098, DOI 10.1016/j.jhep.2005.09.023; Deckmann K, 2015, INT IMMUNOPHARMACOL, V29, P51, DOI 10.1016/j.intimp.2015.05.038; Deeble PD, 2007, CANCER RES, V67, P3663, DOI 10.1158/0008-5472.CAN-06-2616; di, 1992, CANCER, V70, P254; DISANTAGNESE PA, 1985, ARCH PATHOL LAB MED, V109, P607; DISANTAGNESE PA, 1989, ARCH PATHOL LAB MED, V113, P790; DISANTAGNESE PA, 1984, ARCH PATHOL LAB MED, V108, P693; Diwakar G, 2015, GLYCOCONJUGATE J, V32, P413, DOI 10.1007/s10719-015-9605-7; Erasmus CE, 2002, CAN J NEUROL SCI, V29, P375, DOI 10.1017/S0317167100002250; Fixemer T, 2002, PROSTATE, V53, P118, DOI 10.1002/pros.10133; GNESSI L, 1984, BIOCHEM BIOPH RES CO, V125, P199, DOI 10.1016/S0006-291X(84)80354-X; Harris ML, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003644; Hirobe T, 2011, PIGM CELL MELANOMA R, V24, P462, DOI 10.1111/j.1755-148X.2011.00845.x; Ivanov VN, 2015, APOPTOSIS, V20, P996, DOI 10.1007/s10495-015-1131-3; Johansson E, 2015, DEVELOPMENT, V142, P3519, DOI 10.1242/dev.126581; KIRKLAND SC, 1988, CANCER, V61, P1359, DOI 10.1002/1097-0142(19880401)61:7<1359::AID-CNCR2820610714>3.0.CO;2-0; KRIJNEN JLM, 1993, HISTOCHEMISTRY, V100, P393, DOI 10.1007/BF00268938; Krivova YS, 2014, B EXP BIOL MED+, V156, P865, DOI 10.1007/s10517-014-2471-7; Larue L, 2013, CELL MOL LIFE SCI, V70, P1067, DOI 10.1007/s00018-012-1112-4; Miskovic J, 2015, ACTA HISTOCHEM, V117, P451, DOI 10.1016/j.acthis.2015.02.002; Murai H, 2015, DEV GROWTH DIFFER, V57, P232, DOI 10.1111/dgd.12201; Murase D, 2015, BIOL OPEN, V4, P1213, DOI 10.1242/bio.011973; Rovasio RA, 2012, EUR J CELL BIOL, V91, P375, DOI 10.1016/j.ejcb.2011.12.007; SJOBERG HE, 1980, ACTA PHYSIOL SCAND, V110, P101, DOI 10.1111/j.1748-1716.1980.tb06636.x; SUNDAY ME, 1988, LAB INVEST, V59, P5; Szeder V, 2003, DEV BIOL, V253, P258, DOI 10.1016/S0012-1606(02)00015-5; Uchida K, 2006, PROSTATE, V66, P536, DOI 10.1002/pros.20369; Vashchenko N, 2005, EUR UROL, V47, P147, DOI 10.1016/j.eururo.2004.09.007; Wakui S, 2015, PROSTATE, V75, P646, DOI 10.1002/pros.22948; Xing NZ, 2001, PROSTATE, V48, P7, DOI 10.1002/pros.1076; Yang J, 2014, EXP CELL RES, V320, P54, DOI 10.1016/j.yexcr.2013.09.017	41	25	25	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					2021	2031		10.1074/jbc.M116.755082	http://dx.doi.org/10.1074/jbc.M116.755082			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28003366	Green Published, hybrid			2022-12-26	WOS:000395515600039
J	Xiao, Y; Ma, HX; Wan, P; Qin, DD; Wang, XX; Zhang, XX; Xiang, YL; Liu, WB; Chen, J; Yi, ZH; Li, L				Xiao, Yi; Ma, Haixia; Wan, Ping; Qin, Dandan; Wang, Xiaoxiao; Zhang, Xiaoxin; Xiang, Yunlong; Liu, Wenbo; Chen, Jiong; Yi, Zhaohong; Li, Lei			Trp-Asp (WD) Repeat Domain 1 Is Essential for Mouse Peri-implantation Development and Regulates Cofilin Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN DYNAMICS; LIM-KINASE; FUNCTIONAL ROLES; CELL-MIGRATION; IN-VITRO; ADF/COFILIN; PROTEIN; CYTOSKELETON; MECHANISMS; FILAMENTS	Trp-Asp (WD) repeat domain 1 (WDR1) is a highly conserved actin-binding protein across all eukaryotes and is involved in numerous actin-based processes by accelerating Cofilin severing actin filament. However, the function and the mechanism of WDR1 in mammalian early development are still largely unclear. We now report that WDR1 is essential for mouse peri-implantation development and regulates Cofilin phosphorylation in mouse cells. The disruption of maternal WDR1 does not obviously affect ovulation and female fertility. However, depletion of zygotic WDR1 results in embryonic lethality at the peri-implantation stage. In WDR1 knock-out cells, we found that WDR1 regulates Cofilin phosphorylation. Interestingly, WDR1 is overdosed to regulate Cofilin phosphorylation in mouse cells. Furthermore, we showed that WDR1 interacts with Lim domain kinase 1 (LIMK1), a well known phosphorylation kinase of Cofilin. Altogether, our results provide new insights into the role and mechanism of WDR1 in physiological conditions.	[Xiao, Yi; Ma, Haixia; Qin, Dandan; Wang, Xiaoxiao; Zhang, Xiaoxin; Xiang, Yunlong; Liu, Wenbo; Li, Lei] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Xiao, Yi; Ma, Haixia; Qin, Dandan; Wang, Xiaoxiao; Li, Lei] Univ Chinese Acad Sci, Inst Zool, Beijing 100049, Peoples R China; [Wan, Ping; Chen, Jiong] Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, Nanjing 210061, Jiangsu, Peoples R China; [Wan, Ping; Chen, Jiong] Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China; [Yi, Zhaohong] Beijing Agr Univ, Coll Biol Sci & Engn, Minist Agr, Key Lab Urban Agr North, Beijing 102206, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; University of Chinese Academy of Sciences, CAS; Nanjing University; Nanjing University; Beijing University of Agriculture; Ministry of Agriculture & Rural Affairs	Li, L (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.; Li, L (corresponding author), Univ Chinese Acad Sci, Inst Zool, Beijing 100049, Peoples R China.; Chen, J (corresponding author), Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, Nanjing 210061, Jiangsu, Peoples R China.; Chen, J (corresponding author), Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China.; Yi, ZH (corresponding author), Beijing Agr Univ, Coll Biol Sci & Engn, Minist Agr, Key Lab Urban Agr North, Beijing 102206, Peoples R China.	chenjiong@nju.edu.cn; yizhaoh2009@163.com; lil@ioz.ac.cn	Ma, Haixia/ABC-4707-2021	Ma, Haixia/0000-0001-9080-2004; Chen, Jiong/0000-0001-5252-3936; Li, Lei/0000-0001-5478-5681; Wan, Ping/0000-0001-6888-4701	National Natural Science Foundation of China [31590832, 31471353]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01010103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China Grants 31590832 and 31471353 and Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDA01010103. The authors declare that they have no conflicts of interest with the contents of this article.	Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 2010, CURR ALZHEIMER RES, V7, P241, DOI 10.2174/156720510791050902; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; Bedzhov I, 2014, NAT PROTOC, V9, P2732, DOI 10.1038/nprot.2014.186; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Brieher W, 2013, MOL BIOL CELL, V24, P2299, DOI 10.1091/mbc.E12-09-0694; Brieher WM, 2006, J CELL BIOL, V175, P315, DOI 10.1083/jcb.200603149; Bugyi B, 2010, ANNU REV BIOPHYS, V39, P449, DOI 10.1146/annurev-biophys-051309-103849; Chen Q, 2015, J BIOL CHEM, V290, P2289, DOI 10.1074/jbc.M114.612978; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; Doppler H, 2013, J BIOL CHEM, V288, P455, DOI 10.1074/jbc.M112.397448; Edwards DC, 1999, J BIOL CHEM, V274, P11352, DOI 10.1074/jbc.274.16.11352; Elam WA, 2013, BIOCHEM BIOPH RES CO, V438, P728, DOI 10.1016/j.bbrc.2013.07.109; Foletta VC, 2003, J CELL BIOL, V162, P1089, DOI 10.1083/jcb.200212060; Gerisch G, 2004, CELL MOTIL CYTOSKEL, V57, P18, DOI 10.1002/cm.10150; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Gorovoy M, 2005, J BIOL CHEM, V280, P26533, DOI 10.1074/jbc.M502921200; Gressin L, 2015, CURR BIOL, V25, P1437, DOI 10.1016/j.cub.2015.04.011; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Heller E, 2015, J CELL BIOL, V211, P219, DOI 10.1083/jcb.201506106; HSU YC, 1971, NATURE, V231, P100, DOI 10.1038/231100a0; Huang W, 2013, NAT NEUROSCI, V16, P441, DOI 10.1038/nn.3351; Kaji N, 2008, J BIOL CHEM, V283, P4983, DOI 10.1074/jbc.M708644200; Kile BT, 2007, BLOOD, V110, P2371, DOI 10.1182/blood-2006-10-055087; Kuhns DB, 2016, BLOOD, V128, P2135, DOI 10.1182/blood-2016-03-706028; Lee-Hoeflich ST, 2004, EMBO J, V23, P4792, DOI 10.1038/sj.emboj.7600418; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; Liang QX, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.122127; Liu LJ, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15027381; Luxenburg C, 2015, NAT CELL BIOL, V17, P592, DOI 10.1038/ncb3146; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; NISHIDA E, 1984, BIOCHEMISTRY-US, V23, P5307, DOI 10.1021/bi00317a032; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Nomura K, 2016, J BIOL CHEM, V291, P5146, DOI 10.1074/jbc.M115.713495; Ohashi K, 2015, DEV GROWTH DIFFER, V57, P275, DOI 10.1111/dgd.12213; Oleinik NV, 2014, J BIOL CHEM, V289, P26383, DOI 10.1074/jbc.M114.569657; Parast MM, 2001, DEV BIOL, V230, P43, DOI 10.1006/dbio.2000.0102; Pollard T.D, 2016, COLD SPRING HARBOR P, V8; Qi DC, 2015, MOL MED REP, V12, P2570, DOI 10.3892/mmr.2015.3773; Ren N, 2007, GENETICS, V176, P2223, DOI 10.1534/genetics.107.072959; Rodal AA, 1999, J CELL BIOL, V145, P1251, DOI 10.1083/jcb.145.6.1251; SCHEJTER ED, 1993, ANNU REV CELL BIOL, V9, P67, DOI 10.1146/annurev.cellbio.9.1.67; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Xu HC, 2016, AM J TRANSL RES, V8, P1253; Xu J, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.182; Yae K, 2006, MOL CELL BIOL, V26, P6185, DOI 10.1128/MCB.00018-06; Yuan BY, 2014, AM J PATHOL, V184, P1967, DOI 10.1016/j.ajpath.2014.04.007; Zhao ZA, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150092	52	7	7	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1438	1448		10.1074/jbc.M116.759886	http://dx.doi.org/10.1074/jbc.M116.759886			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27994054	Green Published, hybrid			2022-12-26	WOS:000393339800025
J	Cebrat, K; Sobczynski, M				Cebrat, Krzysztof; Sobczynski, Maciej			Scaling Laws in City Growth: Setting Limitations with Self-Organizing Maps	PLoS One			English	Article							CITIES; NETWORKS; SIZE	Do scaling relations always provide the means to anticipate the relationships between the size of cities, costs of maintenance, and the socio-economic benefits resulting from their growth? Scaling laws are considered a universal principle that describes the development of complex systems such as cities. It seems that regardless of their location or history, the growth of cities is associated with the super-linear or sublinear scaling of features such as the amount of space required, infrastructure, or human activities. However, the results of our research, based on grouping by Self-Organizing Maps, reveal some limitations in the application of scaling laws: the trends of urban growth behave in a different manner when we consider both a large and diverse collection of cities and a subset of cities alike. This finding complements the existing body of knowledge on the growth of cities and allows for a more accurate prediction of their future.	[Cebrat, Krzysztof] Wroclaw Univ Technol, Fac Architecture, Wroclaw, Poland; [Sobczynski, Maciej] Univ Wroclaw, Fac Biotechnol, Wroclaw, Poland	Wroclaw University of Science & Technology; University of Wroclaw	Cebrat, K (corresponding author), Wroclaw Univ Technol, Fac Architecture, Wroclaw, Poland.	krzysztof.cebrat@pwr.edu.pl		Sobczynski, Maciej/0000-0003-2428-0927; Cebrat, Krzysztof/0000-0002-1733-8492				Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Batty M, 2008, EUR PHYS J B, V63, P303, DOI 10.1140/epjb/e2008-00251-5; Batty M, 2013, SCIENCE, V340, P1418, DOI 10.1126/science.1239870; Bernardes AT, ARXIVCONDMAT0111147V; Bettencourt L, 2010, NATURE, V467, P912, DOI 10.1038/467912a; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2013, SCIENCE, V340, P1438, DOI 10.1126/science.1235823; Fuller RA, 2009, BIOL LETTERS, V5, P352, DOI 10.1098/rsbl.2009.0010; Gomez-Lievano A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040393; Kennedy C, 2011, ENVIRON POLLUT, V159, P1965, DOI 10.1016/j.envpol.2010.10.022; Kohonen T., 2001, SELF ORGANIZING MAPS, P347; Kuhnert C, 2006, PHYSICA A, V363, P96, DOI 10.1016/j.physa.2006.01.058; Larson W, 2015, J URBAN ECON, V90, P35, DOI 10.1016/j.jue.2015.08.001; Ma XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119044; Mansury Y, 2015, COMPUT ENVIRON URBAN, V54, P428, DOI 10.1016/j.compenvurbsys.2015.08.004; Marshall JD, 2007, URBAN STUD, V44, P1889, DOI 10.1080/00420980701471943; Sarzynski A, 2012, URBAN STUD, V49, P3121, DOI 10.1177/0042098011432557; Shlapfer M, 2014, INTERFACE J ROYAL SO, V11; Strano E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159465; van Raan AFJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146775; Zhang Y, 2009, ECOL MODEL, V220, P1431, DOI 10.1016/j.ecolmodel.2009.02.001	21	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168753	10.1371/journal.pone.0168753	http://dx.doi.org/10.1371/journal.pone.0168753			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005994	Green Published, gold			2022-12-26	WOS:000392843200090
J	de Castro-Miro, M; Tonda, R; Escudero-Ferruz, P; Andres, R; Mayor-Lorenzo, A; Castro, J; Ciccioli, M; Hidalgo, DA; Rodriguez-Ezcurra, JJ; Farrando, J; Perez-Santonja, JJ; Cormand, B; Marfany, G; Gonzalez-Duarte, R				de Castro-Miro, Marta; Tonda, Raul; Escudero-Ferruz, Paula; Andres, Rosa; Mayor-Lorenzo, Andres; Castro, Joaquin; Ciccioli, Marcela; Hidalgo, Daniel A.; Jose Rodriguez-Ezcurra, Juan; Farrando, Jorge; Perez-Santonja, Juan J.; Cormand, Bru; Marfany, Gemma; Gonzalez-Duarte, Roser			Novel Candidate Genes and a Wide Spectrum of Structural and Point Mutations Responsible for Inherited Retinal Dystrophies Revealed by Exome Sequencing	PLOS ONE			English	Article							RECESSIVE RETINITIS-PIGMENTOSA; LEBER CONGENITAL AMAUROSIS; USHER-SYNDROME; MOLECULAR DIAGNOSIS; DISEASE; OFD1; PENETRANCE; PHENOTYPE; GENOTYPE; FAMILIES	Background NGS-based genetic diagnosis has completely revolutionized the human genetics field. In this study, we have aimed to identify new genes and mutations by Whole Exome Sequencing (WES) responsible for inherited retinal dystrophies (IRD). Methods A cohort of 33 pedigrees affected with a variety of retinal disorders was analysed by WES. Initial prioritization analysis included around 300 IRD-associated genes. In non-diagnosed families a search for pathogenic mutations in novel genes was undertaken. Results Genetic diagnosis was attained in 18 families. Moreover, a plausible candidate is proposed for 10 more cases. Two thirds of the mutations were novel, including 4 chromosomal rearrangements, which expand the IRD allelic heterogeneity and highlight the contribution of private mutations. Our results prompted clinical re-evaluation of some patients resulting in assignment to a syndromic instead of non-syndromic IRD. Notably, WES unveiled four new candidates for non-syndromic IRD: SEMA6B, CEP78, CEP250, SCLT1, the two latter previously associated to syndromic disorders. We provide functional data supporting that missense mutations in CEP250 alter cilia formation. Conclusion The diagnostic efficiency of WES, and strictly following the ACMG/AMP criteria is 55% in reported causative genes or functionally supported new candidates, plus 30% families in which likely pathogenic or VGUS/VUS variants were identified in plausible candidates. Our results highlight the clinical utility of WES for molecular diagnosis of IRD, provide a wider spectrum of mutations and concomitant genetic variants, and challenge our view on syndromic vs non-syndromic, and causative vs modifier genes.	[de Castro-Miro, Marta; Escudero-Ferruz, Paula; Andres, Rosa; Cormand, Bru; Marfany, Gemma; Gonzalez-Duarte, Roser] Univ Barcelona, Fac Biol, Dept Genet Microbiol & Estadist, Barcelona, Spain; [de Castro-Miro, Marta; Andres, Rosa; Cormand, Bru; Marfany, Gemma; Gonzalez-Duarte, Roser] Inst Salud Carlos III, CIBERER, Barcelona, Spain; [de Castro-Miro, Marta; Cormand, Bru; Marfany, Gemma; Gonzalez-Duarte, Roser] Univ Barcelona, Inst Biomed IBUB, Barcelona, Spain; [Tonda, Raul] BIST, CRG, CNAG CRG, Barcelona, Spain; [Tonda, Raul] UPF, Barcelona, Spain; [Mayor-Lorenzo, Andres] Asociac EsRetina Asturias, Oviedo, Asturias, Spain; [Castro, Joaquin] Hosp Univ Cent Asturias, Unidad Retina, Serv Oftalmol, Oviedo, Spain; [Ciccioli, Marcela] Stargardt APNES Retina, Buenos Aires, DF, Argentina; [Hidalgo, Daniel A.] Hosp Interzonal Gen Agudos Eva Peron, Buenos Aires, DF, Argentina; [Jose Rodriguez-Ezcurra, Juan] Barraquer Ctr Oftalmol Barcelona, Barcelona, Spain; [Farrando, Jorge] Inst Oftalmol Quiron Barcelona, Barcelona, Spain; [Perez-Santonja, Juan J.] Univ Alicante, Gen Hosp, Alicante Inst Hlth & Biomed Res, Dept Ophthalmol,ISABIAL FISABIO Fdn, Alicante, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; University of Barcelona; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Central University Hospital Asturias; General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL)	Gonzalez-Duarte, R (corresponding author), Univ Barcelona, Fac Biol, Dept Genet Microbiol & Estadist, Barcelona, Spain.; Gonzalez-Duarte, R (corresponding author), Inst Salud Carlos III, CIBERER, Barcelona, Spain.; Gonzalez-Duarte, R (corresponding author), Univ Barcelona, Inst Biomed IBUB, Barcelona, Spain.	rgonzalez@ub.edu	Cormand, Bru/H-5338-2015; /L-5926-2018; Tonda, Raul/I-1606-2015; Marfany, Gemma/I-5668-2015	Cormand, Bru/0000-0001-5318-4382; /0000-0001-8685-3378; Tonda, Raul/0000-0001-7893-2404; Marfany, Gemma/0000-0001-7941-983X; Perez-Santonja, Juan J./0000-0003-1892-2372	Ministerio de Economia y Competitividad [SAF2013-49069-C2-1-R, PT13/0001/0044]; Generalitat de Catalunya [2014SGR-0932]; La Marato TV3 [201417-30-31-32]	Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); La Marato TV3	This study was supported by grants SAF2013-49069-C2-1-R (Ministerio de Economia y Competitividad), 2014SGR-0932 (Generalitat de Catalunya), and La Marato TV3 (Project Marato 201417-30-31-32) to G.M. and R. G-D and PT13/0001/0044 (Ministerio de Economia y Competitividad) to R.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulwahab F, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0693-2; Abu Safieh L, 2010, J MED GENET, V47, P236, DOI 10.1136/jmg.2009.070755; Abu-Safieh L, 2013, GENOME RES, V23, P236, DOI 10.1101/gr.144105.112; Adly N, 2014, HUM MUTAT, V35, P36, DOI 10.1002/humu.22477; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aller E, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041764; Andermatt I, 2014, DEVELOPMENT, V141, P3709, DOI 10.1242/dev.112185; Beryozkin A, 2015, SCI REP-UK, V5, DOI 10.1038/srep13187; Bisschoff IJ, 2013, HUM MUTAT, V34, P237, DOI 10.1002/humu.22224; Bonnet C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-21; Bravo-Gil N, 2016, SCI REP-UK, V6, DOI 10.1038/srep23910; Chen R, 2016, NAT BIOTECHNOL, V34, P531, DOI 10.1038/nbt.3514; Cideciyan AV, 2009, HUM MOL GENET, V18, P931, DOI 10.1093/hmg/ddn421; Cooper DN, 2013, HUM GENET, V132, P1077, DOI 10.1007/s00439-013-1331-2; Coppieters F, 2014, GENET MED, V16, P671, DOI 10.1038/gim.2014.24; Corton M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065574; Corton M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-20; de Castro-Miro M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088410; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Dreyer B, 2008, HUM MUTAT, V29, P451, DOI 10.1002/humu.9524; Ellingford JM, 2016, OPHTHALMOLOGY; Ellingford JM, 2016, J MED GENET; Eudy JD, 1998, SCIENCE, V280, P1753, DOI 10.1126/science.280.5370.1753; Fry AM, 1998, J CELL BIOL, V141, P1563, DOI 10.1083/jcb.141.7.1563; Ge ZQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep18287; Glockle N, 2013, EUR J HUM GENET, P1; Hanein S, 2004, HUM MUTAT, V23, P306, DOI 10.1002/humu.20010; Jansen GA, 2004, HUM MUTAT, V23, P209, DOI 10.1002/humu.10315; Jose PFS, 2015, INVEST OPHTH VIS SCI, V56, P2173, DOI 10.1167/iovs.14-16178; Karwath M, 2015, RUNS HOMOZYGOSITY RE; Khateb S, 2014, J MED GENET, V51, P460, DOI 10.1136/jmedgenet-2014-102287; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Lee K, 2015, AM J OPHTHALMOL, V160, P354, DOI 10.1016/j.ajo.2015.04.026; Manes G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095768; Marfany G, 2015, WORLD J MED GENET, V5, P14; Matsuoka RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063207; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Nishiguchi KM, 2005, HUM MUTAT, V25, P248, DOI 10.1002/humu.20142; Nishiguchi KM, 2013, P NATL ACAD SCI; Nishiguchi KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041902; Perez-Carro R, 2016, SCI REP-UK, V6, DOI 10.1038/srep19531; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rachel Rivka A, 2012, Cilia, V1, P22, DOI 10.1186/2046-2530-1-22; Ratnapriya R, 2013, GENOME MED, V5, DOI 10.1186/gm488; Rivolta C, 2000, AM J HUM GENET, V66, P1975, DOI 10.1086/302926; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rose AM, 2016, CLIN GENET, V90, P118, DOI 10.1111/cge.12758; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Sundin OH, 2000, NAT GENET, V25, P289, DOI 10.1038/77162; Thauvin-Robinet C, 2013, CLIN GENET, V84, P86, DOI 10.1111/cge.12013; Tiwari A, 2016, SCI REP-UK, V6, DOI 10.1038/srep28755; Wang J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155860; Wang Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150555; Webb TR, 2012, HUM MOL GENET, V21, P3647, DOI 10.1093/hmg/dds194; Zernant J, 2014, HUM MOL GENET, V23, P6797, DOI 10.1093/hmg/ddu396	57	30	30	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168966	10.1371/journal.pone.0168966	http://dx.doi.org/10.1371/journal.pone.0168966			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005958	gold, Green Published, Green Submitted			2022-12-26	WOS:000392843200117
J	Nattero, J; Pita, S; Calleros, L; Crocco, L; Panzera, Y; Rodriguez, CS; Panzera, F				Nattero, Julieta; Pita, Sebastian; Calleros, Lucia; Crocco, Liliana; Panzera, Yanina; Rodriguez, Claudia S.; Panzera, Francisco			Morphological and Genetic Differentiation within the Southernmost Vector of Chagas Disease: Triatoma patagonica (Hemiptera - Reduviidae)	PLOS ONE			English	Article							DEL PONTE; EXPERIMENTAL CROSSES; INFESTANS; POPULATION; FLOW; EVOLUTIONARY; PHYLOGENY; SELECTION; HYBRIDS; REVEAL	The epidemiological importance of Chagas disease vectors largely depends on their spreading ability and adaptation to domestic habitats. Triatoma patagonica is a secondary vector of Chagas disease endemic of Argentina, and it has been found colonizing domiciles and most commonly peridomiciliary structures in several Argentine provinces and morphological variation along its distribution range have been described. To asses if population differentiation represents geographic variants or true biological species, multiple genetic and phenotypic approaches and laboratory cross-breeding were performed in T. patagonica peridomestic populations. Analyses of chromatic variation of forewings, their size and the content of C-heterochromatin on chromosomes revealed that populations are structured following a North-South latitudinal variation. Cytochrome c oxidase I mitochondrial gene (COI) nucleotide analysis showed a mean genetic distance of 5.2% between the most distant populations. The cross-breeding experiments suggest a partial reproductive isolation between some populations with 40% of couples not laying eggs and low hatching efficiency. Our findings reveal phenotypic and genetic variations that suggest an incipient differentiation processes among T. patagonica populations with a pronounced phenotypic and genetic divergence between the most distant populations. The population differentiation here reported is probably related to differential environmental conditions and it could reflect the occurrence of an incipient speciation process in T. patagonica.	[Nattero, Julieta; Crocco, Liliana; Rodriguez, Claudia S.] Univ Nacl Cordoba, CONICET, IIByT,Catedra Intro Biol, Fac Ciencias Exactas Fis & Nat, Avda Velez Sarsfield,Piso 2, Cordoba, Argentina; [Nattero, Julieta] UBA, FCEyN, EGE, CONICET,Inst Ecol Genet & Evoluc Buenos Aires,Lab, Intendente Guiraldes 2160,Ciudad Univ,Pabellon 2, Buenos Aires, DF, Argentina; [Pita, Sebastian; Calleros, Lucia; Panzera, Yanina; Panzera, Francisco] Univ Republica, Fac Ciencias, Secc Genet Evolut, Montevideo, Uruguay	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Universidad de la Republica, Uruguay	Nattero, J (corresponding author), Univ Nacl Cordoba, CONICET, IIByT,Catedra Intro Biol, Fac Ciencias Exactas Fis & Nat, Avda Velez Sarsfield,Piso 2, Cordoba, Argentina.; Nattero, J (corresponding author), UBA, FCEyN, EGE, CONICET,Inst Ecol Genet & Evoluc Buenos Aires,Lab, Intendente Guiraldes 2160,Ciudad Univ,Pabellon 2, Buenos Aires, DF, Argentina.; Panzera, F (corresponding author), Univ Republica, Fac Ciencias, Secc Genet Evolut, Montevideo, Uruguay.	julietanattero@ege.fcen.uba.ar; fcopanzera@gmail.com	Panzera, Francisco/M-9884-2015; Pita, Sebastián/Z-6090-2019	Panzera, Francisco/0000-0001-5148-957X; Pita, Sebastián/0000-0002-4102-5808; Crocco, Liliana/0000-0002-1277-8157	Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba from Argentina [05/I554]; "Comision Sectorial de Investigacion Cientifica" (CSIC-Udelar-Uruguay); Programa de Desarrollo de las Ciencias Basicas (PEDECIBA Uruguay); Agencia Nacional de Investigacion e Innovacion (ANII, Uruguay); CONICET (Argentina)	Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba from Argentina; "Comision Sectorial de Investigacion Cientifica" (CSIC-Udelar-Uruguay); Programa de Desarrollo de las Ciencias Basicas (PEDECIBA Uruguay); Agencia Nacional de Investigacion e Innovacion (ANII, Uruguay); CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This research has been supported by project grants (no 05/I554) "Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba from Argentina" to LCr, (no. 370) from the "Comision Sectorial de Investigacion Cientifica" (CSIC-Udelar-Uruguay), Programa de Desarrollo de las Ciencias Basicas (PEDECIBA Uruguay) to FP and Agencia Nacional de Investigacion e Innovacion (ANII, Uruguay) to FP. JN is member of CONICET Researcher's Career. This work was done during the course of a fellowship for young researchers from CONICET (Argentina) given to JN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold ML, 2004, MOL ECOL, V13, P997, DOI 10.1111/j.1365-294X.2004.02145.x; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Burkart R, 1999, ECOREGIONES ARGENTIN; Cabrera AL., 1971, BOLET N SOC ARGENTIN, V14, P1; Calleros L, 2010, INFECT GENET EVOL, V10, P221, DOI 10.1016/j.meegid.2009.12.002; Campos-Soto R, 2016, INFECT GENET EVOL, V45, P205, DOI 10.1016/j.meegid.2016.09.001; Chunco AJ, 2007, EVOLUTION, V61, P2504, DOI 10.1111/j.1558-5646.2007.00213.x; Costa J, 2003, MEM I OSWALDO CRUZ, V98, P637, DOI 10.1590/S0074-02762003000500009; Dobzhansky T, 1970, GENETICS EVOLUTIONAR; Dujardin JP, 2009, ACTA TROP, V110, P101, DOI 10.1016/j.actatropica.2008.09.026; Dujardin JP, 1999, MEM I OSWALDO CRUZ, V94, P223, DOI 10.1590/S0074-02761999000700036; Edh K, 2007, MOL ECOL, V16, P4972, DOI 10.1111/j.1365-294X.2007.03585.x; Efron B, 1996, P NATL ACAD SCI USA, V93, P13429, DOI 10.1073/pnas.93.23.13429; Endler J.A., 1977, Monographs in Population Biology, pi; Ferrero Adriana A., 1999, Revista de la Sociedad Entomologica Argentina, V58, P79; Galvao C., 2014, VETORES DOENCA CHAGA, DOI DOI 10.7476/9788598203096; Garcia BA, 2001, J MED ENTOMOL, V38, P675, DOI 10.1603/0022-2585-38.5.675; Giraldez E, 2009, REV MED ROSARIO, V75, P38; GORLA DE, 1989, MED VET ENTOMOL, V3, P179, DOI 10.1111/j.1365-2915.1989.tb00497.x; Gurgel-Goncalves R, 2011, MED VET ENTOMOL, V25, P84, DOI 10.1111/j.1365-2915.2010.00920.x; Hoffmann KH, 1985, ENV PHYSL BIOCH INSE, P33, DOI [DOI 10.1007/978-3-642-70020-0_2, 10.1007/978-3-642-70020-0_2]; Hypsa V, 2002, MOL PHYLOGENET EVOL, V23, P447, DOI 10.1016/S1055-7903(02)00023-4; Justi SA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-149; LENT H, 1979, Bulletin of the American Museum of Natural History, V163, P123; Mendonca VJ, 2014, INFECT GENET EVOL, V26, P123, DOI 10.1016/j.meegid.2014.05.015; Monteiro FA, 2003, MOL ECOL, V12, P997, DOI 10.1046/j.1365-294X.2003.01802.x; Nattero J, 2002, MEM I OSWALDO CRUZ, V97, P1063, DOI 10.1590/S0074-02762002000700022; Nattero J, 2013, J VECTOR ECOL, V38, P127, DOI 10.1111/j.1948-7134.2013.12018.x; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Panzera F, 1997, AM J TROP MED HYG, V57, P732, DOI 10.4269/ajtmh.1997.57.732; Panzera F, 2006, TROP MED INT HEALTH, V11, P1092, DOI 10.1111/j.1365-3156.2006.01656.x; Panzera F, 2004, EMERG INFECT DIS, V10, P438, DOI 10.3201/eid1003.020812; Panzera F, 2010, CYTOGENET GENOME RES, V128, P77, DOI 10.1159/000298824; Panzera F, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1109-6; Panzera F, 2014, INFECT GENET EVOL, V27, P105, DOI 10.1016/j.meegid.2014.07.006; Perez R, 2005, GENETICA, V125, P261, DOI 10.1007/s10709-005-0369-z; Pita S, 2016, INFECT GENET EVOL, V43, P225, DOI 10.1016/j.meegid.2016.05.028; Rabinovich J, 2006, PHYSIOL ENTOMOL, V31, P361, DOI 10.1111/j.1365-3032.2006.00529.x; Rodriguez CS, 2013, ACTA TROP, V125, P143, DOI 10.1016/j.actatropica.2012.11.006; Rodriguez CS, 2008, REV SOC BRAS MED TRO, V41, P330, DOI 10.1590/S0037-86822008000400002; Rohlf F. J., 2013, TPSDIG DIGITIZE LAND; RYCKMAN RAYMOND E., 1962, UNIV CALIF PUBLICATION ENTOMOL, V27, P93; SANDOVAL CP, 1994, EVOLUTION, V48, P1866, DOI 10.1111/j.1558-5646.1994.tb02220.x; Schachter-Broide J, 2004, J MED ENTOMOL, V41, P643, DOI 10.1603/0022-2585-41.4.643; Schofield CJ, 2006, TRENDS PARASITOL, V22, P583, DOI 10.1016/j.pt.2006.09.011; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Verma RS, 1988, HETEROCHROMATIN MOL	48	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168853	10.1371/journal.pone.0168853	http://dx.doi.org/10.1371/journal.pone.0168853			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005972	Green Published, Green Submitted, gold			2022-12-26	WOS:000392843200105
J	Schaefer, PM; von Einem, B; Walther, P; Calzia, E; von Arnim, CAF				Schaefer, Patrick M.; von Einem, Bjoern; Walther, Paul; Calzia, Enrico; von Arnim, Christine A. F.			Metabolic Characterization of Intact Cells Reveals Intracellular Amyloid Beta but Not Its Precursor Protein to Reduce Mitochondrial Respiration	PLOS ONE			English	Article							A-BETA; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; ENERGY-METABOLISM; NEURONAL DEGENERATION; MOLECULAR-MECHANISMS; INSULIN-RESISTANCE; SYNAPSE PATHOLOGY; BRAIN; DYSFUNCTION	One hallmark of Alzheimer's disease are senile plaques consisting of amyloid beta (A beta), which derives from the processing of the amyloid precursor protein (APP). Mitochondrial dysfunction has been linked to the pathogenesis of Alzheimer's disease and both A beta and APP have been reported to affect mitochondrial function in isolated systems. However, in intact cells, considering a physiological localization of APP and A beta, it is pending what triggers the mitochondrial defect. Thus, the aim of this study was to dissect the impact of APP versus A beta in inducing mitochondrial alterations with respect to their subcellular localization. We performed an overexpression of APP or beta-site amyloid precursor protein cleaving enzyme 1 (BACE1), increasing APP and A beta levels or A beta alone, respectively. Conducting a comprehensive metabolic characterization we demonstrate that only APP overexpression reduced mitochondrial respiration, despite lower extracellular A beta levels compared to BACE overexpression. Surprisingly, this could be rescued by a gamma secretase inhibitor, oppositionally indicating an A beta-mediated mitochondrial toxicity. Analyzing A beta localization revealed that intracellular levels of A beta and an increased spatial association of APPA beta with mitochondria are associated with reduced mitochondrial respiration. Thus, our data provide marked evidence for a prominent role of intracellular A beta accumulation in Alzheimer's disease associated mitochondrial dysfunction. Thereby it highlights the importance of the localization of APP processing and intracellular transport as a decisive factor for mitochondrial function, linking two prominent hallmarks of neurodegenerative diseases.	[Schaefer, Patrick M.; von Einem, Bjoern; von Arnim, Christine A. F.] Univ Ulm, Inst Neurol, Ulm, Germany; [Walther, Paul] Univ Ulm, Cent Facil Electron Microscopy, Ulm, Germany; [Calzia, Enrico] Univ Ulm Klinikum, Inst Anasthesiol Pathophysiol & Verfahrensentwick, Ulm, Germany	Ulm University; Ulm University; Ulm University	von Arnim, CAF (corresponding author), Univ Ulm, Inst Neurol, Ulm, Germany.	christine.arnim@uni-ulm.de			German Federal Ministry of Economics and Energy (BMWi) within the Promotion of Joint Industrial Research Program (IGF); German Federation of Industrial Research Associations (AiF) [18239 N]	German Federal Ministry of Economics and Energy (BMWi) within the Promotion of Joint Industrial Research Program (IGF); German Federation of Industrial Research Associations (AiF)	This research was funded by the German Federal Ministry of Economics and Energy (BMWi) within the Promotion of Joint Industrial Research Program (IGF) due to a decision of the German Bundestag. It was part of the research project 18239 N by the Association for Research in Precision Mechanics, Optics and Medical Technology (F.O.M.) under the auspices of the German Federation of Industrial Research Associations (AiF).	Aleardi AM, 2005, J BIOENERG BIOMEMBR, V37, P207, DOI 10.1007/s10863-005-6631-3; Anandatheerthavarada HK, 2007, NEUROSCIENTIST, V13, P626, DOI 10.1177/1073858407303536; Anandatheerthavarada HK, 2003, J CELL BIOL, V161, P41, DOI 10.1083/jcb.200207030; Barone E, 2016, ANTIOXID REDOX SIGNA; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bobba A, 2013, MITOCHONDRION, V13, P298, DOI 10.1016/j.mito.2013.03.008; Buser C, 2008, J MICROSC-OXFORD, V230, P268, DOI 10.1111/j.1365-2818.2008.01984.x; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Cha MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034929; Chang KL, 2015, J ALZHEIMERS DIS, V44, P215, DOI 10.3233/JAD-140429; Cunnane S, 2011, NUTRITION, V27, P3, DOI 10.1016/j.nut.2010.07.021; de la Monte SM, 2012, CURR ALZHEIMER RES, V9, P35; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; Devi L, 2012, NEUROBIOL DIS, V45, P417, DOI 10.1016/j.nbd.2011.09.001; Dragicevic N, 2010, J ALZHEIMERS DIS, V20, pS535, DOI 10.3233/JAD-2010-100342; Eckert SH, 2012, J ALZHEIMERS DIS, V31, P21, DOI 10.3233/JAD-2012-120310; Feldhaus P, 2011, METAB BRAIN DIS, V26, P229, DOI 10.1007/s11011-011-9253-y; Hernandez-Zimbron LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042344; Forkink M, 2014, BBA-BIOENERGETICS, V1837, P1247, DOI 10.1016/j.bbabio.2014.04.008; Gouras GK, 2014, NEURODEGENER DIS, V13, P142, DOI 10.1159/000354776; Gouras GK, 2010, ACTA NEUROPATHOL, V119, P523, DOI 10.1007/s00401-010-0679-9; Gray NE, 2015, J ALZHEIMERS DIS, V45, P933, DOI 10.3233/JAD-142217; Horan MP, 2012, J GERONTOL A-BIOL, V67, P1022, DOI 10.1093/gerona/glr263; Kaminsky YG, 2015, FRONT BIOSCI-LANDMRK, V20, P173, DOI 10.2741/4304; Kinoshita A, 2001, J NEUROSCI, V21, P8354, DOI 10.1523/JNEUROSCI.21-21-08354.2001; Krako N, 2013, J ALZHEIMERS DIS, V37, P747, DOI 10.3233/JAD-130728; Kwon B, 2015, BBA-MOL BASIS DIS, V1852, P1810, DOI 10.1016/j.bbadis.2015.05.012; Landor SKJ, 2011, P NATL ACAD SCI USA, V108, P18814, DOI 10.1073/pnas.1104943108; Lee EB, 2005, J CELL BIOL, V168, P291, DOI 10.1083/jcb.200407070; Lee I, 2001, BIOL CHEM, V382, P1629, DOI 10.1515/BC.2001.198; Lin MT, 2006, NAT MED, V12, P1241, DOI 10.1038/nm1106-1241; Luque-Contreras D, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/497802; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Mattson MP, 1999, ANN NY ACAD SCI, V893, P154, DOI 10.1111/j.1749-6632.1999.tb07824.x; Mitani Y, 2012, J NEUROSCI, V32, P2037, DOI 10.1523/JNEUROSCI.4264-11.2012; Mosconi L, 2008, ANN NY ACAD SCI, V1147, P180, DOI 10.1196/annals.1427.007; Pagani Lucia, 2011, Int J Alzheimers Dis, V2011, P925050, DOI 10.4061/2011/925050; Parihar MS, 2007, AM J PHYSIOL-CELL PH, V292, pC8, DOI 10.1152/ajpcell.00232.2006; Parks JK, 2001, J NEUROCHEM, V76, P1050, DOI 10.1046/j.1471-4159.2001.00112.x; Pavlov PF, 2011, FASEB J, V25, P78, DOI 10.1096/fj.10-157230; PERRY EK, 1980, NEUROSCI LETT, V18, P105, DOI 10.1016/0304-3940(80)90220-7; Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105; Pohland M, 2015, NEUROCHEM RES; RAPOPORT SI, 1991, ADV EXP MED BIOL, V291, P231; Rhein V, 2009, CELL MOL NEUROBIOL, V29, P1063, DOI 10.1007/s10571-009-9398-y; Rhein V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012359; Robinson A, 2014, AGING CELL, V13, P263, DOI 10.1111/acel.12183; Rottenberg H, 2009, J BIOL CHEM, V284, P19203, DOI 10.1074/jbc.M109.017376; Sanderson TH, 2013, MOL NEUROBIOL, V47, P9, DOI 10.1007/s12035-012-8344-z; Sarkar S, 2015, BRAIN RES, V1616, P101, DOI 10.1016/j.brainres.2015.04.059; Schreiner B, 2015, J ALZHEIMERS DIS, V43, P369, DOI 10.3233/JAD-132543; Sheng BY, 2009, FREE RADICAL BIO MED, V46, P1362, DOI 10.1016/j.freeradbiomed.2009.02.018; Sultana R, 2009, J BIOENERG BIOMEMBR, V41, P441, DOI 10.1007/s10863-009-9241-7; Upadhaya AR, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-77; von Einem B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129047; Walther Paul, 2013, Methods Mol Biol, V931, P525, DOI 10.1007/978-1-62703-056-4_28; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Weissmiller AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118379; Wilkat M, 2014, HISTOCHEM CELL BIOL, V142, P171, DOI 10.1007/s00418-014-1189-y; Xie H, 2013, J NEUROSCI, V 33, P17042, DOI 10.1523/JNEUROSCI.1836-13.2013; Zhao W, 2015, NEUROPSYCH DIS TREAT, V11, P565, DOI 10.2147/NDT.S74898	62	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168157	10.1371/journal.pone.0168157	http://dx.doi.org/10.1371/journal.pone.0168157			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005987	Green Submitted, Green Published, gold			2022-12-26	WOS:000392843200032
J	Sung, JH; Lee, J; Park, J; Sim, CS				Sung, Joo Hyun; Lee, Jiho; Park, Jin; Sim, Chang Sun			Relationship of Transportation Noise and Annoyance for Two Metropolitan Cities in Korea: Population Based Study	PLOS ONE			English	Article							INDUCED HEARING-LOSS; ENVIRONMENTAL NOISE; AIRCRAFT NOISE; EXPOSURE; POLLUTION; ADULTS; HEALTH	Transportation noise is known to have negative impact on both public health and life quality. This study evaluated the relationship between transportation noise and annoyance levels, and also the difference of annoyance levels in two metropolitan cities based on epidemiologic surveys. Two thousand adult subjects living in Seoul and Ulsan were enrolled by stratified random sampling on the basis of noise maps from July 2015 to January 2016. Individual annoyance in accordance with transportation noise levels in two metropolitan cities were surveyed using an 11-point visual analog scale questionnaire. The results show that transportation noise level was significantly correlated with annoyance in both cities. Logistic regression analysis revealed that the risk of being 'highly annoyed' increased with noise level (L-dn, day-night average sound level) in both cities. After adjusting for age, residence period, sociodemographic factors (sex, education, marriage, income, alcohol, smoking, and exercise) and noise sensitivity, the risk of being 'highly annoyed' was increased with noise levels in both cities. In comparison to those of areas with noise levels below 55 dBA, the adjusted odds ratios of 'highly annoyed' for areas with 55-65 dBA and over 65 dBA were 2.056 (95% confidence interval [CI] 1.225-3.450), 3.519 (95% CI 1.982-6.246) in Seoul and 1.022 (95% CI 0.585-1.785), 1.704 (95% CI 1.005-2.889) in Ulsan, respectively. Based on the results of a population study, we showed that transportation noise levels were significantly associated with annoyance in adults. However, there were some differences between the two cities. In this study, there were differences in transportation noise between the two cities. Seoul has complex noise (traffic and aircraft), compared to single road traffic noise in Ulsan. Therefore, single and complex transportation noise may have different effects on annoyance levels.	[Sung, Joo Hyun; Lee, Jiho; Park, Jin; Sim, Chang Sun] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Occupat & Environm Med, Ulsan, South Korea	University of Ulsan; Ulsan University Hospital	Sim, CS (corresponding author), Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Occupat & Environm Med, Ulsan, South Korea.	zzz0202@naver.com		Sung, Joo Hyun/0000-0001-9043-1127	Korea Ministry of Environment (MOE) as "the Environmental Health Action Program"; Korea Ministry of Environment [2014001350001]	Korea Ministry of Environment (MOE) as "the Environmental Health Action Program"(Ministry of Environment (ME), Republic of Korea); Korea Ministry of Environment(Ministry of Environment (ME), Republic of Korea)	This study was funded by the Korea Ministry of Environment (MOE) as "the Environmental Health Action Program." CSS and JHS received funding from Korea Ministry of Environment (grant number 2014001350001) (URL: http://www.me.go.kr/home/web/main.do). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarsson JJ, 2010, INT J ENV RES PUB HE, V7, P1036, DOI 10.3390/ijerph7031036; [Anonymous], 2003, ASS NOIS ANN MEANS S; Basner M, 2015, NOISE HEALTH, V17, P57, DOI 10.4103/1463-1741.153373; BORSKY PN, 1979, OTOLARYNG CLIN N AM, V12, P521; Buhaug H, 2013, GLOBAL ENVIRON CHANG, V23, P1, DOI 10.1016/j.gloenvcha.2012.10.016; European Commission, 2002, POS PAP DOS RESP REL; Gilles A, 2012, OTOL NEUROTOL, V33, P899, DOI 10.1097/MAO.0b013e31825d640a; Hammer MS, 2014, ENVIRON HEALTH PERSP, V122, P115, DOI 10.1289/ehp.1307272; Hume KI, 2012, NOISE HEALTH, V14, P297, DOI 10.4103/1463-1741.104897; Hurtley C., 2009, NIGHT NOISE GUIDELIN; Jeon JY, 2010, J ACOUST SOC AM, V127, P1357, DOI 10.1121/1.3298437; Kephalopoulos, 2011, BURDEN DIS ENV NOISE; Korean Ministry of Health and Welfare (KMOHW), 2016, NAT HLTH EX GUID; Lekaviciute J, 2013, NOISE HEALTH, V15, P42, DOI 10.4103/1463-1741.107153; Lewis RC, 2013, ENVIRON SCI TECHNOL, V47, P6393, DOI 10.1021/es305161z; LINDVALL T, 1973, ENVIRON RES, V6, P1, DOI 10.1016/0013-9351(73)90014-5; Mahboubi H, 2013, EUR ARCH OTO-RHINO-L, V270, P461, DOI 10.1007/s00405-012-1979-6; Miedema HME, 2001, ENVIRON HEALTH PERSP, V109, P409, DOI 10.2307/3454901; Ministry of Environment (MOE), 2010, ASS COMB NOIS ANN EI; Munzel T, 2014, EUR HEART J, V35, P829, DOI 10.1093/eurheartj/ehu030; Ndrepepa A, 2011, NOISE HEALTH, V13, P251, DOI 10.4103/1463-1741.80163; Pepper CB, 2003, ENVIRON MANAGE, V32, P418, DOI 10.1007/s00267-003-3024-4; SCHULTZ TJ, 1978, J ACOUST SOC AM, V64, P377, DOI 10.1121/1.382013; Sim CS, 2015, YONSEI MED J, V56, P235, DOI 10.3349/ymj.2015.56.1.235; Stansfeld SA, 2003, BRIT MED BULL, V68, P243, DOI 10.1093/bmb/ldg033; Veerappa MPK, 2011, NOISE HEALTH, V13, P16, DOI 10.4103/1463-1741.73996; Wright BA, 2016, NOISE HEALTH, V18, P117, DOI 10.4103/1463-1741.181995; Wu TN, 1995, ARCH ENVIRON HEALTH, V50, P452, DOI 10.1080/00039896.1995.9935982	28	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0169035	10.1371/journal.pone.0169035	http://dx.doi.org/10.1371/journal.pone.0169035			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005976	Green Submitted, Green Published, gold			2022-12-26	WOS:000392843200128
J	El-Ghitany, EM; Farghaly, AG; Farag, S; Abd El-Wahab, EW				El-Ghitany, Engy Mohamed; Farghaly, Azza Galal; Farag, Shehata; Abd El-Wahab, Ekram Wassim			Validation of EGCRISC for Chronic Hepatitis C Infection Screening and Risk Assessment in the Egyptian Population	PLoS One			English	Article							VIRUS-INFECTION; ASSESSMENT TOOL; PRIMARY-CARE	Chronic HCV infection, a highly endemic disease in Egypt, is usually asymptomatic for decades after infection. Prediction questionnaire tool was proofed to be a valuable, feasible and efficient instrument for the screening of several diseases. We previously developed an Egyptian HCV risk screening tool (EGCRISC). This study aims to validate/modify EGCRISC. A cross-sectional study testing 4579 individuals by EGCRISC as well as ELISA/PCR was performed. The sample was a stratified cluster sampling from urban and rural areas in Upper and Lower Egypt using a proportional allocation technique. The degree of agreement and positive and negative posttest probabilities were calculated. ROC curve was done and the cutoff points were customized for best performance. The total score was further classified into three levels according to the risk load. The mean age of the participants was 41.1 +/- 12.2 in whom HCV prevalence was 8.6%. EGCRISC, particularly after modifying the cutoff points, has a good discriminating ability. The degree of agreement was at least 68.1% and the positive posttest probability ranged from 5% to 37.2% whereas the negative posttest probability was in the range 1% to 17%. We conclude that EGCRISC is a valid tool that can potentially screen for HCV infection risk in Egypt and could diminish the demand for mass serologic screening in those apparently at minimal risk. Extensive use of electronic and self-or interviewer-administered risk-based screening strategy may simplify and promote overall screening and detection of HCV dissimilar communities.	[El-Ghitany, Engy Mohamed; Farghaly, Azza Galal; Abd El-Wahab, Ekram Wassim] Univ Alexandria, Trop Hlth Dept, High Inst Publ Hlth, Alexandria, Egypt; [Farag, Shehata] Univ Alexandria, Dept Biostat, High Inst Publ Hlth, Alexandria, Egypt	Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Alexandria University	El-Ghitany, EM (corresponding author), Univ Alexandria, Trop Hlth Dept, High Inst Publ Hlth, Alexandria, Egypt.	ingy.elghitany@gmail.com	El-Wahab, Ekram Abd/V-8831-2017; El-Ghitany, Engy Mohamed/AAH-5599-2019	El-Wahab, Ekram Abd/0000-0003-4220-5859; El-Ghitany, Engy Mohamed/0000-0002-3157-1629	Science and Technology Development Fund (STDF), Egypt [3469]	Science and Technology Development Fund (STDF), Egypt(Science and Technology Development Fund (STDF))	This work was supported financially by the Science and Technology Development Fund (STDF), Egypt; Project No. 3469. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alssema M, 2012, DIABETES CARE, V35, P741, DOI 10.2337/dc11-1417; Arumainayagam J, 2009, INT J STD AIDS, V20, P642, DOI 10.1258/ijsa.2008.008424; Berg AO, 2004, ANN INTERN MED, V140, P462, DOI 10.7326/0003-4819-140-6-200403160-00013; Bialek Stephanie R, 2006, Clin Liver Dis, V10, P697, DOI 10.1016/j.cld.2006.08.003; Boyce Daniel E C, 2009, Hawaii Med J, V68, P113; Dore GJ, 2010, GASTROENTEROLOGY, V138, P123, DOI 10.1053/j.gastro.2009.09.019; Edlin BR, 2005, CLIN INFECT DIS S5, V40; El-Ghitany EM, 2016, J MED VIROL, V88, P1767, DOI 10.1002/jmv.24520; El-Zanaty F, 2015, EGYPT HLTH ISSUE SUR; Gerlach JT, 2003, GASTROENTEROLOGY, V125, P80, DOI 10.1016/S0016-5085(03)00668-1; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Kamal SM, 2006, GASTROENTEROLOGY, V130, P632, DOI 10.1053/j.gastro.2006.01.034; Lapane KL, 1998, AM J GASTROENTEROL, V93, P591, DOI 10.1111/j.1572-0241.1998.170_b.x; Mallette C, 2008, AM J GASTROENTEROL, V103, P131, DOI 10.1111/j.1572-0241.2007.01522.x; McGinn T, 2008, ARCH INTERN MED, V168, P2009, DOI 10.1001/archinte.168.18.2009; Mohamoud YA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-288; National Committee for the Control of Viral Hepatitis, 2008, EG NAT CONTR STRAT V; Nguyen MT, 2005, ARCH INTERN MED, V165, P2013, DOI 10.1001/archinte.165.17.2013; Oh SM, 2016, YONSEI MED J, V57, P187, DOI 10.3349/ymj.2016.57.1.187; Park S, 2014, NEUROPSYCH DIS TREAT, V10, P1837, DOI 10.2147/NDT.S64151; Shehab TM, 2003, AM J GASTROENTEROL, V98, P639, DOI 10.1111/j.1572-0241.2003.07331.x; Vandersmissen GJM, 2015, INT J OCCUP MED ENV, V28, P587, DOI 10.13075/ijomeh.1896.00407; Vickers AJ, 2008, ANN INTERN MED, V149, P200, DOI 10.7326/0003-4819-149-3-200808050-00010; Wand H, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000387; Zuure F, 2010, EUROSURVEILLANCE, V15, P5; Zuure FR, 2013, LIVER INT, V33, P727, DOI 10.1111/liv.12131	26	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168649	10.1371/journal.pone.0168649	http://dx.doi.org/10.1371/journal.pone.0168649			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002458	gold, Green Submitted, Green Published			2022-12-26	WOS:000392853100061
J	Hwang, AW; Trzeciakiewicz, H; Friedmann, D; Yuan, CX; Marmorstein, R; Lee, VMY; Cohen, TJ				Hwang, Andrew W.; Trzeciakiewicz, Hanna; Friedmann, Dave; Yuan, Chao-Xing; Marmorstein, Ronen; Lee, Virginia M. Y.; Cohen, Todd J.			Conserved Lysine Acetylation within the Microtubule-Binding Domain Regulates MAP2/Tau Family Members	PLoS One			English	Article							TAU-PROTEIN; ACETYLTRANSFERASE ACTIVITY; HISTONE ACETYLTRANSFERASE; CATALYTIC MECHANISM; ALZHEIMERS-DISEASE; AUTOACETYLATION; SITES; CELLS; AGGREGATION; PHOSPHORYLATION	Lysine acetylation has emerged as a dominant post-translational modification (PTM) regulating tau proteins in Alzheimer's disease (AD) and related tauopathies. Mass spectrometry studies indicate that tau acetylation sites cluster within the microtubule-binding region (MTBR), a region that is highly conserved among tau, MAP2, and MAP4 family members, implying that acetylation could represent a conserved regulatory mechanism for MAPs beyond tau. Here, we combined mass spectrometry, biochemical assays, and cell-based approaches to demonstrate that the tau family members MAP2 and MAP4 are also subject to reversible acetylation. We identify a cluster of lysines in the MAP2 and MAP4 MTBR that undergo CBP-catalyzed acetylation, many of which are conserved in tau. Similar to tau, MAP2 acetylation can occur in a cysteine-dependent auto-regulatory manner in the presence of acetyl-CoA. Furthermore, tubulin reduced MAP2 acetylation, suggesting tubulin binding dictates MAP acetylation status. Taken together, these results uncover a striking conservation of MAP2/Tau family post-translational modifications that could expand our understanding of the dynamic mechanisms regulating microtubules.	[Hwang, Andrew W.; Lee, Virginia M. Y.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA; [Trzeciakiewicz, Hanna] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA; [Friedmann, Dave; Marmorstein, Ronen] Univ Penn, Dept Biochem & Biophys, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Yuan, Chao-Xing] Alexion Pharmaceut Inc, New Haven, CT USA; [Cohen, Todd J.] Univ N Carolina, Dept Neurol, UNC Neurosci Ctr, Chapel Hill, NC 27514 USA	University of Pennsylvania; Pennsylvania Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania; Pennsylvania Medicine; University of North Carolina; University of North Carolina Chapel Hill	Cohen, TJ (corresponding author), Univ N Carolina, Dept Neurol, UNC Neurosci Ctr, Chapel Hill, NC 27514 USA.	toddcohen@neurology.unc.edu	, Proteomics Core UNC/AAH-3777-2022; , Proteomics Core UNC/AFQ-7201-2022		Alzheimer's Association [NIRG-14-321219]; National Center for Advancing Translational Sciences [UL1TR001111]; National Institute of General Medical Sciences [R01GM060293]; National Institute on Aging [P01AG031862, AG17586]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Alzheimer's Association (NIRG-14-321219), the National Center for Advancing Translational Sciences (UL1TR001111), the National Institute of General Medical Sciences (R01GM060293), and the National Institute on Aging (P01AG031862, AG17586). One of the authors (CXY) has a commercial affiliation with Alexion Pharmaceuticals Inc. The funder provided support in the form of salaries for CXY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. None of the other funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; BURGIN KE, 1994, MOL BIOL CELL, V5, P511, DOI 10.1091/mbc.5.5.511; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cohen TJ, 2013, NAT STRUCT MOL BIOL, V20, P756, DOI 10.1038/nsmb.2555; Cohen TJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1255; Cook C, 2014, HUM MOL GENET, V23, P104, DOI 10.1093/hmg/ddt402; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Dehmelt L, 2005, GENOME BIOL, V6; DUPRET JM, 1992, J BIOL CHEM, V267, P7381; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Illenberger S, 1996, J BIOL CHEM, V271, P10834, DOI 10.1074/jbc.271.18.10834; Irwin DJ, 2013, AM J PATHOL, V183, P344, DOI 10.1016/j.ajpath.2013.04.025; Irwin DJ, 2012, BRAIN, V135, P807, DOI 10.1093/brain/aws013; Jiang HB, 2006, NEUROBIOL DIS, V23, P543, DOI 10.1016/j.nbd.2006.04.011; Kadavath H, 2015, P NATL ACAD SCI USA, V112, P7501, DOI 10.1073/pnas.1504081112; Kamah A, 2014, BIOCHEMISTRY-US, V53, P3020, DOI 10.1021/bi500006v; Karabulut NP, 2015, J STRUCT BIOL, V191, P39, DOI 10.1016/j.jsb.2015.06.001; Karanam B, 2006, J BIOL CHEM, V281, P40292, DOI 10.1074/jbc.M608813200; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Li WK, 2006, BIOCHEMISTRY-US, V45, P15692, DOI 10.1021/bi061422+; Lu L, 2011, CELL RES, V21, P1182, DOI 10.1038/cr.2011.71; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Mohan R, 2015, IUBMB LIFE, V67, P395, DOI 10.1002/iub.1384; Morris M, 2015, NAT NEUROSCI, V18, P1183, DOI 10.1038/nn.4067; Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Olia AS, 2015, ACS CHEM BIOL, V10, P2034, DOI 10.1021/acschembio.5b00342; OLSON KR, 1995, J CELL BIOL, V130, P639, DOI 10.1083/jcb.130.3.639; Rizzu P, 1999, AM J HUM GENET, V64, P414, DOI 10.1086/302256; Tracy TE, 2016, NEURON, V90, P245, DOI 10.1016/j.neuron.2016.03.005; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; Vogelsberg-Ragaglia V, 2000, MOL BIOL CELL, V11, P4093, DOI 10.1091/mbc.11.12.4093; Wang JD, 2010, J BIOL CHEM, V285, P11458, DOI 10.1074/jbc.M109.087585; Yan Y, 2002, NAT STRUCT BIOL, V9, P862, DOI 10.1038/nsb849; Yang C, 2012, J BIOL CHEM, V287, P34917, DOI 10.1074/jbc.M112.359356; Yang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032886; Yuan H, 2012, EMBO J, V31, P58, DOI 10.1038/emboj.2011.382; Zhu XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep19926	43	11	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168913	10.1371/journal.pone.0168913	http://dx.doi.org/10.1371/journal.pone.0168913			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002468	Green Submitted, gold, Green Published			2022-12-26	WOS:000392853100076
J	Kutal, M; Vana, M; Suchomel, J; Chapron, G; Lopez-Bao, JV				Kutal, Miroslav; Vana, Martin; Suchomel, Josef; Chapron, Guillaume; Vicente Lopez-Bao, Jose			Trans-Boundary Edge Effects in the Western Carpathians: The Influence of Hunting on Large Carnivore Occupancy	PLOS ONE			English	Article							WOLVES CANIS-LUPUS; SOURCE-SINK DYNAMICS; POPULATION-DYNAMICS; LYNX OCCURRENCE; WOLF; RANGE; CONSERVATION; DISPERSAL; MOUNTAINS; DENSITY	The conservation and management of wolves Canis lupus in the periphery of their distribution is challenging. Edges of wolf distribution are characterized by very few and intermittent occurrences of individuals, which are modulated by multiple factors affecting the overall population such as human-caused mortality, management targets and food availability. The knowledge of population dynamics in the edges becomes crucial when hunting takes place nearby the edges, which may preclude population expansion. Here, using as example the occurrence of wolves in the Beskydy Mountains (Czech-Slovak border), which are the edge distribution of the wolf and Eurasian lynx Lynx/ynxpopulations in the West Carpathians, we explored how food availability and hunting in the Slovakian core area affected the dynamics of wolves in the edges of this population. During 2003-2012, we monitored large carnivore occurrence by snow-tracking surveys and tested potential differences in the occurrence of these species in Beskydy Mountains and potential mechanisms behind detected patterns. Despite the proximity to the core area, with several wolf reproductions being confirmed at least in recent years, the wolf was a very rare species in Beskydy and was recorded 14 times less often than the lynx. The expected abundance of wolves in the Beskydy Mountains was inversely related to prey availability in the Slovakian core area. Wolf hunting the year before influenced the expected abundance of wolves in Beskydy area. We discuss how different life histories and legal status of both species probably account for most of the observed difference of occurrence at range margins.	[Kutal, Miroslav] Mendel Univ Brno, Fac Forestry & Wood Technol, Dept Forest Ecol, Brno, Czech Republic; [Kutal, Miroslav; Vana, Martin] Friends Earth Czech Republ, Olomouc Branch, Olomouc, Czech Republic; [Suchomel, Josef] Mendel Univ Brno, Fac Agron, Dept Zool Fisheries & Apiculture, Brno, Czech Republic; [Chapron, Guillaume] Swedish Univ Agr Sci SLU, Dept Ecol, Riddarhyttan, Sweden; [Vicente Lopez-Bao, Jose] Univ Oviedo, Res Unit Biodivers UO CSIC PA, Mieres, Spain	Mendel University in Brno; Mendel University in Brno; Swedish University of Agricultural Sciences; Consejo Superior de Investigaciones Cientificas (CSIC); University of Oviedo	Kutal, M (corresponding author), Mendel Univ Brno, Fac Forestry & Wood Technol, Dept Forest Ecol, Brno, Czech Republic.; Kutal, M (corresponding author), Friends Earth Czech Republ, Olomouc Branch, Olomouc, Czech Republic.	miroslav.kutal@hnutiduha.cz	VICENTE, LIERN/B-6112-2008; Suchomel, Josef/B-9609-2014; Kutal, Miroslav/B-9612-2014	VICENTE, LIERN/0000-0001-5883-9640; Suchomel, Josef/0000-0002-6455-135X; Kutal, Miroslav/0000-0003-3857-5419; Lopez-Bao, Jose Vicente/0000-0001-9213-998X	EuroNatur Foundation [CZ-14-470-1]; Swiss - Czech Cooperation Programme [67-BG-030]; Financial Mechanisms of EEA and Norway [333147]; Ministry of the Environment of the Czech Republic [102/7, 244/09/34]; European Outdoor Conservation Association; International Visegrad Fund [21110037]; Mendel University Brno [18/2013]; Spanish Ministry of Economy and Competitiveness [JCI-2012-13066]; Swedish Environmental Protection Agency	EuroNatur Foundation; Swiss - Czech Cooperation Programme; Financial Mechanisms of EEA and Norway; Ministry of the Environment of the Czech Republic; European Outdoor Conservation Association; International Visegrad Fund; Mendel University Brno; Spanish Ministry of Economy and Competitiveness(Spanish Government); Swedish Environmental Protection Agency	This work was supported by the EuroNatur Foundation (CZ-14-470-1: http://euronatur.org/) to MK, the Swiss - Czech Cooperation Programme (67-BG-030: http://www.swiss-contribution.cz/) to MK, the Financial Mechanisms of EEA and Norway (333147: http://eeagrants.cz/) to MK, the Ministry of the Environment of the Czech Republic (102/7 and 244/09/34: http://www.mzp.cz) to MK, the European Outdoor Conservation Association (http://www.outdoorconservation.eu/) to MK, the International Visegrad Fund (21110037: http://visegradfund.org/) to MK, an internal grant (18/2013) of the Mendel University Brno (http://www.mendelu.cz.) to MK, the Spanish Ministry of Economy and Competitiveness: (JCI-2012-13066: www.mineco.gob.es) to JVLB, and the Swedish Environmental Protection Agency (http://www.swedishepa.se/) to GC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LG, 2008, WILDLIFE MONOGR, P1, DOI 10.2193/2008-012; Aikova M, 2016, PROGRAM STAROSTLIVOS; Andera Milos, 2004, Lynx (Prague), P5; Andersen LW, 2015, MAMMAL RES; Andreasen AM, 2012, MOL ECOL, V21, P5689, DOI 10.1111/j.1365-294X.2012.05740.x; [Anonymous], 2021, LANG ENV STAT COMP; Bartosova D, 1998, VERONICA, V12, P1; Boyd DK, 1999, J WILDLIFE MANAGE, V63, P1094, DOI 10.2307/3802828; Brainerd SM, 2008, J WILDLIFE MANAGE, V72, P89, DOI 10.2193/2006-305; Bridle JR, 2007, TRENDS ECOL EVOL, V22, P140, DOI 10.1016/j.tree.2006.11.002; Burbaite Lina, 2010, Acta Zoologica Lituanica, V20, P179, DOI 10.2478/v10043-010-0038-z; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carroll C, 2007, CONSERV BIOL, V21, P1092, DOI 10.1111/j.1523-1739.2007.00719.x; Cerveny Jaroslav, 2002, Acta Zoologica Lituanica, V12, P428; Chapron G, 2003, CR BIOL, V326, P575, DOI 10.1016/S1631-0691(03)00148-3; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Ciucci P, 2009, J WILDLIFE MANAGE, V73, P1300, DOI 10.2193/2008-510; Delibes M, 2001, AM NAT, V158, P277, DOI 10.1086/321319; Epstein Y., 2013, GEO INT ENV L, V25, P589; Epstein Y, 2016, CONSERV LETT, V9, P81, DOI 10.1111/conl.12200; European Commission, 2016, SPEC REP CAN IUP; Find'o S, 2008, PERSPECTIVES OF WOLVES IN CENTRAL EUROPE, P15; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Fritts SH, 1981, WILDLIFE MONOGR, V80, P3; Hell P, 1974, TROFEJOVE SELMY SLOV; Hell P, 2003, VLKY RYSI OBLASTI SL, P5; Hell Pavel, 1996, Acta Scientiarum Naturalium Academiae Scientiarum Bohemicae Brno, V30, P64; Herfindal I, 2005, J ZOOL, V265, P63, DOI 10.1017/S0952836904006053; Hurford A, 2006, THEOR POPUL BIOL, V70, P244, DOI 10.1016/j.tpb.2006.06.009; Iliopoulos Y, 2014, EUR J WILDLIFE RES, V60, P23, DOI 10.1007/s10344-013-0746-3; Jedrzejewski W, 2005, ACTA THERIOL, V50, P417, DOI 10.1007/BF03192636; Jedrzejewski W, 2004, DIVERS DISTRIB, V10, P225, DOI 10.1111/j.1366-9516.2004.00073.x; Kaczensky P, 2009, MONITORING LARGE CAR; Knauer F, 2010, WILDLIFE BIOL, V16, P56, DOI 10.2981/07-040; Kovarik P, 2014, J NAT CONSERV, V22, P479, DOI 10.1016/j.jnc.2014.06.001; KRATOCHVIL J, 1968, Prirodovedne Prace Ustavu Ceskoslovenske Akademie Ved v Brne, V2, P35; Krofel M, 2015, SCIENCE, V350, P518, DOI 10.1126/science.350.6260.518-a; Kunc Ludvik, 1996, Acta Scientiarum Naturalium Academiae Scientiarum Bohemicae Brno, V30, P58; Kutal M, 2015, MONITORING STATUS CA, P52; Kutal M, 2014, VELKE SELMY MORAVE S, P108; Kutal M, 2013, ACTA MUSEI BESKIDENS, V5, P121; Kutal M, 2008, PERSPECTIVES OF WOLVES IN CENTRAL EUROPE, P10; Liberg O, 2012, P ROY SOC B-BIOL SCI, V279, P910, DOI 10.1098/rspb.2011.1275; Linnell JD, 2008, GUIDELINES POPULATIO; Linnell JDC, 2012, HYSTRIX, V23, P80, DOI 10.4404/hystrix-23.1-4676; Llaneza L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093015; Llaneza L, 2012, DIVERS DISTRIB, V18, P459, DOI 10.1111/j.1472-4642.2011.00869.x; Lopez-Bao JV, 2013, CONSERV LETT, V6, P448, DOI 10.1111/conl.12014; Marucco F, 2009, J APPL ECOL, V46, P1003, DOI 10.1111/j.1365-2664.2009.01696.x; Mech L. David, 2003, P1; Melis C, 2006, J BIOGEOGR, V33, P803, DOI 10.1111/j.1365-2699.2006.01434.x; Melis C, 2009, GLOBAL ECOL BIOGEOGR, V18, P724, DOI 10.1111/j.1466-8238.2009.00480.x; MESSIER F, 1985, CAN J ZOOL, V63, P239, DOI 10.1139/z85-037; Molinari-Jobin A., 2006, Acta Biologica Slovenica, V49, P3; Navarro LM, 2012, ECOSYSTEMS, V15, P900, DOI 10.1007/s10021-012-9558-7; Niedzialkowska M, 2006, BIOL CONSERV, V133, P63, DOI 10.1016/j.biocon.2006.05.022; Novaro AJ, 2005, J APPL ECOL, V42, P910, DOI 10.1111/j.1365-2664.2005.01067.x; Nowak S, 2008, FOLIA ZOOL, V57, P392; Nowak S, 2007, J ETHOL, V25, P231, DOI 10.1007/s10164-006-0015-y; Nowak S, 2016, MAMMAL RES, V61, P83, DOI 10.1007/s13364-016-0263-3; PETERSON RO, 1988, J MAMMAL, V69, P89, DOI 10.2307/1381751; Plhal R., 2012, Acta Universitatis Agriculturae et Silviculturae Mendelianae Brunensis, V60, P165; Post E, 2002, NATURE, V420, P168, DOI 10.1038/nature01064; Putman R.J., 2011, UNGULATE MANAGEMENT; RAY C, 1991, BIOL J LINN SOC, V42, P123, DOI 10.1111/j.1095-8312.1991.tb00555.x; Rigg R, 2014, REPORT DG ENV; Robinson HS, 2008, ECOL APPL, V18, P1028, DOI 10.1890/07-0352.1; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Salvatori V, 2002, WILDLIFE BIOL, V8, P3, DOI 10.2981/wlb.2002.002; Schmidt K, 1998, ACTA THERIOL, V43, P391, DOI 10.4098/AT.arch.98-50; Selier SA Jeanetta, 2016, J INT WILDL LAW POLI, V19, P101, DOI DOI 10.1080/13880292.2016.1167460; Taggart-Hodge TD, 2016, ECOL SOC, V21, DOI 10.5751/ES-08669-210429; Lopez-Bao JV, 2015, BIODIVERS CONSERV, V24, P2105, DOI 10.1007/s10531-015-0914-8; Voskar J, 1976, LYNX PRAHA, V18, P99; Wabakken P, 2001, CAN J ZOOL, V79, P710, DOI 10.1139/cjz-79-4-710; Wabakken P, 2007, J WILDLIFE MANAGE, V71, P1631, DOI 10.2193/2006-222; Webb NF, 2011, CAN J ZOOL, V89, P744, DOI [10.1139/Z11-043, 10.1139/z11-043]; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126	78	9	9	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168292	10.1371/journal.pone.0168292	http://dx.doi.org/10.1371/journal.pone.0168292			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002475	Green Published, Green Submitted, gold			2022-12-26	WOS:000392853100038
J	Villar, I; Alves, D; Mato, S				Villar, Iria; Alves, David; Mato, Salustiano			Seafood-Processing Sludge Composting: Changes to Microbial Communities and Physico-Chemical Parameters of Static Treatment versus for Turning during the Maturation Stage	PLoS One			English	Article							SEWAGE-SLUDGE; BACTERIAL COMMUNITIES; ORGANIC WASTES; FOOD WASTE; SOIL; NITROGEN; FATS; BIODEGRADATION; SUCCESSION; STABILITY	In general, in composting facilities the active, or intensive, stage of the process is done separately from the maturation stage, using a specific technology and time. The pre-composted material to be matured can contain enough biodegradable substrates to cause microbial proliferation, which in turn can cause temperatures to increase. Therefore, not controlling the maturation period during waste management at an industrial level can result in undesired outcomes. The main hypothesis of this study is that controlling the maturation stage through turning provides one with an optimized process when compared to the static approach. The waste used was sludge from a seafood-processing plant, mixed with shredded wood (1:2, v/v). The composting system consists of an intensive stage in a 600L static reactor, followed by maturation in triplicate in 200L boxes for 112 days. Two tests were carried out with the same process in reactor and different treatments in boxes: static maturation and turning during maturation when the temperature went above 55 degrees C. PLFAs, organic matter, pH, electrical conductivity, forms of nitrogen and carbon, hydrolytic enzymes and respiratory activity were periodically measured. Turning significantly increased the duration of the thermophilic phase and consequently increased the organic-matter degradation. PCA differentiated significantly the two treatments in function of tracking parameters, especially pH, total carbon, forms of nitrogen and C/N ratio. So, stability and maturity optimum values for compost were achieved in less time with turnings. Whereas turning resulted in microbial group stabilization and a low mono/sat ratio, static treatment produced greater variability in microbial groups and a high mono/sat ratio, the presence of more degradable substrates causes changes in microbial communities and their study during maturation gives an approach of the state of organic-matter degradation. Obtaining quality compost and optimizing the composting process requires using turning as a control mechanism during maturation.	[Villar, Iria; Alves, David; Mato, Salustiano] Univ Vigo, Dept Ecol & Anim Biol, Vigo, Pontevedra, Spain	Universidade de Vigo	Villar, I (corresponding author), Univ Vigo, Dept Ecol & Anim Biol, Vigo, Pontevedra, Spain.	iriavillar@uvigo.es	Mato, Salustiano/AAD-4640-2022; Villar, Iria/F-7693-2019	Villar, Iria/0000-0001-6311-6295	Xunta de Galicia [09MDS024310PR]	Xunta de Galicia(Xunta de GaliciaEuropean Commission)	This work was supported by Xunta de Galicia, 09MDS024310PR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir S, 2010, INT BIODETER BIODEGR, V64, P614, DOI 10.1016/j.ibiod.2010.01.012; [Anonymous], 1998, FEMS MICROBIOL ECOL, V27, P9; Alburquerque JA, 2009, BIODEGRADATION, V20, P257, DOI 10.1007/s10532-008-9218-y; APHA A.W., 2012, STAND METH EX WAT WA; Bastida F, 2008, APPL SOIL ECOL, V40, P318, DOI 10.1016/j.apsoil.2008.05.007; Bernal MP, 1998, BIORESOURCE TECHNOL, V63, P91, DOI 10.1016/S0960-8524(97)00084-9; Bossio DA, 1998, MICROBIAL ECOL, V35, P265, DOI 10.1007/s002489900082; Boulter-Bitzer JI, 2006, APPL SOIL ECOL, V34, P65, DOI 10.1016/j.apsoil.2005.12.007; Brito LM, 2008, BIORESOURCE TECHNOL, V99, P8955, DOI 10.1016/j.biortech.2008.05.005; CABRERA ML, 1993, SOIL SCI SOC AM J, V57, P1007, DOI 10.2136/sssaj1993.03615995005700040021x; Cahyani VR, 2003, SOIL SCI PLANT NUTR, V49, P619, DOI 10.1080/00380768.2003.10410052; Choi MH, 1998, LETT APPL MICROBIOL, V26, P175, DOI 10.1046/j.1472-765X.1998.00307.x; Cook KL, 2015, WASTE MANAG; Danon M, 2008, FEMS MICROBIOL ECOL, V65, P133, DOI 10.1111/j.1574-6941.2008.00506.x; Diaz L.F., 2002, HDB SOLID WASTE MANA, V2nd; EIVAZI F, 1977, SOIL BIOL BIOCHEM, V9, P167, DOI 10.1016/0038-0717(77)90070-0; EIVAZI F, 1988, SOIL BIOL BIOCHEM, V20, P601, DOI 10.1016/0038-0717(88)90141-1; Elouaqoudi FZ, 2015, INT BIODETER BIODEGR, V97, P75, DOI 10.1016/j.ibiod.2014.08.016; European Commission, 2001, WORK DOC BIOL TREATM; FERNANDES F, 1988, BIOL WASTE, V26, P33, DOI 10.1016/0269-7483(88)90147-4; Garcia-Morales JL, 2015, RESIDUOS AGROALIMENT; Gea T, 2007, BIOCHEM ENG J, V33, P275, DOI 10.1016/j.bej.2006.11.007; Getahun T, 2012, RESOUR CONSERV RECY, V65, P79, DOI 10.1016/j.resconrec.2012.05.007; Gomez-Brandon M, 2010, BIORESOURCE TECHNOL, V101, P1348, DOI 10.1016/j.biortech.2009.09.047; Green SJ, 2004, FEMS MICROBIOL LETT, V233, P115, DOI 10.1016/j.femsle.2004.01.049; Haug T.R., 1993, PRACTICAL HDB COMPOS; Iannotti D. A., 1993, Compost Science and Utilization, V1, P52; Insam H, 2007, WASTE MANAG SER, V8, P25; Jindo K, 2012, SCI TOTAL ENVIRON, V416, P476, DOI 10.1016/j.scitotenv.2011.12.009; Kassambara A., 2015, TACTOEXTRA VISUALIZA; LADD J N, 1972, Soil Biology and Biochemistry, V4, P19, DOI 10.1016/0038-0717(72)90038-7; Lin CSK, 2013, ENERG ENVIRON SCI, V6, P426, DOI 10.1039/c2ee23440h; MCKINLEY VL, 1985, APPL ENVIRON MICROB, V50, P1395, DOI 10.1128/AEM.50.6.1395-1403.1985; Nikaeen M, 2015, WASTE MANAGE, V39, P104, DOI 10.1016/j.wasman.2015.01.028; Ogunwande GA, 2008, BIORESOURCE TECHNOL, V99, P7495, DOI 10.1016/j.biortech.2008.02.020; Pinheiro J, 2015, NLME LINEAR NONLINEA; R Foundation for Statistical Computing, 2014, R LANG ENV STAT COMP; Ruggieri L, 2008, INT BIODETER BIODEGR, V62, P297, DOI 10.1016/j.ibiod.2008.02.004; Ryckeboer J, 2003, ANN MICROBIOL, V53, P349; Rynk R, 2000, BIOCYCLE, V41, P54; SIMS GK, 1995, COMMUN SOIL SCI PLAN, V26, P303, DOI 10.1080/00103629509369298; Sundberg C, 2004, BIORESOURCE TECHNOL, V95, P145, DOI 10.1016/j.biortech.2004.01.016; Tiquia SM, 1997, BIORESOURCE TECHNOL, V62, P37, DOI 10.1016/S0960-8524(97)00080-1; *TMECC, 2002, TEST METH EX COMP CO; Tuomela M, 2000, BIORESOURCE TECHNOL, V72, P169, DOI 10.1016/S0960-8524(99)00104-2; Vargas-Garcia MC, 2010, WASTE MANAGE, V30, P771, DOI 10.1016/j.wasman.2009.12.019; Villar I, 2016, WASTE MANAGE, V54, P83, DOI 10.1016/j.wasman.2016.05.011; Wong JWC, 2001, BIORESOURCE TECHNOL, V76, P99, DOI 10.1016/S0960-8524(00)00103-6; Zelles L, 1999, BIOL FERT SOILS, V29, P111, DOI 10.1007/s003740050533; Zucconi F., 1985, Composting of agricultural and other wastes, P73; ZUCCONI F, 1981, BIOCYCLE, V22, P54	51	6	7	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168590	10.1371/journal.pone.0168590	http://dx.doi.org/10.1371/journal.pone.0168590			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002444	Green Submitted, gold, Green Published			2022-12-26	WOS:000392853100056
J	Sun, Y; Ke, HZ; Han, MY; Chen, N; Fang, WH; Yoo, D				Sun, Yan; Ke, Hanzhong; Han, Mingyuan; Chen, Ning; Fang, Weihuan; Yoo, Dongwan			Nonstructural Protein 11 of Porcine Reproductive and Respiratory Syndrome Virus Suppresses Both MAVS and RIG-I Expression as One of the Mechanisms to Antagonize Type I Interferon Production	PLOS ONE			English	Article							MOUSE HEPATITIS-VIRUS; NS1 PROTEIN; ANTIVIRAL RESPONSES; CRYSTAL-STRUCTURE; SARS-CORONAVIRUS; RNA-BINDING; ENDORIBONUCLEASE; INHIBITION; INDUCTION; VIVO	Type I interferons (IFN-alpha/beta) play a key role in antiviral defense, and porcine reproductive and respiratory syndrome virus (PRRSV) is known to down-regulate the IFN response in virus-infected cells and pigs. In this study, we showed that the overexpression of nsp11 of PRRSV induced a strong suppression of IFN production. Nsp11 suppressed both IRF3 and NF-KB activities when stimulated with a dsRNA analogue and TNF-alpha, respectively. This suppression was RLR dependent, since the transcripts and proteins of MAVS and RIG-I, two critical factors in RLR-mediated pathway, were both found to be reduced in the presence of overexpressed nsp11. Since nsp11 is an endoribonuclease (EndoU), the structure function relationship was examined using a series of nsp11 EndoU mutant plasmids. The mutants that impaired the EndoU activity failed to suppress IFN and led to the normal expression of MAVS. Seven single amino acid substitutions (4 in subdomain A and 3 in subdomain B) plus one insertion (frame-shift in nsp11) were then introduced into PRRSV infectious cDNA clones to generate nsp11 mutant viruses. Unfortunately, all EndoU knock-out nsp11 mutant viruses appeared replication-defective and no progenies were produced. Three mutations in EndoU subdomain A expressed the N and nsp2/3 proteins but their infectivity diminished after 2 passages. Taken together, our data show that PRRSV nsp11 endoribonuclease activity is critical for both viral replication and IFN antagonism. More importantly, the endoribonuclease activity of nsp11 demonstrates the substrate specificity towards MAVS and RIG-I (transcripts and proteins) over p65 and IRF3 in the context of gene transfection and overexpression. This is likely a mechanism of nsp11 suppression of type I IFN production.	[Sun, Yan; Ke, Hanzhong; Han, Mingyuan; Chen, Ning; Yoo, Dongwan] Univ Illinois, Dept Pathobiol, Urbana, IL 61801 USA; [Fang, Weihuan] Zhejiang Univ, Inst Prevent Vet Med, Hangzhou, Zhejiang, Peoples R China; [Sun, Yan] Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA; [Han, Mingyuan] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Han, Mingyuan] Univ Michigan, Dept Communicable Dis, Ann Arbor, MI 48109 USA; [Chen, Ning] BI Vet R&D Ctr, Shanghai, Peoples R China	University of Illinois System; University of Illinois Urbana-Champaign; Zhejiang University; University of Pennsylvania; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Yoo, D (corresponding author), Univ Illinois, Dept Pathobiol, Urbana, IL 61801 USA.	dyoo@illinois.edu	Yoo, Dongwan/AAG-8884-2021; Han, Mingyuan/O-5065-2019	Yoo, Dongwan/0000-0002-6730-9729; Han, Mingyuan/0000-0002-2970-6715; Ke, Hanzhong/0000-0001-8148-2897	Agriculture and Food Research Initiative (AFRI) Competitive Grants of US Department of Agriculture NIFA (National Institute of Food and Agriculture) [2008-35204-04634, 2013-67015-21243]	Agriculture and Food Research Initiative (AFRI) Competitive Grants of US Department of Agriculture NIFA (National Institute of Food and Agriculture)	This project was supported by funding to DY by the Agriculture and Food Research Initiative (AFRI) Competitive Grants (no. 2008-35204-04634 and no. 2013-67015-21243) of US Department of Agriculture NIFA (National Institute of Food and Agriculture). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENFIELD DA, 1992, J VET DIAGN INVEST, V4, P127, DOI 10.1177/104063879200400202; Beura LK, 2010, J VIROL, V84, P1574, DOI 10.1128/JVI.01326-09; Bhardwaj K, 2004, J VIROL, V78, P12218, DOI 10.1128/JVI.78.22.12218-12224.2004; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Buddaert W, 1998, ADV EXP MED BIOL, V440, P461; Cao JZ, 2012, VIRUS RES, V167, P247, DOI 10.1016/j.virusres.2012.05.006; De Clercq E, 2006, J INFECT DIS, V194, pS19, DOI 10.1086/505351; Fang Y, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-83; Feng PH, 2001, J VIROL, V75, P10272, DOI 10.1128/JVI.75.21.10272-10280.2001; Firth AE, 2011, J GEN VIROL, V92, P1097, DOI 10.1099/vir.0.029264-0; Frieman M, 2009, J VIROL, V83, P6689, DOI 10.1128/JVI.02220-08; Garcia-Sastre A, 2004, CURR TOP MICROBIOL, V283, P249; Genini S, 2008, J GEN VIROL, V89, P2550, DOI 10.1099/vir.0.2008/003244-0; Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017; Haller O, 2007, CURR TOP MICROBIOL, V316, P315; Huang C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002433; Ivanov KA, 2004, P NATL ACAD SCI USA, V101, P12694, DOI 10.1073/pnas.0403127101; Jacobs BL, 1998, METHODS, V15, P225, DOI 10.1006/meth.1998.0626; Johnson CR, 2011, J GEN VIROL, V92, P1107, DOI 10.1099/vir.0.030213-0; Joseph JS, 2007, J VIROL, V81, P6700, DOI 10.1128/JVI.02817-06; Kang H, 2007, J VIROL, V81, P13587, DOI 10.1128/JVI.00547-07; Keffaber K., 1989, AM ASS SWINE PRACT N, V1, P1; KIM HS, 1993, ARCH VIROL, V133, P477, DOI 10.1007/BF01313785; Kim O, 2010, VIROLOGY, V402, P315, DOI 10.1016/j.virol.2010.03.039; Laneve P, 2003, J BIOL CHEM, V278, P13026, DOI 10.1074/jbc.M211937200; Langland JO, 2006, VIRUS RES, V119, P100, DOI 10.1016/j.virusres.2005.10.014; Lee SM, 2004, VET IMMUNOL IMMUNOP, V102, P217, DOI 10.1016/j.vetimm.2004.09.009; Li SD, 2006, VIROLOGY, V349, P13, DOI 10.1016/j.virol.2006.01.005; Magkouras I, 2008, J GEN VIROL, V89, P2501, DOI 10.1099/vir.0.2008/003749-0; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Nedialkova DD, 2009, J VIROL, V83, P5671, DOI 10.1128/JVI.00261-09; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Posthuma CC, 2006, J VIROL, V80, P1653, DOI 10.1128/JVI.80.4.1653-1661.2006; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rascon-Castelo E, 2015, VIRUSES-BASEL, V7, P873, DOI 10.3390/v7030873; Ricagno S, 2006, P NATL ACAD SCI USA, V103, P11892, DOI 10.1073/pnas.0601708103; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saffran HA, 2010, J VIROL, V84, P6041, DOI 10.1128/JVI.01819-09; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Shi XB, 2011, MOL IMMUNOL, V48, P1568, DOI 10.1016/j.molimm.2011.03.004; Shi YJ, 2016, J VIROL, V90, P4579, DOI 10.1128/JVI.03065-15; Siu KL, 2009, J BIOL CHEM, V284, P16202, DOI 10.1074/jbc.M109.008227; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Solorzano A, 2005, J VIROL, V79, P7535, DOI 10.1128/JVI.79.12.7535-7543.2005; Song C, 2010, VIROLOGY, V407, P268, DOI 10.1016/j.virol.2010.08.025; Sun Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/430508; Sun Y, 2012, VIRUSES-BASEL, V4, P424, DOI 10.3390/v4040424; Sun Z, 2012, J VIROL, V86, P3839, DOI 10.1128/JVI.06466-11; Truong HM, 2004, VIROLOGY, V325, P308, DOI 10.1016/j.virol.2004.04.046; van Aken D, 2006, J GEN VIROL, V87, P3473, DOI 10.1099/vir.0.82269-0; Wathelet MG, 2007, J VIROL, V81, P11620, DOI 10.1128/JVI.00702-07; Weber F, 2007, BIOCHIMIE, V89, P836, DOI 10.1016/j.biochi.2007.01.005; Welsch C, 2015, J HEPATOL, V62, P779, DOI 10.1016/j.jhep.2014.11.009; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G; Xu AT, 2010, BIOTECHNOL LETT, V32, P1905, DOI 10.1007/s10529-010-0370-1; Xu XL, 2006, J VIROL, V80, P7909, DOI 10.1128/JVI.00525-06; Yoo D, 2010, VIRUS RES, V154, P48, DOI 10.1016/j.virusres.2010.07.019; Zhou HX, 2007, J VIROL, V81, P568, DOI 10.1128/JVI.01512-06	59	38	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168314	10.1371/journal.pone.0168314	http://dx.doi.org/10.1371/journal.pone.0168314			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997564	Green Published, gold, Green Submitted			2022-12-26	WOS:000392842900032
J	Chaphalkar, AR; Jain, K; Gangan, MS; Athale, CA				Chaphalkar, Anushree R.; Jain, Kunalika; Gangan, Manasi S.; Athale, Chaitanya A.			Automated Multi-Peak Tracking Kymography (AMTraK): A Tool to Quantify Sub-Cellular Dynamics with Sub-Pixel Accuracy	PLoS One			English	Article							EXCESS MEMBRANE RESERVOIR; TUG-OF-WAR; ESCHERICHIA-COLI; QUANTITATIVE-ANALYSIS; SUPPORTED BILAYERS; VESICLE TRANSPORT; MOTILITY ASSAYS; EDGE-DETECTION; KINESIN; FILAMENTS	Kymographs or space-time plots are widely used in cell biology to reduce the dimensions of a time-series in microscopy for both qualitative and quantitative insight into spatio-temporal dynamics. While multiple tools for image kymography have been described before, quantification remains largely manual. Here, we describe a novel software tool for automated multi-peak tracking kymography (AMTraK), which uses peak information and distance minimization to track and automatically quantify kymographs, integrated in a GUI. The program takes fluorescence time-series data as an input and tracks contours in the kymographs based on intensity and gradient peaks. By integrating a branch-point detection method, it can be used to identify merging and splitting events of tracks, important in separation and coalescence events. In tests with synthetic images, we demonstrate sub-pixel positional accuracy of the program. We test the program by quantifying sub-cellular dynamics in rod-shaped bacteria, microtubule (MT) transport and vesicle dynamics. A time-series of E. coli cell division with labeled nucleoid DNA is used to identify the time-point and rate at which the nucleoid segregates. The mean velocity of microtubule (MT) gliding motility due to a recombinant kinesin motor is estimated as 0.5 mu m/s, in agreement with published values, and comparable to estimates using software for nanometer precision filament-tracking. We proceed to employ AMTraK to analyze previously published time-series microscopy data where kymographs had been manually quantified: clathrin polymerization kinetics during vesicle formation and anterograde and retrograde transport in axons. AMTraK analysis not only reproduces the reported parameters, it also provides an objective and automated method for reproducible analysis of kymographs from in vitro and in vivo fluorescence microscopy time-series of sub-cellular dynamics.	[Chaphalkar, Anushree R.; Jain, Kunalika; Gangan, Manasi S.; Athale, Chaitanya A.] IISER Pune, Div Biol, Pune, Maharashtra, India	Indian Institute of Science Education & Research (IISER) Pune	Athale, CA (corresponding author), IISER Pune, Div Biol, Pune, Maharashtra, India.	cathale@iiserpune.ac.in	; Athale, Chaitanya A./G-8883-2011	Jain, Kunalika/0000-0002-4555-4627; Athale, Chaitanya A./0000-0002-9506-2153	Department of Biotechnology (DBT), Govt. of India [BT/PR1595/BRB/10/1043/2012]; University Grants Commission [F.2-14/2011 (SA-1)]; Department of Science and Technology, Ministry of Science and Technology [INSPIRE IF130394]; Indian Council of Medical Research [3/13/WLC/JRF-2011/HRD-156 (51550)]	Department of Biotechnology (DBT), Govt. of India(Department of Biotechnology (DBT) India); University Grants Commission(University Grants Commission, India); Department of Science and Technology, Ministry of Science and Technology; Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This research was supported by The Department of Biotechnology (DBT), Govt. of India (BT/PR1595/BRB/10/1043/2012), University Grants Commission (F.2-14/2011 (SA-1)), Department of Science and Technology, Ministry of Science and Technology (INSPIRE IF130394), and Indian Council of Medical Research (3/13/WLC/JRF-2011/HRD-156 (51550)).	ALLAN VJ, 1991, J CELL BIOL, V113, P347, DOI 10.1083/jcb.113.2.347; Athale CA, 2011, BIOINFORMATICS, V27, P2944, DOI 10.1093/bioinformatics/btr501; Avinoam O, 2015, SCIENCE, V348, P1369, DOI 10.1126/science.aaa9555; Bicek AD, 2009, MOL BIOL CELL, V20, P2943, DOI 10.1091/mbc.E08-09-0909; Bridgman PC, 1999, J CELL BIOL, V146, P1045, DOI 10.1083/jcb.146.5.1045; Brookes Mike, 2005, VOICEBOX; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Chenouard N, 2010, IEEE INT C IM PROC I; Chetta J, 2011, J NEUROSCI METH, V199, P230, DOI 10.1016/j.jneumeth.2011.05.013; Chiba K, 2014, TRAFFIC, V15, P1, DOI 10.1111/tra.12127; Cytoskeleton, 2005, KIN MOT ASS BIOCH KI; Das M, 2012, SCIENCE, V337, P239, DOI 10.1126/science.1218377; Ducret A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.77, 10.1038/nmicrobiol.2016.77]; Fisher JK, 2013, CELL, V153, P882, DOI 10.1016/j.cell.2013.04.006; Foster PJ, 2015, ELIFE, V4, DOI 10.7554/eLife.10837; Gibbons F, 2001, BIOPHYS J, V80, P2515, DOI 10.1016/S0006-3495(01)76223-6; Guberman JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000233; Hallman S, 2007, MAKE KYMOGRAPH PLUGI; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; Hill DB, 2004, EUR BIOPHYS J BIOPHY, V33, P623, DOI 10.1007/s00249-004-0403-6; Holkar SS, 2015, J BIOL CHEM, V290, P14267, DOI 10.1074/jbc.M115.653394; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Howard J., 2001, MECH MOTOR PROTEINS; Howard J, 2014, MOL BIOL CELL, V25, P3438, DOI 10.1091/mbc.E14-02-0715; Ikuta J, 2014, SCI REP-UK, V4, DOI 10.1038/srep05281; Kalthoff C, 2002, J BIOL CHEM, V277, P8209, DOI 10.1074/jbc.M111587200; Leduc C, 2007, P NATL ACAD SCI USA, V104, P10847, DOI 10.1073/pnas.0701B64104; Maeder CI, 2014, TRAFFIC, V15, P273, DOI 10.1111/tra.12142; Mangeol P, 2016, MOL BIOL CELL, V27, P1948, DOI 10.1091/mbc.E15-06-0404; Martin DS, 2013, METHOD CELL BIOL, V115, P13, DOI 10.1016/B978-0-12-407757-7.00002-5; MEYER F, 1994, SIGNAL PROCESS, V38, P113, DOI 10.1016/0165-1684(94)90060-4; Miura K, 2005, ADV BIOCHEM ENG BIOT, P267; Mondal S, 2011, TRAFFIC, V12, P372, DOI 10.1111/j.1600-0854.2010.01157.x; Neumann S, 2013, NAT PROTOC, V8, P213, DOI 10.1038/nprot.2012.152; Nielsen HJ, 2006, MOL MICROBIOL, V62, P331, DOI 10.1111/j.1365-2958.2006.05346.x; Nitzsche B, 2010, METHOD CELL BIOL, V95, P247, DOI 10.1016/S0091-679X(10)95014-0; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pereira AJ, 2010, METHODS, V51, P214, DOI 10.1016/j.ymeth.2010.01.016; PERONA P, 1990, IEEE T PATTERN ANAL, V12, P629, DOI 10.1109/34.56205; Pucadyil TJ, 2010, BIOPHYS J, V99, P517, DOI 10.1016/j.bpj.2010.04.036; Rietdorf J., 2008, KYMOGRAPH TIME SPACE; Rietdorf J, 2008, MULTIKVMOGRAPH; Ruhnow F, 2011, BIOPHYS J, V100, P2820, DOI 10.1016/j.bpj.2011.04.023; Sachs CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163453; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shekhara S, 2014, MOL BIOL CELL, V25, P3482, DOI 10.1091/mbc.E14-08-1286; Siebrasse JP, 2012, P NATL ACAD SCI USA, V109, P9426, DOI 10.1073/pnas.1201781109; SKARSTAD K, 1985, J BACTERIOL, V163, P661, DOI 10.1128/JB.163.2.661-668.1985; Skruzny M, 2015, DEV CELL, V33, P150, DOI 10.1016/j.devcel.2015.02.023; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; Spahn C, 2014, J STRUCT BIOL, V185, P243, DOI 10.1016/j.jsb.2014.01.007; STEWART RJ, 1993, P NATL ACAD SCI USA, V90, P5209, DOI 10.1073/pnas.90.11.5209; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; TOYOSHIMA YY, 1987, NATURE, V328, P536, DOI 10.1038/328536a0; UNGEWICKELL E, 1981, NATURE, V289, P420, DOI 10.1038/289420a0; Welzel O, 2011, EUR BIOPHYS J BIOPHY, V40, P1061, DOI 10.1007/s00249-011-0722-3; Welzel O, 2009, EUR BIOPHYS J BIOPHY, V38, P883, DOI 10.1007/s00249-009-0458-5; Wery M, 2001, BIOCHIMIE, V83, P193, DOI 10.1016/S0300-9084(01)01254-8; Zanella F, 2010, TRENDS BIOTECHNOL, V28, P237, DOI 10.1016/j.tibtech.2010.02.005	59	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0167620	10.1371/journal.pone.0167620	http://dx.doi.org/10.1371/journal.pone.0167620			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992448	Green Published, gold, Green Submitted			2022-12-26	WOS:000392842600017
J	Sugiyama-Nakagiri, Y; Fujimura, T; Moriwaki, S				Sugiyama-Nakagiri, Yoriko; Fujimura, Tsutomu; Moriwaki, Shigeru			Induction of Skin-Derived Precursor Cells from Human Induced Pluripotent Stem Cells	PLoS One			English	Article							LABEL-RETAINING CELLS; FOLLICLE DERMAL CELLS; NICHE; GROWTH	The generation of full thickness human skin from dissociated cells is an attractive approach not only for treating skin diseases, but also for treating many systemic disorders. However, it is currently not possible to obtain an unlimited number of skin dermal cells. The goal of this study was to develop a procedure to produce skin dermal stem cells from induced pluripotent stem cells (iPSCs). Skin-derived precursor cells (SKPs) were isolated as adult dermal precursors that could differentiate into both neural and mesodermal progenies and could reconstitute the dermis. Thus, we attempted to generate SKPs from iPSCs that could reconstitute the skin dermis. Human iPSCs were initially cultured with recombinant noggin and SB431542, an inhibitor of activin/nodal and TGF beta signaling, to induce neural crest progenitor cells. Those cells were then treated with SKP medium that included CHIR99021, a WNT signal activator. The induction efficacy from neural crest progenitor cells to SKPs was more than 97%. No other modifiers tested were able to induce those cells. Those human iPSC-derived SKPs (hiPSC-SKPs) showed a similar gene expression signature to SKPs isolated from human skin dermis. Human iPSC-SKPs differentiated into neural and mesodermal progenies, including adipocytes, skeletogenic cell types and Schwann cells. Moreover, they could be induced to follicular type keratinization when co-cultured with human epidermal keratinocytes. We here provide a new efficient protocol to create human skin dermal stem cells from hiPSCs that could contribute to the treatment of various skin disorders.	[Sugiyama-Nakagiri, Yoriko; Fujimura, Tsutomu; Moriwaki, Shigeru] Kao Corp, Akabane Ichikai Machi, Tokyo, Tochigi, Japan	KAO Corporation	Sugiyama-Nakagiri, Y (corresponding author), Kao Corp, Akabane Ichikai Machi, Tokyo, Tochigi, Japan.	nakagiri.yoriko@kao.co.jp			Kao Corporation	Kao Corporation	This work was supported by Kao Corporation. The Funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'Author Contributions' section.	Biemaskie J., 2009, CELL STEM CELL, V5, P610, DOI DOI 10.1016/J.STEM.2009.10.019; COHEN J, 1961, J EMBRYOL EXP MORPH, V9, P117; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Higgins CA, 2013, P NATL ACAD SCI USA, V110, P19679, DOI 10.1073/pnas.1309970110; Hill RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050742; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Itoh M, 2011, P NATL ACAD SCI USA, V108, P8797, DOI 10.1073/pnas.1100332108; Jahoda CAB, 2003, EXP DERMATOL, V12, P849, DOI 10.1111/j.0906-6705.2003.00161.x; Lin HF, 2002, NAT REV GENET, V3, P931, DOI 10.1038/nrg952; McKenzie IA, 2006, J NEUROSCI, V26, P6651, DOI 10.1523/JNEUROSCI.1007-06.2006; Mica Y, 2013, CELL REP, V3, P1140, DOI 10.1016/j.celrep.2013.03.025; Morizane A, 2011, J NEUROSCI RES, V89, P117, DOI 10.1002/jnr.22547; Morris RJ, 1999, J INVEST DERMATOL, V112, P470, DOI 10.1046/j.1523-1747.1999.00537.x; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Mukherjee A, 2007, GROWTH HORM IGF RES, V17, P179, DOI 10.1016/j.ghir.2007.01.005; Ohyama M, 2012, J CELL SCI, V125, P4114, DOI 10.1242/jcs.105700; Ohyama M, 2010, EXP DERMATOL, V19, P89, DOI 10.1111/j.1600-0625.2009.00935.x; Oliver RF, 1970, J EMBRYOL EXP MORPHO, V23, P219; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Sabapathy V, 2016, J CELL MOL MED, V20, P1571, DOI 10.1111/jcmm.12839; Sato T, 2005, DEVELOPMENT, V132, P2355, DOI 10.1242/dev.01823; Soma T, 2012, EXP DERMATOL, V21, P299; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Tolar J, 2011, J INVEST DERMATOL, V131, P848, DOI 10.1038/jid.2010.346; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134; Veraitch O, 2013, J INVEST DERMATOL, V133, P1479, DOI 10.1038/jid.2013.7; Yang CC, 2010, J DERMATOL SCI, V57, P2, DOI 10.1016/j.jdermsci.2009.11.005; Yang RF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4071	32	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168451	10.1371/journal.pone.0168451	http://dx.doi.org/10.1371/journal.pone.0168451			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992514	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842600060
J	Hung, CI; Liu, CY; Yang, CH				Hung, Ching-I; Liu, Chia-Yih; Yang, Ching-Hui			Unintentional Injuries among Psychiatric Outpatients with Major Depressive Disorder	PLOS ONE			English	Article							SLEEP QUALITY INDEX; PSYCHOLOGICAL DISTRESS; SYMPTOMS; RISK; ASSOCIATION; ADOLESCENTS; OBESITY	Background No study has investigated the percentages of and factors related to unintentional injuries among psychiatric outpatients with major depressive disorder (MDD). This study aimed to investigate these issues. Methods One-hundred and forty-one outpatients with MDD at baseline were enrolled from psychiatric outpatients by systematic sampling, and 119 subjects attended a one-year follow-up. Self-reported unintentional injuries in the past one year were recorded. Psychiatric disorders were diagnosed using the Structured Clinical Interview for DSM-IV-TR. The severity of depression was evaluated by the Hamilton Depression Rating Scale. Other data, including body weight and height, cigarette smoking, headaches, and medications, were collected. Generalized Estimating Equations were used to investigate independent factors related to unintentional injuries. Results At baseline and follow-up, 40.4% and 27.7% of subjects had experienced at least one unintentional injury in the past one year, respectively. About half of subjects with unintentional injuries needed medical treatment for injuries and had functional impairment due to injuries. A greater severity of depression, cigarette smoking, a higher body mass index, and an older age were independent risk factors related to unintentional injuries. Conclusion Unintentional injuries that increased the medical burden and functional impairment were common among outpatients with MDD and should not be neglected. Treatment of depression, control of body weight, and quitting cigarettes might be helpful to prevent unintentional injuries.	[Hung, Ching-I; Liu, Chia-Yih] Chang Gung Mem Hosp Linkou, Dept Psychiat, Taoyuan, Taiwan; [Hung, Ching-I; Liu, Chia-Yih] Chang Gung Univ, Sch Med, Taoyuan, Taiwan; [Yang, Ching-Hui] Chang Gung Inst Technol, Dept Nursing, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology	Hung, CI (corresponding author), Chang Gung Mem Hosp Linkou, Dept Psychiat, Taoyuan, Taiwan.; Hung, CI (corresponding author), Chang Gung Univ, Sch Med, Taoyuan, Taiwan.	a36250@cgmh.org.tw			National Science Council of Taiwan [NSC 97-2314-B-182A-017-MY2]; Chang Gung Memorial Hospital Research Program [CLRPG3D0043]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital Research Program(Chang Gung Memorial Hospital)	This study was supported in part by grants from the National Science Council of Taiwan (NSC 97-2314-B-182A-017-MY2) and Chang Gung Memorial Hospital Research Program (CLRPG3D0043). The funding sources had no role in the design and conduct of the study; collection, analysis, and interpretation of the data; and preparation, review or approval of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Bouchard DR, 2010, OBESITY FACTS, V3, P363, DOI 10.1159/000322873; Buysse D J, 1989, Psychiatry Res, V28, P193; Chen G, 2005, J ADOLESCENT HEALTH, V37, P460, DOI 10.1016/j.jadohealth.2004.09.005; Chen GM, 2008, INT J INJ CONTROL SA, V15, P157, DOI 10.1080/17457300802207833; de Ramirez SS, 2012, ANNU REV PUBL HEALTH, V33, P175, DOI 10.1146/annurev-publhealth-031811-124558; First MB, 2002, STRUCTURED CLIN INTE; Fragar L, 2013, J RURAL HEALTH, V29, P12, DOI 10.1111/j.1748-0361.2012.00423.x; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Hausdorff JM, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-39; Isometsa E, 2014, CAN J PSYCHIAT, V59, P120, DOI 10.1177/070674371405900303; Kim Yeon-Yong, 2014, J Prev Med Public Health, V47, P150, DOI 10.3961/jpmph.2014.47.3.150; Korniloff K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-516; Lavsa SM, 2010, AM J HEALTH-SYST PH, V67, P1274, DOI 10.2146/ajhp090611; Leistikow B N, 2000, Inj Prev, V6, P277, DOI 10.1136/ip.6.4.277; Martins IP, 2012, HEADACHE, V52, P1471, DOI 10.1111/j.1526-4610.2012.02218.x; McAninch J, 2014, INJURY PREV, V20, P258, DOI 10.1136/injuryprev-2013-040958; McDonald CC, 2014, INJURY PREV, V20, P365, DOI 10.1136/injuryprev-2014-041150; Rowe R, 2004, J PEDIATR PSYCHOL, V29, P119, DOI 10.1093/jpepsy/jsh015; SACKS JJ, 1994, PREV MED, V23, P515, DOI 10.1006/pmed.1994.1070; Schwebel DC, 2008, J PEDIATR PSYCHOL, V33, P323, DOI 10.1093/jpepsy/jsm109; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Tiesman HM, 2006, INJURY PREV, V12, P172, DOI 10.1136/ip.2006.011544; Tsai PS, 2005, QUAL LIFE RES, V14, P1943, DOI 10.1007/s11136-005-4346-x; van der Westhuizen C, 2014, J NERV MENT DIS, V202, P638, DOI 10.1097/NMD.0000000000000176; Wright SL, 2011, J GERIATR PSYCH NEUR, V24, P142, DOI 10.1177/0891988711409408; Xiang H, 2005, AM J PREV MED, V29, P41, DOI 10.1016/j.amepre.2005.03.013	27	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168202	10.1371/journal.pone.0168202	http://dx.doi.org/10.1371/journal.pone.0168202			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8LN	27992483	Green Published, Green Submitted, gold			2022-12-26	WOS:000392758000030
J	Zhang, ZY; Li, C; Gao, W; Yin, XW; Luo, QF; Liu, N; Basnet, S; Dai, ZL; Ge, HY				Zhang, Zhen-yu; Li, Cong; Gao, Wei; Yin, Xiao-wei; Luo, Qi-feng; Liu, Nan; Basnet, Shiva; Dai, Zhen-ling; Ge, Hai-yan			A Nomogram to Predict Adequate Lymph Node Recovery before Resection of Colorectal Cancer	PLOS ONE			English	Article							COMPLETE MESOCOLIC EXCISION; LONG-TERM SURVIVAL; COLON-CANCER; MICROSATELLITE INSTABILITY; INFLAMMATORY RESPONSES; PROGNOSTIC VALUE; TUMOR NECROSIS; COUNT; SURGERY; LYMPHADENECTOMY	Increased lymph node count (LNC) has been associated with prolonged survival in colorectal cancer (CRC), but the underlying mechanisms are still poorly understood. The study aims to identify new predictors and develop a preoperative nomogram for predicting the probability of adequate LNC (>= 12). 501 eligible patients were retrospectively selected to identify clinical-pathological factors associated with LNC >= 12 through univariate and multivariate logistic regression analyses. The nomogram was built according to multivariate analyses of preoperative factors. Model performance was assessed with concordance index (c-index) and area under the receiver operating characteristic curve (AUC), followed by internal validation and calibration using 1000-resample bootstrapping. Clinical validity of the nomogram and LNC impact on stage migration were also evaluated. Multivariate analyses showed patient age, CA19-9, circulating lymphocytes, neutrophils, platelets, tumor diameter, histology and deposit significantly correlated with LNC (P < 0.05). The effects were marginal for CEA, anemia and CRC location (0.05 < P < 0.1). The multivariate analyses of preoperative factors suggested decreased age, CEA, CA19-9, neutrophils, proximal location, and increased platelets and diameter were significantly associated with increased probability of LNC >= 12 (P < 0.05). The nomogram achieved c-indexes of 0.75 and 0.73 before and after correction for overfitting. The AUC was 0.75 (95% CI, 0.70-0.79) and the clinically valid threshold probabilities were between 10% and 60% for the nomogram to predict LNC < 12. Additionally, increased probability of adequate LNC before surgery was associated with increased LNC and negative lymph nodes rather than increased positive lymph nodes, lymph node ratio, pN stages or AJCC stages. Collectively, the results indicate the LNC is multifactorial and irrelevant to stage migration. The significant correlations with preoperative circulating markers may provide new explanations for LNC-related survival advantage which is reflected by the implication of regional and systemic antitumor immune responses.	[Zhang, Zhen-yu; Gao, Wei; Luo, Qi-feng; Liu, Nan; Basnet, Shiva; Dai, Zhen-ling; Ge, Hai-yan] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Gastrointestinal Surg, Shanghai, Peoples R China; [Li, Cong] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Spine Surg, Shanghai, Peoples R China; [Yin, Xiao-wei] Fudan Univ, Zhongshan Hosp, Dept Gen Surg, Qingpu Branch, Shanghai, Peoples R China	Tongji University; Tongji University; Fudan University	Ge, HY (corresponding author), Tongji Univ, Sch Med, Shanghai East Hosp, Dept Gastrointestinal Surg, Shanghai, Peoples R China.	gesurgery@163.com	Gao, Wei/GXH-0380-2022	Basnet, Shiva/0000-0002-6989-911X	Shanghai Science Committee Foundation [34119b0600, 16411970800]; Shanghai Municipal Health Bureau [20134194]; Jiaxing Science Committee Foundation of Zhejiang province [2015AY23071]; Technology Plan Project of Medicine and Health in Zhejiang Province [2016KYB295]	Shanghai Science Committee Foundation; Shanghai Municipal Health Bureau; Jiaxing Science Committee Foundation of Zhejiang province; Technology Plan Project of Medicine and Health in Zhejiang Province	This study was supported by grants from the Shanghai Science Committee Foundation (HYG, no. 34119b0600, no. 16411970800, official website: http://www.stcsm.gov.cn/), Shanghai Municipal Health Bureau (HYG, no. 20134194, official website: http://www.wsjsw.gov.cn/wsj/), Jiaxing Science Committee Foundation of Zhejiang province (HYG, no. 2015AY23071, official website: http.//www.jxkij.gov.cn/) and the Technology Plan Project of Medicine and Health in Zhejiang Province (HYG, no. 2016KYB295, official website: http://www.zjkit.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belt EJT, 2012, ANN SURG ONCOL, V19, P1222, DOI 10.1245/s10434-011-2091-7; Bertelsen CA, 2015, LANCET ONCOL, V16, P161, DOI 10.1016/S1470-2045(14)71168-4; Budde CN, 2014, J AM COLL SURGEONS, V218, P1004, DOI 10.1016/j.jamcollsurg.2014.01.039; Bui L, 2006, J SURG ONCOL, V93, P439, DOI 10.1002/jso.20499; Chapman B, 2013, DIS COLON RECTUM, V56, P1028, DOI 10.1097/DCR.0b013e31829c41ba; Chen LL, 2014, DIS COLON RECTUM, V57, P432, DOI 10.1097/DCR.0000000000000052; Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979; Compton CC, 2004, CA-CANCER J CLIN, V54, P295, DOI 10.3322/canjclin.54.6.295; De Smedt L, 2015, BRIT J CANCER, V113, P500, DOI 10.1038/bjc.2015.213; Denlinger CS, 2016, J NATL COMPR CANC NE, V14, P715, DOI 10.6004/jnccn.2016.0073; Drescher KM, 2009, FAM CANCER, V8, P231, DOI 10.1007/s10689-009-9233-0; Guthrie GJK, 2013, BRIT J CANCER, V109, P131, DOI 10.1038/bjc.2013.291; Guthrie GJK, 2013, CANCER TREAT REV, V39, P89, DOI 10.1016/j.ctrv.2012.07.003; Hari DM, 2013, J AM COLL SURGEONS, V217, P181, DOI 10.1016/j.jamcollsurg.2013.04.018; Ishizuka M, 2013, BRIT J CANCER, V109, P401, DOI 10.1038/bjc.2013.350; Jakub JW, 2009, ARCH SURG-CHICAGO, V144, P1115, DOI 10.1001/archsurg.2009.210; Johnson PM, 2006, J CLIN ONCOL, V24, P3570, DOI 10.1200/JCO.2006.06.8866; Killeen S, 2014, COLORECTAL DIS, V16, P577, DOI 10.1111/codi.12616; Li Destri G, 2014, WORLD J GASTROENTERO, V20, P1951, DOI 10.3748/wjg.v20.i8.1951; Liang JT, 2015, SURG ENDOSC, V29, P2394, DOI 10.1007/s00464-014-3940-9; Ling Khoon Lin, 2007, Cancer Immun, V7, P7; Lykke J, 2013, COLORECTAL DIS, V15, P559, DOI 10.1111/codi.12059; Mathis KL, 2013, ANN SURG, V257, P102, DOI 10.1097/SLA.0b013e318260a8e6; Moore J, 2010, SURGERY, V147, P358, DOI 10.1016/j.surg.2009.10.003; Murphy B, 2014, IRISH J MED SCI, V183, pS23; Nagtegaal ID, 2015, HISTOPATHOLOGY, V66, P102, DOI 10.1111/his.12563; Nash GM, 2011, ANN SURG, V253, P318, DOI 10.1097/SLA.0b013e318204e637; Ogino S, 2009, CLIN CANCER RES, V15, P6412, DOI 10.1158/1078-0432.CCR-09-1438; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Quirke P, 2011, VIRCHOWS ARCH, V458, P1, DOI 10.1007/s00428-010-0977-6; Roxburgh CSD, 2010, COLORECTAL DIS, V12, P987, DOI 10.1111/j.1463-1318.2009.01961.x; Roxburgh CSD, 2009, ANN SURG, V249, P788, DOI 10.1097/SLA.0b013e3181a3e738; Saha S, 2015, AM J SURG, V209, P570, DOI 10.1016/j.amjsurg.2014.12.008; Sasaki K, 2012, WORLD J SURG, V36, P192, DOI 10.1007/s00268-011-1329-7; Schmoll HJ, 2012, ANN ONCOL, V23, P2479, DOI 10.1093/annonc/mds236; Sjo OH, 2012, DIS COLON RECTUM, V55, P307, DOI 10.1097/DCR.0b013e3182423f62; The Helsinki Declaration of the World Medical Association (WMA), 2014, POL MERKUR LEKARSKI, V36, P298; Troxler M, 2007, BRIT J SURG, V94, P674, DOI 10.1002/bjs.5852; Wang DL, 2015, TUMOR BIOL, V36, P5407, DOI 10.1007/s13277-015-3206-8; Willaert W, 2014, CANCER TREAT REV, V40, P405, DOI 10.1016/j.ctrv.2013.09.013; Wong JH, 2011, J AM COLL SURGEONS, V213, P226, DOI 10.1016/j.jamcollsurg.2011.05.003; Xu BL, 2015, ONCOTARGET, V6, P20592, DOI 10.18632/oncotarget.4112	42	2	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168156	10.1371/journal.pone.0168156	http://dx.doi.org/10.1371/journal.pone.0168156			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992611	Green Submitted, gold, Green Published			2022-12-26	WOS:000392758000028
J	Cary, DC; Fujinaga, K; Peterlin, BM				Cary, Daniele C.; Fujinaga, Koh; Peterlin, B. Matija			Euphorbia Kansui Reactivates Latent HIV	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HISTONE DEACETYLASE INHIBITORS; B P-TEFB; POSITIVE TRANSCRIPTION; MOLECULAR-MECHANISMS; IN-VITRO; CD4(+) T; REPLICATION; ELONGATION; RESERVOIR	While highly active anti-retroviral therapy has greatly improved the lives of HIV infected individuals, these treatments are unable to eradicate the virus. Current approaches to reactivate the virus have been limited by toxicity, lack of an orally available therapy, and limited responses in primary CD4+ T cells and in clinical trials. The PKC agonist ingenol, purified from Euphorbia plants, is a potent T cell activator and reactivates latent HIV. Euphorbia kansui itself has been used for centuries in traditional Chinese medicine to treat ascites, fluid retention, and cancer. We demonstrate that an extract of this plant, Euphorbia kansui, is capable of recapitulating T cell activation induced by the purified ingenol. Indeed, Euphorbia kansui induced expression of the early T cell activation marker CD69 and P-TEFb in a dosedependent manner. Furthermore, Euphorbia kansui reactivated latent HIV in a CD4+ T cell model of latency and in HIV+ HAART suppressed PBMC. When combined with the other latency reversing agents, the effective dose of Euphorbia kansui required to reactive HIV was reduced 10-fold and resulted in synergistic reactivation of latent HIV. We conclude that Euphorbia Euphorbia kansui reactivates latent HIV and activates CD4+ T cells. When used in combination with a latency reversing agent, the effective dose of Euphorbia kansui is reduced; which suggests its application as a combination strategy to reactivate latent HIV while limiting the toxicity due to global T cell activation. As a natural product, which has been used in traditional medicine for thousands of years, Euphorbia kansui is attractive as a potential treatment strategy, particularly in resource poor countries with limited treatment options. Further clinical testing will be required to determine its safety with current anti-retroviral therapies.	[Cary, Daniele C.; Fujinaga, Koh; Peterlin, B. Matija] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Cary, Daniele C.; Fujinaga, Koh; Peterlin, B. Matija] Univ Calif San Francisco, Dept Microbiol, San Francisco, CA 94143 USA; [Cary, Daniele C.; Fujinaga, Koh; Peterlin, B. Matija] Univ Calif San Francisco, Dept Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cary, DC (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Cary, DC (corresponding author), Univ Calif San Francisco, Dept Microbiol, San Francisco, CA 94143 USA.; Cary, DC (corresponding author), Univ Calif San Francisco, Dept Immunol, San Francisco, CA 94143 USA.	Daniele.Cary@ucsf.edu			amfAR (Foundation for AIDS Research) Institute for HIV Cure Research; National Institute of Health [U19 AI096113, R01 AI49104, P50 GM082250]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250] Funding Source: NIH RePORTER	amfAR (Foundation for AIDS Research) Institute for HIV Cure Research; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the amfAR (Foundation for AIDS Research) Institute for HIV Cure Research and by the National Institute of Health through grants U19 AI096113 and R01 AI49104 to BMP and grant P50 GM082250. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097257; Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403; Anderson L, 2009, J AM ACAD DERMATOL, V60, P934, DOI 10.1016/j.jaad.2009.01.008; Archin NM, 2014, CURR OPIN INFECT DIS, V27, P29, DOI 10.1097/QCO.0000000000000026; Bartholomeeusen K, 2013, J BIOL CHEM, V288, P14400, DOI 10.1074/jbc.M113.464834; Bartholomeeusen K, 2012, J BIOL CHEM, V287, P36609, DOI 10.1074/jbc.M112.410746; Beans EJ, 2013, P NATL ACAD SCI USA, V110, P11698, DOI 10.1073/pnas.1302634110; Bensky D, 2004, CHINESE HERBAL MED M, V3rd; Blazkova J, 2012, J INFECT DIS, V206, P765, DOI 10.1093/infdis/jis412; Boehm D, 2013, CELL CYCLE, V12, P452, DOI 10.4161/cc.23309; Bullen CK, 2014, NAT MED, V20, P425, DOI 10.1038/nm.3489; Cary DC, 2016, J CLIN INVEST, V126, P448, DOI 10.1172/JCI80565; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Cohn LB, 2015, CELL, V160, P420, DOI 10.1016/j.cell.2015.01.020; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Darcis G, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005063; DeChristopher BA, 2012, NAT CHEM, V4, P705, DOI [10.1038/nchem.1395, 10.1038/NCHEM.1395]; Dutra RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027122; Fabricant DS, 2001, ENVIRON HEALTH PERSP, V109, P69, DOI 10.2307/3434847; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fujinaga K, 2012, NUCLEIC ACIDS RES, V40, P9160, DOI 10.1093/nar/gks682; Gama L, 2016, AIDS; Gu XD, 2007, CHIN J INTEGR MED, V13, P235, DOI 10.1007/s11655-007-0235-1; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; He NH, 2006, MOL CELL BIOL, V26, P7068, DOI 10.1128/MCB.00778-06; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Hon T, 2015, BIOCHEM BIOPH RES CO, V459, P288, DOI 10.1016/j.bbrc.2015.02.102; Hou JJ, 2014, J PHARMACEUT BIOMED, V88, P321, DOI 10.1016/j.jpba.2013.08.049; Jablonski JA, 2009, J VIROL, V83, P981, DOI 10.1128/JVI.01801-08; Jiang GC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005066; Jiang GC, 2014, AIDS, V28, P1555, DOI 10.1097/QAD.0000000000000289; Jose DP, 2014, VIROLOGY, V462, P328, DOI 10.1016/j.virol.2014.05.033; Kim YK, 2011, J MOL BIOL, V410, P896, DOI 10.1016/j.jmb.2011.03.054; Korin YD, 2002, J VIROL, V76, P8118, DOI 10.1128/JVI.76.16.8118-8123.2002; KUPCHAN SM, 1976, SCIENCE, V191, P571, DOI 10.1126/science.1251193; Laird GM, 2015, J CLIN INVEST, V125, P1901, DOI 10.1172/JCI80142; Liu PY, 2014, J BIOL CHEM, V289, P9918, DOI 10.1074/jbc.M113.539015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marin B, 2009, AIDS, V23, P1743, DOI 10.1097/QAD.0b013e32832e9b78; Massanella M, 2016, J CLIN INVEST, V126, P464, DOI 10.1172/JCI80567; Passos GF, 2013, EUR J PHARMACOL, V698, P413, DOI 10.1016/j.ejphar.2012.10.019; Raskin I, 2002, TRENDS BIOTECHNOL, V20, P522, DOI 10.1016/S0167-7799(02)02080-2; Rasmussen TA, 2013, HUM VACC IMMUNOTHER, V9, P993, DOI 10.4161/hv.23800; Routy JP, 2012, HIV MED, V13, P291, DOI 10.1111/j.1468-1293.2011.00975.x; SCHAUFELBERGER DE, 1991, J NAT PROD, V54, P1265, DOI 10.1021/np50077a004; Sedore SC, 2007, NUCLEIC ACIDS RES, V35, P4347, DOI 10.1093/nar/gkm443; Shi QW, 2008, CHEM REV, V108, P4295, DOI 10.1021/cr078350s; Spina CA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003834; Spivak AM, 2015, ANTIMICROB AGENTS CH; Taube R, 2013, VIRUSES-BASEL, V5, P902, DOI 10.3390/v5030902; Tu YY, 2011, NAT MED, V17, P1217, DOI 10.1038/nm.2471; UNAIDS, 2015, AIDS NUMB 2015; Wang C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142739; Wang LY, 2002, J NAT PROD, V65, P1246, DOI 10.1021/np0200921; Wei DG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004071; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Xing F, 2012, J ETHNOPHARMACOL, V139, P343, DOI 10.1016/j.jep.2011.10.040; Yu WD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003146	59	29	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168027	10.1371/journal.pone.0168027	http://dx.doi.org/10.1371/journal.pone.0168027			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977742	Green Published, gold, Green Submitted			2022-12-26	WOS:000391217400050
J	Kouser, K; Lavanya, PG; Rangarajan, L; Kshitish, KA				Kouser, K.; Lavanya, P. G.; Rangarajan, Lalitha; Kshitish, Acharya K.			Effective Feature Selection for Classification of Promoter Sequences	PLOS ONE			English	Article							GENE-EXPRESSION; DNA; PREDICTION; MODES	Exploring novel computational methods in making sense of biological data has not only been a necessity, but also productive. A part of this trend is the search for more efficient in silico methods/tools for analysis of promoters, which are parts of DNA sequences that are involved in regulation of expression of genes into other functional molecules. Promoter regions vary greatly in their function based on the sequence of nucleotides and the arrangement of protein-binding short-regions called motifs. In fact, the regulatory nature of the promoters seems to be largely driven by the selective presence and/or the arrangement of these motifs. Here, we explore computational classification of promoter sequences based on the pattern of motif distributions, as such classification can pave a new way of functional analysis of promoters and to discover the functionally crucial motifs. We make use of Position Specific Motif Matrix (PSMM) features for exploring the possibility of accurately classifying promoter sequences using some of the popular classification techniques. The classification results on the complete feature set are low, perhaps due to the huge number of features. We propose two ways of reducing features. Our test results show improvement in the classification output after the reduction of features. The results also show that decision trees outperform SVM (Support Vector Machine), KNN (K Nearest Neighbor) and ensemble classifier LibD3C, particularly with reduced features. The proposed feature selection methods outperform some of the popular feature transformation methods such as PCA and SVD. Also, the methods proposed are as accurate as MRMR (feature selection method) but much faster than MRMR. Such methods could be useful to categorize new promoters and explore regulatory mechanisms of gene expressions in complex eukaryotic species.	[Kouser, K.; Lavanya, P. G.; Rangarajan, Lalitha] DoS Comp Sci, Mysore, Karnataka, India; [Kshitish, Acharya K.] IBAB, Biotech Pk, Bangalore, Karnataka, India; [Kshitish, Acharya K.] Shodhaka Life Sci Pvt Ltd, IBAB, Biotech Pk, Bangalore, Karnataka, India		Rangarajan, L (corresponding author), DoS Comp Sci, Mysore, Karnataka, India.	lalithar@compsci.uni-mysore.ac.in			private company Shodhaka Life Sciences Pvt. Ltd.	private company Shodhaka Life Sciences Pvt. Ltd.	This work/authors received no specific funding. The private company Shodhaka Life Sciences Pvt. Ltd. provided support in the form of assistance to one of the authors [AKK] in extracting and compiling some of the data, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This commercial affiliation also does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	ALEXANDROV NN, 1990, NUCLEIC ACIDS RES, V18, P1847, DOI 10.1093/nar/18.7.1847; Bercher JF, 2006, AIP CONF PROC, V872, P235; Blanchette M, 2002, GENOME RES, V12, P739, DOI 10.1101/gr.6902; Brieman L., 1998, CLASSIFICATION REGRE; Chan TM, 2010, IEEE C EVOL COMPUTAT; Chang CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022859; Deshpande M., 2002, Advances in Knowledge Discovery and Data Mining. 6th Pacific-Asia Conference, PAKDD 2002. Proceedings (Lecture Notes in Artificial Intelligence Vol.2336), P417; Ding Chris, 2005, Journal of Bioinformatics and Computational Biology, V3, P185, DOI 10.1142/S0219720005001004; Dong X, 2004, BIBE 2004: FOURTH IEEE SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, PROCEEDINGS, P483, DOI 10.1109/BIBE.2004.1317381; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Hu QH, 2011, EXPERT SYST APPL, V38, P10737, DOI 10.1016/j.eswa.2011.01.023; Huang AC, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-20; Huang JP, 2010, COMPUT BIOL MED, V40, P698, DOI 10.1016/j.compbiomed.2010.06.004; Jeffery IB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-359; Kamath U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099982; Kingsford C, 2008, NAT BIOTECHNOL, V26, P1011, DOI 10.1038/nbt0908-1011; Kouser, 2015, PROCEDIA COMPUT SCI, V58, P356, DOI 10.1016/j.procs.2015.08.031; Kouser, 2015, LECT N BIOINFORMAT, V9044, P183, DOI 10.1007/978-3-319-16480-9_19; Kouser K, 2014, P 2014 INT C INT ADV, P37; Lazarevic A., 2001, NEUR NETW 2001 P IJC, V2, P796; LESLIE C, 2002, P PSB, V7, P566; Leung HCM, 2006, BIBE 2006: SIXTH IEEE SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, PROCEEDINGS, P70; Liang KC, 2007, IEEE ACM T COMPUT BI, V4, P430, DOI 10.1109/TCBB.2007.1027; Lin C, 2014, NEUROCOMPUTING, V123, P424, DOI 10.1016/j.neucom.2013.08.004; Liu B, 2016, MOL GENET GENOMICS, V291, P473, DOI 10.1007/s00438-015-1078-7; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu B, 2015, BIOINFORMATICS, V31, P1307, DOI 10.1093/bioinformatics/btu820; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; Mathelier A, 2013, NUCLEIC ACIDS RES; Meera A., THESIS; Mitchell T.M, 2003, MACH LEARN; Murakami K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-112; Pan F, 2004, J BIOMED INFORM, V37, P240, DOI 10.1016/j.jbi.2004.07.003; Pavlidis P, 2001, Pac Symp Biocomput, P151; PRESTRIDGE DS, 1995, J MOL BIOL, V249, P923, DOI 10.1006/jmbi.1995.0349; Qin YM, 2015, BIG DATA RES, V2, P12, DOI 10.1016/j.bdr.2015.02.005; Quinlan JR, 1993, C4 5 PROGRAMMING MAC, P38; Ratsch G, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S9; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Simon R, 2003, BRIT J CANCER, V89, P1599, DOI 10.1038/sj.bjc.6601326; Weston J, 2005, BIOINFORMATICS, V21, P3241, DOI 10.1093/bioinformatics/bti497; Wu SH, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.041908; Xing Z., 2010, ACM SIGKDD EXPLOR NE, V12, P40, DOI DOI 10.1145/1882471.1882478; Yang JY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S3; Yang YH, 2005, BIOINFORMATICS, V21, P1084, DOI 10.1093/bioinformatics/bti108; Yeung KY, 2005, BIOINFORMATICS, V21, P2394, DOI 10.1093/bioinformatics/bti319	50	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0167165	10.1371/journal.pone.0167165	http://dx.doi.org/10.1371/journal.pone.0167165			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27978541	gold, Green Published, Green Submitted			2022-12-26	WOS:000391217400014
J	Okuda, H; DeBoer, K; O'Connor, AE; Merriner, DJ; Jamsai, D; O'Bryan, MK				Okuda, Hidenobu; DeBoer, Kathleen; O'Connor, Anne E.; Merriner, D. Jo; Jamsai, Duangporn; O'Bryan, Moira K.			LRGUK1 is part of a multiprotein complex required for manchette function and male fertility	FASEB JOURNAL			English	Article						elongating spermatids; intracellular transport; cargo adaptor; spermatogenesis; sperm	KINESIN LIGHT-CHAIN; LEUCINE-RICH REPEAT; GENE SPECIFICITY; PROTEIN; FAMILY; CARGO; RECOGNITION; DOMAIN; CELLS; CILIA	Infertility occurs in 1 in 20 young men and is idiopathic in origin in most. We have reported that the leucine-rich repeat (LRR) and guanylate kinase-like domain containing, isoform (LRGUK)-1 is essential for sperm head shaping, via the manchette, and the initiation of sperm tail growth from the centriole/basal body, and thus, male fertility. Within this study we have used a yeast 2-hybrid screen of an adult testis library to identify LRGUK1binding partners, which were then validated with a range of techniques. The data indicate that LRGUK1 likely achieves its function in partnership with members of the HOOK family of proteins (HOOK-1-3), Rab3-interacting molecule binding protein (RIMBP)-3 and kinesin light chain (KLC)-3, all of which are associated with intracellular protein transport as cargo adaptor proteins and are localized to the manchette. LRGUK1 consists of 3 domains; an LRR, a guanylate kinase (GUK)-like and an unnamed domain. In the present study, we showed that the GUK-like domain is essential for binding to HOOK2 and RIMBP3, and the LRR domain is essential for binding to KLC3. These findings establish LRGUK1 as a key component of a multiprotein complex with an essential role in microtubule dynamics with in haploid male germ cells.- Okuda, H., DeBoer, K., O ' Connor, A. E., Merriner, D. J., Jamsai, D., O ' Bryan, M. K. LRGUK1 is part of a multiprotein complex required for manchette function and male fertility.	Monash Univ, Monash Biomed Discovery Inst, Clayton, Vic, Australia; Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [O'Bryan, Moira K.] Monash Univ, Monash Biomed Discovery Inst, Dev & Stem Cells Program, Clayton, Vic 3800, Australia	Monash University; Monash University; Monash University	O'Bryan, MK (corresponding author), Monash Univ, Monash Biomed Discovery Inst, Dev & Stem Cells Program, Clayton, Vic 3800, Australia.	moira.obryan@monash.edu	O'Connor, Anne/AAI-6479-2020; O'Bryan, Moira K/F-8256-2012	O'Connor, Anne/0000-0001-9334-4256; O'Bryan, Moira K/0000-0001-7298-4940	National Health and Medical Research Council (NHMRC) of Australia [606562]; NHMRC [APP1058356]; Japanese Society for the Promotion of Science	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors thank Yan Liu (Monash University) for technical assistance in making the recombinant protein. This research was funded in part by Grant 606562 from the National Health and Medical Research Council (NHMRC) of Australia (to M.K.O.); by Research Fellowship APP1058356 from the NHMRC (M.K.O.); and by a Research Fellowship for Young Scientists from the Japanese Society for the Promotion of Science (to H.O.). The authors declare no conflicts of interest.	Adio S, 2006, J MUSCLE RES CELL M, V27, P153, DOI 10.1007/s10974-005-9054-1; Akhmanova A, 2005, GENE DEV, V19, P2501, DOI 10.1101/gad.344505; Arsov T, 2006, MOL ENDOCRINOL, V20, P1610, DOI 10.1210/me.2005-0494; Baker G., 2012, ENDOTEXT; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Bhullar B, 2003, J BIOL CHEM, V278, P16159, DOI 10.1074/jbc.M213126200; Bielska E, 2014, J CELL BIOL, V204, P989, DOI 10.1083/jcb.201309022; BLOOM GS, 1994, PROTEIN PROFILE, V1, P1059; Caplan J, 2008, CELL HOST MICROBE, V3, P126, DOI 10.1016/j.chom.2008.02.010; Cianfrocco MA, 2015, ANNU REV CELL DEV BI, V31, P83, DOI 10.1146/annurev-cellbio-100814-125438; De Kretser DM, 1999, J CLIN ENDOCR METAB, V84, P3443, DOI 10.1210/jc.84.10.3443; De Masi F, 2005, PROTEOMICS, V5, P4070, DOI 10.1002/pmic.200401279; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; Ellis JG, 2007, ANNU REV PHYTOPATHOL, V45, P289, DOI 10.1146/annurev.phyto.45.062806.094331; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Firat-Karalar EN, 2014, J CELL SCI, V127, P4128, DOI 10.1242/jcs.157008; Gaillard CLB, 2011, MOL BIOL CELL, V22, P4549, DOI 10.1091/mbc.E11-05-0405; Harris EH, 2001, ANNU REV PLANT PHYS, V52, P363, DOI 10.1146/annurev.arplant.52.1.363; Hibino H, 2002, NEURON, V34, P411, DOI 10.1016/S0896-6273(02)00667-0; Holden CA, 2005, LANCET, V366, P218, DOI 10.1016/S0140-6736(05)66911-5; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Junco A, 2001, BIOL REPROD, V64, P1320, DOI 10.1095/biolreprod64.5.1320; Kierszenbaum Abraham L, 2011, Spermatogenesis, V1, P221; Kierszenbaum AL, 2011, DEV DYNAM, V240, P723, DOI 10.1002/dvdy.22563; Kierszenbaum Abraham L, 2007, Soc Reprod Fertil Suppl, V65, P33; Kierszenbaum AL, 2004, ARCH HISTOL CYTOL, V67, P271, DOI 10.1679/aohc.67.271; Kierszenbaum AL, 2003, MOL BIOL CELL, V14, P4628, DOI 10.1091/mbc.E03-04-0226; Kierszenbaum AL, 2002, MOL REPROD DEV, V63, P1, DOI 10.1002/mrd.10179; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kramer H, 1996, J CELL BIOL, V133, P1205, DOI 10.1083/jcb.133.6.1205; Lehti MS, 2016, REPRODUCTION, V151, pR43, DOI 10.1530/REP-15-0310; Lehti MS, 2013, MOL CELL ENDOCRINOL, V377, P44, DOI 10.1016/j.mce.2013.06.030; Liu KSY, 2011, SCIENCE, V334, P1565, DOI 10.1126/science.1212991; Liu Y, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005090; Ma M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/270805; Mai WY, 2005, MOL BIOL CELL, V16, P4398, DOI 10.1091/mbc.E04-11-1019; Maldonado-Baez L, 2013, J CELL BIOL, V201, P233, DOI 10.1083/jcb.201208172; McKenney RJ, 2014, SCIENCE, V345, P337, DOI 10.1126/science.1254198; MEISTRICH ML, 1990, AM J ANAT, V188, P74, DOI 10.1002/aja.1001880109; Mendoza-Lujambio I, 2002, HUM MOL GENET, V11, P1647, DOI 10.1093/hmg/11.14.1647; Mittelstaedt T, 2007, GENE, V403, P70, DOI 10.1016/j.gene.2007.08.004; Mochida K, 1999, MOL REPROD DEV, V52, P434, DOI 10.1002/(SICI)1098-2795(199904)52:4&lt;434::AID-MRD13&gt;3.0.CO;2-D; Moreno RD, 2000, CELL MOTIL CYTOSKEL, V46, P235, DOI 10.1002/1097-0169(200008)46:4<235::AID-CM1>3.0.CO;2-G; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; O'Donnell L, 2014, SEMIN CELL DEV BIOL, V30, P45, DOI 10.1016/j.semcdb.2014.01.003; Oliva C, 2012, DEV NEUROBIOL, V72, P57, DOI 10.1002/dneu.20949; Olsen B, 2005, MATRIX BIOL, V24, P449, DOI 10.1016/j.matbio.2005.09.003; Padmanabhan M, 2009, CELL MICROBIOL, V11, P191, DOI 10.1111/j.1462-5822.2008.01260.x; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Perrin A, 2013, ANDROLOGIA, V45, P1, DOI 10.1111/j.1439-0272.2012.01308.x; RATTNER JB, 1972, J ULTRA MOL STRUCT R, V41, P209, DOI 10.1016/S0022-5320(72)90065-2; ROMRELL LJ, 1976, DEV BIOL, V49, P119, DOI 10.1016/0012-1606(76)90262-1; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; RUSSELL LD, 1991, AM J ANAT, V192, P97, DOI 10.1002/aja.1001920202; Salisbury JL, 2004, CURR BIOL, V14, pR765, DOI 10.1016/j.cub.2004.09.016; Schlager MA, 2014, EMBO J, V33, P1855, DOI 10.15252/embj.201488792; Scholey JM, 2008, J CELL BIOL, V180, P23, DOI 10.1083/jcb.200709133; STEHLE T, 1992, J MOL BIOL, V224, P1127, DOI 10.1016/0022-2836(92)90474-X; Szebenyi G, 2007, TRAFFIC, V8, P32, DOI 10.1111/j.1600-0854.2006.00511.x; Taulman PD, 2001, MOL BIOL CELL, V12, P589, DOI 10.1091/mbc.12.3.589; Walenta JH, 2001, J CELL BIOL, V152, P923, DOI 10.1083/jcb.152.5.923; Wang Y, 2000, J BIOL CHEM, V275, P20033, DOI 10.1074/jbc.M909008199; Xu L, 2008, MOL BIOL CELL, V19, P5059, DOI 10.1091/mbc.E08-05-0473; Zhang J, 2014, J CELL BIOL, V204, P1009, DOI 10.1083/jcb.201308009; Zhang Y, 2004, DEV BIOL, V275, P23, DOI 10.1016/j.ydbio.2004.07.014; Zhang Y, 2012, DEV BIOL, V366, P101, DOI 10.1016/j.ydbio.2012.04.026; Zhou J, 2009, DEVELOPMENT, V136, P373, DOI 10.1242/dev.030858	67	16	21	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1141	+		10.1096/fj.201600909R	http://dx.doi.org/10.1096/fj.201600909R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	28003339				2022-12-26	WOS:000395671200027
J	Ridiandries, A; Tan, JTM; Ravindran, D; Williams, H; Medbury, HJ; Lindsay, L; Hawkins, C; Prosser, HCG; Bursill, CA				Ridiandries, Anisyah; Tan, Joanne T. M.; Ravindran, Dhanya; Williams, Helen; Medbury, Heather J.; Lindsay, Laura; Hawkins, Clare; Prosser, Hamish C. G.; Bursill, Christina A.			CC-chemokine class inhibition attenuates pathological angiogenesis while preserving physiological angiogenesis	FASEB JOURNAL			English	Article						inflammation; ischemia; VEGF	SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR GENE; ACTIVITY IN-VITRO; EXPRESSION; ATHEROSCLEROSIS; RECEPTORS; TRANSCRIPTION; PROGRESSION; RECRUITMENT; ACTIVATION	Increasing evidence shows that CC-chemokines promote inflammatory-driven angiogenesis, with little to no effect on hypoxia-mediated angiogenesis. Inhibition of the CC-chemokine class may therefore affect angiogenesis differently depending on the pathophysiological context. We compared the effect of CC-chemokine inhibition in inflammatory and physiological conditions. In vitro, the broad-spectrum CC-chemokine inhibitor '' 35K '' inhibited inflammatory-induced endothelial cell proliferation, migration, and tubulogenesis, with more modest effects in hypoxia. In vivo, adenoviruses were used to overexpress 35K (Ad35K) and GFP (AdGFP, control virus). Plasma chemokine activity was suppressed by Ad35K in both models. In the periarterial femoral cuff model of inflammatory-driven angiogenesis, overexpression of 35K inhibited adventitial neovessel formation compared with control AdGFP-infused mice. In contrast, 35K preserved neovascularization in the hindlimb ischemia model and had no effect on physiological neovascularization in the chick chorioallantoic membrane assay. Mechanistically, 2 key angiogenic proteins (VEGF and hypoxia-inducible factor-1 alpha) were conditionally regulated by 35K, such that expression was inhibited in inflammation but was unchanged in hypoxia. In conclusion, CC-chemokine inhibition by 35K suppresses inflammatory-driven angiogenesis while preserving physiological ischemia-mediated angiogenesis via conditional regulation of VEGF and hypoxia-inducible factor-1 alpha. CC-chemokine inhibition may be an alternative therapeutic strategy for suppressing diseases associated with inflammatory angiogenesis without inducing the side effects caused by global inhibition.- Ridiandries, A., Tan, J. T. M., Ravindran, D., Williams, H., Medbury, H. J., Lindsay, L., Hawkins, C., Prosser, H. C. G., Bursill, C. A. CC- chemokine class inhibition attenuates pathological angiogenesis while preserving physiological angiogenesis.	[Ridiandries, Anisyah; Tan, Joanne T. M.; Ravindran, Dhanya; Hawkins, Clare; Prosser, Hamish C. G.; Bursill, Christina A.] Heart Res Inst, Newtown, NSW, Australia; [Ridiandries, Anisyah; Tan, Joanne T. M.; Ravindran, Dhanya; Williams, Helen; Medbury, Heather J.; Hawkins, Clare; Prosser, Hamish C. G.; Bursill, Christina A.] Univ Sydney, Sydney Med Sch, Sch Med Sci, Sydney, NSW 2006, Australia; [Lindsay, Laura] Univ Sydney, Sch Med Sci, Dept Anat & Histol, Sydney, NSW 2006, Australia; [Williams, Helen; Medbury, Heather J.] Univ Sydney, Westmead Hosp, Vasc Biol Res Ctr, Dept Surg, Westmead, NSW 2145, Australia	University of Sydney; Heart Research Institute; University of Sydney; University of Sydney; University of Sydney	Bursill, CA (corresponding author), Heart Res Inst, Immunobiol Grp, 7 Eliza St, Washington, DC 20422 USA.	bursillc@hri.org.au	Medbury, Heather/H-6143-2019; Williams, Helen/AAW-9632-2021; Hawkins, Clare/AAV-7424-2021; Tan, Joanne Tsui Ming/Y-4423-2019; Ridiandries, Anisyah/I-4360-2017; Hawkins, Clare L/F-6696-2014; Tan, Ming-Jen/A-3862-2011	Medbury, Heather/0000-0002-1614-7213; Williams, Helen/0000-0001-8221-5766; Hawkins, Clare/0000-0003-2738-5089; Tan, Joanne Tsui Ming/0000-0003-1875-4882; Ridiandries, Anisyah/0000-0001-8996-6896; Hawkins, Clare L/0000-0003-2738-5089; Lindsay, Laura Ann/0000-0003-3139-0702; Tan, Ming-Jen/0000-0002-3583-1723; Bursill, Christina/0000-0002-0682-8760	Heart Research Institute; Heart Foundation of Australia Career Development Fellowship [CR07S3331]; Australian Research Council [FT120100682]	Heart Research Institute(University of Sydney); Heart Foundation of Australia Career Development Fellowship; Australian Research Council(Australian Research Council)	The authors thank the Heart Research Institute (Ph.D. scholarship to A.R.), the Heart Foundation of Australia Career Development Fellowship CR07S3331 (to C.A.B.), and the Australian Research Council Future Fellowship FT120100682 (to C.H). The authors declare no conflicts of interest.	Ali ZA, 2005, CIRCULATION, V112, pI235, DOI 10.1161/CIRCULATIONAHA.104.526129; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Beck CG, 2001, J BIOL CHEM, V276, P43270, DOI 10.1074/jbc.M106305200; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Berkhout TA, 1997, J BIOL CHEM, V272, P16404, DOI 10.1074/jbc.272.26.16404; Bhardwaj S, 2011, ATHEROSCLEROSIS, V219, P84, DOI 10.1016/j.atherosclerosis.2011.07.103; Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Bosco MC, 2004, J IMMUNOL, V172, P1681, DOI 10.4049/jimmunol.172.3.1681; Bursi CA, 2004, CURR OPIN LIPIDOL, V15, P145, DOI [10.1097/00041433-200404000-00007, 10.1097/01.mol.0000124526.75650.13]; Bursill CA, 2009, GENE THER, V16, P93, DOI 10.1038/gt.2008.141; Bursill CA, 2004, CIRCULATION, V110, P2460, DOI 10.1161/01.CIR.0000145122.58420.CO; Bursill CA, 2003, IMMUNOBIOLOGY, V207, P187, DOI 10.1078/0171-2985-00228; Bursill CA, 2006, J IMMUNOL, V177, P5567, DOI 10.4049/jimmunol.177.8.5567; Cabebe Elwyn, 2007, Curr Treat Options Oncol, V8, P15, DOI 10.1007/s11864-007-0022-4; Carfi A, 1999, P NATL ACAD SCI USA, V96, P12379, DOI 10.1073/pnas.96.22.12379; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Dohle Daniel S, 2009, J Vis Exp, DOI 10.3791/1620; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Galvez BG, 2005, J BIOL CHEM, V280, P1292, DOI 10.1074/jbc.M408673200; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Halwani R, 2011, J IMMUNOL, V186, P4156, DOI 10.4049/jimmunol.1001210; Hayes IM, 1998, ARTERIOSCL THROM VAS, V18, P397, DOI 10.1161/01.ATV.18.3.397; Ilan Y, 1999, SEMIN LIVER DIS, V19, P49, DOI 10.1055/s-2007-1007097; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; LEVY AP, 1995, J BIOL CHEM, V270, P13333, DOI 10.1074/jbc.270.22.13333; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Lu X, 2009, J BIOL CHEM, V284, P29087, DOI 10.1074/jbc.M109.035899; Mourad JJ, 2008, ANN ONCOL, V19, P927, DOI 10.1093/annonc/mdm550; Reape TJ, 1999, AM J PATHOL, V154, P365, DOI 10.1016/S0002-9440(10)65283-2; Ribatti D, 2006, NAT PROTOC, V1, P85, DOI 10.1038/nprot.2006.13; Robinson SC, 2003, CANCER RES, V63, P8360; Salcedo R, 2001, J IMMUNOL, V166, P7571, DOI 10.4049/jimmunol.166.12.7571; Satchi-Fainaro R, 2004, NAT MED, V10, P255, DOI 10.1038/nm1002; Scholz D, 2003, MOL CELL BIOCHEM, V246, P57, DOI 10.1023/A:1023403928385; Shi Q, 2001, ONCOGENE, V20, P3751, DOI 10.1038/sj.onc.1204500; Shireman PK, 2006, J SURG RES, V134, P145, DOI 10.1016/j.jss.2005.12.003; Soria G, 2008, CANCER LETT, V267, P271, DOI 10.1016/j.canlet.2008.03.018; Stabile E, 2003, CIRCULATION, V108, P205, DOI 10.1161/01.CIR.0000079225.50817.71; Stamatovic SM, 2006, J IMMUNOL, V177, P2651, DOI 10.4049/jimmunol.177.4.2651; Strasly M, 2004, BLOOD, V103, P40, DOI 10.1182/blood-2003-05-1387; STRIETER RM, 1995, SHOCK, V4, P155, DOI 10.1097/00024382-199509000-00001; Tanaka T, 2005, CANCER SCI, V96, P317, DOI 10.1111/j.1349-7006.2005.00059.x; Turner L, 1999, EUR J IMMUNOL, V29, P2280, DOI 10.1002/(SICI)1521-4141(199907)29:07<2280::AID-IMMU2280>3.0.CO;2-C; Weber C, 2004, ARTERIOSCL THROM VAS, V24, P1997, DOI 10.1161/01.ATV.0000142812.03840.6f; Zhang J, 2010, JNCI-J NATL CANCER I, V102, P522, DOI 10.1093/jnci/djq044; Zhang L, 2006, P NATL ACAD SCI USA, V103, P13985, DOI 10.1073/pnas.0602142103	51	12	12	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1179	1192		10.1096/fj.201600540R	http://dx.doi.org/10.1096/fj.201600540R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27998907				2022-12-26	WOS:000395671200030
J	Cao, GD; Xu, XY; Zhang, JW; Chen, B; Xiong, MM				Cao, Guo-dong; Xu, Xing-yu; Zhang, Jia-wei; Chen, Bo; Xiong, Mao-ming			Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer	PLOS ONE			English	Article							SIGNALING PATHWAY; TUMOR PROGRESSION; EXPRESSION; ACTIVATION; CARCINOMA; OVEREXPRESSION; ADENOCARCINOMA; METASTASIS; INHIBITION; CELLS	Aims The mammalian target of rapamycin (mTOR) and phosphorylated mTOR (p-mTOR) occurring downstream in the PI3K/Akt/mTOR pathway, are regarded as potential prognostic markers for gastric cancer (GC). However, the prognostic value of mTOR/p-mTOR expression remains controversial. In this study, we determined the expression of mTOR, p-mTOR, p70S6k, and p-p70S6K in GC, and investigated the correlation between their overexpression, clinicopathological parameters, and overall survival (OS). Methods The expression of mTOR, p-mTOR, p70S6k, and p-p70S6K was examined in 120 GC patients by immunohistochemistry (IHC). The association of protein expression with clinicopathological features and OS was explored. The p-mTOR expression was detected in normal, adjacent, and GC tissues using Western blot. Eligible studies retrieved from PubMed, Ovid, Web of Science and Cochrane databases, were reviewed in this meta-analysis. Results IHC showed that the rates of expression of the signal transduction molecules mTOR, pmTOR, p70S6k and p-p70S6K in GC were 60.8%, 54.2%, 53.3% and 53.3%, respectively. Overexpression of mTOR and p70S6K showed no significant association with clinical variables. Expression of p-mTOR was significantly associated with differentiation (P < 0.01), depth of invasion (P < 0.01), lymph node metastasis (P = 0.04) and TNM stage (P = 0.02). Expression of p-p70S6K was associated with differentiation (P = 0.006), depth of invasion (P < 0.001), and TNM stage (P = 0.02). In survival analysis, differentiation, depth of invasion, lymph node metastasis and TNM stage were not related to OS (all P > 0.05). Furthermore, p-mTOR and p-p70S6K expression, but not mTOR and p70S6K, were tightly associated with OS of GC patients (P = 0.006 and P < 0.001, respectively). In Western blot, p-mTOR was significantly higher in GC tissues than in normal and adjacent tissues. In the present meta-analysis, mTOR overexpression showed no relationship with any clinicopathological variables. However, p-mTOR was correlated with depth of invasion, and TNM stage (all P < 0.05), and its overexpression was associated with a shorter survival time (P < 0.001). Conclusion The results suggest that p-mTOR is a more valuable prognostic factor than mTOR in GC.	[Cao, Guo-dong; Xu, Xing-yu] Anhui Med Univ, Hefei, Anhui, Peoples R China; [Zhang, Jia-wei; Chen, Bo; Xiong, Mao-ming] Anhui Med Univ, Affiliated Hosp 1, Dept Gen Surg, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Chen, B; Xiong, MM (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Gen Surg, Hefei, Anhui, Peoples R China.	chenbo831116@163.com; ayfyxmm@163.com	Cao, Guodong/AAJ-1089-2020		National Natural Science Foundation of China [81602425]; Natural Science Foundation of Anhui Province [1508085QH152, 1608085MH163]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province)	This work was supported by grants from the National Natural Science Foundation of China (NO: 81602425) and the Natural Science Foundation of Anhui Province (NO: 1508085QH152, 1608085MH163). The funders had no role in study design, data collection and analysis, manuscript preparation, or submission for publication.	Ahn HS, 2010, CANCER-AM CANCER SOC, V116, P5592, DOI 10.1002/cncr.25550; An JY, 2010, INT J CANCER, V126, P2904, DOI 10.1002/ijc.24872; Bian YH, 2015, BIOCHEM BIOPH RES CO, V464, P534, DOI 10.1016/j.bbrc.2015.07.001; Byeon SJ, 2014, J SURG ONCOL, V109, P812, DOI 10.1002/jso.23585; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Gulhati P, 2009, CLIN CANCER RES, V15, P7207, DOI 10.1158/1078-0432.CCR-09-1249; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hassan B, 2013, SURG ONCOL CLIN N AM, V22, P641, DOI 10.1016/j.soc.2013.06.008; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Inokuchi M, 2011, EXP THER MED, V2, P251, DOI 10.3892/etm.2011.187; Ji J, 2010, GYNECOL ONCOL, V117, P103, DOI 10.1016/j.ygyno.2009.12.020; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Li L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116771; Li M, 2012, ONCOL LETT, V4, P1213, DOI 10.3892/ol.2012.930; Murayama T, 2009, BRIT J CANCER, V100, P782, DOI 10.1038/sj.bjc.6604915; Niu HY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-28; Osaki M, 2004, J CANCER RES CLIN, V130, P8, DOI 10.1007/s00432-003-0505-z; Oulhen N, 2010, MOL REPROD DEV, V77, P83, DOI 10.1002/mrd.21110; Philp AJ, 2001, CANCER RES, V61, P7426; Riquelme I, 2016, PATHOL ONCOL RES; Sasako M, 2008, NEW ENGL J MED, V359, P453, DOI 10.1056/NEJMoa0707035; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang D, 2011, ASIAN PAC J CANCER P, V12, P2581; Xiao L, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-152; Xu DZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-536; Yang HY, 2013, MOL MED REP, V7, P537, DOI 10.3892/mmr.2012.1208; Yoon DH, 2012, BRIT J CANCER, V106, P1039, DOI 10.1038/bjc.2012.47; Yu GZ, 2009, CLIN CANCER RES, V15, P1821, DOI 10.1158/1078-0432.CCR-08-2138; Zhou XY, 2004, CLIN CANCER RES, V10, P6779, DOI 10.1158/1078-0432.CCR-04-0112; Zou Wen-Bin, 2015, Zhejiang Da Xue Xue Bao Yi Xue Ban, V44, P9	34	13	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168085	10.1371/journal.pone.0168085	http://dx.doi.org/10.1371/journal.pone.0168085			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005970	Green Submitted, gold, Green Published			2022-12-26	WOS:000392843200028
J	Kaczmarczyk, D; Wolnicki, J				Kaczmarczyk, Dariusz; Wolnicki, Jacek			Genetic Diversity of the Critically Endangered Lake Minnow Eupallasella percnurus in Poland and Its Implications for Conservation	PLoS One			English	Article							CROSS-SPECIES AMPLIFICATION; MICROSATELLITE LOCI; POPULATION-STRUCTURE; VARIABILITY; CYPRINIDAE; BOTTLENECK; DIFFERENTIATION; DISTANCES; TELEOSTEI; SOFTWARE	The lake minnow (Eupallasella percnurus) is critically endangered. In this paper we characterize the genetic properties of this fish over its range of occurrence in Poland and propose the use of this knowledge in its active protection. Twelve populations of lake minnow from across its range in Poland were investigated. 13 microsatellite loci were investigated to evaluate genetic variation and distance among populations. The magnitude of the genetic bottleneck or founder effects was investigated. In the studied populations, the allelic diversity and heterozygosity showed that genetic variation in this species is low. At most loci, only 2-3 alleles per population were detected. The average number of alleles detected across all loci was 35, and ranged from 24 to 53. The average observed heterozygosity (Ho) across all investigated loci was 0.38 (range 0.21-0.59); the average expected heterozygosity (He) was 0.36 (range 0.18-0.55). The populations remained in Hardy-Weinberg equilibrium. The average Garza-Williamson M index value for all populations was low (0.47), suggesting a reduction in genetic variation due to a founder effect or a genetic bottleneck. Genetic distance among populations was high or very high (FST range: 0.20-0.64; delta mu(2) range: 1.32-16.98); this was likely a consequence of low gene flow among isolated populations, a founder effect or other genetic bottleneck, and strong genetic drift. The large genetic differences among the investigated lake minnow populations are likely to also exist among other populations of this species, and knowledge of these differences should inform active protection programs based on translocation of wild or cultivated fish of this species. The method presented here can potentially be applied to any population of lake minnows or closely related species.	[Kaczmarczyk, Dariusz] Univ Warmia & Mazury, Dept Environm Biotechnol, Sloneczna 45G, Olsztyn, Poland; [Wolnicki, Jacek] Inland Fisheries Inst, Pond Fishery Dept, Glowna 48, Zabieniec, Piaseczno, Poland	University of Warmia & Mazury	Kaczmarczyk, D (corresponding author), Univ Warmia & Mazury, Dept Environm Biotechnol, Sloneczna 45G, Olsztyn, Poland.	d.kaczmarczyk@uwm.edu.pl		Wolnicki, Jacek/0000-0003-4396-390X	Ministry of Science and Higher Education in Poland [N N304 324839]; National Science Centre in Poland [2014/15/B/NZ9/05240]	Ministry of Science and Higher Education in Poland(Ministry of Science and Higher Education, Poland); National Science Centre in Poland(National Science Centre, Poland)	Those studies were financed by the Ministry of Science and Higher Education in Poland within project No. N N304 324839 for 2010-2013 and by the National Science Centre in Poland within project No. 2014/15/B/NZ9/05240 for 2015-2018.	Aksoy S, 2013, MOL ECOL RESOUR, V13, P341, DOI 10.1111/1755-0998.12061; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Bellinger MR, 2003, CONSERV BIOL, V17, P717, DOI 10.1046/j.1523-1739.2003.01581.x; Bjornstad G, 2003, ANIM GENET, V34, P55, DOI 10.1046/j.1365-2052.2003.00922.x; Bogutskaya NG, 2005, ICHTHYOL EXPLOR FRES, V16, P93; Burridge CP, 2003, CONSERV GENET, V4, P219, DOI 10.1023/A:1023390606975; CARVALHO GR, 1993, J FISH BIOL, V43, P53, DOI 10.1111/j.1095-8649.1993.tb01179.x; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dimsoski P, 2000, MOL ECOL, V9, P2187, DOI 10.1046/j.1365-294X.2000.105318.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Freyhof J., 2007, HDB EUROPEAN FRESHWA; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Grisolia AB, 2007, GENET MOL RES, V6, P382; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Heath DD, 2001, HEREDITY, V86, P618, DOI 10.1046/j.1365-2540.2001.00867.x; Holmen J, 2005, J FISH BIOL, V66, P851, DOI 10.1111/j.0022-1112.2005.00637.x; Hughes JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121858; Kaczmarczyk D, 2015, CONSERV GENET RESOUR, V7, P49, DOI 10.1007/s12686-014-0356-8; Kaczmarczyk Dariusz, 2011, Archives of Polish Fisheries, V19, P145; King TL, 2001, CONSERV GENET, V2, P103, DOI 10.1023/A:1011895429669; Kusznierz J, 2006, FISHERIES MANAG ECOL, V13, P131, DOI 10.1111/j.1365-2400.2006.00482.x; Kusznierz Jan, 2011, Archives of Polish Fisheries, V19, P161; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; LEVINS RICHARD, 1968; Luenser K, 2005, EUR J WILDLIFE RES, V51, P84, DOI 10.1007/s10344-005-0081-4; Michalakis Y, 1996, GENETICS, V142, P1061; Nei M., 1987, MOL EVOLUTIONARY GEN; OConnell M, 1997, REV FISH BIOL FISHER, V7, P331, DOI 10.1023/A:1018443912945; Paetkau D, 1997, GENETICS, V147, P1943; Piotrowski W., 1994, CHRONMY PRZYR OJCZ, V5, P91; Pritchard JK, 2000, GENETICS, V155, P945; Rowe G, 1998, MOL ECOL, V7, P751, DOI 10.1046/j.1365-294x.1998.00387.x; Ruzzante DE, 1998, CAN J FISH AQUAT SCI, V55, P1, DOI 10.1139/cjfas-55-1-1; Salgueiro P, 2003, BIOL CONSERV, V109, P47, DOI 10.1016/S0006-3207(02)00132-5; Sikorska Justyna, 2011, Archives of Polish Fisheries, V19, P195; Tzika AC, 2008, MOL ECOL, V17, P4943, DOI 10.1111/j.1365-294X.2008.03967.x; Waser PM, 1998, TRENDS ECOL EVOL, V13, P43, DOI 10.1016/S0169-5347(97)01255-X; Whitehouse AM, 2001, MOL ECOL, V10, P2139, DOI 10.1046/j.0962-1083.2001.01356.x; Wisely SM, 2002, J HERED, V93, P231, DOI 10.1093/jhered/93.4.231; Wolnicki J, 2009, KOMUN RYB, V2, P10; Wolnicki Jacek, 2010, Teka Komisji Ochrony i Ksztaltowania Srodowiska Przyrodniczego, V7, P473; Wolnicki Jacek, 2011, Archives of Polish Fisheries, V19, P209, DOI 10.2478/v10086-011-0026-3; Wolnicki Jacek, 2009, Chronmy Przyrode Ojczysta, V65, P329; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Wright S., 1978, EVOLUTION GENETICS P; Zhao N, 2005, J APPL ICHTHYOL, V21, P7, DOI 10.1111/j.1439-0426.2004.00630.x	47	8	11	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168191	10.1371/journal.pone.0168191	http://dx.doi.org/10.1371/journal.pone.0168191			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005951	gold, Green Published, Green Submitted			2022-12-26	WOS:000392843200035
J	Komina, A; Palkina, N; Aksenenko, M; Tsyrenzhapova, S; Ruksha, T				Komina, Anna; Palkina, Nadezhda; Aksenenko, Mariya; Tsyrenzhapova, Seseg; Ruksha, Tatiana			Antiproliferative and Pro-Apoptotic Effects of MiR-4286 Inhibition in Melanoma Cells	PLOS ONE			English	Article							MICRORNA EXPRESSION; PATHWAY; GROWTH; CANCER; PROLIFERATION; PROGRESSION; METASTASIS; IMPACT	Introduction MicroRNAs are essential regulators of gene expression at the post-transcriptional level. Their expression is altered in cancer tissues, and evaluation of these alterations is considered a promising tool used to diagnose and identify prognostic markers. Materials and methods The microRNA expression profiles of formalin-fixed, paraffin-embedded melanoma and melanocytic nevi samples were estimated with a microarray and subsequently validated by real-time PCR. Melanoma cells were transfected with miR-4286 inhibitor to evaluate the influence of this microRNA on the viability, proliferation, apoptosis, migration, and invasion of melanoma cells. Results The microarray revealed that the expression of 1,171 microRNAs was altered in melanoma samples compared to melanocytic nevi. Real-time PCR validation experiments found the microRNA expression levels to correspond to the melanoma/melanocytic nevi microarray results. The pathway analysis identified 52 modulated pathways in melanoma. Moreover, the application of miR-4286 inhibitor to BRO melanoma cells resulted in a 2.6-fold increase in the apoptosis rate and a 1.7-fold decrease in the cell proliferation/viability but did not affect the invasiveness and migration of these cells. Furthermore, the use of miR-4286 inhibitor altered the mRNA expression of several miR-4286 gene targets: folylpolyglutamate synthase, RNA polymerase I-specific transcription initiation factor, apelin, G-protein-coupled receptor 55, and high-mobility group A1 protein, which have been implicated in cell proliferation/apoptosis regulation. Lastly, the transiently transfected SK-MEL-1 cells with miR-4286 inhibitor decreased proliferation rate and modulated folylpolyglutamate synthase rates of these cells. Conclusion Our results demonstrate that miR-4286 mediates proliferation and apoptosis in melanoma cells, these findings may represent a novel mechanism underlying these processes.	[Komina, Anna; Palkina, Nadezhda; Aksenenko, Mariya; Tsyrenzhapova, Seseg; Ruksha, Tatiana] Krasnoyarsk State Med Univ, Dept Pathophysiol, Krasnoyarsk, Russia	Krasnoyarsk State Medical University	Ruksha, T (corresponding author), Krasnoyarsk State Med Univ, Dept Pathophysiol, Krasnoyarsk, Russia.	tatyana_ruksha@mail.ru	Palkina, Nadezhda/P-1585-2015; Tyumentseva, Anna V/O-9770-2015; Ruksha, Tatiana/A-4801-2014	Tyumentseva, Anna V/0000-0002-2269-0298; Ruksha, Tatiana/0000-0001-8142-4283; Palkina, Nadezhda Vladimirovna/0000-0002-6801-3452	Russian Science Foundation [14-15-00074]	Russian Science Foundation(Russian Science Foundation (RSF))	The study was supported by the grant of the Russian Science Foundation (Ruksha T.G., project No 14-15-00074), www.rscf.ru.; The study was supported by a grant from the Russian Science Foundation (project No 14-15-00074).	Acunzo M, 2015, J INFECT DIS, V212, pS74, DOI 10.1093/infdis/jiv197; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boyle GM, 2011, PIGM CELL MELANOMA R, V24, P525, DOI 10.1111/j.1755-148X.2011.00849.x; Brazma A, 2009, THESCIENTIFICWORLDJO, V9, P420, DOI 10.1100/tsw.2009.57; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Cherradi N, 2016, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00195; Cui RR, 2010, AMINO ACIDS, V39, P1193, DOI 10.1007/s00726-010-0555-x; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; Drahos J, 2015, CANC EPIDEMIOL BIOMA; Eberle J, 2002, J INVEST DERMATOL, V119, P549, DOI 10.1046/j.1523-1747.2002.01848.x; Enright AJ, 2004, GENOME BIOL, V5; Fedorenko IV, 2015, J INVEST DERMATOL, V135, P3115, DOI 10.1038/jid.2015.329; Frampton AE, 2013, EXPERT REV MOL DIAGN, V13, P31, DOI [10.1586/ERM.12.136, 10.1586/erm.12.136]; Han XX, 2016, BIOMED PHARMACOTHER, V82, P312, DOI 10.1016/j.biopha.2016.05.004; Hu FY, 2016, BIOCHEM BIOPH RES CO, V474, P35, DOI 10.1016/j.bbrc.2016.04.055; Jayawardana K, 2016, J INVEST DERMATOL, V136, P245, DOI 10.1038/JID.2015.355; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kajdaniuk D, 2013, ENDOKRYNOL POL, V64, P384, DOI 10.5603/EP.2013.0022; Kaushik G, 2014, AM J SURG, V208, P995, DOI 10.1016/j.amjsurg.2014.09.014; Kawai Y, 2013, AM J PHYSIOL-CELL PH, V305, pC1139, DOI 10.1152/ajpcell.00199.2013; Kozubek J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072699; Levati L, 2009, INT J ONCOL, V35, P393, DOI 10.3892/ijo_00000352; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu H, 2012, PROTEIN CELL, V3, P291, DOI 10.1007/s13238-012-2919-3; LOCKSHIN A, 1985, CANCER RES, V45, P345; Lu J, 2012, GENOME RES, V22, P1243, DOI 10.1101/gr.132514.111; Margue C, 2015, ONCOTARGET, V6, P12110, DOI 10.18632/oncotarget.3661; Mazar J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013779; Mueller DW, 2009, J INVEST DERMATOL, V129, P1740, DOI 10.1038/jid.2008.452; Park H, 2014, GYNECOL ONCOL, V135, P565, DOI 10.1016/j.ygyno.2014.09.010; Pentheroudakis G, 2013, CLIN EXP METASTAS, V30, P431, DOI 10.1007/s10585-012-9548-3; Perrot CY, 2013, ANN DERMATOL, V25, P135, DOI 10.5021/ad.2013.25.2.135; Piskounova E, 2015, NATURE, V527, P186, DOI 10.1038/nature15726; Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003; Ryu B, 2013, J INVEST DERMATOL, V133, P1137, DOI 10.1038/jid.2012.505; Sand M, 2013, CELL TISSUE RES, V351, P85, DOI 10.1007/s00441-012-1514-5; Sandru A, 2014, J Med Life, V7, P572; Schlegel NC, 2015, EXP DERMATOL, V24, P22, DOI 10.1111/exd.12580; Schmuhl E, 2014, BIOCHEM PHARMACOL, V87, P489, DOI 10.1016/j.bcp.2013.11.016; Shuang L, 2016, CLIN EXP OBSTET GYN, V43, P409, DOI 10.12891/ceog2133.2016; Villaruz LC, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0092-2; Susluer SY, 2015, J NEUROL SCI-TURK, V32, P64; Zecchin KG, 2011, LAB INVEST, V91, P232, DOI 10.1038/labinvest.2010.157; Zhang J.D., 2013, CITESEER, V48, P346, DOI DOI 10.18129/B9.BIOC.DDC; Zhou JD, 2015, CANCER BIOL THER, V16, P846, DOI 10.1080/15384047.2015.1030545	45	28	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168229	10.1371/journal.pone.0168229	http://dx.doi.org/10.1371/journal.pone.0168229			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005927	Green Published, Green Submitted, gold			2022-12-26	WOS:000392843200039
J	Schoonvaere, K; De Smet, L; Smagghe, G; Vierstraete, A; Braeckman, BP; de Graaf, DC				Schoonvaere, Karel; De Smet, Lina; Smagghe, Guy; Vierstraete, Andy; Braeckman, Bart P.; de Graaf, Dirk C.			Unbiased RNA Shotgun Metagenomics in Social and Solitary Wild Bees Detects Associations with Eukaryote Parasites and New Viruses	PLOS ONE			English	Article							KROMBEINI ACARI CHAETODACTYLIDAE; SEQUENCE ALIGNMENT; BOMBUS-TERRESTRIS; MOLECULAR CHARACTERIZATION; HYMENOPTERA; PATHOGEN; MICROSPORIDIA; POLLINATORS; PERFORMANCE; PASCUORUM	The diversity of eukaryote organisms and viruses associated with wild bees remains poorly characterized in contrast to the well-documented pathosphere of the western honey bee, Apis mellifera. Using a deliberate RNA shotgun metagenomic sequencing strategy in combination with a dedicated bioinformatics workflow, we identified the (micro-)organisms and viruses associated with two bumble bee hosts, Bombus terrestris and Bombus pascuorum, and two solitary bee hosts, Osmia corn uta and Andrena vaga. Ion Torrent semiconductor sequencing generated approximately 3.8 million high quality reads. The most significant eukaryote associations were two protozoan, Apicystis bombiand Crithidia bombi, and one nematode parasite Sphaerularia bombi in bumble bees. The trypanosome protozoan C. bombi was also found in the solitary bee 0. corn uta. Next to the identification of three honey bee viruses Black queen cell virus, Sacbrood virus and Varroa destructor virus-1 and four plant viruses, we describe two novel RNA viruses Scaldis River bee virus (SRBV) and Ganda bee virus (GABV) based on their partial genomic sequences. The novel viruses belong to the class of negative-sense RNA viruses, SRBV is related to the order Mononegavirales whereas GABV is related to the family Bunyaviridae. The potential biological role of both viruses in bees is discussed in the context of recent advances in the field of arthropod viruses. Further, fragmentary sequence evidence for other undescribed viruses is presented, among which a nudivirus in 0. corn uta and an unclassified virus related to Chronic bee paralysis virus in B. terrestris. Our findings extend the current knowledge of wild bee parasites in general and addsto the growing evidence of unexplored arthropod viruses in valuable insects.	[Schoonvaere, Karel; De Smet, Lina; de Graaf, Dirk C.] Univ Ghent, Fac Sci, Dept Biochem & Microbiol, Lab Mol Entomol & Bee Pathol, Ghent, Belgium; [Smagghe, Guy; Vierstraete, Andy] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, Lab Agrozool, Ghent, Belgium; [Braeckman, Bart P.] Univ Ghent, Dept Biol, Lab Ageing Physiol & Mol Evolut, Ghent, Belgium	Ghent University; Ghent University; Ghent University	Schoonvaere, K (corresponding author), Univ Ghent, Fac Sci, Dept Biochem & Microbiol, Lab Mol Entomol & Bee Pathol, Ghent, Belgium.	karel.schoonvaere@ugent.be	Smagghe, Guy/AAE-8914-2019; de Graaf, Dirk C./HGD-4017-2022	Smagghe, Guy/0000-0001-8334-3313; 	Belgian Science Policy (BELSPO) [BR/132/A1/BELBEES]	Belgian Science Policy (BELSPO)(Belgian Federal Science Policy Office)	Belgian Science Policy (BELSPO; BR/132/A1/BELBEES; Multi-disciplinary assessment of BELgian wild BEE decline to adapt mitigation management policy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballinger MJ, 2014, J VIROL, V88, P8783, DOI 10.1128/JVI.00531-14; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Chang JM, 2014, MOL BIOL EVOL, V31, P1625, DOI 10.1093/molbev/msu117; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; de Miranda JR, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.22; DURRER S, 1994, P ROY SOC B-BIOL SCI, V258, P299, DOI 10.1098/rspb.1994.0176; Fan Q.-H., 2007, FAUNA N Z, P291; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fries I, 1999, EUR J PROTISTOL, V35, P183, DOI 10.1016/S0932-4739(99)80036-4; Genersch E, 2006, J INVERTEBR PATHOL, V91, P61, DOI 10.1016/j.jip.2005.10.002; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hadziavdic K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087624; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Kanzaki N, 2007, ZOOL SCI, V24, P1134, DOI 10.2108/zsj.24.1134; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Klatt BK, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2440; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; Ladurner E, 2004, J APICULT RES, V43, P118, DOI 10.1080/00218839.2004.11101121; Li C, 2015, ELIFE, V4, DOI [10.7554/eLife.06587, 10.1155/2015/757269]; LIPA JJ, 1992, APIDOLOGIE, V23, P533, DOI 10.1051/apido:19920605; Maebe K, 2013, APIDOLOGIE, V44, P188, DOI 10.1007/s13592-012-0170-9; McKinney MI, 2013, EXP APPL ACAROL, V60, P153, DOI 10.1007/s10493-012-9629-7; McMahon DP, 2015, J ANIM ECOL, V84, P615, DOI 10.1111/1365-2656.12345; Meeus I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125152; Mu JF, 2014, J GEN VIROL, V95, P2531, DOI 10.1099/vir.0.068262-0; Nouri S, 2016, J VIROL, V90, P2434, DOI 10.1128/JVI.02793-15; Olivier V, 2008, VIRUS RES, V132, P59, DOI 10.1016/j.virusres.2007.10.014; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Otti O, 2007, J INVERTEBR PATHOL, V96, P118, DOI 10.1016/j.jip.2007.03.016; Parmentier L, 2016, APIDOLOGIE, V47, P237, DOI 10.1007/s13592-015-0393-7; Parmentier L, 2016, J INVERTEBR PATHOL, V134, P6, DOI 10.1016/j.jip.2015.12.003; Peng WJ, 2011, APIDOLOGIE, V42, P650, DOI 10.1007/s13592-011-0061-5; Plischuk S, 2015, J INVERTEBR PATHOL, V126, P31, DOI 10.1016/j.jip.2015.01.006; POINAR GO, 1972, NEMATOLOGICA, V18, P239, DOI 10.1163/187529272X00476; POINAR GO, 1972, J NEMATOL, V4, P270; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; POUVREAU A, 1974, Apidologie, V5, P39, DOI 10.1051/apido:19740103; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ravoet J, 2014, J INVERTEBR PATHOL, V122, P55, DOI 10.1016/j.jip.2014.08.007; Reaumur RAF, 1742, MEMOIRES SERVIR HIST, V6; Reddy B, 2015, GENET RES INT, V2015, DOI 10.1155/2015/638679; Roossinck MJ, 2011, NAT REV MICROBIOL, V9, P99, DOI 10.1038/nrmicro2491; Schwarz RS, 2016, CURRENT OPI IN PRESS; Shi M, 2016, J VIROL, V90, P659, DOI 10.1128/JVI.02036-15; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Strand MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002757; Tange O, 2011, USENIX MAG, V36, P42, DOI [10.5281/zenodo.16303, DOI 10.5281/ZENODO.16303]; Vasilakis N, 2013, J VIROL, V87, P2475, DOI 10.1128/JVI.00776-12; Wang YJ, 2011, VIRUS GENES, V42, P444, DOI 10.1007/s11262-011-0589-5; White JB, 2009, J ECON ENTOMOL, V102, P2090, DOI 10.1603/029.102.0611; Yin XW, 2013, CELL MOL LIFE SCI, V70, P3029, DOI 10.1007/s00018-013-1308-2; Yourth CP, 2006, P ROY SOC B-BIOL SCI, V273, P655, DOI 10.1098/rspb.2005.3371	58	28	29	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168456	10.1371/journal.pone.0168456	http://dx.doi.org/10.1371/journal.pone.0168456			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006002	Green Published, Green Submitted, gold			2022-12-26	WOS:000392843200052
J	Torrents, C; Ric, A; Hristovski, R; Torres-Ronda, L; Vicente, E; Sampaio, J				Torrents, Carlota; Ric, Angel; Hristovski, Robert; Torres-Ronda, Lorena; Vicente, Emili; Sampaio, Jaime			Emergence of Exploratory, Technical and Tactical Behavior in Small-Sided Soccer Games when Manipulating the Number of Teammates and Opponents	PLOS ONE			English	Article							HEART-RATE; PHYSIOLOGICAL-RESPONSES; TIME-MOTION; CONSTRAINTS; CREATIVITY; FOOTBALL; MOVEMENT; PLAYERS; STATISTICS; NOVELTY	The effects that different constraints have on the exploratory behavior, measured by the variety and quantity of different responses within a game situation, is of the utmost importance for successful performance in team sports. The aim of this study was to determine how the number of teammates and opponents affects the exploratory behavior of both professional and amateur players in small-sided soccer games. Twenty-two professional (age 25.6 +/- 4.9 years) and 22 amateur (age 23.1 +/- 0.7 years) male soccer players played three small-sided game formats (4 vs. 3, 4 vs. 5, and 4 vs. 7). These trials were video-recorded and a systematic observation instrument was used to notate the actions, which were subsequently analyzed by means of a principal component analysis and the dynamic overlap order parameter (measure to identify the rate and breadth of exploratory behavior on different time scales). Results revealed that a higher the number of opponents required for more frequent ball controls. Moreover, with a higher number of teammates, there were more defensive actions focused on protecting the goal, with more players balancing. In relation to attack, an increase in the number of opponents produced a decrease in passing, driving and controlling actions, while an increase in the number of teammates led to more time being spent in attacking situations. A numerical advantage led to less exploratory behavior, an effect that was especially clear when playing within a team of seven players against four opponents. All teams showed strong effects of the number of teammates on the exploratory behavior when comparing 5 vs 7 or 3 vs 7 teammates. These results seem to be independent of the players' level.	[Torrents, Carlota; Ric, Angel; Vicente, Emili] Univ Lleida, INEFC, Natl Inst Phys Educ Catalonia, Lleida, Spain; [Hristovski, Robert] Sts Cyril & Methodius Univ, Skopje, Macedonia; [Torres-Ronda, Lorena] Texas A&M Univ, Dept Hlth & Kinesiol, Exercise & Sport Nutr Lab, College Stn, TX USA; [Sampaio, Jaime] CIDESD, Res Ctr Sports Sci Hlth Sci & Human Dev, CreativeLab, Vila Real, Portugal; [Sampaio, Jaime] Univ Tras Os Montes & Alto Douro, Sport Sci Dept, Vila Real, Portugal	Universitat de Lleida; Saints Cyril & Methodius University of Skopje; Texas A&M University System; Texas A&M University College Station; University of Tras-os-Montes & Alto Douro	Torrents, C (corresponding author), Univ Lleida, INEFC, Natl Inst Phys Educ Catalonia, Lleida, Spain.	ctorrents@inefc.es	Ric, Angel/F-8977-2016; Sampaio, Jaime/B-7392-2008; Hristovski, Robert/L-4116-2015; Ric, Angel/AAR-6566-2020; Torrents, Carlota/AAX-6166-2020; Torrents, Carlota/D-5704-2017	Ric, Angel/0000-0003-4944-4529; Sampaio, Jaime/0000-0003-2335-9991; Hristovski, Robert/0000-0001-6805-2833; Ric, Angel/0000-0003-4944-4529; Torrents, Carlota/0000-0003-4912-2802; Torrents, Carlota/0000-0003-4912-2802; Mateu Serra, Merce/0000-0001-7809-5597	National Institute of Physical Education of Catalonia (INEFC), Generalitat de Catalunya; Generalitat de Catalunya government project Grup de recerca en Sistemes Complexos i Esport [2014 SGR 975]; Project Symbiotic technology for societal efficiency gains: Deus ex Machina (DEM) [NORTE-01-0145-FEDER-000026]; Fundo Europeu de Desenvolvimento Regional (FEDER) by NORTE	National Institute of Physical Education of Catalonia (INEFC), Generalitat de Catalunya; Generalitat de Catalunya government project Grup de recerca en Sistemes Complexos i Esport; Project Symbiotic technology for societal efficiency gains: Deus ex Machina (DEM); Fundo Europeu de Desenvolvimento Regional (FEDER) by NORTE	This study was supported by the National Institute of Physical Education of Catalonia (INEFC), Generalitat de Catalunya.; We would like to thank the players who volunteered to participate in this study. We gratefully acknowledge the support of the Generalitat de Catalunya government project Grup de recerca en Sistemes Complexos i Esport (2014 SGR 975) and Project Symbiotic technology for societal efficiency gains: Deus ex Machina (DEM), NORTE-01-0145-FEDER-000026, co-financed by Fundo Europeu de Desenvolvimento Regional (FEDER) by NORTE 2020.	Abrantes CI, 2012, J STRENGTH COND RES, V26, P976, DOI 10.1519/JSC.0b013e31822dd398; Aguiar MVD, 2013, J STRENGTH COND RES, V27, P1287, DOI 10.1519/JSC.0b013e318267a35c; Amabile T.M., 1989, GROWING CREATIVE NUR; Araujo D, 2007, ECOL PSYCHOL, V19, P69, DOI 10.1080/10407410709336951; Boden M.A., 1996, DIMENSIONS CREATIVIT, P75; Bruineberg J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00599; Casamichana D, 2010, J SPORT SCI, V28, P1615, DOI 10.1080/02640414.2010.521168; Castaner M, 2009, APUNT EDUC FIS DEPOR, P14; Castellano J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0127505; Chemero A, 2003, ECOL PSYCHOL, V15, P181, DOI 10.1207/S15326969ECO1502_5; Costa I.T., 2011, MOTRICIDADE, V7, P69, DOI [DOI 10.6063/MOTRICIDADE.7(1).121, 10.6063/motricidade.121, DOI 10.6063/MOTRICIDADE.121]; Davids K, 2013, EXERC SPORT SCI REV, V41, P154, DOI 10.1097/JES.0b013e318292f3ec; Dellal A, 2011, J STRENGTH COND RES, V25, P2371, DOI 10.1519/JSC.0b013e3181fb4296; Drazin R, 1999, ACAD MANAGE REV, V24, P286, DOI 10.2307/259083; Duarte R., 2009, OPEN SPORTS SCI J, V2, P37, DOI [10.2174/1875399X00902010037, DOI 10.2174/1875399X00902010037]; Gibson J.J., 1986, ECOLOGICAL APPROACH; Goncalves B, 2016, J SPORT SCI, V34, P1346, DOI 10.1080/02640414.2016.1143111; Guilford J.P., 1967, NATURE HUMAN INTELLI; Halouani J, 2014, J SPORT SCI, V32, P1485, DOI 10.1080/02640414.2014.899707; Hearn G, 2014, CREATIVE WORK BEYOND THE CREATIVE INDUSTRIES: INNOVATION, EMPLOYMENT AND EDUCATION, P175; Hill-Haas SV, 2011, SPORTS MED, V41, P199, DOI 10.2165/11539740-000000000-00000; Hristovski R., 2012, OPEN SPORTS SCI J S, V5, P26, DOI [10.2174/1875399X01205010026, DOI 10.2174/1875399X01205010026]; Hristovski R., 2009, PERSPECTIVES COGNITI, P43; Hristovski R., 2013, COMPLEX SYSTEMS SPOR, P261; Hristovski R, 2011, NONLIN DYNAM PSYCHOL, V15, P175; Joliffe I. T., 2002, PRINCIPAL COMPONENT, V2nd; Jones S., 2007, KINESIOLOGY, V39, P150; Kasof J, 1995, CREATIVITY RES J, V8, P397; Katis A, 2009, J SPORT SCI MED, V8, P374; Keith F, 2011, IEEE INT C INT ROBOT, P3887, DOI 10.1109/IROS.2011.6048309; Kelso J. A., 2009, ENCY COMPLEXITY SYST, P1537, DOI [10.1007/978-0-387-30440-3_101, DOI 10.1007/978-0-387-30440-3_101]; Kelso JAS, 1995, COMPLEX ADAPTIVE SYS; Los Arcos A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137224; Memmert D., 2015, TEACHING TACTICAL CR; Memmert D., 2011, ENCY CREATIVITY, V2, P373, DOI [10.1016/B978-0-12-375038-9.00207-7, DOI 10.1016/B978-0-12-375038-9.00207-7]; Memmert D, 2007, J SPORT SCI, V25, P1423, DOI 10.1080/02640410601129755; Memmert M, 2014, RES PHYS ED SPORT HL, V3, P13, DOI DOI 10.4324/9781315146270-11; Mendes RS, 2007, EUR PHYS J B, V57, P357, DOI [10.1140/epjb/e2007-00177-4, 10.1140/epjb/o2007-00177-4]; Mitchell S, 2007, ECOLOGICAL APPROACH, P161; Mumford MD, 1997, J CREATIVE BEHAV, V31, P1; Newell K.M., 1986, MOTOR DEV CHILDREN A, VVolume 34, P341, DOI DOI 10.1007/978-94-009-4460-2_19; Owen A, 2004, INSIGHT, V7, P50; Owen AL, 2014, INT J SPORTS MED, V35, P286, DOI 10.1055/s-0033-1351333; Owen AL, 2011, J STRENGTH COND RES, V25, P2104, DOI 10.1519/JSC.0b013e3181f0a8a3; Ric A, 2015, RES PHYS ED SPORT HL, V4, P35; Ric A, 2016, J SPORT SCI, V34, P1723, DOI 10.1080/02640414.2015.1136068; Riley MA, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00038; RUNCO MA, 1993, PERS INDIV DIFFER, V15, P537, DOI 10.1016/0191-8869(93)90337-3; Runco MA, 2004, ANNU REV PSYCHOL, V55, P657, DOI 10.1146/annurev.psych.55.090902.141502; Sampaio JE, 2014, J SCI MED SPORT, V17, P229, DOI 10.1016/j.jsams.2013.04.005; Schoner G, 1995, ECOL PSYCHOL, V7, P291, DOI 10.1207/s15326969eco0704_5; Sibani P, 2003, EUROPHYS LETT, V64, P8, DOI 10.1209/epl/i2003-00109-0; Silva P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107112; Sternberg RJ, 1996, AM PSYCHOL, V51, P677, DOI 10.1037/0003-066X.51.7.677; Stokes PD, 2009, PSYCHOL AESTHET CREA, V3, P174, DOI 10.1037/a0014970; Stokes PD, 2008, J CREATIVE BEHAV, V42, P223, DOI 10.1002/j.2162-6057.2008.tb01297.x; Stokes PD, 2001, AM PSYCHOL, V56, P355, DOI 10.1037//0003-066X.56.4.355; Torrents C, 2016, INTERPERSONAL COORDINATION AND PERFORMANCE IN SOCIAL SYSTEMS, P85; Martin CT, 2015, PSYCHOL AESTHET CREA, V9, P65, DOI 10.1037/a0038706; Turvey M. T., 1992, ECOL PSYCHOL, V4, P173, DOI [10.1207/s15326969eco0403_3, DOI 10.1207/S15326969EC00403_]; Westerhuis JA, 1998, J CHEMOMETR, V12, P301, DOI 10.1002/(SICI)1099-128X(199809/10)12:5<301::AID-CEM515>3.0.CO;2-S; Withagen R, 2012, NEW IDEAS PSYCHOL, V30, P250, DOI 10.1016/j.newideapsych.2011.12.003; Yamamoto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029638	63	42	42	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168866	10.1371/journal.pone.0168866	http://dx.doi.org/10.1371/journal.pone.0168866			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QH	28005978	Green Published, Green Submitted, gold			2022-12-26	WOS:000392843200107
J	Vega, ML; Willemoes, M; Thomson, RL; Tolvanen, J; Rutila, J; Samas, P; Strandberg, R; Grim, T; Fossoy, F; Stokke, BG; Thorup, K				Vega, Marta Lomas; Willemoes, Mikkel; Thomson, Robert L.; Tolvanen, Jere; Rutila, Jarkko; Samas, Peter; Strandberg, Roine; Grim, Tomas; Fossoy, Frode; Stokke, Bard Gunnar; Thorup, Kasper			First-Time Migration in Juvenile Common Cuckoos Documented by Satellite Tracking	PLoS One			English	Article							BUZZARDS PERNIS-APIVORUS; CUCULUS-CANORUS; BREEDING SUCCESS; ORIENTATION; POPULATION; BIRDS; TECHNOLOGY; PARASITISM; MIGRANTS; WARBLERS	Being an obligate parasite, juvenile common cuckoos Cuculus canorus are thought to reach their African wintering grounds from Palearctic breeding grounds without guidance from experienced conspecifics but this has not been documented. We used satellite tracking to study naive migrating common cuckoos. Juvenile cuckoos left breeding sites in Finland moving slowly and less consistently directed than adult cuckoos. Migration of the juveniles (N = 5) was initiated later than adults (N = 20), was directed toward the southwest-significantly different from the initial southeast direction of adults-and included strikingly long Baltic Sea crossings (N = 3). After initial migration of juvenile cuckoos toward Poland, the migration direction changed and proceeded due south, directly toward the winter grounds, as revealed by a single tag transmitting until arrival in Northwest Angola where northern adult cuckoos regularly winter. Compared to adults, the juvenile travelled straighter and faster, potentially correcting for wind drift along the route. That both migration route and timing differed from adults indicates that juvenile cuckoos are able to reach proper wintering grounds independently, guided only by their innate migration programme.	[Vega, Marta Lomas; Willemoes, Mikkel; Thorup, Kasper] Univ Copenhagen, Nat Hist Museum Denmark, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark; [Thomson, Robert L.] Univ Turku, Dept Biol, Turku, Finland; [Thomson, Robert L.] Univ Cape Town, FitzPatrick Inst African Ornithol, Cape Town, South Africa; [Tolvanen, Jere] Univ Oulu, Dept Ecol, Oulu, Finland; [Rutila, Jarkko] Univ Eastern Finland, Dept Environm & Biol Sci, Joensuu, Finland; [Samas, Peter; Grim, Tomas] Palacky Univ, Dept Zool, Olomouc, Czech Republic; [Samas, Peter; Grim, Tomas] Palacky Univ, Ornithol Lab, Olomouc, Czech Republic; [Strandberg, Roine] Lund Univ, Dept Biol, Lund, Sweden; [Fossoy, Frode; Stokke, Bard Gunnar] Norwegian Univ Sci & Technol, Dept Biol, Trondheim, Norway; [Fossoy, Frode; Stokke, Bard Gunnar] Norwegian Inst Nat Res NINA, Trondheim, Norway	University of Copenhagen; University of Turku; University of Cape Town; University of Oulu; University of Eastern Finland; Palacky University Olomouc; Palacky University Olomouc; Lund University; Norwegian University of Science & Technology (NTNU); Norwegian Institute Nature Research	Vega, ML (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark.	marta.l.vega@snm.ku.dk	Thomson, Robert L/B-9637-2012; Thorup, Kasper/A-4835-2013; Samas, Peter/E-3152-2016; Fossoy, Frode/O-3073-2017; Willemoes, Mikkel/J-9391-2012; Lomas Vega, Marta/C-6710-2015; Grim, Tomas/A-2852-2008	Thomson, Robert L/0000-0002-6958-1259; Thorup, Kasper/0000-0002-0320-0601; Fossoy, Frode/0000-0002-7535-9574; Willemoes, Mikkel/0000-0001-9363-6304; Lomas Vega, Marta/0000-0002-9397-8803; Grim, Tomas/0000-0002-5775-6269; Tolvanen, Jere/0000-0002-0250-3176	Danish Council for Independent Research [1323-00048B]; Danish National Research Foundation [DNRF96]; Czech Science Foundation [P506/12/2404]; Human Frontier Science Program [RGY69/07, RGY83/12]; Academy of Finland [138049]; Research Council of Norway [218144]	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Danish National Research Foundation(Danmarks Grundforskningsfond); Czech Science Foundation(Grant Agency of the Czech Republic); Human Frontier Science Program(Human Frontier Science Program); Academy of Finland(Academy of Finland); Research Council of Norway(Research Council of Norway)	KT, MLV, and MW were supported by The Danish Council for Independent Research through support to the MATCH project (1323-00048B) and Danish National Research Foundation through support to the Center for Macroecology, Evolution and Climate (DNRF96). PS and TG were supported by the Czech Science Foundation (grant no. P506/12/2404) and TG by Human Frontier Science Program (awards RGY69/07 and RGY83/12). RUT was supported by Academy of Finland (#138049). The Research Council of Norway funded BGS and FF (218144). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini N, 2004, J AVIAN BIOL, V35, P469, DOI 10.1111/j.0908-8857.2004.03450.x; Akesson S, 2005, CURR BIOL, V15, P1591, DOI 10.1016/j.cub.2005.07.027; ALERSTAM T, 2015, VAR FAGELVARLD, P38; Bridge ES, 2011, BIOSCIENCE, V61, P689, DOI 10.1525/bio.2011.61.9.7; Brown JM, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0593; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; Fossoy F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10272; Gill RE, 2009, P ROY SOC B-BIOL SCI, V276, P447, DOI 10.1098/rspb.2008.1142; Grim T, 2009, BEHAV ECOL, V20, P1138, DOI 10.1093/beheco/arp108; Guilford T, 2011, J EXP BIOL, V214, P3705, DOI 10.1242/jeb.051292; Hake M, 2003, OIKOS, V103, P385, DOI 10.1034/j.1600-0706.2003.12145.x; Hake M, 2001, J AVIAN BIOL, V32, P47, DOI 10.1034/j.1600-048X.2001.320107.x; Hewson CM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12296; Kemp MU, 2012, METHODS ECOL EVOL, V3, P65, DOI 10.1111/j.2041-210X.2011.00138.x; Kleven O, 2004, J AVIAN BIOL, V35, P394, DOI 10.1111/j.0908-8857.2004.03359.x; Kovach WL, 2009, ORIANA CIRCULAR STAT; Larkin R.P., 1982, P28; Mellone U, 2013, J AVIAN BIOL, V44, P417, DOI 10.1111/j.1600-048X.2013.00139.x; MEWALDT LR, 1964, SCIENCE, V146, P941, DOI 10.1126/science.146.3646.941; MORTON ML, 1991, ORNIS SCAND, V22, P98, DOI 10.2307/3676540; Mukhin A, 2005, P ROY SOC B-BIOL SCI, V272, P1535, DOI 10.1098/rspb.2005.3120; Oppel S, 2015, IBIS, V157, P545, DOI 10.1111/ibi.12258; Payne R, 2016, HDB BIRDS WORLD ALIV; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; SEEL DC, 1977, IBIS, V119, P309, DOI 10.1111/j.1474-919X.1977.tb08250.x; Sklepowicz B, 2009, ACTA ORNITHOL, V44, P177, DOI 10.3161/000164509X482759; SUTHERLAND WJ, 1988, NATURE, V334, P471, DOI 10.1038/334471a0; Thomson RL, 2016, J AVIAN BIOL, V47, P363, DOI 10.1111/jav.00915; Thorup K, 2003, P ROY SOC B-BIOL SCI, V270, pS8, DOI 10.1098/rsbl.2003.0014; Thorup K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017903; Thorup K, 2010, INTEGR COMP BIOL, V50, P315, DOI 10.1093/icb/icq065; Valkama J., 2014, SUOMEN RENGASTUSATLA, VII; Willemoes M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083515; Wyllie I., 1981, CUCKOO; ZUUR B, 1984, Vogelwarte, V32, P206	35	25	25	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168940	10.1371/journal.pone.0168940	http://dx.doi.org/10.1371/journal.pone.0168940			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005960	gold, Green Published			2022-12-26	WOS:000392843200112
J	Weiss, J; Devoto, SH				Weiss, Julian; Devoto, Stephen H.			Osmotic and Heat Stress Effects on Segmentation	PLoS One			English	Article							CONGENITAL SCOLIOSIS; C. ELEGANS; SHOCK; ZEBRAFISH; SOMITOGENESIS; ETIOLOGY; DEFECTS; EMBRYO; TBX6	During vertebrate embryonic development, early skin, muscle, and bone progenitor populations organize into segments known as somites. Defects in this conserved process of segmentation lead to skeletal and muscular deformities, such as congenital scoliosis, a curvature of the spine caused by vertebral defects. Environmental stresses such as hypoxia or heat shock produce segmentation defects, and significantly increase the penetrance and severity of vertebral defects in genetically susceptible individuals. Here we show that a brief exposure to a high osmolarity solution causes reproducible segmentation defects in developing zebrafish ( Danio rerio) embryos. Both osmotic shock and heat shock produce border defects in a dose-dependent manner, with an increase in both frequency and severity of defects. We also show that osmotic treatment has a delayed effect on somite development, similar to that observed in heat shocked embryos. Our results establish osmotic shock as an alternate experimental model for stress, affecting segmentation in a manner comparable to other known environmental stressors. The similar effects of these two distinct environmental stressors support a model in which a variety of cellular stresses act through a related response pathway that leads to disturbances in the segmentation process.	[Weiss, Julian; Devoto, Stephen H.] Wesleyan Univ, Dept Biol, Middletown, CT 06459 USA	Wesleyan University	Devoto, SH (corresponding author), Wesleyan Univ, Dept Biol, Middletown, CT 06459 USA.	sdevoto@wesleyan.edu	Devoto, Stephen/H-3088-2019	Devoto, Stephen/0000-0001-9513-3962; Weiss, Julian/0000-0003-4050-6690	National Institute of Arthritis and Musculoskeletal and Skin Diseases [1R15AR066284-01]; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [1R15AR066284-01]	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding for this study was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases 1R15AR066284-01 to Dr. Stephen Henri Devoto. Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number 1R15AR066284-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama R, 2014, DEVELOPMENT, V141, P1104, DOI 10.1242/dev.098905; Alexander PG, 2010, BIRTH DEFECTS RES C, V90, P118, DOI 10.1002/bdrc.20179; Bando Y, 2012, ANAT SCI INT, V87, P14, DOI 10.1007/s12565-011-0127-5; Burkewitz K, 2011, AM J PHYSIOL-CELL PH, V301, pC566, DOI 10.1152/ajpcell.00030.2011; Eckalbar WL, 2012, WIRES DEV BIOL, V1, P401, DOI 10.1002/wdev.34; ELSDALE T, 1976, J EMBRYOL EXP MORPH, V35, P625; Enserink JM, 2015, CELL DIV, V10, DOI 10.1186/s13008-015-0010-1; Giampietro PF, 2009, ANN NY ACAD SCI, V1151, P38, DOI 10.1111/j.1749-6632.2008.03452.x; Hubaud A, 2014, CELL BIOL, V15, P709, DOI [10.1038/nrm3891, DOI 10.1038/NRM3891]; Maroto M, 2012, DEVELOPMENT, V139, P2453, DOI 10.1242/dev.069310; Pourquie O, 2001, DEV CELL, V1, P619, DOI 10.1016/S1534-5807(01)00082-X; PRIMMETT DRN, 1988, DEVELOPMENT, V104, P331; Rodriguez M, 2013, TRENDS GENET, V29, P367, DOI 10.1016/j.tig.2013.01.010; Roy MN, 1999, MECH DEVELOP, V85, P27, DOI 10.1016/S0925-4773(99)00039-8; Schmidt K, 2010, J EXP ZOOL PART B, V314B, P166, DOI 10.1002/jez.b.21320; Sparrow DB, 2012, CELL, V149, P295, DOI 10.1016/j.cell.2012.02.054; Sparrow DB, 2011, MAMM GENOME, V22, P362, DOI 10.1007/s00335-011-9335-5; Wallace EWJ, 2015, CELL, V162, P1286, DOI 10.1016/j.cell.2015.08.041; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wargelius A, 2005, DEV GENES EVOL, V215, P350, DOI 10.1007/s00427-005-0482-0; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Windner SE, 2015, DEVELOPMENT, V142, P1159, DOI 10.1242/dev.113431; Wu N, 2015, NEW ENGL J MED, V372, P341, DOI 10.1056/NEJMoa1406829	23	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168335	10.1371/journal.pone.0168335	http://dx.doi.org/10.1371/journal.pone.0168335			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006008	Green Published, gold, Green Submitted			2022-12-26	WOS:000392843200044
J	Maenner, MJ; Yeargin-Allsopp, M; Braun, KV; Christensen, DL; Schieve, LA				Maenner, Matthew J.; Yeargin-Allsopp, Marshalyn; Braun, Kim Van Naarden; Christensen, Deborah L.; Schieve, Laura A.			Development of a Machine Learning Algorithm for the Surveillance of Autism Spectrum Disorder	PLOS ONE			English	Article							CHILDREN; DIAGNOSIS; COMORBIDITY; PREVALENCE; AGE	The Autism and Developmental Disabilities Monitoring (ADDM) Network conducts population-based surveillance of autism spectrum disorder (ASD) among 8-year old children in multiple US sites. To classify ASD, trained clinicians review developmental evaluations collected from multiple health and education sources to determine whether the child meets the ASD surveillance case criteria. The number of evaluations collected has dramatically increased since the year 2000, challenging the resources and timeliness of the surveillance system. We developed and evaluated a machine learning approach to classify case status in ADDM using words and phrases contained in children's developmental evaluations. We trained a random forest classifier using data from the 2008 Georgia ADDM site which included 1,162 children with 5,396 evaluations (601 children met ADDM ASD criteria using standard ADDM methods). The classifier used the words and phrases from the evaluations to predict ASD case status. We evaluated its performance on the 2010 Georgia ADDM surveillance data (1,450 children with 9,811 evaluations; 754 children met ADDM ASD criteria). We also estimated ASD prevalence using predictions from the classification algorithm. Overall, the machine learning approach predicted ASD case statuses that were 86.5% concordant with the clinician-determined case statuses (84.0% sensitivity, 89.4% predictive value positive). The area under the resulting receiver-operating characteristic curve was 0.932. Algorithm-derived ASD "prevalence" was 1.46% compared to the published (clinician-determined) estimate of 1.55%. Using only the text contained in developmental evaluations, a machine learning algorithm was able to discriminate between children that do and do not meet ASD surveillance criteria at one surveillance site.	[Maenner, Matthew J.; Yeargin-Allsopp, Marshalyn; Braun, Kim Van Naarden; Christensen, Deborah L.; Schieve, Laura A.] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA; [Maenner, Matthew J.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Maenner, MJ (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.; Maenner, MJ (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA.	xde8@cdc.gov						American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Bakian AV, 2015, J AUTISM DEV DISORD, V45, P873, DOI 10.1007/s10803-014-2187-6; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Burke JP, 2014, AUTISM, V18, P321, DOI 10.1177/1362361312467709; *CDCP, 2009, MMWR-MORBID MORTAL W, V58, P1; Centers for Disease Control and Prevention (CDC), 2007, MMWR SURVEILL SUMM, V56, P2; Croen LA, 2006, PEDIATRICS, V118, pE1203, DOI 10.1542/peds.2006-0127; Dodds L, 2009, CHRONIC DIS CAN, V29, P102; Doshi-Velez F, 2014, PEDIATRICS, V133, pE54, DOI 10.1542/peds.2013-0819; Fombonne E, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-5; Hahn Robert, 2007, MMWR Recomm Rep, V56, P1; Henley SJ, 2014, MMWR-MORBID MORTAL W, V63, P1; Hertz-Picciotto I, 2009, EPIDEMIOLOGY, V20, P84, DOI 10.1097/EDE.0b013e3181902d15; Jain A, 2015, JAMA-J AM MED ASSOC, V313, P1534, DOI 10.1001/jama.2015.3077; Lauritsen MB, 2010, J AUTISM DEV DISORD, V40, P139, DOI 10.1007/s10803-009-0818-0; MacFarlane JR, 2009, J CHILD FAM STUD, V18, P662, DOI 10.1007/s10826-009-9268-8; Maenner MJ, 2010, PEDIATRICS, V126, pE1018, DOI 10.1542/peds.2010-1023; Mandell DS, 2010, J AUTISM DEV DISORD, V40, P1241, DOI 10.1007/s10803-010-0982-2; Mandell DS, 2002, J AM ACAD CHILD PSY, V41, P1447, DOI 10.1097/00004583-200212000-00016; Mengwen Liu, 2013, 2013 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), P566, DOI 10.1109/BIBM.2013.6732559; Moshfegh Alanna J., 2012, Morbidity and Mortality Weekly Report, V61, P92; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Polyak A, 2015, AM J MED GENET B, V168, P600, DOI 10.1002/ajmg.b.32338; Rice CE, 2007, PAEDIATR PERINAT EP, V21, P179, DOI 10.1111/j.1365-3016.2007.00801.x; Rice CE, 2014, IMFAR 2014 ATL GA; Savel Thomas G, 2012, MMWR Suppl, V61, P20	26	36	36	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168224	10.1371/journal.pone.0168224	http://dx.doi.org/10.1371/journal.pone.0168224			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9TW	28002438	Green Published, Green Submitted, gold			2022-12-26	WOS:000392853100035
J	Martin, T; Ronnberg-Wastljung, AC; Stenlid, J; Samils, B				Martin, Tom; Ronnberg-Wastljung, Ann-Christin; Stenlid, Jan; Samils, Berit			Identification of a Differentially Expressed TIR-NBS-LRR Gene in a Major QTL Associated to Leaf Rust Resistance in Salix	PLoS One			English	Article							MELAMPSORA-LARICI-POPULINA; STRUCTURAL BASIS; WILLOW; SPECIFICITY; TRICHOCARPA; SELECTION; IMMUNITY; POPLAR; GENOME; FLAX	An earlier identified major quantitative trait locus for resistance towards the willow leaf rust fungus Melampsora larici-epitea in a Salix viminalis x (S. viminalis x S. schwerinii) population was used to identify potential resistance genes to the rust pathogen. Screening a genomic bacterial artificial chromosome library with markers from the peak position of the QTL region revealed one gene with TIR-NBS-LRR (Toll Interleukin1 Receptor-Nucleotide Binding Site-Leucine-Rich Repeat) domain structure indicative of a resistance gene. The resistance gene analog was denoted RGA1 and further analysis revealed a number of non-synonymous single nucleotide polymorphisms in the LRR domain between the resistant and susceptible Salix genotypes. Gene expression levels under controlled conditions showed a significantly lower constitutive expression of RGA1 in the susceptible genotype. In addition, the susceptible genotype showed a significantly reduced expression level of the RGA1 gene at 24 hours post inoculation with M. larici-epitea. This indicates that the pathogen may actively suppress RGA1 gene expression allowing a compatible plant-pathogen interaction and causing infection.	[Martin, Tom; Ronnberg-Wastljung, Ann-Christin] Swedish Univ Agr Sci, Dept Plant Biol, Uppsala, Sweden; [Stenlid, Jan; Samils, Berit] Swedish Univ Agr Sci, Dept Forest Mycol & Plant Pathol, Uppsala, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Samils, B (corresponding author), Swedish Univ Agr Sci, Dept Forest Mycol & Plant Pathol, Uppsala, Sweden.	berit.samils@slu.se	Stenlid, Jan/K-5909-2019		governmental Swedish Energy Agency; NLfaculty at the Swedish University of Agricultural Sciences	governmental Swedish Energy Agency; NLfaculty at the Swedish University of Agricultural Sciences	This research was supported by the governmental Swedish Energy Agency (JS) (http://www.energimyndigheten.se/en/) and The NLfaculty at the Swedish University of Agricultural Sciences (JS) (http //www.slu.se/en/faculties/nj/). The two funders above had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The SNP Technology Platform, Uppsala, Sweden (JS) (http://molmed.medsci.uu.se/SNP+SEQ+Technology+Platform/Genotyping/) performed the high-throughput sequencing.	Baxter RHG, 2010, P NATL ACAD SCI USA, V107, P16817, DOI 10.1073/pnas.1010575107; Berlin S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-129; Bertholdsson NO, 2001, ASP APPL BIOL, V65, P205; Cao YL, 2007, GENETICS, V177, P523, DOI 10.1534/genetics.107.075176; Chen ZJ, 2014, GENET MOL RES, V13, P2082, DOI 10.4238/2014.March.24.12; De Leonardis AM, 2013, INT J MOL SCI, V14, P7302, DOI [10.3390/ijms14047302, DOI 10.3390/IJMS14047302]; Ellis JG, 2007, MOL PLANT PATHOL, V8, P103, DOI 10.1111/J.1364-3703.2006.00375.X; Garnica DP, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004329; Helft L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021614; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kohler A, 2008, PLANT MOL BIOL, V66, P619, DOI 10.1007/s11103-008-9293-9; Laurans E, 1999, PHYTOPATHOLOGY, V89, P233, DOI 10.1094/PHYTO.1999.89.3.233; McCracken AR, 1998, EUR J FOREST PATHOL, V28, P241; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; Michelmore RW, 1998, GENOME RES, V8, P1113, DOI 10.1101/gr.8.11.1113; Padmanabhan M, 2009, CELL MICROBIOL, V11, P191, DOI 10.1111/j.1462-5822.2008.01260.x; Pei MH, 2000, EUR J PLANT PATHOL, V106, P771, DOI 10.1023/A:1026593119871; Puckett EE, 2012, ENVIRON EXP BOT, V75, P248, DOI 10.1016/j.envexpbot.2011.07.008; Rinaldi C, 2007, PLANT PHYSIOL, V144, P347, DOI 10.1104/pp.106.094987; Salmon J, 2014, PLANT BIOTECHNOL J, V12, P480, DOI 10.1111/pbi.12154; Samils B, 2001, EUR J PLANT PATHOL, V107, P399, DOI 10.1023/A:1011270315251; Samils B, 2011, TREE GENET GENOMES, V7, P1219, DOI 10.1007/s11295-011-0408-0; Sekine KT, 2008, MOL PLANT MICROBE IN, V21, P1398, DOI 10.1094/MPMI-21-11-1398; Takken FLW, 2012, CURR OPIN PLANT BIOL, V15, P375, DOI 10.1016/j.pbi.2012.05.001; Tsarouhas V, 2002, THEOR APPL GENET, V105, P277, DOI 10.1007/s00122-002-0918-0; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Volk TA, 2004, FRONT ECOL ENVIRON, V2, P411, DOI 10.1890/1540-9295(2004)002[0411:GFASAO]2.0.CO;2; Wang CIA, 2007, PLANT CELL, V19, P2898, DOI 10.1105/tpc.107.053611; Wirthmueller L, 2013, NAT REV MICROBIOL, V11, P761, DOI 10.1038/nrmicro3118; Xu M, 2011, ANAL BIOCHEM, V408, P337, DOI 10.1016/j.ab.2010.08.044	30	10	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168776	10.1371/journal.pone.0168776	http://dx.doi.org/10.1371/journal.pone.0168776			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002449	Green Published, gold, Green Submitted			2022-12-26	WOS:000392853100067
J	Quinlan, J; Pearson, LN; Clukay, CJ; Mitchell, MM; Boston, Q; Gravlee, CC; Mulligan, CJ				Quinlan, Jacklyn; Pearson, Laurel N.; Clukay, Christopher J.; Mitchell, Miaisha M.; Boston, Qasimah; Gravlee, Clarence C.; Mulligan, Connie J.			Genetic Loci and Novel Discrimination Measures Associated with Blood Pressure Variation in African Americans Living in Tallahassee	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; MAJOR DEPRESSIVE DISORDER; BODY-MASS INDEX; MISSING HERITABILITY; PERCEIVED DISCRIMINATION; HYPERTROPHIC CARDIOMYOPATHY; CARDIOVASCULAR-DISEASE; RACIAL-DISCRIMINATION; POPULATION-STRUCTURE	Sequencing of the human genome and decades of genetic association and linkage studies have dramatically improved our understanding of the etiology of many diseases. However, the multiple causes of complex diseases are still not well understood, in part because genetic and sociocultural risk factors are not typically investigated concurrently. Hypertension is a leading risk factor for cardiovascular disease and afflicts more African Americans than any other racially defined group in the US. Few genetic loci for hypertension have been replicated across populations, which may reflect population-specific differences in genetic variants and/or inattention to relevant sociocultural factors. Discrimination is a salient sociocultural risk factor for poor health and has been associated with hypertension. Here we use a biocultural approach to study blood pressure (BP) variation in African Americans living in Tallahassee, Florida by genotyping over 30,000 single nucleotide polymorphisms (SNPs) and capturing experiences of discrimination using novel measures of unfair treatment of self and others (n = 157). We perform a joint admixture and genetic association analysis for BP that prioritizes regions of the genome with African ancestry. We only report significant SNPs that were confirmed through our simulation analyses, which were performed to determine the false positive rate. We identify eight significant SNPs in five genes that were previously associated with cardiovascular diseases. When we include measures of unfair treatment and test for interactions between SNPs and unfair treatment, we identify a new class of genes involved in multiple phenotypes including psychosocial distress and mood disorders. Our results suggest that inclusion of culturally relevant stress measures, like unfair treatment in African Americans, may reveal new genes and biological pathways relevant to the etiology of hypertension, and may also improve our understanding of the complexity of gene-environment interactions that underlie complex diseases.	[Quinlan, Jacklyn; Clukay, Christopher J.; Gravlee, Clarence C.; Mulligan, Connie J.] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA; [Quinlan, Jacklyn; Mulligan, Connie J.] Univ Florida, Genet Inst, Gainesville, FL 32611 USA; [Pearson, Laurel N.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Mitchell, Miaisha M.; Boston, Qasimah; Gravlee, Clarence C.] HEAT, Tallahassee, FL USA; [Mitchell, Miaisha M.] Greater Frenchtown Revitalizat Council, Tallahassee, FL USA; [Boston, Qasimah] Florida Dept Children & Families, Subst Abuse & Mental Hlth Program, Tallahassee, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Quinlan, J (corresponding author), Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA.; Quinlan, J (corresponding author), Univ Florida, Genet Inst, Gainesville, FL 32611 USA.	jacki.quinlan@gmail.com	Gravlee, Clarence C/A-2249-2009	Gravlee, Clarence C/0000-0002-0913-2320; Clukay, Christopher/0000-0002-4310-6484	National Science Foundation [BCS 0820687, BCS 0724032]	National Science Foundation(National Science Foundation (NSF))	This study was supported by National Science Foundation (http://www.nsf.gov/) grants BCS 0820687 (CJM) and BCS 0724032 (CCG).	Adeyemo A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000564; Ansari KI, 2011, BIOCHEMISTRY-US, V50, P3517, DOI 10.1021/bi102037t; Ball MK, 2014, AM J RESP CRIT CARE, V189, P314, DOI 10.1164/rccm.201302-0302OC; Beitelshees AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015180; Biino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059612; Borrell LN, 2006, SOC SCI MED, V63, P1415, DOI 10.1016/j.socscimed.2006.04.008; Boulter AC, 2015, HUMAN BIOL IN PRESS; Brewster LM, 2004, ANN INTERN MED, V141, P614, DOI 10.7326/0003-4819-141-8-200410190-00009; Brody GH, 2011, DEV PSYCHOPATHOL, V23, P617, DOI 10.1017/S0954579411000046; Busca R, 2005, J CELL BIOL, V170, P49, DOI 10.1083/jcb.200501067; Chen X, 2015, AM J HUM GENET, V97, P708, DOI 10.1016/j.ajhg.2015.10.004; Choi M, 2011, SCIENCE, V331, P768, DOI 10.1126/science.1198785; Congiu C, 2015, PSYCHIAT RES, V225, P489, DOI 10.1016/j.psychres.2014.11.061; Conomos MP, 2015, GENET EPIDEMIOL, V39, P276, DOI 10.1002/gepi.21896; Cui JS, 2002, HYPERTENSION, V40, P7, DOI 10.1161/01.HYP.0000022693.11752.E9; DARLU P, 1990, ANN HUM BIOL, V17, P387, DOI 10.1080/03014469000001162; Deo RC, 2007, PLOS GENET, V3, P2200, DOI 10.1371/journal.pgen.0030196; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Engert V, 2014, PSYCHONEUROENDOCRINO, V45, P192, DOI 10.1016/j.psyneuen.2014.04.005; Fernandez AP, 2008, P NATL ACAD SCI USA, V105, P12581, DOI 10.1073/pnas.0803174105; Fox ER, 2011, HUM MOL GENET, V20, P2273, DOI 10.1093/hmg/ddr092; Geronimus AT, 2006, AM J PUBLIC HEALTH, V96, P826, DOI 10.2105/AJPH.2004.060749; Goosby BJ, 2015, AM J HUM BIOL, V27, P546, DOI 10.1002/ajhb.22683; Gravlee CC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006821; Gravlee CC, 2009, AM J PHYS ANTHROPOL, V139, P47, DOI 10.1002/ajpa.20983; GRIENDLING KK, 1993, CIRCULATION, V87, P1816, DOI 10.1161/01.CIR.87.6.1816; HAVLIK RJ, 1979, AM J EPIDEMIOL, V110, P304, DOI 10.1093/oxfordjournals.aje.a112815; Hicken MT, 2014, AM J PUBLIC HEALTH, V104, P117, DOI 10.2105/AJPH.2013.301395; Honda T, 2007, CIRC J, V71, P1263, DOI 10.1253/circj.71.1263; Hosseini M, 2015, EXCLI J, V14, P465, DOI 10.17179/excli2014-635; Huang J, 2010, AM J PSYCHIAT, V167; Kaess BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014529; Karlsen S, 2002, AM J PUBLIC HEALTH, V92, P624, DOI 10.2105/AJPH.92.4.624; Klimentidis YC, 2012, J HUM HYPERTENS, V26, P98, DOI 10.1038/jhh.2010.130; Law MR, 1997, AM J HYPERTENS, V10, pS42, DOI 10.1016/S0895-7061(97)00073-3; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Liberzon I, 2014, JAMA PSYCHIAT, V71, P1174, DOI 10.1001/jamapsychiatry.2014.999; Liou YJ, 2009, PHARMACOGENET GENOM, V19, P735, DOI 10.1097/FPC.0b013e32832cbe61; Longo D, 2003, BLOOD PRESS MONIT, V8, P91, DOI 10.1097/00126097-200304000-00006; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mensah GA, 2007, HEALTH AFFAIR, V26, P38, DOI 10.1377/hlthaff.26.1.38; Non AL, 2012, AM J PUBLIC HEALTH, V102, P1559, DOI 10.2105/AJPH.2011.300448; Ordonez-Razo RM, 2012, GENET TEST MOL BIOMA, V16, P855, DOI 10.1089/gtmb.2011.0343; Pasaniuc B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001371; Pascoe EA, 2009, PSYCHOL BULL, V135, P531, DOI 10.1037/a0016059; Perlis RH, 2010, AM J PSYCHIAT, V167, P1499, DOI 10.1176/appi.ajp.2010.10040541; Polsinelli G, 2013, J NEURAL TRANSM, V120, P253, DOI 10.1007/s00702-012-0851-6; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reiner AP, 2005, AM J HUM GENET, V76, P463, DOI 10.1086/428654; Rose JE, 2010, MOL MED, V16, P247, DOI 10.2119/molmed.2009.00159; Ryan AM, 2006, J HEALTH CARE POOR U, V17, P116, DOI 10.1353/hpu.2006.0092; Sankararaman S, 2008, AM J HUM GENET, V82, P290, DOI 10.1016/j.ajhg.2007.09.022; Satcher D, 2005, HEALTH AFFAIR, V24, P459, DOI 10.1377/hlthaff.24.2.459; Schulz AJ, 2006, AM J PUBLIC HEALTH, V96, P1265, DOI 10.2105/AJPH.2005.064543; Shen GQ, 2012, ANN HUM GENET, V76, P193, DOI 10.1111/j.1469-1809.2012.00705.x; Shriner D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002325; Simon GE, 2001, WESTERN J MED, V175, P292, DOI 10.1136/ewjm.175.5.292; Tang H, 2006, HUM GENET, V119, P624, DOI 10.1007/s00439-006-0175-4; Taylor JY, 2012, ETHNIC DIS, V22, P155; Taylor JY, 2010, BIOL RES NURS, V12, P149, DOI 10.1177/1099800410371225; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Trerotola M, 2015, HUM GENOMICS, V9, DOI 10.1186/s40246-015-0041-3; Uher R, 2008, MOL PSYCHIATR, V13, P131, DOI 10.1038/sj.mp.4002067; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; WARD RH, 1983, AM J PHYS ANTHROPOL, V62, P91, DOI 10.1002/ajpa.1330620113; Williams D R, 1997, J Health Psychol, V2, P335, DOI 10.1177/135910539700200305; Williams DR, 2005, HEALTH AFFAIR, V24, P325, DOI 10.1377/hlthaff.24.2.325; WILLIAMS DR, 1995, ANNU REV SOCIOL, V21, P349, DOI 10.1146/annurev.so.21.080195.002025; Yan LJL, 2003, JAMA-J AM MED ASSOC, V290, P2138, DOI 10.1001/jama.290.16.2138; Yu B, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004212; Zhu XF, 2005, NAT GENET, V37, P177, DOI 10.1038/ng1510; Zhu XF, 2011, HUM MOL GENET, V20, P2285, DOI 10.1093/hmg/ddr113; Ziegelstein RC, 2015, J PSYCHOSOM RES, V78, P301, DOI 10.1016/j.jpsychores.2015.02.003	76	21	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167700	10.1371/journal.pone.0167700	http://dx.doi.org/10.1371/journal.pone.0167700			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9TW	28002425	gold, Green Published, Green Submitted			2022-12-26	WOS:000392853100016
J	Jaffe, R; Prous, X; Zampaulo, R; Giannini, TC; Imperatriz-Fonseca, VL; Maurity, C; Oliveira, G; Brandi, IV; Siqueira, JO				Jaffe, Rodolfo; Prous, Xavier; Zampaulo, Robson; Giannini, Tereza C.; Imperatriz-Fonseca, Vera L.; Maurity, Clovis; Oliveira, Guilherme; Brandi, Iuri V.; Siqueira, Jose O.			Reconciling Mining with the Conservation of Cave Biodiversity: A Quantitative Baseline to Help Establish Conservation Priorities	PLOS ONE			English	Article							INVERTEBRATE COMMUNITIES; SEED DISPERSAL; BATS; RANGE; BIRDS; EVOLUTION; ENDEMISM; SERVICE	Caves pose significant challenges for mining projects, since they harbor many endemic and threatened species, and must therefore be protected. Recent discussions between academia, environmental protection agencies, and industry partners, have highlighted problems with the current Brazilian legislation for the protection of caves. While the licensing process is long, complex and cumbersome, the criteria used to assign caves into conservation relevance categories are often subjective, with relevance being mainly determined by the presence of obligate cave dwellers (troglobites) and their presumed rarity. However, the rarity of these troglobitic species is questionable, as most remain unidentified to the species level and their habitats and distribution ranges are poorly known. Using data from 844 iron caves retrieved from different speleology reports for the Carajas region (South-Eastern Amazon, Brazil), one of the world's largest deposits of high-grade iron ore, we assess the influence of different cave characteristics on four biodiversity proxies (species richness, presence of troglobites, presence of rare troglobites, and presence of resident bat populations). We then examine how the current relevance classification scheme ranks caves with different biodiversity indicators. Large caves were found to be important reservoirs of biodiversity, so they should be prioritized in conservation programs. Our results also reveal spatial autocorrelation in all the biodiversity proxies assessed, indicating that iron caves should be treated as components of a cave network immersed in the karst landscape. Finally, we show that by prioritizing the conservation of rare troglobites, the current relevance classification scheme is undermining overall cave biodiversity and leaving ecologically important caves unprotected. We argue that conservation efforts should target subterranean habitats as a whole and propose an alternative relevance ranking scheme, which could help simplify the assessment process and channel more resources to the effective protection of overall cave biodiversity.	[Jaffe, Rodolfo; Giannini, Tereza C.; Imperatriz-Fonseca, Vera L.; Maurity, Clovis; Oliveira, Guilherme; Siqueira, Jose O.] Vale Inst Technol Sustainable Dev, Belem, Para, Brazil; [Prous, Xavier; Zampaulo, Robson; Brandi, Iuri V.] Vale, Environm Licensing & Speleol, Nova Lima, MG, Brazil	Instituto Tecnologico Vale Desenvolvimento Sustentavel	Jaffe, R (corresponding author), Vale Inst Technol Sustainable Dev, Belem, Para, Brazil.	rodolfo.jaffe@itv.org	Prous, Xavier/T-8183-2019; Jaffé, Rodolfo/K-3230-2013; Imperatriz-Fonseca, Vera Lucia/AAU-7633-2021; Giannini, Tereza Cristina/AAA-2958-2019; Giannini, Tereza C/F-2676-2012; Imperatriz-Fonseca, Vera Lucia/H-5582-2012	Jaffé, Rodolfo/0000-0002-2101-5282; Imperatriz-Fonseca, Vera Lucia/0000-0002-1079-2158; Giannini, Tereza Cristina/0000-0001-9830-1204; Imperatriz-Fonseca, Vera Lucia/0000-0002-1079-2158; Prous, Xavier/0000-0001-9260-1441	Vale Institute of Technology	Vale Institute of Technology	The study was funded by the Vale Institute of Technology, a non-profit research institution.	Andelman SJ, 2000, P NATL ACAD SCI USA, V97, P5954, DOI 10.1073/pnas.100126797; Asaad I, BIOL CONSERV; Auler A. S., 2015, HYPOGENE CAVE MORPHO, V18, P15; Auler AS, 2014, ENVIRON EARTH SCI, V1, P487, DOI DOI 10.1007/978-3-642-17435-3_; Bivand R, 2015, COMP IMPLEMENTATIONS; Brunet AK, 2001, J MAMMAL, V82, P1114, DOI 10.1644/1545-1542(2001)082<1114:TSARIB>2.0.CO;2; Campbell JW, 2011, J NAT HIST, V45, P2645, DOI 10.1080/00222933.2011.597884; Cardiff S.G., 2007, MADAGASCAR CONSERV D, V2, P28; Christman MC, 2005, J BIOGEOGR, V32, P1441, DOI 10.1111/j.1365-2699.2005.01263.x; Cleveland CJ, 2006, FRONT ECOL ENVIRON, V4, P238, DOI 10.1890/1540-9295(2006)004[0238:EVOTPC]2.0.CO;2; Csuti B, 1997, BIOL CONSERV, V80, P83, DOI 10.1016/S0006-3207(96)00068-7; Culver D. C., 2009, BIOL CAVES OTHER SUB, P40; Culver David C., 2004, Subterranean Biology, V2, P27; CULVER DC, 1970, EVOLUTION, V24, P463, DOI 10.1111/j.1558-5646.1970.tb01776.x; Ferreira RL, 1999, TROP ZOOL, V12, P231, DOI 10.1080/03946975.1999.10539391; Ferreira RL, 2015, GEOSSISTEMAS FERRUGI, P195; Ferreira RL, 2005, CARSTE, V3, P106; Ferreira Rodrigo Lopes, 1998, Diversity & Distributions, V4, P235; Fleming TH, 2003, BAT ECOLOGY, P156; Fleming TH, 2009, ANN BOT-LONDON, V104, P1017, DOI 10.1093/aob/mcp197; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Gardner TA, 2013, CONSERV BIOL, V27, P1254, DOI 10.1111/cobi.12118; Harvey MS, 2011, INVERTEBR SYST, V25, P1, DOI 10.1071/IS11011; Harvey MS, 2002, INVERTEBR SYST, V16, P555, DOI 10.1071/IS02009; Hougner C, 2006, ECOL ECON, V59, P364, DOI 10.1016/j.ecolecon.2005.11.007; Iskali G, 2015, J CAVE KARST STUD, V77, P28, DOI 10.4311/2013LSC0128; Jacomassa FAF, 2010, ACTA OECOL, V36, P493, DOI 10.1016/j.actao.2010.07.001; Juan C, 2010, MOL ECOL, V19, P3865, DOI 10.1111/j.1365-294X.2010.04759.x; Karp DS, 2014, ECOLOGY, V95, P1065, DOI 10.1890/13-1012.1; Kriebel D, 2001, ENVIRON HEALTH PERSP, V109, P871, DOI 10.2307/3454986; Ledford J, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.167.1833; Lomolino M.V., 2010, BIOGEOGRAPHY, Vfourth; Lunghi E, 2014, ACTA OECOL, V55, P29, DOI 10.1016/j.actao.2013.11.003; Maas B, 2013, ECOL LETT, V16, P1480, DOI 10.1111/ele.12194; MacArthur R.H., 1967, THEORY ISLAND BIOGEO; Maine JJ, 2015, P NATL ACAD SCI USA, V112, P12438, DOI 10.1073/pnas.1505413112; Pape RB, 2014, J CAVE KARST STUD, V76, P1, DOI 10.4311/2012LSC0266; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Pinheiro J, 2020, R PACKAGE VERSION 31; Pipan T, 2013, ENCY BIODIVERSITY, P44, DOI DOI 10.1016/B0-12-226865-2/00262-5; Pipan T, 2007, HYDROGEOL J, V15, P817, DOI 10.1007/s10040-006-0114-4; POULSON TL, 1969, SCIENCE, V165, P971; Poveromo JJ, 1999, MAKING SHAPING TREAT, P547; Prous X, 2011, AN 31 C BRAS ESP PON, P515; R-Core T, 2015, R LANG ENV STAT COMP; Sarmento R, 2014, ZOOLOGIA-CURITIBA, V31, P245, DOI 10.1590/S1984-46702014000300006; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Silva MS, 2011, BIODIVERS CONSERV, V20, P1713, DOI 10.1007/s10531-011-0057-5; Silveira M, 2011, ACTA OECOL, V37, P31, DOI 10.1016/j.actao.2010.11.003; Simoes Matheus Henrique, 2015, Subterranean Biology, V16, P103, DOI 10.3897/subtbiol.16.5470; Soares G, 2016, 23 INT C SUBT BIOL F, P96; Sochi K, 2016, J APPL ECOL, V53, P317, DOI 10.1111/1365-2664.12583; Souza-Silva M, 2012, ACTA CARSOLOGICA, V1, P41; Stone FD., 2012, ENCYCL CAVES, V2, P658, DOI [10.1016/B978-0-12-383832-2.00097-9, DOI 10.1016/B978-0-12-383832-2.00097-9, 10.1016/b978-0-12-383832-2.00097-9]; Taylor SJ, 2005, AM MIDL NAT, V154, P97, DOI 10.1674/0003-0031(2005)154[0097:FRAHUO]2.0.CO;2; Trajano E, 2010, ESPELEO TEMA, V21, P105; White W. B., 2012, ENCY CAVES; Winter Y, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P148, DOI 10.1017/CBO9780511542268.009; Wunderle JM, 1997, FOREST ECOL MANAG, V99, P223, DOI 10.1016/S0378-1127(97)00208-9; Wynne JJ, 2013, W N AM NAT, V74, P1	60	35	35	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168348	10.1371/journal.pone.0168348	http://dx.doi.org/10.1371/journal.pone.0168348			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997576	gold, Green Submitted, Green Published			2022-12-26	WOS:000392842900036
J	Kitagori, K; Yoshifuji, H; Oku, T; Sasaki, C; Miyata, H; Mori, KP; Nakajima, T; Ohmura, K; Kawabata, D; Yukawa, N; Imura, Y; Murakami, K; Nakashima, R; Usui, T; Fujii, T; Sakai, K; Yanagita, M; Hirayama, Y; Mimori, T				Kitagori, Koji; Yoshifuji, Hajime; Oku, Takuma; Sasaki, Chiyomi; Miyata, Hitomi; Mori, Keita P.; Nakajima, Toshiki; Ohmura, Koichiro; Kawabata, Daisuke; Yukawa, Naoichiro; Imura, Yoshitaka; Murakami, Kosaku; Nakashima, Ran; Usui, Takashi; Fujii, Takao; Sakai, Kaoru; Yanagita, Motoko; Hirayama, Yoshitaka; Mimori, Tsuneyo			Cleaved Form of Osteopontin in Urine as a Clinical Marker of Lupus Nephritis	PLoS One			English	Article							NEPHROTIC SYNDROME; REVISED CRITERIA; IN-VITRO; ERYTHEMATOSUS; GLOMERULONEPHRITIS; CLASSIFICATION; EXPRESSION; PATHOGENESIS; NEPHROPATHY; PROGRESSION	We assessed the utility of two forms of osteopontin (OPN), OPN full and its cleaved form (OPN N-half), in plasma and urine as markers of disease activity in lupus nephritis (LN). Samples were collected from patients with systemic lupus erythematosus (SLE) (LN: N = 29, non-LN: N = 27), IgA nephropathy (IgAN) (N = 14), minimal change nephrotic syndrome (MCNS) (N = 5), diabetic nephropathy (DN) (N = 14) and healthy volunteers (HC) (N = 17). While there was no significant difference in urine OPN full concentration between groups, urine OPN N-half concentration was significantly higher in patients with LN than HC (p < 0.05). Moreover, urine OPN N-half was higher in LN patients with overt proteinuria (urine protein/creatinine ratio: P/C > 0.5) than LN patients with minimal proteinuria (P/C < 0.5, p < 0.0001), and also higher than in DN patients with overt proteinuria (P/C > 0.5, p < 0.01). Urine thrombin activity correlated with urine OPN N-half concentration (p < 0.0001), but not with urine OPN full concentration. These results suggest that urine OPN N-half concentration reflects renal inflammation. Thus, urine OPN N-half may be a novel disease activity marker for LN.	[Kitagori, Koji; Yoshifuji, Hajime; Nakajima, Toshiki; Ohmura, Koichiro; Kawabata, Daisuke; Imura, Yoshitaka; Murakami, Kosaku; Nakashima, Ran; Usui, Takashi; Fujii, Takao; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan; [Oku, Takuma; Sasaki, Chiyomi; Hirayama, Yoshitaka] Kyoto Univ, Ctr Innovat Immunoregulat Technol & Therapeut, Grad Sch Med, Kyoto, Japan; [Oku, Takuma; Sasaki, Chiyomi; Hirayama, Yoshitaka] Astellas Pharma Inc, Res Portfolio & Sci, Tokyo, Japan; [Miyata, Hitomi; Mori, Keita P.; Sakai, Kaoru; Yanagita, Motoko] Kyoto Univ, Grad Sch Med, Dept Nephrol, Kyoto, Japan; [Yukawa, Naoichiro; Fujii, Takao] Wakayama Med Univ, Dept Rheumatol & Clin Immunol, Wakayama, Japan	Kyoto University; Kyoto University; Astellas Pharmaceuticals; Kyoto University; Wakayama Medical University	Yoshifuji, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan.	yossii@kuhp.kyoto-u.ac.jp	Yanagita, Motoko/AAJ-7731-2021; Yoshifuji, Hajime/AAZ-1657-2020; Kosaku, Murakami/T-8806-2019; Sakai, Kaoru/HGE-2792-2022	Yanagita, Motoko/0000-0002-0339-9008	Special Coordination Funds for Promoting Science and Technology of the Japanese Government; Astellas Pharma Inc. in the Formation of Innovation Center for Fusion of Advanced Technologies Program	Special Coordination Funds for Promoting Science and Technology of the Japanese Government; Astellas Pharma Inc. in the Formation of Innovation Center for Fusion of Advanced Technologies Program	This work was supported in part by the Special Coordination Funds for Promoting Science and Technology of the Japanese Government and in part by Astellas Pharma Inc. in the Formation of Innovation Center for Fusion of Advanced Technologies Program. Publication of this article was approved by an intellectual property committee composed of representatives from Kyoto University and Astellas Pharma Inc. TO, CS and YH are employees of Astellas Pharma Inc. The funder provided support in the form of salaries for authors (see above), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section.	Agnihotri R, 2001, J BIOL CHEM, V276, P28261, DOI 10.1074/jbc.M103608200; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Cornell LD., 2011, DIAGNOSTIC PATHOLOGY, P142; Daniel V, 1997, CLIN NEPHROL, V47, P289; Denhardt DT, 1998, J CELL BIOCHEM, P92, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<92::AID-JCB13>3.0.CO;2-A; DENHARDT DT, 1993, FASEB J, V7, P1475, DOI 10.1096/fasebj.7.15.8262332; Gang X, 2001, AM J KIDNEY DIS, V37, P374, DOI 10.1053/ajkd.2001.21316; Hertig A, 2004, J AM SOC NEPHROL, V15, P844, DOI 10.1097/01.ASN.0000115400.52705.83; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Ihara H, 2001, J BIOL CHEM, V276, P13065, DOI 10.1074/jbc.M010938200; Ikeuchi H, 2016, MOD RHEUMATOL, P1; Kitamoto Y, 2004, ANN CLIN BIOCHEM, V41, P133, DOI 10.1258/000456304322880023; Kon S, 2008, J EXP MED, V205, P25, DOI 10.1084/jem.20071324; Naito T, 2000, J AM SOC NEPHROL, V11, P2243, DOI 10.1681/ASN.V11122243; O'Regan AW, 1999, J IMMUNOL, V162, P1024; Okada H, 2000, AM J KIDNEY DIS, V36, P498, DOI 10.1053/ajkd.2000.9790; PATARCA R, 1989, J EXP MED, V170, P145, DOI 10.1084/jem.170.1.145; Qiong L, 2010, CHIN J DERMATOL, V43; Rittling SR, 1998, J BONE MINER RES, V13, P1101, DOI 10.1359/jbmr.1998.13.7.1101; Rullo OJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4150; Sahali D, 2002, J AM SOC NEPHROL, V13, P1238, DOI 10.1681/ASN.V1351238; Smith LL, 1996, J BIOL CHEM, V271, P28485, DOI 10.1074/jbc.271.45.28485; Tahir S, 2015, J IMMUNOL, V194, P5725, DOI 10.4049/jimmunol.1500319; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Weening JJ, 2004, KIDNEY INT, V65, P521, DOI 10.1111/j.1523-1755.2004.00443.x; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Wong CK, 2005, RHEUMATOLOGY, V44, P602, DOI 10.1093/rheumatology/keh558; Yamaguchi H, 2004, ENDOCR J, V51, P499, DOI 10.1507/endocrj.51.499; YAMAMOTO S, 1995, ANN NY ACAD SCI, V760, P378, DOI 10.1111/j.1749-6632.1995.tb44662.x	29	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0167141	10.1371/journal.pone.0167141	http://dx.doi.org/10.1371/journal.pone.0167141			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992535	Green Published, gold, Green Submitted			2022-12-26	WOS:000392842600011
J	Laperine, O; Cloitre, A; Caillon, J; Huck, O; Bugueno, IM; Pilet, P; Sourice, S; Le Tilly, E; Palmer, G; Davideau, JL; Geoffroy, V; Guicheux, J; Beck-Cormier, S; Lesclous, P				Laperine, Olivier; Cloitre, Alexandra; Caillon, Jocelyne; Huck, Olivier; Bugueno, Isaac Maximiliano; Pilet, Paul; Sourice, Sophie; Le Tilly, Elodie; Palmer, Gaby; Davideau, Jean-Luc; Geoffroy, Valerie; Guicheux, Jerome; Beck-Cormier, Sarah; Lesclous, Philippe			Interleukin-33 and RANK-L Interplay in the Alveolar Bone Loss Associated to Periodontitis	PLOS ONE			English	Article							PORPHYROMONAS-GINGIVALIS INFECTION; EPITHELIAL-CELLS; IN-VIVO; DISEASE; IL-33; EXPRESSION; CYTOKINE; RECEPTOR; PREVALENCE; SEVERITY	Introduction Chronic Periodontitis (CP) is an inflammatory disease of bacterial origin that results in alveolar bone destruction. Porphyromonas gingivalis (Pg), one of the main periopathogens, initiates an inflammatory cascade by host immune cells thereby increasing recruitment and activity of osteoclasts, the bone resorbing cells, through enhanced production of the crucial osteoclastogenic factor, RANK-L. Antibodies directed against some cytokines (IL-1 beta, IL-6 and TNF-alpha) failed to exhibit convincing therapeutic effect in CP. It has been suggested that IL-33, could be of interest in CP. Objective the present study aims to analyze whether and how IL-33 and RANK-L and/or their interplay are involved in the bone destruction associated to CP. Material and Methods mRNAs and protein expressions of IL-33 and RANK-L were analyzed in healthy and CP human gingival samples by immunohistochemistry (IHC) and RT-qPCR. Murine experimental periodontitis (EP) was induced using Pg infected ligature and Pg free ligature around the first maxillary molar. Alveolar bone loss was recorded by mu CT. Mouse gingival explants were stimulated for 24 hours with IL-33 and RANK-L mRNA expression investigated by RT-qPCR. Human oral epithelial cells were infected by Pg for 6, 12; 24 hours and IL-33 and RANK-L mRNA expressions were analyzed by RT-qPCR. Results IL-33 is overexpressed in gingival epithelial cells in human affected by CP as in the murine EP. In human as in murine gingival cells, RANK-L was independently induced by Pg and IL33. We also showed that the Pg-dependent RANK-L expression in gingival epithelial cells occured earlier than that of IL-33. Conclusion Our results evidence that IL-33 overexpression in gingival epithelial cells is associated with CP and may trigger RANK-L expression in addition to a direct effect of Pg. Finally, IL-33 may act as an extracellular alarmin (danger signal) showing proinflammatory properties in CP perpetuating bone resorption induced by Pg infection.	[Laperine, Olivier; Cloitre, Alexandra; Pilet, Paul; Sourice, Sophie; Le Tilly, Elodie; Guicheux, Jerome; Beck-Cormier, Sarah; Lesclous, Philippe] INSERM, U791, LIOAD, Nantes, France; [Laperine, Olivier; Cloitre, Alexandra; Pilet, Paul; Sourice, Sophie; Le Tilly, Elodie; Guicheux, Jerome; Beck-Cormier, Sarah; Lesclous, Philippe] Univ Nantes, UMR S 791, LIOAD, Nantes, France; [Laperine, Olivier; Cloitre, Alexandra; Pilet, Paul; Sourice, Sophie; Le Tilly, Elodie; Guicheux, Jerome; Beck-Cormier, Sarah; Lesclous, Philippe] UFR Odontol, Nantes, France; [Cloitre, Alexandra; Pilet, Paul; Guicheux, Jerome; Lesclous, Philippe] ONIRIS, UMR S 791, LIOAD, Nantes, France; [Caillon, Jocelyne] EA 3826 Therapeut Clin & Expt Infect, Nantes, France; [Huck, Olivier; Bugueno, Isaac Maximiliano; Davideau, Jean-Luc] INSERM, U1109, Osteoarticular & Dent Regenerat Nanomed, FMTS, Strasbourg, France; [Huck, Olivier; Davideau, Jean-Luc] Univ Strasbourg, Fac Chirurg Dent, Dept Parodontol, Strasbourg, France; [Palmer, Gaby] Univ Hosp Geneva, Div Rheumatol, Dept Internal Med Specialties, Geneva, Switzerland; [Palmer, Gaby] Univ Geneva, Sch Med, Dept Pathol Immunol, Geneva, Switzerland; [Geoffroy, Valerie] Hop Lariboisiere, INSERM, U1132, BIOSCAR, Paris, France; [Geoffroy, Valerie] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France	Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Nantes Universite; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Geneva; University of Geneva; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Guicheux, J; Lesclous, P (corresponding author), INSERM, U791, LIOAD, Nantes, France.; Guicheux, J; Lesclous, P (corresponding author), Univ Nantes, UMR S 791, LIOAD, Nantes, France.; Guicheux, J; Lesclous, P (corresponding author), UFR Odontol, Nantes, France.; Guicheux, J; Lesclous, P (corresponding author), ONIRIS, UMR S 791, LIOAD, Nantes, France.	jerome.guicheux@inserm.fr; philippe.lesclous@univ-nantes.fr	CAILLON, Jocelyne/AAF-8179-2020; Cloitre, Alexandra/AAC-4048-2019; Lesclous, Philippe/P-6255-2014; huck, olivier/AFH-8285-2022; Beck-Cormier, Sarah/P-3091-2014; guicheux, Jerome/F-7767-2013; Geoffroy, Valerie/P-1521-2014; palmer, gaby/AAA-7117-2021	Cloitre, Alexandra/0000-0001-9178-5154; Beck-Cormier, Sarah/0000-0001-5258-1933; guicheux, Jerome/0000-0003-2754-3024; Geoffroy, Valerie/0000-0003-3920-7482; palmer, gaby/0000-0001-7567-1798; lesclous, Philippe/0000-0002-9840-4542; Bugueno, Isaac Maximiliano/0000-0002-6994-6262; huck, olivier/0000-0002-7988-2290	Region des pays de la Loire [2012-05775-05776]	Region des pays de la Loire(Region Pays de la Loire)	Support was provided by Region des pays de la Loire (grant 2012-05775-05776) [http://www.paysdelaloire.fr/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors were supported by the SFBTM (Societe Francaise de Biologie des Tissus Mineralises) for technical support, UTE-IRS-UN for animal facilities and "Region des pays de la Loire" (grant 2012-05775-05776).	Balato A, 2014, ARCH DERMATOL RES, V306, P299, DOI 10.1007/s00403-014-1447-9; Byers DE, 2013, J CLIN INVEST, V123, P3967, DOI 10.1172/JCI65570; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; da Luz FAC, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/342410; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Eke PI, 2015, J PERIODONTOL, V86, P611, DOI 10.1902/jop.2015.140520; Fujihara R, 2014, J PERIODONTAL RES, V49, P508, DOI 10.1111/jre.12131; Graves Dana T, 2011, J Oral Microbiol, V3, DOI 10.3402/jom.v3i0.5304; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Han XZ, 2013, INFECT IMMUN, V81, P1502, DOI 10.1128/IAI.00043-13; Hienz SA, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/615486; Holtfreter B, 2015, J CLIN PERIODONTOL, V42, P407, DOI 10.1111/jcpe.12392; Kawai T, 2006, AM J PATHOL, V169, P987, DOI 10.2353/ajpath.2006.060180; Kiyomiya H, 2015, BIOCHEM BIOPH RES CO, V460, P320, DOI 10.1016/j.bbrc.2015.03.033; Komai-Koma M, 2011, J IMMUNOL, V186, P2584, DOI 10.4049/jimmunol.1002103; Koseoglu S, 2015, J PERIODONTAL RES, V50, P525, DOI 10.1111/jre.12235; Kursunlu SF, 2015, ARCH ORAL BIOL, V60, P77, DOI 10.1016/j.archoralbio.2014.08.021; Laperine O, 2016, BONEKEY REP, V5, DOI 10.1038/bonekey.2016.21; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Lin J, 2014, INFECT IMMUN, V82, P4127, DOI 10.1128/IAI.02084-14; Liu D, 2003, INT J MOL MED, V11, P17; Malcolm J, 2015, J DENT RES, V94, P968, DOI 10.1177/0022034515577815; Martin P, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4143; Moulin D, 2007, CYTOKINE, V40, P216, DOI 10.1016/j.cyto.2007.09.013; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Palmer G, 2011, NAT REV RHEUMATOL, V7, P321, DOI 10.1038/nrrheum.2011.53; Palmer G, 2009, ARTHRITIS RHEUM-US, V60, P738, DOI 10.1002/art.24305; Papathanasiou E, 2014, J PERIODONTAL RES, V49, P55, DOI 10.1111/jre.12078; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Preshaw PM, 2011, J CLIN PERIODONTOL, V38, P60, DOI 10.1111/j.1600-051X.2010.01671.x; Saadi-Thiers K, 2013, J PERIODONTOL, V84, P396, DOI 10.1902/jop.2012.110540; Saglam M, 2016, INCREASED LEVELS INT; Saidi S, 2011, CYTOKINE, V53, P347, DOI 10.1016/j.cyto.2010.11.021; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Sundnes O, 2015, J INVEST DERMATOL, V135, P1771, DOI 10.1038/jid.2015.85; Tada H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152794; Usui M, 2016, J PERIODONTAL RES, V51, P462, DOI 10.1111/jre.12323; Zhao JJ, 2012, INFLAMMATION, V35, P1330, DOI 10.1007/s10753-012-9446-5	39	29	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168080	10.1371/journal.pone.0168080	http://dx.doi.org/10.1371/journal.pone.0168080			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992569	Green Published, gold, Green Submitted			2022-12-26	WOS:000392842600034
J	Cao, LX; Weetall, M; Bombard, J; Qi, HY; Arasu, T; Lennox, W; Hedrick, J; Sheedy, J; Risher, N; Brooks, PC; Trifillis, P; Trotta, C; Moon, YC; Babiak, J; Almstead, NG; Colacino, JM; Davis, TW; Peltz, SW				Cao, Liangxian; Weetall, Marla; Bombard, Jenelle; Qi, Hongyan; Arasu, Tamil; Lennox, William; Hedrick, Jean; Sheedy, Josephine; Risher, Nicole; Brooks, Peter C.; Trifillis, Panayiota; Trotta, Christopher; Moon, Young-Choon; Babiak, John; Almstead, Neil G.; Colacino, Joseph M.; Davis, Thomas W.; Peltz, Stuart W.			Discovery of Novel Small Molecule Inhibitors of VEGF Expression in Tumor Cells Using a Cell-Based High Throughput Screening Platform	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INTERNAL RIBOSOME ENTRY; FACTOR MESSENGER-RNA; TRANSLATION INITIATION COMPLEX; URIDINE-RICH ELEMENTS; POSTTRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; CANCER-THERAPY; IN-VIVO; HYPOXIA	Current anti-VEGF (Vascular Endothelial Growth Factor A) therapies to treat various cancers indiscriminately block VEGF function in the patient resulting in the global loss of VEGF signaling which has been linked to dose-limiting toxicities as well as treatment failures due to acquired resistance. Accumulating evidence suggests that this resistance is at least partially due to increased production of compensatory tumor angiogenic factors/cytokines. VEGF protein production is differentially controlled depending on whether cells are in the normal "homeostatic" state or in a stressed state, such as hypoxia, by post-transcriptional regulation imparted by elements in the 5' and 3' untranslated regions (UTR) of the VEGF mRNA. Using the Gene Expression Modulation by Small molecules (GEMS (TM)) phenotypic assay system, we performed a high throughput screen to identify low molecular weight compounds that target the VEGF mRNA UTR-mediated regulation of stress-induced VEGF production in tumor cells. We identified a number of compounds that potently and selectively reduce endogenous VEGF production under hypoxia in HeLa cells. Medicinal chemistry efforts improved the potency and pharmaceutical properties of one series of compounds resulting in the discovery of PTC-510 which inhibits hypoxia-induced VEGF expression in HeLa cells at low nanomolar concentration. In mouse xenograft studies, oral administration of PTC-510 results in marked reduction of intratumor VEGF production and single agent control of tumor growth without any evident toxicity. Here, we show that selective suppression of stress-induced VEGF production within tumor cells effectively controls tumor growth. Therefore, this approach may minimize the liabilities of current global anti-VEGF therapies.	[Cao, Liangxian; Weetall, Marla; Bombard, Jenelle; Qi, Hongyan; Arasu, Tamil; Lennox, William; Hedrick, Jean; Sheedy, Josephine; Risher, Nicole; Trifillis, Panayiota; Trotta, Christopher; Moon, Young-Choon; Babiak, John; Almstead, Neil G.; Colacino, Joseph M.; Davis, Thomas W.; Peltz, Stuart W.] PTC Therapeut Inc, South Plainfield, NJ 07080 USA; [Brooks, Peter C.] Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME USA; [Arasu, Tamil] US FDA, Parsippany, NJ USA; [Davis, Thomas W.] PMV Pharmaceut Inc, Cedar Brook Corp Ctr, Cranbury Township, NJ USA	Maine Medical Center; US Food & Drug Administration (FDA)	Cao, LX (corresponding author), PTC Therapeut Inc, South Plainfield, NJ 07080 USA.	lcao@ptcbio.com			NIH [2 R44 CA108330-02]; PTC Therapeutics, Inc.	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PTC Therapeutics, Inc.	This program was partially supported by funding from NIH to JMC and LXC (2 R44 CA108330-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors [LC, MW, WL, JH, JS, NR, PT, CT, YM, JBabiak, NA, JMC, TD and SP], have received funding support for the conduct of this study and have also received salary compensation for time, effort, and reimbursed travel expenses related to data discussions and presentations from PTC Therapeutics, Inc. The specific roles of these authors are articulated in the 'author contributions' section.	Akiri G, 1998, ONCOGENE, V17, P227, DOI 10.1038/sj.onc.1202019; Arcondeguy T, 2013, NUCLEIC ACIDS RES, V41, P7997, DOI 10.1093/nar/gkt539; Bhattacharyya A, 2007, DRUG DISCOV TODAY, V12, P553, DOI 10.1016/j.drudis.2007.05.009; Bornes S, 2004, J BIOL CHEM, V279, P18717, DOI 10.1074/jbc.M308410200; Braunstein S, 2009, MOL CELL BIOL, V29, P5645, DOI 10.1128/MCB.00711-09; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Brooks PC, 1999, METH MOL B, V129, P257; Cammas A, 2015, RNA BIOL, V12, P320, DOI 10.1080/15476286.2015.1017236; Duda DG, 2007, TRENDS MOL MED, V13, P223, DOI 10.1016/j.molmed.2007.04.001; ERNST TJ, 1989, LEUKEMIA, V3, P620; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 2005, ONCOLOGY-BASEL, V69, P11, DOI 10.1159/000088479; GOLDBERG MA, 1991, BLOOD, V77, P271; Houzet L, 2001, BLOOD, V98, P1281, DOI 10.1182/blood.V98.5.1281; Huez I, 1998, MOL CELL BIOL, V18, P6178, DOI 10.1128/MCB.18.11.6178; Huez I, 2001, MOL ENDOCRINOL, V15, P2197, DOI 10.1210/me.15.12.2197; Ilouga PE, 2012, J BIOMOL SCREEN, V17, P705, DOI 10.1177/1087057112441623; Kadenhe-Chiweshe A, 2008, MOL CANCER RES, V6, P1, DOI 10.1158/1541-7786.MCR-07-0101; Kasprzak A, 2013, INT J ONCOL, V42, P305, DOI 10.3892/ijo.2012.1706; Kawai M, 2010, ENDOCRINOLOGY, V151, P4861, DOI 10.1210/en.2010-0407; Khatri NI, 2012, CRIT REV THER DRUG, V29, P487, DOI 10.1615/CritRevTherDrugCarrierSyst.v29.i6.20; Konicek BW, 2008, CELL CYCLE, V7, P2466, DOI 10.4161/cc.7.16.6464; Levy AP, 1996, J BIOL CHEM, V271, P2746, DOI 10.1074/jbc.271.5.2746; Levy NS, 1997, BBA-GENE STRUCT EXPR, V1352, P167, DOI 10.1016/S0167-4781(97)00052-3; Lu Kan V, 2013, CNS Oncol, V2, P49; Mayr LM, 2009, CURR OPIN PHARMACOL, V9, P580, DOI 10.1016/j.coph.2009.08.004; Meadows KL, 2012, PERSPECT MED, V2; Miller DL, 1998, FEBS LETT, V434, P417, DOI 10.1016/S0014-5793(98)01025-4; Mullard A, 2015, NAT REV DRUG DISCOV, V14, P807, DOI 10.1038/nrd4783; Nabors LB, 2001, CANCER RES, V61, P2154; Packer RJ, 2015, J NEURO-ONCOL, V121, P217, DOI 10.1007/s11060-014-1665-1; Pelletier J, 2015, CANCER RES, V75, P250, DOI 10.1158/0008-5472.CAN-14-2789; Rapisarda A, 2012, ADV CANCER RES, V114, P237, DOI 10.1016/B978-0-12-386503-8.00006-5; Ribatti D., 2016, ONCOTARGET; Richards Lisa, 2011, Nat Rev Clin Oncol, V8, P194, DOI 10.1038/nrclinonc.2011.28; Roodhart JM, 2008, CURR CLIN PHARMACOL, V3, P132, DOI 10.2174/157488408784293705; Sambrook J., 2001, MOL CLONING LAB MANU; Scandurro AB, 1998, BIOCHEM BIOPH RES CO, V246, P436, DOI 10.1006/bbrc.1998.8639; Shim MS, 2010, FEBS J, V277, P4814, DOI 10.1111/j.1742-4658.2010.07904.x; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Stein I, 1998, MOL CELL BIOL, V18, P3112, DOI 10.1128/MCB.18.6.3112; Story MT, 1996, PROSTATE, V28, P219; Tandle Anita, 2003, Clin Adv Hematol Oncol, V1, P41; Tang XR, 2013, J CELL MOL MED, V17, P386, DOI 10.1111/jcmm.12020; Villar HO, 2009, EXPERT OPIN DRUG DIS, V4, P1215, DOI 10.1517/17460440903397368; Walters B, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00128; Wang EH, 1997, CANCER RES, V57, P5426; Weetall M, 2016, CLIN PHARM DRUG DEV, V5, P296, DOI 10.1002/cpdd.240; Yao P, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001635; Zheng W, 2013, DRUG DISCOV TODAY, V18, P1067, DOI 10.1016/j.drudis.2013.07.001	50	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168366	10.1371/journal.pone.0168366	http://dx.doi.org/10.1371/journal.pone.0168366			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992500	Green Published, gold, Green Submitted			2022-12-26	WOS:000392758000042
J	Dovom, MR; Tehrani, FR; Djalalinia, S; Cheraghi, L; Gandavani, SB; Azizi, F				Dovom, Marzieh Rostami; Tehrani, Fahimeh Ramezani; Djalalinia, Shirin; Cheraghi, Leila; Gandavani, Samira Behboudi; Azizi, Fereidoun			Menstrual Cycle Irregularity and Metabolic Disorders: A Population-Based Prospective Study	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; CORONARY-HEART-DISEASE; IMPAIRED GLUCOSE-TOLERANCE; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; INCREASED RISK; WOMEN; ENDOCRINE; WEIGHT; ASSOCIATION	The regularity of menstrual cycles is considered an indicator of women's reproductive health. Previous studies with a cross-sectional design have documented the relationship between menstrual cycle irregularities, insulin-resistance and the future risks for metabolic disorders. Limited data documented by prospective studies can lead to premature conclusions regarding the relationship between menstrual cycle irregularities and other conditions influencing women's health. The present study therefore, using a prospective design aimed to assess the risk of metabolic disorders in women with a history of irregular menstrual cycles, was based on the data gathered from the Tehran Lipid and Glucose study (TLGS) an ongoing prospective cohort study initiated in 1999. Participants of the current study were 2128 women, aged between 18-49 years, followed for 15 years. Based on their menstrual cycles, the women were divided into two groups: (i) women with regular menstrual cycles (n = 1749), and (ii) those with irregular menstrual cycles (n = 379). The proportional COX regression model was used to compare hazard ratios (HRs) between the groups for the proposed events, including diabetes mellitus (DM), pre-diabetes (pre-DM), hypertension (HTN), pre-hypertension (pre-HTN) and dyslipidemia. It was found that during a 15-year follow up, there were 123 cases of DM, 456 cases of pre-DM, 290 cases of HTN, 481 cases of pre-HTN, and 402 cases of dyslipidemia. Compared to those with regular cycles, women with irregular menstrual cycles were found to have an increased risk for DM2 (age adjusted Hazard Ratios (HRs), 2.01; 95% confidence intervals (CI: 1.59-3.50), the increased risk for DM, associated with irregular cycles remained significant after the adjustment for Body Mass Index (BMI), fasting blood sugar (FBS), family history of diabetes, and parity (HRS, 1.73; 95% CI: 1.14-2.64). There was no significant difference in the increased risk for pre-DM between the groups (age adjusted HRs, 1.33, 95% CI: 1.05-1.69). However, after the adjustment of BMI, FBS and family history of pre-DM, compared to those with regular menstrual cycles, irregular menstrual cycles showed an increased risk for pre-DM (HRs, 1.33; 95% CI: 1.05-1.69). No statistically significant difference was found in the increasing risk for other proposed events between the groups demonstrating that menstrual cycle irregularities could be considered a marker of metabolic disorders and a predisposing factor of the increased risk for diabetes mellitus and pre-diabetes in women with irregular menstrual cycles.	[Dovom, Marzieh Rostami; Tehrani, Fahimeh Ramezani; Gandavani, Samira Behboudi] Shahid Beheshti Univ Med Sci, Reprod Endocrinol Res Ctr, Res Inst Endocrine Sci, Tehran, Iran; [Djalalinia, Shirin] Univ Tehran Med Sci, Noncommunicable Dis Res Ctr, Endocrinol & Metab Res Inst, Tehran, Iran; [Djalalinia, Shirin] Dev Res Technol Ctr, Deputy Res & Technol, Minist Hlth & Med Educ, Tehran, Iran; [Cheraghi, Leila] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Dept Biostatist & Epidemiol, Tehran, Iran; [Azizi, Fereidoun] Shahid Beheshti Univ Med Sci, Endocrine Res Ctr, Res Inst Endocrine Sci, Tehran, Iran	Shahid Beheshti University Medical Sciences; Tehran University of Medical Sciences; Ministry of Health & Medical Education (MOHME); Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Tehrani, FR (corresponding author), Shahid Beheshti Univ Med Sci, Reprod Endocrinol Res Ctr, Res Inst Endocrine Sci, Tehran, Iran.	ramezani@endocrine.ac.ir	Tehrani, Fahimeh Ramezani/H-6133-2017; Azizi, Fereidoun/ABD-4136-2021; Dovom, Marzieh Rostami/AAD-7225-2020	Tehrani, Fahimeh Ramezani/0000-0002-4609-065X; Azizi, Fereidoun/0000-0002-6470-2517; Behboudi-Gandevani, Samira/0000-0003-3526-640X				Amato MC, 2015, J ENDOCRINOL INVEST, V38, P1319, DOI 10.1007/s40618-015-0372-x; American Diabetes Association, 2016, DIABETES CARE S1, V39; Azizi F, 2002, SOZ PRAVENTIV MED, V47, P408, DOI 10.1007/s000380200008; Beckers NGM, 2002, FERTIL STERIL, V78, P291, DOI 10.1016/S0015-0282(02)03227-2; Bozorgmanesh M, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-100; Buccola JM, 2003, PRIMARY CARE, V30, P697, DOI 10.1016/S0095-4543(03)00089-7; Carmina E, 2013, HUM REPROD, V28, P2245, DOI 10.1093/humrep/det119; Carter AN, 2016, AM J CARDIOVASC DIS, V6, P129; Cibula D, 2000, HUM REPROD, V15, P785, DOI 10.1093/humrep/15.4.785; Committee on Practice BulletinsGynecology, 2012, Obstet Gynecol, V120, P197, DOI 10.1097/AOG.0b013e318262e320; Cupisti S, 2008, EUR J ENDOCRINOL, V158, P711, DOI 10.1530/EJE-07-0515; Du DF, 2013, INT J CLIN EXP MED, V6, P880; DUNAIF A, 1987, J CLIN ENDOCR METAB, V65, P499, DOI 10.1210/jcem-65-3-499; Galassi A, 2006, AM J MED, V119, P812, DOI 10.1016/j.amjmed.2006.02.031; Gast GCM, 2010, FERTIL STERIL, V94, P2379, DOI 10.1016/j.fertnstert.2010.03.044; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hadaegh F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149780; Hosseinpanah F, 2011, CLIN ENDOCRINOL, V75, P692, DOI 10.1111/j.1365-2265.2011.04113.x; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kirwan JP, 2002, DIABETES, V51, P2207, DOI 10.2337/diabetes.51.7.2207; Legro RS, 1999, J CLIN ENDOCR METAB, V84, P165, DOI 10.1210/jc.84.1.165; Lo JC, 2006, J CLIN ENDOCR METAB, V91, P1357, DOI 10.1210/jc.2005-2430; Momenan AA, 2011, INT J PREVENTIVE MED, V2, P243; Mueller NT, 2013, BJOG-INT J OBSTET GY, V120, P1483, DOI 10.1111/1471-0528.12364; Nejat A, 2014, CLIN BIOCHEM, V47, P1239, DOI 10.1016/j.clinbiochem.2014.03.004; Nicholson WK, 2006, DIABETES CARE, V29, P2349, DOI 10.2337/dc06-0825; Panidis D, 2013, EUR J ENDOCRINOL, V168, P145, DOI 10.1530/EJE-12-0655; Pannacciulli N, 2003, DIABETES CARE, V26, P1230, DOI 10.2337/diacare.26.4.1230; Pereira M A, 1997, Med Sci Sports Exerc, V29, pS1; Rao SS, 2004, AM FAM PHYSICIAN, V69, P1961; ROBINSON S, 1993, CLIN ENDOCRINOL, V39, P351, DOI 10.1111/j.1365-2265.1993.tb02376.x; Roney JR, 2013, HORM BEHAV, V63, P636, DOI 10.1016/j.yhbeh.2013.02.013; Salagre S B, 2016, J Assoc Physicians India, V64, P22; Silverthorn DU, 2013, HUMAN PHYSL INTEGRAT, V6a; Solomon CG, 2002, J CLIN ENDOCR METAB, V87, P2013, DOI 10.1210/jc.87.5.2013; Solomon CG, 2001, JAMA-J AM MED ASSOC, V286, P2421, DOI 10.1001/jama.286.19.2421; Strowitzki T, 2010, EUR J OBSTET GYN R B, V149, P178, DOI 10.1016/j.ejogrb.2009.12.024; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Talbott E, 1998, J CLIN EPIDEMIOL, V51, P415, DOI 10.1016/S0895-4356(98)00010-9; Tehrani FR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137609; Tehrani FR, 2014, HUM REPROD, V29, P2522, DOI 10.1093/humrep/deu249; Vrbikova J, 2005, HUM REPROD, V20, P3328, DOI 10.1093/humrep/dei221; Wang ET, 2011, J CLIN ENDOCR METAB, V96, pE114, DOI 10.1210/jc.2010-1709; Welt CK, 2006, J CLIN ENDOCR METAB, V91, P4842, DOI 10.1210/jc.2006-1327; WILD RA, 1988, AM J OBSTET GYNECOL, V159, P423, DOI 10.1016/S0002-9378(88)80099-1; Wild S, 2000, CLIN ENDOCRINOL, V52, P595, DOI 10.1046/j.1365-2265.2000.01000.x; World Health Organization (WHO), 2009, GLOB PHYS ACT SURV; Zadeh-Vakili A, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-18	48	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168402	10.1371/journal.pone.0168402	http://dx.doi.org/10.1371/journal.pone.0168402			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992506	gold, Green Published, Green Submitted			2022-12-26	WOS:000392758000047
J	Jakobsen, MD; Braaten, T; Obstfelder, A; Abelsen, B				Jakobsen, Monika Dybdahl; Braaten, Tonje; Obstfelder, Aud; Abelsen, Birgit			Self-Reported Food Hypersensitivity: Prevalence, Characteristics, and Comorbidities in the Norwegian Women and Cancer Study	PLOS ONE			English	Article							ALLERGY; INTOLERANCE; CHILDREN; COMPLEXITY; SYMPTOMS; PROFILE; BURDEN; COHORT; MODEL	Background This study aims to investigate the prevalence of self-reported food hypersensitivity, (SFH), the characteristics of women with SFH, and whether SFH is associated with multiple health complaints among the participants of the Norwegian Women and Cancer study (NOWAC). Methods We conducted a cross-sectional study among 64,316 women aged 41-76 years. The women were randomly selected from the Norwegian Central Person Register. Information on SFH and all covariates except age and place of residence was collected by questionnaires in 2002-2005. Results The prevalence of SFH in our study sample was 6.8% (95% confidence interval: 6.7-7.0). Logistic regression analysis showed a negative association between SFH and age (odds ratio [OR] 0.97). The odds of SFH increased among women living in or near urban centers, women with more than 9 years of education, women who did not have full-time work, women who had experienced poor economic conditions in childhood, those living without a partner, and those who did not consume alcohol or smoke (OR varied from 1.10 to 1.70). Women with a low body mass index had higher odds of SFH (OR 1.37) than those with a moderate body mass index. SFH was positively associated with poor self-perceived health (OR 2.56). The odds of SFH increased with the number of concurrent health complaints, with an OR for 5-6 comorbidities of 4.93. Conclusion We found an association between SFH, poor health, and different socio demographic and lifestyle characteristics. Women with SFH had increased odds of reporting multiple health complaints.	[Jakobsen, Monika Dybdahl; Braaten, Tonje] UiT Arctic Univ Norway, Dept Community Med, Tromso, Norway; [Obstfelder, Aud] Norwegian Univ Sci & Technol NTNU, Ctr Care Res, Gjovik, Norway; [Obstfelder, Aud] UiT Arctic Univ Norway, Dept Hlth & Care Sci, Tromso, Norway; [Abelsen, Birgit] UiT Arctic Univ Norway, Dept Community Med, Norwegian Ctr Rural Med, Tromso, Norway	UiT The Arctic University of Tromso; Norwegian University of Science & Technology (NTNU); UiT The Arctic University of Tromso; UiT The Arctic University of Tromso	Jakobsen, MD (corresponding author), UiT Arctic Univ Norway, Dept Community Med, Tromso, Norway.	monika.d.jakobsen@uit.no			Department of Community Medicine, UiT, The Arctic University of Norway [4025]	Department of Community Medicine, UiT, The Arctic University of Norway	MJ was supported by the Department of Community Medicine, UiT, The Arctic University of Norway, grant agreement 4025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinbami LJ, 2016, J ASTHMA, V53, P356, DOI 10.3109/02770903.2015.1126848; Baanders AN, 2002, EUR J PUBLIC HEALTH, V12, P124, DOI 10.1093/eurpub/12.2.124; Berstad A, 2012, SCAND J GASTROENTERO, V47, P914, DOI 10.3109/00365521.2012.690045; Blekesaune M, 2003, SAMFUNNSSPEILET, V17, P6; Cardona V, 2012, ALLERGY, V67, P1316, DOI [10.1111/j.1398-9995.2012.02877.x, 10.1111/j.1398-9995.2012.02877.x.]; Carroccio A, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0230-2; Ch'ng CL, 2007, CLIN MED RES, V5, P184, DOI 10.3121/cmr.2007.738; Dominguez-Ortega G, 2014, J PEDIATR GASTR NUTR, V59, P210, DOI 10.1097/MPG.0000000000000391; Dong J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144872; Dyregrov S, 2014, MATINTOLERANSE HAR B; Eiliv L, 2003, CANCER CAUSE CONTROL, V14, P1001, DOI 10.1023/B:CACO.0000007982.18311.2e; Grembowski D, 2014, MED CARE, V52, pS7, DOI 10.1097/MLR.0000000000000045; JANSEN JJN, 1994, J ALLERGY CLIN IMMUN, V93, P446; Johansson SGO, 2001, ALLERGY, V56, P813, DOI 10.1034/j.1398-9995.2001.t01-1-00001.x; Kanny G, 2001, J ALLERGY CLIN IMMUN, V108, P133, DOI 10.1067/mai.2001.116427; Kerr A, 2009, BIOSOCIETIES, V4, P3, DOI 10.1017/S1745855209006401; KNIBB RC, 2000, PSYCHOL HEALTH MED, V5, P419; Lind R, 2005, DIGEST DIS SCI, V50, P1245, DOI 10.1007/s10620-005-2767-6; Lind R, 2008, GASTROENTEROL NURS, V31, P401, DOI 10.1097/SGA.0b013e31818e4a4d; Linneberg A, 2008, CLIN EXP ALLERGY, V38, P145, DOI 10.1111/j.1365-2222.2007.02837.x; Lund E, 2008, INT J EPIDEMIOL, V37, P36, DOI 10.1093/ije/dym137; May CR, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-281; McBride D, 2012, PEDIAT ALLERG IMM-UK, V23, P230, DOI 10.1111/j.1399-3038.2011.01254.x; Molloy J, 2013, INT J ENV RES PUB HE, V10, P7235, DOI 10.3390/ijerph10127235; Nettleton S, 2009, HEALTH-LONDON, V13, P647, DOI 10.1177/1363459308341433; Nwaru BI, 2014, ALLERGY, V69, P62, DOI 10.1111/all.12305; PARKER SL, 1990, J ALLERGY CLIN IMMUN, V86, P503, DOI 10.1016/S0091-6749(05)80206-4; Power C, 2013, ANNU REV PUBL HEALTH, V34, P7, DOI 10.1146/annurev-publhealth-031912-114423; Rona RJ, 2007, J ALLERGY CLIN IMMUN, V120, P638, DOI 10.1016/j.jaci.2007.05.026; Roy A, 2016, DIG DIS SCI; Shippee ND, 2012, J CLIN EPIDEMIOL, V65, P1041, DOI 10.1016/j.jclinepi.2012.05.005; Soost S, 2009, CLIN EXP ALLERGY, V39, P1036, DOI 10.1111/j.1365-2222.2008.03184.x; Sova C, 2013, NUTR CLIN PRACT, V28, P669, DOI 10.1177/0884533613505870; Stein AC, 2015, J CLIN GASTROENTEROL; Sterne JA, 2009, BMJ, V338; Tavakkoli A, 2014, DIGEST DIS SCI, V59, P1255, DOI 10.1007/s10620-013-2981-6; Verrill L, 2015, ALLERGY ASTHMA PROC, V36, P458, DOI 10.2500/aap.2015.36.3895; Voordouw J, 2012, SOC INDIC RES, V107, P465, DOI 10.1007/s11205-011-9858-x; Wong RK, 2013, CLIN GASTROENTEROL H, V11, P151, DOI 10.1016/j.cgh.2012.07.019; Woods RK, 2001, EUR J CLIN NUTR, V55, P298, DOI 10.1038/sj.ejcn.1601159; Zingone F, 2015, UNITED EUR GASTROENT, V3, P136, DOI 10.1177/2050640614560786; Zuidmeer L, 2008, J ALLERGY CLIN IMMUN, V121, P1210, DOI 10.1016/j.jaci.2008.02.019	42	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168653	10.1371/journal.pone.0168653	http://dx.doi.org/10.1371/journal.pone.0168653			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8LN	27992542	gold, Green Published, Green Submitted			2022-12-26	WOS:000392758000074
J	Lohberger, B; Steinecker-Frohnwieser, B; Stuendl, N; Kaltenegger, H; Leithner, A; Rinner, B				Lohberger, Birgit; Steinecker-Frohnwieser, Bibiane; Stuendl, Nicole; Kaltenegger, Heike; Leithner, Andreas; Rinner, Beate			The Proteasome Inhibitor Bortezomib Affects Chondrosarcoma Cells via the Mitochondria-Caspase Dependent Pathway and Enhances Death Receptor Expression and Autophagy	PLOS ONE			English	Article							PHASE-I TRIAL; APOPTOSIS; COMBINATION; CHEMOTHERAPY; RADIATION; THERAPY; TARGET	High grade chondrosarcoma is characterized by its lack of response to conventional cytotoxic chemotherapy, the tendency to develop lung metastases, and low survival rates. Research within the field prioritizes the development and expansion of new treatment options for dealing with unresectable or metastatic diseases. Numerous clinical trials using the proteasome inhibitor bortezomib have shown specific efficacy as an active antitumor agent for treating a variety of solid tumors. However, as of yet the effect of bortezomib on chondrosarcoma has not been investigated. In our study, bortezomib decreased cell viability and proliferation in two different chondrosarcoma cell lines in a time-and dose dependent manner. FACS analysis, mRNA-and protein expression studies illustrated that induction of apoptosis developed through the intrinsic mitochondria-caspase dependent pathway. Furthermore, bortezomib treatment significantly increased expression of the death receptors TRAILR-1 and TRAILR-2 in chondrosarcoma cells. An increased expression of the autophagy markers Atg5/12, Beclin, and LC3BI-II supports the interpretation that bortezomib functions as a trigger for autophagy. Our results demonstrated for the first time that bortezomib reduced viability and proliferation of chondrosarcoma cells, induced apoptosis via the mitochondria-caspase dependent pathway and enhanced death receptor expression and autophagy.	[Lohberger, Birgit; Stuendl, Nicole; Kaltenegger, Heike; Leithner, Andreas] Med Univ Graz, Dept Orthoped Surg, Graz, Austria; [Steinecker-Frohnwieser, Bibiane] Ludwig Boltzmann Inst Rehabil Internal Dis, Ludwig Boltzmann Cluster Rheumatol Balneol & Reha, Saalfelden, Austria; [Steinecker-Frohnwieser, Bibiane] Med Univ Graz, Inst Biophys, Graz, Austria; [Rinner, Beate] Med Univ Graz, Div Biomed Res, Graz, Austria	Medical University of Graz; Ludwig Boltzmann Institute; Medical University of Graz; Medical University of Graz	Lohberger, B (corresponding author), Med Univ Graz, Dept Orthoped Surg, Graz, Austria.	birgit.lohberger@medunigraz.at		Steinecker-Frohnwieser, Bibiane/0000-0001-6852-4466; Rinner, Beate/0000-0002-6340-4905				Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; [Anonymous], 2013, WHO CLASSIFICATION T; Apel A, 2008, CANCER RES, V68, P1485, DOI 10.1158/0008-5472.CAN-07-0562; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Besse B, 2012, LUNG CANCER, V76, P78, DOI 10.1016/j.lungcan.2011.09.006; Blaney SM, 2004, J CLIN ONCOL, V22, P4804, DOI 10.1200/JCO.2004.12.185; Cacan E, 2015, INT J MOL SCI, V16, P30405, DOI 10.3390/ijms161226238; Carew JS, 2007, BLOOD, V110, P313, DOI 10.1182/blood-2006-10-050260; Dalby KN, 2010, AUTOPHAGY, V6, P322, DOI 10.4161/auto.6.3.11625; Damron TA, 2007, CLIN ORTHOP RELAT R, P40, DOI 10.1097/BLO.0b013e318059b8c9; El-Khattouti Abdelouahid, 2013, J Cell Death, V6, P37, DOI 10.4137/JCD.S11034; Fenichel MP, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv165; Frankland-Searby S, 2012, BBA-REV CANCER, V1825, P64, DOI 10.1016/j.bbcan.2011.10.003; Geng JF, 2008, AUTOPHAGY, V4, P955, DOI 10.4161/auto.6791; Giuffrida AY, 2009, J BONE JOINT SURG AM, V91A, P1063, DOI 10.2106/JBJS.H.00416; Hu YM, 2015, TOXICOL APPL PHARM, V283, P1, DOI 10.1016/j.taap.2014.12.015; Kamada M, 2007, MOL CANCER THER, V6, P299, DOI 10.1158/1535-7163.MCT-06-0417; Kao C, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.468; Lanneau D, 2008, J CELL MOL MED, V12, P743, DOI 10.1111/j.1582-4934.2008.00273.x; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Long JS, 2012, ONCOGENE, V31, P5045, DOI 10.1038/onc.2012.7; Ludwig H, 2005, CANCER-AM CANCER SOC, V104, P1794, DOI 10.1002/cncr.21414; Luster TA, 2009, MOL CANCER THER, V8, P292, DOI 10.1158/1535-7163.MCT-08-0918; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Messersmith WA, 2006, CLIN CANCER RES, V12, P1270, DOI 10.1158/1078-0432.CCR-05-1942; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Munoz-Galvan S, 2015, MOL CANCER THER, V14, P1454, DOI 10.1158/1535-7163.MCT-14-1053; Piperdi B, 2012, J THORAC ONCOL, V7, P1032, DOI 10.1097/JTO.0b013e31824de2fa; Poklepovic A, 2013, INVEST NEW DRUG, V31, P937, DOI 10.1007/s10637-012-9913-8; Pryczynicz A, 2010, FOLIA HISTOCHEM CYTO, V48, P425, DOI 10.2478/v10042-010-0058-3; Qadir MA, 2008, BREAST CANCER RES TR, V112, P389, DOI 10.1007/s10549-007-9873-4; Ridzewski R, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00130; Rouschop KMA, 2009, CURR MOL MED, V9, P417, DOI 10.2174/156652409788167131; Sui X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.350; van Maldegem AM, 2014, CANCER-AM CANCER SOC, V120, P3159, DOI 10.1002/cncr.28845; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Wong PM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9048	40	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168193	10.1371/journal.pone.0168193	http://dx.doi.org/10.1371/journal.pone.0168193			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27978543	Green Published, gold, Green Submitted			2022-12-26	WOS:000391217400074
J	Vicente, RL; Gullon, S; Marin, S; Mellado, RP				Vicente, Rebeca L.; Gullon, Sonia; Marin, Silvia; Mellado, Rafael P.			The Three Streptomyces lividans HtrA-Like Proteases Involved in the Secretion Stress Response Act in a Cooperative Manner	PLOS ONE			English	Article							METAL AFFINITY-CHROMATOGRAPHY; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; EXTRACELLULAR PROTEOME; CONJUGAL TRANSFER; SERINE PROTEASES; CLONING VECTORS; PROTEINS; CHAPERONE; STRAINS	Overproduction of Sec-proteins in S. lividans accumulates misfolded proteins outside of the cytoplasmic membrane where the accumulated proteins interfere with the correct functioning of the secretion machinery and with the correct cell functionality, triggering the expression in S. lividans of a CssRS two-component system which regulates the degradation of the accumulated protein, the so-called secretion stress response. Optimization of secretory protein production via the Sec route requires the identification and characterisation of quality factors involved in this process. The phosphorylated regulator (CssR) interacts with the regulatory regions of three genes encoding three different HtrA-like proteases. Individual mutations in each of these genes render degradation of the misfolded protein inoperative, and propagation in high copy number of any of the three proteases encoding genes results on indiscriminate alpha-amylase degradation. None of the proteases could complement the other two deficiencies and only propagation of each single copy protease gene can restore its own deficiency. The obtained results strongly suggest that the synthesis of the three HtrA-like proteases needs to be properly balanced to ensure the effective degradation of misfolded overproduced secretory proteins and, at the same time, avoid negative effects in the secreted proteins and the secretion machinery. This is particularly relevant when considering the optimisation of Streptomyces strains for the overproduction of homologous or heterologous secretory proteins of industrial application.	[Vicente, Rebeca L.; Gullon, Sonia; Marin, Silvia; Mellado, Rafael P.] CNB CSIC, Dept Biotecnol Microbiana, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Mellado, RP (corresponding author), CNB CSIC, Dept Biotecnol Microbiana, Madrid, Spain.	rpmellado@cnb.csic.es	Gullón, Sonia/P-7460-2018; Mellado, Rafael P/D-2680-2009		MINECO/FEDER [BIO201571504-R]	MINECO/FEDER	This work was supported by MINECO/FEDER grant BIO201571504-R.	Anne J, 2012, J BIOTECHNOL, V158, P159, DOI 10.1016/j.jbiotec.2011.06.028; Antelmann H, 2003, MOL MICROBIOL, V49, P143, DOI 10.1046/j.1365-2958.2003.03565.x; Ausubel F., 1995, SHORT PROTOCOLS MOL, P2; Bernfeld P, 1955, METHOD ENZYMOL, P140; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Bolanos-Garcia VM, 2006, BBA-GEN SUBJECTS, V1760, P1304, DOI 10.1016/j.bbagen.2006.03.027; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Darmon E, 2002, J BACTERIOL, V184, P5661, DOI 10.1128/JB.184.20.5661-5671.2002; De Wulf P, 1999, J BACTERIOL, V181, P6772, DOI 10.1128/JB.181.21.6772-6778.1999; DENIS F, 1992, GENE, V111, P115, DOI 10.1016/0378-1119(92)90611-R; Escutia MR, 2006, PROTEOMICS, V6, P4137, DOI 10.1002/pmic.200500927; Flett F, 1997, FEMS MICROBIOL LETT, V155, P223, DOI 10.1111/j.1574-6968.1997.tb13882.x; Gullon S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048987; Hopwood D. A., 1985, GENETIC MANIPULATION; Hyyrylainen HL, 2001, MOL MICROBIOL, V41, P1159, DOI 10.1046/j.1365-2958.2001.02576.x; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIPINSKA B, 1990, J BACTERIOL, V172, P1791, DOI 10.1128/jb.172.4.1791-1797.1990; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; Lulko AT, 2007, APPL ENVIRON MICROB, V73, P5354, DOI 10.1128/AEM.00472-07; Noone D, 2001, J BACTERIOL, V183, P654, DOI 10.1128/JB.183.2.654-663.2001; Nybo SE, 2010, CURR PROTOC MICROBIO; Palacin A, 2002, J BACTERIOL, V184, P4875, DOI 10.1128/JB.184.17.4875-4880.2002; Pallen MJ, 1997, MOL MICROBIOL, V26, P209, DOI 10.1046/j.1365-2958.1997.5601928.x; Palomino C, 2008, INT MICROBIOL, V11, P25, DOI 10.2436/20.1501.01.41; Raivio TL, 1999, J BACTERIOL, V181, P5263, DOI 10.1128/JB.181.17.5263-5272.1999; Raju RM, 2012, NAT REV DRUG DISCOV, V11, P777, DOI 10.1038/nrd3846; Robichon C, 2011, APPL ENVIRON MICROB, V77, P4634, DOI 10.1128/AEM.00119-11; Ruckert C, 2015, J BIOTECHNOL, V199, P21, DOI 10.1016/j.jbiotec.2015.02.004; Sarvas M, 2004, BBA-MOL CELL RES, V1694, P311, DOI 10.1016/j.bbamcr.2004.04.009; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; STRUMEYE.DH, 1967, ANAL BIOCHEM, V19, P61, DOI 10.1016/0003-2697(67)90134-0; TIMMONS TM, 1990, METHOD ENZYMOL, V182, P679; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; WARD JM, 1986, MOL GEN GENET, V203, P468, DOI 10.1007/BF00422072; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	39	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168112	10.1371/journal.pone.0168112	http://dx.doi.org/10.1371/journal.pone.0168112			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977736	Green Published, Green Submitted, gold			2022-12-26	WOS:000391217400062
J	Motoyama, K; Unno, H; Hattori, A; Takaoka, T; Ishikita, H; Kawaide, H; Yoshimura, T; Hemmi, H				Motoyama, Kento; Unno, Hideaki; Hattori, Ai; Takaoka, Tomohiro; Ishikita, Hiroshi; Kawaide, Hiroshi; Yoshimura, Tohru; Hemmi, Hisashi			A Single Amino Acid Mutation Converts (R)-5-Diphosphomevalonate Decarboxylase into a Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEVALONATE DIPHOSPHATE DECARBOXYLASE; ARCHAEON SULFOLOBUS-SOLFATARICUS; PANCREATIC RIBONUCLEASE-A; CRYSTAL-STRUCTURES; HISTIDINE-RESIDUES; DIFFRACTION DATA; IMIDAZOLE RING; PATHWAY; BINDING; MODEL	The biosynthesis of isopentenyl diphosphate, a fundamental precursor for isoprenoids, via the mevalonate pathway is completed by diphosphomevalonate decarboxylase. This enzyme catalyzes the formation of isopentenyl diphosphate through the ATP-dependent phosphorylation of the 3-hydroxyl group of (R)-5-diphosphomevalonate followed by decarboxylation coupled with the elimination of the 3-phosphate group. In this reaction, a conserved aspartate residue has been proposed to be involved in the phosphorylation step as the general base catalyst that abstracts a proton from the 3-hydroxyl group. In this study, the catalytic mechanism of this rare type of decarboxylase is re-investigated by structural and mutagenic studies on the enzyme from a thermoacidophilic archaeon Sulfolobus solfataricus. The crystal structures of the archaeal enzyme in complex with (R)-5-diphosphomevalonate and adenosine 5'-O-(3-thio) triphosphate or with (R)-5-diphosphomevalonate and ADP are newly solved, and theoretical analysis based on the structure suggests the inability of proton abstraction by the conserved aspartate residue, Asp-281. Site-directed mutagenesis on Asp-281 creates mutants that only show diphosphomevalonate 3-kinase activity, demonstrating that the residue is required in the process of phosphate elimination/decarboxylation, rather than in the preceding phosphorylation step. These results enable discussion of the catalytic roles of the aspartate residue and provide clear proof of the involvement of a long predicted intermediate, (R)-3-phospho-5-diphosphomevalonate, in the reaction of the enzyme.	[Motoyama, Kento; Hattori, Ai; Yoshimura, Tohru; Hemmi, Hisashi] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan; [Unno, Hideaki] Nagasaki Univ, Grad Sch Engn, Bunkyo Machi, Nagasaki, Nagasaki 8528521, Japan; [Takaoka, Tomohiro; Ishikita, Hiroshi] Univ Tokyo, Dept Appl Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138654, Japan; [Ishikita, Hiroshi] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Komaba 4-6-1, Tokyo 1538904, Japan; [Kawaide, Hiroshi] Tokyo Univ Agr & Technol, Inst Agr, Saiwaicho 3-5-8, Fuchu, Tokyo 1838509, Japan	Nagoya University; Nagasaki University; University of Tokyo; University of Tokyo; Tokyo University of Agriculture & Technology	Hemmi, H (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	hhemmi@agr.nagoya-u.ac.jp	Hideaki, UNNO/ABG-9471-2020; Hemmi, Hisashi/I-6868-2014; Ishikita, Hiroshi/G-9864-2018; Kawaide, Hiroshi/F-9243-2013	Hideaki, UNNO/0000-0001-5917-269X; Hemmi, Hisashi/0000-0002-9538-809X; Ishikita, Hiroshi/0000-0002-5849-8150; Kawaide, Hiroshi/0000-0001-6693-1332	Japan Society for the Promotion of Science KAKENHI Grants [25108712, 16K14882, 15H00864, 26711008]; Takeda Science Foundation; Japan Science and Technology Agency CREST; Materials Integration for Engineering Polymers of Cross-ministerial Strategic Innovation Promotion Program(SIP); Interdisciplinary Computational Science Program in CCS, University of Tsukuba; Grants-in-Aid for Scientific Research [15K06977, 15K21719, 26105001, 26711008] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI Grants(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Science and Technology Agency CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Materials Integration for Engineering Polymers of Cross-ministerial Strategic Innovation Promotion Program(SIP); Interdisciplinary Computational Science Program in CCS, University of Tsukuba; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grants 25108712 and 16K14882 (to H. H.) and Grants 15H00864, 26105012, and 26711008 (to H. I.), Takeda Science Foundation (to H. H.), Japan Science and Technology Agency CREST (to H. I.), Materials Integration for Engineering Polymers of Cross-ministerial Strategic Innovation Promotion Program(SIP) (to H. I.), and the Interdisciplinary Computational Science Program in CCS, University of Tsukuba. The authors declare that they have no conflicts of interest with the contents of this article.	Azami Y, 2014, J BIOL CHEM, V289, P15957, DOI 10.1074/jbc.M114.562686; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barta ML, 2012, BIOCHEMISTRY-US, V51, P5611, DOI 10.1021/bi300591x; Barta ML, 2011, J BIOL CHEM, V286, P23900, DOI 10.1074/jbc.M111.242016; BASHFORD D, 1990, BIOCHEMISTRY-US, V29, P10219, DOI 10.1021/bi00496a010; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Bertoldi M, 2014, ARCH BIOCHEM BIOPHYS, V546, P1, DOI 10.1016/j.abb.2013.12.020; Bjerrum J., 1958, STABILITY CONSTANTS; BLOCH K, 1959, J BIOL CHEM, V234, P2595; Bochevarov AD, 2013, INT J QUANTUM CHEM, V113, P2110, DOI 10.1002/qua.24481; Bonanno JB, 2001, P NATL ACAD SCI USA, V98, P12896, DOI 10.1073/pnas.181466998; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Byres E, 2007, J MOL BIOL, V371, P540, DOI 10.1016/j.jmb.2007.05.094; CORNFORTH JW, 1966, J BIOL CHEM, V241, P3970; Dellas N, 2013, ELIFE, V2, DOI 10.7554/eLife.00672; DHEPAGANON S, 1994, BIOCHEMISTRY-US, V33, P13355, DOI 10.1021/bi00249a023; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Froese DS, 2013, STRUCTURE, V21, P1182, DOI 10.1016/j.str.2013.05.001; Hattori A, 2015, J BACTERIOL, V197, P3463, DOI 10.1128/JB.00352-15; Krepkiy D, 2004, PROTEIN SCI, V13, P1875, DOI 10.1110/ps.04725204; Kutter S, 2006, FEBS J, V273, P4199, DOI 10.1111/j.1742-4658.2006.05415.x; Kuzuyama T, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 1: NATURAL PRODUCTS STRUCTURAL DIVERSITY-I: SECONDARY METABOLITES: ORGANIZATION AND BIOSYNTHESIS, P493; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lefurgy ST, 2010, J BIOL CHEM, V285, P20654, DOI 10.1074/jbc.M109.098350; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li TF, 2012, BIOORG CHEM, V43, P2, DOI 10.1016/j.bioorg.2012.03.001; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Miziorko HM, 2011, ARCH BIOCHEM BIOPHYS, V505, P131, DOI 10.1016/j.abb.2010.09.028; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NAVE JF, 1985, BIOCHEM J, V227, P247, DOI 10.1042/bj2270247; Nishimura H, 2013, J BIOCHEM, V153, P415, DOI 10.1093/jb/mvt006; NOZAKI Y, 1967, J AM CHEM SOC, V89, P736, DOI 10.1021/ja00980a002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Payne KAP, 2015, NATURE, V522, P497, DOI 10.1038/nature14560; Rabenstein B, 2001, BIOPHYS J, V80, P1141, DOI 10.1016/S0006-3495(01)76091-2; REEVE W, 1979, CAN J CHEM, V57, P2747, DOI 10.1139/v79-444; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Styer L., 1988, BIOCHEMISTRY-US, P1046; Sugai Y, 2011, BIOSCI BIOTECH BIOCH, V75, P128, DOI 10.1271/bbb.100733; TANOKURA M, 1983, BIOCHIM BIOPHYS ACTA, V742, P576, DOI 10.1016/0167-4838(83)90276-5; TANOKURA M, 1983, BIOCHIM BIOPHYS ACTA, V742, P586, DOI 10.1016/0167-4838(83)90277-7; TANOKURA M, 1983, J BIOCHEM-TOKYO, V94, P51, DOI 10.1093/oxfordjournals.jbchem.a134353; VanNice JC, 2014, J BACTERIOL, V196, P1055, DOI 10.1128/JB.01230-13; Vinokur JM, 2015, PROTEIN SCI, V24, P212, DOI 10.1002/pro.2607; Vinokur JM, 2014, BIOCHEMISTRY-US, V53, P4161, DOI 10.1021/bi500566q; Voynova NE, 2008, ARCH BIOCHEM BIOPHYS, V480, P58, DOI 10.1016/j.abb.2008.08.024; Yang JM, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0236-2	48	8	9	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2457	2469		10.1074/jbc.M116.752535	http://dx.doi.org/10.1074/jbc.M116.752535			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28003359	Green Published, hybrid			2022-12-26	WOS:000395530300033
J	Kollndorfer, K; Ohrenberger, I; Schopf, V				Kollndorfer, Kathrin; Ohrenberger, Iris; Schoepf, Veronika			Contraceptive Use Affects Overall Olfactory Performance: Investigation of Estradiol Dosage and Duration of Intake	PLOS ONE			English	Article							MENSTRUAL-CYCLE PHASE; HORMONE REPLACEMENT THERAPY; ODOR IDENTIFICATION; COGNITIVE FUNCTION; NASAL-MUCOSA; WOMEN; DISCRIMINATION; PREFERENCES; SENSITIVITY; IMPAIRMENT	The influence of female sex steroids on cognitive performance and sensory perception has been investigated for decades. However, previous research that studied olfaction revealed inconsistent results. The main aim of this study was to investigate the effects of different ethinyl estradiol (EE) concentrations of oral contraceptives and duration of intake on olfactory function. Forty-two healthy women, with regular intake of either high or low EE dosage over at least one year and up to 15 years participated in this study. Results revealed a significant concordance between a priori categorization in the two groups with high and low EE dosage and data-driven hierarchical clustering (p = 0.008). Furthermore, significantly higher olfactory performance was observed in women using low-dose products compared to women using high-dosed products (p = 0.019). These findings indicate different effects of pill use with regard to EE concentration. We therefore strongly recommend the acquisition of information about EE dosage of oral contraceptives to reduce potential confounding factors when investigating sensory systems.	[Kollndorfer, Kathrin; Ohrenberger, Iris] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Schoepf, Veronika] Graz Univ, Inst Psychol, Graz, Austria; [Schoepf, Veronika] BioTechMed, Graz, Austria	Medical University of Vienna; University of Graz	Schopf, V (corresponding author), Graz Univ, Inst Psychol, Graz, Austria.; Schopf, V (corresponding author), BioTechMed, Graz, Austria.	veronika.schoepf@uni-graz.at		Schopf, Veronika/0000-0003-1937-4216; Kollndorfer, Kathrin/0000-0002-5983-5307				Beltz AM, 2015, HORM BEHAV, V74, P209, DOI 10.1016/j.yhbeh.2015.06.012; Bonenberger M, 2013, NEUROREPORT, V24, P951, DOI 10.1097/WNR.0000000000000024; Brinton RD, 2015, NAT REV ENDOCRINOL, V11, P393, DOI 10.1038/nrendo.2015.82; Caruso S, 2004, HUM REPROD, V19, P2959, DOI 10.1093/humrep/deh465; Caruso S, 2001, HUM REPROD, V16, P2288, DOI 10.1093/humrep/16.11.2288; Cherian S, 2014, NEUROSCIENCE, V269, P43, DOI 10.1016/j.neuroscience.2014.03.011; Daniels K, 2014, NATL HLTH STAT REPOR; Daniels Kimberly, 2015, Natl Health Stat Report, P1; DEEMS DA, 1991, ARCH OTOLARYNGOL, V117, P519; Derntl B, 2013, CHEM SENSES, V38, P67, DOI 10.1093/chemse/bjs084; Doty RL, 2015, NEUROBIOL AGING, V36, P2053, DOI 10.1016/j.neurobiolaging.2015.02.028; Doty RL, 2009, PHYSIOL BEHAV, V97, P213, DOI 10.1016/j.physbeh.2009.02.032; EVANS WJ, 1995, ELECTROEN CLIN NEURO, V95, P293, DOI 10.1016/0013-4694(95)00055-4; Farage MA, 2008, ARCH GYNECOL OBSTET, V278, P299, DOI 10.1007/s00404-008-0708-2; Frasnelli J, 2005, EUR ARCH OTO-RHINO-L, V262, P231, DOI 10.1007/s00405-004-0796-y; Gogos A, 2014, NEUROCHEM RES, V39, P2288, DOI 10.1007/s11064-014-1444-6; Grillo C, 2001, ANN OTO RHINOL LARYN, V110, P785; Haskell SG, 1997, J CLIN EPIDEMIOL, V50, P1249, DOI 10.1016/S0895-4356(97)00169-8; Hughes LF, 2002, CLIMACTERIC, V5, P140, DOI 10.1080/713605233; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Jones J., 2012, CURRENT CONTRACEPTIV; Kobal G., 1996, Rhinology (Utrecht), V34, P222; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; Krajnik J, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00195; Landis BN, 2004, LARYNGOSCOPE, V114, P1764, DOI 10.1097/00005537-200410000-00017; Larsson M, 2004, CHEM SENSES, V29, P547, DOI 10.1093/chemse/bjh059; Little AC, 2013, PSYCHONEUROENDOCRINO, V38, P1777, DOI 10.1016/j.psyneuen.2013.02.014; Mareckova K, 2014, SOC COGN AFFECT NEUR, V9, P191, DOI 10.1093/scan/nss128; Maruska KP, 2010, BEHAV BRAIN RES, V213, P208, DOI 10.1016/j.bbr.2010.04.058; Merkonidis C, 2014, EUR ARCH OTORHINOLAR; Millas I, 2011, CONTRACEPTION, V83, P571, DOI 10.1016/j.contraception.2010.09.008; Miwa T, 2001, ARCH OTOLARYNGOL, V127, P497, DOI 10.1001/archotol.127.5.497; Mordecai KL, 2008, HORM BEHAV, V54, P286, DOI 10.1016/j.yhbeh.2008.03.006; Murphy C, 2002, JAMA-J AM MED ASSOC, V288, P2307, DOI 10.1001/jama.288.18.2307; Nathan BP, 2012, EXP NEUROL, V237, P1, DOI 10.1016/j.expneurol.2012.06.001; Navarrete-Palacios E, 2003, BIOL PSYCHOL, V63, P269, DOI 10.1016/S0301-0511(03)00076-0; Navarrete-Palacios E, 2003, ARCH OTOLARYNGOL, V129, P460, DOI 10.1001/archotol.129.4.460; Ohla K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00607; Pause BM, 1996, BIOL PSYCHOL, V44, P31, DOI 10.1016/S0301-0511(96)05207-6; PELIKAN Z, 1978, ANN ALLERGY, V40, P211; Petersen N, 2015, SOC COGN AFFECT NEUR, V10, P1266, DOI 10.1093/scan/nsv010; Petersen N, 2014, NEUROIMAGE, V90, P24, DOI 10.1016/j.neuroimage.2013.12.016; Philpott CM, 2008, RHINOLOGY, V46, P221; Philpott CM, 2008, J OTOLARYNGOL-HEAD N, V37, P540, DOI 10.2310/7070.2008.0102; PHOENIX CH, 1959, ENDOCRINOLOGY, V65, P369, DOI 10.1210/endo-65-3-369; Pierman S, 2008, EUR J NEUROSCI, V27, P423, DOI 10.1111/j.1460-9568.2007.06016.x; Pletzer B, 2014, BRAIN RES, V1543, P128, DOI 10.1016/j.brainres.2013.11.007; Renfro KJ, 2013, HORM BEHAV, V63, P491, DOI 10.1016/j.yhbeh.2013.01.001; Roberts SC, 2008, P ROY SOC B-BIOL SCI, V275, P2715, DOI 10.1098/rspb.2008.0825; SANGHERA MK, 1991, ENDOCRINOLOGY, V129, P2834, DOI 10.1210/endo-129-6-2834; Seki N, 2009, ACTA OTO-LARYNGOL, V124, P958; Stubner UP, 1999, ALLERGY, V54, P865, DOI 10.1034/j.1398-9995.1999.00961.x; Temmel AFP, 2002, ARCH OTOLARYNGOL, V128, P635, DOI 10.1001/archotol.128.6.635; Watanabe K, 2002, JPN J PHYSIOL, V52, P353, DOI 10.2170/jjphysiol.52.353; Wolstenholme CR, 2006, AM J RHINOL, V20, P238, DOI 10.1177/194589240602000225	56	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167520	10.1371/journal.pone.0167520	http://dx.doi.org/10.1371/journal.pone.0167520			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002464	Green Published, Green Submitted, gold			2022-12-26	WOS:000392853100011
J	Busschaert, C; Scherrens, AL; De Bourdeaudhuij, I; Cardon, G; Van Cauwenberg, J; De Cocker, K				Busschaert, Cedric; Scherrens, Anne-Lore; De Bourdeaudhuij, Ilse; Cardon, Greet; Van Cauwenberg, Jelle; De Cocker, Katrien			Socio-Ecological Variables Associated with Context-Specific Sitting Time in Belgian Older Adults: A One-Year Follow-Up Study	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; PHYSICAL-ACTIVITY; DETERMINANTS; RELIABILITY; VALIDITY; FEASIBILITY; ADOLESCENTS; MOTIVATION; BARRIERS; PEOPLE	Introduction Knowledge about variables associated with context-specific sitting time in older adults is limited. Therefore, this study explored cross-sectional and longitudinal associations of sociodemographic, social-cognitive, physical-environmental and health-related variables with sitting during TV viewing, computer use and motorized transport in older adults. Methods A sample of Belgian older adults completed structured interviews on context-specific sitting time and associated variables using a longitudinal study design. Objective measurements of grip strength and physical performance were also completed. Complete baseline data were available of 258 participants (73.98 6.16 years) of which 229 participants remained in the study at one year follow-up (retention rate: 91.60%). Cross-sectional correlates (baseline data) and longitudinal predictors (change-scores in relation with change in sitting time) were explored through multiple linear regression analyses. Results Per context-specific sitting time, most of the cross-sectional correlates differed from the longitudinal predictors. Increases over time in enjoyment of watching TV (+one unit), encouragement of partner to watch less TV (+one unit) and TV time of partner (+30.0 min/day) were associated with respectively 9.1 min/day (p<0.001), 16.0 min/day (p<0.001) and 12.0 min/day (p<0.001) more sitting during TV viewing at follow-up. Increases over time in enjoyment of using a computer (+one unit), the number of smartphones and tablets (+1) and computer use of the partner (+30.0 min/day) were associated with respectively 5.5 min/day (p < .01), 10.4 min/day (p < .05) and 3.0 min/day (p < .05) more sitting during computer use at follow-up. An increase over time in self-efficacy regarding taking a bicycle or walking was associated with 2.9 min/day (p < .05) less sitting during motorized transport at follow-up. Conclusions The results stressed the importance of looking at separate contexts of sitting. Further, the results highlighted the importance of longitudinal research in order to reveal which changes in particular variables predicted changes in context-specific sitting time. Variables at the social-cognitive level were most frequently related to context-specific sitting.	[Busschaert, Cedric; De Bourdeaudhuij, Ilse; Cardon, Greet; De Cocker, Katrien] Univ Ghent, Dept Movement & Sport Sci, Ghent, Belgium; [Busschaert, Cedric; Van Cauwenberg, Jelle; De Cocker, Katrien] Res Fdn Flanders FWO, Brussels, Belgium; [Scherrens, Anne-Lore; Van Cauwenberg, Jelle] Univ Ghent, Dept Publ Hlth, Ghent, Belgium; [Scherrens, Anne-Lore] Vrije Univ Brussel, Dept Primary Care, Brussels, Belgium; [Van Cauwenberg, Jelle] Vrije Univ Brussel, Dept Human Biometry & Biomech, Brussels, Belgium	Ghent University; Ghent University; Vrije Universiteit Brussel; Vrije Universiteit Brussel	De Bourdeaudhuij, I (corresponding author), Univ Ghent, Dept Movement & Sport Sci, Ghent, Belgium.	Ilse.Debourdeaudhuij@UGent.be	De Cocker, Katrien/AEV-4609-2022; De+Bourdeaudhuij, Ilse/AAC-5528-2019; De Cocker, Katrien/AAA-5783-2020	De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; De Cocker, Katrien/0000-0001-7510-4419; Cardon, Greet/0000-0003-4983-6557	Fund for Scientific Research Flanders [B/12530/01]	Fund for Scientific Research Flanders(FWO)	Funded by Fund for Scientific Research Flanders (fund no. B/12530/01): CB IDB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Allison DP, 2012, HANDLING MISSING DAT; [Anonymous], 2005, GUIDELINES DATA PROC; Balboa-Castillo T, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-47; Bann D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116058; Bin Cheung Y, 2002, STAT MED, V21, P1461, DOI 10.1002/sim.1088; Brug J, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0293-2; Busschaert C, 2015, J ADOLESCENT HLTH OF; Busschaert C, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0277-2; Chastin SFM, 2014, BONE, V64, P254, DOI 10.1016/j.bone.2014.04.009; Chastin SFM, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0292-3; Chastin SFM, 2014, INT J ENV RES PUB HE, V11, P773, DOI 10.3390/ijerph110100773; Chastin SFM, 2013, PLOS ONE, V8; De Bourdeaudhuij I, 2005, OBES RES, V13, P1097, DOI 10.1038/oby.2005.128; De Bourdeaudhuij I, 2002, PREV MED, V34, P279, DOI 10.1006/pmed.2001.0979; Deforche B, 2010, PREV MED, V50, pS24, DOI 10.1016/j.ypmed.2009.08.017; Dogra S, 2014, INT J PUBLIC HLTH; Gardiner PA, 2011, AM J PREV MED, V41, P174, DOI 10.1016/j.amepre.2011.03.020; Gardner B, 2014, INT J BEHAV NUTR PHY, V11; Gianoudis J, 2015, OSTEOPOROSIS INT, V26, P571, DOI 10.1007/s00198-014-2895-y; Griffith DM, 2013, AM J MENS HEALTH, V7, P169, DOI 10.1177/1557988312465887; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Hamer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066222; Harvey JA, 2015, J AGING PHYS ACTIV, V23, P471, DOI 10.1123/japa.2014-0164; Haywood KL, 2005, QUAL LIFE RES, V14, P1651, DOI 10.1007/s11136-005-1743-0; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Healy GN, 2015, EUROPEAN HEART J; Keevil VL, 2015, MED SCI SPORT EXER, V47, P735, DOI 10.1249/MSS.0000000000000453; Kikuchi H, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-213; Kolbe-Alexander TL, 2006, J AGING PHYS ACTIV, V14, P98, DOI 10.1123/japa.14.1.98; de Rezende LFM, 2014, BMC PUBLIC HEALTH, V14, DOI [10.1186/1471-2458-14-485, 10.1186/1471-2458-14-333]; Meneguci J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1426-x; Owen N, 2014, BRIT J SPORT MED, V48, P174, DOI 10.1136/bjsports-2013-093107; Owen N, 2011, AM J PREV MED, V41, P189, DOI 10.1016/j.amepre.2011.05.013; Rosenberg DE, 2015, J GERONTOLOGY A; Rovniak LS, 2014, J SCI MED SPORT, V17, P376, DOI 10.1016/j.jsams.2013.07.014; Salmon J, 2003, HEALTH PSYCHOL, V22, P178, DOI 10.1037/0278-6133.22.2.178; Sedentary Behaviour Research Network, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/h2012-024, DOI 10.1139/H2012-024]; Stamatakis E, 2012, PREV MED, V54, P82, DOI 10.1016/j.ypmed.2011.10.009; Thogersen-Ntoumani C, 2009, SCAND J MED SCI SPOR, V19, P286, DOI 10.1111/j.1600-0838.2007.00751.x; Tomioka K, 2011, J EPIDEMIOL, V21, P459, DOI 10.2188/jea.JE20110003; Tran DV, 2013, HEALTH PROMOT J AUST, V24, P126, DOI 10.1071/HE13012; Uijtdewilligen L, 2014, SCAND J MED SCI SPOR; Van Cauwenberg J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133175; Van Cauwenberg J, 2014, J AGING PHYS ACTIV, V22, P508, DOI [10.1123/japa.2013-0015, 10.1123/JAPA.2013-0015]; van der Berg JD, 2014, MED SCI SPORT EXER, V46, P1359, DOI 10.1249/MSS.0000000000000246; Van Dyck D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-668; Van Holle V, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0110-3; Walters SJ, 2001, AGE AGEING, V30, P337, DOI 10.1093/ageing/30.4.337; Ware J.E., 1994, SF 36 PHYS MENTAL HL; Zhai L, 2015, BRIT J SPORT MED, V49, P705, DOI 10.1136/bjsports-2014-093613	51	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0167881	10.1371/journal.pone.0167881	http://dx.doi.org/10.1371/journal.pone.0167881			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QF	27997603	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000392842900016
J	Davoudi, M; Kotarsky, H; Hansson, E; Kallijarvi, J; Fellman, V				Davoudi, Mina; Kotarsky, Heike; Hansson, Eva; Kallijarvi, Jukka; Fellman, Vineta			COX7A2L/SCAFI and Pre-Complex III Modify Respiratory Chain Supercomplex Formation in Different Mouse Strains with a Bcs1/Mutation	PLOS ONE			English	Article							PROTEIN; MITOCHONDRIA; RCF1	The COX7A2L (Supercomplex Assembly Factor I, SCAFI) protein has been proposed to be a mitochondrial supercomplex assembly factor required for respirasome (supercomplex containing complexes I, III, and IV) formation. In the C57BU6 mouse strain a homozygous in-frame 6-base-pair deletion in the COX7a2I/SCAF1 gene resulting in unstable protein and suggesting loss of function was previously identified. The loss of SCAFI was shown to impede respirasome formation, a major concern for the use of C57BL mouse strains in mitochondrial research. In contradiction, another recent study suggested that supercomplex formation is independent of SCAFI isoforms. We investigated whether SCAFI isoform status affected the disease severity and supercomplex formation in the liver of Bcs1a232A>G knock-in mice with incomplete complex III assembly. In homozygotes (Bcs1/(G/G)) of mixed (C57BL/6:129/Sv) genetic background, the lifespan was similar in mice with wild-type SCAFI allele and in those homozygous (SCAF/(short/short)) for the deleted SCAF1 variant (34 3 days; n = 6 vs. 32 +/- 2 days; n = 7, respectively). SCAFI heterozygosity (SCAF/(long/short)) resulted in decreased SCAFI protein but respirasome assembly was unaffected. Congenic (C57BL/6) mice were of the genotype SCAF(short/short) and had no detectable SCAFI protein. In their liver mitochondria, respirasome composition was altered as compared to mixed background mice. Complex IV was mainly present as monomers and dimers, and only low amounts were found in combination with complex I and complex III or with precomplex III. The main supercomplex in the liver mitochondria of C57BU6 mice comprised only complexes I and III. In conclusion, in liver mitochondria of C57BL/6 mice, supercomplexes had markedly reduced amount of, but were not completely depleted of, complex IV, supporting a role for COX7A2L/SCAFI in supercomplex assembly. However, the disease progression of the Bcs1/mutant mice was unrelated to SCAFI isoforms and supercomplex composition, suggesting that other genetic factors contribute to the different survival in the different genetic backgrounds.	[Davoudi, Mina; Kotarsky, Heike; Hansson, Eva; Fellman, Vineta] Lund Univ, Pediat, Dept Clin Sci, Lund, Sweden; [Kallijarvi, Jukka; Fellman, Vineta] Folkhalsan Res Ctr, Helsinki, Finland; [Fellman, Vineta] Univ Helsinki, Childrens Hosp, Helsinki, Finland	Lund University; Folkhalsan Research Center; University of Helsinki	Fellman, V (corresponding author), Lund Univ, Pediat, Dept Clin Sci, Lund, Sweden.; Fellman, V (corresponding author), Folkhalsan Res Ctr, Helsinki, Finland.; Fellman, V (corresponding author), Univ Helsinki, Childrens Hosp, Helsinki, Finland.	Vineta.Fellman@med.lu.se	Kallijarvi, Jukka/AAV-5091-2021	Kallijarvi, Jukka/0000-0003-3773-7025; Fellman, Vineta/0000-0002-1355-5633; Davoudi, Mina/0000-0002-4952-1099	Lund University; Swedish Research Council [521-2011-3877]; Skane Council Foundation for Research and Development; Academy of Finland [259296]; Folkhalsan Research Center	Lund University; Swedish Research Council(Swedish Research CouncilEuropean Commission); Skane Council Foundation for Research and Development; Academy of Finland(Academy of Finland); Folkhalsan Research Center	This study was supported by grants to VF from Lund University, the Swedish Research Council (grant no. 521-2011-3877), the Skane Council Foundation for Research and Development, and Academy of Finland (Grant 259296), and Folkhalsan Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Boyce R, 2016, SCIENCE, V352, P812, DOI 10.1126/science.aad5252; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; Davoudi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086767; Diaz F, 2012, MOL CELL BIOL, V32, P415, DOI 10.1128/MCB.06051-11; Ikeda K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3147; Kotarsky H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041156; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Leveen P, 2011, HEPATOLOGY, V53, P437, DOI 10.1002/hep.24031; Maranzana E, 2013, ANTIOXID REDOX SIGN, V19, P1469, DOI 10.1089/ars.2012.4845; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; Mileykovskaya E, 2014, CHEM PHYS LIPIDS, V179, P42, DOI 10.1016/j.chemphyslip.2013.10.012; Mourier A, 2014, CELL METAB, V20, P1069, DOI 10.1016/j.cmet.2014.11.005; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Strogolova V, 2012, MOL CELL BIOL, V32, P1363, DOI 10.1128/MCB.06369-11; Visapaa I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086/342773; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016	17	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168774	10.1371/journal.pone.0168774	http://dx.doi.org/10.1371/journal.pone.0168774			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997587	Green Published, gold			2022-12-26	WOS:000392842900075
J	Thor, P; Bailey, A; Halsband, C; Guscelli, E; Gorokhova, E; Fransson, A				Thor, Peter; Bailey, Allison; Halsband, Claudia; Guscelli, Ella; Gorokhova, Elena; Fransson, Agneta			Seawater pH Predicted for the Year 2100 Affects the Metabolic Response to Feeding in Copepodites of the Arctic Copepod Calanus glacialis	PLOS ONE			English	Article							OCEAN ACIDIFICATION; EGG-PRODUCTION; DYNAMIC ACTION; ACARTIA-TONSA; CARBONIC-ACID; LONG-TERM; FINMARCHICUS; TEMPERATURE; POPULATION; STRESS	Widespread ocean acidification (OA) is transforming the chemistry of the global ocean, and the Arctic is recognised as a region where the earliest and strongest impacts of OA are expected. In the present study, metabolic effects of OA and its interaction with food availability was investigated in Calanus glacialis from the Kongsfjord, West Spitsbergen. We measured metabolic rates and RNA/DNA ratios (an indicator of biosynthesis) concurrently in fed and unfed individuals of copepodite stages CII-CIII and CV subjected to two different pH levels representative of present day and the "business as usual" IPCC scenario (RCP8.5) prediction for the year 2100. The copepods responded more strongly to changes in food level than to decreasing pH, both with respect to metabolic rate and RNA/DNA ratio. However, significant interactions between effects of pH and food level showed that effects of pH and food level act in synergy in copepodites of C. glacialis. While metabolic rates in copepodites stage CII-CIII increased by 78% as a response to food under present day conditions (high pH), the increase was 195% in CII-CIlls kept at low pH-a 2.5 times greater increase. This interaction was absent for RNA/DNA, so the increase in metabolic rates were clearly not a reaction to changing biosynthesis at low pH per se but rather a reaction to increased metabolic costs per unit of biosynthesis. Interestingly, we did not observe this difference in costs of growth in stage CV. A 2.5 times increase in metabolic costs of growth will leave the copepodites with much less energy for growth. This may infer significant changes to the C. glacialis population during future OA.	[Thor, Peter; Bailey, Allison; Fransson, Agneta] Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway; [Halsband, Claudia] Akvaplan Niva, Fram Ctr, Tromso, Norway; [Guscelli, Ella] Univ Florence, Florence, Italy; [Gorokhova, Elena] Stockholm Univ, Dept Environm Sci & Analyt Chem, Stockholm, Sweden	Norwegian Polar Institute; Akvaplan-niva; University of Florence; Stockholm University	Thor, P (corresponding author), Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway.	peter.thor@npolar.no	Thor, Peter/ABF-1114-2021; Gorokhova, Elena/E-7105-2018; Thor, Peter/A-7522-2009; Halsband, Claudia/B-7770-2008	Thor, Peter/0000-0002-2603-2284; Gorokhova, Elena/0000-0002-4192-6956; Thor, Peter/0000-0002-2603-2284; Halsband, Claudia/0000-0002-8570-9056	FRAM High North Research Centre for Climate and the Environment; Norwegian Research Council [225279]	FRAM High North Research Centre for Climate and the Environment; Norwegian Research Council(Research Council of NorwayEuropean Commission)	The study was financially supported by grants from the FRAM High North Research Centre for Climate and the Environment through the Ocean Acidification and Ecosystem Effects in Northern Waters Flagship and a grant from the Norwegian Research Council (grant # 225279), both to PT and CH.	AMAP, 2013, AMAP ASS 2013 ARCT O; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arnkvaern G, 2005, POLAR BIOL, V28, P528, DOI 10.1007/s00300-005-0715-8; Bailey A, 2016, ICES J MAR SCI; Caldarone EM, 2006, LIMNOL OCEANOGR-METH, V4, P153, DOI 10.4319/lom.2006.4.153; Calliari D, 2006, MAR ECOL PROG SER, V312, P177, DOI 10.3354/meps312177; CALOW P, 1990, FUNCT ECOL, V4, P283, DOI 10.2307/2389587; Clark RA, 2003, ICES J MAR SCI, V60, P187, DOI 10.1016/S1054-3139(02)00253-9; Collins M, 2014, PHYS SCI BASIS CONTR; Dahlhoff EP, 2004, ANNU REV PHYSIOL, V66, P183, DOI 10.1146/annurev.physiol.66.032102.114509; Dam HG, 2003, J EXP MAR BIOL ECOL, V292, P119, DOI 10.1016/S0022-0981(03)00162-X; Dickson A.G., 2007, GUIDE BEST PRACTICES, V3; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Dupont S, 2010, ESTUAR COAST SHELF S, V89, P182, DOI 10.1016/j.ecss.2010.06.013; Fabry VJ, 2009, OCEANOGRAPHY, V22, P160, DOI 10.5670/oceanog.2009.105; Finke DL, 2004, NATURE, V429, P407, DOI 10.1038/nature02554; Fransson A, 2016, POLAR BIOL, V39, P1841, DOI 10.1007/s00300-016-1955-5; Fransson A, 2001, CONT SHELF RES, V21, P225, DOI 10.1016/S0278-4343(00)00088-1; Freese D, 2015, LIMNOL OCEANOGR, V60, P2121, DOI 10.1002/lno.10158; Gorokhova E, 2002, J PLANKTON RES, V24, P511, DOI 10.1093/plankt/24.5.511; Gorokhova E, 2009, HARMFUL ALGAE, V8, P264, DOI 10.1016/j.hal.2008.06.006; HANSEN B, 1990, J PLANKTON RES, V12, P1173, DOI 10.1093/plankt/12.6.1173; Hernroth B, 2012, FISH SHELLFISH IMMUN, V33, P1095, DOI 10.1016/j.fsi.2012.08.011; Hildebrandt N, 2016, ICES J MAR SCI, V73, P927, DOI 10.1093/icesjms/fsv226; Hildebrandt N, 2014, MAR POLLUT BULL, V80, P59, DOI 10.1016/j.marpolbul.2014.01.050; Hop H, 2013, MAR BIOL RES, V9, P878, DOI 10.1080/17451000.2013.775458; Isari S, 2015, J PLANKTON RES; JOBLING M, 1983, J FISH BIOL, V23, P549, DOI 10.1111/j.1095-8649.1983.tb02934.x; Karnovsky NJ, 2003, MAR ECOL PROG SER, V253, P289, DOI 10.3354/meps253289; KIORBOE T, 1985, MAR ECOL PROG SER, V26, P85, DOI 10.3354/meps026085; Lewis CN, 2013, P NATL ACAD SCI USA, V110, pE4960, DOI 10.1073/pnas.1315162110; Li W, 2012, MAR POLLUT BULL, V64, P699, DOI 10.1016/j.marpolbul.2012.01.033; Lowry L., 1993, BOWHEAD WHALES; Mackas DL, 1998, CAN J FISH AQUAT SCI, V55, P1878, DOI 10.1139/cjfas-55-8-1878; Madsen SD, 2001, MAR BIOL, V139, P75; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Mumm N, 1998, POLAR BIOL, V20, P189, DOI 10.1007/s003000050295; Nielsen TG, 2014, MAR BIOL, V161, P1299, DOI 10.1007/s00227-014-2419-5; Omori M., 1984, METHODS MARINE ZOOPL; Pan T-CF, 2015, P NATL ACAD SCI US; Pedersen SA, 2014, ENVIRON SCI TECHNOL, V48, P12275, DOI 10.1021/es501581j; Petes LE, 2007, J EXP MAR BIOL ECOL, V351, P83, DOI 10.1016/j.jembe.2007.06.025; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Runge JA, 2016, ICES J MAR SCI, V73, P937, DOI 10.1093/icesjms/fsv258; Scott CL, 2000, POLAR BIOL, V23, P510, DOI 10.1007/s003000000114; Sokolova IM, 2012, MAR ENVIRON RES, V79, P1, DOI 10.1016/j.marenvres.2012.04.003; Steinacher M, 2009, BIOGEOSCIENCES, V6, P515, DOI 10.5194/bg-6-515-2009; STRATHMANN RR, 1967, LIMNOL OCEANOGR, V12, P411, DOI 10.4319/lo.1967.12.3.0411; Stumpp M, 2012, P NATL ACAD SCI USA, V109, P18192, DOI 10.1073/pnas.1209174109; Svetlichny LS, 2005, J PLANKTON RES, V27, P671, DOI 10.1093/plankt/fbi041; Thor P, 2002, J EXP MAR BIOL ECOL, V272, P159, DOI 10.1016/S0022-0981(02)00131-4; Thor P, 2002, J PLANKTON RES, V24, P293, DOI 10.1093/plankt/24.4.293; Thor P, 2000, J EXP MAR BIOL ECOL, V245, P171, DOI 10.1016/S0022-0981(99)00159-8; Thor P, 2015, GLOB CHANGE BIOL; Thor P, 2015, MAR BIOL, V162, P799, DOI 10.1007/s00227-015-2625-9; VIDAL J, 1980, MAR BIOL, V56, P195, DOI 10.1007/BF00645343; Wallace D, 2006, MS EXCEL PROGRAM DEV; Wendt I, 2015, CRUSTACEANA, V88, P675, DOI 10.1163/15685403-00003436; Weydmann A, 2016, POLAR BIOL, V39, P2311, DOI 10.1007/s00300-016-1898-x; Weydmann A, 2012, J EXP MAR BIOL ECOL, V428, P39, DOI 10.1016/j.jembe.2012.06.002; Zervoudaki S, 2014, MEDITERR MAR SCI, V15, P74, DOI 10.12681/mms.553; Zhang DJ, 2012, WATER SCI TECHNOL, V65, P30, DOI 10.2166/wst.2011.821	63	9	9	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168735	10.1371/journal.pone.0168735	http://dx.doi.org/10.1371/journal.pone.0168735			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992579	gold, Green Published, Green Submitted			2022-12-26	WOS:000392842600096
J	Tsukuda, K; Mogi, M; Iwanami, J; Kanno, H; Nakaoka, H; Wang, XL; Bai, HY; Shan, BS; Kukida, M; Higaki, A; Yamauchi, T; Min, LJ; Horiuchi, M				Tsukuda, Kana; Mogi, Masaki; Iwanami, Jun; Kanno, Harumi; Nakaoka, Hirotomo; Wang, Xiao-Li; Bai, Hui-Yu; Shan, Bao-Shuai; Kukida, Masayoshi; Higaki, Akinori; Yamauchi, Toshifumi; Min, Li-Juan; Horiuchi, Masatsugu			Enhancement of Adipocyte Browning by Angiotensin II Type 1 Receptor Blockade	PLoS One			English	Article							1A RECEPTOR; PPAR-GAMMA; EXPRESSION; DIFFERENTIATION; SYSTEM; MICE; CONVERSION; MOUSE; WHITE	Browning of white adipose tissue (WAT) has been highlighted as a new possible therapeutic target for obesity, diabetes and lipid metabolic disorders, because WAT browning could increase energy expenditure and reduce adiposity. The new clusters of adipocytes that emerge with WAT browning have been named 'beige' or 'brite' adipocytes. Recent reports have indicated that the renin-angiotensin system (RAS) plays a role in various aspects of adipose tissue physiology and dysfunction. The biological effects of angiotensin II, a major component of RAS, are mediated by two receptor subtypes, angiotensin II type 1 receptor (AT(1)R) and type 2 receptor (AT(2)R). However, the functional roles of angiotensin II receptor subtypes in WAT browning have not been defined. Therefore, we examined whether deletion of angiotensin II receptor subtypes (AT(1a)R and AT(2)R) may affect white-to-beige fat conversion in vivo. AT(1a) receptor knockout (AT(1a)KO) mice exhibited increased appearance of multilocular lipid droplets and upregulation of thermogenic gene expression in inguinal white adipose tissue (iWAT) compared to wild-type (WT) mice. AT(2) receptor-deleted mice did not show miniaturization of lipid droplets or alteration of thermogenic gene expression levels in iWAT. An in vitro experiment using adipose tissue-derived stem cells showed that deletion of the AT(1a) receptor resulted in suppression of adipocyte differentiation, with reduction in expression of thermogenic genes. These results indicate that deletion of the AT(1a) receptor might have some effects on the process of browning of WAT and that blockade of the AT(1) receptor could be a therapeutic target for the treatment of metabolic disorders.	[Tsukuda, Kana; Mogi, Masaki; Iwanami, Jun; Kanno, Harumi; Nakaoka, Hirotomo; Wang, Xiao-Li; Bai, Hui-Yu; Shan, Bao-Shuai; Kukida, Masayoshi; Higaki, Akinori; Yamauchi, Toshifumi; Min, Li-Juan; Horiuchi, Masatsugu] Ehime Univ, Grad Sch Med, Dept Mol Cardiovasc Biol & Pharmacol, Tohon, Ehime, Japan; [Kukida, Masayoshi; Higaki, Akinori] Ehime Univ, Grad Sch Med, Dept Cardiol Pulmonol Hypertens & Nephrol, Tohon, Ehime, Japan; [Yamauchi, Toshifumi] Ehime Univ, Grad Sch Med, Dept Pediat, Tohon, Ehime, Japan	Ehime University; Ehime University; Ehime University	Horiuchi, M (corresponding author), Ehime Univ, Grad Sch Med, Dept Mol Cardiovasc Biol & Pharmacol, Tohon, Ehime, Japan.	horiuchi@m.ehime-u.ac.jp	Higaki, Akinori/AAA-2551-2019	Higaki, Akinori/0000-0002-0827-874X	JSPS KAKENHI [25293310, 25462220, 15K19974, 26860567]; Ajinomoto Pharmaceuticals Co. Ltd.; Astellas Pharma Inc.; Bayer Yakuhin Ltd.; Daiichi-Sankyo Pharmaceutical Co. Ltd.; Nippon Boehringer Ingelheim Co. Ltd.; Novartis Pharma K.K.; Shionogi Co. Ltd.; Takeda Pharmaceutical Co. Ltd.	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ajinomoto Pharmaceuticals Co. Ltd.; Astellas Pharma Inc.(Astellas Pharmaceuticals); Bayer Yakuhin Ltd.; Daiichi-Sankyo Pharmaceutical Co. Ltd.; Nippon Boehringer Ingelheim Co. Ltd.(Boehringer Ingelheim); Novartis Pharma K.K.(Novartis); Shionogi Co. Ltd.; Takeda Pharmaceutical Co. Ltd.(Takeda Pharmaceutical Company Ltd)	This study was supported by JSPS KAKENHI [Grant Number 25293310 to MH, 25462220 to MM, 15K19974 to JI, and 26860567 to LJM] and research grants from pharmaceutical companies: Ajinomoto Pharmaceuticals Co. Ltd., Astellas Pharma Inc., Bayer Yakuhin Ltd., Daiichi-Sankyo Pharmaceutical Co. Ltd., Nippon Boehringer Ingelheim Co. Ltd., Novartis Pharma K.K., Shionogi & Co. Ltd., and Takeda Pharmaceutical Co. Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURSON JM, 1994, AM J PHYSIOL, V267, pE260, DOI 10.1152/ajpendo.1994.267.2.E260; de Kloet AD, 2014, PHYSIOL BEHAV, V136, P31, DOI 10.1016/j.physbeh.2014.01.016; de Kloet AD, 2013, J NEUROSCI, V33, P4825, DOI 10.1523/JNEUROSCI.3806-12.2013; Fujimoto M, 2004, FEBS LETT, V576, P492, DOI 10.1016/j.febslet.2004.09.027; Furuhashi M, 2004, J HYPERTENS, V22, P1977, DOI 10.1097/00004872-200410000-00021; Garcia-Alonso V, 2013, J BIOL CHEM, V288, P28230, DOI 10.1074/jbc.M113.468603; Giralt M, 2013, ENDOCRINOLOGY, V154, P2992, DOI 10.1210/en.2013-1403; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Head GA, 2001, ANN NY ACAD SCI, V940, P361; Iwai M, 2005, CIRCULATION, V112, P1636, DOI 10.1161/CIRCULATIONAHA.104.525550; Iwai M, 2009, AM J HYPERTENS, V22, P784, DOI 10.1038/ajh.2009.85; Jing F, 2013, MOL CELL ENDOCRINOL, V378, P23, DOI 10.1016/j.mce.2012.03.005; Kouyama R, 2005, ENDOCRINOLOGY, V146, P3481, DOI 10.1210/en.2005-0003; LLORENSCORTES C, 1994, HYPERTENSION, V24, P538, DOI 10.1161/01.HYP.24.5.538; Lob HE, 2010, HYPERTENSION, V55, P277, DOI 10.1161/HYPERTENSIONAHA.109.142646; Marcus Y, 2013, DIABETES, V62, P1121, DOI 10.2337/db12-0792; Matsushita K, 2006, HYPERTENSION, V48, P1095, DOI 10.1161/01.HYP.0000248211.82232.a7; Mogi M, 2006, HYPERTENSION, V48, P1020, DOI 10.1161/01.HYP.0000248196.14826.31; Ohshima K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048387; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; SASAMURA H, 1992, BIOCHEM BIOPH RES CO, V185, P253, DOI 10.1016/S0006-291X(05)80983-0; SUGAYA T, 1995, J BIOL CHEM, V270, P18719, DOI 10.1074/jbc.270.32.18719; Tham DM, 2002, PHYSIOL GENOMICS, V11, P21, DOI 10.1152/physiolgenomics.00062.2002; Tiyerili V, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-30; Tomono Y, 2008, AM J HYPERTENS, V21, P206, DOI 10.1038/ajh.2007.50; Wang Chih-Hong, 2010, Open Hypertens J, V3, P1	27	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0167704	10.1371/journal.pone.0167704	http://dx.doi.org/10.1371/journal.pone.0167704			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992452	Green Submitted, gold, Green Published			2022-12-26	WOS:000392842600018
J	Kofuji, P; Mure, LS; Massman, LJ; Purrier, N; Panda, S; Engeland, WC				Kofuji, Paulo; Mure, Ludovic S.; Massman, Logan J.; Purrier, Nicole; Panda, Satchidananda; Engeland, William C.			Intrinsically Photosensitive Retinal Ganglion Cells (ipRGCs) Are Necessary for Light Entrainment of Peripheral Clocks	PLOS ONE			English	Article							CIRCADIAN TIMING SYSTEM; SUPRACHIASMATIC NUCLEUS; RETINOHYPOTHALAMIC TRACT; MAMMALIAN RETINA; MELANOPSIN; MOUSE; RESPONSES; OSCILLATORS; RHYTHMS; MICE	Light is a powerful entrainer of circadian clocks in almost all eukaryotic organisms promoting synchronization of internal circadian rhythms with external environmental light-dark (LD) cycles. In mammals, the circadian system is organized in a hierarchical manner, in which a central pacemaker in the suprachiasmatic nucleus (SCN) synchronizes oscillators in peripheral tissues. Recent evidence demonstrates that photoentrainment of the SCN proceeds via signaling from a subpopulation of retinal ganglion cells (RGCs) which are melanopsin-expressing and intrinsically photosensitive (ipRGCs). However, it is still unclear whether photoentrainment of peripheral clocks is mediated exclusively by the ipRGC system or if signaling from RGCs that do not express melanopsin also plays a role. Here we have used genetic "silencing" of ipRGC neurotransmission in mice to investigate whether this photoreceptive system is obligatory for the photoentrainment of peripheral circadian clocks. Genetic silencing of ipRGC neurotransmission in mice was achieved by expression of tetanus toxin light chain in melanopsin-expressing cells (Opn4:: TeNT mouse line). Rhythms of the clock gene Period 2 in various peripheral tissues were measured by crossbreeding Opn4:: TeNT mice with PER2 luciferase knock-in mice (mPER2(Luc)). We found that in Opn4:: TeNT mice the pupillary light reflex, light modulation of activity, and circadian photoentrainment of locomotor activity were severely impaired. Furthermore, ex vivo cultures from Opn4:: TeNT, mPER2(Luc) mice of the adrenal gland, cornea, lung, liver, pituitary and spleen exhibited robust circadian rhythms of PER2:: LUC bioluminescence. However, their peak bioluminescence rhythms were not aligned to the projected LD cycles indicating their lack of photic entrainment in vivo. Finally, we found that the circadian rhythm in adrenal corticosterone in Opn4:: TeNT mice, as monitored by in vivo subcutaneous microdialysis, was desynchronized from environmental LD cycles. Our findings reveal a non-redundant role of ipRGCs for photic entrainment of peripheral tissues, highlighting the importance of this photoreceptive system for the organismal adaptation to daily environmental LD cycles.	[Kofuji, Paulo; Massman, Logan J.; Purrier, Nicole; Engeland, William C.] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; [Mure, Ludovic S.; Panda, Satchidananda] Salk Inst Biol Studies, Regulatory Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA	University of Minnesota System; University of Minnesota Twin Cities; Salk Institute	Kofuji, P (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.	kofuj001@umn.edu	Kofuji, Paulo/AAR-7835-2021; Mure, Ludovic/AAR-9132-2021	Kofuji, Paulo/0000-0002-4840-9986; Mure, Ludovic/0000-0002-2485-1032; Massman, Logan/0000-0002-5579-4798	NIH [R03NS094419]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support was provided by NIH grant R03NS094419.	Albrecht U, 2012, NEURON, V74, P246, DOI 10.1016/j.neuron.2012.04.006; Baba K, 2015, INVEST OPHTH VIS SCI, V56, P4753, DOI 10.1167/iovs.15-17124; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Buhr ED, 2015, P NATL ACAD SCI USA, V112, P13093, DOI 10.1073/pnas.1516259112; Buhr ED, 2014, P NATL ACAD SCI USA, V111, P8625, DOI 10.1073/pnas.1323350111; COLWELL CS, 1992, J COMP NEUROL, V324, P135, DOI 10.1002/cne.903240202; Davidson AJ, 2009, EUR J NEUROSCI, V29, P171, DOI 10.1111/j.1460-9568.2008.06534.x; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Evans JA, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0157-x; Figueiro MG, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/829351; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hannibal J, 2004, NEUROREPORT, V15, P2317, DOI 10.1097/00001756-200410250-00003; Hannibal J, 2004, INVEST OPHTH VIS SCI, V45, P4202, DOI 10.1167/iovs.04-0313; Hannibal J, 2006, INT REV CYTOL, V251, P1, DOI 10.1016/S0074-7696(06)51001-0; Hardin PE, 2013, CURR OPIN NEUROBIOL, V23, P724, DOI 10.1016/j.conb.2013.02.018; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Husse J, 2015, BIOESSAYS, V37, P1119, DOI 10.1002/bies.201500026; Husse J, 2014, FASEB J, V28, P4950, DOI 10.1096/fj.14-256594; Izumo M, 2014, ELIFE, V3, DOI 10.7554/eLife.04617; Kasahara T, 2010, P NATL ACAD SCI USA, V107, P6412, DOI 10.1073/pnas.0914399107; Kerschensteiner D, 2009, NATURE, V460, P1016, DOI 10.1038/nature08236; KORNHAUSER JM, 1990, NEURON, V5, P127, DOI 10.1016/0896-6273(90)90303-W; Lee IT, 2015, NEURON, V85, P1086, DOI 10.1016/j.neuron.2015.02.006; Menaker M, 2013, CURR OPIN NEUROBIOL, V23, P741, DOI 10.1016/j.conb.2013.03.003; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; MOORE RY, 1995, J COMP NEUROL, V352, P351, DOI 10.1002/cne.903520304; Mrosovsky N, 2003, CHRONOBIOL INT, V20, P989, DOI 10.1081/CBI-120026043; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Partch CL, 2013, TRENDS CELL BIOL; Peirson S, 2006, NEURON, V49, P331, DOI 10.1016/j.neuron.2006.01.006; Pezuk P, 2012, ENDOCRINOLOGY, V153, P4775, DOI 10.1210/en.2012-1486; PICKARD GE, 1981, J COMP NEUROL, V196, P155, DOI 10.1002/cne.901960111; Pilorz V, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002482; Purrier N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111449; Qian XX, 2012, ENDOCRINOLOGY, V153, P4346, DOI 10.1210/en.2012-1484; Rahman SA, 2011, AM J PHYSIOL-ENDOC M, V300, pE518, DOI 10.1152/ajpendo.00597.2010; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Reddy AB, 2007, HEPATOLOGY, V45, P1478, DOI 10.1002/hep.21571; Reifler ANN, 2015, CURR BIOL, V25, P2763, DOI 10.1016/j.cub.2015.09.018; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schmidt TM, 2008, J NEUROPHYSIOL, V100, P371, DOI 10.1152/jn.00062.2008; Schmidt TM, 2011, TRENDS NEUROSCI, V34, P572, DOI 10.1016/j.tins.2011.07.001; Schmidt TM, 2009, J NEUROSCI, V29, P476, DOI 10.1523/JNEUROSCI.4117-08.2009; Sekaran S, 2005, CURR BIOL, V15, P1099, DOI 10.1016/j.cub.2005.05.053; Son GH, 2008, P NATL ACAD SCI USA, V105, P20970, DOI 10.1073/pnas.0806962106; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Windle RJ, 1998, ENDOCRINOLOGY, V139, P4044, DOI 10.1210/en.139.10.4044; Yoder JM, 2014, AM J PHYSIOL-REG I, V306, pR387, DOI 10.1152/ajpregu.00519.2013; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zhang YP, 2008, CISP 2008: FIRST INTERNATIONAL CONGRESS ON IMAGE AND SIGNAL PROCESSING, VOL 1, PROCEEDINGS, P60, DOI 10.1109/CISP.2008.483	57	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168651	10.1371/journal.pone.0168651	http://dx.doi.org/10.1371/journal.pone.0168651			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992553	Green Published, gold, Green Submitted			2022-12-26	WOS:000392758000072
J	Mizuyama, R; Soma, S; Suemastu, N; Shimegi, S				Mizuyama, Ryo; Soma, Shogo; Suemastu, Naofumi; Shimegi, Satoshi			Noradrenaline Improves Behavioral Contrast Sensitivity via the beta-Adrenergic Receptor	PLOS ONE			English	Article							RAT VISUAL-CORTEX; LOCUS-COERULEUS; NEURONS; NOREPINEPHRINE; SEROTONIN; MONKEY	Noradrenaline (NA) is released from the locus coeruleus in the brainstem to almost the whole brain depending on the physiological state or behavioral context. NA modulates various brain functions including vision, but many questions about the functional role of its effects and mechanisms remain unclear. To explore these matters, we focused on three questions, 1) whether NA improves detectability of a behavior-relevant visual stimulus, 2) which receptor subtypes contribute to the NA effects, and 3) whether the NA effects are specific for visual features such as spatial frequency (SF). We measured contrast sensitivity in rats by a two-alternative forced choice visual detection task and tested the effects of NA receptor blockers in three SF conditions. Propranolol, a beta-adrenergic receptor inhibitor, significantly decreased contrast sensitivity, but neither prazosin nor idazoxan, alpha(1)- and alpha(2)-adrenergic receptor inhibitors, respectively, had an effect. This beta blocker effect was observed only at optimal SF. These results indicate that endogenous NA enhances visual detectability depending on stimulus spatial properties via mainly beta-adrenergic receptors.	[Mizuyama, Ryo; Shimegi, Satoshi] Osaka Univ, Lab Cognit & Behav Neurosci, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Soma, Shogo; Suemastu, Naofumi; Shimegi, Satoshi] Osaka Univ, Lab Cognit & Behav Neurosci, Grad Sch Med, Toyonaka, Osaka, Japan; [Soma, Shogo] Tamagawa Univ, Brain Sci Inst, Tokyo, Japan; [Suemastu, Naofumi] Osaka Univ, Grad Sch Engn, Suita, Osaka, Japan	Osaka University; Osaka University; Osaka University	Shimegi, S (corresponding author), Osaka Univ, Lab Cognit & Behav Neurosci, Grad Sch Frontier Biosci, Suita, Osaka, Japan.; Shimegi, S (corresponding author), Osaka Univ, Lab Cognit & Behav Neurosci, Grad Sch Med, Toyonaka, Osaka, Japan.	shimegi@vision.hss.osaka-u.ac.jp		Soma, Shogo/0000-0002-7381-9477	KAKENHI [22500573, 25282216, 25560302, 16H01869]; Grants-in-Aid for Scientific Research [16H01869] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI (http://www.mext.go.jp/english/), 22500573, 25282216, 25560302, and 16H01869 to S. Shimegi.	ARENA/OLAW, 2002, I AN CAR US COMM GUI, V2nd; ASTONJONES G, 1994, J NEUROSCI, V14, P4467; Bakshi VP, 1999, NEUROSCIENCE, V92, P113, DOI 10.1016/S0306-4522(98)00752-0; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; DEVAUGES V, 1990, BEHAV BRAIN RES, V39, P19, DOI 10.1016/0166-4328(90)90118-X; Edeline JM, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00045; Histed MH, 2012, J NEUROPHYSIOL, V107, P758, DOI 10.1152/jn.00609.2011; JONES BE, 1977, BRAIN RES, V127, P1, DOI 10.1016/0006-8993(77)90377-8; Khalifa AE, 2001, J ETHNOPHARMACOL, V76, P49, DOI 10.1016/S0378-8741(01)00210-0; KOLTA A, 1989, CAN J PHYSIOL PHARM, V67, P615, DOI 10.1139/y89-098; KOLTA A, 1987, LIFE SCI, V41, P281, DOI 10.1016/0024-3205(87)90150-0; Lee S. B., 2012, INT J TOUR RES, V15, P209, DOI DOI 10.1016/J.NEUR0N.2012.09.012; Manunta Y, 1997, EUR J NEUROSCI, V9, P833, DOI 10.1111/j.1460-9568.1997.tb01433.x; OHRSTROM A, 1980, ARCH OPHTHALMOL-CHIC, V98, P2182; OLPE HR, 1980, BRAIN RES, V186, P9, DOI 10.1016/0006-8993(80)90251-6; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; RAJKOWSKI J, 1994, BRAIN RES BULL, V35, P607, DOI 10.1016/0361-9230(94)90175-9; Ramos BP, 2007, PHARMACOL THERAPEUT, V113, P523, DOI 10.1016/j.pharmthera.2006.11.006; READER TA, 1978, EXPERIENTIA, V34, P1586, DOI 10.1007/BF02034690; SATO H, 1989, J NEUROPHYSIOL, V62, P946, DOI 10.1152/jn.1989.62.4.946; Soma S, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12060; Soma S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00063; Soma S, 2013, BEHAV BRAIN RES, V256, P362, DOI 10.1016/j.bbr.2013.08.022; Usher M, 1999, SCIENCE, V283, P549, DOI 10.1126/science.283.5401.549; VIDEEN TO, 1984, J NEUROSCI, V4, P1607; WATERHOUSE BD, 1990, BRAIN RES, V514, P276, DOI 10.1016/0006-8993(90)91422-D	26	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168455	10.1371/journal.pone.0168455	http://dx.doi.org/10.1371/journal.pone.0168455			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992510	Green Published, gold, Green Submitted			2022-12-26	WOS:000392758000051
J	Arif, R; Farag, M; Zaradzki, M; Reissfelder, C; Pianka, F; Bruckner, T; Kremer, J; Franz, M; Ruhparwar, A; Szabo, G; Beller, CJ; Karck, M; Kallenbach, K; Weymann, A				Arif, Rawa; Farag, Mina; Zaradzki, Marcin; Reissfelder, Christoph; Pianka, Frank; Bruckner, Thomas; Kremer, Jamila; Franz, Maximilian; Ruhparwar, Arjang; Szabo, Gabor; Beller, Carsten J.; Karck, Matthias; Kallenbach, Klaus; Weymann, Alexander			Ischemic Colitis after Cardiac Surgery: Can We Foresee the Threat?	PLOS ONE			English	Article							NONOCCLUSIVE MESENTERIC ISCHEMIA; OPEN-HEART-SURGERY; CARDIOPULMONARY-BYPASS; GASTROINTESTINAL COMPLICATIONS; RISK-FACTORS; SURGICAL-PATIENTS; MUCOSAL ISCHEMIA; DYSFUNCTION; DIAGNOSIS; GUT	Introduction Ischemic colitis (IC) remains a great threat after cardiac surgery with use of extracorporeal circulation. We aimed to identify predictive risk factors and influence of early catecholamine therapy for this disease. Methods We prospectively collected and analyzed data of 224 patients, who underwent laparotomy due to IC after initial cardiac surgery with use of extracorporeal circulation during 2002 and 2014. For further comparability 58 patients were identified, who underwent bypass surgery, aortic valve replacement or combination of both. Age +/-5 years, sex, BMI +/- 5, left ventricular function, peripheral arterial disease, diabetes and urgency status were used for match-pair analysis (1: 1) to compare outcome and detect predictive risk factors. Highest catecholamine doses during 1 POD were compared for possible predictive potential. Results Patients' baseline characteristics showed no significant differences. In-hospital mortality of the IC group with a mean age of 71 years (14% female) was significantly higher than the control group with a mean age of 70 (14% female) (67% vs. 16%, p < 0.001). Despite significantly longer bypass time in the IC group (133 +/- 68 vs. 101 +/- 42, p = 0.003), cross-clamp time remained comparable (64 +/- 33 vs. 56 +/- 25 p = 0.150). The majority of the IC group suffered low-output syndrome (71% vs. 14%, p < 0.001) leading to significant higher lactate values within first 24h after operation (55 +/- 46 mg/dl vs. 31 +/- 30 mg/dl, p = 0.002). Logistic regression revealed elevated lactate values to be significant predictor for colectomy during the postoperative course (HR 1.008, CI 95% 1.003 +/- 1.014, p = 0.003). However, Receiver Operating Characteristic Curve calculates a cut-off value for lactate of 22.5 mg/dl (sensitivity 73% and specificity 57%). Furthermore, multivariate analysis showed low-output syndrome (HR 4.301, CI 95% 2.108-8.776, p < 0.001) and vasopressin therapy (HR 1.108, CI 95% 1.012-1.213, p = 0.027) significantly influencing necessity of laparotomy. Conclusion Patients who undergo laparotomy for IC after initial cardiac surgery have a substantial inhospital mortality risk. Early postoperative catecholamine levels do not influence the development of an IC except vasopressin. Elevated lactate remains merely a vague predictive risk factor.	[Arif, Rawa; Farag, Mina; Zaradzki, Marcin; Kremer, Jamila; Franz, Maximilian; Ruhparwar, Arjang; Szabo, Gabor; Beller, Carsten J.; Karck, Matthias; Weymann, Alexander] Heidelberg Univ, Heart & Marfan Ctr, Dept Cardiac Surg, Heidelberg, Germany; [Reissfelder, Christoph] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Visceral Thorac & Vasc Surg, Fetscherstr, Dresden, Germany; [Pianka, Frank] Univ Heidelberg Hosp, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany; [Bruckner, Thomas] Heidelberg Univ, Inst Med Biometry & Informat, Heidelberg, Germany; [Kallenbach, Klaus] HaerzZenter INCCI, Dept Cardiac Surg, Rue Ernest Barble, Luxembourg, Luxembourg	Ruprecht Karls University Heidelberg; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Arif, R (corresponding author), Heidelberg Univ, Heart & Marfan Ctr, Dept Cardiac Surg, Heidelberg, Germany.	rawa.arif@med.uni-heidelberg.de	Weymann, Alexander/AAQ-5115-2021	Szabo, Gabor/0000-0001-6038-9968				Abboud B, 2008, WORLD J GASTROENTERO, V14, P5361, DOI 10.3748/wjg.14.5361; Acosta S, 2006, J INTERN MED, V259, P305, DOI 10.1111/j.1365-2796.2006.01613.x; ALLEN KB, 1992, J VASC SURG, V16, P391, DOI 10.1016/0741-5214(92)90372-F; BAILEY RW, 1986, ANN SURG, V203, P590, DOI 10.1097/00000658-198606000-00002; BAUE AE, 1993, ANN THORAC SURG, V55, P822, DOI 10.1016/0003-4975(93)90098-3; Bolcal C, 2005, CAN J GASTROENTEROL, V19, P613, DOI 10.1155/2005/975612; Bomberg H, 2016, ANN THORAC SURG; Bomberg H, 2015, EUR SURG RES, V54, P75, DOI 10.1159/000368355; Chang RW, 2006, WORLD J GASTROENTERO, V12, P3243, DOI 10.3748/wjg.v12.i20.3243; Demir IE, 2012, DIGEST SURG, V29, P226, DOI 10.1159/000338086; Demir M, 2014, MED PRIN PRACT, V23, P140, DOI 10.1159/000356860; Ghosh S, 2002, EUR J CARDIO-THORAC, V21, P411, DOI 10.1016/S1010-7940(02)00015-5; Groesdonk HV, 2013, J THORAC CARDIOV SUR, V145, P1603, DOI 10.1016/j.jtcvs.2012.11.022; Hasan S, 2004, Interact Cardiovasc Thorac Surg, V3, P475, DOI 10.1016/j.icvts.2004.04.003; Klotz S, 2001, ANN THORAC SURG, V72, P1583, DOI 10.1016/S0003-4975(01)03179-4; Mangi AA, 2005, ANN SURG, V241, P895, DOI 10.1097/01.sla.0000164173.05762.32; Reissfelder C, 2011, SURGERY, V149, P585, DOI 10.1016/j.surg.2010.11.008; Ritz JP, 2005, ANN VASC SURG, V19, P328, DOI 10.1007/s10016-005-0005-5; Schutz A, 1998, ANGIOLOGY, V49, P267, DOI 10.1177/000331979804900404; TAO WK, 1995, J THORAC CARDIOV SUR, V110, P819, DOI 10.1016/S0022-5223(95)70116-8; Tofukuji M, 2000, ANN THORAC SURG, V69, P799, DOI 10.1016/S0003-4975(99)01408-3; Trompeter M, 2002, EUR RADIOL, V12, P1179, DOI 10.1007/s00330-001-1220-2; Vassiliou I, 2008, CARDIOLOGY, V111, P94, DOI 10.1159/000119696; Venkateswaran RV, 2002, EUR J CARDIO-THORAC, V22, P534, DOI 10.1016/S1010-7940(02)00373-1; Zacharias A, 2000, TEX HEART I J, V27, P93	25	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0167601	10.1371/journal.pone.0167601	http://dx.doi.org/10.1371/journal.pone.0167601			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977704	Green Published, gold, Green Submitted			2022-12-26	WOS:000391217400024
J	Hillier, A; Kelly, RP; Klinger, T				Hillier, Ann; Kelly, Ryan P.; Klinger, Terrie			Narrative Style Influences Citation Frequency in Climate Change Science	PLOS ONE			English	Article							PERSPECTIVE-TAKING; COMPREHENSION; STORIES	Peer-reviewed publications focusing on climate change are growing exponentially with the consequence that the uptake and influence of individual papers varies greatly. Here, we derive metrics of narrativity from psychology and literary theory, and use these metrics to test the hypothesis that more narrative climate change writing is more likely to be influential, using citation frequency as a proxy for influence. From a sample of 732 scientific abstracts drawn from the climate change literature, we find that articles with more narrative abstracts are cited more often. This effect is closely associated with journal identity: higher-impact journals tend to feature more narrative articles, and these articles tend to be cited more often. These results suggest that writing in a more narrative style increases the uptake and influence of articles in climate literature, and perhaps in scientific literature more broadly.	[Hillier, Ann; Kelly, Ryan P.; Klinger, Terrie] Univ Washington, Sch Marine & Environm Affairs, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Kelly, RP (corresponding author), Univ Washington, Sch Marine & Environm Affairs, Seattle, WA 98195 USA.	rpkelly@uw.edu						Abbott H.P., 2002, CAMBRIDGE INTRO NARR; Andrade Chittaranjan, 2011, Indian J Psychiatry, V53, P172, DOI 10.4103/0019-5545.82558; Andrews M., 2013, DOING NARRATIVE RES; [Anonymous], 2014, R LANG ENV STAT COMP; Behrend TS, 2011, BEHAV RES METHODS, V43, P800, DOI 10.3758/s13428-011-0081-0; Bilandzic H, 2014, EXEMPLARS ANECDOTES; BOWER GH, 1969, PSYCHON SCI, V14, P181, DOI 10.3758/BF03332778; Bruner J. S., 1986, ACTUAL MINDS POSSIBL, DOI DOI 10.4159/9780674029019; Brunye TT, 2009, PSYCHOL SCI, V20, P27, DOI 10.1111/j.1467-9280.2008.02249.x; Dahlstrom MF, 2015, COMMUN RES, V42, P779, DOI 10.1177/0093650213487374; Dahlstrom MF, 2014, P NATL ACAD SCI USA, V111, P13614, DOI 10.1073/pnas.1320645111; De Clercq O, 2014, NAT LANG ENG, V1, P59; Fisher WR., 1994, ARGUMENTATION, V8, P21, DOI [10.1007/BF00710701, DOI 10.1007/BF00710701]; Glasser MF, 2016, NATURE, V536, P171, DOI 10.1038/nature18933; Graesser A.C., 2002, DOES MIND CONSTRUCT, P229; Gross A.G., 2002, COMMUNICATING SCI SC; Haunschild R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160393; Herman D., 2005, ROUTLEDGE ENCY NARRA; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Holstein J.A., 2012, VARIETIES NARRATIVE; Hurley LA, 2013, P ASIST ANN M, V50; Jones MD, 2014, SOC SCI QUART, V95, P1, DOI 10.1111/ssqu.12043; Kelly RP, 2014, AMBIO, V43, P592, DOI 10.1007/s13280-013-0442-2; LAWANI SM, 1983, J AM SOC INFORM SCI, V34, P59, DOI 10.1002/asi.4630340109; Lejano R, 2013, AM COMP ENVIRON POLI, P1; Mano Y, 2009, NEUROPSYCHOLOGIA, V47, P813, DOI 10.1016/j.neuropsychologia.2008.12.011; McBeth MK, 2010, POLICY SCI, V43, P391, DOI 10.1007/s11077-010-9114-2; Muurlink O, 2015, JCOM-J SCI COMMUN, V14; Norris SP, 2005, SCI EDUC, V89, P535, DOI 10.1002/sce.20063; Paschen JA, 2014, RES POLICY, V43, P1083, DOI 10.1016/j.respol.2013.12.006; Peterson EE, 2006, NARRAT INQ, V16, P173, DOI 10.1075/ni.16.1.22pet; Spoel P, 2008, TECH COMMUN Q, V18, P49, DOI 10.1080/10572250802437382; Stewart A.J., 2004, NARRATIVE ANAL STUDY, P223; Sydserff R., 1999, ACCOUNT AUDIT ACCOUN, V12, P459, DOI [10.1108/09513579910283503, DOI 10.1108/09513579910283503]; Tijssen RJW, 1990, SCIENCE, V41, P298; Wechsler D, 2014, FUTURES, V60, P14, DOI 10.1016/j.futures.2014.02.005; Weinberger CJ, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004205	37	22	22	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0167983	10.1371/journal.pone.0167983	http://dx.doi.org/10.1371/journal.pone.0167983			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7HN	27978538	Green Published, Green Submitted, gold			2022-12-26	WOS:000391217400045
J	Kar, S; Smith, DW; Gardiner, BS; Grodzinsky, AJ				Kar, Saptarshi; Smith, David W.; Gardiner, Bruce S.; Grodzinsky, Alan J.			Systems Based Study of the Therapeutic Potential of Small Charged Molecules for the Inhibition of IL-1 Mediated Cartilage Degradation	PLOS ONE			English	Article							CALCIUM PENTOSAN POLYSULFATE; GROWTH-FACTOR-I; ARTICULAR-CARTILAGE; SYNOVIAL-FLUID; INTRAARTICULAR INJECTION; GLUCOSAMINE SULFATE; CHONDROITIN SULFATE; SWELLING PRESSURE; GENE-EXPRESSION; DOUBLE-BLIND	Inflammatory cytokines are key drivers of cartilage degradation in post-traumatic osteoarthritis. Cartilage degradation mediated by these inflammatory cytokines has been extensively investigated using in vitro experimental systems. Based on one such study, we have developed a computational model to quantitatively assess the impact of charged small molecules intended to inhibit IL-1 mediated cartilage degradation. We primarily focus on the simplest possible computational model of small molecular interaction with the IL-1 system-direct binding of the small molecule to the active site on the IL-1 molecule itself. We first use the model to explore the uptake and release kinetics of the small molecule inhibitor by cartilage tissue. Our results show that negatively charged small molecules are excluded from the negatively charged cartilage tissue and have uptake kinetics in the order of hours. In contrast, the positively charged small molecules are drawn into the cartilage with uptake and release timescales ranging from hours to days. Using our calibrated computational model, we subsequently explore the effect of small molecule charge and binding constant on the rate of cartilage degradation. The results from this analysis indicate that the small molecules are most effective in inhibiting cartilage degradation if they are either positively charged and/or bind strongly to IL-1 alpha, or both. Furthermore, our results showed that the cartilage structural homeostasis can be restored by the small molecule if administered within six days following initial tissue exposure to IL-1 alpha. We finally extended the scope of the computational model by simulating the competitive inhibition of cartilage degradation by the small molecule. Results from this model show that small molecules are more efficient in inhibiting cartilage degradation by binding directly to IL-1 alpha rather than binding to IL-1a receptors. The results from this study can be used as a template for the design and development of more pharmacologically effective osteoarthritis drugs, and to investigate possible therapeutic options.	[Kar, Saptarshi; Smith, David W.] Univ Western Australia, Sch Comp Sci & Software Engn, Crawley, WA USA; [Gardiner, Bruce S.] Murdoch Univ, Dept Phys & Nanotechnol, Murdoch, WA, Australia; [Grodzinsky, Alan J.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA	University of Western Australia; Murdoch University; Massachusetts Institute of Technology (MIT)	Smith, DW (corresponding author), Univ Western Australia, Sch Comp Sci & Software Engn, Crawley, WA USA.	david.smith@uwa.edu.au	Gardiner, Bruce/C-8593-2012; Smith, David W/H-5856-2014	Smith, David W/0000-0003-4864-0288; Gardiner, Bruce/0000-0001-8770-5908; Kar, Saptarshi/0000-0002-3788-372X	National Health and Medical Research Council Australia (NHMRC) [1051455]; National Institutes of Health (NIH) [AR060331]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060331] Funding Source: NIH RePORTER	National Health and Medical Research Council Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study is supported by the National Health and Medical Research Council Australia (NHMRC Project Grant 1051455) and the National Institutes of Health (NIH; Grant AR060331)	Ackerman GL., 1990, SERUM SODIUM; Bajpayee AG, 2015, OSTEOARTHRITIS CARTI; Bajpayee AG, 2014, J ORTHOP RES, V32, P1044, DOI 10.1002/jor.22630; Bajpayee AG, 2014, BIOMATERIALS, V35, P538, DOI 10.1016/j.biomaterials.2013.09.091; Barta E, 2006, J THEOR BIOL, V241, P628, DOI 10.1016/j.jtbi.2006.01.004; Bashir A, 1999, MAGNET RESON MED, V41, P857, DOI 10.1002/(SICI)1522-2594(199905)41:5<857::AID-MRM1>3.0.CO;2-E; BASSLEER C, 1992, INT J TISSUE REACT, V14, P231; Bodmer MW, 1996, THERAPEUTIC MODULATI; BROCKLEHURST R, 1984, J BONE JOINT SURG AM, V66A, P95, DOI 10.2106/00004623-198466010-00013; BUSCHMANN MD, 1995, J BIOMECH ENG-T ASME, V117, P179, DOI 10.1115/1.2796000; Cameron M, 1997, AM J SPORT MED, V25, P751, DOI 10.1177/036354659702500605; Catt C J, 2011, Eur Cell Mater, V22, P377; Catterall JB, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3216; Chakraborty Abhijit, 2012, Clin Pharmacokinet, V51, pe1, DOI 10.2165/11599820-000000000-00000; Chan PS, 2006, J RHEUMATOL, V33, P1329; Chevalier X, 2009, ARTHRIT RHEUM-ARTHR, V61, P344, DOI 10.1002/art.24096; CHIN JE, 1990, FASEB J, V4, P1481, DOI 10.1096/fasebj.4.5.2137805; Choi DW, 2003, J PHARMACEUT BIOMED, V31, P1229, DOI 10.1016/S0731-7085(02)00731-8; Church LD, 2008, BIOL-TARGETS THER, V2, P733; Cohen S, 1989, ROLE LYMPHOKINES IMM; Coombe DR, 2008, IMMUNOL CELL BIOL, V86, P598, DOI 10.1038/icb.2008.49; Cussler E. L, 2009, DIFFUSION MASS TRANS; Day RO, 1999, CLIN PHARMACOKINET, V36, P191, DOI 10.2165/00003088-199936030-00002; Dhimolea E, 2010, CANAKINUMAB MABS; DIAMANT B, 1968, EXPERIENTIA, V24, P1195, DOI 10.1007/BF02146615; DiLeo MV, 2009, ANN BIOMED ENG, V37, P222, DOI 10.1007/s10439-008-9587-8; Dimicco MA, 2003, TRANSPORT POROUS MED, V50, P57, DOI 10.1023/A:1020677829069; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Economides AN, 2003, NAT MED, V9, P47, DOI 10.1038/nm811; Einstein A., 1905, ANN PHYS, V4; Fallon EM, 2000, BIOTECHNOL PROGR, V16, P905, DOI 10.1021/bp000097t; Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010; FROELICH CJ, 1993, J IMMUNOL, V151, P7161; Gaisinskaya-Kipnis A, 2014, BIOMACROMOLECULES, V15, P4178, DOI 10.1021/bm501189g; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Georgiev K, 2015, PHARM PROPERTIES MON; Ghosh P, 2005, CURR THER RES CLIN E, V66, P552, DOI 10.1016/j.curtheres.2005.12.012; GUSTAFSSON K, 1988, J REPROD IMMUNOL, V14, P139, DOI 10.1016/0165-0378(88)90065-4; Han E, 2011, BIOPHYS J, V101, P916, DOI 10.1016/j.bpj.2011.07.006; Han L, 2008, BIOPHYS J, V95, P4862, DOI 10.1529/biophysj.107.128389; Henrotin Y, 2010, THER ADV MUSCULOSKEL, V2, P335, DOI 10.1177/1759720X10383076; Hooper NM, 2005, ADAM FAMILY PROTEASE; Hulme EC, 2010, BRIT J PHARMACOL, V161, P1219, DOI 10.1111/j.1476-5381.2009.00604.x; Hunter CJ, 2002, BIORHEOLOGY, V39, P79; Hunziker EB, 1997, MICROSC RES TECHNIQ, V37, P271; Irrechukwu ON, 2007, THE ROLE OF MATRIX C; Jadin KD, 2005, J HISTOCHEM CYTOCHEM, V53, P1109, DOI 10.1369/jhc.4A6511.2005; JEBENS EH, 1959, BLOOD, V20, P58; JENSEN LT, 1993, EUR J CLIN INVEST, V23, P778, DOI 10.1111/j.1365-2362.1993.tb00731.x; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kar S, 2016, ARCH BIOCH BIOPHYSIC; Karsdal MA, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2434; Kilgore KS, 1998, J PHARMACOL EXP THER, V285, P987; Klein TJ, 2007, BIOMECH MODEL MECHAN, V6, P21, DOI 10.1007/s10237-006-0045-y; Klein TJ, 2007, J BIOMECH, V40, P182, DOI 10.1016/j.jbiomech.2005.11.002; Kulkarni Priya, 2014, J Med Case Rep, V8, P137, DOI 10.1186/1752-1947-8-137; Kumagai Kenji, 2010, BMC Clin Pharmacol, V10, P7, DOI 10.1186/1472-6904-10-7; Kumar A, 2015, OSTEOARTHR CARTILAGE, V23, P151, DOI 10.1016/j.joca.2014.09.019; LAI WM, 1991, J BIOMECH ENG-T ASME, V113, P245, DOI 10.1115/1.2894880; Lauffenburger D. A., 1993, RECEPTORS MODELS BIN; Leddy HA, 2003, ANN BIOMED ENG, V31, P753, DOI 10.1114/1.1581879; LESPERANCE LM, 1992, J ORTHOPAED RES, V10, P1, DOI 10.1002/jor.1100100102; Li Y, 2015, OSTEOARTHR CARTILAGE, V23, P266, DOI 10.1016/j.joca.2014.11.006; Liu MY, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-68; Lupia E, 2012, LAB INVEST, V92, P236, DOI 10.1038/labinvest.2011.154; Mantovani A, 1999, CHEMOKINES; MAROUDAS A, 1976, NATURE, V260, P808, DOI 10.1038/260808a0; MAROUDAS A, 1972, Connective Tissue Research, V1, P69, DOI 10.3109/03008207209152058; MARTELPELLETIER J, 1992, ARTHRITIS RHEUM, V35, P530, DOI 10.1002/art.1780350507; Matuska A, 2013, J ORTHOP RES, V31, P1929, DOI 10.1002/jor.22464; McNulty AL, 2013, J ORTHOP RES, V31, P1039, DOI 10.1002/jor.22334; Miller RE, 2010, ARTHRITIS RHEUM-US, V62, P3686, DOI 10.1002/art.27709; Morales TI, 2007, OSTEOARTHR CARTILAGE, V15, P861, DOI 10.1016/j.joca.2007.02.022; Morgen M, 2013, PHARM RES-DORDR, V30, P257, DOI 10.1007/s11095-012-0870-x; Munteanu SE, 2000, ARTHRITIS RHEUM, V43, P2211, DOI 10.1002/1529-0131(200010)43:10<2211::AID-ANR8>3.0.CO;2-D; Munteanu SE, 2002, MATRIX BIOL, V21, P429, DOI 10.1016/S0945-053X(02)00034-3; Nagase H, 2003, ARTHRITIS RES THER, V5, P94, DOI 10.1186/ar630; Nagase H, 2000, CANC DRUG DISC DEV, P39; Netea MG, 2015, ANNU REV IMMUNOL, V33, P49, DOI 10.1146/annurev-immunol-032414-112306; OWEN SG, 1994, BRIT J CLIN PHARMACO, V38, P349, DOI 10.1111/j.1365-2125.1994.tb04365.x; Pratta MA, 2003, J BIOL CHEM, V278, P45539, DOI 10.1074/jbc.M303737200; Radin A, 2010, J CLIN PHARMACOL, V50, P835, DOI 10.1177/0091270009351882; RAMSDEN L, 1992, EUR J IMMUNOL, V22, P3027, DOI 10.1002/eji.1830221139; Razaq S, 2000, INTERNATIONAL JOURNA, V81, pA24; RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769; Ropes MW, 1940, J CLIN INVEST, V19, P795, DOI 10.1172/JCI101182; Rovati LC, 2012, THER ADV MUSCULOSKEL, V4, P167, DOI 10.1177/1759720X12437753; Rugstad HE, 1992, IMMUNOPHARMACOLOGY A; Sarkar SK, 2012, CURR BIOL, V22, P1047, DOI 10.1016/j.cub.2012.04.012; Sengers BG, 2007, BIOMATERIALS, V28, P1926, DOI 10.1016/j.biomaterials.2006.12.008; Shapiro EM, 2002, MAGNET RESON MED, V47, P284, DOI 10.1002/mrm.10054; Shulgin B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149154; Smith DW, 2013, J TISSUE ENG REGEN M; Spillmann D, 1998, J BIOL CHEM, V273, P15487, DOI 10.1074/jbc.273.25.15487; Sujatha M., 2011, KERALA J ORTHOP, V25, P51; Sunaga T, 2012, J VET MED SCI, V74, P707, DOI 10.1292/jvms.11-0511; Troeberg L, 2008, FASEB J, V22, P3515, DOI 10.1096/fj.08-112680; Troeberg L, 2012, BIOCHEM J, V443, P307, DOI 10.1042/BJ20112159; Tugal-Tutkun I, 2017, OCUL IMMUNOL INFLAMM, V25, P62, DOI 10.3109/09273948.2015.1092558; Vempati P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011860; Wayne GJ, 2007, J BIOL CHEM, V282, P20991, DOI 10.1074/jbc.M610721200; Wittwer AJ, 2007, BIOCHEMISTRY-US, V46, P6393, DOI 10.1021/bi7000642; Yamamoto K, 2014, J BIOL CHEM, V289, P6462, DOI 10.1074/jbc.M113.545376; Young DA, 2005, ARTHRITIS RES THER, V7, pR503, DOI 10.1186/ar1702; Zhang L. R., 2013, PLOS ONE, V8; Zhang Lihai, 2008, Molecular & Cellular Biomechanics, V5, P133	106	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168047	10.1371/journal.pone.0168047	http://dx.doi.org/10.1371/journal.pone.0168047			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977731	Green Published, gold			2022-12-26	WOS:000391217400052
J	Lee, XW; Mat-Isa, MN; Mohd-Elias, NA; Aizat-Juhari, MA; Goh, HH; Dear, PH; Chow, KS; Adam, JH; Mohamed, R; Firdaus-Raih, M; Wan, KL				Lee, Xin-Wei; Mat-Isa, Mohd-Noor; Mohd-Elias, Nur-Atiqah; Aizat-Juhari, Mohd Afiq; Goh, Hoe-Han; Dear, Paul H.; Chow, Keng-See; Adam, Jumaat Haji; Mohamed, Rahmah; Firdaus-Raih, Mohd; Wan, Kiew-Lian			Perigone Lobe Transcriptome Analysis Provides Insights into Rafflesia cantleyi Flower Development	PLOS ONE			English	Article							EMBRYOGENESIS ABUNDANT PROTEINS; GLUTAMATE-DEHYDROGENASE; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; TARGET GENES; CLASS-I; PETAL; RNA; IDENTIFICATION; CHLOROPLAST	Rafflesia is a biologically enigmatic species that is very rare in occurrence and possesses an extraordinary morphology. This parasitic plant produces a gigantic flower up to one metre in diameter with no leaves, stem or roots. However, little is known about the floral biology of this species especially at the molecular level. In an effort to address this issue, we have generated and characterised the transcriptome of the Rafflesia cantleyi flower, and performed a comparison with the transcriptome of its floral bud to predict genes that are expressed and regulated during flower development. Approximately 40 million sequencing reads were generated and assembled de novo into 18,053 transcripts with an average length of 641 bp. Of these, more than 79% of the transcripts had significant matches to annotated sequences in the public protein database. A total of 11,756 and 7,891 transcripts were assigned to Gene Ontology categories and clusters of orthologous groups respectively. In addition, 6,019 transcripts could be mapped to 129 pathways in Kyoto Encyclopaedia of Genes and Genomes Pathway database. Digital abundance analysis identified 52 transcripts with very high expression in the flower transcriptome of R. cantleyi. Subsequently, analysis of differential expression between developing flower and the floral bud revealed a set of 105 transcripts with potential role in flower development. Our work presents a deep transcriptome resource analysis for the developing flower of R. cantleyi. Genes potentially involved in the growth and development of the R. cantleyi flower were identified and provide insights into biological processes that occur during flower development.	[Lee, Xin-Wei; Mohd-Elias, Nur-Atiqah; Mohamed, Rahmah; Firdaus-Raih, Mohd; Wan, Kiew-Lian] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Biosci & Biotechnol, Bangi, Selangor, Malaysia; [Mat-Isa, Mohd-Noor] Malaysia Genome Inst, Kajang, Selangor, Malaysia; [Aizat-Juhari, Mohd Afiq; Adam, Jumaat Haji] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Environm & Nat Resource Sci, Bangi, Selangor, Malaysia; [Goh, Hoe-Han; Firdaus-Raih, Mohd] Univ Kebangsaan Malaysia, Inst Syst Biol, Bangi, Selangor, Malaysia; [Dear, Paul H.] Mote Res Ltd, Babraham Hall,Babraham Res Campus, Cambridge, England; [Chow, Keng-See] Malaysian Rubber Board, Rubber Res Inst Malaysia, Genom & Bioinformat Ctr, Sungai Buloh, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Institute Penyelidikan Getah Malaysia; Malaysian Rubber Board	Wan, KL (corresponding author), Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Biosci & Biotechnol, Bangi, Selangor, Malaysia.	klwan@ukm.edu.my	Firdaus-Raih, Mohd/A-9217-2011; Firdaus-Raih, Mohd/H-3286-2019; Goh, Hoe-Han/I-2943-2012; Wan, Kiew-Lian/A-4632-2012	Firdaus-Raih, Mohd/0000-0003-4275-4663; Firdaus-Raih, Mohd/0000-0003-4275-4663; Goh, Hoe-Han/0000-0002-8508-9977; Wan, Kiew-Lian/0000-0003-4027-1211	Universiti Kebangsaan Malaysia [UKM-AP-KPB-18-2010, LAUREATE-2013-001, GUP-2016-008]; Mote Research Limited	Universiti Kebangsaan Malaysia; Mote Research Limited	The work was supported financially by Research University Grants from Universiti Kebangsaan Malaysia (Grant No. UKM-AP-KPB-18-2010, LAUREATE-2013-001 and GUP-2016-008). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Mote Research Limited provided support in the form of salaries for PHD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasiou E, 2007, DEV CELL, V13, P843, DOI 10.1016/j.devcel.2007.10.001; BAKER J, 1988, PLANT MOL BIOL, V11, P277, DOI 10.1007/BF00027385; Baumann K, 2007, DEVELOPMENT, V134, P1691, DOI 10.1242/dev.02836; Bey M, 2004, PLANT CELL, V16, P3197, DOI 10.1105/tpc.104.026724; Bies N, 1998, J EXP BOT, V49, P1925, DOI 10.1093/jexbot/49.329.1925; BOSTOCK RM, 1992, PLANT PHYSIOL, V98, P1356, DOI 10.1104/pp.98.4.1356; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Cornbier JP, 2008, MOL PLANT MICROBE IN, V21, P1118, DOI 10.1094/MPMI-21-8-1118; Covey PA, 2010, PLANT PHYSIOL, V153, P703, DOI 10.1104/pp.110.155457; Dafny-Yelin M, 2005, PLANTA, V222, P37, DOI 10.1007/s00425-005-1512-x; Dinneny JR, 2004, DEVELOPMENT, V131, P1101, DOI 10.1242/dev.00949; Dubois F, 2003, PLANT PHYSIOL BIOCH, V41, P565, DOI 10.1016/S0981-9428(03)00075-5; DURE L, 1981, BIOCHEMISTRY-US, V20, P4162, DOI 10.1021/bi00517a033; Dutilleul C, 2008, PLANT PHYSIOL, V147, P239, DOI 10.1104/pp.107.114033; Escobar-Restrepo JM, 2007, SCIENCE, V317, P656, DOI 10.1126/science.1143562; Flechner A, 1999, FEBS LETT, V447, P200, DOI 10.1016/S0014-5793(99)00285-9; Germain H, 2005, PLANTA, V220, P447, DOI 10.1007/s00425-004-1352-0; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gross W, 1999, GENE, V230, P7, DOI 10.1016/S0378-1119(99)00059-1; Guo AY, 2008, NUCLEIC ACIDS RES, V36, pD966, DOI 10.1093/nar/gkm841; HILL JP, 1989, CAN J BOT, V67, P2922, DOI 10.1139/b89-375; Huck N, 2003, DEVELOPMENT, V130, P2149, DOI 10.1242/dev.00458; Hugouvieux V, 2009, PLANT PHYSIOL, V151, P768, DOI 10.1104/pp.109.144808; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Irish VF, 1999, CURR TOP DEV BIOL, V41, P133; KUIJT J., 1969, The biology of parasitic flowering plants. University of California Press, Berkeley.; Kumar M, 2015, PHYTOCHEMISTRY, V112, P91, DOI 10.1016/j.phytochem.2014.07.009; LOPEZGOMEZ R, 1992, HORTSCIENCE, V27, P440, DOI 10.21273/HORTSCI.27.5.440; Lu W, 2012, GENE, V503, P65, DOI 10.1016/j.gene.2012.04.042; Mara CD, 2010, PLANT CELL, V22, P690, DOI 10.1105/tpc.109.065946; Meijer W, 1997, FLORA MALESIANA 1, P1; MeloOliveira R, 1996, P NATL ACAD SCI USA, V93, P4718, DOI 10.1073/pnas.93.10.4718; Merkouropoulos G, 2003, PLANTA, V217, P356, DOI 10.1007/s00425-003-1002-y; Molina J, 2014, MOL BIOL EVOL, V31, P793, DOI 10.1093/molbev/msu051; Murthy N, 2007, J BIOL CHEM, V282, P18254, DOI 10.1074/jbc.M701428200; Nais J., 2001, RAFFLESIA WORLD; NODA K, 1994, NATURE, V369, P661, DOI 10.1038/369661a0; Pearce G, 2001, P NATL ACAD SCI USA, V98, P12843, DOI 10.1073/pnas.201416998; Restivo FM, 2004, PLANT SCI, V166, P971, DOI 10.1016/j.plantsci.2003.12.011; Riechmann JL, 1997, MOL BIOL CELL, V8, P1243, DOI 10.1091/mbc.8.7.1243; RIED JL, 1993, PLANT PHYSIOL, V102, P125, DOI 10.1104/pp.102.1.125; Running MP, 1996, DEVELOPMENT, V122, P1261; Sauret-Gueto S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001550; Sawada K, 2004, BIOSCI BIOTECH BIOCH, V68, P873, DOI 10.1271/bbb.68.873; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Shiu S.H., 2001, STKE, V2001, pR, DOI DOI 10.1126/SCISIGNAL.1132001RE22; Skopelitis DS, 2006, PLANT CELL, V18, P2767, DOI 10.1105/tpc.105.038323; SKRIVER K, 1990, PLANT CELL, V2, P503, DOI 10.1105/tpc.2.6.503; Szecsi J, 2006, EMBO J, V25, P3912, DOI 10.1038/sj.emboj.7601270; Terce-Laforgue T, 2004, PHYSIOL PLANTARUM, V120, P220, DOI 10.1111/j.0031-9317.2004.0241.x; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wu JS, 2007, PLANT J, V52, P877, DOI 10.1111/j.1365-313X.2007.03289.x; Xi Z, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-227; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xu XM, 2006, EMBO J, V25, P900, DOI 10.1038/sj.emboj.7600968; Ye H, 2006, NEW PHYTOL, V171, P285, DOI 10.1111/j.1469-8137.2006.01751.x; Zahn LM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r101; Zik M, 2003, PLANT CELL, V15, P207, DOI 10.1105/tpc.006353	60	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0167958	10.1371/journal.pone.0167958	http://dx.doi.org/10.1371/journal.pone.0167958			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977777	Green Submitted, Green Published, gold			2022-12-26	WOS:000391217400044
J	Spaulding, HR; Ballmann, CG; Quindry, JC; Selsby, JT				Spaulding, Hannah R.; Ballmann, Christopher G.; Quindry, John C.; Selsby, Joshua T.			Long-Term Quercetin Dietary Enrichment Partially Protects Dystrophic Skeletal Muscle	PLOS ONE			English	Article							UTROPHIN GENE-EXPRESSION; MDX MICE; MUSCULAR-DYSTROPHY; PGC-1-ALPHA; PHENOTYPE; EXERCISE; KINASE; INFLAMMATION; INJURY; AMPK	Duchenne muscular dystrophy (DMD) results from a genetic lesion in the dystrophin gene and leads to progressive muscle damage. PGC-1 alpha pathway activation improves muscle function and decreases histopathological injury. We hypothesized that mild disease found in the limb muscles of mdx mice may be responsive to quercetin-mediated protection of dystrophic muscle via PGC-1 alpha pathway activation. To test this hypothesis muscle function was measured in the soleus and EDL from 14 month old C57, mdx, and mdx mice treated with quercetin (mdxQ; 0.2% dietary enrichment) for 12 months. Quercetin reversed 50% of disease-related losses in specific tension and partially preserved fatigue resistance in the soleus. Specific tension and resistance to contraction-induced injury in the EDL were not protected by quercetin. Given some functional gain in the soleus it was probed with histological and biochemical approaches, however, in dystrophic muscle histopathological outcomes were not improved by quercetin and suppressed PGC-1 alpha pathway activation was not increased. Similar to results in the diaphragm from these mice, these data suggest that the benefits conferred to dystrophic muscle following 12 months of quercetin enrichment were underwhelming. Spontaneous activity at the end of the treatment period was greater in mdxQ compared to mdx indicating that quercetin fed mice were more active in addition to engaging in more vigorous activity. Hence, modest preservation of muscle function (specific tension) and elevated spontaneous physical activity largely in the absence of tissue damage in mdxQ suggests dietary quercetin may mediate protection.	[Spaulding, Hannah R.; Selsby, Joshua T.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; [Ballmann, Christopher G.; Quindry, John C.] Auburn Univ, Sch Kinesiol, Auburn, AL 36849 USA	Iowa State University; Auburn University System; Auburn University	Selsby, JT (corresponding author), Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA.	jselsby@iastate.edu		Ballmann, Christopher/0000-0002-7839-8894	Duchenne Alliance; Zack Heger Foundation, Pietro's Fight, Race MD; Romito Foundation; Harrison's Fund; Alex's Wish; Two Smiles One Hope Foundation [100065, 100071]	Duchenne Alliance; Zack Heger Foundation, Pietro's Fight, Race MD; Romito Foundation; Harrison's Fund; Alex's Wish; Two Smiles One Hope Foundation	This work was supported by the Duchenne Alliance and its member foundations (Ryan's Quest, Hope for Gus, Team Joseph, Michael's Cause, Duchenne Now, Zack Heger Foundation, Pietro's Fight, Race MD, JB's Keys, Romito Foundation, Harrison's Fund, Alex's Wish, and Two Smiles One Hope Foundation) grants 100065 and 100071 to JS and JQ. The funders had no role in study design,data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2008, BIOCHEM BIOPH RES CO, V373, P545, DOI 10.1016/j.bbrc.2008.06.077; Alexander SPH, 2006, PHYTOTHER RES, V20, P1009, DOI 10.1002/ptr.1975; ANDERSON JE, 1988, J MUSCLE RES CELL M, V9, P499, DOI 10.1007/BF01738755; Angus LM, 2005, AM J PHYSIOL-CELL PH, V289, pC908, DOI 10.1152/ajpcell.00196.2005; Ballmann C, 2015, EXP PHYSIOL, V100, P12, DOI 10.1113/expphysiol.2014.083360; Boots AW, 2011, CLIN NUTR, V30, P506, DOI 10.1016/j.clnu.2011.01.010; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Bueno CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045699; Camerino GM, 2014, HUM MOL GENET, V23, P5720, DOI 10.1093/hmg/ddu287; Cerletti M, 2003, GENE THER, V10, P750, DOI 10.1038/sj.gt.3301941; Barbin ICC, 2016, J ANAT, V228, P784, DOI 10.1111/joa.12443; Chalkiadaki A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004490; Davis JM, 2009, AM J PHYSIOL-REG I, V296, pR1071, DOI 10.1152/ajpregu.90925.2008; Dong J, 2014, J LIPID RES, V55, P363, DOI 10.1194/jlr.M038786; ERVASTI JM, 1994, FEBS LETT, V350, P173, DOI 10.1016/0014-5793(94)00748-9; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Godin Richard, 2012, J Physiol, V590, P5487, DOI 10.1113/jphysiol.2012.240390; Gordon BS, 2013, CLIN NUTR, V32, P104, DOI 10.1016/j.clnu.2012.06.003; Guedes-Dias P, 2013, BBA-MOL BASIS DIS, V1832, P1345, DOI 10.1016/j.bbadis.2013.04.005; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; Hollinger K, 2015, EXP PHYSIOL, V100, P1145, DOI 10.1113/EP085339; Hollinger K, 2015, CLIN NUTR, V34, P515, DOI 10.1016/j.clnu.2014.06.008; Hollinger K, 2013, AM J PHYSIOL-REG I, V305, pR13, DOI 10.1152/ajpregu.00221.2012; Hourde C, 2013, AM J PATHOL, V182, P1509, DOI 10.1016/j.ajpath.2013.01.020; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hyzewicz Janek, 2015, J Neuromuscul Dis, V2, P325; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Lynch GS, 2001, J PHYSIOL-LONDON, V535, P591, DOI 10.1111/j.1469-7793.2001.00591.x; Martin P., 2007, MEASURING BEHAV; Nemoto S, 2005, SIRT1 FUNCTIONALLY I; PASTORET C, 1995, J NEUROL SCI, V129, P97, DOI 10.1016/0022-510X(94)00276-T; Peladeau C, 2016, HUM MOL GENET, V25, P24, DOI 10.1093/hmg/ddv444; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Selsby J, 2010, AM J PHYSIOL-REG I, V299, pR1192, DOI 10.1152/ajpregu.00586.2009; Selsby JT, 2013, J APPL PHYSIOL, V115, P660, DOI 10.1152/japplphysiol.00252.2013; Selsby JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030063; Selsby JT, 2011, EXP PHYSIOL, V96, P194, DOI 10.1113/expphysiol.2010.054379; Selsby JT, 2016, J PHYSL; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Suchankova G, 2009, BIOCHEM BIOPH RES CO, V378, P836, DOI 10.1016/j.bbrc.2008.11.130; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0; Wakefield PM, 2000, GENE THER, V7, P201, DOI 10.1038/sj.gt.3301066; Wineinger MA, 1998, AM J PHYS MED REHAB, V77, P20, DOI 10.1097/00002060-199801000-00004; Zhang Y, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6236; Zhao LR, 2014, INT J MOL MED, V34, P1025, DOI 10.3892/ijmm.2014.1852	47	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168293	10.1371/journal.pone.0168293	http://dx.doi.org/10.1371/journal.pone.0168293			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977770	Green Published, gold, Green Submitted			2022-12-26	WOS:000391217400089
J	Wu, CJ; Fang, WH; Kao, TW; Chen, YJ; Liaw, FY; Chang, YW; Wang, GC; Peng, TC; Chen, WL				Wu, Chen-Jung; Fang, Wen-Hui; Kao, Tung-Wei; Chen, Ying-Jen; Liaw, Fang-Yih; Chang, Yaw-Wen; Wang, Gia-Chi; Peng, Tao-Chun; Chen, Wei-Liang			Postprandial Glucose as a Risk Factor for Elevated Intraocular Pressure	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; CORNEAL THICKNESS; PLASMA-GLUCOSE; HYPERGLYCEMIA; POPULATION	The aim of this study was to investigate the association between postprandial glucose and intraocular pressure in a relatively healthy population. We examined 1,439 adults getting a health check-up in a health promotion center at Tri-Service General Hospital (TSGH) in Taiwan between 2012 and 2013. All participants underwent examinations to measure metabolic variables and intraocular pressure. Multiple linear regression analyses were performed to assess the relationship between postprandial glucose and intraocular pressure. The levels of postprandial glucose were divided into quartiles with subjects in the lowest quartile being regarded as the reference group to perform quartile-based analysis. Covariate adjustment was designed for three models for further analysis. Subjects with higher quartiles of postprandial glucose level had a higher systolic blood pressure, a greater waist circumference and an elevated fasting glucose level (all p < 0.001). The beta coefficient with adjusted covariates showed a significant positive association between postprandial glucose and intraocular pressure. The trends of intraocular pressure across increasing quartiles of postprandial glucose were statistically significant (all p for trend < 0.001). Thus, higher levels of postprandial glucose positively correlated with elevated intraocular pressure.	[Wu, Chen-Jung; Fang, Wen-Hui; Kao, Tung-Wei; Liaw, Fang-Yih; Chang, Yaw-Wen; Wang, Gia-Chi; Peng, Tao-Chun; Chen, Wei-Liang] Triserv Gen Hosp, Dept Family & Community Med, Div Family Med, Taipei, Taiwan; [Wu, Chen-Jung; Fang, Wen-Hui; Kao, Tung-Wei; Liaw, Fang-Yih; Chang, Yaw-Wen; Wang, Gia-Chi; Peng, Tao-Chun; Chen, Wei-Liang] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Wu, Chen-Jung] Taoyuan Armed Forces Gen Hosp, Div Family Med, Dept Community Med, Taoyuan, Taiwan; [Kao, Tung-Wei; Liaw, Fang-Yih; Chang, Yaw-Wen; Chen, Wei-Liang] Triserv Gen Hosp, Dept Family & Community Med, Div Geriatr Med, Taipei, Taiwan; [Kao, Tung-Wei; Liaw, Fang-Yih; Chang, Yaw-Wen; Chen, Wei-Liang] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Kao, Tung-Wei] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Chen, Ying-Jen] Triserv Gen Hosp, Dept Ophthalmol, Taipei, Taiwan; [Chen, Ying-Jen] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Chen, Ying-Jen; Chen, Wei-Liang] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan	Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Taiwan University; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center	Chen, WL (corresponding author), Triserv Gen Hosp, Dept Family & Community Med, Div Family Med, Taipei, Taiwan.; Chen, WL (corresponding author), Natl Def Med Ctr, Sch Med, Taipei, Taiwan.; Chen, WL (corresponding author), Triserv Gen Hosp, Dept Family & Community Med, Div Geriatr Med, Taipei, Taiwan.; Chen, WL (corresponding author), Natl Def Med Ctr, Sch Med, Taipei, Taiwan.; Chen, WL (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.	weiliang0508@gmail.com	Peng, Tao‑Chun/AAY-7035-2020; Chang, Yaw-Wen/AAF-2630-2020	Chang, Yaw-Wen/0000-0002-8436-0518				Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Caccamo G, 2010, ATHEROSCLEROSIS, V211, P672, DOI 10.1016/j.atherosclerosis.2010.03.033; Ceriello A, 2004, ARCH INTERN MED, V164, P2090, DOI 10.1001/archinte.164.19.2090; Ceriello A, 2002, CIRCULATION, V106, P1211, DOI 10.1161/01.CIR.0000027569.76671.A8; Choi J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/141905; Chun YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0112929; Chung HJ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/827516; Coleman AL, 2008, SURV OPHTHALMOL, V53, pS3, DOI 10.1016/j.survophthal.2008.08.006; Critchell CD, 2007, INTENS CARE MED, V33, P2079, DOI 10.1007/s00134-007-0835-4; De Caterina R, 2000, CURR OPIN LIPIDOL, V11, P9; de Vegt F, 1999, DIABETOLOGIA, V42, P926, DOI 10.1007/s001250051249; Doughty MJ, 2000, SURV OPHTHALMOL, V44, P367, DOI 10.1016/S0039-6257(00)00110-7; Imai K, 2010, INT J OBESITY, V34, P1209, DOI 10.1038/ijo.2010.32; Kahn R, 2001, DIABETES CARE, V24, P775; Kendrick M, 2003, MED HYPOTHESES, V60, P6, DOI 10.1016/S0306-9877(02)00319-5; Ketema EB, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0088-6; Mantravadi AV, 2015, PRIMARY CARE, V42, P437, DOI 10.1016/j.pop.2015.05.008; MAPSTONE R, 1985, BRIT MED J, V291, P93, DOI 10.1136/bmj.291.6488.93; Meigs JB, 2002, DIABETES CARE, V25, P1845, DOI 10.2337/diacare.25.10.1845; Memarzadeh F, 2008, AM J OPHTHALMOL, V146, P69, DOI 10.1016/j.ajo.2008.03.015; Pimentel LGM, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/832058; Mori K, 2000, INT J EPIDEMIOL, V29, P661, DOI 10.1093/ije/29.4.661; O'Neill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229; Oh SW, 2005, DIABETES-METAB RES, V21, P434, DOI 10.1002/dmrr.529; Resnikoff S, 2002, B WORLD HEALTH ORGAN, V82, P844; Sato T, 2002, INVEST OPHTH VIS SCI, V43, P170; Shen L, 2016, AM J EPIDEMIOL, V183, P147, DOI 10.1093/aje/kwv204; Shim SH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/425835; Tan GS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1354, DOI 10.1001/archophthalmol.2009.268; Ullal Aarti, 2013, Indian J Endocrinol Metab, V17, pS688, DOI 10.4103/2230-8210.123569; WHITACRE MM, 1993, AM J OPHTHALMOL, V115, P592, DOI 10.1016/S0002-9394(14)71455-2; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Wolever TMS, 1998, DIABETES CARE, V21, P336, DOI 10.2337/diacare.21.3.336; Xu L, 2005, AM J OPHTHALMOL, V140, P913, DOI 10.1016/j.ajo.2005.04.050; Zhao D, 2015, OPHTHALMOLOGY, V122, P72, DOI 10.1016/j.ophtha.2014.07.051; Zhao D, 2014, AM J OPHTHALMOL, V158, P615, DOI 10.1016/j.ajo.2014.05.029	36	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168142	10.1371/journal.pone.0168142	http://dx.doi.org/10.1371/journal.pone.0168142			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977733	gold, Green Published			2022-12-26	WOS:000391217400068
J	Neugarten, RA; Honzak, M; Carret, P; Koenig, K; Andriamaro, L; Cano, CA; Grantham, HS; Hole, D; Juhn, D; McKinnon, M; Rasolohery, A; Steininger, M; Wright, TM; Turner, WR				Neugarten, Rachel A.; Honzak, Miroslav; Carret, Pierre; Koenig, Kellee; Andriamaro, Luciano; Cano, Carlos Andres; Grantham, Hedley S.; Hole, David; Juhn, Daniel; McKinnon, Madeleine; Rasolohery, Andriambolantsoa; Steininger, Marc; Wright, Timothy Max; Turner, Will R.			Rapid Assessment of Ecosystem Service Co-Benefits of Biodiversity Priority Areas in Madagascar	PLOS ONE			English	Article							DRY FORESTS; CONSERVATION; DEFORESTATION; MANAGEMENT; DIVERSITY; SUPPORT; SCIENCE; POLICY	The importance of ecosystems for supporting human well-being is increasingly recognized by both the conservation and development sectors. Our ability to conserve ecosystems that people rely on is often limited by a lack of spatially explicit data on the location and distribution of ecosystem services (ES), the benefits provided by nature to people. Thus there is a need to map ES to guide conservation investments, to ensure these co-benefits are maintained. To target conservation investments most effectively, ES assessments must be rigorous enough to support conservation planning, rapid enough to respond to decision-making timelines, and often must rely on existing data. We developed a framework for rapid spatial assessment of ES that relies on expert and stakeholder consultation, available data, and spatial analyses in order to rapidly identify sites providing multiple benefits. We applied the framework in Madagascar, a country with globally significant biodiversity and a high level of human dependence on ecosystems. Our objective was to identify the ES co-benefits of biodiversity priority areas in order to guide the investment strategy of a global conservation fund. We assessed key provisioning (fisheries, hunting and non-timber forest products, and water for domestic use, agriculture, and hydropower), regulating (climate mitigation, flood risk reduction and coastal protection), and cultural (nature tourism) ES. We also conducted multi-criteria analyses to identify sites providing multiple benefits. While our approach has limitations, including the reliance on proximity-based indicators for several ES, the results were useful for targeting conservation investments by the Critical Ecosystem Partnership Fund (CEPF). Because our approach relies on available data, standardized methods for linking ES provision to ES use, and expert validation, it has the potential to quickly guide conservation planning and investment decisions in other data-poor regions.	[Neugarten, Rachel A.; Honzak, Miroslav; Koenig, Kellee; Cano, Carlos Andres; Hole, David; Juhn, Daniel; McKinnon, Madeleine; Wright, Timothy Max; Turner, Will R.] Conservat Int, Arlington, VA 22202 USA; [Carret, Pierre] Crit Ecosyst Partnership Fund, Arlington, VA USA; [Andriamaro, Luciano; Rasolohery, Andriambolantsoa] Conservat Int, Antananarivo, Madagascar; [Grantham, Hedley S.] Wildlife Conservat Soc, Byron Bay, Australia; [McKinnon, Madeleine] Vulcan Inc, Seattle, WA USA; [Steininger, Marc] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA	Conservation International; University System of Maryland; University of Maryland College Park	Neugarten, RA (corresponding author), Conservat Int, Arlington, VA 22202 USA.	rneugarten@conservation.org	BITOUN, RACHEL Elisabeth/AAC-9538-2021; Hole, David/Q-1692-2019; Neugarten, Rachel A/AAH-9166-2021	BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Neugarten, Rachel A/0000-0003-0647-0516; Koenig, Kellee/0000-0002-2505-860X	Gordon and Betty Moore Foundation [3519]; Critical Ecosystem Partnership Fund	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Critical Ecosystem Partnership Fund	This study was supported by funding from the Gordon and Betty Moore Foundation (https://www.moore.org/, Grant Number 3519) and the Critical Ecosystem Partnership Fund (http://www.cepf.net/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allnutt TF, 2013, TROP CONSERV SCI, V6, P1, DOI 10.1177/194008291300600101; [Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], [No title captured]; Astuti Rita., 2006, PEOPLE SEA IDENTITY; Bagstad K.J., 2011, ARIES REPORT SERIES; Bagstad KJ, 2013, ECOSYST SERV, V4, P117, DOI 10.1016/j.ecoser.2012.07.012; Bakoariniaina LN, 2006, J AFR EARTH SCI, V44, P241, DOI 10.1016/j.jafrearsci.2005.10.013; Barbier EB, 2008, SCIENCE, V319, P321, DOI 10.1126/science.1150349; Benstead JP, 2003, ECOL APPL, V13, P1473, DOI 10.1890/02-5125; Bottero M, 2013, LAND USE POLICY, V30, P730, DOI 10.1016/j.landusepol.2012.05.015; Boumans R, 2015, ECOSYST SERV, V12, P30, DOI 10.1016/j.ecoser.2015.01.004; Bright E.A., 2012, LANDSCAN 2011; Brown KA, 2004, P NATL ACAD SCI USA, V101, P6045, DOI 10.1073/pnas.0401456101; Burke L., 2011, REEFS RISK REVISITED; Burkhard B, 2013, ECOSYST SERV, V4, P1, DOI 10.1016/j.ecoser.2013.04.005; Cinner JE, 2009, MAR POLICY, V33, P489, DOI 10.1016/j.marpol.2008.11.001; Costanza R, 2014, GLOBAL ENVIRON CHANG, V26, P152, DOI 10.1016/j.gloenvcha.2014.04.002; Crossman ND, 2013, ECOSYST SERV, V4, P4, DOI 10.1016/j.ecoser.2013.02.001; de Groot RS, 2010, ECOL COMPLEX, V7, P260, DOI 10.1016/j.ecocom.2009.10.006; Desbureaux S, 2015, ECOL ECON, V118, P10, DOI 10.1016/j.ecolecon.2015.07.002; Eastman J.R., 2012, IDRISI SELVA TUTORIA; ESRI, 2013, ARCGIS DESKT; Fisher B, 2011, PROG PHYS GEOG, V35, P595, DOI 10.1177/0309133311422968; Foiben-Taosaritanin'i Madagascar, 1998, BD500 BAS DONN VECT; Giri C, 2011, GLOBAL ECOL BIOGEOGR, V20, P154, DOI 10.1111/j.1466-8238.2010.00584.x; Golden CD, 2009, ORYX, V43, P386, DOI 10.1017/S0030605309000131; Goodman SM, 2005, ORYX, V39, P73, DOI 10.1017/S0030605305000128; Grinand C, 2013, REMOTE SENS ENVIRON, V139, P68, DOI 10.1016/j.rse.2013.07.008; Habel JC, 2011, BIODIVERSITY HOTSPOT; Haines-Young Potschin, 2013, EEAIEA09003; Hanson C., 2012, CORPORATE ECOSYSTEM; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; Harvey CA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0089; Jones JPG, 2008, CONSERV BIOL, V22, P976, DOI 10.1111/j.1523-1739.2008.00970.x; Kew Royal Botanic Gardens Conservation International Missouri Botanic Garden, 2007, MAD VEG ATL; Kramer RA, 1997, J ENVIRON MANAGE, V49, P277, DOI 10.1006/jema.1995.0085; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Kumar Pushpam, 2010, EC ECOSYSTEMS BIODIV, DOI DOI 10.1017/S1355770X11000088; Langhammer P.F., 2007, IDENTIFICATION GAP A; Le Manach F, 2012, MAR POLICY, V36, P218, DOI 10.1016/j.marpol.2011.05.007; Lehner B., 2006, HYDROSHEDS; Luck Gary W, 2012, F1000Res, V1, P17, DOI 10.12688/f1000research.1-17.v1; Maes J, 2012, ECOSYST SERV, V1, P31, DOI 10.1016/j.ecoser.2012.06.004; Moser C, 2008, SUIVI RECENSEMENT CO; Mulligan M., 2015, TRADING AGR NATURES, DOI [10.1201/b18652, DOI 10.1201/B18652]; Mulligan M, 2013, HYDROL RES, V44, P748, DOI 10.2166/nh.2012.217; Office National pour l'Environnement Directorate-General Forests Foiben-Taosaritanin'i Madagascar Madagascar National Parks Conservation International, 2013, EV COUV FOR NAT MAD; Peh KSH, 2013, ECOSYST SERV, V5, pE51, DOI 10.1016/j.ecoser.2013.06.003; Peypoch N, 2012, TOURISM MANAGE, V33, P1230, DOI 10.1016/j.tourman.2011.11.003; Pickard BR, 2015, ECOSYST SERV, V14, P45, DOI 10.1016/j.ecoser.2015.04.005; Portela R., 2012, ASSESSING VALUING EC; Razafindralambo R, 2004, POVERTY HOUSEHOLD WA; Rogers HM, 2010, LANDSCAPE URBAN PLAN, V96, P48, DOI 10.1016/j.landurbplan.2010.02.002; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Seppelt R, 2011, J APPL ECOL, V48, P630, DOI 10.1111/j.1365-2664.2010.01952.x; Swartz W, 2012, ENVIRON RESOUR ECON, P1; Tallis H, 2009, ANN NY ACAD SCI, V1162, P265, DOI 10.1111/j.1749-6632.2009.04152.x; Turner RK, 2008, ENVIRON RESOUR ECON, V39, P25, DOI 10.1007/s10640-007-9176-6; Turner WR, 2007, BIOSCIENCE, V57, P868, DOI 10.1641/B571009; United Nations Environment Program, 2013, PREVIEW GLOB RISK DA; United Nations General Assembly, 2015, A69L85 UN GEN ASS; Vieilledent G, 2012, ECOL APPL, V22, P572, DOI 10.1890/11-0039.1; Waeber PO, 2015, INT FOREST REV, V17, P127, DOI 10.1505/146554815815834822; Wendland KJ, 2010, ECOL ECON, V69, P2093, DOI 10.1016/j.ecolecon.2009.01.002; World Bank, 2010, POV HEADC RAT 1 25 D; Wright PC, 1999, YEARB PHYS ANTHROPOL, V42, P31	66	16	16	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168575	10.1371/journal.pone.0168575	http://dx.doi.org/10.1371/journal.pone.0168575			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QH	28006005	gold, Green Published			2022-12-26	WOS:000392843200066
J	Tadesse, E; Teshome, M; Amsalu, A; Shimelis, T				Tadesse, Endale; Teshome, Million; Amsalu, Anteneh; Shimelis, Techalew			Genital Chlamydia trachomatis Infection among Women of Reproductive Age Attending the Gynecology Clinic of Hawassa University Referral Hospital, Southern Ethiopia	PLOS ONE			English	Article							PELVIC-INFLAMMATORY-DISEASE; RISK; INFERTILITY; PREVALENCE; GONORRHEA	Background Urogenital infection with Chlamydia trachomatis(CT) is one of the most common bacterial sexually transmitted infections (STIs) world-wide, especially in developing nations where routine laboratory diagnosis is unavailable. Little is known about the epidemiology of this infection in Ethiopia where other STIs are prevalent. This study was conducted to determine the prevalence and associated factors of CT infection among women of reproductive age. Methods A cross-sectional study was conducted among 322 consecutive women aged between 15-49 years at Hawassa University Referral Hospital from November 2014 to April 2015. Data on socio-demography and potential risk factors for genital infection were collected using structured questionnaires. Moreover, endocervical swabs were collected from all participants, screened for CT antigen using rapid immunochromatography assay, and cultured following the standard bacteriological method to isolate Neisseria gonorrhoeae. Result In this study, the overall prevalence of CT antigen and N. gonorrhoeae infection was 61 (18.9%) and 1(0.31%), respectively. Women aged 15-24 years had the highest prevalence of CT infection (24.2%),followed by those aged 25-34 years (16.8%) and those aged 35-49 years (9.6%). CTinfection was associated with women who had unprotected sex within the last six months (aOR = 3.459; 95% CI = 1.459-8.222) and were sexually active for 6-10 years (aOR = 3.076; 95% CI = 1.152-8.209). None of the clinical symptoms and diagnoses was significantly associated with CT antigen positivity. Conclusions The high prevalence of genital CT infection in this study highlights the need for further large-scale studies on the general population. Thus, screening of women regardless of their symptoms should be in place.	[Tadesse, Endale; Amsalu, Anteneh; Shimelis, Techalew] Hawassa Univ, Dept Med Lab Sci, Coll Med & Hlth Sci, Hawassa, Ethiopia; [Teshome, Million] Hawassa Univ, Coll Med & Hlth Sci, Gynecol & Obstet Unit, Hawassa, Ethiopia; [Amsalu, Anteneh] Univ Gondar, Dept Med Microbiol, Gondar, Ethiopia	Hawassa University; Hawassa University; University of Gondar	Tadesse, E (corresponding author), Hawassa Univ, Dept Med Lab Sci, Coll Med & Hlth Sci, Hawassa, Ethiopia.	endaletd@yahoo.com	Shimelis, Techalew/AFL-2401-2022; Asfaw, Endale Taddesse/T-6423-2019	Amsalu, Anteneh/0000-0001-7919-4546; Asfaw, Endale Taddesse/0000-0003-0744-896X	Hawassa University, Research Development office; Hawassa University	Hawassa University, Research Development office; Hawassa University	Support was provided by Hawassa University, Research Development office.; We express our gratitude to the study participants who took part in the study. We thank nurses, physicians and laboratory staffs of Hawassa University Referral Hospital for kind assistance during data collection, clinical examination and laboratory diagnosis. Finally, our special acknowledgment goes to Hawassa University for financial support.	Alam N, 2007, SEX TRANSM DIS, V34, P99, DOI 10.1097/01.olq.0000225325.23340.a3; Aslanimehr M, 2015, BIOTECH HLTH SCI, V2; Bender N, 2011, SEX TRANSM INFECT, V87, P601, DOI 10.1136/sextrans-2011-050205; CDC, 2014, DIV SEX TRANSM DIS T; Cheesbrough M, 2006, DISTRICT LAB PRACTIC, V2nd; Chen KT, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-120; DUNCAN ME, 1992, GENITOURIN MED, V68, P221; Einwalter LA, 2005, PERSPECT SEX REPRO H, V37, P135, DOI 10.1363/3713505; El Qouqa IA, 2009, INT J INFECT DIS, V13, P334, DOI 10.1016/j.ijid.2008.07.013; Elias J, 2011, MANUAL CLIN MICROBIO, V10th, P559; Silva LCF, 2012, BRAZ J INFECT DIS, V16, P335, DOI 10.1016/j.bjid.2012.06.023; FMOH, 2015, NAT GUID MAN SEX TRA; Francis SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101221; Gewirtzman A, 2011, SEXUALLY TRANSMITTED; Haggerty CL, 2010, J INFECT DIS, V201, pS134, DOI 10.1086/652395; Hailemariam M, 2013, ETHIOP J HEALTH SCI, V23, P10; Kerubo E, 2016, SEX TRANSM INFECT, P1; Mania-Pramanik Jayanti, 2012, J Reprod Infertil, V13, P204; Marks M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007276; Mawak J. D., 2011, Shiraz E Medical Journal, V12, P100; Musa M, 2016, J HLTH MED NURSING, V26, P20; Nguyen My Huong, 2009, BMC Womens Health, V9, P1, DOI 10.1186/1472-6874-9-1; Nwankwo EO, 2014, AFR HEALTH SCI, V14, P672, DOI 10.4314/ahs.v14i3.24; Okoror L E, 2007, Afr Health Sci, V7, P18; Oloyede OAO, 2009, INT J HLTH RES, V2, P157; Price MJ, 2013, AM J EPIDEMIOL, V178, P484, DOI 10.1093/aje/kws583; Romoren M, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-27; Tibebu M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-415; Wallace LA, 2008, SEX TRANSM INFECT, V84, P171, DOI 10.1136/sti.2007.026047; World Health Organization, 2012, WHO BAS REP GLOB SEX; Yirenya-Tawiah Dzidzo, 2014, BMC Res Notes, V7, P349, DOI 10.1186/1756-0500-7-349	31	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168580	10.1371/journal.pone.0168580	http://dx.doi.org/10.1371/journal.pone.0168580			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006003	gold, Green Submitted, Green Published			2022-12-26	WOS:000392843200068
J	Powell, CD; Paullin, TR; Aoisa, C; Menzie, CJ; Ubaldini, A; Westerheide, SD				Powell, Chase D.; Paullin, Trillitye R.; Aoisa, Candice; Menzie, Christopher J.; Ubaldini, Ashley; Westerheide, Sandy D.			The Heat Shock Transcription Factor HSF1 Induces Ovarian Cancer Epithelial-Mesenchymal Transition in a 3D Spheroid Growth Model	PLOS ONE			English	Article							MULTICELLULAR TUMOR SPHEROIDS; HEPATOCELLULAR-CARCINOMA; IN-VITRO; METASTASIS; MIGRATION; INVASION; PROTEIN; GENERATION; GENOMICS; CELLS	Ovarian cancer is the most lethal gynecological cancer, with over 200,000 women diagnosed each year and over half of those cases leading to death. The proteotoxic stress responsive transcription factor HSF1 is frequently overexpressed in a variety of cancers and is vital to cellular proliferation and invasion in some cancers. Upon analysis of various patient data sets, we find that HSF1 is frequently overexpressed in ovarian tumor samples. In order to determine the role of HSF1 in ovarian cancer, inducible HSF1 knockdown cell lines were created. Knockdown of HSF1 in SKOV3 and HEY ovarian cancer cell lines attenuates the epithelial-to-mesenchymal transition (EMT) in cells treated with TG93, as determined by western blot and quantitative RT-PCR analysis of multiple EMT markers. To further explore the role of HSF1 in ovarian cancer EMT, we cultured multicellular spheroids in a non-adherent environment to simulate early avascular tumors. In the spheroid model, cells more readily undergo EMT; however, EMT inhibition by HSF1 becomes more pronounced in the spheroid model. These findings suggest that HSF1 is important in the ovarian cancer TGF beta response and in EMT.	[Powell, Chase D.; Paullin, Trillitye R.; Aoisa, Candice; Menzie, Christopher J.; Ubaldini, Ashley; Westerheide, Sandy D.] Univ S Florida, Coll Arts & Sci, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Westerheide, SD (corresponding author), Univ S Florida, Coll Arts & Sci, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA.	swesterheide@usf.edu		Westerheide, Sandy/0000-0003-4683-9648	University of South Florida	University of South Florida	This work was supported by a start-up grant to SDW from the University of South Florida. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cannistra SA, 2002, J CLIN ONCOL, V20, P1158, DOI 10.1200/JCO.2002.20.5.1158; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Carpenter RL, 2014, ONCOGENE; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen YF, 2013, CANCER SCI, V104, P1683, DOI 10.1111/cas.12277; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Fang F, 2012, CANCER-AM CANCER SOC, V118, P1782, DOI 10.1002/cncr.26482; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hay ED, 1995, ACTA ANAT, V154, P8; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; Jemal A, 2002, CA-CANCER J CLIN, V52, P23, DOI 10.3322/canjclin.52.1.23; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kelm JM, 2003, BIOTECHNOL BIOENG, V83, P173, DOI 10.1002/bit.10655; Korch C, 2012, GYNECOL ONCOL, V127, P241, DOI 10.1016/j.ygyno.2012.06.017; KROEGER PE, 1994, MOL CELL BIOL, V14, P7592, DOI 10.1128/MCB.14.11.7592; Li Y, 2015, ONCOTARGET, V6, P2421, DOI 10.18632/oncotarget.2965; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Moreno-Bueno G, 2009, NAT PROTOC, V4, P1591, DOI 10.1038/nprot.2009.152; Nakamura Y, 2014, CANCER LETT, V354, P329, DOI 10.1016/j.canlet.2014.08.029; O'Callaghan-Sunol C, 2006, CELL CYCLE, V5, P1431, DOI 10.4161/cc.5.13.2915; Olson A, 2006, NUCLEIC ACIDS RES, V34, pD153, DOI 10.1093/nar/gkj051; Schilling D, 2015, CANCER LETT, V360, P294, DOI 10.1016/j.canlet.2015.02.033; Shield K, 2009, GYNECOL ONCOL, V113, P143, DOI 10.1016/j.ygyno.2008.11.032; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Timmins Nicholas E., 2007, V140, P141; Toma-Jonik A, 2015, CELL SIGNAL, V27, P394, DOI 10.1016/j.cellsig.2014.11.029; Torres MP, 2009, MINERVA MED, V100, P385; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Xi CX, 2012, J BIOL CHEM, V287, P35646, DOI 10.1074/jbc.M112.377481; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5	33	27	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168389	10.1371/journal.pone.0168389	http://dx.doi.org/10.1371/journal.pone.0168389			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997575	Green Published, gold, Green Submitted			2022-12-26	WOS:000392842900040
J	Chi, C; Shen, YQ; Yin, LH; Ke, XW; Han, D; Zuo, YH				Chi, Chao; Shen, Yongqiang; Yin, Lihua; Ke, Xiwang; Han, Dong; Zuo, Yuhu			Selection and Validation of Reference Genes for Gene Expression Analysis in Vigna angularis Using Quantitative Real-Time RT-PCR	PLOS ONE			English	Article							HOUSEKEEPING GENES; INTERNAL CONTROL; PROTEIN GENES; NORMALIZATION; IDENTIFICATION; ARABIDOPSIS	Adzuki bean (Vigna angularis) is one of the most important legume crops in Asian countries like China, Japan and Korea due to its nutritious protein and starch contents. In spite of its economic importance, gene expression analysis system for gene function verification of adzuki bean is still absent. Therefore, reference genes for gene expression analysis based on the quantitative real time PCR (qRT-PCR) were screened in current study. A total of nine general housekeeping genes, including ACT, Fbox, ZMPP, GAPDH, EF, PP2A, UBC, UBN and PTB were evaluated for their expression stability by qRT-PCR in four adzuki bean cultivars, three different tissues, four abiotic stress and one biotic stress. The best group of candidates as reference genes were as follows: PTB and ACT for different cultivars; EF and UBN for different tissues; ACT and ZMPP for biotic stress and water-logging stress; Fbox and UBC for salinity-alkalinity stress; Fbox and PTB for drought stress. Our results will provide a more accurate and reliable normalization of qRT-PCR data in adzuki bean.	[Chi, Chao; Shen, Yongqiang; Yin, Lihua; Ke, Xiwang; Han, Dong; Zuo, Yuhu] Heilongjiang Bayi Agr Univ, Daqing, Heilongjiang, Peoples R China	Heilongjiang Bayi Agricultural University	Ke, XW; Zuo, YH (corresponding author), Heilongjiang Bayi Agr Univ, Daqing, Heilongjiang, Peoples R China.	kexiwang@byau.edu.cn; zuoyuhu@byau.edu.cn	Ke, Xiwang/AAW-6439-2020		Ministry of Science and Technology of the People's Republic of China [2014BAD07B05-06/H08]; National Natural Science Foundation of China [31501629]; China Postdoctoral Science Foundation [2014M561378]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	2014BAD07B05-06/H08 (http://www.most.gov.cn/, Ministry of Science and Technology of the People's Republic of China, ZYH received the funding. The funder role in study design and decision to publish. 31501629, http://isisn.nsfc.gov.cn/egrantweb/, National Natural Science Foundation of China, KXW received the funding. The funder role in data collection. 2014M561378, http://jj.chinapostdoctor.org.cn/V1/Program2/Default.aspx, China Postdoctoral Science Foundation, YLH received the funding. The funder role in data analysis.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; de Vega-Bartol JJ, 2013, PLANT CELL REP, V32, P715, DOI 10.1007/s00299-013-1407-4; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Gutierrez L, 2008, PLANT CELL, V20, P1734, DOI 10.1105/tpc.108.059774; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Iskandar HM, 2004, PLANT MOL BIOL REP, V22, P325, DOI 10.1007/BF02772676; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Kang YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08069; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Ma R, 2016, FRONTIERS PLANT SCI, V7; Nakamura T, 2003, PLANT CELL PHYSIOL, V44, P16, DOI 10.1093/pcp/pcg002; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Reddy DS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148451; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Ruan WJ, 2007, CLIN CHIM ACTA, V385, P1, DOI 10.1016/j.cca.2007.07.003; Saint-Marcoux D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118678; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Thorrez L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001854; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vasquez-Robinet C, 2010, PLANT PHYSIOL BIOCH, V48, P256, DOI 10.1016/j.plaphy.2009.12.005; Walker NJ, 2002, SCIENCE, V296, P557, DOI 10.1126/science.296.5567.557; Wei YC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147224; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Yamaguchi M, 1997, PLANT SCI TXB; Yin ZY, 2013, WORLD J MICROB BIOT, V29, P1563, DOI 10.1007/s11274-013-1320-6; Zheng Sujiao, 2015, Weishengwu Xuebao, V55, P425; Zhu J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-172	35	18	29	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168479	10.1371/journal.pone.0168479	http://dx.doi.org/10.1371/journal.pone.0168479			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992593	Green Published, gold, Green Submitted			2022-12-26	WOS:000392758000053
J	Kim, KY; Kim, JH; Hong, AR; Seong, MW; Lee, KE; Kim, SJ; Kim, SW; Shin, CS; Kim, SY				Kim, Kyong Young; Kim, Jung Hee; Hong, A. Ram; Seong, Moon-Woo; Lee, Kyu Eun; Kim, Su-Jin; Kim, Sang Wan; Shin, Chan Soo; Kim, Seong Yeon			Disentangling of Malignancy from Benign Pheochromocytomas/Paragangliomas	PLOS ONE			English	Article							GLAND SCALED SCORE; CLINICAL-PRACTICE GUIDELINE; GERMLINE MUTATIONS; GENE-MUTATIONS; PARAGANGLIOMA; RECURRENCE; METASTASIS; DIAGNOSIS; FEATURES; SOCIETY	Objective Many malignant tumors initially appear benign but subsequently exhibit extensive metastases. Early identification of malignant pheochromocytomas and paragangliomas (PPGLs) before metastasis is important for improved prognosis. However, there are no robust prognostic indices of recurrence and malignancy. The aim of this study was to identify the clinical and histopathological factors that predict malignant PPGLs. Design Retrospective follow-up study. Methods In this study, we included 223 patients with pathologically confirmed PPGLs who were treated between 2000 and 2015 at the Seoul National University Hospital in South Korea. Results Of these patients, 29 were diagnosed with malignancy, 12 of whom presented with metastatic lesions at the initial diagnosis while 17 developed metastases during follow-up. Nineteen patients with recurrent PPGLs consisted of ones with malignant PPGLs (n = 17) and multifocal PPGLs (n = 2) who had VHL and RET mutations. The mean age at presentation for malignant PPGLs was significantly younger than that for benign PPGLs (43.0 vs. 49.0 years, respectively; p = 0.023). Tumor size was not a distinguishing factor between malignant and benign PPGLs (5.0 vs. 4.5 cm, respectively; p = 0.316) nor did it predict recurrence. Of 119 patients with available pheochromocytoma of adrenal gland scaled score (PASS) data, those with malignant PPGLs presented PASS values >= 4. Of 12 parameters of PASS, necrosis, capsular invasion, vascular invasion, cellular monotony, high mitosis, atypical mitotic figures, and nuclear hyperchromasia were significant predictors of malignancy. Conclusions Tumor size did not predict malignancy or recurrence of PPGLs. PPGL patients with characteristic pathologic findings and PASS >= 4 or germline mutations require close follow-up.	[Kim, Kyong Young; Kim, Jung Hee; Hong, A. Ram; Shin, Chan Soo; Kim, Seong Yeon] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Kyong Young; Kim, Seong Yeon] Gyeongsang Natl Univ, Changwon Hosp, Dept Internal Med, Changwon Si, South Korea; [Seong, Moon-Woo] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Lab Med, Seoul, South Korea; [Lee, Kyu Eun; Kim, Su-Jin] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Surg, Seoul, South Korea; [Kim, Sang Wan] Seoul Natl Univ, Seoul Metropolitan Govt Boramae Med Ctr, Dept Internal Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Gyeongsang National University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Kim, JH (corresponding author), Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Internal Med, Seoul, South Korea.	jhkxingfu@gmail.com	Kim, Su-jin/AAR-5059-2020; Kim, Jung Hee/AAG-1191-2019; Kim, Sang Wan/J-5399-2012	Kim, Su-jin/0000-0001-5511-3596; Kim, Jung Hee/0000-0003-1932-0234; Kim, Sang Wan/0000-0001-9561-9110; Seong, Moon-Woo/0000-0003-2954-3677				Agarwal A, 2010, WORLD J SURG, V34, P3022, DOI 10.1007/s00268-010-0744-5; Amar L, 2005, J CLIN ENDOCR METAB, V90, P2110, DOI 10.1210/jc.2004-1398; Amar L, 2007, J CLIN ENDOCR METAB, V92, P3822, DOI 10.1210/jc.2007-0709; Andersen KF, 2011, CANCER TREAT REV, V37, P111, DOI 10.1016/j.ctrv.2010.07.002; Ayala-Ramirez M, 2011, J CLIN ENDOCR METAB, V96, P717, DOI 10.1210/jc.2010-1946; Brouwers FM, 2006, J CLIN ENDOCR METAB, V91, P4505, DOI 10.1210/jc.2006-0423; Chrisoulidou A, 2007, ENDOCR-RELAT CANCER, V14, P569, DOI 10.1677/ERC-07-0074; de Wailly P, 2012, LANGENBECK ARCH SURG, V397, P239, DOI 10.1007/s00423-011-0850-3; Feng F, 2011, J UROLOGY, V185, P1583, DOI 10.1016/j.juro.2010.12.050; Goldstein RE, 1999, ANN SURG, V229, P755, DOI 10.1097/00000658-199906000-00001; Harari A, 2011, AM J SURG, V201, P693, DOI 10.1016/j.amjsurg.2010.04.012; Kim JH, 2014, CLIN GENET, V86, P482, DOI 10.1111/cge.12304; Kimura N, 2014, ENDOCR-RELAT CANCER, V21, P405, DOI 10.1530/ERC-13-0494; Korevaar TIM, 2011, ENDOCRINE, V40, P354, DOI 10.1007/s12020-011-9545-3; Lenders JWM, 2014, J CLIN ENDOCR METAB, V99, P1915, DOI 10.1210/jc.2014-1498; Neumann HPH, 2004, JAMA-J AM MED ASSOC, V292, P943, DOI 10.1001/jama.292.8.943; ORiordain DS, 1996, WORLD J SURG, V20, P916, DOI 10.1007/s002689900139; Park J, 2011, KOREAN J UROL, V52, P241, DOI 10.4111/kju.2011.52.4.241; Plouin PF, 2016, EUR J ENDOCRINOL, V174, pG1, DOI 10.1530/EJE-16-0033; Plouin PF, 1997, HYPERTENSION, V29, P1133, DOI 10.1161/01.HYP.29.5.1133; Strong VE, 2008, SURGERY, V143, P759, DOI 10.1016/j.surg.2008.02.007; TANAKA S, 1993, INTERNAL MED, V32, P789, DOI 10.2169/internalmedicine.32.789; Thompson L, 2004, PATHOLOGY GENETICS T; Thompson LDR, 2002, AM J SURG PATHOL, V26, P551, DOI 10.1097/00000478-200205000-00002; van der Harst E, 2002, EUR J ENDOCRINOL, V147, P85, DOI 10.1530/eje.0.1470085; van Heerden JA, 1999, ANN SURG, V229, P764; Van Slycke S, 2009, SURGERY, V146, P986, DOI 10.1016/j.surg.2009.10.055; Wu D, 2009, AM J SURG PATHOL, V33, P599, DOI 10.1097/PAS.0b013e318190d12e	28	55	56	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168413	10.1371/journal.pone.0168413	http://dx.doi.org/10.1371/journal.pone.0168413			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992508	Green Published, gold, Green Submitted			2022-12-26	WOS:000392758000048
J	Minsky, N; Roeder, RG				Minsky, Neri; Roeder, Robert G.			Inhibition of Adhesion Molecule Gene Expression and Cell Adhesion by the Metabolic Regulator PGC-1 alpha	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; THERMOGENIC COACTIVATOR PGC-1; TRANSCRIPTIONAL COACTIVATORS; MITOCHONDRIAL BIOGENESIS; ENERGY-METABOLISM; EXERCISE; DISEASE; MICE; RNA	Cell adhesion plays an important role in determining cell shape and function in a variety of physiological and pathophysiological conditions. While links between metabolism and cell adhesion were previously suggested, the exact context and molecular details of such a cross-talk remain incompletely understood. Here we show that PGC-1 alpha, a pivotal transcriptional co-activator of metabolic gene expression, acts to inhibit expression of cell adhesion genes. Using cell lines, primary cells and mice, we show that both endogenous and exogenous PGC-1 alpha down-regulate expression of a variety of cell adhesion molecules. Furthermore, results obtained using mRNA stability measurements as well as intronic RNA expression are consistent with a transcriptional effect of PGC-1 alpha on cell adhesion gene expression. Interestingly, the L2/L3 motifs of PGC-1 alpha, necessary for nuclear hormone receptor activation, are only partly required for inhibition of several cell adhesion genes by PGC-1 alpha. Finally, PGC-1 alpha is able to modulate adhesion of primary fibroblasts and hepatic stellate cells to extracellular matrix proteins. Our results delineate a cross talk between a central pathway controlling metabolic regulation and cell adhesion, and identify PGC-1 alpha as a molecular link between these two major cellular networks.	[Minsky, Neri; Roeder, Robert G.] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA	Rockefeller University	Roeder, RG (corresponding author), Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA.	roeder@rockefeller.edu			Machiah Foundation; Merck; NIH [DK071900]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071900] Funding Source: NIH RePORTER	Machiah Foundation; Merck(Merck & Company); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Machiah Foundation Fellowship and a Merck Postdoctoral Fellowship to N.M. and by NIH grant DK071900 to R.G.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Eisele PS, 2013, J BIOL CHEM, V288, P2246, DOI 10.1074/jbc.M112.375253; Elferink CJ, 1996, BIOTECHNIQUES, V20, P470; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Kang CH, 2012, ANN NY ACAD SCI, V1271, P110, DOI 10.1111/j.1749-6632.2012.06738.x; Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708; Li S, 2008, CELL METAB, V8, P105, DOI 10.1016/j.cmet.2008.06.013; Li Y, 2008, J BIOL CHEM, V283, P19132, DOI 10.1074/jbc.M802040200; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Liu C, 2011, ACTA BIOCH BIOPH SIN, V43, P248, DOI 10.1093/abbs/gmr007; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Minsky N, 2015, P NATL ACAD SCI USA, V112, pE5669, DOI 10.1073/pnas.1516219112; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Olesen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032222; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Shema E, 2011, MOL CELL, V42, P477, DOI 10.1016/j.molcel.2011.03.011; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Wallberg AE, 2003, MOL CELL, V12, P1137, DOI 10.1016/S1097-2765(03)00391-5; Wu YF, 2003, J BIOL CHEM, V278, P8637, DOI 10.1074/jbc.M210910200; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	27	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0165598	10.1371/journal.pone.0165598	http://dx.doi.org/10.1371/journal.pone.0165598			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27984584	Green Published, Green Submitted, gold			2022-12-26	WOS:000392758000004
J	Stojak, J; McDevitt, AD; Herman, JS; Krystufek, B; Uhlikova, J; Purger, JJ; Lavrenchenko, LA; Searle, JB; Wojcik, JM				Stojak, Joanna; McDevitt, Allan D.; Herman, Jeremy S.; Krystufek, Boris; Uhlikova, Jitka; Purger, Jeno J.; Lavrenchenko, Leonid A.; Searle, Jeremy B.; Wojcik, Jan M.			Between the Balkans and the Baltic: Phylogeography of a Common Vole Mitochondrial DNA Lineage Limited to Central Europe	PLOS ONE			English	Article							MICROTUS-ARVALIS; POSTGLACIAL COLONIZATION; GLACIAL REFUGIA; POPULATION-STRUCTURE; CLETHRIONOMYS-GLAREOLUS; STATISTICAL TESTS; SMALL MAMMALS; MARKERS; EVOLUTIONARY; SOFTWARE	The common vole (Microtus arvalis) has been a model species of small mammal for studying end-glacial colonization history. In the present study we expanded the sampling from central and eastern Europe, analyzing contemporary genetic structure to identify the role of a potential 'northern glacial refugium', i.e. a refugium at a higher latitude than the traditional Mediterranean refugia. Altogether we analyzed 786 cytochrome b (cytb) sequences (representing mitochondrial DNA; mtDNA) from the whole of Europe, adding 177 new sequences from central and eastern Europe, and we conducted analyses on eight microsatellite loci for 499 individuals (representing nuclear DNA) from central and eastern Europe, adding data on 311 new specimens. Our new data fill gaps in the vicinity of the Carpathian Mountains, the potential northern refugium, such that there is now dense sampling from the Balkans to the Baltic Sea. Here we present evidence that the Eastern mtDNA lineage of the common vole was present in the vicinity of this Carpathian refugium during the Last Glacial Maximum and the Younger Dryas. The Eastern lineage expanded from this refugium to the Baltic and shows low cytb nucleotide diversity in those most northerly parts of the distribution. Analyses of microsatellites revealed a similar pattern but also showed little differentiation between all of the populations sampled in central and eastern Europe.	[Stojak, Joanna; Wojcik, Jan M.] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland; [Stojak, Joanna; Searle, Jeremy B.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14850 USA; [McDevitt, Allan D.] Univ Salford, Sch Environm & Life Sci, Ecosyst & Environm Res Ctr, Salford M5 4WT, Lancs, England; [Herman, Jeremy S.] Natl Museums Scotland, Dept Nat Sci, Edinburgh, Midlothian, Scotland; [Krystufek, Boris] Slovenian Museum Nat Hist, Vertebrate Dept, Ljubljana, Slovenia; [Uhlikova, Jitka] Nat Conservat Agcy Czech Republ, Prague, Czech Republic; [Purger, Jeno J.] Univ Pecs, Inst Biol, Dept Ecol, Pecs, Hungary; [Lavrenchenko, Leonid A.] Russian Acad Sci, AN Severtsov Inst Ecol & Evolut, Dept Mammalian Microevolut, Moscow, Russia	Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; Cornell University; University of Salford; University of Pecs; Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Severtsov Institute of Ecology & Evolution	Stojak, J (corresponding author), Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland.; Stojak, J (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14850 USA.	jstojak@ibs.bialowieza.pl	Lavrenchenko, Leonid/N-7129-2017; Stojak, Joanna/AAK-2886-2021; Wójcik, Jan/I-4568-2014	Lavrenchenko, Leonid/0000-0001-9961-8748; Wójcik, Jan/0000-0002-4921-6780; Stojak, Joanna/0000-0003-2423-5026; Purger, Jeno/0000-0002-3302-6544	National Science Centre in Poland [UMO-2013/09/N/NZ8/ 03205, N N304 058340, DEC-2015/16/T/NZ8/00015]; European Commission [PIRSES-GA-2009-247652]; Russian Foundation for Basic Research [15-04-03801-a]	National Science Centre in Poland(National Science Centre, Poland); European Commission(European CommissionEuropean Commission Joint Research Centre); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	The study was financed by the National Science Centre in Poland (UMO-2013/09/N/NZ8/ 03205 to JS and N N304 058340 to JMW). This study forms part of the PhD thesis of JS, where she was awarded a PhD scholarship from the National Science Centre in Poland (DEC-2015/16/T/NZ8/00015). The research was supported by the European Commission's project No. PIRSES-GA-2009-247652 (BIOGEAST) and the Russian Foundation for Basic Research (project no. 15-04-03801-a). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Baele G, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-85; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beysard M, 2014, MOL ECOL, V23, P673, DOI 10.1111/mec.12613; Bilton DT, 1998, P ROY SOC B-BIOL SCI, V265, P1219, DOI 10.1098/rspb.1998.0423; Braaker S, 2009, MOL ECOL, V18, P2518, DOI 10.1111/j.1365-294X.2009.04189.x; Brace S, 2012, P NATL ACAD SCI USA, V109, P20532, DOI 10.1073/pnas.1213322109; Bulatova NS, 2010, RUSS J GENET+, V46, P586, DOI 10.1134/S1022795410050121; Buzan EV, 2010, BIOL J LINN SOC, V100, P788, DOI 10.1111/j.1095-8312.2010.01451.x; Canestrelli D, 2014, SCI REP-UK, V4, DOI 10.1038/srep05042; Carlson A.E., 2013, ENCY Q SCI, V3, P126, DOI DOI 10.1016/B978-0-444-53643-3.00029-7; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; de Bruyn M, 2011, TRENDS ECOL EVOL, V26, P405, DOI 10.1016/j.tree.2011.03.021; Deffontaine V, 2005, MOL ECOL, V14, P1727, DOI 10.1111/j.1365-294X.2005.02506.x; DEGLIESPOSTI M, 1993, BIOCHIM BIOPHYS ACTA, V1143, P243, DOI 10.1016/0005-2728(93)90197-N; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frantz AC, 2014, HEREDITY, V113, P443, DOI 10.1038/hdy.2014.45; Fu YX, 1997, GENETICS, V147, P915; Gaziev AI, 2010, MOL BIOL+, V44, P358, DOI 10.1134/S0026893310030027; Goudet J, 2011, FSTAT PROGRAM ESTIMA; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Haynes S, 2003, MOL ECOL, V12, P951, DOI 10.1046/j.1365-294X.2003.01795.x; Heckel G, 2005, EVOLUTION, V59, P2231; Herman JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103949; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2015, TUTORIAL SPATIAL ANA; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kotlik P, 2006, P NATL ACAD SCI USA, V103, P14860, DOI 10.1073/pnas.0603237103; Lagerholm VK, 2014, MOL ECOL, V23, P2060, DOI 10.1111/mec.12698; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lokrantz H, 2006, TR0636; MANTEL N, 1967, CANCER RES, V27, P209; Markova A.K., 1984, P209; Markova AK, 2011, QUATERN INT, V231, P22, DOI 10.1016/j.quaint.2010.07.016; Martinkova N, 2013, MOL ECOL, V22, P5205, DOI 10.1111/mec.12462; McDevitt AD, 2011, HEREDITY, V107, P548, DOI 10.1038/hdy.2011.41; Mcdevitt AD, 2012, BIOL J LINN SOC, V106, P57, DOI 10.1111/j.1095-8312.2012.01840.x; Meyer MN, 1997, ZOOL ZH, V76, P487; Mix AC, 2001, QUATERNARY SCI REV, V20, P627, DOI 10.1016/S0277-3791(00)00145-1; Mraz P, 2016, BIOL J LINN SOC, V119, P528, DOI 10.1111/bij.12918; Pauperio J, 2012, MOL ECOL, V21, P6015, DOI 10.1111/mec.12024; Pazonyi P, 2004, PALAEOGEOGR PALAEOCL, V212, P295, DOI 10.1016/j.palaeo.2004.06.008; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A, 2007, TRACER 1 4; Rasmussen SO, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006079; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; RStudio, 2012, RSTUDIO INT DEV ENV; Schenekar T, 2011, HEREDITY, V107, P511, DOI 10.1038/hdy.2011.48; Schneider S, 1999, GENETICS, V152, P1079; Sommer RS, 2006, MAMMAL REV, V36, P251, DOI 10.1111/j.1365-2907.2006.00093.x; Starkel L, 2001, GEOGR SPAT ORG MONOG, V2; Starkel L., 1991, HOLOCENE, V1, P234, DOI [DOI 10.1177/095968369100100305, 10.1177/095968369100100305]; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Stojak J, 2016, MAMMAL RES, V61, P141, DOI 10.1007/s13364-015-0260-y; Stojak J, 2015, BIOL J LINN SOC, V115, P927, DOI 10.1111/bij.12535; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Tajima F, 1989, GENETICS, V123, P453; Tougard C, 2013, BIOL J LINN SOC, V108, P434, DOI 10.1111/j.1095-8312.2012.02034.x; Tzedakis PC, 2013, TRENDS ECOL EVOL, V28, P696, DOI 10.1016/j.tree.2013.09.001; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Valdiosera CE, 2007, MOL ECOL, V16, P5140, DOI 10.1111/j.1365-294X.2007.03590.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEBB T, 1992, ANNU REV ECOL SYST, V23, P141, DOI 10.1146/annurev.es.23.110192.001041; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wielstra B, 2015, BIOL J LINN SOC, V114, P574, DOI 10.1111/bij.12446; Wojcik JM, 2010, J ZOOL, V281, P249, DOI 10.1111/j.1469-7998.2010.00699.x; WOJCIK JM, 1993, ACTA THERIOL, V38, P315, DOI 10.4098/AT.arch.93-27; WYSOTA W, 2002, GEOCHRONOMETRIA, V21, P137; Wysota W, 2009, QUATERN INT, V207, P26, DOI 10.1016/j.quaint.2008.12.015; Yu ZC, 2001, GEOGR PHYS QUATERN, V55, P171, DOI 10.7202/008301ar; Zagorodnyuk I, 2008, MICROTUS LEVIS IUCN; Zhang DX, 1996, TRENDS ECOL EVOL, V11, P247, DOI 10.1016/0169-5347(96)10031-8	86	21	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168621	10.1371/journal.pone.0168621	http://dx.doi.org/10.1371/journal.pone.0168621			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992546	Green Submitted, Green Published, gold			2022-12-26	WOS:000392758000068
J	Xi, JY; Ouyang, Q				Xi, J. Y.; Ouyang, Q.			Using Sub-Network Combinations to Scale Up an Enumeration Method for Determining the Network Structures of Biological Functions	PLOS ONE			English	Article							GENE REGULATORY NETWORKS; FEEDBACK LOOPS; TRANSCRIPTION NETWORKS; IN-SILICO; EVOLUTION; DESIGN; MOTIFS; TOPOLOGIES; MODELS	Deduction of biological regulatory networks from their functions is one of the focus areas of systems biology. Among the different techniques used in this reverse-engineering task, one powerful method is to enumerate all candidate network structures to find suitable ones. However, this method is severely limited by calculation capability: due to the brute-force approach, it is infeasible for networks with large number of nodes to be studied using traditional enumeration method because of the combinatorial explosion. In this study, we propose a new reverse-engineering technique based on the enumerating method: sub-network combinations. First, a complex biological function is divided into several sub-functions. Next, the three-node-network enumerating method is applied to search for sub-networks that are able to realize each of the sub-functions. Finally, complex whole networks are constructed by enumerating all possible combinations of sub-networks. The optimal ones are selected and analyzed. To demonstrate the effectiveness of this new method, we used it to deduct the network structures of a Pavlovian-like function. The whole Pavlovian-like network was successfully constructed by combining robust sub-networks, and the results were analyzed. With sub-network combination, the complexity has been largely reduced. Our method also provides a functional modular view of biological systems.	[Xi, J. Y.; Ouyang, Q.] Peking Univ, Ctr Quantitat Biol, Acad Adv Interdisciplinary Studies, Beijing, Peoples R China; [Xi, J. Y.; Ouyang, Q.] Peking Univ, Peking Tsinghua Ctr Life Sci, Acad Adv Interdisciplinary Studies, Beijing, Peoples R China; [Ouyang, Q.] Peking Univ, State Key Lab Artificial Microstruct & Mesoscop P, Sch Phys, Beijing, Peoples R China	Peking University; Peking University; Peking University	Ouyang, Q (corresponding author), Peking Univ, Ctr Quantitat Biol, Acad Adv Interdisciplinary Studies, Beijing, Peoples R China.; Ouyang, Q (corresponding author), Peking Univ, Peking Tsinghua Ctr Life Sci, Acad Adv Interdisciplinary Studies, Beijing, Peoples R China.; Ouyang, Q (corresponding author), Peking Univ, State Key Lab Artificial Microstruct & Mesoscop P, Sch Phys, Beijing, Peoples R China.	qi@pku.edu.cn			National Natural Science Foundation of China [11434001, 91530321]; Ministry of Science and Technology of China [2012AA02A702]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by National Natural Science Foundation of China (11434001,91530321) 382 and Ministry of Science and Technology of China (2012AA02A702). JYX and QO received the fundings from the above sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Chau AH, 2012, CELL, V151, P320, DOI 10.1016/j.cell.2012.08.040; Francois P, 2004, P NATL ACAD SCI USA, V101, P580, DOI 10.1073/pnas.0304532101; Francois P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002585; Francois P, 2010, DEVELOPMENT, V137, P2385, DOI 10.1242/dev.048033; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Kwon YK, 2008, BIOINFORMATICS, V24, P1926, DOI 10.1093/bioinformatics/btn337; Li H, 2003, CURR OPIN GENET DEV, V13, P611, DOI 10.1016/j.gde.2003.10.012; Ma WZ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100111; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mazur J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-448; Mckay MD, 2000, TECHNOMETRICS, V42, P55, DOI 10.2307/1271432; Nochomovitz YD, 2006, P NATL ACAD SCI USA, V103, P4180, DOI 10.1073/pnas.0507032103; Peter IS, 2011, CELL, V144, P970, DOI 10.1016/j.cell.2011.02.017; Rong Y, 2011, TOPOLOGY, V4, P1565; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Sneppen K, 2010, ANNU REV BIOPHYS, V39, P43, DOI 10.1146/annurev.biophys.093008.131241; Sontag E, 2008, BIOPHYS J, V95, P518, DOI 10.1529/biophysj.107.125021; Stelling J, 2002, NATURE, V420, P190, DOI 10.1038/nature01166; THOMAS R, 1995, B MATH BIOL, V57, P247, DOI 10.1007/BF02460618; Tkacik G, 2009, ENCY COMPLEXITY SYST, P719; Tyson JJ, 2010, ANNU REV PHYS CHEM, V61, P219, DOI 10.1146/annurev.physchem.012809.103457; Walczak AM, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.041905; Wang GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040330; Wang W, 2002, P NATL ACAD SCI USA, V99, P16893, DOI 10.1073/pnas.252638199; Warmflash A, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/5/056001; Whitaker WR, 2012, P NATL ACAD SCI USA, V109, P18090, DOI 10.1073/pnas.1209230109; Wu YL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000442; Yan L, 2012, PLOS ONE, V7; Yu YH, 2007, PLOS COMPUT BIOL, V3, P1657, DOI 10.1371/journal.pcbi.0030171; Zhang H., 2013, QUANTITATIVE BIOL, V1, P209; Zhang H, 2014, NATURE COMMUNICATION, V5; Zheng MM, 2016, J THEOR BIOL, V408, P88, DOI 10.1016/j.jtbi.2016.08.005	36	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168214	10.1371/journal.pone.0168214	http://dx.doi.org/10.1371/journal.pone.0168214			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992476	Green Published, gold, Green Submitted			2022-12-26	WOS:000392758000031
J	Acevedo, N; Bornacelly, A; Mercado, D; Unneberg, P; Mittermann, I; Valenta, R; Kennedy, M; Scheynius, A; Caraballo, L				Acevedo, Nathalie; Bornacelly, Adriana; Mercado, Dilia; Unneberg, Per; Mittermann, Irene; Valenta, Rudolf; Kennedy, Malcolm; Scheynius, Annika; Caraballo, Luis			Genetic Variants in CHIA and CHI3L1 Are Associated with the IgE Response to the Ascaris Resistance Marker ABA-1 and the Birch Pollen Allergen Bet v 1	PLOS ONE			English	Article							LUMBRICOIDES INFECTION; IMMUNOGLOBULIN-E; ANTIBODY REPERTOIRE; WIDE ASSOCIATION; BINDING FUNCTION; INNATE IMMUNITY; HIGH PREVALENCE; FATTY-ACID; POLYMORPHISMS; ASTHMA	Helminth infections and allergic diseases are associated with IgE hyperresponsiveness but the genetics of this phenotype remain to be defined. Susceptibility to Ascaris lumbricoides infection and antibody levels to this helminth are associated with polymorphisms in locus 13q33-34. We aimed to explore this and other genomic regions to identify genetic variants associated with the IgE responsiveness in humans. Forty-eight subjects from Cartagena, Colombia, with extreme values of specific IgE to Ascaris and ABA-1, a resistance marker of this nematode, were selected for targeted resequencing. Burden analyses were done comparing extreme groups for IgE values. One-hundred one SNPs were genotyped in 1258 individuals of two well-characterized populations from Colombia and Sweden. Two low-frequency coding variants in the gene encoding the Acidic Mammalian Chitinase (CHIA rs79500525, rs139812869, tagged by rs10494133) were found enriched in high IgE responders to ABA-1 and confirmed by genetic association analyses. The SNP rs4950928 in the Chitinase 3 Like 1 gene (CHI3L1) was associated with high IgE to ABA-1 in Colombians and with high IgE to Bet v 1 in the Swedish population. CHIA rs10494133 and ABDH13 rs3783118 were associated with IgE responses to Ascaris. SNPs in the Tumor Necrosis Factor Superfamily Member 13b gene (TNFSF13B) encoding the cytokine B cell activating Factor were associated with high levels of total IgE in both populations. This is the first report on the association between low-frequency and common variants in the chitinases- related genes CHIA and CHI3L1 with the intensity of specific IgE to ABA-1 in a population naturally exposed to Ascaris and with Bet v 1 in a Swedish population. Our results add new information about the genetic influences of human IgE responsiveness; since the genes encode for enzymes involved in the immune response to parasitic infections, they could be helpful for understanding helminth immunity and allergic responses. We also confirmed that TNFSF13B has an important and conserved role in the regulation of total IgE levels, which supports potential evolutionary links between helminth immunity and allergic response.	[Acevedo, Nathalie; Bornacelly, Adriana; Mercado, Dilia; Caraballo, Luis] Univ Cartagena, Immunol Res Inst, Cartagena, Colombia; [Acevedo, Nathalie; Scheynius, Annika] Karolinska Inst, Sci Life Lab, Dept Clin Sci & Educ, Stockholm, Sweden; [Acevedo, Nathalie] Soder Sjukhuset, Sachs Children & Youth Hosp, Stockholm, Sweden; [Unneberg, Per] Stockholm Univ, Sci Life Lab, Dept Biochem & Biophys, Solna, Sweden; [Mittermann, Irene; Valenta, Rudolf] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Div Immunopathol, Ctr Pathophysiol Infectol & Immunol, Vienna, Austria; [Kennedy, Malcolm] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	Universidad de Cartagena; Karolinska Institutet; Sodersjukhuset Hospital; Stockholm University; Medical University of Vienna; University of Glasgow	Caraballo, L (corresponding author), Univ Cartagena, Immunol Res Inst, Cartagena, Colombia.	lcaraballog@unicartagena.edu.co		Valenta, Rudolf/0000-0001-5944-3365; Acevedo, Nathalie/0000-0002-5154-2964; Unneberg, Per/0000-0001-5735-3315; Bornacelly, Adriana/0000-0001-7762-6632; Mittermann, Irene/0000-0002-6240-6730	Administrative Department of Science, Technology and Innovation (Colciencias, Colombia) [680-2009]; University of Cartagena, Colombia; Swedish Research Council; Cancer and Allergy Research Foundation; Karolinska Institutet; Karolinska University Hospital; Wellcome Trust [048488, 042679, WT083625MA]; Austrian Science Fund (FWF) [F4605]; Colciencias [680-2009]; Science for Life Laboratory (SciLifeLab); National Genomics Infrastructure (NGI); Mutation Analysis Facility (MAF) at Karolinska Institutet	Administrative Department of Science, Technology and Innovation (Colciencias, Colombia); University of Cartagena, Colombia; Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancer and Allergy Research Foundation; Karolinska Institutet(Karolinska Institutet); Karolinska University Hospital(Karolinska Institutet); Wellcome Trust(Wellcome TrustEuropean Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Science for Life Laboratory (SciLifeLab); National Genomics Infrastructure (NGI); Mutation Analysis Facility (MAF) at Karolinska Institutet	This work was funded by the Administrative Department of Science, Technology and Innovation (Colciencias, Colombia) Grant 680-2009, the University of Cartagena, Colombia; grants to AS from the Swedish Research Council, the Cancer and Allergy Research Foundation, and through the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and the Karolinska Institutet and the Karolinska University Hospital, and by grant numbers 048488, 042679, and WT083625MA to MK from the Wellcome Trust, UK. RV research was founded in part by grant F4605 of the Austrian Science Fund (FWF).; We thank all the patients and controls for their voluntary participation in the study. Also we thank Dr. Lena Lundeberg and PhD Catharina Johansson for their support with Swedish cohort recruitment. We acknowledge Colciencias for financial support (Contract 680-2009), the Science for Life Laboratory (SciLifeLab) and the National Genomics Infrastructure (NGI) for sequencing service and the Mutation Analysis Facility (MAF) at Karolinska Institutet for genotyping service.	Acevedo N, 2011, INT ARCH ALLERGY IMM, V154, P195, DOI 10.1159/000321106; Acevedo N, 2009, ALLERGY, V64, P1635, DOI 10.1111/j.1398-9995.2009.02084.x; Acevedo N, 2009, CLIN EXP IMMUNOL, V157, P282, DOI 10.1111/j.1365-2249.2009.03948.x; Acevedo N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078353; Ahumada V, 2015, CLIN EXP ALLERGY, V45, P1189, DOI 10.1111/cea.12513; Alcantara-Neves NM, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-114; Bornacelly A, 2014, BMC IMMUNOL, V15, DOI 10.1186/1471-2172-15-22; Bottema RWB, 2008, EUR RESPIR J, V32, P593, DOI 10.1183/09031936.00162407; Bottema RWB, 2010, INT ARCH ALLERGY IMM, V153, P259, DOI 10.1159/000314366; Chen YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022202; Choi EH, 2001, GENES IMMUN, V2, P248, DOI 10.1038/sj.gene.6363767; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cooper PJ, 2000, J INFECT DIS, V182, P1207, DOI 10.1086/315830; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Donnelly LE, 2004, TRENDS PHARMACOL SCI, V25, P509, DOI 10.1016/j.tips.2004.08.002; FERNANDEZCALDAS E, 1993, CLIN EXP ALLERGY, V23, P292, DOI 10.1111/j.1365-2222.1993.tb00325.x; Filbey KJ, 2014, IMMUNOL CELL BIOL, V92, P436, DOI 10.1038/icb.2013.109; Fitzsimmons CM, 2009, TRENDS PARASITOL, V25, P447, DOI 10.1016/j.pt.2009.07.004; Fumagalli M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-264; Gao PS, 2000, J MED GENET, V37, P380; Grencis RK, 2015, ANNU REV IMMUNOL, V33, P201, DOI 10.1146/annurev-immunol-032713-120218; HAGEL I, 1993, CLIN EXP IMMUNOL, V94, P80, DOI 10.1111/j.1365-2249.1993.tb05981.x; Hagel I, 2008, J TROP PEDIATRICS, V54, P354, DOI 10.1093/tropej/fmn032; Hagel Isabel, 2006, Invest. clín, V47, P241; Hise AG, 2003, GENES IMMUN, V4, P524, DOI 10.1038/sj.gene.6364015; Hoerauf A, 2002, MICROBES INFECT, V4, P37, DOI 10.1016/S1286-4579(01)01507-6; Hong XM, 2010, J ALLERGY CLIN IMMUN, V126, P1059, DOI 10.1016/j.jaci.2010.08.029; Hopkin J, 2009, PARASITE IMMUNOL, V31, P267, DOI 10.1111/j.1365-3024.2009.01104.x; Humphreys K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022547; Hunninghake GM, 2007, J ALLERGY CLIN IMMUN, V120, P84, DOI 10.1016/j.jaci.2007.04.032; KENNEDY MW, 1991, IMMUNOLOGY, V72, P577; KENNEDY MW, 1990, CLIN EXP IMMUNOL, V80, P219, DOI 10.1111/j.1365-2249.1990.tb05237.x; KENNEDY MW, 1995, BIOCHEMISTRY-US, V34, P6700, DOI 10.1021/bi00020a015; Kim KW, 2015, J ALLERGY CLIN IMMUN, V136, P678, DOI 10.1016/j.jaci.2015.03.030; Levin ME, 2008, PEDIAT ALLERG IMM-UK, V19, P449, DOI 10.1111/j.1399-3038.2007.00663.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; Liang LM, 2015, NATURE, V520, P670, DOI 10.1038/nature14125; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Long X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135360; Lupinek C, 2014, METHODS, V66, P106, DOI 10.1016/j.ymeth.2013.10.008; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Manno N, 2014, CARBOHYD POLYM, V113, P607, DOI 10.1016/j.carbpol.2014.07.011; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McSharry C, 1999, INFECT IMMUN, V67, P484, DOI 10.1128/IAI.67.2.484-489.1999; Mittermann I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156077; Moller M, 2007, HUM MOL GENET, V16, P1828, DOI 10.1093/hmg/ddm131; Moore J, 1999, BIOCHEM J, V340, P337, DOI 10.1042/0264-6021:3400337; Peisong G, 2004, GENES IMMUN, V5, P58, DOI 10.1038/sj.gene.6364030; Plomin R, 2009, NAT REV GENET, V10, P872, DOI 10.1038/nrg2670; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; Ramsay CE, 1999, HUM GENET, V104, P269, DOI 10.1007/s004390050947; Soto-Quiros ME, 2002, PEDIAT ALLERG IMM-UK, V13, P342, DOI 10.1034/j.1399-3038.2002.02035.x; Souza V, 2014, ALLERGOL IMMUNOPATH, V42, P206, DOI 10.1016/j.aller.2012.12.009; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; TOMLINSON LA, 1989, J IMMUNOL, V143, P2349; Turner JD, 2005, MICROBES INFECT, V7, P990, DOI 10.1016/j.micinf.2005.03.036; Tyagi N, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004546; Vergara C, 2013, GENET EPIDEMIOL, V37, P393, DOI 10.1002/gepi.21702; Vergara C, 2009, HUM GENET, V125, P565, DOI 10.1007/s00439-009-0649-2; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Welch JS, 2002, J BIOL CHEM, V277, P42821, DOI 10.1074/jbc.M205873200; Williams-Blangero S, 2002, P NATL ACAD SCI USA, V99, P5533, DOI 10.1073/pnas.082115999; Williams-Blangero S, 2008, J INFECT DIS, V197, P66, DOI 10.1086/524060; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Xia Y, 2000, PARASITOLOGY, V120, P211, DOI 10.1017/S0031182099005363; Zakzuk J, 2013, PEDIAT ALLERG IMM-UK, V24, P788, DOI 10.1111/pai.12161; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	68	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0167453	10.1371/journal.pone.0167453	http://dx.doi.org/10.1371/journal.pone.0167453			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977724	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000391217400020
J	Liarzi, O; Bar, E; Lewinsohn, E; Ezra, D				Liarzi, Orna; Bar, Einat; Lewinsohn, Efraim; Ezra, David			Use of the Endophytic Fungus Daldinia cf. concentrica and Its Volatiles as Bio-Control Agents	PLOS ONE			English	Article							MUSCODOR-ALBUS; ORGANIC-COMPOUNDS; GROWTH; ANTIMICROBIALS; MYCOTOXINS; ANTIFUNGAL; BIOCONTROL; DIVERSITY; CULTURES; PRODUCT	Endophytic fungi are organisms that spend most of their life cycle within plant tissues without causing any visible damage to the host plant. Many endophytes were found to secrete specialized metabolites and/or emit volatile organic compounds (VOCs), which may be biologically active and assist fungal survival inside the plant as well as benefit their hosts. We report on the isolation and characterization of a VOCs-emitting endophytic fungus, isolated from an olive tree (Olea europaea L.) growing in Israel; the isolate was identified as Daldinia cf. concentrica. We found that the emitted VOCs were active against various fungi from diverse phyla. Results from postharvest experiments demonstrated that D. cf. concentrica prevented development of molds on organic dried fruits, and eliminated Aspergillus niger infection in peanuts. Gas chromatography-mass spectrometry analysis of the volatiles led to identification of 27 VOCs. On the basis of these VOCs we prepared two mixtures that displayed a broad spectrum of antifungal activity. In postharvest experiments these mixtures prevented development of molds on wheat grains, and fully eliminated A. niger infection in peanuts. In light of these findings, we suggest use of D. cf. concentrica and/or its volatiles as an alternative approach to controlling phytopathogenic fungi in the food industry and in agriculture.	[Liarzi, Orna; Ezra, David] Agr Res Org, Dept Plant Pathol & Weed Res, Volcani Ctr, Rishon Leziyyon, Israel; [Bar, Einat; Lewinsohn, Efraim] Newe Yaar Reg Res Ctr, Ramat Yishai, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Ezra, D (corresponding author), Agr Res Org, Dept Plant Pathol & Weed Res, Volcani Ctr, Rishon Leziyyon, Israel.	dezra@volcani.agri.gov.il			Israel's Ministry of Agriculture and Rural Development (MOARD) [132-1252-06]; Israel's Ministry of Economy [47106]	Israel's Ministry of Agriculture and Rural Development (MOARD); Israel's Ministry of Economy	This work was financed by the Chief Scientist of Israel's Ministry of Agriculture and Rural Development (MOARD) (https://agriscience.co.il), under grant number 132-1252-06, and the Chief Scientist of Israel's Ministry of Economy (http://www.matimop.org.il/ocs.html), under grant number 47106. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The grants were given to D.E.	ALLPORT DC, 1960, J CHEM SOC, P654, DOI 10.1039/jr9600000654; Ando H, 2015, J APPL MICROBIOL, V118, P873, DOI 10.1111/jam.12764; Ando H, 2012, FOOD CONTROL, V26, P472, DOI 10.1016/j.foodcont.2012.02.017; ANKE H, 1995, CAN J BOT, V73, pS932, DOI 10.1139/b95-341; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; Azevedo Joao Lucio, 2000, EJB Electronic Journal of Biotechnology, V3, P1, DOI 10.2225/vol3-issue1-fulltext-4; Bacon CW, 2000, ENDOPHYTES; Baraka EA, 2002, BIOL, V24, P135; Bashyal B, 1999, MYCOTAXON, V72, P33; Bisignano G, 2001, FEMS MICROBIOL LETT, V198, P9, DOI 10.1111/j.1574-6968.2001.tb10611.x; Bitzer J, 2008, MYCOL RES, V112, P251, DOI 10.1016/j.mycres.2007.07.004; Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076; BOWLES BL, 1993, J FOOD PROTECT, V56, P795, DOI 10.4315/0362-028X-56.9.795; Carbone I, 1999, MYCOLOGIA, V91, P553, DOI 10.2307/3761358; Daisy BH, 2002, MICROBIOL-SGM, V148, P3737, DOI 10.1099/00221287-148-11-3737; Davis TS, 2013, J CHEM ECOL, V39, P860, DOI 10.1007/s10886-013-0278-z; Ezra D, 2004, MICROBIOL-SGM, V150, P4023, DOI 10.1099/mic.0.27334-0; Ezra D, 2004, MICROBIOL-SGM, V150, P785, DOI 10.1099/mic.0.26645-0; Ezra D, 2003, PLANT SCI, V165, P1229, DOI 10.1016/S0168-9452(03)00330-3; Fialho MB, 2011, PESQUI AGROPECU BRAS, V46, P137, DOI 10.1590/S0100-204X2011000200004; Garbeva P, 2014, FEMS MICROBIOL ECOL, V87, P639, DOI 10.1111/1574-6941.12252; Groenhagen U, 2013, J CHEM ECOL, V39, P892, DOI 10.1007/s10886-013-0315-y; Hedlund K, 1995, FUNCT ECOL, V9, P869, DOI 10.2307/2389984; Hung R, 2014, AMB EXPRESS, V4, DOI 10.1186/s13568-014-0053-8; Inamdar AA, 2010, TOXICOL SCI, V117, P418, DOI 10.1093/toxsci/kfq222; Johannesson H, 2000, MYCOL RES, V104, P275, DOI 10.1017/S0953756299001719; Kanchiswamy CN, 2015, TRENDS PLANT SCI, V20, P206, DOI 10.1016/j.tplants.2015.01.004; Kanchiswamy CN, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00151; Korpi A, 2009, CRIT REV TOXICOL, V39, P139, DOI [10.1080/10408440802291497, 10.1080/10408440802291497 ]; Lacey LA, 2009, J ECON ENTOMOL, V102, P43, DOI 10.1603/029.102.0107; Liarzi O., 2013, ADV ENDOPHYTIC RES, P335, DOI [10.1007/978-81-322-1575-2_18, DOI 10.1007/978-81-322-1575-2_18]; Liarzi O., 2016, PLOS ONE IN PRESS; Macias-Rubalcava ML, 2010, J CHEM ECOL, V36, P1122, DOI 10.1007/s10886-010-9848-5; Malinowski DP, 2000, CROP SCI, V40, P923, DOI 10.2135/cropsci2000.404923x; Mari M, 2012, POSTHARVEST BIOL TEC, V73, P56, DOI 10.1016/j.postharvbio.2012.05.014; Mari M, 2012, BIOL CONTROL, V60, P132, DOI 10.1016/j.biocontrol.2011.10.013; Mburu DM, 2011, J EXP BIOL, V214, P956, DOI 10.1242/jeb.050419; McAfee BJ, 1999, NAT TOXINS, V7, P283, DOI 10.1002/1522-7189(199911/12)7:6<283::AID-NT70>3.0.CO;2-N; Mends M. T., 2012, J PET ENV BIOTECHNOL, V3, P117, DOI [10.4172, DOI 10.4172/2157-7463.1000117]; Mercier J, 2005, BIOL CONTROL, V32, P401, DOI 10.1016/j.biocontrol.2004.12.002; Mercier J, 2004, POSTHARVEST BIOL TEC, V31, P1, DOI 10.1016/j.postharvbio.2003.08.004; Miller CM, 1998, J APPL MICROBIOL, V84, P937; Morath Shannon U., 2012, Fungal Biology Reviews, V26, P73, DOI 10.1016/j.fbr.2012.07.001; Mousa WK, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00065; Murugesan GR, 2015, POULTRY SCI, V94, P1298, DOI 10.3382/ps/pev075; Pazoutova S, 2013, FUNGAL DIVERS, V60, P107, DOI 10.1007/s13225-013-0238-5; Qin XD, 2008, J ANTIBIOT, V61, P556, DOI 10.1038/ja.2008.74; Rohlfs Marko, 2005, Front Zool, V2, P2, DOI 10.1186/1742-9994-2-2; Sambrook J., 2001, MOL CLONING LAB MANU; Sanchez-Ortiz BL, 2016, J APPL MICROBIOL, V120, P1313, DOI 10.1111/jam.13101; Sopalun K, 2003, MYCOTAXON, V88, P239; Splivallo R, 2007, PHYTOCHEMISTRY, V68, P2584, DOI 10.1016/j.phytochem.2007.03.030; Splivallo R, 2007, NEW PHYTOL, V175, P417, DOI 10.1111/j.1469-8137.2007.02141.x; Stadler M, 2004, MYCOL RES, V108, P257, DOI 10.1017/S0953756204009335; Stadler M, 2014, STUD MYCOL, P1, DOI 10.3114/sim0016; Stinson M, 2003, PLANT SCI, V165, P913, DOI 10.1016/S0168-9452(03)00299-1; Stoev SD, 2015, ENVIRON TOXICOL PHAR, V39, P794, DOI 10.1016/j.etap.2015.01.022; Strobel G, 2003, MICROBIOL MOL BIOL R, V67, P491, DOI 10.1128/MMBR.67.4.491-502.2003; Strobel GA, 2001, MICROBIOL-SGM, V147, P2943, DOI 10.1099/00221287-147-11-2943; Strobel G, 2006, J IND MICROBIOL BIOT, V33, P514, DOI 10.1007/s10295-006-0090-7; Strobel G, 2006, CURR OPIN MICROBIOL, V9, P240, DOI 10.1016/j.mib.2006.04.001; Strobel G, 2011, FEMS MICROBIOL LETT, V320, P87, DOI 10.1111/j.1574-6968.2011.02297.x; Strobel GA, 2008, MICROBIOL-SGM, V154, P3319, DOI 10.1099/mic.0.2008/022186-0; Thakeow P, 2008, CHEM SENSES, V33, P379, DOI 10.1093/chemse/bjn005; Ul-Hassan SR, 2012, MICROBIOL-SGM, V158, P465, DOI 10.1099/mic.0.054643-0; Uvidelio F, 2002, MICROBIOLOGY, V148, P2675, DOI [10.1099/00221287-148-9-2675, DOI 10.1099/00221287-148-9-2675]; Walker V, 2001, CLIN CHIM ACTA, V306, P51, DOI 10.1016/S0009-8981(01)00390-4; Webber J. F., 1989, Insect-fungus interactions. 14th Symposium of the Royal Entomological Society of London in collaboration with the British Mycological Society., P161; Wheeler W.B., 2002, PESTICIDES AGR ENV; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wood WF, 2001, BIOCHEM SYST ECOL, V29, P531, DOI 10.1016/S0305-1978(00)00076-4; Worapong J, 2002, MYCOTAXON, V81, P463; Worapong J, 2001, MYCOTAXON, V79, P67; WRIGHT SJL, 1991, LETT APPL MICROBIOL, V13, P130, DOI 10.1111/j.1472-765X.1991.tb00589.x; Yuan ZL, 2012, CRIT REV BIOTECHNOL, V32, P363, DOI 10.3109/07388551.2011.651429; ZERINGUE HJ, 1991, APPL ENVIRON MICROB, V57, P2433, DOI 10.1128/AEM.57.8.2433-2434.1991; ZERINGUE HJ, 1989, J AM OIL CHEM SOC, V66, P581, DOI 10.1007/BF02885452	77	29	31	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168242	10.1371/journal.pone.0168242	http://dx.doi.org/10.1371/journal.pone.0168242			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977739	Green Published, Green Submitted, gold			2022-12-26	WOS:000391217400079
J	Zhang, D; Jin, N; Sun, W; Li, X; Liu, B; Xie, Z; Qu, J; Xu, J; Yang, X; Su, Y; Tang, S; Han, H; Chen, D; Ding, J; Tan, M; Huang, M; Geng, M				Zhang, D.; Jin, N.; Sun, W.; Li, X.; Liu, B.; Xie, Z.; Qu, J.; Xu, J.; Yang, X.; Su, Y.; Tang, S.; Han, H.; Chen, D.; Ding, J.; Tan, M.; Huang, M.; Geng, M.			Phosphoglycerate mutase 1 promotes cancer cell migration independent of its metabolic activity	ONCOGENE			English	Article							PYRUVATE-KINASE M2; GENE-TRANSCRIPTION; CREATINE-KINASE; ACTIN ACTA2; GLYCOLYSIS; TARGET; IDENTIFICATION; PHOSPHATASE; ISOENZYMES; APOPTOSIS	Phosphoglycerate mutase 1 (PGAM1) is a glycolytic enzyme that coordinates glycolysis and biosynthesis to promote cancer growth via its metabolic activity. Here, we report the discovery of a non-metabolic function of PGAM1 in promoting cancer metastasis. A proteomic study identified a-smooth muscle actin (ACTA2) as a PGAM1-associated protein. PGAM1 modulated actin filaments assembly, cell motility and cancer cell migration via directly interacting with ACTA2, which was independent of its metabolic activity. The enzymatically inactive H186R mutant retained its association with ACTA2, whereas 201-210 amino acids deleted PGAM1 mutant lost the interaction with ACTA2 regardless of intact metabolic activity. Importantly, PGAM1 knockdown decreased metastatic potential of breast cancer cells in vivo and PGAM1 and ACTA2 were jointly associated with the prognosis of breast cancer patients. Together, this study provided the first evidence revealing a non-metabolic function of PGAM1 in promoting cell migration, and gained new insights into the role of PGAM1 in cancer progression.	[Zhang, D.; Jin, N.; Sun, W.; Li, X.; Xie, Z.; Qu, J.; Xu, J.; Yang, X.; Su, Y.; Tang, S.; Ding, J.; Huang, M.; Geng, M.] Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, State Key Lab Drug Res, Room 2431,555 Zuchongzhi Rd,Room 1320, Shanghai 201203, Peoples R China; [Liu, B.; Tan, M.] Chinese Acad Sci, Shanghai Inst Mat Med, Chem Prote Ctr, State Key Lab Drug Res, Shanghai, Peoples R China; [Han, H.; Chen, D.] Chinese Acad Sci, Shanghai Inst Mat Med, Lab Pharmaceut Anal, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Huang, M; Geng, M (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, State Key Lab Drug Res, Room 2431,555 Zuchongzhi Rd,Room 1320, Shanghai 201203, Peoples R China.	mhuang@simm.ac.cn; mygeng@simm.ac.cn	Tan, Minjia/C-4491-2014; huang, min/AAC-6965-2022	Tan, Minjia/0000-0002-6784-9653; 	China International Science and Technology Cooperation Program [2015DFM30040]; National Science and Technology Major Project [2015ZX09101009]; National Natural Science Foundation of China [81573464, 81321092]; NSFC-Shandong Joint Fund for Marine Science Research Centers [U1406402]	China International Science and Technology Cooperation Program; National Science and Technology Major Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC-Shandong Joint Fund for Marine Science Research Centers	This work was supported by the China International Science and Technology Cooperation Program (No. 2015DFM30040 to MH), the National Science and Technology Major Project (No. 2015ZX09101009 to MH), grants from the National Natural Science Foundation of China (No. 81573464 to MH, No. 81321092 to JD) and NSFC-Shandong Joint Fund for Marine Science Research Centers (No. U1406402 to JD)	Chen GA, 2003, P NATL ACAD SCI USA, V100, P13537, DOI 10.1073/pnas.2233850100; Croise Pauline, 2014, Small GTPases, V5, pe29469, DOI 10.4161/sgtp.29469; Durany N, 1997, BRIT J CANCER, V76, P1139, DOI 10.1038/bjc.1997.525; Durany N, 2000, BRIT J CANCER, V82, P20; Engel M, 2004, J BIOL CHEM, V279, P35803, DOI 10.1074/jbc.M402768200; Evans MJ, 2005, NAT BIOTECHNOL, V23, P1303, DOI 10.1038/nbt1149; Fothergill-Gilmore L. A., 1989, ADV ENZYMOLOGY RELAT, V62, P227; Fritz G, 2006, CURR CANCER DRUG TAR, V6, P1, DOI 10.2174/156800906775471752; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hallows WC, 2012, J BIOL CHEM, V287, P3850, DOI 10.1074/jbc.M111.317404; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hinz B, 2002, J CELL BIOL, V157, P657, DOI 10.1083/jcb.200201049; Hitosugi T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2759; Hitosugi T, 2012, CANCER CELL, V22, P585, DOI 10.1016/j.ccr.2012.09.020; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Hu H, 2016, CELL, V164, P433, DOI 10.1016/j.cell.2015.12.042; Kondoh H, 2005, CANCER RES, V65, P177; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Lambrechts A, 2004, INT J BIOCHEM CELL B, V36, P1890, DOI 10.1016/j.biocel.2004.01.024; Lee HW, 2013, CLIN CANCER RES, V19, P5879, DOI 10.1158/1078-0432.CCR-13-1181; Lee HW, 2012, INT J ONCOL, V41, P2013, DOI 10.3892/ijo.2012.1663; Li C, 2006, PROTEOMICS, V6, P547, DOI 10.1002/pmic.200500256; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006; Morisaki H, 2009, HUM MUTAT, V30, P1406, DOI 10.1002/humu.21081; Narayanan NK, 2004, CANCER DETECT PREV, V28, P443, DOI 10.1016/j.cdp.2004.08.009; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Ren FL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-81; Rockey DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077166; Thomasson MS, 2013, ANAL BIOCHEM, V443, P156, DOI 10.1016/j.ab.2013.09.008; Turhani D, 2006, ELECTROPHORESIS, V27, P1417, DOI 10.1002/elps.200500510; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Yeh CS, 2008, ONCOL REP, V19, P81	38	54	57	3	23	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 18	2017	36	20					2900	2909		10.1038/onc.2016.446	http://dx.doi.org/10.1038/onc.2016.446			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EV3ZM	27991922				2022-12-26	WOS:000401697800012
J	Braganza, A; Li, JF; Zeng, XM; Yates, NA; Dey, NB; Andrews, J; Clark, J; Zamani, L; Wang, XH; St Croix, C; O'Sullivan, R; Garcia-Exposito, L; Brodsky, JL; Sobol, RW				Braganza, Andrea; Li, Jianfeng; Zeng, Xuemei; Yates, Nathan A.; Dey, Nupur B.; Andrews, Joel; Clark, Jennifer; Zamani, Leila; Wang, Xiao-Hong; St Croix, Claudette; O'Sullivan, Roderick; Garcia-Exposito, Laura; Brodsky, Jeffrey L.; Sobol, Robert W.			UBE3B Is a Calmodulin-regulated, Mitochondrion-associated E3 Ubiquitin Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAUFMAN OCULOCEREBROFACIAL SYNDROME; BASE EXCISION-REPAIR; DNA-POLYMERASE-BETA; INTERACTING PROTEINS; IQ DOMAIN; PROTEASOME; FUSION; MITOPHAGY; SYSTEM; DEGRADATION	Recent genome-wide studies found that patients with hypotonia, developmental delay, intellectual disability, congenital anomalies, characteristic facial dysmorphic features, and low cholesterol levels suffer from Kaufman oculocerebrofacial syndrome (KOS, also reported as blepharophimosis-ptosis-intellectual disability syndrome). The primary cause of KOS is autosomal recessive mutations in the gene UBE3B. However, to date, there are no studies that have determined the cellular or enzymatic function of UBE3B. Here, we report that UBE3B is a mitochondrion-associated protein with homologous to the E6-AP C terminus (HECT) E3 ubiquitin ligase activity. Mutating the catalytic cysteine (C1036A) or deleting the entire HECT domain (amino acids 758-1068) results in loss of UBE3B's ubiquitylation activity. Knockdown of UBE3B in human cells induces changes in mitochondrial morphology and physiology, a decrease in mitochondrial volume, and a severe suppression of cellular proliferation. We also discovered that UBE3B interacts with calmodulin via its N-terminal isoleucine-glutamine (IQ) motif. Deletion of the IQ motif (amino acids 29-58) results in loss of calmodulin binding and a significant increase in the in vitro ubiquitylation activity of UBE3B. In addition, we found that changes in calcium levels in vitro disrupt the calmodulin-UBE3B interaction. These studies demonstrate that UBE3B is an E3 ubiquitin ligase and reveal that the enzyme is regulated by calmodulin. Furthermore, the modulation of UBE3B via calmodulin and calcium implicates a role for calcium signaling in mitochondrial protein ubiquitylation, protein turnover, and disease.	[Braganza, Andrea; O'Sullivan, Roderick; Garcia-Exposito, Laura; Sobol, Robert W.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Braganza, Andrea; Yates, Nathan A.; Wang, Xiao-Hong; O'Sullivan, Roderick; Garcia-Exposito, Laura; Sobol, Robert W.] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15213 USA; [Zeng, Xuemei; Yates, Nathan A.] Univ Pittsburgh, Sch Hlth Sci, Biomed Mass Spectrometry Ctr, Pittsburgh, PA 15213 USA; [St Croix, Claudette] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15213 USA; [Li, Jianfeng; Dey, Nupur B.; Andrews, Joel; Clark, Jennifer; Zamani, Leila; Sobol, Robert W.] Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, Mobile, AL 36604 USA; [Yates, Nathan A.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of South Alabama; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sobol, RW (corresponding author), Univ S Alabama, Mitchell Canc Inst, 1660 Springhill Ave, Mobile, AL 36604 USA.	rwsobol@health.southalabama.edu	St Croix, Claudette/AAA-3338-2022; Sobol, Robert W./E-4125-2013	Sobol, Robert W./0000-0001-7385-3563; Braganza Jardini, Andrea/0000-0002-7391-3658; Garcia Exposito, Laura/0000-0002-8172-7986	National Institutes of Health Cancer Center Support Grant [CA047904]; Abraham A. Mitchell Distinguished Investigator award; NATIONAL CANCER INSTITUTE [P30CA047904, R01CA148629, R01CA207209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R44GM087798, R43GM087798, R01GM075061] Funding Source: NIH RePORTER	National Institutes of Health Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abraham A. Mitchell Distinguished Investigator award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. David Svilar for valuable comments during the preparation of this manuscript and Dr. Qingming Fang, Dr. Elise Fouquerrel, Zhongxun Yu, Ashley Brown, Sandy Schamus, and Morgan Jessup for technical help. The recombinant human ubiquitin expression vector (wild type) was a generous gift from Drs. Fumika Koyano and Noriyuki Matsuda (Tokyo Metropolitan Institute of Medical Science). Support for the University of Pittsburgh Cancer Institute Lentiviral Facility, the Biomedical Mass Spectrometry Center, and the University of Pittsburgh Cancer Institute Cancer Proteomics Facility was provided by the National Institutes of Health Cancer Center Support Grant CA047904. Support for the MCI Gene Expression, Editing, and Discovery Facility was provided by funds from the Abraham A. Mitchell Distinguished Investigator award.	Basel-Vanagaite L, 2014, HUM GENET, V133, P939, DOI 10.1007/s00439-014-1436-2; Basel-Vanagaite L, 2012, AM J HUM GENET, V91, P998, DOI 10.1016/j.ajhg.2012.10.011; Benard G, 2009, SEMIN CELL DEV BIOL, V20, P365, DOI 10.1016/j.semcdb.2008.12.012; Budhidarmo R, 2012, TRENDS BIOCHEM SCI, V37, P58, DOI 10.1016/j.tibs.2011.11.001; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Chahrour MH, 2012, PLOS GENET, V8, P236, DOI 10.1371/journal.pgen.1002635; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chen BB, 2011, MOL CELL BIOL, V31, P1905, DOI 10.1128/MCB.00723-10; Cohen MMJ, 2008, MOL BIOL CELL, V19, P2457, DOI 10.1091/mbc.E08-02-0227; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Eng JK, 2013, PROTEOMICS, V13, P22, DOI 10.1002/pmic.201200439; Escobar-Henriques M, 2006, J CELL BIOL, V173, P645, DOI 10.1083/jcb.200512079; Fang QM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6513; Ferree AW, 2013, AUTOPHAGY, V9, P1887, DOI 10.4161/auto.26503; Findeisen F, 2013, J MOL BIOL, V425, P3217, DOI 10.1016/j.jmb.2013.06.024; Fischer C, 2013, PLANT CELL PHYSIOL, V54, P573, DOI 10.1093/pcp/pct021; Flex E, 2013, J MED GENET, V50, P493, DOI 10.1136/jmedgenet-2012-101405; Fouquerel E, 2014, CELL REP, V8, P1819, DOI 10.1016/j.celrep.2014.08.036; Franz A, 2015, CURR OPIN CELL BIOL, V37, P18, DOI 10.1016/j.ceb.2015.08.004; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Goellner EM, 2011, CANCER RES, V71, P2308, DOI 10.1158/0008-5472.CAN-10-3213; Gong TWL, 2003, GENOMICS, V82, P143, DOI 10.1016/S0888-7543(03)00111-3; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Hernandez G, 2013, AUTOPHAGY, V9, P1852, DOI 10.4161/auto.26501; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Huang H., 2012, ISPRS, V1-3, P377; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P5249, DOI 10.1073/pnas.92.11.5249-a; Jang DJ, 2011, MOL CELLS, V32, P511, DOI 10.1007/s10059-011-0109-4; Kawabe H, 2011, NAT REV NEUROSCI, V12, P251, DOI 10.1038/nrn3009; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim DI, 2014, P NATL ACAD SCI USA, V111, pE2453, DOI 10.1073/pnas.1406459111; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Laker RC, 2014, J BIOL CHEM, V289, P12005, DOI 10.1074/jbc.M113.530527; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li YY, 2015, CELL PROLIFERAT, V48, P338, DOI 10.1111/cpr.12184; Lu Q, 2015, NAT STRUCT MOL BIOL, V22, P81, DOI 10.1038/nsmb.2923; Miedel MT, 2014, METHODS, V68, P536, DOI 10.1016/j.ymeth.2014.04.019; Neutzner A, 2005, J BIOL CHEM, V280, P18598, DOI 10.1074/jbc.M500807200; Neutzner Albert, 2007, Novartis Found Symp, V287, P4; Neutzner A, 2008, ANN NY ACAD SCI, V1147, P242, DOI 10.1196/annals.1427.012; Paweletz CP, 2010, J PROTEOME RES, V9, P1392, DOI 10.1021/pr900925d; Pedurupillay CRJ, 2015, AM J MED GENET A, V167, P657, DOI 10.1002/ajmg.a.36944; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Schmidt M, 2014, BBA-MOL CELL RES, V1843, P13, DOI 10.1016/j.bbamcr.2013.08.012; Shirihai OS, 2015, CIRC RES, V116, P1835, DOI 10.1161/CIRCRESAHA.116.306374; Svilar D, 2012, MOL CANCER RES, V10, P1580, DOI 10.1158/1541-7786.MCR-12-0168; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tang JB, 2010, MOL CANCER RES, V8, P67, DOI 10.1158/1541-7786.MCR-09-0411; Theivanthiran B, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005903; Trivedi RN, 2008, MOL PHARMACOL, V74, P505, DOI 10.1124/mol.108.045112; Varshavsky A, 2012, ANNU REV BIOCHEM, V81, P167, DOI 10.1146/annurev-biochem-051910-094049; Venhoranta H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-890; Wang J, 2010, J BIOL CHEM, V285, P12279, DOI 10.1074/jbc.M109.086405; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; Wen JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115622; Wenzel DM, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-24; Wiener MC, 2004, ANAL CHEM, V76, P6085, DOI 10.1021/ac0493875; Xu S, 2011, MOL BIOL CELL, V22, P291, DOI 10.1091/mbc.E10-09-0748; Xu S, 2016, MOL BIOL CELL, V27, P349, DOI 10.1091/mbc.E15-09-0678	63	19	19	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2470	2484		10.1074/jbc.M116.766824	http://dx.doi.org/10.1074/jbc.M116.766824			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28003368	Green Published, hybrid			2022-12-26	WOS:000395530300034
J	Srivastava, S; Katorcha, E; Daus, ML; Lasch, P; Beekes, M; Baskakov, IV				Srivastava, Saurabh; Katorcha, Elizaveta; Daus, Martin L.; Lasch, Peter; Beekes, Michael; Baskakov, Ilia V.			Sialylation Controls Prion Fate in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLLICULAR DENDRITIC CELLS; SIALIC ACIDS; MASS-SPECTROMETRY; LYMPHOID-TISSUES; SCRAPIE AGENT; FACTOR-H; PROTEIN; INFECTIVITY; CLEARANCE; GLYCANS	Prions or PrPSc are proteinaceous infectious agents that consist of misfolded, self-replicating states of a sialoglycoprotein called the prion protein or PrPC. The current work tests a new hypothesis that sialylation determines the fate of prions in an organism. To begin, we produced control PrPSc from PrPC using protein misfolding cyclic amplification with beads (PMCAb), and also generated PrPSc with reduced sialylation levels using the same method but with partially desialylated PrPC as a substrate (dsPMCAb). Syrian hamsters were inoculated intraperitoneally with brain-derived PrPSc or PrPSc produced in PMCAb or dsPMCAb and then monitored for disease. Animals inoculated with brain-or PMCAb-derived PrPSc developed prion disease, whereas administration of dsPMCAb-derived PrPSc with reduced sialylation did not cause prion disease. Animals inoculated with dsPMCAb-derived material were not subclinical carriers of scrapie, as no PrPSc was detected in brains or spleen of these animals by either Western blotting or after amplification by serial PMCAb. In subsequent experiments, trafficking of brain-, PMCAb-, and dsPMCAb-derived PrPSc to secondary lymphoid organs was monitored in wild type mice. PrPSc sialylation was found to be critical for effective trafficking of PrPSc to secondary lymphoid organs. By 6 hours after inoculation, brain-and PMCAb- derived PrPSc were found in spleen and lymph nodes, whereas dsPMCAb-derived PrPSc was found predominantly in liver. This study demonstrates that the outcome of prion transmission to a wild type host is determined by the sialylation status of the inoculated PrPSc. Furthermore, this work suggests that the sialylation status of PrPSc plays an important role in prion lymphotropism.	[Srivastava, Saurabh; Katorcha, Elizaveta; Baskakov, Ilia V.] Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, 111 S Penn St, Baltimore, MD 21201 USA; [Srivastava, Saurabh; Katorcha, Elizaveta; Baskakov, Ilia V.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Daus, Martin L.; Lasch, Peter; Beekes, Michael] Robert Koch Inst, Ctr Biol Threats & Special Pathogens, D-13353 Berlin, Germany	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Robert Koch Institute	Baskakov, IV (corresponding author), Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, 111 S Penn St, Baltimore, MD 21201 USA.	Baskakov@umaryland.edu	Beekes, Michael/S-1975-2018; Srivastava, Saurabh/L-1188-2017	Beekes, Michael/0000-0002-6454-6657; Srivastava, Saurabh/0000-0003-3159-7826; Lasch, Peter/0000-0001-6193-3144	National Institutes of Health [R01 NS045585]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant R01 NS045585 (to I.V.B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguzzi A, 2013, NAT REV IMMUNOL, V13, P888, DOI 10.1038/nri3553; AMINOFF D, 1977, P NATL ACAD SCI USA, V74, P1521, DOI 10.1073/pnas.74.4.1521; Baskakov IV, 2007, BBA-MOL BASIS DIS, V1772, P692, DOI 10.1016/j.bbadis.2006.07.007; Baskakov IV, 2016, FRONT NEUROSCI-SWITZ, V10, DOI [10.3389/fnins.2076.00358, 10.3389/fnins.2016.00358]; Beringue V, 2000, J PATHOL, V190, P495, DOI 10.1002/(SICI)1096-9896(200003)190:4&lt;495::AID-PATH535&gt;3.0.CO;2-T; Beringue V, 2012, SCIENCE, V335, P472, DOI 10.1126/science.1215659; Boerner S, 2013, LAB ANIM-UK, V47, P106, DOI 10.1177/0023677213476856; BOLTON DC, 1985, J VIROL, V53, P596, DOI 10.1128/JVI.53.2.596-606.1985; Brown GC, 2014, NAT REV NEUROSCI, V15, P209, DOI 10.1038/nrn3710; Brown KL, 1999, NAT MED, V5, P1308, DOI 10.1038/15264; Brown P, 1991, Curr Top Microbiol Immunol, V172, P1; Cao HA, 2011, IMMUNOLOGY, V132, P18, DOI 10.1111/j.1365-2567.2010.03368.x; Carlin AF, 2009, BLOOD, V113, P3333, DOI 10.1182/blood-2008-11-187302; CARP RI, 1981, INTERVIROLOGY, V16, P8, DOI 10.1159/000149241; Castro-Seoane R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002538; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; Daus ML, 2013, J BIOL CHEM, V288, P35068, DOI 10.1074/jbc.M113.497131; DINI L, 1992, FEBS LETT, V296, P174, DOI 10.1016/0014-5793(92)80373-O; ENDO T, 1989, BIOCHEMISTRY-US, V28, P8380, DOI 10.1021/bi00447a017; Glatzel M, 2001, NEURON, V31, P25, DOI 10.1016/S0896-6273(01)00331-2; Gonzalez-Montalban N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041210; Gonzalez-Montalban N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001277; Halliez S, 2014, J VIROL, V88, P8678, DOI 10.1128/JVI.01118-14; Huang FP, 2002, J GEN VIROL, V83, P267, DOI 10.1099/0022-1317-83-1-267; Jansen AJG, 2012, BLOOD, V119, P1263, DOI 10.1182/blood-2011-05-355628; Jin JK, 2007, NEUROSCI LETT, V420, P138, DOI 10.1016/j.neulet.2007.04.069; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kajander T, 2011, P NATL ACAD SCI USA, V108, P2897, DOI 10.1073/pnas.1017087108; Katorcha E, 2016, SCI REP-UK, V6, DOI 10.1038/srep33119; Katorcha E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143218; Katorcha E, 2015, SCI REP-UK, V5, DOI 10.1038/srep16912; Katorcha E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004366; KIMBERLIN RH, 1986, J GEN VIROL, V67, P255, DOI 10.1099/0022-1317-67-2-255; Klingeborn M, 2011, P NATL ACAD SCI USA, V108, pE1244, DOI 10.1073/pnas.1111255108; Kujala P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002449; Lasch P., 2015, ENCY ANAL CHEM, P1, DOI DOI 10.1002/9780470027318.A0117.PUB2; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Mabbott NA, 2000, NAT MED, V6, P719, DOI 10.1038/77401; Mabbott NA, 2012, PRION, V6, P322, DOI 10.4161/pri.20676; Makarava N, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0248-5; Makarava N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1730; Makarava N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002419; McCulloch L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002402; Michel B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00440; Miller MW, 2004, CURR TOP MICROBIOL, V284, P193; Mok SWF, 2007, BIOCHEM BIOPH RES CO, V359, P672, DOI 10.1016/j.bbrc.2007.05.163; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; O'Sullivan JM, 2016, J THROMB HAEMOST, V14, P2446, DOI 10.1111/jth.13537; Pangburn MK, 2000, J IMMUNOL, V164, P4742, DOI 10.4049/jimmunol.164.9.4742; Prinz M, 2003, NATURE, V425, P957, DOI 10.1038/nature02072; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Rudd PM, 1999, P NATL ACAD SCI USA, V96, P13044, DOI 10.1073/pnas.96.23.13044; Sassa Y, 2010, MICROBIOL IMMUNOL, V54, P763, DOI 10.1111/j.1348-0421.2010.00272.x; Sassa Y, 2010, VET IMMUNOL IMMUNOP, V133, P33, DOI 10.1016/j.vetimm.2009.06.018; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Spassov S, 2006, BBA-GEN SUBJECTS, V1760, P1138, DOI 10.1016/j.bbagen.2006.02.018; Srivastava S, 2015, P NATL ACAD SCI USA, V112, pE6654, DOI 10.1073/pnas.1517993112; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; Stimson E, 1999, BIOCHEMISTRY-US, V38, P4885, DOI 10.1021/bi982330q; Takakura I, 2011, AM J PATHOL, V179, P1301, DOI 10.1016/j.ajpath.2011.05.058; Tanaka K, 2010, ANGEW CHEM INT EDIT, V49, P8195, DOI 10.1002/anie.201000892; TURK E, 1988, EUR J BIOCHEM, V176, P21, DOI 10.1111/j.1432-1033.1988.tb14246.x; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Varki A, 2010, P NATL ACAD SCI USA, V107, P8939, DOI 10.1073/pnas.0914634107; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; Walker LC, 2015, ANNU REV NEUROSCI, V38, P87, DOI 10.1146/annurev-neuro-071714-033828; Wang SJ, 2015, TUMOR BIOL, V36, P885, DOI 10.1007/s13277-014-2638-x; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967	70	24	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2359	2368		10.1074/jbc.M116.768010	http://dx.doi.org/10.1074/jbc.M116.768010			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	27998976	Green Published, hybrid			2022-12-26	WOS:000395530300026
J	De Beer, CJ; Venter, GJ; Vreysen, MJB				De Beer, Chantel J.; Venter, Gert J.; Vreysen, Marc J. B.			Improving the Diet for the Rearing of Glossina brevipalpis Newstead and Glossina austeni Newstead: Blood Source and Collection - Processing - Feeding Procedures	PLOS ONE			English	Article							TSETSE-FLIES GLOSSINA; GORGING RESPONSE; DIPTERA; ATP; MOSQUITOS; PALPALIS; AFRICA	One of the challenges to maintain tsetse fly (Diptera: Glossinidae) colonies is the sustainable supply of high quality blood meals. The effect of using anticoagulants during collection of the blood, the addition of phagostimulants to the blood meals as well as using mixtures of bovine and porcine blood in different proportions for feeding on colony productivity was assessed. Defibrinated bovine blood was found to be suitable to maintain both the Glossina brevipalpis Newstead and Glossina austeni Newstead colonies. Blood collected with the anticoagulants sodium citrate, citric sodium combination, citrate phosphate dextrose adenine and citric acid did not affect colony performance of both species. Defibrinated bovine and porcine blood in a 1:1 ratio or the feeding of either bovine or porcine blood on alternating days improved pupae production of G. austeni and can be used to enhance colony growth. Bovine blood is appropriate to maintain G. brevipalpis colonies, however, feeding either bovine or porcine blood on alternating days did improve productivity. Adding the phagostimulants inosine tri-phosphate, cytosine mono-phosphate and guanosine mono-phosphate to the blood at a concentration of 10(-4) M improved pupae production of the G. brevipalpis colony. The addition of adenosine tri-phosphate and inosine tri-phosphate improved the performance of the G. austeni colony. Decisions on the most suitable rearing diet and feeding protocols will not only depend on the biological requirements of the species but also on the continuous supply of a suitable blood source that can be collected and processed in a cost-effective way.	[De Beer, Chantel J.; Venter, Gert J.] ARC OVI, Parasites Vectors & Vectorborne Dis, Pretoria, South Africa; [De Beer, Chantel J.] Univ Free State, Fac Nat & Agr Sci, Dept Zool & Entomol, Bloemfontein, South Africa; [Venter, Gert J.] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, ZA-0002 Pretoria, South Africa; [Vreysen, Marc J. B.] Insect Pest Control Lab, Joint FAO IAEA Div Nucl Tech Food & Agr, Bloemfontein, South Africa	University of the Free State; University of Pretoria	De Beer, CJ (corresponding author), ARC OVI, Parasites Vectors & Vectorborne Dis, Pretoria, South Africa.; De Beer, CJ (corresponding author), Univ Free State, Fac Nat & Agr Sci, Dept Zool & Entomol, Bloemfontein, South Africa.	debeerc@arc.agric.za		de Beer, Chantel/0000-0002-6244-4905	Agricultural Research Council-Onderstepoort Veterinary Institute [000773]; Joint Food and Agriculture Organization / International Atomic Energy Agency Division of Nuclear Techniques in Food and Agriculture Department of Technical Cooperation of the International Atomic Energy Agency [12618/R0/RBF, RAF 5069]	Agricultural Research Council-Onderstepoort Veterinary Institute; Joint Food and Agriculture Organization / International Atomic Energy Agency Division of Nuclear Techniques in Food and Agriculture Department of Technical Cooperation of the International Atomic Energy Agency	This work was supported by the National Assets (000773) at the Agricultural Research Council-Onderstepoort Veterinary Institute and the Joint Food and Agriculture Organization / International Atomic Energy Agency Division of Nuclear Techniques in Food and Agriculture under the coordinated research project (CRP) 12618/R0/RBF Department of Technical Cooperation of the International Atomic Energy Agency under project RAF 5069. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, GRAPHPAD INST VERS 3; Bagnall RJ, 1993, P 24 M SARCCUS STAND, P41; BAUER B, 1976, B ENTOMOL RES, V65, P563, DOI 10.1017/S0007485300006246; Bourtzis K, 2016, ACTA TROP, V157, P115, DOI 10.1016/j.actatropica.2016.01.009; Clausen PH, 1998, MED VET ENTOMOL, V12, P169, DOI 10.1046/j.1365-2915.1998.00097.x; de Beer CJ, 2016, ONDERSTEPOORT J VET, V83, DOI 10.4102/ojvr.v83i1.1172; De Beer CJ, 2012, IAEA TECDOC, P5; DEVI S G, 1985, Proceedings of the Indian National Science Academy Part B Biological Sciences, V51, P566; Du Toit R., 1954, Onderstepoort Journal of Veterinary Research, V26, P317; Feldmann U., 1994, TECHNIQUES INSECT RE, VSecond, P13; Feldmann U, 1994, TECHNIQUES INSECT RE, P449; Food and Agriculture Organization of the United Nations/International Atomic Energy Agency, 2006, FAO IAEA STAND OP PR; GALUN R, 1985, PHYSIOL ENTOMOL, V10, P145, DOI 10.1111/j.1365-3032.1985.tb00029.x; GALUN R, 1988, EXPERIENTIA, V44, P800, DOI 10.1007/BF01959172; GALUN R, 1987, INSECT SCI APPL, V8, P623, DOI 10.1017/S1742758400022700; GALUN R, 1988, PHYSIOL ENTOMOL, V13, P419, DOI 10.1111/j.1365-3032.1988.tb01125.x; GALUN R, 1993, J MED ENTOMOL, V30, P513, DOI 10.1093/jmedent/30.3.513; GALUN R, 1970, T ROY SOC TROP MED H, V64, P171, DOI 10.1016/0035-9203(70)90225-7; GEE JD, 1977, J INSECT PHYSIOL, V23, P137, DOI 10.1016/0022-1910(77)90119-6; Gooding R. H., 1997, The molecular biology of insect disease vectors: a methods manual., P41; KABAYO JP, 1986, J INSECT PHYSIOL, V32, P543, DOI 10.1016/0022-1910(86)90069-7; KABAYO JP, 1988, EXPERIENTIA, V44, P802, DOI 10.1007/BF01959174; Kappmeier Green K., 2002, THESIS; Klassen W, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P3, DOI 10.1007/1-4020-4051-2_1; LANGLEY PA, 1972, B ENTOMOL RES, V62, P215, DOI 10.1017/S0007485300047672; Mamabolo MV, 2009, PARASITOLOGY, V136, P425, DOI 10.1017/S0031182009005587; MELLANBY HELEN, 1937, PARASITOLOGY, V29, P131, DOI 10.1017/S0031182000026263; MEWS AR, 1976, B ENTOMOL RES, V65, P631, DOI 10.1017/S0007485300006325; MOLOO SK, 1988, MED VET ENTOMOL, V2, P201, DOI 10.1111/j.1365-2915.1988.tb00074.x; MOLOO SK, 1993, INSECT SCI APPL, V14, P511, DOI 10.1017/S1742758400014211; Motloang M, 2012, ONDERSTEPOORT J VET, V79, DOI 10.4102/ojvr.v79i1.353; Motloang MY, 2014, ONDERSTEPOORT J VET, V81; Parker AG, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P209, DOI 10.1007/1-4020-4051-2_8; Robinson AS, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P95, DOI 10.1007/1-4020-4051-2_4; Romero A, 2014, J EXP BIOL, V217, P552, DOI 10.1242/jeb.096727; Snedecor GW, 1980, STAT METHODS, V7th; Tarimo C.S., 1988, P271; Vreysen M.J.B., 2007, AREA WIDE CONTROL IN, P308; VSN International, 2012, GENSTAT WINDOWS; WARD R A, 1970, Bulletin of the Entomological Society of America, V16, P111; WETZEL H, 1978, TROPENMED PARASITOL, V29, P239	41	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168799	10.1371/journal.pone.0168799	http://dx.doi.org/10.1371/journal.pone.0168799			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006007	Green Submitted, Green Published, gold			2022-12-26	WOS:000392843200096
J	Lamprianou, S; Gysemans, C; Saab, JB; Pontes, H; Mathieu, C; Meda, P				Lamprianou, Smaragda; Gysemans, Conny; Saab, Joanna Bou; Pontes, Helena; Mathieu, Chantal; Meda, Paolo			Glibenclamide Prevents Diabetes in NOD Mice	PLoS One			English	Article							PANCREATIC BETA-CELLS; PERIPHERAL-TISSUES; BB RAT; MOUSE; APOPTOSIS; CHANNELS; RECEPTOR; SULFONYLUREAS; EXPRESSION; MANAGEMENT	Previous work has revealed that Cx36, the sole connexin expressed in the insulin-producing beta cells, enhances the secretion of insulin, and promotes the resistance of beta cells against pro-inflammatory cytokines. In parallel, the anti-diabetic sulphonylurea glibenclamide was shown to promote the assembly and function of Cx36 channels. Here, we assessed whether glibenclamide could protect the insulin-producing cells against conditions mimicking those expected at the onset of type 1 diabetes. We found that the drug 1) protected in vitro the mouse MIN6 cells from the apoptosis and loss of Cx36, which are induced by Th1 cytokines; 2) prevented the development of hyperglycemia as well as the loss of beta cells and Cx36, which rapidly develop with aging in untreated NOD mice; 3) modified the proportion of effector CD4(+) and CD8(+) T cells in pancreatic draining lymph nodes. The data imply that an early glibenclamide treatment may help protecting beta cells against the autoimmune attack, which triggers the development of type 1 diabetes.	[Lamprianou, Smaragda; Saab, Joanna Bou; Pontes, Helena; Meda, Paolo] Univ Geneva, Dept Cell Physiol & Metab, Geneva, Switzerland; [Gysemans, Conny; Mathieu, Chantal] Katholieke Univ Leuven KULEUVEN, Lab Clin & Expt Endocrinol, Leuven, Belgium	University of Geneva; KU Leuven	Lamprianou, S (corresponding author), Univ Geneva, Dept Cell Physiol & Metab, Geneva, Switzerland.	Smaragda.Lamprianou@unige.ch	mathieu, chantal/ABD-5505-2021	mathieu, chantal/0000-0002-4055-5233; gysemans, conny/0000-0003-3559-6089	Swiss National Science Foundation [310000-141162]; Juvenile Diabetes Research Foundation [40-2011-11]; European Union [IMIDIA C2008-T7]; KUL [GOA 2014/010]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Union(European Commission); KUL	The Geneva team was supported by grants from the Swiss National Science Foundation (310000-141162), the Juvenile Diabetes Research Foundation (40-2011-11), and the European Union (IMIDIA C2008-T7). The Leuven team is supported by a grant from the KUL (GOA 2014/010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allagnat F, 2013, CELL DEATH DIFFER, V20, P1742, DOI 10.1038/cdd.2013.134; Ansar MM, 2006, NITRIC OXIDE-BIOL CH, V14, P39, DOI 10.1016/j.niox.2005.09.002; Ashcroft FM, 2013, NAT REV ENDOCRINOL, V9, P660, DOI 10.1038/nrendo.2013.166; Bavamian S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041535; Berggren EK, 2013, CLIN OBSTET GYNECOL, V56, P827, DOI 10.1097/GRF.0b013e3182a8e0a5; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; Chahal A, 2011, COMP SAFETY EFFICACY; Charpantier E, 2007, DIABETOLOGIA, V50, P2332, DOI 10.1007/s00125-007-0807-9; Cigliola V, 2013, DIABETES RES CLIN PR, V99, P250, DOI 10.1016/j.diabres.2012.10.016; David R, 2009, BLOOD, V113, P3696, DOI 10.1182/blood-2008-09-176511; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Grishman EK, 2012, PEDIATR RES, V71, P626, DOI 10.1038/pr.2012.24; HOSSZUFALUSI N, 1994, J AUTOIMMUN, V7, P753, DOI 10.1006/jaut.1994.1059; Jayasimhan A, 2014, CLIN SCI, V126, P1, DOI 10.1042/CS20120627; Jorns A, 2014, DIABETOLOGIA, V57, P512, DOI 10.1007/s00125-013-3125-4; Klee P, 2011, J CLIN INVEST, V121, P4870, DOI 10.1172/JCI40509; Koh GCKW, 2011, CLIN INFECT DIS, V52, P717, DOI 10.1093/cid/ciq192; Kwon MJ, 2013, KOREAN J INTERN MED, V28, P339, DOI 10.3904/kjim.2013.28.3.339; Larsson HE, 2014, PEDIATR DIABETES, V15, P118, DOI 10.1111/pedi.12066; MEDA P, 1979, J CELL BIOL, V82, P441, DOI 10.1083/jcb.82.2.441; MEDA P, 1980, SCIENCE, V209, P1026, DOI 10.1126/science.6773144; Radenkovic M, 2016, CLIN EXP IMMUNOL, V186, P46, DOI 10.1111/cei.12834; Regnell SE, 2013, DIABETIC MED, V30, P155, DOI 10.1111/dme.12099; Rendell M, 2004, DRUGS, V64, P1339, DOI 10.2165/00003495-200464120-00006; Sawada F, 2008, METABOLISM, V57, P1038, DOI 10.1016/j.metabol.2008.01.038; Serre-Beinier V, 2009, HUM MOL GENET, V18, P428, DOI 10.1093/hmg/ddn370; TOCHINO Y, 1988, CRIT REV IMMUNOL, V8, P49; WILLIAMS AJK, 1993, DIABETOLOGIA, V36, P487, DOI 10.1007/BF02743262; Yu JY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7074	30	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168839	10.1371/journal.pone.0168839	http://dx.doi.org/10.1371/journal.pone.0168839			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006000	Green Submitted, gold, Green Published			2022-12-26	WOS:000392843200101
J	Yabuta, S; Urata, M; Kun, RYW; Masaki, M; Shidoji, Y				Yabuta, Suemi; Urata, Masanori; Kun, Roseline Yap Wai; Masaki, Motofumi; Shidoji, Yoshihiro			Common SNP rs6564851 in the BCO1 Gene Affects the Circulating Levels of beta-Carotene and the Daily Intake of Carotenoids in Healthy Japanese Women	PLoS One			English	Article							VITAMIN-A PRODUCTION; PLASMA CAROTENOIDS; ALPHA-TOCOPHEROL; SERUM; ASSOCIATIONS; BIOMARKERS; RETINOL; CANCER; POLYMORPHISMS; METABOLISM	The circulating levels of beta-carotene are modulated not only by sex, but also by autosomal gene variations and fruit intake. The aim of this study was to investigate the interactions between beta-carotene metabolism-related gene single nucleotide polymorphisms (SNPs; genetic factors) and nutrient intake (environmental factors) relating to their effects on circulating beta-carotene. The serum concentrations of beta-carotene and the habitual food intake of 92 healthy Japanese adults were examined. All subjects were genotyped for three common SNPs: rs6564851 in the beta-carotene 15,15'-oxygenase 1 (BCO1) gene, rs2278986 in the scavenger receptor class B member 1 (SCARB1) gene and rs362090 in the intestine-specific homeobox (ISX) gene. Univariate analysis revealed that the circulating beta-carotene levels were significantly higher in rs6564851 GG homozygotes (p = 0.003). Additionally, the daily intake of beta-cryptoxanthin was positively associated with the circulating beta-carotene levels in female GG homozygotes of rs6564851 (p = 0.023), and the daily intake of alpha- and beta-carotenes, and beta-cryptoxanthin was significantly lower in female rs6564851 T allele carries than in female GG homozygotes (p = 0.009, 0.008, 0.009, respectively). The present study apparently indicates that higher circulating beta-carotene levels in female rs6564851 GG homozygotes depend on carotenoid intake.	[Yabuta, Suemi; Urata, Masanori; Shidoji, Yoshihiro] Nagasaki Univ, Grad Sch Human Hlth Sci, Mol & Cellular Biol, Nagasaki, Japan; [Kun, Roseline Yap Wai; Masaki, Motofumi] Nagasaki Univ, Grad Sch Human Hlth Sci, Nutr Epidemiol, Nagasaki, Japan	Nagasaki University; Nagasaki University	Shidoji, Y (corresponding author), Nagasaki Univ, Grad Sch Human Hlth Sci, Mol & Cellular Biol, Nagasaki, Japan.	shidoji@sun.ac.jp			University of Nagasaki [B-3]	University of Nagasaki	YS received a research grant B-3 from the University of Nagasaki (sun.ac.jp). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Delaimy WK, 2005, EUR J CLIN NUTR, V59, P1397, DOI 10.1038/sj.ejcn.1602253; Al-Delaimy WK, 2005, EUR J CLIN NUTR, V59, P1387, DOI 10.1038/sj.ejcn.1602252; Amengual J, 2013, J BIOL CHEM, V288, P34081, DOI 10.1074/jbc.M113.501049; Brady WE, 1996, J NUTR, V126, P129, DOI 10.1093/jn/126.1.129; Burri BJ, 2015, J SCI FOOD AGR, V95, P1786, DOI 10.1002/jsfa.6942; CAMPBELL DR, 1994, CANCER EPIDEM BIOMAR, V3, P493; CUTLER RG, 1984, P NATL ACAD SCI-BIOL, V81, P7627, DOI 10.1073/pnas.81.23.7627; de Araujo IE, 2008, NEURON, V57, P930, DOI 10.1016/j.neuron.2008.01.032; dela Sena C, 2013, J BIOL CHEM, V288, P37094, DOI 10.1074/jbc.M113.507160; Feigl B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089069; Ferrucci L, 2009, AM J HUM GENET, V84, P123, DOI 10.1016/j.ajhg.2008.12.019; Ford ES, 2003, EUR J CLIN NUTR, V57, P1157, DOI 10.1038/sj.ejcn.1601667; Gruber M, 2004, J NUTR, V134, P2387, DOI 10.1093/jn/134.9.2387; Higuchi K, 2015, NUTRITION, V31, P975, DOI 10.1016/j.nut.2015.02.015; Jansen MCJF, 2004, EUR J CLIN NUTR, V58, P1386, DOI 10.1038/sj.ejcn.1601981; Kolodziejczyk JK, 2012, WOMEN HEALTH, V52, P731, DOI 10.1080/03630242.2012.728189; Kritchevsky SB, 2000, AM J EPIDEMIOL, V152, P1065, DOI 10.1093/aje/152.11.1065; Leung WC, 2009, FASEB J, V23, P1041, DOI 10.1096/fj.08-121962; Lietz G, 2012, J NUTR, V142, p161S, DOI 10.3945/jn.111.140756; Lobo GP, 2013, J BIOL CHEM, V288, P9017, DOI 10.1074/jbc.M112.444240; Lobo GP, 2010, FASEB J, V24, P1656, DOI 10.1096/fj.09-150995; PARKER RS, 1989, J NUTR, V119, P101, DOI 10.1093/jn/119.1.101; Ryden M, 2012, J INTERN MED, V272, P371, DOI [10.1111/j.1365-2796.2012.2534.x, 10.1111/j.1365-2796.2012.2534x.x]; Sclafani A, 2012, AM J PHYSIOL-REG I, V302, pR1119, DOI 10.1152/ajpregu.00038.2012; Siegel EM, 2004, CANCER EPIDEM BIOMAR, V13, P1693; Takahashi K., 2001, Japanese Journal of Nutrition, V59, P221; TANGNEY CC, 1987, AM J CLIN NUTR, V45, P764, DOI 10.1093/ajcn/45.4.764; Wang L, 2008, AM J CLIN NUTR, V88, P747, DOI 10.1093/ajcn/88.3.747; West M, 2009, J CLIN ENDOCR METAB, V94, P1451, DOI 10.1210/jc.2008-1223; Widjaja-Adhi MAK, 2015, HUM MOL GENET, V24, P3206, DOI 10.1093/hmg/ddv072; Xiang J, 2008, ASIAN PAC J CANCER P, V9, P413; Yabuta S, 2016, J NUTR HEALTH AGING, V20, P267, DOI 10.1007/s12603-015-0577-x	32	21	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168857	10.1371/journal.pone.0168857	http://dx.doi.org/10.1371/journal.pone.0168857			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005968	gold, Green Submitted, Green Published			2022-12-26	WOS:000392843200106
J	Hetland, G; Eide, DM; Tangen, JM; Haugen, MH; Mirlashari, MR; Paulsen, JE				Hetland, Geir; Eide, Dag M.; Tangen, Jon M.; Haugen, Mads H.; Mirlashari, Mohammad R.; Paulsen, Jan E.			The Agaricus blazei-Based Mushroom Extract, Andosan (TM), Protects against Intestinal Tumorigenesis in the A/J Min/ plus Mouse	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; BLOOD EX-VIVO; MEDICINAL MUSHROOM; COLORECTAL-CANCER; LEGUMAIN EXPRESSION; ANTITUMOR-ACTIVITY; GRIFOLA-FRONDOSA; FRUITING BODIES; GENE-EXPRESSION; BREAST-CANCER	Background The novel A/J Min/+ mouse, which is a model for human Familial Adenomatous Polyposis (FAP), develops spontaneously multiple adenocarcinomas in the colon as well as in the small intestine. Agaricus blazei Murill (AbM) is an edible Basidiomycetes mushroom that has been used in traditional medicine against cancer and other diseases. The mushroom contains immunomodulating 8-glucans and is shown to have antitumor effects in murine cancer models. Andosan (TM) is a water extract based on AbM (82%), but it also contains the medicinal Basidiomycetes mushrooms Hericeum erinaceus and Grifola frondosa. Methods and findings Tap water with 10% Andosan (TM) was provided as the only drinking water for 15 or 22 weeks to AM Min/+ mice and A/J wild-type mice (one single-nucleotide polymorphism (SNP) difference), which then were exsanguinated and their intestines preserved in formaldehyde and the serum frozen. The intestines were examined blindly by microscopy and also stained for the tumor-associated protease, legumain. Serum cytokines (pro- and anti-inflammatory, Th1-, Th2 -and Th17 type) were measured by Luminex multiplex analysis. Andosan (TM) treated AM Min/+ mice had a significantly lower number of adenocarcinomas in the intestines, as well as a 60% significantly reduced intestinal tumor load (number of tumors x size) compared to control. There was also reduced legumain expression in intestines from Andosan (TM) treated animals. Moreover, Andosan (TM) had a significant cytotoxic effect correlating with apoptosis on the human cancer colon cell line, Caco-2, in vitro. When examining serum from both AM Min/+ and wild type mice, there was a significant increase in anti-tumor Th1 type and pro-inflammatory cytokines in the Andosan (TM) treated mice. Conclusions The results from this mouse model for colorectal cancer shows significant protection of orally administered Andosan (TM) against development of intestinal cancer. This is supported by the finding of less legumain in intestines of Andosan (TM) treated mice and increased systemic Th1 cytokine response. The mechanism is probably both immuno-modulatory and growth inhibition of tumor cells by induction of apoptosis.	[Hetland, Geir; Mirlashari, Mohammad R.] Oslo Univ Hosp, Dept Immunol, Oslo, Norway; [Hetland, Geir; Tangen, Jon M.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Eide, Dag M.] Norwegian Inst Publ Hlth, Dept Chem & Radiat, Oslo, Norway; [Tangen, Jon M.] Oslo Univ Hosp, Dept Acute Med, Oslo, Norway; [Tangen, Jon M.] Oslo Univ Hosp, Natl CBRNE Med & Advisory Ctr Norway, Oslo, Norway; [Haugen, Mads H.] Norwegian Radium Hosp, Oslo Univ Hosp, Dept Tumor Biol, Inst Canc Res, Oslo, Norway; [Paulsen, Jan E.] Norwegian Univ Life Sci, Dept Food Safety & Infect Biol, Oslo, Norway	University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH); University of Oslo; University of Oslo; University of Oslo; Norwegian University of Life Sciences	Hetland, G (corresponding author), Oslo Univ Hosp, Dept Immunol, Oslo, Norway.; Hetland, G (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.	geir.hetland@medisin.uio.no			Norwegian company Immunopharma	Norwegian company Immunopharma	The authors received no specific funding for this work, except for Andosan (TM) that was provided free of charge for the study from the Norwegian company Immunopharma.	Bernardshaw S, 2006, SHOCK, V25, P420, DOI 10.1097/01.shk.0000209526.58614.92; Bernardshaw S, 2007, APMIS, V115, P719, DOI 10.1111/j.1600-0463.2007.apm_619.x; Berven L, 2015, J MED FOOD, V18, P429, DOI 10.1089/jmf.2014.0018; Chan CB, 2009, P NATL ACAD SCI USA, V106, P468, DOI 10.1073/pnas.0809824105; De Jesus M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091002; Ellertsen Linda K, 2009, Clin Mol Allergy, V7, P6, DOI 10.1186/1476-7961-7-6; Ellertsen LK, 2006, INT IMMUNOPHARMACOL, V6, P133, DOI 10.1016/j.intimp.2005.07.007; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Fodde R, 2002, EUR J CANCER, V38, P867, DOI 10.1016/S0959-8049(02)00040-0; Fodde R, 2001, TRENDS MOL MED, V7, P369, DOI 10.1016/S1471-4914(01)02050-0; Forland DT, 2011, SCAND J IMMUNOL, V73, P66, DOI 10.1111/j.1365-3083.2010.02477.x; Forland DT, 2010, CYTOKINE, V49, P245, DOI 10.1016/j.cyto.2009.09.002; Gao L, 2007, BRAZ J MED BIOL RES, V40, P1545, DOI 10.1590/S0100-879X2007001100015; Gatner BN, 2003, J EXP MED, V197, P1107, DOI [10.1084/jem.20021787, DOI 10.1084/JEM.20021787]; Gawenda J, 2007, BREAST CANCER RES TR, V102, P1, DOI 10.1007/s10549-006-9311-z; Grinde B, 2006, INT IMMUNOPHARMACOL, V6, P1311, DOI 10.1016/j.intimp.2006.04.005; Half E, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-22; Haugen MH, 2015, EUR J CANCER, V51, P9, DOI 10.1016/j.ejca.2014.10.020; Hetland G, 2008, SCAND J IMMUNOL, V68, P363, DOI 10.1111/j.1365-3083.2008.02156.x; Hetland G, 2011, ADV PHARMACOL SCI, V2011, DOI 10.1155/2011/157015; Holson RR, 2008, NEUROTOXICOL TERATOL, V30, P326, DOI 10.1016/j.ntt.2007.06.001; Hopkins MH, 2012, BIOMARK INSIGHTS, V7, P143, DOI 10.4137/BMI.S10092; IKUZAWA M, 1988, INT J IMMUNOPHARMACO, V10, P415; ITOH H, 1994, JPN J PHARMACOL, V66, P265, DOI 10.1254/jjp.66.265; Johnson E, 2009, SCAND J IMMUNOL, V69, P242, DOI 10.1111/j.1365-3083.2008.02218.x; KAWAGISHI H, 1989, CARBOHYD RES, V186, P267, DOI 10.1016/0008-6215(89)84040-6; Kerrigan RW, 2005, MYCOLOGIA, V97, P12, DOI 10.3852/mycologia.97.1.12; Kim SP, 2013, J AGR FOOD CHEM, V61, P4898, DOI 10.1021/jf400916c; Lin YY, 2013, CANCER SCI, V104, P1217, DOI 10.1111/cas.12202; Liu C, 2003, CANCER RES, V63, P2957; Liu Y, 2012, MOL PHARMACEUT, V9, P168, DOI 10.1021/mp200434n; Luo YP, 2006, J CLIN INVEST, V116, P2132, DOI 10.1172/JCI27648; Masuda Y, 2013, INT J CANCER, V133, P108, DOI 10.1002/ijc.27999; Metzler-Zebeli BU, 2011, FEMS MICROBIOL ECOL, V75, P402, DOI 10.1111/j.1574-6941.2010.01017.x; Miller G, 2011, FASEB J, V25, P1606, DOI 10.1096/fj.10-172312; Morita Y, 2007, FEBS LETT, V581, P1417, DOI 10.1016/j.febslet.2007.02.064; Murthy RV, 2005, CLIN CANCER RES, V11, P2293, DOI 10.1158/1078-0432.CCR-04-1642; Paulsen JE, 1997, CARCINOGENESIS, V18, P1905, DOI 10.1093/carcin/18.10.1905; Paulsen JE, 2000, TOXICOL LETT, V112, P403, DOI 10.1016/S0378-4274(99)00262-3; Pinheiro F, 2003, FOOD CHEM TOXICOL, V41, P1543, DOI 10.1016/S0278-6915(03)00171-6; Sodring M, 2016, INT J CANCER, V138, P1936, DOI 10.1002/ijc.29928; Sorimachi K, 2001, CELL STRUCT FUNCT, V26, P103, DOI 10.1247/csf.26.103; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; SUZUKI I, 1984, J PHARMACOBIO-DYNAM, V7, P492; Takaku T, 2001, J NUTR, V131, P1409, DOI 10.1093/jn/131.5.1409; Takimoto H, 2008, IMMUNOPHARM IMMUNOT, V30, P747, DOI [10.1080/08923970802279092, 10.1080/08923970802279092 ]; Tangen J. M., 2014, APPL SCI REPORTS, V1, P1, DOI DOI 10.7243/2054-9903-1-1; Tangen JM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/718539; Therkelsen SP, 2016, PLOS ONE; van Es JH, 2001, EXP CELL RES, V264, P126, DOI 10.1006/excr.2000.5142; Vetvicka V, 1996, J CLIN INVEST, V98, P50, DOI 10.1172/JCI118777; Yoo JY, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030173; Ziliotto L, 2009, NUTR CANCER, V61, P245, DOI 10.1080/01635580802395717	53	7	8	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167754	10.1371/journal.pone.0167754	http://dx.doi.org/10.1371/journal.pone.0167754			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002446	Green Published, Green Accepted, gold			2022-12-26	WOS:000392853100021
J	Jiao, CC; Cui, LH; Ma, AG; Li, N; Si, HZ				Jiao, Congcong; Cui, Lianhua; Ma, Aiguo; Li, Na; Si, Hongzong			Elevated Serum Levels of Retinol-Binding Protein 4 Are Associated with Breast Cancer Risk: A Case-Control Study	PLOS ONE			English	Article							INSULIN-RESISTANCE; METABOLIC SYNDROME; PLASMA ADIPONECTIN; PREDICTIVE-VALUE; PROSTATE-CANCER; FATTY LIVER; WEIGHT-LOSS; OBESITY; ADIPOKINES; RETINOL-BINDING-PROTEIN-4	Background Retinol binding protein 4 (RBP4) is a recently identified adipokine that is elevated in patients with obesity or type 2 diabetes. A growing body of research has shown that RBP4 is associated with several types of cancer. However, no studies have investigated the relationship between serum RBP4 levels and breast cancer risk. We performed a case-control study to evaluate the association between serum RBP4 levels and the risk of breast cancer. Methods From August 2012 to December 2013, four-hundred subjects including 200 patients diagnosed with primary breast cancer and 200 matched healthy women were consecutively enrolled from Affiliated Hospital of Qingdao University Medical College. Blood samples were collected from healthy controls and breast cancer patients before commencement of treatment. Enzyme-linked immunosorbent assay was used to evaluate the serum RBP4 levels in separated serum samples. Meanwhile, the characteristics of breast cancer cases and controls were collected from medical records and pathological data. Results The serum levels of RBP4 were significantly higher in patients with breast cancer than that in the healthy control group (33.77 9.92 vs. 28.77 6.47pg/ml, P < 0.05). Compared to the subjects in the lowest quartile of serum RBP4 level, the adjusted ORs (95% Cls) is 2.16 (1.01-4.61) and 2.07 (1.07-4.00) for women in the second and highest RBP4 tertile, respectively. For breast cancer patients, patients with PR or ER negative displayed significantly higher serum RBP4 levels than those with PR or ER positive. Conclusion Our results for the first time suggested serum RBP4 levels could be associated with the risk of breast cancer. However, further prospective studies are essential to confirm these observed results.	[Jiao, Congcong; Cui, Lianhua; Ma, Aiguo; Li, Na; Si, Hongzong] Qingdao Univ, Coll Med, Dept Publ Hlth, Qingdao, Shandong, Peoples R China	Qingdao University	Cui, LH (corresponding author), Qingdao Univ, Coll Med, Dept Publ Hlth, Qingdao, Shandong, Peoples R China.	lianhuacui520@hanmail.net			Chinese Nutrition Society Research Fund - DSM Specialized Research Fund	Chinese Nutrition Society Research Fund - DSM Specialized Research Fund	This work was supported by 2014 the Chinese Nutrition Society Research Fund - DSM Specialized Research Fund.	Abola MV, 2015, ENDOCR-RELAT CANCER, V22, pL1, DOI 10.1530/ERC-14-0429; Abulaizi Mayinuer, 2011, Int J Proteomics, V2011, P628787, DOI 10.1155/2011/628787; Aliustaoglu M, 2010, MED ONCOL, V27, P388, DOI 10.1007/s12032-009-9222-z; Alsheikh-Ali AA, 2008, J AM COLL CARDIOL, V52, P1141, DOI 10.1016/j.jacc.2008.06.037; Amadou A, 2013, OBES REV, V14, P665, DOI 10.1111/obr.12028; Assiri AMA, 2016, OBES RES CLIN PRACT, V10, P442, DOI 10.1016/j.orcp.2015.08.017; Berry DC, 2014, CANCER RES, V74, P6341, DOI 10.1158/0008-5472.CAN-14-1052; Bluher M, 2014, MOL METAB, V3, P230, DOI 10.1016/j.molmet.2014.01.005; Boyle P, 2013, EUR J NUTR, V52, P1533, DOI 10.1007/s00394-012-0460-z; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chang XX, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0033-2; Chen Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109012; Cheng YS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/179040; Cho YM, 2006, DIABETES CARE, V29, P2457, DOI 10.2337/dc06-0360; COLANTUONI V, 1983, NUCLEIC ACIDS RES, V11, P7769, DOI 10.1093/nar/11.22.7769; Coughlin Steven S, 2015, Cancer Clin Oncol, V4, P24; Cui XH, 2007, CANCER EPIDEM BIOMAR, V16, P1443, DOI 10.1158/1055-9965.EPI-07-0059; Dobbins M, 2013, ISRN Prev Med, V2013, P680536, DOI 10.5402/2013/680536; Duffy MJ, 2005, CLIN CHEM, V51, P494, DOI 10.1373/clinchem.2004.046227; Emens LA, 2005, CANCER RES, V65, P8059, DOI 10.1158/0008-5472.CAN-05-1797; Fan L, 2009, BREAST CANCER RES TR, V117, P409, DOI 10.1007/s10549-008-0303-z; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Haider DG, 2007, J CLIN ENDOCR METAB, V92, P1168, DOI 10.1210/jc.2006-1839; Ishikawa M, 2005, CLIN CANCER RES, V11, P466; Janke J, 2006, DIABETES, V55, P2805, DOI 10.2337/db06-0616; Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184; Kabat GC, 2009, INT J CANCER, V125, P2704, DOI 10.1002/ijc.24609; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Khan S, 2013, CYTOKINE GROWTH F R, V24, P503, DOI 10.1016/j.cytogfr.2013.10.001; Kotnik P, 2011, EUR J ENDOCRINOL, V165, P703, DOI 10.1530/EJE-11-0431; Kucharska-Newton AM, 2008, ANN EPIDEMIOL, V18, P671, DOI 10.1016/j.annepidem.2008.06.006; Larsson SC, 2007, INT J CANCER, V121, P856, DOI 10.1002/ijc.22717; Lehr S, 2012, PROTEOM CLIN APPL, V6, P91, DOI 10.1002/prca.201100052; Liu Y, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-25; Lorincz AM, 2006, ENDOCR-RELAT CANCER, V13, P279, DOI 10.1677/erc.1.00729; Maehle BO, 2001, BREAST CANCER RES TR, V68, P159, DOI 10.1023/A:1011977118921; Millikan RC, 2008, BREAST CANCER RES TR, V109, P123, DOI 10.1007/s10549-007-9632-6; Hermsdorff HHM, 2009, NUTRITION, V25, P392, DOI 10.1016/j.nut.2008.09.015; Mistry T, 2007, EUR UROL, V52, P46, DOI 10.1016/j.eururo.2007.03.054; Miyoshi Y, 2003, CLIN CANCER RES, V9, P5699; Muti P, 2002, CANCER EPIDEM BIOMAR, V11, P1361; Nath SD, 2005, JAMA-J AM MED ASSOC, V293, P2210, DOI 10.1001/jama.293.18.2210-b; Patz EF, 2007, J CLIN ONCOL, V25, P5578, DOI 10.1200/JCO.2007.13.5392; Qi QB, 2007, J CLIN ENDOCR METAB, V92, P4827, DOI 10.1210/jc.2007-1219; Ray G, 2001, CLIN BIOCHEM, V34, P71, DOI 10.1016/S0009-9120(00)00200-9; Saki F, 2013, IRAN J PEDIATR, V23, P396; Saki F, 2012, HEPAT MON, V12, DOI 10.5812/hepatmon.7103; Saxena NK, 2010, GASTROENTEROLOGY, V139, P1762, DOI 10.1053/j.gastro.2010.07.001; Sims AH, 2007, NAT CLIN PRACT ONCOL, V4, P516, DOI 10.1038/ncponc0908; Stefan N, 2007, DIABETES CARE, V30, P1173, DOI 10.2337/dc06-2342; Sun Q, 2013, CIRCULATION, V127, P1938, DOI 10.1161/CIRCULATIONAHA.113.002073; Tschoner A, 2008, OBESITY, V16, P2439, DOI 10.1038/oby.2008.391; Tworoger SS, 2007, J CLIN ENDOCR METAB, V92, P1510, DOI 10.1210/jc.2006-1975; Uehara H, 2013, INT J ONCOL, V43, P365, DOI 10.3892/ijo.2013.1954; Viale G, 2007, J CLIN ONCOL, V25, P3846, DOI 10.1200/JCO.2007.11.9453; Vona-Davis L, 2007, ENDOCR-RELAT CANCER, V14, P189, DOI 10.1677/ERC-06-0068; Wang DD, 2011, J CANCER RES CLIN, V137, P651, DOI 10.1007/s00432-010-0927-3; Wang Yong-chuan, 2012, Cancer Biology Medicine, V9, P128, DOI 10.3969/j.issn.2095-3941.2012.02.009; Won JC, 2012, J DIABETES INVEST, V3, P457, DOI 10.1111/j.2040-1124.2012.00213.x; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yang XR, 2011, JNCI-J NATL CANCER I, V103, P250, DOI 10.1093/jnci/djq526; ZOVICH DC, 1992, J BIOL CHEM, V267, P13884	62	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167498	10.1371/journal.pone.0167498	http://dx.doi.org/10.1371/journal.pone.0167498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002423	Green Published, gold, Green Submitted			2022-12-26	WOS:000392853100010
J	Tsuchiya, M; Giuliani, A; Hashimoto, M; Erenpreisa, J; Yoshikawa, K				Tsuchiya, Masa; Giuliani, Alessandro; Hashimoto, Midori; Erenpreisa, Jekaterina; Yoshikawa, Kenichi			Self-Organizing Global Gene Expression Regulated through Criticality: Mechanism of the Cell-Fate Change	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; EMERGENT COMPUTATION; ALLOSTERIC DRUGS; HL-60 CELLS; C-MYC; DIFFERENTIATION; DYNAMICS; CHROMATIN; NETWORK; GENOME	Background A fundamental issue in bioscience is to understand the mechanism that underlies the dynamic control of genome-wide expression through the complex temporal-spatial self organization of the genome to regulate the change in cell fate. We address this issue by elucidating a physically motivated mechanism of self-organization. Principal Findings Building upon transcriptome experimental data for seven distinct cell fates, including early embryonic development, we demonstrate that self-organized criticality (SOC) plays an essential role in the dynamic control of global gene expression regulation at both the population and single-cell levels. The novel findings are as follows: i) Mechanism of cell-fate changes: A sandpile-type critical transition self-organizes overall expression into a few transcription response domains (critical states). A cell-fate change occurs by means of a dissipative pulse-like global perturbation in self-organization through the erasure of initial state critical behaviors (criticality). Most notably, the reprogramming of early embryo cells destroys the zygote SOC control to initiate self-organization in the new embryonal genome, which passes through a stochastic overall expression pattern. ii) Mechanism of perturbation of SOC controls: Global perturbations in self-organization involve the temporal regulation of critical states. Quantitative evaluation of this perturbation in terminal cell fates reveals that dynamic interactions between critical states determine the critical-state coherent regulation. The occurrence of a temporal change in criticality perturbs this between-states interaction, which directly affects the entire genomic system. Surprisingly, a sub-critical state, corresponding to an ensemble of genes that shows only marginal changes in expression and consequently are considered to be devoid of any interest, plays an essential role in generating a global perturbation in self-organization directed toward the cell-fate change. Conclusion and Significance 'Whole-genome' regulation of gene expression through self-regulatory SOC control complements gene-by-gene fine tuning and represents a still largely unexplored non-equilibrium statistical mechanism that is responsible for the massive reprogramming of genome expression.	[Tsuchiya, Masa] Keio Univ, Sch Media & Governance, Syst Biol Program, Fujisawa, Kanagawa, Japan; [Giuliani, Alessandro] Ist Super Sanita, Environm & Hlth Dept, Rome, Italy; [Hashimoto, Midori] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Erenpreisa, Jekaterina] Latvian Biomed Res & Study Ctr, Riga, Latvia; [Yoshikawa, Kenichi] Doshisha Univ, Fac Life & Med Sci, Kyotanabe, Japan	Keio University; Istituto Superiore di Sanita (ISS); University of Tokyo; Latvian Biomedical Research & Study Centre; Doshisha University	Tsuchiya, M (corresponding author), Keio Univ, Sch Media & Governance, Syst Biol Program, Fujisawa, Kanagawa, Japan.	tsuchiya.masa@gmail.com	Giuliani, Alessandro/K-7589-2016; Giuliani, Alessandro/AAF-1740-2020; Yoshikawa, Kenichi/N-1867-2019	Giuliani, Alessandro/0000-0002-4640-804X; Giuliani, Alessandro/0000-0002-4640-804X; Yoshikawa, Kenichi/0000-0002-2751-7136	Japan Society for the Promotion of Science [15H02121, 25103012]; Latvian Council of Science (LZP grant), Latvia [341/2012]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Latvian Council of Science (LZP grant), Latvia	This study was supported in part by Japan Society for the Promotion of Science (Grants-in-Aid, KAKENHI: Nos.15H02121 and 25103012) and by Latvian Council of Science (LZP grant 341/2012), Latvia.	BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonabeau E, 1997, ACTA BIOTHEOR, V45, P29, DOI 10.1023/A:1000259222500; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Buganim Y, 2013, NAT REV GENET, V14, P427, DOI 10.1038/nrg3473; Choy JS, 2010, J AM CHEM SOC, V132, P1782, DOI 10.1021/ja910264z; Cinquin O, 2005, J THEOR BIOL, V233, P391, DOI 10.1016/j.jtbi.2004.10.027; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Clar S, 1996, J PHYS-CONDENS MAT, V8, P6803, DOI 10.1088/0953-8984/8/37/004; de Oliveira PM, 2001, THEOR BIOSCI, V120, P1, DOI 10.1078/1431-7613-00023; DeDecker BS, 2000, CHEM BIOL, V7, pR103, DOI 10.1016/S1074-5521(00)00115-0; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Dror RO, 2013, NATURE, V503, P295, DOI 10.1038/nature12595; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Estrada J, 2016, CELL, V166, P234, DOI 10.1016/j.cell.2016.06.012; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Gilbert S.F, 2013, DEV BIOL, VTenth; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Halley JD, 2012, STEM CELL RES, V8, P324, DOI 10.1016/j.scr.2011.11.001; Halley JD, 2004, INSECT SOC, V51, P226, DOI 10.1007/s00040-003-0725-x; Halley JD, 2008, BIOSYSTEMS, V92, P148, DOI 10.1016/j.biosystems.2008.01.005; Halley JD, 2009, STEM CELL RES, V2, P165, DOI 10.1016/j.scr.2009.03.001; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jensen H.J., 1998, SELF ORG CRITICALITY; Jost D, 2014, NUCLEIC ACIDS RES, V42, P9553, DOI 10.1093/nar/gku698; Kinouchi O, 1999, PHYS REV E, V59, P4964, DOI 10.1103/PhysRevE.59.4964; Kornyshev AA, 2010, PHYS CHEM CHEM PHYS, V12, P12352, DOI 10.1039/c004107f; LANGTON CG, 1990, PHYSICA D, V42, P12, DOI 10.1016/0167-2789(90)90064-V; Launay S, 1999, BLOOD, V93, P4395, DOI 10.1182/blood.V93.12.4395.412k06_4395_4405; Le Treut G, 2016, BIOPHYS J, V110, P51, DOI 10.1016/j.bpj.2015.10.027; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Li GH, 2011, CURR OPIN GENET DEV, V21, P175, DOI 10.1016/j.gde.2011.01.022; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Lukovic M, 2014, PHYSICA A, V416, P430, DOI 10.1016/j.physa.2014.08.066; Ma'ayan A, 2005, SCIENCE, V309, P1078, DOI 10.1126/science.1108876; MacArthur BD, 2013, CELL, V154, P484, DOI 10.1016/j.cell.2013.07.024; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Markovic D, 2014, PHYS REP, V536, P41, DOI 10.1016/j.physrep.2013.11.002; McClintick JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-49; Nagahara H, 2010, CHEM PHYS LETT, V494, P88, DOI 10.1016/j.cplett.2010.05.083; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Nagashima T, 2007, J BIOL CHEM, V282, P4045, DOI 10.1074/jbc.M608653200; Nakakuki T, 2010, CELL, V141, P884, DOI 10.1016/j.cell.2010.03.054; Niakan KK, 2012, DEVELOPMENT, V139, P829, DOI 10.1242/dev.060426; Nykter M, 2008, P NATL ACAD SCI USA, V105, P1897, DOI 10.1073/pnas.0711525105; Papp B, 2012, BIOMOLECULES, V2, P165, DOI 10.3390/biom2010165; Peaston AE, 2007, BIOCHEM SOC T, V35, P618, DOI 10.1042/BST0350618; Plenz D., 2014, CRITICALITY NEURAL S; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Sabo A, 2014, NATURE, V511, P488, DOI 10.1038/nature13537; Saeki Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-545; SCHAEFER A, 1994, J BIOL CHEM, V269, P8786; Schiessel H, 2003, J PHYS-CONDENS MAT, V15, pR699, DOI 10.1088/0953-8984/15/19/203; Sexton T, 2009, SEMIN CELL DEV BIOL, V20, P849, DOI 10.1016/j.semcdb.2009.06.004; Sole R., 2011, PHASE TRANSITIONS; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takenaka Y, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.031905; TARELLA C, 1982, CANCER RES, V42, P445; TELFORD NA, 1990, MOL REPROD DEV, V26, P90, DOI 10.1002/mrd.1080260113; Transtrum MK, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4923066; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; TSIFTSOGLOU AS, 1985, CANCER RES, V45, P2334; Tsuchiya M., 2015, PLOS ONE, V11, DOI 10. 1371/journal. pone. 0128565 26067993; Tsuchiya M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097411; Tsuchiya M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012116; Tsuchiya M, 2009, PHYSICA A, V388, P1738, DOI 10.1016/j.physa.2008.12.030; Tsuchiya M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004905; Tsuchyia M, 2007, FEBS J, V274, P2878, DOI 10.1111/j.1742-4658.2007.05822.x; Turalska M, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021110; Turcotte DL, 2001, NONLINEAR PROC GEOPH, V8, P193, DOI 10.5194/npg-8-193-2001; Wennekamp S, 2013, NAT REV MOL CELL BIO, V14, P452, DOI 10.1038/nrm3602; Whitaker M, 2006, PHYSIOL REV, V86, P25, DOI 10.1152/physrev.00023.2005; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yang CX, 2013, REPRODUCTION, V145, P149, DOI 10.1530/REP-11-0421; YEN A, 1987, CANCER RES, V47, P129; Yoshikawa K, 2002, J BIOL PHYS, V28, P701, DOI 10.1023/A:1021251125101; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032	83	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0167912	10.1371/journal.pone.0167912	http://dx.doi.org/10.1371/journal.pone.0167912			47	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997556	Green Published, gold, Green Submitted			2022-12-26	WOS:000392842900018
J	Yuan, B; Liang, S; Kwon, JW; Jin, YX; Park, SH; Wang, HY; Sun, TY; Zhang, JB; Kim, NH				Yuan, Bao; Liang, Shuang; Kwon, Jeong-Woo; Jin, Yong-Xun; Park, Shun-Ha; Wang, Hai-Yang; Sun, Tian-Yi; Zhang, Jia-Bao; Kim, Nam-Hyung			The Role of Glucose Metabolism on Porcine Oocyte Cytoplasmic Maturation and Its Possible Mechanisms	PLOS ONE			English	Article							IN-VITRO MATURATION; PENTOSE-PHOSPHATE PATHWAY; MOUSE OOCYTES; FOLLICULAR-FLUID; CUMULUS CELLS; DEVELOPMENTAL COMPETENCE; MEIOTIC MATURATION; EMBRYO DEVELOPMENT; ENERGY-METABOLISM; LIPID-METABOLISM	In the present study, we investigated the potential role of glucose and pyruvate in the cytoplasmic maturation of porcine oocytes by investigating the effect of glucose and/or pyruvate supplementation, in the presence or absence of 10% porcine follicular fluid (PFF), on meiotic maturation and subsequent embryo development. In the absence of 10% PFF, without exogenous addition of glucose and pyruvate, the medium seemed unable to support maturation. In the presence of 10% PFF, the addition of 5.6 mM glucose and/or 2 mM pyruvate during in vitro maturation of cumulus enclosed oocytes increased MII oocyte and blastocyst rates. In contrast, oocytes denuded of cumulus cells were not able to take full advantage of the glucose in the medium, as only pyruvate was able to increase the MII rate and the subsequent early embryo developmental ability. Treatment of cumulus enclosed oocytes undergoing maturation with 200 pM dehydroepiandrosterone (DHEA), a pentose phosphate pathway inhibitor, or 2 pM iodoacetate (IA), a glycolysis inhibitor, significantly reduced GHS, intra-oocyte ATP, maternal gene expression, and MPF activity levels. DHEA was also able to increase ROS and reduce the levels of NADPH. Moreover, blastocysts of the DHEA-or IA-treated groups presented higher apoptosis rates and markedly lower cell proliferation cell rates than those of the non-treated group. In conclusion, our results suggest that oocytes maturing in the presence of 10% PFF can make full use of energy sources through glucose metabolism only when they are accompanied by cumulus cells, and that pentose phosphate pathway (PPP) and glycolysis promote porcine oocyte cytoplasmic maturation by supplying energy, regulating maternal gene expression, and controlling MPF activity.	[Yuan, Bao; Jin, Yong-Xun; Zhang, Jia-Bao; Kim, Nam-Hyung] Jilin Univ, Coll Anim Sci, Dept Lab Anim, Changchun, Jilin, Peoples R China; [Yuan, Bao; Liang, Shuang; Kwon, Jeong-Woo; Jin, Yong-Xun; Park, Shun-Ha; Wang, Hai-Yang; Sun, Tian-Yi; Kim, Nam-Hyung] Chungbuk Natl Univ, Dept Anim Sci, Mol Embryol Lab, Cheongju, Chungbuk, South Korea	Jilin University; Chungbuk National University	Zhang, JB; Kim, NH (corresponding author), Jilin Univ, Coll Anim Sci, Dept Lab Anim, Changchun, Jilin, Peoples R China.; Kim, NH (corresponding author), Chungbuk Natl Univ, Dept Anim Sci, Mol Embryol Lab, Cheongju, Chungbuk, South Korea.	zjb515@126.com; nhkim@chungbuk.ac.kr		WANG, HAIYANG/0000-0002-6362-6022	BioGreen 21 Program [PJ011126]; National Natural Science Foundation of China [31572400, 31501954]	BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the BioGreen 21 Program (No. PJ011126) and the National Natural Science Foundation of China (31572400, 31501954). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agung B, 2013, J REPROD DEVELOP, V59, P103, DOI 10.1262/jrd.2011-050; Alvarez GM, 2013, REPROD DOMEST ANIM, V48, P545, DOI 10.1111/rda.12123; Arias-Alvarez M, 2016, IN VIVO IN VITRO MAT; Ashraf S, 2014, J ASSIST REPROD GEN, V31, P1349, DOI 10.1007/s10815-014-0275-3; Boruszewska D, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0044-x; Cetica P, 2002, REPRODUCTION, V124, P675, DOI 10.1530/reprod/124.5.675; Comizzoli P, 2003, BIOL REPROD, V68, P1934, DOI 10.1095/biolreprod.102.011452; da Costa NN, 2016, THERIOGENOLOGY, V85, P323, DOI 10.1016/j.theriogenology.2015.08.010; Dai XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142564; Downs SM, 1999, BIOL REPROD, V60, P1446, DOI 10.1095/biolreprod60.6.1446; Downs SM, 1996, MOL REPROD DEV, V44, P121, DOI 10.1002/(SICI)1098-2795(199605)44:1&lt;121::AID-MRD14&gt;3.0.CO;2-7; Downs SM, 2003, MOL REPROD DEV, V66, P90, DOI 10.1002/mrd.10326; Frolova AI, 2011, MOL ENDOCRINOL, V25, P1444, DOI 10.1210/me.2011-0026; Funahashi H, 2008, THERIOGENOLOGY, V70, P1041, DOI 10.1016/j.theriogenology.2008.06.025; Herrick JR, 2006, REPRODUCTION, V131, P289, DOI 10.1530/rep.1.00835; Huang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122370; Jimenez PT, 2013, ENDOCRINOLOGY, V154, P4835, DOI 10.1210/en.2012-2140; Kim Yunna, 2012, Clin Exp Reprod Med, V39, P58, DOI 10.5653/cerm.2012.39.2.58; Krisher RL, 2007, ANIM REPROD SCI, V98, P72, DOI 10.1016/j.anireprosci.2006.10.006; Krisher RL, 1999, MOL REPROD DEV, V53, P19, DOI 10.1002/(SICI)1098-2795(199905)53:1&lt;19::AID-MRD3&gt;3.0.CO;2-U; Lee SK, 2014, J REPROD DEVELOP, V60, P128, DOI 10.1262/jrd.2013-098; Lee YJ, 2006, AM J PHYSIOL-RENAL, V291, pF98, DOI 10.1152/ajprenal.00486.2005; Lin LT, 2016, GYNECOL ENDOCRINOL, P1; Lin ZL, 2014, REPROD DOMEST ANIM, V49, P219, DOI 10.1111/rda.12254; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao J, 2012, THERIOGENOLOGY, V78, P887, DOI 10.1016/j.theriogenology.2012.04.002; Alvarez GM, 2016, THERIOGENOLOGY, V86, P2096, DOI 10.1016/j.theriogenology.2015.11.008; MEINECKE B, 1978, Anatomia Histologia Embryologia, V7, P58, DOI 10.1111/j.1439-0264.1978.tb00494.x; Nandi S, 2008, THERIOGENOLOGY, V69, P186, DOI 10.1016/j.theriogenology.2007.08.036; OBrien JK, 1996, REPROD FERT DEVELOP, V8, P1029, DOI 10.1071/RD9961029; Ptak G, 2012, HUM REPROD, V27, P1034, DOI 10.1093/humrep/der454; RAMSOONDAR J, 1995, CAN J VET RES, V59, P8; RIEGER D, 1994, J REPROD FERTIL, V100, P257; Sanchez-Lazo L, 2014, MOL ENDOCRINOL, V28, P1502, DOI 10.1210/me.2014-1049; Schmidt Maike M, 2009, Front Neuroenergetics, V1, P1, DOI 10.3389/neuro.14.001.2009; Somfai T, 2011, REPROD FERT DEVELOP, V23, P912, DOI 10.1071/RD10339; Sturmey RG, 2003, REPRODUCTION, V126, P197, DOI 10.1530/rep.0.1260197; Truman AW, 2012, CELL, V151, P1308, DOI 10.1016/j.cell.2012.10.051; Wang HF, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-4; Wang Q, 2012, AM J PHYSIOL-ENDOC M, V302, pE1511, DOI 10.1152/ajpendo.00016.2012; Xie HL, 2016, SCI REP-UK, V6, DOI 10.1038/srep20764; Yang MY, 2002, ANIM REPROD SCI, V70, P159, DOI 10.1016/S0378-4320(01)00186-5; Yuan B, 2016, PEERJ, V4, DOI 10.7717/peerj.2454; Zhang DX, 2010, MOL REPROD DEV, V77, P38, DOI 10.1002/mrd.21095	44	18	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168329	10.1371/journal.pone.0168329	http://dx.doi.org/10.1371/journal.pone.0168329			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997591	Green Submitted, Green Published, gold			2022-12-26	WOS:000392842900035
J	Zhang, BW; Xu, JL; Zhang, H; Zhang, Q; Lu, J; Wang, JH				Zhang, Bi-Wei; Xu, Jin-Long; Zhang, Hua; Zhang, Qiang; Lu, Jie; Wang, Jun-Hui			Structure Elucidation of a Polysaccharide from Umbilicaria esculenta and Its Immunostimulatory Activity	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITIES; ANTITHROMBOTIC ACTIVITY; ANTITUMOR-ACTIVITY; PURIFICATION; METHYLATION; CHINENSIS; FRACTIONS; LICHENS; GLUCAN; STEMS	Umbilicaria esculenta has been used as a tonic food in China for several centuries owing to its pleasant flavor and health benefits. In this study, a water soluble polysaccharide, which we designated as UP2, with an average molecular weight of 3.33 x 10(5) Da, was isolated from U. esculenta cultivated in the Huangshan Mountain, by consecutive hot water extraction and anion-exchange chromatography. Gas chromatography analysis indicated that UP2 contained three kinds of monosaccharides, including mannose, glucose, and galactose at a molar ratio of 1.7:1.0:1.2. Linkage analysis of UP2 revealed the presence of (1 -> 6)-linked glucosyl, (1 -> 3,6)-linked glucosyl, t-linked galactosyl, (1 -> 6)-linked galactosyl and (1 -> 6)-linked mannosyl at a molar ratio of 0.7:4.6:4.1:2.2:9.1. Structural analysis determined that UP2 possessed a backbone consisting of (1 -> 6)-linked /3-D-glucopyranosyl and (1 -> 6)-linked a-D-mannopyranosyl residues, which substituted at the 0-3 position of (1 -> 6)-linked beta-D-glucopyranosyl residues by branches of (1 -> 6)-linked alpha-D-galactopyranosyl and 1-linked beta-D-galactopyranosyl residues. Immunostimulatory activity analysis showed that UP2 could stimulate the proliferation of RAW264.7 cells in a dose-dependent manner, and all the samples (20-500 mu g/mL) were found to enhance nitric oxide production. The highest phagocytic activity of UP2 was observed at 200 mu g/mL. Thus, UP2 may be a potential source of biological and pharmacological agents.	[Zhang, Bi-Wei; Xu, Jin-Long; Zhang, Hua; Wang, Jun-Hui] Hefei Univ Technol, Sch Biotechnol & Food Engn, Hefei, Peoples R China; [Zhang, Qiang; Lu, Jie] Anhui Qiangwang Flavouring Food Co LTD, Dongcheng Dev Zone, Jieshou City, Anhui, Peoples R China	Hefei University of Technology	Wang, JH (corresponding author), Hefei Univ Technol, Sch Biotechnol & Food Engn, Hefei, Peoples R China.	junhuiwang@hfut.edu.cn			National Natural Science Foundation of China [31370371]; Natural Science Foundation of Anhui Province [1408085MC45]; Fundamental Research Funds for the Central Universities [2015HGCH0008]; China Postdoctoral Science Foundation; Anhui Qiangwang Flavouring Food Co., LTD	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Anhui Qiangwang Flavouring Food Co., LTD	This research was financially supported by the National Natural Science Foundation of China (No. 31370371), the Natural Science Foundation of Anhui Province (No. 1408085MC45), the Fundamental Research Funds for the Central Universities (No. 2015HGCH0008) and China Postdoctoral Science Foundation. Anhui Qiangwang Flavouring Food Co., LTD provided support in the form of salaries for authors [QZ and JL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was financially supported by the National Natural Science Foundation of China (No. 31370371), the Natural Science Foundation of Anhui Province (No. 1408085MC45), the Fundamental Research Funds for the Central Universities (No. 2015HGCH0008) and China Postdoctoral Science Foundation.	Bates ST, 2011, APPL ENVIRON MICROB, V77, P1309, DOI 10.1128/AEM.02257-10; Beeley JG., 1986, KLIN WOCHENSCHR, V64, P397; Bi HT, 2009, CARBOHYD RES, V344, P1254, DOI 10.1016/j.carres.2009.04.009; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; Chen S, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/738631; Chen ZG, 2014, CARBOHYD POLYM, V106, P217, DOI 10.1016/j.carbpol.2014.02.004; Chien RC, 2015, CARBOHYD POLYM, V128, P90, DOI 10.1016/j.carbpol.2015.03.088; Dai H, 2012, GLYCOBIOLOGY, V22, P1673, DOI 10.1093/glycob/cws099; Du YQ, 2015, INT J BIOL MACROMOL, V72, P1272, DOI 10.1016/j.ijbiomac.2014.09.057; Han XQ, 2012, INT J BIOL MACROMOL, V51, P597, DOI 10.1016/j.ijbiomac.2012.06.029; Hartley JW, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-1; HIRABAYASHI K, 1989, CHEM PHARM BULL, V37, P2410, DOI 10.1248/cpb.37.2410; IKEKAWA T, 1969, CANCER RES, V29, P734; Jiang CX, 2015, CARBOHYD POLYM, V115, P200, DOI 10.1016/j.carbpol.2014.08.095; Jing YS, 2014, J AGR FOOD CHEM, V62, P902, DOI 10.1021/jf404752c; Kim MS, 2006, J ETHNOPHARMACOL, V105, P342, DOI 10.1016/j.jep.2005.11.011; Kosanic M, 2014, LWT-FOOD SCI TECHNOL, V59, P518, DOI 10.1016/j.lwt.2014.04.047; Leung MYK, 2004, GLYCOBIOLOGY, V14, P501, DOI 10.1093/glycob/cwh050; Liao NB, 2014, J AGR FOOD CHEM, V62, P2344, DOI 10.1021/jf403896c; Liu Y, 2014, INT J BIOL MACROMOL, V64, P63, DOI 10.1016/j.ijbiomac.2013.11.029; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu CL, 2015, CARBOHYD POLYM, V122, P428, DOI 10.1016/j.carbpol.2014.11.035; NEEDS PW, 1993, CARBOHYD RES, V245, P1, DOI 10.1016/0008-6215(93)80055-J; NISHIKAWA Y, 1970, CHEM PHARM BULL, V18, P1431; Olafsdottir ES, 2003, PHYTOMEDICINE, V10, P318, DOI 10.1078/094471103322004811; Omarsdottir S, 2006, CARBOHYD RES, V341, P2449, DOI 10.1016/j.carres.2006.06.026; Omarsdottir S, 2006, INT IMMUNOPHARMACOL, V6, P1642, DOI 10.1016/j.intimp.2006.06.006; Stocker-Worgotter E, 2013, STUD NAT PROD CHEM, V39, P337, DOI 10.1016/B978-0-444-62615-8.00010-2; Sun HX, 2015, CARBOHYD POLYM, V121, P388, DOI 10.1016/j.carbpol.2014.12.023; Wang JH, 2015, CURR TOP NUTRACEUT R, V13, P205; Wang JH, 2015, CARBOHYD POLYM, V131, P240, DOI 10.1016/j.carbpol.2015.05.052; Wang JH, 2015, BIOTECHNOL BIOTEC EQ, V29, P714, DOI 10.1080/13102818.2015.1022222; Wang JH, 2010, FOOD CHEM, V122, P572, DOI 10.1016/j.foodchem.2010.03.012; Wang JH, 2010, CARBOHYD POLYM, V79, P114, DOI 10.1016/j.carbpol.2009.07.032; Wang JunHui, 2015, Journal of Chemical and Pharmaceutical Research, V7, P678; Wang MC, 2013, FOOD CHEM, V138, P41, DOI 10.1016/j.foodchem.2012.09.098; Wang YF, 2014, CARBOHYD POLYM, V105, P231, DOI 10.1016/j.carbpol.2014.01.082; Xie G, 2008, PHYTOCHEMISTRY, V69, P1359, DOI 10.1016/j.phytochem.2008.01.009; Xie JH, 2013, FOOD CHEM, V136, P1453, DOI 10.1016/j.foodchem.2012.09.078; Xu X, 2014, PLOS ONE, V10; Xu X, 2014, J AGR FOOD CHEM, V62, P3168, DOI 10.1021/jf405633n; Yin JY, 2012, CARBOHYD POLYM, V87, P2416, DOI 10.1016/j.carbpol.2011.11.009; Zha XQ, 2015, INT J BIOL MACROMOL, V78, P429, DOI 10.1016/j.ijbiomac.2015.04.047	43	12	12	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168472	10.1371/journal.pone.0168472	http://dx.doi.org/10.1371/journal.pone.0168472			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997616	gold, Green Published, Green Submitted			2022-12-26	WOS:000392842900050
J	Fall, B; Scott, CR; Mauer, M; Shankland, S; Pippin, J; Jefferson, JA; Wallace, E; Warnock, D; Najafian, B				Fall, Brent; Scott, C. Ronald; Mauer, Michael; Shankland, Stuart; Pippin, Jeffrey; Jefferson, Jonathan A.; Wallace, Eric; Warnock, David; Najafian, Behzad			Urinary Podocyte Loss Is Increased in Patients with Fabry Disease and Correlates with Clinical Severity of Fabry Nephropathy	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; AGALSIDASE-BETA; IGA NEPHROPATHY; KIDNEY-DISEASES; RENAL-DISEASE; GLOMERULOSCLEROSIS; EXCRETION; CELL; PODOCALYXIN; PROGRESSION	Chronic kidney disease is a major complication of Fabry disease. Podocytes accumulate globotriaosylceramide inclusions more than other kidney cell types in Fabry patients. Podocyte injury occurs early in age, and is progressive. Since injured podocytes detach into the urine (podocyturia), we hypothesized that podocyturia would increase in Fabry patients and correlate with clinical severity of Fabry nephropathy. Urine specimens from 39 Fabry patients and 24 healthy subjects were evaluated for podocyturia. Most of the Fabry patients and many healthy subjects had podocyturia. The number of podocytes per gram of urine creatinine (UPodo/g Cr) was 3.6 fold greater in Fabry patients (3,741 +/- 2796; p = 0.001) than healthy subjects (1,040 +/- 972). Fabry patients with normoalbuminuria and normoproteinuria had over 2-fold greater UPodo/g Cr than healthy subjects (p = 0.048). UPodo/gCr was inversely related to eGFR in male patients (r = -0.69, p = 0.003). UPodo/gCr was directly related to urine protein creatinine ratio (r = 0.33; p = 0.04) in all Fabry patients. These studies confirm increased podocyturia in Fabry disease, even when proteinuria and albuminuria are absent. Podocyturia correlates with clinical severity of Fabry nephropathy, and potentially may be of prognostic value.	[Fall, Brent; Najafian, Behzad] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Scott, C. Ronald] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Mauer, Michael] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Mauer, Michael] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Shankland, Stuart; Pippin, Jeffrey; Jefferson, Jonathan A.] Univ Washington, Dept Med, Seattle, WA USA; [Wallace, Eric; Warnock, David] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Washington; University of Washington Seattle; University of Alabama System; University of Alabama Birmingham	Najafian, B (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	najafian@uw.edu	Mauer, Michael/ABD-5415-2020; Jefferson, Jonathan/AAA-9679-2019	Najafian, Behzad/0000-0002-0904-6721				Asao R, 2012, CLIN J AM SOC NEPHRO, V7, P1385, DOI 10.2215/CJN.08110811; Bariety J, 2006, J AM SOC NEPHROL, V17, P2770, DOI 10.1681/ASN.2006040325; Biegstraaten M, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0253-6; Germain DP, 2007, J AM SOC NEPHROL, V18, P1547, DOI 10.1681/ASN.2006080816; Germain DP, 2015, J MED GENET, V52, P353, DOI 10.1136/jmedgenet-2014-102797; Hanamura K, 2014, CLIN EXP NEPHROL, V18, P95, DOI 10.1007/s10157-013-0814-8; Hara M, 1998, AM J NEPHROL, V18, P35, DOI 10.1159/000013302; Hara M, 2001, NEPHRON, V89, P342, DOI 10.1159/000046097; Hara M, 2007, CLIN J AM SOC NEPHRO, V2, P231, DOI 10.2215/CJN.01470506; Hodgin JB, 2015, J AM SOC NEPHROL, V26, P3162, DOI 10.1681/ASN.2014080752; Ito S, 2016, PEDIATR NEPHROL, V31, P1369, DOI 10.1007/s00467-016-3387-4; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; Kirk A, 2010, NEPHROL DIAL TRANSPL, V25, P2107, DOI 10.1093/ndt/gfq006; Kriz W, 1996, NEPHROL DIAL TRANSPL, V11, P1738, DOI 10.1093/oxfordjournals.ndt.a027660; Kriz W, 2002, MICROSC RES TECHNIQ, V57, P189, DOI 10.1002/jemt.10072; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lidove O, 2010, GENET MED, V12, P668, DOI 10.1097/GIM.0b013e3181f13b75; Liebau MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063506; Mauer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112188; Melk A, 2003, KIDNEY INT, V63, P2134, DOI 10.1046/j.1523-1755.2003.00032.x; Najafian B, 2011, KIDNEY INT, V79, P663, DOI 10.1038/ki.2010.484; Pereira Ester Miranda, 2016, J Bras Nefrol, V38, P49, DOI 10.5935/0101-2800.20160008; Ramsuran D, 2012, PREGNANCY HYPERTENS, V2, P43, DOI 10.1016/j.preghy.2011.09.004; Rigoldi M, 2014, CLIN GENET, V86, P258, DOI 10.1111/cge.12261; Salako SE, 2006, MED LAW, V25, P341; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Selvarajah M, 2011, NEPHROL DIAL TRANSPL, V26, P3195, DOI 10.1093/ndt/gfr084; Shankland SJ, 2014, SEMIN NEPHROL, V34, P418, DOI 10.1016/j.semnephrol.2014.06.008; Shen PC, 2014, CLIN LAB, V60, P1709, DOI 10.7754/Clin.Lab.2014.131225; Skrunes R., 2016, NEPHROL DIAL TRANSPL; Sun D, 2012, RENAL FAILURE, V34, P403, DOI 10.3109/0886022X.2011.649627; Thurberg BL, 2002, KIDNEY INT, V62, P1933, DOI 10.1046/j.1523-1755.2002.00675.x; Tondel C, 2015, NEPHRON, V129, P16, DOI 10.1159/000369309; Tondel C, 2013, J AM SOC NEPHROL, V24, P137, DOI 10.1681/ASN.2012030316; Toyoda M, 2007, DIABETES, V56, P2155, DOI 10.2337/db07-0019; Trimarchi H, 2015, Case Rep Nephrol, V2015, P257628, DOI 10.1155/2015/257628; Trimarchi H, 2016, J NEPHROL; Tsutsumi O, 1985, Asia Oceania J Obstet Gynaecol, V11, P39; Vogelmann SU, 2003, AM J PHYSIOL-RENAL, V285, pF40, DOI 10.1152/ajprenal.00404.2002; Warnock DG, 2014, J AM SOC NEPHROL, V25, P653, DOI 10.1681/ASN.2013121322; Warnock DG, 2012, NEPHROL DIAL TRANSPL, V27, P1042, DOI 10.1093/ndt/gfr420; White WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092693	42	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168346	10.1371/journal.pone.0168346	http://dx.doi.org/10.1371/journal.pone.0168346			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992580	Green Published, Green Submitted, gold			2022-12-26	WOS:000392758000037
J	Oral, E; Simonsen, N; Brennan, C; Berken, J; Su, LJ; Mohler, JL; Bensen, JT; Fontham, ETH				Oral, Evrim; Simonsen, Neal; Brennan, Christine; Berken, Jennifer; Su, L. Joseph; Mohler, James L.; Bensen, Jeannette T.; Fontham, Elizabeth T. H.			Unit Nonresponse in a Population-Based Study of Prostate Cancer	PLOS ONE			English	Article							MAILED QUESTIONNAIRE; POSTAL QUESTIONNAIRE; PARTICIPATION RATES; AFRICAN-AMERICANS; CLINICAL-TRIALS; LIFE-STYLE; BIAS; EXPOSURE; HEALTH; NONPARTICIPATION	Low unit response rates can increase bias and compromise study validity. Response rates have continued to fall over the past decade despite all efforts to increase participation. Many factors have been linked to reduced response, yet relatively few studies have employed multivariate approaches to identify characteristics that differentiate respondents from nonrespondents since it is hard to collect information on the latter. We aimed to assess factors contributing to enrollment of prostate cancer (PCa) patients. We combined data from the North Carolina-Louisiana (LA) PCa Project's LA cohort, with additional sources such as US census tract and LA tumor registry data. We included specific analyses focusing on blacks, a group often identified as hard to enroll in health-related research. The ability to study the effect of Hurricane Katrina, which occurred amidst enrollment, as a potential determinant of nonresponse makes our study unique. Older age (>= 70) for blacks (OR 0.65) and study phase with respect to Hurricane Katrina for both races (OR 0.59 for blacks, OR 0.48 for whites) were significant predictors of participation with lower odds. Neighborhood poverty for whites (OR 1.53) also was a significant predictor of participation, but with higher odds. Among blacks, residence in Orleans parish was associated with lower odds of participation (OR 0.33) before Katrina. The opposite occurred in whites, with lower odds (OR 0.43) after Katrina. Our results overall underscore the importance of tailoring enrollment approaches to specific target population characteristics to confront the challenges posed by nonresponse. Our results also show that recruitment-related factors may change when outside forces bring major alterations to a population's environment and demographics.	[Oral, Evrim] LSUHSC Sch Publ Hlth, Biostat Program, New Orleans, LA 70112 USA; [Brennan, Christine] LSUHSC Sch Publ Hlth, Hlth Policy Syst Management Program, New Orleans, LA USA; [Berken, Jennifer] McNeese State Univ, Dept Math Sci, Lake Charles, LA 70605 USA; [Su, L. Joseph] Univ Arkansas Med Sci, Dept Epidemiol, Little Rock, AR 72205 USA; [Mohler, James L.] Roswell Pk Canc Inst, Dept Urol, Buffalo, NY 14263 USA; [Mohler, James L.; Bensen, Jeannette T.] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; [Fontham, Elizabeth T. H.] LSUHSC Sch Publ Hlth, Program Epidemiol, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Louisiana System; McNeese State University; University of Arkansas System; University of Arkansas Medical Sciences; Roswell Park Cancer Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Oral, E (corresponding author), LSUHSC Sch Publ Hlth, Biostat Program, New Orleans, LA 70112 USA.	eoral@lsuhsc.edu	Oral, Evrim/C-9268-2016	Oral, Evrim/0000-0003-2976-0778	Department of Defense [DAMD 17-03-2-0052]; NIH [NCI R15 CA151031]	Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The North Carolina-Louisiana Prostate Cancer Project (PCaP) is carried out as a collaborative study supported by the Department of Defense contract DAMD 17-03-2-0052 and NIH grant NCI R15 CA151031. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanerud M, 2013, J TELEMED TELECARE, P1; Abel GA, 2016, CANCER EPIDEMIOL, V41, P34, DOI 10.1016/j.canep.2015.12.010; BAKKE P, 1990, J EPIDEMIOL COMMUN H, V44, P316, DOI 10.1136/jech.44.4.316; Bakke PS, 2010, RESP MED, V104, P323, DOI 10.1016/j.rmed.2009.11.018; BENNETT CM, 1964, J EDUC RES, V58, P178, DOI 10.1080/00220671.1964.10883202; Bethlehem J., 2011, HDB NONRESPONSE HOUS; Bethlehem J.G., 1985, J OFF STAT, V1, P287; Biemer P., 2003, INTRO SURVEY QUALITY; BOSTROM G, 1993, SCAND J SOC MED, V21, P77, DOI 10.1177/140349489302100204; Brennan C, 2012, AM MED J, V3, P104; Brick JM, 2013, ANN AM ACAD POLIT SS, V645, P36, DOI 10.1177/0002716212456834; Buelens BJ, 2010, SURVEY PRACTICE, V3; Burg JAR, 1997, TOXICOL IND HEALTH, V13, P1; Calderwood L, 2010, WORKING PAPER; Camara RJA, 2011, J EPIDEMIOL, V21, P44, DOI 10.2188/jea.JE20100087; COPE RG, 1968, J EXP EDUC, V36, P32, DOI 10.1080/00220973.1968.11011054; Corbie-Smith G, 1999, J GEN INTERN MED, V14, P537, DOI 10.1046/j.1525-1497.1999.07048.x; Couper MP, 1997, PUBLIC OPIN QUART, V61, P317, DOI 10.1086/297797; Cunradi CB, 2005, SUBST USE MISUSE, V40, P171, DOI 10.1081/JA-200048447; Curtin R, 2005, PUBLIC OPIN QUART, V69, P87, DOI 10.1093/poq/nfi002; De Leeuw E.D, 2005, J OFF STAT, V21, P233, DOI DOI 10.1111/J.1524-4733.2007.00231.X; De Leeuw E, 2007, PUBLIC OPIN QUART, V71, P413, DOI 10.1093/poq/nfm014; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Drivsholm T, 2006, SCAND J PUBLIC HEALT, V34, P623, DOI 10.1080/14034940600607616; Durant RW, 2011, J NATL MED ASSOC, V103, P123, DOI 10.1016/S0027-9684(15)30261-3; Eagan TML, 2002, J CLIN EPIDEMIOL, V55, P775, DOI 10.1016/S0895-4356(02)00431-6; Elliott JR, 2009, ORGAN ENVIRON, V22, P410, DOI 10.1177/1086026609347184; Falk W.W., 2006, DU BOIS REV, V3, P115, DOI DOI 10.1017/S1742058X06060036; Fejer R, 2006, EUR J EPIDEMIOL, V21, P171, DOI 10.1007/s10654-006-0006-x; Ford JG, 2008, CANCER, V112, P228, DOI 10.1002/cncr.23157; Fricker S. S., 2007, THESIS; Fussell E, 2007, J AM HIST, V94, P846, DOI 10.2307/25095147; Fussell E, 2010, POPUL ENVIRON, V31, P20, DOI 10.1007/s11111-009-0092-2; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; GERSHEN JA, 1983, PSYCHOL REP, V52, P555, DOI 10.2466/pr0.1983.52.2.555; Gomella LG, 2009, UROLOGY, V73, P28, DOI 10.1016/j.urology.2009.03.003; Groves R.M., 1998, NONRESPONSE HOUSEHOL; Hall AE, 2013, J CLIN EPIDEMIOL, V66, P85, DOI 10.1016/j.jclinepi.2012.07.016; Hartge P, 2006, EPIDEMIOLOGY, V17, P252, DOI 10.1097/01.ede.0000209441.24307.92; Heraty S, 2012, 13 ANN RES C, P36; Hill A, 1997, J PUBLIC HEALTH MED, V19, P203, DOI 10.1093/oxfordjournals.pubmed.a024610; Hille ETM, 2005, PEDIATRICS, V116, pE662, DOI 10.1542/peds.2005-0682; Hussain A, 2009, J TRAUMA STRESS, V22, P324, DOI 10.1002/jts.20431; Jackson R, 1996, J CLIN EPIDEMIOL, V49, P1441, DOI 10.1016/0895-4356(95)00047-X; Jacomb PA, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-4; Johnson T., 2003, 58 ANN M AM ASS PUBL; KESSLER RC, 1995, EPIDEMIOL REV, V17, P192, DOI 10.1093/oxfordjournals.epirev.a036176; Lahaut VMHCJ, 2002, ALCOHOL ALCOHOLISM, V37, P256, DOI 10.1093/alcalc/37.3.256; Link M, 2003, IMPROVING RESPONSE R, P141; Logan JR, 2006, IMPACT KATRINA RACE; Lynn P., 2002, SURVEY NONRESPONSE; Martin E. A., 2007, GUIDELINES DESIGNING; May L, 2014, INFECT CONT HOSP EP, V35, P1114, DOI 10.1086/677637; Mazloum M, 2012, PAEDIATR PERINAT EP, V26, P276, DOI 10.1111/j.1365-3016.2011.01253.x; Moorman PG, 1999, ANN EPIDEMIOL, V9, P188, DOI 10.1016/S1047-2797(98)00057-X; Morton LM, 2006, AM J EPIDEMIOL, V163, P197, DOI 10.1093/aje/kwj036; ONEIL MJ, 1979, PUBLIC OPIN QUART, V43, P218, DOI 10.1086/268513; Partin MR, 2003, J CLIN EPIDEMIOL, V56, P867, DOI 10.1016/S0895-4356(03)00061-1; Reijneveld SA, 1999, INT J EPIDEMIOL, V28, P1134, DOI 10.1093/ije/28.6.1134; Richiardi L, 2002, J CLIN EPIDEMIOL, V55, P1033, DOI 10.1016/S0895-4356(02)00455-9; Ronmark E, 1999, EUR J EPIDEMIOL, V15, P293, DOI 10.1023/A:1007582518922; Safir A, 2008, P AM STAT ASS, P4436; Scharff DP, 2010, J HEALTH CARE POOR U, V21, P879, DOI 10.1353/hpu.0.0323; Schroeder JC, 2006, PROSTATE, V66, P1162, DOI 10.1002/pros.20449; Shahar E, 1996, ANN EPIDEMIOL, V6, P498, DOI 10.1016/S1047-2797(96)00104-4; SINGER E, 2002, USE INCENTIVES REDUC, P163; Sinibaldi J, 2009, INTERVIEWER CHARACTE, P5955; Slattery Martha L., 1995, Annals of Epidemiology, V5, P245, DOI 10.1016/1047-2797(94)00113-8; Smith G, 1999, J GEN INTERNAL MED, V14, P537, DOI [10.1046/j.1525-14971999.07048.x, DOI 10.1046/J.1525-14971999.07048.XPMID:10491242]; SOGAARD AJ, 2004, INT J EQUITY HEALTH, V3, DOI DOI 10.1186/1475-9276-3-3; Stang A, 2003, EUR J EPIDEMIOL, V18, P929, DOI 10.1023/A:1025877501423; Symonds RP, 2012, BRIT J CANCER, V107, P1017, DOI 10.1038/bjc.2012.240; The American Association for Public Opinion Research, 2016, STAND DEF FIN DISP C, V9; TIBBLIN G, 1965, ACTA MED SCAND, V178, P453; Tolonen H, 2006, EUR J EPIDEMIOL, V21, P409, DOI 10.1007/s10654-006-9019-8; Vink JM, 2004, EUR J EPIDEMIOL, V19, P623, DOI 10.1023/B:EJEP.0000036814.56108.66; WILHELMSEN L, 1976, J CHRON DIS, V29, P331, DOI 10.1016/0021-9681(76)90093-X	77	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168364	10.1371/journal.pone.0168364	http://dx.doi.org/10.1371/journal.pone.0168364			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8LN	27992587	Green Published, gold, Green Submitted			2022-12-26	WOS:000392758000040
J	Li, J; Wang, Y; Li, QG; Xue, JJ; Wang, Z; Yuan, X; Tong, JD; Xu, LC				Li, Jing; Wang, Ying; Li, Qing-Guo; Xue, Jin-Jun; Wang, Zhu; Yuan, Xin; Tong, Jian-Dong; Xu, Li-Chun			Downregulation of FBP1 Promotes Tumor Metastasis and Indicates Poor Prognosis in Gastric Cancer via Regulating Epithelial-Mesenchymal Transition	PLOS ONE			English	Article							COLORECTAL-CANCER; GLYCOLYSIS; METABOLISM; BINDING	Background Recent studies indicated that some glycolytic enzymes are complicated, multifaceted proteins rather than simple components of the glycolytic pathway. FBP1 plays a vital role in glucose metabolism, but its role in gastric cancer tumorigenesis and metastasis has not been fully understood. Methods The prognostic value of FBP1 was first studied in The Cancer Genome Atlas (TCGA) database and validated in in-house database. The effect of FBP1 on cell proliferation and metastasis was examined in vitro. Nonparametric test and Log-rank test were used to evaluate the clinical significance of FBP1 expression. Results In the TCGA cohort, FBP1 mRNA level were shown to be predictive of overall survival in gastric cancer (P = 0.029). In the validation cohort, FBP1 expression were inversely correlated with advanced N stage (P = 0.021) and lymphovascular invasion (P = 0.011). Multivariate Cox regression analysis demonstrated that FBP1 was an independent predictor for both overall survival (P = 0.004) and disease free survival (P< 0.001). Functional studies demonstrated that ectopic FBP1 expression inhibited proliferation and invasion in gastric cancer cells, while silencing FBP1 expression had opposite effects (P< 0.05). Mechanically, FBP1 serves as a tumor suppressor by inhibiting epithelial-mesenchymal transition (EMT). Conclusions Downregulation of FBP1 promotes gastric cancer metastasis by facilitating EMT and acts as a potential prognostic factor and therapeutic target in gastric cancer.	[Li, Jing; Wang, Ying; Xue, Jin-Jun; Wang, Zhu; Yuan, Xin; Tong, Jian-Dong] Yangzhou Univ, Clin Sch 2, Yangzhou Peoples Hosp 1, Dept Oncol, Yangzhou, Jiangsu, Peoples R China; [Li, Jing; Xu, Li-Chun] Yangzhou Univ, Coll Med, Res Ctr Canc Prevent & Treatment, Yangzhou, Jiangsu, Peoples R China; [Li, Qing-Guo] Fudan Univ, Shanghai Canc Ctr, Dept Colorectal Surg, Shanghai, Peoples R China; [Li, Qing-Guo] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China	Yangzhou University; Yangzhou University; Fudan University; Fudan University	Tong, JD (corresponding author), Yangzhou Univ, Clin Sch 2, Yangzhou Peoples Hosp 1, Dept Oncol, Yangzhou, Jiangsu, Peoples R China.; Xu, LC (corresponding author), Yangzhou Univ, Coll Med, Res Ctr Canc Prevent & Treatment, Yangzhou, Jiangsu, Peoples R China.	drtong_yz@163.com; xzyxyxlc@sohu.com						Alderton GK, 2014, NAT REV CANCER, V14, P575, DOI 10.1038/nrc3810; Dong CF, 2013, CANCER CELL, V23, P316, DOI 10.1016/j.ccr.2013.01.022; Feo S, 2000, FEBS LETT, V473, P47, DOI 10.1016/S0014-5793(00)01494-0; Hamajima N, 2006, CANCER SCI, V97, P1129, DOI 10.1111/j.1349-7006.2006.00290.x; He XX, 2016, ONCOTARGETS THER, V9, P1231, DOI 10.2147/OTT.S99228; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Kondaveeti Y, 2015, CANCER LETT, V364, P44, DOI 10.1016/j.canlet.2015.04.025; Li B, 2014, NATURE, V513, P251, DOI 10.1038/nature13557; Li H, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-110; Li QG, 2015, AM J CANCER RES, V5, P2022; Liu X, 2010, ONCOGENE, V29, P442, DOI 10.1038/onc.2009.332; Majewski N, 2004, MOL CELL BIOL, V24, P730, DOI 10.1128/MCB.24.2.730-740.2004; MITCHELL CJ, 1987, J AM MOSQUITO CONTR, V3, P142; Morabito A, 2009, CRIT REV ONCOL HEMAT, V70, P216, DOI 10.1016/j.critrevonc.2008.08.005; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Qiu ZP, 2015, GASTROENTEROLOGY, V149, P1587, DOI 10.1053/j.gastro.2015.07.050; Seyfried TN, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-7; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Subramanian A, 2000, J BIOL CHEM, V275, P5958, DOI 10.1074/jbc.275.8.5958; Vakiani E, 2012, J CLIN ONCOL, V30, P2956, DOI 10.1200/JCO.2011.38.2994; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xie QP, 2016, J ZHEJIANG UNIV-SC B, V17, P361, DOI 10.1631/jzus.B1500236; Zhang W, 2013, CANCER-AM CANCER SOC, V119, P814, DOI 10.1002/cncr.27826; Zhang Y, 2013, CANCER BIOL THER, V14, P81, DOI 10.4161/cbt.22958	26	23	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0167857	10.1371/journal.pone.0167857	http://dx.doi.org/10.1371/journal.pone.0167857			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27978536	Green Published, Green Submitted, gold			2022-12-26	WOS:000391217400036
J	Ranjan, R; Biswal, JK; Subramaniam, S; Singh, KP; Stenfeldt, C; Rodriguez, LL; Pattnaik, B; Arzt, J				Ranjan, Rajeev; Biswal, Jitendra K.; Subramaniam, Saravanan; Singh, Karam Pal; Stenfeldt, Carolina; Rodriguez, Luis L.; Pattnaik, Bramhadev; Arzt, Jonathan			Foot-and-Mouth Disease Virus-Associated Abortion and Vertical Transmission following Acute Infection in Cattle under Natural Conditions	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS; VIRAL PATHWAYS; CARRIER STATE; PATHOGENESIS; LOCALIZATION; LAMBS; RNA; HYBRIDIZATION; EPIDEMIOLOGY; MYOCARDITIS	Foot-and-mouth disease (FMD) is a highly contagious and economically important viral disease of cloven-hoofed animals, including domestic and wild host species. During recent FMD outbreaks in India, spontaneous abortions were reported amongst FMD-affected and asymptomatic cows. The current study was an opportunistic investigation of these naturally occurring bovine abortions to assess causality of abortion and vertical transmission of FMDV from infected cows to fetuses. For this purpose, fetal tissue samples of eight abortuses (heart, liver, kidney, spleen, palatine tonsil, umbilical cord, soft palate, tongue, lungs, and submandibular lymph node) were collected and screened by various detection methods, including viral genome detection, virus isolation, and immunomicroscopy. Amongst these cases, gross pathological changes were observed in 3 abortuses. Gross pathological findings included blood-tinged peritoneal and pleural effusions and myocarditis. Hearts of infected calves had mild to moderate degeneration and necrosis of the myocardium with moderate infiltration by mixed inflammatory cells. Localization of FMDV antigen was demonstrated in lungs and soft palate by immunomicroscopy. FMDV serotype O viral genome was recovered from 7 of 8 cases. Infectious FMDV serotype O was rescued by chemical transfection of the total RNA extracted from three soft palate samples and was sequenced to confirm 100% identity of the VP1 (capsid) coding region with isolates collected from infected cattle during the acute phase of infection. Based upon these findings, it may be concluded that FMDV-associated abortion occurred among the infected pregnant cows included within this study and FMDV was subsequently transmitted vertically to fetuses. This is the first documentation of FMDV-associated abortions in cattle.	[Ranjan, Rajeev; Biswal, Jitendra K.; Subramaniam, Saravanan; Pattnaik, Bramhadev] ICAR Res Complex, Directorate Foot & Mouth Dis, Naini Tal, Uttarakhand, India; [Singh, Karam Pal] IVRI Izatnagar, CADRAD, Bareilly, Uttar Pradesh, India; [Stenfeldt, Carolina; Rodriguez, Luis L.; Arzt, Jonathan] ARS, Foreign Anim Dis Res Unit, USDA, Plum Isl Anim Dis Ctr, Greenport, NY 11944 USA; [Stenfeldt, Carolina] Oak Ridge Inst Sci & Educ, PIADC Res Participat Program, Oak Ridge, TN USA	Indian Council of Agricultural Research (ICAR); ICAR - Directorate on Foot & Mouth Disease; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; United States Department of Agriculture (USDA); Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education	Ranjan, R (corresponding author), ICAR Res Complex, Directorate Foot & Mouth Dis, Naini Tal, Uttarakhand, India.; Arzt, J (corresponding author), ARS, Foreign Anim Dis Res Unit, USDA, Plum Isl Anim Dis Ctr, Greenport, NY 11944 USA.	drrajraj@gmail.com; jonathan.arzt@ars.usda.gov	Subramaniam, Saravanan/J-8444-2014; Stenfeldt, Carolina/AAG-7940-2021	Pattnaik, Bramhadev/0000-0003-0869-7722; Arzt, Jonathan/0000-0002-7517-7893; Stenfeldt, Carolina/0000-0002-2074-3886; Subramaniam, Saravanan/0000-0003-1737-4976	Indian Council of Agricultural Research, New Delhi; Agricultural Research Service-Current Research information System Project [1940-32000-057-00D]; United States Department of State, Biosecurity Engagement Program through the United States Department of Agriculture, Agricultural Research Service Office of International Research Programs; Plum Island Animal Disease Center Research Participation Program fellowship; PIADC Research Participation Program fellowships; Biological Engagement Program, Department of State	Indian Council of Agricultural Research, New Delhi(Indian Council of Agricultural Research (ICAR)); Agricultural Research Service-Current Research information System Project; United States Department of State, Biosecurity Engagement Program through the United States Department of Agriculture, Agricultural Research Service Office of International Research Programs; Plum Island Animal Disease Center Research Participation Program fellowship; PIADC Research Participation Program fellowships; Biological Engagement Program, Department of State	This work was funded by the Indian Council of Agricultural Research, New Delhi. Additional funding was provided by Agricultural Research Service-Current Research information System Project 1940-32000-057-00D and the United States Department of State, Biosecurity Engagement Program through the United States Department of Agriculture, Agricultural Research Service Office of International Research Programs. The funding sources had no role in study design, data collection and analysis or the decision to publish the work. CS is a recipient of a Plum Island Animal Disease Center Research Participation Program fellowship, administered by the Oak Ridge Institute for Science and Education (ORISE, www.orau.org) through an interagency agreement with the US Department of Energy.; We are thankful to staff of experimental dairy farm for their invaluable cooperation during this study. Technical assistance of Mr. Basant, Uttam Nath Goswami, Shyam Lal Tamta, and Mr. B. D as are highly acknowledged. Steven Pauszek and Michael Eschbaumer areacknowledged for review of the manuscript. CS was a recipient of PIADC Research Participation Program fellowships, administered by the Oak Ridge Institute for Science and Education (ORISE) through an interagency agreement with the U.S. Department of Energy. The Office of International Research Programs, Agricultural Research Service USDA facilitated funding from the Biological Engagement Program, Department of State.	Alexandersen S, 2003, J COMP PATHOL, V129, P268, DOI 10.1016/S0021-9975(03)00045-8; Alexandersen S, 2003, J COMP PATHOL, V129, P1, DOI 10.1016/S0021-9975(03)00041-0; Ali S. M., 2013, Global Veterinaria, V11, P472; AMEDEE AM, 1995, J VIROL, V69, P7982, DOI 10.1128/JVI.69.12.7982-7990.1995; Arzt J, 2011, TRANSBOUND EMERG DIS, V58, P305, DOI 10.1111/j.1865-1682.2011.01236.x; Arzt J, 2011, TRANSBOUND EMERG DIS, V58, P291, DOI 10.1111/j.1865-1682.2011.01204.x; Arzt J, 2010, VET PATHOL, V47, P1048, DOI 10.1177/0300985810372509; Arzt J, 2009, J VET DIAGN INVEST, V21, P779, DOI 10.1177/104063870902100604; Belbis G, 2013, VET MICROBIOL, V166, P394, DOI 10.1016/j.vetmic.2013.06.020; Bhattacharyya R, 1996, INDIAN J ANIM SCI, V66, P39; Bisht P, 2014, J VIROL METHODS, V196, P65, DOI 10.1016/j.jviromet.2013.10.041; Biswal J. K., 2015, Indian Journal of Veterinary Pathology, V39, P376, DOI 10.5958/0973-970X.2015.00094.2; Biswal JK, 2012, INDIAN J ANIM SCI, V82, P109; BROWN CC, 1992, CAN J VET RES, V56, P189; Brown CC, 1996, J VIROL, V70, P5638, DOI 10.1128/JVI.70.8.5638-5641.1996; BURROWS R, 1981, J COMP PATHOL, V91, P599, DOI 10.1016/0021-9975(81)90089-X; BURROWS R, 1966, J HYG-CAMB, V64, P81, DOI 10.1017/S0022172400040365; Charleston B, 2011, SCIENCE, V332, P726, DOI 10.1126/science.1199884; DEBELDER AJ, 1993, LANCET, V341, P84, DOI 10.1016/0140-6736(93)92559-C; Geering W. A., 1967, Australian Veterinary Journal, V43, P485, DOI 10.1111/j.1751-0813.1967.tb04774.x; Giridharan P, 2005, J VIROL METHODS, V126, P1, DOI 10.1016/j.jviromet.2005.01.015; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Gulbahar MY, 2007, VET PATHOL, V44, P589, DOI 10.1354/vp.44-5-589; Hemadri D, 2002, VIRUS GENES, V25, P23, DOI 10.1023/A:1020165923805; Juleff N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003434; Kandeil A, 2013, ARCH VIROL, V158, P619, DOI 10.1007/s00705-012-1529-y; Karapinar T, 2010, CAN VET J, V51, P397; Kelly RA, 1996, CIRC RES, V79, P363, DOI 10.1161/01.RES.79.3.363; KHUROO MS, 1995, LANCET, V345, P1025, DOI 10.1016/S0140-6736(95)90761-0; Knowles NJ, 2003, VIRUS RES, V91, P65, DOI 10.1016/S0168-1702(02)00260-5; Knowles NJ, 1994, RPT SESS RES GP STAN, P45; Knowles NJ, 2014, TRANSBOUND EMERG DIS; MacLachlan J, 2011, FENNERS VET VIROLOGY; Meas S, 2002, VET MICROBIOL, V84, P275, DOI 10.1016/S0378-1135(01)00458-8; Mohapatra JK, 2011, J GEN VIROL, V92, P873, DOI 10.1099/vir.0.028555-0; Murphy MLP, 1999, VIRUS RES, V62, P67, DOI 10.1016/S0168-1702(99)00050-7; Nazlioglu M., 1972, Bulletin de l'Office International des Epizooties, V77, P1281; Orsel K, 2009, PREV VET MED, V88, P158, DOI 10.1016/j.prevetmed.2008.09.001; Pacheco JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125698; Pacheco JM, 2010, VET J, V183, P46, DOI 10.1016/j.tvjl.2008.08.023; Ranjan Rajeev, 2014, VirusDisease, V25, P358, DOI 10.1007/s13337-014-0211-2; Reid HW, 2002, VET REC, V150, P791; ROBSON KJH, 1977, J GEN VIROL, V37, P271, DOI 10.1099/0022-1317-37-2-271; Ryan E, 2008, J COMP PATHOL, V138, P108, DOI 10.1016/j.jcpa.2007.12.001; Ryan E, 2008, VET MICROBIOL, V127, P258, DOI 10.1016/j.vetmic.2007.08.029; Samuel AR, 2001, J GEN VIROL, V82, P609, DOI 10.1099/0022-1317-82-3-609; Senturk B, 2005, VET MED-CZECH, V50, P451, DOI 10.17221/5649-VETMED; Singh R, 2008, INDIAN J ANIM SCI, V78, P3; Stenfeldt C, 2016, J VIROL, V90, P6344, DOI 10.1128/JVI.00388-16; Stenfeldt C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143666; Stenfeldt C, 2014, ACTA VET SCAND, V56, DOI 10.1186/s13028-014-0042-6; Subramaniam S, 2015, INFECT GENET EVOL, V30, P59, DOI 10.1016/j.meegid.2014.12.009; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TRAUTWEIN G, 1986, J VET MED B, V33, P260, DOI 10.1111/j.1439-0450.1986.tb00031.x; Valdazo-Gonzalez B, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00242-14; van der Sluijs MTW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081429; WRL-FMD, 2015, WRLFMD Q REP APR JUN; WRL-FMD, 2015, OIE FAO REF LAB NETW; Zhang SJ, 2005, J GEN VIROL, V86, P2721, DOI 10.1099/vir.0.81168-0; Zhang ZD, 2004, J GEN VIROL, V85, P2567, DOI 10.1099/vir.0.80011-0; Zhang ZD, 2001, J COMP PATHOL, V124, P89, DOI 10.1053/jcpa.2000.0431	61	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0167163	10.1371/journal.pone.0167163	http://dx.doi.org/10.1371/journal.pone.0167163			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977708	gold, Green Submitted, Green Published			2022-12-26	WOS:000391217400013
J	Yu, C; Hu, XM; Deng, W; Li, Y; Han, GM; Xiong, C				Yu, Cui; Hu, Xingming; Deng, Wen; Li, Yong; Han, Guangming; Xiong, Chao			Response of Bacteria Community to Long-Term Inorganic Nitrogen Application in Mulberry Field Soil	PLOS ONE			English	Article							MICROBIAL COMMUNITY; DIVERSITY; PH; FERTILIZER; BARLEY; MANURE	The bacterial community and diversity in mulberry field soils with different application ages of inorganic nitrogen fertilizer (4Y, 4-year-old; 17Y, 17-year-old; 32Y, 32-year-old) were investigated using next-generation sequencing. The results demonstrated that the application ages of nitrogen fertilizer significantly altered soil bacterial community and diversity. Soil bacterial Shannon diversity index and Chao 1 index decreased with the consecutive application of nitrogen fertilizer, and the 4Y soil exhibited the highest bacterial relative abundance and diversity. Of 45 bacterial genera (relative abundance ratio of genera greater than 0.3%), 18 were significantly affected by the plant age, and seven belong to Acidobacteria. The relative abundances of Acidobacteria Gp 1, Gp4 and Gp6 in the 4Y soil were significantly lower than that of in the 17Y and 32Y soils. However, the relative abundance of Pseudononas sp. in the 4Y soil was significantly higher than that of in the 17Y and 32Y soils. Most microbial parameters were significantly affected by soil pH and organic matter content which were significantly changed by long-term application of inorganic nitrogen fertilizer.	[Yu, Cui; Hu, Xingming; Deng, Wen; Li, Yong; Han, Guangming; Xiong, Chao] Hubei Acad Agr Sci, Ind Crops Inst, Wuhan, Peoples R China	Hubei Academy of Agricultural Sciences	Yu, C; Hu, XM (corresponding author), Hubei Acad Agr Sci, Ind Crops Inst, Wuhan, Peoples R China.	mrsyu888@hotmail.com; 13607121598@163.com			National Natural Science Foundation of China [31300518]; Earmarked Fund for Modern Agro-industry Technology Research System [CARS-22]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Earmarked Fund for Modern Agro-industry Technology Research System	This study was supported by the National Natural Science Foundation of China, 31300518 to Dr. Cui Yu, and the Earmarked Fund for Modern Agro-industry Technology Research System, CARS-22 to Dr. Xingming Hu.	Blakemore L. C., 1972, Scientific Report, New Zealand Soil Bureau; Bossio DA, 2006, SOIL BIOL BIOCHEM, V38, P1223, DOI 10.1016/j.soilbio.2005.09.027; Chan YK, 2013, APPL SOIL ECOL, V68, P26, DOI 10.1016/j.apsoil.2013.03.004; Chen F, 2009, J PLANT NUTR SOIL SC, V172, P245, DOI 10.1002/jpln.200800093; Chu HY, 2010, ENVIRON MICROBIOL, V12, P2998, DOI 10.1111/j.1462-2920.2010.02277.x; Doran JW, 2000, APPL SOIL ECOL, V15, P3, DOI 10.1016/S0929-1393(00)00067-6; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fu QingXia, 2015, Acta Ecologica Sinica - International Journal, V35, P22; Gopalakrishnan S, 2015, 3 BIOTECH, V5, P653, DOI 10.1007/s13205-014-0263-4; Griffiths RI, 2011, ENVIRON MICROBIOL, V13, P1642, DOI 10.1111/j.1462-2920.2011.02480.x; [顾美英 Gu Meiying], 2012, [生态学报, Acta Ecologica Sinica], V32, P3031; Kennedy N, 2005, ENVIRON MICROBIOL, V7, P780, DOI 10.1111/j.1462-2920.2005.00748.x; Lan YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032491; Lanyon L. E., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P247; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Luo PY, 2015, ANN MICROBIOL, V65, P533, DOI 10.1007/s13213-014-0889-9; Lupwayi NZ, 2012, SOIL TILL RES, V118, P139, DOI 10.1016/j.still.2011.11.006; Lupwayi NZ, 2011, AGRON J, V103, P1064, DOI 10.2134/agronj2010.0334; Lupwayi NZ, 2010, APPL SOIL ECOL, V45, P254, DOI 10.1016/j.apsoil.2010.04.013; [马宁宁 Ma Ningning], 2013, [园艺学报, Acta Horticulturae Sinica], V40, P255; Mannisto MK, 2007, FEMS MICROBIOL ECOL, V59, P452, DOI 10.1111/j.1574-6941.2006.00232.x; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Nicol GW, 2004, ENVIRON MICROBIOL, V6, P861, DOI 10.1111/j.1462-2920.2004.00627.x; Ogilvie LA, 2008, MICROB ECOL, V56, P525, DOI 10.1007/s00248-008-9372-0; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Sarathchandra SU, 2001, SOIL BIOL BIOCHEM, V33, P953, DOI 10.1016/S0038-0717(00)00245-5; Shen CC, 2013, SOIL BIOL BIOCHEM, V57, P204, DOI 10.1016/j.soilbio.2012.07.013; Sradnick A, 2013, APPL SOIL ECOL, V63, P23, DOI 10.1016/j.apsoil.2012.09.011; Yao HY, 2006, PLANT SOIL, V284, P195, DOI 10.1007/s11104-006-0023-2; Yeoh YK, 2016, ENVIRON MICROBIOL, V18, P1338, DOI 10.1111/1462-2920.12925; Yu C, 2015, APPL SOIL ECOL, V86, P30, DOI 10.1016/j.apsoil.2014.09.013; Yu C, 2011, SCI SERICUL, V37, P0899; Zhang NL, 2008, PLANT SOIL, V311, P19, DOI 10.1007/s11104-008-9650-0	33	12	13	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168152	10.1371/journal.pone.0168152	http://dx.doi.org/10.1371/journal.pone.0168152			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977728	Green Published, gold			2022-12-26	WOS:000391217400070
J	Takahashi, M; Li, YP; Dillon, TJ; Stork, PJS				Takahashi, Maho; Li, Yanping; Dillon, Tara J.; Stork, Philip J. S.			Phosphorylation of Rap1 by cAMP-dependent Protein Kinase (PKA) Creates a Binding Site for KSR to Sustain ERK Activation by cAMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASES; B-RAF; CYCLIC-AMP; CELL-PROLIFERATION; MELANOMA-CELLS; MAP KINASE; PATHWAY; SUPPRESSOR; SCAFFOLD; CALCIUM	Cyclic adenosine monophosphate (cAMP) is an important mediator of hormonal stimulation of cell growth and differentiation through its activation of the extracellular signal-regulated kinase (ERK) cascade. Two small G proteins, Ras and Rap1 have been proposed to mediate this activation. Using HEK293 cells as a model system, we have recently shown that both Ras and Rap1 are required for cAMP signaling to ERKs. However, cAMP-dependent Ras signaling to ERKs is transient and rapidly terminated by PKA phosphorylation of the Raf isoforms C-Raf and B-Raf. In contrast, cAMP-dependent Rap1 signaling to ERKs and Rap1 is potentiated by PKA. We show that this is due to sustained binding of B-Raf to Rap1. One of the targets of PKA is Rap1 itself, directly phosphorylating Rap1a on serine 180 and Rap1b on serine 179. We show that these phosphorylations create potential binding sites for the adaptor protein 14-3-3 that links Rap1 to the scaffold protein KSR. These results suggest that Rap1 activation of ERKs requiresPKAphosphorylation and KSR binding. Because KSR and B-Raf exist as heterodimers within the cell, this binding also brings B-Raf to Rap1, allowing Rap1 to couple to ERKs through B-Raf binding to Rap1 independently of its Ras-binding domain.	[Takahashi, Maho; Li, Yanping; Dillon, Tara J.; Stork, Philip J. S.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Oregon Health & Science University	Stork, PJS (corresponding author), Oregon Hlth & Sci Univ, L474,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	stork@ohsu.edu	li, yan/GTI-4638-2022		National Institutes of Health [R01 DK090309, R21 CA191392-01]; NATIONAL CANCER INSTITUTE [T32CA106195, R21CA191392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090309] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK090309 and R21 CA191392-01. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alleaume C, 2003, NEUROPEPTIDES, V37, P98, DOI 10.1016/S0143-4179(03)00020-9; ALTSCHULER D, 1993, J BIOL CHEM, V268, P7527; Athuluri-Divakar SK, 2016, CELL, V165, P643, DOI 10.1016/j.cell.2016.03.045; Bhatt KV, 2007, ONCOGENE, V26, P1056, DOI 10.1038/sj.onc.1209861; Cacace AM, 1999, MOL CELL BIOL, V19, P229; Carey KD, 2003, J BIOL CHEM, V278, P3185, DOI 10.1074/jbc.M207014200; Chadee DN, 2004, NAT CELL BIOL, V6, P770, DOI 10.1038/ncb1152; Dugan LL, 1999, J BIOL CHEM, V274, P25842, DOI 10.1074/jbc.274.36.25842; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; Dumaz N, 2003, J BIOL CHEM, V278, P29819, DOI 10.1074/jbc.C300182200; Edreira MM, 2009, J BIOL CHEM, V284, P27480, DOI 10.1074/jbc.M109.011312; Ehses JA, 2002, J BIOL CHEM, V277, P37088, DOI 10.1074/jbc.M205055200; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Fernandez MR, 2012, MOL CELL BIOL, V32, P3718, DOI 10.1128/MCB.06754-11; FISCHER TH, 1991, FEBS LETT, V283, P173, DOI 10.1016/0014-5793(91)80581-M; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Fujita T, 2002, J BIOL CHEM, V277, P22191, DOI 10.1074/jbc.M110364200; Gao L, 2006, CANCER RES, V66, P7880, DOI 10.1158/0008-5472.CAN-06-0254; Gomez E, 2002, J BIOL CHEM, V277, P48146, DOI 10.1074/jbc.M209165200; Grewal SS, 2000, J BIOL CHEM, V275, P3722, DOI 10.1074/jbc.275.5.3722; Hisata S, 2007, J CELL BIOL, V178, P843, DOI 10.1083/jcb.200610073; Hu JC, 2013, CELL, V154, P1036, DOI 10.1016/j.cell.2013.07.046; Hu JC, 2011, P NATL ACAD SCI USA, V108, P6067, DOI 10.1073/pnas.1102554108; Iacovelli L, 2001, MOL PHARMACOL, V60, P924, DOI 10.1124/mol.60.5.924; Insel PA, 2003, CELL MOL NEUROBIOL, V23, P305, DOI 10.1023/A:1023684503883; Jagemann LR, 2008, J BIOL CHEM, V283, P17450, DOI 10.1074/jbc.M709185200; Karhoff D, 2007, NEUROENDOCRINOLOGY, V85, P45, DOI 10.1159/000100508; Kortum RL, 2006, MOL CELL BIOL, V26, P2202, DOI 10.1128/MCB.26.6.2202-2214.2006; Kovalovsky D, 2002, MOL ENDOCRINOL, V16, P1638, DOI 10.1210/me.16.7.1638; Kuroda S, 1996, J BIOL CHEM, V271, P14680, DOI 10.1074/jbc.271.25.14680; Le Pechon-Vallee C, 2000, NEUROENDOCRINOLOGY, V72, P46, DOI 10.1159/000054570; Li YP, 2016, J BIOL CHEM, V291, P21584, DOI 10.1074/jbc.M116.730978; Li YP, 2013, J BIOL CHEM, V288, P27646, DOI 10.1074/jbc.M113.463067; Light Y, 2002, MOL CELL BIOL, V22, P4984, DOI 10.1128/MCB.22.14.4984-4996.2002; Liu C, 2008, MOL CELL BIOL, V28, P7109, DOI 10.1128/MCB.01060-08; Liu C, 2010, MOL CELL BIOL, V30, P3956, DOI 10.1128/MCB.00242-10; McKay Melissa M, 2011, Small GTPases, V2, P276; McKay MM, 2011, CURR BIOL, V21, P563, DOI 10.1016/j.cub.2011.02.033; McKay MM, 2009, P NATL ACAD SCI USA, V106, P11022, DOI 10.1073/pnas.0901590106; Monaghan TK, 2008, J NEUROCHEM, V104, P74, DOI 10.1111/j.1471-4159.2007.05018.x; Morozov A, 2003, NEURON, V39, P309, DOI 10.1016/S0896-6273(03)00404-5; Muller J, 2001, MOL CELL, V8, P983, DOI 10.1016/S1097-2765(01)00383-5; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Ottmann C, 2007, EMBO J, V26, P902, DOI 10.1038/sj.emboj.7601530; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P422, DOI 10.1016/S0968-0004(96)30038-8; Qiu WS, 2000, J BIOL CHEM, V275, P31921, DOI 10.1074/jbc.M003327200; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Ribeiro-Neto F, 2002, P NATL ACAD SCI USA, V99, P5418, DOI 10.1073/pnas.082122499; Riou P, 2013, CELL, V153, P640, DOI 10.1016/j.cell.2013.03.044; Romano D, 2003, J BIOL CHEM, V278, P51386, DOI 10.1074/jbc.M308372200; Roskoski R, 2010, BIOCHEM BIOPH RES CO, V399, P313, DOI 10.1016/j.bbrc.2010.07.092; Schmitt JM, 2000, J BIOL CHEM, V275, P25342, DOI 10.1074/jbc.M003213200; Seifert R, 2012, TRENDS PHARMACOL SCI, V33, P64, DOI 10.1016/j.tips.2011.10.006; Smith FD, 2010, NAT CELL BIOL, V12, P1242, DOI 10.1038/ncb2130; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Takahashi M, 2013, J BIOL CHEM, V288, P27712, DOI 10.1074/jbc.M113.466904; Therrien M, 1996, GENE DEV, V10, P2684, DOI 10.1101/gad.10.21.2684; Van Kolen K, 2010, NEUROPHARMACOLOGY, V58, P135, DOI 10.1016/j.neuropharm.2009.06.022; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Vuchak LA, 2009, MOL PHARMACOL, V76, P1123, DOI 10.1124/mol.109.060129; Wang ZP, 2006, MOL CELL BIOL, V26, P2130, DOI 10.1128/MCB.26.6.2130-2145.2006; Wohlgemuth S, 2005, J MOL BIOL, V348, P741, DOI 10.1016/j.jmb.2005.02.048; Yamaguchi T, 2004, J BIOL CHEM, V279, P40419, DOI 10.1074/jbc.M405079200; Zeiller C, 2012, CELL SIGNAL, V24, P2237, DOI 10.1016/j.cellsig.2012.08.006; Zhou M, 2002, J MOL BIOL, V315, P435, DOI 10.1006/jmbi.2001.5263	68	30	31	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1449	1461		10.1074/jbc.M116.768986	http://dx.doi.org/10.1074/jbc.M116.768986			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	28003362	Green Published, hybrid			2022-12-26	WOS:000393339800026
J	Boer, EF; Jette, CA; Stewart, RA				Boer, Elena F.; Jette, Cicely A.; Stewart, Rodney A.			Neural Crest Migration and Survival Are Susceptible to Morpholino-Induced Artifacts	PLoS One			English	Article							ZEBRAFISH FOXD3; GENE; EXPRESSION; EMBRYO; MUTANT; SPECIFICATION; DERIVATIVES; TECHNOLOGY; KNOCKDOWNS; TFAP2A	The neural crest (NC) is a stem cell-like embryonic population that is essential for generating and patterning the vertebrate body, including the craniofacial skeleton and peripheral nervous system. Defects in NC development underlie many birth defects and contribute to formation of some of the most malignant cancers in humans, such as melanoma and neuroblastoma. For these reasons, significant research efforts have been expended to identify genes that control NC development, as it is expected to lead to a deeper understanding of the genetic mechanisms controlling vertebrate development and identify new treatments for NC-derived diseases and cancers. However, a number of inconsistencies regarding gene function during NC development have emerged from comparative analyses of gene function between mammalian and non-mammalian systems (chick, frog, zebrafish). This poses a significant barrier to identification of single genes and/or redundant pathways to target in NC diseases. Here, we determine whether technical differences, namely morpholino-based approaches used in non mammalian systems, could contribute to these discrepancies, by examining the extent to which NC phenotypes in fascin la (fscnla) morphant embryos are similar to or different from fscnla null mutants in zebrafish. Analysis of fscnla morphants showed that they mimicked early NC phenotypes observed in fscnla null mutants; however, these embryos also displayed NC migration and derivative phenotypes not observed in null mutants, including accumulation of p53-independent cell death. These data demonstrate that morpholinos can cause seemingly specific NC migration and derivative phenotypes, and thus have likely contributed to the inconsistencies surrounding NC gene function between species. We suggest that comparison of genetic mutants between different species is the most rigorous method for identifying conserved genetic mechanisms controlling NC development and is critical to identify new treatments for NC diseases.	[Boer, Elena F.; Jette, Cicely A.; Stewart, Rodney A.] Univ Utah, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Stewart, RA (corresponding author), Univ Utah, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.	rodney.stewart@hci.utah.edu	Stewart, Rodney/ABA-6757-2020	Stewart, Rodney/0000-0003-1220-1830; Boer, Elena/0000-0002-7015-4852	March of Dimes Foundation [5-FY12-29]; Huntsman Cancer Foundation; American Cancer Society [124250-RSG-13-025-01-CSM]; NIH Developmental Biology Training Grant [5T32 HD07491]; NCRR Shared Equipment Grant [1S10RR024761-01]	March of Dimes Foundation(March of Dimes); Huntsman Cancer Foundation; American Cancer Society(American Cancer Society); NIH Developmental Biology Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR Shared Equipment Grant	RAS is supported by grants from the March of Dimes Foundation 5-FY12-29 (http://www.marchofdimes.com), Huntsman Cancer Foundation (http://healthcare.utah.edu/huntsmancancerinstrtute/giving/huntsrnan-cancer-foundation/) and the American Cancer Society 124250-RSG-13-025-01-CSM (www.cancer.org). EFB was supported by an NIH Developmental Biology Training Grant (5T32 HD07491). Microscopy equipment was obtained using a NCRR Shared Equipment Grant #1S10RR024761-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arduini BL, 2009, DEVELOPMENT, V136, P1987, DOI 10.1242/dev.033209; Auer TO, 2014, METHODS, V69, P142, DOI 10.1016/j.ymeth.2014.03.027; Barriga EH, 2015, DEVELOPMENT, V142, P1555, DOI 10.1242/dev.121590; Bill BR, 2009, ZEBRAFISH, V6, P69, DOI 10.1089/zeb.2008.0555; Blader P, 2003, MECH DEVELOP, V120, P211, DOI 10.1016/S0925-4773(02)00413-6; Boer EF, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004946; Duong TD, 2004, DEV DYNAM, V229, P42, DOI 10.1002/dvdy.10465; Dutton K, 2001, GENESIS, V30, P188, DOI 10.1002/gene.1062; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Ekker SC, 2001, GENESIS, V30, P89, DOI 10.1002/gene.1038; Etchevers HC, 2006, ADV EXP MED BIOL, V589, P213; Fafeur V, 1997, CELL GROWTH DIFFER, V8, P655; Gao ZG, 2010, DEVELOPMENT, V137, P1543, DOI 10.1242/dev.047696; Hashimoto Y, 2011, J PATHOL, V224, P289, DOI 10.1002/path.2894; Hoffman TL, 2007, J EXP ZOOL PART B, V308B, P679, DOI 10.1002/jez.b.21189; Huang P, 2012, J GENET GENOMICS, V39, P421, DOI 10.1016/j.jgg.2012.07.004; Inoue K, 2006, J BIOL CHEM, V281, P33814, DOI 10.1074/jbc.M607290200; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Jette CA, 2008, CELL DEATH DIFFER, V15, P1063, DOI 10.1038/cdd.2008.42; Kimmel CB, 1998, DEV BIOL, V203, P245, DOI 10.1006/dbio.1998.9016; Kirby BB, 2006, NAT NEUROSCI, V9, P1506, DOI 10.1038/nn1803; Knight RD, 2003, DEVELOPMENT, V130, P5755, DOI 10.1242/dev.00575; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Law SHW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100268; Lawson ND, 2011, DEV CELL, V21, P48, DOI 10.1016/j.devcel.2011.06.007; Le Douarin N. M, 2009, NEURAL CREST; Lister JA, 2006, DEV BIOL, V290, P92, DOI 10.1016/j.ydbio.2005.11.014; Maguire LH, 2015, DEV DYNAM, V244, P311, DOI 10.1002/dvdy.24226; Mikami S, 2015, BIOL OPEN, V4, P1576, DOI 10.1242/bio.014225; Montero-Balaguer M, 2006, DEV DYNAM, V235, P3199, DOI 10.1002/dvdy.20959; Murray SA, 2006, P NATL ACAD SCI USA, V103, P10300, DOI 10.1073/pnas.0602234103; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nechiporuk A, 2007, DEVELOPMENT, V134, P611, DOI 10.1242/dev.02749; Novodvorsky P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141611; Piotrowski T, 2000, DEV BIOL, V225, P339, DOI 10.1006/dbio.2000.9842; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Schulte-Merker S, 2014, DEVELOPMENT, V141, P3103, DOI 10.1242/dev.112003; Shmukler BE, 2015, HAEMATOLOGICA, V100, pE483, DOI 10.3324/haematol.2015.132449; Simoes-Costa M, 2015, DEVELOPMENT, V142, P242, DOI 10.1242/dev.105445; Sorrells S, 2013, JOVE-J VIS EXP, DOI 10.3791/51060; Sorrells S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002922; Stewart RA, 2006, DEV BIOL, V292, P174, DOI 10.1016/j.ydbio.2005.12.035; Taibi A, 2013, DEV DYNAM, V242, P614, DOI 10.1002/dvdy.23958; THISSE C, 1993, DEVELOPMENT, V119, P1203; Tucker B, 2007, ZEBRAFISH, V4, P113, DOI 10.1089/zeb.2007.0508; Wang WD, 2011, DEV BIOL, V360, P173, DOI 10.1016/j.ydbio.2011.09.019; Westerfield M, 1993, ZEBRAFISH BOOK	49	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0167278	10.1371/journal.pone.0167278	http://dx.doi.org/10.1371/journal.pone.0167278			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005909	Green Published, gold, Green Submitted			2022-12-26	WOS:000392843200012
J	Strona, G; Mauri, A; Veech, JA; Seufert, G; Ayanz, JSM; Fattorini, S				Strona, Giovanni; Mauri, Achille; Veech, Joseph A.; Seufert, Guenther; Ayanz, Jesus San-Miguel; Fattorini, Simone			Far from Naturalness: How Much Does Spatial Ecological Structure of European Tree Assemblages Depart from Potential Natural Vegetation?	PLOS ONE			English	Article							NULL MODEL; FOREST; NESTEDNESS; DIVERSITY; COOCCURRENCE; COMPETITION; MODULARITY; NETWORKS; PATTERNS; WORLDS	Contemporaneous plant communities may retain a mark of past disturbances in their ecological patterns. However, unraveling the history of disturbance on natural systems at a large scale is often unfeasible, due to the complexity of the factors involved and lack of historical data. Here we aim at demonstrating how comparing observed spatial structure of tree assemblages with that expected in a hypothetical, undisturbed scenario can shed light on how natural European forests are. Borrowing an analytical approach developed in the field of network analysis, we assessed how much the observed ecological patterns of nestedness (i.e. positive co-occurrence), segregation (i.e. negative co-occurrence), and modularity in tree assemblages deviate from randomness, and from those projected by Potential Natural Vegetation (PNV) geobotanical expert assessments. We found clear evidence that European forests are far from a natural condition, showing only moderate signals (especially at higher latitudes) of the ecological spatial structure typical of undisturbed vegetation (i.e. nestedness). Our results highlight how taking into account spatial structure along with diversity can be a fundamental tool to address this problem and assess the degree of naturalness in species assemblages.	[Strona, Giovanni; Mauri, Achille; Seufert, Guenther; Ayanz, Jesus San-Miguel] European Commiss, Joint Res Ctr, Directorate D Sustainable Resources Bioecon Unit, Ispra, VA, Italy; [Veech, Joseph A.] Texas State Univ, Dept Biol, San Marcos, TX USA; [Fattorini, Simone] Univ Laquila, Dept Life Hlth & Environm Sci, Laquila, Italy; [Fattorini, Simone] Azorean Biodivers Grp, CE3C Ctr Ecol Evolut & Environm Changes, Azores, Portugal; [Fattorini, Simone] Univ Acores, Dept Ciencias Agr, Azores, Portugal	European Commission Joint Research Centre; EC JRC ISPRA Site; Texas State University System; Texas State University San Marcos; University of L'Aquila; Universidade dos Acores	Strona, G (corresponding author), European Commiss, Joint Res Ctr, Directorate D Sustainable Resources Bioecon Unit, Ispra, VA, Italy.	goblinshrimp@gmail.com	Fattorini, Simone/E-7075-2012	Fattorini, Simone/0000-0002-4517-2135; Strona, Giovanni/0000-0003-2294-4013				ATTIWILL PM, 1994, FOREST ECOL MANAG, V63, P247, DOI 10.1016/0378-1127(94)90114-7; Azovsky AI, 2009, ECOL COMPLEX, V6, P308, DOI 10.1016/j.ecocom.2008.12.001; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bobiec A, 2002, FOREST ECOL MANAG, V165, P125, DOI 10.1016/S0378-1127(01)00655-7; Bohn U, 2003, MAP NATURAL VEGETATI; Bohn Udo, 2006, Biology and Environment, V106B, P199, DOI 10.3318/BIOE.2006.106.3.199; Bradshaw CJA, 2007, GLOBAL CHANGE BIOL, V13, P2379, DOI 10.1111/j.1365-2486.2007.01446.x; Brooks ML, 2004, BIOSCIENCE, V54, P677, DOI 10.1641/0006-3568(2004)054[0677:EOIAPO]2.0.CO;2; Brown J. H., 1995, MACROECOLOGY; Butaye J, 2001, ECOGRAPHY, V24, P369, DOI 10.1034/j.1600-0587.2001.d01-193.x; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Chiarucci A, 2010, J VEG SCI, V21, P1172, DOI 10.1111/j.1654-1103.2010.01218.x; Clements F.E., 1916, PLANT SUCCESSION ANA; Diamond J.M., 1975, P342; DIAMOND JM, 1982, OECOLOGIA, V52, P64, DOI 10.1007/BF00349013; Dickie IA, 2005, ECOL LETT, V8, P1191, DOI 10.1111/j.1461-0248.2005.00822.x; Diez JM, 2007, ECOLOGY, V88, P3144, DOI 10.1890/07-0047.1; Durrant T, 2011, 24777 EUR EN, P36; Ellenberg H., 1963, VEGETATION MITTELEUR; Fukami T, 2005, ECOL LETT, V8, P1283, DOI 10.1111/j.1461-0248.2005.00829.x; GAILLARD MJ, 2007, ENCY QUATERNARY SCI, P2570, DOI DOI 10.1016/B0-44-452747-8/00214-3; Gaston K.J., 2000, PATTERN PROCESS MACR, DOI [10.1002/9780470999592, DOI 10.1002/9780470999592]; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.2307/3072040; Haas SE, 2011, ECOL LETT, V14, P1108, DOI 10.1111/j.1461-0248.2011.01679.x; Hansen MC, 2000, INT J REMOTE SENS, V21, P1331, DOI 10.1080/014311600210209; Hausdorf B, 2007, OIKOS, V116, P818, DOI 10.1111/j.2007.0030-1299.15661.x; Honnay O, 1999, OIKOS, V84, P119, DOI 10.2307/3546872; Hubbell Stephen P., 2001, V32, pi; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Jimenez JJ, 2014, BMC ECOL, V14, DOI 10.1186/s12898-014-0026-4; Kaplan JO, 2009, QUATERNARY SCI REV, V28, P3016, DOI 10.1016/j.quascirev.2009.09.028; Karadimou E, 2015, J VEG SCI, V26, P501, DOI 10.1111/jvs.12255; Kier G, 2005, J BIOGEOGR, V32, P1107, DOI 10.1111/j.1365-2699.2005.01272.x; Leibold MA, 1998, EVOL ECOL, V12, P95, DOI 10.1023/A:1006511124428; Liu JG, 2007, AMBIO, V36, P639, DOI 10.1579/0044-7447(2007)36[639:CHANS]2.0.CO;2; Lloyd C. D., 2010, LOCAL MODELS SPATIAL; Loidi J, 2012, J VEG SCI, V23, P596, DOI 10.1111/j.1654-1103.2012.01387.x; Lomolino M.V., 2010, BIOGEOGRAPHY, Vfourth; Mauri A, 2017, SCI DATA, V4, DOI 10.1038/sdata.2016.123; McGill BJ, 2003, NATURE, V422, P881, DOI 10.1038/nature01583; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Perrings C, 2005, TRENDS ECOL EVOL, V20, P212, DOI 10.1016/j.tree.2005.02.011; Potapov P, 2008, ECOL SOC, V13, DOI 10.5751/es-02670-130251; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; Punchi-Manage R, 2014, ECOLOGY, V95, P376, DOI 10.1890/12-2102.1; Ricotta C, 2002, APPL VEG SCI, V5, P271, DOI 10.1111/j.1654-109X.2002.tb00557.x; Simova I, 2015, ECOGRAPHY, V38, P649, DOI 10.1111/ecog.00867; Skelsey P, 2005, PHYTOPATHOLOGY, V95, P328, DOI 10.1094/PHYTO-95-0328; Somodi I, 2012, J VEG SCI, V23, P590, DOI 10.1111/j.1654-1103.2011.01378.x; Staniczenko PPA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2422; STEADMAN DW, 1993, P NATL ACAD SCI USA, V90, P818, DOI 10.1073/pnas.90.3.818; Stokstad E, 2009, SCIENCE, V326, P33, DOI 10.1126/science.326_33; Strona G, 2015, METHODS ECOL EVOL, V6, P907, DOI 10.1111/2041-210X.12395; Strona G, 2015, OIKOS, V124, P685, DOI 10.1111/oik.01850; Thebault E, 2013, J BIOGEOGR, V40, P759, DOI 10.1111/jbi.12015; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Ulrich W, 2012, ECOGRAPHY, V35, P865, DOI 10.1111/j.1600-0587.2012.07671.x; Verhoef HermanA., 2010, COMMUNITY ECOLOGY PR, DOI [10.1093/acprof:oso/9780199228973.001.0001, DOI 10.1093/ACPROF:OSO/9780199228973.001.0001]; Westhoff V., 1973, HDB VEGETATION SCI, P617; Zerbe S, 1998, APPL VEG SCI, V1, P165, DOI 10.2307/1478945	62	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0165178	10.1371/journal.pone.0165178	http://dx.doi.org/10.1371/journal.pone.0165178			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005931	Green Submitted, Green Published, gold			2022-12-26	WOS:000392843200003
J	Kim, J; Kim, Y; Pai, H				Kim, Jieun; Kim, Yeonjae; Pai, Hyunjoo			Clinical Characteristics and Treatment Outcomes of Clostridium difficile Infections by PCR Ribotype 017 and 018 Strains	PLOS ONE			English	Article							TOXIN-B; INCREASED SPORULATION; RISK-FACTORS; EPIDEMIOLOGY; EMERGENCE; RESISTANT; JAPAN	The objective of this study was to identify the clinical characteristics of Clostridium difficile infections (CDIs) caused by toxin A-negative/toxin B-positive (A-B+) PCR ribotype 017 (R017) and A+B+ ribotype 018 (R018) strains, prevalent in Asian countries. From February 2010 through January 2013, all CDI patients in our hospital were enrolled; their medical records were retrospectively reviewed, and the isolates were characterized by toxigenic culture and PCR ribotyping. Based on the ribotypes, a total of 510 cases were categorized as R017 (139, 27.3%), R018 (157, 30.8%) and other ribotypes groups (214, 42.0%), and clinical variables were compared between R017 and other ribotypes, R018 and other ribotypes and R018 and R017 groups. The patients with R017 infections had a higher mean Charlson's comorbidity index (OR 1.1, 1-1.21, p = 0.05), lower serum albumin (OR 0.47, 0.31-0.73, p = 0.001) and lower CRP levels (OR 0.96, 0.92-0.99, p = 0.022) than those with other ribotypes. R018 infections caused more azotemia (OR 4.06, 1.28-12.91, p = 0.018) and more frequent severe CDI (OR 1.87, 1.12-3.13, p = 0.016) than the other ribotypes infections. R017 and R018 infections were more often associated with toxin positive stools (OR 2.94, 1.65-4.09, p<0.001; OR 4.55, 2.82-7.33, p<0.001). In terms of treatment outcomes, R017 infections caused a marginally higher 30-day mortality than other ribotypes infection. In a final multiple logistic regression model, 30-day mortality was associated with leukocytosis (OR 2.45, 1.0-6.01, p = 0.05) and hypoalbuminemia (OR 4.57, 1.83-11.39, p = 0.001), but only marginally with R017 infection (OR 2.14, 0.88-5.22, p = 0.094). In conclusion, infections by C. difficile R018 strains tend to cause more severe disease, while there was a trend for higher mortality with R017 infections.	[Kim, Jieun; Pai, Hyunjoo] Hanyang Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Kim, Yeonjae] Natl Med Ctr, Ctr Infect Dis, Seoul, South Korea	Hanyang University; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Infectious Disease; National Medical Center - Korea	Pai, H (corresponding author), Hanyang Univ, Dept Internal Med, Coll Med, Seoul, South Korea.	paihj@hanyang.ac.kr		Kim, Jieun/0000-0002-6214-3889				Awad MM, 2014, GUT MICROBES, V5, P579, DOI 10.4161/19490976.2014.969632; Baldan R, 2015, J CLIN MICROBIOL, V53, P2575, DOI 10.1128/JCM.00533-15; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Cheng VCC, 2011, EUR J CLIN MICROBIOL, V30, P1371, DOI 10.1007/s10096-011-1231-0; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Collins DA, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-21; Dingle KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019993; Erb S, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.07.016; Freeman J, 2015, CLIN MICROBIOL INFEC, V21, DOI [10.1128/AAC.00220-12, DOI 10.1128/AAC.00220-12]; Gerding DN, 2013, CLIN INFECT DIS, V56, P1601, DOI 10.1093/cid/cit133; Goorhuis A, 2011, CLIN INFECT DIS, V53, P860, DOI 10.1093/cid/cir549; Hawkey PM, 2013, J CLIN MICROBIOL, V51, P3308, DOI 10.1128/JCM.00587-13; Huelsenbeck J, 2007, INFECT IMMUN, V75, P801, DOI 10.1128/IAI.01705-06; Johnson S, 2003, J CLIN MICROBIOL, V41, P1543, DOI 10.1128/JCM.41.4.1543-1547.2003; Kato H, 2001, J CLIN MICROBIOL, V39, P1391, DOI 10.1128/JCM.39.4.1391-1395.2001; Khanna S, 2012, AM J GASTROENTEROL, V107, P89, DOI 10.1038/ajg.2011.398; Kim J, 2014, CLIN MICROBIOL INFEC, V20, P1198, DOI 10.1111/1469-0691.12704; Kim J, 2013, CLIN MICROBIOL INFEC, V19, P521, DOI 10.1111/j.1469-0691.2012.03910.x; Kim J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-109; Kim J, 2012, INT J ANTIMICROB AG, V40, P24, DOI 10.1016/j.ijantimicag.2012.03.015; Kim J, 2011, J KOREAN MED SCI, V26, P1258, DOI 10.3346/jkms.2011.26.10.1258; Komatsu M, 2003, EUR J CLIN MICROBIOL, V22, P525, DOI 10.1007/s10096-003-0992-5; Merrigan M, 2010, J BACTERIOL, V192, P4904, DOI 10.1128/JB.00445-10; See I, 2014, CLIN INFECT DIS, V58, P1394, DOI 10.1093/cid/ciu125; Senoh M, 2015, J MED MICROBIOL, V64, P1226, DOI 10.1099/jmm.0.000149; Spigaglia P, 2010, J CLIN MICROBIOL, V48, P2892, DOI 10.1128/JCM.02482-09; Tenover FC, 2012, ANTIMICROB AGENTS CH, V56, P2929, DOI 10.1128/AAC.00220-12; Vedantam G, 2012, GUT MICROBES, V3, P121, DOI 10.4161/gmic.19399; Walk ST, 2012, CLIN INFECT DIS, V55, P1661, DOI 10.1093/cid/cis786; Walker AS, 2013, CLIN INFECT DIS, V56, P1589, DOI 10.1093/cid/cit127	31	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168849	10.1371/journal.pone.0168849	http://dx.doi.org/10.1371/journal.pone.0168849			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002482	gold, Green Submitted, Green Published			2022-12-26	WOS:000392853100071
J	Nyborg, AC; Ward, C; Zacco, A; Chacko, B; Grinberg, L; Geoghegan, JC; Bean, R; Wendeler, M; Bartnik, F; O'Connor, E; Gruia, F; Iyer, V; Feng, H; Roy, V; Berge, M; Miner, JN; Wilson, DM; Zhou, DM; Nicholson, S; Wilker, C; Wu, CY; Wilson, S; Jermutus, L; Wu, H; Owen, DA; Osbourn, J; Coats, S; Baca, M				Nyborg, Andrew C.; Ward, Chris; Zacco, Anna; Chacko, Benoy; Grinberg, Luba; Geoghegan, James C.; Bean, Ryan; Wendeler, Michaela; Bartnik, Frank; O'Connor, Ellen; Gruia, Flaviu; Iyer, Vidyashankara; Feng, Hui; Roy, Varnika; Berge, Mark; Miner, Jeffrey N.; Wilson, David M.; Zhou, Dongmei; Nicholson, Simone; Wilker, Clynn; Wu, Chi Y.; Wilson, Susan; Jermutus, Lutz; Wu, Herren; Owen, David A.; Osbourn, Jane; Coats, Steven; Baca, Manuel			A Therapeutic Uricase with Reduced Immunogenicity Risk and Improved Development Properties	PLOS ONE			English	Article							URATE OXIDASE; POLYETHYLENE-GLYCOL; CHRONIC GOUT; ACID; RASBURICASE; PEGLOTICASE; EFFICACY; EVOLUTION; PHARMACOKINETICS; CHROMATOGRAPHY	Humans and higher primates are unique in that they lack uricase, the enzyme capable of oxidizing uric acid. As a consequence of this enzyme deficiency, humans have high serum uric acid levels. In some people, uric acid levels rise above the solubility limit resulting in crystallization in joints, acute inflammation in response to those crystals causes severe pain; a condition known as gout. Treatment for severe gout includes injection of non-human uricase to reduce serum uric acid levels. Krystexxa is a hyper-PEGylated pig-baboon chimeric uricase indicated for chronic refractory gout that induces an immunogenic response in 91% of treated patients, including infusion reactions (26%) and anaphylaxis (6.5%). These properties limit its use and effectiveness. An innovative approach has been used to develop a therapeutic uricase with improved properties such as: soluble expression, neutral pH solubility, high E. coli expression level, thermal stability, and excellent activity. More than 200 diverse uricase sequences were aligned to guide protein engineering and reduce putative sequence liabilities. A single uricase lead candidate was identified, which showed low potential for immunogenicity in >200 human donor samples selected to represent diverse HLA haplotypes. Cysteines were engineered into the lead sequence for site specific PEGylation and studies demonstrated >95% PEGylation efficiency. PEGylated uricase retains enzymatic activity in vitro at neutral pH, in human serum and in vivo (rats and canines) and has an extended half-life. In canines, an 85% reduction in serum uric acid levels was observed with a single subcutaneous injection. This PEGylated, non-immunogenic uricase has the potential to provide meaningful benefits to patients with gout.	[Nyborg, Andrew C.; Ward, Chris; Zacco, Anna; Chacko, Benoy; Grinberg, Luba; Geoghegan, James C.; Bean, Ryan; Wendeler, Michaela; Bartnik, Frank; O'Connor, Ellen; Gruia, Flaviu; Iyer, Vidyashankara; Feng, Hui; Roy, Varnika; Berge, Mark; Nicholson, Simone; Wilson, Susan; Wu, Herren; Coats, Steven; Baca, Manuel] MedImmune LLC, Gaithersburg, MD 20878 USA; [Miner, Jeffrey N.; Wilson, David M.; Zhou, Dongmei; Wilker, Clynn] Ardea Biosci, San Diego, CA USA; [Wu, Chi Y.] MedImmune LLC, Mountain View, CA USA; [Jermutus, Lutz; Owen, David A.; Osbourn, Jane] MedImmune LTD, Cambridge, England	AstraZeneca; Medimmune; AstraZeneca; AstraZeneca; Medimmune; AstraZeneca; Medimmune	Nyborg, AC (corresponding author), MedImmune LLC, Gaithersburg, MD 20878 USA.	nyborga@medimmune.com	Jermutus, Lutz/AAU-2047-2020	Wendeler, Michaela/0000-0001-7503-5257	MedImmune LLC	MedImmune LLC(AstraZenecaMedimmune)	The funder provided support in the form of salaries for authors (MedImmune LLC - ACN CW AZ, BC, LG, JG, RB, MW, FB, EO, FG, VI, HF, VR, MB, SN, CYVV, SW, LJ, HW, SC, and MB; MedImmune LTD - DAO and JO; Ardea - JNM, DMW, DZ, and CW), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alvarez-Lario B, 2010, RHEUMATOLOGY, V49, P2010, DOI 10.1093/rheumatology/keq204; Bach MH, 2014, CURR OPIN RHEUMATOL, V26, P169, DOI 10.1097/BOR.0000000000000035; Baraf HSB, 2014, JCR-J CLIN RHEUMATOL, V20, P427, DOI 10.1097/RHU.0000000000000200; BARBAS CF, 1993, P NATL ACAD SCI USA, V90, P10003, DOI 10.1073/pnas.90.21.10003; Bayol A, 2002, BIOTECHNOL APPL BIOC, V36, P21, DOI 10.1042/BA20010083; BAYOL A, 1995, BIOPHYS CHEM, V54, P229, DOI 10.1016/0301-4622(94)00150-I; Bobulescu A, 2012, ADV CHRONIC KIDNEY D, V19, P358, DOI 10.1053/j.ackd.2012.07.009; Bomalaski JS, 2002, J RHEUMATOL, V29, P1942; Cheah CY, 2013, ACTA HAEMATOL-BASEL, V130, P254, DOI 10.1159/000351048; Coiffier B, 2003, J CLIN ONCOL, V21, P4402, DOI 10.1200/JCO.2003.04.115; Cox D, 2010, NAT REV DRUG DISCOV, V9, P804, DOI 10.1038/nrd3266; Fishburn CS, 2008, J PHARM SCI-US, V97, P4167, DOI 10.1002/jps.21278; Fraisse L, 2002, ANAL BIOCHEM, V309, P173, DOI 10.1016/S0003-2697(02)00293-2; Ganson NJ, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1861; Garay RP, 2012, EXPERT OPIN DRUG DEL, V9, P1319, DOI 10.1517/17425247.2012.720969; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Glantzounis GK, 2005, CURR PHARM DESIGN, V11, P4145, DOI 10.2174/138161205774913255; GOLDFARB E, 1966, ARTHRITIS RHEUM, V9, P414, DOI 10.1002/art.1780090306; Hershfield MS, 2010, P NATL ACAD SCI USA, V107, P14351, DOI 10.1073/pnas.1001072107; Hershfield MS, 2006, USA patent, Patent No. [US 7056713 B1, 7056713]; Jawa V, 2013, CLIN IMMUNOL, V149, P534, DOI 10.1016/j.clim.2013.09.006; Johnson RJ, 2005, SEMIN NEPHROL, V25, P3, DOI 10.1016/j.semnephrol.2004.09.002; Juan ECM, 2008, ACTA CRYSTALLOGR D, V64, P815, DOI 10.1107/S0907444908013590; Kahn K, 1998, BIOCHEMISTRY-US, V37, P11651, DOI 10.1021/bi980446g; Kratzer JT, 2014, P NATL ACAD SCI USA, V111, P3763, DOI 10.1073/pnas.1320393111; Lanaspa MA, 2012, J BIOL CHEM, V287, P40732, DOI 10.1074/jbc.M112.399899; Latha S M, 2015, Indian J Nephrol, V25, P91, DOI 10.4103/0971-4065.139092; Lipsky PE, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4497; MAHLER HR, 1955, J BIOL CHEM, V216, P625; MULLER M, 1969, EUR J BIOCHEM, V9, P424, DOI 10.1111/j.1432-1033.1969.tb00626.x; OROWAN E, 1955, NATURE, V175, P683, DOI 10.1038/175683a0; Parmar MS, 2009, NEW ENGL J MED, V360, P539; Ramazzina I, 2006, NAT CHEM BIOL, V2, P144, DOI 10.1038/nchembio768; Richette P, 2010, LANCET, V375, P318, DOI 10.1016/S0140-6736(09)60883-7; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; SAKUMA R, 1987, CLIN CHEM, V33, P1427; Schellekens H, 2013, PHARM RES-DORDR, V30, P1729, DOI 10.1007/s11095-013-1067-7; Shire SJ, 2010, CURRENT TRENDS MONOC, Vxiv; SOFAER JA, 1981, J MED GENET, V18, P410, DOI 10.1136/jmg.18.6.410; Stove V, 2007, CLIN CHEM, V53, P369, DOI 10.1373/clinchem.2006.081414; Sundy JS, 2007, ARTHRITIS RHEUM-US, V56, P1021, DOI 10.1002/art.22403; Sundy JS, 2011, JAMA-J AM MED ASSOC, V306, P711, DOI [10.1001/jama.2011.1169, 10.1001/jama.2011.116]; Ueng Sis, 2005, Proc (Bayl Univ Med Cent), V18, P275; VARELAECHAVARRIA A, 1988, FASEB J, V2, P3092, DOI 10.1096/fasebj.2.15.3192041; Watanabe S, 2002, HYPERTENSION, V40, P355, DOI 10.1161/01.HYP.0000028589.66335.AA; WAYNER EA, 1991, J CELL BIOL, V113, P919, DOI 10.1083/jcb.113.4.919; Wertheimer Albert, 2013, Curr Ther Res Clin Exp, V75, P1, DOI 10.1016/j.curtheres.2013.04.003; Yeldandi AV, 1995, GENE EXPRESSION, V5, P123; Zhang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039659; Zhang C, 2012, INT J PHARMACEUT, V430, P307, DOI 10.1016/j.ijpharm.2012.03.057	50	25	26	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167935	10.1371/journal.pone.0167935	http://dx.doi.org/10.1371/journal.pone.0167935			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002433	Green Submitted, Green Published, gold			2022-12-26	WOS:000392853100027
J	Jin, M; Wang, J; Chu, MX; Piao, J; Piao, JA; Zhao, FQ				Jin, Mei; Wang, Jing; Chu, Ming-Xing; Piao, Jun; Piao, Jing-Ai; Zhao, Feng-Qin			The Study on Biological Function of Keratin 26, a Novel Member of Liaoning Cashmere Goat Keratin Gene Family	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; HAIR FOLLICLE GROWTH; IN-VITRO; IGF-I; SKIN; MELATONIN; INDUCTION; CYCLE; DIFFERENTIATION; REGULATOR	In our research, we explored the relationship between Keratin26 and the regulation of fine hair, BMP signaling pathway, MT, FGF5, and IGF-I. The result of hybridization in situ revealed that Keratin 26 was specially expressed in cortex of skin hair follicles; the result of immunohistochemistry indicated that Keratin 26 was expressed in internal root sheath, external root sheath. Then, Real-time quantitative PCR results showed that relative expressive quantity of Keratin 26 was 1.08 or 3.3 x greater in secondary follicle than primary follicle during anagen or catagen; the difference during anagen was not remarkable (p>0.05), however, that of catagen was extremely significant (p<0.01). Relative expressive quantity of Keratin 26 increased during telogen; the difference was extremely significant (p<0.01). Moreover, after Noggin expression interference using RNAi technology, we found that relative expressive quantity of Keratin 26 extremely remarkably declined (p<0.01); after K26 overexpression, we found that relative expressive quantity of Noggin extremely remarkably increased (p<0.01). We detected expressive quantity change of Keratin 26 and Keratin 26 using Real-time quantitative PCR and immunofluorescence technologies after fibroblasts were treated with MT, FGF5 or IGF-I; the results indicated that MT and FGF5 played a positive role in Keratin 26 and Keratin 26 expression, IGF-I played a negative role in Keratin26 expression, positive role in Keratin 26 expression. The results above showed that Keratin 26 could inhibit cashmere growth, and was related to entering to catagen and telogen of hair follicles; Keratin 26 and BMP signaling pathway were two antagonistic pathways each other which could inhibit growth and development of cashmere; MT, FGF5 and IGF-I could affect expression of Keratin 26 and Keratin 26, and Keratin 26 was one of the important pathways that MT induced cashmere production in advance, FGF5 regulated cashmere growth and IGF-I promoted cashmere growth and development.	[Jin, Mei; Wang, Jing; Piao, Jun; Piao, Jing-Ai; Zhao, Feng-Qin] Liaoning Normal Univ, Dept Life Sci, Dalian, Liaoning, Peoples R China; [Chu, Ming-Xing] Chinese Acad Agr Sci, Inst Anim Sci, Beijing, Peoples R China	Liaoning Normal University; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS	Zhao, FQ (corresponding author), Liaoning Normal Univ, Dept Life Sci, Dalian, Liaoning, Peoples R China.	eco-env@163.com			National Natural Science Foundation of China [31172188]; Distinguished Professor Subsidy Scheme in Liaoning Province; Scientific Research Projects in Liaoning Province Department of Education [L2014425]; Agricultural Science and Technology Innovation Program of China [ASTIP-IAS13]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Distinguished Professor Subsidy Scheme in Liaoning Province; Scientific Research Projects in Liaoning Province Department of Education; Agricultural Science and Technology Innovation Program of China	This work was supported by: 1. National Natural Science Foundation of China (No. 31172188); http//www.nsfc.gov.cn/; MJ; 2. Distinguished Professor Subsidy Scheme in Liaoning Province; http://old.lnen.cn/; 3. Scientific Research Projects in Liaoning Province Department of Education (No. L2014425); http//www.Inein.gov.en/kj/web/; JP; and 4. Agricultural Science and Technology Innovation Program of China (No. ASTIP-IAS13); http//www.zgnykj.org/, MJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAIN D, 1980, REPROD NUTR DEV, V20, P197, DOI 10.1051/rnd:19800114; BHORA FY, 1995, J SURG RES, V59, P236, DOI 10.1006/jsre.1995.1160; Bordeleau F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038780; Botchkarev VA, 2004, DIFFERENTIATION, V72, P512, DOI 10.1111/j.1432-0436.2004.07209005.x; Botchkarev VA, 2003, J INVEST DERMATOL, V120, P36, DOI 10.1046/j.1523-1747.2003.12002.x; Botchkarev VA, 1999, NAT CELL BIOL, V1, P158, DOI 10.1038/11078; Botchkarev VA, 2001, FASEB J, V15, P2205, DOI 10.1096/fj.01-0207com; Caricasole A, 2000, INT J DEV BIOL, V44, P443; Drogemuller C, 2007, ANIM GENET, V38, P218, DOI 10.1111/j.1365-2052.2007.01590.x; Duncan A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-90; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; Fang Y, 2010, ASIAN J ANIM VET ADV, V5, P34; Fischer TW, 2006, FASEB J, V20, P1564, DOI 10.1096/fj.05-5227fje; Fischer TW, 2008, J PINEAL RES, V44, P1, DOI 10.1111/j.1600-079X.2007.00512.x; Fischer TW, 2004, BRIT J DERMATOL, V150, P341, DOI 10.1111/j.1365-2133.2004.05685.x; Fuchs E, 2008, GENE DEV, V22, P976, DOI 10.1101/gad.1645908; Gao ZY, 2012, INT J OPHTHALMOL-CHI, V5, P661, DOI 10.3980/j.issn.2222-3959.2012.06.02; Gregg K., 1986, BIOL INTEGUMENT, P666; HARRIS PM, 1993, J ENDOCRINOL, V139, P463, DOI 10.1677/joe.0.1390463; HEBERT JM, 1994, CELL, V78, P1017, DOI 10.1016/0092-8674(94)90276-3; Housley DJE, 2006, ANIM GENET, V37, P309, DOI 10.1111/j.1365-2052.2006.01448.x; IBRAHEEM M, 1994, J ANAT, V185, P135; Jin M, 2010, SMALL RUMINANT RES, V93, P24, DOI 10.1016/j.smallrumres.2010.04.026; Jing NH, 2009, CHIN J CELL BIOL, V31, P2; Kan LX, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-92; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Langbein L, 2003, J INVEST DERMATOL, V120, P512, DOI 10.1046/j.1523-1747.2003.12087.x; Liffers ST, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-137; Mayer JA, 2008, AM J PATHOL, V173, P1339, DOI 10.2353/ajpath.2008.070920; Meng YG, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-96; Mou C, 2006, P NATL ACAD SCI USA, V103, P9075, DOI 10.1073/pnas.0600825103; Nanashima N, 2008, J BIOL CHEM, V283, P16868, DOI 10.1074/jbc.M802539200; NIXON AJ, 1993, J EXP ZOOL, V267, P47, DOI 10.1002/jez.1402670108; Park GT, 2002, NUCLEIC ACIDS RES, V30, P515, DOI 10.1093/nar/30.2.515; Philpott M P, 1995, J Invest Dermatol, V104, p44S; PHILPOTT MP, 1994, J INVEST DERMATOL, V102, P857, DOI 10.1111/1523-1747.ep12382494; Plowman JE, 2000, ELECTROPHORESIS, V21, P1899, DOI 10.1002/(SICI)1522-2683(20000501)21:9<1899::AID-ELPS1899>3.0.CO;2-R; Rogers MA, 2002, J BIOL CHEM, V277, P48993, DOI 10.1074/jbc.M206422200; Rogers MA, 2007, J INVEST DERMATOL, V127, P1197, DOI 10.1038/sj.jid.5700702; Sharov AA, 2006, P NATL ACAD SCI USA, V103, P18166, DOI 10.1073/pnas.0608899103; Slominski A, 2003, J CELL PHYSIOL, V196, P144, DOI 10.1002/jcp.10287; Stewart CEH, 1996, PHYSIOL REV, V76, P1005, DOI 10.1152/physrev.1996.76.4.1005; Suzuki S, 2000, J INVEST DERMATOL, V114, P456, DOI 10.1046/j.1523-1747.2000.00912.x; Tong XM, 2006, GENE DEV, V20, P1353, DOI 10.1101/gad.1387406; Tsumaki N, 2005, CYTOKINE GROWTH F R, V16, P279, DOI 10.1016/j.cytogfr.2005.04.001; Uchiumi A, 2012, EXP THER MED, V3, P443, DOI 10.3892/etm.2011.413; URIST MARSHALL R., 1967, CLIN ORTHOP RELATED RESIN COMPLICATIONS OF ORTHOPAEDIC SURGERY, V53, P243; Weger N, 2005, J INVEST DERMATOL, V125, P873, DOI 10.1111/j.0022-202X.2005.23946.x; XIAO Y, 1995, J REPROD FERTIL, V105, P9, DOI 10.1530/jrf.0.1050009; Yan JC, 2013, INT J CARDIOL, V169, pE87, DOI 10.1016/j.ijcard.2013.10.039; Yu ZD, 2009, DIFFERENTIATION, V77, P307, DOI 10.1016/j.diff.2008.10.009; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	52	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168015	10.1371/journal.pone.0168015	http://dx.doi.org/10.1371/journal.pone.0168015			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997570	gold, Green Submitted, Green Published			2022-12-26	WOS:000392842900021
J	Liarzi, O; Bucki, P; Miyara, SB; Ezra, D				Liarzi, Orna; Bucki, Patricia; Miyara, Sigal Braun; Ezra, David			Bioactive Volatiles from an Endophytic Daldinia cf. concentrica Isolate Affect the Viability of the Plant Parasitic Nematode Meloidogyne javanica	PLOS ONE			English	Article							ROOT-KNOT NEMATODE; COMPOUNDS IN-VITRO; BIOLOGICAL-CONTROL; MUSCODOR-ALBUS; PSEUDOMONAS-FLUORESCENS; NEMATOCIDAL ACTIVITY; POSTHARVEST DECAY; ORGANIC-COMPOUNDS; BIOCONTROL; TOMATO	Plant-parasitic nematodes form one of the largest sources of biotic stress imposed on plants, and are very difficult to control; among them are the obligate parasites, the sedentary root-knot nematodes (RKNs) Meloidogyne spp. which are extremely polyphagous and exploit a very wide range of hosts. Endophytic fungi are organisms that spend most of their life cycle within plant tissue without causing visible damage to the host plant. Many endophytes secrete specialized metabolites and/or emit volatile organic compounds (VOCs) that exhibit biological activity. Recently, we demonstrated that the endophytic fungus Daldinia cf. concentrica secrets biologically active VOCs. Here we examined the ability of the fungus and its VOCs to control the RKN M. javanica both in vitro and greenhouse experiments. The D. cf. concentrica VOCs showed bionematicidal activity against the second-stage juveniles (J2s) of M. javanica. We found that exposure of J2s to fungal volatiles caused 67% reduction in viability, and that application of a synthetic volatile mixture (SVM), comprising 3-methyl-1-butanol, (+/-)-2-methyl-1-butanol, 4-heptanone, and isoamyl acetate, in volumetric ratio of 1:1:2:1 further reduced J2s viability by 99%. We demonstrated that, although each of the four VOCs significantly reduced the viability of J2s relative to the control, only 4-heptanone elicited the same effect as the whole mixture, with nematicidal activity of 90% reduction in viability of the J2s. Study of the effect of the SVM on egg hatching demonstrated that it decreased eggs hatching by 87%. Finally, application of the SVM to soil inoculated with M. javanica eggs or J2s prior to planting susceptible tomato plants resulted in a significantly reduced galling index and fewer eggs produced on each root system, with no effect on root weight. Thus, D. cf. concentrica and/or SVM based on fungal VOCs may be considered as a novel alternative approach to controlling the RKN M. javanica.	[Liarzi, Orna; Ezra, David] ARO, Dept Plant Pathol & Weed Res, Rishon Leziyyon, Israel; [Bucki, Patricia; Miyara, Sigal Braun] ARO, Dept Entomol, Rishon Leziyyon, Israel; [Bucki, Patricia; Miyara, Sigal Braun] ARO, Nematol Unit, Rishon Leziyyon, Israel; [Bucki, Patricia; Miyara, Sigal Braun] ARO, Chem Unit, Rishon Leziyyon, Israel		Ezra, D (corresponding author), ARO, Dept Plant Pathol & Weed Res, Rishon Leziyyon, Israel.	dezra@volcani.agri.gov.il			Israel's Ministry of Agriculture and Rural Development (MOARD) [132-1252-06]; Israel's Ministry of Economy [47106]; "Kamin" project of the Israeli Ministry of Economy	Israel's Ministry of Agriculture and Rural Development (MOARD); Israel's Ministry of Economy; "Kamin" project of the Israeli Ministry of Economy	This work was financed by the Chief Scientist of Israel's Ministry of Agriculture and Rural Development (MOARD) (https://agriscience.coil), under grant number 132-1252-06, and the Chief Scientist of Israel's Ministry of Economy (http://www.matimop.org.il/ocs.html), under grant number 47106 ("Kamin project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The grants were given to D.E.; This work was partially financed by the "Kamin" project of the Israeli Ministry of Economy and the Chief Scientist of the Israeli Ministry of Agriculture and Rural Development (MOARD); grant number 132-1252-06. This paper is Contribution No. 557/16 from the Agricultural Research Organization, the Volcani Center, P.O. Box 15159, Rishon LeZion 7528809 Israel.	Abad P, 2003, MOL PLANT PATHOL, V4, P217, DOI [10.1046/j.1364-3703.2003.00170.x, 10.1046/J.1364-3703.2003.00170.X]; Agbenin Nnennaya O., 2011, Plant Protection Science, V47, P62; Anastasiadis I, 2010, COMMUNICATIONS AGR A, V76, P333; ANKE H, 1995, CAN J BOT, V73, pS932, DOI 10.1139/b95-341; Azevedo Joao Lucio, 2000, EJB Electronic Journal of Biotechnology, V3, P1, DOI 10.2225/vol3-issue1-fulltext-4; Bacon C. W., 2000, MICROBIAL ENDOPHYTES, DOI 10.1201/9781482277302; Barker TR., 1985, ADV TREATISE MELOIDO, P19; Barnes EC, 2016, CHEM-EUR J, V22, P4551, DOI 10.1002/chem.201504005; Bashyal B, 1999, MYCOTAXON, V72, P33; Bayram O, 2012, FEMS MICROBIOL REV, V36, P1, DOI 10.1111/j.1574-6976.2011.00285.x; Bird DM, 2004, CURR OPIN PLANT BIOL, V7, P372, DOI 10.1016/j.pbi.2004.05.005; Castillo UF, 2002, MICROBIOL-SGM, V148, P2675, DOI 10.1099/00221287-148-9-2675; Dubreuil G, 2007, NEW PHYTOL, V176, P426, DOI 10.1111/j.1469-8137.2007.02181.x; Ezra D, 2004, MICROBIOL-SGM, V150, P785, DOI 10.1099/mic.0.26645-0; Fialho Mauricio Batista, 2012, Summa phytopathol., V38, P152, DOI 10.1590/S0100-54052012000200008; Freire ES, 2012, J NEMATOL, V44, P321; Gheysen G, 2002, ANNU REV PHYTOPATHOL, V40, P191, DOI 10.1146/annurev.phyto.40.121201.093719; Grimme E, 2007, PLANT DIS, V91, P220, DOI 10.1094/PDIS-91-2-0220; Hamid M, 2003, LETT APPL MICROBIOL, V36, P239, DOI 10.1046/j.1472-765X.2003.01299.x; HUSSEY RS, 1973, PLANT DIS REP, V57, P1025; Iberkleid I, 2014, PHYTOPATHOLOGY, V104, P484, DOI 10.1094/PHYTO-07-13-0181-R; JANSSON HB, 1985, J NEMATOL, V17, P327; JONES MGK, 1981, ANN APPL BIOL, V97, P353, DOI 10.1111/j.1744-7348.1981.tb05122.x; Koenning SR, 1999, J NEMATOL, V31, P587; Lamovsek Janja, 2013, Acta Agriculturae Slovenica, V101, P263, DOI 10.2478/acas-2013-0022; Li Bin, 2005, J Zhejiang Univ Sci B, V6, P496, DOI 10.1631/jzus.2005.B0496; Liarzi O., 2013, ADV ENDOPHYTIC RES, P335, DOI [10.1007/978-81-322-1575-2_18, DOI 10.1007/978-81-322-1575-2_18]; Liarzi O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168242; Mari M, 2012, POSTHARVEST BIOL TEC, V73, P56, DOI 10.1016/j.postharvbio.2012.05.014; Mari M, 2012, BIOL CONTROL, V60, P132, DOI 10.1016/j.biocontrol.2011.10.013; McAfee BJ, 1999, NAT TOXINS, V7, P283, DOI 10.1002/1522-7189(199911/12)7:6<283::AID-NT70>3.0.CO;2-N; Miller CM, 1998, J APPL MICROBIOL, V84, P937; Moosavi MR, 2012, PROG BIOL CONTROL, V12, P67, DOI 10.1007/978-94-007-1933-0_4; Moosavi MR, 2010, J INVERTEBR PATHOL, V104, P125, DOI 10.1016/j.jip.2010.03.002; Morath Shannon U., 2012, Fungal Biology Reviews, V26, P73, DOI 10.1016/j.fbr.2012.07.001; Ntalli NG, 2012, J AGR FOOD CHEM, V60, P9929, DOI 10.1021/jf303107j; O'Halloran DM, 2003, PARASITOLOGY, V127, P375, DOI 10.1017/S0031182003003688; Olivares-Bernabeu Concepcion Ma., 2002, Revista Iberoamericana de Micologia, V19, P104; Pazoutova S, 2013, FUNGAL DIVERS, V60, P107, DOI 10.1007/s13225-013-0238-5; Rahul S, 2014, NAT PROD RES, V28, P1399, DOI 10.1080/14786419.2014.904310; Riga E, 2008, BIOL CONTROL, V45, P380, DOI 10.1016/j.biocontrol.2008.01.002; Sharon E, 2001, PHYTOPATHOLOGY, V91, P687, DOI 10.1094/PHYTO.2001.91.7.687; Siddiqui IA, 2004, LETT APPL MICROBIOL, V39, P74, DOI 10.1111/j.1472-765X.2004.01540.x; Siddiqui IA, 2004, LETT APPL MICROBIOL, V38, P169, DOI 10.1111/j.1472-765X.2003.01481.x; Siddiqui IA, 2004, LETT APPL MICROBIOL, V38, P185, DOI 10.1111/j.1472-765X.2003.01472.x; Siddiqui IA, 2002, LETT APPL MICROBIOL, V35, P212, DOI 10.1046/j.1472-765X.2002.01162.x; Siddiqui ZA, 1996, BIORESOURCE TECHNOL, V58, P229, DOI 10.1016/S0960-8524(96)00122-8; Singh LP, 2011, PLANT SIGNAL BEHAV, V6, P175, DOI 10.4161/psb.6.2.14146; Stadler M, 2014, STUD MYCOL, P1, DOI 10.3114/sim0016; Stinson M, 2003, PLANT SCI, V165, P913, DOI 10.1016/S0168-9452(03)00299-1; Stone J, 2011, BIODIVERSITY FUNGI I; Strobel GA, 2001, MICROBIOL-SGM, V147, P2943, DOI 10.1099/00221287-147-11-2943; Strobel G, 2006, J IND MICROBIOL BIOT, V33, P514, DOI 10.1007/s10295-006-0090-7; Strobel G, 2011, FEMS MICROBIOL LETT, V320, P87, DOI 10.1111/j.1574-6968.2011.02297.x; Suwannarach N, 2013, CROP PROT, V45, P63, DOI 10.1016/j.cropro.2012.11.015; Terrill WF, 1996, J CHEM ECOL, V22, P1463, DOI 10.1007/BF02027725; Worapong J, 2001, MYCOTAXON, V79, P67; Xia YF, 2011, FEMS MICROBIOL LETT, V322, P99, DOI 10.1111/j.1574-6968.2011.02336.x; Zasada IA, 2010, ANNU REV PHYTOPATHOL, V48, P311, DOI 10.1146/annurev-phyto-073009-114425	59	31	33	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168437	10.1371/journal.pone.0168437	http://dx.doi.org/10.1371/journal.pone.0168437			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997626	Green Published, gold, Green Submitted			2022-12-26	WOS:000392842900046
J	Kida, T; Ayabe, S; Omori, K; Nakamura, T; Maehara, T; Aritake, K; Urade, Y; Murata, T				Kida, Taiki; Ayabe, Shinya; Omori, Keisuke; Nakamura, Tatsuro; Maehara, Toko; Aritake, Kosuke; Urade, Yoshihiro; Murata, Takahisa			Prostaglandin D-2 Attenuates Bleomycin-Induced Lung Inflammation and Pulmonary Fibrosis	PLoS One			English	Article							INHIBITS FIBROBLAST; RECEPTOR; INJURY; PROLIFERATION; MODULATION; EXPRESSION; AGONIST; PGD(2); CELLS; ACID	Pulmonary fibrosis is a progressive and fatal lung disease with limited therapeutic options. Although it is well known that lipid mediator prostaglandins are involved in the development of pulmonary fibrosis, the role of prostaglandin D-2 (PGD(2)) remains unknown. Here, we investigated whether genetic disruption of hematopoietic PGD synthase (H-PGDS) affects the bleomycin-induced lung inflammation and pulmonary fibrosis in mouse. Compared with H-PGDS naive (WT) mice, H-PGDS-deficient mice (H-PGDS(-/-)) represented increased collagen deposition in lungs 14 days after the bleomycin injection. The enhanced fibrotic response was accompanied by an increased mRNA expression of inflammatory mediators, including tumor necrosis factor-alpha, monocyte chemoattractant protein-1, and cyclooxygenase-2 on day 3. H-PGDS deficiency also increased vascular permeability on day 3 and infiltration of neutrophils and macrophages in lungs on day 3 and 7. Immunostaining showed that the neutrophils and macrophages expressed H-PGDS, and its mRNA expression was increased on day 3and 7 in WT lungs. These observations suggest that H-PGDS-derived PGD(2) plays a protective role in bleomycin-induced lung inflammation and pulmonary fibrosis.	[Kida, Taiki; Ayabe, Shinya; Omori, Keisuke; Nakamura, Tatsuro; Maehara, Toko; Murata, Takahisa] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Radiol, Tokyo, Japan; [Aritake, Kosuke; Urade, Yoshihiro] Univ Tsukuba, Int Inst Integrat Sleep Med, Tsukuba, Ibaraki 305, Japan	University of Tokyo; University of Tsukuba	Murata, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Radiol, Tokyo, Japan.	amurata@mail.ecc.u-tokyo.ac.jp	Ayabe, Shinya/AAH-6911-2020	Ayabe, Shinya/0000-0003-2737-5315; Murata, Takahisa/0000-0002-3328-0796	Japan Society for the Promotion of Science [25252049]; Foundation for Dietary Scientific Research; Cardiovascular Research Fund; Kurozumi Medical Foundation; Naito Foundation; Suzuken Memorial Foundation; Nipponham Foundation; Sapporo Bioscience Foundation; Japan Foundation for Pediatric Research; Grants-in-Aid for Scientific Research [15J10795] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Foundation for Dietary Scientific Research; Cardiovascular Research Fund; Kurozumi Medical Foundation(Kurozumi Medical Foundation); Naito Foundation(Naito Memorial Foundation); Suzuken Memorial Foundation; Nipponham Foundation; Sapporo Bioscience Foundation; Japan Foundation for Pediatric Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grant-in-Aid for Scientific Research from The Japan Society for the Promotion of Science, 25252049, http://www.jsps.go.jp/english/index.html; Foundation for Dietary Scientific Research, http://www.z-ssk.org/about/outline.html; Cardiovascular Research Fund, http://www.jcvrf.jp/; Kurozumi Medical Foundation, http://www.kmf.or.jp/index.html; Naito Foundation, https://www.naito-f.or.jp/jp/index.php; Suzuken Memorial Foundation, http://suzukenzaidan.or.jp/index.html; Nipponham Foundation, https://www.miraizaidan.or.jp/public/detail01.html; Sapporo Bioscience Foundation, http://www.sapporoholdings.jp/english/index.html; and Japan Foundation for Pediatric Research, http://www.jfpedres.or.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando M, 2003, AM J RESP CELL MOL, V28, P582, DOI 10.1165/rcmb.2002-0162OC; Angeli W, 2004, J IMMUNOL, V172, P3822, DOI 10.4049/jimmunol.172.6.3822; Ayabe S, 2013, J PHARMACOL SCI, V121, P312, DOI 10.1254/jphs.12275FP; Bringardner BD, 2008, ANTIOXID REDOX SIGN, V10, P287, DOI 10.1089/ars.2007.1897; CLARK JG, 1982, J BIOL CHEM, V257, P8098; Crystal RG, 2002, AM J RESP CRIT CARE, V166, P236, DOI 10.1164/rccm.2201069; Dackor RT, 2011, AM J PHYSIOL-LUNG C, V301, pL645, DOI 10.1152/ajplung.00176.2011; Failla M, 2009, AM J RESP CELL MOL, V41, P50, DOI 10.1165/rcmb.2007-0438OC; Fernandez Isis E, 2012, Proc Am Thorac Soc, V9, P111, DOI 10.1513/pats.201203-023AW; Gasse P, 2009, AM J RESP CRIT CARE, V179, P903, DOI 10.1164/rccm.200808-1274OC; Hirai H, 2001, J EXP MED, V193, P255, DOI 10.1084/jem.193.2.255; Kohyama T, 2002, AM J PHYSIOL-LUNG C, V283, pL428, DOI 10.1152/ajplung.00432.2001; Kohyama T, 2001, AM J PHYSIOL-LUNG C, V281, pL1257, DOI 10.1152/ajplung.2001.281.5.L1257; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; Kolodsick JE, 2003, AM J RESP CELL MOL, V29, P537, DOI 10.1165/rcmb.2002-0243OC; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; Mohri I, 2006, J NEUROSCI, V26, P4383, DOI 10.1523/JNEUROSCI.4531-05.2006; Murakami S, 2006, AM J PHYSIOL-LUNG C, V290, pL59, DOI 10.1152/ajplung.00042.2005; Murata T, 2013, P NATL ACAD SCI USA, V110, P5205, DOI 10.1073/pnas.1218091110; Murata T, 2011, P NATL ACAD SCI USA, V108, P19802, DOI 10.1073/pnas.1110011108; Nakamura T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8514; Oga T, 2009, NAT MED, V15, P1426, DOI 10.1038/nm.2066; PIGUET PF, 1993, AM J PATHOL, V143, P651; Riteau N, 2010, AM J RESP CRIT CARE, V182, P774, DOI 10.1164/rccm.201003-0359OC; Sarashina H, 2014, J IMMUNOL, V192, P459, DOI 10.4049/jimmunol.1302080; Tanaka K, 2000, J IMMUNOL, V164, P2277, DOI 10.4049/jimmunol.164.5.2277; Todd NW, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-11; URADE Y, 1990, J BIOL CHEM, V265, P371; van den Brule S, 2010, J PHARMACOL EXP THER, V335, P472, DOI 10.1124/jpet.110.169250; Wilson MS, 2010, J EXP MED, V207, P535, DOI 10.1084/jem.20092121; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Yoshimura-Uchiyama C, 2004, CLIN EXP ALLERGY, V34, P1283, DOI 10.1111/j.1365-2222.2004.02027.x; Zhu YJ, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-34	33	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0167729	10.1371/journal.pone.0167729	http://dx.doi.org/10.1371/journal.pone.0167729			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992456	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842600021
J	Liu, R; Zheng, Z; Du, J; Christoffel, KK; Liu, X				Liu, Rong; Zheng, Zheng; Du, Jie; Christoffel, Katherine Kaufer; Liu, Xin			Racial Disparity in the Associations of Cotinine with Insulin Secretion: Data from the National Health and Nutrition Examination Survey, 2007-2012	PLoS One			English	Article							HOMEOSTASIS MODEL ASSESSMENT; BETA-CELL FUNCTION; RESISTANCE HOMA-IR; SERUM COTININE; NICOTINIC RECEPTORS; METABOLIC SYNDROME; GLUCOSE-TOLERANCE; CIGARETTE-SMOKING; SMOKERS; RISK	Background Although relationships between smoking/high cotinine and type 2 diabetes have consistently been observed, few studies have investigated the relationship between cotinine and underlying pathophysiological defects that characterize diabetes aetiology. This study aimed to test the associations between cotinine and measures of insulin resistance or insulin secretion. Methods This analysis included 5,751 non-diabetic adult American from the National Health and Nutrition Examination Survey (NHANES) from 2007-2012. Insulin function was represented with two indexes: insulin resistance index (HOMA-IR) and insulin secretion index (HOMA-B) estimated by homeostasis model assessment. We categorized cotinine levels into quartiles and estimated the odds of HOMA-IR in the 4 th quartile and HOMA-B in the 1 st quartile among cotinine categories using multiple logistic regression models. Results Cotinine concentration was not associated with the risk of high HOMA-IR. Association of cotinine with low HOMA-B existed and differed by race/ethnicity (P for interaction<0.05). High cotinine concentration (in the 4 th quartile) was associated with an increased risk of low HOMA-B compared with low cotinine concentrations(1 st-2 nd quartiles) among white (odds ratio[OR], 1.51 [95% confidence interval[CI], 1.16-1.97]) or black participants ( OR, 2.98 [95% CI, 1.90-4.69]) but not among Mexican ( OR, 1.79 [95% CI, 0.90-3.53]) or other Hispanic( OR, 1.02 [95% CI, 0.56-1.86]) participants. Such associations remained significant even after further adjustment for HOMA-IR. Conclusions High cotinine is associated with decreased insulin secretion function only in white and black non-diabetic U. S. adult population. Results evaluating cotinine in ethnically homogeneous populations may not be broadly generalizable to other racial/ethnic groups.	[Liu, Rong] Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis Beijin, Dept Epidemiol, Beijing, Peoples R China; [Zheng, Zheng] Capital Med Univ, Beijing Xuan Wu Hosp, Beijing Inst Geriatr, Dept Neurobiol, Beijing, Peoples R China; [Du, Jie] Capital Med Univ, Beijing An Zhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Key Lab Remodeling Related Cardiovasc Dis,Minist, Beijing, Peoples R China; [Christoffel, Katherine Kaufer; Liu, Xin] Northwestern Univ Feinberg, Sch Med, Dept Pediat, Mary Ann & J Milburn Smith Child Hlth Res Program, Chicago, IL USA; [Liu, Xin] Chinese Acad Sci, China Gastrointestinal Canc Res Ctr, Beijing Inst Genom, Key Lab Genom & Precis Med, Beijing, Peoples R China; [Liu, Xin] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL USA; [Liu, Xin] Univ Chinese Acad Sci, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; Northwestern University; Feinberg School of Medicine; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Northwestern University; Feinberg School of Medicine; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, R (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis Beijin, Dept Epidemiol, Beijing, Peoples R China.	rongliu606@gmail.com; liuxin@big.ac.cn	Liu, Rong/B-8173-2014	Liu, Rong/0000-0001-9674-0561	100 Talents Program of the Chinese Academy of Sciences	100 Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported in part by 100 Talents Program of the Chinese Academy of Sciences (to X Liu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benowitz NL, 2009, AM J EPIDEMIOL, V169, P236, DOI 10.1093/aje/kwn301; Bernert JT, 1997, CLIN CHEM, V43, P2281; Bruin JE, 2008, TOXICOL SCI, V103, P362, DOI 10.1093/toxsci/kfn012; Bruin JE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003371; Caraballo RS, 1998, JAMA-J AM MED ASSOC, V280, P135, DOI 10.1001/jama.280.2.135; Carlsson S, 2004, DIABETOLOGIA, V47, P1953, DOI 10.1007/s00125-004-1554-9; Clair C, 2011, DIABETES CARE, V34, P2250, DOI 10.2337/dc11-0710; Conti-Fine BM, 2000, EUR J PHARMACOL, V393, P279, DOI 10.1016/S0014-2999(00)00036-4; Cowie CC, 2010, DIABETES CARE, V33, P562, DOI 10.2337/dc09-1524; Daniel M, 2004, DIABETIC MED, V21, P188, DOI 10.1046/j.1464-5491.2003.01064.x; EJIRI K, 1989, DIABETES RES CLIN PR, V6, P53, DOI 10.1016/0168-8227(89)90057-0; Eliasson B, 1996, CIRCULATION, V94, P878, DOI 10.1161/01.CIR.94.5.878; Esteghamati A, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-26; Gao S, 2012, CHINESE MED J-PEKING, V125, P1686, DOI 10.3760/cma.j.issn.0366-6999.2012.10.002; JARVIS MJ, 1988, AM J PUBLIC HEALTH, V78, P696, DOI 10.2105/AJPH.78.6.696; LITHELL HOL, 1991, DIABETES CARE, V14, P203, DOI 10.2337/diacare.14.3.203; Madeira IR, 2008, ARQ BRAS ENDOCRINOL, V52, P1466, DOI 10.1590/S0004-27302008000900010; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mora-Martinez JM, 2004, METAB SYNDR RELAT D, V2, P227, DOI 10.1089/met.2004.2.227; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; NELSON L, 1982, CELL MOTIL CYTOSKEL, V2, P225, DOI 10.1002/cm.970020304; Ostgren CJ, 2000, DIABETIC MED, V17, P445, DOI 10.1046/j.1464-5491.2000.00294.x; Perez-Stable EJ, 1998, JAMA-J AM MED ASSOC, V280, P152, DOI 10.1001/jama.280.2.152; R Core Team, 2013, R LANG ENV STAT COMP; Ronnemaa T, 1996, DIABETES CARE, V19, P1229, DOI 10.2337/diacare.19.11.1229; STAGNER JI, 1986, DIABETES, V35, P849, DOI 10.2337/diabetes.35.8.849; WAGENKNECHT LE, 1990, AM J PUBLIC HEALTH, V80, P1053, DOI 10.2105/AJPH.80.9.1053; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Wongwananuruk T, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/571035; Yamada C, 2011, J DIABETES INVEST, V2, P373, DOI 10.1111/j.2040-1124.2011.00113.x; Yoshikawa H, 2005, METABOLISM, V54, P247, DOI 10.1016/j.metabol.2004.08.020	32	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0167260	10.1371/journal.pone.0167260	http://dx.doi.org/10.1371/journal.pone.0167260			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992538	Green Published, gold, Green Submitted			2022-12-26	WOS:000392842600013
J	Bisgaard, LS; Bosteen, MH; Fink, LN; Sorensen, CM; Rosendahl, A; Mogensen, CK; Rasmussen, SE; Rolin, B; Nielsen, LB; Pedersen, TX				Bisgaard, Line S.; Bosteen, Markus H.; Fink, Lisbeth N.; Sorensen, Charlotte M.; Rosendahl, Alexander; Mogensen, Christina K.; Rasmussen, Salka E.; Rolin, Bidda; Nielsen, Lars B.; Pedersen, Tanja X.			Liraglutide Reduces Both Atherosclerosis and Kidney Inflammation in Moderately Uremic LDLr-/- Mice	PLOS ONE			English	Article							CD4(+) T-CELLS; RECEPTOR AGONIST; RENAL FIBROSIS; DISEASE; MACROPHAGES; ADHESION; RATS; ALBUMINURIA; DYSFUNCTION; PROGRESSION	Chronic kidney disease (CKD) leads to uremia. CKD is characterized by a gradual increase in kidney fibrosis and loss of kidney function, which is associated with a progressive increase in risk of atherosclerosis and cardiovascular death. To prevent progression of both kidney fibrosis and atherosclerosis in uremic settings, insight into new treatment options with effects on both parameters is warranted. The GLP-1 analogue liraglutide improves glucose homeostasis, and is approved for treatment of type 2 diabetes. Animal studies suggest that GLP-1 also dampens inflammation and atherosclerosis. Our aim was to examine effects of liraglutide on kidney fibrosis and atherosclerosis in a mouse model of moderate uremia (5/6 nephrectomy (NX)). Uremic (n = 29) and sham-operated (n = 14) atherosclerosis-prone low density lipoprotein receptor knockout mice were treated with liraglutide (1000 mu g/kg, s.c. once daily) or vehicle for 13 weeks. As expected, uremia increased aortic atherosclerosis. In the remnant kidneys from NX mice, flow cytometry revealed an increase in the number of monocyte-like cells (CD68(+) F4/80(-)), CD4(+), and CD8(+) T-cells, suggesting that moderate uremia induced kidney inflammation. Furthermore, markers of fibrosis (i.e. Col1a1 and Col3a1) were upregulated, and histological examinations showed increased glomerular diameter in NX mice. Importantly, liraglutide treatment attenuated atherosclerosis (similar to 40%, p < 0.05) and reduced kidney inflammation in NX mice. There was no effect of liraglutide on expression of fibrosis markers and/or kidney histology. This study suggests that liraglutide has beneficial effects in a mouse model of moderate uremia by reducing atherosclerosis and attenuating kidney inflammation.	[Bisgaard, Line S.; Bosteen, Markus H.; Sorensen, Charlotte M.; Nielsen, Lars B.; Pedersen, Tanja X.] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Bisgaard, Line S.; Fink, Lisbeth N.; Rosendahl, Alexander; Mogensen, Christina K.; Rasmussen, Salka E.; Rolin, Bidda] Novo Nordisk, Global Res, Malov, Denmark; [Bosteen, Markus H.; Nielsen, Lars B.] Univ Copenhagen, Hosp Rigshosp, Dept Clin Biochem, Copenhagen, Denmark; [Rosendahl, Alexander] Shire, Med Affairs Nord, Soborg, Denmark	University of Copenhagen; Novo Nordisk; Rigshospitalet; University of Copenhagen	Pedersen, TX (corresponding author), Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark.	tanjax@sund.ku.dk	Sorensen, Charlotte Mehlin/A-8092-2010; Bisgaard, Line S/F-2004-2018; Fink, Lisbeth/AAN-7830-2020	Sorensen, Charlotte Mehlin/0000-0002-9984-3125; Bisgaard, Line S/0000-0001-6077-4487; 	Novo Nordisk A/S; Innovation Fund Denmark (Ministry of Science, Innovation and Higher education)	Novo Nordisk A/S(Novo Nordisk); Innovation Fund Denmark (Ministry of Science, Innovation and Higher education)	This study was supported by a joint Novo Nordisk A/S and Innovation Fund Denmark (Ministry of Science, Innovation and Higher education) grant. The funder Novo Nordisk A/S provided support in the form of research materials and salaries for authors LSB, SER, CM, AR, and LFIN, but did not have any additional role in the study design, data collection and analysis, or decision to publish. After preparation of the manuscript, employees from Novo Nordisk A/S (not co-authors) read and commented on the manuscript prior to its submission. The specific roles of the authors employed by Novo Nordisk are articulated in the 'author contributions' section.	Arakawa M, 2010, DIABETES, V59, P1030, DOI 10.2337/db09-1694; Betz B, 2014, NEPHRON EXP NEPHROL, V126, P191, DOI 10.1159/000363300; Bro S, 2006, ARTERIOSCL THROM VAS, V26, P570, DOI 10.1161/01.ATV.0000201060.47945.cb; Bro S, 2004, J AM SOC NEPHROL, V15, P1495, DOI 10.1097/01.ASN.0000128371.33195.7B; Canaud G, 2013, NAT MED, V19, P1288, DOI 10.1038/nm.3313; Cao Q, 2015, J AM SOC NEPHROLOGY; Chaudhuri A, 2012, J CLIN ENDOCR METAB, V97, P198, DOI 10.1210/jc.2011-1508; Duffield JS, 2010, SEMIN NEPHROL, V30, P234, DOI 10.1016/j.semnephrol.2010.03.003; Duffield JS, 2005, AM J PATHOL, V167, P1207, DOI 10.1016/S0002-9440(10)61209-6; Eddy AA, 2011, KIDNEY INT S, V2014, P2; El Nahas AM, 2003, KIDNEY INT, V64, P1553, DOI 10.1046/j.1523-1755.2003.00255.x; Gaspari T, 2013, DIABETES VASC DIS RE, V10, P353, DOI 10.1177/1479164113481817; Gaspari T, 2011, DIABETES VASC DIS RE, V8, P117, DOI 10.1177/1479164111404257; Ghosh SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141109; Guo SH, 2011, KIDNEY INT, V80, P946, DOI 10.1038/ki.2011.249; Hendarto H, 2012, METABOLISM, V61, P1422, DOI 10.1016/j.metabol.2012.03.002; Huang W, 2001, P NATL ACAD SCI USA, V98, P13330, DOI 10.1073/pnas.231476798; Kliem V, 1996, KIDNEY INT, V49, P666, DOI 10.1038/ki.1996.95; Kodera R, 2011, DIABETOLOGIA, V54, P965, DOI 10.1007/s00125-010-2028-x; Laouari D, 2011, J AM SOC NEPHROL, V22, P327, DOI 10.1681/ASN.2010040356; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Macconi D, 2009, J AM SOC NEPHROL, V20, P123, DOI 10.1681/ASN.2007111233; Massy ZA, 2005, J AM SOC NEPHROL, V16, P109, DOI 10.1681/ASN.2004060495; Monroy MA, 2015, FRONT BIOSCI-LANDMRK, V20, P784, DOI 10.2741/4337; Mori Y, 2012, METABOLISM, V61, P379, DOI 10.1016/j.metabol.2011.07.004; Mu W, 2005, J AM SOC NEPHROL, V16, P3651, DOI 10.1681/ASN.2005030297; Nagashima M, 2011, DIABETOLOGIA, V54, P2649, DOI 10.1007/s00125-011-2241-2; Ohashi K, 2007, ARTERIOSCL THROM VAS, V27, P1910, DOI 10.1161/ATVBAHA.107.147645; Pedersen TX, 2013, CARDIOVASC RES, V98, P352, DOI 10.1093/cvr/cvt049; Pedersen TX, 2010, NEPHROL DIAL TRANSPL, V25, P2486, DOI 10.1093/ndt/gfq059; Pedersen TX, 2009, ATHEROSCLEROSIS, V202, P372, DOI 10.1016/j.atherosclerosis.2008.04.041; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Shankman LS, 2015, NAT MED, V21, P628, DOI 10.1038/nm.3866; Tampe D, 2014, NAT REV NEPHROL, V10, P226, DOI 10.1038/nrneph.2014.14; Tapmeier TT, 2010, KIDNEY INT, V78, P351, DOI 10.1038/ki.2010.177; Tashiro Y, 2014, PEPTIDES, V54, P19, DOI 10.1016/j.peptides.2013.12.015; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Tsuprykov O, 2016, KIDNEY INT, V89, P1049, DOI 10.1016/j.kint.2016.01.016; U.S. Renal Data System, 2013, USRDS 2013 ANN DAT R; Vielhauer V, 2004, KIDNEY INT, V66, P2264, DOI 10.1111/j.1523-1755.2004.66038.x; Wang Y, 2014, BRIT J PHARMACOL, V171, P723, DOI 10.1111/bph.12490; Wang YP, 2001, KIDNEY INT, V59, P975, DOI 10.1046/j.1523-1755.2001.059003975.x; Wicks SE, 2015, BIOCHIMIE	43	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168396	10.1371/journal.pone.0168396	http://dx.doi.org/10.1371/journal.pone.0168396			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992511	gold, Green Published, Green Submitted			2022-12-26	WOS:000392758000046
J	Amini, M; Bashirova, D; Prins, BP; Corpeleijn, E; Bruinenberg, M; Franke, L; van der Harst, P; Navis, G; Wolffenbuttel, BHR; Stolk, RP; Wijmenga, C; Postma, DS; Koppelman, GH; Boezen, HM; Vonk, J; Snieder, H; Alizadeh, BZ				Amini, Marzyeh; Bashirova, Dinara; Prins, Bram P.; Corpeleijn, Eva; Bruinenberg, Marcel; Franke, Lude; van der Harst, Pim; Navis, Gerjan; Wolffenbuttel, Bruce H. R.; Stolk, Ronald P.; Wijmenga, Cisca; Postma, Dirkje S.; Koppelman, Gerard H.; Boezen, H. Marike; Vonk, Judith; Snieder, Harold; Alizadeh, Behrooz Z.		LifeLines Cohort Study	Eosinophil Count Is a Common Factor for Complex Metabolic and Pulmonary Traits and Diseases: The LifeLines Cohort Study	PLOS ONE			English	Article							DIFFERENTIAL LEUKOCYTE COUNTS; BLOOD-CELL COUNTS; AIRWAY EOSINOPHILIA; GENETIC-VARIANTS; HEART-DISEASE; ASTHMA; EXACERBATIONS; INFLAMMATION; INTERLEUKIN-5; DETERMINANTS	There is ongoing debate on the association between eosinophil count and diseases, as previous studies were inconsistent. We studied the relationship of eosinophil count with 22 complex metabolic, cardiac, and pulmonary traits and diseases. From the population-based LifeLines Cohort Study (N = 167,729), 13,301 individuals were included. We focused on relationship of eosinophil count with three classes of metabolic (7 traits, 2 diseases), cardiac (6 traits, 2 diseases), and pulmonary (2 traits, 2 diseases) outcomes. Regression analyses were applied in overall, women and men, while adjusted for age, sex, BMI and smoking. A p-value of < 0.00076 was considered statistically significant. 58.2% of population were women (mean+/-SD 51.3+/-11.1 years old). In overall, one-SD higher of ln-eosinophil count was associated with a 0.04 (+/-SE +/-0.002; p = 6.0x10(-6)) SD higher levels in ln-BMI, 0.06 (+/-0.007; p = 3.1x10-12) SD in ln-TG, 0.04 (+/-0.003; p = 7.0x10(-6)) SD in TC, 0.04 (+/-0.004; p = 6.3x10(-7)) SD in LDL, 0.04 (+/-0.006; p = 6.0x10-6) SD in HbA1c; and with a 0.05 (+/-0.004; p = 1.7x10(-8)) SD lower levels in HDL, 0.05 (+/-0.007; p = 3.4x10(-23)) SD in FEV1, and 0.09 (+/-0.001; p = 6.6x10(-28)) SD in FEV1/ FVC. A higher ln-eosinophil count was associated with 1.18 (95% CI 1.09 +/-1.28; p = 2.0x10(-5)) odds ratio of obesity, 1.29 (1.19 +/-1.39; p = 1.1x10(-10)) of metabolic syndrome, 1.40 (1.25 +/-1.56; p = 2.7x10-9) of COPD and 1.81 (1.61 +/-2.03; p = 1.0x10-23) of asthma. Similar results were found in women. We found no association between ln-eosinophil count either with blood pressure indices in overall, women and men; or with BMI, LDL, HbA1c and obesity in men. In a large population based cohort, we confirmed eosinophil count as a potential factor implicated in metabolic and pulmonary outcomes.	[Amini, Marzyeh; Bashirova, Dinara; Prins, Bram P.; Corpeleijn, Eva; Stolk, Ronald P.; Boezen, H. Marike; Vonk, Judith; Snieder, Harold; Alizadeh, Behrooz Z.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Bruinenberg, Marcel; Stolk, Ronald P.] Univ Groningen, Univ Med Ctr Groningen, LifeLines Cohort Study, Groningen, Netherlands; [Franke, Lude; Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Navis, Gerjan] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands; [Wolffenbuttel, Bruce H. R.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands; [Postma, Dirkje S.; Koppelman, Gerard H.; Boezen, H. Marike; Vonk, Judith] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma, Groningen, Netherlands; [Postma, Dirkje S.; Koppelman, Gerard H.; Boezen, H. Marike; Vonk, Judith] Univ Groningen, Univ Med Ctr Groningen, COPD, Groningen, Netherlands; [Koppelman, Gerard H.] Beatrix Childrens Hosp, Dept Pediat Pulmonol & Pediat Allergol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen	Amini, M; Alizadeh, BZ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.	m.amini@umcg.nl; b.z.alizadeh@umcg.nl	Vonk, Judith M/ABA-3009-2020; Wijmenga, Cisca/AAE-7719-2019; Koppelman, Gerard/AAG-9187-2020; Vonk, Judith/K-8477-2019; Franke, Lude/P-7036-2016	Vonk, Judith M/0000-0001-7531-4547; Wijmenga, Cisca/0000-0002-5635-1614; Vonk, Judith/0000-0001-7531-4547; Prins, Bram/0000-0001-5774-034X; Koppelman, Gerard/0000-0001-8567-3252; Stolk, Ronald/0000-0002-0518-1205; Corpeleijn, Eva/0000-0002-2974-3305; Franke, Lude/0000-0002-5159-8802; Wolffenbuttel, Bruce H.R./0000-0001-9262-6921	Netherlands Organization of Scientific Research NWO [175.010.2007.006]; Economic Structure Enhancing Fund (FES) of the Dutch government; Ministry of Economic Affairs; Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; Northern Netherlands Collaboration of Provinces (SNN); Province of Groningen; University Medical Center Groningen; University of Groningen; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; Groningen University Institute for Drug Exploration (GUIDE); UMCG, Groningen, the Netherlands; Digestive Disease Research Institute (DDRI), TUMS, Tehran, Iran	Netherlands Organization of Scientific Research NWO(Netherlands Organization for Scientific Research (NWO)); Economic Structure Enhancing Fund (FES) of the Dutch government; Ministry of Economic Affairs; Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; Northern Netherlands Collaboration of Provinces (SNN); Province of Groningen; University Medical Center Groningen; University of Groningen; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; Groningen University Institute for Drug Exploration (GUIDE); UMCG, Groningen, the Netherlands(Netherlands Government); Digestive Disease Research Institute (DDRI), TUMS, Tehran, Iran	The Life Lines Cohort Study is supported by the Netherlands Organization of Scientific Research NWO (grant 175.010.2007.006), the Economic Structure Enhancing Fund (FES) of the Dutch government, the Ministry of Economic Affairs, the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the Northern Netherlands Collaboration of Provinces (SNN), the Province of Groningen, University Medical Center Groningen, the University of Groningen, Dutch Kidney Foundation and Dutch Diabetes Research Foundation. Mrs. M. Amini was supported by Groningen University Institute for Drug Exploration (GUIDE), UMCG, Groningen, the Netherlands, and Digestive Disease Research Institute (DDRI), TUMS, Tehran, Iran.	Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; [Anonymous], 2012, DIABETES CARE S1, V35, pS4, DOI DOI 10.2337/DC12-S004; Babio N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058354; Bafadhel M, 2012, AM J RESP CRIT CARE, V186, P48, DOI 10.1164/rccm.201108-1553OC; Bafadhel M, 2011, AM J RESP CRIT CARE, V184, P662, DOI 10.1164/rccm.201104-0597OC; Banos G., 2011, Cardiovascular & Hematological Agents in Medicinal Chemistry, V9, P137; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Behm CA, 2000, PARASITOL TODAY, V16, P202, DOI 10.1016/S0169-4758(99)01620-8; Belda J, 2001, CHEST, V119, P1011, DOI 10.1378/chest.119.4.1011; Broekema M, 2010, RESP MED, V104, P1254, DOI 10.1016/j.rmed.2010.03.030; Chung FM, 2005, DIABETES CARE, V28, P1710, DOI 10.2337/diacare.28.7.1710; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; de Jong K, 2014, OCCUP ENVIRON MED, V71, P88, DOI 10.1136/oemed-2013-101639; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Exley MA, 2014, J ENDOCRINOL, V223, pR41, DOI 10.1530/JOE-13-0516; Gkrania-Klotsas E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013405; GLEICH GJ, 1990, J ALLERGY CLIN IMMUN, V85, P422, DOI 10.1016/0091-6749(90)90151-S; Gorska K, 2008, J PHYSIOL PHARMACOL, V59, P261; Hospers JJ, 1999, AM J RESP CRIT CARE, V160, P1869, DOI 10.1164/ajrccm.160.6.9811041; Huang ZS, 2001, LIPIDS, V36, P237, DOI 10.1007/s11745-001-0713-9; Jansen DF, 1999, AM J RESP CRIT CARE, V159, P924, DOI 10.1164/ajrccm.159.3.9804024; Jansen H, 2013, J INTERN MED, V273, P283, DOI 10.1111/joim.12010; Janssen I, 2002, ARCH INTERN MED, V162, P2074, DOI 10.1001/archinte.162.18.2074; Jatakanon A, 2000, AM J RESP CRIT CARE, V161, P64, DOI 10.1164/ajrccm.161.1.9809100; Johansson MW, 2014, CLIN EXP ALLERGY, V44, P482, DOI 10.1111/cea.12292; Kim DJ, 2008, J KOREAN MED SCI, V23, P193, DOI 10.3346/jkms.2008.23.2.193; Lacy P, 2001, CURR OPIN ALLERGY CL, V1, P79, DOI 10.1097/00130832-200102000-00014; Lampinen M, 2008, J LEUKOCYTE BIOL, V84, P1392, DOI 10.1189/jlb.0807513; Langholz B, 2005, CASE CONTROL STUDY N, P646; Lee SH, 2011, ALLERGY ASTHMA IMMUN, V3, P236, DOI 10.4168/aair.2011.3.4.236; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li NS, 2014, DIABETES, V63, P3149, DOI 10.2337/db13-1800; Lippi G, 2009, J THROMB THROMBOLYS, V28, P90, DOI 10.1007/s11239-008-0247-5; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Medoff BD, 2009, AM J RESP CELL MOL, V41, P397, DOI 10.1165/rcmb.2008-0415OC; Meng WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049875; Mensinga Tjeert T., 1994, Annals of Epidemiology, V4, P382; MENSINGA TT, 1992, AM REV RESPIR DIS, V146, P638, DOI 10.1164/ajrccm/146.3.638; Menzies-Gow A, 2002, CURR OPIN PULM MED, V8, P33, DOI 10.1097/00063198-200201000-00006; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; National Institutes of Health Heart Lung and Blood Institute, 2007, NATL TOXICOL PROGRAM, V08-5846, P1; Niccoli G, 2010, ATHEROSCLEROSIS, V211, P606, DOI 10.1016/j.atherosclerosis.2010.02.038; Oda E, 2014, J CLIN TRANSL ENDOCR, V1, P49, DOI 10.1016/j.jcte.2014.05.001; Petsky HL, 2007, COCHRANE DB SYST REV, V2; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Postma DS, 2007, GENDER MED, V4, pS133, DOI 10.1016/S1550-8579(07)80054-4; PRENTICE RL, 1982, AM J EPIDEMIOL, V116, P496, DOI 10.1093/oxfordjournals.aje.a113434; Rothenberg ME, 2001, IMMUNOL REV, V179, P139, DOI 10.1034/j.1600-065X.2001.790114.x; Saetta M, 1996, CLIN EXP ALLERGY, V26, P766, DOI 10.1111/j.1365-2222.1996.tb00606.x; Sampson AP, 2000, CLIN EXP ALLERGY, V30, P22; Saudek CD, 2008, J CLIN ENDOCR METAB, V93, P2447, DOI 10.1210/jc.2007-2174; Scholtens S, 2015, INT J EPIDEMIOL, V44, P1172, DOI 10.1093/ije/dyu229; Shim WS, 2006, DIABETES RES CLIN PR, V73, P284, DOI 10.1016/j.diabres.2006.02.001; Siroux V, 2004, J ALLERGY CLIN IMMUN, V114, P491, DOI 10.1016/j.jaci.2004.05.027; Song JW, 2010, PLAST RECONSTR SURG, V126, P2234, DOI 10.1097/PRS.0b013e3181f44abc; Sriaroon P, 2016, CLIN REV ALLERG IMMU, V50, P252, DOI 10.1007/s12016-014-8444-9; Stolk RP, 2008, EUR J EPIDEMIOL, V23, P67, DOI 10.1007/s10654-007-9204-4; Sweetnam PM, 1997, AM J EPIDEMIOL, V145, P416; Talini D, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005748; Ullmann N, 2013, ALLERGY, V68, P402, DOI 10.1111/all.12101; Umemoto S, 2000, AM J CARDIOL, V85, P715, DOI 10.1016/S0002-9149(99)00846-2; van den Berge M, 2003, CHEST, V123, p417S, DOI 10.1378/chest.123.3_suppl.417S-a; Vozarova B, 2002, DIABETES, V51, P455, DOI 10.2337/diabetes.51.2.455; Wang XB, 2004, AM J RESP CRIT CARE, V169, P941, DOI 10.1164/rccm.2201011; Weng M, 2011, AM J PHYSIOL-LUNG C, V301, pL927, DOI 10.1152/ajplung.00049.2011; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xu W, 2013, INT J MED SCI, V10, P758, DOI 10.7150/ijms.6155; Zhu LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067613	69	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168480	10.1371/journal.pone.0168480	http://dx.doi.org/10.1371/journal.pone.0168480			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27978545	Green Submitted, Green Published, gold			2022-12-26	WOS:000391217400111
J	Chen, TI; Chen, MYC				Chen, Tsung-I; Chen, Michael Yu-Chih			Zinc Is Indispensable in Exercise-Induced Cardioprotection against Intermittent Hypoxia-Induced Left Ventricular Function Impairment in Rats	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; IMPROVES MYOCARDIAL TOLERANCE; OXIDATIVE STRESS; ISCHEMIA-REPERFUSION; INFLAMMATORY MARKERS; CARDIAC-FUNCTION; HEART-FAILURE; TNF-ALPHA; DYSFUNCTION; APOPTOSIS	In obstructive sleep apnea (OSA), recurrent obstruction of the upper airway leads to intermittent hypoxia (IH) during sleep, which can result in impairment of cardiac function. Although exercise can have beneficial effects against IH-induced cardiac dysfunction, the mechanism remains unclear. This study aimed to investigate the interactions of zinc and exercise on IH-triggered left ventricular dysfunction in a rat model that mimics IH in OSA patients. Nine-week-old male Sprague-Dawley rats were randomly assigned to either a control group (CON) or to a group receiving 10 weeks of exercise training (EXE). During weeks 9 and 10, half the rats in each group were subjected to IH for 8 h per day for 14 days (IHCON, IHEXE), whereas the remainder continued to breathe room air. Rats within each of the CON, IHCON, EXE, and IHEXE groups were further randomly assigned to receive intraperitoneal injections of either zinc chloride, the zinc chelator N, N, N', N'-tetrakis(2-pyridylmethyl) ethylenediamine (TPEN), or injection vehicle only. IH induced a lower left ventricular fractional shortening, reduced ejection fraction, higher myocardial levels of inflammatory factors, increased levels oxidative stress, and lower levels of antioxidative capacity, all of which were abolished by zinc treatment. IHEXE rats exhibited higher levels of cardiac function and antioxidant capacity and lower levels of inflammatory factors and oxidative stress than IHCON rats; however, IHEXE rats receiving TPEN did not exhibit these better outcomes. In conclusion, zinc is required for protecting against IH-induced LV functional impairment and likely plays a critical role in exercise-induced cardioprotection by exerting a dual antioxidant and anti-inflammatory effect.	[Chen, Tsung-I] Tzu Chi Univ, Ctr Phys Educ, Off Gen & Basic Educ, Hualien, Taiwan; [Chen, Michael Yu-Chih] Buddhist Tzu Chi Gen Hosp, Dept Cardiol, Hualien, Taiwan; [Chen, Michael Yu-Chih] Tzu Chi Univ, PhD Program Inst Med, Hualien, Taiwan	Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University	Chen, TI (corresponding author), Tzu Chi Univ, Ctr Phys Educ, Off Gen & Basic Educ, Hualien, Taiwan.	tichen@gms.tcu.edu.tw		Chen, Tsung-I/0000-0003-3533-0846	Ministry of Science and Technology, Taiwan, R.O.C. [MOST-102-2410-H-320-009]	Ministry of Science and Technology, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This study was supported by Ministry of Science and Technology (www.most.gov.tw), Taiwan, R.O.C. Grant MOST-102-2410-H-320-009. The receiver of this funding was Tsung-I Chen. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves ED, 2013, SLEEP BREATH, V17, P505, DOI 10.1007/s11325-012-0729-8; Baguet JP, 2012, NAT REV CARDIOL, V9, P679, DOI 10.1038/nrcardio.2012.141; Beguin PC, 2005, J APPL PHYSIOL, V99, P1064, DOI 10.1152/japplphysiol.00056.2005; Bicer M, 2012, BRATISL MED J, V113, P199, DOI 10.4149/BLL_2012_046; Carpagnano GE, 2003, CHEST, V124, P1386, DOI 10.1378/chest.124.4.1386; Chao PC, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-33; Chaumont SB, 2001, MED SCI SPORT EXER, V33, P724; Chen L, 2005, AM J RESP CRIT CARE, V172, P915, DOI 10.1164/rccm.200504-560OC; Chen L, 2010, J APPL PHYSIOL, V109, P1675, DOI 10.1152/japplphysiol.01372.2009; Chen MYC, 2015, CHINESE J PHYSIOL, V58, P254, DOI 10.4077/CJP.2015.BAE357; Chen PC, 2013, J NUTR HEALTH AGING, V17, P639, DOI 10.1007/s12603-013-0023-x; Chen S, 2008, J BEIJING SPORT U, V31, P196; Chen TI, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00462; Chen TI, 2014, CELL PHYSIOL BIOCHEM, V33, P513, DOI 10.1159/000358631; Chen TI, 2011, EUR J APPL PHYSIOL, V111, P1939, DOI 10.1007/s00421-010-1824-9; Chen TI, 2011, SLEEP BREATH, V15, P845, DOI 10.1007/s11325-010-0448-y; Dayan A, 2005, ANN CLIN LAB SCI, V35, P73; Demirel HA, 2001, J APPL PHYSIOL, V91, P2205, DOI 10.1152/jappl.2001.91.5.2205; Duranteau J, 1998, J BIOL CHEM, V273, P11619, DOI 10.1074/jbc.273.19.11619; Fertin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071280; FIELD KJ, 1993, LAB ANIM, V27, P258, DOI 10.1258/002367793780745471; Filgueiras-Rama D, 2013, PULM MED, V2013, DOI 10.1155/2013/426758; Foster GE, 2010, HYPERTENSION, V56, P369, DOI 10.1161/HYPERTENSIONAHA.110.152108; Fukuyama Satoru, 2011, Allergology International, V60, P259, DOI 10.2332/allergolint.09-OA-0167; Ghaemian A, 2011, BIOL TRACE ELEM RES, V143, P1239, DOI 10.1007/s12011-011-8956-6; Guo J, 2011, SCI REP-UK, V1, DOI 10.1038/srep00113; Gupta M, 2014, DERMAT RES PRACT, V2014, DOI 10.1155/2014/709152; Hara K, 2002, ANESTH ANALG, V94, P313, DOI 10.1097/00000539-200202000-00015; Hashimoto K, 2009, NEUROSCIENCE, V163, P244, DOI 10.1016/j.neuroscience.2009.05.067; Janssen BJA, 2004, AM J PHYSIOL-HEART C, V287, pH1618, DOI 10.1152/ajpheart.01192.2003; Joyeux-Faure M, 2005, J APPL PHYSIOL, V98, P1691, DOI 10.1152/japplphysiol.01146.2004; Kasai T, 2011, J AM COLL CARDIOL, V57, P119, DOI 10.1016/j.jacc.2010.08.627; KIMBALL TR, 1993, J PEDIATR-US, V122, pS89, DOI 10.1016/S0022-3476(09)90050-6; Kline CE, 2011, SLEEP, V34, P1631, DOI 10.5665/sleep.1422; Kosmala W, 2008, CORONARY ARTERY DIS, V19, P375, DOI 10.1097/MCA.0b013e3282fc617c; Koyama RG, 2012, SLEEP MED, V13, P1028, DOI 10.1016/j.sleep.2012.06.017; Kumar SD, 2012, FREE RADICAL BIO MED, V53, P1595, DOI 10.1016/j.freeradbiomed.2012.07.008; Lai CJ, 2006, J APPL PHYSIOL, V100, P1974, DOI 10.1152/japplphysiol.01051.2005; Lam SY, 2012, HISTOCHEM CELL BIOL, V137, P303, DOI 10.1007/s00418-011-0900-5; Lavie L, 2002, AM J RESP CRIT CARE, V165, P1624, DOI 10.1164/rccm.20110-040OC; Lennon SL, 2004, J APPL PHYSIOL, V96, P1299, DOI 10.1152/japplphysiol.00920.2003; Li B, 2012, TOXICOLOGY MECH METH; Mallet RT, 2006, BASIC RES CARDIOL, V101, P436, DOI 10.1007/s00395-006-0599-y; Minoguchi K, 2005, AM J RESP CRIT CARE, V172, P625, DOI 10.1164/rccm.200412-1652OC; Ni H, 2011, BIOL TRACE ELEM RES, V142, P704, DOI 10.1007/s12011-010-8793-z; Noda A, 2013, PULM MED, V2013, DOI 10.1155/2013/814169; Norman J F, 2000, Sleep Res Online, V3, P121; Ohga E, 1999, J APPL PHYSIOL, V87, P10, DOI 10.1152/jappl.1999.87.1.10; Park AM, 2007, J APPL PHYSIOL, V102, P1806, DOI 10.1152/japplphysiol.01291.2006; Pelin Z, 2013, TURK J PHARM SCI, V10, P415; Penkowa M, 2005, EXP PHYSIOL, V90, P477, DOI 10.1113/expphysiol.2004.029371; Pialoux V, 2011, J PHYSIOL-LONDON, V589, P5529, DOI 10.1113/jphysiol.2011.218156; Powers SK, 2008, FREE RADICAL BIO MED, V44, P193, DOI 10.1016/j.freeradbiomed.2007.02.006; Quindry J, 2005, EXP GERONTOL, V40, P416, DOI 10.1016/j.exger.2005.03.010; Ramar K, 2015, J CLIN SLEEP MED; Ramirez TA, 2012, HYPERTENS RES, V35, P811, DOI 10.1038/hr.2012.32; Roh J, 2016, CIRC RES, V118, P279, DOI 10.1161/CIRCRESAHA.115.305250; Serra AJ, 2010, J PHYSIOL-LONDON, V588, P2431, DOI 10.1113/jphysiol.2010.187310; Shao CH, 2009, J APPL PHYSIOL, V106, P1280, DOI 10.1152/japplphysiol.91280.2008; Siu PM, 2004, FASEB J, V18, P1150, DOI 10.1096/fj.03-1291fje; Smith Simon S, 2007, J Clin Sleep Med, V3, P689; Spina RJ, 1997, AM J PHYSIOL-HEART C, V272, pH995, DOI 10.1152/ajpheart.1997.272.2.H995; Tam CS, 2007, SLEEP, V30, P723, DOI 10.1093/sleep/30.6.723; Thomas JJ, 2012, CLIN EXPT PHARM PHYS; Thorp DB, 2007, AM J PHYSIOL-REG I, V293, pR363, DOI 10.1152/ajpregu.00363.2006; Tomisawa M, 2003, TOXICOL LETT, V142, P111, DOI 10.1016/S0378-4274(03)00018-3; Ueno LM, 2009, SLEEP, V32, P637, DOI 10.1093/sleep/32.5.637; Vgontzas Alexandros N., 2008, Archives of Physiology and Biochemistry, V114, P211, DOI [10.1080/13813450802364627, 10.1080/13813450802364627 ]; Vgontzas AN, 2005, SLEEP MED REV, V9, P211, DOI 10.1016/j.smrv.2005.01.006; Williams A, 2007, SLEEP BREATH, V11, P69, DOI 10.1007/s11325-007-0106-1; Williams AL, 2010, SLEEP BREATH, V14, P51, DOI 10.1007/s11325-009-0279-x; Yang D, 2013, MED SCI MONITOR, V19, P251, DOI 10.12659/MSM.883874; Zhao YM, 2014, STROKE, V45, P1139, DOI 10.1161/STROKEAHA.113.004296; Zhao YG, 2011, TOXICOL LETT, V200, P100, DOI 10.1016/j.toxlet.2010.11.001; Ziada AM, 2009, J HYPERTENS, V27, P1309, DOI 10.1097/HJH.0b013e328329fb55; Zong P, 2004, EXP BIOL MED, V229, P806, DOI 10.1177/153537020422900813	76	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168600	10.1371/journal.pone.0168600	http://dx.doi.org/10.1371/journal.pone.0168600			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977796	Green Published, gold, Green Submitted			2022-12-26	WOS:000391217400120
J	Choi, YJ; Ki, EY; Zhang, CQ; Ho, WCS; Lee, SJ; Jeong, MJ; Chan, PKS; Park, JS				Choi, Youn Jin; Ki, Eun Young; Zhang, Chuqing; Ho, Wendy C. S.; Lee, Sung-Jong; Jeong, Min Jin; Chan, Paul K. S.; Park, Jong Sup			Analysis of Sequence Variation and Risk Association of Human Papillomavirus 52 Variants Circulating in Korea	PLOS ONE			English	Article							CERVICAL-CANCER; GENITAL-TRACT; POLYMORPHISM; NEOPLASIA; WOMEN; CLASSIFICATION; TYPE-52; LESIONS; E6	Introduction Human papillomavirus (HPV) 52 is a carcinogenic, high-risk genotype frequently detected in cervical cancer cases from East Asia, including Korea. Materials and Methods Sequences of HPV52 detected in 91 cervical samples collected from women attending Seoul St. Mary's Hospital were analyzed. HPV52 genomic sequences were obtained by polymerase chain reaction (PCR)-based sequencing and analyzed using Seq-Scape software, and phylogenetic trees were constructed using MEGA6 software. Results Of the 91 cervical samples, 40 were normal, 22 were low-grade lesions, 21 were high-grade lesions and 7 were squamous cell carcinomas. Four HPV52 variant lineages (A, B, C and D) were identified. Lineage B was the most frequently detected lineage, followed by lineage C. By analyzing the two most frequently detected lineages (B and C), we found that distinct variations existed in each lineage. We also found that a lineage B-specific mutation K93R (A379G) was associated with an increased risk of cervical neoplasia. Conclusions To our knowledge, we are the first to reveal the predominance of the HPV52 lineages, B and C, in Korea. We also found these lineages harbored distinct genetic alterations that may affect oncogenicity. Our findings increase our understanding on the heterogeneity of HPV52 variants, and may be useful for the development of new diagnostic assays and therapeutic vaccines.	[Choi, Youn Jin; Ki, Eun Young; Lee, Sung-Jong; Jeong, Min Jin; Park, Jong Sup] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Obstet, Seoul, South Korea; [Choi, Youn Jin; Ki, Eun Young; Lee, Sung-Jong; Jeong, Min Jin; Park, Jong Sup] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Gynecol, Seoul, South Korea; [Zhang, Chuqing; Ho, Wendy C. S.; Chan, Paul K. S.] Chinese Univ Hong Kong, Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Chinese University of Hong Kong	Park, JS (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Obstet, Seoul, South Korea.; Park, JS (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Gynecol, Seoul, South Korea.; Chan, PKS (corresponding author), Chinese Univ Hong Kong, Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	paulkschan@cuhk.edu.hk; jspark@catholic.ac.kr	Choi, Youn Jin/AAS-3301-2021; Chan, Paul KS/J-9360-2013	Chan, Paul KS/0000-0002-6360-4608	National R&D Program for Cancer Control [0720510]; Ministry of Health and Welfare, Republic of Korea; Korean Health Technology R&D Project grant from the Ministry of Health & Welfare, Republic of Korea [HI14C1731]	National R&D Program for Cancer Control(Ministry of Health & Welfare (MOHW), Republic of Korea); Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korean Health Technology R&D Project grant from the Ministry of Health & Welfare, Republic of Korea	The work was supported by Grants of National R&D Program for Cancer Control (0720510), Ministry of Health and Welfare, Republic of Korea and Statistical consultations were supported by a Korean Health Technology R&D Project grant from the Ministry of Health & Welfare, Republic of Korea (HI14C1731).	Aho J, 2003, J INFECT DIS, V188, P1517, DOI 10.1086/379198; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bernard HU, 2005, J CLIN VIROL, V32, pS1, DOI 10.1016/j.jcv.2004.10.021; Castle PE, 2010, CANCER EPIDEM BIOMAR, V19, P1675, DOI 10.1158/1055-9965.EPI-10-0251; Chan PKS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107573; Chang YJ, 2011, INT J CANCER, V129, P965, DOI 10.1002/ijc.25724; Chen ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020183; Choi IH, 2011, KOREAN J PATHOL, V45, P612, DOI 10.4132/KoreanJPathol.2011.45.6.612; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Formentin A, 2013, INT J CANCER, V132, P1821, DOI 10.1002/ijc.27874; Gagnon S, 2004, J INFECT DIS, V190, P1575, DOI 10.1086/424854; Giannoudis A, 2001, J PATHOL, V193, P295, DOI 10.1002/1096-9896(2000)9999:9999&lt;::AID-PATH809&gt;3.0.CO;2-C; Grodzki M, 2006, CANCER EPIDEM BIOMAR, V15, P820, DOI 10.1158/1055-9965.EPI-05-0864; HWA LEE， KEUN, 2011, Obstetrics & Gynecology Science, V54, P689; Ishizaki A, 2013, J MED VIROL, V85, P1069, DOI 10.1002/jmv.23566; Jones DL, 1996, SEMIN CANCER BIOL, V7, P327, DOI 10.1006/scbi.1996.0042; Kim Tae Eun, 2014, Korean J Pathol, V48, P24, DOI 10.4132/KoreanJPathol.2014.48.1.24; Munger K, 2004, J VIROL, V78, P11451, DOI 10.1128/JVI.78.21.11451-11460.2004; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Scheffner M, 2003, SEMIN CANCER BIOL, V13, P59, DOI 10.1016/S1044-579X(02)00100-1; Schiffman M, 2010, CANCER RES, V70, P3159, DOI 10.1158/0008-5472.CAN-09-4179; Serrano B, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-38; Sichero L, 2007, INT J CANCER, V120, P1763, DOI 10.1002/ijc.22481; Sun ZR, 2012, INT J MOL SCI, V13, P14962, DOI 10.3390/ijms131114962; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wheeler CM, 2009, JNCI-J NATL CANCER I, V101, P475, DOI 10.1093/jnci/djn510; Bosch FX, 2008, VACCINE, V26, pK1, DOI 10.1016/j.vaccine.2008.05.064; Xin CY, 2001, CANCER LETT, V170, P19, DOI 10.1016/S0304-3835(01)00570-5; Zhang CQ, 2014, J INFECT DIS, V210, P1600, DOI 10.1093/infdis/jiu310; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	34	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168178	10.1371/journal.pone.0168178	http://dx.doi.org/10.1371/journal.pone.0168178			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977741	Green Published, gold, Green Submitted			2022-12-26	WOS:000391217400073
J	Marateb, HR; Farahi, M; Rojas, M; Maanas, MA; Farina, D				Marateb, Hamid Reza; Farahi, Morteza; Rojas, Monica; Maanas, Miguel Angel; Farina, Dario			Detection of Multiple Innervation Zones from Multi-Channel Surface EMG Recordings with Low Signal-to-Noise Ratio Using Graph-Cut Segmentation	PLOS ONE			English	Article							EXTERNAL ANAL-SPHINCTER; MOTOR UNITS; MUSCLE; ELECTROMYOGRAPHY; CLASSIFICATION; EXTRACTION; LOCATION; POSITION	Knowledge of the location of muscle Innervation Zones (IZs) is important in many applications, e.g. for minimizing the quantity of injected botulinum toxin for the treatment of spasticity or for deciding on the type of episiotomy during child delivery. Surface EMG (sEMG) can be noninvasively recorded to assess physiological and morphological characteristics of contracting muscles. However, it is not often possible to record signals of high quality. Moreover, muscles could have multiple IZs, which should all be identified. We designed a fully-automatic algorithm based on the enhanced image Graph-Cut segmentation and morphological image processing methods to identify up to five IZs in 60-ms intervals of very-low to moderate quality sEMG signal detected with multi-channel electrodes (20 bipolar channels with Inter Electrode Distance (IED) of 5 mm). An anisotropic multilayered cylinder model was used to simulate 750 sEMG signals with signal-to-noise ratio ranging from -5 to 15 dB (using Gaussian noise) and in each 60-ms signal frame, 1 to 5 IZs were included. The micro-and macro-averaged performance indices were then reported for the proposed IZ detection algorithm. In the micro-averaging procedure, the number of True Positives, False Positives and False Negatives in each frame were summed up to generate cumulative measures. In the macro-averaging, on the other hand, precision and recall were calculated for each frame and their averages are used to determine F1-score. Overall, the micro (macro)averaged sensitivity, precision and F1-score of the algorithm for IZ channel identification were 82.7% (87.5%), 92.9% (94.0%) and 87.5% (90.6%), respectively. For the correctly identified IZ locations, the average bias error was of 0.02 +/- 0.10 IED ratio. Also, the average absolute conduction velocity estimation error was 0.41 +/- 0.40 m/s for such frames. The sensitivity analysis including increasing IED and reducing interpolation coefficient for time samples was performed. Meanwhile, the effect of adding power-line interference and using other image interpolation methods on the deterioration of the performance of the proposed algorithm was investigated. The average running time of the proposed algorithm on each 60-ms sEMG frame was 25.5 +/- 8.9 (s) on an Intel dual-core 1.83 GHz CPU with 2 GB of RAM. The proposed algorithm correctly and precisely identified multiple IZs in each signal epoch in a wide range of signal quality and is thus a promising new offline tool for electrophysiological studies.	[Marateb, Hamid Reza; Farahi, Morteza] Univ Isfahan, Fac Engn, Dept Biomed Engn, Esfahan, Iran; [Marateb, Hamid Reza; Rojas, Monica; Maanas, Miguel Angel] Univ Politecn Cataluna, BarcelonaTech, Biomed Engn Res Ctr, Dept Automat Control, Barcelona, Spain; [Rojas, Monica] Univ El Bosque, Dept Bioengn, Bogota, Colombia; [Farina, Dario] Georg August Univ, Univ Med Ctr Gottingen, Bernstein Ctr Computat Neurosci, Dept NeuroRehabil Engn, Gottingen, Germany	University of Isfahan; Universitat Politecnica de Catalunya; Universidad El Bosque; University of Gottingen	Marateb, HR (corresponding author), Univ Isfahan, Fac Engn, Dept Biomed Engn, Esfahan, Iran.; Marateb, HR (corresponding author), Univ Politecn Cataluna, BarcelonaTech, Biomed Engn Res Ctr, Dept Automat Control, Barcelona, Spain.	hamid.reza.marateb@upc.edu	Mañanas, Miguel Angel/AAI-2961-2021; Rojas-Martínez, Mónica/AAJ-6997-2021; Marateb, Hamid Reza/G-5556-2013; Farina, Dario/AAB-2648-2019	Rojas-Martínez, Mónica/0000-0002-9971-3566; Marateb, Hamid Reza/0000-0003-4408-2397; Mananas, Miguel Angel/0000-0001-9836-6083	People Programme (Marie Curie Actions) of the Seventh Framework Programme of the European Union (FP7) [600388]; Agency for Business Competitiveness of the Government of Catalonia; ACCIO; Spanish Ministry of Economy and Competitiveness- Spain [DPI2014-59049-R]	People Programme (Marie Curie Actions) of the Seventh Framework Programme of the European Union (FP7); Agency for Business Competitiveness of the Government of Catalonia; ACCIO; Spanish Ministry of Economy and Competitiveness- Spain	The research leading to these results has received funding from the People Programme (Marie Curie Actions) of the Seventh Framework Programme of the European Union (FP7/2007-2013) under REA grant agreement no. 600388 (TECNIOspring programme), from the Agency for Business Competitiveness of the Government of Catalonia, ACCIO, and from Spanish Ministry of Economy and Competitiveness- Spain (project DPI2014-59049-R).	Afsharipour B., 2014, P IFMBE P, P293, DOI DOI 10.1007/978-3-319-00846-2_73; Al-Kofahi Y, 2010, IEEE T BIO-MED ENG, V57, P841, DOI 10.1109/TBME.2009.2035102; Allen DP, 2009, J NEUROSCI METH, V177, P303, DOI 10.1016/j.jneumeth.2008.10.019; Barbero M., 2012, ATLAS MUSCLE INNERVA, DOI [10.1007/978-88-470-2463-2, DOI 10.1007/978-88-470-2463-2]; Beck A, 2014, INTRO NONLINEAR OPTI, Vxii; Beck TW, 2012, COMPUT METH PROG BIO, V105, P13, DOI 10.1016/j.cmpb.2010.07.003; Ben Salah M, 2011, IEEE T IMAGE PROCESS, V20, P545, DOI 10.1109/TIP.2010.2066982; Ben Salah M, 2008, LECT NOTES COMPUT SC, V5358, P268, DOI 10.1007/978-3-540-89639-5_26; Bilodeau M, 1997, J ELECTROMYOGR KINES, V7, P87, DOI 10.1016/S1050-6411(96)00024-7; Boykov Y, 2006, HANDBOOK OF MATHEMATICAL MODELS IN COMPUTER VISION, P79, DOI 10.1007/0-387-28831-7_5; Boykov Y, 2001, IEEE T PATTERN ANAL, V23, P1222, DOI 10.1109/34.969114; Brown R, 2014, ANN CLIN TRANSL NEUR, V1, P867, DOI 10.1002/acn3.124; Cescon C, 2006, IEEE INT WORK MED ME, P87; Cescon C, 2014, INT UROGYNECOL J, V25, P1491, DOI 10.1007/s00192-014-2375-0; Cescon C, 2014, INT UROGYNECOL J, V25, P1097, DOI 10.1007/s00192-014-2356-3; Childers MK, 2004, AM J PHYS MED REHAB, V83, pS38, DOI 10.1097/01.PHM.0000141129.23219.42; Chowdhury RH, 2013, SENSORS-BASEL, V13, P12431, DOI 10.3390/s130912431; Couprie C, 2011, IEEE T PATTERN ANAL, V33, P1384, DOI 10.1109/TPAMI.2010.200; DE LUCA CJ, 1979, IEEE T BIO-MED ENG, V26, P313, DOI 10.1109/TBME.1979.326534; Ebdon D., 1985, STAT GEOGRAPHY, Vviii; Farahi M, 2014, 20 C INT SOC EL KIN, P432; Farina D, 2004, IEEE T BIO-MED ENG, V51, P415, DOI 10.1109/TBME.2003.820998; Farina D, 2001, IEEE T BIO-MED ENG, V48, P637, DOI 10.1109/10.923782; Farina D, 2001, MED BIOL ENG COMPUT, V39, P225, DOI 10.1007/BF02344807; Farina D, 2014, J APPL PHYSIOL, V117, P1215, DOI 10.1152/japplphysiol.00162.2014; Felzenszwalb PF, 2011, IEEE T PATTERN ANAL, V33, P721, DOI 10.1109/TPAMI.2010.135; Gallina A, 2013, PHYSIOL MEAS, V34, P1411, DOI 10.1088/0967-3334/34/11/1411; Gazzoni M, 2004, J NEUROSCI METH, V136, P165, DOI 10.1016/j.jneumeth.2004.01.002; Ghaderi P, 2016, IEEE T BIOMEDICAL EN; Gobbo M, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-17; Gonzalez R., 2001, DIGITAL IMAGE PROCES, V2; Groenen P.J.F., 2007, ADV FUZZY CLUSTERING, P53, DOI [10.1002/9780470061190.ch3, DOI 10.1002/9780470061190.CH3]; Gustafsson F, 1996, IEEE T SIGNAL PROCES, V44, P988, DOI 10.1109/78.492552; HEIJMANS HJAM, 1995, SIAM REV, V37, P1, DOI 10.1137/1037001; Hilbe JM., 2007, NEGATIVE BINOMIAL RE, Vxii; Hofmann T, 1998, IEEE T PATTERN ANAL, V20, P803, DOI 10.1109/34.709593; Hogrel JY, 2005, NEUROPHYSIOL CLIN, V35, P59, DOI 10.1016/j.neucli.2005.03.001; HOU HS, 1978, IEEE T ACOUST SPEECH, V26, P508; Jahanmiri-Nezhad F, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00239; Kay S. M., 1993, FUNDAMENTALS STAT SI; Lapatki BG, 2011, CLIN NEUROPHYSIOL, V122, P1611, DOI 10.1016/j.clinph.2010.11.018; Lateva ZC, 2010, J APPL PHYSIOL, V108, P1530, DOI 10.1152/japplphysiol.01163.2009; Lehmann TM, 1999, IEEE T MED IMAGING, V18, P1049, DOI 10.1109/42.816070; Lezoray O, 2012, IMAGE PROCESSING ANA, Vxxiv; LYNN PA, 1979, IEEE T BIO-MED ENG, V26, P564, DOI 10.1109/TBME.1979.326444; MacIntosh BR, 2006, SKELETAL MUSCLE FORM, Vviii; Marateb HR, 2012, MED BIOL ENG COMPUT, V50, P79, DOI 10.1007/s11517-011-0790-7; MASUDA T, 1985, IEEE T BIO-MED ENG, V32, P36, DOI 10.1109/TBME.1985.325614; Meijering EHW, 1999, MED IMAGE COMPUTING; Merletti R, 2003, J ELECTROMYOGR KINES, V13, P37, DOI 10.1016/S1050-6411(02)00082-2; Merletti R, 2001, Exerc Sport Sci Rev, V29, P20, DOI 10.1097/00003677-200101000-00005; Merletti R., 2013, CONVERGING CLIN ENG, P1205; Mesin L, 2009, J ELECTROMYOGR KINES, V19, pE413, DOI 10.1016/j.jelekin.2009.02.002; Mihalik J, 1995, RADIOENGINEERING; Moritani T, 2005, BASIC PHYSL BIOPHYSI, P1; Muller KR, 2001, IEEE T NEURAL NETWOR, V12, P181, DOI 10.1109/72.914517; Nawab SH, 2010, CLIN NEUROPHYSIOL, V121, P1602, DOI 10.1016/j.clinph.2009.11.092; Ostlund N, 2007, J ELECTROMYOGR KINES, V17, P549, DOI 10.1016/j.jelekin.2006.06.002; POGGIO T, 1985, NATURE, V317, P314, DOI 10.1038/317314a0; Rainoldi A, 2004, J NEUROSCI METH, V134, P37, DOI 10.1016/j.jneumeth.2003.10.014; Saitou K, 2000, J Hum Ergol (Tokyo), V29, P35; Smith S.W., 1997, SCI ENG GUIDE DIGITA, V14; Soares FA, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0079-4; Sokolova M, 2009, INFORM PROCESS MANAG, V45, P427, DOI 10.1016/j.ipm.2009.03.002; StataCorp L, 2007, STAT DAT AN STAT SOF; Stegeman DF, 1997, J CLIN NEUROPHYSIOL, V14, P429, DOI 10.1097/00004691-199709000-00009; Turkowski K., 1990, GRAPHICS GEMS, P147, DOI [10.1.1.116.7898, DOI 10.1016/B978-0-08-050753-8.50042-5]; Ullah K, 2014, J ELECTROMYOGR KINES, V24, P860, DOI 10.1016/j.jelekin.2014.05.003; UNSER M, 1991, IEEE T PATTERN ANAL, V13, P277, DOI 10.1109/34.75515; Unser M, 1999, IEEE SIGNAL PROC MAG, V16, P22, DOI 10.1109/79.799930; Veksler O., 1999, EFFICIENT GRAPH BASE; Vieira TMM, 2010, J BIOMECH, V43, P2149, DOI 10.1016/j.jbiomech.2010.03.049; Zhang L, 2011, IEEE T IMAGE PROCESS, V20, P2378, DOI 10.1109/TIP.2011.2109730; Zwarts MJ, 2003, MUSCLE NERVE, V28, P1, DOI 10.1002/mus.10358	74	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0167954	10.1371/journal.pone.0167954	http://dx.doi.org/10.1371/journal.pone.0167954			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27978535	Green Published, Green Submitted, gold			2022-12-26	WOS:000391217400043
J	Plugis, NM; Palanski, BA; Weng, CH; Albertelli, M; Khosla, C				Plugis, Nicholas M.; Palanski, Brad A.; Weng, Chih-Hisang; Albertelli, Megan; Khosla, Chaitan			Thioredoxin-1 Selectively Activates Transglutaminase 2 in the Extracellular Matrix of the Small Intestine IMPLICATIONS FOR CELIAC DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; disulfide; intestine; thioredoxin; transglutaminase	ALLOSTERIC DISULFIDE BOND; HUMAN MACROPHAGES; REDOX REGULATION; T-CELLS; DOMAIN; INACTIVATION; INHIBITION; REDUCTION; CD4	Transglutaminase 2 (TG2) catalyzes transamidation or deamidation of its substrates and is ordinarily maintained in a catalytically inactive state in the intestine and other organs. Aberrant TG2 activity is thought to play a role in celiac disease, suggesting that a better understanding of TG2 regulation could help to elucidate the mechanistic basis of this malady. Structural and biochemical analysis has led to the hypothesis that extracellular TG2 activation involves reduction of an allosteric disulfide bond by thioredoxin-1 (TRX), but cellular and in vivo evidence for this proposal is lacking. To test the physiological relevance of this hypothesis, we first showed that macrophages exposed to pro-inflammatory stimuli released TRX in sufficient quantities to activate their extracellular pools of TG2. By using the C35S mutant of TRX, which formed a metastable mixed disulfide bond with TG2, we demonstrated that these proteins specifically recognized each other in the extracellular matrix of fibroblasts. When injected into mice and visualized with antibodies, we observed the C35S TRX mutant bound to endogenous TG2 as its principal protein partner in the small intestine. Control experiments showed no labeling of TG2 knock-out mice. Intravenous administration of recombinant TRX in wild-type mice, but not TG2 knock-out mice, led to a rapid rise in intestinal transglutaminase activity in a manner that could be inhibited by small molecules targeting TG2 or TRX. Our findings support the potential pathophysiological relevance of TRX in celiac disease and establish the Cys(370)-Cys(371) disulfide bond of TG2 as one of clearest examples of an allosteric disulfide bond in mammals.	[Plugis, Nicholas M.; Palanski, Brad A.; Weng, Chih-Hisang; Khosla, Chaitan] Stanford Univ, Dept Chem, 443 Via Ortega,Rm. 269, Stanford, CA 94305 USA; [Khosla, Chaitan] Stanford Univ, Dept Chem Engn, 443 Via Ortega,Rm. 269, Stanford, CA 94305 USA; [Albertelli, Megan] Stanford Univ, Dept Comparat Med, Stanford, CA 94305 USA; [Weng, Chih-Hisang] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Weng, Chih-Hisang] Stanford Univ, Dept Med Sci Training Program, Stanford, CA 94305 USA; [Khosla, Chaitan] Stanford Univ, Stanford ChEM H, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Khosla, C (corresponding author), Stanford Univ, Dept Chem, 443 Via Ortega,Rm. 269, Stanford, CA 94305 USA.; Khosla, C (corresponding author), Stanford Univ, Dept Chem Engn, 443 Via Ortega,Rm. 269, Stanford, CA 94305 USA.; Khosla, C (corresponding author), Stanford Univ, Stanford ChEM H, Shriram Ctr Bioengn & Chem Engn, 443 Via Ortega,Rm. 269, Stanford, CA 94305 USA.	khosla@stanford.edu	Albertelli, Megan/C-7650-2011	Albertelli, Megan/0000-0001-9433-229X; Khosla, Chaitan/0000-0001-6529-495X	National Institutes of Health [R01 DK063158]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R01 DK063158 (to C.K.). C.K. is an advisor to and shareholder of Sitari Pharmaceuticals, a company that is developing drugs that target transglutaminase 2. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adamczyk M, 2015, J CELL SCI, V128, P4615, DOI 10.1242/jcs.175968; Angelini G, 2002, P NATL ACAD SCI USA, V99, P1491, DOI 10.1073/pnas.022630299; Azimi I, 2010, J BIOL CHEM, V285, P40072, DOI 10.1074/jbc.M110.185371; Azimi I, 2011, ANTIOXID REDOX SIGN, V14, P113, DOI 10.1089/ars.2010.3620; Barbouche R, 2003, J BIOL CHEM, V278, P3131, DOI 10.1074/jbc.M205467200; BOOTHE RL, 1969, J BIOL CHEM, V244, P399; Checconi P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127086; Collighan RJ, 2009, AMINO ACIDS, V36, P659, DOI 10.1007/s00726-008-0190-y; CONNELLAN JM, 1969, J BIOL CHEM, V244, P3173; Dafik L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030642; De Laurenzi V, 2001, MOL CELL BIOL, V21, P148, DOI 10.1128/MCB.21.1.148-155.2001; DiRaimondo TR, 2014, ACS CHEM BIOL, V9, P266, DOI 10.1021/cb4006408; DiRaimondo TR, 2013, J MED CHEM, V56, P1301, DOI 10.1021/jm301775s; Ganderton T, 2007, J THROMB HAEMOST, V5, P204, DOI 10.1111/j.1538-7836.2006.02292.x; Genin M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1546-9; Gundemir S, 2012, BBA-MOL CELL RES, V1823, P406, DOI 10.1016/j.bbamcr.2011.09.012; Hofer S, 2009, CRIT CARE MED, V37, P2155, DOI 10.1097/CCM.0b013e31819fff67; Holmgren A, 2010, BIOCHEM BIOPH RES CO, V396, P120, DOI 10.1016/j.bbrc.2010.03.083; Jin X, 2011, J BIOL CHEM, V286, P37866, DOI 10.1074/jbc.M111.287490; Klock C, 2012, SEMIN IMMUNOPATHOL, V34, P513, DOI 10.1007/s00281-012-0305-0; Klock C, 2014, J MED CHEM, V57, P9042, DOI 10.1021/jm501145a; Klock C, 2012, PROTEIN SCI, V21, P1781, DOI 10.1002/pro.2162; Krudysz-Amblo J, 2013, BBA-GEN SUBJECTS, V1830, P3489, DOI 10.1016/j.bbagen.2013.02.013; Kumar S, 2013, AMINO ACIDS, V44, P81, DOI 10.1007/s00726-011-1139-0; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Martinez FO, 2013, BLOOD, V121, pE57, DOI 10.1182/blood-2012-06-436212; Matsuo Y, 2013, CYTOKINE GROWTH F R, V24, P345, DOI 10.1016/j.cytogfr.2013.01.001; Matthias LJ, 2002, NAT IMMUNOL, V3, P727, DOI 10.1038/ni815; Metcalfe C, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110010; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Nadalutti CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077277; Nadella V, 2015, BBA-MOL CELL RES, V1853, P201, DOI 10.1016/j.bbamcr.2014.09.020; Nakamura H, 2004, ANTIOXID REDOX SIGN, V6, P15, DOI 10.1089/152308604771978309; Nakamura H, 2001, P NATL ACAD SCI USA, V98, P2688, DOI 10.1073/pnas.041624998; Nakamura H, 2009, ADV DRUG DELIVER REV, V61, P303, DOI 10.1016/j.addr.2009.01.003; Nilsen EM, 1998, GASTROENTEROLOGY, V115, P551, DOI 10.1016/S0016-5085(98)70134-9; NILSEN EM, 1995, GUT, V37, P766, DOI 10.1136/gut.37.6.766; Owen GR, 2016, BIOCHEMISTRY-US, V55, P2227, DOI 10.1021/acs.biochem.6b00154; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; RUBARTELLI A, 1992, J BIOL CHEM, V267, P24161; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; Seluanov A., 2010, J VIS EXP; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Stamnaes J, 2010, J BIOL CHEM, V285, P25402, DOI 10.1074/jbc.M109.097162; van de Wal Y, 1998, J IMMUNOL, V161, P1585; Wang P, 2013, J BIOL CHEM, V288, P3346, DOI 10.1074/jbc.M112.418046; Wu CG, 2014, MOL CELL PROTEOMICS, V13, P3507, DOI 10.1074/mcp.M114.040931; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Yi MC, 2015, BIOORG MED CHEM LETT, V25, P4922, DOI 10.1016/j.bmcl.2015.05.006; Zemskov EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019414; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P9226, DOI 10.1073/pnas.0903679106; Zucker M, 2016, J THROMB HAEMOST, V14, P2202, DOI 10.1111/jth.13488	53	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					2000	2008		10.1074/jbc.M116.767988	http://dx.doi.org/10.1074/jbc.M116.767988			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28003361	Green Published, hybrid			2022-12-26	WOS:000395515600037
J	Mellema, M; Stoller, M; Queau, Y; Ho, SP; Chi, T; Larsen, JA; Passlack, N; Fascetti, AJ; Mohr, C; Westropp, JL				Mellema, M.; Stoller, M.; Queau, Y.; Ho, S. P.; Chi, T.; Larsen, J. A.; Passlack, N.; Fascetti, A. J.; Mohr, C.; Westropp, J. L.			Nanoparticle Tracking Analysis for the Enumeration and Characterization of Mineralo-Organic Nanoparticles in Feline Urine	PLOS ONE			English	Article							CALCIUM-OXALATE UROLITHIASIS; MULTICOLOR FLOW-CYTOMETRY; STONE FORMATION; ELECTRON-MICROSCOPY; KIDNEY-STONES; RENAL STONE; NANOBACTERIA; CATS; EXOSOMES; RECURRENCE	Urinary stone disease, particularly calcium oxalate, is common in both humans and cats. Calcifying nanoparticles (CNP) are spherical nanocrystallite material, and are composed of proteins (fetuin, albumin) and inorganic minerals. CNP are suggested to play a role in a wide array of pathologic mineralization syndromes including urolithiasis. We documented the development of a clinically relevant protocol to assess urinary CNP in 9 healthy cats consuming the same diet in a controlled environment using Nanoparticle Tracking Analysis (NTA). NIA is a novel method that allows for characterization of the CNP in an efficient, accurate method that can differentiate these particles from other urinary submicron particulates. The predominant nanoscale particles in feline urine are characteristic of CNP in terms of their size, their ability to spontaneously form under suitable conditions, and the presence of an outer layer that is rich in calcium and capable of binding to hydroxyapatite binders such as alendronate and osteopontin. The expansion of this particle population can be suppressed by the addition of citrate to urine samples. Further, compounds targeting exosomal surfaces do not label these particulates. As CNP have been associated with a number of significant urologic maladies, the method described herein may prove to be a useful adjunct in evaluating lithogenesis risk in mammals.	[Mellema, M.] Univ Calif Davis, Sch Vet Med, Dept Vet Surg & Radiol Sci, Davis, CA 95616 USA; [Stoller, M.; Chi, T.] Univ Calif San Francisco, Sch Med, Dept Urol, San Francisco, CA 94143 USA; [Queau, Y.] Royal Canin Res & Dev Ctr, Aimargues, France; [Ho, S. P.] Univ Calif San Francisco, Sch Dent, Dept Prevent & Restorat Dent Sci, San Francisco, CA 94143 USA; [Fascetti, A. J.] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA; [Passlack, N.] Free Univ Berlin, Inst Anim Nutr, Dept Vet Med, Berlin, Germany; [Mohr, C.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Westropp, J. L.] Univ Calif Davis, Sch Vet Med, Dept Vet Med & Epidemiol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis; Free University of Berlin; University of California System; University of California Davis; University of California System; University of California Davis	Westropp, JL (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Vet Med & Epidemiol, Davis, CA 95616 USA.	jlwestropp@ucdavis.edu	Ho, Sunita P/B-1084-2008		Royal Canin Research and Development [V435RCG]; Royal Canin	Royal Canin Research and Development; Royal Canin	This study was supported by a grant from Royal Canin Research and Development. Grant number V435RCG. One of the co-authors (YQ), helped participate in study design and writing and editing the manuscript Dr. Yann Queau, an employee of Royal Canin, was a coauthor of this study. Royal Canin provided no salary support for any of the authors. Royal Canin provided a grant/contract for us (MM, JLW, JAL) to purchase the NTA equipment used to analyze the urine samples we obtained from the cats in this study. Dr. Queau did not participate in study design, but did help review and edit the manuscript.	Ahmad I, 2013, PAK J MED SCI, V29, P1363; Albasan H, 2009, JAVMA-J AM VET MED A, V235, P1450, DOI 10.2460/javma.235.12.1450; Cannon AB, 2007, JAVMA-J AM VET MED A, V231, P570, DOI 10.2460/javma.231.4.570; Chi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124150; Ciftcioglu N, 1999, KIDNEY INT, V56, P1893, DOI 10.1046/j.1523-1755.1999.00755.x; Ciftcioglu N, 2008, INT J NANOMED, V3, P105; Dijcker JC, 2012, VET REC, V171, P646, DOI 10.1136/vr.101130; Dragovic RA, 2015, METHODS, V87, P64, DOI 10.1016/j.ymeth.2015.03.028; Dragovic RA, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.113266; Drancourt M, 2003, J CLIN MICROBIOL, V41, P368, DOI 10.1128/JCM.41.1.368-372.2003; Duan CY, 2013, INT J NANOMED, V8, P909, DOI 10.2147/IJN.S39642; Hernandez-Santana A, 2011, BIOANALYSIS, V3, P1085, DOI 10.4155/BIO.11.35; Hesse A, 2003, EUR UROL, V44, P709, DOI 10.1016/S0302-2838(03)00415-9; Hezel A, 2007, VET THER, V8, P247; Kajander EO, 2003, UROL RES, V31, P47, DOI 10.1007/s002440-003-0304-7; Kajander EO, 1998, P NATL ACAD SCI USA, V95, P8274, DOI 10.1073/pnas.95.14.8274; Kumon H, 2011, INT J UROL, V18, P458, DOI 10.1111/j.1442-2042.2011.02763.x; Kutikhin AG, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00214; Lekcharoensuk C, 2001, J AM VET MED ASSOC, V219, P1228, DOI 10.2460/javma.2001.219.1228; Lieske JC, 2014, CLIN J AM SOC NEPHRO, V9, P2141, DOI 10.2215/CJN.05660614; Mehdiani Arash, 2015, J Vis Exp, P50974, DOI 10.3791/50974; Miller J, 2013, J UROLOGY, V190, P1648, DOI 10.1016/j.juro.2013.03.010; National Research Council (US) Steering Group for the Workshop on Size Limits of Very Small Microorganisms, 1999, SIZ LIM VER SMALL MI; Oosthuyzen W, 2013, J PHYSIOL-LONDON, V591, P5833, DOI 10.1113/jphysiol.2013.264069; Pasch A, 2012, J AM SOC NEPHROL, V23, P1744, DOI 10.1681/ASN.2012030240; Plumb D, 2011, VET DRUG HDB; Shiekh FA, 2006, UROL RES, V34, P53, DOI 10.1007/s00240-005-0034-0; Sokolova V, 2011, COLLOID SURFACE B, V87, P146, DOI 10.1016/j.colsurfb.2011.05.013; Soygur T, 2002, J ENDOUROL, V16, P149, DOI 10.1089/089277902753716098; Stamatelou KK, 2003, KIDNEY INT, V63, P1817, DOI 10.1046/j.1523-1755.2003.00917.x; SUTHERLAND JW, 1985, MINER ELECTROL METAB, V11, P267; Trinchieri A, 2013, MINERVA MED, V104, P41; Trinchieri A, 1996, Arch Ital Urol Androl, V68, P203; van der Pol E, 2014, J THROMB HAEMOST, V12, P1182, DOI 10.1111/jth.12602; van der Pol E, 2014, NANO LETT, V14, P6195, DOI 10.1021/nl503371p; WONG TY, 2015, NATURE SCI REPORTS, V5, P15272, DOI DOI 10.1038/SREP15272; Wu CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075501; Xu HS, 2013, EXPERT OPIN PHARMACO, V14, P435, DOI 10.1517/14656566.2013.775250	38	1	2	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0166045	10.1371/journal.pone.0166045	http://dx.doi.org/10.1371/journal.pone.0166045			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005930	Green Published, gold, Green Submitted			2022-12-26	WOS:000392843200004
J	Ruiz-Martinez, J; Ferraguti, M; Figuerola, J; Martinez-de la Puente, J; Williams, RAJ; Herrera-Duenas, A; Aguirre, JI; Soriguer, R; Escudero, C; Moens, MAJ; Perez-Tris, J; Benitez, L				Ruiz-Martinez, Jorge; Ferraguti, Martina; Figuerola, Jordi; Martinez-de la Puente, Josue; John Williams, Richard Alexander; Herrera-Duenas, Amparo; Ignacio Aguirre, Jose; Soriguer, Ramon; Escudero, Clara; Jean Moens, Michael Andre; Perez-Tris, Javier; Benitez, Laura			Prevalence and Genetic Diversity of Avipoxvirus in House Sparrows in Spain	PLOS ONE			English	Article							POX-LIKE LESIONS; AVIAN POX; POXVIRUS; BIRDS; MALARIA; IDENTIFICATION; VIRUS; SEX; PCR	Avipoxvirus (APV) is a fairly common virus affecting birds that causes morbidity and mortality in wild and captive birds. We studied the prevalence of pox-like lesions and genetic diversity of APV in house sparrows (Passer domesticus) in natural, agricultural and urban areas in southern Spain in 2013 and 2014 and in central Spain for 8 months (2012-2013). Overall, 3.2% of 2,341 house sparrows visually examined in southern Spain had cutaneous lesions consistent with avian pox. A similar prevalence (3%) was found in 338 birds from central Spain. Prevalence was higher in hatch-year birds than in adults. We did not detect any clear spatial or temporal patterns of APV distribution. Molecular analyses of poxvirus-like lesions revealed that 63% of the samples were positive. Molecular and phylogenetic analyses of 29 DNA sequences from the fpv167 gene, detected two strains belonging to the canarypox clade (subclades B1 and B2) previously found in Spain. One of them appears predominant in Iberia and North Africa and shares 70% similarity to fowlpox and canarypox virus. This APV strain has been identified in a limited number of species in the Iberian Peninsula, Morocco and Hungary. The second one has a global distribution and has been found in numerous wild bird species around the world. To our knowledge, this represents the largest study of avian poxvirus disease in the broadly distributed house sparrow and strongly supports the findings that Avipox prevalence in this species in South and central Spain is moderate and the genetic diversity low.	[Ruiz-Martinez, Jorge; Escudero, Clara; Benitez, Laura] Univ Complutense Madrid, Fac Biol, Dept Microbiol 3, Madrid, Spain; [Ferraguti, Martina; Figuerola, Jordi; Martinez-de la Puente, Josue; Soriguer, Ramon] CSIC, Estn Biol Donana, Seville, Spain; [Figuerola, Jordi; Martinez-de la Puente, Josue; Soriguer, Ramon] CIBERESP, Madrid, Spain; [John Williams, Richard Alexander; Herrera-Duenas, Amparo; Ignacio Aguirre, Jose; Jean Moens, Michael Andre; Perez-Tris, Javier] Univ Complutense Madrid, Dept Zool & Antropol Fis, Fac Biol, Madrid, Spain; [John Williams, Richard Alexander] Linnaeus Univ, Ctr Ecol & Evolut Microbial Model Syst, Kalmar, Sweden	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Complutense University of Madrid; Linnaeus University	Benitez, L (corresponding author), Univ Complutense Madrid, Fac Biol, Dept Microbiol 3, Madrid, Spain.	lbenitez@ucm.es	Herrera-Dueñas, Amparo/I-3697-2014; Figuerola, Jordi/B-7917-2008; Williams, Richard/HGB-7918-2022; Aguirre, Jose I/L-1305-2013; Pérez-Tris, Javier/D-4087-2012; Williams, Richard AJ/J-9185-2014; la Puente, Josué Martínez-de/E-8597-2011; Ferraguti, Martina/C-6109-2015; Casimiro-Soriguer, Ramon/J-1494-2014	Herrera-Dueñas, Amparo/0000-0002-0185-7124; Figuerola, Jordi/0000-0002-4664-9011; Aguirre, Jose I/0000-0002-0210-890X; Pérez-Tris, Javier/0000-0001-5535-3100; Williams, Richard AJ/0000-0002-3263-2657; la Puente, Josué Martínez-de/0000-0001-8055-4115; Ferraguti, Martina/0000-0001-7481-4355; Escudero Duch, Clara/0000-0002-5617-0995; Casimiro-Soriguer, Ramon/0000-0002-9165-7766	Spanish Ministry of Science and Innovation [CGL2010-15734/BOS]; Spanish Ministry of Economy and Competitiveness [CGL2013-41642-P/BOS, Juan de la Cierva- JCI-2012-11868, FPI BES-2011-047609]; Innovation and Development Agency of Andalusia (Spain) [P11-RNM-7038]; RAJW [CEI-PICATA2012]; CEI Campus of International Excellence; Spanish Ministry of Education, Culture and Sports [FPU12/0568]; Craaford Foundation [20160971]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Economy and Competitiveness(Spanish Government); Innovation and Development Agency of Andalusia (Spain); RAJW; CEI Campus of International Excellence; Spanish Ministry of Education, Culture and Sports(Spanish Government); Craaford Foundation	This study was funded by the Spanish Ministry of Science and Innovation (Project CGL2010-15734/BOS), the Spanish Ministry of Economy and Competitiveness (Project CGL2013-41642-P/BOS) and the Innovation and Development Agency of Andalusia (Spain) (P11-RNM-7038). Grants were awarded to JMP (Juan de la Cierva- JCI-2012-11868) and MAJM (FPI BES-2011-047609), Spanish Ministry of Economy and Competitiveness; RAJW (CEI-PICATA2012), CEI Campus of International Excellence; MM (FPU12/0568), Spanish Ministry of Education, Culture and Sports. RAJW was supported by the Craaford Foundation (grant 20160971) during the writing of this publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah FM, 2013, VIRUS GENES, V46, P63, DOI 10.1007/s11262-012-0821-y; Aruch S, 2007, J WILDLIFE DIS, V43, P567, DOI 10.7589/0090-3558-43.4.567; Atkinson CT, 2005, CONDOR, V107, P537, DOI 10.1650/0010-5422(2005)107[0537:POPLAM]2.0.CO;2; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Ferraguti M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066237; Gholami-Ahangaran M, 2014, TROP ANIM HEALTH PRO, V46, P349, DOI 10.1007/s11250-013-0495-z; GIDDENS WE, 1971, VET PATHOL, V8, P260, DOI 10.1177/030098587100800308; Giraudeau M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086747; Griffiths R, 1996, P ROY SOC B-BIOL SCI, V263, P1251, DOI 10.1098/rspb.1996.0184; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Gutierrez-Lopez R, 2015, J VECTOR ECOL, V40, P11, DOI 10.1111/jvec.12127; Gyuranecz M, 2013, J VIROL, V87, P4938, DOI 10.1128/JVI.03183-12; Ha HJ, 2011, VET MICROBIOL, V150, P80, DOI 10.1016/j.vetmic.2011.01.011; Henriques AM, 2016, J ZOO WILDLIFE MED, V47, P161, DOI 10.1638/2011-0101.1; Illera JC, 2008, PARASITOL RES, V103, P1435, DOI 10.1007/s00436-008-1153-7; Jarmin S, 2006, J GEN VIROL, V87, P2191, DOI 10.1099/vir.0.81738-0; King A. M., 2012, VIRUS TAXONOMY CLASS; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kulich P, 2008, AVIAN PATHOL, V37, P101, DOI 10.1080/03079450701805332; Lachish S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038316; Lanfear R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-82; Lawson B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040176; Le Loc'h G, 2014, VET RES, V45, DOI 10.1186/s13567-014-0098-3; Lee LH, 1997, J VIROL METHODS, V63, P113, DOI 10.1016/S0166-0934(96)02119-2; Luschow D, 2004, AVIAN DIS, V48, P453, DOI 10.1637/7111; MCCLURE HE, 1989, J FIELD ORNITHOL, V60, P421; Parker PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015989; Pawar RM, 2011, EUR J WILDLIFE RES, V57, P785, DOI 10.1007/s10344-010-0488-4; Perez-Tris J, 2011, AVIAN DIS, V55, P545, DOI 10.1637/9685-021411-Reg.1; Pinilla J., 2001, MANUAL ANILLAMIENTO; Roiz D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128112; Smits JE, 2005, VET PATHOL, V42, P59, DOI 10.1354/vp.42-1-59; Svensson L.A., 2006, IDENTIFICATION GUIDE; Thiel T, 2005, J WILDLIFE DIS, V41, P342, DOI 10.7589/0090-3558-41.2.342; Van Riper C, 2002, AUK, V119, P929, DOI 10.1642/0004-8038(2002)119[0929:EAEOAP]2.0.CO;2; van Riper C, 2007, INFECT DIS WILD BIRD, P136; VARGAS H, 1987, J FIELD ORNITHOL, V58, P101; Weli SC, 2004, ARCH VIROL, V149, P2035, DOI 10.1007/s00705-004-0357-0; Young LC, 2008, J FIELD ORNITHOL, V79, P93, DOI 10.1111/j.1557-9263.2008.00149.x; Zylberberg M, 2012, BIOL CONSERV, V153, P72, DOI 10.1016/j.biocon.2012.04.022	41	12	13	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168690	10.1371/journal.pone.0168690	http://dx.doi.org/10.1371/journal.pone.0168690			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005936	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000392843200082
J	Perez-Parra, S; Chueca, N; Alvarez, M; Pasquau, J; Omar, M; Collado, A; Vinuesa, D; Lozano, AB; Yebra, G; Garcia, F				Perez-Parra, Santiago; Chueca, Natalia; Alvarez, Marta; Pasquau, Juan; Omar, Mohamed; Collado, Antonio; Vinuesa, David; Lozano, Ana B.; Yebra, Gonzalo; Garcia, Federico			Phylodynamic and Phylogeographic Profiles of Subtype B HIV-1 Epidemics in South Spain	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; DRUG-RESISTANCE; TRANSMISSION DYNAMICS; POPULATION-DYNAMICS; ANTIRETROVIRAL THERAPY; INFECTED INDIVIDUALS; NORTHWEST SPAIN; BASQUE COUNTRY; PREVALENCE; EVOLUTION	Background Since 1982, HIV-1 epidemics have evolved to different scenarios in terms of transmission routes, subtype distribution and characteristics of transmission clusters. We investigated the evolutionary history of HIV-1 subtype B in south Spain. Patients & Methods We studied all newly diagnosed HIV-1 subtype B patients in East Andalusia during the 2005-2012 period. For the analysis, we used the reverse transcriptase and protease sequences from baseline resistance, and the Trugene (R) HIV Genotyping kit (Siemens, Barcelona, Spain). Subtyping was done with REGA v3.0. The maximum likelihood trees constructed with RAxML were used to study HIV-1 clustering. Phylogeographic and phylodynamic profiles were studied by Bayesian inference methods with BEAST v1.7.5 and SPREAD v1.0.6. Results Of the 493 patients infected with HIV-1 subtype B, 234 grouped into 55 clusters, most of which were small (44 clusters <= 5 patients, 31 with 2 patients, 13 with 3). The rest (133/234) were grouped into 11 clusters with >= 5 patients, and most (82%, 109/133) were men who have sex with men (MSM) grouped into 8 clusters. The association with clusters was more frequent in Spanish (p = 0.02) men (p< 0.001), MSM (p<0.001) younger than 35 years (p = 0.001) and with a CD4+ T-cell count above 350 cells/ul (p<0.001). We estimated the date of HIV-1 subtype B regional epidemic diversification around 1970 (95% CI: 1965-1987), with an evolutionary rate of 2.4 (95%Cl: 1.7-3.1) x 10(-3) substitutions/site/year. Most clusters originated in the 1990s in MSMs. We observed exponential subtype B HIV-1 growth in 1980-1990 and 2005-2008. The most significant migration routes for subtype B went from inland cities to seaside locations. Conclusions We provide the first data on the phylodynamic and phylogeographic profiles of HIV-1 subtype B in south Spain. Our findings of transmission clustering among MSMs should alert healthcare managers to enhance preventive measures in this risk group in order to prevent future outbreaks.	[Perez-Parra, Santiago; Chueca, Natalia; Alvarez, Marta; Garcia, Federico] Hosp Univ San Cecilio, Serv Microbiol Clin, Complejo Hosp, Granada, Spain; [Perez-Parra, Santiago; Chueca, Natalia; Alvarez, Marta; Garcia, Federico] Inst Invest IBS, Granada, Spain; [Pasquau, Juan] Hosp Virgen de las Nieves, Serv Infecciosas, Granada, Spain; [Omar, Mohamed] Hosp Ciudad Jaen, Serv Infecciosas, Jaen, Spain; [Collado, Antonio] Hosp Torrecardenas, Serv Med Interna, Almeria, Spain; [Vinuesa, David] Hosp Univ San Cecilio, Serv Infecciosas, Granada, Spain; [Lozano, Ana B.] Hosp Poniente, Serv Infecciosas, Almeria, Spain; [Yebra, Gonzalo] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland	Hospital Universitario San Cecilio; Instituto de Investigacion Biosanitaria IBS Granada; Hospital Universitario Virgen de las Nieves; Hospital Torrecardenas; Hospital Universitario San Cecilio; University of Edinburgh	Garcia, F (corresponding author), Hosp Univ San Cecilio, Serv Microbiol Clin, Complejo Hosp, Granada, Spain.; Garcia, F (corresponding author), Inst Invest IBS, Granada, Spain.	fegarcia@ugr.es	Garcia, Federico/AAA-3175-2020; Chueca, Natalia/T-9734-2019	Garcia, Federico/0000-0001-7611-781X; Chueca, Natalia/0000-0002-3420-3290; Yebra, Gonzalo/0000-0002-3472-3667; Pasquau, Juan/0000-0001-9409-9205	National Plan of I+D+i [RD12/0017/006]; Health institute Carlos III(ISCIII) [RI12/01053]; Ministry of Health of Andalusia [AC-0082-2013]	National Plan of I+D+i; Health institute Carlos III(ISCIII); Ministry of Health of Andalusia	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funded by National Plan of I+D+i (RD12/0017/006), Health institute Carlos III(ISCIII), RI12/01053 (General Ministry of Evaluation and European Fund of Regional Development-FEDER), granted to FGG. Ministry of Health of Andalusia (AC-0082-2013), granted to FGG.	Abecasis AB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-7; Abecasis AB, 2009, J VIROL, V83, P12917, DOI 10.1128/JVI.01022-09; Ambrosioni J, 2012, AIDS, V26, P2079, DOI 10.1097/QAD.0b013e32835805b6; Bannister WP, 2006, ANTIVIR THER, V11, P707; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Bezemer D, 2004, AIDS, V18, P1571, DOI 10.1097/01.aids.0000131357.52457.33; Brown AJL, 2011, J INFECT DIS, V204, P1463, DOI 10.1093/infdis/jir550; Burns S, 2007, AIDS, V21, P1035, DOI 10.1097/QAD.0b013e3280b07761; Castro-Nallar E, 2012, MOL PHYLOGENET EVOL, V62, P777, DOI 10.1016/j.ympev.2011.11.019; Chalmet K, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-262; Ciccozzi M, 2012, AIDS RES HUM RETROV, V28, P1280, DOI 10.1089/aid.2011.0138; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Da vila PF, 2012, CONDUCTAS RIESGO PRU; Dalai SC, 2009, AIDS, V23, P2523, DOI 10.1097/QAD.0b013e3283320ef3; de Silva TI, 2013, AIDS, V27, P125, DOI 10.1097/QAD.0b013e32835ab12c; Delatorre EO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041904; Dennis AM, 1999, J ACQ IMMUN DEF SYND, V2014, P181; Drummond AJ, 2003, TRENDS ECOL EVOL, V18, P481, DOI 10.1016/S0169-5347(03)00216-7; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Esbjornsson J, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew010; Faria NR, 2012, INFECT GENET EVOL, V12, P453, DOI 10.1016/j.meegid.2011.04.028; Fox J, 2010, AIDS, V24, P2397, DOI 10.1097/QAD.0b013e32833cbb5b; Frost SDW, 2010, PHILOS T R SOC B, V365, P1879, DOI 10.1098/rstb.2010.0060; Garcia F, 2011, ANTIVIR RES, V91, P150, DOI 10.1016/j.antiviral.2011.05.010; Grabowski MK, 2014, CURR OPIN HIV AIDS, V9, P126, DOI 10.1097/COH.0000000000000040; Gray RR, 2009, AIDS, V23, pF9, DOI 10.1097/QAD.0b013e32832faf61; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Jetzt AE, 2000, J VIROL, V74, P1234, DOI 10.1128/JVI.74.3.1234-1240.2000; Kim GJ, 2012, AIDS RES HUM RETROV, V28, P880, DOI [10.1089/aid.2011.0267, 10.1089/AID.2011.0267]; Kouyos RD, 2010, J INFECT DIS, V201, P1488, DOI 10.1086/651951; Lai A, 2010, HIV MED, V11, P593, DOI 10.1111/j.1468-1293.2010.00832.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lohse N, 2006, ANTIVIR THER, V11, P591; Lunar MM, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0802-6; Maartens G, 2014, LANCET, V384, P258, DOI 10.1016/S0140-6736(14)60164-1; Mbisa JL, 2012, AIDS RES HUM RETROV, V28, P961, DOI [10.1089/aid.2011.0390, 10.1089/AID.2011.0390]; Mehta SR, 2011, INFECT GENET EVOL, V11, P975, DOI 10.1016/j.meegid.2011.03.009; Miller M.A., 2010, P GAT COMP ENV WORKS; Montagnier L, 2002, SCIENCE, V298, P1727, DOI 10.1126/science.1079027; National AIDS Case Registry, 2010, EP SURV AIDS SPAIN; Ng KT, 2013, PLOS ONE, V8; Palma AC, 2007, INFECT GENET EVOL, V7, P391, DOI 10.1016/j.meegid.2007.01.009; Patino-Galindo JA, 2016, INFECT GENET EVOL, V40, P91, DOI 10.1016/j.meegid.2016.02.028; Perez-Parra S, 2015, ENFERM INFEC MICR CL, V33, P603, DOI 10.1016/j.eimc.2014.11.016; Pernas B, 2015, J MED VIROL, V87, P1319, DOI 10.1002/jmv.24185; Pernas B, 2014, AIDS, V28, P1837, DOI 10.1097/QAD.0000000000000326; Recordon-Pinson P, 2009, ANTIVIR THER, V14, P551; Roy CN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129896; Siljic M, 2014, ARCH BIOL SCI, V66, P507, DOI 10.2298/ABS1402507S; Cuevas MT, 2009, JAIDS-J ACQ IMM DEF, V51, P99, DOI 10.1097/QAI.0b013e318199063e; Thomson MM, 2012, JAIDS-J ACQ IMM DEF, V59, pE49, DOI 10.1097/QAI.0b013e3182400fc4; Vega Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125699; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Volz EM, 2009, GENETICS, V183, P1421, DOI 10.1534/genetics.109.106021; Vrancken B, 2015, AIDS, V29, P1549, DOI 10.1097/QAD.0000000000000731; Walker Polly R., 2005, Infection Genetics and Evolution, V5, P199, DOI 10.1016/j.meegid.2004.06.011; Wertheim JO, 2012, MOL BIOL EVOL, V29, P451, DOI 10.1093/molbev/msr266; Yebra G, 2013, INFECT GENET EVOL, V14, P232, DOI 10.1016/j.meegid.2012.12.006; Yerly S, 2007, AIDS, V21, P2223, DOI 10.1097/QAD.0b013e3282f0b685; Zehender G, 2010, JAIDS-J ACQ IMM DEF, V55, P156, DOI 10.1097/QAI.0b013e3181eb3002	64	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168099	10.1371/journal.pone.0168099	http://dx.doi.org/10.1371/journal.pone.0168099			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002469	Green Published, gold, Green Submitted			2022-12-26	WOS:000392853100032
J	Rupsys, P				Rupsys, Petras			New Insights into Tree Height Distribution Based on Mixed Effects Univariate Diffusion Processes	PLOS ONE			English	Article							STOCHASTIC DIFFERENTIAL-EQUATIONS; BIVARIATE DISTRIBUTION; LAPLACE APPROXIMATION; MODELS; DIAMETERS; FOREST; REGRESSION; COPULAS; GROWTH; VOLUME	The aim of this paper is twofold: to introduce the mathematics of stochastic differential equations (SDEs) for forest dynamics modeling and to describe how such a model can be applied to aid our understanding of tree height distribution corresponding to a given diameter using the large dataset provided by the Lithuanian National Forest Inventory (LNFI). Tree height diameter dynamics was examined with Ornstein-Uhlenbeck family mixed effects SDEs. Dynamics of a tree height, volume and their coefficients of variation, quantile regression curves of the tree height, and height-diameter ratio were demonstrated using newly developed tree height distributions for a given diameter. The parameters were estimated by considering a discrete sample of the diameter and height and by using an approximated maximum likelihood procedure. All models were evaluated using a validation dataset. The dataset provided by the LNFI (2006-2010) of Scots pine trees is used in this study to estimate parameters and validate our modeling technique. The verification indicated that the newly developed models are able to accurately capture the behavior of tree height distribution corresponding to a given diameter. All of the results were implemented in a MAPLE symbolic algebra system.	[Rupsys, Petras] Aleksandras Stulginskis Univ, Ctr Math Phys & Informat Technol, Kaunas, Lithuania; [Rupsys, Petras] Aleksandras Stulginskis Univ, Inst Forest Management & Wood Sci, Kaunas, Lithuania	Vytautas Magnus University; Vytautas Magnus University	Rupsys, P (corresponding author), Aleksandras Stulginskis Univ, Ctr Math Phys & Informat Technol, Kaunas, Lithuania.; Rupsys, P (corresponding author), Aleksandras Stulginskis Univ, Inst Forest Management & Wood Sci, Kaunas, Lithuania.	petras.rupsys@asu.lt	Rupšys, Petras/I-5255-2019; Rupšys, Petras/AAB-9429-2019	Rupšys, Petras/0000-0002-1738-2039				Adamec Z., 2015, Journal of Forest Science (Prague), V61, P439, DOI 10.17221/68/2015-JFS; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Almquist J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124050; [Anonymous], 1928, Z PFLANZENERN DUNGUN, DOI DOI 10.1002/JPLN.19280120502; CAPOCELLI RM, 1974, KYBERNETIK, V15, P147, DOI 10.1007/BF00274586; Chen CM, 1978, MINNESOTA FORESTRY R, P267; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Corradi V, 2006, HBK ECON, V24, P197, DOI 10.1016/S1574-0706(05)01005-0; Duan AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062605; GARCIA O, 1983, BIOMETRICS, V39, P1059, DOI 10.2307/2531339; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; Gutierrez-Jaimez R, 2014, STOCH ENV RES RISK A, V28, P1125, DOI 10.1007/s00477-013-0802-2; Ito K., 1942, JPN J MATH, V18, P261, DOI [DOI 10.4099/JJM1924.18.0_261, 10.4099/jjm1924.18.0_261]; Joe H, 2008, COMPUT STAT DATA AN, V52, P5066, DOI 10.1016/j.csda.2008.05.002; Kempes CP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020551; Kullback S., 1997, INFORM THEORY STAT; Li FS, 2002, FOREST SCI, V48, P47; Monagan M.B., 2007, MAPLE ADV PROGRAMMIN; Monness E, 2015, CAN J FOREST RES, V45, P307, DOI 10.1139/cjfr-2014-0333; Petrauskas E, 2013, RURAL DEVELOPMENT, V6, P407; Petrauskas E, 2013, BALT FOR, V19, P143; Rennolls K, 2009, FOR BIOM MODEL INFOR, V1, P1; Roitman I, 2015, ECOL MODEL, V297, P118, DOI 10.1016/j.ecolmodel.2014.11.009; Roman-Roman P, 2010, J THEOR BIOL, V263, P59, DOI 10.1016/j.jtbi.2009.12.009; Rupsys P, 2015, AIP CONF PROC, V1684, DOI 10.1063/1.4934322; Rupsys P, 2015, INT J BIOMATH, V8, DOI 10.1142/S1793524515500606; Rupsys P, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/375270; Rupsys P, 2015, J FOREST RES-JPN, V20, P9, DOI 10.1007/s10310-014-0454-1; Schmidt M, 1999, FORSTWISS CENTRALBL, V118, P355, DOI 10.1007/BF02768999; SCHREUDER HT, 1977, BIOMETRICS, V33, P471, DOI 10.2307/2529361; Schumacher FX, 1933, J AGRIC RES, V47, P0719; SHUN ZM, 1995, J ROY STAT SOC B MET, V57, P749; Smith LB, 2015, ANN APPL STAT, V9, P1226, DOI 10.1214/15-AOAS841; Suzuki T., 1971, MITT FORSTL BUNDESVE, V91, P69; Uhlenbeck GE, 1930, PHYS REV, V36, P0823, DOI 10.1103/PhysRev.36.823; Vidal C., 2010, NATL FOREST INVENTOR; Wang ML, 2008, FOREST SCI, V54, P284; Wong E, 1985, STOCHASTIC PROCESSES; Xu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104012; Zucchini W, 2001, SILVA FENN, V35, P169, DOI 10.14214/sf.594	41	12	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168507	10.1371/journal.pone.0168507	http://dx.doi.org/10.1371/journal.pone.0168507			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002500	Green Submitted, Green Published, gold			2022-12-26	WOS:000392853100049
J	Shin, JM; Kang, JH; Lee, SA; Park, IH; Lee, HM				Shin, Jae-Min; Kang, Ju-Hyung; Lee, Seoung-Ae; Park, Il-Ho; Lee, Heung-Man			Baicalin Down-Regulates IL-1 beta-Stimulated Extracellular Matrix Production in Nasal Fibroblasts	PLoS One			English	Article							ACUTE LUNG INJURY; NF-KAPPA-B; CHRONIC RHINOSINUSITIS; PULMONARY-FIBROSIS; COLLAGEN-SYNTHESIS; EPITHELIAL-CELLS; EXPRESSION; INTERLEUKIN-1-BETA; INFLAMMATION; PHOSPHORYLATION	Purpose Baicalin, a Chinese herbal medicine, has anti-fibrotic and anti-inflammatory effects. The aims of present study were to investigate the effects of baicalin on the myofibroblast differentiation, extracellular matrix production, migration, and collagen contraction of interleukin (IL)-1 beta-stimulated nasal fibroblasts and to determine the molecular mechanism of baicalin in nasal fibroblasts. Methods Nasal fibroblasts were isolated from the inferior turbinate of patients. Baicalin was used to treat IL-1 beta-stimulated nasal fibroblasts. To evaluate cytotoxicity, a 3-(4,5-dimethylthiazol-2y1)-2,5diphenyl-tetrazolium bromide assay was used. The expression levels of a-smooth muscle actin (SMA), fibronectin, phospho-mitogen-activated protein kinase (p-MAPK), p-Akt, p-p50, p-p65, and p-IKB alpha were measured by western blotting, reverse transcription-polymerase chain reaction (RT-PCR),or immunofluorescence staining. Fibroblast migration was analyzed with scratch assays and transwell migration assays. Total collagen was evaluated with the Sircol collagen assay. Contractile activity was measured with a collagen gel contraction assay. Results Baicalin (0-50 mu M) had no significant cytotoxic effects in nasal fibroblasts. The expression of a SMA and fibronectin were significantly down-regulated in baicalin-treated nasal fibroblasts. Migration, collagen production, and contraction of IL-1 beta-stimulated nasal fibroblasts were significantly inhibited by baicalin treatment. Baicalin also significantly down-regulated p-MAPK, p-Akt, p-p50, p-p65, and p-IKB alpha in IL-1 beta-stimulated nasal fibroblasts. Conclusions We showed that baicalin down-regulated myofibroblast differentiation, extracellular matrix production, migration, and collagen contraction via the MAPK and Akt/NF-kappa B pathways in IL-1 beta-stimulated nasal fibroblasts.	[Shin, Jae-Min; Park, Il-Ho; Lee, Heung-Man] Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Kang, Ju-Hyung; Lee, Heung-Man] Korea Univ, Coll Med, Div Brain Korea Program Biomed Sci 21, Seoul, South Korea; [Lee, Seoung-Ae; Lee, Heung-Man] Korea Univ, Coll Med, Inst Korea Univ Med Devices Support Ctr, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Lee, HM (corresponding author), Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea.; Lee, HM (corresponding author), Korea Univ, Coll Med, Div Brain Korea Program Biomed Sci 21, Seoul, South Korea.; Lee, HM (corresponding author), Korea Univ, Coll Med, Inst Korea Univ Med Devices Support Ctr, Seoul, South Korea.	lhman@korea.ac.kr		PARK, IL-HO/0000-0002-7011-6071	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI15C1512, HI13C1501]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI15C1512 and HI13C1501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aumiller V, 2013, AM J RESP CELL MOL, V49, P96, DOI 10.1165/rcmb.2012-0524OC; Bachert C, 2015, J ALLERGY CLIN IMMUN, V136, P1431, DOI 10.1016/j.jaci.2015.10.010; Ball SL, 2016, AM J PATHOL, V186, P225, DOI 10.1016/j.ajpath.2015.09.020; Barkhordar RA, 2002, J ENDODONT, V28, P157, DOI 10.1097/00004770-200203000-00003; Bujak M, 2008, AM J PATHOL, V173, P57, DOI 10.2353/ajpath.2008.070974; Cho JS, 2012, CLIN EXP ALLERGY, V42, P872, DOI 10.1111/j.1365-2222.2011.03931.x; Furukido K, 2005, EUR ARCH OTO-RHINO-L, V262, P50, DOI 10.1007/s00405-003-0713-9; Furuyama A, 2008, MATRIX BIOL, V27, P429, DOI 10.1016/j.matbio.2008.02.005; Grzegorczyk-Karolak I, 2015, ACTA BIOCHIM POL, V62, P253, DOI 10.18388/abp.2014_944; Hong SM, 2013, AM J RHINOL ALLERGY, V27, P278, DOI 10.2500/ajra.2013.27.3909; Hu Q, 2009, NEPHROL DIAL TRANSPL, V24, P3033, DOI 10.1093/ndt/gfp245; Kang JS, 2014, PHYTOTHER RES, V28, P98, DOI 10.1002/ptr.4971; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; Liu PP, 2015, INT J MOL MED, V35, P901, DOI 10.3892/ijmm.2015.2110; Lu HK, 2010, J PERIODONTAL RES, V45, P451, DOI 10.1111/j.1600-0765.2009.01255.x; Ren K, 2009, BRAIN RES REV, V60, P57, DOI 10.1016/j.brainresrev.2008.12.020; ROTHWARF DM, 1999, SCI STKE, V5, pRE1; Shin YO, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/456846; Sun J, 2013, PLANTA MED, V79, P199, DOI 10.1055/s-0032-1328197; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wang HZ, 2014, J PHARMACOL EXP THER, V350, P435, DOI 10.1124/jpet.114.215145; White KE, 2008, J IMMUNOL, V180, P637, DOI 10.4049/jimmunol.180.1.637; Xiao Hua, 2008, Shengli Xuebao, V60, P355; Zha WJ, 2016, ALLERGY ASTHMA IMMUN, V8, P161, DOI 10.4168/aair.2016.8.2.161	25	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168195	10.1371/journal.pone.0168195	http://dx.doi.org/10.1371/journal.pone.0168195			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002421	gold, Green Submitted, Green Published			2022-12-26	WOS:000392853100034
J	Dixit, VV; Chand, S; Nair, DJ				Dixit, Vinayak V.; Chand, Sai; Nair, Divya J.			Autonomous Vehicles: Disengagements, Accidents and Reaction Times	PLOS ONE			English	Article								Autonomous vehicles are being viewed with scepticism in their ability to improve safety and the driving experience. A critical issue with automated driving at this stage of its development is that it is not yet reliable and safe. When automated driving fails, or is limited, the autonomous mode disengages and the drivers are expected to resume manual driving. For this transition to occur safely, it is imperative that drivers react in an appropriate and timely manner. Recent data released from the California trials provide compelling insights into the current factors influencing disengagements of autonomous mode. Here we show that the number of accidents observed has a significantly high correlation with the autonomous miles travelled. The reaction times to take control of the vehicle in the event of a disengagement was found to have a stable distribution across different companies at 0.83 seconds on average. However, there were differences observed in reaction times based on the type of disengagements, type of roadway and autonomous miles travelled. Lack of trust caused by the exposure to automated disengagements was found to increase the likelihood to take control of the vehicle manually. Further, with increased vehicle miles travelled the reaction times were found to increase, which suggests an increased level of trust with more vehicle miles travelled. We believe that this research would provide insurers, planners, traffic management officials and engineers fundamental insights into trust and reaction times that would help them design and engineer their systems.	[Dixit, Vinayak V.; Chand, Sai; Nair, Divya J.] UNSW Australia, Sch Civil & Environm Engn, Res Ctr Integrated Transport Innovat, Sydney, NSW, Australia	University of New South Wales Sydney	Dixit, VV (corresponding author), UNSW Australia, Sch Civil & Environm Engn, Res Ctr Integrated Transport Innovat, Sydney, NSW, Australia.	v.dixit@unsw.edu.au	Chand, Sai/X-3138-2019	Chand, Sai/0000-0001-8084-1413; Dixit, Vinayak/0000-0001-7643-409X; Nair, Divya J/0000-0002-9873-9166				Anderson J. M., 2014, AUTONOMOUS VEHICLE T; Fagnant DJ, 2015, TRANSPORT RES A-POL, V77, P167, DOI 10.1016/j.tra.2015.04.003; Fambro D.B., 1997, DETERMINATION STOPPI; Helldin T., 2013, P 5 INT C AUTOMOTIVE, P210; Koppa RJ, 2005, REVISED MONOGRAPH TR; Litman T., 2021, AUTONOMOUS VEHICLE I; Martens MH, 2013, IEEE INT C INTELL TR, P2262, DOI 10.1109/ITSC.2013.6728564; Merat N, 2014, TRANSPORT RES F-TRAF, V27, P274, DOI 10.1016/j.trf.2014.09.005; Payre W, 2014, TRANSPORT RES F-TRAF, V27, P252, DOI 10.1016/j.trf.2014.04.009; Rodel C., 2014, P 6 INT C AUT US INT, P11; Shladover SE, 2012, TRANSPORT RES REC, P63, DOI 10.3141/2324-08; Silverman B.W., 1986, DENSITY ESTIMATION S	12	143	146	15	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168054	10.1371/journal.pone.0168054	http://dx.doi.org/10.1371/journal.pone.0168054			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997566	Green Published, gold, Green Submitted			2022-12-26	WOS:000392842900022
J	Hoffman, GE; Koban, M				Hoffman, Gloria E.; Koban, Michael			Hypothalamic L-Histidine Decarboxylase Is Up-Regulated During Chronic REM Sleep Deprivation of Rats	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; CORTICOTROPIN-RELEASING HORMONE; NEURONAL HISTAMINE INTERACT; SYMPATHETIC-NERVE ACTIVITY; IN-SITU HYBRIDIZATION; ADRENAL AXIS ACTIVITY; TUBEROMAMMILLARY NUCLEUS; FEEDING-BEHAVIOR; GENE-EXPRESSION; BRAIN HISTAMINE	A competition of neurobehavioral drives of sleep and wakefulness occurs during sleep deprivation. When enforced chronically, subjects must remain awake. This study examines histaminergic neurons of the tuberomammillary nucleus of the posterior hypothalamus in response to enforced wakefulness in rats. We tested the hypothesis that the rate-limiting enzyme for histamine biosynthesis, L-histidine decarboxylase (HDC), would be up-regulated during chronic rapid eye movement sleep deprivation (REM-SD) because histamine plays a major role in maintaining wakefulness. Archived brain tissues of male Sprague Dawley rats from a previous study were used. Rats had been subjected to REM-SD by the flowerpot paradigm for 5, 10, or 15 days. For immunocytochemistry, rats were transcardially perfused with acrolein-paraformaldehyde for immunodetection of L-HDC; separate controls used carbodiimide-paraformaldehyde for immunodetection of histamine. Immunolocalization of histamine within the tuberomammillary nucleus was validated using carbodiimide. Because HDC antiserum has cross-reactivity with other decarboxylases at high antibody concentrations, titrations localized L-HDC to only tuberomammillary nucleus at a dilution of >1:300,000. REM-SD increased immunoreactive HDC by day5 and it remained elevated in both dorsal and ventral aspects of the tuberomammillary complex. Our results suggest that up-regulation of L-HDC within the tuberomammillary complex during chronic REM-SD may be responsible for maintaining wakefulness.	[Hoffman, Gloria E.; Koban, Michael] Morgan State Univ, Dept Biol, Baltimore, MD 21239 USA	Morgan State University	Koban, M (corresponding author), Morgan State Univ, Dept Biol, Baltimore, MD 21239 USA.	michael.koban@morgan.edu	Koban, Michael/A-7130-2009; Hoffman, Gloria E/AAU-3760-2021		National Institutes of Health, National Institute of Neurological Disorders and Stroke [5R01NS043788-04]; National Institutes of Health, National Institute of Eunice Kennedy Shriver National Institute of Child Health & Human Development [5U01HD066435-05]; Clinical Nutrition Research Unit of Maryland [P30DK072488, NIH/P30-DK072488-05S1]; National Institute of Health, National Center for Research Resources [5G12RR017581-05]; National Institutes of Health, National Institute of General Medical Sciences [5S06GM051971-05]; TEDCO (Technology Development Corporation of Maryland)/U.S. Army [Q81XWH-07-2-0055]	National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health, National Institute of Eunice Kennedy Shriver National Institute of Child Health & Human Development; Clinical Nutrition Research Unit of Maryland; National Institute of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); TEDCO (Technology Development Corporation of Maryland)/U.S. Army	This work was supported by the National Institutes of Health, National Institute of Neurological Disorders and Stroke, 5R01NS043788-04 (http://www.ninds.nih.gov), GEH; National Institutes of Health, National Institute of Eunice Kennedy Shriver National Institute of Child Health & Human Development, 5U01HD066435-05 (https://www.nichd.nih.gov), GEH Pilot and Feasibility grant from Clinical Nutrition Research Unit of Maryland, P30DK072488, (http:grantome.com/grant/NIH/P30-DK072488-05S1), GEH National Institute of Health, National Center for Research Resources, 5G12RR017581-05 (httn.//www.nih.gov/about/almanac/organization/NCRR.htm), MK National Institutes of Health, National Institute of General Medical Sciences, 5S06GM051971-05 (http://www.nigms.nih.gov/Pages/default.aspx), MK TEDCO (Technology Development Corporation of Maryland, http://tedco.md/)/U.S. Army contract Q81XWH-07-2-0055, MK. TEDCO had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIRAKSINEN MS, 1989, J COMP NEUROL, V286, P289, DOI 10.1002/cne.902860302; AIRAKSINEN MS, 1992, J COMP NEUROL, V323, P103, DOI 10.1002/cne.903230109; AIRAKSINEN MS, 1988, J COMP NEUROL, V273, P163, DOI 10.1002/cne.902730204; Allada R, 2008, CURR BIOL, V18, pR670, DOI 10.1016/j.cub.2008.06.033; ANDOYAMAMOTO M, 1986, BIOCHEM BIOPH RES CO, V141, P306, DOI 10.1016/S0006-291X(86)80369-2; Banerji A, 2007, ALLERGY ASTHMA PROC, V28, P418, DOI 10.2500/aap.2007.28.3015; Barf RP, 2012, PHYSIOL BEHAV, V107, P322, DOI 10.1016/j.physbeh.2012.09.005; Barf RP, 2012, AM J PHYSIOL-REG I, V302, pR112, DOI 10.1152/ajpregu.00326.2011; Basheer R, 1998, MOL BRAIN RES, V57, P235, DOI 10.1016/S0169-328X(98)00088-6; BAYLISS D A, 1990, Molecular and Cellular Neuroscience, V1, P3, DOI 10.1016/1044-7431(90)90036-4; BENINGTON JH, 1995, PROG NEUROBIOL, V45, P347, DOI 10.1016/0301-0082(94)00057-O; BERGMANN BM, 1989, SLEEP, V12, P31, DOI 10.1093/sleep/12.1.31; Blanco-Centurion C, 2007, J NEUROSCI, V27, P14041, DOI 10.1523/JNEUROSCI.3217-07.2007; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Caron AM, 2010, SLEEP, V33, P1226, DOI 10.1093/sleep/33.9.1226; CASTREN E, 1990, NEUROSCI LETT, V120, P113, DOI 10.1016/0304-3940(90)90181-8; Chisholm NC, 2012, ENDOCRINOLOGY, V153, P4874, DOI 10.1210/en.2012-1412; COHEN HB, 1965, SCIENCE, V150, P1318, DOI 10.1126/science.150.3701.1318; EVERSON CA, 1995, BEHAV BRAIN RES, V69, P43, DOI 10.1016/0166-4328(95)00009-I; Everson CA, 2004, AM J PHYSIOL-ENDOC M, V286, pE1060, DOI 10.1152/ajpendo.00553.2003; EVERSON CA, 1989, SLEEP, V12, P13, DOI 10.1093/sleep/12.1.13; Martins PJF, 2010, AM J PHYSIOL-ENDOC M, V298, pE726, DOI 10.1152/ajpendo.00660.2009; Gessa GL, 1995, EUR NEUROPSYCHOPHARM, V5, P89, DOI 10.1016/0924-977X(95)00023-I; Gotoh K, 2013, J NEUROCHEM, V125, P588, DOI 10.1111/jnc.12213; Gotoh K, 2013, J NEUROCHEM, V124, P90, DOI 10.1111/jnc.12066; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Hipolide DC, 2006, J NEUROENDOCRINOL, V18, P231, DOI 10.1111/j.1365-2826.2006.01412.x; Hoffman GE, 2004, PEPTIDES, V25, P425, DOI 10.1016/j.peptides.2004.02.004; HOFFMAN GE, 1992, NEUROPROTOCOLS, V1, P52; Hoffman GE, 2008, CURR PROTOC NEUROSCI, DOI DOI 10.1002/0471142301; INAGAKI N, 1990, EXP BRAIN RES, V80, P374; KENDALL PA, 1971, EXPERIENTIA, V27, P1104, DOI 10.1007/BF02138909; KING JC, 1983, J HISTOCHEM CYTOCHEM, V31, P62, DOI 10.1177/31.1.6187805; KITAHAMA K, 1988, J COMP NEUROL, V270, P337, DOI 10.1002/cne.902700304; Koban M, 2006, ENDOCRINOLOGY, V147, P421, DOI 10.1210/en.2005-0695; Koban M, 2005, AM J PHYSIOL-ENDOC M, V289, pE68, DOI 10.1152/ajpendo.00543.2004; Koban M, 2008, SLEEP, V31, P927; KUSHIDA CA, 1989, SLEEP, V12, P22, DOI 10.1093/sleep/12.1.22; Galvao MDL, 2009, PSYCHONEUROENDOCRINO, V34, P1176, DOI 10.1016/j.psyneuen.2009.03.003; LIN JS, 1988, NEUROPHARMACOLOGY, V27, P111, DOI 10.1016/0028-3908(88)90159-1; LIN JS, 1989, BRAIN RES, V479, P225, DOI 10.1016/0006-8993(89)91623-5; Longordo F, 2009, EUR J NEUROSCI, V29, P1810, DOI 10.1111/j.1460-9568.2009.06719.x; Machado RB, 2004, BRAIN RES, V1004, P45, DOI 10.1016/j.brainres.2004.01.019; MADL JE, 1986, J HISTOCHEM CYTOCHEM, V34, P317, DOI 10.1177/34.3.2419390; Martins PJF, 2008, PHYSIOL BEHAV, V93, P229, DOI 10.1016/j.physbeh.2007.08.026; Martins PJF, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-86; Masaki T, 2004, DIABETES, V53, P2250, DOI 10.2337/diabetes.53.9.2250; MAZURKIEWICZKWILECKI IM, 1982, PHARMACOL BIOCHEM BE, V16, P591, DOI 10.1016/0091-3057(82)90421-X; MAZURKIEWICZKWILECKI IM, 1986, PHARMACOL BIOCHEM BE, V24, P513, DOI 10.1016/0091-3057(86)90550-2; MAZURKIEWICZKWILECKI IM, 1980, PHARMACOL BIOCHEM BE, V12, P35, DOI 10.1016/0091-3057(80)90412-8; Meerlo P, 2002, J NEUROENDOCRINOL, V14, P397, DOI 10.1046/j.0007-1331.2002.00790.x; Miklos IH, 2003, EUR J NEUROSCI, V18, P3069, DOI 10.1111/j.1460-9568.2003.03033.x; MIZUGUCHI H, 1990, BIOCHEM BIOPH RES CO, V173, P1299, DOI 10.1016/S0006-291X(05)80928-3; MONTI JM, 1986, J NEURAL TRANSM, V66, P1, DOI 10.1007/BF01262953; Morimoto T, 1999, PHYSIOL BEHAV, V67, P679, DOI 10.1016/S0031-9384(99)00123-7; PANULA P, 1984, P NATL ACAD SCI-BIOL, V81, P2572, DOI 10.1073/pnas.81.8.2572; PANULA P, 1988, J HISTOCHEM CYTOCHEM, V36, P259, DOI 10.1177/36.3.3343510; PANULA P, 1989, NEUROSCIENCE, V28, P585, DOI 10.1016/0306-4522(89)90007-9; PORKKAHEISKANEN T, 1995, AM J PHYSIOL-REG I, V268, pR1456, DOI 10.1152/ajpregu.1995.268.6.R1456; PORKKAHEISKANEN T, 1994, LIFE SCI, V54, P1719, DOI 10.1016/0024-3205(94)00612-1; Ramesh V, 2004, BEHAV BRAIN RES, V152, P271, DOI 10.1016/j.bbr.2003.10.031; RECHTSCHAFFEN A, 1983, SCIENCE, V221, P182, DOI 10.1126/science.6857280; Rechtschaffen A, 2002, SLEEP, V25, P18, DOI 10.1093/sleep/25.1.18; Sakata T, 2003, EXP BIOL MED, V228, P1106, DOI 10.1177/153537020322801002; Sakata T, 1997, NUTRITION, V13, P403, DOI 10.1016/S0899-9007(97)91277-6; Saper Clifford B, 2013, Continuum (Minneap Minn), V19, P19, DOI 10.1212/01.CON.0000427215.07715.73; Sarvari A, 2012, BRAIN RES, V1488, P72, DOI 10.1016/j.brainres.2012.10.010; Scharf MT, 2008, PROG NEUROBIOL, V86, P264, DOI 10.1016/j.pneurobio.2008.08.003; SCHWARTZ JC, 1991, PHYSIOL REV, V71, P1, DOI 10.1152/physrev.1991.71.1.1; Siegel JM, 2008, TRENDS NEUROSCI, V31, P208, DOI 10.1016/j.tins.2008.02.001; Soya A, 2008, NEUROSCI LETT, V430, P224, DOI 10.1016/j.neulet.2007.11.002; Strecker RE, 2002, NEUROSCIENCE, V113, P663, DOI 10.1016/S0306-4522(02)00158-6; Suchecki D, 2003, J NEUROENDOCRINOL, V15, P815, DOI 10.1046/j.1365-2826.2003.01067.x; Suchecki D, 1998, J SLEEP RES, V7, P276, DOI 10.1046/j.1365-2869.1998.00122.x; Szymusiak R, 2007, SLEEP MED, V8, P291, DOI 10.1016/j.sleep.2007.03.013; TAGUCHI Y, 1985, BRAIN RES, V340, P235, DOI 10.1016/0006-8993(85)90919-9; TAYLOR KM, 1971, SCIENCE, V172, P1037, DOI 10.1126/science.172.3987.1037; Thakkar MM, 2011, SLEEP MED REV, V15, P65, DOI 10.1016/j.smrv.2010.06.004; Ugrumov MV, 2009, J CHEM NEUROANAT, V38, P241, DOI 10.1016/j.jchemneu.2009.08.004; WAHLESTEDT C, 1985, AGENTS ACTIONS, V16, P231, DOI 10.1007/BF01983147; WATANABE T, 1983, NEUROSCI LETT, V39, P249, DOI 10.1016/0304-3940(83)90308-7; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; Whyment AD, 2006, J NEUROPHYSIOL, V95, P2492, DOI 10.1152/jn.01135.2004; Yasuda T, 2004, NEUROSCIENCE, V125, P535, DOI 10.1016/j.neuroscience.2003.11.039; Yasuda T, 2004, NEUROSCI LETT, V362, P71, DOI 10.1016/j.neulet.2003.10.052; Zant JC, 2012, J NEUROSCI, V32, P13244, DOI 10.1523/JNEUROSCI.5933-11.2012	86	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0152252	10.1371/journal.pone.0152252	http://dx.doi.org/10.1371/journal.pone.0152252			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997552	Green Published, gold, Green Submitted			2022-12-26	WOS:000392842900001
J	Brinkman, CL; Schmidt-Malan, SM; Karau, MJ; Greenwood-Quaintance, K; Hassett, DJ; Mandrekar, JN; Patel, R				Brinkman, Cassandra L.; Schmidt-Malan, Suzannah M.; Karau, Melissa J.; Greenwood-Quaintance, Kerryl; Hassett, Daniel J.; Mandrekar, Jayawant N.; Patel, Robin			Exposure of Bacterial Biofilms to Electrical Current Leads to Cell Death Mediated in Part by Reactive Oxygen Species	PLoS One			English	Article							PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-EPIDERMIDIS; GENE-EXPRESSION; IRON UPTAKE; REDUCTION; VIABILITY; SYSTEM	Bacterial biofilms may form on indwelling medical devices such as prosthetic joints, heart valves and catheters, causing challenging-to-treat infections. We have previously described the 'electricidal effect', in which bacterial biofilms are decreased following exposure to direct electrical current. Herein, we sought to determine if the decreased bacterial quantities are due to detachment of biofilms or cell death and to investigate the role that reactive oxygen species (ROS) play in the observed effect. Using confocal and electron microscopy and flow cytometry, we found that direct current (DC) leads to cell death and changes in the architecture of biofilms formed by Gram-positive and Gram-negative bacteria. Reactive oxygen species (ROS) appear to play a role in DC-associated cell death, as there was an increase in ROS-production by Staphylococcus aureus and Staphylococcus epidermidis biofilms following exposure to DC. An increase in the production of ROS response enzymes catalase and superoxide dismutase (SOD) was observed for S. aureus, S. epidermidis and Pseudomonas aeruginosa biofilms following exposure to DC. Additionally, biofilms were protected from cell death when supplemented with antioxidants and oxidant scavengers, including catalase, mannitol and Tempol. Knocking out SOD (sodAB) in P. aeruginosa led to an enhanced DC effect. Microarray analysis of P. aeruginosa PAO1 showed transcriptional changes in genes related to the stress response and cell death. In conclusion, the electricidal effect results in death of bacteria in biofilms, mediated, at least in part, by production of ROS.	[Brinkman, Cassandra L.; Schmidt-Malan, Suzannah M.; Karau, Melissa J.; Greenwood-Quaintance, Kerryl; Patel, Robin] Mayo Clin, Dept Lab Med & Pathol, Div Clin Microbiol, Rochester, MN 55905 USA; [Hassett, Daniel J.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH USA; [Mandrekar, Jayawant N.] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN USA; [Patel, Robin] Mayo Clin, Dept Med, Div Infect Dis, Rochester, MN 55905 USA	Mayo Clinic; University System of Ohio; University of Cincinnati; Mayo Clinic; Mayo Clinic	Patel, R (corresponding author), Mayo Clin, Dept Lab Med & Pathol, Div Clin Microbiol, Rochester, MN 55905 USA.; Patel, R (corresponding author), Mayo Clin, Dept Med, Div Infect Dis, Rochester, MN 55905 USA.	patel.robin@mayo.edu		Patel, Robin/0000-0001-6344-4141	National Institute of Allergy and Infectious Diseases [R01 AI091594]; National Institute of Arthritis and Musculoskeletal and Skin Diseases for the Musculoskeletal Research Training Program [T32 AR56950];  [R01 AR056647]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR056950] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Arthritis and Musculoskeletal and Skin Diseases for the Musculoskeletal Research Training Program; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases under Award Number R01 AI091594 and the National Institute of Arthritis and Musculoskeletal and Skin Diseases for the Musculoskeletal Research Training Program (T32 AR56950). R.P. is also supported by R01 AR056647. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berney M, 2007, APPL ENVIRON MICROB, V73, P3283, DOI 10.1128/AEM.02750-06; Boulos L, 1999, J MICROBIOL METH, V37, P77, DOI 10.1016/S0167-7012(99)00048-2; Cap M, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/976753; COX CD, 1985, INFECT IMMUN, V48, P130, DOI 10.1128/IAI.48.1.130-138.1985; COX CD, 1980, J BACTERIOL, V142, P581, DOI 10.1128/JB.142.2.581-587.1980; CRONAN JE, 1975, BACTERIOL REV, V39, P232, DOI 10.1128/MMBR.39.3.232-256.1975; Del Pozo JL, 2009, ANTIMICROB AGENTS CH, V53, P4064, DOI 10.1128/AAC.00432-09; del Pozo JL, 2009, ANTIMICROB AGENTS CH, V53, P41, DOI 10.1128/AAC.00680-08; del Pozo JL, 2009, ANTIMICROB AGENTS CH, V53, P35, DOI 10.1128/AAC.00237-08; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Esposito S, 2008, INT J ANTIMICROB AG, V32, P287, DOI 10.1016/j.ijantimicag.2008.03.010; Faure LM, 2013, MICROBIOL-SGM, V159, P1315, DOI 10.1099/mic.0.067645-0; Guttenplan SB, 2013, FEMS MICROBIOL REV, V37, P849, DOI 10.1111/1574-6976.12018; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; HASSETT DJ, 1995, J BACTERIOL, V177, P6330, DOI 10.1128/jb.177.22.6330-6337.1995; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Ince D, 2015, J BACTERIOL, V197, P2003, DOI 10.1128/JB.00030-15; Kim J, 2013, FEMS MICROBIOL LETT, V343, P89, DOI 10.1111/1574-6968.12135; Koide T, 2006, J BACTERIOL, V188, P5821, DOI 10.1128/JB.00182-06; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; Lesniak J, 2002, EMBO J, V21, P6649, DOI 10.1093/emboj/cdf670; Li F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061195; Liu WK, 1997, J ANTIMICROB CHEMOTH, V39, P687, DOI 10.1093/jac/39.6.687; Mishra S, 2012, ARCH BIOCHEM BIOPHYS, V525, P145, DOI 10.1016/j.abb.2012.04.014; Modi N, 2015, BIOPHYS J, V109, P1429, DOI 10.1016/j.bpj.2015.07.035; PAREILLEUX A, 1970, APPL MICROBIOL, V19, P421, DOI 10.1128/AEM.19.3.421-424.1970; Reimmann C, 2001, J BACTERIOL, V183, P813, DOI 10.1128/JB.183.3.813-820.2001; Romling U, 2014, J INTERN MED, V276, P98, DOI 10.1111/joim.12242; Ruiz-Ruigomez Maria, 2016, Int J Bacteriol, V2016, P9727810, DOI 10.1155/2016/9727810; Sandvik EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055118; Schmidt-Malan SM, 2015, ANTIMICROB AGENTS CH, V59, P4610, DOI 10.1128/AAC.00483-15; Stiefel P, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0376-x; Ueshima M, 2002, J BIOMED MATER RES, V60, P578, DOI 10.1002/jbm.10113; van der Borden AJ, 2005, BIOMATERIALS, V26, P6731, DOI 10.1016/j.biomaterials.2004.04.052; Vatansever F, 2013, FEMS MICROBIOL REV, V37, P955, DOI 10.1111/1574-6976.12026; Voulhoux R, 2006, J BACTERIOL, V188, P3317, DOI 10.1128/JB.188.9.3317-3323.2006; Weimer RM, 1998, J BACTERIOL, V180, P5357, DOI 10.1128/JB.180.20.5357-5368.1998; Wolcott RD, 2010, J WOUND CARE, V19, P45, DOI 10.12968/jowc.2010.19.2.46966; Yuan ZC, 2005, MOL MICROBIOL, V58, P877, DOI 10.1111/j.1365-2958.2005.04874.x; Yura T, 1996, EXS, V77, P165; Zhao XL, 2014, CURR OPIN MICROBIOL, V21, P1, DOI 10.1016/j.mib.2014.06.008	41	23	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168595	10.1371/journal.pone.0168595	http://dx.doi.org/10.1371/journal.pone.0168595			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992529	Green Submitted, Green Published, gold			2022-12-26	WOS:000392842600077
J	Sinha, J; Cao, Z; Dai, JL; Tang, HY; Partyka, K; Hostetter, G; Simeone, DM; Feng, ZD; Allen, PJ; Brand, RE; Haab, BB				Sinha, Jessica; Cao, Zheng; Dai, Jianliang; Tang, Huiyuan; Partyka, Katie; Hostetter, Galen; Simeone, Diane M.; Feng, Ziding; Allen, Peter J.; Brand, Randall E.; Haab, Brian B.			A Gastric Glycoform of MUC5AC Is a Biomarker of Mucinous Cysts of the Pancreas	PLoS One			English	Article							CLINICAL-IMPLICATIONS; DIFFERENTIAL-DIAGNOSIS; PRECURSOR LESIONS; FLUID BIOMARKER; HIGH-THROUGHPUT; NEOPLASMS; CANCER; CLASSIFICATION; ADENOCARCINOMA; IDENTIFICATION	Molecular indicators to specify the risk posed by a pancreatic cyst would benefit patients. Previously we showed that most cancer-precursor cysts, termed mucinous cysts, produce abnormal glycoforms of the proteins MUC5AC and endorepellin. Here we sought to validate the glycoforms as a biomarker of mucinous cysts and to specify the oligosaccharide linkages that characterize MUC5AC. We hypothesized that mucinous cysts secrete MUC5AC displaying terminal N-acetylglucosamine (GlcNAc) in either alpha or beta linkage. We used antibody-lectin sandwich assays to detect glycoforms of MUC5AC and endorepellin in cyst fluid samples from three independent cohorts of 49, 32, and 66 patients, and we used monoclonal antibodies to test for terminal, alpha-linked GlcNAc and the enzyme that produces it. A biomarker panel comprising the previously-identified glycoforms of MUC5AC and endorepellin gave 96%, 96%, and 87% accuracy for identifying mucinous cysts in the three cohorts with an average sensitivity of 92% and an average specificity of 94%. Glycan analysis showed that MUC5AC produced by a subset of mucinous cysts displays terminal alpha-GlcNAc, a motif expressed in stomach glands. The alpha-linked glycoform of MUC5AC was unique to intraductal papillary mucinous neoplasms (IPMN), whereas terminal beta-linked GlcNAc was increased in both IPMNs and mucinous cystic neoplasms (MCN). The enzyme that synthesizes alpha-GlcNAc, A4GNT, was expressed in the epithelia of mucinous cysts that expressed alpha-GlcNAc, especially in regions with high-grade dysplasia. Thus IPMNs secrete a gastric glycoform of MUC5AC that displays terminal alpha-GlcNAc, and the combined alpha-GlcNAc and beta-GlcNAc glycoforms form an accurate biomarker of mucinous cysts.	[Sinha, Jessica; Cao, Zheng; Tang, Huiyuan; Partyka, Katie; Hostetter, Galen; Haab, Brian B.] Van Andel Res Inst, Grand Rapids, MI 49503 USA; [Dai, Jianliang; Feng, Ziding] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Simeone, Diane M.] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Allen, Peter J.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Brand, Randall E.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA	Van Andel Institute; University of Texas System; UTMD Anderson Cancer Center; University of Michigan System; University of Michigan; Memorial Sloan Kettering Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Haab, BB (corresponding author), Van Andel Res Inst, Grand Rapids, MI 49503 USA.	brian.haab@vai.org			National Cancer Institute [U01CA152653, U01CA168896]; NATIONAL CANCER INSTITUTE [P30CA008748, U01CA200466, U01CA168896, U01CA152653] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the National Cancer Institute (Early Detection Research Network, U01CA152653; Alliance of Glycobiologists for Cancer Detection, U01CA168896). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adsay NV, 2004, AM J SURG PATHOL, V28, P839, DOI 10.1097/00000478-200407000-00001; Ahmad NA, 2001, AM J GASTROENTEROL, V96, P3295; Basturk O, 2009, ARCH PATHOL LAB MED, V133, P423, DOI 10.1043/1543-2165-133.3.423; Brugge WR, 2004, GASTROENTEROLOGY, V126, P1330, DOI 10.1053/j.gastro.2004.02.013; Cao Z, 2013, MOL CELL PROTEOMICS, V12, P2724, DOI 10.1074/mcp.M113.030700; Cho CS, 2013, ANN SURG ONCOL, V20, P3112, DOI 10.1245/s10434-013-2986-6; Correa-Gallego C, 2013, ANN SURG ONCOL, V20, P4348, DOI 10.1245/s10434-013-3207-z; Distler M, 2013, ANN SURG; Ensink E, 2015, ANAL CHEM, V87, P9715, DOI 10.1021/acs.analchem.5b03159; Fisher WE, 2008, HPB, V10, P483, DOI 10.1080/13651820802291225; Forrester S, 2007, MOL ONCOL, V1, P216, DOI 10.1016/j.molonc.2007.06.001; Fritz S, 2012, ANN SURG, V256, P313, DOI 10.1097/SLA.0b013e31825d355f; Frossard JL, 2003, AM J GASTROENTEROL, V98, P1516, DOI 10.1016/S0002-9270(03)00359-9; Gaddam S, 2015, GASTROINTESTINAL END; Haab BB, 2011, METHODS MOL BIOL, V785, P223, DOI 10.1007/978-1-61779-286-1_15; Haab BB, 2010, ANN SURG, V251, P937, DOI 10.1097/SLA.0b013e3181d7738d; Ito Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078191; Izeradjene K, 2007, CANCER CELL, V11, P229, DOI 10.1016/j.ccr.2007.01.017; Jones M, 2015, GASTROINTESTINAL END; Kanda M, 2013, GUT, V62, P1024, DOI 10.1136/gutjnl-2012-302823; Karasawa F, 2012, J CLIN INVEST, V122, P923, DOI 10.1172/JCI59087; Kawakubo M, 2004, SCIENCE, V305, P1003, DOI 10.1126/science.1099250; Khalid A, 2009, GASTROINTEST ENDOSC, V69, P1095, DOI 10.1016/j.gie.2008.07.033; Kobayashi M, 2014, ACTA HISTOCHEM CYTOC, V47, P45, DOI 10.1267/ahc.13027; Maitra A, 2005, ADV ANAT PATHOL, V12, P81, DOI 10.1097/01.pap.0000155055.14238.25; Maker AV, 2011, CLIN CANCER RES, V17, P1502, DOI 10.1158/1078-0432.CCR-10-1561; Matthaei HH, 2012, CLIN CANC RES OFFICI; Nadig SN, 2012, PANCREAS, V41, P441, DOI 10.1097/MPA.0b013e318229b9b8; Nagula S, 2010, J GASTROINTEST SURG, V14, P1997, DOI 10.1007/s11605-010-1281-0; Nakamura N, 1998, J HISTOCHEM CYTOCHEM, V46, P793, DOI 10.1177/002215549804600702; Nakayama J, 1999, P NATL ACAD SCI USA, V96, P8991, DOI 10.1073/pnas.96.16.8991; Park WG, 2013, GASTROINTESTINAL END; Partyka K, 2012, J PROTEOME RES, V11, P2904, DOI 10.1021/pr2012736; Raty S, 2013, PANCREATOLOGY, V13, P530, DOI 10.1016/j.pan.2013.06.008; Rockacy M, 2013, GASTROENTEROLOGY, V26, P122; Ryu JK, 2011, PANCREATOLOGY, V11, P343, DOI 10.1159/000329183; Sahora K, 2013, ANN SURG, V258, P466, DOI 10.1097/SLA.0b013e3182a18f48; Schaberg KB, 2015, AM J SURG PATHOLOGY; Singh M, 2007, PANCREATOLOGY, V7, P9, DOI 10.1159/000101873; Singhi AD, 2014, CLIN CANCER RES, V20, P4381, DOI 10.1158/1078-0432.CCR-14-0513; Siveke JT, 2007, CANCER CELL, V12, P266, DOI 10.1016/j.ccr.2007.08.002; Springer S, 2015, GASTROENTEROLOGY, V149, P1501, DOI 10.1053/j.gastro.2015.07.041; Thiruvengadam N, 2015, CLIN TRANSL GASTROEN, V6, DOI 10.1038/ctg.2015.17; van der Waaij LA, 2005, GASTROINTEST ENDOSC, V62, P383, DOI 10.1016/S0016-5107(05)01581-6; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543; Yip-Schneider MT, 2014, J AM COLL SURGEONS, V218, P608, DOI 10.1016/j.jamcollsurg.2013.12.019; Zhang MX, 2001, J HISTOCHEM CYTOCHEM, V49, P587, DOI 10.1177/002215540104900505	48	14	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0167070	10.1371/journal.pone.0167070	http://dx.doi.org/10.1371/journal.pone.0167070			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992432	gold, Green Submitted, Green Published			2022-12-26	WOS:000392842600010
J	Yu, JL; Yang, L; Liu, XB; Tang, RJ; Wang, Y; Ge, HM; Wu, MT; Zhang, J; Zhao, FG; Luan, S; Lan, WZ				Yu, Jingling; Yang, Lei; Liu, Xiaobing; Tang, Renjie; Wang, Yuan; Ge, Haiman; Wu, Mengting; Zhang, Jiang; Zhao, Fugeng; Luan, Sheng; Lan, Wenzhi			Overexpression of Poplar Pyrabactin Resistance-Like Abscisic Acid Receptors Promotes Abscisic Acid Sensitivity and Drought Resistance in Transgenic Arabidopsis	PLOS ONE			English	Article							EXPRESSION; RESPONSES; TOLERANCE; BINDING; FAMILY	Drought stress is an important environmental factor limiting productivity of plants, especially fast growing species with high water consumption like poplar. Abscisic acid (ABA) is a phytohormone that positively regulates seed dormancy and drought resistance. The PYR1 (Pyrabactin Resistance 1)/ PYRL (PYR-Like)/ RCAR (Regulatory Component of ABA Receptor) (PYR/PYL/RCAR) ABA receptor family has been identified and widely characterized in Arabidopsis thaliana. However, their functions in poplars remain unknown. Here, we report that 2 of 14 PYR/PYL/RCAR orthologues in poplar (Populus trichocarpa) (PtPYRLs) function as a positive regulator of the ABA signal transduction pathway. The Arabidopsis transient expression and yeast two-hybrid assays showed the interaction among PtPYRL1 and PtPYRL5, a Glade A protein phosphatase 2C, and a SnRK2, suggesting that a core signalling complex for ABA signaling pathway exists in poplars. Phenotypic analysis of PtPYRL1 and PtPYRL5 transgenic Arabidopsis showed that these two genes positively regulated the ABA responses during the seed germination. More importantly, the overexpression of PtPYRL1 and PtPYRL5 substantially improved ABA sensitivity and drought stress tolerance in transgenic plants. In summary, we comprehensively uncovered the properties of PtPYRL1 and PtPYRL5, which might be good target genes to genetically engineer drought-Resistant plants.	[Yu, Jingling; Yang, Lei; Liu, Xiaobing; Wang, Yuan; Ge, Haiman; Zhao, Fugeng; Lan, Wenzhi] Nanjing Univ, Nanjing Forestry Univ, Coll Life Sci, Joint Inst Plant Mol Biol,State Key Lab Pharmaceu, Nanjing, Jiangsu, Peoples R China; [Tang, Renjie; Luan, Sheng] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Wu, Mengting; Zhang, Jiang] Hubei Univ, Hubei Collaborat Innovat Ctr Green Transformat Bi, Coll Life Sci, Wuhan, Peoples R China	Nanjing Forestry University; Nanjing University; University of California System; University of California Berkeley; Hubei University	Yang, L; Lan, WZ (corresponding author), Nanjing Univ, Nanjing Forestry Univ, Coll Life Sci, Joint Inst Plant Mol Biol,State Key Lab Pharmaceu, Nanjing, Jiangsu, Peoples R China.; Luan, S (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	Leiyang@nju.edu.cn; sluan@berkeley.edu; lanw@nju.edu.cn	Tang, Renjie/X-8372-2019	Tang, Renjie/0000-0003-0323-7348; yang, lei/0000-0003-2009-7316	Natural Science Foundation of Jiangsu Province of China [BK2012306]; National Natural Science Foundation of China [31271626]	Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Foundation of Jiangsu Province of China (BK2012306) and National Natural Science Foundation of China grant (31271626).	Arshad M, 2014, TREES-STRUCT FUNCT, V28, P531, DOI 10.1007/s00468-013-0969-7; BATES TR, 1973, J PHARM SCI-US, V62, P2057, DOI 10.1002/jps.2600621241; Boaretto LF, 2014, PLANT PHYSIOL BIOCH, V74, P165, DOI 10.1016/j.plaphy.2013.11.016; Chen JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139466; Chen THH, 2002, WEED SCI, V50, P232, DOI 10.1614/0043-1745(2002)050[0232:MGAODR]2.0.CO;2; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Finkelstein Ruth, 2013, Arabidopsis Book, V11, pe0166, DOI 10.1199/tab.0166; Garcia MV, 2007, HEREDITY, V99, P381, DOI 10.1038/sj.hdy.6801012; Gonzalez-Guzman M, 2014, J EXP BOT, V65, P4451, DOI 10.1093/jxb/eru219; Gonzalez-Guzman M, 2012, PLANT CELL, V24, P2483, DOI 10.1105/tpc.112.098574; Iyer LM, 2001, PROTEINS, V43, P134, DOI 10.1002/1097-0134(20010501)43:2<134::AID-PROT1025>3.3.CO;2-9; Kim H, 2014, J EXP BOT, V65, P453, DOI 10.1093/jxb/ert397; Lee SC, 2013, MOL PLANT, V6, P528, DOI 10.1093/mp/sss078; Lee SC, 2012, PLANT CELL ENVIRON, V35, P53, DOI 10.1111/j.1365-3040.2011.02426.x; Lee SC, 2009, P NATL ACAD SCI USA, V106, P21419, DOI 10.1073/pnas.0910601106; LERUDULIER D, 1984, SCIENCE, V224, P1064, DOI 10.1126/science.224.4653.1064; LEUNG J, 1994, SCIENCE, V264, P1448, DOI 10.1126/science.7910981; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Monclus R, 2006, NEW PHYTOL, V169, P765, DOI 10.1111/j.1469-8137.2005.01630.x; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pizzio GA, 2013, PLANT PHYSIOL, V163, P441, DOI 10.1104/pp.113.224162; Song XQ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00612; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; Yang T, 2015, PLANT J, V84, P1274, DOI 10.1111/tpj.13080; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	29	28	29	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168040	10.1371/journal.pone.0168040	http://dx.doi.org/10.1371/journal.pone.0168040			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992471	Green Published, gold, Green Submitted			2022-12-26	WOS:000392842600029
J	Alexandru, H; Muthuraman, M; Chirumamilla, VC; Koirala, N; Paktas, B; Deuschl, G; Zeuner, KE; Groppa, S				Alexandru, Hanganu; Muthuraman, Muthuraman; Chirumamilla, Venkata Chaitanya; Koirala, Nabin; Paktas, Burcu; Deuschl, Guenther; Zeuner, Kirsten E.; Groppa, Sergiu			Grey Matter Microstructural Integrity Alterations in Blepharospasm Are Partially Reversed by Botulinum Neurotoxin Therapy	PLOS ONE			English	Article							BASAL-GANGLIA; HEMIFACIAL SPASM; FOCAL DYSTONIA; DISCRIMINATION; SUPPLEMENTARY; SEGMENTATION; STIMULATION; ACTIVATION; DISEASE; CORTEX	Objective Benign Essential Blepharospasm (BEB) and hemifacial spasm (HFS) are the most common hyperkinetic movement disorders of facial muscles. Although similar in clinical presentation different pathophysiological mechanisms are assumed. Botulinum Neurotoxin (BoNT) is a standard evidence-based treatment for both conditions. In this study we aimed to assess grey matter microstructural differences between these two groups of patients and compared them with healthy controls. In patients we furthermore tracked the longitudinal morphometric changes associated with BoNT therapy. We hypothesized microstructural differences between the groups at the time point of maximum symptoms representation and distinct longitudinal grey matter dynamics with symptom improvement. Methods Cross-sectional and longitudinal analyses of 3T 3D-T1 MRI images from BEB, HFS patients prior to and one month after BoNT therapy and from a group of age and sex matched healthy controls. Cortical thickness as extracted from Freesurfer was assessed as parameter of microstructural integrity. Results BoNT therapy markedly improved motor symptoms in patients with BEB and HFS. Significant differences of grey matter integrity have been found between the two patients groups. The BEB group showed lower cortical thickness at baseline in the frontal-rostral, supramarginal and temporal regions compared to patients with HFS. In this group BoNT treatment was associated with a cortical thinning in the primary motor cortex and the pre-supplementary motor area (pre-SMA). Contrary patients with HFS showed no longitudinal CT changes. A decreased cortical thickness was attested bilaterally in the temporal poles and in the right superior frontal region in BEB patients in comparison to HC. Patients in the HFS group presented a decreased CT in the left lingual gyrus and temporal pole. Conclusions Although patients with BEB and HFS present clinically with involuntary movements of facial muscles, they exhibited differences in cortical thickness. While BoNT therapy was equally effective in both groups, widespread changes of cortical morphology occurred only in BEB patients. We demonstrated specific disease-and therapy-dependent structural changes induced by BoNT in the studied hyperkinetic conditions.	[Alexandru, Hanganu; Muthuraman, Muthuraman; Paktas, Burcu; Deuschl, Guenther; Zeuner, Kirsten E.; Groppa, Sergiu] Univ Kiel, Dept Neurol, Kiel, Germany; [Muthuraman, Muthuraman; Chirumamilla, Venkata Chaitanya; Koirala, Nabin; Groppa, Sergiu] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Neuroimage Ctr NIC Focus Program Translat Neurosc, Movement Disorders & Neurostimulat,Dept Neurol, Mainz, Germany	University of Kiel; Johannes Gutenberg University of Mainz	Groppa, S (corresponding author), Univ Kiel, Dept Neurol, Kiel, Germany.; Groppa, S (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Neuroimage Ctr NIC Focus Program Translat Neurosc, Movement Disorders & Neurostimulat,Dept Neurol, Mainz, Germany.	segroppa@uni-mainz.de	Deuschl, Gunther/A-7986-2010; Koirala, Nabin/Y-3055-2019; Groppa, Sergiu/A-5711-2019; Groppa, Sergiu/G-4606-2014; Muthuraman, Muthuraman/ABD-2021-2020	Deuschl, Gunther/0000-0002-4176-9196; Koirala, Nabin/0000-0002-8261-8271; Groppa, Sergiu/0000-0002-2551-5655; Muthuraman, Muthuraman/0000-0001-6158-2663	German Research Council [CRC 1193]	German Research Council(German Research Foundation (DFG))	This work was supported by the German Research Council (CRC 1193, project B05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER FG, 1995, J NEUROSURG, V82, P201, DOI 10.3171/jns.1995.82.2.0201; BERARDELLI A, 1985, BRAIN, V108, P593, DOI 10.1093/brain/108.3.593; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Curtis CE, 2005, CEREB CORTEX, V15, P1281, DOI 10.1093/cercor/bhi011; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dresel C, 2011, MOVEMENT DISORD, V26, P1496, DOI 10.1002/mds.23497; Du AT, 2007, BRAIN, V130, P1159, DOI 10.1093/brain/awm016; Etgen T, 2006, J NEUROL NEUROSUR PS, V77, P1017, DOI 10.1136/jnnp.2005.087148; Fahn S, 1985, ADV OPHTHALMIC PLAST, V4, P97; Fiorio M, 2008, J NEUROL NEUROSUR PS, V79, P796, DOI 10.1136/jnnp.2007.131524; FRIED I, 1991, J NEUROSCI, V11, P3656; Granert O, 2011, NEUROIMAGE, V54, P32, DOI 10.1016/j.neuroimage.2010.08.013; Hallett M, 2002, NEUROLOGY, V59, P1306, DOI 10.1212/01.WNL.0000027361.73814.0E; Hallett M, 2008, NEUROLOGY, V71, P1275, DOI 10.1212/01.wnl.0000327601.46315.85; Herz DM, 2014, ANN NEUROL, V75, P829, DOI 10.1002/ana.24138; Horovitz SG, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-12; JANNETTA PJ, 1977, NEUROCHIRURGIE, V20, P145; Martino D, 2011, MOVEMENT DISORD, V26, P1907, DOI 10.1002/mds.23724; Molloy FM, 2003, BRAIN, V126, P2175, DOI 10.1093/brain/awg219; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Nakamura K, 1998, J NEUROPHYSIOL, V80, P2671, DOI 10.1152/jn.1998.80.5.2671; Obermann M, 2008, EUR J NEUROL, V15, P831, DOI 10.1111/j.1468-1331.2008.02196.x; Obermann M, 2007, MOVEMENT DISORD, V22, P1117, DOI 10.1002/mds.21495; Peller M, 2006, BRAIN, V129, P2697, DOI 10.1093/brain/awl181; Quartarone A, 2006, J NEUROSCI, V26, P716, DOI 10.1523/JNEUROSCI.3948-05.2006; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; SHALE H, 1987, MOVEMENT DISORD, V2, P321, DOI 10.1002/mds.870020411; Simonyan K, 2012, CEREB CORTEX, V22, P417, DOI 10.1093/cercor/bhr120; Simpson DM, 2008, NEUROLOGY, V70, P1699, DOI 10.1212/01.wnl.0000311389.26145.95; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Sohn YH, 2004, CLIN NEUROPHYSIOL, V115, P341, DOI 10.1016/j.clinph.2003.10.035; Wolpe N, 2014, BRAIN, V137, P208, DOI 10.1093/brain/awt302	36	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168652	10.1371/journal.pone.0168652	http://dx.doi.org/10.1371/journal.pone.0168652			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992533	Green Published, gold, Green Submitted			2022-12-26	WOS:000392758000073
J	Burillo, A; Marin, M; Cercenado, E; Ruiz-Carrascoso, G; Perez-Granda, MJ; Oteo, J; Bouza, E				Burillo, Almudena; Marin, Mercedes; Cercenado, Emilia; Ruiz-Carrascoso, Guillermo; Jesus Perez-Granda, Maria; Oteo, Jesus; Bouza, Emilio			Evaluation of the Xpert Carba-R (Cepheid) Assay Using Contrived Bronchial Specimens from Patients with Suspicion of Ventilator-Associated Pneumonia for the Detection of Prevalent Carbapenemases	PLOS ONE			English	Article							GRAM-NEGATIVE BACILLI; KLEBSIELLA-PNEUMONIAE; BACTERIAL PNEUMONIA; ACQUIRED PNEUMONIA; RAPID DETECTION; RECTAL SWABS; IMPACT; ENTEROBACTERIACEAE; MANAGEMENT; THERAPY	There is a critical need for rapid diagnostic methods for multidrug-resistant (MDR) pathogens in patients with a suspicion of ventilator-associated pneumonia (VAP). The Xpert Carba-R detects 5 targets for carbapenemase-producing organisms (bla(KPC), bla(NDM), bla(VIM), bla(OXA-48), and bla(IMP-1)). Our objective was to evaluate the performance of this assay directly on bronchial aspirates and to correlate the cycle number for a positive result (Ct) with the bacterial count. Bronchial aspirates from patients with a suspicion of VAP were spiked with a dilution of 1 of 4 MDR organisms carrying the resistance genes detected by the test prepared to a final concentration of 10(2)-10(5) cfu/ mL. We used a ROC curve and provided areas under the curve (AUC) with their 95% confidence intervals (CI). A point of maximum sensitivity (Se) and specificity (Sp) was derived and validity indices were calculated. One hundred contrived tests were performed. Se and Sp were 100% for all bacterial counts. A positive sample with a Ct <= 24.7 corresponded to a count >= 10(5) cfu/mL; if the Ct was within the range >24.7-<= 26.9, this corresponded to a count >= 10(4) cfu/mL. When the Ct was >26.9, this corresponded to a count <10(4) cfu/ mL. The Xpert Carba-R detects carbapenemase-producing organisms directly in contrived bronchial aspirates. Still, an important issue to consider is that the number of gene copies may vary according to many factors in vivo. If confirmed in further studies, the strong correlation observed between Ct values and the results of semi-quantitative cultures suggests this test could serve to differentiate between infection and colonization in routine clinical practice.	[Burillo, Almudena; Marin, Mercedes; Cercenado, Emilia; Bouza, Emilio] Hosp Gen Univ Gregorio Maranon, Clin Microbiol & Infect Dis Dept, Madrid, Spain; [Burillo, Almudena; Marin, Mercedes; Cercenado, Emilia; Bouza, Emilio] Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain; [Burillo, Almudena; Marin, Mercedes; Cercenado, Emilia; Bouza, Emilio] Univ Complutense Madrid, Sch Med, Dept Med, Madrid, Spain; [Marin, Mercedes; Cercenado, Emilia; Jesus Perez-Granda, Maria; Bouza, Emilio] CIBER Enfermedades Resp CIBERES CB06 06 0058, Madrid, Spain; [Ruiz-Carrascoso, Guillermo] Hosp Univ La Paz, Dept Microbiol, Madrid, Spain; [Jesus Perez-Granda, Maria] Hosp Gen Univ Gregorio Maranon, Dept Anesthesiol, Cardiac Surg Intens Care Unit, Madrid, Spain; [Oteo, Jesus] Inst Salud Carlos III, Antibiot Lab, Dept Bacteriol, Ctr Nacl Microbiol, Majadahonda, Spain	General University Gregorio Maranon Hospital; Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Hospital Universitario La Paz; General University Gregorio Maranon Hospital; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Burillo, A (corresponding author), Hosp Gen Univ Gregorio Maranon, Clin Microbiol & Infect Dis Dept, Madrid, Spain.; Burillo, A (corresponding author), Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain.; Burillo, A (corresponding author), Univ Complutense Madrid, Sch Med, Dept Med, Madrid, Spain.	almudena.burillo@gmail.com	Bouza, Emilio/D-8661-2014; GRANDA, MARIA JESUS mjpg PEREZ/L-3040-2015; Ruiz-Carrascoso, Guillermo/AAD-8914-2021	Bouza, Emilio/0000-0001-6967-9267; GRANDA, MARIA JESUS mjpg PEREZ/0000-0002-0613-2122; Ruiz-Carrascoso, Guillermo/0000-0002-8957-6596; Burillo, Almudena/0000-0003-2545-4204; Oteo, Jesus/0000-0003-3327-8263	Cepheid, Sunnyvale, CA; Cepheid	Cepheid, Sunnyvale, CA; Cepheid	This work was supported by a grant from Cepheid, Sunnyvale, CA. Cepheid provided the assay cartridges and paid for the laboratory expenses derived from the work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, CLIN INFECT DIS S4, V52, pS384; Arango MV, 2003, ARCH BRONCONEUMOL, V39, P394; Barbier F, 2013, CURR OPIN PULM MED, V19, P216, DOI 10.1097/MCP.0b013e32835f27be; Birgand G, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-30; Centers for Disease Control and Prevention, 2016, VENT ASS EV VAE; Cercenado E, 2012, J CLIN MICROBIOL, V50, P4095, DOI 10.1128/JCM.02409-12; Chambers HF, 2014, CLIN INFECT DIS, V58, P1571, DOI 10.1093/cid/ciu132; Chastre Jean, 2005, Respir Care, V50, P975; Dollow JM, 2014, DRUG DES DEV THER, V8, P175, DOI 10.2147/DDDT.S52446; El Solh AA, 2007, CRIT CARE, V11, DOI 10.1186/cc5917; Hortal J, 2009, CRIT CARE, V13, DOI 10.1186/cc7896; Iregui M, 2002, CHEST, V122, P262, DOI 10.1378/chest.122.1.262; Kollef MH, 2007, CLIN INFECT DIS, V44, P388, DOI 10.1086/510595; Kollef Marin H, 2005, Respir Care, V50, P714; Kuti EL, 2008, J CRIT CARE, V23, P91, DOI 10.1016/j.jcrc.2007.08.007; Lerner A, 2013, ANTIMICROB AGENTS CH, V57, P1474, DOI 10.1128/AAC.01275-12; Luna CM, 2006, EUR RESPIR J, V27, P158, DOI 10.1183/09031936.06.00049105; Miro E, 2013, EUR J CLIN MICROBIOL, V32, P253, DOI 10.1007/s10096-012-1737-0; Muscedere JG, 2008, J CRIT CARE, V23, P5, DOI 10.1016/j.jcrc.2007.11.012; Oteo J, 2013, ANTIMICROB AGENTS CH, V57, P6344, DOI 10.1128/AAC.01513-13; Oteo J, 2012, J MED MICROBIOL, V61, P864, DOI 10.1099/jmm.0.043190-0; Rello J, 2005, CRIT CARE, V9, P259, DOI 10.1186/cc3014; Sharpe JP, 2015, J AM COLL SURGEONS, V220, P489, DOI 10.1016/j.jamcollsurg.2014.12.016; Soubirou JF, 2014, SCAND J INFECT DIS, V46, P215, DOI 10.3109/00365548.2013.871644; Spellberg B, 2010, CLIN INFECT DIS, V51, pS150, DOI 10.1086/653065; Stenehjem E, 2012, J CLIN MICROBIOL, V50, P2079, DOI 10.1128/JCM.06690-11; Tato M, 2016, J CLIN MICROBIOL, V54, P1814, DOI 10.1128/JCM.00341-16; Tenover FC, 2013, J CLIN MICROBIOL, V51, P3780, DOI 10.1128/JCM.01092-13; van der Zee A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-27; Woodford N, 2004, ANTIMICROB AGENTS CH, V48, P4793, DOI 10.1128/AAC.48.12.4793-4799.2004; York MK, 2010, CLIN MICROBIOLOGY PR	31	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168473	10.1371/journal.pone.0168473	http://dx.doi.org/10.1371/journal.pone.0168473			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992521	Green Published, gold, Green Submitted			2022-12-26	WOS:000392758000052
J	Burke, NJ; Napoles, TM; Banks, PJ; Orenstein, FS; Luce, JA; Joseph, G				Burke, Nancy J.; Napoles, Tessa M.; Banks, Priscilla J.; Orenstein, Fern S.; Luce, Judith A.; Joseph, Galen			Survivorship Care Plan Information Needs: Perspectives of Safety-Net Breast Cancer Patients	PLOS ONE			English	Article							AFRICAN-AMERICAN; HEPATITIS-B; EDUCATION; PROGRAM; SUPPORT; LATINA; HEALTH	Purpose Despite the Institute of Medicine's (IOM) 2005 recommendation, few care organizations have instituted standard survivorship care plans (SCPs). Low health literacy and low English proficiency are important factors to consider in SCP development. Our study aimed to identify information needs and survivorship care plan preferences of low literacy, multi-lingual patients to support the transition from oncology to primary care and ongoing learning in survivorship. Methods We conducted focus groups in five languages with African American, Latina, Russian, Filipina, White, and Chinese medically underserved breast cancer patients. Topics explored included the transition to primary care, access to information, knowledge of treatment history, and perspectives on SCPs. Results Analysis of focus group data identified three themes: 1) the need for information and education on the transition between "active treatment" and "survivorship"; 2) information needed (and often not obtained) from providers; and 3) perspectives on SCP content and delivery. Conclusions Our data point to the need to develop a process as well as written information for medically underserved breast cancer patients. An SCP document will not replace direct communication with providers about treatment, symptom management and transition, a communication that is missing in participating safety-net patients' experiences of cancer care. Women turned to peer support and community-based organizations in the absence of information from providers. Implications for Cancer Survivors "Clear and effective" communication of survivorship care for safety-net patients requires dedicated staff trained to address wide-ranging information needs and uncertainties.	[Burke, Nancy J.] Univ Calif Merced, Sch Social Sci Humanities & Arts, Merced, CA 95340 USA; [Burke, Nancy J.; Napoles, Tessa M.; Joseph, Galen] Univ Calif San Francisco, Dept Anthropol Hist & Social Med, San Francisco, CA 94143 USA; [Burke, Nancy J.; Banks, Priscilla J.; Joseph, Galen] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Orenstein, Fern S.; Luce, Judith A.] San Francisco Gen Hosp, Breast Care Dispar Program, San Francisco, CA 94110 USA; [Luce, Judith A.] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA	University of California System; University of California Merced; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Burke, NJ (corresponding author), Univ Calif Merced, Sch Social Sci Humanities & Arts, Merced, CA 95340 USA.; Burke, NJ (corresponding author), Univ Calif San Francisco, Dept Anthropol Hist & Social Med, San Francisco, CA 94143 USA.; Burke, NJ (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.	Nburke2@ucmerced.edu		Joseph, Galen/0000-0001-9179-7075	Avon Foundation Breast Cancer Disparities Grant [012015037]; Mount Zion Health Fund [20130088]	Avon Foundation Breast Cancer Disparities Grant; Mount Zion Health Fund	Research reported was funded by the Avon Foundation Breast Cancer Disparities Grant (012015037, Luce PI) and the Mount Zion Health Fund (20130088, Burke PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Surgeons Commission on Cancer, 2012, CANC PROGR STAND 201; Ashing-Giwa K, 2013, J CANCER SURVIV, V7, P283, DOI 10.1007/s11764-013-0270-1; Ashing-Giwa KT, 2004, PSYCHO-ONCOLOGY, V13, P408, DOI 10.1002/pon.750; Bernard H. H. R., 2009, ANAL QUALITATIVE DAT; Bucholtz M, 2000, J PRAGMATICS, V32, P1439, DOI 10.1016/S0378-2166(99)00094-6; Burg MA, 2009, J GEN INTERN MED, V24, P467, DOI 10.1007/s11606-009-1012-y; Burke NJ, 2012, QUAL HEALTH RES, V22, P189, DOI 10.1177/1049732311420577; Burke NJ, 2011, J COMMUN HEALTH, V36, P27, DOI 10.1007/s10900-010-9277-y; Burke NJ, 2004, J CANCER EDUC, V19, P244, DOI 10.1207/s15430154jce1904_13; Burke NJ, 2004, ETHNIC HEALTH, V9, P153, DOI 10.1080/1355785042000222860; Burke NJ, ONCOLOGY PROVI UNPUB; Burke NJ, 2008, CANC HLTH DISP SUMM; Chung LK, 2009, CANCER NURS, V32, P236, DOI 10.1097/NCC.0b013e318196c67b; Hawley ST, 2008, PATIENT EDUC COUNS, V73, P363, DOI 10.1016/j.pec.2008.07.036; Hewitt ME, 2007, J CLIN ONCOL, V25, P2270, DOI 10.1200/JCO.2006.10.0826; Hewitt ME, 2006, AM SOC CLIN ONCOLOGY; Kantsiper M, 2009, J GEN INTERN MED, V24, P459, DOI 10.1007/s11606-009-1000-2; Ko CM, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-27; Marbach TJ, 2011, ONCOL NURS FORUM, V38, P335, DOI 10.1188/11.ONF.335-342; Mathews HF, 2009, CONFRONTING CANC MET, P43; O'Malley DM, 2016, J CANCER EDUC, V31, P63, DOI 10.1007/s13187-014-0775-y; Pasick RJ, 1995, P NAT C HLTH STAT JU; Pratt-Chapman M, CANC SURVIVORSHIP PO; Rechis R, 2011, ESSENTIAL ELEMENTS S; Rust C, 2011, SOC WORK HEALTH CARE, V50, P739, DOI 10.1080/00981389.2011.585703; Salz T, 2012, CA-CANCER J CLIN, V62, P101, DOI 10.3322/caac.20142; Wen KY, 2014, J COMMUNITY SUPPORT, V12, P439, DOI 10.12788/jcso.0095	27	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168383	10.1371/journal.pone.0168383	http://dx.doi.org/10.1371/journal.pone.0168383			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8LN	27992491	Green Published, gold, Green Submitted			2022-12-26	WOS:000392758000045
J	Ho, VW; Hofs, E; Elisia, I; Lam, V; Hsu, BE; Lai, J; Luk, B; Samudio, I; Krystal, G				Ho, Victor W.; Hofs, Elyse; Elisia, Ingrid; Lam, Vivian; Hsu, Brian E.; Lai, June; Luk, Beryl; Samudio, Ismael; Krystal, Gerald			Trans Retinoic Acid, Transforming Growth Factor beta and Prostaglandin E-2 in Mouse Plasma Synergize with Basophil-Secreted Interleukin-4 to M2 Polarize Murine Macrophages	PLOS ONE			English	Article							T-CELLS; SUPPRESSOR-CELLS; SHIP REPRESSES; M1 MACROPHAGES; ACTIVATION; INDUCTION; GENERATION; SYSTEM; DYSFUNCTION; EXPRESSION	In previous studies we found that macrophages (M Phi s) from SH2-containing inositol-5'phosphatase (SHIP) deficient mice are M2 polarized while their wild type (WT) counterparts are M1 polarized and that this difference in M Phi phenotype can be recapitulated during in vitro derivation from bone marrow if mouse plasma (MP), but not fetal calf serum, is added to standard M-CSF-containing cultures. In the current study we investigated the mechanism by which MP skews SHIP-/- but not +/+ M Phi s to an M2 phenotype. Our results suggest that SHIP-/-basophils constitutively secrete higher levels of IL-4 than SHIP+/+ basophils and this higher level of IL-4 is sufficient to skew both SHIP+/+ and SHIP-/-M Phi s to an M2 phenotype, but only when MP is present to increase the sensitivity of the M Phi s to this level of IL-4. MP increases the IL-4 sensitivity of both SHIP+/+ and -/-M Phi s not by increasing cell surface IL-4 or CD36 receptor levels, but by triggering the activation of Erk and Akt and the production of ROS, all of which play a critical role in sensitizing M Phi s to IL-4-induced M2 skewing. Studies to identify the factor(s) in MP responsible for promoting IL-4-induced M2 skewing suggests that all-trans retinoic acid (ATRA), TGF beta and prostaglandin E-2 (PGE(2)) all play a role. Taken together, these results indicate that basophil-secreted IL-4 plays an essential role in M2 skewing and that ATRA, TGF beta and PGE2 within MP collaborate to dramatically promote M2 skewing by acting directly on M Phi s to increase their sensitivity to IL-4.	[Ho, Victor W.; Hofs, Elyse; Elisia, Ingrid; Lam, Vivian; Hsu, Brian E.; Lai, June; Luk, Beryl; Samudio, Ismael; Krystal, Gerald] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC, Canada	British Columbia Cancer Agency	Krystal, G (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC, Canada.	gkrystal@bccrc.ca	Samudio, Ismael/D-3581-2013	Samudio, Ismael/0000-0001-8676-1035; Krystal, Gerald/0000-0002-1961-6281	Canadian Cancer Society; Lotte & John Hecht Memorial Foundation [3968]; NCI C [016107]; Terry Fox Foundation Program [018006]; BC Cancer Foundation; BC Cancer Agency	Canadian Cancer Society(Canadian Cancer Society (CCS)); Lotte & John Hecht Memorial Foundation; NCI C(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Terry Fox Foundation Program; BC Cancer Foundation; BC Cancer Agency	The research was supported by the Canadian Cancer Society, the Lotte & John Hecht Memorial Foundation Grant ID #3968, NCI C grant #016107 and Terry Fox Foundation Program grant #018006, with core support from the BC Cancer Foundation and the BC Cancer Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong JS, 2002, CELL DEATH DIFFER, V9, P252, DOI 10.1038/sj.cdd.4400959; BENSASSON SZ, 1990, P NATL ACAD SCI USA, V87, P1421, DOI 10.1073/pnas.87.4.1421; Blunt MD, 2012, CURR OPIN PHARMACOL, V12, P444, DOI 10.1016/j.coph.2012.02.015; Boorsma CE, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/769214; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Brown SD, 2012, ALCOHOL CLIN EXP RES, V36, P1952, DOI 10.1111/j.1530-0277.2012.01825.x; CHAM BE, 1976, J LIPID RES, V17, P176; DaCosta BS, 2004, MOL PHARM, V65, P744, DOI DOI 10.1124/M0L.65.3.744; DAMEN JE, 1995, EMBO J, V14, P5557, DOI 10.1002/j.1460-2075.1995.tb00243.x; Denzel A, 2008, NAT IMMUNOL, V9, P733, DOI 10.1038/ni.1621; Desmedt M, 1998, J IMMUNOL, V160, P5300; Eruslanov E, 2011, INT IMMUNOPHARMACOL, V11, P848, DOI 10.1016/j.intimp.2011.01.033; Eruslanov E, 2010, J LEUKOCYTE BIOL, V88, P839, DOI 10.1189/jlb.1209821; Feng JW, 2000, J LIPID RES, V41, P688; Galdiero MR, 2013, J CELL PHYSIOL, V228, P1404, DOI 10.1002/jcp.24260; Gallo P, 2010, IMMUNOL LETT, V133, P70, DOI 10.1016/j.imlet.2010.07.004; GORSCH SM, 1992, CANCER RES, V52, P6949; Guo YX, 2015, PHYSIOL REV, V95, P125, DOI 10.1152/physrev.00032.2013; Hamilton MJ, 2010, J IMMUNOL, V185, P4545, DOI 10.4049/jimmunol.1002045; Han WGH, 2010, EUR J IMMUNOL, V40, P2731, DOI 10.1002/eji.201040574; Hebenstreit D, 2006, CYTOKINE GROWTH F R, V17, P173, DOI 10.1016/j.cytogfr.2006.01.004; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Heusinkveld M, 2011, J IMMUNOL, V187, P1157, DOI 10.4049/jimmunol.1100889; Ho VW, 2014, CARCINOGENESIS, V35, P2291, DOI 10.1093/carcin/bgu147; Khan Shaukat A, 2012, BMC Res Notes, V5, P636, DOI 10.1186/1756-0500-5-636; Kuroda E, 2011, J IMMUNOL, V186, P323, DOI 10.4049/jimmunol.1002778; Kuroda E, 2009, J IMMUNOL, V183, P3652, DOI 10.4049/jimmunol.0900864; Lo HM, 2014, FOOD FUNCT, V5, P140, DOI 10.1039/c3fo60309a; Mamidi S, 2012, IMMUNOBIOLOGY, V217, P593, DOI 10.1016/j.imbio.2011.10.022; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Martinez TN, 2012, ANTIOXID REDOX SIGN, V16, P920, DOI 10.1089/ars.2011.4033; Morrison AC, 2002, J IMMUNOL, V168, P853, DOI 10.4049/jimmunol.168.2.853; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Obrochta KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099435; Ostman A, 2011, J BIOCHEM, V150, P345, DOI 10.1093/jb/mvr104; Rauh MJ, 2005, IMMUNITY, V23, P361, DOI 10.1016/j.immuni.2005.09.003; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Ruhl R, 2008, NUTRITION, V24, P1224, DOI 10.1016/j.nut.2008.05.022; Salagianni M, 2012, CIRCULATION, V126, P952, DOI 10.1161/CIRCULATIONAHA.111.067678; SCHALKWIJK CG, 1992, EUR J BIOCHEM, V210, P169, DOI 10.1111/j.1432-1033.1992.tb17405.x; Sinha P, 2005, J IMMUNOL, V174, P636, DOI 10.4049/jimmunol.174.2.636; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Surace MJ, 2013, AM J CLIN EXP IMMUNO, V2, P117; Traore K, 2008, J CELL PHYSIOL, V216, P276, DOI 10.1002/jcp.21403; Ushio-Fukai M, 1999, J BIOL CHEM, V274, P22699, DOI 10.1074/jbc.274.32.22699; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285; Zhang Y, 2013, CELL RES, V23, P898, DOI 10.1038/cr.2013.75; Zhou XL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-210	51	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168072	10.1371/journal.pone.0168072	http://dx.doi.org/10.1371/journal.pone.0168072			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977740	Green Published, Green Submitted, gold			2022-12-26	WOS:000391217400054
J	Huang, N; Wang, L; Hu, YS; Tian, HF; Niu, Z				Huang, Ni; Wang, Li; Hu, Yongsen; Tian, Haifeng; Niu, Zheng			Spatial Variation of Soil Respiration in a Cropland under Winter Wheat and Summer Maize Rotation in the North China Plain	PLOS ONE			English	Article							SPECTRAL VEGETATION INDEXES; CO2 EFFLUX; ECOSYSTEM RESPIRATION; TEMPERATURE-DEPENDENCE; CLUSTER-ANALYSIS; ABIOTIC FACTORS; BOREAL FOREST; WATER-CONTENT; PHOTOSYNTHESIS; PRODUCTIVITY	Spatial variation of soil respiration (R-s) in cropland ecosystems must be assessed to evaluate the global terrestrial carbon budget. This study aims to explore the spatial characteristics and controlling factors of Rs in a cropland under winter wheat and summer maize rotation in the North China Plain. We collected R-s data from 23 sample plots in the cropland. At the late jointing stage, the daily mean R-s of summer maize (4.74 mu mol CO2 m(-2) s(-1)) was significantly higher than that of winter wheat (3.77 mu mol CO2 m(-2) s(-1)). However, the spatial variation of R-s in summer maize (coefficient of variation, CV = 12.2%) was lower than that in winter wheat (CV = 18.5%). A similar trend in CV was also observed for environmental factors but not for biotic factors, such as leaf area index, aboveground biomass, and canopy chlorophyll content. Pearson's correlation analyses based on the sampling data revealed that the spatial variation of R-s was poorly explained by the spatial variations of biotic factors, environmental factors, or soil properties alone for winter wheat and summer maize. The similarly non-significant relationship was observed between R-s and the enhanced vegetation index (EVI), which was used as surrogate for plant photosynthesis. EVI was better correlated with fieldmeasured leaf area index than the normalized difference vegetation index and red edge chlorophyll index. All the data from the 23 sample plots were categorized into three clusters based on the cluster analysis of soil carbon/nitrogen and soil organic carbon content. An apparent improvement was observed in the relationship between R-s and EVI in each cluster for both winter wheat and summer maize. The spatial variation of R-s in the cropland under winter wheat and summer maize rotation could be attributed to the differences in spatial variations of soil properties and biotic factors. The results indicate that applying cluster analysis to minimize differences in soil properties among different clusters can improve the role of remote sensing data as a proxy of plant photosynthesis in semi-empirical R-s models and benefit the acquisition of R-s in cropland ecosystems at large scales.	[Huang, Ni; Wang, Li; Hu, Yongsen; Tian, Haifeng; Niu, Zheng] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, State Key Lab Remote Sensing Sci, Beijing, Peoples R China; [Tian, Haifeng] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, L (corresponding author), Chinese Acad Sci, Inst Remote Sensing & Digital Earth, State Key Lab Remote Sensing Sci, Beijing, Peoples R China.	wangli@radi.ac.cn	Wang, Li/P-9811-2018; niu, zheng/M-9923-2017	Wang, Li/0000-0002-2929-4255; 	National Natural Science Foundation of China [41301498]; Youth Innovation Promotion Association CAS [2014052]; Special Foundation for Young Scientists from the director of the Institute of Remote Sensing and Digital Earth, Chinese Academy of Sciences; National High Technology Research and Development Program of China (863Program) [2014AA06A511]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Innovation Promotion Association CAS; Special Foundation for Young Scientists from the director of the Institute of Remote Sensing and Digital Earth, Chinese Academy of Sciences; National High Technology Research and Development Program of China (863Program)(National High Technology Research and Development Program of China)	This work was supported by the National Natural Science Foundation of China (41301498), the Youth Innovation Promotion Association CAS (2014052), the Special Foundation for Young Scientists from the director of the Institute of Remote Sensing and Digital Earth, Chinese Academy of Sciences, and the National High Technology Research and Development Program of China (863Program) (2014AA06A511).	Alexandrov GA, 2007, ECOL MODEL, V200, P189, DOI 10.1016/j.ecolmodel.2006.07.012; Amos B, 2006, SOIL SCI SOC AM J, V70, P1489, DOI 10.2136/sssaj2005.0216; Asner GP, 2004, GLOBAL CHANGE BIOL, V10, P844, DOI 10.1111/j.1529-8817.2003.00766.x; Aubrey DP, 2009, NEW PHYTOL, V184, P35, DOI 10.1111/j.1469-8137.2009.02971.x; Balogh J, 2011, SOIL BIOL BIOCHEM, V43, P1006, DOI 10.1016/j.soilbio.2011.01.017; Chang CT, 2014, BIOGEOSCIENCES, V11, P6173, DOI 10.5194/bg-11-6173-2014; Chen DM, 2013, J ECOL, V101, P1322, DOI 10.1111/1365-2745.12119; Chen Z, 2015, AGR FOREST METEOROL, V203, P180, DOI 10.1016/j.agrformet.2015.01.012; Cook FJ, 2008, SOIL BIOL BIOCHEM, V40, P1013, DOI 10.1016/j.soilbio.2007.12.012; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Ding WX, 2007, SOIL SCI SOC AM J, V71, P944, DOI 10.2136/sssaj2006.0160; Eugster W, 2010, AGR ECOSYST ENVIRON, V139, P346, DOI 10.1016/j.agee.2010.09.001; Everitt B, 2009, QUAL QUANT, V14, P75; Gaumont-Guay D, 2006, AGR FOREST METEOROL, V140, P220, DOI 10.1016/j.agrformet.2006.08.003; Geng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034968; Giammanco S, 2009, B VOLCANOL, V71, P201, DOI 10.1007/s00445-008-0218-x; Gitelson, 2003, GEOPHYS RES LETT, V30; Han GX, 2007, SOIL BIOL BIOCHEM, V39, P418, DOI 10.1016/j.soilbio.2006.08.009; Hanesch M, 2001, PHYS CHEM EARTH PT A, V26, P885, DOI 10.1016/S1464-1895(01)00137-5; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; Hashimoto S, 2015, BIOGEOSCIENCES DISCU, V12, P4331, DOI DOI 10.5194/BGD-12-4331-; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Huang N., 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0105150, DOI 10.1371/JOURNAL.PONE.0105150]; Huang N, 2014, J GEOPHYS RES-ATMOS, V119, P6393, DOI 10.1002/2013JD020515; Huang N, 2013, PLANT SOIL, V367, P535, DOI 10.1007/s11104-012-1488-9; Huang N, 2013, ECOL INDIC, V26, P117, DOI 10.1016/j.ecolind.2012.10.027; Huang N, 2012, AGR FOREST METEOROL, V160, P80, DOI 10.1016/j.agrformet.2012.03.005; Huang W, 2007, PRECIS AGRIC, V8, P187, DOI 10.1007/s11119-007-9038-9; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Irisarri JGN, 2012, J VEG SCI, V23, P114, DOI 10.1111/j.1654-1103.2011.01326.x; Jagermeyr J, 2014, GLOBAL CHANGE BIOL, V20, P1191, DOI 10.1111/gcb.12443; Janssens IA, 2003, GLOBAL CHANGE BIOL, V9, P911, DOI 10.1046/j.1365-2486.2003.00636.x; Janssens IA, 2001, GLOBAL CHANGE BIOL, V7, P269, DOI 10.1046/j.1365-2486.2001.00412.x; Jiang JS, 2015, SOIL TILL RES, V150, P139, DOI 10.1016/j.still.2015.02.002; Jiang Y, 2015, CHEM ERDE GEOCHEMIST, V75; Katayama A, 2009, AGR FOREST METEOROL, V149, P1666, DOI 10.1016/j.agrformet.2009.05.007; Kaufman L, 1990, J AM STAT ASS; Keeney R.D., 1982, METHODS SOIL ANAL, P101; Kuzyakov Y, 2005, J PLANT NUTR SOIL SC, V168, P503, DOI 10.1002/jpln.200421703; Kuzyakov Y, 2010, GLOBAL CHANGE BIOL, V16, P3386, DOI 10.1111/j.1365-2486.2010.02179.x; Levy-Varon JH, 2012, OECOLOGIA, V169, P211, DOI 10.1007/s00442-011-2182-y; Moitinho MR, 2015, SOIL TILL RES, V148, P127, DOI 10.1016/j.still.2014.12.012; Nguyen C, 2003, AGRONOMIE, V23, P375, DOI 10.1051/agro:2003011; Olsson P, 2005, GLOBAL CHANGE BIOL, V11, P1745, DOI 10.1111/j.1365-2486.2005.001033.x; Ortega RA, 2007, COMPUT ELECTRON AGR, V58, P49, DOI 10.1016/j.compag.2006.12.011; Parkin TB, 2005, J HYDROMETEOROL, V6, P812, DOI 10.1175/JHM459.1; Phillips SC, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2008JG000858; Prolingheuer N, 2010, BIOGEOSCIENCES, V12, P9137; Raich JW, 2000, BIOGEOCHEMISTRY, V48, P71, DOI 10.1023/A:1006112000616; Raich JW, 2002, GLOBAL CHANGE BIOL, V8, P800, DOI 10.1046/j.1365-2486.2002.00511.x; Rayment MB, 2000, SOIL BIOL BIOCHEM, V32, P35, DOI 10.1016/S0038-0717(99)00110-8; Reichstein M, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002035; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Ryan MG, 2005, BIOGEOCHEMISTRY, V73, P3, DOI 10.1007/s10533-004-5167-7; Shi PL, 2006, AGR FOREST METEOROL, V137, P220, DOI 10.1016/j.agrformet.2006.02.008; Sims DA, 2008, REMOTE SENS ENVIRON, V112, P1633, DOI 10.1016/j.rse.2007.08.004; Sims DA, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2006JG000162; Song XY, 2009, PRECIS AGRIC, V10, P471, DOI 10.1007/s11119-009-9108-2; Stadler A, 2015, EUROPEAN J AGRONOMY, P8; Supit I, 2012, AGR FOREST METEOROL, V164, P96, DOI 10.1016/j.agrformet.2012.05.005; Tang JW, 2005, GLOBAL CHANGE BIOL, V11, P1298, DOI 10.1111/j.1365-2486.2005.00978.x; Turner DP, 2004, BIOSCIENCE, V54, P573, DOI 10.1641/0006-3568(2004)054[0573:IRSAEP]2.0.CO;2; Vargas R, 2011, NEW PHYTOL, V191, P1006, DOI 10.1111/j.1469-8137.2011.03771.x; Vargas R, 2011, BIOGEOCHEMISTRY, V102, P1, DOI 10.1007/s10533-010-9462-1; Wagle P, 2014, BIOENERG RES, V7, P789, DOI 10.1007/s12155-014-9434-8; Wang B, 2014, BIOGEOSCIENCES, V11, P259, DOI 10.5194/bg-11-259-2014; Xu M, 2001, GLOBAL CHANGE BIOL, V7, P667, DOI 10.1046/j.1354-1013.2001.00435.x; Zhang CP, 2014, SOIL BIOL BIOCHEM, V75, P113, DOI 10.1016/j.soilbio.2014.04.013; Zhang Q, 2013, AGR FOREST METEOROL, V180, P34, DOI 10.1016/j.agrformet.2013.04.028; Zhao CJ, 2007, NEW ZEAL J AGR RES, V50, P735	71	1	1	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168249	10.1371/journal.pone.0168249	http://dx.doi.org/10.1371/journal.pone.0168249			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977743	gold, Green Published, Green Submitted			2022-12-26	WOS:000391217400080
J	Mijiti, M; Mijiti, P; Axier, A; Amuti, M; Zhu, GH; Cheng, XJ; Kadeer, K; Wang, XX; Geng, D; Maimaitili, A				Mijiti, Maimaitili; Mijiti, Peierdun; Axier, Aximujiang; Amuti, Maiwulanjiang; Zhu Guohua; Cheng Xiaojiang; Kadeer, Kaheerman; Wang Xixian; Geng, Dangmurenjiafu; Maimaitili, Aisha			Incidence and Predictors of Angiographic Vasospasm, Symptomatic Vasospasm and Cerebral Infarction in Chinese Patients with Aneurysmal Subarachnoid Hemorrhage	PLOS ONE			English	Article							OF-THE-LITERATURE; TRANSCRANIAL DOPPLER; CLINICAL-TRIALS; OUTCOME EVENT; FISHER SCALE; RISK-FACTORS; ISCHEMIA; ASSOCIATION; REPAIR; BLOOD	Introduction Cerebral vasospasm (CVS) is the most common neurological complication after aneurysmal subarachnoid hemorrhage (aSAH) and associated with poor functional outcome and mortality. Reports on incidence and predictors of CVS in Chinese patients with aSAH were scarce. We aimed to estimate the incidence and predictors of angiographic vasospasm (AV), symptomatic vasospasm (SV), and cerebral infarction in Chinese patients with aSAH. Methods We retrospectively reviewed the medical records of 542 consecutive aSAH patients admitted to neurosurgery department of the First Affiliated Hospital of Xinjiang Medical University in Urumqi city of China between January 1, 2011 and December 31, 2015. AV, SV and cerebral infarction were defined based on clinical data and neuroimaging findings. Univariate and multivariate analyses were performed to identify predictors of AV, SV or cerebral infarction. Results 343 (63.3%) patients fulfilled the inclusion and exclusion criteria. Of them, 182(53.1%) developed AV, 99 (28.9%) developed SV, and 87 (25.4%) developed cerebral infarction. A history of hypertension, poor modified Fisher grade (3-4) and poor Hunt-Hess grade (4-5) on admission were common risk factors for AV, SV and cerebral infarction. Patients from Uyghur ethnic group or other minorities were less likely to develop AV, SV or cerebral infarction, compared to those from Han ethic group after adjustment of other potential confounders. Additionally, age-53 years, leukocyte count >= 11x10(9)/L on admission and being current or former smokers were independent risk factors of cerebral infarction. Leukocyte count >= 11x 10(9)/L on admission and aneurysm size >= 10 mm were independent risk factors of SV. Serum glucose level >= 7.0 mmol/L on admission was an independent risk factor of AV. Conclusion Risk factors of different definitions of CVS were diverse in Chinese patients with aSAH; however, risk factors of SV and cerebral infarction seem to be similar. We recommend early and aggressive therapy in these patients at-risk of CVS.	[Mijiti, Maimaitili; Axier, Aximujiang; Zhu Guohua; Cheng Xiaojiang; Kadeer, Kaheerman; Wang Xixian; Geng, Dangmurenjiafu; Maimaitili, Aisha] Xinjiang Med Univ, Dept Neurosurg, Affiliated Hosp 1, Urumqi, Xinjiang, Peoples R China; [Mijiti, Peierdun] Xinjiang Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Urumqi, Xinjiang, Peoples R China; [Amuti, Maiwulanjiang] Peoples Hosp Kashi, Dept Neurosurg, Kashi, Xinjiang, Peoples R China	Xinjiang Medical University; Xinjiang Medical University	Geng, D (corresponding author), Xinjiang Med Univ, Dept Neurosurg, Affiliated Hosp 1, Urumqi, Xinjiang, Peoples R China.	aximjan9@126.com			Regional Science Fund Project of Xinjiang, China [81160150]	Regional Science Fund Project of Xinjiang, China	This study was financially supported by the Regional Science Fund Project of Xinjiang, China (No.81160150).	Carrera E, 2009, NEUROSURGERY, V65, P316, DOI 10.1227/01.NEU.0000349209.69973.88; Charpentier C, 1999, STROKE, V30, P1402, DOI 10.1161/01.STR.30.7.1402; Claassen J, 2001, STROKE, V32, P2012, DOI 10.1161/hs0901.095677; Crowley RW, 2011, STROKE, V42, P919, DOI 10.1161/STROKEAHA.110.597005; Etminan N, 2013, ACTA NEUROCHIR SUPPL, V115, P33, DOI 10.1007/978-3-7091-1192-5_8; Fassbender K, 2001, J NEUROL NEUROSUR PS, V70, P534, DOI 10.1136/jnnp.70.4.534; Fergusen S, 2007, NEUROSURGERY, V60, P658, DOI 10.1227/01.NEU.0000255396.23280.31; Frontera JA, 2009, CORD C P, V40, P1963, DOI DOI 10.1161/STR0KEAHA.108.544700; Frontera JA, 2006, NEUROSURGERY, V59, P21, DOI 10.1227/01.NEU.0000218821.34014.1B; Harrod CG, 2005, NEUROSURGERY, V56, P633, DOI 10.1227/01.NEU.0000156644.45384.92; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Inagawa T, 2016, WORLD NEUROSURG, V85, P56, DOI 10.1016/j.wneu.2015.08.052; Inagawa T, 2014, NEUROL MED-CHIR, V54, P465, DOI 10.2176/nmc.oa.2013-0169; Jabbarli R, 2015, EUR J NEUROL, V22, P941, DOI 10.1111/ene.12686; Kale SP, 2013, J STROKE CEREBROVASC, V22, P22, DOI 10.1016/j.jstrokecerebrovasdis.2011.05.024; Kanamaru K, 2016, ACTA NEUROCHIR SUPPL, V121, P167, DOI 10.1007/978-3-319-18497-5_30; Kanamaru Kenji, 2015, Acta Neurochir Suppl, V120, P291, DOI 10.1007/978-3-319-04981-6_49; Kasius KM, 2010, CEREBROVASC DIS, V29, P576, DOI 10.1159/000306645; KASSELL NF, 1985, STROKE, V16, P562, DOI 10.1161/01.STR.16.4.562; Ko SB, 2011, STROKE, V42, P669, DOI 10.1161/STROKEAHA.110.600775; Korbakis G, 2016, NEUROCRIT CARE, V24, P428, DOI 10.1007/s12028-015-0212-z; Kozak N, 2016, TURK NEUROSURG, V26, P545, DOI 10.5137/1019-5149.JTN.14408-15.1; Krejza J, 2005, RADIOLOGY, V236, P621, DOI 10.1148/radiol.2362031662; Kumar A, 2013, NEUROSURGERY, V73, P617, DOI 10.1227/NEU.0000000000000057; Kumar G, 2016, J NEUROSURG, V124, P1257, DOI 10.3171/2015.4.JNS15428; Lasner TM, 1997, NEUROSURGERY, V87, P381, DOI [10.3171/jns.1997.87.3.0381, DOI 10.3171/JNS.1997.87.3.0381]; Lysakowski C, 2001, STROKE, V32, P2292, DOI 10.1161/hs1001.097108; Macdonald RL, 2003, J NEUROSURG, V99, P644, DOI 10.3171/jns.2003.99.4.0644; McGirt MJ, 2003, J NEUROSURG, V98, P1222, DOI 10.3171/jns.2003.98.6.1222; Mocco J, 2006, NEUROSURGERY, V58, P305, DOI 10.1227/01.NEU.0000195009.02412.E8; Naidech AM, 2010, NEUROCRIT CARE, V12, P181, DOI 10.1007/s12028-009-9311-z; Oyama Katie, 2004, Crit Care Nurse, V24, P58; Pearl JD, 2008, ACTA NEUROCHIR SUPPL, V105, P207; Qureshi AI, 2000, CRIT CARE MED, V28, P984, DOI 10.1097/00003246-200004000-00012; Rabinstein AA, 2005, STROKE, V36, P992, DOI 10.1161/01.STR.0000163090.59350.5a; Roos YBWEM, 2000, J NEUROL NEUROSUR PS, V68, P337, DOI 10.1136/jnnp.68.3.337; Su FW, 2010, J NEUROL, V257, P264, DOI 10.1007/s00415-009-5306-0; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732; Turowski B, 2015, CLIN NEURORADIOL, V25, P205, DOI 10.1007/s00062-015-0444-5; Vergouwen MDI, 2011, NEUROCRIT CARE, V15, P308, DOI 10.1007/s12028-011-9586-8; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Wong GKC, 2016, ACTA NEUROCHIR SUPPL, V121, P157, DOI 10.1007/978-3-319-18497-5_28; Yousef K, 2010, NEUROCRIT CARE, V13, P366, DOI 10.1007/s12028-010-9408-4; Zafar SF, 2016, J CLIN NEUROPHYSIOL, V33, P235, DOI 10.1097/WNP.0000000000000276	44	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168657	10.1371/journal.pone.0168657	http://dx.doi.org/10.1371/journal.pone.0168657			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977801	Green Submitted, gold, Green Published			2022-12-26	WOS:000391217400125
J	Wang, X; Lang, M; Zhao, T; Feng, X; Zheng, C; Huang, C; Hao, J; Dong, J; Luo, L; Li, X; Lan, C; Yu, W; Yu, M; Yang, S; Ren, H				Wang, X.; Lang, M.; Zhao, T.; Feng, X.; Zheng, C.; Huang, C.; Hao, J.; Dong, J.; Luo, L.; Li, X.; Lan, C.; Yu, W.; Yu, M.; Yang, S.; Ren, H.			Cancer-FOXP3 directly activated CCL5 to recruit FOXP3(+) Treg cells in pancreatic ductal adenocarcinoma	ONCOGENE			English	Article							REGULATORY T-CELLS; TUMOR-CELLS; CARCINOMA CELLS; IMMUNE ESCAPE; MURINE MODEL; EXPRESSION; ANTIBODY; INFILTRATION; INHIBITION; INFECTION	Forkheadbox protein 3 (FOXP3), initially identified as a key transcription factor for regulatory T cells (Treg cells), was also expressed in many tumors including pancreatic ductal adenocarcinoma (PDAC). However, its role in PDAC progression remains elusive. In this study, we utilized 120 PDAC tissues after radical resection to detect cancer-FOXP3 and Treg cells by immunohistochemistry and evaluated clinical and pathological features of these patients. Cancer-FOXP3 was positively correlated with Treg cells accumulation in tumor tissues derived from PDAC patients. In addition, high cancer-FOXP3 expression was associated with increased tumor volumes and poor prognosis in PDAC especially combined with high levels of Treg cells. Overexpression of cancer-FOXP3 promoted the tumor growth in immunocompetent syngeneic mice but not in immunocompromised or Treg cell-depleted mice. Furthermore, CCL5 was directly trans-activated by cancer-FOXP3 and promoted the recruitment of Treg cells from peripheral blood to the tumor site in vitro and in vivo. This finding has been further reinforced by the evidence that Treg cells recruitment by cancer-FOXP3 was impaired by neutralization of CCL5, thereby inhibiting the growth of PDAC. In conclusion, cancer-FOXP3 serves as a prognostic biomarker and a crucial determinant of immunosuppressive microenvironment via recruiting Treg cells by directly trans-activating CCL5. Therefore, cancer-FOXP3 could be used to select patients with better response to CCL5/CCR5 blockade immunotherapy.	[Wang, X.; Lang, M.; Zhao, T.; Zheng, C.; Huang, C.; Hao, J.; Li, X.; Lan, C.; Yu, W.; Ren, H.] Tianjin Med Univ, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy,Dept Pancreat Canc, Tianjin, Peoples R China; [Feng, X.] Chinese Acad Med Sci, Inst Hematol & Hosp Blood Dis, State Key Lab Expt Hematol, Tianjin, Peoples R China; [Feng, X.] Peking Union Med Coll, Tianjin, Peoples R China; [Dong, J.; Yu, W.] Tianjin Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Tianjin, Peoples R China; [Luo, L.] Hepingqu Gynaecol & Obster Hosp, Dept Gynaecol, Tianjin, Peoples R China; [Yang, S.] Penn State Coll Med, Hershey, PA USA	Tianjin Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tianjin Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Ren, H (corresponding author), Tianjin Med Univ, Dept Pancreat Canc, Canc Inst & Hosp, Tianjin 300060, Peoples R China.	renhe@tjmuch.com		WANG, XIUCHAO/0000-0002-3205-8544	National Natural Science Foundation of China [81272685, 81525021, 81672431, 81672435, 81502067, 81302082, 31471340, 31470957, 81401957, 81472264]; National Key Clinical Specialist Construction Programs of China [2013-544]; Key Program of Public Health Bureau Foundation of Tianjin [15KG 144]; NATIONAL CANCER INSTITUTE [R01CA175741] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Clinical Specialist Construction Programs of China; Key Program of Public Health Bureau Foundation of Tianjin; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Natural Science Foundation of China (grants 81272685, 81525021, 81672431, 81672435, 81502067, 81302082, 31471340, 31470957, 81401957 and 81472264), the National Key Clinical Specialist Construction Programs of China (no. 2013-544) and Key Program of Public Health Bureau Foundation of Tianjin (15KG 144).	Bayry J, 2008, P NATL ACAD SCI USA, V105, P10221, DOI 10.1073/pnas.0803453105; Borczuk AC, 2008, ONCOGENE, V27, P557, DOI 10.1038/sj.onc.1210662; Cavassani KA, 2006, J IMMUNOL, V177, P5811, DOI 10.4049/jimmunol.177.9.5811; deLeeuw RJ, 2012, CLIN CANCER RES, V18, P3022, DOI 10.1158/1078-0432.CCR-11-3216; Ene-Obong A, 2013, GASTROENTEROLOGY, V145, P1121, DOI 10.1053/j.gastro.2013.07.025; Facciabene A, 2012, CANCER RES, V72, P2162, DOI 10.1158/0008-5472.CAN-11-3687; Facciabene A, 2011, NATURE, V475, P226, DOI 10.1038/nature10169; Foley K, 2016, CANCER LETT, V381, P244, DOI 10.1016/j.canlet.2015.12.020; Generali D, 2009, CLIN CANCER RES, V15, P1046, DOI 10.1158/1078-0432.CCR-08-1507; Heinze E, 2009, INT J ONCOL, V35, P167, DOI 10.3892/ijo_00000325; Hinz S, 2007, CANCER RES, V67, P8344, DOI 10.1158/0008-5472.CAN-06-3304; Hiraoka N, 2006, CLIN CANCER RES, V12, P5423, DOI 10.1158/1078-0432.CCR-06-0369; Ino Y, 2013, BRIT J CANCER, V108, P914, DOI 10.1038/bjc.2013.32; Jacobs JFM, 2010, CLIN CANCER RES, V16, P5067, DOI 10.1158/1078-0432.CCR-10-1757; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Karanikas V, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-19; Kryczek I, 2009, CANCER RES, V69, P3995, DOI 10.1158/0008-5472.CAN-08-3804; Kurose K, 2015, CLIN CANCER RES, V21, P4327, DOI 10.1158/1078-0432.CCR-15-0357; Li X, 2007, CANCER LETT, V253, P144, DOI 10.1016/j.canlet.2007.01.024; Lin YC, 2009, J IMMUNOL, V182, P6095, DOI 10.4049/jimmunol.0803829; Lutz ER, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/21624011.2014.962401; Ma C, 2015, BIOCHEM BIOPH RES CO, V458, P234, DOI 10.1016/j.bbrc.2015.01.067; Martin F, 2010, ONCOGENE, V29, P4121, DOI 10.1038/onc.2010.174; Medema RH, 2012, ONCOGENE, V31, P2601, DOI 10.1038/onc.2011.451; Menetrier-Caux C, 2012, ONCOIMMUNOLOGY, V1, P759, DOI 10.4161/onci.19680; Moo-Young TA, 2009, J IMMUNOTHER, V32, P12, DOI 10.1097/CJI.0b013e318189f13c; Pastille E, 2014, CANCER RES, V74, P4258, DOI 10.1158/0008-5472.CAN-13-3065; Pillarisetty VG, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/21624011.2014.950171; Qin XJ, 2009, CLIN CANCER RES, V15, P2231, DOI 10.1158/1078-0432.CCR-08-2641; Righi E, 2011, CANCER RES, V71, P5522, DOI 10.1158/0008-5472.CAN-10-3143; Royal RE, 2010, J IMMUNOTHER, V33, P828, DOI 10.1097/CJI.0b013e3181eec14c; Schlecker E, 2012, J IMMUNOL, V189, P5602, DOI 10.4049/jimmunol.1201018; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Strauss L, 2009, J IMMUNOL, V182, P1469, DOI 10.4049/jimmunol.182.3.1469; Tan MCB, 2009, J IMMUNOL, V182, P1746, DOI 10.4049/jimmunol.182.3.1746; Tang YK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088267; Triulzi T, 2013, J CELL PHYSIOL, V228, P30, DOI 10.1002/jcp.24125; Trujillo G, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-18; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Vonderheide RH, 2013, CURR OPIN IMMUNOL, V25, P200, DOI 10.1016/j.coi.2013.01.006; Wang YP, 2014, CANCER RES, V74, P2217, DOI 10.1158/0008-5472.CAN-13-2928; Ward ST, 2015, BRIT J CANCER, V112, P319, DOI 10.1038/bjc.2014.572; Yamamoto T, 2012, PANCREAS, V41, P409, DOI 10.1097/MPA.0b013e3182373a66; Yang PY, 2012, CANCER CELL, V22, P291, DOI 10.1016/j.ccr.2012.07.023; Yoshii M, 2012, BRIT J CANCER, V106, P1668, DOI 10.1038/bjc.2012.141; Yurchenko E, 2006, J EXP MED, V203, P2451, DOI 10.1084/jem.20060956; Zhao TS, 2015, ONCOTARGET, V6, P2250, DOI 10.18632/oncotarget.2948; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	48	120	126	0	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 25	2017	36	21					3048	3058		10.1038/onc.2016.458	http://dx.doi.org/10.1038/onc.2016.458			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EV7ZP	27991933	Green Published, hybrid			2022-12-26	WOS:000402000400012
J	Dermit, M; Casado, P; Rajeeve, V; Wilkes, EH; Foxler, DE; Campbell, H; Critchlow, S; Sharp, TV; Gribben, JG; Unwin, R; Cutillas, PR				Dermit, M.; Casado, P.; Rajeeve, V.; Wilkes, E. H.; Foxler, D. E.; Campbell, H.; Critchlow, S.; Sharp, T. V.; Gribben, J. G.; Unwin, R.; Cutillas, P. R.			Oxidative stress downstream of mTORC1 but not AKT causes a proliferative defect in cancer cells resistant to PI3K inhibition	ONCOGENE			English	Article							IN-VITRO; MYC; EXPRESSION; THERAPY; REVEALS; PATHWAY; APOPTOSIS; HYPOXIA; SGK1	Compounds targeting phosphatidylinositol-3-kinase/mammalian target of rapamycin (PI3K/mTOR) signaling are being investigated in multiple clinical settings, but drug resistance may reduce their benefit. Compound rechallenge after drug holidays can overcome such resistance, yet little is known about the impact of drug holidays on cell biochemistry. We found that PI3K inhibitor (PI3Ki)-resistant cells cultured in the absence of PI3Ki developed a proliferative defect, increased oxygen consumption and accumulated reactive oxygen species (ROS), leading to lactate production through hypoxia-inducible factor-1 alpha. This metabolic imbalance was reversed by mammalian target of rapamycin complex 1 (mTORC1) inhibitors. Interestingly, neither AKT nor c-MYC was involved in mediating the metabolic phenotype, despite the latter contributing to resistant cells' proliferation. These data suggest that an AKT-independent PI3K/mTORC1 axis operates in these cells. The excessive ROS hampered cell division, and the metabolic phenotype made resistant cells more sensitive to hydrogen peroxide and nutrient starvation. Thus, the proliferative defect of PI3Ki-resistant cells during drug holidays is caused by defective metabolic adaptation to chronic PI3K/ mTOR pathway inhibition. This metabolic imbalance may open the therapeutic window for challenge with metabolic drugs during drug holidays.	[Dermit, M.; Casado, P.; Rajeeve, V.; Wilkes, E. H.; Cutillas, P. R.] Queen Mary Univ London, Barts Canc Inst, Ctr Haematooncol, Cell Signalling Prote, London, England; [Foxler, D. E.; Sharp, T. V.] Queen Mary Univ London, Barts Canc Inst, Ctr Mol Oncol, London, England; [Campbell, H.; Critchlow, S.] AstraZeneca, Oncol iMED, Macclesfield, Cheshire, England; [Gribben, J. G.] Queen Mary Univ London, Barts Canc Inst, Canc Immunol Grp, Ctr Haematooncol, London, England; [Unwin, R.] UCL, UCL Ctr Nephrol, Royal Free Campus & Hosp, London, England	University of London; Queen Mary University London; University of London; Queen Mary University London; AstraZeneca; University of London; Queen Mary University London; University of London; University College London	Cutillas, PR (corresponding author), Queen Mary Univ London, Barts Canc Inst, John Vane Sci Ctr, Charterhouse Sq, London EC1M 6BQ, England.	p.cutillas@qmul.ac.uk	Izquierdo, Pedro Casado/AAD-9960-2021; Dermit, Maria/AAH-9618-2019; Sharp, Tyson/AAD-6190-2020	Izquierdo, Pedro Casado/0000-0002-4207-9349; Sharp, Tyson/0000-0003-1861-7984; Foxler, Daniel/0000-0003-3753-0278; Dermit, Maria/0000-0002-6287-8367	St Peters Trust; Barts and The London Charity [BLT 297/2249]; BBSRC [BB/M006174/1]; BBSRC [BB/G015023/1, BB/L027755/1] Funding Source: UKRI; MRC [MR/N009185/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L027755/1, BB/M006174/1, BB/G015023/1] Funding Source: researchfish; Cancer Research UK [12733] Funding Source: researchfish; Medical Research Council [MR/N009185/1] Funding Source: researchfish	St Peters Trust; Barts and The London Charity; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Gemma Bridge for advice with Seahorse experiments and Dr Soong and Dr Baselga for kindly providing LB771-HNC, CAL33, KYSE70 and KYSE180 parental/resistant pairs of cells. This work was supported by St Peters Trust and Barts and The London Charity (BLT 297/2249). PRC was supported by BBSRC Grant BB/M006174/1	Anacker C, 2013, P NATL ACAD SCI USA, V110, P8708, DOI 10.1073/pnas.1300886110; Bey EA, 2007, P NATL ACAD SCI USA, V104, P11832, DOI 10.1073/pnas.0702176104; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; Carracedo A, 2008, CELL CYCLE, V7, P3805, DOI 10.4161/cc.7.24.7244; Chmielecki J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002356; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Das Thakur M, 2013, CANCER RES, V73, P6106, DOI 10.1158/0008-5472.CAN-13-1633; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; De Saedeleer CJ, 2014, ONCOGENE, V33, P4060, DOI 10.1038/onc.2013.454; Elkabets M, 2015, CANCER CELL, V27, P533, DOI 10.1016/j.ccell.2015.03.010; Follis AV, 2008, CHEM BIOL, V15, P1149, DOI 10.1016/j.chembiol.2008.09.011; Foxler DE, 2012, NAT CELL BIOL, V14, P201, DOI 10.1038/ncb2424; Friedman AA, 2015, NAT REV CANCER, V15, P747, DOI 10.1038/nrc4015; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Gilmartin AG, 2011, CLIN CANCER RES, V17, P989, DOI 10.1158/1078-0432.CCR-10-2200; GUPTA S, 1993, P NATL ACAD SCI USA, V90, P3216, DOI 10.1073/pnas.90.8.3216; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanfstein B, 2011, HAEMATOL-HEMATOL J, V96, P360, DOI 10.3324/haematol.2010.030999; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Huang MJ, 2006, EXP HEMATOL, V34, P1480, DOI 10.1016/j.exphem.2006.06.019; Ilic N, 2011, P NATL ACAD SCI USA, V108, pE699, DOI 10.1073/pnas.1108237108; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kessler J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-605; Kim SY, 2006, EXP MOL MED, V38, P535, DOI 10.1038/emm.2006.63; Lindsley CW, 2005, BIOORG MED CHEM LETT, V15, P761, DOI 10.1016/j.bmcl.2004.11.011; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Liu PX, 2011, NAT MED, V17, P1116, DOI 10.1038/nm.2402; Mahalingaiah PKS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087371; Marin-Hernandez A, 2009, MINI-REV MED CHEM, V9, P1084, DOI 10.2174/138955709788922610; Miskimins WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085576; Muellner MK, 2011, NAT CHEM BIOL, V7, P787, DOI 10.1038/nchembio.695; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; OMURA S, 1976, BACTERIOL REV, V40, P681, DOI 10.1128/MMBR.40.3.681-697.1976; Park HS, 2004, MOL CELL BIOL, V24, P4384, DOI 10.1128/MCB.24.10.4384-4394.2004; Park JH, 2013, BIOCHEM BIOPH RES CO, V433, P420, DOI 10.1016/j.bbrc.2013.02.108; Piguet AC, 2014, CLIN SCI, V126, P775, DOI 10.1042/CS20130081; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Rehan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109705; Sceneay J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066388; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Sommer EM, 2013, BIOCHEM J, V452, P499, DOI 10.1042/BJ20130342; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; Tagami M, 1998, LAB INVEST, V78, P1415; Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Widlansky ME, 2011, ANTIOXID REDOX SIGN, V15, P1517, DOI 10.1089/ars.2010.3642; Wilkes EH, 2015, P NATL ACAD SCI USA, V112, P7719, DOI 10.1073/pnas.1423344112; Zhu CP, 2014, SCI REP-UK, V4, DOI 10.1038/srep05029	50	14	14	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 11	2017	36	19					2762	2774		10.1038/onc.2016.435	http://dx.doi.org/10.1038/onc.2016.435			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EU6CF	27991931	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000401120900013
J	Baker, ST; Grill, B				Baker, Scott T.; Grill, Brock			Defining Minimal Binding Regions in Regulator of Presynaptic Morphology 1 (RPM-1) Using Caenorhabditis elegans Neurons Reveals Differential Signaling Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE COMPLEX; SYNAPTIC TERMINAL GROWTH; MAP KINASE PATHWAY; PHR PROTEIN RPM-1; C-ELEGANS; AXON TERMINATION; GENE-TRANSFER; HIGHWIRE; DROSOPHILA; SYNAPTOGENESIS	The intracellular signaling protein regulator of presynaptic morphology 1 (RPM-1) is a conserved regulator of synapse formation and axon termination in Caenorhabditis elegans. RPM-1 functions in a ubiquitin ligase complex with the F-box protein FSN-1 and functions through the microtubule binding protein RAE-1. Using a structure-function approach and positive selection for transgenic C. elegans, we explored the biochemical relationship between RPM-1, FSN-1, and RAE-1. This led to the identification of two new domains in RPM-1 that are sufficient for binding to FSN-1, called FSN-1 binding domain 2 (FBD2) and FBD3. Furthermore, we map the RAE-1 binding domain to a much smaller region of RPM-1. Point mutations in RPM-1 that reduce binding to RAE-1 did not affect FSN-1 binding, indicating that RPM-1 utilizes different biochemical mechanisms to bind these molecules. Analysis of RPM-1 protein complexes in the neurons of C. elegans elucidated two further discoveries: FSN-1 binds to RAE-1, and this interaction is not mediated by RPM-1, and RPM-1 binding to FSN-1 and RAE-1 reduces FSN-1.RAE-1 complex formation. These results indicate that RPM-1 uses different mechanisms to recruit FSN-1 and RAE-1 into independent signaling complexes in neurons.	[Baker, Scott T.; Grill, Brock] Scripps Florida, Scripps Res Inst, Dept Neurosci, 130 Scripps Way, Jupiter, FL 33458 USA	Scripps Research Institute; State University System of Florida; University of Florida	Grill, B (corresponding author), Scripps Florida, Scripps Res Inst, Dept Neurosci, 130 Scripps Way, Jupiter, FL 33458 USA.	bgrill@scripps.edu		Grill, Brock/0000-0002-0379-3267	National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072129] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health Office of Research Infrastructure Programs; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the C. elegans knockout consortium for generating alleles and the C. elegans Genetics Center for providing strains (National Institutes of Health Office of Research Infrastructure Programs, P40 OD010440).	Abrams B, 2008, DEV DYNAM, V237, P630, DOI 10.1002/dvdy.21446; Babetto E, 2013, CELL REP, V3, P1422, DOI 10.1016/j.celrep.2013.04.013; Baker ST, 2015, GENETICS, V199, P151, DOI 10.1534/genetics.114.170589; Baker ST, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004297; Bloom AJ, 2007, GENE DEV, V21, P2593, DOI 10.1101/gad.1592107; Brace EJ, 2014, J NEUROSCI, V34, P8398, DOI 10.1523/JNEUROSCI.4715-13.2014; BRENNER S, 1974, GENETICS, V77, P71; Burgess RW, 2004, MOL CELL BIOL, V24, P1096, DOI 10.1128/MCB.24.3.1096-1105.2004; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Giles AC, 2015, G3-GENES GENOM GENET, V5, P2745, DOI 10.1534/g3.115.021410; GRANATO M, 1994, NUCLEIC ACIDS RES, V22, P1762, DOI 10.1093/nar/22.9.1762; Grill B, 2007, NEURON, V55, P587, DOI 10.1016/j.neuron.2007.07.009; Grill B, 2016, NEURAL DEV, V11, DOI 10.1186/s13064-016-0063-0; Grill B, 2012, J NEUROSCI, V32, P2628, DOI 10.1523/JNEUROSCI.2901-11.2012; Huntwork-Rodriguez S, 2013, J CELL BIOL, V202, P747, DOI 10.1083/jcb.201303066; Kim JH, 2013, NEURON, V78, P827, DOI 10.1016/j.neuron.2013.05.020; Lewcock JW, 2007, NEURON, V56, P604, DOI 10.1016/j.neuron.2007.09.009; Li H.T., 2008, INT WORKSH EARTH OBS, V1, P1, DOI DOI 10.1117/1.2943286; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Opperman KJ, 2014, NEURAL DEV, V9, DOI 10.1186/1749-8104-9-10; Po MD, 2010, CURR OPIN NEUROBIOL, V20, P100, DOI 10.1016/j.conb.2009.12.007; Saiga T, 2009, MOL CELL BIOL, V29, P3529, DOI 10.1128/MCB.00364-09; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Sharma J, 2014, J BIOL CHEM, V289, P34654, DOI 10.1074/jbc.M114.614065; Shin JE, 2011, J NEUROSCI, V31, P17689, DOI 10.1523/JNEUROSCI.3902-11.2011; Tian XL, 2011, NAT NEUROSCI, V14, P1267, DOI 10.1038/nn.2922; Tulgren ED, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004481; Tulgren ED, 2011, GENETICS, V189, P1297, DOI 10.1534/genetics.111.134791; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wu CL, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-16; Xiong X, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001440; Yan D, 2009, CELL, V138, P1005, DOI 10.1016/j.cell.2009.06.023; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8	35	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2519	2530		10.1074/jbc.M116.748004	http://dx.doi.org/10.1074/jbc.M116.748004			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	27979965	hybrid, Green Published			2022-12-26	WOS:000395530300038
J	Li, JJ; Sun, ZJ; Yuan, YM; Yin, FF; Bian, YG; Long, LY; Zhang, XL; Xie, D				Li, Jing-Jing; Sun, Zhi-Jian; Yuan, Yan-Mei; Yin, Fen-Fen; Bian, Yao-Gang; Long, Ling-Yun; Zhang, Xue-li; Xie, Dong			EphB3 Stimulates Cell Migration and Metastasis in a Kinase-dependent Manner through Vav2-Rho GTPase Axis in Papillary Thyroid Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTORS; RECEPTOR TYROSINE KINASES; MEMBRANE PROTRUSION; TUMOR-METASTASIS; MULTIPLE ROLES; GROWTH-FACTOR; RHO-GTPASES; CARCINOMA; ADHESION; EPHRINS	Eph receptors, the largest subfamily of transmembrane tyrosine kinase receptors, have been increasingly implicated in various physiologic and pathologic processes, and the roles of the Eph family members during tumorigenesis have recently attracted growing attentions. In the present study, we explored the function of EphB3, one member of Eph family, in papillary thyroid cancer (PTC). We found that the expression of EphB3 was significantly elevated in PTC. Either overexpression of EphB3 or activation of EphB3 by EfnB1-Fc/EfnB2-Fc stimulated in vitro migration of PTC cells. In contrast, siRNA-mediated knockdown of EphB3 or EphB3-Fc treatment, which only blocked EphB3-mediated forward signaling, inhibited migration and metastasis of PTC cells. A mechanism study revealed that EphB3 knockdown led to suppressed activity of Rac1 and enhanced activity of RhoA. Moreover, we found that Vav2, an important regulator of Rho family GTPases, was activated by EphB3 in a kinase-dependent manner. Altogether, our work suggested that EphB3 acted as a tumor promoter in PTC by increasing the in vitro migration as well as the in vivo metastasis of PTC cells through regulating the activities of Vav2 and Rho GTPases in a kinase-dependent manner.	[Li, Jing-Jing; Sun, Zhi-Jian; Yuan, Yan-Mei; Yin, Fen-Fen; Long, Ling-Yun; Xie, Dong] Chinese Acad Sci, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Bian, Yao-Gang; Zhang, Xue-li] Southern Med Univ, Dept Gen Surg, Fengxian Hosp, 6600 Nanfeng Rd, Shanghai 201499, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Southern Medical University - China	Zhang, XL (corresponding author), Southern Med Univ, Dept Gen Surg, Fengxian Hosp, 6600 Nanfeng Rd, Shanghai 201499, Peoples R China.; Xie, D (corresponding author), Chinese Acad Sci, Mol Oncol Lab, Inst Nutr Sci, Shanghai Inst Biol Sci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	lejing1996@aliyun.com; dxie@sibs.ac.cn	Long, Lingyun/C-2455-2019	Long, Lingyun/0000-0002-8565-4948; Xie, Dong/0000-0002-1150-8657; Xie, Dong/0000-0003-2804-8578	National Basic Research Program of China [2010CB912102]; Ministry of Science and Technology Key Program [2012ZX10002009-017]; National Natural Science Foundation of China [81230058, 81321062, 30930023, 31100551, 31201046, 81021002, 31520103907]; CAS/SAFEA International Partnership Program for Creative Research Teams; Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [SIBS2012004]; Technology Commission of Shanghai Municipality [12XD1405600]; National Science Foundation of China [31201046]; Sanofi-Aventis-Sibs Scholarship Program	National Basic Research Program of China(National Basic Research Program of China); Ministry of Science and Technology Key Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences); Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences(Chinese Academy of Sciences); Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sanofi-Aventis-Sibs Scholarship Program	This work was supported by the National Basic Research Program of China (2010CB912102), Ministry of Science and Technology Key Program (2012ZX10002009-017), the National Natural Science Foundation of China (81230058, 81321062, 30930023, 31100551, 31201046, 81021002, 31520103907), CAS/SAFEA International Partnership Program for Creative Research Teams, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (SIBS2012004), and Technology Commission of Shanghai Municipality (12XD1405600) (to D. X.). This work was also supported by Young Scientist Fund of National Science Foundation of China (31201046) and Sanofi-Aventis-Sibs Scholarship Program (2011) (to J.-J.L.). The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], 1997, Cell, V90, P403; Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; BRAMBILLA R, 1995, EMBO J, V14, P3116, DOI 10.1002/j.1460-2075.1995.tb07314.x; Brambilla R, 1996, MOL CELL NEUROSCI, V8, P199, DOI 10.1006/mcne.1996.0057; Brantley-Sieders DM, 2006, CANCER RES, V66, P10315, DOI 10.1158/0008-5472.CAN-06-1560; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Cantisani MC, 2016, ONCOTARGET, V7, P28510, DOI 10.18632/oncotarget.8577; Caron E, 2003, NAT CELL BIOL, V5, P185, DOI 10.1038/ncb0303-185; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Castellone MD, 2008, BEST PRACT RES CL EN, V22, P1023, DOI 10.1016/j.beem.2008.09.012; Cortina C, 2007, NAT GENET, V39, P1376, DOI 10.1038/ng.2007.11; Cowan CW, 2005, NEURON, V46, P205, DOI 10.1016/j.neuron.2005.03.019; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; DULGEROFF AJ, 1994, ENDOCR REV, V15, P500, DOI 10.1210/edrv-15-4-500; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Eustatia-Rutten CFA, 2006, J CLIN ENDOCR METAB, V91, P313, DOI 10.1210/jc.2005-1322; Farivar RS, 2003, J SURG RES, V115, P219, DOI 10.1016/S0022-4804(03)00246-4; Garrett TA, 2007, EXP CELL RES, V313, P3285, DOI 10.1016/j.yexcr.2007.05.027; Gimm O, 2001, CANCER LETT, V163, P143, DOI 10.1016/S0304-3835(00)00697-2; Heo J, 2005, BIOCHEMISTRY-US, V44, P6573, DOI 10.1021/bi047443q; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Huang J, 2014, ONCOGENE, V33, P2737, DOI 10.1038/onc.2013.238; Hundahl SA, 2000, CANCER-AM CANCER SOC, V89, P202, DOI 10.1002/1097-0142(20000701)89:1<202::AID-CNCR27>3.0.CO;2-A; Hunter SG, 2006, MOL CELL BIOL, V26, P4830, DOI 10.1128/MCB.02215-05; Ji XD, 2011, CANCER RES, V71, P1156, DOI 10.1158/0008-5472.CAN-10-0717; Karidis NP, 2011, MED SCI MONITOR, V17, pBR257, DOI 10.12659/MSM.881929; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Lang BHH, 2007, ANN SURG ONCOL, V14, P730, DOI 10.1245/s10434-006-9207-5; Liu DP, 2007, INT J ONCOL, V30, P865; von Zangen IL, 2007, ACTA NEUROPATHOL, V113, P325, DOI 10.1007/s00401-006-0190-5; Mazzaferri EL, 2001, J CLIN ENDOCR METAB, V86, P1447, DOI 10.1210/jc.86.4.1447; Meyer S, 2005, INT J ONCOL, V27, P1197; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; Nemoto T, 1997, PATHOBIOLOGY, V65, P195, DOI 10.1159/000164123; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Palmer A, 2003, GENE DEV, V17, P1429, DOI 10.1101/gad.1093703; Parri M, 2007, J BIOL CHEM, V282, P19619, DOI 10.1074/jbc.M701319200; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sastry SK, 2006, J BIOL CHEM, V281, P11627, DOI 10.1074/jbc.M600897200; Sherman SI, 1998, CANCER-AM CANCER SOC, V83, P1012; Surawska H, 2004, CYTOKINE GROWTH F R, V15, P419, DOI 10.1016/j.cytogfr.2004.09.002; Tamas P, 2003, J BIOL CHEM, V278, P5163, DOI 10.1074/jbc.M207555200; Tamas P, 2001, CELL SIGNAL, V13, P475, DOI 10.1016/S0898-6568(01)00172-3; Wang HY, 2014, INT J CLIN EXP PATHO, V7, P313; Wennerberg K, 2002, J BIOL CHEM, V277, P47810, DOI 10.1074/jbc.M203816200; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Wimmer-Kleikamp SH, 2005, IUBMB LIFE, V57, P421, DOI 10.1080/15216540500138337; Wu B, 2016, ANTICANCER RES, V36, P1211; Yin H, 2013, CANCER BIOMARK, V13, P261, DOI 10.3233/CBM-130356	52	12	13	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					1112	1121		10.1074/jbc.M116.750349	http://dx.doi.org/10.1074/jbc.M116.750349			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27986811	hybrid, Green Published			2022-12-26	WOS:000392318700030
J	Badin, PM; Sopariwala, DH; Lorca, S; Narkar, VA				Badin, Pierre-Marie; Sopariwala, Danesh H.; Lorca, Sabina; Narkar, Vihang A.			Muscle Arnt/Hif1 beta Is Dispensable in Myofiber Type Determination, Vascularization and Insulin Sensitivity	PLoS One			English	Article							RECEPTOR NUCLEAR TRANSLOCATOR; ARYL-HYDROCARBON RECEPTOR; HIGH-FAT DIET; SKELETAL-MUSCLE; OXIDATIVE CAPACITY; GENE-EXPRESSION; CELL VIABILITY; LIMB ISCHEMIA; IN-VIVO; ANGIOGENESIS	Aryl Hydrocarbon Receptor Nuclear Translocator/hypoxia-inducible factor 1 beta (ARNT/HIF1 beta), a member of bHLH-PAS family of transcriptional factors, plays a critical role in metabolic homeostasis, insulin resistance and glucose intolerance. The contributions of ARNT in pancreas, liver and adipose tissue to energy balance through gene regulation have been described. Surprisingly, the impact of ARNT signaling in the skeletal muscles, one of the major organs involved in glucose disposal, has not been investigated, especially in type II diabetes. Here we report that ARNT is expressed in the skeletal muscles, particularly in the energy-efficient oxidative slow-twitch myofibers, which are characterized by increased oxidative capacity, mitochondrial content, vascular supply and insulin sensitivity. However, muscle-specific deletion of ARNT did not change myofiber type distribution, oxidative capacity, mitochondrial content, capillarity, or the expression of genes associated with these features. Consequently, the lack of ARNT in the skeletal muscle did not affect weight gain, lean/fat mass, insulin sensitivity and glucose tolerance in lean mice, nor did it impact insulin resistance and glucose intolerance in high fat diet-induced obesity. Therefore, skeletal muscle ARNT is dispensable for controlling muscle fiber type and metabolic regulation, as well as diet-induced weight control, insulin sensitivity and glucose tolerance.	[Badin, Pierre-Marie; Sopariwala, Danesh H.; Lorca, Sabina; Narkar, Vihang A.] UTHealth, McGovern Med Sch, Brown Fdn Inst Mol Med, Metab & Degenerat Dis, Houston, TX 77058 USA; [Narkar, Vihang A.] UTHealth, McGovern Med Sch, Integrat Biol & Pharmacol, Houston, TX 77058 USA; [Narkar, Vihang A.] UTHealth, McGovern Med Sch, Grad Sch Biomed Sci, Houston, TX 77058 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Narkar, VA (corresponding author), UTHealth, McGovern Med Sch, Brown Fdn Inst Mol Med, Metab & Degenerat Dis, Houston, TX 77058 USA.; Narkar, VA (corresponding author), UTHealth, McGovern Med Sch, Integrat Biol & Pharmacol, Houston, TX 77058 USA.; Narkar, VA (corresponding author), UTHealth, McGovern Med Sch, Grad Sch Biomed Sci, Houston, TX 77058 USA.	vihang.a.narkar@uth.tmc.edu			UTHealth; Welch Foundation endowment in Chemistry & Related Science [L-AU-0002]; American Diabetes Association (ADA) [1-13-BS-127]; National Institute of Health/National Heart Lung and Blood Institute [1 R01 HL129191-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL129191] Funding Source: NIH RePORTER	UTHealth; Welch Foundation endowment in Chemistry & Related Science; American Diabetes Association (ADA)(American Diabetes Association); National Institute of Health/National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by UTHealth intramural funds and The Welch Foundation endowment in Chemistry & Related Science (#L-AU-0002), as well as grants from American Diabetes Association (ADA#1-13-BS-127) and National Institute of Health/National Heart Lung and Blood Institute (1 R01 HL129191-01) to V.A.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers PH, 2015, DIABETES, V64, P485, DOI 10.2337/db14-0590; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Badin PM, 2016, SCI REP-UK, V6, DOI 10.1038/srep26442; Badin PM, 2013, ENDOCRINOLOGY, V154, P1444, DOI 10.1210/en.2012-2029; Bajpeyi S, 2012, APPL PHYSIOL NUTR ME, V37, P822, DOI [10.1139/h2012-051, 10.1139/H2012-051]; Cheng K, 2010, J CLIN INVEST, V120, P2171, DOI 10.1172/JCI35846; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Goodpaster BH, 2014, DIABETES, V63, P2611, DOI 10.2337/db14-0277; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Han Y, 2012, ANGIOGENESIS, V15, P409, DOI 10.1007/s10456-012-9269-x; Iossa S, 2002, INT J OBESITY, V26, P65, DOI 10.1038/sj.ijo.0801844; Jiang CT, 2011, DIABETES, V60, P2484, DOI 10.2337/db11-0174; Krock BL, 2015, BLOOD, V125, P3263, DOI 10.1182/blood-2014-10-607267; LaGory EL, 2015, CELL REP, V12, P116, DOI 10.1016/j.celrep.2015.06.006; Lalwani A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098435; Lau SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077419; Lee KY, 2011, CELL METAB, V14, P491, DOI 10.1016/j.cmet.2011.08.006; Li MY, 2011, MICROVASC RES, V81, P26, DOI 10.1016/j.mvr.2010.09.008; Lindholm ME, 2016, EXP PHYSIOL, V101, P28, DOI 10.1113/EP085318; MacKrell JG, 2012, J GERONTOL A-BIOL, V67, P1286, DOI 10.1093/gerona/gls194; Majmundar AJ, 2015, DEVELOPMENT, V142, P2405, DOI 10.1242/dev.123026; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Mandl M, 2014, MOL MED, V20, P215, DOI 10.2119/molmed.2014.00032; Mason SD, 2004, PLOS BIOL, V2, P1540, DOI 10.1371/journal.pbio.0020288; Matsakas A, 2013, FASEB J, V27, P4004, DOI 10.1096/fj.13-228296; Matsakas A, 2012, CIRC RES, V110, P1087, DOI 10.1161/CIRCRESAHA.112.266478; Milkiewicz M, 2004, J PHYSIOL-LONDON, V560, P21, DOI 10.1113/jphysiol.2004.069757; Niemi H, 2014, EUR J CLIN INVEST, V44, P989, DOI 10.1111/eci.12333; Ouma GO, 2014, J VASC SURG, V59, P786, DOI 10.1016/j.jvs.2013.04.043; Pajusola K, 2005, FASEB J, V19, P1365, DOI 10.1096/fj.05-3720fje; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Rasbach KA, 2010, P NATL ACAD SCI USA, V107, P21866, DOI 10.1073/pnas.1016089107; Saito Yasuko, 1993, Hokkaido Journal of Medical Science, V68, P190; Sarkar K, 2009, P NATL ACAD SCI USA, V106, P18769, DOI 10.1073/pnas.0910561106; Silvennoinen M, 2013, ANGIOGENESIS, V16, P297, DOI 10.1007/s10456-012-9315-8; STURCHLER C, 1992, NUCLEIC ACIDS RES, V20, P1215, DOI 10.1093/nar/20.6.1215; Thomas MM, 2014, PHYSL REP; Tomita S, 2000, MOL ENDOCRINOL, V14, P1674, DOI 10.1210/me.14.10.1674; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Vila IK, 2014, CELL REP, V7, P1116, DOI 10.1016/j.celrep.2014.03.062; Wang XL, 2009, CELL METAB, V9, P428, DOI 10.1016/j.cmet.2009.04.001; Wu RX, 2014, J CLIN INVEST, V124, P4795, DOI 10.1172/JCI76737; Yadav V, 2014, CELL REP, V8, P783, DOI 10.1016/j.celrep.2014.06.040	43	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168457	10.1371/journal.pone.0168457	http://dx.doi.org/10.1371/journal.pone.0168457			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005939	Green Published, Green Submitted, gold			2022-12-26	WOS:000392843200053
J	Harada, T; Taniguchi, F; Onishi, K; Kurozawa, Y; Hayashi, K; Harada, T				Harada, Takashi; Taniguchi, Fuminori; Onishi, Kazunari; Kurozawa, Youichi; Hayashi, Kunihiko; Harada, Tasuku		Japan Environm Children's Study Gr	Obstetrical Complications in Women with Endometriosis: A Cohort Study in Japan	PLOS ONE			English	Article							ASSISTED REPRODUCTIVE TECHNOLOGY; ADVERSE PREGNANCY OUTCOMES; PERITONEAL-FLUID; SINGLETON PREGNANCIES; INFERTILE PATIENTS; EMBRYO-TRANSFER; EXPRESSION; RISK; PROSTAGLANDINS; MECHANISMS	Background Endometriosis, which occurs in approximately 10% of women of reproductive age, is defined as the presence of endometrial tissue outside the uterus. Women with endometriosis are more likely to have difficulty conceiving and tend to receive infertility treatment, including assisted reproductive technology (ART) therapy. There has not yet been a prospective cohort study examining the effects of endometriosis on pregnancy outcome in pregnant Japanese women. Methodology This was a prospective cohort study of the incidence of obstetrical complications in women with endometriosis using data of the Japan Environment & Children's Study (JECS). Included in this study were 9,186 pregnant women in the JECS with or without a history of endometriosis who gave birth or stillbirth or whose pregnancy was terminated with abortion between February and December 2011. Main Outcome Measures The effects of endometriosis on pregnancy outcome. Results Of the 9,186 pregnant women in the JECS, 4,119 (44.8%) had obstetrical complications; 330 participants reported a diagnosis of endometriosis before pregnancy, and these women were at higher risk for complications of pregnancy than those without a history of endometriosis (odds ratio (OR) = 1.50; 95% confidence interval (Cl) 1.20 to 1.87). Logistic regression analyses showed that the adjusted OR for obstetrical complications of pregnant women who conceived naturally and had a history of endometriosis was 1.45 (Cl 1.11 to 1.90). Among pregnant women with endometriosis, the ORs of preterm premature rupture of the membranes (PROM) and placenta previa were significantly higher compared with women never diagnosed with endometriosis who conceived naturally or conceived after infertility treatment, except for ART therapy (OR 2.14, CI 1.03-4.45 and OR 3.37, CI 1.32-8.65). Conclusions This study showed that endometriosis significantly increased the incidence of preterm PROM and placenta previa after adjusting for confounding of the data by ART therapy.	[Harada, Takashi; Taniguchi, Fuminori; Harada, Tasuku] Tottori Univ, Fac Med, Dept Obstet & Gynecol, Yonago, Tottori, Japan; [Onishi, Kazunari; Kurozawa, Youichi] Tottori Univ, Fac Med, Dept Publ Hlth, Yonago, Tottori, Japan; [Hayashi, Kunihiko] Gunma Univ, Grad Sch Hlth Sci, Dept Lab Sci & Environm Hlth Sci, Maebashi, Gunma, Japan	Tottori University; Tottori University; Gunma University	Harada, T (corresponding author), Tottori Univ, Fac Med, Dept Obstet & Gynecol, Yonago, Tottori, Japan.	tasuku@med.tottori-u.ac.jp	一成, 大西/D-7193-2019	一成, 大西/0000-0001-5791-4418; Hayashi, Kunihiko/0000-0003-4648-3936; Saito, Hirohisa/0000-0002-6630-8337	Ministry of the Environment, the Government of Japan	Ministry of the Environment, the Government of Japan	The Japan Environment and Children's Study was funded by the Ministry of the Environment, the Government of Japan.	Aris A, 2014, GYNECOL ENDOCRINOL, V30, P34, DOI 10.3109/09513590.2013.848425; BADAWY SZA, 1982, FERTIL STERIL, V38, P166; Benaglia L, 2012, HUM REPROD, V27, P1663, DOI 10.1093/humrep/des054; Brosens I, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.02.024; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Fanchin R, 1998, HUM REPROD, V13, P1968, DOI 10.1093/humrep/13.7.1968; Fernando S, 2009, FERTIL STERIL, V91, P325, DOI 10.1016/j.fertnstert.2008.01.096; FRASER IS, 1992, BAILLIERE CLIN OB GY, V6, P829, DOI 10.1016/S0950-3552(05)80191-9; Harada T, 1997, AM J OBSTET GYNECOL, V176, P593, DOI 10.1016/S0002-9378(97)70553-2; Hayashi M, 2012, FERTIL STERIL, V98, P922, DOI 10.1016/j.fertnstert.2012.05.049; Horcajadas JA, 2005, MOL HUM REPROD, V11, P195, DOI 10.1093/molehr/gah150; Iwabe T, 1998, FERTIL STERIL, V69, P924, DOI 10.1016/S0015-0282(98)00049-1; Izawa M, 2008, FERTIL STERIL, V89, P1390, DOI 10.1016/j.fertnstert.2007.03.078; Kanatani KT, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004863; Kawamoto T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-25; Khine Yin Mon, 2016, Reproductive Medicine and Biology, V15, P217, DOI 10.1007/s12522-016-0237-9; Kortelahti M, 2003, GYNECOL OBSTET INVES, V56, P207, DOI 10.1159/000074815; Maggiore ULR, 2015, HUM REPROD, V30, P299, DOI 10.1093/humrep/deu308; Maggiore ULR, 2016, HUM REPROD UPDATE, V22, P70, DOI 10.1093/humupd/dmv045; Mansour R, 2005, HUM REPROD, V20, P170, DOI 10.1093/humrep/deh573; Mekaru K, 2014, EUR J OBSTET GYN R B, V172, P36, DOI 10.1016/j.ejogrb.2013.10.024; Minakami H, 2011, J OBSTET GYNAECOL RE, V37, P1174, DOI 10.1111/j.1447-0756.2011.01653.x; Osteen KG, 1996, SEMIN REPROD ENDOCR, V14, P247, DOI 10.1055/s-2007-1016334; Pizzo A, 2002, GYNECOL OBSTET INVES, V54, P82, DOI 10.1159/000067717; Qin JB, 2016, FERTIL STERIL, V105, P73, DOI 10.1016/j.fertnstert.2015.09.007; Rosenberg T, 2011, ARCH GYNECOL OBSTET, V284, P47, DOI 10.1007/s00404-010-1598-7; Sales KJ, 2003, REPRODUCTION, V126, P559, DOI 10.1530/rep.0.1260559; Smith R, 2007, NEW ENGL J MED, V356, P271, DOI 10.1056/NEJMra061360; Stephansson O, 2009, HUM REPROD, V24, P2341, DOI 10.1093/humrep/dep186; Van Holsbeke C, 2010, ULTRASOUND OBST GYN, V35, P730, DOI 10.1002/uog.7668; Wu Y, 2006, ENDOCRINOLOGY, V147, P232, DOI 10.1210/en.2005-0426	31	46	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168476	10.1371/journal.pone.0168476	http://dx.doi.org/10.1371/journal.pone.0168476			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005934	Green Submitted, Green Published, gold			2022-12-26	WOS:000392843200059
J	Dhurmeea, Z; Zudaire, I; Chassot, E; Cedras, M; Nikolic, N; Bourjea, J; West, W; Appadoo, C; Bodin, N				Dhurmeea, Zahirah; Zudaire, Iker; Chassot, Emmanuel; Cedras, Maria; Nikolic, Natacha; Bourjea, Jerome; West, Wendy; Appadoo, Chandani; Bodin, Nathalie			Reproductive Biology of Albacore Tuna (Thunnus alalunga) in the Western Indian Ocean	PLOS ONE			English	Article							SWORDFISH XIPHIAS-GLADIUS; COD GADUS-MORHUA; SPAWNING FREQUENCY; BATCH FECUNDITY; YELLOWFIN TUNA; BLUEFIN TUNA; KATSUWONUS-PELAMIS; SEXUAL-MATURITY; SKIPJACK TUNA; L.	The reproductive biology of albacore tuna, Thunnus alalunga, in the western Indian Ocean was examined through analysis of the sex ratio, spawning season, length-at-maturity (L-50), spawning frequency and fecundity. From 2013 to 2015, a total of 923 female and 867 male albacore were sampled. A bias in sex ratio was found in favor of females with fork length (L-F) < 100 cm. Using histological analyses and gonadosomatic index, spawning was found to occur between 10 degrees S and 30 degrees S, mainly to the east of Madagascar from October to January. Large females contributed more to reproduction through their longer spawning period compared to small individuals. The L-50 (mean standard error) of female albacore was estimated at 85.3 +/- 0.7 cm LF. Albacore spawn on average every 2.2 days within the spawning region and spawning months, from November to January. Batch fecundity ranged between 0.26 and 2.09 million oocytes and the relative batch fecundity (mean standard deviation) was estimated at 53.4 +/- 23.2 oocytes g(-1) of somatic-gutted weight. The study provides new information on the reproductive development and classification of albacore in the western Indian Ocean. The reproductive parameters will reduce uncertainty in current stock assessment models which will eventually assist the fishery to be sustainable for future generations.	[Dhurmeea, Zahirah] Univ Mauritius, Fac Sci, Dept Biosci, Reduit, Mauritius; [Dhurmeea, Zahirah; Zudaire, Iker; Chassot, Emmanuel; Bodin, Nathalie] IRD Res Unit MARine Biodivers Exploitat & Conserv, Victoria, Mahe, Seychelles; [Zudaire, Iker] Basque Fdn Sci, Ikerbasque, Bilbao, Spain; [Chassot, Emmanuel; Cedras, Maria; Bodin, Nathalie] SFA, Victoria, Mahe, Seychelles; [Nikolic, Natacha] IFREMER, DOI Reunion, F-97822 Le Port, Reunion, France; [Bourjea, Jerome] IFREMER, Res Unit MARine Biodivers Exploitat & Con, F-34203 Sete, France; [West, Wendy] DAFF, Cape Town, South Africa; [Appadoo, Chandani] Univ Mauritius, Dept Marine & Ocean Sci, Fisheries & Mariculture, Fac Ocean Studies, Reduit, Mauritius	University of Mauritius; Ifremer; Basque Foundation for Science; Ifremer; Ifremer; University of Mauritius	Dhurmeea, Z (corresponding author), Univ Mauritius, Fac Sci, Dept Biosci, Reduit, Mauritius.; Dhurmeea, Z (corresponding author), IRD Res Unit MARine Biodivers Exploitat & Conserv, Victoria, Mahe, Seychelles.	dzahirah@hotmail.com	Bodin, Nathalie/D-2184-2009; Dhurmeea, Zahirah/AAL-4006-2021	Bourjea, Jerome/0000-0001-7149-3648; Natacha, Nikolic/0000-0002-6055-0923; Zudaire, Iker/0000-0002-4249-4622; CHASSOT, Emmanuel/0000-0002-6779-4955; Bodin, Nathalie/0000-0001-8464-0213	"Allocations de Recherche pour une These au Sud" (ARTS) programme of the French Institute of Research for Development (IRD); Western Indian Ocean Marine Science Association (WIOMSA); European Data Collection Framework (EU DCF project) [199/2008, 665/2008]; Fisheries European Funds (EU FEP) [759/DMSOI/2013]; Seychelles Fishing Authority (SFA); University of Mauritius	"Allocations de Recherche pour une These au Sud" (ARTS) programme of the French Institute of Research for Development (IRD); Western Indian Ocean Marine Science Association (WIOMSA); European Data Collection Framework (EU DCF project); Fisheries European Funds (EU FEP); Seychelles Fishing Authority (SFA); University of Mauritius	This work was part of the PhD of the first author ZD co-funded by the "Allocations de Recherche pour une These au Sud" (ARTS) programme of the French Institute of Research for Development (IRD), and the Western Indian Ocean Marine Science Association (WIOMSA). Sampling was conducted under the framework of the European Data Collection Framework (EU DCF project (Reg. 199/2008 and 665/2008) and the Fisheries European Funds (EU FEP 2007-2013 project GERMON No 759/DMSOI/2013). Laboratory analysis was co-funded by Seychelles Fishing Authority (SFA) and University of Mauritius. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Aranda G, 2013, J SEA RES, V76, P154, DOI 10.1016/j.seares.2012.08.005; Arocha F., 1994, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V42, P309; Arocha F., 1996, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V45, P350; Auguie B, 2017, GRIDEXTRA MISCELLANE; Bard FX, 1981, THESIS; Bivanand R, 2016, PACKAGE RGDAL; Brown-Peterson NJ, 2011, MAR COAST FISH, V3, P52, DOI 10.1080/19425120.2011.555724; Chen IC, 2005, FISH OCEANOGR, V14, P71, DOI 10.1111/j.1365-2419.2004.00322.x; Chen KS, 2010, J FISH BIOL, V77, P119, DOI 10.1111/j.1095-8649.2010.02662.x; Claramunt G, 2007, FISH RES, V85, P248, DOI 10.1016/j.fishres.2007.01.009; Coelho R, 2014, REUNION ISLAND PELAG; Collette BB., 1983, FAO FISH SYNOP, V125; Conand F, 1982, BIOL OCEANOGR, V1, P31; Dhurmeea Z, 2012, IOTC2012WPTMT0412; Dhurmeea Z, 2016, IOTC2016WPTMT0628; Farley J, 2008, WCPFCSC42008BIIP1; Farley JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083017; Farley JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060577; Farley JH, 1998, FISH B-NOAA, V96, P223; FITZHUGH GR, 1995, FISH B-NOAA, V93, P568; FLETCHER DA, 1995, J FISH BIOL, V46, P657, DOI 10.1111/j.1095-8649.1995.tb01102.x; Grande M, 2014, FISH RES, V156, P14, DOI 10.1016/j.fishres.2014.04.011; Guraya Sardul S., 1994, Proceedings of the Indian National Science Academy Part B Biological Sciences, V60, P15; Harley S., 2003, INTERAMERICAN TROPIC; Helfman GS, 2009, DIVERSITY FISHES BIO; Hoyle S, 2008, 4 SCI COMM M W CENTR; Hoyle SD, 2014, IOTC2014WPTMT0524; Hsu CC, 2005, ALB WORK GROUP M 28; Hunter J.R., 1985, NOAA Technical Report NMFS, V36, P63; HUNTER JR, 1992, FISH B-NOAA, V90, P101; HUNTER JR, 1986, FISH B-NOAA, V84, P895; Hunter JR, 1989, CALCOFI REP, V30, P1; IOTC, 2014, 5 SESS IOTC WORK PAR; IOTC, 2013, 16 SESS IOTC SCI COM; IOTC, 2015, IOTC2015SC18R; IOTC, 2012, IOTC2012SC15; ISSF, 2015, 201503A ISSF; Itano DG, 2000, JIMAR CONTRIBUTION; Juan-Jorda MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070405; KarlouRiga C, 1997, J APPL ICHTHYOL, V13, P97, DOI 10.1111/j.1439-0426.1997.tb00108.x; Kennedy J, 2008, J FISH BIOL, V72, P78, DOI 10.1111/j.1095-8649.2007.01651.x; Kerwath S.E., 2012, INT COMM CONS ATL CO, V68, P604; KJESBU OS, 1991, CAN J FISH AQUAT SCI, V48, P2333, DOI 10.1139/f91-274; Knaggs EH, 1973, 3 CAL DEP FISH GAM, V3; Lambert Yvan, 2003, Journal of Northwest Atlantic Fishery Science, V33, P115, DOI 10.2960/J.v33.a7; Lambert Yvan, 2009, Journal of Northwest Atlantic Fishery Science, V41, P93; Le Gall J.-Y., 1974, FAO Fish Synopsis, VNo. 109, P1; Lowerre-Barbieri SK, 2011, MAR COAST FISH, V3, P71, DOI 10.1080/19425120.2011.556932; MacCall AD, 1980, NOAA TECH REP; Marshall C. Tara, 2009, P395, DOI 10.1002/9781444312133.ch11; Maunder Mark N., 2003, Inter-American Tropical Tuna Commission Bulletin, V22, P435; Morgan MJ, 2009, CAN J FISH AQUAT SCI, V66, P404, DOI 10.1139/F09-009; Morgan M. Joanne, 2009, Journal of Northwest Atlantic Fishery Science, V41, P37; Murua H., 2003, Journal of Northwest Atlantic Fishery Science, V33, P33, DOI 10.2960/J.v33.a3; Murua H., 2003, Journal of Northwest Atlantic Fishery Science, V33, P23, DOI 10.2960/J.v33.a2; Murua H, 2006, J FISH BIOL, V69, P1288, DOI 10.1111/j.1095-8649.2006.01169.x; Murua H, 2010, FISH RES, V104, P100, DOI 10.1016/j.fishres.2009.06.007; Newcombe HC, 2011, THESIS; NIKAIDO H, 1991, B NATL RES I FAR SEA, V28, P47; Nootmorn P, 2005, IOTC2005EPTT14; Okochi Y, 2016, FISH RES, V174, P30, DOI 10.1016/j.fishres.2015.08.020; Ortiz de Zarate V., 2004, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V56, P1450; Otsu T., 1959, Fishery Bulletin United States, V59, P287; Otsu T., 1962, Fishery Bulletin United States, V62, P151; Poisson F, 2009, AQUAT LIVING RESOUR, V22, P45, DOI 10.1051/alr/2009007; Poisson F, 2009, AQUAT LIVING RESOUR, V22, P59, DOI 10.1051/alr/2009012; Ramon D, 1996, FISH B-NOAA, V94, P725; Saber S., 2011, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V66, P1919; Saber S, 2016, FISH RES, V176, P76, DOI 10.1016/j.fishres.2015.12.013; Saber S, 2015, J MAR BIOL ASSOC UK, V95, P1705, DOI 10.1017/S002531541500020X; Saborido-Rey F, 1998, ICES J MAR SCI, V55, P515, DOI 10.1006/jmsc.1997.0344; Schaefer KM, 1996, FISH B-NOAA, V94, P98; Schaefer KM, 1998, B INTERAMERICAN TROP, V21, P201; Schaefer Kurt M., 2001, Fish Physiology, V19, P225; Schaefer MB, 1956, INTERAM TROP TUNA CO, V1, P283; Schott FA, 2001, PROG OCEANOGR, V51, P1, DOI 10.1016/S0079-6611(01)00083-0; Shiohama T, 1985, TWS8522 IPTP, P91; Solemdal P, 1997, J SEA RES, V37, P213, DOI 10.1016/S1385-1101(97)00029-4; Suda A, 1974, B FAR SEAS FISH RES, V10, P27; Sun CL, 2006, WCPFCSC22006BIWP1; Tsuruta Y., 1992, Bulletin of National Research Institute of Fisheries Engineering, P129; UEYANAGI S, 1969, Bulletin Far Seas Fisheries Research Laboratory (Shimizu), V2, P177; Williams AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039318; Wootton R.J., 1984, P1; Wu Chi-Lun, 1993, Journal of the Fisheries Society of Taiwan, V20, P135; Wyrtki K., 1973, ECOL STUD, V3, P18, DOI [10.1007/978-3-642-65468-8_3, DOI 10.1007/978-3-642-65468-8_3]; Xu J, 2005, STATA J, V5, P537, DOI 10.1177/1536867X0500500405; Zudaire I, 2013, FISH RES, V138, P80, DOI 10.1016/j.fishres.2012.07.022; Zudaire I, 2013, FISH B-NOAA, V111, P252, DOI 10.7755/FB.111.3.4	90	15	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168605	10.1371/journal.pone.0168605	http://dx.doi.org/10.1371/journal.pone.0168605			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002431	Green Published, gold, Green Submitted			2022-12-26	WOS:000392853100057
J	Kamigaki, T; Chaw, L; Tan, AG; Tamaki, R; Alday, PP; Javier, JB; Olveda, RM; Oshitani, H; Tallo, VL				Kamigaki, Taro; Chaw, Liling; Tan, Alvin G.; Tamaki, Raita; Alday, Portia P.; Javier, Jenaline B.; Olveda, Remigio M.; Oshitani, Hitoshi; Tallo, Veronica L.			Seasonality of Influenza and Respiratory Syncytial Viruses and the Effect of Climate Factors in Subtropical-Tropical Asia Using Influenza-Like Illness Surveillance Data, 2010-2012	PLOS ONE			English	Article							ABSOLUTE-HUMIDITY; METEOROLOGICAL FACTORS; HONG-KONG; INFECTIONS; DISEASE; EPIDEMIOLOGY; TRANSMISSION; ASSOCIATION; TEMPERATURE; PATTERNS	Introduction The seasonality of influenza and respiratory syncytial virus (RSV) is well known, and many analyses have been conducted in temperate countries; however, this is still not well understood in tropical countries. Previous studies suggest that climate factors are involved in the seasonality of these viruses. However, the extent of the effect of each climate variable is yet to be defined. Materials and Methods We investigated the pattern of seasonality and the effect of climate variables on influenza and RSV at three sites of different latitudes: the Eastern Visayas region and Baguio City in the Philippines, and Okinawa Prefecture in Japan. Wavelet analysis and the dynamic linear regression model were applied. Climate variables used in the analysis included mean temperature, relative and specific humidity, precipitation, and number of rainy days. The Akaike Information Criterion estimated in each model was used to test the improvement of fit in comparison with the baseline model. Result At all three study sites, annual seasonal peaks were observed in influenza A and RSV; peaks were unclear for influenza B. Ranges of climate variables at the two Philippine sites were narrower and mean variables were significantly different among the three sites. Whereas all climate variables except the number of rainy days improved model fit to the local trend model, their contributions were modest. Mean temperature and specific humidity were positively associated with influenza and RSV at the Philippine sites and negatively associated with influenza A in Okinawa. Precipitation also improved model fit for influenza and RSV at both Philippine sites, except for the influenza A model in the Eastern Visayas. Conclusions Annual seasonal peaks were observed for influenza A and RSV but were less clear for influenza B at all three study sites. Including additional data from subsequent more years would help to ascertain these findings. Annual amplitude and variation in climate variables are more important than their absolute values for determining their effect on the seasonality of influenza and RSV.	[Kamigaki, Taro; Chaw, Liling; Tamaki, Raita; Oshitani, Hitoshi] Tohoku Univ, Dept Virol, Grad Sch Med, Sendai, Miyagi, Japan; [Tan, Alvin G.; Alday, Portia P.; Javier, Jenaline B.; Tallo, Veronica L.] Dept Hlth, Res Inst Trop Med, Dept Epidemiol & Biostat, Manila, Philippines; [Olveda, Remigio M.] Dept Hlth, Res Inst Trop Med, Manila, Philippines; [Chaw, Liling] Univ Brunei Darussalam, PAPRSB Inst Hlth Sci, Negara, Brunei	Tohoku University; Philippine Department Health; Research Institute for Tropical Medicine - Philippines; Philippine Department Health; Research Institute for Tropical Medicine - Philippines; University Brunei Darussalam	Kamigaki, T (corresponding author), Tohoku Univ, Dept Virol, Grad Sch Med, Sendai, Miyagi, Japan.	kamigakit@med.tohoku.ac.jp	Chaw, Liling/R-1591-2019; Oshitani, Hitoshi/AAE-4349-2019	Chaw, Liling/0000-0003-3301-7565; 	US-CDC [U50/CCU2444, 5U5IIP000335]; Japan Initiative for Global Research Network on Infectious Diseases; JSPS KAKENHI [JP15H05281]	US-CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Japan Initiative for Global Research Network on Infectious Diseases(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funded by US-CDC Cooperative AgreementU50/CCU2444, 5U5IIP000335, Remigio M. Olveda, Ministry of Education, Culture, Sports, Science and Technology, Japan Grant-in-Aid from the Japan Initiative for Global Research Network on Infectious Diseases, Hitoshi Oshitani, Japan Science and Technology Agency/Japan International Cooperation Agency the Science and Technology Research Partnership for Sustainable Development, Hitoshi Oshitani, JSPS KAKENHI JP15H05281, Taro Kamigak.	Agrawal AS, 2009, J MED MICROBIOL, V58, P1616, DOI 10.1099/jmm.0.011304-0; Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Alonso WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17214; Alonso WJ, 2012, PEDIATR INFECT DIS J, V31, pE9, DOI 10.1097/INF.0b013e31823883be; Baumgartner EA, 2012, J INFECT DIS, V206, P838, DOI 10.1093/infdis/jis467; Belshe RB, 2008, VACCINE, V26, pD10, DOI 10.1016/j.vaccine.2008.06.083; Bloom-Feshbach K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054445; Chan PKS, 2009, J MED VIROL, V81, P1797, DOI 10.1002/jmv.21551; Chan PKS, 1999, EPIDEMIOL INFECT, V123, P257, DOI 10.1017/S0950268899002824; Chan PWK, 2002, PEDIATR PULM, V34, P47, DOI 10.1002/ppul.10095; Chen ZR, 2014, ARCH VIROL, V159, P631, DOI 10.1007/s00705-013-1863-8; Chew FT, 1998, EPIDEMIOL INFECT, V121, P121, DOI 10.1017/S0950268898008905; Chittaganpitch M, 2012, INFLUENZA OTHER RESP, V6, P276, DOI 10.1111/j.1750-2659.2011.00302.x; Gustin KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125874; Haynes AK, 2013, J INFECT DIS, V208, pS246, DOI 10.1093/infdis/jit515; Heaton MJ, 2012, STAT MED, V31, P2123, DOI 10.1002/sim.5350; Higa F, 2009, JPN J INFECT DIS, V62, P399; Iha Y, 2012, JPN J INFECT DIS, V65, P295, DOI 10.7883/yoken.65.295; Imai C, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.24413; KFAS J H., 2016, KALMAN FILTER SMOOTH; Khor CS, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-32; Killingley B, 2013, INFLUENZA OTHER RESP, V7, P42, DOI 10.1111/irv.12080; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Koul PA, 2014, EMERG INFECT DIS, V20, P1723, DOI 10.3201/eid2010.140431; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Lowen AC, 2008, J VIROL, V82, P5650, DOI 10.1128/JVI.00325-08; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Lowen AC, 2014, J VIROL, V88, P7692, DOI 10.1128/JVI.03544-13; McDevitt J, 2010, APPL ENVIRON MICROB, V76, P3943, DOI 10.1128/AEM.02674-09; Meerhoff TJ, 2009, PEDIATR INFECT DIS J, V28, P860, DOI 10.1097/INF.0b013e3181a3e949; Nguyen YT, 2013, VACCINE, V31, P4368, DOI 10.1016/j.vaccine.2013.07.018; Noti JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057485; Omer SB, 2008, EPIDEMIOL INFECT, V136, P1319, DOI 10.1017/S0950268807000015; Otomaru H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123755; Paynter S, 2015, EPIDEMIOL INFECT, V143, P1110, DOI 10.1017/S0950268814002702; Paynter S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090094; Thai PQ, 2015, EPIDEMICS-NETH, V13, P65, DOI 10.1016/j.epidem.2015.06.002; Portland State Aerospace Society, 2004, QUICK DER REL ALT AI; R Development Core Team, 2016, R LANG ENV STAT COMP; Saat Z, 2010, SE ASIAN J TROP MED, V41, P1368; Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Soebiyanto RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100659; Spicknall IH, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000969; Tallo VL, 2014, INFLUENZA OTHER RESP, V8, P159, DOI 10.1111/irv.12223; Tamerius J, 2011, ENVIRON HEALTH PERSP, V119, P439, DOI 10.1289/ehp.1002383; Tamerius JD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003194; Tang JLW, 2014, REV MED VIROL, V24, P15, DOI 10.1002/rmv.1771; Tarik C, BIWAVELET CONDUCT UN; Ud-Dean SMM, 2010, J THEOR BIOL, V264, P822, DOI 10.1016/j.jtbi.2010.03.013; Wallace J., 2006, ATMOSPHERIC SCI INTR, V2nd; Welliver Robert, 2009, Paediatr Respir Rev, V10 Suppl 1, P6, DOI 10.1016/S1526-0542(09)70004-1; World Health Organization (WHO), WHO REC SURV STAND; Yang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046789; Yu HJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001552; Yusuf S, 2007, EPIDEMIOL INFECT, V135, P1077, DOI 10.1017/S095026880600776X	56	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167712	10.1371/journal.pone.0167712	http://dx.doi.org/10.1371/journal.pone.0167712			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002419	Green Published, Green Submitted, gold			2022-12-26	WOS:000392853100018
J	Trier, NH; Holm, BE; Slot, O; Locht, H; Lindegaard, H; Svendsen, A; Houen, G				Trier, Nicole Hartwig; Holm, Bettina Eide; Slot, Ole; Locht, Henning; Lindegaard, Hanne; Svendsen, Anders; Houen, Gunnar			Physical Characteristics of a Citrullinated Pro-Filaggrin Epitope Recognized by Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis Sera	PLoS One			English	Article							PROTEIN/PEPTIDE ANTIBODIES; ANTIKERATIN ANTIBODIES; PEPTIDE ANTIBODIES; DISEASE COURSE; CCP ANTIBODY; AUTOANTIBODIES; ASSOCIATION; HLA-DRB1; CLASSIFICATION; IDENTIFICATION	Rheumatoid arthritis (RA) is an autoimmune disease of complex etiology. A characteristic feature of a subset of RA is the presence of anti-citrullinated protein antibodies (ACPA), which correlate with a progressive disease course. In this study, we employed streptavidin capture enzyme-linked immunosorbent assay to analyze ACPA reactivity. Using the profilaggrin peptide HQCHQEST-Cit-GRSRGRCGRSGS, as template, we analyzed the reactivity of RA sera and healthy donor sera to various peptides in order to determine the physical characteristics of the citrullinated pro-filaggrin epitope and to examine whether biotin labelling influence antibody recognition. The full-length cyclic pro-filaggrin peptide and a linear form with a N-terminal biotin, was recognized to the same level, whereas, a notable difference in ACPA reactivity to the linear peptides with a C-terminal biotin was found, probably due to steric hindrance. Screening of linear and cyclic truncated peptides, revealed that small cyclic peptides containing 10-12 amino acids are favored over the linear. Moreover, the charged amino acids C-terminal to citrulline were found to be essential for antibody reactivity, most important was the charged amino acid in position 4 C-terminal to citrulline. Collectively, peptide structure, length, the presence of charged amino acids and biotin labelling markedly influence antibody reactivity. In relation to the clinical diagnostics of ACPA, these findings may reflect the differences in diagnostic assays used for detection of ACPA, which relates to differences in sensitivity and specificity dependent on the assay applied.	[Trier, Nicole Hartwig; Holm, Bettina Eide; Houen, Gunnar] Statens Serum Inst, Dept Autoimmunol & Biomarkers, Copenhagen S, Denmark; [Slot, Ole] Glostrup Cty Hosp, Dept Rheumatol, Glostrup, Denmark; [Locht, Henning] Frederiksberg Univ Hosp, Dept Rheumatol, Frederiksberg, Denmark; [Lindegaard, Hanne] Odense Univ Hosp, Dept Rheumatol, Sondre Blvd, Odense C, Denmark; [Svendsen, Anders] Univ Southern Denmark, Dept Epidemiol Biostat & Biodemog, Inst Publ Hlth, Campusvej, Odense M, Denmark	Statens Serum Institut; University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Trier, NH (corresponding author), Statens Serum Inst, Dept Autoimmunol & Biomarkers, Copenhagen S, Denmark.	nhp@ssi.dk	Lindegaard, Hanne Merete/AAV-5437-2020; Trier, Nicole/AAA-5164-2020; Nekrasov, Alexei/S-1322-2016	Lindegaard, Hanne Merete/0000-0002-5675-3859; Trier, Nicole/0000-0003-1548-2009; Nekrasov, Alexei/0000-0001-6814-3735; Svendsen, Anders/0000-0002-3481-9001				Aho K, 2000, J RHEUMATOL, V27, P2743; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bartold PM, 2010, J CLIN PERIODONTOL, V37, P405, DOI 10.1111/j.1600-051X.2010.01552.x; Beers JJ, 2012, ARTHRITIS RES THER, V14, pR35, DOI [10.1186/ar3744, DOI 10.1186/AR3744]; Burkhardt H, 2005, EUR J IMMUNOL, V35, P1643, DOI 10.1002/eji.200526000; Chibnik LB, 2009, J RHEUMATOL, V36, P706, DOI 10.3899/jrheum.080895; DOROW DS, 1985, MOL IMMUNOL, V22, P1255, DOI 10.1016/0161-5890(85)90044-6; DYSON HJ, 1995, FASEB J, V9, P37, DOI 10.1096/fasebj.9.1.7821757; Engel A, 1966, Vital Health Stat 11, P1; Fernandes-Cerqueira C, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0666-6; Babos F, 2013, BIOCONJUGATE CHEM, V24, P817, DOI 10.1021/bc400073z; Girbal-Neuhauser E, 1999, J IMMUNOL, V162, P585; Kallberg H, 2007, AM J HUM GENET, V80, P867, DOI 10.1086/516736; Kastbom A, 2004, ANN RHEUM DIS, V63, P1085, DOI 10.1136/ard.2003.016808; Kinloch A, 2005, ARTHRITIS RES THER, V7, pR1421, DOI 10.1186/ar1845; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Klareskog L, 2008, ANNU REV IMMUNOL, V26, P651, DOI 10.1146/annurev.immunol.26.021607.090244; Kobylyansky AG, 2011, B EXP BIOL MED+, V151, P615; LI SC, 1995, BIOPOLYMERS, V35, P667, DOI 10.1002/bip.360350612; Mahalakshmi R, 2006, D AMINO ACIDS NEW FR, P415; Nair DT, 2002, J IMMUNOL, V168, P2371, DOI 10.4049/jimmunol.168.5.2371; Nell VPK, 2005, ANN RHEUM DIS, V64, P1731, DOI 10.1136/ard.2005.035691; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P380, DOI 10.1002/art.20018; Pedersen JK, 2009, RHEUMATOL INT, V29, P411, DOI 10.1007/s00296-008-0713-6; Pedersen M, 2007, ARTHRITIS RHEUM-US, V56, P1446, DOI 10.1002/art.22597; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Ronnelid J, 2005, ANN RHEUM DIS, V64, P1744, DOI 10.1136/ard.2004.033571; Sangha O, 2000, RHEUMATOLOGY, V39, P3, DOI 10.1093/rheumatology/39.suppl_2.3; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; Schellekens GA, 2000, ARTHRITIS RHEUM-US, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3; SEBBAG M, 1995, J CLIN INVEST, V95, P2672, DOI 10.1172/JCI117969; SHMERLING RH, 1991, AM J MED, V91, P528, DOI 10.1016/0002-9343(91)90190-9; SIMON M, 1993, J CLIN INVEST, V92, P1387, DOI 10.1172/JCI116713; Snir O, 2009, ANN RHEUM DIS, V68, P736, DOI 10.1136/ard.2008.091355; Soutullo A, 2007, J MOL RECOGNIT, V20, P227, DOI 10.1002/jmr.825; Takizawa Y, 2006, ANN RHEUM DIS, V65, P1013, DOI 10.1136/ard.2005.044743; Tarcsa E, 1996, J BIOL CHEM, V271, P30709, DOI 10.1074/jbc.271.48.30709; Trier NH, 2012, PROTEIN SCI, V21, P1929, DOI 10.1002/pro.2178; van der Helm-van Mil AHM, 2007, ARTHRITIS RHEUM, V56, P425, DOI 10.1002/art.22373; van der Woude D, 2010, ANN RHEUM DIS, V69, P1554, DOI 10.1136/ard.2009.124537; van Venrooij WJ, 2008, ANN NY ACAD SCI, V1143, P268, DOI 10.1196/annals.1443.013; Visser H, 1996, ANN RHEUM DIS, V55, P157, DOI 10.1136/ard.55.3.157; Vossenaar ER, 2004, ARTHRITIS RES THER, V6, pR142, DOI 10.1186/ar1149; Waaler E, 2007, APMIS, V115, P422; Wesoly J, 2005, ARTHRITIS RHEUM-US, V52, P2948, DOI 10.1002/art.21294; WILLIAMSON MP, 1986, INT J PEPT PROT RES, V27, P562	49	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168542	10.1371/journal.pone.0168542	http://dx.doi.org/10.1371/journal.pone.0168542			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002483	gold, Green Published, Green Submitted			2022-12-26	WOS:000392853100052
J	Khajah, MA; Ananthalakshmi, KV; Edafiogho, I				Khajah, Maitham A.; Ananthalakshmi, Kethireddy V.; Edafiogho, Ivan			Anti-Inflammatory Properties of the Enaminone E121 in the Dextran Sulfate Sodium (DSS) Colitis Model	PLOS ONE			English	Article							NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; NITRIC-OXIDE-SYNTHASE; INTESTINAL EPITHELIAL-CELLS; ANTICONVULSANT ACTIVITY; ULCERATIVE-COLITIS; CROHNS-DISEASE; SIGNALING PATHWAY; PATHOGENESIS; EXPRESSION	Background Enaminones are synthetic compounds with an established role in the prevention of various forms of seizures. Recent evidence suggests potent anti-tussive, bronchodilation and antiinflammatory properties. Pre-treatment with particularly E121 compound resulted in a decrease in leukocyte recruitment in the ovalbumin induced-model of asthma, immune cell proliferation and cytokine release in vitro. We hypothesize that E121 might serve as a therapeutic potential in intestinal inflammation through modulating immune cell functions. Methods Colitis was induced by daily dextran sulfate sodium (DSS) administration for 5 days, and its severity was determined by gross and histological assessments. The plasma level of various cytokines was measured using flow cytometry-based assay. The colonic expression/phosphorylation level of various molecules was determined by immunofluorescence and western blotting. The effects of E121 treatment on in vitro neutrophil chemotaxis (under-agarose assay), superoxide release (luminol oxidation assay) and apoptosis (annexin V/7AAD) were also determined. Results DSS-induced colitis in mice was significantly reduced by daily E121 treatment (30-100 mg/kg) at gross and histological levels. This effect was due to modulated plasma levels of interleukin (IL-2) and colonic expression levels of various signaling molecules and proteins involved in apoptosis. In vitro neutrophil survival, chemotaxis, and superoxide release were also reduced by E121 treatment. Conclusion Our results indicate important anti-inflammatory actions of E121 in the pathogenesis of IBD.	[Khajah, Maitham A.; Ananthalakshmi, Kethireddy V.] Kuwait Univ, Fac Pharm, Safat, Kuwait; [Edafiogho, Ivan] Univ St Joseph, Sch Pharm, Dept Pharmaceut Sci, Hartford, CT USA	Kuwait University	Khajah, MA (corresponding author), Kuwait Univ, Fac Pharm, Safat, Kuwait.	maitham@hsc.edu.kw	Khajah, Maitham/AAZ-8841-2020		Kuwait University Research Sector grant [PT03/15];  [SRUL02/13]	Kuwait University Research Sector grant; 	This work was supported by Kuwait University Research Sector grant PT03/15. Parts of this work were supported by grant SRUL02/13 to the Research Unit for Genomics, Proteomics and Cellomics Studies (OMICS), Kuwait University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2014, MUCOSAL IMMUNOL, V7, P1340, DOI 10.1038/mi.2014.21; Ananthalakshmi KVV, 2006, NEUROSCIENCE, V141, P345, DOI 10.1016/j.neuroscience.2006.03.021; Ananthalakshmi KVV, 2007, EPILEPSY RES, V76, P85, DOI 10.1016/j.eplepsyres.2007.07.001; Anderson SL, 2016, EQUINE VET J, V2016, P12576; Anselmi L, 2015, NEUROGASTROENT MOTIL, V27, P509, DOI 10.1111/nmo.12521; Arumugam S, 2015, CYTOKINE, V74, P305, DOI 10.1016/j.cyto.2015.03.017; Bai JA, 2015, WORLD J GASTROENTERO, V21, P6180, DOI 10.3748/wjg.v21.i20.6180; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; BEAL MF, 1995, ANN NEUROL, V38, P357, DOI 10.1002/ana.410380304; Beck PL, 2007, GASTROENTEROLOGY, V132, P1778, DOI 10.1053/j.gastro.2007.01.032; Becker C, 2001, J IMMUNOL, V167, P2608, DOI 10.4049/jimmunol.167.5.2608; Becker C, 2006, J IMMUNOL, V177, P2760, DOI 10.4049/jimmunol.177.5.2760; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Bocker U, 1998, GASTROENTEROLOGY, V115, P1426, DOI 10.1016/S0016-5085(98)70021-6; BOUGHTONSMITH NK, 1993, LANCET, V342, P338, DOI 10.1016/0140-6736(93)91476-3; Chassaing B, 2014, CURR PROTOC IMMUNOL, V2014; Chen TT, 2015, AM J PATHOL, V185, P2441, DOI 10.1016/j.ajpath.2015.05.020; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Crespo I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050407; DANNHARDT G, 1993, ARZNEIMITTEL-FORSCH, V43-1, P441; Dominguez JN, 1997, J MED CHEM, V40, P2726, DOI 10.1021/jm970266p; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Edafiogho IO, 2002, BIOORGAN MED CHEM, V10, P593, DOI 10.1016/S0968-0896(01)00314-5; EDAFIOGHO IO, 1992, J MED CHEM, V35, P2798, DOI 10.1021/jm00093a012; Edafiogho IO, 2007, J PHARM SCI-US, V96, P2509, DOI 10.1002/jps.20967; Edafiogho IO, 2014, EUR J MED CHEM, V76, P20, DOI 10.1016/j.ejmech.2014.02.002; Eddington ND, 2002, EUR J MED CHEM, V37, P635, DOI 10.1016/S0223-5234(02)01377-6; Eddington ND, 2000, CURR MED CHEM, V7, P417, DOI 10.2174/0929867003375092; Edelblum KL, 2008, GASTROENTEROLOGY, V135, P539, DOI 10.1053/j.gastro.2008.04.025; El-Hashim AZ, 2011, LIFE SCI, V89, P378, DOI 10.1016/j.lfs.2011.07.007; Fan H, 2014, J ETHNOPHARMACOL, V154, P88, DOI 10.1016/j.jep.2014.03.021; Ferrari R, 1996, J CARDIOVASC PHARM, V28, pS1; Foster JE, 1999, BIOORGAN MED CHEM, V7, P2415, DOI 10.1016/S0968-0896(99)00185-6; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Gayle JM, 2000, J AM VET MED ASSOC, V217, P498, DOI 10.2460/javma.2000.217.498; Gelbmann CM, 2003, GUT, V52, P1448, DOI 10.1136/gut.52.10.1448; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Halpert G, 2014, J BIOL CHEM, V289, P17215, DOI 10.1074/jbc.M113.536664; Heit B, 2002, J CELL BIOL, V159, P91, DOI 10.1083/jcb.200202114; Heit B, 2008, NAT IMMUNOL, V9, P743, DOI 10.1038/ni.1623; Hill MM, 2004, EMBO J, V23, P2134, DOI 10.1038/sj.emboj.7600210; Hirota SA, 2011, INFLAMM BOWEL DIS, V17, P1359, DOI 10.1002/ibd.21478; Holtmann MH, 2004, CURR MOL MED, V4, P439, DOI 10.2174/1566524043360636; Hommes D, 2002, GASTROENTEROLOGY, V122, P7, DOI 10.1053/gast.2002.30770; Huang XL, 2011, INFLAMM RES, V60, P727, DOI 10.1007/s00011-011-0325-6; Iimura M, 2000, GUT, V47, P228, DOI 10.1136/gut.47.2.228; Impellizzeri D, 2015, CLIN NUTR, V34, P1146, DOI 10.1016/j.clnu.2014.11.012; Jin X., 2015, INFLAMMATION, P3; Leon AJ, 2006, MED CLIN-BARCELONA, V127, P145, DOI 10.1157/13090382; Khajah M, 2013, J IMMUNOL, V190, P2208, DOI 10.4049/jimmunol.1200322; Khajah M, 2011, J LEUKOCYTE BIOL, V89, P945, DOI 10.1189/jlb.0809546; Khajah MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150861; Kombian SB, 2005, BRIT J PHARMACOL, V145, P945, DOI 10.1038/sj.bjp.0706250; KORSMEYER SJ, 1995, BBA-MOL BASIS DIS, V1271, P63, DOI 10.1016/0925-4439(95)00011-R; KRISHNA M, 1995, MODERN PATHOL, V8, P654; Laroui H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032084; LI P, 1991, CELL, V64, P479, DOI 10.1016/0092-8674(91)90228-Q; Lieber JG, 2004, BLOOD, V103, P852, DOI 10.1182/blood-2003-04-1030; Liu X, 2016, BIOCHEM PHARMACOL, V2952, P30075; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Los M, 2001, TRENDS IMMUNOL, V22, P31, DOI 10.1016/S1471-4906(00)01814-7; LOTEM J, 1995, CELL GROWTH DIFFER, V6, P647; LUNDBERG JON, 1994, LANCET, V344, P1673, DOI 10.1016/S0140-6736(94)90460-X; Marquez-Flores YK, 2016, J NUTR BIOCHEM, V30, P143, DOI 10.1016/j.jnutbio.2015.12.002; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; MIDDLETON SJ, 1993, LANCET, V341, P465, DOI 10.1016/0140-6736(93)90211-X; MIYASHITA T, 1994, CANCER RES, V54, P3131; Monteleone G, 1997, GASTROENTEROLOGY, V112, P1169, DOI 10.1016/S0016-5085(97)70128-8; Natsui M, 1997, J GASTROEN HEPATOL, V12, P801, DOI 10.1111/j.1440-1746.1997.tb00375.x; Neurath MF, 1996, NAT MED, V2, P998, DOI 10.1038/nm0996-998; Pallone F, 2001, CURR OPIN GASTROEN, V17, P307, DOI 10.1097/00001574-200107000-00002; Papadakis KA, 2000, ANNU REV MED, V51, P289, DOI 10.1146/annurev.med.51.1.289; Park S, 2014, EUR J PHARMACOL, V735, P184, DOI 10.1016/j.ejphar.2014.04.024; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Peng XD, 2010, J PHARMACOL EXP THER, V332, P46, DOI 10.1124/jpet.109.153494; Perse M, 2012, J BIOMED BIOTECHNOL, V2012, P14; Piao JH, 2012, IMMUNOL CELL BIOL, V90, P881, DOI 10.1038/icb.2012.22; Piao JH, 2011, J BIOL CHEM, V286, P17879, DOI 10.1074/jbc.M111.221853; Plevy SE, 1997, J IMMUNOL, V159, P6276; Ponder Alexis, 2013, Clin Epidemiol, V5, P237, DOI 10.2147/CLEP.S33961; Poritz LS, 2007, J SURG RES, V140, P12, DOI 10.1016/j.jss.2006.07.050; Qian J, 2016, MOL IMMUNOL, V75, P48, DOI 10.1016/j.molimm.2016.05.011; Qiao YQ, 2013, J DIGEST DIS, V14, P244, DOI 10.1111/1751-2980.12044; Qualls JE, 2006, J LEUKOCYTE BIOL, V80, P802, DOI 10.1189/jlb.1205734; Regeling A, 2016, BBA-MOL BASIS DIS, V1862, P788, DOI 10.1016/j.bbadis.2016.01.020; Reifen R, 2015, NUTRITION, V31, P1402, DOI 10.1016/j.nut.2015.05.011; Rogler G, 1998, GASTROENTEROLOGY, V115, P357, DOI 10.1016/S0016-5085(98)70202-1; SARTOR RB, 1995, GASTROENTEROL CLIN N, V24, P475; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Sartor RB, 1997, AM J GASTROENTEROL, V92, pS5; Sax JK, 2002, NAT CELL BIOL, V4, P842, DOI 10.1038/ncb866; SCOTT KR, 1995, J MED CHEM, V38, P4033, DOI 10.1021/jm00020a019; SCOTT KR, 1993, J MED CHEM, V36, P1947, DOI 10.1021/jm00066a003; Sklyarov AY, 2011, J PHYSIOL PHARMACOL, V62, P65; Sun J, 2015, INT J CLIN EXP MED, V8, P358; TAN S, 1993, FREE RADICAL BIO MED, V15, P407, DOI 10.1016/0891-5849(93)90040-2; Tang QY, 2015, DIGEST DIS SCI, V60, P393, DOI 10.1007/s10620-014-3189-0; Thoreson R, 2007, SURG CLIN N AM, V87, P575, DOI 10.1016/j.suc.2007.03.001; Tirosh O, 2007, NUTRITION, V23, P878, DOI 10.1016/j.nut.2007.08.019; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wajant H, 2002, SCIENCE, V296, P1635, DOI 10.1126/science.1071553; Wang LX, 2003, J IMMUNOL, V171, P3194, DOI 10.4049/jimmunol.171.6.3194; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Xu AT, 2015, INFLAMM BOWEL DIS, V21, P241, DOI 10.1097/MIB.0000000000000267; YAMADA T, 1991, KLIN WOCHENSCHR, V69, P988, DOI 10.1007/BF01645144; Yamaguchi O, 2004, J CLIN INVEST, V114, P937, DOI 10.1172/JCI200420317; Yasukawa K, 2012, FREE RADICAL RES, V46, P1427, DOI 10.3109/10715762.2012.732698	109	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168567	10.1371/journal.pone.0168567	http://dx.doi.org/10.1371/journal.pone.0168567			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997590	Green Published, gold, Green Submitted			2022-12-26	WOS:000392842900059
J	Failmezger, J; Nitschel, R; Sanchez-Kopper, A; Kraml, M; Siemann-Herzberg, M				Failmezger, Jurek; Nitschel, Robert; Sanchez-Kopper, Andres; Kraml, Michael; Siemann-Herzberg, Martin			Site-Specific Cleavage of Ribosomal RNA in Escherichia coli-Based Cell-Free Protein Synthesis Systems	PLoS One			English	Article							FREE EXPRESSION SYSTEM; AMINO-ACID; GEL-ELECTROPHORESIS; DEGRADATION; TRANSLATION; BACTERIA; REGENERATION; STARVATION; RESOLUTION; PHOSPHATE	Cell-free protein synthesis, which mimics the biological protein production system, allows rapid expression of proteins without the need to maintain a viable cell. Nevertheless, cell free protein expression relies on active in vivo translation machinery including ribosomes and translation factors. Here, we examined the integrity of the protein synthesis machinery, namely the functionality of ribosomes, during (i) the cell-free extract preparation and (ii) the performance of in vitro protein synthesis by analyzing crucial components involved in translation. Monitoring the 16S rRNA, 23S rRNA, elongation factors and ribosomal protein Si, we show that processing of a cell-free extract results in no substantial alteration of the translation machinery. Moreover, we reveal that the 16S rRNA is specifically cleaved at helix 44 during in vitro translation reactions, resulting in the removal of the anti-Shine-Dalgarno sequence. These defective ribosomes accumulate in the cell-free system. We demonstrate that the specific cleavage of the 16S rRNA is triggered by the decreased concentrations of Mg2+. In addition, we provide evidence that helix 44 of the 30S ribosomal subunit serves as a point-of-entry for ribosome degradation in Escherichia coli. Our results suggest that Mg2+ homeostasis is fundamental to preserving functional ribosomes in cell-free protein synthesis systems, which is of major importance for cell-free protein synthesis at preparative scale, in order to create highly efficient technical in vitro systems.	[Failmezger, Jurek; Nitschel, Robert; Kraml, Michael; Siemann-Herzberg, Martin] Univ Stuttgart, Inst Biochem Engn, Stuttgart, Germany; [Sanchez-Kopper, Andres] Costa Rica Inst Technol, Ceqiatec, Cartago, Costa Rica	University of Stuttgart; Instituto Tecnologico de Costa Rica	Siemann-Herzberg, M (corresponding author), Univ Stuttgart, Inst Biochem Engn, Stuttgart, Germany.	siemann@ibvt.uni-stuttgart.de		SANCHEZ-KOPPER, ANDRES/0000-0002-8469-4366	Bundesministerium fur Bildung and Forschung	Bundesministerium fur Bildung and Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by the Bundesministerium fur Bildung and Forschung. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basturea GN, 2011, RNA, V17, P338, DOI 10.1261/rna.2448911; BENHAMID.F, 1966, BIOCHIM BIOPHYS ACTA, V119, P183, DOI 10.1016/0005-2787(66)90049-9; Calhoun KA, 2007, IN VITRO TRANSCRIPTI, P3; Calhoun KA, 2006, J BIOTECHNOL, V123, P193, DOI 10.1016/j.jbiotec.2005.11.011; Caschera F, 2015, METAB ENG, V27, P29, DOI 10.1016/j.ymben.2014.10.007; Caschera F, 2014, BIOCHIMIE, V99, P162, DOI 10.1016/j.biochi.2013.11.025; Catherine C, 2013, BIOTECHNOL ADV, V31, P797, DOI 10.1016/j.biotechadv.2013.04.009; Chi EY, 2003, PHARM RES-DORDR, V20, P1325, DOI 10.1023/A:1025771421906; DAVIS BD, 1986, J BACTERIOL, V166, P439, DOI 10.1128/jb.166.2.439-445.1986; Deutscher MP, 2003, J BIOL CHEM, V278, P45041, DOI 10.1074/jbc.R300031200; DONG HJ, 1995, J BACTERIOL, V177, P1497, DOI 10.1128/jb.177.6.1497-1504.1995; Draper DE, 2005, ANNU REV BIOPH BIOM, V34, P221, DOI 10.1146/annurev.biophys.34.040204.144511; Freischmidt A, 2010, J BIOTECHNOL, V150, P44, DOI 10.1016/j.jbiotec.2010.07.017; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; GORISCH H, 1976, BIOCHEMISTRY-US, V15, P5743; Hardiman T, 2008, ANAL BIOCHEM, V374, P79, DOI 10.1016/j.ab.2007.09.032; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; Hong SH, 2014, ACS SYNTH BIOL, V3, P398, DOI 10.1021/sb400140t; Katzen F, 2005, TRENDS BIOTECHNOL, V23, P150, DOI 10.1016/j.tibtech.2005.01.003; Kiga D, 2002, P NATL ACAD SCI USA, V99, P9715, DOI 10.1073/pnas.142220099; Kim DM, 1999, BIOTECHNOL BIOENG, V66, P180, DOI 10.1002/(SICI)1097-0290(1999)66:3<180::AID-BIT6>3.0.CO;2-S; Kim DM, 2001, BIOTECHNOL BIOENG, V74, P309, DOI 10.1002/bit.1121; Kim HC, 2009, J BIOSCI BIOENG, V108, P1, DOI 10.1016/j.jbiosc.2009.02.007; Kim RG, 2000, J BIOTECHNOL, V84, P27, DOI 10.1016/S0168-1656(00)00326-6; Kim TW, 2007, BIOTECHNOL BIOENG, V97, P1510, DOI 10.1002/bit.21337; Kim TW, 2006, J BIOTECHNOL, V124, P373, DOI 10.1016/j.jbiotec.2005.12.030; Liu DV, 2005, BIOTECHNOL PROGR, V21, P460, DOI 10.1021/bp049789y; MARUYAMA H, 1970, BIOCHIM BIOPHYS ACTA, V199, P159, DOI 10.1016/0005-2787(70)90704-5; Masek T, 2005, ANAL BIOCHEM, V336, P46, DOI 10.1016/j.ab.2004.09.010; MCCARTHY BJ, 1962, BIOCHIM BIOPHYS ACTA, V55, P880; Neidhardt, 1996, ESCHERICHIA COLI SAL; Paier A, 2015, SCI REPORTS, P5; Petrov AI, 2013, RNA, V19, P1327, DOI 10.1261/rna.039438.113; Piir K, 2011, EMBO REP, V12, P458, DOI 10.1038/embor.2011.47; PRATT JM, 1984, TRANSCRIPTION TRANSL, P179; Ramesh A, 2010, RNA BIOL, V7, P77, DOI 10.4161/rna.7.1.10490; Reddy K, 1987, CURRENT PROTOCOLS MO; Rimbon J, 2015, ENG LIFE SCI, V15, P499, DOI 10.1002/elsc.201400103; Schindler PT, 1999, ELECTROPHORESIS, V20, P806, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<806::AID-ELPS806>3.3.CO;2-9; Shenvi CL, 2005, RNA, V11, P1898, DOI 10.1261/rna.2192805; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Smith MT, 2014, FEBS LETT, V588, P2755, DOI 10.1016/j.febslet.2014.05.062; Swartz J, 2006, J IND MICROBIOL BIOT, V33, P476, DOI 10.1007/s10295-006-0127-y; Tabuchi M, 2002, PROTEOMICS, V2, P430, DOI 10.1002/1615-9861(200204)2:4<430::AID-PROT430>3.0.CO;2-5; Underwood KA, 2005, BIOTECHNOL BIOENG, V91, P425, DOI 10.1002/bit.20529; Vesper O, 2011, CELL, V147, P147, DOI 10.1016/j.cell.2011.07.047; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang YR, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-58; ZUBAY G, 1973, ANNU REV GENET, V7, P267, DOI 10.1146/annurev.ge.07.120173.001411; Zundel MA, 2009, RNA, V15, P977, DOI 10.1261/rna.1381309	50	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168764	10.1371/journal.pone.0168764	http://dx.doi.org/10.1371/journal.pone.0168764			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992588	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842600097
J	Yang, L; Yang, HL; Tu, ZC; Wang, XL				Yang, Lin; Yang, Hui-lin; Tu, Zong-cai; Wang, Xiao-lan			High-Throughput Sequencing of Microbial Community Diversity and Dynamics during Douchi Fermentation	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; LACTIC-ACID BACTERIA; SOLID-STATE FERMENTATION; MOLECULAR-IDENTIFICATION; ENVIRONMENTAL-CONDITIONS; GUT MICROBIOTA; CHINESE DOUCHI; SOYBEAN PASTE; PCR-DGGE; SOIL	Douchi is a type of Chinese traditional fermented food that is an important source of protein and is used in flavouring ingredients. The end product is affected by the microbial community present during fermentation, but exactly how microbes influence the fermentation process remains poorly understood. We used an Illumina MiSeq approach to investigate bacterial and fungal community diversity during both douchi-koji making and fermentation. A total of 181,443 high quality bacterial 16S rRNA sequences and 221,059 high quality fungal internal transcribed spacer reads were used for taxonomic classification, revealing eight bacterial and three fungal phyla. Firmicutes, Actinobacteria and Proteobacteria were the dominant bacterial phyla, while Ascomycota and Zygomycota were the dominant fungal phyla. At the genus level, Staphylococcus and Weissella were the dominant bacteria, while Aspergillus and Lichtheimia were the dominant fungi. Principal coordinate analysis showed structural separation between the composition of bacteria in koji making and fermentation. However, multivariate analysis of variance based on unweighted UniFrac distances did identify distinct differences (p < 0.05), and redundancy analysis identified two key genera that are largely responsible for the differences in bacterial composition between the two steps. Staphylococcus was enriched in koji making, while Corynebacterium was enriched in fermentation. This is the first investigation to integrate douchi fermentation and koji making and fermentation processes through this technological approach. The results provide insight into the microbiome of the douchi fermentation process, and reveal a structural separation that may be stratified by the environment during the production of this traditional fermented food.	[Yang, Lin; Yang, Hui-lin; Tu, Zong-cai; Wang, Xiao-lan] Jiangxi Normal Univ, Key Lab Protect & Utilizat Subtrop Plant Resource, Nanchang, Jiangxi, Peoples R China	Jiangxi Normal University	Wang, XL (corresponding author), Jiangxi Normal Univ, Key Lab Protect & Utilizat Subtrop Plant Resource, Nanchang, Jiangxi, Peoples R China.	xlwang08@aliyun.com			China Agricultural Science and Technology Achievements Transformation Project; Natural Science Foundation of Jiangxi Province [20142BAB214008, 20151BAB204003]; Development Foundation of Key Lab of Protection and Utilization of Subtropic Plant Resources [YRD201405]	China Agricultural Science and Technology Achievements Transformation Project; Natural Science Foundation of Jiangxi Province(Natural Science Foundation of Jiangxi Province); Development Foundation of Key Lab of Protection and Utilization of Subtropic Plant Resources	This work was supported by China Agricultural Science and Technology Achievements Transformation Project(2014), by the Natural Science Foundation of Jiangxi Province (20142BAB214008, 20151BAB204003) and by the Development Foundation of Key Lab of Protection and Utilization of Subtropic Plant Resources (YRD201405).; This work was supported by a China Agricultural Science and Technology Achievements Transformation Project (2014), by the Natural Science Foundation of Jiangxi Province (grant Nos. 20142BAB214008 and 20151BAB204003) and by the Development Foundation of the Key Lab of Protection and Utilization of Subtropical Plant Resources (grant No. YRD201405).	Aldrete-Tapia A, 2014, FOOD MICROBIOL, V44, P136, DOI 10.1016/j.fm.2014.05.022; Balachandar D, 2014, COMMUN SOIL SCI PLAN, V45, P189, DOI 10.1080/00103624.2013.841919; Burgess SA, 2010, INT J FOOD MICROBIOL, V144, P215, DOI 10.1016/j.ijfoodmicro.2010.09.027; Chen C, 2015, J APPL MICROBIOL, V119, P1324, DOI 10.1111/jam.12917; Chen J, 2007, FOOD CHEM, V103, P1091, DOI 10.1016/j.foodchem.2006.10.003; Chen TT, 2014, J FOOD SCI, V79, pM653, DOI 10.1111/1750-3841.12417; Chen TT, 2012, J SCI FOOD AGR, V92, P2171, DOI 10.1002/jsfa.5604; Chen TT, 2011, FOOD SCI BIOTECHNOL, V20, P1633, DOI 10.1007/s10068-011-0225-0; Chen TT, 2011, INT J FOOD SCI TECH, V46, P1878, DOI 10.1111/j.1365-2621.2011.02696.x; Crawford PA, 2009, P NATL ACAD SCI USA, V106, P11276, DOI 10.1073/pnas.0902366106; Cuecas A, 2014, MICROB ECOL, V68, P729, DOI 10.1007/s00248-014-0437-y; Dineen SM, 2010, J APPL MICROBIOL, V109, P1886, DOI 10.1111/j.1365-2672.2010.04816.x; Ezeokoli OT, 2016, INT J FOOD MICROBIOL, V220, P58, DOI 10.1016/j.ijfoodmicro.2016.01.003; Filleron A, 2014, J MICROBIOL METH, V98, P67, DOI 10.1016/j.mimet.2013.12.022; Furuhata K, 2010, BIOCONTROL SCI, V15, P81, DOI 10.4265/bio.15.81; Georgieva R, 2009, INT DAIRY J, V19, P696, DOI 10.1016/j.idairyj.2009.06.006; Huang XQ, 2015, MICROBIOL RES, V181, P33, DOI 10.1016/j.micres.2015.08.004; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Igarashi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107909; Ishida H, 1998, BIOL PHARM BULL, V21, P62, DOI 10.1248/bpb.21.62; Jeyaram K, 2008, INT J FOOD MICROBIOL, V122, P259, DOI 10.1016/j.ijfoodmicro.2007.12.026; Juan MY, 2010, FOOD MICROBIOL, V27, P918, DOI 10.1016/j.fm.2010.05.009; Juste A, 2014, FOOD MICROBIOL, V39, P39, DOI 10.1016/j.fm.2013.10.010; Kemp PF, 2004, FEMS MICROBIOL ECOL, V47, P161, DOI 10.1016/S0168-6496(03)00257-5; Kim JH, 2005, FOOD CONTROL, V16, P43, DOI 10.1016/j.foodcont.2003.11.004; Kim Joo-Shin, 2008, Preventive Nutrition and Food Science, V13, P12; Kim T, 2010, CURR MICROBIOL, V60, P315, DOI 10.1007/s00284-009-9542-4; Kim TW, 2009, INT J FOOD MICROBIOL, V131, P265, DOI 10.1016/j.ijfoodmicro.2009.03.001; Koort J, 2006, INT J FOOD MICROBIOL, V109, P164, DOI 10.1016/j.ijfoodmicro.2006.01.021; Kyselkova M, 2008, ANTON LEEUW INT J G, V94, P439, DOI 10.1007/s10482-008-9261-z; Leite AMO, 2012, FOOD MICROBIOL, V31, P215, DOI 10.1016/j.fm.2012.03.011; Li P, 2015, APPL ENVIRON MICROB, V81, P5144, DOI 10.1128/AEM.01325-15; Garcia NFL, 2015, ELECTRON J BIOTECHN, V18, P314, DOI 10.1016/j.ejbt.2015.05.007; Liu BH, 2012, BIOINFORMATICS, V28, P2870, DOI 10.1093/bioinformatics/bts563; Liu CJ, 2012, J ZHEJIANG UNIV-SC B, V13, P298, DOI 10.1631/jzus.B1100221; Liu WJ, 2015, ANN MICROBIOL, V65, P1741, DOI 10.1007/s13213-014-1013-x; Luckow T, 2004, FOOD QUAL PREFER, V15, P751, DOI 10.1016/j.foodqual.2003.12.007; Marsh AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069371; MESSINA MJ, 1994, NUTR CANCER, V21, P113, DOI 10.1080/01635589409514310; Mills DK, 2007, SOIL SCI SOC AM J, V71, P572, DOI 10.2136/sssaj2006.0147; Mohammadi P, 2015, JUNDISHAPUR J MICROB, V8, DOI 10.5812/jjm.22249; MOMOSE H, 1978, AGR BIOL CHEM TOKYO, V42, P1911, DOI 10.1080/00021369.1978.10863274; Montel MC, 2014, INT J FOOD MICROBIOL, V177, P136, DOI 10.1016/j.ijfoodmicro.2014.02.019; Ndagano D, 2011, J FOOD SCI, V76, pM305, DOI 10.1111/j.1750-3841.2011.02257.x; Nicolaisen MH, 2002, J MICROBIOL METH, V50, P189, DOI 10.1016/S0167-7012(02)00026-X; O'Sullivan DJ, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0596-0; Pires ACC, 2012, APPL ENVIRON MICROB, V78, P5520, DOI 10.1128/AEM.00386-12; Polka J, 2015, FOOD MICROBIOL, V46, P342, DOI 10.1016/j.fm.2014.08.023; Quigley L, 2012, APPL ENVIRON MICROB, V78, P5717, DOI 10.1128/AEM.00918-12; Ranjard L, 2001, APPL ENVIRON MICROB, V67, P4479, DOI 10.1128/AEM.67.10.4479-4487.2001; Saratale GD, 2011, BIODEGRADATION, V22, P905, DOI 10.1007/s10532-010-9450-0; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shen ZZ, 2015, BIOL FERT SOILS, V51, P553, DOI 10.1007/s00374-015-1002-7; Tang J, 2015, J IMMUNOL METHODS, V421, P112, DOI 10.1016/j.jim.2015.04.004; Van Hamme JD, 2003, MICROBIOL MOL BIOL R, V67, P503, DOI 10.1128/MMBR.67.4.503-549.2003; Wang W, 2016, MICROBIOL RES, V182, P59, DOI 10.1016/j.micres.2015.10.003; Xie ZF, 2014, BIORESOURCE TECHNOL, V161, P29, DOI 10.1016/j.biortech.2014.03.014; You J, 2016, APPL MICROBIOL BIOT, V100, P1469, DOI 10.1007/s00253-015-7073-4; Yovita Siti P, 2005, THESIS; Zhao JX, 2009, INT J FOOD SCI TECH, V44, P2526, DOI 10.1111/j.1365-2621.2009.02079.x; Zheng XW, 2014, INT J FOOD MICROBIOL, V182, P57, DOI 10.1016/j.ijfoodmicro.2014.05.008	61	51	53	7	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168166	10.1371/journal.pone.0168166	http://dx.doi.org/10.1371/journal.pone.0168166			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992473	Green Published, gold, Green Submitted			2022-12-26	WOS:000392842600039
J	De Toni, L; Garolla, A; Menegazzo, M; Magagna, S; Di Nisio, A; Sabovic, I; Rocca, MS; Scattolini, V; Filippi, A; Foresta, C				De Toni, Luca; Garolla, Andrea; Menegazzo, Massimo; Magagna, Sabina; Di Nisio, Andrea; Sabovic, Iva; Rocca, Maria Santa; Scattolini, Valentina; Filippi, Andrea; Foresta, Carlo			Heat Sensing Receptor TRPV1 Is a Mediator of Thermotaxis in Human Spermatozoa	PLOS ONE			English	Article							SPERM PLASMA-MEMBRANE; CALCIUM ACCUMULATION; VANILLOID RECEPTORS; ACROSOME REACTION; BOAR SPERMATOZOA; FERTILIZATION; CAPSAICIN; CHANNELS; CAPACITATION; ANANDAMIDE	The molecular bases of sperm thermotaxis, the temperature-oriented cell motility, are currently under investigation. Thermal perception relies on a subclass of the transient receptor potential [TRP] channels, whose member TRPV1 is acknowledged as the heat sensing receptor. Here we investigated the involvement of TRPV1 in human sperm thermotaxis. We obtained semen samples from 16 normozoospermic subjects attending an infertility survey programme, testis biopsies from 6 patients with testicular germ cell cancer and testis fine needle aspirates from 6 patients with obstructive azoospermia undergoing assisted reproductive technologies. Expression of TRPV1 mRNA was assessed by RT-PCR. Protein expression of TRPV1 was determined by western blot, flow cytometry and immunofluorescence. Sperm motility was assessed by Sperm Class Analyser. Acrosome reaction, apoptosis and intracellular-Ca2+ content were assessed by flow cytometry. We found that TRPV1 mRNA and protein were highly expressed in the testis, in both Sertoli cells and germ-line cells. Moreover, compared to no-gradient controls at 31 degrees C or 37 degrees C (Ctrl 31 degrees C and Ctrl 37 degrees C respectively), sperm migration towards a temperature gradient of 31 - 37 degrees C (T gradient) in non-capacitated conditions selected a higher number of cells (14,9 +/- 4,2x10(6) cells T gradient vs 5,1 +/- 0,3x10(6) cells Ctrl 31 degrees C and 5,71 +/- 0,74x10(6) cells Ctrl 37 degrees C; P = 0,039). Capacitation amplified the migrating capability towards the T gradient. Sperms migrated towards the T gradient showed enriched levels of both TRPV1 protein and mRNA. In addition, sperm cells were able to migrate toward a gradient of capsaicin, a specific agonist of TRPV1, whilst capsazepine, a specific agonist of TRPV1, blocked this effect. Finally, capsazepine severely blunted migration towards T gradient without abolishing. These results suggest that TRPV1 may represent a facilitating mediator of sperm thermotaxis.	[De Toni, Luca; Garolla, Andrea; Menegazzo, Massimo; Magagna, Sabina; Di Nisio, Andrea; Sabovic, Iva; Rocca, Maria Santa; Foresta, Carlo] Univ Padua, Unit Androl & Reprod Med, Dept Med, Padua, Italy; [Sabovic, Iva] IRCCS Ist Oncol Veneto IOV, Padua, Italy; [Scattolini, Valentina] Univ Padua, Dept Med, Padua, Italy; [Scattolini, Valentina] Venetian Inst Mol Med, Padua, Italy; [Filippi, Andrea] Univ Padua, Dept Phys & Astron G Galilei, Padua, Italy	University of Padua; IRCCS Istituto Oncologico Veneto (IOV); University of Padua; Veneto Institute Molecular Medicine; University of Padua	Foresta, C (corresponding author), Univ Padua, Unit Androl & Reprod Med, Dept Med, Via Giustiniani, Padua, Italy.	carlo.foresta@unipd.it	menegazzo, massimo/AAD-2548-2022; Santa Rocca, Maria/AAB-9909-2022; Santa Rocca, Maria/AAS-5445-2020; Di Nisio, Andrea/AAI-3161-2020; Garolla, Andrea/AFS-1388-2022; Garolla, Andrea/AAC-4607-2022	Santa Rocca, Maria/0000-0002-4794-9745; Garolla, Andrea/0000-0003-4736-9051; Garolla, Andrea/0000-0003-4736-9051; De Toni, Luca/0000-0003-4958-5217; Di Nisio, Andrea/0000-0002-7251-9210; Scattolini, Valentina/0000-0002-0855-9402				Armon L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028359; Bahat A, 2003, NAT MED, V9, P149, DOI 10.1038/nm0203-149; Bahat A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041915; Bahat A, 2010, BIOL REPROD, V82, P606, DOI 10.1095/biolreprod.109.080127; BALDI E, 1991, J ANDROL, V12, P323; Bernabo N, 2010, MOL CELL ENDOCRINOL, V323, P224, DOI 10.1016/j.mce.2010.02.025; Bettella A, 2005, ASIAN J ANDROL, V7, P289, DOI 10.1111/j.1745-7262.2005.00043.x; Boryshpolets S, 2015, HUM REPROD, V30, P884, DOI 10.1093/humrep/dev002; Caterina MJ, 2003, PAIN, V105, P5, DOI 10.1016/S0304-3959(03)00259-8; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; COHENDAYAG A, 1995, P NATL ACAD SCI USA, V92, P11039, DOI 10.1073/pnas.92.24.11039; DAVID A, 1972, International Journal of Gynecology and Obstetrics, V10, P52; De Petrocellis L, 2000, FEBS LETT, V483, P52, DOI 10.1016/S0014-5793(00)02082-2; De Toni L, 2016, J CLIN ENDOCR METAB, V101, P953, DOI 10.1210/jc.2015-3967; deLamirande E, 1997, MOL HUM REPROD, V3, P175, DOI 10.1093/molehr/3.3.175; Eisenbach M, 2006, NAT REV MOL CELL BIO, V7, P276, DOI 10.1038/nrm1893; Eisenbach M, 1999, BIOESSAYS, V21, P203, DOI 10.1002/(SICI)1521-1878(199903)21:3<203::AID-BIES4>3.0.CO;2-T; Eisenbach M, 1999, REV REPROD, V4, P56, DOI 10.1530/revreprod/4.1.56; Fadini GP, 2016, DIABETES, V65, P1061, DOI 10.2337/db15-0863; Flesch FM, 2000, BBA-REV BIOMEMBRANES, V1469, P197, DOI 10.1016/S0304-4157(00)00018-6; Foresta C, 2014, HUM REPROD, V29, P1134, DOI 10.1093/humrep/deu075; Francavilla F, 2009, ENDOCRINOLOGY, V150, P4692, DOI 10.1210/en.2009-0057; Garolla A, 2013, HUM REPROD, V28, P877, DOI 10.1093/humrep/det020; Gervasi MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016993; Hail N, 2003, APOPTOSIS, V8, P251, DOI 10.1023/A:1023620821878; Jimenez-Gonzalez C, 2006, HUM REPROD UPDATE, V12, P253, DOI 10.1093/humupd/dmi050; Jung A, 2007, ANDROLOGIA, V39, P203, DOI 10.1111/j.1439-0272.2007.00794.x; Kasvandik S, 2015, PROTEOMICS, V15, P1906, DOI 10.1002/pmic.201400297; Klionsky L, 2006, J PHARMACOL EXP THER, V319, P192, DOI 10.1124/jpet.106.108092; Lewis SEM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047704; Maccarrone M, 2005, J CELL SCI, V118, P4393, DOI 10.1242/jcs.02536; Miller S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107151; Mizrak SC, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-52; Moiseenkova-Bell VY, 2009, J GEN PHYSIOL, V133, P239, DOI 10.1085/jgp.200810123; Naziroglu M, 2015, NEUROSCIENCE, V293, P55, DOI 10.1016/j.neuroscience.2015.02.041; Oh U, 1996, J NEUROSCI, V16, P1659; Ottaviano G, 2013, EUR ARCH OTO-RHINO-L, V270, P3079, DOI 10.1007/s00405-013-2441-0; Perez-Cerezales S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16146; Schuel H, 2002, MOL REPROD DEV, V63, P376, DOI 10.1002/mrd.90021; Shimada M, 2008, DEVELOPMENT, V135, P2001, DOI 10.1242/dev.020461; Teves ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008211; Vay L, 2012, BRIT J PHARMACOL, V165, P787, DOI 10.1111/j.1476-5381.2011.01601.x; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Wu CC, 2006, MUTAT RES-FUND MOL M, V601, P71, DOI 10.1016/j.mrfmmm.2006.06.015; Yu JM, 2012, HUM REPROD, V27, P25, DOI 10.1093/humrep/der377; Zuccarello D, 2011, INT J ANDROL, V34, pE554, DOI 10.1111/j.1365-2605.2011.01158.x; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	48	33	33	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0167622	10.1371/journal.pone.0167622	http://dx.doi.org/10.1371/journal.pone.0167622			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992447	Green Published, Green Submitted, gold			2022-12-26	WOS:000392758000013
J	Holko, P; Kawalec, P; Mossakowska, M; Pilc, A				Holko, Przemyslaw; Kawalec, Pawel; Mossakowska, Malgorzata; Pilc, Andrzej			Health-Related Quality of Life Impairment and Indirect Cost of Crohn's Disease: A Self-Report Study in Poland	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; WORK PRODUCTIVITY; ECONOMIC EVALUATIONS; INFORMAL CARE; ULCERATIVE-COLITIS; FOLLOW-UP; QUESTIONNAIRE; VALIDITY; BURDEN; DETERMINANTS	Background and Aims Evidence on indirect cost of Crohn's disease (CD) is available but typically provides information on the loss of productivity at paid work of patients. In the present study, the quality of life and indirect costs of CD patients were assessed (overall and by disease severity). Methods A self-report questionnaire-based study among adult Polish patients with CD was performed. We collected data on patients' characteristics, quality of life, loss of productivity, consumption of medical resources, and out-of-pocket expenses. The disease severity was determined using the patient's version of the Harvey-Bradshaw index. Productivity costs were assessed from the social perspective, using a human capital approach. The cost of absenteeism, presenteeism and permanent work disability was valuated using the gross domestic product per worker. The patients' productivity loss at unpaid work was measured by time inputs of others to assist patients. The productivity loss among informal caregivers and patients' productivity loss at unpaid work were valuated with the average wage in Poland. The results were adjusted for confounders. Results The responses from 200 patients (47% in remission) were analysed. The mean utility index was 0.839 (SD 0.171). The total indirect cost was estimated at (sic)462.47 per patient per month (24.0%, absenteeism; 35.0%, work disability; 30.4%, presenteeism; 0.4%, productivity loss at unpaid work; and 10.4%, informal care). A significant correlation of the quality of life and productivity losses with disease severity was observed. Compared with active disease, the remission subgroup had a higher utility index by 16% (p<0.001) and lower indirect costs by 71% (p = 0.003) for absenteeism, 41% (p = 0.030) for presenteeism, 76% (p<0.001) for productivity loss at unpaid work, and 75% (p<0.001) for informal care. Conclusions Our study revealed the social burden of CD and high dependency of indirect costs and quality of life on the severity of CD in Poland.	[Holko, Przemyslaw; Kawalec, Pawel] Jagiellonian Univ, Coll Med, Drug Management Dept, Krakow, Poland; [Mossakowska, Malgorzata] Polish Assoc Supporting People Inflammatory Bowel, Warsaw, Poland; [Mossakowska, Malgorzata] Int Inst Mol & Cell Biol, Warsaw, Poland; [Pilc, Andrzej] Polish Acad Sci, Dept Neurobiol, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Polish Academy of Sciences	Holko, P (corresponding author), Jagiellonian Univ, Coll Med, Drug Management Dept, Krakow, Poland.	p.holko@uj.edu.pl	Holko, Przemyslaw/H-5720-2011; Pilc, Andrzej/A-3948-2008	Holko, Przemyslaw/0000-0002-6821-4078; Pilc, Andrzej/0000-0002-4045-0597	fund for statuary activities of Drug Management Department, Jagiellonian University	fund for statuary activities of Drug Management Department, Jagiellonian University	The author(s) received no specific funding for this work. This work was supported from the fund for statuary activities of Drug Management Department, Jagiellonian University.	Belotti F, 2015, STATA J, V15, P3, DOI 10.1177/1536867X1501500102; Benedini V, 2012, CLINICOECONOMIC OUTC, V4, P209, DOI 10.2147/CEOR.S31114; Binion DG, 2011, CAN J GASTROENTEROL, V25, P492, DOI 10.1155/2011/938194; Bouwmans C, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-217; Burisch J, 2013, J CROHNS COLITIS, V7, P322, DOI 10.1016/j.crohns.2013.01.010; Busch K, 2014, J CROHNS COLITIS, V8, P1362, DOI 10.1016/j.crohns.2014.06.006; Central Statistical Office of Poland, 2015, AV WAG 3 Q 2015; Central Statistical Office of Poland, 2016, GROSS DOM PROD 2015; Central Statistical Office of Poland, 2016, LAB FORC SURV POL 3; Evertsz' FB, 2013, J CLIN GASTROENTEROL, V47, P850, DOI 10.1097/MCG.0b013e31828b2196; Feagan BG, 2010, ALIMENT PHARM THER, V31, P1276, DOI 10.1111/j.1365-2036.2010.04303.x; Gibson PR, 2014, J CROHNS COLITIS, V8, P598, DOI 10.1016/j.crohns.2013.11.017; Golicki D, 2015, POL ARCH MED WEWN, V125, P18, DOI 10.20452/pamw.2638; Golicki D, 2010, VALUE HEALTH, V13, P289, DOI 10.1111/j.1524-4733.2009.00596.x; Gomollon Garcia F, 2012, J CROHNS COLITIS, V6, pS115; Gregori D, 2011, INT J QUAL HEALTH C, V23, P331, DOI 10.1093/intqhc/mzr010; Havik K, 2014, EC PAPERS, V535; Jacobs P, 2011, J RHEUMATOL, V38, P55, DOI 10.3899/jrheum.110901; Jo C, 2014, CLIN MOL HEPATOL, V20, P327, DOI 10.3350/cmh.2014.20.4.327; Juan J, 2003, DIGEST LIVER DIS, V35, P853, DOI 10.1016/j.dld.2003.07.002; Kawalec P, 2015, EXPERT REV PHARM OUT, V15, P253, DOI 10.1586/14737167.2015.1011130; Koopmanschap MA, 2008, PHARMACOECONOMICS, V26, P269, DOI 10.2165/00019053-200826040-00001; Krol M, 2015, PHARMACOECONOMICS, V33, P123, DOI 10.1007/s40273-014-0218-y; Krol M, 2014, PHARMACOECONOMICS, V32, P335, DOI 10.1007/s40273-014-0132-3; Mesterton J, 2009, INFLAMM BOWEL DIS, V15, P1882, DOI 10.1002/ibd.20939; Michael MD, 2014, EUR J HEALTH ECON, V15, pS121, DOI 10.1007/s10198-014-0603-7; Noyes K, 2007, MED DECIS MAKING, V27, P327, DOI 10.1177/0272989X07301822; Odes S, 2006, GASTROENTEROLOGY, V131, P719, DOI 10.1053/j.gastro.2006.05.052; Polish Health Technology Assessment Agency, 2012, AOTMOT4351222012 POL; President of the National Health Fund of Poland, 2016, ORD DET COND CONCL I; Reilly MC, 2008, CLIN THER, V30, P393, DOI 10.1016/j.clinthera.2008.02.016; REILLY MC, 1993, PHARMACOECONOMICS, V4, P353, DOI 10.2165/00019053-199304050-00006; Stark R, 2006, PHARMACOECONOMICS, V24, P797, DOI 10.2165/00019053-200624080-00006; Tang K, 2015, PHARMACOECONOMICS, V33, P31, DOI 10.1007/s40273-014-0209-z; The National Health Fund of Poland, 2016, SIZ REF COST AM REIM; van den Berg B, 2006, SOC SCI MED, V62, P835, DOI 10.1016/j.socscimed.2005.06.046; van den Berg Bernard, 2004, Eur J Health Econ, V5, P36, DOI 10.1007/s10198-003-0189-y; van der Valk ME, 2014, GUT, V63, P72, DOI 10.1136/gutjnl-2012-303376; Vegh Z, 2015, J CROHNS COLITIS, V9, P747, DOI 10.1093/ecco-jcc/jjv099; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Wladysiuk M, 2014, VALUE HEALTH, V17, pA382, DOI 10.1016/j.jval.2014.08.2627; World Health Organization Collaborating Centre for Drug Statisctics Methodology, 2016, ATC DDD IND; Zhang W, 2011, SOC SCI MED, V72, P185, DOI 10.1016/j.socscimed.2010.10.026	43	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168586	10.1371/journal.pone.0168586	http://dx.doi.org/10.1371/journal.pone.0168586			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8LN	27992531	gold, Green Published			2022-12-26	WOS:000392758000061
J	Pocock, NS; Kiss, L; Oram, S; Zimmerman, C				Pocock, Nicola S.; Kiss, Ligia; Oram, Sian; Zimmerman, Cathy			Labour Trafficking among Men and Boys in the Greater Mekong Subregion: Exploitation, Violence, Occupational Health Risks and Injuries	PLOS ONE			English	Article							WORK-RELATED INJURIES; MIGRANT WORKERS; DISORDERS; FISHERMEN; SEAFARERS; THAILAND; PATTERNS; INDUSTRY; COST	Background Men comprise nearly two-thirds of trafficked and forced labourers in common low-skilled labour sectors including fishing, agriculture and factory work. Yet, most evidence on human trafficking has focused on women and girls trafficked for sex work, with scant research on trafficked men and boys. Methods We analyse survey data from the largest systematic consecutive sample of trafficked people collected to date to describe the prevalence of violence, occupational health risks and injuries and associated factors. Participants were labour-trafficked men and boys using post-trafficking support services in Thailand, Cambodia and Vietnam. Findings Data are presented on 446 males aged 10-58. Men and boys were mainly trafficked for fishing (61.7%), manufacturing (19.1%) and begging (5.2%). Fishermen worked extensive hours (mean 18.8 hours/day, SD 5.9) and factory workers worked on average 11.9 hours/day (SD 2.9). 35.5% of male survivors had been injured while trafficked; 29.4% received no personal protective equipment (e.g. gloves). The most commonly reported injuries among all males were deep cuts (61.8%) and skin injuries (36.7%), injuries for which fewer than one-quarter reported receiving medical care. Six fishermen lost body parts, none of whom received medical care. Most males (80.5%) had no or very few rest breaks. One-third (37.8%) experienced severe violence. Work-related injuries were associated with severe violence (AOR 3.44, CI: 1.63-7.26), being in the fishing sector, (AOR 4.12, CI: 2.39-7.09) and threats (AOR 2.77, CI: 1.62-4.75). Experiencing any violence was associated with threats (AOR 26.86, CI: 14.0-51.23), being in the fishing sector (AOR 18.53, CI: 8.74-39.28) and fluency in language of destination country (AOR 0.39, CI: 0.20-0.75). Conclusion This study highlights the abuse and extreme occupational hazards suffered by trafficked men and boys. Occupational health and safety interventions are urgently needed to protect male migrant labourers working in high-risk sectors, particularly fishing.	[Pocock, Nicola S.; Kiss, Ligia; Zimmerman, Cathy] London Sch Hyg & Trop Med, Gender Violence & Hlth Ctr, Dept Global Hlth & Dev, London, England; [Oram, Sian] Kings Coll London, Inst Psychiat, Sect Womens Mental Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; King's College London	Pocock, NS (corresponding author), London Sch Hyg & Trop Med, Gender Violence & Hlth Ctr, Dept Global Hlth & Dev, London, England.	nicola.pocock@lshtm.ac.uk	Oram, Sian/G-3342-2013	Oram, Sian/0000-0001-8704-0379; Kiss, Ligia/0000-0002-3334-7110	Anesvad Foundation; International Organization for Migration International Development Fund; Economic and Social Science Research Council, UK	Anesvad Foundation; International Organization for Migration International Development Fund; Economic and Social Science Research Council, UK	This study was funded by Anesvad Foundation and the International Organization for Migration International Development Fund, with additional support from the Economic and Social Science Research Council, UK. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Ahonen EQ, 2007, SCAND J WORK ENV HEA, V33, P96, DOI 10.5271/sjweh.1112; Allen P, 2008, INT MARIT HEALTH, V59, P81; Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; [Anonymous], 2011, WORKING PAPER; [Anonymous], 2006, ARCH EMERG MED; Barron L, 2015, MYANMAR TIMES   1223; Brennan M., 2009, OUT SIGHT OUT MIND H; Buller AM, 2015, LABOUR EXPLOITATION; Carotenuto A, 2012, INT MARIT HEALTH, V63, P188; Cha S, 2014, AM J IND MED, V57, P1043, DOI 10.1002/ajim.22349; Day K., 2015, REINTEGRATION CAMBOD; DRISCOLL TR, 1994, OCCUP ENVIRON MED, V51, P612, DOI 10.1136/oem.51.9.612; Environmental Justice Foundation (EJF), 2015, PIR SLAV OV THAIL FU; FAO, 2005, RISKS FISH FISH AQ T; FIDH SUARAM, 2008, 4892 FIDH SUARAM; Finnwatch, 2014, 3 FINNW; Finnwatch, 2013, CHEAP HAS HIGH PRIC; Finnwatch, 2014, 7 FINNW; Finnwatch SACOM SOMO, 2011, SACOM SOMO GAM CONS; Fitzgerald S, 2013, INJURY PREV, V19, P348, DOI 10.1136/injuryprev-2012-040578; Flood M., 2014, OXFORD TXB VIOLENCE, P201; Flynn MA, 2015, AM J IND MED, V58, P1127, DOI 10.1002/ajim.22531; Fujita K, 2010, 257 JETRO I DEV EC; Gallagher A, 2010, HUM RIGHTS QUART, V32, P73, DOI 10.1353/hrq.0.0136; Garcia-Moreno C, 2005, WHO MULTICOUNTRY STU; Hodal K., 2014, GUARDIAN; Hossain M, 2010, AM J PUBLIC HEALTH, V100, P2442, DOI 10.2105/AJPH.2009.173229; HRW, 2010, TIG CROC AB MIGR WOR; ILO, 2003, COD PRACT WORKPL VIO; ILO (International Labour Office), 2012, GLOB EST FORC LAB RE; ILO (International Labour Organization), 2013, EMPL PRACT WORK COND; International Labor Rights Forum and the Migrant Workers Rights Network (ILRF, 2016, BUILD RIGHTS CULT WO; Isarabhakdi P., 2004, ASIAN PAC MIGR J, V13, P107, DOI DOI 10.1177/011719680401300106; Jin KZ, 2010, INJURY PREV, V16, P42, DOI 10.1136/ip.2008.019737; Kara S., 2011, HARVARD INT REV, V33, P66; Kiss L, 2015, JAMA PEDIATR, V169, DOI 10.1001/jamapediatrics.2015.2278; Kiss L, 2015, LANCET GLOB HEALTH, V3, pE154, DOI 10.1016/S2214-109X(15)70016-1; Kongtip P, 2015, NEW SOLUT, V25, P189, DOI 10.1177/1048291115586036; Lee K., 2011, RES OCCUPATIONAL SAF; LSCW CLEC LICADHO Chab Dai IOM ILO, 2012, CAMB FISH AFR; Marks E, 2015, ANTITRAFFICK REV, V5; Matheson C, 2001, OCCUP MED-OXFORD, V51, P305, DOI 10.1093/occmed/51.5.305; Mayhew C, 2007, INT J LAW PSYCHIAT, V30, P327, DOI 10.1016/j.ijlp.2007.06.006; McDermott S, 1990, J Community Health, V15, P297, DOI 10.1007/BF01325137; McDowell R., 2015, AP EXPLORE SEAFOOD S; Ministry of Social Affairs Veterans and Youth Rehabilitation (MOSVY)., 2015, GUID FORMS PROC PREL; Mischke C, 2013, COCHRANE DATABASE SY, V8; Naing Saw Yan, 2014, IRRAWADDY; Naing T, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-22; NORRISH AE, 1990, BRIT J IND MED, V47, P726; Office of Anti-Trafficking in Persons Committee Ministry of Social Development and Human Security, 2008, PREL CHECK LIST ID T; Oram S, 2016, AM J PUBLIC HEALTH, V106, P1073, DOI 10.2105/AJPH.2016.303095; Ottisova L, 2016, EPIDEMIOL PSYCHIAT S, V12, P1; Pearson E, 2006, MEKONG CHALLENGE UND, VOne; Robertson P., 2011, TRAFFICKING FISHERME; Santos A, 2014, PUBLIC HEALTH, V128, P759, DOI 10.1016/j.puhe.2014.04.003; Schenker M, 2008, OCCUP ENVIRON MED, V65, P717, DOI 10.1136/oem.2008.040907; Schenker MB, 2010, AM J IND MED, V53, P329, DOI 10.1002/ajim.20834; StataCorp, 2015, STAT STAT SOFTW REL; Sun GW, 1996, J CLIN EPIDEMIOL, V49, P907, DOI 10.1016/0895-4356(96)00025-X; Turner-Moss E, 2014, J IMMIGR MINOR HEALT, V16, P473, DOI 10.1007/s10903-013-9832-6; UNIAP, 2009, CB03 UNIAP; UNOCHA, 2012, HUM TRAFF GLOB SUPPL; Urbina I., 2015, NY TIMES; Verite International, 2014, FORC LAB PROD EL GOO; Walter N, 2004, SOC SCI MED, V59, P1159, DOI 10.1016/j.socscimed.2003.12.013; Walter N, 2002, J GEN INTERN MED, V17, P221, DOI 10.1046/j.1525-1497.2002.10501.x; Wei L, 2013, ECONOMICS; WHITE G, 1989, CAN FAM PHYSICIAN, V35, P2331; WHO, 2002, WHO WORLD REP VIOL H; Wongcha-um P, 2016, CHANNEL NEWS AS 0118; Yang Long-yu, 2013, Zhonghua Yu Fang Yi Xue Za Zhi, V47, P1132; Yea S., 2012, TROUBLED WATERS TRAF; Yu WZ, 2012, ACCIDENT ANAL PREV, V48, P457, DOI 10.1016/j.aap.2012.03.001; Zheng L, 2014, INJURY, V45, P599, DOI 10.1016/j.injury.2013.07.004; Zheng L, 2010, AM J IND MED, V53, P588, DOI 10.1002/ajim.20833; Zimmerman, 2003, WHO ETHICAL SAFETY R; Zimmerman C., 2006, STOLEN SMILES SUMMAR; Zimmerman C, 2014, HUMAN TRAFFICKING FO; Zimmerman C, 2014, HLTH HUMAN TRAFFICKI; Zweynert A, 2015, SLAVERY TRAFFICKED F	81	27	27	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168500	10.1371/journal.pone.0168500	http://dx.doi.org/10.1371/journal.pone.0168500			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8LN	27992583	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000392758000055
J	Yang, WL; Zhu, XY; Zhu, N; Su, CY; Han, QF; Wang, T; Zhang, AH				Yang, Wen-Ling; Zhu, Xue-Yan; Zhu, Ning; Su, Chun-Yan; Han, Qing-Feng; Wang, Tao; Zhang, Ai-Hua			What's the Optimal Lipids Level for Dialysis Patients? A Cohort Study from a Chinese Dialysis Center in a University Hospital	PLOS ONE			English	Article							ATHEROSCLEROTIC CARDIOVASCULAR EVENTS; DENSITY-LIPOPROTEIN CHOLESTEROL; CHRONIC KIDNEY-DISEASE; MANAGING DYSLIPIDEMIA; NON-HDL; HEMODIALYSIS; ABNORMALITIES; POPULATION; GUIDELINES	Background With lipid level being a major contributing factor for cardiovascular health, the high cardiovascular mortality among dialysis patients has raised substantial concerns in regard to the optimal lipid level in these patient population. Objective To explore the optimal lipid level for the survival of dialysis patients. Methods The lipid profile was measured for each patient. All participants were followed throughout the course of the study. Cox proportional hazards analysis was performed to analyze the prognostic value of lipid level on the survival of these patients. Results In our study that included 311 stable maintenance dialysis patients, 54.98% of the participants had LDL-C level >= 100 mg/dl and 82.91% of the patients with triglycerides >= 200 mg/dl had non-HDL level >= 130 mg/dl. During the follow-up period of 48.0 (18.0, 55.5) months, 149 (47.91%) participants died. Among those who died, 59 patients died of cardiovascular disease (CVD) and 33 patients died of ischemic CVD (12.0, 4.7, and 2.7 events per 100 patient-years, respectively). Patients with LDL-C 100-130 mg/dl or non-HDL 130-160 mg/dl had a lower all-cause mortality rate than those who did not meet these criteria. After adjusting for the traditional and ESRD-related risk factors, non-HDL was found to be the independent risk factor for the all-cause mortality. Compared to those patients with non-HDL 130-160 mg/dl, patients with non-HDL < 100 mg/dl, 100-130 mg/dl, 160-190 mg/dl, or >= 190 mg/dl all had higher all-cause mortality: HR (95% CI) 3.207 (1.801, 5.713), 2.493 (1.485, 4.184), 2.476 (1.423, 4.307), and 1.917 (1.099, 3.345), respectively. There were no differences in nutrition, comorbidity, and inflammation indices among the patients with different non-HDL groups. However, patients with non-HDL of 130-160 mg/dl had the lowest corrected calcium and calcium phosphate product values as compared with other non-HDL groups. Conclusion Our study demonstrated that non-HDL 130-160 mg/dl might be the most appropriate lipid level in our dialysis patients. Our follow-up data also showed that patients with higher lipid level had poorer prognosis, just as in the general population.	[Yang, Wen-Ling; Zhu, Ning; Su, Chun-Yan; Han, Qing-Feng; Wang, Tao; Zhang, Ai-Hua] Peking Univ, Hosp 3, Dept Nephrol, Beijing, Peoples R China; [Zhu, Xue-Yan] Jilin Med Univ, Dept Nephrol, Changchun, Jilin Province, Peoples R China	Peking University; Jilin Medical University	Zhang, AH (corresponding author), Peking Univ, Hosp 3, Dept Nephrol, Beijing, Peoples R China.	hanqingfeng@sina.com; zgbjrose9985@yahoo.com			peking university third hospital; Atherosclerosis Clinical medical research special funds projects by Chinese Medical Association [09010030158]	peking university third hospital; Atherosclerosis Clinical medical research special funds projects by Chinese Medical Association	Funded by the seed money of the peking university third hospital and Atherosclerosis Clinical medical research special funds projects by Chinese Medical Association (grant number: 09010030158) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Bolton K, 2005, AM J KIDNEY DIS, V45, pS7, DOI 10.1053/j.ajkd.2005.01.016; Chae JW, 2011, NEPHRON CLIN PRACT, V117, pC379, DOI 10.1159/000321525; Chan DT, 2008, ATHEROSCLEROSIS, V196, P823, DOI 10.1016/j.atherosclerosis.2007.01.023; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chawla V, 2010, CLIN J AM SOC NEPHRO, V5, P1582, DOI 10.2215/CJN.01450210; Collins AJ, 2003, AM J KIDNEY DIS, V41, pV, DOI 10.1016/S0272-6386(03)80001-X; Echida Y, 2012, CLIN EXP NEPHROL, V16, P767, DOI 10.1007/s10157-012-0615-5; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Keane WF, 2005, CARDIOL CLIN, V23, P363, DOI 10.1016/j.ccl.2005.03.004; Kim C-G, 2014, ELECTRON J DIFFER EQ, V2014, P38, DOI DOI 10.1159/000367803; Longenecker JC, 2002, J AM SOC NEPHROL, V13, P1918, DOI 10.1097/01.ASN.0000019641.41496.1E; Lupton JR, 2016, J CLIN LIPIDOL, V10, P72, DOI 10.1016/j.jacl.2015.09.006; Marz W, 2011, CLIN J AM SOC NEPHRO, V6, P1316, DOI 10.2215/CJN.09121010; Navaneethan SD, 2009, COCHRANE DATABASE SY, VD4289; Nogueira J, 2007, CLIN J AM SOC NEPHRO, V2, P766, DOI 10.2215/CJN.04131206; Patwardhan VG, 2015, J CLIN LIPIDOL, V9, P652, DOI 10.1016/j.jacl.2015.05.007; Pennell P, 2006, CLIN NEPHROL, V66, P336; Quaschning T, 2001, AM J KIDNEY DIS, V38, pS14, DOI 10.1053/ajkd.2001.27384; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Shoji T, 2006, THER APHER DIAL, V10, P305, DOI 10.1111/j.1744-9987.2006.00382.x; Shoji T, 2014, CLIN EXP NEPHROL, V18, P257, DOI 10.1007/s10157-013-0871-z; Shoji T, 2011, CLIN J AM SOC NEPHRO, V6, P1112, DOI 10.2215/CJN.09961110; Sidhu Manavjot S, 2010, Adv Perit Dial, V26, P47; Snyder JJ, 2009, AM J NEPHROL, V30, P44, DOI 10.1159/000201014; Stone NJ, 2014, ANN INTERN MED, V160, P339, DOI 10.7326/M14-0126; Tonelli M, 2014, ANN INTERN MED, V160, P182, DOI 10.7326/M13-2453; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Weiner DE, 2004, J GEN INTERN MED, V19, P1045, DOI 10.1111/j.1525-1497.2004.40049.x; Zoppellaro G, 2012, AM J KIDNEY DIS, V59, P135, DOI 10.1053/j.ajkd.2011.07.027	31	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0167258	10.1371/journal.pone.0167258	http://dx.doi.org/10.1371/journal.pone.0167258			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992532	Green Published, Green Submitted, gold			2022-12-26	WOS:000392758000012
J	Amoroso, G; Ventura, T; Cobcroft, JM; Adams, MB; Elizur, A; Carter, CG				Amoroso, Gianluca; Ventura, Tomer; Cobcroft, Jennifer M.; Adams, Mark B.; Elizur, Abigail; Carter, Chris G.			Multigenic Delineation of Lower Jaw Deformity in Triploid Atlantic Salmon (Salmo salar L.)	PLOS ONE			English	Article							VERTEBRAL DEFORMITIES; SKELETAL ANOMALIES; TRANSGENIC MICE; COL2A1 GENE; BONE; GROWTH; CARTILAGE; PERFORMANCE; GALECTIN-3; MUTATIONS	Lower jaw deformity (LJD) is a skeletal anomaly affecting farmed triploid Atlantic salmon (Salmo salar L.) which leads to considerable economic losses for industry and has animal welfare implications. The present study employed transcriptome analysis in parallel with real-time qPCR techniques to characterise for the first time the LJD condition in triploid Atlantic salmon juveniles using two independent sample sets: experimentally-sourced salmon (60 g) and commercially produced salmon (100 g). A total of eleven genes, some detected/identified through the transcriptome analysis (fbn2, gal and gphb5) and others previously determined to be related to skeletal physiology (alp, bmp4, col1a1, col2a1, fgf23, igf1, mmp13, ocn), were tested in the two independent sample sets. Gphb5, a recently discovered hormone, was significantly (P < 0.05) down-regulated in LJD affected fish in both sample sets, suggesting a possible hormonal involvement. In-situ hybridization detected gphb5 expression in oral epithelium, teeth and skin of the lower jaw. Col2a1 showed the same consistent significant (P < 0.05) down-regulation in LJD suggesting a possible cartilaginous impairment as a distinctive feature of the condition. Significant (P < 0.05) differential expression of other genes found in either one or the other sample set highlighted the possible effect of stage of development or condition progression on transcription and showed that anomalous bone development, likely driven by cartilage impairment, is more evident at larger fish sizes. The present study improved our understanding of LJD suggesting that a cartilage impairment likely underlies the condition and col2a1 may be a marker. In addition, the involvement of gphb5 urges further investigation of a hormonal role in LJD and skeletal physiology in general.	[Amoroso, Gianluca; Cobcroft, Jennifer M.; Adams, Mark B.; Carter, Chris G.] Univ Tasmania, IMAS, Private Bag 49, Hobart, Tas, Australia; [Ventura, Tomer; Cobcroft, Jennifer M.; Elizur, Abigail] Univ Sunshine Coast, Sch Sci & Engn, Genecol Res Ctr, Locked Bag 4, Maroochydore, Qld, Australia	University of Tasmania; University of the Sunshine Coast	Amoroso, G (corresponding author), Univ Tasmania, IMAS, Private Bag 49, Hobart, Tas, Australia.	gianluca.amoroso@utas.edu.au	Carter, Chris Guy/A-3438-2008; Adams, Mark/P-7598-2019; Cobcroft, Jennifer/E-3331-2013; Amoroso, Gianluca/J-3911-2019; Ventura, T./H-9832-2019	Carter, Chris Guy/0000-0001-5210-1282; Adams, Mark/0000-0002-5737-5474; Cobcroft, Jennifer/0000-0002-2398-9267; Amoroso, Gianluca/0000-0003-2985-4205; Ventura, T./0000-0002-0777-2367; Elizur, Abigail/0000-0002-2960-302X	Commonwealth Government's Collaborative Research Network (CRN) Program; Institute for Marine and Antarctic Studies (IMAS); University of Tasmania; IMAS "Tasmania Graduate Research Scholarship"; University of the Sunshine Coast CRN Research Fellowship	Commonwealth Government's Collaborative Research Network (CRN) Program; Institute for Marine and Antarctic Studies (IMAS); University of Tasmania; IMAS "Tasmania Graduate Research Scholarship"; University of the Sunshine Coast CRN Research Fellowship	This research was supported by the Commonwealth Government's Collaborative Research Network (CRN) Program funding and the Institute for Marine and Antarctic Studies (IMAS). The authors would like to thank Petuna, Shaun Slevec and Ryan Wilkinson for their support. Ylenia Pennacchi and Deborah Leonard are thanked for technical assistance during experiments and samplings. Stephen Battaglene is thanked for his contribution to the development of this research. GA was supported by a University of Tasmania and IMAS "Tasmania Graduate Research Scholarship" and JC was supported by a University of the Sunshine Coast CRN Research Fellowship.	Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Amoroso G, 2016, J FISH DIS, V39, P1509, DOI 10.1111/jfd.12492; Amoroso G, 2016, J FISH DIS, V39, P449, DOI 10.1111/jfd.12438; Arteaga-Solis E, 2011, MATRIX BIOL, V30, P188, DOI 10.1016/j.matbio.2011.03.004; Bai H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107050; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Bassett JHD, 2015, ENDOCRINOLOGY, V156, P3098, DOI 10.1210/en.2014-1943; BENFEY TJ, 1984, CAN J FISH AQUAT SCI, V41, P980, DOI 10.1139/f84-112; Benfey TJ, 2001, ICES J MAR SCI, V58, P525, DOI 10.1006/jmsc.2000.1019; Bhat R, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-6; Bikle Daniel D, 2012, Curr Mol Pharmacol, V5, P135; Bodo E, 2010, ENDOCRINOLOGY, V151, P1633, DOI 10.1210/en.2009-0306; Boglione C, 2013, REV AQUACULT, V5, pS121, DOI 10.1111/raq.12016; BRUNO DW, 1990, VET REC, V126, P402; CHEAH KSE, 1985, P NATL ACAD SCI USA, V82, P2555, DOI 10.1073/pnas.82.9.2555; CHEAH KSE, 1991, MAMM GENOME, V1, P171, DOI 10.1007/BF00351064; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Cobcroft JM, 2013, AQUACULTURE, V396, P51, DOI 10.1016/j.aquaculture.2013.02.027; DiGirolamo DJ, 2012, NAT REV RHEUMATOL, V8, P674, DOI 10.1038/nrrheum.2012.157; Donahue LR, 2003, J BONE MINER RES, V18, P1612, DOI 10.1359/jbmr.2003.18.9.1612; ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5; Fjelldal PG, 2016, AQUACULT NUTR, V22, P72, DOI 10.1111/anu.12238; Fjelldal PG, 2012, AQUACULT NUTR, V18, P610, DOI 10.1111/j.1365-2095.2011.00918.x; Fraser TWK, 2015, J FISH DIS, V38, P75, DOI 10.1111/jfd.12206; Fraser TWK, 2013, AQUACULTURE, V416, P255, DOI 10.1016/j.aquaculture.2013.09.034; GAROFALO S, 1991, P NATL ACAD SCI USA, V88, P9648, DOI 10.1073/pnas.88.21.9648; Gillis JA, 2006, J FISH BIOL, V68, P1133, DOI 10.1111/j.0022-1112.2006.00998.x; Golub EE., 2007, CURR OPIN ORTHOP, V18, P444, DOI [10.1097/BCO.0b013e3282630851, 10.1084/jem.93.5.415, DOI 10.1084/JEM.93.5.415]; Guevremont M, 2004, ANN RHEUM DIS, V63, P636, DOI 10.1136/ard.2003.007229; Guntur AR, 2013, BONEKEY REPORTS, V2; Hsu SY, 2002, MOL ENDOCRINOL, V16, P1538, DOI 10.1210/me.16.7.1538; Hu D, 2008, DEV DYNAM, V237, P3727, DOI 10.1002/dvdy.21781; Hughes D., 1992, 1992 SALTAS RES DEV, P17; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; JOHNSTONE R, 1991, CAN TECH REP FISH AQ, V1789, P00015; Jungalwalla P.J, 1991, CANADIAN TECHNICAL R, V1789, P47; Karsenty G, 1995, Int Rev Immunol, V12, P177, DOI 10.3109/08830189509056711; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kuivaniemi H, 1997, HUM MUTAT, V9, P300, DOI 10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; LI SW, 1995, GENE DEV, V9, P2821, DOI 10.1101/gad.9.22.2821; Li YJ, 2009, LAB INVEST, V89, P26, DOI 10.1038/labinvest.2008.111; Lien S, 2016, NATURE, V533, P200, DOI 10.1038/nature17164; Lijalad M, 2009, AQUACULTURE, V290, P145, DOI 10.1016/j.aquaculture.2009.01.039; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Liu W, 2005, DEV BIOL, V283, P282, DOI 10.1016/j.ydbio.2005.04.019; MURRAY LW, 1989, AM J HUM GENET, V45, P5; Nakabayashi K, 2002, J CLIN INVEST, V109, P1445, DOI 10.1172/JCI200214340; Ohshima S, 2003, ARTHRITIS RHEUM-US, V48, P2788, DOI 10.1002/art.11287; Parsons KJ, 2009, ANNU REV GENET, V43, P369, DOI 10.1146/annurev-genet-102808-114917; Pendas AM, 1997, GENOMICS, V40, P222, DOI 10.1006/geno.1996.4554; Piferrer F, 2009, AQUACULTURE, V293, P125, DOI 10.1016/j.aquaculture.2009.04.036; Prockop DJ, 1997, BRIT J RHEUMATOL, V36, P827; Ramirez F, 2009, EXTRACELLULAR MICROF, V21, P616, DOI [10.1016/j.ceb.2009.05.005, DOI 10.1016/J.CEB.2009.05.005]; Rani PU, 1999, DEV DYNAM, V214, P26, DOI 10.1002/(SICI)1097-0177(199901)214:1<26::AID-DVDY3>3.0.CO;2-V; Richards AJ, 2010, HUM MUTAT, V31, pE1461, DOI 10.1002/humu.21257; Robinson PN, 2000, J MED GENET, V37, P9, DOI 10.1136/jmg.37.1.9; Rossert J, 2000, NEPHROL DIAL TRANSPL, V15, P66, DOI 10.1093/ndt/15.suppl_6.66; Sadler J, 2001, AQUACULTURE, V198, P369, DOI 10.1016/S0044-8486(01)00508-7; Sadler J., 2000, THESIS; Sahlman J, 2004, ARTHRITIS RHEUM-US, V50, P3153, DOI 10.1002/art.20552; Savontaus M, 2004, Orthod Craniofac Res, V7, P216, DOI 10.1111/j.1601-6343.2004.00304.x; Stock M, 2003, J BIOL CHEM, V278, P17360, DOI 10.1074/jbc.M207631200; STOCKWELL RA, 1979, BIOL CARTILAGE CELLS; Suazo J, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-163; Tahimic Candice G T, 2013, Front Endocrinol (Lausanne), V4, P6, DOI 10.3389/fendo.2013.00006; Tang SY, 2012, J BONE MINER RES, V27, P1936, DOI 10.1002/jbmr.1646; Tanikawa R, 2010, BIOCHEM BIOPH RES CO, V394, P317, DOI 10.1016/j.bbrc.2010.02.175; Taylor JF, 2014, AQUACULTURE, V432, P163, DOI 10.1016/j.aquaculture.2014.05.014; Taylor JF, 2013, AQUACULTURE, V410, P41, DOI 10.1016/j.aquaculture.2013.06.004; TILLER GE, 1990, P NATL ACAD SCI USA, V87, P3889, DOI 10.1073/pnas.87.10.3889; Upholt WB, 1989, COLLAGEN, VV, P31; Venegas Felipe, 2003, Int. J. Morphol., V21, P211, DOI 10.4067/S0717-95022003000300005; Ventura Tomer, 2011, ISRN Endocrinol, V2011, P476283, DOI 10.5402/2011/476283; VIKKULA M, 1994, ANN MED, V26, P107; Vinik Y, 2015, ELIFE, V4, DOI 10.7554/eLife.05914; Wang RN, 2014, GENES DIS, V1, P87, DOI 10.1016/j.gendis.2014.07.005; WHYTE MP, 1994, ENDOCR REV, V15, P439, DOI 10.1210/er.15.4.439; Witten PE, 2003, J ANAT, V203, P435, DOI 10.1046/j.1469-7580.2003.00239.x; Witten PE, 2002, INT J DEV BIOL, V46, P719; Xue F, 2014, ORTHOD CRANIOFAC RES, V17, P144, DOI 10.1111/ocr.12038; Yakar S, 2002, J CLIN INVEST, V110, P771, DOI 10.1172/JCI200215463; Ytteborg Elisabeth, 2010, BMC Physiology, V10, P12, DOI 10.1186/1472-6793-10-12; Ytteborg Elisabeth, 2010, BMC Physiology, V10, P13, DOI 10.1186/1472-6793-10-13	84	5	5	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168454	10.1371/journal.pone.0168454	http://dx.doi.org/10.1371/journal.pone.0168454			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977809	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000391217400109
J	Hosotsubo, M; Magota, T; Egusa, M; Miyawaki, T; Matsumoto, T				Hosotsubo, Miyu; Magota, Tetsuro; Egusa, Masahiko; Miyawaki, Takuya; Matsumoto, Takuya			Fabrication of Artificial Food Bolus for Evaluation of Swallowing	PLOS ONE			English	Article							DYSPHAGIA; VISCOSITY; TEXTURE; MASTICATION; PHYSIOLOGY; TRANSPORT; VOLUME	Simple and easy methods to evaluate swallowing are required because of the recently increased need of rehabilitation for dysphagia. "Artificial food bolus", but not "artificial food", would be a valuable tool for swallowing evaluation without considering the mastication effect which is altered according to the individual's oral condition. Thus, this study was carried out to fabricate artificial bolus resembling natural food bolus. The mechanical property and the volume change of food bolus in normal people were firstly investigated. Thirty healthy adults without dysphagia were selected and asked to chew four sample foods (rice cake, peanut, burdock, and gummy candy). The results indicated that Young's modulus of bolus before swallowing was below 150 kPa. The bolus volume before swallowing was below 400 mm(3). In addition, the saliva component ratio of each bolus was approximately 30wt%, and the average saliva viscosity of research participants was approximately 10 mPa.s. Based on the obtained data, artificial food bolus was designed and fabricated by using alginate hydrogel as a visco-elastic material and gelatin solution as a viscotic material with a ratio of 7: 3 based on weight. Consequently, the swallowing time of fabricated artificial food bolus was measured among the same participants. The results indicated the participants swallowed fabricated food bolus with similar manner reflecting their mechanical property and volume. Thus, this artificial food bolus would be a promising tool for evaluation of swallowing.	[Hosotsubo, Miyu; Magota, Tetsuro; Egusa, Masahiko] Okayama Univ Hosp, Ctr Special Needs Dent, Kita Ku, Shikata Cho, Okayama, Japan; [Hosotsubo, Miyu; Magota, Tetsuro; Miyawaki, Takuya] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Dent Anesthesiol, Kita Ku, Shikata Cho, Okayama, Japan; [Hosotsubo, Miyu; Magota, Tetsuro; Matsumoto, Takuya] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biomat, Kita Ku, Shikata Cho, Okayama, Japan	Okayama University; Okayama University; Okayama University	Matsumoto, T (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biomat, Kita Ku, Shikata Cho, Okayama, Japan.	tmatsu@md.okayama-u.ac.jp		Miyawaki, Takuya/0000-0002-6378-2623				Bailey AJ, 1998, J SOC LEATH TECH CH, V82, P104; Chen JS, 2013, ARCH ORAL BIOL, V58, P293, DOI 10.1016/j.archoralbio.2012.10.014; Cichero Julie A Y, 2013, Curr Phys Med Rehabil Rep, V1, P280; Costa Milton M. B., 2007, Arq. Gastroenterol., V44, P297, DOI 10.1590/S0004-28032007000400004; de Loubens C, 2011, J THEOR BIOL, V280, P180, DOI 10.1016/j.jtbi.2011.04.016; Glassburn DL, 1998, DYSPHAGIA, V13, P218, DOI 10.1007/PL00009575; Inokuchi H, 2014, DYSPHAGIA, V29, P685, DOI 10.1007/s00455-014-9562-5; Kim IS, 2005, ARCH PHYS MED REHAB, V86, P1986, DOI 10.1016/j.apmr.2005.05.004; KOHLER PF, 1985, ARTHRITIS RHEUM-US, V28, P1128, DOI 10.1002/art.1780281008; Lucas PW, 2004, J TEXTURE STUD, V35, P159, DOI 10.1111/j.1745-4603.2004.tb00831.x; Marciani L, 2001, AM J PHYSIOL-GASTR L, V280, pG1227, DOI 10.1152/ajpgi.2001.280.6.G1227; Molfenter SM, 2013, DYSPHAGIA, V28, P226, DOI 10.1007/s00455-012-9437-6; Nagasaki N, 2003, J COOKERY SCI JPN, V36, P364; Narita K, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1249-3; Nicosia MA, 2001, J BIOMECH, V34, P1537, DOI 10.1016/S0021-9290(01)00147-6; Palmer JB, 2007, PHYSIOL BEHAV, V91, P66, DOI 10.1016/j.physbeh.2007.01.018; POUDEROUX P, 1995, GASTROENTEROLOGY, V108, P1418, DOI 10.1016/0016-5085(95)90690-8; Rogus-Pulia NM, 2015, HEAD NECK-J SCI SPEC, V37, P1122, DOI 10.1002/hed.23720; Rosenbek JC, 1996, DYSPHAGIA, V11, P225, DOI 10.1007/BF00265206; Saha D, 2010, J FOOD SCI TECH MYS, V47, P587, DOI 10.1007/s13197-010-0162-6; Schimmel M, 2007, J ORAL REHABIL, V34, P671, DOI 10.1111/j.1365-2842.2007.01773.x; Steele CM, 2015, DYSPHAGIA, V30, P2, DOI 10.1007/s00455-014-9578-x; Stokes JR, 2013, CURR OPIN COLLOID IN, V18, P349, DOI 10.1016/j.cocis.2013.04.010; Swan K, 2015, QUAL LIFE RES, V24, P2447, DOI 10.1007/s11136-015-0990-y; Tsuru H, 1966, J JAPAN PROSTHODONTI, V10, P163; Uchida M, 2012, J CLIN WELFARE, V9, P34; Waldman AS, 1998, J CHEM EDUC, V75, P1430; Yagishita K., 1981, JAPANESE J PEDIATRIC, V19, P489; Yamada Y, 2005, JAPANESE J IN PRESS, V9, P23; Yoshikawa M, 2011, DYSPHAGIA, V26, P232, DOI 10.1007/s00455-010-9291-3; Zoungrana OR, 2000, EXP BRAIN RES, V132, P500, DOI 10.1007/s002210000361	31	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168378	10.1371/journal.pone.0168378	http://dx.doi.org/10.1371/journal.pone.0168378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977775	Green Published, Green Submitted, gold			2022-12-26	WOS:000391217400103
J	Masuda, T; Wan, J; Yerrabelli, A; Berlinicke, C; Kallman, A; Qian, J; Zack, DJ				Masuda, Tomohiro; Wan, Jun; Yerrabelli, Anitha; Berlinicke, Cindy; Kallman, Alyssa; Qian, Jiang; Zack, Donald J.			Off Target, but Sequence-Specific, shRNA-Associated Trans-Activation of Promoter Reporters in Transient Transfection Assays	PLOS ONE			English	Article							ROD PHOTORECEPTOR DEVELOPMENT; RNA INTERFERENCE; MAMMALIAN-CELLS; RETINAL DISEASE; GENE-EXPRESSION; HOMEOBOX GENE; CRX; NRL; RHODOPSIN; PROTEIN	Transient transfection promoter reporter assays are commonly used in the study of transcriptional regulation, and can be used to define and characterize both cis-acting regulatory sequences and trans-acting factors. In the process of using a variety of reporter assays designed to study regulation of the rhodopsin (rho) promoter, we discovered that rhodopsin promoter-driven reporter expression could be activated by certain species of shRNA in a gene-target-independent but shRNA sequence-specific manner, suggesting involvement of a specific shRNA associated pathway. Interestingly, the shRNA-mediated increase of rhodopsin promoter activity was synergistically enhanced by the rhodopsin transcriptional regulators CRX and NRL. Additionally, the effect was cell line-dependent, suggesting that this pathway requires the expression of cell-type specific factors. Since microRNA (miRNA) and interferon response-mediated processes have been implicated in RNAi off-target phenomena, we performed miRNA and gene expression profiling on cells transfected with shRNAs that do target a specific gene but have varied effects on rho reporter expression in order to identify transcripts whose expression levels are associated with shRNA induced rhodopsin promoter reporter activity. We identified a total of 50 miRNA species, and by microarray analysis, 320 protein-coding genes, some of which were predicted targets of the identified differentially expressed miRNAs, whose expression was altered in the presence of shRNAs that stimulated rhodopsin-promoter activity in a non-gene-targeting manner. Consistent with earlier studies on shRNA off-target effects, a number of interferon response genes were among those identified to be upregulated. Taken together, our results confirm the importance of considering off-target effects when interpreting data from RNAi experiments and extend prior results by focusing on the importance of including multiple and carefully designed controls in the design and analysis of the effects of shRNA on transient transfection-based transcriptional assays.	[Masuda, Tomohiro; Wan, Jun; Yerrabelli, Anitha; Berlinicke, Cindy; Qian, Jiang; Zack, Donald J.] Johns Hopkins Univ, Sch Med, Wilmer Inst, Dept Ophthalmol, Baltimore, MD 21205 USA; [Kallman, Alyssa; Zack, Donald J.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21218 USA; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Zack, Donald J.] Univ Paris 06, Inst Vis, Paris, France	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; UDICE-French Research Universities; Sorbonne Universite	Zack, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Wilmer Inst, Dept Ophthalmol, Baltimore, MD 21205 USA.; Zack, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21218 USA.; Zack, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.; Zack, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.; Zack, DJ (corresponding author), Univ Paris 06, Inst Vis, Paris, France.	donzack@gmail.com	Wan, Jun/AAN-1337-2020; Wan, Jun/H-7132-2013	Wan, Jun/0000-0001-9286-6562; Wan, Jun/0000-0001-9286-6562	NIH [EY009769, P30EY001765, EY012543, EY02687]; Foundation Fighting Blindness; Guerrieri Family Foundation; NATIONAL EYE INSTITUTE [P30EY001765] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); Guerrieri Family Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Grants from NIH [EY009769, P30EY001765, EY012543, and EY02687], (https://www.nih.gov/) to DJZ, the Foundation Fighting Blindness (http://www.blindness.org/) and a generous gifts from the Guerrieri Family Foundation and from Mr. and Mrs. Robert and Clarice Smith. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez VA, 2006, J NEUROSCI, V26, P7820, DOI 10.1523/JNEUROSCI.1957-06.2006; Arora S, 2013, MOL GENET GENOMICS, V288, P77, DOI 10.1007/s00438-013-0734-z; Baek ST, 2014, NEURON, V82, P1255, DOI 10.1016/j.neuron.2014.04.036; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; CHABRE M, 1989, EUR J BIOCHEM, V179, P255, DOI 10.1111/j.1432-1033.1989.tb14549.x; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Ehlert EM, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-20; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fellmann C, 2014, NAT CELL BIOL, V16, P10, DOI 10.1038/ncb2895; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Garriga P, 2002, FEBS LETT, V528, P17, DOI 10.1016/S0014-5793(02)03241-6; Goerke AR, 2008, METAB ENG, V10, P187, DOI 10.1016/j.ymben.2008.04.001; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Gu S, 2014, NUCLEIC ACIDS RES, V42, P12169, DOI 10.1093/nar/gku854; Gu S, 2011, P NATL ACAD SCI USA, V108, P9208, DOI 10.1073/pnas.1018023108; Hennig AK, 2008, BRAIN RES, V1192, P114, DOI 10.1016/j.brainres.2007.06.036; Herrera-Carrillo E, 2015, RNA BIOL, V12, P447, DOI 10.1080/15476286.2015.1022024; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Kumar R, 1996, J BIOL CHEM, V271, P29612, DOI 10.1074/jbc.271.47.29612; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mitton KP, 2000, J BIOL CHEM, V275, P29794, DOI 10.1074/jbc.M003658200; Mockenhaupt S, 2015, P NATL ACAD SCI USA, V112, pE4007, DOI 10.1073/pnas.1510476112; Morrow EM, 1998, TRENDS CELL BIOL, V8, P353, DOI 10.1016/S0962-8924(98)01341-5; Naash MI, 2004, J COMP NEUROL, V478, P149, DOI 10.1002/cne.20283; Ng L, 2011, J NEUROSCI, V31, P11118, DOI 10.1523/JNEUROSCI.1709-11.2011; Onishi A, 2010, NAT NEUROSCI, V13, P1059, DOI 10.1038/nn.2618; Onishi A, 2009, NEURON, V61, P234, DOI 10.1016/j.neuron.2008.12.006; Ros XBD, 2016, METHODS, V103, P157, DOI 10.1016/j.ymeth.2016.04.003; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Singh S, 2011, PHARM RES-DORDR, V28, P2996, DOI 10.1007/s11095-011-0608-1; Sioud M, 2007, ADV DRUG DELIVER REV, V59, P153, DOI 10.1016/j.addr.2007.03.006; Song HW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118549; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717; Yoshida S, 2004, HUM MOL GENET, V13, P1487, DOI 10.1093/hmg/ddh160; Zhou NN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117357	41	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0167867	10.1371/journal.pone.0167867	http://dx.doi.org/10.1371/journal.pone.0167867			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977714	Green Submitted, Green Published, gold			2022-12-26	WOS:000391217400038
J	Masre, SF; Rath, N; Olson, MF; Greenhalgh, DA				Masre, S. F.; Rath, N.; Olson, M. F.; Greenhalgh, D. A.			ROCK2/ras(Ha) co-operation induces malignant conversion via p53 loss, elevated NF-kappa B and tenascin C-associated rigidity, but p21 inhibits ROCK2/NF-kappa B-mediated progression	ONCOGENE			English	Article							CYCLIC TENSILE STRAIN; TUMOR-CELL INVASION; CANCER-CELLS; EPIDERMAL HYPERPLASIA; SIGNALING PATHWAYS; TISSUE STIFFNESS; BREAST-CANCER; AKT ACTIVITY; RHO-GTPASES; DNA-DAMAGE	To study ROCK2 activation in carcinogenesis, mice expressing 4-hydroxytamoxifen (4HT)-activated ROCK2 (K14. ROCKer) were crossed with mice expressing epidermal-activated ras(Ha) (HK1.ras(1205)). At 8 weeks, 4HT-treated K14. ROCKer/HK1.ras(1205) cohorts exhibited papillomas similar to HK1.ras1205 controls; however, K14. ROCKer/HK1.ras(1205) histotypes comprised a mixed papilloma/well-differentiated squamous cell carcinoma (wdSCC), exhibiting p53 loss, increased proliferation and novel NF-kB expression. By 12 weeks, K14. ROCKer/HK1. ras(1205) wdSCCs exhibited increased NF-kB and novel tenascin C, indicative of elevated rigidity; yet despite continued ROCK2 activities/p-Mypt1 inactivation, progression to SCC required loss of compensatory p21 expression. K14. ROCKer/ HK1. ras1205 papillomatogenesis also required a wound promotion stimulus, confirmed by breeding K14. ROCKer into promotioninsensitive HK1. ras(1276) mice, suggesting a permissive K14. ROCKer/ HK1. ras1205 papilloma context (wound-promoted/NF-.B+/p53 -/ p21(+)) preceded K14. ROCKer-mediated (p-Mypt1/ tenascinC/rigidity) malignant conversion. Malignancy depended on ROCKer/ pMypt1 expression, as cessation of 4HT treatment induced disorganized tissue architecture and p21-associated differentiation in wdSCCs; yet tenascin C retention in connective tissue extracellular matrix suggests the rigidity laid down for conversion persists. Novel papilloma outgrowths appeared expressing intense, basal layer p21 that confined endogenous ROCK2/p-Mypt1/NF-k\B to supra-basal layers, and was paralleled by restored basal layer p53. In later SCCs, 4HT cessation became irrelevant as endogenous ROCK2 expression increased, driving progression via p21 loss, elevated NF-kB expression and tenascin C-associated rigidity, with p-Mypt1 inactivation/actinomyosin-mediated contractility to facilitate invasion. However, p21-associated inhibition of early-stage malignant progression and the intense expression in papilloma outgrowths, identifies a novel, significant antagonism between p21 and rasHa/ROCK2/NF-kB signalling in skin carcinogenesis. Collectively, these data show that ROCK2 activation induces malignancy in rasHa-initiated/promoted papillomas in the context of p53 loss and novel NF-kB expression, whereas increased tissue rigidity and cell motility/contractility help mediate tumour progression.	[Masre, S. F.; Greenhalgh, D. A.] Glasgow Univ, Coll Med Vet & Life Sci, Sch Med Dent & Nursing, Sect Dermatol & Mol Carcinogenesis, Glasgow, Lanark, Scotland; [Masre, S. F.] Natl Univ Malaysia, Univ Kebangsaan, Fac Allied Hlth Sci, Biomed Sci Programme,Sch Diagnost & Appl Hlth Sci, Kuala Lumpur, Malaysia; [Rath, N.; Olson, M. F.] Canc Res UK, Beatson Inst Canc Res, Mol Cell Biol Lab, Glasgow, Lanark, Scotland; [Rath, N.; Olson, M. F.] Univ Glasgow, Inst Canc Sci, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow; Universiti Kebangsaan Malaysia; Beatson Institute; Cancer Research UK; University of Glasgow	Greenhalgh, DA (corresponding author), Univ Glasgow, Glasgow Royal Infirm, Sect Dermatol & Mol Carcinogenesis, Level 2,New Lister Bldg,10 Alexandra Parade, Glasgow G31 2ER, Lanark, Scotland.	david.greenhalgh@glasgow.ac.uk	Masre, Siti Fathiah/M-3576-2017; Olson, Michael/ABA-4240-2021	Masre, Siti Fathiah/0000-0002-4202-2289; Olson, Michael/0000-0003-3428-3507	Government of Malaysia; Scott Endowment Fund, Dermatology, Glasgow University; Cancer Research UK; Cancer Research UK [18276] Funding Source: researchfish	Government of Malaysia; Scott Endowment Fund, Dermatology, Glasgow University; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	We thank Dr Jean Quinn for help and advice; Stuart Lannigan and Denis Duggan for assistance with animal husbandry. This work was supported by: The Government of Malaysia; the Scott Endowment Fund, Dermatology, Glasgow University; and Cancer Research UK.	Balmain A, 2014, J INVEST DERMATOL, V134, P2; Barboza JA, 2006, P NATL ACAD SCI USA, V103, P19842, DOI 10.1073/pnas.0606343104; Benitah SA, 2003, MOL BIOL CELL, V14, P3041, DOI 10.1091/mbc.E03-01-0016; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Chiquet M, 2004, BBA-MOL CELL RES, V1693, P193, DOI 10.1016/j.bbamcr.2004.08.001; Croft DR, 2006, MOL CELL BIOL, V26, P4612, DOI 10.1128/MCB.02061-05; DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; Ehedego H, 2015, CANCER RES, V75, P1144, DOI 10.1158/0008-5472.CAN-14-1356; Gao CX, 2015, ELIFE, V4, DOI 10.7554/eLife.10072; Ghosh JC, 2005, CLIN CANCER RES, V11, P4580, DOI 10.1158/1078-0432.CCR-04-2624; GREENHALGH DA, 1993, CANCER RES, V53, P5071; GREENHALGH DA, 1993, MOL CARCINOGEN, V7, P99, DOI 10.1002/mc.2940070208; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Ibbetson SJ, 2013, AM J PATHOL, V183, P930, DOI 10.1016/j.ajpath.2013.05.014; Iliopoulos D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000356; Jachetti E, 2015, CANCER RES, V75, P2095, DOI 10.1158/0008-5472.CAN-14-2346; Kamai T, 2003, CLIN CANCER RES, V9, P2632; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Keely PJ, 2011, J MAMMARY GLAND BIOL, V16, P205, DOI 10.1007/s10911-011-9226-0; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Kumper S, 2011, CANCER CELL, V19, P695, DOI 10.1016/j.ccr.2011.05.021; Leonard B, 2015, CANCER RES, V75, P4538, DOI 10.1158/0008-5472.CAN-15-2171-T; Lock FE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008190; Lowy CM, 2015, CELL ADHES MIGR, V9, P112, DOI 10.1080/19336918.2015.1008331; Macdonald FH, 2014, ONCOGENE, V33, P4132, DOI 10.1038/onc.2013.372; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; Olson MF, 1998, NATURE, V394, P295, DOI 10.1038/28425; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Rath N, 2012, EMBO REP, V13, P900, DOI 10.1038/embor.2012.127; Sadok A, 2015, CANCER RES, V75, P2272, DOI 10.1158/0008-5472.CAN-14-2156; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Samuel MS, 2011, CANCER CELL, V19, P776, DOI 10.1016/j.ccr.2011.05.008; Samuel MS, 2009, GENESIS, V47, P440, DOI 10.1002/dvg.20519; Sarasa-Renedo A, 2006, EXP CELL RES, V312, P1361, DOI 10.1016/j.yexcr.2005.12.025; Schlingemann J, 2003, INT J CANCER, V104, P699, DOI 10.1002/ijc.11008; Shah KN, 2015, MOL CANCER THER, V14, P2411, DOI 10.1158/1535-7163.MCT-14-0689; Shi MY, 2015, APOPTOSIS, V20, P843, DOI 10.1007/s10495-015-1106-4; Topley GI, 1999, P NATL ACAD SCI USA, V96, P9089, DOI 10.1073/pnas.96.16.9089; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Valastyan S, 2011, J CELL SCI, V124, P999, DOI 10.1242/jcs.081513; Wang J, 2005, CANCER RES, V65, P6601, DOI 10.1158/0008-5472.CAN-04-4184; Warfel NA, 2013, CURR OPIN ONCOL, V25, P52, DOI 10.1097/CCO.0b013e32835b639e; Webster GA, 1999, MOL CELL BIOL, V19, P3485; Yao DG, 2008, J CELL SCI, V121, P1758, DOI 10.1242/jcs.021147; Yao DG, 2006, CANCER RES, V66, P1302, DOI 10.1158/0008-5472.CAN-05-2341; Zheng BQ, 2011, CLIN CANCER RES, V17, P7574, DOI 10.1158/1078-0432.CCR-11-1714; Zhu JJ, 2015, NATURE, V525, P206, DOI 10.1038/nature15251	50	10	10	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 4	2017	36	18					2529	2542		10.1038/onc.2016.402	http://dx.doi.org/10.1038/onc.2016.402			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET9AN	27991921	Green Accepted			2022-12-26	WOS:000400597300004
J	Saupe, F; Reichel, M; Huijbers, EJM; Femel, J; Markgren, PO; Andersson, CE; Deindl, S; Danielson, UH; Hellman, LT; Olsson, AK				Saupe, Falk; Reichel, Matthias; Huijbers, Elisabeth J. M.; Femel, Julia; Markgren, Per-Olof; Andersson, C. Evalena; Deindl, Sebastian; Danielson, U. Helena; Hellman, Lars T.; Olsson, Anna-Karin			Development of a novel therapeutic vaccine carrier that sustains high antibody titers against several targets simultaneously	FASEB JOURNAL			English	Article						cancer; VLRB; tolerance; ED-A; ED-B	EPITOPE-SPECIFIC REGULATION; ADAPTIVE IMMUNITY; FIBRONECTIN; RESPONSES; CANCER; DOMAIN; IGE; ANGIOGENESIS; SUPPRESSION; VERTEBRATES	With the aim to improve the efficacy of therapeutic vaccines that target self-antigens, we have developed a novel fusion protein vaccine on the basis of the C-terminal multimerizing end of the variable lymphocyte receptor B (VLRB), the Ig equivalent in jawless fishes. Recombinant vaccines were produced in Escherichia coli by fusing the VLRB sequence to 4 different cancer-associated target molecules. The anti-self-immune response generated in mice that were vaccinated with VLRB vaccines was compared with the response in mice that received vaccines that contained bacterial thioredoxin (TRX), previously identified as an efficient carrier. The anti-self-Abswere analyzed with respect to titers, binding properties, and duration of response. VLRB-vaccinatedmice displayed a 2-to 10-fold increase in anti-self-Ab titers and a substantial decrease in Abs against the foreign part of the fusion protein compared with the response in TRX-vaccinated mice (P < 0.01). VLRB-generated Ab response had duration similar to the corresponding TRX-generatedAbs, but displayed a higher diversity in binding characteristics. Of importance, VLRB vaccines could sustain an immune response against several targets simultaneously. VLRB vaccines fulfill several key criteria for an efficient therapeutic vaccine that targets self-antigens as a result of its small size, its multimerizing capacity, and nonexposed foreign sequences in the fusion protein.- Saupe, F., Reichel, M., Huijbers, E. J. M., Femel, J., Markgren, P.- O., Andersson, C. E., Deindl, S., Danielson, U. H., Hellman, L. T., Olsson, A.- K. Development of a novel therapeutic vaccine carrier that sustains high antibody titers against several targets simultaneously.	[Saupe, Falk; Reichel, Matthias; Huijbers, Elisabeth J. M.; Femel, Julia; Olsson, Anna-Karin] Uppsala Univ, Dept Med Biochem & Microbiol, Husargatan 3,Box 582, SE-75123 Uppsala, Sweden; [Markgren, Per-Olof; Danielson, U. Helena] Uppsala Univ, Chem BMC, Biomed Ctr, Uppsala, Sweden; [Andersson, C. Evalena; Deindl, Sebastian; Hellman, Lars T.] Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Uppsala, Sweden; [Huijbers, Elisabeth J. M.] Vrije Univ Amsterdam Med Ctr, Dept Med Oncol, Amsterdam, Netherlands; [Femel, Julia] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA	Uppsala University; Uppsala University; Uppsala University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Oregon Health & Science University	Olsson, AK (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Husargatan 3,Box 582, SE-75123 Uppsala, Sweden.	anna-karin.olsson@imbim.uu.se	Danielson, Helena/A-4217-2012; Huijbers, Elisabeth J.M./K-7764-2013	Danielson, Helena/0000-0003-2728-0340; Huijbers, Elisabeth J.M./0000-0002-7742-9839; Deindl, Sebastian/0000-0001-6807-8654	Swedish Cancer Society [110653]; Vinnova; Swedish Research Council [D0571301]; Alice Wallenberg Foundation/Wallenberg Academy; Ragna and Emil Borjeson's Foundation (Uppsala University)	Swedish Cancer Society(Swedish Cancer Society); Vinnova(Vinnova); Swedish Research Council(Swedish Research CouncilEuropean Commission); Alice Wallenberg Foundation/Wallenberg Academy; Ragna and Emil Borjeson's Foundation (Uppsala University)	This work was supported by the Swedish Cancer Society (110653; to A.-K.O.) and Vinnova (to L.T.H.). U.H.D. was funded by the Swedish Research Council (VR; D0571301) and S.D. by Alice Wallenberg Foundation/Wallenberg Academy Fellows and VR. F.S. was supported by Ragna and Emil Borjeson's Foundation (Uppsala University).	Astorgues-Xerri L, 2014, CANCER TREAT REV, V40, P307, DOI 10.1016/j.ctrv.2013.07.007; Astrof S, 2009, ANGIOGENESIS, V12, P165, DOI 10.1007/s10456-009-9136-6; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Berndt A, 2010, HISTOCHEM CELL BIOL, V133, P467, DOI 10.1007/s00418-010-0685-y; CASTELLANI P, 1994, INT J CANCER, V59, P612, DOI 10.1002/ijc.2910590507; Cavelti-Weder C, 2016, MOL THER, V24, P1003, DOI 10.1038/mt.2015.227; Cho M, 1996, BIOCHEMISTRY-US, V35, P13081, DOI 10.1021/bi961181d; Fattorusso R, 1999, STRUCTURE, V7, P381, DOI 10.1016/S0969-2126(99)80051-3; Femel J, 2014, ONCOTARGET, V5, P12418, DOI 10.18632/oncotarget.2628; Guan Q, 2012, CLIN EXP ALLERGY, V42, P1397, DOI 10.1111/j.1365-2222.2012.04022.x; Hellman L, 2008, EXPERT REV VACCINES, V7, P193, DOI 10.1586/14760584.7.2.193; Herrin BR, 2008, P NATL ACAD SCI USA, V105, P2040, DOI 10.1073/pnas.0711619105; HERZENBERG LA, 1982, J EXP MED, V155, P1741, DOI 10.1084/jem.155.6.1741; HERZENBERG LA, 1982, J EXP MED, V155, P1730, DOI 10.1084/jem.155.6.1730; Hirano M, 2011, ADV IMMUNOL, V109, P125, DOI 10.1016/B978-0-12-387664-5.00004-2; Huijbers EJM, 2012, VACCINE, V30, P225, DOI 10.1016/j.vaccine.2011.11.010; Huijbers EJM, 2010, FASEB J, V24, P4535, DOI 10.1096/fj.10-163022; Jegerlehner A, 2010, VACCINE, V28, P5503, DOI 10.1016/j.vaccine.2010.02.103; Johansson J, 2004, VACCINE, V22, P2873, DOI 10.1016/j.vaccine.2003.12.029; Johansson J, 2007, VACCINE, V25, P1676, DOI 10.1016/j.vaccine.2006.10.055; Kasahara M, 2014, ADV IMMUNOL, V122, P59, DOI 10.1016/B978-0-12-800267-4.00002-X; La Greca F, 2011, HUM VACCINES, V7, P1225, DOI 10.4161/hv.7.11.18203; Lei Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133774; Long CA, 2016, CURR OPIN MICROBIOL, V32, P96, DOI 10.1016/j.mib.2016.04.006; McCluskie MJ, 2016, IMMUNOPHARM IMMUNOT, V38, P184, DOI 10.3109/08923973.2016.1165246; Molehin AJ, 2016, EXPERT REV VACCINES, V15, P619, DOI 10.1586/14760584.2016.1131127; Nandakumar KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013511; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Ringvall M, 2009, VACCINE, V28, P48, DOI 10.1016/j.vaccine.2009.09.122; Saupe F, 2015, FASEB J, V29, P3253, DOI 10.1096/fj.15-271502; Tissot AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009809; Vernersson M, 2002, FASEB J, V16, P875, DOI 10.1096/fj.01-0879fje	32	10	11	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1204	1214		10.1096/fj.201600820R	http://dx.doi.org/10.1096/fj.201600820R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27993994				2022-12-26	WOS:000395671200032
J	Susan-Resiga, D; Girard, E; Kiss, RS; Essalmani, R; Hamelin, J; Asselin, MC; Awan, Z; Butkinaree, C; Fleury, A; Soldera, A; Dory, YL; Baass, A; Seidah, NG				Susan-Resiga, Delia; Girard, Emmanuelle; Kiss, Robert Scott; Essalmani, Rachid; Hamelin, Josee; Asselin, Marie-Claude; Awan, Zuhier; Butkinaree, Chutikarn; Fleury, Alexandre; Soldera, Armand; Dory, Yves L.; Baass, Alexis; Seidah, Nabil G.			The Proprotein Convertase Subtilisin/Kexin Type 9-resistant R410S Low Density Lipoprotein Receptor Mutation: A NOVEL MECHANISM CAUSING FAMILIAL HYPERCHOLESTEROLEMIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell biology; cholesterol metabolism; low density lipoprotein (LDL); lysosome; proprotein convertase subtilisin; kexin type 9 (PCSK9); familial hypercholesterolemia; human natural mutations; LDL receptor; subcellular localization; loss-of-function	AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; LDL-RECEPTOR; RECYCLING RECEPTORS; LIVER-REGENERATION; MOLECULAR-DYNAMICS; PCSK9; DEGRADATION; CHOLESTEROL; GENE; DOMAIN	Familial hypercholesterolemia (FH) is characterized by severely elevated low density lipoprotein (LDL) cholesterol. Herein, we identified an FH patient presenting novel compound heterozygote mutations R410S and G592E of the LDL receptor (LDLR). The patient responded modestly to maximum rosuvastatin plus ezetimibe therapy, even in combination with a PCSK9 monoclonal antibody injection. Using cell biology and molecular dynamics simulations, we aimed to define the underlying mechanism(s) by which these LDLR mutations affect LDL metabolism and lead to hypercholesterolemia. Our data showed that the LDLR-G592E is a class 2b mutant, because it mostly failed to exit the endoplasmic reticulum and was degraded. Even though LDLR-R410S and LDLR-WT were similar in levels of cell surface and total receptor and bound equally well to LDL or extracellular PCSK9, the LDLR-R410S was resistant to exogenous PCSK9-mediated degradation in endosomes/lysosomes and showed reduced LDL internalization and degradation relative to LDLR-WT. Evidence is provided for a tighter association of LDL with LDLR-R410S at acidic pH, a reduced LDL delivery to late endosomes/lysosomes, and an increased release in the medium of the bound/internalized LDL, as compared with LDLR-WT. These data suggested that LDLR-R410S recycles loaded with its LDL-cargo. Our findings demonstrate that LDLR-R410S represents an LDLR loss-of-function through a novel class 8 FH-causing mechanism, thereby rationalizing the observed phenotype.	[Asselin, Marie-Claude; Awan, Zuhier; Butkinaree, Chutikarn; Seidah, Nabil G.] Univ Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Baass, Alexis] Univ Montreal, Inst Rech Clin Montreal, Nutr Metab & Atherosclerosis Clin, Montreal, PQ H2W 1R7, Canada; [Kiss, Robert Scott] McGill Univ, Dept Med, Montreal, PQ H3G 2M1, Canada; [Fleury, Alexandre; Soldera, Armand; Dory, Yves L.] Univ Sherbrooke, Dept Chem, Lab Supramol Chem, Sherbrooke, PQ J1K 2R1, Canada; [Asselin, Marie-Claude] Culture Collect European Collect Authenticated Ce, Porton Down SP4 0JG, England; [Awan, Zuhier] King Abdulaziz Univ, Jeddah 22254, Saudi Arabia; [Butkinaree, Chutikarn] Chulabhorn Grad Inst, Bangkok 10210, Thailand	Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University; University of Sherbrooke; King Abdulaziz University; Chulabhorn Graduate Institute	Seidah, NG (corresponding author), Inst Rech Clin Montreal, Biochem Neuroendocrinol Lab, 110 Pine Ave West, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Soldera, Armand/K-2808-2019; Susan-Resiga@ircm.qc.ca, Delia/O-2548-2017; Soldera, Armand/I-7007-2013; Seidah, Nabil/I-3596-2013	Soldera, Armand/0000-0001-5467-5714; Susan-Resiga@ircm.qc.ca, Delia/0000-0002-4856-090X; Soldera, Armand/0000-0001-5467-5714; Seidah, Nabil/0000-0001-6503-9342; Girard, Emmanuelle/0000-0001-8375-7970; Awan, Zuhier/0000-0002-4176-335X	Canadian Institutes of Health Research Foundation [148363]; Canada Research Chair [216684]; Pfizer Aspire CV IIR [W1207162]; Fondation Leducq [13CVD03]	Canadian Institutes of Health Research Foundation(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Pfizer Aspire CV IIR; Fondation Leducq(Leducq Foundation)	This work was supported in part by Canadian Institutes of Health Research Foundation Grant 148363 and Canada Research Chair 216684 and in part by Pfizer Aspire CV IIR Grant W1207162 and Fondation Leducq Grant 13CVD03 (to N. G. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Abifadel M, 2012, ATHEROSCLEROSIS, V223, P394, DOI 10.1016/j.atherosclerosis.2012.04.006; AULINSKAS TH, 1985, ARTERIOSCLEROSIS, V5, P45, DOI 10.1161/01.ATV.5.1.45; Awan Z, 2014, CLIN BIOCHEM, V47, P1033, DOI 10.1016/j.clinbiochem.2014.03.022; Awan Z, 2012, CLIN CHEM, V58, P183, DOI 10.1373/clinchem.2011.172932; Beglova N, 2005, TRENDS BIOCHEM SCI, V30, P309, DOI 10.1016/j.tibs.2005.03.007; Beglova N, 2004, MOL CELL, V16, P281, DOI 10.1016/j.molcel.2004.09.038; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bertolini S, 2013, ATHEROSCLEROSIS, V227, P342, DOI 10.1016/j.atherosclerosis.2013.01.007; Bottomley MJ, 2009, J BIOL CHEM, V284, P1313, DOI 10.1074/jbc.M808363200; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BROWN MS, 1983, CELL, V32, P663, DOI 10.1016/0092-8674(83)90052-1; Brown MS, 1997, NATURE, V388, P629, DOI 10.1038/41672; Butkinaree C, 2015, J BIOL CHEM, V290, P18609, DOI 10.1074/jbc.M115.647180; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; Canuel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064145; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Denis M, 2012, CIRCULATION, V125, P894, DOI 10.1161/CIRCULATIONAHA.111.057406; Denis N, 2011, J PROTEOME RES, V10, P2011, DOI 10.1021/pr2000072; Dubuc G, 2010, J LIPID RES, V51, P140, DOI 10.1194/jlr.M900273-JLR200; Essalmani R, 2011, J BIOL CHEM, V286, P4257, DOI 10.1074/jbc.M110.192104; Etxebarria A, 2015, HUM MUTAT, V36, P129, DOI 10.1002/humu.22721; Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438; Goldstein JL, 2001, METABOLIC MOL BASES, V8th, P2863; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; Holla OL, 2011, J LIPID RES, V52, P1787, DOI 10.1194/jlr.M018093; Huijgen R, 2012, EUR HEART J, V33, P2325, DOI 10.1093/eurheartj/ehs038; Jeon H, 2005, ANNU REV BIOCHEM, V74, P535, DOI 10.1146/annurev.biochem.74.082803.133354; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Koivisto UM, 2001, CELL, V105, P575, DOI 10.1016/S0092-8674(01)00371-3; Kuzmanic A, 2010, BIOPHYS J, V98, P861, DOI 10.1016/j.bpj.2009.11.011; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Langslet G, 2015, EXPERT REV CARDIOVAS, V13, P477, DOI 10.1586/14779072.2015.1030395; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lind S, 2004, J INTERN MED, V256, P406, DOI 10.1111/j.1365-2796.2004.01401.x; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lo Surdo P, 2011, EMBO REP, V12, P1300, DOI 10.1038/embor.2011.205; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pedersen NB, 2014, J BIOL CHEM, V289, P17312, DOI 10.1074/jbc.M113.545053; PITAS RE, 1981, ARTERIOSCLEROSIS, V1, P177, DOI 10.1161/01.ATV.1.3.177; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poirier S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157230; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Raal F, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000028; Rader DJ, 2014, CIRCULATION, V129, P1022, DOI 10.1161/CIRCULATIONAHA.113.001292; Ranheim T, 2006, CLIN CHEM, V52, P1469, DOI 10.1373/clinchem.2006.068627; Roubtsova A, 2015, J LIPID RES, V56, P2133, DOI 10.1194/jlr.M061952; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Saavedra YGL, 2012, J BIOL CHEM, V287, P43492, DOI 10.1074/jbc.M112.394023; Sabatine MS, 2015, NEW ENGL J MED, V372, P1500, DOI 10.1056/NEJMoa1500858; Seidah NG, 2014, CIRC RES, V114, P1022, DOI 10.1161/CIRCRESAHA.114.301621; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Sorensen S, 2006, J BIOL CHEM, V281, P468, DOI 10.1074/jbc.M507071200; Stein EA, 2014, ANNU REV MED, V65, P417, DOI 10.1146/annurev-med-022613-090402; Tavori H, 2013, CIRCULATION, V127, P2403, DOI 10.1161/CIRCULATIONAHA.113.001592; Topchiy E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155030; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VASSILIOU G, 1994, J BIOL CHEM, V269, P15172; Vendome J, 2011, NAT STRUCT MOL BIOL, V18, P693, DOI 10.1038/nsmb.2051; Weider E, 2016, J BIOL CHEM, V291, P16659, DOI 10.1074/jbc.M116.717736; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105	71	21	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1573	1590		10.1074/jbc.M116.769430	http://dx.doi.org/10.1074/jbc.M116.769430			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27998977	Green Published, hybrid			2022-12-26	WOS:000395515600004
J	Wendt, T; Holme, I; Dockter, C; Preuss, A; Thomas, W; Druka, A; Waugh, R; Hansson, M; Braumann, I				Wendt, Toni; Holme, Inger; Dockter, Christoph; Preuss, Aileen; Thomas, William; Druka, Arnis; Waugh, Robbie; Hansson, Mats; Braumann, Ilka			HvDep1 Is a Positive Regulator of Culm Elongation and Grain Size in Barley and Impacts Yield in an Environment-Dependent Manner	PLOS ONE			English	Article							PROTEIN GAMMA-SUBUNIT; ARABIDOPSIS-THALIANA; NATURAL VARIATION; ORGAN SIZE; MUTATION; GENES; DEP1; AGG3; SEED; GS3	Heterotrimeric G proteins are intracellular membrane-attached signal transducers involved in various cellular processes in both plants and animals. They consist of three subunits denoted as alpha, beta and gamma. The gamma-subunits of the so-called AGG3 type, which comprise a transmembrane domain, are exclusively found in plants. In model species, these proteins have been shown to participate in the control of plant height, branching and seed size and could therefore impact the harvestable yield of various crop plants. Whether AGG3-type gamma-subunits influence yield in temperate cereals like barley and wheat remains unknown. Using a transgenic complementation approach, we show here that the Scottish malting barley cultivar (cv.) Golden Promise carries a loss-of-function mutation in HvDep1, an AGG3-type subunit encoding gene that positively regulates culm elongation and seed size in barley. Somewhat intriguingly, agronomic field data collected over a 12-year period reveals that the HvDep1 loss-of-function mutation in cv. Golden Promise has the potential to confer either a significant increase or decrease in harvestable yield depending on the environment. Our results confirm the role of AGG3-type subunit-encoding genes in shaping plant architecture, but interestingly also indicate that the impact HvDep1 has on yield in barley is both genotypically and environmentally sensitive. This may explain why widespread exploitation of variation in AGG3-type subunit-encoding genes has not occurred in temperate cereals while in rice the DEP1 locus is widely exploited to improve harvestable yield.	[Wendt, Toni; Dockter, Christoph; Preuss, Aileen; Braumann, Ilka] Carlsberg Res Lab, Copenhagen, Denmark; [Holme, Inger] Aarhus Univ, Fac Sci & Technol, Dept Mol Biol & Genet, Slagelse, Denmark; [Thomas, William; Druka, Arnis; Waugh, Robbie] James Hutton Inst, Dundee, Scotland; [Waugh, Robbie] Univ Dundee, Div Plant Sci, Dundee DD1 4HN, Scotland; [Hansson, Mats] Lund Univ, Dept Biol, Lund, Sweden	Aarhus University; James Hutton Institute; University of Dundee; Lund University	Braumann, I (corresponding author), Carlsberg Res Lab, Copenhagen, Denmark.	ilka.braumann@carlsberg.com		Hansson, Mats/0000-0002-0168-9968; Holme, Inger/0000-0001-5008-0086	Deutscher Akademischer Austauschdienst (DAAD) [DK-BI-478]; Gront Udviklings- og Demonstrationsprogram (GUDP) [34009-12-0552]; Carlsberg Foundation [2008_01_0291]; Biotechnology and Biological Sciences Research Council [BB/K008188/1] Funding Source: researchfish; BBSRC [BB/K008188/1] Funding Source: UKRI	Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Gront Udviklings- og Demonstrationsprogram (GUDP); Carlsberg Foundation(Carlsberg Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Deutscher Akademischer Austauschdienst (DAAD, www.daad.de): DK-BI-478 (AP/IB); Gront Udviklings- og Demonstrationsprogram (GUDP, http://www.cartsbergfondet.dk/da): 34009-12-0552 (MH); and Carlsberg Foundation (http://www.cartsbergfondet.dk/da): 2008_01_0291 (MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahloowalia BS, 2004, EUPHYTICA, V135, P187, DOI 10.1023/B:EUPH.0000014914.85465.4f; Badr A, 2000, MOL BIOL EVOL, V17, P499, DOI 10.1093/oxfordjournals.molbev.a026330; Baik BK, 2008, J CEREAL SCI, V48, P233, DOI 10.1016/j.jcs.2008.02.002; Belanger S, 2014, EUPHYTICA; Botella JR, 2012, TRENDS PLANT SCI, V17, P563, DOI 10.1016/j.tplants.2012.06.002; Bregitzer P, 2002, BARLEY GENET NEWSL, V32, P86; Chakravorty D, 2011, PLANT J, V67, P840, DOI 10.1111/j.1365-313X.2011.04638.x; Chloupek O, 2006, THEOR APPL GENET, V112, P779, DOI 10.1007/s00122-005-0147-4; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Dockter C, 2014, PLANT PHYSIOL, V166, P1912, DOI 10.1104/pp.114.250738; Druka A, 2011, PLANT PHYSIOL, V155, P617, DOI 10.1104/pp.110.166249; Ellis RP, 2002, J EXP BOT, V53, P1163, DOI 10.1093/jexbot/53.371.1163; Forster BP, 2001, EUPHYTICA, V120, P317, DOI 10.1023/A:1017592618298; Harwood WA., 2011, J EXP BOT; Hiei Y, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00628; Holme IB, 2012, PLANT BIOTECHNOL J, V10, P237, DOI 10.1111/j.1467-7652.2011.00660.x; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; Kesavan M, 2013, PHYSIOL PLANTARUM, V147, P113, DOI 10.1111/j.1399-3054.2012.01664.x; KUCERA J, 1975, HEREDITAS, V80, P263; Kumlehn J, 2014, BIOTECH AGR FOREST, V69, P393, DOI 10.1007/978-3-662-44406-1_21; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Li SJ, 2012, PLANT SIGNAL BEHAV, V7, P1357, DOI 10.4161/psb.21620; Li SJ, 2012, NEW PHYTOL, V194, P690, DOI 10.1111/j.1469-8137.2012.04083.x; Liu H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-104; Lundqvist U, 2011, BARLEY GENET NEWSL, V41, P131; Mao HL, 2010, P NATL ACAD SCI USA, V107, P19579, DOI 10.1073/pnas.1014419107; Marthe C, 2015, METHODS MOL BIOL, V1223, P71, DOI 10.1007/978-1-4939-1695-5_6; Mascher M, 2013, PLANT J, V76, P718, DOI 10.1111/tpj.12319; Mason MG, 2001, BBA-GENE STRUCT EXPR, V1520, P147, DOI 10.1016/S0167-4781(01)00262-7; Mason MG, 2000, P NATL ACAD SCI USA, V97, P14784, DOI 10.1073/pnas.97.26.14784; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Meyer RC, 2000, GENETIC APPROACHES I; Munoz-Amatriain M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094688; Taguchi-Shiobara F, 2011, BREEDING SCI, V61, P17, DOI 10.1270/jsbbs.61.17; Temple BRS, 2007, ANNU REV PLANT BIOL, V58, P249, DOI 10.1146/annurev.arplant.58.032806.103827; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; THOMAS WTB, 1984, HEREDITY, V53, P177, DOI 10.1038/hdy.1984.73; Thomas WTB, 1998, MOL BREEDING, V4, P381, DOI 10.1023/A:1009646115967; Trusov Yuri, 2012, BMC Res Notes, V5, P608, DOI 10.1186/1756-0500-5-608; Urano D, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120186; Van Ooijen JW, 2006, SOFTWARE CALCULATION; Wolfenstetter S, 2014, PLANT J; Yi XH, 2011, J GENET GENOMICS, V38, P217, DOI 10.1016/j.jgg.2011.03.011; Zhou Y, 2009, GENETICS, V183, P315, DOI 10.1534/genetics.109.102681	44	43	46	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168924	10.1371/journal.pone.0168924	http://dx.doi.org/10.1371/journal.pone.0168924			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005988	gold, Green Published, Green Submitted			2022-12-26	WOS:000392843200110
J	Marano, F; Rinella, L; Argenziano, M; Cavalli, R; Sassi, F; D'Amelio, P; Battaglia, A; Gontero, P; Bosco, O; Peluso, R; Fortunati, N; Frairia, R; Catalano, MG				Marano, Francesca; Rinella, Letizia; Argenziano, Monica; Cavalli, Roberta; Sassi, Francesca; D'Amelio, Patrizia; Battaglia, Antonino; Gontero, Paolo; Bosco, Ornella; Peluso, Rossella; Fortunati, Nicoletta; Frairia, Roberto; Catalano, Maria Graziella			Targeting Taxanes to Castration-Resistant Prostate Cancer Cells by Nanobubbles and Extracorporeal Shock Waves	PLoS One			English	Article							ANAPLASTIC THYROID-CANCER; DRUG-DELIVERY; PACLITAXEL; THERAPY; NANOPARTICLES; DOXORUBICIN; DOCETAXEL; EFFICACY; RELEASE; ENHANCE	To target taxanes to castration-resistant prostate cancer cells, glycol-chitosan nanobubbles loaded with paclitaxel and docetaxel were constructed. The loaded nanobubbles were then combined with Extracorporeal Shock Waves, acoustic waves widely used in urology and orthopedics, with no side effects. Nanobubbles, with an average diameter of 353.3 +/- 15.5 nm, entered two different castration-resistant prostate cancer cells (PC3 and DU145) as demonstrated by flow cytometry and immunofluorescence. The shock waves applied increased the amount of intracellular nanobubbles. Loading nanobubbles with paclitaxel and docetaxel and combining them with shock waves generated the highest cytotoxic effects, resulting in a paclitaxel GI(50) reduction of about 55% and in a docetaxel GI(50) reduction of about 45% respectively. Combined treatment also affected cell migration. Paclitaxel-loaded nanobubbles and shock waves reduced cell migration by more than 85% with respect to paclitaxel alone; whereas docetaxel-loaded nanobubbles and shock waves reduced cell migration by more than 82% with respect to docetaxel alone. The present data suggest that nanobubbles can act as a stable taxane reservoir in castration-resistant prostate cancer cells and shock waves can further increase drug release from nanobubbles leading to higher cytotoxic and anti-migration effect.	[Marano, Francesca; Rinella, Letizia; Sassi, Francesca; D'Amelio, Patrizia; Bosco, Ornella; Peluso, Rossella; Frairia, Roberto; Catalano, Maria Graziella] Univ Turin, Dept Med Sci, Turin, Italy; [Argenziano, Monica; Cavalli, Roberta] Univ Turin, Dept Drug Sci & Technol, Turin, Italy; [Battaglia, Antonino; Gontero, Paolo] Univ Turin, Dept Surg Sci, Turin, Italy; [Fortunati, Nicoletta] AO Citta Salute & Sci Torino, Oncol Endocrinol, Turin, Italy	University of Turin; University of Turin; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino	Frairia, R (corresponding author), Univ Turin, Dept Med Sci, Turin, Italy.	roberto.frairia@unito.it	Bosco, Ornella/AAB-2105-2019	Frairia, Roberto/0000-0001-9453-772X; Battaglia, Antonino/0000-0003-1961-8217; D'AMELIO, PATRIZIA/0000-0002-4467-8337	Fondazione CRT, University of Turin [2015.1688]	Fondazione CRT, University of Turin	This work was supported by Fondazione CRT 2015.1688 to MGC; "Research Fund ex-60%", University of Turin, to RF and RC.	Boissenot T, 2016, J CONTROL RELEASE, V241, P144, DOI 10.1016/j.jconrel.2016.09.026; Canaparo R, 2008, TECHNOL CANCER RES T, V7, P117, DOI 10.1177/153303460800700204; Catalano MG, 2007, THYROID, V17, P91, DOI 10.1089/thy.2006.0142; Cavalli R, 2016, THER DELIV, V7, P117, DOI 10.4155/tde.15.92; Cavalli R, 2012, INT J NANOMED, V7, P3309, DOI 10.2147/IJN.S30912; Cerqueira BBS, 2015, EUR J PHARM BIOPHARM, V97, P140, DOI 10.1016/j.ejpb.2015.10.007; Darshan MS, 2011, CANCER RES, V71, P6019, DOI 10.1158/0008-5472.CAN-11-1417; Fan XZ, 2016, INT J NANOMED, V11, P3585, DOI 10.2147/IJN.S111808; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Frairia R, 2003, BREAST CANCER RES TR, V81, P11, DOI 10.1023/A:1025477421467; Ganju A, 2014, DRUG RESIST UPDATE, V17, P13, DOI 10.1016/j.drup.2014.04.001; Gao Z, 2008, ULTRASONICS, V48, P260, DOI 10.1016/j.ultras.2007.11.002; Gu F, 2009, METHODS MOL BIOL, V544, P589, DOI 10.1007/978-1-59745-483-4_37; JOCHAM D, 1986, UROL INT, V41, P357, DOI 10.1159/000281236; Kim SC, 2005, J PHARMACEUT BIOMED, V39, P170, DOI 10.1016/j.jpba.2005.02.023; Kodama T, 2002, BBA-MOL CELL RES, V1542, P186, DOI 10.1016/S0167-4889(01)00177-X; Loblaw DA, 2013, CLIN ONCOL-UK, V25, P406, DOI 10.1016/j.clon.2013.03.002; Maeda H, 2010, BIOCONJUGATE CHEM, V21, P797, DOI 10.1021/bc100070g; Marano F, 2016, THYROID, V26, P705, DOI 10.1089/thy.2015.0342; Martin SK, 2014, AM J CLIN EXP UROL, V2, P15; Musumeci T, 2006, INT J PHARMACEUT, V325, P172, DOI 10.1016/j.ijpharm.2006.06.023; Ogden JA, 2001, CLIN ORTHOP RELAT R, P22; Ohl SW, 2015, INTERFACE FOCUS, V5, DOI 10.1098/rsfs.2015.0019; Palmero A, 2006, ONCOL REP, V15, P267; Sanna V, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-260; Scher HI, 2008, J CLIN ONCOL, V26, P1148, DOI 10.1200/JCO.2007.12.4487; Schutz FA, 2014, CRIT REV ONCOL HEMAT, V91, P248, DOI 10.1016/j.critrevonc.2014.02.003; Shapira A, 2011, DRUG RESIST UPDATE, V14, P150, DOI 10.1016/j.drup.2011.01.003; Shiota M, 2016, INT J UROL, V23, P360, DOI 10.1111/iju.13091; Wadosky KM, 2016, ONCOTARGET; Wasungu L, 2014, BIOELECTROCHEMISTRY, V100, P36, DOI 10.1016/j.bioelechem.2014.06.011; Zhong JP, 2016, J CONTROL RELEASE, V226, P77, DOI 10.1016/j.jconrel.2016.02.010	32	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168553	10.1371/journal.pone.0168553	http://dx.doi.org/10.1371/journal.pone.0168553			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002459	Green Published, gold, Green Submitted			2022-12-26	WOS:000392853100054
J	Peeters, F; Atamanchuk, D; Tengberg, A; Encinas-Fernandez, J; Hofmann, H				Peeters, Frank; Atamanchuk, Dariia; Tengberg, Anders; Encinas-Fernandez, Jorge; Hofmann, Hilmar			Lake Metabolism: Comparison of Lake Metabolic Rates Estimated from a Diel CO2- and the Common Diel O(2-)Technique	PLoS One			English	Article							LIFETIME-BASED OPTODE; ECOSYSTEM METABOLISM; CARBON-DIOXIDE; WATER; SYSTEM; OXYGEN	Lake metabolism is a key factor for the understanding of turnover of energy and of organic and inorganic matter in lake ecosystems. Long-term time series on metabolic rates are commonly estimated from diel changes in dissolved oxygen. Here we present long-term data on metabolic rates based on diel changes in total dissolved inorganic carbon (DIC) utilizing an open-water diel CO2-technique. Metabolic rates estimated with this technique and the traditional diel O-2-technique agree well in alkaline Lake Illmensee (pHof-8.5), although the diel changes in molar CO2 concentrations are much smaller than those of the molar O-2 concentrations. The open-water diel CO2- and diel O-2-techniques provide independent measures of lake metabolic rates that differ in their sensitivity to transport processes. Hence, the combination of both techniques can help to constrain uncertainties arising from assumptions on vertical fluxes due to gas exchange and turbulent diffusion. This is particularly important for estimates of lake respiration rates because these are much more sensitive to assumptions on gradients in vertical fluxes of O-2 or DIC than estimates of lake gross primary production. Our data suggest that it can be advantageous to estimate respiration rates assuming negligible gradients in vertical fluxes rather than including gas exchange with the atmosphere but neglecting vertical mixing in the water column. During two months in summer the average lake net production was close to zero suggesting at most slightly autotrophic conditions. However, the lake emitted O-2 and CO2 during the entire time period suggesting that O-2 and CO2 emissions from lakes can be decoupled from the metabolism in the near surface layer.	[Peeters, Frank; Encinas-Fernandez, Jorge; Hofmann, Hilmar] Univ Konstanz, Dept Biol, Environm Phys, Constance, Germany; [Atamanchuk, Dariia; Tengberg, Anders] Univ Gothenburg, Dept Marine Sci, Gothenburg, Sweden; [Atamanchuk, Dariia] Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada; [Tengberg, Anders] Aanderaa Data Instruments AS, Bergen, Norway	University of Konstanz; University of Gothenburg; Dalhousie University	Peeters, F (corresponding author), Univ Konstanz, Dept Biol, Environm Phys, Constance, Germany.	frank.peeters@uni-konstanz.de	Hofmann, Hilmar/G-8445-2011	Atamanchuk, Dariia/0000-0002-9117-502X	Ministry of Science, Research and the Arts of the federal state Baden-Wurttemberg, Germany; University of Konstanz [AFF 38/03]; German Research Foundation [YSF-DFG 419-14]	Ministry of Science, Research and the Arts of the federal state Baden-Wurttemberg, Germany; University of Konstanz; German Research Foundation(German Research Foundation (DFG))	JEF received funding from the Ministry of Science, Research and the Arts of the federal state Baden-Wurttemberg, Germany (grant: Water Research Network project: Challenges of Reservoir Management - Meeting Environmental and Social Requirements). University of Konstanz (grant: AFF 38/03) and the German Research Foundation (grant: YSF-DFG 419-14) financially supported the field work and construction of field instruments.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, J GEOPHYS RES, V114; Atamanchuk D, 2015, J MARINE SYST, V148, P272, DOI 10.1016/j.jmarsys.2015.03.002; Atamanchuk D, 2014, LIMNOL OCEANOGR-METH, V12, P63, DOI 10.4319/lom.2014.12.63; Balzer F, 2015, DATA ENV 2015; Bellido JL, 2013, BIOGEOCHEMISTRY, V113, P613, DOI 10.1007/s10533-012-9792-2; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Cole JJ, 1998, LIMNOL OCEANOGR, V43, P647, DOI 10.4319/lo.1998.43.4.0647; Cole JJ, 2000, LIMNOL OCEANOGR, V45, P1718, DOI 10.4319/lo.2000.45.8.1718; Coloso JJ, 2011, ECOSYSTEMS, V14, P935, DOI 10.1007/s10021-011-9455-5; Ducharme-Riel V, 2015, ECOSYSTEMS, V18, P547, DOI 10.1007/s10021-015-9846-0; Hanson PC, 2003, LIMNOL OCEANOGR, V48, P1112, DOI 10.4319/lo.2003.48.3.1112; Hoellein TJ, 2013, LIMNOL OCEANOGR, V58, P2089, DOI 10.4319/lo.2013.58.6.2089; Hofmann H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080913; HONDZO M, 1993, J HYDRAUL ENG, V119, P1251, DOI 10.1061/(ASCE)0733-9429(1993)119:11(1251); Livingstone DM, 1996, CAN J FISH AQUAT SCI, V53, P924, DOI 10.1139/cjfas-53-4-924; MILLERO FJ, 1995, GEOCHIM COSMOCHIM AC, V59, P661, DOI 10.1016/0016-7037(94)00354-O; North RP, 2012, INFLUENCE CLIMATE CH; Obrador B, 2014, LIMNOL OCEANOGR, V59, P1228, DOI 10.4319/lo.2014.59.4.1228; ODUM HT, 1956, LIMNOL OCEANOGR, V1, P102, DOI 10.4319/lo.1956.1.2.0102; ODUM HT, 1957, ECOL MONOGR, V27, P55, DOI 10.2307/1948571; OVIATT CA, 1986, MAR ECOL PROG SER, V28, P57, DOI 10.3354/meps028057; Redfield A. C, 1963, SEA, P26, DOI DOI 10.1016/J.ORGGEOCHEM.2014.06.002; Reidel D, 1986, ROLE AIR SEA EXCHANG, P113; Robinson C, 2005, RESPIRATION IN AQUATIC ECOSYSTEMS, P147, DOI 10.1093/acprof:oso/9780198527084.003.0009; SCHINDLE.DW, 1973, J FISH RES BOARD CAN, V30, P1501, DOI 10.1139/f73-240; Staehr PA, 2012, LIMNOL OCEANOGR, V57, P1317, DOI 10.4319/lo.2012.57.5.1317; Staehr PA, 2012, AQUAT SCI, V74, P15, DOI 10.1007/s00027-011-0199-2; Staehr PA, 2010, LIMNOL OCEANOGR-METH, V8, P628, DOI 10.4319/lom.2010.8.0628; Stumm W., 2012, AQUATIC CHEM CHEM EQ; Tengberg A, 2006, LIMNOL OCEANOGR-METH, V4, P7, DOI 10.4319/lom.2006.4.7; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; Verspagen JMH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104325; Weiss R.F., 1974, MAR CHEM, V2, P203, DOI DOI 10.1016/0304-4203(74)90015-2; WEISS RF, 1970, DEEP-SEA RES, V17, P721, DOI 10.1016/0011-7471(70)90037-9; WILLIAMS PJL, 1991, J PLANKTON RES, V13, pS153; Wolf-Gladrow DA, 2007, MAR CHEM, V106, P287, DOI 10.1016/j.marchem.2007.01.006; WU J, 1980, J PHYS OCEANOGR, V10, P727, DOI 10.1175/1520-0485(1980)010<0727:WSCOSS>2.0.CO;2	37	23	25	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168393	10.1371/journal.pone.0168393	http://dx.doi.org/10.1371/journal.pone.0168393			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002477	Green Published, Green Submitted, gold			2022-12-26	WOS:000392853100043
J	Wang, X; Liu, WJ; O'Donnell, M; Lutgendorf, S; Bradley, C; Schrepf, A; Liu, LW; Kreder, K; Luo, Y				Wang, Xu; Liu, Wujiang; O'Donnell, Michael; Lutgendorf, Susan; Bradley, Catherine; Schrepf, Andrew; Liu, Liwei; Kreder, Karl; Luo, Yi			Evidence for the Role of Mast Cells in Cystitis-Associated Lower Urinary Tract Dysfunction: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Animal Model Study	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE CYSTITIS; INTERSTITIAL CYSTITIS; BLADDER INFLAMMATION; MICE; ACTIVATION; MEDIATE	Bladder inflammation frequently causes cystitis pain and lower urinary tract dysfunction (LUTD) such as urinary frequency and urgency. Although mast cells have been identified to play a critical role in bladder inflammation and pain, the role of mast cells in cystitis-associated LUTD has not been demonstrated. Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic and debilitating inflammatory condition of the urinary bladder characterized by the hallmark symptoms of pelvic pain and LUTD. In this study we investigated the role of mast cells in LUTD using a transgenic autoimmune cystitis model (URO-OVA) that reproduces many clinical correlates of IC/BPS. URO-OVA mice express the membrane form of the model antigen ovalbumin (OVA) as a self-antigen on the urothelium and develop bladder inflammation upon introduction of OVA-specific T cells. To investigate the role of mast cells, we crossed URO-OVA mice with mast cell-deficient Kit(W-sh) mice to generate URO-OVA/Kit(W-sh) mice that retained urothelial OVA expression but lacked endogenous mast cells. We compared URO-OVA mice with URO-OVA/Kit(W-sh) mice with and without mast cell reconstitution in response to cystitis induction. URO-OVA mice developed profound bladder inflammation with increased mast cell counts and LUTD, including increased total number of voids, decreased mean volume voided per micturition, and decreased maximum volume voided per micturition, after cystitis induction. In contrast, similarly cystitis-induced URO-OVA/Kit(W-sh) mice developed reduced bladder inflammation with no mast cells and LUTD detected. However, after mast cell reconstitution URO-OVA/Kit(W-sh) mice restored the ability to develop bladder inflammation and LUTD following cystitis induction. We further treated URO-OVA mice with cromolyn, a mast cell membrane stabilizer, and found that cromolyn treatment reversed bladder inflammation and LUTD in the animal model. Our results provide direct evidence for the role of mast cells in cystitis-associated LUTD, supporting the use of mast cell inhibitors for treatment of certain forms of IC/BPS.	[Wang, Xu; Liu, Wujiang; O'Donnell, Michael; Lutgendorf, Susan; Bradley, Catherine; Liu, Liwei; Kreder, Karl; Luo, Yi] Univ Iowa, Dept Urol, Iowa City, IA 52242 USA; [Wang, Xu; Liu, Liwei] Tianjin Med Univ, Hosp 2, Tianjin Inst Urol, Tianjin, Peoples R China; [Lutgendorf, Susan; Schrepf, Andrew] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA; [Lutgendorf, Susan; Bradley, Catherine; Kreder, Karl] Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA	University of Iowa; Tianjin Medical University; University of Iowa; University of Iowa	Luo, Y (corresponding author), Univ Iowa, Dept Urol, Iowa City, IA 52242 USA.	yi-luo@uiowa.edu	Liu, Wujiang/ABG-9073-2021	O'Donnell, Michael/0000-0001-7202-6427; Bradley, Catherine/0000-0002-7402-5476; liu, wujiang/0000-0003-3510-7468; Kreder, Karl/0000-0002-8981-5286; Luo, Yi/0000-0002-4013-6805	National Institutes of Health [U01DK082344, R01DK100891]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100891, U01DK082316, U01DK082344] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health, U01DK082344, (https://projectreposter.nih.gov/project_info_details.cfrn? aib=9120958&icde=31468144&ddparam=&ddvalue=&ddsub=&cr=1&csb=default&cs=ASC Karl Kreder) and the National Institutes of Health, R01DK100891, (https://projectreporter.nih.gov/project_info_details.cfm?aid=8626530&icde=31468170&ddparam=&ddvalue=&ddsub=&cr=10&csb=default&cs=ASC) to YL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuntas CZ, 2012, EUR UROL, V61, P193, DOI 10.1016/j.eururo.2011.06.028; Bicer F, 2015, AM J PHYSIOL-RENAL, V308, pF103, DOI 10.1152/ajprenal.00202.2014; Bjorling DE, 1999, J UROLOGY, V162, P231, DOI 10.1097/00005392-199907000-00073; Bouchelouche K, 2003, CURR OPIN UROL, V13, P309, DOI 10.1097/00042307-200307000-00007; BULLOCK AD, 1992, J UROLOGY, V148, P1951, DOI 10.1016/S0022-5347(17)37091-X; Chen MC, 2006, J UROLOGY, V175, P754, DOI 10.1016/S0022-5347(05)00171-0; Clarke SRM, 2000, IMMUNOL CELL BIOL, V78, P110, DOI 10.1046/j.1440-1711.2000.00889.x; Erickson DR, 1997, J UROLOGY, V158, P790, DOI 10.1016/S0022-5347(01)64317-9; Hanno PM, 2015, J UROLOGY, V193, P1545, DOI 10.1016/j.juro.2015.01.086; Kim R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/937061; Lai H, 2015, UROLOGY, V85, P1454, DOI 10.1016/j.urology.2015.03.007; LIEBERT M, 1993, J UROLOGY, V149, P470, DOI 10.1016/S0022-5347(17)36121-9; Lin YH, 2008, BJU INT, V102, P1724, DOI 10.1111/j.1464-410X.2008.07891.x; Liu HT, 2009, BJU INT, V104, P1476, DOI 10.1111/j.1464-410X.2009.08675.x; Liu W, 2011, MUCOSAL IMMUNOL, V4, P428, DOI 10.1038/mi.2010.90; Liu WJ, 2008, J AUTOIMMUN, V30, P257, DOI 10.1016/j.jaut.2007.10.005; Liu WJ, 2007, J IMMUNOL, V178, P539, DOI 10.4049/jimmunol.178.1.539; LuberNarod J, 1996, UROL RES, V24, P367, DOI 10.1007/BF00389795; MACDERMOTT JP, 1991, J UROLOGY, V145, P274, DOI 10.1016/S0022-5347(17)38313-1; Mitra S, 1999, UROL RES, V27, P351, DOI 10.1007/s002400050162; Park Chang-Shin, 2011, Int Neurourol J, V15, P61, DOI 10.5213/inj.2011.15.2.61; Peeker R, 2003, SCAND J UROL NEPHROL, V37, P60, DOI 10.1080/00365590310008721; Phull H, 2007, BJU INT, V100, P664, DOI 10.1111/j.1464-410X.2007.07035.x; Rudick CN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002096; Saban R, 2002, AM J PHYSIOL-RENAL, V283, pF616, DOI 10.1152/ajprenal.00096.2002; Sant GR, 2007, UROLOGY, V69, P34, DOI 10.1016/j.urology.2006.08.1109; SHAPIRO GG, 1985, PHARMACOTHERAPY, V5, P156; Taneja R, 2007, SCAND J UROL NEPHROL, V41, P511, DOI 10.1080/00365590701435918; Theoharides TC, 2005, INT J IMMUNOPATH PH, V18, P183, DOI 10.1177/039463200501800119; Theoharides TC, 1997, UROLOGY, V49, P108, DOI 10.1016/S0090-4295(97)00182-9; van de Merwe JP, 2007, NAT CLIN PRACT UROL, V4, P484, DOI 10.1038/ncpuro0874; van de Merwe Joop P, 2003, Int J Urol, V10 Suppl, pS35, DOI 10.1046/j.1442-2042.10.s1.10.x; Wolters PJ, 2005, CLIN EXP ALLERGY, V35, P82, DOI 10.1111/j.1365-2222.2005.02136.x; Worobec AS, 2000, HEMATOL ONCOL CLIN N, V14, P659, DOI 10.1016/S0889-8588(05)70301-4; Xu SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163829	35	23	26	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168772	10.1371/journal.pone.0168772	http://dx.doi.org/10.1371/journal.pone.0168772			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002455	Green Published, Green Submitted, gold			2022-12-26	WOS:000392853100066
J	Brennan, CE; Blanchard, H; Fennel, K				Brennan, Catherine E.; Blanchard, Hannah; Fennel, Katja			Putting Temperature and Oxygen Thresholds of Marine Animals in Context of Environmental Change: A Regional Perspective for the Scotian Shelf and Gulf of St. Lawrence	PLOS ONE			English	Article							FOOD CONVERSION EFFICIENCY; COD GADUS-MORHUA; CLIMATE-CHANGE; OCEAN ACIDIFICATION; HYPOXIA TOLERANCE; ATLANTIC-OCEAN; CTENOPHORE MNEMIOPSIS; SWIMMING PERFORMANCE; FISH RECRUITMENT; NORTH-AMERICAN	We conducted a literature review of reported temperature, salinity, pH, depth and oxygen preferences and thresholds of important marine species found in the Gulf of St. Lawrence and Scotian Shelf region. We classified 54 identified fishes and macroinvertebrates as important either because they support a commercial fishery, have threatened or at risk status, or meet one of the following criteria: bycatch, baitfish, invasive, vagrant, important for ecosystem energy transfer, or predators or prey of the above species. The compiled data allow an assessment of species-level impacts including physiological stress and mortality given predictions of future ocean physical and biogeochemical conditions. If an observed, multi-decadal oxygen trend on the central Scotian Shelf continues, a number of species will lose favorable oxygen conditions, experience oxygen-stress, or disappear due to insufficient oxygen in the coming half-century. Projected regional trends and natural variability are both large, and natural variability will act to alternately amplify and dampen anthropogenic changes. When estimates of variability are included with the trend, species encounter unfavourable oxygen conditions decades sooner. Finally, temperature and oxygen thresholds of adult Atlantic wolffish (Anarhichas lupus) and adult Atlantic cod (Gadus morhua) are assessed in the context of a potential future scenario derived from high-resolution ocean models for the central Scotian Shelf.	[Brennan, Catherine E.; Blanchard, Hannah; Fennel, Katja] Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada; [Brennan, Catherine E.] Bedford Inst Oceanog, Dartmouth, NS, Canada	Dalhousie University; Bedford Institute of Oceanography	Brennan, CE (corresponding author), Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada.; Brennan, CE (corresponding author), Bedford Inst Oceanog, Dartmouth, NS, Canada.	cebrennan.climate@gmail.com	Fennel, Katja/A-7470-2009	Fennel, Katja/0000-0003-3170-2331; Brennan, Catherine/0000-0003-2593-7222	Marine Environmental Observation Prediction and Response Network; Marine Environmental Observation Prediction and Response Network (MEOPAR)	Marine Environmental Observation Prediction and Response Network; Marine Environmental Observation Prediction and Response Network (MEOPAR)	The authors were funded by the Marine Environmental Observation Prediction and Response Network (http://meopar.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are thankful to the two anonymous reviewers whose comments significantly improved the quality of our manuscript. We thank Mathieu Dever and the OTN Glider Group for assisting with OTN benthic pod data. We are especially grateful to Laura Bianucci, Jae Choi, and Anya Waite for providing helpful comments during preparation of the manuscript. We acknowledge funding by the Marine Environmental Observation Prediction and Response Network (MEOPAR).	Anderson G., 1985, US FISH WILDL SERV B, V82; [Anonymous], 2013, SPEC RISK PUBL REG; [Anonymous], 1977, AQUAT TOXICOL; Arnberg M, 2013, MAR BIOL, V160, P2037, DOI 10.1007/s00227-012-2072-9; Bechmann RK, 2011, J TOXICOL ENV HEAL A, V74, P424, DOI 10.1080/15287394.2011.550460; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Berge JA, 2006, CHEMOSPHERE, V62, P681, DOI 10.1016/j.chemosphere.2005.04.111; Bianucci L, 2016, ICES J MAR SCI, V73, P263, DOI 10.1093/icesjms/fsv220; Bigelow H.B., 1953, FISHES GULF MAINE, V53; Bopp L, 2013, BIOGEOSCIENCES, V10, P6225, DOI 10.5194/bg-10-6225-2013; Breitburg D, 2002, ESTUARIES, V25, P767, DOI 10.1007/BF02804904; Breitburg DL, 2009, ANNU REV MAR SCI, V1, P329, DOI 10.1146/annurev.marine.010908.163754; Brennan CE, 2016, ATMOS OCEAN, V54, P230, DOI 10.1080/07055900.2016.1147416; Brewer PG, 2009, SCIENCE, V324, P347, DOI 10.1126/science.1170756; Chabot D, 2013, CLIMATE CHANGE IMPAC, Vp, P83; Cheung WWL, 2013, NAT CLIM CHANGE, V3, P254, DOI 10.1038/NCLIMATE1691; Cheung WWL, 2012, AQUAT CONSERV, V22, P368, DOI 10.1002/aqc.2248; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Childress JJ, 1998, J EXP BIOL, V201, P1223; Choi JS, 2004, CAN J FISH AQUAT SCI, V61, P505, DOI 10.1139/F04-079; Claireaux G, 1999, J SEA RES, V42, P157, DOI 10.1016/S1385-1101(99)00019-2; Collins M, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1029; Corkum CP, 2009, J EXP ZOOL PART A, V311A, P231, DOI 10.1002/jez.520; CRANFORD PJ, 1988, CAN J ZOOL, V66, P459, DOI 10.1139/z88-065; Curran K, 2012, STATE SCOTIAN SHELF; DAVIS JC, 1975, J FISH RES BOARD CAN, V32, P2295, DOI 10.1139/f75-268; Deutsch C, 2015, SCIENCE, V348, P1132, DOI 10.1126/science.aaa1605; DFO, 2016, COMM FISH LAND; DFO, 2009, 2009002 DFO CAN SCI; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Drinkwater KF, 2005, ICES J MAR SCI, V62, P1327, DOI 10.1016/j.icesjms.2005.05.015; Dufour R, 2007, CAN TECH REP FISH AQ, p2744E; Ekau W, 2010, BIOGEOSCIENCES, V7, P1669, DOI 10.5194/bg-7-1669-2010; Enfield DB, 2001, GEOPHYS RES LETT, V28, P2077, DOI 10.1029/2000GL012745; Fay C, 1983, EL824 TR US FISH WIL; Foss A, 2003, AQUACULTURE, V220, P607, DOI 10.1016/S0044-8486(02)00613-0; Foss A, 2006, AQUACULTURE, V256, P255, DOI 10.1016/j.aquaculture.2006.02.032; Fowler AE, 2013, AQUAT INVASIONS, V8, P89, DOI 10.3391/ai.2013.8.1.10; Frommel AY, 2013, MAR BIOL, V160, P1825, DOI 10.1007/s00227-011-1876-3; Fry F.E.J., 1971, P1; Fry F.E.J., 1957, PHYSL FISHES, P1; Galbraith PS, 2012, DEEP-SEA RES PT II, V77-80, P10, DOI 10.1016/j.dsr2.2012.04.001; Gilbert D, 2005, LIMNOL OCEANOGR, V50, P1654, DOI 10.4319/lo.2005.50.5.1654; Gilbert D, 2010, BIOGEOSCIENCES, V7, P2283, DOI 10.5194/bg-7-2283-2010; Haigh R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117533; Hamer HH, 2011, J PLANKTON RES, V33, P137, DOI 10.1093/plankt/fbq100; Handeland SO, 2008, AQUACULTURE, V283, P36, DOI 10.1016/j.aquaculture.2008.06.042; Hendrickson L., 2006, STATUS FISHERY RESOU, P13; Hendrickson L., 2008, ASS 19 NE GROUNDFISH; HOUGHTON RW, 1978, J FISH RES BOARD CAN, V35, P414, DOI 10.1139/f78-073; Hutchings JA, 2012, ENVIRON REV, V20, P220, DOI 10.1139/a2012-011; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; KAZAKOV RV, 1981, AQUACULTURE, V25, P289, DOI 10.1016/0044-8486(81)90192-7; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Keeling RF, 2002, P NATL ACAD SCI USA, V99, P7848, DOI 10.1073/pnas.122154899; Keppel Elise A., 2012, Journal of Northwest Atlantic Fishery Science, V44, P61, DOI 10.2960/J.v44.m683; Klassen G., 2007, CAN MANUSCR REP FISH, pvii; Kordas RL, 2011, J EXP MAR BIOL ECOL, V400, P218, DOI 10.1016/j.jembe.2011.02.029; Levin PS, 2009, PLOS BIOL, V7, P23, DOI 10.1371/journal.pbio.1000014; LOUGH RG, 2004, NMFSNE190 NOAA; LYNCH M, 1993, BIOTIC INTERACTIONS AND GLOBAL CHANGE, P234; Melzner F, 2009, AQUAT TOXICOL, V92, P30, DOI 10.1016/j.aquatox.2008.12.011; Mistri M, 2004, J EXP MAR BIOL ECOL, V312, P385, DOI 10.1016/j.jembe.2004.07.012; Moran D, 2011, AQUAT TOXICOL, V102, P24, DOI 10.1016/j.aquatox.2010.12.014; Moser ML, 1996, MAR ECOL PROG SER, V144, P57, DOI 10.3354/meps144057; Mucci A, 2011, ATMOS OCEAN, V49, P206, DOI 10.1080/07055900.2011.599265; Najjar RG, 2000, GLOBAL BIOGEOCHEM CY, V14, P573, DOI 10.1029/1999GB900086; Neill W. H., 1991, AQUACULTURE WATER QU, V3, P30; NEILL WH, 1994, NETH J SEA RES, V32, P135, DOI 10.1016/0077-7579(94)90037-X; Nye J., 2010, CLIMATE CHANGE ITS E; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; O'Boyle R., 2012, FISH STOCK STATUS CO; O'Dea NR, 2002, CAN FIELD NAT, V116, P423; PEDERSEN T, 1989, AQUACULTURE, V81, P161, DOI 10.1016/0044-8486(89)90242-1; PETRIE B, 1993, J GEOPHYS RES-OCEANS, V98, P20079, DOI 10.1029/93JC02191; Petrie B, 2000, CAN J FISH AQUAT SCI, V57, P2536, DOI 10.1139/cjfas-57-12-2536; Petrie B, 2007, ATMOS OCEAN, V45, P141, DOI 10.3137/ao.450302; PIHL L, 1991, MAR BIOL, V108, P349, DOI 10.1007/BF01313644; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Pinsky ML, 2012, CLIMATIC CHANGE, V115, P883, DOI 10.1007/s10584-012-0599-x; Plante S, 1998, J FISH BIOL, V53, P1342, DOI 10.1006/jfbi.1998.0798; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Portner HO, 2008, MAR ECOL PROG SER, V373, P203, DOI 10.3354/meps07768; Pohle G., 1990, CANADIAN TECHNICAL R, V1771, P1; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; POSEY MH, 1991, ECOLOGY, V72, P2155, DOI 10.2307/1941567; Purcell JE, 2001, HYDROBIOLOGIA, V451, P145, DOI 10.1023/A:1011826618539; Rhein M., 2013, CLIMATE CHANGE 2013; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Rijnsdorp AD, 2009, ICES J MAR SCI, V66, P1570, DOI 10.1093/icesjms/fsp056; Roessig JM, 2004, REV FISH BIOL FISHER, V14, P251, DOI 10.1007/s11160-004-6749-0; Rogers NJ, 2016, CONSERV PHYSIOL, V4, DOI 10.1093/conphys/cow012; Roman J, 2006, P ROY SOC B-BIOL SCI, V273, P2453, DOI 10.1098/rspb.2006.3597; Saba VS, 2016, J GEOPHYS RES-OCEANS, V121, P118, DOI 10.1002/2015JC011346; Sanford E, 2011, ANNU REV MAR SCI, V3, P509, DOI 10.1146/annurev-marine-120709-142756; SCOTT J S, 1982, Journal of Northwest Atlantic Fishery Science, V3, P29; Scott W.B., 1988, CAN B FISH AQUAT SCI, V219, P1; Seibel BA, 2011, J EXP BIOL, V214, P326, DOI 10.1242/jeb.049171; Shackell NL, 2012, ICES J MAR SCI, V69, P151, DOI 10.1093/icesjms/fsr195; Shimps EL, 2005, J EXP MAR BIOL ECOL, V325, P146, DOI 10.1016/j.jembe.2005.04.026; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; STEFFENSEN JF, 1994, POLAR BIOL, V14, P49; Steimle FW, 1999, ESSENTIAL FISH HABIT; Stendardo I, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC007909; Stevens ED, 1998, CAN J FISH AQUAT SCI, V55, P2028, DOI 10.1139/cjfas-55-9-2028; Stevenson D, 2005, ESSENTIAL FISH HABIT; STICKLE WB, 1989, BIOL BULL, V177, P303, DOI 10.2307/1541945; Stillman JH, 2015, J EXP BIOL, V218, P1946, DOI 10.1242/jeb.115584; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; Sunday JM, 2014, TRENDS ECOL EVOL, V29, P117, DOI 10.1016/j.tree.2013.11.001; Sutton RT, 2005, SCIENCE, V309, P115, DOI 10.1126/science.1109496; Tremblay M. J., 1997, Journal of Northwest Atlantic Fishery Science, V21, P7; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; WEARE BC, 1977, Q J ROY METEOR SOC, V103, P467, DOI 10.1002/qj.49710343707; WITTING DA, 1995, MAR ECOL PROG SER, V123, P23, DOI 10.3354/meps123023; Youcef WA, 2013, FISH OCEANOGR, V22, P41, DOI 10.1111/fog.12004	116	22	23	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0167411	10.1371/journal.pone.0167411	http://dx.doi.org/10.1371/journal.pone.0167411			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997536	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842900007
J	Chavez, JD; Eng, JK; Schweppe, DK; Cilia, M; Rivera, K; Zhong, XF; Wu, X; Allen, T; Khurgel, M; Kumar, A; Lampropoulos, A; Larsson, M; Maity, S; Morozov, Y; Pathmasiri, W; Perez-Neut, M; Pineyro-Ruiz, C; Polina, E; Post, S; Rider, M; Tokmina-Roszyk, D; Tyson, K; Sant'Ana, DVP; Bruce, JE				Chavez, Juan D.; Eng, Jimmy K.; Schweppe, Devin K.; Cilia, Michelle; Rivera, Keith; Zhong, Xuefei; Wu, Xia; Allen, Terrence; Khurgel, Moshe; Kumar, Akhilesh; Lampropoulos, Athanasios; Larsson, Marten; Maity, Shuvadeep; Morozov, Yaroslav; Pathmasiri, Wimal; Perez-Neut, Mathew; Pineyro-Ruiz, Coriness; Polina, Elizabeth; Post, Stephanie; Rider, Mark; Tokmina-Roszyk, Dorota; Tyson, Katherine; Sant'Ana, Debora Vieira Parrine; Bruce, James E.			A General Method for Targeted Quantitative Cross-Linking Mass Spectrometry	PLOS ONE			English	Article							PROTEIN INTERACTIONS; HSP90; SOFTWARE; DATABASE; CELLS	Chemical cross-linking mass spectrometry (XL-MS) provides protein structural information by identifying covalently linked proximal amino acid residues on protein surfaces. The information gained by this technique is complementary to other structural biology methods such as x-ray crystallography, NMR and cryo-electron microscopy[1]. The extension of traditional quantitative proteomics methods with chemical cross-linking can provide information on the structural dynamics of protein structures and protein complexes. The identification and quantitation of cross-linked peptides remains challenging for the general community, requiring specialized expertise ultimately limiting more widespread adoption of the technique. We describe a general method for targeted quantitative mass spectrometric analysis of cross linked peptide pairs. We report the adaptation of the widely used, open source software package Skyline, for the analysis of quantitative XL-MS data as a means for data analysis and sharing of methods. We demonstrate the utility and robustness of the method with a cross-laboratory study and present data that is supported by and validates previously published data on quantified cross-linked peptide pairs. This advance provides an easy to use resource so that any lab with access to a LC-MS system capable of performing targeted quantitative analysis can quickly and accurately measure dynamic changes in protein structure and protein interactions.	[Chavez, Juan D.; Eng, Jimmy K.; Schweppe, Devin K.; Zhong, Xuefei; Wu, Xia; Bruce, James E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98105 USA; [Cilia, Michelle] Boyce Thompson Inst Plant Res, Ithaca, NY USA; [Cilia, Michelle] ARS, USDA, Ithaca, NY USA; [Cilia, Michelle] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY USA; [Rivera, Keith] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Allen, Terrence; Khurgel, Moshe; Kumar, Akhilesh; Lampropoulos, Athanasios; Larsson, Marten; Maity, Shuvadeep; Morozov, Yaroslav; Pathmasiri, Wimal; Perez-Neut, Mathew; Pineyro-Ruiz, Coriness; Polina, Elizabeth; Post, Stephanie; Rider, Mark; Tokmina-Roszyk, Dorota; Tyson, Katherine; Sant'Ana, Debora Vieira Parrine] Cold Spring Harbor Lab, Prote Course 2016, POB 100, Cold Spring Harbor, NY 11724 USA	University of Washington; University of Washington Seattle; Cornell University; Boyce Thompson Institute for Plant Research; United States Department of Agriculture (USDA); Cornell University; Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory	Bruce, JE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98105 USA.	jimbruce@uw.edu	Maity, Shuvadeep/I-7846-2019; Eng, Jimmy K/I-4202-2012	Maity, Shuvadeep/0000-0002-6031-4744; Eng, Jimmy K/0000-0001-6352-6737; Pathmasiri, Wimal/0000-0002-5199-5744; Chavez, Juan/0000-0001-8849-0304; Rivera, Keith/0000-0003-2979-9576; Whipple, Stephanie/0000-0003-2354-736X; Larsson, Marten/0000-0002-7855-9539; Schweppe, Devin/0000-0002-3241-6276	National Institutes of Health [5R01RR023334, 1R01GM097112, 5R01GM086688, 7S10RR025107, 5U19AI107775, 4T15HD072999, 1R01HL110879]; UW Proteome Resource [UWPR95794]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T15HD072999] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001115, UL1TR001117] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR023334, S10RR025107] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI107775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113237, R01GM086688, R01GM097112, R25GM109439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG041688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UW Proteome Resource; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health through grant numbers: 5R01RR023334, 1R01GM097112, 5R01GM086688, 7S10RR025107, 5U19AI107775, 4T15HD072999 and 1R01HL110879 and supported in part by the UW Proteome Resource UWPR95794.; We thank all of the members of the Bruce Laboratory and the UWPR for their advice and helpful discussions. We also thank the organizers of the CSHL 2016 proteomics workshop. This work was supported by the National Institutes of Health through grant numbers: 5R01RR023334, 1R01GM097112, 5R01GM086688, 7S 10RR025107, 5U19AI107775, 4T15HD072999 1R01HL110879, and R01GM113237 and supported in part by the UW Proteome Resource UWPR95794.	Bourmaud A, 2016, PROTEOMICS, V16, P2146, DOI 10.1002/pmic.201500543; Chavez JD, 2016, CELL CHEM BIOL, V23, P716, DOI 10.1016/j.chembiol.2016.05.012; Chavez JD, 2013, MOL CELL PROTEOMICS, V12, P1451, DOI 10.1074/mcp.M112.024497; Chen Z.A., 2016, MOL CELL PROTEOMICS; Eng JK, 2013, PROTEOMICS, V13, P22, DOI 10.1002/pmic.201200439; Holding AN, 2015, METHODS, V89, P54, DOI 10.1016/j.ymeth.2015.06.010; Kaake RM, 2014, MOL CELL PROTEOMICS, V13, P3533, DOI 10.1074/mcp.M114.042630; Kusebauch U, 2016, CELL, V166, P766, DOI 10.1016/j.cell.2016.06.041; Leitner A, 2016, TRENDS BIOCHEM SCI, V41, P20, DOI 10.1016/j.tibs.2015.10.008; Liu F, 2015, NAT METHODS, V12, P1179, DOI 10.1038/nmeth.3603; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Picotti P, 2012, NAT METHODS, V9, P555, DOI [10.1038/NMETH.2015, 10.1038/nmeth.2015]; Schmidt C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2985; Schulte TW, 1998, CANCER CHEMOTH PHARM, V42, P273, DOI 10.1007/s002800050817; Schweppe DK, 2016, BIOINFORMATICS, V32, P2716, DOI 10.1093/bioinformatics/btw232; Schweppe DK, 2015, CHEM BIOL, V22, P1521, DOI 10.1016/j.chembiol.2015.09.015; Sharma V, 2014, J PROTEOME RES, V13, P4205, DOI 10.1021/pr5006636; Tan D, 2016, ELIFE, V5, DOI 10.7554/eLife.12509; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Walzthoeni T, 2015, NAT METHODS, V12, P1185, DOI 10.1038/nmeth.3631; Weisbrod CR, 2013, J PROTEOME RES, V12, P1569, DOI 10.1021/pr3011638; Wu X, 2015, MOL CELL PROTEOMICS, V14, P2126, DOI 10.1074/mcp.M115.050161; YERGEY JA, 1983, INT J MASS SPECTROM, V52, P337, DOI 10.1016/0020-7381(83)85053-0; Yu C, 2016, ANAL CHEM; Zheng CX, 2013, J PROTEOME RES, V12, P1989, DOI 10.1021/pr301162j	27	33	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0167547	10.1371/journal.pone.0167547	http://dx.doi.org/10.1371/journal.pone.0167547			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997545	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000392842900010
J	Khanam, R; Creanga, AA; Koffi, AK; Mitra, DK; Mahmud, A; Begum, N; Moin, SMI; Ram, M; Quaiyum, MA; Ahmed, S; Saha, SK; Baqui, AH				Khanam, Rasheda; Creanga, Andreea A.; Koffi, Alain K.; Mitra, Dipak K.; Mahmud, Arif; Begum, Nazma; Moin, Syed Mamun Ibne; Ram, Malathi; Quaiyum, Md Abdul; Ahmed, Saifuddin; Saha, Samir K.; Baqui, Abdullah H.		Projahnmo Study Grp Bangladesh	Patterns and Determinants of Care-Seeking for Antepartum and Intrapartum Complications in Rural Bangladesh: Results from a Cohort Study	PLOS ONE			English	Article							HEALTH-CARE; MATERNAL HEALTH; SYLHET DISTRICT; DECISION-MAKING; WOMENS AUTONOMY; ACCESS; MORTALITY; PREGNANCY; SERVICES; DELIVERY	Background The burden of maternal complications during antepartum and intrapartum periods is high and care seeking from a trained provider is low, particularly in low middle income countries of sub-Saharan Africa and South Asia. Identification of barriers to access to trained care and development of strategies to address them will contribute to improvements in maternal health. Using data from a community-based cohort of pregnant women, this study identified the prevalence of antepartum and intrapartum complications and determinants of care seeking for these complications in rural Bangladesh. Methods The study was conducted in 24,274 pregnant women between June 2011 and December 2013 in rural Sylhet district of Bangladesh. Women were interviewed during pregnancy to collect data on demographic and socioeconomic characteristics; prior miscarriages, stillbirths, live births, and neonatal deaths; as well as data on their ability to make decision to go to health center alone. They were interviewed within the first 7 days of child birth to collect data on self-reported antepartum and intrapartum complications and care seeking for those complications. Bivariate analysis was conducted to explore association between predisposing (socio-demographic), enabling (economic), perceived need, and service related factors with care seeking for self-reported antepartum and intrapartum complications. Multivariable multinomial logistic regression was performed to examine the association of selected factors with care-seeking for self-reported antepartum and intrapartum complications adjusting for co-variates. Results Self-reported antepartum and intrapartum complications among women were 14.8% and 20.9% respectively. Among women with any antepartum complication, 58.9% sought care and of these 46.5% received care from a trained provider. Of the women with intrapartum complications, 61.4% sought care and of them 46.5% did so from a trained provider. Care seeking for both antepartum and intrapartum complications from a trained provider was significantly higher for women with higher household wealth status, higher literacy level of both women and their husbands, and for those living close to a health facility (<10 km). Women's decision making ability to go to health centre alone was associated with untrained care only for antepartum complications, but was associated with both trained and untrained care for intrapartum complications. Conclusions Nearly 40.0% of the women who experienced either an antepartum or intrapartum complications did not seek care from any provider and 11.5%-14.9% received care from untrained providers, primarily because of economic and geographic barriers to access. Development and evaluation of context specific, cost-effective, and sustainable strategies that will address these barriers to access to care for the maternal complications will enhance care seeking from trained health care providers and improve maternal health.	[Khanam, Rasheda; Creanga, Andreea A.; Koffi, Alain K.; Mahmud, Arif; Begum, Nazma; Moin, Syed Mamun Ibne; Ram, Malathi; Baqui, Abdullah H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Int Ctr Maternal & Newborn Hlth, Baltimore, MD 21205 USA; [Khanam, Rasheda; Quaiyum, Md Abdul] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; [Mitra, Dipak K.] Independent Univ, Dhaka, Bangladesh; [Ahmed, Saifuddin] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA; [Saha, Samir K.] Dhaka Shishu Hosp, Dept Microbiol, Dhaka, Bangladesh	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; International Centre for Diarrhoeal Disease Research (ICDDR); Independent University Bangladesh (IUB); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Khanam, R (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Int Ctr Maternal & Newborn Hlth, Baltimore, MD 21205 USA.; Khanam, R (corresponding author), Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.	rkhanam1@jhu.edu	Khanam, Rasheda/P-8050-2018; Mitra, Dipak/W-9569-2018	Khanam, Rasheda/0000-0002-9365-8594; Koffi, Alain/0000-0003-3499-0949; Mitra, Dipak/0000-0001-8680-4146	Bill & Melinda Gates Foundation [OPPGH5307]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was funded by Bill & Melinda Gates Foundation (grant no. OPPGH5307), http://www.gatestoundation.org/, AHB and SKS received the funding.; The study was funded by Bill & Melinda Gates Foundation (Grant No. OPPGH5307). The authors thank the members of the Projahnmo study team in Bangladesh and the study participants in Sylhet district who gave their time generously. Projahnmo is a research partnership of Johns Hopkins University (JHU) with the Bangladesh Ministry of Health and Family Welfare (MOHFW) and other Bangladeshi institutions including ICDDR,B, Shimantik, Sylhet Osmani Medical College (SOMC), Banghabandhu Shaik Mujib Medical University (BSMMU), and Child Health Research Foundation (CHRF). The other members of the Projahnmo Study Group include: Dr. A. E. Md. Muhiuddin Osmani; Dr. Habibur Rahman, Dr. Mohammad Sharif, Dr. A K M Saiedur Rahman, Dr. Gour Moni Sinha, Md. Kutub Uddin, Dr. Lutfunnahar Jesmin, Dr. Md. Abul Kalam Azad, Dr. Md. Abdullah Al Mehedi, Dr. Md. Moazzem Ali Khan Chowdhury, Dr. Md. Mashuqur Rahman of MOHFW; Prof. Manajjir Ali of SOMC; Prof. Mohammod Shahidullah of BSMMU; Prof. Mathuram Santosham, Dr. Salahuddin Ahmed, Dr. Arunangshu Dutta Roy, Sayed Mamun Moin of JHU; Prof. Nawshad Ahmed, Maksuda Islam, Iftekhar Rafiquilah, Shahidul Islam, Md. Hasanuzzaman of CHRF; and Dr. Ahmed Al Kabir of Shimantik. Abdullah H. Baqui (abaqui@jhu.edu) is the led author of this group.	Afulani PA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154110; Ahmed S, 2011, SOC SCI MED, V72, P1704, DOI 10.1016/j.socscimed.2011.03.031; Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; Allanson ER, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0472-9; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Dietz P, 2014, MATERN CHILD HLTH J, V18, P2489, DOI 10.1007/s10995-014-1487-y; El Arifeen S, 2012, LANCET, V379, P1022, DOI 10.1016/S0140-6736(11)61848-5; Fotso JC, 2009, MATERN CHILD HLTH J, V13, P130, DOI 10.1007/s10995-008-0326-4; Fournier P, 2009, B WORLD HEALTH ORGAN, V87, P30, DOI 10.2471/BLT.07.047076; Glassman A, 2013, J HEALTH POPUL NUTR, V31, P48; Hardee K, 2012, GLOB PUBLIC HEALTH, V7, P603, DOI 10.1080/17441692.2012.668919; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Islam N, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-86; Jacobs B, 2012, HEALTH POLICY PLANN, V27, P288, DOI 10.1093/heapol/czr038; Koenig MA, 2007, INT FAM PLAN PERSPEC, V33, P75, DOI 10.1363/3307507; Lagarde M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008137; Lakew S, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0102-z; Malqvist M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066453; Mitra DK, 2016, PEDIATR INFECT DIS J, V35, pS55, DOI 10.1097/INF.0000000000001108; Mpembeni Rose Nm, 2007, BMC Pregnancy Childbirth, V7, P29, DOI 10.1186/1471-2393-7-29; Murray SF, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-30; National Institute of Population Research and Training (NIPORT), 2012, MEASURE EV ICDDR B B; Nonyane BAS, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.010605; Osamor PE, 2016, INT J WOMENS HEALTH, V8, P191, DOI 10.2147/IJWH.S105483; Peters DH, 2008, ANN NY ACAD SCI, V1136, P161, DOI 10.1196/annals.1425.011; Qureshi RN, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0140-1; Ronsmans C, 1997, STUD FAMILY PLANN, V28, P203, DOI 10.2307/2137888; Rutstein SO, 2004, DHS COMP REPORTS, V6; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Senarath U, 2009, ASIA-PAC J PUBLIC HE, V21, P137, DOI 10.1177/1010539509331590; Sikder SS, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0832-1; Vogel JP, 2014, BJOG-INT J OBSTET GY, V121, P76, DOI 10.1111/1471-0528.12633; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; Worku AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060171; World Health Organization (WHO), 2009, INT MAN PREGN CHILDB	37	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0167814	10.1371/journal.pone.0167814	http://dx.doi.org/10.1371/journal.pone.0167814			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QF	27997537	Green Published, gold, Green Submitted			2022-12-26	WOS:000392842900014
J	Chopin, J; Laga, H; Miklavcic, SJ				Chopin, Joshua; Laga, Hamid; Miklavcic, Stanley J.			A Hybrid Approach for Improving Image Segmentation: Application to Phenotyping of Wheat Leaves	PLOS ONE			English	Article							CORNER DETECTION; COLOR	In this article we propose a novel tool that takes an initial segmented image and returns a more accurate segmentation that accurately captures sharp features such as leaf tips, twists and axils. Our algorithm utilizes basic a-priori information about the shape of plant leaves and local image orientations to fit active contour models to important plant features that have been missed during the initial segmentation. We compare the performance of our approach with three state-of-the-art segmentation techniques, using three error metrics. The results show that leaf tips are detected with roughly one half of the original error, segmentation accuracy is almost always improved and more than half of the leaf breakages are corrected.	[Chopin, Joshua; Miklavcic, Stanley J.] Univ South Australia, Phen & Bioinformat Res Ctr, Mawson Lakes, SA, Australia; [Laga, Hamid] Murdoch Univ, Sch Engn & Informat Technol, Perth, WA, Australia	University of South Australia; Murdoch University	Miklavcic, SJ (corresponding author), Univ South Australia, Phen & Bioinformat Res Ctr, Mawson Lakes, SA, Australia.	stan.miklavcic@unisa.edu.au		Miklavcic, Stanley/0000-0002-2361-246X; Chopin, Joshua/0000-0002-5012-5827	Grains Research and Development Corporation [GRS10512]	Grains Research and Development Corporation(Grains R&D Corp)	JC received a scholarship from the Grains Research and Development Corporation #GRS10512.	Cai J, 2012, IET IMAGE PROCESS, V6, P687, DOI 10.1049/iet-ipr.2011.0281; Cai JH, 2015, J EXP BOT, V66, P6551, DOI 10.1093/jxb/erv359; Chopin J, 2016, COMPUT J, V59, P603, DOI 10.1093/comjnl/bxv086; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Fahlgren N, 2015, MOL PLANT, V8, P1520, DOI 10.1016/j.molp.2015.06.005; Fritsche-Neto R, PHENOMICS NEXT GENER; Harris C., 1988, P ALV VIS C MANCH UK, V15, P147, DOI [10.5244/C.2.23, DOI 10.5244/C.2.23]; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hartmann A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-148; Kacira M, 2002, T ASAE, V45, P1147, DOI 10.13031/2013.9923; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Klukas C, 2014, PLANT PHYSIOL, V165, P506, DOI 10.1104/pp.113.233932; Kumar P, P INT C CONTR AUT RO, P211; Kumar P, 2014, PLANT SOIL, V380, P193, DOI 10.1007/s11104-014-2071-3; Kurata K, ACTA HORTIC, V440, P389; Laga H, P DICTA DIG IM COMP, P1; Laga H, 2013, 20TH INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION (MODSIM2013), P524; Laga H, 2014, J THEOR BIOL, V363, P41, DOI 10.1016/j.jtbi.2014.07.036; Lin K., 2013, COMMUN COMPUT INF SC, V363, P192, DOI DOI 10.1007/978-3-642-37149-3_23; Manh AG, 2001, J AGR ENG RES, V80, P139, DOI 10.1006/jaer.2001.0725; Midtiby H, INT C AGR ENG; Mokhtarian F, 1998, IEEE T PATTERN ANAL, V20, P1376, DOI 10.1109/34.735812; Mylona EA, 2012, IEEE IMAGE PROC, P2565, DOI 10.1109/ICIP.2012.6467422; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Permuter H, 2006, PATTERN RECOGN, V39, P695, DOI 10.1016/j.patcog.2005.10.028; Pound MP, 2014, PLANT PHYSIOL, V166, P1688, DOI 10.1104/pp.114.248971; Rousseau D., 2015, PHENOMICS CROP PLANT, P61; Ruzon MA, 2001, IEEE T PATTERN ANAL, V23, P1281, DOI 10.1109/34.969118; Seginer I, PLANT WILT DETECTION, V35, P1563; Sorensen T., 1948, BIOL SKAR, V5, P1; Tessmer OL, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S6-S17; Vantaram SR, 2012, J ELECTRON IMAGING, V21, DOI 10.1117/1.JEI.21.4.040901; Witkin A.P., 1983, P 8 INT JOINT C ART, P1019, DOI DOI 10.1007/978-3-8348-9190-729; Yin X, 2014, IEEE WINT CONF APPL, P437	34	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168496	10.1371/journal.pone.0168496	http://dx.doi.org/10.1371/journal.pone.0168496			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992594	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000392842600069
J	du Plessis, J; Korf, H; van Pelt, J; Windmolders, P; Vander Elst, I; Verrijken, A; Hubens, G; Van Gaal, L; Cassiman, D; Nevens, F; Francque, S; van der Merwe, S				du Plessis, Johannie; Korf, Hannelie; van Pelt, Jos; Windmolders, Petra; Vander Elst, Ingrid; Verrijken, An; Hubens, Guy; Van Gaal, Luc; Cassiman, David; Nevens, Frederik; Francque, Sven; van der Merwe, Schalk			Pro-Inflammatory Cytokines but Not Endotoxin-Related Parameters Associate with Disease Severity in Patients with NAFLD	PLoS One			English	Article							FATTY LIVER-DISEASE; TOLL-LIKE RECEPTORS; NONALCOHOLIC STEATOHEPATITIS; GUT MICROBIOTA; INSULIN-RESISTANCE; INTESTINAL PERMEABILITY; GENE-EXPRESSION; OBESITY; MICE; PATHOGENESIS	Intestinal dysbiosis and elevated lipopolysaccharides (LPS) levels have been implicated in the development of obesity, insulin resistance and non-alcoholic steatohepatitis (NASH). In order to determine if LPS levels are elevated in patients with NASH compared to patients with non-alcoholic fatty liver (NAFL) and, if elevated LPS levels correlated with histological severity of non-alcoholic fatty liver disease (NAFLD) we compared LPS, markers of LPS bioactivity and pro-inflammatory cytokines/chemokines in patients undergoing bariatric surgery. At the time of surgery a liver biopsy was taken allowing the stratification into well-delineated subgroups including: No NAFL/NAFL; NASH; NASH with fibrosis and NASH cirrhotics, using the NAFLD Activity Score (NAS). Anthropometric data and plasma were collected for assessment of LPS, lipopolysaccharide binding protein (LBP), soluble CD14 (sCD14), intestinal-type fatty acid binding protein (iFABP), Toll-like receptors 2 and 4 (TLR2, 4) and a panel of cytokines/chemokines. Similar analysis was performed on plasma from a cohort of healthy controls. Our data indicate elevated levels of LPS, LBP, sCD14, iFABP and TLR2,4 in obese patients compared to healthy controls, however, these parameters remained unaltered within patients with limited liver disease (NAFL) compared to NASH/NASH with fibrosis subgroups. Hierarchic cluster analysis using endotoxin-related parameters failed to discriminate between lean controls, NAFLD. While similar cluster analysis implementing inflammation-related parameters clearly distinguished lean controls, NALFD subgroups and NASH cirrhotics. In addition, LPS levels was not associated with disease severity while TNF alpha, IL8, and CCL3 featured a clear correlation with transaminase levels and the histological severity of NALFD. In conclusion our data indicate a stronger correlation for circulating inflammatory-rather than endotoxin-related parameters in progression of NAFLD and highlights the need for additional larger studies in unravelling further mechanistic insights.	[du Plessis, Johannie; Korf, Hannelie; van Pelt, Jos; Windmolders, Petra; Vander Elst, Ingrid; Cassiman, David; Nevens, Frederik; van der Merwe, Schalk] Katholieke Univ Leuven, Dept Clin & Expt Med, Lab Hepatol, Leuven, Belgium; [Korf, Hannelie] Katholieke Univ Leuven, Dept Clin & Expt Med, Translat Res Ctr Gastrointestinal Disorders TARGI, Leuven, Belgium; [Verrijken, An] Univ Antwerp, Univ Antwerp Hosp, Dept Endocrinol Diabetol & Metab, Antwerp, Belgium; [Hubens, Guy] Univ Antwerp, Univ Antwerp Hosp, Dept Abdominal Surg, Antwerp, Belgium; [Van Gaal, Luc; Francque, Sven] Univ Antwerp, Univ Antwerp Hosp, Dept Gastroenterol & Hepatol, Antwerp, Belgium; [Cassiman, David; Nevens, Frederik; van der Merwe, Schalk] Katholieke Univ Leuven, Div Liver & Biliopancreat Disorders, Dept Internal Med, Leuven, Belgium	KU Leuven; KU Leuven; University of Antwerp; University of Antwerp; University of Antwerp; KU Leuven	van der Merwe, S (corresponding author), Katholieke Univ Leuven, Dept Clin & Expt Med, Lab Hepatol, Leuven, Belgium.; van der Merwe, S (corresponding author), Katholieke Univ Leuven, Div Liver & Biliopancreat Disorders, Dept Internal Med, Leuven, Belgium.	schalk.vandermerwe@uzleuven.be	; Cassiman, David/H-6813-2014	Van der Merwe, Schalk/0000-0002-9891-2686; Cassiman, David/0000-0002-6154-0970; Korf, Hannelie/0000-0003-3540-0138; van Pelt, Jos/0000-0001-6903-4338	Flanders fund for scientific research (FWO klinisch mandaat); FWO; European Union [LSHM-CT-2005-018734, 305707]; European Association	Flanders fund for scientific research (FWO klinisch mandaat)(FWO); FWO(FWO); European Union(European Commission); European Association	Schalk van der Merwe, Frederik Nevens, David Cassiman and Sven Francque are recipients of Flanders fund for scientific research (FWO klinisch mandaat). Hannelie Korf is a recipient of FWO post-doctoral mandate. Research at the department of Endocrinology, Diabetology and Metabolism and the department of Gastroenterology and Hepatology of the Antwerp University Hospital (Belgium) was supported by the European Union: FP6 (HEPADIP Contract LSHM-CT-2005-018734) and FP7-HEALTH (RESOLVE nr. 305707). Johannie du Plessis is a recipient of an European Association for the Study of the Liver (EASL) scholarship.	Abu-Shanab A, 2010, NAT REV GASTRO HEPAT, V7, P691, DOI 10.1038/nrgastro.2010.172; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; DeMinicis S, 2014, HEPATOLOGY, V59, P1738, DOI 10.1002/hep.26695; du Plessis J, 2015, GASTROENTEROLOGY, V149, P635, DOI 10.1053/j.gastro.2015.05.044; Du Plessis J, 2013, J HEPATOL, V58, P1125, DOI 10.1016/j.jhep.2013.01.038; Engstler AJ, 2016, GUT, V65, P1564, DOI 10.1136/gutjnl-2014-308379; Francque SMA, 2012, CLIN GASTROENTEROL H, V10, P1162, DOI 10.1016/j.cgh.2012.06.019; Garcia-Martinez I, 2016, J CLIN INVEST, V126, P859, DOI 10.1172/JCI83885; Gonzalez-Quintela A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054600; Harte AL, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-15; Heinrichs D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066106; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim JS, 2012, PEDIATR OBES, V7, P158, DOI 10.1111/j.2047-6310.2011.00014.x; Le Roy T, 2013, GUT, V62, P1787, DOI 10.1136/gutjnl-2012-303816; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; Moschen AR, 2013, TRENDS ENDOCRIN MET, V24, P537, DOI 10.1016/j.tem.2013.05.009; Mouzaki M, 2013, HEPATOLOGY, V58, P120, DOI 10.1002/hep.26319; Musso G, 2010, CURR OPIN LIPIDOL, V21, P76, DOI 10.1097/MOL.0b013e3283347ebb; Ogawa Y, 2013, PLOS ONE, V7; Phillips CM, 2013, REV ENDOCR METAB DIS, V14, P219, DOI 10.1007/s11154-013-9252-x; Ruiz AG, 2007, OBES SURG, V17, P1374; Sandler NG, 2011, GASTROENTEROLOGY, V141, P1220, DOI 10.1053/j.gastro.2011.06.063; Spruss A, 2009, HEPATOLOGY, V50, P1094, DOI 10.1002/hep.23122; Testro AG, 2009, J GASTROEN HEPATOL, V24, P943, DOI 10.1111/j.1440-1746.2009.05854.x; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Verdam FJ, 2011, J CLIN GASTROENTEROL, V45, P149, DOI 10.1097/MCG.0b013e3181e12c24; Verrijken A, 2014, HEPATOLOGY, V59, P121, DOI 10.1002/hep.26510; Wigg AJ, 2001, GUT, V48, P206, DOI 10.1136/gut.48.2.206; Wlodarska M, 2014, CELL, V156, P1045, DOI 10.1016/j.cell.2014.01.026; Yuan JY, 2014, J GASTROEN HEPATOL, V29, P1292, DOI 10.1111/jgh.12510; Zhu LX, 2013, HEPATOLOGY, V57, P601, DOI 10.1002/hep.26093	39	42	42	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0166048	10.1371/journal.pone.0166048	http://dx.doi.org/10.1371/journal.pone.0166048			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992443	Green Published, gold, Green Submitted			2022-12-26	WOS:000392842600008
J	Corley, SM; Tsai, SY; Wilkins, MR; Weickert, CS				Corley, Susan M.; Tsai, Shan-Yuan; Wilkins, Marc R.; Weickert, Cynthia Shannon			Transcriptomic Analysis Shows Decreased Cortical Expression of NR4A1, NR4A2 and RXRB in Schizophrenia and Provides Evidence for Nuclear Receptor Dysregulation	PLOS ONE			English	Article							RETINOIC-ACID-RECEPTOR; DORSOLATERAL PREFRONTAL CORTEX; ESTROGEN-RECEPTOR; MESSENGER-RNA; NGFI-B; DIFFERENTIAL EXPRESSION; GENE-EXPRESSION; X-RECEPTOR; TUMOR INITIATION; SPLICE VARIANT	Many genes are differentially expressed in the cortex of people with schizophrenia, implicating factors that control transcription more generally. Hormone nuclear receptors dimerize to coordinate context-dependent changes in gene expression. We hypothesized that members of two families of nuclear receptors (NR4As), and retinoid receptors (RARs and RXRs), are altered in the dorsal lateral prefrontal cortex (DLPFC) of people with schizophrenia. We used next generation sequencing and then qPCR analysis to test for changes in mRNA levels for transcripts encoding nuclear receptors: orphan nuclear receptors (3 in the NR4A, 3 in the RAR, 3 in the RXR families and KLF4) in total RNA extracted from the DLPFC from people with schizophrenia compared to controls (n = 74). We also correlated mRNA levels with demographic factors and with estimates of antipsychotic drug exposure (schizophrenia group only). We tested for correlations between levels of transcription factor family members and levels of genes putatively regulated by these transcription factors. We found significantly down regulated expression of NR4A1 (Nurr 77) and KLF4 mRNAs in people with schizophrenia compared to controls, by both NGS and qPCR (p = or < 0.01). We also detected decreases in NR4A2 (Nurr1) and RXRB mRNAs by using qPCR in the larger cohort (p< 0.05 and p< 0.01, respectively). We detected decreased expression of RARG and NR4A2 mRNAs in females with schizophrenia (p< 0.05). The mRNA levels of NR4A1, NR4A2 and NR4A3 were all negative correlated with lifetime estimates of antipsychotic exposure. These novel findings, which may be influenced by antipsychotic drug exposure, implicate the orphan and retinoid nuclear receptors in the cortical pathology found in schizophrenia. Genes down stream of these receptors can be dysregulated as well, but the direction of change is not immediately predictable based on the putative transcription factor changes.	[Corley, Susan M.; Wilkins, Marc R.] Univ New South Wales, Sch Biotechnol & Biomol Sci, Syst Biol Initiat, Sydney, NSW, Australia; [Tsai, Shan-Yuan; Weickert, Cynthia Shannon] Schizophrenia Res Inst, Randwick, NSW, Australia; [Tsai, Shan-Yuan; Weickert, Cynthia Shannon] Neurosci Res Australia, Randwick, NSW, Australia; [Tsai, Shan-Yuan; Weickert, Cynthia Shannon] Univ New South Wales Sydney, Sch Psychiat, Sydney, NSW, Australia	University of New South Wales Sydney; Neuroscience Research Australia; University of New South Wales Sydney	Corley, SM (corresponding author), Univ New South Wales, Sch Biotechnol & Biomol Sci, Syst Biol Initiat, Sydney, NSW, Australia.	s.corley@unsw.edu.au	Corley, Susan/R-6407-2019	Corley, Susan/0000-0003-0605-6411; Shannon Weickert, Cynthia/0000-0002-4560-0259	Australian Federal Government; NCRIS; New South Wales State Government Science Leveraging Fund; Research Attraction and Acceleration Program; University of New South Wales; Schizophrenia Research Institute (NSW Ministry of Health); Schizophrenia Research Institute (Macquarie Group Foundation); Neuroscience Research Australia; National Health and Medical Research Council (Australia) Senior Research Fellowship [1021970]; Australia Project Grant [568807]; Cowled Postgraduate Research Scholarship in Brain Research; Schizophrenia Research Institute; National Institute of Alcohol Abuse and Alcoholism (NIH (NIAAA)) [R28AA012725]; Lundbeck Australia Advisory Board; Astellas Pharma Inc., Japan; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R28AA012725] Funding Source: NIH RePORTER	Australian Federal Government(Australian Government); NCRIS(Australian GovernmentDepartment of Industry, Innovation and Science); New South Wales State Government Science Leveraging Fund; Research Attraction and Acceleration Program; University of New South Wales; Schizophrenia Research Institute (NSW Ministry of Health); Schizophrenia Research Institute (Macquarie Group Foundation); Neuroscience Research Australia; National Health and Medical Research Council (Australia) Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australia Project Grant; Cowled Postgraduate Research Scholarship in Brain Research; Schizophrenia Research Institute; National Institute of Alcohol Abuse and Alcoholism (NIH (NIAAA))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Lundbeck Australia Advisory Board; Astellas Pharma Inc., Japan(Astellas Pharmaceuticals); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	MRW and SC acknowledge support from the Australian Federal Government's Super Science and NCRIS Schemes, from the New South Wales State Government Science Leveraging Fund and Research Attraction and Acceleration Program and from the University of New South Wales. This work was supported by Schizophrenia Research Institute (utilizing infrastructure funding from the NSW Ministry of Health and the Macquarie Group Foundation), the University of New South Wales, and Neuroscience Research Australia. CSW is a recipient of a National Health and Medical Research Council (Australia) Senior Research Fellowship (#1021970) Australia Project Grant No. 568807. Shan-Yuan Tsai is supported by The Cowled Postgraduate Research Scholarship in Brain Research. Tissues were received from the New South Wales Brain Tissue Resource Centre at the University of Sydney which is supported by the Schizophrenia Research Institute and National Institute of Alcohol Abuse and Alcoholism (NIH (NIAAA) R28AA012725). The authors received additional funding from the Lundbeck Australia Advisory Board and Astellas Pharma Inc., Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnisalo P, 2002, J BIOL CHEM, V277, P35118, DOI 10.1074/jbc.M201707200; Allen KM, 2016, AUST NZ J PSYCHIAT, V50, P473, DOI 10.1177/0004867415589793; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Beaudry G, 2000, J NEUROCHEM, V75, P1694, DOI 10.1046/j.1471-4159.2000.0751694.x; Bertolino A, 2009, BRAIN, V132, P417, DOI 10.1093/brain/awn248; Biddie SC, 2010, TRENDS ENDOCRIN MET, V21, P3, DOI 10.1016/j.tem.2009.08.006; Bobes Julio, 2007, Dialogues Clin Neurosci, V9, P215; Chao LC, 2012, J LIPID RES, V53, P2610, DOI 10.1194/jlr.M029355; Cohen O, 2015, MOL PSYCHIAT; Ethier I, 2004, NEUROPSYCHOPHARMACOL, V29, P335, DOI 10.1038/sj.npp.1300318; Fillman SG, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.8; Fillman SG, 2013, MOL PSYCHIATR, V18, P206, DOI 10.1038/mp.2012.110; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Foster KW, 2000, CANCER RES, V60, P6488; Gilbert F, 2006, BIOL PSYCHIAT, V60, P538, DOI 10.1016/j.biopsych.2006.04.023; Goodman AB, 1998, P NATL ACAD SCI USA, V95, P7240, DOI 10.1073/pnas.95.13.7240; Hawk JD, 2011, BRAIN RES BULL, V85, P21, DOI 10.1016/j.brainresbull.2011.02.001; Hawk JD, 2012, J CLIN INVEST, V122, P3593, DOI 10.1172/JCI64145; Hua SJ, 2009, CELL, V137, P1259, DOI 10.1016/j.cell.2009.04.043; Huang CC, 2005, CANCER BIOL THER, V4, P1401, DOI 10.4161/cbt.4.12.2355; Jagannathan V, 2011, MOL CELL ENDOCRINOL, V334, P91, DOI 10.1016/j.mce.2010.06.012; Jiang W, 2009, CANCER BIOL THER, V8, P285, DOI 10.4161/cbt.8.3.7486; Kaalund SS, 2014, MOL PSYCHIATR, V19, P1258, DOI 10.1038/mp.2013.165; Kastner P, 1996, GENE DEV, V10, P80, DOI 10.1101/gad.10.1.80; Kempermann G, 2008, CURR OPIN PSYCHIATR, V21, P290, DOI 10.1097/YCO.0b013e3282fad375; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Klinge CM, 1997, NUCLEIC ACIDS RES, V25, P1903, DOI 10.1093/nar/25.10.1903; Kozlovsky N, 2004, J NEURAL TRANSM, V111, P1583, DOI 10.1007/s00702-004-0166-3; Krezel W, 1999, NEUROSCIENCE, V89, P1291, DOI 10.1016/S0306-4522(98)00342-X; Krezel W, 1998, SCIENCE, V279, P863, DOI 10.1126/science.279.5352.863; Kuzawa CW, 2014, P NATL ACAD SCI USA, V111, P13010, DOI 10.1073/pnas.1323099111; Laganiere J, 2005, MOL ENDOCRINOL, V19, P1584, DOI 10.1210/me.2005-0040; Langlois MC, 2001, NEUROSCIENCE, V106, P117, DOI 10.1016/S0306-4522(01)00248-2; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee SK, 1998, MOL ENDOCRINOL, V12, P1184, DOI 10.1210/me.12.8.1184; Lee YM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/210604; Lefebvre P, VITAMINS HORMONES, P199; Lefebvre P, 2010, TRENDS ENDOCRIN MET, V21, P676, DOI 10.1016/j.tem.2010.06.009; Levesque D, 2007, TRENDS NEUROSCI, V30, P22, DOI 10.1016/j.tins.2006.11.006; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu M, 2005, ONCOGENE, V24, P4362, DOI 10.1038/sj.onc.1208661; Maheux J, 2005, J PHARMACOL EXP THER, V313, P460, DOI 10.1124/jpet.104.080184; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; Nunez SB, RECENT PROGR HORMONE, V50, P409; Paillasse MR, 2015, MED HYPOTHESES, V84, P135, DOI 10.1016/j.mehy.2014.12.003; Pearen MA, 2013, MOL ENDOCRINOL, V27, P1897, DOI 10.1210/me.2013-1205; Pearen MA, 2012, MOL ENDOCRINOL, V26, P372, DOI 10.1210/me.2011-1274; Perlman WR, 2004, BIOL PSYCHIAT, V56, P844, DOI 10.1016/j.biopsych.2004.09.006; PERLMANN T, 1995, GENE DEV, V9, P769, DOI 10.1101/gad.9.7.769; Peters R, 2006, POSTGRAD MED J, V82, P84, DOI 10.1136/pgmj.2005.036665; Pols TWH, 2008, PIGM CELL MELANOMA R, V21, P342, DOI 10.1111/j.1755-148X.2008.00469.x; Qin S, 2012, MOL CELL BIOL, V32, P4297, DOI 10.1128/MCB.00838-12; Qin S, 2011, P NATL ACAD SCI USA, V108, P21117, DOI 10.1073/pnas.1112351109; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ross-Innes CS, 2010, GENE DEV, V24, P171, DOI 10.1101/gad.552910; Rousseau C, 2003, J STEROID BIOCHEM, V86, P1, DOI 10.1016/S0960-0760(03)00255-3; Sacchetti P, 2002, J BIOL CHEM, V277, P35088, DOI 10.1074/jbc.M205816200; SEGARS JH, 1993, MOL CELL BIOL, V13, P2258, DOI 10.1128/MCB.13.4.2258; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Serretti A, 2004, CURR MED CHEM, V11, P343, DOI 10.2174/0929867043456043; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi JH, 2012, J BIOL CHEM, V287, P10799, DOI 10.1074/jbc.M111.321836; Sinclair D, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-84; Sinclair D, 2011, NEUROPSYCHOPHARMACOL, V36, P2698, DOI 10.1038/npp.2011.160; Smith AG, 2008, J BIOL CHEM, V283, P12564, DOI 10.1074/jbc.M800480200; Song MR, 1998, BIOCHEM J, V336, P711, DOI 10.1042/bj3360711; Warnes GR, 2013, GPLOTS VARIOUS R PRO; Webster MJ, 2002, MOL PSYCHIATR, V7, P985, DOI 10.1038/sj.mp.4001139; Weickert CS, 2003, MOL PSYCHIATR, V8, P592, DOI 10.1038/sj.mp.4001308; Weickert CS, 2008, HUM MOL GENET, V17, P2293, DOI 10.1093/hmg/ddn130; Weickert CS, 2010, AUST NZ J PSYCHIAT, V44, P59, DOI 10.3109/00048670903393662; Wong J, 2009, J BIOL CHEM, V284, P18824, DOI 10.1074/jbc.M109.013243; Xing GQ, 2006, SCHIZOPHR RES, V84, P36, DOI 10.1016/j.schres.2005.11.006; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Zetterstrom RH, 1996, MOL ENDOCRINOL, V10, P1656, DOI 10.1210/me.10.12.1656; Zheng B, 2009, J BIOL CHEM, V284, P22773, DOI 10.1074/jbc.M109.026989	79	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0166944	10.1371/journal.pone.0166944	http://dx.doi.org/10.1371/journal.pone.0166944			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992436	Green Published, gold, Green Submitted			2022-12-26	WOS:000392758000011
J	Chen, CC; Liang, CJ; Leu, YL; Chen, YL; Wang, SH				Chen, Chin-Chuan; Liang, Chan-Jung; Leu, Yann-Lii; Chen, Yuh-Lien; Wang, Shu-Huei			Viscolin Inhibits In Vitro Smooth Muscle Cell Proliferation and Migration and Neointimal Hyperplasia In Vivo	PLOS ONE			English	Article							MYELOLEUKEMIC U937 CELLS; II-INDUCED APOPTOSIS; POTENT ANTIINFLAMMATORY AGENT; ENDOTHELIAL PROGENITOR CELLS; ACTIVATED PROTEIN-KINASE; LECTIN-INDUCED APOPTOSIS; KAPPA-B; HEPATOCARCINOMA CELLS; VISCUM-COLORATUM; SUPEROXIDE ANION	Viscolin, an extract of Viscum coloratum, has anti-inflammatory and anti-proliferative properties against harmful stimuli. The aim of the study was to examine the anti-proliferative effects of viscolin on platelet derived growth factor-BB (PDGF)-treated human aortic smooth muscle cells (HASMCs) and identify the underlying mechanism responsible for these effects. Viscolin reduced the PDGF-BB-induced HASMC proliferation and migration in vitro; it also arrested HASMCs in the G0/G1 phase by decreasing the protein expression of Cyclin D1, CDK2, Cyclin E, CDK4, and p21(Cip1) as detected by Western blot analysis. These effects may be mediated by reduced PDGF-induced phosphorylation of ERK1/2, JNK, and P38, but not AKT as well as inhibition of PDGF-mediated nuclear factor (NF)-kappa B p65 and activator protein 1 (AP-1)/c-fos activation. Furthermore, viscolin pre-treatment significantly reduced neointimal hyperplasia of an endothelial-denuded femoral artery in vivo. Taken together, viscolin attenuated PDGF-BB-induced HASMC proliferation in vitro and reduced neointimal hyperplasia in vivo. Thus, viscolin may represent a therapeutic candidate for the prevention and treatment of vascular proliferative diseases.	[Chen, Chin-Chuan; Leu, Yann-Lii] Chang Gung Univ, Grad Inst Nat Prod, Taoyuan, Taiwan; [Chen, Chin-Chuan; Leu, Yann-Lii] Chang Gung Univ, Hlth Aging Res Ctr, Chinese Herbal Med Res Team, Taoyuan, Taiwan; [Chen, Chin-Chuan] Chang Gung Mem Hosp, Tissue Bank, Taoyuan, Taiwan; [Liang, Chan-Jung] Kaohsiung Med Univ, CLGR, Kaohsiung, Taiwan; [Liang, Chan-Jung] Kaohsiung Med Univ Hosp, CLB, Kaohsiung, Taiwan; [Leu, Yann-Lii] Chang Gung Mem Hosp, Ctr Tradit Chinese Med, Taoyuan, Taiwan; [Chen, Yuh-Lien; Wang, Shu-Huei] Natl Taiwan Univ, Dept Anat & Cell Biol, Coll Med, Taipei, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Chang Gung Memorial Hospital; National Taiwan University	Wang, SH (corresponding author), Natl Taiwan Univ, Dept Anat & Cell Biol, Coll Med, Taipei, Taiwan.	shwang@ntu.edu.tw	Chen, Chin-Chuan/G-3094-2013	Chen, Chin-Chuan/0000-0002-8938-3209; WANG, SHU-HUEI/0000-0002-9208-3135; Chen, Yuh-Lien/0000-0002-6498-4008	National Science Council	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council.	Camici GG, 2010, EUR HEART J, V31, P236, DOI 10.1093/eurheartj/ehp259; Choi SH, 2004, ARCH PHARM RES, V27, P68, DOI 10.1007/BF02980049; Conley KE, 2007, CURR OPIN CLIN NUTR, V10, P688, DOI 10.1097/MCO.0b013e3282f0dbfb; Golias CH, 2004, INT J CLIN PRACT, V58, P1134, DOI 10.1111/j.1742-1241.2004.00284.x; Graf K, 1997, HYPERTENSION, V29, P334, DOI 10.1161/01.HYP.29.1.334; Hoshi S, 2000, J BIOL CHEM, V275, P883, DOI 10.1074/jbc.275.2.883; Hwang TL, 2006, FREE RADICAL BIO MED, V41, P1433, DOI 10.1016/j.freeradbiomed.2006.08.001; Imanishi T, 2006, ATHEROSCLEROSIS, V189, P288, DOI 10.1016/j.atherosclerosis.2005.12.031; Jung HY, 2012, J MED FOOD, V15, P621, DOI 10.1089/jmf.2010.1469; Kim MS, 2003, LIFE SCI, V73, P1231, DOI 10.1016/S0024-3205(03)00418-1; Kim MS, 2000, GEN PHARMACOL-VASC S, V34, P349, DOI 10.1016/S0306-3623(01)00072-6; Kim WH, 2004, MOL PHARMACOL, V66, P1383, DOI 10.1124/mol.104.001347; Kuo PC, 2012, CHEM PHARM BULL, V60, P557, DOI 10.1248/cpb.60.557; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Leu YL, 2006, CHEM PHARM BULL, V54, P1063, DOI 10.1248/cpb.54.1063; Liang CJ, 2011, FREE RADICAL BIO MED, V51, P1337, DOI 10.1016/j.freeradbiomed.2011.06.023; Lyu SY, 2002, ARCH PHARM RES, V25, P93, DOI 10.1007/BF02975269; Nelson PR, 1998, J VASC SURG, V27, P117, DOI 10.1016/S0741-5214(98)70298-8; Obata H, 1996, BIOCHEM BIOPH RES CO, V224, P27, DOI 10.1006/bbrc.1996.0979; Ota H, 2009, J AM COLL CARDIOL, V53, P2298, DOI 10.1016/j.jacc.2009.01.072; Park R, 2000, BIOCHEM PHARMACOL, V60, P1685, DOI 10.1016/S0006-2952(00)00482-2; Raines EW, 2004, CYTOKINE GROWTH F R, V15, P237, DOI 10.1016/j.cytogfr.2004.03.004; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sata M, 2000, J MOL CELL CARDIOL, V32, P2097, DOI 10.1006/jmcc.2000.1238; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Su CS, 2006, BIOORG MED CHEM LETT, V16, P6155, DOI 10.1016/j.bmcl.2006.09.046; Wang SH, 2009, ARTERIOSCL THROM VAS, V29, P816, DOI 10.1161/ATVBAHA.109.184739; Weiss RH, 2000, J BIOL CHEM, V275, P10285, DOI 10.1074/jbc.275.14.10285; Zhan YM, 2003, ARTERIOSCL THROM VAS, V23, P795, DOI 10.1161/01.ATV.0000066132.32063.F2; Zhang H, 2012, J NANOMATER, V2012, DOI [10.1155/2012/217412, 10.1186/2049-1891-3-26]; Zhang Po, 2006, Zhonghua Xinxueguanbing Zazhi, V34, P1021	31	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168092	10.1371/journal.pone.0168092	http://dx.doi.org/10.1371/journal.pone.0168092			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977759	gold, Green Submitted, Green Published			2022-12-26	WOS:000391217400058
J	Madoshi, BP; Kudirkiene, E; Mtambo, MMA; Muhairwa, AP; Lupindu, AM; Olsen, JE				Madoshi, Balichene P.; Kudirkiene, Egle; Mtambo, Madundo M. A.; Muhairwa, Amandus P.; Lupindu, Athumani M.; Olsen, John E.			Characterisation of Commensal Escherichia coli Isolated from Apparently Healthy Cattle and Their Attendants in Tanzania	PLOS ONE			English	Article							VIRULENCE FACTORS; ANTIMICROBIAL RESISTANCE; ANTIBIOTIC-RESISTANCE; FOOD ANIMALS; STRAINS; PCR; IDENTIFICATION; PREVALENCE; HUMANS; GENES	While pathogenic types of Escherichia coli are well characterized, relatively little is known about the commensal E. coli flora. In the current study, antimicrobial resistance in commensal E. coli and distribution of ERIC-PCR genotypes among isolates of such bacteria from cattle and cattle attendants on cattle farms in Tanzania were investigated. Seventeen E. coli genomes representing different ERIC-PCR types of commensal E. coli were sequenced in order to determine their possible importance as a reservoir for both antimicrobial resistance genes and virulence factors. Both human and cattle isolates were highly resistant to tetracycline (40.8% and 33.1%), sulphamethazole-trimethoprim (49.0% and 8.8%) and ampicillin (44.9% and 21.3%). However, higher proportion of resistant E. coli and higher frequency of resistance to more than two antimicrobials was found in isolates from cattle attendants than isolates from cattle. Sixteen out of 66 ERIC-PCR genotypes were shared between the two hosts, and among these ones, seven types contained isolates from cattle and cattle attendants from the same farm, suggesting transfer of strains between hosts. Genome-wide analysis showed that the majority of the sequenced cattle isolates were assigned to phylogroups B1, while human isolates represented phylogroups A, C, D and E. In general, in silico resistome and virulence factor identification did not reveal differences between hosts or phylogroups, except for lpfA and iss found to be cattle and B1 phylogroup specific. The most frequent plasmids replicon genes found in strains from both hosts were of IncF type, which are commonly associated with carriage of antimicrobial and virulence genes. Commensal E. coli from cattle and attendants were found to share same genotypes and to carry antimicrobial resistance and virulence genes associated with both intra and extraintestinal E. coli pathotypes.	[Madoshi, Balichene P.; Muhairwa, Amandus P.; Lupindu, Athumani M.] Sokoine Univ Agr, Dept Vet Med & Publ Hlth, Morogoro, Tanzania; [Madoshi, Balichene P.] Livestock Training Agcy, Mpwapwa Campus, Mpwapwa, Dodoma, Tanzania; [Kudirkiene, Egle; Olsen, John E.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg, Denmark; [Mtambo, Madundo M. A.] Tanzania Ind Res Dev Org, TIRDO Complex, Dar Es Salaam, Tanzania	Sokoine University of Agriculture; University of Copenhagen	Olsen, JE (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg, Denmark.	jeo@sund.ku.dk	Kudirkiene, Egle/ABG-5736-2021; Madoshi, Balichene/AAG-9707-2020; Olsen, John Elmerdahl/N-9271-2019	Olsen, John Elmerdahl/0000-0001-6225-6587	Ministry of Foreign affairs of Denmark through the Danish International Development Agency (DANIDA) [12-P02-TAN]	Ministry of Foreign affairs of Denmark through the Danish International Development Agency (DANIDA)	The authors appreciate the Ministry of Foreign affairs of Denmark through the Danish International Development Agency (DANIDA) for financial support (12-P02-TAN). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABULREESH HH, 2014, INT J BIOL, V6, pNIL32, DOI DOI 10.5539/ijb.v6n2p31; Akiyama Y, 2015, FOOD HYG SAFE SCI, V56, P118, DOI 10.3358/shokueishi.56.118; Anderson MA, 2006, APPL ENVIRON MICROB, V72, P6914, DOI 10.1128/AEM.01029-06; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Ben Sallem R, 2015, J CHEMOTHERAPY, V27, P114, DOI 10.1179/1973947814Y.0000000172; Blum SE, 2013, VET MICROBIOL, V163, P305, DOI 10.1016/j.vetmic.2012.12.037; Brinas L, 2002, ANTIMICROB AGENTS CH, V46, P3156, DOI 10.1128/AAC.46.10.3156-3163.2002; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Chase-Topping ME, 2012, EMERG INFECT DIS, V18, P439, DOI 10.3201/eid1803.111236; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Clermont O, 2011, INFECT GENET EVOL, V11, P654, DOI 10.1016/j.meegid.2011.02.005; Contreras-Moreira B, 2013, APPL ENVIRON MICROB, V79, P7696, DOI 10.1128/AEM.02411-13; Croxen MA, 2013, CLIN MICROBIOL REV, V26, P822, DOI 10.1128/CMR.00022-13; da Costa MM, 2008, BRAZ J MICROBIOL, V39, P741, DOI 10.1590/S1517-838220080004000027; Dahms C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143326; de Jong J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-677; Deng Y, 2011, CLIN MICROBIOL INFEC, V17, P1740, DOI 10.1111/j.1469-0691.2011.03472.x; Dogan B, 2012, VET MICROBIOL, V159, P163, DOI 10.1016/j.vetmic.2012.03.033; Escobar-Paramo P, 2006, ENVIRON MICROBIOL, V8, P1975, DOI 10.1111/j.1462-2920.2006.01077.x; Gordon DM, 2015, ENV MICROBIOL REP, V7, P642, DOI 10.1111/1758-2229.12300; Hong PY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025042; Huasai S, 2012, BRAZ J MICROBIOL, V43, P528, DOI 10.1590/S1517-83822012000200013; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Johnson JR, 2005, J CLIN MICROBIOL, V43, P6064, DOI 10.1128/JCM.43.12.6064-6072.2005; Jouini A, 2013, J FOOD PROTECT, V76, P323, DOI 10.4315/0362-028X.JFP-12-251; Kaas RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104984; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Le Bouguenec C, 1999, VET RES, V30, P317; Leimbach A, 2013, CURR TOP MICROBIOL, V358, P3, DOI 10.1007/82_2012_303; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Mohapatra BR, 2007, FEMS MICROBIOL LETT, V277, P98, DOI 10.1111/j.1574-6968.2007.00948.x; Mora A, 2011, INT J ANTIMICROB AG, V37, P16, DOI 10.1016/j.ijantimicag.2010.09.012; Mora A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-132; Mosquito S, 2015, SCI WORLD J, V2015, DOI [10.1155/2015/610403, DOI 10.1155/2015/610403]; NATARO JP, 1995, J INFECT DIS, V171, P465, DOI 10.1093/infdis/171.2.465; Nyholm O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135936; Peirano G, 2013, J MED MICROBIOL, V62, P525, DOI 10.1099/jmm.0.048983-0; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Reiss G, 2006, J AM GERIATR SOC, V54, P680, DOI 10.1111/j.1532-5415.2006.00682.x; Sargeant JA, 2004, PREV VET MED, V66, P175, DOI 10.1016/j.prevetmed.2004.09.007; Scott TM, 2002, APPL ENVIRON MICROB, V68, P5796, DOI 10.1128/AEM.68.12.5796-5803.2002; Silvestro L, 2004, EPIDEMIOL INFECT, V132, P915, DOI 10.1017/S0950268804002390; Smati M, 2013, APPL ENVIRON MICROB, V79, P5005, DOI 10.1128/AEM.01423-13; Sousa C, 2013, SCI REP-UK, V3, DOI 10.1038/srep03278; Szmolka A, 2012, VET MICROBIOL, V156, P110, DOI 10.1016/j.vetmic.2011.09.030; Tahamtan Y, 2010, IRAN J MICROBIOL, V2, P9; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tartof SY, 2005, J CLIN MICROBIOL, V43, P5860, DOI 10.1128/JCM.43.12.5860-5864.2005; Telli M, 2010, FEMS MICROBIOL LETT, V306, P117, DOI 10.1111/j.1574-6968.2010.01945.x; Toma C, 2003, J CLIN MICROBIOL, V41, P2669, DOI 10.1128/JCM.41.6.2669-2671.2003; Tristram SG, 2008, J ANTIMICROB CHEMOTH, V61, P509, DOI 10.1093/jac/dkm523; van den Bogaard AE, 2001, J ANTIMICROB CHEMOTH, V47, P763, DOI 10.1093/jac/47.6.763; Vargas M, 1999, J CLIN MICROBIOL, V37, P3608, DOI 10.1128/JCM.37.11.3608-3611.1999; Vila J, 2000, J INFECT DIS, V182, P1780, DOI 10.1086/317617; Wei GF, 2004, J MICROBIOL METH, V59, P91, DOI 10.1016/j.mimet.2004.06.007; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wu GH, 2012, VET MICROBIOL, V160, P197, DOI 10.1016/j.vetmic.2012.05.029; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhao J., 2011, WORLD HLTH DIGEST ME, V8, P8; Zhao JJ, 2010, ANTIMICROB AGENTS CH, V54, P4219, DOI 10.1128/AAC.00139-10	67	20	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168160	10.1371/journal.pone.0168160	http://dx.doi.org/10.1371/journal.pone.0168160			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977751	Green Published, gold			2022-12-26	WOS:000391217400071
J	Matsuzaka, Y; Tanihata, J; Komaki, H; Ishiyama, A; Oya, Y; Ruegg, U; Takeda, S; Hashido, K				Matsuzaka, Yasunari; Tanihata, Jun; Komaki, Hirofumi; Ishiyama, Akihiko; Oya, Yasushi; Ruegg, Urs; Takeda, Shin-ichi; Hashido, Kazuo			Characterization and Functional Analysis of Extracellular Vesicles and Muscle-Abundant miRNAs (miR-1, miR-133a, and miR-206) in C2C12 Myocytes and mdx Mice	PLOS ONE			English	Article							INDUCED CARDIOMYOCYTE APOPTOSIS; EXOSOME-MEDIATED TRANSFER; HUMAN SKELETAL-MUSCLE; MUSCULAR-DYSTROPHY; NEUTRAL SPHINGOMYELINASE-2; MULTIVESICULAR ENDOSOMES; HORIZONTAL TRANSFER; SERUM BIOMARKERS; MESSENGER-RNAS; STEM-CELLS	Duchenne muscular dystrophy (DMD) is a progressive neuromuscular disorder. Here, we show that the CD63 antigen, which is located on the surface of extracellular vesicles (EVs), is associated with increased levels of muscle-abundant miRNAs, namely myomiRs miR-1, miR-133a, and miR-206, in the sera of DMD patients and mdx mice. Furthermore, the release of EVs from the murine myoblast C2C12 cell line was found to be modulated by intracellular ceramide levels in a Ca2+-dependent manner. Next, to investigate the effects of EVs on cell survival, C2C12 myoblasts and myotubes were cultured with EVs from the sera of mdx mice or C2C12 cells overexpressing myomiRs in presence of cellular stresses. Both the exposure of C2C12 myoblasts and myotubes to EVs from the serum of mdx mice, and the overexpression of miR-133a in C2C12 cells in presence of cellular stress resulted in a significant decrease in cell death. Finally, to assess whether miRNAs regulate skeletal muscle regeneration in vivo, we intraperitoneally injected GW4869 (an inhibitor of exosome secretion) into mdx mice for 5 and 10 days. Levels of miRNAs and creatine kinase in the serum of GW4869-treated mdx mice were significantly downregulated compared with those of controls. The tibialis anterior muscles of the GW4869-treated mdx mice showed a robust decrease in Evans blue dye uptake. Collectively, these results indicate that EVs and myomiRs might protect the skeletal muscle of mdx mice from degeneration.	[Matsuzaka, Yasunari; Hashido, Kazuo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Adm Sect Radiat Protect, Kodaira, Tokyo, Japan; [Tanihata, Jun; Takeda, Shin-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Kodaira, Tokyo, Japan; [Komaki, Hirofumi; Ishiyama, Akihiko] Natl Ctr Neurol & Psychiat, Dept Child Neurol, Kodaira, Tokyo, Japan; [Oya, Yasushi] Natl Ctr Neurol & Psychiat, Dept Neurol, Kodaira, Tokyo, Japan; [Ruegg, Urs] Univ Geneva, Geneva Lausanne Sch Pharmaceut Sci, Dept Pharmacol, Geneva, Switzerland; [Ruegg, Urs] Univ Lausanne, Geneva, Switzerland	National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; University of Geneva; University of Lausanne	Hashido, K (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Adm Sect Radiat Protect, Kodaira, Tokyo, Japan.	hashido@ncnp.go.jp		RUEGG, Urs/0000-0001-6078-8280	Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP. [25-5]	Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP.(National Center for Neurology & Psychiatry - Japan)	Intramural Research Grant (25-5) for Neurological and Psychiatric Disorders of NCNP.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; BODENSTEINER JB, 1978, NEUROLOGY, V28, P439, DOI 10.1212/WNL.28.5.439; Cacchiarelli D, 2011, EMBO MOL MED, V3, P258, DOI 10.1002/emmm.201100133; Cacchiarelli D, 2010, CELL METAB, V12, P341, DOI 10.1016/j.cmet.2010.07.008; Cazzella V, 2012, MOL THER, V20, P2134, DOI 10.1038/mt.2012.178; Choi JS, 2016, J CONTROL RELEASE, V222, P107, DOI 10.1016/j.jconrel.2015.12.018; Clarke CJ, 2007, J BIOL CHEM, V282, P1384, DOI 10.1074/jbc.M609216200; Clarke CJ, 2006, BBA-BIOMEMBRANES, V1758, P1893, DOI 10.1016/j.bbamem.2006.06.025; Dakhlallah D, 2015, J CARDIOVASC PHARM, V65, P241, DOI 10.1097/FJC.0000000000000183; Deng ZL, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-115; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Drawnel FM, 2012, J CELL BIOL, V199, P783, DOI 10.1083/jcb.201111095; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Ekstrom EJ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-88; Forterre A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084153; Ge QY, 2014, MOLECULES, V19, P1568, DOI 10.3390/molecules19021568; Guller I, 2010, J PHYSIOL-LONDON, V588, P4075, DOI 10.1113/jphysiol.2010.194175; He B, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-22; Honda A, 2007, J MUSCLE RES CELL M, V28, P243, DOI 10.1007/s10974-007-9122-9; Hu Guoku, 2012, Frontiers in Genetics, V3, P56, DOI 10.3389/fgene.2012.00056; Izarra A, 2014, STEM CELL REP, V3, P1029, DOI 10.1016/j.stemcr.2014.10.010; Kajimoto T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3712; Kim YK, 2012, MOL CELL, V46, P893, DOI 10.1016/j.molcel.2012.05.036; Kosaka N, 2013, J BIOL CHEM, V288, P10849, DOI 10.1074/jbc.M112.446831; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kubota S, 2015, ONCOL REP, V33, P67, DOI 10.3892/or.2014.3605; Lane RE, 2015, SCI REP-UK, V5, DOI 10.1038/srep07639; Lee S, 2013, ADV EXP MED BIOL, V768, P97, DOI 10.1007/978-1-4614-5107-5_7; Levy M, 2006, BIOCHEM BIOPH RES CO, V344, P900, DOI 10.1016/j.bbrc.2006.04.013; Li AY, 2015, MOL CELL BIOCHEM, V400, P173, DOI 10.1007/s11010-014-2273-2; Li S, 2015, J HUM GENET, V60, P709, DOI 10.1038/jhg.2015.96; Li XH, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.29; Mallouk N, 2000, P NATL ACAD SCI USA, V97, P4950, DOI 10.1073/pnas.97.9.4950; Malm C, 2004, J PHYSIOL-LONDON, V556, P983, DOI 10.1113/jphysiol.2003.056598; Matsuzaka Y, 2015, RNA DIS, V2, P558; Matsuzaka Y, 2014, ENVIRON HEALTH PREV, V19, P452, DOI 10.1007/s12199-014-0405-7; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Mizuno H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018388; Mouisel E, 2010, MUSCLE NERVE, V41, P809, DOI 10.1002/mus.21624; Nakasa T, 2010, J CELL MOL MED, V14, P2495, DOI 10.1111/j.1582-4934.2009.00898.x; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Robert V, 2001, J BIOL CHEM, V276, P4647, DOI 10.1074/jbc.M006337200; Roberts TC, 2013, NUCLEIC ACIDS RES, V41, P9500, DOI 10.1093/nar/gkt724; Roberts TC, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.26; Savina A, 2005, TRAFFIC, V6, P131, DOI 10.1111/j.1600-0854.2004.00257.x; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Shamseddine Achraf A, 2015, Adv Biol Regul, V57, P24, DOI 10.1016/j.jbior.2014.10.002; Singh R, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-256; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Sultan Ambreen, 2008, J Ayub Med Coll Abbottabad, V20, P7; Svensson KJ, 2013, J BIOL CHEM, V288, P17713, DOI 10.1074/jbc.M112.445403; Takeshima Y, 2010, J HUM GENET, V55, P379, DOI 10.1038/jhg.2010.49; Tamai K, 2010, BIOCHEM BIOPH RES CO, V399, P384, DOI 10.1016/j.bbrc.2010.07.083; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vandebrouck C, 2002, J CELL BIOL, V158, P1089, DOI 10.1083/jcb.200203091; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wang K, 2010, NUCLEIC ACIDS RES, V38, P7248, DOI 10.1093/nar/gkq601; Wang L, 2014, N-S ARCH PHARMACOL, V387, P197, DOI 10.1007/s00210-013-0929-1; ZATZ M, 1991, J NEUROL SCI, V102, P190, DOI 10.1016/0022-510X(91)90068-I; Zeringer Emily, 2013, World J Methodol, V3, P11, DOI 10.5662/wjm.v3.i1.11; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zhu HY, 2011, AM J CARDIOVASC DIS, V1, P138	66	34	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0167811	10.1371/journal.pone.0167811	http://dx.doi.org/10.1371/journal.pone.0167811			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977725	Green Submitted, Green Published, gold			2022-12-26	WOS:000391217400034
J	Brunel, H; Massanet, R; Martinez-Perez, A; Ziyatdinov, A; Martin-Fernandez, L; Souto, JC; Perera, A; Soria, JM				Brunel, Helena; Massanet, Raimon; Martinez-Perez, Angel; Ziyatdinov, Andrey; Martin-Fernandez, Laura; Carlos Souto, Juan; Perera, Alexandre; Manuel Soria, Jose			The Central Role of KNG1 Gene as a Genetic Determinant of Coagulation Pathway-Related Traits: Exploring Metaphenotypes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LINKAGE ANALYSIS; PLASMA-LEVELS; LOCI; SUSCEPTIBILITY; PHENOTYPES; REGRESSION; SCAN; RISK	Traditional genetic studies of single traits may be unable to detect the pleiotropic effects involved in complex diseases. To detect the correlation that exists between several phenotypes involved in the same biological process, we introduce an original methodology to analyze sets of correlated phenotypes involved in the coagulation cascade in genome-wide association studies. The methodology consists of a two-stage process. First, we define new phenotypic meta-variables (linear combinations of the original phenotypes), named meta phenotypes, by applying Independent Component Analysis for the multivariate analysis of correlated phenotypes (i.e. the levels of coagulation pathway related proteins). The resulting metaphenotypes integrate the information regarding the underlying biological process (i.e. thrombus/clot formation). Secondly, we take advantage of a family based Genome Wide Association Study to identify genetic elements influencing these metaphenotypes and consequently thrombosis risk. Our study utilized data from the GAIT Project (Genetic Analysis of Idiopathic Thrombophilia). We obtained 15 metaphenotypes, which showed significant heritabilities, ranging from 0.2 to 0.7. These results indicate the importance of genetic factors in the variability of these traits. We found 4 metaphenotypes that showed significant associations with SNPs. The most relevant were those mapped in a region near the HRG, FETUB and KNG1 genes. Our results are provocative since they show that the KNG1 locus plays a central role as a genetic determinant of the entire coagulation pathway and thrombus/clot formation. Integrating data from multiple correlated measurements through meta phenotypes is a promising approach to elucidate the hidden genetic mechanisms underlying complex diseases.	[Brunel, Helena; Martinez-Perez, Angel; Ziyatdinov, Andrey; Martin-Fernandez, Laura; Manuel Soria, Jose] Sant Pau Inst Biomed Res IIB Sant Pau, Unit Genom Complex Dis, Barcelona, Spain; [Massanet, Raimon] Univ Politecn Cataluna, Dept Engn Sistemes Automat & Informat Ind, B2SLab, Barcelona, Spain; [Carlos Souto, Juan; Perera, Alexandre] St Pau Inst Biomed Res IIB St Pau, Thrombosis & Haemostasis Unit, Barcelona, Spain	Universitat Politecnica de Catalunya	Soria, JM (corresponding author), Sant Pau Inst Biomed Res IIB Sant Pau, Unit Genom Complex Dis, Barcelona, Spain.	jsoria@santpau.cat	Perera Lluna, Alexandre/CAG-2156-2022; Lluna, Alexandre Perera/R-8546-2018; Martinez-Perez, Angel/AAC-4339-2019; Soria Fernández, José Manuel/AAD-6761-2019	Perera Lluna, Alexandre/0000-0001-6427-851X; Lluna, Alexandre Perera/0000-0001-6427-851X; Martinez-Perez, Angel/0000-0002-5934-1454; Soria Fernández, José Manuel/0000-0002-6226-4293; Martin-Fernandez, Laura/0000-0002-8909-508X	Institut de Salud Carlos III Fondo de Investigacion Sanitaria [PI 11/0184, PI 14/00582]; Red Investigacion Cardiovascular [RD12/0042/0032]; Generalitat de Catalunya [2009 SGR 1147, 2014 SGR 1063]; Ayudas Predoctorales de Formacion en Investigacion en Salud (PFIS) [FI12/00322]; Spanish National Grants from Ministry of Economy and Competitiveness [TEC2014-60337-R]	Institut de Salud Carlos III Fondo de Investigacion Sanitaria; Red Investigacion Cardiovascular; Generalitat de Catalunya(Generalitat de Catalunya); Ayudas Predoctorales de Formacion en Investigacion en Salud (PFIS); Spanish National Grants from Ministry of Economy and Competitiveness	This study was supported by funds from the Institut de Salud Carlos III Fondo de Investigacion Sanitaria PI 11/0184 and PI 14/00582, Red Investigacion Cardiovascular RD12/0042/0032 and AGAUR 2009 SGR 1147 from Generalitat de Catalunya. Laura Martin-Fernandez was supported by Ayudas Predoctorales de Formacion en Investigacion en Salud (PFIS) FI12/00322. This work has been partially supported by the Supported by the Spanish National Grants from Ministry of Economy and Competitiveness with grant TEC2014-60337-R, and the Generalitat de Catalunya, under the grant 2014 SGR 1063. CIBER-BBN is an initiative of the ISCIII.014 SGR 1063. CIBER-BBN is an initiative of the ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Aschard H, 2014, AM J HUM GENET, V94, P662, DOI 10.1016/j.ajhg.2014.03.016; Athanasiadis G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029168; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Houlihan LM, 2010, AM J HUM GENET, V86, P626, DOI 10.1016/j.ajhg.2010.02.016; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Josse J, 2012, COMPUT STAT DATA AN, V56, P1869, DOI 10.1016/j.csda.2011.11.012; Khachidze M, 2006, J THROMB HAEMOST, V4, P1537, DOI 10.1111/j.1538-7836.2006.02024.x; Klei L, 2010, GENETIC EPIDEMIOLOGY, V34, P444; Knott SA, 2000, GENETICS, V156, P899; Lee C, 2009, FRONT BIOSCI-LANDMRK, V14, P2911, DOI 10.2741/3422; Lefkowitz J.B., 2008, ALGORITHMIC APPROACH, P3; Soria JM, 2009, HUM BIOL, V81, P853, DOI 10.3378/027.081.0627; Mathias RA, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-22; Mei H, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-100; Morange PE, 2011, BLOOD, V117, P3692, DOI 10.1182/blood-2010-11-319053; Park KJ, 2012, BLOOD COAGUL FIBRIN, V23, P35, DOI 10.1097/MBC.0b013e32834a6136; Sabater-Lleal M, 2012, ARTERIOSCL THROM VAS, V32, P2008, DOI 10.1161/ATVBAHA.112.248492; Soria JM, 2005, ARTERIOSCL THROM VAS, V25, P1287, DOI 10.1161/01.ATV.0000161927.38739.6f; Soria JM, 2002, AM J HUM GENET, V70, P567, DOI 10.1086/339259; Souto JC, 2000, AM J HUM GENET, V67, P1452, DOI 10.1086/316903; Souto JC, 2003, THROMB HAEMOSTASIS, V89, P468; Souto JC, 2001, THROMB HAEMOSTASIS, V85, P88; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Stephens M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065245; Tang WH, 2012, AM J HUM GENET, V91, P152, DOI 10.1016/j.ajhg.2012.05.009; Viel KR, 2007, BLOOD, V109, P3713, DOI 10.1182/blood-2006-06-026104; Weller JI, 1996, THEOR APPL GENET, V92, P998, DOI 10.1007/BF00224040; Xu X, 2003, BIOSTATISTICS, V4, P223, DOI 10.1093/biostatistics/4.2.223; Yang QO, 2010, GENET EPIDEMIOL, V34, P444, DOI 10.1002/gepi.20497; Ziyatdinov A, 2016, BIOINFORMATICS	32	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0167187	10.1371/journal.pone.0167187	http://dx.doi.org/10.1371/journal.pone.0167187			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005926	Green Submitted, Green Published, gold			2022-12-26	WOS:000392843200010
J	Calvente, A; Santos, JL; Rufas, JS				Calvente, Adela; Luis Santos, Juan; Rufas, Julio S.			Do Exogenous DNA Double-Strand Breaks Change Incomplete Synapsis and Chiasma Localization in the Grasshopper Stethophyma grossum?	PLoS One			English	Article							MEIOTIC RECOMBINATION HOTSPOTS; SISTER-CHROMATID COHESION; SYNAPTONEMAL COMPLEXES; MOUSE SPERMATOCYTES; CROSSOVER HOTSPOTS; AXIAL ELEMENTS; CROSSING-OVER; MEIOSIS; CHROMOSOMES; PROTEINS	Meiotic recombination occurs as a programmed event that initiates by the formation of DNA double-strand breaks (DSBs) that give rise to the formation of crossovers that are observed as chiasmata. Chiasmata are essential for the accurate chromosome segregation and the generation of new combinations of parental alleles. Some treatments that provoke exogenous DSBs also lead to alterations in the recombination pattern of some species in which full homologous synapsis is achieved at pachytene. We have carried out a similar approach in males of the grasshopper Stethophyma grossum, whose homologues show incomplete synapsis and proximal chiasma localization. After irradiating males with. rays we have studied the distribution of both the histone variant gamma-H2AX and the recombinase RAD51. These proteins are cytological markers of DSBs at early prophase I. We have inferred synaptonemal complex (SC) formation via identification of SMC3 and RAD 21 cohesin subunits. Whereas thick and thin SMC3 filaments would correspond to synapsed and unsynapsed regions, the presence of RAD21 is only restricted to synapsed regions. Results show that irradiated spermatocytes maintain restricted synapsis between homologues. However, the frequency and distribution of chiasmata in metaphase I bivalents is slightly changed and quadrivalents were also observed. These results could be related to the singular nuclear polarization displayed by the spermatocytes of this species.	[Calvente, Adela; Rufas, Julio S.] Univ Autonoma Madrid, Dept Biol, Edificio Biol, Madrid, Spain; [Luis Santos, Juan] Univ Complutense Madrid, Fac Biol, Dept Genet, Madrid, Spain	Autonomous University of Madrid; Complutense University of Madrid	Rufas, JS (corresponding author), Univ Autonoma Madrid, Dept Biol, Edificio Biol, Madrid, Spain.	Julio.S.Rufas@uam.es	Santos, Juan/R-1410-2017; Rufas, Julio S/L-5174-2014	Santos, Juan/0000-0003-4475-9628; Rufas, Julio S/0000-0002-7516-809X	Ministerio de Ciencia e Innovacion [BFU2015-71786-REDT]; Ministerio de Economia y Competitividad (Spain);  [AGL2012-38852];  [CGL2014-53106-P]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Economia y Competitividad (Spain)(Spanish Government); ; 	This work was supported by grants BFU2015-71786-REDT from Ministerio de Ciencia e Innovacion, and grants AGL2012-38852 and CGL2014-53106-P and from Ministerio de Economia y Competitividad (Spain).	Ahmed EA, 2010, MUTAT RES-FUND MOL M, V688, P12, DOI 10.1016/j.mrfmmm.2010.02.004; ALBINI SM, 1984, EXP CELL RES, V155, P588, DOI 10.1016/0014-4827(84)90219-2; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; Cai X, 2011, MUTAGENESIS, V26, P721, DOI 10.1093/mutage/ger038; Calvente A, 2005, J CELL SCI, V118, P2957, DOI 10.1242/jcs.02391; Darlington CD, 1931, SCIENCE, V73, P561, DOI 10.1126/science.73.1899.561-a; delCerro AL, 1997, CHROMOSOME RES, V5, P69, DOI 10.1023/A:1018449604187; Eijpe M, 2000, J CELL SCI, V113, P673; Falk M, 2008, BBA-MOL CELL RES, V1783, P2398, DOI 10.1016/j.bbamcr.2008.07.010; FLETCHER HL, 1978, CHROMOSOMA, V65, P247, DOI 10.1007/BF00327621; Hanneman WH, 1997, P NATL ACAD SCI USA, V94, P8681, DOI 10.1073/pnas.94.16.8681; JONES GH, 1973, CHROMOSOMA, V42, P145, DOI 10.1007/BF00320937; Keeney S, 2006, BIOCHEM SOC T, V34, P523, DOI 10.1042/BST0340523; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Lake CM, 2016, SEMIN CELL DEV BIOL, V54, P117, DOI 10.1016/j.semcdb.2016.01.008; Lichten M, 1995, ANNU REV GENET, V29, P423, DOI 10.1146/annurev.ge.29.120195.002231; Mercier R, 2001, GENE DEV, V15, P1859, DOI 10.1101/gad.203201; Mezard C, 2006, BIOCHEM SOC T, V34, P531, DOI 10.1042/BST0340531; Moens PB, 1997, CHROMOSOMA, V106, P207, DOI 10.1007/s004120050241; Moens PB, 2002, J CELL SCI, V115, P1611; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Neumann R, 2006, HUM MOL GENET, V15, P1401, DOI 10.1093/hmg/ddl063; Nussenzweig A, 2006, NATURE, V439, P406, DOI 10.1038/439406a; Page J, 1998, CHROMOSOME RES, V6, P639, DOI 10.1023/A:1009209628300; Page J, 2003, J CELL SCI, V116, P551, DOI 10.1242/jcs.00252; Paigen K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000119; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pelttari J, 2001, MOL CELL BIOL, V21, P5667, DOI 10.1128/MCB.21.16.5667-5677.2001; PERRY PE, 1974, CHROMOSOMA, V47, P227, DOI 10.1007/BF00328858; Plug AW, 1998, J CELL SCI, V111, P413; Price BD, 2013, CELL, V152, P1344, DOI 10.1016/j.cell.2013.02.011; Sanchez-Moran E, 2007, GENE DEV, V21, P2220, DOI 10.1101/gad.439007; Schoenmakers S, 2008, DEV BIOL, V317, P270, DOI 10.1016/j.ydbio.2008.02.027; Serrentino ME, 2012, EXP CELL RES, V318, P1347, DOI 10.1016/j.yexcr.2012.03.025; SHAW DD, 1971, CHROMOSOMA, V34, P19, DOI 10.1007/BF00285514; Storlazzi A, 2003, GENE DEV, V17, P2675, DOI 10.1101/gad.275203; Tarsounas M, 1999, J CELL BIOL, V147, P207, DOI 10.1083/jcb.147.2.207; Valdeolmillos AM, 2007, PLOS GENET, V3, P204, DOI 10.1371/journal.pgen.0030028; Viera A, 2004, EMBO REP, V5, P385, DOI 10.1038/sj.embor.7400112; Viera A, 2003, CHROMOSOME RES, V11, P797, DOI 10.1023/B:CHRO.0000005781.71466.da; Viera A, 2010, CYTOGENET GENOME RES, V128, P139, DOI 10.1159/000290637; Viera A, 2009, CHROMOSOMA; Viera Alberto, 2010, Journal of Orthoptera Research, V19, P267, DOI 10.1665/034.019.0213; Viera A, 2009, CHROMOSOMA, V118, P377, DOI 10.1007/s00412-009-0204-x; WALLACE BMN, 1978, HEREDITY, V40, P385, DOI 10.1038/hdy.1978.45; WHITE M. J. D., 1936, ZEITSCHR ZELLFORSCH U MIKROSK ANAT, V24, P128, DOI 10.1007/BF00401218; Yokoo R, 2012, CELL, V149, P75, DOI 10.1016/j.cell.2012.01.052; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	48	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168499	10.1371/journal.pone.0168499	http://dx.doi.org/10.1371/journal.pone.0168499			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005992	Green Published, Green Submitted, gold			2022-12-26	WOS:000392843200062
J	Tugume, AK; Mukasa, SB; Valkonen, JPT				Tugume, Arthur K.; Mukasa, Settumba B.; Valkonen, Jari P. T.			Mixed Infections of Four Viruses, the Incidence and Phylogenetic Relationships of Sweet Potato Chlorotic Fleck Virus (Betaflexiviridae) Isolates in Wild Species and Sweetpotatoes in Uganda and Evidence of Distinct Isolates in East Africa	PLOS ONE			English	Article							FEATHERY-MOTTLE-VIRUS; MULTIPLE SEQUENCE ALIGNMENT; RNA SILENCING SUPPRESSION; BROWN-STREAK-VIRUS; STUNT-VIRUS; COAT PROTEIN; MOSAIC-VIRUS; MILD-MOTTLE; SYNERGISTIC INTERACTIONS; SELECTION PRESSURE	Viruses infecting wild flora may have a significant negative impact on nearby crops, and vice-versa. Only limited information is available on wild species able to host economically important viruses that infect sweetpotatoes (Ipomoea batatas). In this study, Sweet potato chlorotic fleck virus (SPCFV; Carla virus, Betaflexiviridae) and Sweet potato chlorotic stunt virus (SPCSV; Crinivirus, Closteroviridae) were surveyed in wild plants of family ConvoIvulaceae (genera Astripomoea, Ipomoea, Hewittia and Lepistemon) in Uganda. Plants belonging to 26 wild species, including annuals, biannuals and perennials from four agroecological zones, were observed for virus-like symptoms in 2004 and 2007 and sampled for virus testing. SPCFV was detected in 84 (2.9%) of 2864 plants tested from 17 species. SPCSV was detected in 66 (5.4%) of the 1224 plants from 12 species sampled in 2007. Some SPCSV-infected plants were also infected with Sweet potato feathery mottle virus (SPFMV; Potyvirus, Potyviridae; 1.3%), Sweet potato mild mottle virus (SPMMV; Ipomovirus, Potyviridae; 0.5%) or both (0.4%), but none of these three viruses were detected in SPCFV-infected plants. Co-infection of SPFMV with SPMMV was detected in 1.2% of plants sampled. Virus-like symptoms were observed in 367 wild plants (12.8%), of which 42 plants (11.4%) were negative for the viruses tested. Almost all (92.4%) the 419 sweetpotato plants sampled from fields close to the tested wild plants displayed virus-like symptoms, and 87.1% were infected with one or more of the four viruses. Phylogenetic and evolutionary analyses of the 3'-proximal genomic region of SPCFV, including the silencing suppressor (NaBP)- and coat protein (CP)-coding regions implicated strong purifying selection on the CP and NaBP, and that the SPCFV strains from East Africa are distinguishable from those from other continents. However, the strains from wild species and sweetpotato were indistinguishable, suggesting reciprocal movement of SPCFV between wild and cultivated Convolvulaceae plants in the field.	[Tugume, Arthur K.; Valkonen, Jari P. T.] Univ Helsinki, Fac Agr & Forestry, Dept Agr Sci, Helsinki, Finland; [Tugume, Arthur K.] Makerere Univ, Sch Biosci, Dept Plant Sci Microbiol & Biotechnol, Coll Nat Sci, Kampala, Uganda; [Mukasa, Settumba B.] Makerere Univ, Sch Agr Sci, Dept Agr Prod, Coll Agr & Environm Sci, Kampala, Uganda	University of Helsinki; Makerere University; Makerere University	Tugume, AK (corresponding author), Univ Helsinki, Fac Agr & Forestry, Dept Agr Sci, Helsinki, Finland.; Tugume, AK (corresponding author), Makerere Univ, Sch Biosci, Dept Plant Sci Microbiol & Biotechnol, Coll Nat Sci, Kampala, Uganda.	aktugume@cns.mak.ac.ug		Tugume, Arthur/0000-0003-3689-6745; Valkonen, Jari/0000-0002-3704-9911	Academy of Finland [1276136]	Academy of Finland(Academy of Finland)	This work was funded by the Academy of Finland (1276136 to JPTV) and is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar Z, 2003, J GEN VIROL, V84, P733, DOI 10.1099/vir.0.18759-0; Adikini S, 2015, CAN J PLANT PATHOL, V37, P136, DOI 10.1080/07060661.2015.1004111; Alabi OJ, 2011, ONLINE APSNET FEATUR; Alabi OJ, 2008, ARCH VIROL, V153, P1743, DOI 10.1007/s00705-008-0169-8; Alexander HM, 2014, EUR J PLANT PATHOL, V138, P529, DOI 10.1007/s10658-013-0317-1; Alicai T, 1999, PLANT PATHOL, V48, P718, DOI 10.1046/j.1365-3059.1999.00402.x; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Aritua V, 2009, PLANT DIS, V93, P87, DOI 10.1094/PDIS-93-1-0087; Aritua V, 2007, ARCH VIROL, V152, P813, DOI 10.1007/s00705-006-0891-z; Ateka EM, 2004, ANN APPL BIOL, V144, P371, DOI 10.1111/j.1744-7348.2004.tb00353.x; BENNETZEN JL, 1982, J BIOL CHEM, V257, P3026; Bi YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042758; Bigirimana S., 2011, New Disease Reports, V24, P26; Borer ET, 2007, P NATL ACAD SCI USA, V104, P5473, DOI 10.1073/pnas.0608573104; Borer ET, 2010, ECOL LETT, V13, P810, DOI 10.1111/j.1461-0248.2010.01475.x; Borer ET, 2009, P NATL ACAD SCI USA, V106, P503, DOI 10.1073/pnas.0808778106; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Brunt A. A., 1996, VIRUSES PLANTS DESCR; Canto T, 2009, GLOBAL CHANGE BIOL, V15, P1884, DOI 10.1111/j.1365-2486.2008.01820.x; Chare ER, 2004, J GEN VIROL, V85, P3149, DOI 10.1099/vir.0.80134-0; Clark CA, 2012, PLANT DIS, V96, P168, DOI 10.1094/PDIS-07-11-0550; Cooper I, 2006, ADV VIRUS RES, V67, P1, DOI 10.1016/S0065-3527(06)67001-2; Cronin JP, 2014, AM NAT, V184, P172, DOI 10.1086/676854; Cronin JP, 2010, ECOL LETT, V13, P1221, DOI 10.1111/j.1461-0248.2010.01513.x; Cuellar WJ, 2008, J GEN VIROL, V89, P573, DOI 10.1099/vir.0.83471-0; Cuellar WJ, 2015, MOL PLANT PATHOL, V16, P459, DOI 10.1111/mpp.12200; Cuellar WJ, 2011, VIRUS RES, V157, P111, DOI 10.1016/j.virusres.2011.01.010; De Bruyn A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-228; De Souza J, 2013, ARCH VIROL, V158, P1393, DOI 10.1007/s00705-013-1614-x; Deng XG, 2014, PLANT DIS, V98, P163, DOI 10.1094/PDIS-05-13-0578-PDN; Deng XG, 2015, MOL PLANT PATHOL, V16, P365, DOI 10.1111/mpp.12186; Fargette D, 2006, ANNU REV PHYTOPATHOL, V44, P235, DOI 10.1146/annurev.phyto.44.120705.104644; Fargette D, 2004, J VIROL, V78, P3252, DOI 10.1128/JVI.78.7.3252-3261.2004; Fraile A, 2016, CURR OPIN VIROL, V17, P50, DOI 10.1016/j.coviro.2016.01.008; Friess N, 1996, NEW PHYTOL, V132, P103, DOI 10.1111/j.1469-8137.1996.tb04514.x; Funayama S, 2001, AM J BOT, V88, P616, DOI 10.2307/2657060; Garcia-Andres S, 2006, VIROLOGY, V350, P433, DOI 10.1016/j.virol.2006.02.028; GIBB KS, 1993, INT J PEST MANAGE, V39, P223, DOI 10.1080/09670879309371795; Gibson RW, 1998, PLANT PATHOL, V47, P95, DOI 10.1046/j.1365-3059.1998.00196.x; Gibson RW, 2009, REV SWEETPOTATO SEED; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Gu YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098884; Ha C, 2008, ARCH VIROL, V153, P45, DOI 10.1007/s00705-007-1067-1; HAMMOND J, 1981, PLANT PATHOL, V30, P237, DOI 10.1111/j.1365-3059.1981.tb01263.x; HilleRisLambers J, 2010, J ECOL, V98, P1147, DOI 10.1111/j.1365-2745.2010.01706.x; HOLLINGS M, 1976, ANN APPL BIOL, V82, P511, DOI 10.1111/j.1744-7348.1976.tb00588.x; Horrocks M, 2006, J ARCHAEOL SCI, V33, P200, DOI 10.1016/j.jas.2005.07.014; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ivanov KI, 2012, CURR OPIN VIROL, V2, P712, DOI 10.1016/j.coviro.2012.10.001; Jones RAC, 2007, AUSTRALAS PLANT PATH, V36, P591, DOI 10.1071/AP07069; Jones RAC, 2014, ANN APPL BIOL, V164, P320, DOI 10.1111/aab.12123; Jones RAC, 2015, MOL PLANT PATHOL, V16, P541, DOI 10.1111/mpp.12268; Jones RAC, 2009, VIRUS RES, V141, P113, DOI 10.1016/j.virusres.2008.07.028; Karyeija RF, 2000, VIROLOGY, V269, P26, DOI 10.1006/viro.1999.0169; Karyeija RF, 1998, ANN APPL BIOL, V133, P39, DOI 10.1111/j.1744-7348.1998.tb05800.x; Kashif M, 2012, PLANT DIS, V96, P1430, DOI 10.1094/PDIS-03-12-0268-RE; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Kreuze JF, 2000, ARCH VIROL, V145, P567, DOI 10.1007/s007050050047; Kwak HR, 2014, PLANT PATHOLOGY J, V30, P416, DOI 10.5423/PPJ.OA.04.2014.0029; Kwon SJ, 2016, PLANT PATHOLOGY J, V32, P65, DOI 10.5423/PPJ.NT.07.2015.0138; Legg JP, 2011, VIRUS RES, V159, P161, DOI 10.1016/j.virusres.2011.04.018; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lovisolo O, 2003, ADV VIRUS RES, V62, P325, DOI 10.1016/S0065-3527(03)62006-3; Low J., 2009, P359, DOI 10.1007/978-1-4020-9475-0_16; Lukhovitskaya NI, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25263; Maina S, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00414-16; Malmstrom CM, 2016, CURR OPIN VIROL, V19, P30, DOI 10.1016/j.coviro.2016.06.008; Malmstrom CM, 2005, OECOLOGIA, V145, P153, DOI 10.1007/s00442-005-0099-z; Malmstrom CM, 2005, NEW PHYTOL, V168, P217, DOI 10.1111/j.1469-8137.2005.01479.x; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Maskell LC, 1999, ANN APPL BIOL, V135, P401, DOI 10.1111/j.1744-7348.1999.tb00867.x; Mbanzibwa DR, 2014, ANN APPL BIOL, V165, P329, DOI 10.1111/aab.12136; Mbanzibwa DR, 2011, J VIROL METHODS, V171, P394, DOI 10.1016/j.jviromet.2010.09.024; Mbanzibwa DR, 2011, J GEN VIROL, V92, P974, DOI 10.1099/vir.0.026922-0; Mbanzibwa DR, 2009, ARCH VIROL, V154, P353, DOI 10.1007/s00705-008-0301-9; Hily JM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004492; MIYATA T, 1979, J MOL EVOL, V12, P219, DOI 10.1007/BF01732340; Moore SM, 2011, B MATH BIOL, V73, P2707, DOI 10.1007/s11538-011-9654-4; Moore SM, 2012, ECOLOGY, V93, P1095, DOI 10.1890/11-0086.1; Moreno-Perez MG, 2014, J VIROL, V88, P3359, DOI 10.1128/JVI.02980-13; Mukasa SB, 2006, PLANT PATHOL, V55, P458, DOI 10.1111/j.1365-3059.2006.01350.x; Mukasa SB, 2003, PLANT DIS, V87, P329, DOI 10.1094/PDIS.2003.87.4.329; Mukasa SB, 2003, VIRUS GENES, V27, P49, DOI 10.1023/A:1025172402230; Mukasa SB, 2003, ARCH VIROL, V148, P487, DOI 10.1007/s00705-002-0930-3; Mukhopadhyay SK, 2011, FOOD SECUR, V3, P283, DOI 10.1007/s12571-011-0134-3; Mulimbi W., 2012, New Disease Reports, V26, P11, DOI 10.5197/j.2044-0588.2012.026.011; Muthukumar V, 2009, VIRUS RES, V141, P169, DOI 10.1016/j.virusres.2008.06.016; Nagano AJ, 2015, METHODS MOL BIOL, V1236, P89, DOI 10.1007/978-1-4939-1743-3_8; Namanda S, 2011, J SUSTAIN AGR, V35, P870, DOI 10.1080/10440046.2011.590572; Ndunguru J, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-21; Ndunguru J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139321; Ndunguru J, 2009, AFR J AGR RES, V4, P334; Ngailo S, 2016, ACTA AGR SCAND B-S P, V66, P52, DOI 10.1080/09064710.2015.1063684; Nguyen HD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055336; Njeru RW, 2008, ANN APPL BIOL, V153, P215, DOI 10.1111/j.1744-7348.2008.00252.x; Njeru RW, 2004, ANN APPL BIOL, V145, P71, DOI 10.1111/j.1744-7348.2004.tb00360.x; OBRIEN PJ, 1972, AM ANTHROPOL, V74, P342, DOI 10.1525/aa.1972.74.3.02a00070; Ochola D, 2015, VIRUS RES, V195, P64, DOI 10.1016/j.virusres.2014.09.004; Ooi K, 1997, J PLANT RES, V110, P247, DOI 10.1007/BF02509313; Opiyo SA, 2010, J PLANT PATHOL, V92, P797; Power AG, 2011, VIRUS RES, V159, P95, DOI 10.1016/j.virusres.2011.05.016; Power Alison G., 2008, P15, DOI 10.1007/978-3-540-75763-4_2; Prendeville HR, 2014, NEW PHYTOL, V202, P1346, DOI 10.1111/nph.12730; Prendeville HR, 2012, AM J BOT, V99, P1033, DOI 10.3732/ajb.1100509; Qin YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106323; Rannali M, 2009, PLANT DIS, V93, P933, DOI 10.1094/PDIS-93-9-0933; Raybould AF, 1999, NEW PHYTOL, V141, P265, DOI 10.1046/j.1469-8137.1999.00339.x; Remold SK, 2002, J ECOL, V90, P967, DOI 10.1046/j.1365-2745.2002.00731.x; Reynolds TW, 2015, FOOD SECUR, V7, P795, DOI 10.1007/s12571-015-0478-1; Roossinck MJ, 2015, PHYTOPATHOLOGY, V105, P716, DOI 10.1094/PHYTO-12-14-0356-RVW; Roossinck MJ, 2015, CURR OPIN VIROL, V10, P56, DOI 10.1016/j.coviro.2015.01.005; Roossinck MJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003304; Roossinck MJ, 2012, ANNU REV GENET, V46, P359, DOI 10.1146/annurev-genet-110711-155600; Roossinck MJ, 2010, PHILOS T R SOC B, V365, P1899, DOI 10.1098/rstb.2010.0057; Roossinck MJ, 2010, MOL ECOL, V19, P81, DOI 10.1111/j.1365-294X.2009.04470.x; Roullier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062707; Rybicki EP, 1999, ADV VIRUS RES, V53, P127, DOI 10.1016/S0065-3527(08)60346-2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHAEFERS GA, 1976, PHYTOPATHOLOGY, V66, P642, DOI 10.1094/Phyto-66-642; Seabloom EW, 2015, ECOL LETT, V18, P401, DOI 10.1111/ele.12418; Seabloom EW, 2010, ECOLOGY, V91, P721, DOI 10.1890/08-2170.1; Seabloom EW, 2009, J ECOL, V97, P1264, DOI 10.1111/j.1365-2745.2009.01550.x; Seabloom EW, 2009, AM NAT, V173, pE79, DOI 10.1086/596529; Senshu H, 2011, J VIROL, V85, P10269, DOI 10.1128/JVI.05273-11; Senshu H, 2009, J GEN VIROL, V90, P1014, DOI 10.1099/vir.0.008243-0; Sossah FL, 2015, J PLANT PATHOL, V97, P109; Srisuwan S, 2006, PLANT SCI, V171, P424, DOI 10.1016/j.plantsci.2006.05.007; Stobbe AH, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00150; Strange RN, 2005, ANNU REV PHYTOPATHOL, V43, P83, DOI 10.1146/annurev.phyto.43.113004.133839; Sumner JG, 2012, J THEOR BIOL, V298, P16, DOI 10.1016/j.jtbi.2011.12.017; Sumner JG, 2012, SYST BIOL, V61, P1069, DOI 10.1093/sysbio/sys042; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; Tairo F, 2005, MOL PLANT PATHOL, V6, P199, DOI 10.1111/j.1364-3703.2005.00267.x; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thresh JM, 2006, ADV VIRUS RES, V67, P245, DOI 10.1016/S0065-3527(06)67007-3; Thurston MI, 2001, ANN APPL BIOL, V139, P277, DOI 10.1111/j.1744-7348.2001.tb00140.x; Tomitaka Y, 2006, MOL ECOL, V15, P4437, DOI 10.1111/j.1365-294X.2006.03094.x; Traore O, 2005, MOL ECOL, V14, P2097, DOI 10.1111/j.1365-294X.2005.02578.x; Traore O, 2009, VIRUS RES, V141, P258, DOI 10.1016/j.virusres.2009.01.011; Tsuneyoshi T, 1998, ARCH VIROL, V143, P1093, DOI 10.1007/s007050050358; Tugume AK, 2008, PHYTOPATHOLOGY, V98, P640, DOI 10.1094/PHYTO-98-6-0640; Tugume AK, 2016, VECTOR MEDIATED TRAN, P447; Tugume AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081479; Tugume AK, 2010, MOL ECOL, V19, P3139, DOI 10.1111/j.1365-294X.2010.04682.x; Tugume AK, 2010, J GEN VIROL, V91, P1092, DOI 10.1099/vir.0.016089-0; Untiveros M, 2008, ARCH VIROL, V153, P473, DOI 10.1007/s00705-007-0019-0; Untiveros M, 2007, PLANT DIS, V91, P669, DOI 10.1094/PDIS-91-6-0669; Untiveros M, 2010, ARCH VIROL, V155, P2059, DOI 10.1007/s00705-010-0805-y; Valkonen JPT, 2002, MOL PLANT MICROBE IN, V15, P683, DOI 10.1094/MPMI.2002.15.7.683; Valverde RA., 2007, PLANT VIRUSES, V1, P116; Verdcourt B., 1963, FLORA TROPICAL E AFR; Vincent SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091224; Visser M, 2016, VIROLOGY, V495, P122, DOI 10.1016/j.virol.2016.05.008; Weber PH, 2015, VIRUS RES, V196, P140, DOI 10.1016/j.virusres.2014.11.014; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Wren JD, 2006, PLOS BIOL, V4, P314, DOI 10.1371/journal.pbio.0040080; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; YAHARA T, 1993, OECOLOGIA, V96, P310, DOI 10.1007/BF00317499; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; YEN D. E., 1963, ECON BOT, V17, P31, DOI 10.1007/BF02985351; Zhang DP, 2004, GENET RESOUR CROP EV, V51, P115, DOI 10.1023/B:GRES.0000020853.04508.a0	168	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0167769	10.1371/journal.pone.0167769	http://dx.doi.org/10.1371/journal.pone.0167769			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005969	Green Submitted, Green Published, gold			2022-12-26	WOS:000392843200020
J	Campbell, TM; Castro, MAA; Ponder, BAJ; Meyer, KB				Campbell, Thomas M.; Castro, Mauro A. A.; Ponder, Bruce A. J.; Meyer, Kerstin B.			Identification of Post-Transcriptional Modulators of Breast Cancer Transcription Factor Activity Using MINDy	PLOS ONE			English	Article							GENE-EXPRESSION; TUMOR-METASTASIS; PROSTATE-CANCER; RECEPTOR; PDEF; RISK; SUPPRESSOR; REGULATORS	We have recently identified transcription factors (TFs) that are key drivers of breast cancer risk. To better understand the pathways or sub-networks in which these TFs mediate their function we sought to identify upstream modulators of their activity. We applied the MINDy (Modulator Inference by Network Dynamics) algorithm to four TFs (ESR1, FOXA1, GATA3 and SPDEF) that are key drivers of estrogen receptor-positive (ER+) breast cancer risk, as well as cancer progression. Our computational analysis identified over 500 potential modulators. We assayed 189 of these and identified 55 genes with functional characteristics that were consistent with a role as TF modulators. In the future, the identified modulators may be tested as potential therapeutic targets, able to alter the activity of TFs that are critical in the development of breast cancer.	[Campbell, Thomas M.; Ponder, Bruce A. J.; Meyer, Kerstin B.] Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Robinson Way, Cambridge, England; [Castro, Mauro A. A.] Fed Univ Parana UFPR, Bioinformat & Syst Biol Lab, Polytech Ctr, Rua Alcides Vieira Arcoverde, Curitiba, Parana, Brazil	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Universidade Federal do Parana	Meyer, KB (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Robinson Way, Cambridge, England.	Kerstin.Meyer@cruk.cam.ac.uk	Castro, Mauro A. A./A-5467-2008	Castro, Mauro A. A./0000-0003-4942-8131	Cancer Research UK [C20/A17031]; Breast Cancer Research Foundation [BCRF-16-127]; Cancer Research UK Gibb Fellowship Award [C20/A16967]	Cancer Research UK(Cancer Research UK); Breast Cancer Research Foundation; Cancer Research UK Gibb Fellowship Award	This work was supported by Cancer Research UK C20/A17031 (http://www.cancerresearchuk.org/); Breast Cancer Research Foundation BCRF-16-127 (https://www.bcrfcure.org/) and the Cancer Research UK Gibb Fellowship Award C20/A16967 (http://www.cancerresearchuk.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Bansal M, 2012, METHODS MOL BIOL, V786, P131, DOI 10.1007/978-1-61779-292-2_8; Campbell TM, 2016, CARCINOGENESIS, V37, P741, DOI 10.1093/carcin/bgw065; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Castro MAA, 2016, NAT GENET, V48, P12, DOI 10.1038/ng.3458; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Eirew P, 2015, NATURE, V518, P422, DOI 10.1038/nature13952; Feldman RJ, 2003, CANCER RES, V63, P4626; Fletcher MNC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3464; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Jozwik KM, 2012, NAT REV CANCER, V12, P381, DOI 10.1038/nrc3263; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Oettgen P, 2000, J BIOL CHEM, V275, P1216, DOI 10.1074/jbc.275.2.1216; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sood AK, 2007, HUM PATHOL, V38, P1628, DOI 10.1016/j.humpath.2007.03.010; Sood AK, 2012, PROSTATE, V72, P592, DOI 10.1002/pros.21461; Steffan JJ, 2012, J BIOL CHEM, V287, P29968, DOI 10.1074/jbc.M112.379396; Steffan JJ, 2011, CANCER LETT, V310, P109, DOI 10.1016/j.canlet.2011.06.011; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Takaku M, 2015, GENE EXPRESSION, V16, P163, DOI 10.3727/105221615X14399878166113; Turcotte S, 2007, NEOPLASIA, V9, P788, DOI 10.1593/neo.07460; Verdine GL, 2007, CLIN CANCER RES, V13, P7264, DOI 10.1158/1078-0432.CCR-07-2184; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Welboren WJ, 2007, MOL ONCOL, V1, P138, DOI 10.1016/j.molonc.2007.04.001	26	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168770	10.1371/journal.pone.0168770	http://dx.doi.org/10.1371/journal.pone.0168770			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997592	Green Submitted, Green Published, gold			2022-12-26	WOS:000392842900074
J	Chitrala, KN; Nagarkatti, P; Nagarkatti, M				Chitrala, Kumaraswamy Naidu; Nagarkatti, Prakash; Nagarkatti, Mitzi			Prediction of Possible Biomarkers and Novel Pathways Conferring Risk to Post-Traumatic Stress Disorder	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED GENES; QUALITY-CONTROL; PTSD; TWIN; DEPRESSION; GENETICS; TRAUMA; COMBAT; BIOINFORMATICS; BIOCONDUCTOR	Post-traumatic stress disorder is one of the common mental ailments that is triggered by exposure to traumatic events. Till date, the molecular factors conferring risk to the development of PTSD is not well understood. In this study, we have conducted a meta-analysis followed by hierarchical clustering and functional enrichment, to uncover the potential molecular networks and critical genes which play an important role in PTSD. Two datasets of expression profiles from Peripheral Blood Mononuclear Cells from 62 control samples and 63 PTSD samples were included in our study. In PTSD samples of GSE860 dataset, we identified 26 genes informative when compared with Post-deploy PTSD condition and 58 genes informative when compared with Pre-deploy and Post-deploy PTSD of GSE63878 dataset. We conducted the meta-analysis using Fisher, roP, Stouffer, AW, SR, PR and RP methods in MetaDE package. Results from the rOP method of MetaDE package showed that among these genes, the following showed significant changes including, OR2B6, SOX21, MOBP, 1L15, PTPRK, PPBPP2 and SEC14L5. Gene ontology analysis revealed enrichment of these significant PTSD-related genes for cell proliferation, DNA damage and repair (p-value < 0.05). Furthermore, interaction network analysis was performed on these 7 significant genes. This analysis revealed highly connected functional interaction networks with two candidate genes, IL15 and SEC14L5 highly enriched in networks. Overall, from these results, we concluded that these genes can be recommended as some of the potential targets for PTSD.	[Chitrala, Kumaraswamy Naidu; Nagarkatti, Prakash; Nagarkatti, Mitzi] Univ South Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA	University of South Carolina System; University of South Carolina Columbia	Nagarkatti, M (corresponding author), Univ South Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	Mitzi.Nagarkatti@uscmed.sc.edu	Chitrala, Kumara Swamy Naidu/U-1617-2019	Nagarkatti, Prakash/0000-0003-2663-0759; Chitrala, Kumaraswamy naidu/0000-0003-0663-9529	NIH [P01AT003961, R01AT006888, R01ES019313, R01MH094755, R01AI129788, P20GM103641]; National Center for Complementary & Integrative Health [P01AT003961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI129788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094755] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The present study was supported by NIH grants P01AT003961, R01AT006888, R01ES019313, R01MH094755, R01AI129788, and P20GM103641.	Alim TN, 2006, J NATL MED ASSOC, V98, P1630; Almli LM, 2014, INT J NEUROPSYCHOPH, V17, P355, DOI 10.1017/S1461145713001090; Amador-Arjona A, 2015, P NATL ACAD SCI USA, V112, pE1936, DOI 10.1073/pnas.1421480112; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Amstadter AB, 2009, PSYCHIAT ANN, V39, P358, DOI 10.3928/00485713-20090526-01; Andrews JA, 2012, J NEUROCHEM, V120, P26, DOI 10.1111/j.1471-4159.2011.07545.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashley-Koch AE, 2015, J AFFECT DISORDERS, V184, P225, DOI 10.1016/j.jad.2015.03.049; Atwoli L, 2015, CURR OPIN PSYCHIATR, V28, P307, DOI 10.1097/YCO.0000000000000167; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Becker KG, 2000, BIOINFORMATICS, V16, P745, DOI 10.1093/bioinformatics/16.8.745; Boyd Oa, 1925, STAT METHODS RES WOR; Breen MS, 2015, MOL PSYCHIAT; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Bremner JD, 2007, PROG BRAIN RES, V167, P171, DOI 10.1016/S0079-6123(07)67012-5; Breslau N, 2002, CAN J PSYCHIAT, V47, P923, DOI 10.1177/070674370204701003; Broekman BFP, 2007, NEUROSCI BIOBEHAV R, V31, P348, DOI 10.1016/j.neubiorev.2006.10.001; Cabrera OA, 2007, AM J PREV MED, V33, P77, DOI 10.1016/j.amepre.2007.03.019; Caglayan D, 2013, INT J CANCER, V133, P1345, DOI 10.1002/ijc.28147; Chu CM, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/634123; Cornelis MC, 2010, CURR PSYCHIAT REP, V12, P313, DOI 10.1007/s11920-010-0126-6; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Dreyfuss JM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-71; Fare TL, 2003, ANAL CHEM, V75, P4672, DOI 10.1021/ac034241b; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Geracioti TD, 2008, PSYCHONEUROENDOCRINO, V33, P416, DOI 10.1016/j.psyneuen.2007.12.012; Gillespie CF, 2009, DEPRESS ANXIETY, V26, P984, DOI 10.1002/da.20605; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gola H, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-40; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiao XL, 2012, BIOINFORMATICS, V28, P1805, DOI 10.1093/bioinformatics/bts251; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kapfhammer HP, 2014, DIALOGUES CLIN NEURO, V16, P227; Kauffmann A, 2010, GENOMICS, V95, P138, DOI 10.1016/j.ygeno.2010.01.003; Keane TM, 2006, ANNU REV CLIN PSYCHO, V2, P161, DOI 10.1146/annurev.clinpsy.2.022305.095305; King DW, 1996, J CONSULT CLIN PSYCH, V64, P520, DOI 10.1037/0022-006X.64.3.520; Koenen KC, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-29; Koenen KC, 2005, ARCH GEN PSYCHIAT, V62, P1258, DOI 10.1001/archpsyc.62.11.1258; Koenen KC, 2003, TWIN RES, V6, P218, DOI 10.1375/136905203765693870; Komori T, 2004, J EXP CLIN CANC RES, V23, P521; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Kristiansson M, 2004, J AM ACAD PSYCHIATRY, V32, P399; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li J, 2011, ANN APPL STAT, V5, P994, DOI 10.1214/10-AOAS393; Logue MW, 2015, PSYCHONEUROENDOCRINO, V57, P1, DOI 10.1016/j.psyneuen.2015.03.016; Marinova Z, 2015, EUR J PSYCHOTRAUMATO, V6, DOI 10.3402/ejpt.v6.25913; Mehta D, 2013, P NATL ACAD SCI USA, V110, P8302, DOI 10.1073/pnas.1217750110; Nakamura M, 2003, CANCER RES, V63, P737; Nemeroff CB, 2004, J CLIN PSYCHIAT, V65, P18; Olff M, 2007, PSYCHOL BULL, V133, P183, DOI 10.1037/0033-2909.133.2.183; Parkitny L, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0122-z; Passos IC, 2015, LANCET PSYCHIAT, V2, P1002, DOI 10.1016/S2215-0366(15)00309-0; Raabe Florian Joachim, 2013, Front Psychiatry, V4, P80, DOI 10.3389/fpsyt.2013.00080; Rajkowska G, 2015, J PSYCHIATR RES, V65, P53, DOI 10.1016/j.jpsychires.2015.04.010; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878; Saito K, 2007, BBA-MOL CELL BIOL L, V1771, P719, DOI 10.1016/j.bbalip.2007.02.010; Segman RH, 2005, MOL PSYCHIATR, V10, P514, DOI 10.1038/sj.mp.4001654; Skelton K, 2012, NEUROPHARMACOLOGY, V62, P628, DOI 10.1016/j.neuropharm.2011.02.013; Song C, 2014, ANN APPL STAT, V8, P777, DOI 10.1214/13-AOAS683; Steenkamp MM, 2015, J AFFECT DISORDERS, V176, P87, DOI 10.1016/j.jad.2015.01.043; Stein MB, 2002, BIOL PSYCHIAT, V52, P1079, DOI 10.1016/S0006-3223(02)01414-2; Stevens D, 2013, DEPRESS ANXIETY, V30, P940, DOI 10.1002/da.22160; STOUFFER S A, 1949, Sci Am, V180, P11; Strawn JR, 2008, DEPRESS ANXIETY, V25, P260, DOI 10.1002/da.20292; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; TRUE WR, 1993, ARCH GEN PSYCHIAT, V50, P257, DOI 10.1001/archpsyc.1993.01820160019002; Tseng GC, 2012, NUCLEIC ACIDS RES, V40, P3785, DOI 10.1093/nar/gkr1265; Voisey J, 2014, J ANXIETY DISORD, V28, P873, DOI 10.1016/j.janxdis.2014.09.014; Waldron L, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju049; Wang XB, 2012, BIOINFORMATICS, V28, P2534, DOI 10.1093/bioinformatics/bts485; Wilk JE, 2015, AGGRESS BEHAV; Xian H, 2000, DRUG ALCOHOL DEPEN, V61, P95, DOI 10.1016/S0376-8716(00)00127-7; Yehuda R, 1999, CAN J PSYCHIAT, V44, P34, DOI 10.1177/070674379904400104; Yehuda R, 2006, ANN NY ACAD SCI, V1071, P137, DOI 10.1196/annals.1364.012; Yehuda R, 2013, PSYCHONEUROENDOCRINO, V38, P1912, DOI 10.1016/j.psyneuen.2013.06.009; Young JM, 2002, HUM MOL GENET, V11, P1153, DOI 10.1093/hmg/11.10.1153	83	8	8	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168404	10.1371/journal.pone.0168404	http://dx.doi.org/10.1371/journal.pone.0168404			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QF	27997584	Green Published, gold, Green Submitted			2022-12-26	WOS:000392842900041
J	Dissanayake, AA; Wagner, CM; Nair, MG				Dissanayake, Amila A.; Wagner, C. Michael; Nair, Muraleedharan G.			Chemical Characterization of Lipophilic Constituents in the Skin of Migratory Adult Sea Lamprey from the Great Lakes Region	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; PETROMYZON-MARINUS; ESTERS; BIODEGRADATION; PHOSPHOLIPIDS; INACTIVATION; DEGRADATION; MECHANISMS; MUSCLE; GROWTH	The sea lamprey (Petromzons marinus) is an invasive ectoparasite of large-bodied fishes that adversely affects the fishing industry and ecology of the Laurentian Great Lakes. Lipid content in the whole sea lamprey and muscles, liver and kidney of metamorphosing larval stages has been reported. Similarly, the fatty acid profile of the rope tissues of sexually-mature male sea lampreys has also been reported. The average body weight of a sub-adult migratory sea lamprey is 250 g, which includes 14.4% skin (36 g). Our preliminary extraction data of an adult sea lamprey skin revealed that it contained approximately 8.5% of lipophilic compounds. Lamprey skin is home to a naturally aversive compound (an alarm cue) that is being developed into a repellent for use in pest management. As part of an ongoing investigation to identify the chemical structure of the sea lamprey alarm cue, we extracted the skin with water and methanol, respectively. The methanolic extract (1.55%) contained exclusively lipophilic compounds and did not include the alarm cue. We chemically characterized all compounds present in the methanolic extract as cholesterol esters (CE), tri- and di-glycerides (TG and DG), cholesterol, free fatty acids (FFA) and minor amounts of plasticizers. The free fatty acids fraction was composed of saturated (41.8%), monounsaturated (40.7%) and polyunsaturated (17.4%) fatty acids, respectively. The plasticizers characterized were phthalate and benzoate and found to be 0.95 mg and 2.54 mg, respectively, per adult sea lamprey skin. This is the first report of the chemical characterization of all the lipophilic constituents in the skin of sub-adult migratory sea lamprey. The CEs isolated and characterized from sea lamprey skin are also for the first time.	[Dissanayake, Amila A.; Nair, Muraleedharan G.] Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA; [Wagner, C. Michael] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Nair, Muraleedharan G.] King Saud Univ, Chair Date Palm Res, Coll Food & Agr Sci, Riyadh, Saudi Arabia	Michigan State University; Michigan State University; King Saud University	Nair, MG (corresponding author), Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA.; Nair, MG (corresponding author), King Saud Univ, Chair Date Palm Res, Coll Food & Agr Sci, Riyadh, Saudi Arabia.	nairm@msu.edu	Nair, Muraleedharan G./AAF-9984-2019	Nair, Muraleedharan G./0000-0001-9604-0055; Dissanayake, Amila/0000-0001-6274-6017	Great Lake Fisheries Commission (GLFC) [2016-NAI-54051]; NIH [1-S10-RR04750]; NSF [CHE-88-00770, CHE-92-13241]; Biotechnology Research Technology Program [DRR-00480]; National Center for Research Resources, National Institutes of Health	Great Lake Fisheries Commission (GLFC); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Biotechnology Research Technology Program; National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research is a contribution from Michigan State University AgBioResearch and funded by the Great Lake Fisheries Commission (GLFC) under the contract 2016-NAI-54051. The NMR data were obtained on instrumentation that was purchased, in part, with the funds from NIH grant no. 1-S10-RR04750, NSF grant no. CHE-88-00770, and NSF grant no. CHE-92-13241. MS data were obtained at the Michigan State University Mass Spectrometry Facility, which is supported, in part, by a grant (DRR-00480) from the Biotechnology Research Technology Program, National Center for Research Resources, National Institutes of Health.; This research is a contribution from Michigan State University AgBioResearch and funded by the Great Lake Fisheries Commission (GLFC) under the contract 2016-NAI-54051. The NMR data were obtained on instrumentation that was purchased, in part, with the funds from NIH grant no. 1-S10-RR04750, NSF grant no. CHE-88-00770, and NSF grant no. CHE-92-13241. MS data were obtained at the Michigan State University Mass Spectrometry Facility, which is supported, in part, by a grant (DRR-00480) from the Biotechnology Research Technology Program, National Center for Research Resources, National Institutes of Health. Authors acknowledge Dr. Chuan-Rui Zhang for his assistance in the sequential extraction of lyophilized whole sea lampreys.	Almeida PR, 2002, LARVAL HABITAT SEA L, P121; Alvarez JA, 2006, J LIQ CHROMATOGR, V10, P1291; Applegate VC, 1950, NATURAL HIST SEA LAM; Araujo MJ, 2013, J APPL ICHTHYOL, V29, P808, DOI 10.1111/jai.12192; Bals JD, 2012, BEHAVIOUR, V149, P901, DOI 10.1163/1568539X-00003009; Bell JG, 2006, AQUAC RES, V37, P606, DOI 10.1111/j.1365-2109.2006.01470.x; Bergsson G, 1998, ANTIMICROB AGENTS CH, V42, P2290, DOI 10.1128/AAC.42.9.2290; Bergsson G, 2001, APMIS, V109, P670, DOI 10.1034/j.1600-0463.2001.d01-131.x; BIRD DJ, 1983, COMP BIOCHEM PHYS B, V75, P31, DOI 10.1016/0305-0491(83)90036-6; BORGMANN U, 1991, J GREAT LAKES RES, V17, P368, DOI 10.1016/S0380-1330(91)71373-7; Botelho G, 2004, POLYM DEGRAD STABIL, V85, P991, DOI 10.1016/j.polymdegradstab.2003.04.006; Bulla M. K., 2011, Food and Nutrition Sciences, V2, P440, DOI 10.4236/fns.2011.25062; Chivers DP, 2007, P ROY SOC B-BIOL SCI, V274, P2611, DOI 10.1098/rspb.2007.0709; Christie GC, 2003, J GREAT LAKES RES, V29, P1, DOI 10.1016/S0380-1330(03)70474-2; Chung-Davidson YW, 2013, J EXP BIOL, V216, P2702, DOI 10.1242/jeb.085746; Cline TJ, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00059.1; Desbois AP, 2010, APPL MICROBIOL BIOT, V85, P1629, DOI 10.1007/s00253-009-2355-3; Elliot SL, 2002, P ROY SOC B-BIOL SCI, V269, P1599, DOI 10.1098/rspb.2002.2067; FELLOWS FCI, 1982, LIPIDS, V17, P741, DOI 10.1007/BF02534661; GALBRAITH H, 1971, J APPL BACTERIOL, V34, P803, DOI 10.1111/j.1365-2672.1971.tb01019.x; Gartshore J, 2003, ENVIRON TOXICOL CHEM, V22, P1244, DOI 10.1897/1551-5028(2003)022&lt;1244:BOPBRR&gt;2.0.CO;2; GIBBONS JA, 1989, ENVIRON TOXICOL CHEM, V8, P283, DOI 10.1897/1552-8618(1989)8[283:MDOSSO]2.0.CO;2; Hardisty M.W, 1971, P127; Hardisty MW, 1979, BIOL CYCLOSTOMES, P272; HENDERSON RJ, 1987, PROG LIPID RES, V26, P281, DOI 10.1016/0163-7827(87)90002-6; Jensen IJ, 2012, NUTR BULL, V37, P25, DOI 10.1111/j.1467-3010.2011.01941.x; JIE MSFLK, 1995, CHEM PHYS LIPIDS, V77, P155; Kao YH, 2002, COMP BIOCHEM PHYS B, V131, P153, DOI 10.1016/S1096-4959(01)00491-2; Kao YH, 1997, FISH PHYSIOL BIOCHEM, V16, P281, DOI 10.1023/A:1007799028951; Kaya Y., 2008, Journal of FisheriesSciences.com, V2, P693; KEITH LH, 1979, ENVIRON SCI TECHNOL, V13, P416, DOI 10.1021/es60152a601; KROON PA, 1981, J BIOL CHEM, V256, P5340; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lanca MJ, 2013, SCI MAR, V77, P281, DOI 10.3989/scimar.03779.27B; LARSEN LO, 1980, CAN J FISH AQUAT SCI, V37, P1762, DOI 10.1139/f80-221; LEBLANC PJ, 1995, CAN J ZOOL, V73, P916, DOI 10.1139/z95-107; Liao CY, 2013, ENVIRON SCI TECHNOL, V47, P3918, DOI 10.1021/es400724s; Malcolmson RJ, 1996, CHEM PHYS LIPIDS, V84, P93, DOI 10.1016/S0009-3084(96)02626-6; Manzon RG, 2015, FISH FISH SER, V37, P139, DOI 10.1007/978-94-017-9306-3_4; Marichamy G., 2009, CURR RES J BIOL SCI, V1, P109; McCauley DW, 2015, BIOSCIENCE, V65, P1046, DOI 10.1093/biosci/biv139; McDaniel JC, 2008, WOUND REPAIR REGEN, V16, P337, DOI 10.1111/j.1524-475X.2008.00388.x; MCGRATTAN CJ, 1976, J PHYCOL, V12, P129, DOI 10.1111/j.1529-8817.1976.tb02839.x; Nieva-Echevarria B, 2014, FOOD RES INT, V66, P379, DOI 10.1016/j.foodres.2014.09.031; NIKITINA N, 2009, COLD SPRING HARB PRO, V4, P4, DOI DOI 10.1101/PDB.PROT5124); Pinela S, 2009, SCI MAR, V73, P785, DOI 10.3989/scimar.2009.73n4785; Pour AK, 2013, BIOCHEM ENG J, V70, P35, DOI 10.1016/j.bej.2012.09.014; Pour AK, 2009, CHEMOSPHERE, V77, P258, DOI 10.1016/j.chemosphere.2009.06.048; Quintella BR, 2009, J APPL ICHTHYOL, V25, P46, DOI 10.1111/j.1439-0426.2008.01200.x; Quintella BR, 2003, ECOL FRESHW FISH, V12, P286, DOI 10.1046/j.1600-0633.2002.00030.x; SACCHI R, 1994, CHEM PHYS LIPIDS, V69, P65, DOI 10.1016/0009-3084(94)90028-0; Shu DG, 1999, NATURE, V402, P42, DOI 10.1038/46965; Soni MG, 2005, FOOD CHEM TOXICOL, V43, P985, DOI 10.1016/j.fct.2005.01.020; Sorensen PW, 2005, NAT CHEM BIOL, V1, P324, DOI 10.1038/nchembio739; Soubias O, 2004, CHEM-EUR J, V10, P6005, DOI 10.1002/chem.200400246; THORMAR H, 1987, ANTIMICROB AGENTS CH, V31, P27, DOI 10.1128/AAC.31.1.27; Xue J, 2016, ACCUMULATIO IN PRESS; YOUSON JH, 1979, CAN J ZOOL, V57, P237, DOI 10.1139/z79-022; Zhang CR, 2015, J FUNCT FOODS, V18, P266, DOI 10.1016/j.jff.2015.07.012; Zhang CR, 2013, J AGR FOOD CHEM, V61, P5834, DOI 10.1021/jf401371v	60	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168609	10.1371/journal.pone.0168609	http://dx.doi.org/10.1371/journal.pone.0168609			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992570	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842600080
J	Levac, DE; Glegg, SMN; Sveistrup, H; Colquhoun, H; Miller, P; Finestone, H; DePaul, V; Harris, JE; Velikonja, D				Levac, Danielle E.; Glegg, Stephanie M. N.; Sveistrup, Heidi; Colquhoun, Heather; Miller, Patricia; Finestone, Hillel; DePaul, Vincent; Harris, Jocelyn E.; Velikonja, Diana			Promoting Therapists' Use of Motor Learning Strategies within Virtual Reality-Based Stroke Rehabilitation	PLOS ONE			English	Article							PHYSICAL-THERAPY; CHILDREN; INTERVENTIONS; RELIABILITY; INSTRUMENT	Purpose Therapists use motor learning strategies (MLSs) to structure practice conditions within stroke rehabilitation. Virtual reality (VR)-based rehabilitation is an MLS-oriented stroke intervention, yet little support exists to assist therapists in integrating MLSs with VR system use. Method A pre-post design evaluated a knowledge translation (KT) intervention incorporating interactive e-learning and practice, in which 11 therapists learned how to integrate MLSs within VR-based therapy. Self-report and observer-rated outcome measures evaluated therapists' confidence, clinical reasoning and behaviour with respect to MLS use. A focus group captured therapists' perspectives on MLS use during VR-based therapy provision. Results The intervention improved self-reported confidence about MLS use as measured by confidence ratings (p <0.001). Chart-Stimulated Recall indicated a moderate level of competency in therapists' clinical reasoning about MLSs following the intervention, with no changes following additional opportunities to use VR (p =.944). On the Motor Learning Strategy Rating Instrument, no behaviour change with respect to MLS use was noted (p = 0.092). Therapists favoured the strategy of transferring skills from VR to real-life tasks over employing a more comprehensive MLS approach. Conclusion The KT intervention improved therapists' confidence but did not have an effect on clinical reasoning or behaviour with regard to MLS use during VR-based therapy.	[Levac, Danielle E.] Northwestern Univ, Bouve Coll Hlth Sci, Dept Phys Therapy Movement Sci & Rehabil, Boston, MA 60208 USA; [Glegg, Stephanie M. N.] Sunny Hill Hlth Ctr Children, Therapy Dept, Vancouver, BC, Canada; [Sveistrup, Heidi; Harris, Jocelyn E.] Univ Ottawa, Fac Hlth Sci, Sch Rehabil Sci, Ottawa, ON, Canada; [Colquhoun, Heather] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Miller, Patricia] McMaster Univ, Fac Hlth Sci, Sch Rehabil Sci, Hamilton, ON, Canada; [Finestone, Hillel] Eiisabeth Bruyere Hosp & Bruyere Continuing Care, Physiat, Ottawa, ON, Canada; [DePaul, Vincent] Queens Univ, Sch Rehabil Therapy, Kingston, ON, Canada; [Velikonja, Diana] Hamilton Hlth Sci, Reg Rehabil Ctr, Hamilton, ON, Canada	Northeastern University; Northwestern University; University of Ottawa; University of Toronto; McMaster University; Queens University - Canada; McMaster University	Levac, DE (corresponding author), Northwestern Univ, Bouve Coll Hlth Sci, Dept Phys Therapy Movement Sci & Rehabil, Boston, MA 60208 USA.	d.levac@northeastern.edu	Harris, Jocelyn Ellen/ABE-7420-2021; Levac, Danielle/O-9008-2015	Harris, Jocelyn Ellen/0000-0002-3293-1833; Levac, Danielle/0000-0001-7356-9335; Glegg, Stephanie/0000-0002-8164-6983	Ontario Ministry of Health and Long-Term Care; Ontario Stroke Network; Canadian Institutes of Health Research; Canadian Child Health Clinician Scientist Program; NeuroDevNet	Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Ontario Stroke Network; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Child Health Clinician Scientist Program; NeuroDevNet	This project has been generously funded, by a grant from the Ontario Ministry of Health and Long-Term Care, administered and supported by the Ontario Stroke Network (www.ontariostrokenetwork.ca), to DEL, SMNG, HS, HC, PM, HF, VD, and JEH. The views expressed do not necessarily reflect those of the Ministry or the Ontario Stroke Network. Dr. Levac's postdoctoral fellowship was supported by the Canadian Institutes of Health Research, the Canadian Child Health Clinician Scientist Program and NeuroDevNet.	Baker R, 2015, COCHRANE DB SYST REV, V29; Barker M, 2015, KNOWLEDGE PRAC UNPUB; Darekar A, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0035-3; Fisher BE, 2014, J NEUROL PHYS THER, V38, P149, DOI 10.1097/NPT.0000000000000043; Glegg SMN, DISABI REHA IN PRESS; Glegg SMN, 2012, J CYBERTHER REHABIL, V5; Glegg SMN, 2014, NEUROREHABILITATION, V35, P563, DOI 10.3233/NRE-141152; Glegg SMN, 2014, DISABIL REHABIL-ASSI, V9, P89, DOI 10.3109/17483107.2013.799236; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Jones CA, 2015, PHYS THER, V95, P663, DOI 10.2522/ptj.20130512; Kamath T, 2012, PHYS OCCUP THER PEDI, V32, P288, DOI 10.3109/01942638.2012.672551; Kaminker MK, 2004, PHYS THER, V84, P919, DOI 10.1093/ptj/84.10.919; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Kleynen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135522; Krakauer JW, 2006, CURR OPIN NEUROL, V19, P84, DOI 10.1097/01.wco.0000200544.29915.cc; Laver K, 2012, EUR J PHYS REHAB MED, V48, P523; Laver KE, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008349.pub2, 10.1002/14651858.CD008349.pub3, 10.1002/14651858.CD008349.pub4]; Levac D, 2015, PHYS THER, V95, P648, DOI 10.2522/ptj.20130500; Levac D, 2013, PEDIATR PHYS THER, V25, P53, DOI 10.1097/PEP.0b013e3182750c28; Levac D, 2012, PHYS OCCUP THER PEDI, V32, P180, DOI 10.3109/01942638.2011.616266; Levac D, 2012, RES DEV DISABIL, V33, P214, DOI 10.1016/j.ridd.2011.09.007; Levac D, 2011, PHYS THER, V91, P689, DOI 10.2522/ptj.20100415; Levac DE, 2013, PHYSIOTHER THEOR PR, V29, P504, DOI 10.3109/09593985.2012.762078; Levac DE, BMC HLTH SE IN PRESS; Levac DE, 2012, ARCH PHY MEDREHABIL; Levin MF, 2008, P 8 INT C VIRT REH; Levin MF, 2015, PHYS THER, V95, P415, DOI 10.2522/ptj.20130579; Levin MF, 2012, NEUROL THER, V1, DOI 10.1007/s40120-012-0003-9; Levin MF, 2011, EXPERT REV NEUROTHER, V11, P153, DOI 10.1586/ERN.10.201; MacDermid JC, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-14; Mathur S, 2005, PHYS THER, V85, P226, DOI 10.1093/ptj/85.3.226; Rizzo A, 2005, PRESENCE-TELEOP VIRT, V14, P119, DOI 10.1162/1054746053967094; Salvatori P, 2000, Can J Occup Ther, V67, P51; Saposnik G, 2011, STROKE, V42, P1380, DOI 10.1161/STROKEAHA.110.605451; Schmidt R. A, 2011, MOTOR CONTROL LEARNI; Schmidt RA., 1991, CONT MANAGEMENT MOTO, P49; Schoemaker M. M., 2013, THESIS; Scott SD, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-70; Squires JE, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0152-6; Subramanian SK, 2010, NEUROREHAB NEURAL RE, V24, P113, DOI 10.1177/1545968309349941; Sveistrup Heidi, 2004, J Neuroeng Rehabil, V1, P10, DOI 10.1186/1743-0003-1-10; Tatla SK, 2015, JMIR SERIOUS GAMES, V3, DOI 10.2196/games.3401; Wilson PN, 1997, DISABIL REHABIL, V19, P213, DOI 10.3109/09638289709166530; Winstein C, 2014, J NEUROL PHYS THER, V38, P190, DOI 10.1097/NPT.0000000000000046	45	24	26	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168311	10.1371/journal.pone.0168311	http://dx.doi.org/10.1371/journal.pone.0168311			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QC	27992492	gold, Green Submitted, Green Published			2022-12-26	WOS:000392842600047
J	Melo, AHN; Macedo, MA				Nunes Melo, Adolfo Henrique; Macedo, Marcelo Andrade			Permanent Data Storage in ZnO Thin Films by Filamentary Resistive Switching	PLOS ONE			English	Article							EPITAXIAL-GROWTH; MEMRISTOR; BEHAVIOR; OXIDE	Resistive memories are considered the most promising candidates for the next generation of non-volatile memory; however, attention has so far been limited to rewritable memory features for applications in resistive random access memories (RRAM). In this article, we provide a new insight into the applicability of resistive memories. The characteristics of non-rewritable resistive memories (NRRM) were investigated. Devices with Pt/ZnO/ITO architecture were prepared using magnetron sputtering, upon which various bipolar and unipolar resistive switching tests were performed. The results showed excellent distinction between the high resistance state (HRS) and low resistance state (LRS), with RHRS/RLRS = 5.2 x 10(11) for the Pt/ZnO/ITO device with deposition time of 1 h. All samples were stable for more than 10(4) s, indicating that the devices have excellent applicability in NRRMs.	[Nunes Melo, Adolfo Henrique; Macedo, Marcelo Andrade] Univ Fed Sergipe, Dept Phys, Sao Cristovao, Sergipe, Brazil	Universidade Federal de Sergipe	Melo, AHN (corresponding author), Univ Fed Sergipe, Dept Phys, Sao Cristovao, Sergipe, Brazil.	adolfohnmelo@gmail.com	Macedo, Marcelo/ABF-2394-2020	Macedo, Marcelo/0000-0002-7396-6194; Nunes Melo, Adolfo Henrique/0000-0003-1207-7104				Asmar RA, 2005, J CRYST GROWTH, V279, P394, DOI 10.1016/j.jcrysgro.2005.02.035; Bae S, 2015, J ELECTRON MATER, V44, P4175, DOI 10.1007/s11664-015-3935-x; Ben Yahia S, 2008, SPECTROCHIM ACTA A, V71, P1234, DOI 10.1016/j.saa.2008.03.032; Chang WY, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2834852; Dugaiczyk L, 2013, CHEM PHYS LETT, V575, P112, DOI 10.1016/j.cplett.2013.05.005; Huang CH, 2013, ACS APPL MATER INTER, V5, P6017, DOI 10.1021/am4007287; Jin CM, 2005, MAT SCI ENG B-SOLID, V117, P348, DOI 10.1016/j.mseb.2004.12.003; Kang YH, 2011, SOLID STATE COMMUN, V151, P1739, DOI 10.1016/j.ssc.2011.08.036; Kim DS, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.174430; LAMPERT MA, 1956, PHYS REV, V103, P1648, DOI 10.1103/PhysRev.103.1648; Lee JW, 2015, SOLID STATE COMMUN, V209, P11, DOI [10.1016/j.ssc.2015.02.019, 10.1016/j.ssc.2015.02.045]; Lee S, 2010, J APPL PHYS, V108, DOI 10.1063/1.3489882; Li HX, 2013, THIN SOLID FILMS, V537, P279, DOI 10.1016/j.tsf.2013.04.028; Lin CL, 2015, MICROELECTRON ENG, V136, P15, DOI 10.1016/j.mee.2015.03.027; Melo AHN, 2014, ADV MATER RES-SWITZ, V975, P238, DOI 10.4028/www.scientific.net/AMR.975.238; Park G, 2016, OBSERVATION ELECT FI, V222103, P0; Pearton SJ, 2005, PROG MATER SCI, V50, P293, DOI 10.1016/j.pmatsci.2004.04.001; Qi J, 2012, ACS NANO, V6, P1051, DOI 10.1021/nn204809a; Ramachandran S, 2006, J CRYST GROWTH, V291, P212, DOI 10.1016/j.jcrysgro.2006.02.010; Santos DAA, 2015, MATER RES BULL, V66, P147, DOI 10.1016/j.materresbull.2015.02.051; Snure M, 2007, J APPL PHYS, V101, DOI 10.1063/1.2749487; Strukov DB, 2008, NATURE, V453, P80, DOI 10.1038/nature06932; Tapily K, 2010, ECS TRANSACTIONS, V33, P117, DOI 10.1149/1.3485248; Tiwari A, 2002, J MATER RES, V17, P2480, DOI 10.1557/JMR.2002.0361; Waser R, 2007, NAT MATER, V6, P833, DOI 10.1038/nmat2023; Yang JJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/21/215201; Yang YC, 2009, J APPL PHYS, V106, DOI 10.1063/1.3273329; Zhang R, 2014, J NON-CRYST SOLIDS, V406, P102, DOI 10.1016/j.jnoncrysol.2014.09.055	28	13	13	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168515	10.1371/journal.pone.0168515	http://dx.doi.org/10.1371/journal.pone.0168515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992513	gold, Green Published, Green Submitted			2022-12-26	WOS:000392842600073
J	Zhang, ZX; Tian, X; Bai, YG; Liu, HF; Niu, XL; Wang, ZW; Wang, Q				Zhang, Zhixin; Tian, Xun; Bai, Yuguang; Liu, Huifang; Niu, Xueli; Wang, Zhiwei; Wang, Qian			Field Sandbur (Cenchrus pauciflorus) Seeds in the Same Bur Respond Differently to Temperature and Water Potential in Relation to Germination in a Semi-Arid Environment, China	PLOS ONE			English	Article							THERMAL TIME; ALIEN; INVASION; DESERT; DORMANCY; MODEL; SIZE	The success of a biological invasion relies on the environment and is closely linked to factors such as water and temperature. Invasive plant species display different seed characteristics, including shape. Field sandbur (Cenchrus pauciflorus) is a globally widespread invasive species capable of adapting to broad environmental conditions. However, its germination response to water and temperature still remains unclear. C. pauciflorus contains two seeds in the same bur that differ in size: big seeds (M) and small seeds (P). Separate greenhouse experiments were conducted under different temperature regimes (0/10 degrees C, 5/15 degrees C, 10/20 degrees C, 15/25 degrees C, 18/28 degrees C, 20/30 degrees C and 25/35 degrees C) and water potentials (-1.50Mpa, -1.00Mpa, -0.75Mpa, -0.50Mpa, -0.25Mpa and OMpa) for M and P seeds. The results support the hypothesis that germination of C. pauciflorus is significantly influenced by seed type, temperature and water potential. M and P seeds responded differently to varied alternative temperatures and water potentials. However, M and P seeds were more sensitive to water potential than to temperature. Optimal conditions for M and P seed germination were measured at 25/35 degrees C (night temperature/day temperature) and 20/30 degrees C, respectively. In contrast, the highest germination rate was observed for the OMpa of the water potential treatment. Additionally, base temperature (T-base) and base water potential (W-base) were lower for M (7.7 degrees C, -1.11Mpa at 10/20 degrees C, and -1.07Mpa at 20/, base, 30 degrees C) than for P (9.4 degrees C, -0.92Mpa at 10/20 degrees C, and -0.52Mpa at 20/30 degrees C). These different germination strategies of M and P seeds with respect to temperature and water potential increased overall plant propagation. These results indicate that tropical and subtropical regions water potentials beyond -0.50Mpa (10/20 degrees C) or -1.00Mpa (20/30 degrees C) face a potential risk of C. pauciflorus invasion.	[Zhang, Zhixin; Liu, Huifang; Niu, Xueli] Lanzhou Univ, State Key Lab Grassland Agroecosyst, Lanzhou, Gansu, Peoples R China; [Zhang, Zhixin; Niu, Xueli] Lanzhou Univ, Coll Pastoral Agr Sci & Technol, Lanzhou, Gansu, Peoples R China; [Tian, Xun] Inner Mongolia Univ Nationalities, Coll Life Sci, Tongliao, Inner Mongolia, Peoples R China; [Bai, Yuguang] Univ Saskatchewan, Coll Agr & Bioresources, Saskatoon, SK, Canada; [Wang, Zhiwei; Wang, Qian] Guizhou Acad Agr Sci, Guizhou Inst Prataculture, Guiyang, Guizhou, Peoples R China	Lanzhou University; Lanzhou University; Inner Mongolia University for Nationalities; University of Saskatchewan; Guizhou Academy of Agricultural Sciences	Tian, X (corresponding author), Inner Mongolia Univ Nationalities, Coll Life Sci, Tongliao, Inner Mongolia, Peoples R China.	tianxun@imun.edu.cn			State Key Basic Research Program 973 [2014 -CB138706]; National Natural Science Foundation of China [31360574, 31301922, 31570332]; Natural Science Foundation of Inner Mongolia [2011MS0403]	State Key Basic Research Program 973(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Inner Mongolia	The research was supported by the following projects: State Key Basic Research Program 973 (2014 -CB138706), http://program.most.gov.cn/; the National Natural Science Foundation of China (31360574, 31301922, 31570332), http://www.nsfc.gov.cn/; Natural Science Foundation of Inner Mongolia (2011MS0403), http://nsbr.nmkjt.gov.cn/.	Acosta JM, 2014, WEED RES, V54, P584, DOI 10.1111/wre.12114; [Anonymous], 1991, WORLDS WORST WEEDS D; Bradley BA, 2010, BIOL INVASIONS, V12, P1855, DOI 10.1007/s10530-009-9597-y; Brandel M, 2004, FLORA, V199, P228, DOI 10.1078/0367-2530-00150; Cui JY, 2007, ARID LAND RES MANAG, V21, P165, DOI 10.1080/15324980701426306; Dana E, 2001, PLANT INVADERS SPAIN; Du Gm, 1995, DISTRIBUTION HARMFUL; Durr C, 2015, AGR FOREST METEOROL, V200, P222, DOI 10.1016/j.agrformet.2014.09.024; Ebrahimi E, 2012, WEED RES, V52, P50, DOI 10.1111/j.1365-3180.2011.00896.x; EMMERICH WE, 1990, AGRON J, V82, P1103, DOI 10.2134/agronj1990.00021962008200060015x; Fandrich L, 2005, WEED SCI, V53, P594, DOI 10.1614/WS-05-03R1.1; Fenner M., 1985, SEED ECOLOGY, P87; Flores J, 2001, J ARID ENVIRON, V47, P485, DOI 10.1006/jare.2000.0728; Fumanal B, 2007, ANN BOT-LONDON, V100, P305, DOI 10.1093/aob/mcm108; Gomez JM, 2004, EVOLUTION, V58, P71, DOI 10.1111/j.0014-3820.2004.tb01574.x; Belo RG, 2014, IND CROP PROD, V62, P537, DOI 10.1016/j.indcrop.2014.09.029; Gritti ES, 2006, J BIOGEOGR, V33, P145, DOI 10.1111/j.1365-2699.2005.01377.x; Guillemin JP, 2013, WEED RES, V53, P76, DOI 10.1111/wre.12000; Hu XW, 2015, AM J BOT, V102, P649, DOI 10.3732/ajb.1400507; Imbert E, 1997, OIKOS, V79, P325, DOI 10.2307/3546016; Luo J, 2012, WEED RES, V52, P112, DOI 10.1111/j.1365-3180.2011.00898.x; Lv LY, 2011, PRATACULT SCI, V1, P21; Mifsud S, CENTRAL MEDITERRANEA, V5, P6; Na C, 2011, SEED, V3, P9; Parsons W.T., 2001, NOXIOUS WEEDS AUSTR, Vsecond; Perglova I, 2009, PRESLIA, V81, P357; Pysek Petr, 2007, V193, P97; Quattrocchi U., 2006, CRC WORLD DICT GRASS; Schlaepfer DR, 2010, NEW PHYTOL, V185, P1087, DOI 10.1111/j.1469-8137.2009.03114.x; SCHONBECK MW, 1980, PLANT PHYSIOL, V65, P1149, DOI 10.1104/pp.65.6.1149; Song WJ, 2005, WEED RES, V45, P467, DOI 10.1111/j.1365-3180.2005.00477.x; Trudgill DL, 2005, ANN APPL BIOL, V146, P1, DOI 10.1111/j.1744-7348.2005.04088.x; Venable DL, 1998, EVOLUTION, V52, P344, DOI 10.1111/j.1558-5646.1998.tb01636.x; Wainwright CE, 2013, BIOL INVASIONS, V15, P2253, DOI 10.1007/s10530-013-0449-4; Wang R, 2004, ENVIRON EXP BOT, V51, P183, DOI 10.1016/j.envexpbot.2003.10.001; Weber E, 2008, BIOL INVASIONS, V10, P1411, DOI 10.1007/s10530-008-9216-3; Wen B, 2015, WEED RES, V55, P155, DOI 10.1111/wre.12134; Bin W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141567; Windauer LB, 2011, ANN BOT, P242; Windauer LB, 2012, ANN BOT-LONDON, V109, P265, DOI 10.1093/aob/mcr242; Xu HG, 2006, BIOL INVASIONS, V8, P1495, DOI 10.1007/s10530-005-5841-2; Xu J, 2011, CHINESE J GRASSLAND, V2, P5; Zhang ZX, 2012, PRATACULT SCI, V12, P21; Zhang ZX, 2011, PRATACULT SCI, V2, P5; Zhao Y, 2010, PRATACULT SCI, V4, P21; Zhu M. X., 2011, Middle East Journal of Scientific Research, V8, P479	46	3	7	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168394	10.1371/journal.pone.0168394	http://dx.doi.org/10.1371/journal.pone.0168394			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992496	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842600054
J	Kaneko, M; Hashikami, K; Yamamoto, S; Matsumoto, H; Nishimoto, T				Kaneko, Manami; Hashikami, Kentarou; Yamamoto, Satoshi; Matsumoto, Hirokazu; Nishimoto, Tomoyuki			Phospholamban Ablation Using CRISPR/Cas9 System Improves Mortality in a Murine Heart Failure Model	PLOS ONE			English	Article							GENE-TRANSFER; CARDIAC-HYPERTROPHY; MOUSE MODEL; SURVIVAL; RESYNCHRONIZATION; CARDIOMYOPATHY; CARDIOMYOCYTES; CONTRACTILITY; MYOCARDIUM; MECHANISMS	Sarcoplasmic reticulum Ca2+-ATPase 2a (SERCA2a) and its inhibitory protein called phospholamban (PLN) are pivotal for Ca2+ handling in cardiomyocyte and are known that their expression level and activity were changed in the heart failure patients. To examine whether PLN inhibition can improve survival rate as well as cardiac function in heart failure, we performed PLN ablation in calsequestrin overexpressing (CSQ-Tg) mice, a severe heart failure model, using clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas) system. According this method, generation rate of PLN wild type mice (PLN copy >0.95) and PLN homozygous knockout (KO) mice (PLN copy <0.05) were 39.1% and 10.5%, respectively. While CSQ overexpression causes severe heart failure symptoms and premature death, a significant ameliorating effect on survival rate was observed in PLN homozygous KO/CSQ-Tg mice compared to PLN wild type/CSQ-Tg mice (median survival days are 55 and 50 days, respectively). Measurement of cardiac function with cardiac catheterization at the age of 5 weeks revealed that PLN ablation improved cardiac function in CSQ-Tg mice without affecting heart rate and blood pressure. Furthermore, increases in atrial and lung weight, an index of congestion, were significantly inhibited by PLN ablation. These results suggest that PLN deletion would be a promising approach to improve both mortality and cardiac function in the heart failure.	[Kaneko, Manami; Nishimoto, Tomoyuki] Takeda Pharmaceut Co Ltd, Cardiovasc & Metab Drug Discovery Unit, Div Pharmaceut Res, Fujisawa, Kanagawa, Japan; [Hashikami, Kentarou; Yamamoto, Satoshi; Matsumoto, Hirokazu] Takeda Pharmaceut Co Ltd, Integrated Technol Res Labs, Div Pharmaceut Res, Fujisawa, Kanagawa, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd	Kaneko, M (corresponding author), Takeda Pharmaceut Co Ltd, Cardiovasc & Metab Drug Discovery Unit, Div Pharmaceut Res, Fujisawa, Kanagawa, Japan.	manami.kaneko@takeda.com			Takeda Pharmaceutical Company Limited	Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd)	This study was financially supported by Takeda Pharmaceutical Company Limited. The authors as employees of Takeda played their roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WT, 2005, J AM COLL CARDIOL, V46, P57, DOI 10.1016/j.jacc.2005.03.051; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Byrne MJ, 2008, GENE THER, V15, P1550, DOI 10.1038/gt.2008.120; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cho GW, 2016, BBA-MOL BASIS DIS, V1862, P763, DOI 10.1016/j.bbadis.2016.01.011; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; del Monte F, 1999, CIRCULATION, V100, P2308, DOI 10.1161/01.CIR.100.23.2308; del Monte F, 2002, CIRCULATION, V105, P904, DOI 10.1161/hc0802.105564; del Monte F, 2001, CIRCULATION, V104, P1424, DOI 10.1161/hc3601.095574; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Engelhardt S, 2004, CIRCULATION, V109, P1154, DOI 10.1161/01.CIR.0000117254.68497.39; Gheorghiade M, 2009, J AM COLL CARDIOL, V53, P557, DOI 10.1016/j.jacc.2008.10.041; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Gorski PA, 2015, CELL METAB, V21, P183, DOI 10.1016/j.cmet.2015.01.005; GWATHMEY JK, 1985, CIRC RES, V57, P836, DOI 10.1161/01.RES.57.6.836; GWATHMEY JK, 1987, CIRC RES, V61, P70, DOI 10.1161/01.RES.61.1.70; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; Harding VB, 2001, P NATL ACAD SCI USA, V98, P5809, DOI 10.1073/pnas.091102398; Jones LR, 1998, J CLIN INVEST, V101, P1385, DOI 10.1172/JCI1362; Kaye DM, 2007, J AM COLL CARDIOL, V50, P253, DOI 10.1016/j.jacc.2007.03.047; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; LECHAT P, 1994, CIRCULATION, V90, P1765, DOI 10.1161/01.CIR.90.4.1765; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; LUO WS, 1994, CIRC RES, V75, P401, DOI 10.1161/01.RES.75.3.401; Lyon AR, 2011, CIRC-ARRHYTHMIA ELEC, V4, P362, DOI 10.1161/CIRCEP.110.961615; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marks AR, 2013, J CLIN INVEST, V123, P46, DOI 10.1172/JCI62834; McMullen JR, 2003, P NATL ACAD SCI USA, V100, P12355, DOI 10.1073/pnas.1934654100; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Moore JD, 2015, DRUG DISCOV TODAY, V20, P450, DOI 10.1016/j.drudis.2014.12.016; O'Connor CM, 1999, AM HEART J, V138, P78, DOI 10.1016/S0002-8703(99)70250-4; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Pogwizd SM, 2002, J CARDIOVASC ELECTR, V13, P88, DOI 10.1046/j.1540-8167.2002.00088.x; Sakata S, 2006, MOL THER, V13, P987, DOI 10.1016/j.ymthe.2006.01.002; Sato Y, 2001, J BIOL CHEM, V276, P9392, DOI 10.1074/jbc.M006889200; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Suzuki M, 2002, CIRCULATION, V105, P1824, DOI 10.1161/01.CIR.0000014926.32463.89; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Szymanska G, 2000, PFLUG ARCH EUR J PHY, V439, P339, DOI 10.1007/s004240050948; Tham YK, 2015, ARCH TOXICOL, V89, P1401, DOI 10.1007/s00204-015-1477-x; Wheeler FC, 2005, MAMM GENOME, V16, P414, DOI 10.1007/s00335-005-2468-7; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017; Zhao ZZ, 2012, AM J PHYSIOL-HEART C, V302, pH1636, DOI 10.1152/ajpheart.00742.2011; Zhong H, 2015, SCI REP-UK, V5, DOI 10.1038/srep08366	45	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168486	10.1371/journal.pone.0168486	http://dx.doi.org/10.1371/journal.pone.0168486			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992596	Green Published, gold, Green Submitted			2022-12-26	WOS:000392758000054
J	Liao, YH; Tang, JS; Liu, JB; Xie, A; Yang, M; Johnson, M; Wang, XY; Deng, QJ; Chen, HX; Xiang, XJ; Liu, TQ; Chen, XG; Song, M; Hao, W				Liao, Yanhui; Tang, Jinsong; Liu, Jianbin; Xie, An; Yang, Mei; Johnson, Maritza; Wang, Xuyi; Deng, Qijian; Chen, Hongxian; Xiang, Xiaojun; Liu, Tieqiao; Chen, Xiaogang; Song, Ming; Hao, Wei			Decreased Thalamocortical Connectivity in Chronic Ketamine Users	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; NONMEDICAL USE; THALAMUS; ADDICTION; CORTEX; BRAIN; SCHIZOPHRENIA; NEUROBIOLOGY; MATTER	Disintegration in thalamocortical integration suggests its role in the mechanistic 'switch' from recreational to dysregulated drug seeking/addiction. In this study, we aimed to address whether thalamic nuclear groups show altered functional connectivity within the cerebral cortex in chronic ketamine users. One hundred and thirty subjects (41 ketamine users and 89 control subjects) underwent rsfMRI (resting-state functional Magnetic Resonance Imaging). Based on partial correlation functional connectivity analysis we partitioned the thalamus into six nuclear groups that correspond well with human histology. Then, in the area of each nuclear group, the functional connectivity differences between the chronic ketamine user group and normal control group were investigated. We found that the ketamine user group showed significantly less connectivity between the thalamic nuclear groups and the cortical regions-of-interest, including the prefrontal cortex, the motor cortex/supplementary motor area, and the posterior parietal cortex. However, no increased thalamic connectivity was observed for these regions as compared with controls. This study provides the first evidence of abnormal thalamocortical connectivity of resting state brain activity in chronic ketamine users. Further understanding of pathophysiological mechanisms of the thalamus in addiction (ketamine addiction) may facilitate the evaluation of much-needed novel pharmacological agents for improved therapy of this complex disease.	[Liao, Yanhui; Tang, Jinsong; Yang, Mei; Wang, Xuyi; Deng, Qijian; Chen, Hongxian; Xiang, Xiaojun; Liu, Tieqiao; Chen, Xiaogang; Hao, Wei] Cent S Univ, Xiangya Hosp 2, Inst Mental Hlth,Key Lab Psychiat & Mental Hlth H, China Natl Clin Res Ctr Mental Hlth Disorders,Nat, Changsha, Hunan, Peoples R China; [Liao, Yanhui; Tang, Jinsong; Johnson, Maritza] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, 760 Westwood Plaza, Los Angeles, CA 90024 USA; [Liu, Jianbin; Xie, An] Peoples Hosp Hunan Prov, Dept Radiol, Changsha, Hunan, Peoples R China; [Yang, Mei] Hunan Brain Hosp, Dept Addict Med, Changsha, Hunan, Peoples R China; [Yang, Mei] Shenzhen Kangning Hosp, Shenzhen Mental Hlth Ctr, Dept Addict Med, Shenzhen, Peoples R China; [Song, Ming] Chinese Acad Sci, Inst Automat, Brainnetome Ctr, Beijing, Peoples R China; [Song, Ming] Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, Beijing, Peoples R China	Central South University; University of California System; University of California Los Angeles; Chinese Academy of Sciences; Institute of Automation, CAS; Chinese Academy of Sciences; Institute of Automation, CAS	Tang, JS; Hao, W (corresponding author), Cent S Univ, Xiangya Hosp 2, Inst Mental Hlth,Key Lab Psychiat & Mental Hlth H, China Natl Clin Res Ctr Mental Hlth Disorders,Nat, Changsha, Hunan, Peoples R China.; Tang, JS (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, 760 Westwood Plaza, Los Angeles, CA 90024 USA.; Song, M (corresponding author), Chinese Acad Sci, Inst Automat, Brainnetome Ctr, Beijing, Peoples R China.; Song, M (corresponding author), Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, Beijing, Peoples R China.	tangjinsonghn@gmail.com; msong@nlpr.ia.ac.cn; weihaochangsha@gmail.com	liu, tieqiao/GSE-2327-2022		Natural Science Foundation of China [81100996, 81671325, 81101040, 81471380, 81371480, 81371465, 81130020]; Beijing Municipal Science & Technology Commission [Z161100000216152]; Hunan Province '225' training project	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); Hunan Province '225' training project	This work was supported by the Natural Science Foundation of China (Grant No. 81100996 and 81671325 to Y.L., 81101040 and 81471380 to M.S., 81371480 to J.T., 81371465 to T.L., 81130020 to W.H.) and Beijing Municipal Science & Technology Commission (No. Z161100000216152 to M.S.). J.T. was funded by Hunan Province '225' training project for high-level health professionals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balleine BW, 2015, BRAIN RES, V1628, P104, DOI 10.1016/j.brainres.2014.12.023; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Chan KWS, 2013, ADDICT BEHAV, V38, P2128, DOI 10.1016/j.addbeh.2013.01.014; DOMINO EF, 1965, CLIN PHARMACOL THER, V6, P279; Driesen NR, 2013, MOL PSYCHIATR, V18, P1199, DOI 10.1038/mp.2012.194; Gu H, 2010, NEUROIMAGE, V53, P593, DOI 10.1016/j.neuroimage.2010.06.066; Haber S, 2001, NEUROSCIENTIST, V7, P315, DOI 10.1177/107385840100700408; Hoeflich A, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyv040; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Jansen KLR, 2000, J PSYCHOACTIVE DRUGS, V32, P419, DOI 10.1080/02791072.2000.10400244; Jansen KLR, 2001, J PSYCHOACTIVE DRUGS, V33, P151, DOI 10.1080/02791072.2001.10400480; Kelly C, 2011, BIOL PSYCHIAT, V69, P684, DOI 10.1016/j.biopsych.2010.11.022; Li SJ, 2000, MAGNET RESON MED, V43, P45, DOI 10.1002/(SICI)1522-2594(200001)43:1<45::AID-MRM6>3.0.CO;2-0; Liang HJ, 2013, ADDICT BEHAV, V38, P2661, DOI 10.1016/j.addbeh.2013.06.017; Liao YH, 2012, NEUROSCI LETT, V522, P36, DOI 10.1016/j.neulet.2012.06.009; Liao YH, 2011, BIOL PSYCHIAT, V69, P42, DOI 10.1016/j.biopsych.2010.08.030; Liao YH, 2010, BRAIN, V133, P2115, DOI 10.1093/brain/awq131; Liu JX, 2009, NEUROSCI LETT, V460, P72, DOI 10.1016/j.neulet.2009.05.038; Ma N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016560; Ma N, 2010, NEUROIMAGE, V49, P738, DOI 10.1016/j.neuroimage.2009.08.037; Morgan CJA, 2006, PSYCHOPHARMACOLOGY, V188, P408, DOI 10.1007/s00213-006-0572-3; Morgan CJA, 2012, ADDICTION, V107, P27, DOI 10.1111/j.1360-0443.2011.03576.x; Mottola C A, 1993, Decubitus, V6, P56; Pal R, 2013, DRUG ALCOHOL DEPEN, V132, P189, DOI 10.1016/j.drugalcdep.2013.02.005; Scheidegger M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044799; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Sherman SM, 2002, PHILOS T R SOC B, V357, P1695, DOI 10.1098/rstb.2002.1161; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Sutherland MT, 2012, NEUROIMAGE, V62, P2281, DOI 10.1016/j.neuroimage.2012.01.117; Tang WK, 2015, SUBST ABUS, V36, P67, DOI 10.1080/08897077.2014.935560; Tsai GC, 2002, ANNU REV PHARMACOL, V42, P165, DOI 10.1146/annurev.pharmtox.42.082701.160735; Urbano FJ, 2009, BIOL PSYCHIAT, V66, P769, DOI 10.1016/j.biopsych.2009.04.026; Vollenweider FX, 2010, NAT REV NEUROSCI, V11, P642, DOI 10.1038/nrn2884; Weiss F, 2005, CURR OPIN PHARMACOL, V5, P9, DOI 10.1016/j.coph.2004.11.001; Welsh RC, 2010, SCHIZOPHRENIA BULL, V36, P713, DOI 10.1093/schbul/sbn145; Woodward ND, 2012, AM J PSYCHIAT, V169, P1092, DOI 10.1176/appi.ajp.2012.12010056; Yue WH, 2011, NAT GENET, V43, P1228, DOI 10.1038/ng.979; Zhang DY, 2008, J NEUROPHYSIOL, V100, P1740, DOI 10.1152/jn.90463.2008; Zhang DY, 2010, CEREB CORTEX, V20, P1187, DOI 10.1093/cercor/bhp182; Zhang S, 2014, NEUROIMAGE-CLIN, V4, P585, DOI 10.1016/j.nicl.2014.01.015	40	19	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0167381	10.1371/journal.pone.0167381	http://dx.doi.org/10.1371/journal.pone.0167381			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977717	gold, Green Published, Green Submitted			2022-12-26	WOS:000391217400018
J	Shamsudhin, N; Laeubli, N; Atakan, HB; Vogler, H; Hu, CZ; Haeberle, W; Sebastian, A; Grossniklaus, U; Nelson, BJ				Shamsudhin, Naveen; Laeubli, Nino; Atakan, Huseyin Baris; Vogler, Hannes; Hu, Chengzhi; Haeberle, Walter; Sebastian, Abu; Grossniklaus, Ueli; Nelson, Bradley J.			Massively Parallelized Pollen Tube Guidance and Mechanical Measurements on a Lab-on-a-Chip Platform	PLOS ONE			English	Article							CELL-WALL; CYTOMECHANICAL PROPERTIES; SPERM DELIVERY; PLANT-CELLS; GROWTH; ARABIDOPSIS; TRANSCRIPTOME; INCOMPATIBILITY; QUANTIFICATION; GERMINATION	Pollen tubes are used as a model in the study of plant morphogenesis, cellular differentiation, cell wall biochemistry, biomechanics, and intra-and intercellular signaling. For a "systems- understanding" of the bio-chemo-mechanics of tip-polarized growth in pollen tubes, the need for a versatile, experimental assay platform for quantitative data collection and analysis is critical. We introduce a Lab-on-a-Chip (LoC) concept for high-throughput pollen germination and pollen tube guidance for parallelized optical and mechanical measurements. The LoC localizes a large number of growing pollen tubes on a single plane of focus with unidirectional tip-growth, enabling high-resolution quantitative microscopy. This species- independent LoC platform can be integrated with micro-/nano-indentation systems, such as the cellular force microscope (CFM) or the atomic force microscope (AFM), allowing for rapid measurements of cell wall stiffness of growing tubes. As a demonstrative example, we show the growth and directional guidance of hundreds of lily (Lilium longiflorum) and Arabidopsis (Arabidopsis thaliana) pollen tubes on a single LoC microscopy slide. Combining the LoC with the CFM, we characterized the cell wall stiffness of lily pollen tubes. Using the stiffness statistics and finite-element-method (FEM)-based approaches, we computed an effective range of the linear elastic moduli of the cell wall spanning the variability space of physiological parameters including internal turgor, cell wall thickness, and tube diameter. We propose the LoC device as a versatile and high-throughput phenomics platform for plant reproductive and development biology using the pollen tube as a model.	[Shamsudhin, Naveen; Laeubli, Nino; Atakan, Huseyin Baris; Hu, Chengzhi; Nelson, Bradley J.] ETH, Multiscale Robot Lab, Zurich, Switzerland; [Vogler, Hannes; Grossniklaus, Ueli] Univ Zurich, Dept Plant & Microbial Biol, Zurich, Switzerland; [Vogler, Hannes; Grossniklaus, Ueli] Zurich Basel Plant Sci Ctr, Zurich, Switzerland; [Haeberle, Walter; Sebastian, Abu] IBM Res Zurich, Ruschlikon, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; International Business Machines (IBM)	Hu, CZ; Nelson, BJ (corresponding author), ETH, Multiscale Robot Lab, Zurich, Switzerland.; Grossniklaus, U (corresponding author), Univ Zurich, Dept Plant & Microbial Biol, Zurich, Switzerland.; Grossniklaus, U (corresponding author), Zurich Basel Plant Sci Ctr, Zurich, Switzerland.	huc@ethz.ch; grossnik@botinst.uzh.ch; bnelson@ethz.ch	Grossniklaus, Ueli/E-9995-2016; vogler, hannes/K-8487-2012; Hu, Chengzhi/H-6903-2018; Nelson, Bradley/B-7761-2013; Läubli, Nino F./ABE-8136-2020; Sebastian, Abu/C-1652-2009	Grossniklaus, Ueli/0000-0002-0522-8974; vogler, hannes/0000-0002-6552-4708; Hu, Chengzhi/0000-0002-8627-2335; Nelson, Bradley/0000-0001-9070-6987; Läubli, Nino F./0000-0003-2894-2385; Sebastian, Abu/0000-0001-5603-5243	Research and Technology Development project MecanX by SystemsX.ch, the Swiss Initiative in Systems Biology; IBM Research - Zurich	Research and Technology Development project MecanX by SystemsX.ch, the Swiss Initiative in Systems Biology; IBM Research - Zurich	The authors acknowledge the financial support through the Research and Technology Development project MecanX, funded by SystemsX.ch, the Swiss Initiative in Systems Biology (www.systemsx.ch). IBM Research - Zurich provided support in the form of salaries for authors A.S. and W.H., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agudelo CG, 2013, PLANT J, V73, P1057, DOI 10.1111/tpj.12093; Altartouri B, 2014, CURRENT OPINION PL C, V23C, P76; Arata H, 2014, BIOCHEM SOC T, V42, P320, DOI 10.1042/BST20130258; BEDINGER P, 1992, PLANT CELL, V4, P879, DOI 10.1105/tpc.4.8.879; Benkert R, 1997, PROTOPLASMA, V198, P1, DOI 10.1007/BF01282125; Beyeler F, 2007, J MICROELECTROMECH S, V16, P7, DOI 10.1109/JMEMS.2006.885853; Beyeler F, 2009, J MICROELECTROMECH S, V18, P433, DOI 10.1109/JMEMS.2009.2013387; Bhargav SDB, 2015, MECH MACH THEORY, V91, P258, DOI 10.1016/j.mechmachtheory.2015.04.002; Boavida LC, 2007, PLANT J, V52, P570, DOI 10.1111/j.1365-313X.2007.03248.x; Boyer JS, 2009, FUNCT PLANT BIOL, V36, P383, DOI 10.1071/FP09048; Burri JT, 2016, DUAL AXIS CELL UNPUB; Busch W, 2012, NAT METHODS, V9, P1101, DOI [10.1038/NMETH.2185, 10.1038/nmeth.2185]; Chebli Y, 2012, PLANT PHYSIOL, V160, P1940, DOI 10.1104/pp.112.199729; Cheung AY, 2013, MOL PLANT, V6, P995, DOI 10.1093/mp/sst108; Cooper JR, 2009, PROC IEEE MICR ELECT, P208, DOI 10.1109/MEMSYS.2009.4805355; Cosgrove DJ, 1997, P NATL ACAD SCI USA, V94, P5504, DOI 10.1073/pnas.94.11.5504; Dresselhaus T, 2011, ANN BOT-LONDON, V108, P727, DOI 10.1093/aob/mcr017; Esch EW, 2015, NAT REV DRUG DISCOV, V14, P248, DOI 10.1038/nrd4539; Fayant P, 2010, PLANT CELL, V22, P2579, DOI 10.1105/tpc.110.075754; Feijo JA, 2004, CURR OPIN PLANT BIOL, V7, P589, DOI 10.1016/j.pbi.2004.07.014; Felekis D, 2011, MICRO NANO LETT, V6, P311, DOI 10.1049/mnl.2011.0024; Felekis D, 2015, INT J ROBOT RES, P1; Geitmann A, 2004, SEX PLANT REPROD, V17, P9, DOI 10.1007/s00497-004-0210-3; Geitmann A, 2004, BIOPHYS J, V86, P3314, DOI 10.1016/S0006-3495(04)74379-9; Grobei MA, 2009, GENOME RES, V19, P1786, DOI 10.1101/gr.089060.108; Haduch-Sendecka A, 2014, PLANTA, V240, P263, DOI 10.1007/s00425-014-2083-5; Hepler PK, 2006, PLANT CELL MONOGR, V3, P47, DOI 10.1007/7089_043; Honys D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r85; Horade M, 2014, MICROELECTRON ENG, V118, P25, DOI 10.1016/j.mee.2014.01.017; Jiang HW, 2014, LAB CHIP, V14, P1281, DOI 10.1039/c3lc51326b; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lang V, 2015, PLANT MOL BIOL, V87, P69, DOI 10.1007/s11103-014-0261-2; Lew RR, 2011, NAT REV MICROBIOL, V9, P509, DOI 10.1038/nrmicro2591; Loraine AE, 2013, PLANT PHYSIOL, V162, P1092, DOI 10.1104/pp.112.211441; Lord E, 2000, TRENDS PLANT SCI, V5, P368, DOI 10.1016/S1360-1385(00)01744-1; Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509; Malho R, 2000, ANN BOT-LONDON, V85, P59, DOI 10.1006/anbo.1999.0991; Meister A, 2009, NANO LETT, V9, P2501, DOI 10.1021/nl901384x; MONEY NP, 1993, PLANTA, V190, P426; Nezhad AS, 2013, P NATL ACAD SCI USA, V110, P8093, DOI 10.1073/pnas.1221677110; Nezhad AS, 2013, LAB CHIP, V13, P2599, DOI [10.1039/c3lc00012e, 10.1039/c31c00012e]; Parre E, 2005, PLANTA, V220, P582, DOI 10.1007/s00425-004-1368-5; Parton RM, 2003, J CELL SCI, V116, P2707, DOI 10.1242/jcs.00468; Pina C, 2005, PLANT PHYSIOL, V138, P744, DOI 10.1104/pp.104.057935; Prado AM, 2004, DEVELOPMENT, V131, P2707, DOI 10.1242/dev.01153; Raman A, 2011, NAT NANOTECHNOL, V6, P809, DOI [10.1038/nnano.2011.186, 10.1038/NNANO.2011.186]; Rato C, 2004, PLANT J, V38, P887, DOI 10.1111/j.1365-313X.2004.02091.x; ROSEN WG, 1964, AM J BOT, V51, P61, DOI 10.2307/2440065; Rounds CM, 2010, PLANT PHYSIOL, V152, P736, DOI 10.1104/pp.109.150896; Routier-Kierzkowska AL, 2013, CURR OPIN PLANT BIOL, V16, P25, DOI 10.1016/j.pbi.2012.11.002; Routier-Kierzkowska AL, 2012, PLANT PHYSIOL, V158, P1514, DOI 10.1104/pp.111.191460; Smith AE, 2000, P NATL ACAD SCI USA, V97, P9871, DOI 10.1073/pnas.97.18.9871; Sun Y, 2002, INT J ROBOT RES, V21, P861, DOI 10.1177/0278364902021010833; Takayama S, 2001, NATURE, V411, P1016, DOI 10.1038/35082637; Vogler F, 2014, PLANT REPROD, V27, P153, DOI 10.1007/s00497-014-0247-x; Vogler H, 2013, PLANT J, V73, P617, DOI 10.1111/tpj.12061; Weber A, 2015, J EXP BOT, V66, P3229, DOI 10.1093/jxb/erv135; Wilsen KL, 2007, BIOSCIENCE, V57, P835, DOI 10.1641/b571006; Yakubov GE, 2016, J EXP BOT, V67, P2799, DOI 10.1093/jxb/erw117; Yetisen AK, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/5/054018; Zerzour R, 2009, DEV BIOL, V334, P437, DOI 10.1016/j.ydbio.2009.07.044; Zhang T, 2016, PLANT J, V85, P179, DOI 10.1111/tpj.13102; Zhao LM, 2005, BIOTECHNOL PROGR, V21, P292, DOI 10.1021/bp0497233	63	26	26	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168138	10.1371/journal.pone.0168138	http://dx.doi.org/10.1371/journal.pone.0168138			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977748	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000391217400067
J	Ran, YC; Thibodeau, PH				Ran, Yanchao; Thibodeau, Patrick H.			Stabilization of Nucleotide Binding Domain Dimers Rescues ABCC6 Mutants Associated with Pseudoxanthoma Elasticum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; biosynthesis; calcification; protein stability; protein structure; abcc6; pseudoxanthoma elasticum	TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS MUTATION; INTRACELLULAR TRAFFICKING; ECTOPIC MINERALIZATION; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; P-GLYCOPROTEIN; IN-VIVO; CFTR; TRANSPORTER	ABC transporters are polytopic membrane proteins that utilize ATP binding and hydrolysis to facilitate transport across biological membranes. Forty-eight human ABC transporters have been identified in the genome, and the majority of these are linked to heritable disease. Mutations in the ABCC6 (ATP binding cassette transporter C6) ABC transporter are associated with pseudoxanthoma elasticum, a disease of altered elastic properties in multiple tissues. Although similar to 200 mutations have been identified in pseudoxanthoma elasticum patients, the underlying structural defects associated with the majority of these are poorly understood. To evaluate the structural consequences of these missense mutations, a combination of biophysical and cell biological approaches were applied to evaluate the local and global folding and assembly of the ABCC6 protein. Structural and bioinformatic analyses suggested that a cluster of mutations, representing roughly 20% of the patient population with identified missense mutations, are located in the interface between the transmembrane domain and the C-terminal nucleotide binding domain. Biochemical and cell biological analyses demonstrate these mutations influence multiple steps in the biosynthetic pathway, minimally altering local domain structure but adversely impacting ABCC6 assembly and trafficking. The differential impacts on local and global protein structure are consistent with hierarchical folding and assembly of ABCC6. Stabilization of specific domain-domain interactions via targeted amino acid substitution in the catalytic site of the C-terminal nucleotide binding domain restored proper protein trafficking and cell surface localization of multiple biosynthetic mutants. This rescue provides a specific mechanism by which chemical chaperones could be developed for the correction of ABCC6 biosynthetic defects.	[Ran, Yanchao; Thibodeau, Patrick H.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, 450 Technol Dr,517 Bridgeside Point 2, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Thibodeau, PH (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, 450 Technol Dr,517 Bridgeside Point 2, Pittsburgh, PA 15219 USA.	thibodea@pitt.edu			NIDDK; National Institutes of Health Grant [DK083284]; Cystic Fibrosis Foundation Therapeutics Grant [THIBOD13XX0]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083284, R56DK083284] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation Therapeutics Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by NIDDK, National Institutes of Health Grant DK083284 (to P. H. T.). This work was also supported by Cystic Fibrosis Foundation Therapeutics Grant THIBOD13XX0 (to P. H. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aleksandrov LA, 2015, PROTEIN EXPRES PURIF, V116, P159, DOI 10.1016/j.pep.2015.09.018; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Babenko AP, 2003, J BIOL CHEM, V278, P41577, DOI 10.1074/jbc.C300363200; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bompadre SG, 2008, J BIOL CHEM, V283, P5364, DOI 10.1074/jbc.M709417200; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Cai J, 2002, BIOCHEMISTRY-US, V41, P8058, DOI 10.1021/bi012082p; Chan KM, 2000, J GEN PHYSIOL, V116, P163, DOI 10.1085/jgp.116.2.163; Chaptal V., 2014, BIOCHEM PHARMACOL, V3, P150; Csanady L, 2000, J GEN PHYSIOL, V116, P477, DOI 10.1085/jgp.116.3.477; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; deCarvalho ACV, 2002, J BIOL CHEM, V277, P35896, DOI 10.1074/jbc.M205644200; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Farinha CM, 2013, FEBS J, V280, P4396, DOI 10.1111/febs.12392; Fulop K, 2009, BIOCHEM BIOPH RES CO, V379, P706, DOI 10.1016/j.bbrc.2008.12.142; Gong QM, 2005, J BIOL CHEM, V280, P19419, DOI 10.1074/jbc.M502327200; GOODMAN RM, 1963, MEDICINE, V42, P297, DOI 10.1097/00005792-196309000-00001; Gorgels TGMF, 2005, HUM MOL GENET, V14, P1763, DOI 10.1093/hmg/ddi183; Gyimesi G, 2012, HUM MUTAT, V33, P1547, DOI 10.1002/humu.22138; He LH, 2010, FASEB J, V24, P3103, DOI 10.1096/fj.09-141788; Hirai M, 2011, BLOOD, V117, P500, DOI 10.1182/blood-2010-05-284737; Hosen MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102779; Ilias A, 2002, J BIOL CHEM, V277, P16860, DOI 10.1074/jbc.M110918200; Jansen RS, 2014, ARTERIOSCL THROM VAS, V34, P1985, DOI 10.1161/ATVBAHA.114.304017; Jansen RS, 2013, P NATL ACAD SCI USA, V110, P20206, DOI 10.1073/pnas.1319582110; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Jiang QJ, 2009, J INVEST DERMATOL, V129, P348, DOI 10.1038/jid.2008.212; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Klement JF, 2005, MOL CELL BIOL, V25, P8299, DOI 10.1128/MCB.25.18.8299-8310.2005; Le Saux O, 2000, NAT GENET, V25, P223, DOI 10.1038/76102; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Marconi B, 2015, INTRACTABLE RARE DIS, V4, P113, DOI 10.5582/irdr.2015.01014; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Perlmutter DH, 2002, PEDIATR RES, V52, P832, DOI 10.1203/01.PDR.0000036878.28942.14; Pissarra LS, 2008, CHEM BIOL, V15, P62, DOI 10.1016/j.chembiol.2007.11.012; Plomp AS, 2008, MOL VIS, V14, P118; Pollet JF, 2000, BBA-MOL BASIS DIS, V1500, P59, DOI 10.1016/S0925-4439(99)00088-5; Pomozi V, 2014, J INVEST DERMATOL, V134, P946, DOI 10.1038/jid.2013.482; Pratt EB, 2011, J GEN PHYSIOL, V137, P299, DOI 10.1085/jgp.201010557; Protasevich I, 2010, PROTEIN SCI, V19, P1917, DOI 10.1002/pro.479; Ramachandran S, 2011, PROTEINS, V79, P261, DOI 10.1002/prot.22879; Rubenstein RC, 2000, AM J PHYSIOL-CELL PH, V278, pC259, DOI 10.1152/ajpcell.2000.278.2.C259; Shintre CA, 2013, P NATL ACAD SCI USA, V110, P9710, DOI 10.1073/pnas.1217042110; Slot AJ, 2011, ESSAYS BIOCHEM, V50, P179, DOI [10.1042/BSE0500179, 10.1042/bse0500179]; Thibodeau PH, 2010, J BIOL CHEM, V285, P35825, DOI 10.1074/jbc.M110.131623; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; Tombline G, 2004, J BIOL CHEM, V279, P46518, DOI 10.1074/jbc.M408052200; Uitto J, 2014, EXPERT OPIN ORPHAN D, V2, P567, DOI 10.1517/21678707.2014.908702; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wigley WC, 2001, NAT BIOTECHNOL, V19, P131, DOI 10.1038/84389; Xue P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097360; YANG YP, 1993, HUM MOL GENET, V2, P1253, DOI 10.1093/hmg/2.8.1253; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657	59	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1559	1572		10.1074/jbc.M116.759811	http://dx.doi.org/10.1074/jbc.M116.759811			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27994049	Green Published, hybrid			2022-12-26	WOS:000395515600003
J	Chiha, J; Mitchell, P; Gopinath, B; Burlutsky, G; Plant, A; Kovoor, P; Thiagalingam, A				Chiha, Joseph; Mitchell, Paul; Gopinath, Bamini; Burlutsky, George; Plant, Adam; Kovoor, Pramesh; Thiagalingam, Aravinda			Prediction of Coronary Artery Disease Extent and Severity Using Pulse Wave Velocity	PLOS ONE			English	Article							EXPERT CONSENSUS DOCUMENT; ANGIOGRAPHIC ANALYSIS; MYOCARDIAL-INFARCTION; SYNDROME-X; STIFFNESS; WOMEN; HEART; ANGINA; MEN; ATHEROSCLEROSIS	Background Pulse-wave velocity (PWV) measures aortic stiffness. It is an independent predictor of cardiovascular events and mortality, yet there is paucity in the literature on its association with the severity and extent of coronary artery disease (CAD). Methods To examine the utility of PWV in predicting CAD burden in men and women the PWV was determined in 344 patients (Men = 266, Women = 78) presenting for invasive coronary angiography for the assessment of suspected CAD. Pearson correlations and multivariate analysis were used to evaluate the relationship between these coronary scores, PWV and traditional cardiovascular risk factors. Results Compared to men, women with chest pain had lower mean Extent scores (19.2 vs. 35.6; p = 0.0001) and Gensini scores (23.6 vs. 41.9; p = 0.0001). PWV was similar between men and women (12.35 +/- 3.74 vs. 12.43 +/- 4.58; p = 0.88) and correlated with Extent score (r = 0.21, p = 0.0001) but not Gensini or vessel score (r = 0.03, p = 0.64 and r = 0.06, p = 0.26, respectively). PWV was associated with Extent score in men (B = 2.25 +/- 0.78, p = 0.004 for men and B = 1.50 +/- 0.88, p = 0.09 for women). It was not a predictor of Gensini score (B = -0.10, P = 0.90). Conclusion PWV correlates with the extent of CAD, as measured by the 'Extent' score in men more than women. However, it does not correlate with the severity of obstructive CAD in either gender.	[Chiha, Joseph; Kovoor, Pramesh; Thiagalingam, Aravinda] Univ Sydney, Westmead Millennium Inst, Ctr Heart Res, Sydney, NSW, Australia; [Mitchell, Paul; Gopinath, Bamini; Burlutsky, George; Plant, Adam] Univ Sydney, Westmead Millennium Inst, Dept Ophthalmol, Ctr Vis Res, Sydney, NSW, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney; Westmead Institute for Medical Research	Chiha, J (corresponding author), Univ Sydney, Westmead Millennium Inst, Ctr Heart Res, Sydney, NSW, Australia.	chiha.j@gmail.com	Gopinath, Bamini/K-4286-2019; Stefanadis, Christodoulos/ABH-2232-2020; Mitchell, Paul/P-1498-2014	Gopinath, Bamini/0000-0003-3573-359X; Stefanadis, Christodoulos/0000-0001-5974-6454; 	Australian National Health and Medical Research Council [571012]; Westmead Millennium Institute, University of Sydney	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Westmead Millennium Institute, University of Sydney(University of Sydney)	Funding was provided by the Australian National Health and Medical Research Council (Grant No. 571012); and the Westmead Millennium Institute, University of Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhayaratna WP, 2006, AM J CARDIOL, V98, P1387, DOI 10.1016/j.amjcard.2006.06.035; Ben-Shlomo Y, 2014, J AM COLL CARDIOL, V63, P636, DOI 10.1016/j.jacc.2013.09.063; Bigi R, 2003, HEART, V89, P1009, DOI 10.1136/heart.89.9.1009; Bugiardini R, 2005, JAMA-J AM MED ASSOC, V293, P477, DOI 10.1001/jama.293.4.477; Coutinho T, 2011, JACC-CARDIOVASC IMAG, V4, P754, DOI 10.1016/j.jcmg.2011.04.011; DUCIMETIERE P, 1993, EUR HEART J, V14, P727, DOI 10.1093/eurheartj/14.6.727; Enbergs A, 2000, EUR HEART J, V21, P45, DOI 10.1053/euhj.1999.1763; Gehrie ER, 2009, AM HEART J, V158, P688, DOI 10.1016/j.ahj.2009.08.004; GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-2; HACKETT D, 1988, EUR HEART J, V9, P1317, DOI 10.1093/oxfordjournals.eurheartj.a062449; HERMILLER JB, 1992, CATHETER CARDIO DIAG, V25, P110, DOI 10.1002/ccd.1810250207; Hope SA, 2007, J HYPERTENS, V25, P2105, DOI 10.1097/HJH.0b013e3282a9be41; Jespersen L, 2012, EUR HEART J, V33, P734, DOI 10.1093/eurheartj/ehr331; Jones E, 2012, TRENDS CARDIOVAS MED, V22, P161, DOI 10.1016/j.tcm.2012.07.014; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; KEMP HG, 1986, J AM COLL CARDIOL, V7, P479, DOI 10.1016/S0735-1097(86)80456-9; Kreis AJ, 2009, MICROCIRCULATION, V16, P177, DOI 10.1080/10739680802458980; Kullo IJ, 2006, HYPERTENSION, V47, P174, DOI 10.1161/01.HYP.0000199605.35173.14; Lamendola P, 2010, INT J CARDIOL, V140, P197, DOI 10.1016/j.ijcard.2008.11.026; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Mattace-Raso FUS, 2010, EUR HEART J, V31, P2338, DOI 10.1093/eurheartj/ehq165; McLeod AL, 2004, J HYPERTENS, V22, P363, DOI 10.1097/00004872-200402000-00021; Merz CNB, 2011, CIRCULATION, V124, P1477, DOI 10.1161/CIRCULATIONAHA.110.974212; Neeland IJ, 2012, AM HEART J, V164, P547, DOI 10.1016/j.ahj.2012.07.007; Norgaz T, 2005, INT HEART J, V46, P639, DOI 10.1536/ihj.46.639; ORourke MF, 1996, J HYPERTENS, V14, pS147; Patel Manesh R, 2010, N Engl J Med, V362, P886, DOI 10.1056/NEJMoa0907272; Pepine CJ, 2010, J AM COLL CARDIOL, V55, P2825, DOI 10.1016/j.jacc.2010.01.054; QIAO JH, 1991, J AM COLL CARDIOL, V17, P1138, DOI 10.1016/0735-1097(91)90844-Y; RUMBERGER JA, 1994, AM J CARDIOL, V73, P1169, DOI 10.1016/0002-9149(94)90176-7; Sharaf BL, 2001, AM J CARDIOL, V87, P937, DOI 10.1016/S0002-9149(01)01424-2; SULLIVAN DR, 1990, AM HEART J, V119, P1262, DOI 10.1016/S0002-8703(05)80173-5; Van Bortel LM, 2012, J HYPERTENS, V30, P445, DOI 10.1097/HJH.0b013e32834fa8b0; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Weber T, 2003, CURR PHARM DESIGN, V9, P1049, DOI 10.2174/1381612033455080; Weintraub WS, 2011, J AM COLL CARDIOL, V58, P202, DOI 10.1016/j.jacc.2011.05.001	37	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168598	10.1371/journal.pone.0168598	http://dx.doi.org/10.1371/journal.pone.0168598			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005967	Green Submitted, Green Published, gold			2022-12-26	WOS:000392843200070
J	Kaliszewski, K; Strutynska-Karpinska, M; Zubkiewicz-Kucharska, A; Wojtczak, B; Domoslawski, P; Balcerzak, W; Lukienczuk, T; Forkasiewicz, Z				Kaliszewski, Krzysztof; Strutynska-Karpinska, Marta; Zubkiewicz-Kucharska, Agnieszka; Wojtczak, Beata; Domoslawski, Pawel; Balcerzak, Waldemar; Lukienczuk, Tadeusz; Forkasiewicz, Zdzislaw			Should the Prevalence of Incidental Thyroid Cancer Determine the Extent of Surgery in Multinodular Goiter?	PLOS ONE			English	Article							COMPLETION THYROIDECTOMY; SUBTOTAL THYROIDECTOMY; SURGICAL-MANAGEMENT; PROGNOSTIC-FACTORS; NONTOXIC GOITER; NODULAR GOITER; CARCINOMA; DISEASE; COMPLICATIONS; MALIGNANCY	Background The most appropriate surgical procedure for multinodular goiter (MNG) remains under debate. Incidental thyroid carcinoma (ITC) is often identified on histopathological examination after thyroidectomy performed for presumed benign MNG. Aim of the study The aim of the study was to determine the value of radical surgery for MNG patients considering the prevalence of ITC diagnosed postoperatively. Materials and Methods We conducted retrospective analysis of the medical records of 2,306 patients surgically treated for MNG between 2008 and 2013 at one center. None of the patients presented with any suspicion of malignancy, history of familial thyroid cancer, multiple endocrine neoplasia syndrome or previous head or neck radiation exposure. Results Among the 2,306 MNG patients, ITC was detected in 49 (2.12%) (44 women and 5 men, with average ages of 52.2 (21-79) and 55.6 (52-62), respectively). Papillary thyroid carcinoma was significantly more frequently observed than other types of ITC (p<0.00001). Among the MNG patients, 866 (37.5%) underwent total/near total surgery, 464 (20.1%) received subtotal thyroidectomy, and 701 (30.3%) received the Dunhill operation. The remaining 275 (11.9%) patients underwent a less radical procedure and were classified as "others." Among the 49 (100%) patients with ITC, 28 (57.1%) underwent radical surgery. Another 21 (42.9%) patients required completion surgery due to an insufficient primary surgical procedure. A total of 21 (2.42%) patients in the total/near total surgery group were diagnosed with ITC, as well as 16 (2.48%) in the subtotal thyroidectomy group and 12 (1.71%) in the Dunhill operation group; 21 (100%), 4 (25%) and 3 (25%) of these patients, respectively, underwent radical surgery; thus, 0 (0%), 12 (75%) and 9 (75%) required completion surgery. The prevalence rates of ITC were comparable between the radical and subtotal surgery groups (2.42% and 3.44%, respectively, p = 0.4046), and the prevalence was higher in the radical surgery group than in the Dunhill operation group (2.42% and 1.71%, respectively, p = 0.0873). A significant difference was observed between the group of patients who underwent total/near total surgery, among whom all of the patients with ITC (100%) received primary radical surgery, and the groups of patients who received the subtotal and Dunhill operations, among whom only 25% of the patients with ITC in each group received primary radical surgery (p<0.0001). Conclusions More radical procedures for MNG result in a lower risk of reoperation for ITC. The prevalence of ITC on postoperative histopathological examination should determine the extent of surgery in MNG patients. In the future, total/near total thyroidectomy should be considered for MNG patients due to the increased prevalence of ITC to avoid the necessity for reoperation.	[Kaliszewski, Krzysztof; Strutynska-Karpinska, Marta; Wojtczak, Beata; Domoslawski, Pawel; Balcerzak, Waldemar; Lukienczuk, Tadeusz; Forkasiewicz, Zdzislaw] Wroclaw Med Univ, Dept & Clin Gen Gastroenterol & Endocrine Surg 1, Wroclaw, Poland; [Zubkiewicz-Kucharska, Agnieszka] Wroclaw Med Univ, Dept Endocrinol & Diabetol Children & Adolescents, Wroclaw, Poland	Wroclaw Medical University; Wroclaw Medical University	Kaliszewski, K (corresponding author), Wroclaw Med Univ, Dept & Clin Gen Gastroenterol & Endocrine Surg 1, Wroclaw, Poland.	krzysztofkali@wp.pl	Zubkiewicz-Kucharska, Agnieszka/AAY-5957-2020	Zubkiewicz-Kucharska, Agnieszka/0000-0002-6641-6776; Domoslawski, Pawel/0000-0003-1903-0843; Kaliszewski, Krzysztof/0000-0002-3291-5294; Wojtczak, Beata/0000-0002-9953-0460				Bae JS, 2009, WORLD J SURG ONCOL, V7, DOI 10.1186/1477-7819-7-63; Bahl M, 2014, WORLD J SURG, V38, P1312, DOI 10.1007/s00268-013-2407-9; Baloch Z, 2013, J CLIN PATHOL, V66, P733, DOI 10.1136/jclinpath-2013-201626; Barczynski M, 2010, WORLD J SURG, V34, P1203, DOI 10.1007/s00268-010-0491-7; Baudin E, 1998, CANCER, V83, P553, DOI 10.1002/(SICI)1097-0142(19980801)83:3<553::AID-CNCR25>3.0.CO;2-U; Bergamaschi R, 1998, AM J SURG, V176, P71, DOI 10.1016/S0002-9610(98)00099-3; Bombil I, 2014, S AFR J SURG, V52, DOI 10.7196/SAJS.1970; Bononi M, 2000, INT SURG, V85, P190; Bradly DP, 2009, SURGERY, V146, P1099, DOI 10.1016/j.surg.2009.09.025; Brindle R, 2014, EJSO-EUR J SURG ONC, V40, P1528, DOI 10.1016/j.ejso.2014.05.005; CALABRO S, 1988, HEAD NECK-J SCI SPEC, V10, P235, DOI 10.1002/j.1930-2398.1988.tb00005.x; Cerci C, 2007, J POSTGRAD MED, V53, P157, DOI 10.4103/0022-3859.33855; Chao TC, 1997, WORLD J SURG, V21, P644, DOI 10.1007/s002689900287; Chun AR, 2015, ENDOCRINOL METAB, V30, P71, DOI 10.3803/EnM.2015.30.1.71; Ciftci F, 2015, INT J CLIN EXP MED, V8, P4596; Costamagna D, 2013, G CHIR, V34, P21; Delbridge L, 1999, ARCH SURG-CHICAGO, V134, P1389, DOI 10.1001/archsurg.134.12.1389; Ergin AB, 2014, AM J OTOLARYNG, V35, P784, DOI 10.1016/j.amjoto.2014.04.013; Gal Istvan, 2013, Magy Seb, V66, P245, DOI 10.1556/MaSeb.66.2013.5.3; GEERDSEN JP, 1986, ACTA MED SCAND, V220, P341; GEERDSEN JP, 1984, CLIN ENDOCRINOL, V21, P529, DOI 10.1111/j.1365-2265.1984.tb01391.x; Gilbert MR, 2012, OTOLARYNG HEAD NECK, V147, P647, DOI 10.1177/0194599812451559; Giles Y, 2004, ARCH SURG-CHICAGO, V139, P179, DOI 10.1001/archsurg.139.2.179; Gough IR, 2000, WORLD J SURG, V24, P962, DOI 10.1007/s002680010158; GOULD EA, 1965, ARCH SURG-CHICAGO, V90, P81; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; HAY ID, 1993, SURGERY, V114, P1050; Hoang JK, 2015, RADIOL CLIN N AM, V53, P145, DOI 10.1016/j.rcl.2014.09.002; Huang LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127354; John Anulekha Mary, 2014, Indian J Endocrinol Metab, V18, P410, DOI 10.4103/2230-8210.131211; Kang HW, 2004, THYROID, V14, P29, DOI 10.1089/105072504322783812; Karakoyun R, 2013, INT J CLIN EXP MED, V6, P922; KRAIMPS JL, 1993, SURG GYNECOL OBSTET, V176, P319; Lasithiotakis K, 2012, WORLD J SURG, V36, P1286, DOI 10.1007/s00268-012-1554-8; Liu Q, 1998, SURGERY, V123, P2, DOI 10.1067/msy.1998.83301; Lombardi C P, 2007, Minerva Chir, V62, P395; Luo J, 2012, J SURG RES, V174, P207, DOI 10.1016/j.jss.2011.11.1035; Menegaux F, 1999, SURGERY, V126, P479, DOI 10.1016/S0039-6060(99)70088-7; Miccoli P, 2006, ANZ J SURG, V76, P123, DOI 10.1111/j.1445-2197.2006.03667.x; Mishra A, 2001, WORLD J SURG, V25, P307, DOI 10.1007/s002680020100; Nayan S, 2014, OTOLARYNG HEAD NECK, V151, P190, DOI 10.1177/0194599814530861; Nikiforova MN, 2003, J CLIN ENDOCR METAB, V88, P5399, DOI 10.1210/jc.2003-030838; Ozbas S, 2005, ENDOCR J, V52, P199, DOI 10.1507/endocrj.52.199; Pacini F, 2001, THYROID, V11, P877, DOI 10.1089/105072501316973145; Pappalardo G, 1998, EUR J SURG, V164, P501; Pattou F, 1998, WORLD J SURG, V22, P718, DOI 10.1007/s002689900459; Pedrazzini L, 2013, MINERVA ENDOCRINOL, V38, P269; Pezzullo L, 1997, EUR J SURG ONCOL, V23, P215, DOI 10.1016/S0748-7983(97)92340-4; Preece J, 2014, SURGERY, V156, P1153, DOI 10.1016/j.surg.2014.04.025; REEVE TS, 1987, ANN SURG, V206, P782, DOI 10.1097/00000658-198712000-00016; Rios A, 2005, ARCH SURG-CHICAGO, V140, P49, DOI 10.1001/archsurg.140.1.49; ROJDMARK J, 1995, EUR J SURG, V161, P725; Sachmechi I, 2000, Endocr Pract, V6, P5; Sakorafas GH, 2007, J POSTGRAD MED, V53, P23, DOI 10.4103/0022-3859.30323; Sakorafas GH, 2005, CANCER TREAT REV, V31, P423, DOI 10.1016/j.ctrv.2005.04.009; Scheffler P, 2014, THYROID, V24, P852, DOI 10.1089/thy.2013.0191; Senchenkov A, 2004, SURG CLIN N AM, V84, P973, DOI 10.1016/j.suc.2004.04.007; SHAH JP, 1992, AM J SURG, V164, P658, DOI 10.1016/S0002-9610(05)80729-9; SIMONOWITZ D, 1976, ARCH SURG-CHICAGO, V111, P477; Slijepcevic N, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1352-4; Smith JJ, 2013, J AM COLL SURGEONS, V216, P571, DOI 10.1016/j.jamcollsurg.2012.12.022; Tollin SR, 2000, THYROID, V10, P235, DOI 10.1089/thy.2000.10.235; Untch BR, 2014, ANN SURG ONCOL, V21, P1374, DOI 10.1245/s10434-013-3428-1; Wilhelm S, 2014, SURG CLIN N AM, V94, P485, DOI 10.1016/j.suc.2014.02.004; Wilson DB, 1998, AM SURGEON, V64, P674; Yaylali O, 2014, INDIAN J CANCER, V51, P236, DOI 10.4103/0019-509X.146737; Yoshida A, 2014, WORLD J SURG, V38, P2311, DOI 10.1007/s00268-014-2536-9; Zaraca F, 2000, Chir Ital, V52, P41	68	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168654	10.1371/journal.pone.0168654	http://dx.doi.org/10.1371/journal.pone.0168654			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005977	Green Published, gold, Green Submitted			2022-12-26	WOS:000392843200075
J	Yuan, HF; Wang, W; Hu, B; Pan, CK; Chen, ML; Ke, LL; Yang, LR; Chen, JM				Yuan, Huifang; Wang, Wei; Hu, Bin; Pan, Changkun; Chen, Mingliang; Ke, Linlin; Yang, Lirong; Chen, Jianming			Cloning and Functional Analysis of Pax6 from the Hydrothermal Vent Tubeworm Ridgeia piscesae	PLoS One			English	Article							MEXICAN BLIND CAVEFISH; EYE-SPECIFIC ENHANCER; TWIN-OF-EYELESS; FINE-STRUCTURE; SINE-OCULIS; PLATYNEREIS-DUMERILII; LINEAGE SPECIFICATION; ECTOPIC EYES; ADULT EYES; CELL-DEATH	The paired box 6 (Pax6) gene encodes a transcription factor essential for eye development in a wide range of animal lineages. Here we describe the cloning and characterization of Pax6 gene from the blind hydrothermal vent tubeworm Ridgeia piscesae (RpPax6). The deduced RpPax6 protein shares extensive sequence identity with Pax6 proteins from other species and contains both the paired domain and a complete homeodomain. Phylogenetic analysis indicates that it clusters with the corresponding sequence from the closely related species Platynereis dumerilii (P. dumerilii) of Annelida. Luciferase reporter assay indicate that RpPax6 protein suppresses the transcription of sine oculis (so) in D. melanogaster, interfering with the C-terminal of RpPax6. Taking advantage of Drosophila model, we show that RpPax6 expression is not able to rescue small eye phenotype of ey(2) mutant, only to cause a more severe headless phenotype. In addition, RpPax6 expression induced apoptosis and inhibition of apoptosis can partially rescue RpPax6-induced headless phenotype. We provide evidence RpPax6 plays at least two roles: it blocks the expression of later-acting transcription factors in the eye development cascade, and it promotes cell apoptosis. Our results indicate alternation of the Pax6 function may be one of the possible causes that lead the eye absence in vestimentiferan tubeworms.	[Yuan, Huifang; Wang, Wei; Hu, Bin; Pan, Changkun; Chen, Mingliang; Ke, Linlin; Yang, Lirong; Chen, Jianming] State Ocean Adm, Inst Oceanog 3, Key Lab Marine Biogenet Resources, Xiamen, Fujian Province, Peoples R China; [Pan, Changkun] Ningbo Univ, Sch Marine Sci, Ningbo, Zhejiang, Peoples R China	State Oceanic Administration; Ningbo University	Wang, W; Chen, JM (corresponding author), State Ocean Adm, Inst Oceanog 3, Key Lab Marine Biogenet Resources, Xiamen, Fujian Province, Peoples R China.	wangw.sz@tio.org.cn; chenjm@xmu.edu.cn			Scientific Research Foundation of Third Institute of Oceanography (SOA) [2015001]; China Ocean Mineral Resources R & D Association (COMRA) [DY125-22-QY-05, DY-125-15-T-08]; Natural Science Foundation of China [31271567, 31272684]; Fujian Marine Hi-tech Industry Program [2014-05]; Aquatic Sanxin Engineering Project of Jiangsu Province [D2015-11-5]	Scientific Research Foundation of Third Institute of Oceanography (SOA); China Ocean Mineral Resources R & D Association (COMRA); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian Marine Hi-tech Industry Program; Aquatic Sanxin Engineering Project of Jiangsu Province	This work was supported by the Scientific Research Foundation of Third Institute of Oceanography (SOA, grant: 2015001), the China Ocean Mineral Resources R & D Association (COMRA, grants: DY125-22-QY-05 and DY-125-15-T-08), the Natural Science Foundation of China (grants: 31271567 and 31272684), the Fujian Marine Hi-tech Industry Program (grant: 2014-05), and the Aquatic Sanxin Engineering Project of Jiangsu Province (grant: D2015-11-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Arendt D, 2002, DEVELOPMENT, V129, P1143; Bartolomaeus Thomas, 1993, Microfauna Marina, V8, P99; Behrens M, 1997, MOL BIOL EVOL, V14, P299, DOI 10.1093/oxfordjournals.molbev.a025765; Blake JA, 2014, DEVELOPMENT, V141, P737, DOI 10.1242/dev.091785; Bouchard M, 2002, GENE DEV, V16, P2958, DOI 10.1101/gad.240102; BRANDENBURGER JL, 1973, Z ZELLFORSCH MIK ANA, V142, P89, DOI 10.1007/BF00306706; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Callaerts P, 1997, ANNU REV NEUROSCI, V20, P483, DOI 10.1146/annurev.neuro.20.1.483; CARRIERE C, 1995, CELL GROWTH DIFFER, V6, P1531; Caullery M, 1914, CR HEBD ACAD SCI, V158, P2014; Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X; Chow RL, 1999, DEVELOPMENT, V126, P4213; Czerny T, 1999, MOL CELL, V3, P297, DOI 10.1016/S1097-2765(00)80457-8; Dahl E, 1997, BIOESSAYS, V19, P755, DOI 10.1002/bies.950190905; EAKIN RM, 1965, Z ZELLFORSCH MIK ANA, V68, P278, DOI 10.1007/BF00342434; Friedrich M, 2006, ARTHROPOD STRUCT DEV, V35, P357, DOI 10.1016/j.asd.2006.08.010; Gage J. D., 1991, DEEP SEA BIOL NATURA; Gehring WJ, 2005, J HERED, V96, P171, DOI 10.1093/jhered/esi027; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Glardon S, 1997, DEVELOPMENT, V124, P817; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Halder G, 1998, DEVELOPMENT, V125, P2181; Hauck B, 1999, P NATL ACAD SCI USA, V96, P564, DOI 10.1073/pnas.96.2.564; Heanue TA, 1999, GENE DEV, V13, P3231, DOI 10.1101/gad.13.24.3231; HERMANS CO, 1969, Z ZELLFORSCH MIK ANA, V100, P325, DOI 10.1007/BF00571490; HERMANS CO, 1974, Z MORPHOL TIERE, V79, P245; Herring PJ, 2002, BIOL DEEP OCEAN; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Ikeda K, 2002, MOL CELL BIOL, V22, P6759, DOI 10.1128/MCB.22.19.6759-6766.2002; Jacobsson L, 2009, MOL GENET GENOMICS, V282, P217, DOI 10.1007/s00438-009-0458-2; Jeffery WR, 2005, J HERED, V96, P185, DOI 10.1093/jhered/esi028; Jeffery WR, 2003, INTEGR COMP BIOL, V43, P531, DOI 10.1093/icb/43.4.531; Jeffery WR, 1998, AM ZOOL, V38, P685; Jones ML., 1985, P BIOL SOC WASH, V6, P117; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Karim FD, 1998, DEVELOPMENT, V125, P1; KOJIMA S, 1993, J MOL EVOL, V37, P66; Kronhamn J, 2002, DEVELOPMENT, V129, P1015; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lacalli TC, 1996, PHILOS T ROY SOC B, V351, P243, DOI 10.1098/rstb.1996.0022; Land MF, 2002, ANIMAL EYES; Leys SP, 2001, BIOL BULL-US, V201, P323, DOI 10.2307/1543611; Lionakis MS, 2005, J INFECT DIS, V191, P1188, DOI 10.1086/428587; Little CTS, 1997, NATURE, V385, P146, DOI 10.1038/385146a0; Loosli F, 1996, P NATL ACAD SCI USA, V93, P2658, DOI 10.1073/pnas.93.7.2658; Lynch VJ, 2011, J EXP ZOOL PART B, V316B, P93, DOI 10.1002/jez.b.21373; McMullin ER, 2003, SYMBIOSIS, V34, P1; Morante J, 2011, DEVELOPMENT, V138, P687, DOI 10.1242/dev.056069; Niimi T, 1999, DEVELOPMENT, V126, P2253; Nordstrom K, 2003, P ROY SOC B-BIOL SCI, V270, P2349, DOI 10.1098/rspb.2003.2504; Nyholm SV, 2008, BIOL BULL-US, V214, P255, DOI 10.2307/25470667; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Onuma Y, 2002, P NATL ACAD SCI USA, V99, P2020, DOI 10.1073/pnas.022626999; Pauli T, 2005, DEVELOPMENT, V132, P2771, DOI 10.1242/dev.01841; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Punzo C, 2004, DEVELOPMENT, V131, P3943, DOI 10.1242/dev.01278; Punzo C, 2001, GENE DEV, V15, P1716, DOI 10.1101/gad.196401; Purschke G, 2006, ARTHROPOD STRUCT DEV, V35, P211, DOI 10.1016/j.asd.2006.07.005; Purschke G, 2015, ACTA ZOOL-STOCKHOLM, V96, P67, DOI 10.1111/azo.12052; Raupach MJ, 2009, P ROY SOC B-BIOL SCI, V276, P799, DOI 10.1098/rspb.2008.1063; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2015, SEMIN CELL DEV BIOL, V44, P62, DOI 10.1016/j.semcdb.2015.10.036; REX MA, 1981, ANNU REV ECOL SYST, V12, P331, DOI 10.1146/annurev.es.12.110181.001555; RHODE B, 1993, J MORPHOL, V217, P327, DOI 10.1002/jmor.1052170307; RHODE B, 1992, J MORPHOL, V212, P71, DOI 10.1002/jmor.1052120108; Riesenberg AN, 2009, GENESIS, V47, P175, DOI 10.1002/dvg.20479; Ruan LW, 2008, EXTREMOPHILES, V12, P735, DOI 10.1007/s00792-008-0172-8; Schulze A, 2003, ZOOL SCR, V32, P321, DOI 10.1046/j.1463-6409.2003.00119.x; Suschenko D, 2009, ZOOMORPHOLOGY, V128, P75, DOI 10.1007/s00435-008-0075-3; Tomarev SI, 1997, P NATL ACAD SCI USA, V94, P2421, DOI 10.1073/pnas.94.6.2421; Tunnicliffe V, 1998, ADV MAR BIOL, V34, P353, DOI 10.1016/S0065-2881(08)60213-8; TUNNICLIFFE V, 1991, OCEANOGR MAR BIOL, V29, P319; Urcuyo IA, 2003, DEEP-SEA RES PT I, V50, P763, DOI 10.1016/S0967-0637(03)00061-X; van Heyningen V, 2002, HUM MOL GENET, V11, P1161, DOI 10.1093/hmg/11.10.1161; von Dohren J, 2007, ZOOLOGY, V110, P430, DOI 10.1016/j.zool.2007.07.006; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Warrant E, 2004, J COMP PHYSIOL A, V190, P765, DOI 10.1007/s00359-004-0546-z; Weasner BM, 2009, DEV BIOL, V334, P492, DOI 10.1016/j.ydbio.2009.04.027; Xu PX, 1997, DEVELOPMENT, V124, P219; YAMAMOTO T, 1965, J CELL BIOL, V25, P345, DOI 10.1083/jcb.25.2.345; Yamamoto Y, 2002, METHODS, V28, P420, DOI 10.1016/S1046-2023(02)00261-X; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101; Zhang TY, 2006, DEVELOPMENT, V133, P4881, DOI 10.1242/dev.02669; Zimmerman JE, 2000, GENETICS, V154, P237	85	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168579	10.1371/journal.pone.0168579	http://dx.doi.org/10.1371/journal.pone.0168579			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005979	gold, Green Submitted, Green Published			2022-12-26	WOS:000392843200067
J	Baseia, IG; Silva, BDB; Ishikawa, NK; Soares, JVC; Franca, IF; Ushijima, S; Maekawa, N; Martin, MP				Baseia, Iuri G.; Silva, Bianca D. B.; Ishikawa, Noemia K.; Soares, Joao V. C.; Franca, Isadora F.; Ushijima, Shuji; Maekawa, Nitaro; Martin, Maria P.			Discovery or Extinction of New Scleroderma Species in Amazonia?	PLOS ONE			English	Article							ECTOMYCORRHIZAL FUNGI; GASTEROID FUNGI; DIVERSITY; RECORDS; FOREST; PLANT; DEFORESTATION; CONSERVATION; BIODIVERSITY; EVOLUTION	The Amazon Forest is a hotspot of biodiversity harboring an unknown number of undescribed taxa. Inventory studies are urgent, mainly in the areas most endangered by human activities such as extensive dam construction, where species could be in risk of extinction before being described and named. In 2015, intensive studies performed in a few locations in the Brazilian Amazon rainforest revealed three new species of the genus Scleroderma: S. anomalosporum, S. camassuense and S. duckei. The two first species were located in one of the many areas flooded by construction of hydroelectric dams throughout the Amazon; and the third in the Reserva Florestal Adolpho Ducke, a protected reverse by the INPA. The species were identified through morphology and molecular analyses of barcoding sequences (Internal Transcribed Spacer nrDNA). Scleroderma anomalosporum is characterized mainly by the smooth spores under LM in mature basidiomata (under SEM with small, unevenly distributed granules, a characteristic not observed in other species of the genus), the large size of the basidiomata, up to 120 mm diameter, and the stelliform dehiscence; S. camassuense mainly by the irregular to stellate dehiscence, the subreticulated spores and the bright sulfur-yellow colour, and Scleroderma duckei mainly by the verrucose exoperidium, stelliform dehiscence, and verrucose spores. Description, illustration and affinities with other species of the genus are provided.	[Baseia, Iuri G.] Univ Fed Rio Grande do Norte, Dept Bot & Zool, Natal, RN, Brazil; [Baseia, Iuri G.; Silva, Bianca D. B.] Univ Fed Bahia, Inst Biol, Dept Bot, Salvador, BA, Brazil; [Ishikawa, Noemia K.] Inst Nacl de Pesquisas da Amazonia, Coordenacao Biodiversidade, Manaus, Amazonas, Brazil; [Soares, Joao V. C.] Inst Nacl de Pesquisas da Amazonia, Div Suporte Estacoes & Reservas, Manaus, Amazonas, Brazil; [Franca, Isadora F.] Univ Fed Para, Fac Ciencias Biol, Campus Univ Altamira, Altamira, Para, Brazil; [Ushijima, Shuji; Maekawa, Nitaro] Tottori Univ, Fac Agr, Fungus Mushroom Resource & Res Ctr, Tottori, Japan; [Martin, Maria P.] CSIC, RJB, Dept Micol, Madrid, Spain	Universidade Federal do Rio Grande do Norte; Universidade Federal da Bahia; Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia; Universidade Federal do Para; Tottori University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid	Martin, MP (corresponding author), CSIC, RJB, Dept Micol, Madrid, Spain.	maripaz@rjb.csic.es	Martín, María/HDL-9512-2022; Martín, María/H-8069-2012	Martín, María/0000-0002-1235-4418; Silva, Bianca/0000-0002-8920-0652	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Brazil) [PVE/407474/2013-7, PPBio/457476/2012-5]; Fundacao de Amparo a Pesquisas do Estado do Amazonas (FAPEAM-Brazil); Centro de Estudos Integrados da Biodiversidade Amazonica	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisas do Estado do Amazonas (FAPEAM-Brazil); Centro de Estudos Integrados da Biodiversidade Amazonica	We are grateful to the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Brazil, process PVE/407474/2013-7 and PPBio/457476/2012-5), and Fundacao de Amparo a Pesquisas do Estado do Amazonas (FAPEAM-Brazil) for the financial support; as well as to Centro de Estudos Integrados da Biodiversidade Amazonica.	Alfredo DS, 2012, MYCOSPHERE, V3, P294, DOI 10.5943/mycosphere/3/3/4; Alfredo DS, 2012, MYCOSPHERE, V3, P66, DOI 10.5943/mycosphere/3/1/8; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; da Silva BDB, 2013, NOVA HEDWIGIA, V96, P445, DOI 10.1127/0029-5035/2013/0089; Baseis I. G., 2000, Acta Botanica Brasilica, V14, P181; Benchimol M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129818; Binder M, 2002, MYCOLOGIA, V94, P85, DOI 10.2307/3761848; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; BONONI V L R, 1981, Rickia, V9, P37; Brook BW, 2006, BIOTROPICA, V38, P302, DOI 10.1111/j.1744-7429.2006.00141.x; Cabral TS, 2015, MYCOTAXON, V130, P315, DOI 10.5248/130.315; Cabral TS, 2014, PHYTOTAXA, V183, P239, DOI 10.11646/phytotaxa.183.4.3; Calonge F.D., 1998, FL MYCOL IBER, V3, P1; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Casadevall A, 2005, FUNGAL GENET BIOL, V42, P98, DOI 10.1016/j.fgb.2004.11.008; Cisneros E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136402; Clement CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004564; Cochrane G, 2011, NUCLEIC ACIDS RES, V39, pD15, DOI 10.1093/nar/gkq1150; Cortez V.G., 2011, J YEAST FUNGAL RES, V2, P44; Cracraft J, 1985, ORNITHOLOGICAL MONOG, V36, P49, DOI DOI 10.2307/40168278; Crous PW, 2016, PERSOONIA, V36, P316, DOI 10.3767/003158516X692185; Drechsler-Santos ER, 2008, MYCOTAXON, V104, P9; Fearnside PM, 2008, ECOL SOC, V13; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Finer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035126; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; Giachini AJ, 2000, MYCOLOGIA, V92, P1166, DOI 10.2307/3761484; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Grgurinovic C.A., 1997, LARGER FUNGI S AUSTR; Gurgel FE, 2008, MYCOTAXON, V105, P399; Guzman G, 2004, MYCOLOGIA, V96, P1370, DOI 10.2307/3762153; GUZMAN G, 1970, Darwiniana (San Isidro), V16, P233; Guzman G, 2000, MYCOLOGIA, V92, P174, DOI 10.2307/3761461; Guzman G, 2013, REV MEX BIODIVERS, V84, pS173, DOI 10.7550/rmb.31979; Haffer J, 2008, BRAZ J BIOL, V68, P917, DOI 10.1590/S1519-69842008000500003; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hawksworth DL, 1997, PHYTOPATHOLOGY, V87, P888, DOI 10.1094/PHYTO.1997.87.9.888; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; Hayes TB, 2010, J EXP BIOL, V213, P921, DOI 10.1242/jeb.040865; Hennings P., 1904, HEDWIGIA, V43, P154; Hopkins MJG, 2007, J BIOGEOGR, V34, P1400, DOI 10.1111/j.1365-2699.2007.01737.x; Huelsenbeck JP, 2000, GENETICS, V154, P1879; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hyde KD, 2001, MYCOL RES, V105, P1514, DOI 10.1017/S0953756201004889; Kahn JR, 2014, ENERGIES, V7, P6063, DOI 10.3390/en7096063; Kirk P., 2008, Ainsworth and Bisby�s Dictionary of the Fungi, DOI 10.1079/9780851998268.0000; KORNERUP A., 1967, Methuen handbook of colour.; Kumla J, 2013, MYCOTAXON, V123, P1, DOI 10.5248/123.1; Ladle R., 2013, FRONT BIOGEOGR, V5, P103; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Lees AC, 2016, BIODIVERS CONSERV, V25, P451, DOI 10.1007/s10531-016-1072-3; Leite AG, 2011, MYCOTAXON, V118, P383, DOI 10.5248/118.383; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Luizao FJ, 2002, FLORESTA TROPICAL UM; Lutzoni F, 2004, AM J BOT, V91, P1446, DOI 10.3732/ajb.91.10.1446; Maia Leonor C., 2015, Rodriguésia, V66, P1033, DOI 10.1590/2175-7860201566407; Martin MP, 2000, LICHENOLOGIST, V32, P189, DOI 10.1006/lich.1999.0254; Meijer AAR de, 2006, B MUSEU BOT ANICO MU, V68, P1; Miller M. A., 2010, CIPRES PORTALS; Milliken W., 2011, KEW B, V65, P1; Mittermeier RA, 1998, CONSERV BIOL, V12, P516, DOI 10.1046/j.1523-1739.1998.012003516.x; Nilsson RH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000059; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Phosri C, 2009, AN JARDIN BOT MADRID, V66, P83, DOI 10.3989/ajbm.2199; Pringle CM, 2000, BIOSCIENCE, V50, P807, DOI 10.1641/0006-3568(2000)050[0807:REOHAO]2.0.CO;2; RICK J., 1961, BRASILIA IHERINGIA, V9, P451; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Roy M, 2016, BIOTROPICA, V48, P90, DOI 10.1111/btp.12297; Rusevska K, 2014, TURK J BOT, V38, P375, DOI 10.3906/bot-1301-36; Rylands A.B., 2002, WILDERNESS EARTHS LA, P56; Sobestiansky G, 2005, BRAZ ARCH BIOL TECHN, V48, P437, DOI 10.1590/S1516-89132005000300015; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tabarelli M, 2005, CONSERV BIOL, V19, P695, DOI 10.1111/j.1523-1739.2005.00694.x; TERBORGH J, 1990, ECOL MONOGR, V60, P213, DOI 10.2307/1943045; THIOLLAY JM, 1994, J TROP ECOL, V10, P449, DOI 10.1017/S0266467400008154; Tibbett M, 2002, ANN BOT-LONDON, V89, P783, DOI 10.1093/aob/mcf129; Trierveiler-Pereira L, 2009, MYCOTAXON, V110, P73, DOI 10.5248/110.73; Veresoglou SD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9862; Viegas A. P., 1945, BRAGANTIA, V5, P583; Vieira ICG, 2008, BRAZ J BIOL, V68, P949, DOI 10.1590/S1519-69842008000500004; Watling R, 2004, MEM NEW YORK BOTAN G, V89, P93; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wilson AW, 2012, NEW PHYTOL, V194, P1079, DOI 10.1111/j.1469-8137.2012.04109.x	87	10	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167879	10.1371/journal.pone.0167879	http://dx.doi.org/10.1371/journal.pone.0167879			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002414	Green Published, Green Submitted, gold			2022-12-26	WOS:000392853100024
J	Savage, AF; Kolev, NG; Franklin, JB; Vigneron, A; Aksoy, S; Tschudi, C				Savage, Amy F.; Kolev, Nikolay G.; Franklin, Joseph B.; Vigneron, Aurelien; Aksoy, Serap; Tschudi, Christian			Transcriptome Profiling of Trypanosoma brucei Development in the Tsetse Fly Vector Glossina morsitans	PLOS ONE			English	Article							VARIANT SURFACE GLYCOPROTEIN; ADENYLATE CYCLASES; GENE-EXPRESSION; LIFE-CYCLE; AFRICAN TRYPANOSOMES; ANTIGEN REPERTOIRE; STAGE; DIFFERENTIATION; PROTEINS; RHODESIENSE	African trypanosomes, the causative agents of sleeping sickness in humans and nagana in animals, have a complex digenetic life cycle between a mammalian host and an insect vector, the blood-feeding tsetse fly. Although the importance of the insect vector to transmit the disease was first realized over a century ago, many aspects of trypanosome development in tsetse have not progressed beyond a morphological analysis, mainly due to considerable challenges to obtain sufficient material for molecular studies. Here, we used high-throughput RNA-Sequencing (RNA-Seq) to profile Trypanosoma brucei transcript levels in three distinct tissues of the tsetse fly, namely the midgut, proventriculus and salivary glands. Consistent with current knowledge and providing a proof of principle, transcripts coding for procyclin isoforms and several components of the cytochrome oxidase complex were highly up-regulated in the midgut transcriptome, whereas transcripts encoding metacyclic VSGs (mVSGs) and the surface coat protein brucei alanine rich protein or BARP were extremely up-regulated in the salivary gland transcriptome. Gene ontology analysis also supported the upregulation of biological processes such as DNA metabolism and DNA replication in the proventriculus transcriptome and major changes in signal transduction and cyclic nucleotide metabolism in the salivary gland transcriptome. Our data highlight a small repertoire of expressed mVSGs and potential signaling pathways involving receptor-type adenylate cyclases and members of a surface carboxylate transporter family, called PADs (Proteins Associated with Differentiation), to cope with the changing environment, as well as RNA-binding proteins as a possible global regulators of gene expression.	[Savage, Amy F.; Kolev, Nikolay G.; Vigneron, Aurelien; Aksoy, Serap; Tschudi, Christian] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA; [Franklin, Joseph B.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Savage, Amy F.] Bard Coll, Dept Biol, Annandale On Hudson, NY USA; [Franklin, Joseph B.] US FDA, 10903 New Hampshire Ave, Silver Spring, MD USA	Yale University; Yale University; US Food & Drug Administration (FDA)	Aksoy, S; Tschudi, C (corresponding author), Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.	serap.aksoy@yale.edu; christian.tschudi@yale.edu	Aksoy, Serap/K-2244-2019; Vigneron, Aurélien/G-7268-2011	Aksoy, Serap/0000-0001-9941-143X; Vigneron, Aurélien/0000-0003-4986-6465	National Institutes of Health [AI051584, AI076879, AI028798, AI110325]; Ambrose-Monell Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076879, R01AI051584, R01AI028798, R01AI110325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ambrose-Monell Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (http://www.nih.gov) grants AI051584 and AI076879 to S.A. and AI028798 and AI110325 to C.T., and by the Ambrose-Monell Foundation (http://www.monellfoundation.org/) to S.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Serrano A, 2001, P NATL ACAD SCI USA, V98, P1513, DOI 10.1073/pnas.041611698; ALARCON CM, 1994, MOL CELL BIOL, V14, P5579, DOI 10.1128/MCB.14.8.5579; Alexandre S, 1996, MOL BIOCHEM PARASIT, V77, P173, DOI 10.1016/0166-6851(96)02591-1; ALEXANDRE S, 1990, MOL BIOCHEM PARASIT, V43, P279, DOI 10.1016/0166-6851(90)90152-C; Alsford S, 2012, NATURE, V482, P232, DOI 10.1038/nature10771; Archer SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000565; Barry JD, 1998, MOL BIOCHEM PARASIT, V91, P93, DOI 10.1016/S0166-6851(97)00193-X; BARRY JD, 1983, NATURE, V306, P699, DOI 10.1038/306699a0; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; BRINGAUD F, 1992, MOL BIOCHEM PARASIT, V52, P111, DOI 10.1016/0166-6851(92)90040-Q; CAPALDI RA, 1990, ANNU REV BIOCHEM, V59, P569, DOI 10.1146/annurev.bi.59.070190.003033; Dean S, 2009, NATURE, V459, P213, DOI 10.1038/nature07997; Dyer NA, 2013, TRENDS PARASITOL, V29, P188, DOI 10.1016/j.pt.2013.02.003; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Ginger ML, 2002, EUKARYOT CELL, V1, P1000, DOI 10.1128/EC.1.6.1000-1009.2002; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; GRAHAM SV, 1995, MOL CELL BIOL, V15, P5945; Graham SV, 1999, MOL BIOCHEM PARASIT, V103, P141, DOI 10.1016/S0166-6851(99)00128-0; Gunzl A, 2010, EUKARYOT CELL, V9, P1159, DOI 10.1128/EC.00113-10; Hendriks EF, 2001, EMBO J, V20, P6700, DOI 10.1093/emboj/20.23.6700; Horn D, 2014, MOL BIOCHEM PARASIT, V195, P123, DOI 10.1016/j.molbiopara.2014.05.001; Imhoft S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004493; Jackson AP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002121; Kolev NG, 2014, CELL MICROBIOL, V16, P482, DOI 10.1111/cmi.12268; Kolev NG, 2012, SCIENCE, V338, P1352, DOI 10.1126/science.1229641; Kolev NG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001090; LENARDO MJ, 1984, P NATL ACAD SCI-BIOL, V81, P6642, DOI 10.1073/pnas.81.21.6642; LEWIS EA, 1947, ANN TROP MED PARASIT, V41, P6, DOI 10.1080/00034983.1947.11685305; Ling AS, 2011, J BIOL CHEM, V286, P20152, DOI 10.1074/jbc.M110.139261; MacGregor P, 2012, NAT REV MICROBIOL, V10, P431, DOI 10.1038/nrmicro2779; Mani J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022463; Oberholzer M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010538; Ooi Cher-Pheng, 2013, Front Cell Infect Microbiol, V3, P71, DOI 10.3389/fcimb.2013.00071; PAINDAVOINE P, 1992, MOL CELL BIOL, V12, P1218, DOI 10.1128/MCB.12.3.1218; PAYS E, 1989, CELL, V57, P835, DOI 10.1016/0092-8674(89)90798-8; PRIEST JW, 1994, J BIOENERG BIOMEMBR, V26, P179, DOI 10.1007/BF00763067; Prohaska K, 2009, EUKARYOT CELL, V8, P77, DOI 10.1128/EC.00234-08; Rico E, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00078; Saada EA, 2014, EUKARYOT CELL, V13, P1064, DOI 10.1128/EC.00019-14; Salmon D, 2012, SCIENCE, V337, P463, DOI 10.1126/science.1222753; Salmon D, 2012, MOL MICROBIOL, V84, P225, DOI 10.1111/j.1365-2958.2012.08013.x; Savage AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001708; Sharma R, 2008, PROTIST, V159, P137, DOI 10.1016/j.protis.2007.07.004; Sharma R, 2009, TRENDS PARASITOL, V25, P517, DOI 10.1016/j.pt.2009.08.001; Simarro PP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001007; Subota I, 2014, MOL CELL PROTEOMICS, V13, P1769, DOI 10.1074/mcp.M113.033357; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Szoor B, 2010, GENE DEV, V24, P1306, DOI 10.1101/gad.570310; Szoor B, 2006, J CELL BIOL, V175, P293, DOI 10.1083/jcb.200605090; Telleria EL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002649; TETLEY L, 1987, J CELL SCI, V87, P363; TURNER CMR, 1988, PARASITOLOGY, V97, P269, DOI 10.1017/S0031182000058479; Urwyler S, 2007, MOL MICROBIOL, V63, P218, DOI 10.1111/j.1365-2958.2006.05492.x; Van den Abbeele J, 1999, PARASITOLOGY, V118, P469, DOI 10.1017/S0031182099004217; van Hellemond JJ, 2005, ADV MICROB PHYSIOL, V50, P199, DOI 10.1016/S0065-2911(05)50005-5; Vassella E, 2000, GENE DEV, V14, P615; VICKERMAN K, 1985, BRIT MED BULL, V41, P105, DOI 10.1093/oxfordjournals.bmb.a072036; Weirather JL, 2012, MOL BIOCHEM PARASIT, V181, P141, DOI 10.1016/j.molbiopara.2011.10.011; ZIEGELBAUER K, 1992, J BIOL CHEM, V267, P10791	59	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168877	10.1371/journal.pone.0168877	http://dx.doi.org/10.1371/journal.pone.0168877			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002435	Green Published, gold, Green Submitted			2022-12-26	WOS:000392853100074
J	Wang, Y; Li, Z; Hu, G; Hao, SY; Deng, XH; Huang, M; Ren, M; Jiang, XY; Kanegaye, JT; Ha, KS; Lee, J; Li, XF; Jiang, XJ; Yu, YX; Tremoulet, AH; Burns, JC; Whitin, JC; Shin, AY; Sylvester, KG; McElhinney, DB; Cohen, HJ; Ling, XFB				Wang, Yue; Li, Zhen; Hu, Guang; Hao, Shiying; Deng, Xiaohong; Huang, Min; Ren, Miao; Jiang, Xiyuan; Kanegaye, John T.; Ha, Kee-Soo; Lee, JungHwa; Li, Xiaofeng; Jiang, Xuejun; Yu, Yunxian; Tremoulet, Adriana H.; Burns, Jane C.; Whitin, John C.; Shin, Andrew Y.; Sylvester, Karl G.; McElhinney, Doff B.; Cohen, Harvey J.; Ling, Xuefeng B.		Pediat Emergency Med Kawasaki Dis	Unique Molecular Patterns Uncovered in Kawasaki Disease Patients with Elevated Serum Gamma Glutamyl Transferase Levels: Implications for Intravenous Immunoglobulin Responsiveness	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; AUTOIMMUNE NEUTROPENIA; UNITED-STATES; THERAPY; PREDICTION; RESISTANCE; GLOBULIN; CHILDREN; AUTOANTIBODIES; ASSOCIATION	Background Resistance to intravenous immunoglobulin (IVIG) occurs in 10-20% of patients with Kawasaki disease (KD). The risk of resistance is about two-fold higher in patients with elevated gamma glutamyl transferase (GGT) levels. We sought to understand the biological mechanisms underlying IVIG resistance in patients with elevated GGT levels. Method We explored the association between elevated GGT levels and IVIG-resistance with a cohort of 686 KD patients (Cohort I). Gene expression data from 130 children with acute KD (Cohort II) were analyzed using the R square statistic and false discovery analysis to identify genes that were differentially represented in patients with elevated GGT levels with regard to IVIG responsiveness. Two additional KD cohorts (Cohort III and IV) were used to test the hypothesis that sialylation and GGT may be involved in IVIG resistance through neutrophil apoptosis. Results Thirty-six genes were identified that significantly explained the variations of both GGT levels and IVIG responsiveness in KD patients. After Bonferroni correction, significant associations with IVIG resistance persisted for 12 out of 36 genes among patients with elevated GGT levels and none among patients with normal GGT levels. With the discovery of ST6GALNAC3, a sialyltransferase, as the most differentially expressed gene, we hypothesized that sialylation and GGT are involved in IVIG resistance through neutrophil apoptosis. We then confirmed that in Cohort III and IV there was significantly less reduction in neutrophil count in IVIG non-responders. Conclusions Gene expression analyses combining molecular and clinical datasets support the hypotheses that: (1) neutrophil apoptosis induced by IVIG may be a mechanism of action of IVIG in KD; (2) changes in sialylation and GGT level in KD patients may contribute synergistically to IVIG resistance through blocking IVIG-induced neutrophil apoptosis. These findings have implications for understanding the mechanism of action in IVIG resistance, and possibly for development of novel therapeutics.	[Wang, Yue; Yu, Yunxian; Ling, Xuefeng B.] Zhejiang Univ, Sch Publ Hlth, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Wang, Yue; Li, Zhen; Hu, Guang; Hao, Shiying; Deng, Xiaohong; Ren, Miao; Jiang, Xiyuan; Whitin, John C.; Shin, Andrew Y.; Sylvester, Karl G.; McElhinney, Doff B.; Cohen, Harvey J.; Ling, Xuefeng B.] Stanford Univ, Stanford, CA 94305 USA; [Li, Zhen] Southeast Univ, Sch Elect Engn, Nanjing, Jiangsu, Peoples R China; [Huang, Min] Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Shanghai, Peoples R China; [Kanegaye, John T.; Tremoulet, Adriana H.; Burns, Jane C.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Kanegaye, John T.; Tremoulet, Adriana H.; Burns, Jane C.] Rady Childrens Hosp San Diego, San Diego, CA USA; [Ha, Kee-Soo; Lee, JungHwa] Korea Univ, Med Ctr, Guro Hosp, Dept Pediat, Seoul, South Korea; [Li, Xiaofeng] Beijing Childrens Hosp, Dept Heart Ctr, Beijing, Peoples R China; [Jiang, Xuejun] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA	Zhejiang University; Stanford University; Southeast University - China; Shanghai Jiao Tong University; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; Korea University; Korea University Medicine (KU Medicine); Capital Medical University; Memorial Sloan Kettering Cancer Center	Ling, XFB (corresponding author), Zhejiang Univ, Sch Publ Hlth, Sch Med, Hangzhou, Zhejiang, Peoples R China.; Ling, XFB (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	bxling@stanford.edu	li, xiao/GSN-6181-2022; li, xiaofeng/GXF-9442-2022	McElhinney, Doff/0000-0001-7242-0934; Hao, Shiying/0000-0002-7527-2460; Sylvester, Karl G./0000-0002-8559-0155; Jiang, Xiyuan/0000-0003-3508-2221; Ling, Bruce/0000-0002-5386-3884; Ha, Kee Soo/0000-0001-6753-5411	American Heart Association; Stanford University Spark Program; David Gordon Louis Daniel Foundation; Mario Batali Foundation; National Institutes of Health, National Heart, Lung, Blood Institute [HL69413]; Hartwell Foundation; Harold Amos Medical Faculty Development Program/Robert Wood Johnson Foundation; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Stanford University Spark Program(Stanford University); David Gordon Louis Daniel Foundation; Mario Batali Foundation; National Institutes of Health, National Heart, Lung, Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Hartwell Foundation; Harold Amos Medical Faculty Development Program/Robert Wood Johnson Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the American Heart Association to HJC and XBL, Stanford University Spark Program Grant to HJC and XBL, the David Gordon Louis Daniel Foundation to JCB, the Mario Batali Foundation to JCB, the National Institutes of Health, National Heart, Lung, Blood Institute HL69413 to JCB, The Hartwell Foundation to AHT, and The Harold Amos Medical Faculty Development Program/Robert Wood Johnson Foundation to AHT.	Abe J, 2008, J ALLERGY CLIN IMMUN, V122, P1008, DOI 10.1016/j.jaci.2008.09.011; [Anonymous], 1984, REP SUBC STAND DIAGN; Biezeveld MH, 2005, CLIN EXP IMMUNOL, V141, P183, DOI 10.1111/j.1365-2249.2005.02829.x; Bonferroni CE, 1936, SUPERIORE SCI EC COM, V8, P3; Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1; Burns JC, 1998, PEDIATR INFECT DIS J, V17, P1144, DOI 10.1097/00006454-199812000-00009; DURONGPISITKUL K, 1995, PEDIATRICS, V96, P1057; Fu PP, 2013, PEDIATR INFECT DIS J, V32, pE319, DOI 10.1097/INF.0b013e31828e887f; Fukunishi M, 2000, J PEDIATR-US, V137, P172, DOI 10.1067/mpd.2000.104815; Fury W, 2010, HUM IMMUNOL, V71, P865, DOI 10.1016/j.humimm.2010.06.008; Galeotti C, 2015, TRENDS MOL MED, V21, P145, DOI 10.1016/j.molmed.2015.01.005; Ha KS, 2015, AM J CARDIOL, V116, P301, DOI 10.1016/j.amjcard.2015.04.021; Hoang LT, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0102-6; Hwang JY, 2011, ARCH DIS CHILD, V96, P1088, DOI 10.1136/adc.2010.184101; Igarashi H, 1999, BRIT J HAEMATOL, V105, P613, DOI 10.1046/j.1365-2141.1999.01381.x; Jandus C, 2011, BIOCHEM PHARMACOL, V82, P323, DOI 10.1016/j.bcp.2011.05.018; Kanai T, 2011, CIRCULATION, V124, P2822, DOI 10.1161/CIRCULATIONAHA.111.028423; Kato H, 1996, CIRCULATION, V94, P1379, DOI 10.1161/01.CIR.94.6.1379; Kobayashi T, 2006, CIRCULATION, V113, P2606, DOI 10.1161/CIRCULATIONAHA.105.592865; Lee SM, 2014, KOREAN CIRC J, V44, P415, DOI 10.4070/kcj.2014.44.6.415; Lin MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063399; Ling XB, 2009, BIOINFORMATICS, V25, P1461, DOI 10.1093/bioinformatics/btp176; Liu L, 2015, INFLAMMATION RES OFF; Long JS, 1997, REGRESSION MODELS CA, P104; Marschner IC, 2011, R J, V3, P12; MATSUBARA T, 1990, CLIN IMMUNOL IMMUNOP, V56, P29, DOI 10.1016/0090-1229(90)90166-N; McFadden D., 1973, FRONTIERS ECONOMETRI, P105, DOI [10.1108/eb028592, DOI 10.1108/EB028592]; Miller RGJ, 1991, SIMULTANEOUS STAT IN; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; NEWBURGER JW, 1991, NEW ENGL J MED, V324, P1633, DOI 10.1056/NEJM199106063242305; NEWBURGER JW, 1986, NEW ENGL J MED, V315, P341, DOI 10.1056/NEJM198608073150601; Ogata S, 2013, INT J CARDIOL, V168, P3825, DOI 10.1016/j.ijcard.2013.06.027; Okada S, 2015, PEDIATR INT, V57, P1012, DOI 10.1111/ped.12701; R-Core-Team, 2015, LANG ENV STAT COMP; Schaub A, 2011, ALLERGY, V66, P1030, DOI 10.1111/j.1398-9995.2011.02579.x; Ting EC, 1998, PEDIATR INFECT DIS J, V17, P431, DOI 10.1097/00006454-199805000-00020; Tremoulet AH, 2008, J PEDIATR-US, V153, P117, DOI 10.1016/j.jpeds.2007.12.021; Tremoulet AH, 2014, LANCET, V383, P1731, DOI 10.1016/S0140-6736(13)62298-9; Tremoulet AH, 2011, PEDIATR INFECT DIS J, V30, P1022, DOI 10.1097/INF.0b013e31822d4f56; Tsai MH, 2006, J PEDIATR-US, V148, P38, DOI 10.1016/j.jpeds.2005.08.024; Tsuchida A, 2005, J BIOCHEM, V138, P237, DOI 10.1093/jb/mvi124; Tsujimoto H, 2002, CLIN IMMUNOL, V103, P161, DOI 10.1006/clim.2002.5209; Uehara R, 2012, J EPIDEMIOL, V22, P79, DOI 10.2188/jea.JE20110131; Ueno K, 2011, PEDIATR INT, V53, P388, DOI 10.1111/j.1442-200X.2011.03376.x; von Gunten S, 2008, AUTOIMMUN REV, V7, P453, DOI 10.1016/j.autrev.2008.03.015; von Gunten S, 2006, BLOOD, V108, P4255, DOI 10.1182/blood-2006-05-021568; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yamaji T, 2002, J BIOL CHEM, V277, P6324, DOI 10.1074/jbc.M110146200; Yoshimura K, 2009, EUR J PEDIATR, V168, P1037, DOI 10.1007/s00431-008-0872-1; Zhang JQ, 2000, J BIOL CHEM, V275, P22121, DOI 10.1074/jbc.M002788200	50	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167434	10.1371/journal.pone.0167434	http://dx.doi.org/10.1371/journal.pone.0167434			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002448	Green Published, gold, Green Submitted			2022-12-26	WOS:000392853100008
J	Song, YX; Xu, LY; Chen, Y; Zhang, LP; Gao, HJ; Zhu, B; Niu, H; Zhang, WG; Xia, JW; Gao, X; Li, JY				Song, Yuxin; Xu, Lingyang; Chen, Yan; Zhang, Lupei; Gao, Huijiang; Zhu, Bo; Niu, Hong; Zhang, Wengang; Xia, Jiangwei; Gao, Xue; Li, Junya			Genome-Wide Association Study Reveals the PLAG1 Gene for Knuckle, Biceps and Shank Weight in Simmental Beef Cattle	PLOS ONE			English	Article							SEQUENCE VARIANTS; CARCASS TRAITS; BODY-WEIGHT; GROWTH; PREDICTION	Carcass traits of beef cattle have been genetically improved to increase yield of high quality meat. Genome-wide association study (GWAS) is a powerful method to identify genetic variants associated with carcass traits. For the 770K genotyped SNPs from 1141 Chinese Simmental cattle, we used the compressed mixed linear model (CMLM) to perform a genomewide association study for knuckle, biceps and shank of beef carcass traits. Seventeen significantly associated SNPs were found, which are located on BTA6, BTA14 and BTA15. Interestingly, one pleiotropic quantitative trait nucleotide (QTN), named BovineHD1400007259 (p < 10(-8)) within the well-known gene region PLAG1-CHCHD7 on BTA14, was found to govern variation of the knuckle, biceps and shank traits. The QTN accounted for 8.6% of phenotypic variance for biceps. In addition, 16 more SNPs distributed on BTA14 were detected as being associated with the carcass traits.	[Song, Yuxin; Xu, Lingyang; Chen, Yan; Zhang, Lupei; Gao, Huijiang; Zhu, Bo; Niu, Hong; Zhang, Wengang; Xia, Jiangwei; Gao, Xue; Li, Junya] Chinese Acad Agr Sci, Inst Anim Sci, Lab Mol Biol & Bovine Breeding, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS	Gao, X; Li, JY (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Lab Mol Biol & Bovine Breeding, Beijing, Peoples R China.	gaoxue76@126.com; jl1@iascaas.net.cn	Xu, Lingyang/W-8664-2019	Gao, Xue/0000-0002-9083-6658	Cattle Breeding Innovative Research Team [cxgc-ias-03]; 12th "Five-Year" National Science and Technology Support Project [2011BAD28B04]; Basic Research Fund Program; Chinese Academy of Agricultural Sciences Fundamental Research Budget Increment Projects [2013ZL031, 2014ZL006]; Chinese Academy of Agricultural Sciences Foundation [2014ywf-yb-4]; Beijing Natural Science Foundation [6154032]; National Natural Science Foundations of China [31472079, 31372294, 31402039]; National High Technology Research and Development Program of China (863 Program) [2013AA102505-4]	Cattle Breeding Innovative Research Team; 12th "Five-Year" National Science and Technology Support Project; Basic Research Fund Program; Chinese Academy of Agricultural Sciences Fundamental Research Budget Increment Projects; Chinese Academy of Agricultural Sciences Foundation(Chinese Academy of Sciences); Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This study was supported by Cattle Breeding Innovative Research Team (cxgc-ias-03), the 12th "Five-Year" National Science and Technology Support Project (2011BAD28B04) Basic Research Fund Program, the National High Technology Research and Development Program of China (863 Program 2013AA102505-4), Chinese Academy of Agricultural Sciences Fundamental Research Budget Increment Projects (2013ZL031 and 2014ZL006), Chinese Academy of Agricultural Sciences Foundation (2014ywf-yb-4), Beijing Natural Science Foundation (6154032), and the National Natural Science Foundations of China (31472079, 31372294, and 31402039).	Barendse W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029601; Bolormaa S, 2013, J ANIM SCI, V91, P3088, DOI 10.2527/jas.2012-5827; Bolormaa S, 2011, J ANIM SCI, V89, P2297, DOI 10.2527/jas.2010-3138; Bolormaa S, 2011, J ANIM SCI, V89, P1684, DOI 10.2527/jas.2010-3079; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Cesar ASM, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-39; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Crispim AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139906; Dang CG, 2014, ASIAN AUSTRAL J ANIM, V27, P1328, DOI 10.5713/ajas.2013.13690; Fan HZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep18389; Gautier M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-550; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Hensen K, 2004, DEV GROWTH DIFFER, V46, P459, DOI 10.1111/j.1440-169x.2004.00762.x; Hibbard MK, 2000, CANCER RES, V60, P4869; Hoshiba H, 2013, ANIM SCI J, V84, P529, DOI 10.1111/asj.12033; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Karim L, 2011, NAT GENET, V43, P405, DOI 10.1038/ng.814; Kim Y, 2011, ANIM GENET, V42, P361, DOI 10.1111/j.1365-2052.2010.02156.x; Lee SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074677; Lee Seung Hwan, 2013, PLOS ONE; Lindholm-Perry AK, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-103; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Littlejohn M, 2012, ANIM GENET, V43, P591, DOI 10.1111/j.1365-2052.2011.02293.x; Martins C, 2005, MODERN PATHOL, V18, P1048, DOI 10.1038/modpathol.3800386; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Nishimura S, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-40; Pant SD, 2010, GENOMICS, V95, P176, DOI 10.1016/j.ygeno.2010.01.001; Pryce JE, 2011, GENETICS, V187, P981, DOI 10.1534/genetics.110.123943; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sasaki S, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0282-0; Snelling WM, 2010, J ANIM SCI, V88, P837, DOI 10.2527/jas.2009-2257; WANG H, 2014, BMC BIOINFORMATICS, V15, DOI DOI 10.1186/S12863-014-0125-4; Weng ZQ, 2016, LIVEST SCI, V183, P4, DOI 10.1016/j.livsci.2015.11.011; Wu XP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-897; Wu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109330; Xu LY, 2015, MOL BIOL EVOL, V32, P711, DOI 10.1093/molbev/msu333; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	39	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168316	10.1371/journal.pone.0168316	http://dx.doi.org/10.1371/journal.pone.0168316			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997562	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842900033
J	Comber, H; Cancela, MD; Haase, T; Johnson, H; Sharp, L; Pratschke, J				Comber, Harry; Cancela, Marianna De Camargo; Haase, Trutz; Johnson, Howard; Sharp, Linda; Pratschke, Jonathan			Affluence and Private Health Insurance Influence Treatment and Survival in Non-Hodgkin's Lymphoma	PLOS ONE			English	Article							CANCER SURVIVAL; ELDERLY-PATIENTS; COMMON CANCERS; SOCIOECONOMIC INEQUALITIES; MARITAL-STATUS; BREAST-CANCER; RARER CANCERS; AGE; DISPARITIES; DIAGNOSIS	Background The aim of this study was to investigate inequalities in survival for non-Hodgkin's lymphoma (NHL), distinguishing between direct and indirect effects of patient, social and process-of care factors. Methods All cases of NHL diagnosed in Ireland in 2004-2008 were included. Variables describing patient, cancer, stage and process of care were included in a discrete-time model of survival using Structural Equation Modelling software. Results Emergency admissions were more common in patients with co-morbid conditions or with more aggressive cancers, and less frequent for patients from more affluent areas. Aggressive morphology, female sex, emergency admission, increasing age, comorbidity, treatment in a high caseload hospital and late stage were associated with increased hazard of mortality. Private patients had a reduced hazard of mortality, mediated by systemic therapy, admission to high caseload hospitals and fewer emergency admissions. Discussion The higher rate of emergency presentation, and consequent poorer survival, of uninsured patients, suggests they face barriers to early presentation. Social, educational and cultural factors may also discourage disadvantaged patients from consulting with early symptoms of NHL. Non-insured patients, who present later and have more emergency admissions would benefit from better access to diagnostic services. Older patients remain disadvantaged by sub-optimal treatment, treatment in non-specialist centres and emergency admission.	[Comber, Harry] Natl Canc Registry, Cork, Ireland; [Cancela, Marianna De Camargo] Brazilian Natl Canc Inst, Div Epidemiol, Rio De Janeiro, Brazil; [Johnson, Howard] Hlth Serv Execut, Hlth & Wellbeing Directorate, Hlth Intelligence Unit, Dublin, Ireland; [Sharp, Linda] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England; [Pratschke, Jonathan] Univ Salerno, Dept Econ & Stat, Salerno, Italy	National Cancer Institute (Inca); Newcastle University - UK; University of Salerno	Comber, H (corresponding author), Natl Canc Registry, Cork, Ireland.	hcomber1@gmail.com	De Camargo Cancela, Marianna/D-4053-2015; de Camargo Cancela, Marianna/F-7309-2017	De Camargo Cancela, Marianna/0000-0002-8169-8054; 	Department of Health; Irish Cancer Society [H1COM12]	Department of Health; Irish Cancer Society	The National Cancer Registry is funded by the Department of Health. Additional funding for this study was provided by Irish Cancer Society grant H1COM12. There was no additional external source of funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel GA, 2015, BRIT J CANCER, V112, pS129, DOI 10.1038/bjc.2015.52; Aizer AA, 2013, J CLIN ONCOL, V31, P3869, DOI 10.1200/JCO.2013.49.6489; Al-Hamadani M, 2015, AM J HEMATOL, V90, P790, DOI 10.1002/ajh.24086; Alberto Q, 2013, CRIT REV ONCOL HEMAT, V85, P266, DOI 10.1016/j.critrevonc.2012.08.007; Bonnet C, 2007, J CLIN ONCOL, V25, P787, DOI 10.1200/JCO.2006.07.0722; Braga IC, 2015, J CANC ED; Bray C, 2008, LEUKEMIA LYMPHOMA, V49, P917, DOI 10.1080/10428190801933377; Brown LM, 2015, INT J CANC; Burns RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106456; Cancela MDC, 2015, CANCER EPIDEMIOL, V39, P778, DOI 10.1016/j.canep.2015.08.006; Chang CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044325; Charlson M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112479; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Cox B, 2014, J CANCER EPIDEMIOL, V2014, DOI 10.1155/2014/315378; Crozier JA, 2015, CL LYMPH MYELOM LEUK, V15, P578, DOI 10.1016/j.clml.2015.06.005; De Angelis R, 2015, EUR J CANCER, V51, P2254, DOI 10.1016/j.ejca.2015.08.003; De Angelis R, 2014, LANCET ONCOL, V15, P23, DOI 10.1016/S1470-2045(13)70546-1; deRijke JM, 1996, ANN ONCOL, V7, P677; Economic and Social Research Institute Department of Health Health Service Executive, 2013, ACT AC PUBL HOSP IR; Ewing J C, 2003, Hematology, V8, P211, DOI 10.1080/1024533031000135685; Firat S, 2006, AM J CLIN ONCOL-CANC, V29, P252, DOI 10.1097/01.coc.0000217824.20290.ab; Forbes LJL, 2011, BRIT J CANCER, V105, P1474, DOI 10.1038/bjc.2011.406; Frederiksen BL, 2012, BRIT J CANCER, V106, P988, DOI 10.1038/bjc.2012.3; Frederiksen BL, 2011, EUR J CANCER, V47, P910, DOI 10.1016/j.ejca.2010.11.014; Haase T, 2012, POBAL HP DEPRIVATION; Hastert TA, 2016, SOC SCI MED, V148, P52, DOI 10.1016/j.socscimed.2015.11.023; Health Service Executive, 2014, HLTH SERV PERF ASS R; Inverso G, 2015, CANCER-AM CANCER SOC, V121, P1273, DOI 10.1002/cncr.29171; Irish Health, 2011, ALL HAIL MIGHT WAIT; Issa DE, 2015, HAEMATOLOGICA, V100, P528, DOI 10.3324/haematol.2014.107300; Jansen L, 2015, INT J CANCER, V136, P2649, DOI 10.1002/ijc.29316; Kato Ikuko, 2012, J Registry Manag, V39, P158; Kent EE, 2015, CANCER CAUSE CONTROL, V26, P1153, DOI 10.1007/s10552-015-0609-1; Kogevinas M, 1997, IARC Sci Publ, P177; Luddy G, 2007, Ir Med J, V100, P71; Lyratzopoulos G, 2015, BRIT J CANCER, V112, pS35, DOI 10.1038/bjc.2015.40; Lyratzopoulos G, 2015, CANCER EPIDEM BIOMAR, V24, P720, DOI 10.1158/1055-9965.EPI-14-0969; Macleod U, 2009, BRIT J CANCER, V101, pS92, DOI 10.1038/sj.bjc.6605398; Marlow LAV, 2014, PSYCHO-ONCOLOGY, V23, P749, DOI 10.1002/pon.3464; Muthen L, 2007, MUTH N MUTH N; O'Brien K, 2014, IRISH J MED SCI, V183, P219, DOI 10.1007/s11845-013-0993-z; Olszewski AJ, 2015, ONCOLOGIST, V20, P1223, DOI 10.1634/theoncologist.2015-0228; Ozturk C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141244; Pratschke J, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0130-6; Pulte D, 2008, ARCH INTERN MED, V168, P469, DOI 10.1001/archinternmed.2007.125; Quaglia A, 2005, CRIT REV ONCOL HEMAT, V54, P117, DOI 10.1016/j.critrevonc.2004.12.001; Roswall N, 2008, EUR J CANCER, V44, P2058, DOI 10.1016/j.ejca.2008.06.011; Sant M, 2014, LANCET ONCOL, V15, P931, DOI 10.1016/S1470-2045(14)70282-7; Scottish Cancer Intelligence Unit, 2000, TRENDS CANC SURV SCO; Sharp L, 2014, J URBAN HEALTH, V91, P510, DOI 10.1007/s11524-013-9846-3; Shephard EA, 2015, BRIT J GEN PRACT, V65, pE289, DOI 10.3399/bjgp15X684805; Shiels MS, 2013, CANCER EPIDEM BIOMAR, V22, P1069, DOI 10.1158/1055-9965.EPI-13-0040; Smith A, 2015, CANC EPIDEMIOL; Tang SY, 2015, SOCIOL HEALTH ILL, V37, P698, DOI 10.1111/1467-9566.12236; The Health Insurance Authority, 2014, ANN REP ACC 2013; Thompson AS, 2016, J MULTILING MULTICUL, V37, P115, DOI 10.1080/01434632.2015.1031136; Vasudev NS, 2004, BRIT J GEN PRACT, V54, P595; Vedsted P, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X588484; Vulto AJCM, 2006, CANCER-AM CANCER SOC, V106, P2734, DOI 10.1002/cncr.21934; Wang M, 2008, CANCER-AM CANCER SOC, V113, P3231, DOI 10.1002/cncr.23914; Woods LM, 2006, ANN ONCOL, V17, P5, DOI 10.1093/annonc/mdj007; Zhang Amy Y, 2003, Oncol Nurs Forum, V30, P1022; Zhou R, 2015, J GASTROENTEROL HEPA	63	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168684	10.1371/journal.pone.0168684	http://dx.doi.org/10.1371/journal.pone.0168684			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QC	27992551	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842600087
J	Schonberger, B; Chen, XC; Mager, S; Ludewig, U				Schoenberger, Brigitte; Chen, Xiaochao; Mager, Svenja; Ludewig, Uwe			Site-Dependent Differences in DNA Methylation and Their Impact on Plant Establishment and Phosphorus Nutrition in Populus trichocarpa	PLOS ONE			English	Article							PHOSPHATE-STARVATION RESPONSE; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; EPIGENETIC INHERITANCE; SMALL RNAS; GENOME; MICRORNAS; DRM; METHYLTRANSFERASES; TRANSCRIPTION	The propagation via clonal stem cuttings is a frequent practice in tree plantations. Despite their clonal origin, the trees establish differently according to weather, temperature and nutrient availability, as well as the presence of various stresses. Here, clonal Populus trichocarpa (cv. Muhle Larson) cuttings from different sites were transferred into a common, fully nutrient supplied environment. Despite identical underlying genetics, stem cuttings derived from sites with lower phosphorus availability established worse, independent of phosphorus (P) level after transplantation. Differential growth of material from the sites was reflected in differences in the whole genome DNA methylome. Methylation differences were sequence context-dependent, but differentially methylated regions (DMRs) were apparently unrelated to P nutrition genes. Despite the undisputed negative general correlation of DNA promoter methylation with gene repression, only few of the top-ranked DMRs resulted in differential gene expression in roots or shoots. However, differential methylation was associated with site-dependent, different total amounts of microRNAs (miRNAs), with few miRNAs sequences directly targeted by differential methylation. Interestingly, in roots and shoots, the miRNA amount was dependent on the previous habitat and changed in roots in a habitat-dependent way under phosphate starvation conditions. Differentially methylated miRNAs, together with their target genes, showed P-dependent expression profiles, indicating miRNA expression differences as a P-related epigenetic modification in poplar. Together with differences in DNA methylation, such epigenetic mechanisms may explain habitat or seasonal memory in perennials and site-dependent growth performances.	[Schoenberger, Brigitte; Chen, Xiaochao; Mager, Svenja; Ludewig, Uwe] Univ Hohenheim, Crop Sci Inst, Dept Nutr Crop Physiol, Stuttgart, Germany	University Hohenheim	Ludewig, U (corresponding author), Univ Hohenheim, Crop Sci Inst, Dept Nutr Crop Physiol, Stuttgart, Germany.	u.ludewig@uni-hohenheim.de			Deutsche Forschungsgemeinschaft (DFG) [SPP1685, Lu673/18-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (DFG) in the Priority Program SPP1685 under grant Lu673/18-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceituno FF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-438; Bari R, 2006, PLANT PHYSIOL, V141, P988, DOI 10.1104/pp.106.079707; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Bergmann W., 1993, ERNAHRUNGSSTORUNGEN, V3; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Calderon-Vazquez C, 2011, PLANT PHYSIOL, V156, P1067, DOI 10.1104/pp.111.174987; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Cao XF, 2002, P NATL ACAD SCI USA, V99, P16491, DOI 10.1073/pnas.162371599; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Chiou TJ, 2011, ANNU REV PLANT BIOL, V62, P185, DOI 10.1146/annurev-arplant-042110-103849; Ci D, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00921; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Dai Xinbin, 2011, Nucleic Acids Res, V39, pW155, DOI 10.1093/nar/gkr319; Douhovnikoff V, 2015, PLANT ECOL, V216, P227, DOI 10.1007/s11258-014-0430-z; Dowen RH, 2012, P NATL ACAD SCI USA, V109, pE2183, DOI 10.1073/pnas.1209329109; Feng SH, 2011, CURR OPIN PLANT BIOL, V14, P179, DOI 10.1016/j.pbi.2010.12.002; Finnegan EJ, 2000, CURR OPIN GENET DEV, V10, P217, DOI 10.1016/S0959-437X(00)00061-7; Fujii H, 2005, CURR BIOL, V15, P2038, DOI 10.1016/j.cub.2005.10.016; Guarino F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131480; Hansen KD, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r83, 10.1186/gb-2012-13-10-R83]; Holliday R, 2006, EPIGENETICS-US, V1, P76, DOI 10.4161/epi.1.2.2762; Janssen A, 2012, ZUCHTUNG ERTRAGSLEIS, V8; Kankel MW, 2003, GENETICS, V163, P1109; Kawakatsu T, 2016, CELL, V166, P492, DOI 10.1016/j.cell.2016.06.044; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Latzel V, 2010, EVOL ECOL, V24, P1537, DOI 10.1007/s10682-010-9385-2; Lei KJ, 2016, PLANT CELL PHYSIOL, V57, DOI 10.1093/pcp/pcv197; Lewis JD, 2010, NEW PHYTOL, V187, P438, DOI 10.1111/j.1469-8137.2010.03307.x; Liang CY, 2013, PLANT PHYSIOL, V161, P1347, DOI 10.1104/pp.112.208934; Liang D, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-S1-S9; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Medvedeva YA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-119; Mirouze M, 2009, NATURE, V461, P427, DOI 10.1038/nature08328; Ong-Abdullah M, 2015, NATURE, V525, P533, DOI 10.1038/nature15365; Peng MS, 2007, PLANT J, V50, P320, DOI 10.1111/j.1365-313X.2007.03050.x; Piriyapongsa J, 2008, RNA, V14, P814, DOI 10.1261/rna.916708; Puzey JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033034; Raj S, 2011, P NATL ACAD SCI USA, V108, P12521, DOI 10.1073/pnas.1103341108; Roberts Justin T, 2014, Mob Genet Elements, V4, pe29255; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Saze H, 2011, CURR OPIN PLANT BIOL, V14, P81, DOI 10.1016/j.pbi.2010.08.017; Schachtman DP, 1998, PLANT PHYSIOL, V116, P447, DOI 10.1104/pp.116.2.447; Secco D, 2015, ELIFE, V4, DOI 10.7554/eLife.09343; Seymour DK, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004785; Sjodin A, 2009, NEW PHYTOL, V182, P1013, DOI 10.1111/j.1469-8137.2009.02807.x; Smith AP, 2010, PLANT PHYSIOL, V152, P217, DOI 10.1104/pp.109.145532; Song YP, 2015, J EXP BOT, V66, P1891, DOI 10.1093/jxb/eru531; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Taghavi S, 2005, APPL ENVIRON MICROB, V71, P8500, DOI 10.1128/AEM.71.12.8500-8505.2005; Takuno S, 2012, MOL BIOL EVOL, V29, P219, DOI 10.1093/molbev/msr188; Tomizawa S, 2011, DEVELOPMENT, V138, P811, DOI 10.1242/dev.061416; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; van den Driessche R, 2000, NEW FOREST, V19, P143, DOI 10.1023/A:1006607410673; VDLUFA, 2000, BEST KALKB ACK GRUNL; VDLUFA, 1997, HDB LANDW VERS UNT M; Verhoeven KJF, 2014, EVOLUTION, V68, P644, DOI 10.1111/evo.12320; Vining KJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-27; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; Xu M, 2011, ANAL BIOCHEM, V408, P337, DOI 10.1016/j.ab.2010.08.044; Yang XJ, 2014, CANCER CELL, V26, P577, DOI 10.1016/j.ccr.2014.07.028; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zemach A, 2010, P NATL ACAD SCI USA, V107, P18729, DOI 10.1073/pnas.1009695107; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhang YJ, 2005, NUCLEIC ACIDS RES, V33, pW701, DOI 10.1093/nar/gki383; Zhou FF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-14; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	75	21	22	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168623	10.1371/journal.pone.0168623	http://dx.doi.org/10.1371/journal.pone.0168623			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992519	Green Submitted, Green Published, gold			2022-12-26	WOS:000392842600081
J	Soh, Z; Nishikawa, S; Kurita, Y; Takiguchi, N; Tsuji, T				Soh, Zu; Nishikawa, Shinya; Kurita, Yuichi; Takiguchi, Noboru; Tsuji, Toshio			A Mathematical Model of the Olfactory Bulb for the Selective Adaptation Mechanism in the Rodent Olfactory System	PLOS ONE			English	Article							GLOMERULAR LAYER; FEEDBACK-CONTROL; ODOR MIXTURES; RAT; ORGANIZATION; PATTERNS; QUALITY	To predict the odor quality of an odorant mixture, the interaction between odorants must be taken into account. Previously, an experiment in which mice discriminated between odorant mixtures identified a selective adaptation mechanism in the olfactory system. This paper proposes an olfactory model for odorant mixtures that can account for selective adaptation in terms of neural activity. The proposed model uses the spatial activity pattern of the mitral layer obtained from model simulations to predict the perceptual similarity between odors. Measured glomerular activity patterns are used as input to the model. The neural interaction between mitral cells and granular cells is then simulated, and a dissimilarity index between odors is defined using the activity patterns of the mitral layer. An odor set composed of three odorants is used to test the ability of the model. Simulations are performed based on the odor discrimination experiment on mice. As a result, we observe that part of the neural activity in the glomerular layer is enhanced in the mitral layer, whereas another part is suppressed. We find that the dissimilarity index strongly correlates with the odor discrimination rate of mice: r = 0.88 (p = 0.019). We conclude that our model has the ability to predict the perceptual similarity of odorant mixtures. In addition, the model also accounts for selective adaptation via the odor discrimination rate, and the enhancement and inhibition in the mitral layer may be related to this selective adaptation.	[Soh, Zu; Kurita, Yuichi; Tsuji, Toshio] Hiroshima Univ, Inst Engn, Dept Syst Cybernet, Higashihiroshima, Japan; [Nishikawa, Shinya] Hiroshima Univ, Grad Sch Engn, Dept Syst Cybernet, Higashihiroshima, Japan; [Takiguchi, Noboru] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Mat Sci, Kanazawa, Ishikawa, Japan	Hiroshima University; Hiroshima University; Kanazawa University	Soh, Z; Tsuji, T (corresponding author), Hiroshima Univ, Inst Engn, Dept Syst Cybernet, Higashihiroshima, Japan.	sozu@bsys.hiroshima-u.ac.jp; tsuji@bsys.hiroshima-u.ac.jp	Soh, Zu/J-3875-2015; Takiguchi, Noboru/F-3419-2014; Tsuji, Toshio/D-6210-2011; Kurita, Yuichi/D-6196-2011	Soh, Zu/0000-0001-7182-9383; Takiguchi, Noboru/0000-0001-7266-0276; Tsuji, Toshio/0000-0002-7689-3963; Kurita, Yuichi/0000-0002-7848-1460	Japan Society for the Promotion of Science KAKENHI [26730144, 25540125]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 26730144 (ZS) and 25540125 (TT) (URL: https://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atanasova B, 2005, CHEM SENSES, V30, P209, DOI 10.1093/chemse/bji016; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; Boyd AM, 2012, NEURON, V76, P1161, DOI 10.1016/j.neuron.2012.10.020; Cleland TA, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00005; ERDI P, 1993, BIOL CYBERN, V69, P57, DOI 10.1007/BF00201408; Fletcher ML, 2009, J NEUROPHYSIOL, V102, P817, DOI 10.1152/jn.00020.2009; Giraudet P, 2002, J NEUROPHYSIOL, V88, P829, DOI 10.1152/jn.2002.88.2.829; Goyert HF, 2007, BRAIN RES BULL, V72, P1, DOI 10.1016/j.brainresbull.2006.12.010; Grossman KJ, 2008, EUR J NEUROSCI, V27, P2676, DOI 10.1111/j.1460-9568.2008.06213.x; HABERLY LB, 1978, J COMP NEUROL, V181, P781, DOI 10.1002/cne.901810407; Haddad R, 2008, NAT METHODS, V5, P425, DOI [10.1038/nmeth.1197, 10.1038/NMETH.1197]; Haddad R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000740; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Johnson BA, 2005, J COMP NEUROL, V483, P205, DOI 10.1002/cne.20409; Johnson BA, 2002, J COMP NEUROL, V449, P180, DOI 10.1002/cne.10284; Johnson BA, 1998, J COMP NEUROL, V393, P457, DOI 10.1002/(SICI)1096-9861(19980420)393:4<457::AID-CNE5>3.0.CO;2-#; Johnson BA, 2007, J COMP NEUROL, V503, P1, DOI 10.1002/cne.21396; Khan RM, 2007, J NEUROSCI, V27, P10015, DOI 10.1523/JNEUROSCI.1158-07.2007; LI Z, 1989, BIOL CYBERN, V61, P379, DOI 10.1007/BF00200803; Linster C, 2009, LEARN MEMORY, V16, P452, DOI 10.1101/lm.1403509; Maresh A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002640; Miyamichi K, 2013, NEURON, V80, P1232, DOI 10.1016/j.neuron.2013.08.027; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Naritsuka H, 2009, J COMP NEUROL, V515, P409, DOI 10.1002/cne.22063; Sakano H, 2010, NEURON, V67, P530, DOI 10.1016/j.neuron.2010.07.003; Snitz K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003184; Soh Z, 2014, CHEM SENSES, V39, P91, DOI 10.1093/chemse/bjt057; Soh Z, 2011, CHEM SENSES, V36, P413, DOI 10.1093/chemse/bjq147; Takiguchi N, 2008, CHEM SENSES, V33, P283, DOI 10.1093/chemse/bjm086; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; YAMAGUCHI M, 1981, P NATL ACAD SCI-BIOL, V78, P5817, DOI 10.1073/pnas.78.9.5817; Yamazaki K, 1999, P NATL ACAD SCI USA, V96, P1522, DOI 10.1073/pnas.96.4.1522; Youngentob SL, 2006, BEHAV NEUROSCI, V120, P1337, DOI 10.1037/0735-7044.120.6.1337	33	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0165230	10.1371/journal.pone.0165230	http://dx.doi.org/10.1371/journal.pone.0165230			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992433	Green Published, Green Submitted, gold			2022-12-26	WOS:000392842600003
J	Galluzzi, L; Diotallevi, A; De Santi, M; Ceccarelli, M; Vitale, F; Brandi, G; Magnani, M				Galluzzi, Luca; Diotallevi, Aurora; De Santi, Mauro; Ceccarelli, Marcello; Vitale, Fabrizio; Brandi, Giorgio; Magnani, Mauro			Leishmania infantum Induces Mild Unfolded Protein Response in Infected Macrophages	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; CELL-SURVIVAL; ENDOTHELIAL-CELLS; INDUCED APOPTOSIS; GENE-EXPRESSION; TRANSLATION; CONTRIBUTES; ACTIVATION; REPRESSION; INDUCTION	The Leishmaniases are a group of parasitic diseases caused by protozoa of the Leishmania genus affecting both humans and other vertebrates. Leishmania is an intracellular pathogen able to confer resistance to apoptosis in the early phase of macrophages infection by activation of host PI3K/Akt pathway and inhibition of caspase-3 activation. Intracellular pathogens hijack organelles such as ER to facilitate survival and replication, thus eliciting ER stress and activating/modulating the unfolded protein response (UPR) in the host cell. The UPR is aimed to mitigate ER stress, thereby promoting cell survival. However, prolonged ER stress will activate the apoptotic pathway. The aim of this study was to investigate the ER stress response in Leishmania-infected macrophages to gain insights about the mechanisms underlying the apoptosis resistance in parasitized cells. Macrophages differentiated from human monocytic cell lines (U937 and THP-1) and murine primary macrophages were infected with Leishmania infantum MHOM/TN/80/IPT1 (WHO international reference strain). Several ER stress/autophagy expression markers, as well as cell survival/apoptosis markers (phospho-Akt and cleaved caspase-3) were evaluated by qPCR and/or by western blotting. As ER stress positive control, cells were treated with tunicamycin or dithiothreitol (DTT). The gene expression analyses showed a mild but significant induction of the ER stress/autophagy markers. The western blot analyses revealed that the Leishmania infection induced Akt phosphorylation and significantly inhibited the induction of caspase-3 cleavage, eIF2 alpha phosphorylation and DDIT3/CHOP expression in tunicamycin and DTT treated cells. The mild but significant increase in ER stress expression markers and the delay/attenuation of the effects of ER stress inducers in infected cells support the hypothesis that L. infantum could promote survival of host cells by inducing a mild ER stress response. The host ER stress response could be not only a common pathogenic mechanism among Leishmania species but also a target for development of new drugs.	[Galluzzi, Luca; Diotallevi, Aurora; De Santi, Mauro; Ceccarelli, Marcello; Brandi, Giorgio; Magnani, Mauro] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy; [Vitale, Fabrizio] Ist Zooprofilatt Sperimentale Sicily A Mirri, Palermo, Italy	University of Urbino	Galluzzi, L (corresponding author), Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy.	luca.galluzzi@uniurb.it	De Santi, Mauro/F-5401-2013; Diotallevi, Aurora/ABB-2931-2021; Galluzzi, Luca/G-3969-2012; Magnani, Mauro/A-1919-2008; Vitale, Fabrizio/I-6015-2016	De Santi, Mauro/0000-0003-2983-8344; Diotallevi, Aurora/0000-0001-5456-1821; Galluzzi, Luca/0000-0002-1747-526X; Magnani, Mauro/0000-0001-6456-6626; Vitale, Fabrizio/0000-0002-5527-1890	Italian Ministry of Health [2014 IZS SI 03/14, H78F15000030001]	Italian Ministry of Health(Ministry of Health, Italy)	This work was partially supported by Italian Ministry of Health (Ricerca corrente 2014 IZS SI 03/14; code H78F15000030001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akarid K, 2004, J LEUKOCYTE BIOL, V76, P95, DOI 10.1189/jlb.1001877; Bettigole SE, 2015, ANNU REV IMMUNOL, V33, P107, DOI 10.1146/annurev-immunol-032414-112116; Buates S, 2001, J IMMUNOL, V166, P3416, DOI 10.4049/jimmunol.166.5.3416; Calegari-Silva TC, 2009, IMMUNOL LETT, V127, P19, DOI 10.1016/j.imlet.2009.08.009; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Castelli G, 2014, J PARASITOL, V100, P228, DOI 10.1645/13-253.1; Ceccarelli M, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0460-3; Ceccarelli M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088845; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; De Santi M, 2015, ANTI-CANCER AGENT ME, V15, P896; Dias-Teixeira KL, 2016, FASEB J, V30, P1557, DOI 10.1096/fj.15-281550; Duque GA, 2015, CURR OPIN MICROBIOL, V26, P32, DOI 10.1016/j.mib.2015.04.007; Galluzzi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043249; Hamanaka RB, 2009, ONCOGENE, V28, P910, DOI 10.1038/onc.2008.428; Inacio P, 2015, EMBO REP, V16, P955, DOI 10.15252/embr.201439979; Jaramillo M, 2011, CELL HOST MICROBE, V9, P331, DOI 10.1016/j.chom.2011.03.008; Kennedy D, 2014, FEBS OPEN BIO, V4, P813, DOI 10.1016/j.fob.2014.09.004; Li B, 2011, CELL SIGNAL, V23, P35, DOI 10.1016/j.cellsig.2010.07.019; Lim YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028531; Lisi S, 2005, J EUKARYOT MICROBIOL, V52, P211, DOI 10.1111/j.1550-7408.2005.00026.x; Luz NF, 2012, J IMMUNOL, V188, P4460, DOI 10.4049/jimmunol.1103072; Margariti A, 2013, J BIOL CHEM, V288, P859, DOI 10.1074/jbc.M112.412783; Martin D, 2014, J BIOL CHEM, V289, P30625, DOI 10.1074/jbc.M114.571984; Martinon F, 2011, CURR OPIN IMMUNOL, V23, P35, DOI 10.1016/j.coi.2010.10.016; Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007; Menotta M, 2012, J BIOL CHEM, V287, P41352, DOI 10.1074/jbc.M112.344473; Mercado G, 2013, TRENDS MOL MED, V19, P165, DOI 10.1016/j.molmed.2012.12.005; Mollereau B, 2014, J CELL COMMUN SIGNAL, V8, P311, DOI 10.1007/s12079-014-0251-9; Mollereau B, 2013, MOL CELL BIOL, V33, P2372, DOI 10.1128/MCB.00315-13; MOORE KJ, 1994, J IMMUNOL, V152, P2930; Ovalle-Bracho C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128934; Pal S, 2006, J CELL BIOL, V174, P1047, DOI 10.1083/jcb.200603152; Podinovskaia M, 2015, FUTURE MICROBIOL, V10, P111, DOI 10.2217/fmb.14.103; Preston AM, 2013, J CELL SCI, V126, P4253, DOI 10.1242/jcs.130336; Real F, 2014, CELL MICROBIOL, V16, P1549, DOI 10.1111/cmi.12311; Reale S, 1999, J CLIN MICROBIOL, V37, P2931, DOI 10.1128/JCM.37.9.2931-2935.1999; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Ruhland A, 2007, CELL MICROBIOL, V9, P84, DOI 10.1111/j.1462-5822.2006.00769.x; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; van 't Wout EFA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004946; Vivarini AD, 2011, FASEB J, V25, P4162, DOI 10.1096/fj.11-185165; Yamaguchi S, 2008, CELL METAB, V7, P269, DOI 10.1016/j.cmet.2008.01.008; Yamamoto M, 2011, J EXP MED, V208, P1533, DOI 10.1084/jem.20101660; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145; Zhang XZ, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-4	45	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168339	10.1371/journal.pone.0168339	http://dx.doi.org/10.1371/journal.pone.0168339			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27978534	Green Published, Green Submitted, gold			2022-12-26	WOS:000391217400095
J	Pabbidi, MR; Ji, X; Maxwell, JT; Mignery, GA; Samarel, AM; Lipsius, SL				Pabbidi, M. R.; Ji, X.; Maxwell, J. T.; Mignery, G. A.; Samarel, A. M.; Lipsius, S. L.			Inhibition of cAMP-Dependent PKA Activates beta(2)-Adrenergic Receptor Stimulation of Cytosolic Phospholipase A(2) via Raf-1/MEK/ERK and IP3-Dependent Ca2+ Signaling in Atrial Myocytes	PLOS ONE			English	Article							PROTEIN-KINASE-C; ARACHIDONIC-ACID RELEASE; CARDIAC-MUSCLE-CELLS; VENTRICULAR MYOCYTES; ADENYLYL-CYCLASE; HEART-FAILURE; MESSENGER-RNA; NO RELEASE; CAVEOLAE; PHOSPHORYLATION	We previously reported in atrial myocytes that inhibition of cAMP-dependent protein kinase (PKA) by laminin (LMN)-integrin signaling activates beta(2)-adrenergic receptor (beta(2)-AR) stimulation of cytosolic phospholipase A(2) (cPLA(2)). The present study sought to determine the signaling mechanisms by which inhibition of PKA activates beta(2)-AR stimulation of cPLA(2). We therefore determined the effects of zinterol (0.1 mu M; zint-beta(2)-AR) to stimulate I-Ca,I- L in atrial myocytes in the absence (+ PKA) and presence (-PKA) of the PKA inhibitor (1 mu M) KT5720 and compared these results with atrial myocytes attached to laminin (+ LMN). Inhibition of Raf-1 (10 mu M GW5074), phospholipase C (PLC; 0.5 mu M edelfosine), PKC (4 mu M chelerythrine) or IP3 receptor (IP3R) signaling (2 mu M 2-APB) significantly inhibited zint-beta(2)-AR stimulation of ICa, L in-PKA but not + PKA myocytes. Western blots showed that zint-beta(2)-AR stimulation increased ERK1/2 phosphorylation in-PKA compared to + PKA myocytes. Adenoviral (Adv) expression of dominant negative (dn)-PKC alpha, dn-Raf-1 or an IP3 affinity trap, each inhibited zint-beta(2)-AR stimulation of ICa, L in + LMN myocytes compared to control + LMN myocytes infected with Adv-beta gal. In + LMN myocytes, zint-beta(2)-AR stimulation of ICa, L was enhanced by adenoviral overexpression of wild-type cPLA(2) and inhibited by double dn-cPLA2 S505A/S515A mutant compared to control + LMN myocytes infected with Adv-beta gal. In-PKA myocytes depletion of intracellular Ca2+ stores by 5 mu M thapsigargin failed to inhibit zint-beta(2)-AR stimulation of ICa, L via cPLA(2). However, disruption of caveolae formation by 10 mM methyl-beta-cyclodextrin inhibited zint-beta(2)-AR stimulation of ICa, L -PKA myocytes significantly more than in + PKA myocytes. We conclude that inhibition of PKA removes inhibition of Raf-1 and thereby allows beta(2)-AR stimulation to act via PKCa/Raf-1/MEK/ERK1/2 and IP3-mediated Ca2+ signaling to stimulate cPLA(2) signaling within caveolae. These findings may be relevant to the remodeling of beta-AR signaling in failing and/or aging heart, both of which exhibit decreases in adenylate cyclase activity.	[Pabbidi, M. R.] Univ Mississippi, Med Ctr, Dept Pharmacol, Jackson, MS 39216 USA; [Ji, X.; Maxwell, J. T.; Mignery, G. A.; Lipsius, S. L.] Loyola Univ, Med Ctr, Dept Physiol, Maywood, IL 60153 USA; [Samarel, A. M.] Loyola Univ, Med Ctr, Dept Med, Maywood, IL 60153 USA	University of Mississippi; University of Mississippi Medical Center; Loyola University Chicago; Loyola University Chicago	Pabbidi, MR (corresponding author), Univ Mississippi, Med Ctr, Dept Pharmacol, Jackson, MS 39216 USA.	mpabbidi@umc.edu	Samarel, Allen/Q-9810-2019		NIH [HL079038, HL62426-Project 4]; AHA [13SDG14000006]; Dr.Ralph and Marian Falk Medical Research Trust	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); Dr.Ralph and Marian Falk Medical Research Trust	This work was supported by NIH grants HL079038 (S.L.L.), HL62426-Project 4 and AHA Scientist Development Grant (13SDG14000006) (M.R.P.) and a grant from the Dr.Ralph and Marian Falk Medical Research Trust (A.M.S.).	Ait-Mamar B, 2005, J BIOL CHEM, V280, P18881, DOI 10.1074/jbc.M410305200; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; BRISTOW MR, 1989, MOL PHARMACOL, V35, P295; BRODDE OE, 1995, J CARDIOVASC PHARM, V26, P20, DOI 10.1097/00005344-199507000-00004; Carpenter L, 2001, J BIOL CHEM, V276, P5368, DOI 10.1074/jbc.M010036200; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Domeier TL, 2008, AM J PHYSIOL-HEART C, V294, pH596, DOI 10.1152/ajpheart.01155.2007; Farrell SR, 2008, MECH AGEING DEV, V129, P735, DOI 10.1016/j.mad.2008.09.017; FUJIMOTO T, 1992, J CELL BIOL, V119, P1507, DOI 10.1083/jcb.119.6.1507; Gerits N, 2008, CELL SIGNAL, V20, P1592, DOI 10.1016/j.cellsig.2008.02.022; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Gijon MA, 1999, J LEUKOCYTE BIOL, V65, P330, DOI 10.1002/jlb.65.3.330; Goel A, 2003, CLIN CANCER RES, V9, P383; HAFNER S, 1994, MOL CELL BIOL, V14, P6696; Heidkamp MC, 2001, CIRC RES, V89, P882, DOI 10.1161/hh2201.099434; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; Hirabayashi T, 2004, BIOL PHARM BULL, V27, P1168, DOI 10.1248/bpb.27.1168; Iijima Y, 2002, J BIOL CHEM, V277, P23065, DOI 10.1074/jbc.M200328200; ISHIKAWA Y, 1994, J CLIN INVEST, V93, P2224, DOI 10.1172/JCI117219; Kohno Michiaki, 2003, Prog Cell Cycle Res, V5, P219; Lefkowitz RJ, 2002, MOL PHARMACOL, V62, P971, DOI 10.1124/mol.62.5.971; Liu YC, 2007, CLIN EXP PHARMACOL P, V34, P1173, DOI 10.1111/j.1440-1681.2007.04696.x; Luciani MG, 2007, CARCINOGENESIS, V28, P2207, DOI 10.1093/carcin/bgm101; Magne S, 2001, J BIOL CHEM, V276, P39539, DOI 10.1074/jbc.M100954200; MARZO KP, 1991, CIRC RES, V69, P1546, DOI 10.1161/01.RES.69.6.1546; Moschella PC, 2007, J MOL CELL CARDIOL, V43, P754, DOI 10.1016/j.yjmcc.2007.09.015; Nalli AD, 2014, CELL BIOCHEM BIOPHYS, V70, P867, DOI 10.1007/s12013-014-9992-6; Pabbidi MR, 2009, J PHYSIOL-LONDON, V587, P4785, DOI 10.1113/jphysiol.2009.179226; Pavicevic Z, 2008, J LIPID RES, V49, P724, DOI 10.1194/jlr.M700419-JLR200; Pavoine C, 1999, J BIOL CHEM, V274, P628, DOI 10.1074/jbc.274.2.628; Ping PP, 1999, AM J PHYSIOL-HEART C, V276, pH1468, DOI 10.1152/ajpheart.1999.276.5.H1468; POWIS G, 1992, CANCER RES, V52, P2835; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; SCHNITZER JE, 1995, P NATL ACAD SCI USA, V92, P1759, DOI 10.1073/pnas.92.5.1759; Smart EJ, 2002, METHOD ENZYMOL, V353, P131; Taylor RP, 2003, ACTA PHYSIOL SCAND, V178, P107, DOI 10.1046/j.1365-201X.2003.01132.x; Tselentakis EV, 2006, J SURG RES, V135, P68, DOI 10.1016/j.jss.2006.03.024; Uddin S, 2010, INT J CANCER, V126, P382, DOI 10.1002/ijc.24757; van Rossum DB, 2009, CELL CALCIUM, V45, P535, DOI 10.1016/j.ceca.2009.02.008; Wang LC, 2013, MOL MED REP, V8, P1465, DOI 10.3892/mmr.2013.1676; Wang YZ, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/1/015001; Wang YG, 2005, J PHYSIOL-LONDON, V567, P143, DOI 10.1113/jphysiol.2005.090035; Wang YG, 2002, J GEN PHYSIOL, V119, P69, DOI 10.1085/jgp.119.1.69; Wang YG, 2000, J PHYSIOL-LONDON, V526, P57, DOI 10.1111/j.1469-7793.2000.t01-1-00057.x; Wang YG, 2000, J PHYSIOL-LONDON, V527, P3, DOI 10.1111/j.1469-7793.2000.t01-2-00003.x; Wu X, 2006, CIRC RES, V99, P283, DOI 10.1161/01.RES.0000233386.02708.72; Yan L, 2007, CELL, V130, P247, DOI 10.1016/j.cell.2007.05.038; Zamah AM, 2002, J BIOL CHEM, V277, P31249, DOI 10.1074/jbc.M202753200; Zima AV, 2004, J PHYSIOL-LONDON, V555, P607, DOI 10.1113/jphysiol.2003.058529	50	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168505	10.1371/journal.pone.0168505	http://dx.doi.org/10.1371/journal.pone.0168505			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977772	gold, Green Submitted, Green Published			2022-12-26	WOS:000391217400114
J	Shimizu, M; Tanaka, M; Atomi, Y				Shimizu, Miho; Tanaka, Mikihito; Atomi, Yoriko			Small Heat Shock Protein alpha B-Crystallin Controls Shape and Adhesion of Glioma and Myoblast Cells in the Absence of Stress	PLOS ONE			English	Article							SKELETAL-MUSCLE; MITOCHONDRIAL-FUNCTION; TUBULIN; MIGRATION; CYTOSKELETON; HYPERTROPHY; ASSOCIATION; MECHANISM; ACTIN; LENS	Cell shape and adhesion and their proper controls are fundamental for all biological systems. Mesenchymal cells migrate at an average rate of 6 to 60 mu m/hr, depending on the extracellular matrix environment and cell signaling. Myotubes, fully differentiated muscle cells, are specialized for power-generation and therefore lose motility. Cell spreading and stabilities of focal adhesion are regulated by the critical protein vinculin from immature myoblast to mature costamere of differentiated myotubes where myofibril Z-band linked to sarcolemma. The Z-band is constituted from microtubules, intermediate filaments, cell adhesion molecules and other adapter proteins that communicate with the outer environment. Mesenchymal cells, including myoblast cells, convert actomyosin contraction forces to tension through mechanoresponsive adhesion assembly complexes as Z-band equivalents. There is growing evidence that microtubule dynamics are involved in the generation of contractile forces; however, the roles of microtubules in cell adhesion dynamics are not well determined. Here, we show for the first time that alpha B-crystallin, a molecular chaperon for tubulin/microtubules, is involved in cell shape determination. Moreover, knockdown of this molecule caused myoblasts and glioma cells to lose their ability for adhesion as they tended to behave like migratory cells. Surprisingly, aB-crystallin knockdown in both C6 glial cells and L6 myoblast permitted cells to migrate more rapidly (2.7 times faster for C6 and 1.3 times faster for L6 cells) than dermal fibroblast. On the other hand, overexpression of aB-crystallin in cells led to an immortal phenotype because of persistent adhesion. Position of matured focal adhesion as visualized by vinculin immuno-staining, stress fiber direction, length, and density were clearly aB-crystallin dependent. These results indicate that the small HSP aB-crystallin has important roles for cell adhesion, and thus microtubule dynamics are necessary for persistent adhesion.	[Shimizu, Miho; Atomi, Yoriko] Tokyo Univ Agr & Technol, Grad Sch Engn, Mat Hlth Sci Lab, Tokyo, Japan; [Tanaka, Mikihito] Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan; [Tanaka, Mikihito] Waseda Univ, Grad Sch Polit Sci, Tokyo, Japan	Tokyo University of Agriculture & Technology; University of Tokyo; Waseda University	Atomi, Y (corresponding author), Tokyo Univ Agr & Technol, Grad Sch Engn, Mat Hlth Sci Lab, Tokyo, Japan.	yatomi@cc.tuat.ac.jp	Atomi, Yoriko/AAF-4783-2019; Shimizu, Miho/O-9903-2019	Atomi, Yoriko/0000-0003-3808-6543; Shimizu, Miho/0000-0003-4070-8209	Japan Society for the Promotion of Science [10480004, 11167218, 12308001, 13022213, 21650171, 23650416, 26560323]; Japan Space Utilization Promotion Center [FY1999-2001]; Japan Space Forum [FY1997-2000]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Space Utilization Promotion Center; Japan Space Forum	YA received Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (#10480004: https://kaken.nii.ac.jp/d/p/10480004.ja.html; #11167218: https://kaken.nii.ac.jp/d/p/11167218.ja.html; #12308001: https://kaken.nii.ac.jp/d/p/12308001.ja.html; #13022213: https://kaken.nii.ac.jp/d/p/13022213.ja.html; #21650171: https://kaken.nii.ac.jp/d/p/21650171.ja.html; #23650416: https://kaken.nii.ac.jp/d/p/23650416.ja.html; #26560323: https://kaken.nii.ac.jp/d/p/26560323.ja.html), Research grant from Japan Space Utilization Promotion Center (FY1999-2001), and Research grant from Japan Space Forum (FY1997-2000).	Arac A, 2011, P NATL ACAD SCI USA, V108, P13287, DOI 10.1073/pnas.1107368108; Arrigo AP, 2007, FEBS LETT, V581, P3665, DOI 10.1016/j.febslet.2007.04.033; ATOMI Y, 1991, J BIOCHEM-TOKYO, V110, P812, DOI 10.1093/oxfordjournals.jbchem.a123665; ATOMI Y, 1991, BIOCHEM BIOPH RES CO, V181, P1323, DOI 10.1016/0006-291X(91)92083-V; Atomi Y, 2000, J APPL PHYSIOL, V88, P1355, DOI 10.1152/jappl.2000.88.4.1355; Bai F, 2004, MOL CELL BIOCHEM, V265, P115, DOI 10.1023/B:MCBI.0000044365.48900.82; Bailey AP, 2015, CELL, V163, P340, DOI 10.1016/j.cell.2015.09.020; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; Bonakdar N, 2015, EXP CELL RES, V331, P331, DOI 10.1016/j.yexcr.2014.10.001; Bullard B, 2004, J BIOL CHEM, V279, P7917, DOI 10.1074/jbc.M307473200; Case LB, 2015, NAT CELL BIOL, V17, P880, DOI 10.1038/ncb3180; Chao CC, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.414; Collin L, 2008, BIOL CELL, V100, P243, DOI 10.1042/BC20070123; Dimou L, 2014, PHYSIOL REV, V94, P709, DOI 10.1152/physrev.00036.2013; Ellis RJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0398; Ferreira MM, 2015, INTEGR BIOL-UK, V7, P569, DOI 10.1039/c5ib00060b; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Friedl P, 2008, NAT IMMUNOL, V9, P960, DOI 10.1038/ni.f.212; Fujita Y, 2004, J CELL SCI, V117, P1719, DOI 10.1242/jcs.01021; Gangalum RK, 2011, J BIOL CHEM, V286, P3261, DOI 10.1074/jbc.M110.160135; Gangalum RK, 2009, INVEST OPHTH VIS SCI, V50, P3283, DOI 10.1167/iovs.08-3052; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Greenlee M, 2016, MOL BIOL CELL, V27; Guo AH, 2010, J INVEST DERMATOL, V130, P2320, DOI 10.1038/jid.2010.96; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Houck SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011795; Hsia DA, 2003, J CELL BIOL, V160, P753, DOI 10.1083/jcb.200212114; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; IWAKI T, 1994, J CELL BIOL, V125, P1385, DOI 10.1083/jcb.125.6.1385; Kampinga HH, 2012, INT J BIOCHEM CELL B, V44, P1706, DOI 10.1016/j.biocel.2012.06.005; Knight B, 2000, CURR BIOL, V10, P576, DOI 10.1016/S0960-9822(00)00486-3; Kobayashi T, 1997, ZOOL SCI, V14, P595, DOI 10.2108/zsj.14.595; Kuznetsov AV, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00082; Lee J, 1999, NATURE, V400, P382, DOI 10.1038/22578; Lepekhin EA, 2001, J NEUROCHEM, V79, P617, DOI 10.1046/j.1471-4159.2001.00595.x; Lorea-Hernandez JJ, 2016, GLIA, V64, P603, DOI 10.1002/glia.22951; Martinac B, 2014, BBA-BIOMEMBRANES, V1838, P682, DOI 10.1016/j.bbamem.2013.07.015; McGreal RS, 2012, BBA-GEN SUBJECTS, V1820, P921, DOI 10.1016/j.bbagen.2012.04.004; Menconi M, 2008, J CELL BIOCHEM, V105, P353, DOI 10.1002/jcb.21833; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Molyneaux KA, 2001, DEV BIOL, V240, P488, DOI 10.1006/dbio.2001.0436; Nadarajah B, 2003, CEREB CORTEX, V13, P607, DOI 10.1093/cercor/13.6.607; Ng DHJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115213; Ohto-Fujita E, 2007, CELL STRESS CHAPERON, V12, P163, DOI 10.1379/CSC-255.1; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Pereira MBM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6159; Peterson Courtney M, 2012, J Aging Res, V2012, P194821, DOI 10.1155/2012/194821; Pletjushkina OJ, 2001, CELL MOTIL CYTOSKEL, V48, P235, DOI 10.1002/cm.1012.abs; Prosser BL, 2011, SCIENCE, V333, P1440, DOI 10.1126/science.1202768; Pullar CE, 2005, J CELL SCI, V118, P2023, DOI 10.1242/jcs.02330; Quinlan RA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0091; Ray PS, 2001, FASEB J, V15, P393, DOI 10.1096/fj.00-0199com; Reddy VS, 2015, CURR MOL MED, V15, P47, DOI 10.2174/1566524015666150114112853; Rostovtseva TK, 2012, BBA-BIOMEMBRANES, V1818, P1526, DOI 10.1016/j.bbamem.2011.11.004; Sakurai T, 2005, FASEB J, V19, P1199, DOI 10.1096/fj.04-3060fje; SARABIA V, 1990, BIOCHEM CELL BIOL, V68, P536, DOI 10.1139/o90-076; Schmidt T, 2012, HISTOCHEM CELL BIOL, V138, P407, DOI 10.1007/s00418-012-0964-x; Shao W, 2013, NATURE, V494, P90, DOI 10.1038/nature11748; Sharples AP, 2011, CURR OPIN CLIN NUTR, V14, P230, DOI 10.1097/MCO.0b013e3283457ade; SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320; Stehbens SJ, 2014, NAT CELL BIOL, V16, P558, DOI 10.1038/ncb2975; Stephens DJ, 2012, J CELL SCI, V125, P2795, DOI 10.1242/jcs.097675; Su SP, 2011, BBA-PROTEINS PROTEOM, V1814, P647, DOI 10.1016/j.bbapap.2011.03.014; Valeyev Najl V., 2006, In Silico Biology, V6, P545; van Wessel T, 2010, EUR J APPL PHYSIOL, V110, P665, DOI 10.1007/s00421-010-1545-0; Versaevel M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1668; Volkenhoff A, 2015, CELL METAB, V22, P437, DOI 10.1016/j.cmet.2015.07.006; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Wojtowicz I, 2015, DEVELOPMENT, V142, P994, DOI 10.1242/dev.115352; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yamamoto S, 2014, BIOCHEM BIOPH RES CO, V455, P241, DOI 10.1016/j.bbrc.2014.10.151	73	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168136	10.1371/journal.pone.0168136	http://dx.doi.org/10.1371/journal.pone.0168136			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977738	gold, Green Published, Green Submitted			2022-12-26	WOS:000391217400066
J	Moretti, S; Menicali, E; Nucci, N; Voce, P; Colella, R; Melillo, RM; Liotti, F; Morelli, S; Fallarino, F; Macchiarulo, A; Santoro, M; Avenia, N; Puxeddu, E				Moretti, Sonia; Menicali, Elisa; Nucci, Nicole; Voce, Pasquale; Colella, Renato; Melillo, Rosa Marina; Liotti, Federica; Morelli, Silvia; Fallarino, Francesca; Macchiarulo, Antonio; Santoro, Massimo; Avenia, Nicola; Puxeddu, Efisio			Signal Transducer and Activator of Transcription 1 Plays a Pivotal Role in RET/PTC3 Oncogene-induced Expression of Indoleamine 2,3-Dioxygenase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; cell signaling; indoleamine-pyrrole 2; 3-dioxygenase (IDO1); interferon regulatory factor (IRF); signal transducers and activators of transcription 1 (STAT1)	NF-KAPPA-B; THYROID PCCL3 CELLS; KINASE-C-DELTA; DENDRITIC CELLS; GENE-EXPRESSION; STAT1; IDO; PHOSPHORYLATION; RESISTANCE	Indoleamine 2,3-dioxygenase 1 (IDO1) is a single chain oxidoreductase that catalyzes tryptophan degradation to kynurenine. In cancer, it exerts an immunosuppressive function as part of an acquired mechanism of immune escape. Recently, we demonstrated that IDO1 expression is significantly higher in all thyroid cancer histotypes compared with normal thyroid and that its expression levels correlate with T regulatory (Treg) lymphocyte densities in the tumor microenvironment. BRAF(V600E)- and RET/PTC3-expressing PcCL3 cells were used as cellular models for the evaluation of IDO1 expression in thyroid carcinoma cells and for the study of involved signal transduction pathways. BRAF(V600E)-expressing PcCL3 cells did not show IDO1 expression. Conversely, RET/PTC3-expressing cells were characterized by a high IDO1 expression. Moreover, we found that, the STAT1-IRF1 pathway was instrumental for IDO1 expression in RET/PTC3 expressing cells. In detail, RET/PTC3 induced STAT1 overexpression and phosphorylation at Ser-727 and Tyr-701. STAT1 transcriptional regulation appeared to require activation of the canonical NF-B pathway. Conversely, activation of the MAPK and PI3K-AKT pathways primarily regulated Ser-727 phosphorylation, whereas a physical interaction between RET/PTC3 and STAT1, followed by a direct tyrosine phosphorylation event, was necessary for STAT1 Tyr-701 phosphorylation. These data provide the first evidence of a direct link between IDO1 expression and the oncogenic activation of RET in thyroid carcinoma and describe the involved signal transduction pathways. Moreover, they suggest possible novel molecular targets for the abrogation of tumor microenvironment immunosuppression. The detection of those targets is becoming increasingly important to yield the full function of novel immune checkpoint inhibitors.	[Moretti, Sonia; Menicali, Elisa; Nucci, Nicole; Voce, Pasquale; Morelli, Silvia; Puxeddu, Efisio] Univ Perugia, Dept Med, I-06100 Perugia, Italy; [Colella, Renato; Fallarino, Francesca] Univ Perugia, Dept Expt Med, I-06100 Perugia, Italy; [Macchiarulo, Antonio] Univ Perugia, Dept Pharmaceut Sci, I-06100 Perugia, Italy; [Avenia, Nicola] Univ Perugia, Dept Surg & Biomed Sci, I-06100 Perugia, Italy; [Moretti, Sonia; Menicali, Elisa; Nucci, Nicole; Voce, Pasquale; Morelli, Silvia; Avenia, Nicola; Puxeddu, Efisio] Univ Perugia, Res Ctr Thyroid Prote & Genom CRiProGeT, I-05100 Terni, Italy; [Melillo, Rosa Marina; Liotti, Federica; Santoro, Massimo] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Melillo, Rosa Marina] CNR, Ist Endocrinol & Oncol Sperimentale, I-80131 Naples, Italy	University of Perugia; University of Perugia; University of Perugia; University of Perugia; University of Perugia; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR)	Puxeddu, E (corresponding author), Edificio D,Piano 2,Piazza L Severi 1, I-06132 Perugia, Italy.	efisio.puxeddu@unipg.it	Liotti, Federica/AAC-1614-2019; Macchiarulo, Antonio/L-2846-2017; Avenia, Nicola/AAL-4546-2021; melillo, rosa marina/O-5255-2015; Fallarino, Francesca/O-3358-2013	Liotti, Federica/0000-0002-0145-988X; Macchiarulo, Antonio/0000-0001-9535-4183; Fallarino, Francesca/0000-0002-8501-2136	Fondazione Cassa di Risparmio di Perugia; Associazione Italiana per la Ricerca sul Cancro [IG 9338]; Beadle Family Foundation; Brunello Cucinelli Foundation	Fondazione Cassa di Risparmio di Perugia(Fondazione Cassa Risparmio Perugia); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Beadle Family Foundation; Brunello Cucinelli Foundation	This work was supported by grants from the Fondazione Cassa di Risparmio di Perugia, Associazione Italiana per la Ricerca sul Cancro (IG 9338), and a liberal contribution from the Beadle Family Foundation (San Antonio, TX) and the Brunello Cucinelli Foundation (Corciano, Italy) (all to E.P.). The authors declare that they have no conflicts of interest with the contents of this article.	Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Carlomagno F, 2004, ONCOGENE, V23, P6056, DOI 10.1038/sj.onc.1207810; Carlomagno F, 2002, CANCER RES, V62, P1077; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Deb DK, 2003, J IMMUNOL, V171, P267, DOI 10.4049/jimmunol.171.1.267; Encinas M, 2004, J BIOL CHEM, V279, P18262, DOI 10.1074/jbc.M400505200; FUSCO A, 1987, MOL CELL BIOL, V7, P3365, DOI 10.1128/MCB.7.9.3365; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang L, 2010, INT REV IMMUNOL, V29, P133, DOI 10.3109/08830180903349669; Hwang ES, 2004, MOL ENDOCRINOL, V18, P2672, DOI 10.1210/me.2004-0168; Iavarone C, 2006, J BIOL CHEM, V281, P10567, DOI 10.1074/jbc.M513397200; Jeong YI, 2009, J BIOL CHEM, V284, P3700, DOI 10.1074/jbc.M807328200; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Menicali Elisa, 2012, Front Endocrinol (Lausanne), V3, P67, DOI 10.3389/fendo.2012.00067; Mitsutake N, 2006, ENDOCRINOLOGY, V147, P1014, DOI 10.1210/en.2005-0280; Mitsutake N, 2005, CANCER RES, V65, P2465, DOI 10.1158/0008-5472.CAN-04-3314; Moretti S, 2014, J CLIN ENDOCR METAB, V99, pE832, DOI 10.1210/jc.2013-3351; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Neely RJ, 2011, ONCOGENE, V30, P87, DOI 10.1038/onc.2010.396; Nguyen H, 2001, J BIOL CHEM, V276, P33361, DOI 10.1074/jbc.M105070200; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Ogasawara N, 2009, J CELL BIOCHEM, V108, P716, DOI 10.1002/jcb.22308; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Puccetti P, 2007, NAT REV IMMUNOL, V7, P817, DOI 10.1038/nri2163; Puxeddu E, 2005, ENDOCR-RELAT CANCER, V12, P319, DOI 10.1677/erc.1.00947; Tas SW, 2007, BLOOD, V110, P1540, DOI 10.1182/blood-2006-11-056010; Uddin S, 2002, J BIOL CHEM, V277, P14408, DOI 10.1074/jbc.M109671200; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Wang JW, 2003, MOL ENDOCRINOL, V17, P1425, DOI 10.1210/me.2003-0041	32	14	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1785	1797		10.1074/jbc.M116.745448	http://dx.doi.org/10.1074/jbc.M116.745448			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27994058	hybrid, Green Published			2022-12-26	WOS:000395515600020
J	Taylor, NG; Swenson, S; Harris, NJ; Germany, EM; Fox, JL; Khalimonchuk, O				Taylor, Nicholas G.; Swenson, Samantha; Harris, Nicholas J.; Germany, Edward M.; Fox, Jennifer L.; Khalimonchuk, Oleh			The Assembly Factor Pet117 Couples Heme a Synthase Activity to Cytochrome Oxidase Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome c oxidase (Complex IV); heme; mitochondria; mitochondrial disease; oligomerization; Cox15; Pet117	SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL FERREDOXIN; COX1 MATURATION; YEAST; PROTEIN; BIOGENESIS; CENTERS; MSS51P; OMA1; COA2	Heme a is an essential metalloporphyrin cofactor of the mitochondrial respiratory enzyme cytochrome c oxidase (CcO). Its synthesis from heme b requires several enzymes, including the evolutionarily conserved heme a synthase (Cox15). Oligomerization of Cox15 appears to be important for the process of heme a biosynthesis and transfer to maturing CcO. However, the details of this process remain elusive, and the roles of any additional CcO assembly factors that may be involved remain unclear. Here we report the systematic analysis of one such uncharacterized assembly factor, Pet117, and demonstrate in Saccharomyces cerevisiae that this evolutionarily conserved protein is necessary for Cox15 oligomerization and function. Pet117 is shown to reside in the mitochondrial matrix, where it is associated with the inner membrane. Pet117 functions at the later maturation stages of the core CcO subunit Cox1 that precede Cox1 hemylation. Pet117 also physically interacts with Cox15 and specifically mediates the stability of Cox15 oligomeric complexes. This Cox15-Pet117 interaction observed by co-immunoprecipitation persists in the absence of heme a synthase activity, is dependent upon Cox1 synthesis and early maturation steps, and is further dependent upon the presence of the matrix-exposed, unstructured linker region of Cox15 needed for Cox15 oligomerization, suggesting that this region mediates the interaction or that the interaction is lost when Cox15 is unable to oligomerize. Based on these findings, it was concluded that Pet117 mediates coupling of heme a synthesis to the CcO assembly process in eukaryotes.	[Taylor, Nicholas G.; Harris, Nicholas J.; Fox, Jennifer L.] Coll Charleston, Dept Chem & Biochem, 66 George St, Charleston, SC 29424 USA; [Swenson, Samantha; Germany, Edward M.; Khalimonchuk, Oleh] Univ Nebraska, Dept Biochem, 1901 Vine St,N230 BEAD, Lincoln, NE 68588 USA; [Swenson, Samantha; Germany, Edward M.; Khalimonchuk, Oleh] Univ Nebraska, Nebraska Redox Biol Ctr, 1901 Vine St,N230 BEAD, Lincoln, NE 68588 USA	College of Charleston; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Fox, JL (corresponding author), Coll Charleston, Dept Chem & Biochem, 66 George St, Charleston, SC 29424 USA.; Khalimonchuk, O (corresponding author), Univ Nebraska, Dept Biochem, 1901 Vine St,N230 BEAD, Lincoln, NE 68588 USA.; Khalimonchuk, O (corresponding author), Univ Nebraska, Nebraska Redox Biol Ctr, 1901 Vine St,N230 BEAD, Lincoln, NE 68588 USA.	foxjl@cofc.edu; okhalimonchuk2@unl.edu	Khalimonchuk, Oleh/AAM-1194-2021	Khalimonchuk, Oleh/0000-0002-3972-8678; Swenson, Samantha/0000-0002-5650-3841	National Institutes of Health [P30GM103335, R01GM108975, T32 GM107001-01A1,, 5 P20 RR016461, 8 P20 GM103499]; Research Corporation for Science Advancement [22643]; NSF-Major Research Instrumentation [CHE1229559]; College of Charleston Summer Undergraduate Research with Faculty; Howard Hughes Medical Institute through the Pre-college and Undergraduate Science Education Program [52007537]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK110858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103335, R01GM108975, P20GM103499, T32GM107001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Corporation for Science Advancement(Research Corporation for Science Advancement); NSF-Major Research Instrumentation(National Science Foundation (NSF)); College of Charleston Summer Undergraduate Research with Faculty; Howard Hughes Medical Institute through the Pre-college and Undergraduate Science Education Program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants P30GM103335 (to the Nebraska Redox Biology Center), R01GM108975 (to O.K.), T32 GM107001-01A1, 5 P20 RR016461, and 8 P20 GM103499; Cottrell College Science Award 22643 (to J. L.F.) from the Research Corporation for Science Advancement; NSF-Major Research Instrumentation Grant CHE1229559 (to J.L.F. as co- principal investigator); College of Charleston Summer Undergraduate Research with Faculty grants (to J.L.F., N.G.T., and N.J.H.); and Howard Hughes Medical Institute Grant 52007537 through the Pre-college and Undergraduate Science Education Program (to the College of Charleston). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Atkinson A, 2010, J BIOL CHEM, V285, P19450, DOI 10.1074/jbc.M110.109793; Bareth B, 2013, MOL CELL BIOL, V33, P4128, DOI 10.1128/MCB.00747-13; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barros MH, 2002, J BIOL CHEM, V277, P9997, DOI 10.1074/jbc.M112025200; Barros MH, 2002, FEBS LETT, V516, P119, DOI 10.1016/S0014-5793(02)02514-0; Barros MH, 2001, FEBS LETT, V492, P133, DOI 10.1016/S0014-5793(01)02249-9; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Bestwick M, 2010, MOL CELL BIOL, V30, P172, DOI 10.1128/MCB.00869-09; Bohovych I, 2014, J BIOL CHEM, V289, P13259, DOI 10.1074/jbc.M113.542910; Broadley SA, 2001, MOL CELL BIOL, V21, P7663, DOI 10.1128/MCB.21.22.7663-7672.2001; Capaldi RA, 1995, METHOD ENZYMOL, V260, P117, DOI 10.1016/0076-6879(95)60134-1; Carr HS, 2002, J BIOL CHEM, V277, P31237, DOI 10.1074/jbc.M204854200; Claypool SM, 2011, J CELL BIOL, V192, P447, DOI 10.1083/jcb.201008177; Cui TZ, 2012, MOL CELL BIOL, V32, P4400, DOI 10.1128/MCB.00441-12; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Dienhart MK, 2008, MOL BIOL CELL, V19, P3934, DOI 10.1091/mbc.E08-04-0402; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Khalimonchuk E, 2005, MITOCHONDRION, V5, P363, DOI 10.1016/j.mito.2005.08.002; Khalimonchuk O, 2007, J BIOL CHEM, V282, P17442, DOI 10.1074/jbc.M702379200; Khalimonchuk O, 2006, EUKARYOT CELL, V5, P997, DOI 10.1128/EC.00092-06; Khalimonchuk O, 2012, J BIOL CHEM, V287, P26715, DOI 10.1074/jbc.M112.377200; Khalimonchuk O, 2012, J BIOL CHEM, V287, P7289, DOI 10.1074/jbc.M111.313148; Khalimonchuk O, 2010, MOL CELL BIOL, V30, P1004, DOI 10.1128/MCB.00640-09; Kim HJ, 2012, BBA-MOL CELL RES, V1823, P1604, DOI 10.1016/j.bbamcr.2012.04.008; MCEWEN JE, 1993, CURR GENET, V23, P9, DOI 10.1007/BF00336742; Mick DU, 2011, NAT REV MOL CELL BIO, V12, P14, DOI 10.1038/nrm3029; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Pierrel F, 2008, MOL CELL BIOL, V28, P4927, DOI 10.1128/MCB.00057-08; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Soto IC, 2012, BBA-BIOENERGETICS, V1817, P883, DOI 10.1016/j.bbabio.2011.09.005; Swenson S, 2016, J BIOL CHEM, V291, P10411, DOI 10.1074/jbc.M115.707539; Veniamin S, 2011, FREE RADICAL BIO MED, V51, P1589, DOI 10.1016/j.freeradbiomed.2011.06.024	37	27	27	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1815	1825		10.1074/jbc.M116.766980	http://dx.doi.org/10.1074/jbc.M116.766980			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27998984	Green Published, hybrid			2022-12-26	WOS:000395515600023
J	Ueda, F; Tago, K; Tamura, H; Funakoshi-Tago, M				Ueda, Fumihito; Tago, Kenji; Tamura, Hiroomi; Funakoshi-Tago, Megumi			Three Tyrosine Residues in the Erythropoietin Receptor Are Essential for Janus Kinase 2 V617F Mutant-induced Tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						erythropoietin; Janus kinase (JAK); mutant; STAT transcription factor; tumor; Janus kinase 2 (JAK2); V617F mutant; erythropoietin receptor (EpoR); myeloproliferative neoplasms (MPN); signal transducer and activator of transcription 5 (STAT5)	ERYTHROID PROGENITOR CELLS; POLYCYTHEMIA-VERA; EPO RECEPTOR; FERM DOMAIN; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; BINDING-SITES; DNA-BINDING; STAT5; JAK2	The erythropoietin receptor (EpoR) regulates development of blood cells, and its full activation normally requires the cytokine erythropoietin (Epo). In the case of myeloproliferative neoplasms (MPN), Epo-independent signaling through EpoR can be caused by a point mutation, V617F, in the EpoR-interacting tyrosine kinase Janus kinase 2 (JAK2). In cells expressing the JAK2 V617F mutant, eight tyrosine residues in the intracellular domain of EpoR are phosphorylated, but the functional role of these phosphorylations in oncogenic signaling is incompletely understood. Here, to evaluate the functional consequences of the phosphorylation of these tyrosine residues, we constructed an EpoR-8YF mutant in which we substituted all eight tyrosine residues with phenylalanine. Co-expression of EpoR-8YF with the JAK2 V617F mutant failed to induce cytokine-independent cell proliferation and tumorigenesis, indicating that JAK2-mediated EpoR phosphorylation is the reason for JAK2 V617F mutant-induced oncogenic signaling. An exhaustive mutational analysis of the eight EpoR tyrosine residues indicated that three of these residues, Tyr-343, Tyr-460, and Tyr-464, are required for the JAK2 V617F mutant to exhibit its oncogenic activity. We also showed that phosphorylation at these three residues was necessary for full activation of the transcription factor STAT5, which is a critical downstream factor of JAK2 V617F-induced oncogenic signaling. In contrast, Epo stimulation could moderately stimulate the proliferation of cells expressing wild type JAK2 and EpoR-8YF, suggesting that the requirement of the phosphorylation of these three tyrosine residues seems to be specific for the oncogenic proliferation provoked by V617F mutation. Collectively, these results have revealed that phosphorylation of Tyr-343, Tyr-460, and Tyr-464 in EpoR underlies JAK2 V617F mutant-induced tumorigenesis. We propose that the targeted disruption of this pathway has therapeutic utility for managing MPN.	[Ueda, Fumihito; Tamura, Hiroomi; Funakoshi-Tago, Megumi] Keio Univ, Fac Pharm, Div Hygien Chem, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan; [Tago, Kenji] Jichi Med Univ, Dept Biochem, Div Struct Biochem, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan	Keio University; Jichi Medical University	Funakoshi-Tago, M (corresponding author), Keio Univ, Fac Pharm, Div Hygien Chem, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan.	tago-mg@pha.keio.ac.jp		Ueda, Fumihito/0000-0003-1241-1643	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23790096]; Takeda Science Foundation; Uehara Memorial Foundation; Keio Gijuku Fukuzawa Memorial Fund for the Advancement of Education and Research	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Keio Gijuku Fukuzawa Memorial Fund for the Advancement of Education and Research	This work was supported in part by Grant 23790096 from Ministry of Education, Culture, Sports, Science and Technology (MEXT), the Takeda Science Foundation, Uehara Memorial Foundation, and Keio Gijuku Fukuzawa Memorial Fund for the Advancement of Education and Research. Theauthorsdeclare that they have no conflicts of interest with the contents of this article	Abe M, 2009, INT IMMUNOPHARMACOL, V9, P870, DOI 10.1016/j.intimp.2009.03.011; Arai A, 2001, J BIOL CHEM, V276, P33282, DOI 10.1074/jbc.M102924200; Berger A, 2014, LEUKEMIA, V28, P629, DOI 10.1038/leu.2013.351; Chin H, 1996, BLOOD, V88, P4415, DOI 10.1182/blood.V88.12.4415.bloodjournal88124415; Friedbichler K, 2010, BLOOD, V116, P1548, DOI 10.1182/blood-2009-12-258913; Funakoshi-Tago M, 2008, MOL CELL BIOL, V28, P1792, DOI 10.1128/MCB.01447-07; Funakoshi-Tago M, 2006, EMBO J, V25, P4763, DOI 10.1038/sj.emboj.7601365; Funakoshi-Tago M, 2010, J BIOL CHEM, V285, P5296, DOI 10.1074/jbc.M109.040733; Giordanetto F, 2002, PROTEIN ENG, V15, P727, DOI 10.1093/protein/15.9.727; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; Haan C, 2006, BIOCHEM PHARMACOL, V72, P1538, DOI 10.1016/j.bcp.2006.04.013; Halupa A, 2005, EXP CELL RES, V309, P1, DOI 10.1016/j.yexcr.2005.04.030; Hortner M, 2002, EUR J BIOCHEM, V269, P2516, DOI 10.1046/j.1432-1033.2002.02916.x; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kashii Y, 2000, BLOOD, V96, P941, DOI 10.1182/blood.V96.3.941.015k14_941_949; Ketteler R, 2003, J BIOL CHEM, V278, P2654, DOI 10.1074/jbc.M211236200; Kirito K, 2002, BLOOD, V99, P102, DOI 10.1182/blood.V99.1.102; Kirken Robert A., 1994, Progress in Growth Factor Research, V5, P195, DOI 10.1016/0955-2235(94)90005-1; Kiuchi N, 1999, J EXP MED, V189, P63, DOI 10.1084/jem.189.1.63; Klingmuller U, 1997, P NATL ACAD SCI USA, V94, P3016, DOI 10.1073/pnas.94.7.3016; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Li K, 2003, BLOOD, V102, P3147, DOI 10.1182/blood-2003-01-0078; Li K, 2003, J BIOL CHEM, V278, P40702, DOI 10.1074/jbc.M307182200; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; Lin TS, 2000, ONCOGENE, V19, P2496, DOI 10.1038/sj.onc.1203486; Liu L, 1997, LEUKEMIA, V11, P181, DOI 10.1038/sj.leu.2400559; Lu XH, 2005, P NATL ACAD SCI USA, V102, P18962, DOI 10.1073/pnas.0509714102; Mason JM, 2000, J BIOL CHEM, V275, P4398, DOI 10.1074/jbc.275.6.4398; METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0; Meyer WKH, 1997, J BIOL CHEM, V272, P31821, DOI 10.1074/jbc.272.50.31821; Moriggl R, 2005, CANCER CELL, V7, P87, DOI 10.1016/j.ccr.2004.12.010; Nakaya Y, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2013.73; Pardanani A, 2011, LEUKEMIA, V25, P218, DOI 10.1038/leu.2010.269; Pircher TJ, 1999, MOL ENDOCRINOL, V13, P555, DOI 10.1210/mend.13.4.0263; Ram PA, 1996, J BIOL CHEM, V271, P5929, DOI 10.1074/jbc.271.10.5929; RAVICHANDRAN KS, 1995, MOL CELL BIOL, V15, P593; Rayman JB, 2002, GENE DEV, V16, P933, DOI 10.1101/gad.969202; Sasaki A, 2000, J BIOL CHEM, V275, P29338, DOI 10.1074/jbc.M003456200; Soldaini E, 2000, MOL CELL BIOL, V20, P389, DOI 10.1128/MCB.20.1.389-401.2000; Tauchi T, 1996, BLOOD, V87, P4495, DOI 10.1182/blood.V87.11.4495.bloodjournal87114495; Tefferi A, 2012, BLOOD, V119, P2721, DOI 10.1182/blood-2011-11-395228; Uddin S, 2000, BIOCHEM BIOPH RES CO, V275, P16, DOI 10.1006/bbrc.2000.3266; Wernig G, 2008, BLOOD, V111, P3751, DOI 10.1182/blood-2007-07-102186; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; WOJCHOWSKI DM, 1993, STEM CELLS, V11, P381, DOI 10.1002/stem.5530110505; Wu H, 1997, P NATL ACAD SCI USA, V94, P1806, DOI 10.1073/pnas.94.5.1806	47	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1826	1846		10.1074/jbc.M116.749465	http://dx.doi.org/10.1074/jbc.M116.749465			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27998978	hybrid, Green Published			2022-12-26	WOS:000395515600024
J	Cortjens, B; Lutter, R; Boon, L; Bem, RA; van Woensel, JBM				Cortjens, Bart; Lutter, Rene; Boon, Louis; Bem, Reinout A.; van Woensel, Job B. M.			Pneumovirus-Induced Lung Disease in Mice Is Independent of Neutrophil-Driven Inflammation	PLoS One			English	Article							RESPIRATORY SYNCYTIAL VIRUS; INFLUENZA INFECTION; VIRAL BRONCHIOLITIS; DISTRESS-SYNDROME; PNEUMONIA VIRUS; INFANTS; RESPONSES; SEVERITY; INJURY; MOUSE	The human pneumovirus respiratory syncytial virus (RSV) is the most common pathogen causing lower respiratory tract disease in young children worldwide. A hallmark of severe human RSV infection is the strong neutrophil recruitment to the airways and lungs. Massive neutrophil activation has been proven detrimental in numerous diseases, yet in RSV the contribution of neutrophils to disease severity, and thereby, the relevance of targeting them, is largely unknown. To determine the relevance of potential neutrophil targeting therapies, we implemented antibody-mediated neutrophil depletion in a mouse pneumonia virus of mice (PVM) model. PVM is a host specific murine pneumovirus closely related to human RSV, which reproduces many of the features of RSV infection, such as high viral replication and neutrophil recruitment. Clinical disease and markers of lung inflammation and injury were studied in PVM-infected mice treated with either depleting or isotype control antibodies. To confirm our results we performed all experiments in two mice strains: C57Bl6 and BALBc mice. Neutrophil depletion in blood and lungs was efficient throughout the disease. Remarkably, in both mouse strains we found no difference in clinical disease severity between neutrophil-depleted and control arms. In line with this observation, we found no differences between groups in histopathological lung injury and lung viral loads. In conclusion, our study shows that in mice neutrophil recruitment to the lungs does not affect disease outcome or viral clearance during severe PVM infection. As such, this model does not support the notion that neutrophils play a key role in mouse pneumovirus disease.	[Cortjens, Bart; Bem, Reinout A.; van Woensel, Job B. M.] Emma Childrens Hosp AMC, Pediat Intens Care Unit, Amsterdam, Netherlands; [Lutter, Rene] Acad Med Ctr, Expt Immunol & Resp Med, Amsterdam, Netherlands; [Boon, Louis] Epirus Biopharmaceut Netherlands, Utrecht, Netherlands	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Cortjens, B (corresponding author), Emma Childrens Hosp AMC, Pediat Intens Care Unit, Amsterdam, Netherlands.	b.cortjens@amc.nl	Boon, Laurence/HCI-3629-2022; A., Reinout/AAN-1411-2021	Cortjens, Bart/0000-0002-0289-4250; Bem, Reinout Alexander/0000-0002-9454-5321; Boon, Louis/0000-0002-0937-9171	Epirus Biopharmaceuticals Netherlands	Epirus Biopharmaceuticals Netherlands	Epirus Biopharmaceuticals Netherlands provided support in the form of salaries for author LB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anh DBT, 2006, AM J PHYSIOL-LUNG C, V291, pL426, DOI 10.1152/ajplung.00483.2005; Awasthi YC, 2008, FREE RADICAL BIO MED, V45, P111, DOI 10.1016/j.freeradbiomed.2008.04.007; Bem RA, 2011, AM J PHYSIOL-LUNG C, V301, pL148, DOI 10.1152/ajplung.00065.2011; Bem RA, 2010, J IMMUNOL, V184, P931, DOI 10.4049/jimmunol.0903029; Bem RA, 2009, AM J PHYSIOL-LUNG C, V296, pL46, DOI 10.1152/ajplung.00467.2007; Bonville CA, 2007, VIROLOGY, V368, P182, DOI 10.1016/j.virol.2007.06.020; Bonville CA, 2006, VIROLOGY, V349, P87, DOI 10.1016/j.virol.2006.02.017; Brandes M, 2013, CELL, V154, P197, DOI 10.1016/j.cell.2013.06.013; Cortjens B, 2016, J PATHOL, V238, P401, DOI 10.1002/path.4660; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; DeVincenzo JP, 2010, AM J RESP CRIT CARE, V182, P1305, DOI 10.1164/rccm.201002-0221OC; DeVincenzo JP, 2005, J INFECT DIS, V191, P1861, DOI 10.1086/430008; Domachowske JB, 2000, CELL IMMUNOL, V206, P1, DOI 10.1006/cimm.2000.1730; EVERARD ML, 1994, ARCH DIS CHILD, V71, P428, DOI 10.1136/adc.71.5.428; Frey S, 2008, J VIROL, V82, P11619, DOI 10.1128/JVI.00375-08; Geerdink RJ, 2015, J ALLERGY CLIN IMMUN, V136, P838, DOI 10.1016/j.jaci.2015.06.034; Halfhide CP, 2011, J INFECT DIS, V204, P451, DOI 10.1093/infdis/jir280; Jain S, 2015, NEW ENGL J MED, V372, P835, DOI 10.1056/NEJMoa1405870; Jenne CN, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004546; Marguet C, 2008, PEDIAT ALLERG IMM-UK, V19, P157, DOI 10.1111/j.1399-3038.2007.00600.x; Meissner HC, 2016, NEW ENGL J MED, V374, P62, DOI 10.1056/NEJMra1413456; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Mizgerd JP, 2008, NEW ENGL J MED, V358, P716, DOI 10.1056/NEJMra074111; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; Pickles RJ, 2015, J PATHOL, V235, P266, DOI 10.1002/path.4462; Rygiel TP, 2009, J IMMUNOL, V183, P1990, DOI 10.4049/jimmunol.0900252; Schene KM, 2014, PEDIATR PULM, V49, P1138, DOI 10.1002/ppul.22974; Smyth RL, 2002, PEDIATR PULM, V33, P339, DOI 10.1002/ppul.10080; Stokes KL, 2013, J VIROL, V87, P10070, DOI 10.1128/JVI.01347-13; Tate MD, 2012, IMMUNOL CELL BIOL, V90, P197, DOI 10.1038/icb.2011.26; Tate MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017618; Tate MD, 2009, J IMMUNOL, V183, P7441, DOI 10.4049/jimmunol.0902497; Wang S Z, 2000, Respirology, V5, P1, DOI 10.1046/j.1440-1843.2000.00219.x; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Welliver TP, 2007, J INFECT DIS, V195, P1126, DOI 10.1086/512615; Wojtasiak M, 2010, J GEN VIROL, V91, P2158, DOI 10.1099/vir.0.021915-0	38	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168779	10.1371/journal.pone.0168779	http://dx.doi.org/10.1371/journal.pone.0168779			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005954	Green Published, gold, Green Submitted			2022-12-26	WOS:000392843200092
J	Morin-Moncet, O; Therrien-Blanchet, JM; Ferland, MC; Theoret, H; West, GL				Morin-Moncet, Olivier; Therrien-Blanchet, Jean-Marc; Ferland, Marie C.; Theoret, Hugo; West, Greg L.			Action Video Game Playing Is Reflected In Enhanced Visuomotor Performance and Increased Corticospinal Excitability	PLoS One			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; HUMAN MOTOR CORTEX; WHITE-MATTER; INTERHEMISPHERIC INHIBITION; FINGER MOVEMENTS; THRESHOLD; PLASTICITY; PLAYERS; SKILL; BRAIN	Action video game playing is associated with improved visuomotor performance; however, the underlying neural mechanisms associated with this increased performance are not well understood. Using the Serial Reaction Time Task in conjunction with Transcranial Magnetic Stimulation, we investigated if improved visuomotor performance displayed in action video game players (actionVGPs) was associated with increased corticospinal plasticity in primary motor cortex (M1) compared to non-video game players (nonVGPs). Further, we assessed if actionVGPs and nonVGPs displayed differences in procedural motor learning as measured by the SRTT. We found that at the behavioral level, both the actionVGPs and nonVGPs showed evidence of procedural learning with no significant difference between groups. However, the actionVGPs displayed higher visuomotor performance as evidenced by faster reaction times in the SRTT. This observed enhancement in visuomotor performance amongst actionVGPs was associated with increased corticospinal plasticity in M1, as measured by corticospinal excitability changes pre- and post-SRTT and corticospinal excitability at rest before motor practice. Our results show that aVGPs, who are known to have better performance on visual and motor tasks, also display increased corticospinal excitability after completing a novel visuomotor task.	[Morin-Moncet, Olivier; Therrien-Blanchet, Jean-Marc; Ferland, Marie C.; Theoret, Hugo; West, Greg L.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Theoret, Hugo] Hop St Justine, Res Ctr, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	West, GL (corresponding author), Univ Montreal, Dept Psychol, Montreal, PQ, Canada.	gregory.west@umontreal.ca		Theoret, Hugo/0000-0002-7458-8797; Therrien-Blanchet, Jean-Marc/0000-0003-1867-1606	Natural Sciences and Engineering Research Council of Canada; Canada Graduate Scholarship; Natural Sciences and Engineering Research Council of Canada [436140-2013]; Fonds de Recherche du Quebec - Nature et Technologies [181515]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Graduate Scholarship; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de Recherche du Quebec - Nature et Technologies	Natural Sciences and Engineering Research Council of Canada (http://dx.doi.org/10.13039/501100000038) Canada Graduate Scholarship to Olivier Morin-Moncet; Natural Sciences and Engineering Research Council of Canada (http://dx.doi.org/10.13939/501100000038) 436140-2013 to Prof. Greg West; Fonds de Recherche du Quebec - Nature et Technologies (http://dx.doi.org/10.13039/501100003151) 181515 to Prof. Greg West.	Bastani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047582; Bavelier D, 2012, VISION RES, V61, P132, DOI 10.1016/j.visres.2011.08.007; Bavelier D, 2012, ANNU REV NEUROSCI, V35, P391, DOI 10.1146/annurev-neuro-060909-152832; Bischoff-Grethe A, 2004, J COGNITIVE NEUROSCI, V16, P127, DOI 10.1162/089892904322755610; Blacker KJ, 2013, ATTEN PERCEPT PSYCHO, V75, P1128, DOI 10.3758/s13414-013-0487-0; Borecki L, 2013, ADV EXP MED BIOL, V755, P343, DOI 10.1007/978-94-007-4546-9_43; Castel AD, 2005, ACTA PSYCHOL, V119, P217, DOI 10.1016/j.actpsy.2005.02.004; Chang WH, 2016, CLIN NEUROPHYSIOL, V127, P2892, DOI 10.1016/j.clinph.2016.04.001; Chen R, 2004, EXP BRAIN RES, V154, P1, DOI 10.1007/s00221-003-1684-1; Cicinelli P, 1997, MUSCLE NERVE, V20, P535, DOI 10.1002/(SICI)1097-4598(199705)20:5<535::AID-MUS1>3.0.CO;2-A; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; Daselaar SM, 2003, NEUROBIOL AGING, V24, P1013, DOI 10.1016/S0197-4580(03)00030-7; Di Lazzaro V, 1999, EXP BRAIN RES, V124, P520, DOI 10.1007/s002210050648; Di Lazzaro V, 2004, CLIN NEUROPHYSIOL, V115, P255, DOI 10.1016/j.clinph.2003.10.009; Doeltgen SH, 2009, J NEUROSCI METH, V178, P134, DOI 10.1016/j.jneumeth.2008.12.005; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; Doyon J, 2009, BEHAV BRAIN RES, V199, P61, DOI 10.1016/j.bbr.2008.11.012; Duncan N., 2012, DEMISE GUYS WHY BOYS; Dye MWG, 2009, NEUROPSYCHOLOGIA, V47, P1780, DOI 10.1016/j.neuropsychologia.2009.02.002; Feng J, 2007, PSYCHOL SCI, V18, P850, DOI 10.1111/j.1467-9280.2007.01990.x; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Fields RD, 2015, NAT REV NEUROSCI, V16, P756, DOI 10.1038/nrn4023; Ghacibeh GA, 2007, CLIN NEUROPHYSIOL, V118, P325, DOI 10.1016/j.clinph.2006.10.003; Gozli DG, 2014, HUM MOVEMENT SCI, V38, P152, DOI 10.1016/j.humov.2014.09.004; Grafton ST, 1998, J NEUROSCI, V18, P9420; Green CS, 2007, PSYCHOL SCI, V18, P88, DOI 10.1111/j.1467-9280.2007.01853.x; Green CS, 2006, COGNITION, V101, P217, DOI 10.1016/j.cognition.2005.10.004; Green CS, 2012, COMPUT HUM BEHAV, V28, P984, DOI 10.1016/j.chb.2011.12.020; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Hallett M, 1996, Electroencephalogr Clin Neurophysiol Suppl, V46, P43; Hardwick RM, 2013, NEUROIMAGE, V67, P283, DOI 10.1016/j.neuroimage.2012.11.020; Herbsman T, 2009, HUM BRAIN MAPP, V30, P2044, DOI 10.1002/hbm.20649; Holper L, 2009, NEUROIMAGE, V46, P1105, DOI 10.1016/j.neuroimage.2009.03.027; Honda M, 1998, BRAIN, V121, P2159, DOI 10.1093/brain/121.11.2159; Japikse KC, 2003, EXP BRAIN RES, V148, P38, DOI 10.1007/s00221-002-1264-9; Kloppel S, 2008, NEUROIMAGE, V40, P1782, DOI 10.1016/j.neuroimage.2008.01.019; Kobayashi M, 2004, NEUROLOGY, V62, P91, DOI 10.1212/WNL.62.1.91; Kobayashi M, 2003, NEUROIMAGE, V20, P2259, DOI 10.1016/S1053-8119(03)00220-9; Kobayashi M, 2009, EUR J NEUROSCI, V29, P833, DOI 10.1111/j.1460-9568.2009.06628.x; Koeneke S, 2006, EXP BRAIN RES, V174, P199, DOI 10.1007/s00221-006-0440-8; Kozel FA, 2000, J NEUROPSYCH CLIN N, V12, P376, DOI 10.1176/appi.neuropsych.12.3.376; Li RJ, 2009, NAT NEUROSCI, V12, P549, DOI 10.1038/nn.2296; McConnell KA, 2001, BIOL PSYCHIAT, V49, P454, DOI 10.1016/S0006-3223(00)01039-8; MEYER BU, 1995, BRAIN, V118, P429, DOI 10.1093/brain/118.2.429; Mills KR, 1997, MUSCLE NERVE, V20, P570, DOI 10.1002/(SICI)1097-4598(199705)20:5<570::AID-MUS5>3.3.CO;2-F; Mishra J, 2011, J NEUROSCI, V31, P992, DOI 10.1523/JNEUROSCI.4834-10.2011; Morin-Moncet O, 2014, J NEUROPHYSIOL, V111, P2094, DOI 10.1152/jn.00388.2013; Muellbacher W, 2002, ARCH NEUROL-CHICAGO, V59, P1278, DOI 10.1001/archneur.59.8.1278; Muellbacher W, 2000, CLIN NEUROPHYSIOL, V111, P344, DOI 10.1016/S1388-2457(99)00243-6; Muellbacher W, 2001, EXP BRAIN RES, V136, P431, DOI 10.1007/s002210000614; Muller-Dahlhaus JFM, 2008, EXP BRAIN RES, V187, P467, DOI 10.1007/s00221-008-1319-7; Murakami T, 2012, J PHYSIOL-LONDON, V590, P5765, DOI 10.1113/jphysiol.2012.238519; PARLOW SE, 1989, BRAIN COGNITION, V11, P98, DOI 10.1016/0278-2626(89)90008-0; Pascual-Leone A, 1999, NEUROPSYCHOLOGIA, V37, P207; PASCUALLEONE A, 1994, SCIENCE, V263, P1287, DOI 10.1126/science.8122113; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; Perez MA, 2007, J NEUROSCI, V27, P1045, DOI 10.1523/JNEUROSCI.4128-06.2007; Powers KL, 2013, PSYCHON B REV, V20, P1055, DOI 10.3758/s13423-013-0418-z; Rand MK, 1998, EXP BRAIN RES, V118, P293, DOI 10.1007/s002210050284; Reis J, 2008, J PHYSIOL-LONDON, V586, P325, DOI 10.1113/jphysiol.2007.144824; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Rossi S, 2011, CLIN NEUROPHYSIOL, V122, P1686, DOI 10.1016/j.clinph.2010.12.037; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Sampaio-Baptista C, 2013, J NEUROSCI, V33, P19499, DOI 10.1523/JNEUROSCI.3048-13.2013; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Stokes MG, 2005, J NEUROPHYSIOL, V94, P4520, DOI 10.1152/jn.00067.2005; Tinazzi M, 1998, NEUROSCI LETT, V244, P121, DOI 10.1016/S0304-3940(98)00150-5; Waldvogel D, 2000, NATURE, V406, P995, DOI 10.1038/35023171; WASSERMANN EM, 1992, ELECTROEN CLIN NEURO, V85, P1, DOI 10.1016/0168-5597(92)90094-R; West GL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2952; West GL, 2013, ACTA PSYCHOL, V142, P38, DOI 10.1016/j.actpsy.2011.08.005; West GL, 2008, J VISION, V8, DOI 10.1167/8.16.13; Willingham DB, 2000, MEM COGNITION, V28, P366, DOI 10.3758/BF03198552; Zhang Y, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00098; Ziemann U, 1996, ANN NEUROL, V40, P367, DOI 10.1002/ana.410400306; Ziemann U, 2001, BRAIN, V124, P1171, DOI 10.1093/brain/124.6.1171	76	11	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0169013	10.1371/journal.pone.0169013	http://dx.doi.org/10.1371/journal.pone.0169013			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QH	28005989	Green Submitted, gold, Green Published			2022-12-26	WOS:000392843200124
J	Kamat, P; Vandenberghe, S; Christen, S; Bongoni, AK; Meier, B; Rieben, R; Khattab, AA				Kamat, Pranitha; Vandenberghe, Stijn; Christen, Stephan; Bongoni, Anjan K.; Meier, Bernhard; Rieben, Robert; Khattab, Ahmed A.			Dexrazoxane Shows No Protective Effect in the Acute Phase of Reperfusion during Myocardial Infarction in Pigs	PLoS One			English	Article							CHRONIC DOXORUBICIN CARDIOTOXICITY; CARDIOPROTECTIVE DRUG DEXRAZOXANE; ISCHEMIA-REPERFUSION; FREE-RADICALS; ISCHAEMIA/REPERFUSION INJURY; ANTHRACYCLINE CHEMOTHERAPY; HYDROLYSIS-ACTIVATION; ENDOTHELIAL FUNCTION; RAT-HEART; IN-VIVO	Calcium and iron overload participate in the mechanisms of ischemia/reperfusion (I/R) injury during myocardial infarction (MI). Calcium overload induces cardiomyocyte death by hyper contraction, while iron catalyses generation of reactive oxygen species (ROS). We therefore hypothesized that dexrazoxane, an intracellular metal chelator, would attenuate I/R injury. MI was induced in pigs by occlusion of the left anterior descending artery for 1 hour followed by 2 hours reperfusion. Thirty minutes before reperfusion either 5 mg/mI dexrazoxane (n = 5) or saline (n = 5) was infused intravenously. Myocardial necrosis as percentage of the area at ischemic risk was found to be similar in both groups (77.2 +/- 18% for dexrazoxane and 76.4 +/- 14% for saline group) as determined by triphenyl tetrazolium chloride staining of the ischemic myocardium. Also, serum levels of troponin-I were similar in both groups. A conductance catheter was used to measure left ventricular pressure and volume at all times. Markers for tissue damage due to ROS (HNE), endothelial cell activation (CD31) and inflammation (IgG, C3b/c, C5b9, MCP-1) were assessed on tissue and/or in serum. No significant differences were observed between the groups for the parameters analyzed. To conclude, in this clinically relevant model of early reperfusion after acute myocardial ischemia, dexrazoxane lacked attenuating effects on I/R injury as shown by the measured parameters.	[Kamat, Pranitha; Bongoni, Anjan K.; Rieben, Robert] Univ Bern, Dept Clin Res, Bern, Switzerland; [Vandenberghe, Stijn] Univ Bern, ARTORG Ctr, Bern, Switzerland; [Christen, Stephan] Univ Bern, Dept Infect Dis, Bern, Switzerland; [Meier, Bernhard; Khattab, Ahmed A.] Univ Hosp Bern, Dept Cardiol, Bern, Switzerland; [Vandenberghe, Stijn] Cardioctr Ticino, Ticino, Switzerland; [Christen, Stephan] Univ Zurich, Dept Mol Mech Dis, Zurich, Switzerland; [Bongoni, Anjan K.] St Vincents Hosp, Immunol Res Ctr, Melbourne, Vic, Australia	University of Bern; University of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Zurich; St Vincent's Hospital Melbourne	Rieben, R (corresponding author), Univ Bern, Dept Clin Res, Bern, Switzerland.	robert.rieben@dkf.unibe.ch	Christen, Stephan/B-8602-2009; Vandenberghe, Stijn/T-9364-2019; Rieben, Robert/D-7044-2017	Vandenberghe, Stijn/0000-0003-1464-0597; Kamat, Pranitha/0000-0002-9177-3513; Rieben, Robert/0000-0003-4179-8891	Swiss National Science Foundation [3200B0-116618, 32003B_135272]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the Swiss National Science Foundation, grants no. 3200B0-116618 and 32003B_135272. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGCHI M, 1989, FREE RADICAL RES COM, V7, P375, DOI 10.3109/10715768909087964; Banz Y, 2005, EUR HEART J, V26, P2334, DOI 10.1093/eurheartj/ehi421; Banz Y, 2007, CARDIOVASC RES, V76, P482, DOI 10.1016/j.cardiores.2007.07.016; Banz Y, 2012, CARDIOLOGY, V121, P59, DOI 10.1159/000336485; Berenshtein E, 1997, J MOL CELL CARDIOL, V29, P3025, DOI 10.1006/jmcc.1997.0535; BOLLI R, 1990, CIRCULATION, V82, P723, DOI 10.1161/01.CIR.82.3.723; BOLLI R, 1989, P NATL ACAD SCI USA, V86, P4695, DOI 10.1073/pnas.86.12.4695; Chen XL, 2004, AM J PHYSIOL-HEART C, V286, pH1001, DOI 10.1152/ajpheart.00716.2003; COUDRAY C, 1995, INT J BIOCHEM CELL B, V27, P61, DOI 10.1016/1357-2725(94)00055-7; Cvetkokic RS, 2005, DRUGS, V65, P1005, DOI 10.2165/00003495-200565070-00008; Duilio C, 2001, AM J PHYSIOL-HEART C, V280, pH2649, DOI 10.1152/ajpheart.2001.280.6.H2649; Fox KAA, 2007, JAMA-J AM MED ASSOC, V297, P1892, DOI 10.1001/jama.297.17.1892; Frangogiannis NG, 2015, COMPR PHYSIOL, V5, P1841, DOI 10.1002/cphy.c150006; Hasinoff BB, 1998, CURR MED CHEM, V5, P1; Hasinoff BB, 1998, SEMIN ONCOL, V25, P3; HASINOFF BB, 1994, J PHARM SCI, V83, P64, DOI 10.1002/jps.2600830115; Hasinoff BB, 2003, MOL PHARMACOL, V64, P670, DOI 10.1124/mol.64.3.670; HASINOFF BB, 1990, DRUG METAB DISPOS, V18, P344; Hasinoff Brian B, 2002, Cardiovasc Toxicol, V2, P111, DOI 10.1385/CT:2:2:111; HERMAN EH, 1981, CANCER RES, V41, P3436; HERMAN EH, 1983, LAB INVEST, V49, P69; HESS ML, 1984, J MOL CELL CARDIOL, V16, P969, DOI 10.1016/S0022-2828(84)80011-5; Kane RC, 2008, ONCOLOGIST, V13, P445, DOI 10.1634/theoncologist.2007-0247; Karck M, 2001, J THORAC CARDIOV SUR, V121, P1169, DOI 10.1067/mtc.2001.113325; KLONER RA, 1989, CIRCULATION, V80, P1115, DOI 10.1161/01.CIR.80.5.1115; Krumholz HM, 2009, JAMA-J AM MED ASSOC, V302, P767, DOI 10.1001/jama.2009.1178; Kumar AG, 1997, CIRCULATION, V95, P693, DOI 10.1161/01.CIR.95.3.693; Lakshminarayanan V, 2001, AM J PATHOL, V159, P1301, DOI 10.1016/S0002-9440(10)62517-5; Lakshminarayanan V, 1997, J BIOL CHEM, V272, P32910, DOI 10.1074/jbc.272.52.32910; Liochev SI, 1999, MET IONS BIOL SYST, V36, P1; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; LOETSCHER P, 1994, FASEB J, V8, P1055, DOI 10.1096/fasebj.8.13.7926371; McCormick J, 2006, FASEB J, V20, P2115, DOI 10.1096/fj.06-6188fje; MINEZAKI KK, 1994, J PHYSIOL-LONDON, V476, P459, DOI 10.1113/jphysiol.1994.sp020147; MITSOS SE, 1986, CIRCULATION, V73, P1077, DOI 10.1161/01.CIR.73.5.1077; Mochizuki S, 1998, JPN HEART J, V39, P707; Neckar J, 2012, CAN J PHYSIOL PHARM, V90, P1303, DOI [10.1139/Y2012-096, 10.1139/y2012-096]; POWELL SR, 1992, J SURG RES, V53, P417, DOI 10.1016/0022-4804(92)90070-G; Ramu E, 2006, CARDIOVASC DRUG THER, V20, P343, DOI 10.1007/s10557-006-0497-4; Schroeder PE, 2005, DRUG METAB DISPOS, V33, P1367, DOI 10.1124/dmd.105.005546; SEINO Y, 1995, CYTOKINE, V7, P301, DOI 10.1006/cyto.1995.0037; Sinning JM, 2011, EUR HEART J; Sukmawan R, 2007, J PHARMACOL SCI, V104, P341, DOI 10.1254/jphs.FP0070186; Szocs K, 2004, GEN PHYSIOL BIOPHYS, V23, P265; Tompkins AJ, 2006, BBA-MOL BASIS DIS, V1762, P223, DOI 10.1016/j.bbadis.2005.10.001; van Diepen S, J THROMB THROMBOLYSI; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P112, DOI 10.1161/01.ATV.0000191634.13057.15	47	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168541	10.1371/journal.pone.0168541	http://dx.doi.org/10.1371/journal.pone.0168541			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002439	Green Submitted, Green Published, gold			2022-12-26	WOS:000392853100051
J	Ladds, MA; Thompson, AP; Slip, DJ; Hocking, DP; Harcourt, RG				Ladds, Monique A.; Thompson, Adam P.; Slip, David J.; Hocking, David P.; Harcourt, Robert G.			Seeing It All: Evaluating Supervised Machine Learning Methods for the Classification of Diverse Otariid Behaviours	PLOS ONE			English	Article							ACCELERATION DATA; ENERGY-EXPENDITURE; BODY ACCELERATION; PHYSICAL-ACTIVITY; FUR SEALS; ACCELEROMETRY; ANIMALS; RECOGNITION; PLAY	Constructing activity budgets for marine animals when they are at sea and cannot be directly observed is challenging, but recent advances in bio-logging technology offer solutions to this problem. Accelerometers can potentially identify a wide range of behaviours for animals based on unique patterns of acceleration. However, when analysing data derived from accelerometers, there are many statistical techniques available which when applied to different data sets produce different classification accuracies. We investigated a selection of supervised machine learning methods for interpreting behavioural data from captive otariids (fur seals and sea lions). We conducted controlled experiments with 12 seals, where their behaviours were filmed while they were wearing 3-axis accelerometers. From video we identified 26 behaviours that could be grouped into one of four categories (foraging, resting, travelling and grooming) representing key behaviour states for wild seals. We used data from 10 seals to train four predictive classification models: stochastic gradient boosting (GBM), random forests, support vector machine using four different kernels and a baseline model: penalised logistic regression. We then took the best parameters from each model and cross-validated the results on the two seals unseen so far. We also investigated the influence of feature statistics (describing some characteristic of the seal), testing the models both with and without these. Cross-validation accuracies were lower than training accuracy, but the SVM with a polynomial kernel was still able to classify seal behaviour with high accuracy (>70%). Adding feature statistics improved accuracies across all models tested. Most categories of behaviour-resting, grooming and feeding were all predicted with reasonable accuracy (52-81%) by the SVM while travelling was poorly categorised (31-41%). These results show that model selection is important when classifying behaviour and that by using animal characteristics we can strengthen the overall accuracy.	[Ladds, Monique A.; Slip, David J.; Harcourt, Robert G.] Macquarie Univ, Dept Biol Sci, Marine Predator Res Grp, N Ryde, NSW, Australia; [Thompson, Adam P.] ABC, Digital Network, Sydney, NSW, Australia; [Slip, David J.] Taronga Conservat Soc Australia, Bradleys Head Rd, Mosman, NSW, Australia; [Hocking, David P.] Monash Univ, Sch Biol Sci, Melbourne, Vic, Australia; [Hocking, David P.] Museum Victoria, Geosci, Melbourne, Vic, Australia	Macquarie University; Monash University; Museum Victoria	Ladds, MA (corresponding author), Macquarie Univ, Dept Biol Sci, Marine Predator Res Grp, N Ryde, NSW, Australia.	monique.ladds@hdr.mq.edu.au	; Hocking, David/A-2666-2017	Slip, David/0000-0002-9010-7236; Harcourt, Robert/0000-0003-4666-2934; Hocking, David/0000-0001-6848-1208	Australian Research Council Linkage Grant [LP110200603]; Taronga Conservation Society Australia; Macquarie University Research Excellence Scholarship	Australian Research Council Linkage Grant(Australian Research Council); Taronga Conservation Society Australia; Macquarie University Research Excellence Scholarship	This project is funded by Australian Research Council Linkage Grant [Grant number LP110200603 http://www.arc.gov.au/grants] to RH and DS, with support from Taronga Conservation Society Australia. ML is a recipient of a Macquarie University Research Excellence Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RD, 1998, MAR ECOL PROG SER, V175, P289, DOI 10.3354/meps175289; [Anonymous], 2016, R PACK VERS 6 0 29; [Anonymous], 2015, E1071 MISC FUNCTIONS; Austin D, 2006, ECOLOGY, V87, P3095, DOI 10.1890/0012-9658(2006)87[3095:LMDAHT]2.0.CO;2; Battaile BC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118761; BEENTJES MP, 1990, ZOOL J LINN SOC-LOND, V98, P307, DOI 10.1111/j.1096-3642.1990.tb01204.x; Beniczky S, 2013, EPILEPSIA, V54, pe58, DOI 10.1111/epi.12120; Bom RA, 2014, MOV ECOL, V2, DOI 10.1186/2051-3933-2-6; Boyd IL, 1999, BEHAV ECOL, V10, P198, DOI 10.1093/beheco/10.2.198; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown DD, 2013, ANIM BIOTELEM, V1, P20, DOI DOI 10.1186/2050-3385-1-20; Campbell HA, 2013, J EXP BIOL, V216, P4501, DOI 10.1242/jeb.089805; Carroll G, 2014, J EXP BIOL, V217, P4295, DOI 10.1242/jeb.113076; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dewancker I, 2014, P REH ENG ASS TECHN; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; gbm, 2015, GPM GEN BOOSTED REGR; Gerencser L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077814; GOLDSTEIN DL, 1988, AM ZOOL, V28, P829; Graf PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136751; Halsey LG, 2009, PHYSIOL BIOCHEM ZOOL, V82, P396, DOI 10.1086/589815; Halsey LG, 2009, COMP BIOCHEM PHYS A, V152, P197, DOI 10.1016/j.cbpa.2008.09.021; Halsey LG, 2011, COMP BIOCHEM PHYS A, V158, P305, DOI 10.1016/j.cbpa.2010.09.002; Hammond TT, 2016, J EXP BIOL, V219, P1618, DOI 10.1242/jeb.136135; HARCOURT R, 1991, ANIM BEHAV, V42, P509, DOI 10.1016/S0003-3472(05)80055-7; HARCOURT R, 1991, ETHOLOGY, V88, P191; Hocking D, 2016, PREY CAPTURE PROCESS; Hocking DP, 2016, MAR MAMMAL SCI, V32, P568, DOI 10.1111/mms.12285; Hussey NE, 2015, SCIENCE, V348, DOI 10.1126/science.1255642; Insley Stephen J., 2003, Aquatic Mammals, V29, P181, DOI 10.1578/016754203101024149; Iwata T, 2013, AQUAT MAMM, V39, P378, DOI 10.1578/AM.39.4.2013.378; MARLOW B J, 1975, Mammalia, V39, P159, DOI 10.1515/mamm.1975.39.2.159; Martin P., 1993, MEASURING BEHAV INTR; Martiskainen P, 2009, APPL ANIM BEHAV SCI, V119, P32, DOI 10.1016/j.applanim.2009.03.005; McClune D.W., 2014, ANIM BIOTELEM, V2, P1, DOI [10.1186/2050-3385-2-5, DOI 10.1186/2050-3385-2-5]; Naito Y, 2010, POLAR SCI, V4, P309, DOI 10.1016/j.polar.2010.05.009; Nathan R, 2012, J EXP BIOL, V215, P986, DOI 10.1242/jeb.058602; Nishizawa H, 2013, J ETHOL, V31, P315, DOI 10.1007/s10164-013-0381-1; Pierce SE, 2011, J ANAT, V219, P502, DOI 10.1111/j.1469-7580.2011.01406.x; Pober DM, 2006, MED SCI SPORT EXER, V38, P1626, DOI 10.1249/01.mss.0000227542.43669.45; Qasem L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031187; R Core Team, 2021, R LANGUAGE ENV STAT; Ravi N., 2005, P 17 C INN APPL ART, P1541, DOI DOI 10.1007/978-3-642-02481-8_120; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005379; Sathya R., 2013, International Journal of Advanced Research in Artificial Intelligence, V2, P34; Shepard Emily L. C., 2010, Endangered Species Research, V10, P47, DOI 10.3354/esr00084; Shepard ELC, 2009, AQUAT BIOL, V4, P235, DOI 10.3354/ab00104; Skinner JP, 2014, J EXP MAR BIOL ECOL, V461, P107, DOI 10.1016/j.jembe.2014.08.002; STIRLING I, 1970, J MAMMAL, V51, P766, DOI 10.2307/1378300; Tapia EM, 2004, P EXT ABSTR UB 2004; Vazquez Diosdado J.A., 2015, ANIM BIOTELEM, V3, P15, DOI [10.1186/s40317-015-0045-8, DOI 10.1186/S40317-015-0045-8]; Viviant M, 2010, POLAR BIOL, V33, P713, DOI 10.1007/s00300-009-0750-y; Watanabe S, 2005, APPL ANIM BEHAV SCI, V94, P117, DOI 10.1016/j.applanim.2005.01.010; Westerterp KR, 2009, EUR J APPL PHYSIOL, V105, P823, DOI 10.1007/s00421-009-1000-2; Whitney Nicholas M., 2010, Endangered Species Research, V10, P71, DOI 10.3354/esr00247; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; Yang JY, 2008, PATTERN RECOGN LETT, V29, P2213, DOI 10.1016/j.patrec.2008.08.002; Ydesen KS, 2014, J EXP BIOL, V217, P2239, DOI 10.1242/jeb.100016; Zughrat A, 2014, P 19 WORLD C INT FED	62	20	20	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0166898	10.1371/journal.pone.0166898	http://dx.doi.org/10.1371/journal.pone.0166898			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002450	Green Published, gold, Green Submitted			2022-12-26	WOS:000392853100005
J	Steiniger, BS; Stachniss, V; Wilhelmi, V; Seiler, A; Lampp, K; Neff, A; Guthe, M; Lobachev, O				Steiniger, Birte S.; Stachniss, Vitus; Wilhelmi, Verena; Seiler, Anja; Lampp, Katrin; Neff, Andreas; Guthe, Michael; Lobachev, Oleg			Three-Dimensional Arrangement of Human Bone Marrow Microvessels Revealed by Immunohistology in Undecalcified Sections	PLOS ONE			English	Article							HEMATOPOIETIC STEM; CELLS; NICHES; ANGIOGENESIS; DENSITY; MEMORY	The arrangement of microvessels in human bone marrow is so far unknown. We combined monoclonal antibodies against CD34 and against CD141 to visualise all microvessel endothelia in 21 serial sections of about 1 cm(2) size derived from a human iliac crest. The specimen was not decalcified and embedded in Technovit (R) 9100. In different regions of interest, the microvasculature was reconstructed in three dimensions using automatic methods. The three-dimensional models were subject to a rigid semiautomatic and manual quality control. In iliac crest bone marrow, the adipose tissue harbours irregularly distributed haematopoietic areas. These are fed by networks of large sinuses, which are loosely connected to networks of small capillaries prevailing in areas of pure adipose tissue. Our findings are compatible with the hypothesis that capillaries and sinuses in human iliac crest bone marrow are partially arranged in parallel.	[Steiniger, Birte S.; Wilhelmi, Verena; Seiler, Anja; Lampp, Katrin] Univ Marburg, Inst Anat & Cell Biol, Dept Immunobiol, Marburg, Germany; [Stachniss, Vitus] Univ Marburg, Histol Lab, Dent Clin, Marburg, Germany; [Neff, Andreas] Marburg Univ Hosp, Dept Oral & Maxillofacial Surg, Marburg, Germany; [Guthe, Michael; Lobachev, Oleg] Univ Bayreuth, Inst Comp Sci, Visual Comp, Bayreuth, Germany	Philipps University Marburg; Philipps University Marburg; University of Bayreuth	Steiniger, BS (corresponding author), Univ Marburg, Inst Anat & Cell Biol, Dept Immunobiol, Marburg, Germany.; Lobachev, O (corresponding author), Univ Bayreuth, Inst Comp Sci, Visual Comp, Bayreuth, Germany.	steinigb@staff.uni-marburg.de; oleg.lobachev@uni-bayreuth.de	Lobachev, Oleg/F-2843-2012	Lobachev, Oleg/0000-0002-7193-6258; Steiniger, Birte/0000-0002-3602-7331	Dental Clinics, Universitat Marburg, Marburg, Germany; German Research Foundation (DFG); University of Marburg; University of Bayreuth	Dental Clinics, Universitat Marburg, Marburg, Germany; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Marburg; University of Bayreuth	Our thanks are due to Prof. Dr. R. Frankenberger, former managing director of the Dental Clinics, Universitat Marburg, Marburg, Germany, for financial support concerning hardware for video editing. Open access publication of this work was funded by the German Research Foundation (DFG), the University of Marburg and the University of Bayreuth.; Our thanks are due to Prof. Dr. R. Frankenberger, former managing director of the Dental Clinics, Universitat Marburg, Marburg, Germany, for financial support concerning hardware for video editing. S. Fischer, former representative of Leica Microsystems, gave decisive advice and technical support with respect to microtomy of hard tissues. U. Schneider, former representative of Heraeus Kulzer, gave technical information for handling of Technovit sections after cutting. Dr. A. Schauss, Dr. S. Iden, and Dr. N. Kladt, CECAD Imaging Facility, Institute of Genetics, Universitat Koln, Cologne, Germany, helped with image acquisition and kindly provided access to the Leica SCN 400 slide scanning microscope. W. Bockler and S. Bubel, Precision Engineering Research Centre, Universitat Marburg, Marburg, Germany, skilfully manufactured the pressure embedding device and further laboratory equipment. Open access publication of this work was funded by the German Research Foundation (DFG), the University of Marburg and the University of Bayreuth.	Acar M, 2015, NATURE, V526, P126, DOI 10.1038/nature15250; Alt H, 2000, HANDBOOK OF COMPUTATIONAL GEOMETRY, P121, DOI 10.1016/B978-044482537-7/50004-8; Boveri E, 2008, BRIT J HAEMATOL, V140, P162, DOI 10.1111/j.1365-2141.2007.06885.x; Bradski G., 2008, LEARNING OPENCV COMP; Cariappa A, 2005, IMMUNITY, V23, P397, DOI 10.1016/j.immuni.2005.09.004; Cassoni P, 2008, J Cell Mol Med, V12, P564, DOI 10.1111/j.1582-4934.2007.00206.x; Cignoni P, 2008, COMPUTING, P129, DOI DOI 10.2312/LOCALCHAPTEREVENTS/ITALCHAP/ITALIANCHAPCONF2008/129-136; Farneback G, 2003, LECT NOTES COMPUT SC, V2749, P363, DOI 10.1007/3-540-45103-x_50; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Gijtenbeek J. M. M., 2005, Angiogenesis, V8, P297; Gilhuis H. Jacobus, 2006, Angiogenesis, V9, P201, DOI 10.1007/s10456-006-9054-9; Gur-Cohen S, 2015, NAT MED, V21, P1307, DOI 10.1038/nm.3960; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Iones A, 2003, IEEE COMPUT GRAPH, V23, P54, DOI 10.1109/MCG.2003.1198263; Itkin T, 2016, NATURE, V532, P323, DOI 10.1038/nature17624; Ju T, 2004, ACM T GRAPHIC, V23, P888, DOI 10.1145/1015706.1015815; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kopp HG, 2009, ANN NY ACAD SCI, V1176, P47, DOI 10.1111/j.1749-6632.2009.04964.x; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Kusumbe AP, 2016, NATURE, V532, P380, DOI 10.1038/nature17638; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Kvasnicka HM, 2004, HISTOL HISTOPATHOL, V19, P1245, DOI 10.14670/HH-19.1245; Li XM, 2009, CIRCULATION, V120, P1910, DOI 10.1161/CIRCULATIONAHA.109.871574; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Lobachev O, 2016, MED IMAGE A IN PRESS; Lorensen W.E., 1987, ACM SIGGRAPH COMPUTE, V21, P163, DOI [DOI 10.1145/37402.37422, 10.1145/37401.37422]; Meixlsperger S, 2013, BLOOD, V121, P5034, DOI 10.1182/blood-2012-12-473413; Mercier FE, 2012, NAT REV IMMUNOL, V12, P49, DOI 10.1038/nri3132; Negaard HFS, 2009, LEUKEMIA, V23, P162, DOI 10.1038/leu.2008.255; Nombela-Arrieta C, 2013, NAT CELL BIOL, V15, P533, DOI 10.1038/ncb2730; Panteli K, 2005, ACTA HAEMATOL-BASEL, V114, P99, DOI 10.1159/000086583; Schmidt R, 2013, IEEE COMPUT GRAPH, V33, P26, DOI 10.1109/MCG.2013.90; Shapira L, 2008, VISUAL COMPUT, V24, P249, DOI 10.1007/s00371-007-0197-5; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Steiniger BS, 2013, CELLS TISSUES ORGANS, V198, P57, DOI 10.1159/000351608; Takaku T, 2010, BLOOD, V116, pE41, DOI 10.1182/blood-2010-02-268466; Taubin G., 1995, Computer Graphics Proceedings. SIGGRAPH 95, P351, DOI 10.1145/218380.218473; Tokoyoda K, 2010, NAT REV IMMUNOL, V10, P193, DOI 10.1038/nri2727; Tokoyoda K, 2009, IMMUNITY, V30, P721, DOI 10.1016/j.immuni.2009.03.015; Ulrich C., 2014, P 4 EUROGRAPHICS WOR, P69, DOI DOI 10.2312/VCBM.20141185; Willbold E, 2010, ACTA BIOMATER, V6, P4447, DOI 10.1016/j.actbio.2010.06.022; Yang R, 2003, Eur Cell Mater, V6, P57; Zehentmeier S, 2014, EUR J IMMUNOL, V44, P2306, DOI 10.1002/eji.201344313	43	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168173	10.1371/journal.pone.0168173	http://dx.doi.org/10.1371/journal.pone.0168173			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997569	gold, Green Published, Green Submitted			2022-12-26	WOS:000392842900024
J	Fontaine, V; Monteiro, E; Brazhnikova, E; Lesage, L; Balducci, C; Guibout, L; Feraille, L; Elena, PP; Sahel, JA; Veillet, S; Lafont, R				Fontaine, Valerie; Monteiro, Elodie; Brazhnikova, Elena; Lesage, Laetitia; Balducci, Christine; Guibout, Louis; Feraille, Laurence; Elena, Pierre-Paul; Sahel, Jose-Alain; Veillet, Stanislas; Lafont, Rene			Norbixin Protects Retinal Pigmented Epithelium Cells and Photoreceptors against A2E-Mediated Phototoxicity In Vitro and In Vivo	PLOS ONE			English	Article							SINGLET-OXYGEN GENERATION; LIGHT-INDUCED DAMAGE; PHASE-II ENZYMES; OXIDATIVE-STRESS; LIPOFUSCIN ACCUMULATION; ANIMAL-MODEL; MOUSE MODEL; RPE CELLS; A2E; DEGENERATION	The accumulation of N-retinylidene-N-retinylethanolamine (A2E, a toxic by-product of the visual pigment cycle) in the retinal pigment epithelium (RPE) is a major cause of visual impairment in the elderly. Photooxidation of A2E results in retinal pigment epithelium degeneration followed by that of associated photoreceptors. Present treatments rely on nutrient supplementation with antioxidants. 9'-cis-Norbixin (a natural diapocarotenoid, 97% purity) was prepared from Bixa orellana seeds. It was first evaluated in primary cultures of porcine retinal pigment epithelium cells challenged with A2E and illuminated with blue light, and it provided an improved photo-protection as compared with lutein or zeaxanthin. In Abca4(-/-) Rdh8(-/-) mice (a model of dry AMD), intravitreally-injected norbixin maintained the electroretinogram and protected photoreceptors against light damage. In a standard rat blue-light model of photodamage, norbixin was at least equally as active as phenyl-N-tert-butylnitrone, a free radical spin-trap. Chronic experiments performed with Abca4(-/-) Rdh8(-/-) mice treated orally for 3 months with norbixin showed a reduced A2E accumulation in the retina. Norbixin appears promising for developing an oral treatment of macular degeneration. A drug candidate (BIO201) with 9'-cis-norbixin as the active principle ingredient is under development, and its potential will be assessed in a forthcoming clinical trial.	[Fontaine, Valerie; Monteiro, Elodie; Brazhnikova, Elena; Lesage, Laetitia; Sahel, Jose-Alain] Sorbonne Univ, UPMC Univ Paris, INSERM, CNRS,Inst Vis, Paris, France; [Balducci, Christine; Guibout, Louis; Veillet, Stanislas; Lafont, Rene] Parc BIOCITECH, Biophytis, Romainville, France; [Feraille, Laurence; Elena, Pierre-Paul] IRIS Pharma, La Gaude, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Fontaine, V (corresponding author), Sorbonne Univ, UPMC Univ Paris, INSERM, CNRS,Inst Vis, 17 Rue Moreau, Paris, France.	valerie.fontaine@inserm.fr	Sahel, Jose-Alain/F-3172-2017; LAFONT, Rene/GYA-4891-2022	Sahel, Jose-Alain/0000-0002-4831-1153; LESAGE, LAETITIA/0000-0001-8592-2482	European FEDER grant [PRESAGE 41583]; City of Paris [2012 DDEEES 103G]; City of Paris; Biophytis; Iris Pharma; FEDER grant (Fonds Europeen pour le DEveloppement Regional)	European FEDER grant; City of Paris(Region Ile-de-France); City of Paris(Region Ile-de-France); Biophytis; Iris Pharma; FEDER grant (Fonds Europeen pour le DEveloppement Regional)	This manuscript results from a collaborative work between one public laboratory (Institut de la Vision) and two private companies (Biophytis and Iris Pharma). Financial support came from the private companies, a European FEDER grant (PRESAGE 41583) and a grant from the City of Paris (no 2012 DDEEES 103G). The experimental work was shared between the three organisations. Biophytis and Iris Pharma participated to the design and realization of the experiments. They declare, however, that their potential commercial interests had no impact on the scientific conduct of the study or the analysis/ interpretation of data. The grant providers (FEDER and City of Paris) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The City of Paris grant supported in particular the salaries of the three engineers (EM, EB, LL). PPE and LF are employees of Iris Pharma, while CB, LG, SV and RL are employees of Biophytis.; This work was supported by Biophytis and Iris Pharma. Part of this work was supported by a FEDER grant (Fonds Europeen pour le DEveloppement Regional) and the City of Paris (grant to the Institut de la Vision).	Anderson OA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067263; Arnault E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071398; Aronow ME, 2014, CURR OPIN OPHTHALMOL, V25, P186, DOI 10.1097/ICU.0000000000000046; Asai A, 2005, J AGR FOOD CHEM, V53, P7302, DOI 10.1021/jf0509355; Ben-Shabat S, 2002, J BIOL CHEM, V277, P7183, DOI 10.1074/jbc.M108981200; Bernstein PS, 2016, PROG RETIN EYE RES, V50, P34, DOI 10.1016/j.preteyeres.2015.10.003; Bhosale P, 2009, ARCH BIOCHEM BIOPHYS, V483, P175, DOI 10.1016/j.abb.2008.09.012; Bian QN, 2012, FREE RADICAL BIO MED, V53, P1298, DOI 10.1016/j.freeradbiomed.2012.06.024; Buschini E, 2015, CLIN OPHTHALMOL, V9, P563, DOI 10.2147/OPTH.S59724; Chen Y, 2012, ADVANCES IN OPHTHALM, P427; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; De S, 2002, J GEN PHYSIOL, V120, P147, DOI 10.1085/jgp.20028566; Dillon J, 2004, EXP EYE RES, V79, P537, DOI 10.1016/j.exer.2004.06.024; Dobri N, 2013, INVEST OPHTH VIS SCI, V54, P85, DOI 10.1167/iovs.12-10050; Dwyer MA, 2011, MOL ENDOCRINOL, V25, P360, DOI 10.1210/me.2010-0392; Eldred GE, 1995, GERONTOLOGY, V41, P15; Ferrington DA, 2016, PROG RETIN EYE RES, V51, P69, DOI 10.1016/j.preteyeres.2015.09.002; Finnemann SC, 2002, P NATL ACAD SCI USA, V99, P3842, DOI 10.1073/pnas.052025899; Forest DL, 2015, DIS MODEL MECH, V8, P421, DOI 10.1242/dmm.017236; Golczak M, 2005, P NATL ACAD SCI USA, V102, P8162, DOI 10.1073/pnas.0503318102; Goto T, 2012, J AGR FOOD CHEM, V60, P11952, DOI 10.1021/jf303639f; Guha S, 2014, ADV EXP MED BIOL, V801, P105, DOI 10.1007/978-1-4614-3209-8_14; Gutierrez DB, 2010, PHOTOCH PHOTOBIO SCI, V9, P1513, DOI 10.1039/c0pp00230e; Hagiwara A, 2003, FOOD CHEM TOXICOL, V41, P1157, DOI 10.1016/S0278-6915(03)00104-2; Hammer M, 2006, MOL VIS, V12, P1348; Hanneken A, 2006, INVEST OPHTH VIS SCI, V47, P3164, DOI 10.1167/iovs.04-1369; Hanus J, 2016, BRIT J OPHTHALMOL, V100, P122, DOI 10.1136/bjophthalmol-2015-306972; Herzlich AA, 2008, PPAR RES, V2008, DOI 10.1155/2008/389507; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103; Iriyama A, 2009, J CELL PHYSIOL, V220, P469, DOI 10.1002/jcp.21792; Jang YP, 2005, PHOTOCHEM PHOTOBIOL, V81, P529, DOI 10.1562/2004-12-14-RA-402.1; Julien S, 2012, NEUROBIOL AGING, V33, P2390, DOI 10.1016/j.neurobiolaging.2011.12.009; Justilien V, 2007, INVEST OPHTH VIS SCI, V48, P4407, DOI 10.1167/iovs.07-0432; Kam JH, 2015, EXP EYE RES, V135, P59, DOI 10.1016/j.exer.2015.03.023; Kanofsky JR, 2003, PHOTOCHEM PHOTOBIOL, V77, P235, DOI 10.1562/0031-8655(2003)077<0235:SOGFA>2.0.CO;2; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Kaufman Y, 2011, J BIOL CHEM, V286, P7958, DOI 10.1074/jbc.M110.178640; Kaulmann A, 2014, NUTR RES, V34, P907, DOI 10.1016/j.nutres.2014.07.010; Kijlstra A, 2012, PROG RETIN EYE RES, V31, P303, DOI 10.1016/j.preteyeres.2012.03.002; Kinnunen K, 2012, ACTA OPHTHALMOL, V90, P299, DOI 10.1111/j.1755-3768.2011.02179.x; Kroes R, 2004, WHO FOOD ADDITIVE SE, V52; Leonarduzzi G, 2010, PHARMACOL THERAPEUT, V128, P336, DOI 10.1016/j.pharmthera.2010.08.003; Levy LW, 1997, ANALYST, V122, P977, DOI 10.1039/a701304c; Li ZR, 2013, MOL VIS, V19, P1656; Liu J, 2008, INVEST OPHTH VIS SCI, V49, P772, DOI 10.1167/iovs.07-0675; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2012, NAT CHEM BIOL, V8, P170, DOI 10.1038/nchembio.759; Maiti P, 2006, BIOCHEMISTRY-US, V45, P852, DOI 10.1021/bi0518545; Malek G, 2014, CELL MOL LIFE SCI, V71, P4617, DOI 10.1007/s00018-014-1709-x; Mata NL, 2001, INVEST OPHTH VIS SCI, V42, P1685; Miyake S, 2014, BIOCHEM BIOPH RES CO, V446, P535, DOI 10.1016/j.bbrc.2014.02.135; Nociari MM, 2014, P NATL ACAD SCI USA, V111, pE1402, DOI 10.1073/pnas.1400530111; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Penn J, 2015, DIS MODEL MECH, V8, P131, DOI 10.1242/dmm.017194; Petrukhin Konstantin, 2013, Drug Discov Today Ther Strateg, V10, pe11; Pinazo-Duran MD, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/901686; Puntel A, 2015, BIOMATERIALS, V44, P103, DOI 10.1016/j.biomaterials.2014.12.019; Qin S, 2007, DRUG DEVELOP RES, V68, P213, DOI 10.1002/ddr.20185; Querques G, 2014, OPHTHALMIC RES, V52, P107, DOI 10.1159/000363187; Radu RA, 2005, INVEST OPHTH VIS SCI, V46, P4393, DOI 10.1167/iovs.05-0820; Radu RA, 2003, P NATL ACAD SCI USA, V100, P4742, DOI 10.1073/pnas.0737855100; Ramkumar HL, 2013, J NUTR, V143, P1129, DOI 10.3945/jn.112.169649; Ranchon I, 2001, INVEST OPHTH VIS SCI, V42, P1375; REMTULLA S, 1985, VISION RES, V25, P21, DOI 10.1016/0042-6989(85)90076-8; Rozanowska M, 1998, FREE RADICAL BIO MED, V24, P1107, DOI 10.1016/S0891-5849(97)00395-X; Santos AAA, 2002, FOOD CHEM, V77, P393, DOI 10.1016/S0308-8146(01)00363-6; Sawada O, 2014, EXP EYE RES, V123, P27, DOI 10.1016/j.exer.2014.04.003; Schutt F, 2000, INVEST OPHTH VIS SCI, V41, P2303; Scotter MJ, 1998, J AGR FOOD CHEM, V46, P1031, DOI 10.1021/jf970063+; Sparrow JR, 2014, ADV EXP MED BIOL, V801, P593, DOI 10.1007/978-1-4614-3209-8_75; Sparrow JR, 2003, VISION RES, V43, P2983, DOI 10.1016/S0042-6989(03)00475-9; Sparrow JR, 2003, J BIOL CHEM, V278, P18207, DOI 10.1074/jbc.M300457200; Sparrow JR, 2002, INVEST OPHTH VIS SCI, V43, P1222; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981; Stiles M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145305; Takahashi N, 2009, BIOCHEM BIOPH RES CO, V390, P1372, DOI 10.1016/j.bbrc.2009.10.162; Tao SS, 2015, FREE RADICAL BIO MED, V89, P690, DOI 10.1016/j.freeradbiomed.2015.08.028; Tokarz P, 2013, BIOGERONTOLOGY, V14, P461, DOI 10.1007/s10522-013-9463-2; Tomita H, 2005, INVEST OPHTH VIS SCI, V46, P427, DOI 10.1167/iovs.04-0946; Toops KA, 2015, MOL BIOL CELL, V26, P1, DOI 10.1091/mbc.E14-05-1028; Tsuruma K, 2012, MOL NUTR FOOD RES, V56, P713, DOI 10.1002/mnfr.201100607; Umigai N, 2011, PHYTOMEDICINE, V18, P575, DOI 10.1016/j.phymed.2010.10.019; Veillet S, 2015, United States patent, Patent No. [US 2012/149775, 2012149775]; Wang Z, 2006, PHOTOCHEM PHOTOBIOL, V82, P1251, DOI 10.1562/2006-04-01-RA-864; Washington I, 2016, ADV EXP MED BIOL, V854, P347, DOI 10.1007/978-3-319-17121-0_46; Wielgus AR, 2010, PHOTOCH PHOTOBIO SCI, V9, P1505, DOI 10.1039/c0pp00133c; Wu WQ, 2015, MOL NUTR FOOD RES, V59, P1663, DOI 10.1002/mnfr.201500109; Wu YL, 2011, J AM CHEM SOC, V133, P849, DOI 10.1021/ja107195u; Wu YL, 2010, P NATL ACAD SCI USA, V107, P7275, DOI 10.1073/pnas.0913112107; Yamauchi M, 2011, EUR J PHARMACOL, V650, P110, DOI 10.1016/j.ejphar.2010.09.081; Yoon KD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041309; Zampatti S, 2014, NUTR RES, V34, P95, DOI 10.1016/j.nutres.2013.10.011; Zhang J, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.330; Zhang JY, 2015, J CLIN INVEST, V125, P2781, DOI 10.1172/JCI80950; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103; Zhou JL, 2015, J BIOL CHEM, V290, P27215, DOI 10.1074/jbc.M115.680363; Zou X, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.190; 郭朋辉, 2009, [中草药, Chinese Traditional and Herbal Drugs], V40, P782	98	14	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0167793	10.1371/journal.pone.0167793	http://dx.doi.org/10.1371/journal.pone.0167793			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992460	Green Published, Green Submitted, gold			2022-12-26	WOS:000392758000017
J	Lanzoni, O; Fokin, SI; Lebedeva, N; Migunova, A; Petroni, G; Potekhin, A				Lanzoni, Olivia; Fokin, Sergei I.; Lebedeva, Natalia; Migunova, Alexandra; Petroni, Giulio; Potekhin, Alexey			Rare Freshwater Ciliate Paramecium chlorelligerum Kahl, 1935 and Its Macronuclear Symbiotic Bacterium "Candidatus Holospora parva"	PLOS ONE			English	Article							IN-SITU; SP-NOV; PHYLOGENETIC-RELATIONSHIPS; OLIGONUCLEOTIDE PROBES; CILIOPHORA; BURSARIA; ENDOSYMBIONTS; ELEGANS; GENUS; IDENTIFICATION	Ciliated protists often form symbioses with many diverse microorganisms. In particular, symbiotic associations between ciliates and green algae, as well as between ciliates and intracellular bacteria, are rather wide-spread in nature. In this study, we describe the complex symbiotic system between a very rare ciliate, Paramecium chlorelligerum, unicellular algae inhabiting its cytoplasm, and novel bacteria colonizing the host macronucleus. Paramecium chlorelligerum, previously found only twice in Germany, was retrieved from a novel location in vicinity of St. Petersburg in Russia. Species identification was based on both classical morphological methods and analysis of the small subunit rDNA. Numerous algae occupying the cytoplasm of this ciliate were identified with ultrastructural and molecular methods as representatives of the Meyerella genus, which before was not considered among symbiotic algae. In the same locality at least fifteen other species of "green" ciliates were found, thus it is indeed a biodiversity hot-spot for such protists. A novel species of bacterial symbionts living in the macronucleus of Paramecium chlorelligerum cells was morphologically and ultrastructurally investigated in detail with the description of its life cycle and infection capabilities. The new endosymbiont was molecularly characterized following the full-cycle rRNA approach. Furthermore, phylogenetic analysis confirmed that the novel bacterium is a member of Holospora genus branching basally but sharing all characteristics of the genus except inducing connecting piece formation during the infected host nucleus division. We propose the name "Candidatus Holospora parva" for this newly described species. The described complex system raises new questions on how these microorganisms evolve and interact in symbiosis.	[Lanzoni, Olivia; Fokin, Sergei I.; Petroni, Giulio; Potekhin, Alexey] Univ Pisa, Dept Biol, Pisa, Italy; [Fokin, Sergei I.] St Petersburg State Univ, Fac Biol, Dept Invertebrate Zool, St Petersburg, Russia; [Lebedeva, Natalia] St Petersburg State Univ, Ctr Core Facil Culture Collect Microorganisms, St Petersburg, Russia; [Migunova, Alexandra; Potekhin, Alexey] St Petersburg State Univ, Fac Biol, Dept Microbiol, St Petersburg, Russia	University of Pisa; Saint Petersburg State University; Saint Petersburg State University; Saint Petersburg State University	Potekhin, A (corresponding author), Univ Pisa, Dept Biol, Pisa, Italy.	giulio.petroni@unipi.it; alexey.potekhin@spbu.ru	Petroni, Giulio/B-6086-2008; Ale[andra, Migunova/G-1106-2015; Potekhin, Alexey A./K-3633-2013	Petroni, Giulio/0000-0001-9572-9897; Ale[andra, Migunova/0000-0001-6151-5719; Potekhin, Alexey A./0000-0003-4162-5923; Lanzoni, Olivia/0000-0002-3930-8462	European Commission FP7-PEOPLE-IRSES project CINAR PATHOBACTER [247658]; PRIN grant from Italian Research Ministry (MIUR) [2012A4F828 002]; St Petersburg RFBR mobility grant [16-34-50043]; Pisa mobility grant of St Petersburg State University [1.42.1450.2015]; RFBR [16-04-01195]; RSF [16-14-10157]; European Commission FP7 post grant Open Access Pilot Open AIRE	European Commission FP7-PEOPLE-IRSES project CINAR PATHOBACTER; PRIN grant from Italian Research Ministry (MIUR)(Ministry of Education, Universities and Research (MIUR)); St Petersburg RFBR mobility grant; Pisa mobility grant of St Petersburg State University; RFBR(Russian Foundation for Basic Research (RFBR)); RSF(Russian Science Foundation (RSF)); European Commission FP7 post grant Open Access Pilot Open AIRE	This work was supported by European Commission FP7-PEOPLE-2009-IRSES project CINAR PATHOBACTER (247658, cordis.europa.eu): mobility support to OL SF NL GP AP; PRIN grant (2012A4F828 002, prin.miur.it) from the Italian Research Ministry (MIUR) to GP for general research; work in St Petersburg 2016 RFBR mobility grant (16-34-50043, rffi.ru) to OL AP; work in Pisa 2015 mobility grant 1.42.1450.2015 of St Petersburg State University (spbu.ru) to AP; algae studies and infection experiments were supported by RFBR (grant 16-04-01195,rffi.ru) to AP; sequencing was done with a support from RSF (grant 16-14-10157, grant.rscf.ru) to AP. The publication costs were covered by European Commission FP7 post grant Open Access Pilot Open AIRE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN R, 1991, NATURE, V351, P161, DOI 10.1038/351161a0; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Andreoli I, 2009, ZOOL SCR, V38, P651, DOI 10.1111/j.1463-6409.2009.00395.x; Andreyeva V.M., 1998, SOIL AEROPHILIC GREE; Banerji A, 2015, J ANIM ECOL, V84, P723, DOI 10.1111/1365-2656.12317; BERNINGER UG, 1986, J PROTOZOOL, V33, P557, DOI 10.1111/j.1550-7408.1986.tb05662.x; BORCHSENIUS ON, 1983, TSITOLOGIYA+, V25, P91; Boscaro V, 2013, MICROB ECOL, V65, P255, DOI 10.1007/s00248-012-0110-2; Boscaro V, 2012, MOL PHYLOGENET EVOL, V65, P1004, DOI 10.1016/j.ympev.2012.09.001; Bykova SV., 2013, NEWS SAMARA SCI CTR, V15, P2224; Castelli M, 2016, CURR MICROBIOL, V72, P723, DOI 10.1007/s00284-016-1006-z; Castelli M, 2015, EUR J PROTISTOL, V51, P98, DOI 10.1016/j.ejop.2014.11.006; Chatton E, 1933, CR SOC BIOL, V114, P988; Cole JR, 2014, NUCL ACIDS RES; Coleman AW, 2005, J EUKARYOT MICROBIOL, V52, P68, DOI 10.1111/j.1550-7408.2005.3327r.x; CORLISS JO, 1953, STAIN TECHNOL, V28, P97, DOI 10.3109/10520295309105108; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dohra H, 2014, FEMS MICROBIOL LETT, V359, P16, DOI 10.1111/1574-6968.12577; Driscoll T, 2013, GENOME BIOL EVOL, V5, P621, DOI 10.1093/gbe/evt036; Duncan AB, 2015, ECOLOGY, V96, P284, DOI 10.1890/14-0137.1; Dusi E, 2015, EVOLUTION, V69, P1069, DOI 10.1111/evo.12638; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Esteban GF, 2010, PROTIST, V161, P621, DOI 10.1016/j.protis.2010.08.002; Fawley MW, 2005, PHYCOLOGIA, V44, P35, DOI 10.2216/0031-8884(2005)44[35:DAEOSC]2.0.CO;2; Ferla MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083383; Ferrantini F., 2007, J EUKARYOT MICROBIOL, V54, p75a; Finlay BJ, 1996, FEMS MICROBIOL ECOL, V20, P229; FOISSNER W, 1991, EUR J PROTISTOL, V27, P313, DOI 10.1016/S0932-4739(11)80248-8; FOKIN S, 1993, EUR J PROTISTOL, V29, P390, DOI 10.1016/S0932-4739(11)80401-3; Fokin S, 2006, ZOOL SCR, V35, P289, DOI 10.1111/j.1463-6409.2006.00231.x; FOKIN S, 1993, ARCH PROTISTENKD, V143, P319, DOI 10.1016/S0003-9365(11)80328-3; Fokin S., 1999, J EUKARYOT MICROBIOL, V46, P11; Fokin SI, 2012, EUR J PROTISTOL, V48, P138, DOI 10.1016/j.ejop.2011.12.001; Fokin Sergei I., 2011, Protistology, V6, P227; Fokin SI, 2009, MICROBIOL MONOGR, V12, P161, DOI 10.1007/978-3-540-92677-1_7; FOKIN SI, 1991, TSITOLOGIYA+, V33, P135; Fokin SI, 2004, EUR J PROTISTOL, V40, P225, DOI 10.1016/j.ejop.2004.02.001; Fokin SI, 1999, J EUKARYOT MICROBIOL, V46, P416, DOI 10.1111/j.1550-7408.1999.tb04622.x; Fokin SI., 1989, CYTOLOGY, V31, P839; Fokin SI., 1996, EUR J PROTISTOL S1, V3, P19, DOI DOI 10.1016/S0932-4739(96)80072-1; Fokin SI, 2015, 7 EUR C PROT SEV SPA; Fokin SI, 2004, INT REV CYTOL, P181; Fried J, 2007, J EUKARYOT MICROBIOL, V54, P381, DOI 10.1111/j.1550-7408.2007.00277.x; Fucikova K, 2014, PHYCOL RES, V62, P294, DOI 10.1111/pre.12062; Gelei J., 1925, Allattani Kozlemenyek Budapest, V22, P121; Georgiades K, 2011, PLOS ONE; Gillespie JJ, 2012, INTERCELLULAR PATHOGENS II: RICKETTSIALES, P84, DOI 10.1128/9781555817336.ch3; GORTZ HD, 1980, PROTISTOLOGICA, V16, P591; Greuter D, 2016, NUCL ACIDS RES; GROMOV BV, 1981, INT J SYST BACTERIOL, V31, P348, DOI 10.1099/00207713-31-3-348; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hess S, 2016, APPL ENVIRON MICROB, V82, P659, DOI 10.1128/AEM.02680-15; Holzinger A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00327; Hori M, 2008, J EUKARYOT MICROBIOL, V55, P515, DOI 10.1111/j.1550-7408.2008.00352.x; Hoshina R, 2006, ACTA PROTOZOOL, V45, P377; Hoshina R, 2016, PROTIST, V167, P174, DOI 10.1016/j.protis.2016.02.004; Kahl A., 1935, Dahl Die Tierwelt Deutschlands, V30, P651; KARAKASHIAN SJ, 1965, EVOLUTION, V19, P368, DOI 10.2307/2406447; Karpagam R, 2015, ENERG FUEL, V29, P143, DOI 10.1021/ef501969a; KAWAKAMI H, 1978, J PROTOZOOL, V25, P217, DOI 10.1111/j.1550-7408.1978.tb04399.x; Krenek S, 2015, ORG DIVERS EVOL, V15, P215, DOI 10.1007/s13127-015-0207-9; Kreutz Martin, 2006, Protozoological Monographs, V3, P1; Kreutz M, 2012, J EUKARYOT MICROBIOL, V59, P548, DOI 10.1111/j.1550-7408.2012.00638.x; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Millot L, 2006, CRYOBIOLOGY, V52, P161, DOI 10.1016/j.cryobiol.2005.10.014; Montagna M, 2013, APPL ENVIRON MICROB, V79, P3241, DOI 10.1128/AEM.03971-12; Muller O. F., 1786, ANIMACULA INFUSORIA; Neustupa J, 2013, INT J SYST EVOL MICR, V63, P377, DOI 10.1099/ijs.0.047944-0; NICHOLS HW, 1965, J PHYCOL, V1, P34, DOI 10.1111/j.1529-8817.1965.tb04552.x; OSSIPOV DV, 1980, CYTOLOGY, V22, P922; Petroni G, 2003, MICROBIAL ECOL, V45, P156, DOI 10.1007/s00248-002-2016-x; Petroni G, 2002, MOL PHYLOGENET EVOL, V22, P118, DOI 10.1006/mpev.2001.1030; Pitsch G, 2016, J EUKARYOTIC MICROBI; PREER JR, 1982, INT J SYST BACTERIOL, V32, P140, DOI 10.1099/00207713-32-1-140; PREER LB, 1969, J PROTOZOOL, V16, P570, DOI 10.1111/j.1550-7408.1969.tb02315.x; Proschold T, 2011, ENVIRON MICROBIOL, V13, P350, DOI 10.1111/j.1462-2920.2010.02333.x; Quast C., 2013, NUCL ACIDS RES; Rautian MS, 2013, INT J SYST EVOL MICR, V63, P1930, DOI 10.1099/ijs.0.046631-0; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosati G, 2004, J EUKARYOT MICROBIOL, V51, P49, DOI 10.1111/j.1550-7408.2004.tb00160.x; Schulz F, 2015, ENV MICROBIOLOGY; Serra V, 2016, FRONTIERS MICROBIOLO; Shi XB, 1997, J EUKARYOT MICROBIOL, V44, P134, DOI 10.1111/j.1550-7408.1997.tb05950.x; SKOVORODKIN IN, 1990, TSITOLOGIYA+, V32, P301; Struder-Kypke MC, 2000, MOL PHYLOGENET EVOL, V14, P122, DOI 10.1006/mpev.1999.0686; Struder-Kypke MC, 2010, SYST BIODIVERS, V8, P131, DOI 10.1080/14772000903507744; Summerer M, 2008, J PHYCOL, V44, P77, DOI 10.1111/j.1529-8817.2007.00455.x; Szokoli F, 2016, APPL ENV MICROBIOLOG; Szokoli F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145743; Vakkerov-Kouzova ND, 2011, MICROBIOLOGY+, V80, P728, DOI 10.1134/S0026261711050171; VANETTEN JL, 1982, P NATL ACAD SCI-BIOL, V79, P3867; Vannini C, 2004, INT J SYST EVOL MICR, V54, P1151, DOI 10.1099/ijs.0.02759-0; Vuxanovici A, 1960, STUDII CERC BIOL BIO, V12, P353; Wichterman R, 1953, BIOL PARAMECIUM; Wichterman R., 1986, BIOL PARAMECIUM, V2nd ed., DOI DOI 10.1007/978-1-4757-0372-6; WIEMANN M, 1989, EUR J PROTISTOL, V25, P100, DOI 10.1016/S0932-4739(89)80021-5; Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330; Yashchenko VV, 2012, EUR J PROTISTOL, V48, P149, DOI 10.1016/j.ejop.2011.05.002; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	102	27	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0167928	10.1371/journal.pone.0167928	http://dx.doi.org/10.1371/journal.pone.0167928			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992463	Green Published, gold			2022-12-26	WOS:000392758000018
J	Buendia-Roldan, I; Ruiz, V; Sierra, P; Montes, E; Ramirez, R; Vega, A; Salgado, A; Vargas, MH; Mejia, M; Pardo, A; Selman, M				Buendia-Roldan, Ivette; Ruiz, Victor; Sierra, Patricia; Montes, Eduardo; Ramirez, Remedios; Vega, Anita; Salgado, Alfonso; Vargas, Mario H.; Mejia, Mayra; Pardo, Annie; Selman, Moises			Increased Expression of CC16 in Patients with Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							CELL SECRETORY PROTEIN; CHRONIC HYPERSENSITIVITY PNEUMONITIS; CLASSIFICATION CRITERIA; INTERSTITIAL PNEUMONIA; AMERICAN-COLLEGE; SERUM-LEVELS; COHORT; CLARA; BIOMARKERS; DIAGNOSIS	Idiopathic pulmonary fibrosis (IPF) is a devastating disease of unknown etiology. The pathogenic mechanisms are unclear, but evidence indicates that aberrantly activated alveolar epithelial cells secrete a variety of mediators which induce the migration, proliferation and activation of fibroblasts and finally the excessive accumulation of extracellular matrix with the consequent destruction of the lung parenchyma. CC16 (approved symbol SCGB1A1), a putative anti-inflammatory protein produced by "club" cells in the distal airways, has not been evaluated in IPF lungs. In this study, we determined the serum and bronchoalveolar lavage (BAL) levels as well as the lung cell localization of this protein. Also, we explored the usefulness of serum levels of CC16 for the differential diagnosis of IPF (n = 85), compared with non-IPF interstitial lung diseases [chronic hypersensitivity pneumonitis (cHP; n = 85) and connective tissue diseases (CTD-ILD; n = 85)]. CC16 was significantly increased in serum and BAL fluids of IPF patients and was found not only in club cells but also in alveolar epithelial cells. When compared with non-IPF patients and controls, serum levels were significantly increased (p< 0.0001). Sensitivity and specificity for CC16 (cut-off 41ng/mL) were 24% and 90%, positive predictive value 56% and negative predictive value 69%. These findings demonstrate that CC16 is upregulated in IPF patients suggesting that may participate in its pathogenesis. Although higher than the serum levels of non-IPF patients it shows modest sensitivity to be useful as a potential biomarker for the differential diagnosis.	[Buendia-Roldan, Ivette; Ruiz, Victor; Sierra, Patricia; Montes, Eduardo; Vega, Anita; Salgado, Alfonso; Vargas, Mario H.; Mejia, Mayra; Selman, Moises] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Mexico City, DF, Mexico; [Ramirez, Remedios; Pardo, Annie] Univ Nacl Autonoma Mexico, Fac Ciencias, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico	Selman, M (corresponding author), Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Mexico City, DF, Mexico.	mselmanl@yahoo.com.mx	Ruiz, Victor/DSX-5036-2022; Vargas, Mario H./ABC-8393-2020	Vargas, Mario H./0000-0002-8420-980X; Salgado, Alfonso/0000-0001-8102-3690; Ruiz, Victor/0000-0003-0440-2093; Buendia, Ivette/0000-0002-8230-0749	CONACYT [SALUD-2011-1-162010]; National Institute of Respiratory Diseases, Mexico	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institute of Respiratory Diseases, Mexico	This study was supported by CONACYT SALUD-2011-1-162010 and by the National Institute of Respiratory Diseases, Mexico. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Akram KM, 2013, EUR RESPIR J, V41, P683, DOI 10.1183/09031936.00213411; Gioldassi XM, 2004, J PHARMACEUT BIOMED, V34, P823, DOI 10.1016/S0731-7085(03)00570-3; Guerra S, 2015, LANCET RESP MED, V3, P613, DOI 10.1016/S2213-2600(15)00196-4; Guerra S, 2013, LANCET RESP MED, V1, P779, DOI 10.1016/S2213-2600(13)70220-0; Hambly N, 2015, RESPIROLOGY, V20, P1010, DOI 10.1111/resp.12569; Hasegawa M, 2011, J RHEUMATOL, V38, P877, DOI 10.3899/jrheum.100591; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Kokuho N, 2015, COPD, V12, P347, DOI 10.3109/15412555.2014.948994; Laucho-Contreras ME, 2015, EUR RESPIR J, V45, P1544, DOI 10.1183/09031936.00134214; Ley B, 2014, AM J PHYSIOL-LUNG C, V307, pL681, DOI 10.1152/ajplung.00014.2014; Morell F, 2013, LANCET RESP MED, V1, P685, DOI 10.1016/S2213-2600(13)70191-7; Neogi T, 2010, ARTHRITIS RHEUM-US, V62, P2582, DOI 10.1002/art.27580; Ohno Y, 2015, CURR RHEUMATOL REP, V17, DOI 10.1007/s11926-015-0546-8; Oikonomou A, 2013, INSIGHTS IMAGING, V4, P9, DOI 10.1007/s13244-012-0207-7; Olewicz-Gawlik A, 2016, REV BRAS REUMATOL, V56, P309, DOI [10.1016/j.rbre.2015.07.005, 10.1016/j.rbr.2015.04.001]; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Park JH, 2007, AM J RESP CRIT CARE, V175, P705, DOI 10.1164/rccm.200607-912OC; Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Robin M, 2002, EUR RESPIR J, V20, P1152, DOI 10.1183/09031936.02.02042001; Selman M, 2006, AM J RESP CRIT CARE, V173, P188, DOI 10.1164/rccm.200504-644OC; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Selman M, 2014, AM J RESP CRIT CARE, V189, P1161, DOI 10.1164/rccm.201312-2221PP; Selman M, 2012, AM J RESP CRIT CARE, V186, P314, DOI 10.1164/rccm.201203-0513CI; Shiboski SC, 2012, ARTHRIT CARE RES, V64, P475, DOI 10.1002/acr.21591; Takemura T, 2012, HISTOPATHOLOGY, V61, P1026, DOI 10.1111/j.1365-2559.2012.04322.x; White ES, 2016, AM J RESPIR CRIT CAR	29	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168552	10.1371/journal.pone.0168552	http://dx.doi.org/10.1371/journal.pone.0168552			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977812	Green Submitted, gold, Green Published			2022-12-26	WOS:000391217400116
J	Gao, XY; Zhao, YX; Su, YS; Liu, K; Yu, XC; Cui, CX; Yang, ZK; Shi, H; Jing, XH; Zhu, B				Gao, Xinyan; Zhao, Yuxue; Su, Yangshuai; Liu, Kun; Yu, Xiaochun; Cui, Changxiang; Yang, Zhaokun; Shi, Hong; Jing, Xianghong; Zhu, Bing			beta(1/2) or M-2/3 Receptors Are Required for Different Gastrointestinal Motility Responses Induced by Acupuncture at Heterotopic or Homotopic Acupoints	PLOS ONE			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTORS; GASTRIC-ACID-SECRETION; SMOOTH-MUSCLE; ELECTRICAL-STIMULATION; NEURAL MECHANISM; URINARY-BLADDER; M-3; CONTRACTIONS; ANTAGONISTS; SUBTYPES	Acupuncture at homotopic acupoints or heterotopic acupoints is known to either inhibit or facilitate gastrointestinal motility, depending on the acupoint location. However, little effort has been made to investigate the roles of specific receptors (such as adrenergic and muscarinic acetylcholine receptors) in mediating the effects of acupuncture at heterotopic and homotopic acupoints. Different adrenergic receptor subtypes or cholinergic receptor subtypes are predominantly expressed in various sections of the gut, resulting in variations between the effects of acupuncture at heterotopic or homotopic acupoints on gastrointestinal motility. Here, we investigated the role of beta(1)/beta(2) receptors and M-2/M-3 receptors in gastrointestinal motility regulated by acupuncture at ST37, a heterotopic acupoint, and ST25, a homotopic acupoint, by simultaneously recording intraluminal pressures in the distal colon and stomach or jejunum and examining fecal phenol red excretion in beta(1/2) receptor-knockout mice and M-2/3 receptor-knockout mice. We found that knockout of the M-2/3 receptor significantly inhibited ST37 acupuncture-induced enhancement of gastric motility, jejunal motility, and colonic motility. Additionally, knocking out of the beta(1/2) receptor significantly diminished the ST25 acupuncture-induced inhibition of gastric motility and jejunal motility without significantly altering the enhancement of colonic motility induced by acupuncture at ST25. Acupuncture at ST37 significantly accelerated gastrointestinal transition in beta(1/2) receptorknockout mice and their wild-type littermates. However, this acceleration of gastrointestinal transition was markedly diminished in M-2/3 receptor-knockout mice relative to their wild-type littermates. Acupuncture at ST25 significantly increased gastrointestinal transition in beta(1/2) receptor-knockout mice and significantly decreased gastrointestinal transition in M-2/3 receptor- knockout mice without altering gastrointestinal transition in wild-type littermates of either. Our study revealed that M-2/3 receptors are required for the gastrointestinal motility associated with whole gastrointestinal transition enhanced by acupuncture at heterotopic acupoints, whereas beta(1/2) receptors are required for the same gastrointestinal motility processes inhibited by acupuncture at homotopic acupoints. Therefore, our findings reveal important biological mechanisms underlying acupuncture treatment of disorders involving gastrointestinal motility dysfunction.	[Gao, Xinyan; Zhao, Yuxue; Su, Yangshuai; Liu, Kun; Yu, Xiaochun; Cui, Changxiang; Yang, Zhaokun; Shi, Hong; Jing, Xianghong; Zhu, Bing] China Acad Chinese Med Sci, Inst Acupuncture & Moxibust, Beijing, Peoples R China; [Cui, Changxiang] Peoples Hosp Ri Zhao, Rizhao, Peoples R China	China Academy of Chinese Medical Sciences; Institute of Acupuncture & Moxibustion, CACMS	Jing, XH; Zhu, B (corresponding author), China Acad Chinese Med Sci, Inst Acupuncture & Moxibust, Beijing, Peoples R China.	jxhtjb@263.net; zhubing@mail.cintcm.ac.cn	Gao, Xinyan/HHN-8438-2022; Jing, Xianghong/HHS-4003-2022	Liu, Kun/0000-0002-1388-3514	National Basic Research Program of China [2011CB505201, 2014CB543103]; National Natural Science Foundation of China [81173345, 81130063]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China granted to BZ (No.2011CB505201) and to XG (No. 2014CB543103), and by National Natural Science Foundation of China granted to XG (No. 81173345) and to BZ (No. 81130063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSSON H, 1983, DIGEST DIS SCI, V28, P590, DOI 10.1007/BF01299918; AHLUWALIA NK, 1994, GUT, V35, P1356, DOI 10.1136/gut.35.10.1356; Ahluwalia NK, 1993, J GASTROINTEST MOTIL, V5, P177; Aihara T, 2005, AM J PHYSIOL-GASTR L, V288, pG1199, DOI 10.1152/ajpgi.00514.2004; Broccardo A, 2005, PEPTIDES, V26, P1590, DOI 10.1016/j.peptides.2005.02.018; Caulfield MP, 1998, PHARMACOL REV, V50, P279; Chang CS, 2001, DIGESTION, V64, P184, DOI 10.1159/000048860; Chiba T, 2002, NEUROGASTROENT MOTIL, V14, P535, DOI 10.1046/j.1365-2982.2002.00357.x; DePonti F, 1996, PHARMACOL THERAPEUT, V69, P59, DOI 10.1016/0163-7258(95)02031-4; Eglen RM, 1996, PHARMACOL REV, V48, P531; Ehlert FJ, 2003, LIFE SCI, V74, P355, DOI 10.1016/j.lfs.2003.09.023; Ehlert FJ, 1997, LIFE SCI, V61, P1729, DOI 10.1016/S0024-3205(97)00433-5; Ehlert FJ, 1997, MUSCARINIC RECEPTOR, P87; Ehlert Frederick J, 2012, Handb Exp Pharmacol, P343, DOI 10.1007/978-3-642-23274-9_15; Gao X, 2015, NEUROGASTROENT MOTIL, V27, P1817, DOI 10.1111/nmo.12694; Goyal RK, 1996, NEW ENGL J MED, V334, P1106, DOI 10.1056/NEJM199604253341707; HEDGES A, 1969, BRIT J PHARMACOL, V37, pP547; Hutchinson DS, 2001, BRIT J PHARMACOL, V132, P433, DOI 10.1038/sj.bjp.0703828; Kaan SK, 1996, EUR J PHARMACOL, V317, P115, DOI 10.1016/S0014-2999(96)00705-4; KOIZUMI K, 1980, BRAIN RES, V182, P85, DOI 10.1016/0006-8993(80)90832-X; Li YQ, 2007, WORLD J GASTROENTERO, V13, P709, DOI 10.3748/wjg.v13.i5.709; Li YQ, 2006, WORLD J GASTROENTERO, V12, P7642, DOI 10.3748/wjg.v12.i47.7642; LI YY, 1992, AM J GASTROENTEROL, V87, P1372; Lin XM, 1997, AM J GASTROENTEROL, V92, P1527; Lomasney KW, 2014, AM J PHYSIOL-GASTR L, V307, pG241, DOI 10.1152/ajpgi.00401.2013; Luo D, 2008, DIGEST DIS SCI, V53, P689, DOI 10.1007/s10620-007-9929-7; LUX G, 1994, GUT, V35, P1026, DOI 10.1136/gut.35.8.1026; Matsui M, 2000, P NATL ACAD SCI USA, V97, P9579, DOI 10.1073/pnas.97.17.9579; Matsui M, 2002, J NEUROSCI, V22, P10627; MCINTYRE AS, 1992, ALIMENT PHARM THERAP, V6, P125; Mule F, 2010, J PHYSIOL SCI, V60, P75, DOI 10.1007/s12576-009-0060-8; Ouyang H, 2004, ALIMENT PHARM THER, V20, P831, DOI 10.1111/j.1365-2036.2004.02196.x; Qin QG, 2014, WORLD J GASTROENTERO, V20, P18271, DOI 10.3748/wjg.v20.i48.18271; SATO A, 1993, NEUROSCI RES, V18, P53, DOI 10.1016/0168-0102(93)90105-Y; SATO A, 1992, J MANIP PHYSIOL THER, V15, P57; Stengel PW, 2003, J PHARMACOL EXP THER, V304, P675, DOI 10.1124/jpet.102.042283; Stengel PW, 2002, AM J PHYSIOL-REG I, V282, pR1443, DOI 10.1152/ajpregu.00486.2001; Stengel PW, 2000, J PHARMACOL EXP THER, V292, P877; Tache Y, 2002, HDB AUTONOMIC NERVOU, P474; Tada H, 2003, DIGEST DIS SCI, V48, P59, DOI 10.1023/A:1021730314068; Takahashi T, 2011, NEUROMODULATION, V14, P8, DOI 10.1111/j.1525-1403.2010.00295.x; Takahashi T, 2006, J GASTROENTEROL, V41, P408, DOI 10.1007/s00535-006-1773-6; Tobin G, 1995, J AUTON PHARMACOL, V15, P451, DOI 10.1111/j.1474-8673.1995.tb00410.x; Unno T, 2005, BRIT J PHARMACOL, V146, P98, DOI 10.1038/sj.bjp.0706300; Unno T, 2006, BRIT J PHARMACOL, V149, P1022, DOI 10.1038/sj.bjp.0706955; Wallis RM, 1999, LIFE SCI, V64, P395, DOI 10.1016/S0024-3205(98)00585-2; Wess J, 1996, CRIT REV NEUROBIOL, V10, P69, DOI 10.1615/CritRevNeurobiol.v10.i1.40; Yang B, 2015, MOL MED REP, V11, P2735, DOI 10.3892/mmr.2014.3039; Yin JY, 2010, AUTON NEUROSCI-BASIC, V157, P31, DOI 10.1016/j.autneu.2010.03.007; Yoshimoto S, 2012, DIGEST DIS SCI, V57, P1213, DOI 10.1007/s10620-012-2040-8; Yu O, 1997, DIGEST DIS SCI, V42, P1146, DOI 10.1023/A:1018877318101; Zhao YX, 2015, J TRADIT CHIN MED, V35, P227, DOI 10.1016/S0254-6272(15)30033-9	52	12	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168200	10.1371/journal.pone.0168200	http://dx.doi.org/10.1371/journal.pone.0168200			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27978539	Green Published, Green Submitted, gold			2022-12-26	WOS:000391217400075
